FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Wang, W
   Sun, Y
   Lin, Y
   Xu, XB
   Zhao, DD
   Ji, KQ
   Li, W
   Zhao, YY
   Yan, CZ
AF Wang, Wei
   Sun, Yuan
   Lin, Yan
   Xu, Xuebi
   Zhao, Dandan
   Ji, Kunqian
   Li, Wei
   Zhao, Yuying
   Yan, Chuanzhu
TI A novel nonsense variant in <i>MT</i>-<i>CO3</i> causes MELAS syndrome
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE MELAS; MT-COX3; m.9553G>A; Cytochrome c oxidase; Heteroplasmy
ID CYTOCHROME-C-OXIDASE; MITOCHONDRIAL MYOPATHY; FRAMESHIFT MUTATION;
   MISSENSE MUTATION; I GENE; DEFICIENCY; MTDNA; FAMILY; MICRODELETION;
   PATIENT
AB Both mitochondrial and nuclear gene mutations can cause cytochrome c oxidase (COX, complex.) dysfunction, leading to mitochondrial diseases. Although numerous diseases caused by defects of the COX subunits or COX assembly factors have been documented, clinical cases directly related to mitochondrial cytochrome c oxidase subunit 3 gene (MT-CO3) mutations are relatively rare. Here, we report a 47-year-old female patient presented with mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome. Muscle pathology revealed ragged-red fibres and remarkable COX-deficient muscle fibres. Muscle mitochondrial DNA sequencing analysis identified a novel MT-CO3 variant (m.9553G>A) that changed a highly conserved amino acid to a stop codon (p.Trp116*). This variant was heteroplasmic in multiple tissues, where the mutation load was 13% in oral epithelial cells, 89% in muscle samples, and not detectable in the peripheral blood lymphocytes. Single muscle fiber PCR analysis showed clear segregation of the mutation load with COX deficient fibres. Western blot analysis of the muscle samples revealed a significant decrease in the levels of COX1, COX2, COX3, COX4 and UQCRC2. COX respiration activity was remarkably reduced (58.84%) relative to the controls according to spectrophotometric assays. Taken together, our results indicated that this m.9553G>A variant may be responsible for the MELAS symdrome in the proband by affecting the stability and function of COX. The study expands the clinical and molecular spectrum of COX3-specific mitochondrial diseases. (C) 2021 Elsevier B.V. All rights reserved.
C1 [Wang, Wei; Lin, Yan; Zhao, Dandan; Ji, Kunqian; Li, Wei; Zhao, Yuying; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Res Inst Neuromuscular & Neurodegenerat Dis, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
   [Wang, Wei; Lin, Yan; Zhao, Dandan; Ji, Kunqian; Li, Wei; Zhao, Yuying; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
   [Sun, Yuan; Yan, Chuanzhu] Shandong Univ, Qilu Hosp Qingdao, Dept Neurol, Cheeloo Coll Med, Qingdao 266035, Shandong, Peoples R China.
   [Xu, Xuebi] Wenzhou Med Univ, Dept Neurol, Affiliated Hosp 1, Nanbaixiang St, Wenzhou 325000, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Qilu Hosp Qingdao, Mitochondrial Med Lab, Qingdao 266035, Shandong, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Brain Sci Res Inst, Jinan 250000, Shandong, Peoples R China.
C3 Shandong University; Shandong University; Shandong University; Wenzhou
   Medical University; Shandong University; Shandong University
RP Ji, KQ; Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Res Inst Neuromuscular & Neurodegenerat Dis, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.; Ji, KQ; Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp Qingdao, Dept Neurol, Cheeloo Coll Med, Qingdao 266035, Shandong, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp Qingdao, Mitochondrial Med Lab, Qingdao 266035, Shandong, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Brain Sci Res Inst, Jinan 250000, Shandong, Peoples R China.
EM jikunqian@qq.com; czyan@sdu.edu.cn
RI zhao, dandan/AAP-3407-2021; Wang, Yuanzhuo/A-9114-2012
OI Wang, Wei/0000-0001-7585-384X; Lin, Yan/0000-0003-0282-6749
FU National Natural Science Foundation of China [81701237, 81671235];
   People's benefit project of science and technology in Qingdao
   [16-6-2-1-nsh]; Taishan Scholars Program of Shandong Province; projects
   of collaborative innovation and achievement transformation in
   universities and research institutes of Jinan [2019GXRC050]
FX This study was supported by the National Natural Science Foundation of
   China (No.81701237 and 81671235) , People's benefit project of science
   and technology in Qingdao (16621nsh) and the Taishan Scholars Program of
   Shandong Province, the projects of collaborative innovation and
   achievement transformation in universities and research institutes of
   Jinan (2019GXRC050) .
CR Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Bortot B, 2009, MITOCHONDRION, V9, P123, DOI 10.1016/j.mito.2009.01.006
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Campos Y, 2001, ANN NEUROL, V50, P409, DOI 10.1002/ana.1141
   Choi BO, 2008, EXP MOL MED, V40, P354, DOI 10.3858/emm.2008.40.3.354
   Cogliati S, 2016, NATURE, V539, P579, DOI 10.1038/nature20157
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Debray FG, 2014, MITOCHONDRION, V17, P101, DOI 10.1016/j.mito.2014.06.003
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910
   Horváth R, 2005, NEUROMUSCULAR DISORD, V15, P851, DOI 10.1016/j.nmd.2005.09.005
   Horváth R, 2002, J MED GENET, V39, P812, DOI 10.1136/jmg.39.11.812
   Kadenbach B, 2015, MITOCHONDRION, V24, P64, DOI 10.1016/j.mito.2015.07.002
   Karadimas CL, 2000, NEUROLOGY, V55, P644, DOI 10.1212/WNL.55.5.644
   Keightley JA, 1996, NAT GENET, V12, P410, DOI 10.1038/ng0496-410
   Kollberg G, 2005, J NEUROPATH EXP NEUR, V64, P123, DOI 10.1093/jnen/64.2.123
   Kytövuori L, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0883-5
   Liu Ching-Hsiung, 2011, Acta Neurol Taiwan, V20, P53
   Lobo-Jarne T, 2018, SEMIN CELL DEV BIOL, V76, P179, DOI 10.1016/j.semcdb.2017.07.021
   Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44
   MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O
   Marotta R, 2011, J CLIN NEUROSCI, V18, P290, DOI 10.1016/j.jocn.2010.06.001
   Meola G, 2012, J NEUROL, V259, P601, DOI 10.1007/s00415-011-6193-8
   Mkaouar-Rebai E, 2014, MITOCHONDR DNA, V25, P394, DOI 10.3109/19401736.2013.803086
   Mkaouar-Rebai E, 2011, J CHILD NEUROL, V26, P12, DOI 10.1177/0883073810371227
   Murgia M, 2015, EMBO REP, V16, P387, DOI 10.15252/embr.201439757
   Pérez-Pérez R, 2016, CELL REP, V16, P2387, DOI 10.1016/j.celrep.2016.07.081
   Poole OV, 2019, MITOCHONDRION, V47, P294, DOI 10.1016/j.mito.2019.02.004
   Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590
   Rak M, 2016, CLIN SCI, V130, P393, DOI 10.1042/CS20150707
   Roos S, 2019, EUR J HUM GENET, V27, P331, DOI 10.1038/s41431-018-0286-0
   Rossmanith W, 2008, J MED GENET, V45, P117, DOI 10.1136/jmg.2007.052076
   Seneca S, 2015, EUR J HUM GENET, V23, P41, DOI 10.1038/ejhg.2014.49
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Tabebi M, 2015, BIOCHEM BIOPH RES CO, V459, P353, DOI 10.1016/j.bbrc.2015.01.151
   Timón-Gómez A, 2018, SEMIN CELL DEV BIOL, V76, P163, DOI 10.1016/j.semcdb.2017.08.055
   Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733
   Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001
   Wong LJC, 2001, AM J MED GENET, V102, P95, DOI 10.1002/1096-8628(20010722)102:1<95::AID-AJMG1412>3.0.CO;2-U
NR 40
TC 7
Z9 8
U1 1
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JUN
PY 2021
VL 31
IS 6
BP 558
EP 565
DI 10.1016/j.nmd.2021.02.020
EA JUN 2021
PG 8
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA SU3LB
UT WOS:000663041300012
PM 33863631
DA 2024-11-01
ER

PT J
AU Gonzalez-Chapa, JA
   Macêdo, MB
   Lood, C
AF Gonzalez-Chapa, Jorge Armando
   Macedo, Marina Barguil
   Lood, Christian
TI The Emerging Role of Mitochondrial Dysfunction in the Pathogenesis of
   Idiopathic Inflammatory Myopathies
SO RAMBAM MAIMONIDES MEDICAL JOURNAL
LA English
DT Review
DE Dermatomyositis; inclusion body myositis; mitochondria; muscular
   diseases
ID AMYLOID PRECURSOR PROTEIN; INCLUSION-BODY MYOSITIS; HUMAN
   SKELETAL-MUSCLE; ANTIMITOCHONDRIAL ANTIBODIES; DNA DELETIONS;
   OXIDATIVE-PHOSPHORYLATION; SEQUENCE POLYMORPHISMS; DIAGNOSTIC-VALUE;
   ANIMAL-MODELS; LOOP REGION
AB Increasing evidence points towards mitochondria as crucial players in the initiation and progression of auto-immune and degenerative disorders, to which impaired cell metabolism is but a facet of the subjacent etiopathogenesis. This review aims to introduce the reader to essential concepts of mitochondrial abnor-malities in idiopathic inflammatory myopathy (IIM), underscoring inclusion-body myositis and dermato-myositis. Far surpassing the initial simplistic view of being responsible for energy generation, mitochondria have gathered attention regarding their role in inflammatory processes, being able to fuel autoimmunity, as shown by the presence of anti-mitochondrial antibodies (AMAs) in up to 10% of IIM patients. As cellular respiration takes place, mitochondrial metabolites might help to shape the pro-inflammatory milieu in affected muscle, beyond generating reactive oxygen species, which are well-recognized inducers of damage -associated molecular patterns. A series of mitochondrial components might facilitate the sterile activation of pro-inflammatory cells and the production of several cytokines responsible for enhancing auto-immune responses. Marked variation in the mitochondrial genome has also been reported in IIM patients. As such, we summarize key historical and recent advances linking aberrations and instabilities of mitochondrial DNA to impaired muscle function. Besides discussing mitochondrial dysfunction as an essential part of IIM development, we also highlight possible associations between presence of AMAs and a particular phenotype of IIM, with its own characteristic clinical and radiological pattern. Finally, we present promising treatment approaches targeting mitochondria, while briefly discussing experimental models for gaining deeper insight into the disease process, and ultimately leading to novel drug development.
C1 [Gonzalez-Chapa, Jorge Armando; Macedo, Marina Barguil; Lood, Christian] Univ Washington, Div Rheumatol, Seattle, WA 98195 USA.
C3 University of Washington; University of Washington Seattle
RP Lood, C (corresponding author), Univ Washington, Div Rheumatol, Seattle, WA 98195 USA.
EM Loodc@uw.edu
RI Lood, Christian/H-5670-2019; Macêdo, Marina/AID-8278-2022; Chapa,
   Jorge/KVY-8166-2024
OI Macedo, Marina Barguil/0000-0002-8927-5566; Gonzalez Chapa, Jorge
   Armando/0000-0001-5231-2469
CR Afzali AM, 2017, AUTOIMMUN REV, V16, P478, DOI 10.1016/j.autrev.2017.03.001
   Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4
   Akhtar M, 2021, BIOLOGY-BASEL, V10, DOI 10.3390/biology10060501
   Albayda J, 2018, SEMIN ARTHRITIS RHEU, V47, P552, DOI 10.1016/j.semarthrit.2017.06.004
   Alhatou MI, 2004, J MOL HISTOL, V35, P615
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Askanas V, 1996, P NATL ACAD SCI USA, V93, P1314, DOI 10.1073/pnas.93.3.1314
   Askanas V, 1998, ARCH NEUROL-CHICAGO, V55, P915, DOI 10.1001/archneur.55.7.915
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Barbieri Elena, 2012, J Signal Transduct, V2012, P982794, DOI 10.1155/2012/982794
   Becker YLC, 2022, NAT REV RHEUMATOL, V18, P621, DOI 10.1038/s41584-022-00834-z
   Betteridge Z, 2019, J AUTOIMMUN, V101, P48, DOI 10.1016/j.jaut.2019.04.001
   Boncompagni S, 2012, J BIOL CHEM, V287, P20534, DOI 10.1074/jbc.M112.359588
   BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405
   Brunn A, 2012, J NEUROPATH EXP NEUR, V71, P855, DOI 10.1097/NEN.0b013e31826bf7f3
   Bujo S, 2019, CAN J CARDIOL, V35, DOI 10.1016/j.cjca.2019.07.002
   Buzkova J, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809091
   Catalán-García M, 2016, CLIN SCI, V130, P1741, DOI 10.1042/CS20160080
   Cea G, 2002, BRAIN, V125, P1635, DOI 10.1093/brain/awf163
   Cenini G, 2016, MOL BIOL CELL, V27, P3257, DOI 10.1091/mbc.E16-05-0313
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Chang ML, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.869018
   Chen JT, 2001, MAGNET RESON MED, V46, P870, DOI 10.1002/mrm.1271
   Colapietro F, 2022, CLIN REV ALLERG IMMU, V63, P166, DOI 10.1007/s12016-021-08904-y
   Conte M, 2020, SEMIN IMMUNOPATHOL, V42, P607, DOI 10.1007/s00281-020-00813-0
   Dalakas MC, 2015, NEW ENGL J MED, V372, P1734, DOI 10.1056/NEJMra1402225
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   Danielsson O, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239176
   Davis MA, 2019, P NATL ACAD SCI USA, V116, P5061, DOI 10.1073/pnas.1818598116
   De Luna N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09309-8
   De Paepe B, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9010015
   De Paepe B, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2016.12.68
   Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Duvvuri B, 2021, J AUTOIMMUN, V119, DOI 10.1016/j.jaut.2021.102630
   Duvvuri Bhargavi, 2021, Immunometabolism, V3, DOI 10.20900/immunometab20210008
   Elpeleg O, 2002, J MOL MED-JMM, V80, P389, DOI 10.1007/s00109-002-0343-5
   EMSLIESMITH AM, 1990, ANN NEUROL, V27, P343, DOI 10.1002/ana.410270402
   Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355
   Ghirardello A, 2014, AUTOIMMUN HIGHLIGHTS, V5, P69, DOI 10.1007/s13317-014-0060-4
   Kalko SG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-91
   Greenberg SA, 2019, NAT REV RHEUMATOL, V15, P257, DOI 10.1038/s41584-019-0186-x
   Greenberg Steven A, 2010, Curr Rheumatol Rep, V12, P198, DOI 10.1007/s11926-010-0101-6
   Guo ZJ, 2016, MITOCHONDRIAL DNA A, V27, P4244, DOI 10.3109/19401736.2014.1003920
   Hagen CM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208828
   Hargreaves M, 2020, NAT METAB, V2, P817, DOI 10.1038/s42255-020-0251-4
   Hedberg-Oldfors C, 2022, NEUROPATH APPL NEURO, V48, DOI 10.1111/nan.12841
   Hedberg-Oldfors C, 2021, BRAIN PATHOL, V31, DOI 10.1111/bpa.12931
   Herman AM, 2011, BRAIN RES, V1386, P191, DOI 10.1016/j.brainres.2011.02.052
   Hesselstrand R., 2022, ARTHRITIS RHEUMATOL, V12, DOI 10.3389/fimmu.2021.785275
   Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001
   Hoffmann RF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51517-x
   Hojgaard P, 2021, OXF MED CASE REP, P89, DOI 10.1093/omcr/omaa150
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Horvath R, 1998, J NEUROPATH EXP NEUR, V57, P396, DOI 10.1097/00005072-199805000-00003
   Hou Y, 2019, NEUROMUSCULAR DISORD, V29, P5, DOI 10.1016/j.nmd.2018.11.004
   Hu SL, 2014, CLIN CHEM LAB MED, V52, P1533, DOI 10.1515/cclm-2013-0926
   Huntley ML, 2019, LAB INVEST, V99, P1041, DOI 10.1038/s41374-019-0233-x
   Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9
   Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001
   Javed F, 2010, AM J CLIN NUTR, V91, P907, DOI 10.3945/ajcn.2009.28512
   Jiang D, 2014, ACTA PHARMACOL SIN, V35, P135, DOI 10.1038/aps.2013.144
   Kadosaka T, 2020, ESC HEART FAIL, V7, P4315, DOI 10.1002/ehf2.12984
   Katsumata Y, 2008, CURR OPIN RHEUMATOL, V20, P681, DOI 10.1097/BOR.0b013e328310e0ac
   KEMP GJ, 1994, MAGNET RESON MED, V31, P248, DOI 10.1002/mrm.1910310303
   KEMP GJ, 1995, CLIN SCI, V89, P581, DOI 10.1042/cs0890581
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Khorramizadeh M.Reza., 2020, Anim Biotechnol, P153, DOI [DOI 10.1016/B978-0-12-811710-1.00008-2, 10.1016/B978-0-12811710-1.00008-2, DOI 10.1016/B978-0-12811710-1.00008-2]
   Kim GT, 2010, CLIN RHEUMATOL, V29, P273, DOI 10.1007/s10067-009-1316-7
   Kim Hyeonhui, 2018, Lab Anim Res, V34, P147
   Koo JH, 2019, GERONTOLOGY, V65, P240, DOI 10.1159/000494723
   Krishnan KJ, 2006, J INVEST DERMATOL, V126, P408, DOI 10.1038/sj.jid.5700099
   Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Lahoria R, 2016, BRAIN, V139, P1891, DOI 10.1093/brain/aww122
   Lai RX, 2021, ARCH RHEUMATOL, V36, P375, DOI 10.46497/ArchRheumatol.2021.8101
   Lax NZ, 2011, NEUROSCIENTIST, V17, P645, DOI 10.1177/1073858411385469
   Leclair V, 2021, CURR OPIN RHEUMATOL, V33, P537, DOI 10.1097/BOR.0000000000000837
   Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011
   Lightfoot AP, 2015, ANN RHEUM DIS, V74, P1340, DOI 10.1136/annrheumdis-2014-207172
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   Lindor KD, 2019, HEPATOLOGY, V69, P394, DOI 10.1002/hep.30145
   Liu DL, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-020-00440-z
   Liu ZH, 2022, CELL BIOSCI, V12, DOI 10.1186/s13578-022-00805-7
   Lodi R, 1998, BRAIN, V121, P2119, DOI 10.1093/brain/121.11.2119
   Lood C, 2016, NAT MED, V22, P146, DOI 10.1038/nm.4027
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Lundberg IE, 2017, ANN RHEUM DIS, V76, P1955, DOI 10.1136/annrheumdis-2017-211468
   Maeda MH, 2012, BRAIN, V135, P1767, DOI 10.1093/brain/aws106
   Mahler M, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11122246
   Malik A, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00064
   Marchi S, 2023, NAT REV IMMUNOL, V23, P159, DOI 10.1038/s41577-022-00760-x
   Mariappan N, 2007, AM J PHYSIOL-HEART C, V293, pH2726, DOI 10.1152/ajpheart.00376.2007
   Mauhin W, 2018, JOINT BONE SPINE, V85, P375, DOI 10.1016/j.jbspin.2017.04.004
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Melki I, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.aav5928
   Meyer A, 2017, ACTA NEUROPATHOL, V134, P655, DOI 10.1007/s00401-017-1731-9
   Michailidou D, 2022, ARTHRITIS RES THER, V24, DOI 10.1186/s13075-022-02849-z
   Milkiewicz M, 2012, AUTOIMMUN HIGHLIGHTS, V3, P105, DOI 10.1007/s13317-012-0038-z
   Minamiyama S, 2020, MUSCLE NERVE, V61, P81, DOI 10.1002/mus.26731
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Muravchick S, 2006, ANESTHESIOLOGY, V105, P819, DOI 10.1097/00000542-200610000-00029
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   Naddaf E, 2018, NEUROTHERAPEUTICS, V15, P995, DOI 10.1007/s13311-018-0658-8
   Nagaraju K, 2000, J IMMUNOL, V164, P5459, DOI 10.4049/jimmunol.164.10.5459
   Nakashima Ran, 2018, Immunol Med, V41, P103, DOI 10.1080/25785826.2018.1531188
   Nelke C, 2022, ACTA NEUROPATHOL COM, V10, DOI 10.1186/s40478-022-01389-6
   Oikawa Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231064
   Oldfors A, 2006, NEUROLOGY, V66, pS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Paradies G, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070728
   Park SY, 2014, AM J PHYSIOL-HEART C, V307, pH346, DOI 10.1152/ajpheart.00227.2014
   Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363
   Perenthaler E, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00352
   Phadke R, 2017, J CLIN MED, V6, DOI 10.3390/jcm6070064
   Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89
   Phaniendra A, 2015, INDIAN J CLIN BIOCHE, V30, P11, DOI 10.1007/s12291-014-0446-0
   Pirkmajer S, 2022, FRONT PHYSIOL, V13, DOI 10.3389/fphys.2022.1113860
   Platteel ACM, 2019, J TRANSL AUTOIMMUN, V2, DOI 10.1016/j.jtauto.2019.100013
   Qiu MQ, 2021, RHEUMATOLOGY, V60, P2826, DOI 10.1093/rheumatology/keaa721
   Qualls AE, 2021, AM J PHYSIOL-CELL PH, V320, pC681, DOI 10.1152/ajpcell.00462.2020
   RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107
   Riley JS, 2020, EMBO REP, V21, DOI 10.15252/embr.201949799
   Rodríguez-Nuevo A, 2018, EMBO J, V37, DOI 10.15252/embj.201796553
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Sabbagh SE, 2021, CLIN RHEUMATOL, V40, P4095, DOI 10.1007/s10067-021-05730-7
   Sakellariou GK, 2016, SCI REP-UK, V6, DOI 10.1038/srep33944
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schulz C, 2015, TRENDS CELL BIOL, V25, P265, DOI 10.1016/j.tcb.2014.12.001
   Shi J, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.783616
   Shokolenko Inna N, 2014, World J Exp Med, V4, P46
   Singh B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139846
   Song JY, 2021, NAT REV MOL CELL BIO, V22, P54, DOI 10.1038/s41580-020-00300-2
   Souza Fernando Henrique Carlos de, 2012, Rev Bras Reumatol, V52, P642
   Stribl C, 2014, J BIOL CHEM, V289, P10769, DOI 10.1074/jbc.M113.515940
   Sugarman MC, 2006, NEUROBIOL AGING, V27, P423, DOI 10.1016/j.neurobiolaging.2005.02.011
   Suk TR, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00397-1
   Sun JY, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abp9245
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Suzuki T, 2015, TOHOKU J EXP MED, V236, P225, DOI 10.1620/tjem.236.225
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Tanaka A, 2002, CELL MOL BIOL, V48, P295
   Tawata M, 1998, DIABETES, V47, P276, DOI 10.2337/diab.47.2.276
   TAYLOR DJ, 1994, J NEUROL SCI, V127, P198, DOI 10.1016/0022-510X(94)90073-6
   Uenaka T, 2017, EUR NEUROL, V78, P290, DOI 10.1159/000481503
   Vattemi G, 2009, ACTA NEUROPATHOL, V117, P569, DOI 10.1007/s00401-009-0511-6
   Vogel H, 2001, J NEUROPATH EXP NEUR, V60, P217, DOI 10.1093/jnen/60.3.217
   WAGNER I, 1994, EMBO J, V13, P5135, DOI 10.1002/j.1460-2075.1994.tb06843.x
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220
   Wang CH, 2014, MOD RHEUMATOL, V24, P865, DOI 10.3109/14397595.2013.874741
   Wang F, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.675465
   WOO M, 1988, J NEUROL SCI, V88, P133, DOI 10.1016/0022-510X(88)90211-0
   Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010
   Yamada T, 2022, ARTHRITIS RES THER, V24, DOI 10.1186/s13075-022-02846-2
   Yamanaka Tetsuo, 2017, BMJ Case Rep, V2017, DOI 10.1136/bcr-2016-218469
   Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200
   Yin X, 2016, CHINESE MED J-PEKING, V129, P1047, DOI 10.4103/0366-6999.180528
   Yokokawa T, 2021, INTERNAL MED, V60, P201, DOI 10.2169/internalmedicine.5422-20
   Yusoff AAM, 2019, ONCOL REV, V13, P54, DOI 10.4081/oncol.2019.409
   Zhang L, 2021, SEMIN ARTHRITIS RHEU, V51, P741, DOI 10.1016/j.semarthrit.2021.05.019
   Zhang YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128624
   Zhao YD, 2009, CALCIFIED TISSUE INT, V85, P267, DOI 10.1007/s00223-009-9271-5
   Zhao YF, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-09943-x
   Zhou ZJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00770
NR 166
TC 7
Z9 7
U1 0
U2 3
PU RAMBAM HEALTH CARE CAMPUS
PI HAIFA
PA 6 HA ALIYA ST, HAIFA, 31096, ISRAEL
SN 2076-9172
J9 RAMBAM MAIMONIDES ME
JI Rambam Maimonides Med. J.
PD APR
PY 2023
VL 14
IS 2
AR e0006
DI 10.5041/RMMJ.10493
PG 18
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA F9KV4
UT WOS:000985472800005
PM 37116066
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Schlapakow, E
   Peeva, V
   Zsurka, G
   Jeub, M
   Wabbels, B
   Kornblum, C
   Kunz, WS
AF Schlapakow, Elena
   Peeva, Viktoriya
   Zsurka, Gabor
   Jeub, Monika
   Wabbels, Bettina
   Kornblum, Cornelia
   Kunz, Wolfram S.
TI Distinct segregation of the pathogenic m.5667G>A mitochondrial
   tRNA<SUP>Asn</SUP> mutation in extraocular and skeletal muscle in
   chronic progressive external ophthalmoplegia
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Chronic progressive external ophthalmoplegia (CPEO); mt-tRNA(Asn);
   Single muscle fiber; Heteroplasmy; mtDNA copy number
ID DNA MUTATIONS; POINT MUTATIONS; GENE; MYOPATHY; DELETIONS; PATIENT
AB Chronic progressive external ophthalmoplegia (CPEO) is a frequent clinical manifestation of disorders caused by pathogenic mitochondrial DNA mutations. However, for diagnostic purposes skeletal muscle tissue is used, since extraocular muscle tissue is usually not available for work-up. In the present study we aimed to identify causative factors that are responsible for extraocular muscle to be primarily affected in CPEO. We performed comparative histochemical and molecular genetic analyses of extraocular muscle and skeletal muscle single fibers in a case of isolated CPEO caused by the heteroplasmic m.5667G>A mutation in the mitochondrial tRNA(Asn) gene (MT-TN). Histochemical analyses revealed higher proportion of cytochrome c oxidase deficient fibers in extraocular muscle (41%) compared to skeletal muscle (10%). However, genetic analyses of single fibers revealed no significant difference either in the mutation loads between extraocular muscle and skeletal muscle cytochrome c oxidase deficient single fibers (extraocular muscle 86%+/- 4.6%; skeletal muscle 87.8%+/- 5.7%, p = 0.246) nor in the mutation threshold (extraocular muscle 74%+/- 3%; skeletal muscle 74%+/- 4%). We hypothesize that higher proportion of cytochrome c oxidase deficient fibers in extraocular muscle compared to skeletal muscle might be due to facilitated segregation of the m.5667G>A mutation into extraocular muscle, which may explain the preferential ocular manifestation and clinically isolated CPEO. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Schlapakow, Elena; Jeub, Monika; Kornblum, Cornelia] Univ Hosp Bonn, Dept Neurol, Bonn, Germany.
   [Peeva, Viktoriya; Zsurka, Gabor; Kunz, Wolfram S.] Univ Bonn, Inst Expt Epileptol & Cognit Res, Div Neurochem, Sigmund Freud Str 25, D-53105 Bonn, Germany.
   [Zsurka, Gabor; Kunz, Wolfram S.] Univ Bonn, Dept Epileptol, Bonn, Germany.
   [Schlapakow, Elena; Kornblum, Cornelia] Univ Hosp Bonn, Ctr Rare Dis, Bonn, Germany.
   [Wabbels, Bettina] Univ Bonn, Dept Ophthalmol, Bonn, Germany.
C3 University of Bonn; University of Bonn; University of Bonn; University
   of Bonn; University of Bonn
RP Kunz, WS (corresponding author), Univ Bonn, Inst Expt Epileptol & Cognit Res, Div Neurochem, Sigmund Freud Str 25, D-53105 Bonn, Germany.
EM wolfram.kunz@ukbonn.de
RI Kornblum, Cornelia/IUM-4180-2023; Wabbels, Bettina/AAT-4804-2021; Kunz,
   Wolfram/K-1232-2019
OI Kunz, Wolfram/0000-0003-1113-3493; Zsurka, Gabor/0000-0002-6379-849X
FU Deutsche Forschungsgemeinschaft [KU 911/21-2, ZS 99/3-2]; BONFOR
FX This research was supported by grants of Deutsche Forschungsgemeinschaft
   (KU 911/21-2 to W.S.K. and ZS 99/3-2 to G.Z.) and BONFOR to V.P.
CR [Anonymous], 2013, MUSCLE BIOPSY PRACTI
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Bohnsack BL, 2011, ARCH OPHTHALMOL-CHIC, V129, P1030, DOI 10.1001/archophthalmol.2011.75
   Bruno C, 2011, BIOCHEM BIOPH RES CO, V412, P518, DOI 10.1016/j.bbrc.2011.06.155
   Coulbault L, 2005, BIOCHEM BIOPH RES CO, V329, P1152, DOI 10.1016/j.bbrc.2005.02.083
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Hao HL, 1997, MOL CELL BIOL, V17, P6831, DOI 10.1128/MCB.17.12.6831
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Meulemans A, 2006, ARCH NEUROL-CHICAGO, V63, P1194, DOI 10.1001/archneur.63.8.1194
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   MUNSCHER C, 1993, BIOL CHEM H-S, V374, P1099, DOI 10.1515/bchm3.1993.374.7-12.1099
   Pinós T, 2013, NEUROMUSCULAR DISORD, V23, P330, DOI 10.1016/j.nmd.2013.01.001
   PORTER JD, 1995, SURV OPHTHALMOL, V39, P451, DOI 10.1016/S0039-6257(05)80055-4
   Rocha MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15037
   Ronchi D, 2012, EUR J HUM GENET, V20, P357, DOI 10.1038/ejhg.2011.238
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   SEIBEL P, 1994, BIOCHEM BIOPH RES CO, V204, P482, DOI 10.1006/bbrc.1994.2485
   Spinazzola A, 2004, NEUROMUSCULAR DISORD, V14, P815, DOI 10.1016/j.nmd.2004.09.002
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Vives-Bauza C, 2003, J INHERIT METAB DIS, V26, P507, DOI 10.1023/A:1025133629685
   Wiedemann FR, 2000, ANAL BIOCHEM, V279, P55, DOI 10.1006/abio.1999.4434
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
   Yu CY, 2005, NEUROMUSCULAR DISORD, V15, P17, DOI 10.1016/j.nmd.2004.10.002
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
   Zierz S, 2014, MUSKELERKRANKUNGEN, P274
   Zsurka G, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.022566
   Zsurka G, 2008, J NEUROPATH EXP NEUR, V67, P857, DOI 10.1097/NEN.0b013e3181839b2d
NR 32
TC 8
Z9 8
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD MAY
PY 2019
VL 29
IS 5
BP 358
EP 367
DI 10.1016/j.nmd.2019.02.009
PG 10
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA ID5RT
UT WOS:000471734400003
PM 30962064
DA 2024-11-01
ER

PT J
AU Rahman, S
   Hanna, MG
AF Rahman, S.
   Hanna, M. G.
TI Diagnosis and therapy in neuromuscular disorders: diagnosis and new
   treatments in mitochondrial diseases
SO JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
LA English
DT Review
ID HEREDITARY OPTIC NEUROPATHY; STROKE-LIKE EPISODES; PROGRESSIVE EXTERNAL
   OPHTHALMOPLEGIA; CYTOCHROME-C-OXIDASE; PREIMPLANTATION GENETIC
   DIAGNOSIS; RAGGED-RED FIBERS; COENZYME Q(10); COCHLEAR IMPLANTATION;
   MTDNA MUTATION; DNA DEPLETION
AB Mitochondrial disease enters the differential diagnosis of a wide range of CNS and PNS presentations. Respiratory chain ATP production is under bigenomic genetic control. Adult mitochondrial diseases are mainly caused by mutations in mitochondrial DNA (mtDNA), and nuclear gene defects usually present with more severe childhood phenotypes. Recently, mutations in certain nuclear genes-for example POLG, MFN2 and OPA1, have been associated with an increasing number of adult-onset phenotypes. Achieving an accurate diagnosis can be complex and requires the coordinated interplay of clinical assessment, muscle histochemistry, muscle respiratory chain enzymology and genetics. Factors influencing the transmission and expression of mtDNA defects are not fully defined, presenting difficulties in calculating accurate recurrence risks for patients. Curative therapy exists for primary coenzyme Q(10) deficiency. For certain mtDNA mutations new therapeutic strategies, including resistance training, have the potential to reduce mutant mtDNA load. Allogeneic stem cell transplant may produce benefit in the nuclear recessive mitochondrial disorder mitochondrial neurogastrointestinal encephalomyopathy and should be considered in this nuclear driven multiple mtDNA deletion disorder. Supportive therapies in a multidisciplinary team environment are essential to reduce morbidity and mortality.
C1 [Rahman, S.; Hanna, M. G.] UCL Inst Neurol, Ctr Neuromuscular Dis, MRC, London WC1N 3BG, England.
   [Rahman, S.; Hanna, M. G.] UCL Inst Child Hlth, Mitochondrial Res Grp, London, England.
C3 University of London; University College London; University of London;
   University College London
RP Rahman, S (corresponding author), UCL Inst Neurol, Ctr Neuromuscular Dis, MRC, Queen Sq, London WC1N 3BG, England.
EM s.rahman@ich.ucl.ac.uk
RI Rahman, Shamima/C-5232-2008; Hanna, Michael/B-1995-2009
OI Hanna, Michael/0000-0003-0825-4075
FU MRC Centre for Neuromuscular Diseases [G0601943]; SPARKS; Great Ormond
   Street Hospital and Institute of Child Health Science Development
   Initiative; Department of Health's National Institute for Health
   Research Biomedical Research Centres; MRC [G0800674, G0200335, G0601943]
   Funding Source: UKRI
FX MGH is supported by an MRC Centre grant: MRC Centre for Neuromuscular
   Diseases [G0601943] http://www.cnmd.ac.uk/Home. SR is a DH/HEFCE senior
   lecturer and receives grant funding from SPARKS and the Great Ormond
   Street Hospital and Institute of Child Health Science Development
   Initiative. The work of SR, and MGH is undertaken at University College
   London Hospitals/University College London, which received a proportion
   of funding from the Department of Health's National Institute for Health
   Research Biomedical Research Centres funding scheme. The UK clinical and
   diagnostic service for mitochondrial disease at Queen Square, Oxford and
   Newcastle is supported by the National Commissioning Group, Department
   of Health, UK. Further details about the mitochondrial service are
   available from each centre.
CR ALLEN RJ, 1983, ANN NEUROL, V13, P679, DOI 10.1002/ana.410130620
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Bastin J, 2008, J CLIN ENDOCR METAB, V93, P1433, DOI 10.1210/jc.2007-1701
   Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396
   Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329
   Brown DT, 2006, LANCET, V368, P87, DOI 10.1016/S0140-6736(06)68972-1
   Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190
   Chinnery P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub2
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T
   Cullington HE, 1999, J LARYNGOL OTOL, V113, P353, DOI 10.1017/S0022215100143956
   Dean NL, 2003, MOL HUM REPROD, V9, P631, DOI 10.1093/molehr/gag077
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Dimmock DP, 2008, LIVER TRANSPLANT, V14, P1480, DOI 10.1002/lt.21556
   DOUGADOS M, 1983, ANN NEUROL, V13, P687, DOI 10.1002/ana.410130624
   Duncan AJ, 2005, CLIN CHEM, V51, P2380, DOI 10.1373/clinchem.2005.054643
   Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013
   Feyereisen E, 2007, FERTIL STERIL, V87, P60, DOI 10.1016/j.fertnstert.2006.05.059
   Finsterer J, 2006, NETH J MED, V64, P61
   Freisinger P, 2004, J INHERIT METAB DIS, V27, P67, DOI 10.1023/B:BOLI.0000016614.47380.2f
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO YI, 1994, BIOCHEM BIOPH RES CO, V202, P1624, DOI 10.1006/bbrc.1994.2119
   Hanna MG, 1997, CURR OPIN NEUROL, V10, P351, DOI 10.1097/00019052-199708000-00012
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   HARDING AE, 1992, AM J HUM GENET, V50, P629
   HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   Jacobs HT, 1997, ANN MED, V29, P483, DOI 10.3109/07853899709007472
   JOHNS DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P495, DOI 10.1001/archopht.1993.01090040087038
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kirby DM, 2000, ANN NEUROL, V48, P102, DOI 10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.3.CO;2-D
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267
   LAFORET P, 1995, NEUROMUSCULAR DISORD, V5, P399, DOI 10.1016/0960-8966(94)00080-S
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lalani SR, 2005, ARCH NEUROL-CHICAGO, V62, P317, DOI 10.1001/archneur.62.2.317
   Lara MC, 2006, NEUROLOGY, V67, P1461, DOI 10.1212/01.wnl.0000239824.95411.52
   LARSSON NG, 1995, MUSCLE NERVE       S, V3, P102
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Leshinsky-Silver E, 2003, PRENATAL DIAG, V23, P31, DOI 10.1002/pd.516
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   Mahata B, 2006, SCIENCE, V314, P471, DOI 10.1126/science.1129754
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Moran NF, 2008, NEUROLOGY, V71, P686, DOI 10.1212/01.wnl.0000324602.97205.ab
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Murphy MP, 2008, BBA-BIOENERGETICS, V1777, P1028, DOI 10.1016/j.bbabio.2008.03.029
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849
   NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   Pineda M, 2006, ANN NEUROL, V59, P394, DOI 10.1002/ana.20746
   Poulton J, 2001, J MED GENET, V38, pS73
   Rahman S, 2001, J PEDIATR-US, V139, P456, DOI 10.1067/mpd.2001.117575
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Rosenthal EL, 1999, AM J OTOL, V20, P187
   Rötig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salviati L, 2002, BIOCHEM J, V363, P321, DOI 10.1042/0264-6021:3630321
   Sanaker PS, 2007, ACTA NEUROL SCAND, V115, P64, DOI 10.1111/j.1600-0404.2007.00850.x
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Sinnathuray AR, 2003, OTOL NEUROTOL, V24, P418, DOI 10.1097/00129492-200305000-00012
   Sobreira C, 1997, NEUROLOGY, V48, P1238, DOI 10.1212/WNL.48.5.1238
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Suzuki S, 1998, DIABETOLOGIA, V41, P584, DOI 10.1007/s001250050950
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.7.e85
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Tono T, 1998, AM J OTOL, V19, P754
   TRAFF J, 1995, ACTA NEUROL SCAND, V92, P394
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Maldergem L, 2002, ANN NEUROL, V52, P750, DOI 10.1002/ana.10371
   Vandebona H, 2009, NEW ENGL J MED, V360, P642, DOI 10.1056/NEJMc0806397
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126
   WALLACE DC, 1970, BRAIN, V93, P121, DOI 10.1093/brain/93.1.121
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   White SL, 1999, PRENATAL DIAG, V19, P1165, DOI 10.1002/(SICI)1097-0223(199912)19:12<1165::AID-PD719>3.3.CO;2-4
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Yavuz H, 2007, ARCH NEUROL-CHICAGO, V64, P435, DOI 10.1001/archneur.64.3.435
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 114
TC 59
Z9 63
U1 0
U2 8
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-3050
EI 1468-330X
J9 J NEUROL NEUROSUR PS
JI J. Neurol. Neurosurg. Psychiatry
PD SEP
PY 2009
VL 80
IS 9
BP 943
EP 953
DI 10.1136/jnnp.2008.158279
PG 11
WC Clinical Neurology; Psychiatry; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Psychiatry; Surgery
GA 483VS
UT WOS:000268997800004
PM 19684231
OA Green Submitted
DA 2024-11-01
ER

PT B
AU Barness, LA
   Wong, K
AF Barness, Lewis A.
   Wong, Kondi
BE GilbertBarness, E
   Barness, LA
   Farrell, PM
TI Mitochondrial Myopathies and Disorders
SO METABOLIC DISEASES: FOUNDATIONS OF CLINICAL MANAGEMENT, GENETICS, AND
   PATHOLOGY, 2ND EDITION
LA English
DT Article; Book Chapter
DE lactic acidosis; ragged red fibers; Leigh syndrome; Leber hereditary
   optic neuropathy; Kearns-Sayre syndrome; biotinidase deficiency
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; HEREDITARY OPTIC NEUROPATHY;
   KEARNS-SAYRE-SYNDROME; SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY;
   PYRUVATE-DEHYDROGENASE COMPLEX; LINKED CARDIOSKELETAL MYOPATHY;
   RAGGED-RED FIBERS; NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY MNGIE;
   NEUTROPENIA BARTH-SYNDROME; TRANSFER RNALEU(UUR) GENE
AB Genetic disorders of mitochondria cause disease when they reduce subcellular energy production through a variety of impairments in the electron transport chain, thus decreasing oxidative phosphorylation. Such abnormalities typically lead to neuropathies and/or myopathies including cardiomyopathies. Hepatic and renal pathology may also occur. The age of onset and severity are variable, but signs and symptoms are often present during infancy. The metabolic hallmarks include lactic acidosis, an increased ratio of blood lactate to pyruvate, and ketonemia. Muscle biopsies show characteristic ragged red fibers, which are obvious with trichrome staining. Some disorders which are inherited through the mother, source of all mitochondrial DNA, lead to early blindness due to progressive optic neuropathy, i.e., Leber's Hereditary Optic Neuropathy. Exciting recent research with gene replacement therapy and stem cell technology has provided new insights and hope for patients with genetic blindness. Other disorders affecting mitochondrial DNA mutations may also eventually be treated with molecular (gene replacement) or advanced cellular (stem cell) therapeutic strategies. In addition, early diagnosis through newborn screening is now routinely achieved for some disorders such as biotinidase deficiency, allowing curative therapy through nutritional supplements.
C1 [Barness, Lewis A.] Univ S Florida, Pediat, Morsani Coll Med, Tampa, FL 33620 USA.
   [Barness, Lewis A.] Univ Wisconsin, Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA.
   [Wong, Kondi] Tampa Gen Hosp, 1 Tampa Gen Circle, Tampa, FL 33606 USA.
C3 State University System of Florida; University of South Florida;
   University of Wisconsin System; University of Wisconsin Madison; Tampa
   General Hospital
RP Barness, LA (corresponding author), Univ S Florida, Pediat, Morsani Coll Med, Tampa, FL 33620 USA.; Barness, LA (corresponding author), Univ Wisconsin, Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA.
CR Abe K, 1997, NEUROLOGY, V49, P837, DOI 10.1212/WNL.49.3.837
   Acehan D, 2007, LAB INVEST, V87, P40, DOI 10.1038/labinvest.3700480
   Aeby A, 2007, J INHERIT METAB DIS, V30, P827, DOI 10.1007/s10545-007-0612-0
   Ambonville C, 2008, DIABETES METAB, V34, P389, DOI 10.1016/j.diabet.2008.05.002
   ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   APPENZELLER O, 1976, ARCH NEUROL-CHICAGO, V33, P733, DOI 10.1001/archneur.1976.00500110001001
   ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   ATKIN BM, 1979, PEDIATR RES, V13, P109, DOI 10.1203/00006450-197902000-00005
   ATKIN BM, 1979, PEDIATR RES, V13, P38, DOI 10.1203/00006450-197901000-00009
   Avis HJ, 2011, J PEDIATR-US, V158, P458, DOI 10.1016/j.jpeds.2010.08.015
   BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
   Barness LA, 1997, POTTERS PATHOLOGY FE, P571
   Barness LA, 1997, METABOLIC DIS
   Barritt G.J., 1985, P141
   Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660
   BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Barth PG, 1999, J INHERIT METAB DIS, V22, P555, DOI 10.1023/A:1005568609936
   BARTON DE, 1987, CYTOGENET CELL GENET, V46, P577
   BEHBEHANI AW, 1984, EUR J PEDIATR, V143, P67, DOI 10.1007/BF00442753
   BERENBERG RA, 1977, ANN NEUROL, V1, P37, DOI 10.1002/ana.410010104
   BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231
   BERTORINI T, 1978, ARCH NEUROL-CHICAGO, V35, P643, DOI 10.1001/archneur.1978.00500340019004
   Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385
   BIRCHMACHIN MA, 1989, PEDIATR RES, V25, P553, DOI 10.1203/00006450-198905000-00025
   BIRD LM, 1994, AM J MED GENET, V53, P141, DOI 10.1002/ajmg.1320530205
   BLACKWOOD W, 1963, ARCH DIS CHILD, V38, P193, DOI 10.1136/adc.38.199.193
   BLASS JP, 1972, J CLIN INVEST, V51, P1845, DOI 10.1172/JCI106986
   BODNAR AG, 1993, AM J HUM GENET, V53, P663
   Boles RG, 1998, EUR J PEDIATR, V157, P643, DOI 10.1007/s004310050902
   BOLHUIS PA, 1991, AM J HUM GENET, V48, P481
   BONNEFONT JP, 1992, J PEDIATR-US, V121, P255, DOI 10.1016/S0022-3476(05)81199-0
   Bouchet C, 2006, J MED GENET, V43, P788, DOI 10.1136/jmg.2005.034140
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   BOUSTANY RN, 1983, ANN NEUROL, V14, P462, DOI 10.1002/ana.410140411
   BOYD SG, 1986, NEUROPEDIATRICS, V17, P75, DOI 10.1055/s-2008-1052505
   Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256
   BRUTON D, 1977, PATHOLOGY, V9, P115, DOI 10.3109/00313027709085249
   BU XD, 1991, P NATL ACAD SCI USA, V88, P8198, DOI 10.1073/pnas.88.18.8198
   Bykhovskaya Y, 2000, AM J HUM GENET, V66, P1905, DOI 10.1086/302914
   Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423
   Carta A, 2005, BRIT J OPHTHALMOL, V89, P825, DOI 10.1136/bjo.2004.060590
   CASALI C, 1995, BIOCHEM BIOPH RES CO, V213, P588, DOI 10.1006/bbrc.1995.2172
   Cathelineau CL, 1989, ACTA PAEDIATR SCAND, V65, P717
   CEDERBAUM SD, 1976, PEDIATR RES, V10, P713, DOI 10.1203/00006450-197610080-00002
   Challa S, 2004, NEUROL INDIA, V52, P353
   Chalmers RM, 1996, BRAIN, V119, P1481, DOI 10.1093/brain/119.5.1481
   Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   CHUN K, 1990, EUR J BIOCHEM, V194, P587, DOI 10.1111/j.1432-1033.1990.tb15656.x
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   COOPER JR, 1969, SCIENCE, V164, P74, DOI 10.1126/science.164.3875.74
   COOPER JR, 1970, NEW ENGL J MED, V283, P793, DOI 10.1056/NEJM197010082831506
   CORMIER V, 1991, J PEDIATR-US, V119, P951, DOI 10.1016/S0022-3476(05)83054-9
   Cornelio F, 1987, PERSP INHER METAB DI, V7, P45
   Cossee M, 1997, P NATL ACAD SCI USA, V94, P7452, DOI 10.1073/pnas.94.14.7452
   Cotán D, 2011, FASEB J, V25, P2669, DOI 10.1096/fj.10-165340
   Cree LM, 2009, BBA-MOL BASIS DIS, V1792, P1097, DOI 10.1016/j.bbadis.2009.03.002
   Crispim D, 2008, ARQ BRAS ENDOCRINOL, V52, P1228, DOI 10.1590/S0004-27302008000800005
   D'Aurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   Dahl HHM, 1998, AM J HUM GENET, V63, P1594, DOI 10.1086/302169
   DAVIDSON M, 1983, BIOCHEM J, V214, P703, DOI 10.1042/bj2140703
   DEVIVO DC, 1990, BIOL NEONATE, V58, P54
   DEVIVO DC, 1993, BRAIN DEV-JPN, V15, P1, DOI 10.1016/0387-7604(93)90002-P
   DEVIVO DC, 1977, J CLIN ENDOCR METAB, V45, P1281, DOI 10.1210/jcem-45-6-1281
   DIMAURO S, 1987, J INHERIT METAB DIS, V10, P113, DOI 10.1007/BF01812852
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DIMAURO S, 1990, NEUROL CLIN, V8, P483, DOI 10.1016/S0733-8619(18)30332-3
   DiMauro S, 1996, ANN NEUROL, V40, P5, DOI 10.1002/ana.410400104
   DiMauro S, 1997, MITOCHONDRIAL ENCEPH, P201
   DiMauro S., 1993, GENEREVIEWS
   DiMauro S, 1997, PROMISING AVENUES IN
   Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833
   DUBOIS LG, 1992, J CLIN NEURO-OPHTHAL, V12, P15
   Duby G, 2002, HUM MOL GENET, V11, P2635, DOI 10.1093/hmg/11.21.2635
   EGGER J, 1987, CLIN PEDIATR, V26, P167, DOI 10.1177/000992288702600401
   Emmanuele V, 2012, ARCH NEUROLOGY
   ENDO H, 1991, J INHERIT METAB DIS, V14, P793, DOI 10.1007/BF01799952
   Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676
   ESTOURNET B, 1991, REV NEUROL-FRANCE, V147, P491
   EVANS OB, 1984, J PEDIATR-US, V105, P961, DOI 10.1016/S0022-3476(84)80090-6
   FALK RE, 1976, PEDIATRICS, V58, P713
   FARMER TW, 1973, NEUROLOGY, V23, P429
   FARRELL DF, 1975, SCIENCE, V187, P1082, DOI 10.1126/science.803713
   FAYON M, 1992, GASTROENTEROLOGY, V103, P1332, DOI 10.1016/0016-5085(92)91525-9
   FEIGENBAUM AS, 1993, GENOMICS, V17, P376, DOI 10.1006/geno.1993.1335
   FERRANS VJ, 1976, CIRCULATION, V53, P708, DOI 10.1161/01.CIR.53.4.708
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Finegold D, 1997, DIAGNOSIS PROMISE DN
   FRANCIOSI RA, 1988, HUM PATHOL, V19, P1361, DOI 10.1016/S0046-8177(88)80296-X
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Freckmann ML, 1997, J PEDIATR-US, V130, P431, DOI 10.1016/S0022-3476(97)70206-3
   Frederiksen AL, 2009, J CLIN ENDOCR METAB, V94, P2872, DOI 10.1210/jc.2009-0235
   FRERMAN FE, 1985, P NATL ACAD SCI USA, V82, P4517, DOI 10.1073/pnas.82.13.4517
   Frerman FE, 1995, NUCL ENCODED DEFECTS
   FREYTAG SO, 1984, J BIOL CHEM, V259, P2831
   FULHAM M, 1988, MED J AUSTRALIA, V149, P320, DOI 10.5694/j.1326-5377.1988.tb120635.x
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   GILBERT EF, 1983, ARCH PATHOL LAB MED, V107, P162
   Goodman SI, 1991, INT PEDIAT, V6, P59
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GREENBERG DA, 1984, J NEUROCHEM, V42, P1062, DOI 10.1111/j.1471-4159.1984.tb12711.x
   HALE DE, 1992, J PEDIATR-US, V121, P1, DOI 10.1016/S0022-3476(05)82532-6
   HAMMANS SR, 1994, MITOCHONDRIAL DISORD, P49
   Hanke SP, 2012, PEDIAT CARDIOLOGY
   HANSEN TL, 1983, CLIN CHIM ACTA, V131, P39, DOI 10.1016/0009-8981(83)90350-9
   HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589
   HARDING AE, 1983, Q J MED, V52, P489
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   HARDING BN, 1986, BRAIN, V109, P181, DOI 10.1093/brain/109.1.181
   Hassani A, 2010, CURR OPIN NEUROL, V23, P459, DOI 10.1097/WCO.0b013e32833d1096
   HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015
   He QA, 2010, AM J PHYSIOL-HEART C, V299, pH210, DOI 10.1152/ajpheart.00098.2010
   Hinttala R, 2006, J MED GENET, V43, P881, DOI 10.1136/jmg.2006.042168
   Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Hirano M., 1996, Handbook of Muscle Disease, P479
   Hirano M, 2012, BBA-GEN SUBJECTS, V1820, P625, DOI 10.1016/j.bbagen.2012.01.006
   HO L, 1986, J CLIN INVEST, V78, P844, DOI 10.1172/JCI112651
   Hofmann S, 1999, SURF 1 MUTATIONS ARE
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   HOMMES FA, 1973, PEDIATR RES, V7, P616, DOI 10.1203/00006450-197307000-00003
   Hommes FA, 1979, INHERITED DISORDERS, P239
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Huynen MA, 2001, HUM MOL GENET, V10, P2463, DOI 10.1093/hmg/10.21.2463
   Hwang J M, 1996, Korean J Ophthalmol, V10, P122
   INO T, 1988, J PEDIATR-US, V113, P511, DOI 10.1016/S0022-3476(88)80642-5
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   JABER L, 1992, J MED GENET, V29, P86, DOI 10.1136/jmg.29.2.86
   JAMES TN, 1975, CIRCULATION, V52, P333, DOI 10.1161/01.CIR.52.2.333
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kawamata H, 2011, HUM MOL GENET, V20, P2964, DOI 10.1093/hmg/ddr200
   KEARNEY DL, 1987, CIRCULATION, V75, P705, DOI 10.1161/01.CIR.75.4.705
   KEARNS THOMAS P., 1965, TRANS AMER OPHTHALMOL SOC, V63, P559
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   KELLER BB, 1987, AM HEART J, V114, P782, DOI 10.1016/0002-8703(87)90789-7
   KELLEY R I, 1989, American Journal of Human Genetics, V45, pA7
   KIMURA S, 1991, PEDIATR NEUROL, V7, P56, DOI 10.1016/0887-8994(91)90108-W
   KITANO A, 1990, NEUROLOGY, V40, P1312, DOI 10.1212/WNL.40.8.1312
   Kobayashi T, 1997, DIABETES, V46, P1567, DOI 10.2337/diabetes.46.10.1567
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   KOBAYASHI Y, 1991, AM J HUM GENET, V49, P590
   KODAMA S, 1983, BRAIN DEV-JPN, V5, P381, DOI 10.1016/S0387-7604(83)80043-6
   KOIKE K, 1990, P NATL ACAD SCI USA, V87, P5594, DOI 10.1073/pnas.87.15.5594
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Komulainen T, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-29
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   KURE K, 1990, ACTA NEUROPATHOL, V80, P393, DOI 10.1007/BF00307693
   Laberge AM, 2005, AM J HUM GENET, V77, P313, DOI 10.1086/432491
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   LEW EO, 1989, ACTA NEUROPATHOL, V77, P599, DOI 10.1007/BF00687887
   LEWIN R, 1987, SCIENCE, V238, P24, DOI 10.1126/science.3116666
   LI K, 1989, J BIOL CHEM, V264, P13998
   Liang WC, 2009, NEUROMUSCULAR DISORD, V19, P212, DOI 10.1016/j.nmd.2009.01.008
   Limongelli A, 2004, J MED GENET, V41, P342, DOI 10.1136/jmg.2003.016048
   Lin CM, 2007, METAB BRAIN DIS, V22, P105, DOI 10.1007/s11011-006-9039-9
   LOMBES A, 1989, ANN NEUROL, V26, P20, DOI 10.1002/ana.410260104
   LOMBES A, 1991, NEUROLOGY, V41, P491, DOI 10.1212/WNL.41.4.491
   López LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Lynn S, 2003, DIABETOLOGIA, V46, P296, DOI 10.1007/s00125-002-1018-z
   MACAYA A, 1993, NEUROPEDIATRICS, V24, P60, DOI 10.1055/s-2008-1071515
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Makaryan V, 2012, EUR J HAEMATOL, V88, P195, DOI 10.1111/j.1600-0609.2011.01725.x
   MALHOTRA V, 1994, AM HEART J, V128, P1009, DOI 10.1016/0002-8703(94)90601-7
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   Mancuso M, 2005, ARCH NEUROL-CHICAGO, V62, P745, DOI 10.1001/archneur.62.5.745
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MARAGOS C, 1989, J BIOL CHEM, V264, P12294
   Marchiafava E., 1903, RIV PATOL NERV MENT, V8, P544
   MARSAC C, 1982, CLIN CHIM ACTA, V119, P121, DOI 10.1016/0009-8981(82)90412-0
   Martelli A, 2012, DIS MODEL MECH, V5, P165, DOI 10.1242/dmm.008706
   Matsuoka T, 1991, Neuromuscul Disord, V1, P443, DOI 10.1016/0960-8966(91)90007-F
   MATTHEWS PM, 1993, NEUROLOGY, V43, P2025, DOI 10.1212/WNL.43.10.2025
   MAZZIOTTA MRM, 1992, J PEDIATR-US, V121, P896, DOI 10.1016/S0022-3476(05)80335-X
   MCCORMICK K, 1985, AM J MED GENET, V22, P291, DOI 10.1002/ajmg.1320220211
   McFarland R, 2007, NEUROLOGY, V69, P911, DOI 10.1212/01.wnl.0000267843.10977.4a
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MCGREGOR CGA, 1984, AM J CARDIOL, V53, P982, DOI 10.1016/0002-9149(84)90553-8
   MCKAY N, 1986, EUR J PEDIATR, V144, P445, DOI 10.1007/BF00441736
   McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   MEDINA L, 1990, AM J NEURORADIOL, V11, P379
   Miles MV, 2008, MITOCHONDRION, V8, P170, DOI 10.1016/j.mito.2008.01.003
   Miles MV, 2011, MITOCHONDRION, V11, P127, DOI 10.1016/j.mito.2010.08.010
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   MOLNAR M, 1995, NEUROPATH APPL NEURO, V21, P432, DOI 10.1111/j.1365-2990.1995.tb01080.x
   Momoi N, 2012, EUR J PEDIATR, V171, P515, DOI 10.1007/s00431-011-1597-0
   MONTPETIT VJ, 1971, BRAIN, V94, P1, DOI 10.1093/brain/94.1.1
   MOOY PD, 1984, EUR J PEDIATR, V143, P92, DOI 10.1007/BF00445792
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Morris AAM, 1996, ANN NEUROL, V40, P25, DOI 10.1002/ana.410400107
   Mühlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025
   MUNNICH A, 1992, J INHERIT METAB DIS, V15, P448, DOI 10.1007/BF01799603
   MURPHY JV, 1981, PEDIATRICS, V68, P401
   MURPHY JV, 1973, PEDIATRICS, V51, P710
   Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849
   NAGAI T, 1992, PEDIATR NEUROL, V8, P328, DOI 10.1016/0887-8994(92)90084-C
   Narbonne H, 2004, DIABETES METAB, V30, P61, DOI 10.1016/S1262-3636(07)70090-3
   NARKEWICZ MR, 1991, J PEDIATR-US, V119, P260, DOI 10.1016/S0022-3476(05)80736-X
   Naviaux RK, 1997, SPECTRUM MITOCHONDRI
   Naylor EW, 1997, ELECTROSPRAY TANDEM
   NEUSTEIN HB, 1979, PEDIATRICS, V64, P24
   Newman N.J., 1993, OPHTHALMOL CLIN N AM, V4, P431
   Nielsen Mette Lundgren, 2011, Ugeskr Laeger, V173, P2943
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   Ohkuma A, 2009, MUSCLE NERVE, V39, P333, DOI 10.1002/mus.21167
   OLD SE, 1989, ANN NEUROL, V26, P746, DOI 10.1002/ana.410260610
   OLDFORS A, 1995, ACTA NEUROPATHOL, V90, P328
   Olson S, 1990, AM J HUM GENET, V46, P340
   Olsson C, 1998, HUM MUTAT, V12, P52, DOI 10.1002/(SICI)1098-1004(1998)12:1<52::AID-HUMU8>3.0.CO;2-K
   Ontko J, 1976, ENZYMES MITOCHONDRIA
   OTULAKOWSKI G, 1988, SOMAT CELL MOLEC GEN, V14, P411, DOI 10.1007/BF01534650
   PAMPHLETT R, 1985, MED J AUSTRALIA, V143, P306, DOI 10.5694/j.1326-5377.1985.tb123019.x
   Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3
   PAPADIMITRIOU A, 1984, PEDIATR RES, V18, P1023, DOI 10.1203/00006450-198418100-00023
   Park SB, 2004, YONSEI MED J, V45, P727, DOI 10.3349/ymj.2004.45.4.727
   PARROTROULAUD F, 1991, J INHERIT METAB DIS, V14, P289, DOI 10.1007/BF01811684
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   PEIFFER J, 1988, PATHOL RES PRACT, V183, P706, DOI 10.1016/S0344-0338(88)80056-6
   PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915
   Phadke M, 2012, INDIAN J PEDIAT
   PINCUS JH, 1973, PEDIATRICS, V51, P716
   PINCUS JH, 1969, NEUROLOGY, V19, P841, DOI 10.1212/WNL.19.9.841
   Pineda M, 2006, ANN NEUROL, V59, P394, DOI 10.1002/ana.20746
   Pineda M, 2010, MOVEMENT DISORD, V25, P1262, DOI 10.1002/mds.23129
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   POULTON J, 1989, LANCET, V1, P236
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   PRICK MJJ, 1982, NEUROPEDIATRICS, V13, P108, DOI 10.1055/s-2008-1059608
   Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Quinzii CM, 2011, BIOFACTORS, V37, P361, DOI 10.1002/biof.155
   Quinzii CM, 2005, NEUROLOGY, V64, P539, DOI 10.1212/01.WNL.0000150588.75281.58
   REICHMANN H, 1993, ACTA NEUROPATHOL, V85, P679, DOI 10.1007/BF00334681
   REID JD, 1968, J PEDIATR-US, V73, P335, DOI 10.1016/S0022-3476(68)80109-X
   RHEAD W, 1993, PEDIATR RES, V33, P129, DOI 10.1203/00006450-199302000-00008
   Robinson B H, 1989, Adv Hum Genet, V18, P151
   ROBINSON BH, 1984, J INHERIT METAB DIS, V7, P69, DOI 10.1007/BF03047378
   ROBINSON BH, 1989, ANN NY ACAD SCI, V573, P337, DOI 10.1111/j.1749-6632.1989.tb15009.x
   ROBINSON BH, 1980, PEDIATR RES, V14, P956, DOI 10.1203/00006450-198008000-00013
   ROBINSON BH, 1987, J PEDIATR-US, V111, P525, DOI 10.1016/S0022-3476(87)80112-9
   ROBINSON BH, 1985, PRENATAL DIAG, V5, P67, DOI 10.1002/pd.1970050112
   Robinson BH., 1995, LACTIC ACIDEMIA DISO
   ROBINSON BH, 1989, ANN NY ACAD SCI, V573, P337
   Robinson BH, 1997, J PEDIAT, V111, P525
   Ronchi D, 2011, J NEUROL SCI, V308, P173, DOI 10.1016/j.jns.2011.05.042
   ROSSI L, 1985, CHEST, V87, P340, DOI 10.1378/chest.87.3.340
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   ROYAL V, 1991, NUCLEIC ACIDS RES, V19, P4021, DOI 10.1093/nar/19.14.4021
   RUSTIN P, 1994, J PEDIATR-US, V124, P224, DOI 10.1016/S0022-3476(94)70308-6
   Sacconi S, 2010, NEUROMUSCULAR DISORD, V20, P44, DOI 10.1016/j.nmd.2009.10.014
   Saitoh S, 1998, NEUROLOGY, V50, P531, DOI 10.1212/WNL.50.2.531
   SALO MK, 1992, ARCH DIS CHILD, V67, P1033, DOI 10.1136/adc.67.8.1033
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Sanchez MIGL, 2016, PHARMACOL THERAPEUT, V165, P132, DOI 10.1016/j.pharmthera.2016.06.004
   Sarnat HB, 2005, CAN J NEUROL SCI, V32, P152, DOI 10.1017/S0317167100003929
   Scaglia F, 2010, DEV DISABIL RES REV, V16, P136, DOI 10.1002/ddrr.115
   Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199
   Schuepbach WMM, 2007, J NEUROL, V254, P146, DOI 10.1007/s00415-006-0255-3
   SENGERS RCA, 1984, EUR J PEDIATR, V141, P192, DOI 10.1007/BF00572761
   SENGERS RCA, 1983, EUR J PEDIATR, V140, P332, DOI 10.1007/BF00442676
   Servidei S, 1994, Adv Pediatr, V41, P1
   Sgarbi G, 2009, ARCH NEUROL-CHICAGO, V66, P951, DOI 10.1001/archneurol.2009.134
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   Shehata BM, 1998, PEDIATR DEVEL PATHOL, V1, P56, DOI 10.1007/s100249900007
   Sherer SW, 1989, J BIOL CHEM, V264, P12294
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SHOFFNER JM, 1990, ADV HUM GENET, V19, P267
   SHOFFNER JM, 1992, NEUROLOGY, V42, P2168, DOI 10.1212/WNL.42.11.2168
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shoffner JM., 1995, METABOLIC MOL BASES, V7th, P1535
   SILVER MM, 1980, HUM PATHOL, V11, P598, DOI 10.1016/S0046-8177(80)80071-2
   SILVESTRI G, 1994, HUM MUTAT, V3, P37, DOI 10.1002/humu.1380030107
   Silvestri G, NEUROLOGY, V1993, P1200
   SINGLETON R, 1990, NEUROLOGY, V40, P363, DOI 10.1212/WNL.40.2.363
   SMITH D, 1990, OPHTHALMOLOGY, V97, P1156
   SMITH JL, 1973, ARCH OPHTHALMOL-CHIC, V90, P349
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spencer CT, 2005, PEDIATR CARDIOL, V26, P632, DOI 10.1007/s00246-005-0873-z
   SPERL W, 1988, EUR J PEDIATR, V147, P418, DOI 10.1007/BF00496424
   STACPOOLE PW, 1983, NEW ENGL J MED, V309, P390, DOI 10.1056/NEJM198308183090702
   STANSBIE D, 1986, J INHERIT METAB DIS, V9, P105, DOI 10.1007/BF01799447
   SUSSMAN W, 1950, AM HEART J, V40, P312, DOI 10.1016/0002-8703(50)90175-X
   SUZUKI K, 1969, ARCH NEUROL-CHICAGO, V20, P62, DOI 10.1001/archneur.1969.00480070072008
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Taanman JW, 1997, HUM MOL GENET, V6, P935, DOI 10.1093/hmg/6.6.935
   Tadiboyina VT, 2005, AM J MED GENET A, V135A, P289, DOI 10.1002/ajmg.a.30748
   Takeuchi Jun, 2008, Nihon Ronen Igakkai Zasshi, V45, P95, DOI 10.3143/geriatrics.45.95
   Tanji K, 1999, ANN NEUROL, V45, P377, DOI 10.1002/1531-8249(199903)45:3<377::AID-ANA14>3.0.CO;2-M
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   tHart LM, 1996, HUM MUTAT, V7, P193
   TRIJBELS JMF, 1988, EUR J PEDIATR, V148, P92, DOI 10.1007/BF00445910
   Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062
   TULINIUS MH, 1991, J PEDIATR-US, V119, P242, DOI 10.1016/S0022-3476(05)80734-6
   TULINIUS MH, 1991, J PEDIATR-US, V119, P251, DOI 10.1016/S0022-3476(05)80735-8
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Ulicná O, 2012, PHYSIOL RES, V61, P185, DOI 10.33549/physiolres.932236
   Vallejo-Torres L, 2015, PEDIATRICS, V136, pE424, DOI 10.1542/peds.2014-3399
   van Essen EHR, 2000, DIABETIC MED, V17, P841, DOI 10.1046/j.1464-5491.2000.00379.x
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   van Raam BJ, 2009, CURR OPIN HEMATOL, V16, P14, DOI 10.1097/MOH.0b013e32831c83f3
   VANCOSTER R, 1991, J NEUROL SCI, V104, P97, DOI 10.1016/0022-510X(91)90222-S
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   VazquezMemije ME, 1996, J INHERIT METAB DIS, V19, P43, DOI 10.1007/BF01799347
   Velho G, 1996, DIABETES, V45, P478, DOI 10.2337/diabetes.45.4.478
   VILASECA MA, 1991, J INHERIT METAB DIS, V14, P285, DOI 10.1007/BF01811683
   VONGLUTZ G, 1976, FEBS LETT, V72, P299, DOI 10.1016/0014-5793(76)80991-X
   WALKER B E, 1992, Gastroenterology, V102, pA907
   Wallace D C, 1987, Birth Defects Orig Artic Ser, V23, P137
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   WALTER GF, 1986, NEUROPATH APPL NEURO, V12, P95, DOI 10.1111/j.1365-2990.1986.tb00683.x
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang QJ, 2016, ADV EXP MED BIOL, V854, P543, DOI 10.1007/978-3-319-17121-0_72
   Wang XW, 2008, HUM MOL GENET, V17, P4036, DOI 10.1093/hmg/ddn306
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
   WICKING CA, 1986, BIOCHEM J, V239, P89, DOI 10.1042/bj2390089
   WILSON DC, 1993, EUR J PEDIATR, V152, P260, DOI 10.1007/BF01956158
   WITZLEBEN CL, 1978, ARCH PATHOL LAB MED, V102, P306
   WONG LTK, 1986, PEDIATR RES, V20, P274, DOI 10.1203/00006450-198603000-00016
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yen MY, 2006, PROG RETIN EYE RES, V25, P381, DOI 10.1016/j.preteyeres.2006.05.002
   Young JM, 2011, ATHEROSCLEROSIS, V218, P188, DOI 10.1016/j.atherosclerosis.2011.04.034
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zeviani M, 1998, NEUROLOGY, V51, P1525, DOI 10.1212/WNL.51.6.1525-a
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zeviani M, 2003, CURR OPIN NEUROL, V16, P585, DOI 10.1097/00019052-200310000-00004
   Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133
   ZIMMERMANN A, 1982, VIRCHOWS ARCH A, V396, P187, DOI 10.1007/BF00431240
NR 344
TC 0
Z9 0
U1 0
U2 4
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
BN 978-1-61499-718-4; 978-1-61499-717-7
PY 2017
BP 191
EP 269
DI 10.3233/978-1-61499-718-4-191
PG 79
WC Genetics & Heredity; Pediatrics
WE Book Citation Index – Science (BKCI-S)
SC Genetics & Heredity; Pediatrics
GA BH3OQ
UT WOS:000399881700009
DA 2024-11-01
ER

PT J
AU Mezuki, S
   Fukuda, K
   Matsushita, T
   Fukushima, Y
   Matsuo, R
   Goto, Y
   Yasukawa, T
   Uchiumi, T
   Kang, DC
   Kitazono, T
   Ago, T
AF Mezuki, Satomi
   Fukuda, Kenji
   Matsushita, Tomonaga
   Fukushima, Yoshihisa
   Matsuo, Ryu
   Goto, Yu-ichi
   Yasukawa, Takehiro
   Uchiumi, Takeshi
   Kang, Dongchon
   Kitazono, Takanari
   Ago, Tetsuro
TI Isolated and repeated stroke-like episodes in a middle-aged man with a
   mitochondrial ND3 T10158C mutation: a case report
SO BMC NEUROLOGY
LA English
DT Article
DE Cognitive impairment; MELAS; Mitochondrial ND3 gene; T10158C; Sporadic
ID COMPLEX-I DEFICIENCY; MISSENSE MUTATION; LEIGH-SYNDROME; GENE;
   ENCEPHALOPATHY; DISEASE
AB Background: Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome, is the most common phenotype of mitochondrial disease. It often develops in childhood or adolescence, usually before the age of 40, in a maternally-inherited manner. Mutations in mitochondrial DNA (mtDNA) are frequently responsible for MELAS.
   Case presentation: A 55-year-old man, who had no family or past history of mitochondrial disorders, suddenly developed bilateral visual field constriction and repeated stroke-like episodes. He ultimately presented with cortical blindness, recurrent epilepsy and severe cognitive impairment approximately 6 months after the first episode. Genetic analysis of biopsied biceps brachii muscle, but not of peripheral white blood cells, revealed a T10158C mutation in the mtDNA-encoded gene of NADH dehydrogenase subunit 3 (ND3), which has previously been thought to be associated with severe or fatal mitochondrial disorders that develop during the neonatal period or in infancy.
   Conclusion: A T10158C mutation in the ND3 gene can cause atypical adult-onset stroke-like episodes in a sporadic manner.
C1 [Mezuki, Satomi; Fukuda, Kenji; Matsushita, Tomonaga; Fukushima, Yoshihisa] St Marys Hosp, Stroke Ctr, 422 Tsubukuhonmachi, Kurume, Fukuoka 8308543, Japan.
   [Mezuki, Satomi; Matsuo, Ryu; Kitazono, Takanari; Ago, Tetsuro] Kyushu Univ, Dept Med & Clin Sci, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.
   [Goto, Yu-ichi] Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, NCNP, 4-1-1 Ogawa Higashi, Kodaira, Tokyo 1878551, Japan.
   [Yasukawa, Takehiro; Uchiumi, Takeshi; Kang, Dongchon] Kyushu Univ, Dept Pathol Sci, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.
C3 Kyushu University; National Center for Neurology & Psychiatry - Japan;
   Kyushu University
RP Mezuki, S (corresponding author), St Marys Hosp, Stroke Ctr, 422 Tsubukuhonmachi, Kurume, Fukuoka 8308543, Japan.; Ago, T (corresponding author), Kyushu Univ, Dept Med & Clin Sci, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.
EM smezuki@intmed2.med.kyushu-u.ac.jp; agou@intmed2.med.kyushu-u.ac.jp
RI Yasukawa, Takehiro/AAP-1335-2020
OI Yasukawa, Takehiro/0000-0001-9531-8780; Ago, Tetsuro/0000-0003-4560-6594
FU Grants-in-Aid for Scientific Research [17H01550] Funding Source: KAKEN
CR Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   Galkin A, 2008, J BIOL CHEM, V283, P20907, DOI 10.1074/jbc.M803190200
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Kreutz M, 2015, METHODS MOL BIOL, V1315, P17, DOI 10.1007/978-1-4939-2715-9_2
   Leshinsky-Silver E, 2005, BIOCHEM BIOPH RES CO, V334, P582, DOI 10.1016/j.bbrc.2005.06.134
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Mukai M, 2015, NEUROL CLIN NEUROSCI, V3, P153, DOI 10.1111/ncn3.173
   Mukai M, 2017, INTERNAL MED, V56, P95, DOI 10.2169/internalmedicine.56.7301
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Wang K, 2009, NEUROGENETICS, V10, P337, DOI 10.1007/s10048-009-0194-0
   Werner KGE, 2009, PEDIATR NEUROL, V41, P27, DOI 10.1016/j.pediatrneurol.2009.02.010
NR 16
TC 12
Z9 12
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2377
J9 BMC NEUROL
JI BMC Neurol.
PD DEC 13
PY 2017
VL 17
AR 217
DI 10.1186/s12883-017-1001-4
PG 5
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA FQ2EW
UT WOS:000418170700001
PM 29237403
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Pula, S
   Urankar, K
   Norman, A
   Pierre, G
   Langton-Hewer, S
   Selby, V
   Mason, F
   Vijayakumar, K
   McFarland, R
   Taylor, RW
   Majumdar, A
AF Pula, Shpresa
   Urankar, Kathryn
   Norman, Andrew
   Pierre, Germaine
   Langton-Hewer, Simon
   Selby, Victoria
   Mason, Faye
   Vijayakumar, Kayal
   McFarland, Robert
   Taylor, Robert W.
   Majumdar, Anirban
TI A novel <i>de novo ACTA1</i> variant in a patient with nemaline myopathy
   and mitochondrial Complex I deficiency
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Nemaline myopathy; ACTA1; Mitochondrial dysfunction
ID CLINICAL APPROACH; MUTATIONS; MECHANISMS; DIAGNOSIS; PHENOTYPE; DISEASE;
   GENE; DNA
AB We describe the presentation and follow-up of a three-year-old girl with nemaline myopathy due to a de-novo variant in ACTA1 (encoding skeletal alpha actin) and moderately low enzyme level of Complex I of the mitochondrial respiratory chain. She presented in the neonatal period with hypotonia, followed by weakness in the facial, bulbar, respiratory and neck flexors muscles. A biopsy of her quadriceps muscle at the age of one year showed nemaline rods. Based on her clinical presentation of a congenital myopathy and histopathological features on a muscle biopsy, ACTA1 was sequenced, and this revealed a novel sequence variant, c.760 A >C p. (Asn254His). In addition, mitochondrial respiratory chain enzymatic activity of skeletal muscle biopsy showed a moderately low activity of complex I (nicotinamide adenine dinucleotide (NADH): ubiquinone oxidoreductase). Disturbances of Complex I of the respiratory chain have been reported in patients with nemaline myopathy, although the mechanism remains unclear. Crown Copyright (C) 2019 Published by Elsevier B.V. All rights reserved.
C1 [Pula, Shpresa; Pierre, Germaine; Selby, Victoria; Mason, Faye; Vijayakumar, Kayal; Majumdar, Anirban] Univ Hosp Bristol NHS Fdn Trust, Dept Paediat Neurol, 6th Floor Educ Ctr,Upper Maudlin St, Bristol BS2 8BJ, Avon, England.
   [Urankar, Kathryn] North Bristol Hosp NHS Fdn Trust, Dept Neuropathol, Bristol, Avon, England.
   [Norman, Andrew] Univ Hosp Bristol NHS Fdn Trust, Dept Clin Genet, Bristol, Avon, England.
   [Langton-Hewer, Simon] Univ Hosp Bristol NHS Fdn Trust, Bristol Royal Hosp Children, Dept Paediat Resp Med, Bristol, Avon, England.
   [McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Neurosci, Newcastle, England.
C3 University of Bristol; University of Bristol; University of Bristol;
   Bristol Royal Hospital For Children; Newcastle University - UK
RP Majumdar, A (corresponding author), Univ Hosp Bristol NHS Fdn Trust, Dept Paediat Neurol, 6th Floor Educ Ctr,Upper Maudlin St, Bristol BS2 8BJ, Avon, England.
EM Anirban.Majumdar@uhbristol.nhs.uk
OI Langton Hewer, Simon/0000-0002-2711-8258; Taylor,
   Robert/0000-0002-7768-8873
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical
   Research Council (MRC) Centre for Translational Research in
   Neuromuscular Disease, Mitochondrial Disease Patient Cohort (UK)
   [G0800674]; Lily Foundation; UK NIHR Biomedical Research Centre for
   Ageing and Agerelated disease award; MRC/EPSRC Molecular Pathology Node;
   UK NHS Highly Specialised Service for Rare Mitochondrial Disorders of
   Adults and Children
FX RWT and RM are supported by the Wellcome Centre for Mitochondrial
   Research (203105/Z/16/Z), the Medical Research Council (MRC) Centre for
   Translational Research in Neuromuscular Disease, Mitochondrial Disease
   Patient Cohort (UK) (G0800674), the Lily Foundation, the UK NIHR
   Biomedical Research Centre for Ageing and Agerelated disease award to
   the Newcastle upon Tyne Foundation Hospitals NHS Trust, the MRC/EPSRC
   Molecular Pathology Node and the UK NHS Highly Specialised Service for
   Rare Mitochondrial Disorders of Adults and Children.
CR Berger A, 2003, ACTA NEUROPATHOL, V105, P245, DOI 10.1007/s00401-002-0638-1
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Finsterer J, 2015, PEDIATR NEUROL, V53, P473, DOI 10.1016/j.pediatrneurol.2015.08.014
   Gajda A, 2015, J CHILD NEUROL, V30, P627, DOI 10.1177/0883073813494476
   Gommans IMP, 2002, NEUROMUSCULAR DISORD, V12, P13, DOI 10.1016/S0960-8966(01)00231-0
   Kisler JE, 2010, DEV MED CHILD NEUROL, V52, P422, DOI 10.1111/j.1469-8749.2009.03605.x
   KORNFELD M, 1980, ACTA NEUROPATHOL, V51, P185, DOI 10.1007/BF00687385
   Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059
   Lamont PJ, 2004, NEUROPEDIATRICS, V35, P302, DOI 10.1055/s-2004-821243
   Levesque L, 2013, NEUROMUSCULAR DISORD, V23, P239, DOI 10.1016/j.nmd.2012.12.004
   Lindqvist J, 2013, J NEUROPATH EXP NEUR, V72, P472, DOI 10.1097/NEN.0b013e318293b1cc
   Lornage X, 2017, ANN NEUROL, V81, P467, DOI 10.1002/ana.24900
   Malfatti Edoardo, 2015, J Neuromuscul Dis, V2, P219
   Nilipour Y, 2018, EUR J NEUROL, V25, P841, DOI 10.1111/ene.13607
   Niyazov DM, 2016, MOL SYNDROMOL, V7, P122, DOI 10.1159/000446586
   North KN, 2011, SEMIN PEDIATR NEUROL, V18, P216, DOI 10.1016/j.spen.2011.10.002
   Rocha MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15037
   Romero NB, 2013, CURR OPIN NEUROL, V26, P519, DOI 10.1097/WCO.0b013e328364d681
   Sandaradura SA, 2018, HUM MUTAT, V39, P383, DOI 10.1002/humu.23385
   Taylor RW, 1998, BIOCHEM BIOPH RES CO, V243, P47, DOI 10.1006/bbrc.1997.8055
   Tucker EJ, 2011, IUBMB LIFE, V63, P669, DOI 10.1002/iub.495
   Wallgren-Pettersson C, 2011, SEMIN PEDIATR NEUROL, V18, P230, DOI 10.1016/j.spen.2011.10.004
NR 23
TC 6
Z9 7
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD FEB
PY 2020
VL 30
IS 2
BP 159
EP 164
DI 10.1016/j.nmd.2019.11.014
PG 6
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA LD1XA
UT WOS:000525823700008
PM 32005493
DA 2024-11-01
ER

PT J
AU Davidzon, G
   Mancuso, M
   Ferraris, S
   Quinzii, C
   Hirano, M
   Peters, HL
   Kirby, D
   Thorburn, DR
   DiMauro, S
AF Davidzon, G
   Mancuso, M
   Ferraris, S
   Quinzii, C
   Hirano, M
   Peters, HL
   Kirby, D
   Thorburn, DR
   DiMauro, S
TI <i>POLG</i> mutations and Alpers syndrome
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID MITOCHONDRIAL-DNA DEPLETION; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   POLYMERASE-GAMMA-A; THYMIDINE KINASE; DEGENERATION; DISEASE; GENE;
   CHILDHOOD; DEFICIENCY; FEATURES
AB Alpers-Huttenlocher syndrome (AHS) an autosomal recessive hepatocerebral syndrome of early onset, has been associated with mitochondrial DNA (mtDNA) depletion and mutations in polymerase gamma gene (POLG). We have identified POLG mutations in four patients with hepatocerebral syndrome and mtDNA depletion in liver, who fulfilled. criteria for AHS. All were compound heterozygous for the G848S and W748S mutations, previously reported in patients with progressive external ophtalmoplegia or ataxia. We conclude that AHS should be included in the clinical spectrum of mtDNA depletion and is often associated with POLG mutations, which can cause either multiple mtDNA deletions or mtDNA depletion.
C1 Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA.
   Univ Pisa, Inst Neurol, Dept Neurosci, Pisa, Italy.
   Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.
   Victoria Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   Victoria Royal Childrens Hosp, Genet Hlth Serv, Melbourne, Vic, Australia.
C3 Columbia University; University of Pisa; University of Melbourne;
   Murdoch Children's Research Institute; Royal Children's Hospital
   Melbourne; Royal Children's Hospital Melbourne
RP Columbia Univ, Coll Phys & Surg 4 420, 630 West 168th St, New York, NY 10032 USA.
EM sd12@columbia.edu
RI peters, heidi/GWD-0358-2022; Thorburn, David/G-6266-2013; Mancuso,
   Michelangelo/K-4170-2016
OI Peters, Heidi/0000-0001-7189-5874; thorburn, david/0000-0002-7725-9470;
   Davidzon, Guido/0000-0001-5579-6825
FU NICHD NIH HHS [HD32062] Funding Source: Medline; NINDS NIH HHS [NS11766]
   Funding Source: Medline
CR Alpers BJ, 1931, ARCH NEURO PSYCHIATR, V25, P469, DOI 10.1001/archneurpsyc.1931.02230030027002
   Bai RK, 2004, ANN NY ACAD SCI, V1011, P304, DOI 10.1196/annals.1293.029
   BICKNESE AR, 1992, ANN NEUROL, V32, P767, DOI 10.1002/ana.410320610
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   HUTTENLOCHER PR, 1976, ARCH NEUROL-CHICAGO, V33, P186, DOI 10.1001/archneur.1976.00500030042009
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   PRICK MJJ, 1983, CLIN NEUROL NEUROSUR, V85, P57, DOI 10.1016/0303-8467(83)90024-0
   Rasmussen M, 2000, J CHILD NEUROL, V15, P473, DOI 10.1177/088307380001500709
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Simonati A, 2003, ACTA NEUROPATHOL, V106, P57, DOI 10.1007/s00401-003-0698-x
   Uusimaa J, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e262
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
NR 20
TC 102
Z9 107
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD JUN
PY 2005
VL 57
IS 6
BP 921
EP 923
DI 10.1002/ana.20498
PG 3
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 931XH
UT WOS:000229518300019
PM 15929042
DA 2024-11-01
ER

PT J
AU Chae, HW
   Na, JH
   Kim, HS
   Lee, YM
AF Chae, Hyun-Wook
   Na, Ji-Hoon
   Kim, Ho-Seong
   Lee, Young-Mock
TI Mitochondrial diabetes and mitochondrial DNA mutation load in MELAS
   syndrome
SO EUROPEAN JOURNAL OF ENDOCRINOLOGY
LA English
DT Article
ID INSULIN SENSITIVITY; CUTOFF POINTS; GENE; PATHOGENESIS; RESISTANCE;
   PHENOTYPE; DIAGNOSIS; MELLITUS; DEAFNESS; DISEASE
AB Objective: Mitochondria! myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is a very rare condition; it encompasses a diverse group of disorders including diabetes. Phenotypic variability can be attributed to heteroplasmy along with varying proportions of mutant and WT mitochondrial DNA (mtDNA). To examine the clinical relationship between mitochondrial diabetes and mutational load, we analyzed the mtDNA of children and young adolescents with MELAS syndrome using next generation sequencing (NGS).
   Design and methods: Of 57 subjects with suspected MELAS syndrome, 32 children and young adolescents were diagnosed as MELAS syndrome with mtDNA A-to-G transition at nucleotide 3243. Mutation load studies and NGS were performed for 25 subjects.
   Results: The mean mutation load was 60.4 +/- 18.4% (range: 22.5-100). Of the 25 subjects with NGS results, 15 (60%) were diagnosed with DM and 2 (8%) were diagnosed with impaired glucose tolerance (IGT). The mutational load of subjects inversely correlated with first symptom onset, age at diagnosis of MELAS syndrome, and DM (P < 0.001). However, mutational load did not correlate with the clinical severity or progression of DM/IGT. There was no significant difference in insulin resistance or sensitivity indices between the low- and high-mutation load groups. During the 3.7 years of follow-up, insulin resistance indices were not significantly different between baseline and follow-up.
   Conclusions: We can infer that the mutation load in the MELAS syndrome is significantly associated with the onset of symptoms and associated diseases, including mitochondrial diabetes. However, it may not influence disease progression.
C1 [Chae, Hyun-Wook; Na, Ji-Hoon; Kim, Ho-Seong; Lee, Young-Mock] Yonsei Univ, Severance Childrens Hosp, Gangnam Severance Hosp, Dept Pediat,Coll Med, Seoul, South Korea.
C3 Yonsei University; Yonsei University Health System
RP Lee, YM (corresponding author), Yonsei Univ, Severance Childrens Hosp, Gangnam Severance Hosp, Dept Pediat,Coll Med, Seoul, South Korea.
EM ymleemd@yuhs.ac
RI Lee, Jun Young/CAI-2335-2022
OI LEE, YOUNG-MOCK/0000-0002-5838-249X; Kim, Ho-Seong/0000-0003-1135-099X;
   Chae, Hyun Wook/0000-0001-5016-8539; Na, Ji-Hoon/0000-0002-3051-2010
CR Bratic I, 2010, BBA-BIOENERGETICS, V1797, P961, DOI 10.1016/j.bbabio.2010.01.004
   de Wit HM, 2012, NETH J MED, V70, P460
   DiMauro S, 2013, JAMA NEUROL, V70, P1484, DOI 10.1001/jamaneurol.2013.4401
   Duan MQ, 2018, MOLECULES, V23, DOI 10.3390/molecules23020323
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Fromont I, 2009, J NEUROL, V256, P1696, DOI 10.1007/s00415-009-5185-4
   Ghasemi A, 2015, ACTA DIABETOL, V52, P905, DOI 10.1007/s00592-015-0730-3
   Henríquez S, 2013, NUTR HOSP, V28, P1594, DOI 10.3305/nh.2013.28.5.6512
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hrebícek J, 2002, J CLIN ENDOCR METAB, V87, P144, DOI 10.1210/jc.87.1.144
   Ikeda T, 2018, HUM GENOME VAR, V5, DOI 10.1038/s41439-018-0026-6
   Jansen JJ, 1997, J AM SOC NEPHROL, V8, P1118
   Joung KH, 2011, PEDIATR INT, V53, P832, DOI 10.1111/j.1442-200X.2011.03394.x
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lynn S, 2003, DIABETOLOGIA, V46, P296, DOI 10.1007/s00125-002-1018-z
   Maassen J. A., 2002, Archives of Physiology and Biochemistry, V110, P186, DOI 10.1076/apab.110.3.186.8294
   Maassen JA, 1996, DIABETOLOGIA, V39, P375
   Maassen JA, 2006, ENDOCRIN METAB CLIN, V35, P385, DOI 10.1016/j.ecl.2006.02.014
   Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103
   Maechler P, 2013, MOL CELL ENDOCRINOL, V379, P12, DOI 10.1016/j.mce.2013.06.019
   Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462
   Motamed N, 2016, J DIABETES COMPLICAT, V30, P269, DOI 10.1016/j.jdiacomp.2015.11.019
   Niyazov DM, 2016, MOL SYNDROMOL, V7, P122, DOI 10.1159/000446586
   Nsiah-Sefaa A, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150295
   Piechota Janusz, 2001, Journal of Applied Genetics, V42, P351
   Schaefer AM, 2013, MOL CELL ENDOCRINOL, V379, P2, DOI 10.1016/j.mce.2013.06.004
   Skupien Jan, 2006, Review of Diabetic Studies, V3, P17, DOI 10.1900/RDS.2006.3.17
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Sweet IR, 2004, DIABETES, V53, P401, DOI 10.2337/diabetes.53.2.401
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tsuruzoe K, 1998, DIABETES, V47, P621, DOI 10.2337/diabetes.47.4.621
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220
NR 36
TC 11
Z9 12
U1 1
U2 7
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA STARLING HOUSE, 1600 BRISTOL PARKWAY N, BRISTOL, ENGLAND
SN 0804-4643
EI 1479-683X
J9 EUR J ENDOCRINOL
JI Eur. J. Endocrinol.
PD NOV
PY 2020
VL 183
IS 5
BP 505
EP 512
DI 10.1530/EJE-20-0189
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA NZ8AR
UT WOS:000577325000008
PM 33107434
OA Bronze
DA 2024-11-01
ER

PT J
AU Pancrudo, J
   Shanske, S
   Cau, J
   Lu, J
   Mardach, R
   Akinan, O
   Krishna, S
   Bonilla, E
   DiNlauro, S
AF Pancrudo, Jacklyn
   Shanske, Sara
   Cau, Jorida
   Lu, J.
   Mardach, Rebecca
   Akinan, Orhan
   Krishna, Sindu
   Bonilla, Eduardo
   DiNlauro, Salvatore
TI Mitochondrial myopathy associated with a novel mutation in mtDNA
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE mtDNA mutation; tRNA-arginine; mitochondrial encephalomyopathy
ID DNA; ABNORMALITIES; GENES
AB A 6-year-old boy had progressive muscle weakness since age 4 and emotional problems diagnosed as Asperger syndrome. His mother and two older siblings are in good health and there is no family history of neuromuscular disorders. Muscle biopsy showed ragged-red and cytochrome c oxidase (COX)-negative fibers. Respiratory chain activities were reduced for all enzymes containing mtDNA-encoded subunits, especially COX. Sequence analysis of the 22 tRNA genes revealed a novel G10406A base substitution, which was heteroplasmic in multiple tissues of the patient by RFLP analysis (muscle, 96%; urinary sediment, 94%; cheek mucosa, 36%; blood, 29%). The mutation was not detected in any accessible tissues from his mother or siblings. It appears that this mutation arose de novo in the proband, probably early in embryogenesis. (C) 2007 Elsevier B.V. All rights reserved.
C1 Columbia Univ, Coll Phys & Surg 4 420, Med Ctr,Dept Neurol, H Houston Merritt Clin Res Ctr Muscular Dystrophy, New York, NY 10032 USA.
   Kaiser Permanente Med Ctr, Div Med Genet, Los Angeles, CA 90034 USA.
C3 Columbia University; Kaiser Permanente
RP DiNlauro, S (corresponding author), Columbia Univ, Coll Phys & Surg 4 420, Med Ctr,Dept Neurol, H Houston Merritt Clin Res Ctr Muscular Dystrophy, 630 W 168th St, New York, NY 10032 USA.
EM sd12@columbia.edu
FU NICHD NIH HHS [P01 HD032062, P01 HD032062-049001, HD 32062] Funding
   Source: Medline
CR DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   HAYASHI JI, 1994, J BIOL CHEM, V269, P19060
   Pons R, 2004, J PEDIATR-US, V144, P81, DOI 10.1016/j.jpeds.2003.10.023
   SCHON EA, 2006, MITOCHONDRIAL MED, P329
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Tanji K, 2001, METHOD CELL BIOL, V65, P311, DOI 10.1016/S0091-679X(01)65019-2
   Uusimaa J, 2004, PEDIATRICS, V114, P443, DOI 10.1542/peds.114.2.443
NR 7
TC 15
Z9 19
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD AUG
PY 2007
VL 17
IS 8
BP 651
EP 654
DI 10.1016/j.nmd.2007.04.005
PG 4
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 202BJ
UT WOS:000248876200008
PM 17588757
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Carossa, V
   Ghelli, A
   Tropeano, CV
   Valentino, ML
   Iommarini, L
   Maresca, A
   Caporali, L
   La Morgia, C
   Liguori, R
   Barboni, P
   Carbonelli, M
   Rizzo, G
   Tonon, C
   Lodi, R
   Martinuzzi, A
   De Nardo, V
   Rugolo, M
   Ferretti, L
   Gandini, F
   Pala, M
   Achilli, A
   Olivieri, A
   Torroni, A
   Carelli, V
AF Carossa, Valeria
   Ghelli, Anna
   Tropeano, Concetta Valentina
   Valentino, Maria Lucia
   Iommarini, Luisa
   Maresca, Alessandra
   Caporali, Leonardo
   La Morgia, Chiara
   Liguori, Rocco
   Barboni, Piero
   Carbonelli, Michele
   Rizzo, Giovanni
   Tonon, Caterina
   Lodi, Raffaele
   Martinuzzi, Andrea
   De Nardo, Vera
   Rugolo, Michela
   Ferretti, Luca
   Gandini, Francesca
   Pala, Maria
   Achilli, Alessandro
   Olivieri, Anna
   Torroni, Antonio
   Carelli, Valerio
TI A Novel in-Frame 18-bp Microdeletion in <i>MT</i>-<i>CYB</i> Causes a
   Multisystem Disorder with Prominent Exercise Intolerance
SO HUMAN MUTATION
LA English
DT Article
DE mtDNA; MT-CYB; exercise intolerance; multi system mitochondrial disease;
   cybrid
ID CYTOCHROME-B GENE; HUMAN MITOCHONDRIAL-DNA; COMPLEX-III DEFICIENCY;
   RESPIRATORY-CHAIN; MUTATION; DELETION; TREE
AB A novel heteroplasmic mitochondrial DNA (mtDNA) microdeletion affecting the cytochrome b gene (MT-CYB) was identified in an Italian female patient with a multisystem disease characterized by sensorineural deafness, cataracts, retinal pigmentary dystrophy, dysphagia, postural and gait instability, and myopathy with prominent exercise intolerance. The deletion is 18-base pair long and encompasses nucleotide positions 15,649-15,666, causing the loss of six amino acids (Ile-Leu-Ala-Met-Ile-Pro) in the protein, but leaving the remaining of the MT-CYB sequence in frame. The defective complex III function was cotransferred with mutant mtDNA in cybrids, thus unequivocally establishing its pathogenic role. Maternal relatives failed to show detectable levels of the deletion in blood and urinary epithelium, suggesting a de novo mutational event. This is the second report of an in-frame intragenic deletion in MT-CYB, which most likely occurred in early stages of embryonic development, associated with a severe multisystem disorder with prominent exercise intolerance. (C) 2014 Wiley Periodicals, Inc.
C1 [Carossa, Valeria; Ferretti, Luca; Gandini, Francesca; Pala, Maria; Olivieri, Anna; Torroni, Antonio] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, I-27100 Pavia, Italy.
   [Ghelli, Anna; Tropeano, Concetta Valentina; Iommarini, Luisa; Rugolo, Michela] Univ Bologna, Dipartimento Farm & Biotecnol, Bologna, Italy.
   [Valentino, Maria Lucia; Maresca, Alessandra; Caporali, Leonardo; La Morgia, Chiara; Liguori, Rocco; Carelli, Valerio] IRCCS Ist Sci Neurol Bologna, Bologna, Italy.
   [Valentino, Maria Lucia; Maresca, Alessandra; La Morgia, Chiara; Liguori, Rocco; Rizzo, Giovanni; Carelli, Valerio] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie, Unita Neurol, Bologna, Italy.
   [Barboni, Piero; Carbonelli, Michele] Studio Oculist DAzeglio, Bologna, Italy.
   [Rizzo, Giovanni; Tonon, Caterina; Lodi, Raffaele] Univ Bologna, Policlin S Orsola Malpighi, Dipartimento Sci Biomed & Neuromotorie, Unita RM Funz, Bologna, Italy.
   [Martinuzzi, Andrea] IRCSS E Medea La Nostra Famiglia, Conegliano, TV, Italy.
   [De Nardo, Vera] Univ Padua, Dipartimento Sci Farmaco, Padua, Italy.
   [Achilli, Alessandro] Univ Perugia, Dipartimento Chim Biol & Biotecnol, I-06100 Perugia, Italy.
   [Torroni, Antonio] IRCCS Ist Neurol Nazl C Mondino, Pavia, Italy.
C3 University of Pavia; University of Bologna; IRCCS Istituto delle Scienze
   Neurologiche di Bologna (ISNB); University of Bologna; IRCCS Azienda
   Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS
   Eugenio Medea; University of Padua; University of Perugia; IRCCS
   Fondazione Casimiro Mondino
RP Carelli, V (corresponding author), Univ Bologna, Neurogenet Lab, IRCCS Inst Neurol Sci Bologna, Dept Biomed & NeuroMotor Sci DIBINEM, Via Altura 3, Bologna, Italy.
EM valerio.carelli@unibo.it
RI Lodi, Raffaele/K-4984-2016; Rugolo, Michela/AAY-8640-2020; Tonon,
   Caterina/K-6680-2016; Liguori, Rocco/AAB-7860-2020; Rizzo,
   Giovanni/AAB-9888-2020; Torroni, Antonio/E-1557-2011; La Morgia,
   Chiara/H-6765-2012; Ferretti, Luca/D-2337-2013; Achilli,
   Alessandro/I-9236-2012; Gandini, Francesca/H-8936-2015; Maresca,
   Alessandra/J-7393-2016; Iommarini, Luisa/J-2328-2018; Barboni,
   Piero/AAA-9936-2020; Martinuzzi, Andrea/K-3887-2016; Caporali,
   Leonardo/J-7398-2016; OLIVIERI, ANNA/I-9235-2012
OI Achilli, Alessandro/0000-0001-6871-3451; VALENTINO, MARIA
   LUCIA/0000-0001-5323-0115; Torroni, Antonio/0000-0002-4163-4478; Rugolo,
   Michela/0000-0002-4597-0452; Liguori, Rocco/0000-0002-1815-1013; Pala,
   Maria/0000-0001-9202-8331; LA MORGIA, Chiara/0000-0002-4639-8929; TONON,
   CATERINA/0000-0002-0506-499X; Gandini, Francesca/0000-0001-8930-8295;
   Lodi, Raffaele/0000-0003-3878-304X; Maresca,
   Alessandra/0000-0002-8959-8832; Iommarini, Luisa/0000-0002-6804-7302;
   Barboni, Piero/0000-0002-0118-4177; GHELLI, ANNA
   MARIA/0000-0003-0830-0000; Ferretti, Luca/0000-0001-5044-8442; CARELLI,
   VALERIO/0000-0003-4923-6404; Martinuzzi, Andrea/0000-0002-0319-3579;
   Caporali, Leonardo/0000-0002-0666-4380; Rizzo,
   Giovanni/0000-0002-9718-2044; OLIVIERI, ANNA/0000-0002-3941-8098;
   Tropeano, Concetta Valentina/0000-0001-5257-5648
FU Italian Ministry of Education, University and Research: Progetti Futuro
   in Ricerca [RBFR08U07M, RBFR126B8I]; Progetti Ricerca Interesse
   Nazionale; National Institutes of Health [GM 38237]
FX Contract grant sponsors: Italian Ministry of Education, University and
   Research: Progetti Futuro in Ricerca 2008 (RBFR08U07M) and 2012
   (RBFR126B8I); Progetti Ricerca Interesse Nazionale 2012; National
   Institutes of Health (GM 38237).
CR Acín-Pérez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002
   Bénit P, 2009, BBA-MOL CELL RES, V1793, P181, DOI 10.1016/j.bbamcr.2008.06.004
   Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005
   Blakely EL, 2005, FEBS J, V272, P3583, DOI 10.1111/j.1742-4658.2005.04779.x
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   Diaz F, 2012, MOL CELL BIOL, V32, P415, DOI 10.1128/MCB.06051-11
   Fragaki K, 2009, MITOCHONDRION, V9, P346, DOI 10.1016/j.mito.2009.06.002
   Ghelli A, 2013, HUM MOL GENET, V22, P2141, DOI 10.1093/hmg/ddt067
   Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873
   Keightley JA, 2000, AM J HUM GENET, V67, P1400, DOI 10.1086/316900
   Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381
   Rana M, 2000, ANN NEUROL, V48, P774, DOI 10.1002/1531-8249(200011)48:5<774::AID-ANA11>3.3.CO;2-9
   Robinson B H, 1996, Methods Enzymol, V264, P454, DOI 10.1016/S0076-6879(96)64041-5
   Schägger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200
   Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921
NR 20
TC 35
Z9 36
U1 1
U2 16
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-7794
EI 1098-1004
J9 HUM MUTAT
JI Hum. Mutat.
PD AUG
PY 2014
VL 35
IS 8
BP 954
EP 958
DI 10.1002/humu.22596
PG 5
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA AL9AL
UT WOS:000339431600008
PM 24863938
OA gold
DA 2024-11-01
ER

PT J
AU Lu, JQ
   Mubaraki, A
   Yan, CZ
   Provias, J
   Tarnopolsky, MA
AF Lu, Jian-Qiang
   Mubaraki, Adnan
   Yan, Chuanzhu
   Provias, John
   Tarnopolsky, Mark A.
TI Neurogenic Muscle Biopsy Findings Are Common in Mitochondrial Myopathy
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE Denervation atrophy; Fiber type grouping; Mitochondrial disease;
   Mitochondrial myopathy; Neurogenic features; Neuropathy; Type 2 fiber
   predominance
ID PERIPHERAL NEUROPATHY; NEUROMUSCULAR SYSTEM; DENERVATED MUSCLE;
   SKELETAL-MUSCLE; DNA; GENERATION; ABNORMALITIES; INVOLVEMENT; DISORDERS;
   MUTATIONS
AB Mitochondrial diseases (MIDs) involve peripheral nerves and skeletal muscle, but the prevalence of mitochondrial neuropathy is still unclear. Mitochondrial neuropathy has been found to correlate with muscle weakness that may be due to myopathic and/or neurogenic myopathy in patients with MIDs. We examined vastus lateralis muscle biopsies of 58 consecutive patients with mitochondrial myopathy (MM), compared with 204 consecutive non-MM patients. Muscle fiber denervation atrophy was found in 39/58 (67%) of MM patients, significantly more than 41/204 (20%) of non-MM patients and 20/58 (34%) of clinically diagnosed neuropathy. Fiber type grouping was noted in 15/58 (26%) of MM patients, significantly more than 15/204 (7%) of non-MM patients. Type 2 fiber predominance (T2FP) was identified in 7/58 (12%) of MM patients, significantly more than 1/204 (0.5%) of non-MM patients. After dividing patients into age groups, muscle fiber denervation atrophy was significantly more in MM patients aged >50 years than MM patients aged <= 50 years, without differences from all MM patients; there were no differences in fiber type grouping or T2FP between the 2 age groups. Finally, electron microscopy demonstrated MM ultrastructural changes in the neuromuscular junctions. Our findings suggest that a neurogenic component in MM is common.
C1 [Lu, Jian-Qiang; Provias, John] McMaster Univ, Dept Pathol & Mol Med Neuropathol, Hamilton, ON, Canada.
   [Mubaraki, Adnan; Tarnopolsky, Mark A.] McMaster Univ, Dept Med Neurol, Hamilton, ON, Canada.
   [Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada.
   [Yan, Chuanzhu] Shandong Univ, Neuromuscular Ctr, Qilu Hosp, Jinan, Shandong, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Mitochondrial Med Lab, Qilu Hosp, Jinan, Shandong, Peoples R China.
C3 McMaster University; McMaster University; McMaster University; Shandong
   University; Shandong University
RP Lu, JQ (corresponding author), McMaster Univ, Hamilton Gen Hosp, 237 Barton St, Hamilton, ON L8L 2X2, Canada.
EM luj85@mcmaster.ca
RI LU, JIAN-QIANG/AAL-1634-2020
OI Lu, Jian-Qiang/0000-0003-1945-5569; Mubaraki, Adnan
   A/0000-0002-6200-5080
CR [Anonymous], 2013, MUSCLE BIOPSY PRACTI
   Areti A, 2016, CURR NEUROPHARMACOL, V14, P593, DOI 10.2174/1570159X14666151126215358
   Chu CC, 1997, EUR NEUROL, V37, P110, DOI 10.1159/000117420
   Cormio A, 2005, NEUROBIOL AGING, V26, P655, DOI 10.1016/j.neurobiolaging.2004.06.014
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DING R, 1982, BRAIN RES, V253, P47, DOI 10.1016/0006-8993(82)90672-2
   EISENBERG HA, 1994, J APPL PHYSIOL, V76, P859, DOI 10.1152/jappl.1994.76.2.859
   Enns GM, 2005, CLIN GENET, V68, P337, DOI 10.1111/j.1399-0004.2005.00499.x
   Finsterer J, 2005, CLIN NEUROL NEUROSUR, V107, P181, DOI 10.1016/j.clineuro.2004.07.001
   Finsterer J, 2018, J CLIN MED, V7, DOI 10.3390/jcm7020016
   Finsterer J, 2016, NEUROMUSCULAR DISORD, V26, P548, DOI 10.1016/j.nmd.2016.06.006
   Flippo KH, 2017, J CELL SCI, V130, P671, DOI 10.1242/jcs.171017
   Gehrig SM, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0488-x
   Girlanda P, 1999, CLIN NEUROPHYSIOL, V110, P1284, DOI 10.1016/S1388-2457(98)00041-8
   Haas RH, 2014, SEMIN NEUROL, V34, P321, DOI 10.1055/s-0034-1386770
   Heighton JN, 2019, MITOCHONDRION, V44, P15, DOI 10.1016/j.mito.2017.12.006
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Kerkhof J, 2017, J MOL DIAGN, V19, P905, DOI 10.1016/j.jmoldx.2017.07.004
   KRENDEL DA, 1987, MUSCLE NERVE, V10, P299, DOI 10.1002/mus.880100404
   Lu JQ, 2016, J NEUROL SCI, V360, P84, DOI 10.1016/j.jns.2015.11.053
   Mancuso M, 2016, NEUROMUSCULAR DISORD, V26, P272, DOI 10.1016/j.nmd.2016.02.008
   Mancuso M, 2012, NEUROL SCI, V33, P449, DOI 10.1007/s10072-011-0703-4
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Mitchell WK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00260
   Mosole S, 2014, J NEUROPATH EXP NEUR, V73, P284, DOI 10.1097/NEN.0000000000000032
   Pareyson D, 2013, LANCET NEUROL, V12, P1011, DOI 10.1016/S1474-4422(13)70158-3
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Pollock N, 2017, FREE RADICAL BIO MED, V112, P84, DOI 10.1016/j.freeradbiomed.2017.07.017
   Rygiel KA, 2016, J PHYSIOL-LONDON, V594, P4499, DOI 10.1113/JP271212
   Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850
   Schenkel LC, 2016, J MOL DIAGN, V18, P657, DOI 10.1016/j.jmoldx.2016.04.002
   Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010
   Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945
   van Stralen KJ, 2010, NEPHRON CLIN PRACT, V116, pC143, DOI 10.1159/000315883
   Vandervoort AA, 2002, MUSCLE NERVE, V25, P17, DOI 10.1002/mus.1215
   Venhoff N, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4076
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   WICKS KL, 1991, AM J PHYSIOL, V260, pC841, DOI 10.1152/ajpcell.1991.260.4.C841
   YOSHINAGA H, 1993, J CHILD NEUROL, V8, P129, DOI 10.1177/088307389300800204
NR 39
TC 10
Z9 10
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-3069
EI 1554-6578
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD JUN
PY 2019
VL 78
IS 6
BP 508
EP 514
DI 10.1093/jnen/nlz029
PG 7
WC Clinical Neurology; Neurosciences; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pathology
GA IF0ZD
UT WOS:000472806000005
PM 31100146
OA Bronze
DA 2024-11-01
ER

PT J
AU Murphy, JL
   Blakely, EL
   Schaefer, AM
   He, L
   Wyrick, P
   Haller, RG
   Taylor, RW
   Turnbull, DM
   Taivassalo, T
AF Murphy, Julie L.
   Blakely, Emma L.
   Schaefer, Andrew M.
   He, Langping
   Wyrick, Phil
   Haller, Ronald G.
   Taylor, Robert W.
   Turnbull, Douglass M.
   Taivassalo, Tanja
TI Resistance training in patients with single, large-scale deletions of
   mitochondrial DNA
SO BRAIN
LA English
DT Article
ID HUMAN SKELETAL-MUSCLE; REAL-TIME PCR; SATELLITE CELLS; PHYSIOLOGICAL
   ADAPTATIONS; INDIVIDUAL CELLS; TRAPEZIUS MUSCLE; POINT MUTATION; OLDER
   MEN; MYOPATHIES; ENCEPHALOMYOPATHY
AB Dramatic tissue variation in mitochondrial heteroplasmy has been found to exist in patients with sporadic mitochondrial DNA (mtDNA) mutations. Despite high abundance in mature skeletal muscle, levels of the causative mutation are low or undetectable in satellite cells. The activation of these typically quiescent mitotic cells and subsequent shifting of wild-type mtDNA templates to mature muscle have been proposed as a means of restoring a more normal mitochondrial genotype and function in these patients. Because resistance exercise is known to serve as a stimulus for satellite cell induction within active skeletal muscle, this study sought to assess the therapeutic potential of resistance training in eight patients with single, large-scale mtDNA deletions by assessing: physiological determinants of peak muscle strength and oxidative capacity and muscle biopsy-derived measures of damage, mtDNA mutation load, level of oxidative impairment and satellite cell numbers. Our results show that 12 weeks of progressive overload leg resistance training led to: (i) increased muscle strength; (ii) myofibre damage and regeneration; (iii) increased proportion of neural cell adhesion molecule (NCAM)-positive satellite cells; (iv) improved muscle oxidative capacity. Taken together, we believe these findings support the hypothesis of resistance exercise-induced mitochondrial gene-shifting in muscle containing satellite cells which have low or absent levels of deleted mtDNA. Further investigation is warranted to refine parameters of the exercise training protocol in order to maximize the training effect on mitochondrial genotype and treatment potential for patients with selected, sporadic mutations of mtDNA in skeletal muscle.
C1 [Murphy, Julie L.; Blakely, Emma L.; Schaefer, Andrew M.; He, Langping; Taylor, Robert W.; Turnbull, Douglass M.] Univ Newcastle, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Wyrick, Phil; Haller, Ronald G.] Inst Exercise & Environm Med, Dallas, TX USA.
   [Taivassalo, Tanja] McGill Univ, Dept Kinesiol, Montreal, PQ H3A 2T5, Canada.
   [Taivassalo, Tanja] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.
C3 Newcastle University - UK; McGill University; McGill University
RP Murphy, JL (corresponding author), Univ Newcastle, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM d.m.turnbull@ncl.ac.uk
OI Schaefer, Andrew/0000-0001-9891-7332
FU uscular Dystrophy Campaign UK; Welcome Trust; United Mitochondrial
   Disease Foundation; Canadian Institutes of Health Research; VA Merit
   Review; Muscular Dystrophy Association USA; Fonds de Recherche en Sante
   du Quebec (FRSQ); MRC [G0601943] Funding Source: UKRI
FX Muscular Dystrophy Campaign UK and Welcome Trust (J.L.M., A.M.S. R.W.T.,
   D.M.T.); United Mitochondrial Disease Foundation and Canadian Institutes
   of Health Research in partnership with Muscular Dystrophy Association of
   Canada (T.T.); VA Merit Review (R.G.H.); the Muscular Dystrophy
   Association USA (R.G.H.);. T.T. is a Junior I Investigator of the Fonds
   de Recherche en Sante du Quebec (FRSQ).
CR Andrews H, 2006, J NEUROSCI RES, V83, P1533, DOI 10.1002/jnr.20842
   Barron MJ, 2005, NEUROMUSCULAR DISORD, V15, P768, DOI 10.1016/j.nmd.2005.06.018
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Blakely EL, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011296
   BROOKE MH, 1970, ARCH NEUROL-CHICAGO, V23, P369, DOI 10.1001/archneur.1970.00480280083010
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   Crameri RM, 2007, J PHYSIOL-LONDON, V583, P365, DOI 10.1113/jphysiol.2007.128827
   DARR KC, 1987, J APPL PHYSIOL, V63, P1816, DOI 10.1152/jappl.1987.63.5.1816
   Deschenes MR, 2002, AM J PHYS MED REHAB, V81, pS3, DOI 10.1097/01.PHM.0000029722.06777.E9
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Hikida RS, 2000, J GERONTOL A-BIOL, V55, pB347, DOI 10.1093/gerona/55.7.B347
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Kadi F, 2000, HISTOCHEM CELL BIOL, V113, P99, DOI 10.1007/s004180050012
   Kadi F, 1999, HISTOCHEM CELL BIOL, V111, P189, DOI 10.1007/s004180050348
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   KRAEMER WJ, 1988, SPORTS MED, V6, P246, DOI 10.2165/00007256-198806040-00006
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Roth SM, 2001, J GERONTOL A-BIOL, V56, pB240, DOI 10.1093/gerona/56.6.B240
   SCHULTZ E, 1985, MUSCLE NERVE, V8, P217, DOI 10.1002/mus.880080307
   SCHULTZ E, 1994, REV PHYSIOL BIOCH P, V123, P213, DOI 10.1007/BFb0030904
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 1998, NEUROLOGY, V50, P1055, DOI 10.1212/WNL.50.4.1055
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Taivassalo T, 2004, BBA-BIOENERGETICS, V1659, P221, DOI 10.1016/j.bbabio.2004.09.007
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Weber K, 1997, AM J HUM GENET, V60, P373
NR 34
TC 121
Z9 127
U1 1
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
J9 BRAIN
JI Brain
PD NOV
PY 2008
VL 131
BP 2832
EP 2840
DI 10.1093/brain/awn252
PN 11
PG 9
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 373MQ
UT WOS:000260976400005
PM 18984605
OA Bronze
DA 2024-11-01
ER

PT J
AU Spinazzola, A
   Zeviani, M
AF Spinazzola, Antonella
   Zeviani, Massimo
TI Disorders of nuclear-mitochondrial intergenomic communication
SO BIOSCIENCE REPORTS
LA English
DT Article; Proceedings Paper
CT Conference on Mitochondrial Medicine
CY OCT 25, 2006
CL Univ Pisa, Dept Neurosci, Pisa, ITALY
HO Univ Pisa, Dept Neurosci
DE mitochondrial disease; mitochondrial DNA; mtDNA depletion; mtDNA
   multiple deletions; nucleus-mitochondrion cross-talk
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; NEUROGASTROINTESTINAL
   ENCEPHALOMYOPATHY MNGIE; ADENINE-NUCLEOTIDE TRANSLOCATOR; ONSET
   SPINOCEREBELLAR ATAXIA; POLYMERASE-GAMMA MUTATIONS; DNA DEPLETION;
   AUTOSOMAL-DOMINANT; MULTIPLE DELETIONS; POLG MUTATIONS; THYMIDINE
   PHOSPHORYLASE
AB In the course of evolution, mitochondria lost their independence, and mtDNA became "slave" of nDNA, depending on numerous nucleus-encoded factors for its integrity, replication and expression. Mutations in any of these factors may alter the cross-talk between the two genomes and cause diseases that affect mtDNA integrity or expression, being inherited as mendelian traits.
C1 Fdn IRCCS, C Besta Neurol Inst, I-20126 Milan, Italy.
RP Zeviani, M (corresponding author), Fdn IRCCS, C Besta Neurol Inst, Via Libero Temolo 4, I-20126 Milan, Italy.
EM zeviani@istituto-besta.it
RI Zeviani, Massimo/K-2891-2014; Spinazzola, Antonella/P-5298-2017
OI Zeviani, Massimo/0000-0002-9067-5508; Spinazzola,
   Antonella/0000-0003-4242-8091
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Clayton DA, 2000, EXP CELL RES, V255, P4, DOI 10.1006/excr.1999.4763
   Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878
   Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Gao J, 2001, GENOMICS, V74, P109, DOI 10.1006/geno.2001.6536
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Jacobi CA, 2005, CHIR GASTROENTEROL, V21, P6, DOI 10.1159/000083359
   Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Koc EC, 2002, J BIOL CHEM, V277, P35541, DOI 10.1074/jbc.M202498200
   KOSKINEN T, 1994, MUSCLE NERVE, V17, P509, DOI 10.1002/mus.880170507
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Ling MF, 1997, GENE, V197, P325, DOI 10.1016/S0378-1119(97)00279-5
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   MA L, 1995, J BIOL CHEM, V270, P1859, DOI 10.1074/jbc.270.4.1859
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Martí R, 2005, ANN NEUROL, V58, P649, DOI 10.1002/ana.20615
   Martinková Z, 2004, PLANT SOIL ENVIRON, V50, P1, DOI 10.17221/3635-PSE
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   MIZUSAWA H, 1988, J NEUROL SCI, V86, P171, DOI 10.1016/0022-510X(88)90096-2
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TRITSCHLER HJ, 1992, NEUROLOGY, V42, P209, DOI 10.1212/WNL.42.1.209
   Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Vu TH, 2001, HEPATOLOGY, V34, P116, DOI 10.1053/jhep.2001.25921
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   XIN H, 1995, J BIOL CHEM, V270, P17243, DOI 10.1074/jbc.270.29.17243
   YUZAKI M, 1989, BIOCHEM BIOPH RES CO, V164, P1352, DOI 10.1016/0006-291X(89)91818-4
   Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang YL, 1998, BBA-GENE STRUCT EXPR, V1443, P245, DOI 10.1016/S0167-4781(98)00223-1
NR 68
TC 46
Z9 54
U1 0
U2 7
PU PORTLAND PRESS LTD
PI LONDON
PA THIRD FLOOR, EAGLE HOUSE, 16 PROCTER STREET, LONDON WC1V 6 NX, ENGLAND
SN 0144-8463
J9 BIOSCIENCE REP
JI Biosci. Rep.
PD JUN
PY 2007
VL 27
IS 1-3
BP 39
EP 51
DI 10.1007/s10540-007-9036-1
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology; Cell Biology
GA 178YM
UT WOS:000247256300006
PM 17510790
DA 2024-11-01
ER

PT J
AU Bortot, B
   Barbi, E
   Biffi, S
   Angelini, C
   Faleschini, E
   Severini, GM
   Carrozzi, M
AF Bortot, B.
   Barbi, E.
   Biffi, S.
   Angelini, C.
   Faleschini, E.
   Severini, G. M.
   Carrozzi, M.
TI Two novel cosegregating mutations in tRNA<SUP>Met</SUP> and COX III, in
   a patient with exercise intolerance and autoimmune polyendocrinopathy
SO MITOCHONDRION
LA English
DT Article
DE Met-tRNA and Cox III cosegregating mutations; Exercise intolerance;
   Autoimmune polyendocrinopathy
ID CYTOCHROME-C-OXIDASE; MITOCHONDRIAL-DNA MUTATIONS; LACTIC-ACIDOSIS;
   CHINESE FAMILY; RNA GENE; A1555G MUTATION; HEARING-LOSS; MYOPATHY;
   DEFICIENCY; MTDNA
AB We report a 12-year-old patient with growth retardation, exercise intolerance, lactic acidosis (increasing after exercise) and autoimmune polyendocrinopathy type 2. Muscle biopsy shows abundant COX-negative fibers, subsarcolemmal mitochondrial aggregates and markedly reduced activities of all respiratory chain complexes. Genetic analysis identified two new cosegregating mutations in Met-tRNA (m.4415A > G) and Cox III (m.9922A > C), located in highly conserved regions of MtDNA. Both the mutations are heteroplasmics in multiple patients' tissues. Single-muscle fiber analysis showed significantly higher levels of both the mutations in COX-negative than in normal fibers. in addition, a possible link between the mitochondrial dysfunction and the autoimmune disease is suggested. (C) 2009 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Bortot, B.; Biffi, S.; Severini, G. M.; Carrozzi, M.] IRCCS, Inst Child Hlth, Child Neurol & Psychiat Unit, I-34137 Trieste, Italy.
   [Barbi, E.; Faleschini, E.] Univ Trieste, Inst Child Hlth, IRCCS, Dept Pediat, I-34137 Trieste, Italy.
   [Bortot, B.; Severini, G. M.] IRCCS, Inst Child Hlth, Med Genet Unit, I-34137 Trieste, Italy.
   [Angelini, C.] Univ Padua, Dept Neurosci, Padua, Italy.
   [Biffi, S.] CBM Scrl, Opt Imaging Lab, Trieste, Italy.
C3 University of Trieste; University of Padua
RP Carrozzi, M (corresponding author), IRCCS, Inst Child Hlth, Child Neurol & Psychiat Unit, Via Istria 65-1, I-34137 Trieste, Italy.
EM carrozzi@burlo.trieste.it
RI Angelini, Corrado/J-3655-2019; Barbi, Egidio/K-4016-2018; biffi,
   stefania/C-6652-2015
OI Angelini, Corrado/0000-0002-9554-8794; Barbi,
   Egidio/0000-0002-6343-846X; biffi, stefania/0000-0003-2257-2053;
   Carrozzi, Marco/0000-0001-6282-4417
FU Italian Ministry of Health [Ricerca Finalizzata N ICS 73/04]; Institute
   of Child Health IRCCS Burlo Garofolo [R.C. 43/03]; Eurobiobank project;
   Telethon Bank n [GUP05003]
FX This work was funded by the following Grants: Italian Ministry of Health
   (Ricerca Finalizzata N ICS 73/04), R.C. 43/03 of the Institute of Child
   Health IRCCS Burlo Garofolo, Eurobiobank project and Telethon Bank n
   GUP05003. We would like to thank Dr. Salvatore DiMauro for his precious
   advice and contributions in revising this paper.
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   [Anonymous], HUMAN MITOCHONDRIAL
   Arenas J, 1999, NEUROLOGY, V52, P377, DOI 10.1212/WNL.52.2.377
   Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   Bidooki SK, 1997, AM J HUM GENET, V60, P1430, DOI 10.1086/515460
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   BONILLA E, 1992, BRAIN PATHOL, V2, P113, DOI 10.1111/j.1750-3639.1992.tb00679.x
   Bonin S, 2003, J CLIN PATHOL-MOL PA, V56, P184, DOI 10.1136/mp.56.3.184
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611
   BRUNORI M, 1987, EUR J BIOCHEM, V169, P1, DOI 10.1111/j.1432-1033.1987.tb13572.x
   Campos Y, 2002, MUSCLE NERVE, V25, P185, DOI 10.1002/mus.10012.abs
   CAPALDI RA, 1990, ARCH BIOCHEM BIOPHYS, V280, P252, DOI 10.1016/0003-9861(90)90327-U
   Chabi B, 2003, CLIN CHEM, V49, P1309, DOI 10.1373/49.8.1309
   DiMauro S, 2000, BRAIN PATHOL, V10, P431
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   DiMauro S, 2001, SEMIN CELL DEV BIOL, V12, P397, DOI 10.1006/scdb.2001.0277
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Eystathioy T, 2003, J MOL MED, V81, P811, DOI 10.1007/s00109-003-0495-y
   Finsterer J, 2006, NETH J MED, V64, P61
   HALTIA T, 1989, EMBO J, V8, P3571, DOI 10.1002/j.1460-2075.1989.tb08529.x
   Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079
   Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910
   Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378
   Horváth R, 2005, NEUROMUSCULAR DISORD, V15, P851, DOI 10.1016/j.nmd.2005.09.005
   Horváth R, 2002, J MED GENET, V39, P812, DOI 10.1136/jmg.39.11.812
   Jakymiw A, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1959
   JAUME JC, 2004, BASIC CLIN ENDOCRINO
   Keightley JA, 1996, NAT GENET, V12, P410, DOI 10.1038/ng0496-410
   Li RH, 2004, AM J MED GENET A, V124A, P113, DOI 10.1002/ajmg.a.20305
   Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513
   Lombes A, 1998, HUM MUTAT, pS175
   Lu T, 2006, BBA-MOL BASIS DIS, V1762, P719, DOI 10.1016/j.bbadis.2006.06.007
   Maniataki E, 2005, RNA, V11, P849, DOI 10.1261/rna.2210805
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007
   Meulemans A, 2007, ARCH NEUROL-CHICAGO, V64, P1339, DOI 10.1001/archneur.64.9.1339
   Mimaki M, 2003, J HUM GENET, V48, P47, DOI 10.1007/s100380300005
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Ohno K, 1996, ANN NEUROL, V39, P761, DOI 10.1002/ana.410390612
   Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665
   Qu J, 2007, MITOCHONDRION, V7, P140, DOI 10.1016/j.mito.2006.11.015
   Remes AM, 2005, NEUROLOGY, V64, P976, DOI 10.1212/01.WNL.0000154518.31302.ED
   Ronghua L, 2006, GENE, V376, P79, DOI 10.1016/j.gene.2006.02.014
   Sambrook J., 1989, Molecular Cloning
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Seneca S, 2005, AM J MED GENET A, V137A, P170, DOI 10.1002/ajmg.a.30854
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Spruijt L, 2006, AM J MED GENET A, V140A, P1478, DOI 10.1002/ajmg.a.31324
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Tanji K, 2000, BRAIN PATHOL, V10, P422
   Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Ueki I, 2006, MITOCHONDRION, V6, P29, DOI 10.1016/j.mito.2005.10.003
   Vissing J, 1998, NEUROLOGY, V50, P1875, DOI 10.1212/WNL.50.6.1875
   Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168
   WILSON KS, 1990, ARCH BIOCHEM BIOPHYS, V282, P413, DOI 10.1016/0003-9861(90)90137-N
   Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006
   Yuan HJ, 2005, AM J MED GENET A, V138A, P133, DOI 10.1002/ajmg.a.30952
   Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444
NR 60
TC 17
Z9 17
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD APR
PY 2009
VL 9
IS 2
BP 123
EP 129
DI 10.1016/j.mito.2009.01.006
PG 7
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 428PO
UT WOS:000264861400006
PM 19460300
DA 2024-11-01
ER

PT J
AU Swalwell, H
   Deschauer, M
   Hartl, H
   Strauss, M
   Turnbull, DM
   Zierz, S
   Taylor, RW
AF Swalwell, H
   Deschauer, M
   Hartl, H
   Strauss, M
   Turnbull, DM
   Zierz, S
   Taylor, RW
TI Pure myopathy associated with a novel mitochondrial tRNA gene mutation
SO NEUROLOGY
LA English
DT Article
ID DISEASE; DNA; DIAGNOSIS
AB The authors describe a 47-year-old man who presented with proximal muscle weakness, myalgia, elevated creatine kinase, and features of a pure myopathic syndrome in whom they have identified a novel mutation in the mitochondrial tRNAAla gene. This 5591G > A transition is heteroplasmic, segregates with cytochrome c oxidase deficiency in single muscle fibers, and fulfills recognized criteria for pathogenicity. This case exemplifies the wide-ranging clinical spectrum of mitochondrial disease presentations.
C1 Univ Newcastle Upon Tyne, Sch Med, Sch Neurol Neurobiol & Psychiat, Mitochodrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   Univ Halle Wittenberg, Dept Neurol, Halle, Germany.
C3 Newcastle University - UK; Martin Luther University Halle Wittenberg
RP Univ Newcastle Upon Tyne, Sch Med, Sch Neurol Neurobiol & Psychiat, Mitochodrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.w.taylor@ncl.ac.uk
RI Strauss, Maria/LCD-9676-2024
OI Strauss, Maria/0000-0002-0072-2199
FU Wellcome Trust [074454] Funding Source: Medline
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   Laval SH, 2004, NEUROPATH APPL NEURO, V30, P91, DOI 10.1111/j.1365-2990.2004.00555.x
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   Spagnolo M, 2001, NEUROMUSCULAR DISORD, V11, P481, DOI 10.1016/S0960-8966(01)00195-X
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
NR 10
TC 22
Z9 22
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD FEB 14
PY 2006
VL 66
IS 3
BP 447
EP 449
DI 10.1212/01.wnl.0000196490.36349.83
PG 3
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 012ON
UT WOS:000235348600035
PM 16476954
DA 2024-11-01
ER

PT J
AU Debray, FG
   Seneca, S
   Gonce, M
   Vancampenhaut, K
   Bianchi, E
   Boemer, F
   Weekers, L
   Smet, J
   Van Coster, R
AF Debray, Francois-Guillaume
   Seneca, Sara
   Gonce, Michel
   Vancampenhaut, Kim
   Bianchi, Elettra
   Boemer, Francois
   Weekers, Laurent
   Smet, Joel
   Van Coster, Rudy
TI Mitochondrial encephalomyopathy with cytochrome <i>c</i> oxidase
   deficiency caused by a novel mutation in the <i>MTCO1</i> gene
SO MITOCHONDRION
LA English
DT Article
DE Encephalomyopathy; Mitochondrial DNA; Cytochrome c oxidase; MTCO1
ID COX-I GENE; SUBUNIT-I; NONSENSE MUTATION; MISSENSE MUTATION;
   LACTIC-ACIDOSIS; DNA; MYOPATHY; PATIENT
AB Cytochrome c oxidase (COX) deficiency is one of the most common respiratory chain deficiencies. A woman was presented at the age of 18 y with acute loss of consciousness, non-convulsive status epilepticus, slow neurological deterioration, transient cortical blindness, exercise intolerance, muscle weakness, hearing loss, cataract and cognitive decline. Muscle biopsy revealed ragged-red fibers, COX negative fibers and a significant decreased activity of complex IV in a homogenate. Using next generation massive parallel sequencing of the mtDNA, a novel heteroplasmic mutation was identified in MTCO1, m.7402delC, causing frameshift and a premature termination codon. Single fiber PCR showed co-segregation of high mutant load in COX negative fibers. Mutation in mitochondrially encoded complex IV subunits should be considered in mitochondrial encephalomyopathies and COX negative fibers after the common mtDNA mutations have been excluded. (C) 2014 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Debray, Francois-Guillaume; Boemer, Francois; Weekers, Laurent] Sart Tilman Univ Hosp, Dept Med Genet, Metab Unit, B-4000 Liege, Belgium.
   [Seneca, Sara; Vancampenhaut, Kim] Vrije Univ Brussel, UZ Brussel & Reprod & Genet REGE, Ctr Med Genet, B-1090 Brussels, Belgium.
   [Gonce, Michel] CHR Citadelle, Dept Neurol, B-4000 Liege, Belgium.
   [Bianchi, Elettra] Sart Tilman Univ Hosp, Dept Neuropathol, B-4000 Liege, Belgium.
   [Smet, Joel; Van Coster, Rudy] Ghent Univ Hosp, Dept Pediat, Div Pediat Neurol & Metab, B-9000 Ghent, Belgium.
C3 Vrije Universiteit Brussel; Ghent University; Ghent University Hospital
RP Debray, FG (corresponding author), Sart Tilman Univ Hosp, Dept Med Genet, Metab Unit, Bat B35 DomaineSart Tilman, B-4000 Liege, Belgium.
EM fg.debray@chu.ulg.ac.be
OI Seneca, Sara/0000-0002-0853-9890; BOEMER, Francois/0000-0003-4470-9524
CR Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   DiMauro S, 2013, NEUROLOGY, V81, P281, DOI 10.1212/WNL.0b013e31829bfe89
   DiMauro S, 2012, ADV EXP MED BIOL, V748, P341, DOI 10.1007/978-1-4614-3573-0_14
   Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972
   Herrero-Martin Maria D, 2008, Hum Mutat, V29, pE112, DOI 10.1002/humu.20800
   Karadimas CL, 2000, NEUROLOGY, V55, P644, DOI 10.1212/WNL.55.5.644
   Kollberg G, 2005, J NEUROPATH EXP NEUR, V64, P123, DOI 10.1093/jnen/64.2.123
   Lamperti C, 2012, NEUROMUSCULAR DISORD, V22, P990, DOI 10.1016/j.nmd.2012.06.003
   Lucioli S, 2006, NEUROGENETICS, V7, P51, DOI 10.1007/s10048-005-0015-z
   Massie R, 2012, J NEUROL SCI, V319, P158, DOI 10.1016/j.jns.2012.05.003
   Seneca S, 2014, EUR J HUM GENET
   Tam EWY, 2008, NEUROPEDIATRICS, V39, P328, DOI 10.1055/s-0029-1202287
   Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   Vandewoestyne M, 2012, FORENSIC SCI INT-GEN, V6, P258, DOI 10.1016/j.fsigen.2011.06.002
   Varlamov DA, 2002, HUM MOL GENET, V11, P1797, DOI 10.1093/hmg/11.16.1797
   Zecic A, 2009, PEDIATR RES, V66, P317, DOI 10.1203/PDR.0b013e3181b40a80
NR 18
TC 8
Z9 11
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL
PY 2014
VL 17
BP 101
EP 105
DI 10.1016/j.mito.2014.06.003
PG 5
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA AO1LD
UT WOS:000341072700011
PM 24956508
DA 2024-11-01
ER

PT J
AU Domínguez-González, C
   Hernández-Laín, A
   Rivas, E
   Hernández-Voth, A
   Catalán, JS
   Fernández-Torrón, R
   Fuiza-Luces, C
   García, JG
   Morís, G
   Olivé, M
   Miralles, F
   Díaz-Manera, J
   Caballero, C
   Méndez-Ferrer, B
   Martí, R
   Arumi, EG
   Badosa, MC
   Esteban, J
   Jimenez-Mallebrera, C
   Encinar, AB
   Arenas, J
   Hirano, M
   Martin, MA
   Paradas, C
AF Dominguez-Gonzalez, Cristina
   Hernandez-Lain, Aurelio
   Rivas, Eloy
   Hernandez-Voth, Ana
   Catalan, Javier Sayas
   Fernandez-Torron, Roberto
   Fuiza-Luces, Carmen
   Garcia Garcia, Jorge
   Moris, German
   Olive, Montse
   Miralles, Frances
   Diaz-Manera, Jordi
   Caballero, Candela
   Mendez-Ferrer, Bosco
   Marti, Ramon
   Garcia Arumi, Elena
   Carmen Badosa, Maria
   Esteban, Jesus
   Jimenez-Mallebrera, Cecilia
   Blazquez Encinar, Alberto
   Arenas, Joaquin
   Hirano, Michio
   Angel Martin, Miguel
   Paradas, Carmen
TI Late-onset thymidine kinase 2 deficiency: a review of 18 cases
SO ORPHANET JOURNAL OF RARE DISEASES
LA English
DT Review
DE TK2 deficiency; Mitochondrial myopathy; Multiple deletions
ID MITOCHONDRIAL; MUTATIONS
AB BackgroundTK2 gene encodes for mitochondrial thymidine kinase, which phosphorylates the pyrimidine nucleosides thymidine and deoxycytidine. Recessive mutations in the TK2 gene are responsible for the myopathic form' of the mitochondrial depletion/multiple deletions syndrome, with a wide spectrum of severity.MethodsWe describe 18 patients with mitochondrial myopathy due to mutations in the TK2 gene with absence of clinical symptoms until the age of 12.ResultsThe mean age of onset was 31years. The first symptom was muscle limb weakness in 10/18, eyelid ptosis in 6/18, and respiratory insufficiency in 2/18. All patients developed variable muscle weakness during the evolution of the disease. Half of patients presented difficulty in swallowing. All patients showed evidence of respiratory muscle weakness, with need for non-invasive Mechanical Ventilation in 12/18. Four patients had deceased, all of them due to respiratory insufficiency. We identified common radiological features in muscle magnetic resonance, where the most severely affected muscles were the gluteus maximus, semitendinosus and sartorius. On muscle biopsies typical signs of mitochondrial dysfunction were associated with dystrophic changes. All mutations identified were previously reported, being the most frequent the in-frame deletion p.Lys202del. All cases showed multiple mtDNA deletions but mtDNA depletion was present only in two patients.ConclusionsThe late-onset is the less frequent form of presentation of the TK2 deficiency and its natural history is not well known. Patients with late onset TK2 deficiency have a consistent and recognizable clinical phenotype and a poor prognosis, due to the high risk of early and progressive respiratory insufficiency.
C1 [Dominguez-Gonzalez, Cristina; Esteban, Jesus] 12 Octubre Hosp, Neurol Dept, Neuromuscular Disorders Unit, Madrid, Spain.
   [Dominguez-Gonzalez, Cristina; Fuiza-Luces, Carmen; Esteban, Jesus; Blazquez Encinar, Alberto; Arenas, Joaquin; Angel Martin, Miguel] 12 Octubre Hosp, Res Inst I 12, Madrid, Spain.
   [Dominguez-Gonzalez, Cristina; Fuiza-Luces, Carmen; Diaz-Manera, Jordi; Marti, Ramon; Garcia Arumi, Elena; Esteban, Jesus; Jimenez-Mallebrera, Cecilia; Blazquez Encinar, Alberto; Arenas, Joaquin; Angel Martin, Miguel] Inst Salud Carlos III, Biomed Network Res Ctr Rare Dis CIBERER, Madrid, Spain.
   [Hernandez-Lain, Aurelio] 12 Octubre Hosp, Pathol Dept, Neuromuscular Disorders Unit, Neuropathol, Madrid, Spain.
   [Rivas, Eloy] Univ Seville, Hosp Univ Virgen del Rocio, Pathol Anat Dept,CSIC, Neuromuscular Disorders Unit,Inst Biomed Sevilla, Seville, Spain.
   [Hernandez-Voth, Ana; Catalan, Javier Sayas] 12 Octubre Hosp, Neumol Dept, Neuromuscular Disorders Unit, Madrid, Spain.
   [Fernandez-Torron, Roberto] Hosp Donostia, Neuromuscular Disorders Unit, Neurol Dept, San Sebastian, Spain.
   [Fuiza-Luces, Carmen; Blazquez Encinar, Alberto; Arenas, Joaquin; Angel Martin, Miguel] Hosp 12 Octubre I 12, Res Inst, Mitochondrial & Neuromuscular Dis Lab, Madrid, Spain.
   [Garcia Garcia, Jorge] Hosp Albacete, Neurol Dept, Albacete, Spain.
   [Moris, German] Hosp Cent Asturias, Neurol Dept, Neuromuscular Disorders Unit, Oviedo, Spain.
   [Olive, Montse] Hosp Bellvitge Princeps Espanya, IDIBELL, Neuromuscular Disorders Unit, Pathol Anat Dept, Barcelona, Spain.
   [Miralles, Frances] Hosp Univ Son Espases, Neurol Dept, Neuromuscular Disorders Unit, Palma De Mallorca, Spain.
   [Diaz-Manera, Jordi] Hosp Santa Creu & Sant Pau, Neurol Dept, Neuromuscular Disorders Unit, Barcelona, Spain.
   [Caballero, Candela] Univ Seville, Inst Biomed Sevilla, Resp Dept, Hosp Univ Virgen del Rocio,CSIC,CIBERES, Seville, Spain.
   [Mendez-Ferrer, Bosco] Hosp Virgen del Rocio, Rehabil Dept, Seville, Spain.
   [Garcia Arumi, Elena] Univ Autonoma Barcelona, ValldHebron Res Inst, Res Grp Neuromuscular & Mitochondrial Dis, Barcelona, Spain.
   [Marti, Ramon; Carmen Badosa, Maria; Jimenez-Mallebrera, Cecilia] Hosp St Joan de Deu, Inst Recerca St Joan de Deu, Neurol Dept, Neuromuscular Unit, Barcelona, Spain.
   [Hirano, Michio] Columbia Univ, Med Ctr, H Houston Merritt Ctr, Dept Neurol, New York, NY USA.
   [Paradas, Carmen] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Neurol Dept,Neuromuscular Disorders Unit,Inst Bio, Avd Manuel Siurot S-N, Seville 41013, Spain.
   [Paradas, Carmen] Biomed Network Res Ctr Neurodegenerat Dis CIBERNE, Madrid, Spain.
C3 Hospital Universitario 12 de Octubre; Hospital Universitario 12 de
   Octubre; University of Barcelona; Instituto de Salud Carlos III; CIBER -
   Centro de Investigacion Biomedica en Red; CIBERER; Hospital
   Universitario 12 de Octubre; Consejo Superior de Investigaciones
   Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de
   Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital;
   Hospital Universitario 12 de Octubre; University Hospital Donostia;
   Hospital Universitario 12 de Octubre; Central University Hospital
   Asturias; University of Barcelona; Institut d'Investigacio Biomedica de
   Bellvitge (IDIBELL); Hospital Universitari Son Espases; Hospital of
   Santa Creu i Sant Pau; Virgen del Rocio University Hospital; CIBER -
   Centro de Investigacion Biomedica en Red; CIBERES; Consejo Superior de
   Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE -
   Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University
   Hospital; Autonomous University of Barcelona; University of Barcelona;
   Columbia University; Consejo Superior de Investigaciones Cientificas
   (CSIC); Virgen del Rocio University Hospital; University of Sevilla
RP Paradas, C (corresponding author), Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Neurol Dept,Neuromuscular Disorders Unit,Inst Bio, Avd Manuel Siurot S-N, Seville 41013, Spain.; Paradas, C (corresponding author), Biomed Network Res Ctr Neurodegenerat Dis CIBERNE, Madrid, Spain.
EM cparadas@us.es
RI Garcia-García, Jorge/AFF-9149-2022; Martin, Miguel/S-2758-2018; Martí,
   Ramon/Q-3442-2016; Moris, German/AAT-8916-2021; Olivé,
   Montse/AAI-6150-2021; Garcia-Arumi, Elena/ABH-4229-2020; Encinar,
   Alberto/S-4425-2018; Moris, German/M-2920-2018; Martin, Miguel
   Angel/B-6261-2017; Jimenez-Mallebrera, Cecilia/F-5030-2016
OI Dominguez, Cristina/0000-0001-5151-988X; Esteban-Perez,
   Jesus/0000-0002-3424-7357; Sayas Catalan, Javier/0000-0003-2399-4370;
   Olive, Montse/0000-0001-5727-0165; Moris, German/0000-0001-7608-2194;
   Martin, Miguel Angel/0000-0003-4741-772X; Fernandez-Torron,
   Roberto/0000-0002-2202-8165; Garcia-Arumi, Elena/0000-0003-0096-3336;
   Rivas Infante, Eloy/0000-0001-6014-8048; Jimenez-Mallebrera,
   Cecilia/0000-0001-8203-7103; Garcia-Garcia, Jorge/0000-0001-9867-9709;
   Marti, Ramon/0000-0002-8273-9540
FU Plan Nacional de I + D + I [PI16-01843, PI16/00579, CP09/00011];
   Instituto de Salud Carlos III (ISCIII), Subdireccion General de
   Evaluacion y Fomento de la Investigacion Sanitaria [PI16-01843,
   PI16/00579, CP09/00011]; European Regional Development Fund (FEDER a way
   to achieve Europe); Spanish ISCIII [PI 15/00431]; ISCIII [PMP15/00025]
FX This work was supported by research grants of Plan Nacional de I + D + I
   and Instituto de Salud Carlos III (ISCIII), Subdireccion General de
   Evaluacion y Fomento de la Investigacion Sanitaria", project PI16-01843
   (CP), PI16/00579 and CP09/00011 for CJM and the European Regional
   Development Fund (FEDER a way to achieve Europe). MAM has received
   funding from the Spanish ISCIII (grant PI 15/00431). A multicentric
   grant funded by the ISCIII (PMP15/00025 to MAM, RM, MO, CP).
CR Alston CL, 2013, NEUROLOGY, V81, P2051, DOI 10.1212/01.wnl.0000436931.94291.e6
   Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006
   Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1465, DOI 10.1249/MSS.0b013e31820ca81c
   Cámara Y, 2015, NEUROLOGY, V84, P2286, DOI 10.1212/WNL.0000000000001644
   Cámara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Carbonell-Corvilloa P, 2018, NEUROMUSCULAR DISORD, V28, P828, DOI 10.1016/j.nmd.2018.07.006
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Fernández J, 2000, MED CLIN-BARCELONA, V114, P121, DOI 10.1016/S0025-7753(00)71216-4
   Fischer D, 2008, NEUROLOGY, V71, P758, DOI 10.1212/01.wnl.0000324927.28817.9b
   Fiuza-Luces C, 2018, MED SCI SPORT EXER, V50, P1142, DOI 10.1249/MSS.0000000000001546
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Kalko SG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-91
   Hedermann G, 2018, NEUROMUSCULAR DISORD, V28, P408, DOI 10.1016/j.nmd.2018.02.008
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Martí R, 2010, PEDIATR RES, V68, P151, DOI 10.1203/00006450-201011001-00294
   Milone M, 2013, MOL GENET METAB, V110, P35, DOI 10.1016/j.ymgme.2013.07.007
   Montero R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148709
   Olivé M, 2011, NEUROMUSCULAR DISORD, V21, P533, DOI 10.1016/j.nmd.2011.05.002
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Tordjman M, 2018, EUR RADIOL, V28, P5293, DOI 10.1007/s00330-018-5472-5
   Trucco F, 2018, J INT MED RES, V46, P1153, DOI 10.1177/0300060517728857
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wang JL, 2018, MOL GENET METAB, V124, P124, DOI 10.1016/j.ymgme.2018.04.012
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
NR 29
TC 30
Z9 32
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1750-1172
J9 ORPHANET J RARE DIS
JI Orphanet J. Rare Dis.
PD MAY 6
PY 2019
VL 14
AR 100
DI 10.1186/s13023-019-1071-z
PG 10
WC Genetics & Heredity; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Research & Experimental Medicine
GA HX3DG
UT WOS:000467271200001
PM 31060578
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Chong, JW
   Annuar, AA
   Wong, KT
   Thong, MK
   Goh, KJ
AF Chong, Jia-Woei
   Annuar, Azlina Ahmad
   Wong, Kum-Thong
   Thong, Meow-Keong
   Goh, Khean-Jin
TI Single mitochondrial DNA deletions in chronic progressive external
   ophthalmoplegia (CPEO) and Kearns-Sayre syndrome (KSS) patients from a
   multiethnic Asian population
SO NEUROLOGY ASIA
LA English
DT Article
ID DIRECT REPEATS; MUTATIONS
AB Mitochondrial DNA (mtDNA) deletions are a major cause of chronic progressive external ophthalmoplegia (CPEO) and Kearns-Sayre syndrome (KSS). We analyzed single mtDNA deletions in 11 CPEO and one KSS patients by means of Southern blot and long polymerase chain reaction (PCR) assays. The deletion sizes ranged from 3.4 kb to 6.9 kb whereas the heteroplasmy level varied from 18.8% to 85.5%. Two unique deletions sized 4320 bp and 4717 bp were found. This study represents the first genetic screen of mtDNA disorders in Malaysia, and it follows the data seen in other published reports on CPEO and KSS genetic aetiology.
C1 [Chong, Jia-Woei; Goh, Khean-Jin] Univ Malaya, Dept Med, Div Neurol, Kuala Lumpur 50603, Malaysia.
   [Annuar, Azlina Ahmad] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Malaysia.
   [Wong, Kum-Thong] Univ Malaya, Fac Med, Dept Pathol, Kuala Lumpur 50603, Malaysia.
   [Thong, Meow-Keong] Univ Malaya, Fac Med, Dept Pediat, Kuala Lumpur 50603, Malaysia.
C3 Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti
   Malaya
RP Goh, KJ (corresponding author), Univ Malaya, Fac Med, Dept Med, Kuala Lumpur 50603, Malaysia.
EM gohkj@ummc.edu.my
RI AHMAD-ANNUAR, AZLINA/B-8305-2010; Wong, Kum/B-2788-2010; Goh,
   Khean/D-1990-2010; Thong, Meow-Keong/B-9960-2010
OI Thong, Meow-Keong/0000-0002-7288-7910; Ahmad-Annuar,
   Azlina/0000-0001-6329-4366
FU Ministry of Science, Technology and Innovation, Malaysia [12-02-03-2038]
FX This study was supported by Science Fund 12-02-03-2038 from the Ministry
   of Science, Technology and Innovation, Malaysia
CR Bau V, 2005, STRABISMUS, V13, P133, DOI 10.1080/09273970500216432
   Blakely EL, 2005, FEBS J, V272, P3583, DOI 10.1111/j.1742-4658.2005.04779.x
   CHENG S, 1994, NAT GENET, V7, P350, DOI 10.1038/ng0794-350
   DEGOUL F, 1991, J NEUROL SCI, V101, P168, DOI 10.1016/0022-510X(91)90042-6
   Fisher N, 2004, J BIOL CHEM, V279, P12951, DOI 10.1074/jbc.M313866200
   Goto YI, 1996, BIOCHEM BIOPH RES CO, V222, P215, DOI 10.1006/bbrc.1996.0724
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   John DR, 1990, BIOCHEM BIOPH RES CO, V174, P244
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Nishizuka S, 1998, BIOCHEM BIOPH RES CO, V247, P24, DOI 10.1006/bbrc.1998.8709
   ROWLAND LP, 1983, NEUROLOGY, V33, P1179, DOI 10.1212/WNL.33.9.1179
   Sadikovic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015687
   Sambrook J, 1990, Cold Spring Harbor Laboratories, V186, P182
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Schon EA, 2003, GENETICS MITOCHONDRI, P111
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Thajeb P, 2006, CLIN NEUROL NEUROSUR, V108, P407, DOI 10.1016/j.clineuro.2005.01.004
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wong LJC, 2010, DEV DISABIL RES REV, V16, P154, DOI 10.1002/ddrr.104
   Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
NR 23
TC 1
Z9 1
U1 0
U2 7
PU ASEAN NEUROLOGICAL ASSOC
PI KUALA LUMPUR
PA UNIV MALAYA MEDICAL CENTRE, NEUROLOGY LABORATORY, KUALA LUMPUR, 59100,
   MALAYSIA
SN 1823-6138
J9 NEUROL ASIA
JI Neurol. Asia
PD MAR
PY 2014
VL 19
IS 1
BP 27
EP 36
PG 10
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA AE4NY
UT WOS:000333960600004
DA 2024-11-01
ER

PT J
AU Knierim, E
   Seelow, D
   Gill, E
   von Moers, A
   Schuelke, M
AF Knierim, Ellen
   Seelow, Dominik
   Gill, Esther
   von Moers, Arpad
   Schuelke, Markus
TI Clinical application of whole exome sequencing reveals a novel compound
   heterozygous <i>TK2</i>-mutation in two brothers with rapidly
   progressive combined muscle-brain atrophy, axonal neuropathy, and
   <i>status epilepticus</i>
SO MITOCHONDRION
LA English
DT Article
DE Thymidine kinase 2; mtDNA depletion syndrome; Myopathy; Brain atrophy;
   Status epilepticus; Identity-by-state analysis
ID MITOCHONDRIAL-DNA DEPLETION; THYMIDINE KINASE; TK2 GENE; MUTATIONS;
   SPECTRUM; MICE
AB Mutations in several genes cause mtDNA depletion associated with encephalomyopathy. Due to phenotypic overlap, it is difficult to conclude from clinical phenotype to genetic defect. Here we report on two brothers who presented with rapid fatty muscle degeneration, axonal neuropathy, rapid loss of supratentorial white and gray matter, and status epilepticus. Whole exome sequencing coupled with 'identity-by-state' (IBS) analysis revealed a compound heterozygous missense mutation (p.M117V, p.A139V) in the thymidine kinase 2 (TK2) gene that segregated with the phenotype. Both mutations were located in the thymidine binding pouch of the enzyme. Residual mtDNA copy numbers in muscle were 8.5%, but normal in blood and fibroblasts. Our results broaden the clinical phenotype spectrum of TK2 mutations and promote WES as a useful method in the clinical setting for mutation detection, even in untypical cases. If two or more affected siblings from a non-consanguineous family can be investigated, IBS-analysis provides a powerful tool to narrow the number of disease candidates, similarly to autozygosity mapping in consanguineous families. (C) 2014 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Knierim, Ellen; Seelow, Dominik; Gill, Esther; Schuelke, Markus] Charite, NCRC, D-13353 Berlin, Germany.
   [Knierim, Ellen; Seelow, Dominik; Schuelke, Markus] Charite, Dept Neuropediat, D-13353 Berlin, Germany.
   [von Moers, Arpad] Childrens Hosp, DRK Kliniken Westend, Berlin, Germany.
C3 Berlin Institute of Health; Berlin Institute of Health; Free University
   of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin
   Berlin; Berlin Institute of Health; Berlin Institute of Health; Free
   University of Berlin; Humboldt University of Berlin; Charite
   Universitatsmedizin Berlin
RP Schuelke, M (corresponding author), Charite Campus Virchow Klinikum, D-13353 Berlin, Germany.
EM markus.schuelke@charite.de
RI ; Seelow, Dominik/HGB-3124-2022
OI Schuelke, Markus/0000-0003-2824-3891; Seelow,
   Dominik/0000-0002-9746-4412; Knierim, Ellen/0000-0002-4769-7322
FU Deutsche Forschungsgemeinschaft (DFG) [SFB 665 TP C4]; German
   Bundesministerium fur Bildung und Forschung
FX We thank the patients and their parents for participation at this study
   and Angelika Zwirner for excellent technical assistance. The project was
   funded by the Deutsche Forschungsgemeinschaft (DFG) via the SFB 665 TP
   C4. M.S. is a member of the NeuroCure Center of Excellence (DFG Exc 257)
   and of mitoNET (01GM1113D) financed by the German Bundesministerium fur
   Bildung und Forschung.
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Al-Hussaini A, 2014, J PEDIATR-US, V164, P553, DOI 10.1016/j.jpeds.2013.10.082
   ARNER ESJ, 1992, BIOCHEM BIOPH RES CO, V188, P712, DOI 10.1016/0006-291X(92)91114-6
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013
   Mikkelsen NE, 2003, BIOCHEMISTRY-US, V42, P5706, DOI 10.1021/bi0340043
   Nemesure BB, 1999, GENET EPIDEMIOL, V17, pS673
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Pfaffl M. W., 2001, RT PCR NUCL ACIDS RE, V29, P2001
   Poulton J, 2009, BBA-MOL BASIS DIS, V1792, P1109, DOI 10.1016/j.bbadis.2009.08.016
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890
   Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575
   Sheng ZH, 2014, J CELL BIOL, V204, P1087, DOI 10.1083/jcb.201312123
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 21
TC 14
Z9 16
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JAN
PY 2015
VL 20
BP 1
EP 6
DI 10.1016/j.mito.2014.10.007
PG 6
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA CA0UQ
UT WOS:000348632200001
PM 25446393
DA 2024-11-01
ER

PT J
AU Vincent, AE
   Rosa, HS
   Alston, CL
   Grady, JP
   Rygiel, KA
   Rocha, MC
   Barresi, R
   Taylor, RW
   Turnbull, DM
AF Vincent, Amy E.
   Rosa, Hannah S.
   Alston, Charlotte L.
   Grady, John P.
   Rygiel, Karolina A.
   Rocha, Mariana C.
   Barresi, Rita
   Taylor, Robert W.
   Turnbull, Doug M.
TI Dysferlin mutations and mitochondrial dysfunction
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Dysferlin; Mitochondria; LGMD2B; Immunofluorescence; Histochemistry;
   Cytochrome c oxidase deficiency
ID GIRDLE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; MIYOSHI MYOPATHY; MEMBRANE
   REPAIR; 2B; PHOSPHORYLATION; GENE
AB Dysferlinopathies are caused by mutations in the DYSF gene and patients may present with proximal or distal myopathy. Dysferlin is responsible for membrane resealing, and mutations may result in a defect in membrane repair following mechanical or chemical stress, causing an influx of Ca2+. Since mitochondria are involved in Ca2+ buffering, we hypothesised that mitochondrial defects may be present in skeletal muscle biopsies from patients with mutations in this gene. The aim was to characterise mitochondrial defects in muscle from patients with dysferlinopathies. Here, we analysed skeletal muscle biopsies for eight patients by quadruple immunofluorescent assay to assess oxidative phosphorylation protein abundance. Long-range PCR in single muscle fibres was used to look for presence of clonally expanded large-scale mitochondrial DNA rearrangements in patients' skeletal muscle (n = 3). Immunofluorescence demonstrated that the percentage of complex I- and complex IV-deficient fibres was higher in patients with DYSF mutations than in age-matched controls. No clonally expanded mtDNA deletions were detected using long-range PCR in any of the analysed muscle fibres. We conclude that complex I and complex IV deficiency is higher in patients than age matched controls but patients do not have rearrangements of the mtDNA. We hypothesise that respiratory chain deficiency may be the results of an increased cytosolic Ca2+ concentration (due to a membrane resealing defect) causing mitochondrial aberrations. (C) 2016 The Authors. Published by Elsevier B.V.
C1 [Vincent, Amy E.; Rosa, Hannah S.; Alston, Charlotte L.; Grady, John P.; Rygiel, Karolina A.; Rocha, Mariana C.; Taylor, Robert W.; Turnbull, Doug M.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Barresi, Rita] Newcastle Tyne Hosp NHS Fdn Trust, Rare Dis Advisory Grp, Muscle Immunoanal Unit, Serv Rare Neuromuscular Dis, Newcastle Upon Tyne NE2 4AZ, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation
   Trust
RP Turnbull, DM (corresponding author), Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM doug.turnbull@ncl.ac.uk
RI Barresi, Rita/AAB-9569-2022; Alston, Charlotte/ABG-9602-2020; Vincent,
   Amy/J-7284-2019; Rocha, Mariana/O-4313-2017
OI Rosa, Hannah/0000-0003-4624-752X; Turnbull, Doug/0000-0002-8878-9901;
   Vincent, Amy/0000-0002-0360-6644; Rocha, Mariana/0000-0002-0056-9315;
   Alston, Charlotte/0000-0003-2095-5464; Grady, John/0000-0001-9667-3872
FU MRC studentship as part of the MRC Centre for Neuromuscular Disease
   [MR/K501074/1, MR/K000608/1]; Wellcome Trust Centre for Mitochondrial
   Research [096919Z/11/Z]; Medical Research Council (UK) Centre for
   Translational Muscle Disease Research [G0601943]; UK NIHR Biomedical
   Research Centre in Age and Age Related Diseases award; Lily Foundation;
   UK NHS Highly Specialised Commissioners; National Institute for Health
   Research (NIHR) doctoral fellowship [NIHR-HCS-D12-03-04]; MRC [G0700718,
   MR/K000608/1, MR/L016354/1, G0800674, G0601943, MC_G0802536] Funding
   Source: UKRI
FX AEV is funded by an MRC studentship (MR/K501074/1) as part of the MRC
   Centre for Neuromuscular Disease (MR/K000608/1). This work was supported
   by The Wellcome Trust Centre for Mitochondrial Research (096919Z/11/Z),
   the Medical Research Council (UK) Centre for Translational Muscle
   Disease Research (G0601943), the UK NIHR Biomedical Research Centre in
   Age and Age Related Diseases award to the Newcastle upon Tyne Hospitals
   NHS Foundation Trust, The Lily Foundation and the UK NHS Highly
   Specialised Commissioners, which funds the "Rare Mitochondrial Disorders
   of Adults and Children" Diagnostic Service in Newcastle upon Tyne. CLA
   is the recipient of a National Institute for Health Research (NIHR)
   doctoral fellowship (NIHR-HCS-D12-03-04). The views expressed are those
   of the author(s) and not necessarily those of the NHS, the NIHR or the
   Department of Health.
CR Abdullah N, 2014, BIOPHYS J, V106, P382, DOI 10.1016/j.bpj.2013.11.4492
   Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001
   Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573
   Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Gallardo E, 2001, NEUROLOGY, V57, P2136, DOI 10.1212/WNL.57.11.2136
   Gayathri N, 2011, INDIAN J PATHOL MICR, V54, P350, DOI 10.4103/0377-4929.81636
   Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164
   Illarioshkin SN, 2000, NEUROLOGY, V55, P1931, DOI 10.1212/WNL.55.12.1931
   Lek A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-231
   Liu FC, 2016, INT J NEUROSCI, V126, P499, DOI 10.3109/00207454.2015.1034801
   Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Rocha MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15037
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Weiler T, 1999, HUM MOL GENET, V8, P871, DOI 10.1093/hmg/8.5.871
NR 17
TC 24
Z9 26
U1 0
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD NOV
PY 2016
VL 26
IS 11
BP 782
EP 788
DI 10.1016/j.nmd.2016.08.008
PG 7
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA EB8FF
UT WOS:000387626200010
PM 27666772
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Liu, JR
AF Liu, JR
TI Precipitation of stroke-like event by chickenpox in a child with MELAS
   syndrome
SO NEUROLOGY INDIA
LA English
DT Article
DE apparent diffusion coefficient mapping; chickenpox; diffusion weighted
   MRI; MELAS syndrome; stroke-like episode
ID LACTIC-ACIDOSIS; ENCEPHALOPATHY; VARICELLA; EPISODES
AB The mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes syndrome (MELAS) is a rare congenital disorder of mitochondrial DNA (mtDNA). Herein we report a case of MELAS, whose second stroke-like episode was provoked by chickenpox. A point mutation at nucleotide (nt) 3243 in mtDNA supported the diagnosis of MELAS in this case. History of myopathy, the presence of lesions that did not conform to accepted distributions of vascular territories on cranial magnetic resonance imaging (MRI), normal result of cranial magnetic resonance angiography, hyperintensity on diffusion weighted MRI and apparent diffusion coefficient mapping indicating the presence of vasogenic edema in the fresh stroke-like lesion, and mitochondrial DNA analysis helped to exclude the diagnosis of ischemic cerebral infarction which can also be induced by chickenpox.
C1 Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurol, Hangzhou, Peoples R China.
C3 Zhejiang University
RP Liu, JR (corresponding author), 88 Jie Fang Rd, Hangzhou 310009, Peoples R China.
EM liujianren@medmail.com.cn
CR Abe K, 2004, NEURORADIOLOGY, V46, P113, DOI 10.1007/s00234-003-1138-2
   Dashe JF, 1998, NEW ENGL J MED, V339, P1914, DOI 10.1056/NEJM199812243392608
   Kolb SJ, 2003, J NEUROL SCI, V216, P11, DOI 10.1016/S0022-510X(03)00218-1
   McKee DH, 2000, J NEUROL NEUROSUR PS, V68, P765, DOI 10.1136/jnnp.68.6.765
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Sébire G, 1999, ANN NEUROL, V45, P679, DOI 10.1002/1531-8249(199905)45:5<679::AID-ANA22>3.0.CO;2-E
   Sharfstein SR, 1999, ARCH NEUROL-CHICAGO, V56, P241, DOI 10.1001/archneur.56.2.241
   Ueno M, 2002, BRAIN DEV-JPN, V24, P106, DOI 10.1016/S0387-7604(02)00005-0
NR 8
TC 11
Z9 13
U1 0
U2 2
PU NEUROL SOC INDIA
PI CHANDIGARH
PA C/O J S CHOPRA, PGIMER, DEPT NEUROLOGY, CHANDIGARH 160 012, INDIA
SN 0028-3886
J9 NEUROL INDIA
JI Neurol. India
PD SEP
PY 2005
VL 53
IS 3
BP 323
EP 325
DI 10.4103/0028-3886.16932
PG 3
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 979TG
UT WOS:000232967100021
PM 16230801
OA Green Submitted
DA 2024-11-01
ER

PT J
AU Ruppert, V
   Nolte, D
   Aschenbrenner, T
   Pankuweit, S
   Funck, R
   Maisch, B
AF Ruppert, V
   Nolte, D
   Aschenbrenner, T
   Pankuweit, S
   Funck, R
   Maisch, B
TI Novel point mutations in the mitochondrial DNA detected in patients with
   dilated cardiomyopathy by screening the whole mitochondrial genome
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE dilated cardiomyopathy; mitochondrial DNA; mutation analysis; dideoxy
   fingerprinting polymorphisms
ID MATERNAL INHERITANCE; ORGANIZATION; FAMILY; HEART; RNA
AB Dilated cardiomyopathy (DCM) is widely accepted as a pluricausal or multifactorial disease. Because of the linkage between energy metabolism in the mitochondria and cardiac muscle contraction, it is reasonable to assume that mitochondrial abnormalities may, e responsible for some forms of DCM. We analysed the whole mitochondrial genome in a series of 45 patients with DCM for alterations and compared the findings with those of 62 control subjects. A total of 458 sequence changes could be identified. These sequence changes were distributed among the whole mitochondrial DNA (mtDNA). An increased number of novel missense mutations could be detected nearly in all genes encoding for protein subunits in DCM patients. In genes coding for NADH dehydrogenase subunits the number of mtDNA Mutations detected in patients with DCM was significantly increased (p < 0.05) compared with control subjects. Eight mutations were found to Occur in conserved amino acids in the above species. The c.5973G > A (Ala-Trp) and the c.7042T > G (Val-Asp) mutations were located in highly conserved domains of the gene coding for cytochrome c oxidase subunit. Two tRNA mutations could be detected in the mtDNA of DCM patients alone. The T-C transition at nt 15,924 is connected with respiratory enzyme deficiency, mitochondrial myopathy, and cardiomyopathy. The c.16189T > C mutation in the D-loop region that is associated with susceptibility to DCM Could be detected in 15.6% of patients as well as in 9.7% of controls. Thus, mutations altering the function of the enzyme subunits of the respiratory chain can be relevant for the pathogenesis of dilated cardiomyopathy. (C) 2004 Elsevier Inc. All rights reserved.
C1 Univ Marburg, Dept Internal Med & Cardiol, Marburg, Germany.
C3 Philipps University Marburg
RP Univ Marburg, Dept Internal Med & Cardiol, Marburg, Germany.
EM ruppert@med.uni-marburg.de
RI Maisch, Bernhard/AAH-9198-2020; Nolte, David/AAG-9523-2019
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Arbustini E, 1998, AM J PATHOL, V153, P1501, DOI 10.1016/S0002-9440(10)65738-0
   BROWN MD, 1992, AM J HUM GENET, V51, P446
   CAFORIO ALP, 1994, LANCET, V344, P773, DOI 10.1016/S0140-6736(94)92339-6
   CASE JT, 1981, SOMAT CELL GENET, V7, P103, DOI 10.1007/BF01544751
   COTTON RGH, 1993, MUTAT RES, V285, P125, DOI 10.1016/0027-5107(93)90060-S
   Fatkin D, 2002, PHYSIOL REV, V82, P945, DOI 10.1152/physrev.00012.2002
   FELMLEE TA, 1995, J CLIN MICROBIOL, V33, P1617, DOI 10.1128/JCM.33.6.1617-1623.1995
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   GROMPE M, 1993, NAT GENET, V5, P111, DOI 10.1038/ng1093-111
   HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I
   KANDOLF R, 1989, SPRINGER SEMIN IMMUN, V11, P1, DOI 10.1007/BF00197080
   Khogali SS, 2001, LANCET, V357, P1265, DOI 10.1016/S0140-6736(00)04422-6
   Kogelnik AM, 1998, NUCLEIC ACIDS RES, V26, P112, DOI 10.1093/nar/26.1.112
   Kuhl U, 1996, HEART, V75, P295, DOI 10.1136/hrt.75.3.295
   Li YY, 1997, J MOL CELL CARDIOL, V29, P2699, DOI 10.1006/jmcc.1997.0501
   Marin-Garcia J, 2001, CARDIOVASC RES, V49, P17, DOI 10.1016/S0008-6363(00)00241-8
   Nollau P, 1997, CLIN CHEM, V43, P1114
   OZAWA T, 1991, BIOCHEM BIOPH RES CO, V177, P518, DOI 10.1016/0006-291X(91)92014-B
   Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841
   Ruppert V, 2000, HERZ, V25, P161, DOI 10.1007/s000590050002
   Santorelli F M, 2001, Am Heart J, V141, pE1, DOI 10.1067/mhj.2001.112088
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   SCHONIAN U, 1993, CLIN IMMUNOL IMMUNOP, V68, P229, DOI 10.1006/clin.1993.1123
   SCHWARTZ K, 1995, CIRCULATION, V91, P532, DOI 10.1161/01.CIR.91.2.532
   Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148
   Wallace DC, 2000, AM HEART J, V139, pS70, DOI 10.1067/mhj.2000.103934
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WHY HJF, 1994, CIRCULATION, V89, P2582, DOI 10.1161/01.CIR.89.6.2582
   YOON KL, 1991, BIOCHEM BIOPH RES CO, V176, P1112, DOI 10.1016/0006-291X(91)90399-R
   Zhang D, 2003, CARDIOVASC RES, V57, P147, DOI 10.1016/S0008-6363(02)00695-8
NR 31
TC 38
Z9 39
U1 0
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAY 28
PY 2004
VL 318
IS 2
BP 535
EP 543
DI 10.1016/j.bbrc.2004.04.061
PG 9
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 819LD
UT WOS:000221315500031
PM 15120634
DA 2024-11-01
ER

PT J
AU Rocher, C
   Taanman, JW
   Pierron, D
   Faustin, B
   Benard, G
   Rossignol, R
   Malgat, M
   Pedespan, L
   Letellier, T
AF Rocher, Christophe
   Taanman, Jan-Willem
   Pierron, Denis
   Faustin, Benjamin
   Benard, Giovani
   Rossignol, Rodrigue
   Malgat, Monique
   Pedespan, Laurence
   Letellier, Thierry
TI Influence of mitochondrial DNA level on cellular energy metabolism:
   implications for mitochondrial diseases
SO JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
LA English
DT Article
DE mitochondrial DNA depletion syndrome; oxidative phosphorylation;
   respiratory chain; threshold effect
ID MTDNA DEPLETION; COPY NUMBER; DEOXYRIBONUCLEIC-ACID; HELA-CELLS; MUSCLE;
   EXPRESSION; MYOPATHY; 2',3'-DIDEOXYCYTIDINE; TRANSCRIPTION; REPLICATION
AB The total amount of cellular mitochondrial DNA (mtDNA) varies widely and seems to be related to the nature and metabolic state of tissues and cells in culture. It is not known, however, whether this variation has any significance in vivo, and to which extent it regulates energy production. To better understand the importance of the cellular mtDNA level, we studied the influence of a gradual reduction of mtDNA copy number on oxidative phosphorylation in two models: (a) a control human cell line treated with different concentrations of 2', 3'-dideoxycytidine, a nucleoside analogue that inhibits mtDNA replication by interfering with mitochondrial DNA polymerase gamma, and (b) a cell line derived from a patient presenting mtDNA depletion. The two models were used to construct biochemical and phenotypic threshold curves. Our results show that oxidative phosphorylation activities are under a tight control by the amount of mtDNA in the cell, and that the full complement of mtDNA molecules are necessary to maintain a normal energy production level.
C1 [Rocher, Christophe; Pierron, Denis; Faustin, Benjamin; Benard, Giovani; Rossignol, Rodrigue; Malgat, Monique; Letellier, Thierry] Univ Victor Segalen Bordeaux2, INSERM, U688, F-33076 Bordeaux, France.
   [Taanman, Jan-Willem] UCL, Inst Neurol, Univ Dept Clin Neurosci, London NW3 2PF, England.
   [Pedespan, Laurence] Hop Pellegrin Enfants, F-33076 Bordeaux, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   Universite de Bordeaux; University of London; University College London;
   CHU Bordeaux
RP Letellier, T (corresponding author), Univ Victor Segalen Bordeaux2, INSERM, U688, 146 Rue Leo Saignat, F-33076 Bordeaux, France.
EM tletel@u-bordeaux2.fr
RI Bénard, Giovanni/M-3485-2014; Rocher, Christophe/JYP-4475-2024; Taanman,
   Jan-Willem/A-5379-2011
OI Rocher, Christophe/0000-0003-1859-9704; Taanman,
   Jan-Willem/0000-0002-5476-9785
FU Wellcome Trust [048410] Funding Source: Medline
CR ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   Bakker HD, 1996, J PEDIATR-US, V128, P683, DOI 10.1016/S0022-3476(96)80135-1
   Benbrik E, 1997, J NEUROL SCI, V149, P19, DOI 10.1016/S0022-510X(97)05376-8
   Blake JC, 1999, AM J PATHOL, V155, P67, DOI 10.1016/S0002-9440(10)65100-0
   BODNAR AG, 1993, AM J HUM GENET, V53, P663
   BOGENHAGEN D, 1974, J BIOL CHEM, V249, P7991
   Brown TA, 2002, NUCLEIC ACIDS RES, V30, P2004, DOI 10.1093/nar/30.9.2004
   CHEN CH, 1989, J BIOL CHEM, V264, P11934
   Duclos M, 2004, AM J PHYSIOL-ENDOC M, V286, pE159, DOI 10.1152/ajpendo.00281.2003
   Ducluzeau PH, 1999, J HEPATOL, V30, P149, DOI 10.1016/S0168-8278(99)80019-1
   Faustin B, 2004, J BIOL CHEM, V279, P20411, DOI 10.1074/jbc.M314259200
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4
   LECHER P, 1994, BIOL CELL, V80, P25, DOI 10.1016/0248-4900(94)90013-2
   LETELLIER T, 1994, BIOCHEM J, V302, P171, DOI 10.1042/bj3020171
   LETELLIER T, 1992, PEDIATR RES, V32, P17, DOI 10.1203/00006450-199207000-00004
   MARIOTTI C, 1995, J NEUROL, V242, P547, DOI 10.1007/BF00868806
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Morris AAM, 1998, J HEPATOL, V28, P556, DOI 10.1016/S0168-8278(98)80278-X
   Nelson I, 1997, SOMAT CELL MOLEC GEN, V23, P287, DOI 10.1007/BF02674419
   Nouette-Gaulain K, 2005, CARDIOVASC RES, V66, P132, DOI 10.1016/j.cardiores.2004.12.023
   Ouhabi R, 1998, ANAL BIOCHEM, V263, P169, DOI 10.1006/abio.1998.2776
   POULTON J, 1994, HUM MOL GENET, V3, P1763, DOI 10.1093/hmg/3.10.1763
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Rossignol R, 2000, BIOCHEM J, V347, P45, DOI 10.1042/0264-6021:3470045
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   SHAY JW, 1990, J BIOL CHEM, V265, P14802
   SPELBRINK JN, 1994, HUM MOL GENET, V3, P1989, DOI 10.1093/hmg/3.11.1989
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   VANDENBOGERT C, 1993, BIOCHIM BIOPHYS ACTA, V1144, P177, DOI 10.1016/0005-2728(93)90170-K
   WALLACE DC, 1986, SOMAT CELL MOLEC GEN, V12, P41, DOI 10.1007/BF01560726
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WILLIAMS RS, 1986, J BIOL CHEM, V261, P376
NR 37
TC 47
Z9 51
U1 0
U2 7
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0145-479X
EI 1573-6881
J9 J BIOENERG BIOMEMBR
JI J. Bioenerg. Biomembr.
PD APR
PY 2008
VL 40
IS 2
BP 59
EP 67
DI 10.1007/s10863-008-9130-5
PG 9
WC Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biophysics; Cell Biology
GA 302GK
UT WOS:000255956600001
PM 18415670
DA 2024-11-01
ER

PT J
AU Cirigliano, A
   Amelina, A
   Biferali, B
   Macone, A
   Mozzetta, C
   Bianchi, MM
   Mori, M
   Botta, B
   Pick, E
   Negri, R
   Rinaldi, T
AF Cirigliano, Angela
   Amelina, Antonia
   Biferali, Beatrice
   Macone, Alberto
   Mozzetta, Chiara
   Bianchi, Michele Maria
   Mori, Mattia
   Botta, Bruno
   Pick, Elah
   Negri, Rodolfo
   Rinaldi, Teresa
TI Statins interfere with the attachment of <i>S. cerevisiae</i> mtDNA to
   the inner mitochondrial membrane
SO JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
LA English
DT Article
DE Statins; ergosterol; cholesterol; mitochondrial DNA; myopathy
ID HMG-COA REDUCTASE; SKELETAL-MUSCLE; KLUYVEROMYCES-LACTIS; STEROL LEVELS;
   YEAST; IMPAIRMENT; OVEREXPRESSION; MEVINOLIN; MUTATIONS; TOXICITY
AB The 3-hydroxy-3-methylglutaryl-CoA reductase, a key enzyme of the mevalonate pathway for the synthesis of cholesterol in mammals (ergosterol in fungi), is inhibited by statins, a class of cholesterol lowering drugs. Indeed, statins are in a wide medical use, yet statins treatment could induce side effects as hepatotoxicity and myopathy in patients. We used Saccharomyces cerevisiae as a model to investigate the effects of statins on mitochondria. We demonstrate that statins are active in S.cerevisiae by lowering the ergosterol content in cells and interfering with the attachment of mitochondrial DNA to the inner mitochondrial membrane. Experiments on murine myoblasts confirmed these results in mammals. We propose that the instability of mitochondrial DNA is an early indirect target of statins.
C1 [Cirigliano, Angela; Amelina, Antonia; Biferali, Beatrice; Mozzetta, Chiara; Bianchi, Michele Maria; Negri, Rodolfo; Rinaldi, Teresa] Sapienza Univ Rome, Dept Biol & Biotechnol Charles Darwin, Piazzale A Moro 5, I-00185 Rome, Italy.
   [Macone, Alberto; Rinaldi, Teresa] Pasteur Inst Cenci Bolognetti Fdn, Rome, Italy.
   [Biferali, Beatrice; Mozzetta, Chiara; Negri, Rodolfo] Sapienza Univ Rome, Dept Biol & Biotechnol Charles Darwin, CNR, Inst Mol Biol & Pathol, Rome, Italy.
   [Macone, Alberto] Sapienza Univ Rome, Dipartimento Sci Biochim A Rossi Fanelli, CNR, Inst Mol Biol & Pathol, Rome, Italy.
   [Mori, Mattia] Univ Siena, Dept Biotechnol Chem & Pharm, Siena, Italy.
   [Botta, Bruno] Sapienza Univ Rome, Dipartimento Chim & Tecnol Farmaco, Rome, Italy.
   [Pick, Elah] Univ Haifa, Fac Nat Sci, Dept Biol & Environm, Tivon, Israel.
C3 Sapienza University Rome; Fondazione Cenci Bolognetti; Consiglio
   Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia
   Molecolari (IBPM-CNR); Sapienza University Rome; Sapienza University
   Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e
   Patologia Molecolari (IBPM-CNR); University of Siena; Sapienza
   University Rome; University of Haifa
RP Rinaldi, T (corresponding author), Sapienza Univ Rome, Dept Biol & Biotechnol Charles Darwin, Piazzale A Moro 5, I-00185 Rome, Italy.
EM teresa.rinaldi@uniroma1.it
RI Rinaldi, Teresa/AAC-9710-2020; Pick, Elah/G-6137-2018; Bianchi,
   Michele/H-2951-2019; Macone, Alberto/AAB-2570-2019; Biferali,
   Beatrice/AFR-6412-2022; Mozzetta, Chiara/K-9947-2018
OI Negri, Rodolfo/0000-0002-4806-7090; Biferali,
   Beatrice/0000-0002-2399-885X; Rinaldi, Teresa/0000-0001-6291-245X; Reis,
   AlessanRSS/0000-0001-8486-7469; Macone, Alberto/0000-0003-0455-1400;
   CIRIGLIANO, ANGELA/0000-0003-0790-4638; Mozzetta,
   Chiara/0000-0002-7147-7266; Mori, Mattia/0000-0003-2398-1254; Botta,
   Bruno/0000-0001-8707-4333
FU Ateneo Sapienza, Sapienza University of Rome, Italy [RP11715C541D4BFF,
   RP11816418C88AAC, RM11816413C50F4B]; Israel Ministry of Science and
   Technology (MOST)Italy Ministry of Foreign Affairs (MAECI) [3-9022];
   Israel Science Foundation [162/17]
FX This research was supported by Ateneo Sapienza, Sapienza University of
   Rome, Italy, grant number RP11715C541D4BFF and RP11816418C88AAC to MMB,
   grant number RM11816413C50F4B to RN and TR; Israel Ministry of Science
   and Technology (MOST)Italy Ministry of Foreign Affairs (MAECI), grant
   number 3-9022 to EP and TR; Israel Science Foundation, grant number
   162/17 for EP.
CR Altmann K, 2005, MOL BIOL CELL, V16, P5410, DOI 10.1091/mbc.E05-07-0678
   Apostolopoulou M, 2015, EUR J CLIN INVEST, V45, P745, DOI 10.1111/eci.12461
   BARD M, 1988, J GEN MICROBIOL, V134, P1071
   Barrientos A, 2003, IUBMB LIFE, V55, P83, DOI 10.1080/1521654031000098122
   Bianchi MM, 2001, APPL ENVIRON MICROB, V67, P5621, DOI 10.1128/AEM.67.12.5621-5625.2001
   BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846
   Bolotin-Fukuhara M, 2014, YEAST, V31, P279, DOI 10.1002/yea.3019
   Buhaescu I, 2007, CLIN BIOCHEM, V40, P575, DOI 10.1016/j.clinbiochem.2007.03.016
   Burg JS, 2011, PROG LIPID RES, V50, P403, DOI 10.1016/j.plipres.2011.07.002
   CHARIOT P, 1993, AM J MED, V94, P109, DOI 10.1016/0002-9343(93)90129-D
   CHEN XJ, 1993, GENETICS, V133, P517
   Cirigliano A, 2019, BBA-MOL CELL BIOL L, V1864, P290, DOI 10.1016/j.bbalip.2018.12.002
   Davies BSJ, 2006, GENETICS, V174, P191, DOI 10.1534/genetics.106.059964
   De Angelis L, 2016, MICROBIOL-SGM, V162, P1435, DOI 10.1099/mic.0.000315
   De Luca C, 2009, MITOCHONDRION, V9, P408, DOI 10.1016/j.mito.2009.07.004
   DePinieux G, 1996, BRIT J CLIN PHARMACO, V42, P333, DOI 10.1046/j.1365-2125.1996.04178.x
   Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588
   du Souich P, 2017, PHARMACOL THERAPEUT, V175, P1, DOI 10.1016/j.pharmthera.2017.02.029
   FERGUSON LR, 1992, MUTAT RES, V265, P103, DOI 10.1016/0027-5107(92)90042-Z
   Feuermann M, 2003, EMBO REP, V4, P53, DOI 10.1038/sj.embor.embor713
   Fowler DM, 2011, MOL BIOSYST, V7, P533, DOI 10.1039/c0mb00166j
   Francisci S, 2017, BBA-MOL CELL RES, V1864, P666, DOI 10.1016/j.bbamcr.2017.01.008
   Friesen JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-248
   Gerhold JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15292
   Gilkerson R, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011080
   Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004
   He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266
   Istvan ES, 2002, AM HEART J, V144, pS27, DOI 10.1067/mhj.2002.130300
   Kang CH, 2015, FASEB J, V29, P4092, DOI 10.1096/fj.14-266619
   Katz DH, 2014, J CARDIOVASC PHARM T, V19, P533, DOI 10.1177/1074248414529622
   Kaufmann P, 2006, CELL MOL LIFE SCI, V63, P2415, DOI 10.1007/s00018-006-6235-z
   Knauer MJ, 2010, CIRC RES, V106, P297, DOI 10.1161/CIRCRESAHA.109.203596
   Larsen S, 2013, J AM COLL CARDIOL, V61, P44, DOI 10.1016/j.jacc.2012.09.036
   LORENZ RT, 1990, ANTIMICROB AGENTS CH, V34, P1660, DOI 10.1128/AAC.34.9.1660
   Maciejak A, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-68
   Matsubara A, 2018, TOXICOL LETT, V291, P184, DOI 10.1016/j.toxlet.2018.04.016
   Montanari A, 2008, RNA, V14, P275, DOI 10.1261/rna.740108
   Murley A, 2013, ELIFE, V2, DOI 10.7554/eLife.00422
   Nadanaciva S, 2007, TOXICOL APPL PHARM, V223, P277, DOI 10.1016/j.taap.2007.06.003
   Ottaviano D, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov028
   Peralta S, 2018, J CELL SCI, V131, DOI 10.1242/jcs.217075
   Ramachandran R, 2017, J CLIN MED, V6, DOI 10.3390/jcm6080075
   Rinaldi T, 2010, FEMS YEAST RES, V10, P1006, DOI 10.1111/j.1567-1364.2010.00685.x
   Schick BA, 2007, CLIN PHARMACOL THER, V81, P650, DOI 10.1038/sj.clpt.6100124
   Serratore ND, 2018, GENETICS, V208, P1037, DOI 10.1534/genetics.117.300554
   Sezgin E, 2017, NAT REV MOL CELL BIO, V18, P361, DOI 10.1038/nrm.2017.16
   Shakoury-Elizeh M, 2010, J BIOL CHEM, V285, P14823, DOI 10.1074/jbc.M109.091710
   Sin J, 2016, AUTOPHAGY, V12, P369, DOI 10.1080/15548627.2015.1115172
   Sirvent P, 2005, BIOCHEM BIOPH RES CO, V338, P1426, DOI 10.1016/j.bbrc.2005.10.108
   Sirvent P, 2012, TOXICOL APPL PHARM, V259, P263, DOI 10.1016/j.taap.2012.01.008
   Stringer HAJ, 2013, J NEUROL SCI, V325, P142, DOI 10.1016/j.jns.2012.12.023
   Tay SKH, 2008, PEDIATR NEUROL, V39, P426, DOI 10.1016/j.pediatrneurol.2008.09.002
   Tomaszewski M, 2011, PHARMACOL REP, V63, P859, DOI 10.1016/S1734-1140(11)70601-6
   Tourlaki A, 2020, J DERMATOL TREAT, V31, P183, DOI 10.1080/09546634.2019.1590520
   Vladutiu GD, 2006, MUSCLE NERVE, V34, P153, DOI 10.1002/mus.20567
   Westermeyer C, 2007, FEMS YEAST RES, V7, P436, DOI 10.1111/j.1567-1364.2006.00194.x
NR 56
TC 7
Z9 7
U1 0
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1475-6366
EI 1475-6374
J9 J ENZYM INHIB MED CH
JI J. Enzym. Inhib. Med. Chem.
PD JAN 1
PY 2020
VL 35
IS 1
DI 10.1080/14756366.2019.1687461
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Medicinal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA JK5JI
UT WOS:000494879200001
PM 31694426
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Kuncova, K
   Sedlackova, M
   Vencovsky, J
   Mann, H
   Tomcik, M
   Wenchich, L
   Zamecnik, J
AF Kuncova, Klara
   Sedlackova, Marie
   Vencovsky, Jiri
   Mann, Herman
   Tomcik, Michal
   Wenchich, Laszlo
   Zamecnik, Josef
TI Inflammatory myopathy associated with statins: report of three cases
SO MODERN RHEUMATOLOGY
LA English
DT Article
DE Drug-induced myopathy; Muscle biopsy; Inflammatory myopathy; Statins
ID COA REDUCTASE INHIBITORS; MEDIATED NECROTIZING MYOPATHY; RETICULUM
   STRESS-RESPONSE; INDUCED DERMATOMYOSITIS; AUTOIMMUNE MYOSITIS;
   POLYMYOSITIS; SIMVASTATIN; ACTIVATION; MUTATIONS; THERAPY
AB Statins are well-established lipid-lowering drugs that reduce morbidity and mortality due to cardiovascular disease and cause adverse effects relatively rarely. It is still unclear whether statins are capable of inducing an immune-mediated response directed against skeletal muscle. Here, we present the cases of three patients who developed inflammatory myopathy in the course of statin treatment. Moreover, multiple mitochondrial DNA deletions were found in two of them. The ability of statins to induce an immune-mediated response and their interactions with mitochondrial metabolism pathways are discussed.
C1 [Kuncova, Klara; Zamecnik, Josef] Charles Univ Prague, Fac Med 2, Dept Pathol & Mol Med, Prague 15006 5, Czech Republic.
   [Kuncova, Klara; Zamecnik, Josef] Charles Univ Prague, Univ Hosp Motol, Prague 15006 5, Czech Republic.
   [Sedlackova, Marie] Thomayer Hosp, Dept Rheumatol & Rehabil, Prague 4, Czech Republic.
   [Vencovsky, Jiri; Mann, Herman; Tomcik, Michal] Charles Univ Prague, Fac Med 1, Inst Rheumatol, Dept Rheumatol, Prague 2, Czech Republic.
   [Wenchich, Laszlo] Charles Univ Prague, Fac Med 1, Dept Pediat, Prague 2, Czech Republic.
C3 Motol University Hospital; Charles University Prague; Charles University
   Prague; Motol University Hospital; Thomayer Hospital; Institute of
   Rheumatology; Charles University Prague; Charles University Prague
RP Zamecnik, J (corresponding author), Charles Univ Prague, Fac Med 2, Dept Pathol & Mol Med, Uvalu 84, Prague 15006 5, Czech Republic.
EM josef.zamecnik@lf2.cuni.cz
RI Wenchich, Laszlo/Q-5147-2018; Mann, Herman/G-5871-2014; Vencovsky,
   Jiri/G-6094-2017; Tomcik, Michal/P-1510-2017
OI Wenchich, Laszlo/0000-0002-8250-2981; Mann, Herman/0000-0002-4243-235X;
   Vencovsky, Jiri/0000-0002-0851-0713; Tomcik, Michal/0000-0002-8616-7850
FU Ministry of Health of the Czech Republic [00064203]
FX Supported by the Ministry of Health of the Czech Republic project for
   the conceptual development of research organization 00064203 (University
   Hospital Motol, Prague, Czech Republic).
CR Ahmad A, 2000, Tenn Med, V93, P21
   [Anonymous], 2004, DRUGS, V64, P1181
   BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807
   BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706
   Caso G, 2007, AM J CARDIOL, V99, P1409, DOI 10.1016/j.amjcard.2006.12.063
   Christopher-Stine L, 2010, ARTHRITIS RHEUM-US, V62, P2757, DOI 10.1002/art.27572
   Dalakas MC, 2009, J NEUROL NEUROSUR PS, V80, P832, DOI 10.1136/jnnp.2008.168294
   Fauchais AL, 2004, REV MED INTERNE, V25, P294, DOI 10.1016/j.revmed.2003.10.013
   Folzenlogen D, 2001, JCR-J CLIN RHEUMATOL, V7, P340, DOI 10.1097/00124743-200110000-00019
   Fornuskova D, 2008, BBA-MOL BASIS DIS, V1782, P317, DOI 10.1016/j.bbadis.2008.02.001
   Ghirardello A, 2006, AUTOIMMUNITY, V39, P217, DOI 10.1080/08916930600622645
   Giordano N, 1997, LANCET, V349, P1600, DOI 10.1016/S0140-6736(05)61628-5
   Grable-Esposito P, 2010, MUSCLE NERVE, V41, P185, DOI 10.1002/mus.21486
   Henriques-Pons A, 2009, CURR OPIN RHEUMATOL, V21, P581, DOI 10.1097/BOR.0b013e3283319265
   KHATTAK FH, 1994, BRIT J RHEUMATOL, V33, P199
   Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219
   Kwak BR, 2003, AUTOIMMUN REV, V2, P332, DOI 10.1016/S1568-9972(03)00049-1
   Lamperti C, 2005, ARCH NEUROL-CHICAGO, V62, P1709, DOI 10.1001/archneur.62.11.1709
   Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748
   Liebhaber MI, 1999, CHEST, V115, P886, DOI 10.1378/chest.115.3.886
   Mach F, 2004, CIRCULATION, V109, P15, DOI 10.1161/01.CIR.0000129502.10459.fe
   Mammen AL, 2011, ARTHRITIS RHEUM-US, V63, P713, DOI 10.1002/art.30156
   McClure DL, 2007, PHARMACOEPIDEM DR S, V16, P132, DOI 10.1002/pds.1341
   Nagaraju K, 2005, ARTHRITIS RHEUM, V52, P1824, DOI 10.1002/art.21103
   Needham M, 2007, NEUROMUSCULAR DISORD, V17, P194, DOI 10.1016/j.nmd.2006.10.007
   Noël B, 2001, AM J MED, V110, P670, DOI 10.1016/S0002-9343(01)00711-2
   Pascuzzi Robert M., 1998, Current Opinion in Rheumatology, V10, P511, DOI 10.1097/00002281-199811000-00003
   Paulweber B, 1999, Wien Med Wochenschr, V149, P129
   Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009
   Radcliffe KA, 2008, CURR NEUROL NEUROSCI, V8, P66, DOI 10.1007/s11910-008-0011-4
   RodriguezGarcia JL, 1996, POSTGRAD MED J, V72, P694, DOI 10.1136/pgmj.72.853.694
   Rudski L, 1998, MEDICINE, V77, P378, DOI 10.1097/00005792-199811000-00002
   Sadeghi MM, 2001, TRANSPLANTATION, V71, P1262, DOI 10.1097/00007890-200105150-00014
   Scalvini Tiziano, 1995, Recenti Progressi in Medicina, V86, P198
   Sieb JP, 2003, MUSCLE NERVE, V27, P142, DOI 10.1002/mus.10244
   Takagi Akio, 2004, Rinsho Shinkeigaku, V44, P25
   Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681
   Thual N, 2005, ANN DERMATOL VENER, V132, P996, DOI 10.1016/S0151-9638(05)79565-X
   Toth Peter P, 2008, Expert Rev Cardiovasc Ther, V6, P955, DOI 10.1586/14779072.6.7.955
   Vogel H, 2005, J NEUROPATH EXP NEUR, V64, P181, DOI 10.1093/jnen/64.3.181
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Young JA, 2007, AM J CARDIOL, V100, P1400, DOI 10.1016/j.amjcard.2007.06.030
   Zamecnik J, 2007, NEUROMUSCULAR DISORD, V17, P935, DOI 10.1016/j.nmd.2007.05.010
   Zuech P, 2005, REV MED INTERNE, V26, P897, DOI 10.1016/j.revmed.2005.07.005
NR 44
TC 6
Z9 7
U1 1
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1439-7595
EI 1439-7609
J9 MOD RHEUMATOL
JI Mod. Rheumatol.
PD MAR
PY 2014
VL 24
IS 2
BP 366
EP 371
DI 10.3109/14397595.2013.852848
PG 6
WC Rheumatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Rheumatology
GA AC4IC
UT WOS:000332483500027
PM 24593216
DA 2024-11-01
ER

PT J
AU Lu, YY
   Deng, JW
   Zhao, YY
   Zhang, Z
   Hong, DJ
   Yao, S
   Zhao, DH
   Xie, J
   Fang, HZ
   Yuan, Y
   Wang, ZX
AF Lu, Yuanyuan
   Deng, Jianwen
   Zhao, Yuying
   Zhang, Zhe
   Hong, Daojun
   Yao, Sheng
   Zhao, Danhua
   Xie, Jie
   Fang, Hezhi
   Yuan, Yun
   Wang, Zhaoxia
TI Patients with MELAS with negative myopathology for characteristic
   ragged-red fibers
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE MELAS; Mitochondrial DNA; Diagnosis; Ragged-red fibers; Strongly
   succinate dehydrogenase-stained vessels
ID STROKE-LIKE-EPISODES; LACTIC-ACIDOSIS; MITOCHONDRIAL-MYOPATHY;
   COMPLEX-I; CLINICAL-FEATURES; MUSCLE BIOPSY; ENCEPHALOPATHY; DNA;
   MUTATIONS; PHENOTYPE
AB Background: Muscle pathology usually contributes to mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode (MELAS), even in patients without prominent muscle symptoms. We report a series of patients with MELAS without significant myopathic changes.
   Methods: Twelve patients without ragged-red fibers (RRFs) on muscle pathology (RRF-negative group) and 99 patients with MELAS and RRFs and/or cytochrome c oxidase (COX)-deficient fibers (control RRF-positive group) were recruited. We analyzed clinical features, neuroimaging and pathological findings, gene mutation data, immunofluorescence assay of key respiratory chain subunits of complexes I and IV and mitochondrial DNA (mtDNA) mutation load in biopsied muscle samples.
   Results: None of the RRF-negative patients had RRF or COX-negative fibers, but four patients had strongly succinate dehydrogenase-stained vessels (SSVs). There was a lower proportion of m.3243A > G and higher proportion of mitochondria-encoded ND gene mutations in RRF-negative than RRF-positive patients. The proportion of aphasia was relatively higher, while complex I and IV subunit abundance in muscle and mutation load were lower in RRF-negative than in RRF-positive patients.
   Conclusion: RRF-negative patients had a similar disease course, clinical symptoms, and neuroimaging results to RRF-positive patients with MELAS. SSV is a valuable diagnostic indicator for MELAS. For highly suspected MELAS yet without positive myopathological findings, combined immunofluorescence and genetic studies should be used to achieve final diagnosis.
C1 [Lu, Yuanyuan; Deng, Jianwen; Yuan, Yun; Wang, Zhaoxia] Peking Univ, Dept Neurol, Hosp 1, 8 Xishiku St, Beijing 100034, Peoples R China.
   [Zhao, Yuying] Shandong Univ, Dept Neurol, Qilu Hosp, Jinan, Peoples R China.
   [Zhang, Zhe] Beijing Tian Tan Hosp, Dept Neurol, Beijing, Peoples R China.
   [Hong, Daojun] Peking Univ, Dept Neurol, Peoples Hosp, Beijing, Peoples R China.
   [Yao, Sheng] PLA Navy Gen Hosp, Dept Neurol, Beijing, Peoples R China.
   [Zhao, Danhua] Peking Univ, Dept Neurol, Int Hosp, Beijing, Peoples R China.
   [Xie, Jie; Fang, Hezhi] Wenzhou Med Univ, Coll Lab Med & Life Sci, Zhejiang Prov Key Lab Med Genet, Key Lab Lab Med,Minist Educ, Wenzhou, Zhejiang, Peoples R China.
C3 Peking University; Shandong University; Peking University; Sixth Medical
   Center of Chinese PLA General Hospital; Peking University; Wenzhou
   Medical University
RP Yuan, Y; Wang, ZX (corresponding author), Peking Univ, Dept Neurol, Hosp 1, 8 Xishiku St, Beijing 100034, Peoples R China.
EM yuanyun2002@126.com; drwangzx@163.com
RI hu, xin/KHT-2406-2024; chen, minghui/KFR-8832-2024
OI Deng, Jianwen/0000-0003-1206-1778; Lu, yuanyuan/0000-0002-4628-3195
FU Beijing Municipal Science and Technology Commission [Z151100003915126]
FX This work was financially supported by grants from the Beijing Municipal
   Science and Technology Commission (No. Z151100003915126).
CR Baek MS, 2019, YONSEI MED J, V60, P98, DOI 10.3349/ymj.2019.60.1.98
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   GOTO Y, 1995, MUSCLE NERVE, pS107
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Leng YL, 2015, MITOCHONDR DNA, V26, P208, DOI 10.3109/19401736.2014.905860
   Lim BC, 2009, J CHILD NEUROL, V24, P828, DOI 10.1177/0883073808331085
   Lorenzoni PJ, 2015, ARQ NEURO-PSIQUIAT, V73, P959
   Lorenzoni PJ, 2009, ARQ NEURO-PSIQUIAT, V67, P668, DOI 10.1590/S0004-282X2009000400018
   Lu YY, 2017, J NEUROL SCI, V379, P137, DOI 10.1016/j.jns.2017.05.056
   MIMAKI N, 1991, No To Hattatsu, V23, P606
   Moslemi A, 2007, NEUROMUSCULAR DISORD, V17, P771, DOI 10.1016/j.nmd.2007.06.037
   Ozawa M, 1998, J NEUROL SCI, V159, P170, DOI 10.1016/S0022-510X(98)00152-X
   Raymond FL, 2018, NAT REV GENET, V19, P399, DOI 10.1038/s41576-018-0022-1
   Rocha MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15037
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   TOKUNAGA M, 1994, ANN NEUROL, V35, P413, DOI 10.1002/ana.410350407
   Tsao CY, 2000, J CHILD NEUROL, V15, P445, DOI 10.1177/088307380001500704
   UJIKE H, 1993, JPN J PSYCHIAT NEUR, V47, P637
   Yan JB, 2014, J MOL DIAGN, V16, P431, DOI 10.1016/j.jmoldx.2014.03.005
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Zhao D, 2011, J HUM GENET, V56, P759, DOI 10.1038/jhg.2011.96
NR 25
TC 8
Z9 11
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD JAN 15
PY 2020
VL 408
AR 116499
DI 10.1016/j.jns.2019.116499
PG 7
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA KH9EP
UT WOS:000510952200020
PM 31726383
DA 2024-11-01
ER

PT J
AU Lindgren, U
   Roos, S
   Oldfors, CH
   Moslemi, AR
   Lindberg, C
   Oldfors, A
AF Lindgren, Ulrika
   Roos, Sara
   Oldfors, Carola Hedberg
   Moslemi, Ali-Reza
   Lindberg, Christopher
   Oldfors, Anders
TI Mitochondrial pathology in inclusion body myositis
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Inclusion body myositis; Mitochondrial DNA; mtDNA; Cytochrome c oxidase
   deficiency
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; DNA DELETIONS; SYNONYMOUS
   MUTATIONS; PARKINSON-DISEASE; DIAGNOSIS; POLG1; PATHOGENESIS; CHILDHOOD;
   DEPLETION; ANT1
AB Inclusion body myositis (IBM) is usually associated with a large number of cytochrome c oxidase (COX)-deficient muscle fibers and acquired mitochondrial DNA (mtDNA) deletions.
   We studied the number of COX-deficient fibers and the amount of mtDNA deletions, and if variants in nuclear genes involved in mtDNA maintenance may contribute to the occurrence of mtDNA deletions in IBM muscle.
   Twenty-six IBM patients were included. COX-deficient fibers were assayed by morphometry and mtDNA deletions by qPCR. POLG was analyzed in all patients by Sanger sequencing and C10orf2 (Twinkle), DNA2, MGME1, OPA1, POLG2, RRM2B, SLC25A4 and TYMP in six patients by next generation sequencing.
   Patients with many COX-deficient muscle fibers had a significantly higher proportion of mtDNA deletions than patients with few COX-deficient fibers. We found previously unreported variants in POLG and C10orf2 and IBM patients had a significantly higher frequency of an RRM2B variant than controls. POLG variants appeared more common in IBM patients with many COX-deficient fibers, but the difference was not statistically significant.
   We conclude that COX-deficient fibers in inclusion body myositis are associated with multiple mtDNA deletions. In IBM patients we found novel and also previously reported variants in genes of importance for mtDNA maintenance that warrants further studies. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Lindgren, Ulrika; Roos, Sara; Oldfors, Carola Hedberg; Moslemi, Ali-Reza; Oldfors, Anders] Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Biomed, Dept Pathol, SE-41345 Gothenburg, Sweden.
   [Lindberg, Christopher] Sahlgrens Univ Hosp, Neuromuscular Ctr, Dept Neurol, Gothenburg, Sweden.
C3 University of Gothenburg; Sahlgrenska University Hospital; Sahlgrenska
   University Hospital
RP Oldfors, A (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Biomed, Dept Pathol, SE-41345 Gothenburg, Sweden.
EM anders.oldfors@gu.se
RI Lindgren, Ulrika/HJH-0146-2022
FU Lung GO Sequencing Project [HL-102923]; WHI Sequencing Project
   [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO
   Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010];
   Research Fund for Neuromuscular Disorders in West Sweden; Swedish
   Research Council [07122]
FX The authors are grateful to Gabriella Almen and Anna-Carin Ericson for
   skilled methodical and technical assistance and Kirsten Mehlig for
   statistical advice. The authors would like to thank the NHLBI GO Exome
   Sequencing Project and its ongoing studies which produced and provided
   exome variant calls for comparison: the Lung GO Sequencing Project
   (HL-102923), the WHI Sequencing Project (HL-102924), the Broad GO
   Sequencing Project (HL-102925), the Seattle GO Sequencing Project
   (HL-102926) and the Heart GO Sequencing Project (HL-103010).This study
   was supported by The Research Fund for Neuromuscular Disorders in West
   Sweden and the Swedish Research Council (project no. 07122).
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   [Anonymous], 2012, POLYPHEN 2
   [Anonymous], 2014, EXOME VARIANT SERVER
   [Anonymous], 2013, MUSCLE BIOPSY PRACTI
   Anvret A, 2010, NEUROSCI LETT, V485, P117, DOI 10.1016/j.neulet.2010.08.082
   Badrising UA, 2005, J NEUROL, V252, P1448, DOI 10.1007/s00415-005-0884-y
   Balafkan N, 2012, MITOCHONDRION, V12, P640, DOI 10.1016/j.mito.2012.08.004
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Benveniste O, 2011, BRAIN, V134, P3176, DOI 10.1093/brain/awr213
   Brady S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004552
   Cox FM, 2011, BRAIN, V134, P3167, DOI 10.1093/brain/awr217
   Dahlbom K, 2002, NEUROMUSCULAR DISORD, V12, P853, DOI 10.1016/S0960-8966(02)00098-6
   Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055
   Eerola J, 2010, NEUROSCI LETT, V477, P1, DOI 10.1016/j.neulet.2010.04.021
   Greenberg SA, 2012, CURR OPIN NEUROL, V25, P630, DOI 10.1097/WCO.0b013e328357f211
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Needham M, 2007, LANCET NEUROL, V6, P620, DOI 10.1016/S1474-4422(07)70171-0
   Needham M, 2008, J CLIN NEUROSCI, V15, P1350, DOI 10.1016/j.jocn.2008.01.011
   Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601
   Oldfors A, 2006, NEUROLOGY, V66, pS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   Oldfors A, 2005, CURR OPIN NEUROL, V18, P497, DOI 10.1097/01.wco.0000183115.14175.29
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Roos S, 2013, HUM MOL GENET, V22, P2411, DOI 10.1093/hmg/ddt094
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051
   Sharer JD, 2005, IUBMB LIFE, V57, P607, DOI 10.1080/15216540500217735
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
NR 39
TC 32
Z9 35
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD APR
PY 2015
VL 25
IS 4
BP 281
EP 288
DI 10.1016/j.nmd.2014.12.010
PG 8
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA CG2CE
UT WOS:000353081700001
PM 25638290
DA 2024-11-01
ER

PT J
AU Mehrazin, M
   Shanske, S
   Kaufmann, P
   Wei, Y
   Coku, J
   Engelstad, K
   Naini, A
   De Vivo, DC
   DiMauro, S
AF Mehrazin, Mahsa
   Shanske, Sara
   Kaufmann, Petra
   Wei, Ying
   Coku, Jorida
   Engelstad, Kristin
   Naini, Ali
   De Vivo, Darryl C.
   DiMauro, Salvatore
TI Longitudinal Changes of mtDNA A3243G Mutation Load and Level of
   Functioning in MELAS
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE mitochondrial DNA mutation; MELAS; A3243G; heteroplasmy; mutant load
ID STROKE-LIKE EPISODES; MITOCHONDRIAL-DNA MUTATION; LACTIC-ACIDOSIS; POINT
   MUTATION; PROTEIN-SYNTHESIS; MYOPATHY; GENE; ENCEPHALOMYOPATHIES;
   ENCEPHALOPATHY; PREVALENCE
AB Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), one of the most common mitochondrial multisystemic diseases, is most commonly associated with an A-to-G transition at nucleotide position 3243 (A3243G) in mitochondrial DNA. We studied 34 individuals harboring the A3243G mutation for up to 7 years; 17 had the full MELAS phenotype and 17 who were classified as "carrier relatives" because they were either asymptomatic or had some symptoms suggestive of mitochondrial disease but no seizures or strokes. Using the sensitive real-time polymerase chain reaction to quantify the A3243G mutation, we confirmed that the percent mutation decreases progressively in DNA isolated from blood: the average percent decrease was 0.5% per year for fully symptomatic patients and 0.2% per year for oligosymptomatic carrier relatives. We also correlated mutant loads with functional status estimated by the Karnofksky score: even though the mutation load decreases, the level of functioning worsens in fully symptomatic patients, whereas the level of functioning of carrier relatives remains largely unchanged. This study suggests that A3243G mutant load in DNA isolated from blood is neither useful for prognosis nor for functional assessment. (C) 2009 Wiley-Liss, Inc.
C1 [Mehrazin, Mahsa; Shanske, Sara; Kaufmann, Petra; Coku, Jorida; Engelstad, Kristin; Naini, Ali; De Vivo, Darryl C.; DiMauro, Salvatore] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.
   [Wei, Ying] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA.
C3 Columbia University; Columbia University
RP DiMauro, S (corresponding author), Russ Berrie Med Sci Pavil,Room 313,1150 St Nichol, New York, NY 10032 USA.
EM sd12@columbia.edu
FU NIH [HD32062]; Marriott Mitochondrial Disorders Clinical Research Fund
   (MMD- CRF)
FX Grant sponsor: NIH; Grant number: HD32062; Grant sponsor: Marriott
   Mitochondrial Disorders Clinical Research Fund (MMD- CRF).
CR CAMPOS Y, 1995, ACTA NEUROL SCAND, V91, P62
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   CIAFALONI E, 1991, NEUROLOGY, V41, P1663, DOI 10.1212/WNL.41.10.1663
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Karnofsky DA, 1949, EVALUATION CHEMOTHER, P196
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683
   KOBAYASHI Y, 1991, AM J HUM GENET, V49, P590
   KOBAYASHI Y, 1992, J INHERIT METAB DIS, V15, P803, DOI 10.1007/BF01800025
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   LIOU CW, 1994, ACTA NEUROL SCAND, V90, P354
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   MARTINUZZI A, 1992, J NEUROL SCI, V113, P222, DOI 10.1016/0022-510X(92)90250-O
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   SHIRAIWA N, 1993, J NEUROL SCI, V120, P174, DOI 10.1016/0022-510X(93)90270-9
   Singh R, 2006, J MOL DIAGN, V8, P225, DOI 10.2353/jmoldx.2006.050067
   Sue CM, 1998, J NEUROL SCI, V161, P36, DOI 10.1016/S0022-510X(98)00179-8
   THART LM, 1994, DIABETOLOGIA, V37, P1169
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
NR 33
TC 37
Z9 46
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD APR
PY 2009
VL 149A
IS 4
BP 584
EP 587
DI 10.1002/ajmg.a.32703
PG 4
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 430IN
UT WOS:000264982900006
PM 19253345
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Lederer, SR
   Klopstock, T
   Schiffl, H
AF Lederer, Stephan R.
   Klopstock, Thomas
   Schiffl, Helmut
TI MELAS: a mitochondrial disorder in an adult patient with a renal
   transplant
SO WIENER KLINISCHE WOCHENSCHRIFT
LA English
DT Article
DE Mitochondrial disorders; stroke-like episodes; multisystemic disorders;
   kidney transplantation; kidney failure
ID STROKE-LIKE-EPISODES; LACTIC-ACIDOSIS; ENCEPHALOPATHY; MANAGEMENT;
   MYOPATHY; DISEASE; DNA
AB Mitochondrial diseases are a heterogeneous group of syndromes caused by genetic defects in mitochondrial DNA (mtDNA) or nuclear-encoded mitochondrial genes [1]. They present with a wide range of clinical phenotypes. Myopathy may be the sole or main sign, or merely an incidental finding occurring in the late course of a multisystemic illness. Although mitochondrial disorders are increasingly being recognized, confirming a specific diagnosis remains a great challenge due to the clinical heterogeneity of the diseases. Several well-defined clinical syndromes associated with specific mutations have been described. Thus, suspicion of mitochondrial diseases among patients with multiple, seemingly unrelated neuromuscular and multisystem disorders should be confirmed by the finding of deleterious mutations in genes involving mitochondrial biogenesis and function.
   This case report describes a 58-year-old patient with a 40-year course of a multisystemic illness representing the diagnostic challenges of mitochondrial disease.
C1 [Lederer, Stephan R.; Schiffl, Helmut] Klinikum Univ Munchen, KfH Nierenzentrum Munchen, W & Nephrol Zentrum, Munich, Germany.
   [Klopstock, Thomas] Klinikum Univ Munchen, Friedrich Baur Inst, Neurol Klin & Poliklin, Munich, Germany.
C3 University of Munich; University of Munich
RP Lederer, SR (corresponding author), KfH Nierenzentrum, Elsenheimerstr 63, D-80687 Munich, Germany.
EM Stephan.lederer@kfh-dialyse.de
CR Guéry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Testai FD, 2010, ARCH NEUROL-CHICAGO, V67, P19, DOI 10.1001/archneurol.2009.309
   Thambisetty M, 2004, EXPERT REV MOL DIAGN, V4, P631, DOI 10.1586/14737159.4.5.631
   Wong LJC, 2007, MITOCHONDRION, V7, P45, DOI 10.1016/j.mito.2006.11.025
NR 7
TC 10
Z9 10
U1 0
U2 2
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0043-5325
J9 WIEN KLIN WOCHENSCHR
JI Wien. Klin. Wochen.
PD JUN
PY 2010
VL 122
IS 11-12
BP 363
EP 365
DI 10.1007/s00508-010-1388-z
PG 3
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 621HY
UT WOS:000279568000009
PM 20552288
DA 2024-11-01
ER

PT J
AU Lindgren, U
   Hedberg-Oldfors, C
   Pullerits, R
   Lindberg, C
   Oldfors, A
AF Lindgren, Ulrika
   Hedberg-Oldfors, Carola
   Pullerits, Rille
   Lindberg, Christopher
   Oldfors, Anders
TI Inclusion body myositis with early onset: a population-based study
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE Inclusion body myositis; Inflammatory myopathy; Muscular weakness;
   Mitochondrial DNA; Epidemiology
ID MITOCHONDRIAL
AB IntroductionInclusion body myositis (IBM), an inflammatory myopathy with progressive weakness without efficient treatment, typically presents after 45 years of age and younger patients are sparsely studied.MethodsIn a population-based study during a 33-year period, 142 patients with IBM were identified in western Sweden. Six patients fell outside the European Neuromuscular Centre 2011 criteria for IBM due to young age at symptom onset, verified by a muscle biopsy < 50 years of age. These were defined as early-onset IBM and included in this study. Medical records, muscle strength, comorbidities, muscle biopsies, and nuclear- and mitochondrial DNA were examined and compared with patients with IBM and age matched controls from the same population.ResultsThe median age at symptom onset was 36 (range 34-45) years and at diagnosis 43 (range 38-58) years. Four patients were deceased at a median age of 59 (range 50-75) years. The median survival from diagnosis was 14 (range 10-18) years. The prevalence December 31 2017 was 1.2 per million inhabitants and the mean incidence 0.12 patients per million inhabitants and year. The mean decline in quadriceps strength & PLUSMN; 1 standard deviation was 1.21 & PLUSMN; 0.2 Newton or 0.91 & PLUSMN; 0.2% per month and correlated to time from diagnosis (p < 0.001). Five patients had swallowing difficulties. All patients displayed mitochondrial changes in muscle including cytochrome c oxidase deficiency and the mitochondrial DNA mutation load was high.ConclusionsEarly-onset IBM is a severe disease, causing progressive muscle weakness, high muscle mitochondrial DNA mutation load and a reduced cumulative survival in young and middle-aged individuals.
C1 [Lindgren, Ulrika; Hedberg-Oldfors, Carola; Oldfors, Anders] Univ Gothenburg, Inst Biomed, Sahlgrenska Acad, Dept Lab Med, Gothenburg, Sweden.
   [Lindgren, Ulrika; Lindberg, Christopher] Sahlgrens Univ Hosp, Neuromuscular Ctr, Dept Neurol, Gothenburg, Sweden.
   [Pullerits, Rille] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.
   [Pullerits, Rille] Sahlgrens Univ Hosp, Dept Clin Immunol & Transfus Med, Gothenburg, Sweden.
C3 University of Gothenburg; Sahlgrenska University Hospital; University of
   Gothenburg; Sahlgrenska University Hospital
RP Lindgren, U (corresponding author), Univ Gothenburg, Inst Biomed, Sahlgrenska Acad, Dept Lab Med, Gothenburg, Sweden.; Lindgren, U (corresponding author), Sahlgrens Univ Hosp, Neuromuscular Ctr, Dept Neurol, Gothenburg, Sweden.
EM ulrika.lindgren@gu.se
RI Lindgren, Ulrika/HJH-0146-2022; Pullerits, Rille/ABC-0141-2022
OI Pullerits, Rille/0000-0002-5383-9817
CR Alamr M, 2022, MUSCLE NERVE, V66, P686, DOI 10.1002/mus.27716
   Askanas Valerie, 2011, Presse Med, V40, pe219, DOI 10.1016/j.lpm.2010.11.024
   Badrising UA, 2005, J NEUROL, V252, P1448, DOI 10.1007/s00415-005-0884-y
   Basu S, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1009242
   Benveniste O, 2011, BRAIN, V134, P3176, DOI 10.1093/brain/awr213
   Carpenter S., 1975, RECENT ADV MYOLOGY, P374
   Danckert B., 2019, NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic countries
   Ding J, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1005306, 10.1371/journal.pgen.1005549]
   Dobloug G. C., 2015, European Journal of Neurology, V22, P672, DOI 10.1111/ene.12627
   Dobloug GC, 2015, SEMIN ARTHRITIS RHEU, V45, P301, DOI 10.1016/j.semarthrit.2015.06.005
   Dubowitz V., 2021, MUSCLE BIOPSY A PRAC
   Eaton WW, 2007, J AUTOIMMUN, V29, P1, DOI 10.1016/j.jaut.2007.05.002
   Engholm G, 2010, ACTA ONCOL, V49, P725, DOI 10.3109/02841861003782017
   Felice KJ, 2001, MEDICINE, V80, P320, DOI 10.1097/00005792-200109000-00006
   GRIGGS RC, 1995, ANN NEUROL, V38, P705, DOI 10.1002/ana.410380504
   Hedberg-Oldfors C, 2021, BRAIN PATHOL, V31, DOI 10.1111/bpa.12931
   Jeppesen TD, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.547638
   Lindberg C, 2012, ACTA NEUROL SCAND, V125, P353, DOI 10.1111/j.1600-0404.2011.01584.x
   Lindgren S, 1991, Dysphagia, V6, P187
   Lindgren U, 2022, ANN NEUROL, V92, P201, DOI 10.1002/ana.26412
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   LOTZ BP, 1989, BRAIN, V112, P727, DOI 10.1093/brain/112.3.727
   Michelle EH, 2023, NEUROLOGY, V100, pE1406, DOI 10.1212/WNL.0000000000206777
   Naddaf E, 2022, RHEUMATOLOGY, V61, P2016, DOI 10.1093/rheumatology/keab716
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   Richards Sue, 2015, Genet Med, V17, P405, DOI 10.1038/gim.2015.30
   Rose MR, 2013, NEUROMUSCULAR DISORD, V23, P1044, DOI 10.1016/j.nmd.2013.08.007
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Shelly S, 2021, NEUROLOGY, V96, pE2653, DOI 10.1212/WNL.0000000000012004
   Statistics Sweden, about us
NR 30
TC 2
Z9 2
U1 0
U2 2
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD NOV
PY 2023
VL 270
IS 11
BP 5483
EP 5492
DI 10.1007/s00415-023-11878-w
EA JUL 2023
PG 10
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA W0FA5
UT WOS:001034417500001
PM 37498322
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Yano, T
   Tanaka, M
   Fukuda, N
   Ueda, T
   Nagase, H
AF Yano, Takamitsu
   Tanaka, Masashi
   Fukuda, Noboru
   Ueda, Takuya
   Nagase, Hiroki
TI Loss of mutant mitochondrial DNA harboring the MELAS A3243G mutation in
   human cybrid cells after cell-cell fusion with normal tissue-derived
   fibroblast cells
SO INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
LA English
DT Article
DE Mitochondrial DNA; cybrid cells; A3243G mutation; cell fusion;
   osteosarcoma; non-tumorigenic fibroblast cell; mitochondrial myopathy;
   encephalomyopathy; lactic acidosis; stroke-like episodes
ID TRANSFER RNALEU(UUR) GENE; STROKE-LIKE EPISODES; POINT MUTATION;
   TRANSCRIPTION TERMINATION; LACTIC-ACIDOSIS; PROTEIN-SYNTHESIS;
   ENCEPHALOPATHY; MYOPATHY; MTDNA; ENCEPHALOMYOPATHIES
AB Mutant mitochondrial (mt) DNA variants are related to human disease and have been investigated using cytoplasmic hybrid (cybrid) cells generated from human tumor cells in which mutant nit maintenance depends on the cell line. It is, however, unclear whether human intercellular fusion of non-tumorous cells influences the maintenance of disease-related mutant mt. A preliminary experiment of cell-cell fusion between a human skin fibroblast cell line from a Lesch-Nyhan syndrome patient and an osteosarcoma cybrid cell line harboring the mitochondrial tRNA(Leu(UUR))A3243G mutation showed a decrease of A3243G mutant mtDNA in fused cells during passages. In order to confirm the decrease of mutant mtDNA, we performed cell-cell fusion experiments using another human lung fibroblastic cell line. When the hygromycin-resistant osteosarcoma cybrid cell line was fused with the fibroblasts without any A3243G mtDNA mutations, the proportion of A3243G mutant mtDNA in the hybrid cells gradually decreased during cell culture and almost completely disappeared in all hybrid clones at the end of 15 passages. These results indicated that A3243G mutant specific mtDNA decreases in the hybrid background when normal fibroblast-derived cell contents, including the nucleus and mt, were introduced. Thus, we are hypothesizing that the non-tumorigenic fibroblast cellular components induce a difference in replication efficacy between the mtDNAs with and without the A3243G mutant sequence, which may be related to the decrease of disease-related mutant mtDNA in the hybrid cells.
C1 [Nagase, Hiroki] Nihon Univ, Div Canc Genet, Dept Adv Med Sci, Sch Med,Itabashi Ku, Tokyo 1738610, Japan.
   [Yano, Takamitsu; Ueda, Takuya] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba, Japan.
   [Tanaka, Masashi] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan.
   [Fukuda, Noboru; Nagase, Hiroki] Nihon Univ, Adv Res Inst Sci & Humanities, Tokyo 1738610, Japan.
   [Nagase, Hiroki] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA.
C3 Nihon University; University of Tokyo; Tokyo Metropolitan Institute of
   Gerontology; Nihon University; Roswell Park Comprehensive Cancer Center
RP Nagase, H (corresponding author), Nihon Univ, Div Canc Genet, Dept Adv Med Sci, Sch Med,Itabashi Ku, 30-1 Ooyaguchi Kamicho, Tokyo 1738610, Japan.
EM nagase.hiroki@nihon-u.ac.jp
RI Ueda, Takuya/K-5217-2014
OI Ueda, Takuya/0000-0002-7760-8271; Yano, Takamitsu/0009-0000-7888-6639;
   Fukuda, Noboru/0000-0003-0098-054X
FU academic frontier project; Grants-in-Aid for Scientific Research
   [21590411] Funding Source: KAKEN
FX This work is supported by an academic frontier project in 2006 (to
   H.N.).
CR Börner GV, 2000, HUM MOL GENET, V9, P467, DOI 10.1093/hmg/9.4.467
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   CHRISTIANSON TW, 1988, MOL CELL BIOL, V8, P4502, DOI 10.1128/MCB.8.10.4502
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0
   Hyvärinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676
   Kaufmann P, 1996, ANN NEUROL, V40, P172, DOI 10.1002/ana.410400208
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   KRUSE B, 1989, CELL, V58, P391, DOI 10.1016/0092-8674(89)90853-2
   MARTINUZZI A, 1992, J NEUROL SCI, V113, P222, DOI 10.1016/0022-510X(92)90250-O
   Moraes CT, 1999, MOL BIOL CELL, V10, P3345, DOI 10.1091/mbc.10.10.3345
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   SHOUBRIDGE EA, 1995, BIOCHEM BIOPH RES CO, V213, P189, DOI 10.1006/bbrc.1995.2115
   Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
NR 22
TC 2
Z9 2
U1 0
U2 4
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1107-3756
EI 1791-244X
J9 INT J MOL MED
JI Int. J. Mol. Med.
PD JAN
PY 2010
VL 25
IS 1
BP 153
EP 158
DI 10.3892/ijmm_00000325
PG 6
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 635WQ
UT WOS:000280688500020
PM 19956914
OA Bronze
DA 2024-11-01
ER

PT J
AU Cheldi, A
   Ronchi, D
   Bordoni, A
   Bordo, B
   Lanfranconi, S
   Bellotti, MG
   Corti, S
   Lucchini, V
   Sciacco, M
   Moggio, M
   Baron, P
   Comi, GP
   Colombo, A
   Bersano, A
AF Cheldi, Antonella
   Ronchi, Dario
   Bordoni, Andreina
   Bordo, Bianca
   Lanfranconi, Silvia
   Bellotti, Maria Grazia
   Corti, Stefania
   Lucchini, Valeria
   Sciacco, Monica
   Moggio, Maurizio
   Baron, Pierluigi
   Comi, Giacomo Pietro
   Colombo, Antonio
   Bersano, Anna
CA Lombardia GENS Collaborators
TI POLG1 mutations and stroke like episodes: a distinct clinical entity
   rather than an atypical MELAS syndrome
SO BMC NEUROLOGY
LA English
DT Article
DE POLG1; MELAS; Red-ragged fibers; Stroke-like
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MITOCHONDRIAL-DNA DELETIONS;
   POLYMERASE GAMMA-A; GENE; DISEASE; ENCEPHALOPATHY; POPULATION; SPECTRUM
AB Background: POLG1 mutations have been associated with MELAS-like phenotypes. However given several clinical differences it is unknown whether POLG1 mutations are possible causes of MELAS or give raise to a distinct clinical and genetic entity, named POLG1-associated encephalopathy.
   Case presentation: We describe a 74 years old man carrying POLG1 mutations presenting with strokes, myopathy and ragged red fibers with some atypical aspects for MELAS such as late onset, lack of cerebral calcification and presence of frontal and occipital MRI lesions better consistent with the POLG associated-encephalopathy spectrum.
   Conclusion: The lack of available data hampers a definite diagnosis in our patient as well as makes it difficult to compare MELAS, which is a clearly defined clinical syndrome, with POLG1-associated encephalopathy, which is so far a purely molecularly defined syndrome with a quite heterogeneous clinical picture. However, the present report contributes to expand the phenotypic spectrum of POLG1 mutations underlining the importance of searching POLG1 mutations in patients with mitochondrial signs and MELAS like phenotypes but negative for common mtDNA mutations.
C1 [Cheldi, Antonella; Bordo, Bianca; Bellotti, Maria Grazia; Colombo, Antonio] Azienda Osped Desio & Vimercate, Osped Desio, Neurol Unit, Monza, Italy.
   [Ronchi, Dario; Bordoni, Andreina; Lanfranconi, Silvia; Corti, Stefania; Baron, Pierluigi; Comi, Giacomo Pietro] Univ Milan, Dept Pathophysiol & Transplantat DEPT, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dino Ferrari Ctr,Neurol Unit,Neurosci Sect, I-20122 Milan, Italy.
   [Lucchini, Valeria; Sciacco, Monica; Moggio, Maurizio] Univ Milan, Neuromuscular Unit, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dino Ferrari Ctr, I-20122 Milan, Italy.
   [Bersano, Anna] IRCCS Fdn Neurol Inst C Besta, Cerebrovasc Unit, I-20135 Milan, Italy.
C3 University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico;
   IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan
RP Bersano, A (corresponding author), IRCCS Fdn Neurol Inst C Besta, Cerebrovasc Unit, Via Celoria 23, I-20135 Milan, Italy.
EM anna.bersano@gmail.com
RI Comi, Giacomo/K-5702-2016; Ronchi, Dario/K-8011-2016; Sciacco,
   Monica/AAC-6500-2022; bersano, anna/J-8315-2018; colombo,
   antonio/N-2960-2015; corti, stefania/K-6034-2016
OI Ronchi, Dario/0000-0002-6093-9816; Sciacco, Monica/0000-0003-4593-4977;
   bersano, anna/0000-0002-2493-628X; colombo, antonio/0000-0002-2940-2455;
   Lanfranconi, Silvia/0000-0002-7281-7218; Comi,
   Giacomo/0000-0002-1383-5248; corti, stefania/0000-0001-5425-969X
FU 'LOMBARDIA GENS' network; Associazione Amici del Centro Dino Ferrari;
   University of Milan; Telethon project [GTB07001]; Eurobiobank project
   [QLTR-2001-02769]; Criobanca Automatizzata di Materiale Biologico [R.F.
   02.187]
FX We wish to thank 'LOMBARDIA GENS' network and project for their support.
   The existent network and the research grants of Regione Lombardia is
   gratefully acknowledged. The financial support of Associazione Amici del
   Centro Dino Ferrari, University of Milan, the Telethon project GTB07001,
   the Eurobiobank project QLTR-2001-02769 and R.F. 02.187 Criobanca
   Automatizzata di Materiale Biologico are gratefully acknowledged.
   Written consent was obtained from the patient for publication.
CR Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Echaniz-Laguna A, 2010, ARCH NEUROL-CHICAGO, V67, P1140, DOI 10.1001/archneurol.2010.219
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   Sciacco M, 2001, J NEUROL, V248, P778, DOI 10.1007/s004150170094
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Tzoulis C, 2008, NEUROLOGY, V70, P1054, DOI 10.1212/01.wnl.0000307661.98694.c3
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Tzoulis C, 2010, BRAIN, V133, P1428, DOI 10.1093/brain/awq067
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118
NR 23
TC 25
Z9 28
U1 1
U2 12
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2377
J9 BMC NEUROL
JI BMC Neurol.
PD JAN 15
PY 2013
VL 13
AR 8
DI 10.1186/1471-2377-13-8
PG 6
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 088LL
UT WOS:000314835800001
PM 23324391
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Hathazi, D
   Griffin, H
   Jennings, MJ
   Giunta, M
   Powell, C
   Pearce, SF
   Munro, B
   Wei, W
   Boczonadi, V
   Poulton, J
   Pyle, A
   Calabrese, C
   Gomez-Duran, A
   Schara, U
   Pitceathly, RD
   Hanna, MG
   Joost, K
   Cotta, A
   Paim, JF
   Navarro, MM
   Duff, J
   Mattmann, A
   Chapman, K
   Servidei, S
   Della Marina, A
   Uusimaa, J
   Roos, A
   Mootha, V
   Hirano, M
   Tulinius, M
   Giri, M
   Hoffmann, EP
   Lochmuller, H
   DiMauro, S
   Minczuk, M
   Chinnery, PF
   Muller, JS
   Horvath, R
AF Hathazi, Denisa
   Griffin, Helen
   Jennings, Matthew J.
   Giunta, Michele
   Powell, Christopher
   Pearce, Sarah F.
   Munro, Benjamin
   Wei, Wei
   Boczonadi, Veronika
   Poulton, Joanna
   Pyle, Angela
   Calabrese, Claudia
   Gomez-Duran, Aurora
   Schara, Ulrike
   Pitceathly, Robert D. S.
   Hanna, Michael G.
   Joost, Kairit
   Cotta, Ana
   Paim, Julia Filardi
   Navarro, Monica Machado
   Duff, Jennifer
   Mattmann, Andre
   Chapman, Kristine
   Servidei, Serenella
   Della Marina, Adela
   Uusimaa, Johanna
   Roos, Andreas
   Mootha, Vamsi
   Hirano, Michio
   Tulinius, Mar
   Giri, Manta
   Hoffmann, Eric P.
   Lochmuller, Hanns
   DiMauro, Salvatore
   Minczuk, Michal
   Chinnery, Patrick F.
   Muller, Juliane S.
   Horvath, Rita
TI Metabolic shift underlies recovery in reversible infantile respiratory
   chain deficiency
SO EMBO JOURNAL
LA English
DT Article
DE digenic inheritance; homoplasmic tRNA mutation; mitochondrial myopathy;
   reversible infantile respiratory chain deficiency
ID CITRIC-ACID CYCLE; STRESS-RESPONSE; MITOCHONDRIAL TRANSLATION;
   REACTION-MECHANISM; FATTY-ACID; KEY ROLE; RNA; GLUTAMINASE; REGULATOR;
   OXIDATION
AB Reversible infantile respiratory chain deficiency (RIRCD) is a rare mitochondrial myopathy leading to severe metabolic disturbances in infants, which recover spontaneously after 6-months of age. RIRCD is associated with the homoplasmic m.14674T>C mitochondrial DNA mutation; however, only similar to 1/100 carriers develop the disease. We studied 27 affected and 15 unaffected individuals from 19 families and found additional heterozygous mutations in nuclear genes interacting with mt-tRNAGlu including EARS2 and TRMU in the majority of affected individuals, but not in healthy carriers of m.14674T>C, supporting a digenic inheritance. Our transcriptomic and proteomic analysis of patient muscle suggests a stepwise mechanism where first, the integrated stress response associated with increased FGF21 and GDF15 expression enhances the metabolism modulated by serine biosynthesis, one carbon metabolism, TCA lipid oxidation and amino acid availability, while in the second step mTOR activation leads to increased mitochondrial biogenesis. Our data suggest that the spontaneous recovery in infants with digenic mutations may be modulated by the above described changes. Similar mechanisms may explain the variable penetrance and tissue specificity of other mtDNA mutations and highlight the potential role of amino acids in improving mitochondrial disease.
C1 [Hathazi, Denisa; Jennings, Matthew J.; Munro, Benjamin; Wei, Wei; Calabrese, Claudia; Gomez-Duran, Aurora; Chinnery, Patrick F.; Muller, Juliane S.; Horvath, Rita] Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cambridge, England.
   [Griffin, Helen; Giunta, Michele; Boczonadi, Veronika; Pyle, Angela; Duff, Jennifer] Newcastle Univ, Translat & Clin Res Inst, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Powell, Christopher; Pearce, Sarah F.; Wei, Wei; Calabrese, Claudia; Gomez-Duran, Aurora; Minczuk, Michal; Chinnery, Patrick F.] MRC Mitochondrial Biol Unit, Cambridge, England.
   [Pearce, Sarah F.] Univ Stockholm, Karolinska Inst, Stockholm, Sweden.
   [Poulton, Joanna] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.
   [Schara, Ulrike; Della Marina, Adela; Roos, Andreas] Univ Essen Gesamthsch, Pediat Neurol, Essen, Germany.
   [Pitceathly, Robert D. S.; Hanna, Michael G.] UCL Queen Sq Inst Neurol, Dept Neuromuscular Dis, London, England.
   [Pitceathly, Robert D. S.; Hanna, Michael G.] Natl Hosp Neurol & Neurosurg, London, England.
   [Joost, Kairit] East Tallinn Cent Hosp, Ctr Allergol & Immunol, Tallinn, Estonia.
   [Cotta, Ana; Paim, Julia Filardi] SARAH Network Rehabil Hosp, Neuromuscular Unit, Dept Pathol, Belo Horizonte, MG, Brazil.
   [Navarro, Monica Machado] SARAH Network Rehabil Hosp, Neuromuscular Unit, Dept Pediat, Belo Horizonte, MG, Brazil.
   [Mattmann, Andre; Chapman, Kristine] St Pauls Hosp, Dept Pathol & Lab Med SPH, Vancouver, BC, Canada.
   [Servidei, Serenella] Univ Cattolica Sacro Cuore, Dept Neurol, Rome, Italy.
   [Uusimaa, Johanna] Oulu Univ Hosp, Med Res Ctr Oulu, PEDEGO Res Unit Pediat Neurol, Oulu, Finland.
   [Uusimaa, Johanna] Univ Oulu, Oulu, Finland.
   [Roos, Andreas] Leibniz Inst Analyt Sci ISAS, Dortmund, Germany.
   [Mootha, Vamsi] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA.
   [Hirano, Michio; DiMauro, Salvatore] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA.
   [Tulinius, Mar] Univ Gothenburg, Sahlgrenska Acad, Dept Pediat, Gothenburg, Sweden.
   [Giri, Manta; Hoffmann, Eric P.] Binghampton Univ, Sch Pharm & Pharmaceut Sci, New York, NY USA.
   [Lochmuller, Hanns] Univ Freiburg, Med Ctr, Fac Med, Dept Neuropediat & Muscle Disorders, Freiburg, Germany.
   [Lochmuller, Hanns] Barcelona Inst Sci & Technol BIST, Ctr Genom Regulat, Ctr Nacl Anal Genom CNAG CRG, Barcelona, Spain.
   [Lochmuller, Hanns] Univ Ottawa, Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON, Canada.
   [Lochmuller, Hanns] Ottawa Hosp, Div Neurol, Dept Med, Ottawa, ON, Canada.
C3 University of Cambridge; Newcastle University - UK; Stockholm
   University; Karolinska Institutet; University of Oxford; University of
   Duisburg Essen; University of London; University College London;
   University of London; University College London; UCL Medical School;
   University College London Hospitals NHS Foundation Trust; St. Paul's
   Hospital; Catholic University of the Sacred Heart; IRCCS Policlinico
   Gemelli; University of Oulu; University of Oulu; Dortmund University of
   Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS);
   Harvard University; Harvard Medical School; Howard Hughes Medical
   Institute; Columbia University; University of Gothenburg; University of
   Freiburg; Barcelona Institute of Science & Technology; Pompeu Fabra
   University; Centre de Regulacio Genomica (CRG); University of Ottawa;
   Children's Hospital of Eastern Ontario; University of Ottawa; Ottawa
   Hospital Research Institute
RP Horvath, R (corresponding author), Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cambridge, England.
EM rh732@medschl.cam.ac.uk
RI Pearce, Sarah/AAE-7196-2019; Servidei, Serenella/ABC-4262-2021; wei,
   wei/HHR-8613-2022; Cotta, Ana/AAC-6002-2022; Poulton,
   Joanna/AAB-4828-2021; Jennings, Matthew/HKE-3497-2023; Horvath,
   Rita/AAY-7042-2020; Gomez-Duran, Aurora/ABE-1973-2021; Gomez-Duran,
   Aurora/T-6392-2017; Minczuk, Michal/G-1638-2014
OI Gomez-Duran, Aurora/0000-0002-5895-6860; Cotta, Ana/0000-0003-2931-6589;
   Wei, Wei/0000-0002-2945-3543; SERVIDEI, Serenella/0000-0001-8478-2799;
   Pearce, Sarah F/0000-0003-2950-7078; Calabrese,
   Claudia/0000-0002-8941-2620; Hanna, Michael/0000-0003-0825-4075;
   Griffin, Helen R/0000-0002-5288-3322; Giunta,
   Michele/0000-0002-5829-0245; Jennings, Matthew
   James/0000-0002-2794-7910; Powell, Christopher/0000-0001-7501-0586;
   Minczuk, Michal/0000-0001-8242-1420; Chinnery,
   Patrick/0000-0002-7065-6617; Horvath, Rita/0000-0002-9841-170X; Munro,
   Benjamin/0000-0003-4506-7092
FU European Research Council [309548]; Wellcome Investigator Award
   [109915/Z/15/Z]; Medical Research Council (UK) [MR/N025431/1]; Wellcome
   Trust Pathfinder Scheme [201064/Z/16/Z]; Newton Fund [UK/Turkey]
   [MR/N027302/1]; Lily Foundation; Evelyn Trust; Medical Research Council
   Mitochondrial Biology Unit [MC_UU_00015/9]; Medical Research Council
   (MRC) International Centre for Genomic Medicine in Neuromuscular
   Disease; National Institute for Health Research (NIHR) Biomedical
   Research Centre based at Cambridge University Hospitals NHS Foundation
   Trust and the University of Cambridge; Bundesministerium fur Bildung und
   Forschung; French Muscular Dystrophy Association (AFMTelethon) [21466];
   Canadian Institute of Health and Research [CIHR FDN-167281]; Medical
   Research Council Clinician Scientist Fellowship [MR/S002065/1];
   Department of Health's NIHR BRC funding scheme; UK NHS; Ministerium fur
   Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen;
   MRC [MC_UU_00015/4, MR/N025431/2, MR/J010448/1, MR/N025431/1,
   MR/N010035/1, G0800674, G1000848] Funding Source: UKRI; Newton Fund
   [MR/N027302/2, MR/N027302/1] Funding Source: UKRI
FX RH was supported by the European Research Council [309548], the Wellcome
   Investigator Award [109915/Z/15/Z]. the Medical Research Council (UK)
   [MR/N025431/1]; the Wellcome Trust Pathfinder Scheme [201064/Z/16/Z],
   the Newton Fund [UK/Turkey, MR/N027302/1], the Lily Foundation and the
   Evelyn Trust. PFC is a Wellcome Trust Principal Research Fellow
   (212219/Z/18/Z) and a UK NIHR Senior Investigator, who receives support
   from the Medical Research Council Mitochondrial Biology Unit
   (MC_UU_00015/9), the Medical Research Council (MRC) International Centre
   for Genomic Medicine in Neuromuscular Disease, the Evelyn Trust, and the
   National Institute for Health Research (NIHR) Biomedical Research Centre
   based at Cambridge University Hospitals NHS Foundation Trust and the
   University of Cambridge. The views expressed are those of the author(s)
   and not necessarily those of the NHS, the NIHR or the Department of
   Health. DH and AR gratefully acknowledge the financial support by the
   Ministerium fur Innovation, Wissenschaft und Forschung des Landes
   Nordrhein-Westfalen and the Bundesministerium fur Bildung und Forschung.
   This work was also supported by a grant of the French Muscular Dystrophy
   Association (AFMTelethon; #21466) to AR. HL received funding from the
   Canadian Institute of Health and Research (CIHR FDN-167281). RDSP is
   supported by a Medical Research Council Clinician Scientist Fellowship
   (MR/S002065/1). Part of this work was undertaken in the UCLH/UCL Queen
   Square Institute of Neurology sequencing facility, which received a
   proportion of funding from the Department of Health's NIHR BRC funding
   scheme. The clinical and diagnostic "Rare Mitochondrial Disorders"
   Service in London is funded by the UK NHS Highly Specialised
   Commissioners. We thank the NIHR BioResource volunteers for their
   participation, and gratefully acknowledge NIHR BioResource centres, NHS
   Trusts and staff for their contribution. We thank the National Institute
   for Health Research and NHS Blood and Transplant. The views expressed
   are those of the author(s) and not necessarily those of the NHS, the
   NIHR or the Department of Health. The analysis of allele frequencies in
   the UK Biobank Resource was conducted under application number 18794. We
   thank Reinaldo Issado Takata and Alessandra de la Rocque Ferreira for
   molecular studies and Dr. Luisa Iommarini (University of Bologna) for
   the fruitful discussion about the cysteine depletion experiment.
CR Aljohani A, 2019, J BIOL CHEM, V294, P19475, DOI 10.1074/jbc.RA119.009868
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Bareth B, 2016, MOL BIOL CELL, V27, P1570, DOI 10.1091/mbc.E15-12-0811
   Bartsakoulia Marina, 2016, J Neuromuscul Dis, V3, P363
   Boczonadi V, 2015, J INHERIT METAB DIS, V38, P427, DOI 10.1007/s10545-014-9784-6
   Boczonadi V, 2013, HUM MOL GENET, V22, P4602, DOI 10.1093/hmg/ddt309
   Burns DT, 2018, AM J HUM GENET, V102, P858, DOI 10.1016/j.ajhg.2018.03.011
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Duggan AT, 2014, AM J HUM GENET, V94, P721, DOI 10.1016/j.ajhg.2014.03.014
   Ferreira N, 2019, EMBO J, V38, DOI 10.15252/embj.2019102155
   Forsström S, 2019, CELL METAB, V30, P1040, DOI [10.1016/j.cmet.2019.013.019, 10.1016/j.cmet.2019.08.019]
   FORSTER MEC, 1992, INT J BIOCHEM, V24, P1111, DOI 10.1016/0020-711X(92)90381-A
   Friederich MW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06250-w
   García-Villegas R, 2017, J BIOL CHEM, V292, P10912, DOI 10.1074/jbc.M116.773077
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Griffin HR, 2014, GENET MED, V16, P962, DOI 10.1038/gim.2014.66
   Haapalainen AM, 2007, BIOCHEMISTRY-US, V46, P4305, DOI 10.1021/bi6026192
   Han Q, 2011, BIOSCIENCE REP, V31, P323, DOI 10.1042/BSR20100117
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   HOUSHMAND M, 1994, BBA-MOL BASIS DIS, V1226, P49, DOI 10.1016/0925-4439(94)90058-2
   Joost K, 2012, MOL SYNDROMOL, V3, P113, DOI 10.1159/000341375
   Kandasamy P, 2018, TRENDS BIOCHEM SCI, V43, P752, DOI 10.1016/j.tibs.2018.05.003
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Kiema TR, 2014, ACTA CRYSTALLOGR D, V70, P3212, DOI 10.1107/S1399004714023827
   Koletzko B, 2018, ANN NUTR METAB, V73, P29, DOI 10.1159/000494780
   Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   LI S, 2000, EUR J HUM GENET, V22, P1040
   LIAW SH, 1994, BIOCHEMISTRY-US, V33, P675, DOI 10.1021/bi00169a007
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Majer M, 1998, MOL GENET METAB, V65, P181, DOI 10.1006/mgme.1998.2748
   Masson GR, 2019, BIOCHEM SOC T, V47, P1481, DOI 10.1042/BST20190331
   Melber A, 2018, CELL RES, V28, P281, DOI 10.1038/cr.2018.16
   Meng FL, 2017, J BIOL CHEM, V292, P2881, DOI 10.1074/jbc.M116.749374
   Morten KJ, 2007, MITOCHONDRION, V7, P386, DOI 10.1016/j.mito.2007.09.001
   Moulinier L, 2017, HUM MUTAT, V38, P1316, DOI 10.1002/humu.23277
   Moyer Adam L, 2015, J Neuromuscul Dis, V2, P371
   Nagara M, 2018, EUR J MED GENET, V61, P1, DOI 10.1016/j.ejmg.2017.10.002
   Nakamura A, 2006, SCIENCE, V312, P1954, DOI 10.1126/science.1127156
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Numata T, 2006, NATURE, V442, P419, DOI 10.1038/nature04896
   Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200
   Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200
   Pabarcus MK, 2002, BBA-PROTEIN STRUCT M, V1596, P201, DOI 10.1016/S0167-4838(02)00232-7
   Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195
   Park S, 2018, DIABETES METAB J, V42, P270
   Pearce SF, 2017, ELIFE, V6, DOI 10.7554/eLife.27596
   Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106
   Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046
   Quirós PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058
   Reza M, 2017, NEUROMUSCULAR DISORD, V27, P1054, DOI 10.1016/j.nmd.2017.07.001
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784
   Roos A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01040
   Sauer SW, 2007, J INHERIT METAB DIS, V30, P673, DOI 10.1007/s10545-007-0678-8
   Steele H, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911589
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   STURMAN JA, 1970, SCIENCE, V169, P74, DOI 10.1126/science.169.3940.74
   Talim B, 2013, BRAIN, V136, DOI 10.1093/brain/aws197
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Tillander V, 2014, CELL MOL LIFE SCI, V71, P933, DOI 10.1007/s00018-013-1422-1
   Uusimaa J, 2011, J MED GENET, V48, P660, DOI 10.1136/jmg.2011.089995
   van Karnebeek CDM, 2019, AM J HUM GENET, V105, P534, DOI 10.1016/j.ajhg.2019.07.015
   van Kuilenburg ABP, 2019, NEW ENGL J MED, V380, P1433, DOI 10.1056/NEJMoa1806627
   Vaudel M, 2011, PROTEOMICS, V11, P996, DOI 10.1002/pmic.201000595
   von Holstein-Rathlou S, 2016, CELL METAB, V23, P335, DOI 10.1016/j.cmet.2015.12.003
   Wei W, 2019, SCIENCE, V364, P749, DOI 10.1126/science.aau6520
   Xia XJ, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-017-0022-5
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
   Zhang SH, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-016-0139-z
NR 71
TC 27
Z9 27
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD DEC 1
PY 2020
VL 39
IS 23
AR e105364
DI 10.15252/embj.2020105364
EA OCT 2020
PG 19
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA PB0KH
UT WOS:000582980600001
PM 33128823
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Nobuhara, Y
   Nakahara, K
   Higuchi, I
   Yoshida, T
   Fushiki, S
   Osame, M
   Arimura, K
   Nakagawa, M
AF Nobuhara, Y
   Nakahara, K
   Higuchi, I
   Yoshida, T
   Fushiki, S
   Osame, M
   Arimura, K
   Nakagawa, M
TI Juvenile form of Alexander disease with <i>GFAP</i> mutation and
   mitochondrial abnormality
SO NEUROLOGY
LA English
DT Article
AB The authors report a 29-year-old woman with marked atrophy of the cerebellum, medulla oblongata, and spinal cord, dementia, diffuse white matter abnormality on MRI, ragged-red fibers, and R88C mutation in the human glial fibrillary acidic protein (GFAP). Mitochondria DNA ( mtDNA) analysis showed a rare polymorphism at A8291G. This mtDNA polymorphism, which has been associated with limb-girdle type mitochondrial myopathy, may modify the clinical symptoms of this juvenile form of Alexander disease with GFAP mutation.
C1 Kyoto Prefectural Univ Med, Dept Neurol & Gerontol, Res Inst Neurol dis & Geriatr, Kamigyo Ku, Kyoto 6020841, Japan.
   Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Neurol & Geriatr, Kagoshima 890, Japan.
   Miyazaki Prefectural Hosp, Div Neurol, Miyazaki, Japan.
   Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pathol & Appl Neurobiol, Kyoto 602, Japan.
C3 Kyoto Prefectural University of Medicine; Kagoshima University; Kyoto
   Prefectural University of Medicine
RP Kyoto Prefectural Univ Med, Dept Neurol & Gerontol, Res Inst Neurol dis & Geriatr, Kamigyo Ku, Kawaramachi Hirokoji 465, Kyoto 6020841, Japan.
EM mnakagaw@koto.kpu-m.ac.jp
CR Castellani RJ, 1998, BRAIN RES, V787, P15, DOI 10.1016/S0006-8993(97)01224-9
   Gingold MK, 1999, J CHILD NEUROL, V14, P325, DOI 10.1177/088307389901400510
   Gorospe JR, 2002, NEUROLOGY, V58, P1494, DOI 10.1212/WNL.58.10.1494
   Hirata K, 1999, J HUM GENET, V44, P210, DOI 10.1007/s100380050145
   Kinoshita T, 2003, NEUROSCI LETT, V350, P169, DOI 10.1016/S0304-3940(03)00900-5
   Okamoto Y, 2002, J NEUROL SCI, V195, P71, DOI 10.1016/S0022-510X(01)00687-6
   Rodriguez D, 2001, AM J HUM GENET, V69, P1134, DOI 10.1086/323799
   Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772
NR 8
TC 16
Z9 19
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD OCT 12
PY 2004
VL 63
IS 7
BP 1302
EP 1304
DI 10.1212/01.WNL.0000140695.90497.E2
PG 3
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 861HV
UT WOS:000224408000033
PM 15477559
DA 2024-11-01
ER

PT J
AU Berardo, A
   Çoku, J
   Kurt, B
   DiMauro, S
   Hirano, M
AF Berardo, Andres
   Coku, Jorida
   Kurt, Bulent
   DiMauro, Salvatore
   Hirano, Michio
TI A novel mutation in the tRNA<SUP>Ile</SUP> gene (<i>MTTI</i>) affecting
   the variable loop in a patient with chronic progressive external
   ophthalmoplegia (CPEO)
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondrial DNA (mtDNA); Point mutation; tRNA(Ile); Chronic
   progressive external ophthalmoplegia (CPEO)
ID MUSCLE MITOCHONDRIAL-DNA; POINT MUTATION; CARDIOMYOPATHY; DELETIONS;
   ENCEPHALOMYOPATHIES; MYOPATHIES
AB We describe a 62-year-old woman with chronic progressive external ophthalmoplegia (CPEO), multiple lipomas, diabetes mellitus, and a novel mitochondrial DNA (mtDNA) mutation at nucleotide 4302 (4302A > G) of the tRNA(Ile) gene (MTTI). This is the first mutation at position 44 in the variable loop (V loop) of any mitochondrial tRNA.
   The muscle biopsy revealed 10% ragged-red/ragged-blue fibers and 25% cytochrome c oxidase (COX)deficient fibers.
   No deletions or duplications were detected by Southern blot analysis. The 4302A > G transition was present only in the patient's muscle and single-fiber analysis revealed significantly higher levels of the mutation in COX-deficient than in normal fibers. Like tRNA(Leu(UUR)), tRNA(Ile) appears to be a "hot spot" for mtDNA mutations causing CPEO. (c) 2010 Elsevier B.V. All rights reserved.
C1 [Berardo, Andres; Coku, Jorida; Kurt, Bulent; DiMauro, Salvatore; Hirano, Michio] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA.
C3 Columbia University
RP Hirano, M (corresponding author), Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA.
EM mh29@columbia.edu
RI KURT, Bülent/HKW-2919-2023
FU NIH [HD32062]; Marriott Mitochondrial Disorders Clinical Research Fund
   (MMDCRF)
FX This work has been supported by NIH Grant HD32062 and the Marriott
   Mitochondrial Disorders Clinical Research Fund (MMDCRF).
CR BONILLA E, 1992, BRAIN PATHOL, V2, P113, DOI 10.1111/j.1750-3639.1992.tb00679.x
   CASALI C, 1995, BIOCHEM BIOPH RES CO, V213, P588, DOI 10.1006/bbrc.1995.2172
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chinnery PF, 1997, NEUROLOGY, V49, P1166, DOI 10.1212/WNL.49.4.1166
   DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Dirheimer G., 1995, P93
   Franceschina L, 1998, J NEUROL, V245, P755, DOI 10.1007/s004150050283
   GIEGE R, 1993, PROG NUCLEIC ACID RE, V45, P129, DOI 10.1016/S0079-6603(08)60869-7
   HART PE, 2002, MITOCHONDRIAL DISORD, V2, P235
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   ITO T, 1992, JPN CIRC J, V56, P1045, DOI 10.1253/jcj.56.1045
   Merante F, 1996, HUM MUTAT, V8, P216, DOI 10.1002/(SICI)1098-1004(1996)8:3<216::AID-HUMU4>3.0.CO;2-7
   Negro R, 2009, NEUROMUSCULAR DISORD, V19, P423, DOI 10.1016/j.nmd.2009.04.008
   SANAKER PS, 2009, ACTA NEUROL SCAND
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   Silvestri G, 1996, BIOCHEM BIOPH RES CO, V220, P623, DOI 10.1006/bbrc.1996.0453
   Smits BW, 2007, J NEUROL, V254, P1614, DOI 10.1007/s00415-007-0608-6
   TANIIKE M, 1992, BIOCHEM BIOPH RES CO, V186, P47, DOI 10.1016/S0006-291X(05)80773-9
   Tanji K, 2008, J NEUROL SCI, V270, P23, DOI 10.1016/j.jns.2008.01.016
   Taylor RW, 1998, BIOCHEM BIOPH RES CO, V243, P47, DOI 10.1006/bbrc.1997.8055
NR 22
TC 11
Z9 12
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD MAR
PY 2010
VL 20
IS 3
BP 204
EP 206
DI 10.1016/j.nmd.2010.01.006
PG 3
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 584NK
UT WOS:000276759100009
PM 20149659
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Vandiver, AR
   Pielstick, B
   Gilpatrick, T
   Hoang, AN
   Vernon, HJ
   Wanagat, J
   Timp, W
AF Vandiver, Amy R.
   Pielstick, Brittany
   Gilpatrick, Timothy
   Hoang, Austin N.
   Vernon, Hillary J.
   Wanagat, Jonathan
   Timp, Winston
TI Long read mitochondrial genome sequencing using Cas9-guided adaptor
   ligation
SO MITOCHONDRION
LA English
DT Article
DE mtDNA; Sequencing; mtDNA deletions; SNPs; Aging
ID HUMAN SKELETAL-MUSCLE; POINT MUTATIONS; MTDNA MUTATIONS; DNA DELETIONS;
   MELAS; GENE
AB The mitochondrial genome (mtDNA) is an important source of disease-causing genetic variability, but existing sequencing methods limit understanding, precluding phased measurement of mutations and clear detection of large sporadic deletions. We adapted a method for amplification-free sequence enrichment using Cas9 cleavage to obtain full length nanopore reads of mtDNA. We then utilized the long reads to phase mutations in a patient with an mtDNA-linked syndrome and demonstrated that this method can map age-induced mtDNA deletions. We believe this method will offer deeper insight into our understanding of mtDNA variation.
C1 [Vandiver, Amy R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA.
   [Pielstick, Brittany; Timp, Winston] Johns Hopkins Univ, Dept Mol Biol & Genet, Sch Med, Baltimore, MD 21218 USA.
   [Gilpatrick, Timothy; Timp, Winston] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.
   [Hoang, Austin N.; Wanagat, Jonathan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.
   [Vernon, Hillary J.; Timp, Winston] Johns Hopkins Univ, Dept Genet Med, Sch Med, Baltimore, MD 21218 USA.
   [Wanagat, Jonathan] Vet Adm Greater Angeles Healthcare Syst, Los Angeles, CA 90073 USA.
   [Timp, Winston] Johns Hopkins Univ, 3400 N Charles St,Clark 102A, Baltimore, MD 21218 USA.
C3 University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; Johns Hopkins University; Johns Hopkins University;
   University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; Johns Hopkins University; US Department of Veterans
   Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles
   Healthcare System; Johns Hopkins University
RP Vandiver, AR (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA.; Timp, W (corresponding author), Johns Hopkins Univ, 3400 N Charles St,Clark 102A, Baltimore, MD 21218 USA.
EM avandiver@mednet.ucla.edu; wtimp@jhu.edu
RI Wanagat, Jonathan/B-2856-2009; Timp, Winston/B-5215-2008
OI Timp, Winston/0000-0003-2083-6027; Vandiver, Amy/0000-0003-2176-9161
FU NIH/NIAMS [T32 AR071307]; Dermatology Foundation; NIH [R01HG009190,
   U01CA253481, T32 GM007445, T32 GM136577, R56AG060880, R01AG055518,
   K02AG059847]; National Institute of Arthritis and Musculoskeletal and
   Skin Diseases [T32AR071307] Funding Source: NIH RePORTER; National
   Institute of General Medical Sciences [T32GM136577, T32GM007445] Funding
   Source: NIH RePORTER; National Institute on Aging [R01AG055518,
   K02AG059847] Funding Source: NIH RePORTER
FX AV has received support from NIH/NIAMS T32 AR071307 and The Dermatology
   Foundation. This work was funded in part by NIH R01HG009190 and
   U01CA253481 (WT, BP, TG) , NIH T32 GM007445 (BP) , NIH T32 GM136577 (TG)
   , and (R56AG060880, R01AG055518, and K02AG059847) to JW.
CR Aganezov S, 2020, GENOME RES, V30, P1258, DOI 10.1101/gr.260497.119
   Albayrak L, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3375-x
   Alkanaq AN, 2019, J HUM GENET, V64, P1107, DOI 10.1038/s10038-019-0654-9
   Allio R, 2017, MOL BIOL EVOL, V34, P2762, DOI 10.1093/molbev/msx197
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Basu S, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1009242
   Berneburg M, 1998, J INVEST DERMATOL, V111, P709, DOI 10.1046/j.1523-1747.1998.00337.x
   Bosworth CM, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1821-7
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chakrabarty RP, 2021, CELL STEM CELL, V28, P394, DOI 10.1016/j.stem.2021.02.011
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   de Coo IFM, 1998, NEUROLOGY, V50, P293, DOI 10.1212/WNL.50.1.293
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Gilpatrick T, 2020, NAT BIOTECHNOL, V38, P433, DOI 10.1038/s41587-020-0407-5
   Goudenège D, 2019, GENET MED, V21, P1407, DOI 10.1038/s41436-018-0350-8
   Gould MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139253
   HARRIS DA, 1991, BIOCHEM J, V280, P561, DOI 10.1042/bj2800561
   Herbst A, 2021, AGING CLIN EXP RES, V33, P1811, DOI 10.1007/s40520-020-01698-7
   Herbst A, 2016, AGING CELL, V15, P1132, DOI 10.1111/acel.12520
   Hopkins JF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00377-y
   KELLARWOOD H, 1994, ANN NEUROL, V36, P109, DOI 10.1002/ana.410360121
   Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Ludwig LS, 2019, CELL, V176, P1325, DOI 10.1016/j.cell.2019.01.022
   Lujan SA, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02138-5
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Palculict ME, 2016, METHODS MOL BIOL, V1351, P3, DOI 10.1007/978-1-4939-3040-1_1
   Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Sato A, 2005, P NATL ACAD SCI USA, V102, P6057, DOI 10.1073/pnas.0408666102
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Sedlazeck FJ, 2018, NAT METHODS, V15, P461, DOI 10.1038/s41592-018-0001-7
   Sevini F, 2014, EXP GERONTOL, V56, P234, DOI 10.1016/j.exger.2014.03.022
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Stewart JB, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005333
   Sun CB, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.601307
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Taylor RW, 1996, ANN NEUROL, V40, P459, DOI 10.1002/ana.410400318
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Wallace AD, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0241253
   Yao Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53449-y
   Yuan Y, 2020, NAT GENET, V52, P342, DOI 10.1038/s41588-019-0557-x
   Yusoff AAM, 2019, ONCOL REV, V13, P54, DOI 10.4081/oncol.2019.409
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
   Zook JM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.25
NR 51
TC 7
Z9 8
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL
PY 2022
VL 65
BP 176
EP 183
DI 10.1016/j.mito.2022.06.003
EA JUL 2022
PG 8
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 3E8RH
UT WOS:000830245400002
PM 35787470
OA Green Submitted, Green Accepted, Bronze
DA 2024-11-01
ER

PT J
AU Mkaouar-Rebai, E
   Chamkha, I
   Kammoun, T
   Chabchoub, I
   Aloulou, H
   Fendri, N
   Hachicha, M
   Fakhfakh, F
AF Mkaouar-Rebai, Emna
   Chamkha, Imen
   Kammoun, Thouraya
   Chabchoub, Imen
   Aloulou, Hajer
   Fendri, Nourhene
   Hachicha, Mongia
   Fakhfakh, Faiza
TI A case of Kearns-Sayre syndrome with two novel deletions (9.768 and
   7.253 kb) of the mtDNA associated with the common deletion in blood
   leukocytes, buccal mucosa and hair follicles
SO MITOCHONDRION
LA English
DT Article
DE Kearns-Sayre syndrome; mtDNA deletion; Mitochondrial DNA; Heteroplasmy;
   Long-range PCR; Common deletion
ID MITOCHONDRIAL-DNA DELETIONS; HEREDITARY OPTIC NEUROPATHY; PROGRESSIVE
   EXTERNAL OPHTHALMOPLEGIA; MUTATIONS; HEART; DISEASE; PATIENT; GENOME
AB Kearns-Sayre syndrome is a mitochondrial disorder characterized by the emergence before the age of 20 years of progressive external ophthalmoplegia, pigmentary retinopathy, with other heterogeneous clinical manifestations. Generally, mitochondria! DNA deletions were associated with KSS but the size and position of these deletions differ among patients. This study reported a Tunisian patient with typical features of KSS. Long-range PCR amplification of the mtDNA in different tissues from this patient showed multiple mitochondrial deletions: two novel 9.768 and 7.253 kb deletions spanning respectively nucleotides 6124-15,893 and 8572-15,826 associated with the common 4.977 kb deletion. (C) 2010 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Mkaouar-Rebai, Emna; Chamkha, Imen; Fendri, Nourhene; Fakhfakh, Faiza] Fac Med Sfax, Human Mol Genet Lab, Sfax 3029, Tunisia.
   [Kammoun, Thouraya; Chabchoub, Imen; Aloulou, Hajer; Hachicha, Mongia] CHU Habib Bourguiba Sfax, Serv Pediat, Sfax, Tunisia.
C3 Universite de Sfax; Universite de Sfax; Hopital Hedi Chaker; Hopital
   Habib Bourguiba
RP Mkaouar-Rebai, E (corresponding author), Fac Med Sfax, Human Mol Genet Lab, Ave Magida Boulila, Sfax 3029, Tunisia.
EM emna_mkaouar@mail2world.com
RI MKAOUAR-REBAI, Emna/AAE-6650-2019
OI Mkaouar-Rebai, Emna/0000-0003-3095-510X; Chamkha,
   Imen/0000-0002-6919-585X
FU Tunisian Ministry of Higher Education, Scientific Research and
   Technology
FX We thank the patient and her family for their cooperation in the present
   study. This work was supported by The Tunisian Ministry of Higher
   Education, Scientific Research and Technology.
CR Abu-Amero KK, 2008, MOL VIS, V14, P29
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   BLOK RB, 1995, HUM GENET, V95, P75
   Bosbach S, 2003, BRAIN, V126, P1231, DOI 10.1093/brain/awg101
   BROCKINGTON M, 1995, J NEUROL SCI, V131, P78, DOI 10.1016/0022-510X(95)00091-F
   BROWN MD, 1994, AM J HUM GENET, V55, P410
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Coulter-Mackie MB, 1998, CLIN BIOCHEM, V31, P627, DOI 10.1016/S0009-9120(98)00074-5
   DEGOUL F, 1991, NUCLEIC ACIDS RES, V19, P493, DOI 10.1093/nar/19.3.493
   Fromenty B, 1997, AM J MED GENET, V71, P443, DOI 10.1002/(SICI)1096-8628(19970905)71:4<443::AID-AJMG14>3.0.CO;2-G
   HARDING AE, 1992, J INHERIT METAB DIS, V15, P480, DOI 10.1007/BF01799606
   JOHNS DR, 1993, BIOCHEM BIOPH RES CO, V196, P810, DOI 10.1006/bbrc.1993.2321
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   KIYOMOTO BH, 1997, J NEUROL SCI, V25, P160
   Laloi-Michelin M, 2006, DIABETES METAB, V32, P182, DOI 10.1016/S1262-3636(07)70267-7
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   MIYABAYASHI S, 1991, J INHERIT METAB DIS, V14, P805, DOI 10.1007/BF01799954
   Mohamed SA, 2006, EXP GERONTOL, V41, P508, DOI 10.1016/j.exger.2006.03.014
   Mohri I, 1998, J NEUROL SCI, V158, P106, DOI 10.1016/S0022-510X(98)00082-3
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MULLERHOCKER J, 1992, HUM PATHOL, V23, P1431, DOI 10.1016/0046-8177(92)90065-B
   Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566
   OOSTRA RJ, 1995, AM J HUM GENET, V57, P954
   Pineda M, 2006, ANN NEUROL, V59, P394, DOI 10.1002/ana.20746
   Pistilli D, 2003, HUM PATHOL, V34, P1058, DOI 10.1053/S0046-8177(03)00344-7
   Puoti G, 2003, J MED GENET, V40, P858, DOI 10.1136/jmg.40.11.858
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   Remes AM, 2005, NEUROLOGY, V64, P976, DOI 10.1212/01.WNL.0000154518.31302.ED
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Ro LS, 2003, MUSCLE NERVE, V28, P737, DOI 10.1002/mus.10504
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Seneca S, 2001, ARCH NEUROL-CHICAGO, V58, P1113, DOI 10.1001/archneur.58.7.1113
   Toth T, 1998, CLIN GENET, V53, P210
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 38
TC 13
Z9 16
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
J9 MITOCHONDRION
JI Mitochondrion
PD AUG
PY 2010
VL 10
IS 5
BP 449
EP 455
DI 10.1016/j.mito.2010.04.003
PG 7
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 640LA
UT WOS:000281051500006
PM 20388556
DA 2024-11-01
ER

PT J
AU Cherry, ABC
   Gagne, KE
   Mcloughlin, EM
   Baccei, A
   Gorman, B
   Hartung, O
   Miller, JD
   Zhang, J
   Zon, RL
   Ince, TA
   Neufeld, EJ
   Lerou, PH
   Fleming, MD
   Daley, GQ
   Agarwal, S
AF Cherry, Anne B. C.
   Gagne, Katelyn E.
   Mcloughlin, Erin M.
   Baccei, Anna
   Gorman, Bryan
   Hartung, Odelya
   Miller, Justine D.
   Zhang, Jin
   Zon, Rebecca L.
   Ince, Tan A.
   Neufeld, Ellis J.
   Lerou, Paul H.
   Fleming, Mark D.
   Daley, George Q.
   Agarwal, Suneet
TI Induced Pluripotent Stem Cells with a Mitochondrial DNA Deletion
SO STEM CELLS
LA English
DT Article
DE Induced pluripotent stem cells; Pearson's marrow pancreas syndrome;
   Mitochondrial DNA; Heteroplasmy; Human genetics; Hematopoiesis
ID MUTATION; MTDNA; FIBROBLASTS; GENERATION; GENETICS; PATIENT; MUSCLE
AB In congenital mitochondrial DNA (mtDNA) disorders, a mixture of normal and mutated mtDNA (termed heteroplasmy) exists at varying levels in different tissues, which determines the severity and phenotypic expression of disease. Pearson marrow pancreas syndrome (PS) is a congenital bone marrow failure disorder caused by heteroplasmic deletions in mtDNA. The cause of the hematopoietic failure in PS is unknown, and adequate cellular and animal models are lacking. Induced pluripotent stem (iPS) cells are particularly amenable for studying mtDNA disorders, as cytoplasmic genetic material is retained during direct reprogramming. Here, we derive and characterize iPS cells from a patient with PS. Taking advantage of the tendency for heteroplasmy to change with cell passage, we isolated isogenic PS-iPS cells without detectable levels of deleted mtDNA. We found that PS-iPS cells carrying a high burden of deleted mtDNA displayed differences in growth, mitochondrial function, and hematopoietic phenotype when differentiated in vitro, compared to isogenic iPS cells without deleted mtDNA. Our results demonstrate that reprogramming somatic cells from patients with mtDNA disorders can yield pluripotent stem cells with varying burdens of heteroplasmy that might be useful in the study and treatment of mitochondrial diseases. STEM CELLS2013;31:1287-1297
C1 [Cherry, Anne B. C.; Gagne, Katelyn E.; Mcloughlin, Erin M.; Hartung, Odelya; Miller, Justine D.; Zhang, Jin; Zon, Rebecca L.; Neufeld, Ellis J.; Daley, George Q.; Agarwal, Suneet] Boston Childrens Hosp, Stem Cell Transplantat Program, Div Hematol Oncol, Boston, MA USA.
   [Cherry, Anne B. C.; Gagne, Katelyn E.; Mcloughlin, Erin M.; Hartung, Odelya; Miller, Justine D.; Zhang, Jin; Zon, Rebecca L.; Daley, George Q.; Agarwal, Suneet] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.
   [Cherry, Anne B. C.; Gagne, Katelyn E.; Mcloughlin, Erin M.; Hartung, Odelya; Miller, Justine D.; Zhang, Jin; Zon, Rebecca L.; Daley, George Q.; Agarwal, Suneet] Harvard Stem Cell Inst, Cambridge, MA USA.
   [Cherry, Anne B. C.; Gagne, Katelyn E.; Mcloughlin, Erin M.; Hartung, Odelya; Miller, Justine D.; Zhang, Jin; Zon, Rebecca L.; Daley, George Q.; Agarwal, Suneet] Manton Ctr Orphan Dis Res, Boston, MA USA.
   [Cherry, Anne B. C.; Mcloughlin, Erin M.; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.
   [Cherry, Anne B. C.; Mcloughlin, Erin M.; Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA.
   [Baccei, Anna; Gorman, Bryan; Lerou, Paul H.] Brigham & Womens Hosp, Dept Newborn Med, Boston, MA 02115 USA.
   [Baccei, Anna; Gorman, Bryan; Lerou, Paul H.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA.
   [Baccei, Anna; Gorman, Bryan; Lerou, Paul H.] Boston Childrens Hosp, Dept Newborn Med, Boston, MA USA.
   [Baccei, Anna; Gorman, Bryan; Lerou, Paul H.] Harvard Univ, Sch Med, Boston, MA USA.
   [Ince, Tan A.] Univ Miami, Miller Sch Med, Braman Family Breast Canc Inst, Dept Pathol, Miami, FL 33136 USA.
   [Ince, Tan A.] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA.
   [Fleming, Mark D.] Boston Childrens Hosp, Dept Pathol, Boston, MA USA.
C3 Harvard University; Boston Children's Hospital; Harvard University;
   Dana-Farber Cancer Institute; Harvard University; Harvard University;
   Harvard Medical School; Howard Hughes Medical Institute; Harvard
   University; Brigham & Women's Hospital; Harvard University; Brigham &
   Women's Hospital; Harvard University; Boston Children's Hospital;
   Harvard University; Harvard Medical School; University of Miami;
   University of Miami; Harvard University; Boston Children's Hospital
RP Agarwal, S (corresponding author), 3 Blackfan Circle,CLS 3002, Boston, MA 02115 USA.
EM george.daley@childrens.harvard.edu; suneet.agarwal@childrens.harvard.edu
RI Cherry, Anne/E-7333-2011; Daley, George/F-6429-2012; ZHANG,
   JIN/D-1435-2013; Neufeld, Ellis/F-9331-2011
OI Eastman, Anna/0000-0002-1455-291X; Ince, Tan/0000-0003-0315-6425;
   Gorman, Bryan/0000-0002-4239-4672; Fleming, Mark/0000-0003-0948-4024;
   Neufeld, Ellis/0000-0001-8092-6281
FU National Heart, Lung, and Blood Institute [U01 HL100001]; Progenitor
   Cell Biology Consortium; Manton Center for Orphan Disease Research; 
   [K08 HL089150]
FX We thank the patients and families for their participation in research.
   The work was supported by grants from the National Heart, Lung, and
   Blood Institute: U01 HL100001, Progenitor Cell Biology Consortium (G. Q.
   D.) and K08 HL089150 (S. A.), and the Manton Center for Orphan Disease
   Research (G. Q. D. and S.A.).
CR Bacman SR, 2007, METHOD CELL BIOL, V80, P503, DOI 10.1016/S0091-679X(06)80025-7
   Cerdan C., 2007, CURR PROTOC STEM CEL, DOI DOI 10.3324/haematol.12594
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Cock HR, 1998, ANN NEUROL, V44, P187, DOI 10.1002/ana.410440208
   DiMauro S, 2007, BIOSCIENCE REP, V27, P5, DOI 10.1007/s10540-007-9032-5
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Grossman LI, 1996, BIOESSAYS, V18, P983, DOI 10.1002/bies.950181208
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105
   Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177
   Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92
   Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Porteous WK, 1998, EUR J BIOCHEM, V257, P192, DOI 10.1046/j.1432-1327.1998.2570192.x
   Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   ROTIG A, 1989, LANCET, V1, P902
   Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1
   Shoubridge E A, 2000, Hum Reprod, V15 Suppl 2, P229
   SIMONSZ HJ, 1992, DOC OPHTHALMOL, V82, P73, DOI 10.1007/BF00156996
   Swerdlow RH, 2002, ARCH PATHOL LAB MED, V126, P271
   Swerdlow RH, 2007, J NEUROSCI RES, V85, P3416, DOI 10.1002/jnr.21167
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   van den Ouweland JMW, 2000, EUR J HUM GENET, V8, P195, DOI 10.1038/sj.ejhg.5200444
   vandeCorput MPC, 1997, J HISTOCHEM CYTOCHEM, V45, P55
   Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Weber K, 1997, AM J HUM GENET, V60, P373
   Willis JH, 2009, BBA-BIOENERGETICS, V1787, P533, DOI 10.1016/j.bbabio.2008.10.009
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401
NR 33
TC 78
Z9 84
U1 0
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1066-5099
EI 1549-4918
J9 STEM CELLS
JI Stem Cells
PD JUL
PY 2013
VL 31
IS 7
BP 1287
EP 1297
DI 10.1002/stem.1354
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology;
   Oncology; Cell Biology; Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology
GA 176XB
UT WOS:000321339000008
PM 23400930
OA Green Accepted, Bronze
DA 2024-11-01
ER

PT J
AU Blázquez-Bermejo, C
   Molina-Granada, D
   Vila-Julià, F
   Jiménez-Heis, D
   Zhou, XS
   Torres-Torronteras, J
   Karlsson, A
   Martí, R
   Cámara, Y
AF Blazquez-Bermejo, Cora
   Molina-Granada, David
   Vila-Julia, Ferran
   Jimenez-Heis, Daniel
   Zhou, Xiaoshan
   Torres-Torronteras, Javier
   Karlsson, Anna
   Marti, Ramon
   Camara, Yolanda
TI Age-related metabolic changes limit efficacy of deoxynucleoside-based
   therapy in thymidine kinase 2-deficient mice
SO EBIOMEDICINE
LA English
DT Article
DE TK2; Deoxynucleoside therapy; mtDNA depletion; Encephalomyopathy;
   Thymidine; Deoxycytidine
ID MITOCHONDRIAL-DNA; SUBSTRATE-SPECIFICITY; POOLS; EXPRESSION; MUTATIONS;
   ONSET
AB Background: Thymidine kinase 2 (TK2) catalyses the phosphorylation of deoxythymidine (dThd) and deoxycytidine (dCtd) within mitochondria. TK2 deficiency leads to mtDNA depletion or accumulation of multiple deletions. In patients, TK2 mutations typically manifest as a rapidly progressive myopathy with infantile onset, leading to respiratory insufficiency and encephalopathy in the most severe clinical presentations. TK2-deficient mice develop the most severe form of the disease and die at average postnatal day 16. dThd+dCtd administration delayed disease progression and expanded lifespan of a knockin murine model of the disease.
   Methods: We daily administered TK2 knockout mice (Tk2(KO)) from postnatal day 4 with equimolar doses of dThd+dCtd, dTMP+dCMP, dThd alone or dCtd alone. We monitored body weight and survival and studied different variables at 12 or 29 days of age. We determined metabolite levels in plasma and target tissues, mtDNA copy number in tissues, and the expression and activities of enzymes with a relevant role in mitochondrial dNTP anabolism or catabolism.
   Findings: dThd+dCtd treatment extended average lifespan of Tk2(KO) mice from 16 to 34 days, attenuated growth retardation, and rescued mtDNA depletion in skeletal muscle and other target tissues of 12-day-old mice, except in brain. However, the treatment was ineffective in 29-day-old mice that still died prematurely. Bioavailability of dThd and dCtd markedly decreased during mouse development. Activity of enzymes catabolizing dThd and dCtd increased with age in small intestine. Conversely, the activity of the anabolic enzymes decreased in target tissues during mouse development. We also found that administration of dThd alone had the same impact on survival to that of dThd+dCtd, whereas dCtd alone had no influence on lifespan.
   Interpretation: dThd+dCtd treatment recruits alternative cytosolic salvage pathways for dNTP synthesis, suggesting that this therapy would be of benefit for any Tk2 mutation. dThd accounts for the therapeutic effect of the combined treatment in mice. During the first weeks after birth, mice experience marked tissue-specific metabolic regulations and ontogenetic changes in dNTP metabolism-related enzymes that limit therapeutic efficacy to early developmental stages. (C) 2019 The Authors. Published by Elsevier B.V.
C1 [Blazquez-Bermejo, Cora; Molina-Granada, David; Vila-Julia, Ferran; Jimenez-Heis, Daniel; Torres-Torronteras, Javier; Marti, Ramon; Camara, Yolanda] Univ Autonoma Barcelona, Res Grp Neuromuscular & Mitochondrial Disorders, Vall dHebron Inst Recerca, Barcelona, Spain.
   [Blazquez-Bermejo, Cora; Molina-Granada, David; Vila-Julia, Ferran; Torres-Torronteras, Javier; Marti, Ramon; Camara, Yolanda] Inst Salud Carlos III, Biomed Network Res Ctr Rare Dis CIBERER, Madrid, Spain.
   [Zhou, Xiaoshan; Karlsson, Anna] Karolinska Inst, Karolinska Univ Hosp, Div Clin Microbiol, Dept Lab Med, S-14186 Stockholm, Sweden.
C3 Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron;
   Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de
   Investigacion Biomedica en Red; CIBERER; University of Barcelona;
   Instituto de Salud Carlos III; Karolinska Institutet; Karolinska
   University Hospital
RP Cámara, Y (corresponding author), Hosp Univ Vall dHebron, Lab Patol Neuromuscular & Mitocondrial, Inst Recerca, CIBERER, Passeig Vall dHebron 119-129, Barcelona 08035, Spain.
EM yolanda.camara@vhir.org
RI Martí, Ramon/Q-3442-2016; Torres-Torronteras, Javier/K-4974-2014;
   Camara, Yolanda/K-4597-2014
OI Molina Granada, David/0000-0002-8260-7775; Vila-Julia,
   Ferran/0000-0002-3180-2749; Marti, Ramon/0000-0002-8273-9540;
   Torres-Torronteras, Javier/0000-0002-6092-9458; Camara,
   Yolanda/0000-0003-2458-6942
FU SpanishMinistry of Industry, Economy and Competitiveness
   [BFU2014-52618-R, SAF2017-87506-R]; Spanish Instituto de Salud Carlos
   III [PI15/00465, PMP 15/00025]; ERDF; Fundacion Inocente, Inocente;
   AFMTelethon [19,965]; Generalitat de Catalunya (PERIS program)
   [SLT002/16/00370]
FX This studywas funded by grants fromthe SpanishMinistry of Industry,
   Economy and Competitiveness [grant BFU2014-52618-R and SAF2017-87506-R
   to YC], the Spanish Instituto de Salud Carlos III [grant PI15/00465 and
   grant PMP 15/00025 to RM, co-financed with ERDF], the Fundacion
   Inocente, Inocente [grant 2017 to YC], and AFMTelethon [grant 19,965 to
   YC]. JT was funded by a fellowship granted by the Generalitat de
   Catalunya (PERIS program, SLT002/16/00370). The disclosed funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Alston CL, 2013, NEUROLOGY, V81, P2051, DOI 10.1212/01.wnl.0000436931.94291.e6
   Bartesaghi S, 2010, HUM MOL GENET, V19, P1669, DOI 10.1093/hmg/ddq043
   Cámara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Dorado B, 2011, HUM MOL GENET, V20, P155, DOI 10.1093/hmg/ddq453
   ELKOUNI MH, 1993, CANCER RES, V53, P3687
   FANUCCHI MP, 1986, BIOCHEM PHARMACOL, V35, P1199, DOI 10.1016/0006-2952(86)90160-7
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Hu CM, 2007, J BIOMED SCI, V14, P491, DOI 10.1007/s11373-007-9175-1
   Ke PY, 2007, FASEB J, V21, P1276, DOI 10.1096/fj.06-7272com
   Krishnan S, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.588921
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Lopez-Gomez C, 2019, BIOAVAILABILIT UNPUB
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Martí R, 2012, METHODS MOL BIOL, V837, P121, DOI 10.1007/978-1-61779-504-6_8
   Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev
   Pastor-Anglada M, 2018, COMPR PHYSIOL, V8, P1003, DOI 10.1002/cphy.c170039
   Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002
   Redzic Zoran B, 2010, Cerebrospinal Fluid Res, V7, P2, DOI 10.1186/1743-8454-7-2
   Rosa ID, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005779
   Rylova SN, 2007, BIOCHEM PHARMACOL, V74, P169, DOI 10.1016/j.bcp.2007.03.029
   Saada A, 2003, BIOCHEM BIOPH RES CO, V310, P963, DOI 10.1016/j.bbrc.2003.09.104
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SPECTOR R, 1984, FED PROC, V43, P196
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Walker UA, 2006, ANTIVIR THER, V11, P25
   Wang LY, 2016, NUCLEOS NUCLEOT NUCL, V35, P578, DOI 10.1080/15257770.2015.1125001
   Wang LY, 2003, J BIOL CHEM, V278, P6963, DOI 10.1074/jbc.M206143200
   Young JD, 2016, BIOCHEM SOC T, V44, P869, DOI 10.1042/BST20160038
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
   Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4
NR 35
TC 20
Z9 21
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD AUG
PY 2019
VL 46
BP 342
EP 355
DI 10.1016/j.ebiom.2019.07.042
PG 14
WC Medicine, General & Internal; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Research & Experimental Medicine
GA IY7RE
UT WOS:000486592000044
PM 31351931
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Spinazzola, A
   Zeviani, M
AF Spinazzola, A.
   Zeviani, M.
TI Disorders from perturbations of nuclear-mitochondrial intergenomic
   cross-talk
SO JOURNAL OF INTERNAL MEDICINE
LA English
DT Review
DE mitochondrial disorders; mitochondrial DNA; mtDNA depletion; mtDNA
   multiple deletions; oxidative phosphorylation
ID DNA-POLYMERASE-GAMMA; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   ADENINE-NUCLEOTIDE TRANSLOCATOR; ONSET SPINOCEREBELLAR ATAXIA;
   NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY; AUTOSOMAL-DOMINANT; MULTIPLE
   DELETIONS; SACCHAROMYCES-CEREVISIAE; POLG MUTATIONS;
   OXIDATIVE-PHOSPHORYLATION
AB Spinazzola A, Zeviani M ("C. Besta" Neurological Institute, Foundation IRCCS, Milano, Italy). Disorders from perturbations of nuclear-mitochondrial intergenomic cross-talk (Review). J Intern Med 2009; 265: 174-192.
   In the course of evolution, mitochondria lost their independence, and mitochondrial DNA (mtDNA) became the 'slave' of nuclear DNA, depending on numerous nucleus-encoded factors for its integrity, replication and expression. Mutations in any of these factors may alter the cross-talk between the two genomes and cause Mendelian disorders characterized by qualitative (multiple deletions) or quantitative (depletion) alterations of mtDNA, or by defective translation of mtDNA-encoded respiratory chain components.
C1 [Spinazzola, A.; Zeviani, M.] Fdn IRCCS, C Besta Neurol Inst, Unit Mol Neurogenet, I-20126 Milan, Italy.
RP Zeviani, M (corresponding author), Fdn IRCCS, C Besta Neurol Inst, Unit Mol Neurogenet, Via Libero Temolo 4, I-20126 Milan, Italy.
EM zeviani@istituto-besta.it
RI Zeviani, Massimo/K-2891-2014; Spinazzola, Antonella/P-5298-2017
OI Zeviani, Massimo/0000-0002-9067-5508; Spinazzola,
   Antonella/0000-0003-4242-8091
FU Pierfranco and Luisa Mariani Foundation; Telethon-Italy Foundation
   [GGP07019]; Italian Ministry of University and Research [RBLA038RMA];
   Italian Ministry of Health [RF2006 ex 56/05/21]; MITOCIRCLE;
   EUMITOCOMBAT [LSHM-CT-2004-503116]; European Union Framework Program 6
FX This work was supported by the Pierfranco and Luisa Mariani Foundation,
   the Telethon-Italy Foundation grant no GGP07019, the Italian Ministry of
   University and Research (FIRB 2003 - project RBLA038RMA), the Italian
   Ministry of Health (RF2006 ex 56/05/21), MITOCIRCLE and EUMITOCOMBAT
   (LSHM-CT-2004-503116) network grants from the European Union Framework
   Program 6.
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Clayton DA, 2000, EXP CELL RES, V255, P4, DOI 10.1006/excr.1999.4763
   Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878
   Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108
   Galassi G, 2008, NEUROMUSCULAR DISORD, V18, P465, DOI 10.1016/j.nmd.2008.03.013
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Gao J, 2001, GENOMICS, V74, P109, DOI 10.1006/geno.2001.6536
   Giordano C, 2006, GASTROENTEROLOGY, V130, P893, DOI 10.1053/j.gastro.2006.01.004
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Iyengar B, 1999, GENETICS, V153, P1809
   Iyengar B, 2002, P NATL ACAD SCI USA, V99, P4483, DOI 10.1073/pnas.072664899
   Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003
   Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212
   KJER P, 1959, ACTA OPHTHALMOL S54, V37, P1
   Koc EC, 2002, J BIOL CHEM, V277, P35541, DOI 10.1074/jbc.M202498200
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lara MC, 2006, NEUROLOGY, V67, P1461, DOI 10.1212/01.wnl.0000239824.95411.52
   Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294
   Lefai E, 2000, MOL GEN GENET, V264, P37, DOI 10.1007/s004380000301
   Ling MF, 1997, GENE, V197, P325, DOI 10.1016/S0378-1119(97)00279-5
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   MA L, 1995, J BIOL CHEM, V270, P1859, DOI 10.1074/jbc.270.4.1859
   MANDERBACKA K, 2001, SCANDINAVIAN J P S55, V29, P41
   Martí R, 2005, ANN NEUROL, V58, P649, DOI 10.1002/ana.20615
   Martí R, 2004, CLIN CHEM, V50, P120, DOI 10.1373/clinchem.2003.026179
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   MIZUSAWA H, 1988, J NEUROL SCI, V86, P171, DOI 10.1016/0022-510X(88)90096-2
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200
   Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   Song SW, 2003, J BIOL CHEM, V278, P43893, DOI 10.1074/jbc.C300401200
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   Spinazzola A, 2008, NEUROMUSCULAR DISORD, V18, P315, DOI 10.1016/j.nmd.2007.12.007
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Tadiboyina VT, 2005, AM J MED GENET A, V135A, P289, DOI 10.1002/ajmg.a.30748
   Toivonen JM, 2001, GENETICS, V159, P241
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TRITSCHLER HJ, 1992, NEUROLOGY, V42, P209, DOI 10.1212/WNL.42.1.209
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   VISCOMI C, 2008, HUM MOL GENET    SEP
   Vu TH, 2001, HEPATOLOGY, V34, P116, DOI 10.1053/jhep.2001.25921
   Wang XW, 2008, HUM MOL GENET, V17, P4036, DOI 10.1093/hmg/ddn306
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   XIN H, 1995, J BIOL CHEM, V270, P17243, DOI 10.1074/jbc.270.29.17243
   Yavuz H, 2007, ARCH NEUROL-CHICAGO, V64, P435, DOI 10.1001/archneur.64.3.435
   YUZAKI M, 1989, BIOCHEM BIOPH RES CO, V164, P1352, DOI 10.1016/0006-291X(89)91818-4
   Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zeviani M, 2008, BRAIN, V131, P314, DOI 10.1093/brain/awm339
   Zhang YL, 1998, BBA-GENE STRUCT EXPR, V1443, P245, DOI 10.1016/S0167-4781(98)00223-1
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 111
TC 55
Z9 59
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0954-6820
EI 1365-2796
J9 J INTERN MED
JI J. Intern. Med.
PD FEB
PY 2009
VL 265
IS 2
BP 174
EP 192
DI 10.1111/j.1365-2796.2008.02059.x
PG 19
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 393CK
UT WOS:000262348300003
PM 19192035
OA Bronze
DA 2024-11-01
ER

PT J
AU Giordano, C
   Pichiorri, F
   Blakely, EL
   Perli, E
   Orlandi, M
   Gallo, P
   Taylor, RW
   Inghilleri, M
   d'Amati, G
AF Giordano, Carla
   Pichiorri, Floriana
   Blakely, Emma L.
   Perli, Elena
   Orlandi, Maurizia
   Gallo, Pietro
   Taylor, Robert W.
   Inghilleri, Maurizio
   d'Amati, Giulia
TI Isolated Distal Myopathy of the Upper Limbs Associated With
   Mitochondrial DNA Depletion and Polymerase γ Mutations
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID POLG MUTATIONS; DELETIONS
AB Objective: To describe an unusual clinical phenotype in an adult harboring 2 compound heterozygous polymerase gamma (POLG) mutations.
   Design: Case report.
   Setting: University-based outpatient neurology clinic and pathology and genetics laboratory.
   Patient: A 27-year-old man presenting with isolated distal myopathy of the upper extremities in the absence of sensory disturbances.
   Results: Histochemical analysis of a muscle biopsy specimen showed numerous cytochrome c oxidase deficient fibers. Molecular analysis revealed marked depletion of muscle mitochondrial DNA in the absence of multiple mitochondrial DNA deletions. Sequence analysis of the POLG gene revealed heterozygous sequence variants in compound c.1156C>T (p.R386C) and c.2794C>T (p.H932Y) segregating with clinical disease in the family. The p.R386C change appears to be a novel mutation.
   Conclusion: Our case broadens the phenotypic spectrum of disorders associated with POLG mutations and highlights the complex relationship between genotype and phenotype in POLG-related disease.
C1 [Giordano, Carla; Perli, Elena; Orlandi, Maurizia; Gallo, Pietro; d'Amati, Giulia] Sapienza Univ, Dipartimento Med Sperimentale, Rome, Italy.
   [Pichiorri, Floriana; Inghilleri, Maurizio] Sapienza Univ, UOC Neurol B, Rome, Italy.
   [Inghilleri, Maurizio] Sapienza Univ, IRCCS, S Raffaele Inst, Rome, Italy.
   [Blakely, Emma L.; Taylor, Robert W.] Univ Newcastle, Inst Ageing & Hlth, Adults & Children Serv, Natl Commissioning Grp Rare Mitochondrial Disorde, Newcastle Upon Tyne, Tyne & Wear, England.
C3 Sapienza University Rome; Sapienza University Rome; Sapienza University
   Rome; Newcastle University - UK
RP d'Amati, G (corresponding author), Sapienza Univ, Policlin Umberto 1, Sect Pathol, Dept Expt Pathol, Viale Regina Elena 324, I-00161 Rome, Italy.
EM giulia.damati@uniroma1.it
RI d'Amati, Giulia/F-1251-2011; Inghilleri, Maurizio/AAZ-6136-2020;
   GIORDANO, Carla/L-5657-2015; Pichiorri, Floriana/J-9997-2016
OI Inghilleri, Maurizio/0000-0001-5365-3417; GIORDANO,
   Carla/0000-0002-3716-4303; Pichiorri, Floriana/0000-0003-1225-7025
FU Telethon [GGP06233A]; Associazione Serena Talarico per i giovani nel
   mondo; UK National Commissioning Group Rare Mitochondrial Disorders of
   Adults and Children Service
FX This work was supported by Telethon grant GGP06233A and Associazione
   Serena Talarico per i giovani nel mondo. Diagnostic mitochondrial
   genetic testing in the Newcastle Laboratory is funded by the UK National
   Commissioning Group Rare Mitochondrial Disorders of Adults and Children
   Service.
CR Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Giordano C, 2008, AM J PATHOL, V173, P1120, DOI 10.2353/ajpath.2008.080252
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Mussini C, 2005, AIDS, V19, P1627, DOI 10.1097/01.aids.0000186019.47297.0d
   Nishigaki Y, 2004, HUM MOL GENET, V13, P91, DOI 10.1093/hmg/ddh010
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   Tzoulis C, 2009, ACTA NEUROL SCAND, V120, P38, DOI 10.1111/j.1600-0404.2009.01212.x
NR 10
TC 16
Z9 17
U1 0
U2 3
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0003-9942
EI 1538-3687
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD SEP
PY 2010
VL 67
IS 9
BP 1144
EP 1146
PG 3
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 653OW
UT WOS:000282102800017
PM 20837862
DA 2024-11-01
ER

PT S
AU Thajeb, P
   Wu, MC
   Shih, BF
   Tzen, CY
   Chiang, MF
   Yuan, RY
AF Thajeb, P
   Wu, MC
   Shih, BF
   Tzen, CY
   Chiang, MF
   Yuan, RY
BE Wei, YH
   Lee, HM
   Hsu, CY
TI Brain single photon emission computed tomography in patients with A3243G
   mutation in mitochondrial DNA tRNA
SO ROLE OF THE MITOCHONDRIA IN HUMAN AGING AND DISEASE: FROM GENES TO CELL
   SIGNALING
SE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article; Proceedings Paper
CT 2nd Scientific Meeting of the
   Asian-Society-for-Mitochondrial-Research-and-Medicine
CY APR 01-02, 2004
CL Taipei, TAIWAN
SP Asian Soc Mitochondrial Res & Med
DE mitochondrial disease; A3243G mutation; MELAS; brain SPECT; CPEO;
   diaschisis; hypoperfusion; migraine
ID MELAS SYNDROME; TRNA(LEU) A3243G; LACTIC-ACIDOSIS; DIFFUSION;
   ENCEPHALOPATHY; MYOPATHY; FEATURES; EPISODES
AB Brain single photon emission computed tomography (SPECT) studies were conducted in three patients with A3243G mutation of the mitochondrial (mt) DNA tRNA. All were born to mothers suffering from chronic progressive external ophthalmoplegia (CPEO) with the same A3243G point mutation of the mtDNA tRNA. The first case manifested clinically with MELAS, the second case manifested with CPEO, and third case was characterized by recurrent migraine-like headache, tremor, and epilepsy. Brain SPECT of all patients, regardless of whether they had or had not suffered from stroke-like episodes, showed multiple areas of asymmetrical decreased perfusion, particularly in the posterior and lateral head regions, especially the temporal lobes. Crossed-cerebellar diaschisis may occur. Conventional brain magnetic resonance images failed to show some of the lesions. Decreased regional cerebral blood flow, rather than previously proposed hyperemia, is likely to be the cause. We conclude that mitochondrial vasculopathy with regional cerebral hypoperfusion may be seen on brain SPECT in patients with mitochondrial disorders and A3243G mutations, regardless of whether they have or have not suffered from stroke-like episodes.
C1 Mackay Mem Hosp, Dept Neurol, Taipei 11499, Taiwan.
   Mackay Mem Hosp, Dept Nucl Med, Taipei 11499, Taiwan.
   Mackay Mem Hosp, Dept Pathol, Taipei 11499, Taiwan.
   Mackay Mem Hosp, Dept Neurosurg, Taipei 11499, Taiwan.
   Mackay Mem Hosp, Dept Med Res, Taipei 11499, Taiwan.
   Taipei Med Univ Hosp, Sect Neurol, Taipei, Taiwan.
C3 Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial
   Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; Taipei
   Medical University Hospital; Taipei Medical University
RP Thajeb, P (corresponding author), Mackay Mem Hosp, Dept Neurol & Med Res, POB Nei Hu 6-30, Taipei 11499, Taiwan.
EM thajebp@hotmail.com
CR CHIEN D, 1992, AM J NEURORADIOL, V13, P1097
   DiMauro S., 1997, MOL GENETIC BASIS NE, P201
   FANG W, 1993, ARCH NEUROL-CHICAGO, V50, P977, DOI 10.1001/archneur.1993.00540090074013
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HSU CC, 1995, ACTA NEUROL SCAND, V92, P252
   HUANG CC, 1994, J NEUROL NEUROSUR PS, V57, P586, DOI 10.1136/jnnp.57.5.586
   Koga Y, 2000, ACTA NEUROPATHOL, V99, P186, DOI 10.1007/PL00007423
   LIOU CW, 1994, ACTA NEUROL SCAND, V90, P354
   MUNNICH A, 2001, METABOLIC MOL BASES, V2, P2261
   Ohshita T, 2000, NEURORADIOLOGY, V42, P651, DOI 10.1007/s002340000335
   Parry A, 2003, J NEUROIMAGING, V13, P293, DOI 10.1177/1051228403254783
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   PIERPAOLI C, 1993, RADIOLOGY, V189, P439, DOI 10.1148/radiology.189.2.8210373
   SEVICK RJ, 1992, RADIOLOGY, V185, P687, DOI 10.1148/radiology.185.3.1438745
   Sue CM, 1998, J NEUROL NEUROSUR PS, V65, P233, DOI 10.1136/jnnp.65.2.233
   THAJEB P, 1997, CHIN MED J BEIJING, V110, P726
   THAJEB P, 2000, CHIN MED J TAIPEI, V63, P71
   Tzen CY, 2003, MUSCLE NERVE, V28, P575, DOI 10.1002/mus.10473
   Wallace D.C., 2001, The Metabolic and Molecular Basis of Inherited Disease, P2425
   Yonemura K, 2001, AM J NEURORADIOL, V22, P269
   ZHANG Y, 2001, CHIN MED J BEIJING, V114, P129
NR 21
TC 13
Z9 13
U1 0
U2 1
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-541-9
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2005
VL 1042
BP 48
EP 54
DI 10.1196/annals.1338.005
PG 7
WC Biochemistry & Molecular Biology; Cell Biology; Multidisciplinary
   Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Science & Technology -
   Other Topics
GA BCR22
UT WOS:000230893400005
PM 15965044
DA 2024-11-01
ER

PT J
AU Kornblum, C
   Zsurka, G
   Wiesner, RJ
   Schröder, R
   Kunz, WS
AF Kornblum, Cornelia
   Zsurka, Gabor
   Wiesner, Rudolf J.
   Schroeder, Rolf
   Kunz, Wolfram S.
TI Concerted action of two novel tRNA mtDNA point mutations in chronic
   progressive external ophthalmoplegia
SO BIOSCIENCE REPORTS
LA English
DT Article
DE chronic progressive external ophthalmoplegia (CPEO); mitochondrial DNA
   (mtDNA); mitochondrial DNA disease; mitochondrial tRNA; oxidative
   phosphorylation
ID MITOCHONDRIAL TRANSFER-RNA; REFERENCE SEQUENCE; SKELETAL-MUSCLE; DNA;
   GENE; HETEROPLASMY; DISEASES
AB CPEO (chronic progressive external ophthalmoplegia) is a common mitochondrial disease phenotype in adults which is due to mtDNA (mitochondrial DNA) point mutations in a subset of patients. Attributing pathogenicity to novel tRNA mtDNA mutations still poses a challenge, particularly when several mtDNA sequence variants are present. In the present study we report a CPEO patient for whom sequencing of the mitochondrial genome revealed three novel tRNA mtDNA mutations: G5835A, del4315A, T1658C in tRNA(Tyr), tRNA(lle) and tRNA(val) genes. In skeletal muscle, the tRNA(val) and tRNA(lle) mutations were homoplasmic, whereas the tRNA(Tyr) mutation was heteroplasmic. To address the pathogenic relevance, we performed two types of functional tests: (i) single skeletal muscle fibre analysis comparing G5835A mutation loads and biochemical phenotypes of corresponding fibres, and (ii) Northern-blot analyses of mitochondrial tRNA(Tyr), tRNA(lle) and tRNA(val). We demonstrated that both the G5835A tRNA(Tyr) and de14315A tRNA(lle) mutation have serious functional consequences. Single-fibre analyses displayed a high threshold of the tRNATyr mutation load for biochemical phenotypic expression at the single-cell level, indicating a rather mild pathogenic effect. In contrast, skeletal muscle tissue showed a severe decrease in respiratory-chain activities, a reduced overall COX (cytochrome c oxidase) staining intensity and abundant COX-negative fibres. Northern-blot analyses showed a dramatic reduction of tRNA(Tyr) and tRNA(lle) levels in muscle, with impaired charging of tRNA(lle), whereas tRNA(val) levels were only slightly decreased, with amino-acylation unaffected. Our findings suggest that the heteroplasmic tRNA(Tyr) and homoplasmic tRNA(lle) mutation act together, resulting in a concerted effect on the biochemical and histological phenotype. Thus homoplasmic mutations may influence the functional consequences of pathogenic heteroplasmic mtDNA mutations.
C1 [Zsurka, Gabor; Kunz, Wolfram S.] Univ Bonn, Med Ctr, Dept Epileptol, D-53105 Bonn, Germany.
   [Kornblum, Cornelia] Univ Bonn, Med Ctr, Dept Neurol, D-53105 Bonn, Germany.
   [Zsurka, Gabor; Kunz, Wolfram S.] Platform NeuroCognit Life & Brain Ctr, D-53105 Bonn, Germany.
   [Wiesner, Rudolf J.] Univ Cologne, Fac Med, Inst Vegetat Physiol, D-50931 Cologne, Germany.
   [Wiesner, Rudolf J.] Univ Cologne, CMMC, D-50931 Cologne, Germany.
   [Schroeder, Rolf] Univ Erlangen Nurnberg, Dept Neuropathol, D-91054 Erlangen, Germany.
   [Schroeder, Rolf] Univ Erlangen Nurnberg, Dept Neurol, D-91054 Erlangen, Germany.
C3 University of Bonn; University of Bonn; University of Cologne;
   University of Cologne; University of Erlangen Nuremberg; University of
   Erlangen Nuremberg
RP Kunz, WS (corresponding author), Univ Bonn, Med Ctr, Dept Epileptol, D-53105 Bonn, Germany.
EM wolfram.kunz@ukb.uni-bonn.de
RI Kornblum, Cornelia/IUM-4180-2023; Schröder, Rolf/B-2774-2011; Kunz,
   Wolfram/K-1232-2019
OI Schroder, Rolf/0000-0002-2772-2615; Kunz, Wolfram/0000-0003-1113-3493;
   Zsurka, Gabor/0000-0002-6379-849X
CR Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Biousse V, 2003, CURR OPIN NEUROL, V16, P35, DOI 10.1097/00019052-200302000-00005
   Cardaioli E, 2005, BIOCHEM BIOPH RES CO, V327, P675, DOI 10.1016/j.bbrc.2004.11.170
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Dubowitz V., 2006, MUSCLE BIOPSY PRACTI
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   Limongelli A, 2004, J MED GENET, V41, P342, DOI 10.1136/jmg.2003.016048
   Mancuso M, 2007, BIOSCIENCE REP, V27, P31, DOI 10.1007/s10540-007-9035-2
   Maniura-Weber K, 2006, NUCLEIC ACIDS RES, V34, P6404, DOI 10.1093/nar/gkl727
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025
   Scuderi C, 2007, NEUROMUSCULAR DISORD, V17, P258, DOI 10.1016/j.nmd.2006.11.006
   Siciliano G, 2007, BIOSCIENCE REP, V27, P53, DOI 10.1007/s10540-007-9037-0
   Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Tully LA, 2000, AM J HUM GENET, V67, P432, DOI 10.1086/302996
   Varlamov DA, 2002, HUM MOL GENET, V11, P1797, DOI 10.1093/hmg/11.16.1797
   Wiedemann FR, 2000, ANAL BIOCHEM, V279, P55, DOI 10.1006/abio.1999.4434
   Wittenhagen LM, 2002, NAT STRUCT BIOL, V9, P586, DOI 10.1038/nsb820
   Yasukawa T, 2000, NUCLEIC ACIDS RES, V28, P3779, DOI 10.1093/nar/28.19.3779
   Zsurka G, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.022566
   Zsurka G, 2005, NAT GENET, V37, P873, DOI 10.1038/ng1606
NR 28
TC 8
Z9 8
U1 0
U2 0
PU PORTLAND PRESS LTD
PI LONDON
PA THIRD FLOOR, EAGLE HOUSE, 16 PROCTER STREET, LONDON WC1V 6 NX, ENGLAND
SN 0144-8463
J9 BIOSCIENCE REP
JI Biosci. Rep.
PD APR
PY 2008
VL 28
IS 2
BP 89
EP 96
DI 10.1042/BSR20080004
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 317KS
UT WOS:000257019700004
PM 18384291
OA Green Published
DA 2024-11-01
ER

PT J
AU Bannwarth, S
   Ait-El-Mkadem, S
   Chaussenot, A
   Genin, EC
   Lacas-Gervais, S
   Fragaki, K
   Berg-Alonso, L
   Kageyama, Y
   Serre, V
   Moore, DG
   Verschueren, A
   Rouzier, C
   Le Ber, I
   Augé, G
   Cochaud, C
   Lespinasse, F
   N'Guyen, K
   de Septenville, A
   Brice, A
   Yu-Wai-Man, P
   Sesaki, H
   Pouget, J
   Paquis-Flucklinger, V
AF Bannwarth, Sylvie
   Ait-El-Mkadem, Samira
   Chaussenot, Annabelle
   Genin, Emmanuelle C.
   Lacas-Gervais, Sandra
   Fragaki, Konstantina
   Berg-Alonso, Laetitia
   Kageyama, Yusuke
   Serre, Valerie
   Moore, David G.
   Verschueren, Annie
   Rouzier, Cecile
   Le Ber, Isabelle
   Auge, Gaelle
   Cochaud, Charlotte
   Lespinasse, Francoise
   N'Guyen, Karine
   de Septenville, Anne
   Brice, Alexis
   Yu-Wai-Man, Patrick
   Sesaki, Hiromi
   Pouget, Jean
   Paquis-Flucklinger, Veronique
TI A mitochondrial origin for frontotemporal dementia and amyotrophic
   lateral sclerosis through <i>CHCHD10</i> involvement
SO BRAIN
LA English
DT Article
DE CHCHD10; mitochondrial DNA instability; mitochondrial disorder; FTD-ALS
ID DOMINANT OPTIC ATROPHY; RESPIRATORY-CHAIN SUPERCOMPLEXES;
   OXIDATIVE-PHOSPHORYLATION; EXTERNAL OPHTHALMOPLEGIA; HEXANUCLEOTIDE
   REPEAT; MULTIPLE DELETIONS; DNA INSTABILITY; PROTEIN; MUTATIONS; FUSION
AB Using whole-exome sequencing, Bannwarth et al. identify a missense mutation in the mitochondrial gene, CHCHD10, in two families with frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS). CHCHD10 helps to maintain the morphology of mitochondrial cristae and the stability of mitochondrial DNA. Other cases of FTD-ALS may be mitochondrial in origin.Mitochondrial DNA instability disorders are responsible for a large clinical spectrum, among which amyotrophic lateral sclerosis-like symptoms and frontotemporal dementia are extremely rare. We report a large family with a late-onset phenotype including motor neuron disease, cognitive decline resembling frontotemporal dementia, cerebellar ataxia and myopathy. In all patients, muscle biopsy showed ragged-red and cytochrome c oxidase-negative fibres with combined respiratory chain deficiency and abnormal assembly of complex V. The multiple mitochondrial DNA deletions found in skeletal muscle revealed a mitochondrial DNA instability disorder. Patient fibroblasts present with respiratory chain deficiency, mitochondrial ultrastructural alterations and fragmentation of the mitochondrial network. Interestingly, expression of matrix-targeted photoactivatable GFP showed that mitochondrial fusion was not inhibited in patient fibroblasts. Using whole-exome sequencing we identified a missense mutation (c.176C > T; p.Ser59Leu) in the CHCHD10 gene that encodes a coiled-coil helix coiled-coil helix protein, whose function is unknown. We show that CHCHD10 is a mitochondrial protein located in the intermembrane space and enriched at cristae junctions. Overexpression of a CHCHD10 mutant allele in HeLa cells led to fragmentation of the mitochondrial network and ultrastructural major abnormalities including loss, disorganization and dilatation of cristae. The observation of a frontotemporal dementia-amyotrophic lateral sclerosis phenotype in a mitochondrial disease led us to analyse CHCHD10 in a cohort of 21 families with pathologically proven frontotemporal dementia-amyotrophic lateral sclerosis. We identified the same missense p.Ser59Leu mutation in one of these families. This work opens a novel field to explore the pathogenesis of the frontotemporal dementia-amyotrophic lateral sclerosis clinical spectrum by showing that mitochondrial disease may be at the origin of some of these phenotypes.
C1 [Bannwarth, Sylvie; Ait-El-Mkadem, Samira; Chaussenot, Annabelle; Genin, Emmanuelle C.; Fragaki, Konstantina; Berg-Alonso, Laetitia; Rouzier, Cecile; Auge, Gaelle; Lespinasse, Francoise; Paquis-Flucklinger, Veronique] Univ Nice Sophia Antipolis, Sch Med, UNS, IRCAN,UMR CNRS 7284,INSERM U1081, Nice, France.
   [Bannwarth, Sylvie; Ait-El-Mkadem, Samira; Chaussenot, Annabelle; Fragaki, Konstantina; Rouzier, Cecile; Auge, Gaelle; Cochaud, Charlotte; Paquis-Flucklinger, Veronique] Nice Teaching Hosp, Dept Med Genet, Natl Ctr Mitochondrial Dis, Nice, France.
   [Lacas-Gervais, Sandra] Univ Nice Sophia Antipolis, Joint Ctr Appl Electron Microscopy, Nice, France.
   [Kageyama, Yusuke; Sesaki, Hiromi] Johns Hopkins Univ Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.
   [Serre, Valerie] Paris Diderot Univ, CNRS UMR7592, Inst Jacques Monod, Paris, France.
   [Moore, David G.; Yu-Wai-Man, Patrick] Newcastle Univ, Int Ctr Life, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
   [Verschueren, Annie; Pouget, Jean] Marseille Teaching Hosp, Timone Hosp, Dept Neurol, Marseille, France.
   [Le Ber, Isabelle; de Septenville, Anne; Brice, Alexis] Univ Paris 06, Sorbonne Univ, UM75, Inserm U1127,Cnrs UMR7225,Inst Cerveau & Moelle E, F-75013 Paris, France.
   [Le Ber, Isabelle] Grp Hosp Pitie Salpetriere, AP HP, Natl Reference Ctr Rare Dementias, F-75634 Paris, France.
   [N'Guyen, Karine] Marseille Teaching Hosp, Timone Hosp, Dept Med Genet, Marseille, France.
C3 Universite Cote d'Azur; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS);
   CNRS - National Institute for Biology (INSB); CHU Nice; Universite Cote
   d'Azur; Johns Hopkins University; Universite Paris Cite; Centre National
   de la Recherche Scientifique (CNRS); CNRS - National Institute for
   Biology (INSB); Newcastle University - UK; Aix-Marseille Universite;
   Assistance Publique-Hopitaux de Marseille; Centre National de la
   Recherche Scientifique (CNRS); CNRS - National Institute for Biology
   (INSB); Sorbonne Universite; Institut National de la Sante et de la
   Recherche Medicale (Inserm); Sorbonne Universite; Assistance Publique
   Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP;
   Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille
RP Paquis-Flucklinger, V (corresponding author), UNS, INSERM U1081, IRCAN UMR CNRS 7284, Sch Med, 28 Av Valombrose, F-06107 Nice 2, France.
EM paquis@hermes.unice.fr
RI Nguyen, Karine/J-9219-2016; brice, alexis/AAE-8275-2019; Rouzier,
   Cecile/KCY-3619-2024; GENIN, Emmanuelle/HSG-8378-2023
OI LESPINASSE, francoise/0000-0001-7710-0649; Genin, Emmanuelle
   C./0000-0003-3039-7101; Moore, David/0000-0002-0161-7390; Kageyama,
   Yusuke/0000-0002-3382-9881; Serre, Valerie/0000-0001-5277-1120; Brice,
   Alexis/0000-0002-0941-3990
FU Association Francaise contre les Myopathies (AFM); Fondation pour la
   Recherche Medicale (FRM); National Institutes of Health [GM089853];
   program 'Investissements d'avenir' [ANR-10-IAIHU-06]; The Programme
   Hospitalier de Recherche Clinique; European Union [E12009DD]; Medical
   Research Council (UK) [G1002570]; MRC [G0701386, G1002570] Funding
   Source: UKRI
FX This work was made possible by grants to V.P-F from the Association
   Francaise contre les Myopathies (AFM) and the Fondation pour la
   Recherche Medicale (FRM), to H. S from National Institutes of Health
   (GM089853) and to A. B by the program 'Investissements d'avenir'
   ANR-10-IAIHU-06, 'The Programme Hospitalier de Recherche Clinique' (to
   I. L. B.) and the 7th framework program of the European Union (FP7,
   E12009DD, Neuromics). P.YWM is supported by a Clinician Scientist
   Fellowship Award (G1002570) from the Medical Research Council (UK).
CR Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   An J, 2012, J BIOL CHEM, V287, P7411, DOI 10.1074/jbc.M111.277103
   Banci L, 2012, J STRUCT BIOL, V180, P190, DOI 10.1016/j.jsb.2012.07.007
   Banci L, 2009, FEBS LETT, V583, P1699, DOI 10.1016/j.febslet.2009.03.061
   Bannwarth S, 2012, MITOCHONDRION, V12, P654, DOI 10.1016/j.mito.2012.07.111
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brown TA, 2011, MOL CELL BIOL, V31, P4994, DOI 10.1128/MCB.05694-11
   Cavallaro G, 2010, MOL BIOSYST, V6, P2459, DOI 10.1039/c0mb00058b
   Chen H, 2010, ANN NY ACAD SCI, V1201, P21, DOI 10.1111/j.1749-6632.2010.05615.x
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Darshi M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.387696
   Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975
   DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Jans DC, 2013, P NATL ACAD SCI USA, V110, P8936, DOI 10.1073/pnas.1301820110
   Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082
   Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2
   Kim JS, 2011, MOL CELL BIOL, V31, P2756, DOI 10.1128/MCB.01323-10
   Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793
   Longen S, 2009, J MOL BIOL, V393, P356, DOI 10.1016/j.jmb.2009.08.041
   Martherus RSRM, 2010, BIOCHEM BIOPH RES CO, V402, P203, DOI 10.1016/j.bbrc.2010.09.109
   Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Paul R, 1996, TRENDS GENET, V12, P131
   Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Rouzier C, 2010, J MED GENET, V47, P670, DOI 10.1136/jmg.2009.073445
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Schägger H, 2001, J BIOL CHEM, V276, P37861
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Stojanovski D, 2012, BBA-MOL CELL RES, V1823, P1142, DOI 10.1016/j.bbamcr.2012.04.014
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551
   van der Laan M, 2012, TRENDS CELL BIOL, V22, P185, DOI 10.1016/j.tcb.2012.01.004
   Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013
   Zuchner S, 2004, NAT GENET, V36, P459
NR 46
TC 352
Z9 393
U1 0
U2 58
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD AUG
PY 2014
VL 137
BP 2329
EP 2345
DI 10.1093/brain/awu138
PN 8
PG 17
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA AM7MI
UT WOS:000340051100023
PM 24934289
OA Green Submitted, Green Published, Bronze
HC Y
HP N
DA 2024-11-01
ER

PT J
AU Saneto, RP
   Bouldin, A
AF Saneto, Russell P.
   Bouldin, Anthony
TI A boy with muscle weakness, hypercarbia, and the mitochondrial DNA
   A3243G mutation
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
ID TRANSFER RNALEU(UUR) GENE; LACTIC-ACIDOSIS; EPISODES MELAS; POINT
   MUTATION; MYOPATHY; ENCEPHALOPATHY
AB The point mutation in the mitochondrial genome tRNA(Leu) (A3243G) is associated with the syndrome of mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS). We report a boy presenting with respiratory compromise and hypercarbia owing to severe muscle weakness. Historically, he demonstrated idiopathic growth hormone deficiency, retarded bone age, and exercise avoidance. Owing to severe respiratory compromise out of proportion to expected recovery, a metabolic work-up was performed. Muscle biopsy demonstrated abnormal mitochondria structure and heteroplasmic A3243G mutation. Idiopathic growth hormone deficiency and retarded bone age have not been previously reported in MELAS, and these findings delayed testing for mitochondrial disease. This case demonstrates that isolated muscle weakness in the context of other organ system abnormalities should make the investigator consider MELAS.
C1 Univ Washington, Div Pediat Neurol, Childrens Hosp & Reg Med Ctr, Seattle, WA 98105 USA.
C3 Seattle Children's Hospital; University of Washington; University of
   Washington Seattle
RP Saneto, RP (corresponding author), Univ Washington, Div Pediat Neurol, Childrens Hosp & Reg Med Ctr, Neurol 5D-4,4800 Sand Point Way NE, Seattle, WA 98105 USA.
EM russ.saneto@seattlechildrens.org
CR Andreu AL, 1998, NEUROLOGY, V51, P1444, DOI 10.1212/WNL.51.5.1444
   Cholley F, 2001, NEUROPEDIATRICS, V32, P104, DOI 10.1055/s-2001-13878
   DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602
   GOTO Y, 1992, ANN NEUROL, V31, P672, DOI 10.1002/ana.410310617
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hanna MG, 1997, J NEUROL NEUROSUR PS, V62, P544, DOI 10.1136/jnnp.62.5.544
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   SCHAPIRA AHV, 1990, NEW ENGL J MED, V323, P37, DOI 10.1056/NEJM199007053230107
   Varanasi SS, 1999, OSTEOPOROSIS INT, V10, P143, DOI 10.1007/s001980050209
NR 11
TC 5
Z9 6
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD JAN
PY 2006
VL 21
IS 1
BP 77
EP 79
DI 10.1177/08830738060210010601
PG 3
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 046SP
UT WOS:000237831600016
PM 16551459
DA 2024-11-01
ER

PT J
AU Keogh, MJ
   Chinnery, PF
AF Keogh, Michael J.
   Chinnery, Patrick F.
TI Mitochondrial DNA mutations in neurodegeneration
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Review
DE DNA; Mitochondrial; Aging; Parkinson disease; Alzheimer disease; Lewy
   body disease
ID SUBSTANTIA-NIGRA-NEURONS; MTDNA CONTROL-REGION; RESPIRATORY-CHAIN
   FUNCTION; ALZHEIMERS-DISEASE BRAIN; ONSET PARKINSONS-DISEASE;
   KEARNS-SAYRE SYNDROME; HUMAN SKELETAL-MUSCLE; OXIDASE SUBUNIT-I; POINT
   MUTATIONS; COMPLEX-I
AB Mitochondrial dysfunction is observed in both the aging brain, and as a core feature of several neurodegenerative diseases. A central mechanism mediating this dysfunction is acquired molecular damage to mitochondrial DNA (mtDNA). In addition, inherited stable mtDNA variation (mitochondrial haplogroups), and inherited low level variants (heteroplasmy) have also been associated with the development of neurodegenerative disease and premature neural aging respectively. Herein we review the evidence for both inherited and acquired mtDNA mutations contributing to neural aging and neurodegenerative disease. This article is part of a Special Issue entitled: Mitochondrial Dysfunction in Aging. (c) 2015 Elsevier B.V. All rights reserved.
C1 [Keogh, Michael J.; Chinnery, Patrick F.] Newcastle Univ, Ctr Life, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
C3 Newcastle University - UK
EM p.f.chinnery@ncl.ac.uk
OI Keogh, Michael/0000-0001-7594-7379; Chinnery,
   Patrick/0000-0002-7065-6617
FU Wellcome Trust [103396/Z/13/Z, 101876/Z/13/Z, 096919Z/11/Z]; Medical
   Research Council (UK) Centre for Translational Muscle Disease research
   [G0601943]; EU FP7 TIRCON; National Institute for Health Research (NIHR)
   Newcastle Biomedical Research Centre based at Newcastle upon Tyne
   Hospitals NHS Foundation Trust and Newcastle University; Wellcome Trust
   [103396/Z/13/Z] Funding Source: Wellcome Trust; MRC [G0601943] Funding
   Source: UKRI
FX MJK is funded by a Wellcome Trust Clinical Research Training Fellowship
   (103396/Z/13/Z). PFC receives support from the Wellcome Trust
   (101876/Z/13/Z, 096919Z/11/Z), the Medical Research Council (UK) Centre
   for Translational Muscle Disease research (G0601943), and EU FP7 TIRCON,
   and the National Institute for Health Research (NIHR) Newcastle
   Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS
   Foundation Trust and Newcastle University.
CR Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868
   ANDERSON JJ, 1993, J NEUROL NEUROSUR PS, V56, P477, DOI 10.1136/jnnp.56.5.477
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   [Anonymous], J NEUROL NEUROSURG P
   Aomi Y, 2001, BIOCHEM BIOPH RES CO, V280, P265, DOI 10.1006/bbrc.2000.4113
   Bai YD, 2000, MOL CELL BIOL, V20, P805, DOI 10.1128/MCB.20.3.805-815.2000
   Baines HL, 2014, MECH AGEING DEV, V139, P22, DOI 10.1016/j.mad.2014.06.003
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209
   Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P
   Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380
   Campbell GR, 2012, CNS NEUROL DISORD-DR, V11, P589
   Cantuti-Castelvetria I, 2005, NEUROBIOL AGING, V26, P1343, DOI 10.1016/j.neurobiolaging.2004.11.008
   Celsi F, 2009, BBA-BIOENERGETICS, V1787, P335, DOI 10.1016/j.bbabio.2009.02.021
   Chang SW, 2000, BIOCHEM BIOPH RES CO, V273, P203, DOI 10.1006/bbrc.2000.2885
   Chinnery PF, 2010, LANCET NEUROL, V9, P498, DOI 10.1016/S1474-4422(10)70083-1
   Chinnery PF, 2001, AM J HUM GENET, V68, P529, DOI 10.1086/318204
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Cottrell DA, 2001, NEUROLOGY, V57, P260, DOI 10.1212/WNL.57.2.260
   D'Aurelio M, 2001, J BIOL CHEM, V276, P46925, DOI 10.1074/jbc.M106429200
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   DELEON MJ, 1983, AM J NEURORADIOL, V4, P568
   Edland SD, 1996, NEUROLOGY, V47, P254, DOI 10.1212/WNL.47.1.254
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Elston T, 1998, NATURE, V391, P510, DOI 10.1038/35185
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   García-Lozano JR, 2002, EUR NEUROL, V48, P34, DOI 10.1159/000064955
   Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   Grazina M, 2004, NEUROBIOL DIS, V15, P306, DOI 10.1016/j.nbd.2003.11.004
   Gredilla R, 2010, NEUROBIOL AGING, V31, P993, DOI 10.1016/j.neurobiolaging.2008.07.004
   Hamblet NS, 1997, MUTAT RES-FUND MOL M, V379, P253, DOI 10.1016/S0027-5107(97)00158-9
   HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Howell N, 2005, TRENDS GENET, V21, P583, DOI 10.1016/j.tig.2005.08.012
   Hudson G, 2012, NEUROLOGY, V78, P1038, DOI 10.1212/WNL.0b013e31824e8f1d
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Ingram CJE, 2012, AMYOTROPH LATERAL SC, V13, P341, DOI 10.3109/17482968.2012.654394
   Itoh K, 1996, NEUROBIOL AGING, V17, P843, DOI 10.1016/S0197-4580(96)00168-6
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   KATAYAMA M, 1991, BIOCHEM INT, V25, P47
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794
   Khrapko K, 2011, NAT GENET, V43, P726, DOI 10.1038/ng.895
   KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x
   KLEFF S, 1992, EMBO J, V11, P699, DOI 10.1002/j.1460-2075.1992.tb05102.x
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   KRIGE D, 1992, ANN NEUROL, V32, P782, DOI 10.1002/ana.410320612
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lakatos A, 2010, NEUROBIOL AGING, V31, P1355, DOI 10.1016/j.neurobiolaging.2010.04.031
   Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Latsoudis H, 2008, J HUM GENET, V53, P349, DOI 10.1007/s10038-008-0259-1
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Lücking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230
   Mancuso M, 2007, NEUROL SCI, V28, P142, DOI 10.1007/s10072-007-0807-z
   MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333
   Maruszak A, 2009, NEUROBIOL AGING, V30, P1749, DOI 10.1016/j.neurobiolaging.2008.01.004
   Mawrin C, 2004, NEUROSCI LETT, V357, P111, DOI 10.1016/j.neulet.2003.11.073
   Maximov V, 2002, MED HYPOTHESES, V59, P670, DOI 10.1016/S0306-9877(02)00223-2
   Mehta P, 2009, MOVEMENT DISORD, V24, P290, DOI 10.1002/mds.22389
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Molina JA, 1997, NEUROLOGY, V48, P636, DOI 10.1212/WNL.48.3.636
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   Müller SK, 2013, NEUROBIOL AGING, V34, P2231, DOI 10.1016/j.neurobiolaging.2013.03.016
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   MYTILINEOU C, 1994, J NEURAL TRANSM-PARK, V8, P223, DOI 10.1007/BF02260943
   NAKASE H, 1990, AM J HUM GENET, V46, P418
   NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8
   Nishigaki Y, 2007, MITOCHONDRION, V7, P72, DOI 10.1016/j.mito.2006.11.002
   Noji H, 2001, J BIOL CHEM, V276, P1665, DOI 10.1074/jbc.R000021200
   PARKER WD, 1994, NEUROLOGY, V44, P1090, DOI 10.1212/WNL.44.6.1090
   PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Perier C, 2013, BRAIN, V136, P2369, DOI 10.1093/brain/awt196
   PINZ KG, 1995, J BIOL CHEM, V270, P9202, DOI 10.1074/jbc.270.16.9202
   Reeve A, 2013, J NEUROSCI, V33, P10790, DOI 10.1523/JNEUROSCI.3525-12.2013
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Reeve AK, 2012, ARCH NEUROL-CHICAGO, V69, P385, DOI 10.1001/archneurol.2011.2675
   Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x
   Ridge PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045134
   Rosa A, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-57
   Rose G, 2008, EUR J NEUROL, V15, P1006, DOI 10.1111/j.1468-1331.2008.02222.x
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Santoro A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012037
   SCHAPIRA AHV, 1990, J NEUROCHEM, V55, P2142, DOI 10.1111/j.1471-4159.1990.tb05809.x
   Schleicher E, 2007, KIDNEY INT, V72, pS17, DOI 10.1038/sj.ki.5002382
   Schleicher M, 2008, J CELL BIOL, V180, P101, DOI 10.1083/jcb.200706072
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Siguroardóttir S, 2000, AM J HUM GENET, V66, P1599, DOI 10.1086/302902
   Simon DK, 2001, GENOMICS, V73, P113, DOI 10.1006/geno.2001.6515
   Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794
   Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797
   SOONG NW, 1992, NAT GENET, V2, P318
   SPELBRINK JN, 1994, HUM MOL GENET, V3, P1989, DOI 10.1093/hmg/3.11.1989
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   SWERDLOW RH, 2000, MOL MECH NEURODEGENE, P233
   Swerdlow RH, 2012, ANTIOXID REDOX SIGN, V16, P950, DOI 10.1089/ars.2011.3948
   Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Temperley R, 2010, SCIENCE, V327, P301, DOI 10.1126/science.1180674
   TORRONI A, 1993, AM J HUM GENET, V53, P563
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Tysoe C, 1996, J MED GENET, V33, P1002, DOI 10.1136/jmg.33.12.1002
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440
   van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921
   Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040
   WIESNER RJ, 1992, BIOCHEM BIOPH RES CO, V183, P553, DOI 10.1016/0006-291X(92)90517-O
   Yang DZ, 2014, MOL GENET GENOMICS, V289, P1241, DOI 10.1007/s00438-014-0884-7
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   YOSHINO H, 1992, J NEURAL TRANSM-PARK, V4, P27, DOI 10.1007/BF02257619
   Zoccolella S, 2012, EUR J NEUROL, V19, pe63, DOI 10.1111/j.1468-1331.2012.03720.x
NR 142
TC 113
Z9 125
U1 0
U2 55
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 0006-3002
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD NOV
PY 2015
VL 1847
IS 11
SI SI
BP 1401
EP 1411
DI 10.1016/j.bbabio.2015.05.015
PG 11
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA CS1XH
UT WOS:000361861700008
PM 26014345
OA Bronze
DA 2024-11-01
ER

PT J
AU Picard, M
AF Picard, Martin
TI Blood mitochondrial DNA copy number: What are we counting?
SO MITOCHONDRION
LA English
DT Review
DE White blood cells; Mitochondrial function; Mitochondrion; Biomarker;
   Count; Mitochondrial genome; Leukocytes
ID SKELETAL-MUSCLE; MTDNA DEPLETION; IMMUNE CELLS; QUANTIFICATION;
   ASSOCIATION; EXPRESSION; STRESS; HETEROPLASMY; VARIABILITY; BIOGENESIS
AB There is growing scientific interest to develop scalable biological measures that capture mitochondrial (dys) function. Mitochondria have their own genome, the mitochondrial DNA (mtDNA). It has been proposed that the number of mtDNA copies per cell (mtDNA copy number; mtDNAcn) reflects mitochondrial health. The common availability of stored DNA material or existing DNA sequencing data, especially from blood and other easy-tocollect samples, has made its quantification a popular approach in clinical and epidemiological studies. However, the interpretation of mtDNAcn is not univocal, and either a reduction or elevation in mtDNAcn can indicate dysfunction. The major determinants of blood-derived mtDNAcn are the heterogeneous cell type composition of leukocytes and platelet abundance, which can change with time of day, aging, and with disease. Hematopoiesis is a likely driver of blood mtDNAcn. Here we discuss the rationale and available methods to quantify mtDNAcn, the influence of blood cell type variations, and consider important gaps in knowledge that need to be resolved to maximize the scientific value around the investigation of blood mtDNAcn.
C1 [Picard, Martin] Columbia Univ, Div Behav Med, Dept Psychiat, Irving Med Ctr, New York, NY 10027 USA.
   [Picard, Martin] Columbia Univ, Irving Med Ctr, Columbia Translat Neurosci Initiat, Merritt Ctr,Dept Neurol, New York, NY 10027 USA.
   [Picard, Martin] New York State Psychiat Inst & Hosp, New York, NY 10032 USA.
C3 Columbia University; NewYork-Presbyterian Hospital; NewYork-Presbyterian
   Hospital; Columbia University; New York State Psychiatry Institute
RP Picard, M (corresponding author), Columbia Univ, Div Behav Med, Dept Psychiat, Irving Med Ctr, New York, NY 10027 USA.; Picard, M (corresponding author), Columbia Univ, Irving Med Ctr, Columbia Translat Neurosci Initiat, Merritt Ctr,Dept Neurol, New York, NY 10027 USA.; Picard, M (corresponding author), New York State Psychiat Inst & Hosp, New York, NY 10032 USA.
EM martin.picard@columbia.edu
OI Picard, Martin/0000-0003-2835-0478
FU National Institutes of Health [GM119793, MH119336, MH122706, AG066828]
FX The author's laboratory is supported by National Institutes of Health
   grants GM119793, MH119336, MH122706, AG066828.
CR Ajaz Saima, 2015, Methods Mol Biol, V1264, P117, DOI 10.1007/978-1-4939-2257-4_12
   [Anonymous], 2013, BIOENERGETICS 4
   Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Banas B, 2004, EUR J MED RES, V9, P371
   Basel D, 2020, CLIN PERINATOL, V47, P123, DOI 10.1016/j.clp.2019.10.008
   Berry BJ, 2021, GEROSCIENCE, V43, P1591, DOI 10.1007/s11357-021-00365-7
   Biino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054289
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Brinckmann A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013513
   Cai N, 2015, CURR BIOL, V25, P1146, DOI 10.1016/j.cub.2015.03.008
   Chernecky CC., 2013, LAB TESTS DIAGNOSTIC, V6th
   Coté HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035
   Dache ZA, 2020, FASEB J, V34, P3616, DOI 10.1096/fj.201901917RR
   Dhabhar FS, 2012, PSYCHONEUROENDOCRINO, V37, P1345, DOI 10.1016/j.psyneuen.2012.05.008
   DHABHAR FS, 1994, BRAIN BEHAV IMMUN, V8, P66, DOI 10.1006/brbi.1994.1006
   Ding J, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1005306, 10.1371/journal.pgen.1005549]
   Egan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074098
   Fazzini F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33684-5
   Ferrucci L, 2020, NAT REV ENDOCRINOL, V16, P133, DOI 10.1038/s41574-020-0319-y
   Feusier J, 2017, MOBILE DNA-UK, V8, DOI 10.1186/s13100-017-0093-0
   Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021
   Forsström S, 2019, CELL METAB, V30, P1040, DOI [10.1016/j.cmet.2019.013.019, 10.1016/j.cmet.2019.08.019]
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Fuke S, 2011, BBA-BIOENERGETICS, V1807, P270, DOI 10.1016/j.bbabio.2010.11.016
   Furman D, 2019, NAT MED, V25, P1822, DOI 10.1038/s41591-019-0675-0
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343
   Giordano L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.364
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Gumpp AM, 2020, P NATL ACAD SCI USA, V117, P24778, DOI 10.1073/pnas.2005885117
   Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003
   Hägg S, 2021, HUM GENET, V140, P849, DOI 10.1007/s00439-020-02249-w
   Hummel EM, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0264-x
   Hurtado-Roca Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163770
   Ikeda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119687
   Ince LM, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03143
   Kelly RDW, 2012, NUCLEIC ACIDS RES, V40, P10124, DOI 10.1093/nar/gks770
   Kim C, 2015, CANCER EPIDEM BIOMAR, V24, P148, DOI 10.1158/1055-9965.EPI-14-0753
   Knez J, 2016, AM J EPIDEMIOL, V183, P138, DOI 10.1093/aje/kwv175
   Konkel MK, 2015, GENOME BIOL EVOL, V7, P2608, DOI 10.1093/gbe/evv167
   Kramer PA, 2014, JOVE-J VIS EXP, DOI 10.3791/51301
   Kumar P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31122-0
   Lange T, 2010, ANN NY ACAD SCI, V1193, P48, DOI 10.1111/j.1749-6632.2009.05300.x
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Lehtonen JM., Neurology
   Lindqvist D, 2018, NEUROPSYCHOPHARMACOL, V43, P1557, DOI 10.1038/s41386-017-0001-9
   Longchamps RJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228166
   Lujan SA, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02138-5
   Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011
   Malik AN, 2011, BIOCHEM BIOPH RES CO, V412, P1, DOI 10.1016/j.bbrc.2011.06.067
   McLaughlin KL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74718-1
   Melchinger H, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00153
   Meng SS, 2016, ONCOTARGET, V7, P60676, DOI 10.18632/oncotarget.10325
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Meyer JN, 2018, TOXICOL SCI, V162, P15, DOI 10.1093/toxsci/kfy008
   Miliotis S, 2019, MITOCHONDRION, V48, P16, DOI 10.1016/j.mito.2019.02.002
   Moore AZ, 2018, AGING CELL, V17, DOI 10.1111/acel.12683
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7
   Nakahira K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001577
   Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980
   Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011
   O'Hara R, 2019, GENOME RES, V29, P1878, DOI 10.1101/gr.250480.119
   Osto Corey, 2020, Curr Protoc Cell Biol, V89, pe116, DOI 10.1002/cpcb.116
   Patin E, 2018, NAT IMMUNOL, V19, P302, DOI 10.1038/s41590-018-0049-7
   Picard M, 2019, CURR OPIN BEHAV SCI, V28, P142, DOI 10.1016/j.cobeha.2019.04.015
   Picard M, 2018, BIOL PSYCHIAT, V84, P9, DOI 10.1016/j.biopsych.2018.01.012
   Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003
   Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111
   Picard M, 2012, AM J RESP CRIT CARE, V186, P1140, DOI 10.1164/rccm.201206-0982OC
   Puente-Maestu L, 2011, THORAX, V66, P121, DOI 10.1136/thx.2010.153031
   Rath S, 2021, NUCLEIC ACIDS RES, V49, pD1541, DOI 10.1093/nar/gkaa1011
   Rausser S., 2021, MITOCHONDRIAL PHENOT, DOI [10.1101/2020.10.16.342923, DOI 10.1101/2020.10.16.342923]
   Riley JS, 2020, EMBO REP, V21, DOI 10.15252/embr.201949799
   Rosa HS, 2020, FASEB J, V34, P12278, DOI 10.1096/fj.202000959RR
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   Roubicek DA, 2017, TOXICOLOGY, V391, P100, DOI 10.1016/j.tox.2017.06.012
   Saenen ND, 2019, ENVIRON INT, V123, P39, DOI 10.1016/j.envint.2018.11.028
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   Schubert S, 2015, INT J MOL SCI, V16, P9850, DOI 10.3390/ijms16059850
   Scozzi D, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.143299
   Segerstrom SC, 2017, PSYCHONEUROENDOCRINO, V78, P114, DOI 10.1016/j.psyneuen.2017.01.026
   Selvaraj V, 2018, BIOL REPROD, V99, P13, DOI 10.1093/biolre/ioy102
   Sharma R, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI136055
   Shim HB, 2020, MITOCHONDRION, V52, P108, DOI 10.1016/j.mito.2020.03.001
   Stephens OR, 2020, MITOCHONDRION, V54, P102, DOI 10.1016/j.mito.2020.08.002
   Tarasenko TN, 2017, CELL METAB, V25, P1254, DOI 10.1016/j.cmet.2017.05.007
   Theda C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25311-0
   Trumpff C., MITOCHONDRION
   Trumpff C, 2019, PSYCHONEUROENDOCRINO, V106, P268, DOI 10.1016/j.psyneuen.2019.03.026
   Tyrka AR, 2016, BIOL PSYCHIAT, V79, P78, DOI 10.1016/j.biopsych.2014.12.025
   Urata M, 2008, ANN CLIN BIOCHEM, V45, P513, DOI 10.1258/acb.2008.008008
   Verhoeven JE, 2018, MOL PSYCHIATR, V23, P850, DOI 10.1038/mp.2017.48
   Vettor R, 2014, AM J PHYSIOL-ENDOC M, V306, pE519, DOI 10.1152/ajpendo.00617.2013
   Vincent AE, 2018, ANN NEUROL, V84, P289, DOI 10.1002/ana.25288
   Wachsmuth M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005939
   Ware SA, 2020, J BIOL CHEM, V295, P15677, DOI 10.1074/jbc.RA120.015237
   Wei YH, 2001, ANN NY ACAD SCI, V928, P97
   West AP, 2017, NAT REV IMMUNOL, V17, P363, DOI 10.1038/nri.2017.21
   Wu Z., TRENDS BIOCHEM SCI
   Yang SY, 2021, GENOME RES, V31, P349, DOI 10.1101/gr.269381.120
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Yonova-Doing E., NAT GENET, P2021
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
   Zhang J, 2015, Hematol Transfus Int J, V1, P108
   Zhang RY, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4287-0
NR 109
TC 85
Z9 92
U1 0
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD SEP
PY 2021
VL 60
BP 1
EP 11
DI 10.1016/j.mito.2021.06.010
EA JUL 2021
PG 11
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA WD0EX
UT WOS:000704622300001
PM 34157430
OA Bronze, Green Accepted
DA 2024-11-01
ER

PT J
AU Cevoli, S
   Pallotti, F
   La Morgia, C
   Valentino, ML
   Pierangeli, G
   Cortelli, P
   Baruzzi, A
   Montagna, P
   Carelli, V
AF Cevoli, Sabina
   Pallotti, Francesco
   La Morgia, Chiara
   Valentino, Maria L.
   Pierangeli, Giulia
   Cortelli, Pietro
   Baruzzi, Agostino
   Montagna, Pasquale
   Carelli, Valerio
TI High frequency of migraine-only patients negative for the 3243 A&gt;G
   tRNA<SUP>Leu</SUP> mtDNA mutation in two MELAS families
SO CEPHALALGIA
LA English
DT Article
DE MELAS; CPEO; migraine; oxidative phosphorylation; genetic; stroke-like
ID MAGNETIC-RESONANCE-SPECTROSCOPY; MITOCHONDRIAL-DNA; ENERGY-METABOLISM;
   POINT MUTATION; STROKE; BRAIN; HEADACHE; NEURONS; A3243G; AURA
AB Migraine is associated with stroke-like episodes in mitochondrial encephalomyopathy, lactic acidosis, stroke-like syndrome (MELAS). Moreover, abnormalities of oxidative phosphorylation are also reported in migraine. We studied two maternal lineages with MELAS and chronic progressive external ophthalmoplegia (CPEO) affected probands carrying the 3243 A>G tRNA(Leu) (MELAS) mutation, remarkable for a high frequency of subjects suffering only migraine. Thus, migraine could be a monosymptomatic expression of the MELAS mutation. We assessed the 3243 A>G tRNA(Leu) mutational load in skeletal muscle and other somatic tissues from the migraine-only subjects, as well as lactic acid levels after exercise. All migraine-only subjects did not carry the MELAS mutation. Muscle biopsy showed mild mitochondrial abnormalities in the non-mutant, migraine-only subjects and, occasionally, abnormal lactic acid. Clear features of mitochondrial myopathy and pathological lactic acid characterised the subjects carrying the MELAS mutation. Our study demonstrates that migraine-only subjects lacked the MELAS mutation, but still had a possible mtDNA-associated genetic predisposition, being maternally related and having some evidence of impaired mitochondrial oxidative phosphorylation.
C1 [Carelli, Valerio] Univ Bologna, Neurogenet Lab, Dept Neurol Sci, I-40123 Bologna, Italy.
   [Pallotti, Francesco] Univ Insubria, Dept Expt & Clin Biomed Sci, Varese, Italy.
C3 University of Bologna; University of Insubria
RP Carelli, V (corresponding author), Univ Bologna, Neurogenet Lab, Dept Neurol Sci, Via Ugo Foscolo 7, I-40123 Bologna, Italy.
EM valerio.carelli@unibo.it
RI La Morgia, Chiara/H-6765-2012; Cortelli, Pietro/K-6063-2016
OI CARELLI, VALERIO/0000-0003-4923-6404; LA MORGIA,
   Chiara/0000-0002-4639-8929; Pallotti, Francesco/0000-0001-9946-8516;
   Cortelli, Pietro/0000-0002-3633-8818; VALENTINO, MARIA
   LUCIA/0000-0001-5323-0115
FU Bologna University [RFO-ex]
FX The authors are indebted to the patients and their families for their
   invaluable collaboration. The financial support of Bologna University
   grant (RFO-ex 60%) to PC, PM and VC is also gratefully acknowledged.
CR BARBIROLI B, 1992, NEUROLOGY, V42, P1209, DOI 10.1212/WNL.42.6.1209
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   BRESOLIN N, 1991, J NEUROL SCI, V104, P182, DOI 10.1016/0022-510X(91)90308-T
   Buzzi MG, 2000, NEUROLOGY, V54, P1005, DOI 10.1212/WNL.54.4.1005
   CORTELLI P, 1995, LANCET, V345, P1120, DOI 10.1016/S0140-6736(95)90853-6
   Cupini LM, 2003, NEUROLOGY, V60, P717, DOI 10.1212/01.WNL.0000048662.77572.FB
   Di Gennaro G, 2000, HEADACHE, V40, P568, DOI 10.1046/j.1526-4610.2000.00088.x
   Di Lorenzo C, 2009, NEUROLOGY, V72, P1588, DOI 10.1212/WNL.0b013e3181a41269
   Finnila Saara, 2001, Mutation Research, V458, P31, DOI 10.1016/S1383-5726(01)00012-7
   Gilchrist JM, 1996, STROKE, V27, P1420, DOI 10.1161/01.STR.27.8.1420
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GRONSETH GS, 1995, NEUROLOGY, V45, P1263, DOI 10.1212/WNL.45.7.1263
   Haan J, 1999, CEPHALALGIA, V19, P20, DOI 10.1046/j.1468-2982.1999.1901020.x
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Joseph AM, 2006, ESSAYS BIOCHEM, V42, P13, DOI 10.1042/bse0420013
   Klopstock T, 1996, NEUROLOGY, V46, P1735, DOI 10.1212/WNL.46.6.1735
   Kruit MC, 2004, JAMA-J AM MED ASSOC, V291, P427, DOI 10.1001/jama.291.4.427
   La Morgia C, 2008, NEUROLOGY, V70, P762, DOI 10.1212/01.wnl.0000295505.74234.d0
   LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   MONTAGNA P, 1988, HEADACHE, V28, P477, DOI 10.1111/j.1526-4610.1988.hed2807477.x
   MONTAGNA P, 1994, CEPHALALGIA, V14, P184, DOI 10.1046/j.1468-2982.1994.014003184.x
   MONTAGNA P, 1995, J NEUROL NEUROSUR PS, V58, P640, DOI 10.1136/jnnp.58.5.640
   MONTAGNA P, 1994, NEUROLOGY, V44, P666, DOI 10.1212/WNL.44.4.666
   Montagna P, 2000, CEPHALALGIA, V20, P3, DOI 10.1046/j.1468-2982.2000.00003.x
   MONTAGNA P, 1988, NEUROLOGY, V38, P751, DOI 10.1212/WNL.38.5.751
   Montagna Pasquale, 2008, Expert Rev Neurother, V8, P1321, DOI 10.1586/14737175.8.9.1321
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Okada H, 1998, HEADACHE, V38, P39, DOI 10.1046/j.1526-4610.1998.3801039.x
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Rhode AM, 2007, CEPHALALGIA, V27, P1255, DOI 10.1111/j.1468-2982.2007.01453.x
   SANGIORGI S, 1994, CEPHALALGIA, V14, P21, DOI 10.1046/j.1468-2982.1994.1401021.x
   SHIMOMURA T, 1994, LANCET, V344, P625, DOI 10.1016/S0140-6736(94)92015-X
   Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x
   Sparaco M, 2006, CEPHALALGIA, V26, P361, DOI 10.1111/j.1468-2982.2005.01059.x
   von Brevern M, 2005, BRAIN, V128, P365, DOI 10.1093/brain/awh351
   Wang QX, 2004, AM J MED GENET A, V131A, P50, DOI 10.1002/ajmg.a.30323
   Watanabe H., 1996, Neurology, V47, P1093
   WELCH KMA, 1989, NEUROLOGY, V39, P538, DOI 10.1212/WNL.39.4.538
   Zaki E A, 2009, Cephalalgia, V29, P719, DOI 10.1111/j.1468-2982.2008.01793.x
NR 40
TC 10
Z9 11
U1 0
U2 4
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0333-1024
EI 1468-2982
J9 CEPHALALGIA
JI Cephalalgia
PD AUG
PY 2010
VL 30
IS 8
BP 919
EP 927
DI 10.1177/0333102409354654
PG 9
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 691BB
UT WOS:000285054200005
PM 20656703
OA Bronze
DA 2024-11-01
ER

PT J
AU Jeppesen, TD
   Orngreen, MC
   van Hall, G
   Haller, RG
   Vissing, J
AF Jeppesen, Tina Dysgaard
   Orngreen, Mette Cathrine
   van Hall, Gerrit
   Haller, Ronald G.
   Vissing, John
TI Fat Metabolism During Exercise in Patients With Mitochondrial Disease
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID FUEL UTILIZATION; MCARDLE-DISEASE; MUTATION LOAD; GLUCOSE; TOLERANCE;
   MYOPATHY; CARBOHYDRATE; DEFICIENCY; CAPACITY; KINETICS
AB Objective: To determine whether patients with defects of the respiratory chain have metabolic adaptations that promote a preferential use of fats or carbohydrates, similar to what is observed in metabolic myopathies affecting glycolysis or fat oxidation.
   Design: Causation and case-control study. Fat metabolism was determined by means of indirect calorimetry and stable isotope technique in patients and healthy subjects. Patients carried various types and loads (mean [SE], 72% [5%]) of mitochondrial DNA (mtDNA) mutations in skeletal muscle. All subjects exercised at the same absolute workload (mean [SE], 65 [10] W), corresponding to 72% (in patients) and 30% (in healthy subjects) of maximum oxygen consumption.
   Setting: Neuromuscular research unit.
   Participants: Ten patients with mtDNA mutations and 10 sex-matched healthy subjects.
   Main Outcome Measures: Fat turnover, plasma concentrations of palmitate and total free fatty acids, glucose mobilization, and total carbohydrate oxidation.
   Results: Fat turnover and plasma concentrations of palmitate and total free fatty acids were similar in patients and healthy subjects at rest and during exercise. In line with the higher relative workload of the patients, glucose mobilization and total carbohydrate oxidation were higher in the patients compared with the healthy subjects.
   Conclusion: During moderate-intensity exercise, the balance between fat and carbohydrate use in patients with mtDNA mutations matches that seen in healthy subjects, indicating that manipulating dietary fat and carbohydrate content is not a feasible therapeutic option to improve exercise intolerance in these disorders.
C1 [Jeppesen, Tina Dysgaard; Orngreen, Mette Cathrine; van Hall, Gerrit; Vissing, John] Univ Copenhagen, Rigshosp, Dept Neurol, Neuromuscular Res Unit, DK-2100 Copenhagen, Denmark.
   [Jeppesen, Tina Dysgaard; Orngreen, Mette Cathrine; van Hall, Gerrit; Vissing, John] Univ Copenhagen, Rigshosp, Copenhagen Muscle Res Ctr, DK-2100 Copenhagen, Denmark.
   [Haller, Ronald G.] Univ Copenhagen, Rigshosp, Dept Biomed Sci, DK-2100 Copenhagen, Denmark.
   [Haller, Ronald G.] Neuromuscular Ctr, Inst Exercise & Environm Med, Dallas, TX USA.
C3 University of Copenhagen; Rigshospitalet; University of Copenhagen;
   Rigshospitalet; University of Copenhagen; Rigshospitalet
RP Jeppesen, TD (corresponding author), Univ Copenhagen, Rigshosp, Neuromuscular Res Unit 3342, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
EM Dysgaard@yahoo.dk
RI Jeppesen, Tina/AAV-7195-2020; Vissing, John/IUN-4271-2023
OI Orngreen, Mette Cathrine/0000-0002-2991-6309; van Hall,
   Gerrit/0000-0002-2519-8127
FU Copenhagen Hospital Community Foundation; Faculty of Healthy Sciences;
   Novo Nordic Foundation; Danish Medical Research Council; Elsass
   Foundation
FX This study was supported by grants from the Copenhagen Hospital
   Community Foundation (Dr Jeppesen), Faculty of Healthy Sciences (Dr
   Orngreen), Novo Nordic Foundation (Dr Jeppesen), Danish Medical Research
   Council (Dr Vissing), and Elsass Foundation (Dr Vissing).
CR ABUMRAD NN, 1981, METABOLISM, V30, P936, DOI 10.1016/0026-0495(81)90074-3
   Andersen ST, 2008, J NEUROL NEUROSUR PS, V79, P1359, DOI 10.1136/adc.2008.146548
   Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Becker R, 2002, EXP CLIN ENDOCR DIAB, V110, P291, DOI 10.1055/s-2002-34592
   BERIO A, 1994, OPHTHALMOLOGICA, V208, P342, DOI 10.1159/000310536
   BERNSEN PLJA, 1993, J NEUROL SCI, V118, P181, DOI 10.1016/0022-510X(93)90108-B
   BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92
   Chen RS, 1997, EUR NEUROL, V37, P212, DOI 10.1159/000117445
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   de Meer K, 2005, J INHERIT METAB DIS, V28, P95, DOI 10.1007/s10545-005-1485-8
   Frederiksen AL, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039339
   GALBO H, 1995, ENDOCRINOLOGY
   Haller RG, 2002, ARCH NEUROL-CHICAGO, V59, P1395, DOI 10.1001/archneur.59.9.1395
   Haller RG., 2004, Myology, P665
   Hepple RT, 1999, CLIN SCI, V97, P569, DOI 10.1042/CS19980343
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   LEWIS SF, 1986, J APPL PHYSIOL, V61, P391, DOI 10.1152/jappl.1986.61.2.391
   Nielsen JN, 2002, J PHYSIOL-LONDON, V541, P979, DOI 10.1113/jphysiol.2002.018044
   Orngreen MC, 2007, NEUROLOGY, V69, P313, DOI 10.1212/01.wnl.0000265854.41013.84
   Orngreen MC, 2004, ANN NEUROL, V56, P279, DOI 10.1002/ana.20168
   Orngreen MC, 2003, NEUROLOGY, V61, P559, DOI 10.1212/01.WNL.0000078195.05396.20
   Orngreen MC, 2002, NEUROLOGY, V59, P1046, DOI 10.1212/WNL.59.7.1046
   PERONNET F, 1991, CAN J SPORT SCI, V16, P23
   Robertshaw HA, 2008, MUSCLE NERVE, V37, P431, DOI 10.1002/mus.20947
   Roef MJ, 2002, AM J CLIN NUTR, V75, P237, DOI 10.1093/ajcn/75.2.237
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x
   Taivassalo T, 1996, NEUROLOGY, V47, P529, DOI 10.1212/WNL.47.2.529
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Tanaka J, 1997, BRAIN DEV-JPN, V19, P262, DOI 10.1016/S0387-7604(97)00573-1
   van Hall G, 2002, J PHYSIOL-LONDON, V543, P1033, DOI 10.1113/jphysiol.2002.022392
   van Hall G, 1999, P NUTR SOC, V58, P979, DOI 10.1017/S0029665199001299
   van Loon LJC, 2003, EUR J APPL PHYSIOL, V89, P377, DOI 10.1007/s00421-003-0810-x
   van Loon LJC, 2001, J PHYSIOL-LONDON, V536, P295, DOI 10.1111/j.1469-7793.2001.00295.x
   Vissing J, 1998, J CLIN INVEST, V101, P1654, DOI 10.1172/JCI555
   Vissing J, 2003, NEW ENGL J MED, V349, P2503, DOI 10.1056/NEJMoa031836
   Vissing J, 2001, ANN NEUROL, V49, P672, DOI 10.1002/ana.1026
   Wolfe RR., 1992, RADIOACTIVE STABLE I
NR 39
TC 16
Z9 16
U1 0
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0003-9942
EI 1538-3687
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD MAR
PY 2009
VL 66
IS 3
BP 365
EP 370
DI 10.1001/archneurol.2009.24
PG 6
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 416EY
UT WOS:000263989600012
PM 19273755
DA 2024-11-01
ER

PT J
AU Nissanka, N
   Bacman, SR
   Plastini, MJ
   Moraes, CT
AF Nissanka, Nadee
   Bacman, Sandra R.
   Plastini, Melanie J.
   Moraes, Carlos T.
TI The mitochondrial DNA polymerase gamma degrades linear DNA fragments
   precluding the formation of deletions
SO NATURE COMMUNICATIONS
LA English
DT Article
ID TARGETED RESTRICTION-ENDONUCLEASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   DOUBLE-STRAND BREAKS; MTDNA DELETIONS; MUTATIONS; REPLICATION; DEFECTS;
   MICE; HETEROPLASMY; MAINTENANCE
AB Double-strand breaks in the mitochondrial DNA (mtDNA) result in the formation of linear fragments that are rapidly degraded. However, the identity of the nuclease(s) performing this function is not known. We found that the exonuclease function of the mtDNA polymerase gamma (POLG) is required for this rapid degradation of mtDNA fragments. POLG is recruited to linearized DNA fragments in an origin of replication-independent manner. Moreover, in the absence of POLG exonuclease activity, the prolonged existence of mtDNA linear fragments leads to increased levels of mtDNA deletions, which have been previously identified in the mutator mouse, patients with POLG mutations and normal aging.
C1 [Nissanka, Nadee; Plastini, Melanie J.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Neurosci Grad Program, Miami Beach, FL 33136 USA.
   [Bacman, Sandra R.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami Beach, FL 33136 USA.
C3 University of Miami; University of Miami
RP Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Neurosci Grad Program, Miami Beach, FL 33136 USA.; Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami Beach, FL 33136 USA.
EM cmoraes@med.miami.edu
RI Moraes, Carlos/AAT-3818-2021
OI Plastini, Melanie/0000-0003-2011-7882; Nissanka,
   Nadee/0000-0002-4639-7192
FU National Institutes of Health [1R01AG036871, 5R01EY010804,
   1R01NS079965]; American Heart Association [16PRE30480009]; Lois Pope
   LIFE Fellowship program; NEI center grant from the National Institutes
   of Health (NIH) [P30-EY014801]; American Heart Association (AHA)
   [16PRE30480009] Funding Source: American Heart Association (AHA)
FX This work was supported by the National Institutes of Health Grants
   1R01AG036871, 5R01EY010804, and 1R01NS079965 (CTM). Nadee Nissanka is
   supported by an American Heart Association predoctoral fellowship
   (16PRE30480009) and Lois Pope LIFE Fellowship program. We acknowledge
   support from the NEI center grant P30-EY014801 from the National
   Institutes of Health (NIH).
CR Alexeyev M., 2013, Cold Spring Harb Perspect Biol, V5, DOI DOI 10.1101/CSHPERSPECT.A012641
   Bacman SR, 2010, GENE THER, V17, P713, DOI 10.1038/gt.2010.25
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348
   Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   HUARD J, 1995, GENE THER, V2, P107
   Kasiviswanathan R, 2012, BBA-GENE REGUL MECH, V1819, P970, DOI 10.1016/j.bbagrm.2011.12.005
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Macao B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8303
   Matic S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03552-x
   Medeiros TC, 2018, J CELL BIOL, V217, P1601, DOI 10.1083/jcb.201801168
   Moretton A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176795
   Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Pinto M, 2015, FREE RADICAL BIO MED, V85, P250, DOI 10.1016/j.freeradbiomed.2015.05.005
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155
   Yu ZS, 2017, CURR BIOL, V27, P1033, DOI 10.1016/j.cub.2017.02.014
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
NR 43
TC 82
Z9 92
U1 0
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JUN 27
PY 2018
VL 9
AR 2491
DI 10.1038/s41467-018-04895-1
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA GK9DU
UT WOS:000436540700009
PM 29950568
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Wang, YK
   Liu, YW
   Zhao, YQ
   Luo, JJ
AF Wang, Yakun
   Liu, Yuanwu
   Zhao, Yiqiang
   Luo, Junjie
TI Quantification of circadian rhythm in mitochondrial DNA copy number in
   whole blood, and identification of factors that influence it
SO CELLULAR AND MOLECULAR BIOLOGY
LA English
DT Article
DE mtDNA copy number; Circadian rhythm; Platelets; Sampling time
ID PERIPHERAL-BLOOD; RIBOSOMAL-RNA; RISK; CELL; DYSFUNCTION; LEUKOCYTES;
   ASSOCIATION; MUTATION; PLATELETS; MYOPATHY
AB Mitochondrial DNA (mtDNA), the genetic material in mitochondria, encodes key genes related to the respiratory chain and ATP production. To accurate quantification mtDNA content in whole blood is important for various disease states. Absolute quantitative Real-time PCR and platelet contamination erase method were used for mtDNA copy number analysis in whole blood. In the quantitative study of mtDNA content, it was found that whole blood mtDNA copy number showed a fluctuating rhythm during a 24-h period due to dynamic changes in white blood cells combined with platelets. However, when isolated white blood cells were used, or absolute whole blood mtDNA was calculated, the circadian rhythm pattern of mtDNA disappeared. In this study, a feasible method that can accurately quantify mitochondrial DNA in small blood samples was established, and it was found that two factors which greatly influenced mtDNA copy number were sampling time and platelets in blood.
C1 [Wang, Yakun; Liu, Yuanwu; Zhao, Yiqiang; Luo, Junjie] China Agr Univ, Dept Nutr & Hlth, Key Lab Precis Nutr & Food Qual, Beijing, Peoples R China.
   [Zhao, Yiqiang] China Agr Univ, Coll Biol Sci, Beijing, Peoples R China.
C3 China Agricultural University; China Agricultural University
RP Luo, JJ (corresponding author), China Agr Univ, Dept Nutr & Hlth, Key Lab Precis Nutr & Food Qual, Beijing, Peoples R China.
EM luojj@pku.edu.cn
RI LUO, JUNJIE/HPD-1151-2023
FU Beijing Advanced Innovation Center for Food Nutrition and Human Health;
   National Natural Science Foundation of China [U1704233]
FX We gratefully acknowledge Professor Zhenglong Gu for his kindness by way
   of discussion and comments on the manuscript. All experiments were
   supported by the Beijing Advanced Innovation Center for Food Nutrition
   and Human Health and the National Natural Science Foundation of China
   (U1704233).
CR ABO T, 1981, J IMMUNOL, V126, P1360
   [Anonymous], 2016, AUTISM OPEN ACCESS
   Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683
   Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664
   Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014
   Banas B, 2004, EUR J MED RES, V9, P371
   Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8
   Boudreau LH, 2014, BLOOD, V124, P2173, DOI 10.1182/blood-2014-05-573543
   Chandel NS, 2015, CELL METAB, V22, P204, DOI 10.1016/j.cmet.2015.05.013
   Chandel NS, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-34
   Chen N, 2016, SCI REP-UK, V6, DOI 10.1038/srep37404
   Chen S, 2015, BMC PSYCHIATRY, V15, P50
   Chistiakov DA, 2018, ANN MED, V50, P121, DOI 10.1080/07853890.2017.1417631
   Duffy LM, 2011, NEUROPATH APPL NEURO, V37, P336, DOI 10.1111/j.1365-2990.2011.01166.x
   Giorgi C, 2012, MITOCHONDRION, V12, P77, DOI 10.1016/j.mito.2011.07.004
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   He Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096869
   Hurtado-Roca Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163770
   Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850
   Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x
   Lee JY, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/586017
   Lee SH, 2011, METABOLISM, V60, P1677, DOI 10.1016/j.metabol.2011.04.010
   Lei L, 2017, J HUM HYPERTENS, V31, P585, DOI 10.1038/jhh.2017.30
   Leishangthem BD, 2016, LUPUS, V25, P272, DOI 10.1177/0961203315605370
   Lemnrau A, 2015, CANCER RES, V75, P2844, DOI 10.1158/0008-5472.CAN-14-1692
   López-Armada MJ, 2013, MITOCHONDRION, V13, P106, DOI 10.1016/j.mito.2013.01.003
   Malik AN, 2016, MITOCHONDRION, V29, P59, DOI 10.1016/j.mito.2016.05.003
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   Melkonian SC, 2015, CARCINOGENESIS, V36, P249, DOI 10.1093/carcin/bgu248
   Meng FL, 2018, J BIOL CHEM, V293, P3321, DOI 10.1074/jbc.RA117.000530
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Miller WL, 2013, MOL CELL ENDOCRINOL, V379, P62, DOI 10.1016/j.mce.2013.04.014
   MIYAWAKI T, 1984, CLIN EXP IMMUNOL, V55, P618
   Nemzek JA, 2001, INFLAMM RES, V50, P523, DOI 10.1007/PL00000229
   Patterson HC, 2015, P NATL ACAD SCI USA, V112, pE5679, DOI 10.1073/pnas.1517932112
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Purdue MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043149
   Pyle A, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.033
   Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136
   Shen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131649
   SHUSTER RC, 1988, BIOCHEM BIOPH RES CO, V155, P1360, DOI 10.1016/S0006-291X(88)81291-9
   Smith EF, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2017.06.052
   Sun J, 2019, J INFECT DIS, V219, P1285, DOI 10.1093/infdis/jiy658
   Sun YH, 2016, MOL CARCINOGEN, V55, P1111, DOI 10.1002/mc.22373
   Tin A, 2016, J AM SOC NEPHROL, V27, P2467, DOI 10.1681/ASN.2015060661
   Tu HK, 2015, ONCOTARGET, V6, P41988, DOI 10.18632/oncotarget.5889
   Urata M, 2008, ANN CLIN BIOCHEM, V45, P513, DOI 10.1258/acb.2008.008008
   Ward MS, 2013, CURR OPIN PHARMACOL, V13, P654, DOI 10.1016/j.coph.2013.06.009
   Xie H, 2013, CARCINOGENESIS, V34, P1039, DOI 10.1093/carcin/bgt023
   Xu EP, 2013, CARCINOGENESIS, V34, P2521, DOI 10.1093/carcin/bgt230
   Yang Y, 2019, PLOS ONE, V14
   Yoo HJ, 2017, WORLD J BIOL PSYCHIA, V18, P151, DOI 10.1080/15622975.2016.1234069
   Zhang J, 2017, AM J CARDIOL, V119, P473, DOI 10.1016/j.amjcard.2016.10.017
   Zhang P, 2016, MITOCHONDRION, V28, P16, DOI 10.1016/j.mito.2016.03.001
   Zhou WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109470
NR 55
TC 2
Z9 2
U1 0
U2 9
PU C M B  ASSOC
PI POITIERS
PA 34 BOULEVARD SOLFERINO, 86000 POITIERS, FRANCE
SN 0145-5680
EI 1165-158X
J9 CELL MOL BIOL
JI Cell. Mol. Biol.
PY 2020
VL 66
IS 5
BP 179
EP 184
DI 10.14715/cmb/2020.66.5.30
PG 6
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA MY8PI
UT WOS:000558679700029
PM 33040833
DA 2024-11-01
ER

PT J
AU Palin, EJH
   Paetau, A
   Suomalainen, A
AF Palin, Eino J. H.
   Paetau, Anders
   Suomalainen, Anu
TI Mesencephalic complex I deficiency does not correlate with parkinsonism
   in mitochondrial DNA maintenance disorders
SO BRAIN
LA English
DT Article
DE parkinsonism; mitochondrial disorders; mitochondrial dysfunction;
   mitochondrial DNA; ataxia
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; ONSET SPINOCEREBELLAR ATAXIA;
   AUTOSOMAL RECESSIVE ATAXIA; SUBSTANTIA-NIGRA NEURONS; SENSORY
   NEUROPATHY; JUVENILE PARKINSONISM; MULTIPLE DELETIONS; DOPAMINE NEURONS;
   W748S MUTATION; DISEASE
AB Genetic evidence from recessively inherited Parkinson's disease has indicated a clear causative role for mitochondrial dysfunction in Parkinson's disease. This role has long been discussed based on findings that toxic inhibition of mitochondrial respiratory complex I caused parkinsonism and that tissues of patients with Parkinson's disease show complex I deficiency. Disorders of mitochondrial DNA maintenance are a common cause of inherited neurodegenerative disorders, and lead to mitochondrial DNA deletions or depletion and respiratory chain defect, including complex I deficiency. However, parkinsonism associates typically with defects of catalytic domain of mitochondrial DNA polymerase gamma. Surprisingly, however, not all mutations affecting DNA polymerase gamma manifest as parkinsonism, but, for example, spacer region mutations lead to spinocerebellar ataxia and/or severe epilepsy. Furthermore, defective Twinkle helicase, a close functional companion of DNA polymerase gamma in mitochondrial DNA replication, results in infantile-onset spinocerebellar ataxia, epilepsy or adult-onset mitochondrial myopathy, but not typically parkinsonism. Here we sought for clues for this specificity in the neurological manifestations of mitochondrial DNA maintenance disorders by studying mesencephalic neuropathology of patients with DNA polymerase gamma or Twinkle defects, with or without parkinsonism. We show here that all patients with mitochondrial DNA maintenance disorders had neuronopathy in substantia nigra, most severe in DNA polymerase gamma-associated parkinsonism. The oculomotor nucleus was also affected, but less severely. In substantia nigra, all patients had a considerable decrease of respiratory chain complex I, but other respiratory chain enzymes were not affected. Complex I deficiency did not correlate with parkinsonism, age, affected gene or inheritance. We conclude that the cell number in substantia nigra correlated well with parkinsonism in DNA polymerase gamma and Twinkle defects. However, complex I defect is a general consequence of mitochondrial DNA maintenance defects, and does not explain manifestation of parkinsonism or degree of mesencephalic cell death in patients with mitochondrial DNA maintenance disorders.
C1 [Palin, Eino J. H.; Suomalainen, Anu] Univ Helsinki, Res Programs Unit, FIN-00290 Helsinki, Finland.
   [Paetau, Anders] Univ Helsinki, Cent Hosp, Dept Pathol, FIN-00290 Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, FIN-00290 Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; Helsinki University
   Central Hospital; University of Helsinki; Helsinki University Central
   Hospital
RP Palin, EJH (corresponding author), Univ Helsinki, Res Programs Unit, Biomedicum Helsinki, R C518B,POB 63, FIN-00290 Helsinki, Finland.
EM eino.palin@helsinki.fi
OI Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195
FU Finnish Parkinson Foundation; Finnish Foundation for Medicine; Sigrid
   Juselius Foundation; Academy of Finland; University of Helsinki;
   European Research Council
FX The Finnish Parkinson Foundation and Finnish Foundation for Medicine
   (for E. P.), Sigrid Juselius Foundation, Academy of Finland, University
   of Helsinki, European Research Council (for A.S.).
CR Albanese A, 2005, NEUROLOGY, V64, P1958, DOI 10.1212/01.WNL.0000163999.72864.FD
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   BINDOFF LA, 1989, LANCET, V2, P49, DOI 10.1016/S0140-6736(89)90291-2
   Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209
   Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Dekker M, 2003, MOVEMENT DISORD, V18, P751, DOI 10.1002/mds.10422
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283
   Gasser T, 2011, MOVEMENT DISORD, V26, P1042, DOI 10.1002/mds.23637
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Guo JF, 2008, MOVEMENT DISORD, V23, P2074, DOI 10.1002/mds.22156
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   Hague S, 2003, ANN NEUROL, V54, P271, DOI 10.1002/ana.10663
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hornig-Do HT, 2012, EMBO J, V31, P1293, DOI 10.1038/emboj.2011.477
   Ibáñez P, 2006, BRAIN, V129, P686, DOI 10.1093/brain/awl005
   Khan NL, 2003, BRAIN, V126, P1279, DOI 10.1093/brain/awg142
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   KOSKINEN T, 1994, J NEUROL SCI, V121, P50, DOI 10.1016/0022-510X(94)90156-2
   KOSKINEN T, 1994, MUSCLE NERVE, V17, P509, DOI 10.1002/mus.880170507
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   KRIGE D, 1992, ANN NEUROL, V32, P782, DOI 10.1002/ana.410320612
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   LANGSTON JW, 1983, NEW ENGL J MED, V309, P310
   Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X
   Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548
   Lönnqvist T, 1998, J NEUROL SCI, V161, P57, DOI 10.1016/S0022-510X(98)00249-4
   Lücking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mori H, 1998, NEUROLOGY, V51, P890, DOI 10.1212/WNL.51.3.890
   Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Palin EJH, 2012, J NEUROL SCI, V315, P160, DOI 10.1016/j.jns.2011.11.028
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045
   Rantamäki M, 2001, NEUROLOGY, V57, P1043, DOI 10.1212/WNL.57.6.1043
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Saad M, 2011, HUM MOL GENET, V20, P615, DOI 10.1093/hmg/ddq497
   Samaranch L, 2010, BRAIN, V133, P1128, DOI 10.1093/brain/awq051
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Simón-Sánchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Surmeier DJ, 2011, NEUROSCIENCE, V198, P221, DOI 10.1016/j.neuroscience.2011.08.045
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   van de Warrenburg BPC, 2001, NEUROLOGY, V56, P555, DOI 10.1212/WNL.56.4.555
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
NR 61
TC 38
Z9 39
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
J9 BRAIN
JI Brain
PD AUG
PY 2013
VL 136
BP 2379
EP 2392
DI 10.1093/brain/awt160
PN 8
PG 14
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 190KG
UT WOS:000322338000012
PM 23811324
OA Bronze
DA 2024-11-01
ER

PT J
AU Bredenoord, AL
   Dondorp, W
   Pennings, G
   De Die-Smulders, CEM
   De Wert, G
AF Bredenoord, A. L.
   Dondorp, W.
   Pennings, G.
   De Die-Smulders, C. E. M.
   De Wert, G.
TI PGD to reduce reproductive risk: the case of mitochondrial DNA disorders
SO HUMAN REPRODUCTION
LA English
DT Article
DE PGD; mitochondrial DNA; reproductive risk; ethics; genetic disorders
ID PREIMPLANTATION GENETIC DIAGNOSIS; HEREDITARY OPTIC NEUROPATHY;
   ADULT-ONSET CONDITIONS; PRENATAL-DIAGNOSIS; NUCLEOTIDE 8993;
   YOUNG-PEOPLE; TRANSMISSION; MUTATIONS; CHILDREN; ETHICS
AB This paper discusses the pros and cons of introducing PGD for mitochondrial DNA (mtDNA) disorders such as NARP (Neurogenic muscle weakness, Ataxia, Retinis Pigmentosa)/Leigh, MELAS (Mitochondrial myopathy, Encephalopathy, Lactic acidosis, and Stroke-like episodes), private mtDNA mutations and LHON (Leber Hereditary Optic Neuropathy). Although there is little experience with PGD for mtDNA disorders, it is reasonable to assume that in many cases, the best one can achieve is the selection of the 'least' affected embryos for transfer. So instead of 'promising' parents a healthy child, PGD in these cases can only aim at reducing reproductive risk. From an ethical point of view, this raises challenging questions about parental and medical responsibilities. The main argument in favour of PGD is that it offers couples at risk the opportunity of reducing their chances of having a severely affected child. Potential objections are manifold, but we conclude that none of them supplies convincing moral arguments to regard risk-reducing PGD as unacceptable. Nevertheless, introducing this new application of PGD in clinical practice will raise further complex issues of determining conditions for its responsible use.
C1 [Bredenoord, A. L.; Dondorp, W.; De Wert, G.] Maastricht Univ, Hlth Eth & Soc & Res Inst GROW, Maastricht, Netherlands.
   [Pennings, G.] Univ Ghent, Bioeth Inst Ghent, B-9000 Ghent, Belgium.
   [De Die-Smulders, C. E. M.] Univ Hosp Maastricht Clin Genet, Maastricht, Netherlands.
C3 Maastricht University; Ghent University; Maastricht University;
   Maastricht University Medical Centre (MUMC)
RP Bredenoord, AL (corresponding author), Maastricht Univ, Hlth Eth & Soc & Res Inst GROW, Maastricht, Netherlands.
EM a.bredenoord@zw.unimaas.nl
RI Bredenoord, Annelien/AGJ-2217-2022
OI Pennings, Guido/0000-0003-0754-8055
FU European Union [005260]
FX This work was supported by a grant from the European Union sixth
   Research Framework Programme (the MITOCIRCLE project contract no
   005260).
CR Amor DJ, 2008, HUM REPROD, V23, P729, DOI 10.1093/humrep/dem433
   [Anonymous], GUID PREIMPL TEST
   [Anonymous], COCHRANE DATABASE SY
   [Anonymous], 1998, GENETIC TESTING CHIL
   [Anonymous], 2006, PUBL HLTH COUNC NETH
   [Anonymous], 2007, ENHANCING EVOLUTION
   ARRAS JD, 1990, MILBANK Q, V68, P353, DOI 10.2307/3350110
   Benatar D, 2006, HUM REPROD, V21, P2491, DOI 10.1093/humrep/del209
   Bickerstaff H, 2001, Hum Fertil (Camb), V4, P24, DOI 10.1080/1464727012000199221
   Boivin J, 2005, ARCH DIS CHILD, V90, P784, DOI 10.1136/adc.2004.064485
   Borry P, 2006, CLIN GENET, V70, P374, DOI 10.1111/j.1399-0004.2006.00692.x
   Bredenoord AL, 2008, HUM REPROD UPDATE, V14, P83, DOI 10.1093/humupd/dmm037
   Brown DT, 2006, LANCET, V368, P87, DOI 10.1016/S0140-6736(06)68972-1
   Buchanan A., 2000, CHANCE CHOICE GENETI
   BURGESS JA, 1993, J MED ETHICS, V19, P169, DOI 10.1136/jme.19.3.169
   CAVAGHAN C, 2007, DEFENDING GENETIC SU
   Chinnery P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub2
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chinnery PF, 2002, MITOCHONDRION, V2, P149, DOI 10.1016/S1567-7249(02)00046-6
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   CIAFALONI E, 1993, J PEDIATR-US, V122, P419, DOI 10.1016/S0022-3476(05)83431-6
   Dahl H H, 2000, Hum Reprod, V15 Suppl 2, P246
   Dahl HHM, 2001, AM J MED GENET, V106, P1, DOI 10.1002/ajmg.1427
   de Wert G, 2005, HUM REPROD, V20, P3261, DOI 10.1093/humrep/dei222
   de Wert GMWR, 1998, HUM REPROD, V13, P219, DOI 10.1093/humrep/13.suppl_1.219
   de Wert G, 2007, STEM CELLS, V25, P2167, DOI 10.1634/stemcells.2006-0625
   DEWERT G, 1999, THESIS AMSTERDAM
   Duncan RE, 2006, CLIN GENET, V69, P8, DOI 10.1111/j.1399-0004.2005.00505.x
   Duncan RE, 2007, AM J MED GENET A, V143A, P1984, DOI 10.1002/ajmg.a.31720
   Dworkin Ronald., 1993, Life's Dominion: An Argument about Abortion and Euthanasia
   EVERSKIEBOOM G, 2006, TIJDSCHR GENEESKUNDE, V62, P463
   Glover Jonathan., 2006, Choosing Children: Genes, Disability, and Design
   Graff C, 2000, PRENATAL DIAG, V20, P426, DOI 10.1002/(SICI)1097-0223(200005)20:5<426::AID-PD845>3.3.CO;2-B
   Harris J, 2000, HEALTH CARE ANAL, V8, P27, DOI 10.1023/A:1009430326447
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Huoponen K, 2002, ACTA OPHTHALMOL SCAN, V80, P38, DOI 10.1034/j.1600-0420.2002.800108.x
   Jacobs LJAM, 2005, MOL HUM REPROD, V11, P223, DOI 10.1093/molehr/gah152
   LAMB D., 1988, Down the Slippery Slope
   Laurie Graeme T, 1999, Eur J Health Law, V6, P119, DOI 10.1163/15718099920522730
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   McGleenan T, 1995, J MED ETHICS, V21, P350, DOI 10.1136/jme.21.6.350
   Parfit D., 1984, REASONS PERSONS
   Parker Michael, 2005, Hum Fertil (Camb), V8, P13, DOI 10.1080/14647270500050371
   Parker M, 2007, J MED ETHICS, V33, P279, DOI 10.1136/jme.2006.018176
   Pennings G, 1999, HUM REPROD, V14, P1146, DOI 10.1093/humrep/14.5.1146
   Pennings G, 2003, J MED ETHICS, V29, P321, DOI 10.1136/jme.29.6.321
   Pennycook A, 2003, J SOCIOLING, V7, P513, DOI 10.1111/j.1467-9841.2003.00240.x
   Poulton J, 2000, NEUROMUSCULAR DISORD, V10, P484, DOI 10.1016/S0960-8966(00)00130-9
   Rhodes R, 2006, MT SINAI J MED, V73, P609
   Robertson John., 1994, Children of Choice: Freedom and the New Reproductive Technologies
   Robertson S, 2001, BIOETHICS, V15, P26, DOI 10.1111/1467-8519.00210
   Savulescu J, 1999, J MED ETHICS, V25, P121, DOI 10.1136/jme.25.2.121
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Schwartz B., 2004, PARADOX CHOICE WHY M
   Spikings EC, 2006, HUM REPROD UPDATE, V12, P401, DOI 10.1093/humupd/dml011
   SPRUIJT L, 2007, ENCY LIFE SCI, DOI DOI 10.1002/9780470015902.A0005541
   Steffann J, 2007, J MED GENET, V44, P664, DOI 10.1136/jmg.2006.048553
   Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326
   STEINBOCK B, 1994, HASTINGS CENT REP, V24, P15
   Steinbock B, 2007, REPROD BIOMED ONLINE, V15, P38, DOI 10.1016/S1472-6483(10)60548-2
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380
   van der Burg W, 1992, J Clin Ethics, V3, P256
   White SL, 1999, PRENATAL DIAG, V19, P1165, DOI 10.1002/(SICI)1097-0223(199912)19:12<1165::AID-PD719>3.3.CO;2-4
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
NR 68
TC 32
Z9 33
U1 0
U2 12
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
EI 1460-2350
J9 HUM REPROD
JI Hum. Reprod.
PD NOV
PY 2008
VL 23
IS 11
BP 2392
EP 2401
DI 10.1093/humrep/den290
PG 10
WC Obstetrics & Gynecology; Reproductive Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Obstetrics & Gynecology; Reproductive Biology
GA 361QT
UT WOS:000260142900001
PM 18664474
OA Green Published
DA 2024-11-01
ER

PT J
AU Duvezin-Caubet, S
   Jagasia, R
   Wagener, J
   Hofmann, S
   Trifunovic, A
   Hansson, A
   Chomyn, A
   Bauer, MF
   Attardi, G
   Larsson, NG
   Neupert, W
   Reichert, AS
AF Duvezin-Caubet, Stephane
   Jagasia, Ravi
   Wagener, Johannes
   Hofmann, Sabine
   Trifunovic, Aleksandra
   Hansson, Anna
   Chomyn, Anne
   Bauer, Matthias F.
   Attardi, Giuseppe
   Larsson, Nils-Goeran
   Neupert, Walter
   Reichert, Andreas S.
TI Proteolytic processing of OPA1 links mitochondrial dysfunction to
   alterations in mitochondrial morphology
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID DYNAMIN-RELATED PROTEIN; DOMINANT OPTIC ATROPHY; CYTOCHROME-C;
   HUMAN-CELLS; FUSION; APOPTOSIS; MEMBRANE; DNA; FISSION; GTPASE
AB Many muscular and neurological disorders are associated with mitochondrial dysfunction and are often accompanied by changes in mitochondrial morphology. Mutations in the gene encoding OPA1, a protein required for fusion of mitochondria, are associated with hereditary autosomal dominant optic atrophy type I. Here we show that mitochondrial fragmentation correlates with processing of large isoforms of OPA1 in cybrid cells from a patient with myoclonus epilepsy and ragged-red fibers syndrome and in mouse embryonic fibroblasts harboring an error-prone mitochondrial mtDNA polymerase gamma. Furthermore, processed OPA1 was observed in heart tissue derived from heart-specific TFAM knock-out mice suffering from mitochondrial cardiomyopathy and in skeletal muscles from patients suffering from mitochondrial myopathies such as myopathy encephalopathy lactic acidosis and stroke-like episodes. Dissipation of the mitochondrial membrane potential leads to fast induction of proteolytic processing of OPA1 and concomitant fragmentation of mitochondria. Recovery of mitochondrial fusion depended on protein synthesis and was accompanied by resynthesis of large isoforms of OPA1. Fragmentation of mitochondria was prevented by overexpressing OPA1. Taken together, our data indicate that proteolytic processing of OPA1 has a key role in inducing fragmentation of energetically compromised mitochondria. We present the hypothesis that this pathway regulates mitochondrial morphology and serves as an early response to prevent fusion of dysfunctional mitochondria with the functional mitochondrial network.
C1 Univ Munich, Adolf Butenandt Inst Physiol Chem, D-81377 Munich, Germany.
   GSF, Inst Dev Genet, Natl Res Ctr Environm & Hlth, D-85764 Munich, Germany.
   Karolinska Inst, Dept Lab Med, Div Metrol Dis, Novum, S-14186 Huddinge, Sweden.
   CALTECH, Div Biol, Pasadena, CA 91125 USA.
   Acad Hosp, Diabet Res Inst, D-80804 Munich, Germany.
   Acad Hosp, Inst Clin Chem Mol Diagnost & Mitochondrial Genet, D-80804 Munich, Germany.
C3 University of Munich; University of Munich; Helmholtz Association;
   Helmholtz-Center Munich - German Research Center for Environmental
   Health; Karolinska Institutet; California Institute of Technology
RP Reichert, AS (corresponding author), Univ Munich, Adolf Butenandt Inst Physiol Chem, Butenandtstr 5, D-81377 Munich, Germany.
EM Andreas.Reichert@med.uni-muenchen.de
RI Trifunovic, Aleksandra/HHZ-1296-2022; Wagener, Johannes/K-5904-2012;
   Reichert, Andreas/A-4090-2012
OI Larsson, Nils-Goran/0000-0001-5100-996X; Trifunovic,
   Aleksandra/0000-0002-5472-3517; Wagener, Johannes/0000-0002-5952-9422;
   Reichert, Andreas/0000-0001-9340-3113; Duvezin-Caubet,
   Stephane/0000-0002-0243-2697
CR Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200
   Bauer MF, 1999, J MOL BIOL, V289, P69, DOI 10.1006/jmbi.1999.2751
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602
   FISCHER JC, 1986, EUR J PEDIATR, V144, P441, DOI 10.1007/BF00441735
   Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7
   Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200
   Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100
   Herlan M, 2004, J CELL BIOL, V165, P167, DOI 10.1083/jcb.200403022
   Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200
   Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0
   Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184
   Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316
   Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124
   Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294
   Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.e02-06-0330
   Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003
   Lyamzaev KG, 2004, BIOCHEM SOC T, V32, P1070, DOI 10.1042/BST0321070
   Malka F, 2005, EMBO REP, V6, P853, DOI 10.1038/sj.embor.7400488
   Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612
   Meeusen SL, 2005, CURR OPIN CELL BIOL, V17, P389, DOI 10.1016/j.ceb.2005.06.014
   Modica-Napolitano JS, 2004, MITOCHONDRION, V4, P755, DOI 10.1016/j.mito.2004.07.027
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087
   Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233
   Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   Orth M, 2001, AM J MED GENET, V106, P27, DOI 10.1002/ajmg.1425
   Priault M, 2005, CELL DEATH DIFFER, V12, P1613, DOI 10.1038/sj.cdd.4401697
   Satoh M, 2003, BIOCHEM BIOPH RES CO, V300, P482, DOI 10.1016/S0006-291X(02)02874-7
   Sesaki H, 2003, BIOCHEM BIOPH RES CO, V308, P276, DOI 10.1016/S0006-291X(03)01348-2
   Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788
   Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277
   Skulachev VP, 2004, MOL CELL BIOCHEM, V256, P341, DOI 10.1023/B:MCBI.0000009880.94044.49
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wong ED, 2003, J CELL BIOL, V160, P303, DOI 10.1083/jcb.200209015
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 48
TC 351
Z9 397
U1 0
U2 12
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD DEC 8
PY 2006
VL 281
IS 49
BP 37972
EP 37979
DI 10.1074/jbc.M606059200
PG 8
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 111TH
UT WOS:000242477100076
PM 17003040
OA Green Accepted, hybrid
DA 2024-11-01
ER

PT S
AU Bai, RK
   Perng, CL
   Hsu, CH
   Wong, LJC
AF Bai, RK
   Perng, CL
   Hsu, CH
   Wong, LJC
BE Lee, HK
   DiMauro, S
   Tanaka, M
   Wei, YH
TI Quantitative PCR analysis of mitochondrial DNA content in patients with
   mitochondrial disease
SO MITOCHONDRIAL PATHOGENESIS: FROM GENES AND APOPTOSIS TO AGING AND
   DISEASE
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT 1st Scientific Meeting of the
   Asian-Society-for-Mitochondrial-Research-and-Medicine
CY FEB 05-06, 2003
CL Seoul, SOUTH KOREA
SP Asian Soc Mitochondrial Res & Med, Bukwang Pharmaceut, Dalim Pharmaceut, Mitocon Inc
DE mtDNA depletion; quantitative analysis of mtDNA; real-time PCR analysis;
   mitochondrial DNA copy number
AB Molecular diagnosis of mitochondrial DNA disorder is usually focused on point mutations and large deletions. In the absence of detectable mtDNA mutations, abnormal amounts of mtDNA, either depletion or elevation, can be indicative of mitochondrial dysfunction. The amount of mitochondrial DNA (mtDNA), however, varies among individuals of different ages and among different tissues within the same individual. To establish a range of mtDNA levels, we analyzed 300 muscle and 200 blood specimens from patients suspected of having a mitochondrial disorder by real-time quantitative polymerase chain reaction (PCR) method. Copy numbers were calculated from the standard curve and threshold cycle number using TaqMan probes; 6FAM 5'TTACCGGGCTCTGCCATCT3'-TAMRA and VIC-5'AGCAATAACAGGTCTGTGATG3'-TAMRA for mtDNA and 18S rRNA gene (nDNA), respectively. The copy number ratio of mtDNA to nDNA was used as a measure of mtDNA content in each specimen. The mtDNA content in muscle increases steadily from birth to about 5 years of age; thereafter, it stays about the same. On the contrary, the mtDNA content in blood decreases with age. The amount of mtDNA in skeletal muscle is about 5-20 times higher than that in blood. About 7% of patients had mtDNA levels in muscle below 20% of the mean of the age-matched group, and about 10% of patients had muscle mtDNA levels 2- to 16-fold higher than the mean of the age-matched group. Patients with abnormal levels of mtDNA, either depletion or proliferation, had significant clinical manifestations characteristic of mitochondrial disease in addition to abnormal respiratory enzymes and mitochondrial cytopathies. Cardiomyopathy, lactic acidosis, abnormal brain NW findings, hypotonia, developmental delay, seizures, and failure to thrive are general clinical pictures of patients with mtDNA depletion. The average age of patients with mtDNA depletion is 4.1 years, compared to 23.6 years in patients with mtDNA proliferation. Mutations in nuclear genes involved in mtDNA synthesis and deoxynucleotide pools are probably the cause off mtDNA depletion. Our results demonstrate that real time quantitative PCR is a valuable tool for molecular screening of mitochondrial diseases.
RP Georgetown Univ, Med Ctr, Inst Mol & Human Genet, M4000,3800 Reservoir Rd,NW, Washington, DC 20007 USA.
EM wonglj@georgetown.edu
CR Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444
   Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Wong LC, 2002, AM J HUM GENET, V71, P501
   Wong LJC, 1997, CLIN CHEM, V43, P1241
   Wong LJC, 2002, CLIN CHEM, V48, P1901
   Wong LJC, 2001, GENET MED, V3, P399, DOI 10.1097/00125817-200111000-00004
NR 9
TC 110
Z9 129
U1 0
U2 13
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-491-9; 1-57331-490-0
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2004
VL 1011
BP 304
EP 309
DI 10.1196/annals.1293.029
PG 6
WC Biochemistry & Molecular Biology; Multidisciplinary Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Science & Technology - Other Topics
GA BAE70
UT WOS:000221896100029
PM 15126306
DA 2024-11-01
ER

PT J
AU Choi, BO
   Hwang, JH
   Kim, J
   Cho, EM
   Cho, SY
   Hwang, SJ
   Lee, HW
   Kim, SJ
   Chung, KW
AF Choi, Byung-Ok
   Hwang, Jung Hee
   Kim, Joonki
   Cho, Eun Min
   Cho, Sun Young
   Hwang, Su Jin
   Lee, Hyang Woon
   Kim, Song Ja
   Chung, Ki Wha
TI A MELAS syndrome family harboring two mutations in mitochondrial genome
SO EXPERIMENTAL AND MOLECULAR MEDICINE
LA English
DT Article
DE Asian continental ancestry group; cataract; cytochrome-c oxidase
   deficiency; DNA, mitochondrial; Korea; MELAS syndrome; mutation,
   missense; ND5 protein, human
ID HEREDITARY OPTIC NEUROPATHY; LACTIC-ACIDOSIS; EPISODES MELAS; MTDNA;
   GENE; DNA; ENCEPHALOPATHY; MYOPATHY; SEQUENCE; IDENTIFICATION
AB Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is a genetically heterogeneous mitochondrial disorder with variable clinical symptoms. Here, from the sequencing of the entire mitochondrial genome, we report a Korean MELAS family harboring two homoplasmic missense mutations, which were reported 9957T > C (Phe251Leu) transition mutation in the cytochrome c oxidase subunit 3 (COX3) gene and a novel 13849A > C (Asn505His) transversion mutation in the NADH dehydrogenase subunit 5 (ND5) gene. Neither of these mutations was found in 205 normal controls. Both mutations were identified from the proband and his mother, but not his father. The patients showed cataract symptom in addition to MELAS phenotype. We believe that the 9957T > C mutation is pathogenic, however, the 13849A > C mutation is of unclear significance. It is likely that the 13849A > C mutation might function as the secondary mutation which increase the expressivity of overlapping phenotypes of MELAS and cataract. This study also demonstrates the importance of full sequencing of mtDNA for the molecular genetic understanding of mitochondrial disorders.
C1 [Hwang, Jung Hee; Kim, Joonki; Cho, Eun Min; Kim, Song Ja; Chung, Ki Wha] Kongju Natl Univ, Dept Biol Sci, Kong Ju 314701, South Korea.
   [Choi, Byung-Ok; Cho, Sun Young; Hwang, Su Jin; Lee, Hyang Woon] Ewha Womans Univ, Sch Med, Dept Neurol, Seoul 110783, South Korea.
   [Choi, Byung-Ok; Cho, Sun Young; Hwang, Su Jin; Lee, Hyang Woon] Ewha Womans Univ, Sch Med, Ewha Med Res Ctr, Seoul 110783, South Korea.
C3 Kongju National University; Ewha Womans University; Ewha Womans
   University
RP Chung, KW (corresponding author), Kongju Natl Univ, Dept Biol Sci, Kong Ju 314701, South Korea.
EM kwchung@kongju.ac.kr
RI Cho, Sun Young/H-8599-2013
CR Abu-Amero Khaled K, 2005, Ophthalmic Genet, V26, P31, DOI 10.1080/13816810590918235
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Brown MD, 1997, AM J HUM GENET, V60, P381
   Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236
   Crimi M, 2003, NEUROLOGY, V60, P1857, DOI 10.1212/01.WNL.0000066048.72780.69
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835
   Isashiki Y, 1998, ACTA OPHTHALMOL SCAN, V76, P6, DOI 10.1034/j.1600-0420.1998.760103.x
   Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996
   Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130
   Kong QP, 2003, HUM GENET, V113, P391, DOI 10.1007/s00439-003-1004-7
   LERTRIT P, 1992, AM J HUM GENET, V51, P457
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O
   MONTAGNA P, 1988, NEUROLOGY, V38, P751, DOI 10.1212/WNL.38.5.751
   MORTEN KJ, 1993, HUM MOL GENET, V2, P2081, DOI 10.1093/hmg/2.12.2081
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665
   Ronghua L, 2006, GENE, V376, P79, DOI 10.1016/j.gene.2006.02.014
   SAKUTA R, 1993, AM J HUM GENET, V53, P964
   Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   SWEENEY MG, 1993, Q J MED, V86, P709
   Torroni A, 1997, AM J HUM GENET, V60, P1107
   Tzen CY, 2003, MUSCLE NERVE, V28, P575, DOI 10.1002/mus.10473
   Valentino ML, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037507
NR 29
TC 14
Z9 17
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1226-3613
EI 2092-6413
J9 EXP MOL MED
JI Exp. Mol. Med.
PD JUN 30
PY 2008
VL 40
IS 3
BP 354
EP 360
DI 10.3858/emm.2008.40.3.354
PG 7
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Research & Experimental Medicine
GA 322FO
UT WOS:000257360800012
PM 18587274
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Gkiourtzis, N
   Tramma, D
   Papadopoulou-Legbelou, K
   Moutafi, M
   Evangeliou, A
AF Gkiourtzis, Nikolaos
   Tramma, Despoina
   Papadopoulou-Legbelou, Kyriaki
   Moutafi, Maria
   Evangeliou, Athanasios
TI Α rare case of myopathy, lactic acidosis, and severe rhabdomyolysis, due
   to a homozygous mutation of the ferredoxin-2 (<i>FDX2</i>) gene
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE children; FDX2; ferredoxin; lactic acidosis; mitochondrial myopathy;
   rhabdomyolysis
ID CLUSTER
AB Mitochondrial myopathy is a severe metabolic myopathy related to nuclear or mitochondrial DNA dysfunction. We present a rare case of mitochondrial myopathy, presented with multiple episodes of proximal muscle weakness, lactic acidosis, and severe rhabdomyolysis (CPK 319,990 U/L, lactic acid 22.31 mmol/L, and GFR 3.82 mL/min/1.73m(2)). She was hospitalized in the pediatric intensive care unit due to acute kidney injury, elevated blood pressure, and deterioration of respiratory and cardiac function. Investigation for inherited metabolic disorders showed elevated levels of ammonia, lactic acid to pyruvic acid ratio, and urine ketone bodies. Exome sequencing detected a homozygous pathogenic variant in FDX2 (ENST00000541276:p.Met4Leu/c.10A > T) and a heterozygous variant of uncertain significance in MSTO1 (ENST00000538143:p.Leu137Pro/c.410 T > C). After Sanger sequencing, the p.Met4Leu pathogenic variant in FDX2 (ENST00000541276:p.Met4Leu/c.10A > T) was identified in a heterozygous state in both her parents and sister. Recently, pathogenic variants in the FDX2 gene have been associated with mitochondrial myopathy, lactic acidosis, optic atrophy, and leukoencephalopathy. Only four reports of FDX2-related rhabdomyolysis have been described before, but none of the previous patients had hyperammonemia. This is a rare case of severe mitochondrial myopathy in a pediatric patient related to a pathogenic FDX2 variant, suggesting the need for genetic analysis of the FDX2 gene in cases of suspicion of mitochondrial myopathies.
C1 [Gkiourtzis, Nikolaos; Tramma, Despoina; Papadopoulou-Legbelou, Kyriaki; Moutafi, Maria; Evangeliou, Athanasios] Aristotle Univ Thessaloniki, Papageorgiou Gen Hosp, Dept Pediat 4, Thessaloniki, Greece.
   [Gkiourtzis, Nikolaos] Aristotle Univ Thessaloniki, Papageorgiou Gen Hosp, Sch Med, Dept Pediat 4, Thessaloniki, Greece.
C3 Papageorgiou Hospital; Aristotle University of Thessaloniki;
   Papageorgiou Hospital; Aristotle University of Thessaloniki
RP Gkiourtzis, N (corresponding author), Aristotle Univ Thessaloniki, Papageorgiou Gen Hosp, Sch Med, Dept Pediat 4, Thessaloniki, Greece.
EM gkiourtzisnikolaos@gmail.com
RI Evangeliou, Athanasios/LIG-8519-2024; Gkiourtzis, Nikolaos/JFS-0070-2023
OI Gkiourtzis, Nikolaos/0000-0001-8348-8520
CR Aggarwal A, 2022, AM J MED GENET A, V188, P1239, DOI 10.1002/ajmg.a.62608
   Cai K, 2017, BIOCHEMISTRY-US, V56, P487, DOI 10.1021/acs.biochem.6b00447
   Gurgel-Giannetti J, 2018, BRAIN, V141, P2289, DOI 10.1093/brain/awy172
   Lebigot E, 2017, MOL GENET METAB, V122, P85, DOI 10.1016/j.ymgme.2017.08.001
   Lehmann Diana, 2018, J. inborn errors metab. screen., V6, P170017
   Li K, 2020, EUR J MED GENET, V63, DOI 10.1016/j.ejmg.2019.01.013
   Liu LQ, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.947886
   Montealegre S, 2022, NEUROL-GENET, V8, DOI 10.1212/NXG.0000000000000648
   Nance JR, 2015, MUSCLE NERVE, V51, P793, DOI 10.1002/mus.24606
   Nasca A, 2017, HUM MUTAT, V38, P970, DOI 10.1002/humu.23262
   Parikh S, 2017, GENET MED, V19, DOI 10.1038/gim.2017.107
   Perez-Albert Paula, 2018, JIMD Rep, V42, P61, DOI 10.1007/8904_2017_78
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   Scalco RS, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0264-3
   Sheftel AD, 2010, P NATL ACAD SCI USA, V107, P11775, DOI 10.1073/pnas.1004250107
   Spiegel R, 2014, EUR J HUM GENET, V22, P902, DOI 10.1038/ejhg.2013.269
NR 16
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD DEC
PY 2023
VL 191
IS 12
BP 2843
EP 2849
DI 10.1002/ajmg.a.63368
EA AUG 2023
PG 7
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA Y4CT2
UT WOS:001045109100001
PM 37565517
OA Bronze
DA 2024-11-01
ER

PT J
AU Viscomi, C
   Zeviani, M
AF Viscomi, C.
   Zeviani, M.
TI Strategies for fighting mitochondrial diseases
SO JOURNAL OF INTERNAL MEDICINE
LA English
DT Review
DE AAV; antioxidants; autophagy; experimental therapy; mitochondrial
   biogenesis; mitochondrial disease
ID GENE-THERAPY; MOUSE MODEL; RESPIRATORY-CHAIN; LIVER-TRANSPLANTATION;
   CONSENSUS STATEMENT; SKELETAL-MUSCLE; DNA; EXPRESSION; MYOPATHY;
   DEFICIENCY
AB Mitochondrial diseases are extremely heterogeneous genetic conditions characterized by faulty oxidative phosphorylation (OXPHOS). OXPHOS deficiency can be the result of mutation in mtDNA genes, encoding either proteins (13 subunits of the mitochondrial complexes I, III, IV and V) or the tRNA and rRNA components of the in situ mtDNA translation. The remaining mitochondrial disease genes are in the nucleus, encoding proteins with a huge variety of functions, from structural subunits of the mitochondrial complexes, to factors involved in their formation and regulation, components of the mtDNA replication and expression machinery, biosynthetic enzymes for the biosynthesis or incorporation of prosthetic groups, components of the mitochondrial quality control and proteostasis, enzymes involved in the clearance of toxic compounds, factors involved in the formation of the lipid milieu, etc. These different functions represent potential targets for 'general' therapeutic interventions, as they may be adapted to a number of different mitochondrial conditions. This is in contrast with 'tailored', personalized therapeutic approaches, such as gene therapy, cell therapy and organ replacement, that can be useful only for individual conditions. This review will present the most recent concepts emerged from preclinical work and the attempts to translate them into the clinics. The common notion that mitochondrial disorders have no cure is currently challenged by a massive effort of scientists and clinicians, and we do expect that thanks to this intensive investigation work and tangible results for the development of strategies amenable to the treatment of patients with these tremendously difficult conditions are not so far away.
C1 [Viscomi, C.] Univ Padua, Dept Biomed Sci, Padua, Italy.
   [Zeviani, M.] Univ Padua, Dept Neurosci, Padua, Italy.
   [Zeviani, M.] Venetian Inst Mol Med, Padua, Italy.
C3 University of Padua; University of Padua; Veneto Institute Molecular
   Medicine
RP Zeviani, M (corresponding author), Univ Padua, Dept Neurosci, Padua, Italy.; Zeviani, M (corresponding author), Venetian Inst Mol Med, Padua, Italy.
EM massimo.zeviani@unipd.it
RI Zeviani, Massimo/AAU-2632-2021; viscomi, Carlo/R-1940-2016
OI Zeviani, Massimo/0000-0002-9067-5508; Viscomi, Carlo/0000-0001-6050-0566
FU MRC [MC_UU_00015/5]; Telethon [GGP19007]; MRC [MC_UU_00015/5] Funding
   Source: UKRI
FX Our work is supported by the MRC (MC_UU_00015/5) and Telethon
   (GGP19007).
CR Abu-Libdeh B, 2017, EUR J HUM GENET, V25, P1142, DOI 10.1038/ejhg.2017.112
   Ahola S, 2016, EMBO MOL MED, V8, P1234, DOI 10.15252/emmm.201606592
   Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Alcázar-Fabra M, 2018, ESSAYS BIOCHEM, V62, P377, DOI 10.1042/EBC20170107
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Awad AM, 2018, ESSAYS BIOCHEM, V62, P361, DOI 10.1042/EBC20170106
   Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Barriocanal-Casado E, 2019, EBIOMEDICINE, V42, P511, DOI 10.1016/j.ebiom.2019.03.025
   Beyrath J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24900-3
   Blázquez-Bermejo C, 2019, EBIOMEDICINE, V46, P342, DOI 10.1016/j.ebiom.2019.07.042
   Bottani E, 2014, MOL THER, V22, P10, DOI 10.1038/mt.2013.230
   Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Bulst S, 2012, MOL GENET METAB, V107, P95, DOI 10.1016/j.ymgme.2012.04.022
   Byrnes J, 2018, NEUROCHEM INT, V117, P23, DOI 10.1016/j.neuint.2017.07.008
   Cámara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Carelli V, 2017, J NEURO-OPHTHALMOL, V37, P371, DOI 10.1097/WNO.0000000000000570
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Chae S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003266
   Chan KY, 2017, NAT NEUROSCI, V20, P1172, DOI 10.1038/nn.4593
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Civiletto G, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708799
   Civiletto G, 2015, CELL METAB, V21, P845, DOI 10.1016/j.cmet.2015.04.016
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Costa AL, 2014, HUM MOL GENET, V23, P2106, DOI 10.1093/hmg/ddt603
   Dassa EP, 2009, EMBO MOL MED, V1, P30, DOI 10.1002/emmm.200900001
   De Giorgio R, 2016, ANN NEUROL, V80, P448, DOI 10.1002/ana.24724
   de Haas R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09417-5
   Di Meo I, 2017, GENE THER, V24, P661, DOI 10.1038/gt.2017.53
   Di Meo I, 2015, EMBO MOL MED, V7, P1257, DOI 10.15252/emmm.201505040
   Di Meo I, 2012, EMBO MOL MED, V4, P1008, DOI 10.1002/emmm.201201433
   Dillon LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044335
   Dionisi-Vici C, 2016, BRAIN, V139, P1045, DOI 10.1093/brain/aww013
   Dogan SA, 2018, CELL METAB, V28, P764, DOI 10.1016/j.cmet.2018.07.012
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   El-Khoury R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003182
   Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004
   Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917
   Ferrari M, 2017, P NATL ACAD SCI USA, V114, pE4241, DOI 10.1073/pnas.1621511114
   Finsterer J, 2018, OPHTHALMOLOGY, V125, pE14, DOI 10.1016/j.ophtha.2017.08.040
   Frambach SJCM, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165727
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001
   Gammage PA, 2016, METHODS MOL BIOL, V1351, P145, DOI 10.1007/978-1-4939-3040-1_11
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Geffroy G, 2018, BBA-MOL BASIS DIS, V1864, P1596, DOI 10.1016/j.bbadis.2018.02.005
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guy J, 2017, OPHTHALMOLOGY, V124, P1621, DOI 10.1016/j.ophtha.2017.05.016
   Herebian D, 2017, ANN CLIN TRANSL NEUR, V4, P902, DOI 10.1002/acn3.486
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Hordeaux J, 2019, MOL THER, V27, P912, DOI 10.1016/j.ymthe.2019.02.013
   Hyslop LA, 2016, NATURE, V534, P383, DOI [10.1038/nature183030, 10.1038/nature18303]
   Jain IH, 2019, CELL METAB, V30, P824, DOI 10.1016/j.cmet.2019.07.006
   Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642
   Janssen MCH, 2019, CLIN PHARMACOL THER, V105, P101, DOI 10.1002/cpt.1197
   Jardim FR, 2018, MOL NEUROBIOL, V55, P2085, DOI 10.1007/s12035-017-0448-z
   Johnson SC, 2019, KIDNEY INT, V95, P455, DOI 10.1016/j.kint.2018.08.038
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Kallijärvi J, 2019, EBIOMEDICINE, V42, P30, DOI 10.1016/j.ebiom.2019.03.079
   Karaa A, 2018, NEUROLOGY, V90, pE1212, DOI 10.1212/WNL.0000000000005255
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Koene S., 2017, ORPHANET J RARE DIS, V12
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   López LC, 2014, MOL SYNDROMOL, V5, P163, DOI 10.1159/000360494
   Lopez MJA, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3904905
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Lynch DR, 2019, ANN CLIN TRANSL NEUR, V6, P15, DOI 10.1002/acn3.660
   Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198
   Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Peng M, 2015, HUM MOL GENET, V24, P4829, DOI 10.1093/hmg/ddv207
   Perales-Clemente E, 2008, P NATL ACAD SCI USA, V105, P18735, DOI 10.1073/pnas.0810518105
   Polyak E, 2018, MOL GENET METAB, V123, P449, DOI 10.1016/j.ymgme.2018.02.013
   Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109
   Potgieter M, 2013, NUTR REV, V71, P180, DOI 10.1111/nure.12011
   Raimundo N, 2014, TRENDS MOL MED, V20, P282, DOI 10.1016/j.molmed.2014.01.005
   Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027
   Rajendran J, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809456
   Rocha AG, 2018, SCIENCE, V360, P336, DOI 10.1126/science.aao1785
   Roe CR, 2002, J CLIN INVEST, V110, P259, DOI [10.1172/JCI0215311, 10.1172/JCI200215311]
   ROTIG A, 1989, LANCET, V1, P902
   Saada Ann, 2009, Biochem J, V422, pe3, DOI 10.1042/BJ20091194
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Sage-Schwaede A, 2019, ANN CLIN TRANSL NEUR, V6, P1877, DOI 10.1002/acn3.50846
   Samanta D, 2017, REDOX BIOL, V13, P331, DOI 10.1016/j.redox.2017.05.022
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Sanz A, 2010, P NATL ACAD SCI USA, V107, P9105, DOI 10.1073/pnas.0911539107
   Sarzi E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20838-8
   Sasaki K, 2017, TRANSPL P, V49, P1097, DOI 10.1016/j.transproceed.2017.03.065
   Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.02.004, 10.1016/j.cell.2017.03.035]
   Scarpelli M, 2017, APPL CLIN GENET, V10, P21, DOI 10.2147/TACG.S94267
   Schiff M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028823
   Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Szeto HH, 2014, CLIN PHARMACOL THER, V96, P672, DOI 10.1038/clpt.2014.174
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tarnopolsky MA, 2014, J CHILD NEUROL, V29, P1225, DOI 10.1177/0883073814538512
   Torres-Torronteras J, 2018, HUM GENE THER, V29, P708, DOI 10.1089/hum.2017.133
   Varanita T, 2015, CELL METAB, V21, P834, DOI 10.1016/j.cmet.2015.05.007
   Viscomi C, 2019, CELL METAB, V30, P628, DOI 10.1016/j.cmet.2019.09.004
   Viscomi C, 2015, BBA-BIOENERGETICS, V1847, P544, DOI 10.1016/j.bbabio.2015.03.001
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Voet NBM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003907.pub4
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wan X, 2016, SCI REP-UK, V6, DOI 10.1038/srep21587
   Wang A, 2016, ONCOTARGET, V7, P80131, DOI 10.18632/oncotarget.12560
   WATMOUGH NJ, 1990, J CLIN INVEST, V85, P177, DOI 10.1172/JCI114409
   Yang Y, 2018, PROTEIN CELL, V9, P283, DOI 10.1007/s13238-017-0499-y
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
   Zhang XD, 2016, ELIFE, V5, DOI 10.7754/eLife.13374
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 120
TC 42
Z9 46
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0954-6820
EI 1365-2796
J9 J INTERN MED
JI J. Intern. Med.
PD JUN
PY 2020
VL 287
IS 6
BP 665
EP 684
DI 10.1111/joim.13046
EA APR 2020
PG 20
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA LS6JN
UT WOS:000526016300001
PM 32100338
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Virgilio, R
   Ronchi, D
   Bordoni, A
   Fassone, E
   Bonato, S
   Donadoni, C
   Torgano, G
   Moggio, M
   Corti, S
   Bresolin, N
   Comi, GP
AF Virgilio, Roberta
   Ronchi, Dario
   Bordoni, Andreina
   Fassone, Elisa
   Bonato, Sara
   Donadoni, Chiara
   Torgano, Giuseppe
   Moggio, Maurizio
   Corti, Stefania
   Bresolin, Nereo
   Comi, Giacomo P.
TI Mitochondrial DNA G8363A mutation in the tRNA<SUP>Lys</SUP> gene:
   Clinical, biochemical and pathological study
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Mitochondrial encephalomyopathy; Mitochondrial DNA tRNA(Lys) gene
ID RAGGED-RED FIBERS; MYOCLONUS EPILEPSY; LEIGH-SYNDROME; DEFICIENCY;
   CHILDREN
AB The G8363A is a very rare mtDNA tRNA(Lys) gene mutation that has been associated to MERRF-Iike syndrome, cardiomyopathy or Leigh syndrome. Here, we describe the clinical and molecular features of a new large multigenerational family and we review the literature of cases with this mutation.
   In our family seven members presented a heterogeneous mitochondrial disease phenotype, from MERRF-Iike syndrome to isolated psychiatric disorder, associated with the G8363A mutation. The two probands are dizygotic twin sisters affected by mental retardation, neural deafness, myopathy, myoclonic epilepsy and ataxia. Twins' muscle biopsies showed a severe cytochrorne coxidase (COX) deficiency and ragged-red fibers. Their mitochondrial respiratory chain was defective in complexes I and IV in muscle. A severe reduction in complex IV activity was also observed in fibroblasts and myoblasts. Molecular analysis showed a G8363A transition in the mtDNA tRNA(Lys) gene. The Mutation was almost homoplasmic (>90%) in muscle and blood of the twins and heteroplasmic (55 +/- 8%) in blood sample from affected material relatives. Based on our family data and the meta-analysis of the literature, we confirm that mutational load directly correlates with severity of the disease (severe vs mild/moderate phenotype; P = 0.00168) and with disease onset (P<0.00001). However the presence of several exceptions and overlaps among patients with different clinical severity limits the clinical usefulness of this observation.
   Although the pathogenicity of the G8363A Mutation is well established, counselling is a difficult task for clinicians because of the large phenotypical variability. Our Study contributes further data on the clinical spectrum and its relation with the level of G8363A tRNA(Lys) mtDNA mutation. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Virgilio, Roberta; Ronchi, Dario; Bordoni, Andreina; Fassone, Elisa; Donadoni, Chiara; Torgano, Giuseppe; Moggio, Maurizio; Corti, Stefania; Bresolin, Nereo; Comi, Giacomo P.] Univ Milan, Dept Neurol Sci, Dino Ferrari Ctr, IRCCS Fdn Osped Maggiore Policlin Mangiagalli & R, I-20122 Milan, Italy.
   [Corti, Stefania; Bresolin, Nereo; Comi, Giacomo P.] Univ Milan, Ctr Excellence Neurodegenerat Dis, Milan, Italy.
   [Bonato, Sara; Bresolin, Nereo] IRCCS Eugenio Medea, Lecce, Italy.
   [Torgano, Giuseppe] IRCCS Fdn Osped Maggiore Policlin Mangiagalli & R, Emergency Dept, Milan, Italy.
C3 IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan;
   University of Milan; IRCCS Eugenio Medea; IRCCS Ca Granda Ospedale
   Maggiore Policlinico
RP Comi, GP (corresponding author), Univ Milan, Dept Neurol Sci, Dino Ferrari Ctr, IRCCS Fdn Osped Maggiore Policlin Mangiagalli & R, Via Francesco Sforza 35, I-20122 Milan, Italy.
EM giacomo.comi@unimi.it
RI Comi, Giacomo/K-5702-2016; bonato, sara/K-8721-2013; Ronchi,
   Dario/K-8011-2016; corti, stefania/K-6034-2016
OI Bresolin, Nereo/0000-0001-6694-3595; Comi, Giacomo/0000-0002-1383-5248;
   Ronchi, Dario/0000-0002-6093-9816; corti, stefania/0000-0001-5425-969X
FU Telethon [GTB07001] Funding Source: Medline
CR Arenas J, 1999, NEUROLOGY, V52, P377, DOI 10.1212/WNL.52.2.377
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   D'Amati G, 1999, Pathologica, V91, P49
   Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601
   HECKMATT JZ, 1984, MUSCLE NERVE, V7, P594
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Pineda M, 2004, REV NEUROLOGIA, V38, P1023, DOI 10.33588/rn.3811.2004019
   Prelle A, 2002, J NEUROL, V249, P305, DOI 10.1007/s004150200010
   Pronicki M, 2007, FOLIA NEUROPATHOL, V45, P187
   Salani S, 2004, MUSCLE NERVE, V30, P366, DOI 10.1002/mus.20106
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Shtilbans A, 2000, J CHILD NEUROL, V15, P759, DOI 10.1177/088307380001501109
   Sissler M, 2004, RNA, V10, P841, DOI 10.1261/rna.5267604
   ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118
   Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd
NR 19
TC 31
Z9 33
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD JUN 15
PY 2009
VL 281
IS 1-2
BP 85
EP 92
DI 10.1016/j.jns.2009.01.025
PG 8
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 455DI
UT WOS:000266736800019
PM 19278689
DA 2024-11-01
ER

PT J
AU Villarroya, J
   Lara, MC
   Dorado, B
   Garrido, M
   García-Arumí, E
   Meseguer, A
   Hirano, M
   Vilà, MR
AF Villarroya, Joan
   Lara, Mari-Carmen
   Dorado, Beatriz
   Garrido, Marta
   Garcia-Arumi, Elena
   Meseguer, Anna
   Hirano, Michio
   Vila, Maya R.
TI Targeted impairment of thymidine kinase 2 expression in cells induces
   mitochondrial DNA depletion and reveals molecular mechanisms of
   compensation of mitochondrial respiratory activity
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Mitochondrial DNA; siRNA; Thymidine kinase 2; Mitochondrial depletion
   syndrome; Respiratory chaia
ID HUMAN-EQUILIBRATIVE-NUCLEOSIDE-TRANSPORTER-1 HENT1; TRIPHOSPHATE POOLS;
   MTDNA DEPLETION; DEFICIENCY; MUTATIONS; ENCEPHALOMYOPATHY; FIBROBLASTS;
   MEMBRANE; TOXICITY; MYOPATHY
AB The mitochondrial DNA (mtDNA) depletion syndrome comprises a clinically heterogeneous group of diseases characterized by reductions of the mtDNA abundance, without associated point mutations or rearrangements. We have developed the first in vitro model to study of mtDNA depletion due to reduced mitochondrial thymidine kinase 2 gene (77(2) expression in order to understand the molecular mechanisms involved in mtDNA depletion syndrome due to TK2 mutations. Small interfering RNA targeting TK2 mRNA was used to decrease TK2 expression in Ost TK1(-) cells, a cell line devoid of endogenous thymidine kinase 1 (TK1). Stable TK2-deficient cell lines showed a reduction of TK2 levels close to 80%. In quiescent conditions, TK2-deficient cells showed severe mtDNA depletion, also close to 80% the control levels. However, 11(2-deficient clones showed increased cytochrome c oxidase activity, higher cytochrome c oxidase subunit I transcript levels and higher subunit II protein expression respect to control cells. No alterations of the deoxynucleotide pools were found, whereas a reduction in the expression of genes involved in nucleoside/nucleotide homeostasis (human equilibrative nucleoside transporter 1, thymidine phosphorylase) and mtDNA maintenance (DNA-polymerase 7, mitochondrial transcription factor A) was observed. Our findings highlight the importance of cellular compensatory mechanisms that enhance the expression of respiratory components to ensure respiratory activity despite profound depletion in mtDNA levels. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Villarroya, Joan; Lara, Mari-Carmen; Garcia-Arumi, Elena; Meseguer, Anna; Vila, Maya R.] Hosp Univ Vall dHebron, Inst Recerca, Barcelona, Spain.
   [Villarroya, Joan] Hosp Santa Creu & Sant Pau, Inst Recerca, Barcelona, Spain.
   [Lara, Mari-Carmen; Dorado, Beatriz; Hirano, Michio] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA.
   [Lara, Mari-Carmen; Garcia-Arumi, Elena] ISCIII, CIBERER, Madrid, Spain.
   [Garrido, Marta] Hosp del Mar, IMIM, Unitat Biol Cellular & Mol, Barcelona, Spain.
C3 Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron;
   Vall d'Hebron Institut de Recerca (VHIR); Hospital of Santa Creu i Sant
   Pau; Autonomous University of Barcelona; Hospital Universitari Vall
   d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Columbia University;
   Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica
   en Red; CIBERER; Hospital del Mar Research Institute; Hospital del Mar
RP Villarroya, J (corresponding author), Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Avda Diagonal 645, E-08028 Barcelona, Spain.
EM joanvillarroya@gmail.com
RI Garcia-Arumi, Elena/ABH-4229-2020; Villarroya, Joan/W-4066-2018;
   Meseguer, Anna/M-2222-2014
OI Villarroya, Joan/0000-0002-7859-1109; Dorado,
   Beatriz/0000-0002-1958-4558; Garcia-Arumi, Elena/0000-0003-0096-3336;
   Meseguer, Anna/0000-0003-3833-2249
FU Fondo de Investigacion Sanitaria [FIS 04/0415]; CIBER Obesidad y
   Nutricion, Spain; Fundismun Foundation; Muscular Dystrophy Association,
   USA
FX We thank Ramon Marti, Isabel Huber and Marcal Pastor-Anglada for
   critical review of the manuscript, Vera Bianchi for Ost TK1- cells, and
   David Llige for technical support. This work was supported by Fondo de
   Investigacion Sanitaria (FIS 04/0415); CIBER Obesidad y Nutricion,
   Spain, Fundismun Foundation, and Muscular Dystrophy Association, USA.
CR AKMAN HO, 2008, HUM MOL GENET
   Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   BOGENHAGEN D, 1976, J BIOL CHEM, V251, P2938
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Lai YR, 2004, J BIOL CHEM, V279, P4490, DOI 10.1074/jbc.M307938200
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lee EW, 2006, J BIOL CHEM, V281, P16700, DOI 10.1074/jbc.M513825200
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MARIOTTI C, 1995, J NEUROL, V242, P547, DOI 10.1007/BF00868806
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100
   Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200
   PRESSACCO J, 1995, BRIT J CANCER, V72, P939, DOI 10.1038/bjc.1995.437
   Rampazzo C, 2007, J BIOL CHEM, V282, P34758, DOI 10.1074/jbc.M705923200
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Saada A, 2003, BIOCHEM BIOPH RES CO, V310, P963, DOI 10.1016/j.bbrc.2003.09.104
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Srere P.A., 1969, Methods in Enzymology, V13, P3
   Vilá MR, 2008, J NEUROL SCI, V267, P137, DOI 10.1016/j.jns.2007.10.019
   Villarroya J, 2009, EXP CELL RES, V315, P1429, DOI 10.1016/j.yexcr.2009.02.018
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 28
TC 5
Z9 6
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD APR 8
PY 2011
VL 407
IS 2
BP 333
EP 338
DI 10.1016/j.bbrc.2011.03.018
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 753DU
UT WOS:000289746700012
PM 21382338
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Mimaki, M
   Hatakeyama, H
   Komaki, H
   Yokoyama, M
   Arai, H
   Kirino, Y
   Suzuki, T
   Nishino, I
   Nonaka, I
   Goto, Y
AF Mimaki, Masakazu
   Hatakeyama, Hideyuki
   Komaki, Hirofumi
   Yokoyama, Mina
   Arai, Hidee
   Kirino, Yohei
   Suzuki, Tsutomu
   Nishino, Ichizo
   Nonaka, Ikuya
   Goto, Yu-ichi
TI Reversible Infantile Respiratory Chain Deficiency: A Clinical and
   Molecular Study
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID C-OXIDASE DEFICIENCY; MITOCHONDRIAL MYOPATHY; LACTIC-ACIDOSIS;
   MUTATIONS; ENCEPHALOPATHY; MTDNA; ASSOCIATION; FAILURE; DEFECT; GENE
AB Objective: To character ze the clinical features and clarify the pathogenicity of "benign cytochrome c oxidase deficiency myopathy."
   Methods: The study included 8 patients with the phenotype of this disease. Six patients underwent muscle biopsies and all the 8 underwent mitochondrial DNA analyses. To confirm the pathogenicity of the detected mitochondrial DNA mutation, we performed northern blot analysis, using muscle specimens, and blue native polyacrylamide gel electrophoresis and respiratory chain enzyme activity assay of transmitochondrial cell lines (cybrids).
   Results: Clinical symptoms were limited to skeletal muscle and improved spontaneously in all cases; however, 2 siblings had basal ganglia lesions. In all patients, we identified a homoplasmic m.14674T>C or m.14674T>G mitochondrial transfer RNA-glutamate mutation. Northern blot analysis revealed decreased levels of mitochondrial transfer RNA-glutamate molecules. Muscle specimens and cybrids derived from patients showed decreased activity of respiratory complexes IV, and/or I, III; however, this was normal in naive myoblasts.
   Interpretation: Identification of a novel m.14674T>G mutation in addition to m.14674T>C indicated the importance of this site for disease causation. Analyses of cybrids revealed the pathogenicity of m.14674T>C mutation, which resulted in defects of cytochrome c oxidase and multiple respiratory chain enzymes. Furthermore, patients with basal ganglia lesions provided new insights into this disease, in which only skeletal muscle was thought to be affected. Normal respiratory chain enzyme activities in naive myoblasts suggested the compensatory influence of nuclear factors, which may be clue to understanding the mechanisms of spontaneous recovery and low penetrance in families carrying the mutation. ANN NEUROL 2010;68:845-854
C1 [Mimaki, Masakazu; Hatakeyama, Hideyuki; Komaki, Hirofumi; Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Kodaira, Tokyo 1878502, Japan.
   [Komaki, Hirofumi; Yokoyama, Mina; Nonaka, Ikuya; Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Ctr Hosp Neurol & Psychiat, Dept Child Neurol, Kodaira, Tokyo 1878502, Japan.
   [Kirino, Yohei; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan.
   [Arai, Hidee] Chiba Childrens Hosp, Dept Neurol, Chiba, Japan.
   [Nishino, Ichizo; Nonaka, Ikuya] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo 1878502, Japan.
C3 National Center for Neurology & Psychiatry - Japan; National Center for
   Neurology & Psychiatry - Japan; University of Tokyo; Chiba Children's
   Hospital; National Center for Neurology & Psychiatry - Japan
RP Goto, Y (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.
EM goto@ncnp.go.jp
RI Nishino, Ichizo/G-2676-2010; Suzuki, Tsutomu/J-1776-2015
OI Nishino, Ichizo/0000-0001-9452-112X; Kirino, Yohei/0000-0001-5232-4742;
   Suzuki, Tsutomu/0000-0002-9731-1731
FU Ministry of Health, Labour, and Welfare of Japan [15B-4, 18A-5];
   Ministry of Education, Culture, Sports, Science and Technology
   [17790738]; Japan Health Sciences Foundation [KHD2207]; Grants-in-Aid
   for Scientific Research [17790738] Funding Source: KAKEN
FX This work was supported by a grant for Nervous and Mental Disorders from
   the Ministry of Health, Labour, and Welfare of Japan (15B-4 and 18A-5 to
   Y.G.); a Grant-in-Aid for Young Scientists (B) from the Ministry of
   Education, Culture, Sports, Science and Technology (17790738 to MM.);
   and a grant from the Comprehensive Research Project on Health Sciences
   Focusing on Drug Innovation from the Japan Health Sciences Foundation
   (KHD2207 to Y.G.).
CR Akanuma J, 2000, J HUM GENET, V45, P337, DOI 10.1007/s100380070004
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   D'Aurelio M, 2006, HUM MOL GENET, V15, P2157, DOI 10.1093/hmg/ddl141
   DIMAURO S, 1983, ANN NEUROL, V14, P226, DOI 10.1002/ana.410140209
   DIMAURO S, 1990, PEDIATR RES, V28, P536, DOI 10.1203/00006450-199011000-00025
   Goto YI, 1996, BIOCHEM BIOPH RES CO, V222, P215, DOI 10.1006/bbrc.1996.0724
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   JERUSALEM F, 1973, ARCH NEUROL-CHICAGO, V29, P162, DOI 10.1001/archneur.1973.00490270044007
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   MAZZIOTTA MRM, 1992, J PEDIATR-US, V121, P896, DOI 10.1016/S0022-3476(05)80335-X
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Muraki K, 1997, J INHERIT METAB DIS, V20, P697, DOI 10.1023/A:1005378527077
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   NONAKA I, 1988, ACTA NEUROPATHOL, V77, P152
   OLDFORS A, 1989, ACTA NEUROPATHOL, V77, P267, DOI 10.1007/BF00687578
   Pallanck Leo, 1995, P371
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Robinson BH, 2000, PEDIATR RES, V48, P581, DOI 10.1203/00006450-200011000-00004
   Sacconi S, 2003, PEDIATR RES, V53, P224, DOI 10.1203/01.PDR.0000048100.91730.6A
   SALO MK, 1992, ARCH DIS CHILD, V67, P1033, DOI 10.1136/adc.67.8.1033
   SERVIDEI S, 1988, CLIN NEUROPATHOL, V7, P209
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   SUZUKI M, 1989, No To Hattatsu, V21, P543
   TRITSCHLER HJ, 1991, NEUROLOGY, V41, P300, DOI 10.1212/WNL.41.2_Part_1.300
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   VANBIERVLIET JPGM, 1977, PEDIATR RES, V11, P1088, DOI 10.1203/00006450-197711100-00005
   VARSHNEY U, 1991, J BIOL CHEM, V266, P24712
   Wada Hiroko, 1996, No To Hattatsu, V28, P443
   Yasukawa T, 2000, NUCLEIC ACIDS RES, V28, P3779, DOI 10.1093/nar/28.19.3779
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   ZEVIANI M, 1987, NEUROLOGY, V37, P64, DOI 10.1212/WNL.37.1.64
NR 36
TC 28
Z9 32
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD DEC
PY 2010
VL 68
IS 6
BP 845
EP 854
DI 10.1002/ana.22111
PG 10
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 703DE
UT WOS:000285953500012
PM 21194154
DA 2024-11-01
ER

PT J
AU Pyal, A
   Paramasivam, A
   Meena, AK
   Bhavana, VB
   Thangaraj, K
AF Pyal, Anjan
   Paramasivam, Arumugam
   Meena, Angamuthu Kannan
   Bhavana, Velpula Bhagya
   Thangaraj, Kumarasamy
TI <i>MPV17</i> hepatocerebral mitochondrial DNA depletion syndrome
   presenting as acute flaccid paralysis - A case report
SO MITOCHONDRION
LA English
DT Article
DE MPV17 mutation; Mitochondrial DNA; mtDNA maintenance, hepatocerebral
   disease
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MULTIPLE MTDNA DELETIONS;
   MUTATIONS; GENE; FORM
AB Mutations in human MPV17 have been reported in patients with severe mitochondrial DNA (mtDNA) depletion manifesting as early childhood onset failure to thrive, hypoglycemia, encephalopathy and progressive liver failure. We describe an 11 year old girl, born to consanguineous parents, who presented with rapidly progressive weakness of all 4 limbs with symmetrical proximal and distal weakness, gastrointestinal disease and leukoencephalopathy. Genetic analysis of the patient revealed a homozygous pathogenic mutation c.121C > T (p.R41W) in the MPV17 gene. Further, screening for this mutation in the parents revealed the presence of heterozygous mutation in both the parents, suggesting the recessive nature of the disease.
C1 [Pyal, Anjan; Meena, Angamuthu Kannan] Nizams Inst Med Sci, Dept Neurol, Hyderabad 500082, Andhra Prades, India.
   [Paramasivam, Arumugam; Bhavana, Velpula Bhagya; Thangaraj, Kumarasamy] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Prades, India.
C3 Nizam's Institute of Medical Sciences; Council of Scientific &
   Industrial Research (CSIR) - India; CSIR - Centre for Cellular &
   Molecular Biology (CCMB)
RP Meena, AK (corresponding author), Nizams Inst Med Sci, Dept Neurol, Hyderabad 500082, Andhra Prades, India.
EM meenaak@hotmail.com
RI Arumugam, Paramasivam/JAC-6846-2023; Thangaraj, Kumarasamy/G-5596-2010;
   Jayaseelan, Dr. Vijayashree Priyadharsini/AAD-4261-2019
OI Jayaseelan, Dr. Vijayashree Priyadharsini/0000-0001-7884-5466; Arumugam,
   Paramasivam/0000-0001-6117-1178
FU Council of Scientific and Industrial Research (CSIR), Government of
   India [BioAge-BSC0208]; Science and Engineering Research Board (SERB),
   Government of India [PDF/2016/000881]
FX We wish to thank the patient, their families and other participants for
   their contribution to this research. This work was supported by the
   Council of Scientific and Industrial Research (CSIR) (BioAge-BSC0208),
   Government of India; the Science and Engineering Research Board (SERB)
   (reference no.PDF/2016/000881), Government of India.
CR Bijarnia-Mahay S, 2014, INDIAN PEDIATR, V51, P666, DOI 10.1007/s13312-014-0475-z
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   El-Hattab AW, 2010, MOL GENET METAB, V99, P300, DOI 10.1016/j.ymgme.2009.10.003
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Navarro-Sastre A, 2008, MOL GENET METAB, V94, P234, DOI 10.1016/j.ymgme.2008.01.012
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nogueira C, 2014, ITAL J PEDIATR, V40, DOI 10.1186/1824-7288-40-34
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Paramasivam A, 2016, MITOCHONDRION, V26, P81, DOI 10.1016/j.mito.2015.12.006
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   Strauss KA, 2015, AM J HUM GENET, V96, P121, DOI 10.1016/j.ajhg.2014.12.003
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Thangaraj K, 2002, J ANDROL, V23, P815
   Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112
NR 18
TC 5
Z9 5
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV
PY 2017
VL 37
BP 41
EP 45
DI 10.1016/j.mito.2017.06.006
PG 5
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA FN8SO
UT WOS:000416296000005
PM 28673863
DA 2024-11-01
ER

PT J
AU Da Pozzo, P
   Rubegni, A
   Rufa, A
   Cardaioli, E
   Taglia, I
   Gallus, GN
   Malandrini, A
   Federico, A
AF Da Pozzo, Paola
   Rubegni, Anna
   Rufa, Alessandra
   Cardaioli, Elena
   Taglia, Ilaria
   Gallus, Gian Nicola
   Malandrini, Alessandro
   Federico, Antonio
TI Sporadic PEO caused by a novel POLG variation and a Twinkle mutation:
   digenic inheritance?
SO NEUROLOGICAL SCIENCES
LA English
DT Article
DE PEO; POLG gene; C10orf2/Twinkle gene; Digenic disorder
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; ANT1
AB Progressive external ophthalmoplegia (PEO) with multiple deletions of mitochondrial DNA (mtDNA) is associated with several mutations in nuclear genes. They include POLG, POLG2, ANT1, C10orf2/Twinkle, and OPA1. However, digenic inheritance in mitochondrial disorders has been documented in a few cases over the years. Here we describe an 80-year-old man with sporadic PEO associated with mtDNA deletions. Sequencing of the POLG revealed a novel heterozygous mutation (c.2831A > G; p.Glu944Gly), predicted in silico as damaging, in the patient who also carried a heterozygous mutation in C10orf2/Twinkle (c.1142T > C; p.Leu381Pro). This case provides a second report of a PEO with different mutations in the POLG and C10orf2/Twinkle genes, supporting the hypothesis that the PEO phenotype can be determined by the co-existence of two abnormalities in separate genes, both involved in the maintenance and stability of mtDNA. Finally, this study expands the spectrum of POLG mutations and highlights the need to sequence the whole set of nuclear genes associated with PEO and multiple mtDNA deletions.
C1 [Da Pozzo, Paola; Rufa, Alessandra; Cardaioli, Elena; Taglia, Ilaria; Gallus, Gian Nicola; Malandrini, Alessandro; Federico, Antonio] Univ Siena, Dept Med Surg & Neurosci, I-53100 Siena, Italy.
   [Rubegni, Anna] IRCCS Stella Maris, Mol Med Neuromuscular & Neurodegenerat Unit, Pisa, Italy.
C3 University of Siena; IRCCS Fondazione Stella Maris
RP Federico, A (corresponding author), Univ Siena, Dept Med Surg & Neurosci, Viale Bracci 2, I-53100 Siena, Italy.
EM federico@unisi.it
RI Federico, Antonio/H-8871-2017; Rufa, Alessandra/E-8298-2011; GALLUS,
   GIAN NICOLA/Q-3489-2016; Rubegni, Anna/I-3221-2018
OI GALLUS, GIAN NICOLA/0000-0001-5801-223X; Rubegni,
   Anna/0000-0002-0484-3799; Malandrini, Alessandro/0000-0003-1034-0845;
   Rufa, Alessandra/0000-0002-2254-2869; Cardaioli,
   Elena/0000-0003-2850-6698
FU Region of Tuscany; Ministry of Public Health
FX The research was supported in part by a grant from the Region of Tuscany
   and the Ministry of Public Health to AF (project entitled "Risk and
   determinants of dementia in patients with mild cognitive impairment and
   brain subcortical vascular changes: a study of clinical, neuro-imaging
   and biological markers'').
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Galassi G, 2008, NEUROMUSCULAR DISORD, V18, P465, DOI 10.1016/j.nmd.2008.03.013
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
NR 7
TC 3
Z9 4
U1 0
U2 0
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1590-1874
EI 1590-3478
J9 NEUROL SCI
JI Neurol. Sci.
PD SEP
PY 2015
VL 36
IS 9
BP 1713
EP 1715
DI 10.1007/s10072-015-2247-5
PG 3
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA CQ0NE
UT WOS:000360292200031
PM 26050231
DA 2024-11-01
ER

PT J
AU Guo, L
   Wang, X
   Ji, HT
AF Guo, Luo
   Wang, Xin
   Ji, Haiting
TI Clinical Phenotype and Genetic Features of a Pair of Chinese Twins with
   Kearns-Sayre Syndrome
SO DNA AND CELL BIOLOGY
LA English
DT Article
DE mitochondrial disease; deletion; Kearns-Sayre Syndrome
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MITOCHONDRIAL-DNA DELETIONS;
   COMMON DELETION; DISEASE; MUTATIONS
AB Kearns-Sayre Syndrome (KSS) is a severe mitochondrial disorder involving the central nervous system, eyes, ears, skeletal muscles, and heart. The mitochondrial DNA (mtDNA) rearrangements, especially the deletions, are present in almost all KSS patients and considered as the disease-causing factor. However, the size and position of mtDNA deletions are distinct in different individuals. In this study, we report the case of a pair of Chinese twins with KSS. The twin patients revealed typical KSS clinical symptoms, including heart block, bilateral sensorineural hearing loss, progressive external ophthalmoplegia, exercise intolerance, proximal limb weakness, and endocrine disorders. Using long-range polymerase chain reactions (long-range PCR) and next-generation sequencing (NGS), the genetic features of the twin patients were investigated. A large 6600 bp mtDNA deletion, ranging from position 8702 to 15,302, was detected in both patients. To our knowledge, this kind of mtDNA deletion has never been described previously. Our study enriched the mutation spectrum of KSS and showed that NGS is a powerful tool for detecting mtDNA large variants.
C1 [Guo, Luo; Ji, Haiting] Fudan Univ, State Key Lab Med Neurobiol, ENT Inst, Eye & ENT Hosp, Shanghai, Peoples R China.
   [Guo, Luo; Ji, Haiting] Fudan Univ, MOE Frontiers Ctr Brain Sci, ENT Inst, Eye & ENT Hosp, Shanghai, Peoples R China.
   [Guo, Luo; Ji, Haiting] Fudan Univ, Otorhinolaryngol Dept, Eye & ENT Hosp, Shanghai, Peoples R China.
   [Guo, Luo; Ji, Haiting] Fudan Univ, NHC Key Lab Hearing Med, Shanghai, Peoples R China.
   [Wang, Xin] Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China.
   [Wang, Xin] Nantong Univ, Key Lab Neuroregenerat Jiangsu, Nantong, Peoples R China.
   [Wang, Xin] Nantong Univ, Minist Educ, Nantong, Peoples R China.
   [Ji, Haiting] Fudan Univ, Dept Otorhinolaryngol, Affiliated Eye & ENT Hosp, Shanghai 200031, Peoples R China.
C3 Fudan University; Fudan University; Fudan University; Fudan University;
   Fudan University; Nantong University; Nantong University; Fudan
   University
RP Ji, HT (corresponding author), Fudan Univ, Dept Otorhinolaryngol, Affiliated Eye & ENT Hosp, Shanghai 200031, Peoples R China.
EM hj11@fudan.edu.cn
RI xin, wang/GNW-5324-2022
OI xin, wang/0000-0001-7440-3150
FU National Natural Science Foundation of China [81600816]
FX This work was supported by grants from the National Natural Science
   Foundation of China (81600816).
CR Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Bosbach S, 2003, BRAIN, V126, P1231, DOI 10.1093/brain/awg101
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Cherry C, 2016, TRENDS MOL MED, V22, P391, DOI 10.1016/j.molmed.2016.03.009
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dominic EA, 2014, HEART, V100, P611, DOI 10.1136/heartjnl-2013-304657
   Emma F, 2006, PEDIATR NEPHROL, V21, P355, DOI 10.1007/s00467-005-2092-5
   Fisher N, 2001, EUR J BIOCHEM, V268, P1155, DOI 10.1046/j.1432-1327.2001.02010.x
   Kabunga P, 2015, INT J CARDIOL, V181, P303, DOI 10.1016/j.ijcard.2014.12.038
   KLOPSTOCK T, 1995, ACTA NEUROPATHOL, V90, P126
   Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x
   Lertrit P, 1999, HUM GENET, V105, P127, DOI 10.1007/s004390051074
   Maeda K, 2016, JAMA NEUROL, V73, P990, DOI 10.1001/jamaneurol.2016.0886
   Mkaouar-Rebai E, 2010, MITOCHONDRION, V10, P449, DOI 10.1016/j.mito.2010.04.003
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Pitceathly RDS, 2011, J MED GENET, V48, P610, DOI 10.1136/jmg.2010.088328
   Puoti G, 2003, J MED GENET, V40, P858, DOI 10.1136/jmg.40.11.858
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   SCHON EA, 1988, ANN NY ACAD SCI, V550, P348, DOI 10.1111/j.1749-6632.1988.tb35349.x
   Seyrantepe V, 1999, BRAIN DEV-JPN, V21, P413, DOI 10.1016/S0387-7604(99)00035-2
   Sokolova VA, 2002, MITOCHONDRION, V1, P479, DOI 10.1016/S1567-7249(02)00014-4
   Wei YH, 1996, ANN NY ACAD SCI, V786, P82, DOI 10.1111/j.1749-6632.1996.tb39054.x
   Yan XK, 2011, J MED GENET, V48, P682, DOI 10.1136/jmedgenet-2011-100219
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 26
TC 7
Z9 9
U1 0
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1044-5498
EI 1557-7430
J9 DNA CELL BIOL
JI DNA Cell Biol.
PD AUG 1
PY 2020
VL 39
IS 8
BP 1449
EP 1457
DI 10.1089/dna.2019.5010
EA JUN 2020
PG 9
WC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
GA MU1AS
UT WOS:000547119100001
PM 32609007
DA 2024-11-01
ER

PT J
AU McFarland, R
   Turnbull, DM
AF McFarland, R.
   Turnbull, D. M.
TI Batteries not included: diagnosis and management of mitochondrial
   disease
SO JOURNAL OF INTERNAL MEDICINE
LA English
DT Review
DE mitochondrial disease; neurogenetics; respiratory chain disorders
ID HEREDITARY OPTIC NEUROPATHY; CYTOCHROME-C-OXIDASE; PROGRESSIVE EXTERNAL
   OPHTHALMOPLEGIA; KEARNS-SAYRE-SYNDROME; RESPIRATORY-CHAIN DISORDERS;
   MEMBRANE-PROTEIN COMPLEXES; RIBOSOMAL-RNA MUTATION; INHERITED
   HEARING-LOSS; NON-SYNDROMIC DEAFNESS; STROKE-LIKE EPISODES
AB In 1998, Wallace et al. (Science 1988; 242: 1427-30) published evidence that the mutation m.11778G > A was responsible for causing Leber's hereditary optic neuropathy. This was the first account of a mitochondrial DNA mutation being irrefutably linked with a human disease and was swiftly followed by a report from Holt et al. (Nature 1988; 331: 717-9) identifying deletions in mitochondrial DNA as a cause for myopathy. During the subsequent 20 years there has been an exponential growth in 'mitochondrial medicine', with clinical, biochemical and genetic characterizations of a wide range of mitochondrial diseases and evidence implicating mitochondria in a host of many other clinical conditions including ageing, neurodegenerative illness and cancer. In this review we shall focus on the diagnosis and management of mitochondrial diseases that lead directly or indirectly to disruption of the process of oxidative phosphorylation.
C1 [McFarland, R.] Newcastle Univ, Sch Med, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP McFarland, R (corresponding author), Newcastle Univ, Sch Med, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, 4th Floor,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.mcfarland@ncl.ac.uk
OI McFarland, Robert/0000-0002-8833-2688
FU Medical Research Council [G0700718, G0800674, G0601943] Funding Source:
   Medline; MRC [G0700718, G0800674, G0601943] Funding Source: UKRI
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Bataillard M, 2001, NEUROLOGY, V56, P405, DOI 10.1212/WNL.56.3.405
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Biggin A, 2005, MOL GENET METAB, V84, P61, DOI 10.1016/j.ymgme.2004.09.011
   Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Bykhovskaya Y, 2004, MOL GENET METAB, V83, P199, DOI 10.1016/j.ymgme.2004.07.009
   Carrozzo R, 2001, NEUROLOGY, V56, P687, DOI 10.1212/WNL.56.5.687
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   DAMIAN MS, 1995, ACTA NEUROL SCAND, V92, P409
   de Coo IFM, 1998, NEUROLOGY, V50, P293, DOI 10.1212/WNL.50.1.293
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   De Meirleir L, 2003, AM J MED GENET A, V121A, P126, DOI 10.1002/ajmg.a.20171
   DEBRAEKELEER M, 1993, GENET EPIDEMIOL, V10, P17, DOI 10.1002/gepi.1370100103
   Deschauer M, 1999, NEUROMUSCULAR DISORD, V9, P305, DOI 10.1016/S0960-8966(99)00019-X
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676
   Filosto M, 2003, ANN NEUROL, V54, P524, DOI 10.1002/ana.10709
   Gabaldón T, 2004, BBA-BIOENERGETICS, V1659, P212, DOI 10.1016/j.bbabio.2004.07.011
   GERBITZ KD, 1995, BBA-MOL BASIS DIS, V1271, P253, DOI 10.1016/0925-4439(95)00036-4
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Griggs RC, 1999, NEW ENGL J MED, V341, P1077, DOI 10.1056/NEJM199909303411411
   Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   HARDING AE, 1995, MUSCLE NERVE, pS82
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Hobbie SN, 2008, P NATL ACAD SCI USA, V105, P3244, DOI 10.1073/pnas.0707265105
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Huoponen K, 2001, NEUROGENETICS, V3, P119, DOI 10.1007/s100480100115
   HUTCHIN T, 1993, NUCLEIC ACIDS RES, V21, P4174, DOI 10.1093/nar/21.18.4174
   HUTTENLOCHER PR, 1976, ARCH NEUROL-CHICAGO, V33, P186, DOI 10.1001/archneur.1976.00500030042009
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Karanikis P, 2005, INT J CARDIOL, V101, P147, DOI 10.1016/j.ijcard.2004.01.027
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kleiner L, 1996, Optom Clin, V5, P77
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   Lister R, 2005, MOL MEMBR BIOL, V22, P87, DOI 10.1080/09687860500041247
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103
   MACKEY DA, 1992, AUST NZ J OPHTHALMOL, V20, P177, DOI 10.1111/j.1442-9071.1992.tb00937.x
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   MANDERBACKA K, 2001, SCANDINAVIAN J P S55, V29, P41
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Margineantu DH, 2002, MITOCHONDRION, V1, P425, DOI 10.1016/S1567-7249(02)00006-5
   MARGULIS L, 1976, EXP PARASITOL, V39, P277, DOI 10.1016/0014-4894(76)90127-2
   MARTINUZZI A, 1992, J NEUROL SCI, V113, P222, DOI 10.1016/0022-510X(92)90250-O
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MITOMAP, 2008, HUM MIT GEN DAT
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   MORIKAWA Y, 1993, VIRCHOWS ARCH A, V423, P227, DOI 10.1007/BF01614775
   Morten KJ, 2007, MITOCHONDRION, V7, P386, DOI 10.1016/j.mito.2007.09.001
   MORTEN KJ, 1995, HUM MOL GENET, V4, P1689
   Nagashima T, 1999, ACTA NEUROPATHOL, V97, P416, DOI 10.1007/s004010051007
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OLDFORS A, 1995, ACTA NEUROPATHOL, V90, P328
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   POULTON J, 1995, MUSCLE NERVE, pS154
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311
   Rigoli L, 2001, DIABETIC MED, V18, P334, DOI 10.1046/j.1464-5491.2001.00429-2.x
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SANTORELLI FM, 1994, NEUROLOGY, V44, P972, DOI 10.1212/WNL.44.5.972
   SAUNIER P, 1995, NEUROMUSCULAR DISORD, V5, P285, DOI 10.1016/0960-8966(94)00071-G
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   STONE EM, 1992, J CLIN NEURO-OPHTHAL, V12, P10
   Subbiah RN, 2007, PACE, V30, P137
   Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421
   Uusimaa J, 2000, PEDIATRICS, V105, P598, DOI 10.1542/peds.105.3.598
   van den Bosch BJC, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e89
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Vialettes BH, 1997, DIABETES CARE, V20, P1731, DOI 10.2337/diacare.20.11.1731
   Walker M, 2005, DIABETIC MED, V22, P18, DOI 10.1111/j.1464-5491.2005.1761f.x
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   WELZING L, 2008, EUR J PEDIAT    0924
   Whittaker RG, 2007, DIABETOLOGIA, V50, P2085, DOI 10.1007/s00125-007-0779-9
   Whittaker RG, 2007, DIABETES CARE, V30, P2238, DOI 10.2337/dc07-0466
   Wittig I, 2007, ELECTROPHORESIS, V28, P3811, DOI 10.1002/elps.200700367
   Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200
   Yavuz H, 2007, ARCH NEUROL-CHICAGO, V64, P435, DOI 10.1001/archneur.64.3.435
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
   ZUPANC ML, 1991, ANN NEUROL, V29, P680, DOI 10.1002/ana.410290619
NR 121
TC 58
Z9 70
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0954-6820
EI 1365-2796
J9 J INTERN MED
JI J. Intern. Med.
PD FEB
PY 2009
VL 265
IS 2
BP 210
EP 228
DI 10.1111/j.1365-2796.2008.02066.x
PG 19
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 393CK
UT WOS:000262348300005
PM 19192037
OA Bronze
DA 2024-11-01
ER

PT J
AU Pirinen, E
   Auranen, M
   Khan, NA
   Brilhante, V
   Urho, N
   Pessia, A
   Hakkarainen, A
   Kuula, J
   Heinonen, U
   Schmidt, MS
   Haimilahti, K
   Piirilä, P
   Lundbom, N
   Taskinen, MR
   Brenner, C
   Velagapudi, V
   Pietiläinen, KH
   Suomalainen, A
AF Pirinen, Eija
   Auranen, Mari
   Khan, Nahid A.
   Brilhante, Virginia
   Urho, Niina
   Pessia, Alberto
   Hakkarainen, Antti
   Kuula, Juho
   Heinonen, Ulla
   Schmidt, Mark S.
   Haimilahti, Kimmo
   Piirila, Paivi
   Lundbom, Nina
   Taskinen, Marja-Riitta
   Brenner, Charles
   Velagapudi, Vidya
   Pietilainen, Kirsi H.
   Suomalainen, Anu
TI Niacin Cures Systemic NAD<SUP>+</SUP> Deficiency and Improves Muscle
   Performance in Adult-Onset Mitochondrial Myopathy
SO CELL METABOLISM
LA English
DT Article
ID FATTY LIVER-DISEASE; NICOTINAMIDE RIBOSIDE; MULTIPLE DELETIONS;
   LIFE-SPAN; DNA; SPECTROSCOPY; ADIPONECTIN; METABOLISM; MUTATIONS;
   BIOMARKER
AB NAD(+) is a redox-active metabolite, the depletion of which has been proposed to promote aging and degenerative diseases in rodents. However, whether NAD(+) depletion occurs in patients with degenerative disorders and whether NAD(+) repletion improves their symptoms has remained open. Here, we report systemic NAD(+) deficiency in adult-onset mitochondrial myopathy patients. We administered an increasing dose of NAD(+) booster niacin, a vitamin B3 form (to 750-1,000 mg/day; clinicaltrials.gov NCT03973203) for patients and their matched controls for 10 or 4 months, respectively. Blood NAD(+) increased in all subjects, up to 8-fold, and muscle-NAD(+) of patients reached the level of their controls. Some patients showed anemia tendency, while muscle strength and mitochondrial biogenesis increased in all subjects. In patients, muscle metabolome shifted toward controls and liver fat decreased even 50%. Our evidence indicates that blood analysis is useful in identifying NAD(+) deficiency and points niacin to be an efficient NAD(+) booster for treating mitochondrial myopathy.
C1 [Pirinen, Eija; Haimilahti, Kimmo; Taskinen, Marja-Riitta] Univ Helsinki, Fac Med, Res Program Clin & Mol Metab, Helsinki 00290, Finland.
   [Auranen, Mari; Khan, Nahid A.; Brilhante, Virginia; Suomalainen, Anu] Univ Helsinki, Fac Med, Res Program Stem Cells & Metab, Helsinki 00290, Finland.
   [Auranen, Mari; Urho, Niina; Heinonen, Ulla] Helsinki Univ Hosp, Dept Neurosci, Helsinki, Finland.
   [Pessia, Alberto; Velagapudi, Vidya] Inst Mol Med Finland FIMM, Metabol Unit, Helsinki 00290, Finland.
   [Hakkarainen, Antti; Kuula, Juho; Lundbom, Nina] Univ Helsinki, Med Imaging Ctr, Dept Radiol, Helsinki, Finland.
   [Hakkarainen, Antti; Kuula, Juho; Lundbom, Nina] Helsinki Univ Hosp, Helsinki, Finland.
   [Hakkarainen, Antti] Aalto Univ, Sch Sci, Dept Neurosci & Biomed Engn, Espoo 12200, Finland.
   [Schmidt, Mark S.; Brenner, Charles] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA.
   [Piirila, Paivi] Helsinki Univ Hosp, Unit Clin Physiol, Helsinki, Finland.
   [Piirila, Paivi; Pietilainen, Kirsi H.] Univ Helsinki, Helsinki, Finland.
   [Pietilainen, Kirsi H.] Univ Helsinki, Fac Med, Res Program Clin & Mol Metab, Obes Res Unit, Helsinki 00290, Finland.
   [Pietilainen, Kirsi H.] Helsinki Univ Hosp, Endocrinol, Abdominal Ctr, Obes Ctr, Helsinki, Finland.
   [Suomalainen, Anu] Helsinki Univ Hosp, HUSlab, Helsinki 00290, Finland.
   [Suomalainen, Anu] Univ Helsinki, HiLife, Neurosci Ctr, Helsinki 00290, Finland.
   [Velagapudi, Vidya] Astra Zeneca, Biopharmaceut R&D, Discovery Sci, Gothenburg, Sweden.
C3 University of Helsinki; University of Helsinki; University of Helsinki;
   Helsinki University Central Hospital; University of Helsinki; University
   of Helsinki; Helsinki University Central Hospital; Aalto University;
   University of Iowa; University of Helsinki; Helsinki University Central
   Hospital; University of Helsinki; University of Helsinki; University of
   Helsinki; Helsinki University Central Hospital; University of Helsinki;
   Helsinki University Central Hospital; University of Helsinki;
   AstraZeneca
RP Pirinen, E (corresponding author), Univ Helsinki, Fac Med, Res Program Clin & Mol Metab, Helsinki 00290, Finland.; Suomalainen, A (corresponding author), Univ Helsinki, Fac Med, Res Program Stem Cells & Metab, Helsinki 00290, Finland.; Suomalainen, A (corresponding author), Helsinki Univ Hosp, HUSlab, Helsinki 00290, Finland.; Suomalainen, A (corresponding author), Univ Helsinki, HiLife, Neurosci Ctr, Helsinki 00290, Finland.
EM eija.pirinen@helsinki.fi; anu.wartiovaara@helsinki.fi
RI Taskinen, Marja-Riitta/AAN-5432-2020; Pietiläinen, Kirsi/HJA-4960-2022;
   Pessia, Alberto/N-3072-2014; Velagapudi, Vidya/L-7278-2015; Kuula,
   Juho/ABF-9691-2020; Hakkarainen, Antti/AAF-5928-2020; Schmidt,
   Michael/F-1677-2010; Pirinen, Eija/H-9153-2015; Brenner,
   Charles/D-6339-2014; Piirila, Paivi/H-2291-2018
OI Pirinen, Eija/0000-0003-1495-3972; Haimilahti,
   Kimmo/0009-0002-4939-6782; Kuula, Juho/0000-0002-5793-9196; Brenner,
   Charles/0000-0002-4955-3226; Suomalainen-Wartiovaara,
   Anu/0000-0003-4833-5195; Taskinen, Marja-Riitta/0000-0002-6229-3588;
   Khan, Nahid/0000-0002-2835-3655; Piirila, Paivi/0000-0002-2535-4409
FU Centre of Excellence from Academy of Finland [307431]; academy grants
   [307592, 303349, 286359, 272376, 314383, 266286]; Sigrid Juselius
   Foundation; United Mitochondrial Disease Foundation; Finnish Medical
   Foundation; Novo Nordisk Foundation; Gyllenberg Foundation; Finnish
   Diabetes Research Foundation; Finnish Foundation for Cardiovascular
   Research; HiLife/University of Helsinki; Government Research Funds
   (Helsinki University Hospital); Academy of Finland (AKA) [307592,
   303349, 307431] Funding Source: Academy of Finland (AKA)
FX The study was supported by Centre of Excellence funding from the Academy
   of Finland (#307431, A.S. and K.P.), as well as academy grants (307592
   and 303349 [A.S.], 286359 [E.P.], 272376 [K.H.P.], 314383 [K.H.P.],
   266286 [K.H.P.]), Sigrid Juselius Foundation, United Mitochondrial
   Disease Foundation, Finnish Medical Foundation, Novo Nordisk Foundation,
   Gyllenberg Foundation, Finnish Diabetes Research Foundation, Finnish
   Foundation for Cardiovascular Research, HiLife/University of Helsinki,
   Government Research Funds (Helsinki University Hospital).
CR Ahola S, 2016, EMBO MOL MED, V8, P1234, DOI 10.15252/emmm.201606592
   Airhart SE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186459
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Bachorik P S, 1986, Methods Enzymol, V129, P78
   Bao XR, 2016, ELIFE, V5, DOI 10.7554/eLife.10575
   Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006
   Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024
   Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7
   BLANCHE PJ, 1981, BIOCHIM BIOPHYS ACTA, V665, P408, DOI 10.1016/0005-2760(81)90253-8
   Brosnan JT, 2007, ANNU REV NUTR, V27, P241, DOI 10.1146/annurev.nutr.27.061406.093621
   Bruckert E, 2010, ATHEROSCLEROSIS, V210, P353, DOI 10.1016/j.atherosclerosis.2009.12.023
   Cantó C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Elhassan YS, 2019, CELL REP, V28, P1717, DOI 10.1016/j.celrep.2019.07.043
   ERA P, 1992, EUR J APPL PHYSIOL O, V64, P84, DOI 10.1007/BF00376446
   Forsström S, 2019, CELL METAB, V30, P1040, DOI [10.1016/j.cmet.2019.013.019, 10.1016/j.cmet.2019.08.019]
   Ganji SH, 2014, AM J PHYSIOL-GASTR L, V306, pG320, DOI 10.1152/ajpgi.00181.2013
   Gariani K, 2016, HEPATOLOGY, V63, P1190, DOI 10.1002/hep.28245
   Giby VG, 2014, WORLD J HEPATOL, V6, P570, DOI 10.4254/wjh.v6.i8.570
   Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051
   Guyton JR, 2007, AM J CARDIOL, V99, p22C, DOI 10.1016/j.amjcard.2006.11.018
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   HARDIN CD, 1994, J MOL CELL CARDIOL, V26, P1197, DOI 10.1006/jmcc.1994.1138
   HOLT IJ, 1988, LANCET, V1, P1462
   Hu M, 2012, J LIPID RES, V53, P802, DOI 10.1194/jlr.P023614
   Katsyuba E, 2018, NATURE, V563, P354, DOI 10.1038/s41586-018-0645-6
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005
   Kühl I, 2017, ELIFE, V6, DOI 10.7554/eLife.30952
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Liu L, 2018, CELL METAB, V27, P1067, DOI 10.1016/j.cmet.2018.03.018
   LONGO R, 1995, JMRI-J MAGN RESON IM, V5, P281, DOI 10.1002/jmri.1880050311
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Migliavacca E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13694-1
   Mudd SH, 2007, AM J CLIN NUTR, V85, P19, DOI 10.1093/ajcn/85.1.19
   Nandania J, 2018, METABOLITES, V8, DOI 10.3390/metabo8030044
   Nandania J, 2018, J CHROMATOGR B, V1092, P168, DOI 10.1016/j.jchromb.2018.06.008
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Ollila L, 2017, CLIN PHYSIOL FUNCT I, V37, P8, DOI 10.1111/cpf.12260
   Pirinen E, 2014, CELL METAB, V19, P1034, DOI 10.1016/j.cmet.2014.04.002
   Plaisance EP, 2009, AM J PHYSIOL-ENDOC M, V296, pE549, DOI 10.1152/ajpendo.91004.2008
   Rajman L, 2018, CELL METAB, V27, P529, DOI 10.1016/j.cmet.2018.02.011
   Ryu D, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5504
   Shi HJ, 2017, NEW ENGL J MED, V377, P544, DOI [10.1056/NEJMoa1616361, 10.1056/nejmoa1616361]
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spriet LL, 2015, CURR OPIN CLIN NUTR, V18, P96, DOI 10.1097/MCO.0000000000000135
   Stefan D, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/10/104035
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977
   Trammell SAJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26933
   Trammell SAJ, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301012
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Van Bergen NJ, 2019, BRAIN, V142, P50, DOI 10.1093/brain/awy310
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244
   Vosper H, 2009, BRIT J PHARMACOL, V158, P429, DOI 10.1111/j.1476-5381.2009.00349.x
   Westphal S, 2007, ATHEROSCLEROSIS, V193, P361, DOI 10.1016/j.atherosclerosis.2006.06.028
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693
NR 68
TC 140
Z9 146
U1 5
U2 25
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD JUN 2
PY 2020
VL 31
IS 6
BP 1078
EP +
DI 10.1016/j.cmet.2020.04.008
PG 18
WC Cell Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Endocrinology & Metabolism
GA MC6LR
UT WOS:000543396400010
PM 32386566
OA Bronze
DA 2024-11-01
ER

PT J
AU Mimaki, M
   Hatakeyama, H
   Ichiyama, T
   Isumi, H
   Furukawa, S
   Akasaka, M
   Kamei, A
   Komaki, H
   Nishino, I
   Nonaka, I
   Goto, YI
AF Mimaki, Masakazu
   Hatakeyama, Hideyuki
   Ichiyama, Takashi
   Isumi, Hiroshi
   Furukawa, Susumu
   Akasaka, Manami
   Kamei, Atsushi
   Komaki, Hirofumi
   Nishino, Ichizo
   Nonaka, Ikuya
   Goto, Yu-ichi
TI Different effects of novel mtDNA G3242A and G3244A base changes adjacent
   to a common A3243G mutation in patients with mitochondrial disorders
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial DNA tRNA(Leu(UUR)) gene; Mutation; Mitochondrial myopathy
   encephalopathy lactic acidosis and stroke-like episodes (MELAS); Cybrid;
   ATP production; BN-PAGE
ID STROKE-LIKE EPISODES; RESPIRATORY-CHAIN SUPERCOMPLEXES;
   KEARNS-SAYRE-SYNDROME; LACTIC-ACIDOSIS; POINT MUTATION; TRANSFER-RNAS;
   DNA MUTATION; TRANSCRIPTION TERMINATION; TRNA(LEU(UUR)) MUTATION;
   CLINICAL-FEATURES
AB Two novel mitochondrial DNA base changes were identified at both sides of the 3243A > G mutation, the most common mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). One was a 3244G > A transition in a girl with MELAS. The other was a 3242G > A transition in a girl with a mitochondrial disorder without a MELAS phenotype. Although the two base changes were adjacent to the 3243A > G mutation, they had different effects on the clinical phenotype, muscle pathology, and respiratory chain enzyme activity. Investigations of the different effects of the 3244G > A and 3242G > A base changes may provide a better understanding of tRNA dysfunction in mitochondrial disorders. (C) 2009 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Mimaki, Masakazu; Hatakeyama, Hideyuki; Komaki, Hirofumi; Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Dept Mental Retardat & Birth Defect Res, Natl Inst Neurosci, Tokyo, Japan.
   [Ichiyama, Takashi; Isumi, Hiroshi; Furukawa, Susumu] Yamaguchi Univ, Dept Pediat, Sch Med, Yamaguchi, Japan.
   [Akasaka, Manami; Kamei, Atsushi] Iwate Med Univ, Dept Pediat, Morioka, Iwate, Japan.
   [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Dept Neuromuscular Res, Natl Inst Neurosci, Tokyo, Japan.
   [Nonaka, Ikuya] Natl Ctr Neurol & Psychiat, Natl Ctr Hosp Mental Nervous & Muscular Disorders, Tokyo, Japan.
C3 National Center for Neurology & Psychiatry - Japan; Yamaguchi
   University; Iwate Medical University; National Center for Neurology &
   Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan
RP Goto, Y (corresponding author), Natl Ctr Neurol & Psychiat, Dept Mental Retardat & Birth Defect Res, Natl Inst Neurosci, 4-1-1 Ogawahigashi, Tokyo, Japan.
EM goto@ncnp.go.jp
RI Nishino, Ichizo/G-2676-2010
OI Nishino, Ichizo/0000-0001-9452-112X
FU Ministry of Health, Labor and Welfare of Japan [1513-4, 18A-5]; Japan
   Health Sciences Foundation [KHD2207]
FX We thank Mayuko Kato, Mitsuko Tanabe, and Munemitsu Yuasa for technical
   assistance. This work was supported in part by a Research Grant (1513-4,
   18A-5) for Nervous and Mental Disorders from the Ministry of Health,
   Labor and Welfare of Japan (Y.G.), and a grant of the Comprehensive
   Research Project on Health Sciences Focusing on Drug Innovation
   (KHD2207) from the Japan Health Sciences Foundation (Y.G.).
CR Akanuma J, 2000, J HUM GENET, V45, P337, DOI 10.1007/s100380070004
   Campos Y, 2001, NEUROMUSCULAR DISORD, V11, P477, DOI 10.1016/S0960-8966(00)00223-6
   Chinnery PF, 1999, J MED GENET, V36, P505, DOI 10.1136/jmg.36.7.505
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   D'Aurelio M, 2006, HUM MOL GENET, V15, P2157, DOI 10.1093/hmg/ddl141
   Gattermann N, 2004, BLOOD, V103, P1499, DOI 10.1182/blood-2003-07-2446
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO Y, 1995, MUSCLE NERVE, pS107
   GOTO YI, 1994, BIOCHEM BIOPH RES CO, V202, P1624, DOI 10.1006/bbrc.1994.2119
   Habano W, 2000, GASTROENTEROLOGY, V118, P835, DOI 10.1016/S0016-5085(00)70169-7
   Hadjigeorgiou GM, 1999, J NEUROL SCI, V164, P153, DOI 10.1016/S0022-510X(99)00062-3
   Hao HL, 1996, J BIOL CHEM, V271, P2347, DOI 10.1074/jbc.271.4.2347
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Jaksch M, 2001, NEUROLOGY, V57, P1930, DOI 10.1212/WNL.57.10.1930
   Kawarai T, 1997, NEUROLOGY, V49, P598, DOI 10.1212/WNL.49.2.598
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   KOGA Y, 1995, MUSCLE NERVE, pS119
   Komaki H, 2003, MITOCHONDRION, V2, P293, DOI 10.1016/S1567-7249(03)00003-5
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   MORTEN KJ, 1993, HUM MOL GENET, V2, P2081, DOI 10.1093/hmg/2.12.2081
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Nishino I, 1996, MUSCLE NERVE, V19, P1603, DOI 10.1002/(SICI)1097-4598(199612)19:12<1603::AID-MUS10>3.0.CO;2-S
   Robinson B H, 1996, Methods Enzymol, V264, P454, DOI 10.1016/S0076-6879(96)64041-5
   SAKUTA R, 1989, ANN NEUROL, V25, P594, DOI 10.1002/ana.410250611
   Seneca S, 2001, ARCH NEUROL-CHICAGO, V58, P1113, DOI 10.1001/archneur.58.7.1113
   SEVIDEI S, 2002, NEUROMUSCULAR DISORD, V12, P524
   Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
NR 40
TC 22
Z9 26
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD APR
PY 2009
VL 9
IS 2
BP 115
EP 122
DI 10.1016/j.mito.2009.01.005
PG 8
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 428PO
UT WOS:000264861400005
PM 19460299
DA 2024-11-01
ER

PT J
AU Crispim, D
   Estivalet, AAF
   Roisenberg, I
   Gross, JL
   Canani, LH
AF Crispim, Daisy
   Estivalet, Aline A. F.
   Roisenberg, Israel
   Gross, Jorge L.
   Canani, Luis H.
TI Prevalence of 15 Mitochondrial DNA Mutations Among Type 2 Diabetic
   Patients with or without Clinical Characteristics of Maternally
   Inherited Diabetes and Deafness
SO ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA
LA English
DT Article
DE Type 2 diabetes; Mitochondrial DNA mutations; Mitochondrial diabetes;
   MIDD; A3243G tRNA(Leu(UUR)) mutation
ID MTDNA MUTATIONS; GENE; MELLITUS; JAPANESE; ASSOCIATION; EXPRESSION;
   MYOPATHY; SEQUENCE; DEFECTS
AB The aim of the present study is to investigate the prevalence of ten described mitochondrial DNA (mtDNA) mutations in patients with type 2 diabetes, and search for new mutations in four mtDNA genes in a subgroup of patients with characteristics of maternally inherited diabetes and deafness (MIDD). These mutations were investigated in 407 type 2 diabetic patients without characteristics of mitochondrial diabetes ("classical" type 2 diabetes group) and in 38 type 2 diabetic patients with characteristics suggestive of MIDD. Through sequencing of four mtDNA genes in MIDD patients, we selected five others potentially pathogenic mutations that were also screened in the remaining patients. Overall, the frequency of the fifteen analyzed mutations was 36.84% in the MIDD group and 2.45% in the "classical" type 2 diabetes group (p < 0.001). In conclusion, our study reinforces the importance of mtDNA mutations in the pathogenesis of MIDD. (Arq Bras Endocrinol Metab 2008; 52/8:1228-1235)
C1 [Crispim, Daisy] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Endocrinol, Serv Endocrinol, BR-90035003 Porto Alegre, RS, Brazil.
   [Roisenberg, Israel] Univ Fed Rio Grande do Sul, Dept Genet, BR-90035003 Porto Alegre, RS, Brazil.
C3 Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio
   Grande do Sul
RP Crispim, D (corresponding author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Endocrinol, Serv Endocrinol, Rua Ramiro Barcelos 2350,Predio 12,4 Andar, BR-90035003 Porto Alegre, RS, Brazil.
EM daisy_crispim@hotmail.com
RI Crispim, Daisy/R-5170-2019; Canani, Luis/G-9686-2012
OI Crispim, Daisy/0000-0001-5095-9269
CR Alcolado JC, 2002, DIABETIC MED, V19, P89, DOI 10.1046/j.1464-5491.2002.00675.x
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Brown MD, 2001, HUM GENET, V109, P33, DOI 10.1007/s004390100538
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Choo-Kang ATW, 2002, DIABETES, V51, P2317, DOI 10.2337/diabetes.51.7.2317
   Crispim D, 2002, CLIN ENDOCRINOL, V57, P141, DOI 10.1046/j.1365-2265.2002.01569_1.x
   Crispim Daisy, 2006, Arq Bras Endocrinol Metab, V50, P862, DOI 10.1590/S0004-27302006000500006
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Fukuda M, 1999, J DIABETES COMPLICAT, V13, P277, DOI 10.1016/S1056-8727(99)00060-4
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   Hirai M, 1996, BIOCHEM BIOPH RES CO, V219, P951, DOI 10.1006/bbrc.1996.0324
   IKEBE S, 1995, MOL BRAIN RES, V28, P281, DOI 10.1016/0169-328X(94)00209-W
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   LAM CW, 2001, J MED GENET, P38
   Lamson Davis W, 2002, Altern Med Rev, V7, P94
   Lehtonen MS, 2003, HUM GENET, V113, P220, DOI 10.1007/s00439-003-0966-9
   Liu SM, 2007, DIABETES RES CLIN PR, V76, P425, DOI 10.1016/j.diabres.2006.09.032
   Maassen JA, 2006, ENDOCRIN METAB CLIN, V35, P385, DOI 10.1016/j.ecl.2006.02.014
   Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103
   *MITOMAP, 2008, MITOMAP HUM MIT GEN
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   NAKAGAWA Y, 1995, BIOCHEM BIOPH RES CO, V209, P664, DOI 10.1006/bbrc.1995.1550
   Ohkubo K, 2001, CLIN CHEM, V47, P1641
   Perucca-Lostanlen D, 2000, BIOCHEM BIOPH RES CO, V277, P771, DOI 10.1006/bbrc.2000.3751
   Povalko N, 2005, MITOCHONDRION, V5, P194, DOI 10.1016/j.mito.2005.03.003
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Tang DL, 2006, DIABETES RES CLIN PR, V73, P77, DOI 10.1016/j.diabres.2005.12.001
   Tawata M, 1998, DIABETES, V47, P276, DOI 10.2337/diab.47.2.276
   Tawata M, 2000, DIABETES, V49, P1269, DOI 10.2337/diabetes.49.7.1269
   Terasaki F, 2001, JPN CIRC J, V65, P691, DOI 10.1253/jcj.65.691
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Vialettes BH, 1997, DIABETES CARE, V20, P1731, DOI 10.2337/diacare.20.11.1731
   *WHO STUD GROUP, 1985, TECHN REP SER, V727
   Yu P, 2004, CHINESE MED J-PEKING, V117, P985
NR 38
TC 18
Z9 18
U1 0
U2 5
PU SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA
PI RIO DE JANEIRO, RJ
PA RUA HUMAITA, 85 CJ 501, RIO DE JANEIRO, RJ, 22261-000, BRAZIL
SN 0004-2730
EI 1677-9487
J9 ARQ BRAS ENDOCRINOL
JI Arq. Bras. Endocrinol. Metabol.
PD NOV
PY 2008
VL 52
IS 8
BP 1228
EP 1235
DI 10.1590/S0004-27302008000800005
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 392PB
UT WOS:000262313500005
PM 19169474
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Cheng, WQ
   Zhang, YT
   He, L
AF Cheng, Weiqin
   Zhang, Yuting
   He, Ling
TI MRI Features of Stroke-Like Episodes in Mitochondrial Encephalomyopathy
   With Lactic Acidosis and Stroke-Like Episodes
SO FRONTIERS IN NEUROLOGY
LA English
DT Review
DE mitochondrial myopathy; encephalopathy; lactic acidosis and stroke-like
   episodes (MELAS); stroke-like episodes; MRI; neuroimaging; application
ID MAGNETIC-RESONANCE-SPECTROSCOPY; MELAS SYNDROME; ISCHEMIC-STROKE;
   DIFFUSION; ENCEPHALOPATHY; MYOPATHY; LESIONS; HYPERPERFUSION;
   PATHOGENESIS; MUTATION
AB Mitochondrial myopathy encephalopathy lactic acidosis and stroke-like episodes (MELAS) is an important cause of stroke-mimicking diseases that predominantly affect patients before 40 years of age. MELAS results from gene mutations in either mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) responsible for the wide spectrum of clinical symptoms and imaging findings. Neurological manifestations can present with stroke-like episodes (the cardinal features of MELAS), epilepsy, cognitive and mental disorders, or recurrent headaches. Magnetic resonance imaging (MRI) is an important tool for detecting stroke-like lesions, accurate recognition of imaging findings is important in guiding clinical decision making in MELAS patients. With the development of neuroimaging technologies, MRI plays an increasingly important role in course monitoring and efficacy assessment of the disease. In this article, we provide an overview of the neuroimaging features and the application of novel MRI techniques in MELAS syndrome.
C1 [Cheng, Weiqin; Zhang, Yuting; He, Ling] Chongqing Med Univ, Childrens Hosp,China Int Sci & Technol Cooperat B, Dept Radiol,Natl Clin Res Ctr Child Hlth & Diorde, Minist Educ,Key Lab Child Dev & Disorders,Chongqi, Chongqing, Peoples R China.
C3 Chongqing Medical University
RP Zhang, YT; He, L (corresponding author), Chongqing Med Univ, Childrens Hosp,China Int Sci & Technol Cooperat B, Dept Radiol,Natl Clin Res Ctr Child Hlth & Diorde, Minist Educ,Key Lab Child Dev & Disorders,Chongqi, Chongqing, Peoples R China.
EM zhangyuting@cqmu.edu.cn; doctorheling@yeah.net
RI ZHANG, YUTING/HOH-4131-2023
OI He, Ling/0000-0003-2702-2579
FU joint Chongqing Health Commission; Chongqing Science and Technology
   Bureau Medical Research Project [2020FYYX128]; Chongqing Science and
   Technology Bureau, Technology Foresight and System Innovation Project
   [cstc2021jsyj-yzysbAX0019]
FX Funding This study was supported by grants from the joint Chongqing
   Health Commission and Chongqing Science and Technology Bureau Medical
   Research Project (No: 2020FYYX128) and Chongqing Science and Technology
   Bureau, Technology Foresight and System Innovation Project (No:
   cstc2021jsyj-yzysbAX0019).
CR Abe K, 2004, NEURORADIOLOGY, V46, P113, DOI 10.1007/s00234-003-1138-2
   Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Bhatia KD, 2020, AM J NEURORADIOL, V41, P167, DOI 10.3174/ajnr.A6325
   Casimiro C, 2012, ACTA MEDICA PORT, V25, P59
   CASTILLO M, 1995, AM J NEURORADIOL, V16, P233
   Chen CN, 2012, NEUROL INDIA, V60, P86, DOI 10.4103/0028-3886.93609
   Chen H, 2020, SOMATOSENS MOT RES, V37, P45, DOI 10.1080/08990220.2020.1720636
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Gieraerts C, 2013, J COMPUT ASSIST TOMO, V37, P279, DOI 10.1097/RCT.0b013e3182811170
   Goodfellow JA, 2012, POSTGRAD MED J, V88, P326, DOI 10.1136/postgradmedj-2011-130326
   Gramegna LL, 2021, J NEURORADIOLOGY, V48, P359, DOI 10.1016/j.neurad.2021.02.002
   Hovsepian DA, 2019, ACTA NEUROL SCAND, V139, P82, DOI 10.1111/ane.13027
   Hsu YHR, 2016, HEART FAIL REV, V21, P103, DOI 10.1007/s10741-015-9524-5
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Ikawa M, 2013, MITOCHONDRION, V13, P676, DOI 10.1016/j.mito.2013.09.007
   Ishigaki H, 2021, BRAIN DEV-JPN, V43, P931, DOI 10.1016/j.braindev.2021.05.002
   Ito H, 2008, BRAIN DEV-JPN, V30, P483, DOI 10.1016/j.braindev.2008.01.003
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kim JH, 2011, KOREAN J RADIOL, V12, P15, DOI 10.3348/kjr.2011.12.1.15
   Kolb SJ, 2003, J NEUROL SCI, V216, P11, DOI 10.1016/S0022-510X(03)00218-1
   Li C, 2021, MITOCHONDRION, V58, P131, DOI 10.1016/j.mito.2021.02.015
   Li R, 2017, J MAGN RESON IMAGING, V45, P199, DOI 10.1002/jmri.25354
   Li YX, 2019, CLIN NEURORADIOL, V29, P321, DOI 10.1007/s00062-018-0662-8
   Li YX, 2017, J MAGN RESON IMAGING, V46, P915, DOI 10.1002/jmri.25592
   Malhotra K, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0583-7
   Minobe S, 2015, J CLIN NEUROSCI, V22, P407, DOI 10.1016/j.jocn.2014.05.021
   Möller HE, 2005, J NEUROL SCI, V229, P131, DOI 10.1016/j.jns.2004.11.014
   Ohshita T, 2000, NEURORADIOLOGY, V42, P651, DOI 10.1007/s002340000335
   Pittet MP, 2016, J INHERIT METAB DIS, V39, P465, DOI 10.1007/s10545-016-9929-x
   Pizzamiglio C, 2021, GENES-BASEL, V12, DOI 10.3390/genes12101643
   [北京医学会罕见病分会 Rare Diseases Branch of Beijing Medical Association], 2020, [中华神经科杂志, Chinese Journal of Neurology], V53, P171
   Renard D, 2020, ACTA NEUROL BELG, V120, P455, DOI 10.1007/s13760-017-0867-7
   Renard D, 2014, J NEUROL NEUROSUR PS, V85, P1055, DOI 10.1136/jnnp-2013-306933
   Rodan LH, 2015, MITOCHONDRION, V22, P66, DOI 10.1016/j.mito.2015.03.002
   Rodan LH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238224
   Stoquart-ElSankari S, 2008, J NEUROL, V255, P1593, DOI 10.1007/s00415-008-0968-6
   Sun XR, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013866
   Takasu Miyuki, 2002, Magn Reson Med Sci, V1, P50, DOI 10.2463/mrms.1.50
   Tschampa HJ, 2013, J NEUROL, V260, P1071, DOI 10.1007/s00415-012-6763-4
   Tsujikawa T, 2010, BRAIN DEV-JPN, V32, P143, DOI 10.1016/j.braindev.2008.12.003
   Tzoulis C, 2009, STROKE, V40, pE15, DOI 10.1161/STROKEAHA.108.523118
   Virtanen SM, 2011, AM J NEURORADIOL, V32, P522, DOI 10.3174/ajnr.A2309
   Wang R, 2020, NEUROIMAGE-CLIN, V28, DOI 10.1016/j.nicl.2020.102480
   Wang R, 2021, J MAGN RESON IMAGING, V53, P427, DOI 10.1002/jmri.27353
   Wang YX, 2015, CHINESE MED J-PEKING, V128, P1820, DOI 10.4103/0366-6999.159360
   Weiduschat N, 2014, NEUROLOGY, V82, P798, DOI 10.1212/WNL.0000000000000169
   Whitehead MT, 2017, PEDIATR NEUROL, V75, P61, DOI 10.1016/j.pediatrneurol.2017.06.017
   Wilichowski E, 1999, NEUROPEDIATRICS, V30, P256, DOI 10.1055/s-2007-973500
   Xu WXZ, 2018, J COMPUT ASSIST TOMO, V42, P510, DOI 10.1097/RCT.0000000000000712
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yonemura K, 2001, AM J NEURORADIOL, V22, P269
   Yoshida T, 2013, INTERNAL MED, V52, P1389, DOI 10.2169/internalmedicine.52.0188
   Yu HO, 2019, J NEUROL, V266, P1459, DOI 10.1007/s00415-019-09283-3
NR 55
TC 18
Z9 20
U1 0
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
J9 FRONT NEUROL
JI Front. Neurol.
PD FEB 9
PY 2022
VL 13
AR 843386
DI 10.3389/fneur.2022.843386
PG 7
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA ZH1UG
UT WOS:000760730800001
PM 35222261
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Suman, M
   Sharpe, JA
   Bentham, RB
   Kotiadis, VN
   Menegollo, M
   Pignataro, V
   Molgó, J
   Muntoni, F
   Duchen, MR
   Pegoraro, E
   Szabadkai, G
AF Suman, Matteo
   Sharpe, Jenny A.
   Bentham, Robert B.
   Kotiadis, Vassilios N.
   Menegollo, Michela
   Pignataro, Viviana
   Molgo, Jordi
   Muntoni, Francesco
   Duchen, Michael R.
   Pegoraro, Elena
   Szabadkai, Gyorgy
TI Inositol trisphosphate receptor-mediated Ca<SUP>2+</SUP> signalling
   stimulates mitochondrial function and gene expression in core myopathy
   patients
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID CONGENITAL MYOPATHIES; SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM;
   ER-MITOCHONDRIAL; CALCIUM; MUTATION; STRESS; CELLS; FIBER; MICE
AB Core myopathies are a group of childhood muscle disorders caused by mutations of the ryanodine receptor (RyR1), the Ca2+ release channel of the sarcoplasmic reticulum. These mutations have previously been associated with elevated inositol trisphosphate receptor (IP3R) levels in skeletal muscle myotubes derived from patients. However, the functional relevance and the relationship of IP3R mediated Ca2+ signalling with the pathophysiology of the disease is unclear. It has also been suggested that mitochondrial dysfunction underlies the development of central and diffuse multi-mini-cores, devoid of mitochondrial activity, which is a key pathological consequence of RyR1 mutations. Here we qusedmuscle biopsies of central core and multi-minicore disease patients with RyR1 mutations, as well as cellular and in vivo mouse models of the disease to characterize global cellular and mitochondrial Ca2+ signalling, mitochondrial function and gene expression associated with the disease. We show that RyR1 mutations that lead to the depletion of the channel are associated with increased IP3-mediated nuclear and mitochondrial Ca2+ signals and increased mitochondrial activity. Moreover, western blot and microarray analysis indicated enhanced mitochondrial biogenesis at the transcriptional and protein levels and was reflected in increased mitochondrial DNA content. The phenotype was recapitulated by RYR1 silencing in mouse cellular myotube models. Altogether, these data indicate that remodelling of skeletal muscle Ca2+ signalling following loss of functional RyR1 mediates bioenergetic adaptation.
C1 [Suman, Matteo; Menegollo, Michela; Pignataro, Viviana; Szabadkai, Gyorgy] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy.
   [Suman, Matteo; Pegoraro, Elena] Univ Padua, Dept Neurosci, Neuromuscular Unit, I-35131 Padua, Italy.
   [Sharpe, Jenny A.; Bentham, Robert B.; Kotiadis, Vassilios N.; Duchen, Michael R.; Szabadkai, Gyorgy] UCL, Dept Cell & Dev Biol, Consortium Mitochondrial Res, London WC1E 6BT, England.
   [Bentham, Robert B.; Szabadkai, Gyorgy] Francis Crick Inst, London NW1 1AT, England.
   [Molgo, Jordi] Univ Paris Saclay, Commissariat Energie Atom & Energies Alternat CEA, Inst Sci Vivant Frederic Joliot, Serv Ingn Mol Prot, F-91191 Gif Sur Yvette, France.
   [Molgo, Jordi] Univ Paris Sud, CNRS, UMR 9197, Inst Neurosci Paris Saclay, F-91198 Gif Sur Yvette, France.
   [Muntoni, Francesco] UCL, Great Ormond St Inst Child Hlth, Dubowitz Neuromuscular Ctr, London WC1N 1EH, England.
   [Muntoni, Francesco] MRC, Ctr Neuromuscular Dis, London WC1N 1EH, England.
C3 University of Padua; University of Padua; University of London;
   University College London; Francis Crick Institute; CEA; Universite
   Paris Cite; Universite Paris Saclay; Universite Paris Cite; Universite
   Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS
   - National Institute for Biology (INSB); University of London;
   University College London; University of London; University College
   London
RP Szabadkai, G (corresponding author), Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy.; Szabadkai, G (corresponding author), UCL, Dept Cell & Dev Biol, Consortium Mitochondrial Res, London WC1E 6BT, England.; Szabadkai, G (corresponding author), Francis Crick Inst, London NW1 1AT, England.
EM g.szabadkai@ucl.ac.uk
RI Duchen, Michael/A-2116-2009
OI Duchen, Michael/0000-0003-2548-4294; Szabadkai,
   Gyorgy/0000-0002-3006-3577
FU Telethon [GEP12066, GGP16026]; University College London COMPLeX/British
   Heart Foundation Fund [SP/08/004]; Biotechnology and Biological Sciences
   Research Council [BB/L020874/1, BB/P018726/1]; Ricerca Finalizzata,
   Italian Ministry of Health [RF-2013-02359065]; Medical Research Council;
   Telethon BioBank [GTB12001D]; EuroBioBank network; National Institute of
   Health Research Biomedical Research Centre at Great Ormond Street
   Hospital for Children NHS Foundation Trust; MDUK; NHSE; Action Medical
   Research [GN2158]; Biotechnology and Biological Sciences Research
   Council; BBSRC [BB/L020874/1, BB/P018726/1] Funding Source: UKRI; MRC
   [MR/M02492X/1] Funding Source: UKRI
FX This work was supported by the following grants: Telethon (GEP12066 and
   GGP16026), University College London COMPLeX/British Heart Foundation
   Fund (SP/08/004), the Biotechnology and Biological Sciences Research
   Council (BB/L020874/1 and BB/P018726/1) to G.S. and M.R.D.; Ricerca
   Finalizzata, Italian Ministry of Health (RF-2013-02359065) to G.S. and
   E.P. The support of the Medical Research Council to the Neuromuscular
   Centre Biobank is gratefully acknowledged. We greatly appreciate support
   from the Telethon BioBank (GTB12001D), and the EuroBioBank network. F.M.
   was supported by the National Institute of Health Research Biomedical
   Research Centre at Great Ormond Street Hospital for Children NHS
   Foundation Trust. The support of MDUK to the Dubowitz Neuromuscular
   Centre and of NHSE to the NSCT Diagnostic Service for Congenital
   Myopathies is also acknowledged. V.N.K. was supported by an Action
   Medical Research grant (GN2158). Funding to pay the Open Access
   publication charges for this article was provided by Biotechnology and
   Biological Sciences Research Council.
CR Amburgey K, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-117
   Arias-Calderón M, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0087-5
   Boncompagni S, 2010, AGING CELL, V9, P958, DOI 10.1111/j.1474-9726.2010.00623.x
   Boncompagni S, 2009, P NATL ACAD SCI USA, V106, P21996, DOI 10.1073/pnas.0911496106
   Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783
   Bravo R, 2011, J CELL SCI, V124, P2143, DOI 10.1242/jcs.080762
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   Cárdenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007
   Chiesa A, 2001, BIOCHEM J, V355, P1, DOI 10.1042/0264-6021:3550001
   Dowling JJ, 2012, BRAIN, V135, P1115, DOI 10.1093/brain/aws036
   Freyssenet D, 2004, AM J PHYSIOL-CELL PH, V286, pC1053, DOI 10.1152/ajpcell.00418.2003
   Giorgio V, 2018, CELL CALCIUM, V70, P56, DOI 10.1016/j.ceca.2017.05.004
   Glancy B, 2015, NATURE, V523, P617, DOI 10.1038/nature14614
   Hill JM, 2014, METHOD ENZYMOL, V543, P47, DOI 10.1016/B978-0-12-801329-8.00003-9
   Hwang JH, 2012, TRENDS MOL MED, V18, P644, DOI 10.1016/j.molmed.2012.09.006
   Ibarra C, 2013, CIRC RES, V112, P236, DOI 10.1161/CIRCRESAHA.112.273839
   Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270
   Jaimovich E, 2005, FEBS LETT, V579, P2051, DOI 10.1016/j.febslet.2005.02.053
   Jones AWE, 2012, MITOCHONDRION, V12, P86, DOI 10.1016/j.mito.2011.09.009
   Jungbluth H, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00339
   Jungbluth H, 2011, SEMIN PEDIATR NEUROL, V18, P239, DOI 10.1016/j.spen.2011.10.005
   Jungbluth H, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-31
   Klein A, 2012, HUM MUTAT, V33, P981, DOI 10.1002/humu.22056
   Loy RE, 2011, J GEN PHYSIOL, V137, P43, DOI 10.1085/jgp.201010523
   North KN, 2014, NEUROMUSCULAR DISORD, V24, P97, DOI 10.1016/j.nmd.2013.11.003
   Ravenscroft G, 2015, BRAIN, V138, P246, DOI 10.1093/brain/awu368
   Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199
   Rokach O, 2015, HUM MOL GENET, V24, P4636, DOI 10.1093/hmg/ddv195
   Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3
   Rossi AE, 2011, AM J PHYSIOL-CELL PH, V301, pC1128, DOI 10.1152/ajpcell.00194.2011
   Sato I, 2008, NEUROLOGY, V70, P114, DOI 10.1212/01.wnl.0000269792.63927.86
   Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010
   Sewry CA, 2017, NEUROPATH APPL NEURO, V43, P5, DOI 10.1111/nan.12369
   Snoeck M, 2016, CELL BIOCHEM BIOPHYS, V74, P85, DOI 10.1007/s12013-015-0704-7
   Suzuki J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5153
   Szabadkai G, 2001, PFLUG ARCH EUR J PHY, V441, P678, DOI 10.1007/s004240000466
   Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007
   Vassilopoulos S, 2005, J BIOL CHEM, V280, P28601, DOI 10.1074/jbc.M501484200
   Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016
   Wright FA, 2016, PROG MOL BIOL TRANSL, V141, P141, DOI 10.1016/bs.pmbts.2016.02.004
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Yi MQ, 2012, CELL CALCIUM, V52, P355, DOI 10.1016/j.ceca.2012.05.012
   ZHOU H, 2012, NEUROMUSCULAR DIS S1, V22, pS32
   Zhou H, 2007, BRAIN, V130, P2024, DOI 10.1093/brain/awm096
   Zhou HY, 2013, HUM MUTAT, V34, P986, DOI 10.1002/humu.22326
   Zvaritch E, 2007, P NATL ACAD SCI USA, V104, P18537, DOI 10.1073/pnas.0709312104
   Zvaritch E, 2009, P NATL ACAD SCI USA, V106, P21813, DOI 10.1073/pnas.0912126106
NR 47
TC 12
Z9 12
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JUL 1
PY 2018
VL 27
IS 13
BP 2367
EP 2382
DI 10.1093/hmg/ddy149
PG 16
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA GM9OJ
UT WOS:000438578900011
PM 29701772
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Finsterer, J
AF Finsterer, Josef
TI Update Review about Metabolic Myopathies
SO LIFE-BASEL
LA English
DT Review
DE metabolism; myopathy; neuromuscular; genetics; mitochondrial
   deoxy-nucleic acid (mtDNA); fat metabolism; mitochondrial
ID POLYGLUCOSAN BODY MYOPATHY; PALMITOYLTRANSFERASE-II DEFICIENCY; ONSET
   POMPE DISEASE; DANON DISEASE; PHENOTYPIC-EXPRESSION; MUTATIONS;
   MANAGEMENT; DISORDER; EXERCISE; PATIENT
AB The aim of this review is to summarize and discuss recent findings and new insights in the etiology and phenotype of metabolic myopathies. The review relies on a systematic literature review of recent publications. Metabolic myopathies are a heterogeneous group of disorders characterized by mostly inherited defects of enzymatic pathways involved in muscle cell metabolism. Metabolic myopathies present with either permanent (fixed) or episodic abnormalities, such as weakness, wasting, exercise-intolerance, myalgia, or an increase of muscle breakdown products (creatine-kinase, myoglobin) during exercise. Though limb and respiratory muscles are most frequently affected, facial, extra-ocular, and axial muscles may be occasionally also involved. Age at onset and prognosis vary considerably. There are multiple disease mechanisms and the pathophysiology is complex. Genes most recently related to metabolic myopathy include PGM1, GYG1, RBCK1, VMA21, MTO1, KARS, and ISCA2. The number of metabolic myopathies is steadily increasing. There is limited evidence from the literature that could guide diagnosis and treatment of metabolic myopathies. Treatment is limited to mainly non-invasive or invasive symptomatic measures. In conclusion, the field of metabolic myopathies is evolving with the more widespread availability and application of next generation sequencing technologies worldwide. This will broaden the knowledge about pathophysiology and putative therapeutic strategies for this group of neuromuscular disorders.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Messerli Inst, A-1180 Vienna, Austria.
C3 Rudolfstiftung Hospital
RP Finsterer, J (corresponding author), Krankenanstalt Rudolfstiftung Wien, Messerli Inst, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
RI Finsterer, J/AAE-5733-2020
OI finsterer, josef/0000-0003-2839-7305
CR Al-Hassnan ZN, 2015, J MED GENET, V52, P186, DOI 10.1136/jmedgenet-2014-102592
   Alfadhel M, 2018, EUR J PAEDIATR NEURO, V22, P46, DOI 10.1016/j.ejpn.2017.10.003
   Angelini C, 2016, BBA-MOL BASIS DIS, V1862, P1367, DOI 10.1016/j.bbadis.2016.04.008
   Arnold GL, 2009, MOL GENET METAB, V96, P85, DOI 10.1016/j.ymgme.2008.09.008
   Ashwal S, 1985, Pediatr Neurol, V1, P185, DOI 10.1016/0887-8994(85)90062-1
   Balasubramanian M, 2018, MOL GENET METAB REP, V15, P69, DOI 10.1016/j.ymgmr.2018.02.008
   Béhin A, 2016, REV NEUROL-FRANCE, V172, P231, DOI 10.1016/j.neurol.2015.11.008
   Boemer F, 2016, CLIN GENET, V89, P193, DOI 10.1111/cge.12593
   Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457
   Bottillo I, 2016, CARDIOVASC PATHOL, V25, P423, DOI 10.1016/j.carpath.2016.07.005
   Burda P, 2015, CURR OPIN CLIN NUTR, V18, P415, DOI 10.1097/MCO.0000000000000181
   Chan J, 2017, MOL GENET METAB, V120, P163, DOI 10.1016/j.ymgme.2016.12.004
   Chien YH, 2017, MOL GENET METAB REP, V11, P31, DOI 10.1016/j.ymgmr.2017.04.004
   Cohen I, 2018, AM J MED GENET A, V176, P330, DOI 10.1002/ajmg.a.38574
   Comi GP, 2001, ANN NEUROL, V50, P202, DOI 10.1002/ana.1095
   Cucchiari D, 2018, CEN CASE REP, V7, P62, DOI 10.1007/s13730-017-0292-z
   Debashree B, 2018, J NEUROCHEM, V145, P323, DOI 10.1111/jnc.14318
   Desikan M, 2018, NEUROMUSCULAR DISORD, V28, P346, DOI 10.1016/j.nmd.2018.01.002
   Dimauro I, 2018, CELL STRESS CHAPERON, V23, P491, DOI 10.1007/s12192-017-0866-x
   Ding Y, 2018, J PEDIATR ENDOCR MET, V31, P781, DOI 10.1515/jpem-2017-0551
   Dodge JC, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00356
   El-Hattab A.W., 1993, GENEREVIEWS
   Endo Y, 2015, ACTA NEUROPATHOL, V129, P391, DOI 10.1007/s00401-015-1385-4
   Finsterer J, 2017, ACTA NEUROL SCAND, V136, P558, DOI 10.1111/ane.12758
   Finsterer J., 2011, JATR NEUROL PSYCHIAT, V4, P26
   Finsterer J, 2015, REV MED CHILE, V143, P1210, DOI 10.4067/S0034-98872015000900016
   Finsterer J, 2015, PEDIATR NEUROL, V52, P302, DOI 10.1016/j.pediatrneurol.2014.06.023
   Garone C, 2017, HUM MOL GENET, V26, P4257, DOI 10.1093/hmg/ddx314
   Gourzi P, 2019, EUR J MED GENET, V62, P77, DOI 10.1016/j.ejmg.2018.05.015
   Hansen JS, 2018, ACTA NEUROL SCAND, V137, P85, DOI 10.1111/ane.12811
   Hedberg-Oldfors C, 2018, ACTA NEUROL SCAND, V137, P308, DOI 10.1111/ane.12865
   Hedberg-Oldfors C, 2015, MOL ASPECTS MED, V46, P85, DOI 10.1016/j.mam.2015.08.006
   Horvath JJ, 2012, MOL GENET METAB, V107, P496, DOI 10.1016/j.ymgme.2012.09.025
   Inal-Gültekin G, 2017, NEUROMUSCULAR DISORD, V27, P997, DOI 10.1016/j.nmd.2017.06.004
   Kakkar A, 2018, ULTRASTRUCT PATHOL, V42, P211, DOI 10.1080/01913123.2018.1447624
   Kasapkara ÇS, 2017, J PEDIATR ENDOCR MET, V30, P459, DOI 10.1515/jpem-2016-0317
   Kim J, 2014, TEX HEART I J, V41, P332, DOI 10.14503/THIJ-13-3279
   Koo P, 2018, CLIN CHEST MED, V39, P401, DOI 10.1016/j.ccm.2018.02.001
   Krenn M, 2018, J NEUROL, V265, P394, DOI 10.1007/s00415-017-8710-x
   Kyaw H, 2018, CUREUS J MED SCIENCE, V10, DOI 10.7759/cureus.2155
   Laforêt P, 2017, CURR OPIN NEUROL, V30, P449, DOI 10.1097/WCO.0000000000000484
   Leung Doris G, 2018, J Clin Neuromuscul Dis, V19, P117, DOI 10.1097/CND.0000000000000200
   Li SC, 2012, J CHILD NEUROL, V27, P204, DOI 10.1177/0883073811415107
   Longo N, 2016, ANN NUTR METAB, V68, P5, DOI 10.1159/000448321
   Lu YY, 2017, J NEUROL SCI, V379, P137, DOI 10.1016/j.jns.2017.05.056
   Luna-Sánchez M, 2017, EMBO MOL MED, V9, P78, DOI 10.15252/emmm.201606345
   Luo SS, 2014, CLIN NEUROPATHOL, V33, P284, DOI 10.5414/NP300668
   Mamoune A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004711
   Mantilla C, 2018, BIOMEDICA, V38, P30, DOI 10.7705/biomedica.v38i0.3454
   Marino M, 2016, NEUROMUSCULAR DISORD, V26, P890, DOI 10.1016/j.nmd.2016.09.025
   MATSUISHI T, 1988, BRAIN DEV-JPN, V10, P125, DOI 10.1016/S0387-7604(88)80083-4
   McIntosh P, 2017, AM J MED GENET A, V173, P2628, DOI 10.1002/ajmg.a.38369
   Motzek A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151261
   Munteanu I, 2015, NEUROLOGY, V84, P1714, DOI 10.1212/WNL.0000000000001499
   Musumeci O, 2012, NEUROMUSCULAR DISORD, V22, P325, DOI 10.1016/j.nmd.2011.10.022
   Nazari Ferdos, 2018, J Clin Neuromuscul Dis, V19, P203, DOI 10.1097/CND.0000000000000212
   Nilsson J, 2013, ANN NEUROL, V74, P914, DOI 10.1002/ana.23963
   Nolting K, 2017, MOL GENET METAB REP, V13, P33, DOI 10.1016/j.ymgmr.2017.07.010
   O'Byrne JJ, 2018, MOL GENET METAB, V123, P28, DOI 10.1016/j.ymgme.2017.11.003
   Obaid A, 2018, JIMD REP, V40, P47, DOI 10.1007/8904_2017_58
   Olpin SE, 2015, J CLIN PATHOL, V68, P410, DOI 10.1136/jclinpath-2014-202808
   Ondruskova N, 2014, NEUROENDOCRINOL LETT, V35, P137
   Phowthongkum P, 2018, JIMD REP, V41, P11, DOI 10.1007/8904_2017_74
   Piekutowska-Abramczuk D, 2018, AM J HUM GENET, V102, P460, DOI 10.1016/j.ajhg.2018.01.008
   Plöckinger U, 2018, HUM GENOMICS, V12, DOI 10.1186/s40246-018-0145-7
   Preisler N, 2017, MOL GENET METAB, V122, P117, DOI 10.1016/j.ymgme.2017.08.007
   Preisler N, 2015, J INHERIT METAB DIS, V38, P551, DOI 10.1007/s10545-014-9771-y
   Prospec, PROT SPEC
   Raymond FL, 2018, NAT REV GENET, V19, P399, DOI 10.1038/s41576-018-0022-1
   Reuser AJJ, 2019, HUM MUTAT, V40, P2146, DOI 10.1002/humu.23878
   Rowland TJ, 2016, J CELL SCI, V129, P2135, DOI 10.1242/jcs.184770
   Sakai C, 2015, HUM MUTAT, V36, P232, DOI 10.1002/humu.22730
   Samad F, 2017, INT J CARDIOL, V245, P201, DOI 10.1016/j.ijcard.2017.06.031
   Sentner CP, 2016, J INHERIT METAB DIS, V39, P697, DOI 10.1007/s10545-016-9932-2
   Sharpe AJ, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7060046
   Spiekerkoetter U, 2009, J INHERIT METAB DIS, V32, P498, DOI 10.1007/s10545-009-1126-8
   Tan JZ, 2018, CLIN NEUROL NEUROSUR, V168, P102, DOI 10.1016/j.clineuro.2018.03.001
   Tarnopolsky Mark A, 2016, Continuum (Minneap Minn), V22, P1829
   Tasca G, 2016, J NEUROL, V263, P2133, DOI 10.1007/s00415-016-8268-z
   Tonin P, 2009, NEUROMUSCULAR DISORD, V19, P776, DOI 10.1016/j.nmd.2009.08.007
   van Vliet P, 2018, JIMD REP, V38, P101, DOI 10.1007/8904_2017_37
   Verrigni D, 2017, CLIN GENET, V91, P918, DOI 10.1111/cge.12931
   Visuttijai K, 2020, J CLIN ENDOCR METAB, V105, P557, DOI 10.1210/clinem/dgz075
   Vittonatto Elisa, 2017, Acta Myol, V36, P191
   Voermans NC, 2017, NEUROMUSCULAR DISORD, V27, P370, DOI 10.1016/j.nmd.2017.01.014
   Wang JL, 2018, MOL GENET METAB, V124, P124, DOI 10.1016/j.ymgme.2018.04.012
   Wieser T, 2003, NEUROLOGY, V60, P1351, DOI 10.1212/01.WNL.0000055901.58642.48
   Witkowski G, 2018, NEUROL NEUROCHIR POL, V52, P465, DOI 10.1016/j.pjnns.2018.05.002
   Witting N, 2014, JAMA NEUROL, V71, P88, DOI 10.1001/jamaneurol.2013.3209
   Wong SYW, 2016, J PEDIATR-US, V175, P130, DOI 10.1016/j.jpeds.2016.04.021
   Yardeni M, 2017, AM J MED GENET A, V173, P2461, DOI 10.1002/ajmg.a.38320
   Yuan JH, 2013, J CLIN PATHOL, V66, P659, DOI 10.1136/jclinpath-2012-201431
   Yubero D, 2018, EXPERT REV MOL DIAGN, V18, P491, DOI 10.1080/14737159.2018.1478290
   Zhang Y, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-018-0560-6
NR 94
TC 8
Z9 9
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-1729
J9 LIFE-BASEL
JI Life-Basel
PD APR
PY 2020
VL 10
IS 4
AR 43
DI 10.3390/life10040043
PG 18
WC Biology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Microbiology
GA LO8OO
UT WOS:000533885500011
PM 32316520
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Tuppen, HAL
   Naess, K
   Kennaway, NG
   Al-Dosary, M
   Lesko, N
   Yarham, JW
   Bruhn, H
   Wibom, R
   Nennesmo, I
   Weleber, RG
   Blakely, EL
   Taylor, RW
   McFarland, R
AF Tuppen, Helen A. L.
   Naess, Karin
   Kennaway, Nancy G.
   Al-Dosary, Mazhor
   Lesko, Nicole
   Yarham, John W.
   Bruhn, Helene
   Wibom, Rolf
   Nennesmo, Inger
   Weleber, Richard G.
   Blakely, Emma L.
   Taylor, Robert W.
   McFarland, Robert
TI Mutations in the <i>mitochondrial tRNA<SUP>Ser(AGY)</SUP></i> gene are
   associated with deafness, retinal degeneration, myopathy and epilepsy
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE deafness; retinitis pigmentosa; mt-tRNA(Ser(AGY)); mutation
ID SUCCINATE-DEHYDROGENASE; PATHOGENICITY; DEFECTS
AB Although over 200 pathogenic mitochondrial DNA (mtDNA) mutations have been reported to date, determining the genetic aetiology of many cases of mitochondrial disease is still not straightforward. Here, we describe the investigations undertaken to uncover the underlying molecular defect(s) in two unrelated Caucasian patients with suspected mtDNA disease, who presented with similar symptoms of myopathy, deafness, neurodevelopmental delay, epilepsy, marked fatigue and, in one case, retinal degeneration. Histochemical and biochemical evidence of mitochondrial respiratory chain deficiency was observed in the patient muscle biopsies and both patients were discovered to harbour a novel heteroplasmic mitochondrial tRNA (mt-tRNA)(Ser(AGY)) (MTTS2) mutation (m.12264C > T and m.12261T > C, respectively). Clear segregation of the m.12261T > C mutation with the biochemical defect, as demonstrated by single-fibre radioactive RFLP, confirmed the pathogenicity of this novel variant in patient 2. However, unusually high levels of m.12264C > T mutation within both COX-positive (98.4 +/- 1.5%) and COX-deficient (98.2 +/- 2.1%) fibres in patient 1 necessitated further functional investigations to prove its pathogenicity. Northern blot analysis demonstrated the detrimental effect of the m.12264C > T mutation on mt-tRNA(Ser(AGY)) stability, ultimately resulting in decreased steady-state levels of fully assembled complexes I and IV, as shown by blue-native polyacrylamide gel electrophoresis. Our findings expand the spectrum of pathogenic mutations associated with the MTTS2 gene and highlight MTTS2 mutations as an important cause of retinal and syndromic auditory impairment. European Journal of Human Genetics (2012) 20, 897-904; doi:10.1038/ejhg.2012.44; published online 29 February 2012
C1 [McFarland, Robert] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Naess, Karin; Lesko, Nicole; Bruhn, Helene; Wibom, Rolf; Nennesmo, Inger] Karolinska Inst, Dept Lab Med, Stockholm, Sweden.
   [Naess, Karin] Karolinska Inst, Dept Pediat, CLINTEC, S-10401 Stockholm, Sweden.
   [Kennaway, Nancy G.; Weleber, Richard G.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA.
   [Weleber, Richard G.] Oregon Hlth & Sci Univ, Dept Ophthalmol, Casey Eye Inst, Portland, OR 97201 USA.
C3 Newcastle University - UK; Karolinska Institutet; Karolinska Institutet;
   Oregon Health & Science University; Oregon Health & Science University
RP McFarland, R (corresponding author), Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.mcfarland@ncl.ac.uk
OI Naess, Karin/0000-0003-4310-7927; Tuppen, Helen/0000-0001-8762-0824;
   Bruhn, Helene/0009-0007-4449-5382; McFarland,
   Robert/0000-0002-8833-2688; Yarham, John/0000-0003-4792-1790
FU Wellcome Trust Programme Grant [074454/Z/04/Z]; UK NHS Specialised
   Services; Muscular Dystrophy Association; Foundation Fighting Blindness
   (Columbia, MD); Stockholm County Council; Karolinska Institutet; MRC
   [G0800674] Funding Source: UKRI
FX The project was supported by a Wellcome Trust Programme Grant (RWT)
   (Grant number 074454/Z/04/Z). The mitochondrial diagnostic laboratory in
   Newcastle is funded by the UK NHS Specialised Services to provide the
   'Rare Mitochondrial Disease of Adults and Children' service
   (http://www.mitochondrialncg.nhs.uk/). Studies in Portland were
   supported in part by a grant from the Muscular Dystrophy Association (to
   NGK) and the Foundation Fighting Blindness (Columbia, MD) (to RGW).
   Financial support in Stockholm was given through the regional agreement
   on medical training and clinical research between Stockholm County
   Council and Karolinska Institutet.
CR Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Bornstein B, 2005, BIOCHEM J, V387, P773, DOI 10.1042/BJ20040949
   Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023
   Cardaioli E, 2011, J NEUROL SCI, V303, P142, DOI 10.1016/j.jns.2010.12.020
   Davidson MM, 2009, J MOL CELL CARDIOL, V46, P936, DOI 10.1016/j.yjmcc.2009.02.011
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Esteitie N, 2005, ANN NEUROL, V58, P544, DOI 10.1002/ana.20570
   Fischel-Ghodsian N, 2004, MITOCHONDRION, V4, P675, DOI 10.1016/j.mito.2004.07.040
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Guan MX, 2004, ANN NY ACAD SCI, V1011, P259, DOI 10.1196/annals.1293.025
   HALL RE, 1993, J CLIN INVEST, V92, P2660, DOI 10.1172/JCI116882
   Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100
   Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x
   LAUBER J, 1991, NUCLEIC ACIDS RES, V19, P1393, DOI 10.1093/nar/19.7.1393
   Leveque M, 2007, EUR J HUM GENET, V15, P1145, DOI 10.1038/sj.ejhg.5201891
   Levinger L, 2004, J MOL BIOL, V337, P535, DOI 10.1016/j.jmb.2004.02.008
   Lu JX, 2010, MITOCHONDRION, V10, P69, DOI 10.1016/j.mito.2009.09.007
   Lynn S, 1998, DIABETES, V47, P1800, DOI 10.2337/diabetes.47.11.1800
   Mansergh FC, 1999, AM J HUM GENET, V64, P971, DOI 10.1086/302344
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   McFarland R, 2004, AM J MED GENET A, V131A, P107, DOI 10.1002/ajmg.a.30318
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Perli E, 2012, HUM MOL GENET, V21, P85, DOI 10.1093/hmg/ddr440
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Stiggall D L, 1979, Methods Enzymol, V55, P308
   Stiggall DL, 1979, METHOD ENZYMOL, V55, P819
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Tuppen HAL, 2008, J MED GENET, V45, P55, DOI 10.1136/jmg.2007.051185
   Tuppen HAL, 2010, BRAIN, V133, P2952, DOI 10.1093/brain/awq232
   Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4
   Wong LJC, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.040626
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
NR 37
TC 10
Z9 12
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD AUG
PY 2012
VL 20
IS 8
BP 897
EP 904
DI 10.1038/ejhg.2012.44
PG 8
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 976BX
UT WOS:000306556600017
PM 22378285
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Rohrbach, M
   Chitayat, D
   Maegawa, G
   Shanske, S
   Davidzon, G
   Chong, K
   Clarke, JTR
   Toi, A
   Tarnopolsky, M
   Robinson, B
   Blaser, S
AF Rohrbach, M.
   Chitayat, D.
   Maegawa, G.
   Shanske, S.
   Davidzon, G.
   Chong, K.
   Clarke, J. T. R.
   Toi, A.
   Tarnopolsky, M.
   Robinson, B.
   Blaser, S.
TI Intracerebral Periventricular Pseudocysts in a Fetus with Mitochondrial
   Depletion Syndrome: An Association or Coincidence
SO FETAL DIAGNOSIS AND THERAPY
LA English
DT Article
DE Mitochondrial depletion; Prenatal ultrasound; Fetal magnetic resonance
   imaging; Brain pseudocyst
ID DEOXYGUANOSINE KINASE GENE; DNA DEPLETION; RESPIRATORY-CHAIN;
   SUBEPENDYMAL CYSTS; MTDNA DEPLETION; ALPERS-SYNDROME; THYMIDINE KINASE;
   POLG MUTATIONS; DEFICIENCIES; MYOPATHY
AB We report the prenatal ultrasound and magnetic resonance imaging finding of periventricular, large subependymal pseudocysts (SEPCs) in a patient who was later diagnosed as having mitochondrial depletion syndrome (MDS). To our knowledge, this is the first report of fetal SEPCs in a patient with MDS. These findings may provide an important diagnostic tool for prenatal diagnosis of MDS in at risk pregnancies when the gene mutation causing the condition has not been delineated. It may also direct the neonatologist in the postnatal care of the newborn detected prenatally with SEPCs in view of the association of this finding with infection, chromosome abnormalities, metabolic disorders and other abnormalities, when such findings are identified serendipitously. Further research is needed to find if the SEPCs detected in our patient is an association or a coincidental finding. Copyright (C) 2009 S. Karger AG, Basel
C1 [Rohrbach, M.; Chitayat, D.; Maegawa, G.; Chong, K.; Clarke, J. T. R.] Hosp Sick Children, Dept Pediat, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada.
   [Robinson, B.] Hosp Sick Children, Dept Biochem & Paediat, Toronto, ON M5G 1X8, Canada.
   [Blaser, S.] Hosp Sick Children, Div Diagnost Imaging & Neuroradiol, Toronto, ON M5G 1X8, Canada.
   [Chitayat, D.; Chong, K.] Univ Toronto, Dept Obstet & Gynecol, Prenatal Diag & Med Genet Program, Mt Sinai Hosp, Toronto, ON M5G 1Z5, Canada.
   [Toi, A.] Univ Toronto, Mt Sinai Hosp, Dept Diagnost Imaging, Toronto, ON M5G 1Z5, Canada.
   [Tarnopolsky, M.] McMaster Univ, Med Ctr, Neuromuscular & Neurometab Unit, Hamilton, ON, Canada.
   [Shanske, S.; Davidzon, G.] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA.
C3 University of Toronto; Hospital for Sick Children (SickKids); University
   of Toronto; Hospital for Sick Children (SickKids); University of
   Toronto; Hospital for Sick Children (SickKids); University of Toronto;
   Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute;
   University of Toronto; Sinai Health System Toronto; McMaster University;
   Columbia University
RP Chitayat, D (corresponding author), Univ Toronto, Dept Obstet & Gynecol, Prenatal Diag & Med Genet Program, Mt Sinai Hosp, 700 Univ Ave,3rd Floor,Room 3292, Toronto, ON M5G 1Z5, Canada.
EM dchitayat@mtsinai.on.ca
OI Maegawa, Gustavo/0000-0001-6933-4138; Rohrbach,
   Marianne/0000-0002-4013-6012
CR Carrozzo R, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9135
   CUILLIER F, 2004, J GYNECOL OBST BIO R, V28, P325
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   FIGARELLABRANGER D, 1992, J NEUROL SCI, V108, P105, DOI 10.1016/0022-510X(92)90195-Q
   HEIBEL M, 1993, NEURORADIOLOGY, V35, P85, DOI 10.1007/BF00593960
   Hirano M, 2000, BRAIN PATHOL, V10, P451
   Labarthe F, 2005, J HEPATOL, V43, P333, DOI 10.1016/j.jhep.2005.03.023
   Macmillan CJ, 1996, PEDIATR NEUROL, V14, P203, DOI 10.1016/0887-8994(96)00018-5
   Makhoul IR, 2001, ISRAEL MED ASSOC J, V3, P178
   Mancuso M, 2005, ARCH NEUROL-CHICAGO, V62, P745, DOI 10.1001/archneur.62.5.745
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Morris AAM, 1998, J HEPATOL, V28, P556, DOI 10.1016/S0168-8278(98)80278-X
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Naini A, 2007, METHOD CELL BIOL, V80, P437, DOI 10.1016/S0091-679X(06)80022-1
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Rabinowitz SS, 2004, J PEDIATR GASTR NUTR, V38, P216, DOI 10.1097/00005176-200402000-00022
   RUSSEL IMB, 1995, PEDIATR RADIOL, V25, P254, DOI 10.1007/BF02011090
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Scaglia F, 2001, J CHILD NEUROL, V16, P136, DOI 10.1177/088307380101600214
   SHAW CM, 1974, ARCH NEUROL-CHICAGO, V31, P374, DOI 10.1001/archneur.1974.00490420040003
   SHEN EY, 1985, ARCH DIS CHILD, V60, P1072, DOI 10.1136/adc.60.11.1072
   Slama A, 2005, MOL GENET METAB, V86, P462, DOI 10.1016/j.ymgme.2005.09.006
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Squires L, 1997, DEV MED CHILD NEUROL, V39, P267
   Taanman JW, 2002, ANN NEUROL, V52, P237, DOI 10.1002/ana.10247
   Tadiboyina VT, 2005, AM J MED GENET A, V135A, P289, DOI 10.1002/ajmg.a.30748
   Vu TH, 1998, NEUROLOGY, V50, P1783, DOI 10.1212/WNL.50.6.1783
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
   YAMASHITA Y, 1990, PEDIATR NEUROL, V6, P375, DOI 10.1016/0887-8994(90)90003-J
   Yano S, 2003, J INHERIT METAB DIS, V26, P481, DOI 10.1023/A:1025125427868
NR 41
TC 15
Z9 18
U1 0
U2 4
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1015-3837
EI 1421-9964
J9 FETAL DIAGN THER
JI Fetal Diagn. Ther.
PY 2009
VL 25
IS 2
BP 177
EP 182
DI 10.1159/000209385
PG 6
WC Obstetrics & Gynecology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Obstetrics & Gynecology
GA 482OG
UT WOS:000268898000001
PM 19321960
OA Green Published
DA 2024-11-01
ER

PT J
AU Almarzooqi, F
   Vallance, H
   Mezei, MM
   Lehman, A
   Horvath, G
   Rakic, B
   Zypchen, L
   Mattman, A
AF Almarzooqi, Farida
   Vallance, Hilary
   Mezei, Michelle M.
   Lehman, Anna
   Horvath, Gabriella
   Rakic, Bojana
   Zypchen, Leslie
   Mattman, Andre
TI Macrocytosis in Mitochondrial DNA Deletion Syndromes
SO ACTA HAEMATOLOGICA
LA English
DT Article
ID DISEASE
AB Large single mtDNA (mitochondrial DNA) deletion syndrome is a rare inborn error of metabolism with variable heteroplasmy levels and clinical phenotype among affected individuals. Chronic progressive external ophthalmoplegia (CPEO) is the most common phenotype in adults with this form of mitochondrial disease [1-2]. The common CPEO clinical manifestations are ptosis and ophthalmoplegia. More variable phenotypic manifestations of CPEO (CPEO plus) include involvement of the peripheral nervous system and myopathy. Here, we describe a 62-year-old female with CPEO and the major mitochondrial DNA deletion present at 40% heteroplasmy, who had a coexistent previously undescribed CPEO phenotypic feature of persistent unexplained macrocytosis without anemia. Building on this case, we reviewed other major mtDNA deletion cases seen in our Adult Metabolic Diseases Clinic (AMDC) at the University of British Columbia, Vancouver, Canada from 2016 to 2022. The major mtDNA deletion cases (n=26) were compared with mtDNA missense variants identified in the clinic over the same period who acted as the comparison group (n=16). Of these, the most frequent diagnosis was maternally inherited diabetes and deafness (MIDD) and mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS). Ten out of 26 (38%) of mtDNA deletion patients had macrocytosis with elevated MCV (mean corpuscular volume), median (IQR, interquartile range) of 108fl (102-114fl). Seven of the patients with macrocytosis had no pertinent etiology. None of the comparison group had macrocytosis. There was a significant difference (P=0.000) between the MCV & MCH in the mtDNA deletion group compared to the comparison group. This communication sheds light on the association of macrocytosis with the mtDNA deletion syndrome. It would be of great interest to determine if the association is found in other mitochondrial disease clinic populations.
C1 [Almarzooqi, Farida] Univ British Columbia, Dept Med, Vancouver, BC, Canada.
   [Almarzooqi, Farida] UAE Univ, Coll Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates.
   [Almarzooqi, Farida; Rakic, Bojana] Univ British Columbia, Fac Med, Dept Pathol & Lab Med, Vancouver, BC, Canada.
   [Mezei, Michelle M.] Univ British Columbia, Vancouver Gen Hosp, Adult Metab Dis Clin, Vancouver, BC, Canada.
   [Mezei, Michelle M.] Univ British Columbia, Fac Med, Div Neurol, Vancouver, BC, Canada.
   [Lehman, Anna] Univ British Columbia, Fac Med, Dept Med Genet, Vancouver, BC, Canada.
   [Horvath, Gabriella] Univ British Columbia, Fac Med, Dept Pediat, Div Biochem Dis, Vancouver, BC, Canada.
   [Zypchen, Leslie] Univ British Columbia, Dept Med, Div Hematol, Vancouver, BC, Canada.
   [Mattman, Andre] Univ British Columbia, Vancouver Gen Hosp, Adult Metab Dis Clin, Vancouver, BC, Canada.
   [Mattman, Andre] Univ British Columbia, Fac Med, Dept Pathol & Lab Med, Vancouver, BC, Canada.
   [Almarzooqi, Farida] Univ British Columbia, Dept Med, British Colombia,2775 Laurel St, Vancouver, BC V5Z 1M9, Canada.
C3 University of British Columbia; United Arab Emirates University;
   University of British Columbia; University of British Columbia;
   University of British Columbia; University of British Columbia;
   University of British Columbia; University of British Columbia;
   University of British Columbia; University of British Columbia;
   University of British Columbia
RP Almarzooqi, F (corresponding author), Univ British Columbia, Dept Med, British Colombia,2775 Laurel St, Vancouver, BC V5Z 1M9, Canada.
EM famarzooqi@uaeu.ac.ae
RI Lehman, Anna/R-6706-2017
OI Almarzooqi, Farida/0000-0003-4531-6570; Vallance,
   Hilary/0000-0003-1734-1445; Rakic, Bojana/0000-0002-3460-6081; Horvath,
   Gabriella/0000-0003-2573-2489; Zypchen, Leslie/0000-0002-8476-1872
CR Agodi A, 2014, MUTAGENESIS, V29, P101, DOI 10.1093/mutage/get065
   Bao XR, 2016, ELIFE, V5, DOI 10.7554/eLife.10575
   Dietz JV, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10092198
   Ducamp S, 2019, BLOOD, V133, P59, DOI 10.1182/blood-2018-08-815951
   Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Heighton JN, 2019, MITOCHONDRION, V44, P15, DOI 10.1016/j.mito.2017.12.006
   Hildick-Smith GJ, 2013, AM J HUM GENET, V93, P906, DOI 10.1016/j.ajhg.2013.09.011
   La Morgia C, 2020, J INTERN MED, V287, P592, DOI 10.1111/joim.13064
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0652-7
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Ormazabal A, 2015, DRUG DISCOV TODAY, V20, P1349, DOI 10.1016/j.drudis.2015.07.002
   Paul B. T., 2019, SCI REP-UK, V9, P1
   Schaefer A., 2019, DIAGNOSIS MANAGEMENT, P63, DOI [DOI 10.1007/978-3-030-05517-2_4, 10.1007/978-3-030-05517-24]
   Stefano GB, 2016, BIOMED REP, V4, P259, DOI 10.3892/br.2016.590
   Zegallai HM, 2021, MOL CELL BIOCHEM, V476, P1605, DOI 10.1007/s11010-020-04021-0
   Zhang YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128624
NR 17
TC 2
Z9 2
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0001-5792
EI 1421-9662
J9 ACTA HAEMATOL-BASEL
JI Acta Haematol.
PD JUN
PY 2023
VL 146
IS 3
BP 220
EP 225
DI 10.1159/000529311
EA FEB 2023
PG 6
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA J2IU7
UT WOS:000940716400001
PM 36774923
DA 2024-11-01
ER

PT J
AU Chen, HC
   Vermulst, M
   Wang, YE
   Chomyn, A
   Prolla, TA
   McCaffery, JM
   Chan, DC
AF Chen, Hsiuchen
   Vermulst, Marc
   Wang, Yun E.
   Chomyn, Anne
   Prolla, Tomas A.
   McCaffery, J. Michael
   Chan, David C.
TI Mitochondrial Fusion Is Required for mtDNA Stability in Skeletal Muscle
   and Tolerance of mtDNA Mutations
SO CELL
LA English
DT Article
ID DOMINANT OPTIC ATROPHY; DYNAMIN-RELATED GTPASE; SUBSTANTIA-NIGRA
   NEURONS; DNA DELETIONS; FUNCTIONAL MITOCHONDRIA; MEMBRANE FUSION; MICE;
   DISEASE; FIBERS; OPA1
AB Mitochondria are highly mobile and dynamic organelles that continually fuse and divide. These processes allow mitochondria to exchange contents, including mitochondrial DNA (mtDNA). Here we examine the functions of mitochondrial fusion in differentiated skeletal muscle through conditional deletion of the mitofusins Mfn1 and Mfn2, mitochondrial GTPases essential for fusion. Loss of the mitofusins causes severe mitochondrial dysfunction, compensatory mitochondrial proliferation, and muscle atrophy. Mutant mice have severe mtDNA depletion in muscle that precedes physiological abnormalities. Moreover, the mitochondrial genomes of the mutant muscle rapidly accumulate point mutations and deletions. In a related experiment, we find that disruption of mitochondrial fusion strongly increases mitochondrial dysfunction and lethality in a mouse model with high levels of mtDNA mutations. With its dual function in safeguarding mtDNA integrity and preserving mtDNA function in the face of mutations, mitochondrial fusion is likely to be a protective factor in human disorders associated with mtDNA mutations.
C1 [Chen, Hsiuchen; Vermulst, Marc; Wang, Yun E.; Chomyn, Anne; Chan, David C.] CALTECH, Div Biol, Pasadena, CA 91125 USA.
   [Chomyn, Anne; Chan, David C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.
   [Prolla, Tomas A.] Univ Wisconsin, Dept Genet & Med Genet, Madison, WI 53706 USA.
   [McCaffery, J. Michael] Johns Hopkins Univ, Dept Biol, Integrated Imaging Ctr, Baltimore, MD 21218 USA.
C3 California Institute of Technology; Howard Hughes Medical Institute;
   California Institute of Technology; University of Wisconsin System;
   University of Wisconsin Madison; Johns Hopkins University
RP Chan, DC (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.
EM dchan@caltech.edu
FU Ellison Medical Foundation; NCRR [1 S10 RR023454-01];  [R01 GM062967]
FX We thank Drs. S. Burden and P. Soriano for generously providing the
   MLC-Cre and Meox2-Cre mouse strains. We are grateful to Igor
   Antoshechkin, director of the Caltech Genomics Facility, for help with
   analysis of Solexa sequence data. This work was supported by grants to
   D. C. C. (R01 grant GM062967 and an Ellison Medical Foundation Senior
   Scholar Award) and J.M.M. (NCRR grant 1 S10 RR023454-01).
CR Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014
   Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Chomyn A, 2003, BIOCHEM BIOPH RES CO, V304, P519, DOI 10.1016/S0006-291X(03)00625-9
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Duan S, 2003, J BIOL CHEM, V278, P1346, DOI 10.1074/jbc.M209269200
   Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478
   Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101
   Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359
   Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2007, ANN NY ACAD SCI, V1100, P227, DOI 10.1196/annals.1395.024
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465
   Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612
   Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021
   Nakada K, 2001, BIOCHEM BIOPH RES CO, V288, P743, DOI 10.1006/bbrc.2001.5838
   Nakada K, 2009, INT J BIOCHEM CELL B, V41, P1907, DOI 10.1016/j.biocel.2009.05.010
   Ogata T, 1997, ANAT REC, V248, P214
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508
   Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vermulst M, 2008, METHODS, V46, P263, DOI 10.1016/j.ymeth.2008.10.008
   Villani G, 2001, METHOD CELL BIOL, V65, P119, DOI 10.1016/S0091-679X(01)65007-6
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 48
TC 892
Z9 1025
U1 3
U2 88
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
J9 CELL
JI Cell
PD APR 16
PY 2010
VL 141
IS 2
BP 280
EP 289
DI 10.1016/j.cell.2010.02.026
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 584GF
UT WOS:000276738400018
PM 20403324
OA Green Accepted, Bronze
DA 2024-11-01
ER

PT J
AU Wu, YT
   Huang, SC
   Shiao, YM
   Syu, WC
   Wei, YH
   Hsu, YC
AF Wu, Yu-Ting
   Huang, Szu-Chuan
   Shiao, Yu-Ming
   Syu, Wei-Chi
   Wei, Yau-Huei
   Hsu, Yi-Chao
TI Identification of new variants in MTRNR1 and MTRNR2 genes using whole
   mitochondrial genome sequencing in a Taiwanese family with MERRF
   (myoclonic epilepsy with ragged-red fibers) syndrome
SO HEARING RESEARCH
LA English
DT Article
DE MERRF; Mitochondrial DNA; Next generation sequencing; Sensorineural
   hearing loss; MTRNR1; MTRNR2
ID INHERITED HEARING-LOSS; RIBOSOMAL-RNA GENE; MUTATIONAL ANALYSIS;
   DIABETES-MELLITUS; DNA MUTATION; PHENOTYPE; MELAS; IMPAIRMENT
AB Mitochondrial encephalomyopathy is a multi-system disorder mostly caused by inborn errors of the oxidative phosphorylation (OXPHOS) system and usually manifested as complex neurological disorder and muscle weakness. Myoclonic epilepsy with ragged-red fibers (MERRF) syndrome is one of the major subtypes of mitochondrial disease associated with the m.8344A>G mutation in mitochondrial tRNA(Lys )gene. In addition to the symptoms in central nervous and muscle systems, a portion of the patients may develop hearing loss, which has been linked to the genetic mutations of mitochondrial DNA (mtDNA) especially in the mitochondrial ribosome RNA (rRNA) gene. Despite a great number of studies focusing on the consequences of mtDNA mutations, the mechanism of pathogenesis of these overt diseases has remained unclear, and there is no specific and effective treatment for MERRF syndromes. In this study, we developed a high-quality mtDNA sequencing method by next generation sequencing technology to search for the additional pathogenic variations of mtDNA from skin fibroblasts of four members in a Taiwanese family with MERRF syndrome. Through uncovering the signatures of all mtDNA variants in the MERRF family, we identified novel mtDNA variants in the genes encoding mitochondrial 12S and 16S rRNAs. The finding from this study will give us further insight into the molecular mechanisms driving the phenotypic variability and timing of onset of the MERRF syndrome.
C1 [Wu, Yu-Ting; Wei, Yau-Huei] Changhua Christian Hosp, Ctr Mitochondrial Med & Free Rad Res, Changhua 50046, Taiwan.
   [Huang, Szu-Chuan; Shiao, Yu-Ming; Syu, Wei-Chi] Union Clin Lab, Taipei 10665, Taiwan.
   [Hsu, Yi-Chao] Mackay Med Coll, Dept Audiol & Speech Language Pathol, New Taipei City 25245, Taiwan.
   [Hsu, Yi-Chao] Mackay Med Coll, Inst Biomed Sci, New Taipei City 25245, Taiwan.
C3 Changhua Christian Hospital; Mackay Medical College; Mackay Medical
   College
RP Wei, YH (corresponding author), Changhua Christian Hosp, Ctr Mitochondrial Med & Free Rad Res, Changhua 50046, Taiwan.; Hsu, YC (corresponding author), Mackay Med Coll, Dept Audiol & Speech Language Pathol, New Taipei City 25245, Taiwan.; Hsu, YC (corresponding author), Mackay Med Coll, Inst Biomed Sci, New Taipei City 25245, Taiwan.
RI Hsu, Yi-Chao/AAK-7478-2021
OI Syu, Wei-Chi/0009-0001-4318-4255
FU Ministry of Science and Technology of Taiwan Government [MOST
   110-2314-B-715-005, 111-2314-B-715-009-MY3]; Ministry of Science and
   Technology of Taiwan Government [MOST 110-2314-B-715-005,
   111-2314-B-715-009-MY3, NSTC 112-2321-B-715-001, MOST
   110-2311-B-371-001, MOST 110-2320-B-371-001, NSTC 112-2320-B-371-001];
   Mackay Medical College [MMC-RD-111-CF-G002-03, MMC-RD-110-1B-P030,
   MMC-RD-111-1E-P002]; Changhua Christian Hospital, Taiwan
   [110-CCH-MST-179, 110-CCH-MST-127, 111-CCH-HCR-147]
FX The work described in this paper has been supported by grants from the
   Ministry of Science and Technology of Taiwan Government (MOST
   110-2314-B-715-005, 111-2314-B-715-009-MY3, NSTC 112-2321-B-715-001,
   MOST 110-2311-B-371-001, MOST 110-2320-B-371-001, NSTC
   112-2320-B-371-001) , intramural research grants from Mackay Medical
   College (MMC-RD-111-CF-G002-03, MMC-RD-110-1B-P030,
   MMC-RD-111-CF-G002-03, MMC-RD-111-1E-P002) . In addition, we would like
   to acknowledge the financial support of intramural grants
   (110-CCH-MST-179, 110-CCH-MST-127 and 111-CCH-HCR-147) from Changhua
   Christian Hospital, Taiwan.
CR Abe S, 2014, OTOL NEUROTOL, V35, P1087, DOI 10.1097/MAO.0000000000000350
   Austin SA, 1998, NEUROLOGY, V51, P1447, DOI 10.1212/WNL.51.5.1447
   Coulbault L, 2007, BIOCHEM BIOPH RES CO, V362, P601, DOI 10.1016/j.bbrc.2007.08.040
   Crimi M, 2003, NEUROLOGY, V60, P1200, DOI 10.1212/01.WNL.0000055865.30580.39
   de Wit HM, 2012, NETH J MED, V70, P460
   Deschauer M, 2001, ARCH NEUROL-CHICAGO, V58, P1885, DOI 10.1001/archneur.58.11.1885
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002
   Hsieh RH, 2001, J BIOMED SCI, V8, P328, DOI 10.1159/000054051
   Huang CC, 2002, J BIOMED SCI, V9, P527, DOI 10.1007/BF02254979
   Hutchin TP, 2000, J MED GENET, V37, P692, DOI 10.1136/jmg.37.9.692
   Iwanicka-Pronicka K, 2015, MED SCI MONITOR, V21, P694, DOI 10.12659/MSM.890965
   Kanabus M, 2014, BRIT J PHARMACOL, V171, P1798, DOI 10.1111/bph.12456
   Kloss-Brandstätter A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135643
   Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x
   Larman TC, 2012, P NATL ACAD SCI USA, V109, P14087, DOI 10.1073/pnas.1211502109
   Levin BC, 2003, MITOCHONDRION, V2, P387, DOI 10.1016/S1567-7249(03)00010-2
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Li ZY, 2005, HUM GENET, V117, P9, DOI 10.1007/s00439-005-1276-1
   Liu Z, 2014, J MED GENET, V51, P176, DOI 10.1136/jmedgenet-2013-101818
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Lu CY, 2002, CLIN CHIM ACTA, V318, P97, DOI 10.1016/S0009-8981(01)00809-9
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Lv ZY, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008869
   Ma YS, 2005, ANN NY ACAD SCI, V1042, P55, DOI 10.1196/annals.1338.006
   Park SY, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00520
   Riman S, 2017, FORENSIC SCI INT-GEN, V29, P181, DOI 10.1016/j.fsigen.2017.04.005
   Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3
   Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905
   Tang J, 1997, PEDIATR NEUROL, V17, P327, DOI 10.1016/S0887-8994(97)00151-3
   TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421
   Tsutsumi T, 2001, J LARYNGOL OTOL, V115, P777
   Wu J, 2015, J MED GENET, V52, P95, DOI 10.1136/jmedgenet-2014-102753
   Wu YT, 2014, CURR PHARM DESIGN, V20, P5510, DOI 10.2174/1381612820666140306103401
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
   Zheng J, 2020, MITOCHONDRION, V52, P163, DOI 10.1016/j.mito.2020.03.005
NR 38
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-5955
EI 1878-5891
J9 HEARING RES
JI Hear. Res.
PD OCT
PY 2023
VL 438
AR 108876
DI 10.1016/j.heares.2023.108876
EA SEP 2023
PG 9
WC Audiology & Speech-Language Pathology; Neurosciences;
   Otorhinolaryngology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Audiology & Speech-Language Pathology; Neurosciences & Neurology;
   Otorhinolaryngology
GA U1DA9
UT WOS:001082267600001
PM 37683310
DA 2024-11-01
ER

PT J
AU Emmanuele, V
   Sotiriou, E
   Rios, PG
   Ganesh, J
   Ichord, R
   Foley, AR
   Akman, HO
   DiMauro, S
AF Emmanuele, Valentina
   Sotiriou, Evangelia
   Rios, Purificacion Gutierrez
   Ganesh, Jaya
   Ichord, Rebecca
   Foley, A. Reghan
   Akman, H. Orhan
   DiMauro, Salvatore
TI A Novel Mutation in the Mitochondrial DNA Cytochrome <i>b</i> Gene
   (<i>MTCYB</i>) in a Patient With Mitochondrial Encephalomyopathy, Lactic
   Acidosis, and Strokelike Episodes Syndrome
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE cytochrome b, MTCYB; mtDNA; MELAS, mitochondria
ID COMPLEX-III DEFICIENCY; PROGRESSIVE EXERCISE INTOLERANCE; STOP-CODON
   MUTATION; RESPIRATORY-CHAIN; MISSENSE MUTATION; POINT MUTATION; OXIDASE
   DEFICIENCY; L-ARGININE; MYOPATHY; DISORDER
AB Mutations in the mitochondrial DNA cytochrome b gene (MTCYB) have been commonly associated with isolated mitochondrial myopathy and exercise intolerance, rarely with multisystem disorders, and only once with a parkinsonism/mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS) overlap syndrome. Here, we describe a novel mutation (m.14864 T > C) in MTCYB in a 15-year-old girl with a clinical history of migraines, epilepsy, sensorimotor neuropathy, and strokelike episodes, a clinical picture reminiscent of MELAS. The mutation, which changes a highly conserved cysteine to arginine at amino acid position 40 of cytochrome b, was heteroplasmic in muscle, blood, fibroblasts, and urinary sediment from the patient but absent in accessible tissues from her asymptomatic mother. This case demonstrates that MTCYB must be included in the already long list of mitochondrial DNA genes that have been associated with the MELAS phenotype.
C1 [Emmanuele, Valentina; Sotiriou, Evangelia; Rios, Purificacion Gutierrez; Akman, H. Orhan; DiMauro, Salvatore] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA.
   [Emmanuele, Valentina] Univ Genoa, Pediat Clin, IRCCS G Gaslini Inst, Genoa, Italy.
   [Ganesh, Jaya] Childrens Hosp Philadelphia, Sect Metab Dis, Philadelphia, PA 19104 USA.
   [Ichord, Rebecca] Univ Penn, Childrens Hosp Philadelphia, Dept Neurol & Pediat, Philadelphia, PA 19104 USA.
   [Ichord, Rebecca] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Foley, A. Reghan] UCL, Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England.
   [Foley, A. Reghan] Great Ormond St Hosp Sick Children, London, England.
C3 Columbia University; University of Genoa; IRCCS Istituto Giannina
   Gaslini; University of Pennsylvania; Pennsylvania Medicine; Childrens
   Hospital of Philadelphia; University of Pennsylvania; Pennsylvania
   Medicine; Childrens Hospital of Philadelphia; University of
   Pennsylvania; University of London; University College London;
   University of London; University College London; Great Ormond Street
   Hospital for Children NHS Foundation Trust
RP DiMauro, S (corresponding author), Columbia Univ Coll Phys & Surg, Room 4-424B,630 W 168th St, New York, NY 10032 USA.
EM sd12@columbia.edu
OI Emmanuele, Valentina/0000-0002-4892-2042
FU National Institutes of Health [HD32062]; Marriott Mitochondrial Disorder
   Clinical Research Fund (MMDCRF); Ministerio de Educacion y Ciencia,
   Spain
FX The authors disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: This work was
   supported by a grant from the National Institutes of Health (HD32062)
   and by the Marriott Mitochondrial Disorder Clinical Research Fund
   (MMDCRF). PGR is supported by a postdoctoral fellowship from Ministerio
   de Educacion y Ciencia, Spain.
CR Andreu AL, 1999, MOL GENET METAB, V67, P49, DOI 10.1006/mgme.1999.2843
   Andreu AL, 2000, PEDIATR RES, V48, P311, DOI 10.1203/00006450-200009000-00008
   Andreu AL, 1998, NEUROLOGY, V51, P1444, DOI 10.1212/WNL.51.5.1444
   Andreu AL, 1999, ANN NEUROL, V45, P127, DOI 10.1002/1531-8249(199901)45:1<127::AID-ART20>3.0.CO;2-Y
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Barel O, 2008, AM J HUM GENET, V82, P1211, DOI 10.1016/j.ajhg.2008.03.020
   Besch D, 2000, OPHTHALMOLOGE, V97, P27, DOI 10.1007/PL00007105
   Blakely EL, 2005, FEBS J, V272, P3583, DOI 10.1111/j.1742-4658.2005.04779.x
   Bruno C, 2003, MUSCLE NERVE, V28, P508, DOI 10.1002/mus.10429
   Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257
   Chen J, 2009, J MAGN RESON IMAGING, V29, P282, DOI 10.1002/jmri.21641
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   Dumoulin R, 1996, MOL CELL PROBE, V10, P389, DOI 10.1006/mcpr.1996.0053
   Fragaki K, 2009, MITOCHONDRION, V9, P346, DOI 10.1016/j.mito.2009.06.002
   Ghezzi D, 2011, NAT GENET, V43, P259, DOI 10.1038/ng.761
   Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0
   Keightley JA, 2000, AM J HUM GENET, V67, P1400, DOI 10.1086/316900
   KENNAWAY N G, 1984, Pediatric Research, V18, P991, DOI 10.1203/00006450-198418100-00017
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Kubota M, 2004, BRAIN DEV-JPN, V26, P481, DOI 10.1016/j.braindev.2004.01.006
   Lamantea E, 2002, NEUROMUSCULAR DISORD, V12, P49, DOI 10.1016/S0960-8966(01)00244-9
   Legros F, 2001, EUR J HUM GENET, V9, P510, DOI 10.1038/sj.ejhg.5200678
   Mancuso M, 2003, J NEUROL SCI, V209, P61, DOI 10.1016/S0022-510X(02)00462-8
   Massie R, 2010, MUSCLE NERVE, V42, P136, DOI 10.1002/mus.21649
   Mourmans J, 1997, J NEUROL SCI, V149, P111, DOI 10.1016/S0022-510X(97)05379-3
   Schägger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777
   Schnaufer A, 2000, CURR GENET, V37, P234, DOI 10.1007/s002940050525
   Schuelke M, 2002, ANN NEUROL, V51, P388, DOI 10.1002/ana.10151
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Valnot I, 1999, HUM GENET, V104, P460, DOI 10.1007/s004390050988
   Visapää I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773
   von Kleist-Retzow JC, 1998, AM J HUM GENET, V63, P428, DOI 10.1086/301957
   Wang J, 2006, NEUROIMAG CLIN N AM, V16, P149, DOI 10.1016/j.nic.2005.10.002
   Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224
NR 36
TC 28
Z9 29
U1 0
U2 8
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD FEB
PY 2013
VL 28
IS 2
BP 236
EP 242
DI 10.1177/0883073812445787
PG 7
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 075QO
UT WOS:000313901800010
PM 22638077
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Peng, X
   Ma, LX
   Xiao, C
   Zhang, ZZ
   Zhu, M
   Hong, DJ
   Zhan, YA
AF Peng, Xiong
   Ma, Li-xiu
   Xiao, Ce
   Zhang, Zhi-zhe
   Zhu, Min
   Hong, Dao-jun
   Zhan, Yi-an
TI Weaning difficulty after severe pneumonia in adult-onset mitochondrial
   myopathy with A3243G mutation in the mitochondrial tRNA gene: A case
   report
SO HELIYON
LA English
DT Article
DE Mitochondrial myopathy; Severe pneumonia; Acute respiratory failure;
   Difficulty in weaning; A3243G mutation
ID RESPIRATORY INSUFFICIENCY
AB Background: Mitochondrial myopathy is a group of diseases caused by abnormal mitochondrial structure or function. The mitochondrial myopathy impacts muscles of the whole body and exhibits variable symptoms. Respiratory muscle deficits deteriorate pulmonary function in patients with severe pneumonia. Case presentation: We report the case of a male patient with severe pneumonia-induced respiratory failure. He was abnormally dependent invasive ventilator-assisted ventilation after his condition had improved. Then we found abnormal ventilator waveform and a decline in muscle strength of him. Mitochondrial myopathy was ultimately confirmed by muscle pathological biopsy and body fluid genetic testing. Vitamin B complex, coenzyme Q10, Neprinol AFD, L-arginine, and MITOTONIC were used to improve mitochondrial function and muscle metabolism. After treatment, discomfort associated with chest tightness, fatigue, cough, and sputum disappeared, and the patient was discharged. Conclusion: This case presented an uncommon cause of difficult weaning and extubation-acute onset of mitochondrial myopathy. Muscle biopsy and genetic testing of body fluid are essential for diagnosing mitochondrial myopathy. The A3243G mutation in the MT-TL1 gene of mitochondrial DNA contributes to pathogenesis of this case.
C1 [Peng, Xiong; Ma, Li-xiu; Xiao, Ce; Zhang, Zhi-zhe; Zhan, Yi-an] Nanchang Univ, Dept Resp & Crit Care Med, Affiliated Hosp 1, Nanchang 330006, Jiangxi, Peoples R China.
   [Zhu, Min; Hong, Dao-jun] Nanchang Univ, Dept Neurol, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China.
C3 Nanchang University; Nanchang University
RP Zhan, YA (corresponding author), Nanchang Univ, Dept Resp & Crit Care Med, Affiliated Hosp 1, Nanchang 330006, Jiangxi, Peoples R China.
EM ndyfy02169@ncu.edu.cn
RI Zhang, Lu/KHE-5879-2024
FU National Natural Science Foundation of China [82060345]; Natural Science
   Foundation of Jiangxi Province [20192BAB205057]
FX The authors thank the National Natural Science Foundation of China
   (82060345) and Natural Science Foundation of Jiangxi Province
   (20192BAB205057) for financial support.
CR Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4
   Amornvit Jakkrit, 2014, Journal of the Medical Association of Thailand, V97, P467
   BOLTON CF, 1984, J NEUROL NEUROSUR PS, V47, P1223, DOI 10.1136/jnnp.47.11.1223
   Buzkova J, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809091
   Chang K. C., 2002, Hong Kong Medical Journal, V8, P137
   Chotmongkol Verajit, 2001, Journal of the Medical Association of Thailand, V84, P445
   CROS D, 1992, CHEST, V101, P824, DOI 10.1378/chest.101.3.824
   Fan HC, 2021, LIFE-BASEL, V11, DOI 10.3390/life11111111
   Heunks LM, 2010, CRIT CARE, V14, DOI 10.1186/cc9296
   Hutchinson David, 2008, Pract Neurol, V8, P229, DOI 10.1136/pn.2008.152611
   Jeong BH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122810
   Karaa A, 2023, NEUROLOGY, V101, pE238, DOI 10.1212/WNL.0000000000207402
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   KIM G W, 1991, Yonsei Medical Journal, V32, P184
   Murayama A, 2019, J NEUROL SCI, V396, P216, DOI 10.1016/j.jns.2018.11.023
   Naddaf E, 2017, MUSCLE NERVE, V56, P881, DOI 10.1002/mus.25602
   Ortí-Pareja M, 1999, REV NEUROLOGIA, V29, P735, DOI 10.33588/rn.2908.99307
   Padilla F, 1999, Neurologia, V14, P368
   Pan X., 2019, FRONT NEUROL, V10
   Pan XL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00780
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Shibasaki H, 1973, Rinsho Shinkeigaku, V13, P45
   Thille AW, 2013, CURR OPIN CRIT CARE, V19, P57, DOI 10.1097/MCC.0b013e32835c5095
   Zhou Y, 2018, INT J NEUROSCI, V128, P231, DOI 10.1080/00207454.2017.1387113
NR 24
TC 0
Z9 0
U1 1
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
EI 2405-8440
J9 HELIYON
JI Heliyon
PD DEC
PY 2023
VL 9
IS 12
AR e23300
DI 10.1016/j.heliyon.2023.e23300
EA DEC 2023
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA DT4Q7
UT WOS:001134316900001
PM 38149187
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Domenis, DR
   Okubo, PMCI
   Sobreira, C
   Dantas, RO
AF Domenis, Danielle Ramos
   Carvalho Issa Okubo, Paula Macedo
   Sobreira, Claudia
   Dantas, Roberto Oliveira
TI Esophageal Contractions in Patients with Chronic Progressive External
   Ophthalmoplegia
SO DIGESTIVE DISEASES AND SCIENCES
LA English
DT Article
DE Chronic progressive external ophthalmoplegia; Dysphagia; Mitochondrial
   myopathy; Esophageal manometry; Esophageal motility
ID KEARNS-SAYRE-SYNDROME; MITOCHONDRIAL-DNA; DYSPHAGIA; DELETIONS;
   MANIFESTATIONS; MYOPATHIES
AB Background Chronic progressive external ophthalmoplegia is a mitochondrial myopathy that causes muscular or multisystem symptoms and has dysphagia as one manifestation.
   Aim To evaluate esophageal contractions in patients with chronic progressive external ophthalmoplegia.
   Methods We studied 14 patients with chronic progressive external ophthalmoplegia and 16 asymptomatic volunteers. The diagnosis of the disease was established by the clinical picture and by mitochondrial DNA analysis in skeletal muscle. We used the manometric method with a perfusion catheter that recorded the esophageal contractions at 2, 7, 12, 17, and 22 cm from the lower esophageal sphincter (LES). All subjects performed in the supine position 20 swallows of a 5-ml bolus of water at room temperature, ten every 30 s and ten every 10 s.
   Results The amplitude, duration, and area under the curve of contractions at 17 and 22 cm from the LES were lower in patients than in volunteers for swallows performed at 10-s and 30-s intervals (P < 0.01). There was no difference in contractions at 7 and 2 cm, except for the contractions at 2 cm after swallows performed at 30-s intervals. The interval between the onset of contractions between 7 and 2 cm and between 22 and 2 cm was lower in patients than in volunteers, with swallows performed every 10 s and every 30 s.
   Conclusions There is impairment of esophageal contractions in patients with chronic progressive external ophthalmoplegia, mainly in the proximal esophageal body.
C1 [Dantas, Roberto Oliveira] Ribeirao Preto USP, Dept Clin Med, Fac Med, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Domenis, Danielle Ramos; Carvalho Issa Okubo, Paula Macedo; Sobreira, Claudia; Dantas, Roberto Oliveira] Univ Sao Paulo, Med Sch Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil.
   [Domenis, Danielle Ramos; Carvalho Issa Okubo, Paula Macedo] Univ Hosp Ribeirao Preto USP, Dept Ophthalmol Otolaryngol & Head & Neck Surg, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Sobreira, Claudia] Med Sch Ribeirao Preto USP, Dept Neurosci, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Dantas, Roberto Oliveira] Med Sch Ribeirao Preto USP, Dept Med, BR-14049900 Ribeirao Preto, SP, Brazil.
C3 Universidade de Sao Paulo; Universidade de Sao Paulo
RP Dantas, RO (corresponding author), Ribeirao Preto USP, Dept Clin Med, Fac Med, BR-14049900 Ribeirao Preto, SP, Brazil.
EM danefono@ig.com.br; paula_issa@hotmail.com; csobreira@rnp.fmrp.usp.br;
   rodantas@fmrp.usp.br
RI OKUBO, PAULA/F-9612-2012; Sobreira, Cláudia/D-5785-2012
CR Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Carod-Artal FJ, 2003, REV NEUROLOGIA, V37, P1029, DOI 10.33588/rn.3711.2003547
   Chen CL, 2008, NEUROGASTROENT MOTIL, V20, P611, DOI 10.1111/j.1365-2982.2008.01086.x
   DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602
   Franceschina L, 1998, J NEUROL, V245, P755, DOI 10.1007/s004150050283
   Garciduenas A. L. C., 2000, GAC MED MEX, V163, P267
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Jiménez-Caballero PE, 2006, REV NEUROLOGIA, V43, P724, DOI 10.33588/rn.4312.2006440
   Kallmuenzer B, 2008, NEUROGASTROENT MOTIL, V20, P597, DOI 10.1111/j.1365-2982.2007.01075.x
   Katsanos KH, 2001, DIS ESOPHAGUS, V14, P63, DOI 10.1111/j.1442-2050.2001.00152.x
   Kornblum C, 2001, NEUROLOGY, V56, P1409, DOI 10.1212/WNL.56.10.1409
   Littell R.C., 1996, SAS SYSTEMS MIXED MO
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   SCHALL R, 1991, BIOMETRIKA, V78, P719
   Sciacco M, 2001, J NEUROL, V248, P778, DOI 10.1007/s004150170094
   SHAKER R, 1992, GASTROENTEROLOGY, V103, P1328, DOI 10.1016/0016-5085(92)91524-8
   Sonies Barbara C., 1997, Current Opinion in Rheumatology, V9, P486, DOI 10.1097/00002281-199711000-00003
   TRIADAFILOPOULOS G, 1992, DIGEST DIS SCI, V37, P551, DOI 10.1007/BF01307579
   Vu TH, 1998, NEUROLOGY, V50, P1783, DOI 10.1212/WNL.50.6.1783
   Wise James L, 2002, Curr Gastroenterol Rep, V4, P205, DOI 10.1007/s11894-002-0064-5
NR 20
TC 4
Z9 4
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0163-2116
J9 DIGEST DIS SCI
JI Dig. Dis. Sci.
PD AUG
PY 2011
VL 56
IS 8
BP 2343
EP 2348
DI 10.1007/s10620-011-1631-0
PG 6
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 799ON
UT WOS:000293296100019
PM 21399928
DA 2024-11-01
ER

PT J
AU Young, MJ
   Jayaprakash, AD
   Young, CKJ
AF Young, Matthew J.
   Jayaprakash, Anitha D.
   Young, Carolyn K. J.
TI Analysis of Mitochondrial DNA Polymorphisms in the Human Cell Lines
   HepaRG and SJCRH30
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE human mitochondrial DNA (mtDNA); mtDNA homoplasmy; mtDNA heteroplasmy;
   cancer-derived cell lines; next-generation sequencing; Mseek; HepaRG;
   hepatocarcinoma; SJCRH30; rhabdomyosarcoma
ID MUTATIONS; HETEROPLASMY; VARIANTS; DISEASE; MUSCLE; POLG2
AB The mitochondrial DNA (mtDNA) sequences of two commonly used human cell lines, HepaRG and SJCRH30, were determined. HepaRG originates from a liver tumor obtained from a patient with hepatocarcinoma and hepatitis C while SJCRH30 originates from a rhabdomyosarcoma patient tumor. In comparison to the revised Cambridge Reference Sequence, HepaRG and SJCRH30 mtDNA each contain 14 nucleotide variations. In addition to an insertion of a cytosine at position 315 (315insC), the mtDNA sequences from both cell types share six common polymorphisms. Heteroplasmic variants were identified in both cell types and included the identification of the 315insC mtDNA variant at 42 and 75% heteroplasmy in HepaRG and SJCRH30, respectively. Additionally, a novel heteroplasmic G13633A substitution in the HepaRG ND5 gene was detected at 33%. Previously reported cancer-associated mtDNA variants T195C and T16519C were identified in SJCRH30, both at homoplasmy (100%), while HepaRG mtDNA harbors a known prostate cancer-associated T6253C substitution at near homoplasmy, 95%. Based on our sequencing analysis, HepaRG mtDNA is predicted to lie within haplogroup branch H15a1 while SJCRH30 mtDNA is predicted to localize to H27c. The catalog of polymorphisms and heteroplasmy reported here should prove useful for future investigations of mtDNA maintenance in HepaRG and SJCRH30 cell lines.
C1 [Young, Matthew J.; Young, Carolyn K. J.] Southern Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA.
   [Jayaprakash, Anitha D.] Girihlet Inc, Oakland, CA 94609 USA.
C3 Southern Illinois University System; Southern Illinois University
RP Young, MJ (corresponding author), Southern Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA.
EM matthew.young@siu.edu
OI Young, Matthew/0000-0002-5109-4719; Jayaprakash,
   Anitha/0000-0002-9466-243X
FU National Institute of Environmental Health Sciences Pathway to
   Independence Award [5R00ES022638-04]; SIU School of Medicine
FX This research was supported by a National Institute of Environmental
   Health Sciences Pathway to Independence Award to M.J.Y.
   (5R00ES022638-04) and by start-up funds from SIU School of Medicine to
   M.J.Y.
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Aninat C, 2006, DRUG METAB DISPOS, V34, P75, DOI 10.1124/dmd.105.006759
   Bai RK, 2007, CANCER RES, V67, P4687, DOI 10.1158/0008-5472.CAN-06-3554
   Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   Civitarese AE, 2010, CELL METAB, V11, P412, DOI 10.1016/j.cmet.2010.04.004
   Collins DW, 2016, MOL VIS, V22, P454
   Ebner S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027192
   Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077
   Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427
   Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Herrnstadt C, 2002, MUTAT RES-FUND MOL M, V501, P19, DOI 10.1016/S0027-5107(01)00304-9
   Heupink TH, 2016, P NATL ACAD SCI USA, V113, P6892, DOI 10.1073/pnas.1521066113
   Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506
   Jayaprakash AD, 2015, NUCLEIC ACIDS RES, V43, P2177, DOI 10.1093/nar/gkv052
   Kamalian L, 2018, TOXICOL IN VITRO, V53, P136, DOI 10.1016/j.tiv.2018.08.001
   Larman TC, 2012, P NATL ACAD SCI USA, V109, P14087, DOI 10.1073/pnas.1211502109
   Le Guillou D, 2018, J PHARMACOL EXP THER, V365, P711, DOI 10.1124/jpet.117.246751
   Lott MT., 2013, Curr Protoc Bioinf, V44, P1231, DOI DOI 10.1002/0471250953.BI0123S44
   MODRICH P, 1987, ANNU REV BIOCHEM, V56, P435, DOI 10.1146/annurev.biochem.56.1.435
   Morino K, 2012, DIABETES, V61, P877, DOI 10.2337/db11-1391
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Ohnstad HO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-211
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407
   ROBERTS WM, 1989, CANCER RES, V49, P5407
   Rollins B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004913
   Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200
   Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109
   Singh B, 2017, SEMIN CANCER BIOL, V47, P1, DOI 10.1016/j.semcancer.2017.05.004
   Singh KK, 2017, SEMIN CANCER BIOL, V47, pIV, DOI 10.1016/j.semcancer.2017.10.013
   Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102
   Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282
   Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715
   Uphoff CC, 2002, IN VITRO CELL DEV-AN, V38, P79
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wallace KB, 2014, J CHILD NEUROL, V29, P1241, DOI 10.1177/0883073814538510
   Wheeler Joel H, 2019, Curr Protoc Toxicol, V80, pe75, DOI 10.1002/cptx.75
   Young CKJ, 2019, CELL CYCLE, V18, P476, DOI 10.1080/15384101.2019.1578133
   Young MJ, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00074
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   Young MJ, 2015, HUM MOL GENET, V24, P5184, DOI 10.1093/hmg/ddv240
NR 45
TC 4
Z9 5
U1 0
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUL 1
PY 2019
VL 20
IS 13
AR 3245
DI 10.3390/ijms20133245
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA IL1EG
UT WOS:000477041100132
PM 31269646
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU Bonora, E
   Chakrabarty, S
   Kellaris, G
   Tsutsumi, M
   Bianco, F
   Bergamini, C
   Ullah, F
   Isidori, F
   Liparulo, I
   Diquigiovanni, C
   Masin, L
   Rizzardi, N
   Cratere, MG
   Boschetti, E
   Papa, V
   Maresca, A
   Cenacchi, G
   Casadio, R
   Martelli, P
   Matera, I
   Ceccherini, I
   Fato, R
   Raiola, G
   Arrigo, S
   Signa, S
   Sementa, AR
   Severino, M
   Striano, P
   Fiorillo, C
   Goto, T
   Uchino, S
   Oyazato, Y
   Nakamura, H
   Mishra, SK
   Yeh, YS
   Kato, T
   Nozu, K
   Tanboon, J
   Morioka, I
   Nishino, I
   Toda, T
   Goto, Y
   Ohtake, A
   Kosaki, K
   Yamaguchi, Y
   Nonaka, I
   Iijima, K
   Mimaki, M
   Kurahashi, H
   Raams, A
   MacInnes, A
   Alders, M
   Engelen, M
   Linthorst, G
   de Koning, T
   den Dunnen, W
   Dijkstra, G
   van Spaendonck, K
   van Gent, DC
   Aronica, EM
   Picco, P
   Carelli, V
   Seri, M
   Katsanis, N
   Duijkers, FAM
   Taniguchi-Ikeda, M
   De Giorgio, R
AF Bonora, Elena
   Chakrabarty, Sanjiban
   Kellaris, Georgios
   Tsutsumi, Makiko
   Bianco, Francesca
   Bergamini, Christian
   Ullah, Farid
   Isidori, Federica
   Liparulo, Irene
   Diquigiovanni, Chiara
   Masin, Luca
   Rizzardi, Nicola
   Cratere, Mariapia Giuditta
   Boschetti, Elisa
   Papa, Valentina
   Maresca, Alessandra
   Cenacchi, Giovanna
   Casadio, Rita
   Martelli, Pierluigi
   Matera, Ivana
   Ceccherini, Isabella
   Fato, Romana
   Raiola, Giuseppe
   Arrigo, Serena
   Signa, Sara
   Sementa, Angela Rita
   Severino, Mariasavina
   Striano, Pasquale
   Fiorillo, Chiara
   Goto, Tsuyoshi
   Uchino, Shumpei
   Oyazato, Yoshinobu
   Nakamura, Hisayoshi
   Mishra, Sushil K.
   Yeh, Yu-Sheng
   Kato, Takema
   Nozu, Kandai
   Tanboon, Jantima
   Morioka, Ichiro
   Nishino, Ichizo
   Toda, Tatsushi
   Goto, Yu-ichi
   Ohtake, Akira
   Kosaki, Kenjiro
   Yamaguchi, Yoshiki
   Nonaka, Ikuya
   Iijima, Kazumoto
   Mimaki, Masakazu
   Kurahashi, Hiroki
   Raams, Anja
   MacInnes, Alyson
   Alders, Mariel
   Engelen, Marc
   Linthorst, Gabor
   de Koning, Tom
   den Dunnen, Wilfred
   Dijkstra, Gerard
   van Spaendonck, Karin
   van Gent, Dik C.
   Aronica, Eleonora M.
   Picco, Paolo
   Carelli, Valerio
   Seri, Marco
   Katsanis, Nicholas
   Duijkers, Floor A. M.
   Taniguchi-Ikeda, Mariko
   De Giorgio, Roberto
TI Biallelic variants in <i>LIG3</i> cause a novel mitochondrial
   neurogastrointestinal encephalomyopathy
SO BRAIN
LA English
DT Article
DE mtDNA repair; mtDNA replication; LIG3; MNGIE; CIPO
ID DNA-LIGASE III; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; SINGLE-NUCLEOTIDE
   POLYMORPHISMS; REPAIR GENE; MUTATIONS; GLUTAMINE; NUCLEAR; CELLS;
   PATHOPHYSIOLOGY; ASSOCIATION
AB Abnormal gut motility is a feature of several mitochondrial encephalomyopathies, and mutations in genes such as TYMP and POLG, have been linked to these rare diseases. The human genome encodes three DNA ligases, of which only one, ligase III (LIG3), has a mitochondrial splice variant and is crucial for mitochondrial health.
   We investigated the effect of reduced LIG3 activity and resulting mitochondrial dysfunction in seven patients from three independent families, who showed the common occurrence of gut dysmotility and neurological manifestations reminiscent of mitochondrial neurogastrointestinal encephalomyopathy. DNA from these patients was subjected to whole exome sequencing. In all patients, compound heterozygous variants in a new disease gene, LIG3, were identified. All variants were predicted to have a damaging effect on the protein. The LIG3 gene encodes the only mitochondrial DNA (mtDNA) ligase and therefore plays a pivotal role in mtDNA repair and replication. In intro assays in patient-derived cells showed a decrease in LIG3 protein levels and ligase activity. We demonstrated that the LIG3 gene defects affect mtDNA maintenance, leading to mtDNA depletion without the accumulation of multiple deletions as observed in other mitochondrial disorders. This mitochondrial dysfunction is likely to cause the phenotypes observed in these patients. The most prominent and consistent clinical signs were severe gut dysmotility and neurological abnormalities, including leukoencephalopathy, epilepsy, migraine, stroke-like episodes, and neurogenic bladder. A decrease in the number of myenteric neurons, and increased fibrosis and elastin levels were the most prominent changes in the gut. Cytochrome c oxidase (COX) deficient fibres in skeletal muscle were also observed. Disruption of lig3 in zebrafish reproduced the brain alterations and impaired gut transit in uiuo.
   In conclusion, we identified variants in the LIG3 gene that result in a mitochondrial disease characterized by predominant gut dysmotility, encephalopathy, and neuromuscular abnormalities.
C1 [Bonora, Elena; Bianco, Francesca; Isidori, Federica; Diquigiovanni, Chiara; Cratere, Mariapia Giuditta; Boschetti, Elisa; Seri, Marco] Univ Bologna, St Orsola Malpighi Hosp, Dept Med & Surg Sci, I-40138 Bologna, Italy.
   [Chakrabarty, Sanjiban; Raams, Anja; van Gent, Dik C.] Erasmus MC, Dept Mol Genet, NL-3000 CA Rotterdam, Netherlands.
   [Kellaris, Georgios; Ullah, Farid; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC 27710 USA.
   [Tsutsumi, Makiko; Kato, Takema; Kurahashi, Hiroki; Taniguchi-Ikeda, Mariko] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Mol Genet, Toyoake, Aichi 4701192, Japan.
   [Bergamini, Christian; Liparulo, Irene; Masin, Luca; Rizzardi, Nicola; Fato, Romana] Univ Bologna, Dept Pharm & Biotechnol, I-40126 Bologna, Italy.
   [Cratere, Mariapia Giuditta] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy.
   [Papa, Valentina; Cenacchi, Giovanna; Carelli, Valerio] Univ Bologna, Dept Biomed & Neuromotor Sci, I-40123 Bologna, Italy.
   [Maresca, Alessandra; Carelli, Valerio] IRCCS Ist Sci Neurol Bologna, Programma Neurogenet, I-40139 Bologna, Italy.
   [Casadio, Rita; Martelli, Pierluigi] Univ Bologna, Dept Biol Geol Environm Sci, Biocomp Grp, I-40126 Bologna, Italy.
   [Matera, Ivana; Ceccherini, Isabella; Arrigo, Serena; Signa, Sara; Sementa, Angela Rita; Severino, Mariasavina; Striano, Pasquale; Fiorillo, Chiara; Picco, Paolo] IRCCS Ist Giannina Gaslini, I-16128 Genoa, Italy.
   [Raiola, Giuseppe] Pugliese Ciaccio Hosp, Dept Paediat, I-88100 Catanzaro, Italy.
   [Goto, Tsuyoshi; Yeh, Yu-Sheng] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Mol Funct Food, Uji 6110011, Japan.
   [Uchino, Shumpei; Mimaki, Masakazu] Teikyo Univ, Sch Med, Dept Pediat, Tokyo 1738605, Japan.
   [Uchino, Shumpei] Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo 1130033, Japan.
   [Oyazato, Yoshinobu] Kakogawa Cent City Hosp, Dept Pediat, Kakogawa, Hyogo 6758611, Japan.
   [Nakamura, Hisayoshi; Tanboon, Jantima; Nishino, Ichizo; Nonaka, Ikuya] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo 1878502, Japan.
   [Mishra, Sushil K.] Natl Univ Ireland, Glycosci Grp, Galway H91 CF50, Ireland.
   [Nozu, Kandai; Iijima, Kazumoto; Taniguchi-Ikeda, Mariko] Kobe Univ, Grad Sch Med, Dept Pediat, Kobe, Hyogo 6500017, Japan.
   [Morioka, Ichiro] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Tokyo 1738610, Japan.
   [Toda, Tatsushi] Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo 1130033, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo 1878502, Japan.
   [Ohtake, Akira] Saitama Med Univ, Fac Med, Dept Pediat & Clin Genom, Saitama 3500495, Japan.
   [Kosaki, Kenjiro] Keio Univ, Sch Med, Ctr Med Genet, Tokyo 1608582, Japan.
   [Yamaguchi, Yoshiki] Tohoku Med & Pharmaceut Univ, Lab Pharmaceut Phys Chem, Sendai, Miyagi 9818558, Japan.
   [MacInnes, Alyson; Linthorst, Gabor] Univ Amsterdam, Dept Metab Dis, Amsterdam UMC, NL-1100 DD Amsterdam, Netherlands.
   [Alders, Mariel; van Spaendonck, Karin; Duijkers, Floor A. M.] Univ Amsterdam, Dept Clin Genet, Amsterdam UMC, NL-1100 DD Amsterdam, Netherlands.
   [Engelen, Marc] Univ Amsterdam, Dept Neurol, Amsterdam UMC, NL-1100 DD Amsterdam, Netherlands.
   [de Koning, Tom] Univ Med Ctr Groningen, Dept Metab Dis, NL-9700 RB Groningen, Netherlands.
   [den Dunnen, Wilfred] Univ Med Ctr Groningen, Dept Pathol, NL-9700 RB Groningen, Netherlands.
   [Dijkstra, Gerard] Univ Med Ctr Groningen, Dept Gastroenterol, NL-9700 RB Groningen, Netherlands.
   [Aronica, Eleonora M.] Univ Amsterdam, Dept Pathol, Amsterdam UMC, NL-1100 DD Amsterdam, Netherlands.
   [Taniguchi-Ikeda, Mariko] Fujita Hlth Univ Hosp, Dept Clin Genet, 1-98 Dengakugakubo Kutsukake Cho, Toyoake, Aichi 4701192, Japan.
   [De Giorgio, Roberto] Univ Ferrara, St Anna Hosp, Dept Morphol Surg & Expt Med, I-44124 Ferrara, Italy.
C3 IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of
   Bologna; Erasmus University Rotterdam; Erasmus MC; Duke University;
   Fujita Health University; University of Bologna; Vita-Salute San
   Raffaele University; IRCCS Ospedale San Raffaele; University of Bologna;
   IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University
   of Bologna; University of Genoa; IRCCS Istituto Giannina Gaslini; Kyoto
   University; Teikyo University; University of Tokyo; National Center for
   Neurology & Psychiatry - Japan; Kobe University; Nihon University;
   University of Tokyo; National Center for Neurology & Psychiatry - Japan;
   Saitama Medical University; Keio University; Tohoku Medical &
   Pharmaceutical University; University of Amsterdam; University of
   Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam;
   University of Groningen; University of Groningen; University of
   Groningen; University of Amsterdam; Fujita Health University; University
   of Ferrara; Arcispedale Sant'Anna
RP Taniguchi-Ikeda, M (corresponding author), Fujita Hlth Univ Hosp, Dept Clin Genet, 1-98 Dengakugakubo Kutsukake Cho, Toyoake, Aichi 4701192, Japan.; De Giorgio, R (corresponding author), Univ Ferrara, Dept Morphol Surg & Expt Med, I-44124 Ferrara, Italy.; Duijkers, FAM (corresponding author), Univ Amsterdam, Amsterdam Univ, Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands.
EM f.a.duijkers@amsterdamumc.nl; mtani@fujita-hu.ac.jp;
   roberto.degiorgio@unife.it
RI Arrigo, Serena/K-6006-2016; Nishino, Ichizo/G-2676-2010; Yeh,
   Yu-Sheng/GZH-3004-2022; Bianco, Francesca/AGO-7864-2022; van
   Spaendonck-Zwarts, Karin/AAY-1506-2021; Ceccherini,
   Isabella/P-8195-2014; Katsanis, Nicholas/E-1837-2012; De Paepe,
   Boel/B-7548-2013; Goto, Tsuyoshi/AAY-2344-2020; Isidori,
   Federica/AAB-6451-2022; Martelli, Pier/I-8824-2012; chakrabarty,
   sanjiban/GXW-1652-2022; Seri, Marcello/AAE-7037-2020; Casadio,
   Rita/K-3747-2017; Dunnen, Wilfred/A-4034-2009; Severino,
   Maria/ITT-9414-2023; Taniguchi-Ikeda, Mariko/AGE-3152-2022; Kato,
   Takema/AAW-9997-2020; Tanboon, Jantima/IZQ-3380-2023; Engelen,
   Marc/F-8433-2012; Diquigiovanni, Chiara/AAC-3179-2022; Bonora,
   Enzo/AAA-5300-2022; Striano, Pasquale/F-9117-2014; Maresca,
   Alessandra/J-7393-2016; Fiorillo, Chiara/AAB-4142-2021; Boschetti,
   Elisa/J-3684-2016; De Giorgio, Roberto/GSD-7139-2022; Mishra, Sushil
   K./O-4779-2014; Casadio, Rita/K-4814-2015; Signa, Sara/K-2741-2018
OI van Gent, Dik C./0000-0003-1473-8148; Bonora, Elena/0000-0001-6132-7734;
   Maresca, Alessandra/0000-0002-8959-8832; Chakrabarty,
   Sanjiban/0000-0002-6018-8098; Masin, Luca/0000-0002-5287-6886; Isidori,
   Federica/0000-0001-5934-3030; Goto, Tsuyoshi/0000-0003-1283-147X;
   Cratere, Mariapia Giuditta/0000-0001-7326-9965; Diquigiovanni,
   Chiara/0000-0003-3124-6946; /0000-0003-4563-7462; Liparulo,
   Irene/0000-0002-2069-0067; den Dunnen, Wilfred/0000-0002-4168-1207;
   Fiorillo, Chiara/0000-0001-9027-343X; Boschetti,
   Elisa/0000-0003-4503-2770; Yeh, Yu-Sheng/0000-0002-0099-2690; Martelli,
   Pier Luigi/0000-0002-0274-5669; De Giorgio, Roberto/0000-0003-0867-5873;
   Mishra, Sushil K./0000-0002-3080-9754; Casadio,
   Rita/0000-0002-7462-7039; BIANCO, FRANCESCA/0000-0003-4920-9561; Signa,
   Sara/0000-0002-9083-1726
FU Telethon Grant [GGP15171]; Department of General Pediatrics, Kobe
   University Graduate School of Medicine [K550003302]; Dutch Cancer
   Foundation grant [KWF11011]; Italian Ministry of Health; University of
   Ferrara (FAR fund); University of Ferrara (FIR fund); Grants-in-Aid for
   Scientific Research [21H02885, 21K07807, 21K06283, 21K19457, 23K21430,
   20H00526] Funding Source: KAKEN
FX This work was supported by Telethon Grant GGP15171 to E.B. and R.D.G.
   and by a donation from Kobe city to the Department of General
   Pediatrics, Kobe University Graduate School of Medicine (K550003302).
   S.C. was supported by a Dutch Cancer Foundation grant (KWF11011). V.C.
   and A.M. were supported by the Italian Ministry of Health ("Ricerca
   Corrente" funding). R.D.G. is the recipient of grants from University of
   Ferrara (FAR and FIR funds).
CR Akbari M, 2014, DNA REPAIR, V16, P44, DOI 10.1016/j.dnarep.2014.01.015
   Bergamini C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033712
   Bonora E, 2015, GASTROENTEROLOGY, V148, P771, DOI 10.1053/j.gastro.2014.12.034
   Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Carelli V, 2018, ESSAYS BIOCHEM, V62, P235, DOI 10.1042/EBC20170097
   Chen QY, 2018, CELL METAB, V27, P1007, DOI 10.1016/j.cmet.2018.03.002
   Corral R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071211
   Cuneo MJ, 2011, NUCLEIC ACIDS RES, V39, P7816, DOI 10.1093/nar/gkr419
   Czarny P, 2017, MOL NEUROBIOL, V54, P4150, DOI 10.1007/s12035-016-9971-6
   Daye D, 2012, SEMIN CELL DEV BIOL, V23, P362, DOI 10.1016/j.semcdb.2012.02.002
   Di Nardo G, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.12945
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Diquigiovanni C, 2019, FASEB J, V33, P11284, DOI 10.1096/fj.201802722R
   Diquigiovanni C, 2018, INT J CANCER, V143, P1706, DOI 10.1002/ijc.31548
   Downes TJ, 2018, J CLIN GASTROENTEROL, V52, P477, DOI 10.1097/MCG.0000000000001047
   Eales KL, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.50
   El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Furda A, 2014, METHODS MOL BIOL, V1105, P419, DOI 10.1007/978-1-62703-739-6_31
   Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773
   Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343
   Goldstein AM, 2016, DEV BIOL, V417, P217, DOI 10.1016/j.ydbio.2016.03.032
   Guissart C, 2018, AM J HUM GENET, V102, P744, DOI 10.1016/j.ajhg.2018.02.021
   Kanungo S, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.12.13
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kwiatkowski D, 2016, NEUROPSYCHOBIOLOGY, V73, P98, DOI 10.1159/000444643
   Lakshmipathy U, 1999, NUCLEIC ACIDS RES, V27, P1198, DOI 10.1093/nar/27.4.1198
   Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869
   Lazzeri E, 2015, J AM SOC NEPHROL, V26, P1961, DOI 10.1681/ASN.2014010057
   Li DH, 2009, CLIN CANCER RES, V15, P740, DOI 10.1158/1078-0432.CCR-08-1607
   Li GN, 2018, MED SCI MONITOR, V24, P5015, DOI 10.12659/MSM.907492
   Liao YH, 2017, J GENE MED, V19, DOI 10.1002/jgm.2988
   Loviglio MN, 2017, AM J HUM GENET, V101, P564, DOI 10.1016/j.ajhg.2017.08.016
   Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268
   Marjoram L, 2015, P NATL ACAD SCI USA, V112, P2770, DOI 10.1073/pnas.1424089112
   Niederriter AR, 2013, JOVE-J VIS EXP, DOI 10.3791/50338
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Odell ID, 2011, MOL CELL BIOL, V31, P4623, DOI 10.1128/MCB.05715-11
   Ohkubo H, 2012, DIGESTION, V86, P12, DOI 10.1159/000337528
   Pichili VBR, 2007, GLIA, V55, P801, DOI 10.1002/glia.20499
   Rao KVR, 2003, NEUROCHEM INT, V43, P517, DOI 10.1016/S0197-0186(03)00042-1
   Sanna-Cherchi S, 2017, AM J HUM GENET, V101, P789, DOI 10.1016/j.ajhg.2017.09.018
   Savojardo C, 2016, BIOINFORMATICS, V32, P2542, DOI 10.1093/bioinformatics/btw192
   Shokolenko IN, 2013, J BIOL CHEM, V288, P26594, DOI 10.1074/jbc.M113.472977
   Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017
   Tomkinson AE, 2013, GENE, V531, P150, DOI 10.1016/j.gene.2013.08.061
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
NR 51
TC 29
Z9 31
U1 2
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD MAY
PY 2021
VL 144
BP 1451
EP 1466
DI 10.1093/brain/awab056
EA APR 2021
PN 5
PG 16
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA WM2NM
UT WOS:000710927500031
PM 33855352
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Carelli, V
   Maresca, A
   Caporali, L
   Trifunov, S
   Zanna, C
   Rugolo, M
AF Carelli, Valerio
   Maresca, Alessandra
   Caporali, Leonardo
   Trifunov, Selena
   Zanna, Claudia
   Rugolo, Michela
TI Mitochondria: Biogenesis and mitophagy balance in segregation and clonal
   expansion of mitochondrial DNA mutations
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Article
DE Mitochondrial DNA; Mitochondrial DNA mutations; Clonal expansion;
   Mitophagy; Nucleoids
ID OPTIC ATROPHY; RAPID SEGREGATION; GENETIC AUTONOMY; SKELETAL-MUSCLE;
   HUMAN-CELLS; MTDNA; COMPLEMENTATION; DELETIONS; SELECTION; EXPLAINS
AB Mitochondria are cytoplasmic organelles containing their own multi-copy genome. They are organized in a highly dynamic network, resulting from balance between fission and fusion, which maintains homeostasis of mitochondrial mass through mitochondrial biogenesis and mitophagy. Mitochondrial DNA (mtDNA) mutates much faster than nuclear DNA. In particular, mtDNA point mutations and deletions may occur somatically and accumulate with aging, coexisting with the wild type, a condition known as heteroplasmy. Under specific circumstances, clonal expansion of mutant mtDNA may occur within single cells, causing a wide range of severe human diseases when mutant overcomes wild type. Furthermore, mtDNA deletions accumulate and clonally expand as a consequence of deleterious mutations in nuclear genes involved in mtDNA replication and maintenance, as well as in mitochondrial fusion genes (mitofusin-2 and OPA1), possibly implicating mtDNA nucleoids segregation. We here discuss how the intricacies of mitochondrial homeostasis impinge on the intracellular propagation of mutant mtDNA. This article is part of a Directed Issue entitled: Energy Metabolism Disorders and Therapies. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Carelli, Valerio; Maresca, Alessandra; Caporali, Leonardo; Zanna, Claudia] Bellaria Hosp, IRCCS Inst Neurol Sci Bologna, Bologna, Italy.
   [Carelli, Valerio; Maresca, Alessandra; Caporali, Leonardo; Trifunov, Selena] Univ Bologna, Neurol Unit, Dept Biomed & NeuroMotor Sci DiBiNeM, I-40139 Bologna, Italy.
   [Trifunov, Selena; Zanna, Claudia; Rugolo, Michela] Univ Bologna, Dept Pharm & Biotechnol, Unit Cellular Biochem, I-40139 Bologna, Italy.
C3 AUSL di Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna
   (ISNB); University of Bologna; University of Bologna
RP Carelli, V (corresponding author), Univ Bologna, Bellaria Hosp, Dept Biomed & NeuroMotor Sci DiBiNeM, IRCCS Inst Neurol Sci Bologna, Via Altura 3, I-40139 Bologna, Italy.
EM valerio.carelli@unibo.it
RI Rugolo, Michela/AAY-8640-2020; Zanna, Claudia/GVT-1932-2022; Caporali,
   Leonardo/J-7398-2016; Maresca, Alessandra/J-7393-2016
OI Caporali, Leonardo/0000-0002-0666-4380; Trifunov,
   Selena/0000-0002-1807-9621; Maresca, Alessandra/0000-0002-8959-8832;
   Rugolo, Michela/0000-0002-4597-0452; CARELLI,
   VALERIO/0000-0003-4923-6404
FU Marie Curie Project: Mitochondrial European Educational Training (MEET)
   MEET; Futuro in Ricerca-FIRB; Programmi di Ricerca Scientifica di
   Rilevante Interesse Nazionale (PRIN) PRIN; Telethon Grants [GGP06233,
   GPP10005, GGP11182]; Emilia-Romagna regional program ER-MITO; Fondazione
   Galletti
FX This work was supported by grants from Marie Curie Project:
   Mitochondrial European Educational Training (MEET) MEET (ST), Futuro in
   Ricerca-FIRB 2013 (CZ), Programmi di Ricerca Scientifica di Rilevante
   Interesse Nazionale (PRIN) PRIN 2012-2015 (MR), Telethon Grants,
   #GGP06233, #GPP10005 and # GGP11182, the Emilia-Romagna regional program
   ER-MITO, and the Fondazione Galletti and a donation by the Ravaglia
   family (to V.C.).
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Attardi G, 2002, NAT GENET, V30, P360, DOI 10.1038/ng0402-360
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Bukowiecki R, 2014, GERONTOLOGY, V60, P174, DOI 10.1159/000355050
   Busch KB, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0442
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Carlson EA, 2013, MUTAT RES-REV MUTAT, V752, P1, DOI 10.1016/j.mrrev.2012.08.003
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   D'Aurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Elson JL, 2002, NEUROMUSCULAR DISORD, V12, P858, DOI 10.1016/S0960-8966(02)00047-0
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Enríquez JA, 2000, J BIOL CHEM, V275, P11207, DOI 10.1074/jbc.275.15.11207
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Howell N, 2000, Hum Reprod, V15 Suppl 2, P235
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   JOHNSTON W, 1995, ANN NEUROL, V37, P16, DOI 10.1002/ana.410370106
   Khrapko K, 2014, PROG MOL BIOL TRANSL, V127, P29, DOI 10.1016/B978-0-12-394625-6.00002-7
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281
   Melser S, 2013, CELL METAB, V17, P719, DOI 10.1016/j.cmet.2013.03.014
   Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011
   Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506
   Murley A, 2013, ELIFE, V2, DOI 10.7554/eLife.00422
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Popadin K, 2014, AGING CELL, V13, P579, DOI 10.1111/acel.12231
   Renaldo F, 2012, BRAIN, V135, DOI 10.1093/brain/aws111
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Rubio-Cosials A, 2011, NAT STRUCT MOL BIOL, V18, P1281, DOI 10.1038/nsmb.2160
   Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Takai D, 1999, J BIOL CHEM, V274, P11199, DOI 10.1074/jbc.274.16.11199
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vielhaber S, 2013, ACTA NEUROPATHOL, V125, P245, DOI 10.1007/s00401-012-1036-y
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2013, COLD SPRING HARB PER, V5
   Wallace DC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0267
   Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213
   YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
NR 64
TC 57
Z9 61
U1 0
U2 21
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
EI 1878-5875
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PD JUN
PY 2015
VL 63
BP 21
EP 24
DI 10.1016/j.biocel.2015.01.023
PG 4
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA CJ7WJ
UT WOS:000355710800005
PM 25666555
DA 2024-11-01
ER

PT J
AU Kandul, NP
   Zhang, T
   Hay, BA
   Guo, M
AF Kandul, Nikolay P.
   Zhang, Ting
   Hay, Bruce A.
   Guo, Ming
TI Selective removal of deletion-bearing mitochondrial DNA in heteroplasmic
   Drosophila
SO NATURE COMMUNICATIONS
LA English
DT Article
ID SKELETAL-MUSCLE; CELL-GROWTH; PARKIN; FUSION; PINK1; MTDNA; DYSFUNCTION;
   AUTOPHAGY; DEGRADATION; ELIMINATION
AB Mitochondrial DNA (mtDNA) often exists in a state of heteroplasmy, in which mutant mtDNA co-exists in cells with wild-type mtDNA. High frequencies of pathogenic mtDNA result in maternally inherited diseases; maternally and somatically acquired mutations also accumulate over time and contribute to diseases of ageing. Reducing heteroplasmy is therefore a therapeutic goal and in vivo models in post-mitotic tissues are needed to facilitate these studies. Here we describe a transgene-based model of a heteroplasmic lethal mtDNA deletion (mtDNA(Delta)) in adult Drosophila muscle. Stimulation of autophagy, activation of the PINK1/parkin pathway or decreased levels of mitofusin result in a selective decrease in mtDNA(Delta). Decreased levels of mitofusin and increased levels of ATPIF1, an inhibitor of ATP synthase reversal-dependent mitochondrial repolarization, result in a further decrease in mtDNAD levels. These results show that an adult post-mitotic tissue can be cleansed of a deleterious genome, suggesting that therapeutic removal of mutant mtDNA can be achieved.
C1 [Kandul, Nikolay P.; Hay, Bruce A.] CALTECH, Div Biol & Biol Engn, Mail Code 156-29,1200 E Calif Blvd, Pasadena, CA 91125 USA.
   [Zhang, Ting; Guo, Ming] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Brain Res Inst, Los Angeles, CA 90095 USA.
   [Zhang, Ting; Guo, Ming] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.
C3 California Institute of Technology; University of California System;
   University of California Los Angeles; University of California Los
   Angeles Medical Center; David Geffen School of Medicine at UCLA;
   University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA
RP Hay, BA (corresponding author), CALTECH, Div Biol & Biol Engn, Mail Code 156-29,1200 E Calif Blvd, Pasadena, CA 91125 USA.; Guo, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Brain Res Inst, Los Angeles, CA 90095 USA.; Guo, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.
EM haybruce@caltech.edu; mingfly@ucla.edu
OI Kandul, Nikolay/0000-0001-7347-5558
FU Alcott Postdoctoral Fellowship; Ellison Medical Foundation Senior
   Scholar Award; National Institute of Health [NIA R01]; National
   Institute of Health (NINDS EUREKA award); Kenneth Glenn Family
   Foundation; Natalie R. and Eugene S. Jones Fund in Aging and
   Neurodegenerative Disease Research
FX This work was supported by an Alcott Postdoctoral Fellowship (N.P.K.),
   the Ellison Medical Foundation Senior Scholar Award (M.G. and B.A.H.)
   and awards to M.G. from the National Institute of Health (NIA R01 and
   NINDS EUREKA award), the Kenneth Glenn Family Foundation, and the
   Natalie R. and Eugene S. Jones Fund in Aging and Neurodegenerative
   Disease Research. We are grateful to Thomas Neufeld for providing fly
   strains used in this study, and to David J. Anderson and the Milliard
   and Muriel Jacobs Genetics and Genomics laboratory at Caltech for
   technical assistance.
CR Atwal KS, 2004, J MED CHEM, V47, P1081, DOI 10.1021/jm030291x
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   BENZER S, 1973, SCI AM, V229, P24, DOI 10.1038/scientificamerican1273-24
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Dai Y, 2014, HUM MOL GENET, V23, P637, DOI 10.1093/hmg/ddt450
   Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105
   Eisner V, 2014, J CELL BIOL, V205, P179, DOI 10.1083/jcb.201312066
   Feng YC, 2015, TRENDS CELL BIOL, V25, P354, DOI 10.1016/j.tcb.2015.02.002
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Guo M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009944
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Hill JH, 2014, NAT GENET, V46, P389, DOI 10.1038/ng.2920
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Ivanes F, 2014, BRIT J PHARMACOL, V171, P4193, DOI 10.1111/bph.12638
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112
   Lane RK, 2015, BBA-BIOENERGETICS, V1847, P1387, DOI 10.1016/j.bbabio.2015.05.021
   Larsson C, 2004, NAT METHODS, V1, P227, DOI 10.1038/NMETH723
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Lee SB, 2015, MOL CELL, V60, P21, DOI 10.1016/j.molcel.2015.08.011
   Lefebvre V, 2013, AUTOPHAGY, V9, P1770, DOI 10.4161/auto.25413
   Liau WS, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-8
   Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Ma HS, 2014, NAT GENET, V46, P393, DOI 10.1038/ng.2919
   Manzanillo PS, 2013, NATURE, V501, P512, DOI 10.1038/nature12566
   Matic I, 2016, PHARMACOL RES, V103, P56, DOI 10.1016/j.phrs.2015.10.010
   MATSUURA ET, 1989, GENETICS, V122, P663
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Neufeld TP, 2012, J CELL SCI, V125, P2359, DOI 10.1242/jcs.103333
   Nezis IP, 2009, AUTOPHAGY, V5, P298, DOI 10.4161/auto.5.3.7454
   Noda NN, 2015, CELL MOL LIFE SCI, V72, P3083, DOI 10.1007/s00018-015-1917-z
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Patel PK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003108
   Payne BAI, 2015, BBA-BIOENERGETICS, V1847, P1347, DOI 10.1016/j.bbabio.2015.05.022
   Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105
   Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054
   Rebolledo-Jaramillo B, 2014, P NATL ACAD SCI USA, V111, P15474, DOI 10.1073/pnas.1409328111
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   Rodriguez AD, 2012, NAT METHODS, V9, P47, DOI [10.1038/nmeth.1800, 10.1038/NMETH.1800]
   Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043
   Scarffe LA, 2014, TRENDS NEUROSCI, V37, P315, DOI 10.1016/j.tins.2014.03.004
   Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Tam ZY, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004183
   Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Valenci I, 2015, MITOCHONDRION, V20, P64, DOI 10.1016/j.mito.2014.11.001
   Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220
   Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Yun JN, 2014, ELIFE, V3, DOI 10.7554/eLife.01958
   Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107
NR 70
TC 94
Z9 107
U1 0
U2 17
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD NOV 14
PY 2016
VL 7
AR 13100
DI 10.1038/ncomms13100
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA EB7HR
UT WOS:000387558100001
PM 27841259
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Girard, A
   Heindl, B
   Clarkson, S
   Litovsky, S
   Ubogu, E
   Schwartzlow, C
   Tallaj, J
AF Girard, Andrew
   Heindl, Brittain
   Clarkson, Stephen
   Litovsky, Silvio
   Ubogu, Eroboghene
   Schwartzlow, Coreen
   Tallaj, Jose
TI Cardiogenic shock in a woman with a mitochondrial cardiomyopathy: a case
   report
SO EUROPEAN HEART JOURNAL-CASE REPORTS
LA English
DT Article
DE Mitochondrial cardiomyopathy; Mitochondrial DNA disease; Advanced heart
   failure; Mechanical circulatory support device; Case report
ID CLINICAL SPECTRUM; DISEASE; DISORDERS; TRIAL
AB Background Mitochondrial cardiomyopathy (MCM) is an alteration in cardiac structure and function caused by gene mutations or deletions affecting components of the mitochondrial respiratory chain. We report a case of MCM presenting as cardiogenic shock, ultimately requiring left ventricular assist device (LVAD) placement. Case summary A 35-year-old woman with chronic weakness and non-ischaemic cardiomyopathy, on home dobutamine, was referred to our institution for heart transplantation evaluation. She was admitted to the hospital for suspected cardiogenic shock after laboratory tests revealed a lactate level of 5.4 mmol/L (ref: 0.5-2.2 mmol/L). Her hospital course was complicated by persistently undulating lactate levels (0.2-8.6 mmol/L) that increased with exertion and did not correlate with mixed venous oxygen saturation measurements obtained from a pulmonary artery catheter. Electrodiagnostic testing demonstrated a proximal appendicular and axial myopathy. A left deltoid muscle biopsy was performed that demonstrated evidence of a mitochondrial disease on light and electron microscopy. Muscle genetic testing revealed two large-scale mitochondrial deoxyribonucleic acid sequence deletions, confirming the diagnosis of MCM. She subsequently underwent LVAD placement, which was complicated by significant right ventricular failure requiring early mechanical support. She was ultimately discharged home with chronic inotropic support. Discussion Mitochondrial cardiomyopathy in adults is a diagnostic and therapeutic challenge. Prompt diagnosis should be made in patients with unknown causes of heart failure via skeletal muscle histopathology guided by electrodiagnostic studies, and targeted genetic testing in affected tissue. Outcomes in adult MCM patients who receive an LVAD are unknown and warrant further investigation.
C1 [Girard, Andrew] Univ Alabama Birmingham, Dept Med, 1720 2nd Ave S, BDB 327, Birmingham, AL 35233 USA.
   [Heindl, Brittain; Clarkson, Stephen; Tallaj, Jose] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35233 USA.
   [Litovsky, Silvio] Univ Alabama Birmingham, Dept Pathol, Div Anat Pathol, Birmingham, AL 35233 USA.
   [Ubogu, Eroboghene; Schwartzlow, Coreen] Univ Alabama Birmingham, Dept Neurol, Div Neuromuscular Dis, Birmingham, AL 35233 USA.
C3 University of Alabama System; University of Alabama Birmingham;
   University of Alabama System; University of Alabama Birmingham;
   University of Alabama System; University of Alabama Birmingham;
   University of Alabama System; University of Alabama Birmingham
RP Girard, A (corresponding author), Univ Alabama Birmingham, Dept Med, 1720 2nd Ave S, BDB 327, Birmingham, AL 35233 USA.
EM aagirard@uabmc.edu
OI Girard, Andrew/0000-0002-5906-5015; Clarkson,
   Stephen/0000-0002-7923-9676; Heindl, Brittain/0000-0002-0961-3562
CR Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Glover EI, 2010, MUSCLE NERVE, V42, P739, DOI 10.1002/mus.21758
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   Imai-Okazaki A, 2021, INT J CARDIOL, V341, P48, DOI 10.1016/j.ijcard.2021.06.042
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Munnich A, 1996, J INHERIT METAB DIS, V19, P521, DOI 10.1007/BF01799112
   Ochiai Y, 2002, CIRCULATION, V106, pI198, DOI 10.1161/01.cir.0000032906.33237.1c
   Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   Vincent AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30610
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Weiner JG, 2020, J PEDIATR-US, V217, P46, DOI 10.1016/j.jpeds.2019.10.016
NR 18
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
EI 2514-2119
J9 EUR HEART J-CASE REP
JI Eur. Heart J.-Case Rep.
PD APR 10
PY 2023
VL 7
IS 4
AR ytad183
DI 10.1093/ehjcr/ytad183
EA APR 2023
PG 8
WC Cardiac & Cardiovascular Systems
WE Emerging Sources Citation Index (ESCI)
SC Cardiovascular System & Cardiology
GA F0VZ8
UT WOS:000979623600004
PM 37123653
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Ahola-Erkkilä, S
   Carroll, CJ
   Peltola-Mjösund, K
   Tulkki, V
   Mattila, I
   Seppänen-Laakso, T
   Oresic, M
   Tyynismaa, H
   Suomalainen, A
AF Ahola-Erkkila, Sofia
   Carroll, Christopher J.
   Peltola-Mjosund, Katja
   Tulkki, Valtteri
   Mattila, Ismo
   Seppanen-Laakso, Tuulikki
   Oresic, Matej
   Tyynismaa, Henna
   Suomalainen, Anu
TI Ketogenic diet slows down mitochondrial myopathy progression in mice
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID DELETIONS; BIOGENESIS; TWINKLE; FAT; DNA
AB Mitochondrial dysfunction is a major cause of neurodegenerative and neuromuscular diseases of adult age and of multisystem disorders of childhood. However, no effective treatment exists for these progressive disorders. Cell culture studies suggested that ketogenic diet (KD), with low glucose and high fat content, could select against cells or mitochondria with mutant mitochondrial DNA (mtDNA), but proper patient trials are still lacking. We studied here the transgenic Deletor mouse, a disease model for progressive late-onset mitochondrial myopathy, accumulating mtDNA deletions during aging and manifesting subtle progressive respiratory chain (RC) deficiency. We found that these mice have widespread lipidomic and metabolite changes, including abnormal plasma phospholipid and free amino acid levels and ketone body production. We treated these mice with pre-symptomatic long-term and post-symptomatic shorter term KD. The effects of the diet for disease progression were followed by morphological, metabolomic and lipidomic tools. We show here that the diet decreased the amount of cytochrome c oxidase negative muscle fibers, a key feature in mitochondrial RC deficiencies, and prevented completely the formation of the mitochondrial ultrastructural abnormalities in the muscle. Furthermore, most of the metabolic and lipidomic changes were cured by the diet to wild-type levels. The diet did not, however, significantly affect the mtDNA quality or quantity, but rather induced mitochondrial biogenesis and restored liver lipid levels. Our results show that mitochondrial myopathy induces widespread metabolic changes, and that KD can slow down progression of the disease in mice. These results suggest that KD may be useful for mitochondrial late-onset myopathies.
C1 [Ahola-Erkkila, Sofia; Carroll, Christopher J.; Peltola-Mjosund, Katja; Tulkki, Valtteri; Tyynismaa, Henna; Suomalainen, Anu] Univ Helsinki, Biomedicum Helsinki, Res Program Mol Neurol, FIN-00290 Helsinki, Finland.
   [Mattila, Ismo; Seppanen-Laakso, Tuulikki; Oresic, Matej] VTT Tech Res Ctr Finland, FI-02044 Espoo, Vtt, Finland.
   [Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland.
C3 University of Helsinki; VTT Technical Research Center Finland;
   University of Helsinki; Helsinki University Central Hospital
RP Suomalainen, A (corresponding author), Univ Helsinki, Biomedicum Helsinki, Res Program Mol Neurol, R C523B,Haartmaninkatu 8, FIN-00290 Helsinki, Finland.
EM anu.wartiovaara@helsinki.fi
RI Tyynismaa, Henna/F-1428-2011; Oresic, Matej/K-7673-2016; Ahola,
   Sofia/JEP-4595-2023; Carroll, Christopher/AAV-8023-2021
OI Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195; Tyynismaa,
   Henna/0000-0002-2493-2422; Oresic, Matej/0000-0002-2856-9165; Mattila,
   Ismo/0000-0001-9597-7831; Carroll, Christopher/0000-0002-2814-6955;
   Ahola, Sofia/0000-0001-7552-4843
FU Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation; Academy of
   Finland; Finnish Institute of Molecular Medicine; University of
   Helsinki; Helsinki Biomedical Graduate School
FX This work was supported by Sigrid Juselius Foundation, Jane and Aatos
   Erkko Foundation, Centre of Excellence Program of the Academy of
   Finland, Finnish Institute of Molecular Medicine, University of Helsinki
   (for A. S.) and Helsinki Biomedical Graduate School (for S.A.-E).
CR Bough KJ, 2006, ANN NEUROL, V60, P223, DOI 10.1002/ana.20899
   Chinnery P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub2
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104
   Joshi CN, 2009, PEDIATR NEUROL, V40, P314, DOI 10.1016/j.pediatrneurol.2008.10.023
   Kang HC, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2006.00906.x
   Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006
   Lyly A, 2008, HUM MOL GENET, V17, P1406, DOI 10.1093/hmg/ddn028
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
NR 15
TC 147
Z9 160
U1 1
U2 19
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD MAY 15
PY 2010
VL 19
IS 10
BP 1974
EP 1984
DI 10.1093/hmg/ddq076
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 590PD
UT WOS:000277238200010
PM 20167576
DA 2024-11-01
ER

PT J
AU Darin, N
   Hedberg-Oldfors, C
   Kroksmark, AK
   Moslemi, AR
   Kollberg, G
   Oldfors, A
AF Darin, N.
   Hedberg-Oldfors, C.
   Kroksmark, A. -K.
   Moslemi, A. -R.
   Kollberg, G.
   Oldfors, A.
TI Benign mitochondrial myopathy with exercise intolerance in a large
   multigeneration family due to a homoplasmic m.3250T&gt;C mutation in
   <i>MTTL1</i>
SO EUROPEAN JOURNAL OF NEUROLOGY
LA English
DT Article
DE benign; disease; exercise intolerance; m.3250T > C; mitochondrial;
   mitochondrial DNA; MTTL1; myopathy
ID TRANSFER RNALEU(UUR) GENE; COMPLEX I DEFICIENCY; CLINICAL-FEATURES;
   TRNA(TRP) GENE; POINT MUTATION; DNA; ENCEPHALOMYOPATHIES
AB Background and purpose: Most mitochondrial disorders with onset in early childhood are progressive and involve multiple organs. The m.3250T>C mutation in MTTL1 has previously been described in a few individuals with a possibly riboflavin-responsive myopathy and an association with sudden infant death syndrome was suspected. We describe a large family with this mutation and evaluate the effect of riboflavin treatment.
   Methods: Medical data were collected with the help of a standardized data collection form. Sanger sequencing was used to screen for variants in mitochondrial DNA and the proportion of the mutation was analyzed in different tissues. Biochemical and muscle morphological investigations of muscle tissue were performed in two individuals. The effect of riboflavin treatment was evaluated in two individuals.
   Results: Thirteen family members experienced exercise intolerance with fatigue and weakness. Inheritance was maternal with 100% penetrance. The course was either static or showed improvement over time. There was no evidence of other organ involvement except for a possible mild transient cardiac enlargement in one child. Muscle investigations showed isolated complex I deficiency and mitochondrial proliferation. The level of m.3250T>C was apparently 100%, i.e. homoplasmic, in all examined tissues. Riboflavin treatment showed no effect in any treated family member and there have been no cases of sudden infant death in this family.
   Conclusions: This study illustrates the importance of considering mitochondrial disorders in the work-up of individuals with exercise intolerance and provides a better understanding of the phenotype associated with the m.3250T>C.
C1 [Darin, N.; Kroksmark, A. -K.] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Pediat, Gothenburg, Sweden.
   [Hedberg-Oldfors, C.; Moslemi, A. -R.; Oldfors, A.] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Pathol & Genet, Gothenburg, Sweden.
   [Kollberg, G.] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Clin Chem & Transfus Med, Gothenburg, Sweden.
C3 University of Gothenburg; Sahlgrenska University Hospital; Sahlgrenska
   University Hospital; University of Gothenburg; Sahlgrenska University
   Hospital; University of Gothenburg
RP Darin, N (corresponding author), Sahlgrens Univ Hosp, Sahlgrenska Acad, Dept Pediat, Inst Clin Sci, Gothenburg, Sweden.
EM niklas.darin@vgregion.se
RI Darin, Niklas/AAL-6345-2020
FU ALF grants; Ahlqvist's Foundation; Region Vastra Gotaland
FX This work was supported by ALF grants, Region Vastra Gotaland, and
   Ahlqvist's Foundation.
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreu AL, 1999, ANN NEUROL, V45, P820, DOI 10.1002/1531-8249(199906)45:6<820::AID-ANA22>3.0.CO;2-W
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Baric I, 2013, EUR J HUM GENET, V21, P871, DOI 10.1038/ejhg.2012.272
   Berardo A, 2010, CURR NEUROL NEUROSCI, V10, P118, DOI 10.1007/s11910-010-0096-4
   BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   DiMauro S, 2001, ANN MED, V33, P472, DOI 10.3109/07853890109002096
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Gambello MJ, 2006, MUSCLE NERVE, V34, P437, DOI 10.1002/mus.20605
   Gorman GS, 2015, CLIN SCI, V128, P895, DOI 10.1042/CS20140705
   GOTO Y, 1992, ANN NEUROL, V31, P672, DOI 10.1002/ana.410310617
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hiniker A, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0137-3
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Jeppesen TD, 2014, NEUROMUSCULAR DISORD, V24, P162, DOI 10.1016/j.nmd.2013.08.004
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   Kollberg G, 2009, BRAIN, V132, P2170, DOI 10.1093/brain/awp152
   Lehmann D, 2015, EUR J HUM GENET, V23, P1735, DOI 10.1038/ejhg.2015.73
   Melberg A, 1998, NEUROLOGY, V50, P299, DOI 10.1212/WNL.50.1.299
   MORGANHUGHES JA, 1979, J NEUROL SCI, V43, P27, DOI 10.1016/0022-510X(79)90071-6
   Ogle RF, 1997, J PEDIATR-US, V130, P138, DOI 10.1016/S0022-3476(97)70323-8
   Peverelli L, 2014, MUSCLE NERVE, V50, P292, DOI 10.1002/mus.24262
   Shinde A, 2000, Rinsho Shinkeigaku, V40, P561
   Silvestri G, 1998, NEUROMUSCULAR DISORD, V8, P291, DOI 10.1016/S0960-8966(98)00037-6
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Spiegel R, 2014, EUR J HUM GENET, V22, P902, DOI 10.1038/ejhg.2013.269
NR 27
TC 10
Z9 10
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-5101
EI 1468-1331
J9 EUR J NEUROL
JI Eur. J. Neurol.
PD APR
PY 2017
VL 24
IS 4
BP 587
EP 593
DI 10.1111/ene.13249
PG 7
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA EQ3PK
UT WOS:000397984800012
PM 28181352
DA 2024-11-01
ER

PT J
AU Roos, S
   Fyhr, IM
   Sunnerhagen, KS
   Moslemi, AR
   Oldfors, A
   Ullman, M
AF Roos, Sara
   Fyhr, Ing-Marie
   Sunnerhagen, Katharina S.
   Moslemi, Ali-Reza
   Oldfors, Anders
   Ullman, Michael
TI Histopathological changes in skeletal muscle associated with chronic
   ischaemia
SO APMIS
LA English
DT Article
DE Chronic ischaemia; lower limb; mitochondrial DNA; morphology
ID MITOCHONDRIAL-DNA DELETIONS; ARTERIAL OCCLUSIVE DISEASE; INCLUSION-BODY
   MYOSITIS; OXIDATIVE DAMAGE; EXERCISE; MYOPATHY; FIBERS; DYSFUNCTION;
   MUTATIONS; STRESS
AB Muscle biopsy is an essential part in the diagnostic workup in patients with suspected neuromuscular disorders. It is therefore important to be aware of morphological alterations that can be caused by systemic factors or natural ageing. Chronic limb ischaemia is frequent in elderly individuals. This study was performed to examine histopathological and mitochondrial changes in muscle in patients with chronic critical limb ischaemia. Muscle biopsy of skeletal muscle of the lower limb of patients with chronic ischaemia leading to amputation was performed and compared with muscle biopsies of healthy, age-matched controls. The histopathological abnormalities included fibrosis, necrosis, atrophy, glycogen depletion, internal nuclei, rimmed vacuoles, fibre type grouping, cytochrome c oxidase deficient fibres, MHC-I upregulation, and signs of microangiopathy. The only alteration found in age-matched controls was a few cytochrome c oxidase deficient fibres. There were also increased levels of multiple mitochondrial DNA deletions in ischaemic muscles compared with controls. Critical limb ischaemia is associated with significant histopathological changes in muscle tissue and also increased levels of mitochondrial DNA deletions. Since the alterations mimic different primary myopathic changes, chronic ischaemia is important to consider as a differential diagnosis in elderly individuals, investigated with muscle biopsy for muscle disease.
C1 [Roos, Sara; Fyhr, Ing-Marie; Moslemi, Ali-Reza; Oldfors, Anders] Univ Gothenburg, Sahlgrenska Acad, Dept Pathol, Gothenburg, Sweden.
   [Sunnerhagen, Katharina S.] Univ Gothenburg, Sahlgrenska Acad, Dept Rehabil Med, Gothenburg, Sweden.
   [Ullman, Michael] Univ Gothenburg, Sahlgrenska Acad, Dept Orthopaed, Gothenburg, Sweden.
C3 University of Gothenburg; University of Gothenburg; University of
   Gothenburg
RP Roos, S (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Biomed, Gula Straket 8, S-41345 Gothenburg, Sweden.
EM sara.roos@gu.se
RI Sunnerhagen, Katharina/AAE-2405-2020
OI Stibrant Sunnerhagen, Katharina/0000-0002-5940-4400
FU Swedish Research Council [07122]
FX This work was supported by the Swedish Research Council (grant number
   07122).
CR Albani M, 2002, BMC MUSCULOSKEL DIS, V3, DOI 10.1186/1471-2474-3-8
   Askew CD, 2005, J VASC SURG, V41, P802, DOI 10.1016/j.jvs.2005.01.037
   Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2
   Bhat HK, 1999, CIRCULATION, V99, P807, DOI 10.1161/01.CIR.99.6.807
   Brass EP, 2000, VASC MED, V5, P225, DOI 10.1177/1358836X0000500405
   Brass EP, 2000, VASC MED, V5, P55, DOI 10.1177/1358836X0000500109
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Dahlbom K, 2002, NEUROMUSCULAR DISORD, V12, P853, DOI 10.1016/S0960-8966(02)00098-6
   Dubowitz V., 2013, MUSCLE BIOPSY PRACTI
   FARINON AM, 1984, CLIN NEUROPATHOL, V3, P240
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   GOLLNICK PD, 1974, J PHYSIOL-LONDON, V241, P45, DOI 10.1113/jphysiol.1974.sp010639
   Hedberg B, 1989, Eur J Vasc Surg, V3, P315, DOI 10.1016/S0950-821X(89)80067-2
   KARPATI G, 1988, ANN NEUROL, V23, P64, DOI 10.1002/ana.410230111
   Kemp GJ, 2004, MITOCHONDRION, V4, P629, DOI 10.1016/j.mito.2004.07.017
   Kollberg G, 2007, NEW ENGL J MED, V357, P1507, DOI 10.1056/NEJMoa066691
   Lejay A, 2015, EUR J VASC ENDOVASC, V49, P205, DOI 10.1016/j.ejvs.2014.12.010
   LINDBERG C, 1995, SCAND J IMMUNOL, V41, P421, DOI 10.1111/j.1365-3083.1995.tb03587.x
   MAKITIE J, 1977, ARCH PATHOL LAB MED, V101, P658
   Makris KI, 2007, VASCULAR, V15, P336, DOI 10.2310/6670.2007.00054
   McGuigan MRM, 2002, CAN J APPL PHYSIOL, V27, P415, DOI 10.1139/h02-022
   Moslemi AR, 2010, NEW ENGL J MED, V362, P1203, DOI 10.1056/NEJMoa0900661
   Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   Nagaraju K, 2005, ARTHRITIS RHEUM, V52, P1824, DOI 10.1002/art.21103
   Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Pipinos IL, 2003, J VASC SURG, V38, P827, DOI 10.1016/S0741-5214(03)00602-5
   Pipinos Iraklis I, 2007, Vasc Endovascular Surg, V41, P481, DOI 10.1177/1538574407311106
   Pipinos II, 2008, VASC ENDOVASC SURG, V42, P101, DOI 10.1177/1538574408315995
   Pipinos II, 2008, AM J PHYSIOL-REG I, V295, pR290, DOI 10.1152/ajpregu.90374.2008
   Pipinos II, 2006, FREE RADICAL BIO MED, V41, P262, DOI 10.1016/j.freeradbiomed.2006.04.003
   REGENSTEINER JG, 1993, CIRCULATION, V87, P413, DOI 10.1161/01.CIR.87.2.413
   Subherwal S, 2015, EUR J PREV CARDIOL, V22, P317, DOI 10.1177/2047487313519344
   Sunnehagen KS, 2000, SCAND J REHABIL MED, V32, P159
   Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6
   VILLANOVA M, 1993, BRAIN RES, V603, P343, DOI 10.1016/0006-8993(93)91260-Y
   Weiss DJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-230
NR 38
TC 11
Z9 12
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0903-4641
EI 1600-0463
J9 APMIS
JI APMIS
PD NOV
PY 2016
VL 124
IS 11
BP 935
EP 941
DI 10.1111/apm.12586
PG 7
WC Immunology; Microbiology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Microbiology; Pathology
GA EC6RT
UT WOS:000388264900003
PM 27539941
DA 2024-11-01
ER

PT J
AU Gonzalez-Freire, M
   Moore, AZ
   Peterson, CA
   Kosmac, K
   McDermott, MM
   Sufit, RL
   Guralnik, JM
   Polonsky, T
   Tian, L
   Kibbe, MR
   Criqui, MH
   Li, LY
   Leeuwenburgh, C
   Ferrucci, L
AF Gonzalez-Freire, Marta
   Moore, A. Zenobia
   Peterson, Charlotte A.
   Kosmac, Kate
   McDermott, Mary M.
   Sufit, Robert L.
   Guralnik, Jack M.
   Polonsky, Tamar
   Tian, Lu
   Kibbe, Melina R.
   Criqui, Michael H.
   Li, Lingyu
   Leeuwenburgh, Christian
   Ferrucci, Luigi
TI Associations of Peripheral Artery Disease With Calf Skeletal Muscle
   Mitochondrial DNA Heteroplasmy
SO JOURNAL OF THE AMERICAN HEART ASSOCIATION
LA English
DT Article
DE ankle brachial index; D-loop; heteroplasmy; mtDNA; mtDNA copy number;
   peripheral artery disease
ID ANKLE-BRACHIAL INDEX; MUTATIONS; WALKING; PERFORMANCE; MICROARRAY;
   DAMAGE
AB Background Patients with peripheral artery disease (PAD) undergo frequent episodes of ischemia-reperfusion in lower extremity muscles that may negatively affect mitochondrial health and are associated with impaired mobility. We hypothesized that skeletal muscle from PAD patients will show high mitochondrial DNA heteroplasmy, especially in regions more susceptible to oxidative damage, such as the displacement loop, and that the degree of heteroplasmy will be correlated with the severity of ischemia and mobility impairment.
   Methods and Results Mitochondrial mutations and deletions and their relative abundance were identified by targeted mitochondrial DNA sequencing in biopsy specimens of gastrocnemius muscle from 33 PAD (ankle brachial index <0.9) and 9 non-PAD (ankle brachial index >0.9) subjects aged >= 60 years. The probability of heteroplasmy per DNA base was significantly higher for PAD subjects than non-PAD within each region. In adjusted models, PAD was associated with higher heteroplasmy than non-PAD (P=0.003), but the association was limited to microheteroplasmy, that is heteroplasmy found in 1% to 5% of all mitochondrial genomes (P=0.004). Heteroplasmy in the displacement loop and coding regions were significantly higher for PAD than non-PAD subjects after adjustment for age, sex, race, and diabetes mellitus (P=0.037 and 0.004, respectively). Low mitochondrial damage, defined by both low mitochondrial DNA copy number and low microheteroplasmy, was associated with better walking performance.
   Conclusions People with PAD have higher "low frequency" heteroplasmy in gastrocnemius muscle compared with people without PAD. Among people with PAD, those who had evidence of least mitochondrial damage, had better walking performance than those with more mitochondrial damage.
   Registration URL: http://www.clinicaltrials.gov. Unique identifier: NCT02246660.
C1 [Gonzalez-Freire, Marta; Moore, A. Zenobia; Ferrucci, Luigi] NIA, NIH, Baltimore, MD 21224 USA.
   [Gonzalez-Freire, Marta] Hlth Res Inst Balearic Isl IdISBa, Palma De Mallorca, Illes Balears, Spain.
   [Peterson, Charlotte A.; Kosmac, Kate] Univ Kentucky, Coll Hlth Sci, Lexington, KY USA.
   [Peterson, Charlotte A.; Kosmac, Kate] Univ Kentucky, Ctr Muscle Biol, Lexington, KY USA.
   [McDermott, Mary M.; Li, Lingyu] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA.
   [McDermott, Mary M.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.
   [Sufit, Robert L.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA.
   [Guralnik, Jack M.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA.
   [Polonsky, Tamar] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.
   [Tian, Lu] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA.
   [Kibbe, Melina R.] UNC Sch Med, Dept Surg, Chapel Hill, NC USA.
   [Criqui, Michael H.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA.
   [Leeuwenburgh, Christian] Univ Florida, Inst Aging, Dept Aging & Geriatr Res, Gainesville, FL USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA); Institut Investigacio Sanitaria Illes Balears (IdISBa);
   University of Kentucky; University of Kentucky; Northwestern University;
   Feinberg School of Medicine; Northwestern University; Feinberg School of
   Medicine; Northwestern University; Feinberg School of Medicine;
   University System of Maryland; University of Maryland Baltimore;
   University of Chicago; Stanford University; University of North Carolina
   School of Medicine; University of California System; University of
   California San Diego; State University System of Florida; University of
   Florida
RP Ferrucci, L (corresponding author), NIA, 251 Bayview Blvd, Baltimore, MD 21224 USA.; Gonzalez-Freire, M (corresponding author), Biomed Res Ctr, 251 Bayview Blvd, Baltimore, MD 21224 USA.
EM martagonzalezfreire@gmail.com; ferruccilu@mail.nih.gov
RI Ferrucci, Luigi/AED-9724-2022; Kosmac, Kate/JOK-2532-2023;
   Gonzalez-Freire, Marta/ABG-1197-2020; Kibbe, Melina/ABF-2992-2021
OI tian, lu/0000-0002-5893-0169; Gonzalez-Freire,
   Marta/0000-0001-9741-2826; Moore, Ann Zenobia/0000-0002-1471-4253;
   Leeuwenburgh, Christiaan/0000-0003-0826-4257; Ferrucci,
   Luigi/0000-0002-6273-1613
FU National Institute on Aging [R21-AG047510]; National Heart, Lung, and
   Blood Institute [R01-HL107510, R01HL109244, R01-HL088589, R01HL122846];
   Office of Dietary Supplements; Nathan Shock Center for Aging
FX This work was supported by the National Institute on Aging
   (R21-AG047510), by the National Heart, Lung, and Blood Institute
   (R01-HL107510, R01HL109244, R01-HL088589, R01HL122846), the Office of
   Dietary Supplements, and the Nathan Shock Center for Aging.
CR AlGhatrif M, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006604
   [Anonymous], 2013, J THORAC DIS S2, V5, pS168
   [Anonymous], 2012, DIABETES CARE S1, V35, pS12
   [Anonymous], 2018, CURR OPIN TOXICOL
   Arslan F, 2011, NAT REV CARDIOL, V8, P292, DOI 10.1038/nrcardio.2011.38
   Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662
   Bhat HK, 1999, CIRCULATION, V99, P807, DOI 10.1161/01.CIR.99.6.807
   Brass EP, 2004, VASC MED, V9, P293, DOI 10.1191/1358863x04vm572ra
   Chimienti G, 2018, FREE RADICAL BIO MED, V124, P447, DOI 10.1016/j.freeradbiomed.2018.06.041
   Criqui MH, 2015, CIRC RES, V116, P1509, DOI 10.1161/CIRCRESAHA.116.303849
   Del Bo R, 2002, J NEUROL SCI, V202, P85, DOI 10.1016/S0022-510X(02)00247-2
   Fetterman JL, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0372-y
   Gonzalez-Freire M, 2015, J GERONTOL A-BIOL, V70, P1334, DOI 10.1093/gerona/glv070
   Hart CR, 2018, EXP PHYSIOL, V103, P838, DOI 10.1113/EP086905
   Hefti E, 2018, MITOCHONDRIAL DNA A, V29, P587, DOI 10.1080/24701394.2017.1325480
   Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]
   Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504
   McDermott MM, 2008, J AM COLL CARDIOL, V51, P1482, DOI 10.1016/j.jacc.2007.12.034
   McDermott MM, 2007, J AM GERIATR SOC, V55, P400, DOI 10.1111/j.1532-5415.2007.01092.x
   McDermott MM, 2018, VASC MED, V23, P340, DOI 10.1177/1358863X18765667
   McDermott MM, 2017, JAMA CARDIOL, V2, P902, DOI 10.1001/jamacardio.2017.0538
   McDermott MM, 2014, CONTEMP CLIN TRIALS, V38, P121, DOI 10.1016/j.cct.2014.03.009
   McDermott MM, 2011, CIRC-CARDIOVASC IMAG, V4, P246, DOI 10.1161/CIRCIMAGING.110.962183
   McDermott MM, 2015, CIRC RES, V116, P1540, DOI 10.1161/CIRCRESAHA.114.303517
   McDermott MM, 2000, J VASC SURG, V32, P1164, DOI 10.1067/mva.2000.108640
   McDermott MM, 2002, ANN INTERN MED, V136, P873, DOI 10.7326/0003-4819-136-12-200206180-00008
   McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Pastukh VM, 2016, FREE RADICAL BIO MED, V96, P78, DOI 10.1016/j.freeradbiomed.2016.04.011
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Picca A, 2018, REJUV RES, V21, P350, DOI 10.1089/rej.2017.1989
   Picca A, 2015, MITOCHONDRION, V25, P67, DOI 10.1016/j.mito.2015.10.001
   Pipinos II, 2006, FREE RADICAL BIO MED, V41, P262, DOI 10.1016/j.freeradbiomed.2006.04.003
   Powers SK, 2011, COMPR PHYSIOL, V1, P941, DOI 10.1002/cphy.c100054
   Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Smigrodzki RM, 2005, REJUV RES, V8, P172, DOI 10.1089/rej.2005.8.172
   Sobenin IA, 2015, GERONTOLOGY, V61, P343, DOI 10.1159/000368923
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stoccoro A, 2018, EPIGENOMICS-UK, V10, P1431, DOI 10.2217/epi-2018-0072
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Wachsmuth M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005939
   White SH, 2016, J TRANSL MED, V14, DOI [10.1186/s12967-016-1030-6, 10.1186/s12967-017-1127-6]
   Zhou SY, 2006, J MOL DIAGN, V8, P476, DOI 10.2353/jmoldx.2006.060008
   Zhou TY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020417
NR 49
TC 19
Z9 19
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2047-9980
J9 J AM HEART ASSOC
JI J. Am. Heart Assoc.
PD APR 9
PY 2020
VL 9
IS 7
DI 10.1161/JAHA.119.015197
PG 20
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA LF7LD
UT WOS:000527597700044
PM 32200714
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Domínguez-González, C
   Madruga-Garrido, M
   Mavillard, F
   Garone, C
   Aguirre-Rodríguez, FJ
   Donati, MA
   Kleinsteuber, K
   Martí, I
   Martín-Hernández, E
   Morealejo-Aycinena, JP
   Munell, F
   Nascimento, A
   Kalko, SG
   Sardina, MD
   del Vayo, CA
   Serrano, O
   Long, YL
   Tu, YQ
   Levin, B
   Thompson, JLP
   Engelstad, K
   Uddin, J
   Torres-Torronteras, J
   Jimenez-Mallebrera, C
   Martí, R
   Paradas, C
   Hirano, M
AF Dominguez-Gonzalez, Cristina
   Madruga-Garrido, Marcos
   Mavillard, Fabiola
   Garone, Caterina
   Javier Aguirre-Rodriguez, Francisco
   Donati, M. Alice
   Kleinsteuber, Karin
   Marti, Itxaso
   Martin-Hernandez, Elena
   Morealejo-Aycinena, Juan P.
   Munell, Francina
   Nascimento, Andres
   Kalko, Susana G.
   Dolores Sardina, M.
   Alvarez del Vayo, Concepcion
   Serrano, Olga
   Long, Yuelin
   Tu, Yuqi
   Levin, Bruce
   Thompson, John L. P.
   Engelstad, Kristen
   Uddin, Jasim
   Torres-Torronteras, Javier
   Jimenez-Mallebrera, Cecilia
   Marti, Ramon
   Paradas, Carmen
   Hirano, Michio
TI Deoxynucleoside Therapy for Thymidine Kinase 2-Deficient Myopathy
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID MITOCHONDRIAL-DNA DEPLETION; DIFFERENTIATION FACTOR 15; ENZYME-ACTIVITY;
   MUTATIONS; GENE; BIOMARKER
AB Objective Thymidine kinase 2, encoded by the nuclear gene TK2, is required for mitochondrial DNA maintenance. Autosomal recessive TK2 mutations cause depletion and multiple deletions of mtDNA that manifest predominantly as a myopathy usually beginning in childhood and progressing relentlessly. We investigated the safety and efficacy of deoxynucleoside monophosphate and deoxynucleoside therapies. Methods We administered deoxynucleoside monophosphates and deoxynucleoside to 16 TK2-deficient patients under a compassionate use program. Results In 5 patients with early onset and severe disease, survival and motor functions were better than historically untreated patients. In 11 childhood and adult onset patients, clinical measures stabilized or improved. Three of 8 patients who were nonambulatory at baseline gained the ability to walk on therapy; 4 of 5 patients who required enteric nutrition were able to discontinue feeding tube use; and 1 of 9 patients who required mechanical ventilation became able to breathe independently. In motor functional scales, improvements were observed in the 6-minute walk test performance in 7 of 8 subjects, Egen Klassifikation in 2 of 3, and North Star Ambulatory Assessment in all 5 tested. Baseline elevated serum growth differentiation factor 15 levels decreased with treatment in all 7 patients tested. A side effect observed in 8 of the 16 patients was dose-dependent diarrhea, which did not require withdrawal of treatment. Among 12 other TK2 patients treated with deoxynucleoside, 2 adults developed elevated liver enzymes that normalized following discontinuation of therapy. Interpretation This open-label study indicates favorable side effect profiles and clinical efficacy of deoxynucleoside monophosphate and deoxynucleoside therapies for TK2 deficiency. ANN NEUROL 2019;86:293-303
C1 [Dominguez-Gonzalez, Cristina] Hosp 12 Octubre, Neurol Dept, Neuromuscular Disorders Unit, Madrid, Spain.
   [Dominguez-Gonzalez, Cristina; Martin-Hernandez, Elena] Hosp 12 Octubre, Inst Invest I 12, Madrid, Spain.
   [Dominguez-Gonzalez, Cristina; Martin-Hernandez, Elena; Nascimento, Andres; Kalko, Susana G.; Torres-Torronteras, Javier; Jimenez-Mallebrera, Cecilia; Marti, Ramon] Inst Salud Carlos III, Ctr Biomed Network Res Rare Dis CIBERER, Madrid, Spain.
   [Madruga-Garrido, Marcos] Univ Seville, Hosp Univ Virgen Rocio, Neuromuscular Disorders Unit, Pediat Neurol Dept,CSIC,Inst Biomed Sevilla, Seville, Spain.
   [Mavillard, Fabiola; Paradas, Carmen] Univ Seville, Hosp Univ Virgen Rocio, Neuromuscular Disorders Unit, Neurol Dept,CSIC,Inst Biomed Sevilla, Seville, Spain.
   [Mavillard, Fabiola; Alvarez del Vayo, Concepcion; Paradas, Carmen] Inst Salud Carlos III, Ctr Biomed Network Res Neurodegenerat Dis, Madrid, Spain.
   [Garone, Caterina] Cambridge Biomed Campus, Med Res Council, Mitochondrial Biol Unit, Cambridge, England.
   [Javier Aguirre-Rodriguez, Francisco] Torrecardenas Hosp Complex, Dept Pediat Neurol, Almeria, Spain.
   [Donati, M. Alice] Meyer Hosp, Metab & Neuromuscular Unit, Florence, Italy.
   [Kleinsteuber, Karin] Univ Chile, Pediat Neurol Dept, Las Condes Clin, Fac Med, Santiago, Chile.
   [Marti, Itxaso] Donostia Univ Hosp, Pediat Neurol Dept, San Sebastian, Spain.
   [Martin-Hernandez, Elena] October 12 Hosp, Pediat Dept, Hereditary Metab & Mitochondrial Disorders Unit, Madrid, Spain.
   [Morealejo-Aycinena, Juan P.] Hosp Guatemala, Guatemala City, Guatemala.
   [Munell, Francina] Vall dHebron Hosp, Pediat Dept, Barcelona, Spain.
   [Nascimento, Andres; Kalko, Susana G.; Jimenez-Mallebrera, Cecilia] St Joan Deu Hosp, St Joan Deu Res Inst, Neurol Dept, Neuromuscular Unit, Barcelona, Spain.
   [Dolores Sardina, M.] Badajoz Hosp Complex, Pediat Neurol Dept, Badajoz, Spain.
   [Alvarez del Vayo, Concepcion] Virgin Rocio Univ Hosp, Pharm Dept, Seville, Spain.
   [Serrano, Olga] October 12 Hosp, Pharm Dept, Madrid, Spain.
   [Long, Yuelin; Tu, Yuqi; Levin, Bruce; Thompson, John L. P.] Columbia Univ, Med Ctr, Dept Biostat, Mailman Sch Publ Hlth, New York, NY USA.
   [Engelstad, Kristen; Uddin, Jasim; Hirano, Michio] Columbia Univ, Med Ctr, Neurol Dept, H Houston Merritt Ctr, 630 West 168th St,P&S 4-423, New York, NY 10032 USA.
   [Torres-Torronteras, Javier; Marti, Ramon] Autonomous Univ Barcelona, Vall dHebron Res Inst, Res Grp Neuromuscular & Mitochondrial Dis, Barcelona, Spain.
C3 Hospital Universitario 12 de Octubre; Hospital Universitario 12 de
   Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERER;
   Instituto de Salud Carlos III; Consejo Superior de Investigaciones
   Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de
   Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital;
   Consejo Superior de Investigaciones Cientificas (CSIC); University of
   Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS);
   Virgen del Rocio University Hospital; Instituto de Salud Carlos III; UK
   Research & Innovation (UKRI); Medical Research Council UK (MRC);
   Hospital Torrecardenas; University of Florence; Azienda Ospedaliera
   Universitaria (AOU) MEYER; Universidad de Chile; University Hospital
   Donostia; Hospital Universitari Vall d'Hebron; Columbia University;
   Columbia University; Autonomous University of Barcelona; Hospital
   Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)
RP Paradas, C (corresponding author), Univ Seville, Hosp Univ Virgen Rocio, Neuromuscular Disorders Unit, Neurol Dept,CSIC,Inst Biomed Sevilla, Seville, Spain.; Hirano, M (corresponding author), Columbia Univ, Med Ctr, Neurol Dept, H Houston Merritt Ctr, 630 West 168th St,P&S 4-423, New York, NY 10032 USA.
EM cparadas@us.es; mh29@columbia.edu
RI Martí-Carrera, Itxaso/AGP-5583-2022; Garone, Caterina/AAB-8659-2019;
   Martí, Ramon/Q-3442-2016; Kalko, Susana/KXQ-8935-2024; Mavillard,
   Fabiola/B-8184-2013; Jimenez-Mallebrera, Cecilia/F-5030-2016;
   Torres-Torronteras, Javier/K-4974-2014
OI Jimenez-Mallebrera, Cecilia/0000-0001-8203-7103; Mavillard,
   Fabiola/0000-0002-1460-0483; Marti-Carrera, Itxaso/0000-0003-0578-9568;
   Munell Casadesus, Francina/0000-0001-8580-2819; Torres-Torronteras,
   Javier/0000-0002-6092-9458; Martin-Hernandez, Elena/0000-0002-0656-7660;
   Kalko, Susana/0000-0002-6701-0233; Alvarez-Vayo,
   Concepcion/0000-0002-2683-2943; MARIA ALICE, DONATI/0000-0003-4769-5025;
   Garone, Caterina/0000-0003-4928-1037; Dominguez,
   Cristina/0000-0001-5151-988X; Marti, Ramon/0000-0002-8273-9540
FU Carlos III Health Institute Funding Source: Medline; European Regional
   Development Fund Funding Source: Medline; Instituto de Salud Carlos III
   Funding Source: Medline; Muscular Dystrophy Association [577391] Funding
   Source: Medline; NICHD NIH HHS [P01 HD080642] Funding Source: Medline;
   NINDS NIH HHS [U54 NS078059] Funding Source: Medline; Spanish Carlos III
   Health Institute [CP09/00011, PMP15/00025, PI16/00579] Funding Source:
   Medline; Arturo Estopinan TK2 Research Fund Funding Source: Medline;
   Generalitat de Catalunya PERIS program [SLT002/16/00370] Funding Source:
   Medline
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Alston CL, 2013, NEUROLOGY, V81, P2051, DOI 10.1212/01.wnl.0000436931.94291.e6
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   BERK AJ, 1973, J BIOL CHEM, V248, P2722
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Cámara Y, 2015, NEUROLOGY, V84, P2286, DOI 10.1212/WNL.0000000000001644
   Cámara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Carrozzo R, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9135
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   Davis RL, 2016, NEUROLOGY, V86, P2010, DOI 10.1212/WNL.0000000000002705
   Fagoaga J, 2015, REV NEUROLOGIA, V61, P344, DOI 10.33588/rn.6108.2015319
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Kalko SG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-91
   Ji XB, 2017, MOL NEUROBIOL, V54, P8110, DOI 10.1007/s12035-016-0283-7
   Koga Y., Mitochondrion
   Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mayhew AG, 2013, DEV MED CHILD NEUROL, V55, P1046, DOI 10.1111/dmcn.12220
   McDonald CM, 2013, MUSCLE NERVE, V48, P357, DOI 10.1002/mus.23905
   Montero R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148709
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Paradas C, 2013, NEUROLOGY, V80, P504, DOI 10.1212/WNL.0b013e31827f0ff7
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Scott E, 2012, PHYSIOTHER RES INT, V17, DOI 10.1002/pri.520
   Steffensen B, 2001, Physiother Res Int, V6, P119, DOI 10.1002/pri.221
   Tulinius M, 2005, NEUROMUSCULAR DISORD, V15, P412, DOI 10.1016/j.nmd.2005.03.010
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   U.S. Food and Drug Administration, 2017, GUID IND EXP ACC INV
   Wang L, 1999, FEBS LETT, V443, P170, DOI 10.1016/S0014-5793(98)01711-6
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Zhang SL, 2010, MOL GENET METAB, V99, P53, DOI 10.1016/j.ymgme.2009.09.003
NR 36
TC 67
Z9 74
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD AUG
PY 2019
VL 86
IS 2
BP 293
EP 303
DI 10.1002/ana.25506
PG 11
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA IJ1PL
UT WOS:000475670500013
PM 31125140
OA Green Submitted, Green Accepted
DA 2024-11-01
ER

PT J
AU Lorenzoni, PJ
   Scola, RH
   Kay, CSK
   Arndt, RC
   Freund, AA
   Bruck, I
   Santos, MLSF
   Werneck, LC
AF Lorenzoni, Paulo Jose
   Scola, Rosana H.
   Kay, Claudia S. Kamoi
   Arndt, Raquel C.
   Freund, Aline A.
   Bruck, Isac
   Santos, Mara Lucia S. F.
   Werneck, Lineu C.
TI MELAS Clinical features, muscle biopsy and molecular genetics
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE MELAS; mitochondrial myopathies; biopsy; mitochondrial DNA; genetics
ID STROKE-LIKE EPISODES; MITOCHONDRIAL-DNA MUTATION; RAGGED-RED FIBERS;
   LACTIC-ACIDOSIS; BLOOD-VESSELS; ENCEPHALOPATHY; MYOPATHY; DISORDERS;
   ENCEPHALOMYOPATHIES; INVOLVEMENT
AB Objective: The aim of the study was to analyze a series of Brazilian patients suffering from MELAS. Method: Ten patients with MELAS were studied with correlation between clinical findings, laboratorial data, electrophysiology, histochemical and molecular features. Results: Blood lactate was increased in eight patients. Brain image studies revealed a stroke-like pattern in all patients. Muscle biopsy showed ralled-red fibers (RRF) in 90% of patients on modified Gomori-trichrome and in 100% on succinate dehydrogenase stains. Cytochrome c oxidase stain analysis indicated deficient activity in one patient and subsarcolemmal accumulation in seven patients. Strongly succinate dehydrogenase-reactive blood vessels (SSV) occurred in six patients. The molecular analysis of tRNA(Leu(UUR)) gene by PCR/RLFP and direct sequencing showed the A3243G mutation on mtDNA in 4 patients. Conclusion: The muscle biopsy often confirmed the MELAS diagnosis by presence of RRF and SSV. Molecular analysis of tRNA(Leu(UUR)) gene should not be the only diagnostic criteria for MELAS.
C1 [Lorenzoni, Paulo Jose; Scola, Rosana H.; Kay, Claudia S. Kamoi; Arndt, Raquel C.; Freund, Aline A.; Werneck, Lineu C.] Univ Fed Parana, Dept Internal Med, Neurol Neuromuscular Div, BR-80060000 Curitiba, PR, Brazil.
   [Bruck, Isac] Univ Fed Parana, Neuropediat Div, Dept Pediat, BR-80060000 Curitiba, PR, Brazil.
   [Santos, Mara Lucia S. F.] Hosp Pequeno Principe, Pediat Neurol Dept, Curitiba, PR, Brazil.
C3 Universidade Federal do Parana; Universidade Federal do Parana; Hospital
   Pequeno Principe
RP Scola, RH (corresponding author), UFPR, Hosp Clin, Serv Doencas Neuromusculares, Rua Gen Carneiro 181,3 Andar, BR-80060900 Curitiba, PR, Brazil.
EM scola@hc.ufpr.br
RI Werneck, Lineu/Y-4038-2019
FU Fundacao Araucaria; CAPES; CNPq
FX This study was supported by Fundacao Araucaria, CAPES and CNPq.
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Conforto AB, 2007, ARQ NEURO-PSIQUIAT, V65, P371, DOI 10.1590/S0004-282X2007000300001
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO Y, 1995, MUSCLE NERVE S3, V20, pS107
   Haas R, 2004, MITOCHONDRION, V4, P471, DOI 10.1016/j.mito.2004.07.008
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   MARIE SKN, 1994, BIOCHEM MED METAB B, V52, P136, DOI 10.1006/bmmb.1994.1045
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   Schmiedel J, 2003, J NEUROL, V250, P267, DOI 10.1007/s00415-003-0978-3
   Tanji K, 2008, J NEUROL SCI, V270, P23, DOI 10.1016/j.jns.2008.01.016
   TOKUNAGA M, 1993, ANN NEUROL, V33, P275, DOI 10.1002/ana.410330308
   TOKUNAGA M, 1994, ANN NEUROL, V35, P413, DOI 10.1002/ana.410350407
   Vydt TCG, 2007, AM J CARDIOL, V99, P264, DOI 10.1016/j.amjcard.2006.07.089
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Werneck L C, 1987, Arq Neuropsiquiatr, V45, P288
   Werneck LC, 1981, REV BRAS CLIN TER S, V10, pS2
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 29
TC 13
Z9 19
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 2009
VL 67
IS 3A
BP 668
EP 676
DI 10.1590/S0004-282X2009000400018
PG 9
WC Neurosciences; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Psychiatry
GA 489YR
UT WOS:000269463500018
PM 19722047
OA gold, Green Submitted
DA 2024-11-01
ER

PT J
AU McCormick, EM
   Kenyon, L
   Falk, MJ
AF McCormick, Elizabeth M.
   Kenyon, Lawrence
   Falk, Marni J.
TI Desmin common mutation is associated with multi-systemic disease
   manifestations and depletion of mitochondria and mitochondria! DNA
SO FRONTIERS IN GENETICS
LA English
DT Article
ID CYTOSKELETON; MYOPATHY
AB Desmin (DES) is a major muscle scaffolding protein that also functions to anchor mitochondria. Pathogenic DES mutations, however, have not previously been recognized as a cause of multi-systemic mitochondrial disease. Here, we describe a 45-year-old man who presented to The Children's Hospital of Philadelphia Mitochondrial-Genetics Diagnostic Clinic for evaluation of progressive cardiac, neuromuscular, gastrointestinal, and mood disorders. Muscle biopsy at age 45 was remarkable for cytoplasmic bodies, as well as ragged red fibers and SDH positive/COX negative fibers that were suggestive of a mitochondrial myopathy. Muscle also showed significant reductions in mitochondrial content (16% of control mean for citrate synthase activity) and mitochondrial DNA (35% of control mean). His family history was significant for cardiac conduction defects and myopathy in multiple maternal relatives. Multiple single gene and panel-based sequencing studies were unrevealing. Whole exome sequencing identified a known pathogenic p.S13F mutation in DES that had previously been associated with desmin-related myopathy. Desmin-related myopathy is an autosomal dominant disorder characterized by right ventricular hypertrophic cardiomyopathy, myopathy, and arrhythmias. However, neuropathy, gastrointestinal dysfunction, and depletion of both mitochondria and mitochondrial DNA have not previously been widely recognized in this disorder. Recognition that mitochondrial dysfunction occurs in desmin-related myopathy clarifies the basis for the multi-systemic manifestations, as are typical of primary mitochondrial disorders. Understanding the mitochondrial pathophysiology of desmin-related myopathy highlights the possibility of new therapies for this otherwise untreatable and often fatal class of disease. We postulate that drug treatments aimed at improving mitochondrial biogenesis or reducing oxidative stress may be effective therapies to ameliorate the effects of desmin-related disease.
C1 [McCormick, Elizabeth M.; Falk, Marni J.] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Philadelphia, PA 19104 USA.
   [Kenyon, Lawrence] Thomas Jefferson Univ, Dept Pathol, Philadelphia, PA 19107 USA.
   [Falk, Marni J.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.
C3 University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of
   Philadelphia; Jefferson University; University of Pennsylvania
RP Falk, MJ (corresponding author), Childrens Hosp Philadelphia, ARC 1002C,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.
EM falkm@email.chop.edu
RI Falk, Marni/K-1997-2014
OI Falk, Marni/0000-0002-1723-6728; Kenyon, Lawrence/0000-0002-3719-9565
FU NICHD NIH HHS [U54 HD086984] Funding Source: Medline
CR Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Bai RK, 2004, ANN NY ACAD SCI, V1011, P304, DOI 10.1196/annals.1293.029
   Bergman JEH, 2007, EUR J MED GENET, V50, P355, DOI 10.1016/j.ejmg.2007.06.003
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Dalakas MC, 2000, NEW ENGL J MED, V342, P770, DOI 10.1056/NEJM200003163421104
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Enns GM, 2005, CLIN GENET, V68, P337, DOI 10.1111/j.1399-0004.2005.00499.x
   Gellerich FN, 2004, MITOCHONDRION, V4, P427, DOI 10.1016/j.mito.2004.07.007
   Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300
   Henderson M, 2013, ACTA NEUROPATHOL, V125, P917, DOI 10.1007/s00401-013-1113-x
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Schröder R, 2003, HUM MOL GENET, V12, P657, DOI 10.1093/hmg/ddg060
   STROMER MH, 1988, CELL MOTIL CYTOSKEL, V11, P117, DOI 10.1002/cm.970110205
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   van Spaendonck-Zwarts KY, 2012, NETH HEART J, V20, P219, DOI 10.1007/s12471-011-0233-y
   Venegas Victor, 2011, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1907s68
   Vigelso Andreas, 2014, Int J Physiol Pathophysiol Pharmacol, V6, P84
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Ye F, 2013, ANAL BIOCHEM, V437, P52, DOI 10.1016/j.ab.2013.02.010
NR 23
TC 17
Z9 17
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD JUN 5
PY 2015
VL 6
AR 199
DI 10.3389/fgene.2015.00199
PG 5
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA CP1NR
UT WOS:000359643000002
PM 26097489
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Stumpf, JD
   Bailey, CM
   Spell, D
   Stillwagon, M
   Anderson, KS
   Copeland, WC
AF Stumpf, Jeffrey D.
   Bailey, Christopher M.
   Spell, Diana
   Stillwagon, Matthew
   Anderson, Karen S.
   Copeland, William C.
TI <i>mip1</i> containing mutations associated with mitochondrial disease
   causes mutagenesis and depletion of mtDNA in <i>Saccharomyces
   cerevisiae</i>
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID DNA-POLYMERASE-GAMMA; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; TYPE-1
   REVERSE-TRANSCRIPTASE; POLG MUTATIONS; POINT MUTATIONS; DEFECTS;
   DELETIONS; GENE; RESISTANCE; SUBUNIT
AB DNA polymerase gamma (pol gamma) is responsible for replication and repair of mitochondrial DNA (mtDNA). Over 150 mutations in POLG (which encodes pol gamma) have been discovered in patients with mitochondrial disorders including Alpers, progressive external ophthalmoplegia and ataxia-neuropathy syndrome. However, the severity and dominance of many POLG disease-associated mutations are unclear, because they have been reported in sporadic cases. To understand the consequences of pol gamma disease-associated mutations in vivo, we identified dominant and recessive changes in mtDNA mutagenesis, depletion and mitochondrial dysfunction caused by 31 mutations in the conserved regions of the gene, MIP1, which encodes the Saccharomyces cerevisiae ortholog of human pol gamma. Twenty mip1 mutant enzymes were shown to disrupt mtDNA replication and may be sufficient to cause disease. Previously uncharacterized sporadic mutations, Q308H, R807C, G1076V, R1096H and S1104C, caused decreased polymerase activity leading to mtDNA depletion and mitochondrial dysfunction. We present evidence showing a limited role of point mutagenesis by these POLG mutations in mitochondrial dysfunction and disease progression. Instead, most mitochondrial defective mip1 mutants displayed reduced or depleted mtDNA. We also determined that the severity of the phenotype of the mip1 mutant strain correlates with the age of onset of disease associated with the human ortholog. Finally, we demonstrated that increasing nucleotide pools by overexpression of ribonucleotide reductase (RNR1) suppressed mtDNA replication defects caused by several dominant mip1 mutations, and the orthologous human mutations revealed severe nucleotide binding defects.
C1 [Stumpf, Jeffrey D.; Spell, Diana; Stillwagon, Matthew; Copeland, William C.] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA.
   [Bailey, Christopher M.; Anderson, Karen S.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS); Yale University
RP Copeland, WC (corresponding author), NIEHS, Mol Genet Lab, NIH, 111 TW Alexander Dr,Bldg 101,Room E316, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
RI Copeland, William/C-4242-2019
OI Copeland, William/0000-0002-0359-0953; Bailey, Chris/0000-0002-5962-9511
FU National Institute of Environmental Health Sciences National Institutes
   of Health (NIH) [ES 065078]; NIH [GM49551]; National Institutes of
   Health
FX This work was supported by intramural funds from the National Institute
   of Environmental Health Sciences National Institutes of Health (NIH) [ES
   065078 to W.C.C.]; NIH [GM49551 to K.S.A.] and the National Institutes
   of Health Summers of Discovery Program.
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Burgers P.M., 2001, J BIOL CHEM, V28, P28
   Chabes A, 2007, P NATL ACAD SCI USA, V104, P1183, DOI 10.1073/pnas.0610585104
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Doublié S, 1998, CURR OPIN STRUC BIOL, V8, P704, DOI 10.1016/S0959-440X(98)80089-4
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Feng JY, 2004, ANTIMICROB AGENTS CH, V48, P1300, DOI 10.1128/AAC.48.4.1300-1306.2004
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   HU JP, 1995, GENE, V160, P105, DOI 10.1016/0378-1119(95)00215-R
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kalifa L, 2007, DNA REPAIR, V6, P1732, DOI 10.1016/j.dnarep.2007.06.005
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Kim G, 2002, MUTAGENESIS, V17, P375, DOI 10.1093/mutage/17.5.375
   Lebedeva MA, 2007, CELL CYCLE, V6, P2048, DOI 10.4161/cc.6.16.4572
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Merz S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r95
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Ray AS, 2002, J BIOL CHEM, V277, P40479, DOI 10.1074/jbc.M205303200
   REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901
   Shcherbakova Polina V, 2003, Sci Aging Knowledge Environ, V2003, pRE3, DOI 10.1126/sageke.2003.8.re3
   SOR F, 1984, NUCLEIC ACIDS RES, V12, P8313, DOI 10.1093/nar/12.22.8313
   Strand MK, 2003, EUKARYOT CELL, V2, P809, DOI 10.1128/EC.2.4.809-820.2003
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wikstrom JD, 2009, INT J BIOCHEM CELL B, V41, P1914, DOI 10.1016/j.biocel.2009.06.006
   Wiltshire E, 2008, ARCH NEUROL-CHICAGO, V65, P121, DOI 10.1001/archneurol.2007.14
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Yang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000264
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 58
TC 36
Z9 42
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JUN 1
PY 2010
VL 19
IS 11
BP 2123
EP 2133
DI 10.1093/hmg/ddq089
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 593IX
UT WOS:000277448500004
PM 20185557
OA Green Published, Bronze, Green Submitted
DA 2024-11-01
ER

PT J
AU O'Rourke, K
   Buddles, MR
   Farrell, M
   Howley, R
   Sukuraman, S
   Connolly, S
   Turnbull, DM
   Hutchinson, M
   Taylor, RW
AF O'Rourke, Killian
   Buddles, Mark R.
   Farrell, Michael
   Howley, Rachel
   Sukuraman, Sunita
   Connolly, Sean
   Turnbull, Douglass M.
   Hutchinson, Michael
   Taylor, Robert W.
TI PHENOTYPIC DIVERSITY ASSOCIATED WITH THE MITOCHONDRIAL m.8313G&gt;A
   POINT MUTATION
SO MUSCLE & NERVE
LA English
DT Article
DE mitochondrial myopathy; mitochondrial DNA; tRNA mutation; cytochrome c
   oxidase; single muscle fiber mutation analysis
ID SPORADIC PATIENT; DNA DISEASE; MYOPATHY
AB We report the clinical, histochemical, and molecular genetic findings in a patient with progressive mitochondrial cytopathy due to the m.8313G>A point mutation in the mitochondrial tRNA(Lys)(MTTK) gene. The clinical features in this case are severe, including short stature, myopathy, peripheral neuropathy, and osteoporosis, while extensive analysis of maternal relatives indicate that the mutation has arisen de novo and was not maternally inherited. This report of a second case, together with single muscle fiber mutation analysis that shows clear segregation of mutation load with cytochrome c oxidase deficiency, confirms that the mutation is pathologic. Muscle Nerve 40: 648-651, 2009
C1 [O'Rourke, Killian; Sukuraman, Sunita; Connolly, Sean; Hutchinson, Michael] St Vincents Univ Hosp, Dept Neurol, Dublin 4, Ireland.
   [Buddles, Mark R.; Turnbull, Douglass M.; Taylor, Robert W.] Univ Newcastle, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.
   [Farrell, Michael; Howley, Rachel] Beaumont Hosp, Dept Neuropathol, Dublin 9, Ireland.
C3 University College Dublin; Saint Vincent's University Hospital;
   Newcastle University - UK
RP O'Rourke, K (corresponding author), St Vincents Univ Hosp, Dept Neurol, Dublin 4, Ireland.
EM killian.orourke@gmail.com
RI hutchinson, michael/H-3508-2019; Farrell, Michael/A-4769-2012
FU Wellcome Trust [074454] Funding Source: Medline
CR Bacman SR, 2003, BIOCHEM J, V374, P131, DOI 10.1042/BJ20030222
   Blakely EL, 2007, J NEUROL, V254, P1283, DOI 10.1007/s00415-006-0490-7
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Johnson K, 2000, ARTHRITIS RHEUM-US, V43, P1560, DOI 10.1002/1529-0131(200007)43:7<1560::AID-ANR21>3.0.CO;2-S
   Karadimas CL, 2002, NEUROMUSCULAR DISORD, V12, P865, DOI 10.1016/S0960-8966(02)00072-X
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Verma A, 1997, PEDIATR RES, V42, P448, DOI 10.1203/00006450-199710000-00005
NR 11
TC 2
Z9 2
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0148-639X
J9 MUSCLE NERVE
JI Muscle Nerve
PD OCT
PY 2009
VL 40
IS 4
BP 648
EP 651
DI 10.1002/mus.21342
PG 4
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 506SA
UT WOS:000270794900020
PM 19618438
DA 2024-11-01
ER

PT J
AU Vallance, HD
   Jeven, G
   Wallace, DC
   Brown, MD
AF Vallance, HD
   Jeven, G
   Wallace, DC
   Brown, MD
TI A case of sporadic infantile histiocytoid cardiomyopathy caused by the
   A8344G (MERRF) mitochondrial DNA mutation
SO PEDIATRIC CARDIOLOGY
LA English
DT Article
DE cardiomyopathy; mitochondria disorder; MERRF; mtDNA defect
ID CYTOCHROME-B; DEFICIENCY; SCO2; GENE
AB The A8344G mitochondrial DNA (mtDNA) mutation is best known for the MERRF phenotype (myoclonic epilepsy, myopathy, and ragged red fibers). We describe a sporadic case of an infant with the A8344G mtDNA mutation who presented with failure to thrive and sudden unexpected death at 11 months of age. The autopsy revealed a histiocytold cardiomyopathy, diffuse steatosis of the liver, and bilateral retinal hypoplasia. Electron micrographs of cardiac myocytes showed striking mitochondrial hyperplasia, dispersing the sarcomeres. Special stains of frozen heart muscle showed an absence of complex IV (cytochrome c oxidase) in many of the myocytes. Both complexes I and IV of the respiratory chain were reduced in cardiac muscle. The A8344G mtDNA mutation was detected in both liver and cardiac muscle tissue. To our knowledge, this is the first description of the A8344G mtDNA mutation presenting as a sporadic case of fatal infantile cardiomyopathy and the first occurence of this mutation associated with histiocytoid cardiomyopathy.
C1 Univ British Columbia, Childrens & Womens Hlth Ctr BC, Dept Pathol, Vancouver, BC V6H 3N1, Canada.
   Emory Univ, Ctr Mol Med, Atlanta, GA 30322 USA.
   Mercer Univ, Sch Med, Macon, GA 31207 USA.
C3 University of British Columbia; BC Women's Hospital & Health Centre;
   Emory University; Mercer University
RP Vallance, HD (corresponding author), Univ British Columbia, Childrens & Womens Hlth Ctr BC, Dept Pathol, 4500 Oak St, Vancouver, BC V6H 3N1, Canada.
OI Vallance, Hilary/0000-0003-1734-1445
CR Andreu AL, 2000, PEDIATR RES, V48, P311, DOI 10.1203/00006450-200009000-00008
   Hirano M., 1996, Handbook of Muscle Disease, P479
   Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795
   MALHOTRA V, 1994, AM HEART J, V128, P1009, DOI 10.1016/0002-8703(94)90601-7
   Marin-Garcia J, 2000, J INHERIT METAB DIS, V23, P625, DOI 10.1023/A:1005638231195
   OTANI M, 1995, PATHOL INT, V45, P774, DOI 10.1111/j.1440-1827.1995.tb03396.x
   PAPADIMITRIOU A, 1984, PEDIATR RES, V18, P1023, DOI 10.1203/00006450-198418100-00023
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   RUSZKIEWICZ AR, 1995, AM J FOREN MED PATH, V16, P74, DOI 10.1097/00000433-199503000-00017
   SCHULZ MD, 1962, ARCHIVES PATHOLOGY, V74, P464
   Shehata BM, 1998, PEDIATR DEVEL PATHOL, V1, P56, DOI 10.1007/s100249900007
   Stratilova L, 1999, Cas Lek Cesk, V138, P401
NR 12
TC 41
Z9 44
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0172-0643
J9 PEDIATR CARDIOL
JI Pediatr. Cardiol.
PD SEP-OCT
PY 2004
VL 25
IS 5
BP 538
EP 540
DI 10.1007/s00246-003-0446-y
PG 3
WC Cardiac & Cardiovascular Systems; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Pediatrics
GA 861ZR
UT WOS:000224459200018
PM 15164143
DA 2024-11-01
ER

PT J
AU Hirano, M
   Martí, R
   Spinazzola, A
   Nishino, I
   Nishigaki, Y
AF Hirano, M
   Martí, R
   Spinazzola, A
   Nishino, I
   Nishigaki, Y
TI Thymidine phosphorylase deficiency causes MNGIE:: An autosomal recessive
   mitochondrial disorder
SO NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
LA English
DT Article; Proceedings Paper
CT Joint 11th International and 9th European Symposium on Purines and
   Pyrimidines in Man
CY JUN 09-13, 2003
CL Egmond Aan Zee, NETHERLANDS
DE mitochondria; mitochondrial DNA; MNGIE; thymidine phosphorylase;
   thymidine and deoxyuridine
ID NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY MNGIE; DEOXYNUCLEOTIDE CARRIER;
   MULTIPLE DELETIONS; DNA; DEPLETION; KINASE; TOXICITY; GENE; MUTATIONS;
   FIDELITY
AB Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive disorder caused by mutations in the gene encoding thymidine phosphorylase (TP). The disease is characterized clinically by impaired eye movements, gastrointestinal dysmotility, cachexia, peripheral neuropathy, myopathy, and leukoencephalopathy. Molecular genetic studies of MNGIE patients' tissues have revealed multiple deletions, depletion, and site-specific point mutations of mitochondrial DNA. TP is a cytosolic enzyme required for nucleoside homeostasis. In MNGIE, TP activity is severely reduced and consequently levels of thymidine and deoxyuridine in plasma are dramatically elevated. We have hypothesized that the increased levels of intracellular thymidine and deoxyuridine cause imbalances of mitochondrial nucleotide pools that, in turn, lead to the mtDNA abnormalities. MNGIE was the first molecularly characterized genetic disorder caused by abnormal mitochondrial nucleoside/nucleotide metabolism. Future studies are likely to reveal further insight into this expanding group of diseases.
C1 Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.
   Hosp Santo Crew, Dept Neurol, Barcelona, Spain.
   Natl Neurol Inst Carlo Besta, Div Mol Neurogenet, Milan, Italy.
   Natl Inst Neurosci, Natl Ctr Neurol & Psychiat, Dept Neuromuscular Res, Tokyo, Japan.
C3 Columbia University; Fondazione IRCCS Istituto Neurologico Carlo Besta;
   National Center for Neurology & Psychiatry - Japan
RP Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.
RI Martí, Ramon/Q-3442-2016; Nishino, Ichizo/G-2676-2010; Spinazzola,
   Antonella/P-5298-2017
OI Nishino, Ichizo/0000-0001-9452-112X; Marti, Ramon/0000-0002-8273-9540;
   Spinazzola, Antonella/0000-0003-4242-8091
FU NICHD NIH HHS [R01HD37529] Funding Source: Medline; NINDS NIH HHS
   [P01NS11766] Funding Source: Medline
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9
   Bedlack RS, 2004, MUSCLE NERVE, V29, P364, DOI 10.1002/mus.10546
   BESTWICK RK, 1982, J BIOL CHEM, V257, P9300
   BOGENHAGEN D, 1976, J BIOL CHEM, V251, P2938
   BRAHAMS D, 1994, LANCET, V343, P1494, DOI 10.1016/S0140-6736(94)92599-2
   Brown NS, 1998, BIOCHEM J, V334, P1
   Croteau DL, 1999, MUTAT RES-DNA REPAIR, V434, P137, DOI 10.1016/S0921-8777(99)00025-7
   CUI LX, 1995, J CLIN INVEST, V95, P555, DOI 10.1172/JCI117698
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dolce V, 2001, P NATL ACAD SCI USA, V98, P2284, DOI 10.1073/pnas.031430998
   ELKOUNI MH, 1993, CANCER RES, V53, P3687
   Focher F, 2001, CURR CANCER DRUG TAR, V1, P141, DOI 10.2174/1568009013334232
   Gamez J, 2002, NEUROLOGY, V59, P455, DOI 10.1212/WNL.59.3.455
   Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Hirano M, 1998, AM J HUM GENET, V63, P526, DOI 10.1086/301979
   HOLT I, 1988, NATURE, V331, P34
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KUNKEL TA, 1986, J BIOL CHEM, V261, P160
   Ladner RD, 1997, J BIOL CHEM, V272, P19072, DOI 10.1074/jbc.272.30.19072
   LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Martí R, 2003, BIOCHEM BIOPH RES CO, V303, P14, DOI 10.1016/S0006-291X(03)00294-8
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Papadimitriou A, 1998, NEUROLOGY, V51, P1086, DOI 10.1212/WNL.51.4.1086
   Rosenberg MJ, 2002, NAT GENET, V32, P175, DOI 10.1038/ng948
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Teitelbaum JE, 2002, J PEDIATR GASTR NUTR, V35, P377, DOI 10.1097/00005176-200209000-00029
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang LY, 2000, BIOCHEM J, V351, P469, DOI 10.1042/0264-6021:3510469
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 39
TC 20
Z9 23
U1 0
U2 3
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1525-7770
EI 1532-2335
J9 NUCLEOS NUCLEOT NUCL
JI Nucleosides Nucleotides Nucleic Acids
PD OCT
PY 2004
VL 23
IS 8-9
BP 1217
EP 1225
DI 10.1081/NCN-200027485
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology
GA 871EY
UT WOS:000225113700029
PM 15571233
DA 2024-11-01
ER

PT J
AU Sanaker, PS
   Toompuu, M
   Hogan, VE
   He, LP
   Tzoulis, C
   Chrzanowska-Lightowlers, ZMA
   Taylor, RW
   Bindoff, LA
AF Sanaker, Petter S.
   Toompuu, Marina
   Hogan, Vanessa E.
   He, Langping
   Tzoulis, Charalampos
   Chrzanowska-Lightowlers, Zofia M. A.
   Taylor, Robert W.
   Bindoff, Laurence A.
TI Differences in RNA processing underlie the tissue specific phenotype of
   ISCU myopathy
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE Metabolic myopathy; Exercise intolerance; ISCU; Mitochondrial
   respiratory chain; Splice affecting mutation; RNA processing
ID SULFUR CLUSTER BIOGENESIS; EXERCISE INTOLERANCE; MITOCHONDRIAL-DNA;
   MUTATION; DEFICIENCY; COMPLEXES; GENE; CELLS
AB Hereditary myopathy with lactic acidosis, or myopathy with exercise intolerance. Swedish type (OMIM #255125) is caused by mutations in the iron-sulfur cluster scaffold (ISCU) gene. The g.7044G>C ISCU mutation induces a splicing error in the pre-mRNA that strengthens a weak intronic splice site leading to inclusion of a new exon and subsequent loss of mRNA and protein. While ISCU is widely expressed, homozygosity for this particular intronic mutation gives rise to a pure myopathy. In order to investigate tissue specificity and disease mechanism, we studied muscle, myoblasts, fibroblasts and blood cells from the first non-Swedish case of this disease. Consistent with the recognised role of ISCU, we found abnormal activities of respiratory chain complexes containing iron-sulfur clusters in patient muscle. We confirmed that, in the presence of the g.7044G>C mutation, splicing produces both abnormally and normally spliced mRNA in all tissues. The ratio of these products varies dramatically between tissues, being most abnormal in mature skeletal muscle that also has the lowest relative starting levels of ISCU mRNA compared with other tissues. Myoblasts and fibroblasts have more of the normally spliced variant as well as higher starting levels of ISCU mRNA. Up-regulation of mtDNA copy number was found in skeletal muscle and myoblasts, but not fibroblasts, and is thought to represent a compensatory response. Tissue specificity in this disorder appears therefore to be dependent on the mRNA starting level, the amount of remaining normally spliced RNA, and the degree to which compensatory mechanisms can respond. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Sanaker, Petter S.; Toompuu, Marina; Tzoulis, Charalampos; Bindoff, Laurence A.] Univ Bergen, Dept Clin Med, N-5021 Bergen, Norway.
   [Sanaker, Petter S.; Tzoulis, Charalampos; Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Hogan, Vanessa E.; He, Langping; Chrzanowska-Lightowlers, Zofia M. A.; Taylor, Robert W.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 University of Bergen; University of Bergen; Haukeland University
   Hospital; Newcastle University - UK
RP Bindoff, LA (corresponding author), Univ Bergen, Haukeland Univ Hosp, Dept Clin Med, N-5021 Bergen, Norway.
EM laurence.bindoff@nevro.uib.no
RI Toompuu, Marina/G-4656-2016; Tzoulis, Charalampos/AGD-5114-2022
OI Tzoulis, Charalampos/0000-0003-0341-5191; Chrzanowska-Lightowlers,
   Zofia/0000-0002-0045-3152; Bindoff, Laurence/0000-0003-0988-276X
FU Norwegian Research Council; Heise Vest RHF; Wellcome Trust
   [074454/Z/04/Z]
FX Petter Schandl Sanaker and Marina Toompuu are funded by the Norwegian
   Research Council. This work was also supported by Heise Vest RHF and by
   a Wellcome Trust Programme Grant [074454/Z/04/Z] to ZMAC-L and RVVT.
CR Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Bradley JL, 2004, NEUROCHEM RES, V29, P561, DOI 10.1023/B:NERE.0000014826.00881.c3
   Bruno C, 2008, CURR OPIN NEUROL, V21, P601, DOI 10.1097/WCO.0b013e32830dd5a6
   Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391
   DiMauro S, 2001, MUSCLE NERVE, V24, P984, DOI 10.1002/mus.1103
   Downham E, 2008, NEUROMUSCULAR DISORD, V18, P310, DOI 10.1016/j.nmd.2008.01.003
   HALL RE, 1993, J CLIN INVEST, V92, P2660, DOI 10.1172/JCI116882
   Hicks D, 2009, BRAIN, V132, P147, DOI 10.1093/brain/awn289
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Kollberg G, 2009, BRAIN, V132, P2170, DOI 10.1093/brain/awp152
   LARSSON LE, 1964, J NEUROL NEUROSUR PS, V27, P361, DOI 10.1136/jnnp.27.5.361
   Linderholm H, 1992, Lakartidningen, V89, P1283
   Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057
   Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Stehling O, 2009, METHOD ENZYMOL, V456, P209, DOI 10.1016/S0076-6879(08)04412-1
   Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692
   Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003
   Tzoulis C, 2009, ACTA NEUROL SCAND, V120, P38, DOI 10.1111/j.1600-0404.2009.01212.x
   Wilson RB, 1997, NAT GENET, V16, P352, DOI 10.1038/ng0897-352
NR 23
TC 29
Z9 35
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 0006-3002
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD JUN
PY 2010
VL 1802
IS 6
BP 539
EP 544
DI 10.1016/j.bbadis.2010.02.010
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 605AZ
UT WOS:000278321000005
PM 20206689
OA Bronze
DA 2024-11-01
ER

PT J
AU Ceballos, F
   Serrano-Lorenzo, P
   Bermejo-Guerrero, L
   Blázquez, A
   Quesada-Espinosa, JF
   Amigo, J
   Minguez, P
   Ayuso, C
   García-Arumí, E
   Muelas, N
   Jaijo, T
   Nascimento, A
   Galán-Rodriguez, B
   Paradas, C
   Arenas, J
   Carracedo, A
   Martí, R
   Martín, MA
   Domínguez-González, C
AF Ceballos, Francisco
   Serrano-Lorenzo, Pablo
   Bermejo-Guerrero, Laura
   Blazquez, Alberto
   Quesada-Espinosa, Juan F.
   Amigo, Jorge
   Minguez, Pablo
   Ayuso, Carmen
   Garcia-Arumi, Elena
   Muelas, Nuria
   Jaijo, Teresa
   Nascimento, Andres
   Galan-Rodriguez, Beatriz
   Paradas, Carmen
   Arenas, Joaquin
   Carracedo, Angel
   Marti, Ramon
   Martin, Miguel A.
   Dominguez-Gonzalez, Cristina
CA TK2dSpanish-Grp
TI Clinical and Genetic Analysis of Patients With TK2 Deficiency
SO NEUROLOGY-GENETICS
LA English
DT Article
ID MITOCHONDRIAL-DNA DEPLETION; THYMIDINE KINASE 2; ONE WORD; MUTATIONS;
   MAINTENANCE; HOMOZYGOSITY; ASSOCIATION; MYOPATHY; SPECTRUM; DEFECTS
AB ObjectivesThymidine kinase 2 deficiency (TK2d) is a rare autosomal recessive disorder that stems from a perturbation of the mitochondrial DNA maintenance. Nucleoside treatment has recently shown promise as a disease-modifying therapy. TK2d was initially associated with rapidly progressive fatal myopathy in children featuring mitochondrial DNA depletion. Subsequently, less severe variants of the disease were described, with onset of symptoms during adolescence or adulthood and associated with the presence of multiple mtDNA deletions. These less severe phenotypes have been reported in only 15% of the approximately 120 patients described worldwide. However, some reports suggest that these juvenile and adult-onset presentations may be more common. The objective of this study was to describe the clinical phenotype in a sample of patients from Spain.MethodsThis study includes 53 patients harboring biallelic TK2 pathogenic variants, compiling data retrospectively from 7 Spanish centers. We analyzed allele frequency, investigated the most recent common ancestor of core haplotypes, and used the Runs of Homozygosity approach to investigate variant coalescence.ResultsSymptom onset distribution revealed that 32 patients (60%) experienced symptoms beyond 12 years of age. Approximately 30% of patients died of respiratory insufficiency, while 56% of surviving patients needed mechanical ventilation. Genetic analysis identified 16 distinct variants in TK2. Two variants, p.Lys202del and p.Thr108Met, exhibited significantly higher prevalence in the Spanish population than that reported in gnomAD database (86-fold and 13-fold, respectively). These variants are estimated to have originated approximately 16.8 generations ago for p.Thr108Met and 95.2 generations ago for p.Lys202del within the Spanish population, with the increase in frequency attributed to various forms of inbreeding. In late-onset cases, 46.9% carried the p.Lys202del variant.DiscussionThe higher frequency of TK2d in Spain can be partially attributed to the increased prevalence of 2 variants and consanguinity. Notably, in 60% of the cohort, the disease was late-onset, emphasizing the potential underdiagnosis of this subgroup of patients in other regions. Raising awareness of this potentially treatable disorder is of utmost importance because early interventions can significantly affect the quality of life and survival of affected individuals.
C1 [Ceballos, Francisco; Serrano-Lorenzo, Pablo; Blazquez, Alberto; Amigo, Jorge; Minguez, Pablo; Ayuso, Carmen; Garcia-Arumi, Elena; Muelas, Nuria; Jaijo, Teresa; Nascimento, Andres; Arenas, Joaquin; Carracedo, Angel; Marti, Ramon; Martin, Miguel A.; Dominguez-Gonzalez, Cristina] Hosp Res Inst imas12, Spanish Network Biomed Res Rare Dis CIBERER, Madrid, Spain.
   [Serrano-Lorenzo, Pablo; Blazquez, Alberto; Arenas, Joaquin; Martin, Miguel A.; Dominguez-Gonzalez, Cristina] Hosp Res Inst imas12, Mitochondrial & Neuromuscular Res Group?12 Octubre, Madrid, Spain.
   [Bermejo-Guerrero, Laura] Hosp 12 Octubre, Neurol Dept, Neuromuscular Disorders Unit, Madrid, Spain.
   [Quesada-Espinosa, Juan F.; Martin, Miguel A.] Hosp Univ 12 Octubre, Genet Dept, Madrid, Spain.
   [Amigo, Jorge; Carracedo, Angel] Fdn Publ Galega Med Xen FPGMX, Santiago, Spain.
   [Amigo, Jorge; Carracedo, Angel] Santiago de Compostela Res Inst IDIS, Genet Grp, Santiago De Compostela, Spain.
   [Amigo, Jorge; Carracedo, Angel] Santiago de Compostela Univ USC, Res Ctr Mol Med & Chron Dis CIMUS, Med Xen Grp, Santiago De Compostela, Spain.
   [Minguez, Pablo; Ayuso, Carmen] Fdn Jimenez Diaz Univ Hosp, Dept Genet & Genom, Inst Invest Sanitaria, Madrid, Spain.
   [Minguez, Pablo] Univ Autonoma Madrid IIS FJD, Fdn Jimenez Diaz Univ Hosp, Hlth Res Inst, Bioinformat Unit, Madrid, Spain.
   [Garcia-Arumi, Elena] ValldHebron Univ Hosp, Dept Clin & Mol Genet, Barcelona, Spain.
   [Garcia-Arumi, Elena; Marti, Ramon] Univ Autonoma Barcelona, Vall dHebron Res Inst VHIR, Res Grp Neuromuscular & Mitochondrial Disorders, Barcelona, Spain.
   [Muelas, Nuria] Hosp Univ & Politecn La Fe, Dept Neurol, Neuromuscular Unit, Neuromuscular & Ataxias Res Grp, Valencia, Spain.
   [Jaijo, Teresa] Hosp Univ & Politecn Fe Valencia, Dept Genet, Valencia, Spain.
   [Nascimento, Andres] St Joan de Deu Hosp, St Joan de Deu Res Inst, Neurol Dept, Neuromuscular Unit, Barcelona, Spain.
   [Galan-Rodriguez, Beatriz; Paradas, Carmen] Hosp U Virgen del Rocio, Neurol Dept, Neuromuscular Disorders Unit, Inst Biomed Sevilla, Seville, Spain.
   [Paradas, Carmen] Spanish Network Biomed Res Neurodegenerat Dis CIBE, Madrid, Spain.
C3 CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital
   Universitario 12 de Octubre; Hospital Universitario 12 de Octubre;
   Universidade de Santiago de Compostela; Autonomous University of
   Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut
   de Recerca (VHIR); Hospital Universitari i Politecnic La Fe; Consejo
   Superior de Investigaciones Cientificas (CSIC); University of Sevilla;
   CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS)
RP Martín, MA; Domínguez-González, C (corresponding author), Hosp Res Inst imas12, Spanish Network Biomed Res Rare Dis CIBERER, Madrid, Spain.
RI Martin, Miguel/S-2758-2018; Ayuso, Carmen/A-4843-2019; Jaijo,
   Teresa/A-4801-2010; Serrano-Lorenzo, Pablo/S-4744-2018;
   Quesada-Espinosa, Juan Francisco/AAB-6591-2019; Amigo,
   Jorge/A-4892-2010; Minguez, Pablo/D-4822-2013
OI Serrano-Lorenzo, Pablo/0000-0002-5661-7574; Quesada-Espinosa, Juan
   Francisco/0000-0002-4420-5214; Bermejo-Guerrero,
   Laura/0000-0002-8349-715X; Amigo, Jorge/0000-0002-1362-2605; Minguez,
   Pablo/0000-0003-4099-9421; Ayuso, Carmen/0000-0002-9242-7065
FU Instituto de Salud Carlos III, (ISCIII); Ministerio de Ciencia e
   Innovacion (Madrid, Spain); European Regional Development Fund "A way to
   make Europe" [PI22/01587, PI19/01772, PI21/00381]
FX This research was funded by the Instituto de Salud Carlos III, (ISCIII)
   and the Ministerio de Ciencia e Innovacion (Madrid, Spain; cofunded by
   European Regional Development Fund "A way to make Europe"), grant number
   PI22/01587, to C.D.-G., PI19/01772 to E.G.-A. and PI21/00381 to M.A.M.
CR Abouelhoda M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1102-1
   Alkuraya FS, 2010, GENET MED, V12, P765, DOI 10.1097/GIM.0b013e3181fbfcc4
   Alston CL, 2013, NEUROLOGY, V81, P2051, DOI 10.1212/01.wnl.0000436931.94291.e6
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Bray SM, 2010, P NATL ACAD SCI USA, V107, P16222, DOI 10.1073/pnas.1004381107
   Bychkov IO, 2021, MITOCHONDRION, V57, P205, DOI 10.1016/j.mito.2021.01.004
   Ceballos FC, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.925558
   Ceballos FC, 2019, HUM GENET, V138, P1123, DOI 10.1007/s00439-019-02045-1
   Ceballos FC, 2018, NAT REV GENET, V19, P220, DOI 10.1038/nrg.2017.109
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   de la Hoz CPDF, 2021, MOL GENET METAB REP, V26, DOI 10.1016/j.ymgmr.2020.100701
   Domínguez-González C, 2022, NEUROMUSCULAR DISORD, V32, P728, DOI 10.1016/j.nmd.2022.07.399
   Domínguez-González C, 2022, J NEUROL, V269, P3550, DOI 10.1007/s00415-021-10957-0
   Domínguez-González C, 2021, ORPHANET J RARE DIS, V16, DOI 10.1186/s13023-021-02030-w
   Dominguez-Gonzalez C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66940-8
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1071-z
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Florian RT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12763-9
   Gandolfo LC, 2014, GENETICS, V197, P1315, DOI 10.1534/genetics.114.164616
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   JACQUARD A, 1975, THEOR POPUL BIOL, V7, P338, DOI 10.1016/0040-5809(75)90024-6
   Laine-Menéndez S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115598
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Nothnagel M, 2010, HUM MOL GENET, V19, P2927, DOI 10.1093/hmg/ddq198
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Pagnamenta AT, 2021, BRAIN, V144, P584, DOI 10.1093/brain/awaa420
   Palamara PF, 2012, AM J HUM GENET, V91, P809, DOI 10.1016/j.ajhg.2012.08.030
   Paradas C, 2013, NEUROLOGY, V80, P504, DOI 10.1212/WNL.0b013e31827f0ff7
   Park YH, 2020, NAT IMMUNOL, V21, P857, DOI 10.1038/s41590-020-0705-6
   Provine WB, 2004, GENETICS, V167, P1041
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Rodríguez-López C, 2020, J MED GENET, V57, P643, DOI 10.1136/jmedgenet-2019-106649
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salman DO, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.1029947
   Slatkin M, 2004, AM J HUM GENET, V75, P282, DOI 10.1086/423146
   TEMPLETON AR, 1994, EXS, V68, P91
   Tulinius M, 2005, NEUROMUSCULAR DISORD, V15, P412, DOI 10.1016/j.nmd.2005.03.010
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Urtizberea JA, 2023, GENES-BASEL, V14, DOI 10.3390/genes14050954
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wang JL, 2018, MOL GENET METAB, V124, P124, DOI 10.1016/j.ymgme.2018.04.012
   Wang L, 1999, FEBS LETT, V443, P170, DOI 10.1016/S0014-5793(98)01711-6
   Wang LY, 2022, NUCLEOS NUCLEOT NUCL, V41, P264, DOI 10.1080/15257770.2021.2001005
   Weir BS, 2012, PHILOS SCI, V79, P637, DOI 10.1086/667904
   Wills C., 2007, J Hered, V98, P382, DOI [DOI 10.1093/JHERED/ESM035, 10.1093/jhered/esm035]
NR 50
TC 0
Z9 0
U1 2
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2376-7839
J9 NEUROL-GENET
JI Neurol.-Genet.
PD APR
PY 2024
VL 10
IS 2
AR e200138
DI 10.1212/NXG.0000000000200138
PG 13
WC Genetics & Heredity; Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Neurosciences & Neurology
GA E6T5H
UT WOS:001304310900001
PM 38544965
OA Green Published
DA 2024-11-01
ER

PT J
AU Negro, R
   Zoccolella, S
   Dell'Aglio, R
   Amati, A
   Artuso, L
   Bisceglia, L
   Lavolpe, V
   Papa, S
   Serlenga, L
   Petruzzella, V
AF Negro, Roberto
   Zoccolella, Stefano
   Dell'Aglio, Rosa
   Amati, Angela
   Artuso, Lucia
   Bisceglia, Luigi
   Lavolpe, Vito
   Papa, Sergio
   Serlenga, Luigi
   Petruzzella, Vittoria
TI Molecular analysis in a family presenting with a mild form of late-onset
   autosomal dominant chronic progressive external ophthalmoplegia
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE mtDNA multiple deletions; mtDNA copy number; Progressive external
   ophthalmoplegia
ID MITOCHONDRIAL-DNA DELETIONS; TWINKLE; MUTATIONS; HELICASE; DISEASE
AB Nuclear genes affecting mitochondrial genome stability were screened in an Italian family presenting with autosomal dominant progressive external ophthalmoplegia (adPEO) associated with multiple mitochondrial DNA (mtDNA) deletions. We report on a heterozygous c.907C>T (p.R303W) mutation found in the N-terminal domain of the human mitochondrial DNA helicase, Twinkle protein, in six members of a family, in which two individuals manifested late-onset PEO and morphological and molecular signs of mitochondrial dysfunction along with two carriers who are presently free of disease manifestation. We also investigated if the p.R303W mutation in PEO1 gene affected the relative copy number of mitochondrial DNA genomes. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Negro, Roberto; Dell'Aglio, Rosa; Artuso, Lucia; Papa, Sergio; Petruzzella, Vittoria] Univ Bari, Dept Med Biochem Med Biol & Med Phys, I-70124 Bari, Italy.
   [Zoccolella, Stefano] Osped Riuniti Foggia, Clin Nervous Syst Dis, Foggia, Italy.
   [Amati, Angela; Lavolpe, Vito] Univ Bari, Dept Neurol & Psychiat Sci, I-70124 Bari, Italy.
   [Bisceglia, Luigi] IRCCS Casa Sollievo Sofferenza, Foggia, Italy.
   [Papa, Sergio; Petruzzella, Vittoria] CNR, Inst Biomembranes & Bioenerget, Bari, Italy.
   [Serlenga, Luigi] L Bonomo Hosp, Operat Unit Neurol, Bari, Italy.
C3 Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari
   Aldo Moro; IRCCS Casa Sollievo Della Sofferenza; Consiglio Nazionale
   delle Ricerche (CNR)
RP Petruzzella, V (corresponding author), Univ Bari, Dept Med Biochem Med Biol & Med Phys, Piazza Giulio Cesare 11, I-70124 Bari, Italy.
EM v.petruzzella@biochem.uniba.it
RI zoccolella, stefano/AAA-2515-2020; negro, roberto/HJH-1997-2023;
   d’Amati, Antonio/AAT-7253-2021; Petruzzella, Vittoria/K-8863-2016;
   Bisceglia, Luigi/B-8720-2017
OI Petruzzella, Vittoria/0000-0001-8771-6033; Bisceglia,
   Luigi/0000-0001-5367-8518; negro, roberto/0000-0002-4319-5923; Artuso,
   Lucia/0000-0002-3058-9739; Papa, Sergio/0000-0002-4417-1763
FU Italian Ministry of Health (Ricerca Corrente e Finalizzata); MIUR-PRIN
   [2005052128001]; Research Foundation Cassa di Risparmio di Puglia
FX This work was supported in part by grants from the Italian Ministry of
   Health (Ricerca Corrente e Finalizzata), MIUR-PRIN "Molecular
   mechanisms, physiology and pathology of membrane bioenergetics system",
   Project No. 2005052128001 and Research Foundation Cassa di Risparmio di
   Puglia.
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Lee Andrew G, 2002, Curr Neurol Neurosci Rep, V2, P413, DOI 10.1007/s11910-002-0067-5
   Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
NR 10
TC 7
Z9 9
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JUN
PY 2009
VL 19
IS 6
BP 423
EP 426
DI 10.1016/j.nmd.2009.04.008
PG 4
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 474SV
UT WOS:000268305200008
PM 19428252
DA 2024-11-01
ER

PT J
AU Chen, CS
   Matsuoka, R
   Arai, S
   Momiyama, Y
   Murakami, H
   Kuno, S
   Ishikawa, K
   Nakada, K
   Tawata, M
   Hayashi, JI
AF Chen, CS
   Matsuoka, R
   Arai, S
   Momiyama, Y
   Murakami, H
   Kuno, S
   Ishikawa, K
   Nakada, K
   Tawata, M
   Hayashi, JI
TI Determination of normal ranges of mitochondrial respiratory activities
   by mtDNA transfer from 54 human subjects to mtDNA-less HeLa cells for
   identification of the pathogenicities of mutated mtDNAs
SO JOURNAL OF BIOCHEMISTRY
LA English
DT Article
DE mtDNA-less HeLa cells; mtDNA transfer; mitochondrial diseases;
   pathogenic mtDNA mutations; respiratory function
ID PROTEIN-SYNTHESIS; DNA MUTATION; VARIANT; COMPLEMENTATION; DYSFUNCTION;
   MYOPATHY; DEFECTS; PATIENT
AB To determine the pathogenicities of mutated mtDNAs in patients with respiration defects, the possible involvement of nuclear DNA mutations has to be excluded, since respiratory function is controlled by both nuclear DNA and mtDNA. This was achieved by showing that the mutated mtDNAs and respiration defects were co-transferred from patients to mtDNA-less human cells, and the resultant cybrid clones carrying mutated mtDNAs expressed respiration defects. To decide whether the cybrid clones expressed respiration defects, in this study the lowest limits of normal respiratory function were evaluated by transfer of mtDNAs from 54 normal subjects to mtDNA-less HeLa cells. The resultant cybrid clones showed that 71% respiratory function was the lowest limit of mtDNAs from normal subjects. On the other hand, cybrid clones carrying pathogenic mtDNAs from patients with mitochondrial diseases showed 0-64% respiratory function, suggesting that less than 71% respiratory function in cybrid clones should be a reliable indicator of whether the mutated mtDNAs of the patients were pathogenic.
C1 Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 3058572, Japan.
   Univ Tsukuba, Inst Hlth & Sport Sci, Tsukuba, Ibaraki 3058572, Japan.
   Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058572, Japan.
   Tokyo Womens Med Univ, Heart Inst Japan, Shinjuku Ku, Tokyo 1628666, Japan.
   Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Japan.
   Univ Ryukyus, Fac Med, Dept Endocrinol & Metab, Nishihara, Okinawa 9030215, Japan.
C3 University of Tsukuba; University of Tsukuba; University of Tsukuba;
   Tokyo Women's Medical University; Japan Science & Technology Agency
   (JST); University of the Ryukyus
RP Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 3058572, Japan.
EM jih45@sakura.cc.tsukuba.ac.jp
RI MOMIYAMA, YUKIHIKO/GHR-6526-2022
OI Murakami, Haruka/0000-0001-9160-0033
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Ito S, 1999, P NATL ACAD SCI USA, V96, P2099, DOI 10.1073/pnas.96.5.2099
   Johnson KR, 2001, NAT GENET, V27, P191, DOI 10.1038/84831
   Khogali SS, 2001, LANCET, V357, P1265, DOI 10.1016/S0140-6736(00)04422-6
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Matsuoka R, 1999, BIOCHEM BIOPH RES CO, V257, P228, DOI 10.1006/bbrc.1999.0443
   MIYABAYASHI S, 1989, J INHERIT METAB DIS, V12, P373, DOI 10.1007/BF01799245
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Ohkubo E, 2000, BIOCHEM BIOPH RES CO, V278, P808, DOI 10.1006/bbrc.2000.3867
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   Poulton J, 1998, DIABETOLOGIA, V41, P54, DOI 10.1007/s001250050866
   Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581
   Ruster B, 1996, BIOCHEM BIOPH RES CO, V219, P911, DOI 10.1006/bbrc.1996.0340
   Tawata M, 2000, DIABETES, V49, P1269, DOI 10.2337/diabetes.49.7.1269
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699
NR 20
TC 3
Z9 4
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0021-924X
EI 1756-2651
J9 J BIOCHEM
JI J. Biochem.
PD FEB
PY 2004
VL 135
IS 2
BP 237
EP 243
DI 10.1093/jb/mvh028
PG 7
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 813SP
UT WOS:000220927100011
PM 15047726
DA 2024-11-01
ER

PT J
AU Milenkovic, D
   Matic, S
   Kühl, I
   Ruzzenente, B
   Freyer, C
   Jemt, E
   Park, CB
   Falkenberg, M
   Larsson, NG
AF Milenkovic, Dusanka
   Matic, Stanka
   Kuhl, Inge
   Ruzzenente, Benedetta
   Freyer, Christoph
   Jemt, Elisabeth
   Park, Chan Bae
   Falkenberg, Maria
   Larsson, Nils-Goran
TI TWINKLE is an essential mitochondrial helicase required for synthesis of
   nascent D-loop strands and complete mtDNA replication
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; TRANSCRIPTION FACTOR-A; DNA
   HELICASE; RNA-POLYMERASE; COPY NUMBER; MUTATIONS; MAINTENANCE;
   EXPRESSION; DELETIONS; NUCLEOIDS
AB Replication of the mammalian mitochondrial DNA (mtDNA) is dependent on the minimal replisome, consisting of the heterotrimeric mtDNA polymerase (POLG), the hexameric DNA helicase TWINKLE and the tetrameric single-stranded DNA-binding protein (mtSSB). TWINKLE has been shown to unwind DNA during the replication process and many disease-causing mutations have been mapped to its gene. Patients carrying Twinkle mutations develop multiple deletions of mtDNA, deficient respiratory chain function and neuromuscular symptoms. Despite its importance in human disease, it has been unclear whether TWINKLE is the only replicative DNA helicase in mammalian mitochondria. Furthermore, a substantial portion of mtDNA replication events is prematurely terminated at the end of mitochondrial control region (D-loop) and it is unknown whether TWINKLE also has a role in this abortive replication. Here, we present a conditional mouse knockout for Twinkle and demonstrate that TWINKLE is essential for mouse embryonic development and thus is the only replicative DNA helicase in mammalian mitochondria. Conditional knockout of Twinkle results in severe and rapid mtDNA depletion in heart and skeletal muscle. No replication intermediates or deleted mtDNA molecules are observed after Twinkle knockout, suggesting that TWINKLE once loaded is very processive. We also demonstrate that TWINKLE is essential for nascent H-strand synthesis in the D-loop, thus showing that there is no separate DNA helicase responsible for replication of this region. Our data thus suggest that the relative levels of abortive D-loop synthesis versus complete mtDNA replication are regulated and may provide a mechanism to control progression to complete mtDNA replication.
C1 [Milenkovic, Dusanka; Matic, Stanka; Kuhl, Inge; Ruzzenente, Benedetta; Park, Chan Bae; Falkenberg, Maria; Larsson, Nils-Goran] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany.
   [Freyer, Christoph; Larsson, Nils-Goran] Karolinska Inst, Dept Lab Med, Stockholm, Sweden.
   [Jemt, Elisabeth; Falkenberg, Maria] Univ Gothenburg, Dept Biochem & Cell Biol, Gothenburg, Sweden.
   [Park, Chan Bae] Ajou Univ, Inst Med Sci, Sch Med, Suwon 443721, South Korea.
C3 Max Planck Society; Karolinska Institutet; University of Gothenburg;
   Ajou University
RP Larsson, NG (corresponding author), Max Planck Inst Biol Ageing, Robert Koch Str 21, D-50931 Cologne, Germany.
EM larsson@age.mpg.de
RI Matic, Stanka/LHA-4440-2024; Ruzzenente, Benedetta/H-4793-2017; Larsson,
   Nils-Göran/GVS-5578-2022
OI Larsson, Nils-Goran/0000-0001-5100-996X; Freyer,
   Christoph/0000-0003-0418-1673; Kuhl, Inge/0000-0003-4797-0859;
   Ruzzenente, Benedetta/0000-0001-7366-114X; Falkenberg,
   Maria/0000-0001-8713-173X
FU European Research Council; Swedish Research Council; Swedish Cancer
   Foundation; Max-Planck Society
FX This work was supported by a European Research Council Advanced
   Investigator grant to N.G.L. and by Swedish Research Council, Swedish
   Cancer Foundation and European Research Council Starting Independent
   Investigator grants to M. F. Funding to pay the Open Access publication
   charges for this article was provided by Max-Planck Society.
CR Bratic A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002324
   Cámara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Freyer C, 2010, NUCLEIC ACIDS RES, V38, P6577, DOI 10.1093/nar/gkq527
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Goffart S, 2009, METHODS MOL BIOL, V554, P103, DOI 10.1007/978-1-59745-521-3_7
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Jemt E, 2011, NUCLEIC ACIDS RES, V39, P9238, DOI 10.1093/nar/gkr653
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   LARSSON NG, 1994, BIOCHEM BIOPH RES CO, V200, P1374, DOI 10.1006/bbrc.1994.1603
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451
   Liu BY, 2009, MOL CELL, V35, P490, DOI 10.1016/j.molcel.2009.07.004
   Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001
   Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   Pohjoismäki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029
   Polosa PL, 2005, NUCLEIC ACIDS RES, V33, P3812, DOI 10.1093/nar/gki693
   Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392
   Sanchez-Martinez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043954
   Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   TERSCHEGGET J, 1971, BIOCHIM BIOPHYS ACTA, V254, P1
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wanrooij S., 2012, EMBO REP, DOI [10.1038/embor.2012.161, DOI 10.1038/EMB0R.2012.161]
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
NR 50
TC 118
Z9 136
U1 2
U2 15
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD MAY 15
PY 2013
VL 22
IS 10
BP 1983
EP 1993
DI 10.1093/hmg/ddt051
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 139CL
UT WOS:000318559000007
PM 23393161
OA hybrid, Green Published, Green Submitted
DA 2024-11-01
ER

PT J
AU Born, AP
   Duno, M
   Rafiq, J
   Risom, L
   Wibrand, F
   Ostergaard, E
   Vissing, J
AF Born, Alfred Peter
   Duno, Morten
   Rafiq, Jabin
   Risom, Lotte
   Wibrand, Flemming
   Ostergaard, Elsebet
   Vissing, John
TI A mitochondrial tRNA<SUP>Met</SUP> mutation causing developmental delay,
   exercise intolerance and limb girdle phenotype with onset in early
   childhood
SO EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
LA English
DT Article
DE Mitochondrial tRNA(Met) mutation; Limb-girdle muscle weakness; Exercise
   intolerance; Lactic acidosis
AB A 10-year-old girl presented with exercise intolerance, learning difficulty, and muscle weakness in a limb girdle distribution. She had delayed achievement of motor milestones and difficulties with social interaction at pre-school age. Muscle biopsy showed no myopathic or dystrophic features, but 90% COX negative fibres and ragged blue fibres. Respiratory chain enzyme analysis in muscle showed a combined deficiency and mitochondrial DNA sequencing revealed the presence of an m.4450G>A mutation in the MT-TM gene encoding the tRNA for methionine. The mutation was only detected in mtDNA extracted from muscle and skin fibroblast, and could not be found in other tissues or in the mother. This is the second patient reported in the literature with a mitochondrial myopathy due to a mt-tRNA(Met) mutation. The first patient, a 30-year-old woman, presented with exercise intolerance, limb girdle muscle weakness, lactic acidosis, learning difficulty, and growth retardation in early childhood. Thus, the two patients exhibit strikingly overlapping phenotypes. (C) 2014 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
C1 [Born, Alfred Peter] Univ Copenhagen, Rigshosp, Paediat Clin, DK-1168 Copenhagen, Denmark.
   [Duno, Morten; Risom, Lotte; Wibrand, Flemming; Ostergaard, Elsebet] Univ Copenhagen, Rigshosp, Dept Clin Genet, DK-1168 Copenhagen, Denmark.
   [Rafiq, Jabin; Vissing, John] Univ Copenhagen, Rigshosp, Neuromuscular Res Unit, DK-1168 Copenhagen, Denmark.
C3 University of Copenhagen; Rigshospitalet; University of Copenhagen;
   Rigshospitalet; University of Copenhagen; Rigshospitalet
RP Born, AP (corresponding author), Rigshosp, Paediat Clin, Blegdamsvej 9, DK-2100 Copenhagen N, Denmark.
EM peter.born@regionh.dk
RI Østergaard, Elsebet/IZE-6519-2023; Vissing, John/IUN-4271-2023; Born,
   Alfred Peter/GVS-4083-2022
OI Ostergaard, Elsebet/0000-0002-8047-063X
CR Bortot B, 2009, MITOCHONDRION, V9, P123, DOI 10.1016/j.mito.2009.01.006
   Jeppesen TD, 2014, NEUROMUSCULAR DISORD, V24, P162, DOI 10.1016/j.nmd.2013.08.004
   Lombes A, 1998, HUM MUTAT, pS175
   Vissing J, 1998, NEUROLOGY, V50, P1875, DOI 10.1212/WNL.50.6.1875
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
NR 5
TC 8
Z9 10
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1090-3798
EI 1532-2130
J9 EUR J PAEDIATR NEURO
JI Eur. J. Paediatr. Neurol.
PD JAN
PY 2015
VL 19
IS 1
BP 69
EP 71
DI 10.1016/j.ejpn.2014.10.006
PG 3
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA AZ5KJ
UT WOS:000348259700010
PM 25468263
DA 2024-11-01
ER

PT J
AU Taivassalo, T
   Haller, RG
AF Taivassalo, T
   Haller, RG
TI Exercise and training in mitochondrial myopathies
SO MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
LA English
DT Article
DE mtDNA defects; exercise intolerance; treatment; endurance training;
   resistance training; satellite cells
ID CYTOCHROME-C-OXIDASE; SKELETAL-MUSCLE; SATELLITE CELLS; POINT MUTATION;
   MTDNA; ADAPTATIONS; EXPRESSION; ACCUMULATION; METABOLISM; RESPONSES
AB The intriguing concept of exercise training as therapy for mitochondrial disease is currently unsettled: in the unique setting of mitochondrial heteroplasmy, what are the effects of chronic exercise on skeletal muscle containing a mixture of mutated and wild-type mitochondrial DNA (mtDNA)? Furthermore, what are the consequences of habitual physical inactivity on mitochondrial heteroplasmy? In patients with mtDNA defects, deleterious effects of limited physical activity likely magnify the mitochondrial oxidative impairment contributing to varying degrees of exercise intolerance. Normal adaptive responses to endurance training offer the potential to increase levels of functional mitochondria, improving exercise tolerance. The few clinical studies assessing such training effects in patients with mtDNA defects have unequivocally demonstrated physiologic and biochemical adaptations that improve exercise tolerance and quality of life. Uncertain, however, is the training effect on mitochondrial heteroplasmy. To determine therapeutic advisability of endurance training, it remains imperative to establish whether: reported increases in mutant mtDNA levels can be offset by increases in absolute wild-type mtDNA levels; and chronic physical inactivity leads to a selective down-regulation of wild-type mtDNA. Resistance exercise training offers an alternate, innovative therapeutic approach in patients with sporadic mtDNA mutations; exercise-induced transfer of normal mtDNA templates from muscle satellite cells to mature myofibers, thereby lowering mutation load (increasing functional mitochondrial load). Efficacy and safety of this approach needs to be replicated in a larger group of patients. Currently, appropriate recommendation (either in support or against) exercise training in mitochondrial disease is lacking, which is frustrating for physicians and disheartening for patients. Although considerable progress has been made, an immediate urgency exists to resolve the effects of chronic exercise on skeletal muscle in patients with heteroplasmic mtDNA mutations.
C1 Neuromusc Ctr, Inst Exercise & Environm Med, Dallas, TX USA.
   Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75235 USA.
   Dallas VA Med Ctr, Dallas, TX USA.
C3 University of Texas System; University of Texas Dallas; University of
   Texas Southwestern Medical Center Dallas
RP McGill Univ, Dept Kinesiol & Phys Educ, 475 Pine Ave W, Montreal, PQ H2W 1S4, Canada.
EM tanjataivassalo@yahoo.com
CR Adhihetty PJ, 2003, EXP PHYSIOL, V88, P99, DOI 10.1113/eph8802505
   BISCHOFF R, 1994, MYOGENESIS, V2, P97
   BOOTH FW, 1977, J BIOL CHEM, V252, P416
   CHEEK DB, 1985, EARLY HUM DEV, V12, P211, DOI 10.1016/0378-3782(85)90144-6
   Chinnery P F, 2003, Neuromuscul Disord, V13, P757, DOI 10.1016/S0960-8966(03)00097-X
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 2003, J NEUROL SCI, V211, P63, DOI 10.1016/S0022-510X(03)00039-X
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   Crameri RM, 2004, J PHYSIOL-LONDON, V558, P333, DOI 10.1113/jphysiol.2004.061846
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Essig D A, 1996, Exerc Sport Sci Rev, V24, P289
   FAULKNER JA, 1977, MED SCI SPORT EXER, V9, P148
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Goffart S, 2003, EXP PHYSIOL, V88, P33, DOI 10.1113/eph8802500
   Gordon JW, 2001, J APPL PHYSIOL, V90, P389, DOI 10.1152/jappl.2001.90.1.389
   HALLER RG, 1983, NEUROLOGY, V33, P1283, DOI 10.1212/WNL.33.10.1283
   HALLER RG, 1989, J CLIN INVEST, V84, P155, DOI 10.1172/JCI114135
   HALLER RG, 1994, MYOLOGY, P807
   Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534
   HE L, 2002, NUCLEIC ACIDS RES, V15, P30
   HENRIKSSON J, 1992, DIABETES CARE, V15, P1701, DOI 10.2337/diacare.15.11.1701
   Heslop L, 2000, J CELL SCI, V113, P2299
   Hikida RS, 2000, J GERONTOL A-BIOL, V55, pB347, DOI 10.1093/gerona/55.7.B347
   Hood D A, 2000, Exerc Sport Sci Rev, V28, P68
   Ivey FM, 2000, J GERONTOL A-BIOL, V55, pM641, DOI 10.1093/gerona/55.11.M641
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   JOHNSON MA, 1983, J NEUROL SCI, V60, P31, DOI 10.1016/0022-510X(83)90125-9
   Kadi F, 2000, HISTOCHEM CELL BIOL, V113, P99, DOI 10.1007/s004180050012
   Kärppä M, 2004, J NEUROL, V251, P556, DOI 10.1007/s00415-004-0363-x
   Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   MCCOMAS AJ, 1994, MED SCI SPORT EXER, V26, P1498
   MITCHELL JH, 1971, NEW ENGL J MED, V284, P1018, DOI 10.1056/NEJM197105062841809
   MOORE RL, 1987, J APPL PHYSIOL, V63, P1719, DOI 10.1152/jappl.1987.63.5.1719
   Mujika I, 2001, MED SCI SPORT EXER, V33, P1297, DOI 10.1097/00005768-200108000-00009
   NEUFER PD, 1989, SPORTS MED, V8, P302, DOI 10.2165/00007256-198908050-00004
   Pollock ML, 1998, MED SCI SPORT EXER, V30, P975, DOI 10.1097/00005768-199806000-00032
   Roth SM, 2001, J GERONTOL A-BIOL, V56, pB240, DOI 10.1093/gerona/56.6.B240
   SALE DG, 1988, MED SCI SPORT EXER, V20, pS135, DOI 10.1249/00005768-198810001-00009
   SALTIN B, 1980, FED PROC, V39, P1506
   Saltin B., 1983, Comprehensive Physiology, P555
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   Siciliano G, 2000, NEUROMUSCULAR DISORD, V10, P40, DOI 10.1016/S0960-8966(99)00068-1
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T., 2002, Medicine & Science in Sports & Exercise, V34, pS169, DOI 10.1097/00005768-200205001-00943
   Taivassalo T, 1998, NEUROLOGY, V50, P1055, DOI 10.1212/WNL.50.4.1055
   Taivassalo T, 1996, NEUROLOGY, V47, P529, DOI 10.1212/WNL.47.2.529
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   TESCH PA, 1989, J APPL PHYSIOL, V83, P67
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Weber K, 1997, AM J HUM GENET, V60, P373
NR 52
TC 64
Z9 68
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0195-9131
EI 1530-0315
J9 MED SCI SPORT EXER
JI Med. Sci. Sports Exerc.
PD DEC
PY 2005
VL 37
IS 12
BP 2094
EP 2101
DI 10.1249/01.mss.0000177446.97671.2a
PG 8
WC Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Sport Sciences
GA 992DY
UT WOS:000233865800012
PM 16331135
OA Bronze
DA 2024-11-01
ER

PT J
AU Sanaker, PS
   Husebye, ES
   Fondenes, O
   Bindoff, LA
AF Sanaker, P. S.
   Husebye, E. S.
   Fondenes, O.
   Bindoff, L. A.
TI Clinical evolution of Kearns-Sayre syndrome with polyendocrinopathy and
   respiratory failure
SO ACTA NEUROLOGICA SCANDINAVICA
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the Norwegian-Neurological-Association (Nevrodagene
   2006)
CY NOV 20-24, 2006
CL Oslo, NORWAY
SP Norwegian Neurol Assoc
DE endocrine disease; Kearns Sayre syndrome; mitochondrial disease;
   respiratory failure
ID MITOCHONDRIAL-DNA DELETION; VENTILATORY RESPONSE; MUTATION; DISEASE;
   ENCEPHALOMYOPATHY; THYROIDITIS; MYOPATHY; SLEEP; MELAS; GENE
AB Background- The triad of progressive external ophthalmoplegia, atypical retinal pigmentation and cardiac conduction defects characterizes Kearns-Sayre syndrome (KSS), which is most often caused by a single, large deletion of mitochondrial DNA. Endocrine disease appears to be more common in KSS than in other mitochondrial diseases. Materials, methods and results- A patient presenting with KSS developed Addison's disease, hypothyroidism and glucose intolerance. Thyroid peroxidase antibodies and adrenal 21-hydroxylase antibodies were identified. She developed acute respiratory failure requiring invasive ventilatory support, but improved and currently requires only non-invasive, nocturnal BiPAP treatment. Discussion and conclusion- This case confirms the association of KSS and endocrine dysfunction. Our finding of autoantibodies to thyroid and adrenal glands distinguishes this patient from most other published cases and suggests a potential synergy between the two disease mechanisms. In addition, we demonstrate that respiratory failure can be a treatable event in this disease.
C1 Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   Univ Bergen, Inst Clin Med, Bergen, Norway.
   Univ Bergen, Inst Med, Bergen, Norway.
   Haukeland Hosp, Dept Med, N-5021 Bergen, Norway.
   Haukeland Hosp, Dept Pulmonol, Norwegian Ctr Home Mech Ventilat, N-5021 Bergen, Norway.
C3 University of Bergen; Haukeland University Hospital; University of
   Bergen; University of Bergen; University of Bergen; Haukeland University
   Hospital; University of Bergen; Haukeland University Hospital
RP Sanaker, PS (corresponding author), Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
EM petter.schandl.sanaker@helse-bergen.no
OI Fondenes, Ove/0000-0003-1126-926X; Bindoff, Laurence/0000-0003-0988-276X
CR Artuch R, 1998, HORM RES, V50, P99, DOI 10.1159/000023243
   BAROHN RJ, 1990, NEUROLOGY, V40, P103, DOI 10.1212/WNL.40.1.103
   Berio A, 2002, PANMINERVA MED, V44, P265
   Boles RG, 1998, EUR J PEDIATR, V157, P643, DOI 10.1007/s004310050902
   CARROLL JE, 1976, NEUROLOGY, V26, P140, DOI 10.1212/WNL.26.2.140
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   CUMMISKEY J, 1987, NEUROLOGY, V37, P1876, DOI 10.1212/WNL.37.12.1876
   de Andrade PBM, 2006, DIABETOLOGIA, V49, P1816, DOI 10.1007/s00125-006-0301-9
   HARVEY JN, 1992, CLIN ENDOCRINOL, V37, P97, DOI 10.1111/j.1365-2265.1992.tb02289.x
   Isotani H, 1996, CLIN ENDOCRINOL, V45, P637, DOI 10.1046/j.1365-2265.1996.00856.x
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kobayashi T, 1996, DIABETOLOGIA, V39, P1196, DOI 10.1007/BF02658506
   Ohno K, 1996, ANN NEUROL, V39, P761, DOI 10.1002/ana.410390612
   OKA Y, 1993, LANCET, V342, P527, DOI 10.1016/0140-6736(93)91649-7
   Osanai S, 2001, Respirology, V6, P163, DOI 10.1046/j.1440-1843.2001.00318.x
   Schoffner JM.WallaceDC, 1995, METABOLIC MOL BASES, P1535
   Simon DK, 1999, ANNU REV MED, V50, P111
   SUZUKI S, 1994, DIABETOLOGIA, V37, P818, DOI 10.1007/s001250050183
   TANDON N, 1991, CLIN ENDOCRINOL, V34, P383
   TATSUMI C, 1988, EUR NEUROL, V28, P64, DOI 10.1159/000116231
   Vaidya B, 2000, CLIN ENDOCRINOL, V53, P403, DOI 10.1046/j.1365-2265.2000.01116.x
   WENG TR, 1985, CHEST, V88, P488, DOI 10.1378/chest.88.4.488
NR 22
TC 22
Z9 22
U1 0
U2 2
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0001-6314
J9 ACTA NEUROL SCAND
JI Acta Neurol. Scand.
PY 2007
VL 115
SU 187
BP 64
EP 67
DI 10.1111/j.1600-0404.2007.00850.x
PG 4
WC Clinical Neurology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 152AK
UT WOS:000245332300012
PM 17419832
OA gold
DA 2024-11-01
ER

PT J
AU DiMauro, S
AF DiMauro, Salvatore
TI Mitochondrial encephalomyopathies-Fifty years on The Robert Wartenberg
   Lecture
SO NEUROLOGY
LA English
DT Article
ID HEREDITARY OPTIC NEUROPATHY; PHOSPHATIDYLCHOLINE BIOSYNTHESIS;
   MUSCULAR-DYSTROPHY; DNA MUTATION; DISEASE; MTDNA; HETEROPLASMY;
   DELETIONS; DYNAMICS; MUSCLE
C1 Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10027 USA.
C3 Columbia University
RP DiMauro, S (corresponding author), Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10027 USA.
EM sd12@columbia.edu
FU NICHD [P01HD032062]; NINDS/NICHD [U54NS078059]; Marriott Mitochondrial
   Disorder Clinical Research Fund (MMDCRF)
FX Supported by grants from NICHD (P01HD032062), NINDS/NICHD (U54NS078059),
   and the Marriott Mitochondrial Disorder Clinical Research Fund (MMDCRF).
CR Al-Saif A, 2012, ANN NEUROL, V72, P510, DOI 10.1002/ana.23641
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Belzil VV, 2012, ANN NEUROL, V72, P479, DOI 10.1002/ana.23678
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Chan DC, 2007, NEW ENGL J MED, V356, P1707, DOI 10.1056/NEJMp078040
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Christian BE, 2012, BBA-GENE REGUL MECH, V1819, P1035, DOI 10.1016/j.bbagrm.2011.11.009
   Chrzanowska-Lightowlers Z M A, 2011, Neuromuscul Disord, V21, P142, DOI 10.1016/j.nmd.2010.10.005
   Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003
   Craven L, 2011, HUM MOL GENET, V20, pR168, DOI 10.1093/hmg/ddr373
   DiMauro S, 2000, BRAIN PATHOL, V10, P431
   DiMauro S., 2013, MITOCHONDRIAL DISORD, P3
   ENGEL WK, 1963, NEUROLOGY, V13, P919, DOI 10.1212/WNL.13.11.919
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   Milone M, 2012, NEUROLOGY, V78, P1612, DOI 10.1212/WNL.0b013e3182563c46
   Mitsuhashi S, 2011, AM J HUM GENET, V88, P845, DOI 10.1016/j.ajhg.2011.05.010
   Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Ríos PG, 2012, ARCH NEUROL-CHICAGO, V69, P657, DOI 10.1001/archneurol.2011.2333
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Ropper AH, 2012, ANN NEUROL, V72, P1, DOI 10.1002/ana.23657
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   ROWLAND LP, 1983, NEUROLOGY, V33, P1179, DOI 10.1212/WNL.33.9.1179
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022
   Schon EA, 2013, MOL CELL NEUROSCI, V55, P26, DOI 10.1016/j.mcn.2012.07.011
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003
   SENGERS RCA, 1985, BRIT HEART J, V54, P543
   Sher RB, 2006, J BIOL CHEM, V281, P4938, DOI 10.1074/jbc.M512578200
   Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tay SHK, 2006, ARCH NEUROL-CHICAGO, V63, P281, DOI 10.1001/archneur.63.2.281
   Vielhaber S, 2013, ACTA NEUROPATHOL, V125, P245, DOI 10.1007/s00401-012-1036-y
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wortmann SB, 2012, NAT GENET, V44, P797, DOI 10.1038/ng.2325
   Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002
NR 58
TC 24
Z9 26
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD JUL 16
PY 2013
VL 81
IS 3
BP 281
EP 291
DI 10.1212/WNL.0b013e31829bfe89
PG 11
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 304JP
UT WOS:000330743200016
PM 23858410
OA Green Published, Green Accepted
DA 2024-11-01
ER

PT J
AU Zoraster, RM
   Rison, RA
AF Zoraster, Richard M.
   Rison, Richard A.
TI Severe lactic acidosis secondary to minocycline in a teenager with
   infectious mononucleosis and mitochondrial myopathy
SO CLINICAL NEUROLOGY AND NEUROSURGERY
LA English
DT Article
DE mitochondrial myopathy; lactic acidosis; minocycline; infectious
   mononucleosis; G8363A mutation; ribosome inhibitor; respiratory chain
   complexes
ID ANTIRETROVIRAL THERAPY; DNA; MUTATION; DISORDERS; DISEASE; MELAS;
   ENCEPHALOMYOPATHIES; EPIDEMIOLOGY; INHERITANCE; TRNA(LYS)
AB Mitochondrial myopathies are heterogeneous disorders with diverse presentations including laboratory findings of lactic acidosis. Often times they are diagnosed in childhood or the early teenage years following an infectious illness. Minocycline is a common antibiotic used for the treatment of acne. It has been reported to alter mitochondrial respiratory chain complexes. We report an interesting case of a teenager in which mitochondrial myopathy with severe lactic acidosis presented following a bout of infectious mononucleosis and minocycline use. It is hypothesized that oxidative stress from the infectious illness plus the minocycline use triggered the patient's presentation. The clinical manifestations and genetics of mitochondrial myopathies and treatment are discussed along with the management of lactic acidosis. (c) 2008 Elsevier B. V. All rights reserved.
C1 [Rison, Richard A.] Univ So Calif, Keck Sch Med, Med Director Whittier Presbyterian Intercommunity, Los Angeles Cty Med Ctr,Neurol Consultants Med Gr, Whittier, CA 90606 USA.
   [Zoraster, Richard M.] Presbyterian Intercommunity Hosp Whittier, Emergency Dept, Whittier, CA 90602 USA.
C3 University of Southern California
RP Rison, RA (corresponding author), Univ So Calif, Keck Sch Med, Med Director Whittier Presbyterian Intercommunity, Los Angeles Cty Med Ctr,Neurol Consultants Med Gr, 12291 E Washington Blvd,Suite 303, Whittier, CA 90606 USA.
EM RZoraster@yahoo.com; rison@usc.edu
OI Rison, Richard/0000-0002-6088-8246
CR Adrogue HJ, 1999, NEW ENGL J MED, V340, P247
   Alimenti A, 2003, PEDIATR INFECT DIS J, V22, P782, DOI 10.1097/01.inf.0000086400.93257.74
   Casaletto JJ, 2005, EMERG MED CLIN N AM, V23, P771, DOI 10.1016/j.emc.2005.03.007
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   Dickerson BC, 2005, NEW ENGL J MED, V353, P2271, DOI 10.1056/NEJMcpc059032
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dimauro S, 2004, ANN NY ACAD SCI, V1011, P217, DOI 10.1196/annals.1293.022
   DiMauro S, 2000, NEUROL SCI, V21, pS901
   EGGER J, 1983, NEW ENGL J MED, V309, P142, DOI 10.1056/NEJM198307213090304
   Funk MJ, 2007, DRUG SAFETY, V30, P845
   Gold DR, 2001, SEMIN NEUROL, V21, P309, DOI 10.1055/s-2001-17948
   Gropman A L, 2001, Curr Neurol Neurosci Rep, V1, P185
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Katirji B., 2002, NEUROMUSCULAR DISORD
   *MIT, HUM MIT GEN DAT
   MIZOCK BA, 1992, CRIT CARE MED, V20, P80, DOI 10.1097/00003246-199201000-00020
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Prietsch V, 2002, J INHERIT METAB DIS, V25, P531, DOI 10.1023/A:1022040422590
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Spellberg B, 2001, ARCH INTERN MED, V161, P2497, DOI 10.1001/archinte.161.20.2497
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taylor RW, 2003, ANN NEUROL, V54, P521, DOI 10.1002/ana.10673
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a
NR 28
TC 6
Z9 6
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0303-8467
EI 1872-6968
J9 CLIN NEUROL NEUROSUR
JI Clin. Neurol. Neurosurg.
PD JUN
PY 2008
VL 110
IS 6
BP 627
EP 630
DI 10.1016/j.clineuro.2008.03.006
PG 4
WC Clinical Neurology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Surgery
GA 324SH
UT WOS:000257538000017
PM 18440128
DA 2024-11-01
ER

PT J
AU Bermejo-Guerrero, L
   de la Hoz, CPDF
   Serrano-Lorenzo, P
   Blazquez-Encinar, A
   Gutierrez-Gutierrez, G
   Martinez-Vicente, L
   Galan-Davila, L
   Garcia-Garcia, J
   Arenas, J
   Muelas, N
   Hernandez-Lain, A
   Dominguez-Gonzalez, C
   Martin, MA
AF Bermejo-Guerrero, Laura
   de la Hoz, Carlos Pablo de Fuenmayor-fernandez
   Serrano-Lorenzo, Pablo
   Blazquez-Encinar, Alberto
   Gutierrez-Gutierrez, Gerardo
   Martinez-Vicente, Laura
   Galan-Davila, Lucia
   Garcia-Garcia, Jorge
   Arenas, Joaquin
   Muelas, Nuria
   Hernandez-Lain, Aurelio
   Dominguez-Gonzalez, Cristina
   Martin, Miguel A.
TI Clinical, Histological, and Genetic Features of 25 Patients with
   Autosomal Dominant Progressive External Ophthalmoplegia
   (ad-PEO)/PEO-Plus Due to <i>TWNK</i> Mutations
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE TWNK gene; mitochondrial dysfunction; mtDNA maintenance defects;
   progressive external ophthalmoplegia
ID TWINKLE; DIAGNOSIS; VARIANTS; SPECTRUM; SERVER
AB Autosomal dominant mutations in the TWNK gene, which encodes a mitochondrial DNA helicase, cause adult-onset progressive external ophthalmoplegia (PEO) and PEO-plus presentations. In this retrospective observational study, we describe clinical and complementary data from 25 PEO patients with mutations in TWNK recruited from the Hospital 12 de Octubre Mitochondrial Disorders Laboratory Database. The mean ages of onset and diagnosis were 43 and 63 years, respectively. Family history was positive in 22 patients. Ptosis and PEO (92% and 80%) were the most common findings. Weakness was present in 48%, affecting proximal limbs, neck, and bulbar muscles. Exercise intolerance was present in 28%. Less frequent manifestations were cardiac (24%) and respiratory (4%) involvement, neuropathy (8%), ataxia (4%), and parkinsonism (4%). Only 28% had mild hyperCKemia. All 19 available muscle biopsies showed signs of mitochondrial dysfunction. Ten different TWNK mutations were identified, with c.1361T>G (p.Val454Gly) and c.1070G>C (p.Arg357Pro) being the most common. Before definitive genetic confirmation, 56% of patients were misdiagnosed (36% with myasthenia, 20% with oculopharyngeal muscle dystrophy). Accurate differential diagnosis and early confirmation with appropriately chosen complementary studies allow genetic counseling and the avoidance of unnecessary treatments. Thus, mitochondrial myopathies must be considered in PEO/PEO-plus presentations, and particularly, TWNK is an important cause when positive family history is present.
C1 [Bermejo-Guerrero, Laura; de la Hoz, Carlos Pablo de Fuenmayor-fernandez; Dominguez-Gonzalez, Cristina] Hosp Univ 12 Octubre, Dept Neurol, Neuromuscular Unit, Madrid 28041, Spain.
   [Serrano-Lorenzo, Pablo; Blazquez-Encinar, Alberto; Arenas, Joaquin; Hernandez-Lain, Aurelio; Dominguez-Gonzalez, Cristina; Martin, Miguel A.] Hosp 12 Octubre Res Inst Imas12, Madrid 28041, Spain.
   [Serrano-Lorenzo, Pablo; Blazquez-Encinar, Alberto; Arenas, Joaquin; Muelas, Nuria; Dominguez-Gonzalez, Cristina; Martin, Miguel A.] Inst Salud Carlos III, Biomed Network Res Ctr Rare Dis CIBERER, Madrid 28029, Spain.
   [Serrano-Lorenzo, Pablo; Blazquez-Encinar, Alberto; Arenas, Joaquin; Martin, Miguel A.] Hosp Univ 12 Octubre, Clin Biochem Dept, Mitochondrial Disorders Lab, Madrid 28041, Spain.
   [Gutierrez-Gutierrez, Gerardo] Hosp Univ Infanta Sofia, Dept Neurol, Madrid 28703, Spain.
   [Martinez-Vicente, Laura; Galan-Davila, Lucia] Hosp Univ Clin San Carlos, Dept Neurol, Madrid 28040, Spain.
   [Garcia-Garcia, Jorge] Complejo Hosp Univ Albacete, Dept Neurol, Albacete 02006, Spain.
   [Muelas, Nuria] Hosp Univ & Politecn La Fe, Dept Neurol, Neuromuscular Unit, Valencia 46026, Spain.
   [Muelas, Nuria] Inst Invest Sanitaria La Fe, Neuromuscular & Ataxias Res Grp, Valencia 46026, Spain.
   [Hernandez-Lain, Aurelio] Hosp Univ 12 Octubre, Dept Neuropathol, Madrid 28041, Spain.
C3 Hospital Universitario 12 de Octubre; University of Barcelona; CIBER -
   Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud
   Carlos III; Hospital Universitario 12 de Octubre; Hospital Universitario
   Infanta Sofia; Hospital Universitari i Politecnic La Fe; Hospital
   Universitario 12 de Octubre
RP Dominguez-Gonzalez, C (corresponding author), Hosp Univ 12 Octubre, Dept Neurol, Neuromuscular Unit, Madrid 28041, Spain.; Dominguez-Gonzalez, C (corresponding author), Hosp 12 Octubre Res Inst Imas12, Madrid 28041, Spain.; Dominguez-Gonzalez, C (corresponding author), Inst Salud Carlos III, Biomed Network Res Ctr Rare Dis CIBERER, Madrid 28029, Spain.
EM laura.bermejo@salud.madrid.org; carlosdefuenmayor@hotmail.com;
   pabloserra.lor@gmail.com; abencinar@hotmail.com; g3.neuro@gmail.com;
   lmvicente@salud.madrid.org; lgaland@yahoo.com; jorgaga@sescam.jccm.es;
   joaquin.arenas@salud.madrid.org; muelas_nur@gva.es;
   aurelio.hlain@salud.madrid.org; cdgonzalez@salud.madrid.org;
   mamcasanueva.imas12@h12o.es
RI Gutiérrez-Gutiérrez, Gerardo/JAX-7259-2023; Garcia-García,
   Jorge/AFF-9149-2022; Martin, Miguel/S-2758-2018; Blazquez Encinar,
   Alberto/S-4425-2018; Martin, Miguel Angel/B-6261-2017; Serrano-Lorenzo,
   Pablo/S-4744-2018
OI Blazquez Encinar, Alberto/0000-0002-6479-3615; Garcia-Garcia,
   Jorge/0000-0001-9867-9709; Bermejo-Guerrero, Laura/0000-0002-8349-715X;
   Martin, Miguel Angel/0000-0003-4741-772X; Martinez-Vicente,
   L/0000-0003-0622-7380; Serrano-Lorenzo, Pablo/0000-0002-5661-7574;
   Dominguez, Cristina/0000-0001-5151-988X; Gutierrez-Gutierrez,
   Gerardo/0000-0003-1391-754X
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Alonso-Jimenez A, 2019, J NEUROL NEUROSUR PS, V90, P576, DOI 10.1136/jnnp-2018-319578
   [Anonymous], Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP)
   Brais Bernard, 2011, Handb Clin Neurol, V101, P181, DOI 10.1016/B978-0-08-045031-5.00014-1
   Braz LP, 2021, NEUROL-CLIN PRACT, V11, P97, DOI 10.1212/CPJ.0000000000000795
   Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195
   Ciafaloni Emma, 2019, Continuum (Minneap Minn), V25, P1767, DOI 10.1212/CON.0000000000000800
   Clarke L, 2017, NUCLEIC ACIDS RES, V45, pD854, DOI 10.1093/nar/gkw829
   Cohen Bruce H, 2019, Continuum (Minneap Minn), V25, P1732, DOI 10.1212/CON.0000000000000805
   Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405
   Davis RL, 2016, NEUROLOGY, V86, P2010, DOI 10.1212/WNL.0000000000002705
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1071-z
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Engel AG, 2015, LANCET NEUROL, V14, P420, DOI 10.1016/S1474-4422(14)70201-7
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Hubisz MJ, 2011, BRIEF BIOINFORM, V12, P41, DOI 10.1093/bib/bbq072
   Jagadeesh KA, 2016, NAT GENET, V48, P1581, DOI 10.1038/ng.3703
   Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7
   Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892
   Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153
   Martin-Negrier ML, 2011, EUR J NEUROL, V18, P436, DOI 10.1111/j.1468-1331.2010.03171.x
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0652-7
   Orsucci D, 2017, J NEUROL, V264, P1777, DOI 10.1007/s00415-017-8567-z
   Ostos Fernando, 2020, J Clin Neuromuscul Dis, V21, P222, DOI 10.1097/CND.0000000000000277
   Pasnoor M, 2018, NEUROL CLIN, V36, P261, DOI 10.1016/j.ncl.2018.01.010
   Peña-Chilet M, 2021, NUCLEIC ACIDS RES, V49, pD1130, DOI 10.1093/nar/gkaa794
   Peñas A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126396
   Peter B, 2020, GENES-BASEL, V11, DOI 10.3390/genes11040408
   Poulsen NS, 2020, MITOCHONDRION, V50, P35, DOI 10.1016/j.mito.2019.10.005
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Rivera H, 2007, NEUROMUSCULAR DISORD, V17, P677, DOI 10.1016/j.nmd.2007.05.006
   Rodríguez-López C, 2020, J MED GENET, V57, P643, DOI 10.1136/jmedgenet-2019-106649
   Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890
   Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   Wong KT, 1996, NEUROMUSCULAR DISORD, V6, P163, DOI 10.1016/0960-8966(95)00039-9
NR 38
TC 5
Z9 5
U1 0
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD JAN
PY 2022
VL 11
IS 1
AR 22
DI 10.3390/jcm11010022
PG 14
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA ZE0MU
UT WOS:000758587200001
PM 35011763
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Buzkova, J
   Nikkanen, J
   Ahola, S
   Hakonen, AH
   Sevastianova, K
   Hovinen, T
   Yki-Järvinen, H
   Pietiläinen, KH
   Lönnqvist, T
   Velagapudi, V
   Carroll, CJ
   Suomalainen, A
AF Buzkova, Jana
   Nikkanen, Joni
   Ahola, Sofia
   Hakonen, Anna H.
   Sevastianova, Ksenia
   Hovinen, Topi
   Yki-Jarvinen, Hannele
   Pietilainen, Kirsi H.
   Lonnqvist, Tuula
   Velagapudi, Vidya
   Carroll, Christopher J.
   Suomalainen, Anu
TI Metabolomes of mitochondrial diseases and inclusion body myositis
   patients: treatment targets and biomarkers
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE biomarker; inclusion body myositis; metabolomics; mitochondrial diseases
ID ONSET SPINOCEREBELLAR ATAXIA; RECESSIVE ATAXIA; DNA DELETIONS; MELAS;
   MUTATION; MYOPATHY; HYPERLACTATEMIA; METABOANALYST; PREVALENCE;
   DEFICIENCY
AB Mitochondrial disorders (MDs) are inherited multi-organ diseases with variable phenotypes. Inclusion body myositis (IBM), a sporadic inflammatory muscle disease, also shows mitochondrial dysfunction. We investigated whether primary and secondary MDs modify metabolism to reveal pathogenic pathways and biomarkers. We investigated metabolomes of 25 mitochondrial myopathy or ataxias patients, 16 unaffected carriers, six IBM and 15 non-mitochondrial neuromuscular disease (NMD) patients and 30 matched controls. MD and IBM metabolomes clustered separately from controls and NMDs. MDs and IBM showed transsulfuration pathway changes; creatine and niacinamide depletion marked NMDs, IBM and infantile-onset spinocerebellar ataxia (IOSCA). Low blood and muscle arginine was specific for patients with m.3243A>G mutation. A four-metabolite blood multi-biomarker (sorbitol, alanine, myoinositol, cystathionine) distinguished primary MDs from others (76% sensitivity, 95% specificity). Our omics approach identified pathways currently used to treat NMDs and mitochondrial stroke-like episodes and proposes nicotinamide riboside in MDs and IBM, and creatine in IOSCA and IBM as novel treatment targets. The disease-specific metabolic fingerprints are valuable "multi-biomarkers" for diagnosis and promising tools for follow-up of disease progression and treatment effect.
C1 [Buzkova, Jana; Nikkanen, Joni; Ahola, Sofia; Hakonen, Anna H.; Hovinen, Topi; Carroll, Christopher J.; Suomalainen, Anu] Univ Helsinki, Res Programs Unit, Mol Neurol, Biomedicum Helsinki, Helsinki, Finland.
   [Sevastianova, Ksenia; Yki-Jarvinen, Hannele] Univ Helsinki, Dept Med, Helsinki, Finland.
   [Sevastianova, Ksenia; Yki-Jarvinen, Hannele] Helsinki Univ Hosp, Helsinki, Finland.
   [Sevastianova, Ksenia; Yki-Jarvinen, Hannele] Minerva Fdn, Helsinki, Finland.
   [Pietilainen, Kirsi H.] Univ Helsinki, Res Programs Unit, Diabet & Uhes, Uhes Res Unit, Helsinki, Finland.
   [Pietilainen, Kirsi H.] Univ Helsinki, Cent Hosp, Abdominal Ctr, Endocrinol, Helsinki, Finland.
   [Pietilainen, Kirsi H.] Univ Helsinki, Helsinki, Finland.
   [Lonnqvist, Tuula] Univ Helsinki, Dept Child Neurol, Childrens Hosp, Helsinki, Finland.
   [Velagapudi, Vidya] Univ Helsinki, Metabol Unit, FIMM, HiLIFE, Helsinki, Finland.
   [Carroll, Christopher J.] St Georges Univ London, Genet Res Ctr, Mol & Clin Sci Inst, London, England.
   [Suomalainen, Anu] Helsinki Univ Hosp, Dept Neurosci, Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Ctr Neurosci, Helsinki Inst Life Sci, Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; University of Helsinki;
   Helsinki University Central Hospital; University of Helsinki; University
   of Helsinki; Helsinki University Central Hospital; University of
   Helsinki; University of Helsinki; University of Helsinki; City St
   Georges, University of London; University of Helsinki; Helsinki
   University Central Hospital; University of Helsinki
RP Suomalainen, A (corresponding author), Univ Helsinki, Res Programs Unit, Mol Neurol, Biomedicum Helsinki, Helsinki, Finland.; Suomalainen, A (corresponding author), Helsinki Univ Hosp, Dept Neurosci, Helsinki, Finland.; Suomalainen, A (corresponding author), Univ Helsinki, Ctr Neurosci, Helsinki Inst Life Sci, Helsinki, Finland.
EM anu.wartiovaara@helsinki.fi
RI Pietiläinen, Kirsi/HJA-4960-2022; Velagapudi, Vidya/L-7278-2015;
   Carroll, Christopher/AAV-8023-2021; Ahola, Sofia/JEP-4595-2023
OI Ahola, Sofia/0000-0001-7552-4843; Hovinen, Topi/0000-0001-9853-6572;
   Pietilainen, Kirsi/0000-0002-8522-1288; Suomalainen-Wartiovaara,
   Anu/0000-0003-4833-5195; Carroll, Christopher/0000-0002-2814-6955;
   Nikkanen, Joni/0000-0001-7099-4061
FU European Research Council; Academy of Finland (Centre of Excellence in
   Research on Mitochondria, Metabolism and Disease (FinMIT)) [272376];
   Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation; University
   of Helsinki; Helsinki University Central Hospital; Doctoral Programme in
   Integrative Life Science; Academy of Finland postdoctoral fellowship;
   Gyllenberg Foundation; Novo Nordisk Foundation; Finnish Diabetes
   Research Foundation; Biocenter Finland
FX The authors wish to thank all the patients and their relatives for
   participation in the study. Markus Innila is thanked for patient
   sampling and technical assistance, and Jatin Nandania is thanked for
   metabolomics sample analyses. Jenni Lehtonen and Christopher Jackson are
   thanked for valuable discussion and critical reading of the manuscript.
   This work was supported by European Research Council, Academy of Finland
   (Centre of Excellence in Research on Mitochondria, Metabolism and
   Disease (FinMIT), grant number: 272376), Sigrid Juselius Foundation,
   Jane and Aatos Erkko Foundation, University of Helsinki and Helsinki
   University Central Hospital (A.S., K.H.P.), Doctoral Programme in
   Integrative Life Science (J.B.), Academy of Finland postdoctoral
   fellowship (C.J.C), Gyllenberg Foundation, Novo Nordisk Foundation, The
   Finnish Diabetes Research Foundation (K.H.P), Biocenter Finland (V.V).
CR Abdullah M, 2017, METABOLITES, V7, DOI 10.3390/metabo7030038
   Ahola S, 2016, EMBO MOL MED, V8, P1234, DOI 10.15252/emmm.201606592
   [Anonymous], 2011, GUID BIOAN METH VAL
   Askanas V, 2015, BBA-MOL BASIS DIS, V1852, P633, DOI [10.1016/j.bbadis.201409.005, 10.1016/j.bbadis.2014.09.005]
   Bao XR, 2016, ELIFE, V5, DOI 10.7554/eLife.10575
   Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   El-Hattab AW, 2012, MOL GENET METAB, V105, P607, DOI 10.1016/j.ymgme.2012.01.016
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hall AM, 2015, KIDNEY INT, V87, P610, DOI 10.1038/ki.2014.297
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Kley RA, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004760.pub4
   Koenig MK, 2016, JAMA NEUROL, V73, P591, DOI 10.1001/jamaneurol.2015.5072
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Kolho KL, 2017, J CROHNS COLITIS, V11, P321, DOI 10.1093/ecco-jcc/jjw158
   Kühl I, 2017, ELIFE, V6, DOI 10.7554/eLife.30952
   Legault JT, 2015, CELL REP, V13, P981, DOI 10.1016/j.celrep.2015.09.054
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Lindgren U, 2017, NEUROMUSCULAR DISORD, V27, pS153, DOI 10.1016/j.nmd.2017.06.219
   Lönnqvist T, 1998, J NEUROL SCI, V161, P57, DOI 10.1016/S0022-510X(98)00249-4
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Mudd SH, 2012, MOL GENET METAB, V105, P228, DOI 10.1016/j.ymgme.2011.11.006
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   Nandania J, 2018, METABOLITES, V8, DOI 10.3390/metabo8030044
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Noguera A, 2004, PEDIATRICS, V114, pE598, DOI 10.1542/peds.2004-0955
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Ost M, 2015, FASEB J, V29, P1314, DOI 10.1096/fj.14-261503
   Park J, 2013, NEPHROL DIAL TRANSPL, V28, P2146, DOI 10.1093/ndt/gft213
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   SUOMALAINEN A, 1993, HUM MOL GENET, V2, P525, DOI 10.1093/hmg/2.5.525
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Suomalainen A, 2011, J INHERIT METAB DIS, V34, P277, DOI 10.1007/s10545-010-9222-3
   Tadiboyina VT, 2005, AM J MED GENET A, V135A, P289, DOI 10.1002/ajmg.a.30748
   Thabet H, 2000, AM J EMERG MED, V18, P508, DOI 10.1053/ajem.2000.3981
   Thauvin-Robinet C, 2004, J INHERIT METAB DIS, V27, P700, DOI 10.1023/B:BOLI.0000043017.90837.93
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380
   Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
NR 50
TC 54
Z9 56
U1 1
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD DEC
PY 2018
VL 10
IS 12
AR e9091
DI 10.15252/emmm.201809091
PG 15
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA HD4TP
UT WOS:000452521400011
PM 30373890
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Pénisson-Besnier, I
   Biancalana, V
   Reynier, P
   Cossée, M
   Dubas, F
AF Penisson-Besnier, Isabelle
   Biancalana, Valerie
   Reynier, Pascal
   Cossee, Mireille
   Dubas, Frederic
TI Diagnosis of myotubular myopathy in the oldest known manifesting female
   carrier:: A clinical and genetic study
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE X-linked myotubular myopathy; female carrier; symptomatic heterozygote;
   x-inactivation; diaphragmatic paresis
ID SKEWED X-INACTIVATION; METHYLATION; CHROMOSOME; MUTATIONS
AB X-linked myotubular myopathy is a congenital myopathy due to mutation in the MTM1 gene, encoding myotubularin. Most of the affected male neonates die early of respiratory failure. The female carriers are usually asymptomatic. The authors report a novel MTM1 mutation in a 77-year-old woman. She presented with progressive ptosis since childhood, proximal limb weakness, and a severe restrictive respiratory dysfunction with a hemidiaphragmatic paresis, leading to death at 84 years of age. The muscle biopsy showed centrally nucleated fibers and mitochondrial abnormalities. A stop mutation Leu498X in MTM1 gene was identified in the proband and in her two healthy daughters. The X-inactivation pattern was random in the proband's blood and muscle DNA, and in blood DNA from her two unaffected MTM1 mutation carrier daughters. Two large heteroplasmic deletions were also detected in the muscle mitochondrial DNA of the propositus, raising the question of their putative impact on the phenotype. (C) 2006 Elsevier B.V. All rights reserved.
C1 CHU Angers, Ctr Reference Malad Neuromusculaires Rares Nantes, F-49033 Angers, France.
   Dept Neurol, F-49033 Angers, France.
   CHU Angers, Dept Pathol Cellulaire & Tissulaire Neuropathol, F-49033 Angers, France.
   CHRU, Lab Diagnost Genet, F-67085 Strasbourg, France.
   Univ Strasbourg 1, Fac Med, F-67085 Strasbourg, France.
   CHU Angers, Lab Biochim & Biol Mol, F-49033 Angers, France.
C3 Universite d'Angers; Centre Hospitalier Universitaire d'Angers;
   Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU
   Strasbourg; Universites de Strasbourg Etablissements Associes;
   Universite de Strasbourg; Universite d'Angers; Centre Hospitalier
   Universitaire d'Angers
RP Pénisson-Besnier, I (corresponding author), CHU Angers, Ctr Reference Malad Neuromusculaires Rares Nantes, 4 Rue Larrey, F-49033 Angers, France.
EM ispenisson-besnier@chu-angers.fr
RI Reynier, Pascal/K-3677-2015; Biancalana, Valerie/O-2351-2016
OI Reynier, Pascal/0000-0003-0802-4608
CR ALLEN RC, 1992, AM J HUM GENET, V51, P1229
   Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657
   Carrel L, 1996, AM J MED GENET, V64, P27, DOI 10.1002/(SICI)1096-8628(19960712)64:1<27::AID-AJMG3>3.0.CO;2-O
   Grogan PM, 2005, NEUROLOGY, V64, P1638, DOI 10.1212/01.WNL.0000160393.99621.D0
   Hammans SR, 2000, NEUROMUSCULAR DISORD, V10, P133, DOI 10.1016/S0960-8966(99)00073-5
   Jungbluth H, 2003, NEUROMUSCULAR DISORD, V13, P55, DOI 10.1016/S0960-8966(02)00194-3
   Kristiansen M, 2003, NEUROMUSCULAR DISORD, V13, P468, DOI 10.1016/S0960-8966(03)00067-1
   Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175
   Martínez F, 1998, J MED GENET, V35, P284, DOI 10.1136/jmg.35.4.284
   REYNIER P, 1999, MITOCHONDRIAL DIS, P379
   Schara U, 2003, NEUROLOGY, V60, P1363, DOI 10.1212/01.WNL.0000058763.90924.FA
   Sutton IJ, 2001, NEUROLOGY, V57, P900, DOI 10.1212/WNL.57.5.900
   Tanner SM, 1999, HUM GENET, V104, P249, DOI 10.1007/s004390050943
NR 13
TC 21
Z9 22
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD FEB
PY 2007
VL 17
IS 2
BP 180
EP 185
DI 10.1016/j.nmd.2006.10.008
PG 6
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 148AG
UT WOS:000245046300009
PM 17251023
DA 2024-11-01
ER

PT J
AU Mancuso, M
   Filosto, M
   Oh, SJ
   DiMauro, S
AF Mancuso, M
   Filosto, M
   Oh, SJ
   DiMauro, S
TI A novel polymerase γ mutation in a family with ophthalmoplegia,
   neuropathy, and Parkinsonism
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MITOCHONDRIAL COMPLEX I; POLG
   MUTATIONS; GENETIC-HETEROGENEITY; AUTOSOMAL-DOMINANT; DNA; DELETIONS;
   DISEASE; DEFICIENCY; DEAFNESS
AB Background: Mutations in polymerase gamma cause progressive external ophthalmoplegia-and a variety of associated symptoms and signs, including neuropathy, ataxia, hypogonadism, hearing loss, muscle weakness, and psychiatric problems. Extrapyramidal signs have been rarely described.
   Objective: To describe a family with a novel polymerase gamma mutation and autosomal dominant transmission of. progressive external ophthalmoplegia, neuropathy, hypogonadism, and parkinsonism.
   Design: Case report.
   Patients: The proband, a 49-year-old woman with incipient parkinsonism,and her 59-year-old brother-with overt parkinsonian features.
   Main Outcome Measures: Mutation in the proband by sequencing the polymerase gamma gene and in affected relatives by restriction fragment length polymorphism analysis.
   Results: We found multiple mitochondrial DNA deletions in the proband's muscle and a novel missense mutation in the polymerase gamma gene (A2492G) in the proband and in her affected siblings.
   Conclusion: Parkinsonism was a prominent clinical feature in this family with autosomal dominant ophthalmoplegia, multiple mitochondrial DNA deletions, and a novel mutation in the polymerase gamma gene.
C1 Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA.
   Univ Alabama, Dept Neurol, Birmingham, AL 35294 USA.
C3 Columbia University; University of Alabama System; University of Alabama
   Birmingham
RP Columbia Univ, Coll Phys & Surg, Dept Neurol, 4-420,630 W 168th St, New York, NY USA.
EM sd12@columbia.edu
RI Mancuso, Michelangelo/K-4170-2016; Filosto, Massimiliano/S-9446-2019
OI Filosto, Massimiliano/0000-0002-2852-7512
FU NICHD NIH HHS [P01HD 32062] Funding Source: Medline; NINDS NIH HHS
   [NS11766] Funding Source: Medline
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Casali C, 2001, NEUROLOGY, V56, P802, DOI 10.1212/WNL.56.6.802
   Chalmers RM, 1996, J NEUROL SCI, V143, P41, DOI 10.1016/S0022-510X(96)00032-9
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   Klopp N, 2003, OPHTHALMIC RES, V35, P71, DOI 10.1159/000069134
   Kosel S, 1998, NEUROGENETICS, V1, P197, DOI 10.1007/s100480050029
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Siciliano G, 2001, J NEUROL NEUROSUR PS, V71, P685, DOI 10.1136/jnnp.71.5.685
   Thyagarajan D, 2000, ANN NEUROL, V48, P730, DOI 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   VYAS I, 1986, J NEUROCHEM, V46, P1501, DOI 10.1111/j.1471-4159.1986.tb01768.x
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 21
TC 78
Z9 83
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0003-9942
EI 1538-3687
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD NOV
PY 2004
VL 61
IS 11
BP 1777
EP 1779
DI 10.1001/archneur.61.11.1777
PG 3
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 869EJ
UT WOS:000224965900017
PM 15534189
OA Bronze
DA 2024-11-01
ER

PT J
AU Agier, V
   Auré, K
   Lombès, A
AF Agier, V.
   Aure, K.
   Lombes, A.
TI MELAS SYNDROME
SO DRUGS OF THE FUTURE
LA English
DT Article
ID STROKE-LIKE EPISODES; TRANSFER RNALEU(UUR) GENE; MITOCHONDRIAL-DNA;
   LACTIC-ACIDOSIS; A3243G MUTATION; 3243A-GREATER-THAN-G MUTATION;
   TRANSFER RNA(LEU(UUR)); CLINICAL-FEATURES; DIABETES-MELLITUS;
   PROTEIN-SYNTHESIS
AB MELAS syndrome, on acronym for Mitochondrial myopathy, Encephalopathy, Lactic Acidosis, and Strokelike episodes, is a very severe form of mitochondrial encephalopathy It has several genetic causes, the most frequent of which is the m 3243A>C mutation in the MT-TL1 gene on the mitochondrial DNA (mtDNA), often called the "MELAS mutation" This mutation is the most recurrent deleterious mtDNA point mutation It is always heteroplasmic and responsible for very diverse clinical presentations in addition to MELAS syndrome D Diseases associated with the m 3243A>C mutation ore thought to be due to oxidative phospharylation defects They display complex genotype/phenotype relationships and pathophysiological mechanisms, as well as difficulties for the set tip of controlled therapeutic trials
C1 [Agier, V.; Aure, K.; Lombes, A.] Univ Paris 06, INSERM, UMRS 975, Hop La Salpetriere,AP HP, F-75013 Paris, France.
C3 Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et
   de la Recherche Medicale (Inserm)
RP Lombès, A (corresponding author), Univ Paris 06, INSERM, UMRS 975, Hop La Salpetriere,AP HP, F-75013 Paris, France.
RI Lombes, Anne/G-4684-2014
FU AFM (Association Francaise contre les Myopathies)
FX The authors state no potential conflicts of interest The work was
   supported in part by AFM (Association Francaise contre les Myopathies)
CR Auré K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061
   Betts J, 2008, NEUROLOGY, V70, P1290, DOI 10.1212/01.wnl.0000308940.38092.74
   CHINNERY P, 2006, COCHRANE DB SYST REV, P1426
   Chinnery PF, 1999, AM J MED GENET, V85, P498
   Chinnery PF, 2001, NEUROLOGY, V56, P1101, DOI 10.1212/WNL.56.8.1101
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   Dubeau F, 2000, ANN NEUROL, V47, P179, DOI 10.1002/1531-8249(200002)47:2<179::AID-ANA7>3.0.CO;2-Z
   Dunbar DR, 1996, HUM MOL GENET, V5, P123, DOI 10.1093/hmg/5.1.123
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Janssen AJM, 2008, ANN NEUROL, V63, P473, DOI 10.1002/ana.21328
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Kärppä M, 2005, BRAIN, V128, P1861, DOI 10.1093/brain/awh515
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   LAFORET P, 1995, NEUROMUSCULAR DISORD, V5, P399, DOI 10.1016/0960-8966(94)00080-S
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   MANOUVRIER S, 1995, J MED GENET, V32, P654, DOI 10.1136/jmg.32.8.654
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Tanji K, 2000, BRAIN PATHOL, V10, P422
   tHart LM, 1996, HUM MUTAT, V7, P193
   Touati G, 1997, ARCH DIS CHILD, V76, P16, DOI 10.1136/adc.76.1.16
   Uimonen S, 2001, HUM GENET, V108, P284, DOI 10.1007/s004390100475
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   van den Ouweland JMW, 1999, DIABETOLOGIA, V42, P485, DOI 10.1007/s001250051183
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
NR 52
TC 0
Z9 0
U1 0
U2 2
PU PROUS SCIENCE, SAU-THOMSON REUTERS
PI BARCELONA
PA 398 PROVENCA, 08025 BARCELONA, SPAIN
SN 0377-8282
EI 2013-0368
J9 DRUG FUTURE
JI Drug Future
PD MAR
PY 2009
VL 34
IS 3
BP 237
EP 241
DI 10.1358/dof.2009.034.03.1340065
PG 5
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 561MT
UT WOS:000274982400008
DA 2024-11-01
ER

PT J
AU Liu, H
   Han, YC
   Wang, S
   Wang, HB
AF Liu, Hong
   Han, Yuechen
   Wang, Shuai
   Wang, Haibo
TI Association between the mitochondrial DNA 4977 common deletion in the
   hair shaft and hearing loss in presbycusis
SO MOLECULAR MEDICINE REPORTS
LA English
DT Article
DE presbycusis; human hair shaft; common deletion; mitochondria; 4977-bp
   deletion
ID PSYCHIATRIC-DISORDERS; MUTATIONS; AGE; QUANTIFICATION; INCREASES;
   MYOPATHY; PATIENT; BRAIN
AB The aim of the present study was to examine the role of the mitochondrial (mt) DNA (common) (deletion) ((CD)) (4977) ((mtDNACD4977)) in the hair shaft in patients with presbycusis. A total of 87 individuals with presbycusis and 95 normal-hearing controls were selected based on strict audiometric criteria. Nested polymerase chain reaction (PCR), sequencing and quantitative (q)PCR were used to examine the expression levels of mtDNA(CD4977) in the hair shaft in presbycusis. Nested PCR of the hair shaft demonstrated that 8/95 cases with normal hearing were found to be positive for mtDNA(CD4977), as compared with 59/87 cases in the presbycusis group. The mtDNA(CD4977) was positive in 22/43 cases with mild-to-moderate hearing loss, 25/31 cases with moderate-to-severe, severe hearing loss, and 12/13 cases with profound deafness. Statistically significant differences in mtDNA(CD4977) expression were identified among all of the groups (P<0.001). The sequencing and qPCR assays demonstrated a trend towards an increase in the mean CD level of mtDNA(CD4977) with a more severe hearing loss at 8 kHz (r=0.778, P<0.001) and all ranges of frequency (r=0.858, P<0.001). In conclusion, the present study demonstrates a correlation between mtDNA(CD4977) in the human hair shaft and the severity of hearing loss in presbycusis.
C1 [Liu, Hong; Han, Yuechen; Wang, Haibo] Shandong Univ, Dept Otorhinolaryngol Head & Neck Surg, Prov Hosp, Jinan 250000, Shandong, Peoples R China.
   [Wang, Shuai] Shandong Univ, Dept Thorac Surg, Prov Hosp, Jinan 250000, Shandong, Peoples R China.
C3 Shandong University; Shandong University
RP Wang, HB (corresponding author), Shandong Univ, Dept Otorhinolaryngol Head & Neck Surg, Prov Hosp, 4 Duanxingxilu Rd, Jinan 250000, Shandong, Peoples R China.
EM whbotologic797@163.com
RI Wang, Shuai/HZJ-7466-2023; Wang, Haibo/AAH-3749-2020
FU Science and Technology Development Program of Shandong province,
   Provincial Hospital Affiliated to Shandong University (Shandong, China)
   [2012G0021838]
FX The present study was supported by a grant from the Science and
   Technology Development Program of Shandong province, Provincial Hospital
   Affiliated to Shandong University (Shandong, China; grant no.
   2012G0021838).
CR Bai UM, 2001, HEARING RES, V154, P73, DOI 10.1016/S0378-5955(01)00221-0
   Bekaert B, 2012, FORENSIC SCI INT-GEN, V6, P277, DOI 10.1016/j.fsigen.2011.04.009
   Chen B, 2010, BRAIN RES, V1344, P43, DOI 10.1016/j.brainres.2010.04.082
   Dai P, 2004, ACTA OTO-LARYNGOL, V124, P130, DOI 10.1080/00016480410016586
   FischelGhodsian N, 1997, HEARING RES, V110, P147, DOI 10.1016/S0378-5955(97)00077-4
   Gendron SP, 2012, MECH AGEING DEV, V133, P68, DOI 10.1016/j.mad.2012.01.002
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   Kim EJ, 2012, MUTAT RES-GEN TOX EN, V749, P53, DOI 10.1016/j.mrgentox.2012.08.005
   Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055
   Love Rachelle L, 2013, Cochlear Implants Int, V14, P28
   Mao ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065565
   Markaryan A, 2009, LARYNGOSCOPE, V119, P1184, DOI 10.1002/lary.20218
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   Nie HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067953
   Niu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040572
   Obara-Moszynska M, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-27
   Pesce V, 2002, GENE, V286, P143, DOI 10.1016/S0378-1119(01)00815-0
   Sequeira Adolfo, 2012, Frontiers in Genetics, V3, P103, DOI 10.3389/fgene.2012.00103
   Sprinzl GM, 2010, GERONTOLOGY, V56, P351, DOI 10.1159/000275062
   Taylor RW, 2002, NEUROMUSCULAR DISORD, V12, P659, DOI 10.1016/S0960-8966(02)00026-3
   Torrell H, 2013, AM J MED GENET B, V162B, P213, DOI 10.1002/ajmg.b.32134
   Yamasoba T, 2007, HEARING RES, V226, P185, DOI 10.1016/j.heares.2006.06.004
   Yuan Yong-yi, 2009, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V44, P292
   Zheng YJ, 2012, BOSNIAN J BASIC MED, V12, P187, DOI 10.17305/bjbms.2012.2480
   Zhong Y, 2011, MUTAT RES-FUND MOL M, V712, P11, DOI 10.1016/j.mrfmmm.2011.03.013
NR 26
TC 4
Z9 4
U1 0
U2 2
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1791-2997
EI 1791-3004
J9 MOL MED REP
JI Mol. Med. Rep.
PD FEB
PY 2015
VL 11
IS 2
BP 1127
EP 1131
DI 10.3892/mmr.2014.2877
PG 5
WC Oncology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Research & Experimental Medicine
GA CB3CS
UT WOS:000349506400053
PM 25373716
OA Bronze
DA 2024-11-01
ER

PT J
AU Dawod, PGA
   Jancic, J
   Marjanovic, A
   Brankovic, M
   Jankovic, M
   Samardzic, J
   Dawod, AGA
   Novakovic, I
   Motaleb, FAI
   Radlovic, V
   Kostic, VS
   Nikolic, D
AF Dawod, Phepy G. A.
   Jancic, Jasna
   Marjanovic, Ana
   Brankovic, Marija
   Jankovic, Milena
   Samardzic, Janko
   Dawod, Ayman Gamil Anwar
   Novakovic, Ivana
   Abdel Motaleb, Fayda I.
   Radlovic, Vladimir
   Kostic, Vladimir S.
   Nikolic, Dejan
TI Mutational Analysis and mtDNA Haplogroup Characterization in Three
   Serbian Cases of Mitochondrial Encephalomyopathies and Literature Review
SO DIAGNOSTICS
LA English
DT Review
DE MELAS; leigh syndrome; mtDNA; sanger sequencing; mutations; haplogroups
ID LEIGH-SYNDROME; DNA MUTATIONS; TRANSFER-RNA; NATURAL-HISTORY;
   LACTIC-ACIDOSIS; EPISODES MELAS; NT 8993; GENE; DISEASE; TOOL
AB Mitochondrial encephalomyopathies (MEMP) are heterogeneous multisystem disorders frequently associated with mitochondrial DNA (mtDNA) mutations. Clinical presentation varies considerably in age of onset, course, and severity up to death in early childhood. In this study, we performed molecular genetic analysis for mtDNA pathogenic mutation detection in Serbian children, preliminary diagnosed clinically, biochemically and by brain imaging for mitochondrial encephalomyopathies disorders. Sanger sequencing analysis in three Serbian probands revealed two known pathogenic mutations. Two probands had a heteroplasmic point mutation m.3243A > G in the MT-TL1 gene, which confirmed mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode syndrome (MELAS), while a single case clinically manifested for Leigh syndrome had an almost homoplasmic (close to 100%) m.8993T > G mutation in the MT-ATP6 gene. After full mtDNA MITOMASTER analysis and PhyloTree build 17, we report MELAS' association with haplogroups U and H (U2e and H15 subclades); likewise, the mtDNA-associated Leigh syndrome proband shows a preference for haplogroup H (H34 subclade). Based on clinical-genetic correlation, we suggest that haplogroup H may contribute to the mitochondrial encephalomyopathies' phenotypic variability of the patients in our study. We conclude that genetic studies for the distinctive mitochondrial encephalomyopathies should be well-considered for realizing clinical severity and possible outcomes.
C1 [Dawod, Phepy G. A.; Jancic, Jasna; Marjanovic, Ana; Brankovic, Marija; Novakovic, Ivana; Radlovic, Vladimir; Kostic, Vladimir S.; Nikolic, Dejan] Univ Belgrade, Fac Med, Belgrade 11000, Serbia.
   [Dawod, Phepy G. A.; Abdel Motaleb, Fayda I.] Ain Shams Univ, Dept Med Biochem & Mol Biol, Fac Med, Cairo 11591, Egypt.
   [Jancic, Jasna] Clin Neurol & Psychiat Children & Youth, Belgrade 11000, Serbia.
   [Jankovic, Milena; Kostic, Vladimir S.] Clin Ctr Serbia, Neurol Clin, Belgrade 11000, Serbia.
   [Samardzic, Janko; Radlovic, Vladimir] Univ Belgrade, Inst Pharmacol Clin Pharmacol & Toxicol, Fac Med, Belgrade 11000, Serbia.
   [Dawod, Ayman Gamil Anwar; Nikolic, Dejan] Ain Shams Univ, Hepatogastroenterol & Endoscopy Dept, Internal Med, Fac Med, Cairo 11591, Egypt.
   Univ Childrens Hosp, Dept Pediat Surg, Belgrade 11000, Serbia.
   Univ Childrens Hosp, Phys Med & Rehabil Dept, Tirsova 10, Belgrade 11000, Serbia.
C3 University of Belgrade; Egyptian Knowledge Bank (EKB); Ain Shams
   University; Clinical Centre of Serbia; University of Belgrade; Egyptian
   Knowledge Bank (EKB); Ain Shams University; University of Belgrade;
   University of Belgrade
RP Nikolic, D (corresponding author), Ain Shams Univ, Hepatogastroenterol & Endoscopy Dept, Internal Med, Fac Med, Cairo 11591, Egypt.
EM fibygamilanwer@med.asu.edu.eg; jasna.jancic.npk@gmail.com;
   ana.marjanovic@yahoo.com; mara.brankovic@gmail.com;
   milena.jankovic.82@gmail.com; jankomedico@yahoo.es;
   ayman.gamil@med.asu.edu.eg; ivana.novakovic@med.bg.ac.rs;
   dr.fayda@hotmail.com; vladimir.radlovic@gmail.com;
   vladimir.s.kostic@gmail.com; denikol27@gmail.com
RI Jancic, Jasna/L-6008-2019; Samardzic, Janko/H-7897-2019; Jankovic,
   Milena/ABD-7047-2021; Nikolic, Dejan/L-1136-2019
OI Jankovic, Milena/0000-0002-3939-9739; Samardzic,
   Janko/0000-0002-8464-4924; Brankovic, Marija/0000-0001-5208-147X;
   Radlovic, Vladimir/0000-0003-4297-2011; Nikolic,
   Dejan/0000-0002-0609-9916; Marjanovic, Ana/0000-0002-0182-7822; Jancic,
   Jasna/0000-0002-2935-0798
FU Serbian Ministry of Education, Science and Technological Development
   [ON175090, ON175091, 200110]
FX This research is supported by Serbian Ministry of Education, Science and
   Technological Development; grants ON175090 and ON175091 (now contract
   No. 200110 )
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Al Yazidi G, 2022, NEUROHOSPITALIST, V12, P67, DOI 10.1177/19418744211000512
   Alwehaidah MS, 2021, MED PRIN PRACT, V30, P62, DOI 10.1159/000509937
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Angural A, 2019, MITOCHONDRION, V46, P209, DOI 10.1016/j.mito.2018.06.005
   Arning L, 2010, J MOL MED, V88, P431, DOI 10.1007/s00109-010-0589-2
   Balasubramaniam S, 2017, JIMD REP, V33, P99, DOI 10.1007/8904_2016_559
   Bénit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225
   Benson DA, 2017, NUCLEIC ACIDS RES, V45, pD37, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkx1094, 10.1093/nar/gkw1070, 10.1093/nar/gkl986, 10.1093/nar/gks1195, 10.1093/nar/gkg057, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkq1079]
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   Brandon MC, 2009, HUM MUTAT, V30, P1, DOI 10.1002/humu.20801
   Bugiardini E, 2019, HUM MOL GENET, V28, P2711, DOI 10.1093/hmg/ddz093
   Burr SP, 2018, DEV GROWTH DIFFER, V60, P21, DOI 10.1111/dgd.12420
   Caporali L, 2017, MITOCHONDRION, V36, P130, DOI 10.1016/j.mito.2017.07.004
   Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236
   Chaig MR, 2008, BIOCHEM BIOPH RES CO, V368, P631, DOI 10.1016/j.bbrc.2008.01.143
   Chakrabarty S, 2021, J NEUROL, V268, P2192, DOI 10.1007/s00415-020-10390-9
   Chen ZT, 2015, MOL MED REP, V11, P1956, DOI 10.3892/mmr.2014.2911
   Chinnery PF, 1993, GENEREVIEWS
   Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195
   Colina-Tenorio L, 2020, J INTERN MED, V287, P645, DOI 10.1111/joim.13031
   D'Aurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   Dawod PGA, 2020, GENES-BASEL, V11, DOI 10.3390/genes11091037
   de Laat P, 2016, BBA CLIN, V6, P19, DOI 10.1016/j.bbacli.2016.04.007
   Delgado-Sánchez R, 2007, REV NEUROLOGIA, V44, P18, DOI 10.33588/rn.4401.2006032
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Di Lorenzo C, 2009, NEUROLOGY, V72, P1588, DOI 10.1212/WNL.0b013e3181a41269
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   Distelmaier F, 2014, JIMD REP, V13, P53, DOI 10.1007/8904_2013_271
   Dowlati MA, 2013, MOL BIOL REP, V40, P2689, DOI 10.1007/s11033-012-2355-8
   Fassone Elisa, 2013, BMJ Case Rep, V2013, P200838, DOI 10.1136/bcr-2013-200838
   Finsterer J, 2021, AM J CASE REP, V22, DOI 10.12659/AJCR.930175
   Finsterer J, 2020, YONSEI MED J, V61, P904, DOI 10.3349/ymj.2020.61.10.904
   Fiuza-Luces C, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00790
   Fujii T, 1998, PEDIATR NEUROL, V18, P275, DOI 10.1016/S0887-8994(97)00187-2
   Georgiou A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183444
   Ghabaee M, 2009, CELL MOL NEUROBIOL, V29, P341, DOI 10.1007/s10571-008-9325-7
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Fajardo RG, 2021, J RHEUMATOL, V48, P1603, DOI 10.3899/jrheum.201316
   Habbane M, 2020, GENES-BASEL, V11, DOI 10.3390/genes11091007
   Häkli S, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0145-6
   Han J, 2015, BRIT J OPHTHALMOL, V99, P528, DOI 10.1136/bjophthalmol-2014-305704
   Hao XD, 2013, GENE, V512, P460, DOI 10.1016/j.gene.2012.10.054
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Hong CM, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00267
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Inak G., 2019, BIORXIV, DOI [10.1101/551390, DOI 10.1101/551390]
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kelland E, 2016, MOL GENET METAB REP, V6, P64, DOI 10.1016/j.ymgmr.2016.02.003
   Kimata KG, 1998, ARCH NEUROL-CHICAGO, V55, P722, DOI 10.1001/archneur.55.5.722
   Kimura S, 2021, BRAIN DEV-JPN, V43, P157, DOI 10.1016/j.braindev.2020.07.008
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Leslie N, 2016, HUM PATHOL, V49, P27, DOI 10.1016/j.humpath.2015.09.039
   Leung GPH, 2012, ADV EXP MED BIOL, V942, P347, DOI 10.1007/978-94-007-2869-1_16
   Levy RJ, 2014, J CHILD NEUROL, V29, pNP105, DOI 10.1177/0883073813506783
   Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040
   Licchetta L, 2021, ANN CLIN TRANSL NEUR, V8, P704, DOI 10.1002/acn3.51259
   Liu GL, 2020, J NEUROL SCI, V408, DOI 10.1016/j.jns.2019.116562
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   Makino M, 2000, J HUM GENET, V45, P69, DOI 10.1007/s100380050014
   Mancuso M, 2004, NEUROSCI LETT, V371, P158, DOI 10.1016/j.neulet.2004.08.060
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   McWilliams TG, 2019, NATURE, V565, P296, DOI 10.1038/d41586-019-00093-1
   Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138
   Mochizuki H, 1996, CLIN NEPHROL, V46, P347
   MONTAGNA P, 1988, NEUROLOGY, V38, P751, DOI 10.1212/WNL.38.5.751
   Motoda Atsuko, 2013, Rinsho Shinkeigaku, V53, P446
   Ng Y.S., 2019, DIAGNOSIS MANAGEMENT, P1
   Nyhan W.L., 2019, ATLAS INHERITED META, V4th ed.
   Pacheu-Grau D, 2012, EUR ARCH OTO-RHINO-L, V269, P2003, DOI 10.1007/s00405-012-2066-8
   Parsons T, 2010, ARCH NEUROL-CHICAGO, V67, P976, DOI 10.1001/archneurol.2010.174
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pierron D, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-41
   Poulton J, 2017, MOL DIAGN THER, V21, P419, DOI 10.1007/s40291-017-0279-7
   Prasad H.V.R., 2006, INTERNET J PEDIAT NE, V7, P1
   Pütz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407
   Queen RA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187862
   Rahman S., 2017, INHERITED METABOLIC, P521
   Ridge PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045134
   Roberta C, 2018, Trends Biomed Res, V1, P1, DOI [10.15761/JTBR.1000101, DOI 10.15761/JTBR.1000101]
   Robinson R., 2007, NEUROL TODAY, V7, P26, DOI [10.1097/01.NT.0000300461.67787.bb, DOI 10.1097/01.NT.0000300461.67787.BB]
   Ruhoy LS, 2014, APPL CLIN GENET, V7, P221, DOI 10.2147/TACG.S46176
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Saneto RP, 2021, MITOCHONDRION, V59, P58, DOI 10.1016/j.mito.2021.04.010
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Seitun S, 2016, CASE REP CARDIOL, V2016, DOI 10.1155/2016/1490181
   Serrano-Teruel Maria E, 2019, Asian Cardiovasc Thorac Ann, V27, P5, DOI 10.1177/0218492318813220
   Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748
   Sharma R, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI136055
   Sinnecker T, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1306-6
   Sofou K, 2021, EUR J PAEDIATR NEURO, V31, P31, DOI 10.1016/j.ejpn.2021.01.012
   Sofou K, 2018, J MED GENET, V55, P21, DOI 10.1136/jmedgenet-2017-104891
   Sonney S, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005867
   Soto-Hermida A, 2015, RHEUMATOL INT, V35, P337, DOI 10.1007/s00296-014-3104-1
   Sperl W, 1997, WIEN KLIN WOCHENSCHR, V109, P93
   Strachan J, 2001, J INHERIT METAB DIS, V24, P409, DOI 10.1023/A:1010573122748
   Swerdlow RH, 2009, J ALZHEIMERS DIS, V17, P737, DOI 10.3233/JAD-2009-1095
   Tapias V., 2020, MITOCHONDRIAL DYSFUN
   Tay SKH, 2005, J CHILD NEUROL, V20, P670, DOI 10.1177/08830738050200080701
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Thorburn D., 2015, GENEREVIEWS
   Thorburn D.R., 1993, GENEREVIEWS R
   Torraco A, 2021, HUM MUTAT, V42, P699, DOI 10.1002/humu.24195
   Torroni A, 2003, AM J HUM GENET, V72, P1005, DOI 10.1086/373936
   Uziel G, 2011, SEMIN FETAL NEONAT M, V16, P205, DOI 10.1016/j.siny.2011.04.003
   Van Haute L, 2015, J INHERIT METAB DIS, V38, P655, DOI 10.1007/s10545-015-9859-z
   van Oven M, 2015, FORENS SCI INT-GEN S, V5, pE392, DOI 10.1016/j.fsigss.2015.09.155
   Wallace DC, 2015, CELL, V163, P33, DOI 10.1016/j.cell.2015.08.067
   Wang CY, 2008, CHINESE SCI BULL, V53, P2733, DOI 10.1007/s11434-008-0380-8
   Wang YW, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00232
   Weerasinghe CAL, 2018, MOL MED REP, V17, P6919, DOI 10.3892/mmr.2018.8670
   Wei W, 2020, J INTERN MED, V287, P634, DOI 10.1111/joim.13047
   Weiduschat N, 2014, NEUROLOGY, V82, P798, DOI 10.1212/WNL.0000000000000169
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yis U, 2009, EUR J PAEDIATR NEURO, V13, P550, DOI 10.1016/j.ejpn.2008.10.009
   Zhang HX, 2018, ESSAYS BIOCHEM, V62, P225, DOI 10.1042/EBC20170096
NR 120
TC 2
Z9 2
U1 0
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-4418
J9 DIAGNOSTICS
JI Diagnostics
PD NOV
PY 2021
VL 11
IS 11
AR 1969
DI 10.3390/diagnostics11111969
PG 16
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA XN1WY
UT WOS:000729304200001
PM 34829316
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Harbo, HF
   Baets, J
   Van Broeckhoven, C
   Di Donato, S
   Fontaine, B
   De Jonghe, P
   Lossos, A
   Lynch, T
   Mariotti, C
   Schöls, L
   Spinazzola, A
   Szolnoki, Z
   Tabrizi, SJ
   Tallaksen, CME
   Zeviani, M
   Burgunder, JM
   Gasser, T
AF Finsterer, J.
   Harbo, H. F.
   Baets, J.
   Van Broeckhoven, C.
   Di Donato, S.
   Fontaine, B.
   De Jonghe, P.
   Lossos, A.
   Lynch, T.
   Mariotti, C.
   Schoels, L.
   Spinazzola, A.
   Szolnoki, Z.
   Tabrizi, S. J.
   Tallaksen, C. M. E.
   Zeviani, M.
   Burgunder, J. -M.
   Gasser, T.
TI EFNS guidelines on the molecular diagnosis of mitochondrial disorders
SO EUROPEAN JOURNAL OF NEUROLOGY
LA English
DT Article
DE encephalomyopathies; hereditary disease; metabolic myopathies;
   mitochondrial myopathy; molecular genetics
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; INHERITED NEUROLOGIC DISEASES;
   CYTOCHROME-C-OXIDASE; MULTIPLE DELETIONS; GENE-MUTATIONS; LEIGH-DISEASE;
   TASK-FORCE; 2 PARTS; DNA; DEFICIENCY
AB Objectives:
   These European Federation of Neurological Sciences (EFNS) guidelines are designed to provide practical help for the general neurologist to make appropriate use of molecular genetics for diagnosing mitochondrial disorders (MIDs), which gain increasing attention and are more frequently diagnosed due to improved diagnostic tools.
   Background:
   Since the publication of the first EFNS guidelines on the molecular diagnosis of inherited neurological diseases in 2001, rapid progress has been made in this field, necessitating the creation of an updated version.
   Search strategy:
   To collect data about the molecular diagnosis of MIDs search for literature in various electronic databases, such as Cochrane library, MEDLINE, OMIM, GENETEST or Embase, were carried out and original papers, meta-analyses, review papers, and guideline recommendations were reviewed.
   Results:
   The guidelines summarise the possibilities and limitations of molecular genetic diagnosis of MIDs and provide practical recommendations and diagnostic criteria in accordance with the EFNS Scientific Committee to guide the molecular diagnostic work-up of MIDs.
   Recommendations:
   The proposed guidelines suggest an approach to the molecular diagnosis of MIDs in a manner accessible to general neurologists.
C1 [Finsterer, J.] Krankenanstalt Rudolfstiftung Wien, Vienna, Austria.
   [Finsterer, J.] Danube Univ Krems, Krems, Austria.
   [Harbo, H. F.] Oslo Univ Hosp, Dept Neurol, Oslo, Norway.
   [Harbo, H. F.] Univ Oslo, Fac Div Ulleval, Oslo, Norway.
   [Baets, J.; De Jonghe, P.] Univ Antwerp Hosp, Dept Neurol, Antwerp, Belgium.
   [Baets, J.; Van Broeckhoven, C.; De Jonghe, P.] VIB, Dept Mol Genet, Antwerp, Belgium.
   [Baets, J.; Van Broeckhoven, C.; De Jonghe, P.] Univ Antwerp, Inst Born Bunge, Neurogenet Lab, B-2020 Antwerp, Belgium.
   [Mariotti, C.] Ist Neurol Carlo Besta, Fdn IRCCS, Unit Biochem & Genet Neurogenet & Metab Dis, Milan, Italy.
   [Fontaine, B.] Grp Hosp Pitie Salpetriere, AP HP, Ctr Reference Canalopathies Musculaires, F-75634 Paris, France.
   [Lossos, A.] Hadassah Univ Hosp, Dept Neurol, IL-91120 Jerusalem, Israel.
   [Lynch, T.] Mater Misericordiae Univ, Dublin Neurol Inst, Beaumont Hosp, Dublin, Ireland.
   [Lynch, T.] Mater Misericordiae Univ, Dublin Neurol Inst, Mater Private Hosp, Dublin, Ireland.
   [Schoels, L.] Univ Tubingen, Ctr Neurol, Tubingen, Germany.
   [Gasser, T.] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, Tubingen, Germany.
   [Spinazzola, A.; Zeviani, M.] Neurol Inst Carlo Besta, IRCCS Fdn, Div Mol Neurogenet, Milan, Italy.
   [Szolnoki, Z.] Pandy Cty Hosp, Dept Neurol & Cerebrovasc Dis, Gyula, Hungary.
   [Tabrizi, S. J.] Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England.
   [Tabrizi, S. J.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
   [Tallaksen, C. M. E.] Univ Oslo, Univ Hosp, Fac Div Ulleval, Oslo, Norway.
   [Burgunder, J. -M.] Univ Bern, Dept Neurol, Bern, Switzerland.
C3 Rudolfstiftung Hospital; Danube University Krems; University of Oslo;
   University of Oslo; University of Antwerp; Flanders Institute for
   Biotechnology (VIB); University of Antwerp; Fondazione IRCCS Istituto
   Neurologico Carlo Besta; Sorbonne Universite; Assistance Publique
   Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP;
   Hebrew University of Jerusalem; University College Dublin; Mater
   Misericordiae University Hospital; University College Dublin; Mater
   Private Hospital; Mater Misericordiae University Hospital; Eberhard
   Karls University of Tubingen; Helmholtz Association; German Center for
   Neurodegenerative Diseases (DZNE); Eberhard Karls University of
   Tubingen; Eberhard Karls University Hospital; Fondazione IRCCS Istituto
   Neurologico Carlo Besta; University of London; University College
   London; University of London; University College London; UCL Medical
   School; University College London Hospitals NHS Foundation Trust;
   University of Oslo; University of Bern
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
RI Van Broeckhoven, Christine/M-7853-2019; Mariotti,
   Caterina/AAP-9425-2021; Zeviani, Massimo/K-2891-2014; Di Donato,
   Stefano/B-9717-2012; Baets, Jonathan/HKM-5219-2023; Schöls,
   Ludger/ABB-2482-2021; Gasser, Thomas/JAC-6600-2023; Tabrizi,
   Sarah/HKW-6577-2023; Spinazzola, Antonella/P-5298-2017; Van Broeckhoven,
   Christine/G-8362-2017
OI Zeviani, Massimo/0000-0002-9067-5508; Mariotti,
   Caterina/0000-0003-2405-3564; Spinazzola, Antonella/0000-0003-4242-8091;
   Schols, Ludger/0000-0001-7774-5025; Gasser, Thomas/0000-0002-1069-1146;
   Van Broeckhoven, Christine/0000-0003-0183-7665; Tabrizi,
   Sarah/0000-0003-2716-2045
CR Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Berger I, 2008, ANN NEUROL, V63, P405, DOI 10.1002/ana.21332
   Blesa JR, 2007, NEUROMOL MED, V9, P285, DOI 10.1007/s12017-007-8000-3
   Boultwood J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001970
   Brainin M, 2004, EUR J NEUROL, V11, P577, DOI 10.1111/j.1468-1331.2004.00867.x
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Finsterer J, 2001, J INHERIT METAB DIS, V24, P560, DOI 10.1023/A:1012415810881
   Gasser T, 2001, EUR J NEUROL, V8, P299
   Gasser T, 2001, EUR J NEUROL, V8, P407
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Kaukonen J, 1999, AM J HUM GENET, V65, P256, DOI 10.1086/302445
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Oldfors Anders, 2007, Handb Clin Neurol, V86, P125, DOI 10.1016/S0072-9752(07)86006-4
   ROTIG A, 1989, LANCET, V1, P902
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tiranti V, 1999, ANN NEUROL, V46, P161, DOI 10.1002/1531-8249(199908)46:2<161::AID-ANA4>3.0.CO;2-O
   Tsao CY, 2003, J CHILD NEUROL, V18, P62, DOI 10.1177/08830738030180011401
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 33
TC 46
Z9 54
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-5101
EI 1468-1331
J9 EUR J NEUROL
JI Eur. J. Neurol.
PD DEC
PY 2009
VL 16
IS 12
BP 1255
EP 1264
DI 10.1111/j.1468-1331.2009.02811.x
PG 10
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 522BT
UT WOS:000271973400003
PM 19950421
OA Bronze
DA 2024-11-01
ER

PT J
AU Martikainen, MH
   Hinttala, R
   Röyttä, M
   Jääskeläinen, S
   Wendelin-Saarenhovi, M
   Parkkola, R
   Majamaa, K
AF Martikainen, Mika H.
   Hinttala, Reetta
   Roytta, Matias
   Jaaskelainen, Satu
   Wendelin-Saarenhovi, Maria
   Parkkola, Riitta
   Majamaa, Kari
TI Progressive External Ophthalmoplegia in Southwestern Finland: A Clinical
   and Genetic Study
SO NEUROEPIDEMIOLOGY
LA English
DT Article
DE Progressive external ophthalmoplegia; Epidemiology of mitochondrial
   diseases; POLG1; Mitochondrial DNA deletions
ID MITOCHONDRIAL-DNA DELETIONS; AUTOSOMAL-DOMINANT; MULTIPLE DELETIONS;
   MTDNA MAINTENANCE; FREQUENT CAUSE; OPTIC ATROPHY; MUTATIONS; OPA1;
   TWINKLE; INSTABILITY
AB Background: Progressive external ophthalmoplegia (PEO) is a common phenotype of mitochondrial disease. Molecular etiologies include sporadic, large-scale deletions in mitochondrial DNA (mtDNA), multiple mtDNA deletions secondary to autosomal dominant or recessive mutations and mtDNA point mutations. Methods: We studied the prevalence and clinical and genetic characteristics of PEO in a defined population in southwestern Finland. A total of 620 patients were first identified from the patient registry at the Turku University Hospital over an 18-year period. The medical records of these patients were scrutinized, and those with clinical features compatible with PEO were ascertained. Results: We identified 10 patients with possible PEO. The patients were examined clinically, and DNA was analyzed for mtDNA deletions and for the m.3243A>G and m.8344A>G mtDNA point mutations. The AND, PEO1, POLG1 and POLG2 genes were sequenced. We confirmed the clinical diagnosis of PEO in 6 patients. Large-scale mtDNA deletions were detected in 3 out of 6 PEO patients and mutations in the POLG1 gene in 1 out of 6. We did not find any mutations in the ANTI, PEO1 or POLG2 genes. Conclusions: Our results suggest that molecular investigation of patients with PEO, either sporadic or familial, should start with an analysis for mtDNA deletions, followed by an analysis of the POLG1 gene. Copyright (C) 2012 S. Karger AG, Basel
C1 [Hinttala, Reetta; Majamaa, Kari] Univ Oulu, Dept Clin Med, FI-90014 Oulu, Finland.
   [Martikainen, Mika H.] Turku Univ Hosp, Dept Neurol, FIN-20520 Turku, Finland.
   [Roytta, Matias] Turku Univ Hosp, Dept Pathol, FIN-20520 Turku, Finland.
   [Jaaskelainen, Satu] Turku Univ Hosp, Dept Clin Neurophysiol, FIN-20520 Turku, Finland.
   [Wendelin-Saarenhovi, Maria] Turku Univ Hosp, Dept Clin Physiol, FIN-20520 Turku, Finland.
   [Parkkola, Riitta] Turku Univ Hosp, Dept Radiol, FIN-20520 Turku, Finland.
   [Hinttala, Reetta] Oulu Univ Hosp, Clin Res Ctr, Oulu, Finland.
C3 University of Oulu; University of Turku; University of Turku; University
   of Turku; University of Turku; University of Turku; University of Oulu
RP Majamaa, K (corresponding author), Univ Oulu, Dept Clin Med, FI-90014 Oulu, Finland.
EM kari.majamaa@oulu.fi
RI Parkkola, Riitta/AAZ-1341-2020; Jääskeläinen, Satu/X-8755-2019; Majamaa,
   Kari/A-1344-2012
OI Hinttala, Reetta/0000-0002-7642-4008; Majamaa, Kari/0000-0002-9070-3791;
   Martikainen, Mika/0000-0002-7604-8081
FU Research Council for Health at the Academy of Finland; Sigrid Juselius
   Foundation; National Graduate School of Clinical Investigation; Emil
   Aaltonen Foundation; Alfred Kordelin Foundation
FX The authors thank Ms. Anja Heikkinen and Ms. Pirjo Keranen for their
   expert assistance. The work was supported by the Research Council for
   Health at the Academy of Finland, the Sigrid Juselius Foundation, the
   National Graduate School of Clinical Investigation, the Emil Aaltonen
   Foundation and the Alfred Kordelin Foundation.
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329
   Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   Hudson G, 2006, NEUROLOGY, V66, P1439, DOI 10.1212/01.wnl.0000210486.32196.24
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   KALTON G, 1986, J ROY STAT SOC A STA, V149, P65, DOI 10.2307/2981886
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   LAUBER J, 1991, NUCLEIC ACIDS RES, V19, P1393, DOI 10.1093/nar/19.7.1393
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Martikainen Mika H, 2010, BMJ Case Rep, V2010, DOI 10.1136/bcr.01.2010.2604
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Raffelsberger T, 2001, NEUROLOGY, V57, P2298, DOI 10.1212/WNL.57.12.2298
   Remes AM, 2005, NEUROLOGY, V64, P976, DOI 10.1212/01.WNL.0000154518.31302.ED
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Stewart JD, 2008, NEUROLOGY, V71, P1829, DOI 10.1212/01.wnl.0000335931.54095.0a
   SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1991, AM J HUM GENET, V48, P203
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 31
TC 5
Z9 5
U1 0
U2 3
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0251-5350
EI 1423-0208
J9 NEUROEPIDEMIOLOGY
JI Neuroepidemiology
PY 2012
VL 38
IS 2
BP 114
EP 119
DI 10.1159/000336112
PG 6
WC Public, Environmental & Occupational Health; Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Neurosciences & Neurology
GA 910FK
UT WOS:000301622400007
PM 22377773
DA 2024-11-01
ER

PT J
AU Wu, YT
   Hsu, YH
   Huang, CY
   Ho, MC
   Cheng, YC
   Wen, CH
   Ko, HW
   Lu, HE
   Chen, YC
   Tsai, CL
   Hsu, YC
   Wei, YH
   Hsieh, PCH
AF Wu, Yu-Ting
   Hsu, Yu-Hung
   Huang, Ching-Ying
   Ho, Ming-Ching
   Cheng, Yu-Che
   Wen, Cheng-Hao
   Ko, Hui-Wen
   Lu, Huai-En
   Chen, Yen-Chun
   Tsai, Chia-Ling
   Hsu, Yi-Chao
   Wei, Yau-Huei
   Hsieh, Patrick C. H.
TI Generation of an induced pluripotent stem cell (iPSC) line from a
   40-year-old patient with the A8344G mutation of mitochondrial DNA and
   MERRF (myoclonic epilepsy with ragged red fibers) syndrome
SO STEM CELL RESEARCH
LA English
DT Article
ID FIBROBLASTS
AB Mitochondrial defects are associated with clinical manifestations from common diseases to rare genetic disorders. Myoclonus epilepsy associated with ragged-red fibers (MERRF) syndrome results from an A to G transition at nucleotide position 8344 in the tRNALys gene of mitochondrial DNA (mtDNA) and is characterized bymyoclonus, myopathy and severe neurological symptoms. In this study, Sendai reprogramming method was used to generate an iPS cell line carrying the A8344G mutation of mtDNA from a MERRF patient. This patient-specific iPSC line expressed pluripotent stem cell markers, possessed normal karyotype, and displayed the capability to differentiate into mature cells in three germ layers. (c) 2017 The Authors. Published by Elsevier B.V.
C1 [Wu, Yu-Ting; Wei, Yau-Huei] Changhua Christian Hosp, Ctr Mitochondrial Med & Free Rad Res, Changhua, Taiwan.
   [Hsu, Yu-Hung; Huang, Ching-Ying; Ho, Ming-Ching; Cheng, Yu-Che; Hsieh, Patrick C. H.] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.
   [Wen, Cheng-Hao; Ko, Hui-Wen; Lu, Huai-En] Food Ind Res & Dev Inst, Bioresource Collect & Res Ctr, Hsinchu, Taiwan.
   [Chen, Yen-Chun; Tsai, Chia-Ling; Hsu, Yi-Chao; Wei, Yau-Huei] Mackay Med Coll, Inst Biomed Sci, New Taipei, Taiwan.
C3 Changhua Christian Hospital; Academia Sinica - Taiwan; Mackay Medical
   College
RP Wei, YH (corresponding author), Changhua Christian Hosp, Ctr Mitochondrial Med & Free Rad Res, Changhua, Taiwan.; Hsieh, PCH (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.; Hsu, YC; Wei, YH (corresponding author), Mackay Med Coll, Inst Biomed Sci, New Taipei, Taiwan.
EM hsuyc@mmc.edu.tw; yhweibabi@gmail.com; phsieh@ibms.sinica.edu.tw
RI Hsieh, Patrick/H-5108-2015; Wen, Cheng-Hao/B-4993-2009; Wei,
   Yau-Huei/ABA-6841-2021; Hsu, Yi-Chao/AAK-7478-2021
OI Hsu, Yi-Chao/0000-0001-9071-475X; Wei, Yau-Huei/0000-0002-6429-2546
FU Ministry of Science and Technology (MOST), Taiwan [MOST
   106-2319-B-001-003, MOST104-2314-B-715-003-MY3, MOST104-2627-M-715-002,
   MOST104-2320-B-715-006-MY2, MOST105-2627-M-715-001,
   MOST106-2627-M-371-001, MOST106-2320-B-371-002]; Taiwan Mouse Clinic
   [MOST 105-2325-B001-010]
FX We thank the Human Disease iPSC Service Consortium for iPSC generation
   and technical support. The Consortium has been funded by the Ministry of
   Science and Technology (MOST), Taiwan (MOST 106-2319-B-001-003). We also
   thank the Taiwan Mouse Clinic (MOST 105-2325-B001-010) for technical
   support. Part of this study was also supported by
   MOST104-2314-B-715-003-MY3, MOST104-2627-M-715-002,
   MOST104-2320-B-715-006-MY2, MOST105-2627-M-715-001,
   MOST106-2627-M-371-001 and MOST106-2320-B-371-002 from the Ministry of
   Science and Technology, Taiwan.
CR James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Ma YS, 2005, ANN NY ACAD SCI, V1042, P55, DOI 10.1196/annals.1338.006
   Wu SB, 2010, MOL NEUROBIOL, V41, P256, DOI 10.1007/s12035-010-8123-7
NR 3
TC 10
Z9 11
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1873-5061
EI 1876-7753
J9 STEM CELL RES
JI Stem Cell Res.
PD MAR
PY 2018
VL 27
BP 10
EP 14
DI 10.1016/j.scr.2017.12.013
PG 5
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Biotechnology & Applied Microbiology
GA FZ4AQ
UT WOS:000427533700003
PM 29288969
OA gold
DA 2024-11-01
ER

PT J
AU Dvorakova, V
   Kolarova, H
   Magner, M
   Tesarova, M
   Hansikova, H
   Zeman, J
   Honzik, T
AF Dvorakova, V.
   Kolarova, H.
   Magner, M.
   Tesarova, M.
   Hansikova, H.
   Zeman, J.
   Honzik, T.
TI The phenotypic spectrum of fifty Czech m.3243A&gt;G carriers
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE MELAS; m.3243A > G; Heteroplasmy; Natural course; Fully expressed
   phenotype; Oligosymptomatic patients
ID MITOCHONDRIAL-DNA MUTATION; GREATER-THAN-G; SEVERE LACTIC-ACIDOSIS;
   CLINICAL PHENOTYPES; A3243G MUTATION; MELAS SYNDROME; MTDNA MUTATION;
   RHABDOMYOLYSIS; PREVALENCE; FEATURES
AB Background: Mitochondrial myopathy, Encephalopathy, Lactic Acidosis and Stroke-like episodes syndrome (MELAS) is a common mitochondrial disorder with varying multisystemic clinical manifestation. We present a comprehensive clinical picture of 50 Czech m.3243A>G carriers with emphasis on the sequence of symptoms in symptomatic patients.
   Results: Symptoms developed in 33 patients (66%) and 17 carriers remained unaffected (34%). The age of onset varied from 1 month to 47 years of age, with juvenile presentation occurring in 53% of patients. Myopathy was the most common presenting symptom (18%), followed by CPEO/ptosis and hearing loss, with the latter also being the most common second symptom. Stroke-like episodes (SLE) occurred in fourteen patients, although never as a first symptom, and were frequently preceded by migraines (58%). Rhabdomyolysis developed in two patients. The second symptom appeared 5.0 +/- 8.3 years (range 0-28 years) after the first, and the interval between the second and third symptom was 2.0 +/- 6.0 years (range 0-21 years). Four of our patients remained monosymptomatic up to 12 years of follow-up. The sequence of symptoms according to their time of manifestation was migraines, myopathy, seizures, CPEO/ptosis, SLE, hearing loss, and diabetes mellitus. The average age at death was 32.4 +/- 17.7 years (range 9-60 years) in the juvenile form and 44.0 +/- 12.7 years (range 35-53 years) in the adult form. Some patients with SLE harboured very low heteroplasmy levels in various tissues. No threshold for any organ dysfunction could be determined based on these levels.
   Conclusions: Sufficient knowledge of the timeline of the natural course of MELAS syndrome may improve the prediction and management of symptoms in patients with this mitochondrial disease. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Dvorakova, V.; Kolarova, H.; Magner, M.; Tesarova, M.; Hansikova, H.; Zeman, J.; Honzik, T.] Charles Univ Prague, Gen Univ Hosp Prague, Fac Med 1, Dept Paediat & Adolescent Med, Ke Karlovu 2, Prague 12101 2, Czech Republic.
C3 Charles University Prague; General University Hospital Prague
RP Honzik, T (corresponding author), Charles Univ Prague, Gen Univ Hosp Prague, Fac Med 1, Dept Paediat & Adolescent Med, Ke Karlovu 2, Prague 12101 2, Czech Republic.
EM tomas.honzik@vfn.cz
RI Hansikova, Hana/E-9350-2017; Zeman, Jiri/K-2691-2017; Honzik,
   Tomas/N-7509-2017; Magner, Martin/J-3553-2017; Tesarova,
   Marketa/I-1531-2016
OI Zeman, Jiri/0000-0003-3336-7872; Zeman, Jiri/0000-0002-2678-7919;
   Honzik, Tomas/0000-0003-4300-2519; Magner, Martin/0000-0002-5883-9509;
   Tesarova, Marketa/0000-0002-5141-2289
FU Ministry of Health of the Czech Republic [MZ CR AZV 16-32341A, RVO-VFN
   64165]; Grant Agency of the Czech Republic [14-36804G]; Charles
   University in Prague [GAUK 38515/2015, PRVOUK P24/LF1/3, UNCE
   204011/2012, SW 260256/2016]
FX This work was supported by the Ministry of Health of the Czech Republic
   (MZ CR AZV 16-32341A, RVO-VFN 64165), the Grant Agency of the Czech
   Republic (14-36804G), and by Charles University in Prague (GAUK
   38515/2015, PRVOUK P24/LF1/3, UNCE 204011/2012, SW 260256/2016). The
   authors are thankful to Vaclav Capek for the statistical treatment of
   the data.
CR Blum S, 2011, INTERN MED J, V41, P200, DOI 10.1111/j.1445-5994.2010.02379.x
   Cevoli S, 2010, CEPHALALGIA, V30, P919, DOI 10.1177/0333102409354654
   Chae JH, 2004, BRAIN DEV-JPN, V26, P459, DOI 10.1016/j.braindev.2004.01.002
   Chin J, 2014, MITOCHONDRION, V17, P34, DOI 10.1016/j.mito.2014.05.005
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Corman V, 2001, Rev Med Liege, V56, P681
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Di Gennaro G, 2000, HEADACHE, V40, P568, DOI 10.1046/j.1526-4610.2000.00088.x
   DiMauro S., 1993, MELAS GENEREVIEWS R
   El-Hattab AW, 2014, MITOCHONDRION, V18, P63, DOI 10.1016/j.mito.2014.07.008
   Fayssoil Abdallah, 2009, Congest Heart Fail, V15, P284, DOI 10.1111/j.1751-7133.2009.00108.x
   Frederiksen AL, 2009, J CLIN ENDOCR METAB, V94, P2872, DOI 10.1210/jc.2009-0235
   GABOW PA, 1982, MEDICINE, V61, P141, DOI 10.1097/00005792-198205000-00002
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HARA H, 1994, J NEUROL NEUROSUR PS, V57, P1545, DOI 10.1136/jnnp.57.12.1545-a
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   HIROSE Y, 1993, INTERNAL MED, V32, P798, DOI 10.2169/internalmedicine.32.798
   Höschl C, 2012, INT REV PSYCHIATR, V24, P278, DOI 10.3109/09540261.2012.688730
   Honzik T, 2012, J INHERIT METAB DIS, V35, P749, DOI 10.1007/s10545-011-9440-3
   Inczedy-Farkas G, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-9
   Inoue Shigeaki, 2007, J Intensive Care Med, V22, P240, DOI 10.1177/0885066607301343
   Jung I, 2015, J CLIN NEUROL, V11, P104, DOI 10.3988/jcn.2015.11.1.104
   Kanaumi T, 2006, PEDIATR NEUROL, V34, P235, DOI 10.1016/j.pediatrneurol.2005.08.024
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kaufmann P, 2009, ARCH NEUROL-CHICAGO, V66, P85, DOI 10.1001/archneurol.2008.526
   Klopstock T, 1996, NEUROLOGY, V46, P1735, DOI 10.1212/WNL.46.6.1735
   Kwon JH, 2003, EUR NEUROL, V50, P123, DOI 10.1159/000072517
   Lofberg M, 1998, ACTA NEUROL SCAND, V98, P268, DOI 10.1111/j.1600-0404.1998.tb07307.x
   Ma YN, 2010, J NEUROL SCI, V291, P17, DOI 10.1016/j.jns.2010.01.012
   Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103
   Malfatti E, 2013, NEUROLOGY, V80, P100, DOI 10.1212/WNL.0b013e31827b1a2f
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mancuso M, 2013, NEUROL SCI, V34, P71, DOI 10.1007/s10072-011-0901-0
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Ohkubo K, 2001, CLIN CHEM, V47, P1641
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Tan TMM, 2009, CLIN ENDOCRINOL, V70, P340, DOI 10.1111/j.1365-2265.2008.03341.x
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   Vanniarajan A, 2006, AM J MED GENET B, V141B, P440, DOI 10.1002/ajmg.b.30302
   Wortmann SB, 2007, ACTA PAEDIATR, V96, P450, DOI 10.1111/j.1651-2227.2006.00158.x
   YANG CY, 1995, CLIN ENDOCRINOL, V43, P235, DOI 10.1111/j.1365-2265.1995.tb01922.x
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 48
TC 27
Z9 28
U1 0
U2 8
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD AUG
PY 2016
VL 118
IS 4
BP 288
EP 295
DI 10.1016/j.ymgme.2016.06.003
PG 8
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA DT2RL
UT WOS:000381328000010
PM 27296531
DA 2024-11-01
ER

PT J
AU Tang, S
   Wang, J
   Lee, NC
   Milone, M
   Halberg, MC
   Schmitt, ES
   Craigen, WJ
   Zhang, W
   Wong, LJC
AF Tang, Sha
   Wang, Jing
   Lee, Ni-Chung
   Milone, Margherita
   Halberg, Michelle C.
   Schmitt, Eric S.
   Craigen, William J.
   Zhang, Wei
   Wong, Lee-Jun C.
TI Mitochondrial DNA polymerase γ mutations: an ever expanding molecular
   and clinical spectrum
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; COMPARATIVE GENOMIC HYBRIDIZATION;
   POLG MUTATIONS; EXONUCLEASE DOMAIN; DEPLETION SYNDROME; ATAXIC
   NEUROPATHY; PARKINSON-DISEASE; ALPERS-SYNDROME; GENE; ENCEPHALOMYOPATHY
AB Mutations in the POLG gene have emerged as one of the most common causes of inherited mitochondrial diseases in children and adults. This study sequenced the exons and flanking intronic regions of the POLG gene from 2697 unrelated patients with clinical presentations suggestive of POLG deficiency. Informative mutations have been identified in 136 unrelated individuals (5%), including 92 patients with two recessive pathogenic alleles and three patients harbouring a dominant mutation. Twenty-four novel recessive mutations and a novel possible dominant mutation, p.Y951N, were identified. All missense mutations occurred at evolutionarily conserved amino acids within functionally important regions identified by molecular modelling analyses. Oligonucleotide array comparative genomic hybridisation analyses performed on DNA samples from 81 patients with one mutant POLG allele identified a large intragenic deletion in only one patient, suggesting that large deletions in POLG are rare. The 92 patients with two mutant alleles exhibited a broad spectrum of disease. Almost all patients in all age groups had some degree of neuropathy. Seizures, hepatopathy, and lactic acidaemia were predominant in younger patients. By comparison, patients who developed symptoms in adulthood had a higher percentage of myopathy, sensory ataxia, and chronic progressive external ophthalmoplegia (CPEO)/ptosis. In conclusion, POLG mutations account for a broad clinical spectrum of mitochondrial disorders. Sequence analysis of the POLG gene should be considered as a part of routine screening for mitochondrial disorders, even in the absence of apparent mitochondrial DNA abnormalities.
C1 [Tang, Sha; Wang, Jing; Halberg, Michelle C.; Schmitt, Eric S.; Craigen, William J.; Zhang, Wei; Wong, Lee-Jun C.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Lee, Ni-Chung] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan.
   [Milone, Margherita] Mayo Clin, Dept Neurol, Rochester, MN USA.
C3 Baylor College of Medicine; National Taiwan University; National Taiwan
   University Hospital; Mayo Clinic
RP Wong, LJC (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,NAB 2015, Houston, TX 77030 USA.
EM ljwong@bcm.edu
RI Lu, Chun-yi/JXN-8290-2024
OI LEE, NI-CHUNG/0000-0002-5011-7499
CR Barthélémy C, 2002, HUM GENET, V110, P479, DOI 10.1007/s00439-002-0708-4
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Bolszak M, 2009, EPILEPSY RES, V85, P300, DOI 10.1016/j.eplepsyres.2009.03.004
   Brahimi N, 2009, MOL GENET METAB, V97, P221, DOI 10.1016/j.ymgme.2009.03.007
   Brautbar A, 2008, MOL GENET METAB, V94, P485, DOI 10.1016/j.ymgme.2008.04.004
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Chinault AC, 2009, GENET MED, V11, P518, DOI 10.1097/GIM.0b013e3181abd83c
   Compton AG, 2011, MITOCHONDRION, V11, P104, DOI 10.1016/j.mito.2010.07.012
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   Galassi G, 2008, NEUROMUSCULAR DISORD, V18, P465, DOI 10.1016/j.nmd.2008.03.013
   Giordano C, 2010, ARCH NEUROL-CHICAGO, V67, P1144, DOI 10.1001/archneurol.2010.200
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Lamantea E, 2004, ANN NEUROL, V56, P454, DOI 10.1002/ana.20219
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae
   Rivera H, 2010, MITOCHONDRION, V10, P362, DOI 10.1016/j.mito.2010.03.003
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Stopinska K, 2006, ACTA BIOCHIM POL, V53, P591
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Tarutani Y, 2010, NATURE, V466, P983, DOI 10.1038/nature09308
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Vockley J, 2000, MOL GENET METAB, V71, P10, DOI 10.1006/mgme.2000.3066
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, CLIN CHEM, V54, P1141, DOI 10.1373/clinchem.2008.103721
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
NR 44
TC 124
Z9 129
U1 0
U2 12
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
J9 J MED GENET
JI J. Med. Genet.
PD OCT
PY 2011
VL 48
IS 10
BP 669
EP 681
DI 10.1136/jmedgenet-2011-100222
PG 13
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 822FZ
UT WOS:000295030700004
PM 21880868
DA 2024-11-01
ER

PT J
AU Korzeniewski, B
AF Korzeniewski, Bernard
TI Effects of OXPHOS complex deficiencies and ESA dysfunction in working
   intact skeletal muscle: implications for mitochondrial myopathies
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article
DE Mitochondrial diseases; mtDNA mutations; Oxidative phosphorylation;
   Inborn enzyme deficiencies; Computer model
ID OXIDATIVE-PHOSPHORYLATION; OXYGEN-CONSUMPTION; ATP SYNTHESIS; THRESHOLD;
   FATIGUE; HETEROPLASMY; TRANSITIONS; EFFICIENCY; KINETICS; DISEASES
AB The effects of inborn oxidative phosphorylation (OXPHOS) complex deficiencies or possible each-step activation (ESA) dysfunction on the bioenergetic system in working intact skeletal muscle are studied using a computer model of OXPHOS published previously. The curves representing the dependencies of (V) over dot O-2 and metabolite concentrations on single complex activity, entire OXPHOS activity or ESA intensity exhibit a characteristic threshold at some OXPHOS complex activity/ESA intensity. This threshold for (V) over dot O-2 of single complex activities is significantly lower in intact muscle during moderate and heavy work, than in isolated mitochondria in state 3. Metabolite concentrations and pH in working muscle start to change significantly at much higher OXPHOS complex activities/ESA intensities than (V) over dot O-2. The effect of entire OXPHOS deficiency or ESA dysfunction is potentially much stronger than the effect of a single complex deficiency. Implications of these findings for the genesis of mitochondrial myopathies are discussed. It is concluded that (V) over dot O-2 in state 3 and its dependence on complex activity in isolated mitochondria is not a universal quantitative determinant of the effect of mitochondrial dysfunctions in vivo. Moderate and severe mitochondria dysfunctions are defined: the former affect significantly only metabolite concentrations and pH, while the latter also decrease significantly (V) over dot O-2 in intact skeletal muscle during work. The dysfunction-caused decrease in (V) over dot O-2/oxidative ATP synthesis flux, disturbance of metabolite homeostasis, elevated ROS production and anaerobic glycolysis recruitment can account for such mitochondrial myopathy symptoms as muscle weakness, exercise intolerance (exertional fatigue) and lactic acidosis. (C) 2015 Elsevier B.V. All rights reserved.
C1 Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland.
C3 Jagiellonian University
RP Korzeniewski, B (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Ul Gronostajowa 7, PL-30387 Krakow, Poland.
EM bernard.korzeniewski@gmail.com
RI Korzeniewski, Bernard/KVB-8815-2024
CR Alam MT, 2015, BBA-BIOENERGETICS, V1847, P526, DOI 10.1016/j.bbabio.2015.02.006
   Barclay CJ, 1996, J PHYSIOL-LONDON, V497, P781, DOI 10.1113/jphysiol.1996.sp021809
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   Glancy B, 2013, BIOCHEMISTRY-US, V52, P2793, DOI 10.1021/bi3015983
   Grassi B, 2015, EXERC SPORT SCI REV, V43, P75, DOI 10.1249/JES.0000000000000043
   GROEN AK, 1982, J BIOL CHEM, V257, P2754
   Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908
   KATZ LA, 1989, AM J PHYSIOL, V256, pH265, DOI 10.1152/ajpheart.1989.256.1.H265
   Kawamata H, 2010, MECH AGEING DEV, V131, P517, DOI 10.1016/j.mad.2010.05.003
   Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9
   Korzeniewski B, 2006, J BIOL CHEM, V281, P3057, DOI 10.1074/jbc.M510418200
   Korzeniewski B, 2005, BIOPHYS CHEM, V116, P145, DOI 10.1016/j.bpc.2005.04.001
   Korzeniewski B, 2003, BIOCHEM J, V375, P799, DOI 10.1042/BJ20030882
   Korzeniewski B, 1998, BIOCHEM J, V330, P1189, DOI 10.1042/bj3301189
   Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3
   Korzeniewski B, 2001, BIOCHEM J, V357, P835, DOI 10.1042/0264-6021:3570835
   Korzeniewski B, 2004, BIOPHYS CHEM, V110, P147, DOI 10.1016/j.bpc.2004.01.011
   Korzeniewski B, 1996, BIOCHEM J, V319, P143, DOI 10.1042/bj3190143
   Korzeniewski B, 2007, BIOPHYS CHEM, V129, P93, DOI 10.1016/j.bpc.2007.05.013
   Korzeniewski B, 2006, AM J PHYSIOL-HEART C, V291, pH1466, DOI 10.1152/ajpheart.00004.2006
   Korzeniewski B, 2015, J APPL PHYSIOL, V118, P1240, DOI 10.1152/japplphysiol.00027.2015
   Korzeniewski B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117145
   Korzeniewski B, 2014, J APPL PHYSIOL, V116, P83, DOI 10.1152/japplphysiol.00759.2013
   Korzeniewski B, 2013, J APPL PHYSIOL, V115, P605, DOI 10.1152/japplphysiol.00469.2013
   Korzeniewski B, 2011, PROG BIOPHYS MOL BIO, V107, P274, DOI 10.1016/j.pbiomolbio.2011.08.003
   LETELLIER T, 1994, BIOCHEM J, V302, P171, DOI 10.1042/bj3020171
   LETELLIER T, 1993, BIOCHIM BIOPHYS ACTA, V1141, P58, DOI 10.1016/0005-2728(93)90189-M
   Liguzinski P, 2006, AM J PHYSIOL-CELL PH, V291, pC1213, DOI 10.1152/ajpcell.00078.2006
   Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Rossignol R, 2000, BIOCHEM J, V347, P45, DOI 10.1042/0264-6021:3470045
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Woledge RC, 1998, ACTA PHYSIOL SCAND, V162, P267, DOI 10.1046/j.1365-201X.1998.0294e.x
   Wu F, 2007, AM J PHYSIOL-CELL PH, V292, pC115, DOI 10.1152/ajpcell.00237.2006
NR 41
TC 11
Z9 12
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 1879-2650
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD OCT
PY 2015
VL 1847
IS 10
BP 1310
EP 1319
DI 10.1016/j.bbabio.2015.07.007
PG 10
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA CQ8PY
UT WOS:000360872100030
PM 26188374
OA Bronze
DA 2024-11-01
ER

PT J
AU Hämäläinen, RH
   Manninen, T
   Koivumäki, H
   Kislin, M
   Otonkoski, T
   Suomalainen, A
AF Hamalainen, Riikka H.
   Manninen, Tuula
   Koivumaki, Hanna
   Kislin, Mikhail
   Otonkoski, Timo
   Suomalainen, Anu
TI Tissue- and cell-type-specific manifestations of heteroplasmic mtDNA
   3243A&gt;G mutation in human induced pluripotent stem cell-derived
   disease model
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE mitochondria; disease modeling
ID STROKE-LIKE EPISODES; MITOCHONDRIAL-DNA MUTATIONS; COMPLEX-I DEFICIENCY;
   LACTIC-ACIDOSIS; CLINICAL-FEATURES; RAPID SEGREGATION; BALBIANI BODY;
   MELAS; ENCEPHALOPATHY; MYOPATHY
AB Mitochondrial DNA (mtDNA) mutations manifest with vast clinical heterogeneity. The molecular basis of this variability is mostly unknown because the lack of model systems has hampered mechanistic studies. We generated induced pluripotent stem cells from patients carrying the most common human disease mutation in mtDNA, m.3243A>G, underlying mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome. During reprogramming, heteroplasmic mtDNA showed bimodal segregation toward homoplasmy, with concomitant changes in mtDNA organization, mimicking mtDNA bottleneck during epiblast specification. Induced pluripotent stem cell-derived neurons and various tissues derived from teratomas manifested cell-type specific respiratory chain (RC) deficiency patterns. Similar to MELAS patient tissues, complex I defect predominated. Upon neuronal differentiation, complex I specifically was sequestered in perinuclear PTEN-induced putative kinase 1 (PINK1) and Parkin-positive autophagosomes, suggesting active degradation through mitophagy. Other RC enzymes showed normal mitochondrial network distribution. Our data show that cellular context actively modifies RC deficiency manifestation in MELAS and that autophagy is a significant component of neuronal MELAS pathogenesis.
C1 [Hamalainen, Riikka H.; Manninen, Tuula; Koivumaki, Hanna; Otonkoski, Timo; Suomalainen, Anu] Univ Helsinki, Res Programs Unit, Helsinki 00280, Finland.
   [Kislin, Mikhail] Univ Helsinki, Ctr Neurosci, Helsinki 00790, Finland.
   [Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, FIN-00290 Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; University of Helsinki;
   Helsinki University Central Hospital
RP Suomalainen, A (corresponding author), Univ Helsinki, Res Programs Unit, Helsinki 00280, Finland.
EM anu.wartiovaara@helsinki.fi
RI Martikainen, Riikka/AAR-8397-2020; Kislin, Mikhail/ABC-6334-2021
OI Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195; Kislin,
   Mikhail/0000-0002-5447-8881
FU Academy of Finland; Sigrid Juselius Foundation; Jane and Aatos Erkko
   Foundation; University of Helsinki; European Research Council
FX We thank A. Oksanen, A. Harju, M. Innila, and M. Mikkola for technical
   assistance; R. Aanismaa and S. Narkilahti for advice in neuronal
   differentiation; L. Khirug in Ca-homeostasis measurements; and H.
   Sariola in histology analysis. This work was supported by the Academy of
   Finland, the Sigrid Juselius Foundation, the Jane and Aatos Erkko
   Foundation, the University of Helsinki, and The European Research
   Council.
CR ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325
   Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970
   Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200
   Chae JH, 2004, BRAIN DEV-JPN, V26, P459, DOI 10.1016/j.braindev.2004.01.002
   Cherry ABC, 2013, STEM CELLS, V31, P1287, DOI 10.1002/stem.1354
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   De Smedt V, 2000, GENESIS, V26, P208, DOI 10.1002/(SICI)1526-968X(200003)26:3<208::AID-GENE6>3.0.CO;2-N
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fornuskova D, 2008, BBA-MOL BASIS DIS, V1782, P317, DOI 10.1016/j.bbadis.2008.02.001
   Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427
   Fujikura J, 2012, DIABETOLOGIA, V55, P1689, DOI 10.1007/s00125-012-2508-2
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Götz A, 2012, PEDIATR RES, V72, P90, DOI 10.1038/pr.2012.43
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   LAIPIS PJ, 1988, P NATL ACAD SCI USA, V85, P8107, DOI 10.1073/pnas.85.21.8107
   Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   Liu CS, 2006, ACTA NEUROL SCAND, V113, P334, DOI 10.1111/j.1600-0404.2006.00586.x
   LUCOCQ JM, 1987, EMBO J, V6, P3239, DOI 10.1002/j.1460-2075.1987.tb02641.x
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Nakada K, 2011, EXP ANIM TOKYO, V60, P421
   Nat R, 2007, GLIA, V55, P385, DOI 10.1002/glia.20463
   OLSON W, 1972, ARCH NEUROL-CHICAGO, V26, P193, DOI 10.1001/archneur.1972.00490090019001
   Palin EJH, 2013, BRAIN, V136, P2379, DOI 10.1093/brain/awt160
   Parker WD, 2008, BRAIN RES, V1189, P215, DOI 10.1016/j.brainres.2007.10.061
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Prigione A, 2011, STEM CELLS, V29, P1338, DOI 10.1002/stem.683
   Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Santorelli FM, 1997, NEUROLOGY, V49, P270, DOI 10.1212/WNL.49.1.270
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]
   SUOMALAINEN A, 1993, HUM MOL GENET, V2, P525, DOI 10.1093/hmg/2.5.525
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trokovic R, 2013, STEM CELLS DEV, V22, P114, DOI 10.1089/scd.2012.0157
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
NR 56
TC 154
Z9 165
U1 0
U2 9
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 17
PY 2013
VL 110
IS 38
BP E3622
EP E3630
DI 10.1073/pnas.1311660110
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 219GW
UT WOS:000324495300013
PM 24003133
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Schaller, A
   Desetty, R
   Hahn, D
   Jackson, CB
   Nuoffer, JM
   Gallati, S
   Levinger, L
AF Schaller, A.
   Desetty, R.
   Hahn, D.
   Jackson, C. B.
   Nuoffer, J. -M.
   Gallati, S.
   Levinger, L.
TI Impairment of mitochondrial tRNA<SUP>Ile</SUP> processing by a novel
   mutation associated with chronic progressive external ophthalmoplegia
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial disease; CPEO; Mitochondrial tRNA; 3 ' end processing;
   MT-TI
ID DNA POINT MUTATION; TRANSFER-RNA; HYPERTROPHIC CARDIOMYOPATHY;
   PARKINSONS-DISEASE; HUMAN-CELLS; IN-VITRO; GENE; MYOPATHY; GENOME;
   ENCEPHALOMYOPATHY
AB We report a sporadic case of chronic progressive external ophthalmoplegia associated with ragged red fibers. The patient presented with enlarged mitochondria with deranged internal architecture and crystalline inclusions. Biochemical studies showed reduced activities of complex I, III and IV in skeletal muscle. Molecular genetic analysis of all mitochondrial tRNAs revealed a G to A transition at nt 4308; the G is a highly conserved nucleotide that participates in a GC base-pair in the T-stem of mammalian mitochondrial tRNA(Ile). The mutation was detected at a high level (approx. 50%) in muscle but not in blood. The mutation co-segregated with the phenotype, as the mutation was absent from blood and muscle in the patient's healthy mother. Functional characterization of the mutation revealed a six-fold reduced rate of tRNA(Ile) precursor 3' end maturation in vitro by tRNAse Z. Furthermore, the mutated tRNA(Ile) displays local structural differences from wild-type. These results suggest that structural perturbations reduce efficiency of tRNA(Ile) precursor 3' end processing and contribute to the molecular pathomechanism of this mutation. (C) 2011 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Schaller, A.; Jackson, C. B.; Gallati, S.] Univ Hosp Bern, Div Human Genet, Bern, Switzerland.
   [Desetty, R.; Levinger, L.] CUNY York Coll, Dept Biol, Jamaica, NY 11451 USA.
   [Hahn, D.; Nuoffer, J. -M.] Univ Hosp Bern, Inst Clin Chem, Bern, Switzerland.
C3 University of Bern; University Hospital of Bern; City University of New
   York (CUNY) System; York College NY (CUNY); University of Bern;
   University Hospital of Bern
RP Schaller, A (corresponding author), Inselspital Bern, Dept Paediat, Div Human Genet, CH-3010 Bern, Switzerland.
EM andre.schaller@insel.ch
RI Jackson, Christopher B./M-3222-2013; Schaller, Andre/L-4174-2018;
   Nuoffer, Jean-Marc/C-8936-2009
OI Jackson, Christopher B./0000-0003-1035-6417; Schaller,
   Andre/0000-0001-5174-5764; Nuoffer, Jean-Marc/0000-0003-3650-6153
FU Novartis; NIH [R15CA12072, SC3GM08153]
FX The authors are indebted to the patient and family members involved for
   their cooperation. We are grateful to K.-M. Rosler (Inselspital, Bern),
   Christopher Wilson (York College/CUNY) and C. Florentz (IBMC,
   Strasbourg) for helpful discussions, and to T. Lauterburg for excellent
   technical assistance. This work was supported by a grant from Novartis
   (AS) and from the NIH (R15CA12072 and SC3GM08153) to LL.
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Berardo A, 2010, NEUROMUSCULAR DISORD, V20, P204, DOI 10.1016/j.nmd.2010.01.006
   Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4
   Borthwick Gillian M, 2006, Ann Neurol, V59, P570, DOI 10.1002/ana.20758
   Campos Y, 2002, MUSCLE NERVE, V25, P185, DOI 10.1002/mus.10012.abs
   CASALI C, 1995, BIOCHEM BIOPH RES CO, V213, P588, DOI 10.1006/bbrc.1995.2172
   Chinnery PF, 1997, NEUROLOGY, V49, P1166, DOI 10.1212/WNL.49.4.1166
   Corona P, 2002, ANN NEUROL, V51, P118, DOI 10.1002/ana.10059
   Degoul F, 1998, HUM MOL GENET, V7, P347, DOI 10.1093/hmg/7.3.347
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Elson JL, 2009, HUM MUTAT, V30, pE984, DOI 10.1002/humu.21113
   Fechter P, 1998, FEBS LETT, V436, P99, DOI 10.1016/S0014-5793(98)01096-5
   Florentz C, 2001, EMBO REP, V2, P481, DOI 10.1093/embo-reports/kve111
   Franceschina L, 1998, J NEUROL, V245, P755, DOI 10.1007/s004150050283
   Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1
   HAYASHI JI, 1994, J BIOL CHEM, V269, P19060
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010
   KAIDO M, 1995, J NEUROL SCI, V131, P170, DOI 10.1016/0022-510X(95)00111-E
   Kelley SO, 2001, J BIOL CHEM, V276, P10607, DOI 10.1074/jbc.M008320200
   Kleinle S, 1997, HUM GENET, V100, P643, DOI 10.1007/s004390050567
   Kleinle S, 1998, BIOCHEM BIOPH RES CO, V247, P112, DOI 10.1006/bbrc.1998.8729
   Levinger L, 2004, NUCLEIC ACIDS RES, V32, P5430, DOI 10.1093/nar/gkh884
   Levinger L, 2003, NUCLEIC ACIDS RES, V31, P1904, DOI 10.1093/nar/gkg282
   Levinger L, 2001, NUCLEIC ACIDS RES, V29, P4334, DOI 10.1093/nar/29.21.4334
   Liechti-Gallati S, 1999, EUR J HUM GENET, V7, P590, DOI 10.1038/sj.ejhg.5200338
   Limongelli A, 2004, J MED GENET, V41, P342, DOI 10.1136/jmg.2003.016048
   Maizels N, 1999, BIOL BULL, V196, P331, DOI 10.2307/1542963
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   MCKECHNIE NM, 1985, BRIT J OPHTHALMOL, V69, P63, DOI 10.1136/bjo.69.1.63
   Merante F, 1996, HUM MUTAT, V8, P216, DOI 10.1002/(SICI)1098-1004(1996)8:3<216::AID-HUMU4>3.0.CO;2-7
   Mierau GW, 2004, PEDIATR DEVEL PATHOL, V7, P637, DOI 10.1007/s10024-004-5048-z
   MITSUMOTO H, 1983, NEUROLOGY, V33, P452, DOI 10.1212/WNL.33.4.452
   MONTOYA J, 1981, NATURE, V290, P465, DOI 10.1038/290465a0
   OBAYASHI T, 1992, AM HEART J, V124, P1263, DOI 10.1016/0002-8703(92)90410-W
   OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0
   OZAWA T, 1991, BIOCHEM BIOPH RES CO, V177, P518, DOI 10.1016/0006-291X(91)92014-B
   OZAWA T, 1991, BIOCHEM BIOPH RES CO, V176, P938, DOI 10.1016/S0006-291X(05)80276-1
   Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487
   ROSSMANITH W, 1995, J BIOL CHEM, V270, P12885, DOI 10.1074/jbc.270.21.12885
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   SANTORELLI FM, 1995, BIOCHEM BIOPH RES CO, V216, P835, DOI 10.1006/bbrc.1995.2697
   SHEPHERD D, 1969, BIOCHEM J, V114, P597, DOI 10.1042/bj1140597
   SIHEM S, 2010, J NEUROL SCI, V300, P187
   Silvestri G, 1996, BIOCHEM BIOPH RES CO, V220, P623, DOI 10.1006/bbrc.1996.0453
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
   Suomalainen A, 1997, ANN MED, V29, P235, DOI 10.3109/07853899708999341
   TANAKA M, 1990, LANCET, V336, P1452, DOI 10.1016/0140-6736(90)93162-I
   TANIIKE M, 1992, BIOCHEM BIOPH RES CO, V186, P47, DOI 10.1016/S0006-291X(05)80773-9
   Taylor RW, 1998, BIOCHEM BIOPH RES CO, V243, P47, DOI 10.1006/bbrc.1997.8055
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Taylor RW, 2002, NEUROMUSCULAR DISORD, V12, P659, DOI 10.1016/S0960-8966(02)00026-3
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Valentino ML, 2002, ANN NEUROL, V51, P774, DOI 10.1002/ana.10193
   Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521
   Yan H, 2006, J BIOL CHEM, V281, P3926, DOI 10.1074/jbc.M509822200
   Zanssen S, 1997, MOL CELL BIOCHEM, V174, P231, DOI 10.1023/A:1006864709515
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 58
TC 15
Z9 16
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
J9 MITOCHONDRION
JI Mitochondrion
PD MAY
PY 2011
VL 11
IS 3
BP 488
EP 496
DI 10.1016/j.mito.2011.01.005
PG 9
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 753HS
UT WOS:000289763500015
PM 21292040
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Kolarova, H
   Liskova, P
   Tesarova, M
   Vidrova, VK
   Forgac, M
   Zamecnik, J
   Hansikova, H
   Honzik, T
AF Kolarova, Hana
   Liskova, Petra
   Tesarova, Marketa
   Vidrova, Vendula Kucerova
   Forgac, Martin
   Zamecnik, Josef
   Hansikova, Hana
   Honzik, Tomas
TI Unique presentation of LHON/MELAS overlap syndrome caused by
   m.13046T&gt;C in <i>MTND5</i>
SO OPHTHALMIC GENETICS
LA English
DT Article
DE LHON; loss of vision; MELAS; mitochondrial DNA; ND5; overlap syndrome
ID STROKE-LIKE EPISODES; MITOCHONDRIAL-DNA; LACTIC-ACIDOSIS; COMMON-CAUSE;
   ND5 GENE; MUTATION; DISEASE; ENCEPHALOPATHY; MYOPATHY; MELAS
AB Background: Leber hereditary optic neuropathy (LHON) and mitochondrial encephalopathy, myopathy, lactic acidosis and stroke-like episodes (MELAS) syndromes are mitochondrially inherited disorders characterized by acute visual failure and variable multiorgan system presentation, respectively.
   Materials and methods: A 12-year-old girl with otherwise unremarkable medical history presented with abrupt, painless loss of vision. Over the next few months, she developed moderate sensorineural hearing loss, vertigo, migraines, anhedonia and thyroiditis. Ocular examination confirmed bilateral optic nerve atrophy. Metabolic workup documented elevated cerebrospinal fluid lactate. Initial genetic analyses excluded the three most common LHON mutations. Subsequently, Sanger sequencing of the entire mitochondrial DNA (mtDNA) genome was performed.
   Results: Whole mtDNA sequencing revealed a pathogenic heteroplasmic mutation m.13046T>C in MTND5 encoding the ND5 subunit of complex I. This particular variant has previously been described in a single case report of MELAS/Leigh syndrome (subacute necrotizing encephalopathy). Based on the constellation of clinical symptoms in our patient, we diagnose the condition as LHON/MELAS overlap syndrome.
   Conclusions: We describe a unique presentation of LHON/MELAS overlap syndrome resulting from a m.13046T>C mutation in a 12-year-old girl. In patients with sudden vision loss in which three of the most prevalent LHON mitochondrial mutations have been ruled out, molecular genetic examination should be extended to other mtDNA-encoded subunits of MTND5 complex I. Furthermore, atypical clinical presentations must be considered, even in well-described phenotypes.
C1 [Kolarova, Hana; Tesarova, Marketa; Vidrova, Vendula Kucerova; Hansikova, Hana; Honzik, Tomas] Charles Univ Prague, Fac Med 1, Dept Pediat & Adolescent Med, Ke Karlovu 2, Prague 12808 2, Czech Republic.
   [Liskova, Petra] Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Lab Biol & Pathol Eye, Prague, Czech Republic.
   [Liskova, Petra] Charles Univ Prague, Fac Med 1, Dept Ophthalmol, Prague, Czech Republic.
   [Forgac, Martin] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic.
   [Forgac, Martin] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic.
   [Forgac, Martin] Gen Univ Hosp Prague, Ke Karlovu 2, Prague 12808 2, Czech Republic.
   [Zamecnik, Josef] Charles Univ Prague, Fac Med 2, Dept Pathol & Mol Med, Prague, Czech Republic.
   [Zamecnik, Josef] Univ Hosp Motol Prague, Prague, Czech Republic.
C3 Charles University Prague; Charles University Prague; Charles University
   Prague; Charles University Prague; Charles University Prague; General
   University Hospital Prague; Charles University Prague; Charles
   University Prague; Motol University Hospital; Motol University Hospital
RP Honzik, T (corresponding author), Charles Univ Prague, Fac Med 1, Dept Pediat & Adolescent Med, Ke Karlovu 2, Prague 12808 2, Czech Republic.; Honzik, T (corresponding author), Gen Univ Hosp Prague, Ke Karlovu 2, Prague 12808 2, Czech Republic.
EM tomas.honzik@vfn.cz
RI Hansikova, Hana/E-9350-2017; Kucerova Vidrova, Vendula/G-7161-2017;
   Honzik, Tomas/N-7509-2017; Tesarova, Marketa/I-1531-2016; Liskova,
   Petra/C-9680-2011
OI Kucerova Vidrova, Vendula/0000-0001-9046-1123; Honzik,
   Tomas/0000-0003-4300-2519; Tesarova, Marketa/0000-0002-5141-2289;
   Liskova, Petra/0000-0001-7834-8486
FU Charles University in Prague [PRVOUK P24/LF1/3, RVO-VFN 64165, SVV UK
   260148/2015];  [IGA NT 14156/3];  [IGA NT 13114/4];  [GAUK 38515/2015]
FX This work was supported by grants IGA NT 14156/3, IGA NT 13114/4, GAUK
   38515/2015 and by institutional research support by Charles University
   in Prague (PRVOUK P24/LF1/3, RVO-VFN 64165, SVV UK 260148/2015).
CR Bai YD, 2000, MOL CELL BIOL, V20, P805, DOI 10.1128/MCB.20.3.805-815.2000
   Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363
   Blok MJ, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.045716
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   CAVANAGH JB, 1994, BRAIN, V117, P1357, DOI 10.1093/brain/117.6.1357
   Crimi M, 2003, NEUROLOGY, V60, P1857, DOI 10.1212/01.WNL.0000066048.72780.69
   Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   Hofman P, 2011, INVEST OPHTHALMOL, V42, P895
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mayorov V, 2005, ANN NEUROL, V58, P807, DOI 10.1002/ana.20669
   NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160
   Pulkes T, 1999, ANN NEUROL, V46, P916, DOI 10.1002/1531-8249(199912)46:6<916::AID-ANA16>3.0.CO;2-R
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   WALLACE DC, 1970, BRAIN, V93, P121, DOI 10.1093/brain/93.1.121
   Zhao D, 2011, J HUM GENET, V56, P759, DOI 10.1038/jhg.2011.96
NR 16
TC 10
Z9 11
U1 0
U2 5
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1381-6810
EI 1744-5094
J9 OPHTHALMIC GENET
JI Ophthalmic Genet.
PY 2016
VL 37
IS 4
BP 419
EP 423
DI 10.3109/13816810.2015.1092045
PG 5
WC Genetics & Heredity; Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Ophthalmology
GA EC0HQ
UT WOS:000387780700011
PM 26894521
DA 2024-11-01
ER

PT J
AU Gomes, TMB
   Ng, YS
   Pickett, SJ
   Turnbull, DM
   Vincent, AE
AF Gomes, Tiago M. Bernardino
   Ng, Yi Shiau
   Pickett, Sarah J.
   Turnbull, Doug M.
   Vincent, Amy E.
TI Mitochondrial DNA disorders: from pathogenic variants to preventing
   transmission
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID CYTOCHROME-C-OXIDASE; PREIMPLANTATION GENETIC DIAGNOSIS; HEREDITARY
   OPTIC NEUROPATHY; MUSCLE-FIBER ANALYSIS; RAGGED-RED FIBERS; EXTERNAL
   OPHTHALMOPLEGIA; MYOCLONIC EPILEPSY; PEARSON-SYNDROME; MUTATION; DISEASE
AB Mitochondrial DNA (mtDNA) disorders are recognized as one of the most common causes of inherited metabolic disorders. The mitochondrial genome occurs in multiple copies resulting in both homoplasmic and heteroplasmic pathogenic mtDNA variants. A biochemical defect arises when the pathogenic variant level reaches a threshold, which differs between variants. Moreover, variants can segregate, clonally expand, or be lost from cellular populations resulting in a dynamic and tissue-specific mosaic pattern of oxidative deficiency. MtDNA is maternally inherited but transmission patterns of heteroplasmic pathogenic variants are complex. During oogenesis, a mitochondrial bottleneck results in offspring with widely differing variant levels to their mother, whilst highly deleterious variants, such as deletions, are not transmitted. Complemented by a complex interplay between mitochondrial and nuclear genomes, these peculiar genetics produce marked phenotypic variation, posing challenges to the diagnosis and clinical management of patients. Novel therapeutic compounds and several genetic therapies are currently under investigation, but proven disease-modifying therapies remain elusive. Women who carry pathogenic mtDNA variants require bespoke genetic counselling to determine their reproductive options. Recent advances in in vitro fertilization techniques, have greatly improved reproductive choices, but are not without their challenges. Since the first pathogenic mtDNA variants were identified over 30 years ago, there has been remarkable progress in our understanding of these diseases. However, many questions remain unanswered and future studies are required to investigate the mechanisms of disease progression and to identify new disease-specific therapeutic targets.
C1 [Gomes, Tiago M. Bernardino; Ng, Yi Shiau; Pickett, Sarah J.; Turnbull, Doug M.; Vincent, Amy E.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Gomes, Tiago M. Bernardino; Ng, Yi Shiau] Newcastle upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Serv Rare Mitochondrial Di, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation
   Trust
RP Turnbull, DM (corresponding author), Newcastle Univ, Wellcome Ctr Mitochondrial Res, Med Sch, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM doug.turnbull@newcastle.ac.uk
RI Ng, Yi/AFF-1445-2022; Gomes, Tiago/J-4598-2019; Vincent, Amy/J-7284-2019
OI Ng, Yi Shiau/0000-0002-7591-2034; Bernardino Gomes,
   Tiago/0000-0001-6520-5363
FU National Institute for Health Research [CL-2016-01-003]; Wellcome
   [204709/Z/16/Z, 215888/Z/19/Z, 203105/Z/16/Z]; United Kingdom National
   Institute for Health Research Biomedical Research Centre for Ageing and
   Age-Related Disease award; Lily Foundation; United Kingdom National
   Health Service; Newcastle University Centre for Ageing and Vitality;
   Biotechnology and Biological Sciences Research Council; Medical Research
   Council [G016354/1]; Wellcome Trust [203105/Z/16/Z, 204709/Z/16/Z,
   215888/Z/19/Z] Funding Source: Wellcome Trust
FX This work was supported by the National Institute for Health Research
   [CL-2016-01-003 to Y.S.N.]; Wellcome [204709/Z/16/Z to S.J.P.,
   215888/Z/19/Z to A.E.V., 203105/Z/16/Z]; and Newcastle University Centre
   for Ageing and Vitality, Biotechnology and Biological Sciences Research
   Council and Medical Research Council [G016354/1]. Additional support was
   also provided by the United Kingdom National Institute for Health
   Research Biomedical Research Centre for Ageing and Age-Related Disease
   award to the Newcastle upon Tyne Hospitals National Health Service
   Foundation Trust, by the Lily Foundation, and by the United Kingdom
   National Health Service Specialist Commissioners, which funds the Rare
   Mitochondrial Disorders of Adults and Children Diagnostic Service in
   Newcastle upon Tyne (http://www.newca stlemitochondria.com). For the
   purpose of Open Access, the authors has applied a CC BY public copyright
   licence to any Author Accepted Manuscript version arising from this
   submission.
CR Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Bredenoord AL, 2008, HUM REPROD UPDATE, V14, P83, DOI 10.1093/humupd/dmm037
   Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061
   Craven L, 2016, STEM CELLS, V34, P265, DOI 10.1002/stem.2221
   Craven L, 2011, HUM MOL GENET, V20, pR168, DOI 10.1093/hmg/ddr373
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013
   Feeney CL, 2019, BJOG-INT J OBSTET GY, V126, P1380, DOI 10.1111/1471-0528.15667
   Floros VI, 2018, NAT CELL BIOL, V20, P144, DOI 10.1038/s41556-017-0017-8
   Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Gorman GS, 2018, LANCET, V392, P1191, DOI 10.1016/S0140-6736(18)31868-3
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004369
   Jankauskaite E, 2020, J APPL GENET, V61, P195, DOI 10.1007/s13353-020-00550-y
   JOHNSON MA, 1983, J NEUROL SCI, V60, P31, DOI 10.1016/0022-510X(83)90125-9
   Kärppä M, 2005, BRAIN, V128, P1861, DOI 10.1093/brain/awh515
   Kawamura E, 2020, MOL THER-NUCL ACIDS, V20, P687, DOI 10.1016/j.omtn.2020.04.004
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Kraja AT, 2019, AM J HUM GENET, V104, P112, DOI 10.1016/j.ajhg.2018.12.001
   Langdahl JH, 2018, CLIN GENET, V93, P925, DOI 10.1111/cge.13201
   Lawless C, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200061
   Lee HF, 2007, EUR J PAEDIATR NEURO, V11, P208, DOI 10.1016/j.ejpn.2006.12.008
   Lim AZ, 2020, NEUROMUSCULAR DISORD, V30, P661, DOI 10.1016/j.nmd.2020.06.008
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Scholle LM, 2020, GENES-BASEL, V11, DOI 10.3390/genes11020212
   Muratovska A, 2001, NUCLEIC ACIDS RES, V29, P1852, DOI 10.1093/nar/29.9.1852
   Ng YS, 2019, ANN NEUROL, V86, P310, DOI 10.1002/ana.25525
   Otten ABC, 2018, HUM REPROD, V33, P1331, DOI 10.1093/humrep/dey114
   Ozawa M, 1998, J NEUROL SCI, V159, P170, DOI 10.1016/S0022-510X(98)00152-X
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   Pickett SJ, 2019, NEW ENGL J MED, V380, P1971, DOI 10.1056/NEJMc1808565
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Pisano A, 2015, HUM MOL GENET, V24, P6921, DOI 10.1093/hmg/ddv396
   Poincenot L, 2020, OPHTHALMOLOGY, V127, P679, DOI 10.1016/j.ophtha.2019.11.014
   Poulton J, 2019, NEUROMUSCULAR DISORD, V29, P725, DOI 10.1016/j.nmd.2019.08.004
   Puomila A, 2007, EUR J HUM GENET, V15, P1079, DOI 10.1038/sj.ejhg.5201828
   Rath S, 2021, NUCLEIC ACIDS RES, V49, pD1541, DOI 10.1093/nar/gkaa1011
   ROTIG A, 1989, LANCET, V1, P902
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   Salas A, 2020, FORENSIC SCI INT-GEN, V47, DOI 10.1016/j.fsigen.2020.102274
   Sallevelt SCEH, 2017, J MED GENET, V54, P114, DOI 10.1136/jmedgenet-2016-103876
   Sallevelt SCEH, 2013, J MED GENET, V50, P125, DOI 10.1136/jmedgenet-2012-101172
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   The Royal Society; National Academy of Sciences; National Academy of Medicine; International Commission on the Clinical Use of Human Germline Genome Editing, 2020, HER HUM GEN ED, DOI [10.17226/25665, DOI 10.17226/25665]
   TOKUNAGA M, 1994, ANN NEUROL, V35, P413, DOI 10.1002/ana.410350407
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wei W, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15336-3
   Wilson IJ, 2016, HUM MOL GENET, V25, P1031, DOI 10.1093/hmg/ddv626
   Yu-Wai-Man P, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz7423
   Zaidi AA, 2019, P NATL ACAD SCI USA, V116, P25172, DOI 10.1073/pnas.1906331116
   Zhang HX, 2018, ESSAYS BIOCHEM, V62, P225, DOI 10.1042/EBC20170096
   Zierz CM, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060789
NR 80
TC 15
Z9 16
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD OCT 15
PY 2021
VL 30
IS R2
BP R245
EP R253
DI 10.1093/hmg/ddab156
EA JUN 2021
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA WJ1JG
UT WOS:000708804800011
PM 34169319
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Burr, SP
   Chinnery, PF
AF Burr, Stephen P.
   Chinnery, Patrick F.
TI Measuring Single-Cell Mitochondrial DNA Copy Number and Heteroplasmy
   using Digital Droplet Polymerase Chain Reaction
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
ID PCR; DELETIONS; TRANSCRIPTION; MUTATION; MUSCLE
AB The mammalian mitochondrial (mt)DNA is a small, circular, double-stranded, intra-mitochondrial DNA molecule, encoding 13 subunits of the electron transport chain. Unlike the diploid nuclear genome, most cells contain many more copies of mtDNA, ranging from less than 100 to over 200,000 copies depending on cell type. MtDNA copy number is increasingly used as a biomarker for a number of age-related degenerative conditions and diseases, and thus, accurate measurement of the mtDNA copy number is becoming a key tool in both research and diagnostic settings. Mutations in the mtDNA, often occurring as single nucleotide polymorphisms (SNPs) or deletions, can either exist in all copies of the mtDNA within the cell (termed homoplasmy) or as a mixture of mutated and WT mtDNA copies (termed heteroplasmy). Heteroplasmic mtDNA mutations are a major cause of clinical mitochondrial pathology, either in rare diseases or in a growing number of common late-onset diseases such as Parkinson's disease. Determining the level of heteroplasmy present in cells is a critical step in the diagnosis of rare mitochondrial diseases and in research aimed at understanding common late-onset disorders where mitochondria may play a role. MtDNA copy number and heteroplasmy have traditionally been measured by quantitative (q)PCR-based assays or deep sequencing. However, the recent introduction of ddPCR technology has provided an alternative method for measuring both parameters. It offers several advantages over existing methods, including the ability to measure absolute mtDNA copy number and sufficient sensitivity to make accurate measurements from single cells even at low copy numbers. Presented here is a detailed protocol describing the measurement of mtDNA copy number in single cells using ddPCR, referred to as droplet generation PCR henceforth, with the option for simultaneous measurement of heteroplasmy in cells with mtDNA deletions. The possibility of expanding this method to measure heteroplasmy in cells with mtDNA SNPs is also discussed.
C1 [Burr, Stephen P.; Chinnery, Patrick F.] Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cambridge Biomed Campus, Cambridge, England.
   [Burr, Stephen P.; Chinnery, Patrick F.] Univ Cambridge, MRC, Mitochondria Biol Unit, Cambridge Biomed Campus, Cambridge, England.
C3 University of Cambridge; University of Cambridge
RP Burr, SP (corresponding author), Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cambridge Biomed Campus, Cambridge, England.; Burr, SP (corresponding author), Univ Cambridge, MRC, Mitochondria Biol Unit, Cambridge Biomed Campus, Cambridge, England.
EM spb54@cam.ac.uk
OI Burr, Stephen Peter/0000-0001-8865-126X
FU SPB at the Medical Research Council Mitochondrial Biology Unit,
   University of Cambridge [MC_UU_00015/9]; Wellcome Trust [212219/Z/18/Z];
   Wellcome Trust [212219/Z/18/Z] Funding Source: Wellcome Trust
FX Thank you to Dr. L Bozhilova for advice on the statistical analysis of
   droplet generation PCR data. Thank you to Dr. H Zhang for providing the
   oocytes used to generate data in Figure 3C and Figure 4B . This work was
   carried out by SPB at the Medical Research Council Mitochondrial Biology
   Unit (MC_UU_00015/9) , University of Cambridge, and funded by a Wellcome
   Trust Principal Research Fellowship held by PFC (212219/Z/18/Z) .
CR Belmonte FR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25186
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Cossarizza A, 2017, EUR J IMMUNOL, V47, P1584, DOI 10.1002/eji.201646632
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   D'Erchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85
   Filograna R, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav9824
   Herbst A, 2017, J GERONTOL A-BIOL, V72, P1327, DOI 10.1093/gerona/glx058
   Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633
   Kamitaki N, 2018, METHODS MOL BIOL, V1768, P401, DOI 10.1007/978-1-4939-7778-9_23
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Lee J, 2020, EXP MOL MED, V52, P1428, DOI 10.1038/s12276-020-0420-2
   Li ZD, 2021, BIOSENS BIOELECTRON, V177, DOI 10.1016/j.bios.2020.112952
   Lin XY, 2019, ACS SENSORS, V4, P242, DOI 10.1021/acssensors.8b01419
   Liu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067146
   Lowes H, 2019, MITOCHONDRION, V46, P307, DOI 10.1016/j.mito.2018.07.008
   Ludwig LS, 2019, CELL, V176, P1325, DOI 10.1016/j.cell.2019.01.022
   Macaulay IC, 2016, NAT PROTOC, V11, P36, DOI 10.1038/nprot.2016.138
   Maeda R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67686-z
   Nissanka N, 2019, TRENDS GENET, V35, P235, DOI 10.1016/j.tig.2019.01.001
   O'Hara R, 2019, GENOME RES, V29, P1878, DOI 10.1101/gr.250480.119
   Perier C, 2013, BRAIN, V136, P2369, DOI 10.1093/brain/awt196
   Quan PL, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18041271
   Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Taylor SC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02217-x
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   Wang Y, 2005, GYNECOL ONCOL, V98, P104, DOI 10.1016/j.ygyno.2005.04.015
NR 32
TC 9
Z9 9
U1 4
U2 6
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD JUL
PY 2022
IS 185
AR e63870
DI 10.3791/63870
PG 21
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 3Q4YP
UT WOS:000838239000027
PM 35913155
DA 2024-11-01
ER

PT J
AU Bruno, C
   Cassandrini, D
   Fattori, F
   Pedemonte, M
   Fiorillo, C
   Brigati, G
   Brisca, G
   Minetti, C
   Santorelli, FM
AF Bruno, Claudio
   Cassandrini, Denise
   Fattori, Fabiana
   Pedemonte, Marina
   Fiorillo, Chiara
   Brigati, Giorgia
   Brisca, Giacomo
   Minetti, Carlo
   Santorelli, Filippo M.
TI Mitochondrial myopathy in a child with a muscle-restricted mutation in
   the mitochondrial transfer RNA<SUP>Asn</SUP> gene
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Mitochondrial myopathy; mt-tRNA gene; Exercise intolerance
ID TRANSFER-RNA MUTATIONS; TRNA(ASN) GENE; DNA MUTATIONS; DISEASE;
   OPHTHALMOPLEGIA; DISORDERS; SEQUENCE
AB We report an 11-year-old boy with exercise-related myopathy, and a novel mutation m.5669G>A in the mitochondrial tRNA Asparagine gene (mt-tRNA(Asn), MTTN). Muscle biopsy studies showed COX-negative, SDH-positive fibers at histochemistry and biochemical defects of oxidative metabolism. The m.5669G>A mutation was present only in patient's muscle resulting in the first muscle-specific MTTN mutation. Mt-tRNA(Asn) steady-state levels and in silico predictions supported the pathogenicity of this mutation. A mitochondrial myopathy should be considered in the differential diagnosis of exercise intolerance in children. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Bruno, Claudio; Pedemonte, Marina; Brigati, Giorgia; Brisca, Giacomo; Minetti, Carlo] IRCCS Giannina Gaslini Inst, Lab Muscle Pathol, Unit Muscular & Neurodegenerat Dis, I-16147 Genoa, Italy.
   [Cassandrini, Denise; Fiorillo, Chiara; Santorelli, Filippo M.] IRCCS Stella Maris, Mol Med Unit, Pisa, Italy.
   [Fattori, Fabiana] IRCCS Bambino Gesu Hosp, Unit Mol Med Neuromuscular & Neurodegenerat Disor, Rome, Italy.
C3 University of Genoa; IRCCS Istituto Giannina Gaslini; IRCCS Fondazione
   Stella Maris; IRCCS Bambino Gesu
RP Bruno, C (corresponding author), IRCCS Giannina Gaslini Inst, Lab Muscle Pathol, Unit Muscular & Neurodegenerat Dis, Largo G Gaslini 5, I-16147 Genoa, Italy.
EM claudiobruno@ospedale-gaslini.ge.it
RI Brigati, Giorgia/AAB-1408-2020; Bruno, Claudio/A-3148-2015; Santorelli,
   Filippo M/ABE-5124-2020; cassandrini, denise/J-7783-2016; Fattori,
   Fabiana/K-1033-2016; Brisca, Giacomo/K-8928-2016; MINETTI,
   Carlo/K-4666-2018; Fiorillo, Chiara/AAB-4142-2021
OI Santorelli, Filippo M/0000-0002-1359-9062; cassandrini,
   denise/0000-0002-3556-8638; Fattori, Fabiana/0000-0002-1820-8489;
   Pedemonte, Marina/0000-0001-8410-6918; Brisca,
   Giacomo/0000-0001-7992-0181; MINETTI, Carlo/0000-0002-0640-1804;
   Fiorillo, Chiara/0000-0001-9027-343X; Brigati,
   Giorgia/0000-0002-8040-5950
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Coulbault L, 2005, BIOCHEM BIOPH RES CO, V329, P1152, DOI 10.1016/j.bbrc.2005.02.083
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2001, ANN MED, V33, P472, DOI 10.3109/07853890109002096
   Dubowitz V., 2007, Muscle Biopsy: A Practical Approach
   Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   Meulemans A, 2006, ARCH NEUROL-CHICAGO, V63, P1194, DOI 10.1001/archneur.63.8.1194
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   MUNSCHER C, 1993, BIOL CHEM H-S, V374, P1099, DOI 10.1515/bchm3.1993.374.7-12.1099
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917
   SEIBEL P, 1994, BIOCHEM BIOPH RES CO, V204, P482, DOI 10.1006/bbrc.1994.2485
   Spinazzola A, 2004, NEUROMUSCULAR DISORD, V14, P815, DOI 10.1016/j.nmd.2004.09.002
   Sternberg D, 1998, HUM MOL GENET, V7, P33, DOI 10.1093/hmg/7.1.33
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Tuppen HAL, 2008, J MED GENET, V45, P55, DOI 10.1136/jmg.2007.051185
   Vives-Bauza C, 2003, J INHERIT METAB DIS, V26, P507, DOI 10.1023/A:1025133629685
   Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807
   Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548
NR 20
TC 6
Z9 6
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD SEP 9
PY 2011
VL 412
IS 4
BP 518
EP 521
DI 10.1016/j.bbrc.2011.06.155
PG 4
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 823TD
UT WOS:000295148500002
PM 21741368
DA 2024-11-01
ER

PT J
AU Milone, M
   Wang, J
   Liewluck, T
   Chen, LC
   Leavitt, JA
   Wong, LJ
AF Milone, Margherita
   Wang, Jing
   Liewluck, Teerin
   Chen, Li-Chieh
   Leavitt, Jacqueline A.
   Wong, Lee-Jun
TI Novel <i>POLG</i> Splice Site Mutation and Optic Atrophy
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID MOLECULAR DIAGNOSIS; POLYMERASE-GAMMA; OPA1 MUTATIONS; MITOCHONDRIAL;
   DISEASE
AB Objective: To investigate the molecular etiology of 2 unrelated patients with a multisystem mitochondrial disorder accompanied by optic atrophy in one of them.
   Design: Clinical examination and neurophysiological, radiological, morphological, and molecular analyses.
   Setting: Tertiary care neuromuscular clinic and molecular genetics laboratory.
   Patients: A 65-year-old man (patient 1) with dyschromatopsia and vision loss since childhood developed progressive external ophthalmoplegia, ptosis, and myopathy in the seventh decade of life and was found to have optic atrophy. A 63-year-old man (patient 2) with a similar phenotype, without visual symptoms, experienced also hearing loss and parkinsonism.
   Main Outcome Measures: Description of the clinical and molecular findings.
   Results: A muscle biopsy specimen showed ragged-red, ragged-blue, and cytochrome c oxidase-negative fibers in both patients. Because optic atrophy in patient 1 suggested an autosomal dominant OPA1-related disorder, the OPA1 gene was first sequenced, the results of which did not detect any mutations. Southern blot and polymerase chain reaction analyses of muscle mitochondrial DNA revealed multiple deletions. Sequencing of POLG detected a novel variant, c.3104 + 3A>T, in both patients. Patient 1 was compound heterozygous for a known p. F749S mutation; patient 2 had p.G848S as the second mutation. Analysis of POLG complementary DNA showed that c.3104 + 3A>T results in skipping of exon 18.
   Conclusion: Early-onset dyschromatopsia and optic atrophy can occur not only in OPA1-related but also in POLG-related disorders with significant impact on genetic counseling.
C1 [Milone, Margherita; Liewluck, Teerin] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.
   [Leavitt, Jacqueline A.] Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA.
   [Wang, Jing; Chen, Li-Chieh; Wong, Lee-Jun] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
C3 Mayo Clinic; Mayo Clinic; Baylor College of Medicine
RP Milone, M (corresponding author), Mayo Clin, Dept Neurol, 200 1st St SW, Rochester, MN 55905 USA.
EM Milone.Margherita@mayo.edu
OI Liewluck, Teerin/0000-0002-0212-5697
FU National Institutes of Health/National Center for Research Resources
   [UL1 RR024150]
FX This article was supported by grant UL1 RR024150 from the National
   Institutes of Health/National Center for Research Resources Clinical and
   Translational Science Awards (Dr Milone).
CR Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   [Anonymous], 2010, GENEREVIEWS
   Chinault AC, 2009, GENET MED, V11, P518, DOI 10.1097/GIM.0b013e3181abd83c
   Echaniz-Laguna A, 2010, ARCH NEUROL-CHICAGO, V67, P1140, DOI 10.1001/archneurol.2010.219
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Milone M, 2009, MITOCHONDRION, V9, P279, DOI 10.1016/j.mito.2009.03.001
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
NR 11
TC 23
Z9 24
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60654-0946 USA
SN 0003-9942
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD JUN
PY 2011
VL 68
IS 6
BP 806
EP 811
PG 6
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 776ON
UT WOS:000291546100019
PM 21670405
OA Bronze
DA 2024-11-01
ER

PT J
AU Wong, LJC
AF Wong, Lee-Jun C.
TI Pathogenic mitochondrial DNA mutations in protein-coding genes
SO MUSCLE & NERVE
LA English
DT Review
DE mitochondrial mRNA mutations; mtDNA mutations; mtDNA mutations; in
   protein coding regions; pathogenic mtDNA mutations
ID CYTOCHROME-C-OXIDASE; HEREDITARY OPTIC NEUROPATHY; COMPLEX-III
   DEFICIENCY; STOP-CODON MUTATION; LHON/MELAS OVERLAP SYNDROME; MISSENSE
   MUTATION; NONSENSE MUTATION; LEIGH-SYNDROME; B GENE; SUBUNIT-III
AB More than 200 disease-related mitochondrial DNA (mtDNA) point mutations have been reported in the Mitomap (http://www.mitomap. org) database. These mutations can be divided into two groups: mutations affecting mitochondrial protein synthesis, including mutations in tRNA and rRNA genes; and mutations in protein-encoding genes (mRNAs). This review focuses on mutations in mitochondrial genes that encode proteins. These mutations are involved in a broad spectrum of human diseases, including a variety of multisystem disorders as well as more tissue-specific diseases such as isolated myopathy and Leber hereditary optic neuropathy (LHON). Because the mitochondrial genome contains a large number of apparently neutral polymorphisms that have little pathogenic significance, along with secondary homoplasmic mutations that do not have primary disease-causing effect, the pathogenic role of all newly discovered mutations must be rigorously established. A scoring system has been applied to evaluate the pathogenicity of the mutations in mtDNA protein-encoding genes and to review the predominant clinical features and the molecular characteristics of mutations in each mtDNA-encoded respiratory chain complex.
C1 Baylor Coll Med, Dept Human Mol Genet, Houston, TX 77030 USA.
C3 Baylor College of Medicine
RP Wong, LJC (corresponding author), Baylor Coll Med, Dept Human Mol Genet, 1 Baylor Pl,NAB2015, Houston, TX 77030 USA.
EM ljwong@bcm.edu
CR Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P4211, DOI 10.1167/iovs.06-0295
   Abu-Amero Khaled K, 2005, Ophthalmic Genet, V26, P31, DOI 10.1080/13816810590918235
   Andreu AL, 1999, MOL GENET METAB, V67, P49, DOI 10.1006/mgme.1999.2843
   Andreu AL, 2000, PEDIATR RES, V48, P311, DOI 10.1203/00006450-200009000-00008
   Andreu AL, 1999, ANN NEUROL, V45, P820, DOI 10.1002/1531-8249(199906)45:6<820::AID-ANA22>3.0.CO;2-W
   Andreu AL, 1998, NEUROLOGY, V51, P1444, DOI 10.1212/WNL.51.5.1444
   Andreu AL, 1999, ANN NEUROL, V45, P127, DOI 10.1002/1531-8249(199901)45:1<127::AID-ART20>3.0.CO;2-Y
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Blakely EL, 2005, FEBS J, V272, P3583, DOI 10.1111/j.1742-4658.2005.04779.x
   Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363
   Bouzidi MF, 1996, BBA-MOL BASIS DIS, V1317, P199, DOI 10.1016/S0925-4439(96)00055-5
   Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P
   Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8
   BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Campos Y, 2001, ANN NEUROL, V50, P409, DOI 10.1002/ana.1141
   CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033
   Carrozzo R, 2000, FEBS LETT, V486, P297, DOI 10.1016/S0014-5793(00)02244-4
   Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Clark KM, 1999, AM J HUM GENET, V64, P1330, DOI 10.1086/302361
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T
   Crimi M, 2003, NEUROLOGY, V60, P1857, DOI 10.1212/01.WNL.0000066048.72780.69
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   DEMEIRLEIR L, 1995, PEDIATR NEUROL, V13, P242, DOI 10.1016/0887-8994(95)00184-H
   Deschauer M, 2003, NEUROLOGY, V60, P1357, DOI 10.1212/01.WNL.0000055869.99975.4B
   DeVries DD, 1996, AM J HUM GENET, V58, P703
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 1998, NAT GENET, V19, P214, DOI 10.1038/883
   Dionisi-Vici C, 1998, J INHERIT METAB DIS, V21, P2, DOI 10.1023/A:1005397227996
   Dumoulin R, 1996, MOL CELL PROBE, V10, P389, DOI 10.1006/mcpr.1996.0053
   Enns GM, 2006, MOL GENET METAB, V88, P364, DOI 10.1016/j.ymgme.2006.02.001
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2003, ANN NEUROL, V54, P524, DOI 10.1002/ana.10709
   Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972
   Gropman A, 2004, AM J MED GENET A, V124A, P377, DOI 10.1002/ajmg.a.20456
   HALTIA T, 1991, EMBO J, V10, P2015, DOI 10.1002/j.1460-2075.1991.tb07731.x
   HALTIA T, 1989, EMBO J, V8, P3571, DOI 10.1002/j.1460-2075.1989.tb08529.x
   Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910
   Horváth R, 2005, NEUROMUSCULAR DISORD, V15, P851, DOI 10.1016/j.nmd.2005.09.005
   Horváth R, 2002, J MED GENET, V39, P812, DOI 10.1136/jmg.39.11.812
   IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0
   JOHNS DR, 1994, J NEURO-OPHTHALMOL, V14, P135
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Karadimas CL, 2000, NEUROLOGY, V55, P644, DOI 10.1212/WNL.55.5.644
   Keightley JA, 2000, AM J HUM GENET, V67, P1400, DOI 10.1086/316900
   Keightley JA, 1996, NAT GENET, V12, P410, DOI 10.1038/ng0496-410
   Kim JY, 2002, ANN NEUROL, V51, P630, DOI 10.1002/ana.10177
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kollberg G, 2005, J NEUROPATH EXP NEUR, V64, P123, DOI 10.1093/jnen/64.2.123
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Legros F, 2001, EUR J HUM GENET, V9, P510, DOI 10.1038/sj.ejhg.5200678
   LeoKottler B, 1996, GER J OPHTHALMOL, V5, P233
   Li XM, 2005, BIOCHEM BIOPH RES CO, V328, P491, DOI 10.1016/j.bbrc.2005.01.006
   Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   Luberichs J, 2002, GRAEF ARCH CLIN EXP, V240, P96, DOI 10.1007/s00417-001-0423-1
   Makino M, 1998, NEUROMUSCULAR DISORD, V8, P149, DOI 10.1016/S0960-8966(98)00017-0
   Mancuso M, 2003, J NEUROL SCI, V209, P61, DOI 10.1016/S0022-510X(02)00462-8
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O
   Matsumoto M, 1999, Ophthalmic Genet, V20, P153, DOI 10.1076/opge.20.3.153.2281
   Mayorov V, 2005, ANN NEUROL, V58, P807, DOI 10.1002/ana.20669
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   Moslemi AR, 2005, NEUROPEDIATRICS, V36, P314, DOI 10.1055/s-2005-872845
   Munakata K, 2004, GENOMICS, V84, P1041, DOI 10.1016/j.ygeno.2004.08.015
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   NEWMAN NJ, 1994, AM J OPHTHALMOL, V118, P158, DOI 10.1016/S0002-9394(14)72895-8
   Opdal SH, 2002, PEDIATR NEUROL, V27, P23, DOI 10.1016/S0887-8994(02)00384-3
   Pandya A, 1999, AM J HUM GENET, V65, P1803, DOI 10.1086/302658
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Penisson-Besnier I, 2000, NEUROLOGY, V55, P317, DOI 10.1212/WNL.55.2.317
   Péquignot MO, 2001, HUM MUTAT, V17, P374, DOI 10.1002/humu.1112.abs
   PROCHASKA LJ, 1987, J BIOENERG BIOMEMBR, V19, P143, DOI 10.1007/BF00762722
   Pulkes T, 1999, ANN NEUROL, V46, P916, DOI 10.1002/1531-8249(199912)46:6<916::AID-ANA16>3.0.CO;2-R
   Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590
   Rani DS, 2006, FERTIL STERIL, V86, P1783, DOI 10.1016/j.fertnstert.2006.04.044
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   Rocha H, 1999, AM J HUM GENET, V65, P1457, DOI 10.1086/302641
   Rubio-Gozalbo ME, 2000, HUM MUTAT, V15, P522, DOI 10.1002/1098-1004(200006)15:6<522::AID-HUMU4>3.0.CO;2-Y
   Ruiter EM, 2007, EUR J HUM GENET, V15, P155, DOI 10.1038/sj.ejhg.5201735
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Schagger H, 1995, METHOD ENZYMOL, V260, P82, DOI 10.1016/0076-6879(95)60132-5
   Schnopp NM, 1996, CLIN NEUROPATHOL, V15, P348
   Schuelke M, 2002, ANN NEUROL, V51, P388, DOI 10.1002/ana.10151
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   SHOFFNER JM, 2001, METABOLIC MOL BASES, V2, P2367
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Simon DK, 2003, NEUROGENETICS, V4, P199, DOI 10.1007/s10048-003-0150-3
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Sudo A, 2004, J HUM GENET, V49, P92, DOI 10.1007/s10038-003-0116-1
   Sue CM, 1999, J PEDIATR-US, V134, P696, DOI 10.1016/S0022-3476(99)70283-0
   Tarnopolsky MA, 2004, MUSCLE NERVE, V29, P537, DOI 10.1002/mus.20020
   Tarnopolsky MA, 2004, AM J MED GENET A, V124A, P372, DOI 10.1002/ajmg.a.20449
   Temperley RJ, 2003, HUM MOL GENET, V12, P2341, DOI 10.1093/hmg/ddg238
   Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733
   Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136
   Ugalde C, 2007, MOL GENET METAB, V90, P10, DOI 10.1016/j.ymgme.2006.08.003
   Uusimaa J, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e262
   Valentino ML, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037507
   Valentino ML, 2004, ANN NEUROL, V56, P631, DOI 10.1002/ana.20236
   Valentino ML, 2002, ANN NEUROL, V51, P774, DOI 10.1002/ana.10193
   Valnot I, 1999, HUM GENET, V104, P460, DOI 10.1007/s004390050988
   Varlamov DA, 2002, HUM MOL GENET, V11, P1797, DOI 10.1093/hmg/11.16.1797
   Wallace D.C., 2001, The Metabolic and Molecular Basis of Inherited Disease, P2425
   WALLACE DC, 2006, MITOMAP HUMAN MITOCH
   Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224
   Wong LJC, 2001, AM J MED GENET, V102, P95, DOI 10.1002/1096-8628(20010722)102:1<95::AID-AJMG1412>3.0.CO;2-U
   Yan H, 2006, J BIOL CHEM, V281, P3926, DOI 10.1074/jbc.M509822200
   Yuan HJ, 2005, AM J MED GENET A, V138A, P133, DOI 10.1002/ajmg.a.30952
   Zhou XT, 2006, BIOCHEM BIOPH RES CO, V340, P69, DOI 10.1016/j.bbrc.2005.11.150
NR 117
TC 89
Z9 100
U1 0
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 1097-4598
J9 MUSCLE NERVE
JI Muscle Nerve
PD SEP
PY 2007
VL 36
IS 3
BP 279
EP 293
DI 10.1002/mus.20807
PG 15
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 202IO
UT WOS:000248895400001
PM 17503499
DA 2024-11-01
ER

PT J
AU Sarzi, E
   Goffart, S
   Serre, V
   Chrétein, D
   Slama, A
   Munnich, A
   Spelbrink, JN
   Rötig, A
AF Sarzi, Emmanuelle
   Goffart, Steffi
   Serre, Valerie
   Chretein, Dominique
   Slama, Abdethamid
   Munnich, Arnold
   Spelbrink, Johannes N.
   Roetig, Agnes
TI Twinkle helicase (<i>PEO1</i>) gene mutation causes mitochondrial DNA
   depletion
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MTDNA MAINTENANCE; SWISS-MODEL;
   PROTEIN; DELETIONS; POLG; REPLICATION; DEFICIENCY; KINASE
AB Objective: Mitochondrial DNA (mtDNA) depletion syndrome (MDS) is a clinically and genetically heterogeneous group of autosomal recessive diseases characterized by a reduction in mtDNA copy number. Several nuclear genes have been shown to account for these severe oxidative phosphorylation disorders, but the disease-causing mutations remain largely unknown.
   Methods: By virtue of homozygosity mapping, we tested candidate genes involved in mtDNA maintenance in patients born to consanguineous parents.
   Results: We found homozygosity for microsatellite markers flanking the PEO1 gene, encoding the mitochondrial Twinkle helicase, in two sibs presenting a hepatocerebral form of MDS. Sequencing the PEO1 gene showed a homozygous mutation at a conserved position of the protein in the two patients (T457I). The modeling of the Twinkle protein showed that T457 is located in the interface between two monomers of the hexameric enzyme. Finally, using purified recombinant protein, we demonstrated that the T457I mutant Twinkle has a defective helicase activity.
   Interpretation: Although dominant Twinkle mutations have been previously reported in patients with autosomal dominant progressive external ophthalmoplegia and multiple mtDNA deletions, we report here the first recessive Twinkle mutation in patients with hepatocerebral form of MDS. Identifying other Twinkle mutations in MDS and/or autosomal dominant progressive external ophthalmoplegia and studying their impact on the isolated proteins should help in understanding why some mutations are recessive and others are dominant.
C1 [Sarzi, Emmanuelle; Serre, Valerie; Chretein, Dominique; Munnich, Arnold; Roetig, Agnes] Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France.
   [Sarzi, Emmanuelle; Serre, Valerie; Chretein, Dominique; Munnich, Arnold; Roetig, Agnes] Hop Necker Enfants Malad, Serv Genet, F-75015 Paris, France.
   [Goffart, Steffi; Spelbrink, Johannes N.] Tampere Univ Hosp, Tampere, Finland.
   [Goffart, Steffi; Spelbrink, Johannes N.] Inst Med Technol, Tampere, Finland.
   [Slama, Abdethamid] Hop Kremlin Bicetre, Biochim Lab, Le Kremlin Bicetre, France.
C3 Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Necker-Enfants Malades - APHP; Institut National
   de la Sante et de la Recherche Medicale (Inserm); Assistance Publique
   Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire
   Necker-Enfants Malades - APHP; Tampere University; Tampere University
   Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Bicetre - APHP; Universite Paris Saclay
RP Rötig, A (corresponding author), Hop Necker Enfants Malad, INSERM, U781, 149 Rue Sevres, F-75015 Paris, France.
EM roetig@necker.fr
RI Goffart, Steffi/N-3597-2015; Spelbrink, Johannes/L-4661-2015; ROTIG,
   AGNES/G-9592-2017
OI Dominique, Chretien/0000-0002-9954-1549; Spelbrink,
   Johannes/0000-0002-9756-2602; Sarzi, Emmanuelle/0000-0002-7623-6699;
   ROTIG, AGNES/0000-0003-0589-0703
CR Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027
   Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Liao JC, 2005, J MOL BIOL, V350, P452, DOI 10.1016/j.jmb.2005.04.051
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Ziegelin G, 2003, NUCLEIC ACIDS RES, V31, P5917, DOI 10.1093/nar/gkg790
NR 27
TC 129
Z9 143
U1 0
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD DEC
PY 2007
VL 62
IS 6
BP 579
EP 587
DI 10.1002/ana.21207
PG 9
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 248AM
UT WOS:000252123700007
PM 17722119
DA 2024-11-01
ER

PT J
AU Kornblum, C
   Nicholls, TJ
   Haack, TB
   Schöler, S
   Peeva, V
   Danhauser, K
   Hallmann, K
   Zsurka, G
   Rorbach, J
   Iuso, A
   Wieland, T
   Sciacco, M
   Ronchi, D
   Comi, GP
   Moggio, M
   Quinzii, CM
   DiMauro, S
   Calvo, SE
   Mootha, VK
   Klopstock, T
   Strom, TM
   Meitinger, T
   Minczuk, M
   Kunz, WS
   Prokisch, H
AF Kornblum, Cornelia
   Nicholls, Thomas J.
   Haack, Tobias B.
   Schoeler, Susanne
   Peeva, Viktoriya
   Danhauser, Katharina
   Hallmann, Kerstin
   Zsurka, Gabor
   Rorbach, Joanna
   Iuso, Arcangela
   Wieland, Thomas
   Sciacco, Monica
   Ronchi, Dario
   Comi, Giacomo P.
   Moggio, Maurizio
   Quinzii, Catarina M.
   DiMauro, Salvatore
   Calvo, Sarah E.
   Mootha, Vamsi K.
   Klopstock, Thomas
   Strom, Tim M.
   Meitinger, Thomas
   Minczuk, Michal
   Kunz, Wolfram S.
   Prokisch, Holger
TI Loss-of-function mutations in <i>MGME1</i> impair mtDNA replication and
   cause multisystemic mitochondrial disease
SO NATURE GENETICS
LA English
DT Article
ID HUMAN DNA2; DEFICIENCY; DEPLETION; PROTEIN; GENE; POLG; TWINKLE; KINASE;
   REPAIR
AB Known disease mechanisms in mitochondria! DNA (mtDNA) maintenance disorders alter either the mitochondrial replication machinery (POLG, POLG2 and C10orf2)(1-3) or the biosynthesis pathways of deoxyribonucleoside 5'-triphosphates for mtDNA synthesis(4-11). However, in many of these disorders, the underlying genetic defect has yet to be discovered. Here, we identify homozygous nonsense and missense mutations in the orphan gene C20orf72 in three families with a mitochondrial syndrome characterized by external ophthalmoplegia, emaciation and respiratory failure. Muscle biopsies showed mtDNA depletion and multiple mtDNA deletions. C20orf72, hereafter MGME1 (mitochondrial genome maintenance exonuclease 1), encodes a mitochondria! RecB-type exonuclease belonging to the PD-(D/E)XK nuclease superfamily. We show that MGME1 cleaves single-stranded DNA and processes DNA flap substrates. Fibroblasts from affected individuals do not repopulate after chemically induced mtDNA depletion. They also accumulate intermediates of stalled replication and show increased levels of 7S DNA, as do MGME1-depleted cells. Thus, we show that MGME1-mediated mtDNA processing is essential for mitochondrial genome maintenance.
C1 [Kornblum, Cornelia] Univ Bonn, Dept Neurol, Med Ctr, Bonn, Germany.
   [Nicholls, Thomas J.; Rorbach, Joanna; Minczuk, Michal] MRC, Mitochondrial Biol Unit, Cambridge, England.
   [Haack, Tobias B.; Danhauser, Katharina; Iuso, Arcangela; Wieland, Thomas; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany.
   [Haack, Tobias B.; Danhauser, Katharina; Iuso, Arcangela; Wieland, Thomas; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Munich, Germany.
   [Schoeler, Susanne; Peeva, Viktoriya; Hallmann, Kerstin; Zsurka, Gabor; Kunz, Wolfram S.] Univ Bonn, Med Ctr, Dept Epileptol, Bonn, Germany.
   [Schoeler, Susanne; Peeva, Viktoriya; Hallmann, Kerstin; Zsurka, Gabor; Kunz, Wolfram S.] Univ Bonn, Med Ctr, Life & Brain Ctr, Bonn, Germany.
   [Sciacco, Monica; Moggio, Maurizio] Univ Milan, Fdn Ist Ricovero & Cura Carattere Sci IRCCS Ca Gr, Neuromuscular Unit, Osped Maggiore Policlin,Ctr Dino Ferrari, Milan, Italy.
   [Ronchi, Dario; Comi, Giacomo P.] Univ Milan, Fdn IRCCS Ca Granda, Neurol Unit, Osped Maggiore Policlin,Ctr Dino Ferrari, Milan, Italy.
   [Quinzii, Catarina M.; DiMauro, Salvatore] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA.
   [Calvo, Sarah E.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol & Med, Boston, MA 02114 USA.
   [Calvo, Sarah E.; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA.
   [Calvo, Sarah E.; Mootha, Vamsi K.] Broad Inst, Cambridge, MA USA.
   [Klopstock, Thomas] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80539 Munich, Germany.
C3 University of Bonn; Technical University of Munich; Helmholtz
   Association; Helmholtz-Center Munich - German Research Center for
   Environmental Health; University of Bonn; University of Bonn; University
   of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of
   Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Columbia
   University; Harvard University; Massachusetts General Hospital; Harvard
   University; Harvard Medical School; Harvard University; Massachusetts
   Institute of Technology (MIT); Broad Institute; University of Munich
RP Minczuk, M (corresponding author), MRC, Mitochondrial Biol Unit, Cambridge, England.
EM michal.minczuk@mrc-mbu.cam.ac.uk; wolfram.kunz@ukb.uni-bonn.de
RI Prokisch, Holger/N-8964-2013; Iuso, Arcangela/KQU-6746-2024; Ronchi,
   Dario/K-8011-2016; Wieland, Thomas/ACE-6378-2022; Sciacco,
   Monica/AAC-6500-2022; rorbach, Joanna/AAM-5683-2021; Haack,
   Tobias/JLM-8099-2023; Comi, Giacomo/K-5702-2016; Meitinger,
   Thomas/O-1318-2015; Kornblum, Cornelia/IUM-4180-2023; Minczuk,
   Michal/G-1638-2014; Kunz, Wolfram/K-1232-2019
OI Comi, Giacomo/0000-0002-1383-5248; Zsurka, Gabor/0000-0002-6379-849X;
   Minczuk, Michal/0000-0001-8242-1420; Prokisch,
   Holger/0000-0003-2379-6286; Sciacco, Monica/0000-0003-4593-4977;
   Rorbach, Joanna/0000-0002-2891-2840; Ronchi, Dario/0000-0002-6093-9816;
   Meitinger, Thomas/0000-0002-8838-8403; Nicholls,
   Thomas/0000-0002-3034-4109; Kunz, Wolfram/0000-0003-1113-3493
FU Medical Research Council UK; German Bundesministerium fur Bildung und
   Forschung (BMBF) [SysMBo 0315494A]; E-Rare project GENOMIT [01GM1207];
   German Network for mitochondrial disorders (mitoNET) [mitoNET 01GM0862,
   01GM1113A, mitoNET 01GM0867, 01GM1113C, mitoNET 01GM0868]; Deutsche
   Forschungsgemeinschaft [SFB TR3 All, D12]; US National Institutes of
   Health [GM077465, GM097136]; Associazione Amici del Centro Dino Ferrari;
   University of Milan; Telethon project [GTB07001ER]; Eurobiobank project
   [QLTR-2001-02769]; Criobanca Automatizzata di Materiale Biologico
   [R.F.02.187]; MRC [MC_U105697135] Funding Source: UKRI
FX T.J.N. and M. Minczuk are grateful to S. Wood and I. Holt for
   stimulating discussions during the course of this work We are grateful
   to S. Beyer, K. Kappes-Horn, M. Stepien-Mering, E. Botz and R. Hellinger
   for technical assistance. We thank R. Wiesner (University of Cologne)
   for providing the TFAM antibody. This work was supported by the Medical
   Research Council UK (T.J.N., J.R. and M. Minczuk) and the German
   Bundesministerium fur Bildung und Forschung (BMBF) through funding of
   the Systems Biology of Metabotypes grant (SysMBo 0315494A), the E-Rare
   project GENOMIT (01GM1207) and the German Network for mitochondrial
   disorders (mitoNET), including C.K., T.K. (mitoNET 01GM0862 and
   01GM1113A), T.M., H.P. (mitoNET 01GM0867 and 01GM1113C) and W.S.K.
   (mitoNET 01GM0868). W.S.K. was funded by the Deutsche
   Forschungsgemeinschaft (SFB TR3 All and D12). V.K.M. was supported by
   grants from the US National Institutes of Health (GM077465 and
   GM097136). The financial support of Associazione Amici del Centro Dino
   Ferrari, University of Milan, the Telethon project GTB07001ER, the
   Eurobiobank project QLTR-2001-02769 and R.F.02.187 Criobanca
   Automatizzata di Materiale Biologico to M.M. and M.S. are gratefully
   acknowledged.
CR Aravind L, 2000, NUCLEIC ACIDS RES, V28, P3417, DOI 10.1093/nar/28.18.3417
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Brown TA, 2002, NUCLEIC ACIDS RES, V30, P2004, DOI 10.1093/nar/30.9.2004
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Copeland WC, 2008, MOL CELL, V32, P457, DOI 10.1016/j.molcel.2008.11.007
   Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Elstner M, 2008, MOL BIOTECHNOL, V40, P306, DOI 10.1007/s12033-008-9100-5
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Pohjoismäki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Steczkiewicz K, 2012, NUCLEIC ACIDS RES, V40, P7016, DOI 10.1093/nar/gks382
   Stewart JD, 2011, BBA-MOL BASIS DIS, V1812, P321, DOI 10.1016/j.bbadis.2010.11.012
   Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
NR 28
TC 171
Z9 184
U1 3
U2 30
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1061-4036
EI 1546-1718
J9 NAT GENET
JI Nature Genet.
PD FEB
PY 2013
VL 45
IS 2
BP 214
EP 219
DI 10.1038/ng.2501
PG 6
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 081PB
UT WOS:000314333000019
PM 23313956
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Spinazzola, A
   Perez-Rodriguez, D
   Jezek, J
   Holt, IJ
AF Spinazzola, Antonella
   Perez-Rodriguez, Diego
   Jezek, Jan
   Holt, Ian J.
TI Mitochondrial DNA competition: starving out the mutant genome
SO TRENDS IN PHARMACOLOGICAL SCIENCES
LA English
DT Review
ID RANDOM GENETIC DRIFT; GLUTAMINE-METABOLISM; SKELETAL-MUSCLE;
   QUALITY-CONTROL; OPTIC ATROPHY; MTDNA; DELETIONS; HETEROPLASMY;
   SEGREGATION; MUTATIONS
AB High levels of pathogenic mitochondrial DNA (mtDNA) variants lead to severe genetic diseases, and the accumulation of such mutants may also contribute to common disorders. Thus, selecting against these mutants is a major goal in mitochondrial medicine. Although mutant mtDNA can drift randomly, mounting evidence indicates that active forces play a role in the selection for and against mtDNA variants. The underlying mechanisms are beginning to be clarified, and recent studies suggest that metabolic cues, including fuel availability, contribute to shaping mtDNA heteroplasmy. In the context of pathological mtDNAs, remodeling of nutrient metabolism supports mitochondria with deleterious mtDNAs and enables them to outcompete functional variants owing to a replicative advantage. The elevated nutrient requirement represents a mutant Achilles' heel because small molecules that restrict nutrient consumption or interfere with nutrient sensing can purge cells of deleterious mtDNAs and restore mitochondrial respiration. These advances herald the dawn of a new era of small-molecule therapies to counteract pathological mtDNAs.
C1 [Spinazzola, Antonella; Perez-Rodriguez, Diego; Jezek, Jan; Holt, Ian J.] UCL, Queen Sq Inst Neurol, Dept Clin & Movement Neurosci, Royal Free Campus, London NW3 2PF, England.
   [Holt, Ian J.] Biodonostia Hlth Res Inst, San Sebastian 20014, Spain.
   [Holt, Ian J.] IKERBASQUE, Basque Fdn Sci, Bilbao 48013, Spain.
   [Holt, Ian J.] Minist Econ & Competitiveness, Inst Carlos III, Ctr Networked Biomed Res Neurodegenerat Dis, CIBERNED, Madrid 28031, Spain.
   [Holt, Ian J.] Univ Basque Country, Barrio Sarriena S-N, Leioa 48940, Bilbao, Spain.
C3 University of London; University College London; Instituto de
   Investigacion Sanitaria Biogipuzkoa; Basque Foundation for Science;
   Spanish Ministry of Economy & Competitiveness; CIBERNED; University of
   Basque Country
RP Spinazzola, A; Holt, IJ (corresponding author), UCL, Queen Sq Inst Neurol, Dept Clin & Movement Neurosci, Royal Free Campus, London NW3 2PF, England.; Holt, IJ (corresponding author), Biodonostia Hlth Res Inst, San Sebastian 20014, Spain.; Holt, IJ (corresponding author), IKERBASQUE, Basque Fdn Sci, Bilbao 48013, Spain.; Holt, IJ (corresponding author), Minist Econ & Competitiveness, Inst Carlos III, Ctr Networked Biomed Res Neurodegenerat Dis, CIBERNED, Madrid 28031, Spain.; Holt, IJ (corresponding author), Univ Basque Country, Barrio Sarriena S-N, Leioa 48940, Bilbao, Spain.
EM a.spinazzola@ucl.ac.uk; ian.holt@biodonostia.org
RI Pereira, Gustavo José Silva/ABH-1344-2020; Spinazzola,
   Antonella/P-5791-2019; Spinazzola, Antonella/P-5298-2017; holt,
   ian/AFT-2565-2022
OI Spinazzola, Antonella/0000-0003-4242-8091; holt, ian/0000-0001-5468-0193
FU UK Medical Research Council [MR/X002365/1]; Muscular Dystrophy UK
   [17GRO-PG24-0184-1]; Lily Foundation; CHAMP Foundation; Brain Research
   UK [202021-26]; Carlos III Health Program (ISCIII) [2018111043]; Pas
   Vasco Department of Health [2018222031, PI17/00380];  [PI20/00096]
FX The authors receive research support from the UK Medical Research
   Council (MR/X002365/1 to A.S. and I.J.H.) , Muscular Dystrophy UK
   (17GRO-PG24-0184-1 to A.S. and I.J.H.) , the Lily Foundation (to A.S.) ,
   and the CHAMP Foundation (to A.S. and I.J.H.) . A.S. is the recipient of
   a Miriam Marks Senior Fellowship, Brain Research UK (202021-26) . I.J.H.
   receives support from the Carlos III Health Program (ISCIII: PI17/00380
   and PI20/00096) , and Pais Vasco Department of Health (2018111043 and
   2018222031) .
CR Aiestaran-Zelaia I, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-10168-1
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Arroyo JD, 2016, CELL METAB, V24, P875, DOI 10.1016/j.cmet.2016.08.017
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bhatt AN, 2022, BMC INFECT DIS, V22, DOI 10.1186/s12879-022-07642-6
   Bhatt AN, 2022, LIFE SCI, V295, DOI 10.1016/j.lfs.2022.120411
   BLANC H, 1980, P NATL ACAD SCI-BIOL, V77, P3942, DOI 10.1073/pnas.77.7.3942
   Bojkova D, 2020, NATURE, V583, P469, DOI 10.1038/s41586-020-2332-7
   Borella R, 2019, MOLECULES, V24, DOI 10.3390/molecules24224097
   Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035
   Burgstaller JP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04797-2
   Burr SP, 2023, CELL, V186, P1212, DOI 10.1016/j.cell.2023.01.034
   Burt A., 2006, GENES CONFLICT BIOL
   Cannino G, 2012, J BIOL CHEM, V287, P38729, DOI 10.1074/jbc.M112.386060
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen QY, 2018, CELL METAB, V27, P1007, DOI 10.1016/j.cmet.2018.03.002
   Chen Z, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201905160
   Chiang ACY, 2019, CURR BIOL, V29, P4330, DOI 10.1016/j.cub.2019.10.060
   Chiaravalli M, 2016, J AM SOC NEPHROL, V27, P1958, DOI 10.1681/ASN.2015030231
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chung CY, 2022, TRENDS CELL BIOL, V32, P391, DOI 10.1016/j.tcb.2021.10.005
   Chung CY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26746-2
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Clerc I, 2019, NAT METAB, V1, P717, DOI 10.1038/s42255-019-0084-1
   Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023
   de Zeeuw D, 2013, NEW ENGL J MED, V369, P2492, DOI 10.1056/NEJMoa1306033
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   Durán RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043
   Durigon R, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708550
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Falabella M, 2022, NAT REV NEUROL, V18, P689, DOI 10.1038/s41582-022-00715-9
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Floros VI, 2018, NAT CELL BIOL, V20, P144, DOI 10.1038/s41556-017-0017-8
   Frezza C, 2017, INTERFACE FOCUS, V7, DOI 10.1098/rsfs.2016.0100
   Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791
   Gaude E, 2018, MOL CELL, V69, P581, DOI 10.1016/j.molcel.2018.01.034
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Gitschlag BL, 2020, ELIFE, V9, DOI 10.7554/eLife.56686
   Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008
   Gomes LC, 2011, CELL CYCLE, V10, P2635, DOI 10.4161/cc.10.16.17002
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403
   Gupta R, 2023, NATURE, V620, DOI 10.1038/s41586-023-06426-5
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Hill JH, 2014, NAT GENET, V46, P389, DOI 10.1038/ng.2920
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 1997, HUM MOL GENET, V6, P1251, DOI 10.1093/hmg/6.8.1251
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Hyvärinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676
   Ignatenko O, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.202000797
   Jakubke C, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abi8886
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472
   Jokinen R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001161
   Kandul NP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13100
   Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037
   Keshavan N, 2024, J INHERIT METAB DIS, V47, P145, DOI 10.1002/jimd.12699
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Kim M, 2022, TRENDS CANCER, V8, P1046, DOI 10.1016/j.trecan.2022.08.001
   Kopinski PK, 2019, P NATL ACAD SCI USA, V116, P16028, DOI 10.1073/pnas.1906896116
   Latorre-Pellicer A, 2019, CELL METAB, V30, P1120, DOI 10.1016/j.cmet.2019.09.007
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   Le S, 2021, JOVE-J VIS EXP, DOI 10.3791/62756
   Lee JY, 2014, J CELL SCI, V127, P4954, DOI 10.1242/jcs.157321
   Lee JJ, 2018, J CELL BIOL, V217, P1613, DOI 10.1083/jcb.201801044
   Lehtinen SK, 2000, GENETICS, V154, P363
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Leiter I, 2019, NEUROBIOL DIS, V130, DOI 10.1016/j.nbd.2019.104510
   Lewis SC, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5549
   Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001
   Li MK, 2016, GENOME RES, V26, P417, DOI 10.1101/gr.203216.115
   Lickfett S, 2022, STAR PROTOC, V3, DOI 10.1016/j.xpro.2022.101567
   Lieber T, 2019, NATURE, V570, P380, DOI 10.1038/s41586-019-1213-4
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Ma HS, 2016, NAT GENET, V48, P798, DOI 10.1038/ng.3587
   Ma HS, 2014, NAT GENET, V46, P393, DOI 10.1038/ng.2919
   Malena A, 2016, AUTOPHAGY, V12, P2098, DOI 10.1080/15548627.2016.1226734
   Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281
   Martínez-Reyes I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13668-3
   McWilliams TG, 2018, CELL METAB, V27, P439, DOI 10.1016/j.cmet.2017.12.008
   Medeiros TC, 2018, J CELL BIOL, V217, P1601, DOI 10.1083/jcb.201801168
   Minor RK, 2010, TOXICOL APPL PHARM, V243, P332, DOI 10.1016/j.taap.2009.11.025
   Scholle LM, 2020, GENES-BASEL, V11, DOI 10.3390/genes11020212
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Palozzi JM, 2022, CELL METAB, V34, P1809, DOI 10.1016/j.cmet.2022.10.005
   Pantic B, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26829-0
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Picard M, 2022, CELL METAB, V34, P1620, DOI 10.1016/j.cmet.2022.10.008
   Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111
   Podrini C, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0200-x
   Raez LE, 2013, CANCER CHEMOTH PHARM, V71, P523, DOI 10.1007/s00280-012-2045-1
   Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108
   Ramos ES, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008085
   Rath S, 2021, NUCLEIC ACIDS RES, V49, pD1541, DOI 10.1093/nar/gkaa1011
   Rebolledo-Jaramillo B, 2014, P NATL ACAD SCI USA, V111, P15474, DOI 10.1073/pnas.1409328111
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Rowe I, 2013, NAT MED, V19, P488, DOI 10.1038/nm.3092
   Sanchez-Contreras M, 2023, ELIFE, V12, DOI 10.7554/eLife.83395
   Schrepfer E, 2016, MOL CELL, V61, P683, DOI 10.1016/j.molcel.2016.02.022
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Silva-Pinheiro P, 2023, NAT BIOMED ENG, V7, P692, DOI 10.1038/s41551-022-00968-1
   Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
   Stein M, 2010, PROSTATE, V70, P1388, DOI 10.1002/pros.21172
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Terse PS, 2016, INT J TOXICOL, V35, P284, DOI 10.1177/1091581815624397
   Thorburn D.R., 1993, GeneReviews
   Tostes K, 2022, AUTOPHAGY, V18, P2397, DOI 10.1080/15548627.2022.2038501
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Valle-Casuso JC, 2019, CELL METAB, V29, P611, DOI 10.1016/j.cmet.2018.11.015
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Lechuga-Vieco AV, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba5345
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang FL, 2018, CELL METAB, V28, P463, DOI 10.1016/j.cmet.2018.08.012
   Wei W, 2019, SCIENCE, V364, P749, DOI 10.1126/science.aau6520
   WOODWARD GE, 1954, CANCER RES, V14, P599
   Xi HB, 2011, CANCER CHEMOTH PHARM, V67, P899, DOI 10.1007/s00280-010-1391-0
   Yang QY, 2022, NAT CELL BIOL, V24, P181, DOI 10.1038/s41556-021-00840-5
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
   Zhang HX, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abi5657
   Zhang Y, 2019, MOL CELL, V73, P1127, DOI 10.1016/j.molcel.2019.01.013
NR 133
TC 1
Z9 1
U1 1
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0165-6147
EI 1873-3735
J9 TRENDS PHARMACOL SCI
JI Trends Pharmacol. Sci.
PD MAR
PY 2024
VL 45
IS 3
BP 225
EP 242
DI 10.1016/j.tips.2024.01.011
EA MAR 2024
PG 18
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA PL4S4
UT WOS:001214226700001
PM 38402076
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU van den Bosch, BJC
   de Coo, IFM
   Hendrickx, ATM
   Busch, HFM
   de Jong, G
   Scholte, HR
   Smeets, HJM
AF van den Bosch, BJC
   de Coo, IFM
   Hendrickx, ATM
   Busch, HFM
   de Jong, G
   Scholte, HR
   Smeets, HJM
TI Increased risk for cardiorespiratory failure associated with the A3302G
   mutation in the mitochondrial DNA encoded tRNA<SUP>Leu(UUR)</SUP> gene
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE mitochondrial tRNA; point mutation; mitochondrial encephalomyopathy;
   cardiorespiratory failure; tRNA(Leut(UUR))
ID TRANSFER RNALEU(UUR) GENE; A3243G MUTATION; DIABETES-MELLITUS; MELAS
   MUTATION; CARDIOMYOPATHY; MYOPATHY; DISEASE; ENCEPHALOMYOPATHIES;
   DISORDERS; DEAFNESS
AB Screening the mitochondrial DNA of a 64-year-old woman with mitochondrial myopathy revealed 76% of the tRNA(Leu(UUR)) A3302G mutation in muscle. Muscle of her affected son carried 96% mutated mitochondrial DNA. Both patients were biopsied twice, showing isolated complex I deficiency in the son's first biopsy, additional increased (within normal range) complex II+III activities in his second biopsy, combined complex I, II+III deficiency in mothers first biopsy and additional complex IV deficiency in her second biopsy. After a stay in the mountains, the son died of cardiac arrhythmia. The A3302G mutation has been reported before and is associated with mitochondrial myopathy and cardiorespiratory failure. Pathogenesis is explained by abnormal mtRNA processing, which was also reported for the adjacent C3303T mutation associated with cardiomyopathy and/or skeletal myopathy. Our findings suggest that a high mutation load of the A3302G mutation can lead to fatal cardiorespiratory failure, likely triggered by low environmental oxygen pressure and exercise. (C) 2004 Elsevier B.V. All rights reserved.
C1 Maastricht Univ, CARIM, Dept Genet & Cell Biol, NL-6200 MD Maastricht, Netherlands.
   Erasmus MC, Dept Child Neurol, NL-3000 DR Rotterdam, Netherlands.
   Erasmus MC, Dept Neurol, NL-3000 DR Rotterdam, Netherlands.
   Erasmus MC, Dept Internal Med, NL-3000 DR Rotterdam, Netherlands.
   Erasmus MC, Dept Biochem, NL-3000 DR Rotterdam, Netherlands.
C3 Maastricht University; Maastricht University Medical Centre (MUMC);
   Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam;
   Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University
   Rotterdam; Erasmus MC
RP Maastricht Univ, CARIM, Dept Genet & Cell Biol, POB 616, NL-6200 MD Maastricht, Netherlands.
EM bert.smeets@molcelb.unimaas.nl
CR BINDOFF LA, 1993, J BIOL CHEM, V268, P19559
   Bruno C, 1999, J PEDIATR-US, V135, P197, DOI 10.1016/S0022-3476(99)70022-3
   BUSCH HFM, 1981, MITOCHONDRIA MUSCULA, P207
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Deschauer M, 2001, ARCH NEUROL-CHICAGO, V58, P1885, DOI 10.1001/archneur.58.11.1885
   GOTO Y, 1992, ANN NEUROL, V31, P672, DOI 10.1002/ana.410310617
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Iwanaga R, 2001, ACTA NEUROPATHOL, V101, P179
   Jacobs HT, 2003, HUM MOL GENET, V12, pR293, DOI 10.1093/hmg/ddg285
   Jacobs HT, 2000, HUM MOL GENET, V9, P463, DOI 10.1093/hmg/9.4.463
   JEANFRANCOIS MJB, 1994, AUST NZ J MED, V24, P188, DOI 10.1111/j.1445-5994.1994.tb00556.x
   Koga A, 2003, NEUROMUSCULAR DISORD, V13, P259, DOI 10.1016/S0960-8966(02)00267-5
   Levinger L, 2004, J MOL BIOL, V337, P535, DOI 10.1016/j.jmb.2004.02.008
   Maassen JA, 2001, EXP CLIN ENDOCR DIAB, V109, P127, DOI 10.1055/s-2001-14834
   Marín-García J, 2002, J CARD FAIL, V8, P347, DOI 10.1054/jcaf.2002.127774
   Marín-García J, 2002, CARDIOVASC RES, V54, P516, DOI 10.1016/S0008-6363(01)00552-1
   Mongini T, 2002, CLIN NEUROPATHOL, V21, P72
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Santorelli F M, 2001, Am Heart J, V141, pE1, DOI 10.1067/mhj.2001.112088
   SCHOLTE HR, 1995, BBA-MOL BASIS DIS, V1271, P75, DOI 10.1016/0925-4439(95)00013-T
   Sciacco M, 2001, J NEUROL, V248, P778, DOI 10.1007/s004150170094
   Servidei Serenella, 2003, Neuromuscul Disord, V13, P848
   SILVESTRI G, 1994, HUM MUTAT, V3, P37, DOI 10.1002/humu.1380030107
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Torroni A, 2003, AM J HUM GENET, V72, P1005, DOI 10.1086/373936
   van den Bosch BJC, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e89
   van den Ouweland JMW, 1999, DIABETOLOGIA, V42, P485, DOI 10.1007/s001250051183
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   WALLACE DC, 2003, MITOMAP HUMAN MITOCH
   WATMOUGH NJ, 1990, J CLIN INVEST, V85, P177, DOI 10.1172/JCI114409
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
   ZEVIANI M, 1995, MUSCLE NERVE, pS170
NR 32
TC 18
Z9 18
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD OCT
PY 2004
VL 14
IS 10
BP 683
EP 688
DI 10.1016/j.nmd.2004.06.004
PG 6
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 860HC
UT WOS:000224332100006
PM 15351426
DA 2024-11-01
ER

PT J
AU Lorenzoni, PJ
   Scala, RH
   Kay, CSK
   Silvado, CES
   Werneck, LC
AF Lorenzoni, Paulo Jose
   Scala, Rosana Herminia
   Kamoi Kay, Claudia Suemi
   Silvado, Carlos Eduardo S.
   Werneck, Lineu Cesar
TI When should MERRF (myoclonus epilepsy associated with ragged-red fibers)
   be the diagnosis?
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Review
DE MERRF; mitochondrial; epilepsy; myoctonus; myopathy
ID STROKE-LIKE EPISODES; MITOCHONDRIAL TRNA(LYS) GENE; CLINICAL-FEATURES;
   SKELETAL-MUSCLE; LACTIC-ACIDOSIS; TRANSFER RNALYS; G8363A MUTATION;
   MTDNA MUTATION; BLOOD-VESSELS; DNA MUTATION
AB Myoclonic epilepsy associated with ragged red fibers (MERRF) is a rare mitochondrial disorder. Diagnostic criteria for MERRF include typical manifestations of the disease: myoclonus, generalized epilepsy, cerebellar ataxia and ragged red fibers (RRF) on muscle biopsy. Clinical features of MERRF are not necessarily uniform in the early stages of the disease, and correlations between clinical manifestations and physiopathology have not been fully elucidated. It is estimated that point mutations in the tRNA(Lys) gene of the DNAmt, mainly A8344G, are responsible for almost 90% of MERRF cases. Morphological changes seen upon muscle biopsy in MERRF include a substantive proportion of RRF, muscle fibers showing a deficient activity of cytochrome c oxidase (COX) and the presence of vessels with a strong reaction for succinate dehydrogenase and COX deficiency. In this review, we discuss mainly clinical and laboratory manifestations, brain images, electrophysiological patterns, histology and molecular findings as well as some differential diagnoses and treatments.
C1 [Lorenzoni, Paulo Jose; Scala, Rosana Herminia; Kamoi Kay, Claudia Suemi; Silvado, Carlos Eduardo S.; Werneck, Lineu Cesar] Univ Fed Parana, Dept Neurol, Hosp Clin, BR-80060000 Curitiba, Parana, Brazil.
C3 Universidade Federal do Parana
RP Scala, RH (corresponding author), UFPR, Hosp Clin, Serv Doencas Neuromusculares, Rua Gen Carneiro 181,3 Andar, BR-80060900 Curitiba, Parana, Brazil.
EM rosana.scola@hc.ufpr.br
RI Werneck, Lineu/Y-4038-2019; Silvado, Carlos/V-5207-2019
CR Arruda W O, 1990, Arq Neuropsiquiatr, V48, P32
   BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
   BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231
   BINDOFF LA, 1991, J NEUROL SCI, V102, P17, DOI 10.1016/0022-510X(91)90088-O
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   Brackmann F, 2012, EUR J PEDIATR, V171, P859, DOI 10.1007/s00431-011-1662-8
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   COQUET M, 1993, NEUROMUSCULAR DISORD, V3, P593, DOI 10.1016/0960-8966(93)90122-Z
   De Paepe B, 2009, J CLIN PATHOL, V62, P172, DOI 10.1136/jcp.2008.061267
   DiMauro S, 2002, ADV NEUROL, V89, P217
   DiMauro S, 1999, Adv Neurol, V79, P411
   EKBOM K, 1975, ACTA NEUROL SCAND, V51, P393
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   Finsterer J, 2009, CAN J NEUROL SCI, V36, P543, DOI 10.1017/S0317167100008027
   Folbergrová J, 2012, MITOCHONDRION, V12, P35, DOI 10.1016/j.mito.2011.04.004
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   FUKUHARA N, 1995, MUSCLE NERVE SUPPL 1, V18, pS90
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1995, MUSCLE NERVE, pS107
   HAMMANS SR, 1991, LANCET, V337, P1311, DOI 10.1016/0140-6736(91)92981-7
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   HASEGAWA H, 1993, ACTA NEUROPATHOL, V85, P280
   Hirano M., 1996, Handbook of Muscle Disease, P479
   Ito S, 2008, AM J NEURORADIOL, V29, P392, DOI 10.3174/ajnr.A0865
   James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x
   Kazakos K, 2012, ANN HUM GENET, V76, P296, DOI 10.1111/j.1469-1809.2012.00711.x
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Lorenzoni PJ, 2009, ARQ NEURO-PSIQUIAT, V67, P668, DOI 10.1590/S0004-282X2009000400018
   Mancuso M, 2007, BIOCHEM BIOPH RES CO, V354, P1058, DOI 10.1016/j.bbrc.2007.01.099
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Marotta R, 2004, INTERN MED J, V34, P10, DOI 10.1111/j.1444-0903.2004.t01-3-.x
   MATSUOKA T, 1991, J NEUROL SCI, V106, P193, DOI 10.1016/0022-510X(91)90257-8
   Mita S, 1998, MUSCLE NERVE, V21, P490, DOI 10.1002/(SICI)1097-4598(199804)21:4<490::AID-MUS7>3.0.CO;2-4
   Orcesi S, 2006, J CHILD NEUROL, V21, P79, DOI 10.1177/08830738060210010901
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   OZAWA M, 1995, NEUROMUSCULAR DISORD, V5, P483, DOI 10.1016/0960-8966(95)00009-C
   ROSING HS, 1985, ANN NEUROL, V17, P228, DOI 10.1002/ana.410170303
   Rossmanith W, 2003, ANN NEUROL, V54, P820, DOI 10.1002/ana.10753
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Shahwan A, 2005, LANCET NEUROL, V4, P239, DOI 10.1016/S1474-4422(05)70043-0
   SHOFFNER JM, 1992, AM J HUM GENET, V51, P1179
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shtilbans A, 2000, J CHILD NEUROL, V15, P759, DOI 10.1177/088307380001501109
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Sinha S, 2007, J NEUROL SCI, V252, P16, DOI 10.1016/j.jns.2006.09.021
   SO N, 1989, BRAIN, V112, P1261, DOI 10.1093/brain/112.5.1261
   TANNO Y, 1991, BIOCHEM BIOPH RES CO, V179, P880, DOI 10.1016/0006-291X(91)91900-W
   Teive HAG, 2008, MOVEMENT DISORD, V23, P1191, DOI 10.1002/mds.21990
   TSAIRIS P, 1973, NEUROLOGY, V23, P408
   Virgilio R, 2009, J NEUROL SCI, V281, P85, DOI 10.1016/j.jns.2009.01.025
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   Yasukawa T, 2005, FEBS LETT, V579, P2948, DOI 10.1016/j.febslet.2005.04.038
   YONEDA M, 1990, BIOCHEM INT, V21, P789
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   ZEVIANI M, 1991, AM J HUM GENET, V48, P203
   Zeviani Massimo, 1993, European Journal of Human Genetics, V1, P80
NR 59
TC 33
Z9 37
U1 0
U2 18
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD OCT
PY 2014
VL 72
IS 10
BP 803
EP 811
DI 10.1590/0004-282X20140124
PG 9
WC Neurosciences; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Psychiatry
GA AS0FM
UT WOS:000343953600013
PM 25337734
OA gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Tyynismaa, H
   Suomalainen, A
AF Tyynismaa, Henna
   Suomalainen, Anu
TI Mouse models of mitochondrial DNA defects and their relevance for human
   disease
SO EMBO REPORTS
LA English
DT Review
DE mitochondria; mitochondrial DNA; mouse model
ID TRANSCRIPTION FACTOR-A; ADENINE-NUCLEOTIDE TRANSLOCATOR; MULTIPLE MTDNA
   DELETIONS; THYMIDINE KINASE; POLYMERASE-GAMMA; RAPID SEGREGATION; POINT
   MUTATION; KNOCKOUT MICE; GENE; MYOPATHY
AB Qualitative and quantitative changes in mitochondrial DNA (mtDNA) have been shown to be common causes of inherited neurodegenerative and muscular diseases, and have also been implicated in ageing. These diseases can be caused by primary mtDNA mutations, or by defects in nuclear-encoded mtDNA maintenance proteins that cause secondary mtDNA mutagenesis or instability. Furthermore, it has been proposed that mtDNA copy number affects cellular tolerance to environmental stress. However, the mechanisms that regulate mtDNA copy number and the tissue-specific consequences of mtDNA mutations are largely unknown. As post-mitotic tissues differ greatly from proliferating cultured cells in their need for mtDNA maintenance, and as most mitochondrial diseases affect post-mitotic cell types, the mouse is an important model in which to study mtDNA defects. Here, we review recently developed mouse models, and their contribution to our knowledge of mtDNA maintenance and its role in disease.
C1 [Tyynismaa, Henna; Suomalainen, Anu] Univ Helsinki, Biomedicum, Res Programme Mol Neurol, FIN-00290 Helsinki, Finland.
   [Tyynismaa, Henna; Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, FIN-00290 Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; Helsinki University
   Central Hospital
RP Tyynismaa, H (corresponding author), Univ Helsinki, Biomedicum, Res Programme Mol Neurol, RC523B,Haartmaninkatu 8,POB 63, FIN-00290 Helsinki, Finland.
EM henna.tyynismaa@helsinki.fi
RI Tyynismaa, Henna/F-1428-2011
OI Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195; Tyynismaa,
   Henna/0000-0002-2493-2422
FU European Molecular Biology organization; Sigrid Juselius Foundation;
   Academy of Finland; University of Helsinki; Helsinki University Central
   Hospital; Helsinki Biomedical Graduate School
FX This work was supported by the European Molecular Biology organization
   young investigator programme, the Sigrid Juselius Foundation, the
   Academy of Finland, the University of Helsinki, the Helsinki University
   Central Hospital and the Helsinki Biomedical Graduate School.
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Battersby BJ, 2005, HUM MOL GENET, V14, P2587, DOI 10.1093/hmg/ddi293
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Haraguchi M, 2002, MOL CELL BIOL, V22, P5212, DOI 10.1128/MCB.22.14.5212-5221.2002
   Hayashi M, 2006, NAT MED, V12, P128, DOI 10.1038/nm1327
   Hayashi Y, 2008, J NEUROSCI, V28, P8624, DOI 10.1523/JNEUROSCI.1957-08.2008
   Hosseini SH, 2007, AM J PATHOL, V170, P865, DOI 10.2353/ajpath.2007.060655
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Huo L, 2001, MOL CELL BIOL, V21, P644, DOI 10.1128/MCB.21.2.644-654.2001
   Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004
   Kasahara T, 2006, MOL PSYCHIATR, V11, P577, DOI 10.1038/sj.mp.4001824
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212
   KOBAYASHI Y, 1991, AM J HUM GENET, V49, P590
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467
   Marchington DR, 1999, NAT MED, V5, P957, DOI 10.1038/11403
   McGregor A, 2001, MOL GENET GENOMICS, V265, P721, DOI 10.1007/s004380100469
   Nakada K, 2004, BIOCHEM BIOPH RES CO, V323, P175, DOI 10.1016/j.bbrc.2004.08.073
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   Silva JP, 2002, BBA-BIOENERGETICS, V1555, P106, DOI 10.1016/S0005-2728(02)00263-3
   Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   WEIHER H, 1990, CELL, V62, P425, DOI 10.1016/0092-8674(90)90008-3
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 69
TC 71
Z9 79
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-221X
EI 1469-3178
J9 EMBO REP
JI EMBO Rep.
PD FEB
PY 2009
VL 10
IS 2
BP 137
EP 143
DI 10.1038/embor.2008.242
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 403ZE
UT WOS:000263119700010
PM 19148224
OA Green Published
DA 2024-11-01
ER

PT J
AU Endres, D
   Süss, P
   Maier, SJ
   Friedel, E
   Nickel, K
   Ziegler, C
   Fiebich, BL
   Glocker, FX
   Stock, F
   Eggers, K
   Lange, T
   Dacko, M
   Venhoff, N
   Erny, D
   Doostkam, S
   Komlosi, K
   Domschke, K
   van Elst, LT
AF Endres, Dominique
   Suess, Patrick
   Maier, Simon J.
   Friedel, Evelyn
   Nickel, Kathrin
   Ziegler, Christiane
   Fiebich, Bernd L.
   Glocker, Franz X.
   Stock, Friedrich
   Eggers, Karl
   Lange, Thomas
   Dacko, Michael
   Venhoff, Nils
   Erny, Daniel
   Doostkam, Soroush
   Komlosi, Katalin
   Domschke, Katharina
   van Elst, Ludger Tebartz
TI New Variant of MELAS Syndrome With Executive Dysfunction, Heteroplasmic
   Point Mutation in the <i>MT-ND4</i> Gene (m.12015T>C; p.Leu419Pro) and
   Comorbid Polyglandular Autoimmune Syndrome Type 2
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE MELAS; mitochondrial disease; polyglandular autoimmune syndrome; ND4
   gene; dysexecutive syndrome
ID ENDOCRINE DISORDERS; MITOCHONDRIAL; LACTATE; DISEASE
AB Background: Mitochondrial diseases are caused by dysfunctions in mitochondrial metabolic pathways. MELAS syndrome is one of the most frequent mitochondrial disorders; it is characterized by encephalopathy, myopathy, lactic acidosis, and stroke-like episodes. Typically, it is associated with a point mutation with an adenine-to-guanine transition at position 3243 of the mitochondrial DNA (mtDNA; m.3243A>G) in the mitochondrially encoded tRNA leucine 1 (MT-TL1) gene. Other point mutations are possible and the association with polyglandular autoimmune syndrome type 2 has not yet been described.
   Case presentation: We present the case of a 25-year-old female patient with dysexecutive syndrome, muscular fatigue, and continuous headache. Half a year ago, she fought an infection-triggered Addison crisis. As the disease progressed, she had two epileptic seizures and stroke-like episodes with hemiparesis on the right side. Cerebral magnetic resonance imaging showed a substance defect of the parieto-occipital left side exceeding the vascular territories with a lactate peak. The lactate ischemia test was clearly positive, and a muscle biopsy showed single cytochrome c oxidase-negative muscle fibers. Genetic testing of blood mtDNA revealed a heteroplasmic base exchange mutation in the mitochondrially encoded NADH: ubiquinone oxidoreductase core subunit 4 (MT-ND4) gene (m.12015T>C; p.Leu419Pro; heteroplasmy level in blood 12%, in muscle tissue: 15%). The patient suffered from comorbid autoimmune polyglandular syndrome type 2 with Hashimoto's thyroiditis, Addison's disease, and autoimmune gastritis. In addition, we found increased anti-glutamic acid decarboxylase 65, anti-partial cell, anti-intrinsic factor, and anti-nuclear antibodies.
   Conclusion: We present an atypical case of MELAS syndrome with predominant symptoms of a dysexecutive syndrome, two stroke-like episodes, and fast-onset fatigue. The symptoms were associated with a not yet described base and aminoacid exchange mutation in the MT-ND4 gene (m.12015T>C to p.Leu419Pro). The resulting changed protein complex in our patient is part of the respiratory chain multicomplex I and might be the reason for the mitochondriopathy. However, different simulations for pathogenetic relevance are contradictory and rather speak for a benign variant. To our knowledge this case report is the first reporting MELAS syndrome with comorbid polyglandular autoimmune syndrome type 2. Screening for autoimmune alterations in those patients is important to prevent damage to end organs.
C1 [Endres, Dominique; Suess, Patrick; Maier, Simon J.; Friedel, Evelyn; Nickel, Kathrin; van Elst, Ludger Tebartz] Univ Freiburg, Fac Med, Med Ctr, Sect Expt Neuropsychiat,Dept Psychiat & Psychothe, Freiburg, Germany.
   [Endres, Dominique; Suess, Patrick; Maier, Simon J.; Friedel, Evelyn; Nickel, Kathrin; Ziegler, Christiane; Fiebich, Bernd L.; Domschke, Katharina; van Elst, Ludger Tebartz] Univ Freiburg, Fac Med, Med Ctr, Dept Psychiat & Psychotherapy, Freiburg, Germany.
   [Glocker, Franz X.] Univ Freiburg, Fac Med, Med Ctr, Dept Neurol, Freiburg, Germany.
   [Stock, Friedrich] Univ Hosp Muenster, Inst Human Genet, Munster, Germany.
   [Eggers, Karl] Univ Freiburg, Fac Med, Med Ctr, Dept Neuroradiol, Freiburg, Germany.
   [Lange, Thomas; Dacko, Michael] Univ Freiburg, Fac Med, Med Ctr, Dept Radiol,Med Phys, Freiburg, Germany.
   [Venhoff, Nils] Univ Freiburg, Fac Med, Med Ctr, Dept Rheumatol & Clin Immunol, Freiburg, Germany.
   [Erny, Daniel; Doostkam, Soroush] Univ Freiburg, Fac Med, Med Ctr, Inst Neuropathol, Freiburg, Germany.
   [Erny, Daniel] Univ Freiburg, Fac Med, Berta Ottenstein Programme, Freiburg, Germany.
   [Komlosi, Katalin] Univ Freiburg, Fac Med, Med Ctr, Inst Human Genet, Freiburg, Germany.
C3 University of Freiburg; University of Freiburg; University of Freiburg;
   University of Munster; University of Freiburg; University of Freiburg;
   University of Freiburg; University of Freiburg; University of Freiburg;
   University of Freiburg
RP Endres, D (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Sect Expt Neuropsychiat,Dept Psychiat & Psychothe, Freiburg, Germany.; Endres, D (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Dept Psychiat & Psychotherapy, Freiburg, Germany.
EM dominique.endres@uniklinik-Freiburg.de
RI Maier, Simon/H-6074-2019; Nickel, PD Dr. Kathrin/AAF-1630-2019; Erny,
   Daniel/AAU-7015-2020
OI Nickel, PD Dr. Kathrin/0000-0001-9863-317X; Fiebich, Bernd
   L./0000-0002-9261-6771; Endres, Dominique/0000-0001-7322-1195; Friedel,
   Evelyn Barbara Nicola/0000-0001-9862-9656; Erny,
   Daniel/0000-0001-6000-8838
FU German Research Foundation (DFG); University of Freiburg
FX The article processing charge was funded by the German Research
   Foundation (DFG) and the University of Freiburg in the funding program
   Open Access Publishing.
CR Afroze B, 2014, BRAIN DEV-JPN, V36, P924, DOI 10.1016/j.braindev.2013.12.009
   Al-Gadi IS, 2018, J ENDOCR SOC, V2, P361, DOI 10.1210/js.2017-00434
   BEHAR KL, 1994, MAGNET RESON MED, V32, P294, DOI 10.1002/mrm.1910320304
   Brabant G, 2002, DTSCH ARZTEBL INT, V99, P1428
   Cutolo M, 2014, AUTOIMMUN REV, V13, P85, DOI 10.1016/j.autrev.2013.07.006
   de Castro CSA, 2013, NMR BIOMED, V26, P1213, DOI 10.1002/nbm.2937
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Finsterer J, 1998, J NEUROL SCI, V159, P176, DOI 10.1016/S0022-510X(98)00170-1
   Kornblum C., 2012, MITOCHONDRIALE ERKRA
   LERTRIT P, 1992, AM J HUM GENET, V51, P457
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J
   Nieves-Moreno M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180450
   O'Grady Michael J, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2014-208514
   Ohno K, 1996, ANN NEUROL, V39, P761, DOI 10.1002/ana.410390612
   PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604
   Schaefer AM, 2013, MOL CELL ENDOCRINOL, V379, P2, DOI 10.1016/j.mce.2013.06.004
   Seidowsky A, 2013, CLIN NEPHROL, V80, P456, DOI 10.5414/CN107063
   Tarnopolsky MA, 1998, MUSCLE NERVE, V21, P25, DOI 10.1002/(SICI)1097-4598(199801)21:1<25::AID-MUS4>3.0.CO;2-I
   Velankar S, 2016, NUCLEIC ACIDS RES, V44, pD385, DOI 10.1093/nar/gkv1047
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 22
TC 7
Z9 7
U1 0
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD MAR 21
PY 2019
VL 10
AR 412
DI 10.3389/fimmu.2019.00412
PG 11
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA HP7GM
UT WOS:000461855800001
PM 30949164
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Cai, H
   Li, LM
   Zhang, M
   Zhou, YY
   Li, P
AF Cai, Hao
   Li, Li-Min
   Zhang, Miao
   Zhou, Yuying
   Li, Pan
TI Case report: Late-onset MELAS syndrome with mtDNA 5783G&gt;A mutation
   diagnosed by urinary sediment genetic testing
SO FRONTIERS IN GENETICS
LA English
DT Article
DE MELAS; late-onset; MT-TC; m.5783G > A; urinary sediment
ID STROKE-LIKE-EPISODES; MITOCHONDRIAL-MYOPATHY; LACTIC-ACIDOSIS;
   CLINICAL-FEATURES; A3243G MUTATION; ENCEPHALOPATHY; TISSUES
AB Background: Patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) usually present with multisystemic dysfunction with a wide range of clinical manifestations. When the tests for common mitochondrial DNA (mtDNA) point mutations are negative and the mtDNA defects hypothesis remains, urine epithelial cells can be used to screen the mitochondrial genome for unknown mutations to confirm the diagnosis. Case presentation: A 66-year-old Chinese woman presented with symptoms of MELAS and was initially misdiagnosed with acute encephalitis at another institution. Although genetic analysis of blood lymphocyte DNA was negative, brain imaging, including magnetic resonance imaging, magnetic resonance spectroscopy, and clinical and laboratory findings, were all suggestive of MELAS. Finally, the patient was eventually diagnosed with MELAS with the mtDNA 5783G>A mutation in the MT-TC gene with a urinary sediment genetic test. Conclusion: This case report expands the genetic repertoire associated with MELAS syndrome and highlights the importance that full mtDNA sequencing should be warranted beside the analysis of classical variants when a mitochondrial disorder is highly suspected. Furthermore, urine sediment genetic testing has played a crucial role in the diagnosis of MELAS.
C1 [Cai, Hao; Zhang, Miao; Zhou, Yuying; Li, Pan] Tianjin Huanhu Hosp, Dept Neurol, Tianjin, Peoples R China.
   [Cai, Hao; Zhang, Miao; Zhou, Yuying; Li, Pan] Tianjin Huanhu Hosp, Tianjin Neurosurg Inst, Tianjin Key Lab Cerebral Vasc & Neurodegenerat Dis, Tianjin, Peoples R China.
   [Cai, Hao; Zhang, Miao; Zhou, Yuying; Li, Pan] Tianjin Med Univ, Clin Coll Neurol Neurosurg & Neurorehabil, Tianjin, Peoples R China.
   [Cai, Hao; Zhang, Miao; Zhou, Yuying; Li, Pan] Tianjin Univ, Tianjin Huanhu Hosp, Huanhu Hosp, Tianjin, Peoples R China.
   [Li, Li-Min] Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin, Peoples R China.
   [Li, Li-Min] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Tianjin, Peoples R China.
C3 Tianjin Medical University; Tianjin University; Tianjin Medical
   University; Tianjin Medical University
RP Li, P (corresponding author), Tianjin Huanhu Hosp, Dept Neurol, Tianjin, Peoples R China.; Li, P (corresponding author), Tianjin Huanhu Hosp, Tianjin Neurosurg Inst, Tianjin Key Lab Cerebral Vasc & Neurodegenerat Dis, Tianjin, Peoples R China.; Li, P (corresponding author), Tianjin Med Univ, Clin Coll Neurol Neurosurg & Neurorehabil, Tianjin, Peoples R China.; Li, P (corresponding author), Tianjin Univ, Tianjin Huanhu Hosp, Huanhu Hosp, Tianjin, Peoples R China.
EM doc_panpan@163.com
FU Tianjin Health Research Project [TJWJ 2022QN008]; Tianjin Key Medical
   Discipline (Specialty) Construction Project [TJYXZDXK-052B]; Tianjin
   Health Industry High level Talent Training Project (Young Medical
   Emerging Talents) [TJSQNYXXR-D2-107]
FX The author(s) declare that financial support was received for the
   research, authorship, and/or publication of this article. This study was
   supported by the Tianjin Health Research Project (TJWJ 2022QN008),
   Tianjin Key Medical Discipline (Specialty) Construction Project (No.
   TJYXZDXK-052B), and Tianjin Health Industry High level Talent Training
   Project (Young Medical Emerging Talents) (No. TJSQNYXXR-D2-107).
CR Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Baker K, 2018, BRAIN, V141, P2576, DOI 10.1093/brain/awy209
   Feigenbaum A, 2006, AM J MED GENET A, V140A, P2216, DOI 10.1002/ajmg.a.31436
   Frederiksen AL, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039339
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO Y, 1995, MUSCLE NERVE, pS107
   Gropman A, 2004, AM J MED GENET A, V124A, P377, DOI 10.1002/ajmg.a.20456
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kawazoe T, 2022, INTERNAL MED, V61, P547, DOI 10.2169/internalmedicine.7767-21
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Lareau CA, 2021, NAT BIOTECHNOL, V39, P451, DOI 10.1038/s41587-020-0645-6
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   Lorenzoni PJ, 2015, ARQ NEURO-PSIQUIAT, V73, P959
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873
   Marotta R, 2009, J CLIN NEUROSCI, V16, P1223, DOI 10.1016/j.jocn.2008.11.012
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   Meng FL, 2022, NUCLEIC ACIDS RES, V50, P9453, DOI 10.1093/nar/gkac720
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Tarnopolsky MA, 2004, AM J MED GENET A, V124A, P372, DOI 10.1002/ajmg.a.20449
   Walker MA, 2020, NEW ENGL J MED, V383, P1556, DOI 10.1056/NEJMoa2001265
   Yokota M, 2015, HUM MOL GENET, V24, P4698, DOI 10.1093/hmg/ddv201
NR 26
TC 0
Z9 0
U1 4
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD MAY 31
PY 2024
VL 15
AR 1367716
DI 10.3389/fgene.2024.1367716
PG 7
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA UH2H3
UT WOS:001247095200001
PM 38881794
OA gold
DA 2024-11-01
ER

PT S
AU Giordano, C
   d'Amati, G
AF Giordano, Carla
   d'Amati, Giulia
BE Murray, GI
TI Evaluation of Gastrointestinal mtDNA Depletion in Mitochondrial
   Neurogastrointestinal Encephalomyopathy (MNGIE)
SO LASER CAPTURE MICRODISSECTION: METHODS AND PROTOCOLS, SECOND EDITION
SE Methods in Molecular Biology
LA English
DT Article; Book Chapter
DE Mitochondrial disease; mtDNA depletion; mtDNA deletion; CPEO
AB Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is a rare disease characterized by severe gastro-intestinal (GI) dysmotility caused by mutations in the thymidine phosphorylase gene. Thymidine phosphorylase (TP) is involved in the control of the pyrimidine nucleoside pool of the cell. Reduced TP activity induces nucleotide pool imbalances that in turn affect both the rate and fidelity of mtDNA replication, leading to multiple deletions and depletion of mtDNA. By using laser capture microdissection and quantitative real-time-polymerase chain reaction technique, we showed that depletion of mitochondrial DNA (mtDNA) is the most prominent molecular defect in the gut wall of MNGIE patients. Depletion affects severely the smooth muscle cells of muscularis propria and the skeletal muscle component of the upper esophagus, while ganglion cells of the myenteric plexus show only a milder mtDNA reduction.
C1 [Giordano, Carla; d'Amati, Giulia] Univ Roma La Sapienza, Dept Expt Med, Rome, Italy.
C3 Sapienza University Rome
RP Giordano, C (corresponding author), Univ Roma La Sapienza, Dept Expt Med, Rome, Italy.
RI d'Amati, Giulia/F-1251-2011; GIORDANO, Carla/L-5657-2015
OI GIORDANO, Carla/0000-0002-3716-4303
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Cossarizza A, 2003, ANTIVIR THER, V8, P315
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000537
   Giordano C, 2006, GASTROENTEROLOGY, V130, P893, DOI 10.1053/j.gastro.2006.01.004
   Giordano C, 2008, AM J PATHOL, V173, P1120, DOI 10.2353/ajpath.2008.080252
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Nishino I, 2000, ANN NEUROL, V47, P792
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
NR 9
TC 10
Z9 10
U1 0
U2 1
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1064-3745
EI 1940-6029
BN 978-1-61779-162-8
J9 METHODS MOL BIOL
JI Methods Mol. Biol.
PY 2011
VL 755
BP 223
EP 232
DI 10.1007/978-1-61779-163-5_18
D2 10.1007/978-1-61779-163-5
PG 10
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Pathology
WE Book Citation Index – Science (BKCI-S)
SC Biochemistry & Molecular Biology; Pathology
GA BWE67
UT WOS:000293771800018
PM 21761307
DA 2024-11-01
ER

PT J
AU Zweers, H
   van Wegberg, AMJ
   Janssen, MCH
   Wortmann, SB
AF Zweers, Heidi
   van Wegberg, Annemiek M. J.
   Janssen, Mirian C. H.
   Wortmann, Saskia B.
TI Ketogenic diet for mitochondrial disease: a systematic review on
   efficacy and safety
SO ORPHANET JOURNAL OF RARE DISEASES
LA English
DT Review
DE Epilepsy; Complex I; Treatment; Management; Mitochondrial myopathy;
   OXPHOS; Mitochondrial DNA deletion; Adverse event; Modified Atkins diet;
   High fat diet
ID TRIACYLGLYCEROL INFUSION; PRISMA STATEMENT; AGC1 DEFICIENCY; MYOPATHY;
   METAANALYSES; CHILDREN; HEALTH; MUSCLE; FAT
AB BackgroundNo curative therapy for mitochondrial disease (MD) exists, prioritizing supportive treatment for symptom relief. In animal and cell models ketones decrease oxidative stress, increase antioxidants and scavenge free radicals, putting ketogenic diets (KDs) on the list of management options for MD. Furthermore, KDs are well-known, safe and effective treatments for epilepsy, a frequent symptom of MD. This systematic review evaluates efficacy and safety of KD for MD.MethodsWe searched Pubmed, Cochrane, Embase and Cinahl (November 2020) with search terms linked to MD and KD. From the identified records, we excluded studies on Pyruvate Dehydrogenase Complex deficiency. From these eligible reports, cases without a genetically confirmed diagnosis and cases without sufficient data on KD and clinical course were excluded. The remaining studies were included in the qualitative analysis.ResultsOnly 20 cases (14 pediatric) from the 694 papers identified met the inclusion criteria (one controlled trial (n=5), 15 case reports). KD led to seizure control in 7 out of 8 cases and improved muscular symptoms in 3 of 10 individuals. In 4 of 20 cases KD reversed the clinical phenotype (e.g. cardiomyopathy, movement disorder). In 5 adults with mitochondrial DNA deletion(s) related myopathy rhabdomyolysis led to cessation of KD. Three individuals with POLG mutations died while being on KD, however, their survival was not different compared to individuals with POLG mutations without KD.ConclusionData on efficacy and safety of KD for MD is too scarce for general recommendations. KD should be considered in individuals with MD and therapy refractory epilepsy, while KD is contraindicated in mitochondrial DNA deletion(s) related myopathy. When considering KD for MD the high rate of adverse effects should be taken into account, but also spectacular improvements in individual cases. KD is a highly individual management option in this fragile patient group and requires an experienced team. To increase knowledge on this-individually-promising management option more (prospective) studies using adequate outcome measures are crucial.
C1 [Zweers, Heidi; van Wegberg, Annemiek M. J.] Radboudumc, Dept Gastroenterol & Hepatol Dietet, Postbus 9101, NL-6500 HB Nijmegen, Netherlands.
   [Zweers, Heidi; van Wegberg, Annemiek M. J.; Janssen, Mirian C. H.; Wortmann, Saskia B.] Radboudumc, Amalia Childrens Hosp, Radboud Ctr Mitochondrial Med RCMM, Nijmegen, Netherlands.
   [Wortmann, Saskia B.] Paracelsus Med Univ, Univ Childrens Hosp, Salzburg, Austria.
   [Janssen, Mirian C. H.] Radboudumc, Dept Internal Med, Nijmegen, Netherlands.
C3 Radboud University Nijmegen; Paracelsus Private Medical University;
   Radboud University Nijmegen
RP Zweers, H (corresponding author), Radboudumc, Dept Gastroenterol & Hepatol Dietet, Postbus 9101, NL-6500 HB Nijmegen, Netherlands.; Zweers, H (corresponding author), Radboudumc, Amalia Childrens Hosp, Radboud Ctr Mitochondrial Med RCMM, Nijmegen, Netherlands.
EM Heidi.Zweers-vanEssen@radboudumc.nl
RI Wortmann, Saskia/E-6125-2010; van Wegberg, Annemiek/JLM-8324-2023;
   Zweers, Heidi/P-6858-2019; Janssen, Mirian/D-9777-2016; Zweers,
   Heidi/E-2342-2016
OI Zweers, Heidi/0000-0003-3465-4646
CR Ahola S, 2016, EMBO MOL MED, V8, P1234, DOI 10.15252/emmm.201606592
   Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Bough KJ, 2006, ANN NEUROL, V60, P223, DOI 10.1002/ana.20899
   Dahlin M, 2015, EPILEPSIA, V56, pe176, DOI 10.1111/epi.13193
   Danial NN, 2013, J CHILD NEUROL, V28, P1027, DOI 10.1177/0883073813487598
   de Meer K, 2005, J INHERIT METAB DIS, V28, P95, DOI 10.1007/s10545-005-1485-8
   Deberles E, 2020, CAN J CARDIOL, V36, DOI 10.1016/j.cjca.2020.04.024
   Della Marina Adela, 2020, JIMD Rep, V53, P10, DOI 10.1002/jmd2.12109
   Distelmaier F, 2017, BRAIN, V140, DOI 10.1093/brain/aww303
   Emperador S, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1128-z
   Fraser JL, 2014, MOLEC GENET METAB RE, V1, P66, DOI 10.1016/j.ymgmr.2013.12.007
   Guzmán M, 2004, PROSTAG LEUKOTR ESS, V70, P287, DOI 10.1016/j.plefa.2003.05.001
   Hasan-Olive MM, 2019, NEUROCHEM RES, V44, P22, DOI 10.1007/s11064-018-2588-6
   Hikmat O, 2017, J INHERIT METAB DIS, V40, P861, DOI 10.1007/s10545-017-0084-9
   Huang X, 2017, SUCCINYL COA SYNTHET
   Hughes SD, 2014, J NEUROCHEM, V129, P426, DOI 10.1111/jnc.12646
   Illsinger S, 2020, EUR J MED GENET, V63, DOI 10.1016/j.ejmg.2020.104046
   Jeremy Howick ICJLL, 2011, The Oxford Levels of Evidence 2OCEBM levels of evidence working group
   Joshi CN, 2009, PEDIATR NEUROL, V40, P314, DOI 10.1016/j.pediatrneurol.2008.10.023
   Kang HC, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2006.00906.x
   Koessler Miriam, 2021, JIMD Rep, V57, P3, DOI 10.1002/jmd2.12169
   Köse E, 2020, TURKISH J PEDIATR, V62, P652, DOI 10.24953/turkjped.2020.04.016
   Kossoff Eric H, 2018, Epilepsia Open, V3, P175, DOI 10.1002/epi4.12225
   Kossoff EH, 2012, CURR OPIN NEUROL, V25, P173, DOI 10.1097/WCO.0b013e3283515e4a
   Kotecha S, 2019, BMJ CASE REP, V12, DOI 10.1136/bcr-2019-229668
   Laugel V, 2007, PEDIATR NEUROL, V36, P54, DOI 10.1016/j.pediatrneurol.2006.08.007
   Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065
   Martin-McGill KJ, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001903.pub4
   Masino S.A., 2016, Ketogenic Diet and Metabolic Therapies: Expanded Roles in Health and Disease
   Moher D, 2015, SYST REV-LONDON, V4, DOI [10.1371/journal.pmed.1000097, 10.1186/2046-4053-4-1, 10.1016/j.ijsu.2010.07.299, 10.1136/bmj.i4086, 10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2700, 10.1136/bmj.b2535]
   Moher D, 2009, PHYS THER, V89, P873, DOI 10.1093/ptj/89.9.873
   Na JH, 2020, THER ADV NEUROL DISO, V13, DOI 10.1177/1756286419897813
   O'Byrne JJ, 2018, MOL GENET METAB, V123, P28, DOI 10.1016/j.ymgme.2017.11.003
   Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4
   Pfeiffer B, 2020, NEUROPEDIATRICS, V51, P160, DOI 10.1055/s-0039-3400976
   Rahman S, 2012, DEV MED CHILD NEUROL, V54, P397, DOI 10.1111/j.1469-8749.2011.04214.x
   Repp BM, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0784-8
   Rho JM, 2017, NEUROSCI LETT, V637, P4, DOI 10.1016/j.neulet.2015.07.034
   Roef MJ, 2002, AM J CLIN NUTR, V75, P228, DOI 10.1093/ajcn/75.2.228
   Roef MJ, 2002, AM J CLIN NUTR, V75, P237, DOI 10.1093/ajcn/75.2.237
   Schiff M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028823
   Schiff M, 2011, NUTR REV, V69, P65, DOI 10.1111/j.1753-4887.2010.00363.x
   Seo JH, 2010, BRAIN DEV-JPN, V32, P253, DOI 10.1016/j.braindev.2008.12.020
   Sofou K, 2017, J INHERIT METAB DIS, V40, P237, DOI 10.1007/s10545-016-0011-5
   Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926
   Spiegler J, 2011, NEUROPEDIATRICS, V42, P194, DOI 10.1055/s-0031-1287812
   Stafford P, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-74
   Steriade C, 2014, PEDIATR NEUROL, V50, P498, DOI 10.1016/j.pediatrneurol.2014.01.009
   Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919
   Sullivan PG, 2004, ANN NEUROL, V55, P576, DOI 10.1002/ana.20062
   Takahara S, 2022, CARDIOVASC RES, V118, P977, DOI 10.1093/cvr/cvab068
   Theunissen TEJ, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00336
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   Vehmeijer FOL, 2015, EUR J PAEDIATR NEURO, V19, P701, DOI 10.1016/j.ejpn.2015.06.004
   Wibom R, 2009, NEW ENGL J MED, V361, P489, DOI 10.1056/NEJMoa0900591
   Wortmann SB, 2017, NEUROPEDIATRICS, V48, P309, DOI 10.1055/s-0037-1603776
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Wortmann SB, 2009, PEDIATR RES, V65, P103, DOI 10.1203/PDR.0b013e31818d1c8a
   Zweers H, 2020, NUTRITION, V69, DOI 10.1016/j.nut.2019.06.025
NR 59
TC 30
Z9 33
U1 0
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1750-1172
J9 ORPHANET J RARE DIS
JI Orphanet J. Rare Dis.
PD JUL 3
PY 2021
VL 16
IS 1
AR 295
DI 10.1186/s13023-021-01927-w
PG 15
WC Genetics & Heredity; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Research & Experimental Medicine
GA TH1PC
UT WOS:000671865800001
PM 34217336
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Decoux-Poullot, AG
   Bannwarth, S
   Procaccio, V
   Lebre, AS
   Jardel, C
   Vialettes, B
   Paquis-Flucklinger, V
   Chevalier, N
AF Decoux-Poullot, Anne-Gaelle
   Bannwarth, Sylvie
   Procaccio, Vincent
   Lebre, Anne-Sophie
   Jardel, Claude
   Vialettes, Bernard
   Paquis-Flucklinger, Veronique
   Chevalier, Nicolas
TI Clinical phenotype of mitochondrial diabetes due to rare mitochondrial
   DNA mutations
SO ANNALES D ENDOCRINOLOGIE
LA English
DT Article
DE Diabetes; Mitochondrial diabetes; Mitochondrial DNA; Mitochondrial
   disease; Rare mutation
ID POINT MUTATION; T14709C MUTATION; JAPANESE FAMILY; GENE-MUTATIONS;
   DEAFNESS; MELLITUS; MYOPATHY; PATIENT; ONSET; CARDIOMYOPATHY
AB Objective. - While the most frequent mutation responsible for mitochondrial diabetes is the point mutation m.3243 A>G of mitochondrial DNA (mtDNA), few data are available about the role of rare mtDNA mutations in the pathophysiology of diabetes. The main objective of our study was to describe the phenotypic characteristics of patients suffering from diabetes linked to rare mtDNA mutations.
   Research design and methods. - We performed a post-hoc analysis of a prospective multicenter cohort of 743 patients with mitochondrial disorder (previously published by the French Network of Mitochondrial Diseases), associated to a literature review of the PubMed database from 1992 to May 2016. We extracted all reported patients with diabetes and identified rare mtDNA mutations and described their clinical and metabolic phenotypes.
   Results. - The 50 identified patients (10 from the princeps study; 40 from the review of the literature) showed a heterogeneous metabolic phenotype in terms of age, symptoms prior to diagnosis, treatments, and associated clinical and biological signs. However, neurological symptoms were more frequent in case of rare mtDNA mutations compared to the classical m.3243 A> G mutation (A=0.024). In contrast, deafness (65% vs. 95%, P= 3.7E-5), macular pattern dystrophy (20% vs. 86%, P= 1.6E-10) and nephropathy (8% vs. 28%, P= 0.018) were significantly less frequent than in case of the classical m.3243 A>G mutation.
   Conclusion. - Although no specific metabolic phenotype could be identified suggesting or eliminating implication of rare mtDNA mutations in diabetes, clinical phenotypes featured more frequent neurological signs. (C) 2020 Elsevier Masson SAS. All rights reserved.
C1 [Decoux-Poullot, Anne-Gaelle; Chevalier, Nicolas] Univ Cote Azur, CHU Nice, Hop Archet 2, Serv Endocrinol Diabetol & Med Reprod, Nice, France.
   [Bannwarth, Sylvie; Paquis-Flucklinger, Veronique] Univ Cote Azur, CHU Nice, IRCAN, Inserm,CNRS, Nice, France.
   [Procaccio, Vincent] CHU Angers, IBS Lab Genet, Angers, France.
   [Lebre, Anne-Sophie] Univ Paris 05, Hop Necker Enfants Malad, Serv Genet, Inserm U781, Paris, France.
   [Jardel, Claude] Grp Hosp Pitie Salpetriere, Ctr Genet Mol & Chromosom, Biochim Metab, Paris, France.
   [Vialettes, Bernard] CHU Marseille, Hop Concept, Serv Endocrinol Diabet Malad Metab, F-13385 Marseille 5, France.
   [Chevalier, Nicolas] Univ Cote Azur, CHU Nice,Ctr Mediterraneen Med Mol C3M, Equipe Cellular Basis & Signaling Tumor Metab 5, Inst Natl Sante & Rech Med Inserm,UMR U1065,UNS, Nice, France.
C3 CHU Nice; Universite Cote d'Azur; Centre National de la Recherche
   Scientifique (CNRS); Institut National de la Sante et de la Recherche
   Medicale (Inserm); Universite Cote d'Azur; CHU Nice; Universite
   d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National
   de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite;
   Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Necker-Enfants Malades - APHP; Sorbonne Universite; Assistance Publique
   Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP;
   Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille;
   Universite Cote d'Azur; CHU Nice; Institut National de la Sante et de la
   Recherche Medicale (Inserm)
RP Chevalier, N (corresponding author), Hop Archet 2, Dept Endocrinol Diabetol & Med Reprod, 151 Route St Antoine Ginestiere,CS 23079, F-06202 Nice 3, France.
EM chevalier.n@chu-nice.fr
RI CHEVALIER, Nicolas/HTL-6875-2023; Lebre, Anne-Sophie/AAO-1413-2020;
   Procaccio, Vincent/M-2596-2015
OI CHEVALIER, Nicolas/0000-0001-7160-4301
FU French Ministry of Health (PSTIC 2008, Programme de Soutien aux
   Techniques Innovantes et Couteuses)
FX This work was made possible by grants to VP-F from the French Ministry
   of Health (PSTIC 2008, Programme de Soutien aux Techniques Innovantes et
   Couteuses).
CR BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Bayreuther C, 2008, DIABETES METAB, V34, P386, DOI 10.1016/j.diabet.2008.02.002
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Chen FL, 2006, MUTAT RES-FUND MOL M, V602, P26, DOI 10.1016/j.mrfmmm.2006.07.006
   Choo-Kang ATW, 2002, DIABETES, V51, P2317, DOI 10.2337/diabetes.51.7.2317
   Damore ME, 1999, J PEDIATR ENDOCR MET, V12, P207
   De Block CEM, 2004, EXP CLIN ENDOCR DIAB, V112, P80, DOI 10.1055/s-2004-815754
   DeFronzo R, 2016, METABOLISM, V65, P20, DOI 10.1016/j.metabol.2015.10.014
   GERBITZ KD, 1995, BBA-MOL BASIS DIS, V1271, P253, DOI 10.1016/0925-4439(95)00036-4
   Gerbitz KD, 1996, DIABETES, V45, P113, DOI 10.2337/diabetes.45.2.113
   GORELICK FS, 1983, YALE J BIOL MED, V56, P271
   Guillausseau PJ, 2004, DIABETES METAB, V30, P181, DOI 10.1016/S1262-3636(07)70105-2
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   Hattori Y, 2005, EXP CLIN ENDOCR DIAB, V113, P318, DOI 10.1055/s-2005-865646
   Hattori Y, 2003, DIABETES CARE, V26, P952, DOI 10.2337/diacare.26.3.952
   Hirai M, 1998, J CLIN ENDOCR METAB, V83, P992, DOI 10.1210/jc.83.3.992
   Kameoka K, 1998, DIABETES CARE, V21, P2034, DOI 10.2337/diacare.21.11.2034
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Liu H, 2015, MITOCHONDRION, V21, P49, DOI 10.1016/j.mito.2015.01.004
   Lynn S, 1998, DIABETES, V47, P1800, DOI 10.2337/diabetes.47.11.1800
   Maassen JA, 1996, DIABETOLOGIA, V39, P375
   Maassen JA, 2005, ANN MED, V37, P213, DOI 10.1080/07853890510007188
   Meas T, 2010, REV MED INTERNE, V31, P216, DOI 10.1016/j.revmed.2008.11.017
   Mezghani N, 2010, J DIABETES COMPLICAT, V24, P270, DOI 10.1016/j.jdiacomp.2009.11.002
   MORTEN KJ, 1993, HUM MOL GENET, V2, P2081, DOI 10.1093/hmg/2.12.2081
   Mosbah H, 2021, ANN ENDOCRINOL-PARIS, V82, P146, DOI 10.1016/j.ando.2020.03.002
   Nakano S, 1998, ENDOCR J, V45, P625, DOI 10.1507/endocrj.45.625
   Odawara M, 1996, BIOCHEM BIOPH RES CO, V227, P147, DOI 10.1006/bbrc.1996.1481
   Ohkubo K, 2001, CLIN CHEM, V47, P1641
   Perucca-Lostanlen D, 2000, BIOCHEM BIOPH RES CO, V277, P771, DOI 10.1006/bbrc.2000.3751
   Ramachandran R, 2017, J CLIN MED, V6, DOI 10.3390/jcm6080075
   REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3
   Rigoli L, 2001, DIABETIC MED, V18, P334, DOI 10.1046/j.1464-5491.2001.00429-2.x
   Salles JE, 2007, PANCREAS, V34, P133, DOI 10.1097/01.mpa.0000246659.38375.4d
   Sano M, 1996, J NEUROL, V243, P441, DOI 10.1007/BF00900496
   Sollier C, 2020, ANN ENDOCRINOL-PARIS, V81, P51, DOI 10.1016/j.ando.2019.10.003
   Souied EH, 1998, AM J OPHTHALMOL, V125, P100, DOI 10.1016/S0002-9394(99)80243-8
   SUZUKI S, 1994, DIABETES CARE, V17, P1428, DOI 10.2337/diacare.17.12.1428
   Suzuki Y, 1997, DIABETES CARE, V20, P1138, DOI 10.2337/diacare.20.7.1138
   Suzuki Y, 2002, DIABETES CARE, V25, P1097, DOI 10.2337/diacare.25.6.1097
   Suzuki Y, 1996, DIABETES CARE, V19, P1304, DOI 10.2337/diacare.19.11.1304
   Tabebi M, 2015, BIOCHEM BIOPH RES CO, V459, P353, DOI 10.1016/j.bbrc.2015.01.151
   Tawata M, 2000, DIABETES, V49, P1269, DOI 10.2337/diabetes.49.7.1269
   Tsukuda K, 1997, DIABETIC MED, V14, P1032, DOI 10.1002/(SICI)1096-9136(199712)14:12<1032::AID-DIA504>3.0.CO;2-Y
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Vialettes BH, 1997, DIABETES CARE, V20, P1731, DOI 10.2337/diacare.20.11.1731
   Whittaker RG, 2007, DIABETES CARE, V30, P2238, DOI 10.2337/dc07-0466
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
NR 51
TC 2
Z9 3
U1 0
U2 12
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0003-4266
EI 2213-3941
J9 ANN ENDOCRINOL-PARIS
JI Ann Endocrinol.
PD JUN
PY 2020
VL 81
IS 2-3
BP 68
EP 77
DI 10.1016/j.ando.2020.04.007
PG 10
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA LU2EH
UT WOS:000537572500003
PM 32409007
OA Bronze
DA 2024-11-01
ER

PT J
AU Hutchison, WM
   Thyagarajan, D
   Poulton, J
   Marchington, DR
   Kirby, DM
   Manji, SSM
   Dahl, HHM
AF Hutchison, WM
   Thyagarajan, D
   Poulton, J
   Marchington, DR
   Kirby, DM
   Manji, SSM
   Dahl, HHM
TI Clinical and molecular features of encephalomyopathy due to the A3302G
   mutation in the mitochondrial <i>tRNA</i> <SUP>Leu(UUR)</SUP> gene
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID RESPIRATORY-CHAIN; DNA; DISORDER
AB Background: The mitochondrial DNA mutation A3302G in the tRNA(Leu(UUR)) gene causes respiratory chain complex 1 deficiency. The main clinical feature appears to be a progressive mitochondrial myopathy with proximal muscle weakness.
   Objective: To report on clinical and molecular features in 4 novel patients with the A3302G mutation.
   Design: Case reports.
   Patients: Four patients (3 of whom are from the same family) with a myopathy caused by the A3302G mitochondrial DNA mutation.
   Main Outcome Measure: Identification of the A3302G mutation by DNA sequencing.
   Results: All 4 patients had an adult-onset progressive mitochondrial myopathy with proximal muscle weakness, resulting in exercise intolerance. In 2 unrelated patients, upper limb reflexes were absent with preservation of at least some lower limb reflexes. Other features including hearing loss, recurrent headaches, ptosis, progressive external oplithalmoplegia, and depression were present.
   Conclusion: While the dominant clinical features of the A3302G mutation were exercise intolerance and proximal muscle weakness, other features of mitochondrial encephalomyopathies, previously not described for this mutation, were present.
C1 Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.
   Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic 3052, Australia.
   Flinders Med Ctr, Dept Neurol, Bedford Pk, SA, Australia.
   John Radcliffe Hosp, Womens Ctr, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.
C3 Royal Children's Hospital Melbourne; Murdoch Children's Research
   Institute; University of Melbourne; Royal Children's Hospital Melbourne;
   Flinders Medical Centre; University of Oxford
RP Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.
EM hen-rik.dahl@mcri.edu.au
RI Poulton, Joanna/AAB-4828-2021; Thyagarajan, Dominic/H-6633-2014
OI Poulton, Joanna/0000-0002-2460-5587
CR BINDOFF LA, 1993, J BIOL CHEM, V268, P19559
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   DUTKA S, 1993, NUCLEIC ACIDS RES, V21, P4025, DOI 10.1093/nar/21.17.4025
   Gardner A, 2003, ACTA PSYCHIAT SCAND, V107, P233, DOI 10.1034/j.1600-0447.2003.02188.x
   Jaksch M, 2001, NEUROLOGY, V57, P1930, DOI 10.1212/WNL.57.10.1930
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Levinger L, 2004, J MOL BIOL, V337, P535, DOI 10.1016/j.jmb.2004.02.008
   Lewis S, 2002, J NEUROL SCI, V201, P39, DOI 10.1016/S0022-510X(02)00190-9
   Miyaoka H, 1997, BIOL PSYCHIAT, V42, P524, DOI 10.1016/S0006-3223(97)00280-1
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   SAKS ME, 1994, SCIENCE, V263, P191, DOI 10.1126/science.7506844
   SHOFFNER JM, 1993, AM J HUM GENET, V53, P949
   van den Bosch BJC, 2004, NEUROMUSCULAR DISORD, V14, P683, DOI 10.1016/j.nmd.2004.06.004
   Wallace D. C, MITOMAP HUMAN MITOCH
   WATMOUGH NJ, 1990, J CLIN INVEST, V85, P177, DOI 10.1172/JCI114409
NR 15
TC 16
Z9 16
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0003-9942
EI 1538-3687
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD DEC
PY 2005
VL 62
IS 12
BP 1920
EP 1923
DI 10.1001/archneur.62.12.1920
PG 4
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 991QC
UT WOS:000233827500016
PM 16344351
DA 2024-11-01
ER

PT J
AU Maeso, E
   Rueda, A
   Jiménez, S
   del Hoyo, P
   Martín, R
   Cabello, A
   Mendoza, LM
   Arenas, J
   Campos, Y
AF Maeso, E.
   Rueda, A.
   Jimenez, S.
   del Hoyo, P.
   Martin, R.
   Cabello, A.
   Mendoza, L. M.
   Arenas, J.
   Campos, Y.
TI A novel mutation in the mitochondrial DNA tRNA Leu (UUR) gene associated
   with late-onset ocular myopathy
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE mitochondrial diseases; mitochondrial DNA; transfer RNA Leu (UUR);
   ocular myopathy; mitochondria
ID POINT MUTATION; MUSCLE; MELAS
AB We identified a novel G3283A transition in the mitochondrial DNA tRNA(Leu (UUR)) gene in a patient with ptosis, ophthalmoparesis and hyporeftexia. Muscle biopsy showed cytochrome oxidase positive ragged-red fibers, and defects of complexes I, III and IV of the mitochondrial respiratory chain. The mutation was heteroplasmic in muscle of the proband, being absent in her blood. Ragged-red fibers harbored greater levels of mutant genomes than normal fibers. The G3283A mutation affects a strictly conserved base pair in the T Psi C stem of the gene and was not found in controls, thus satisfying the accepted criteria for pathogenicity. (c) 2007 Elsevier B.V. All rights reserved.
C1 Hosp 12 Octubre, Ctr Invest, E-28041 Madrid, Spain.
   Hosp Univ Getafe, Serv Neurol, Madrid, Spain.
   Hosp 12 Octubre, Serv Anat Patol, E-28041 Madrid, Spain.
C3 Hospital Universitario 12 de Octubre; Hospital Universitario de Getafe;
   Hospital Universitario 12 de Octubre
RP Campos, Y (corresponding author), Hosp 12 Octubre, Ctr Invest, Avda Cordoba Km 5-4, E-28041 Madrid, Spain.
EM ycamposg@yahoo.es
RI Yolanda, Campos/A-8711-2017
OI Arenas, Joaquin/0000-0002-2877-5049; CAMPOS, YOLANDA/0000-0003-4785-9659
CR Campos Y, 1998, NEUROMUSCULAR DISORD, V8, P568, DOI 10.1016/S0960-8966(98)00080-7
   Carnpos Y, 2003, NEUROMUSCULAR DISORD, V13, P416, DOI 10.1016/S0960-8966(03)00039-7
   DiMauro S., 1997, MOL GENETIC BASIS NE, P201
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Servidei Serenella, 2004, Neuromuscul Disord, V14, P107
   TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421
NR 10
TC 4
Z9 5
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD MAY
PY 2007
VL 17
IS 5
BP 415
EP 418
DI 10.1016/j.nmd.2007.01.015
PG 4
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 175VB
UT WOS:000247041000009
PM 17363246
DA 2024-11-01
ER

PT J
AU Restrepo-Vera, JL
   Rovira-Moreno, E
   Ramón, J
   Codina-Sola, M
   Llauradó, A
   Salvadó, M
   Sánchez-Tejerina, D
   Sotoca, J
   Martínez-Sáez, E
   Martí, R
   García-Arumí, E
   Juntas-Morales, R
AF Restrepo-Vera, Juan Luis
   Rovira-Moreno, Eulalia
   Ramon, Javier
   Codina-Sola, Marta
   Llaurado, Arnau
   Salvado, Maria
   Sanchez-Tejerina, Daniel
   Sotoca, Javier
   Martinez-Saez, Elena
   Marti, Ramon
   Garcia-Arumi, Elena
   Juntas-Morales, Raul
TI Identification of two novel <i>RRM2B</i> variants associated with
   autosomal recessive progressive external ophthalmoplegia in a family
   with pseudodominant inheritance pattern
SO JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID MITOCHONDRIAL DISEASE; MUTATIONS; DIAGNOSIS; REPLICATION; ADULTS; P53R2
AB RRM2B encodes the p53-inducible small subunit (p53R2) of ribonucleotide reductase, a key protein for mitochondrial DNA (mtDNA) synthesis. Pathogenic variants in this gene result in familial mitochondrial disease in adults and children, secondary to a maintenance disorder of mtDNA. This study describes two patients, mother and son, with early-onset chronic progressive external ophthalmoplegia (PEO). Skeletal muscle biopsy from the latter was examined: cytochrome c oxidase (COX)-negative fibres were shown, and molecular studies revealed multiple mtDNA deletions. A next-generation sequencing gene panel for nuclear-encoded mitochondrial maintenance genes identified two unreported heterozygous missense variants (c.514 G > A and c.682 G > A) in the clinically affected son. The clinically affected mother harboured the first variant in homozygous state, and the clinically unaffected father harboured the remaining variant in heterozygous state. In silico analyses predicted both variants as deleterious. Cell culture studies revealed that patients' skin fibroblasts, but not fibroblasts from healthy controls, responded to nucleoside supplementation with enhanced mtDNA repopulation, thus suggesting an in vitro functional difference in patients' cells. Our results support the pathogenicity of two novel RRM2B variants found in two patients with autosomal recessive PEO with multiple mtDNA deletions inherited with a pseudodominant pattern.
C1 [Restrepo-Vera, Juan Luis; Llaurado, Arnau; Salvado, Maria; Sanchez-Tejerina, Daniel; Sotoca, Javier; Juntas-Morales, Raul] Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Neurol, Neuromuscular Dis Unit,European Reference Network, Barcelona, Spain.
   [Rovira-Moreno, Eulalia; Codina-Sola, Marta; Garcia-Arumi, Elena] Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Clin & Mol Genet, Barcelona, Spain.
   [Rovira-Moreno, Eulalia; Codina-Sola, Marta] Univ Autonoma Barcelona, Vall dHebron Res Inst, Med Genet Grp, Barcelona, Spain.
   [Ramon, Javier; Marti, Ramon; Garcia-Arumi, Elena] Univ Autonoma Barcelona, Vall dHebron Res Inst, Res Grp Neuromusc & Mitochondrial Dis, Barcelona, Spain.
   [Ramon, Javier; Marti, Ramon; Garcia-Arumi, Elena] Inst Salud Carlos III, Biomed Network Res Ctr Rare Dis CIBERER, Madrid, Spain.
   [Martinez-Saez, Elena] Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Pathol, Barcelona 08035, Spain.
C3 Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron;
   Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona;
   Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron;
   Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of
   Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut
   de Recerca (VHIR); Instituto de Salud Carlos III; University of
   Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER;
   Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron
RP Juntas-Morales, R (corresponding author), Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Neurol, Neuromuscular Dis Unit,European Reference Network, Barcelona, Spain.; García-Arumí, E (corresponding author), Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Clin & Mol Genet, Barcelona, Spain.; García-Arumí, E (corresponding author), Univ Autonoma Barcelona, Vall dHebron Res Inst, Res Grp Neuromusc & Mitochondrial Dis, Barcelona, Spain.; García-Arumí, E (corresponding author), Inst Salud Carlos III, Biomed Network Res Ctr Rare Dis CIBERER, Madrid, Spain.
EM e.garcia@vhebron.net; rjuntas@vhebron.net
RI Martinez Saez, Elena/KEH-2514-2024; Martinez-Saez, Elena/E-9097-2018
OI Martinez-Saez, Elena/0000-0001-6004-5364; Restrepo Vera, Juan
   Luis/0000-0002-6332-6126
FU Spanish Instituto de Salud Carlos III, Fondo de Investigaciones
   Sanitarias; ERDF funds [FIS PI19/01772]
FX This work was supported by Spanish Instituto de Salud Carlos III, Fondo
   de Investigaciones Sanitarias and cofounded with ERDF funds (Grant No.
   FIS PI19/01772).
CR Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006
   [Anonymous], 2020, MUSCLE BIOPSY, P408
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Blázquez-Bermejo C, 2019, FASEB J, V33, P7168, DOI 10.1096/fj.201801591R
   Bonora E, 2021, BRAIN, V144, P1451, DOI 10.1093/brain/awab056
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Hadjigeorgiou GM, 2002, NEUROMUSCULAR DISORD, V12, P824, DOI 10.1016/S0960-8966(02)00028-7
   Hou Y, 2022, MOL GENET GENOM MED, V10, DOI 10.1002/mgg3.1921
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Liu HY, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.952
   Miles L, 2012, HUM PATHOL, V43, P1249, DOI 10.1016/j.humpath.2011.09.016
   Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Pitceathly RDS, 2011, J MED GENET, V48, P610, DOI 10.1136/jmg.2010.088328
   Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Rodríguez-López C, 2020, J MED GENET, V57, P643, DOI 10.1136/jmedgenet-2019-106649
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Takata A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r92
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wilichowski EKG, 2014, NEUROMUSCULAR DISORD, V24, P866, DOI 10.1016/j.nmd.2014.06.244
NR 26
TC 1
Z9 1
U1 0
U2 0
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1434-5161
EI 1435-232X
J9 J HUM GENET
JI J. Hum. Genet.
PD AUG
PY 2023
VL 68
IS 8
BP 527
EP 532
DI 10.1038/s10038-023-01144-2
EA MAR 2023
PG 6
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA M5NV5
UT WOS:000955716400001
PM 36959467
DA 2024-11-01
ER

PT S
AU Almannai, M
   El-Hattab, AW
   Scaglia, F
AF Almannai, Mohammed
   El-Hattab, Ayman W.
   Scaglia, Fernando
BE Garone, C
   Minczuk, M
TI Mitochondrial DNA replication: clinical syndromes
SO MITOCHONDRIAL DISEASES
SE Essays in Biochemistry
LA English
DT Review; Book Chapter
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; NUCLEOTIDE TRANSLOCATOR-1 GENE;
   RECESSIVE TWINKLE MUTATIONS; IMPAIR MTDNA REPLICATION; LOSS-OF-FUNCTION;
   POLYMERASE-GAMMA; RIBONUCLEOTIDE REDUCTASE; DEPLETION SYNDROME; GABA
   TRANSAMINASE; RNA-POLYMERASE
AB Each nucleated cell contains several hundreds of mitochondria, which are unique organelles in being under dual genome control. The mitochondria contain their own DNA, the mtDNA, but most of mitochondrial proteins are encoded by nuclear genes, including all the proteins required for replication, transcription, and repair of mtDNA. MtDNA replication is a continuous process that requires coordinated action of several enzymes that are part of the mtDNA replisome. It also requires constant supply of deoxyribonucleotide triphosphates(dNTPs) and interaction with other mitochondria for mixing and unifying the mitochondrial compartment. MtDNA maintenance defects are a growing list of disorders caused by defects in nuclear genes involved in different aspects of mtDNA replication. As a result of defects in these genes, mtDNA depletion and/ or multiple mtDNA deletions develop in affected tissues resulting in variable manifestations that range from adult-onset mild disease to lethal presentation early in life.
C1 [Almannai, Mohammed] King Fahad Med City, Childrens Hosp, Sect Med Genet, POB 59046, Riyadh 11525, Saudi Arabia.
   [El-Hattab, Ayman W.] Tawam Hosp, Div Genet & Metab Disorders, POB 15258, Al Ain, U Arab Emirates.
   [Scaglia, Fernando] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Scaglia, Fernando] Texas Childrens Hosp, Houston, TX 77030 USA.
   [Scaglia, Fernando] Joint Baylor Coll Med, Hong Kong, Hong Kong, Peoples R China.
   [Scaglia, Fernando] Chinese Univ Hong Kong, Ctr Med Genet, Hong Kong, Hong Kong, Peoples R China.
C3 King Fahad Medical City; Baylor College of Medicine; Baylor College of
   Medicine; Chinese University of Hong Kong
RP Scaglia, F (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Scaglia, F (corresponding author), Texas Childrens Hosp, Houston, TX 77030 USA.; Scaglia, F (corresponding author), Joint Baylor Coll Med, Hong Kong, Hong Kong, Peoples R China.; Scaglia, F (corresponding author), Chinese Univ Hong Kong, Ctr Med Genet, Hong Kong, Hong Kong, Peoples R China.
EM fscaglia@bcm.edu
CR Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Caporali L, 2018, BRAIN, V141, DOI 10.1093/brain/awx301
   Carelli V, 2015, BRAIN, V138, DOI 10.1093/brain/awu234
   Chae JH, 2015, J MED GENET, V52, P208, DOI 10.1136/jmedgenet-2014-102819
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Cohen BH, 2010, GENEREVIEWS, P1993
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Copeland WC, 2010, SUBCELL BIOCHEM, V50, P211, DOI 10.1007/978-90-481-3471-7_11
   Dahout-Gonzalez C, 2006, PHYSIOLOGY, V21, P242, DOI 10.1152/physiol.00005.2006
   De Giorgio R, 2016, ANN NEUROL, V80, P448, DOI 10.1002/ana.24724
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   El-Hattab A.W., 1993, GENEREVIEWS
   El-Hattab AW, 2017, MOL GENET METAB, V122, P1, DOI 10.1016/j.ymgme.2017.09.009
   El-Hattab AW, 2017, HUM MUTAT, V38, P1649, DOI 10.1002/humu.23341
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab AW, 2016, CELL CALCIUM, V60, P199, DOI 10.1016/j.ceca.2016.03.003
   Faqeih E., 1993, GENEREVIEWS
   Fernández-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Fusté JM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004832
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Gilkerson R, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011080
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Haghighi A, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0119-3
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Halter JP, 2015, BRAIN, V138, P2847, DOI 10.1093/brain/awv226
   Hebbar M, 2017, EUR J MED GENET, V60, P533, DOI 10.1016/j.ejmg.2017.07.010
   Hikmat O, 2017, GENET MED, V19, P1217, DOI 10.1038/gim.2017.35
   Hirano M., 1993, GeneReviews®
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   Holmes JB, 2015, P NATL ACAD SCI USA, V112, P9334, DOI 10.1073/pnas.1503653112
   Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454
   Johansson M, 1996, P NATL ACAD SCI USA, V93, P7258, DOI 10.1073/pnas.93.14.7258
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Körver-Keularts IMLW, 2015, JIMD REP, V22, P39, DOI 10.1007/8904_2015_409
   Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Louro P, 2016, J INHERIT METAB DIS, V39, P743, DOI 10.1007/s10545-016-9951-z
   Maier D, 2001, MOL BIOL CELL, V12, P821, DOI 10.1091/mbc.12.4.821
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Ngo HB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4077
   Oldak M, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1129-4
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Parikh S, 2016, MOL GENET METAB, V118, P178, DOI 10.1016/j.ymgme.2016.04.009
   Phowthongkum P, 2017, NEUROMUSCULAR DISORD, V27, P616, DOI 10.1016/j.nmd.2017.03.013
   Pierce SB, 2016, CSH MOL CASE STUD, V2, DOI 10.1101/mcs.a001107
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Pitceathly RDS, 2011, J MED GENET, V48, P610, DOI 10.1136/jmg.2010.088328
   Pohjoismäki JLO, 2011, BIOESSAYS, V33, P290, DOI 10.1002/bies.201000137
   Rahman S, 2016, INBORN METABOLIC DIS, P223
   Ranieri M, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/293893
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Rosa ID, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005779
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Shaheen R, 2014, GENOME RES, V24, P291, DOI 10.1101/gr.160572.113
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Sobek S, 2014, EXP GERONTOL, V56, P135, DOI 10.1016/j.exger.2014.01.009
   Spiegel R, 2016, J MED GENET, V53, P127, DOI 10.1136/jmedgenet-2015-103361
   Spinazzola A, 2011, SEMIN FETAL NEONAT M, V16, P190, DOI 10.1016/j.siny.2011.04.011
   Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001
   Strauss KA, 2013, P NATL ACAD SCI USA, V110, P3453, DOI 10.1073/pnas.1300690110
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011395
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Thelander L, 2007, NAT GENET, V39, P703, DOI 10.1038/ng0607-703
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Uhler JP, 2015, DNA REPAIR, V34, P28, DOI 10.1016/j.dnarep.2015.07.003
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Van Maldergem L, 2017, ANN CLIN TRANSL NEUR, V4, P4, DOI 10.1002/acn3.361
   Varma H, 2016, EUR J MED GENET, V59, P540, DOI 10.1016/j.ejmg.2016.08.012
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Yadak R, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00031
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 102
TC 22
Z9 22
U1 0
U2 18
PU PORTLAND PRESS LTD
PI LONDON
PA 5TH FL, 90 HIGH HOLBORN, LONDON, WC1V 6LJ, ENGLAND
SN 0071-1365
EI 1744-1358
J9 ESSAYS BIOCHEM
JI Essays Biochem.
PY 2018
VL 62
IS 3
BP 297
EP 308
DI 10.1042/EBC20170101
PG 12
WC Biochemistry & Molecular Biology
WE Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA BL4NC
UT WOS:000450601700006
PM 29950321
DA 2024-11-01
ER

PT J
AU Sommerville, EW
   Dalla Rosa, I
   Rosenberg, MM
   Bruni, F
   Thompson, K
   Rocha, M
   Blakely, EL
   He, LP
   Falkous, G
   Schaefer, AM
   Yu-Wai-Man, P
   Chinnery, PF
   Hedstrom, L
   Spinazzola, A
   Taylor, RW
   Gorman, GS
AF Sommerville, Ewen W.
   Dalla Rosa, Ilaria
   Rosenberg, Masha M.
   Bruni, Francesco
   Thompson, Kyle
   Rocha, Mariana
   Blakely, Emma L.
   He, Langping
   Falkous, Gavin
   Schaefer, Andrew M.
   Yu-Wai-Man, Patrick
   Chinnery, Patrick F.
   Hedstrom, Lizbeth
   Spinazzola, Antonella
   Taylor, Robert W.
   Gorman, Grainne S.
TI Identification of a novel heterozygous guanosine monophosphate reductase
   (<i>GMPR</i>) variant in a patient with a late-onset disorder of
   mitochondrial DNA maintenance
SO CLINICAL GENETICS
LA English
DT Article
DE GMPR; mitochondrial DNA maintenance; multiple mtDNA deletions; PEO;
   whole exome sequencing
ID HUMAN-EQUILIBRATIVE-NUCLEOSIDE-TRANSPORTER-1 HENT1; RIBONUCLEOTIDE
   REDUCTION; DEFICIENCY; DELETIONS; GENE; REPLICATION; EXPRESSION;
   MUTATIONS; TOXICITY; SUBUNIT
AB Autosomal dominant progressive external ophthalmoplegia (adPEO) is a late-onset, Mendelian mitochondrial disorder characterised by paresis of the extraocular muscles, ptosis, and skeletal-muscle restricted multiple mitochondrial DNA (mtDNA) deletions. Although dominantly inherited, pathogenic variants in POLG, TWNK and RRM2B are among the most common genetic defects of adPEO, identification of novel candidate genes and the underlying pathomechanisms remains challenging. We report the clinical, genetic and molecular investigations of a patient who presented in the seventh decade of life with PEO. Oxidative histochemistry revealed cytochrome c oxidase-deficient fibres and occasional ragged red fibres showing subsarcolemmal mitochondrial accumulation in skeletal muscle, while molecular studies identified the presence of multiple mtDNA deletions. Negative candidate screening of known nuclear genes associated with PEO prompted diagnostic exome sequencing, leading to the prioritisation of a novel heterozygous c.547G>C variant in GMPR (NM_006877.3) encoding guanosine monophosphate reductase, a cytosolic enzyme required for maintaining the cellular balance of adenine and guanine nucleotides. We show that the novel c.547G>C variant causes aberrant splicing, decreased GMPR protein levels in patient skeletal muscle, proliferating and quiescent cells, and is associated with subtle changes in nucleotide homeostasis protein levels and evidence of disturbed mtDNA maintenance in skeletal muscle. Despite confirmation of GMPR deficiency, demonstrating marked defects of mtDNA replication or nucleotide homeostasis in patient cells proved challenging. Our study proposes that GMPR is the 19th locus for PEO and highlights the complexities of uncovering disease mechanisms in late-onset PEO phenotypes.
C1 [Sommerville, Ewen W.; Bruni, Francesco; Thompson, Kyle; Rocha, Mariana; Blakely, Emma L.; He, Langping; Falkous, Gavin; Schaefer, Andrew M.; Taylor, Robert W.; Gorman, Grainne S.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Neurosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Dalla Rosa, Ilaria; Spinazzola, Antonella] UCL, Dept Clin & Movement Neurosci, UCL Queens Sq Inst Neurol, Royal Free Campus, London, England.
   [Rosenberg, Masha M.; Hedstrom, Lizbeth] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.
   [Bruni, Francesco] Univ Bari Ldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.
   [Yu-Wai-Man, Patrick] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England.
   [Yu-Wai-Man, Patrick] UCL Inst Ophthalmol, London, England.
   [Yu-Wai-Man, Patrick] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge, England.
   [Yu-Wai-Man, Patrick] Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge, England.
   [Chinnery, Patrick F.] Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cambridge, England.
   [Chinnery, Patrick F.] Univ Cambridge, Sch Clin Med, Med Res Council Mitochondria Biol Unit, Cambridge, England.
   [Hedstrom, Lizbeth] Brandeis Univ, Dept Chem, 415 South St, Waltham, MA 02254 USA.
   [Spinazzola, Antonella] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London, England.
   [Spinazzola, Antonella] Natl Hosp Neurol & Neurosurg, London, England.
C3 Newcastle University - UK; University of London; University College
   London; Brandeis University; University of London; University College
   London; Moorfields Eye Hospital NHS Foundation Trust; University of
   London; University College London; University of Cambridge; University
   of Cambridge; University of Cambridge; University of Cambridge; Brandeis
   University; University of London; University College London; University
   of London; University College London; UCL Medical School; University
   College London Hospitals NHS Foundation Trust
RP Taylor, RW (corresponding author), Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Neurosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.taylor@ncl.ac.uk
RI Bruni, Francesco/I-4074-2018; Rocha, Mariana/O-4313-2017; Spinazzola,
   Antonella/P-5791-2019; Spinazzola, Antonella/P-5298-2017
OI Spinazzola, Antonella/0000-0003-4242-8091; BRUNI,
   Francesco/0000-0001-5120-5936; Chinnery, Patrick/0000-0002-7065-6617
FU Evelyn Trust; Fight for Sight UK; Isaac Newton Trust; Medical Research
   Council UK [G1002570, MC_PC_13029, MC_UP_1501/2]; MRC Centre for
   Neuromuscular Diseases [G0601943]; MRC/ESPRC Newcastle Molecular
   Pathology Node; National Institute for Health Research (NIHR) Biomedical
   Research Centre based at Cambridge University Hospitals NHS Foundation
   Trust; Newcastle University Centre for Ageing and Vitality [G016354/1];
   NIHR Biomedical Research Centre based at Moorfields Eye Hospital NHS
   Foundation Trust; Lily Foundation; UK NHS Highly Specialised Service for
   Rare Mitochondrial Disorders; UK NIHR Biomedical Research Centre in Age
   and Age Related Diseases; Wellcome Centre for Mitochondrial Research
   [203105/Z/16/Z]; Wellcome Trust [212219/Z/18/Z]; MRC [G0701386,
   MC_PC_13029/2, MC_UU_00015/8, G1002570, G0601943, MC_UU_00015/9] Funding
   Source: UKRI
FX Evelyn Trust; Fight for Sight UK; Isaac Newton Trust; Medical Research
   Council UK, Grant/Award Numbers: G1002570, MC_PC_13029, MC_UP_1501/2;
   MRC Centre for Neuromuscular Diseases, Grant/Award Number: G0601943;
   MRC/ESPRC Newcastle Molecular Pathology Node; National Institute for
   Health Research (NIHR) Biomedical Research Centre based at Cambridge
   University Hospitals NHS Foundation Trust; Newcastle University Centre
   for Ageing and Vitality, Grant/Award Number: G016354/1; NIHR Biomedical
   Research Centre based at Moorfields Eye Hospital NHS Foundation Trust;
   The Lily Foundation; UK NHS Highly Specialised Service for Rare
   Mitochondrial Disorders; UK NIHR Biomedical Research Centre in Age and
   Age Related Diseases award to the Newcastle upon Tyne Hospitals NHS
   Foundation; Wellcome Centre for Mitochondrial Research, Grant/Award
   Number: 203105/Z/16/Z; Wellcome Trust, Grant/Award Number: 212219/Z/18/Z
CR Berglund AK, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006628
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bruni F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064670
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   Dalla Rosa I, 2014, NUCLEIC ACIDS RES, V42, P8500, DOI 10.1093/nar/gku513
   Deng YF, 2002, INT J BIOCHEM CELL B, V34, P1035, DOI 10.1016/S1357-2725(02)00024-9
   Di Noia MA, 2014, J BIOL CHEM, V289, P33137, DOI 10.1074/jbc.M114.610808
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Franzolin E, 2012, EXP CELL RES, V318, P2226, DOI 10.1016/j.yexcr.2012.05.028
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Gasteiger E., 2005, The proteomics protocols handbook, P571, DOI [DOI 10.1385/1592598900, 10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]
   Kalko SG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-91
   Håkansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Johnson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093597
   Lai YR, 2004, J BIOL CHEM, V279, P4490, DOI 10.1074/jbc.M307938200
   Lee EW, 2006, J BIOL CHEM, V281, P16700, DOI 10.1074/jbc.M513825200
   Li JX, 2006, J MOL BIOL, V355, P980, DOI 10.1016/j.jmb.2005.11.047
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Moss CF, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx1009
   Nicholls TJ, 2018, MOL CELL, V69, P9, DOI 10.1016/j.molcel.2017.11.033
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443
   Oláhová M, 2017, J INHERIT METAB DIS, V40, P121, DOI 10.1007/s10545-016-9977-2
   Oliveira R, 2017, JIMD REP, V33, P61, DOI 10.1007/8904_2016_581
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200
   Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109
   Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002
   Rocha MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15037
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Rosa ID, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005779
   Rosenberg MM, 2016, J BIOL CHEM, V291, P22988, DOI 10.1074/jbc.M116.739516
   Sommerville Ewen W, 2014, J Neuromuscul Dis, V1, P119
   Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102
   SPECTOR T, 1979, J BIOL CHEM, V254, P2308
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wang LY, 2016, NUCLEOS NUCLEOT NUCL, V35, P578, DOI 10.1080/15257770.2015.1125001
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 46
TC 7
Z9 7
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0009-9163
EI 1399-0004
J9 CLIN GENET
JI Clin. Genet.
PD FEB
PY 2020
VL 97
IS 2
BP 276
EP 286
DI 10.1111/cge.13652
EA NOV 2019
PG 11
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA KE5QB
UT WOS:000496413600001
PM 31600844
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Lin, Y
   Wang, JY
   Ren, H
   Ma, XT
   Wang, W
   Zhao, Y
   Xu, ZH
   Liu, SW
   Wang, WQ
   Xu, XB
   Wang, B
   Zhao, DD
   Wang, DD
   Li, W
   Liu, FC
   Zhao, YY
   Lu, JQ
   Yan, CZ
   Ji, KQ
AF Lin, Yan
   Wang, Jiayin
   Ren, Hong
   Ma, Xiaotian
   Wang, Wei
   Zhao, Ying
   Xu, Zhihong
   Liu, Shuangwu
   Wang, Wenqing
   Xu, Xuebi
   Wang, Bin
   Zhao, Dandan
   Wang, Dongdong
   Li, Wei
   Liu, Fuchen
   Zhao, Yuying
   Lu, Jianqiang
   Yan, Chuanzhu
   Ji, Kunqian
TI Mitochondrial myopathy without extraocular muscle involvement: a unique
   clinicopathologic profile
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE Mitochondrial disorders; MiMy; PEO; MELAS; Clinicopathologic features
ID DIFFERENTIATION FACTOR 15; EXERCISE INTOLERANCE; PERIPHERAL NEUROPATHY;
   MUTATIONS; DISEASE; COHORT; DIAGNOSIS; GENETICS
AB Objective Mitochondrial myopathy without extraocular muscles involvement (MiMy) represents a distinct form of mitochondrial disorder predominantly affecting proximal/distal or axial muscles, with its phenotypic, genotypic features, and long-term prognosis poorly understood.Methods A cross-sectional study conducted at a national diagnostic center for mitochondrial disease involved 47 MiMy patients, from a cohort of 643 mitochondrial disease cases followed up at Qilu Hospital from January 1, 2000, to January 1, 2021. We compared the clinical, pathological, and genetic features of MiMy to progressive external ophthalmoplegia (PEO) and mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) patients.Results MiMy patients demonstrated a more pronounced muscle involvement syndrome, with lower 6MWT scores, higher FSS, and lower BMI compared to PEO and MELAS patients. Serum levels of creatinine kinase (CK), lactate, and growth and differentiation factor 15 (GDF15) were substantially elevated in MiMy patients. Nearly a third (31.9%) displayed signs of subclinical peripheral neuropathy, mostly axonal neuropathy. Muscle biopsies revealed that cytochrome c oxidase strong (COX-s) ragged-red fibers (RRFs) were a typical pathological feature in MiMy patients. Genetic analysis predominantly revealed mtDNA point pathogenic variants (59.6%) and less frequently single (12.8%) or multiple (4.2%) mtDNA deletions. During the follow-up, a majority (76.1%) of MiMy patients experienced stabilization or improvement after therapeutic intervention.Conclusions This study provides a comprehensive profile of MiMy through a large patient cohort, elucidating its unique clinical, genetic, and pathological features. These findings offer significant insights into the diagnostic and therapeutic management of MiMy, ultimately aiming to ameliorate patient outcomes and enhance the quality of life.
C1 [Lin, Yan; Wang, Jiayin; Wang, Wei; Zhao, Ying; Xu, Zhihong; Liu, Shuangwu; Wang, Wenqing; Wang, Bin; Zhao, Dandan; Wang, Dongdong; Li, Wei; Liu, Fuchen; Zhao, Yuying; Yan, Chuanzhu; Ji, Kunqian] Shandong Univ, Qilu Hosp, Res Inst Neuromuscular & Neurodegenerat Dis, Cheeloo Coll Med, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
   [Lin, Yan; Wang, Jiayin; Wang, Wei; Zhao, Ying; Xu, Zhihong; Liu, Shuangwu; Wang, Wenqing; Wang, Bin; Zhao, Dandan; Wang, Dongdong; Li, Wei; Liu, Fuchen; Zhao, Yuying; Yan, Chuanzhu; Ji, Kunqian] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
   [Ren, Hong] Shandong Univ Tradit Chinese Med, Dept Neurol, Affiliated Hosp, Jinan 250012, Shandong, Peoples R China.
   [Ma, Xiaotian; Yan, Chuanzhu] Shandong Univ, Qilu Hosp Qingdao, Mitochondrial Med Lab, Qingdao 266035, Shandong, Peoples R China.
   [Xu, Xuebi] Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurol, Nanbaixiang St, Wenzhou 325000, Peoples R China.
   [Lu, Jianqiang] McMaster Univ, Dept Pathol & Mol Med, Neuropathol Sect, Hamilton, ON, Canada.
   [Yan, Chuanzhu] Shandong Univ, Brain Sci Res Inst, Jinan 250012, Shandong, Peoples R China.
C3 Shandong University; Shandong University; Shandong University of
   Traditional Chinese Medicine; Shandong University; Wenzhou Medical
   University; McMaster University; Shandong University
RP Ji, KQ (corresponding author), Shandong Univ, Qilu Hosp, Res Inst Neuromuscular & Neurodegenerat Dis, Cheeloo Coll Med, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.; Ji, KQ (corresponding author), Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
EM jikunqian@email.sdu.edu.cn
RI zhao, dandan/AAP-3407-2021; LU, JIAN-QIANG/AAL-1634-2020; Liu,
   Shuangwu/LKL-9856-2024; zhou, chen/KHW-8121-2024; wang,
   Dongdong/AAN-1786-2020; zhou, yuwei/KHD-4127-2024
OI Lin, Yan/0000-0003-0282-6749
FU National Key R&D Program of China [2021YFC2700904]; National Natural
   Science Foundation of China [82171394, 82071412, 82301590]; Shandong
   Provincial Postdoctoral Innovation Talent Support Program [SDBX2022061];
   Natural Science Foundation of Shandong Province [ZR2023QH106]; People's
   Benefit Project of Science and Technology in Qingdao [20-3-4-42-nsh,
   22-8-7-smjk-1-nsh]; Taishan Scholars Program of Shandong Province
FX We thank the Grants from the National Key R&D Program of China (No.
   2021YFC2700904), National Natural Science Foundation of China (Nos.
   82171394, 82071412 and 82301590), Shandong Provincial Postdoctoral
   Innovation Talent Support Program (No. SDBX2022061), Natural Science
   Foundation of Shandong Province (No. ZR2023QH106), People's Benefit
   Project of Science and Technology in Qingdao (20-3-4-42-nsh,
   22-8-7-smjk-1-nsh), and the Taishan Scholars Program of Shandong
   Province.
CR Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426
   Bermejo-Guerrero L, 2023, J CLIN MED, V12, DOI 10.3390/jcm12062435
   Bin Dayel FF, 2023, BIOMEDICINES, V11, DOI 10.3390/biomedicines11051485
   Boal RL, 2019, J CLIN ENDOCR METAB, V104, P2057, DOI 10.1210/jc.2018-00957
   Darin N, 2017, EUR J NEUROL, V24, P587, DOI 10.1111/ene.13249
   de la Hoz CPDF, 2021, MOL GENET METAB REP, V26, DOI 10.1016/j.ymgmr.2020.100701
   Di Donato S, 2009, J NEUROL, V256, P693, DOI 10.1007/s00415-009-5028-3
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Doughty CT, 2018, AM J MED, V131, P1010, DOI 10.1016/j.amjmed.2017.12.042
   Horvath R, 2006, NEUROLOGY, V66, P253, DOI 10.1212/01.wnl.0000194241.35115.7c
   Horvath Rita, 2023, Handb Clin Neurol, V194, P99, DOI 10.1016/B978-0-12-821751-1.00014-2
   Huddar A, 2021, MITOCHONDRION, V60, P170, DOI 10.1016/j.mito.2021.08.011
   Ji KQ, 2020, J NEUROL, V267, P3319, DOI 10.1007/s00415-020-10017-z
   Karaa A, 2023, NEUROLOGY, V101, pE238, DOI 10.1212/WNL.0000000000207402
   Kim-Muller JY, 2023, CELL REP, V42, DOI 10.1016/j.celrep.2022.111947
   Krag TO, 2013, MITOCHONDRION, V13, P63, DOI 10.1016/j.mito.2013.01.009
   Lehmann D, 2015, EUR J HUM GENET, V23, P1735, DOI 10.1038/ejhg.2015.73
   Lehtonen JM, 2021, J INHERIT METAB DIS, V44, P469, DOI 10.1002/jimd.12307
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Lin Y, 2021, MITOCHONDRION, V57, P1, DOI 10.1016/j.mito.2020.11.015
   Lin Y, 2020, ANN CLIN TRANSL NEUR, V7, P1204, DOI 10.1002/acn3.51104
   Lu JQ, 2021, MITOCHONDRION, V56, P52, DOI 10.1016/j.mito.2020.11.005
   Lu YY, 2017, J NEUROL SCI, V379, P137, DOI 10.1016/j.jns.2017.05.056
   Luigetti M, 2016, EUR J NEUROL, V23, P1020, DOI 10.1111/ene.12954
   Madsen KL, 2020, NEUROLOGY, V94, pE687, DOI 10.1212/WNL.0000000000008861
   Mancuso M, 2017, NEUROMUSCULAR DISORD, V27, P1126, DOI 10.1016/j.nmd.2017.08.006
   Mancuso M, 2016, NEUROMUSCULAR DISORD, V26, P272, DOI 10.1016/j.nmd.2016.02.008
   Massie R, 2010, MUSCLE NERVE, V42, P136, DOI 10.1002/mus.21649
   Meola G, 2012, J NEUROL, V259, P601, DOI 10.1007/s00415-011-6193-8
   Montano V, 2022, J NEUROL, V269, P6555, DOI 10.1007/s00415-022-11324-3
   Montano V, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000519
   Mori Masato, 2002, Nihon Rinsho, V60 Suppl 4, P302
   Morris A, 2020, NAT REV ENDOCRINOL, V16, P129, DOI 10.1038/s41574-020-0327-y
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   Orsucci D, 2018, EBIOMEDICINE, V30, P3, DOI 10.1016/j.ebiom.2018.03.007
   Ost M, 2020, EMBO REP, V21, DOI 10.15252/embr.201948804
   Pareyson D, 2013, LANCET NEUROL, V12, P1011, DOI 10.1016/S1474-4422(13)70158-3
   Xiao MQ, 2017, FREE RADICAL BIO MED, V111, P316, DOI 10.1016/j.freeradbiomed.2017.04.363
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Zanolini A, 2017, MOL GENET METAB REP, V10, P24, DOI 10.1016/j.ymgmr.2016.11.009
NR 44
TC 1
Z9 1
U1 2
U2 3
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD FEB
PY 2024
VL 271
IS 2
BP 864
EP 876
DI 10.1007/s00415-023-12005-5
EA OCT 2023
PG 13
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA IX5R7
UT WOS:001087737400002
PM 37847292
DA 2024-11-01
ER

PT J
AU Hirano, M
   Lagier-Tourenne, C
   Valentino, ML
   Martí, R
   Nishigaki, Y
AF Hirano, M
   Lagier-Tourenne, C
   Valentino, ML
   Martí, R
   Nishigaki, Y
TI Thymidine phosphorylase mutations cause instability of mitochondrial DNA
SO GENE
LA English
DT Article; Proceedings Paper
CT Meeting on Cross Talk between Nucleus and Organelles
CY SEP 15-18, 2004
CL Stazione Zool Anton Dohrn, Naples, ITALY
HO Stazione Zool Anton Dohrn
DE mitochondrial DNA; thymidine phosphorylase; MNGIE; nucleoside;
   nucleotide
ID CELL GROWTH-FACTOR; NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY MNGIE;
   MULTIPLE DELETIONS; TISSUE DISTRIBUTION; AUTOSOMAL-DOMINANT;
   GENE-MUTATIONS; EXPRESSION; DEPLETION; FIDELITY; MTDNA
AB Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive disorder characterized by ptosis and progressive external ophthalmoplegia, peripheral neuropathy, severe gastrointestinal dysmotility, cachexia and leukoencephalopathy. Muscle biopsies of MNGIE patients have revealed morphologically abnormal mitochondria and defects of respiratory chain enzymes. In addition, patients harbor depletion, multiple deletions, and point mutations of mitochondrial DNA (mtDNA). This disorder is caused by loss-of-function mutations in the gene encoding thymidine phosphorylase (TP) a cytosolic enzyme. In MNGIE patients, TP activity is very low or absent resulting in dramatically elevated levels of plasma thymidine and deoxyuridine. We have hypothesized that the increased levels of thymidine and deoxyuridine cause mitochondrial nucleotide pool imbalances that, in turn, generate mtDNA alterations. (c) 2005 Elsevier B.V. All rights reserved.
C1 Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.
   Hosp Univ Vall Hebron, Ctr Invest Bioquim & Biol Mol, Barcelona, Spain.
   Natl Inst Neurosci, Dept Neuromuscular Res, Natl Ctr Neurol & Psychiat, Tokyo, Japan.
C3 Columbia University; Hospital Universitari Vall d'Hebron; National
   Center for Neurology & Psychiatry - Japan
RP Columbia Univ, Coll Phys & Surg, Dept Neurol, 630 W 168th St,P&S 4-443, New York, NY 10032 USA.
EM mh29@columbia.edu
RI Martí, Ramon/Q-3442-2016
OI VALENTINO, MARIA LUCIA/0000-0001-5323-0115; Marti,
   Ramon/0000-0002-8273-9540
CR Brown NS, 1998, BIOCHEM J, V334, P1
   BUROKER NE, 1990, GENETICS, V124, P157
   Carrozzo R, 1998, NEUROLOGY, V50, P99, DOI 10.1212/WNL.50.1.99
   Croteau DL, 1999, MUTAT RES-DNA REPAIR, V434, P137, DOI 10.1016/S0921-8777(99)00025-7
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   FERSHT AR, 1979, P NATL ACAD SCI USA, V76, P4946, DOI 10.1073/pnas.76.10.4946
   Focher F, 2001, CURR CANCER DRUG TAR, V1, P141, DOI 10.2174/1568009013334232
   FOX SB, 1995, J PATHOL, V176, P183, DOI 10.1002/path.1711760212
   Gamez J, 2005, J NEUROL SCI, V228, P35, DOI 10.1016/j.jns.2004.09.034
   Gamez J, 2002, NEUROLOGY, V59, P455, DOI 10.1212/WNL.59.3.455
   Hirano M, 2004, TOP CURR GENET, V8, P177
   Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Hirano M, 1998, AM J HUM GENET, V63, P526, DOI 10.1086/301979
   Johnson AA, 2001, J BIOL CHEM, V276, P38090
   Kocaefe YÇ, 2003, EUR J HUM GENET, V11, P102, DOI 10.1038/sj.ejhg.5200908
   KUNKEL TA, 1988, J BIOL CHEM, V263, P14784
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Martí R, 2004, CLIN CHEM, V50, P120, DOI 10.1373/clinchem.2003.026179
   Martí R, 2003, BIOCHEM BIOPH RES CO, V303, P14, DOI 10.1016/S0006-291X(03)00294-8
   Martín MA, 2004, NEUROLOGY, V63, P1536
   Matsukawa K, 1996, BBA-MOL CELL RES, V1314, P71, DOI 10.1016/S0167-4889(96)00078-X
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Nishigaki Y, 2004, HUM MOL GENET, V13, P91, DOI 10.1093/hmg/ddh010
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Papadimitriou A, 1998, NEUROLOGY, V51, P1086, DOI 10.1212/WNL.51.4.1086
   PHEAR G, 1987, P NATL ACAD SCI USA, V84, P4450, DOI 10.1073/pnas.84.13.4450
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Song SW, 2003, J BIOL CHEM, V278, P43893, DOI 10.1074/jbc.C300401200
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Szigeti K, 2004, J MED GENET, V41, P125, DOI 10.1136/jmg.2003.013789
   WALTENBERGER J, 1992, FEBS LETT, V313, P129, DOI 10.1016/0014-5793(92)81428-O
   YOSHIMURA A, 1990, BIOCHIM BIOPHYS ACTA, V1034, P107, DOI 10.1016/0304-4165(90)90160-X
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   ZEVIANI M, 1992, J INHERIT METAB DIS, V15, P456, DOI 10.1007/BF01799604
NR 40
TC 41
Z9 42
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD JUL 18
PY 2005
VL 354
SI SI
BP 152
EP 156
DI 10.1016/j.gene.2005.04.041
PG 5
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Genetics & Heredity
GA 959DN
UT WOS:000231497200023
PM 15975738
DA 2024-11-01
ER

PT J
AU Mkaouar-Rebai, E
   Ellouze, E
   Chamkha, I
   Kammoun, F
   Triki, C
   Fakhfakh, F
AF Mkaouar-Rebai, Emna
   Ellouze, Emna
   Chamkha, Imen
   Kammoun, Fatma
   Triki, Chahnez
   Fakhfakh, Faiza
TI Molecular-Clinical Correlation in a Family With a Novel Heteroplasmic
   Leigh Syndrome Missense Mutation in the Mitochondrial Cytochrome c
   Oxidase III Gene
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE mitochondrial mutation; COXIII; Leigh syndrome; m.9478T > C
ID NONSENSE MUTATION; SUBUNIT-II; COX DEFICIENCY; DNA MUTATIONS; MTDNA;
   DISEASE; MYOPATHY; SURF1; SEGREGATION; DELETION
AB Cytochrome c oxidase is an essential component of the mitochondrial respiratory chain that catalyzes the reduction of molecular oxygen by reduced cytochrome c. In this study, the authors report the second mutation associated with Leigh syndrome in the blood and buccal mucosa of 2 affected members of a Tunisian family. It was a novel heteroplasmic missense mitochondrial mutation at nucleotide 9478 in the gene specifying subunit III of cytochrome c oxidase substituting the valine at position 91 to alanine in a highly conserved amino acid. It was found with a high mutant load in tissues derived from endoderm (buccal mucosa) and mesoderm (blood). However, it was nearly absent in tissue derived from ectoderm (hair follicles). It was absent in 120 healthy controls, and PolyPhen analysis showed that the hydropathy index changed from +1.276 to +0.242, and the number of structures of the 3D protein decreased from 39 to 32.
C1 [Mkaouar-Rebai, Emna; Chamkha, Imen; Fakhfakh, Faiza] Fac Med Sfax, Lab Genet Mol Humaine, Sfax 3029, Tunisia.
   [Ellouze, Emna; Kammoun, Fatma; Triki, Chahnez] CHU Hedi Chaker Sfax, Serv Neurol Infantile, Sfax, Tunisia.
C3 Universite de Sfax; Universite de Sfax; Hopital Hedi Chaker
RP Mkaouar-Rebai, E (corresponding author), Fac Med Sfax, Lab Genet Mol Humaine, Ave Magida Boulila, Sfax 3029, Tunisia.
EM emna_mkaouar@mai12world.com
RI MKAOUAR-REBAI, Emna/AAE-6650-2019; Triki, chahnez/AEZ-5216-2022;
   Abdelhedi, Fatma/AAT-3786-2021
OI kamoun, fatma/0000-0002-5058-7693; Mkaouar-Rebai,
   Emna/0000-0003-3095-510X; Chamkha, Imen/0000-0002-6919-585X
FU Ministry of Higher Education and Scientific Research in Tunisia
FX The author(s) disclosed receipt of the following financial support for
   the research and/or authorship of this article: this work was supported
   by the Ministry of Higher Education and Scientific Research in Tunisia.
CR Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P4211, DOI 10.1167/iovs.06-0295
   Abu-Amero Khaled K, 2005, Ophthalmic Genet, V26, P31, DOI 10.1080/13816810590918235
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   BRUNORI M, 1987, EUR J BIOCHEM, V169, P1, DOI 10.1111/j.1432-1033.1987.tb13572.x
   Campos Y, 2001, ANN NEUROL, V50, P409, DOI 10.1002/ana.1141
   Choi BO, 2008, EXP MOL MED, V40, P354, DOI 10.3858/emm.2008.40.3.354
   DiMauro S, 2003, NEW ENGL J MED, V349, P1294
   HALTIA T, 1989, EMBO J, V8, P3571, DOI 10.1002/j.1460-2075.1989.tb08529.x
   Hamblet NS, 2006, ELECTROPHORESIS, V27, P398, DOI 10.1002/elps.200500420
   Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   Hoffbuhr KC, 2000, J BIOL CHEM, V275, P13994, DOI 10.1074/jbc.275.18.13994
   Horváth R, 2005, NEUROMUSCULAR DISORD, V15, P851, DOI 10.1016/j.nmd.2005.09.005
   Horváth R, 2002, J MED GENET, V39, P812, DOI 10.1136/jmg.39.11.812
   JOHNS DR, 1994, J NEURO-OPHTHALMOL, V14, P135
   Karadimas CL, 2000, NEUROLOGY, V55, P644, DOI 10.1212/WNL.55.5.644
   Keightley JA, 1996, NAT GENET, V12, P410, DOI 10.1038/ng0496-410
   Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161
   Kollberg G, 2005, J NEUROPATH EXP NEUR, V64, P123, DOI 10.1093/jnen/64.2.123
   LERTRIT P, 1992, HUM GENET, V90, P251
   LEWIN HA, 1992, BIOTECHNIQUES, V13, P522
   MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O
   Matsumoto M, 1999, Ophthalmic Genet, V20, P153, DOI 10.1076/opge.20.3.153.2281
   McFarland R, 2007, CURR TOP DEV BIOL, V77, P113, DOI 10.1016/S0070-2153(06)77005-3
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Péquignot MO, 2001, J BIOL CHEM, V276, P15326, DOI 10.1074/jbc.M100388200
   Poulton J, 2002, REPRODUCTION, V123, P751, DOI 10.1530/rep.0.1230751
   Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   SAVONTAUS ML, 1995, BBA-MOL BASIS DIS, V1271, P261, DOI 10.1016/0925-4439(95)00037-5
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591
   Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Varlamov DA, 2002, HUM MOL GENET, V11, P1797, DOI 10.1093/hmg/11.16.1797
   Williams SL, 2004, J BIOL CHEM, V279, P7462, DOI 10.1074/jbc.M309232200
   Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807
   Wong LJC, 2001, AM J MED GENET, V102, P95, DOI 10.1002/1096-8628(20010722)102:1<95::AID-AJMG1412>3.0.CO;2-U
   Yao JB, 1999, HUM MOL GENET, V8, P2541, DOI 10.1093/hmg/8.13.2541
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 42
TC 20
Z9 20
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD JAN
PY 2011
VL 26
IS 1
BP 12
EP 20
DI 10.1177/0883073810371227
PG 9
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 703VE
UT WOS:000286008600003
PM 20525945
DA 2024-11-01
ER

PT J
AU Crimi, M
   Galbiati, S
   Sciacco, M
   Bordoni, A
   Natali, MG
   Raimondi, M
   Bresolin, N
   Comi, GP
AF Crimi, M
   Galbiati, S
   Sciacco, M
   Bordoni, A
   Natali, MG
   Raimondi, M
   Bresolin, N
   Comi, GP
TI Mitochondrial-DNA nucleotides G4298A and T10010C as pathogenic
   mutations: the confirmation in two new cases
SO MITOCHONDRION
LA English
DT Article
DE mitochondrial (mt)DNA; tRNA gene; encephalomyopathy and point mutation
ID C-OXIDASE DEFICIENCY; MYOCLONUS EPILEPSY; 2ND FAMILY; GENE; MYOPATHY;
   CARDIOMYOPATHY; PATIENT; OPHTHALMOPLEGIA
AB Mitochondrial encephalomyopathies are highly variable clinically and at the genetic level. In practice, when the mitochondrial DNA (mtDNA) of any mitochondrial-patient is sequenced, a very high number of variations are noted. The vast majority of these differences are simply polymorphisms, that is, non-pathologic, homoplasmic sequence variations; however, when a heteroplasmic variant is detected (co-existence of two different populations in the same tissue) this is clinically significant. We identified two different heteroplasmic mutations in the mtDNA of two subjects: G4298A in the tRNA(Ala) (Alanine) gene and T10010C in the tRNA(Gly) (Glycine), both of which have been reported previously. This work confirms the pathogenicity of these mutations and helps define the correlation between genotype and phenotype. (C) 2004 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 Univ Milan, Osped Maggiore Policlin, IRCCS, Ctr Dino Ferrari,Dipartimento Sci Neurol, I-20122 Milan, Italy.
   Univ Milan, Osped Maggiore Policlin, IRCCS, CEND,Dipartimento Sci Neurol, I-20122 Milan, Italy.
   IRCCS E Medea, Bosisio Parini, LC, Italy.
   Ist Sci San Raffaele, Milan, Italy.
   Osped Civile, Lugano, Switzerland.
C3 University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico;
   IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan;
   IRCCS Eugenio Medea; Vita-Salute San Raffaele University; IRCCS Ospedale
   San Raffaele
RP Univ Milan, Osped Maggiore Policlin, IRCCS, Ctr Dino Ferrari,Dipartimento Sci Neurol, Via F Sforza 35, I-20122 Milan, Italy.
EM marcreamy@tiscali.it
RI Crimi, Marco/A-4032-2008; Comi, Giacomo/K-5702-2016; Sciacco,
   Monica/AAC-6500-2022; Galbiati, Sara/AAA-7115-2020
OI Crimi, Marco/0000-0001-6903-9163; Sciacco, Monica/0000-0003-4593-4977;
   Bresolin, Nereo/0000-0001-6694-3595; Comi, Giacomo/0000-0002-1383-5248;
   Galbiati, Sara/0000-0001-6810-359X
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Bidooki SK, 1997, AM J HUM GENET, V60, P1430, DOI 10.1086/515460
   Bruno C, 1999, J PEDIATR-US, V135, P197, DOI 10.1016/S0022-3476(99)70022-3
   Dubowitz V., 1985, MUSCLE BIOPSY PRACTI, V2nd
   Goldstein JD, 1999, PEDIATR DEVEL PATHOL, V2, P78, DOI 10.1007/s100249900094
   Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601
   IOANESCU VV, 1994, NEUROLOGY, V44, P975
   Jaksch M, 1998, ANN NEUROL, V44, P635, DOI 10.1002/ana.410440409
   Karadimas CL, 2002, NEUROMUSCULAR DISORD, V12, P865, DOI 10.1016/S0960-8966(02)00072-X
   Mansergh FC, 1999, AM J HUM GENET, V64, P971, DOI 10.1086/302344
   Moraes C T, 1996, Methods Enzymol, V264, P522, DOI 10.1016/S0076-6879(96)64046-4
   Nishigaki Y, 2002, NEUROLOGY, V58, P1282, DOI 10.1212/WNL.58.8.1282
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Sacconi S, 2002, ARCH NEUROL-CHICAGO, V59, P1013, DOI 10.1001/archneur.59.6.1013
   Santorelli FM, 1997, NEUROMUSCULAR DISORD, V7, P156, DOI 10.1016/S0960-8966(97)00444-6
   SWEENEY MG, 1993, Q J MED, V86, P435
   Tanji K, 2000, BRAIN PATHOL, V10, P422
   Taylor RW, 1998, BIOCHEM BIOPH RES CO, V243, P47, DOI 10.1006/bbrc.1997.8055
   Tulinius M, 2003, NEUROPEDIATRICS, V34, P87
   Uziel G, 2000, NEUROMUSCULAR DISORD, V10, P415, DOI 10.1016/S0960-8966(99)00115-7
   ZEVIANI M, 1990, AM J HUM GENET, V47, P904
NR 21
TC 7
Z9 8
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD APR
PY 2004
VL 3
IS 5
BP 279
EP 283
DI 10.1016/j.mito.2004.02.004
PG 5
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 818MZ
UT WOS:000221250500003
PM 16120360
DA 2024-11-01
ER

PT J
AU Shanske, S
   Wong, LJC
AF Shanske, S
   Wong, LJC
TI Molecular analysis for mitochondrial DNA disorders
SO MITOCHONDRION
LA English
DT Article; Proceedings Paper
CT 1st Mitochondrial Standards Workshop
CY 2002
CL Dallas, TX
SP United Mitochondrial Dis Fdn, Mitochondrial Res Soc, Natl Inst Stand & Technol
DE mitochondrial DNA; mitochondrial disorders; molecular analysis : DNA
   diagnosis
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; KEARNS-SAYRE-SYNDROME; TISSUE
   DISTRIBUTION; POINT MUTATIONS; DELETION; DISEASE; MTDNA; WOMAN;
   TRANSMISSION; DIAGNOSIS
AB In this article, we review the current methodologies used for the molecular diagnosis of mitochondrial DNA defects. Definition of mitochondrial disorders at the molecular level has been difficult because of both clinical and genetic heterogeneity. Direct DNA analysis for common point mutations and large mtDNA deletions is readily performed and can be done routinely. However, a large number of patients who have the clinical manifestations and muscle pathology findings consistent with mitochondrial DNA disorders do not have detectable common mutations. Additional mutation screening methods are required for the detection of rare and previously undescribed mutations in the mitochondrial genome. (C) 2004 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 Georgetown Univ, Med Ctr, Inst Mol & Human Genet, Washington, DC 20007 USA.
   Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.
C3 Georgetown University; Columbia University
RP Georgetown Univ, Med Ctr, Inst Mol & Human Genet, POB 571477,3800 Reservoir Rd,NW,Room M4000, Washington, DC 20007 USA.
EM wonglj@georgetown.edu
CR Akman CI, 2004, J CHILD NEUROL, V19, P258, DOI 10.1177/088307380401900403
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   BERNES SM, 1993, J PEDIATR-US, V123, P598, DOI 10.1016/S0022-3476(05)80962-X
   Boles RG, 1998, EUR J PEDIATR, V157, P643, DOI 10.1007/s004310050902
   Boles RG, 1997, LANCET, V350, P1299, DOI 10.1016/S0140-6736(05)62477-4
   Chabi B, 2003, CLIN CHEM, V49, P1309, DOI 10.1373/49.8.1309
   Chen TJ, 1999, CLIN CHEM, V45, P1162
   Chinnery PF, 1998, LANCET, V351, P448, DOI 10.1016/S0140-6736(05)78396-3
   DEMARCHI JM, 1994, HUM MUTAT, V4, P281, DOI 10.1002/humu.1380040409
   DiMauro S, 2002, MUSCLE NERVE, V26, P597, DOI 10.1002/mus.10194
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   DIMAURO S, 2003, MOL GENETIC BASIS NE, P189
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Gourlain K, 2003, HIV Med, V4, P287, DOI 10.1046/j.1468-1293.2003.00158.x
   Graff C, 2000, PRENATAL DIAG, V20, P426, DOI 10.1002/(SICI)1097-0223(200005)20:5<426::AID-PD845>3.3.CO;2-B
   Hirano M, 2003, MOL GENETIC BASIS NE, P197
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   KADOWAKI T, 1995, MUSCLE NERVE, pS137
   Lacbawan F, 2000, AM J MED GENET, V95, P266, DOI 10.1002/1096-8628(20001127)95:3<266::AID-AJMG13>3.3.CO;2-S
   LARSSON NG, 1992, AM J HUM GENET, V50, P360
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   LIANG MH, 2000, AM J MED GENET, V7, P385
   Michikawa Y, 1997, NUCLEIC ACIDS RES, V25, P2455, DOI 10.1093/nar/25.12.2455
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   Moraes C T, 1996, Methods Enzymol, V264, P522, DOI 10.1016/S0076-6879(96)64046-4
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   SERVIDEI S, 2003, NEUROMUSCULAR DISORD, V13, P685
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   SHANSKE S, 2004, IN PRESS AM J MED GE
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Sternberg D, 1998, HUM MOL GENET, V7, P33, DOI 10.1093/hmg/7.1.33
   Sue CM, 1999, J PEDIATR-US, V134, P696, DOI 10.1016/S0022-3476(99)70283-0
   SUOMALAINEN A, 1992, J NEUROL SCI, V111, P222, DOI 10.1016/0022-510X(92)90074-U
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   van den Bosch BJC, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e89
   Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   WARTELL RM, 1990, NUCLEIC ACIDS RES, V18, P2699, DOI 10.1093/nar/18.9.2699
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Wong LC, 2002, AM J HUM GENET, V71, P501
   Wong LJC, 1997, CLIN CHEM, V43, P1857
   Wong LJC, 2003, J MED GENET, V40
   Wong LJC, 2002, CLIN CHEM, V48, P1901
   Wong LJC, 2002, AM J MED GENET, V113, P59, DOI 10.1002/ajmg.10767
   Wong LJC, 2001, GENET MED, V3, P399, DOI 10.1097/00125817-200111000-00004
   Wong LJC, 2001, AM J MED GENET, V102, P95, DOI 10.1002/1096-8628(20010722)102:1<95::AID-AJMG1412>3.0.CO;2-U
   ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 54
TC 29
Z9 31
U1 2
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD SEP
PY 2004
VL 4
IS 5-6
BP 403
EP 415
DI 10.1016/j.mito.2004.07.026
PG 13
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Cell Biology; Genetics & Heredity
GA 885QS
UT WOS:000226172600007
PM 16120402
DA 2024-11-01
ER

PT J
AU Sanchez-Martinez, A
   Calleja, M
   Peralta, S
   Matsushima, Y
   Hernandez-Sierra, R
   Whitworth, AJ
   Kaguni, LS
   Garesse, R
AF Sanchez-Martinez, Alvaro
   Calleja, Manuel
   Peralta, Susana
   Matsushima, Yuichi
   Hernandez-Sierra, Rosana
   Whitworth, Alexander J.
   Kaguni, Laurie S.
   Garesse, Rafael
TI Modeling Pathogenic Mutations of Human Twinkle in <i>Drosophila</i>
   Suggests an Apoptosis Role in Response to Mitochondrial Defects
SO PLOS ONE
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; DNA-POLYMERASE-GAMMA; MULTIPLE
   DELETIONS; THYMIDINE PHOSPHORYLASE; LINKER REGION; HELICASE; MUTANT;
   REPLICATION; DISORDERS; PROTEINS
AB The human gene C10orf2 encodes the mitochondrial replicative DNA helicase Twinkle, mutations of which are responsible for a significant fraction of cases of autosomal dominant progressive external ophthalmoplegia (adPEO), a human mitochondrial disease caused by defects in intergenomic communication. We report the analysis of orthologous mutations in the Drosophila melanogaster mitochondrial DNA (mtDNA) helicase gene, d-mtDNA helicase. Increased expression of wild type d-mtDNA helicase using the UAS-GAL4 system leads to an increase in mtDNA copy number throughout adult life without any noteworthy phenotype, whereas overexpression of d-mtDNA helicase containing the K388A mutation in the helicase active site results in a severe depletion of mtDNA and a lethal phenotype. Overexpression of two d-mtDNA helicase variants equivalent to two human adPEO mutations shows differential effects. The A442P mutation exhibits a dominant negative effect similar to that of the active site mutant. In contrast, overexpression of d-mtDNA helicase containing the W441C mutation results in a slight decrease in mtDNA copy number during the third instar larval stage, and a moderate decrease in life span in the adult population. Overexpression of d-mtDNA helicase containing either the K388A or A442P mutations causes a mitochondrial oxidative phosphorylation (OXPHOS) defect that significantly reduces cell proliferation. The mitochondrial impairment caused by these mutations promotes apoptosis, arguing that mitochondria regulate programmed cell death in Drosophila. Our study of d-mtDNA helicase overexpression provides a tractable Drosophila model for understanding the cellular and molecular effects of human adPEO mutations.
C1 [Sanchez-Martinez, Alvaro; Peralta, Susana; Hernandez-Sierra, Rosana; Garesse, Rafael] Univ Autonoma Madrid, Fac Med, Dept Bioquim,Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, Madrid, Spain.
   [Sanchez-Martinez, Alvaro; Peralta, Susana; Hernandez-Sierra, Rosana; Garesse, Rafael] Univ Autonoma Madrid, Fac Med, Ctr Invest Biomed Red Enfermedades Raras, Madrid, Spain.
   [Sanchez-Martinez, Alvaro; Peralta, Susana; Hernandez-Sierra, Rosana; Garesse, Rafael] Hosp 12 Octubre I 12, Inst Invest Santitaria, Madrid, Spain.
   [Calleja, Manuel] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain.
   [Matsushima, Yuichi; Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.
   [Matsushima, Yuichi; Kaguni, Laurie S.] Michigan State Univ, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA.
   [Whitworth, Alexander J.] Univ Sheffield, Dept Biomed Sci, MRC Ctr Dev & Biomed Genet, Sheffield S10 2TN, S Yorkshire, England.
C3 Autonomous University of Madrid; Consejo Superior de Investigaciones
   Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas
   Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red;
   CIBERER; Autonomous University of Madrid; Hospital Universitario 12 de
   Octubre; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC -
   Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University
   of Madrid; Michigan State University; Michigan State University;
   University of Sheffield
RP Sanchez-Martinez, A (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Bioquim,Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, Madrid, Spain.
EM rafael.garesse@uam.es
RI Sanchez-Martinez, Alvaro/L-3851-2019; Garesse, Rafael/F-3836-2012;
   Whitworth, Alexander/D-3969-2009
OI Garesse, Rafael/0000-0002-0338-2281; Sanchez-Martinez,
   Alvaro/0000-0002-2728-6251; Whitworth, Alexander/0000-0002-1154-6629
FU Centre for Biomedical Research on Rare Diseases, Instituto de Salud
   Carlos III [PI 07/0167]; Comunidad de Madrid [GEN-0269/2006]; National
   Institutes of Health [GM45295]; MRC [MC_G1000735] Funding Source: UKRI
FX This work was supported by grants from the Centre for Biomedical
   Research on Rare Diseases, Instituto de Salud Carlos III (grant number
   PI 07/0167), and the Comunidad de Madrid (grant number GEN-0269/2006) to
   RG, and the National Institutes of Health (grant number GM45295) to LSK.
   ASM was a Fellow from the Comunidad de Madrid. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abdelwahid E, 2007, DEV CELL, V12, P793, DOI 10.1016/j.devcel.2007.04.004
   Abdelwahid E, 2011, BBA-MOL CELL RES, V1813, P597, DOI 10.1016/j.bbamcr.2010.10.008
   Adán C, 2008, J BIOL CHEM, V283, P12333, DOI 10.1074/jbc.M801342200
   Arama E, 2006, EMBO J, V25, P232, DOI 10.1038/sj.emboj.7600920
   Clayton D A, 2000, Hum Reprod, V15 Suppl 2, P11
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   El-Khoury R, 2009, GENETICS, V183, P861, DOI 10.1534/genetics.109.107813
   Frangini M, 2009, FEBS J, V276, P1104, DOI 10.1111/j.1742-4658.2008.06853.x
   Garesse R, 2001, GENE, V263, P1, DOI 10.1016/S0378-1119(00)00582-5
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303
   Haraguchi M, 2002, MOL CELL BIOL, V22, P5212, DOI 10.1128/MCB.22.14.5212-5221.2002
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Krieser RJ, 2009, APOPTOSIS
   Lefai E, 2000, MOL GEN GENET, V264, P37, DOI 10.1007/s004380000301
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Martínez-Azorín F, 2008, J NEUROCHEM, V105, P165, DOI 10.1111/j.1471-4159.2007.05122.x
   Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017
   Matsushima Y, 2004, J BIOL CHEM, V279, P26900, DOI 10.1074/jbc.M401643200
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   Mendes CS, 2006, EMBO REP, V7, P933, DOI 10.1038/sj.embor.7400773
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2
   Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50
   PATEL SS, 1994, BIOCHEMISTRY-US, V33, P7857, DOI 10.1021/bi00191a013
   Pickrell AM, 2009, J BIOENERG BIOMEMBR, V41, P453, DOI 10.1007/s10863-009-9245-3
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Umate Pavan, 2011, Commun Integr Biol, V4, P118, DOI 10.4161/cib.4.1.13844
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Walker DW, 2004, P NATL ACAD SCI USA, V101, P10290, DOI 10.1073/pnas.0403767101
   Wanrooij S, BIOCH BIOPHYS ACTA, V1797, P1378
   Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
   Ziviani E, AUTOPHAGY, V6
   Ziviani E, 2010, AUTOPHAGY, V6, P660, DOI 10.4161/auto.6.5.12242
NR 46
TC 17
Z9 19
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 28
PY 2012
VL 7
IS 8
AR e43954
DI 10.1371/journal.pone.0043954
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 998CA
UT WOS:000308213600064
PM 22952820
OA Green Accepted, gold, Green Published, Green Submitted
DA 2024-11-01
ER

PT J
AU Park, KP
   Kim, HS
   Kim, ES
   Park, YE
   Lee, CH
   Kim, DS
AF Park, Kyung-Pil
   Kim, Hyang-Sook
   Kim, Eun-Sook
   Park, Young-Eun
   Lee, Chang-Hoon
   Kim, Dae-Seong
TI <i>SLC25A4</i> and <i>C10ORF2</i> Mutations in Autosomal Dominant
   Progressive External Ophthalmoplegia
SO JOURNAL OF CLINICAL NEUROLOGY
LA English
DT Article
DE autosomal dominant trait; progressive external ophthalmoplegia;
   mutation; SLC25A4; C10ORF2
ID MITOCHONDRIAL-DNA DELETIONS; MULTIPLE DELETIONS; POLYMERASE-GAMMA;
   TWINKLE; GENE; PROTEIN
AB Background and Purpose Progressive external ophthalmoplegia (PEO) with Mendelian inheritance is a heterogeneous group of diseases associated with multiple deletions of mitochondrial DNA (mtDNA), which results from the disturbed replication and maintenance of mtDNA secondary to the mutations of nuclear genes including POLG, SLC25A4, C10ORF2, POLG2, OPA1, and RRM2B. The aim of this study was to identify the genetic defects underlying the pathology and clinical features in two Korean kindreds with autosomal dominant PEO.
   Methods Two pathologically proven PEO patients with a clear autosomal dominant pattern of inheritance were selected. To exclude a large-scale rearrangement, a long-range polymerase chain reaction (PCR) was performed using DNA extracted from biopsied muscle tissue taken from each patient. All coding regions and exon-intron boundaries of POLG, SLC25A4, C10ORF2, and POLG2 were amplified by PCR and directly sequenced.
   Results One patient showed multiple deletions of mtDNA on long-range PCR analysis, and two known heterozygous missense mutations in SLC25A4 (p.Asp104Gly) and C10ORF2 (p.Glu479Lys) were identified in each patient. The p.Asp104Gly mutation in SLC25A4 was identified in the patient with an early onset, slowly progressive, pure PEO phenotype, while the p.Glu479Lys mutation in C10ORF2 was identified in the other patient, with a late-onset disease and PEO plus phenotype.
   Conclusions Two mutations affecting nuclear genes were identified in Korean patients with autosomal dominant PEO. Further studies are necessary to identify the clear pathogenetic mechanisms and establish genotype-phenotype correlations in autosomal dominant PEO. J Clin Neurol 2011;7:25-30
C1 [Park, Kyung-Pil; Kim, Dae-Seong] Pusan Natl Univ, Yangsan Hosp, Dept Neurol, Yangsan 626770, South Korea.
   [Park, Kyung-Pil; Kim, Hyang-Sook; Kim, Eun-Sook; Park, Young-Eun; Lee, Chang-Hoon; Kim, Dae-Seong] Pusan Natl Univ, Sch Med, Med Res Inst, Yangsan 626770, South Korea.
   [Park, Young-Eun] Pusan Natl Univerd Hosp, Dept Neurol, Pusan, South Korea.
   [Lee, Chang-Hoon] Pusan Natl Univerd Hosp, Dept Pathol, Pusan, South Korea.
C3 Pusan National University; Pusan National University Hospital; Pusan
   National University; Pusan National University Hospital; Pusan National
   University; Pusan National University Hospital; Pusan National
   University; Pusan National University Hospital
RP Kim, DS (corresponding author), Pusan Natl Univ, Yangsan Hosp, Dept Neurol, Yangsan 626770, South Korea.
EM dskim@pusan.ac.kr
OI Park, Kyung-Pil/0000-0003-4952-3796
FU Pusan National University [2007-7]
FX This study was supported by a Medical Research Institute Grant (2007-7)
   from Pusan National University.
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   DiMauro S, GENEREVIEWS
   Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116
   GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KIM SH, 2006, J KOREAN NEUROL ASS, V24, P260
   Kleinle S, 1997, HUM GENET, V100, P643, DOI 10.1007/s004390050567
   KOH KN, 2004, J KOREAN CHILD NEURO, V12, P43
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   LI K, 1989, J BIOL CHEM, V264, P13998
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873
   SEONG MW, 2005, J KOREAN OPHTHALMOL, V46, P323
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 23
TC 9
Z9 11
U1 0
U2 1
PU KOREAN NEUROLOGICAL ASSOC
PI SEOUL
PA 1111 DAEIL BLD, 43 INSA-DONG, JONGNO-GU, SEOUL, 110-741, SOUTH KOREA
SN 1738-6586
J9 J CLIN NEUROL
JI J. Clin. Neurol.
PD MAR
PY 2011
VL 7
IS 1
BP 25
EP 30
DI 10.3988/jcn.2011.7.1.25
PG 6
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 751IQ
UT WOS:000289611100004
PM 21519523
OA Green Published, Green Accepted, Green Submitted, gold
DA 2024-11-01
ER

PT S
AU Krishnan, KJ
   Blackwood, JK
   Reeve, AK
   Turnbull, DM
   Taylor, RW
AF Krishnan, Kim J.
   Blackwood, John K.
   Reeve, Amy K.
   Turnbull, Douglass M.
   Taylor, Robert W.
BE Barnes, MR
   Breen, G
TI Detection of Mitochondrial DNA Variation in Human Cells
SO GENETIC VARIATION: METHODS AND PROTOCOLS
SE Methods in Molecular Biology
LA English
DT Article; Book Chapter
DE Mitochondrial DNA; Variation; Mutations; mtDNA disease; Polymorphisms;
   Ageing; Real-time PCR
ID REAL-TIME PCR; SUBSTANTIA-NIGRA NEURONS; POINT MUTATIONS; COMMON
   DELETION; MUSCLE-FIBERS; STEM-CELLS; RAPID IDENTIFICATION; INDIVIDUAL
   CELLS; SKELETAL-MUSCLE; DISEASE
AB The ability to detect mitochondrial DNA (mtDNA) variation within human cells is important not only to identify mutations causing mtDNA disease, but also as mtDNA mutations are being increasingly described in many ageing tissues and in complex diseases such as diabetes, neurodegeneration and cancer. In this review, we discuss the main molecular genetic techniques that can be applied to study the two main types of mtDNA mutation: point mutations and large-scale mtDNA rearrangements. We then describe in detail protocols routinely used within our laboratory to analyse mtDNA mutations in individual human cells such as single muscle fibres and individual neurons to study the relationship between mtDNA mutation load and respiratory chain dysfunction.
C1 [Krishnan, Kim J.; Blackwood, John K.; Reeve, Amy K.; Turnbull, Douglass M.; Taylor, Robert W.] Newcastle Univ, Mitochondrial Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 Newcastle University - UK
RP Krishnan, KJ (corresponding author), Newcastle Univ, Mitochondrial Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
RI Clugston, Kim/KBA-3107-2024
OI Blackwood, John/0000-0003-1511-7562; Reeve, Amy/0000-0002-4474-2204;
   Turnbull, Doug/0000-0002-8878-9901
FU Medical Research Council [G0700718] Funding Source: Medline; Wellcome
   Trust [074454] Funding Source: Medline; MRC [G0700718] Funding Source:
   UKRI
CR Bannwarth S, 2005, HUM MUTAT, V25, P575, DOI 10.1002/humu.20177
   Bannwarth S, 2006, NAT PROTOC, V1, P2037, DOI 10.1038/nprot.2006.318
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Blakely EL, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011296
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chabi B, 2003, CLIN CHEM, V49, P1309, DOI 10.1373/49.8.1309
   Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   *EM U CTR MOL MED, 2006, MITOMAP
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   JOHNSON MA, 1993, ANN NEUROL, V33, P28, DOI 10.1002/ana.410330106
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2007, NUCLEIC ACIDS RES, V35, P7399, DOI 10.1093/nar/gkm635
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Krishnan KJ, 2006, J INVEST DERMATOL, V126, P408, DOI 10.1038/sj.jid.5700099
   McDonald SAC, 2006, CELL CYCLE, V5, P808, DOI 10.4161/cc.5.8.2641
   Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Poe BG, 2007, ANAL BIOCHEM, V362, P193, DOI 10.1016/j.ab.2006.12.035
   Pogozelski WK, 2003, MITOCHONDRION, V2, P415, DOI 10.1016/S1567-7249(03)00033-3
   POULTON J, 1989, LANCET, V1, P236
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   TANNO Y, 1991, BIOCHEM BIOPH RES CO, V179, P880, DOI 10.1016/0006-291X(91)91900-W
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   van den Bosch BJC, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e89
   White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190
NR 47
TC 3
Z9 4
U1 0
U2 1
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1064-3745
BN 978-1-60327-366-4
J9 METHODS MOL BIOL
JI Methods Mol. Biol.
PY 2010
VL 628
BP 227
EP 257
DI 10.1007/978-1-60327-367-1_13
D2 10.1007/978-1-60327-367-1
PG 31
WC Biochemical Research Methods; Biochemistry & Molecular Biology
WE Book Citation Index – Science (BKCI-S)
SC Biochemistry & Molecular Biology
GA BRC40
UT WOS:000282342500013
PM 20238085
DA 2024-11-01
ER

PT J
AU Ni, J
   Liu, Z
   Yuan, YC
   Li, WZ
   Hu, YT
   Liu, P
   Hou, XR
   Zhu, XY
   Tang, XX
   Liang, MY
   Zheng, SQ
   Hou, X
   Du, J
   Tang, JG
   Jiang, H
   Shen, L
   Tang, BS
   Wang, JL
AF Ni, Jie
   Liu, Zhen
   Yuan, Yanchun
   Li, Wanzhen
   Hu, Yiting
   Liu, Pan
   Hou, Xiaorong
   Zhu, Xiangyu
   Tang, Xuxiong
   Liang, Mingyu
   Zheng, Siqi
   Hou, Xuan
   Du, Juan
   Tang, Jianguang
   Jiang, Hong
   Shen, Lu
   Tang, Beisha
   Wang, Junling
TI Mitochondrial genome variations are associated with amyotrophic lateral
   sclerosis in patients from mainland China
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE Amyotrophic lateral sclerosis; Long-range polymerase chain reaction;
   Mitochondrial DNA haplogroup; Mitochondrial DNA variation; Whole
   mitochondrial genome screening
ID DNA MUTATIONS; SKELETAL-MUSCLE; HAPLOGROUPS; DISEASE; REVISION; NEURONS;
   DAMAGE; GENES; ALS
AB Background Amyotrophic lateral sclerosis (ALS) is a late-onset neurodegenerative disorder. Mitochondrial dysfunction is involved in the complex pathophysiology of ALS; however, the role of mitochondrial DNA (mtDNA) variants in ALS is poorly understood. We aimed to elucidate the role of mtDNA variants in the pathogenesis of ALS. Methods The mitochondrial haplogroups of 585 ALS patients and 371 healthy controls were determined; 38 ALS patients and 42 controls underwent long-range polymerase chain reaction combined with next-generation sequencing technology to analyze whole mitochondrial genome variants. Results A higher percentage of variants accumulated in ALS patients than in controls. Analysis of coding region variations that were further stratified by mtDNA genes revealed that nonsynonymous variants were more vulnerable in ALS patients than in controls, particularly in the ND4L, ND5, and ATP8 genes. Moreover, pathogenic nonsynonymous variants tended to over-represent in ALS patients. Unsurprisingly, nonsynonymous variants were not related to the phenotype. Haplogroup analysis did not found evidence of association between haplogroups with the risk of ALS, however, patients belonging to haplogroup Y and M7c were prone to develop later onset of ALS. Conclusions This is the first study to profile mtDNA variants in ALS patients from mainland China. Our results suggest that an increase in the number of nonsynonymous variants is linked to the pathogenesis of ALS. Moreover, haplogroup Y and M7c may modulate the clinical expression of ALS. Our findings provide independent, albeit limited, evidence for the role of mtDNA in the pathogenesis of ALS.
C1 [Ni, Jie; Liu, Zhen; Yuan, Yanchun; Li, Wanzhen; Hu, Yiting; Liu, Pan; Hou, Xiaorong; Zhu, Xiangyu; Tang, Xuxiong; Hou, Xuan; Du, Juan; Jiang, Hong; Shen, Lu; Tang, Beisha; Wang, Junling] Cent South Univ, Xiangya Hosp, Dept Neurol, 87 Xiangya Rd, Changsha, Hunan, Peoples R China.
   [Liang, Mingyu; Zheng, Siqi] Cent South Univ, Xiangya Sch Med, Changsha, Hunan, Peoples R China.
   [Tang, Jianguang] Cent South Univ, Xiangya Hosp 2, Dept Neurol, Changsha, Hunan, Peoples R China.
   [Jiang, Hong; Shen, Lu; Tang, Beisha; Wang, Junling] Cent South Univ, Lab Med Genet, Changsha 410008, Hunan, Peoples R China.
   [Jiang, Hong; Shen, Lu; Tang, Beisha; Wang, Junling] Cent South Univ, Key Lab Hunan Prov Neurodegenerat Disorders, Changsha 410008, Hunan, Peoples R China.
   [Jiang, Hong; Shen, Lu; Tang, Beisha; Wang, Junling] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Dis, Changsha 410008, Hunan, Peoples R China.
C3 Central South University; Central South University; Central South
   University; Central South University; Central South University; Central
   South University
RP Wang, JL (corresponding author), Cent South Univ, Xiangya Hosp, Dept Neurol, 87 Xiangya Rd, Changsha, Hunan, Peoples R China.; Wang, JL (corresponding author), Cent South Univ, Lab Med Genet, Changsha 410008, Hunan, Peoples R China.; Wang, JL (corresponding author), Cent South Univ, Key Lab Hunan Prov Neurodegenerat Disorders, Changsha 410008, Hunan, Peoples R China.; Wang, JL (corresponding author), Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Dis, Changsha 410008, Hunan, Peoples R China.
EM junling.wang@csu.edu.cn
RI Li, Fan/JRY-4017-2023; Zhu, Xiangyu/IYS-8629-2023
FU National Key Research and Development Program of China [2018YFC1312003];
   Program of National Natural Science Foundation of China [81671120,
   81300981]; Natural Science Fund for Distinguished Young Scholars of
   Hunan province, China [2020JJ2057]; Project Program of National Clinical
   Research Center for Geriatric Disorders (Xiangya Hospital) [2020LNJJ13];
   Degree & Postgraduate Education Reform Project of Central South
   University [2020JGB136]
FX This work was supported by the National Key Research and Development
   Program of China (#2018YFC1312003); the Program of National Natural
   Science Foundation of China (#81671120, 81300981); and Natural Science
   Fund for Distinguished Young Scholars of Hunan province, China
   (#2020JJ2057); the Project Program of National Clinical Research Center
   for Geriatric Disorders (Xiangya Hospital) (#2020LNJJ13); and the Degree
   & Postgraduate Education Reform Project of Central South University
   (#2020JGB136).
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Artuso L, 2013, AMYOTROPH LAT SCL FR, V14, P261, DOI 10.3109/21678421.2012.735239
   Bi R, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.10.009
   Bris C, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00632
   Brown RH, 2017, NEW ENGL J MED, V377, P162, DOI [10.1056/NEJMra1603471, 10.1016/S0140-6736(17)31287-4, 10.1056/NEJMc1710379, 10.1038/nrdp.2017.85, 10.1016/S0140-6736(10)61156-7]
   Cha MY, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.122
   Chen YF, 2015, CHINESE MED J-PEKING, V128, P1748, DOI 10.4103/0366-6999.159348
   Chia R, 2018, LANCET NEUROL, V17, P94, DOI 10.1016/S1474-4422(17)30401-5
   Chinnery PF, 2007, NEUROGENETICS, V8, P65, DOI 10.1007/s10048-006-0066-9
   Coxhead J, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.036
   Fan L, 2013, MITOCHONDRION, V13, P360, DOI 10.1016/j.mito.2013.04.011
   Ghasemi M, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a024125
   Hoekstra JG, 2016, ANN NEUROL, V80, P301, DOI 10.1002/ana.24709
   Ingram CJE, 2012, AMYOTROPH LATERAL SC, V13, P341, DOI 10.3109/17482968.2012.654394
   Keeney PM, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-21
   Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794
   Ladd AC, 2017, BRAIN RES, V1667, P74, DOI 10.1016/j.brainres.2017.05.010
   Lott MT., 2013, CURR PROTOC BIOINF, V44, P1, DOI 10.1002/0471250953.bi0123s44
   Ludolph A, 2015, AMYOTROPH LAT SCL FR, V16, P291, DOI 10.3109/21678421.2015.1049183
   Lynch D, 2008, MITOCHONDRION, V8, P109, DOI 10.1016/j.mito.2007.09.002
   Mancuso M, 2004, NEUROSCI LETT, V371, P158, DOI 10.1016/j.neulet.2004.08.060
   Muratai T, 2008, FREE RADICAL RES, V42, P221, DOI 10.1080/10715760701877262
   Preste R, 2019, NUCLEIC ACIDS RES, V47, pD1202, DOI 10.1093/nar/gky1024
   Reiff DM, 2011, NEUROL SCI, V32, P883, DOI 10.1007/s10072-011-0735-9
   Ryan TE, 2014, MUSCLE NERVE, V50, P767, DOI 10.1002/mus.24223
   Siddiqui A, 2012, FREE RADICAL BIO MED, V53, P1478, DOI 10.1016/j.freeradbiomed.2012.06.008
   Stoccoro A, 2018, EPIGENOMICS-UK, V10, P1431, DOI 10.2217/epi-2018-0072
   Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Wei W, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-016-0404-6
   Yuan HY, 2020, GENE, V738, DOI 10.1016/j.gene.2020.144487
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
   Zhang W, 2014, J GENET GENOMICS, V41, P397, DOI 10.1016/j.jgg.2014.05.004
NR 33
TC 3
Z9 3
U1 0
U2 9
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD FEB
PY 2022
VL 269
IS 2
BP 805
EP 814
DI 10.1007/s00415-021-10659-7
EA JUN 2021
PG 10
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA YL5DP
UT WOS:000661792800002
PM 34129120
DA 2024-11-01
ER

PT J
AU Gorman, GS
   Pfeffer, G
   Griffin, H
   Blakely, EL
   Kurzawa-Akanbi, M
   Gabriel, J
   Sitarz, K
   Roberts, M
   Schoser, B
   Pyle, A
   Schaefer, AM
   McFarland, R
   Turnbull, DM
   Horvath, R
   Chinnery, PF
   Taylor, RW
AF Gorman, Grainne S.
   Pfeffer, Gerald
   Griffin, Helen
   Blakely, Emma L.
   Kurzawa-Akanbi, Marzena
   Gabriel, Jessica
   Sitarz, Kamil
   Roberts, Mark
   Schoser, Benedikt
   Pyle, Angela
   Schaefer, Andrew M.
   McFarland, Robert
   Turnbull, Douglass M.
   Horvath, Rita
   Chinnery, Patrick F.
   Taylor, Robert W.
TI Clonal Expansion of Secondary Mitochondrial DNA Deletions Associated
   With Spinocerebellar Ataxia Type 28
SO JAMA NEUROLOGY
LA English
DT Article
ID SPASTIC PARAPLEGIA; MUTATIONS; AFG3L2; DEGENERATION; IMPAIRMENT; SCA28
AB IMPORTANCE Progressive external ophthalmoplegia (PEO) is a common feature in adults with mitochondrial (mt) DNA maintenance disorders associated with somatic mtDNA deletions in muscle, yet the causal genetic defect in many patients remains undetermined.
   OBSERVATIONS Whole-exome sequencing identified a novel, heterozygous p.(Gly671Trp) mutation in the AFG3L2 gene encoding anmt protease-previously associated with dominant spinocerebellar ataxia type 28 disease-in a patient with indolent ataxia and PEO. Targeted analysis of a larger, genetically undetermined cohort of patients with PEO with suspected mtDNA maintenance abnormalities identified a second unrelated patient with a similar phenotype and a novel, heterozygous p.(Tyr689His) AFG3L2 mutation. Analysis of patient fibroblasts revealed mt fragmentation and decreased AFG3L2 transcript expression. Western blotting of patient fibroblast and muscle showed decreased AFG3L2 protein levels.
   CONCLUSIONS AND RELEVANCE Our observations suggest that AFG3L2 mutations are another important cause, albeit rare, of a late-onset ataxic PEO phenotype due to a disturbance of mtDNA maintenance.
C1 [Gorman, Grainne S.; Pfeffer, Gerald; Griffin, Helen; Blakely, Emma L.; Kurzawa-Akanbi, Marzena; Gabriel, Jessica; Sitarz, Kamil; Pyle, Angela; Schaefer, Andrew M.; McFarland, Robert; Turnbull, Douglass M.; Horvath, Rita; Chinnery, Patrick F.; Taylor, Robert W.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Gorman, Grainne S.; Blakely, Emma L.; McFarland, Robert; Turnbull, Douglass M.; Taylor, Robert W.] Newcastle Univ, Inst Ageing & Hlth, Natl Inst Hlth Res Biomed Res Ctr Ageing, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Pfeffer, Gerald; Griffin, Helen; Kurzawa-Akanbi, Marzena; Sitarz, Kamil; Pyle, Angela; Horvath, Rita; Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Roberts, Mark] Hope Hosp, Dept Neurol, Salford M6 8HD, Lancs, England.
   [Schoser, Benedikt] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80539 Munich, Germany.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle
   University - UK; University of Munich
RP Taylor, RW (corresponding author), Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Inst Ageing & Hlth, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.taylor@ncl.ac.uk
RI Inerbaev, Talgat/AAB-7633-2020; Horvath, Rita/AAY-7042-2020
OI Pfeffer, Gerald/0000-0002-7657-7098; McFarland,
   Robert/0000-0002-8833-2688; Schoser, Benedikt/0000-0002-2757-8131;
   Turnbull, Doug/0000-0002-8878-9901; Griffin, Helen
   R/0000-0002-5288-3322; Schaefer, Andrew/0000-0001-9891-7332; Horvath,
   Rita/0000-0002-9841-170X; Chinnery, Patrick/0000-0002-7065-6617;
   Kurzawa-Akanbi, Marzena/0000-0002-2482-2741; Gorman,
   Grainne/0000-0002-7585-3409
FU UK National Health Service (NHS) Specialised Service for Rare
   Mitochondrial Diseases of Adults and Children, Newcastle; National
   Institute for Health Research (NIHR) Biomedical Research Centre funding
   scheme based at Newcastle upon Tyne Hospitals NHS Foundation Trust;
   Newcastle University; Wellcome Trust Centre for Mitochondrial Research
   [096919Z/11/Z]; Medical Research Council (UK) Centre for Translational
   Muscle Disease Research [G0601943]; Medical Research Council (UK)
   Mitochondrial Disease Patient Cohort [G0800674]; UK NHS Highly
   Specialised Rare Mitochondrial Disorders of Adults and Children Service;
   Canadian Institutes of Health Research; EU FP7 TIRCON; NIHR Newcastle
   Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS
   Foundation Trust; MRC [MR/K006312/1, G0601943, G0800674] Funding Source:
   UKRI
FX This study was supported by the UK National Health Service (NHS)
   Specialised Service for Rare Mitochondrial Diseases of Adults and
   Children, Newcastle, and the National Institute for Health Research
   (NIHR) Biomedical Research Centre funding scheme based at Newcastle upon
   Tyne Hospitals NHS Foundation Trust and Newcastle University. Drs
   Turnbull, Chinnery, and Taylor receive support from the Wellcome Trust
   Centre for Mitochondrial Research (096919Z/11/Z). Drs Taylor, Horvath,
   McFarland, Turnbull, and Gorman receive support from the Medical
   Research Council (UK) Centre for Translational Muscle Disease Research
   (G0601943). Drs Taylor, McFarland, and Turnbull are supported by the
   Medical Research Council (UK) Mitochondrial Disease Patient Cohort
   (G0800674) and the UK NHS Highly Specialised Rare Mitochondrial
   Disorders of Adults and Children Service. Dr Pfeffer is the recipient of
   a Bisby Fellowship from the Canadian Institutes of Health Research. Dr
   Chinnery is a Wellcome Trust senior fellow in clinical science
   (084980/Z/08/Z) and a UK NIHR senior investigator and receives
   additional support from EU FP7 TIRCON. Drs Turnbull and Chinnery are
   also funded by the NIHR Newcastle Biomedical Research Centre based at
   Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle
   University.
CR Cagnoli C, 2006, BRAIN, V129, P235, DOI 10.1093/brain/awh651
   Cagnoli C, 2010, HUM MUTAT, V31, P1117, DOI 10.1002/humu.21342
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   Di Bella D, 2010, NAT GENET, V42, P313, DOI 10.1038/ng.544
   Ferreirinha F, 2004, J CLIN INVEST, V113, P231, DOI 10.1172/JCI200420138
   Koppen M, 2007, MOL CELL BIOL, V27, P758, DOI 10.1128/MCB.01470-06
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Maltecca F, 2008, J NEUROSCI, V28, P2827, DOI 10.1523/JNEUROSCI.4677-07.2008
   Maltecca F, 2009, J NEUROSCI, V29, P9244, DOI 10.1523/JNEUROSCI.1532-09.2009
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Wedding IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086340
NR 12
TC 33
Z9 33
U1 1
U2 7
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD JAN
PY 2015
VL 72
IS 1
BP 106
EP 111
DI 10.1001/jamaneurol.2014.1753
PG 6
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA AY8PI
UT WOS:000347815300017
PM 25420100
OA Bronze
DA 2024-11-01
ER

PT J
AU Auré, K
   Fayet, G
   Lacène, E
   Romero, NB
   Lombès, A
AF Auré, K
   Fayet, G
   Lacène, E
   Romero, NB
   Lombès, A
TI Apoptosis in mitochondrial myopathies is linked to mitochondrial
   proliferation
SO BRAIN
LA English
DT Article
DE apoptosis; mitochondrial myopathies; mitochondrial DNA; deletion
ID C-OXIDASE DEFICIENCY; DNA DELETIONS; MUTATION LOAD; MUSCLE-FIBERS;
   CELL-DEATH; IN-VIVO; GENE; ENCEPHALOMYOPATHIES; DISORDERS; DEFECTS
AB Increased susceptibility to apoptosis has been shown in many models of mitochondrial defects but its relevance to human diseases is still discussed. We addressed the presence of apoptosis in muscle from patients with mitochondrial DNA (mtDNA) disorders. Taking advantage of the mosaic pattern of muscle morphological anomalies associated with heteroplasmic mtDNA alterations, we have used an in situ approach to address the relationship between apoptosis and respiratory defect, mitochondrial proliferation and mutation load. Different patterns of mitochondrial morphological alterations were provided by the analysis of muscles with large mtDNA deletion (16 cases) or with the MELAS mutation (4 cases). The patient's age at biopsy ranged from 0.4 to 66 years and the muscle mutant mtDNA proportion from 32 to 82%. Apoptotic muscle fibres were observed in a small proportion of muscle fibres of 16 out of the 20 biopsies by three different detection methods for different steps of apoptosis: caspase 3 activation, fragmentation of nuclear DNA [terminal deoxynucleotidyl transferase-mediated dUTP nick end labelling (TUNEL) assay] or overexpression of the pro-apoptotic factor Bax. Analysis of apoptotic features in parallel to cytochrome c oxidase (COX) and succinate dehydrogenase activity of more than 34 000 individual muscle fibres showed that apoptosis occurred only in muscle fibres with mitochondrial proliferation (ragged red fibres, RRF) irrespective of their COX activity. Molecular analyses of single muscle fibres evidenced that, as expected, the presence of COX defect was associated with higher proportion of mutant mtDNA and lower amount of normal mtDNA. Within COX-defective fibres, the presence of mitochondrial proliferation was associated with increase of the mtDNA content but without change in the ratio between normal and mutant mtDNA molecules, thus showing that mitochondrial proliferation was accompanied by similar amplification of normal and mutant mtDNA molecules. Within RRF, apoptosis was associated with higher mutation proportion, suggesting that it was provoked by severe respiratory defect in the same time as increased mitochondrial mass. In conclusion, apoptosis most probably contributes to mitochondrial pathology. It is tightly linked to mitochondrial proliferation and high mutation load. When considering training therapeutics, one will have to take into account the possibility to induce apoptosis in parallel to mitochondrial proliferation.
C1 Grp Hosp Pitie Salpetriere, INSERM, Inst Myol, F-75013 Paris, France.
   Univ Paris 06, F-75013 Paris, France.
   CHU Pitie Salpetriere, AP HP, Inst Myol, F-75013 Paris, France.
   Hop Ambroise Pare, AP HP, Boulogne, France.
   UFR Med Paris Ile France Ouest, Paris, France.
   Hop Morvan, Serv Anat Pathol, Brest, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Sorbonne
   Universite; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Pitie-Salpetriere - APHP; Assistance Publique Hopitaux
   Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; CHU Brest;
   Universite de Bretagne Occidentale
RP Grp Hosp Pitie Salpetriere, INSERM, Inst Myol, 47-83 Blvd Hop, F-75013 Paris, France.
EM a.lombes@myologie.chups.jussieu.fr
RI Lombes, Anne/G-4684-2014
CR Bernardi P, 2001, TRENDS BIOCHEM SCI, V26, P112, DOI 10.1016/S0968-0004(00)01745-X
   Carrozzo R, 2004, J NEUROCHEM, V90, P490, DOI 10.1111/j.1471-4159.2004.02505.x
   Chinnery PF, 2001, NEUROLOGY, V56, P1101, DOI 10.1212/WNL.56.8.1101
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Coulbault L, 2005, BIOCHEM BIOPH RES CO, V329, P1152, DOI 10.1016/j.bbrc.2005.02.083
   Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   DiMauro S, 2004, ANN NY ACAD SCI, V1011, P232, DOI 10.1196/annals.1293.023
   Duan WR, 2003, J PATHOL, V199, P221, DOI 10.1002/path.1289
   Fagiolari G, 2002, MUSCLE NERVE, V26, P265, DOI 10.1002/mus.10172
   FORMICHI P, 2003, CYTOL PATHOL, V35, P29
   Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221
   HAMMANS SR, 1992, BRAIN, V115, P343, DOI 10.1093/brain/115.2.343
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Ikezoe K, 2002, ACTA NEUROPATHOL, V103, P531, DOI 10.1007/s00401-001-0502-8
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Leonard JV, 2000, LANCET, V355, P389, DOI 10.1016/S0140-6736(99)05226-5
   Liu CY, 2004, ANN NY ACAD SCI, V1011, P133, DOI 10.1196/annals.1293.014
   McKenzie M, 2004, NEUROCHEM RES, V29, P589, DOI 10.1023/B:NERE.0000014829.42364.dd
   Mirabella M, 2000, BRAIN, V123, P93, DOI 10.1093/brain/123.1.93
   OLDFORS A, 1992, J NEUROL SCI, V110, P169, DOI 10.1016/0022-510X(92)90025-G
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   PRELLE A, 1994, ACTA NEUROPATHOL, V87, P371
   Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3
   Sciacco M, 2001, NEUROLOGY, V56, P1070, DOI 10.1212/WNL.56.8.1070
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Sternberg D, 1998, HUM MOL GENET, V7, P33, DOI 10.1093/hmg/7.1.33
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Taivassalo T, 1998, NEUROLOGY, V50, P1055, DOI 10.1212/WNL.50.4.1055
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2004, BBA-BIOENERGETICS, V1659, P221, DOI 10.1016/j.bbabio.2004.09.007
   Tanji K, 2000, BRAIN PATHOL, V10, P422
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Umaki Y, 2002, ACTA NEUROPATHOL, V103, P163
   Wang JM, 2001, P NATL ACAD SCI USA, V98, P4038, DOI 10.1073/pnas.061038798
   Wyllie A H, 1980, Int Rev Cytol, V68, P251
   Zhang D, 2003, CARDIOVASC RES, V57, P147, DOI 10.1016/S0008-6363(02)00695-8
NR 39
TC 62
Z9 69
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD MAY
PY 2006
VL 129
BP 1249
EP 1259
DI 10.1093/brain/awl061
PN 5
PG 11
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 035JV
UT WOS:000236998000019
PM 16537564
OA Bronze
DA 2024-11-01
ER

PT J
AU Rygiel, KA
   Miller, J
   Grady, JP
   Rocha, MC
   Taylor, RW
   Turnbull, DM
AF Rygiel, K. A.
   Miller, J.
   Grady, J. P.
   Rocha, M. C.
   Taylor, R. W.
   Turnbull, D. M.
TI Mitochondrial and inflammatory changes in sporadic inclusion body
   myositis
SO NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
LA English
DT Article
DE atrophy; complex I; inflammation; mitochondria; mitochondrial deletions;
   sIBM
ID REAL-TIME PCR; DNA DELETIONS; MUSCLE-FIBERS; MUTATIONS; CELLS;
   QUANTIFICATION; MYOPATHIES; EXPRESSION; SINGLE
AB AimsSporadic inclusion body myositis (sIBM) is the most common late onset muscle disease causing progressive weakness. In light of the lack of effective treatment, we investigated potential causes underlying muscle wasting. We hypothesized that accumulation of mitochondrial respiratory deficiency in muscle fibres may lead to fibre atrophy and degeneration, contributing to muscle mass reduction.
   MethodsHistochemical and immunohistochemical analyses were performed on muscle biopsies from 16 sIBM patients to detect activity of mitochondrial enzymes and expression of mitochondrial respiratory chain proteins along with inflammatory markers respectively. Mitochondrial DNA mutations were assessed in single muscle fibres using real-time PCR.
   ResultsWe identified respiratory-deficient fibres at different stages of mitochondrial dysfunction, with downregulated expression of complex I of mitochondrial respiratory chain being the initial feature. We detected mitochondrial DNA rearrangements in the majority of individual respiratory-deficient muscle fibres. There was a strong correlation between number of T lymphocytes and macrophages residing in muscle tissue and the abundance of respiratory-deficient fibres. Moreover, we found that respiratory-deficient muscle fibres were more likely to be atrophic compared with respiratory-normal counterparts.
   ConclusionsOur findings suggest that mitochondrial dysfunction has a role in sIBM progression. A strong correlation between the severity of inflammation, degree of mitochondrial changes and atrophy implicated existence of a mechanistic link between these three parameters. We propose a role for inflammatory cells in the initiation of mitochondrial DNA damage, which when accumulated, causes respiratory dysfunction, fibre atrophy and ultimately degeneration of muscle fibres.
C1 [Rygiel, K. A.; Grady, J. P.; Rocha, M. C.; Taylor, R. W.; Turnbull, D. M.] Newcastle Univ, Inst Ageing & Hlth, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Rygiel, K. A.; Turnbull, D. M.] Newcastle Univ, Inst Ageing & Hlth, Sch Med, Ctr Brain Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Miller, J.] Newcastle Upon Tyne Hosp NHS Fdn Trust Royal Vict, Dept Neurol, Newcastle Upon Tyne, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle Upon
   Tyne Hospitals NHS Foundation Trust
RP Turnbull, DM (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM doug.turnbull@newcastle.ac.uk
RI Rocha, Mariana/O-4313-2017
OI Rocha, Mariana/0000-0002-0056-9315; Grady, John/0000-0001-9667-3872;
   Turnbull, Doug/0000-0002-8878-9901
FU Newcastle University Centre for Brain Ageing and Vitality; Biotechnology
   and Biological Sciences Research Council; Engineering and Physical
   Sciences Research Council; Economic and Social Research Council; Medical
   Research Council [G0700718]; UK NIHR Biomedical Research Centre in Age
   and Age Related Diseases; MRC Centre for Neuromuscular Disease
   [G000608-1]; Wellcome Trust Centre for Mitochondrial Research
   [096919/Z/11/Z]; Lily Foundation; UK NHS Highly Specialised 'Rare
   Mitochondrial Disorders of Adults and Children' Service; MRC [G0700718,
   MR/K000608/1] Funding Source: UKRI
FX This work was funded by Newcastle University Centre for Brain Ageing and
   Vitality [supported by the Biotechnology and Biological Sciences
   Research Council, Engineering and Physical Sciences Research Council,
   Economic and Social Research Council and Medical Research Council
   (G0700718)], the UK NIHR Biomedical Research Centre in Age and Age
   Related Diseases award to the Newcastle upon Tyne Hospitals NHS
   Foundation Trust, MRC Centre for Neuromuscular Disease (G000608-1), The
   Wellcome Trust Centre for Mitochondrial Research (096919/Z/11/Z), The
   Lily Foundation and the UK NHS Highly Specialised 'Rare Mitochondrial
   Disorders of Adults and Children' Service.
CR ARAHATA K, 1986, ANN NEUROL, V19, P112, DOI 10.1002/ana.410190203
   Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109
   Dahlbom K, 2002, NEUROMUSCULAR DISORD, V12, P853, DOI 10.1016/S0960-8966(02)00098-6
   Dalakas MC, 2011, NEUROPATH APPL NEURO, V37, P226, DOI 10.1111/j.1365-2990.2010.01153.x
   Dubowitz V., 2007, Muscle Biopsy: A Practical Approach
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Engel WK, 1998, NEUROLOGY, V51, P655, DOI 10.1212/WNL.51.3.655
   Fischer MT, 2012, BRAIN, V135, P886, DOI 10.1093/brain/aws012
   Greaves LC, 2009, AGING CELL, V8, P566, DOI 10.1111/j.1474-9726.2009.00505.x
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Hilton-Jones D, 2010, NEUROMUSCULAR DISORD, V20, P622, DOI [10.1016/j.nmd.2010.07.087, 10.1016/j.nmd.2009.11.003]
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   McKiernan SH, 2009, EXP GERONTOL, V44, P170, DOI 10.1016/j.exger.2008.09.014
   Miró O, 1998, BRIT J RHEUMATOL, V37, P1047
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Oldfors A, 2006, NEUROLOGY, V66, pS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107
   Tateyama M, 2006, J NEUROL SCI, V249, P158, DOI 10.1016/j.jns.2006.06.021
   Tawil R, 2002, CURR OPIN RHEUMATOL, V14, P653, DOI 10.1097/00002281-200211000-00004
   Taylor RW, 2000, METH MOLEC MED, V38, P265, DOI 10.1385/1-59259-070-5:265
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Temiz P, 2009, J NEUROL SCI, V278, P25, DOI 10.1016/j.jns.2008.11.010
   Waschbisch A, 2010, J NEUROIMMUNOL, V225, P137, DOI 10.1016/j.jneuroim.2010.03.013
NR 28
TC 71
Z9 77
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0305-1846
EI 1365-2990
J9 NEUROPATH APPL NEURO
JI Neuropathol. Appl. Neurobiol.
PD APR
PY 2015
VL 41
IS 3
BP 288
EP 303
DI 10.1111/nan.12149
PG 16
WC Clinical Neurology; Neurosciences; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pathology
GA CD2LY
UT WOS:000350911100002
PM 24750247
OA Green Published
DA 2024-11-01
ER

PT J
AU Nakhonsri, V
   Kaewsutthi, S
   Suktitipat, B
   Suthammarak, W
   Chuenkongkaew, WL
   Wasitthankasem, R
   Tongsima, S
   Lertrit, P
AF Nakhonsri, Vorthunju
   Kaewsutthi, Supannee
   Suktitipat, Bhoom
   Suthammarak, Wichit
   Chuenkongkaew, Wanicha L.
   Wasitthankasem, Rujipat
   Tongsima, Sissades
   Lertrit, Patcharee
TI Exome Sequencing Reveals a Rare Autosomal Dominant Variant in MSTO1 Gene
   as a Novel Leber's Hereditary Optic Neuropathy (LHON) Modifier in a Thai
   Family with High Penetrance of G11778A Mutation
SO JOURNAL OF HEALTH RESEARCH
LA English
DT Article
DE LHON; G11778A mtDNA; MSTO1; Nuclear modifier
ID MITOCHONDRIAL-DNA MUTATIONS; AMINO-ACID SUBSTITUTIONS; DATABASE;
   PROTEIN; IDENTIFICATION; PREDICTIONS; MYOPATHY; SPECTRUM; DYNAMICS;
   ATROPHY
AB Background: Leber's hereditary optic neuropathy (LHON) is a prevalent mitochondrial disease that is predominantly caused by mitochondrial (mtDNA) mutations. However, not all siblings with identical LHON mutations develop visual impairment, suggesting the influence of nuclear genetic variants. This study explores the role of these variants in LHON expression among siblings and relatives with the same maternal LHON mutations. Methods: A family with a homoplasmic G11778A mutation displaying significant LHON penetrance (50 % in female carriers) was examined. Exome sequencing was performed on four members (two affected, two unaffected). Detected variations were predicted using a Variant Effect Predictor (VEP) with a dbNSFP (database for nonsynonymous single nucleotide polymorphisms' functional predictions) plugin. Candidate variants were chosen based on their scores and LHON-related gene variations. Sanger sequencing was used for validation of 15 family members. Results: Exome analysis identified nine potential variations across eight genes. However, only the MSTO1 c.692 693delCC mutation showed a significant linkage to LHON expression in both additive (adj. p -value = 0.04) and dominant models (adj. p -value = 0.0112). This rare variant, located at the cleavage and polyadenylation site of the MSTO1 gene, could disrupt transcriptional termination, and thus alter MSTO1 gene expression. Conclusions: Given the role of the MSTO1 gene in controlling mitochondrial morphology, the MSTO1 c.692 693delCC mutation might instigate mitochondrial dysfunction. Thus, the MSTO1 gene is potentially a novel nuclear modifier for LHON. These findings pave the way for further research into the underlying mechanisms of LHON.
C1 [Nakhonsri, Vorthunju; Kaewsutthi, Supannee; Suktitipat, Bhoom; Suthammarak, Wichit; Lertrit, Patcharee] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Biochem, Bangkok, Thailand.
   [Nakhonsri, Vorthunju; Wasitthankasem, Rujipat; Tongsima, Sissades] Natl Sci & Technol Dev Agcy, Natl Biobank Thailand, Pathum Thani 12120, Khong Luang, Thailand.
   [Chuenkongkaew, Wanicha L.] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Ophthalmol, Bangkok, Thailand.
C3 Mahidol University; National Science & Technology Development Agency -
   Thailand; Mahidol University
RP Lertrit, P (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Biochem, Bangkok, Thailand.
EM lertrito@yahoo.com
RI Tongsima, Sissades/F-4891-2011; Suktitipat, Bhoom/H-4239-2019;
   Nakhonsri, Vorthunju/Q-7104-2017
FU Royal Golden Jubilee PhD Program [PHD/0368/2552]; Mahidol University
   [R015820002]
FX Acknowledgements The authors would like to thank the patients and their
   families for their participation in this study. This work was supported
   by the Royal Golden Jubilee PhD Program (Grant PHD/0368/2552) to V.
   Nakhonsri and P. Lertrit, and Mahidol University (Grant No. R015820002)
   to P. Lertrit.
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Cagalinec M, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002511
   Cai Q, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010150
   Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055
   Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195
   Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109
   Clarke R, 2012, CANCER RES, V72, P1321, DOI 10.1158/0008-5472.CAN-11-3213
   Dagda RK, 2015, REV NEUROSCIENCE, V26, P359, DOI 10.1515/revneuro-2014-0085
   Delettre C, 2002, MOL GENET METAB, V75, P97, DOI 10.1006/mgme.2001.3278
   Donkervoort S, 2019, ACTA NEUROPATHOL, V138, P1013, DOI 10.1007/s00401-019-02059-z
   EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547
   Fu J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004579
   Gal A, 2017, EMBO MOL MED, V9, P967, DOI 10.15252/emmm.201607058
   Gehring NH, 2001, NAT GENET, V28, P389, DOI 10.1038/ng578
   Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343
   HARDING AE, 1995, AM J HUM GENET, V57, P77
   Hill JT, 2014, DEV DYNAM, V243, P1632, DOI 10.1002/dvdy.24183
   Janke C, 2020, NAT REV MOL CELL BIO, V21, P307, DOI 10.1038/s41580-020-0214-3
   Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7
   Kimura M, 2007, EXP CELL RES, V313, P1393, DOI 10.1016/j.yexcr.2007.02.004
   Kroeger H, 2019, FEBS J, V286, P399, DOI 10.1111/febs.14522
   Krueger SK, 2005, PHARMACOL THERAPEUT, V106, P357, DOI 10.1016/j.pharmthera.2005.01.001
   Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153
   Leber T., 1871, ARCH OPHTHALMOL-CHIC, V17, P249
   Lee KY, 2013, J CELL BIOL, V200, P31, DOI 10.1083/jcb.201206084
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   LI AR, 1995, J NEUROSCI, V15, P385
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li K, 2020, EUR J MED GENET, V63, DOI 10.1016/j.ejmg.2019.01.013
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376
   Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517
   López-Gallardo E, 2018, FOOD CHEM TOXICOL, V120, P89, DOI 10.1016/j.fct.2018.07.014
   MACKEY D, 1992, AM J HUM GENET, V51, P1218
   Mashima Y, 1998, CURR EYE RES, V17, P403, DOI 10.1080/02713689808951221
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4
   Nasca A, 2017, HUM MUTAT, V38, P970, DOI 10.1002/humu.23262
   NEWMAN NJ, 1993, ARCH NEUROL-CHICAGO, V50, P540, DOI 10.1001/archneur.1993.00540050082021
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Palmer CS, 2011, CELL SIGNAL, V23, P1534, DOI 10.1016/j.cellsig.2011.05.021
   Phasukkijwatana N, 2006, J HUM GENET, V51, P298, DOI 10.1007/s10038-006-0361-1
   Phasukkijwatana N, 2010, HUM GENET, V128, P39, DOI 10.1007/s00439-010-0821-8
   Plutino M, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-018-0568-y
   R Core Team, 2020, R: A Language and Environment for Statistical Computing
   Rubinstein WS, 2013, NUCLEIC ACIDS RES, V41, pD925, DOI 10.1093/nar/gks1173
   Sambrook J., 2006, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot4455, DOI 10.1101/PDB.PROT4455, 10.1101/pdb.prot4540, 10.1101/PDB.PROT4455]
   Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390
   Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890
   Sharma LK, 2020, HUM MOL GENET, V29, P352, DOI 10.1093/hmg/ddz224
   Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225
   Smibert P, 2012, CELL REP, V1, P277, DOI 10.1016/j.celrep.2012.01.001
   Sudoyo H, 2002, J HUM GENET, V47, P594, DOI 10.1007/s100380200091
   Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]
   Vaser R, 2016, NAT PROTOC, V11, P1, DOI 10.1038/nprot.2015.123
   Wagner AH, 2013, EXP EYE RES, V111, P105, DOI 10.1016/j.exer.2013.03.004
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Ye CT, 2019, RNA BIOL, V16, P785, DOI 10.1080/15476286.2019.1586139
   Yen MY, 2002, JPN J OPHTHALMOL, V46, P45, DOI 10.1016/S0021-5155(01)00460-9
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 62
TC 0
Z9 0
U1 0
U2 0
PU COLL PUBLIC HEALTH SCIENCES, CHULALONGKORN UNIV
PI BANGKOK
PA Sabbasastravicaya Building, 10-12 Floor for INST BUILDING 3 10 11 FLR,
   BANGKOK, 10330, THAILAND
SN 0857-4421
EI 2586-940X
J9 J HEALTH RES
JI J. Health Res.
PY 2024
VL 38
IS 3
PG 12
WC Health Care Sciences & Services
WE Emerging Sources Citation Index (ESCI)
SC Health Care Sciences & Services
GA KJ3K9
UT WOS:001179551200001
DA 2024-11-01
ER

PT J
AU Reddy, P
   Ocampo, A
   Suzuki, K
   Luo, J
   Bacman, SR
   Williams, SL
   Sugawara, A
   Okamura, D
   Tsunekawa, Y
   Wu, J
   Lam, D
   Xiong, X
   Montserrat, N
   Esteban, CR
   Liu, GH
   Sancho-Martinez, I
   Manau, D
   Civico, S
   Cardellach, F
   O'Callaghan, MD
   Campistol, J
   Zhao, H
   Campistol, JM
   Moraes, CT
   Belmonte, JCI
AF Reddy, Pradeep
   Ocampo, Alejandro
   Suzuki, Keiichiro
   Luo, Jinping
   Bacman, Sandra R.
   Williams, Sion L.
   Sugawara, Atsushi
   Okamura, Daiji
   Tsunekawa, Yuji
   Wu, Jun
   Lam, David
   Xiong, Xiong
   Montserrat, Nuria
   Esteban, Concepcion Rodriguez
   Liu, Guang-Hui
   Sancho-Martinez, Ignacio
   Manau, Dolors
   Civico, Salva
   Cardellach, Francesc
   O'Callaghan, Maria del Mar
   Campistol, Jaime
   Zhao, Huimin
   Campistol, Josep M.
   Moraes, Carlos T.
   Belmonte, Juan Carlos Izpisua
TI Selective Elimination of Mitochondrial Mutations in the Germline by
   Genome Editing
SO CELL
LA English
DT Article
ID DNA MUTATIONS; DISEASE; TRANSMISSION; HETEROPLASMY; DEGRADATION;
   SEQUENCE; EMBRYOS; DRIFT
AB Mitochondrial diseases include a group of maternally inherited genetic disorders caused by mutations in mtDNA. In most of these patients, mutated mtDNA coexists with wild-type mtDNA, a situation known as mtDNA heteroplasmy. Here, we report on a strategy toward preventing germline transmission of mitochondrial diseases by inducing mtDNA heteroplasmy shift through the selective elimination of mutated mtDNA. As a proof of concept, we took advantage of NZB/BALB heteroplasmic mice, which contain two mtDNA haplotypes, BALB and NZB, and selectively prevented their germline transmission using either mitochondria-targeted restriction endonucleases or TALENs. In addition, we successfully reduced human mutated mtDNA levels responsible for Leber's hereditary optic neuropathy (LHOND), and neurogenic muscle weakness, ataxia, and retinitis pigmentosa (NARP), in mammalian oocytes using mitochondria-targeted TALEN (mito-TALENs). Our approaches represent a potential therapeutic avenue for preventing the trans-generational transmission of human mitochondrial diseases caused by mutations in mtDNA.
C1 [Reddy, Pradeep; Ocampo, Alejandro; Suzuki, Keiichiro; Luo, Jinping; Sugawara, Atsushi; Okamura, Daiji; Wu, Jun; Lam, David; Esteban, Concepcion Rodriguez; Sancho-Martinez, Ignacio; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA.
   [Bacman, Sandra R.; Williams, Sion L.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
   [Tsunekawa, Yuji] RIKEN Ctr Dev Biol, Lab Cell Asymmetry, Kobe, Hyogo 6500047, Japan.
   [Xiong, Xiong; Zhao, Huimin] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
   [Montserrat, Nuria] Inst Bioengn Catalonia IBEC, Pluripotent Stem Cells & Organ Regenerat, Barcelona 08028, Spain.
   [Liu, Guang-Hui] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.
   [Liu, Guang-Hui] Ctr Mol & Translat Med CMTM, Beijing 100101, Peoples R China.
   [Liu, Guang-Hui] Beijing Inst Brain Disorders, Beijing 100069, Peoples R China.
   [Manau, Dolors; Civico, Salva] Univ Barcelona, Hosp Clin, Inst Clin Gynecol Obstet & Neonatol ICGON, E-08036 Barcelona, Spain.
   [Cardellach, Francesc] Univ Barcelona, IDIBAPS CIBER Rare Dis, Mitochondrial Res Lab, E-08036 Barcelona, Spain.
   [Cardellach, Francesc] Univ Barcelona, Dept Internal Med, Hosp Clin, E-08036 Barcelona, Spain.
   [O'Callaghan, Maria del Mar; Campistol, Jaime] Hosp Univ St Joan de Deu, Neuropediat Dept CIBERER, Esplugas de Llobregat 08950, Spain.
   [Campistol, Josep M.] Univ Barcelona, IDIBAPS, Hosp Clin, Renal Div, E-08036 Barcelona, Spain.
   [Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA.
C3 Salk Institute; University of Miami; RIKEN; University of Illinois
   System; University of Illinois Urbana-Champaign; University of
   Barcelona; Barcelona Institute of Science & Technology; Institut de
   Bioenginyeria de Catalunya; Chinese Academy of Sciences; Institute of
   Biophysics, CAS; University of Barcelona; Hospital Clinic de Barcelona;
   University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER -
   Centro de Investigacion Biomedica en Red; CIBERER; University of
   Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion
   Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de
   Barcelona; IDIBAPS; University of Miami
RP Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA.
EM belmonte@salk.edu
RI Moraes, Carlos/AAT-3818-2021; Manau, Dolors/D-8977-2019; Wu,
   Jun/AAF-1830-2019; Reddy, Pradeep/G-1770-2014; Montserrat,
   Nuria/F-3136-2016
OI Manau Trullas, Dolors/0000-0002-1377-9565; Ocampo,
   Alejandro/0000-0002-3731-3647; Wu, Jun/0000-0001-9863-1668; Reddy,
   Pradeep/0000-0002-9173-3845; Montserrat, Nuria/0000-0002-1603-1755;
   Josep M, Campistol/0000-0001-6244-0253; Suzuki,
   Keiichiro/0000-0001-5603-9105
FU Leona M. and Harry B. Helmsley Charitable Trust; NIH Ruth L. Kirschstein
   National Research Service Award Individual Postdoctoral Fellowship;
   National Basic Research Program of China (973 Program) [2015CB964800,
   2014CB964600]; Strategic Priority Research Program of the Chinese
   Academy of Sciences [XDA01020312]; National Natural Science Foundation
   of China (NSFC) [81271266, 31222039, 31201111, 81371342]; NIH
   [5R01EY010804, 1R01AG036871]; JDM Fund; Muscular Dystrophy Association;
   United Mitochondrial Disease Foundation; Florida Department of Health
   [3KN09]; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M.
   and Harry B. Helmsley Charitable Trust [2012-PG-MED002]
FX Financial support: M.M. Ku and S. Heinz are supported by the Leona M.
   and Harry B. Helmsley Charitable Trust. A.O. was partially supported by
   an NIH Ruth L. Kirschstein National Research Service Award Individual
   Postdoctoral Fellowship. G.-H.L. was supported by National Basic
   Research Program of China (973 Program, 2015CB964800; 2014CB964600), the
   Strategic Priority Research Program of the Chinese Academy of Sciences
   (XDA01020312), National Natural Science Foundation of China (NSFC:
   81271266; 31222039; 31201111; 81371342). C.T.M. was supported by NIH
   grants 5R01EY010804, 1R01AG036871, the JDM Fund, the Muscular Dystrophy
   Association and the United Mitochondrial Disease Foundation. S.L.W. is
   supported by Florida Department of Health Grant 3KN09. Work in the
   laboratory of J.C.I.B. was supported by the G. Harold and Leila Y.
   Mathers Charitable Foundation and the Leona M. and Harry B. Helmsley
   Charitable Trust (2012-PG-MED002).
CR Alexeyev M., 2013, COLD SPRING HARB PER, V5
   Alexeyev MF, 2008, GENE THER, V15, P516, DOI 10.1038/sj.gt.2008.11
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bacman SR, 2010, GENE THER, V17, P713, DOI 10.1038/gt.2010.25
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Brown DT, 2006, LANCET, V368, P87, DOI 10.1016/S0140-6736(06)68972-1
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Cree LM, 2009, BBA-MOL BASIS DIS, V1792, P1097, DOI 10.1016/j.bbadis.2009.03.002
   Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   Hayden EC, 2013, NATURE, V502, P284, DOI 10.1038/502284a
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Marc P, 2002, EMBO REP, V3, P159, DOI 10.1093/embo-reports/kvf025
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800
   Reinhardt K, 2013, SCIENCE, V341, P1345, DOI 10.1126/science.1237146
   Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Russell O, 2014, EXP CELL RES, V325, P38, DOI 10.1016/j.yexcr.2014.03.012
   Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431
   Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Vogel G, 2014, SCIENCE, V343, P827, DOI 10.1126/science.343.6173.827
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220
   Wang T, 2014, CELL, V157, P1591, DOI 10.1016/j.cell.2014.04.042
NR 32
TC 219
Z9 251
U1 0
U2 102
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD APR 23
PY 2015
VL 161
IS 3
BP 459
EP 469
DI 10.1016/j.cell.2015.03.051
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA CG8JN
UT WOS:000353553600008
PM 25910206
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Okulla, T
   Kunz, WS
   Klockgether, T
   Schröder, R
   Kornblum, C
AF Okulla, T
   Kunz, WS
   Klockgether, T
   Schröder, R
   Kornblum, C
TI Diagnostic value of mitochondrial DNA mutation analysis in juvenile
   unilateral ptosis
SO GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
LA English
DT Article
ID DISEASES; FEATURES
AB Purpose: To highlight the diagnostic relevance of mitochondrial DNA ( mtDNA) mutation analysis in acquired juvenile unilateral upper eyelid ptosis. Methods: A 13-year-old boy presented with acquired, slowly progressive unilateral ptosis. We performed ophthalmological and neurological examinations, laboratory testing, skeletal muscle biopsy including histological and histochemical investigations, biochemical analysis of respiratory chain enzymes in skeletal muscle homogenate and molecular genetic testing of skeletal muscle DNA. Results: Though clinical, laboratory, histological and biochemical analyses did not reveal any hints suggesting a mitochondrial cytopathy, molecular genetic testing by Southern blot analysis of total DNA from skeletal muscle tissue showed a 5.8 kb mtDNA deletion thus proving the diagnosis of mitochondrial chronic progressive external ophthalmoplegia ( CPEO). Conclusions: In patients with unexplained acquired juvenile unilateral ptosis, an underlying mitochondrial cytopathy should be considered even in cases of inconspicuous ancillary examinations comprising skeletal muscle histology and biochemistry. To establish the diagnosis, molecular genetic testing of DNA derived from skeletal muscle tissue is essential in those patients.
C1 Univ Bonn, Dept Neurol, D-53105 Bonn, Germany.
   Univ Bonn, Dept Epileptol, D-53105 Bonn, Germany.
C3 University of Bonn; University of Bonn
RP Univ Bonn, Dept Neurol, Sigmund Freud Str 25, D-53105 Bonn, Germany.
EM cornelia.kornblum@ukb.uni-bonn.de
RI Kornblum, Cornelia/IUM-4180-2023; Schröder, Rolf/B-2774-2011; Kunz,
   Wolfram/K-1232-2019
OI Schroder, Rolf/0000-0002-2772-2615; Kunz, Wolfram/0000-0003-1113-3493
CR Biousse V, 2003, CURR OPIN NEUROL, V16, P35, DOI 10.1097/00019052-200302000-00005
   Chinnery PF, 1997, J NEUROL NEUROSUR PS, V63, P559, DOI 10.1136/jnnp.63.5.559
   DiMauro S, 2001, SEMIN NEUROL, V21, P251, DOI 10.1055/s-2001-17942
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Goetz C., 1999, TXB CLIN NEUROLOGY
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   Schröder R, 2000, J NEUROPATH EXP NEUR, V59, P353, DOI 10.1093/jnen/59.5.353
   Simon DK, 1999, ANNU REV MED, V50, P111
   Von Graefe A., 1867, SYMPTOMENLEHRE AUGEN
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
NR 10
TC 6
Z9 6
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0721-832X
EI 1435-702X
J9 GRAEF ARCH CLIN EXP
JI Graefes Arch. Clin. Exp. Ophthalmol.
PD APR
PY 2005
VL 243
IS 4
BP 380
EP 382
DI 10.1007/s00417-004-1000-1
PG 3
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA 922RW
UT WOS:000228856700016
PM 15864628
DA 2024-11-01
ER

PT J
AU Li, J
   Zhou, K
   Meng, X
   Wu, Q
   Li, S
   Liu, Y
   Wang, J
AF Li, J.
   Zhou, K.
   Meng, X.
   Wu, Q.
   Li, S.
   Liu, Y.
   Wang, J.
TI Increased ROS generation and SOD activity in heteroplasmic tissues of
   transmitochondrial mice with A3243G mitochondrial DNA mutation
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE Mitochondria; Mitochondrial DNA; A3243G mutation; Mitochondrial
   disorders; Transmitochondrial mice; Transmitochondrial
ID COMPLEX-I; MYOPATHY; DISEASE; MTDNA; MELAS; ACID; GENE
AB The mitochondrial A3243G tRNALeu(UUR) mutation associated with a variety of mitochondrial disorders results in a severe respiratory deficiency, an increase in reactive oxygen species (ROS) production and activities of anti-oxidative enzyme in vitro. However, the phenotypic implications of this mutation have not been described in vivo. Here, mitochondria carrying A3243G transition from the peripheral blood of diabetes mellitus patients were microinjected into zygotes. Influence of this mutation on mitochondrial respiratory enzyme activities, ROS generation, and antioxidative enzyme activities in the heteroplasmic tissues of transmitochondrial mice was evaluated. The chimeric mice exhibited a subtle impaired oxidative phosphorylation, reduced activity of complex I/IV, increased activity of superoxide dismutase, and in turn, enhanced ROS generation. Our results suggest that mitochondrial A3243G mutation may be responsible for the high ROS production in vivo. Increased generation of ROS caused by mtDNA mutation may also play a role in the pathogenesis of the A3243G mutationassociated diseases.
C1 [Li, J.; Meng, X.; Wu, Q.; Li, S.; Wang, J.] Capital Med Univ, Dept Lab Anim Sci, Beijing, Peoples R China.
   [Zhou, K.; Li, S.] Guangdong Med Coll, Dept Biochem, Dongguan, Peoples R China.
C3 Capital Medical University; Guangdong Medical University
RP Wang, J (corresponding author), Capital Med Univ, Dept Lab Anim Sci, Beijing, Peoples R China.
EM wangju53@263.net
RI xiao, ming/KHT-1774-2024; Li, Jixia/IQU-0730-2023
OI Li, Jixia/0000-0003-2218-5563
FU Beijing science and technology
FX Research supported by Beijing science and technology grant. We are
   grateful to Zhiyun Quan and other members (Institute of Laboratory
   Animal Sciences, Chinese Academy of Medical Sciences and Peking Union
   Medical College) for technical assistance, to Yanfei Huang (Beijing
   Tongren Hospital, China) for clinical sample collection and to Dr.
   Qunzhou Zhang (Center for Craniofacial Molecular Biology, University of
   Southern California School of Dentistry, USA) and Prof. Wengong Wang
   (Department of Biochemistry, Peking University) for insightful comments.
CR [Anonymous], CHIN GERM J CLIN ONC
   Beretta S, 2006, NEUROBIOL DIS, V24, P308, DOI 10.1016/j.nbd.2006.07.016
   Bonora E, 2006, CANCER RES, V66, P6087, DOI 10.1158/0008-5472.CAN-06-0171
   Carelli V, 2007, BIOSCIENCE REP, V27, P173, DOI 10.1007/s10540-007-9045-0
   Gardner JL, 2007, BIOSCIENCE REP, V27, P139, DOI 10.1007/s10540-007-9042-3
   Hervouet E, 2007, BIOCHIMIE, V89, P1080, DOI 10.1016/j.biochi.2007.03.010
   Ishikawa K, 2005, CIRC J, V 69, P617, DOI 10.1253/circj.69.617
   Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4
   KASRAIE S, 2008, CELL MOL NEUROBIOL
   Lionetti L, 2004, CELL MOL LIFE SCI, V61, P1366, DOI 10.1007/s00018-004-4073-4
   Long JG, 2007, BIOGERONTOLOGY, V8, P373, DOI 10.1007/s10522-007-9081-y
   Maechler P, 2006, BIOCHEM SOC T, V34, P824, DOI 10.1042/BST0340824
   McKenzie M, 2004, NEUROCHEM RES, V29, P589, DOI 10.1023/B:NERE.0000014829.42364.dd
   McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200
   Meany DL, 2006, FREE RADICAL BIO MED, V41, P950, DOI 10.1016/j.freeradbiomed.2006.06.003
   Meissner C, 2007, Z GERONTOL GERIATR, V40, P325, DOI 10.1007/s00391-007-0481-z
   Meulemans A, 2006, ARCH NEUROL-CHICAGO, V63, P1194, DOI 10.1001/archneur.63.8.1194
   Mkaouar-Rebai E, 2007, BIOCHEM BIOPH RES CO, V355, P1031, DOI 10.1016/j.bbrc.2007.02.083
   Panov AV, 2005, MOL CELL BIOCHEM, V269, P143, DOI 10.1007/s11010-005-3454-9
   Petrozzi L, 2007, BIOSCIENCE REP, V27, P87, DOI 10.1007/s10540-007-9038-z
   Pinkert CA, 1997, TRANSGENIC RES, V6, P379, DOI 10.1023/A:1018431316831
   Rusanen H, 2000, BBA-MOL BASIS DIS, V1500, P10, DOI 10.1016/S0925-4439(99)00081-2
   Sandhu JK, 2005, BIOCHEM J, V391, P191, DOI 10.1042/BJ20050272
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Urata M, 1998, CLIN CHEM, V44, P2088
   Vergani L, 2007, BRAIN, V130, P2715, DOI 10.1093/brain/awm151
   Vives-Bauza C, 2006, NEUROSCI LETT, V391, P136, DOI 10.1016/j.neulet.2005.08.049
   Wang ZX, 2002, CHINESE MED J-PEKING, V115, P995
   Zhang Ying, 2005, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V27, P77
NR 29
TC 17
Z9 18
U1 1
U2 5
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000,
   BRAZIL
SN 1676-5680
J9 GENET MOL RES
JI Genet. Mol. Res.
PY 2008
VL 7
IS 4
BP 1054
EP 1062
DI 10.4238/vol7-4gmr480
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 362WF
UT WOS:000260227200008
PM 19048484
OA Bronze
DA 2024-11-01
ER

PT J
AU Paradas, C
   Camaño, P
   Otaegui, D
   Oz, O
   Emmanuele, V
   DiMauro, S
   Hirano, M
AF Paradas, Carmen
   Camano, Pilar
   Otaegui, David
   Oz, Oguzhan
   Emmanuele, Valentina
   DiMauro, Salvatore
   Hirano, Michio
TI Longitudinal Clinical Follow-up of a Large Family With the R357P Twinkle
   Mutation
SO JAMA NEUROLOGY
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MITOCHONDRIAL-DNA DEPLETION;
   HELICASE; DELETIONS
AB IMPORTANCE Autosomal dominant progressive external ophthalmoplegia due to PEO1 mutations is considered relatively benign, but no data about long-term progression of this disease have been reported. The aim of this study was to provide a 16-year clinical follow-up of autosomal dominant progressive external ophthalmoplegia due to the p. R357P gene mutation in PEO1.
   OBSERVATIONS Twenty-two members of an Irish-American family were examined in 1996, when PEO1 sequencing revealed a c. 1071G>C/p. R357P mutation in 9 of them. We reexamined the family in 2012 using a standardized clinical protocol. Autosomal dominant progressive external ophthalmoplegia due to the p. R357P PEO1 mutation is a late-onset ocular myopathy beginning with ptosis and progressing slowly. Ophthalmoparesis, if present, is mild and evident only by neurological examination.
   CONCLUSIONS AND RELEVANCE Our results are important for prognosis and genetic counseling.
C1 [Paradas, Carmen] Univ Seville, CSIC, Hosp Univ Virgen Rocio, Inst Biomed Sevilla,Serv Neurol,Unidad Enfermedad, Seville, Spain.
   [Paradas, Carmen; Camano, Pilar] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Minist Econ & Competitiveness, Madrid, Spain.
   [Paradas, Carmen; Camano, Pilar; Otaegui, David; Oz, Oguzhan; Emmanuele, Valentina; DiMauro, Salvatore; Hirano, Michio] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.
   [Camano, Pilar] Ilundain Haritz Berri Fundazioa, Valle De Aranguren, Spain.
   [Camano, Pilar; Otaegui, David] Donostia Hosp, BioDonostia Hlth Res Inst, Dept Neurosci, San Sebastian, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); University of
   Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS);
   Virgen del Rocio University Hospital; Instituto de Salud Carlos III;
   Spanish Ministry of Economy & Competitiveness; CIBERNED; Columbia
   University; Instituto de Investigacion Sanitaria Biogipuzkoa; University
   Hospital Donostia
RP Hirano, M (corresponding author), Columbia Univ Coll Phys & Surg, 630 W 168th St,Room 4-423, New York, NY 10032 USA.
EM mh29@columbia.edu
RI Oz, Oguzhan/B-1237-2016; Otaegui, David/H-4390-2013; Camano,
   Pilar/B-7733-2018
OI Otaegui, David/0000-0002-6625-5976; Paradas, Carmen/0000-0002-6917-2236;
   Emmanuele, Valentina/0000-0002-4892-2042; Camano,
   Pilar/0000-0002-4116-5579; Oz, Oguzhan/0000-0002-9619-0464
FU Eunice Kennedy Shriver National Institute of Child Health and Human
   Development [HD32062, R01 HD057543, R01 HD056103]; National Institute of
   Neurological Disorders and Stroke [U54NS078059]; Marriott Mitochondrial
   Disorder Clinical Research Fund; Office of Dietary Supplements; Muscular
   Dystrophy Association; Spanish government, Health Institute Carlos III,
   Ministerio de Economia y Competitividad. [BA12/0097]
FX This study was supported by grant HD32062 from the Eunice Kennedy
   Shriver National Institute of Child Health and Human Development, by
   grant U54NS078059 from the National Institute of Neurological Disorders
   and Stroke and the Eunice Kennedy Shriver National Institute of Child
   Health and Human Development, and by the Marriott Mitochondrial Disorder
   Clinical Research Fund. Hirano was supported by grants R01 HD057543 and
   R01 HD056103 from the Eunice Kennedy Shriver National Institute of Child
   Health and Human Development and the Office of Dietary Supplements as
   well as by the Muscular Dystrophy Association. Paradas was supported by
   fellowship BA12/0097 from the Spanish government, Health Institute
   Carlos III, Ministerio de Economia y Competitividad.
CR Allen RC, 2012, BRIT J OPHTHALMOL, V96, P841, DOI 10.1136/bjophthalmol-2011-300667
   Bladen JC, 2012, ORBIT, V31, P114, DOI 10.3109/01676830.2011.648805
   Bohlega S, 2009, NEUROMUSCULAR DISORD, V19, P845, DOI 10.1016/j.nmd.2009.10.002
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Johnson JA, 1998, PHARMACOECONOMICS, V13, P421, DOI 10.2165/00019053-199813040-00005
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Martin-Negrier ML, 2011, EUR J NEUROL, V18, P436, DOI 10.1111/j.1468-1331.2010.03171.x
   Rivera H, 2007, NEUROMUSCULAR DISORD, V17, P677, DOI 10.1016/j.nmd.2007.05.006
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
NR 15
TC 3
Z9 3
U1 0
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60654-0946 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD NOV
PY 2013
VL 70
IS 11
BP 1425
EP 1428
DI 10.1001/jamaneurol.2013.3185
PG 4
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 295LG
UT WOS:000330117000013
PM 24018892
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Katsetos, CD
   Koutzaki, S
   Melvin, JJ
AF Katsetos, Christos D.
   Koutzaki, Sirma
   Melvin, Joseph J.
TI Mitochondrial Dysfunction in Neuromuscular Disorders
SO SEMINARS IN PEDIATRIC NEUROLOGY
LA English
DT Review
ID CONGENITAL MUSCULAR-DYSTROPHY; AMYOTROPHIC-LATERAL-SCLEROSIS;
   RESPIRATORY-CHAIN DYSFUNCTION; SKELETAL-MUSCLE FIBERS; MDX MOUSE MODEL;
   INFLAMMATORY MYOPATHIES; OXIDATIVE STRESS; CENTRONUCLEAR MYOPATHY;
   PERIPHERAL NEUROPATHY; LIPID-METABOLISM
AB This review deciphers aspects of mitochondrial (mt) dysfunction among nosologically, pathologically, and genetically diverse diseases of the skeletal muscle, lower motor neuron, and peripheral nerve, which fall outside the traditional realm of mt cytopathies. Special emphasis is given to well-characterized mt abnormalities in collagen VI myopathies (Ullrich congenital muscular dystrophy and Bethlem myopathy), megaconial congenital muscular dystrophy, limb-girdle muscular dystrophy type 2 (calpainopathy), centronuclear myopathies, core myopathies, inflammatory myopathies, spinal muscular atrophy, Charcot-Marie-Tooth neuropathy type 2, and drug-induced peripheral neuropathies. Among inflammatory myopathies, mt abnormalities are more prominent in inclusion body myositis and a subset of polymyositis with mt pathology, both of which are refractory to corticosteroid treatment. Awareness is raised about instances of phenotypic mimicry between cases harboring primary mtDNA depletion, in the context of mtDNA depletion syndrome, and established neuromuscular disorders such as spinal muscular atrophy. A substantial body of experimental work, derived from animal models, attests to a major role of mitochondria (mt) in the early process of muscle degeneration. Common mechanisms of mt-related cell injury include dysregulation of the mt permeability transition pore opening and defective autophagy. The therapeutic use of mt permeability transition pore modifiers holds promise in various neuromuscular disorders, including muscular dystrophies. (C) 2013 Published by Elsevier Inc.
C1 [Katsetos, Christos D.; Melvin, Joseph J.] Drexel Univ, Coll Med, St Christophers Hosp Children, Dept Pediat, Philadelphia, PA 19104 USA.
   [Katsetos, Christos D.; Koutzaki, Sirma] Drexel Univ, Coll Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
   [Katsetos, Christos D.; Melvin, Joseph J.] Drexel Univ, Coll Med, Dept Neurol, Philadelphia, PA 19104 USA.
C3 Drexel University; Drexel University; Drexel University
RP Katsetos, CD (corresponding author), St Christophers Hosp Children, Neurol Sect, 3601 A St, Philadelphia, PA 19134 USA.
EM Christos.Katsetos@drexelmed.edu
FU St. Christophers Foundation for Children
FX Supported in part by the St. Christophers Foundation for Children (CDK).
CR AFIFI AK, 1973, J NEUROL NEUROSUR PS, V36, P643, DOI 10.1136/jnnp.36.4.643
   Allison WS, 2009, METHODS ENZYMOLOGY A, V456
   Angelin A, 2008, BBA-BIOENERGETICS, V1777, P893, DOI 10.1016/j.bbabio.2008.03.026
   Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104
   [Anonymous], 1999, GENEREVIEWS
   ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   Askanas V, 2012, J NEUROPATH EXP NEUR, V71, P680, DOI 10.1097/NEN.0b013e31826183c8
   Baloh RH, 2008, NEUROSCIENTIST, V14, P12, DOI 10.1177/1073858407307354
   Baron D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026952
   Bartolome F, 2013, NEURON, V78, P57, DOI 10.1016/j.neuron.2013.02.028
   Bencze KZ, 2006, CRIT REV BIOCHEM MOL, V41, P269, DOI 10.1080/10409230600846058
   Bennett GJ, 2010, ONCOLOGIST, V15, P9, DOI 10.1634/theoncologist.2009-S503
   Berger A, 2003, ACTA NEUROPATHOL, V105, P245, DOI 10.1007/s00401-002-0638-1
   Berger P, 2006, GLIA, V54, P243, DOI 10.1002/glia.20386
   Bernardi P, 1999, ITAL J NEUROL SCI, V20, P395
   Bernardi P, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011387
   Bernardi P, 2008, ANN NY ACAD SCI, V1147, P303, DOI 10.1196/annals.1427.009
   Bevilacqua JA, 2009, ACTA NEUROPATHOL, V117, P283, DOI 10.1007/s00401-008-0472-1
   Boncompagni S, 2012, J BIOL CHEM, V287, P20534, DOI 10.1074/jbc.M112.359588
   Broglio L, 2010, NEUROLOGIST, V16, P340, DOI 10.1097/NRL.0b013e3181d35b39
   Buj-Bello A, 2008, HUM MOL GENET, V17, P2132, DOI 10.1093/hmg/ddn112
   Burelle Y, 2010, J MOL CELL CARDIOL, V48, P310, DOI 10.1016/j.yjmcc.2009.09.004
   Calore E. E., 1994, Pathologica (Genoa), V86, P649
   Cartoni R, 2009, EXP NEUROL, V218, P268, DOI 10.1016/j.expneurol.2009.05.003
   Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326
   Chowdhury SKR, 2013, NEUROBIOL DIS, V51, P56, DOI 10.1016/j.nbd.2012.03.016
   Chowdhury SKR, 2011, MITOCHONDRION, V11, P845, DOI 10.1016/j.mito.2011.06.007
   Cohen N, 2006, PROTEOMICS, V6, P6075, DOI 10.1002/pmic.200600199
   Constantin B, 2006, J MUSCLE RES CELL M, V27, P375, DOI 10.1007/s10974-006-9085-2
   Corti S, 2009, J NEUROL SCI, V276, P170, DOI 10.1016/j.jns.2008.09.030
   Cossarizza A, 2004, AIDS, V18, P137, DOI 10.1097/00002030-200401230-00002
   Crugnola V, 2010, ARCH NEUROL-CHICAGO, V67, P849, DOI 10.1001/archneurol.2010.128
   Dalton JC, 2006, GENEREVIEWS
   DiMauro S, 1998, BBA-BIOENERGETICS, V1366, P199, DOI 10.1016/S0005-2728(98)00113-3
   DOBKIN BH, 1976, NEUROLOGY, V26, P754, DOI 10.1212/WNL.26.8.754
   Durieux AC, 2010, HUM MOL GENET, V19, P4820, DOI 10.1093/hmg/ddq413
   Eisenberg I, 2008, HUM MOL GENET, V17, P3663, DOI 10.1093/hmg/ddn261
   Eschbach J, 2013, NEUROBIOL DIS, V58, P220, DOI 10.1016/j.nbd.2013.05.015
   EVEN PC, 1994, BIOCHEM J, V304, P649, DOI 10.1042/bj3040649
   Ferrier J, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0364-5
   Fidzianska A, 2012, MUSCLE NERVE, V46, P125, DOI 10.1002/mus.23365
   Frank S, 2006, ACTA NEUROPATHOL, V111, P93, DOI 10.1007/s00401-005-0002-3
   GANNOUNZAKI L, 1995, FEBS LETT, V375, P268, DOI 10.1016/0014-5793(95)01225-4
   Gardner K., 2013, Toxicol Pathol
   Gayathri N, 2011, INDIAN J PATHOL MICR, V54, P350, DOI 10.4103/0377-4929.81636
   Giacomello M, 2007, CELL DEATH DIFFER, V14, P1267, DOI 10.1038/sj.cdd.4402147
   Giacomotto J, 2013, HUM MOL GENET, V22, P4562, DOI 10.1093/hmg/ddt302
   GIMENO A, 1973, J NEUROL NEUROSUR PS, V36, P806, DOI 10.1136/jnnp.36.5.806
   Gissel H, 2005, ANN NY ACAD SCI, V1066, P166, DOI 10.1196/annals.1363.013
   GOBERNADO JM, 1980, J NEUROL NEUROSUR PS, V43, P546, DOI 10.1136/jnnp.43.6.546
   Godin Richard, 2012, J Physiol, V590, P5487, DOI 10.1113/jphysiol.2012.240390
   González-Cabo P, 2013, J NEUROCHEM, V126, P53, DOI 10.1111/jnc.12303
   Grumati P, 2011, AUTOPHAGY, V7, P426, DOI 10.4161/auto.7.4.14392
   Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247
   Herasse M, 2007, J NEUROPATH EXP NEUR, V66, P57, DOI 10.1097/NEN.0b013e31802d47ce
   Hervias I, 2006, MUSCLE NERVE, V33, P598, DOI 10.1002/mus.20489
   Herzig S, 2008, CURR MOL MED, V8, P131, DOI 10.2174/156652408783769625
   Hicks D, 2009, BRAIN, V132, P147, DOI 10.1093/brain/awn289
   Hirano M, 2008, ARCH NEUROL-CHICAGO, V65, P403, DOI 10.1001/archneurol.2007.65
   Hnia K, 2011, J CLIN INVEST, V121, P70, DOI 10.1172/JCI44021
   Huber N, 2013, EMBO REP, V14, P545, DOI 10.1038/embor.2013.56
   Jaggi AS, 2012, TOXICOLOGY, V291, P1, DOI 10.1016/j.tox.2011.10.019
   Jahnke VE, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-16
   Janes K, 2013, PAIN, V13
   Jongpiputvanich S, 2005, J CLIN NEUROSCI, V12, P426, DOI 10.1016/j.jocn.2004.06.014
   Jungbluth H, 2011, SEMIN PEDIATR NEUROL, V18, P239, DOI 10.1016/j.spen.2011.10.005
   Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082
   Katsetos CD, 2013, SEMIN PEDIATR NEUROL, V20, P216, DOI 10.1016/j.spen.2013.09.003
   Kramerova I, 2007, BBA-MOL BASIS DIS, V1772, P128, DOI 10.1016/j.bbadis.2006.07.002
   Kramerova I, 2009, HUM MOL GENET, V18, P3194, DOI 10.1093/hmg/ddp257
   Krasnianski A, 2005, BRAIN, V128, P1870, DOI 10.1093/brain/awh540
   Leinninger GM, 2006, NAT CLIN PRACT NEURO, V2, P620, DOI 10.1038/ncpneuro0320
   Liu N, 2011, J CLIN INVEST, V121, P3258, DOI 10.1172/JCI46267
   Mancuso M, 2003, ACTA NEUROPATHOL, V105, P621, DOI 10.1007/s00401-003-0699-9
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mason KE, 2005, ARCH BIOCHEM BIOPHYS, V437, P138, DOI 10.1016/j.abb.2005.03.004
   Menazza S, 2010, HUM MOL GENET, V19, P4207, DOI 10.1093/hmg/ddq339
   Merlini L, 2008, P NATL ACAD SCI USA, V105, P5225, DOI 10.1073/pnas.0800962105
   MHIRI C, 1991, ANN NEUROL, V29, P606, DOI 10.1002/ana.410290607
   Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736
   Milone M, 2012, NEUROLOGY, V78, P1612, DOI 10.1212/WNL.0b013e3182563c46
   Mitsuhashi S, 2013, CURR OPIN NEUROL, V26, P536, DOI 10.1097/WCO.0b013e328364c82d
   Mitsuhashi S, 2011, AM J HUM GENET, V88, P845, DOI 10.1016/j.ajhg.2011.05.010
   Molnar M, 1998, ACTA NEUROPATHOL, V96, P41, DOI 10.1007/s004010050858
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Moyle G, 2005, ANTIVIR THER S2, V10, pM47
   Moyle Graeme, 2004, J HIV Ther, V9, P45
   Nasu S, 2013, CLIN NEUROPHYSIOL, V13
   Nicolson GL, 2008, CLIN EXP METASTAS, V25, P161, DOI 10.1007/s10585-007-9129-z
   Niemann A, 2006, NEUROMOL MED, V8, P217, DOI 10.1385/NMM:8:1:217
   Nomura H, 2001, NEUROPATHOLOGY, V21, P212, DOI 10.1046/j.1440-1789.2001.00388.x
   Oldfors A, 2006, NEUROLOGY, V66, pS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   Oldfors A, 1999, CURR OPIN NEUROL, V12, P527, DOI 10.1097/00019052-199910000-00006
   Ouvrier R, 2010, DEV MED CHILD NEUROL, V52, P328, DOI 10.1111/j.1469-8749.2010.03613.x
   Palau F, 2009, ADV EXP MED BIOL, V652, P129, DOI 10.1007/978-90-481-2813-6_9
   Pauly M, 2012, AM J PATHOL, V181, P583, DOI 10.1016/j.ajpath.2012.04.004
   Pellegrini C, 2013, J CELL PHYSIOL, V228, P1323, DOI 10.1002/jcp.24290
   Percival JM, 2013, HUM MOL GENET, V22, P153, DOI 10.1093/hmg/dds415
   Pestronk A, 2011, CURR OPIN RHEUMATOL, V23, P595, DOI 10.1097/BOR.0b013e32834bab42
   Pons R, 1996, PEDIATR NEUROL, V15, P153, DOI 10.1016/0887-8994(96)00118-X
   POULTON J, 1995, J INHERIT METAB DIS, V18, P4, DOI 10.1007/BF00711367
   Quinlivan R, 2013, NEUROMUSCULAR DISORD, V23, P549, DOI 10.1016/j.nmd.2013.04.002
   Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310
   Reutenauer J, 2008, BRIT J PHARMACOL, V155, P574, DOI 10.1038/bjp.2008.285
   RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107
   Ríos PG, 2012, ARCH NEUROL-CHICAGO, V69, P657, DOI 10.1001/archneurol.2011.2333
   ROWLAND LP, 1991, REV NEUROL-FRANCE, V147, P467
   Rubio-Gozalbo ME, 1999, NEUROLOGY, V52, P383, DOI 10.1212/WNL.52.2.383
   Rusconi F, 2010, NEUROBIOL DIS, V38, P273, DOI 10.1016/j.nbd.2010.01.017
   Sabatelli P, 2012, J CELL PHYSIOL, V227, P2927, DOI 10.1002/jcp.23039
   SCHOLTE HR, 1980, J NEUROL SCI, V45, P217, DOI 10.1016/0022-510X(80)90167-7
   Schroder JM, 1997, MOL CELL BIOCHEM, V174, P277, DOI 10.1023/A:1006829129079
   Sewry CA, 2008, CURR OPIN NEUROL, V21, P569, DOI 10.1097/WCO.0b013e32830f93c7
   Siepmann T, 2013, ANN DIAGN PATHOL, V17, P183, DOI 10.1016/j.anndiagpath.2012.10.004
   Sperl W, 1997, MOL CELL BIOCHEM, V174, P71, DOI 10.1023/A:1006880529195
   Talwalkar SS, 2006, CLIN NEUROPATHOL, V25, P180
   Tecilazich F, 2013, J VASC SURG, V57, P997, DOI 10.1016/j.jvs.2012.10.011
   Telfer WR, 2010, HUM MOL GENET, V19, P2433, DOI 10.1093/hmg/ddq126
   Temiz P, 2009, J NEUROL SCI, V278, P25, DOI 10.1016/j.jns.2008.11.010
   Tinelli E, 2013, HUM MOL GENET, V22, P4417, DOI 10.1093/hmg/ddt292
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Turki A, 2012, FREE RADICAL BIO MED, V53, P1068, DOI 10.1016/j.freeradbiomed.2012.06.041
   Verkhratsky A, 2008, CELL CALCIUM, V44, P112, DOI 10.1016/j.ceca.2007.11.010
   Viader A, 2013, NEURON, V77, P886, DOI 10.1016/j.neuron.2013.01.012
   Vielhaber S, 1999, J NEUROL SCI, V169, P133, DOI 10.1016/S0022-510X(99)00236-1
   Wanschitz J, 2002, CLIN NEUROPATHOL, V21, P220
   Wiedemann FR, 1998, J NEUROL SCI, V156, P65, DOI 10.1016/S0022-510X(98)00008-2
   YAMAMOTO M, 1989, J NEUROL SCI, V91, P207, DOI 10.1016/0022-510X(89)90088-9
   Zenker J, 2013, TRENDS NEUROSCI, V36, P439, DOI 10.1016/j.tins.2013.04.008
   Zorzano A, 2009, CURR OPIN DRUG DISC, V12, P597
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 132
TC 55
Z9 64
U1 0
U2 16
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 1071-9091
EI 1558-0776
J9 SEMIN PEDIATR NEUROL
JI Semin. Pediatr. Neurol.
PD SEP
PY 2013
VL 20
IS 3
BP 202
EP 215
DI 10.1016/j.spen.2013.10.010
PG 14
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 269SK
UT WOS:000328262000006
PM 24331362
DA 2024-11-01
ER

PT J
AU Siciliano, G
   Volpi, L
   Piazza, S
   Ricci, G
   Mancuso, M
   Murri, L
AF Siciliano, Gabriele
   Volpi, Leda
   Piazza, Selina
   Ricci, Giulia
   Mancuso, Michelangelo
   Murri, Luigi
TI Functional diagnostics in mitochondrial diseases
SO BIOSCIENCE REPORTS
LA English
DT Article; Proceedings Paper
CT Conference on Mitochondrial Medicine
CY OCT 25, 2006
CL Univ Pisa, Dept Neurosci, Pisa, ITALY
HO Univ Pisa, Dept Neurosci
DE mitochondrial myopathy; exercise; muscle fatigue
ID CYTOCHROME-C-OXIDASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   MAGNETIC-RESONANCE-SPECTROSCOPY; COENZYME Q(10) DEFICIENCY;
   SKELETAL-MUSCLE; CEREBELLAR-ATAXIA; DNA DEPLETION; ANAEROBIC THRESHOLD;
   ENDURANCE EXERCISE; SPERM MITOCHONDRIA
AB Mitochondrial diseases (MD) with respiratory chain defects are caused by genetic mutations that determine an impairment of the electron transport chain functioning. Diagnosis often requires a complex approach with measurements of serum lactate, magnetic resonance spectroscopy (MRS), muscle histology and ultrastructure, enzymology, genetic analysis, and exercise testing. The ubiquitous distribution of the mitochondria in the human body explains the multiple organ involvement. Exercise intolerance is a common symptom of MD, due to increased dependence of skeletal muscle on anaerobic metabolism, with an excess lactate generation, phosphocreatine depletion, enhanced free radical production, reduced oxygen extraction and electron flux through the respiratory chain. MD treatment has included antioxidants (vitamin E, alpha lipoic acid), coenzyme Q10, riboflavin, creatine monohydrate, dichloroacetate and exercise training. Exercise is a particularly important tool in diagnosis as well as in the management of these diseases.
C1 Univ Pisa, Dept Neurosci, Neurol Sect, I-56126 Pisa, Italy.
C3 University of Pisa
RP Siciliano, G (corresponding author), Univ Pisa, Dept Neurosci, Neurol Sect, Cia Roma 67, I-56126 Pisa, Italy.
EM g.siciliano@med.unipi.it
RI Mancuso, Michelangelo/K-4170-2016; Ricci, Giulia/K-6731-2016
OI Ricci, Giulia/0000-0002-6612-5995
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038
   ANDERSEN P, 1977, ACTA PHYSIOL SCAND, V99, P123, DOI 10.1111/j.1748-1716.1977.tb10361.x
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106
   Argov Z, 2000, MUSCLE NERVE, V23, P1316, DOI 10.1002/1097-4598(200009)23:9<1316::AID-MUS2>3.3.CO;2-9
   ARGOV Z, 1987, NEUROLOGY, V37, P257, DOI 10.1212/WNL.37.2.257
   Auré K, 2004, NEUROLOGY, V63, P727, DOI 10.1212/01.WNL.0000134607.76780.B2
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902
   Bohr VA, 2002, GENE, V286, P127, DOI 10.1016/S0378-1119(01)00813-7
   BONNE G, 1993, EUR J BIOCHEM, V217, P1099, DOI 10.1111/j.1432-1033.1993.tb18342.x
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Cejudo P, 2005, MUSCLE NERVE, V32, P342, DOI 10.1002/mus.20368
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   Di Giovanni S, 2001, NEUROLOGY, V57, P515, DOI 10.1212/WNL.57.3.515
   DiMauro S, 1996, J INHERIT METAB DIS, V19, P489, DOI 10.1007/BF01799110
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602
   Edwards R H, 1981, Ciba Found Symp, V82, P1
   Fadic R, 1996, SEMIN NEUROL, V16, P11, DOI 10.1055/s-2008-1040954
   Finsterer J, 2000, METAB BRAIN DIS, V15, P163
   Gillis L, 2002, PEDIATR CLIN N AM, V49, P203, DOI 10.1016/S0031-3955(03)00115-9
   Gimenez-Roqueplo AP, 2002, J CLIN ENDOCR METAB, V87, P4771, DOI 10.1210/jc.2002-020525
   Gironi M, 2004, NEUROLOGY, V62, P818, DOI 10.1212/01.WNL.0000113719.67643.B7
   Irrcher I, 2003, SPORTS MED, V33, P783, DOI 10.2165/00007256-200333110-00001
   Jeppesen TD, 2003, J NEUROL, V250, P293, DOI 10.1007/s00415-003-0993-4
   KEMP GJ, 1993, NMR BIOMED, V6, P302, DOI 10.1002/nbm.1940060504
   KEMP GJ, 1993, J NEUROL SCI, V116, P201, DOI 10.1016/0022-510X(93)90326-T
   KLAUSEN K, 1981, ACTA PHYSIOL SCAND, V113, P9, DOI 10.1111/j.1748-1716.1981.tb06854.x
   Kornblum C, 2005, EUR J NEUROL, V12, P300, DOI 10.1111/j.1468-1331.2004.00970.x
   Lalani SR, 2005, ARCH NEUROL-CHICAGO, V62, P317, DOI 10.1001/archneur.62.2.317
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lamperti C, 2003, NEUROLOGY, V60, P1206, DOI 10.1212/01.WNL.0000055089.39373.FC
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   MACRAE HSH, 1995, EUR J APPL PHYSIOL O, V71, P523, DOI 10.1007/BF00238555
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   McKenzie S, 2000, AM J PHYSIOL-ENDOC M, V278, pE580, DOI 10.1152/ajpendo.2000.278.4.E580
   Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849
   Naccarati A, 2000, NEUROL SCI, V21, pS963, DOI 10.1007/s100720070010
   Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152
   Olsen DB, 2005, NEUROLOGY, V64, P1064, DOI 10.1212/01.WNL.0000150584.45055.27
   Orngreen MC, 2005, ANN NEUROL, V57, P754, DOI 10.1002/ana.20460
   Rollins S, 2001, AM J CLIN PATHOL, V116, P326
   Rötig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9
   Rustin P, 2002, BBA-BIOENERGETICS, V1553, P117, DOI 10.1016/S0005-2728(01)00228-6
   Salviati L, 2005, NEUROLOGY, V65, P606, DOI 10.1212/01.wnl.0000172859.55579.a7
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Salviati L, 2002, BIOCHEM J, V363, P321, DOI 10.1042/0264-6021:3630321
   Salviati L, 2002, ARCH NEUROL-CHICAGO, V59, P862, DOI 10.1001/archneur.59.5.862
   SCHAGGER H, 1995, EUR J BIOCHEM, V230, P235, DOI 10.1111/j.1432-1033.1995.0235i.x
   Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176
   Sciacco M, 1998, MUSCLE NERVE, V21, P1374, DOI 10.1002/(SICI)1097-4598(199811)21:11<1374::AID-MUS3>3.0.CO;2-6
   Shitara H, 2001, FEBS LETT, V500, P7, DOI 10.1016/S0014-5793(01)02574-1
   SHOFFNER JM, 1990, ADV HUM GENET, V19, P267
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   Siciliano G, 2000, NEUROMUSCULAR DISORD, V10, P40, DOI 10.1016/S0960-8966(99)00068-1
   Siciliano G, 1999, NEUROMUSCULAR DISORD, V9, P411, DOI 10.1016/S0960-8966(99)00047-4
   SJODIN B, 1976, ACTA PHYSIOL SCAND, V97, P150, DOI 10.1111/j.1748-1716.1976.tb10247.x
   Sobreira C, 1997, NEUROLOGY, V48, P1238, DOI 10.1212/WNL.48.5.1238
   Sperl W, 1997, WIEN KLIN WOCHENSCHR, V109, P93
   Sutovsky P, 2000, BIOL REPROD, V63, P582, DOI 10.1095/biolreprod63.2.582
   TAANMAN JW, 1992, BIOCHIM BIOPHYS ACTA, V1139, P155, DOI 10.1016/0925-4439(92)90095-5
   Taivassalo T, 1998, NEUROLOGY, V50, P1055, DOI 10.1212/WNL.50.4.1055
   Taivassalo T, 1996, NEUROLOGY, V47, P529, DOI 10.1212/WNL.47.2.529
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Takahashi Y, 2002, MOL CELL BIOL, V22, P7614, DOI 10.1128/MCB.22.21.7614-7621.2002
   Tarnopolsky M, 2004, MITOCHONDRION, V4, P529, DOI 10.1016/j.mito.2004.07.011
   Tarnopolsky MA, 2005, MED SCI SPORT EXER, V37, P2086, DOI 10.1249/01.mss.0000177341.89478.06
   Tarnopolsky MA, 2001, ANN NEUROL, V49, P561, DOI 10.1002/ana.1028.abs
   Tomasetti M, 1999, FREE RADICAL BIO MED, V27, P1027, DOI 10.1016/S0891-5849(99)00132-X
   Triepels RH, 2001, AM J MED GENET, V106, P37, DOI 10.1002/ajmg.1397
   TZAGOLOFF A, 1986, ANNU REV BIOCHEM, V55, P249, DOI 10.1146/annurev.biochem.55.1.249
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Van Maldergem L, 2002, ANN NEUROL, V52, P750, DOI 10.1002/ana.10371
   Visapää I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773
   Vissing J, 2003, ANN NEUROL, V54, P539, DOI 10.1002/ana.10725
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   WASSERMAN K, 1973, J APPL PHYSIOL, V35, P236, DOI 10.1152/jappl.1973.35.2.236
   Weltman A, 1997, MED SCI SPORT EXER, V29, P669, DOI 10.1097/00005768-199705000-00013
   Zeviani M, 2003, CURR OPIN NEUROL, V16, P585, DOI 10.1097/00019052-200310000-00004
NR 91
TC 38
Z9 42
U1 0
U2 7
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0144-8463
EI 1573-4935
J9 BIOSCIENCE REP
JI Biosci. Rep.
PD JUN
PY 2007
VL 27
IS 1-3
BP 53
EP 67
DI 10.1007/s10540-007-9037-0
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology; Cell Biology
GA 178YM
UT WOS:000247256300007
PM 17492503
DA 2024-11-01
ER

PT J
AU Galassi, G
   Lamantea, E
   Invernizzi, F
   Tavani, F
   Pisano, I
   Ferrero, I
   Palmieri, L
   Zeviani, M
AF Galassi, Giuliana
   Lamantea, Eleonora
   Invernizzi, Federica
   Tavani, Federica
   Pisano, Isabella
   Ferrero, Ileana
   Palmieri, Luigi
   Zeviani, Massimo
TI Additive effects of POLG1 and ANT1 mutations in a complex
   encephalomyopathy
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE mitochondrial DNA; mtDNA multiple deletions; progressive external
   ophthalmoplegia; sensory-cerebellar ataxia; ANT1; POLG1
ID DNA-POLYMERASE-GAMMA; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   ADENINE-NUCLEOTIDE TRANSLOCATOR; SACCHAROMYCES-CEREVISIAE; BACTERIAL
   EXPRESSION; MITOCHONDRIAL; RECONSTITUTION; TRANSPORT; SPECTRUM; PROTEIN
AB MtDNA instability is associated with a wide spectrum of clinical presentations, from dominant or recessive progressive external ophthalmoplegia (PEO) to juvenile-onset spino-cerebellar ataxia and epilepsy (SCAE) or infantile Alpers-Huttenlocher syndrome. We present here the clinical and molecular features of a patient with a clinical presentation characterized initially by PEO with mtDNA multiple deletions lately evolving into a severe neurological syndrome, which included sensory and cerebellar ataxia, peripheral neuropathy, parkinsonism, and depression. This complex phenotype is the result of mutations in two distinct proteins, ANTI and Pol gamma A, which cause additive, deleterious effects on mtDNA maintenance and integrity. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Lamantea, Eleonora; Invernizzi, Federica; Zeviani, Massimo] IRCCS, C Besta Neurol Inst Fdn, Unit Mol Neurogenet Peirfranco, I-20126 Milan, Italy.
   [Lamantea, Eleonora; Invernizzi, Federica; Zeviani, Massimo] IRCCS, C Besta Neurol Inst Fdn, Luisa Mariani Ctr Study Childrens Mitochondrial D, I-20126 Milan, Italy.
   [Galassi, Giuliana] Univ Modena, Dept Neurosci, I-41100 Modena, Italy.
   [Tavani, Federica] Univ Modena, Serv Neuroradiol, I-41100 Modena, Italy.
   [Pisano, Isabella] Univ Bari, Biochem & Mol Biol Lab, Dept Pharmacobiol, Bari, Italy.
   [Ferrero, Ileana] Univ Parma, Dept Genet Anthropol Evolut, I-43100 Parma, Italy.
   [Palmieri, Luigi] CNR Inst Biomembranes & Bioenerget, Bari, Italy.
C3 Universita di Modena e Reggio Emilia; Universita di Modena e Reggio
   Emilia; Universita degli Studi di Bari Aldo Moro; University of Parma;
   Consiglio Nazionale delle Ricerche (CNR)
RP Zeviani, M (corresponding author), IRCCS, C Besta Neurol Inst Fdn, Unit Mol Neurogenet Peirfranco, Via Libero, I-20126 Milan, Italy.
EM zeviani@istituto-besta.it
RI Zeviani, Massimo/K-2891-2014; Lamantea, Eleonora/J-8339-2016;
   Invernizzi, Federica/J-9849-2016
OI Zeviani, Massimo/0000-0002-9067-5508; PISANO,
   Isabella/0000-0003-0728-2226; Lamantea, Eleonora/0000-0001-5090-6028;
   Invernizzi, Federica/0000-0001-8072-0152
FU Telethon [GGP07019] Funding Source: Medline
CR Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293
   Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
NR 19
TC 28
Z9 28
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JUN
PY 2008
VL 18
IS 6
BP 465
EP 470
DI 10.1016/j.nmd.2008.03.013
PG 6
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 331PB
UT WOS:000258023000006
PM 18504126
DA 2024-11-01
ER

PT J
AU Campbell, G
   Krishnan, KJ
   Deschauer, M
   Taylor, RW
   Turnbull, DM
AF Campbell, Georgia
   Krishnan, Kim J.
   Deschauer, Marcus
   Taylor, Robert W.
   Turnbull, Doug M.
TI Dissecting the mechanisms underlying the accumulation of mitochondrial
   DNA deletions in human skeletal muscle
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID CLONAL EXPANSION; MUTATIONS; MTDNA; REPLICATION; DISEASE; GENOMES;
   FIBERS; LENGTH
AB Large-scale mitochondrial DNA (mtDNA) deletions are an important cause of mitochondrial disease, while somatic mtDNA deletions cause focal respiratory chain deficiency associated with ageing and neurodegenerative disorders. As mtDNA deletions only cause cellular pathology at high levels of mtDNA heteroplasmy, an mtDNA deletion must accumulate to levels which can result in biochemical dysfunction-a process known as clonal expansion. A number of hypotheses have been proposed for clonal expansion of mtDNA deletions, including a replicative advantage for deleted mitochondrial genomes inferred by their smaller size-implying that the largest mtDNA deletions would also display a replicative advantage over smaller mtDNA deletions. We proposed that in muscle fibres from patients with mtDNA maintenance disorders, which lead to the accumulation of multiple mtDNA deletions, we would observe the largest mtDNA deletions spreading the furthest longitudinally through individual muscle fibres by means of a greater rate of clonal expansion. We characterized mtDNA deletions in patients with mtDNA maintenance disorders from a range of 'large' and 'small' cytochrome c oxidase (COX)-deficient regions in skeletal muscle fibres. We measured the size of clonally expanded deletions in 62 small and 60 large individual COX-deficient f regions. No significant difference was observed in individual patients or in the total dataset (small fibre regions mean 6.59 kb-large fibre regions mean 6.51 kb). Thus no difference existed in the rate of clonal expansion throughout muscle fibres between mtDNA deletions of different sizes; smaller mitochondrial genomes therefore do not appear to have an inherent replicative advantage in human muscle.
C1 [Campbell, Georgia; Krishnan, Kim J.; Taylor, Robert W.; Turnbull, Doug M.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Campbell, Georgia; Krishnan, Kim J.; Turnbull, Doug M.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Univ Ctr Brain Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Deschauer, Marcus] Univ Halle Wittenberg, Dept Neurol, D-06120 Halle, Saale, Germany.
C3 Newcastle University - UK; Newcastle University - UK; Martin Luther
   University Halle Wittenberg
RP Turnbull, DM (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Newcastle Univ Ctr Brain Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM doug.turnbull@newcastle.ac.uk
RI Clugston, Kim/KBA-3107-2024
OI Turnbull, Doug/0000-0002-8878-9901
FU Medical Research Council; MRC [MR/K006312/1, MC_G0802536, MR/K000608/1,
   G0700718] Funding Source: UKRI
FX Funding to pay the Open Access publication charges for this article was
   provided by Medical Research Council.
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Coller HA, 2002, ANN NY ACAD SCI, V959, P434, DOI 10.1111/j.1749-6632.2002.tb02113.x
   Cottrell DA, 2000, J NEUROPATH EXP NEUR, V59, P621, DOI 10.1093/jnen/59.7.621
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Elson JL, 2002, NEUROMUSCULAR DISORD, V12, P858, DOI 10.1016/S0960-8966(02)00047-0
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Herbst A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059006
   HUEMER RP, 1971, EXP GERONTOL, V6, P327, DOI 10.1016/0531-5565(71)90001-5
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   Nicholas A, 2009, EXP NEUROL, V218, P316, DOI 10.1016/j.expneurol.2009.04.029
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   WALLACE DC, 1989, TRENDS GENET, V5, P9, DOI 10.1016/0168-9525(89)90005-X
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Weber K, 1997, AM J HUM GENET, V60, P373
NR 33
TC 34
Z9 36
U1 2
U2 9
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD SEP 1
PY 2014
VL 23
IS 17
BP 4612
EP 4620
DI 10.1093/hmg/ddu176
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA AM9YU
UT WOS:000340238200011
PM 24740879
OA Green Published, Green Submitted, hybrid
DA 2024-11-01
ER

PT J
AU Zereg, E
   Chaussenot, A
   Morel, G
   Bannwarth, S
   Sacconi, S
   Soriani, MH
   Attarian, S
   Cano, A
   Pouget, J
   Bellance, R
   Tranchant, C
   Lannes, B
   de Paula, AM
   Ait-El-Mkadem, SS
   Chafino, B
   Berthet, M
   Fragaki, K
   Paquis-Flucklinger, V
   Rouzier, C
AF Zereg, Elamine
   Chaussenot, Annabelle
   Morel, Godelieve
   Bannwarth, Sylvie
   Sacconi, Sabrina
   Soriani, Marie-Helene
   Attarian, Shahram
   Cano, Aline
   Pouget, Jean
   Bellance, Remi
   Tranchant, Christine
   Lannes, Beatrice
   de Paula, Andre Maues
   Ait-El-Mkadem, Samira Saadi
   Chafino, Bernadette
   Berthet, Mathieu
   Fragaki, Konstantina
   Paquis-Flucklinger, Veronique
   Rouzier, Cecile
TI Single-fiber studies for assigning pathogenicity of eight mitochondrial
   DNA variants associated with mitochondrial diseases
SO HUMAN MUTATION
LA English
DT Article
DE ATP6; mitochondrial tRNA; mtDNA heteroplasmy; ND2; single-fiber analysis
ID COMPLEX-I; MTDNA MUTATIONS; TRNA(ASN) GENE; PHENOTYPE; NUCLEAR;
   DELETIONS; SEQUENCE; GENOME; LEADS
AB Whole mitochondrial DNA (mtDNA) sequencing is now systematically used in clinical laboratories to screen patients with a phenotype suggestive of mitochondrial disease. Next Generation Sequencing (NGS) has significantly increased the number of identified pathogenic mtDNA variants. Simultaneously, the number of variants of unknown significance (VUS) has increased even more, thus challenging their interpretation. Correct classification of the variants' pathogenicity is essential for optimal patient management, including treatment and genetic counseling. Here, we used single muscle fiber studies to characterize eight heteroplasmic mtDNA variants, among which were three novel variants. By applying the pathogenicity scoring system, we classified four variants as "definitely pathogenic" (m.590A>G, m.9166T>C, m.12293G>A, and m.15958A>T). Two variants remain "possibly pathogenic" (m.4327T>C and m.5672T>C) but should these be reported in a different family, they would be reclassified as "definitely pathogenic." We also illustrate the contribution of single-fiber studies to the diagnostic approach in patients harboring pathogenic variants with low level heteroplasmy.
C1 [Zereg, Elamine; Chaussenot, Annabelle; Morel, Godelieve; Bannwarth, Sylvie; Ait-El-Mkadem, Samira Saadi; Chafino, Bernadette; Berthet, Mathieu; Fragaki, Konstantina; Paquis-Flucklinger, Veronique; Rouzier, Cecile] Nice Teaching Hosp, Natl Ctr Mitochondrial Dis, Dept Med Genet, Nice, France.
   [Chaussenot, Annabelle; Bannwarth, Sylvie; Ait-El-Mkadem, Samira Saadi; Fragaki, Konstantina; Paquis-Flucklinger, Veronique; Rouzier, Cecile] Univ Cote dAzur, IRCAN, CNRS, Inserm U1081,UMR7284, Nice, France.
   [Sacconi, Sabrina; Soriani, Marie-Helene] Nice Teaching Hosp, Neuromuscular Dis Ctr, Dept Clin Neurosci, Nice, France.
   [Attarian, Shahram; Pouget, Jean] Aix Marseille Univ, Timone Univ Hosp, Referral Ctr ALS & Neuromuscular Dis, Neurol Dept, Marseille, France.
   [Cano, Aline] Timone Hosp, Reference Ctr Inherited Metab Dis, Pediat Neurol Dept, Marseille, France.
   [Bellance, Remi] Fort de France Teaching Hosp, Neuromuscular Reference Ctr, Neuromyol Dept, Fort De France, Martinique, France.
   [Tranchant, Christine] Strasbourg Teaching Hosp, Dept Movement Pathol, Strasbourg, France.
   [Lannes, Beatrice] Hop Univ Strasbourg, Pathol Dept, Hop Hautepierre, Strasbourg, France.
   [de Paula, Andre Maues] Aix Marseille Univ, Timone Univ Hosp, Pathol Dept, Marseille, France.
C3 CHU Nice; Institut National de la Sante et de la Recherche Medicale
   (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS -
   National Institute for Biology (INSB); Universite Cote d'Azur; CHU Nice;
   Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille;
   Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU
   Strasbourg; CHU Strasbourg; Universites de Strasbourg Etablissements
   Associes; Universite de Strasbourg; Aix-Marseille Universite; Assistance
   Publique-Hopitaux de Marseille
RP Paquis-Flucklinger, V; Rouzier, C (corresponding author), Hop Archet 2, Lab Biol Mol, Serv Genet Med, Ctr Reference Malad Mitochondriales, 151 Route St Antoine de Ginestiere, F-06200 Nice, France.
EM Veronique.PAQUIS@unice.fr; rouzier.c@chu-nice.fr
RI SACCONI, Sabrina/AFT-1096-2022; Attarian, Shahram/AAE-6214-2021;
   Rouzier, Cecile/KCY-3619-2024
OI MOREL, Godelieve/0000-0002-4132-6264; SACCONI,
   Sabrina/0000-0002-0246-1455; Zereg, Elamine/0000-0002-6111-3805
FU Centre Hospitalier Universitaire de Nice [AOI [16-AOIP-04], IDRCB:
   2017-A00688-45]
FX Centre Hospitalier Universitaire de Nice, Grant/Award Numbers: AOI
   [16-AOIP-04 (promoteur CHU de Nice), No IDRCB: 2017-A00688-45]
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Angebault C, 2015, HUM MOL GENET, V24, P3948, DOI 10.1093/hmg/ddv133
   Bacalhau M, 2017, EUR J MED GENET, V60, P172, DOI 10.1016/j.ejmg.2016.12.009
   Brown MD, 2001, HUM GENET, V109, P33, DOI 10.1007/s004390100538
   Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   Ortigoza-Escobar JD, 2016, MITOCHONDRION, V28, P73, DOI 10.1016/j.mito.2016.04.001
   Deschauer M, 2006, ARCH NEUROL-CHICAGO, V63, P902, DOI 10.1001/archneur.63.6.902
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elson JL, 2009, HUM MUTAT, V30, pE984, DOI 10.1002/humu.21113
   Florentz C, 2001, EMBO REP, V2, P481, DOI 10.1093/embo-reports/kve111
   Fragaki K, 2017, MOL GENET METAB, V121, P224, DOI 10.1016/j.ymgme.2017.05.002
   Fu J, 2019, CHINESE MED J-PEKING, V132, P865, DOI 10.1097/CM9.0000000000000151
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Guerrero-Castillo S, 2017, CELL METAB, V25, P128, DOI 10.1016/j.cmet.2016.09.002
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hao HL, 1997, MOL CELL BIOL, V17, P6831, DOI 10.1128/MCB.17.12.6831
   Hiniker A, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0137-3
   Hoefs SJG, 2011, EUR J HUM GENET, V19, P270, DOI 10.1038/ejhg.2010.204
   Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86
   Lyu LH, 2018, DATA BRIEF, V17, P1149, DOI 10.1016/j.dib.2018.02.040
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   Minoia F, 2017, JIMD REP, V37, P37, DOI 10.1007/8904_2017_9
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   Morel G, 2016, NEUROMUSCULAR DISORD, V26, P885, DOI 10.1016/j.nmd.2016.09.012
   Moslemi AR, 2004, NEUROMUSCULAR DISORD, V14, P46, DOI 10.1016/S0960-8966(03)00168-8
   Nishigaki Y, 2010, MITOCHONDRION, V10, P300, DOI 10.1016/j.mito.2010.01.003
   Paul R, 1996, TRENDS GENET, V12, P131
   Plutino M, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-018-0568-y
   Pulkes T, 2005, NEUROLOGY, V64, P1091, DOI 10.1212/01.WNL.0000154471.33156.55
   Rahman J, 2018, LANCET, V391, P2560, DOI 10.1016/S0140-6736(18)30727-X
   Raymond FL, 2018, NAT REV GENET, V19, P399, DOI 10.1038/s41576-018-0022-1
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Schägger H, 2001, J BIOL CHEM, V276, P37861
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Sonney S, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005867
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307
   Tang S, 2010, BIOTECHNIQUES, V48, P287, DOI 10.2144/000113389
   Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793
   THORBURN DR, 2003, MITOCHONDR DNA, P48
   Ugalde C, 2007, MOL GENET METAB, V90, P10, DOI 10.1016/j.ymgme.2006.08.003
   Vives-Bauza C, 2003, J INHERIT METAB DIS, V26, P507, DOI 10.1023/A:1025133629685
   Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955
   Ware SM, 2009, J MED GENET, V46, P308, DOI 10.1136/jmg.2008.063149
   Weber K, 1997, AM J HUM GENET, V60, P373
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
NR 53
TC 4
Z9 4
U1 0
U2 1
PU WILEY-HINDAWI
PI LONDON
PA ADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND
SN 1059-7794
EI 1098-1004
J9 HUM MUTAT
JI Hum. Mutat.
PD AUG
PY 2020
VL 41
IS 8
BP 1394
EP 1406
DI 10.1002/humu.24037
EA JUN 2020
PG 13
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA MQ0WG
UT WOS:000539774700001
PM 32419253
OA gold
DA 2024-11-01
ER

PT J
AU Papadopoulos, C
   Wahbi, K
   Behin, A
   Bougouin, W
   Stojkovic, T
   Leonard-Louis, S
   Berber, N
   Lombès, A
   Duboc, D
   Jardel, C
   Eymard, B
   Laforêt, P
AF Papadopoulos, Constantinos
   Wahbi, Karim
   Behin, Anthony
   Bougouin, Wulfran
   Stojkovic, Tanya
   Leonard-Louis, Sarah
   Berber, Nawal
   Lombes, Anne
   Duboc, Denis
   Jardel, Claude
   Eymard, Bruno
   Laforet, Pascal
TI Incidence and predictors of total mortality in 267 adults presenting
   with mitochondrial diseases
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
DE cohort studies; mitochondrial disorders; mortality; prognosis
ID LACTIC-ACIDOSIS; MUTATION; DEATH; MELAS; 3243A-GREATER-THAN-G;
   STATEMENT; DIAGNOSIS; PROGNOSIS; MYOPATHY; SPECTRUM
AB Assessing long-term mortality and identifying predictors of death in adults with mitochondrial diseases. We retrospectively included adult patients with genetically proven mitochondrial diseases referred to our centre between January 2000 and June 2016, and collected information relative to their genetic testing, clinical assessments, and vital status. We performed single and multiple variable analyses in search of predictors of total mortality, and calculated hazard ratios (HR) and 95% confidence intervals (CI). We included 267 patients (women 59%; median age 43.3 [31.3-54.2] years), including 111 with mitochondrial DNA (mtDNA) single large-scale deletions, 65 with m.3243A>G, 24 with m.8344A>G, 32 with other mtDNA point mutations, and 36 patients with nuclear genes mutations. Over a median follow-up of 8.9 years (0.3 to 18.7), 61 patients (22.8%) died, at a median age of 50.7 (37.9-51.9) years. Primary cause of death was cardiovascular disease in 16 patients (26.2%), respiratory in 11 (18.0%), and gastrointestinal in 5 (8.1%). By multiple variable analysis, diabetes (HR 2.75; 95% CI 1.46-5.18), intraventricular cardiac conduction defects (HR 3.38; 95% CI 1.71-6.76) and focal brain involvement (HR 2.39; 95% CI 1.25-4.57) were independent predictors of death. Adult patients with mitochondrial diseases present high morbidity that can be independently predicted by the presence of diabetes, intraventricular cardiac conduction defects, and focal brain involvement.
C1 [Papadopoulos, Constantinos; Behin, Anthony; Stojkovic, Tanya; Leonard-Louis, Sarah; Berber, Nawal; Eymard, Bruno] Pitie Salpetrere Hosp, AP HP, Myol Inst, Nord Est Ile de France Neuromuscular Reference Ct, Paris, France.
   [Papadopoulos, Constantinos] Natl & Kapodistrian Univ Athens, Eginit Hosp, Med Sch, Dept Neurol 1, Athens, Greece.
   [Wahbi, Karim; Duboc, Denis] Sorbonne Paris Cite Univ, Cochin Hosp, AP HP, FILNEMUS,Cardiol Dept,Paris Descartes, Paris, France.
   [Wahbi, Karim; Bougouin, Wulfran] Paris Cardiovasc Res Ctr PARCC, INSERM Unit 970, Paris, France.
   [Bougouin, Wulfran] Cochin Hosp, AP HP, Med Intens Care Unit, Paris, France.
   [Lombes, Anne] Cochin Hosp, AP HP, INSERM, UMRS 975, Paris, France.
   [Jardel, Claude] Hop La Pitie Salpetriere, AP HP, Biochem Dept, Paris, France.
   [Jardel, Claude] Hop La Pitie Salpetriere, AP HP, Genet Ctr, Paris, France.
   [Jardel, Claude] Inst Cochin, Inserm U 1016, CNRS, UMR 8104, Paris, France.
   [Jardel, Claude] Univ Paris 06, GRC UPMC Neurometab, Paris, France.
   [Laforet, Pascal] Raymond Poincare Teaching Hosp, AP HP, Nord Est Ile de France Neuromuscular Reference Ct, Neurol Dept, Garches, France.
C3 Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Pitie-Salpetriere - APHP; National & Kapodistrian University of Athens;
   Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Cochin - APHP; Institut National de la Sante et de
   la Recherche Medicale (Inserm); Universite Paris Cite; Assistance
   Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital
   Universitaire Cochin - APHP; Institut National de la Sante et de la
   Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP);
   Universite Paris Cite; Hopital Universitaire Cochin - APHP; Assistance
   Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere
   - APHP; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP);
   Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite;
   Centre National de la Recherche Scientifique (CNRS); CNRS - National
   Institute for Biology (INSB); Universite Paris Cite; Institut National
   de la Sante et de la Recherche Medicale (Inserm); Sorbonne Universite;
   Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Raymond-Poincare - APHP
RP Papadopoulos, C (corresponding author), Natl & Kapodistrian Univ Athens, Eginit Hosp, Med Sch, Dept Neurol 1, Athens, Greece.
EM constantinospapadopoulos@yahoo.com
RI Bougouin, Wulfran/AAS-7565-2021; STOJKOVIC, Tanya/AAA-3967-2021
FU French Alliance against Myopathies
FX French Alliance against Myopathies
CR Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Barends M, 2016, JIMD REP, V26, P103, DOI 10.1007/8904_2015_449
   CROS D, 1992, CHEST, V101, P824, DOI 10.1378/chest.101.3.824
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2013, NEUROLOGY, V81, P281, DOI 10.1212/WNL.0b013e31829bfe89
   Fayssoil A, 2017, EUR J NEUROL, V24, P255, DOI 10.1111/ene.13176
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Klopstock T, 1999, NEUROLOGY, V53, P855, DOI 10.1212/WNL.53.4.855
   Majamaa-Voltti K, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.122648
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   Malfatti E, 2013, NEUROLOGY, V80, P100, DOI 10.1212/WNL.0b013e31827b1a2f
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   MarinGarcia J, 1997, PEDIATR CARDIOL, V18, P251, DOI 10.1007/s002469900169
   Neeve VCM, 2012, BRAIN, V135, P3614, DOI 10.1093/brain/aws298
   Ng YS, 2016, EUR HEART J, V37, P2552, DOI 10.1093/eurheartj/ehv306
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Roglic G, 2010, DIABETES RES CLIN PR, V87, P15, DOI 10.1016/j.diabres.2009.10.006
   Roper NA, 2001, BRIT MED J, V322, P1389, DOI 10.1136/bmj.322.7299.1389
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   von Elm E, 2007, BMJ-BRIT MED J, V335, P806
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 26
TC 8
Z9 8
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0141-8955
EI 1573-2665
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD MAY
PY 2020
VL 43
IS 3
BP 459
EP 466
DI 10.1002/jimd.12185
PG 8
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA LM7PS
UT WOS:000532441300007
PM 31652339
DA 2024-11-01
ER

PT J
AU Blum, S
   Robertson, T
   Klingberg, S
   Henderson, RD
   McCombe, P
AF Blum, S.
   Robertson, T.
   Klingberg, S.
   Henderson, R. D.
   McCombe, P.
TI Atypical clinical presentations of the A3243G mutation, usually
   associated with MELAS
SO INTERNAL MEDICINE JOURNAL
LA English
DT Article
DE MELAS syndrome; mitochondrial diseases; mitochondrial DNA;
   rhabdomyolysis; retinitis pigmentosa
ID MITOCHONDRIAL-DNA MUTATIONS; SEVERE LACTIC-ACIDOSIS; IN-VIVO;
   RHABDOMYOLYSIS; POPULATION; ENCEPHALOPATHY; MYOPATHY; EPISODES; BLOOD;
   LOAD
AB Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) is a clinical syndrome associated with mitochondrial abnormalities. In approximately 80% of patients, the syndrome is associated with the A3243G mutation. However, it has been realized that the A3243G mutation is not uncommon in the general population and is found in many patients with clinical presentations other than MELAS. We present four patients who presented with rhabdomyolysis, muscle fatigue, external ophthalmoplegia and myoclonic jerks respectively. These patients were all found to have the A3243G mutation on muscle biopsy. These patients illustrate the variety of presentations associated with A3243G mutation.
C1 [McCombe, P.] Univ Queensland Ctr Clin Res, Brisbane, Qld, Australia.
C3 University of Queensland
RP Blum, S (corresponding author), Royal Brisbane & Womens Hosp, Dept Neurol, Dr Stefan Blum, Cnr Butterfield St & Bowen Bridge Rd, Herston, Qld 7675, Australia.
EM stefan_blum@health.qld.gov.au
RI McCombe, Pamela Ann/C-9692-2010; Blum, Stefan/O-2680-2015
OI McCombe, Pamela Ann/0000-0003-2704-8517; Blum,
   Stefan/0000-0002-2702-3742
FU RBWH
FX SB has been funded by the RBWH Research Scholarship.
CR Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2000, MOL MED TODAY, V6, P425, DOI 10.1016/S1357-4310(00)01805-0
   Chinnery PF, 2001, NEUROLOGY, V56, P1101, DOI 10.1212/WNL.56.8.1101
   Chinnery PF, 2000, ANN NEUROL, V47, P381, DOI 10.1002/1531-8249(200003)47:3<381::AID-ANA17>3.0.CO;2-2
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   HARA H, 1994, J NEUROL NEUROSUR PS, V57, P1545, DOI 10.1136/jnnp.57.12.1545-a
   HIROSE Y, 1993, INTERNAL MED, V32, P798, DOI 10.2169/internalmedicine.32.798
   Inoue Shigeaki, 2007, J Intensive Care Med, V22, P240, DOI 10.1177/0885066607301343
   Jacobs L, 2007, MOL HUM REPROD, V13, P149, DOI 10.1093/molehr/gal112
   Kaufmann P, 2009, ARCH NEUROL-CHICAGO, V66, P85, DOI 10.1001/archneurol.2008.526
   Kwon JH, 2003, EUR NEUROL, V50, P123, DOI 10.1159/000072517
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
NR 20
TC 9
Z9 9
U1 0
U2 0
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1444-0903
J9 INTERN MED J
JI Intern. Med. J.
PD FEB
PY 2011
VL 41
IS 2
BP 200
EP 202
DI 10.1111/j.1445-5994.2010.02379.x
PG 3
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 726UM
UT WOS:000287751900012
PM 22747555
DA 2024-11-01
ER

PT J
AU Echaniz-Laguna, A
   Chassagne, M
   Ceresuela, J
   Rouvet, I
   Padet, S
   Acquaviva, C
   Nataf, S
   Vinzio, S
   Bozon, D
   de Camaret, BM
AF Echaniz-Laguna, Andoni
   Chassagne, Maite
   Ceresuela, Jennifer
   Rouvet, Isabelle
   Padet, Sylvie
   Acquaviva, Cecile
   Nataf, Serge
   Vinzio, Stephane
   Bozon, Dominique
   de Camaret, Benedicte Mousson
TI Complete loss of expression of the <i>ANT1</i> gene causing
   cardiomyopathy and myopathy
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID ADENINE-NUCLEOTIDE TRANSLOCATOR; MITOCHONDRIAL ADP/ATP CARRIER;
   CONGENITAL CATARACT; LACTIC-ACIDOSIS; DEFICIENCY; MUSCLE; MOUSE;
   ANTIOXIDANT; SKELETAL; ISOFORM
AB Background The ANT1 gene, encoding ADP/ATP translocase 1, was investigated in an adult patient with an autosomal recessive mitochondrial disorder characterised by congenital cataracts, hypertrophic cardiomyopathy, myopathy and lactic acidosis.
   Methods and results ANT1 sequencing showed that the patient was homozygous for a new nucleotide variation, c.111+1G -> A, abolishing the invariant GT splice donor site of intron 1. The ANT1 transcript was undetectable in both muscle and skin fibroblasts. A markedly abnormal metabolic profile was found, and skeletal muscle showed a dramatic proliferation of abnormal mitochondria, increased mitochondrial mass, and multiple mitochondrial DNA deletions. No compensating increase in the transcript level of the ANT3 gene, which encodes the human ubiquitous isoform of the ADP/ATP translocase, was observed. The patient's heterozygous mother had normal clinical, biochemical and pathological features.
   Conclusions Complete loss of expression of the ANT1 gene causes a clinical syndrome mainly characterised by cardiomyopathy and myopathy. This report expands the clinical spectrum of ANT1-related human diseases, and emphasises the crucial role of the mitochondrial ADP/ATP carriers in muscle function and pathophysiology of human myopathies.
C1 [Echaniz-Laguna, Andoni] Hop Hautepierre, Hop Univ, Dept Neurol, F-67098 Strasbourg, France.
   [Echaniz-Laguna, Andoni] Univ Strasbourg, INSERM U692, Strasbourg, France.
   [Chassagne, Maite; Ceresuela, Jennifer; Padet, Sylvie; Acquaviva, Cecile; de Camaret, Benedicte Mousson] CHU Lyon, Serv Malad Hereditaires Metab, Ctr Biol & Pathol Est, Bron, France.
   [Rouvet, Isabelle; Nataf, Serge] CHU Lyon, Ctr Biotechnol Cellulaire, Ctr Biol & Pathol Est, Bron, France.
   [Vinzio, Stephane] Hop Univ, Dept Med Interne, Strasbourg, France.
   [Bozon, Dominique] CHU Lyon, Unite Cardiogenet Mol, Ctr Biol & Pathol Est, Bron, France.
C3 Universites de Strasbourg Etablissements Associes; Universite de
   Strasbourg; CHU Strasbourg; Institut National de la Sante et de la
   Recherche Medicale (Inserm); Universites de Strasbourg Etablissements
   Associes; Universite de Strasbourg; CHU Lyon; CHU Lyon; CHU Strasbourg;
   CHU Lyon
RP Echaniz-Laguna, A (corresponding author), Hop Hautepierre, Hop Univ, Dept Neurol, F-67098 Strasbourg, France.
EM andoni.echaniz-laguna@chru-strasbourg.fr
RI Echaniz-Laguna, Andoni/IUN-5392-2023
CR Chabi B, 2003, CLIN CHEM, V49, P1309, DOI 10.1373/49.8.1309
   CRUYSBERG JRM, 1986, AM J OPHTHALMOL, V102, P740, DOI 10.1016/0002-9394(86)90402-2
   Dahout-Gonzalez C, 2006, PHYSIOLOGY, V21, P242, DOI 10.1152/physiol.00005.2006
   de Camaret BM, 2011, MITOCHONDRION, V11, P223, DOI 10.1016/j.mito.2010.07.011
   Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Jordens EZ, 2002, ANN NEUROL, V52, P95, DOI 10.1002/ana.10214
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Markova NG, 2009, FREE RADICAL BIO MED, V46, P1168, DOI 10.1016/j.freeradbiomed.2009.01.021
   Narula N, 2011, JACC-CARDIOVASC IMAG, V4, P1, DOI 10.1016/j.jcmg.2010.06.018
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056
   SENGERS RCA, 1975, J PEDIATR-US, V86, P873, DOI 10.1016/S0022-3476(75)80217-4
   SMEITINK JAM, 1989, EUR J PEDIATR, V148, P656, DOI 10.1007/BF00441527
   STEPIEN G, 1992, J BIOL CHEM, V267, P14592
   Subrarnaniam V, 2008, BBA-BIOENERGETICS, V1777, P666, DOI 10.1016/j.bbabio.2008.03.015
   VALSSON J, 1988, AM J CARDIOL, V61, P193, DOI 10.1016/0002-9149(88)91331-8
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Yin H, 2005, INVEST OPHTH VIS SCI, V46, P4555, DOI 10.1167/iovs.05-0695
NR 20
TC 53
Z9 59
U1 0
U2 7
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
J9 J MED GENET
JI J. Med. Genet.
PD FEB
PY 2012
VL 49
IS 2
BP 146
EP 150
DI 10.1136/jmedgenet-2011-100504
PG 5
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 879DC
UT WOS:000299308900012
PM 22187496
DA 2024-11-01
ER

PT J
AU Smith, PM
   Lightowlers, RN
AF Smith, Paul M.
   Lightowlers, Robert N.
TI Altering the balance between healthy and mutated mitochondrial DNA
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
ID TARGETED RESTRICTION-ENDONUCLEASE; HUMAN-CELLS; HETEROPLASMY;
   EXPRESSION; DISEASE; SINGLE; GENE; MYOPATHIES; DISORDERS; DELETIONS
AB Pathogenic mutations of the mitochondrial genome are frequently found to co-exist with wild-type mtDNA molecules, a state known as heteroplasmy. In most disease cases, the mutation is recessive with manifestation of a clinical phenotype occurring when the proportion of mutated mtDNA exceeds a high threshold. The concept of increasing the ratio of healthy to mutated mtDNA as a means to correcting the biochemical defect has received much attention. A number of strategies are highlighted in this article, including manipulation of the mitochondrial genome by antigenomic drugs or restriction endonucleases, zinc finger peptide-targeted nucleases and exercise-induced gene shifting. The feasibility of these approaches has been demonstrated in a number of models, however more work is necessary before use in human patients.
C1 [Smith, Paul M.; Lightowlers, Robert N.] Med Sch Newcastle Upon Tyne, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Smith, PM (corresponding author), Med Sch Newcastle Upon Tyne, Inst Ageing & Hlth, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM Paul.smith@ncl.ac.uk
FU Wellcome Trust [074454] Funding Source: Medline
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bacman SR, 2007, GENE THER, V14, P1309, DOI 10.1038/sj.gt.3302981
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   Dassa EP, 2009, EMBO MOL MED, V1, P30, DOI 10.1002/emmm.200900001
   KING MP, 1988, CELL, V52, P811, DOI 10.1016/0092-8674(88)90423-0
   Manfred G, 1999, J BIOL CHEM, V274, P9386, DOI 10.1074/jbc.274.14.9386
   McFarland R, 2007, CURR TOP DEV BIOL, V77, P113, DOI 10.1016/S0070-2153(06)77005-3
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   Muratovska A, 2001, NUCLEIC ACIDS RES, V29, P1852, DOI 10.1093/nar/29.9.1852
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Ross GF, 2003, BIOCONJUGATE CHEM, V14, P962, DOI 10.1021/bc034050f
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   Smith PM, 2004, BBA-BIOENERGETICS, V1659, P232, DOI 10.1016/j.bbabio.2004.09.003
   Spelbrink JN, 1997, CURR GENET, V32, P115, DOI 10.1007/s002940050255
   Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093
   Srivastava S, 2009, HUM MOL GENET, V18, P1805, DOI 10.1093/hmg/ddp093
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
NR 25
TC 22
Z9 26
U1 0
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-8955
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD APR
PY 2011
VL 34
IS 2
BP 309
EP 313
DI 10.1007/s10545-010-9122-6
PG 5
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 739YI
UT WOS:000288757700008
PM 20506041
DA 2024-11-01
ER

PT J
AU Liu, H
   Ma, YN
   Fang, F
   Zhang, Y
   Zou, LP
   Yang, YL
   Zhu, SN
   Wang, ST
   Zheng, XF
   Pei, P
   Li, L
   Wu, HR
   Xiao, Y
   Xu, YF
   Wang, LW
   Cao, YY
   Pan, H
   Qi, Y
AF Liu, Hui
   Ma, Yinan
   Fang, Fang
   Zhang, Ying
   Zou, Liping
   Yang, Yanling
   Zhu, Sainan
   Wang, Songtao
   Zheng, Xuefei
   Pei, Pei
   Li, Lin
   Wu, Hairong
   Xiao, Yang
   Xu, Yufeng
   Wang, Liwen
   Cao, Yanyan
   Pan, Hong
   Qi, Yu
TI Wild-Type Mitochondrial DNA Copy Number in Urinary Cells as a Useful
   Marker for Diagnosing Severity of the Mitochondrial Diseases
SO PLOS ONE
LA English
DT Article
ID SACCHAROMYCES-CEREVISIAE; A3243G MUTATION; MTDNA; MELAS; PHENOTYPE;
   POPULATION; DEAFNESS; GENE; LOAD
AB The genotype-phenotype relationship in diseases with mtDNA point mutations is still elusive. The maintenance of wild-type mtDNA copy number is essential to the normal mitochondrial oxidative function. This study examined the relationship between mtDNA copy number in blood and urine and disease severity of the patients harboring A3243G mutation. We recruited 115 A3243G patients, in which 28 were asymptomatic, 42 were oligo-symptomatic, and 45 were poly-symptomatic. Increase of total mtDNA copy number without correlation to the proportion of mutant mtDNA was found in the A3243G patients. Correlation analyses revealed that wild-type mtDNA copy number in urine was the most important factor correlated to disease severity, followed by proportion of mutant mtDNA in urine and proportion of mutant mtDNA in blood. Wild-type copy number in urine negatively correlated to the frequencies of several major symptoms including seizures, myopathy, learning disability, headache and stroke, but positively correlated to the frequencies of hearing loss and diabetes. Besides proportion of mutant mtDNA in urine, wild-type copy number in urine is also an important marker for disease severity of A3243G patients.
C1 [Liu, Hui; Ma, Yinan; Zhang, Ying; Wang, Songtao; Zheng, Xuefei; Pei, Pei; Li, Lin; Wu, Hairong; Xiao, Yang; Xu, Yufeng; Pan, Hong; Qi, Yu] Peking Univ, Hosp 1, Cent Lab, Beijing 100871, Peoples R China.
   [Fang, Fang] Beijing Childrens Hosp, Dept Neurol, Beijing, Peoples R China.
   [Zou, Liping] Beijing 301 Hosp, Dept Pediat, Beijing, Peoples R China.
   [Yang, Yanling] Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China.
   [Zhu, Sainan] Peking Univ, Hosp 1, Dept Biostat, Beijing 100871, Peoples R China.
   [Wang, Liwen; Cao, Yanyan] Capital Inst Pediat, Dept Neurol, Beijing, Peoples R China.
C3 Peking University; Capital Medical University; Peking University; Peking
   University; Capital Institute of Pediatrics (CIP)
RP Ma, YN (corresponding author), Peking Univ, Hosp 1, Cent Lab, Beijing 100871, Peoples R China.
EM mayinan1014@163.com; qiyu0724@163.com
RI LI, LI/GVS-5344-2022; Zhang, Ying/JWP-8962-2024; Yang,
   Yanling/F-5954-2014
FU National Natural Science Foundation of China [81271256]; Capital Medical
   Development Foundation of China [2009-2022]
FX This work was supported by the National Natural Science Foundation of
   China (grant number 81271256); the Capital Medical Development
   Foundation of China (grant number 2009-2022). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   Bentlage HACM, 1996, HUM MOL GENET, V5, P197, DOI 10.1093/hmg/5.2.197
   BOYLE JS, 1995, TRENDS GENET, V11, P8, DOI 10.1016/S0168-9525(00)88977-5
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Francisci S, 1998, CURR GENET, V33, P110, DOI 10.1007/s002940050315
   Guillausseau PJ, 2004, DIABETES METAB, V30, P181, DOI 10.1016/S1262-3636(07)70105-2
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Koga Y, 2012, BBA-GEN SUBJECTS, V1820, P608, DOI 10.1016/j.bbagen.2011.09.005
   Liu CS, 2006, ACTA NEUROL SCAND, V113, P334, DOI 10.1111/j.1600-0404.2006.00586.x
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503
   Oka T, 1996, DIABETIC MED, V13, pS98
   Rinaldi T, 2003, GENE, V303, P63, DOI 10.1016/S0378-1119(02)01154-X
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
NR 21
TC 14
Z9 20
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 27
PY 2013
VL 8
IS 6
AR e67146
DI 10.1371/journal.pone.0067146
PG 7
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 174IX
UT WOS:000321150000034
PM 23826218
OA Green Submitted, Green Published, gold
DA 2024-11-01
ER

PT J
AU Milone, M
   Klassen, BT
   Landsverk, ML
   Haas, RH
   Wong, LJ
AF Milone, Margherita
   Klassen, Bryan T.
   Landsverk, Megan L.
   Haas, Richard H.
   Wong, Lee-Jun
TI Orthostatic Tremor, Progressive External Ophthalmoplegia, and Twinkle
SO JAMA NEUROLOGY
LA English
DT Article
ID PARKINSONISM; MUTATIONS; SPECTRUM; DISEASE
AB IMPORTANCE Orthostatic tremor (OT) is a high-frequency (13-18 Hz) leg tremor occurring in standing position. Orthostatic tremor has an unknown pathophysiologic mechanism. It is thought to be sporadic but siblings with OT from 3 unrelated families were reported. No mutations have been reported in OT. We describe a patient with OT carrying a C10orf2 TWINKLE mutation to highlight the possible association of OT with mitochondrial dysfunction and mutations in the mitochondrial replicative helicase Twinkle.
   OBSERVATIONS A man in his late 60s had ptosis and tremor on standing for 30 years, followed by development of progressive external ophthalmoplegia. Polygraphic recordings revealed an orthostatic synchronic tremor with 17.5-Hz frequency. Electromyography/nerve conduction studies showed evidence for a mild myopathy and associated mild axonal sensorimotor peripheral neuropathy. Muscle biopsy revealed ragged red fibers; mild cerebral atrophy was evident by magnetic resonance imaging. Molecular analysis revealed a novel heterozygous missense mutation at an evolutionarily conserved residue of the C10orf2 TWINKLE gene.
   CONCLUSIONS AND RELEVANCE Although the incidental association of OT and C10orf2 TWINKLE mutation is possible, the simultaneous onset of OT and eyelid ptosis at a much younger age than usually observed for OT raises the possibility of mitochondrial dysfunction and loss of mitochondrial DNA integrity in the pathogenesis of OT.
C1 [Milone, Margherita; Klassen, Bryan T.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.
   [Landsverk, Megan L.; Wong, Lee-Jun] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Haas, Richard H.] Univ Calif San Diego, Dept Neurosci & Pediat, San Diego, CA 92103 USA.
C3 Mayo Clinic; Baylor College of Medicine; University of California
   System; University of California San Diego
RP Milone, M (corresponding author), Mayo Clin, Dept Neurol, 200 1st St SW, Rochester, MN 55905 USA.
EM milone.margherita@mayo.edu
FU Mayo Clinic Center for Translational Science Activities from the
   National Institutes of Health National Center for Research Resources
   [UL1 RR024150]
FX This study was supported by the Mayo Clinic Center for Translational
   Science Activities through grant UL1 RR024150 from the National
   Institutes of Health National Center for Research Resources (Dr Milone).
CR Baker M, 2009, MOVEMENT DISORD, V24, P1550, DOI 10.1002/mds.22630
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Contarino MF, 2006, NEUROLOGY, V66, P1600, DOI 10.1212/01.wnl.0000216263.23642.db
   Fischer M, 2007, J NEUROL, V254, P1759, DOI 10.1007/s00415-007-0647-z
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Gerschlager W, 2004, MOVEMENT DISORD, V19, P788, DOI 10.1002/mds.20132
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   HEILMAN KM, 1984, ARCH NEUROL-CHICAGO, V41, P880, DOI 10.1001/archneur.1984.04050190086020
   Katzenschlager R, 2003, ANN NEUROL, V53, P489, DOI 10.1002/ana.10475
   Leu-Semenescu S, 2007, MOVEMENT DISORD, V22, P2063, DOI 10.1002/mds.21651
   Piboolnurak P, 2005, MOVEMENT DISORD, V20, P1455, DOI 10.1002/mds.20588
   Song LY, 2012, HUM MOL GENET, V21, P5147, DOI 10.1093/hmg/dds365
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   Virmani T, 2012, NEUROLOGY, V79, P288, DOI 10.1212/WNL.0b013e31825fdfb3
   Wegner F, 2008, J NEUROL, V255, P1840, DOI 10.1007/s00415-008-0023-7
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
NR 16
TC 10
Z9 12
U1 0
U2 3
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60654-0946 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD NOV
PY 2013
VL 70
IS 11
BP 1429
EP 1431
DI 10.1001/jamaneurol.2013.3521
PG 3
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 295LG
UT WOS:000330117000014
PM 24061067
DA 2024-11-01
ER

PT J
AU Baruffini, E
   Lodi, T
   Dallabona, C
   Puglisi, A
   Zeviani, M
   Ferrero, I
AF Baruffini, Enrico
   Lodi, Tiziana
   Dallabona, Cristina
   Puglisi, Andrea
   Zeviani, Massimo
   Ferrero, Iliana
TI Genetic and chemical rescue of the <i>Saccharomyces cerevisiae</i>
   phenotype induced by mitochondrial DNA polymerase mutations associated
   with progressive external ophthalmoplegia in humans
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID ADENINE-NUCLEOTIDE TRANSLOCATOR; RIBONUCLEOTIDE REDUCTASE;
   SMALL-SUBUNIT; CATALYTIC SUBUNIT; GAMMA; MTDNA; YEAST; DELETIONS;
   PROTEIN; DAMAGE
AB The human POLG gene encodes the catalytic subunit of mitochondrial DNA polymerase gamma (pol gamma). Mutations in pol gamma are associated with a spectrum of disease phenotypes including autosomal dominant and recessive forms of progressive external ophthalmoplegia, spino-cerebellar ataxia and epilepsy, and Alpers-Huttenlocher hepatocerebral poliodystrophy. Multiple deletions, or depletion of mtDNA in affected tissues, are the molecular hallmarks of pol gamma mutations. To shed light on the pathogenic mechanisms leading to these phenotypes, we have introduced in MIP1, the yeast homologue of POLG, two mutations equivalent to the human Y955C and G268A mutations, which are associated with dominant and recessive PEO, respectively. Both mutations induced the generation of petite colonies, carrying either rearranged (rho(-)) or no (rho(0)) mtDNA. Mutations in genes that control the mitochondrial supply of deoxynucleotides (dNTP) affect the mtDNA integrity in both humans and yeast. To test whether the manipulation of the dNTP pool can modify the effects of pol gamma mutations in yeast, we have overexpressed a dNTP checkpoint enzyme, ribonucleotide reductase, RNR1, or deleted its inhibitor, SML1. In both mutant strains, the petite mutability was dramatically reduced. The same result was obtained by exposing the mutant strains to dihydrolipoic acid, an anti-oxidant agent. Therefore, an increase of the mitochondrial dNTP pool and/or a decrease of reactive oxygen species can prevent the mtDNA damage induced by pol gamma mutations in yeast and, possibly, in humans.
C1 Natl Neurol Inst C Besta, Div Mol Neurogenet, Pierfranco & Luisa Mariana Ctr Mitochondrial Dis, I-20126 Milan, Italy.
   Univ Parma, Dept Genet, I-43100 Parma, Italy.
   Univ Catholique Louvain, Fac Ingn Biol, Inst Sci Vie, B-1348 Louvain, Belgium.
   Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland.
   Univ Geneva, NCCR Program Frontiers Genet, CH-1211 Geneva 4, Switzerland.
C3 Fondazione IRCCS Istituto Neurologico Carlo Besta; University of Parma;
   Universite Catholique Louvain; University of Geneva; University of
   Geneva
RP Zeviani, M (corresponding author), Natl Neurol Inst C Besta, Div Mol Neurogenet, Pierfranco & Luisa Mariana Ctr Mitochondrial Dis, Via Temolo 4, I-20126 Milan, Italy.
EM zeviani@istituto-besta.it
RI Zeviani, Massimo/K-2891-2014; Baruffini, Enrico/C-1057-2015; Lodi,
   Tiziana/A-5993-2012
OI Baruffini, Enrico/0000-0002-8280-7849; DALLABONA,
   Cristina/0000-0003-4397-9143; Lodi, Tiziana/0000-0002-7294-8971;
   Zeviani, Massimo/0000-0002-9067-5508
FU Telethon [GGP030039] Funding Source: Medline
CR [Anonymous], 1983, COLD SPRING HARBOR L
   BENNETZEN JL, 1982, J BIOL CHEM, V257, P3026
   Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002
   BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609
   Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8
   CHI NW, 1994, J BIOL CHEM, V269, P29984
   DEFONTAINE A, 1991, NUCLEIC ACIDS RES, V19, P185, DOI 10.1093/nar/19.1.185
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Doudican NA, 2005, MOL CELL BIOL, V25, P5196, DOI 10.1128/MCB.25.12.5196-5204.2005
   Dujon B., 1981, MOL BIOL YEAST SACCH, P505
   ELLEDGE SJ, 1990, GENE DEV, V4, P740, DOI 10.1101/gad.4.5.740
   ELLEDGE SJ, 1987, MOL CELL BIOL, V7, P2783, DOI 10.1128/MCB.7.8.2783
   Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108
   Foury F, 2004, CELL MOL LIFE SCI, V61, P2799, DOI 10.1007/s00018-004-4220-y
   FOURY F, 1989, J BIOL CHEM, V264, P20552
   Fukuhara H., 1977, MITOCHONDRIA, P123
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kaukonen J, 1999, AM J HUM GENET, V65, P256, DOI 10.1086/302445
   LAWSON JE, 1988, J BIOL CHEM, V263, P14812
   LECRENIER N, 1995, MOL GEN GENET, V249, P1, DOI 10.1007/BF00290229
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8
   MATHE G, 1977, CANCER IMMUNOL IMMUN, V2, P139
   McKenzie M, 2004, NEUROCHEM RES, V29, P589, DOI 10.1023/B:NERE.0000014829.42364.dd
   O'Rourke TW, 2005, GENE, V354, P86, DOI 10.1016/j.gene.2005.03.031
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Saada A, 2004, DNA CELL BIOL, V23, P797
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wang PJ, 1997, MOL CELL BIOL, V17, P6114, DOI 10.1128/MCB.17.10.6114
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901
   ZEVIANI M, 1990, AM J HUM GENET, V47, P904
   ZEVIANI M, 1989, NEUROL CLIN, V7, P123, DOI 10.1016/S0733-8619(18)30832-6
   Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544
   Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4
   Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299
NR 48
TC 73
Z9 81
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD OCT 1
PY 2006
VL 15
IS 19
BP 2846
EP 2855
DI 10.1093/hmg/ddl219
PG 10
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 086TO
UT WOS:000240696100002
PM 16940310
OA Bronze, Green Published
DA 2024-11-01
ER

PT J
AU Burusnukul, P
   de los Reyes, EC
AF Burusnukul, Prinyarat
   de los Reyes, Emily C.
TI Phenotypic Variations in 3 Children With POLG1 Mutations
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE mitochondrial disease; DNA polymerase gamma; progressive external
   ophthalmoplegia; Alpers-Huttenlocher syndrome
ID DNA-POLYMERASE-GAMMA; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   ALPERS-SYNDROME; MALE-INFERTILITY; MITOCHONDRIAL; DISORDERS; GENE;
   CHILDHOOD
AB Autosomal inherited mitochondrial diseases have been of increasing interest among clinicians and mitochondrial research groups because these diseases are caused through a secondary effect on the mitochondrial DNA. It was thought that the genetic stability of mitochondrial DNA relies on the accuracy of DNA polymerase gamma. Mutations of DNA polymerase gamma 1 gene (MIM# 174763) have been shown to be a cause of mitochondrial disorders associated with Mendelian disorders characterized by multiple mitochondrial DNA deletions or depletions. To date, several clinical phenotypes associated with polymerase gamma mutation have been reported presenting in both adults and children. We present 3 children in whom were found to have reported pathogenic DNA polymerase gamma 1 mutations: heterozygous p.G517V in 2 half siblings and heterozygous p.T251I and p.P587L in the other. The aim of this communication is to report 3 pediatric cases associated with DNA polymerase gamma 1 mutations to augment the expanding clinical phenotype that has been previously reported.
C1 [Burusnukul, Prinyarat; de los Reyes, Emily C.] Ohio State Univ, Dept Pediat & Neurol, Natl Childrens Hosp, Columbus, OH 43210 USA.
C3 University System of Ohio; Ohio State University; Nationwide Childrens
   Hospital
RP de los Reyes, EC (corresponding author), Ohio State Univ, Dept Pediat & Neurol, Natl Childrens Hosp, 700 Childrens Dr, Columbus, OH 43210 USA.
EM delosReyes@nationwidechildrens.org
RI de los Reyes, Emily/AAP-3836-2020
CR Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   de Vries MC, 2008, J INHERIT METAB DIS, V31, pS299, DOI 10.1007/s10545-008-0871-4
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Krausz C, 2004, J CLIN ENDOCR METAB, V89, P4292, DOI 10.1210/jc.2004-0008
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Uusimaa J, 2008, EPILEPSIA, V49, P1038, DOI 10.1111/j.1528-1167.2008.01544.x
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Walker RL, 1997, GENOMICS, V40, P376, DOI 10.1006/geno.1996.4580
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
NR 22
TC 12
Z9 12
U1 0
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
J9 J CHILD NEUROL
JI J. Child Neurol.
PD APR
PY 2009
VL 24
IS 4
BP 482
EP 486
DI 10.1177/0883073808324539
PG 5
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 424UH
UT WOS:000264593300016
PM 19189930
DA 2024-11-01
ER

PT J
AU Taylor, RW
   Schaefer, AM
   Barron, MJ
   McFarland, R
   Turnbull, DM
AF Taylor, RW
   Schaefer, AM
   Barron, MJ
   McFarland, R
   Turnbull, DM
TI The diagnosis of mitochondrial muscle disease
SO NEUROMUSCULAR DISORDERS
LA English
DT Review
DE mitochondrial muscle disease; mitochondrial DNA; laboratory diagnosis;
   genetic testing; COX deficiency
ID CYTOCHROME-C-OXIDASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   RESPIRATORY-CHAIN; MTDNA MUTATION; LACTIC-ACIDOSIS; COMPLEX-I; POINT
   MUTATION; DNA MUTATIONS; LEIGH-DISEASE; EXERCISE INTOLERANCE
AB Mitochondrial respiratory chain abnormalities are an important cause of neuromuscular disease and may be due to defects of either the mitochondrial or nuclear genome. On account of the clinical and genetic heterogeneity exhibited by the mitochondrial myopathies, their investigation and diagnosis remains a challenge, requiring a combination of techniques including muscle histochemistry, biochemical assessment of respiratory chain function and molecular genetic studies. Here, we describe a step-by-step approach to the clinical and laboratory diagnosis of mitochondrial muscle disease, highlighting the many potential problems that can hinder reaching the correct diagnosis. (C) 2004 Elsevier B.V. All rights reserved.
C1 Newcastle Univ, Sch Med, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Newcastle Univ, Sch Med, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM d.m.turnbull@ncl.ac.uk
RI ; Barron, Martin/E-9649-2015
OI Schaefer, Andrew/0000-0001-9891-7332; McFarland,
   Robert/0000-0002-8833-2688; Barron, Martin/0000-0002-2047-3513
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreu AL, 1999, ANN NEUROL, V45, P820, DOI 10.1002/1531-8249(199906)45:6<820::AID-ANA22>3.0.CO;2-W
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Austin SA, 1998, NEUROLOGY, V51, P1447, DOI 10.1212/WNL.51.5.1447
   BERNES SM, 1993, J PEDIATR-US, V123, P598, DOI 10.1016/S0022-3476(05)80962-X
   BINDOFF LA, 1991, J NEUROL SCI, V102, P17, DOI 10.1016/0022-510X(91)90088-O
   Bodyak ND, 2001, HUM MOL GENET, V10, P17, DOI 10.1093/hmg/10.1.17
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 1997, LANCET, V350, P560, DOI 10.1016/S0140-6736(97)05005-8
   CHINNERY PF, 1999, LANCET S1, V354, P17
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   CHRETIEN D, 1994, CLIN CHIM ACTA, V228, P53, DOI 10.1016/0009-8981(94)90056-6
   Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Fromenty B, 1996, BBA-GENE STRUCT EXPR, V1308, P222, DOI 10.1016/0167-4781(96)00110-8
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO YI, 1994, BIOCHEM BIOPH RES CO, V202, P1624, DOI 10.1006/bbrc.1994.2119
   HAMMANS SR, 1991, LANCET, V337, P1311, DOI 10.1016/0140-6736(91)92981-7
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064
   Jaksch M, 1998, ANN NEUROL, V44, P635, DOI 10.1002/ana.410440409
   Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795
   Janssen AJM, 2003, ANN CLIN BIOCHEM, V40, P3, DOI 10.1258/000456303321016114
   Kirby DM, 2000, ANN NEUROL, V48, P102, DOI 10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.3.CO;2-D
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Lamperti C, 2003, NEUROLOGY, V60, P1206, DOI 10.1212/01.WNL.0000055089.39373.FC
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   MORTEN KJ, 1993, HUM MOL GENET, V2, P2081, DOI 10.1093/hmg/2.12.2081
   Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   POULTON J, 1991, AM J HUM GENET, V48, P649
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Santorelli FM, 1998, ANN NEUROL, V44, P962, DOI 10.1002/ana.410440616
   Schaefer Andrew M., 2001, Current Opinion in Pharmacology, V1, P288
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277
   Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905
   Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379
   Taanman JW, 1997, HUM MOL GENET, V6, P935, DOI 10.1093/hmg/6.6.935
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   TASSIN S, 1980, NEUROPATH APPL NEURO, V6, P337, DOI 10.1111/j.1365-2990.1980.tb00670.x
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Taylor R.W., 1997, Organelle Diseases : Clinical Features, Diagnosis, Pathogenesis, and Management, P341
   TAYLOR RW, 1993, BIOCHIM BIOPHYS ACTA, V1181, P261, DOI 10.1016/0925-4439(93)90030-5
   Taylor RW, 1996, ANN NEUROL, V39, P224, DOI 10.1002/ana.410390212
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Taylor RW, 2002, NEUROMUSCULAR DISORD, V12, P659, DOI 10.1016/S0960-8966(02)00026-3
   Taylor RW, 2000, METH MOLEC MED, V38, P245, DOI 10.1385/1-59259-070-5:245
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Taylor RW, 1996, ANN NEUROL, V40, P459, DOI 10.1002/ana.410400318
   Thorburn DR, 2001, J INHERIT METAB DIS, V24, P312, DOI 10.1023/A:1010347808082
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Triepels RH, 2001, AM J MED GENET, V106, P37, DOI 10.1002/ajmg.1397
   Trijbels FJM, 1997, MOL CELL BIOCHEM, V174, P243, DOI 10.1023/A:1006868810424
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   van den Bosch BJC, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e89
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Weber K, 1997, AM J HUM GENET, V60, P373
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 88
TC 153
Z9 165
U1 0
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD APR
PY 2004
VL 14
IS 4
BP 237
EP 245
DI 10.1016/j.nmd.2003.12.004
PG 9
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 807LX
UT WOS:000220504100001
PM 15019701
DA 2024-11-01
ER

PT J
AU Sakiyama, Y
   Okamoto, Y
   Higuchi, I
   Inamori, Y
   Sangatsuda, Y
   Michizono, K
   Watanabe, O
   Hatakeyama, H
   Goto, Y
   Arimura, K
   Takashima, H
AF Sakiyama, Yusuke
   Okamoto, Yuji
   Higuchi, Itsuro
   Inamori, Yukie
   Sangatsuda, Yoko
   Michizono, Kumiko
   Watanabe, Osamu
   Hatakeyama, Hideyuki
   Goto, Yu-ichi
   Arimura, Kimiyoshi
   Takashima, Hiroshi
TI A new phenotype of mitochondrial disease characterized by familial
   late-onset predominant axial myopathy and encephalopathy
SO ACTA NEUROPATHOLOGICA
LA English
DT Article
DE Mitochondrial disease; Predominant axial myopathy; Encephalopathy;
   Late-onset; Familial case
ID HEREDITARY OPTIC NEUROPATHY; BENT SPINE SYNDROME; MUSCULAR-DYSTROPHY;
   TRNA(PHE) GENE; DNA MUTATION; CAMPTOCORMIA; IDENTIFICATION; THYROIDITIS;
   DEFECTS; PATIENT
AB Axial myopathy is a rare neuromuscular disease that is characterized by paraspinal muscle atrophy and abnormal posture, most notably camptocormia (also known as bent spine). The genetic cause of familial axial myopathy is unknown. Described here are the clinical features and cause of late-onset predominant axial myopathy and encephalopathy. A 73-year-old woman presented with a 10-year history of severe paraspinal muscle atrophy and cerebellar ataxia. Her 84-year-old sister also developed late-onset paraspinal muscle atrophy and generalized seizures with encephalopathy. Computed tomography showed severe atrophy and fatty degeneration of their paraspinal muscles. Their mother and maternal aunt also developed bent spines. The existence of many ragged-red fibers and cytochrome c oxidase-negative fibers in the biceps brachii muscle of the proband indicated a mitochondrial abnormality. No significant abnormalities were observed in the respiratory chain enzyme activities; however, the activities of complexes I and IV were relatively low compared with the activities of other complexes. Sequence analysis of the mitochondrial DNA from the muscle revealed a novel heteroplasmic mutation (m.602C > T) in the mitochondrial tRNA(Phe) gene. This familial case of late-onset predominant axial myopathy and encephalopathy may represent a new clinical phenotype of a mitochondrial disease.
C1 [Sakiyama, Yusuke; Okamoto, Yuji; Higuchi, Itsuro; Inamori, Yukie; Michizono, Kumiko; Watanabe, Osamu; Takashima, Hiroshi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Neurol & Geriatr, Kagoshima 8908520, Japan.
   [Sangatsuda, Yoko] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Kagoshima 8908520, Japan.
   [Hatakeyama, Hideyuki; Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo, Japan.
   [Arimura, Kimiyoshi] Okatsu Hosp, Div Neurol, Kagoshima, Japan.
C3 Kagoshima University; Kagoshima University; National Center for
   Neurology & Psychiatry - Japan
RP Takashima, H (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Neurol & Geriatr, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.
EM thiroshi@m3.kufm.kagoshima-u.ac.jp
FU Nervous and Mental Disorders and Research Committee for Ataxic Disease
   of the Japanese Ministry of Health, Welfare and Labor [19A-1]; Ministry
   of Education, Culture, Sports, Science and Technology of Japan
   [21591095, 21591094]; Grants-in-Aid for Scientific Research [22590939,
   21591095, 21591094] Funding Source: KAKEN
FX We wish to thank Dr. A. Sano and Dr. M. Nakamura for performing the
   quantitative PCR studies. We also wish to thank Ms. A. Yoshimura, Ms. N.
   Hirata, Ms. Y. Shirahama, and Ms. M. Ishigami for their excellent
   technical assistance. This study was supported in part by grants from
   the Nervous and Mental Disorders and Research Committee for Ataxic
   Disease of the Japanese Ministry of Health, Welfare and Labor (grant
   19A-1, H.T.) and the Ministry of Education, Culture, Sports, Science and
   Technology of Japan (grant 21591095, H.T.; 21591094, I. H.).
CR Azher SN, 2005, NEUROLOGY, V65, P355, DOI 10.1212/01.wnl.0000171857.09079.9f
   Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   Berio A, 2002, PANMINERVA MED, V44, P265
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Boerkoel CF, 2001, AM J HUM GENET, V68, P325, DOI 10.1086/318208
   D'Aurelio M, 2006, HUM MOL GENET, V15, P2157, DOI 10.1093/hmg/ddl141
   Darin N, 2006, NEUROMUSCULAR DISORD, V16, P504, DOI 10.1016/j.nmd.2006.05.010
   Delcey V, 2002, REV MED INTERNE, V23, P144, DOI 10.1016/S0248-8663(01)00530-6
   Deschauer M, 2006, ARCH NEUROL-CHICAGO, V63, P902, DOI 10.1001/archneur.63.6.902
   Genasetti A, 2007, J MOL DIAGN, V9, P538, DOI 10.2353/jmoldx.2007.060183
   Gómez-Puerta JA, 2007, CLIN RHEUMATOL, V26, P1017, DOI 10.1007/s10067-006-0259-5
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   Higuchi I, 1999, ACTA NEUROPATHOL, V98, P313, DOI 10.1007/s004010051086
   Iizuka T, 2009, J NEUROL SCI, V278, P35, DOI 10.1016/j.jns.2008.11.016
   Jungbluth H, 2009, NEUROMUSCULAR DISORD, V19, P344, DOI 10.1016/j.nmd.2009.02.005
   Karbowski K, 1999, SPINE, V24, P1494, DOI 10.1097/00007632-199907150-00017
   Kleinle S, 1998, BIOCHEM BIOPH RES CO, V247, P112, DOI 10.1006/bbrc.1998.8729
   Konings A, 2008, MITOCHONDRION, V8, P377, DOI 10.1016/j.mito.2008.08.001
   Kottlors M, 2010, MUSCLE NERVE, V42, P273, DOI 10.1002/mus.21722
   Kovács GG, 2005, BRAIN, V128, P35, DOI 10.1093/brain/awh310
   Mahjneh I, 2002, J NEUROL, V249, P730, DOI 10.1007/s00415-002-0701-9
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   Mithani SK, 2007, CLIN CANCER RES, V13, P7335, DOI 10.1158/1078-0432.CCR-07-0220
   Moslemi AR, 2004, NEUROMUSCULAR DISORD, V14, P46, DOI 10.1016/S0960-8966(03)00168-8
   Müller-Höcker J, 1998, ULTRASTRUCT PATHOL, V22, P91
   Ohno K, 1996, ANN NEUROL, V39, P761, DOI 10.1002/ana.410390612
   POULLIN P, 1993, REV RHUM, V60, P159
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Schäbitz WR, 2003, MOVEMENT DISORD, V18, P408, DOI 10.1002/mds.10385
   Serratrice G, 1996, J NEUROL NEUROSUR PS, V60, P51, DOI 10.1136/jnnp.60.1.51
   Serratrice G, 2007, Acta Myol, V26, P11
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Tzen CY, 2001, KIDNEY INT, V59, P846, DOI 10.1046/j.1523-1755.2001.00567.x
   Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
   Zhou SY, 2006, J MOL DIAGN, V8, P476, DOI 10.2353/jmoldx.2006.060008
NR 37
TC 17
Z9 17
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0001-6322
J9 ACTA NEUROPATHOL
JI Acta Neuropathol.
PD JUN
PY 2011
VL 121
IS 6
BP 775
EP 783
DI 10.1007/s00401-011-0818-y
PG 9
WC Clinical Neurology; Neurosciences; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pathology
GA 766OX
UT WOS:000290796000008
PM 21424749
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Nakamura, M
   Yabe, I
   Sudo, A
   Hosoki, K
   Yaguchi, H
   Saitoh, S
   Sasaki, H
AF Nakamura, M.
   Yabe, I.
   Sudo, A.
   Hosoki, K.
   Yaguchi, H.
   Saitoh, S.
   Sasaki, H.
TI MERRF/MELAS overlap syndrome: a double pathogenic mutation in
   mitochondrial tRNA genes
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID HEREDITARY OPTIC NEUROPATHY; RAGGED-RED FIBERS; STROKE-LIKE EPISODES;
   DNA MUTATION; LACTIC-ACIDOSIS; MTDNA MUTATION; MYOCLONIC EPILEPSY;
   CLINICAL-FEATURES; FAMILY; MYOPATHY
AB Background Myoclonic epilepsy with ragged-red fibres (MERU) and mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) are established phenotypes of mitochondrial encephalomyopathy. The m.8356T>C transition in the mitochondrial tRNA(LYs) gene is a pathogenic mutations of MERRF. The m.3243A>G transition in the mitochondrial tRNALeu gene is detected in most MELAS patients. Although previous analyses of double mutations in mitochondrial DNA (mtDNA) were useful for discussing their nature, many unsolved questions remain.
   Objective To describe the clinical and genetic features of a family with the above mtDNA double-point mutations and discuss the role of double mtDNA mutations in diverse clinical features in the family.
   Patients and methods The proband was a 23-year-old woman with MERRF harbouring m.8356T>C and m.3243A>G transitions in mitochondrial tRNA genes. We assessed clinical aspects of her and those other three relatives and performed mutation analyses on their mtDNA.
   Results Phenotypes of the four patients were MERRF, MERRF/MELAS overlap syndrome and asymptomatic carrier. We hypothesise that the course of the phenotype of this family begins with MERRF and is followed by MELAS. This double mutation was heteroplasmic in blood of all four patients but with different rates in each patient, while m.8356T>C appeared homoplasmic and m.3243A>G was heteroplasmic in muscle of the two examined cases. No other mutations were detected in the total mtDNA sequence in this family.
   Conclusions This is the first reported case of a double-point mutation in mtDNA, both of which were heteroplasmic and pathogenic for the established phenotypes.
C1 [Nakamura, M.; Yabe, I.; Yaguchi, H.; Sasaki, H.] Hokkaido Univ, Dept Neurol, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan.
   [Sudo, A.; Hosoki, K.; Saitoh, S.] Hokkaido Univ, Dept Pediat, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan.
C3 Hokkaido University; Hokkaido University
RP Yabe, I (corresponding author), Hokkaido Univ, Dept Neurol, Grad Sch Med, Kita Ku, N15W7, Sapporo, Hokkaido 0608638, Japan.
EM yabe@med.hokudai.ac.jp
RI Saitoh, Shinji/AFT-1159-2022; Yabe, Ichiro/AAU-2495-2020
OI Saitoh, Shinji/0000-0001-6911-3351
FU Ministry of Education, Science, Sports and Culture, Japan; Uehara
   Foundation
FX We thank all patients for their active cooperation. This work was
   supported in part by a Grant-in-Aid for Scientific Research from the
   Ministry of Education, Science, Sports and Culture, Japan and by a grant
   from the Uehara Foundation.
CR Arenas J, 1999, NEUROLOGY, V52, P377, DOI 10.1212/WNL.52.2.377
   Bidooki SK, 1997, AM J HUM GENET, V60, P1430, DOI 10.1086/515460
   Brown MD, 2001, AM J MED GENET, V104, P331, DOI 10.1002/1096-8628(2001)104:4<331::AID-AJMG10054>3.0.CO;2-8
   Campos Y, 1996, MUSCLE NERVE, V19, P187, DOI 10.1002/(SICI)1097-4598(199602)19:2<187::AID-MUS10>3.0.CO;2-S
   Dai DC, 2008, BIOCHEM BIOPH RES CO, V377, P1152, DOI 10.1016/j.bbrc.2008.10.132
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   Fabrizi GM, 1996, J NEUROL NEUROSUR PS, V61, P47, DOI 10.1136/jnnp.61.1.47
   FOLGERO T, 1995, EUR NEUROL, V35, P168, DOI 10.1159/000117115
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO Y, 1995, MUSCLE NERVE       S, V3, P107
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   Mimaki M, 2003, J HUM GENET, V48, P47, DOI 10.1007/s100380300005
   Mongini T, 2002, CLIN NEUROPATHOL, V21, P72
   Ohno K, 1996, ANN NEUROL, V39, P761, DOI 10.1002/ana.410390612
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319
   Sano M, 1996, J NEUROL, V243, P441, DOI 10.1007/BF00900496
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Tonska K, 2008, MITOCHONDRION, V8, P383, DOI 10.1016/j.mito.2008.08.002
   Verma A, 1996, NEUROLOGY, V46, P1334, DOI 10.1212/WNL.46.5.1334
   Weber K, 1997, AM J HUM GENET, V60, P373
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Zeviani Massimo, 1993, European Journal of Human Genetics, V1, P80
   Zhang AM, 2008, BIOCHEM BIOPH RES CO, V376, P221, DOI 10.1016/j.bbrc.2008.08.128
NR 29
TC 16
Z9 22
U1 0
U2 4
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD OCT
PY 2010
VL 47
IS 10
BP 659
EP 664
DI 10.1136/jmg.2009.072058
PG 6
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 671TI
UT WOS:000283533500002
PM 20610441
OA Green Submitted
DA 2024-11-01
ER

PT J
AU Abdullah, H
   Shah, S
   Husain, H
   Hassan, F
   Maqsood, H
AF Abdullah, Hassan
   Shah, Syed
   Husain, Humza
   Hassan, Furqan
   Maqsood, Hamza
TI Late-onset Mitochondrial Encephalomyopathy with Lactic Acidosis and
   Stroke-like Episodes (MELAS) Syndrome in a 63-year-old Patient
SO CUREUS JOURNAL OF MEDICAL SCIENCE
LA English
DT Article
DE melas; stroke; myopathy; encephalopathy; lactic acidosis; seizures; mri;
   mitochondrial dna mutation
ID ENCEPHALOPATHY; FEATURES; MYOPATHY
AB Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) usually manifests in early life. Clinical hallmarks of the disease are mitochondrial myopathies, encephalopathy with stroke-like episodes, seizures, and lactic acidosis. It rarely manifests in late adulthood. Here we present the case of a 63-year-old female patient who developed recurrent stroke-like symptoms with typical resolving and remitting pattern of findings on imaging. Later on, it was confirmed as a case of MELAS upon genetic analysis.
C1 [Abdullah, Hassan; Hassan, Furqan] Nishtar Med Univ, Med, Multan, Pakistan.
   [Abdullah, Hassan] Univ Alabama Birmingham, Neurol, Birmingham, AL 35294 USA.
   [Shah, Syed; Maqsood, Hamza] Nishtar Med Univ, Nishtar Hosp, Med, Multan, Pakistan.
   [Husain, Humza] Nishtar Med Univ, Internal Med, Multan, Pakistan.
C3 University of Alabama System; University of Alabama Birmingham
RP Abdullah, H (corresponding author), Nishtar Med Univ, Med, Multan, Pakistan.; Abdullah, H (corresponding author), Univ Alabama Birmingham, Neurol, Birmingham, AL 35294 USA.
EM dochassanabdullah@gmail.com
OI Shakeel, Hassan Abdullah/0000-0003-2045-1119; Maqsood,
   Hamza/0000-0001-5721-9511
CR Brady E, 2018, CLIN IMAG, V47, P80, DOI 10.1016/j.clinimag.2017.08.008
   CASTILLO M, 1995, AM J NEURORADIOL, V16, P233
   Geberhiwot T, 2006, NEW ENGL J MED, V354, P1096
   Gieraerts C, 2013, J COMPUT ASSIST TOMO, V37, P279, DOI 10.1097/RCT.0b013e3182811170
   Malhotra K, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0583-7
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   MONTAGNA P, 1988, NEUROLOGY, V38, P751, DOI 10.1212/WNL.38.5.751
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Sinnecker T, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1306-6
   Sue CM, 1998, J NEUROL NEUROSUR PS, V65, P233, DOI 10.1136/jnnp.65.2.233
   Testai FD, 2010, ARCH NEUROL-CHICAGO, V67, P19, DOI 10.1001/archneurol.2009.309
NR 11
TC 1
Z9 1
U1 0
U2 1
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2168-8184
J9 CUREUS J MED SCIENCE
JI Cureus J Med Sci
PD APR 27
PY 2020
VL 12
IS 4
AR e7862
DI 10.7759/cureus.7862
PG 7
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA LH4YC
UT WOS:000528791500019
PM 32483512
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Addo, MG
   Cossard, R
   Pichard, D
   Obiri-Danso, K
   Rötig, A
   Delahodde, A
AF Addo, Matthew Glover
   Cossard, Raynald
   Pichard, Damien
   Obiri-Danso, Kwasi
   Roetig, Agnes
   Delahodde, Agnes
TI <i>Caenorhabditis elegans</i>, a pluricellular model organism to screen
   new genes involved in mitochondrial genome maintenance
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE Mitochondria; mtDNA maintenance; Nematode/Caenorhabditis elegans
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MEMBRANE-PROTEIN; DNA DEPLETION;
   ATP SYNTHASE; MUTATIONS; INNER; EXPRESSION; BROMIDE; RNAI; DYNAMICS
AB The inheritance of functional mitochondria depends on faithful replication and transmission of mitochondrial DNA (mtDNA). A large and heterogeneous group of human disorders is associated with mitochondrial genome quantitative and qualitative anomalies. Several nuclear genes have been shown to account for these severe OXPHOS disorders. However, in several cases, the disease-causing mutations still remain unknown.
   Caenorhabditis elegans has been largely used for studying various biological functions because this multicellular organism has short life cycle and is easy to grow in the laboratory. Mitochondrial functions are relatively well conserved between human and C. elegans, and heteroplasmy exists in this organism as in human. C elegans therefore represents a useful tool for studying mtDNA maintenance. Suppression by RNA interference of genes involved in mtDNA replication such as polg-1, encoding the mitochondrial DNA polymerase, results in reduced mtDNA copy number but in a normal phenotype of the F1 worms. By combining RNAi of genes involved in mtDNA maintenance and EtBr exposure, we were able to reveal a strong and specific phenotype (developmental larval arrest) associated to a severe decrease of mtDNA copy number. Moreover, we tested and validated the screen efficiency for human orthologous genes encoding mitochondrial nucleoid proteins. This allowed us to identify several genes that seem to be closely related to mtDNA maintenance in C elegans.
   This work reports a first step in the further development of a large-scale screening in C. elegans that should allow to identify new genes of mtDNA maintenance whose human orthologs will obviously constitute new candidate genes for patients with quantitative or qualitative mtDNA anomalies. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Addo, Matthew Glover; Cossard, Raynald; Pichard, Damien; Delahodde, Agnes] Univ Paris 11, CNRS, UMR 8621, Inst Genet & Microbiol, F-91405 Orsay, France.
   [Addo, Matthew Glover; Obiri-Danso, Kwasi] Kwame Nkrumah Univ Sci & Technol, Dept Theoret & Appl Biol, Kumasi, Ghana.
   [Roetig, Agnes] Univ Paris 05, Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France.
C3 Centre National de la Recherche Scientifique (CNRS); Universite Paris
   Saclay; Kwame Nkrumah University Science & Technology; Universite Paris
   Cite; Institut National de la Sante et de la Recherche Medicale
   (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Necker-Enfants Malades - APHP
RP Delahodde, A (corresponding author), Univ Paris 11, CNRS, UMR 8621, Inst Genet & Microbiol, F-91405 Orsay, France.
EM agnes.delahodde@igmors.u-psud.fr
RI ; ROTIG, AGNES/G-9592-2017
OI Addo, Matthew Glover/0000-0002-0031-8233; Addo,
   Marylyn/0000-0003-2836-9224; ROTIG, AGNES/0000-0003-0589-0703
FU ANR GENOPAT; French government
FX We would like to thank Drs Monique Bolotin-Fukuhara and Emmanuel Dassa
   for discussions and reading the manuscript. This work was supported by
   ANR GENOPAT (D.P) and French government fellowship for M.G.A.
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   ALLEN RD, 1995, PROTOPLASMA, V189, P1, DOI 10.1007/BF01280286
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Belzacq AS, 2001, ONCOGENE, V20, P7579, DOI 10.1038/sj.onc.1204953
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bratic I, 2009, NUCLEIC ACIDS RES, V37, P1817, DOI 10.1093/nar/gkp018
   Burger G, 2003, P NATL ACAD SCI USA, V100, P892, DOI 10.1073/pnas.0336115100
   Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000
   Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Farina F, 2008, DEV DYNAM, V237, P1668, DOI 10.1002/dvdy.21578
   Fernandez AG, 2005, GENOME RES, V15, P250, DOI 10.1101/gr.3194805
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Gieffers C, 1997, EXP CELL RES, V232, P395, DOI 10.1006/excr.1997.3539
   Gilquin B, 2010, MOL CELL BIOL, V30, P1984, DOI 10.1128/MCB.00007-10
   Giraud S, 1998, J MOL BIOL, V281, P409, DOI 10.1006/jmbi.1998.1955
   Gönczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526
   Hayakawa T, 1998, J BIOL CHEM, V273, P20300, DOI 10.1074/jbc.273.32.20300
   HAYASHI J, 1990, BIOCHEM BIOPH RES CO, V167, P216, DOI 10.1016/0006-291X(90)91753-F
   Hayashi M, 2006, NAT MED, V12, P128, DOI 10.1038/nm1327
   Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01
   Hoffmann M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007644
   Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4
   Lefebvre-Legendre L, 2005, J BIOL CHEM, V280, P18386, DOI 10.1074/jbc.M410789200
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OKIMOTO R, 1992, GENETICS, V130, P471
   Olichon A, 2006, BBA-MOL CELL RES, V1763, P500, DOI 10.1016/j.bbamcr.2006.04.003
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Park SY, 2004, J BIOL CHEM, V279, P7512, DOI 10.1074/jbc.M307677200
   Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221
   Praitis V, 2001, GENETICS, V157, P1217
   RICHARDS.JP, 1973, J MOL BIOL, V78, P703, DOI 10.1016/0022-2836(73)90290-8
   RICHARDS.JP, 1973, J MOL BIOL, V78, P715, DOI 10.1016/0022-2836(73)90291-X
   Rötig A, 2009, BBA-MOL BASIS DIS, V1792, P1103, DOI 10.1016/j.bbadis.2009.06.009
   Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882
   Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Shoubridge EA, 1998, CURR OPIN NEUROL, V11, P491, DOI 10.1097/00019052-199810000-00012
   Sönnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Sugimoto T, 2008, EXP CELL RES, V314, P103, DOI 10.1016/j.yexcr.2007.08.015
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Tsang WY, 2002, BIOCHEM CELL BIOL, V80, P645, DOI 10.1139/O02-135
   Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wang YH, 1999, P NATL ACAD SCI USA, V96, P8046, DOI 10.1073/pnas.96.14.8046
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Williamson D, 2002, NAT REV GENET, V3, P475, DOI 10.1038/nrg814
   Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052
   Zeng XM, 2007, GENETICS, V175, P55, DOI 10.1534/genetics.106.065821
NR 61
TC 22
Z9 34
U1 2
U2 19
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD SEP
PY 2010
VL 1802
IS 9
BP 765
EP 773
DI 10.1016/j.bbadis.2010.05.007
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 638VN
UT WOS:000280925700009
PM 20580819
OA Green Submitted
DA 2024-11-01
ER

PT J
AU Kami, K
   Fujita, Y
   Igarashi, S
   Koike, S
   Sugawara, S
   Ikeda, S
   Sato, N
   Ito, M
   Tanaka, M
   Tomita, M
   Soga, T
AF Kami, Kenjiro
   Fujita, Yasunori
   Igarashi, Saori
   Koike, Sayaka
   Sugawara, Shoko
   Ikeda, Satsuki
   Sato, Naomi
   Ito, Masafumi
   Tanaka, Masashi
   Tomita, Masaru
   Soga, Tomoyoshi
TI Metabolomic profiling rationalized pyruvate efficacy in cybrid cells
   harboring MELAS mitochondrial DNA mutations
SO MITOCHONDRION
LA English
DT Article
DE MELAS; Pyruvate; Cybrid; Energy metabolism; Metabolome; CE-MS
ID STROKE-LIKE EPISODES; ELECTROPHORESIS-MASS-SPECTROMETRY;
   LACTIC-ACIDOSIS; ESCHERICHIA-COLI; MTDNA MUTATION; LEIGH-SYNDROME;
   ENCEPHALOPATHY; THERAPY; MYOPATHY; ENCEPHALOMYOPATHY
AB Pyruvate treatment was found to alleviate clinical symptoms of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome and is highly promising therapeutic. Using capillary electrophoresis time-of-flight mass spectrometry (CE-TOFMS), we measured time-changes of 161 intracellular and 85 medium metabolites to elucidate metabolic effects of pyruvate treatment on cybrid human 143B osteosarcoma cells harboring normal (2SA) and MELAS mutant (2SD) mitochondria. The results demonstrated dramatic and sustainable effects of pyruvate administration on the energy metabolism of 2SD cells, corroborating pyruvate as a metabolically rational treatment regimen for improving symptoms associated with MELAS and possibly other mitochondrial diseases. (C) 2012 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Tanaka, Masashi] Tokyo Metropolitan Inst Gerontol, Dept Genom Longev & Hlth, Itabashi Ku, Tokyo 1730015, Japan.
   [Kami, Kenjiro; Igarashi, Saori; Koike, Sayaka; Sugawara, Shoko; Ikeda, Satsuki; Sato, Naomi; Tomita, Masaru; Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970017, Japan.
   [Kami, Kenjiro; Tomita, Masaru; Soga, Tomoyoshi] Keio Univ, Grad Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa 2528520, Japan.
   [Fujita, Yasunori; Ito, Masafumi] Tokyo Metropolitan Inst Gerontol, Res Team Mech Aging, Itabashi Ku, Tokyo 1730015, Japan.
   [Tomita, Masaru; Soga, Tomoyoshi] Human Metabolome Technol Inc, Tsuruoka, Yamagata 9970052, Japan.
C3 Tokyo Metropolitan Institute of Gerontology; Keio University; Keio
   University; Tokyo Metropolitan Institute of Gerontology
RP Tanaka, M (corresponding author), Tokyo Metropolitan Inst Gerontol, Dept Genom Longev & Hlth, Itabashi Ku, 35-2 Sake Cho, Tokyo 1730015, Japan.
EM mtanaka@tmig.or.jp
RI Tomita, Masaru/C-8380-2014; Soga, Tomoyoshi/B-8105-2014
OI Fujita, Yasunori/0009-0006-0334-7212
FU Ministry of Education, Culture, Sports, Science, and Technology (MEXT)
   of Japan [A-22240072, B-21390459, 180 73004, 18GS0314, F-3]; Ministry of
   Health, Labour and Welfare (MHLW) of Japan [H23-016, H23-119, H24-005];
   Takeda Science Foundation; Gifu Prefecture, Japan; Government of
   Yamagata Prefecture; Tsuruoka City, Japan; Grants-in-Aid for Scientific
   Research [22300244] Funding Source: KAKEN
FX The authors thank Dr. Masahiro Sugimoto for software development and Dr.
   Maria R. Monton and Ms. Kaori Igarashi for conducting the metabolome
   analysis. This work was supported in part by the following grants: a
   grant of the Global COE Program entitled, "Human Metabolomic Systems
   Biology," "Grant-in-Aid" research grants for the 21st Century Centre of
   Excellence (COE) Program (F-3); Scientific Research (A-22240072 and
   B-21390459), Creative Scientific Research (180 73004, 18GS0314),
   Targeted Proteins Research Program (TPRP), and Scientific Research on
   Priority Areas "Systems Genomes" and "Lifesurveyor" from the Ministry of
   Education, Culture, Sports, Science, and Technology (MEXT) of Japan;
   Grant-in-Aids (H23-016, H23-119, and H24-005) for the Research on
   Intractable Diseases (Mitochondrial Disease) from the Ministry of
   Health, Labour and Welfare (MHLW) of Japan; grants for scientific
   research from the Takeda Science Foundation; a grant for biological
   research from Gifu Prefecture, Japan; and research funds from the
   Government of Yamagata Prefecture and Tsuruoka City, Japan.
CR CASTILLO M, 1995, AM J NEURORADIOL, V16, P233
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Desagher S, 1997, J NEUROSCI, V17, P9060
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Fujita Y, 2007, MITOCHONDRION, V7, P80, DOI 10.1016/j.mito.2006.11.003
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806
   Hussein Ahmed, 2009, Eur J Intern Med, V20, pe114, DOI 10.1016/j.ejim.2008.09.018
   ICHIKI T, 1989, PEDIATR RES, V25, P194, DOI 10.1203/00006450-198902000-00023
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067
   Junker BH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-109
   Koga Y, 2012, BBA-GEN SUBJECTS, V1820, P608, DOI 10.1016/j.bbagen.2011.09.005
   Koga Y, 2012, BRAIN DEV-JPN, V34, P87, DOI 10.1016/j.braindev.2011.03.003
   Komaki H, 2010, BBA-GEN SUBJECTS, V1800, P313, DOI 10.1016/j.bbagen.2009.07.008
   Liu CY, 2004, ANN NY ACAD SCI, V1011, P133, DOI 10.1196/annals.1293.014
   NATH KA, 1995, AM J PHYSIOL-CELL PH, V268, pC227, DOI 10.1152/ajpcell.1995.268.1.C227
   Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rusanen H, 2000, BBA-MOL BASIS DIS, V1500, P10, DOI 10.1016/S0925-4439(99)00081-2
   Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01
   Saito K, 2012, BBA-GEN SUBJECTS, V1820, P632, DOI 10.1016/j.bbagen.2011.08.006
   Sandhu JK, 2005, BIOCHEM J, V391, P191, DOI 10.1042/BJ20050272
   Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623
   Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m
   Soga T, 2007, J CHROMATOGR A, V1159, P125, DOI 10.1016/j.chroma.2007.05.054
   Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Tanaka M, 2007, MITOCHONDRION, V7, P399, DOI 10.1016/j.mito.2007.07.002
   van Winden WA, 2002, BIOTECHNOL BIOENG, V80, P477, DOI 10.1002/bit.10393
   Voet D., 1995, Biochemistry, V2
   Wilichowski E, 1998, J NEUROL SCI, V157, P206, DOI 10.1016/S0022-510X(98)00068-9
   YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699
   YONEDA M, 1989, J NEUROL SCI, V92, P143, DOI 10.1016/0022-510X(89)90132-9
   Zhang J, 1998, BIOCHEM MOL BIOL INT, V46, P71
NR 39
TC 16
Z9 19
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV
PY 2012
VL 12
IS 6
BP 644
EP 653
DI 10.1016/j.mito.2012.07.113
PG 10
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 046IQ
UT WOS:000311759100008
PM 22884939
DA 2024-11-01
ER

PT J
AU Punsoni, M
   Mangray, S
   Lombardo, KA
   Heath, N
   Stopa, EG
   Yakirevich, E
AF Punsoni, Michael
   Mangray, Shamlal
   Lombardo, Kara A.
   Heath, Nancy
   Stopa, Edward G.
   Yakirevich, Evgeny
TI Succinate Dehydrogenase B (SDHB) Immunohistochemistry for the Evaluation
   of Muscle Biopsies
SO APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
LA English
DT Article
DE succinate dehydrogenase B; SDHB; immunohistochemistry; muscle biopsy;
   mitochondrial myopathy
ID MITOCHONDRIAL-DNA DELETIONS; SKELETAL-MUSCLE; COMPLEX II; MUTATIONS
AB Succinate dehydrogenase (SDH) is a key mitochondrial enzyme complex composed of 4 subunits. SDH histochemistry is routinely utilized in the assessment of muscle biopsies to reveal underlying pathology such as subsarcolemmal mitochondrial aggregates. In this study, we evaluated the utility of succinate dehydrogenase B (SDHB) immunohistochemistry (IHC) in 27 muscle biopsies, including 13 mitochondrial myopathies (MMs), 9 inflammatory myopathies, and 5 controls. SDHB IHC was performed on formalin-fixed, paraffin-embedded tissue sections with a mouse monoclonal antibody (Abcam 21A11AE7) in parallel with histochemical SDH stains on a fresh-frozen tissue. In all muscle biopsies, SDHB IHC exhibited granular immunoreactivity and highlighted the dark type 1 and lighter type 2 staining pattern observed by histochemistry. In all cases of MM, SDHB IHC showed subsarcolemmal granular aggregates involving the entire periphery of the fibers that were more distinct than those seen by SDH histochemistry. In 3 extraocular muscle biopsies, SDHB immunoreactive speckles of various sizes were distributed throughout the entire sarcoplasm that were more prominent than those seen on SDH histochemistry. Subsarcolemmal and cytoplasmic granular aggregates seen on SDHB IHC correlated with mitochondrial pathology on electron microscopy. In cases of inflammatory myopathy, there was diffuse sarcoplasmic SDHB immunoreactivity in degenerating fibers, but no evidence of subsarcolemmal aggregates. This study demonstrates that SDHB IHC is highly sensitive and specific in the identification of MM. The automation, reproducibility, and cost efficiency of SDHB IHC offer advantages over the labor-intensive histochemical method requiring frozen sections. As this technique is performed on formalin-fixed, paraffin-embedded tissues, it can be easily applied for retrospective studies.
C1 [Punsoni, Michael; Mangray, Shamlal; Lombardo, Kara A.; Heath, Nancy; Stopa, Edward G.; Yakirevich, Evgeny] Rhode Isl Hosp, Dept Pathol & Lab Med, Providence, RI 02903 USA.
   [Punsoni, Michael; Mangray, Shamlal; Lombardo, Kara A.; Heath, Nancy; Stopa, Edward G.; Yakirevich, Evgeny] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.
C3 Lifespan Health Rhode Island; Rhode Island Hospital; Brown University
RP Yakirevich, E (corresponding author), Rhode Isl Hosp, Dept Pathol, APC12,593 Eddy St, Providence, RI 02903 USA.
EM eyakirevich@lifespan.org
FU Molecular Pathology Core of the COBRE Center for Cancer Research
   Development - National Institute of General Medical Sciences of the
   National Institutes of Health [P20GM103421]
FX Supported by the Molecular Pathology Core of the COBRE Center for Cancer
   Research Development, funded by the National Institute of General
   Medical Sciences of the National Institutes of Health under Award Number
   P20GM103421. The content is solely the responsibility of the authors and
   does not necessarily represent the official views of the National
   Institutes of Health.
CR Alston CL, 2012, J MED GENET, V49, P569, DOI 10.1136/jmedgenet-2012-101146
   Bancroft JD, 1990, THEORY PRACTICE HIST
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   Chen T, 2014, INT J CLIN EXP PATHO, V7, P8887
   Dubowitz V., 2013, MUSCLE BIOPSY PRACTI
   Gill AJ, 2012, PATHOLOGY, V44, P285, DOI 10.1097/PAT.0b013e3283539932
   HINTZ CS, 1984, J HISTOCHEM CYTOCHEM, V32, P655, DOI 10.1177/32.6.6202737
   Hoekstra AS, 2013, BBA-BIOENERGETICS, V1827, P543, DOI 10.1016/j.bbabio.2012.11.005
   JAY V, 1994, ARCH PATHOL LAB MED, V118, P917
   KUN E, 1949, SCIENCE, V109, P144, DOI 10.1126/science.109.2824.144
   MALATY HA, 1953, NATURE, V171, P295, DOI 10.1038/171295a0
   Meng H, 2014, JOVE-J VIS EXP, DOI 10.3791/51586
   Miles L, 2012, HUM PATHOL, V43, P1249, DOI 10.1016/j.humpath.2011.09.016
   OLDFORS A, 1992, J NEUROL SCI, V110, P169, DOI 10.1016/0022-510X(92)90025-G
   Pytel P, 2015, ROBBINS COTRAN PATHO, P1227
   Rahman S, 2000, BRAIN, V123, P591, DOI 10.1093/brain/123.3.591
   RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107
   Rojiani AM, 1998, MODERN PATHOL, V11, P334
   RUTENBURG AM, 1950, CANCER RES, V10, P113
   Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001
   SELIGMAN AM, 1951, SCIENCE, V113, P317, DOI 10.1126/science.113.2934.317-a
   Sheehan DC., 1980, THEORY PRACTICE HIST, P292
   van Nederveen FH, 2009, LANCET ONCOL, V10, P764, DOI 10.1016/S1470-2045(09)70164-0
   Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605
   Zierz CM, 2015, NEUROPATHOLOGY, V35, P130, DOI 10.1111/neup.12173
NR 25
TC 11
Z9 13
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1541-2016
EI 1533-4058
J9 APPL IMMUNOHISTO M M
JI Appl. Immunohistochem.
PD OCT
PY 2017
VL 25
IS 9
BP 645
EP 650
DI 10.1097/PAI.0000000000000432
PG 6
WC Anatomy & Morphology; Medical Laboratory Technology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anatomy & Morphology; Medical Laboratory Technology; Pathology
GA FO2WX
UT WOS:000416660800011
PM 27556822
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Cardaioli, E
   Da Pozzo, P
   Gallus, GN
   Malandrini, A
   Gambelli, S
   Gaudiano, C
   Malfatti, E
   Viscomi, C
   Zicari, E
   Berti, G
   Serni, G
   Dotti, MT
   Federico, A
AF Cardaioli, Elena
   Da Pozzo, Paola
   Gallus, Gian Nicola
   Malandrini, Alessandro
   Gambelli, Simona
   Gaudiano, Carnien
   Malfatti, Edoardo
   Viscomi, Carlo
   Zicari, Enza
   Berti, Gianna
   Serni, Giovanni
   Dotti, Maria Teresa
   Federico, Antonio
TI A novel heteroplasmic tRNA<SUP>Ser(UCN)</SUP> mtDNA point mutation
   associated with progressive external ophthalmoplegia and hearing loss
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE progressive external ophthalmoplegia; mitochondrial DNA; tRNA(Ser(UCN))
ID A3243G MUTATION; MITOCHONDRIAL; DELETIONS; GENE
AB We sequenced all mitochondrial tRNA genes from a patient with sporadic external ophthalmoplegia (PEO) and 5% COX-negative fibers in muscle biopsy, who had no detectable large mtDNA deletions. Direct sequencing showed a heteroplasmic mutation at nucleotide 7506 in the dihydrouridine stem of the tRNA(Ser(UCN)) gene. RFLP analysis confirmed that 30% of muscle and 20% of urinary epithelium mtDNA harbored the mutation, which was absent in other tissues of the proband as well as in mtDNA of his mother and 100 patients with various encephalomyopathies. Several point mutations on mitochondrial tRNA genes have been reported in PEO patients without large-scale rearrangements of mtDNA but no point mutations have hitherto been found in the gene coding for tRNA(Ser(UCN)) . (C) 2007 Elsevier B.V. All rights reserved.
C1 [Cardaioli, Elena; Da Pozzo, Paola; Gallus, Gian Nicola; Malandrini, Alessandro; Gambelli, Simona; Gaudiano, Carnien; Malfatti, Edoardo; Zicari, Enza; Berti, Gianna; Serni, Giovanni; Dotti, Maria Teresa; Federico, Antonio] Univ Siena, Dept Neurol & Behav Sci, I-53100 Siena, Italy.
   [Viscomi, Carlo] Natl Inst Neurol C Besta, Unit Mol Neurogenet, I-20126 Milan, Italy.
C3 University of Siena
RP Federico, A (corresponding author), Univ Siena, Dept Neurol & Behav Sci, Via Bracci 2, I-53100 Siena, Italy.
EM federico@unisi.it
RI Federico, Antonio/H-8871-2017; viscomi, Carlo/R-1940-2016; Malfatti,
   Edoardo/KEI-9379-2024; GALLUS, GIAN NICOLA/Q-3489-2016
OI GALLUS, GIAN NICOLA/0000-0001-5801-223X; Cardaioli,
   Elena/0000-0003-2850-6698; Viscomi, Carlo/0000-0001-6050-0566; federico,
   antonio/0000-0002-5246-1621
CR Bidooki S, 2004, NEUROMUSCULAR DISORD, V14, P417, DOI 10.1016/j.nmd.2004.03.004
   Cardaioli E, 2005, BIOCHEM BIOPH RES CO, V327, P675, DOI 10.1016/j.bbrc.2004.11.170
   Chinnery PF, 2000, ANN NEUROL, V47, P381, DOI 10.1002/1531-8249(200003)47:3<381::AID-ANA17>3.0.CO;2-2
   EDQVIST J, 1993, NUCLEIC ACIDS RES, V21, P413, DOI 10.1093/nar/21.3.413
   Koga Y, 2000, ARCH DIS CHILD, V82, P407, DOI 10.1136/adc.82.5.407
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   PUGLISI JD, 1993, NUCLEIC ACIDS RES, V21, P41, DOI 10.1093/nar/21.1.41
   ZEVIANI M, 1990, AM J HUM GENET, V47, P904
NR 8
TC 13
Z9 15
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD OCT
PY 2007
VL 17
IS 9-10
BP 681
EP 683
DI 10.1016/j.nmd.2007.05.001
PG 3
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 221WL
UT WOS:000250258000005
PM 17614276
DA 2024-11-01
ER

PT J
AU Villar, P
   Bretón, B
   García-Pavía, P
   González-Páramos, C
   Blázquez, A
   Gómez-Bueno, M
   García-Silva, T
   García-Consuegra, I
   Martín, MA
   Garesse, R
   Bornstein, B
   Gallardo, ME
AF Villar, Pedro
   Breton, Begona
   Garcia-Pavia, Pablo
   Gonzalez-Paramos, Cristina
   Blazquez, Alberto
   Gomez-Bueno, Manuel
   Garcia-Silva, Teresa
   Garcia-Consuegra, Ines
   Angel Martin, Miguel
   Garesse, Rafael
   Bornstein, Belen
   Esther Gallardo, M.
TI Cardiac Dysfunction in Mitochondrial Disease - Clinical and Molecular
   Features
SO CIRCULATION JOURNAL
LA English
DT Article
DE Cardiomyopathy; Cybrid; Mitochondrial disease; Mitochondrial DNA; mtDNA
ID TRNA(VAL) GENE MUTATION; HYPERTROPHIC CARDIOMYOPATHY; COMPLEX-I;
   NEUROLOGICAL PRESENTATION; PEDIATRIC-PATIENTS; POINT MUTATION; DNA
   MUTATION; DEFICIENCY; MYOPATHY; SPECTRUM
AB Background: Mitochondrial disorders (MD) are multisystem diseases that arise as a result of dysfunction of the oxidative phosphorylation System. The predominance of neuromuscular manifestations in MD could mask the presence of other clinical phenotypes such as cardiac dysfunction. Reported here is a retrospective study, the main objective of which was to characterize the clinical and molecular features of a cohort of patients with cardiomyopathy and MD.
   Methods and Results: Hospital charts of 2,520 patients, evaluated for presumed MD were reviewed. The clinical criterion for inclusion in this study was the presence of a cardiac disturbance accompanied by a mitochondrial dysfunction. Only 71 patients met this criterion. The mitochondrial genome (mtDNA) could be sequenced only in 45 and the pathogenicity of 2 of the found changes was investigated using transmitochondrial cybrids. Three nucleotide changes in mtDNA that may be relevant and 3 with confirmed pathogenicity were identified but no mutations were found in the 13 nuclear genes analyzed.
   Conclusions: The mtDNA should be sequenced in patients with cardiac dysfunction accompanied by symptoms suggestive of MD; databases should be carefully and periodically screened to discard mitochondrial variants that could be associated with MD; functional assays are necessary to classify mitochondrial variants as pathogenic or polymorphic; and additional efforts must be made in order to identify nuclear genes that can explain some as yet uncharacterized molecular features of mitochondria! cardiomyopathy.
C1 [Gonzalez-Paramos, Cristina; Garesse, Rafael; Bornstein, Belen; Esther Gallardo, M.] UAM CSIC, Coll Med, Biomed Res Inst Alberto Sols, Dept Biochem, Madrid 28029, Spain.
   [Blazquez, Alberto; Angel Martin, Miguel; Garesse, Rafael; Bornstein, Belen; Esther Gallardo, M.] Rare Dis Biomed Res Ctr CIBERER, Madrid, Spain.
   [Blazquez, Alberto; Garcia-Silva, Teresa; Garcia-Consuegra, Ines; Angel Martin, Miguel; Garesse, Rafael; Bornstein, Belen; Esther Gallardo, M.] Hosp 12 Octubre I 12, Hlth Res Inst, Madrid, Spain.
   [Villar, Pedro; Breton, Begona; Bornstein, Belen] Hosp Univ Puerta de Hieno, Biochem Unit, Madrid, Spain.
   [Garcia-Pavia, Pablo; Gomez-Bueno, Manuel] Hosp Univ Puerta de Hieno, Cardiol Unit, Madrid, Spain.
   [Garcia-Pavia, Pablo; Gomez-Bueno, Manuel] Net Clin & Basic Res Heart Failure REDINSCOR, Madrid, Spain.
   [Blazquez, Alberto; Garcia-Consuegra, Ines; Angel Martin, Miguel] Res Ctr, Lab Mitochondrial Dis, Madrid, Spain.
   [Garcia-Silva, Teresa] Hosp Univ 12 Octubre, Pediat Unit, Madrid, Spain.
   [Villar, Pedro; Breton, Begona; Garcia-Pavia, Pablo; Gomez-Bueno, Manuel; Bornstein, Belen] Res Inst Puerta de Hierro Majadahonda IDIPHIM, Madrid, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto
   de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de
   Investigacion Biomedica en Red; CIBERER; Hospital Universitario 12 de
   Octubre; Hospital Universitario 12 de Octubre
RP Gallardo, ME (corresponding author), UAM CSIC, Coll Med, Biomed Res Inst Alberto Sols, Dept Biochem, Avda Arzobispo Morcillo S-N, Madrid 28029, Spain.
EM belen.bornstein@uam.es; egallardo@iib.uam.es
RI Garesse, Rafael/F-3836-2012; Gallardo, M./AFK-7298-2022;
   González-Páramos, Cristina/AAB-5064-2019; Garcia-Pavia,
   Pablo/T-9100-2019; Martin, Miguel/S-2758-2018; Martin, Miguel
   Angel/B-6261-2017; Blazquez Encinar, Alberto/S-4425-2018
OI Gomez-Bueno, Manuel/0000-0002-9764-7518; Garesse,
   Rafael/0000-0002-0338-2281; Martin, Miguel Angel/0000-0003-4741-772X;
   Villar, Pedro/0000-0002-4356-3554; GALLARDO PEREZ, M.
   ESTHER/0000-0002-8699-8734; Blazquez Encinar,
   Alberto/0000-0002-6479-3615; Garcia-Pavia, Pablo/0000-0002-5470-2257;
   Gonzalez-Paramos, Cristina/0000-0002-8558-2868
FU Instituto de Salud Carlos III [PI 07/0167, PI 10/0703, PI 09/00941, PI
   06/0205, PI060547]; Comunidad de Madrid [GEN-0269/2006]; Instituto de
   Salud Carlos III-Ministerio de Ciencia e Innovacion (CIII-MICIN);
   Agencia Lain Entralgo (Comunidad de Madrid); Centre for Biomedical
   Research on Rare Diseases (CIBERER); Instituto de Investigacion Puerta
   de Hierro Majadahonda (IDIPHIM)
FX We would like to acknowledge Sara Fernandez Mate and Gonzalo Carreno for
   their contributions in the sequencing of nuclear genes; Veronica Domingo
   for doing the analyses of the heteroplasmy levels and Aitor Delmiro for
   measuring RC activities. This work was supported by the Instituto de
   Salud Carlos III (grants PI 07/0167 and PI 10/0703 to R.G., PI 09/00941
   and PI 06/0205 to B.B. and PI060547 to M.A.M.) and the Comunidad de
   Madrid (grant number GEN-0269/2006 to R.G). B.B. is supported by the
   programme "Intensificacion de la Actividad Investigadora", from
   Instituto de Salud Carlos III-Ministerio de Ciencia e Innovacion
   (CIII-MICIN) and the Agencia Lain Entralgo (Comunidad de Madrid). M.E.G.
   receives grant support from the Centre for Biomedical Research on Rare
   Diseases (CIBERER) and P. Villar and B. Breton from Instituto de
   Investigacion Puerta de Hierro Majadahonda (IDIPHIM).
CR Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Apte SM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-16
   Arredondo JJ, 2012, MITOCHONDRION, V12, P357, DOI 10.1016/j.mito.2011.09.010
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002
   Bénit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225
   Blakely EL, 2004, J NEUROL SCI, V225, P99, DOI 10.1016/j.jns.2004.07.007
   Bornstein B, 2005, BIOCHEM J, V387, P773, DOI 10.1042/BJ20040949
   Campos Y, 2001, ANN NEUROL, V50, P409, DOI 10.1002/ana.1141
   Chalmers RM, 1997, NEUROLOGY, V49, P589, DOI 10.1212/WNL.49.2.589
   de Coo IFM, 1998, NEUROLOGY, V50, P293, DOI 10.1212/WNL.50.1.293
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   García-Cazorla A, 2005, PEDIATRICS, V116, P1170, DOI 10.1542/peds.2004-2407
   Hollingsworth KG, 2012, NEUROMUSCULAR DISORD, V22, P592, DOI 10.1016/j.nmd.2012.03.001
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   Horvath R, 2009, J NEUROL, V256, P810, DOI 10.1007/s00415-009-5023-8
   Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Kimura A, 2011, CIRC J, V75, P1756, DOI 10.1253/circj.CJ-11-0368
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   Lim BC, 2009, J CHILD NEUROL, V24, P828, DOI 10.1177/0883073808331085
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   MASUCCI JP, 1995, MOL CELL BIOL, V15, P2872
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Paterick TE, 2012, CIRC J, V76, P1556, DOI 10.1253/circj.CJ-12-0666
   Prasad GN, 2006, INT J CARDIOL, V109, P432, DOI 10.1016/j.ijcard.2005.07.065
   Rötig A, 2003, J AM SOC NEPHROL, V14, P2995, DOI 10.1097/01.ASN.0000095481.24091.C9
   Sacconi S, 2002, ARCH NEUROL-CHICAGO, V59, P1013, DOI 10.1001/archneur.59.6.1013
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Tanji K, 2008, J NEUROL SCI, V270, P23, DOI 10.1016/j.jns.2008.01.016
   Taylor RW, 1996, ANN NEUROL, V40, P459, DOI 10.1002/ana.410400318
   Tiranti V, 1998, ANN NEUROL, V43, P98, DOI 10.1002/ana.410430116
   TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421
   Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461
   van Oven M, 2012, J HUM GENET, V57, P65, DOI 10.1038/jhg.2011.120
   Verhoeven WMA, 2011, NEUROPSYCH DIS TREAT, V7, P293, DOI 10.2147/NDT.S20153
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
NR 50
TC 6
Z9 6
U1 0
U2 8
PU JAPANESE CIRCULATION SOC
PI TOYKO
PA 18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO,
   100-0011, JAPAN
SN 1346-9843
EI 1347-4820
J9 CIRC J
JI Circ. J.
PD NOV
PY 2013
VL 77
IS 11
BP 2799
EP 2806
DI 10.1253/circj.CJ-13-0557
PG 8
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA 243LJ
UT WOS:000326317600026
PM 23965802
OA gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Lee, IC
   Lee, NC
   Lu, JJ
   Su, PH
AF Lee, Inn-Chi
   Lee, Ni-Chung
   Lu, Jang-Jih
   Su, Pen-Hua
TI Mitochondrial Depletion Causes Neonatal-Onset Leigh Syndrome, Myopathy,
   and Renal Tubulopathy
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE mitochondrial depletion; Leigh syndrome; newborn; myopathy; renal
   tubulopathy
ID CYTOCHROME-C-OXIDASE; SURF1 GENE-MUTATIONS; DNA DEPLETION; SUCLA2
   MUTATIONS; COX DEFICIENCY; ENCEPHALOMYOPATHY; HYPERTRICHOSIS; DISEASE;
   RRM2B
AB The authors describe a newborn with postnatal myopathy who subsequently developed feeding difficulties, ophthalmoplegia, ptosis, encephalopathy, and seizures. She became ventilator dependent after sudden apnea. The myopathy was without ragged red fibers in the muscle biopsy. An electron transport chain study showed a markedly generalized low level of enzyme activity, particularly in complexes I, I + III, and IV. An initial electroencephalogram finding was normal; subsequent electroencephalograms showed suppression bursts. The mitochondrial copy number in skeletal muscle was 2% of normal.
C1 [Lee, Inn-Chi; Su, Pen-Hua] Chung Shan Med Univ Hosp, Dept Pediat, Taichung 402, Taiwan.
   [Lee, Inn-Chi; Su, Pen-Hua] Chung Shan Med Univ, Inst Med, Sch Med, Taichung, Taiwan.
   [Lee, Ni-Chung] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan.
   [Lu, Jang-Jih] Linkou Chang Gung Mem Hosp, Dept Lab Med, Tao Yuan, Taiwan.
C3 Chung Shan Medical University; Chung Shan Medical University Hospital;
   Chung Shan Medical University; National Taiwan University; National
   Taiwan University Hospital; Chang Gung Memorial Hospital
RP Lee, IC (corresponding author), Chung Shan Med Univ Hosp, Dept Pediat, 0 Chien Kuo N Rd,Sec 1, Taichung 402, Taiwan.
EM y610@mercury.csmu.edu.tw
RI Lu, Chun-yi/JXN-8290-2024
OI LEE, NI-CHUNG/0000-0002-5011-7499
FU National Taiwan University Hospital, Taipei, Taiwan [99-N1440]
FX This study was funded by grant 99-N1440 from National Taiwan University
   Hospital, Taipei, Taiwan.
CR Barthélémy C, 2001, ANN NEUROL, V49, P607, DOI 10.1002/ana.1002.abs
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bruno C, 2002, J CHILD NEUROL, V17, P233, DOI 10.1177/088307380201700318
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Collins J, 2009, NEUROMUSCULAR DISORD, V19, P784, DOI 10.1016/j.nmd.2009.08.002
   Dahl H.-H. M., 1992, Human Mutation, V1, P97, DOI 10.1002/humu.1380010203
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Moslemi AR, 2003, NEUROLOGY, V61, P991, DOI 10.1212/01.WNL.0000082391.98672.0A
   Ostergaard E, 2005, AM J MED GENET A, V138A, P384, DOI 10.1002/ajmg.a.30972
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rossi A, 2003, AM J NEURORADIOL, V24, P1188
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Tay SKH, 2005, J CHILD NEUROL, V20, P670, DOI 10.1177/08830738050200080701
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Williams SL, 2001, MOL GENET METAB, V73, P340, DOI 10.1006/mgme.2001.3206
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807
   Yüksel A, 2006, PEDIATR NEUROL, V34, P486, DOI 10.1016/j.pediatrneurol.2005.10.020
   Zeviani M, 2001, CURR OPIN NEUROL, V14, P553, DOI 10.1097/00019052-200110000-00002
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 24
TC 6
Z9 8
U1 0
U2 4
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
J9 J CHILD NEUROL
JI J. Child Neurol.
PD MAR
PY 2013
VL 28
IS 3
BP 404
EP 408
DI 10.1177/0883073812469722
PG 5
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 127ER
UT WOS:000317680100018
PM 23307888
DA 2024-11-01
ER

PT J
AU Swalwell, H
   Kirby, DM
   Blakely, EL
   Mitchell, A
   Salemi, R
   Sugiana, C
   Compton, AG
   Tucker, EJ
   Ke, X
   Lamont, PJ
   Turnbull, DM
   McFarland, R
   Taylor, RW
   Thorburn, DR
AF Swalwell, Helen
   Kirby, Denise M.
   Blakely, Emma L.
   Mitchell, Anna
   Salemi, Renato
   Sugiana, Canny
   Compton, Alison G.
   Tucker, Elena J.
   Ke, Xia
   Lamont, Phillipa J.
   Turnbull, Douglass M.
   McFarland, Robert
   Taylor, Robert W.
   Thorburn, David R.
TI Respiratory chain complex I deficiency caused by mitochondrial DNA
   mutations
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE respiratory chain; complex I; mitochondrial DNA; mutation; genetic
   counselling
ID LEIGH-SYNDROME; UBIQUINONE OXIDOREDUCTASE; G13513A MUTATION;
   LACTIC-ACIDOSIS; COMMON-CAUSE; ND3 GENE; DISEASE; DISORDERS; CHILDREN;
   MYOPATHY
AB Defects of the mitochondrial respiratory chain are associated with a diverse spectrum of clinical phenotypes, and may be caused by mutations in either the nuclear or the mitochondrial genome (mitochondrial DNA (mtDNA)). Isolated complex I deficiency is the most common enzyme defect in mitochondrial disorders, particularly in children in whom family history is often consistent with sporadic or autosomal recessive inheritance, implicating a nuclear genetic cause. In contrast, although a number of recurrent, pathogenic mtDNA mutations have been described, historically, these have been perceived as rare causes of paediatric complex I deficiency. We reviewed the clinical and genetic findings in a large cohort of 109 paediatric patients with isolated complex I deficiency from 101 families. Pathogenic mtDNA mutations were found in 29 of 101 probands (29%), 21 in MTND subunit genes and 8 in mtDNA tRNA genes. Nuclear gene defects were inferred in 38 of 101 (38%) probands based on cell hybrid studies, mtDNA sequencing or mutation analysis (nuclear gene mutations were identified in 22 probands). Leigh or Leigh-like disease was the most common clinical presentation in both mtDNA and nuclear genetic defects. The median age at onset was higher in mtDNA patients (12 months) than in patients with a nuclear gene defect (3 months). However, considerable overlap existed, with onset varying from 0 to 460 months in both groups. Our findings confirm that pathogenic mtDNA mutations are a significant cause of complex I deficiency in children. In the absence of parental consanguinity, we recommend whole mitochondrial genome sequencing as a key approach to elucidate the underlying molecular genetic abnormality. European Journal of Human Genetics (2011) 19, 769-775; doi:10.1038/ejhg.2011.18; published online 2 March 2011
C1 [Kirby, Denise M.; Salemi, Renato; Sugiana, Canny; Compton, Alison G.; Tucker, Elena J.; Ke, Xia; Thorburn, David R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Swalwell, Helen; Blakely, Emma L.; Mitchell, Anna; Turnbull, Douglass M.; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Sugiana, Canny; Tucker, Elena J.; Thorburn, David R.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.
   [Lamont, Phillipa J.] Royal Perth Hosp, Dept Neurol, Neurogenet Unit, Perth, WA, Australia.
   [Thorburn, David R.] Royal Childrens Hosp, Genet Hlth Serv Victoria, Melbourne, Vic, Australia.
C3 Royal Children's Hospital Melbourne; Murdoch Children's Research
   Institute; Newcastle University - UK; University of Melbourne; East
   Metropolitan Health Service; Royal Perth Hospital; University of Western
   Australia; Royal Children's Hospital Melbourne
RP Thorburn, DR (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.
EM david.thorburn@mcri.edu.au
RI Tucker, Elena/B-3487-2012; Compton, Alison/KOT-7713-2024; Thorburn,
   David/G-6266-2013
OI McFarland, Robert/0000-0002-8833-2688; thorburn,
   david/0000-0002-7725-9470; Compton, Alison/0000-0002-2725-7055;
   Turnbull, Doug/0000-0002-8878-9901; Tucker, Elena/0000-0002-6380-5100
FU Australian National Health and Medical Research Council; Muscular
   Dystrophy Association, USA; Medical Research Council, UK; Wellcome
   Trust, UK; UK National Commissioning Group; MRC [G0800674, G0601943,
   G0900390] Funding Source: UKRI
FX We thank the large number of physicians who referred patients for
   investigative studies, Dr Henrik Dahl for advice and Drs Vamsi Mootha
   and Sarah Calvo for identification of three of the mtDNA mutations
   described herein, as part of a High Throughput sequencing study of
   complex I deficiency. We also thank Drs Lisa Worgan, Edwin Kirk, Peter
   Taylor and Michael Buckley for the dHPLC analyses that identified
   subunit mutations in five patients. This work was supported by grants
   and a Principal Research Fellowship from the Australian National Health
   and Medical Research Council (DRT), the Muscular Dystrophy Association,
   USA (DRT), the Medical Research Council, UK (RM) and the Wellcome Trust,
   UK (DMT and RWT). Diagnostic studies in the Newcastle laboratory are
   supported by the UK National Commissioning Group 'Rare Mitochondrial
   Disorders of Adults and Children' service
   (http://www.mitochondrialncg.nhs.uk). This study was performed under the
   ethical guidelines issued by each of our Institutions for clinical
   studies.
CR Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Blok MJ, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.045716
   Bruno C, 1999, J PEDIATR-US, V135, P197, DOI 10.1016/S0022-3476(99)70022-3
   Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659
   Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200
   Chae JH, 2007, PEDIATR RES, V61, P622, DOI 10.1203/pdr.0b013e3180459f2d
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   Dinopoulos A, 2005, ACTA NEUROPATHOL, V110, P199, DOI 10.1007/s00401-005-1036-2
   Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748
   Esteitie N, 2005, ANN NEUROL, V58, P544, DOI 10.1002/ana.20570
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   Hoefs SJG, 2008, AM J HUM GENET, V82, P1306, DOI 10.1016/j.ajhg.2008.05.007
   HOPPEL CL, 1987, J CLIN INVEST, V80, P71, DOI 10.1172/JCI113066
   Kirby DM, 2008, TWIN RES HUM GENET, V11, P395, DOI 10.1375/twin.11.4.395
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Kirby DM, 2000, ANN NEUROL, V48, P102, DOI 10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.3.CO;2-D
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07
   Lazarou M, 2009, FEBS J, V276, P6701, DOI 10.1111/j.1742-4658.2009.07384.x
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057
   MOREADITH RW, 1984, J CLIN INVEST, V74, P685, DOI 10.1172/JCI111484
   Moslemi AR, 2008, NEUROPEDIATRICS, V39, P24, DOI 10.1055/s-2008-1076739
   Naess K, 2009, BBA-BIOENERGETICS, V1787, P484, DOI 10.1016/j.bbabio.2008.11.014
   Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002
   Ogle RF, 1997, J PEDIATR-US, V130, P138, DOI 10.1016/S0022-3476(97)70323-8
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Robinson BH, 1998, BBA-BIOENERGETICS, V1364, P271, DOI 10.1016/S0005-2728(98)00033-4
   ROBINSON BH, 1985, AM J HUM GENET, V37, P938
   Rötig A, 2004, BBA-BIOENERGETICS, V1659, P129, DOI 10.1016/j.bbabio.2004.07.007
   Ruitenbeek W, 1996, J INHERIT METAB DIS, V19, P581, DOI 10.1007/BF01799118
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Schägger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Smeitink J, 2001, J BIOENERG BIOMEMBR, V33, P259, DOI 10.1023/A:1010743321800
   Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Triepels RH, 2001, AM J MED GENET, V106, P37, DOI 10.1002/ajmg.1397
   Ugalde C, 2004, HUM MOL GENET, V13, P659, DOI 10.1093/hmg/ddh071
   Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001
   Vasta V, 2009, GENOME MED, V1, DOI 10.1186/gm100
NR 51
TC 99
Z9 107
U1 0
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD JUL
PY 2011
VL 19
IS 7
BP 769
EP 775
DI 10.1038/ejhg.2011.18
PG 7
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 778DA
UT WOS:000291678400011
PM 21364701
OA Bronze, Green Published
DA 2024-11-01
ER

PT J
AU Lamperti, C
   Diodato, D
   Lamantea, E
   Carrara, F
   Ghezzi, D
   Mereghetti, P
   Rizzi, R
   Zeviani, M
AF Lamperti, Costanza
   Diodato, Daria
   Lamantea, Eleonora
   Carrara, Franco
   Ghezzi, Daniele
   Mereghetti, Paolo
   Rizzi, Romana
   Zeviani, Massimo
TI MELAS-like encephalomyopathy caused by a new pathogenic mutation in the
   mitochondrial DNA encoded cytochrome c oxidase subunit I
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE mtDNA; Mutation; MELAS; Cytochrome c oxidase; COX; Ragged-red fibers;
   SDH; Stroke-like episode; MTCOI; Mitochondrial disorder; Respiratory
   chain
ID DEFICIENCY; ELECTROPHORESIS; CELLS; MTDNA; GENE
AB We report a 35-year-old woman presenting a stroke-like episode with transitory aphasia followed by generalized tonic-clonic seizures. She had severe hearing loss and suffered from frequent episodes of migraine. Although a brain MRI disclosed a T2-hyperintense lesion in the left parietal lobe, she had hardly any long-term sequela. Exercise intolerance, myalgias and limb-girdle muscle weakness indicated a slowly progressive myopathy. Extra-neurological features included short stature, and secondary amenorrhea with low gonadotropin levels, indicating secondary hypogonadism. However, she had three mutation-free, healthy children by ovarian stimulation. A muscle biopsy showed ragged-red, cytochrome c oxidase-negative fibers, and an isolated defect of cytochrome c oxidase activity in muscle mitochondria. Sequence analysis of muscle mtDNA revealed a previously unreported heteroplasmic m.6597C>A transversion in the MTCOI gene, encoding subunit I of cytochrome c oxidase, corresponding to p.Q232K aminoacid change. Analysis on transmitochondrial cybrids demonstrated that the mutation is indeed associated with COX deficiency, i.e. pathogenic. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Lamperti, Costanza; Diodato, Daria; Lamantea, Eleonora; Carrara, Franco; Ghezzi, Daniele; Zeviani, Massimo] Fdn Ist Neurol Carlo Besta IRCCS, Unit Mol Neurogenet, I-20126 Milan, Italy.
   [Mereghetti, Paolo] EML Res gGmbH, Mol & Cellular Modeling Grp, D-69118 Heidelberg, Germany.
   [Rizzi, Romana] Publ Hosp Santa Maria Nuova, Div Neurol, I-42123 Reggio Emilia, Italy.
C3 Fondazione IRCCS Istituto Neurologico Carlo Besta
RP Zeviani, M (corresponding author), Fdn Ist Neurol Carlo Besta IRCCS, Unit Mol Neurogenet, Via Temolo 4, I-20126 Milan, Italy.
EM Massimo.Zeviani@istituto-besta.it
RI Zeviani, Massimo/K-2891-2014; lamperti, costanza/J-8801-2016; Diodato,
   Daria/K-2639-2016; Ghezzi, Daniele/J-7873-2016; Rizzi,
   Romana/R-7051-2016; Lamantea, Eleonora/J-8339-2016
OI Diodato, Daria/0000-0003-3607-8523; Ghezzi, Daniele/0000-0002-6564-3766;
   Zeviani, Massimo/0000-0002-9067-5508; Rizzi, Romana/0000-0002-0875-8575;
   Lamantea, Eleonora/0000-0001-5090-6028; Mereghetti,
   Paolo/0000-0001-6012-592X
FU Fondazione Pierfranco e Luisa Mariani; Fondazione Telethon [GGP11011,
   GPP10005]; Fondazione CARIPLO [2011/0526]; Italian Association of
   Mitochondrial Disease Patients and Families (Mitocon)
FX This work was supported by the Fondazione Pierfranco e Luisa Mariani;
   Fondazione Telethon Grants GGP11011 and GPP10005; Fondazione CARIPLO
   Grant 2011/0526; and the Italian Association of Mitochondrial Disease
   Patients and Families (Mitocon).
CR Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Dubowitz V, 1985, MUSCLE BIOPSY PRATIC
   Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Kaila VRI, 2011, BBA-BIOENERGETICS, V1807, P769, DOI 10.1016/j.bbabio.2010.12.016
   Karadimas CL, 2000, NEUROLOGY, V55, P644, DOI 10.1212/WNL.55.5.644
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   MARIOTTI C, 1994, J CLIN INVEST, V93, P1102, DOI 10.1172/JCI117061
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Rossmanith W, 2008, J MED GENET, V45, P117, DOI 10.1136/jmg.2007.052076
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Tam EWY, 2008, NEUROPEDIATRICS, V39, P328, DOI 10.1055/s-0029-1202287
   Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136
   Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001
NR 18
TC 19
Z9 21
U1 0
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD NOV
PY 2012
VL 22
IS 11
BP 990
EP 994
DI 10.1016/j.nmd.2012.06.003
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 047CU
UT WOS:000311816100010
PM 22832341
DA 2024-11-01
ER

PT J
AU Cassereau, J
   Codron, P
   Funalot, B
AF Cassereau, J.
   Codron, P.
   Funalot, B.
TI Inherited peripheral neuropathies due to mitochondrial disorders
SO REVUE NEUROLOGIQUE
LA English
DT Article
DE Peripheral neuropathies; Mitochondrial disorders; Multisystem disease;
   Bioenergetics; Mitochondrial DNA; Polymerase gamma; Charcot-Marie-Tooth
   disease
ID MARIE-TOOTH-DISEASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; TRANSFER
   RNALEU(UUR) GENE; MITOFUSIN 2 MUTATIONS; DNA POLYMERASE-GAMMA; SENSORY
   NEUROPATHY; HEREDITARY MOTOR; AXONAL NEUROPATHY; LACTIC-ACIDOSIS; LEIGHS
   SYNDROME
AB Mitochondrial disorders (MIDs) are frequently responsible for neuropathies with variable severity. Mitochondrial diseases causing peripheral neuropathies (PNP) may be due to mutations of mitochondrial DNA (mtDNA), as is the case in MERRF and MELAS syndromes, or to mutations of nuclear genes. Secondary abnormalities of mtDNA (such as multiple deletions of muscle mtDNA) may result from mitochondrial disorders due to mutations in nuclear genes involved in mtDNA maintenance. This is the case in several syndromes caused by impaired mtDNA maintenance, such as Sensory Ataxic Neuropathy, Dysarthria and Ophthalmoplegia (SANDO) due to recessive mutations in the POLG gene, which encodes the catalytic subunit of mtDNA polymerase (DNA polymerase gamma), or Mitochondrial Neuro-Gastro-Intestinal Encephalomyopathy (MNGIE), due to recessive mutations in the TYMP gene, which encodes thymidine phosphorylase. The last years have seen a growing list of evidence demonstrating that mitochondrial bioenergetics and dynamics might be dysfunctional in axonal Charcot-Marie-Tooth disease (CMT2), and these mechanisms might present a common link between dissimilar CMT2-causing genes. (c) 2014 Elsevier Masson SAS. All rights reserved.
C1 [Cassereau, J.; Codron, P.] CHU Angers, Serv Neurol, F-49033 Angers, France.
   [Cassereau, J.] CNRS UMR 6214, F-49033 Angers, France.
   [Cassereau, J.] Inserm UMR 1083, F-49033 Angers, France.
   [Funalot, B.] CHU Limoges, Ctr Reference Neuropathies Peripher Rare, F-87042 Limoges, France.
   [Funalot, B.] CHU Limoges, Serv Biochim & Genet Mol, F-87042 Limoges, France.
   [Funalot, B.] Fac Med, EA6309, F-87045 Limoges, France.
C3 Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Centre
   National de la Recherche Scientifique (CNRS); Institut National de la
   Sante et de la Recherche Medicale (Inserm); Universite d'Angers; CHU
   Limoges; CHU Limoges
RP Cassereau, J (corresponding author), CHU Angers, Serv Neurol, 4 Rue Larrey, F-49033 Angers, France.
EM JuCassereau@chu-angers.fr
RI Cassereau, Julien/K-2484-2015
OI Funalot, Benoit/0000-0001-6352-6518
CR Ackerley S, 2006, HUM MOL GENET, V15, P347, DOI 10.1093/hmg/ddi452
   APPENZELLER O, 1976, ARCH NEUROL-CHICAGO, V33, P733, DOI 10.1001/archneur.1976.00500110001001
   Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007
   Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381
   CAPALDI RA, 1988, J BIOENERG BIOMEMBR, V20, P291, DOI 10.1007/BF00769634
   Cartoni R, 2010, BRAIN, V133, P1460, DOI 10.1093/brain/awq082
   Cassereau J, 2011, EXP NEUROL, V227, P31, DOI 10.1016/j.expneurol.2010.09.006
   Cassereau J, 2009, NEUROGENETICS, V10, P145, DOI 10.1007/s10048-008-0166-9
   Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002
   Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638
   Chen XJ, 2007, J NEUROSCI, V27, P14515, DOI 10.1523/JNEUROSCI.4338-07.2007
   Chung KW, 2006, BRAIN, V129, P2103, DOI 10.1093/brain/awl174
   Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101
   Courchesne Stephanie L, 2011, PLoS One, V6, pe16753, DOI 10.1371/journal.pone.0016753
   d'Ydewalle C, 2011, NAT MED, V17, P968, DOI 10.1038/nm.2396
   de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Echaniz-Laguna A, 2013, NEUROLOGY, V81, P1523, DOI 10.1212/WNL.0b013e3182a4a518
   Estela A, 2011, J BIOL CHEM, V286, P36777, DOI 10.1074/jbc.M111.260042
   Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354
   Fernyhough P, 2003, J PERIPHER NERV SYST, V8, P227, DOI 10.1111/j.1085-9489.2003.03028.x
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Gelfand JM, 2011, J NEUROL, V258, P440, DOI 10.1007/s00415-010-5775-1
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guillet V, 2011, FASEB J, V25, P1618, DOI 10.1096/fj.10-173609
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Hirokawa N, 2004, CURR OPIN NEUROBIOL, V14, P564, DOI 10.1016/j.conb.2004.08.011
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Holve S, 1999, J PEDIATR-US, V135, P482, DOI 10.1016/S0022-3476(99)70172-1
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Hulgan T, 2005, AIDS, V19, P1341, DOI 10.1097/01.aids.0000180786.02930.a1
   Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078
   Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328
   Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kennerson ML, 2013, HUM MOL GENET, V22, P1404, DOI 10.1093/hmg/dds557
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Melberg A, 1996, MUSCLE NERVE, V19, P751
   Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010
   Nicholson GA, 2008, NEUROLOGY, V70, P1678, DOI 10.1212/01.wnl.0000311275.89032.22
   Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087
   Niemann A, 2009, NEUROBIOL DIS, V36, P509, DOI 10.1016/j.nbd.2009.09.011
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Noack R, 2012, HUM MOL GENET, V21, P150, DOI 10.1093/hmg/ddr450
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Polke JM, 2011, NEUROLOGY, V77, P168, DOI 10.1212/WNL.0b013e3182242d4d
   Rinaldi C, 2012, AM J HUM GENET, V91, P1095, DOI 10.1016/j.ajhg.2012.10.008
   Rojo M, 2002, J CELL SCI, V115, P1663
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   RUSANEN H, 1995, NEUROLOGY, V45, P1188, DOI 10.1212/WNL.45.6.1188
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Santoro L, 2000, NEUROMUSCULAR DISORD, V10, P450, DOI 10.1016/S0960-8966(99)00122-4
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Vallat JM, 2008, J NEUROPATH EXP NEUR, V67, P1097, DOI 10.1097/NEN.0b013e31818b6cbc
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126
   Vucic S, 2003, NEUROLOGY, V60, P696, DOI 10.1212/01.WNL.0000048561.61921.71
   Weedon MN, 2011, AM J HUM GENET, V89, P308, DOI 10.1016/j.ajhg.2011.07.002
   WILLIAMS LL, 1979, NEUROLOGY, V29, P1492, DOI 10.1212/WNL.29.11.1492
   Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 70
TC 15
Z9 17
U1 0
U2 7
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0035-3787
EI 2213-0004
J9 REV NEUROL-FRANCE
JI Rev. Neurol.
PD MAY
PY 2014
VL 170
IS 5
BP 366
EP 374
DI 10.1016/j.neurol.2013.11.005
PG 9
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA AH4JK
UT WOS:000336093000007
PM 24768438
DA 2024-11-01
ER

PT J
AU Cohen, BH
AF Cohen, Bruce H.
TI Neuromuscular and Systemic Presentations in Adults: diagnoses beyond
   MERRF and MELAS
SO NEUROTHERAPEUTICS
LA English
DT Review
DE Mitochondria; mtDNA; Myopathy; Clinical evaluation; Muscle enzymology;
   Mitochondrial genetics
ID RESPIRATORY-CHAIN DISORDERS; HEREDITARY OPTIC NEUROPATHY; KEARNS-SAYRE
   SYNDROME; MITOCHONDRIAL-DNA DAMAGE; CHRONIC-FATIGUE-SYNDROME;
   EHLERS-DANLOS-SYNDROME; CYTOCHROME-C-OXIDASE; STROKE-LIKE EPISODES;
   DIABETES-MELLITUS; LACTIC-ACIDOSIS
AB Mitochondrial diseases are a diverse group of inherited and acquired disorders that result in inadequate energy production. They can be caused by inheritable genetic mutations, acquired somatic mutations, and exposure to toxins (including some prescription medications). Normal mitochondrial physiology is responsible, in part, for the aging process itself, as free radical production within the mitochondria results in a lifetime burden of oxidative damage to DNA, especially the mitochondrial DNA that, in turn, replicate the mutational burden in future copies of itself, and lipid membranes. Primary mitochondrial diseases are those caused by mutations in genes that encode for mitochondrial structural and enzymatic proteins, and those proteins required for mitochondrial assembly and maintenance. A number of common adult maladies are associated with defective mitochondrial energy production and function, including diabetes, obesity, hyperthyroidism, hypothyroidism, and hyperlipidemia. Mitochondrial dysfunction has been demonstrated in many neurodegenerative disorders, including Alzheimer's disease, Parkinson disease, amyotrophic lateral sclerosis, and some cancers. Polymorphisms in mitochondrial DNA have been linked to disease susceptibility, including death from sepsis and survival after head injury. There is considerable overlap in symptoms caused by primary mitochondrial diseases and those illnesses that affect mitochondrial function, but are not caused by primary mutations, as well as disorders that mimic mitochondrial diseases, but are caused by other identified mutations. Evaluation of these disorders is complex, expensive, and not without false-negative and false-positive results that can mislead the physician. Most of the common heritable mitochondrial disorders have been well-described in the literature, but can be overlooked by many clinicians if they are uneducated about these disorders. In general, the evaluation of the classic mitochondrial disorders has become straightforward if the clinician recognized the phenotype and orders appropriate confirmatory testing. However, the majority of patients referred for a mitochondrial evaluation do not have a clear presentation that allows for rapid identification and testing. This article provides introductory comments on mitochondrial structure, physiology, and genetics, but will focus on the presentation and evaluation of adults with mitochondrial symptoms, but who may not have a primary mitochondrial disease.
C1 Childrens Hosp Med Ctr Akron, NeuroDev Sci Ctr, Akron, OH 44308 USA.
RP Cohen, BH (corresponding author), Childrens Hosp Med Ctr Akron, NeuroDev Sci Ctr, 215 West Bowery St,Suite 4400, Akron, OH 44308 USA.
EM bcohen@chmca.org
CR Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   [Anonymous], 1987, N ENGL J MED, V317, P493
   Ballana E, 2006, BIOCHEM BIOPH RES CO, V341, P950, DOI 10.1016/j.bbrc.2006.01.049
   Barbeau A., 1996, S PROGR MUSK DYSTR B, P102
   BARDOSI A, 1987, ACTA NEUROPATHOL, V74, P248, DOI 10.1007/BF00688189
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bindoff L., 2006, Mitochondrial Medicine, P143
   Bindoff LA, 2012, EPILEPSIA, V53, P92, DOI 10.1111/j.1528-1167.2012.03618.x
   Bird T.D., 1998, GENEREVIEWS
   Brais B, GENEREVIEWS
   Celletti C, 2012, RES DEV DISABIL, V33, P1914, DOI 10.1016/j.ridd.2012.06.018
   Chalmers RM, 1999, BBA-BIOENERGETICS, V1410, P147, DOI 10.1016/S0005-2728(98)00163-7
   CHEN CM, 1995, EUR NEUROL, V35, P281, DOI 10.1159/000117150
   Cohen BH, GENEREVIEWS
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Cooper J M., 1994, Mitochondrial disorders in neurology, P1
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   DiMauro S., 1997, MOL GENETIC BASIS NE, P201
   DiMauro S., 2006, Mitochondrial Medicine, P7
   Doleris LM, 2000, KIDNEY INT, V58, P1851, DOI 10.1046/j.1523-1755.2000.00356.x
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Finsterer J, 2001, J INHERIT METAB DIS, V24, P560, DOI 10.1023/A:1012415810881
   Fischel-Ghodsian N, 1998, P SOC EXP BIOL MED, V218, P1
   Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002
   Friedman SD, 2010, DEV DISABIL RES REV, V16, P129, DOI 10.1002/ddrr.103
   GERBITZ KD, 1995, BBA-MOL BASIS DIS, V1271, P253, DOI 10.1016/0925-4439(95)00036-4
   Gerrits KHL, 2013, MUSCLE NERVE, V47, P96, DOI 10.1002/mus.23482
   Goodfellow JA, 2012, POSTGRAD MED J, V88, P326, DOI 10.1136/postgradmedj-2011-130326
   Goto Y, 1990, NATURE, V348, P653
   Griggs RC, 1999, NEW ENGL J MED, V341, P1077, DOI 10.1056/NEJM199909303411411
   Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389
   Guéry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hammans SR, 1994, MITOCHONDRIAL DISORD, P1
   HARVEY JN, 1992, CLIN ENDOCRINOL, V37, P97, DOI 10.1111/j.1365-2265.1992.tb02289.x
   Hinson JT, 2007, NEW ENGL J MED, V356, P809, DOI 10.1056/NEJMoa055262
   Hirano M., 2006, Mitochondrial Medicine, P27
   Huang CC, 1999, ACTA NEUROL SCAND, V99, P125, DOI 10.1111/j.1600-0404.1999.tb00670.x
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Jacobs HT, 1997, ANN MED, V29, P483, DOI 10.3109/07853899709007472
   Jobgen WS, 2006, J NUTR BIOCHEM, V17, P571, DOI 10.1016/j.jnutbio.2005.12.001
   KENNY D, 1990, AM HEART J, V120, P440, DOI 10.1016/0002-8703(90)90097-H
   Kerrison JB, 2000, ARCH OPHTHALMOL-CHIC, V118, P298
   KURATSUNE H, 1994, CLIN INFECT DIS   S1, V18, P62
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   LIETMAN PS, 1971, MOL PHARMACOL, V7, P122
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Mashima Y, 1996, CLIN GENET, V50, P535
   Matsuzaki M, 2002, NEUROPEDIATRICS, V33, P271, DOI 10.1055/s-2002-36742
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122
   Michot C, 2012, J INHERIT METAB DIS, V35, P1119, DOI 10.1007/s10545-012-9461-6
   Morris AAM, 1999, LIVER, V19, P357, DOI 10.1111/j.1478-3231.1999.tb00063.x
   Niaudet P, 1998, ARCH DIS CHILD, V78, P387, DOI 10.1136/adc.78.4.387
   Niaudet P, 1997, KIDNEY INT, V51, P1000, DOI 10.1038/ki.1997.140
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Odawara M, 1996, ANN NY ACAD SCI, V786, P72, DOI 10.1111/j.1749-6632.1996.tb39053.x
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   PEYRONNARD JM, 1980, ANN NEUROL, V7, P262, DOI 10.1002/ana.410070310
   PLIOPLYS AV, 1995, NEUROPSYCHOBIOLOGY, V32, P132, DOI 10.1159/000119226
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   QUADE A, 1992, CLIN INVESTIGATOR, V70, P396
   Quinlivan R, 2012, DEV MED CHILD NEUROL, V54, P886, DOI 10.1111/j.1469-8749.2012.04320.x
   Rosenberg H, GeneReviews(®)
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Schon E.A., 1994, Mitochondrial DNA and the Genetics of Mitochondrial Disease, P31
   Schrier SA, 2011, CURR OPIN OPHTHALMOL, V22, P325, DOI 10.1097/ICU.0b013e328349419d
   Sekijima Y., GENEREVIEWS
   Serviddio G, 2011, EXPERT REV GASTROENT, V5, P233, DOI [10.1586/EGH.11.11, 10.1586/egh.11.11]
   Shoffner JM., 1995, METABOLIC MOL BASES, V7th, P1535
   Sitarz KS, 2012, CURR NEUROL NEUROSCI, V12, P308, DOI 10.1007/s11910-012-0260-0
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   Smits B, 2011, MITOCHONDRION, V11, P735, DOI 10.1016/j.mito.2011.05.005
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   Ventura-Clapier R, 2004, J PHYSIOL-LONDON, V555, P1, DOI 10.1113/jphysiol.2003.055095
   Vial G, 2010, ACTA BIOCHIM POL, V57, P389
   Voermans NC, 2009, ANN NEUROL, V65, P687, DOI 10.1002/ana.21643
   Vydt TCG, 2007, AM J CARDIOL, V99, P264, DOI 10.1016/j.amjcard.2006.07.089
   Wallace D C., 1997, The Molecular and Genetic Basis of Neurological Disease, P237
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wenning GK, 2009, J NEUROL, V256, P1791, DOI 10.1007/s00415-009-5173-8
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Wong LJC, 2012, SEMIN NEUROL, V32, P55, DOI 10.1055/s-0032-1306387
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   YANG CY, 1995, CLIN ENDOCRINOL, V43, P235, DOI 10.1111/j.1365-2265.1995.tb01922.x
   Zeviani M, 2008, BRAIN, V131, P314, DOI 10.1093/brain/awm339
   Zhang F, 2011, PROG NEUROBIOL, V95, P373, DOI 10.1016/j.pneurobio.2011.09.001
NR 91
TC 21
Z9 24
U1 0
U2 19
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1933-7213
J9 NEUROTHERAPEUTICS
JI Neurotherapeutics
PD APR
PY 2013
VL 10
IS 2
BP 227
EP 242
DI 10.1007/s13311-013-0188-3
PG 16
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA 127EC
UT WOS:000317677900005
PM 23549648
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Phowthongkum, P
   Sun, A
AF Phowthongkum, P.
   Sun, A.
TI Novel truncating variant in <i>DNA2</i>-related congenital onset
   myopathy and ptosis suggests genotype phenotype correlation
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE DNA2; Myopathy; Mitochondrial disease; Genotype-phenotype correlation
ID MITOCHONDRIAL-DNA INSTABILITY; DISEASE; GENES
AB DNA2 encodes a protein with nuclease, ATPase, and helicase domains, and serves to maintain mitochondrial DNA integrity. Mutations in DNA2 cause autosomal dominant progressive ophthalmoplegia with mitochondrial DNA deletions. This disorder was first reported in four patients with heterozygous, missense mutations in DNA2. Clinical symptoms include limb-girdle and lower extremity weakness, myalgia, and ophthalmbplegia. All had a slowly progressive disease course and did not present for clinical evaluation until the fifth or sixth decade. We report a case of congenital-onset myopathy and ptosis in a child who was found to have a novel DNA2 variant resulting in a premature termination codon (p.Asn568Ilefs*4). Only one other case of a truncating mutation in DNA2 has been reported, and that patient also had early-onset, severe disease. We hypothesize that haploinsufficiency for the DNA2 protein due to truncating mutations results in mitochondrial genome instability and clinical symptoms of early-onset myopathy. Missense mutations that allow for residual protein function lead to a milder clinical phenotype. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Phowthongkum, P.; Sun, A.] Univ Washington, Dept Pediat, Div Med Genet, Seattle, WA 98105 USA.
   [Phowthongkum, P.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.
C3 University of Washington; University of Washington Seattle; University
   of Washington; University of Washington Seattle
RP Sun, A (corresponding author), Univ Washington, Dept Pediat, Div Med Genet, Seattle, WA 98105 USA.
EM Angela.Sun@seattlechildrens.org
OI Phowthongkum, Prasit/0000-0003-2665-6668
FU King Anandamahidol Foundation; American College of Medical Genetics
   Foundation/Horizon Pharma fellowship
FX We would like to thank our patient and her family. PP is a fellow of
   Medical Genetics at the University of Washington and affiliated
   hospitals. He is the recipient of the King Anandamahidol Foundation
   scholarship and the American College of Medical Genetics
   Foundation/Horizon Pharma fellowship award.
CR Ahmed N, 2015, INT J MOL SCI, V16, P18054, DOI 10.3390/ijms160818054
   Chae JH, 2015, J MED GENET, V52, P208, DOI 10.1136/jmedgenet-2014-102819
   Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Shaheen R, 2014, GENOME RES, V24, P291, DOI 10.1101/gr.160572.113
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
NR 7
TC 9
Z9 9
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JUL
PY 2017
VL 27
IS 7
BP 616
EP 618
DI 10.1016/j.nmd.2017.03.013
PG 3
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA EZ1SL
UT WOS:000404491000002
PM 28554558
DA 2024-11-01
ER

PT J
AU Kirino, Y
   Goto, Y
   Campos, Y
   Arenas, J
   Suzuki, T
AF Kirino, Y
   Goto, Y
   Campos, Y
   Arenas, J
   Suzuki, T
TI Specific correlation between the wobble modification deficiency in
   mutant tRNAs and the clinical features of a human mitochondrial disease
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE mitochondrial tRNA; taurine modification
ID STROKE-LIKE EPISODES; TRANSFER RNALEU(UUR) GENE; CELLS LACKING MTDNA;
   LACTIC-ACIDOSIS; POINT MUTATION; TRANSCRIPTION TERMINATION; MELAS
   SUBGROUP; DNA MUTATIONS; ENCEPHALOPATHY; MYOPATHY
AB Mutations in mtDNA are responsible for a variety of mitochondrial diseases, where the mitochondrial tRNA(Leu(UUR)) gene has especially hot spots for pathogenic mutations. Clinical features often depend on the tRNA species and/or positions of the mutations; however, molecular pathogenesis elucidating the relation between the location of the mutations and their leading phenotype are not fully understood. We report here that mitochondrial tRNAS(Leu(UUR)) harboring one of five mutations found in tissues from patients with symptoms of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) (A3243G, G3244A, T3258C, T3271C, and T32911C) lacked the normal taurine-containing modification (5-taurinomethyluridine) at the anticodon wobble position. In contrast, mitochondrial tRNASLeu(UUR) with different mutations found in patients that have mitochondrial diseases but do not show the MELAS symptoms (G3242A, T3250C, C3254T, and A3280G) had the normal 5-taurinomethyluridine modifications. These observations were made by using a modified primer extension technique that can detect the modification deficiency in the extremely limited quantities of mutant tRNAs obtainable from patient tissues. These results strongly suggest deficient wobble modification could be a key molecular factor responsible for the phenotypic features of MELAS, which can explain why the different MELAS-associated mutations result in indistinguishable clinical features.
C1 Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan.
   Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Bunkyo Ku, Tokyo 1138656, Japan.
   Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Kodaira, Tokyo 1878502, Japan.
   Hosp 12 Octubre, Ctr Invest, E-28041 Madrid, Spain.
C3 University of Tokyo; University of Tokyo; National Center for Neurology
   & Psychiatry - Japan; Hospital Universitario 12 de Octubre
RP Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
EM ts@chembio.t.u-tokyo.ac.jp
RI Yolanda, Campos/A-8711-2017; Suzuki, Tsutomu/J-1776-2015
OI Arenas, Joaquin/0000-0002-2877-5049; Suzuki,
   Tsutomu/0000-0002-9731-1731; Kirino, Yohei/0000-0001-5232-4742; CAMPOS,
   YOLANDA/0000-0003-4785-9659
CR Bjork G.R., 1995, TRNA, P165
   Carnpos Y, 2003, NEUROMUSCULAR DISORD, V13, P416, DOI 10.1016/S0960-8966(03)00039-7
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Dunbar DR, 1996, HUM MOL GENET, V5, P123, DOI 10.1093/hmg/5.1.123
   Flierl A, 1997, J BIOL CHEM, V272, P27189, DOI 10.1074/jbc.272.43.27189
   Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1
   GODDARD JP, 1977, PROG BIOPHYS MOL BIO, V32, P233
   GOTO Y, 1992, ANN NEUROL, V31, P672, DOI 10.1002/ana.410310617
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO YI, 1994, BIOCHEM BIOPH RES CO, V202, P1624, DOI 10.1006/bbrc.1994.2119
   Grosjean H., 1998, Modification and editing of RNA, P21
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   HAYASHI JI, 1993, BIOCHEM BIOPH RES CO, V197, P1049, DOI 10.1006/bbrc.1993.2584
   HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   KOGA Y, 1988, ANN NEUROL, V24, P749, DOI 10.1002/ana.410240609
   MADEN BEH, 1995, BIOCHIMIE, V77, P22, DOI 10.1016/0300-9084(96)88100-4
   MORAS D, 1980, NATURE, V288, P669, DOI 10.1038/288669a0
   RICH A, 1976, ANNU REV BIOCHEM, V45, P805, DOI 10.1146/annurev.bi.45.070176.004105
   SAKUTA R, 1993, J NEUROL SCI, V115, P158, DOI 10.1016/0022-510X(93)90219-O
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656
   Suzuki T, 2005, TOP CURR GENET, V12, P23, DOI 10.1007/b106361
   Wittenhagen LM, 2003, NUCLEIC ACIDS RES, V31, P596, DOI 10.1093/nar/gkg131
   Wittenhagen LM, 2002, NAT STRUCT BIOL, V9, P586, DOI 10.1038/nsb820
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
   Yokoyama Shigeyuki, 1995, P207
   2003, NEUROMUSCUL DISORD, V13, P277
NR 35
TC 138
Z9 165
U1 0
U2 8
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAY 17
PY 2005
VL 102
IS 20
BP 7127
EP 7132
DI 10.1073/pnas.0500563102
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 928SO
UT WOS:000229292200015
PM 15870203
OA Green Published
DA 2024-11-01
ER

PT J
AU Yu, Q
   Zhang, Y
   Wang, ZX
   Yang, YL
   Yuan, Y
   Niu, SL
   Pei, P
   Wang, ST
   Ma, YA
   Bu, DF
   Zou, LP
   Fang, F
   Xiao, J
   Sun, F
   Zhang, Y
   Wu, Y
   Wang, S
   Xiong, H
   Wu, XR
AF Yu, Qi
   Zhang, Ying
   Wang, Zhaoxia
   Yang, Yanling
   Yuan, Yun
   Niu, Shulan
   Pei, Pei
   Wang, Songtao
   Ma, Yinan
   Bu, Dingfang
   Zou, Liping
   Fang, Fang
   Xiao, Jing
   Sun, Fang
   Zhang, Yao
   Wu, Ye
   Wang, Shuang
   Xiong, Hui
   Wu, Xiru
TI Screening of common mitochondrial mutations in Chinese patients with
   mitochondrial encephalomyopathies
SO MITOCHONDRION
LA English
DT Article
DE mitochondrial encephalomyopathy; MELAS; MERRF; Leigh's syndrome;
   mitochondrial DNA (mtDNA); mutation
ID STROKE-LIKE EPISODES; LACTIC-ACIDOSIS; MTDNA MUTATION; DNA; MELAS;
   DISEASE; GENE; ENCEPHALOPATHY; MYOPATHY; DEAFNESS
AB To investigate the spectrum of common mitochondrial mutations in Northern China during the years of 2000-2005, 552 patients of mitochondrial encephalomyopathies clinically diagnosed as MELAS, MERRF or Leigh's syndrome, 14 cases of LHON and 46 cases of aminoglycoside induced deafness along with their family members, accepted routine point mutation tests at nucleotide positions 3243, 8344, 8993, 11778 or 1555 in mitochondrial genome. PCR-RFLP analysis, site-specific PCR and PCR-sequencing methods were used to identify the mutations. Fifty-seven cases with A3243G mutation, 4 cases with A8344G, 2 cases with T8993C and 1 case with T8993G were identified from the 552 encephalomyopathy patients. In addition, one case with G11778A was found from the 14 cases of LHON, and 5 cases with A1555G from the 46 cases of aminoglycoside ototoxicity patients. Additional screening for T8356G and T3271C merely had limited significance for the diagnosis of MERRF and MELAS. Differential diagnosis among mitochondrial encephalomyopathies was often complicated due to many similar clinical manifestations. For A3243G mutation, the proportion of mutant mtDNA was not related to severity of the disease but to the age of onset. (c) 2006 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 Peking Univ, Hosp 1, Cent Lab, Beijing, Peoples R China.
   Peking Univ, Hosp 1, Dept Neurol, Beijing, Peoples R China.
   Peking Univ, Hosp 1, Dept Pediat, Beijing, Peoples R China.
   Beijing Childrens Hosp, Dept Neurol, Beijing, Peoples R China.
C3 Peking University; Peking University; Peking University; Capital Medical
   University
RP Yu, Q (corresponding author), Peking Univ, Hosp 1, Cent Lab, Beijing, Peoples R China.
EM qiyu0724@yahoo.com
RI Yang, Yanling/F-5954-2014; Zhao, Wensi/JDW-1266-2023
CR FANG W, 1994, MUSCLE NERVE, V17, P52, DOI 10.1002/mus.880170107
   Goto Y, 1995, Rinsho Shinkeigaku, V35, P1425
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guo YP, 1997, CHINESE MED J-PEKING, V110, P851
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   HUANG CC, 1994, J NEUROL NEUROSUR PS, V57, P586, DOI 10.1136/jnnp.57.5.586
   LOTT MT, 1990, AM J OPHTHALMOL, V109, P625, DOI 10.1016/S0002-9394(14)72429-8
   MATTHEWS PM, 1994, J MED GENET, V31, P41, DOI 10.1136/jmg.31.1.41
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Niu Shu-lan, 2003, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V25, P153
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   SANTORELLI FM, 1994, NEUROLOGY, V44, P972, DOI 10.1212/WNL.44.5.972
   Song DL, 2001, CHINESE MED J-PEKING, V114, P1273
   Tarnopolsky MA, 1998, MUSCLE NERVE, V21, P25, DOI 10.1002/(SICI)1097-4598(199801)21:1<25::AID-MUS4>3.0.CO;2-I
   Thajeb P, 2000, Zhonghua Yi Xue Za Zhi (Taipei), V63, P71
   Ueki I, 2006, MITOCHONDRION, V6, P29, DOI 10.1016/j.mito.2005.10.003
   van den Ouweland JMW, 1999, DIABETOLOGIA, V42, P485, DOI 10.1007/s001250051183
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   Zhang Ying, 2005, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V27, P77
NR 20
TC 19
Z9 24
U1 2
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD FEB-APR
PY 2007
VL 7
IS 1-2
BP 147
EP 150
DI 10.1016/j.mito.2006.11.019
PG 4
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 157EM
UT WOS:000245701400022
PM 17276742
DA 2024-11-01
ER

PT J
AU Bris, C
   Goudenège, D
   Desquiret-Dumas, V
   Gueguen, N
   Bannwarth, S
   Gaignard, P
   Rucheton, B
   Trimouille, A
   Allouche, S
   Rouzier, C
   Saadi, S
   Jardel, C
   Slama, A
   Barth, M
   Verny, C
   Spinazzi, M
   Cassereau, J
   Colin, E
   Armelle, M
   Pereon, Y
   Martin-Negrier, ML
   Paquis-Flucklinger, V
   Letournel, F
   Lenaers, G
   Bonneau, D
   Reynier, P
   Amati-Bonneau, P
   Procaccio, V
AF Bris, Celine
   Goudenege, David
   Desquiret-Dumas, Valerie
   Gueguen, Naig
   Bannwarth, Sylvie
   Gaignard, Pauline
   Rucheton, Benoit
   Trimouille, Aurelien
   Allouche, Stephane
   Rouzier, Cecile
   Saadi, Samira
   Jardel, Claude
   Slama, Abdel
   Barth, Magalie
   Verny, Christophe
   Spinazzi, Marco
   Cassereau, Julien
   Colin, Estelle
   Armelle, Magot
   Pereon, Yann
   Martin-Negrier, Marie Laure
   Paquis-Flucklinger, Veronique
   Letournel, Franck
   Lenaers, Guy
   Bonneau, Dominique
   Reynier, Pascal
   Amati-Bonneau, Patrizia
   Procaccio, Vincent
TI Improved detection of mitochondrial DNA instability in mitochondrial
   genome maintenance disorders
SO GENETICS IN MEDICINE
LA English
DT Article
ID RIBOSOMAL-RNA; MUTATIONS; DELETIONS; SINGLE
AB Purpose Diseases caused by defects in mitochondrial DNA (mtDNA) maintenance machinery, leading to mtDNA deletions, form a specific group of disorders. However, mtDNA deletions also appear during aging, interfering with those resulting from mitochondrial disorders. Methods Here, using next-generation sequencing (NGS) data processed by eKLIPse and data mining, we established criteria distinguishing age-related mtDNA rearrangements from those due to mtDNA maintenance defects. MtDNA deletion profiles from muscle and urine patient samples carrying pathogenic variants in nuclear genes involved in mtDNA maintenance (n = 40) were compared with age-matched controls (n = 90). Seventeen additional patient samples were used to validate the data mining model. Results Overall, deletion number, heteroplasmy level, deletion locations, and the presence of repeats at deletion breakpoints were significantly different between patients and controls, especially in muscle samples. The deletion number was significantly relevant in adults, while breakpoint repeat lengths surrounding deletions were discriminant in young subjects. Conclusion Altogether, eKLIPse analysis is a powerful tool for measuring the accumulation of mtDNA deletions between patients of different ages, as well as in prioritizing novel variants in genes involved in mtDNA stability.
C1 [Bris, Celine; Goudenege, David; Desquiret-Dumas, Valerie; Gueguen, Naig; Verny, Christophe; Spinazzi, Marco; Cassereau, Julien; Colin, Estelle; Lenaers, Guy; Bonneau, Dominique; Reynier, Pascal; Amati-Bonneau, Patrizia; Procaccio, Vincent] Univ Angers, Inst MitoVasc, UMR CNRS 6015, MitoLab,INSERM U1083, F-6015 Angers, France.
   [Bris, Celine; Goudenege, David; Desquiret-Dumas, Valerie; Gueguen, Naig; Barth, Magalie; Colin, Estelle; Bonneau, Dominique; Reynier, Pascal; Amati-Bonneau, Patrizia; Procaccio, Vincent] CHU Angers, Dept Biochim & Genet, Angers, France.
   [Bannwarth, Sylvie; Rouzier, Cecile; Saadi, Samira; Paquis-Flucklinger, Veronique] Univ Cote Azur, IRCAN, CNRS, INSERM,CHU Nice, Nice, France.
   [Gaignard, Pauline; Slama, Abdel] Univ Paris Saclay, CHU Bicetre, AP HP, Serv Biochim, Le Kremlin Bicetre, France.
   [Rucheton, Benoit; Jardel, Claude] GHU Pitie Salpetriere, AP HP, Dept Biochim & Genet, Paris, France.
   [Trimouille, Aurelien] CHU Bordeaux, Serv Genet Med, Bordeaux, France.
   [Allouche, Stephane] Ctr Hosp Univ, Serv Biochim, EA4650, Caen, France.
   [Armelle, Magot; Pereon, Yann] CHU Nantes, Ctr Reference Malad Neuromusculaires, Nantes, France.
   [Martin-Negrier, Marie Laure] CHU Bordeaux, Serv Pathol, Bordeaux, France.
   [Letournel, Franck] Mint, UF Neurobiol Neuropathol, UMR INSERM 1066, CNRS 6021, Angers, France.
C3 Universite d'Angers; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire
   d'Angers; CHU Nice; Universite Cote d'Azur; Institut National de la
   Sante et de la Recherche Medicale (Inserm); Centre National de la
   Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris
   (APHP); Hopital Universitaire Bicetre - APHP; Universite Paris Cite;
   Universite Paris Saclay; Sorbonne Universite; Assistance Publique
   Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP;
   CHU Bordeaux; Universite de Bordeaux; CHU de Caen NORMANDIE; Universite
   de Caen Normandie; Nantes Universite; CHU de Nantes; CHU Bordeaux;
   Universite de Bordeaux; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Universite d'Angers
RP Procaccio, V (corresponding author), Univ Angers, Inst MitoVasc, UMR CNRS 6015, MitoLab,INSERM U1083, F-6015 Angers, France.; Procaccio, V (corresponding author), CHU Angers, Dept Biochim & Genet, Angers, France.
EM ViProcaccio@chu-angers.fr
RI Spinazzi, Marco/AFO-9978-2022; Procaccio, Vincent/M-2596-2015; Reynier,
   Pascal/K-3677-2015; Desquiret-Dumas, Valérie/K-2695-2015; Rouzier,
   Cecile/KCY-3619-2024; Trimouille, Aurelien/KSM-0596-2024
OI SPINAZZI, Marco/0000-0003-0048-9558; Goudenege,
   David/0000-0003-0738-2905; Reynier, Pascal/0000-0003-0802-4608
FU Association contre les Maladies Mitochondriales (AMMi); AFM-Telethon;
   Aviesan INSERM Genomic Variability Project; Angers University Hospital
FX This work was supported by grants from Association contre les Maladies
   Mitochondriales (AMMi), AFM-Telethon, Aviesan INSERM Genomic Variability
   Project, and from the Angers University Hospital. We thank all members
   of the French mitochondrial disease network (MITODIAG) for their
   support.
CR Boucret L, 2017, HUM REPROD, V32, P2101, DOI 10.1093/humrep/dex268
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   Damas J, 2012, NUCLEIC ACIDS RES, V40, P7606, DOI 10.1093/nar/gks500
   Diot A, 2016, MAMM GENOME, V27, P381, DOI 10.1007/s00335-016-9651-x
   Dong DW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-677
   Dörrenhaus A, 2000, ARCH TOXICOL, V74, P618, DOI 10.1007/s002040000173
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Elson JL, 2015, MITOCHONDRION, V25, P17, DOI 10.1016/j.mito.2015.08.004
   Fayssoil A, 2017, EUR J NEUROL, V24, P255, DOI 10.1111/ene.13176
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Goudenège D, 2019, GENET MED, V21, P1407, DOI 10.1038/s41436-018-0350-8
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Grady JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114462
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   LAUBER J, 1991, NUCLEIC ACIDS RES, V19, P1393, DOI 10.1093/nar/19.7.1393
   Lehmann D, 2019, NUCLEIC ACIDS RES, V47, P7430, DOI 10.1093/nar/gkz472
   Liu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067146
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Lott MT., 2013, Curr Protoc Bioinf, V44, P1231, DOI DOI 10.1002/0471250953.BI0123S44
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Nissanka N, 2019, TRENDS GENET, V35, P235, DOI 10.1016/j.tig.2019.01.001
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Raymond FL, 2018, NAT REV GENET, V19, P399, DOI 10.1038/s41576-018-0022-1
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Rocha MC, 2018, ANN NEUROL, V83, P115, DOI 10.1002/ana.25127
   Rodríguez-López C, 2020, J MED GENET, V57, P643, DOI 10.1136/jmedgenet-2019-106649
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sadikovic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015687
   Schon KR, 2020, TRENDS GENET, V36, P702, DOI 10.1016/j.tig.2020.06.009
   Smith PM, 2014, HUM MOL GENET, V23, P949, DOI 10.1093/hmg/ddt490
   Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307
   Varhaug KN, 2020, ANN CLIN TRANSL NEUR, V7, P1318, DOI 10.1002/acn3.51119
   Wallace D. C., 2018, EMERY RIMOINS PRINCI, P267
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wong LJC, 2013, MITOCHONDRION, V13, P379, DOI 10.1016/j.mito.2013.02.001
   Wong LJC, 2001, GENET MED, V3, P399, DOI 10.1097/00125817-200111000-00004
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
NR 39
TC 6
Z9 6
U1 1
U2 4
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1098-3600
EI 1530-0366
J9 GENET MED
JI Genet. Med.
PD SEP
PY 2021
VL 23
IS 9
BP 1769
EP 1778
DI 10.1038/s41436-021-01206-w
EA MAY 2021
PG 10
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA UW6TR
UT WOS:000654878400001
PM 34040194
OA Bronze
DA 2024-11-01
ER

PT J
AU Villarroya, J
   Dorado, B
   Vilà, MR
   Garcia-Arumí, E
   Domingo, P
   Giralt, M
   Hirano, M
   Villarroya, F
AF Villarroya, Joan
   Dorado, Beatriz
   Vila, Maya R.
   Garcia-Arumi, Elena
   Domingo, Pere
   Giralt, Marta
   Hirano, Michio
   Villarroya, Francesc
TI Thymidine Kinase 2 Deficiency-Induced Mitochondrial DNA Depletion Causes
   Abnormal Development of Adipose Tissues and Adipokine Levels in Mice
SO PLOS ONE
LA English
DT Article
ID GENE-EXPRESSION; BIOGENESIS; TRANSCRIPTION; ADIPOCYTE; ACTIVATION;
   MUTATIONS; TRANSPORT; MYOPATHY; DEPOTS; LIPOMA
AB Mammal adipose tissues require mitochondrial activity for proper development and differentiation. The components of the mitochondrial respiratory chain/oxidative phosphorylation system (OXPHOS) are encoded by both mitochondrial and nuclear genomes. The maintenance of mitochondrial DNA (mtDNA) is a key element for a functional mitochondrial oxidative activity in mammalian cells. To ascertain the role of mtDNA levels in adipose tissue, we have analyzed the alterations in white (WAT) and brown (BAT) adipose tissues in thymidine kinase 2 (Tk2) H126N knockin mice, a model of TK2 deficiency-induced mtDNA depletion. We observed respectively severe and moderate mtDNA depletion in TK2-deficient BAT and WAT, showing both tissues moderate hypotrophy and reduced fat accumulation. Electron microscopy revealed altered mitochondrial morphology in brown but not in white adipocytes from TK2-deficient mice. Although significant reduction in mtDNA-encoded transcripts was observed both in WAT and BAT, protein levels from distinct OXPHOS complexes were significantly reduced only in TK2-deficient BAT. Accordingly, the activity of cytochrome c oxidase was significantly lowered only in BAT from TK2-deficient mice. The analysis of transcripts encoding up to fourteen components of specific adipose tissue functions revealed that, in both TK2-deficient WAT and BAT, there was a consistent reduction of thermogenesis related gene expression and a severe reduction in leptin mRNA. Reduced levels of resistin mRNA were found in BAT from TK2-deficient mice. Analysis of serum indicated a dramatic reduction in circulating levels of leptin and resistin. In summary, our present study establishes that mtDNA depletion leads to a moderate impairment in mitochondrial respiratory function, especially in BAT, causes substantial alterations in WAT and BAT development, and has a profound impact in the endocrine properties of adipose tissues.
C1 [Villarroya, Joan; Giralt, Marta; Villarroya, Francesc] Univ Barcelona, Dept Bioquim & Biol Mol, Barcelona, Spain.
   [Villarroya, Joan; Giralt, Marta; Villarroya, Francesc] Univ Barcelona, Inst Biomed IBUB, Barcelona, Spain.
   [Villarroya, Joan; Domingo, Pere] Hosp Santa Creu & Sant Pau, Inst Recerca, Barcelona, Spain.
   [Villarroya, Joan; Giralt, Marta; Villarroya, Francesc] ISCIII, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Santiago De Compostela, Spain.
   [Dorado, Beatriz; Hirano, Michio] Columbia Univ Med Ctr, Dept Neurol, New York, NY USA.
   [Vila, Maya R.; Garcia-Arumi, Elena] Hosp Univ Vall dHebron, Inst Recerca, Barcelona, Spain.
   [Garcia-Arumi, Elena] ISCIII, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Valencia, Spain.
C3 University of Barcelona; University of Barcelona; Hospital of Santa Creu
   i Sant Pau; Autonomous University of Barcelona; Hospital Universitari
   Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Instituto de
   Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red;
   CIBEROBN; Columbia University; Autonomous University of Barcelona;
   Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca
   (VHIR); Instituto de Salud Carlos III; CIBER - Centro de Investigacion
   Biomedica en Red; CIBERER
RP Villarroya, J (corresponding author), Univ Barcelona, Dept Bioquim & Biol Mol, Barcelona, Spain.
EM joanvillarroya@gmail.com
RI Villarroya, Francesc/K-4357-2014; Garcia-Arumi, Elena/ABH-4229-2020;
   Domingo, Pere/AAP-7571-2021; Giralt, Marta/A-4756-2013; Villarroya,
   Joan/W-4066-2018
OI Giralt, Marta/0000-0001-7968-4190; Villarroya,
   Francesc/0000-0003-1266-9142; Villarroya, Joan/0000-0002-7859-1109;
   Dorado, Beatriz/0000-0002-1958-4558; Garcia-Arumi,
   Elena/0000-0003-0096-3336
FU Ministerio de Ciencia e Innovacion [SAF2008-01896]; Instituto de Salud
   Carlos III; Red de Investigacion en SIDA [PI081715]; Fundacion para la
   Investigacion y la Prevencion del Sida en Espana (FIPSE) [36610/06]
FX Ministerio de Ciencia e Innovacion SAF2008-01896, Instituto de Salud
   Carlos III and Red de Investigacion en SIDA PI081715, Fundacion para la
   Investigacion y la Prevencion del Sida en Espana (FIPSE)36610/06. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   BADDELEY AJ, 1986, J MICROSC-OXFORD, V142, P259, DOI 10.1111/j.1365-2818.1986.tb04282.x
   Bogacka I, 2005, J CLIN ENDOCR METAB, V90, P6650, DOI 10.1210/jc.2005-1024
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   Carmona MC, 2002, J BIOL CHEM, V277, P21489, DOI 10.1074/jbc.M201710200
   Chevillotte E, 2007, DIABETES, V56, P1042, DOI 10.2337/db06-1300
   Cote HC, 2005, ANTIVIR THER, P10
   Dessolin S, 1997, FASEB J, V11, P382, DOI 10.1096/fasebj.11.5.9141506
   DeVos P, 1996, J CLIN INVEST, V98, P1004, DOI 10.1172/JCI118860
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   GREENWOOD MR, 1974, J LIPID RES, V15, P474
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5
   HE YF, 1995, J BIOL CHEM, V270, P28887, DOI 10.1074/jbc.270.48.28887
   HOUSTEK J, 1995, J BIOL CHEM, V270, P7689, DOI 10.1074/jbc.270.13.7689
   Kim MJ, 2008, ANTIMICROB AGENTS CH, V52, P1670, DOI 10.1128/AAC.01449-07
   LARSSON NG, 1994, BIOCHEM BIOPH RES CO, V200, P1374, DOI 10.1006/bbrc.1994.1603
   LIN PY, 1977, J NUTR, V107, P1715, DOI 10.1093/jn/107.9.1715
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Nagy GS, 2003, CLIN INFECT DIS, V36, P795, DOI 10.1086/367859
   Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006
   Nolan D, 2003, AIDS, V17, P1329, DOI 10.1097/00002030-200306130-00007
   Oliver P, 2003, MOL CELL BIOCHEM, V252, P397, DOI 10.1023/A:1025500605884
   Oliver P, 2001, PFLUG ARCH EUR J PHY, V442, P383, DOI 10.1007/s004240100540
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Pace CS, 2003, ANTIVIR THER, V8, P323
   Ravussin E, 2009, OBES REV, V10, P265, DOI 10.1111/j.1467-789X.2008.00559.x
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Shi XR, 2008, J BIOL CHEM, V283, P30658, DOI 10.1074/jbc.M800510200
   SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415
   Srere P.A., 1969, Methods in Enzymology, V13, P3
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Suzuki Y, 2004, DIABETES RES CLIN PR, V63, P225, DOI 10.1016/j.diabres.2003.10.024
   Suzuki Y, 2002, DIABETES CARE, V25, P407, DOI 10.2337/diacare.25.2.407
   Vilá MR, 2008, J NEUROL SCI, V267, P137, DOI 10.1016/j.jns.2007.10.019
   Vilà MR, 2003, NEUROLOGY, V60, P1203, DOI 10.1212/01.WNL.0000055928.58122.47
   Villarroya F, 2005, TRENDS PHARMACOL SCI, V26, P88, DOI 10.1016/j.tips.2004.12.005
   Villarroya J, 2010, ANTIVIR THER, V15, P1021, DOI 10.3851/IMP1669
   Villarroya J, 2009, OBESITY, V17, P1814, DOI 10.1038/oby.2009.152
   Villena JA, 2002, CELL MOL LIFE SCI, V59, P1934, DOI 10.1007/PL00012516
   Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752
   Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 47
TC 17
Z9 19
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 27
PY 2011
VL 6
IS 12
AR e29691
DI 10.1371/journal.pone.0029691
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 897SB
UT WOS:000300674900054
PM 22216345
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU Echaniz-Laguna, A
   Chassagne, M
   de Sèze, J
   Mohr, M
   Clerc-Renaud, P
   Tranchant, C
   de Camaret, BM
AF Echaniz-Laguna, Andoni
   Chassagne, Maite
   de Seze, Jerome
   Mohr, Michel
   Clerc-Renaud, Pascale
   Tranchant, Christine
   de Camaret, Benedicte Mousson
TI <i>POLG1</i> Variations Presenting as Multiple Sclerosis
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID MUTATIONS
AB Objective: To describe 2 unrelated patients with novel variations in the POLG1 gene and features undistinguishable from multiple sclerosis, ie, optic neuritis, brain white matter hyperintense areas, and unmatched cerebrospinal fluid oligoclonal bands.
   Design: Case report.
   Setting: University hospital.
   Patients: Both patients subsequently developed bilateral ophthalmoplegia, ptosis, myopathy, cardiomyopathy, ataxia, dysphagia, and hearing and cognitive impairment.
   Main Outcome Measures: Detailed clinical and laboratory examinations including brain magnetic reso-nance imaging, morphological analysis of a muscle biopsy, characterization of mitochondrial DNA integrity, sequencing of the POLG1 gene, and screening of control subjects for POLG1 sequence variants.
   Results: Ragged red fibers and multiple deletions of mitochondrial DNA were detected in the skeletal muscle. Four compound heterozygous variations, including 3 previously unreported, were identified in POLG1.
   Conclusion: Clinicians should be aware of the existence of POLG1-related multiple sclerosis like illness, as it has important implications for management, treatment, and genetic counseling.
C1 [Echaniz-Laguna, Andoni; de Seze, Jerome; Tranchant, Christine] Hop Civil, Dept Neurol, F-67091 Strasbourg, France.
   [Echaniz-Laguna, Andoni] INSERM, Fac Med, U692, Strasbourg, France.
   [Chassagne, Maite; Clerc-Renaud, Pascale; de Camaret, Benedicte Mousson] CHU Lyon, Ctr Biol & Pathol Est, Serv Malad Hereditaires Metab, Bron, France.
   [Mohr, Michel] Hop Hautepierre, Dept Anatomopathol, Strasbourg, France.
C3 CHU Strasbourg; Universites de Strasbourg Etablissements Associes;
   Universite de Strasbourg; Institut National de la Sante et de la
   Recherche Medicale (Inserm); CHU Lyon; Universites de Strasbourg
   Etablissements Associes; Universite de Strasbourg; CHU Strasbourg
RP Echaniz-Laguna, A (corresponding author), Hop Civil, Dept Neurol, BP 426, F-67091 Strasbourg, France.
EM andoni.echaniz-laguna@chru-strasbourg.fr
RI Christine, Tranchant-Dubreuil/JAC-6513-2023; Echaniz-Laguna,
   Andoni/IUN-5392-2023; de Seze, Jerome/M-8316-2016
OI tranchant, christine/0000-0002-2895-1292; de Seze,
   Jerome/0000-0002-7197-7578
CR Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Miller D, 2005, LANCET NEUROL, V4, P281, DOI 10.1016/S1474-4422(05)70071-5
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
NR 7
TC 28
Z9 28
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60654-0946 USA
SN 0003-9942
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD SEP
PY 2010
VL 67
IS 9
BP 1140
EP 1143
PG 4
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 653OW
UT WOS:000282102800016
PM 20837861
DA 2024-11-01
ER

PT J
AU Friederich, MW
   Geddes, GC
   Wortmann, SB
   Punnoose, A
   Wartchow, E
   Knight, KM
   Prokisch, H
   Creadon-Swindell, G
   Mayr, JA
   Van Hove, JLK
AF Friederich, Marisa W.
   Geddes, Gabrielle C.
   Wortmann, Saskia B.
   Punnoose, Ann
   Wartchow, Eric
   Knight, Kaz M.
   Prokisch, Holger
   Creadon-Swindell, Geralyn
   Mayr, Johannes A.
   Van Hove, Johan L. K.
TI Pathogenic variants in <i>MRPL44</i> cause infantile cardiomyopathy due
   to a mitochondrial translation defect
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Cardiomyopathy; Combined deficiency; Mitochondrial translation;
   Mitochondrial ribosome; Genetic cause
ID MUTATIONS CAUSE; LARGE SUBUNIT; RIBOSOME; DISEASE; DEFICIENCY
AB Cardiac dysfunction is a common phenotypic manifestation of primary mitochondrial disease with multiple nuclear and mitochondrial DNA pathogenic variants as a cause, including disorders of mitochondrial translation. To date, five patients have been described with pathogenic variants in MRPL44, encoding the ml44 protein which is part of the large subunit of the mitochondrial ribosome (mitoribosome). Three presented as infants with hypertrophic cardiomyopathy, mild lactic acidosis, and easy fatigue and muscle weakness, whereas two presented in adolescence with myopathy and neurological symptoms. We describe two infants who presented with cardiomyopathy from the neonatal period, failure to thrive, hypoglycemia and in one infant lactic acidosis. A decompensation of the cardiac function in the first year resulted in demise. Exome sequencing identified compound heterozygous variants in the MRPL44 gene including the known pathogenic variant c.467 T > G and two novel pathogenic variants. We document a combined respiratory chain enzyme deficiency with emphasis on complex I and IV, affecting heart muscle tissue more than skeletal muscle or fibroblasts. We show this to be caused by reduced mitochondrial DNA encoded protein synthesis affecting all subunits, and resulting in dysfunction of complex I and IV assembly. The degree of oxidative phosphorylation dysfunction correlated with the impairment of mitochondrial protein synthesis due to different pathogenic variants. These functional studies allow for improved understanding of the pathogenesis of MRPL44-associated mitochondrial disorder. (c) 2021 Elsevier Inc. All rights reserved.
C1 [Friederich, Marisa W.; Knight, Kaz M.; Van Hove, Johan L. K.] Univ Colorado, Sect Clin Genet & Metab, Dept Pediat, Aurora, CO USA.
   [Friederich, Marisa W.; Wartchow, Eric; Creadon-Swindell, Geralyn; Van Hove, Johan L. K.] Childrens Hosp Colorado, Dept Pathol & Lab Serv, Aurora, CO USA.
   [Geddes, Gabrielle C.] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.
   [Geddes, Gabrielle C.] Indiana Univ, Dept Mol & Med Genet, Indianapolis, IN 46204 USA.
   [Wortmann, Saskia B.; Mayr, Johannes A.] Paracelsus Med Univ PMU, Univ Childrens Hosp, Salzburg, Austria.
   [Wortmann, Saskia B.] RadboudUMC, Amalia Childrens Hosp, Nijmegen, Netherlands.
   [Punnoose, Ann] Childrens Hosp Wisconsin, Herma Heart Inst, Milwaukee, WI 53201 USA.
   [Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Neurogen, Neuherberg, Germany.
   [Prokisch, Holger] Tech Univ Munich, Inst Human Genet, Munich, Germany.
C3 University of Colorado System; University of Colorado Anschutz Medical
   Campus; Children's Hospital Colorado; Medical College of Wisconsin;
   Indiana University System; Indiana University Indianapolis; Paracelsus
   Private Medical University; Radboud University Nijmegen; Children's
   Hospital of Wisconsin; Helmholtz Association; Helmholtz-Center Munich -
   German Research Center for Environmental Health; Technical University of
   Munich
RP Van Hove, JLK (corresponding author), Mailstop 8400,Educ 2 South L28-4114, Aurora, CO 80045 USA.
RI Wortmann, Saskia/E-6125-2010; Wartchow, Eric/AAZ-8554-2021; Geddes,
   Gabrielle/F-1839-2018; Prokisch, Holger/N-8964-2013
OI Geddes, Gabrielle/0000-0003-2077-4997
FU Children's Hospital Colorado Foundation; National Institutes of Health
   [NIH U54NS078059]; NCATS; Austrian Science Fund (FWF) [GENOMIT I
   4695-B]; German Federal Ministry of Education and Research (BMBF, Bonn,
   Germany) research grant "German Network for Mitochondrial Disorders"
   (mitoNET) [01GM1906B]; German BMBF; Horizon2020 through the ERare
   project GENOMIT [01GM1920A]; Horizon2020 through ERA PerMed project
   PerMiM [01KU2016A]
FX Financial support for this study was received from Children's Hospital
   Colorado Foundation, Summits for Samantha and Miracles for Mito (JVH,
   MWF, KMK) . JVH, KMK, and MWF are supported by a grant from the National
   Institutes of Health, NIH U54NS078059 for the North American
   Mitochondrial Disease Consortium (NAMDC) . NAMDC is part of Rare
   Diseases Clinical Research Network (RDCRN) , an initiative of the Office
   of Rare Diseases Research (ORDR) , NCATS. This consortium is funded
   through collaboration with NCATS. Contents are the authors'sole
   responsibility and do not necessarily represent official NIH views. The
   study was also supported by the Austrian Science Fund (FWF) GENOMIT I
   4695-B to JAM. HP was supported by a German Federal Ministry of
   Education and Research (BMBF, Bonn, Germany) research grant "German
   Network for Mitochondrial Disorders" (mitoNET, 01GM1906B) ; by the
   German BMBF and Horizon2020 through the ERare project GENOMIT
   (01GM1920A) and the ERA PerMed project PerMiM (01KU2016A) . Funding
   sources had no role in the design or execution of the study, in the
   interpretation of data or the writing of the study.
CR Boczonadi V, 2018, ESSAYS BIOCHEM, V62, P321, DOI 10.1042/EBC20170103
   BOOKELMAN H, 1978, BIOCHEM MED METAB B, V20, P395, DOI 10.1016/0006-2944(78)90089-3
   Carroll CJ, 2013, J MED GENET, V50, P151, DOI 10.1136/jmedgenet-2012-101375
   Chatfield KC, 2015, MITOCHONDRION, V21, P1, DOI 10.1016/j.mito.2014.12.005
   Cheong A, 2020, GENE EXPR PATTERNS, V38, DOI 10.1016/j.gep.2020.119147
   Coughlin CR, 2015, J MED GENET, V52, P532, DOI 10.1136/jmedgenet-2015-103049
   De Silva D, 2015, CELL CYCLE, V14, P2226, DOI 10.1080/15384101.2015.1053672
   Dinkova-Kostova AT, 2015, FREE RADICAL BIO MED, V88, P179, DOI 10.1016/j.freeradbiomed.2015.04.036
   Distelmaier F, 2015, NEUROGENETICS, V16, P319, DOI 10.1007/s10048-015-0444-2
   Friederich MW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06250-w
   Friederich MW, 2017, HUM MOL GENET, V26, P702, DOI 10.1093/hmg/ddw431
   Gray VE, 2017, GENETICS, V207, P53, DOI 10.1534/genetics.117.300064
   Greber BJ, 2016, ANNU REV BIOCHEM, V85, P103, DOI 10.1146/annurev-biochem-060815-014343
   Horga A, 2021, MOL BIOL REP, V48, P2093, DOI 10.1007/s11033-021-06188-1
   Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200
   Kremer LS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15824
   Mayr JA, 2004, PEDIATR RES, V55, P988, DOI 10.1203/01.pdr.0000127016.67809.6b
   Oláhová M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291
   Pitceathly RDS, 2021, J INHERIT METAB DIS, V44, P22, DOI 10.1002/jimd.12281
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Sasarman F, 2012, METHODS MOL BIOL, V837, P207, DOI 10.1007/978-1-61779-504-6_14
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Steele H, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911589
   Towbin JA., 2006, Mitochondrial Medicine, P75
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   Vasilescu C, 2018, J AM COLL CARDIOL, V72, P2324, DOI 10.1016/j.jacc.2018.08.2171
   Wagner M, 2019, J INHERIT METAB DIS, V42, P909, DOI 10.1002/jimd.12109
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Yeo JHC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134326
   Zeng R, 2018, CELL METAB, V27, P645, DOI 10.1016/j.cmet.2018.01.012
NR 30
TC 8
Z9 8
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD AUG
PY 2021
VL 133
IS 4
BP 362
EP 371
DI 10.1016/j.ymgme.2021.06.001
EA JUL 2021
PG 10
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA TI5KI
UT WOS:000672841000004
PM 34140213
OA Green Accepted, Bronze
DA 2024-11-01
ER

PT J
AU Narumi, K
   Mishima, E
   Akiyama, Y
   Matsuhashi, T
   Nakamichi, T
   Kisu, K
   Nishiyama, S
   Ikenouchi, H
   Kikuchi, A
   Izumi, R
   Miyazaki, M
   Abe, T
   Sato, H
   Ito, S
AF Narumi, Kaori
   Mishima, Eikan
   Akiyama, Yukako
   Matsuhashi, Tetsuro
   Nakamichi, Takashi
   Kisu, Kiyomi
   Nishiyama, Shuhei
   Ikenouchi, Hajime
   Kikuchi, Akio
   Izumi, Rumiko
   Miyazaki, Mariko
   Abe, Takaaki
   Sato, Hiroshi
   Ito, Sadayoshi
TI Focal Segmental Glomerulosclerosis Associated with Chronic Progressive
   External Ophthalmoplegia and Mitochondrial DNA A3243G Mutation
SO NEPHRON
LA English
DT Article
DE Mitochondrial disease; Chronic progressive external ophthalmoplegia;
   Focal segmental glomerulosclerosis
ID RESISTANT NEPHROTIC SYNDROME; KEARNS-SAYRE-SYNDROME; DISEASE; CYTOPATHY;
   MELAS
AB Focal segmental glomerulosclerosis (FSGS) is caused by various etiologies, with mitochondrial dysfunction being one of the causes. FSGS is known to be associated with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), which is a subclass of mitochondrial disease. However, it has rarely been reported in other mitochondrial disease subclasses. Here, we reported a 20-year-old man diagnosed with FSGS associated with chronic progressive external ophthalmoplegia (CPEO) due to mitochondrial DNA (mtDNA) 3243A>G mutation. He presented with left ptosis, short stature, mild sensorineural deafness, and cardiac conduction block. A renal biopsy sample showed segmental sclerosis and adhesions between capillaries and Bowman's capsule, indicating FSGS. Electron microscopy demonstrated abnormal aggregated mitochondria in podocytes, and the basement membrane and epithelial cells of Bowman's capsule. Skeletal muscle biopsy also showed accumulation of abnormal mitochondria. mtDNA analysis identified heteroplasmic mtDNA 3243A>G mutation with no large-scale deletions. From these findings, we diagnosed the case as CPEO with multi-organ involvement including FSGS. Our report demonstrates that CPEO, as well as MELAS, can be associated with FSGS. Because mitochondrial disease presents with a variety of clinical symptoms, atypical cases with non-classical manifestations are observed. Thus, mitochondrial disease should be considered as an underlying cause of FSGS with systemic manifestations even with atypical phenotypes. (c) 2017 S. Karger AG, Basel
C1 [Narumi, Kaori; Mishima, Eikan; Akiyama, Yukako; Nakamichi, Takashi; Kisu, Kiyomi; Miyazaki, Mariko; Abe, Takaaki; Sato, Hiroshi; Ito, Sadayoshi] Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi, Japan.
   [Matsuhashi, Tetsuro] Tohoku Univ, Grad Sch Med, Dept Pediat, Sendai, Miyagi, Japan.
   [Ikenouchi, Hajime; Kikuchi, Akio; Izumi, Rumiko] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Miyagi, Japan.
   [Abe, Takaaki] Tohoku Univ, Grad Sch Biomed Engn, Div Med Sci, Sendai, Miyagi, Japan.
   [Abe, Takaaki] Tohoku Univ, Grad Sch Med, Dept Clin Biol & Hormonal Regulat, Sendai, Miyagi, Japan.
   [Sato, Hiroshi] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacol & Therapeut, Sendai, Miyagi, Japan.
C3 Tohoku University; Tohoku University; Tohoku University; Tohoku
   University; Tohoku University; Tohoku University
RP Narumi, K (corresponding author), Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Aoba Ku, 1-1 Seiryo Cho, Sendai, Miyagi 9808574, Japan.
EM k-n-0922@med.tohoku.ac.jp
RI Ito, Sadayoshi/A-3933-2015; Ikenouchi, Hajime/AAA-3246-2022; Nishiyama,
   Shuhei/ADT-4304-2022
OI Nakamichi, Takashi/0000-0001-7986-1505; Ito,
   Sadayoshi/0000-0002-5092-3626; Nishiyama, Shuhei/0000-0002-0248-1595;
   ikenouchi, hajime/0000-0003-3918-5551
FU Grants-in-Aid for Scientific Research [16K19474, 17K09789, 26461303]
   Funding Source: KAKEN
CR Ashraf S, 2013, J CLIN INVEST, V123, P5179, DOI 10.1172/JCI69000
   BAN S, 1992, ACTA PATHOL JAPON, V42, P818
   Binder V, 2012, J PEDIAT HEMATOL ONC, V34, P283, DOI 10.1097/MPH.0b013e3182288249
   Bosbach S, 2003, BRAIN, V126, P1231, DOI 10.1093/brain/awg101
   Doleris LM, 2000, KIDNEY INT, V58, P1851, DOI 10.1046/j.1523-1755.2000.00356.x
   Dvorakova V, 2016, MOL GENET METAB, V118, P288, DOI 10.1016/j.ymgme.2016.06.003
   Grunfeld JP, 1996, NEPHROL DIAL TRANSPL, V11, P760, DOI 10.1093/oxfordjournals.ndt.a027391
   Güçer S, 2005, PEDIATR DEVEL PATHOL, V8, P710, DOI 10.1007/s10024-005-0058-z
   Harita Y, 2017, CLIN EXP NEPHROL
   Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693
   Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x
   Caballero PEJ, 2007, NEUROLOGIST, V13, P33, DOI 10.1097/01.nrl.0000252953.49721.f5
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Matsuhashi T, 2017, EBIOMEDICINE, V20, P27, DOI 10.1016/j.ebiom.2017.05.016
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   Mihai Cristina Maria, 2009, J Med Case Rep, V3, P101, DOI 10.1186/1752-1947-3-101
   Mkaouar-Rebai E, 2010, MITOCHONDRION, V10, P449, DOI 10.1016/j.mito.2010.04.003
   Motoda Atsuko, 2013, Rinsho Shinkeigaku, V53, P446
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Nishigaki Y, 2010, MITOCHONDRION, V10, P300, DOI 10.1016/j.mito.2010.01.003
   Sadowski CE, 2015, J AM SOC NEPHROL, V26, P1279, DOI 10.1681/ASN.2014050489
NR 23
TC 11
Z9 13
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1660-8151
EI 2235-3186
J9 NEPHRON
JI Nephron
PY 2018
VL 138
IS 3
BP 243
EP 248
DI 10.1159/000485109
PG 6
WC Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Urology & Nephrology
GA FY6YC
UT WOS:000427007800011
PM 29190634
DA 2024-11-01
ER

PT J
AU Wilcox, RA
   Churchyard, A
   Dahl, HH
   Hutchison, WM
   Kirby, DM
   Thyagarajan, D
AF Wilcox, Robert A.
   Churchyard, Andrew
   Dahl, Henrik H.
   Hutchison, Wendy M.
   Kirby, Denise M.
   Thyagarajan, Dominic
TI Levodopa response in parkinsonism with multiple mitochondrial DNA
   deletions
SO MOVEMENT DISORDERS
LA English
DT Article
DE mitochondrial disease; Parkinson's disease; parkinsonism; chronic
   progressive external ophthalmoplegia; neuropathy
ID DISEASE
AB We report a patient with an autosomal dominant chronic progressive external ophthalmoplegia phenotype associated with multiple mtDNA deletions in muscle from a family in which linkage analysis excluded mutations in DNA polymerase gamma (POLG), adenine nucleotide translocase (ANT-1) or C10orf2 (Twinkle). She presented with prominent Parkinsonism characterized by prolonged benefit from levodopa (L-dopa) and the later development Of L-dopa induced dyskinesias and motor fluctuations. Thus L-dopa responsiveness, L-dopa induced dyskinesias and motor fluctuations may also occur in atypical Parkinsonism of mitochondrial disease, just as they may in multiple system atrophy. (C) 2007 Movement Disorder Society.
C1 Flinders Med Ctr, Dept Neurol, Bedford Pk, SA, Australia.
   Cabini Med Ctr, Malvern, Vic, Australia.
   Murdoch Childrens Res Inst, Dept Paediat, Melbourne, Vic, Australia.
   Univ Melbourne, Royal Childrens Hosp, Melbourne, Vic, Australia.
C3 Flinders Medical Centre; Murdoch Children's Research Institute; Royal
   Children's Hospital Melbourne; University of Melbourne
RP Wilcox, RA (corresponding author), Univ Queensland, Royal Brisbane Hosp, Dept Neurol, Herston, Qld 4029, Australia.
EM robert_wilcox@health.qld.gov.au
OI Wilcox, Robert A./0000-0001-9911-8743
CR Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Berciano J, 2002, MOVEMENT DISORD, V17, P812, DOI 10.1002/mds.10190
   Chalmers RM, 1996, J NEUROL SCI, V143, P41, DOI 10.1016/S0022-510X(96)00032-9
   Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Lewis S, 2002, J NEUROL SCI, V201, P39, DOI 10.1016/S0022-510X(02)00190-9
   Rana M, 2000, ANN NEUROL, V48, P774, DOI 10.1002/1531-8249(200011)48:5<774::AID-ANA11>3.3.CO;2-9
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Thyagarajan D, 2000, ANN NEUROL, V48, P730, DOI 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0
   THYAGARAJAN D, 2006, NEUROLOGICAL THERAPE, P1743
NR 13
TC 10
Z9 10
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-3185
EI 1531-8257
J9 MOVEMENT DISORD
JI Mov. Disord.
PD MAY 15
PY 2007
VL 22
IS 7
BP 1020
EP 1023
DI 10.1002/mds.21416
PG 4
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 174BU
UT WOS:000246917000019
PM 17357142
DA 2024-11-01
ER

PT J
AU Mkaouar-Rebai, E
   Chamkha, I
   Mezghani, N
   Ben Ayed, I
   Fakhfakh, F
AF Mkaouar-Rebai, Emna
   Chamkha, Imen
   Mezghani, Najla
   Ben Ayed, Imen
   Fakhfakh, Faiza
TI Screening of mitochondrial mutations in Tunisian patients with
   mitochondrial disorders: An overview study
SO MITOCHONDRIAL DNA
LA English
DT Review
DE Mitochondrial mutation; deafness; Leigh syndrome; KSS; Pearson syndrome;
   diabetes
ID 12S RIBOSOMAL-RNA; KEARNS-SAYRE-SYNDROME; STROKE-LIKE EPISODES;
   MARROW-PANCREAS-SYNDROME; SYNDROMIC HEARING-LOSS; DIABETES-MELLITUS;
   LEIGH-SYNDROME; POINT MUTATION; WOLFRAM-SYNDROME; DNA DELETION
AB To investigate the spectrum of common mitochondrial mutations in Tunisia during the years of 2002-2012, 226 patients with mitochondrial disorders were clinically diagnosed with hearing loss, Leigh syndrome (LS), diabetes, cardiomyopathy, Kearns-Sayre syndrome (KSS), Pearson syndrome (PS), myopathy, mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes syndrome (MELAS) and Wolfram syndrome. Restriction fragment length polymorphism (PCR-RFLP), radioactive PCR, single specific primer-PCR (SSP-PCR) analysis and PCR-sequencing methods were used to identify the mutations. Two cases with m. 1555A > G mutation and two families with the novel 12S rRNA m. 735A > G transition were detected in patients with hearing loss. Three cases with m. 8993T > G mutation, two patients with the novel m. 5523T > G and m. 5559A > G mutations in the tRNA(Trp) gene, and two individuals with the undescribed m. 9478T > C mutation in the cytochrome c oxidase subunit III (COXIII) gene were found with LS. In addition, one case with hypertrophic cardiomyopathy and deafness presented the ND1 m. 3395A > G mutation and the tRNA(Ile) m.4316A > G variation. Besides, multiple mitochondrial deletions were detected in patients with KSS, PS, and Wolfram syndrome. The m. 14709T > C mutation in the tRNA(Glu) was reported in four maternally inherited diabetes and deafness patients and a novel tRNA(Val) m. 1640A > G mutation was detected in a MELAS patient.
C1 [Mkaouar-Rebai, Emna; Chamkha, Imen; Mezghani, Najla; Ben Ayed, Imen; Fakhfakh, Faiza] Univ Sfax, Fac Med Sfax, Human Mol Genet Lab, Sfax, Tunisia.
C3 Universite de Sfax
RP Mkaouar-Rebai, E (corresponding author), Fac Med Sfax, Human Mol Genet Lab, Ave Magida Boulila, Sfax 3029, Tunisia.
EM emna_mkaouar@mail2world.com; faiza.fakhfakh@gmail.com
RI MKAOUAR-REBAI, Emna/AAE-6650-2019
OI Mkaouar-Rebai, Emna/0000-0003-3095-510X; Chamkha,
   Imen/0000-0002-6919-585X
FU Ministry of Higher Education and Scientific Research in Tunisia
FX This work was supported by The Ministry of Higher Education and
   Scientific Research in Tunisia. The authors report no conflicts of
   interest. The authors alone are responsible for the content and writing
   of the paper.
CR Aharoni S, 2010, J NEUROL SCI, V296, P101, DOI 10.1016/j.jns.2010.06.029
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Au WS, 2008, J MOL ENDOCRINOL, V41, P229, DOI 10.1677/JME-08-0080
   Austin SA, 1998, NEUROLOGY, V51, P1447, DOI 10.1212/WNL.51.5.1447
   Ballana E, 2008, HUM MUTAT, V29, P248, DOI 10.1002/humu.20639
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Baracca A, 2000, J BIOL CHEM, V275, P4177, DOI 10.1074/jbc.275.6.4177
   Barrientos A, 1996, AM J HUM GENET, V58, P963
   Ben Ayed I, 2011, BIOCHEM BIOPH RES CO, V411, P381, DOI 10.1016/j.bbrc.2011.06.154
   Berardo A, 2010, CURR NEUROL NEUROSCI, V10, P118, DOI 10.1007/s11910-010-0096-4
   BLAW ME, 1990, J CHILD NEUROL, V5, P186, DOI 10.1177/088307389000500305
   Bosbach S, 2003, BRAIN, V126, P1231, DOI 10.1093/brain/awg101
   Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7
   Chamkha I, 2011, BIOCHEM BIOPH RES CO, V404, P504, DOI 10.1016/j.bbrc.2010.12.012
   Chen J, 2006, DIABETES RES CLIN PR, V74, P148, DOI 10.1016/j.diabres.2006.03.024
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cremers CW, 1977, ACTA PAEDIATR SC   S, V264, pS1
   Crispim D, 2008, ARQ BRAS ENDOCRINOL, V52, P1228, DOI 10.1590/S0004-27302008000800005
   Dahl HHM, 1998, AM J HUM GENET, V63, P1594, DOI 10.1086/302169
   Dai P, 2006, BIOCHEM BIOPH RES CO, V340, P194, DOI 10.1016/j.bbrc.2005.11.156
   Damore ME, 1999, J PEDIATR ENDOCR MET, V12, P207
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   De Kremer RD, 2001, AM J MED GENET, V99, P83, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1136>3.0.CO;2-X
   Degoul F, 1995, J INHERIT METAB DIS, V18, P682, DOI 10.1007/BF02436757
   del Castillo FJ, 2003, J MED GENET, V40, P632, DOI 10.1136/jmg.40.8.632
   Deschauer M, 2000, MOL GENET METAB, V70, P235, DOI 10.1006/mgme.2000.3002
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Donovan LE, 2006, J CLIN ENDOCR METAB, V91, P4737, DOI 10.1210/jc.2006-1498
   El-Shanti H, 2000, AM J HUM GENET, V66, P1229, DOI 10.1086/302858
   Emmanuele V, 2011, MUSCLE NERVE, V44, P448, DOI 10.1002/mus.22149
   ENTER C, 1991, HUM GENET, V88, P233
   Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676
   Ferlin T, 1997, J PEDIATR-US, V131, P447, DOI 10.1016/S0022-3476(97)80074-1
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   FISCHELGHODSIAN N, 1993, AM J OTOLARYNG, V14, P399, DOI 10.1016/0196-0709(93)90113-L
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   Hirai M, 1998, J CLIN ENDOCR METAB, V83, P992, DOI 10.1210/jc.83.3.992
   Hobbie SN, 2006, BIOCHIMIE, V88, P1033, DOI 10.1016/j.biochi.2006.04.008
   Hofmann S, 1997, GENOMICS, V39, P8, DOI 10.1006/geno.1996.4474
   Hutchin TP, 2000, J MED GENET, V37, P692, DOI 10.1136/jmg.37.9.692
   Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441
   Jung J, 2007, NEUROLOGY, V68, P1429, DOI 10.1212/01.wnl.0000264019.53959.10
   Kameoka K, 1998, DIABETES CARE, V21, P2034, DOI 10.2337/diacare.21.11.2034
   Kawarai T, 1997, NEUROLOGY, V49, P598, DOI 10.1212/WNL.49.2.598
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683
   Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x
   Laloi-Michelin M, 2006, DIABETES METAB, V32, P182, DOI 10.1016/S1262-3636(07)70267-7
   Lam CW, 1997, EUR J PEDIATR, V156, P562, DOI 10.1007/s004310050663
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   Li ZY, 2005, HUM GENET, V117, P9, DOI 10.1007/s00439-005-1276-1
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   Lu JX, 2010, MITOCHONDRION, V10, P380, DOI 10.1016/j.mito.2010.01.007
   Lu JX, 2010, MITOCHONDRION, V10, P69, DOI 10.1016/j.mito.2009.09.007
   Lynn S, 1998, DIABETES, V47, P1800, DOI 10.2337/diabetes.47.11.1800
   Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   MANOUVRIER S, 1995, J MED GENET, V32, P654, DOI 10.1136/jmg.32.8.654
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   MARIE SKN, 1994, BIOCHEM MED METAB B, V52, P136, DOI 10.1006/bmmb.1994.1045
   Marin-Garcia J, 1999, CARDIOVASC PATHOL, V8, P217, DOI 10.1016/S1054-8807(99)00010-1
   MarinGarcia J, 1996, PEDIATR CARDIOL, V17, P387, DOI 10.1007/s002469900084
   Martin L, 2000, BRIT J DERMATOL, V143, P876, DOI 10.1046/j.1365-2133.2000.03797.x
   Matsumoto Joyce, 2005, Rev Neurol Dis, V2, P30
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   Mezghani N, 2011, BIOCHEM BIOPH RES CO, V411, P247, DOI 10.1016/j.bbrc.2011.06.106
   Mezghani N, 2011, BIOCHEM BIOPH RES CO, V407, P747, DOI 10.1016/j.bbrc.2011.03.094
   Mezghani N, 2010, J DIABETES COMPLICAT, V24, P270, DOI 10.1016/j.jdiacomp.2009.11.002
   MIYABAYASHI S, 1991, J INHERIT METAB DIS, V14, P805, DOI 10.1007/BF01799954
   Mkaouar-Rebai E, 2006, BIOCHEM BIOPH RES CO, V340, P1251, DOI 10.1016/j.bbrc.2005.12.123
   Mkaouar-Rebai E, 2011, J CHILD NEUROL, V26, P12, DOI 10.1177/0883073810371227
   Mkaouar-Rebai E, 2010, BIOSCIENCE REP, V30, P405, DOI 10.1042/BSR20090120
   Mkaouar-Rebai E, 2010, MITOCHONDRION, V10, P449, DOI 10.1016/j.mito.2010.04.003
   Mkaouar-Rebai E, 2010, J CHILD NEUROL, V25, P770, DOI 10.1177/0883073809344351
   Mkaouar-Rebai E, 2009, PEDIATR NEUROL, V40, P437, DOI 10.1016/j.pediatrneurol.2009.01.004
   Mkaouar-Rebai E, 2009, MOL GENET METAB, V97, P179, DOI 10.1016/j.ymgme.2009.03.003
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   Nakamura M, 2010, J MED GENET, V47, P659, DOI 10.1136/jmg.2009.072058
   Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8
   OZAWA T, 1990, BIOCHEM BIOPH RES CO, V170, P830, DOI 10.1016/0006-291X(90)92166-W
   PAGE MM, 1976, Q J MED, V45, P505
   Pandya A, 1997, J MED GENET, V34, P169, DOI 10.1136/jmg.34.2.169
   PASTORES GM, 1994, AM J MED GENET, V50, P265, DOI 10.1002/ajmg.1320500310
   Pavicic WH, 2009, MUTAT RES-FUND MOL M, V670, P99, DOI 10.1016/j.mrfmmm.2009.07.009
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Pistilli D, 2003, HUM PATHOL, V34, P1058, DOI 10.1053/S0046-8177(03)00344-7
   POLYMEROPOULOS MH, 1994, NAT GENET, V8, P95, DOI 10.1038/ng0994-95
   Pozzan T, 2000, CELL CALCIUM, V28, P279, DOI 10.1054/ceca.2000.0166
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493
   Ramírez-Miranda A., 2008, Arch Soc Esp Oftalmol, V83, P155
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   Remes AM, 2005, NEUROLOGY, V64, P976, DOI 10.1212/01.WNL.0000154518.31302.ED
   Rigoli L, 2001, DIABETIC MED, V18, P334, DOI 10.1046/j.1464-5491.2001.00429-2.x
   Rötig A, 2010, DIABETES METAB, V36, P97, DOI 10.1016/j.diabet.2009.11.002
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   ROTIG A, 1993, J CLIN INVEST, V91, P1095, DOI 10.1172/JCI116267
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Sano M, 1996, J NEUROL, V243, P441, DOI 10.1007/BF00900496
   Santorelli FM, 1996, NEUROLOGY, V47, P1320, DOI 10.1212/WNL.47.5.1320
   Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Seneca S, 2001, ARCH NEUROL-CHICAGO, V58, P1113, DOI 10.1001/archneur.58.7.1113
   Sevior KB, 1998, AM J MED GENET, V75, P179, DOI 10.1002/(SICI)1096-8628(19980113)75:2<179::AID-AJMG11>3.0.CO;2-M
   Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905
   Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591
   Suzuki Y, 1997, DIABETES CARE, V20, P1138, DOI 10.2337/diacare.20.7.1138
   Tang XW, 2007, GENE, V393, P11, DOI 10.1016/j.gene.2007.01.001
   TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Toth T, 1998, CLIN GENET, V53, P210
   Tsukuda K, 1997, DIABETIC MED, V14, P1032, DOI 10.1002/(SICI)1096-9136(199712)14:12<1032::AID-DIA504>3.0.CO;2-Y
   Tucker EJ, 2010, CURR NEUROL NEUROSCI, V10, P277, DOI 10.1007/s11910-010-0112-8
   Usami S, 2000, J MED GENET, V37, P38, DOI 10.1136/jmg.37.1.38
   Uziel G, 2011, SEMIN FETAL NEONAT M, V16, P205, DOI 10.1016/j.siny.2011.04.003
   van den Ouweland JMW, 2000, EUR J HUM GENET, V8, P195, DOI 10.1038/sj.ejhg.5200444
   van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440
   Velho G, 1996, DIABETES, V45, P478, DOI 10.2337/diabetes.45.4.478
   Verhoeven K, 1999, EUR J HUM GENET, V7, P45, DOI 10.1038/sj.ejhg.5200247
   Vialettes BH, 1997, DIABETES CARE, V20, P1731, DOI 10.2337/diacare.20.11.1731
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wang XJ, 2008, PHARMACOGENET GENOM, V18, P1059, DOI 10.1097/FPC.0b013e3283131661
   Wilichowski E, 1998, J NEUROL SCI, V157, P206, DOI 10.1016/S0022-510X(98)00068-9
   Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807
   Yau Eric K. C., 2009, Hong Kong Medical Journal, V15, P374
   Zifa E, 2008, MITOCHONDRION, V8, P229, DOI 10.1016/j.mito.2008.04.001
NR 135
TC 9
Z9 10
U1 0
U2 16
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1940-1736
EI 1940-1744
J9 MITOCHONDR DNA
JI Mitochondrial DNA
PD JUN
PY 2013
VL 24
IS 3
BP 163
EP 178
DI 10.3109/19401736.2012.748045
PG 16
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 148FB
UT WOS:000319227400001
PM 23301511
DA 2024-11-01
ER

PT J
AU Horga, A
   Pitceathly, RDS
   Blake, JC
   Woodward, CE
   Zapater, P
   Fratter, C
   Mudanohwo, EE
   Plant, GT
   Houlden, H
   Sweeney, MG
   Hanna, MG
   Reilly, MM
AF Horga, Alejandro
   Pitceathly, Robert D. S.
   Blake, Julian C.
   Woodward, Catherine E.
   Zapater, Pedro
   Fratter, Carl
   Mudanohwo, Ese E.
   Plant, Gordon T.
   Houlden, Henry
   Sweeney, Mary G.
   Hanna, Michael G.
   Reilly, Mary M.
TI Peripheral neuropathy predicts nuclear gene defect in patients with
   mitochondrial ophthalmoplegia
SO BRAIN
LA English
DT Article
DE mitochondrial DNA; mitochondrial DNA deletion; peripheral neuropathy;
   POLG; progressive external ophthalmoplegia
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; KEARNS-SAYRE-SYNDROME; DNA
   DELETIONS; CLINICAL PHENOTYPES; ATAXIC NEUROPATHY; A3243G MUTATION;
   DISEASE; SPECTRUM; MELAS; ANT1
AB Progressive external ophthalmoplegia is a common clinical feature in mitochondrial disease caused by nuclear DNA defects and single, large-scale mitochondrial DNA deletions and is less frequently associated with point mutations of mitochondrial DNA. Peripheral neuropathy is also a frequent manifestation of mitochondrial disease, although its prevalence and characteristics varies considerably among the different syndromes and genetic aetiologies. Based on clinical observations, we systematically investigated whether the presence of peripheral neuropathy could predict the underlying genetic defect in patients with progressive external ophthalmoplegia. We analysed detailed demographic, clinical and neurophysiological data from 116 patients with genetically-defined mitochondrial disease and progressive external ophthalmoplegia. Seventy-eight patients (67%) had a single mitochondrial DNA deletion, 12 (10%) had a point mutation of mitochondrial DNA and 26 (22%) had mutations in either POLG, C10orf2 or RRM2B, or had multiple mitochondrial DNA deletions in muscle without an identified nuclear gene defect. Seventy-seven patients had neurophysiological studies; of these, 16 patients (21%) had a large-fibre peripheral neuropathy. The prevalence of peripheral neuropathy was significantly lower in patients with a single mitochondrial DNA deletion (2%) as compared to those with a point mutation of mitochondrial DNA or with a nuclear DNA defect (44% and 52%, respectively; P < 0.001). Univariate analyses revealed significant differences in the distribution of other clinical features between genotypes, including age at disease onset, gender, family history, progressive external ophthalmoplegia at clinical presentation, hearing loss, pigmentary retinopathy and extrapyramidal features. However, binomial logistic regression analysis identified peripheral neuropathy as the only independent predictor associated with a nuclear DNA defect (P = 0.002; odds ratio 8.43, 95% confidence interval 2.24-31.76). Multinomial logistic regression analysis identified peripheral neuropathy, family history and hearing loss as significant predictors of the genotype, and the same three variables showed the highest performance in genotype classification in a decision tree analysis. Of these variables, peripheral neuropathy had the highest specificity (91%), negative predictive value (83%) and positive likelihood ratio (5.87) for the diagnosis of a nuclear DNA defect. These results indicate that peripheral neuropathy is a rare finding in patients with single mitochondrial DNA deletions but that it is highly predictive of an underlying nuclear DNA defect. This observation may facilitate the development of diagnostic algorithms. We suggest that nuclear gene testing may enable a more rapid diagnosis and avoid muscle biopsy in patients with progressive external ophthalmoplegia and peripheral neuropathy.
C1 [Horga, Alejandro; Pitceathly, Robert D. S.; Houlden, Henry; Hanna, Michael G.; Reilly, Mary M.] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England.
   [Horga, Alejandro; Pitceathly, Robert D. S.; Plant, Gordon T.; Houlden, Henry; Hanna, Michael G.; Reilly, Mary M.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
   [Blake, Julian C.] Norfolk & Norwich Univ Hosp, Dept Clin Neurophysiol, Norwich NR4 7UY, Norfolk, England.
   [Woodward, Catherine E.; Mudanohwo, Ese E.; Sweeney, Mary G.] Natl Hosp Neurol & Neurosurg, Neurogenet Unit, London WC1N 3BG, England.
   [Zapater, Pedro] Hosp Gen Univ, Clin Pharmacol Sect, Alicante 03010, Spain.
   [Fratter, Carl] Oxford Univ Hosp NHS Trust, Oxford Med Genet Labs, Oxford OX3 7LE, England.
C3 University of London; University College London; University of London;
   University College London; UCL Medical School; University College London
   Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospitals
   NHS Foundation Trust; Norfolk & Norwich University Hospital; University
   of London; University College London; UCL Medical School; University
   College London Hospitals NHS Foundation Trust; General University
   Hospital of Alicante; Oxford University Hospitals NHS Foundation Trust
RP Horga, A (corresponding author), UCL Inst Neurol, MRC Ctr Neuromuscular Dis, Queen Sq, London WC1N 3BG, England.
EM a.horga@ucl.ac.uk
RI Reilly, Mary/C-8482-2013; Houlden, Henry/C-1532-2008; Horga,
   Alejandro/AAA-1086-2019; Zapater, Pedro/H-7277-2017
OI Houlden, Henry/0000-0002-2866-7777; Zapater, Pedro/0000-0001-7927-858X;
   Hanna, Michael/0000-0003-0825-4075; Reilly, Mary/0000-0003-0686-905X;
   Horga, Alejandro/0000-0002-2120-2213; Pitceathly,
   Robert/0000-0002-6123-4551
FU Medical Research Council (MRC) Centre [G0601943]; UK NHS Specialised
   Service for Rare Mitochondrial Diseases of Adults and Children; National
   Institute for Health Research University College London (UCL)
   Hospitals/UCL Comprehensive Biomedical Research Centre; Department of
   Health's National Institute for Health Research Biomedical Research
   Centres funding scheme; National Institute of Neurological Disorders and
   Stroke/Office of Rare Diseases [1U54NS065712-01]; Myositis Support
   Group; Caja Madrid Foundation, Spain; MRC [MR/K000608/1, MR/J004758/1,
   G0601943, G108/638, G0802760, G1001253] Funding Source: UKRI
FX This study was supported by a Medical Research Council (MRC) Centre
   grant (G0601943), the UK NHS Specialised Service for Rare Mitochondrial
   Diseases of Adults and Children, and the National Institute for Health
   Research University College London (UCL) Hospitals/UCL Comprehensive
   Biomedical Research Centre. This work was undertaken at UCL
   Hospitals/UCL, which received a proportion of funding from the
   Department of Health's National Institute for Health Research Biomedical
   Research Centres funding scheme. MMR received grant funding from the
   National Institute of Neurological Disorders and Stroke/Office of Rare
   Diseases (1U54NS065712-01). MGH is also supported by the Myositis
   Support Group. AH received a research training fellowship from Caja
   Madrid Foundation, Spain.
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Boles RG, 1998, EUR J PEDIATR, V157, P643, DOI 10.1007/s004310050902
   BROCKINGTON M, 1995, J NEUROL SCI, V131, P78, DOI 10.1016/0022-510X(95)00091-F
   Chinnery P F., 2010, Disorders of Voluntary Muscle, P363
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   EYMARD B, 1991, REV NEUROL, V147, P508
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Herrmann DN, 2002, MUSCLE NERVE, V26, P232, DOI 10.1002/mus.10204
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, NEUROLOGY, V66, P1439, DOI 10.1212/01.wnl.0000210486.32196.24
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   Caballero PEJ, 2007, NEUROLOGIST, V13, P33, DOI 10.1097/01.nrl.0000252953.49721.f5
   KAGEYAMA Y, 1991, ACTA NEUROPATHOL, V83, P99, DOI 10.1007/BF00294438
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kärppä M, 2003, J NEUROL, V250, P216, DOI 10.1007/s00415-003-0981-8
   Kaufmann P, 2006, ARCH NEUROL-CHICAGO, V63, P746, DOI 10.1001/archneur.63.5.746
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Lee Andrew G, 2002, Curr Neurol Neurosci Rep, V2, P413, DOI 10.1007/s11910-002-0067-5
   Liu CH, 2012, J FORMOS MED ASSOC, V111, P489, DOI 10.1016/j.jfma.2011.06.014
   LOVE S, 1993, J PATHOL, V170, P9, DOI 10.1002/path.1711700103
   Martikainen MH, 2012, NEUROEPIDEMIOLOGY, V38, P114, DOI 10.1159/000336112
   Molnar M, 1996, ACTA NEUROPATHOL, V91, P654, DOI 10.1007/s004010050480
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Neeve VCM, 2012, BRAIN, V135, P3614, DOI 10.1093/brain/aws298
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Park KP, 2011, J CLIN NEUROL, V7, P25, DOI 10.3988/jcn.2011.7.1.25
   PARTANEN J, 1995, NEW ENGL J MED, V333, P89, DOI 10.1056/NEJM199507133330203
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   PONZETTO C, 1990, J NEUROL SCI, V96, P207, DOI 10.1016/0022-510X(90)90133-8
   Pulkes T, 2003, NEUROLOGY, V61, P1144, DOI 10.1212/01.WNL.0000090465.27024.3D
   Raffelsberger T, 2001, NEUROLOGY, V57, P2298, DOI 10.1212/WNL.57.12.2298
   Rahman S, 2009, J NEUROL NEUROSUR PS, V80, P943, DOI 10.1136/jnnp.2008.158279
   REICHMANN H, 1991, EUR NEUROL, V31, P108, DOI 10.1159/000116656
   Rodríguez-Hernández M, 2000, REV NEUROLOGIA, V30, P1001, DOI 10.33588/rn.3011.2000037
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Smits BW, 2007, J NEUROL, V254, P1614, DOI 10.1007/s00415-007-0608-6
   SWEENEY MG, 1993, Q J MED, V86, P435
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 52
TC 29
Z9 30
U1 0
U2 9
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD DEC
PY 2014
VL 137
BP 3200
EP 3212
DI 10.1093/brain/awu279
PN 12
PG 13
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA AX2GJ
UT WOS:000346761200023
PM 25281868
OA Green Published, hybrid, Green Submitted
DA 2024-11-01
ER

PT J
AU Baqri, RM
   Turner, BA
   Rheuben, MB
   Hammond, BD
   Kaguni, LS
   Miller, KE
AF Baqri, Rehan M.
   Turner, Brittany A.
   Rheuben, Mary B.
   Hammond, Bradley D.
   Kaguni, Laurie S.
   Miller, Kyle E.
TI Disruption of Mitochondrial DNA Replication in <i>Drosophila</i>
   Increases Mitochondrial Fast Axonal Transport <i>In Vivo</i>
SO PLOS ONE
LA English
DT Article
ID MARIE-TOOTH-DISEASE; POLYMERASE-GAMMA; OXIDATIVE-PHOSPHORYLATION;
   CATALYTIC SUBUNIT; ACCESSORY SUBUNIT; ALPERS-SYNDROME; POLG MUTATIONS;
   KINESIN; NEURONS; MELANOGASTER
AB Mutations in mitochondrial DNA polymerase (pol gamma) cause several progressive human diseases including Parkinson's disease, Alper's syndrome, and progressive external ophthalmoplegia. At the cellular level, disruption of pol gamma leads to depletion of mtDNA, disrupts the mitochondrial respiratory chain, and increases susceptibility to oxidative stress. Although recent studies have intensified focus on the role of mtDNA in neuronal diseases, the changes that take place in mitochondrial biogenesis and mitochondrial axonal transport when mtDNA replication is disrupted are unknown. Using high-speed confocal microscopy, electron microscopy and biochemical approaches, we report that mutations in pol gamma deplete mtDNA levels and lead to an increase in mitochondrial density in Drosophila proximal nerves and muscles, without a noticeable increase in mitochondrial fragmentation. Furthermore, there is a rise in flux of bidirectional mitochondrial axonal transport, albeit with slower kinesin-based anterograde transport. In contrast, flux of synaptic vesicle precursors was modestly decreased in pol gamma-alpha mutants. Our data indicate that disruption of mtDNA replication does not hinder mitochondrial biogenesis, increases mitochondrial axonal transport, and raises the question of whether high levels of circulating mtDNA-deficient mitochondria are beneficial or deleterious in mtDNA diseases.
RP Baqri, RM (corresponding author), Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA.
EM kmiller@msu.edu
OI Miller, Kyle/0000-0003-0401-4736
FU NIGMS NIH HHS [R01 GM045295, GM45295] Funding Source: Medline
CR Adán C, 2008, J BIOL CHEM, V283, P12333, DOI 10.1074/jbc.M801342200
   Amiri M, 2008, DEV NEUROBIOL, V68, P1348, DOI 10.1002/dneu.20668
   Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013
   Atlante A, 2005, BBA-BIOENERGETICS, V1708, P50, DOI 10.1016/j.bbabio.2005.01.009
   Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   Betts J, 2004, NEUROCHEM RES, V29, P505, DOI 10.1023/B:NERE.0000014821.07269.8d
   BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0
   Chang DTW, 2006, NEUROBIOL DIS, V22, P388, DOI 10.1016/j.nbd.2005.12.007
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883
   De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226
   DIMAURO S, 1987, J INHERIT METAB DIS, V10, P113, DOI 10.1007/BF01812852
   Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777
   Escobar-Khondiker M, 2007, J NEUROSCI, V27, P7827, DOI 10.1523/JNEUROSCI.1644-07.2007
   Ferreirinha F, 2004, J CLIN INVEST, V113, P231, DOI 10.1172/JCI200420138
   Fisher ME, 2001, P NATL ACAD SCI USA, V98, P7748, DOI 10.1073/pnas.141080498
   FRIEDE RL, 1977, J PHYSIOL-LONDON, V265, P507, DOI 10.1113/jphysiol.1977.sp011727
   Gajewski CD, 2003, MOL BIOL CELL, V14, P3628, DOI 10.1091/mbc.E02-12-0796
   GODDARD JM, 1978, P NATL ACAD SCI USA, V75, P3886, DOI 10.1073/pnas.75.8.3886
   Goldstein AYN, 2008, CURR OPIN NEUROBIOL, V18, P495, DOI 10.1016/j.conb.2008.10.003
   Goldstein LSB, 2003, NEURON, V40, P415, DOI 10.1016/S0896-6273(03)00630-5
   GOTT AL, 1990, HUM REPROD, V5, P104, DOI 10.1093/oxfordjournals.humrep.a137028
   Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100
   Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4
   Heddi A, 1999, J BIOL CHEM, V274, P22968, DOI 10.1074/jbc.274.33.22968
   Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007
   HOLLENBECK PJ, 1985, CELL BIOL INT REP, V9, P193, DOI 10.1016/0309-1651(85)90094-3
   Iyengar B, 1999, GENETICS, V153, P1809
   Iyengar B, 2002, P NATL ACAD SCI USA, V99, P4483, DOI 10.1073/pnas.072664899
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717
   Klopfenstein DR, 2004, MOL BIOL CELL, V15, P3729, DOI 10.1091/mbc.E04-04-0326
   Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417
   Kundu M, 2005, CELL DEATH DIFFER, V12, P1484, DOI 10.1038/sj.cdd.4401780
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Lewis DL, 1996, J BIOL CHEM, V271, P23389, DOI 10.1074/jbc.271.38.23389
   Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201
   Liu D, 2006, NEUROMOL MED, V8, P389, DOI 10.1385/NMM:8:3:389
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Mansouri A, 2003, HEPATOLOGY, V38, P715, DOI 10.1053/jhep.2003.50353
   MARTINEZAZORIN F, 2007, J NEUROCHEM
   McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200
   Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130
   Miller KE, 2005, CURR BIOL, V15, P684, DOI 10.1016/j.cub.2005.02.061
   Mironov SL, 2007, BIOPHYS J, V92, P2944, DOI 10.1529/biophysj.106.092981
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   OCHS S, 1971, J NEUROCHEM, V18, P107, DOI 10.1111/j.1471-4159.1971.tb00172.x
   PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273
   Piccioni F, 2002, FASEB J, V16, P1418, DOI 10.1096/fj.01-1035fje
   PILLING AD, 2006, MOL BIOL CELL
   Samuels DC, 2006, IUBMB LIFE, V58, P403, DOI 10.1080/15216540600791571
   Sanyal S, 2009, GENE EXPR PATTERNS, V9, P371, DOI 10.1016/j.gep.2009.01.002
   SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177
   SHOFFNER JM, 1994, ANNU REV NUTR, V14, P535, DOI 10.1146/annurev.nu.14.070194.002535
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0
   VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4
   Verburg J, 2008, J NEUROSCI, V28, P8306, DOI 10.1523/JNEUROSCI.2614-08.2008
   Wang YX, 1997, J BIOL CHEM, V272, P13640, DOI 10.1074/jbc.272.21.13640
NR 63
TC 31
Z9 33
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 17
PY 2009
VL 4
IS 11
AR e7874
DI 10.1371/journal.pone.0007874
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 520OG
UT WOS:000271854200020
PM 19924234
OA Green Published, gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Stuart, GR
   Santos, JH
   Strand, MK
   Van Houten, B
   Copeland, WC
AF Stuart, GR
   Santos, JH
   Strand, MK
   Van Houten, B
   Copeland, WC
TI Mitochondrial and nuclear DNA defects in <i>Saccharomyces cerevisiae</i>
   with mutations in DNA polymerase γ associated with progressive external
   ophthalmoplegia
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID ACCESSORY SUBUNIT; MULTIPLE DELETIONS; YEAST MITOCHONDRIA; CATALYTIC
   SUBUNIT; GENOME STABILITY; DAMAGE; REPAIR; MTDNA; POLG; GENE
AB A number of nuclear mutations have been identified in a variety of mitochondrial diseases including progressive external ophthalmoplegia (PEO), Alpers syndrome and other neuromuscular and oxidative phosphorylation defects. More than 50 mutations have been identified in POLG, which encodes the human mitochondrial DNA (mtDNA) polymerase gamma, PEO and Alpers patients. To rapidly characterize the effects of these mutations, we have developed a versatile system that enables the consequences of homologous mutations, introduced in situ into the yeast mtDNA polymerase gene MIP1, to be evaluated in vivo in haploid and diploid cells. Overall, distinct phenotypes for expression of each of the mip1-PEO mutations were observed, including respiration-defective cells with decreased viability, dominant-negative mutant polymerases, elevated levels of mitochondrial and nuclear DNA damage and chromosomal mutations. Mutations in the polymerase domain caused the most severe phenotype accompanied by loss of mtDNA and cell viability, whereas the mutation in the exonuclease domain showed mild dominance with loss of mtDNA. Interestingly, the linker region mutation caused elevated mitochondrial and nuclear DNA damage. The cellular processes contributing to these observations in the mutant yeast cells are potentially relevant to understanding the pathologies observed in human mitochondrial disease patients.
C1 NIEHS, Mol Genet Lab, Res Triangle Pk, NC 27709 USA.
   Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS); Duke University
RP NIEHS, Mol Genet Lab, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
RI Van Houten, Bennett/K-2284-2019; Santos, João/G-8387-2017; Copeland,
   William/C-4242-2019
OI Stuart, Victoria/0000-0002-2927-6719; Copeland,
   William/0000-0002-0359-0953
FU Intramural NIH HHS Funding Source: Medline
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   [Anonymous], 1991, Methods Enzymol, V194, P1
   Ayala-Torres S, 2000, METHODS, V22, P135, DOI 10.1006/meth.2000.1054
   Barrientos A, 2003, IUBMB LIFE, V55, P83, DOI 10.1080/1521654031000098122
   Bendich AJ, 1996, J MOL BIOL, V255, P564, DOI 10.1006/jmbi.1996.0048
   Bitterman KJ, 2003, MICROBIOL MOL BIOL R, V67, P376, DOI 10.1128/MMBR.67.3.376-399.2003
   BYRNE E, 1991, REV NEUROL, V147, P532
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Chen KH, 1998, NUCLEIC ACIDS RES, V26, P2001, DOI 10.1093/nar/26.8.2001
   Chen XJ, 1999, MOL GEN GENET, V262, P898, DOI 10.1007/s004380051156
   Copeland WC, 2003, ACTA BIOCHIM POL, V50, P155
   Fan L, 2001, BIOCHEMISTRY-US, V40, P4780, DOI 10.1021/bi010102h
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   FLURY F, 1976, GENETICS, V83, P645
   Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108
   Foury F, 2002, CURR OPIN CHEM BIOL, V6, P106, DOI 10.1016/S1367-5931(01)00276-9
   FOURY F, 1989, J BIOL CHEM, V264, P20552
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   Jazayeri M, 2003, J BIOL CHEM, V278, P9823, DOI 10.1074/jbc.M211730200
   Karthikeyan G, 2005, DNA REPAIR, V4, P141, DOI 10.1016/j.dnarep.2004.07.004
   Karthikeyan G, 2003, HUM MOL GENET, V12, P3331, DOI 10.1093/hmg/ddg349
   Karthikeyan G, 2002, HUM MOL GENET, V11, P1351, DOI 10.1093/hmg/11.11.1351
   Kaukonen JA, 1996, AM J HUM GENET, V58, P763
   LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080
   Lecrenier N, 2000, GENE, V246, P37, DOI 10.1016/S0378-1119(00)00107-4
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   Lucas P, 2004, MITOCHONDRION, V4, P13, DOI 10.1016/j.mito.2004.04.001
   Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   MALESZKA R, 1991, EMBO J, V10, P3923, DOI 10.1002/j.1460-2075.1991.tb04962.x
   Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Otsuga D, 1998, J CELL BIOL, V143, P333, DOI 10.1083/jcb.143.2.333
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Rasmussen AK, 2003, NUCLEIC ACIDS RES, V31, P3909, DOI 10.1093/nar/gkg446
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Santos Janine H, 2002, Methods Mol Biol, V197, P159, DOI 10.1385/1-59259-284-8:159
   Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200
   Shadel GS, 1999, AM J HUM GENET, V65, P1230, DOI 10.1086/302630
   Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X
   SHERMAN F, 1991, METHOD ENZYMOL, V194, P21
   Sherman F., 1986, METHODS YEAST GENETI
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837
   Strand MK, 2003, EUKARYOT CELL, V2, P809, DOI 10.1128/EC.2.4.809-820.2003
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859
   Trancíková A, 2004, FEMS YEAST RES, V5, P149, DOI 10.1016/j.femsyr.2004.06.014
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   VANHOUTEN B, 2006, IN PRESS DNA REPAIR
   Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393
   WHELAN WL, 1979, GENETICS, V91, P35
   Williamson D, 2002, NAT REV GENET, V3, P475, DOI 10.1038/nrg814
   Williamson D H, 1979, Methods Enzymol, V56, P728
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
NR 62
TC 58
Z9 64
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JAN 15
PY 2006
VL 15
IS 2
BP 363
EP 374
DI 10.1093/hmg/ddi454
PG 12
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 002RZ
UT WOS:000234630400018
PM 16368709
OA Bronze
DA 2024-11-01
ER

PT J
AU Jeppesen, TD
   Orngreen, MC
   Van Hall, G
   Vissing, J
AF Jeppesen, Tina D.
   Orngreen, Mette C.
   Van Hall, Gerrit
   Vissing, John
TI Lactate metabolism during exercise in patients with mitochondrial
   myopathy
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondrial myopathy; Lactate kinetics; Lactate acidosis; Premature
   fatigue
ID SKELETAL-MUSCLE; TRIACYLGLYCEROL INFUSION; DICHLOROACETATE; ENDURANCE;
   CAPACITY; ACCLIMATIZATION; PERFORMANCE; DISPOSAL; MUTATION; KINETICS
AB Patients with mitochondrial DNA mutations often have elevated plasma lactate at rest and during exercise, but it is unknown whether the high lactate levels are caused by a high production, an impaired oxidation or a combination. We studied lactate kinetics in 10 patients with mtDNA mutations and 10 matched healthy control subjects at rest and during cycle exercise with a combination of femoral arterio-venous differences of lactate, and lactate tracer dilution methodology. During exercise, lactate concentration and production rates were several-fold higher in patients, but despite mitochondrial dysfunction, lactate was oxidized in muscle to the same extent as in healthy control subjects. This surprisingly high ability to burn lactate in working muscle with defective mitochondria, probably relates to the variability of oxidative capacity among muscle fibers. The data suggests that lactate is not solely an indicator of impaired oxidative capacity, but an important fuel for oxidative metabolism, even in muscle with severely impaired mitochondrial function. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Jeppesen, Tina D.; Orngreen, Mette C.; Vissing, John] Univ Copenhagen, Rigshosp, Dept Neurol, Neuromuscular Res Unit,Sect 3342, DK-2100 Copenhagen, Denmark.
   [Van Hall, Gerrit] Univ Copenhagen, Rigshosp, Dept Biomed Sci, DK-2100 Copenhagen, Denmark.
C3 Rigshospitalet; University of Copenhagen; University of Copenhagen;
   Rigshospitalet
RP Jeppesen, TD (corresponding author), Univ Copenhagen, Rigshosp, Neuromuscular Res Unit, Sect 3342, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
EM Tina@Dysgaard.dk
RI Vissing, John/IUN-4271-2023; Jeppesen, Tina/AAV-7195-2020
OI Orngreen, Mette Cathrine/0000-0002-2991-6309; van Hall,
   Gerrit/0000-0002-2519-8127
CR Bangsbo J, 2000, AM J PHYSIOL-REG I, V279, pR899, DOI 10.1152/ajpregu.2000.279.3.R899
   Bergman BC, 1999, J APPL PHYSIOL, V87, P1684, DOI 10.1152/jappl.1999.87.5.1684
   BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92
   BROOKS GA, 1992, J APPL PHYSIOL, V72, P2435, DOI 10.1152/jappl.1992.72.6.2435
   CONSOLI A, 1990, J CLIN INVEST, V86, P2038, DOI 10.1172/JCI114940
   CONSOLI A, 1990, AM J PHYSIOL, V259, pE677, DOI 10.1152/ajpendo.1990.259.5.E677
   de Meer K, 2005, J INHERIT METAB DIS, V28, P95, DOI 10.1007/s10545-005-1485-8
   Dengler R, 1996, MUSCLE NERVE, V19, P456, DOI 10.1002/(SICI)1097-4598(199604)19:4<456::AID-MUS5>3.0.CO;2-B
   DESTEFANO N, 1995, NEUROLOGY, V45, P1193, DOI 10.1212/WNL.45.6.1193
   Duncan GE, 2004, J CLIN ENDOCR METAB, V89, P1733, DOI 10.1210/jc.2003-031684
   Finsterer J, 1998, J NEUROL SCI, V159, P176, DOI 10.1016/S0022-510X(98)00170-1
   Gladden LB, 2000, MED SCI SPORT EXER, V32, P753, DOI 10.1097/00005768-200004000-00006
   Grassi B, 2005, MED SCI SPORT EXER, V37, P1567, DOI 10.1249/01.mss.0000177472.67419.0a
   Haas Richard H., 1998, Biofactors, V7, P259
   Hammans SR, 2004, MITOCHONDRIAL DISORD, P49
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Jeppesen TD, 2009, ARCH NEUROL-CHICAGO, V66, P365, DOI 10.1001/archneurol.2009.24
   KARLSSON J, 1971, J APPL PHYSIOL, V31, P203, DOI 10.1152/jappl.1971.31.2.203
   Krustrup P, 2004, J PHYSIOL-LONDON, V559, P335, DOI 10.1113/jphysiol.2004.062232
   Lamb GD, 2006, J APPL PHYSIOL, V100, P1410, DOI 10.1152/japplphysiol.00023.2006
   LUDVIK B, 1993, PFLUG ARCH EUR J PHY, V423, P251, DOI 10.1007/BF00374403
   MAZZEO RS, 1986, J APPL PHYSIOL, V60, P232, DOI 10.1152/jappl.1986.60.1.232
   Roef MJ, 2002, AM J CLIN NUTR, V75, P228, DOI 10.1093/ajcn/75.2.228
   Roef MJ, 2002, AM J CLIN NUTR, V75, P237, DOI 10.1093/ajcn/75.2.237
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x
   Taivassalo T, 1996, NEUROLOGY, V47, P529, DOI 10.1212/WNL.47.2.529
   van Hall G, 2003, AM J PHYSIOL-ENDOC M, V284, pE193, DOI 10.1152/ajpendo.00273.2002
   Van Hall G, 2002, AM J PHYSIOL-ENDOC M, V283, pE1203, DOI 10.1152/ajpendo.00134.2001
   van Hall G, 2001, AM J PHYSIOL-ENDOC M, V283, P1203
   van Hall G, 2010, ACTA PHYSIOL, V199, P499, DOI 10.1111/j.1748-1716.2010.02122.x
   Vissing J, 1998, NEUROLOGY, V50, P1875, DOI 10.1212/WNL.50.6.1875
   Vissing J, 2001, ANN NEUROL, V49, P672, DOI 10.1002/ana.1026
   Wolfe RR., 1992, RADIOACTIVE STABLE I
NR 35
TC 18
Z9 18
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD AUG
PY 2013
VL 23
IS 8
BP 629
EP 636
DI 10.1016/j.nmd.2013.05.007
PG 8
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 232QU
UT WOS:000325509900004
PM 23838278
OA Bronze
DA 2024-11-01
ER

PT J
AU Russell, OM
   Gorman, GS
   Lightowlers, RN
   Turnbull, DM
AF Russell, Oliver M.
   Gorman, Grainne S.
   Lightowlers, Robert N.
   Turnbull, Doug M.
TI Mitochondrial Diseases: Hope for the Future
SO CELL
LA English
DT Review
ID ACTIVATED PROTEIN-KINASE; GENE-THERAPY; MOUSE MODEL; SELECTIVE
   ELIMINATION; ALLOTOPIC EXPRESSION; NAD(+) METABOLISM; DNA HETEROPLASMY;
   MTDNA MUTATION; NUCLEAR; MYOPATHY
AB Mitochondrial diseases are clinically heterogeneous disorders caused by a wide spectrum of mutations in genes encoded by either the nuclear or the mitochondrial genome. Treatments for mitochondrial diseases are currently focused on symptomatic management rather than improving the biochemical defect caused by a particular mutation. This review focuses on the latest advances in the development of treatments for mitochondrial disease, both small molecules and gene therapies, as well as methods to prevent transmission of mitochondrial disease through the germline.
C1 [Russell, Oliver M.; Gorman, Grainne S.; Lightowlers, Robert N.; Turnbull, Doug M.] Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Russell, Oliver M.; Gorman, Grainne S.; Turnbull, Doug M.] Newcastle Univ, Fac Med Sci, Clin & Translat Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Gorman, Grainne S.] NuTH NHS Fdn Trust, NIHR Newcastle BRC, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Lightowlers, Robert N.] Newcastle Univ, Fac Med Sci, Biosci Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle Upon
   Tyne Hospitals NHS Foundation Trust; Newcastle University - UK
RP Lightowlers, RN; Turnbull, DM (corresponding author), Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Turnbull, DM (corresponding author), Newcastle Univ, Fac Med Sci, Clin & Translat Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Lightowlers, RN (corresponding author), Newcastle Univ, Fac Med Sci, Biosci Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.lightowlers@newcastle.ac.uk; doug.turnbull@newcastle.ac.uk
OI Russell, Oliver/0000-0002-9414-9193
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; MRC Centre
   for Ageing and Vitality [MR/L016354/1]; MRC Centre for Translational
   Research in Neuromuscular Disease Mitochondrial Disease Patient Cohort
   [G0800674]; EU Marie Sklodowska-Curie ITN [721757]; UK NIHR Biomedical
   Research Centre in Age and Age Related Diseases; Lily Foundation; UK NHS
   Specialist Commissioners "Rare Mitochondrial Disorders of Adults and
   Children'' Service; Marie Curie Actions (MSCA) [721757] Funding Source:
   Marie Curie Actions (MSCA); MRC [MR/L016354/1, G0800674] Funding Source:
   UKRI
FX This work was funded by Wellcome Centre for Mitochondrial Research
   (203105/Z/16/Z); MRC Centre for Ageing and Vitality (MR/L016354/1); MRC
   Centre for Translational Research in Neuromuscular Disease Mitochondrial
   Disease Patient Cohort (G0800674); the EU Marie Sklodowska-Curie ITN
   (721757); the UK NIHR Biomedical Research Centre in Age and Age Related
   Diseases award to the Newcastle upon Tyne Hospitals NHS Foundation
   Trust; The Lily Foundation; and the UK NHS Specialist Commissioners
   "Rare Mitochondrial Disorders of Adults and Children'' Service.
CR Alexeyev MF, 2008, GENE THER, V15, P516, DOI 10.1038/sj.gt.2008.11
   Andreux PA, 2019, NAT METAB, V1, P595, DOI 10.1038/s42255-019-0073-4
   Augustine EF, 2013, J CHILD NEUROL, V28, P1142, DOI 10.1177/0883073813495959
   Avula S, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0292-7
   Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   Barrow JJ, 2016, MOL CELL, V64, P163, DOI 10.1016/j.molcel.2016.08.023
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Bax BE, 2019, J CLIN MED, V8, DOI 10.3390/jcm8081096
   Besouw M, 2013, DRUG DISCOV TODAY, V18, P785, DOI 10.1016/j.drudis.2013.02.003
   Birk AV, 2013, J AM SOC NEPHROL, V24, P1250, DOI 10.1681/ASN.2012121216
   Cantó C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023
   Cantó C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   Cejudo P, 2005, MUSCLE NERVE, V32, P342, DOI 10.1002/mus.20368
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Chatfield KC, 2019, JACC-BASIC TRANSL SC, V4, P147, DOI 10.1016/j.jacbts.2018.12.005
   Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061
   Civiletto G, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708799
   Colella M, 2018, ACS APPL MATER INTER, V10, P40001, DOI 10.1021/acsami.8b15942
   CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x
   Desai S, 2018, EXP BIOL MED, V243, P554, DOI 10.1177/1535370217752351
   Dillon LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044335
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   Dinkova-Kostova AT, 2015, FREE RADICAL BIO MED, V88, P179, DOI 10.1016/j.freeradbiomed.2015.04.036
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371
   Ehinger JK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12317
   El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223
   Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013
   Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917
   Ferrari M, 2017, P NATL ACAD SCI USA, V114, pE4241, DOI 10.1073/pnas.1621511114
   Field Marilyn J, 2010, Rare Diseases and Orphan Products: Accelerating Research and Development
   Fightaging, 2019, MOR SER TRIAL FAIL G
   Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001
   Garone C, 2018, BIOCHEM SOC T, V46, P1247, DOI 10.1042/BST20180134
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Gerards M, 2011, BRAIN, V134, P210, DOI 10.1093/brain/awq273
   Golubitzky A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026883
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Gorman GS, 2018, LANCET, V392, P1191, DOI 10.1016/S0140-6736(18)31868-3
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Greenfield A, 2017, NAT BIOTECHNOL, V35, P1059, DOI 10.1038/nbt.3997
   Guy J, 2017, OPHTHALMOLOGY, V124, P1621, DOI 10.1016/j.ophtha.2017.05.016
   Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   Hellebrekers DMEI, 2012, HUM REPROD UPDATE, V18, P341, DOI 10.1093/humupd/dms008
   Hirano M, 2012, BBA-GEN SUBJECTS, V1820, P625, DOI 10.1016/j.bbagen.2012.01.006
   Hudry E, 2019, NEURON, V101, P839, DOI 10.1016/j.neuron.2019.02.017
   Hyslop LA, 2016, NATURE, V534, P383, DOI [10.1038/nature183030, 10.1038/nature18303]
   Jäger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Jain IH, 2019, CELL METAB, V30, P824, DOI 10.1016/j.cmet.2019.07.006
   Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Johnson SC, 2016, ONCOTARGET, V7, P44876, DOI 10.18632/oncotarget.10381
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Kandul NP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13100
   Katsyuba E, 2018, NATURE, V563, P354, DOI 10.1038/s41586-018-0645-6
   Katsyuba E, 2017, EMBO J, V36, P2670, DOI 10.15252/embj.201797135
   Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Klopstock T, 2013, BRAIN, V136, DOI 10.1093/brain/aws279
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Koene S, 2018, J INHERIT METAB DIS, V41, P1267, DOI 10.1007/s10545-018-0229-5
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   Lee CF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39419-4
   Lott Marie T, 2013, CURRENT PROTOCOLS BI
   Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270
   Madsen KL, 2020, NEUROLOGY, V94, pE687, DOI 10.1212/WNL.0000000000008861
   MCGRATH J, 1983, J EXP ZOOL, V228, P355, DOI 10.1002/jez.1402280218
   McWilliams TG, 2018, CELL METAB, V27, P439, DOI 10.1016/j.cmet.2017.12.008
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110
   Murphy MP, 2018, NAT REV DRUG DISCOV, V17, P865, DOI 10.1038/nrd.2018.174
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Newman Jane, 2015, J Neuromuscul Dis, V2, P151
   Ng Yi Shiau, 2019, Wellcome Open Res, V4, P201, DOI 10.12688/wellcomeopenres.15599.1
   Noe N, 2013, MITOCHONDRION, V13, P417, DOI 10.1016/j.mito.2012.12.003
   Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607
   Parikh S, 2019, NEUROMUSCULAR DISORD, V29, P895, DOI 10.1016/j.nmd.2019.09.012
   Patgiri A, 2020, NAT BIOTECHNOL, V38, P309, DOI 10.1038/s41587-019-0377-7
   Perales-Clemente E, 2011, NUCLEIC ACIDS RES, V39, P225, DOI 10.1093/nar/gkq769
   Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad
   Pickett SJ, 2019, NEW ENGL J MED, V380, P1971, DOI 10.1056/NEJMc1808565
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Poulton J, 2019, NEUROMUSCULAR DISORD, V29, P725, DOI 10.1016/j.nmd.2019.08.004
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   Repp BM, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0784-8
   Robinson BH, 2006, MOL GENET METAB, V89, P3, DOI 10.1016/j.ymgme.2006.05.015
   Robledinos-Antón N, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9372182
   Rudolph G, 2013, J NEURO-OPHTHALMOL, V33, P30, DOI 10.1097/WNO.0b013e318272c643
   Ryan E, 2006, Ir Med J, V99, P262
   Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132
   Saada A, 2019, EBIOMEDICINE, V47, P14, DOI 10.1016/j.ebiom.2019.08.005
   Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Schober P, 2018, ANESTH ANALG, V126, P1068, DOI 10.1213/ANE.0000000000002798
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093
   Steffann J, 2007, J MED GENET, V44, P664, DOI 10.1136/jmg.2006.048553
   Steffann J, 2018, CELL STEM CELL, V22, P481, DOI 10.1016/j.stem.2018.01.004
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Szeto HH, 2014, BRIT J PHARMACOL, V171, P2029, DOI 10.1111/bph.12461
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   Taylor RW, 2001, ADV DRUG DELIVER REV, V49, P121, DOI 10.1016/S0169-409X(01)00130-2
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   To TL, 2019, CELL, V179, P1222, DOI 10.1016/j.cell.2019.10.032
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Valenci I, 2015, MITOCHONDRION, V20, P64, DOI 10.1016/j.mito.2014.11.001
   van de Weijer T, 2015, DIABETES, V64, P1193, DOI 10.2337/db14-0667
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Wenz T, 2016, CELL METAB, V24, P889, DOI 10.1016/j.cmet.2016.11.006
   Wenz T, 2016, P NATL ACAD SCI USA, V113, pE8502, DOI 10.1073/pnas.1619713114
   Whitaker RM, 2016, ANNU REV PHARMACOL, V56, P229, DOI 10.1146/annurev-pharmtox-010715-103155
   Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Yang S, 2016, EBIOMEDICINE, V10, P258, DOI 10.1016/j.ebiom.2016.07.002
   Yang Y, 2018, PROTEIN CELL, V9, P283, DOI 10.1007/s13238-017-0499-y
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
   Zhang J, 2017, REPROD BIOMED ONLINE, V34, P361, DOI 10.1016/j.rbmo.2017.01.013
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505
NR 131
TC 227
Z9 247
U1 3
U2 72
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD APR 2
PY 2020
VL 181
IS 1
BP 168
EP 188
DI 10.1016/j.cell.2020.02.051
PG 21
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA KZ5RI
UT WOS:000523319000020
PM 32220313
OA Bronze
DA 2024-11-01
ER

PT J
AU Ban, R
   Guo, JH
   Pu, CQ
   Shi, Q
   Liu, HX
   Zhang, YT
AF Ban, Rui
   Guo, Jun-Hong
   Pu, Chuan-Qiang
   Shi, Qiang
   Liu, Hua-Xu
   Zhang, Yu-Tong
TI A Novel Mutation of Mitochondrial T14709C Causes Myoclonic Epilepsy with
   Ragged Red Fibers Syndrome in a Chinese Patient
SO CHINESE MEDICAL JOURNAL
LA English
DT Article
DE m.T14709C; Myoclonic Epilepsy with Ragged Red Fibers Syndrome; Novel
   Mutation
ID DIABETES-MELLITUS; TRANSFER RNALYS; ONSET MYOPATHY; DNA; MERRF;
   PREVALENCE; DISORDERS; DIAGNOSIS
AB Background: Myoclonic epilepsy with ragged red fibers (MERRF) syndrome is characterized by myoclonus, generalized epilepsy, cerebellar ataxia, and ragged red fibers (RRFs) in the muscle. T-to-C transition at nucleotide position 14709 in the mitochondrial tRNA glutamic acid (tRNA(G/U)) gene has previously been associated with maternally inherited diabetes and deafness. However, the association between MERRF and mitochondrial T14709C mutation (m.T14709C) has never been reported before.
   Methods: Clinical information of a 17-year-old patient was collected; muscle biopsy and next-generation sequencing (NGS) of whole mitochondrial and neuromuscular disease panel were then conducted. Finally, sanger sequencing was carried out to confirm the mutations.
   Results: The patient presented a typical MERRF phenotype with muscle weakness, epileptic seizure, clonic episodes, cerebellar ataxia, and spinal scoliosis. Muscle biopsy showed RRFs which indicated abnormal mitochondrial functions. NGS of whole mitochondrial gene revealed m.T14709C mutation, confirmed by Sanger sequencing.
   Conclusion: We present a sporadic patient with typical MERRF presentation carrying the mutation of m.T14709C, which expanded the spectrum of m.T14709C.
C1 [Ban, Rui; Pu, Chuan-Qiang; Shi, Qiang; Liu, Hua-Xu; Zhang, Yu-Tong] Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing 100853, Peoples R China.
   [Ban, Rui] Nankai Univ, Sch Med, Dept Neurol, Tianjin 300071, Peoples R China.
   [Guo, Jun-Hong] Shanxi Med Univ, Hosp 1, Dept Neurol, Taiyuan 030001, Shanxi, Peoples R China.
C3 Chinese People's Liberation Army General Hospital; Nankai University;
   Shanxi Medical University
RP Pu, CQ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing 100853, Peoples R China.
EM pucq30128@sina.cn
RI Guo, Junhong/O-6316-2017; Ban, Rui/F-6460-2010; chen, xia/GYR-3948-2022
FU National Natural Science Foundation of China [81771358]
FX This work was supported by a grant of the National Natural Science
   Foundation of China (No. 81771358).
CR Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   Berio A, 1995, Pediatr Med Chir, V17, P455
   Bindu PS, 2018, CLIN NEUROL NEUROSUR, V164, P182, DOI 10.1016/j.clineuro.2017.12.010
   Brackmann F, 2012, EUR J PEDIATR, V171, P859, DOI 10.1007/s00431-011-1662-8
   Chen Gang, 2008, Yichuan, V30, P1279, DOI 10.3724/SP.J.1005.2008.01279
   Cohen BH, 2013, NEUROTHERAPEUTICS, V10, P227, DOI 10.1007/s13311-013-0188-3
   Damore ME, 1999, J PEDIATR ENDOCR MET, V12, P207
   DiMauro S, 2002, J CHILD NEUROL, V17, pS35
   Finsterer J, 2018, PEDIATR NEUROL, V80, P8, DOI 10.1016/j.pediatrneurol.2017.12.005
   Finsterer J, 2017, SEIZURE-EUR J EPILEP, V50, P166, DOI 10.1016/j.seizure.2017.06.010
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   FUKUHARA N, 1995, MUSCLE NERVE, pS90
   [高枫 Gao Feng], 2003, [中风与神经疾病杂志, Journal of Apoplexy and Nervous Diseases], V20, P117
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   HAMMANS SR, 1991, LANCET, V337, P1311, DOI 10.1016/0140-6736(91)92981-7
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   Hiniker A, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0137-3
   Li Z, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000513
   Longworth B, 2014, ARCH PHYS MED REHAB, V95, P1725, DOI 10.1016/j.apmr.2014.02.027
   Lu H, 2014, J BRAIN NERV DIS, V22, P245
   Mancuso M, 2005, J NEUROL SCI, V228, P93, DOI 10.1016/j.jns.2004.10.018
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   Meulemans A, 2007, EUR J PAEDIATR NEURO, V11, P17, DOI 10.1016/j.ejpn.2006.10.004
   Mezghani N, 2010, J DIABETES COMPLICAT, V24, P270, DOI 10.1016/j.jdiacomp.2009.11.002
   SHOFFNER JM, 1992, AM J HUM GENET, V51, P1179
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Sofou K, 2013, MITOCHONDRION, V13, P364, DOI 10.1016/j.mito.2013.04.008
   Song DL, 2001, CHINESE MED J-PEKING, V114, P1273
   Stratilova L, 1999, Cas Lek Cesk, V138, P401
   Vialettes BH, 1997, DIABETES CARE, V20, P1731, DOI 10.2337/diacare.20.11.1731
   YONEDA M, 1990, BIOCHEM INT, V21, P789
   Zhao Juan, 2012, Zhonghua Yi Xue Za Zhi, V92, P2835
   Zhao Man-man, 2015, Beijing Da Xue Xue Bao Yi Xue Ban, V47, P1034
NR 34
TC 8
Z9 8
U1 0
U2 3
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0366-6999
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD JUL 5
PY 2018
VL 131
IS 13
BP 1569
EP 1574
DI 10.4103/0366-6999.235120
PG 6
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA GL1NK
UT WOS:000436869700009
PM 29941710
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Baruffini, E
   Ferrero, I
   Foury, F
AF Baruffini, Enrico
   Ferrero, Iliana
   Foury, Francoise
TI <i>In vivo</i> analysis of mtDNA replication defects in yeast
SO METHODS
LA English
DT Article
DE mtDNA replication; Yeast Saccharomyces cerevisiae; rho(-)/rho(o); Petite
   frequency; mtDNA point mutability
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MITOCHONDRIAL-DNA DEPLETION; LARGE
   RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; RIBONUCLEOTIDE REDUCTASE;
   RESISTANCE MUTATIONS; GENE DISRUPTION; SMALL-SUBUNIT; RIB2 LOCUS;
   POLYMERASE
AB The yeast Saccharomyces cerevisiae has the capacity to survive large deletions or total loss of mtDNA (petite mutants), and thus in the last few years it has been used as a model system to study defects in mitochondrial DNA (mtDNA) maintenance produced by mutations in genes involved in mtDNA replication. In this paper we describe methods to obtain strains harboring mutations in nuclear genes essential for the integrity of mtDNA, to measure the frequency and the nature of petite mutants, to estimate the point mutation frequency in mtDNA and to determine whether a nuclear mutation is recessive or dominant and, in the latter case, the kind of dominance. (C) 2010 Published by Elsevier Inc.
C1 [Foury, Francoise] Inst Life Sci, B-1348 Louvain, Belgium.
   [Baruffini, Enrico; Ferrero, Iliana] Dept Genet, I-43124 Parma, Italy.
RP Foury, F (corresponding author), Inst Life Sci, Batiment Carnoy,Croix Sud 4-5-15, B-1348 Louvain, Belgium.
EM enrico.baruffini@nemo.unipr.it; iferrero@unipr.it;
   francoise.foury@uclouvain.be
RI Baruffini, Enrico/C-1057-2015
OI Baruffini, Enrico/0000-0002-8280-7849
FU Fondazione Telethon-Italy [GGP07019]; Belgian National Fund for
   Scientific Research; Belgian Science Policy; Association Francaise
   contre les Myopathies
FX This work was supported by Grants from the Fondazione Telethon-Italy No.
   GGP07019, the Belgian National Fund for Scientific Research, the
   Interuniversity Attraction Poles Program-Belgian Science Policy and the
   Association Francaise contre les Myopathies.
CR BALDACCI G, 1984, EMBO J, V3, P2115, DOI 10.1002/j.1460-2075.1984.tb02099.x
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2007, GENETICS, V177, P1227, DOI 10.1534/genetics.107.079293
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Baruffini E, 2009, J BIOTECHNOL, V143, P247, DOI 10.1016/j.jbiotec.2009.08.007
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Brachmann CB, 1998, YEAST, V14, P115
   Chatterjee A, 2001, NUCLEIC ACIDS RES, V29, P4935, DOI 10.1093/nar/29.24.4935
   CHI NW, 1994, J BIOL CHEM, V269, P29984
   CONDE J, 1976, P NATL ACAD SCI USA, V73, P3651, DOI 10.1073/pnas.73.10.3651
   Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000
   CUI Z, 1989, CURR GENET, V16, P273, DOI 10.1007/BF00422114
   Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871
   Dimitrov LN, 2009, GENETICS, V183, P365, DOI 10.1534/genetics.109.104497
   Dujon B., 1981, MOL BIOL YEAST SACCH, P505
   ELLEDGE SJ, 1990, GENE DEV, V4, P740, DOI 10.1101/gad.4.5.740
   ELLEDGE SJ, 1987, MOL CELL BIOL, V7, P2783, DOI 10.1128/MCB.7.8.2783
   EPHRUSSI B, 1949, UNITES BIOL DOUEES C, P165
   FANGMAN WL, 1990, MOL CELL BIOL, V10, P10, DOI 10.1128/MCB.10.1.10
   FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x
   FOURY F, 1989, J BIOL CHEM, V264, P20552
   Foury Francoise, 2007, Methods Mol Biol, V372, P167, DOI 10.1007/978-1-59745-365-3_12
   Fukuhara H., 1977, MITOCHONDRIA, P123
   Gaisne M, 1999, CURR GENET, V36, P195, DOI 10.1007/s002940050490
   Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935
   Gietz R Daniel, 2006, Methods Mol Biol, V313, P107
   GREENLEAF AL, 1986, P NATL ACAD SCI USA, V83, P3391, DOI 10.1073/pnas.83.10.3391
   Hess DC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000407
   Kalifa L, 2007, DNA REPAIR, V6, P1732, DOI 10.1016/j.dnarep.2007.06.005
   LISOWSKY T, 1988, MOL GEN GENET, V214, P218, DOI 10.1007/BF00337714
   MARMIROLI N, 1980, MOL GEN GENET, V177, P581
   Mathews S., 1977, Mitochondria, P133
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   O'Rourke TW, 2002, MOL CELL BIOL, V22, P4086, DOI 10.1128/MCB.22.12.4086-4093.2002
   OGUR M, 1956, J BACTERIOL, V72, P500, DOI 10.1128/JB.72.4.500-504.1956
   ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202
   Sedman T, 2000, MOL CELL BIOL, V20, P1816, DOI 10.1128/MCB.20.5.1816-1824.2000
   SHERMAN F, 1964, GENETICS, V49, P39
   Singh KK, 2001, NUCLEIC ACIDS RES, V29, P1381, DOI 10.1093/nar/29.6.1381
   SLONIMSKI PP, 1976, EUR J BIOCHEM, V61, P27, DOI 10.1111/j.1432-1033.1976.tb09994.x
   SOR F, 1984, NUCLEIC ACIDS RES, V12, P8313, DOI 10.1093/nar/12.22.8313
   SOR F, 1982, NUCLEIC ACIDS RES, V10, P6571, DOI 10.1093/nar/10.21.6571
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stricker S, 2009, J NEUROL NEUROSUR PS, V80, P1181, DOI 10.1136/jnnp.2008.166066
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Taxis C, 2006, BIOTECHNIQUES, V40, P73, DOI 10.2144/000112040
   THOMAS BJ, 1989, GENETICS, V123, P725
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690
   VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x
   WACH A, 1994, YEAST, V10, P1808
   Wang PJ, 1997, MOL CELL BIOL, V17, P6114, DOI 10.1128/MCB.17.10.6114
   Willer M, 1999, CURR BIOL, V9, P1085, DOI 10.1016/S0960-9822(99)80477-1
   Young MJ, 2008, YEAST, V25, P903, DOI 10.1002/yea.1644
   ZITOMER RS, 1992, MICROBIOL REV, V56, P1
NR 55
TC 49
Z9 51
U1 0
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD AUG
PY 2010
VL 51
IS 4
BP 426
EP 436
DI 10.1016/j.ymeth.2010.02.023
PG 11
WC Biochemical Research Methods; Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 640KK
UT WOS:000281049900011
PM 20206271
DA 2024-11-01
ER

PT J
AU Blakely, EL
   Alston, CL
   Lecky, B
   Chakrabarti, B
   Falkous, G
   Turnbull, DM
   Taylor, RW
   Gorman, GS
AF Blakely, Emma L.
   Alston, Charlotte L.
   Lecky, Bryan
   Chakrabarti, Biswajit
   Falkous, Gavin
   Turnbull, Douglass M.
   Taylor, Robert W.
   Gorman, Grainne S.
TI Distal weakness with respiratory insufficiency caused by the m.8344A
   &gt; G "MERRF" mutation
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondria; Distal myopathy; MERRF syndrome
ID MITOCHONDRIAL-DNA DISEASE; FAMILIES; EPILEPSY
AB The m.8344A > G mutatfon in the mt-tRNA(Lys) gene, first described in myoclonic epilepsy and ragged red fibers (MERRF), accounts for approximately 80% of mutations in individuals with MERRF syndrome. Although originally described in families with a classical syndrome of myoclonus, ataxia, epilepsy and ragged red fibers in muscle biopsy, the m.8344A > G mutation is increasingly recognised to exhibit marked phenotypic heterogeneity. This paper describes the clinical, morphological and laboratory features of an unusual phenotype in a patient harboring the m.8344A > G 'MERRF' mutation. We present the case of a middle-aged woman with distal weakness since childhood who also had ptosis and facial weakness and who developed mid-life respiratory insufficiency necessitating non-invasive nocturnal ventilator support. Neurophysiological and acetylcholine receptor antibody analyses excluded myasthenia gravis whilst molecular genetic testing excluded myotonic dystrophy, prompting a diagnostic needle muscle biopsy. Mitochondrial histochemical abnoinialities including subsarcolemmal mitochondrial accumulation (ragged-red fibers) and in excess of 90% COX-deficient fibers, was seen leading to sequencing of the mitochondrial genome in muscle. This identified the m.8344A > G mutation commonly associated with the MERRF phenotype. This case extends the evolving phenotypic spectrum of the m.8344A > G mutation and emphasizes that it may cause indolent distal weakness with respiratory insufficiency, with marked histochemical defects in muscle. Our findings support consideration of screening of this gene in cases of indolent myopathy resembling distal limb-girdle muscular dystrophy in which screening of the common genes prove negative. (C) 2014 The Authors. Published by Elsevier B.V.
C1 [Blakely, Emma L.; Alston, Charlotte L.; Falkous, Gavin; Turnbull, Douglass M.; Taylor, Robert W.; Gorman, Grainne S.] Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Lecky, Bryan] Walton Ctr NHS Fdn Trust, Liverpool L9 7LJ, Merseyside, England.
   [Chakrabarti, Biswajit] Aintree Univ Hosp NHS Fdn Trust, Aintree Chest Ctr, Liverpool L9 7AL, Merseyside, England.
C3 Newcastle University - UK; Walton Centre; Aintree University Hospitals
   NHS Foundation Trust
RP Gorman, GS (corresponding author), Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM grainne.gorman@ncl.ac.uk
RI Alston, Charlotte/ABG-9602-2020
OI Gorman, Grainne/0000-0002-7585-3409; Alston,
   Charlotte/0000-0003-2095-5464; Turnbull, Doug/0000-0002-8878-9901
FU Wellcome Trust [096919Z/11/Z, 074454/Z/04/Z]; Medical Research Council
   [G0601943, G0800674]; UK National Institute for Health Research
   Biomedical Research Centre for Ageing and Age-related Diseases; UK NHS
   Specialized Services; Newcastle upon Tyne Hospitals NHS Foundation Trust
   'Rare Mitochondrial Disorders of Adults and Children' Diagnostic
   Service; MRC [MR/K000608/1, G0800674, G0700718, G0601943] Funding
   Source: UKRI
FX This work was supported by the Wellcome Trust [096919Z/11/Z and
   074454/Z/04/Z to D.M.T., R.W.T.]; the Medical Research Council [G0601943
   and G0800674 to D.M.T., R.W.T.]; the UK National Institute for Health
   Research Biomedical Research Centre for Ageing and Age-related Diseases
   award to Newcastle upon Tyne Hospitals NHS Foundation Trust [to D.M.T.,
   G.S.G.] and the UK NHS Specialized Services and Newcastle upon Tyne
   Hospitals NHS Foundation Trust that support the 'Rare Mitochondrial
   Disorders of Adults and Children' Diagnostic Service
   [http://www.newcastle-mitochondria.com].
CR Alston CL, 2011, EUR J HUM GENET, V19, P1226, DOI 10.1038/ejhg.2011.124
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Kazakos K, 2012, ANN HUM GENET, V76, P296, DOI 10.1111/j.1469-1809.2012.00711.x
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Tuppen HAL, 2010, BRAIN, V133, P2952, DOI 10.1093/brain/awq232
NR 7
TC 25
Z9 27
U1 0
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JUN
PY 2014
VL 24
IS 6
BP 533
EP 536
DI 10.1016/j.nmd.2014.03.011
PG 4
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA AJ7EZ
UT WOS:000337861300011
PM 24792523
OA Green Published
DA 2024-11-01
ER

PT J
AU Shree, R
   Mehta, S
   Goyal, MK
   Gaspar, BL
   Lal, V
AF Shree, Ritu
   Mehta, Sahil
   Goyal, Manoj K.
   Gaspar, Balan L.
   Lal, Vivek
TI Muscle Biopsy: A Boon for Diagnosis of Mitochondrial Parkinsonism in
   Developing Countries
SO ANNALS OF INDIAN ACADEMY OF NEUROLOGY
LA English
DT Article
DE Dystonia; mitochondria; muscle biopsy; Parkinsonism
ID MOVEMENT-DISORDERS; MUTATION; OPHTHALMOPLEGIA; NEUROPATHY; MYOPATHY;
   DISEASE
AB Mitochondrial dysfunction plays an important role in the pathogenesis of Parkinson's disease. Primary genetic abnormalities in the mitochondrial DNA or nuclear DNA can cause parkinsonism. Mitochondrial parkinsonism presents with classical features of parkinsonism along with multisystem involvement. Genetic analysis is essential in reaching the diagnosis which is not always possible, especially in developing countries. Muscle biopsy can be a boon in this setting as exemplified in our report of two siblings where a diagnosis of mitochondrial parkinsonism was made on the basis of muscle biopsy.
C1 [Shree, Ritu; Mehta, Sahil; Goyal, Manoj K.; Lal, Vivek] Postgrad Inst Med Educ & Res, Dept Neurol, Chandigarh, India.
   [Gaspar, Balan L.] Postgrad Inst Med Educ & Res, Dept Histopathol, Chandigarh, India.
C3 Post Graduate Institute of Medical Education & Research (PGIMER),
   Chandigarh; Post Graduate Institute of Medical Education & Research
   (PGIMER), Chandigarh
RP Mehta, S (corresponding author), Postgrad Inst Med Educ & Res, Dept Neurol, Chandigarh, India.
EM mehtasahilpgi@gmail.com
RI Gaspar, Balan/H-8183-2019
OI Shree, Ritu/0009-0002-8705-4361; Gaspar, Balan/0000-0001-7935-823X
CR Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Casali C, 2001, NEUROLOGY, V56, P802, DOI 10.1212/WNL.56.6.802
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   Dermaut B, 2010, J NEUROL NEUROSUR PS, V81, P90, DOI 10.1136/jnnp.2008.157354
   Gautier CA, 2014, REV NEUROL-FRANCE, V170, P339, DOI 10.1016/j.neurol.2013.06.003
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Martikainen MH, 2016, JAMA NEUROL, V73, P668, DOI 10.1001/jamaneurol.2016.0355
   Moustris Andreas, 2011, Handb Clin Neurol, V100, P173, DOI 10.1016/B978-0-444-52014-2.00010-0
   Neeve VCM, 2012, BRAIN, V135, P3614, DOI 10.1093/brain/aws298
   Orsucci D, 2011, J MOL NEUROSCI, V44, P17, DOI 10.1007/s12031-010-9488-9
   Thobois S, 1997, REV NEUROL, V153, P595
   Thyagarajan D, 2000, ANN NEUROL, V48, P730, DOI 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0
   Tranchant C, 2016, REV NEUROL-FRANCE, V172, P524, DOI 10.1016/j.neurol.2016.07.003
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
NR 16
TC 0
Z9 0
U1 0
U2 2
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0972-2327
EI 1998-3549
J9 ANN INDIAN ACAD NEUR
JI Ann. Indian Acad. Neurol.
PD APR-JUN
PY 2019
VL 22
IS 2
BP 228
EP 230
DI 10.4103/aian.AIAN_436_17
PG 3
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA HS9DL
UT WOS:000464167900023
PM 31007443
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Brown, KH
AF Brown, K. H.
TI Fish mitochondrial genomics: sequence, inheritance and functional
   variation
SO JOURNAL OF FISH BIOLOGY
LA English
DT Review
DE coadaptation; coevolution; functional variation; maternal inheritance;
   metabolism; mtDNA
ID TROUT ONCORHYNCHUS-MYKISS; CYTOCHROME-C-OXIDASE; COMPLETE
   NUCLEOTIDE-SEQUENCE; JAPANESE BLACK CATTLE; DNA CONTROL REGION;
   RAINBOW-TROUT; DROSOPHILA-SUBOBSCURA; EXPERIMENTAL POPULATIONS;
   TIGRIOPUS-CALIFORNICUS; MUSCLE MITOCHONDRIA
AB Mitochondrial genomic research currently primarily focuses on the analysis and understanding of how mitochondrial mutations produce detrimental phenotypes in humans. Reasons for this focus on negative impacts include the large number of human diseases that are known to result from specific mitochondrial genomes, and the long held belief that mitochondria change only through the accumulation of mutations due to its clonal, maternal inheritance. Recent studies are beginning to challenge these preconceptions and have shown that mitochondrial genomes can have significant positive impacts. Although the number of studies using fishes as models in mitochondrial research is limited, many fish model species provide excellent opportunity for furthering the understanding of mitochondrial genomes, their interactions with the nuclear genome, the potential for understanding the mechanisms of how functional variation effects organisms and how selection for positive functional variation effects population variation. (C) 2008 The Author Journal compilation (C) 2008 The Fisheries Society of the British Isles.
C1 Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.
   Univ Idaho, Ctr Reprod Biol, Moscow, ID 83843 USA.
C3 University of Idaho; University of Idaho
RP Brown, KH (corresponding author), Univ Idaho, Dept Biol Sci, POB 443051, Moscow, ID 83843 USA.
EM khbrown@uidaho.edu
OI Brown, Kim/0000-0002-2358-8578
CR Abbott CL, 2005, MOL ECOL, V14, P3605, DOI 10.1111/j.1365-294X.2005.02672.x
   Amer SAM, 2005, GENE, V346, P249, DOI 10.1016/j.gene.2004.11.014
   Andersson SGE, 2003, PHILOS T R SOC B, V358, P165, DOI 10.1098/rstb.2002.1193
   Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094
   ATTARDI G, 1985, INT REV CYTOL, V93, P93, DOI 10.1016/S0074-7696(08)61373-X
   AVISE JC, 1991, ANNU REV GENET, V25, P45, DOI 10.1146/annurev.ge.25.120191.000401
   AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421
   BALLARD JWO, 1994, GENETICS, V138, P757
   BARRELL BG, 1979, NATURE, V282, P189, DOI 10.1038/282189a0
   Bayona-Bafaluy MP, 2005, MOL BIOL EVOL, V22, P716, DOI 10.1093/molbev/msi059
   BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303
   Birkedal R, 2004, J COMP PHYSIOL B, V174, P255, DOI 10.1007/s00360-003-0410-4
   Birkedal R, 2006, BBA-BIOENERGETICS, V1757, P764, DOI 10.1016/j.bbabio.2006.04.022
   Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231
   Blier PU, 2001, J COMP PHYSIOL B, V171, P247, DOI 10.1007/s003600000169
   Boettcher PJ, 1996, J DAIRY SCI, V79, P655, DOI 10.3168/jds.S0022-0302(96)76411-1
   Bogenhagen DF, 1999, AM J HUM GENET, V64, P1276, DOI 10.1086/302392
   Bouchard P, 2003, J EXP BIOL, V206, P3455, DOI 10.1242/jeb.00578
   Bowen BW, 2006, MAR BIOL, V149, P899, DOI 10.1007/s00227-006-0252-1
   Brown KH, 2006, COMP BIOCHEM PHYS B, V143, P415, DOI 10.1016/j.cbpb.2005.12.015
   Brown KH, 2006, COMP BIOCHEM PHYS D, V1, P219, DOI 10.1016/j.cbd.2005.11.004
   Burton RS, 1999, AM ZOOL, V39, P451
   Burzynski A, 2003, MOL BIOL EVOL, V20, P388, DOI 10.1093/molbev/msg058
   Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638
   CHOMYN A, 1985, NATURE, V314, P592, DOI 10.1038/314592a0
   Christie JS, 2004, HEREDITY, V93, P371, DOI 10.1038/sj.hdy.6800513
   Dalziel AC, 2006, J MOL EVOL, V62, P319, DOI 10.1007/s00239-005-0110-7
   Das J, 2006, BIOESSAYS, V28, P890, DOI 10.1002/bies.20463
   delaBastide PY, 1997, APPL ENVIRON MICROB, V63, P3426, DOI 10.1128/AEM.63.9.3426-3431.1997
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884
   Edmands S, 1999, EVOLUTION, V53, P1972, DOI 10.1111/j.1558-5646.1999.tb04578.x
   Edwards SV, 2005, P ROY SOC B-BIOL SCI, V272, P979, DOI 10.1098/rspb.2004.3035
   Ellison CK, 2006, EVOLUTION, V60, P1382, DOI 10.1554/06-210.1
   FELSENSTEIN J, 1974, GENETICS, V78, P737
   FOS M, 1990, P NATL ACAD SCI USA, V87, P4198, DOI 10.1073/pnas.87.11.4198
   Futuyma D.J., 1998, EVOL BIOL
   Gabaldón T, 2003, SCIENCE, V301, P609, DOI 10.1126/science.1085463
   García-Martínez J, 1998, GENETICS, V149, P1377
   Gemmell NJ, 2004, TRENDS ECOL EVOL, V19, P238, DOI 10.1016/j.tree.2004.02.002
   Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476
   Guderley H, 1996, J EXP BIOL, V199, P1311
   Guderley H, 2002, J EXP BIOL, V205, P2237
   Guderley H, 2004, COMP BIOCHEM PHYS B, V139, P371, DOI 10.1016/j.cbpc.2004.04.001
   Guderley H, 1999, J COMP PHYSIOL B, V169, P474, DOI 10.1007/s003600050244
   Guderley H, 1997, FISH PHYSIOL BIOCHEM, V16, P531, DOI 10.1023/A:1007708826437
   Guo XH, 2006, GENETICS, V172, P1745, DOI 10.1534/genetics.105.049841
   GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   Harrison JS, 2006, MOL BIOL EVOL, V23, P559, DOI 10.1093/molbev/msj058
   HECHT NB, 1984, DEV BIOL, V102, P452, DOI 10.1016/0012-1606(84)90210-0
   Hoarau G, 2002, MOL BIOL EVOL, V19, P2261, DOI 10.1093/oxfordjournals.molbev.a004049
   Hurst CD, 1999, GENE, V239, P237, DOI 10.1016/S0378-1119(99)00425-4
   HUTTER CM, 1995, GENETICS, V140, P537
   Ikeguchi K, 2006, MAR BIOTECHNOL, V8, P178, DOI 10.1007/s10126-005-5110-5
   Itoi S, 2001, FISHERIES SCI, V67, P191, DOI 10.1046/j.1444-2906.2001.00222.x
   Jacobs HT, 2000, BIOESSAYS, V22, P564, DOI 10.1002/(SICI)1521-1878(200006)22:6<564::AID-BIES9>3.0.CO;2-4
   Jansen RPS, 1998, MOL CELL ENDOCRINOL, V145, P81, DOI 10.1016/S0303-7207(98)00173-7
   Johnston IA, 1998, J EXP BIOL, V201, P1
   Kim BC, 2006, DNA SEQUENCE, V17, P181, DOI 10.1080/10425170600806928
   KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0
   KONDO R, 1990, GENETICS, V126, P657
   Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342
   Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000
   Kvist L, 2003, MOL BIOL EVOL, V20, P243, DOI 10.1093/molbev/msg025
   Ladoukakis ED, 2001, MOL BIOL EVOL, V18, P1168, DOI 10.1093/oxfordjournals.molbev.a003904
   Lannig G, 2003, MAR BIOL, V142, P589, DOI 10.1007/s00227-002-0967-6
   LATORRE A, 1992, HEREDITY, V68, P15, DOI 10.1038/hdy.1992.2
   Li S, 1998, J HERED, V89, P222, DOI 10.1093/jhered/89.3.222
   Lunt DH, 1997, NATURE, V387, P247, DOI 10.1038/387247a0
   Lynch M, 1997, MOL BIOL EVOL, V14, P914, DOI 10.1093/oxfordjournals.molbev.a025834
   Lynch M, 1996, MOL BIOL EVOL, V13, P209, DOI 10.1093/oxfordjournals.molbev.a025557
   MAGOULAS A, 1993, MOL BIOL EVOL, V10, P319
   Mannen H, 2003, J ANIM SCI, V81, P68
   Mannen H, 1998, J ANIM SCI, V76, P36
   Martin W, 2001, BIOL CHEM, V382, P1521, DOI 10.1515/BC.2001.187
   McFarland R, 2007, CURR TOP DEV BIOL, V77, P113, DOI 10.1016/S0070-2153(06)77005-3
   Miya M, 2005, BIOL J LINN SOC, V85, P289, DOI 10.1111/j.1095-8312.2005.00483.x
   MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.ecolsys.18.1.269
   MOYA A, 1993, GENOME, V36, P890, DOI 10.1139/g93-117
   MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8
   Nachman MW, 1998, GENETICA, V102-3, P61, DOI 10.1023/A:1017030708374
   Nishida M, 2005, ZOOL SCI, V22, P1394
   Nishimura Y, 2006, P NATL ACAD SCI USA, V103, P1382, DOI 10.1073/pnas.0506911103
   Oliver P, 2005, GENOME, V48, P1010, DOI 10.1139/G05-077
   Pakkasmaa S, 2006, J COMP PHYSIOL B, V176, P387, DOI 10.1007/s00360-005-0057-4
   Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363
   Patterson DA, 2004, CAN J FISH AQUAT SCI, V61, P1225, DOI 10.1139/F04-076
   Pelster B, 2003, AM J PHYSIOL-REG I, V285, pR339, DOI 10.1152/ajpregu.00110.2003
   Rand DM, 2004, TRENDS ECOL EVOL, V19, P645, DOI 10.1016/j.tree.2004.10.003
   Rand DM, 2006, GENETICS, V172, P329, DOI 10.1534/genetics.105.046698
   Rand DM, 1998, GENETICA, V102-3, P393, DOI 10.1023/A:1017006118852
   RAND DM, 1994, TRENDS ECOL EVOL, V9, P125, DOI 10.1016/0169-5347(94)90176-7
   Rawson PD, 2006, J MOL EVOL, V62, P753, DOI 10.1007/s00239-005-0074-7
   RENNIE CM, 1979, CLIN CHIM ACTA, V98, P119, DOI 10.1016/0009-8981(79)90172-4
   Roger AJ, 1999, AM NAT, V154, pS146, DOI 10.1086/303290
   Saitoh K, 2006, J MOL EVOL, V63, P826, DOI 10.1007/s00239-005-0293-y
   SCHUTZ MM, 1994, LIVEST PROD SCI, V37, P283, DOI 10.1016/0301-6226(94)90123-6
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Shigenobu Y, 2005, GENES GENET SYST, V80, P297, DOI 10.1266/ggs.80.297
   SKIBINSKI DOF, 1994, NATURE, V368, P817, DOI 10.1038/368817b0
   Slate J, 2004, TRENDS ECOL EVOL, V19, P561, DOI 10.1016/j.tree.2004.09.001
   Stärner H, 2004, BEHAVIOUR, V141, P1357, DOI 10.1163/1568539042948114
   STPIERRE J, 1998, J EXPT ZOOLOGY, V258, P277
   Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466
   Tatarenkov A, 2007, P R SOC B, V274, P1795, DOI 10.1098/rspb.2007.0169
   Thyagarajan B, 1996, J BIOL CHEM, V271, P27536, DOI 10.1074/jbc.271.44.27536
   Tiano L, 2003, MITOCHONDRION, V2, P428, DOI 10.1016/S1567-7249(03)00032-1
   Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271
   VANDENTHILLART G, 1978, BIOCHIM BIOPHYS ACTA, V510, P38, DOI 10.1016/0005-2736(78)90128-1
   Wilhelm D, 2007, FRONT BIOSCI-LANDMRK, V12, P1229
   Willett CS, 2001, EVOLUTION, V55, P1592
   Yamanoue Y, 2004, ICHTHYOL RES, V51, P269, DOI 10.1007/s10228-004-0218-6
   Yue GH, 2006, DNA SEQUENCE, V17, P115, DOI 10.1080/10425170600700378
   Zardoya R, 1995, J MOL EVOL, V41, P942, DOI 10.1007/BF00173174
   Zeh JA, 2005, TRENDS GENET, V21, P281, DOI 10.1016/j.tig.2005.03.006
   Zeviani M, 2003, CURR OPIN GENET DEV, V13, P262, DOI 10.1016/S0959-437X(03)00052-2
   Zeyl C, 2005, EVOLUTION, V59, P910
NR 118
TC 46
Z9 49
U1 2
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-1112
EI 1095-8649
J9 J FISH BIOL
JI J. Fish Biol.
PD FEB
PY 2008
VL 72
IS 2
BP 355
EP 374
DI 10.1111/j.1095-8649.2007.01690.x
PG 20
WC Fisheries; Marine & Freshwater Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Fisheries; Marine & Freshwater Biology
GA 272IF
UT WOS:000253852400002
DA 2024-11-01
ER

PT J
AU Schon, EA
   DiMauro, S
   Hirano, M
AF Schon, Eric A.
   DiMauro, Salvatore
   Hirano, Michio
TI Human mitochondrial DNA: roles of inherited and somatic mutations
SO NATURE REVIEWS GENETICS
LA English
DT Review
ID CYTOCHROME-C-OXIDASE; HEREDITARY OPTIC NEUROPATHY; PROGRESSIVE EXTERNAL
   OPHTHALMOPLEGIA; DEFICIENT MUSCLE-FIBERS; KEARNS-SAYRE SYNDROME; HUMAN
   SKELETAL-MUSCLE; NITRIC-OXIDE; 1555A-GREATER-THAN-G MUTATION; POINT
   MUTATIONS; MTDNA DELETIONS
AB Mutations in the human mitochondrial genome are known to cause an array of diverse disorders, most of which are maternally inherited, and all of which are associated with defects in oxidative energy metabolism. It is now emerging that somatic mutations in mitochondrial DNA (mtDNA) are also linked to other complex traits, including neurodegenerative diseases, ageing and cancer. Here we discuss insights into the roles of mtDNA mutations in a wide variety of diseases, highlighting the interesting genetic characteristics of the mitochondrial genome and challenges in studying its contribution to pathogenesis.
C1 [Schon, Eric A.; DiMauro, Salvatore; Hirano, Michio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA.
   [Schon, Eric A.] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA.
C3 Columbia University; Columbia University
RP Schon, EA (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, 630 W 168th St, New York, NY 10032 USA.
EM eas3@columbia.edu
FU US National Institutes of Health [HD32062]; US Department of Defense
   [W911NF-12-1-0159]; Muscular Dystrophy Association; Ellison Medical
   Foundation; Alzheimer Drug Discovery Foundation; Marriott Mitochondrial
   Disorder Clinical Research Fund
FX The authors were supported by grants from the US National Institutes of
   Health (HD32062), the US Department of Defense (W911NF-12-1-0159), the
   Muscular Dystrophy Association, the Ellison Medical Foundation, the
   Alzheimer Drug Discovery Foundation and the Marriott Mitochondrial
   Disorder Clinical Research Fund.
CR Amo T, 2007, BIOCHEM J, V404, P345, DOI 10.1042/BJ20061609
   Anderson CD, 2011, ANN NEUROL, V69, P471, DOI 10.1002/ana.22108
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Arning L, 2010, J MOL MED, V88, P431, DOI 10.1007/s00109-010-0589-2
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   Bai RK, 2011, J ONCOL, V2011, DOI 10.1155/2011/496189
   Battersby BJ, 2001, HUM MOL GENET, V10, P2469, DOI 10.1093/hmg/10.22.2469
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396
   Bodyak ND, 2001, HUM MOL GENET, V10, P17, DOI 10.1093/hmg/10.1.17
   BONILLA E, 1992, BRAIN PATHOL, V2, P113, DOI 10.1111/j.1750-3639.1992.tb00679.x
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0
   Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236
   Caro P, 2010, MITOCHONDRION, V10, P479, DOI 10.1016/j.mito.2010.05.004
   Cheng X, 2010, AGING CELL, V9, P919, DOI 10.1111/j.1474-9726.2010.00607.x
   Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9
   Chong P Siao Tick, 2003, J Clin Neuromuscul Dis, V5, P1, DOI 10.1097/00131402-200309000-00001
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Damas J, 2012, NUCLEIC ACIDS RES, V40, P7606, DOI 10.1093/nar/gks500
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2000, BRAIN PATHOL, V10, P431
   DiMauro S, 2006, MUSCLE NERVE, V34, P265, DOI 10.1002/mus.20598
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Ellinger J, 2012, UROL ONCOL-SEMIN ORI, V30, P509, DOI 10.1016/j.urolonc.2010.03.004
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elson JL, 2007, AM J HUM GENET, V80, P378, DOI 10.1086/511652
   ENGEL WK, 1963, NEUROLOGY, V13, P919, DOI 10.1212/WNL.13.11.919
   Ericson NG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002689
   Garcia-Rodriguez Luis J, 2007, Methods Cell Biol, V80, P809, DOI 10.1016/S0091-679X(06)80040-3
   Ghelli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007922
   Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006
   Goldin E, 2004, HUM MUTAT, V24, P460, DOI 10.1002/humu.20094
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   HASEGAWA H, 1993, ACTA NEUROPATHOL, V85, P280
   HAYASHI JI, 1992, SOMAT CELL MOLEC GEN, V18, P123, DOI 10.1007/BF01233159
   Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834
   Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001
   Hirano T, 1999, MUTAT RES-FUND MOL M, V425, P195, DOI 10.1016/S0027-5107(99)00037-8
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Ingram CJE, 2012, AMYOTROPH LATERAL SC, V13, P341, DOI 10.3109/17482968.2012.654394
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Khusnutdinova E, 2008, ANN NY ACAD SCI, V1147, P1, DOI 10.1196/annals.1427.001
   Kiebish MA, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-102
   King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Lang M, 2012, HUM GENET, V131, P757, DOI 10.1007/s00439-011-1125-3
   Lee JH, 2011, PATHOL ONCOL RES, V17, P201, DOI 10.1007/s12253-010-9297-z
   Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006
   LESTIENNE P, 1988, LANCET, V1, P885
   LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F
   Madan E, 2011, ONCOTARGET, V2, P948
   Majewski N, 2004, MOL CELL BIOL, V24, P730, DOI 10.1128/MCB.24.2.730-740.2004
   Maki J, 2008, AM J CLIN PATHOL, V129, P57, DOI 10.1309/UJJTH4HFEPWAQ78Q
   Mancuso Michelangelo, 2008, Human Genomics, V3, P71
   McRae AF, 2008, GENOME RES, V18, P911, DOI 10.1101/gr.074872.107
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   MELNICK PJ, 1965, ANN NY ACAD SCI, V125, P689, DOI 10.1111/j.1749-6632.1965.tb45422.x
   MILLER RW, 1971, ARCH BIOCHEM BIOPHYS, V146, P256, DOI 10.1016/S0003-9861(71)80063-2
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   MORAES CT, 1995, MUSCLE NERVE, pS150
   MORAIS R, 1994, CANCER RES, V54, P3889
   Mourier T, 2001, MOL BIOL EVOL, V18, P1833, DOI 10.1093/oxfordjournals.molbev.a003971
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   NAKASE H, 1990, AM J HUM GENET, V46, P418
   Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishigaki Y, 2010, GERIATR GERONTOL INT, V10, pS221, DOI 10.1111/j.1447-0594.2010.00599.x
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OLDFORS A, 1992, J NEUROL SCI, V110, P169, DOI 10.1016/0022-510X(92)90025-G
   Pallotti F, 1996, AM J HUM GENET, V59, P591
   Parr RL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-185
   Parr RL, 2006, J MOL DIAGN, V8, P312, DOI 10.2353/jmoldx.2006.050112
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100
   PETERS GJ, 1990, CANCER RES, V50, P4644
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Quinzii CM, 2010, FASEB J, V24, P3733, DOI 10.1096/fj.09-152728
   Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027
   Ramos A, 2011, MITOCHONDRION, V11, P946, DOI 10.1016/j.mito.2011.08.009
   Rodríguez-Juárez F, 2007, BIOCHEM J, V405, P223, DOI 10.1042/BJ20070033
   Rose G, 2008, EUR J NEUROL, V15, P1006, DOI 10.1111/j.1468-1331.2008.02222.x
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   Sánchez-Ferrero E, 2012, J NEUROL, V259, P246, DOI 10.1007/s00415-011-6155-1
   SanGiovanni JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005508
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Santoro A., 2012, PLOS ONE, V5
   Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022
   Sequeira Adolfo, 2012, Frontiers in Genetics, V3, P103, DOI 10.3389/fgene.2012.00103
   Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748
   Shiva S, 2001, P NATL ACAD SCI USA, V98, P7212, DOI 10.1073/pnas.131128898
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Storlazzi CT, 2010, GENOME RES, V20, P1198, DOI 10.1101/gr.106252.110
   Suzuki T, 2011, WIRES RNA, V2, P376, DOI 10.1002/wrna.65
   Tay SHK, 2006, ARCH NEUROL-CHICAGO, V63, P281, DOI 10.1001/archneur.63.2.281
   Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849
   TORRES J, 1995, BIOCHEM J, V312, P169, DOI 10.1042/bj3120169
   Tranah GJ, 2011, AGEING RES REV, V10, P238, DOI 10.1016/j.arr.2010.06.003
   Turner C, 2003, HUM GENET, V112, P303, DOI 10.1007/s00439-002-0892-2
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200
   Uusimaa J, 2011, J MED GENET, V48, P660, DOI 10.1136/jmg.2011.089995
   Valsesia A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018369
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   van Nederveen FH, 2009, LANCET ONCOL, V10, P764, DOI 10.1016/S1470-2045(09)70164-0
   Vandebona H, 2009, NEW ENGL J MED, V360, P642, DOI 10.1056/NEJMc0806397
   Vives-Bauza C, 2010, PROG BRAIN RES, V183, P99, DOI 10.1016/S0079-6123(10)83006-7
   Vu TH, 2000, MUSCLE NERVE, V23, P80, DOI 10.1002/(SICI)1097-4598(200001)23:1<80::AID-MUS10>3.0.CO;2-V
   Wang D, 2012, P NATL ACAD SCI USA, V109, P2444, DOI 10.1073/pnas.1117890109
   Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519
   Willett-Brozick JE, 2001, HUM GENET, V109, P216, DOI 10.1007/s004390100564
   Yan QF, 2006, BIOCHEM BIOPH RES CO, V342, P1130, DOI 10.1016/j.bbrc.2006.02.078
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
   YONEDA M, 1995, MUSCLE NERVE, pS95
   Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955
   Yu M, 2011, LIFE SCI, V89, P65, DOI 10.1016/j.lfs.2011.05.010
NR 149
TC 545
Z9 615
U1 0
U2 121
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-0056
EI 1471-0064
J9 NAT REV GENET
JI Nat. Rev. Genet.
PD DEC
PY 2012
VL 13
IS 12
BP 878
EP 890
DI 10.1038/nrg3275
PG 13
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 038ZL
UT WOS:000311212500010
PM 23154810
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Chinopoulos, C
AF Chinopoulos, Christos
TI Quantification of mitochondrial DNA from peripheral tissues: Limitations
   in predicting the severity of neurometabolic disorders and proposal of a
   novel diagnostic test
SO MOLECULAR ASPECTS OF MEDICINE
LA English
DT Review
DE Fibroblast; Blood; Lymphocyte; Oxidative phosphorylation;
   Neuropathology; Ragged-blue fibers
ID RESPIRATORY-CHAIN DEFICIENCY; MTDNA DEPLETION; COPY NUMBER; MUTATIONS;
   SUCCINATE; MUSCLE; ENCEPHALOMYOPATHY; DELETIONS; MAINTENANCE;
   DYSFUNCTION
AB Neurometabolic disorders stem from errors in metabolic processes yielding a neurological phenotype. A subset of those disorders encompasses mitochondrial abnormalities partially due to mitochondrial DNA (mtDNA) depletion. mtDNA depletion can be attributed to inheritance, spontaneous mutations or acquired from drug-related toxicities. In the armamentarium of diagnostic procedures, mtDNA quantification is a standard for disease classification. However, alterations in mtDNA obtained from peripheral tissues such as skin fibroblasts and blood cells do not often reflect the severity of the affected organ, in this case, the brain. The purpose of this review is to highlight the pitfalls of quantitating mtDNA from peripheral -and not limited to-tissues for diagnosing patients suffering from a variety of mtDNA depletion syndromes exhibiting neurologic abnormalities. In lieu, a qualitative test of mitochondrial substrate-level phosphorylation -even from peripheral tissues-reflecting the ability of mitochondria to rely on glutaminolysis in the presence of respiratory chain defects is proposed as a novel diagnostic assessment of mitochondrial functionality.
C1 [Chinopoulos, Christos] Semmelweis Univ, Dept Med Biochem, Tuzolto St 37-47, H-1094 Budapest, Hungary.
C3 Semmelweis University
RP Chinopoulos, C (corresponding author), Semmelweis Univ, Dept Med Biochem, Tuzolto St 37-47, H-1094 Budapest, Hungary.
EM chinopoulos.christos@eok.sote.hu
RI Chinopoulos, Christos/A-5175-2008
OI Chinopoulos, Christos/0000-0003-0183-4149
FU NKFIH [FIKP-6182264888-EATV, VEKOP 2.3.3-15-2016-00012,
   2017-2.3.4-TET-RU2017-00003, KH129567]
FX This work was supported by grants from NKFIH [FIKP-6182264888-EATV],
   [VEKOP 2.3.3-15-2016-00012], [2017-2.3.4-TET-RU2017-00003] and
   [KH129567] to C.C.
CR ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   Balciuniene J, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00518
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Carrozzo R, 2016, J INHERIT METAB DIS, V39, P243, DOI 10.1007/s10545-015-9894-9
   Casula M, 2007, J INFECT DIS, V196, P371, DOI 10.1086/519284
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chinopoulos C, 2019, INT J BIOCHEM CELL B, V115, DOI 10.1016/j.biocel.2019.105580
   Chinopoulos C, 2018, ASN NEURO, V10, DOI 10.1177/1759091418818261
   Chinopoulos C, 2019, MOL GENET METAB, V126, P43, DOI 10.1016/j.ymgme.2018.11.009
   Chinopoulos C, 2011, J NEUROSCI RES, V89, P1897, DOI 10.1002/jnr.22659
   Chinopoulos C, 2011, FEBS LETT, V585, P1255, DOI 10.1016/j.febslet.2011.04.004
   Chinopoulos C, 2010, FASEB J, V24, P2405, DOI 10.1096/fj.09-149898
   Chretien D, 1998, BIOCHEM J, V329, P249, DOI 10.1042/bj3290249
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Dagan T, 2002, MITOCHONDRION, V1, P397, DOI 10.1016/S1567-7249(02)00003-X
   Davis RL, 2013, NEUROLOGY, V81, P1819, DOI 10.1212/01.wnl.0000436068.43384.ef
   Debray FG, 2007, CLIN CHEM, V53, P916, DOI 10.1373/clinchem.2006.081166
   DiMauro S, 1999, J CHILD NEUROL, V14, pS23, DOI 10.1177/0883073899014001051
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Gauthier-Villars M, 2001, NEUROPEDIATRICS, V32, P150, DOI 10.1055/s-2001-16614
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Gourlain K, 2003, HIV Med, V4, P287, DOI 10.1046/j.1468-1293.2003.00158.x
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hensen F, 2014, BIOCHIMIE, V100, P219, DOI 10.1016/j.biochi.2013.09.017
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Johnson JD, 1998, J BIOL CHEM, V273, P27580, DOI 10.1074/jbc.273.42.27580
   Johnston IG, 2015, ELIFE, V4, DOI 10.7554/eLife.07464
   Kacso G, 2016, BIOCHEM J, V473, P3463, DOI 10.1042/BCJ20160594
   Kiss G, 2013, FASEB J, V27, P2392, DOI 10.1096/fj.12-220202
   Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Lacombe ML, 2018, LAB INVEST, V98, P582, DOI 10.1038/s41374-017-0004-5
   Lewis W, 2001, LAB INVEST, V81, P777, DOI 10.1038/labinvest.3780288
   Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201
   Li MK, 2016, GENOME RES, V26, P417, DOI 10.1101/gr.203216.115
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Lutz-Bonengel S, 2019, P NATL ACAD SCI USA, V116, P1821, DOI 10.1073/pnas.1820533116
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   Montaner JSG, 2004, CLIN INFECT DIS, V38, pS73, DOI 10.1086/381449
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7
   Morse CG, 2012, J INFECT DIS, V205, P1778, DOI 10.1093/infdis/jis101
   Morten KJ, 2007, MITOCHONDRION, V7, P386, DOI 10.1016/j.mito.2007.09.001
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Niyazov DM, 2016, MOL SYNDROMOL, V7, P122, DOI 10.1159/000446586
   Nogueira C, 2014, ITAL J PEDIATR, V40, DOI 10.1186/1824-7288-40-34
   Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003
   Ostergaard E, 2008, J INHERIT METAB DIS, V31, P226, DOI 10.1007/s10545-008-0828-7
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Persson Ö, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08673-5
   Poulton Joanna, 2009, Neuromuscul Disord, V19, P439, DOI 10.1016/j.nmd.2009.04.009
   Pyle A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005040
   Ravasz D, 2018, BBA-BIOENERGETICS, V1859, P909, DOI 10.1016/j.bbabio.2018.05.002
   Rebolledo-Jaramillo B, 2014, P NATL ACAD SCI USA, V111, P15474, DOI 10.1073/pnas.1409328111
   Rodenburg RJT, 2013, MITOCHONDRION, V13, P36, DOI 10.1016/j.mito.2012.11.004
   Rötig A, 2009, BBA-MOL BASIS DIS, V1792, P1103, DOI 10.1016/j.bbadis.2009.06.009
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Song SW, 2003, J BIOL CHEM, V278, P43893, DOI 10.1074/jbc.C300401200
   Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Sue CM, 1998, J NEUROL SCI, V161, P36, DOI 10.1016/S0022-510X(98)00179-8
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Suomalainen A, 2011, J INHERIT METAB DIS, V34, P277, DOI 10.1007/s10545-010-9222-3
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tretter L, 2016, BBA-BIOENERGETICS, V1857, P1086, DOI 10.1016/j.bbabio.2016.03.012
   Tucker EJ, 2011, IUBMB LIFE, V63, P669, DOI 10.1002/iub.495
   Tzoulis C, 2014, ANN NEUROL, V76, P66, DOI 10.1002/ana.24185
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Willemsen MA, 2016, NEUROL-CLIN PRACT, V6, P348, DOI 10.1212/CPJ.0000000000000266
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Young MJ, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00074
   Zhang HX, 2018, ESSAYS BIOCHEM, V62, P225, DOI 10.1042/EBC20170096
NR 99
TC 2
Z9 2
U1 0
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0098-2997
EI 1872-9452
J9 MOL ASPECTS MED
JI Mol. Asp. Med.
PD FEB
PY 2020
VL 71
AR 100834
DI 10.1016/j.mam.2019.11.004
PG 8
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Research & Experimental Medicine
GA KN1YC
UT WOS:000514635900003
PM 31740079
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Mordel, P
   Schaeffer, S
   Dupas, Q
   Laville, MA
   Gérard, M
   Chapon, F
   Allouche, S
AF Mordel, Patrick
   Schaeffer, Stephane
   Dupas, Quentin
   Laville, Marie-Alice
   Gerard, Marion
   Chapon, Francoise
   Allouche, S.
TI A 2 bp deletion in the mitochondrial ATP 6 gene responsible for the NARP
   (neuropathy, ataxia, and retinitis pigmentosa) syndrorne
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Mitochondrial disease; Complex V deficiency; Next generation sequencing;
   ATP6 deletion; NARP syndrome
ID COMPLEX-V DEFICIENCY; MUTATION; SYNTHASE; CARDIOMYOPATHY; DNA
AB Mitochondrial (mt) DNA-associated NARP (neurogenic muscle weakness, ataxia, and retinitis pigmentosa) syndrome is due to mutation in the MT-ATP6 gene.
   We report the case of a 18-year-old man who presented with deafness, a myoclonic epilepsy, muscle weakness since the age of 10 and further developed a retinitis pigmentosa and ataxia. The whole mtDNA analysis by next-generation sequencing revealed the presence of the 2 bp microdeletion m.9127-9128 del AT in the ATP6 gene at 82% heteroplasmy in muscle and to a lower load in blood (10-20%) and fibroblasts (50%). Using the patient's fibroblasts, we demonstrated a 60% reduction of the oligomycinsensitive ATPase hydrolytic activity, a 40% decrease in the ATP synthesis and determination of the mitochondrial membrane potential using the fluorescent probe tetramethylrhodamine, ethyl ester indicated a significant reduction in oligomycin sensitivity.
   In conclusion, we demonstrated that this novel AT deletion in the ATP6 gene is pathogenic and responsible for the NARP syndrome. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Mordel, Patrick; Dupas, Quentin; Allouche, S.] Normandie Univ, UNICAEN, CHU Caen, Signalisat Electrophysiol & Imagerie Les Ischemie, F-14032 Caen, France.
   [Schaeffer, Stephane; Chapon, Francoise] CHU Caen, Neuromuscular Competence Ctr, F-14032 Caen, France.
   [Laville, Marie-Alice] CHU Caen, Dept Ophthalmol, F-14032 Caen, France.
   [Gerard, Marion] CHU Caen, Dept Med Genet, F-14032 Caen, France.
   [Chapon, Francoise] CHU Caen, Dept Pathol, F-14032 Caen, France.
   [Allouche, S.] CHU Caen, Dept Biochem, Ave Cote Nacre,CS 30001, F-14032 Caen 9, France.
C3 Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen
   Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de
   Caen NORMANDIE; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU
   de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE
RP Allouche, S (corresponding author), CHU Caen, Dept Biochem, Ave Cote Nacre,CS 30001, F-14032 Caen 9, France.
EM allouche-s@chu-caen.fr
RI Allouche, Stephane/AFW-3810-2022
CR Allegretti M, 2015, NATURE, V521, P237, DOI 10.1038/nature14185
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Cameron JM, 2011, MITOCHONDRION, V11, P191, DOI 10.1016/j.mito.2010.09.008
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   Habersetzer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075429
   Hahn A, 2016, MOL CELL, V63, P445, DOI 10.1016/j.molcel.2016.05.037
   Hao XS, 2015, NEUROREPORT, V26, P588, DOI 10.1097/WNR.0000000000000392
   Honzik T, 2012, J INHERIT METAB DIS, V35, P749, DOI 10.1007/s10545-011-9440-3
   Houstek J, 1999, HUM MOL GENET, V8, P1967
   Imai A, 2016, INT J CARDIOL, V207, P203, DOI 10.1016/j.ijcard.2016.01.026
   Jackson CB, 2017, EUR J MED GENET, V60, P345, DOI 10.1016/j.ejmg.2017.04.006
   Jesina P, 2004, BIOCHEM J, V383, P561, DOI 10.1042/BJ20040407
   JOHN UP, 1986, FEBS LETT, V207, P79, DOI 10.1016/0014-5793(86)80016-3
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Jonckheere AI, 2013, BRAIN, V136, P1544, DOI 10.1093/brain/awt086
   Kucharczyk R, 2010, BBA-BIOENERGETICS, V1797, P1105, DOI 10.1016/j.bbabio.2009.12.022
   López-Gallardo E, 2009, J MED GENET, V46, P64, DOI 10.1136/jmg.2008.060616
   López-Gallardo E, 2014, HUM MOL GENET, V23, P6191, DOI 10.1093/hmg/ddu339
   Martin J, 2015, J BIOL CHEM, V290, P10717, DOI 10.1074/jbc.M115.646430
   Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Morava E, 2006, AM J MED GENET A, V140A, P863, DOI 10.1002/ajmg.a.31194
   Parfait B, 1999, EUR J PEDIATR, V158, P55, DOI 10.1007/s004310051009
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y
   Rühle T, 2015, BBA-BIOENERGETICS, V1847, P849, DOI 10.1016/j.bbabio.2015.02.005
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Seneca S, 2015, EUR J HUM GENET, V23, P41, DOI 10.1038/ejhg.2014.49
   Symersky J, 2012, P NATL ACAD SCI USA, V109, P13961, DOI 10.1073/pnas.1207912109
   Zhou AN, 2015, ELIFE, V4, DOI 10.7554/eLife.10180
   ziel G., NEUROL NEUROSURG PSY, V3, P6
NR 31
TC 16
Z9 16
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD DEC 9
PY 2017
VL 494
IS 1-2
BP 133
EP 137
DI 10.1016/j.bbrc.2017.10.066
PG 5
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA FO2NF
UT WOS:000416615300022
PM 29054413
DA 2024-11-01
ER

PT J
AU Aaltio, J
   Euro, L
   Tynninen, O
   Vu, HS
   Ni, M
   Deberardinis, RJ
   Suomalainen, A
   Isohanni, P
AF Aaltio, Juho
   Euro, Liliya
   Tynninen, Olli
   Vu, Hieu S.
   Ni, Min
   Deberardinis, Ralph J.
   Suomalainen, Anu
   Isohanni, Pirjo
TI Niacin supplementation in a child with novel <i>MTTN</i> variant
   m.5670A&gt;G causing early onset mitochondrial myopathy and
   NAD<SUP>+</SUP> deficiency
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE MTTN; tRNA-Asn; Mitochondrial myopathy; NAD plus deficiency; Niacin;
   Niacin supplementation
ID MUTATION
AB Myopathy is a common manifestation in mitochondrial disorders, but the pathomechanisms are still insufficiently studied in children. Here, we report a severe, progressive mitochondrial myopathy in a four-year-old child, who died at eight years. He developed progressive loss of muscle strength with nocturnal hypoventilation and dilated cardiomyopathy. Skeletal muscle showed ragged red fibers and severe combined respiratory chain deficiency. Mitochondrial DNA sequencing revealed a novel m.5670A>G mutation in mitochondrial tRNA(Asn) (MTTN) with 88 % heteroplasmy in muscle. The proband also had systemic NAD(+) deficiency but rescuing this with the NAD(+) precursor niacin did not stop disease progression. Targeted metabolomics revealed an overall shift of metabolism towards controls after niacin supplementation, with normalized tryptophan metabolites and lipid-metabolic markers, but most amino acids did not respond to niacin therapy. To conclude, we report a new MTTN mutation, secondary NAD(+) deficiency in childhood-onset mitochondrial myopathy with metabolic but meager clinical response to niacin supplementation. (c) 2024 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
C1 [Aaltio, Juho; Euro, Liliya; Suomalainen, Anu; Isohanni, Pirjo] Univ Helsinki, Res Programs Unit, Stem Cells & Metab Res, Helsinki, Finland.
   [Tynninen, Olli] Helsinki Univ Hosp, Dept Pathol, Helsinki, Finland.
   [Tynninen, Olli] Univ Helsinki, Helsinki, Finland.
   [Vu, Hieu S.; Ni, Min; Deberardinis, Ralph J.] Univ Texas Southwestern Med Ctr Dallas, Childrens Med Ctr Res Inst, Dallas, TX USA.
   [Deberardinis, Ralph J.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX USA.
   [Suomalainen, Anu] Helsinki Univ Hosp, HUS Diagnost Ctr, Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, HiLife, Helsinki, Finland.
   [Isohanni, Pirjo] Univ Helsinki, Childrens Hosp, Pediat Res Ctr, Child Neurol, Helsinki, Finland.
   [Isohanni, Pirjo] Helsinki Univ Hosp, Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; Helsinki University
   Central Hospital; University of Helsinki; University of Texas System;
   University of Texas Southwestern Medical Center Dallas; University of
   Texas System; University of Texas Southwestern Medical Center Dallas;
   Howard Hughes Medical Institute; University of Helsinki; Helsinki
   University Central Hospital; University of Helsinki; University of
   Helsinki; University of Helsinki; Helsinki University Central Hospital
RP Aaltio, J (corresponding author), Univ Helsinki, Res Programs Unit, Stem Cells & Metab Res, Helsinki, Finland.
EM juho.aaltio@helsinki.fi
RI ; Liliya, Euro/F-3808-2015
OI Aaltio, Juho/0000-0002-2522-4823; Liliya, Euro/0000-0001-9705-3886
CR Bruno C, 2011, BIOCHEM BIOPH RES CO, V412, P518, DOI 10.1016/j.bbrc.2011.06.155
   Coulbault L, 2005, BIOCHEM BIOPH RES CO, V329, P1152, DOI 10.1016/j.bbrc.2005.02.083
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Hathazi D, 2020, EMBO J, V39, DOI 10.15252/embj.2020105364
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Krall AS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11457
   Lapatto HAK, 2023, SCI ADV, V9, DOI 10.1126/sciadv.add5163
   Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26
   Meulemans A, 2006, ARCH NEUROL-CHICAGO, V63, P1194, DOI 10.1001/archneur.63.8.1194
   Pang ZQ, 2021, NUCLEIC ACIDS RES, V49, pW388, DOI 10.1093/nar/gkab382
   Pirinen E, 2020, CELL METAB, V31, P1078, DOI 10.1016/j.cmet.2020.04.008
   Ronchi D, 2012, EUR J HUM GENET, V20, P357, DOI 10.1038/ejhg.2011.238
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Sonney S, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005867
   Visuttijai K, 2021, ACTA NEUROL SCAND, V143, P103, DOI 10.1111/ane.13339
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
   Zereg E, 2020, HUM MUTAT, V41, P1394, DOI 10.1002/humu.24037
NR 20
TC 0
Z9 0
U1 1
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD OCT
PY 2024
VL 43
BP 14
EP 19
DI 10.1016/j.nmd.2024.07.005
EA AUG 2024
PG 6
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA E2N1T
UT WOS:001301411800001
PM 39173541
OA hybrid
DA 2024-11-01
ER

PT J
AU Del Dotto, V
   Ullah, F
   Di Meo, I
   Magini, P
   Gusic, M
   Maresca, A
   Caporali, L
   Palombo, F
   Tagliavini, F
   Baugh, EH
   Macao, B
   Szilagyi, Z
   Peron, C
   Gustafson, MA
   Khan, K
   La Morgia, C
   Barboni, P
   Carbonelli, M
   Valentino, ML
   Liguori, R
   Shashi, V
   Sullivan, J
   Nagaraj, S
   El-Dairi, M
   Iannaccone, A
   Cutcutache, I
   Bertini, E
   Carrozzo, R
   Emma, F
   Diomedi-Camassei, F
   Zanna, C
   Armstrong, M
   Page, M
   Stong, N
   Boesch, S
   Kopajtich, R
   Wortmann, S
   Sperl, W
   Davis, EE
   Copeland, WC
   Seri, M
   Falkenberg, M
   Prokisch, H
   Katsanis, N
   Tiranti, V
   Pippucci, T
   Carelli, V
AF Del Dotto, Valentina
   Ullah, Farid
   Di Meo, Ivano
   Magini, Pamela
   Gusic, Mirjana
   Maresca, Alessandra
   Caporali, Leonardo
   Palombo, Flavia
   Tagliavini, Francesca
   Baugh, Evan Harris
   Macao, Bertil
   Szilagyi, Zsolt
   Peron, Camille
   Gustafson, Margaret A.
   Khan, Kamal
   La Morgia, Chiara
   Barboni, Piero
   Carbonelli, Michele
   Valentino, Maria Lucia
   Liguori, Rocco
   Shashi, Vandana
   Sullivan, Jennifer
   Nagaraj, Shashi
   El-Dairi, Mays
   Iannaccone, Alessandro
   Cutcutache, Ioana
   Bertini, Enrico
   Carrozzo, Rosalba
   Emma, Francesco
   Diomedi-Camassei, Francesca
   Zanna, Claudia
   Armstrong, Martin
   Page, Matthew
   Stong, Nicholas
   Boesch, Sylvia
   Kopajtich, Robert
   Wortmann, Saskia
   Sperl, Wolfgang
   Davis, Erica E.
   Copeland, William C.
   Seri, Marco
   Falkenberg, Maria
   Prokisch, Holger
   Katsanis, Nicholas
   Tiranti, Valeria
   Pippucci, Tommaso
   Carelli, Valerio
TI <i>SSBP1</i> mutations cause mtDNA depletion underlying a complex optic
   atrophy disorder
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
ID DNA-BINDING PROTEIN; MITOCHONDRIAL TRANSCRIPTION FACTOR; D-LOOP; OPA1;
   GENE; REPLICATION; DELETIONS; PHOSPHORYLATION; INSTABILITY; TWINKLE
AB Inherited optic neuropathies include complex phenotypes, mostly driven by mitochondrial dysfunction. We report an optic atrophy spectrum disorder, including retinal macular dystrophy and kidney insufficiency leading to transplantation, associated with mitochondrial DNA (mtDNA) depletion without accumulation of multiple deletions. By whole-exome sequencing, we identified mutations affecting the mitochondrial single-strand binding protein (SSBP1) in 4 families with dominant and 1 with recessive inheritance. We show that SSBP1 mutations in patient-derived fibroblasts variably affect the amount of SSBP1 protein and alter multimer formation, but not the binding to ssDNA. SSBP1 mutations impaired mtDNA, nucleoids, and 7S-DNA amounts as well as mtDNA replication, affecting replisome machinery. The variable mtDNA depletion in cells was reflected in severity of mitochondrial dysfunction, including respiratory efficiency, OXPHOS subunits, and complex amount and assembly. mtDNA depletion and cytochrome c oxidase-negative cells were found ex vivo in biopsies of affected tissues, such as kidney and skeletal muscle. Reduced efficiency of mtDNA replication was also reproduced in vitro, confirming the pathogenic mechanism. Furthermore, ssbp1 suppression in zebrafish induced signs of nephropathy and reduced optic nerve size, the latter phenotype complemented by WT mRNA but not by SSBP1 mutant transcripts. This previously unrecognized disease of mtDNA maintenance implicates SSBP1 mutations as a cause of human pathology.
C1 [Del Dotto, Valentina; La Morgia, Chiara; Copeland, William C.] Univ Bologna, Dept Biomed & NeuroMotor Sci DIBINEM, Neurol Unit, Bologna, Italy.
   [Ullah, Farid; Khan, Kamal; Davis, Erica E.; Copeland, William C.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC USA.
   [Ullah, Farid; Khan, Kamal] Natl Inst Biotechnol & Genet Engn NIBGE, Hlth Biotechnol Div, Human Mol Genet Lab, Faisalabad, Pakistan.
   [Ullah, Farid; Khan, Kamal] PIEAS, Faisalabad, Pakistan.
   [Di Meo, Ivano; Peron, Camille; Tiranti, Valeria] Fdn IRCCS Ist Neurol C Besta, Unit Med Genet & Neurogenet, Milan, Italy.
   [Magini, Pamela; Pippucci, Tommaso] St Orsola Malpighi Univ Hosp, Med Genet Unit, Via Massarenti 9, I-40138 Bologna, Italy.
   [Gusic, Mirjana; Kopajtich, Robert; Wortmann, Saskia; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany.
   [Gusic, Mirjana; Kopajtich, Robert; Wortmann, Saskia; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, Munich, Germany.
   [Maresca, Alessandra; Caporali, Leonardo; Palombo, Flavia; Tagliavini, Francesca; La Morgia, Chiara; Carbonelli, Michele; Valentino, Maria Lucia; Liguori, Rocco; Pippucci, Tommaso; Carelli, Valerio] IRCCS Ist Sci Neurol Bologna, UOC Clin Neurol, Via Altura 3, I-40139 Bologna, Italy.
   [Baugh, Evan Harris; Stong, Nicholas] Columbia Univ, Inst Genom Med, New York, NY USA.
   [Macao, Bertil; Szilagyi, Zsolt; Falkenberg, Maria] Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.
   [Gustafson, Margaret A.] Natl Inst Environm Hlth Sci, Genome Integr & Struct Biol Lab, Res Triangle Pk, NC USA.
   [Barboni, Piero] Studio Oculistico Azeglio, Dept Ophthalmol, Bologna, Italy.
   [Shashi, Vandana; Sullivan, Jennifer] Duke Univ, Sch Med, Div Med Genet, Dept Pediat, Durham, NC USA.
   [Nagaraj, Shashi] Duke Univ, Sch Med, Div Nephrol, Dept Pediat, Durham, NC USA.
   [El-Dairi, Mays] Duke Univ, Sch Med, Neuroophthalmol Serv, Durham, NC USA.
   [Iannaccone, Alessandro] Duke Univ, Sch Med, Ctr Retinal Degenerat & Ophthalm Genet Dis, Durham, NC USA.
   [Iannaccone, Alessandro] Duke Univ, Sch Med, Visual Funct Diagnost Lab, Durham, NC USA.
   [Cutcutache, Ioana; Bertini, Enrico; Page, Matthew] UCB Pharma, Translat Med, Slough, Berks, England.
   [Bertini, Enrico; Carrozzo, Rosalba] IRCCS, Bambino Gesu Childrens Hosp, Dept Neurosci, Unit Muscular & Neurodegenerat Dis, Rome, Italy.
   [Emma, Francesco; Diomedi-Camassei, Francesca] Bambino Gesu Pediat Hosp, Dept Pediat Subspecialties, Div Nephrol, Rome, Italy.
   [Diomedi-Camassei, Francesca] Univ Bologna, Dept Pharm & Biotechnol FABIT, Bologna, Italy.
   [Zanna, Claudia] UCB Pharma, Translat Med, Braine Lalleud, Belgium.
   [Armstrong, Martin] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria.
   [Boesch, Sylvia; Wortmann, Saskia] Salzburger Landeskliniken, Dept Pediat, Salzburg, Austria.
   [Boesch, Sylvia; Wortmann, Saskia] Paracelsus Med Univ, Salzburg, Austria.
   [Sperl, Wolfgang] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy.
   [Seri, Marco] Ann Robert H Lurie Childrens Hosp Chicago, Stanley Manne Childrens Res Inst, Chicago, IL USA.
   [Katsanis, Nicholas] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA.
   [Katsanis, Nicholas] Northwestern Univ, Feinberg Sch Med, Dept Cellular & Mol Biol, Chicago, IL 60611 USA.
C3 University of Bologna; Duke University; Pakistan Institute of
   Engineering & Applied Science; Pakistan Institute of Engineering &
   Applied Science; Fondazione IRCCS Istituto Neurologico Carlo Besta;
   IRCCS Azienda Ospedaliero-Universitaria di Bologna; Helmholtz
   Association; Helmholtz-Center Munich - German Research Center for
   Environmental Health; Technical University of Munich; IRCCS Istituto
   delle Scienze Neurologiche di Bologna (ISNB); Columbia University;
   University of Gothenburg; National Institutes of Health (NIH) - USA; NIH
   National Institute of Environmental Health Sciences (NIEHS); Duke
   University; Duke University; Duke University; Duke University; Duke
   University; UCB Pharma SA; IRCCS Bambino Gesu; IRCCS Bambino Gesu;
   University of Bologna; UCB Pharma SA; Medical University of Innsbruck;
   Paracelsus Private Medical University; University of Bologna; Ann &
   Robert H. Lurie Children's Hospital of Chicago; Northwestern University;
   Feinberg School of Medicine; Northwestern University; Feinberg School of
   Medicine
RP Pippucci, T (corresponding author), St Orsola Malpighi Univ Hosp, Med Genet Unit, Via Massarenti 9, I-40138 Bologna, Italy.; Carelli, V (corresponding author), IRCCS Ist Sci Neurol Bologna, UOC Clin Neurol, Via Altura 3, I-40139 Bologna, Italy.
EM tomma-so.pippucci@unibo.it; valerio.carelli@unibo.it
RI La Morgia, Chiara/H-6765-2012; Zanna, Claudia/GVT-1932-2022; Tiranti,
   Valeria/AFN-5783-2022; camassei, francesca/AAA-1610-2020; Palombo,
   Flavia/GXV-7458-2022; Del Dotto, Valentina/AAB-7073-2020; Seri,
   Marcello/AAE-7037-2020; Prokisch, Holger/N-8964-2013; Liguori,
   Rocco/AAB-7860-2020; Emma, Francesco/H-2116-2012; Katsanis,
   Nicholas/E-1837-2012; Stong, Nicholas/ABB-7516-2021; Bertini,
   Enrico/ABG-1278-2020; Magini, Pamela/K-4508-2016; Tiranti,
   Valeria/J-8233-2016; Bertini, Enrico/A-2284-2014; Copeland,
   William/C-4242-2019; Peron, Camille/AAN-8288-2020; Caporali,
   Leonardo/J-7398-2016; Di Meo, Ivano/H-7840-2014; Tagliavini,
   Francesca/N-5154-2015; Maresca, Alessandra/J-7393-2016; Carrozzo,
   Rosalba/A-2808-2014; Tagliavini, Fabrizio/AAO-7891-2021
OI Gusic, Mirjana/0000-0002-9350-291X; DEL DOTTO,
   VALENTINA/0000-0002-6053-0893; Magini, Pamela/0000-0002-1752-9977;
   Falkenberg, Maria/0000-0001-8713-173X; Ullah, Farid/0000-0001-8108-8347;
   Tiranti, Valeria/0000-0002-3584-7338; Bertini,
   Enrico/0000-0001-9276-4590; Copeland, William/0000-0002-0359-0953;
   Peron, Camille/0000-0003-4916-2329; Boesch, Sylvia/0000-0003-1657-7368;
   Caporali, Leonardo/0000-0002-0666-4380; Di Meo,
   Ivano/0000-0002-4616-5623; Tagliavini, Francesca/0000-0001-5679-2156;
   Maresca, Alessandra/0000-0002-8959-8832; Stong,
   Nicholas/0000-0002-0678-637X; PALOMBO, FLAVIA/0000-0002-1639-3764;
   Carrozzo, Rosalba/0000-0002-3327-4054; Tagliavini,
   Fabrizio/0000-0003-1039-7315; diomedi camassei,
   francesca/0000-0003-2829-2407
FU Ricerca Corrente from Italian Ministry of Health; Italian Ministry of
   Health [GR-2016-02361449]; German BMBF [01GM1603, FWF-I 2741-B26,
   mitoNET 01GM1906B]; Horizon2020 [01GM1603, FWF-I 2741-B26, mitoNET
   01GM1906B]; Intramural Research Program of the NIH, National Institute
   of Environmental Health Sciences [ES065078]; Mariani Foundation, Milan;
   Mitocon, Italy [2018-01]; Associazione Luigi Comini Onlus, Italy;
   International Research Support Initiative Program fellowship from the
   Higher Education Commission of Pakistan; Duke University Health System;
   UCB Celltech
FX This study was supported by Ricerca Corrente funding (AM, LC, FT, FP,
   MC, and VC) and by grant GR-2016-02361449 to LC, both from the Italian
   Ministry of Health; by the German BMBF and Horizon2020 through E-Rare
   project GENOMIT (01GM1603 to HP and FWF-I 2741-B26) and the German
   Network for Mitochondrial Disorders (mitoNET 01GM1906B to HP); and by
   the Intramural Research Program of the NIH, National Institute of
   Environmental Health Sciences (ES065078 to WCC and MAG). Financial
   support from the Mariani Foundation, Milan, and of Mitocon, Italy (grant
   no. 2018-01 to VT) are acknowledged. CP is supported by a fellowship
   from Associazione Luigi Comini Onlus, Italy. FU and KK were funded by an
   International Research Support Initiative Program fellowship from the
   Higher Education Commission of Pakistan. We thank T. Khan for technical
   assistance with zebrafish experiments. Family 2 was evaluated through
   the Duke Genome Sequencing Clinic, supported by the Duke University
   Health System, and partially funded by UCB Celltech. We thank Federico
   Sadun for referring patients from family 1 and Rosanna Carroccia for
   technical help with the kidney biopsy of PT1.
CR Abrams AJ, 2015, NAT GENET, V47, P926, DOI 10.1038/ng.3354
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Anderson BR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005349
   Antes A, 2010, NUCLEIC ACIDS RES, V38, P6466, DOI 10.1093/nar/gkq493
   Baugh EH, 2016, NUCLEIC ACIDS RES, V44, P2501, DOI 10.1093/nar/gkw120
   Carelli V., 2006, Mitochondrial Medicine, DOI DOI 10.1201/B14623-7
   Carelli V, 2017, HUM MOL GENET, V26, pR139, DOI 10.1093/hmg/ddx273
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Carnes MU, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004372
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Ciesielski GL, 2016, METHODS MOL BIOL, V1351, P211, DOI 10.1007/978-1-4939-3040-1_16
   Del Dotto V, 2018, BBA-MOL BASIS DIS, V1864, P3496, DOI 10.1016/j.bbadis.2018.08.004
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Drummond IA, 2016, METHOD CELL BIOL, V134, P391, DOI 10.1016/bs.mcb.2016.03.041
   Farr CL, 1999, J BIOL CHEM, V274, P14779, DOI 10.1074/jbc.274.21.14779
   Fernández-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8
   Fusté JM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004832
   Genead MA, 2011, INVEST OPHTH VIS SCI, V52, P7298, DOI 10.1167/iovs.11-7762
   Gerber S, 2017, BRAIN, V140, P2586, DOI 10.1093/brain/awx219
   Giordano C, 2008, AM J PATHOL, V173, P1120, DOI 10.2353/ajpath.2008.080252
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Hentschel DM, 2007, AM J PHYSIOL-RENAL, V293, pF1746, DOI 10.1152/ajprenal.00009.2007
   Hjerpe R, 2010, INT J BIOCHEM CELL B, V42, P725, DOI 10.1016/j.biocel.2010.01.010
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Jay JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160519
   Jemt E, 2015, NUCLEIC ACIDS RES, V43, P9262, DOI 10.1093/nar/gkv804
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Kullar PJ, 2018, BRAIN, V141, P55, DOI 10.1093/brain/awx295
   Lu B, 2013, MOL CELL, V49, P121, DOI 10.1016/j.molcel.2012.10.023
   Luo XD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125700
   Lyonnais S, 2017, SCI REP-UK, V7, DOI 10.1038/srep43992
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Mussini C, 2005, AIDS, V19, P1627, DOI 10.1097/01.aids.0000186019.47297.0d
   Posse V, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007781
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Reynier P, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016576
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Samuel A, 2016, SCI REP-UK, V6, DOI 10.1038/srep20267
   Sergouniotis PI, 2012, BRIT J OPHTHALMOL, V96, P213, DOI 10.1136/bjo.2011.203638
   Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Sundaram V, 2014, OPHTHALMOLOGY, V121, P234, DOI 10.1016/j.ophtha.2013.08.017
   TIRANTI V, 1995, GENOMICS, V25, P559, DOI 10.1016/0888-7543(95)80058-T
   TIRANTI V, 1993, GENE, V126, P219, DOI 10.1016/0378-1119(93)90370-I
   Traynelis J, 2017, GENOME RES, V27, P1715, DOI 10.1101/gr.226589.117
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2016, ACTA NEUROPATHOL, V132, P789, DOI 10.1007/s00401-016-1625-2
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 61
TC 61
Z9 63
U1 0
U2 17
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD JAN
PY 2020
VL 130
IS 1
BP 108
EP 125
DI 10.1172/JCI128514
PG 18
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA JZ6IK
UT WOS:000505205000020
PM 31550240
OA Bronze, Green Published
DA 2024-11-01
ER

PT J
AU Bychkov, IO
   Itkis, YS
   Tsygankova, PG
   Krylova, TD
   Mikhaylova, SV
   Klyushnikov, SA
   Pechatnikova, NL
   Degtyareva, AV
   Nikolaeva, EA
   Seliverstov, YA
   Kurbatov, SA
   Dadali, EL
   Rudenskaya, GE
   Illarioshkin, SN
   Zakharova, EY
AF Bychkov, I. O.
   Itkis, Y. S.
   Tsygankova, P. G.
   Krylova, T. D.
   Mikhaylova, S., V
   Klyushnikov, S. A.
   Pechatnikova, N. L.
   Degtyareva, A., V
   Nikolaeva, E. A.
   Seliverstov, Y. A.
   Kurbatov, S. A.
   Dadali, E. L.
   Rudenskaya, G. E.
   Illarioshkin, S. N.
   Zakharova, E. Y.
TI Mitochondrial DNA maintenance disorders in 102 patients from different
   parts of Russia: Mutational spectrum and phenotypes
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial replication; Mutations; Nuclear genes; Mitochondrial DNA
   copy number; Mitochondrial depletion syndrome; qPCR
ID TIME QUANTITATIVE PCR; DEPLETION; VARIANTS; DISEASE; PROTEINS; GENETICS;
   FEATURES; DEFECTS; ATAXIA; ONSET
AB Currently, pathogenic variants in more than 25 nuclear genes, involved in mtDNA maintenance, are associated with human disorders. mtDNA maintenance disorders manifest with a wide range of phenotypes, from severe infantile-onset forms of myocerebrohepatopathy to late-onset forms of myopathies, chronic progressive external ophthalmoplegia, and parkinsonism. This study represents the results of molecular genetic analysis and phenotypes of 102 probands with mtDNA maintenance disorders. So far, this is the largest Russian cohort for this group of diseases. Mutations were identified in 10 mtDNA maintenance genes: POLG (n = 59), DGUOK (n = 14), TWNK (n = 14), TK2 (n = 8), MPV17 (n = 2), OPA3 (n = 1), FBXL4 (n = 1), RRM2B (n = 1), SUCLG1 (n = 1) and TYMP (n = 1). We review a mutation spectrum for the DGUOK and TWNK genes, that can be specific for the Russian population. In 34 patients we measured the blood mtDNA copy number and showed its significant reduction. Novel variants were found in 41 cases, which significantly expands the mutational landscape of mtDNA maintenance disorders.
C1 [Bychkov, I. O.; Itkis, Y. S.; Tsygankova, P. G.; Krylova, T. D.; Dadali, E. L.; Rudenskaya, G. E.; Zakharova, E. Y.] Res Ctr Med Genet, Moscow, Russia.
   [Mikhaylova, S., V] Russian Childrens Hosp, Med Genet Dept, Moscow, Russia.
   [Nikolaeva, E. A.] Pirogov Russian Natl Res Med Univ, Veltishchev Res Clin Inst Pediat, Moscow, Russia.
   [Pechatnikova, N. L.] Morozov Childrens City Clin Hosp, Moscow, Russia.
   [Degtyareva, A., V] Kulakov Natl Med Res Ctr Obstet Gynecol & Perinat, Moscow, Russia.
   [Klyushnikov, S. A.; Seliverstov, Y. A.; Illarioshkin, S. N.] Res Ctr Neurol, Moscow, Russia.
   [Degtyareva, A., V] Sechenov First Moscow State Med Univ, Sechenovskiy Univ, Moscow, Russia.
   [Kurbatov, S. A.] Semant Hub, Moscow, Russia.
   [Kurbatov, S. A.] Zdorovii Rebenok Ltd, Med Ctr, Moscow, Russia.
C3 Research Centre for Medical Genetics; Pirogov Russian National Research
   Medical University; Research Center of Neurology; Sechenov First Moscow
   State Medical University
RP Bychkov, IO (corresponding author), Res Ctr Med Genet, Moscow, Russia.
EM bychkov@med-gen.ru
RI Illarioshkin, Sergey/C-9033-2012; Tsygankova, Polina/M-1001-2014;
   Klyushnikov, Sergey/ABH-2959-2020; Bychkov, Igor/AAU-4365-2021;
   Zakharova, Ekaterina/AAU-8702-2021; Degtyareva, Anna/AAV-1024-2021;
   Krylova, Tatiana/K-6396-2018; Kurbatov, Sergei/AAE-7910-2022; Nikolaeva,
   Elizaveta/JMC-1584-2023; Dadali, Elena/AFG-0883-2022; Seliverstov,
   Yury/F-8362-2015; Nikolaeva, Ekaterina/H-6340-2016; Bychkov,
   Igor/J-6421-2018
OI Dadali, Elena/0000-0001-5602-2805; Seliverstov,
   Yury/0000-0002-6400-6378; Nikolaeva, Ekaterina/0000-0001-7146-7220;
   Kurbatov, Sergei/0000-0002-8886-5222; Bychkov, Igor/0000-0002-6594-6126
CR [Anonymous], PYMOL MOL GRAPHICS S
   Bendl J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003440
   Biino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054289
   Boczonadi V, 2018, GENET MED, V20, P1224, DOI 10.1038/gim.2017.251
   Degtyareva A.V., 2017, ROSSIYSKIY VESTNIK P, V62, P55, DOI 10.21508/1027-4065-2017-62-5-55-62
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618
   Farnum GA, 2014, BBA-BIOENERGETICS, V1837, P1113, DOI 10.1016/j.bbabio.2014.01.021
   Filatova AY, 2019, EUR J HUM GENET, V27, P488, DOI 10.1038/s41431-018-0288-y
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Garone C, 2017, HUM MOL GENET, V26, P4257, DOI 10.1093/hmg/ddx314
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hikmat O., 2020, J INHERIT METAB DIS
   Iodice A, 2016, J PEDIATR NEUROL, V14, P112, DOI 10.1055/s-0036-1586726
   Jaganathan K, 2019, CELL, V176, P535, DOI 10.1016/j.cell.2018.12.015
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kumar P., 2019, COLD SPRING HARB PRO, V2019
   [Курбатов С.А. Kurbatov S.A.], 2019, [Нервно-мышечные болезни, Neuromuscular Diseases, Nervno-myshechnye bolezni], V9, P67
   Kurbatov S.A., 2015, NEUROMUSC DIS, V2015, P2
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   López-Ferrando V, 2017, NUCLEIC ACIDS RES, V45, pW222, DOI 10.1093/nar/gkx313
   Malik AN, 2011, BIOCHEM BIOPH RES CO, V412, P1, DOI 10.1016/j.bbrc.2011.06.067
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   NOVAK RW, 1987, LAB MED, V18, P613, DOI 10.1093/labmed/18.9.613
   Pejaver V., 2017, 134981 BIORXIV
   Peter B, 2019, HUM MOL GENET, V28, P1090, DOI 10.1093/hmg/ddy415
   Piekutowska-Abramczuk D, 2019, MITOCHONDRION, V47, P179, DOI 10.1016/j.mito.2018.11.004
   Punzi G, 2018, HUM MOL GENET, V27, P499, DOI 10.1093/hmg/ddx419
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Scaglia F, 2018, PEDIATR CLIN N AM
   Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
NR 40
TC 10
Z9 11
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAR
PY 2021
VL 57
BP 205
EP 212
DI 10.1016/j.mito.2021.01.004
EA JAN 2021
PG 8
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA RY1HX
UT WOS:000647668600010
PM 33486010
DA 2024-11-01
ER

PT J
AU Lujan, SA
   Longley, MJ
   Humble, MH
   Lavender, CA
   Burkholder, A
   Blakely, EL
   Alston, CL
   Gorman, GS
   Turnbull, DM
   McFarland, R
   Taylor, RW
   Kunkel, TA
   Copeland, WC
AF Lujan, Scott A.
   Longley, Matthew J.
   Humble, Margaret H.
   Lavender, Christopher A.
   Burkholder, Adam
   Blakely, Emma L.
   Alston, Charlotte L.
   Gorman, Grainne S.
   Turnbull, Doug M.
   McFarland, Robert
   Taylor, Robert W.
   Kunkel, Thomas A.
   Copeland, William C.
TI Ultrasensitive deletion detection links mitochondrial DNA replication,
   disease, and aging
SO GENOME BIOLOGY
LA English
DT Article
ID HUMAN SKELETAL-MUSCLE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   POLYMERASE-GAMMA; SATELLITE CELLS; BODY-COMPOSITION; POINT MUTATIONS;
   COPY NUMBER; MTDNA; COMPLEMENTATION; ACCUMULATION
AB Background: Acquired human mitochondrial genome (mtDNA) deletions are symptoms and drivers of focal mitochondrial respiratory deficiency, a pathological hallmark of aging and late-onset mitochondrial disease.
   Results: To decipher connections between these processes, we create LostArc, an ultrasensitive method for quantifying deletions in circular mtDNA molecules. LostArc reveals 35 million deletions (similar to 470,000 unique spans) in skeletal muscle from 22 individuals with and 19 individuals without pathogenic variants in POLG. This nuclear gene encodes the catalytic subunit of replicative mitochondrial DNA polymerase gamma. Ablation, the deleted mtDNA fraction, suffices to explain skeletal muscle phenotypes of aging and POLG-derived disease. Unsupervised bioinformatic analyses reveal distinct age- and disease-correlated deletion patterns.
   Conclusions:These patterns implicate replication by DNA polymerase gamma as the deletion driver and suggest little purifying selection against mtDNA deletions by mitophagy in postmitotic muscle fibers. Observed deletion patterns are best modeled as mtDNA deletions initiated by replication fork stalling during strand displacement mtDNA synthesis.
C1 [Lujan, Scott A.; Kunkel, Thomas A.] NIEHS, Genome Integr & Struct Biol Lab, DNA Replicat Fidel Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.
   [Longley, Matthew J.; Humble, Margaret H.; Copeland, William C.] NIEHS, Genome Integr & Struct Biol Lab, Mitochondrial DNA Replicat Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.
   [Lavender, Christopher A.; Burkholder, Adam] NIEHS, Integrat Bioinformat, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.
   [Blakely, Emma L.; Alston, Charlotte L.; Gorman, Grainne S.; Turnbull, Doug M.; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Fac Med Sci, Translat & Clin Res Inst, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Blakely, Emma L.; Alston, Charlotte L.; Taylor, Robert W.] Newcastle Upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Mitochondrial Diagnost Lab, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS); National Institutes of Health
   (NIH) - USA; NIH National Institute of Environmental Health Sciences
   (NIEHS); National Institutes of Health (NIH) - USA; NIH National
   Institute of Environmental Health Sciences (NIEHS); Newcastle University
   - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust
RP Copeland, WC (corresponding author), NIEHS, Genome Integr & Struct Biol Lab, Mitochondrial DNA Replicat Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
RI Alston, Charlotte/ABG-9602-2020; Kunkel, Thomas/D-5088-2019; Copeland,
   William/C-4242-2019
OI Burkholder, Adam/0000-0002-0237-6920; Copeland,
   William/0000-0002-0359-0953
FU Division of Intramural Research of the NIH, NIEHS [Z01 ES065070, Z01
   ES065078, Z01 ES065080]; Wellcome Centre for Mitochondrial Research
   [203105/Z/16/Z]; Medical Research Council International Centre for
   Genomic Medicine in Neuromuscular Disease, Mitochondrial Disease Patient
   Cohort (UK) [G0800674]; UK National Institute for Health Research (NIHR)
   Biomedical Research Centre for Ageing and Age-related disease award;
   MRC/EPSRC Molecular Pathology Node; Lily Foundation; UK NHS Highly
   Specialised Service for Rare Mitochondrial Disorders of Adults and
   Children; NIHR [PDF-2018-11-ST2-02]; MRC [G0800674] Funding Source: UKRI
FX This work was supported by Projects Z01 ES065070 to T.A.K. and Z01
   ES065078 and Z01 ES065080 to W.C.C. from the Division of Intramural
   Research of the NIH, NIEHS. Work in Newcastle is supported by the
   Wellcome Centre for Mitochondrial Research (203105/Z/16/Z), the Medical
   Research Council International Centre for Genomic Medicine in
   Neuromuscular Disease, Mitochondrial Disease Patient Cohort (UK)
   (G0800674), the UK National Institute for Health Research (NIHR)
   Biomedical Research Centre for Ageing and Age-related disease award to
   the Newcastle upon Tyne Foundation Hospitals NHS Trust, the MRC/EPSRC
   Molecular Pathology Node, The Lily Foundation, and the UK NHS Highly
   Specialised Service for Rare Mitochondrial Disorders of Adults and
   Children. C.L.A. is supported by an NIHR postdoctoral fellowship
   (PDF-2018-11-ST2-02).1.
CR Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119
   Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Bai RK, 2004, ANN NY ACAD SCI, V1011, P304, DOI 10.1196/annals.1293.029
   Bailey LJ, 2017, BIOCHEM SOC T, V45, P513, DOI 10.1042/BST20160162
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bosworth CM, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1821-7
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Burkholder AB, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4753-3
   Chen XJ, 2018, MITOCHONDRION, V38, P17, DOI 10.1016/j.mito.2017.07.009
   Chinnery Patrick F, 2008, Neuromuscul Disord, V18, P259, DOI 10.1016/j.nmd.2007.11.005
   Chinnery PF, 2002, TRENDS GENET, V18, P173, DOI 10.1016/S0168-9525(01)02636-1
   CHOWDHURY B, 1994, INT J OBESITY, V18, P219
   Chrysostomou A, 2016, NEUROPATH APPL NEURO, V42, P477, DOI 10.1111/nan.12282
   Ciesielski GL, 2016, ENZYMES, V39, P255, DOI 10.1016/bs.enz.2016.03.006
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Cristea A, 2010, AGING CELL, V9, P685, DOI 10.1111/j.1474-9726.2010.00594.x
   Damas J, 2014, NUCLEIC ACIDS RES, V42, pD1261, DOI 10.1093/nar/gkt982
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   Del Dotto V, 2020, J CLIN INVEST, V130, P108, DOI 10.1172/JCI128514
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gouzi F, 2013, J APPL PHYSIOL, V115, P346, DOI 10.1152/japplphysiol.01352.2012
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Gustafson MA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221829
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Hjelm BE, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz164
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Hood DA, 2019, ANNU REV PHYSIOL, V81, P19, DOI 10.1146/annurev-physiol-020518-114310
   Joers P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053249
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794
   Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202. Article published online before March 2002
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   KUNKEL TA, 1986, J BIOL CHEM, V261, P3581
   Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153
   Lavender C.A., 2020, ROTLA READER LOST AR
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595
   Lewis SC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004985
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   LONN L, 1994, METABOLISM, V43, P1517, DOI 10.1016/0026-0495(94)90010-8
   Lott MT., 2013, Curr Protoc Bioinf, V44, P1231, DOI DOI 10.1002/0471250953.BI0123S44
   Lujan S.A., 2020, DNA DATASETS
   Lujan SA, 2016, TRENDS CELL BIOL, V26, P640, DOI 10.1016/j.tcb.2016.04.012
   Martin M., 2011, EMBnet.journal, V17, P10, DOI 10.14806/ej.17.1.200
   McKinney EA, 2013, GENET MOL BIOL, V36, P308, DOI 10.1590/s1415-47572013000300002
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Ng YS, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000181
   Nicholls TJ, 2018, MOL CELL, V69, P9, DOI 10.1016/j.molcel.2017.11.033
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Pedregosa F, 2011, J MACH LEARN RES, V12, P2825
   Persson Ö, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08673-5
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014
   Phillips NR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03887
   Pohjoismäki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Reyes A, 2013, NUCLEIC ACIDS RES, V41, P5837, DOI 10.1093/nar/gkt196
   ROBBERSO.DL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810
   Sajko S, 2004, J HISTOCHEM CYTOCHEM, V52, P179, DOI 10.1177/002215540405200205
   Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587
   Sato A, 2009, BIOFACTORS, V35, P130, DOI 10.1002/biof.14
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schon EA, 2010, BBA-GEN SUBJECTS, V1800, P245, DOI 10.1016/j.bbagen.2009.07.007
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014
   Stumpf JD, 2013, GENETICS, V194, P519, DOI 10.1534/genetics.113.150920
   SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146
   Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146
   Tengan CH, 1996, BIOCHEM MOL MED, V58, P130, DOI 10.1006/bmme.1996.0040
   Teo SM, 2012, BIOINFORMATICS, V28, P2711, DOI 10.1093/bioinformatics/bts535
   Torregrosa-Muñumer R, 2017, P NATL ACAD SCI USA, V114, P11398, DOI 10.1073/pnas.1705367114
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Verdijk LB, 2014, AGE, V36, P545, DOI 10.1007/s11357-013-9583-2
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vincent AE, 2018, ANN NEUROL, V84, P289, DOI 10.1002/ana.25288
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wachsmuth M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005939
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220
   Wanagat J, 2015, EXP GERONTOL, V61, P15, DOI 10.1016/j.exger.2014.11.012
   Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002
   Yasukawa T, 2018, J BIOCHEM, V164, P183, DOI 10.1093/jb/mvy058
   YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   Zhao LL, 2019, ENZYMES, V45, P311, DOI 10.1016/bs.enz.2019.08.004
NR 106
TC 42
Z9 45
U1 1
U2 14
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-760X
J9 GENOME BIOL
JI Genome Biol.
PD SEP 17
PY 2020
VL 21
IS 1
AR 248
DI 10.1186/s13059-020-02138-5
PG 34
WC Biotechnology & Applied Microbiology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA NV9FG
UT WOS:000574617200001
PM 32943091
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Lorenzoni, PJ
   Scola, RH
   Kay, CSK
   Arndt, RC
   Silvado, CE
   Werneck, LC
AF Lorenzoni, Paulo Jose
   Scola, Rosana H.
   Kay, Claudia S. Kamoi
   Arndt, Raquel C.
   Silvado, Carlos E.
   Werneck, Lineu C.
TI MERRF: Clinical features, muscle biopsy and molecular genetics in
   Brazilian patients
SO MITOCHONDRION
LA English
DT Article
DE MERRF; Mitochondrial DNA; Mitochondrial myopathy; Muscle biopsy;
   Genetics
ID RAGGED-RED FIBERS; MITOCHONDRIAL DISORDERS; MYOCLONIC EPILEPSY
AB Myoclonic epilepsy with ragged red fibers (MERRF) is a mitochondrial disease that is characterized by myoclonic epilepsy with ragged red fibers (RRF) in muscle biopsies. The aim of this study was to analyze Brazilian patients with MERRF. Six patients with MERRF were studied and correlations between clinical findings, laboratory data, electrophysiology, histology and molecular features were examined. We found that blood lactate was increased in four patients. Electroencephalogram studies revealed generalized epileptiform discharges in five patients and generalized photoparoxysmal responses during intermittent photic stimulation in two patients. Muscle biopsies showed RRF in all patients using modified Gomori-trichrome and succinate dehydrogenase stains. Cytochrome c oxidase (COX) stain analysis indicated deficient activity in five patients and subsarcolemmal accumulation in one patient. Molecular analysis of the tRNA(Lys) gene with PCR/RFLP and direct sequencing showed the A8344G mutation of mtDNA in five patients. The presence of RRFs and COX deficiencies in muscle biopsies often confirmed the MERRF diagnosis. We conclude that molecular analysis of the tRNA(Lys) gene is an important criterion to help confirm the MERRF diagnosis. Furthermore, based on the findings of this study, we suggest a revision of the main characteristics of this disease. (C) 2011 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Lorenzoni, Paulo Jose; Scola, Rosana H.; Kay, Claudia S. Kamoi; Arndt, Raquel C.; Silvado, Carlos E.; Werneck, Lineu C.] Univ Fed Parana, Dept Internal Med, Div Neurol, BR-80060900 Curitiba, Parana, Brazil.
C3 Universidade Federal do Parana
RP Scola, RH (corresponding author), Univ Fed Parana, Hosp Clin, Serv Neurol, Rua Gen Carneiro 181, BR-80060900 Curitiba, Parana, Brazil.
EM scola@hc.ufpr.br
RI Werneck, Lineu/Y-4038-2019; Silvado, Carlos/V-5207-2019; Silvado,
   Carlos/D-5903-2013
OI Silvado, Carlos/0000-0003-2482-893X
FU Fundacao Araucaria; CAPES; CNPq
FX This study was supported by Fundacao Araucaria, CAPES and CNPq.
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Arruda W O, 1990, Arq Neuropsiquiatr, V48, P32
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   Da Cunha FMB, 2006, MUSCLE NERVE, V33, P409, DOI 10.1002/mus.20465
   DiMauro S, 2002, ADV NEUROL, V89, P217
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   FUKUHARA N, 1995, MUSCLE NERVE, pS90
   Haas R, 2004, MITOCHONDRION, V4, P471, DOI 10.1016/j.mito.2004.07.008
   LARSSON NG, 1995, MUSCLE NERVE, pS102
   Lorenzoni PJ, 2009, ARQ NEURO-PSIQUIAT, V67, P668, DOI 10.1590/S0004-282X2009000400018
   OZAWA M, 1995, NEUROMUSCULAR DISORD, V5, P483, DOI 10.1016/0960-8966(95)00009-C
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Shahwan A, 2005, LANCET NEUROL, V4, P239, DOI 10.1016/S1474-4422(05)70043-0
   SHOFFNER JM, 1992, AM J HUM GENET, V51, P1179
   Sinha S, 2007, J NEUROL SCI, V252, P16, DOI 10.1016/j.jns.2006.09.021
   Werneck LC, 1981, REV BRAS CLIN TERAP, P2
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 17
TC 30
Z9 31
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAY
PY 2011
VL 11
IS 3
BP 528
EP 532
DI 10.1016/j.mito.2011.01.003
PG 5
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 753HS
UT WOS:000289763500020
PM 21303704
DA 2024-11-01
ER

PT J
AU Reyes, A
   Melchionda, L
   Nasca, A
   Carrara, F
   Lamantea, E
   Zanolini, A
   Lamperti, C
   Fang, MY
   Zhang, JG
   Ronchi, D
   Bonato, S
   Fagiolari, G
   Moggio, M
   Ghezzi, D
   Zeviani, M
AF Reyes, Aurelio
   Melchionda, Laura
   Nasca, Alessia
   Carrara, Franco
   Lamantea, Eleonora
   Zanolini, Alice
   Lamperti, Costanza
   Fang, Mingyan
   Zhang, Jianguo
   Ronchi, Dario
   Bonato, Sara
   Fagiolari, Gigliola
   Moggio, Maurizio
   Ghezzi, Daniele
   Zeviani, Massimo
TI <i>RNASEH1</i> Mutations Impair mtDNA Replication and Cause Adult-Onset
   Mitochondrial Encephalomyopathy
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID DNA REPLICATION; H1; POLYMERASE; EXPRESSION; SUBUNIT; DISEASE; CELLS;
   MICE
AB Chronic progressive external ophthalmoplegia (CPEO) is common in mitochondrial disorders and is frequently associated with multiple mtDNA deletions. The onset is typically in adulthood, and affected subjects can also present with general muscle weakness. The underlying genetic defects comprise autosomal-dominant or recessive mutations in several nuclear genes, most of which play a role in mtDNA replication. Next-generation sequencing led to the identification of compound-heterozygous RNASEH1 mutations in two singleton subjects and a homozygous mutation in four siblings. RNASEH1, encoding ribonuclease H1 (RNase H1), is an endonuclease that is present in both the nucleus and mitochondria and digests the RNA component of RNA-DNA hybrids. Unlike mitochondria, the nucleus harbors a second ribonuclease (RNase H2). All affected individuals first presented with CPEO and exercise intolerance in their twenties, and these were followed by muscle weakness, dysphagia, and spino-cerebellar signs with impaired gait coordination, dysmetria, and dysarthria. Ragged-red and cytochrome c oxidase (COX)-negative fibers, together with impaired activity of various mitochondrial respiratory chain complexes, were observed in muscle biopsies of affected subjects. Western blot analysis showed the virtual absence of RNase H1 in total lysate from mutant fibroblasts. By an in vitro assay, we demonstrated that altered RNase H1 has a reduced capability to remove the RNA from RNA-DNA hybrids, confirming their pathogenic role. Given that an increasing amount of evidence indicates the presence of RNA primers during mtDNA replication, this result might also explain the accumulation of mtDNA deletions and underscores the importance of RNase H1 for mtDNA maintenance.
C1 [Reyes, Aurelio; Zeviani, Massimo] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England.
   [Melchionda, Laura; Nasca, Alessia; Carrara, Franco; Lamantea, Eleonora; Zanolini, Alice; Lamperti, Costanza; Ghezzi, Daniele] Fdn IRCCS Ist Neurol Carlo Besta, Unit Mol Neurogenet, I-20126 Milan, Italy.
   [Fang, Mingyan; Zhang, Jianguo] Beijing Genom Inst, Shenzhen 518083, Peoples R China.
   [Ronchi, Dario; Bonato, Sara] Univ Milan, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Neurol Unit,Neurosci Sect,Dino Ferrari Ctr, I-20122 Milan, Italy.
   [Fagiolari, Gigliola; Moggio, Maurizio] Univ Milan, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Neuromuscular Unit,Neurosci Sect,Dino Ferrari Ctr, I-20122 Milan, Italy.
C3 Fondazione IRCCS Istituto Neurologico Carlo Besta; Beijing Genomics
   Institute (BGI); IRCCS Ca Granda Ospedale Maggiore Policlinico;
   University of Milan; University of Milan; IRCCS Ca Granda Ospedale
   Maggiore Policlinico
RP Ghezzi, D (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Unit Mol Neurogenet, I-20126 Milan, Italy.
EM daniele.ghezzi@istituto-besta.it; mdz21@mrc-mbu.cam.ac.uk
RI Ronchi, Dario/K-8011-2016; Zeviani, Massimo/AAU-2632-2021; lamperti,
   costanza/J-8801-2016; Fang, Mingyan/B-8505-2017; Lamantea,
   Eleonora/J-8339-2016; Ghezzi, Daniele/J-7873-2016; Nasca,
   Alessia/K-2227-2016
OI Lamantea, Eleonora/0000-0001-5090-6028; Ghezzi,
   Daniele/0000-0002-6564-3766; Nasca, Alessia/0000-0002-0640-9929; Zhang,
   Jianguo/0000-0003-0723-1701; Fang, Mingyan/0000-0001-7185-6445; Ronchi,
   Dario/0000-0002-6093-9816; Zeviani, Massimo/0000-0002-9067-5508
FU "Cell Lines and DNA Bank of Paediatric Movement Disorders and
   Neurodegenerative Diseases" of the Telethon Network of Genetic Biobanks
   [GTB12001J]; EurobiobanK Network; Medical Research Council; Pierfranco
   and Luisa Mariani Foundation; Telethon [GGP11011]; Italian Ministry of
   Health [GR2010-2316392]; European Research Council [FP7-322424]; MRC
   [MC_UP_1002/1] Funding Source: UKRI
FX We acknowledge the "Cell Lines and DNA Bank of Paediatric Movement
   Disorders and Neurodegenerative Diseases" of the Telethon Network of
   Genetic Biobanks (grant GTB12001J) and the EurobiobanK Network. This
   work was supported by the Medical Research Council, the Pierfranco and
   Luisa Mariani Foundation, Telethon grant GGP11011, the Italian Ministry
   of Health (grant GR2010-2316392), and European Research Council advanced
   grant FP7-322424.
CR Alla NR, 2012, FEBS J, V279, P4492, DOI 10.1111/febs.12035
   Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091
   Cerritelli SM, 1998, GENOMICS, V53, P300, DOI 10.1006/geno.1998.5497
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Di Re M, 2009, NUCLEIC ACIDS RES, V37, P5701, DOI 10.1093/nar/gkp614
   He J, 2012, NUCLEIC ACIDS RES, V40, P6097, DOI 10.1093/nar/gks257
   Holt IJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012971
   Kazak L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062340
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Lamperti C, 2009, Acta Myol, V28, P2
   Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336
   Pohjoismäki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029
   Reyes A, 2013, NUCLEIC ACIDS RES, V41, P5837, DOI 10.1093/nar/gkt196
   Reyes A, 2009, METHODS MOL BIOL, V554, P15, DOI 10.1007/978-1-59745-521-3_2
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ruhanen H, 2011, BBA-MOL CELL RES, V1813, P2000, DOI 10.1016/j.bbamcr.2011.08.008
   Stewart JD, 2011, BBA-MOL BASIS DIS, V1812, P321, DOI 10.1016/j.bbadis.2010.11.012
   Suzuki Y, 2010, MOL CELL BIOL, V30, P5123, DOI 10.1128/MCB.00619-10
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wu HJ, 2001, J BIOL CHEM, V276, P23547, DOI 10.1074/jbc.M009676200
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
NR 22
TC 78
Z9 86
U1 0
U2 7
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD JUL 2
PY 2015
VL 97
IS 1
BP 186
EP 193
DI 10.1016/j.ajhg.2015.05.013
PG 8
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA CN1OO
UT WOS:000358189500017
PM 26094573
OA Green Published, Bronze, Green Submitted
DA 2024-11-01
ER

PT J
AU Arnestad, M
   Opdal, SH
   Vege, Å
   Rognum, TO
AF Arnestad, Marianne
   Opdal, Siri Hauge
   Vege, Ashild
   Rognum, Torleiv Ole
TI A mitochondrial DNA polymorphism associated with cardiac arrhythmia
   investigated in sudden infant death syndrome
SO ACTA PAEDIATRICA
LA English
DT Article
DE cardiac arrhythmia; LQTS; mitochondrial myopathy; mtDNA; SIDS
ID HEREDITARY OPTIC NEUROPATHY; LONG-QT SYNDROME; SLEEPING INFANTS; MTDNA;
   CARDIOMYOPATHY; MUTATION; DISEASES; HEART
AB Aim: Long QT syndrome (LQTS) has been shown to be the cause of death in some cases originally diagnosed as sudden infant death syndrome (SIDS). Such cardiac arrhythmias have also been noted in families with mitochondrial disease, and studies indicate that mitochondrial disease could be involved in SIDS. This makes the mtDNA polymorphism T3394C interesting, as a previous study has shown it to be associated with electrocardiographic (ECG) changes after exercise in a family with LQTS, where some members harboured a KCNH2 mutation.
   Subjects: A total of 245 SIDS cases and 176 control cases.
   Methods: DNA was prepared from blood/tissue samples. Polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) were performed to search for the mtDNA polymorphism and KCNH2 mutation. Differences were confirmed by sequencing.
   Results: The T3394C polymorphism was found in 3 pure SIDS cases (1.5%), 2 borderline SIDS cases (4.4%), 1 case of explained death (1.6%) and 2 living control cases (1.8%) (p = 0.62). The KCNH2 mutation was not found in cases or controls.
   Conclusion: The mtDNA polymorphism studied was found in a small number of SIDS cases and the frequency did not differ statistically from control subjects, making an association with increased SIDS risk unlikely.
C1 Univ Oslo, Inst Forens Med, Oslo, Norway.
C3 University of Oslo
RP Arnestad, M (corresponding author), Natl Hosp Norway, Inst Forens Med, N-0027 Oslo, Norway.
EM marianne.arnestad@medisin.ui.no
CR Ackerman MJ, 2001, JAMA-J AM MED ASSOC, V286, P2264, DOI 10.1001/jama.286.18.2264
   Ackerman MJ, 1998, MAYO CLIN PROC, V73, P250, DOI 10.4065/73.3.250
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Arnestad M, 2002, ACTA PAEDIATR, V91, P1060, DOI 10.1080/080352502760311557
   Arnestad M, 2001, ARCH DIS CHILD, V85, P108, DOI 10.1136/adc.85.2.108
   ARNESTAD M, 2005, HEART RHYTHM, V2, pP1
   Brown MD, 1997, AM J HUM GENET, V60, P381
   BROWN MD, 1992, FASEB J, V6, P2791, DOI 10.1096/fasebj.6.10.1634041
   Crotti L, 2005, CIRCULATION, V112, P1251, DOI 10.1161/CIRCULATIONAHA.105.549071
   Gregersen M., 1995, P50
   Hauck F R, 2000, Curr Probl Pediatr, V30, P237
   Hlaing T, 2005, ANN NONINVAS ELECTRO, V10, P211, DOI 10.1111/j.1542-474X.2005.05588.x
   JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5
   Matsuoka R, 1999, BIOCHEM BIOPH RES CO, V257, P228, DOI 10.1006/bbrc.1999.0443
   NIKOSKELAINEN E, 1985, LANCET, V1, P696
   OBAYASHI T, 1992, AM HEART J, V124, P1263, DOI 10.1016/0002-8703(92)90410-W
   Opdal SH, 2002, PEDIATR NEUROL, V27, P23, DOI 10.1016/S0887-8994(02)00384-3
   Passarino G, 2002, EUR J HUM GENET, V10, P521, DOI 10.1038/sj.ejhg.5200834
   ROGNUM TO, 1991, PEDIATRICS, V87, P306
   ROGNUM TO, 2004, SCAND J FORENS SCI, P10
   Schwartz PJ, 1998, NEW ENGL J MED, V338, P1709, DOI 10.1056/NEJM199806113382401
   Schwartz PJ., 2001, Sudden Infant Death Syndrome, P83
   SILVESTRI G, 1994, HUM MUTAT, V3, P37, DOI 10.1002/humu.1380030107
   Tester DJ, 2005, CARDIOVASC RES, V67, P388, DOI 10.1016/j.cardiores.2005.02.013
   Thomas AW, 1996, J MED GENET, V33, P253, DOI 10.1136/jmg.33.3.253
   Tuffnell CS, 1996, ARCH DIS CHILD, V75, P249, DOI 10.1136/adc.75.3.249
   Tuffnell CS, 1995, EARLY HUM DEV, V43, P109, DOI 10.1016/0378-3782(95)01659-7
   Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4
   Wallington TJ, 2002, HANDB ENVIRON CHEM, V3, P85
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
NR 30
TC 11
Z9 13
U1 0
U2 2
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0803-5253
J9 ACTA PAEDIATR
JI Acta Paediatr.
PD FEB
PY 2007
VL 96
IS 2
BP 206
EP 210
DI 10.1111/j.1651-2227.2007.00022.x
PG 5
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA 133DZ
UT WOS:000243993800014
PM 17429906
DA 2024-11-01
ER

PT J
AU Vincent, AE
   Ng, YS
   White, K
   Davey, T
   Mannella, C
   Falkous, G
   Feeney, C
   Schaefer, AM
   McFarland, R
   Gorman, GS
   Taylor, RW
   Turnbull, DM
   Picard, M
AF Vincent, Amy E.
   Ng, Yi Shiau
   White, Kathryn
   Davey, Tracey
   Mannella, Carmen
   Falkous, Gavin
   Feeney, Catherine
   Schaefer, Andrew M.
   McFarland, Robert
   Gorman, Grainne S.
   Taylor, Robert W.
   Turnbull, Doug M.
   Picard, Martin
TI The Spectrum of Mitochondrial Ultrastructural Defects in Mitochondrial
   Myopathy
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; SKELETAL-MUSCLE; INNER-MEMBRANE;
   ATP SYNTHASE; RESPIRATORY-CHAIN; CRISTAE; MORPHOLOGY; TOPOLOGY; PROTEIN;
   INCLUSIONS
AB Mitochondrial functions are intrinsically linked to their morphology and membrane ultrastructure. Characterizing abnormal mitochondrial structural features may thus provide insight into the underlying pathogenesis of inherited and acquired mitochondrial diseases. Following a systematic literature review on ultrastructural defects in mitochondrial myopathy, we investigated skeletal muscle biopsies from seven subjects with genetically defined mtDNA mutations. Mitochondrial ultrastructure and morphology were characterized using two complimentary approaches: transmission electron microscopy (TEM) and serial block face scanning EM (SBF-SEM) with 3D reconstruction. Six ultrastructural abnormalities were identified including i) paracrystalline inclusions, ii) linearization of cristae and abnormal angular features, iii) concentric layering of cristae membranes, iv) matrix compartmentalization, v) nanotunelling, and vi) donut-shaped mitochondria. In light of recent molecular advances in mitochondrial biology, these findings reveal novel aspects of mitochondrial ultrastructure and morphology in human tissues with implications for understanding the mechanisms linking mitochondrial dysfunction to disease.
C1 [Vincent, Amy E.; Ng, Yi Shiau; Falkous, Gavin; Feeney, Catherine; Schaefer, Andrew M.; McFarland, Robert; Gorman, Grainne S.; Taylor, Robert W.; Turnbull, Doug M.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [White, Kathryn; Davey, Tracey] Newcastle Univ, EM Res Serv, Newcastle Upon Tyne, Tyne & Wear, England.
   [Mannella, Carmen] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA.
   [Picard, Martin] Columbia Univ, Dept Psychiat, Div Behav Med, Med Ctr, New York, NY 10027 USA.
   [Picard, Martin] Columbia Univ, Dept Neurol, H Houston Merritt Ctr, Med Ctr, New York, NY 10027 USA.
   [Picard, Martin] Columbia Univ, Med Ctr, H Houston Merritt Ctr, Columbia Translat Neurosci Initiat, New York, NY 10027 USA.
C3 Newcastle University - UK; Newcastle University - UK; Wadsworth Center;
   State University of New York (SUNY) System; Columbia University;
   Columbia University; Columbia University
RP Picard, M (corresponding author), Columbia Univ, Dept Psychiat, Div Behav Med, Med Ctr, New York, NY 10027 USA.; Picard, M (corresponding author), Columbia Univ, Dept Neurol, H Houston Merritt Ctr, Med Ctr, New York, NY 10027 USA.; Picard, M (corresponding author), Columbia Univ, Med Ctr, H Houston Merritt Ctr, Columbia Translat Neurosci Initiat, New York, NY 10027 USA.
EM mp3484@columbia.edu
RI Vincent, Amy/J-7284-2019; Ng, Yi/AFF-1445-2022; Davey,
   Tracey/JWA-4940-2024
OI Gorman, Grainne/0000-0002-7585-3409; Vincent, Amy/0000-0002-0360-6644;
   Turnbull, Doug/0000-0002-8878-9901; Feeney,
   Catherine/0000-0003-3189-3991; Davey, Tracey/0000-0001-9409-7410; Ng, Yi
   Shiau/0000-0002-7591-2034; Picard, Martin/0000-0003-2835-0478; Schaefer,
   Andrew/0000-0001-9891-7332; McFarland, Robert/0000-0002-8833-2688
FU Biotechnology and Biological Sciences Research Council [BB/M012093/1];
   Engineering and Physical Sciences Research Council; Economic and Social
   Research Council; Medical Research Council [G0700718]; Wellcome Trust
   Centre [G906919]; UK NIHR Biomedical Research Centre; MRC studentship as
   part of the MRC Centre [MR/K501074/1, MR/K000608/1]; BBSRC
   [BB/M012093/1] Funding Source: UKRI; MRC [MR/K000608/1, G0800674,
   MC_G0802536, G0700718, MR/L016354/1] Funding Source: UKRI
FX This work was supported by grants from the Biotechnology and Biological
   Sciences Research Council BB/M012093/1, Engineering and Physical
   Sciences Research Council, Economic and Social Research Council and
   Medical Research Council G0700718, The Wellcome Trust Centre for
   Mitochondrial Research G906919, The MRC Centre for Translational
   Research in Neuromuscular Disease Mitochondrial Disease Patient Cohort
   G0800674, the UK NIHR Biomedical Research Centre in Age and Age Related
   Diseases award to the Newcastle upon Tyne Hospitals NHS Foundation
   Trust, The Lily Foundation and the UK NHS Specialist Commissioners "Rare
   Mitochondrial Disorders of Adults and Children" Service. AEV is funded
   by an MRC studentship (MR/K501074/1) as part of the MRC Centre for
   Neuromuscular disease (MR/K000608/1).
CR Ahmad T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.213
   AMCHENKOVA AA, 1988, J CELL BIOL, V107, P481, DOI 10.1083/jcb.107.2.481
   Barbot M, 2015, CELL METAB, V21, P756, DOI 10.1016/j.cmet.2015.04.006
   Bhandari P, 2014, CIRC RES, V114, P257, DOI 10.1161/CIRCRESAHA.114.302734
   Chae S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003266
   CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65
   Cogliati S., 2016, TRENDS BIOCH SCI
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Daum B, 2013, P NATL ACAD SCI USA, V110, P15301, DOI 10.1073/pnas.1305462110
   De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230
   Deerinck T.J., 2010, Microscopy, V1, P6
   Domènech O, 2007, BBA-BIOMEMBRANES, V1768, P100, DOI 10.1016/j.bbamem.2006.06.012
   Dudkina NV, 2005, FEBS LETT, V579, P5769, DOI 10.1016/j.febslet.2005.09.065
   Eisner V, 2014, J CELL BIOL, V205, P179, DOI 10.1083/jcb.201312066
   EPPENBERGEREBERHARDT M, 1991, J CELL BIOL, V113, P289, DOI 10.1083/jcb.113.2.289
   Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Fujioka H, 2013, MICROSC RES TECHNIQ, V76, P237, DOI 10.1002/jemt.22158
   HAMMERSEN F, 1980, ACTA NEUROPATHOL, V49, P35, DOI 10.1007/BF00692217
   Hara Y, 2014, P NATL ACAD SCI USA, V111, P486, DOI 10.1073/pnas.1311310110
   Huang XH, 2013, P NATL ACAD SCI USA, V110, P2846, DOI 10.1073/pnas.1300741110
   HULSMANN WC, 1967, J NEUROL NEUROSUR PS, V30, P519, DOI 10.1136/jnnp.30.6.519
   Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199
   John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.E04-08-0697
   Kanazawa T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000022
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Leduc-Gaudet JP, 2015, ONCOTARGET, V6, P17923, DOI 10.18632/oncotarget.4235
   Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009
   Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13
   Logan CV, 2014, NAT GENET, V46, P188, DOI 10.1038/ng.2851
   Mannella CA, 2006, BBA-MOL BASIS DIS, V1762, P140, DOI 10.1016/j.bbadis.2005.07.001
   Mannella CA, 2013, J MOL CELL CARDIOL, V62, P51, DOI 10.1016/j.yjmcc.2013.05.001
   Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949
   Meimaridou E, 2012, NAT GENET, V44, P740, DOI 10.1038/ng.2299
   Melberg A, 1996, MUSCLE NERVE, V19, P751
   MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x
   MITSUMOTO H, 1983, NEUROLOGY, V33, P452, DOI 10.1212/WNL.33.4.452
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221
   PAYNE CM, 1975, J NEUROL SCI, V25, P99, DOI 10.1016/0022-510X(75)90190-2
   Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011
   Pfanner N, 2014, J CELL BIOL, V204, P1083, DOI 10.1083/jcb.201401006
   Phan Minh D., 2015, BIOPHYS J, V108, P1977
   Picard M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7259
   Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111
   Picard M, 2013, J APPL PHYSIOL, V114, P161, DOI 10.1152/japplphysiol.01096.2012
   Picard M, 2012, BIOESSAYS, V34, P272, DOI 10.1002/bies.201100179
   PRICE HM, 1967, J NEUROPATH EXP NEUR, V26, P475, DOI 10.1097/00005072-196707000-00009
   Rabl R, 2009, J CELL BIOL, V185, P1047, DOI 10.1083/jcb.200811099
   Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025
   Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512
   Shutt TE, 2013, BBA-MOL CELL RES, V1833, P417, DOI 10.1016/j.bbamcr.2012.05.024
   Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Tesson C, 2012, AM J HUM GENET, V91, P1051, DOI 10.1016/j.ajhg.2012.11.001
   van der Laan M, 2012, TRENDS CELL BIOL, V22, P185, DOI 10.1016/j.tcb.2012.01.004
   VANWIJNGAARDEN GK, 1967, BRAIN, V90, P577, DOI 10.1093/brain/90.3.577
   Varanita T, 2015, CELL METAB, V21, P834, DOI 10.1016/j.cmet.2015.05.007
   Wang C, 2015, CELL RES, V25, P1108, DOI 10.1038/cr.2015.89
   Weber TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063683
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013
NR 63
TC 154
Z9 166
U1 1
U2 35
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 10
PY 2016
VL 6
AR 30610
DI 10.1038/srep30610
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA DS9RN
UT WOS:000381121100001
PM 27506553
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Wang, WY
   Shen, PD
   Thiyagarajan, S
   Lin, SR
   Palm, C
   Horvath, R
   Klopstock, T
   Cutler, D
   Pique, L
   Schrijver, I
   Davis, RW
   Mindrinos, M
   Speed, TP
   Scharfe, C
AF Wang, Wenyi
   Shen, Peidong
   Thiyagarajan, Sreedevi
   Lin, Shengrong
   Palm, Curtis
   Horvath, Rita
   Klopstock, Thomas
   Cutler, David
   Pique, Lynn
   Schrijver, Iris
   Davis, Ronald W.
   Mindrinos, Michael
   Speed, Terence P.
   Scharfe, Curt
TI Identification of rare DNA variants in mitochondrial disorders with
   improved array-based sequencing
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; HIGH-THROUGHPUT; MICROARRAYS;
   MUTATIONS; GENES; DELETIONS; ALGORITHM; GENOME; MODEL; POLYMORPHISMS
AB A common goal in the discovery of rare functional DNA variants via medical resequencing is to incur a relatively lower proportion of false positive base-calls. We developed a novel statistical method for resequencing arrays (SRMA, sequence robust multi-array analysis) to increase the accuracy of detecting rare variants and reduce the costs in subsequent sequence verifications required in medical applications. SRMA includes single and multi-array analysis and accounts for technical variables as well as the possibility of both low- and high-frequency genomic variation. The confidence of each base-call was ranked using two quality measures. In comparison to Sanger capillary sequencing, we achieved a false discovery rate of 2% (false positive rate 1.2 x 10(-5), false negative rate 5%), which is similar to automated second-generation sequencing technologies. Applied to the analysis of 39 nuclear candidate genes in disorders of mitochondrial DNA (mtDNA) maintenance, we confirmed mutations in the DNA polymerase gamma POLG in positive control cases, and identified novel rare variants in previously undiagnosed cases in the mitochondrial topoisomerase TOP1MT, the mismatch repair enzyme MUTYH, and the apurinic-apyrimidinic endonuclease APEX2. Some patients carried rare heterozygous variants in several functionally interacting genes, which could indicate synergistic genetic effects in these clinically similar disorders.
C1 [Wang, Wenyi; Shen, Peidong; Thiyagarajan, Sreedevi; Lin, Shengrong; Palm, Curtis; Davis, Ronald W.; Mindrinos, Michael; Scharfe, Curt] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA.
   [Wang, Wenyi; Speed, Terence P.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA.
   [Horvath, Rita] Newcastle Univ, Inst Hlth & Aging, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Klopstock, Thomas] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80336 Munich, Germany.
   [Cutler, David] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA.
   [Pique, Lynn; Schrijver, Iris] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.
   [Schrijver, Iris] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.
C3 Stanford University; University of California System; University of
   California Berkeley; Newcastle University - UK; University of Munich;
   Emory University; Stanford University; Stanford University
RP Scharfe, C (corresponding author), Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA.
EM wenyiw@stanford.edu; curts@stanford.edu
RI Horvath, Rita/AAY-7042-2020; Speed, Terence/B-8085-2009; Fentaw,
   Eshetu/JFK-8917-2023; Thiyagarajan, Sreedevi/KHV-5206-2024; WANG,
   YANAN/KCL-4840-2024
OI Horvath, Rita/0000-0002-9841-170X; Thiyagarajan, Sreedevi
   (Sree)/0000-0002-5166-4371; Wang, Wenyi/0000-0003-0617-9438
FU National Eye Institute [R01EY016240]; German Ministry of Education and
   Research (BMBF); National Institutes of Health
FX National Eye Institute grant (R01EY016240 to R.W.D. and C.S.); T.K. is a
   member of MitoNET funded by the German Ministry of Education and
   Research (BMBF). Funding for open access charge: National Institutes of
   Health.
CR Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828
   Arenas J, 2003, ANN NEUROL, V53, P278, DOI 10.1002/ana.10430
   Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348
   BANFIELD JD, 1993, BIOMETRICS, V49, P803, DOI 10.2307/2532201
   Bengtsson H, 2009, BIOINFORMATICS, V25, P861, DOI 10.1093/bioinformatics/btp074
   Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136
   Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090
   Carvalho B, 2007, BIOSTATISTICS, V8, P485, DOI 10.1093/biostatistics/kxl042
   Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610
   Cole SA, 2010, AM J CLIN NUTR, V91, P191, DOI 10.3945/ajcn.2009.28514
   Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201
   DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x
   Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871
   Di XJ, 2005, P ANN INT IEEE EMBS, P2809
   Ferlin T, 1997, MOL CELL BIOCHEM, V174, P221, DOI 10.1023/A:1006860508606
   Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9
   Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131
   Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Gresham D, 2010, P NATL ACAD SCI USA, V107, P1482, DOI 10.1073/pnas.0913883107
   Hacia JC, 1998, GENOME RES, V8, P1245, DOI 10.1101/gr.8.12.1245
   Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32
   Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118
   Krishnakumar S, 2008, P NATL ACAD SCI USA, V105, P9296, DOI 10.1073/pnas.0803240105
   Lebedeva MA, 2009, BBA-BIOENERGETICS, V1787, P328, DOI 10.1016/j.bbabio.2009.01.004
   Lebet T, 2008, GENET MED, V10, P575, DOI [10.1097/GIM.0b013e31818063bc, 10.1097GIM.0b013e31818063bc]
   Liu WM, 2003, BIOINFORMATICS, V19, P2397, DOI 10.1093/bioinformatics/btg332
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Mandal MNA, 2005, INVEST OPHTH VIS SCI, V46, P3355, DOI 10.1167/iovs.05-0007
   Pandya GA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm918
   Pinheiro JC., 2000, Mixed-effects models in S and S-PLUS
   Poulton J, 2009, BBA-MOL BASIS DIS, V1792, P1109, DOI 10.1016/j.bbadis.2009.08.016
   PURDUE PE, 1991, P NATL ACAD SCI USA, V88, P10900, DOI 10.1073/pnas.88.23.10900
   Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741
   Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493
   ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7
   Scharfe C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000374
   SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136
   Shen YF, 2010, GENOME RES, V20, P273, DOI 10.1101/gr.096388.109
   Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585
   Shendure Jay A, 2008, Curr Protoc Mol Biol, VChapter 7, DOI 10.1002/0471142727.mb0701s81
   Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
   Stephens M, 2006, NAT GENET, V38, P375, DOI 10.1038/ng1746
   Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379
   Szoke D, 2009, INT J MOL MED, V23, P217, DOI 10.3892/ijmm_00000120
   Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Waldmüller S, 2008, CLIN CHEM, V54, P682, DOI 10.1373/clinchem.2007.099119
   Wang AL, 2008, MOL VIS, V14, P644
   Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077
   Wang WY, 2008, J COMPUT BIOL, V15, P857, DOI 10.1089/cmb.2007.0148
   Warrington JA, 2002, HUM MUTAT, V19, P402, DOI 10.1002/humu.10075
   Xiao YY, 2007, BIOINFORMATICS, V23, P1459, DOI 10.1093/bioinformatics/btm131
   Zheng JB, 2009, P NATL ACAD SCI USA, V106, P6712, DOI 10.1073/pnas.0901902106
NR 55
TC 16
Z9 28
U1 0
U2 16
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JAN
PY 2011
VL 39
IS 1
BP 44
EP 58
DI 10.1093/nar/gkq750
PG 15
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 703VD
UT WOS:000286008500009
PM 20843780
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Sandhu, JK
   Sodja, C
   McRae, K
   Li, Y
   Rippstein, P
   Wei, YH
   Lach, B
   Lee, F
   Bucurescu, S
   Harper, ME
   Sikorska, M
AF Sandhu, JK
   Sodja, C
   McRae, K
   Li, Y
   Rippstein, P
   Wei, YH
   Lach, B
   Lee, F
   Bucurescu, S
   Harper, ME
   Sikorska, M
TI Effects of nitric oxide donors on cybrids harbouring the mitochondrial
   myopathy, encephalopathy, lactic acidosis and stroke-like episodes
   (MELAS) A3243G mitochondrial DNA mutation
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE caspase-independent; electron transport chain; MELAS; mitochondrial DNA
   mutation; nitric oxide donor; reactive nitrogen and oxygen species
AB Reactive nitrogen and oxygen species (O-2(center dot-) H2O2, NO center dot and ONOO-) have been strongly implicated in the pathophysiology of neurodegenerative and mitochondrial diseases. In the present study, we examined the effects of nitrosative and/or nitrative stress generated by DETA-NO {(Z)-1-[2-aminoethyl-N-(2-ammonioethyl)amino]diazen-1-ium-1,2-diolate}, SIN-1 (3-morpholino-sydnonimine hydrochloride) and SNP (sodium nitroprusside) on U87MG glioblastoma cybrids carrying wt (wild-type) and mutant [A3243G (Ala(3243) -> Gly)] mtDNA (mitochondrial genome) from a patient suffering from MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes). The mutant cybrids had reduced activity of cytochrome c oxidase, significantly lower ATP level and decreased mitochondrial membrane potential. However, endogenous levels of reactive oxygen species were very similar in all cybrids regardless of whether they carried the mtDNA defects or not. Furthermore, the cybrids were insensitive to the nitrosative and/or nitrative stress produced by either DETA-NO or SIN-1 alone. Cytotoxicity, however, was observed in response to SNP treatment and a combination of SIN-1 and glucose-deprivation. The mutant cybrids were significantly more sensitive to these insults compared with the wt controls. Ultrastructural examination of dying cells revealed several characteristic features of autophagic cell death. We concluded that nitrosative and/or nitrative stress alone were insufficient to trigger cytotoxicity in these cells, but cell death was observed with a combination of metabolic and nitrative stress. The vulnerability of the cybrids to these types of injury correlated with the cellular energy status, which were compromised by the MELAS mutation.
C1 Natl Res Council Canada, Inst Biol Sci, Neurogenesis & Brain Repair Grp, Ottawa, ON K1A 0R6, Canada.
   Ottawa Hosp, Dept Lab Med & Pathol, Ottawa, ON K1Y 4E9, Canada.
   Natl Yang Ming Univ, Dept Biochem, Taipei 112, Taiwan.
   Natl Yang Ming Univ, Ctr Cellular & Mol Biol, Taipei 112, Taiwan.
   King Faisal Specialist Hosp & Res Ctr, Dept Pathol & Lab Med, Riyadh 11211, Saudi Arabia.
   Hlth Canada, Banting Res Ctr, Ottawa, ON K1A 0L2, Canada.
   Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.
C3 National Research Council Canada; University of Ottawa; Ottawa Hospital
   Research Institute; National Yang Ming Chiao Tung University; National
   Yang Ming Chiao Tung University; King Faisal Specialist Hospital &
   Research Center; Health Canada; University of Ottawa
RP Natl Res Council Canada, Inst Biol Sci, Neurogenesis & Brain Repair Grp, M54,1200 Montreal Rd, Ottawa, ON K1A 0R6, Canada.
EM jagdeep.sandhu@nrc.ca; marianna.sikorska@nrc.ca
RI Bucurescu, Septimiu/L-6917-2015; Wei, Yau-Huei/ABA-6841-2021; Harper,
   Mary-Ellen/C-3103-2009
OI Harper, Mary-Ellen/0000-0003-3864-5886; Wei,
   Yau-Huei/0000-0002-6429-2546
CR AVRON M, 1963, ANAL BIOCHEM, V6, P549, DOI 10.1016/0003-2697(63)90149-0
   Baker MA, 2000, ANTIOXID REDOX SIGN, V2, P197, DOI 10.1089/ars.2000.2.2-197
   BATES JN, 1991, BIOCHEM PHARMACOL, V42, pS157, DOI 10.1016/0006-2952(91)90406-U
   Beltrán B, 2000, P NATL ACAD SCI USA, V97, P14602, DOI 10.1073/pnas.97.26.14602
   Brookes PS, 2004, MITOCHONDRION, V3, P187, DOI 10.1016/j.mito.2003.10.001
   Candé C, 2002, J CELL SCI, V115, P4727, DOI 10.1242/jcs.00210
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   Elfering SL, 2002, J BIOL CHEM, V277, P38079, DOI 10.1074/jbc.M205256200
   Fass U, 2004, BRAIN RES, V1005, P90, DOI 10.1016/j.brainres.2004.01.046
   GHADIALLY FN, 1997, ULTRASTRUCT PATHOL, P195
   Ghafourifar P, 2001, BIOL SIGNAL RECEPT, V10, P57
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HARRISON DG, 1993, CIRCULATION, V87, P1461, DOI 10.1161/01.CIR.87.5.1461
   HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015
   HOGG N, 1992, BIOCHEM J, V281, P419, DOI 10.1042/bj2810419
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Keefer LK, 2003, ANNU REV PHARMACOL, V43, P585, DOI 10.1146/annurev.pharmtox.43.100901.135831
   King M P, 1996, Methods Enzymol, V264, P313, DOI 10.1016/S0076-6879(96)64030-0
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282
   Lacza Z, 2003, FREE RADICAL BIO MED, V35, P1217, DOI 10.1016/S0891-5849(03)00510-0
   Land SC, 1999, J EXP BIOL, V202, P211
   LARM JA, 1994, J BIOL CHEM, V269, P30097
   Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897
   LAWEN A, 1994, MOL ASPECTS MED, V15, P13
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   McKenzie M, 2004, NEUROCHEM RES, V29, P589, DOI 10.1023/B:NERE.0000014829.42364.dd
   MORO MA, 1994, P NATL ACAD SCI USA, V91, P6702, DOI 10.1073/pnas.91.14.6702
   Niknahad H, 1996, BIOCHEM PHARMACOL, V51, P1031, DOI 10.1016/0006-2952(96)85086-6
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Radi R, 2002, FREE RADICAL BIO MED, V33, P1451, DOI 10.1016/S0891-5849(02)01111-5
   Ramachandran A, 2002, P NATL ACAD SCI USA, V99, P6643, DOI 10.1073/pnas.102019899
   Rusanen H, 2000, BBA-MOL BASIS DIS, V1500, P10, DOI 10.1016/S0925-4439(99)00081-2
   SATOH MS, 1993, J BIOL CHEM, V268, P5480
   Tarnopolsky MA, 2004, MUSCLE NERVE, V29, P537, DOI 10.1002/mus.20020
   Thyagarajan B, 2002, BRIT J PHARMACOL, V137, P821, DOI 10.1038/sj.bjp.0704949
   Weber K, 2002, BIOL CHEM, V383, P283, DOI 10.1515/BC.2002.030
   Wei YH, 2001, CHINESE J PHYSIOL, V44, P1
   Wiesner RJ, 1997, NEWS PHYSIOL SCI, V12, P178
   Williams AJ, 1999, J CHILD NEUROL, V14, P518, DOI 10.1177/088307389901400807
   Yamamoto T, 2000, P SOC EXP BIOL MED, V225, P200, DOI 10.1046/j.1525-1373.2000.22525.x
   Yasuda Masahiro, 1998, Journal of Toxicological Sciences, V23, P389
   Zigova T, 2001, DEV BRAIN RES, V127, P63, DOI 10.1016/S0165-3806(01)00107-9
NR 45
TC 22
Z9 23
U1 0
U2 1
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD OCT 15
PY 2005
VL 391
BP 191
EP 202
DI 10.1042/BJ20050272
PN 2
PG 12
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 980DF
UT WOS:000232993400005
PM 15969653
OA Green Published
DA 2024-11-01
ER

PT J
AU Prigione, A
   Cortopassi, G
AF Prigione, Alessandro
   Cortopassi, Gino
TI Mitochondrial DNA deletions and chloramphenicol treatment stimulate the
   autophagic transcript ATG12
SO AUTOPHAGY
LA English
DT Article
DE mitochondria; mtDNA deletions; autophagy; ATG12; chloramphenicol; tRNAs
   deletion; mitochondrial protein synthesis
ID SUBSTANTIA-NIGRA NEURONS; PARKINSONS-DISEASE; HUMAN BRAIN; PROTEASOME;
   MUSCLE; NEURODEGENERATION; TRANSLATION; DEGRADATION; PATHWAYS; PROTEINS
AB Deletion mutations of mitochondrial DNA (mtDNA) accumulate somatically on a cell-by-cell basis with age, resulting in decreased cell function in muscle and substantia nigra. In osteosarcoma cells deletions incapacitate mitochondria and induce the autophagic transcript ATG12, which is involved in an early step of the mammalian autophagy pathway. We discuss here which consequences of mtDNA deletions could induce ATG12, and provide two new pieces of data. Our previous studies demonstrated that mtDNA deletions decreased mitochondrial ATP production and proteasomal function, induced the AMPK transcript (likely as a consequence of bioenergetic depletion), and decreased the intracellular concentration of 20 amino acids (possibly as a consequence of decreased proteasomal activity). Deletions eliminate essential tRNAs for mitochondrial protein synthesis, as well as essential components of mitochondrial multisubunit enzymes; therefore, the increased level of ATG12 could result from decreased bioenergetic function, increased oxidative damage, or decreased mitochondrial protein synthesis. However, the bioenergetic inhibitor rotenone does not induce ATG12. We show here that chloramphenicol, which inhibits mitochondrial protein synthesis, induces ATG12, and that mtDNA deletions result in an increased burden of oxidatively damaged protein. Thus, mtDNA deletions could induce ATG12 through a mechanism such as the following: deletions > mitochondrial protein synthesis inhibition or ROS > proteasome inhibition > amino acid depletion > ATG12.
C1 Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA.
   Univ Milano Bicocca, Dept Neurosci & Biomed Technol, Monza, Italy.
C3 University of California System; University of California Davis;
   University of Milano-Bicocca
RP Cortopassi, G (corresponding author), Univ Calif Davis, Dept Mol Biosci, 1311 Haring Hall, Davis, CA 95616 USA.
EM gcortopossi@ucdavis.edu
RI Prigione, Alessandro/ABA-1584-2021; Alessandro, Prigione/B-2959-2013
OI Alessandro, Prigione/0000-0001-9457-1952
CR Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014
   Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25
   Anthony JC, 2000, J NUTR, V130, P2413
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Betarbet R, 2006, NEUROBIOL DIS, V22, P404, DOI 10.1016/j.nbd.2005.12.003
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Darsow T, 1997, J CELL BIOL, V138, P517, DOI 10.1083/jcb.138.3.517
   Davies KJA, 2006, NEUROLOGY, V66, pS93, DOI 10.1212/01.wnl.0000192308.43151.63
   Hanada T, 2005, AUTOPHAGY, V1, P110, DOI 10.4161/auto.1.2.1858
   Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Ishihara N, 2001, MOL BIOL CELL, V12, P3690, DOI 10.1091/mbc.12.11.3690
   Jefferson LS, 2003, J NUTR, V133, p2046S, DOI 10.1093/jn/133.6.2046S
   Jou MJ, 2005, ANN NY ACAD SCI, V1042, P221, DOI 10.1196/annals.1338.024
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Lindsley JE, 2004, COMP BIOCHEM PHYS B, V139, P543, DOI 10.1016/j.cbpc.2004.06.014
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   Muqit MMK, 2006, ARCH NEUROL-CHICAGO, V63, P649, DOI 10.1001/archneur.63.5.649
   PRIGIONE A, 2007, UNPUB AGING CELL
   Reggiori F, 2004, MOL BIOL CELL, V15, P2189, DOI 10.1091/mbc.E03-07-0479
   Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291
   SOONG NW, 1992, NAT GENET, V2, P318
   Sullivan PG, 2004, J BIOL CHEM, V279, P20699, DOI 10.1074/jbc.M313579200
   Zhu JH, 2003, BRAIN PATHOL, V13, P473
   Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524
NR 27
TC 23
Z9 25
U1 0
U2 6
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1554-8627
EI 1554-8635
J9 AUTOPHAGY
JI Autophagy
PD JUL-AUG
PY 2007
VL 3
IS 4
BP 377
EP 380
DI 10.4161/auto.4239
PG 4
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 183DY
UT WOS:000247554100017
PM 17457038
OA Bronze
DA 2024-11-01
ER

PT J
AU Duran, J
   Martinez, A
   Adler, E
AF Duran, Jason
   Martinez, Armando
   Adler, Eric
TI Cardiovascular Manifestations of Mitochondrial Disease
SO BIOLOGY-BASEL
LA English
DT Review
DE mitochondrial; genetic mutations; cardiovascular disease; heart failure;
   cardiomyopathy
ID HEREDITARY OPTIC NEUROPATHY; CYTOCHROME-C-OXIDASE; STEM-CELL
   TRANSPLANTATION; PARKINSON-WHITE-SYNDROME; NEUROGASTROINTESTINAL
   ENCEPHALOMYOPATHY MNGIE; LINKED CARDIOSKELETAL MYOPATHY;
   LEFT-VENTRICULAR MYOCARDIUM; NEUROGENIC MUSCLE WEAKNESS; LETHAL
   METABOLIC-DISORDER; FETAL-GROWTH-RETARDATION
AB Genetic mitochondrial cardiomyopathies are uncommon causes of heart failure that may not be seen by most physicians. However, the prevalence of mitochondrial DNA mutations and somatic mutations affecting mitochondrial function are more common than previously thought. In this review, the pathogenesis of genetic mitochondrial disorders causing cardiovascular disease is reviewed. Treatment options are presently limited to mostly symptomatic support, but preclinical research is starting to reveal novel approaches that may lead to better and more targeted therapies in the future. With better understanding and clinician education, we hope to improve clinician recognition and diagnosis of these rare disorders in order to improve ongoing care of patients with these diseases and advance research towards discovering new therapeutic strategies to help treat these diseases.
C1 [Duran, Jason; Martinez, Armando; Adler, Eric] Univ Calif San Diego, Med Ctr, Dept Cardiol, La Jolla, CA 92037 USA.
C3 University of California System; University of California San Diego
RP Adler, E (corresponding author), Univ Calif San Diego, Med Ctr, Dept Cardiol, La Jolla, CA 92037 USA.
EM jaduran@ucsd.edu; arm021@ucsd.edu; eradler@ucsd.edu
OI Duran, Jason/0000-0003-1666-2319
CR Abbas Afroze, 2008, Expert Rev Cardiovasc Ther, V6, P1135, DOI 10.1586/14779072.6.8.1135
   Achilli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042242
   ADES LC, 1993, AM J MED GENET, V45, P327, DOI 10.1002/ajmg.1320450309
   Aggarwal P, 2001, Hum Hered, V51, P114, DOI 10.1159/000022950
   Akaike M, 1997, CLIN CARDIOL, V20, P239, DOI 10.1002/clc.4960200310
   ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Azevedo O, 2010, CARDIOLOGY, V115, P71, DOI 10.1159/000252811
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Barboni P, 2006, INVEST OPHTH VIS SCI, V47, P5303, DOI 10.1167/iovs.06-0520
   BARDOSI A, 1987, ACTA NEUROPATHOL, V74, P248, DOI 10.1007/BF00688189
   Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660
   BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Battisti C, 2004, J NEUROL NEUROSUR PS, V75, P1731, DOI 10.1136/jnnp.2003.024372
   Bax BE, 2013, NEUROLOGY, V81, P1269, DOI 10.1212/WNL.0b013e3182a6cb4b
   Bell DSH, 2003, DIABETES CARE, V26, P2949, DOI 10.2337/diacare.26.10.2949
   BERNES SM, 1993, J PEDIATR-US, V123, P598, DOI 10.1016/S0022-3476(05)80962-X
   Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385
   Blanco-Grau A, 2013, GENES BRAIN BEHAV, V12, P812, DOI 10.1111/gbb.12089
   Bleyl SB, 1997, AM J HUM GENET, V61, P868, DOI 10.1086/514879
   Blondon H, 2005, GASTROEN CLIN BIOL, V29, P773, DOI 10.1016/S0399-8320(05)86346-8
   BOLHUIS PA, 1991, AM J HUM GENET, V48, P481
   Bonfante E, 2016, PEDIATR RADIOL, V46, P443, DOI 10.1007/s00247-015-3523-5
   Brady AN, 2006, PRENATAL DIAG, V26, P462, DOI 10.1002/pd.1438
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Bugger H, 2010, CARDIOVASC RES, V88, P229, DOI 10.1093/cvr/cvq239
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carelli V, 2011, BRAIN, V134, DOI 10.1093/brain/awr180
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, pC137, DOI 10.1152/ajpcell.00270.2006
   Childs AM, 2007, NEUROPEDIATRICS, V38, P313, DOI 10.1055/s-2008-1065355
   CHIN TK, 1990, CIRCULATION, V82, P507, DOI 10.1161/01.CIR.82.2.507
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209
   Claeys KG, 2016, MUSCLE NERVE, V54, P328, DOI 10.1002/mus.25125
   Clarke SLN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-23
   Crippa BL, 2015, AM J MED GENET A, V167, P621, DOI 10.1002/ajmg.a.36939
   D'Aurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   DAdamo P, 1997, AM J HUM GENET, V61, P862, DOI 10.1086/514886
   Dai DF, 2014, AGING CELL, V13, P529, DOI 10.1111/acel.12203
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   De Giorgio R, 2016, ANN NEUROL, V80, P448, DOI 10.1002/ana.24724
   de la Barca JMC, 2016, BRAIN, V139, P2864, DOI 10.1093/brain/aww222
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   Drinkard BE, 2010, ARCH PHYS MED REHAB, V91, P1044, DOI 10.1016/j.apmr.2010.04.007
   Duncan JG, 2011, BBA-MOL CELL RES, V1813, P1351, DOI 10.1016/j.bbamcr.2011.01.014
   Duno M, 2013, GENE, V515, P372, DOI 10.1016/j.gene.2012.12.066
   Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601
   El-Hattab AW, 2017, MOL GENET METAB, V122, P1, DOI 10.1016/j.ymgme.2017.09.009
   El-Hattab AW, 2016, MOL GENET METAB, V117, P407, DOI 10.1016/j.ymgme.2016.01.010
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   El-Hattab AW, 2013, META GENE, V1, P8, DOI 10.1016/j.mgene.2013.09.001
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013
   FANG W, 1994, MUSCLE NERVE, V17, P52, DOI 10.1002/mus.880170107
   Farruggia P, 2016, JIMD REP, V26, P37, DOI 10.1007/8904_2015_470
   Fellman V, 2002, BLOOD CELL MOL DIS, V29, P444, DOI 10.1006/bcmd.2002.0582
   Fellman V, 1998, LANCET, V351, P490, DOI 10.1016/S0140-6736(97)09272-6
   Fellman V, 2008, J HUM GENET, V53, P554, DOI 10.1007/s10038-008-0284-0
   Fellman V, 2011, SEMIN FETAL NEONAT M, V16, P222, DOI 10.1016/j.siny.2011.05.002
   Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3
   Filosto M, 2012, J NEUROL, V259, P2699, DOI 10.1007/s00415-012-6572-9
   Finsterer J, 2004, ACTA CARDIOL, V59, P187, DOI 10.2143/AC.59.2.2005175
   Finsterer J, 2002, CARDIOVASC PATHOL, V11, P146, DOI 10.1016/S1054-8807(01)00087-4
   Finsterer J, 2018, J INT MED RES, V46, P2054, DOI 10.1177/0300060518765846
   FRYER A, 1994, ARCH DIS CHILD, V71, P419, DOI 10.1136/adc.71.5.419
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Funalot B, 2002, ANN NEUROL, V52, P374, DOI 10.1002/ana.10299
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Ganetzky RD, 2018, MOL GENET METAB, V123, P301, DOI 10.1016/j.ymgme.2018.01.010
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Gaspard GJ, 2015, CHEM PHYS LIPIDS, V193, P1, DOI 10.1016/j.chemphyslip.2015.09.005
   Gerards M, 2013, BRAIN, V136, P882, DOI 10.1093/brain/awt013
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Giraudet S, 2011, BRIT J OPHTHALMOL, V95, P887, DOI 10.1136/bjo.2009.161539
   Gobu P, 2011, Indian Pacing Electrophysiol J, V10, P547
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Guillausseau PJ, 2004, DIABETES METAB, V30, P181, DOI 10.1016/S1262-3636(07)70105-2
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Guy J, 2017, OPHTHALMOLOGY, V124, P1621, DOI 10.1016/j.ophtha.2017.05.016
   Guy J, 2009, INVEST OPHTH VIS SCI, V50, P4205, DOI 10.1167/iovs.08-3214
   Hadzsiev K, 2010, NEUROMOL MED, V12, P277, DOI 10.1007/s12017-010-8115-9
   Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9
   Halter J, 2011, BONE MARROW TRANSPL, V46, P330, DOI 10.1038/bmt.2010.100
   Halter JP, 2015, BRAIN, V138, P2847, DOI 10.1093/brain/awv226
   HAMBY RI, 1974, JAMA-J AM MED ASSOC, V229, P1749, DOI 10.1001/jama.229.13.1749
   HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589
   HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Hirano M, 2001, CURR OPIN CARDIOL, V16, P201, DOI 10.1097/00001573-200105000-00008
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009
   Huntsman RJ, 2005, PEDIATR NEUROL, V32, P334, DOI 10.1016/j.pediatrneurol.2004.12.009
   HUOPONEN K, 1991, AM J HUM GENET, V48, P1147
   Jefferies JL, 2013, AM J MED GENET C, V163, P198, DOI 10.1002/ajmg.c.31372
   Jensen MK, 2012, CIRCULATION, V125, P1591, DOI 10.1161/CIRCULATIONAHA.112.095364
   JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5
   JOHNS DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P495, DOI 10.1001/archopht.1993.01090040087038
   Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Kabunga P, 2015, INT J CARDIOL, V181, P303, DOI 10.1016/j.ijcard.2014.12.038
   Kara B, 2012, MOL GENET METAB, V107, P389, DOI 10.1016/j.ymgme.2012.06.013
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   KELLARWOOD H, 1994, ANN NEUROL, V36, P109, DOI 10.1002/ana.410360121
   KELLEY RI, 1991, J PEDIATR-US, V119, P738, DOI 10.1016/S0022-3476(05)80289-6
   Khan NA, 2017, INVEST OPHTH VIS SCI, V58, P3923, DOI 10.1167/iovs.16-20695
   Kiechl S, 2004, J NEUROL NEUROSUR PS, V75, P1125, DOI 10.1136/jnnp.2003.025890
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010
   Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001
   Koilkonda RD, 2014, JAMA OPHTHALMOL, V132, P409, DOI 10.1001/jamaophthalmol.2013.7630
   Kotarsky H, 2010, MITOCHONDRION, V10, P497, DOI 10.1016/j.mito.2010.05.009
   Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kulik W, 2008, CLIN CHEM, V54, P371, DOI 10.1373/clinchem.2007.095711
   Kung G, 2011, CIRC RES, V108, P1017, DOI 10.1161/CIRCRESAHA.110.225730
   Lane N, 2011, SCIENCE, V334, P184, DOI 10.1126/science.1214012
   Lara MC, 2006, NEUROLOGY, V67, P1461, DOI 10.1212/01.wnl.0000239824.95411.52
   Lee HF, 2007, EUR J PAEDIATR NEURO, V11, P208, DOI 10.1016/j.ejpn.2006.12.008
   Lee HF, 2009, PEDIATR NEUROL, V40, P88, DOI 10.1016/j.pediatrneurol.2008.09.020
   Lee WS, 2013, J PEDIATR-US, V163, P942, DOI 10.1016/j.jpeds.2013.05.036
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Lesnefsky EJ, 2017, ANNU REV PHARMACOL, V57, P535, DOI 10.1146/annurev-pharmtox-010715-103335
   Lesnefsky EJ, 2016, CIRC RES, V118, P1593, DOI 10.1161/CIRCRESAHA.116.307505
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   Lien LM, 2001, ACTA NEUROL SCAND, V103, P159, DOI 10.1034/j.1600-0404.2001.103003159.x
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   López-Gallardo E, 2009, J MED GENET, V46, P64, DOI 10.1136/jmg.2008.060616
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Lott MT., 2013, Curr Protoc Bioinf, V44, P1231, DOI DOI 10.1002/0471250953.BI0123S44
   Maassen JA, 2005, ANN MED, V37, P213, DOI 10.1080/07853890510007188
   Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103
   Majamaa-Voltti Kirsi, 2002, BMC Cardiovasc Disord, V2, P12
   Majander A, 2017, BRIT J OPHTHALMOL, V101, P1505, DOI 10.1136/bjophthalmol-2016-310072
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mariotti C, 2003, NEUROLOGY, V60, P1676, DOI 10.1212/01.WNL.0000055872.50364.FC
   Mascialino B, 2012, EUR J OPHTHALMOL, V22, P461, DOI 10.5301/ejo.5000055
   Mashima Y, 2000, J NEURO-OPHTHALMOL, V20, P166, DOI 10.1097/00041327-200020030-00006
   Mashima Y, 1996, CLIN GENET, V50, P535
   MASHIMA Y, 1992, LANCET, V340, P368, DOI 10.1016/0140-6736(92)91442-B
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   MEIRE FM, 1995, OPHTHALMIC GENET, V16, P119, DOI 10.3109/13816819509059971
   Meyers Deborah E, 2013, Tex Heart Inst J, V40, P635
   Meyers DE, 2013, TEX HEART I J, V40, P385
   Meyerson C, 2015, CLIN OPHTHALMOL, V9, P1165, DOI 10.2147/OPTH.S62021
   Momiyama Y, 2002, DIABETES CARE, V25, P2308, DOI 10.2337/diacare.25.12.2308
   Mordel P, 2017, BIOCHEM BIOPH RES CO, V494, P133, DOI 10.1016/j.bbrc.2017.10.066
   Moslemi AR, 2005, NEUROPEDIATRICS, V36, P314, DOI 10.1055/s-2005-872845
   Moslemi AR, 2003, NEUROLOGY, V61, P991, DOI 10.1212/01.WNL.0000082391.98672.0A
   Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Narbonne H, 2004, DIABETES METAB, V30, P61, DOI 10.1016/S1262-3636(07)70090-3
   NEWMAN NJ, 1993, ARCH NEUROL-CHICAGO, V50, P540, DOI 10.1001/archneur.1993.00540050082021
   NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160
   NIKOSKELAINEN EK, 1994, LANCET, V344, P857, DOI 10.1016/S0140-6736(94)92830-4
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   ORTIZ RG, 1992, AM J OPHTHALMOL, V113, P561, DOI 10.1016/S0002-9394(14)74730-0
   OZAWA M, 1995, NEUROMUSCULAR DISORD, V5, P483, DOI 10.1016/0960-8966(95)00009-C
   PASTORES GM, 1994, AM J MED GENET, V50, P265, DOI 10.1002/ajmg.1320500310
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Péquignot MO, 2001, HUM MUTAT, V17, P374, DOI 10.1002/humu.1112.abs
   Perez F, 2009, CLIN NEUROL NEUROSUR, V111, P83, DOI 10.1016/j.clineuro.2008.06.021
   Pfeffer G, 2013, NEUROLOGY, V81, P2073, DOI 10.1212/01.wnl.0000437308.22603.43
   Pignatelli RH, 2003, CIRCULATION, V108, P2672, DOI 10.1161/01.CIR.0000100664.10777.B8
   Pisano A, 2015, HUM MOL GENET, V24, P6921, DOI 10.1093/hmg/ddv396
   Porto FBO, 2001, AM J OPHTHALMOL, V132, P935, DOI 10.1016/S0002-9394(01)01187-4
   POULTON J, 1991, AM J HUM GENET, V48, P649
   Poyau A, 2000, HUM GENET, V106, P194, DOI 10.1007/s004390051028
   Puglielli L, 2008, NEUROBIOL AGING, V29, P795, DOI 10.1016/j.neurobiolaging.2007.01.010
   Puomila A, 2007, EUR J HUM GENET, V15, P1079, DOI 10.1038/sj.ejhg.5201828
   Puri Aniket, 2012, Indian Heart J, V64, P515, DOI 10.1016/j.ihj.2012.07.010
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rajendran J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111824
   Rapola J, 2002, PEDIATR PATHOL MOL M, V21, P183, DOI 10.1080/15227950252852087
   REGAN TJ, 1977, J CLIN INVEST, V60, P885, DOI 10.1172/JCI108843
   Remes AM, 2005, NEUROLOGY, V64, P976, DOI 10.1212/01.WNL.0000154518.31302.ED
   Rigaud C, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-70
   RIORDANEVA P, 1995, J MED GENET, V32, P81, DOI 10.1136/jmg.32.2.81
   Robberecht K, 2010, OPHTHALMIC GENET, V31, P240, DOI 10.3109/13816810.2010.520297
   Roberts AE, 2012, AM J MED GENET A, V158A, P2726, DOI 10.1002/ajmg.a.35609
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Röeben B, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0687-0
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   RUBLER S, 1972, AM J CARDIOL, V30, P595, DOI 10.1016/0002-9149(72)90595-4
   Rustin P, 1999, LANCET, V354, P477, DOI 10.1016/S0140-6736(99)01341-0
   Sadun AA, 2003, AM J OPHTHALMOL, V136, P231, DOI 10.1016/S0002-9394(03)00099-0
   Sadun AA, 2012, ARCH NEUROL-CHICAGO, V69, P331, DOI 10.1001/archneurol.2011.2972
   Salles JE, 2006, DIABETES RES CLIN PR, V72, P100, DOI 10.1016/j.diabres.2005.09.005
   Santorelli FM, 1996, NEUROLOGY, V47, P1320, DOI 10.1212/WNL.47.5.1320
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Scarpelli M, 2013, NEURORADIOL J, V26, P520, DOI 10.1177/197140091302600505
   Schultz JC, 2009, MAYO CLIN PROC, V84, P1001, DOI [10.4065/84.11.1001, 10.1016/S0025-6196(11)60670-8]
   Sciacco M, 2003, J NEUROL, V250, P1498, DOI 10.1007/s00415-003-0246-6
   Serdaroglu E, 2016, TURKISH J PEDIATR, V58, P658, DOI 10.24953/turkjped.2016.06.013
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Sinnathuray AR, 2003, OTOL NEUROTOL, V24, P418, DOI 10.1097/00129492-200305000-00012
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   Sofou K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-52
   Sonam K, 2014, BRAIN DEV-JPN, V36, P807, DOI 10.1016/j.braindev.2013.10.012
   Spencer CT, 2006, PEDIATRICS, V118, pE337, DOI 10.1542/peds.2005-2667
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   Steriade C, 2014, PEDIATR NEUROL, V50, P498, DOI 10.1016/j.pediatrneurol.2014.01.009
   Steward CG, 2010, PRENATAL DIAG, V30, P970, DOI 10.1002/pd.2599
   Steward CG, 2019, CURR OPIN HEMATOL, V26, P6, DOI 10.1097/MOH.0000000000000472
   Suzuki S, 1998, DIABETOLOGIA, V41, P584, DOI 10.1007/s001250050950
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Tabebi M, 2017, J DIABETES COMPLICAT, V31, P253, DOI 10.1016/j.jdiacomp.2016.06.028
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Tocchi A, 2015, BBA-BIOENERGETICS, V1847, P1424, DOI 10.1016/j.bbabio.2015.07.009
   Torres-Torronteras J, 2016, HUM GENE THER, V27, P656, DOI 10.1089/hum.2015.160
   Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Tsou AY, 2011, J NEUROL SCI, V307, P46, DOI 10.1016/j.jns.2011.05.023
   Valentino ML, 2004, ANN NEUROL, V56, P631, DOI 10.1002/ana.20236
   Valentino ML, 2002, ANN NEUROL, V51, P774, DOI 10.1002/ana.10193
   Valianpour F, 2005, J LIPID RES, V46, P1182, DOI 10.1194/jlr.M500056-JLR200
   van Beynum I, 2012, JIMD REP, V2, P7, DOI 10.1007/8904_2011_32
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Visapää I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955
   Wang Jing, 2015, Clin Nutr Res, V4, P132, DOI 10.7762/cnr.2015.4.2.132
   Wang Shi-Bing, 2008, Pediatrics and Neonatology, V49, P145, DOI 10.1016/S1875-9572(08)60030-3
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Whittaker RG, 2007, DIABETOLOGIA, V50, P2085, DOI 10.1007/s00125-007-0779-9
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Yang S, 2016, EBIOMEDICINE, V10, P258, DOI 10.1016/j.ebiom.2016.07.002
   Yang YL, 2006, CHINESE MED J-PEKING, V119, P373, DOI 10.1097/00029330-200603010-00004
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yavuz H, 2007, ARCH NEUROL-CHICAGO, V64, P435, DOI 10.1001/archneur.64.3.435
   Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang J, 2015, INT J CLIN EXP PATHO, V8, P13411
   Zhu J, 2017, J DIABETES COMPLICAT, V31, P1354, DOI 10.1016/j.jdiacomp.2017.04.001
NR 253
TC 22
Z9 25
U1 0
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2079-7737
J9 BIOLOGY-BASEL
JI Biology-Basel
PD JUN
PY 2019
VL 8
IS 2
AR 34
DI 10.3390/biology8020034
PG 27
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA II6FD
UT WOS:000475287600015
PM 31083569
OA Green Submitted, Green Published, gold
DA 2024-11-01
ER

PT J
AU Oishi, M
   Miki, K
   Morita, A
   Fujioka, K
   Aoki, S
   Nishino, I
   Nonaka, I
   Goto, Y
   Mizutani, T
AF Oishi, Minoru
   Miki, Kenji
   Morita, Akihiko
   Fujioka, Kazumi
   Aoki, Shigeki
   Nishino, Ichizo
   Nonaka, Ikuya
   Goto, Yu-ichi
   Mizutani, Tomohiko
TI Mitochondrial Encephalomyopathy associated with diabetes mellitus,
   cataract, and corpus callosum atrophy
SO INTERNAL MEDICINE
LA English
DT Article
DE mitochondrial encephalomyopathy; diabetes mellitus; cataract; corpus
   callosum; diffusion tensor image
ID CONGENITAL CATARACT; LACTIC-ACIDOSIS; HYPERTROPHIC CARDIOMYOPATHY;
   SKELETAL-MUSCLE; MYOPATHY; MUTATION; MELAS; DISORDERS; HEART; DNA
AB A 44-year-old woman with mitochondrial encephalomyopathy noticed weakness of the lower extremities at the age of 30 years. She also has type 2 diabetes mellitus, posterior subcapsular cataracts in both eyes, and corpus callosum atrophy. Family history showed that a maternal cousin had a myopathy, 3 maternal aunts had diabetes mellitus, and her mother and 2 maternal aunts had cataracts. External ophthalmoplegia, proximal myopathy, and absent deep tendon reflexes were noted. The mitochondrial DNA 3243 point mutation was negative. Muscle biopsy showed ragged-red fibers, cytochrome c oxidase (COX)-positive fibers, and COX-negative fibers.
C1 [Oishi, Minoru; Miki, Kenji; Morita, Akihiko] Nihon Univ, Nerima Hikarigaoka Hosp, Dept Neurol, Tokyo, Japan.
   [Fujioka, Kazumi] Nihon Univ, Sch Med, Dept Radiol, Tokyo, Japan.
   [Aoki, Shigeki] Univ Tokyo, Sch Med, Dept Radiol, Tokyo 113, Japan.
   [Nishino, Ichizo; Nonaka, Ikuya] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo, Japan.
   [Mizutani, Tomohiko] Nihon Univ, Sch Med, Dept Med, Div Neurol, Tokyo, Japan.
C3 Nihon University; Nihon University; University of Tokyo; National Center
   for Neurology & Psychiatry - Japan; National Center for Neurology &
   Psychiatry - Japan; Nihon University
RP Oishi, M (corresponding author), Nihon Univ, Nerima Hikarigaoka Hosp, Dept Neurol, Tokyo, Japan.
EM oishimin@med.nihon-u.ac.jp
RI Nishino, Ichizo/G-2676-2010
OI Nishino, Ichizo/0000-0001-9452-112X
CR Brockmann K, 2004, NEURORADIOLOGY, V46, P267, DOI 10.1007/s00234-004-1181-7
   Drouet A., 2000, Revue Neurologique (Paris), V156, P780
   Ducreux D, 2005, AM J NEURORADIOL, V26, P1840
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Hoshino S, 1997, Rinsho Shinkeigaku, V37, P326
   Huang CN, 1998, CLIN ENDOCRINOL, V49, P265, DOI 10.1046/j.1365-2265.1998.00455.x
   Jaksch M, 1996, HUM MUTAT, V7, P358, DOI 10.1002/(SICI)1098-1004(1996)7:4<358::AID-HUMU11>3.0.CO;2-1
   Joko T, 1997, ENDOCR J, V44, P805, DOI 10.1507/endocrj.44.805
   Komaki H, 2003, MITOCHONDRION, V2, P293, DOI 10.1016/S1567-7249(03)00003-5
   Liao Sui-Zing, 2003, Acta Paediatrica Taiwanica, V44, P360
   Majoie CB, 2002, AM J NEURORADIOL, V23, P813
   Oexle K, 1996, EXP CLIN ENDOCR DIAB, V104, P212, DOI 10.1055/s-0029-1211445
   REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3
   Schmiedel J, 2003, J NEUROL, V250, P267, DOI 10.1007/s00415-003-0978-3
   SENGERS RCA, 1975, J PEDIATR-US, V86, P873, DOI 10.1016/S0022-3476(75)80217-4
   SENGERS RCA, 1985, BRIT HEART J, V54, P543
   SMEITINK JAM, 1989, EUR J PEDIATR, V148, P656, DOI 10.1007/BF00441527
   VANEKEREN GJ, 1993, EUR J PEDIATR, V152, P255, DOI 10.1007/BF01956157
   VANEKEREN GJ, 1987, VIRCHOWS ARCH A, V412, P47
   Wong LJC, 2007, MITOCHONDRION, V7, P45, DOI 10.1016/j.mito.2006.11.025
   Yamamoto M, 1986, Rinsho Shinkeigaku, V26, P1080
NR 21
TC 6
Z9 6
U1 0
U2 1
PU JAPAN SOC INTERNAL MEDICINE
PI TOKYO
PA 34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN
SN 0918-2918
J9 INTERNAL MED
JI Intern. Med.
PY 2008
VL 47
IS 5
BP 441
EP 444
DI 10.2169/internalmedicine.47.0579
PG 4
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 349QY
UT WOS:000259297600020
PM 18310979
OA Bronze
DA 2024-11-01
ER

PT J
AU Yu, XJ
   Li, S
   Guo, QX
   Leng, JH
   Ding, Y
AF Yu, Xuejiao
   Li, Sheng
   Guo, Qinxian
   Leng, Jianhang
   Ding, Yu
TI The Association Between Mitochondrial tRNA<SUP>Glu </SUP>Variants and
   Hearing Loss: A Case-Control Study
SO PHARMACOGENOMICS & PERSONALIZED MEDICINE
LA English
DT Article
DE deafness; mitochondrial tRNA(Glu) variants; pediatrics; tRNA metabolism
ID COMPLETE NUCLEOTIDE-SEQUENCE; TRANSFER-RNA MUTATIONS; DNA MUTATIONS;
   DEAFNESS; GENES; EXPRESSION; PHYLOGENY; MYOPATHY; NUCLEAR; ROLES
AB Purpose: This study aimed to examine the frequencies of mt-tRNA(Glu) variants in 180 pediatric patients with non-syndromic hearing loss (NSHL) and 100 controls.<br /> Methods: Sanger sequencing was performed to screen for mt-tRNA(Glu) variants. These mitochondrial DNA (mtDNA) pathogenic mutations were further assessed using phylogenetic conservation and haplogroup analyses. We also traced the origins of the family history of probands carrying potential pathogenic mtDNA mutations. Mitochondrial functions including mtDNA content, ATP and reactive oxygen species (ROS) were examined in cells derived from patients carrying the mt-tRNA(Glu) A14692G and CO1/tRNA(Ser(UCN)) G7444A variants and controls.<br /> Results: We identified four possible pathogenic variants: m.T14709C, m.A14683G, m.A14692G and m.A14693G, which were found in NSHL patients but not in controls. Genetic counseling suggested that one child with the m.A14692G variant had a family history of NSHL. Sequence analysis of mtDNA suggested the presence of the CO1/tRNA(Ser(UCN)) G7444A and mt-tRNA(Glu) A14692G variants. Molecular analysis suggested that, compared with the controls, patients with these variants exhibited much lower mtDNA copy numbers, ATP production, whereas ROS levels increased (p< 0.05 for all), suggesting that the m.A14692G and m.G7444A variants led to mitochondrial dysfunction.<br /> Conclusion: mt-tRNA(Glu) variants are important risk factors for NSHL.
C1 [Yu, Xuejiao] Wenzhou Med Univ, Quzhou Affiliated Hosp, Quzhou Peoples Hosp, Dept Clin Lab, Quzhou 324000, Zhejiang, Peoples R China.
   [Li, Sheng] Wenzhou Med Univ, Quzhou Peoples Hosp, Dept Otolaryngol, Quzhou Affiliated Hosp, Quzhou 324000, Zhejiang, Peoples R China.
   [Guo, Qinxian; Leng, Jianhang; Ding, Yu] Hangzhou First Peoples Hosp, Cent Lab, Hangzhou 310006, Zhejiang, Peoples R China.
C3 Wenzhou Medical University; Wenzhou Medical University
RP Yu, XJ (corresponding author), Wenzhou Med Univ, Quzhou Affiliated Hosp, Quzhou Peoples Hosp, Dept Clin Lab, Quzhou 324000, Zhejiang, Peoples R China.; Ding, Y (corresponding author), Hangzhou First Peoples Hosp, Cent Lab, Hangzhou 310006, Zhejiang, Peoples R China.
EM ajkc5701@163.com; dingyu_zj@126.com
FU Ministry of Public Health of Zhejiang Province [2021RC022]; Quzhou
   Bureau of Science and Technology [2022K51]
FX <B>Funding</B> This work was supported by the grants from Ministry of
   Public Health of Zhejiang Province (No: 2021RC022) and Quzhou Bureau of
   Science and Technology (No: 2022K51) .
CR Allnér O, 2011, RNA, V17, P2177, DOI 10.1261/rna.029231.111
   An ST, 2018, INT J CLIN EXP MED, V11, P269
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7
   Bitner-Glindzicz M, 2002, BRIT MED BULL, V63, P73, DOI 10.1093/bmb/63.1.73
   Cui Y, 2018, MOL MED REP, V18, P5159, DOI 10.3892/mmr.2018.9519
   Ding Y, 2022, J CLIN MED, V11, DOI 10.3390/jcm11216431
   Ding Y, 2022, GENES-BASEL, V13, DOI 10.3390/genes13101794
   Ding Y, 2019, CURR MOL MED, V19, P136, DOI 10.2174/1566524019666190308121552
   Ding Y, 2019, ENDOCR J, V66, P81, DOI 10.1507/endocrj.EJ18-0308
   Ding Y, 2018, GENE, V642, P299, DOI 10.1016/j.gene.2017.11.049
   Ding Y, 2017, AM J TRANSL RES, V9, P2984
   Ding Y, 2013, BIOCHEM GENET, V51, P588, DOI 10.1007/s10528-013-9589-6
   Ding Y, 2009, J GENET GENOMICS, V36, P241, DOI 10.1016/S1673-8527(08)60111-3
   Ebrahimkhani Somayeh, 2021, Iran J Otorhinolaryngol, V33, P79, DOI 10.22038/ijorl.2020.45196.2483
   Finsterer J, 2005, INT J PEDIATR OTORHI, V69, P621, DOI 10.1016/j.ijporl.2004.12.002
   GADALETA G, 1989, J MOL EVOL, V28, P497, DOI 10.1007/BF02602930
   Gaignard P, 2013, JIMD REP, V11, P117, DOI 10.1007/8904_2013_230
   Gao YJ, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.797124
   Grasbon-Frodl EM, 1999, NEUROGENETICS, V2, P121, DOI 10.1007/s100480050063
   Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868
   Hawk MA, 2018, J BIOL CHEM, V293, P7531, DOI 10.1074/jbc.TM117.000260
   Ibrahim I, 2018, MUTAT RES-FUND MOL M, V810, P39, DOI 10.1016/j.mrfmmm.2018.03.003
   Jafarlou F, 2021, INT J PREVENTIVE MED, V12, DOI 10.4103/ijpvm.IJPVM_270_20
   Jeng JY, 2008, J CELL BIOCHEM, V103, P347, DOI 10.1002/jcb.21625
   Jia ZD, 2022, NUCLEIC ACIDS RES, V50, P9368, DOI 10.1093/nar/gkac698
   Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130
   Levin L, 2013, GENOME BIOL EVOL, V5, P876, DOI 10.1093/gbe/evt058
   Liu Q, 2015, MOL MED REP, V12, P8176, DOI 10.3892/mmr.2015.4484
   Luo LF, 2013, GENE, V520, P79, DOI 10.1016/j.gene.2013.03.041
   Marinelli JP, 2022, LANCET HEALTH LONGEV, V3, pE817, DOI 10.1016/S2666-7568(22)00241-0
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   Memon AA, 2022, ANTIOXID REDOX SIGN, V37, P1168, DOI 10.1089/ars.2022.0100
   Meng FL, 2022, NUCLEIC ACIDS RES, V50, P9453, DOI 10.1093/nar/gkac720
   Meulemans A, 2007, EUR J PAEDIATR NEURO, V11, P17, DOI 10.1016/j.ejpn.2006.10.004
   Moassass F, 2018, INT J PEDIATR OTORHI, V113, P110, DOI 10.1016/j.ijporl.2018.07.028
   Mutai H, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0389-4
   Perucca-Lostanlen D, 2002, BBA-MOL BASIS DIS, V1588, P210, DOI 10.1016/S0925-4439(02)00167-9
   Rayess HM, 2015, AM J OTOLARYNG, V36, P7, DOI 10.1016/j.amjoto.2014.08.010
   ROE BA, 1985, J BIOL CHEM, V260, P9759
   Saoji M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22116066
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921
   Wang M, 2016, J BIOL CHEM, V291, P21029, DOI 10.1074/jbc.M116.739482
   Xue L, 2019, MITOCHONDRION, V46, P370, DOI 10.1016/j.mito.2018.10.001
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yu XJ, 2022, J CLIN LAB ANAL, V36, DOI 10.1002/jcla.24298
   Zheng J, 2020, MITOCHONDRION, V52, P163, DOI 10.1016/j.mito.2020.03.005
   Zheng J, 2012, MITOCHONDRION, V12, P406, DOI 10.1016/j.mito.2012.04.001
   Zhou YG, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.537
NR 51
TC 0
Z9 0
U1 0
U2 2
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1178-7066
J9 PHARMACOGEN PERS MED
JI Pharmacogn. Pers. Med.
PY 2024
VL 17
BP 77
EP 89
DI 10.2147/PGPM.S441281
PG 13
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA MP2M3
UT WOS:001194761000001
PM 38562431
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Bourdon, A
   Minai, L
   Serre, V
   Jais, JP
   Sarzi, E
   Aubert, S
   Chrétien, D
   de Lonlay, P
   Paquis-Flucklinger, V
   Arakawa, H
   Nakamura, Y
   Munnich, A
   Rötig, A
AF Bourdon, Alice
   Minai, Limor
   Serre, Valerie
   Jais, Jean-Philippe
   Sarzi, Emmanuelle
   Aubert, Sophie
   Chretien, Dominique
   de Lonlay, Pascale
   Paquis-Flucklinger, Veronique
   Arakawa, Hirofumi
   Nakamura, Yusuke
   Munnich, Arnold
   Rotig, Agnes
TI Mutation of <i>RRM2B</i>, encoding p53-controlled ribonucleotide
   reductase (p53R2), causes severe mitochondrial DNA depletion
SO NATURE GENETICS
LA English
DT Article
ID SWISS-MODEL; R2 PROTEIN; DNTP POOLS; GENE; ENCEPHALOMYOPATHY; CLUSPRO;
   DOCKING; KINASE; DAMAGE; CELLS
AB Mitochondrial DNA (mtDNA) depletion syndrome (MDS; MIM 251880) is a prevalent cause of oxidative phosphorylation disorders characterized by a reduction in mtDNA copy number. The hitherto recognized disease mechanisms alter either mtDNA replication (POLG (ref. 1)) or the salvage pathway of mitochondrial deoxyribonucleosides 5'- triphosphates (dNTPs) for mtDNA synthesis (DGUOK (ref. 2), TK2 (ref. 3) and SUCLA2 (ref. 4)). A last gene, MPV17 ( ref. 5), has no known function. Yet the majority of cases remain unexplained. Studying seven cases of profound mtDNA depletion (1-2% residual mtDNA in muscle) in four unrelated families, we have found nonsense, missense and splice-site mutations and in-frame deletions of the RRM2B gene, encoding the cytosolic p53-inducible ribonucleotide reductase small subunit. Accordingly, severe mtDNA depletion was found in various tissues of the Rrm2b(-/-) mouse. The mtDNA depletion triggered by p53R2 alterations in both human and mouse implies that p53R2 has a crucial role in dNTP supply for mtDNA synthesis.
C1 Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France.
   Hop Necker Enfants Malad, Serv Genet, F-75015 Paris, France.
   Univ Paris 07, F-75005 Paris, France.
   Univ Paris 05, Hop Necker Enfants Malad, Fac Med, Serv Biostat & Informat, F-75015 Paris, France.
   Archet 2 Hosp, Dept Med Genet, F-06107 Nice, France.
   Univ Tokyo, Inst Med Sci, Human Genome Ctr, Minato Ku, Tokyo 1088639, Japan.
C3 Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Necker-Enfants Malades - APHP; Institut National
   de la Sante et de la Recherche Medicale (Inserm); Assistance Publique
   Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire
   Necker-Enfants Malades - APHP; Universite Paris Cite; Assistance
   Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital
   Universitaire Necker-Enfants Malades - APHP; CHU Nice; University of
   Tokyo
RP Rötig, A (corresponding author), Hop Necker Enfants Malad, INSERM, U781, 149 Rue Sevres, F-75015 Paris, France.
EM roetig@necker.fr
RI JAIS, Jean-Philippe/B-2993-2009; Arakawa, Hirofumi/L-3459-2013; ROTIG,
   AGNES/G-9592-2017
OI Arakawa, Hirofumi/0000-0001-6077-0638; ROTIG, AGNES/0000-0003-0589-0703;
   Dominique, Chretien/0000-0002-9954-1549; Sarzi,
   Emmanuelle/0000-0002-7623-6699
CR Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786
   Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0
   Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100
   Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371
   Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354
   Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Håkansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200
   Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0
   Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212
   Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007
   Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613
   LYCKSELL PO, 1994, BIOCHEMISTRY-US, V33, P2838, DOI 10.1021/bi00176a013
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863
   Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443
   PAQUISFLUCKLINGER V, 1995, EUR J PEDIATR, V154, P557, DOI 10.1007/s004310050342
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SARZI E, IN PRESS J PEDIATR
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506
   Zhou BS, 2003, CANCER RES, V63, P6583
NR 26
TC 429
Z9 476
U1 1
U2 39
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1061-4036
EI 1546-1718
J9 NAT GENET
JI Nature Genet.
PD JUN
PY 2007
VL 39
IS 6
BP 776
EP 780
DI 10.1038/ng2040
PG 5
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 173FO
UT WOS:000246859100022
PM 17486094
DA 2024-11-01
ER

PT J
AU Hakonen, AH
   Goffart, S
   Marjavaara, S
   Paetau, A
   Cooper, H
   Mattila, K
   Lampinen, M
   Sajantila, A
   Lönnqvist, T
   Spelbrink, JN
   Suomalainen, A
AF Hakonen, Anna H.
   Goffart, Steffi
   Marjavaara, Sanna
   Paetau, Anders
   Cooper, Helen
   Mattila, Kimmo
   Lampinen, Milla
   Sajantila, Antti
   Lonnqvist, Tuula
   Spelbrink, Johannes N.
   Suomalainen, Anu
TI Infantile-onset spinocerebellar ataxia and mitochondrial recessive
   ataxia syndrome are associated with neuronal complex I defect and mtDNA
   depletion
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; DNA COPY NUMBER; MULTIPLE
   DELETIONS; POLG MUTATIONS; OXIDATIVE-PHOSPHORYLATION; SENSORY
   NEUROPATHY; TWINKLE HELICASE; ALPERS-SYNDROME; POLYMERASE; REGION
AB Infantile-onset spinocerebellar ataxia (IOSCA) is a severe neurodegenerative disorder caused by the recessive mutation in PEO1, leading to an Y508C change in the mitochondrial helicase Twinkle, in its helicase domain. However, no mitochondrial dysfunction has been found in this disease. We studied here the consequences of IOSCA for the central nervous system, as well as the in vitro performance of the IOSCA mutant protein. The results of the mtDNA analyses were compared to findings in a similar juvenile or adult-onset ataxia syndrome, mitochondrial recessive ataxia syndrome (MIRAS), caused by the W748S mutation in the mitochondrial DNA polymerase (POLG). We show here that IOSCA brain does not harbor mtDNA deletions or increased amount of mtDNA point mutations, whereas MIRAS brain shows multiple deletions of mtDNA. However, IOSCA, and to a lesser extent also MIRAS, show mtDNA depletion in the brain and the liver. In both diseases, especially large neurons show respiratory chain complex I (CI) deficiency, but also CIV is decreased in IOSCA. Helicase activity, hexamerization and nucleoid structure of the IOSCA mutant were, however, unaffected. The lack of in vitro helicase defect or cell culture phenotype suggest that Twinkle-Y508C dysfunction affects mtDNA maintenance in a highly context and cell-type specific manner. Our results indicate that IOSCA is a new member of the mitochondrial DNA depletion syndromes.
C1 [Suomalainen, Anu] Univ Helsinki, Biomedicum, Res Program Mol Neurol, FIN-00290 Helsinki, Finland.
   [Paetau, Anders] Univ Helsinki, Dept Pathol, FIN-00290 Helsinki, Finland.
   [Sajantila, Antti] Univ Helsinki, Dept Forens Med, FIN-00290 Helsinki, Finland.
   [Goffart, Steffi; Cooper, Helen; Spelbrink, Johannes N.] Tampere Univ Hosp, Inst Med Technol, Tampere, Finland.
   [Mattila, Kimmo] Ctr Comp Sci, Espoo, Finland.
   [Lonnqvist, Tuula] Hosp Children & Adolescents, Dept Child Neurol, Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; University of Helsinki;
   Tampere University; Tampere University Hospital; University of Helsinki;
   Helsinki University Central Hospital
RP Suomalainen, A (corresponding author), Univ Helsinki, Biomedicum, Res Program Mol Neurol, Rc523B,POB 63, FIN-00290 Helsinki, Finland.
EM anu.wartiovaara@helsinki.fi
RI Goffart, Steffi/N-3597-2015; Sajantila, Antti/AAY-9084-2021; Spelbrink,
   Johannes/L-4661-2015
OI Sajantila, Antti/0000-0003-4117-5248; Spelbrink,
   Johannes/0000-0002-9756-2602; Lampinen, Milla
   Annika/0000-0002-5963-0395; Suomalainen-Wartiovaara,
   Anu/0000-0003-4833-5195
FU University of Helsinki; Academy of Finland; Sigrid Juselius Foundation;
   Finnish Foundation for Pediatric Research; EU; Tampere University
   Hospital Medical Research Fund [9G072, 9H079]; Biomedicum Helsinki
   foundationc
FX We thank the following organizations for financial support: the
   University of Helsinki, the Academy of Finland, Sigrid Juselius
   Foundation (to A. S. and J. N. S.); Finnish Foundation for Pediatric
   Research (to T. L.); the EU sixth Framework Programme for Research (to
   S. G and J. N. S.); Tampere University Hospital Medical Research Fund
   [9G072, 9H079] (to J. N. S.) and Biomedicum Helsinki foundationc (to A.
   H. H.).
CR Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106
   BARKER PD, 1993, P NATL ACAD SCI USA, V90, P6542, DOI 10.1073/pnas.90.14.6542
   Barthélémy C, 2001, ANN NEUROL, V49, P607, DOI 10.1002/ana.1002.abs
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Braun M, 2005, APPL MICROBIOL BIOT, V67, P234, DOI 10.1007/s00253-004-1804-2
   BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Durham SE, 2005, NEUROLOGY, V65, P453, DOI 10.1212/01.wnl.0000171861.30277.88
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Friedman KL, 1995, METHOD ENZYMOL, V262, P613
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   KOSKINEN T, 1994, J NEUROL SCI, V121, P50, DOI 10.1016/0022-510X(94)90156-2
   Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004
   Kulkarni A, 2008, AM J HUM GENET, V82, P539, DOI 10.1016/j.ajhg.2008.01.009
   Lin YW, 2005, CHEMBIOCHEM, V6, P1356, DOI 10.1002/cbic.200500030
   Lönnqvist T, 1998, J NEUROL SCI, V161, P57, DOI 10.1016/S0022-510X(98)00249-4
   Lonnqvist T, 2000, HDB ATAXIA DISORDERS, P293
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Lyly A, 2008, HUM MOL GENET, V17, P1406, DOI 10.1093/hmg/ddn028
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   VARGAS C, 1993, ANAL BIOCHEM, V209, P323, DOI 10.1006/abio.1993.1127
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 46
TC 95
Z9 102
U1 1
U2 9
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD DEC 1
PY 2008
VL 17
IS 23
BP 3822
EP 3835
DI 10.1093/hmg/ddn280
PG 14
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 373OG
UT WOS:000260980800020
PM 18775955
OA Bronze
DA 2024-11-01
ER

PT J
AU Wei, YL
   Yu, CA
   Yang, P
   Li, AL
   Wen, JY
   Zhao, SM
   Liu, HX
   Ke, YN
   Campbell, W
   Zhang, YG
   Li, XH
   Liao, WQ
AF Wei, Yan-Ling
   Yu, Chang-An
   Yang, Peng
   Li, Ai-Li
   Wen, Jian-Yan
   Zhao, Shu-Min
   Liu, Hong-Xing
   Ke, Yuan-Nan
   Campbell, William
   Zhang, Yi-Guan
   Li, Xiao-Hui
   Liao, Wen-Qiang
TI NOVEL MITOCHONDRIAL DNA MUTATIONS ASSOCIATED WITH CHINESE FAMILIAL
   HYPERTROPHIC CARDIOMYOPATHY
SO CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
LA English
DT Article
DE haplogroup Chinese; hypertrophic cardiomyopathy; mitochondrial DNA
   mutation
ID GENOME; HAPLOGROUPS; MYOPATHY; SEQUENCE; PATIENT; ACID
AB P>Hypertrophic cardiomyopathy (HCM) is a genetic disorder that has a complex set of symptoms and potentially devastating consequences. Increasing evidence indicates that mitochondrial DNA (mtDNA) mutations are responsible for the development of HCM, but the mtDNA mutations appear to differ considerably among different populations and regions.
   In the present study, three families with HCM were found and investigated: one in Shandong province and two in the Chongqing region of China. The entire mtDNA genome from the 18 affected and 66 unaffected family members was sequenced directly and the mtDNA mutations were determined.
   The frequency of haplogroup M10 was significantly higher in family members with HCM (HCM group) than in unaffected family members (normal group). Three mtDNA mutations were found with a significantly higher frequency in affected individuals than in unaffected family individuals, namely G7697A in the cytochrome c oxidase subunit II gene (P < 0.0001; odds ratio (OR) 227.5; 95% confidence interval (CI) 23.6-2194.8) and T12477C (P = 0.0037; OR 5.6; 95% CI 1.8-17.6) and G13135A in the NADH dehydrogenase 5 gene (P < 0.0001; OR 26.0; 95% CI 6.9-98.3), suggesting that these mutations are probably associated with susceptibility to HCM. In addition, mitochondrial Complex I activity was markedly decreased in the HCM group, suggesting that these mutations most likely affect mitochondrial respiratory function.
   In conclusion, the results of the present study imply that mtDNA mutations G7697A, T12477C and G13135A are genetic factors that indicate a susceptibility to HCM and that could be used for the large-scale screening of genetic markers as well as the early diagnosis of HCM.
C1 [Wei, Yan-Ling; Zhang, Yi-Guan; Li, Xiao-Hui] Third Mil Med Univ, Inst Mat Med, Sch Pharm, Chongqing 400038, Peoples R China.
   [Wei, Yan-Ling; Zhang, Yi-Guan; Li, Xiao-Hui] Third Mil Med Univ, Dept Pharmaceut, Sch Pharm, Chongqing 400038, Peoples R China.
   [Yu, Chang-An; Yang, Peng; Li, Ai-Li; Wen, Jian-Yan; Liu, Hong-Xing; Ke, Yuan-Nan; Liao, Wen-Qiang] China Japan Friendship Hosp, Natl Integrat Med Ctr Cardiovasc Dis, Beijing, Peoples R China.
   [Zhao, Shu-Min] Beijing Genovax Biotechnol Corp, Beijing, Peoples R China.
   [Campbell, William] PepMetr & Pegasus Pharmaceut Grp, Richmond, BC, Canada.
C3 Army Medical University; Army Medical University; China-Japan Friendship
   Hospital
RP Li, XH (corresponding author), Third Mil Med Univ, Inst Mat Med, Sch Pharm, Chongqing 400038, Peoples R China.
EM caseml@hotmail.com
RI Li, Xiaohui/W-8959-2019
OI wen, jianyan/0000-0001-5762-6504
FU National Natural Science Foundation of China [30 371 768]; Beijing
   Tai-De Pharmaceuticals (Beijing, China)
FX This work was supported by the National Natural Science Foundation of
   China (no. 30 371 768) and Beijing Tai-De Pharmaceuticals (Beijing,
   China).
CR AMISAGO MK, 2000, NEW ENGL J MED, V343, P1688
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Casali C, 1999, J AM COLL CARDIOL, V33, P1584, DOI 10.1016/S0735-1097(99)00079-0
   Castro MG, 2006, INT J CARDIOL, V112, P202, DOI 10.1016/j.ijcard.2005.09.008
   Chen J, 2006, DIABETES RES CLIN PR, V74, P148, DOI 10.1016/j.diabres.2006.03.024
   Coats Caroline J, 2008, Curr Treat Options Cardiovasc Med, V10, P496, DOI 10.1007/s11936-008-0042-9
   Crimi M, 2008, INT J NANOMED, V3, P51
   Feigenbaum A, 2006, AM J MED GENET A, V140A, P2216, DOI 10.1002/ajmg.a.31436
   Harada K, 2004, J BIOL CHEM, V279, P14488, DOI 10.1074/jbc.M309355200
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   Janssen AJM, 2006, CLIN CHEM, V52, P860, DOI 10.1373/clinchem.2005.062414
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Li JY, 2007, J FORMOS MED ASSOC, V106, P528, DOI 10.1016/S0929-6646(07)60003-5
   Liao WQ, 2008, TOHOKU J EXP MED, V215, P377, DOI 10.1620/tjem.215.377
   MarinGarcia J, 1997, PEDIATR CARDIOL, V18, P251, DOI 10.1007/s002469900169
   Menotti Francesca, 2004, Ital Heart J, V5, P460
   Morita H, 2006, CIRCULATION, V113, P2697, DOI 10.1161/CIRCULATIONAHA.105.593558
   Prasad GN, 2006, INT J CARDIOL, V109, P432, DOI 10.1016/j.ijcard.2005.07.065
   Ruppert V, 2004, BIOCHEM BIOPH RES CO, V318, P535, DOI 10.1016/j.bbrc.2004.04.061
   Santorelli F M, 2001, Am Heart J, V141, pE1, DOI 10.1067/mhj.2001.112088
   Stuart JA, 2006, BBA-BIOENERGETICS, V1757, P79, DOI 10.1016/j.bbabio.2006.01.003
   Takeda N, 1997, MOL CELL BIOCHEM, V176, P287, DOI 10.1023/A:1006869616555
   Tanjore RR, 2008, CAN J CARDIOL, V24, P127, DOI 10.1016/S0828-282X(08)70568-3
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Toylor MR, 2004, EXPERT REV MOL DIAGN, V4, P99, DOI 10.1586/14737159.4.1.99
   Zifa E, 2008, MITOCHONDRION, V8, P229, DOI 10.1016/j.mito.2008.04.001
NR 27
TC 18
Z9 21
U1 2
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1440-1681
J9 CLIN EXP PHARMACOL P
JI Clin. Exp. Pharmacol. Physiol.
PD SEP
PY 2009
VL 36
IS 9
BP 933
EP 939
DI 10.1111/j.1440-1681.2009.05183.x
PG 7
WC Pharmacology & Pharmacy; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Physiology
GA 489WH
UT WOS:000269455600015
PM 19473338
OA Bronze
DA 2024-11-01
ER

PT J
AU Zsurka, G
   Baron, M
   Stewart, JD
   Kornblum, C
   Bös, M
   Sassen, R
   Taylor, RW
   Elger, CE
   Chinnery, PF
   Kunz, WS
AF Zsurka, Gabor
   Baron, Miriam
   Stewart, Joanna D.
   Kornblum, Cornelia
   Boes, Monika
   Sassen, Robert
   Taylor, Robert W.
   Elger, Christian E.
   Chinnery, Patrick F.
   Kunz, Wolfram S.
TI Clonally expanded mitochondrial DNA mutations in epileptic individuals
   with mutated DNA polymerase γ
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE aging; Alpers-Huttenlocher syndrome; clonal expansion; DNA polymerase
   gamma; mitochondrial depletion; mtDNA deletion; mtDNA point mutation;
   POLG
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MULTIPLE DELETIONS; POLG
   MUTATIONS; CONTROL REGION; ACCUMULATION
AB The instability of the mitochondrial genome in individuals harboring pathogenic mutations in the catalytic subunit of mitochondrial DNA (mtDNA) polymerase gamma (POLG) is well recognized, but the underlying molecular mechanisms remain to be elucidated. In 5 pediatric patients with severe myoclonic epilepsy and valproic acid-induced liver failure, we identified I novel and 4 previously described pathogenic mutations in the linker region of this enzyme. Although muscle biopsies in these patients showed unremarkable histologic features, postmortem liver tissue available from I individual exhibited large cytochrome c oxidase-negative areas. These cytochrome c oxidase-negative areas contained 4-fold less mtDNA than cytochrome e oxidase-positive areas. Decreased copy numbers of mtDNA were observed not only in the liver, skeletal muscle, and brain but also in blood samples from all patients. There were also patient-specific patterns of multiple mtDNA deletions in different tissues, and in 2 patients, there were clonally expanded mtDNA point mutations. The low amount of deleted mtDNA molecules makes it unlikely that the deletions contribute significantly to the general biochemical defect. The clonal expansion of a few individual-specific deletions and point mutations indicates all accelerated segregation of early mtDNA mutations that likely are a consequence of low mtDNA copy numbers. Moreover, these results Suggest a potential diagnostic approach for identifying mtDNA depletion in patients.
C1 [Zsurka, Gabor; Baron, Miriam; Boes, Monika; Sassen, Robert; Elger, Christian E.; Kunz, Wolfram S.] Univ Bonn, Dept Epileptol, D-53105 Bonn, Germany.
   [Stewart, Joanna D.; Taylor, Robert W.; Chinnery, Patrick F.] Sch Med, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.
   [Kornblum, Cornelia] Univ Bonn, Dept Neurol, D-53105 Bonn, Germany.
C3 University of Bonn; Newcastle University - UK; University of Bonn
RP Kunz, WS (corresponding author), Univ Bonn, Life & Brain Ctr, Div Neurochem, Sigmund Freud Str 25, D-53105 Bonn, Germany.
EM wolfram.kunz@ukb.uni-bonn.de
RI Kornblum, Cornelia/IUM-4180-2023; Kunz, Wolfram/K-1232-2019; Stewart,
   Joanna D/H-1614-2012
OI Kunz, Wolfram/0000-0003-1113-3493; Chinnery,
   Patrick/0000-0002-7065-6617; Zsurka, Gabor/0000-0002-6379-849X; Stewart,
   Joanna D/0000-0002-2608-1967
FU Deutsche Forschungsgemeinschaft [KU-911/15-1, TR3 A11];
   Bundesministerium fur Bildung und Forschung [01GZ0704]
FX This study was supported by Grants KU-911/15-1 and TR3 A11 from the
   Deutsche Forschungsgemeinschaft and Grant 01GZ0704 from the
   Bundesministerium fur Bildung und Forschung (W.S.K.). P.F.C. is a
   Wellcome Trust Senior Fellow in Clinical Science.
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Coller HA, 2002, ANN NY ACAD SCI, V959, P434, DOI 10.1111/j.1749-6632.2002.tb02113.x
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   PREISS T, 1995, TRENDS GENET, V11, P211, DOI 10.1016/S0168-9525(00)89048-4
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wiedemann FR, 2000, ANAL BIOCHEM, V279, P55, DOI 10.1006/abio.1999.4434
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zsurka G, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.022566
NR 27
TC 32
Z9 32
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-3069
EI 1554-6578
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD SEP
PY 2008
VL 67
IS 9
BP 857
EP 866
DI 10.1097/NEN.0b013e3181839b2d
PG 10
WC Clinical Neurology; Neurosciences; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pathology
GA 344PA
UT WOS:000258938600004
PM 18716558
OA Bronze
DA 2024-11-01
ER

PT J
AU Longley, MJ
   Graziewicz, MA
   Bienstock, RJ
   Copeland, WC
AF Longley, MJ
   Graziewicz, MA
   Bienstock, RJ
   Copeland, WC
TI Consequences of mutations in human DNA polymerase γ
SO GENE
LA English
DT Article; Proceedings Paper
CT Meeting on Cross Talk between Nucleus and Organelles
CY SEP 15-18, 2004
CL Stazione Zool Anton Dohrn, Naples, ITALY
HO Stazione Zool Anton Dohrn
DE mitochondrial DNA replication; PEO; Alpers syndrome; POLG
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; P55 ACCESSORY SUBUNIT;
   MITOCHONDRIAL-DNA; POLG MUTATIONS; AUTOSOMAL-DOMINANT; MULTIPLE
   DELETIONS; MALE-INFERTILITY; ALPERS-SYNDROME; MTDNA; GENE
AB DNA polymerase gamma is responsible for replication and repair of the mitochondrial genome. Human DNA polymerase gamma is composed of a 140-kDa catalytic subunit and a 55-kDa accessory subunit. Mutations in the gene for the catalytic subunit (POLG) have been shown to be a frequent cause of mitochondrial disorders. To date over 40 disease mutations and 9 nonsynonymous polymorphisms in POLG have been found to be associated with autosomal recessive and dominant progressive external ophthalmoplegia (PEO), Alpers syndrome, sensory ataxia, neuropathy, dysarthria and ophthalmoparesis (SANDO), Parkinsonism, and male infertility. In this paper we review the literature of POLG mutations and discuss their impact on mitochondrial diseases. We also describe a public access web database to annotate POLG mutations for the research community. (c) 2005 Elsevier B.V. All rights reserved.
C1 NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA.
   NIEHS, Comp Sci Lab, NIH, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS); National Institutes of Health
   (NIH) - USA; NIH National Institute of Environmental Health Sciences
   (NIEHS)
RP Copeland, WC (corresponding author), NIEHS, Mol Genet Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
RI Copeland, William/C-4242-2019
OI Copeland, William/0000-0002-0359-0953; Bienstock,
   Rachelle/0000-0001-5228-3610
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329
   Carrodeguas JA, 2002, J BIOL CHEM, V277, P50008, DOI 10.1074/jbc.M207030200
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x
   GONZALEZ E, 2004, POLG TWINKLE MUTATIO, V6, P1
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   Jensen M, 2004, HUM REPROD, V19, P65, DOI 10.1093/humrep/deh038
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Krausz C, 2004, J CLIN ENDOCR METAB, V89, P4292, DOI 10.1210/jc.2004-0008
   Lamantea E, 2004, ANN NEUROL, V56, P454, DOI 10.1002/ana.20219
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Rovio AT, 2004, MAMM GENOME, V15, P492, DOI 10.1007/s00335-004-3049-x
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   *U UT GEN, GEN SNP CARD POLG
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333
NR 45
TC 125
Z9 136
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1119
J9 GENE
JI Gene
PD JUL 18
PY 2005
VL 354
SI SI
BP 125
EP 131
DI 10.1016/j.gene.2005.03.029
PG 7
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Genetics & Heredity
GA 959DN
UT WOS:000231497200019
PM 15913923
DA 2024-11-01
ER

PT J
AU Shahni, R
   Wedatilake, Y
   Cleary, MA
   Lindley, KJ
   Sibson, KR
   Rahman, S
AF Shahni, Rojeen
   Wedatilake, Yehani
   Cleary, Maureen A.
   Lindley, Keith J.
   Sibson, Keith R.
   Rahman, Shamima
TI A Distinct Mitochondrial Myopathy, Lactic Acidosis and Sideroblastic
   Anemia (MLASA) Phenotype Associates with <i>YARS2</i> Mutations
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE sideroblastic anemia; MLASA; YARS2; mitochondrial disease; mitochondrial
   myopathy; lactic acidosis
ID MISSENSE MUTATION; GENE; DNA
AB Nuclear-encoded disorders of mitochondrial translation are clinically and genetically heterogeneous. Genetic causes include defects of mitochondrial aminoacyl-tRNA synthetases, and factors required for initiation, elongation and termination of protein synthesis as well as ribosome recycling. We report on a new case of myopathy, lactic acidosis and sideroblastic anemia (MLASA) syndrome caused by defective mitochondrial tyrosyl aminoacylation. The patient presented at 1 year with anemia initially attributed to iron deficiency. Bone marrow aspirate at 5 years revealed ringed sideroblasts but transfusion dependency did not occur until 11 years. Other clinical features included lactic acidosis, poor weight gain, hypertrophic cardiomyopathy and severe myopathy leading to respiratory failure necessitating ventilatory support. Long-range PCR excluded mitochondrial DNA rearrangements. Clinical diagnosis of MLASA prompted direct sequence analysis of the YARS2 gene encoding the mitochondrial tyrosyl-tRNA synthetase, which revealed homozygosity for a known pathogenic mutation, c.156C>G;p.F52L. Comparison with four previously reported cases demonstrated remarkable clinical homogeneity. First line investigation of MLASA should include direct sequence analysis of YARS2 and PUS1 (encoding a tRNA modification factor) rather than muscle biopsy. Early genetic diagnosis is essential for counseling and to facilitate appropriate supportive therapy. Reasons for segregation of specific clinical phenotypes with particular mitochondrial aminoacyl tRNA-synthetase defects remain unknown. (c) 2013 Wiley Periodicals, Inc.
C1 [Shahni, Rojeen; Wedatilake, Yehani; Rahman, Shamima] UCL, Inst Child Hlth, Mitochondrial Res Grp, Clin & Mol Genet Unit, London WC1N 1EH, England.
   [Cleary, Maureen A.; Rahman, Shamima] Great Ormond St Hosp Sick Children, Metab Unit, London, England.
   [Lindley, Keith J.] Great Ormond St Hosp Sick Children, Gastroenterol Unit, London, England.
   [Sibson, Keith R.] Great Ormond St Hosp Sick Children, Haematol Unit, London, England.
C3 University of London; University College London; University of London;
   University College London; Great Ormond Street Hospital for Children NHS
   Foundation Trust; University of London; University College London; Great
   Ormond Street Hospital for Children NHS Foundation Trust; University of
   London; University College London; Great Ormond Street Hospital for
   Children NHS Foundation Trust
RP Rahman, S (corresponding author), UCL, Inst Child Hlth, Mitochondrial Res Grp, Clin & Mol Genet Unit, 30 Guilford St, London WC1N 1EH, England.
EM shamima.rahman@ucl.ac.uk
RI Rahman, Shamima/C-5232-2008
OI Wedatilake, Yehani/0000-0002-9268-7385
FU Great Ormond Street Hospital Children's Charity; Wellcome Trust Research
   Training Fellowship
FX Grant sponsor: Great Ormond Street Hospital Children's Charity; Grant
   sponsor: Wellcome Trust Research Training Fellowship.
CR Bergmann AK, 2010, PEDIATR BLOOD CANCER, V54, P273, DOI 10.1002/pbc.22244
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Fleming MD, 2011, HEMATOL-AM SOC HEMAT, P525, DOI 10.1182/asheducation-2011.1.525
   Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Pulkes T, 2000, NEUROLOGY, V55, P1210, DOI 10.1212/WNL.55.8.1210
   Rahman S, 2000, J INHERIT METAB DIS, V23, P753, DOI 10.1023/A:1005611803306
   Rahman S, 2013, NEUROMUSCULAR DISORD, V23, P506, DOI 10.1016/j.nmd.2013.03.004
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rötig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   Sasarman F, 2002, HUM MOL GENET, V11, P1669, DOI 10.1093/hmg/11.14.1669
   Sasarman F, 2012, HUM MUTAT, V33, P1201, DOI 10.1002/humu.22098
   Scaglia F, 2003, AM J MED GENET A, V123A, P172, DOI 10.1002/ajmg.a.20315
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
NR 17
TC 39
Z9 42
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD SEP
PY 2013
VL 161
IS 9
BP 2334
EP 2338
DI 10.1002/ajmg.a.36065
PG 5
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 263HQ
UT WOS:000327798800030
PM 23918765
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Meulemans, A
   Gerlo, E
   Seneca, S
   Lissens, W
   Smet, J
   Van Coster, R
   De Meirleir, L
AF Meulemans, Ann
   Gerlo, Erik
   Seneca, Sara
   Lissens, Willy
   Smet, Joel
   Van Coster, Rudy
   De Meirleir, Linda
TI The aerobic forearm exercise test, a non-invasive tool to screen for
   mitochondrial disorders
SO ACTA NEUROLOGICA BELGICA
LA English
DT Article
DE aerobic forearm exercise; diagnosis; mitochondrial; disease; muscle;
   oxygen extraction
ID MYOPATHY; MUSCLE; METABOLISM; MUTATIONS; WORKLOAD; LACTATE; DNA
AB The diagnosis of a mitochondrial disorder is often difficult. Therefore, new approaches and diagnostic criteria are being developed. One of these tests is the aerobic forearm exercise test, a screening tool that can contribute to assess whether or not the patient suffers from a mitochondrial myopathy. With this simple, non-invasive test, the oxidative metabolism of muscle can be evaluated in rest and during exercise. We performed the aerobic forearm exercise test in patients with a mitochondrial disorder and an identified pathogenic gene mutation, in patients with a suspected mitochondrial disorder based on their clinical presentation and biochemical results, but without a molecular diagnosis, and in patients with atypical fatigue and no characteristics of a mitochondrial myopathy. In the first two groups, abnormal oxygen extraction from the blood during exercise was observed in four out of twelve patients. In the third group no abnormalities were found.
   The number of patients that we could test so far was limited, but all the patients experienced the aerobic forearm exercise as an easy test. We would like to stimulate clinicians to perform this test whenever a mitochondrial myopathy is suspected, as it can be a valuable diagnostic screening tool.
C1 UZ Brussels, B-1090 Brussels, Belgium.
   Vrije Univ Brussels, Ctr Genet Med, Brussels, Belgium.
   Vrije Univ Brussels, Dept Clin Chem & Radioimmunol, Brussels, Belgium.
   Vrije Univ Brussels, Dept Pediat Neurol, Brussels, Belgium.
   Ghent Univ Hosp, Ghent, Belgium.
C3 Vrije Universiteit Brussel; Vrije Universiteit Brussel; Vrije
   Universiteit Brussel; Ghent University; Ghent University Hospital
RP Meulemans, A (corresponding author), UZ Brussels, Laarbeeklaan 101, B-1090 Brussels, Belgium.
RI Smet, Joél/B-7428-2013; De Meirleir, Linda/D-6591-2016; Lissens,
   Willy/B-2892-2013
OI Lissens, Willy/0000-0003-3875-9955; Seneca, Sara/0000-0002-0853-9890;
   Meulemans, Ann/0000-0003-3938-2408
CR Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   BARBIROLI B, 1995, NEUROLOGY, V45, P1364, DOI 10.1212/WNL.45.7.1364
   Chance B., 1998, Biofactors, V7, P237
   DiMauro S, 2001, ANN MED, V33, P472, DOI 10.3109/07853890109002096
   Finsterer J, 2004, EUR J NEUROL, V11, P811, DOI 10.1111/j.1468-1331.2004.00859.x
   Hammarén E, 2004, EUR NEUROL, V51, P38, DOI 10.1159/000074981
   Hanisch F, 2006, J NEUROL, V253, P417, DOI 10.1007/s00415-006-0987-0
   Jensen TD, 2002, NEUROLOGY, V58, P1533, DOI 10.1212/WNL.58.10.1533
   Jeppesen TD, 2007, J NEUROL, V254, P29, DOI 10.1007/s00415-006-0229-5
   Kazemi-Esfarjani P, 2002, ANN NEUROL, V52, P153, DOI 10.1002/ana.10263
   Seneca S, 2000, J INHERIT METAB DIS, V23, P853, DOI 10.1023/A:1026729223050
   Taivassalo T, 2002, ANN NEUROL, V51, P38, DOI 10.1002/ana.10027
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   van den Bosch BJC, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e89
NR 14
TC 14
Z9 15
U1 0
U2 2
PU ACTA MEDICA BELGICA
PI BRUSSELS
PA AVENUE CIRCULAIRE 138-A, B-1180 BRUSSELS, BELGIUM
SN 0300-9009
J9 ACTA NEUROL BELG
JI Acta Neurol. Belg.
PD SEP
PY 2007
VL 107
IS 3
BP 78
EP 83
PG 6
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 232XY
UT WOS:000251056200004
PM 18072335
DA 2024-11-01
ER

PT J
AU Vital, A
   Vital, C
AF Vital, Anne
   Vital, Claude
TI Mitochondria and Peripheral Neuropathies
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Review
DE Ganglioside-induced differentiation-associated protein 1; Mitochondria;
   Mitofusin 2; Peripheral neuropathy; Peripheral nerve biopsy; Polymerase
   gamma 1
ID CHARCOT-MARIE-TOOTH; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MITOFUSIN 2
   MUTATIONS; NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY MNGIE; SENSORY ATAXIC
   NEUROPATHY; KEARNS-SAYRE SYNDROME; SURAL NERVE BIOPSIES;
   CYTOCHROME-C-OXIDASE; STROKE-LIKE EPISODES; GDAP1 MUTATIONS
AB There has been considerable progress during the past 24 years in the molecular genetics of mitochondrial DNA and related nuclear DNA mutations, and more than 100 nerve biopsies from hereditary neuropathies related to mitochondrial cytopathy have been accurately examined. Neuropathies were first reported in diseases related to point mutations of mitochondrial DNA, but they proved to be a prominent feature of the phenotype in mitochondrial disorders caused by defects in nuclear DNA, particularly in 3 genes: polymerase gamma 1 (POLG1), mitofusin 2 (MFN2), and ganglioside-induced differentiation-associated protein 1 (GDAP1). Most patients have sensory-motor neuropathy, sometimes associated with ophthalmoplegia, ataxia, seizures, parkinsonism, myopathy, or visceral disorders. Some cases are caused by consanguinity, but most are sporadic with various phenotypes mimicking a wide range of other etiologies. Histochemistry on muscle biopsy, as well as identification of crystalloid inclusions at electron microscopy, may provide a diagnostic clue to mitochondriopathy, but nerve biopsy is often less informative. Nevertheless, enlarged mitochondria containing distorted or amputated cristae are highly suggestive, particularly when located in the Schwann cell cytoplasm. Also noticeable are clusters of regenerating myelinated fibers surrounded by concentric Schwann cell processes, and such onion bulb-like formations are frequently observed in neuropathies caused by GDAP1 mutations.
C1 [Vital, Anne; Vital, Claude] Univ Bordeaux, CNRS, Inst Malad Neurodegenerat, Bordeaux, France.
   [Vital, Anne] CHU Bordeaux, Dept Pathol, Bordeaux, France.
C3 Centre National de la Recherche Scientifique (CNRS); Universite de
   Bordeaux; Universite de Bordeaux; CHU Bordeaux
RP Vital, A (corresponding author), Univ Bordeaux 2, Neuropathol Lab, 146 Rue Leo Saignat,BP 42, F-33076 Bordeaux, France.
EM anne.vital@chu-bordeaux.fr
CR Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Ammar N, 2003, NEUROMUSCULAR DISORD, V13, P720, DOI 10.1016/S0960-8966(03)00093-2
   Angelini C, 2009, Acta Myol, V28, P16
   [Anonymous], 2001, PATHOLOGY PERIPHERAL
   [Anonymous], 1975, Peripheral Neuropathy
   Asbury AK, 1978, PATHOLOGY PERIPHERAL
   Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007
   BARDOSI A, 1987, ACTA NEUROPATHOL, V74, P248, DOI 10.1007/BF00688189
   Bedlack RS, 2004, MUSCLE NERVE, V29, P364, DOI 10.1002/mus.10546
   Benard G, 2008, ANTIOXID REDOX SIGN, V10, P1313, DOI 10.1089/ars.2007.2000
   Benedetti S, 2010, ARCH NEUROL-CHICAGO, V67, P1498, DOI 10.1001/archneurol.2010.303
   BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231
   Biancheri R, 2006, J NEUROL, V253, P1234, DOI 10.1007/s00415-006-0149-4
   Birouk N, 2003, ARCH NEUROL-CHICAGO, V60, P598, DOI 10.1001/archneur.60.4.598
   Boerkoel CF, 2003, ANN NEUROL, V53, P400, DOI 10.1002/ana.10505
   Bouillot S, 2002, J PERIPHER NERV SYST, V7, P213, DOI 10.1046/j.1529-8027.2002.02027.x
   Calvo J, 2009, ARCH NEUROL-CHICAGO, V66, P1511, DOI 10.1001/archneurol.2009.284
   Cartoni R, 2009, EXP NEUROL, V218, P268, DOI 10.1016/j.expneurol.2009.05.003
   Carvalho AAS, 2005, J PERIPHER NERV SYST, V10, P85, DOI 10.1111/j.1085-9489.2005.10112.x
   Cassereau J, 2011, NEUROLOGY, V76, P1524, DOI 10.1212/WNL.0b013e318217e77d
   Cassereau J, 2011, EXP NEUROL, V227, P31, DOI 10.1016/j.expneurol.2010.09.006
   Chen HC, 2006, CURR OPIN CELL BIOL, V18, P453, DOI 10.1016/j.ceb.2006.06.004
   Chinnery PF, 2008, GREENFIELDS NEUROPAT, P601
   Chu CC, 1997, EUR NEUROL, V37, P110, DOI 10.1159/000117420
   Chung KW, 2006, BRAIN, V129, P2103, DOI 10.1093/brain/awl174
   Chung KW, 2008, J HUM GENET, V53, P360, DOI 10.1007/s10038-008-0249-3
   CIAFALONI E, 1991, NEUROLOGY, V41, P1663, DOI 10.1212/WNL.41.10.1663
   Claramunt R, 2005, J MED GENET, V42, P358, DOI 10.1136/jmg.2004.022178
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Cottrell DA, 2000, J NEUROPATH EXP NEUR, V59, P621, DOI 10.1093/jnen/59.7.621
   Dashe JF, 1998, NEW ENGL J MED, V339, P1914, DOI 10.1056/NEJM199812243392608
   Debouverie M, 1997, REV NEUROL, V153, P547
   Del Bo R, 2008, NEUROLOGY, V71, P1959, DOI 10.1212/01.wnl.0000327095.32005.a4
   Di Maria E, 2004, J NEUROL NEUROSUR PS, V75, P1495, DOI 10.1136/jnnp.2003.028100
   DiMauro S, 2010, Acta Myol, V29, P333
   DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602
   DiMauro S, 2006, BRAIN, V129, P1637, DOI 10.1093/brain/awl169
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   FARDEAU M, 1969, J NEUROPATH EXP NEUR, V28, P278
   Filosto M, 2011, J INHERIT METAB DIS, V34, P1199, DOI 10.1007/s10545-011-9332-6
   Finsterer J, 2011, J NEUROL SCI, V304, P9, DOI 10.1016/j.jns.2011.02.012
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   Genari AB, 2011, NEUROMUSCULAR DISORD, V21, P428, DOI 10.1016/j.nmd.2011.03.008
   HAHN AF, 1993, BRAIN PATHOL, V3, P147, DOI 10.1111/j.1750-3639.1993.tb00739.x
   HANNA MG, 2005, PERIPHERAL NEUROPATH, P1937
   HARA H, 1994, J NEUROL NEUROSUR PS, V57, P1545, DOI 10.1136/jnnp.57.12.1545-a
   Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Hisama FM, 2005, AM J MED GENET A, V135A, P217, DOI 10.1002/ajmg.a.30672
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Houlden H, 2009, NEUROMUSCULAR DISORD, V19, P264, DOI 10.1016/j.nmd.2009.01.006
   Huang CC, 1999, ACTA NEUROL SCAND, V99, P125, DOI 10.1111/j.1600-0404.1999.tb00670.x
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Kabzinska D, 2007, Acta Myol, V26, P108
   Kabzinska D, 2006, J NEUROL SCI, V241, P7, DOI 10.1016/j.jns.2005.10.002
   Kabzinska D, 2006, Acta Myol, V25, P34
   Kijima K, 2005, HUM GENET, V116, P23, DOI 10.1007/s00439-004-1199-2
   King MD, 1996, NEUROLOGY, V46, P1495, DOI 10.1212/WNL.46.5.1495
   King RHM., 1999, Atlas of peripheral nerve pathology
   Klein CJ, 2011, ARCH NEUROL-CHICAGO, V68, P1295, DOI 10.1001/archneurol.2011.225
   Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   KORTHALS JK, 1978, ANN NEUROL, V4, P487, DOI 10.1002/ana.410040603
   Lamperti C, 2009, Acta Myol, V28, P2
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294
   Luigetti M, 2011, J NEUROL SCI, V307, P168, DOI 10.1016/j.jns.2011.04.025
   MADRID R, 1977, J NEUROL SCI, V32, P91, DOI 10.1016/0022-510X(77)90042-9
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Martin-Negrier ML, 2011, EUR J NEUROL, V18, P436, DOI 10.1111/j.1468-1331.2010.03171.x
   MIDRONI G, 1995, BIOPSY DIAGNOSIS PER
   Milone M, 2012, NEUROLOGY, V78, P1612, DOI 10.1212/WNL.0b013e3182563c46
   Milone M, 2011, NEUROLOGY, V77, P1847, DOI 10.1212/WNL.0b013e318238863a
   MOLNAR M, 1995, NEUROPATH APPL NEURO, V21, P432, DOI 10.1111/j.1365-2990.1995.tb01080.x
   Molnar M, 1996, ACTA NEUROPATHOL, V91, P654, DOI 10.1007/s004010050480
   Moroni I, 2009, NEUROMUSCULAR DISORD, V19, P476, DOI 10.1016/j.nmd.2009.04.014
   Nagashima T, 2001, NEUROMUSCULAR DISORD, V11, P470, DOI 10.1016/S0960-8966(01)00190-0
   Nardin RA, 2001, MUSCLE NERVE, V24, P170, DOI 10.1002/1097-4598(200102)24:2<170::AID-MUS30>3.0.CO;2-0
   Naumann M, 1997, MUSCLE NERVE, V20, P833, DOI 10.1002/(SICI)1097-4598(199707)20:7<833::AID-MUS7>3.0.CO;2-8
   Nelis E, 2002, NEUROLOGY, V59, P1865, DOI 10.1212/01.WNL.0000036272.36047.54
   Nicholson G, 2002, NEUROLOGY, V59, P1835, DOI 10.1212/WNL.59.12.1835
   Nicholson GA, 2008, NEUROLOGY, V70, P1678, DOI 10.1212/01.wnl.0000311275.89032.22
   NICOLL JAR, 1993, CLIN NEUROPATHOL, V12, P38
   Niemann A, 2006, NEUROMOL MED, V8, P217, DOI 10.1385/NMM:8:1:217
   Niemann A, 2009, NEUROBIOL DIS, V36, P509, DOI 10.1016/j.nbd.2009.09.011
   Nishino I, 2000, ANN NEUROL, V47, P792
   Ouvrier R, 2010, DEV MED CHILD NEUROL, V52, P328, DOI 10.1111/j.1469-8749.2010.03613.x
   Pedrola L, 2008, J CELL MOL MED, V12, P679, DOI 10.1111/j.1582-4934.2007.00158.x
   Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317
   Posada IJ, 2010, MED CLIN-BARCELONA, V135, P452, DOI 10.1016/j.medcli.2010.03.031
   Rahman S, 2009, J NEUROL NEUROSUR PS, V80, P943, DOI 10.1136/jnnp.2008.158279
   Roy S, 2005, ACTA NEUROPATHOL, V109, P5, DOI 10.1007/s00401-004-0952-x
   Said G, 2005, J NEUROL, V252, P655, DOI 10.1007/s00415-005-0712-4
   Sander S, 1998, MUSCLE NERVE, V21, P217, DOI 10.1002/(SICI)1097-4598(199802)21:2<217::AID-MUS9>3.0.CO;2-E
   Santoro L, 2000, NEUROMUSCULAR DISORD, V10, P450, DOI 10.1016/S0960-8966(99)00122-4
   Santoro L, 2006, J NEUROL, V253, P869, DOI 10.1007/s00415-006-0082-6
   SASAKI H, 1983, NEUROLOGY, V33, P1288, DOI 10.1212/WNL.33.10.1288
   Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   SCHRODER JM, 1991, ACTA NEUROPATHOL, V82, P471, DOI 10.1007/BF00293381
   Senderek J, 2003, BRAIN, V126, P642, DOI 10.1093/brain/awg068
   Sevilla T, 2003, BRAIN, V126, P2023, DOI 10.1093/brain/awg202
   Sevilla T, 2008, BRAIN, V131, P3051, DOI 10.1093/brain/awn228
   Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156
   Sivera R, 2010, J PERIPHER NERV SYST, V15, P334, DOI 10.1111/j.1529-8027.2010.00286.x
   Sole G, 2009, J PERIPHER NERV SYST, V14, P206, DOI 10.1111/j.1529-8027.2009.00234.x
   SOMMER C, 1989, ARCH NEUROL-CHICAGO, V46, P973, DOI 10.1001/archneur.1989.00520450043017
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Stickler DE, 2006, PEDIATR NEUROL, V34, P127, DOI 10.1016/j.pediatrneurol.2005.08.006
   Stickler DE, 2003, J CHILD NEUROL, V18, P574, DOI 10.1177/08830738030180081101
   Tang S, 2012, J NEUROL, V259, P862, DOI 10.1007/s00415-011-6268-6
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   UNCINI A, 1994, MUSCLE NERVE, V17, P667, DOI 10.1002/mus.880170616
   Valentijn KM, 2011, BLOOD, V117, P5033, DOI 10.1182/blood-2010-09-267492
   Vallat JM, 2008, J NEUROPATH EXP NEUR, V67, P1097, DOI 10.1097/NEN.0b013e31818b6cbc
   Vallat JM, 2009, J NEUROPATH EXP NEUR, V68, P833, DOI 10.1097/NEN.0b013e3181af2b9c
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126
   Viader A, 2011, J NEUROSCI, V31, P10128, DOI 10.1523/JNEUROSCI.0884-11.2011
   VITAL A, 1985, ACTA NEUROPATHOL, V67, P136, DOI 10.1007/BF00688134
   Vital A, 2001, J PERIPHER NERV SYST, V6, P79, DOI 10.1046/j.1529-8027.2001.01011.x
   Vital A, 2012, NEUROMUSCULAR DISORD, V22, P735, DOI 10.1016/j.nmd.2012.04.001
   Vital C, 2006, J PERIPHER NERV SYST, V11, P20, DOI 10.1111/j.1085-9489.2006.00060.x
   VITAL C, 1983, ACTA NEUROPATHOL, V61, P225, DOI 10.1007/BF00691990
   Vital C, 2002, ULTRASTRUCT PATHOL, V26, P9, DOI 10.1080/01913120252934279
   Vital C., 1987, ULTRASTRUCTURAL STUD
   Vital C, 2008, J PERIPHER NERV SYST, V13, P103, DOI 10.1111/j.1529-8027.2008.00163.x
   Vogel H, 2001, J NEUROPATH EXP NEUR, V60, P217, DOI 10.1093/jnen/60.3.217
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046
   Weis J, 2012, CLIN NEUROPATHOL, V31, P7, DOI 10.5414/NP300468
   Weiss MD, 2010, MUSCLE NERVE, V41, P882, DOI 10.1002/mus.21636
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   YIANNIKAS C, 1986, ANN NEUROL, V20, P249, DOI 10.1002/ana.410200211
   Zanssen S, 1998, CLIN NEUROPATHOL, V17, P291
   Zeviani M, 2008, BRAIN, V131, P314, DOI 10.1093/brain/awm339
   Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd
   Zimón M, 2011, NEUROLOGY, V77, P540, DOI 10.1212/WNL.0b013e318228fc70
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 143
TC 35
Z9 38
U1 1
U2 11
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-3069
EI 1554-6578
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD DEC
PY 2012
VL 71
IS 12
BP 1036
EP 1046
DI 10.1097/NEN.0b013e3182764d47
PG 11
WC Clinical Neurology; Neurosciences; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pathology
GA 047OS
UT WOS:000311850900001
PM 23147504
OA Bronze
DA 2024-11-01
ER

PT J
AU Erdinc, D
   Macao, B
   Valenzuela, S
   Lesko, N
   Naess, K
   Peter, B
   Bruhn, H
   Wedell, A
   Wredenberg, A
   Falkenberg, M
AF Erdinc, Direnis
   Macao, Bertil
   Valenzuela, Sebastian
   Lesko, Nicole
   Naess, Karin
   Peter, Bradley
   Bruhn, Helene
   Wedell, Anna
   Wredenberg, Anna
   Falkenberg, Maria
TI The disease-causing mutation p.F907I reveals a novel pathogenic
   mechanism for POL?-related diseases
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE DNA polymerase & gamma;; TWINKLE helicase; mtDNA; Mitochondrial
   replication; Disease
ID DNA-POLYMERASE-GAMMA; MITOCHONDRIAL RNA-POLYMERASE; REPLICATION;
   MAINTENANCE; STABILITY; SUBUNIT; BINDING
AB Mutations in the catalytic domain of mitochondrial DNA polymerase ? (POL?) cause a broad spectrum of clinical conditions. POL? mutations impair mitochondrial DNA replication, thereby causing deletions and/or depletion of mitochondrial DNA, which in turn impair biogenesis of the oxidative phosphorylation system. We here identify a patient with a homozygous p.F907I mutation in POL?, manifesting a severe clinical phenotype with develop-mental arrest and rapid loss of skills from 18 months of age. Magnetic resonance imaging of the brain revealed extensive white matter abnormalities, Southern blot of muscle mtDNA demonstrated depletion of mtDNA and the patient deceased at 23 months of age. Interestingly, the p.F907I mutation does not affect POL? activity on single-stranded DNA or its proofreading activity. Instead, the mutation affects unwinding of parental double-stranded DNA at the replication fork, impairing the ability of the POL? to support leading-strand DNA synthesis with the TWINKLE helicase. Our results thus reveal a novel pathogenic mechanism for POL?-related diseases.
C1 [Erdinc, Direnis; Macao, Bertil; Valenzuela, Sebastian; Peter, Bradley; Falkenberg, Maria] Univ Gothenburg, Dept Med Biochem & Cell Biol, SE-40530 Gothenburg, Sweden.
   [Lesko, Nicole; Naess, Karin; Bruhn, Helene; Wredenberg, Anna] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden.
   [Wedell, Anna; Wredenberg, Anna] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.
   [Lesko, Nicole; Naess, Karin; Bruhn, Helene; Wedell, Anna] Karolinska Univ Hosp, Ctr Inherited Metab Dis, Stockholm, Sweden.
C3 University of Gothenburg; Karolinska Institutet; Karolinska Institutet;
   Karolinska Institutet; Karolinska University Hospital
RP Falkenberg, M (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, SE-40530 Gothenburg, Sweden.; Wredenberg, A (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden.
EM anna.wredenberg@ki.se; maria.falkenberg@medkem.gu.se
OI Erdinc, Direnis/0000-0002-5830-9911; Wredenberg,
   Anna/0000-0002-2500-6121; Valenzuela, Sebastian/0000-0001-5153-8431;
   Bruhn, Helene/0009-0007-4449-5382; Falkenberg, Maria/0000-0001-8713-173X
FU Swedish Research Council [2021-00932, 2020.0228]; Wallenberg Clinical
   Scholar [NNF18OC0032200]; NovoNordisk Foundation [KAW2019.0109]; Knut
   and Alice Wallenberg Foundation [2017.0080, 2018.0204]; Wallenberg
   Scholar [ALFGBG-965954]; Swedish Cancer Foundation; IngaBritt and Arne
   Lundberg Research Foundation; Vastra Gotalandsregionen;  [2016-02179];
   Swedish Research Council [2021-00932] Funding Source: Swedish Research
   Council
FX This work was supported by the Swedish Research Council (2016-02179 to
   A.Wr. and 2021-00932 to M.F) , Wallenberg Clinical Scholar (2020.0228 to
   A.We) , NovoNordisk Foundation (NNF18OC0032200 to A.Wr.) , Knut and
   Alice Wallenberg Foundation (KAW2019.0109 to A. Wr. and 2017.0080 to
   M.F.) , Wallenberg Scholar (2018.0204 to M.F.) , Swedish Cancer
   Foundation, the IngaBritt and Arne Lundberg Research Foundation (to
   M.F.) ; and the Vastra Gotalandsregionen (ALFGBG-965954 to M.F.) .
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   Darin N, 2021, NEUROMUSCULAR DISORD, V31, P348, DOI 10.1016/j.nmd.2021.01.004
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Foster BM, 2019, BIOCHEMISTRY-US, V58, P4466, DOI 10.1021/acs.biochem.9b00525
   Fusté JM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004832
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Gao Y, 2019, SCIENCE, V363, P835, DOI 10.1126/science.aav7003
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Hedberg-Oldfors C, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000391
   Hikmat O, 2019, GENET MED, V21, P1027, DOI 10.1038/s41436-018-0098-1
   Hikmat O, 2017, GENET MED, V19, P1217, DOI 10.1038/gim.2017.35
   Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Macao B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8303
   Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v
   Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Qian YF, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00135
   Roos S, 2013, HUM MOL GENET, V22, P2411, DOI 10.1093/hmg/ddt094
   Siibak T, 2017, HUM MOL GENET, V26, P2515, DOI 10.1093/hmg/ddx146
   Silva-Pinheiro P, 2021, NUCLEIC ACIDS RES, V49, P5230, DOI 10.1093/nar/gkab282
   Stranneheim H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1090
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011395
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2012, EMBO REP, V13, P1130, DOI 10.1038/embor.2012.161
   Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524
NR 32
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD OCT
PY 2023
VL 1869
IS 7
AR 166786
DI 10.1016/j.bbadis.2023.166786
EA JUN 2023
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA Q9WA8
UT WOS:001060935900001
PM 37302426
OA Bronze
DA 2024-11-01
ER

PT J
AU Schaefer, AM
   McFarland, R
   Blakely, EL
   He, L
   Whittaker, RG
   Taylor, RW
   Chinnery, PF
   Turnbull, DM
AF Schaefer, Andrew M.
   McFarland, Robert
   Blakely, Emma L.
   He, Langping
   Whittaker, Roger G.
   Taylor, Robert W.
   Chinnery, Patrick F.
   Turnbull, Douglass M.
TI Prevalence of mitochondrial DNA disease in adults
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID HEREDITARY OPTIC NEUROPATHY; DIABETES-MELLITUS; MUTATION; GENE;
   ENCEPHALOMYOPATHY; EPIDEMIOLOGY; POPULATION; DIAGNOSIS; MYOPATHY; STROKE
AB Objective: Diverse and variable clinical features, a loose genotype-phenotype relationship, and presentation to different medical specialties have all hindered attempts to gauge the epidemiological impact of mitochondrial DNA (mtDNA) disease. Nevertheless, a clear understanding of its prevalence remains an important goal, particularly about planning appropriate clinical services. Consequently, the aim of this study was to accurately define the prevalence of mtDNA disease (primary mutation occurs in mtDNA) in the working-age population of the North East of England.
   Methods: Adults with suspected mitochondrial disease in the North East of England were referred to a single neurology center for investigation from 1990 to 2004. Those with pathogenic mtDNA mutations were identified and pedigree analysis performed. For the midyear period of 2001, we calculated the minimum point prevalence of mtDNA disease for adults of working age (>16 and <60/65 years for female/male patients, respectively).
   Results: In this population, we found that 9.2 in 100,000 people have clinically manifest mtDNA disease, making this one of the commonest inherited neuromuscular disorders. In addition, a further 16.5 in 100,000 children and adults younger than retirement age are at risk for development of mtDNA disease.
   Interpretation: Through detailed pedigree analysis and active family tracing, we have been able to provide revised minimum prevalence figures for mtDNA disease. These estimates confirm that mtDNA disease is a common cause of chronic morbidity and is more prevalent than has been previously appreciated.
C1 [Schaefer, Andrew M.; McFarland, Robert; Blakely, Emma L.; He, Langping; Whittaker, Roger G.; Taylor, Robert W.; Chinnery, Patrick F.; Turnbull, Douglass M.] Newcastle Univ, Sch Med, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP McFarland, R (corresponding author), Newcastle Univ, Sch Med, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, 4th Floor,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.mcfarland@ncl.ac.uk
OI McFarland, Robert/0000-0002-8833-2688; Chinnery,
   Patrick/0000-0002-7065-6617; Whittaker, Roger/0000-0002-3403-0182;
   Schaefer, Andrew/0000-0001-9891-7332
FU Medical Research Council [G108/539] Funding Source: Medline; Wellcome
   Trust [074454] Funding Source: Medline; MRC [G108/539] Funding Source:
   UKRI
CR Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   BOGOUSSLAVSKY J, 1987, ARCH NEUROL-CHICAGO, V44, P479, DOI 10.1001/archneur.1987.00520170009012
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chinnery PF, 1999, AM J MED GENET, V85, P498
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   MACKEY DA, 1992, AUST NZ J OPHTHALMOL, V20, P177, DOI 10.1111/j.1442-9071.1992.tb00937.x
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   Newkirk JE, 1997, DIABETIC MED, V14, P457, DOI 10.1002/(SICI)1096-9136(199706)14:6<457::AID-DIA372>3.3.CO;2-N
   ODAWARA M, 1995, J CLIN ENDOCR METAB, V80, P1290, DOI 10.1210/jc.80.4.1290
   *OFF NAT STAT, 2004, 2001 CENS KEY STAT E
   OTABE S, 1994, J CLIN ENDOCR METAB, V79, P768, DOI 10.1210/jc.79.3.768
   REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Thelander L, 2007, NAT GENET, V39, P703, DOI 10.1038/ng0607-703
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   YANAGISAWA K, 1995, DIABETOLOGIA, V38, P809, DOI 10.1007/s001250050357
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   ZEVIANI M, 1995, MUSCLE NERVE, pS170
NR 27
TC 426
Z9 480
U1 0
U2 41
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD JAN
PY 2008
VL 63
IS 1
BP 35
EP 39
DI 10.1002/ana.21217
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 260KH
UT WOS:000253008700006
PM 17886296
DA 2024-11-01
ER

PT J
AU Uusimaa, J
   Evans, J
   Smith, C
   Butterworth, A
   Craig, K
   Ashley, N
   Liao, CY
   Carver, J
   Diot, A
   Macleod, L
   Hargreaves, I
   Al-Hussaini, A
   Faqeih, E
   Asery, A
   Al Balwi, M
   Eyaid, W
   Al-Sunaid, A
   Kelly, D
   van Mourik, I
   Ball, S
   Jarvis, J
   Mulay, A
   Hadzic, N
   Samyn, M
   Baker, A
   Rahman, S
   Stewart, H
   Morris, AAM
   Seller, A
   Fratter, C
   Taylor, RW
   Poulton, J
AF Uusimaa, Johanna
   Evans, Julie
   Smith, Conrad
   Butterworth, Anna
   Craig, Kate
   Ashley, Neil
   Liao, Chunyan
   Carver, Janet
   Diot, Alan
   Macleod, Lorna
   Hargreaves, Iain
   Al-Hussaini, Abdulrahman
   Faqeih, Eissa
   Asery, Ali
   Al Balwi, Mohammed
   Eyaid, Wafaa
   Al-Sunaid, Areej
   Kelly, Deirdre
   van Mourik, Indra
   Ball, Sarah
   Jarvis, Joanna
   Mulay, Arundhati
   Hadzic, Nedim
   Samyn, Marianne
   Baker, Alastair
   Rahman, Shamima
   Stewart, Helen
   Morris, Andrew A. M.
   Seller, Anneke
   Fratter, Carl
   Taylor, Robert W.
   Poulton, Joanna
TI Clinical, biochemical, cellular and molecular characterization of
   mitochondrial DNA depletion syndrome due to novel mutations in the
   <i>MPV17</i> gene
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE MPV17; mitochondrial DNA depletion; hepatocerebral disease; neonatal
   liver disease
ID HEPATOCEREBRAL FORM; MTDNA; NEUROPATHY; DIAGNOSIS; DELETIONS; FEATURES;
   MUSCLE
AB Mitochondrial DNA (mtDNA) depletion syndromes (MDS) are severe autosomal recessive disorders associated with decreased mtDNA copy number in clinically affected tissues. The hepatocerebral form (mtDNA depletion in liver and brain) has been associated with mutations in the POLG, PEO1 (Twinkle), DGUOK and MPV17 genes, the latter encoding a mitochondria] inner membrane protein of unknown function. The aims of this study were to clarify further the clinical, biochemical, cellular and molecular genetic features associated with MDS due to MPV17 gene mutations. We identified 12 pathogenic mutations in the MPV17 gene, of which 11 are novel, in 17 patients from 12 families. All patients manifested liver disease. Poor feeding, hypoglycaemia, raised serum lactate, hypotonia and faltering growth were common presenting features. mtDNA depletion in liver was demonstrated in all seven cases where liver tissue was available. Mosaic mtDNA depletion was found in primary fibroblasts by PicoGreen staining. These results confirm that MPV17 mutations are an important cause of hepatocerebral mtDNA depletion syndrome, and provide the first demonstration of mosaic mtDNA depletion in human MPV17 mutant fibroblast cultures. We found that a severe clinical phenotype was associated with profound tissue-specific mtDNA depletion in liver, and, in some cases, mosaic mtDNA depletion in fibroblasts.
C1 [Uusimaa, Johanna; Ashley, Neil; Liao, Chunyan; Carver, Janet; Diot, Alan; Macleod, Lorna; Poulton, Joanna] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Womens Ctr, Oxford, England.
   [Uusimaa, Johanna] Univ Oulu, Clin Res Ctr, Oulu Univ Hosp, Inst Clin Med Paediat, Oulu, Finland.
   [Evans, Julie; Smith, Conrad; Seller, Anneke; Fratter, Carl] Oxford Univ Hosp NHS Trust, Oxford Med Genet Labs, Oxford, England.
   [Butterworth, Anna; Craig, Kate; Taylor, Robert W.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Hargreaves, Iain] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London WC1N 3BG, England.
   [Al-Hussaini, Abdulrahman; Faqeih, Eissa; Asery, Ali] King Fahad Med City, Dept Pediat, Riyadh, Saudi Arabia.
   [Al Balwi, Mohammed] King Fahad Med City, Dept Pathol & Lab Med, Riyadh, Saudi Arabia.
   [Eyaid, Wafaa; Al-Sunaid, Areej] King Saud Bin Abdulaziz Univ Hlth & Sci, King Abdulaziz Med City, Dept Pediat, Riyadh, Saudi Arabia.
   [Kelly, Deirdre; van Mourik, Indra] Birmingham Childrens Hosp, Paediat Liver Unit, Birmingham, W Midlands, England.
   [Ball, Sarah] Birmingham Childrens Hosp, Dept Newborn Screening & Biochem Genet, Birmingham, W Midlands, England.
   [Jarvis, Joanna] Birmingham Womens Hosp, Clin Genet Unit, Birmingham, W Midlands, England.
   [Mulay, Arundhati] Manor Hosp, Matern Serv, Walsall, W Midlands, England.
   [Hadzic, Nedim; Samyn, Marianne; Baker, Alastair] Kings Coll Hosp London, Paediat Liver Ctr, London, England.
   [Rahman, Shamima] UCL Inst Child Hlth, Mitochondrial Res Grp, London, England.
   [Stewart, Helen] Oxford Univ Hosp NHS Trust, Dept Clin Genet, Oxford, England.
   [Morris, Andrew A. M.] St Marys Hosp, Willink Biochem Genet Unit, Manchester M13 0JH, Lancs, England.
C3 University of Oxford; University of Oulu; Oxford University Hospitals
   NHS Foundation Trust; Newcastle University - UK; University of London;
   University College London; UCL Medical School; University College London
   Hospitals NHS Foundation Trust; King Fahad Medical City; King Fahad
   Medical City; King Saud Bin Abdulaziz University for Health Sciences;
   King Abdulaziz Medical City - Riyadh; University of Birmingham;
   University of Birmingham; Birmingham Women's Hospital; King's College
   Hospital NHS Foundation Trust; King's College Hospital; University of
   London; University College London; Oxford University Hospitals NHS
   Foundation Trust; University of Manchester
RP Poulton, J (corresponding author), John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Womens Ctr, Oxford OX3 9DU, England.
EM Joanna.Poulton@obs-gyn.ox.ac.uk
RI Poulton, Joanna/AAB-4828-2021; Maier, Andrea/Q-5548-2019; Hadzic,
   Nedim/H-7574-2019; Hargreaves, Iain/AAJ-6757-2020; Rahman,
   Shamima/C-5232-2008; Macleod, Lorna/KCL-3462-2024
OI Diot, Alan/0000-0001-5079-8274; Al Balwi, Mohammed/0000-0003-2910-0390;
   Ashley, Neil/0000-0002-1655-5137; Poulton, Joanna/0000-0002-2460-5587
FU MRC; Wellcome Trust; Angus Memorial Mitochondrial Fund; Foundation for
   Paediatric Research; Sigrid Juselius Foundation; Academy of Finland
   [138566]; Wellcome Trust Strategic Award [906919]; Great Ormond Street
   Hospital Children's Charity; MRC [G0800674, MR/J010448/1, MR/K000608/1]
   Funding Source: UKRI; Academy of Finland (AKA) [138566] Funding Source:
   Academy of Finland (AKA)
FX We thank the patients and their families for participating. This study
   was supported by grants from the MRC, the Wellcome Trust and the Angus
   Memorial Mitochondrial Fund (JP), the Foundation for Paediatric Research
   (JU), the Sigrid Juselius Foundation (JU), and the Academy of Finland
   (JU, Decision number: 138566). RWT is supported by a Wellcome Trust
   Strategic Award (906919). SR is supported by Great Ormond Street
   Hospital Children's Charity. We also thank the UK NHS Specialist
   Commissioners who fund the 'Rare Mitochondrial Disorders of Adults and
   Children' Diagnostic Service (http://www.mitochondrialncg.nhs.uk) in
   Oxford, London and Newcastle upon Tyne.
CR AlSaman A, 2012, SAUDI J GASTROENTERO, V18, P285, DOI 10.4103/1319-3767.98439
   Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   El-Hattab A.W., 1993, GENEREVIEWS
   El-Hattab AW, 2010, MOL GENET METAB, V99, P300, DOI 10.1016/j.ymgme.2009.10.003
   Hargreaves IP, 1999, J INHERIT METAB DIS, V22, P925, DOI 10.1023/A:1005643508075
   JOHNSEN SD, 1993, NEUROLOGY, V43, P1120, DOI 10.1212/WNL.43.6.1120
   Kaji S, 2009, MOL GENET METAB, V97, P292, DOI 10.1016/j.ymgme.2009.04.014
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   LI YY, 1995, BIOCHEM BIOPH RES CO, V210, P211, DOI 10.1006/bbrc.1995.1648
   Merkle A N, 2012, AJNR Am J Neuroradiol, V33, pE34, DOI 10.3174/ajnr.A2455
   Morten KJ, 2007, MITOCHONDRION, V7, P386, DOI 10.1016/j.mito.2007.09.001
   Navarro-Sastre A, 2008, MOL GENET METAB, V94, P234, DOI 10.1016/j.ymgme.2008.01.012
   Navarro-Sastre A, 2010, J INHERIT METAB DIS, V33, pS293, DOI 10.1007/s10545-010-9155-x
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Parini R, 2009, J HEPATOL, V50, P215, DOI 10.1016/j.jhep.2008.08.019
   POULTON J, 1995, J INHERIT METAB DIS, V18, P4, DOI 10.1007/BF00711367
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
NR 27
TC 41
Z9 48
U1 0
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD FEB
PY 2014
VL 22
IS 2
BP 184
EP 191
DI 10.1038/ejhg.2013.112
PG 8
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 299SK
UT WOS:000330415800008
PM 23714749
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Chen, BS
   Harvey, JP
   Gilhooley, MJ
   Jurkute, N
   Yu-Wai-Man, P
AF Chen, Benson S.
   Harvey, Joshua P.
   Gilhooley, Michael J.
   Jurkute, Neringa
   Yu-Wai-Man, Patrick
TI Mitochondria and the eye-manifestations of mitochondrial diseases and
   their management
SO EYE
LA English
DT Review
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; DOMINANT OPTIC ATROPHY; MACULAR
   DYSTROPHY; OPA1 MUTATIONS; DNA; RETINOPATHY; STRABISMUS; PREVALENCE;
   DEAFNESS; MYOPATHY
AB Historically, distinct mitochondrial syndromes were recognised clinically by their ocular features. Due to their predilection for metabolically active tissue, mitochondrial diseases frequently involve the eye, resulting in a range of ophthalmic manifestations including progressive external ophthalmoplegia, retinopathy and optic neuropathy, as well as deficiencies of the retrochiasmal visual pathway. With the wider availability of genetic testing in clinical practice, it is now recognised that genotype-phenotype correlations in mitochondrial diseases can be imprecise: many classic syndromes can be associated with multiple genes and genetic variants, and the same genetic variant can have multiple clinical presentations, including subclinical ophthalmic manifestations in individuals who are otherwise asymptomatic. Previously considered rare diseases with no effective treatments, considerable progress has been made in our understanding of mitochondrial diseases with new therapies emerging, in particular, gene therapy for inherited optic neuropathies.
C1 [Chen, Benson S.; Yu-Wai-Man, Patrick] Univ Cambridge, John van Geest Ctr Brain Repair, Dept Clin Neurosci, MRC Mitochondrial Biol Unit, Cambridge, England.
   [Chen, Benson S.; Yu-Wai-Man, Patrick] Cambridge Univ Hosp, Addenbrookes Hosp, Cambridge Eye Unit, Cambridge, England.
   [Harvey, Joshua P.; Gilhooley, Michael J.; Jurkute, Neringa; Yu-Wai-Man, Patrick] Moorfields Eye Hosp NHS Fdn Trust, London, England.
   [Harvey, Joshua P.; Gilhooley, Michael J.; Jurkute, Neringa; Yu-Wai-Man, Patrick] UCL, Inst Ophthalmol, London, England.
   [Gilhooley, Michael J.; Jurkute, Neringa] Univ Coll London Hosp NHS Fdn Trust, Natl Hosp Neurol & Neurosurg, Queen Sq, London, England.
C3 University of Cambridge; University of Cambridge; Cambridge University
   Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of
   London; University College London; Moorfields Eye Hospital NHS
   Foundation Trust; University of London; University College London;
   University of London; University College London; UCL Medical School;
   University College London Hospitals NHS Foundation Trust
RP Yu-Wai-Man, P (corresponding author), Univ Cambridge, John van Geest Ctr Brain Repair, Dept Clin Neurosci, MRC Mitochondrial Biol Unit, Cambridge, England.; Yu-Wai-Man, P (corresponding author), Cambridge Univ Hosp, Addenbrookes Hosp, Cambridge Eye Unit, Cambridge, England.; Yu-Wai-Man, P (corresponding author), Moorfields Eye Hosp NHS Fdn Trust, London, England.; Yu-Wai-Man, P (corresponding author), UCL, Inst Ophthalmol, London, England.
EM py237@cam.ac.uk
RI Gilhooley, Michael/AAQ-6125-2020; Jurkute, Neringa/V-3175-2019
OI Chen, Benson/0000-0001-8214-0186
FU Cambridge-Rutherford Memorial Scholarship; Royal Society Te
   Aparangi-Rutherford Foundation; Cambridge Commonwealth, European &
   International Trust; Bushell Travelling Fellowship in Medicine or the
   Allied Sciences; Royal Australasian College of Physicians (RACP)
   Foundation; NIHR; Academy of Medical Sciences [SGL023\1051]; Moorfields
   Eye Charity [GR001376]; ProRetina Foundation Deutschland [NIHR301696];
   UK National Institute of Health and Care Research (NIHR); Fight for
   Sight (UK); Isaac Newton Trust (UK); Addenbrooke's Charitable Trust;
   National Eye Research Centre (UK); International Foundation for Optic
   Nerve Disease (IFOND); NIHR Cambridge Biomedical Research Centre
   [BRC-1215-20014]; NIHR Biomedical Research Centre based at Moorfields
   Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology
FX BSC is supported by the Cambridge-Rutherford Memorial Scholarship,
   awarded by the Royal Society Te Aparangi-Rutherford Foundation and the
   Cambridge Commonwealth, European & International Trust; and the Bushell
   Travelling Fellowship in Medicine or the Allied Sciences, awarded by the
   Royal Australasian College of Physicians (RACP) Foundation. MJG
   acknowledges funding from the NIHR (CL-2019-18-004), Academy of Medical
   Sciences (SGL023\1051), Moorfields Eye Charity (GR001207), Eye Research
   UK (SEE 006) & ProRetina Foundation Deutschland
   (Pro-Re/Projekt/Gilhooley-Whitehead-Lindner.04-2021). PYWM is supported
   by an Advanced Fellowship Award (NIHR301696) from the UK National
   Institute of Health and Care Research (NIHR). PYWM also receives funding
   from Fight for Sight (UK), the Isaac Newton Trust (UK), Moorfields Eye
   Charity (GR001376), the Addenbrooke's Charitable Trust, the National Eye
   Research Centre (UK), the International Foundation for Optic Nerve
   Disease (IFOND), the NIHR as part of the Rare Diseases Translational
   Research Collaboration, the NIHR Cambridge Biomedical Research Centre
   (BRC-1215-20014), and the NIHR Biomedical Research Centre based at
   Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of
   Ophthalmology. The views expressed are those of the author(s) and not
   necessarily those of the NHS, the NIHR or the Department of Health.
CR Ahn J, 2008, BRIT J OPHTHALMOL, V92, P1685, DOI 10.1136/bjo.2008.144816
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Bacman SR, 2020, METHOD CELL BIOL, V155, P441, DOI 10.1016/bs.mcb.2019.12.004
   Barboni P, 2022, AM J OPHTHALMOL
   Birtel J, 2022, OPHTHALMOL RETINA, V6, P65, DOI 10.1016/j.oret.2021.02.017
   Bucelli RC, 2016, J NEURO-OPHTHALMOL, V36, P270, DOI 10.1097/WNO.0000000000000384
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   Carelli V, 2017, J NEURO-OPHTHALMOL, V37, P371, DOI 10.1097/WNO.0000000000000570
   Catarino CB, 2020, J NEURO-OPHTHALMOL, V40, P558, DOI 10.1097/WNO.0000000000001023
   Chen BS, 2022, CURR NEUROL NEUROSCI, V22, P881, DOI 10.1007/s11910-022-01246-y
   Del Dotto V, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.681326
   Eshaghi M, 2021, EUR J OPHTHALMOL, V31, P2064, DOI 10.1177/1120672120952344
   Farruggia P, 2018, EXPERT REV HEMATOL, V11, P239, DOI 10.1080/17474086.2018.1426454
   Gorman GS, 2015, NEW ENGL J MED, V372, P885, DOI 10.1056/NEJMc1500960
   Goto Y, 1993, Nihon Rinsho, V51, P2373
   Graefe V.O. N., 1868, Berl Klin Wschr, V5, P125
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Heighton JN, 2019, MITOCHONDRION, V49, P227, DOI 10.1016/j.mito.2019.09.002
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Jankauskaite E, 2020, J APPL GENET, V61, P195, DOI 10.1007/s13353-020-00550-y
   KEARNS THOMAS P., 1965, TRANS AMER OPHTHALMOL SOC, V63, P559
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kerrison JB, 2000, ARCH OPHTHALMOL-CHIC, V118, P298
   LANE CM, 1987, BRIT J OPHTHALMOL, V71, P290, DOI 10.1136/bjo.71.4.290
   Latvala T, 2002, GRAEF ARCH CLIN EXP, V240, P795, DOI 10.1007/s00417-002-0555-y
   Lefevere E, 2017, MITOCHONDRION, V36, P66, DOI 10.1016/j.mito.2017.03.006
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Liu Y, 2022, GENE THER, V29, P368, DOI 10.1038/s41434-022-00333-6
   MAKELABENGS P, 1995, PEDIATR RES, V37, P634
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Massin P, 1999, OPHTHALMOLOGY, V106, P1821, DOI 10.1016/S0161-6420(99)90356-1
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0652-7
   Mejia-Vergara AJ, 2020, CURR NEUROL NEUROSCI, V20, DOI 10.1007/s11910-020-01032-8
   Michaelides M, 2008, ARCH OPHTHALMOL-CHIC, V126, P320, DOI 10.1001/archopht.126.3.320
   Mok BY, 2022, NAT BIOTECHNOL, V40, P1378, DOI 10.1038/s41587-022-01256-8
   Muench NA, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10071593
   Müller PL, 2020, AM J OPHTHALMOL, V213, P134, DOI 10.1016/j.ajo.2020.01.013
   MULLIE MA, 1985, ARCH OPHTHALMOL-CHIC, V103, P1825, DOI 10.1001/archopht.1985.01050120059020
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Newman NJ, 2023, BRAIN, V146, P1328, DOI 10.1093/brain/awac421
   Newman NJ, 2023, LANCET NEUROL, V22, P172, DOI 10.1016/S1474-4422(22)00174-0
   Newman NJ, 2021, OPHTHALMOLOGY, V128, P649, DOI 10.1016/j.ophtha.2020.12.012
   Olichon A, 2007, CELL DEATH DIFFER, V14, P682, DOI 10.1038/sj.cdd.4402048
   Ovens CA, 2020, NEURO-OPHTHALMOLOGY, V44, P168, DOI 10.1080/01658107.2019.1653935
   Park RB, 2023, ORBIT-ABINGDON, V42, P11, DOI 10.1080/01676830.2022.2122514
   Pass T, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.676187
   Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Pfeffer G, 2011, CAN J NEUROL SCI, V38, P119, DOI 10.1017/S031716710001115X
   Pisano A, 2015, HUM MOL GENET, V24, P6921, DOI 10.1093/hmg/ddv396
   PYC Therapeutics, PYC THER SET ANN EFF
   Rantamäki MT, 2005, ANN NEUROL, V58, P337, DOI 10.1002/ana.20555
   Rath PP, 2008, BRIT J OPHTHALMOL, V92, P623, DOI 10.1136/bjo.2007.131177
   Remes AM, 2005, NEUROLOGY, V64, P976, DOI 10.1212/01.WNL.0000154518.31302.ED
   Richardson C, 2005, EYE, V19, P258, DOI 10.1038/sj.eye.6701488
   Ritchie AE, 2010, BRIT J OPHTHALMOL, V94, P1165, DOI 10.1136/bjo.2009.165639
   Romagnoli M, 2020, ANN CLIN TRANSL NEUR, V7, P590, DOI 10.1002/acn3.51026
   Sanchez MIGL, 2021, AM J HUM GENET, V108, P2159, DOI 10.1016/j.ajhg.2021.09.015
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Shinkai A, 2021, MITOCHONDRION, V56, P47, DOI 10.1016/j.mito.2020.11.003
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   Sorkin JA, 1997, AM J OPHTHALMOL, V123, P235, DOI 10.1016/S0002-9394(14)71041-4
   Stoke Therapeutics, STOK THER REP 3 QUAR
   Tinley C, 2010, STRABISMUS, V18, P41, DOI 10.3109/09273971003758388
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Wallace DK, 1997, OPHTHALMOLOGY, V104, P695, DOI 10.1016/S0161-6420(97)30250-4
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220
   Wan X, 2016, SCI REP-UK, V6, DOI 10.1038/srep21587
   Weisschuh N, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253987
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2022, EYE, V36, P818, DOI 10.1038/s41433-021-01535-9
   Yu-Wai-Man P, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz7423
   Yu-Wai-Man P, 2014, INVEST OPHTH VIS SCI, V55
   Yu-Wai-Man P, 2013, OPHTHALMOLOGY, V120, P1712, DOI 10.1016/j.ophtha.2013.04.022
   Yu-Wai-Man P, 2010, OPHTHALMOLOGY, V117, P1538, DOI 10.1016/j.ophtha.2009.12.038
   Zeviani M, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23010210
NR 79
TC 8
Z9 8
U1 1
U2 6
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0950-222X
EI 1476-5454
J9 EYE
JI Eye
PD AUG
PY 2023
VL 37
IS 12
BP 2416
EP 2425
DI 10.1038/s41433-023-02523-x
EA APR 2023
PG 10
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA N6UN8
UT WOS:000989668500001
PM 37185957
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Durham, SE
   Brown, DT
   Turnbull, DM
   Chinnery, PF
AF Durham, Steve E.
   Brown, Denise T.
   Turnbull, Douglass M.
   Chinnery, Patrick F.
TI Progressive depletion of mtDNA in mitochondrial myopathy
SO NEUROLOGY
LA English
DT Article
ID SKELETAL-MUSCLE; DNA; DECREASE; GENOMES; MELAS
AB The authors studied seven patients with mitochondrial DNA ( mtDNA) myopathy. Over time, there was a progressive depletion of mtDNA, which preferentially affected wild-type mitochondrial genomes. This suggests that loss of wild-type mtDNA is a major feature of mtDNA myopathy, and preventing wild-type mtDNA depletion has treatment implications.
C1 Univ Newcastle Upon Tyne, Sch Med, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Chinnery, PF (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM p.f.chinnery@ncl.a.cuk
OI Chinnery, Patrick/0000-0002-7065-6617
FU Wellcome Trust [074454] Funding Source: Medline
CR Barron MJ, 2005, NEUROMUSCULAR DISORD, V15, P768, DOI 10.1016/j.nmd.2005.06.018
   Bentlage HACM, 1996, HUM MOL GENET, V5, P197, DOI 10.1093/hmg/5.2.197
   Horváth R, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.015024
   Kaufmann P, 1996, ANN NEUROL, V40, P172, DOI 10.1002/ana.410400208
   KAWAKAMI Y, 1994, ANN NEUROL, V35, P370, DOI 10.1002/ana.410350322
   Kovalenko SA, 1998, BIOCHEM MOL BIOL INT, V46, P1233
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Welle S, 2003, J APPL PHYSIOL, V94, P1479, DOI 10.1152/japplphysiol.01061.2002
NR 10
TC 11
Z9 11
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0028-3878
J9 NEUROLOGY
JI Neurology
PD AUG 8
PY 2006
VL 67
IS 3
BP 502
EP 504
DI 10.1212/01.wnl.0000227961.55640.2f
PG 3
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 071LK
UT WOS:000239603500030
PM 16894115
DA 2024-11-01
ER

PT J
AU Manini, A
   Abati, E
   Comi, GP
   Corti, S
   Ronchi, D
AF Manini, Arianna
   Abati, Elena
   Comi, Giacomo Pietro
   Corti, Stefania
   Ronchi, Dario
TI Mitochondrial DNA homeostasis impairment and dopaminergic dysfunction: A
   trembling balance
SO AGEING RESEARCH REVIEWS
LA English
DT Review
DE MtDNA homeostasis; Parkinsonism; Parkinson's disease; POLG1; Twinkle;
   Mitochondrion
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MULTIPLE MTDNA DELETIONS;
   GAMMA-GENE POLG; PARKINSONS-DISEASE; POLYMERASE-GAMMA; ALPHA-SYNUCLEIN;
   FAMILIAL PARKINSONISM; SUBSTANTIA-NIGRA; MOUSE MODEL; COPY NUMBER
AB Maintenance of mitochondrial DNA (mtDNA) homeostasis includes a variety of processes, such as mtDNA replication, repair, and nucleotides synthesis, aimed at preserving the structural and functional integrity of mtDNA molecules. Mutations in several nuclear genes (i.e., POLG, POLG2, TWNK, OPA1, DGUOK, MPV17, TYMP) impair mtDNA maintenance, leading to clinical syndromes characterized by mtDNA depletion and/or deletions in affected tissues. In the past decades, studies have demonstrated a progressive accumulation of multiple mtDNA deletions in dopaminergic neurons of the substantia nigra in elderly population and, to a greater extent, in Parkinson's disease patients. Moreover, parkinsonism has been frequently described as a prominent clinical feature in mtDNA instability syndromes. Among Parkinson's disease-related genes with a significant role in mitochondrial biology, PARK2 and LRRK2 specifically take part in mtDNA maintenance. Moreover, a variety of murine models (i.e., "Mutator", "MitoPark", "PD-mitoPstI", "Deletor", "Twinkle-dup" and "TwinkPark") provided in vivo evidence that mtDNA stability is required to preserve nigrostriatal integrity. Here, we review and discuss the clinical, genetic, and pathological background underlining the link between impaired mtDNA homeostasis and dopaminergic degeneration.
C1 [Manini, Arianna; Abati, Elena; Comi, Giacomo Pietro; Corti, Stefania; Ronchi, Dario] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Milan, Italy.
   [Comi, Giacomo Pietro] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Neurosci, Neuromuscular & Rare Dis Unit, Milan, Italy.
   [Corti, Stefania; Ronchi, Dario] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Neurosci, Neurol Unit, Milan, Italy.
C3 University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico;
   IRCCS Ca Granda Ospedale Maggiore Policlinico
RP Ronchi, D (corresponding author), Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Neurosci Sect, Milan, Italy.
EM dario.ronchi@unimi.it
RI Comi, Giacomo/K-5702-2016; Ronchi, Dario/K-8011-2016; MANINI,
   ARIANNA/AGF-1957-2022; Corti, Stefania/K-6034-2016; abati,
   elena/AAY-3879-2021
OI Abati, Elena/0000-0003-0797-8282
FU Italian Ministry of Health (Ministero della Salute), Foundation IRCCS
   Ca' Granda Ospedale Maggiore Policlinico Grant Ricerca Corrente 2020
FX This work was partially supported by Italian Ministry of Health
   (Ministero della Salute), Foundation IRCCS Ca' Granda Ospedale Maggiore
   Policlinico Grant Ricerca Corrente 2020 to GPC.
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Amboni M, 2009, MOVEMENT DISORD, V24, P303, DOI 10.1002/mds.22342
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Anvret A, 2010, NEUROSCI LETT, V485, P117, DOI 10.1016/j.neulet.2010.08.082
   Bai RK, 2021, GENET MED, V23, P1514, DOI 10.1038/s41436-021-01166-1
   Bakshi R, 2019, ANN NEUROL, V85, P593, DOI 10.1002/ana.25436
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Batla Amit, 2015, Mov Disord Clin Pract, V2, P304, DOI 10.1002/mdc3.12164
   Bedford C, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00035
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bender A, 2008, J NEUROL, V255, P1231, DOI 10.1007/s00415-008-0892-9
   Bersano A, 2009, NEUROBIOL AGING, V30, P752, DOI 10.1016/j.neurobiolaging.2007.08.009
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   Billingsley KJ, 2019, NPJ PARKINSONS DIS, V5, DOI 10.1038/s41531-019-0080-x
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Brandon BR, 2013, J NEUROL, V260, P1931, DOI 10.1007/s00415-013-6975-2
   Breen DP, 2020, NEUROLOGY, V95, P644, DOI 10.1212/WNL.0000000000010674
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   Cantuti-Castelvetria I, 2005, NEUROBIOL AGING, V26, P1343, DOI 10.1016/j.neurobiolaging.2004.11.008
   Cao LQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000756
   Caporali L, 2018, BRAIN, V141, DOI 10.1093/brain/awx301
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Carelli V, 2014, NEURON, V84, P1126, DOI 10.1016/j.neuron.2014.11.022
   Chen C, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104631
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Coxhead J, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.036
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Dai Y, 2014, NEUROTOXICOL TERATOL, V46, P62, DOI 10.1016/j.ntt.2014.10.004
   Dai Y, 2013, MITOCHONDRION, V13, P282, DOI 10.1016/j.mito.2013.03.006
   Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Delgado-Alvarado M, 2015, J NEUROL SCI, V350, P93, DOI 10.1016/j.jns.2015.02.011
   di Poggio MB, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-105
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Dolhun R, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-92
   Dölle C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13548
   Eerola J, 2010, NEUROSCI LETT, V477, P1, DOI 10.1016/j.neulet.2010.04.021
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fernández-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514
   Ferreira M, 2017, ACTA NEUROL SCAND, V135, P273, DOI 10.1111/ane.12616
   Ferreira M, 2011, NEUROMUSCULAR DISORD, V21, P483, DOI 10.1016/j.nmd.2011.03.011
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Fukae J, 2007, MITOCHONDRION, V7, P58, DOI 10.1016/j.mito.2006.12.002
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gaare JJ, 2018, MOVEMENT DISORD, V33, P1591, DOI 10.1002/mds.64
   Galassi G, 2008, NEUROMUSCULAR DISORD, V18, P465, DOI 10.1016/j.nmd.2008.03.013
   Galter D, 2010, GENES BRAIN BEHAV, V9, P173, DOI 10.1111/j.1601-183X.2009.00542.x
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Ghaisas S, 2019, NEUROTOXICOLOGY, V75, P186, DOI 10.1016/j.neuro.2019.09.004
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Gómez-Suaga P, 2014, HUM MOL GENET, V23, P6779, DOI 10.1093/hmg/ddu395
   Gómez-Suaga P, 2012, HUM MOL GENET, V21, P511, DOI 10.1093/hmg/ddr481
   Gonzalez-Hunt CP, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74195-6
   Greaves LC, 2009, AGING CELL, V8, P566, DOI 10.1111/j.1474-9726.2009.00505.x
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Gu GY, 2002, J NEUROPATH EXP NEUR, V61, P634, DOI 10.1093/jnen/61.7.634
   Guedes LC, 2010, PARKINSONISM RELAT D, V16, P237, DOI 10.1016/j.parkreldis.2009.11.004
   Gui YX, 2015, PARKINSONISM RELAT D, V21, P282, DOI 10.1016/j.parkreldis.2014.12.030
   Gurgel-Giannetti J, 2012, MUSCLE NERVE, V45, P453, DOI 10.1002/mus.22330
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008
   Hirano M, 2005, GENE, V354, P152, DOI 10.1016/j.gene.2005.04.041
   Howlett EH, 2017, HUM MOL GENET, V26, P4340, DOI 10.1093/hmg/ddx320
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Hudson G, 2009, MOVEMENT DISORD, V24, P1092, DOI 10.1002/mds.22310
   Iannielli A, 2018, CELL REP, V22, P2066, DOI 10.1016/j.celrep.2018.01.089
   Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Irizarry MC, 1998, J NEUROPATH EXP NEUR, V57, P334, DOI 10.1097/00005072-199804000-00005
   Jang S, 2020, MITOCHONDRION, V51, P30, DOI 10.1016/j.mito.2019.11.006
   Jensen MB, 2008, ANN ONCOL, V19, P1910, DOI 10.1093/annonc/mdn407
   Johansson M, 1996, P NATL ACAD SCI USA, V93, P7258, DOI 10.1073/pnas.93.14.7258
   Jüllig M, 2000, EUR J BIOCHEM, V267, P5466, DOI 10.1046/j.1432-1327.2000.01607.x
   Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005
   KASAMATSU H, 1971, P NATL ACAD SCI USA, V68, P2252, DOI 10.1073/pnas.68.9.2252
   Kauppila JHK, 2018, NUCLEIC ACIDS RES, V46, P6642, DOI 10.1093/nar/gky456
   Kett LR, 2012, HUM MOL GENET, V21, P890, DOI 10.1093/hmg/ddr526
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   Kim NC, 2013, NEURON, V78, P65, DOI 10.1016/j.neuron.2013.02.029
   Kim SJ, 2017, J PHYSIOL-LONDON, V595, P6613, DOI 10.1113/JP274472
   Kopinski PK, 2019, P NATL ACAD SCI USA, V116, P16028, DOI 10.1073/pnas.1906896116
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MANN VM, 1992, FEBS LETT, V299, P218, DOI 10.1016/0014-5793(92)80118-Z
   Martijn J, 2018, NATURE, V557, P101, DOI 10.1038/s41586-018-0059-5
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   Mehta AR, 2011, MOVEMENT DISORD, V26, P753, DOI 10.1002/mds.23510
   Meira B, 2019, BMJ CASE REP, V12, DOI 10.1136/bcr-2018-228482
   Miguel R, 2014, CLIN NEUROL NEUROSUR, V126, P47, DOI 10.1016/j.clineuro.2014.08.020
   Miller C, 2011, BBA-MOL BASIS DIS, V1812, P625, DOI 10.1016/j.bbadis.2011.01.013
   Milone M, 2011, ARCH NEUROL-CHICAGO, V68, P806, DOI 10.1001/archneurol.2011.124
   Minnerop M, 2005, J NEUROL NEUROSUR PS, V76, P118, DOI 10.1136/jnnp.2004.040220
   MIYABAYASHI S, 1992, J INHERIT METAB DIS, V15, P797, DOI 10.1007/BF01800024
   Montassir H, 2015, BRAIN DEV-JPN, V37, P719, DOI 10.1016/j.braindev.2014.10.013
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033
   Müller-Nedebock AC, 2019, NEUROCHEM INT, V129, DOI 10.1016/j.neuint.2019.104495
   Müftüoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695
   Mukai Masako, 2014, Rinsho Shinkeigaku, V54, P417
   Mukai M, 2013, PARKINSONISM RELAT D, V19, P821, DOI 10.1016/j.parkreldis.2013.04.011
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Neuhaus JFG, 2014, BRAIN, V137, P354, DOI 10.1093/brain/awt291
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Nido GS, 2018, NEUROBIOL AGING, V63, P120, DOI 10.1016/j.neurobiolaging.2017.10.024
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nissanka N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04895-1
   Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Nuzhnyi E, 2021, CLIN NEUROL NEUROSUR, V201, DOI 10.1016/j.clineuro.2020.106462
   Ouzren N, 2019, ANN NEUROL, V86, P324, DOI 10.1002/ana.25510
   OZAWA T, 1990, BIOCHEM BIOPH RES CO, V172, P483, DOI 10.1016/0006-291X(90)90698-M
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Paisán-Ruíz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   Papadimitriou A, 1998, NEUROLOGY, V51, P1086, DOI 10.1212/WNL.51.4.1086
   Perier C, 2013, BRAIN, V136, P2369, DOI 10.1093/brain/awt196
   Pickrell AM, 2011, J NEUROSCI, V31, P17649, DOI 10.1523/JNEUROSCI.4871-11.2011
   Pickrell AM, 2011, J NEUROSCI, V31, P9895, DOI 10.1523/JNEUROSCI.6223-10.2011
   Pinto M, 2018, J NEUROSCI, V38, P1042, DOI 10.1523/JNEUROSCI.1384-17.2017
   Podlesniy P, 2019, EBIOMEDICINE, V48, P554, DOI 10.1016/j.ebiom.2019.09.015
   Pyle A, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.033
   Pyle A, 2015, ANN NEUROL, V78, P1000, DOI 10.1002/ana.24515
   Rackham O, 2011, RNA, V17, P2085, DOI 10.1261/rna.029405.111
   Sanders LH, 2014, NEUROBIOL DIS, V62, P381, DOI 10.1016/j.nbd.2013.10.013
   Sato K, 2011, J NEUROL, V258, P1327, DOI 10.1007/s00415-011-5936-x
   Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Shoubridge E A, 2000, Hum Reprod, V15 Suppl 2, P229
   Simon DK, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0433-9
   Song LY, 2017, NEUROBIOL DIS, V100, P30, DOI 10.1016/j.nbd.2016.12.024
   Song LY, 2012, HUM MOL GENET, V21, P5147, DOI 10.1093/hmg/dds365
   SOONG NW, 1992, NAT GENET, V2, P318
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108
   Surmeier DJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009290
   Synofzik M, 2010, MOVEMENT DISORD, V25, P243, DOI 10.1002/mds.22865
   Taanman JW, 2005, NEUROSCI LETT, V376, P56, DOI 10.1016/j.neulet.2004.11.023
   Tanaka K, 2020, NEUROSCI RES, V159, P9, DOI 10.1016/j.neures.2020.01.006
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Tzoulis C, 2016, MITOCHONDRION, V28, P33, DOI 10.1016/j.mito.2016.03.003
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Van Maldergem L, 2017, ANN CLIN TRANSL NEUR, V4, P4, DOI 10.1002/acn3.361
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Ye F, 2014, MITOCHONDRION, V17, P157, DOI 10.1016/j.mito.2014.05.004
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yue M, 2015, NEUROBIOL DIS, V78, P172, DOI 10.1016/j.nbd.2015.02.031
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang J, 2002, PARKINSONISM RELAT D, V8, P165, DOI 10.1016/S1353-8020(01)00041-4
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 186
TC 17
Z9 19
U1 0
U2 6
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 1568-1637
EI 1872-9649
J9 AGEING RES REV
JI Ageing Res. Rev.
PD APR
PY 2022
VL 76
AR 101578
DI 10.1016/j.arr.2022.101578
EA FEB 2022
PG 20
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 0I0OW
UT WOS:000779128500002
PM 35114397
DA 2024-11-01
ER

PT J
AU Kraya, T
   Deschauer, M
   Joshi, PR
   Zierz, S
   Gaul, C
AF Kraya, Torsten
   Deschauer, Marcus
   Joshi, Pushpa Raj
   Zierz, Stephan
   Gaul, Charly
TI Prevalence of Headache in Patients With Mitochondrial Disease: A
   Cross-Sectional Study
SO HEADACHE
LA English
DT Article
DE mitochondrial disease; headache; migraine; MELAS; CPEO; MERRF
ID LACTIC-ACIDOSIS; EPISODES MELAS; DNA MUTATIONS; MIGRAINE;
   ENCEPHALOPATHY; DYSFUNCTION; MYOPATHY; FEATURES
AB BackgroundMitochondrial diseases are a heterogeneous group of diseases with different phenotypes and genotypes. Headache and, particularly migraine, seems to occur often in patients with MELAS and in patients with CPEO phenotypes. The International Classification of Headache Disorders (ICHD-3 beta) has classified headache as a secondary entity only in MELAS patients. Other headache phenotypes in mitochondrial diseases are not considered in ICHD-3beta. In this study, we analyzed headache phenomenology in a large group of patients with mitochondrial disorders.
   MethodsA cross-sectional questionnaire-based study on 85 patients with mitochondrial disease with different genotypes and phenotypes was conducted between 2010 and 2011. A structured headache questionnaire according to ICHD-2 was used followed by a telephone interview by a headache expert. Prevalence and characteristics of headache could be analyzed in 42 patients. Headache diagnosis was correlated with genotypes and phenotypes. In addition, the mtDNA haplotype H was analyzed.
   ResultsHeadache was reported in 29/42 (70%; 95% CI, from 55.1 to 83.0%) of the patients. Tension-type headache (TTH) showed the highest prevalence in 16/42 (38%; 95% CI, from 23.4 to 52.8%) patients, followed by migraine and probable migraine in 12/42 (29%; 95% CI, from 14.9 to 42.2%) patients. Nine of the 42 (21%; 95% CI, from 9 to 33.8%) patients reported two different headache types. Patients with the mtDNA mutation m.3243A>G (n=8) and MELAS (n=7) showed the highest prevalence of headaches (88% and 85%, respectively). In patients with the CPEO phenotype (n=32), headache occurred in 14/18 (78%; 95% CI, from 58.6 to 97%) of patients with single deletions, and in 7/13 (54%; 95% CI, from 26.7 to 80.9%) patients with multiple mtDNA deletions. There were no association between the mtDNA haplotype Hand the headache-diagnosis.
   ConclusionsThe prevalence of headache was higher in patients with mitochondrial diseases than reported in the general population. In all phenotype and genotype groups, TTH was more frequent than migraine. The data also show that the current ICHD-3 beta exclusively focused on MELAS syndrome as vasculopathy does not consider the broader spectrum of headache phenotypes in mitochondrial disorders.
C1 [Kraya, Torsten; Joshi, Pushpa Raj; Zierz, Stephan] Univ Hosp Halle Saale, Dept Neurol, Ernst Grube Str 40, D-06097 Halle, Saale, Germany.
   [Deschauer, Marcus] Tech Univ Munich, Dept Neurol, Munich, Germany.
   [Gaul, Charly] Headache & Migraine Clin, Konigstein, Germany.
C3 Martin Luther University Halle Wittenberg; Technical University of
   Munich
RP Kraya, T (corresponding author), Univ Hosp Halle Saale, Dept Neurol, Ernst Grube Str 40, D-06097 Halle, Saale, Germany.
EM torsten.kraya@medizin.uni-halle.de
RI Kraya, Torsten/AFS-5530-2022
OI Kraya, Torsten/0000-0002-6060-3810
FU Genzyme; Ultragenyx
FX T.K. has received honoraria from Allergan Pharma, Grunenthal, MSD, and
   Hormosan. T.K. has no ownership interests and does not own any
   pharmaceutical company stocks. C.G. has received honoraria from Allergan
   Pharma, electroCore, Grunenthal, Desitin, Bayer, Boehringer Ingelheim,
   ratiopharm, Lilly, Reckitt Benckiser, TEVA, Novartis, and Hormosan. C.G.
   has no ownership interests and does not own any pharmaceutical company
   stocks. P.R.J. has not received honoraria, has no ownership interests,
   and does not own any pharmaceutical company stocks. M.D. has received
   fees from Genzyme and Ultragenyx. M.D. has no ownership interests and
   does not own any pharmaceutical company stocks. S.Z. has received
   honoraria from Genzyme. S.Z. has no ownership interests and does not own
   any pharmaceutical company stocks.
CR Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658
   Boehnke C, 2004, EUR J NEUROL, V11, P475, DOI 10.1111/j.1468-1331.2004.00813.x
   de Vries B, 2009, HUM GENET, V126, P115, DOI 10.1007/s00439-009-0684-z
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Di Lorenzo C, 2009, NEUROLOGY, V72, P1588, DOI 10.1212/WNL.0b013e3181a41269
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Guo S, 2016, EUR J NEUROL, V23, P175, DOI 10.1111/ene.12832
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Klopstock T, 1996, NEUROLOGY, V46, P1735, DOI 10.1212/WNL.46.6.1735
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   LAFORET P, 1995, NEUROMUSCULAR DISORD, V5, P399, DOI 10.1016/0960-8966(94)00080-S
   MONTAGNA P, 1988, NEUROLOGY, V38, P751, DOI 10.1212/WNL.38.5.751
   Okada H, 1998, HEADACHE, V38, P39, DOI 10.1046/j.1526-4610.1998.3801039.x
   Pfaffenrath V, 2009, CEPHALALGIA, V29, P48, DOI 10.1111/j.1468-2982.2008.01699.x
   Pfeffer G, 2011, CAN J NEUROL SCI, V38, P119, DOI 10.1017/S031716710001115X
   RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844
   Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x
   Sparaco M, 2006, CEPHALALGIA, V26, P361, DOI 10.1111/j.1468-2982.2005.01059.x
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Stuart S, 2012, MOL GENET GENOMICS, V287, P837, DOI 10.1007/s00438-012-0723-7
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yorns WR, 2013, SEMIN PEDIATR NEUROL, V20, P188, DOI 10.1016/j.spen.2013.09.002
NR 27
TC 32
Z9 34
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0017-8748
EI 1526-4610
J9 HEADACHE
JI Headache
PD JAN
PY 2018
VL 58
IS 1
BP 45
EP 52
DI 10.1111/head.13219
PG 8
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA FR4WP
UT WOS:000419067600004
PM 29139113
DA 2024-11-01
ER

PT J
AU Gorman, GS
   Chinnery, PF
   DiMauro, S
   Hirano, M
   Koga, Y
   McFarland, R
   Suomalainen, A
   Thorburn, DR
   Zeviani, M
   Turnbull, DM
AF Gorman, Grainne S.
   Chinnery, Patrick F.
   DiMauro, Salvatore
   Hirano, Michio
   Koga, Yasutoshi
   McFarland, Robert
   Suomalainen, Anu
   Thorburn, David R.
   Zeviani, Massimo
   Turnbull, Douglass M.
TI Mitochondrial diseases
SO NATURE REVIEWS DISEASE PRIMERS
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; HEREDITARY OPTIC NEUROPATHY;
   IMPAIR MTDNA REPLICATION; TRANSFER-RNA SYNTHETASE; DNA DELETIONS;
   PRONUCLEAR TRANSFER; ADULT PATIENTS; MOUSE MODEL; MUTATIONS; DEFICIENCY
AB Mitochondrial diseases are a group of genetic disorders that are characterized by defects in oxidative phosphorylation and caused by mutations in genes in the nuclear DNA (nDNA) and mitochondrial DNA (mtDNA) that encode structural mitochondrial proteins or proteins involved in mitochondrial function. Mitochondrial diseases are the most common group of inherited metabolic disorders and are among the most common forms of inherited neurological disorders. One of the challenges of mitochondrial diseases is the marked clinical variation seen in patients, which can delay diagnosis. However, advances in next-generation sequencing techniques have substantially improved diagnosis, particularly in children. Establishing a genetic diagnosis allows patients with mitochondrial diseases to have reproductive options, but this is more challenging for women with pathogenetic mtDNA mutations that are strictly maternally inherited. Recent advances in in vitro fertilization techniques, including mitochondrial donation, will offer a better reproductive choice for these women in the future. The treatment of patients with mitochondrial diseases remains a challenge, but guidelines are available to manage the complications of disease. Moreover, an increasing number of therapeutic options are being considered, and with the development of large cohorts of patients and biomarkers, several clinical trials are in progress.
C1 [Gorman, Grainne S.; McFarland, Robert; Turnbull, Douglass M.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Neurosci, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Chinnery, Patrick F.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England.
   [DiMauro, Salvatore; Hirano, Michio] Columbia Univ, Houston Merritt Clin Res Ctr, New York, NY USA.
   [DiMauro, Salvatore; Hirano, Michio] Coll Phys & Surg, Dept Neurol, New York, NY USA.
   [Koga, Yasutoshi] Kurume Univ, Grad Sch Med, Dept Paediat & Child Hlth, Kurume, Fukuoka, Japan.
   [Suomalainen, Anu] Univ Helsinki, Res Programs Unit, Mol Neurol, Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Ctr Neurosci, Helsinki, Finland.
   [Suomalainen, Anu] Helsinki Univ Hosp, Dept Neurol, Helsinki, Finland.
   [Thorburn, David R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Thorburn, David R.] Royal Childrens Hosp, Victorian Clin Genet Serv, Melbourne, Vic, Australia.
   [Thorburn, David R.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.
   [Zeviani, Massimo] MRC, Mitochondrial Biol Unit, Cambridge, England.
C3 Newcastle University - UK; University of Cambridge; Columbia University;
   Kurume University; University of Helsinki; University of Helsinki;
   University of Helsinki; Helsinki University Central Hospital; Murdoch
   Children's Research Institute; Royal Children's Hospital Melbourne;
   Murdoch Children's Research Institute; Victorian Clinical Genetics
   Services; Royal Children's Hospital Melbourne; University of Melbourne
RP Turnbull, DM (corresponding author), Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Neurosci, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM doug.turnbull@newcastle.ac.uk
RI Zeviani, Massimo/AAU-2632-2021; Thorburn, David/G-6266-2013
OI Koga, Yasutoshi/0000-0002-6664-1295; Chinnery,
   Patrick/0000-0002-7065-6617; Turnbull, Doug/0000-0002-8878-9901;
   McFarland, Robert/0000-0002-8833-2688; Suomalainen-Wartiovaara,
   Anu/0000-0003-4833-5195; thorburn, david/0000-0002-7725-9470; Gorman,
   Grainne/0000-0002-7585-3409; Zeviani, Massimo/0000-0002-9067-5508
FU Japan Agency for Medical Research and Development; Australian National
   Health and Medical Research Council Principal Research Fellowship;
   Victorian Government's Operational Infrastructure Support Program;
   Wellcome Trust Centre for Mitochondrial Research, Newcastle University
   Centre for Ageing and Vitality (Biotechnology and Biological Sciences
   Research Council); Wellcome Trust Centre for Mitochondrial Research,
   Newcastle University Centre for Ageing and Vitality (Medical Research
   Council (MRC)); MRC Centre for Neuromuscular Disease; MRC Centre for
   Translational Research in Neuromuscular Disease Mitochondrial Disease
   Patient Cohort (UK); Lily Foundation; UK National Institute for Health
   Research (NIHR) Biomedical Research Centre in Age and Age Related
   Diseases; UK NHS Specialist Commissioners 'Rare Mitochondrial Disorders
   of Adults and Children' Service; European Research Council; Sigrid
   Juselius Foundation; Academy of Finland; MRC; MRC [G0900652, G0502157,
   G0400074, G1100540, MC_UP_1002/1] Funding Source: UKRI
FX Y.K. received research support from the Japan Agency for Medical
   Research and Development. D.R.T. receives research support from the
   Australian National Health and Medical Research Council Principal
   Research Fellowship and by the Victorian Government's Operational
   Infrastructure Support Program. G.S.G., R.M.F. and D.M.T. are supported
   by the Wellcome Trust Centre for Mitochondrial Research, Newcastle
   University Centre for Ageing and Vitality (supported by the
   Biotechnology and Biological Sciences Research Council and the Medical
   Research Council (MRC)), the MRC Centre for Neuromuscular Disease, the
   MRC Centre for Translational Research in Neuromuscular Disease
   Mitochondrial Disease Patient Cohort (UK), the Lily Foundation, the UK
   National Institute for Health Research (NIHR) Biomedical Research Centre
   in Age and Age Related Diseases award to the Newcastle-upon-Tyne
   Hospitals NHS Foundation Trust and UK NHS Specialist Commissioners 'Rare
   Mitochondrial Disorders of Adults and Children' Service. A.S. received
   research support from the European Research Council, the Sigrid Juselius
   Foundation and the Academy of Finland. M.Z. is supported by the MRC and
   a European Research Council advanced grant.
CR Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Al-Hassnan ZN, 2015, J MED GENET, V52, P186, DOI 10.1136/jmedgenet-2014-102592
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   Avula S, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0292-7
   Bax BE, 2013, NEUROLOGY, V81, P1269, DOI 10.1212/WNL.0b013e3182a6cb4b
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bianco A, 2016, BRAIN, V139, DOI 10.1093/brain/awv216
   Boles RG, 2005, AM J MED GENET B, V137B, P20, DOI 10.1002/ajmg.b.30199
   Bonfante E, 2016, PEDIATR RADIOL, V46, P443, DOI 10.1007/s00247-015-3523-5
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Brito S, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00102
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Cámara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Camp KM, 2016, MOL GENET METAB, V119, P187, DOI 10.1016/j.ymgme.2016.09.002
   Carrozzo R, 2016, J INHERIT METAB DIS, V39, P243, DOI 10.1007/s10545-015-9894-9
   Castro-Gago M, 2006, PEDIATR NEUROL, V34, P204, DOI 10.1016/j.pediatrneurol.2005.07.011
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Chinnery P.F., GeneReviews
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Cohen BH, GENEREVIEWS
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Davis RL, 2013, NEUROLOGY, V81, P1819, DOI 10.1212/01.wnl.0000436068.43384.ef
   Di Meo I, 2012, EMBO MOL MED, V4, P1008, DOI 10.1002/emmm.201201433
   DiMauro S, GENEREVIEWS
   Diogo L, 2009, PEDIATR NEUROL, V40, P351, DOI 10.1016/j.pediatrneurol.2008.11.012
   Dionisi-Vici C, 2016, BRAIN, V139, P1045, DOI 10.1093/brain/aww013
   Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895
   Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elo JM, 2012, HUM MOL GENET, V21, P4521, DOI 10.1093/hmg/dds294
   Emmanuele V, 2012, ARCH NEUROL-CHICAGO, V69, P978, DOI 10.1001/archneurol.2012.206
   Enns GM, 2014, J CHILD NEUROL, V29, P1235, DOI 10.1177/0883073814538509
   Falk MJ, 2015, MOL GENET METAB, V114, P388, DOI 10.1016/j.ymgme.2014.11.016
   Ferreira M, 2011, NEUROGENETICS, V12, P9, DOI 10.1007/s10048-010-0265-2
   Gal A, 2015, CLIN NEUROPATHOL, V34, P89, DOI 10.5414/NP300789
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011
   Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   González-Vioque E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002035
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Gorman GS, 2015, JAMA NEUROL, V72, P106, DOI 10.1001/jamaneurol.2014.1753
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Grabhorn E, 2014, LIVER TRANSPLANT, V20, P464, DOI 10.1002/lt.23830
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   Haghighi A, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0119-3
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   Halter JP, 2015, BRAIN, V138, P2847, DOI 10.1093/brain/awv226
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Honzík T, 2010, ARCH DIS CHILD, V95, P296, DOI 10.1136/adc.2009.168096
   Hopper RK, 2006, BIOCHEMISTRY-US, V45, P2524, DOI 10.1021/bi052475e
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Huemer M, 2015, J INHERIT METAB DIS, V38, P905, DOI 10.1007/s10545-015-9836-6
   Hughes DA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-4
   Hyslop LA, 2016, NATURE, V534, P383, DOI [10.1038/nature183030, 10.1038/nature18303]
   Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184
   Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642
   Janer A, 2015, EUR J HUM GENET, V23, P1301, DOI 10.1038/ejhg.2014.293
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Kang HC, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2006.00906.x
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Kim KR, 2010, PEDIATR NEUROL, V42, P271, DOI 10.1016/j.pediatrneurol.2009.11.012
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Klopstock T, 2013, BRAIN, V136, DOI 10.1093/brain/aws279
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Koenig MK, 2016, JAMA NEUROL, V73, P591, DOI 10.1001/jamaneurol.2015.5072
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Koopman WJH, 2016, EMBO MOL MED, V8, P311, DOI 10.15252/emmm.201506131
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kratz L, 2009, FAM SYST HEALTH, V27, P303, DOI 10.1037/a0018114
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381
   Leber T., 1871, ARCH OPHTHALMOL-CHIC, V17, P249
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Luo LF, 2013, GENE, V520, P79, DOI 10.1016/j.gene.2013.03.041
   Macmillan C, 1998, NEUROLOGY, V50, P417, DOI 10.1212/WNL.50.2.417
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Marriage BJ, 2004, MOL GENET METAB, V81, P263, DOI 10.1016/j.ymgme.2003.12.008
   Martinelli D, 2012, MOL GENET METAB, V107, P383, DOI 10.1016/j.ymgme.2012.09.007
   Matthews L, 2015, J NEUROL NEUROSUR PS, V86, P537, DOI 10.1136/jnnp-2014-308186
   MATTHEWS PM, 1993, NEUROLOGY, V43, P884, DOI 10.1212/WNL.43.5.884
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Napolitano A, 2000, NEUROL SCI, V21, pS981, DOI 10.1007/s100720070015
   National Academies Press, 2016, MIT REPL TECHN ETH S
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nesbitt V., 2011, J NEONATAL PERINATAL, V4, P179
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Ng YS, 2016, EUR HEART J, V37, P2552, DOI 10.1093/eurheartj/ehv306
   NICHOLLS P, 1975, BIOCHEM BIOPH RES CO, V67, P610, DOI 10.1016/0006-291X(75)90856-6
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Noorda G, 2007, J INHERIT METAB DIS, V30, P333, DOI 10.1007/s10545-007-0426-0
   Nouws J, 2014, JIMD REP, V12, P37, DOI 10.1007/8904_2013_242
   Nuffield Council on Bioethics, 2012, NOV TECHN PREV MIT D
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Oldfors A, 2006, NEUROLOGY, V66, pS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   Orsucci D, 2012, NEUROEPIDEMIOLOGY, V38, P195, DOI 10.1159/000337161
   ORTIZ RG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1525, DOI 10.1001/archopht.1993.01090110091031
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Panetta J, 2004, J INHERIT METAB DIS, V27, P487, DOI 10.1023/B:BOLI.0000037354.66587.38
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pfeffer G, 2013, NEUROLOGY, V81, P2073, DOI 10.1212/01.wnl.0000437308.22603.43
   Pietiläinen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051
   Pirinen E, 2014, CELL METAB, V19, P1034, DOI 10.1016/j.cmet.2014.04.002
   Quinzii CM, 2014, MOL SYNDROMOL, V5, P141, DOI 10.1159/000360490
   Rantamäki MT, 2005, ANN NEUROL, V58, P337, DOI 10.1002/ana.20555
   Read Catherine Yetter, 2003, J Pediatr Nurs, V18, P181, DOI 10.1053/jpdn.2003.36
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Richter R, 2010, BIOCHEM SOC T, V38, P1523, DOI 10.1042/BST0381523
   Rocha MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15037
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Rogac M, 2011, PEDIATR NEUROL, V44, P340, DOI 10.1016/j.pediatrneurol.2010.12.004
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   ROTIG A, 1989, LANCET, V1, P902
   Ryan E, 2006, Ir Med J, V99, P262
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schiff M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028823
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Seidowsky A, 2013, CLIN NEPHROL, V80, P456, DOI 10.5414/CN107063
   Sexton A C, 2008, J Genet Couns, V17, P261, DOI 10.1007/s10897-007-9145-9
   Shaham O, 2010, P NATL ACAD SCI USA, V107, P1571, DOI 10.1073/pnas.0906039107
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Sofou K, 2015, MOL GENET GENOM MED, V3, P59, DOI 10.1002/mgg3.115
   Sommerville Ewen W, 2014, J Neuromuscul Dis, V1, P119
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326
   Steinfeld R, 2009, AM J HUM GENET, V85, P354, DOI 10.1016/j.ajhg.2009.08.005
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Taivassalo T, 2005, MED SCI SPORT EXER, V37, P2094, DOI 10.1249/01.mss.0000177446.97671.2a
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thommasen Harvey V, 2006, Rural Remote Health, V6, P528
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907
   Torres-Torronteras J, 2014, MOL THER, V22, P901, DOI 10.1038/mt.2014.6
   Tyynismaa H, 2014, EMBO MOL MED, V6, P155, DOI 10.1002/emmm.201303586
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Uittenbogaard M, 2014, CURR PHARM DESIGN, V20, P5574, DOI 10.2174/1381612820666140305224906
   Uluc K, 2008, J NEUROL SCI, V273, P118, DOI 10.1016/j.jns.2008.06.002
   Uusimaa J, 2000, PEDIATRICS, V105, P598, DOI 10.1542/peds.105.3.598
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Varvogli L, 1999, J INHERIT METAB DIS, V22, P615, DOI 10.1023/A:1005521828360
   Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Viscomi C, 2010, NAT MED, V16, P869, DOI 10.1038/nm.2188
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   Wai T, 2015, SCIENCE, V350, DOI 10.1126/science.aad0116
   Wedatilake Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-96
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Wortmann SB, 2013, J INHERIT METAB DIS, V36, P913, DOI 10.1007/s10545-012-9579-6
   Wortmann SB, 2012, NAT GENET, V44, P797, DOI 10.1038/ng.2325
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
   Yelverton JC, 2013, OTOLARYNG HEAD NECK, V148, P1017, DOI 10.1177/0194599813482705
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
NR 204
TC 942
Z9 1026
U1 13
U2 189
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2056-676X
J9 NAT REV DIS PRIMERS
JI Nat. Rev. Dis. Primers
PD OCT 20
PY 2016
VL 2
BP 1
EP 22
DI 10.1038/nrdp.2016.80
PG 22
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA EQ1YW
UT WOS:000397866500001
PM 27775730
HC Y
HP N
DA 2024-11-01
ER

PT J
AU Tarnopolsky, MA
AF Tarnopolsky, Mark A.
TI Exercise as a Therapeutic Strategy for Primary Mitochondrial Cytopathies
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE endurance exercise; mitochondrial gene shifting; mitochondrial myopathy;
   resistance exercise; satellite cells
ID QUALITY-OF-LIFE; MUSCLE STEM-CELLS; OXIDATIVE STRESS; SKELETAL-MUSCLE;
   PHYSICAL-ACTIVITY; ENDURANCE EXERCISE; CARDIAC REHABILITATION; CREATINE
   MONOHYDRATE; RESISTANCE EXERCISE; POINT MUTATION
AB Patients with mitochondrial cytopathies often experience exercise intolerance and may have fixed muscle weakness, leading to impaired functional capacity and lower quality of life. Endurance exercise training increases Vo (2) (max), respiratory chain enzyme activity, and improves quality of life. Resistance exercise training increases muscle strength and may lower mutational burden in patients with mitochondrial DNA deletions. Both modes of exercise appear to be well tolerated. Patients with mitochondrial cytopathy should consider alternating both types of exercise to derive the benefits from each (endurance = greater aerobic fitness; resistance = greater strength). Patients should start an exercise program at a low intensity and duration, gradually increasing duration and intensity. They should listen to their body and not exercise on days they have fever, superimposed illness, muscle pain, or cramps, and/or if they have fasted for more than 12 hours. Children often respond best to play-based exercise and tend to enjoy intermittent activity.
C1 [Tarnopolsky, Mark A.] McMaster Univ, Div Neuromuscular & Neurometab Dis, Hamilton, ON, Canada.
C3 McMaster University
RP Tarnopolsky, MA (corresponding author), McMaster Univ Med Ctr, 1200 Main St W,HSC-2H26, Hamilton, ON L8N 3Z5, Canada.
EM tarnopol@mcmaster.ca
FU Natural Science and Engineering Research Council (NSERC); Canadian
   Institutes of Health Research (CIHR); MitoCanada
FX The author disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: Dr
   Tarnopolsky's work on exercise and mitochondrial disease is supported by
   grants from the Natural Science and Engineering Research Council
   (NSERC), Canadian Institutes of Health Research (CIHR), and MitoCanada
   and donations from Tucker's Time Golf Tournament and in memory of
   Cillian Barrows.
CR Andrews RM, 1999, EYE, V13, P769, DOI 10.1038/eye.1999.225
   Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613
   Bacon CG, 2002, DIABETES CARE, V25, P1458, DOI 10.2337/diacare.25.8.1458
   Bates MGD, 2013, INT J CARDIOL, V168, P3599, DOI 10.1016/j.ijcard.2013.05.062
   Brose A, 2003, J GERONTOL A-BIOL, V58, P11
   Brown JC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036735, 10.1371/journal.pone.0030955]
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Buchman AS, 2012, NEUROLOGY, V78, P1323, DOI 10.1212/WNL.0b013e3182535d35
   Cejudo P, 2005, MUSCLE NERVE, V32, P342, DOI 10.1002/mus.20368
   Chakravarty EF, 2008, ARCH INTERN MED, V168, P1638, DOI 10.1001/archinte.168.15.1638
   Cress ME, 1999, J GERONTOL A-BIOL, V54, pM242, DOI 10.1093/gerona/54.5.M242
   Fakhry F, 2011, ARCH PHYS MED REHAB, V92, P1066, DOI 10.1016/j.apmr.2011.02.007
   FIATARONE MA, 1990, JAMA-J AM MED ASSOC, V263, P3029, DOI 10.1001/jama.263.22.3029
   FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Gianni P, 2004, EXP GERONTOL, V39, P1391, DOI 10.1016/j.exger.2004.06.002
   Grontved A, 2012, ARCH INTERN MED, V172, P1306, DOI 10.1001/archinternmed.2012.3138
   Hegbom Finn, 2006, J Cardiopulm Rehabil, V26, P24, DOI 10.1097/00008483-200601000-00005
   Hegbom F, 2007, INT J CARDIOL, V116, P86, DOI 10.1016/j.ijcard.2006.03.034
   Hong S, 2003, MED SCI SPORT EXER, V35, P1088, DOI 10.1249/01.MSS.0000074566.94791.24
   Hsu CJ, 2011, TRANSPL P, V43, P2714, DOI 10.1016/j.transproceed.2011.04.025
   Huisinga JM, 2011, J REHABIL RES DEV, V48, P881, DOI 10.1682/JRRD.2010.08.0152
   Ikawa M, 2012, EUR NEUROL, V67, P232, DOI 10.1159/000336568
   Izawa K, 2004, CIRC J, V68, P315, DOI 10.1253/circj.68.315
   Jäger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Jeppesen TD, 2009, EUR J NEUROL, V16, P1336, DOI 10.1111/j.1468-1331.2009.02660.x
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Joanisse S, 2013, FASEB J, V27, P4596, DOI 10.1096/fj.13-229799
   Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kwon HR, 2011, DIABETES METAB J, V35, P364, DOI 10.4093/dmj.2011.35.4.364
   Loprinzi PD, 2013, PREV MED, V57, P545, DOI 10.1016/j.ypmed.2013.07.009
   McKay BR, 2010, J PHYSIOL-LONDON, V588, P3307, DOI 10.1113/jphysiol.2010.190876
   McKinnell IW, 2005, CURR TOP DEV BIOL, V71, P113, DOI 10.1016/S0070-2153(05)71004-8
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Parise G, 2005, FREE RADICAL BIO MED, V39, P289, DOI 10.1016/j.freeradbiomed.2005.03.024
   Paterson DH, 2004, J AM GERIATR SOC, V52, P1632, DOI 10.1111/j.1532-5415.2004.52454.x
   Paterson DH, 1999, MED SCI SPORT EXER, V31, P1813, DOI 10.1097/00005768-199912000-00018
   Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Phillips SM, 1996, AM J PHYSIOL-ENDOC M, V270, pE265, DOI 10.1152/ajpendo.1996.270.2.E265
   Phillips SM, 1995, J APPL PHYSIOL, V79, P1862, DOI 10.1152/jappl.1995.79.6.1862
   PICCOLO G, 1991, J NEUROL SCI, V105, P57, DOI 10.1016/0022-510X(91)90118-Q
   Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498
   Roef MJ, 2002, AM J CLIN NUTR, V75, P237, DOI 10.1093/ajcn/75.2.237
   Ruiz JR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a439
   Ruiz JR, 2009, CANCER EPIDEM BIOMAR, V18, P1468, DOI 10.1158/1055-9965.EPI-08-1075
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   SALE DG, 1988, MED SCI SPORT EXER, V20, pS135, DOI 10.1249/00005768-198810001-00009
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schreuder L, 2010, NEUROL INT, V2, P20, DOI 10.4081/ni.2010.e4
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   Siciliano G, 2000, NEUROMUSCULAR DISORD, V10, P40, DOI 10.1016/S0960-8966(99)00068-1
   Siciliano G, 2012, NEUROMUSCULAR DISORD, V22, pS172, DOI 10.1016/j.nmd.2012.10.005
   Spendiff S, 2013, HUM MOL GENET, V22, P4739, DOI 10.1093/hmg/ddt327
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 1998, NEUROLOGY, V50, P1055, DOI 10.1212/WNL.50.4.1055
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Taivassalo T, 2012, BRAIN, V135, P53, DOI 10.1093/brain/awr293
   Tanasescu N, 2002, JAMA-J AM MED ASSOC, V288, P1994, DOI 10.1001/jama.288.16.1994
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   Tarnopolsky M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000991
   Vanhees L, 2012, EUR J PREV CARDIOL, V19, P1333, DOI 10.1177/2047487312437063
   Vital A, 2012, J NEUROPATH EXP NEUR, V71, P1036, DOI 10.1097/NEN.0b013e3182764d47
   Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008
   Wilkinson SB, 2008, J PHYSIOL-LONDON, V586, P3701, DOI 10.1113/jphysiol.2008.153916
   Williams PT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081098
   Williams PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031436
   Zachwieja JJ, 1996, ENDOCRIN METAB CLIN, V25, P965, DOI 10.1016/S0889-8529(05)70365-0
NR 72
TC 23
Z9 26
U1 1
U2 12
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD SEP
PY 2014
VL 29
IS 9
SI SI
BP 1225
EP 1234
DI 10.1177/0883073814538512
PG 10
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA AP1FK
UT WOS:000341812400015
PM 25008908
DA 2024-11-01
ER

PT J
AU Newstead, SM
   Finsterer, J
AF Newstead, Shaundra M.
   Finsterer, Josef
TI Leigh-Like Syndrome With a Novel, Complex Phenotype Due to m.10191T&gt;C
   in Mt-ND3
SO CUREUS JOURNAL OF MEDICAL SCIENCE
LA English
DT Article
DE genetics; respiratory chain; mitochondrial disorder; mtdna; m .10191t >
   c
ID MITOCHONDRIAL-DNA MUTATIONS; MISSENSE MUTATION; CHINESE CHILDREN;
   LACTIC-ACIDOSIS; ENCEPHALOPATHY; ENZYME
AB Leigh-like syndrome (LLS) due to the variant m.10191T>C in ND3 with a number of new phenotypic traits has not been published. In this case report, a 32-year-old woman diagnosed with Leigh-like syndrome presented with a complex novel, progressive, multisystem phenotype, manifesting in the brain (mild cognitive impairment, seizures, choreoathetosis, pseudotumor cerebri, hypersomnia, symmetric pallidal insufficiency, renal tubular acidosis, nephrolithiasis), muscles (myopathy, exercise intolerance, easy fatigability), peripheral nerves (small fiber neuropathy, dysautonomia), connective tissue (hyperlaxity of joints, bruising), and bones (scoliosis, Chiari malformation). A genetic workup revealed the known pathogenic variant m.10191T>C in ND3, which was also carried by the patient's mother. This case demonstrates that the m.10191T>C variant in ND3 can phenotypically manifest with multisystem disease and that this disease is responsive to symptomatic treatment and application of additional compounds.
C1 [Newstead, Shaundra M.] HeatSync Biochem Lab, Biochem, Mesa, AZ USA.
   [Finsterer, Josef] Neurol & Neurophysiol Ctr, Neurol, Vienna, Austria.
RP Finsterer, J (corresponding author), Neurol & Neurophysiol Ctr, Neurol, Vienna, Austria.
EM fipaps@yahoo.de
RI Finsterer, J/AAE-5733-2020
CR Bakare AB, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.693734
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Krysko KM, 2017, NEURO-OPHTHALMOLOGY, V41, P30, DOI 10.1080/01658107.2016.1224256
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Leshinsky-Silver E, 2005, BIOCHEM BIOPH RES CO, V334, P582, DOI 10.1016/j.bbrc.2005.06.134
   Levy RJ, 2014, J CHILD NEUROL, V29, pNP105, DOI 10.1177/0883073813506783
   Li TR, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00347
   Lim BC, 2009, J CHILD NEUROL, V24, P828, DOI 10.1177/0883073808331085
   Ma YY, 2013, MITOCHONDR DNA, V24, P67, DOI 10.3109/19401736.2012.717932
   Ma YY, 2013, J CLIN NEUROSCI, V20, P1591, DOI 10.1016/j.jocn.2013.03.034
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Matsui Jun, 2014, No To Hattatsu, V46, P363
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Na JH, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.752467
   Nesbitt V, 2012, DEV MED CHILD NEUROL, V54, P500, DOI 10.1111/j.1469-8749.2012.04224.x
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Wei YP, 2018, J NEUROL, V265, P2388, DOI 10.1007/s00415-018-9014-5
   Werner KGE, 2009, PEDIATR NEUROL, V41, P27, DOI 10.1016/j.pediatrneurol.2009.02.010
   Zhao D, 2011, J HUM GENET, V56, P759, DOI 10.1038/jhg.2011.96
NR 20
TC 4
Z9 4
U1 0
U2 1
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2168-8184
J9 CUREUS J MED SCIENCE
JI Cureus J Med Sci
PD SEP 9
PY 2022
VL 14
IS 9
AR 28986
DI 10.7759/cureus.28986
PG 10
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA 8Z5VT
UT WOS:000933446400024
PM 36249637
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Kullar, PJ
   Gomez-Duran, A
   Gammage, PA
   Garone, C
   Minczuk, M
   Golder, Z
   Wilson, J
   Montoya, J
   Häkli, S
   Kärppä, M
   Horvath, R
   Majamaa, K
   Chinnery, PF
AF Kullar, Peter J.
   Gomez-Duran, Aurora
   Gammage, Payam A.
   Garone, Caterina
   Minczuk, Michal
   Golder, Zoe
   Wilson, Janet
   Montoya, Julio
   Hakli, Sanna
   Karppa, Mikko
   Horvath, Rita
   Majamaa, Kari
   Chinnery, Patrick F.
TI Heterozygous <i>SSBP1</i> start loss mutation co-segregates with hearing
   loss and the m.1555A&gt;G mtDNA variant in a large multigenerational
   family
SO BRAIN
LA English
DT Article
DE mitochondrial diseases; hearing; muscle disease; neurodegeneration;
   genetics
ID RIBOSOMAL-RNA MUTATION; NON-SYNDROMIC DEAFNESS; DNA-BINDING-PROTEIN;
   MITOCHONDRIAL-DNA; BIOCHEMICAL-EVIDENCE; 7S DNA; DISEASE; MAINTENANCE;
   FREQUENCY
AB The m.1555A>G mtDNA variant causes maternally inherited deafness, but the reasons for the highly variable clinical penetrance are not known. Exome sequencing identified a heterozygous start loss mutation in SSBP1, encoding the single stranded binding protein 1 (SSBP1), segregating with hearing loss in a multi-generational family transmitting m.1555A>G, associated with mtDNA depletion and multiple deletions in skeletal muscle. The SSBP1 mutation reduced steady state SSBP1 levels leading to a perturbation of mtDNA metabolism, likely compounding the intra-mitochondrial translation defect due to m.1555A>G in a tissue-specific manner. This family demonstrates the importance of rare trans-acting genetic nuclear modifiers in the clinical expression of mtDNA disease.
C1 [Kullar, Peter J.; Gomez-Duran, Aurora; Gammage, Payam A.; Garone, Caterina; Minczuk, Michal; Golder, Zoe; Chinnery, Patrick F.] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge CB2 0XY, England.
   [Kullar, Peter J.; Gomez-Duran, Aurora; Golder, Zoe; Chinnery, Patrick F.] Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 0QQ, England.
   [Wilson, Janet] Newcastle Univ, Inst Hlth & Soc, Baddiley Clark Bldg,Richardson Rd, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.
   [Montoya, Julio] Univ Zaragoza, CIBERER, Inst Invest Sanit Arago, Zaragoza, Spain.
   [Hakli, Sanna; Karppa, Mikko; Majamaa, Kari] Univ Oulu, Res Unit Clin Neurosci, Oulu, Finland.
   [Hakli, Sanna; Karppa, Mikko; Majamaa, Kari] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland.
   [Hakli, Sanna; Karppa, Mikko; Majamaa, Kari] Univ Oulu, Oulu, Finland.
   [Horvath, Rita] Newcastle Univ, Inst Genet Med, Newcastle, NSW, Australia.
C3 University of Cambridge; University of Cambridge; Newcastle University -
   UK; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en
   Red; CIBERER; University of Oulu; University of Oulu; University of
   Oulu; University of Newcastle
RP Chinnery, PF (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 0QQ, England.
EM pfc25@cam.ac.uk
RI Horvath, Rita/AAY-7042-2020; Majamaa, Kari/A-1344-2012; Gomez-Duran,
   Aurora/ABE-1973-2021; Garone, Caterina/AAB-8659-2019; Minczuk,
   Michal/G-1638-2014; Gomez-Duran, Aurora/T-6392-2017
OI Horvath, Rita/0000-0002-9841-170X; Gammage, Payam
   A./0000-0003-1968-1726; Garone, Caterina/0000-0003-4928-1037; Wilson,
   Janet Ann/0000-0002-6416-5870; Chinnery, Patrick/0000-0002-7065-6617;
   Minczuk, Michal/0000-0001-8242-1420; Majamaa, Kari/0000-0002-9070-3791;
   Gomez-Duran, Aurora/0000-0002-5895-6860
FU Wellcome Trust [101700/A/13/Z, 101876/Z/13/Z]; Medical Research Council
   Mitochondrial Biology Unit [MC_UP_1501/2]; Wellcome Trust Centre for
   Mitochondrial Research [096919Z/11/Z]; Medical Research Council (UK)
   Centre for Translational Muscle Disease research [G0601943]; EU FP7
   TIRCON; National Institute for Health Research (NIHR) Biomedical
   Research Centre based at Cambridge University Hospitals NHS Foundation
   Trust and the University of Cambridge; European Commission under "Marie
   Sklodowska-Curie Actions", Individual Fellowship - Reintegration Panel
   [Mitobiopath-705560]; Instituto de Salud Carlos III [PI14/00005,
   PI14/00070]; Departamento de Ciencia, Tecnologia y Universidad del
   Gobierno de Aragon (Grupos Consolidados B33); FEDER Funding Program from
   the European Union; and Asociacion de Enfermos de Patologia Mitocondrial
   (AEPMI); Medical Research Council (UK) [MC_U105697135]; MRC [G0601943,
   MC_U105697135, MC_UU_00015/4, MR/N025431/2, G1000848, MR/N010035/1,
   MR/N025431/1] Funding Source: UKRI; Newton Fund [MR/N027302/2,
   MR/N027302/1] Funding Source: UKRI
FX P.J.K. is a Wellcome Trust Clinical Research Training Fellow
   (101700/A/13/Z). P.F.C. is a Wellcome Trust Senior Fellow in Clinical
   Science (101876/Z/13/Z), and a UK NIHR Senior Investigator, who receives
   support from the Medical Research Council Mitochondrial Biology Unit
   (MC_UP_1501/2), the Wellcome Trust Centre for Mitochondrial Research
   (096919Z/11/Z), the Medical Research Council (UK) Centre for
   Translational Muscle Disease research (G0601943), EU FP7 TIRCON, and the
   National Institute for Health Research (NIHR) Biomedical Research Centre
   based at Cambridge University Hospitals NHS Foundation Trust and the
   University of Cambridge. The views expressed are those of the author(s)
   and not necessarily those of the NHS, the NIHR or the Department of
   Health. C.G. is supported by the European Commission under "Marie
   Sklodowska-Curie Actions", Individual Fellowship - Reintegration Panel
   (Mitobiopath-705560). J.M. receives funding from the Instituto de Salud
   Carlos III (PI14/00005 and PI14/00070); Departamento de Ciencia,
   Tecnologia y Universidad del Gobierno de Aragon (Grupos Consolidados
   B33) and FEDER Funding Program from the European Union; and Asociacion
   de Enfermos de Patologia Mitocondrial (AEPMI). P.A.G. and M.M. are
   supported by core funding from Medical Research Council (UK)
   (MC_U105697135).
CR Brown SDM, 2012, MAMM GENOME, V23, P632, DOI 10.1007/s00335-012-9427-x
   Bykhovskaya Y, 1998, AM J MED GENET, V77, P421, DOI 10.1002/(SICI)1096-8628(19980605)77:5<421::AID-AJMG13>3.0.CO;2-K
   Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109
   Fusté JM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004832
   Grady JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114462
   Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389
   Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963
   Häkli S, 2013, AUDIOL NEURO-OTOL, V18, P23, DOI 10.1159/000342905
   Keogh MJ, 2015, J NEUROL, V262, P1822, DOI 10.1007/s00415-015-7772-x
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86
   Lehtonen MS, 2000, EUR J HUM GENET, V8, P315, DOI 10.1038/sj.ejhg.5200455
   Meng FL, 2017, J BIOL CHEM, V292, P2881, DOI 10.1074/jbc.M116.749374
   Mikhailov VS, 1996, J BIOL CHEM, V271, P30774, DOI 10.1074/jbc.271.48.30774
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Rahman S, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000411
   Ruhanen H, 2010, BBA-MOL CELL RES, V1803, P931, DOI 10.1016/j.bbamcr.2010.04.008
   Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575
   Stewart JD, 2011, BBA-MOL BASIS DIS, V1812, P321, DOI 10.1016/j.bbadis.2010.11.012
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Van Haute L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12039
NR 24
TC 17
Z9 20
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD JAN
PY 2018
VL 141
BP 55
EP 62
DI 10.1093/brain/awx295
PN 1
PG 8
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA FS2PD
UT WOS:000419619700016
PM 29182774
OA Green Published, Green Accepted, hybrid
DA 2024-11-01
ER

PT J
AU Lebrecht, D
   Deveaud, C
   Beauvoit, B
   Bonnet, J
   Kirschner, J
   Walker, UA
AF Lebrecht, Dirk
   Deveaud, Catherine
   Beauvoit, Bertrand
   Bonnet, Jacques
   Kirschner, Janbernd
   Walker, Ulrich A.
TI Uridine supplementation antagonizes zidovudine-induced mitochondrial
   myopathy and hyperlactatemia in mice
SO ARTHRITIS AND RHEUMATISM
LA English
DT Article
ID REVERSE-TRANSCRIPTASE INHIBITORS; MUSCLE MITOCHONDRIA; DIDANOSINE DDI;
   TOXICITY; NUCLEOSIDE; CELLS; MTDNA; 3'-AZIDO-3'-DEOXYTHYMIDINE; AZT; DNA
AB Objective. Zidovudine is an antiretroviral nucleoside analog reverse transcriptase inhibitor that induces mitochondrial myopathy by interfering with the replication of mitochondrial DNA (mtDNA). Because zidovudine inhibits thymidine kinases, the mechanism of mtDNA depletion may be related to an impairment of the de novo synthesis of pyrimidine nucleotides, which are required building blocks of mtDNA. This study was undertaken to determine whether mitochondrial myopathy is a class effect of antiretroviral nucleoside analogs, and whether the muscle disease can be prevented by treatment with uridine as a pyrimidine nucleotide precursor.
   Methods. BALB/c mice were treated with zidovudine or zalcitabine. Some of the mice were cotreated with mitocnol, a dietary supplement with high uridine bioavailability. Mice hind limb muscles were examined after 10 weeks.
   Results. Zidovudine induced muscle fiber thinning, myocellular fat deposition, and abnormalities of mitochondrial ultrastructure. In mice treated with zidovudine, organelles contained low mtDNA copy numbers and reduced cytochrome c oxidase activity. The expression of the mtDNA-encoded cytochrome c oxidase I subunit, but not of nucleus-encoded mitochondrial proteins, was impaired. Zidovudine also increased the levels of myocellular reactive oxygen species and blood lactate. Uridine supplementation attenuated or normalized all pathologic abnormalities and had no intrinsic effects. Zalcitabine did not elicit muscle toxicity.
   Conclusion. Our findings indicate that zidovudine, but not zalcitabine, induces mitochondrial myopathy, which is substantially antagonized by uridine supplementation. These results provide proof of the importance of pyrimidine pools in the pathogenesis of zidovudine myopathy. Since uridine supplementation is tolerated well by humans, this treatment strategy should be investigated in clinical trials.
C1 [Walker, Ulrich A.] Univ Basel, Dept Rheumatol, CH-4012 Basel, Switzerland.
   [Lebrecht, Dirk; Kirschner, Janbernd; Walker, Ulrich A.] Med Univ Klin, Freiburg, Germany.
   [Deveaud, Catherine; Beauvoit, Bertrand; Bonnet, Jacques] INSERM, Unite 828, Pessac, France.
C3 University of Basel; University of Freiburg; Institut National de la
   Sante et de la Recherche Medicale (Inserm)
RP Walker, UA (corresponding author), Univ Basel, Dept Rheumatol, Felix Platter Spital,Burgfelderstr 101, CH-4012 Basel, Switzerland.
EM ulrich.walker@fps-basel.ch
RI Walker, Ulrich/KMA-2190-2024; Bonnet, Jacques/KQT-9703-2024; Kirschner,
   Janbernd/Q-1493-2019; Kirschner, Janbernd/H-7418-2016
OI Beauvoit, Bertrand/0000-0002-7666-6429; Kirschner,
   Janbernd/0000-0003-1618-7386
CR ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   Banasch M, 2006, AIDS, V20, P1554, DOI 10.1097/01.aids.0000237373.38939.14
   Benbrik E, 1997, J NEUROL SCI, V149, P19, DOI 10.1016/S0022-510X(97)05376-8
   CHARIOT P, 1994, ARTHRITIS RHEUM, V37, P583, DOI 10.1002/art.1780370421
   Collins ML, 2004, JAIDS-J ACQ IMM DEF, V37, P1132, DOI 10.1097/01.qai.0000131585.77530.64
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   de la Asunción JG, 1998, J CLIN INVEST, V102, P4, DOI 10.1172/JCI1418
   Deveaud C, 2005, BIOCHEM PHARMACOL, V70, P90, DOI 10.1016/j.bcp.2005.04.015
   Fox RI, 1998, J RHEUMATOL, V25, P20
   FRINGS CS, 1972, CLIN CHEM, V18, P673
   Gattermann N, 2004, NUCLEOS NUCLEOT NUCL, V23, P1275, DOI 10.1081/NCN-200027545
   GIROT R, 1983, NEW ENGL J MED, V308, P700, DOI 10.1056/NEJM198303243081207
   Hosseini SH, 2007, AM J PATHOL, V170, P865, DOI 10.2353/ajpath.2007.060655
   Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3
   Koch EC, 2003, ANTIVIR THER, V8, P485
   Lebrecht D, 2003, CIRCULATION, V108, P2423, DOI 10.1161/01.CIR.0000093196.59829.DF
   Lebrecht D, 2007, HEPATOLOGY, V45, P72, DOI 10.1002/hep.21490
   LEWIS W, 1992, J CLIN INVEST, V89, P1354, DOI 10.1172/JCI115722
   Lynx MD, 2006, BIOCHEM PHARMACOL, V72, P239, DOI 10.1016/j.bcp.2006.04.004
   MCCOMSEY GA, 2007, URIDINE SUPPLEMENTAT
   Nohl H, 2005, BIOCHEM PHARMACOL, V69, P719, DOI 10.1016/j.bcp.2004.12.002
   Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031
   Pedrol E, 1996, J NEUROL SCI, V138, P42, DOI 10.1016/0022-510X(96)00009-3
   POULTON J, 1995, J INHERIT METAB DIS, V18, P4, DOI 10.1007/BF00711367
   Rylova SN, 2005, BIOCHEM PHARMACOL, V69, P951, DOI 10.1016/j.bcp.2004.12.010
   SILVESTRI G, 1994, HUM MUTAT, V3, P37, DOI 10.1002/humu.1380030107
   SOMMADOSSI JP, 1988, ANTIMICROB AGENTS CH, V32, P997, DOI 10.1128/AAC.32.7.997
   Susan-Resiga D, 2007, ANTIMICROB AGENTS CH, V51, P1142, DOI 10.1128/AAC.01227-06
   Sutinen J, 2007, ANTIVIR THER, V12, P97
   Tuzgen S, 1998, SPINAL CORD, V36, P654, DOI 10.1038/sj.sc.3100660
   Venhoff N, 2005, AIDS, V19, P739, DOI 10.1097/01.aids.0000166101.44262.52
   Walker UA, 2006, ANTIVIR THER, V11, P25
   Walker UA, 2005, ANTIVIR THER, V10, pM117
   Walker UA, 2003, ANTIVIR THER, V8, P463
   Walker UA, 2002, AIDS, V16, P2165, DOI 10.1097/00002030-200211080-00009
NR 35
TC 21
Z9 22
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0004-3591
EI 1529-0131
J9 ARTHRITIS RHEUM-US
JI Arthritis Rheum.
PD JAN
PY 2008
VL 58
IS 1
BP 318
EP 326
DI 10.1002/art.23235
PG 9
WC Rheumatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Rheumatology
GA 256ML
UT WOS:000252733100036
PM 18163507
DA 2024-11-01
ER

PT J
AU Dillon, LM
   Hida, A
   Garcia, S
   Prolla, TA
   Moraes, CT
AF Dillon, Lloye M.
   Hida, Aline
   Garcia, Sofia
   Prolla, Tomas A.
   Moraes, Carlos T.
TI Long-Term Bezafibrate Treatment Improves Skin and Spleen Phenotypes of
   the mtDNA Mutator Mouse
SO PLOS ONE
LA English
DT Article
ID PROLIFERATOR-ACTIVATED RECEPTORS; MITOCHONDRIAL BIOGENESIS;
   SKELETAL-MUSCLE; MICE; MYOPATHY
AB Pharmacological agents, such as bezafibrate, that activate peroxisome proliferator-activated receptors (PPARs) and PPAR gamma coactivator-1 alpha (PGC-1 alpha) pathways have been shown to improve mitochondrial function and energy metabolism. The mitochondrial DNA (mtDNA) mutator mouse is a mouse model of aging that harbors a proofreading-deficient mtDNA polymerase gamma. These mice develop many features of premature aging including hair loss, anemia, osteoporosis, sarcopenia and decreased lifespan. They also have increased mtDNA mutations and marked mitochondrial dysfunction. We found that mutator mice treated with bezafibrate for 8-months had delayed hair loss and improved skin and spleen aging-like phenotypes. Although we observed an increase in markers of fatty acid oxidation in these tissues, we did not detect a generalized increase in mitochondrial markers. On the other hand, there were no improvements in muscle function or lifespan of the mutator mouse, which we attributed to the rodent-specific hepatomegaly associated with fibrate treatment. These results showed that despite its secondary effects in rodent's liver, bezafibrate was able to improve some of the aging phenotypes in the mutator mouse. Because the associated hepatomegaly is not observed in primates, long-term bezafibrate treatment in humans could have beneficial effects on tissues undergoing chronic bioenergetic-related degeneration.
C1 [Dillon, Lloye M.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA.
   [Hida, Aline; Garcia, Sofia; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
   [Prolla, Tomas A.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.
C3 University of Miami; University of Miami; University of Wisconsin
   System; University of Wisconsin Madison
RP Dillon, LM (corresponding author), Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA.
EM cmoraes@med.miami.edu
RI Moraes, Carlos/AAT-3818-2021
OI Dillon, Lloye/0000-0002-5118-1126
FU U.S. Public Health Service (PHS) [AG036871, EY010804, NS079965];
   Muscular Dystrophy Association; Florida Biomedical Research Foundation
FX This work was supported by The U.S. Public Health Service (PHS) grants
   AG036871, EY010804, NS079965; the Muscular Dystrophy Association and the
   Florida Biomedical Research Foundation. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743
   Cheung MC, 2009, J SURG RES, V153, P326, DOI 10.1016/j.jss.2008.05.002
   De Souza AT, 2006, TOXICOL SCI, V92, P578, DOI 10.1093/toxsci/kfl019
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   Dillon LM, 2012, IUBMB LIFE, V64, P231, DOI 10.1002/iub.608
   Djouadi F, 2011, CELL METAB, V14, P715, DOI 10.1016/j.cmet.2011.11.003
   Ham SA, 2010, J CELL MOL MED, V14, P1747, DOI 10.1111/j.1582-4934.2009.00816.x
   Harries MJ, 2009, J INVEST DERMATOL, V129, P1066, DOI 10.1038/jid.2008.425
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   Johri A, 2012, HUM MOL GENET, V21, P1124, DOI 10.1093/hmg/ddr541
   Kuenzli S, 2003, BRIT J DERMATOL, V149, P229, DOI 10.1046/j.1365-2133.2003.05532.x
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   OIKARINEN A, 1994, PHOTODERMATOL PHOTO, V10, P47
   Pickrell AM, 2011, J NEUROSCI, V31, P9895, DOI 10.1523/JNEUROSCI.6223-10.2011
   Smaldone S, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-8
   Tenenbaum A, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-14
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Wang YX, 2010, CELL RES, V20, P124, DOI 10.1038/cr.2010.13
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
NR 23
TC 38
Z9 41
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 4
PY 2012
VL 7
IS 9
AR e44335
DI 10.1371/journal.pone.0044335
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 002ZJ
UT WOS:000308577600038
PM 22962610
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU Wang, ZX
   Hong, DJ
   Zhang, W
   Li, WR
   Shi, X
   Zhao, DH
   Yang, X
   Lv, H
   Yuan, Y
AF Wang, Zhaoxia
   Hong, Daojun
   Zhang, Wei
   Li, Wurong
   Shi, Xin
   Zhao, Danhua
   Yang, Xu
   Lv, He
   Yuan, Yull
TI Severe sensory neuropathy In patients with adult-onset multiple acyl-CoA
   dehydrogenase deficiency
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Multiple Acyl-CoA dehydrogenase deficiency; Sensory neuropathy; ETFDH;
   Phenotype
ID LIPID STORAGE MYOPATHIES; COENZYME-Q10 DEFICIENCY; OXIDATIVE STRESS;
   CHINESE PATIENTS; MUTATIONS; METABOLISM; DEFECTS
AB Multiple Acyl-CoA dehydrogenase deficiency (MADD) is an autosomal recessive disorder of fatty acid oxidation. Most patients with late-onset MADD are clinically characterized by lipid storage myopathy with dramatic responsiveness to riboflavin treatment. Abnormalities of peripheral neuropathy have rarely been reported in patients with late-onset MADD. We describe six patients who presented with proximal limb weakness and loss of sensation in the distal limbs. Muscle biopsy revealed typical myopathological patterns of lipid storage myopathy and blood acylcarnitine profiles showed a combined elevation of multiple acylcarnitines supporting the diagnosis of MADD. However, nerve conduction investigations and rural nerve biopsies in these patients indicated severe axonal sensory neuropathy. Causative ETFDH gene mutations were found in all six cases. No other causative gene mutations were identified in mitochondrial DNA and genes associated with hereditary neuropathies through next generation-sequencing panel. Late-onset patients with ETFDH mutations can present with proximal muscle weakness and distal sensory neuropathy, which might be a new phenotypic variation, but the precise underlying pathogenesis remains to be elucidated. (C) 2015 Published by Elsevier B.V.
C1 [Wang, Zhaoxia; Zhang, Wei; Shi, Xin; Zhao, Danhua; Lv, He; Yuan, Yull] Peking Univ, Hosp 1, Dept Neurol, Xishiku St 8, Beijing 100034, Peoples R China.
   [Hong, Daojun] Nanchang Univ, Affiliated Hosp 1, Dept Neurol, Nanchang, Peoples R China.
   [Li, Wurong] Capital Med Univ, Beijing Ditan Hosp, Dept Neurol, Beijing, Peoples R China.
   [Yang, Xu] China Aerosp Corp, Cent Hosp, Dept Neurol, Beijing, Peoples R China.
C3 Peking University; Nanchang University; Capital Medical University
RP Yuan, Y (corresponding author), Peking Univ, Hosp 1, Dept Neurol, Xishiku St 8, Beijing 100034, Peoples R China.
EM yuanyun2002@sohu.com
RI Wang, Zilong/IQV-2260-2023
OI Yang, Xu/0000-0002-3615-3063
FU National Natural Science Foundation of China [30870864, 81260194,
   81460199]; Ministry of Science and Technology of the People's Republic
   of China [2011ZX09307-001-07]
FX We thank the patients and their parents for cooperation. Ms. Yuehuan Zuo
   contributed for technical assistance in muscle biopsy preparation. This
   study was supported by the National Natural Science Foundation of China
   (Nos. 30870864, 81260194 and 81460199) and by the Ministry of Science
   and Technology of the People's Republic of China (No.
   2011ZX09307-001-07).
CR Bruno C, 2008, CURR OPIN NEUROL, V21, P601, DOI 10.1097/WCO.0b013e32830dd5a6
   Cornelius N, 2013, HUM MOL GENET, V22, P3819, DOI 10.1093/hmg/ddt232
   Cotelli MS, 2012, NEUROL SCI, V33, P1383, DOI 10.1007/s10072-011-0900-1
   Frerman FE., 2001, METABOLIC MOL BASIS, P2357
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   Gianazza E, 2006, ELECTROPHORESIS, V27, P1182, DOI 10.1002/elps.200500687
   Grünert SC, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0117-5
   Kim SH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003563
   [李务荣 Li Wurong], 2012, [中风与神经疾病杂志, Journal of Apoplexy and Nervous Diseases], V29, P200
   Liang W C, 2010, Acta Myol, V29, P351
   Meyerson C, 2015, CLIN OPHTHALMOL, V9, P1165, DOI 10.2147/OPTH.S62021
   Ohkuma A, 2009, MUSCLE NERVE, V39, P333, DOI 10.1002/mus.21167
   Olsen RKJ, 2007, BRAIN, V130, P2045, DOI 10.1093/brain/awm135
   Olsen RKJ, 2013, MOL GENET METAB, V110, pS31, DOI 10.1016/j.ymgme.2013.10.007
   Olsen RKJ, 2003, HUM MUTAT, V22, P12, DOI 10.1002/humu.10226
   Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5
   Peng YF, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0380-7
   Poorabbas A, 2007, EUR J CLIN NUTR, V61, P892, DOI 10.1038/sj.ejcn.1602594
   Quistad GB, 2002, TOXICOL APPL PHARM, V179, P57, DOI 10.1006/taap.2001.9342
   Simkovic M, 2002, BIOCHEM J, V364, P659, DOI 10.1042/BJ20020042
   Song YQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008329
   Viader A, 2013, NEURON, V77, P886, DOI 10.1016/j.neuron.2013.01.012
   Weiss MD, 2010, MUSCLE NERVE, V41, P882, DOI 10.1002/mus.21636
   Wen B, 2010, J NEUROL NEUROSUR PS, V81, P231, DOI 10.1136/jnnp.2009.176404
   Zhang W, 2010, NEUROL SCI, V31, P61, DOI 10.1007/s10072-009-0128-5
   Zhao D, 2011, J HUM GENET, V56, P759, DOI 10.1038/jhg.2011.96
   Zhu M, 2014, J HUM GENET, V59, P256, DOI 10.1038/jhg.2014.10
NR 27
TC 32
Z9 33
U1 0
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD FEB
PY 2016
VL 26
IS 2
BP 170
EP 175
DI 10.1016/j.nmd.2015.12.002
PG 6
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA DF9AH
UT WOS:000371652100009
PM 26821934
DA 2024-11-01
ER

PT J
AU Roy, A
   Kandettu, A
   Ray, S
   Chakrabarty, S
AF Roy, Abhipsa
   Kandettu, Amoolya
   Ray, Swagat
   Chakrabarty, Sanjiban
TI Mitochondrial DNA replication and repair defects: Clinical phenotypes
   and therapeutic interventions
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Review
DE mtDNA replication; POLG; Base-excision repair; LIG3; CPEO
ID BASE-EXCISION-REPAIR; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; STRAND BREAK
   REPAIR; NUCLEOTIDE TRANSLOCATOR-1 GENE; MESSENGER-RNA LOCALIZATION;
   IMPAIR MTDNA REPLICATION; DOMINANT OPTIC ATROPHY; MOUSE L-CELLS;
   POLYMERASE-GAMMA; AUTOSOMAL-DOMINANT
AB Mitochondria is a unique cellular organelle involved in multiple cellular processes and is critical for maintaining cellular homeostasis. This semi-autonomous organelle contains its circular genome - mtDNA (mitochondrial DNA), that undergoes continuous cycles of replication and repair to maintain the mitochondrial genome integrity. The majority of the mitochondrial genes, including mitochondrial replisome and repair genes, are nuclear-encoded. Although the repair machinery of mitochondria is quite efficient, the mitochondrial genome is highly susceptible to oxidative damage and other types of exogenous and endogenous agent-induced DNA damage, due to the absence of protective histones and their proximity to the main ROS production sites. Mutations in replication and repair genes of mitochondria can result in mtDNA depletion and deletions subsequently leading to mitochondrial genome instability. The combined action of mutations and deletions can result in compromised mitochondrial genome maintenance and lead to various mitochondrial disorders. Here, we review the mechanism of mitochondrial DNA replication and repair process, key proteins involved, and their altered function in mitochondrial disorders. The focus of this review will be on the key genes of mitochondrial DNA replication and repair machinery and the clinical phenotypes associated with mutations in these genes.
C1 [Roy, Abhipsa; Kandettu, Amoolya; Chakrabarty, Sanjiban] Manipal Acad Higher Educ, Manipal Sch Life Sci, Dept Cell & Mol Biol, Manipal 576104, Karnataka, India.
   [Ray, Swagat] Univ Lincoln, Sch Life & Environm Sci, Dept Life Sci, Lincoln LN6 7TS, England.
C3 Manipal Academy of Higher Education (MAHE); University of Lincoln
RP Chakrabarty, S (corresponding author), Manipal Acad Higher Educ, Manipal Sch Life Sci, Dept Cell & Mol Biol, Manipal 576104, Karnataka, India.
EM sanjiban.c@manipal.edu
RI chakrabarty, sanjiban/GXW-1652-2022; Ray, Swagat/H-7611-2016
OI Ray, Swagat/0000-0001-8034-7706
FU Science and Engineering Research Board (SERB) , Department of Science
   and Technology, Government of India [YSS/2015/001051, CRG/2020/004681]
FX Funding This work was supported by Science and Engineering Research
   Board (SERB) , Department of Science and Technology, Government of India
   (YSS/2015/001051 and CRG/2020/004681) .
CR Aamann MD, 2010, FASEB J, V24, P2334, DOI 10.1096/fj.09-147991
   Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819
   Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Ahmed N, 2015, INT J MOL SCI, V16, P18054, DOI 10.3390/ijms160818054
   Akbari M, 2008, DNA REPAIR, V7, P605, DOI 10.1016/j.dnarep.2008.01.002
   Al-Behadili A, 2018, NUCLEIC ACIDS RES, V46, P9471, DOI 10.1093/nar/gky708
   Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Alexeyev M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012641
   Alexeyev MF, 2009, FEBS J, V276, P5768, DOI 10.1111/j.1742-4658.2009.07269.x
   Alston CL, 2013, NEUROLOGY, V81, P2051, DOI 10.1212/01.wnl.0000436931.94291.e6
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   ANDERSON CTM, 1980, NUCLEIC ACIDS RES, V8, P875
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Balkenhol T, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.586119
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   BERK AJ, 1974, J MOL BIOL, V86, P801, DOI 10.1016/0022-2836(74)90355-6
   Bermúdez-Guzmán L, 2019, TRANSL NEURODEGENER, V8, DOI 10.1186/s40035-019-0156-x
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   BICKNESE AR, 1992, ANN NEUROL, V32, P767, DOI 10.1002/ana.410320610
   Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Bogenhagen DF, 1999, AM J HUM GENET, V64, P1276, DOI 10.1086/302392
   Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6
   Bonda E, 2016, ONCOTARGET, V7, P73323, DOI 10.18632/oncotarget.12331
   Bonnefoy Nathalie, 2007, Methods Mol Biol, V372, P153, DOI 10.1007/978-1-59745-365-3_11
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Bonnet C, 2008, BBA-MOL CELL RES, V1783, P1707, DOI 10.1016/j.bbamcr.2008.04.018
   Bonnet C, 2007, REJUV RES, V10, P127, DOI 10.1089/rej.2006.0526
   Bonora E, 2021, BRAIN, V144, P1451, DOI 10.1093/brain/awab056
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bottani E, 2014, MOL THER, V22, P10, DOI 10.1038/mt.2013.230
   Bouaita A, 2012, BRAIN, V135, P35, DOI 10.1093/brain/awr290
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BRESOLIN N, 1990, J NEUROL SCI, V100, P70, DOI 10.1016/0022-510X(90)90015-F
   Broskey NT, 2014, J CLIN ENDOCR METAB, V99, P1852, DOI 10.1210/jc.2013-3983
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Brunyanszki A, 2016, FREE RADICAL BIO MED, V100, P257, DOI 10.1016/j.freeradbiomed.2016.02.024
   Cai SB, 2005, CANCER RES, V65, P3319, DOI 10.1158/0008-5472.CAN-04-3335
   Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380
   Camp KM, 2016, MOL GENET METAB, V119, P187, DOI 10.1016/j.ymgme.2016.09.002
   Caradonna S, 1996, EXP CELL RES, V222, P345, DOI 10.1006/excr.1996.0044
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Carrodeguas JA, 2002, J BIOL CHEM, V277, P50008, DOI 10.1074/jbc.M207030200
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Chakrabarty S, 2021, J NEUROL, V268, P2192, DOI 10.1007/s00415-020-10390-9
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351
   Chen DX, 2006, CANCER RES, V66, P3485, DOI 10.1158/0008-5472.CAN-05-4103
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chiang SC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602506
   Cline SD, 2012, BBA-GENE REGUL MECH, V1819, P979, DOI 10.1016/j.bbagrm.2012.06.002
   Coene ED, 2005, MOL BIOL CELL, V16, P997, DOI 10.1091/mbc.E04-10-0895
   Coffey G, 2000, NUCLEIC ACIDS RES, V28, P3793, DOI 10.1093/nar/28.19.3793
   Cohen B. H., 1993, GeneReviews((R))
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   Copeland WC, 2008, MOL CELL, V32, P457, DOI 10.1016/j.molcel.2008.11.007
   Dahout-Gonzalez C, 2006, PHYSIOLOGY, V21, P242, DOI 10.1152/physiol.00005.2006
   Das BB, 2021, MITOCHONDRION, V60, P234, DOI 10.1016/j.mito.2021.08.017
   Das BB, 2010, P NATL ACAD SCI USA, V107, P19790, DOI 10.1073/pnas.1009814107
   Dassa EP, 2009, EMBO MOL MED, V1, P30, DOI 10.1002/emmm.200900001
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Davies DR, 2003, CHEM BIOL, V10, P139, DOI 10.1016/S1074-5521(03)00021-8
   Davies DR, 2002, STRUCTURE, V10, P237, DOI 10.1016/S0969-2126(02)00707-4
   De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025
   de Souza-Pinto NC, 2009, DNA REPAIR, V8, P704, DOI 10.1016/j.dnarep.2009.01.021
   de Souza-Pinto NC, 2004, ONCOGENE, V23, P6559, DOI 10.1038/sj.onc.1207874
   de Souza-Pinto NC, 2001, CANCER RES, V61, P5378
   Deepha S, 2021, J MOL NEUROSCI, V71, P2219, DOI 10.1007/s12031-020-01765-8
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Demple B, 2005, DNA REPAIR, V4, P1442, DOI 10.1016/j.dnarep.2005.09.004
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   DiMauro S., 2006, MITOCHONDRIAL MED, DOI [10.1201/9780367800154, DOI 10.1201/9780367800154]
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Dizdaroglu M, 2005, MUTAT RES-FUND MOL M, V591, P45, DOI 10.1016/j.mrfmmm.2005.01.033
   DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116
   Dodson ML, 2002, FREE RADICAL BIO MED, V32, P678, DOI 10.1016/S0891-5849(02)00767-0
   Dörner A, 2007, TRENDS CARDIOVAS MED, V17, P284, DOI 10.1016/j.tcm.2007.10.001
   Douarre C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041094
   DRIGGERS WJ, 1993, J BIOL CHEM, V268, P22042
   Duncan GE, 2004, J CLIN ENDOCR METAB, V89, P1733, DOI 10.1210/jc.2003-031684
   Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   Edmonds JL, 2004, MITOCHONDRION, V4, P543, DOI 10.1016/j.mito.2004.07.012
   El-Hattab AW, 2017, HUM MUTAT, V38, P1649, DOI 10.1002/humu.23341
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   Farge G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112770
   Farge G, 2014, CELL REP, V8, P66, DOI 10.1016/j.celrep.2014.05.046
   Farge G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2001
   Farr CL, 1999, J BIOL CHEM, V274, P14779, DOI 10.1074/jbc.274.21.14779
   Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Flierl A, 2005, GENE THER, V12, P570, DOI 10.1038/sj.gt.3302443
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185
   Fusté JM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004832
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773
   Ghosh A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax9778
   Gimenes AC, 2015, BRAZ J MED BIOL RES, V48, P354, DOI 10.1590/1414-431X20143467
   Goffart S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20082041
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   GRAY H, 1992, J BIOL CHEM, V267, P5835
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Graziewicz MA, 2004, NUCLEIC ACIDS RES, V32, P397, DOI 10.1093/nar/gkh213
   Gredilla Ricardo, 2010, J Aging Res, V2011, P257093, DOI 10.4061/2011/257093
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hämäläinen RH, 2019, NAT METAB, V1, P958, DOI 10.1038/s42255-019-0120-1
   Han DD, 2019, ELIFE, V8, DOI 10.7554/eLife.49044
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Hangas A, 2018, NUCLEIC ACIDS RES, V46, P9625, DOI 10.1093/nar/gky793
   Harris JL, 2009, HUM MOL GENET, V18, P4102, DOI 10.1093/hmg/ddp359
   Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799
   Herrmann GK, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100309
   Hirano M., 1993, GeneReviews®
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   Holmes JB, 2015, P NATL ACAD SCI USA, V112, P9334, DOI 10.1073/pnas.1503653112
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hu BW, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00581
   Hu JP, 2005, J BIOL CHEM, V280, P40544, DOI 10.1074/jbc.M508772200
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012
   Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506
   Ide H, 2004, BIOL PHARM BULL, V27, P480, DOI 10.1248/bpb.27.480
   Interthal H, 2005, EMBO J, V24, P2224, DOI 10.1038/sj.emboj.7600694
   Jackson CB, 2020, TRENDS MOL MED, V26, P698, DOI 10.1016/j.molmed.2020.02.006
   Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642
   Jang Y, 2018, LIFE SCI, V209, P455, DOI 10.1016/j.lfs.2018.08.045
   Jeppesen TD, 2009, EUR J NEUROL, V16, P1336, DOI 10.1111/j.1468-1331.2009.02660.x
   Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454
   Johansson M, 1996, P NATL ACAD SCI USA, V93, P7258, DOI 10.1073/pnas.93.14.7258
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kaltimbacher V, 2006, RNA, V12, P1408, DOI 10.1261/rna.18206
   Kanabus M, 2016, J INHERIT METAB DIS, V39, P415, DOI 10.1007/s10545-016-9930-4
   Karahalil B, 2003, J BIOL CHEM, V278, P33701, DOI 10.1074/jbc.M301617200
   Kasiviswanathan R, 2012, J BIOL CHEM, V287, P9222, DOI 10.1074/jbc.M111.306852
   Kasparek TR, 2011, SEMIN CELL DEV BIOL, V22, P886, DOI 10.1016/j.semcdb.2011.10.007
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Kentab A.Y., 2019, JNSK, V9, DOI [10.15406/jnsk.2019.09.00342, DOI 10.15406/JNSK.2019.09.00342]
   Kesäniemi J, 2020, EVOL ECOL, V34, P163, DOI 10.1007/s10682-019-10028-x
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Klopstock T, 2000, NEUROLOGY, V55, P1748, DOI 10.1212/WNL.55.11.1748
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Komen JC, 2014, BRIT J PHARMACOL, V171, P1818, DOI 10.1111/bph.12413
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Kornblum C, 2005, EUR J NEUROL, V12, P300, DOI 10.1111/j.1468-1331.2004.00970.x
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Körver-Keularts IMLW, 2015, JIMD REP, V22, P39, DOI 10.1007/8904_2015_409
   Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710
   Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583
   Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Kumar P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31122-0
   Kuszak AJ, 2018, ANNU REV PATHOL-MECH, V13, P163, DOI 10.1146/annurev-pathol-020117-043644
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lakshmipathy U, 2000, NUCLEIC ACIDS RES, V28, P3880, DOI 10.1093/nar/28.20.3880
   Lakshmipathy U, 1999, NUCLEIC ACIDS RES, V27, P1198, DOI 10.1093/nar/27.4.1198
   Lakshmipathy U, 2001, NUCLEIC ACIDS RES, V29, P668, DOI 10.1093/nar/29.3.668
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   LeDoux SP, 1999, MUTAT RES-DNA REPAIR, V434, P149, DOI 10.1016/S0921-8777(99)00026-9
   LEDOUX SP, 1992, CARCINOGENESIS, V13, P1967, DOI 10.1093/carcin/13.11.1967
   Lee SR, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8060949
   Lee YK, 2013, MOL CELLS, V35, P489, DOI 10.1007/s10059-013-2343-4
   Leon J, 2016, SCI REP-UK, V6, DOI 10.1038/srep22086
   Liet JM, 2003, J PEDIATR-US, V142, P62, DOI 10.1067/mpd.2003.mpd0333
   Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08
   Liu PF, 2010, ENVIRON MOL MUTAGEN, V51, P417, DOI 10.1002/em.20576
   Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Louro P, 2016, J INHERIT METAB DIS, V39, P743, DOI 10.1007/s10545-016-9951-z
   Low RL, 2003, EUR J BIOCHEM, V270, P4173, DOI 10.1046/j.1432-1033.2003.03814.x
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Lyabin DN, 2014, WIRES RNA, V5, P95, DOI 10.1002/wrna.1200
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   Mancuso M, 2010, J NEUROL, V257, P774, DOI 10.1007/s00415-009-5409-7
   Mandal SM, 2012, J BIOL CHEM, V287, P2819, DOI 10.1074/jbc.M111.272179
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Marín-García J, 2016, HEART FAIL REV, V21, P475, DOI 10.1007/s10741-016-9543-x
   MARTENS PA, 1979, J MOL BIOL, V135, P327, DOI 10.1016/0022-2836(79)90440-6
   Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167
   Matic S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03552-x
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MIGNOTTE B, 1985, NUCLEIC ACIDS RES, V13, P1703, DOI 10.1093/nar/13.5.1703
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Millhouse-Flourie TJ, 2004, MITOCHONDRION, V4, P549, DOI 10.1016/j.mito.2004.07.013
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Mishra A, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00489-17
   Moretton A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176795
   Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618
   Murrey DA, 2014, HUM GENE THER CL DEV, V25, P72, DOI 10.1089/humc.2013.208
   MYERS KA, 1988, CARCINOGENESIS, V9, P285, DOI 10.1093/carcin/9.2.285
   Nakamura J, 1999, CANCER RES, V59, P2522
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Naviaux RK, 2005, ANN NEUROL, V58, P491, DOI 10.1002/ana.20544
   Ngo HB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4077
   Nicholls TJ, 2018, MOL CELL, V69, P9, DOI 10.1016/j.molcel.2017.11.033
   Nicolson GL, 2007, J CELL BIOCHEM, V100, P1352, DOI 10.1002/jcb.21247
   Nightingale H, 2016, BRAIN, V139, P1633, DOI 10.1093/brain/aww081
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750
   Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637
   Ohtsubo T, 2000, NUCLEIC ACIDS RES, V28, P1355, DOI 10.1093/nar/28.6.1355
   Omar Garcia-Lepe U., 2019, DNA Repair- An Update, DOI DOI 10.5772/INTECHOPEN.84627
   Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003
   Osenbroch PO, 2009, FEBS J, V276, P2811, DOI 10.1111/j.1742-4658.2009.07004.x
   Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249
   Pannunzio NR, 2018, J BIOL CHEM, V293, P10512, DOI 10.1074/jbc.TM117.000374
   Paramasiyam A, 2019, MITOCHONDRION, V48, P78, DOI 10.1016/j.mito.2019.08.003
   Perales-Clemente E, 2008, P NATL ACAD SCI USA, V105, P18735, DOI 10.1073/pnas.0810518105
   Pinto M, 2015, FREE RADICAL BIO MED, V85, P250, DOI 10.1016/j.freeradbiomed.2015.05.005
   Pohjoismäki JLO, 2011, MITOCHONDRION, V11, P630, DOI 10.1016/j.mito.2011.04.002
   Pohjoismäki JLO, 2011, BIOESSAYS, V33, P290, DOI 10.1002/bies.201000137
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Pommier Y, 2014, DNA REPAIR, V19, P114, DOI 10.1016/j.dnarep.2014.03.020
   Posse V, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007781
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Ragg S, 2000, CANCER RES, V60, P5187
   Ranieri M, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/293893
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Reyes A, 2013, NUCLEIC ACIDS RES, V41, P5837, DOI 10.1093/nar/gkt196
   ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737
   Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Rosa ID, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005779
   Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sage JM, 2010, J BIOL CHEM, V285, P18984, DOI 10.1074/jbc.M109.099846
   Saki M, 2017, FREE RADICAL BIO MED, V107, P216, DOI 10.1016/j.freeradbiomed.2016.11.050
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Santos J, 2014, COLLOID SURFACE B, V121, P129, DOI 10.1016/j.colsurfb.2014.06.003
   Sanz A, 2010, P NATL ACAD SCI USA, V107, P9105, DOI 10.1073/pnas.0911539107
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Schnepp BC, 2003, J VIROL, V77, P3495, DOI 10.1128/JVI.77.6.3495-3504.2003
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Sharma H, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-34
   Sharma NK, 2014, DNA REPAIR, V13, P22, DOI 10.1016/j.dnarep.2013.11.002
   Sharma P, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020100
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Sobek S, 2014, EXP GERONTOL, V56, P135, DOI 10.1016/j.exger.2014.01.009
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spiegelman Bruce M, 2007, Novartis Found Symp, V287, P60
   Spinazzola A, 2011, SEMIN FETAL NEONAT M, V16, P190, DOI 10.1016/j.siny.2011.04.011
   Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093
   Stacpoole PW, 2006, PEDIATRICS, V117, P1519, DOI 10.1542/peds.2005-1226
   Steczkiewicz K, 2012, NUCLEIC ACIDS RES, V40, P7016, DOI 10.1093/nar/gks382
   Stein A, 2017, FRONT BIOSCI-LANDMRK, V22, P920, DOI 10.2741/4525
   Stierum RH, 1999, NUCLEIC ACIDS RES, V27, P3712, DOI 10.1093/nar/27.18.3712
   Stierum RH, 1999, J BIOL CHEM, V274, P7128, DOI 10.1074/jbc.274.11.7128
   Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001
   Strauss KA, 2013, P NATL ACAD SCI USA, V110, P3453, DOI 10.1073/pnas.1300690110
   Subedi S, 2015, ROLE HUMAN POLYNUCLE, DOI [10.7939/R3JM23W6K, DOI 10.7939/R3JM23W6K]
   Svilar D, 2011, ANTIOXID REDOX SIGN, V14, P2491, DOI 10.1089/ars.2010.3466
   Sykora P, 2012, MECH AGEING DEV, V133, P169, DOI 10.1016/j.mad.2011.11.003
   Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200
   Szczesny RJ, 2013, NUCLEIC ACIDS RES, V41, P3144, DOI 10.1093/nar/gkt029
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Tahbaz N, 2012, NUCLEIC ACIDS RES, V40, P3484, DOI 10.1093/nar/gkr1245
   Takao M, 1998, NUCLEIC ACIDS RES, V26, P2917, DOI 10.1093/nar/26.12.2917
   Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715
   TAPPER DP, 1981, J BIOL CHEM, V256, P5109
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   Thelander L, 2007, NAT GENET, V39, P703, DOI 10.1038/ng0607-703
   Tigchelaar W, 2015, AM J PHYSIOL-CELL PH, V308, pC155, DOI 10.1152/ajpcell.00227.2014
   TIRANTI V, 1993, GENE, V126, P219, DOI 10.1016/0378-1119(93)90370-I
   Tomkinson AE, 2013, GENE, V531, P150, DOI 10.1016/j.gene.2013.08.061
   Torregrosa-Muñumer R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45244-6
   TSURUMI T, 1990, J VIROL, V64, P450, DOI 10.1128/JVI.64.1.450-452.1990
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Uhler JP, 2015, DNA REPAIR, V34, P28, DOI 10.1016/j.dnarep.2015.07.003
   Vaisman A, 1999, BIOCHEMISTRY-US, V38, P11026, DOI 10.1021/bi9909187
   Van Houten B, 2016, FRONT BIOSCI-LANDMRK, V21, P42, DOI 10.2741/4375
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Vissing J, 2001, ANN NEUROL, V49, P672, DOI 10.1002/ana.1026
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Wang Y, 2002, P NATL ACAD SCI USA, V99, P12114, DOI 10.1073/pnas.192449499
   Wanrooij PH, 2012, NUCLEIC ACIDS RES, V40, P10334, DOI 10.1093/nar/gks802
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Weiss MD, 2010, MUSCLE NERVE, V41, P882, DOI 10.1002/mus.21636
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Wright WD, 2018, J BIOL CHEM, V293, P10524, DOI 10.1074/jbc.TM118.000372
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yamada Y, 2011, MOL THER, V19, P1449, DOI 10.1038/mt.2011.99
   Yao NNY, 2016, CRIT REV BIOCHEM MOL, V51, P135, DOI 10.3109/10409238.2015.1125845
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Yasuzaki Y, 2015, MOL PHARMACEUT, V12, P4311, DOI 10.1021/acs.molpharmaceut.5b00511
   Youn CK, 2017, SCI REP-UK, V7, DOI 10.1038/srep45290
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   Young MJ, 2015, HUM MOL GENET, V24, P5184, DOI 10.1093/hmg/ddv240
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P., 2016, MITOCHONDRIAL CASE S, P159, DOI [10.1016/B978-0-12-800877-5.00018-8, DOI 10.1016/B978-0-12-800877-5.00018-8]
   Zaiss AK, 2002, J VIROL, V76, P4580, DOI 10.1128/JVI.76.9.4580-4590.2002
   Zeviani M, 2008, BRAIN, V131, P2809, DOI 10.1093/brain/awn264
   Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998
   Zhang HL, 2014, NUCLEIC ACIDS RES, V42, P7259, DOI 10.1093/nar/gku384
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
   Zinovkina LA, 2019, BIOCHEMISTRY-MOSCOW+, V84, P884, DOI 10.1134/S0006297919080042
   Zinovkina LA, 2018, BIOCHEMISTRY-MOSCOW+, V83, P233, DOI 10.1134/S0006297918030045
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 340
TC 12
Z9 15
U1 3
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 1879-2650
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD JUN 1
PY 2022
VL 1863
IS 5
AR 148554
DI 10.1016/j.bbabio.2022.148554
EA MAR 2022
PG 21
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 1K8LQ
UT WOS:000798847800006
PM 35341749
OA Bronze
DA 2024-11-01
ER

PT J
AU McKenzie, M
   Liolitsa, D
   Akinshina, N
   Campanella, M
   Sisodiya, S
   Hargreaves, I
   Nirmalananthan, N
   Sweeney, MG
   Abou-Sleiman, PM
   Wood, NW
   Hanna, MG
   Duchen, MR
AF McKenzie, Matthew
   Liolitsa, Danae
   Akinshina, Natalya
   Campanella, Michelangelo
   Sisodiya, Sanjay
   Hargreaves, Ian
   Nirmalananthan, Niranjanan
   Sweeney, Mary G.
   Abou-Sleiman, Patrick M.
   Wood, Nicholas W.
   Hanna, Michael G.
   Duchen, Michael R.
TI Mitochondrial <i>ND5</i> gene variation associated with
   encephalomyopathy and mitochondrial ATP consumption
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID HEREDITARY OPTIC NEUROPATHY; STROKE-LIKE EPISODES; DNA MUTATION;
   LACTIC-ACIDOSIS; MELAS; DISEASE; ENCEPHALOPATHY; IDENTIFICATION;
   FIBROBLASTS; RESPIRATION
AB Mitochondrial encephalomyopathy and lactic acidosis with strokelike episodes ( MELAS) is a severe young onset stroke disorder without effective treatment. We have identified a MELAS patient harboring a 13528A -> G mitochondrial DNA ( mtDNA) mutation in the Complex I ND5 gene. This mutation was homoplasmic in mtDNA from patient muscle and nearly homoplasmic (99.9%) in blood. Fibroblasts from the patient exhibited decreased mitochondrial membrane potential (Delta psi(m)) and increased lactate production, consistent with impaired mitochondrial function. Transfer of patient mtDNA to a new nuclear background using transmitochondrial cybrid fusions confirmed the pathogenicity of the 13528A -> G mutation; Complex I-linked respiration and Delta psi(m) were both significantly reduced in patient mtDNA cybrids compared with controls. Inhibition of the adenine nucleotide translocase or the F1F0-ATPase with bongkrekic acid or oligomycin caused a loss of potential in patient mtDNA cybrid mitochondria, indicating a requirement for glycolytically generated ATP to maintain Delta psi(m). This was confirmed by inhibition of glycolysis with 2-deoxy-D-glucose, which caused depletion of ATP and mitochondrial depolarization in patient mtDNA cybrids. These data suggest that in response to impaired respiration due to the mtDNA mutation, mitochondria consume ATP to maintain Delta psi(m), representing a potential pathophysiological mechanism in human mitochondrial disease.
C1 [Akinshina, Natalya; Campanella, Michelangelo; Duchen, Michael R.] UCL, Dept Physiol, London WC1E 6BT, England.
   [McKenzie, Matthew] La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia.
   [Liolitsa, Danae; Nirmalananthan, Niranjanan; Hanna, Michael G.] UCL, Inst Neurol, MRC, Ctr Neuromuscular Dis, London WC1N 3BG, England.
   [Liolitsa, Danae; Hargreaves, Ian; Nirmalananthan, Niranjanan; Sweeney, Mary G.; Abou-Sleiman, Patrick M.; Wood, Nicholas W.; Hanna, Michael G.] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England.
   [Sisodiya, Sanjay] UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England.
C3 University of London; University College London; La Trobe University;
   University of London; University College London; University of London;
   University College London; University of London; University College
   London
RP Duchen, MR (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.
EM m.duchen@ucl.ac.uk
RI Hargreaves, Iain/AAJ-6757-2020; McKenzie, Matthew/H-4926-2019;
   Nirmalananthan, Niranjanan/AAF-1115-2019; Hanna, Michael/B-1995-2009;
   Campanella, Michelangelo/K-8172-2016; Duchen, Michael/A-2116-2009;
   Akinshina, Natalya/V-5794-2017; Wood, Nicholas/C-2505-2009
OI Campanella, Michelangelo/0000-0002-6948-4184; McKenzie,
   Matthew/0000-0001-7508-1800; Duchen, Michael/0000-0003-2548-4294; Hanna,
   Michael/0000-0003-0825-4075; Akinshina, Natalya/0000-0001-5968-6172;
   Wood, Nicholas/0000-0002-9500-3348
FU Medical Research Council [G84/6699] Funding Source: Medline; Wellcome
   Trust Funding Source: Medline; MRC [G84/6699] Funding Source: UKRI
CR Appleby RD, 1999, EUR J BIOCHEM, V262, P108, DOI 10.1046/j.1432-1327.1999.00350.x
   AVNER PR, 1973, EUR J BIOCHEM, V32, P312, DOI 10.1111/j.1432-1033.1973.tb02612.x
   Batandier C, 2000, Hum Mutat, V16, P532, DOI 10.1002/1098-1004(200012)16:6<532::AID-HUMU19>3.0.CO;2-P
   Bentlage HACM, 1996, HUM MOL GENET, V5, P197, DOI 10.1093/hmg/5.2.197
   Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Gajewski CD, 2003, MOL BIOL CELL, V14, P3628, DOI 10.1091/mbc.E02-12-0796
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Grover GJ, 2004, AM J PHYSIOL-HEART C, V287, pH1747, DOI 10.1152/ajpheart.01019.2003
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   Hofhaus G, 1996, J BIOL CHEM, V271, P13155, DOI 10.1074/jbc.271.22.13155
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270
   James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   KOGA Y, 1995, MUSCLE NERVE, pS119
   Leyssens A, 1996, J PHYSIOL-LONDON, V496, P111, DOI 10.1113/jphysiol.1996.sp021669
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MOUDY AM, 1995, P NATL ACAD SCI USA, V92, P729, DOI 10.1073/pnas.92.3.729
   Pulkes T, 1999, ANN NEUROL, V46, P916, DOI 10.1002/1531-8249(199912)46:6<916::AID-ANA16>3.0.CO;2-R
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   SCOTT ID, 1980, BIOCHEM J, V186, P21, DOI 10.1042/bj1860021
   Simbula G, 1997, AM J PHYSIOL-CELL PH, V273, pC479, DOI 10.1152/ajpcell.1997.273.2.C479
   St-Pierre J, 2000, P NATL ACAD SCI USA, V97, P8670, DOI 10.1073/pnas.140093597
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
NR 33
TC 60
Z9 62
U1 0
U2 7
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD DEC 21
PY 2007
VL 282
IS 51
BP 36845
EP 36852
DI 10.1074/jbc.M704158200
PG 8
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 241GX
UT WOS:000251646000009
PM 17940288
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Lorenzoni, PJ
   Werneck, LC
   Kay, CSK
   Silvado, CES
   Scola, RH
AF Lorenzoni, Paulo Jose
   Werneck, Lineu Cesar
   Kamoi Kay, Claudia Suemi
   Soares Silvado, Carlos Eduardo
   Scola, Rosana Herminia
TI When should MELAS (<i>Mitochondrial myopathy, Encephalopathy, Lactic
   Acidosis, and Stroke-like episodes</i>) be the diagnosis?
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Review
DE MELAS; mitochondria; myopathy; stroke; encephalopathy; genetics
ID TRANSFER RNALEU(UUR) GENE; MUSCLE-FIBER ANALYSIS; C-OXIDASE DEFICIENCY;
   RAGGED-RED FIBERS; POINT MUTATION; CLINICAL-FEATURES; BLOOD-VESSELS;
   VASCULAR INVOLVEMENT; MOLECULAR-GENETICS; DNA MUTATION
AB Mitochondrial myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes (MELAS) is a rare mitochondrial disorder. Diagnostic criteria for MELAS include typical manifestations of the disease: stroke-like episodes, encephalopathy, evidence of mitochondrial dysfunction ( laboratorial or histological) and known mitochondrial DNA gene mutations. Clinical features of MELAS are not necessarily uniform in the early stages of the disease, and correlations between clinical manifestations and physiopathology have not been fully elucidated. It is estimated that point mutations in the tRNA(Leu(UUR)) gene of the DNAmt, mainly A3243G, are responsible for more of 80% of MELAS cases. Morphological changes seen upon muscle biopsy in MELAS include a substantive proportion of ragged red fibers (RRF) and the presence of vessels with a strong reaction for succinate dehydrogenase. In this review, we discuss mainly diagnostic criterion, clinical and laboratory manifestations, brain images, histology and molecular findings as well as some differential diagnoses and current treatments.
C1 [Lorenzoni, Paulo Jose; Werneck, Lineu Cesar; Kamoi Kay, Claudia Suemi; Soares Silvado, Carlos Eduardo; Scola, Rosana Herminia] Univ Fed Parana, Hosp Clin, Dept Clin Med, Serv Neurol & Doencas Neuromusculares, BR-80060000 Curitiba, Parana, Brazil.
C3 Universidade Federal do Parana
RP Scola, RH (corresponding author), Hosp Clin UFPR, Serv Doencas Neuromusculares, Rua Gen Carneiro,181-3 Andar, BR-80060900 Curitiba, Parana, Brazil.
EM rosana.scola@hc.ufpr.br
RI Werneck, Lineu/Y-4038-2019; Silvado, Carlos/V-5207-2019
CR Abe K, 2004, NEURORADIOLOGY, V46, P113, DOI 10.1007/s00234-003-1138-2
   Bataillard M, 2001, NEUROLOGY, V56, P405, DOI 10.1212/WNL.56.3.405
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Conforto AB, 2007, ARQ NEURO-PSIQUIAT, V65, P371, DOI 10.1590/S0004-282X2007000300001
   DiMauro S., 2013, GeneReviews
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Finsterer J, 2009, EUR J NEUROL, V16, P1178, DOI 10.1111/j.1468-1331.2009.02789.x
   Finsterer Josef, 2012, Open Neurol J, V6, P26, DOI 10.2174/1874205X01206010026
   Finsterer J, 2012, EXPERT OPIN DRUG MET, V8, P71, DOI 10.1517/17425255.2012.644535
   Gilchrist JM, 1996, STROKE, V27, P1420, DOI 10.1161/01.STR.27.8.1420
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO Y, 1995, MUSCLE NERVE, pS107
   Haas R, 2004, MITOCHONDRION, V4, P471, DOI 10.1016/j.mito.2004.07.008
   HAMMANS SR, 1991, LANCET, V337, P1311, DOI 10.1016/0140-6736(91)92981-7
   Hao R, 2004, FEBS LETT, V578, P135, DOI 10.1016/j.febslet.2004.11.004
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Horvath R, 2008, NEUROTHERAPEUTICS, V5, P558, DOI 10.1016/j.nurt.2008.07.002
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Kamada K, 2001, J NEUROL NEUROSUR PS, V70, P675, DOI 10.1136/jnnp.70.5.675
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   KOBAYASHI M, 1986, J INHERIT METAB DIS, V9, P301, DOI 10.1007/BF01799670
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Koenigsberger MR, 1976, 5 ANN M CHILD NEUR S
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Koga Y, 2012, BBA-GEN SUBJECTS, V1820, P608, DOI 10.1016/j.bbagen.2011.09.005
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Lorenzoni PJ, 2009, ARQ NEURO-PSIQUIAT, V67, P668, DOI 10.1590/S0004-282X2009000400018
   MATSUOKA T, 1992, MUSCLE NERVE, V15, P209, DOI 10.1002/mus.880150213
   MIZUKAMI K, 1992, ACTA NEUROPATHOL, V83, P449, DOI 10.1007/BF00713541
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   Nishioka J, 2008, BRAIN DEV-JPN, V30, P100, DOI 10.1016/j.braindev.2007.06.008
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   Oppenheim C, 2000, J NEUROL NEUROSUR PS, V69, P248, DOI 10.1136/jnnp.69.2.248
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   Richardson J, 2015, STEM CELLS, V33, P639, DOI 10.1002/stem.1887
   Rossmanith W, 2008, J MED GENET, V45, P117, DOI 10.1136/jmg.2007.052076
   SAKUTA R, 1989, ANN NEUROL, V25, P594, DOI 10.1002/ana.410250611
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   SHAPIRA Y, 1975, NEUROLOGY, V25, P614, DOI 10.1212/WNL.25.7.614
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   Tanahashi C, 2000, ACTA NEUROPATHOL, V99, P31, DOI 10.1007/PL00007403
   Tanji K, 2008, J NEUROL SCI, V270, P23, DOI 10.1016/j.jns.2008.01.016
   TOKUNAGA M, 1993, ANN NEUROL, V33, P275, DOI 10.1002/ana.410330308
   TOKUNAGA M, 1994, ANN NEUROL, V35, P413, DOI 10.1002/ana.410350407
   Tschampa HJ, 2013, J NEUROL, V260, P1071, DOI 10.1007/s00415-012-6763-4
   Vanderver Adeline, 2005, Curr Neurol Neurosci Rep, V5, P110
   Werneck L C, 1987, Arq Neuropsiquiatr, V45, P288
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zhao D, 2011, J HUM GENET, V56, P759, DOI 10.1038/jhg.2011.96
NR 60
TC 45
Z9 57
U1 0
U2 15
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD NOV
PY 2015
VL 73
IS 11
BP 959
EP 967
DI 10.1590/0004-282X20150154
PG 9
WC Neurosciences; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Psychiatry
GA CV5SR
UT WOS:000364331900014
PM 26517220
OA Green Submitted, Green Published, gold
DA 2024-11-01
ER

PT J
AU Yamasoba, T
   Goto, YI
   Komaki, H
   Mimaki, M
   Sudo, A
   Suzuki, M
AF Yamasoba, T
   Goto, YI
   Komaki, H
   Mimaki, M
   Sudo, A
   Suzuki, M
TI Cochlear damage due to germanium-induced mitochondrial dysfunction in
   guinea pigs
SO NEUROSCIENCE LETTERS
LA English
DT Article
DE hearing loss; mitochondrial myopathy; mitochondrial DNA; cochlea;
   muscle; kidney
ID HEARING-LOSS; MYOPATHY; DEAFNESS; DNA; MUTATION; DIOXIDE; DISEASE;
   MELAS; MODEL; GENE
AB This investigation addressed the effect of germanium dioxide (GeO2)-induced mitochondrial dysfunction on hearing acuity. Guinea pigs were fed chow that contained 0%, 0.15%, or 0.5% GeO2. The animals that were fed 0.5% GeO2 for 2 months developed hearing impairment chiefly due to degeneration of stria vascularis and cochlear supporting cells, which exhibited electron-dense mitochondrial inclusions. Cytochrome c oxidase activity was decreased in the skeletal muscles and kidney, which also exhibited electron-dense mitochondrial inclusions. No apparent pathological changes were observed in the utricle, semicircular canal, or among the vestibular nerve fibers, or in the liver or heart The untreated animals and those treated with 0.15% GeO2 did not exhibit hearing impairment or pathological changes in any organs. These findings suggest that administration of 0.5% GeO2 induces mitochondrial dysfunction in the stria vascularis and supporting cells in the cochlea, as in the skeletal muscles and kidney, thereby causing hearing impairment in the guinea pigs. (C) 2005 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Tokyo, Dept Otolaryngol Head & Neck Surg, Bunkyo Ku, Tokyo 1138655, Japan.
   Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo, Japan.
C3 University of Tokyo; National Center for Neurology & Psychiatry - Japan
RP Yamasoba, T (corresponding author), Univ Tokyo, Dept Otolaryngol Head & Neck Surg, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.
EM tyamasoba-tky@umin.ac.jp
OI Yamasoba, Tatsuya/0000-0003-3608-0973
CR Chinnery PF, 2000, BRAIN, V123, P82, DOI 10.1093/brain/123.1.82
   Fischel-Ghodsian N, 2003, EAR HEARING, V24, P303, DOI 10.1097/01.AUD.0000079802.82344.B5
   HIGUCHI I, 1989, ACTA NEUROPATHOL, V79, P300, DOI 10.1007/BF00294665
   HIGUCHI I, 1991, ACTA NEUROPATHOL, V82, P55, DOI 10.1007/BF00310923
   Hoya N, 2004, NEUROREPORT, V15, P1597, DOI 10.1097/01.wnr.0000133226.94662.80
   Li Xiaodong, 2001, Chinese Medical Sciences Journal, V16, P157
   LINDSAY JR, 1976, ARCH OTOLARYNGOL, V102, P747
   Nakada K, 2004, BIOCHEM BIOPH RES CO, V323, P175, DOI 10.1016/j.bbrc.2004.08.073
   SANAI T, 1990, TOXICOL APPL PHARM, V103, P345, DOI 10.1016/0041-008X(90)90234-L
   SANAI T, 1990, NEPHRON, V54, P53, DOI 10.1159/000185810
   Sue CM, 1998, ANN NEUROL, V43, P350, DOI 10.1002/ana.410430313
   Sugawara M, 2005, JARO-J ASSOC RES OTO, V6, P136, DOI 10.1007/s10162-004-5050-1
   Takahashi K, 2003, LARYNGOSCOPE, V113, P1362, DOI 10.1097/00005537-200308000-00018
   Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   WU CM, 1992, MUSCLE NERVE, V15, P1258, DOI 10.1002/mus.880151107
   Yamasoba T, 1996, LARYNGOSCOPE, V106, P49, DOI 10.1097/00005537-199601000-00010
   Yamasoba T, 1999, BRAIN RES, V815, P317, DOI 10.1016/S0006-8993(98)01100-7
   Yamasoba T, 1999, NEUROLOGY, V52, P1705, DOI 10.1212/WNL.52.8.1705
   Yamasoba T, 1996, HEARING RES, V102, P116, DOI 10.1016/S0378-5955(96)00159-1
NR 20
TC 18
Z9 19
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0304-3940
J9 NEUROSCI LETT
JI Neurosci. Lett.
PD FEB 27
PY 2006
VL 395
IS 1
BP 18
EP 22
DI 10.1016/j.neulet.2005.10.045
PG 5
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 013KK
UT WOS:000235408000004
PM 16289317
DA 2024-11-01
ER

PT J
AU Tyynismaa, H
   Sembongi, H
   Bokori-Brown, M
   Granycome, C
   Ashley, N
   Poulton, J
   Jalanko, A
   Spelbrink, JN
   Holt, IJ
   Suomalainen, A
AF Tyynismaa, H
   Sembongi, H
   Bokori-Brown, M
   Granycome, C
   Ashley, N
   Poulton, J
   Jalanko, A
   Spelbrink, JN
   Holt, IJ
   Suomalainen, A
TI Twinkle helicase is essential for mtDNA maintenance and regulates mtDNA
   copy number
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID MITOCHONDRIAL TRANSCRIPTION FACTOR; PROGRESSIVE EXTERNAL
   OPHTHALMOPLEGIA; DNA-POLYMERASE; FACTOR-A; QUANTITATIVE-ANALYSIS;
   MULTIPLE DELETIONS; MUTATIONS; GENE; SUBUNIT; PROTEIN
AB Mechanisms of mitochondrial DNA (mtDNA) maintenance have recently gained wide interest owing to their role in inherited diseases as well as in aging. Twinkle is a new mitochondrial 5'-3' DNA helicase, defects of which we have previously shown to underlie a mitochondrial disease, progressive external ophthalmoplegia with multiple mtDNA deletions. Mouse Twinkle is highly similar to the human counterpart, suggesting conserved function. Here, we have characterized the mouse Twinkle gene and expression profile and report that the expression patterns are not conserved between human and mouse, but are synchronized with the adjacent gene MrpL43, suggesting a shared promoter. To elucidate the in vivo role of Twinkle in mtDNA maintenance, we generated two transgenic mouse lines overexpressing wild-type Twinkle. We could demonstrate for the first time that increased expression of Twinkle in muscle and heart increases mtDNA copy number up to 3-fold higher than controls, more than any other factor reported to date. Additionally, we utilized cultured human cells and observed that reduced expression of Twinkle by RNA interference mediated a rapid drop in mtDNA copy number, further supporting the in vivo results. These data demonstrate that Twinkle helicase is essential for mtDNA maintenance, and that it may be a key regulator of mtDNA copy number in mammals.
C1 Univ Helsinki, Dept Neurol, Biomedicum Helsinki, FIN-00290 Helsinki, Finland.
   Univ Helsinki, Programme Neurosci, FIN-00290 Helsinki, Finland.
   Dunn Human Nutr Unit, Cambridge CB2 2XY, England.
   John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.
   Natl Publ Hlth Inst, Dept Mol Med, Helsinki 00290, Finland.
   Inst Med Technol, Tampere 33014, Finland.
   Tampere Univ Hosp, Tampere 33014, Finland.
   Univ Helsinki, Cent Hosp, Dept Clin Chem, FIN-00290 Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; UK Research & Innovation
   (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research;
   University of Oxford; Finland National Institute for Health & Welfare;
   Tampere University; Tampere University Hospital; University of Helsinki;
   Helsinki University Central Hospital
RP Univ Helsinki, Dept Neurol, Biomedicum Helsinki, R C522B,Haartmaninkatu 8, FIN-00290 Helsinki, Finland.
EM anu.wartiovaara@helsinki.fi
RI Poulton, Joanna/AAB-4828-2021; Tyynismaa, Henna/F-1428-2011;
   Bokori-Brown, Monika/Y-2302-2019; Spelbrink, Johannes/L-4661-2015; holt,
   ian/AFT-2565-2022
OI Spelbrink, Johannes/0000-0002-9756-2602; Poulton,
   Joanna/0000-0002-2460-5587; Suomalainen-Wartiovaara,
   Anu/0000-0003-4833-5195; Tyynismaa, Henna/0000-0002-2493-2422; Ashley,
   Neil/0000-0002-1655-5137; holt, ian/0000-0001-5468-0193
FU MRC [MC_U105663140] Funding Source: UKRI; Medical Research Council
   [MC_U105663140] Funding Source: Medline
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   Gensler S, 2001, NUCLEIC ACIDS RES, V29, P3657, DOI 10.1093/nar/29.17.3657
   GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831
   Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9
   Kanki T, 2004, ANN NY ACAD SCI, V1011, P61, DOI 10.1196/annals.1293.007
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lefai E, 2000, MOL GEN GENET, V264, P37, DOI 10.1007/s004380000301
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Lewis S, 2002, J NEUROL SCI, V201, P39, DOI 10.1016/S0022-510X(02)00190-9
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Matsushima Y, 2004, J BIOL CHEM, V279, P26900, DOI 10.1074/jbc.M401643200
   Matsushima Y, 2003, J BIOL CHEM, V278, P31149, DOI 10.1074/jbc.M303842200
   Meyer RG, 2003, GENE, V314, P181, DOI 10.1016/S0378-1119(03)00738-8
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Suomalainen A, 1998, METH MOL B, V86, P121
   Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379
   Suomalainen A, 2000, MOL BIOTECHNOL, V15, P123, DOI 10.1385/MB:15:2:123
   Suzuki T, 2001, J BIOL CHEM, V276, P21724, DOI 10.1074/jbc.M100432200
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Zhang LF, 2003, GENOMICS, V82, P660, DOI 10.1016/S0888-7543(03)00211-8
NR 34
TC 190
Z9 230
U1 1
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD DEC 15
PY 2004
VL 13
IS 24
BP 3219
EP 3227
DI 10.1093/hmg/ddh342
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 883ZT
UT WOS:000226055100017
PM 15509589
OA Bronze
DA 2024-11-01
ER

PT J
AU Nascimento, A
   Ortez, C
   Jou, C
   O'Callaghan, M
   Ramos, F
   Garcia-Cazorla, A
AF Nascimento, Andres
   Ortez, Carlos
   Jou, Cristina
   O'Callaghan, Mar
   Ramos, Federico
   Garcia-Cazorla, Angels
TI Neuromuscular Manifestations in Mitochondria! Diseases in Children
SO SEMINARS IN PEDIATRIC NEUROLOGY
LA English
DT Review
ID MARIE-TOOTH-DISEASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MULTIPLE
   MTDNA DELETIONS; DNA-POLYMERASE-GAMMA; NEUROGASTROINTESTINAL
   ENCEPHALOMYOPATHY MNGIE; CEREBRAL FOLATE-DEFICIENCY; TRANSFER
   RNALEU(UUR) GENE; MITOFUSIN 2 MUTATIONS; COMPLEX I DEFICIENCY; C-OXIDASE
   DEFICIENCY
AB Mitochondrial diseases exhibit significant clinical and genetic heterogeneity. Mitochondria are highly dynamic organelles that are the major contributor of adenosine triphosphate, through oxidative phosphorylation. These disorders may be developed at any age, with isolated or multiple system involvement, and in any pattern of inheritance. Defects in the mitochondria! respiratory chain impair energy production and almost invariably involve skeletal muscle and peripheral nerves, causing exercise intolerance, cramps, recurrent myoglobinuria, or fixed weakness, which often affects extraocular muscles and results in droopy eyelids (ptosis), progressive external ophthalmoplegia, peripheral ataxia, and peripheral polyneuropathy. This review describes the main neuromuscular symptomatology through different syndromes reported in the literature and from our experience. We want to highlight the importance of searching for the "clue clinical signs" associated with inheritance pattern as key elements to guide the complex diagnosis process and genetic studies in mitochondrial diseases. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Nascimento, Andres; Ortez, Carlos; Jou, Cristina] Inst Salud Carlos III, Hosp Sant Joan de Deu, Dept Neurol, Neuromuscular Units, Barcelona, Spain.
   [Nascimento, Andres; Jou, Cristina; O'Callaghan, Mar; Ramos, Federico; Garcia-Cazorla, Angels] Inst Pediat Res Sant Joan de Deu, Ctr Biomed Res Rare Dis CIBERER, Madrid, Spain.
   [O'Callaghan, Mar; Ramos, Federico; Garcia-Cazorla, Angels] Inst Salud Carlos III, Hosp Sant Joan de Deu, Dept Neurol, Neurometab Units, Barcelona, Spain.
C3 Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica
   en Red; CIBERER; Instituto de Salud Carlos III
RP Nascimento, A (corresponding author), Univ Barcelona, Dept Neurol, Hosp Sant Joan de Deu, Passeig Sant Joan de Deu 2, Barcelona 08950, Spain.
EM anascimento@hsjdbcn.org
OI Ortez Gonzalez, Carlos Ignacio/0000-0001-8187-8103
CR Ackerley S, 2006, HUM MOL GENET, V15, P347, DOI 10.1093/hmg/ddi452
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Antonelli FM, 1993, ANN NEUROL, V34, P827
   APPENZELLER O, 1976, ARCH NEUROL-CHICAGO, V33, P733, DOI 10.1001/archneur.1976.00500110001001
   Auré K, 2004, NEUROLOGY, V63, P727, DOI 10.1212/01.WNL.0000134607.76780.B2
   Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Barca E, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0590-9
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Buchaklian AH, 2012, MOL GENET METAB, V107, P92, DOI 10.1016/j.ymgme.2012.04.019
   Cámara Y, 2015, NEUROLOGY, V84, P2286, DOI 10.1212/WNL.0000000000001644
   Cámara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Cartoni R, 2010, BRAIN, V133, P1460, DOI 10.1093/brain/awq082
   Casas KA, 2004, AM J MED GENET A, V125A, P201, DOI 10.1002/ajmg.a.20368
   Cassereau J, 2014, REV NEUROL-FRANCE, V170, P366, DOI 10.1016/j.neurol.2013.11.005
   Cassereau J, 2011, EXP NEUROL, V227, P31, DOI 10.1016/j.expneurol.2010.09.006
   Cassereau J, 2009, NEUROGENETICS, V10, P145, DOI 10.1007/s10048-008-0166-9
   Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002
   Chalmers RM, 1996, J NEUROL SCI, V143, P41, DOI 10.1016/S0022-510X(96)00032-9
   Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638
   Chaussenot A, 2014, REV NEUROL-FRANCE, V170, P323, DOI 10.1016/j.neurol.2014.03.007
   Chen XJ, 2007, J NEUROSCI, V27, P14515, DOI 10.1523/JNEUROSCI.4338-07.2007
   Chung KW, 2006, BRAIN, V129, P2103, DOI 10.1093/brain/awl174
   Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101
   Courchesne Stephanie L, 2011, PLoS One, V6, pe16753, DOI 10.1371/journal.pone.0016753
   Craig K, 2012, MITOCHONDRION, V12, P313, DOI 10.1016/j.mito.2011.11.006
   d'Ydewalle C, 2011, NAT MED, V17, P968, DOI 10.1038/nm.2396
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004
   Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   DiMauro S, 2006, CURR OPIN RHEUMATOL, V18, P636, DOI 10.1097/01.bor.0000245729.17759.f2
   Echaniz-Laguna A, 2013, NEUROLOGY, V81, P1523, DOI 10.1212/WNL.0b013e3182a4a518
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Estela A, 2011, J BIOL CHEM, V286, P36777, DOI 10.1074/jbc.M111.260042
   Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Gelfand JM, 2011, J NEUROL, V258, P440, DOI 10.1007/s00415-010-5775-1
   Gerards M, 2011, BRAIN, V134, P210, DOI 10.1093/brain/awq273
   Giordano C, 2009, NEUROLOGY, V72, P1103, DOI 10.1212/01.wnl.0000345002.47396.e1
   Gómez-Zaera M, 2001, MOL GENET METAB, V72, P72, DOI 10.1006/mgme.2000.3107
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Kalko SG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-91
   Guillet V, 2011, FASEB J, V25, P1618, DOI 10.1096/fj.10-173609
   Hays AP., 2006, Mitochondrial Medicine, P45
   Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Hirano M., 2006, Mitochondrial Medicine, P27
   Hirokawa N, 2004, CURR OPIN NEUROBIOL, V14, P564, DOI 10.1016/j.conb.2004.08.011
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Holve S, 1999, J PEDIATR-US, V135, P482, DOI 10.1016/S0022-3476(99)70172-1
   Horváth R, 2005, NEUROMUSCULAR DISORD, V15, P851, DOI 10.1016/j.nmd.2005.09.005
   Horváth R, 2002, J MED GENET, V39, P812, DOI 10.1136/jmg.39.11.812
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Horvath R, 2009, J NEUROL, V256, P810, DOI 10.1007/s00415-009-5023-8
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078
   Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328
   Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kärppä M, 2005, BRAIN, V128, P1861, DOI 10.1093/brain/awh515
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kawamata H, 2011, HUM MOL GENET, V20, P2964, DOI 10.1093/hmg/ddr200
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kennerson ML, 2013, HUM MOL GENET, V22, P1404, DOI 10.1093/hmg/dds557
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Kollberg G, 2005, J NEUROPATH EXP NEUR, V64, P123, DOI 10.1093/jnen/64.2.123
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Lalani SR, 2005, ARCH NEUROL-CHICAGO, V62, P317, DOI 10.1001/archneur.62.2.317
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Logan CV, 2014, NAT GENET, V46, P188, DOI 10.1038/ng.2851
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   Martí R, 2010, PEDIATR RES, V68, P151, DOI 10.1203/00006450-201011001-00294
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   McPherson E, 2006, AM J MED GENET A, V140A, P184, DOI 10.1002/ajmg.a.31041
   Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010
   Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012
   Montero R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148709
   Nicholson GA, 2008, NEUROLOGY, V70, P1678, DOI 10.1212/01.wnl.0000311275.89032.22
   Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087
   Niemann A, 2009, NEUROBIOL DIS, V36, P509, DOI 10.1016/j.nbd.2009.09.011
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Noack R, 2012, HUM MOL GENET, V21, P150, DOI 10.1093/hmg/ddr450
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pineda M, 2006, ANN NEUROL, V59, P394, DOI 10.1002/ana.20746
   Pitceathly RDS, 2014, CURR OPIN NEUROL, V27, P576, DOI 10.1097/WCO.0000000000000126
   Pitceathly RDS, 2013, J NEUROL NEUROSUR PS, V84, P107, DOI 10.1136/jnnp-2012-303232
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Pitceathly RDS, 2011, J MED GENET, V48, P610, DOI 10.1136/jmg.2010.088328
   Polke JM, 2011, NEUROLOGY, V77, P168, DOI 10.1212/WNL.0b013e3182242d4d
   Pulkes T, 2005, NEUROMUSCULAR DISORD, V15, P364, DOI 10.1016/j.nmd.2005.01.006
   Pulkes T, 2005, NEUROLOGY, V64, P1091, DOI 10.1212/01.WNL.0000154471.33156.55
   Quijada-Fraile P, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0217-2
   Quinzii CM, 2008, BIOFACTORS, V32, P113, DOI 10.1002/biof.5520320113
   Riley LG, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-193
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rinaldi C, 2012, AM J HUM GENET, V91, P1095, DOI 10.1016/j.ajhg.2012.10.008
   Rojo M, 2002, J CELL SCI, V115, P1663
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Rouzier C, 2014, EUR J HUM GENET, V22, P542, DOI 10.1038/ejhg.2013.171
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   RUSANEN H, 1995, NEUROLOGY, V45, P1188, DOI 10.1212/WNL.45.6.1188
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Spiegel R, 2014, EUR J HUM GENET, V22, P902, DOI 10.1038/ejhg.2013.269
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Vallat JM, 2008, J NEUROPATH EXP NEUR, V67, P1097, DOI 10.1097/NEN.0b013e31818b6cbc
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126
   Vilá MR, 2008, J NEUROL SCI, V267, P137, DOI 10.1016/j.jns.2007.10.019
   Vilà MR, 2003, NEUROLOGY, V60, P1203, DOI 10.1212/01.WNL.0000055928.58122.47
   Vucic S, 2003, NEUROLOGY, V60, P696, DOI 10.1212/01.WNL.0000048561.61921.71
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Weedon MN, 2011, AM J HUM GENET, V89, P308, DOI 10.1016/j.ajhg.2011.07.002
   WILLIAMS LL, 1979, NEUROLOGY, V29, P1492, DOI 10.1212/WNL.29.11.1492
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 154
TC 6
Z9 6
U1 0
U2 3
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 1071-9091
EI 1558-0776
J9 SEMIN PEDIATR NEUROL
JI Semin. Pediatr. Neurol.
PD NOV
PY 2016
VL 23
IS 4
BP 290
EP 305
DI 10.1016/j.spen.2016.11.004
PG 16
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA EP7IL
UT WOS:000397551400005
PM 28284391
DA 2024-11-01
ER

PT J
AU Nicholls, TJ
   Nadalutti, CA
   Motori, E
   Sommerville, EW
   Gorman, GS
   Basu, S
   Hoberg, E
   Turnbull, DM
   Chinnery, PF
   Larsson, NG
   Larsson, E
   Falkenberg, M
   Taylor, RW
   Griffith, JD
   Gustafsson, CM
AF Nicholls, Thomas J.
   Nadalutti, Cristina A.
   Motori, Elisa
   Sommerville, Ewen W.
   Gorman, Grainne S.
   Basu, Swaraj
   Hoberg, Emily
   Turnbull, Doug M.
   Chinnery, Patrick F.
   Larsson, Nils-Goran
   Larsson, Erik
   Falkenberg, Maria
   Taylor, Robert W.
   Griffith, Jack D.
   Gustafsson, Claes M.
TI Topoisomerase 3α Is Required for Decatenation and Segregation of Human
   mtDNA
SO MOLECULAR CELL
LA English
DT Article
ID MITOCHONDRIAL-DNA INSTABILITY; III-ALPHA; OPTIC ATROPHY; EXTERNAL
   OPHTHALMOPLEGIA; SINGLE-COPY; REPLICATION; MAINTENANCE; MUTATIONS;
   MECHANISM; GENOME
AB How mtDNA replication is terminated and the newly formed genomes are separated remain unknown. We here demonstrate that the mitochondrial isoform of topoisomerase 3 alpha (Top3 alpha) fulfills this function, acting independently of its nuclear role as a component of the Holliday junction-resolving BLMTop-3 alpha-RMI1-RMI2 (BTR) complex. Our data indicate that mtDNA replication termination occurs via a hemicatenane formed at the origin of H-strand replication and that Top3 alpha is essential for resolving this structure. Decatenation is a prerequisite for separation of the segregating unit of mtDNA, the nucleoid, within the mitochondrial network. The importance of this process is highlighted in a patient with mitochondrial disease caused by biallelic pathogenic variants in TOP3A, characterized by muscle-restricted mtDNA deletions and chronic progressive external ophthalmoplegia (CPEO) plus syndrome. Our work establishes Top3 alpha as an essential component of the mtDNA replication machinery and as the first component of the mtDNA separation machinery.
C1 [Nicholls, Thomas J.; Basu, Swaraj; Hoberg, Emily; Larsson, Erik; Falkenberg, Maria; Gustafsson, Claes M.] Univ Gothenburg, Dept Med Biochem & Cell Biol, POB 440, S-40530 Gothenburg, Sweden.
   [Nadalutti, Cristina A.; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Chapel Hill, NC 27514 USA.
   [Motori, Elisa; Larsson, Nils-Goran] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany.
   [Sommerville, Ewen W.; Gorman, Grainne S.; Turnbull, Doug M.; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Chinnery, Patrick F.] Univ Cambridge, Dept Clin Neurosci, Cambridge Biomed Campus, Cambridge CB2 0QQ, England.
   [Larsson, Nils-Goran] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.
C3 University of Gothenburg; University of North Carolina; University of
   North Carolina Chapel Hill; Max Planck Society; Newcastle University -
   UK; University of Cambridge; Karolinska Institutet
RP Gustafsson, CM (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, POB 440, S-40530 Gothenburg, Sweden.
EM claes.gustafsson@medkem.gu.se
RI Motori, Elisa/AAM-2028-2021; Basu, Swaraj/AAN-8338-2020; Nadalutti,
   Cristina/ABA-5652-2021; Larsson Lekholm, Erik/AHE-0932-2022; Larsson,
   Nils-Göran/GVS-5578-2022
OI Nadalutti, Cristina Antonella/0000-0002-4721-6904; Chinnery,
   Patrick/0000-0002-7065-6617; Turnbull, Doug/0000-0002-8878-9901; Basu,
   Swaraj/0000-0001-6107-2487; Gorman, Grainne/0000-0002-7585-3409;
   Nicholls, Thomas/0000-0002-3034-4109; Gustafsson,
   Claes/0000-0003-3531-8468; Falkenberg, Maria/0000-0001-8713-173X;
   Larsson, Nils-Goran/0000-0001-5100-996X; Motori,
   Elisa/0000-0001-5997-6866
FU Swedish Research Council; Swedish Cancer Foundation; European Research
   Council [683191]; IngaBritt and Arne Lundberg Foundation; Knut and Alice
   Wallenbergs Foundation; NIH [GM31819, ESO13773]; Wellcome Centre for
   Mitochondrial Research [203105/Z/16/Z]; Medical Research Council (MRC)
   Centre for Translational Research in Neuromuscular Disease;
   Mitochondrial Disease Patient Cohort (UK) [G0800674]; UK NIHR Biomedical
   Research Centre for Ageing and Age-related disease award; MRC/EPSRC
   Molecular Pathology Node; UK NHS Highly Specialised Service for Rare
   Mitochondrial Disorders of Adults and Children; Medical Research Council
   PhD studentship; Wellcome Trust [101876/Z/13/Z]; Medical Research
   Council Mitochondrial Biology Unit [MC_UP_1501/2]; Medical Research
   Council (UK) Centre for Translational Muscle Disease research
   [G0601943]; EU FP7 TIRCON; National Institute for Health Research (NIHR)
   Biomedical Research Centre based at Cambridge University Hospitals NHS
   Foundation Trust; University of Cambridge; European Research Council
   (ERC) [683191] Funding Source: European Research Council (ERC); MRC
   [MR/K000608/1, G0800674, G0601943, MR/L016354/1] Funding Source: UKRI
FX This work was supported by the Swedish Research Council (M.F., C.M.G.,
   E.L., and N.-G.L.), the Swedish Cancer Foundation (M.F., C.M.G., and
   E.L.), the European Research Council (Project ID: 683191 to M.F.); the
   IngaBritt and Arne Lundberg Foundation (M.F.), the Knut and Alice
   Wallenbergs Foundation (M.F., C.M.G., E.L., and N.-G.L.), the NIH
   (GM31819 and ESO13773 to J.D.G.), the Wellcome Centre for Mitochondrial
   Research (203105/Z/16/Z), the Medical Research Council (MRC) Centre for
   Translational Research in Neuromuscular Disease, the Mitochondrial
   Disease Patient Cohort (UK) (G0800674), the UK NIHR Biomedical Research
   Centre for Ageing and Age-related disease award to the Newcastle upon
   Tyne Foundation Hospitals NHS Trust, the MRC/EPSRC Molecular Pathology
   Node, and the UK NHS Highly Specialised Service for Rare Mitochondrial
   Disorders of Adults and Children (G.S.G., D.M.T., and R.W.T.). E.W.S.
   was funded by a Medical Research Council PhD studentship. P.F.C. is a
   Wellcome Trust Senior Fellow in Clinical Science (101876/Z/13/Z) and a
   UK NIHR Senior Investigator, who receives support from the Medical
   Research Council Mitochondrial Biology Unit (MC_UP_1501/2), the Medical
   Research Council (UK) Centre for Translational Muscle Disease research
   (G0601943), EU FP7 TIRCON, and the National Institute for Health
   Research (NIHR) Biomedical Research Centre based at Cambridge University
   Hospitals NHS Foundation Trust and the University of Cambridge. We would
   like to acknowledge Dr. Christian Junsgt and the CECAD imaging facility,
   and we thank Emma Watson, Gerald Pfeffer, and Alexia Chrysostomou for
   their help in the laboratory work-up of the patient. We would also like
   to thank Zofia Chrzanowska-Lightowlers and Robert N. Lightowlers for
   valuable discussion and reagents.
CR Akman G, 2016, P NATL ACAD SCI USA, V113, pE4276, DOI 10.1073/pnas.1600537113
   ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   Cejka P, 2012, MOL CELL, V47, P886, DOI 10.1016/j.molcel.2012.06.032
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Douarre C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041094
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Goulaouic H, 1999, NUCLEIC ACIDS RES, V27, P2443, DOI 10.1093/nar/27.12.2443
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Hanai R, 1996, P NATL ACAD SCI USA, V93, P3653, DOI 10.1073/pnas.93.8.3653
   Harmon FG, 1999, MOL CELL, V3, P611, DOI 10.1016/S1097-2765(00)80354-8
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   HUDSON B, 1967, NATURE, V216, P647, DOI 10.1038/216647a0
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Ishihara T, 2015, MOL CELL BIOL, V35, P211, DOI 10.1128/MCB.01054-14
   Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110
   Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lewis SC, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5549
   Low RL, 2003, EUR J BIOCHEM, V270, P4173, DOI 10.1046/j.1432-1033.2003.03814.x
   Pallotti F, 2007, METHOD CELL BIOL, V80, P3, DOI 10.1016/S0091-679X(06)80001-4
   PANYUTIN IG, 1994, P NATL ACAD SCI USA, V91, P2021, DOI 10.1073/pnas.91.6.2021
   Plank JL, 2005, J BIOL CHEM, V280, P3564, DOI 10.1074/jbc.M411337200
   Pommier Y, 2016, NAT REV MOL CELL BIO, V17, P703, DOI 10.1038/nrm.2016.111
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Reyes A, 2009, METHODS MOL BIOL, V554, P15, DOI 10.1007/978-1-59745-521-3_2
   Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Sarbajna S, 2014, TRENDS BIOCHEM SCI, V39, P409, DOI 10.1016/j.tibs.2014.07.003
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Shi YH, 2012, P NATL ACAD SCI USA, V109, P16510, DOI 10.1073/pnas.1119738109
   Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534
   Suski C, 2008, MOL CELL, V30, P779, DOI 10.1016/j.molcel.2008.04.020
   THRESHER R, 1992, METHOD ENZYMOL, V211, P481
   Tsai HZ, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0255-2
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wang Y, 2002, P NATL ACAD SCI USA, V99, P12114, DOI 10.1073/pnas.192449499
   Wu JH, 2010, P NATL ACAD SCI USA, V107, P6228, DOI 10.1073/pnas.1001855107
   Yang J, 2010, J BIOL CHEM, V285, P21426, DOI 10.1074/jbc.M110.123216
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998
   Zhang HL, 2014, NUCLEIC ACIDS RES, V42, P7259, DOI 10.1093/nar/gku384
   Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5
NR 48
TC 87
Z9 93
U1 0
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1097-2765
EI 1097-4164
J9 MOL CELL
JI Mol. Cell
PD JAN 4
PY 2018
VL 69
IS 1
BP 9
EP +
DI 10.1016/j.molcel.2017.11.033
PG 21
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA FR7NA
UT WOS:000419255100004
PM 29290614
OA Green Accepted, Green Submitted, hybrid
DA 2024-11-01
ER

PT J
AU Yuan, JH
   Sakiyama, Y
   Higuchi, I
   Inamori, Y
   Higuchi, Y
   Hashiguchi, A
   Higashi, K
   Yoshimura, A
   Takashima, H
AF Yuan, Jun-Hui
   Sakiyama, Yusuke
   Higuchi, Itsuro
   Inamori, Yukie
   Higuchi, Yujiro
   Hashiguchi, Akihiro
   Higashi, Keiko
   Yoshimura, Akiko
   Takashima, Hiroshi
TI Mitochondrial myopathy with autophagic vacuoles in patients with the
   m.8344A&gt;G mutation
SO JOURNAL OF CLINICAL PATHOLOGY
LA English
DT Article
ID RAGGED-RED FIBERS; CLINICAL-FEATURES; MYOCLONIC EPILEPSY; DNA MUTATION;
   A8344G MERRF; HETEROPLASMY; EXPRESSION; TRNA(LYS); DISEASE;
   ABNORMALITIES
AB Background and aims In mitochondrial myopathy, autophagy is presumed to play an important role in mitochondrial dysfunction. Rimmed vacuoles (RVs), a sign of autophagy, can be seen as a secondary phenomenon in muscle ragged-red fibres (RRFs), whereas the uncommon presentation is that some fibres contain RVs, but without any mitochondrial abnormalities. To investigate the pathogenesis beneath this pathological phenomenon.
   Methods We reviewed 783 skeletal muscle specimens and selected five obtained from patients with suspected mitochondrial myopathy, characterised by clearly visible autophagic vacuoles in non-RRFs, besides the coexistence of RRFs and cytochrome oxidase-negative fibres. Immunohistochemical staining with LC-3, and electron microscopy studies were performed. Using resequencing microarray and a next-generation sequencing system, the mitochondrial DNA was screened for mutations and the heteroplasmic level was measured in skeletal muscle and blood.
   Results Muscle fibres with RVs and RRFs, as well as some morphologically normal fibres, stained strongly for LC-3. Electron microscopy disclosed significant abnormal mitochondrial proliferation and existence of autophagic vacuoles. After mutation screening, m.8344A>G in the tRNA(Lys) gene was detected in two patients. The heteroplasmy of mutated G was 45.1% in skeletal muscle and 17.8% in blood in patient 1; patient 2 exhibited 80.3% mutated G in skeletal muscle and 25.2% in blood.
   Conclusions These findings demonstrate a new pathological phenotype for the m.8344A>G mutation- related disease and also provide pathological evidence of a correlation between mitochondrial abnormalities and autophagy.
C1 [Yuan, Jun-Hui; Sakiyama, Yusuke; Higuchi, Itsuro; Inamori, Yukie; Higuchi, Yujiro; Hashiguchi, Akihiro; Higashi, Keiko; Yoshimura, Akiko; Takashima, Hiroshi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Neurol & Geriatr, Kagoshima 8908520, Japan.
C3 Kagoshima University
RP Takashima, H (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Neurol & Geriatr, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.
EM thiroshi@m3.kufm.kagoshima-u.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   [21591095, 21591094]; intramural research grant for neurological and
   psychiatric disorders of the National Center of Neurology and Psychiatry
   [21B-1]; Nervous and Mental Disorders and Research Committee for
   Charcot-Marie-Tooth disease, neuropathy, ataxic disease; Ministry of
   Health, Labour and Welfare of Japan [23300201]; Ministry of Health,
   Welfare and Labour, Japan; Grants-in-Aid for Scientific Research
   [23300201, 21591094, 21591095] Funding Source: KAKEN
FX The project was funded by the Ministry of Education, Culture, Sports,
   Science and Technology of Japan (grant 21591095 to HT; 21591094 to IH),
   intramural research grant (21B-1 to IH) for neurological and psychiatric
   disorders of the National Center of Neurology and Psychiatry, the
   Nervous and Mental Disorders and Research Committee for
   Charcot-Marie-Tooth disease, neuropathy, ataxic disease and applied
   health and technology of the Ministry of Health, Welfare and Labour,
   Japan and a research grant (23300201) from the Ministry of Health,
   Labour and Welfare of Japan.
CR Chen CY, 2011, MITOCHONDRION, V11, P739, DOI 10.1016/j.mito.2011.05.014
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   DiMauro S, 2002, ADV NEUROL, V89, P217
   Erol I, 2009, NEUROMUSCULAR DISORD, V19, P275, DOI 10.1016/j.nmd.2009.01.012
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Higuchi I, 1999, ACTA NEUROPATHOL, V98, P313, DOI 10.1007/s004010051086
   Holland MM, 2011, CROAT MED J, V52, P299, DOI 10.3325/cmj.2011.52.299
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034
   Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012
   Kumamoto T, 2004, ACTA NEUROPATHOL, V107, P59, DOI 10.1007/s00401-003-0774-2
   Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014
   Masucci JP, 1997, MOL CELL BIOCHEM, V174, P215, DOI 10.1023/A:1006808524536
   Mithani SK, 2007, CLIN CANCER RES, V13, P7335, DOI 10.1158/1078-0432.CCR-07-0220
   Molnar MJ, 2009, J NEUROL, V256, P264, DOI 10.1007/s00415-009-0841-2
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   Niiyama T, 2002, ACTA NEUROPATHOL, V104, P67, DOI 10.1007/s00401-002-0522-z
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Orcesi S, 2006, J CHILD NEUROL, V21, P79, DOI 10.1177/08830738060210010901
   Remes AM, 2005, NEUROLOGY, V64, P976, DOI 10.1212/01.WNL.0000154518.31302.ED
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107
   Sakiyama Y, 2011, ACTA NEUROPATHOL, V121, P775, DOI 10.1007/s00401-011-0818-y
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Tang S, 2010, BIOTECHNIQUES, V48, P287, DOI 10.2144/000113389
   Toyono M, 2001, NEUROMUSCULAR DISORD, V11, P300, DOI 10.1016/S0960-8966(00)00176-0
   Vallance HD, 2004, PEDIATR CARDIOL, V25, P538, DOI 10.1007/s00246-003-0446-y
   Wikstrom JD, 2009, INT J BIOCHEM CELL B, V41, P1914, DOI 10.1016/j.biocel.2009.06.006
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   Zhou SY, 2006, J MOL DIAGN, V8, P476, DOI 10.2353/jmoldx.2006.060008
NR 32
TC 11
Z9 12
U1 0
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0021-9746
J9 J CLIN PATHOL
JI J. Clin. Pathol.
PD AUG
PY 2013
VL 66
IS 8
BP 659
EP 664
DI 10.1136/jclinpath-2012-201431
PG 6
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA 201SL
UT WOS:000323163200006
PM 23559353
DA 2024-11-01
ER

PT J
AU Che, L
   Wu, YL
   Sheng, MW
   Xu, JA
   Yu, WL
   Weng, YQ
AF Che, Lu
   Wu, Yuli
   Sheng, Mingwei
   Xu, Jiangang
   Yu, Wenli
   Weng, Yiqi
TI Intraoperative management during liver transplantation in the child with
   mitochondrial depletion syndrome: A case report
SO INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS
LA English
DT Article
DE Intraoperative management; Liver transplantation; Mitochondrial
   depletion syndrome; Case report
ID POSTREPERFUSION SYNDROME; REPERFUSION; PATIENT; INJURY; MAINTENANCE;
   ELEVATION; MYOPATHY; DISEASES
AB Introduction: Mitochondrial DNA depletion syndrome (MDS) is a kind of autosomal recessive genetic disorder associated with a reduction in mitochondrial DNA (mtDNA) copy number caused by mutations in nuclear genes during nucleotide synthesis, which affects the energy production of tissues and organs. Changes in hemodynamics during liver transplantation may lead to high energy-demanding organs and tissues being vulnerable. This report described the intraoperative management during liver transplantation in a child with MDS. Ultimately, the child was discharged smoothly without any complications. Presentation of the case: A five -year -old boy was diagnosed with mitochondrial depletion syndrome preoperatively and scheduled for living donor liver transplantation. The incidence of postreperfusion syndrome (PRS) could not be avoided for 30 min after opening, despite our best efforts to aggressively prevent it before opening. While ensuring hemodynamic stability, we actively prevented and adopted high-energy-demand organ protection strategies to reduce the incidence of postoperative complications. Finally, the child was discharged 28 days after the operation, and no other complications were found. Discussion: Liver transplantation can be performed for liver failure in this disease to improve the quality of life and prolong the life of patients. As this child has mitochondrial DNA depletion syndrome, the disruption of cellular energy generation caused by mitochondrial malfunction puts high-energy-demanding organs and tissues at risk during surgery. It motivates us to pay closer attention to the prevention and treatment of PRS in anesthetic management to minimize damage to the child's organs and tissues with high energy demands. Conclusions: This report describes the intraoperative management during liver transplantation in a child with mitochondrial depletion syndrome. To increase the safety of perioperative anesthesia and reduce mortality in patients with mitochondrial disease, for such patients, maintaining an acid-base balance and a stable internal environment is essential. We should also pay attention to protecting body temperature, using vasoactive drugs beforehand to lessen the incidence of PRS, and protecting high-energy-demanding organs afterward.
C1 [Che, Lu; Sheng, Mingwei; Xu, Jiangang; Yu, Wenli; Weng, Yiqi] Tianjin First Cent Hosp, Dept Anesthesiol, 24 Fukang Rd, Tianjin 300192, Peoples R China.
   [Wu, Yuli] Tianjin Med Univ, Cent Clin Coll 1, Tianjin, Peoples R China.
   [Yu, Wenli; Weng, Yiqi] Tianjin First Cent Hosp, Tianjin, Peoples R China.
C3 Tianjin Medical University; Tianjin Medical University; Tianjin Medical
   University
RP Xu, JA; Yu, WL; Weng, YQ (corresponding author), Tianjin First Cent Hosp, Dept Anesthesiol, 24 Fukang Rd, Tianjin 300192, Peoples R China.; Yu, WL; Weng, YQ (corresponding author), Tianjin First Cent Hosp, Tianjin, Peoples R China.
EM xjgyzx@126.com; 30817029@nankai.edu.cn; wyqhyd@126.com
FU Tianjin Key Medical Discipline (Specialty) Construction Project
   [TJYXZDXK-045A]; Natural Science Foundation of Tianjin [21JCYBJC01190]
FX This work was supported by Tianjin Key Medical Discipline (Specialty)
   Construction Project (TJYXZDXK-045A) , Natural Science Foundation of
   Tianjin (21JCYBJC01190) .
CR AGGARWAL S, 1987, TRANSPLANT P, V19, P54
   Alquézar-Arbé A, 2017, CRIT REV CL LAB SCI, V54, P551, DOI 10.1080/10408363.2017.1410777
   Basel D, 2020, CLIN PERINATOL, V47, P123, DOI 10.1016/j.clp.2019.10.008
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   El-Hattab AW, 2018, HUM MUTAT, V39, P461, DOI 10.1002/humu.23387
   Enns GM, 2017, CURR OPIN PEDIATR, V29, P541, DOI 10.1097/MOP.0000000000000535
   Falk MJ, 2010, CURR OPIN PEDIATR, V22, P711, DOI 10.1097/MOP.0b013e3283402e21
   Hilmi IA, 2015, BRIT J ANAESTH, V114, P919, DOI 10.1093/bja/aeu556
   Huang S, 2016, CLIN TRANSPLANT, V30, P1552, DOI 10.1111/ctr.12855
   Kassel CA, 2021, J CARDIOTHOR VASC AN, V35, P1495, DOI 10.1053/j.jvca.2020.01.056
   Nanashima A, 2001, J Hepatobiliary Pancreat Surg, V8, P557, DOI 10.1007/s005340100025
   Ozacmak VH, 2007, WORLD J GASTROENTERO, V13, P538, DOI 10.3748/wjg.v13.i4.538
   Potgieter K, 2010, J NEUROPHYSIOL, V104, P742, DOI 10.1152/jn.00021.2010
   Romagnoli S, 2009, HEART LUNG VESSEL, V1, P20
   Ryu HG, 2012, LIVER TRANSPLANT, V18, P1430, DOI 10.1002/lt.23511
   Sasano N, 2007, J ANESTH, V21, P72, DOI 10.1007/s00540-006-0449-y
   Sheng MW, 2017, TRANSPLANTATION, V101, P2385, DOI 10.1097/TP.0000000000001732
   Siniscalchi A, 2016, WORLD J GASTROENTERO, V22, P1551, DOI 10.3748/wjg.v22.i4.1551
   Smith A, 2017, EUR J PEDIATR, V176, P83, DOI 10.1007/s00431-016-2813-8
   Sohrabi C, 2023, INT J SURG, V109, P1136, DOI 10.1097/JS9.0000000000000373
   Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112
   Vilchez-Monge AL, 2020, LIVER TRANSPLANT, V26, P681, DOI 10.1002/lt.25716
   Woodward EL, 2017, A A CASE REP, V8, P33, DOI 10.1213/XAA.0000000000000416
   Zhang L, 2018, ANN TRANSPL, V23, P334, DOI 10.12659/AOT.909050
NR 24
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI London
PA 125 London Wall, London, ENGLAND
SN 2210-2612
J9 INT J SURG CASE REP
JI Int. J. Surg. Case Rep.
PD MAR
PY 2024
VL 116
AR 109432
DI 10.1016/j.ijscr.2024.109432
EA MAR 2024
PG 5
WC Surgery
WE Emerging Sources Citation Index (ESCI)
SC Surgery
GA NX4S3
UT WOS:001203745500001
PM 38432165
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Annunen-Rasila, J
   Kärppä, M
   Finnilä, S
   Ylä-Outinen, H
   Veijola, J
   Tuominen, H
   Peltonen, J
   Majamaa, K
AF Annunen-Rasila, Johanna
   Karppa, Mikko
   Finnila, Saara
   Yla-Outinen, Heli
   Veijola, Johanna
   Tuominen, Hannu
   Peltonen, Juha
   Majamaa, Karl
TI Cytoskeletal structure in cells harboring two mutations:: R133C in
   <i>NOTCH3</i> and 5650G&gt;A in mitochondrial DNA
SO MITOCHONDRION
LA English
DT Article
DE CADASIL; immunocytochemistry; histochemistry; mitochondria; muscle
   fibres
ID MUSCLE-FIBERS; CADASIL; MICROTUBULES; PATIENT; NEURONS; GENE
AB We have previously described a patient with cerebral autosomal-dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) caused by R133C mutation in NOTCH3 and with a concomitant myopathy caused by a G to A point mutation at base pair 5650 (5650G>A) in the gene encoding tRNA(Ala) in mitochondrial DNA (mtDNA). In the present study, we have examined the morphology of the cytoskeletal components in fibroblasts and myoblasts of this patient. Immunolabeling revealed that tubulin network was sparse and formed asters in these cells, whereas no changes were found in actin and vimentin networks in comparison to the control cell lines. Furthermore, mitochondria were less abundant and the branches of the mitochondrial network were reduced in number. Muscle histochemical analysis showed ragged red fibres (RRFs) and cytochrome c oxidase (COX)-negative fibres. The mean proportion of mtDNA with 5650G>A was lower in histologically normal muscle fibres than in the COX-negative fibres and in the RRFs. These findings suggest that 5650G>A is a pathogenic mtDNA mutation. However, the changes in tubulin network and mitochondrial distribution in patient fibroblasts and myoblasts cannot solely be explained by this mutation. (c) 2007 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 Univ Oulu, Dept Neurol, FIN-90014 Oulu, Finland.
   Oulu Univ Hosp, Clin Res Ctr, FIN-90014 Oulu, Finland.
   Univ Turku, Dept Anat, FIN-20014 Turku, Finland.
   Oulu Univ Hosp, Dept Pathol, FIN-90029 Oulu, Finland.
   Univ Oulu, Dept Anat & Cell Biol, FIN-90014 Oulu, Finland.
   Univ Oulu, Dept Dermatol, FIN-90014 Oulu, Finland.
   Univ Turku, Dept Dermatol, FIN-20014 Turku, Finland.
   Univ Turku, Dept Neurol, FIN-20014 Turku, Finland.
C3 University of Oulu; University of Oulu; University of Turku; University
   of Oulu; University of Oulu; University of Oulu; University of Turku;
   University of Turku
RP Majamaa, K (corresponding author), Univ Oulu, Dept Neurol, FIN-90014 Oulu, Finland.
EM Kari.Majamaa@utu.fi
RI Majamaa, Kari/A-1344-2012; Peltonen, Juha/C-2817-2008
OI Majamaa, Kari/0000-0002-9070-3791; Peltonen, Juha/0000-0002-5732-4167
CR Allani PK, 2004, TOXICOL APPL PHARM, V196, P29, DOI 10.1016/j.taap.2003.12.010
   Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   de la Peña P, 2001, NEUROLOGY, V57, P1235, DOI 10.1212/WNL.57.7.1235
   Dotti MT, 2004, ARCH NEUROL-CHICAGO, V61, P942, DOI 10.1001/archneur.61.6.942
   Finnilä S, 2001, J MOL MED, V79, P641, DOI 10.1007/s001090100268
   Honore S, 2005, CELL MOL LIFE SCI, V62, P3039, DOI 10.1007/s00018-005-5330-x
   Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0
   Kärppä M, 2005, BRAIN, V128, P1861, DOI 10.1093/brain/awh515
   LI K, 1995, AM J PHYSIOL-CELL PH, V269, pC1265, DOI 10.1152/ajpcell.1995.269.5.C1265
   Malandrini A, 2002, NEUROLOGY, V59, P617, DOI 10.1212/WNL.59.4.617
   MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315
   Moslemi AR, 1998, NEUROMUSCULAR DISORD, V8, P345, DOI 10.1016/S0960-8966(98)00029-7
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   OSBORN M, 1976, P NATL ACAD SCI USA, V73, P867, DOI 10.1073/pnas.73.3.867
   Rosenblatt J, 2005, NAT CELL BIOL, V7, P219, DOI 10.1038/ncb0305-219
   Ruchoux MM, 2003, AM J PATHOL, V162, P329, DOI 10.1016/S0002-9440(10)63824-2
   Rusanen H, 2002, CELL MOTIL CYTOSKEL, V53, P231, DOI 10.1002/cm.10066
   Schröder JM, 2005, ACTA NEUROPATHOL, V110, P587, DOI 10.1007/s00401-005-1082-9
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   THORIG GEW, 1981, GENETICS, V99, P65
   Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493
NR 22
TC 5
Z9 6
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
J9 MITOCHONDRION
JI Mitochondrion
PD FEB-APR
PY 2007
VL 7
IS 1-2
BP 96
EP 100
DI 10.1016/j.mito.2006.11.004
PG 5
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 157EM
UT WOS:000245701400015
PM 17276737
DA 2024-11-01
ER

PT J
AU Richardson, C
   Smith, T
   Schaefer, A
   Turnbull, D
   Griffiths, P
AF Richardson, C
   Smith, T
   Schaefer, A
   Turnbull, D
   Griffiths, P
TI Ocular motility findings in chronic progressive external ophthalmoplegia
SO EYE
LA English
DT Article
DE ophthalmoplegia; mitochondrial myopathy
ID KEARNS-SAYRE SYNDROME; MITOCHONDRIAL-DNA; MYOPATHY; DELETIONS; DISEASE;
   CATARACT; FEATURES; MUSCLE
AB Aims To characterise the ocular motility features of chronic progressive external ophthalmoplegia by quantitative and semiquantitative means.
   To assess the prevalence of diplopia and the binocular adaptations to nonaligned visual axes.
   Method We studied 25 patients with chronic progressive external ophthalmoplegia. In each case muscle biopsies were consistent with mitochondrial myopathy. All patients underwent cover test in the primary position, assessment of binocular status, and measurement of uniocular fields of fixation using the Goldmann perimeter.
   Results A total of 23 (92%) patients had an exo-deviation, with six (26%) of those having an associated vertical deviation: 12 patients were binocular. Of the 13 patients with a manifest deviation seven had diplopia and six had suppression. Of all paired extra-ocular muscles (EOM), 68% had symmetry of movement within 51 of each other.
   Conclusion Almost all patients had an exo-deviation. Diplopia was more common than expected. The majority of patients had symmetry of EOM limitation.
C1 Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   Univ Newcastle Upon Tyne, Dept Neurol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK
RP Royal Victoria Infirm, Dept Ophthalmol, Claremont Wing,Queen Victoria Rd, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
EM p.g.griffiths@ncl.ac.uk
OI Schaefer, Andrew/0000-0001-9891-7332
CR BASTIAENSEN LAK, 1982, OPHTHALMOLOGICA, V184, P40, DOI 10.1159/000309183
   BOOTHE RG, 1985, ANNU REV NEUROSCI, V8, P485
   BORCHERT MS, 1994, PRINCIPLES PRACTICE
   DAROFF RB, 1966, NEUROLOGY, V16, P161, DOI 10.1212/WNL.16.2_Part_1.161
   Graefe V.O. N., 1868, Berl Klin Wschr, V5, P125
   GUPTA SR, 1995, J NEURO-OPHTHALMOL, V15, P20
   HAGGERTY H, 2001, T EUR STRAB ASS 27 A
   HAMED LM, 1977, AM J OPHTHALMOL, V103, P741
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   JA B-E, 1988, STRUCTURAL ORG EXTRA, V2
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   Koutroumanidis M, 1996, MUSCLE NERVE, V19, P1586, DOI 10.1002/(SICI)1097-4598(199612)19:12<1586::AID-MUS8>3.0.CO;2-6
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   Miller NR, 1985, WALSH HOYTS CLIN NEU
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915
   PRATTJOHNSON JA, 1989, AM J OPHTHALMOL, V107, P23, DOI 10.1016/0002-9394(89)90809-X
   ROBINSON DA, 1970, J NEUROPHYSIOL, V33, P393, DOI 10.1152/jn.1970.33.3.393
   Salvan AM, 1998, EUR NEUROL, V40, P46, DOI 10.1159/000007955
   SHARKEY JA, 1994, J PEDIATR OPHTHALMOL, V31, P391
   Sherafat H, 2001, BRIT J OPHTHALMOL, V85, P1057, DOI 10.1136/bjo.85.9.1057
   Snell R.S., 1989, CLIN ANATOMY EYE
   STANWORTH A, 1963, Trans Ophthalmol Soc U K, V83, P515
   VAEGAN TD, 1979, T OPHTHAL SOC UK, V99, P432
   VONNOORDEN GK, 1985, INVEST OPHTH VIS SCI, V26, P1704
   VONNOORDEN GK, 1996, BINOCULAR VISION MOT
   WOOTEN GF, 1972, ARCH NEUROL-CHICAGO, V26, P350, DOI 10.1001/archneur.1972.00490100080008
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 28
TC 48
Z9 48
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0950-222X
EI 1476-5454
J9 EYE
JI Eye
PD MAR
PY 2005
VL 19
IS 3
BP 258
EP 263
DI 10.1038/sj.eye.6701488
PG 6
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA 902CZ
UT WOS:000227330300004
PM 15272295
OA Bronze
DA 2024-11-01
ER

PT J
AU Grady, JP
   Murphy, JL
   Blakely, EL
   Haller, RG
   Taylor, RW
   Turnbull, DM
   Tuppen, HAL
AF Grady, John P.
   Murphy, Julie L.
   Blakely, Emma L.
   Haller, Ronald G.
   Taylor, Robert W.
   Turnbull, Doug M.
   Tuppen, Helen A. L.
TI Accurate Measurement of Mitochondrial DNA Deletion Level and Copy Number
   Differences in Human Skeletal Muscle
SO PLOS ONE
LA English
DT Article
ID REAL-TIME PCR; INDIVIDUAL CELLS; DISEASE; QUANTIFICATION; SINGLE; MTDNA;
   DEPLETION; ASSAY
AB Accurate and reliable quantification of the abundance of mitochondrial DNA (mtDNA) molecules, both wild-type and those harbouring pathogenic mutations, is important not only for understanding the progression of mtDNA disease but also for evaluating novel therapeutic approaches. A clear understanding of the sensitivity of mtDNA measurement assays under different experimental conditions is therefore critical, however it is routinely lacking for most published mtDNA quantification assays. Here, we comprehensively assess the variability of two quantitative Taqman real-time PCR assays, a widely-applied MT-ND1/MT-ND4 multiplex mtDNA deletion assay and a recently developed MT-ND1/B2M singleplex mtDNA copy number assay, across a range of DNA concentrations and mtDNA deletion/copy number levels. Uniquely, we provide a specific guide detailing necessary numbers of sample and real-time PCR plate replicates for accurately and consistently determining a given difference in mtDNA deletion levels and copy number in homogenate skeletal muscle DNA.
C1 [Grady, John P.; Murphy, Julie L.; Blakely, Emma L.; Taylor, Robert W.; Turnbull, Doug M.; Tuppen, Helen A. L.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Haller, Ronald G.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA.
   [Haller, Ronald G.] VA North Texas Med Ctr, Dallas, TX USA.
   [Haller, Ronald G.] Inst Exercise & Environm Med, Neuromuscular Ctr, Dallas, TX USA.
C3 Newcastle University - UK; University of Texas System; University of
   Texas Southwestern Medical Center Dallas; US Department of Veterans
   Affairs; Veterans Health Administration (VHA); VA North Texas Health
   Care System
RP Tuppen, HAL (corresponding author), Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM helen.tuppen@ncl.ac.uk
OI Grady, John/0000-0001-9667-3872; Tuppen, Helen/0000-0001-8762-0824;
   Turnbull, Doug/0000-0002-8878-9901
FU Wellcome Trust Centre for Mitochondrial Research [906919]; National
   Institutes of Health (National Institute of Arthritis, Musculoskeletal
   and Skin Diseases, NIAMS) [RO1-AR050597]; MRC [G0700718, MR/K000608/1,
   MR/K006312/1] Funding Source: UKRI
FX This work was supported by the Wellcome Trust Centre for Mitochondrial
   Research (906919; www.wellcome.ac.uk) and the National Institutes of
   Health (National Institute of Arthritis, Musculoskeletal and Skin
   Diseases, NIAMS, RO1-AR050597 to RGH; www.nih.gov/). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Balakrishnan VS, 2010, CLIN J AM SOC NEPHRO, V5, P996, DOI 10.2215/CJN.09141209
   Blackwood JK, 2010, BIOCHEM BIOPH RES CO, V393, P740, DOI 10.1016/j.bbrc.2010.02.072
   BRUGGER RM, 1969, AM STAT, V23, P32
   Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4
   Damas J, 2014, NUCLEIC ACIDS RES, V42, pD1261, DOI 10.1093/nar/gkt982
   Efron B., 1986, Statistical Science, V1, P54, DOI [DOI 10.1214/SS/1177013815, 10.1214/ss/1177013815, https://doi.org/10.1214/ss/1177013815]
   Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Lax NZ, 2012, BRAIN, V135, P1736, DOI 10.1093/brain/aws110
   Malik AN, 2011, BIOCHEM BIOPH RES CO, V412, P1, DOI 10.1016/j.bbrc.2011.06.067
   Marcuello A, 2005, J APPL PHYSIOL, V99, P1372, DOI 10.1152/japplphysiol.00289.2005
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Pejznochová M, 2008, PHYSIOL RES, V57, P947, DOI 10.33549/physiolres.931246
   Phillips NR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03887
   Poe BG, 2007, ANAL BIOCHEM, V362, P193, DOI 10.1016/j.ab.2006.12.035
   PONTE P, 1983, MOL CELL BIOL, V3, P1783, DOI 10.1128/MCB.3.10.1783
   Rötig A, 2009, BBA-MOL BASIS DIS, V1792, P1103, DOI 10.1016/j.bbadis.2009.06.009
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sabatino L, 2013, ENVIRON MOL MUTAGEN, V54, P299, DOI 10.1002/em.21783
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918
   Sochivko DG, 2013, DOKL BIOCHEM BIOPHYS, V449, P105, DOI 10.1134/S1607672913020154
   Spendiff S, 2013, HUM MOL GENET, V22, P4739, DOI 10.1093/hmg/ddt327
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Venegas V, 2012, METHODS MOL BIOL, V837, P327, DOI 10.1007/978-1-61779-504-6_22
   Wong LJC, 2003, J MED GENET, V40
   Zhang GJ, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-173
NR 31
TC 47
Z9 49
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 4
PY 2014
VL 9
IS 12
AR e114462
DI 10.1371/journal.pone.0114462
PG 15
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA AW6MB
UT WOS:000346382500032
PM 25474153
OA Green Submitted, gold, Green Published
DA 2024-11-01
ER

PT J
AU Hudson, G
   Chinnery, PF
AF Hudson, Gavin
   Chinnery, Patrick F.
TI Mitochondrial DNA polymerase-γ and human disease
SO HUMAN MOLECULAR GENETICS
LA English
DT Review
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; POLG MUTATIONS; ALPERS-SYNDROME;
   MTDNA MAINTENANCE; MALE-INFERTILITY; NEUROGASTROINTESTINAL
   ENCEPHALOMYOPATHY; TRANSCRIPTION FACTOR; ACCESSORY SUBUNIT; POINT
   MUTATIONS; COPY NUMBER
AB The maintenance of mitochondrial DNA (mtDNA) is critically dependent upon polymerase-gamma (pol-gamma), encoded by the nuclear gene POLG. Over the last 5 years, it has become clear that mutations of POLG are a major cause of human disease. Secondary mtDNA defects characterize these disorders, with mtDNA depletion, multiple mtDNA deletions or multiple point mutations of mtDNA in clinically affected tissues. The secondary mtDNA defects cause cell and tissue-specific deficiencies of mitochondrial oxidative phosphorylation, leading to organ dysfunction and human disease. Functional genetic variants of POLG are present in up to similar to 0.5% of the general population, and pathogenic mutations have been described in most exons of the gene. Clinically, POLG mutations can present from early neonatal life to late middle age, with a spectrum of phenotypes that includes common neurological disorders such as migraine, epilepsy and Parkinsonism. Transgenic mice and biochemical studies of recombinant mutated proteins are helping to unravel mechanisms of pathogenesis, and patterns are beginning to emerge relating genotype to phenotype.
C1 Newcastle Univ, Sch Med, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   Newcastle Univ, Sch Med, Inst Human Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK
RP Chinnery, PF (corresponding author), Newcastle Univ, Sch Med, Mitochondrial Res Grp, M41014,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM p.f.chinnery@ncl.ac.uk
RI Hudson, Gavin/E-7117-2017
OI Chinnery, Patrick/0000-0002-7065-6617; Hudson, Gavin/0000-0001-7210-2733
CR Aknin-Seifer IE, 2005, HUM REPROD, V20, P736, DOI 10.1093/humrep/deh666
   BIRKY CW, 1994, J HERED, V85, P355, DOI 10.1093/oxfordjournals.jhered.a111480
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Brusco A, 2006, J ENDOCRINOL INVEST, V29, P1
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Eyer F, 2005, J CLIN PSYCHOPHARM, V25, P376, DOI 10.1097/01.jcp.0000168485.76397.5c
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077
   GHIVIZZANI SC, 1994, MOL CELL BIOL, V14, P7717, DOI 10.1128/MCB.14.12.7717
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hisama FM, 2005, AM J MED GENET A, V135A, P217, DOI 10.1002/ajmg.a.30672
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, NEUROLOGY, V66, P1439, DOI 10.1212/01.wnl.0000210486.32196.24
   HUDSON G, 2006, IN PRESS ARCH NEUROL
   Jensen M, 2004, HUM REPROD, V19, P65, DOI 10.1093/humrep/deh038
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Krausz C, 2004, J CLIN ENDOCR METAB, V89, P4292, DOI 10.1210/jc.2004-0008
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   KUNKEL TA, 1988, J BIOL CHEM, V263, P4450
   Labarthe F, 2005, J HEPATOL, V43, P333, DOI 10.1016/j.jhep.2005.03.023
   Lakshmipathy U, 2001, NUCLEIC ACIDS RES, V29, P668, DOI 10.1093/nar/29.3.668
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Malyarchuk BA, 2005, HUM BIOL, V77, P355, DOI 10.1353/hub.2005.0050
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Marcuello A, 2005, J APPL PHYSIOL, V99, P1372, DOI 10.1152/japplphysiol.00289.2005
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Nishigaki Y, 2004, HUM MOL GENET, V13, P91, DOI 10.1093/hmg/ddh010
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   PAGNAMENTA AT, 2006, HUM REPROD
   ROSSMANITH W, 1995, J BIOL CHEM, V270, P12885, DOI 10.1074/jbc.270.21.12885
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Taanman JW, 2005, NEUROSCI LETT, V376, P56, DOI 10.1016/j.neulet.2004.11.023
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122
   Wang Y, 2002, P NATL ACAD SCI USA, V99, P12114, DOI 10.1073/pnas.192449499
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002
   ZEVIANI M, 1995, BBA-MOL BASIS DIS, V1271, P153, DOI 10.1016/0925-4439(95)00022-V
   ZHANG H, 1994, MOL PHARMACOL, V46, P1063
   Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998
NR 90
TC 170
Z9 194
U1 0
U2 19
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD OCT 15
PY 2006
VL 15
SI 2
BP R244
EP R252
DI 10.1093/hmg/ddl233
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 095SX
UT WOS:000241329700019
PM 16987890
OA Bronze
DA 2024-11-01
ER

PT J
AU Ozlu, C
   Messahel, S
   Minassian, B
   Kayani, S
AF Ozlu, Can
   Messahel, Souad
   Minassian, Berge
   Kayani, Saima
TI Mitochondrial encephalopathies and myopathies: Our tertiary center's
   experience
SO EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
LA English
DT Article
DE Mitochondrial disease; Encephalopathy; Myopathy; Cohort; Mitochondrial
   gene mutation
ID ANTIEPILEPTIC DRUGS; DYSFUNCTION; DISEASE; DEFICIENCY
AB Mitochondrial diseases have a heterogeneous phenotype and can result from mutations in the mitochondrial or nuclear genomes, constituting a diagnostically and therapeutically challenging group of disorders. We report our center's experience with mitochondrial encephalopathies and myopathies with a cohort of 50 genetically and phenotypically diverse patients followed in the Neurology clinic over the last ten years. Seventeen patients had mitochondrial DNA mutations, presented over a wide range of ages with seizures, feeding difficulties, extraocular movements abnormalities, and had high rates of stroke-like episodes and regression. Twenty-seven patients had nuclear DNA mutations, presented early in life with feeding difficulty, failure-to-thrive, and seizures, and had high proportions of developmental delay, wheelchair dependence, spine abnormalities and dystonia. In six patients, a mutation could not be identified, but they were included for having mitochondrial disease confirmed by histopathology, enzyme analysis and clinical features. These patients had similar characteristics to patients with nuclear DNA mutations, suggesting missed underlying mutations in the nuclear genome. Management was variable among patients, but outcomes were universally poor with severe disability in all cases. Therapeutic entryways through elucidation of disease pathways and remaining unknown genes are acutely needed.
C1 [Ozlu, Can; Minassian, Berge; Kayani, Saima] Univ Texas Southwestern Med Ctr, Dallas, TX 75390 USA.
   [Ozlu, Can; Minassian, Berge; Kayani, Saima] Childrens Med Ctr, Dallas, TX USA.
   [Messahel, Souad] Elpida Therapeut, Encino, CA USA.
C3 University of Texas System; University of Texas Southwestern Medical
   Center Dallas
RP Kayani, S (corresponding author), Univ Texas Southwestern Med Ctr, Dallas, TX 75390 USA.
EM saima.kayani@utsouthwestern.edu
OI /0000-0002-9322-0189
CR Abate M, 2020, SEMIN CELL DEV BIOL, V98, P139, DOI 10.1016/j.semcdb.2019.05.022
   Almannai M, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.682780
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrieux P, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222111338
   Ardissone A, 2023, EUR J NEUROL, V30, P2079, DOI 10.1111/ene.15814
   Baker MJ, 2022, OPEN BIOL, V12, DOI 10.1098/rsob.220274
   Barca E, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000402
   Belal S, 2022, BIOMEDICINES, V10, DOI 10.3390/biomedicines10071665
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Brandao SR, 2021, ARCH PHYSIOL BIOCHEM, V127, P210, DOI 10.1080/13813455.2019.1628065
   Busanello ENB, 2010, NEUROCHEM INT, V56, P948, DOI 10.1016/j.neuint.2010.04.002
   Cervellati C, 2015, BBA-MOL BASIS DIS, V1852, P2066, DOI 10.1016/j.bbadis.2015.07.014
   Cicaloni V, 2020, FREE RADICAL BIO MED, V155, P37, DOI 10.1016/j.freeradbiomed.2020.05.014
   Crivellari I, 2021, ARCH BIOCHEM BIOPHYS, V700, DOI 10.1016/j.abb.2021.108790
   De Vries MC, 2020, J INHERIT METAB DIS, V43, P800, DOI 10.1002/jimd.12196
   Eisner V, 2018, NAT CELL BIOL, V20, P755, DOI 10.1038/s41556-018-0133-0
   El-Hattab Ayman W., 2017, J. inborn errors metab. screen., V5, pe160051, DOI 10.1177/2326409817697399
   Emmanuele V, 2022, MOL GENET METAB, V136, P125, DOI 10.1016/j.ymgme.2022.05.001
   Finsterer J, 2020, PEDIATR NEUROL, V110, P25, DOI 10.1016/j.pediatrneurol.2020.03.009
   Finsterer J, 2018, BRAIN DEV-JPN, V40, P366, DOI 10.1016/j.braindev.2017.08.002
   Finsterer J, 2017, HANDB EXP PHARMACOL, V240, P473, DOI 10.1007/164_2016_2
   Gold WA, 2014, MITOCHONDRION, V15, P10, DOI 10.1016/j.mito.2014.02.012
   Goldstein A., 1993, GeneReviews((R))
   Gough SM, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.782657
   Guo L, 2020, DNA CELL BIOL, V39, P1449, DOI 10.1089/dna.2019.5010
   Koga Y, 2018, J NEUROL, V265, P2861, DOI 10.1007/s00415-018-9057-7
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lim AZ, 2022, ANN NEUROL, V91, P117, DOI 10.1002/ana.26260
   Liu SW, 2022, J PEDIATR-US, V241, P154, DOI 10.1016/j.jpeds.2021.09.052
   Lopriore P, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms232113216
   Monzel AS, 2023, NAT METAB, V5, P546, DOI 10.1038/s42255-023-00783-1
   Morio B, 2021, CELL CALCIUM, V94, DOI 10.1016/j.ceca.2020.102336
   Ni M, 2019, CELL REP, V27, P1376, DOI 10.1016/j.celrep.2019.04.005
   Orsucci D, 2021, J CLIN MED, V10, DOI 10.3390/jcm10061249
   Parikh S, 2017, GENET MED, V19, DOI 10.1038/gim.2017.107
   Rashid J, 2020, PEDIATR DRUGS, V22, P279, DOI 10.1007/s40272-020-00384-5
   Rogac M, 2021, BALK J MED GENET, V24, P5, DOI 10.2478/bjmg-2021-0019
   Roginski AC, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165682
   Saffari A, 2017, J INHERIT METAB DIS, V40, P631, DOI 10.1007/s10545-017-0048-0
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Shaito A, 2023, CURR NEUROPHARMACOL, V21, P1184, DOI 10.2174/1570159X20666221012122855
   SIEKEVITZ P, 1957, SCI AM, V197, P131, DOI 10.1038/scientificamerican0757-131
   Steele H, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911589
   Stefanetti RJ, 2022, NEUROLOGY, V98, pE2318, DOI 10.1212/WNL.0000000000200299
   Stowe RC, 2018, AM J MED GENET A, V176, P1184, DOI 10.1002/ajmg.a.38654
   Sun C, 2022, MOL GENET GENOM MED, V10, DOI 10.1002/mgg3.1943
   Tarnopolsky MA, 2008, ADV DRUG DELIVER REV, V60, P1561, DOI 10.1016/j.addr.2008.05.001
   Tetsuka S, 2021, METAB BRAIN DIS, V36, P2181, DOI 10.1007/s11011-021-00772-x
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Tragni V, 2022, MOLECULES, V27, DOI 10.3390/molecules27113494
   Valero T, 2014, CURR PHARM DESIGN, V20, P5507, DOI 10.2174/138161282035140911142118
   Velez-Bartolomei F., 1993, GeneReviews
   Vento JM, 2013, NEUROTHERAPEUTICS, V10, P243, DOI 10.1007/s13311-012-0173-2
   Wajner M, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150240
   Wang ZH, 2022, MITOCHONDRION, V65, P80, DOI 10.1016/j.mito.2022.05.002
   Wesol-Kucharska D, 2021, CHILDREN-BASEL, V8, DOI 10.3390/children8070532
   Xiao CR, 2020, AM J MED GENET A, V182, P2426, DOI 10.1002/ajmg.a.61786
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Youle RJ, 2019, SCIENCE, V365, P655, DOI 10.1126/science.aaw9855
   Zhang XQ, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222011253
NR 60
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER SCI LTD
PI London
PA 125 London Wall, London, ENGLAND
SN 1090-3798
EI 1532-2130
J9 EUR J PAEDIATR NEURO
JI Eur. J. Paediatr. Neurol.
PD MAY
PY 2024
VL 50
BP 31
EP 40
DI 10.1016/j.ejpn.2024.03.005
EA APR 2024
PG 10
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA QS6H4
UT WOS:001222893900001
PM 38583367
DA 2024-11-01
ER

PT J
AU Dohrn, MF
   Heller, C
   Zengeler, D
   Obermaier, CD
   Biskup, S
   Weis, J
   Nikolin, S
   Claeys, KG
   Schöne, U
   Beijer, D
   Winter, N
   Achenbach, P
   Gess, B
   Schulz, JB
   Mulahasanovic, L
AF Dohrn, Maike F.
   Heller, Corina
   Zengeler, Diana
   Obermaier, Carolin D.
   Biskup, Saskia
   Weis, Joachim
   Nikolin, Stefan
   Claeys, Kristl G.
   Schone, Ulrike
   Beijer, Danique
   Winter, Natalie
   Achenbach, Pascal
   Gess, Burkhard
   Schulz, Jorg B.
   Mulahasanovic, Lejla
TI Heterozygous POLG variant Ser1181Asn co-segregating in a family with
   autosomal dominant axonal neuropathy, proximal muscle fatigability,
   ptosis, and ragged red fibers
SO NEUROLOGICAL RESEARCH AND PRACTICE
LA English
DT Article
DE Polymerase gamma; Autosomal dominant; Axonal neuropathy; Myo-neuropathy;
   Mitochondrial myopathy
ID DNA-POLYMERASE-GAMMA; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MUTATIONS
AB By whole-exome sequencing, we found the heterozygous POLG variant c.3542G>A; p.Ser1181Asn in a family of four affected individuals, presenting with a mixed neuro-myopathic phenotype. The variant is located within the active site of polymerase gamma, in a cluster region associated with an autosomal dominant inheritance. In adolescence, the index developed distal atrophies and weakness, sensory loss, afferent ataxia, double vision, and bilateral ptosis. One older sister presented with Charcot-Marie-Tooth-like symptoms, while the youngest sister and father reported exercise-induced muscle pain and proximal weakness. In none of the individuals, we observed any involvement of the central nervous system. Muscle biopsies obtained from the father and the older sister showed ragged-red fibers, and electron microscopy confirmed mitochondrial damage. We conclude that this novel POLG variant explains this family's phenotype.
C1 [Dohrn, Maike F.; Schone, Ulrike; Achenbach, Pascal; Gess, Burkhard; Schulz, Jorg B.] Rhein Westfal TH Aachen, Med Fac, Dept Neurol, Aachen, Germany.
   [Dohrn, Maike F.; Beijer, Danique] Univ Miami, Miller Sch Med, Dept Human Genet, Dr John T Macdonald Fdn, Miami, FL USA.
   [Dohrn, Maike F.; Beijer, Danique] Univ Miami, John P Hussman Inst Human Genom, Miller Sch Med, Miami, FL USA.
   [Heller, Corina; Zengeler, Diana; Obermaier, Carolin D.; Mulahasanovic, Lejla] Praxis Humangenetik Tubingen, Tubingen, Germany.
   [Heller, Corina; Zengeler, Diana; Obermaier, Carolin D.; Biskup, Saskia; Mulahasanovic, Lejla] CeGaT GmbH, Tubingen, Germany.
   [Weis, Joachim; Nikolin, Stefan; Achenbach, Pascal] Rhein Westfal TH Aachen, Inst Neuropathol, Med Fac, Aachen, Germany.
   [Nikolin, Stefan] Univ Hosp Leuven, Dept Neurol, Leuven, Belgium.
   [Claeys, Kristl G.] Katholieke Univ Leuven, Lab Muscle Dis & Neuropathies, Leuven, Belgium.
   [Winter, Natalie] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, Tubingen, Germany.
   [Schulz, Jorg B.] Forschungszentrum Julich GmbH, JARA BRAIN Inst Mol Neuroscience & Neuroimaging, Aachen, Germany.
   [Schulz, Jorg B.] Rhein Westfal TH Aachen, Aachen, Germany.
C3 RWTH Aachen University; University of Miami; University of Miami; CeGaT;
   RWTH Aachen University; KU Leuven; University Hospital Leuven; KU
   Leuven; Eberhard Karls University of Tubingen; Eberhard Karls University
   Hospital; Helmholtz Association; Research Center Julich; RWTH Aachen
   University
RP Dohrn, MF (corresponding author), Rhein Westfal TH Aachen, Med Fac, Dept Neurol, Aachen, Germany.; Dohrn, MF (corresponding author), Univ Miami, Miller Sch Med, Dept Human Genet, Dr John T Macdonald Fdn, Miami, FL USA.; Dohrn, MF (corresponding author), Univ Miami, John P Hussman Inst Human Genom, Miller Sch Med, Miami, FL USA.
EM mdohrn@ukaachen.de
RI Beijer, Danique/KHD-9648-2024; Weis, Joachim/G-1984-2014
OI Weis, Joachim/0000-0003-3280-6773; Claeys, Kristl/0000-0001-9937-443X;
   Beijer, Danique/0000-0001-6593-7644
CR Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Kiechl S, 2004, J NEUROL NEUROSUR PS, V75, P1125, DOI 10.1136/jnnp.2003.025890
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lehmann H, 2020, NEUE Z MUSIK, P20, DOI 10.1186/s42466-020-00064-2
   Mancuso M, 2016, NEUROMUSCULAR DISORD, V26, P272, DOI 10.1016/j.nmd.2016.02.008
   Nurminen A, 2017, BBA CLIN, V7, P147, DOI 10.1016/j.bbacli.2017.04.001
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395
   Tchikviladze M, 2015, J NEUROL NEUROSUR PS, V86, P646, DOI 10.1136/jnnp-2013-306799
NR 12
TC 2
Z9 2
U1 0
U2 0
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2524-3489
J9 NEUROL RES PRACT
JI Neurol. Res. Pract.
PY 2022
VL 4
IS 1
DI 10.1186/s42466-022-00169-w
PG 4
WC Clinical Neurology
WE Emerging Sources Citation Index (ESCI)
SC Neurosciences & Neurology
GA IM5Z7
UT WOS:001166769500005
PM 35101151
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Tyynismaa, H
   Ylikallio, E
   Patel, M
   Molnar, MJ
   Haller, RG
   Suomalainen, A
AF Tyynismaa, Henna
   Ylikallio, Emil
   Patel, Mehul
   Molnar, Maria J.
   Haller, Ronald G.
   Suomalainen, Anu
TI A Heterozygous Truncating Mutation in <i>RRM2B</i> Causes
   Autosomal-Dominant Progressive External Ophthalmoplegia with Multiple
   mtDNA Deletions
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID MITOCHONDRIAL-DNA DEPLETION; ADENINE-NUCLEOTIDE TRANSLOCATOR;
   RIBONUCLEOTIDE REDUCTASE GENE; IN-VITRO; TWINKLE MUTATIONS; P53R2
   PROTEIN; RESTING CELLS; DNTP POOLS; DAMAGE; ATAXIA
AB Autosomal-dominant progressive external ophthalmoplegia (adPEO) is a mitochondrial disorder that is characterized by accumulation of multiple mitochondrial DNA (mtDNA) deletions in postmitotic tissues. The disorder is heterogeneous, with five known nuclear disease genes that encode the proteins ANTI, Twinkle, POLG, POLG2, and OPA1. Defects in these proteins affect mtDNA maintenance, probably leading to stalled replication forks, consequent mtDNA deletion formation, and progressive respiratory chain deficiency. Here we present a large adPEO family with Multiple mtDNA deletions, whose disease was not explained by mutations in any of the known adPEO loci. We mapped the disease locus in this family to chromosome 8q22.1-q23.3. The critical linkage region contained the RRM2B gene, which encodes the small subunit of the ribonucleotide reductase p53R2, which has previously been shown to be essential for the maintenance of mtDNA copy number. Mutation screening of RRM2B revealed a heterozygous nonsense mutation in exon 9 (c.979C -> T [p.R327X]) in all affected individuals that was absent in 380 control chromosomes. The same mutation was found to segregate in another adPEO family. The mutant mRNA escaped nonsense-mediated decay and resulted in a protein with truncation of 25 highly conserved C-terminal amino acids essential for the interaction with the ribonucleotide reductase subunit R1. We conclude that dominant-negative or gain-of-function mutations in RRM2B are a cause of multiple mtDNA deletions and adPEO.
C1 [Tyynismaa, Henna; Ylikallio, Emil; Suomalainen, Anu] Univ Helsinki, Biomedicum Helsinki, Res Program Mol Neurol, FIN-00290 Helsinki, Finland.
   [Patel, Mehul; Haller, Ronald G.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA.
   [Molnar, Maria J.] Semmelweis Univ, Clin & Res Ctr Mol Neurol, H-1083 Budapest, Hungary.
   [Haller, Ronald G.] Dallas VA Med Ctr, Dallas, TX 75231 USA.
   [Haller, Ronald G.] Inst Exercise & Environm Med, Neuromuscular Ctr, Dallas, TX 75231 USA.
   [Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, FIN-00290 Helsinki, Finland.
C3 University of Helsinki; University of Texas System; University of Texas
   Southwestern Medical Center Dallas; Semmelweis University; University of
   Helsinki; Helsinki University Central Hospital
RP Tyynismaa, H (corresponding author), Univ Helsinki, Biomedicum Helsinki, Res Program Mol Neurol, FIN-00290 Helsinki, Finland.
EM henna.tyynisma@helsinki.fi
RI Tyynismaa, Henna/F-1428-2011; Ylikallio, Emil/S-9434-2019
OI Ylikallio, Emil/0000-0001-5178-0703; Suomalainen-Wartiovaara,
   Anu/0000-0003-4833-5195; Molnar, Maria Judit/0000-0001-9350-1864;
   Tyynismaa, Henna/0000-0002-2493-2422; Patel, Mehul/0000-0002-4654-5933
FU Academy of Finland; Sigrid Juselius Foundation; University of Helsinki;
   VA Merit Review grant
FX The authors would like to thank families I and 2 for participation in
   the study; the Finnish Genome Center for performing the SNP chip
   protocol; and K. Ayyad, N. Romaine, and A. Harju for laboratory
   assistance. V. Bianchi and R Reichard are acknowledged for valuable
   comments. This study was supported by the Academy of Finland (H.T. and
   A.S.), the Sigrid Juselius Foundation (A.S.), University of Helsinki
   (A.S.), and a VA Merit Review grant (R.G.H.).
CR Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Byun DS, 2002, INT J CANCER, V98, P718, DOI 10.1002/ijc.10253
   Chang LF, 2008, P NATL ACAD SCI USA, V105, P18519, DOI 10.1073/pnas.0803313105
   Deng ZL, 2005, WORLD J GASTROENTERO, V11, P5169
   FISHER A, 1993, J MED CHEM, V36, P3859, DOI 10.1021/jm00076a015
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Guittet O, 2001, J BIOL CHEM, V276, P40647, DOI 10.1074/jbc.M106088200
   Håkansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   KUNZ BA, 1994, MUTAT RES-REV GENET, V318, P1, DOI 10.1016/0165-1110(94)90006-X
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev
   Melberg A, 1996, MUSCLE NERVE, V19, P751
   Nakano K, 2000, ONCOGENE, V19, P4283, DOI 10.1038/sj.onc.1203774
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200
   Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   Shao JM, 2004, CANCER RES, V64, P1, DOI 10.1158/0008-5472.CAN-03-3048
   Smeds J, 2002, CARCINOGENESIS, V23, P645, DOI 10.1093/carcin/23.4.645
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 39
TC 95
Z9 104
U1 0
U2 15
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD AUG 14
PY 2009
VL 85
IS 2
BP 290
EP 295
DI 10.1016/j.ajhg.2009.07.009
PG 6
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 488EV
UT WOS:000269332900018
PM 19664747
OA Bronze, Green Published, Green Accepted
DA 2024-11-01
ER

PT J
AU Invernizzi, F
   Varanese, S
   Thomas, A
   Carrara, F
   Onofrj, M
   Zeviani, M
AF Invernizzi, Federica
   Varanese, Sara
   Thomas, Astrid
   Carrara, Franco
   Onofrj, Marco
   Zeviani, Massimo
TI Two novel <i>POLG1</i> mutations in a patient with progressive external
   ophthalmoplegia, levodopa-responsive pseudo-orthostatic tremor and
   parkinsonism
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE progressive external ophthalmoplegia; parkinsonism; polymerase gamma;
   mitochondrial DNA; multiple mtDNA deletions
ID DNA-POLYMERASE-GAMMA; FAMILIAL PARKINSONISM; AUTOSOMAL-DOMINANT;
   DISEASE; DELETIONS; NEUROPATHY; REGION
AB Different mutations, or combinations of mutations, in POLG1, the gene encoding pol gamma A, the catalytic subunit of mitochondrial DNA polymerase, are associated with a spectrum of clinical presentations including autosomal dominant or recessive progressive external ophthalmoplegia (PEO), juvenile-onset ataxia and epilepsy, and Alpers-Huttenlocher syndrome. Parkinsonian features have been reported as a late complication of POLG1-associated dominant PEO. Good response to levodopa or dopamine agonists, reduced dopamine uptake in the corpus striatum and neuronal loss of the Substantia Nigra pars compacta have been documented in a few cases. Here we report two novel mutations in POLG1 in a compound heterozygous patient with autosomal recessive PEO, followed by pseudo-orthostatic tremor evolving into levodopa-responsive parkinsonism. These observations support the hypothesis that mtDNA dysfunction is engaged in the pathogenesis of idiopathic Parkinson's disease. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Invernizzi, Federica; Carrara, Franco; Zeviani, Massimo] IRCCS, C Besta Neurol Inst Fdn, Unit Mol Neurogenet Pierfranco, Milan, Italy.
   [Invernizzi, Federica; Carrara, Franco; Zeviani, Massimo] IRCCS, C Besta Neurol Inst Fdn, Luisa Mariani Ctr Study Childrens Mitochondrial D, Milan, Italy.
   [Varanese, Sara; Thomas, Astrid; Onofrj, Marco] Univ G DAnnunzio, Dept Oncol Neurosci & Neurophysiopathol, Chieti, Italy.
   [Varanese, Sara; Thomas, Astrid; Onofrj, Marco] CeSI G DAnnunzio Univ Fdn, Aging Res Ctr, Chieti, Italy.
C3 G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of
   Chieti-Pescara
RP Zeviani, M (corresponding author), IRCCS, C Besta Neurol Inst Fdn, Unit Mol Neurogenet Pierfranco, Milan, Italy.
EM zeviani@istituto-besta.it
RI Thomas, Alan/G-4807-2011; Zeviani, Massimo/K-2891-2014; THOMAS, Astrid
   Maria/K-7727-2016; onofrj, marco/K-7710-2016; Invernizzi,
   Federica/J-9849-2016
OI THOMAS, Astrid Maria/0000-0003-3853-2996; onofrj,
   marco/0000-0002-0480-2495; Invernizzi, Federica/0000-0001-8072-0152;
   Zeviani, Massimo/0000-0002-9067-5508
FU Telethon [GGP07019] Funding Source: Medline
CR Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Stopinska K, 2006, ACTA BIOCHIM POL, V53, P591
   Thomas A, 2007, MOVEMENT DISORD, V22, P1652, DOI 10.1002/mds.21621
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Wilcox RA, 2007, MOVEMENT DISORD, V22, P1020, DOI 10.1002/mds.21416
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 18
TC 41
Z9 42
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JUN
PY 2008
VL 18
IS 6
BP 460
EP 464
DI 10.1016/j.nmd.2008.04.005
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 331PB
UT WOS:000258023000005
PM 18502641
DA 2024-11-01
ER

PT J
AU Jakupciak, JP
   Wang, W
   Markowitz, ME
   Ally, D
   Coble, M
   Srivastava, S
   Maitra, A
   Barker, PE
   Sidransky, D
   O'Connell, CD
AF Jakupciak, JP
   Wang, W
   Markowitz, ME
   Ally, D
   Coble, M
   Srivastava, S
   Maitra, A
   Barker, PE
   Sidransky, D
   O'Connell, CD
TI Mitochondrial DNA as a cancer biomarker
SO JOURNAL OF MOLECULAR DIAGNOSTICS
LA English
DT Article
ID MONONUCLEOTIDE REPEAT; PROSTATE-CANCER; MTDNA MUTATIONS; PRIMARY TUMORS;
   GENOME; REARRANGEMENTS; SEQUENCE; BRAIN; MUSCLE; LOOP
AB As part of a national effort to identify biomarkers for the early detection of cancer, we developed a rapid and high-throughput sequencing protocol for the detection of sequence variants in mitochondrial DNA. Here, we describe the development and implementation of this protocol for clinical samples. Heteroplasmic and homoplasmic sequence variants occur in the mitochondrial genome in patient tumors. We identified these changes by sequencing mitochondrial DNA obtained from tumors and blood from the same individual. We confirmed previously identified primary lung tumor changes and extended these findings in a small patient cohort. Eight sequence variants were identified in stage I to stage IV tumor samples. Two of the sequence variants identified (22%) were found in the D-loop region, which accounts for 6.8% of the mitochondrial genome. The other sequence variants were distributed throughout the coding region. in the forensic community, the sequence variations used for identification are localized to the D-loop region because this region appears to have a higher rate of mutation. However, in lung tumors the majority of sequence variation occurred in the coding region. Hence, incomplete mitochondrial genome sequencing, designed to scan discrete portions of the genome, misses potentially important sequence variants associated with cancer or other diseases.
C1 NIST, Div Biotechnol, Gaithersburg, MD 20899 USA.
   NCI, Early Detect Res Network, Rockville, MD USA.
   Geocenters Inc, Newton, MA USA.
   Johns Hopkins Univ, Sch Med, Baltimore, MD USA.
C3 National Institute of Standards & Technology (NIST) - USA; National
   Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI);
   Geo-Centers Inc.; Johns Hopkins University
RP NIST, Div Biotechnol, 100 Bur Dr,MS 8311, Gaithersburg, MD 20899 USA.
EM johnj@nist.gov
RI Coble, Michael/E-7540-2010
OI Coble, Michael/0000-0003-3687-0342
FU NCI NIH HHS [Y1CN010309, Y1CN2020] Funding Source: Medline
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Attardi G, 2002, MITOCHONDRION, V2, P27, DOI 10.1016/S1567-7249(02)00032-6
   BAGGETTO LG, 1993, EUR J CANCER, V29A, P156, DOI 10.1016/0959-8049(93)90598-A
   BANDY B, 1990, FREE RADIC BIOL MED, V10, P515
   Barker PE, 2003, ANN NY ACAD SCI, V983, P142, DOI 10.1111/j.1749-6632.2003.tb05969.x
   Cavalli LR, 1998, MUTAT RES-FUND MOL M, V398, P19, DOI 10.1016/S0027-5107(97)00223-6
   Chen JJZ, 2002, CANCER RES, V62, P6470
   Chomyn A, 2003, BIOCHEM BIOPH RES CO, V304, P519, DOI 10.1016/S0006-291X(03)00625-9
   Copeland WC, 2002, CANCER INVEST, V20, P557, DOI 10.1081/CNV-120002155
   Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017
   Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798
   Ha PK, 2002, CLIN CANCER RES, V8, P2260
   Hibi K, 2001, INT J CANCER, V94, P429, DOI 10.1002/ijc.1480
   Hirsch FR, 2001, CLIN CANCER RES, V7, P5
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Jazwinski SM, 2000, TRENDS GENET, V16, P506, DOI 10.1016/S0168-9525(00)02119-3
   Jerónimo C, 2001, ONCOGENE, V20, P5195, DOI 10.1038/sj.onc.1204646
   Jones JB, 2001, CANCER RES, V61, P1299
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504
   Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122
   Melov S, 1999, NEUROBIOL AGING, V20, P565, DOI 10.1016/S0197-4580(99)00092-5
   Meyer S, 2003, MOL BIOL EVOL, V20, P182, DOI 10.1093/molbev/msg019
   MILLER BA, RACIAL ETHNIC PATTER
   Murdock DG, 2000, NUCLEIC ACIDS RES, V28, P4350, DOI 10.1093/nar/28.21.4350
   NEUBERT D, 1981, ARCH TOXICOL, V48, P89, DOI 10.1007/BF00310481
   Nomoto S, 2002, CLIN CANCER RES, V8, P481
   Okochi O, 2002, CLIN CANCER RES, V8, P2875
   Opdal SH, 2002, PEDIATR NEUROL, V27, P23, DOI 10.1016/S0887-8994(02)00384-3
   Parrella P, 2003, CANCER LETT, V190, P73, DOI 10.1016/S0304-3835(02)00578-5
   Parrella P, 2001, CANCER RES, V61, P7623
   Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   Richard SM, 2000, CANCER RES, V60, P4231
   Sanchez-Cespedes M, 2001, CANCER RES, V61, P7015
   SCHUMACHER HR, 1973, LANCET, V2, P327
   SHAY JW, 1992, MUTAT RES, V275, P227, DOI 10.1016/0921-8734(92)90026-L
   Suzuki M, 2003, CLIN CANCER RES, V9, P5636
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Toescu EC, 2000, CELL CALCIUM, V28, P329, DOI 10.1054/ceca.2000.0167
   Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511
   TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B
   Wallace D C, 2001, Novartis Found Symp, V235, P247
   Wallace DC, 1999, P NATL ACAD SCI USA, V96, P1817, DOI 10.1073/pnas.96.5.1817
   WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   Wong LJC, 2002, CLIN CHEM, V48, P1901
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
NR 51
TC 70
Z9 86
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1525-1578
EI 1943-7811
J9 J MOL DIAGN
JI J. Mol. Diagn.
PD MAY
PY 2005
VL 7
IS 2
BP 258
EP 267
DI 10.1016/S1525-1578(10)60553-3
PG 10
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA 921AP
UT WOS:000228736900014
PM 15858150
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Safdar, A
   Bourgeois, JM
   Ogborn, DI
   Little, JP
   Hettinga, BP
   Akhtar, M
   Thompson, JE
   Melov, S
   Mocellin, NJ
   Kujoth, GC
   Prolla, TA
   Tarnopolsky, MA
AF Safdar, Adeel
   Bourgeois, Jacqueline M.
   Ogborn, Daniel I.
   Little, Jonathan P.
   Hettinga, Bart P.
   Akhtar, Mahmood
   Thompson, James E.
   Melov, Simon
   Mocellin, Nicholas J.
   Kujoth, Gregory C.
   Prolla, Tomas A.
   Tarnopolsky, Mark A.
TI Endurance exercise rescues progeroid aging and induces systemic
   mitochondrial rejuvenation in mtDNA mutator mice (Publication with
   Expression of Concern)
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article; Publication with Expression of Concern
DE proliferator-activated receptor gamma coactivator-1 alpha; sarcopenia;
   cardiac hypertrophy
ID SKELETAL-MUSCLE; POINT MUTATIONS; DNA MUTATIONS; PHYSICAL-ACTIVITY;
   PGC-1-ALPHA; DISEASES; EXPRESSION; APOPTOSIS; DELETIONS; ATROPHY
AB A causal role for mitochondrial DNA (mtDNA) mutagenesis in mammalian aging is supported by recent studies demonstrating that the mtDNA mutator mouse, harboring a defect in the proofreading-exonuclease activity of mitochondrial polymerase gamma, exhibits accelerated aging phenotypes characteristic of human aging, systemic mitochondrial dysfunction, multisystem pathology, and reduced lifespan. Epidemiologic studies in humans have demonstrated that endurance training reduces the risk of chronic diseases and extends life expectancy. Whether endurance exercise can attenuate the cumulative systemic decline observed in aging remains elusive. Here we show that 5 mo of endurance exercise induced systemic mitochondrial biogenesis, prevented mtDNA depletion and mutations, increased mitochondrial oxidative capacity and respiratory chain assembly, restored mitochondrial morphology, and blunted pathological levels of apoptosis in multiple tissues of mtDNA mutator mice. These adaptations conferred complete phenotypic protection, reduced multisystem pathology, and prevented premature mortality in these mice. The systemic mitochondrial rejuvenation through endurance exercise promises to be an effective therapeutic approach to mitigating mitochondrial dysfunction in aging and related comorbidities.
C1 [Safdar, Adeel; Hettinga, Bart P.; Akhtar, Mahmood; Mocellin, Nicholas J.; Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada.
   [Safdar, Adeel; Little, Jonathan P.] McMaster Univ, Dept Kinesiol, Hamilton, ON L8N 3Z5, Canada.
   [Safdar, Adeel; Tarnopolsky, Mark A.] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada.
   [Bourgeois, Jacqueline M.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada.
   [Ogborn, Daniel I.] McMaster Univ, Dept Med Sci, Hamilton, ON L8N 3Z5, Canada.
   [Thompson, James E.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA.
   [Thompson, James E.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA.
   [Melov, Simon] Buck Inst Age Res, Novato, CA 94945 USA.
   [Kujoth, Gregory C.; Prolla, Tomas A.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.
   [Kujoth, Gregory C.; Prolla, Tomas A.] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA.
C3 McMaster University; McMaster University; McMaster University; McMaster
   University; McMaster University; Roswell Park Comprehensive Cancer
   Center; Roswell Park Comprehensive Cancer Center; Buck Institute for
   Research on Aging; University of Wisconsin System; University of
   Wisconsin Madison; University of Wisconsin System; University of
   Wisconsin Madison
RP Tarnopolsky, MA (corresponding author), McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada.
EM tarnopol@mcmaster.ca
RI Little, Jonathan/T-4076-2019; Melov, Simon/AAC-9469-2020
OI Little, Jonathan/0000-0002-9796-2008; Melov, Simon/0000-0001-8554-2834;
   Safdar, Adeel/0000-0002-7453-7770; Safdar, Adeel/0000-0003-2469-0467
FU Canadian Institutes of Health Research [MOP97805]; Nathan Shock Award
   [P30AG025708]; Canadian Institutes of Health Research Institute of
   Aging; Canada PRESTIGE; National Sciences and Engineering Research
   Council
FX This work was supported by the Canadian Institutes of Health Research
   (Grant MOP97805), a kind donation from Mr. Warren Lammert and family (to
   M.A.T.), and Nathan Shock Award P30AG025708 (to S.M.). A.S. is funded by
   a Canadian Institutes of Health Research Institute of Aging doctoral
   research scholarship and a Canada PRESTIGE fellowship. D.I.O. and J.P.L.
   are funded by National Sciences and Engineering Research Council
   scholarships. G.C.K. and T.A.P. were awarded US Patent 7,126,040 for the
   Polg<SUP>D257A</SUP> mouse.
CR Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Balbuena L, 2009, FUTURE ONCOL, V5, P1051, DOI [10.2217/fon.09.65, 10.2217/FON.09.65]
   Balducci L, 2003, J AM GERIATR SOC, V51, pS2
   Beal MF, 2009, PARKINSONISM RELAT D, V15, pS189, DOI 10.1016/S1353-8020(09)70812-0
   Boveris A, 2008, FREE RADICAL BIO MED, V44, P224, DOI 10.1016/j.freeradbiomed.2007.08.015
   Brenner Ingrid, 2009, Phys Sportsmed, V37, P84, DOI 10.3810/psm.2009.12.1746
   Buchner DM, 2009, CLIN GERIATR MED, V25, P661, DOI 10.1016/j.cger.2009.08.002
   Cantuti-Castelvetria I, 2005, NEUROBIOL AGING, V26, P1343, DOI 10.1016/j.neurobiolaging.2004.11.008
   Chakravarty EF, 2008, ARCH INTERN MED, V168, P1638, DOI 10.1001/archinte.168.15.1638
   Chaturvedi RK, 2009, HUM MOL GENET, V18, P3048, DOI 10.1093/hmg/ddp243
   Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477
   DiMauro S, 2007, BIOSCIENCE REP, V27, P125, DOI 10.1007/s10540-007-9041-4
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206
   Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785
   Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107
   Handschin C, 2009, TRENDS PHARMACOL SCI, V30, P322, DOI 10.1016/j.tips.2009.03.006
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Hawley JA, 2009, NUTR REV, V67, P172, DOI 10.1111/j.1753-4887.2009.00185.x
   Herring MP, 2010, ARCH INTERN MED, V170, P321, DOI 10.1001/archinternmed.2009.530
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421
   ITO M, 1981, BRIT J RADIOL, V54, P384, DOI 10.1259/0007-1285-54-641-384
   Johannsen DL, 2009, CURR OPIN PHARMACOL, V9, P780, DOI 10.1016/j.coph.2009.09.002
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3
   LINDAL S, 1992, ULTRASTRUCT PATHOL, V16, P263, DOI 10.3109/01913129209061355
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Mott JL, 2005, REJUV RES, V8, P216, DOI 10.1089/rej.2005.8.216
   Mott JL, 2004, BIOCHEM BIOPH RES CO, V319, P1210, DOI 10.1016/j.bbrc.2004.05.104
   Nader GA, 2009, CURR OPIN RHEUMATOL, V21, P599, DOI 10.1097/BOR.0b013e3283319d53
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Safdar A, 2010, FREE RADICAL BIO MED, V49, P1487, DOI 10.1016/j.freeradbiomed.2010.08.010
   Safdar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010778
   Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   Seth A, 2007, CELL METAB, V6, P236, DOI 10.1016/j.cmet.2007.08.004
   Srivastava S, 2009, HUM MOL GENET, V18, P1805, DOI 10.1093/hmg/ddp093
   Stessman J, 2009, ARCH INTERN MED, V169, P1476, DOI 10.1001/archinternmed.2009.248
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Sutherland LN, 2009, J PHYSIOL-LONDON, V587, P1607, DOI 10.1113/jphysiol.2008.165464
   TATE EL, 1976, J GERONTOL, V31, P129, DOI 10.1093/geronj/31.2.129
   ten Hacken Nick H T, 2009, Proc Am Thorac Soc, V6, P663, DOI 10.1513/pats.200907-070DP
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39
   Wasilewski M, 2009, TRENDS ENDOCRIN MET, V20, P287, DOI 10.1016/j.tem.2009.03.007
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008
   Wohlgemuth SE, 2010, EXP GERONTOL, V45, P138, DOI 10.1016/j.exger.2009.11.002
NR 56
TC 255
Z9 289
U1 1
U2 43
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
EI 1091-6490
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 8
PY 2011
VL 108
IS 10
BP 4135
EP 4140
DI 10.1073/pnas.1019581108
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 731PA
UT WOS:000288120400060
PM 21368114
OA Green Published
DA 2024-11-01
ER

PT J
AU Neueder, A
   Kojer, K
   Gu, ZL
   Wang, YQ
   Hering, T
   Tabrizi, S
   Taanman, JW
   Orth, M
AF Neueder, Andreas
   Kojer, Kerstin
   Gu, Zhenglong
   Wang, Yiqin
   Hering, Tanja
   Tabrizi, Sarah
   Taanman, Jan-Willem
   Orth, Michael
TI Huntington's disease affects mitochondrial network dynamics predisposing
   to pathogenic mitochondrial DNA mutations
SO BRAIN
LA English
DT Article
DE mitochondrial fission; mitophagy; huntingtin fragments; DNA instability;
   ultra-deep mitochondrial DNA sequencing; proteomics
ID COPY NUMBER; MUTANT HUNTINGTIN; CAG REPEAT; HETEROPLASMY; PATHOLOGY;
   PROTEIN; MITOPHAGY; REPLICATION; LEUKOCYTES; DEPLETION
AB Huntington's disease (HD) predominantly affects the brain, causing a mixed movement disorder, cognitive decline and behavioural abnormalities. It also causes a peripheral phenotype involving skeletal muscle. Mitochondrial dysfunction has been reported in tissues of HD models, including skeletal muscle, and lymphoblast and fibroblast cultures from patients with HD. Mutant huntingtin protein (mutHTT) expression can impair mitochondrial quality control and accelerate mitochondrial ageing.Here, we obtained fresh human skeletal muscle, a post-mitotic tissue expressing the mutated HTT allele at physiological levels since birth, and primary cell lines from HTT CAG repeat expansion mutation carriers and matched healthy volunteers to examine whether such a mitochondrial phenotype exists in human HD. Using ultra-deep mitochondrial DNA (mtDNA) sequencing, we showed an accumulation of mtDNA mutations affecting oxidative phosphorylation. Tissue proteomics indicated impairments in mtDNA maintenance with increased mitochondrial biogenesis of less efficient oxidative phosphorylation (lower complex I and IV activity). In full-length mutHTT expressing primary human cell lines, fission-inducing mitochondrial stress resulted in normal mitophagy. In contrast, expression of high levels of N-terminal mutHTT fragments promoted mitochondrial fission and resulted in slower, less dynamic mitophagy. Expression of high levels of mutHTT fragments due to somatic nuclear HTT CAG instability can thus affect mitochondrial network dynamics and mitophagy, leading to pathogenic mtDNA mutations.We show that life-long expression of mutant HTT causes a mitochondrial phenotype indicative of mtDNA instability in fresh post-mitotic human skeletal muscle. Thus, genomic instability may not be limited to nuclear DNA, where it results in somatic expansion of the HTT CAG repeat length in particularly vulnerable cells such as striatal neurons. In addition to efforts targeting the causative mutation, promoting mitochondrial health may be a complementary strategy in treating diseases with DNA instability such as HD.
   Neueder et al. reveal an accumulation of mitochondrial DNA mutations and impairments in mitochondrial quality control in fresh skeletal muscle samples from patients with Huntington's disease. Accelerated mitochondrial ageing may thus be one of the biological signatures of Huntington's disease, including in peripheral tissues.
C1 [Neueder, Andreas; Kojer, Kerstin; Hering, Tanja; Orth, Michael] Ulm Univ, Dept Neurol, D-89081 Ulm, Germany.
   [Gu, Zhenglong; Wang, Yiqin] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.
   [Tabrizi, Sarah] UCL Queen Sq Inst Neurol, UCL Huntingtons Dis Ctr, London WC1N 3BG, England.
   [Tabrizi, Sarah] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
   [Tabrizi, Sarah] UCL, Dementia Res Inst, London WC1N 3BG, England.
   [Taanman, Jan-Willem] UCL Queen Sq Inst Neurol, Dept Clin & Movement Neurosci, London NW3 2PF, England.
   [Orth, Michael] Siloah AG, Swiss Huntington Ctr, CH-3073 Gumlingen, Switzerland.
   [Orth, Michael] Bern Univ, Univ Hosp Old Age Psychiat & Psychotherapy, Bolligenstr 111, CH-3000 Bern 60, Switzerland.
C3 Ulm University; Cornell University; University of London; University
   College London; University of London; University College London; UCL
   Medical School; University College London Hospitals NHS Foundation
   Trust; University of London; University College London; University of
   London; University College London
RP Orth, M (corresponding author), Bern Univ, Univ Hosp Old Age Psychiat & Psychotherapy, Bolligenstr 111, CH-3000 Bern 60, Switzerland.
EM michael.orth@siloah.ch
RI Neueder, Andreas/K-4319-2015; Tabrizi, Sarah/HKW-6577-2023; Taanman,
   Jan-Willem/A-5379-2011
OI Taanman, Jan-Willem/0000-0002-5476-9785; Tabrizi,
   Sarah/0000-0003-2716-2045; Neueder, Andreas/0000-0002-2389-5236
FU CHDI Foundation Inc. [A-5497]; German Research Foundation (DFG) [NE
   2372/ 1-1]
FX We would like to thank CHDI Foundation Inc. for funding (CHDI foundation
   grant A-5497 to S.J.T., M.O.). This work was also supported by the
   German Research Foundation (DFG grant NE 2372/ 1-1 to A.N.)
CR Andreux PA, 2019, NAT METAB, V1, P595, DOI 10.1038/s42255-019-0073-4
   Arganda-Carreras I, 2010, MICROSC RES TECHNIQ, V73, P1019, DOI 10.1002/jemt.20829
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   COORE HG, 1971, BIOCHEM J, V125, P115, DOI 10.1042/bj1250115
   Costa V, 2010, EMBO MOL MED, V2, P490, DOI 10.1002/emmm.201000102
   Demestre M, 2015, STEM CELL RES, V15, P328, DOI 10.1016/j.scr.2015.07.005
   Erie C, 2015, EUR J NEUROSCI, V42, P1941, DOI 10.1111/ejn.12957
   Franco-Iborra S, 2021, AUTOPHAGY, V17, P672, DOI 10.1080/15548627.2020.1728096
   Franich NR, 2019, J NEUROSCI RES, V97, P1590, DOI 10.1002/jnr.24493
   Garrison E., PREPRINT
   Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419
   Giorgetti E, 2016, CELL REP, V17, P125, DOI 10.1016/j.celrep.2016.08.084
   Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620
   Guo XX, 2020, NAR GENOM BIOINFORM, V2, DOI 10.1093/nargab/lqaa065
   Guo X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12646
   Guo X, 2013, J CLIN INVEST, V123, P5371, DOI 10.1172/JCI70911
   Hering T, 2015, EXP NEUROL, V266, P22, DOI 10.1016/j.expneurol.2015.02.004
   Hong EP, 2021, J HUNTINGTONS DIS, V10, P35, DOI 10.3233/JHD-200427
   Hwang S, 2015, EMBO MOL MED, V7, P1307, DOI 10.15252/emmm.201505256
   Jedrak P, 2017, METAB BRAIN DIS, V32, P1237, DOI 10.1007/s11011-017-0026-0
   Jin J, 2013, J NEUROCHEM, V125, P410, DOI 10.1111/jnc.12190
   Khalil B, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.581
   KING TE, 1967, J BIOL CHEM, V242, P819
   Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892
   Komsta L, 2006, R News, V6, P10
   Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113
   Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01
   Lee JM, 2019, CELL, V178, P887, DOI 10.1016/j.cell.2019.06.036
   Lee JM, 2015, CELL, V162, P516, DOI 10.1016/j.cell.2015.07.003
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Lieber T, 2019, NATURE, V570, P380, DOI 10.1038/s41586-019-1213-4
   Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44
   Lu AT, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18255-5
   Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0
   Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528
   Matsushima Y, 2010, P NATL ACAD SCI USA, V107, P18410, DOI 10.1073/pnas.1008924107
   MOREADITH RW, 1987, J CLIN INVEST, V79, P463, DOI 10.1172/JCI112834
   Napoli E, 2013, HUM MOL GENET, V22, P989, DOI 10.1093/hmg/dds503
   Neueder A, 2022, GENOME BIOL, V23, DOI 10.1186/s13059-022-02752-5
   Neueder A, 2020, NEURODEGENER DIS MAN, V10, P243, DOI 10.2217/nmt-2019-0033
   Neueder A, 2019, J MOL BIOL, V431, P1780, DOI 10.1016/j.jmb.2018.12.012
   Neueder A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06281-3
   Neueder A, 2018, ADV EXP MED BIOL, V1049, P85, DOI 10.1007/978-3-319-71779-1_4
   Neueder A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01510-z
   Ochaba J, 2014, P NATL ACAD SCI USA, V111, P16889, DOI 10.1073/pnas.1420103111
   Palikaras K, 2018, NAT CELL BIOL, V20, P1013, DOI 10.1038/s41556-018-0176-2
   Penney JB, 1997, ANN NEUROL, V41, P689, DOI 10.1002/ana.410410521
   Petersen MH, 2014, MITOCHONDRION, V17, P14, DOI 10.1016/j.mito.2014.05.001
   Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004
   Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007
   Pinto RM, 2020, HUM MOL GENET, V29, P2551, DOI 10.1093/hmg/ddaa139
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Rebolledo-Jaramillo B, 2014, P NATL ACAD SCI USA, V111, P15474, DOI 10.1073/pnas.1409328111
   Rubino F, 2012, NUCLEIC ACIDS RES, V40, pD1150, DOI 10.1093/nar/gkr1086
   Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]
   Shirendeb UP, 2012, HUM MOL GENET, V21, P406, DOI 10.1093/hmg/ddr475
   Siddiqui A, 2012, FREE RADICAL BIO MED, V53, P1478, DOI 10.1016/j.freeradbiomed.2012.06.008
   Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313
   Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603
   Wang YQ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014610118
   Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001
   Wharton D.C., 1967, Methods Enzymol, V10, P245, DOI [10.1016/0076-6879(67)10048-7, DOI 10.1016/0076-6879(67)10048-7]
   Yang QY, 2022, NAT CELL BIOL, V24, P181, DOI 10.1038/s41556-021-00840-5
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Zhang RY, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4287-0
NR 73
TC 4
Z9 4
U1 2
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD JUN 3
PY 2024
VL 147
IS 6
BP 2009
EP 2022
DI 10.1093/brain/awae007
EA MAY 2024
PG 14
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA SW1X0
UT WOS:001222909400001
PM 38195181
DA 2024-11-01
ER

PT J
AU Caer, M
   Viala, K
   Levy, R
   Maisonobe, T
   Chochon, F
   Lombès, A
   Agid, Y
AF Caer, M
   Viala, K
   Levy, R
   Maisonobe, T
   Chochon, F
   Lombès, A
   Agid, Y
TI Adult-onset chorea and mitochondrial cytopathy
SO MOVEMENT DISORDERS
LA English
DT Article
DE chorea; mitochondrial cytopathy; mitochondrial DNA; movement disorders
ID BILATERAL STRIATAL NECROSIS; MOVEMENT-DISORDERS; DNA MUTATION; DYSTONIA;
   DISEASE; GENE
AB We report on 2 adult patients presenting with choreic movements as the main clinical feature of mitochondrial cytopathy. One patient exhibited a sensory neuronopathy and ophthalmoplegia. The other had ptosis, a proximal myopathy, and a sensory neuropathy. The diagnosis of mitochondrial cytopathy was established by the presence of ragged red fibers, cytochrome C oxydase-negative fibers, and a defect of the complex IV of the respiratory chain in muscle biopsy. No mutations in mitochondrial DNA were detected. The choreic movements observed in juvenile forms of mitochondrial cytopathy are rarely observed in adults. Although striatal vulnerability is commonly reported in patients with mitochondrial disorders, the mechanism by which the mitochondrial dysfunction leads to chorea is not known. (c) 2004 Movement Disorder Society.
C1 Grp Hosp Pitie Salpetriere, Federat Neurol, F-75013 Paris, France.
   Grp Hosp Pitie Salpetriere, Neurophysiol Lab, F-75013 Paris, France.
   Grp Hosp Pitie Salpetriere, INSERM, U523, F-75013 Paris, France.
C3 Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Assistance
   Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere
   - APHP; Institut National de la Sante et de la Recherche Medicale
   (Inserm); Sorbonne Universite; Assistance Publique Hopitaux Paris
   (APHP); Hopital Universitaire Pitie-Salpetriere - APHP
RP Grp Hosp Pitie Salpetriere, Federat Neurol, Blvd Hop, F-75013 Paris, France.
EM richard.levy@psl.ap-hop-paris.fr
RI Levy, Richard/D-8411-2011; Lombes, Anne/G-4684-2014
CR DEMEIRLEIR L, 1994, ANN NEUROL, V36, P522
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Hanna MG, 1997, CURR OPIN NEUROL, V10, P351, DOI 10.1097/00019052-199708000-00012
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   LERA G, 1994, MOVEMENT DISORD, V9, P642, DOI 10.1002/mds.870090610
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   NOVOTNY EJ, 1986, NEUROLOGY, V36, P1053, DOI 10.1212/WNL.36.8.1053
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Solano A, 2003, ANN NEUROL, V54, P527, DOI 10.1002/ana.10682
   Sudarsky L, 1999, MOVEMENT DISORD, V14, P488, DOI 10.1002/1531-8257(199905)14:3<488::AID-MDS1017>3.0.CO;2-4
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   TRUONG DD, 1990, MOVEMENT DISORD, V5, P109, DOI 10.1002/mds.870050204
   ZHOU L, 1997, J NEUROSCI, V17, P1746
NR 13
TC 12
Z9 12
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-3185
EI 1531-8257
J9 MOVEMENT DISORD
JI Mov. Disord.
PD APR
PY 2005
VL 20
IS 4
BP 490
EP 492
DI 10.1002/mds.20363
PG 3
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 918KI
UT WOS:000228540300015
PM 15597339
OA Bronze
DA 2024-11-01
ER

PT J
AU Rubino, E
   Zhang, M
   Mongini, T
   Boschi, S
   Vercelli, L
   Vacca, A
   Govone, F
   Gai, A
   Giordana, MT
   Grinberg, M
   Rogaeva, E
   Rainero, I
AF Rubino, Elisa
   Zhang, Ming
   Mongini, Tiziana
   Boschi, Silvia
   Vercelli, Liliana
   Vacca, Alessandro
   Govone, Flora
   Gai, Annalisa
   Giordana, Maria Teresa
   Grinberg, Mark
   Rogaeva, Ekaterina
   Rainero, Innocenzo
TI Mutation analysis of <i>CHCHD2</i> and <i>CHCHD10</i> in Italian
   patients with mitochondrial myopathy
SO NEUROBIOLOGY OF AGING
LA English
DT Article
DE Mitochondrial myopathy; CHCHD10; CHCHD2; Mitochondrial disease
ID AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL DEMENTIA
AB Mutations in CHCHD2 and CHCHD10 were recently reported in a broad spectrum of neurodegenerative diseases, for example, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia, or mitochondrial myopathy (MM). The aim of the study was to evaluate the prevalence of CHCHD2 and CHCHD10 mutations in Italian MM patients without mitochondrial DNA mutations. The coding regions of CHCHD2 and CHCHD10 were sequenced in 62 MM patients. None of the patients showed CHCHD2 mutations, whereas 1 sporadic MM patient carried a homozygous Pro96Thr substitution in CHCHD10. Muscle biopsy of this patient showed intracellular glycogen accumulation with cytochrome c oxidase negative and ragged red fibers. Our study suggests that the homozygous Pro96Thr mutation in CHCHD10 might be pathogenic but does not support a major role for CHCHD2 in MM pathogenesis. Crown Copyright (C) 2018 Published by Elsevier Inc. All rights reserved.
C1 [Rubino, Elisa; Mongini, Tiziana; Boschi, Silvia; Vercelli, Liliana; Vacca, Alessandro; Govone, Flora; Gai, Annalisa; Giordana, Maria Teresa; Rainero, Innocenzo] Univ Turin, Dept Neurosci Rita Levi Montalcini, Via Cherasco 15, I-10126 Turin, Italy.
   [Zhang, Ming; Grinberg, Mark; Rogaeva, Ekaterina] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada.
   [Mongini, Tiziana; Giordana, Maria Teresa; Rainero, Innocenzo] AOU Citta Salute & Sci, Dept Neurosci & Mental Hlth, Neurol 1, Turin, Italy.
   [Boschi, Silvia] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth NEURO, Florence, Italy.
C3 University of Turin; University of Toronto; A.O.U. Citta della Salute e
   della Scienza di Torino; University of Florence
RP Rubino, E (corresponding author), Univ Turin, Dept Neurosci Rita Levi Montalcini, Via Cherasco 15, I-10126 Turin, Italy.
EM elisa.rubino@unito.it
RI Rubino, Elisa/K-3282-2016
OI BOSCHI, SILVIA/0000-0003-1610-1917; rainero,
   innocenzo/0000-0001-6074-9628; Rubino, Elisa/0000-0002-7553-7553; Vacca,
   Alessandro/0000-0002-2475-0784
FU ALS Canada-Brain Canada Hudson Grant; AIRAlzh Onlus-ANCC-COOP
FX This study was in part supported by the ALS Canada-Brain Canada Hudson
   Grant (ER) and AIRAlzh Onlus-ANCC-COOP (SB).
CR Ajroud-Driss S, 2015, NEUROGENETICS, V16, P1, DOI 10.1007/s10048-014-0421-1
   Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   Dols-Icardo O, 2015, BRAIN, V138, pE400, DOI 10.1093/brain/awv175
   Funayama M, 2015, LANCET NEUROL, V14, P274, DOI 10.1016/S1474-4422(14)70266-2
   Rubino E, 2017, NEUROBIOL AGING, V53, DOI 10.1016/j.neurobiolaging.2016.12.027
   Straub IR, 2018, HUM MOL GENET, V27, P178, DOI 10.1093/hmg/ddx393
   Teyssou E, 2016, NEUROBIOL AGING, V42, DOI 10.1016/j.neurobiolaging.2016.03.022
   Zhang M, 2015, BRAIN, V138, DOI 10.1093/brain/awv082
NR 8
TC 8
Z9 9
U1 0
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0197-4580
EI 1558-1497
J9 NEUROBIOL AGING
JI Neurobiol. Aging
PD JUN
PY 2018
VL 66
AR 181.e1
DI 10.1016/j.neurobiolaging.2018.02.007
PG 2
WC Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA GE1WA
UT WOS:000431006300030
PM 29519717
OA Green Submitted
DA 2024-11-01
ER

PT J
AU Kasahara, A
   Ishikawa, K
   Yamaoka, M
   Ito, M
   Watanabe, N
   Akimoto, M
   Sato, A
   Nakada, K
   Endo, H
   Suda, Y
   Aizawa, S
   Hayashi, JI
AF Kasahara, A
   Ishikawa, K
   Yamaoka, M
   Ito, M
   Watanabe, N
   Akimoto, M
   Sato, A
   Nakada, K
   Endo, H
   Suda, Y
   Aizawa, S
   Hayashi, JI
TI Generation of trans-mitochondrial mice carrying homoplasmic mtDNAs with
   a missense mutation in a structural gene using ES cells
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID DNA-LESS CELLS; PROTEIN-SYNTHESIS; MOUSE MTDNA; ELIMINATION; MUTANT;
   COMPLEMENTATION; EXPRESSION; PHENOTYPES; MYOPATHY; DEAFNESS
AB Generation of various kinds of trans-mitochondrial mice, mito-mice, each carrying mtDNAs with a different pathogenic mutation, is required for precise investigation of the pathogenesis of mitochondrial diseases. This study used two respiration-deficient mouse cell lines as donors of mtDNAs with possible pathogenic mutations. One cell line expressed 45-50% respiratory activity due to mouse mtDNAs with a T6589C missense mutation in the COI gene (T6589C mtDNA) and the other expressed 40% respiratory activity due to rat (Rattus norvegicus) mtDNAs in mouse cells. By cytoplasmic transfer of these mtDNAs to mouse ES cells, we isolated respiration-deficient ES cells. We obtained chimeric mice and generated their F-6 progeny carrying mouse T6589C mtDNAs by its female germ line transmission. They were respiration-deficient and thus could be used as models of mitochondrial diseases caused by point mutations in mtDNA structural genes. However, chimeric mice and mito-mice carrying rat mtDNAs were not obtained, suggesting that significant respiration defects or some deficits induced by rat mtDNAs in mouse ES cells prevented their differentiation to generate mice carrying rat mtDNAs.
C1 Univ Tsukuba, Grad Sch Life & Environm Sci, Inst Biol Sci, Tsukuba, Ibaraki 3058572, Japan.
   Univ Tsukuba, Ctr TARA, Tsukuba, Ibaraki 3058572, Japan.
   Jichi Med Sch, Dept Biochem, Minami Kawachi, Tochigi 3290498, Japan.
   RIKEN, CDB, Lab Vertebrate Body Plan, Kobe, Hyogo 6500047, Japan.
C3 University of Tsukuba; University of Tsukuba; Jichi Medical University;
   RIKEN
RP Univ Tsukuba, Grad Sch Life & Environm Sci, Inst Biol Sci, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058572, Japan.
EM jih45@sakura.cc.tsukuba.ac.jp
OI ISHIKAWA, Kaori/0000-0001-9895-5996
CR Acín-Pérez R, 2003, HUM MOL GENET, V12, P329, DOI 10.1093/hmg/ddg021
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   Dey R, 2000, J BIOL CHEM, V275, P31520, DOI 10.1074/jbc.M004053200
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Hirai M, 1996, BIOCHEM BIOPH RES CO, V219, P951, DOI 10.1006/bbrc.1996.0324
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Inoue K, 1997, BIOCHEM BIOPH RES CO, V239, P257, DOI 10.1006/bbrc.1997.7446
   JABER L, 1992, J MED GENET, V29, P86, DOI 10.1136/jmg.29.2.86
   Johnson KR, 2001, NAT GENET, V27, P191, DOI 10.1038/84831
   KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Levy SE, 1999, TRANSGENIC RES, V8, P137, DOI 10.1023/A:1008967412955
   Marchington DR, 1999, NAT MED, V5, P957, DOI 10.1038/11403
   Matsuoka R, 1999, BIOCHEM BIOPH RES CO, V257, P228, DOI 10.1006/bbrc.1999.0443
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   McKenzie M, 2000, J BIOL CHEM, V275, P31514, DOI 10.1074/jbc.M004070200
   McKenzie M, 2004, P NATL ACAD SCI USA, V101, P1685, DOI 10.1073/pnas.0303184101
   MIYABAYASHI S, 1989, J INHERIT METAB DIS, V12, P373, DOI 10.1007/BF01799245
   Nakada K, 2004, BIOCHEM BIOPH RES CO, V323, P175, DOI 10.1016/j.bbrc.2004.08.073
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590
   SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1
   Shitara H, 2000, GENETICS, V156, P1277
   Shitara H, 1998, GENETICS, V148, P851
   Shoubridge EA, 2000, NAT GENET, V26, P132, DOI 10.1038/79832
   Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597
   Varlamov DA, 2002, HUM MOL GENET, V11, P1797, DOI 10.1093/hmg/11.16.1797
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458
   Yamaoka M, 2000, GENETICS, V155, P301
   Yamaoka M, 2001, BIOCHEM BIOPH RES CO, V282, P707, DOI 10.1006/bbrc.2001.4646
   YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699
   ZIEGLER ML, 1981, SOMAT CELL GENET, V7, P73, DOI 10.1007/BF01544749
NR 35
TC 58
Z9 65
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD MAR 15
PY 2006
VL 15
IS 6
BP 871
EP 881
DI 10.1093/hmg/ddl005
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 018NS
UT WOS:000235771800006
PM 16449238
OA Bronze
DA 2024-11-01
ER

PT J
AU Sacconi, S
   Trevisson, E
   Salviati, L
   Aymé, S
   Rigal, O
   Redondo, AG
   Mancuso, M
   Siciliano, G
   Tonin, P
   Angelini, C
   Auré, K
   Lombès, A
   Desnuelle, C
AF Sacconi, Sabrina
   Trevisson, Eva
   Salviati, Leonardo
   Ayme, Segolene
   Rigal, Odile
   Garcia Redondo, Alberto
   Mancuso, Michelangelo
   Siciliano, Gabriele
   Tonin, Paola
   Angelini, Corrado
   Aure, Karine
   Lombes, Anne
   Desnuelle, Claude
TI Coenzyme Q<sub>10</sub> is frequently reduced in muscle of patients with
   mitochondrial myopathy
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Coenzyme Q(10); Myopathy; Mitochondrial disease; Treatment
ID CEREBELLAR-ATAXIA; RESPIRATORY-CHAIN; UBIQUINONE DEFICIENCY; COQ(10)
   DEFICIENCY; ENCEPHALOMYOPATHY; MUTATIONS; SUPPLEMENTATION; NEPHROPATHY;
   APRATAXIN; DIAGNOSIS
AB Coenzyme Q(10) (CoQ(10)) deficiency has been associated with an increasing number of clinical phenotypes. Whereas primary CoQ(10) defects are related to mutations in lubiquinone biosynthetic genes, which are now being unraveled, and respond well to CoQ(10) Supplementation. the etiologies, and clinical phenotypes related to secondary deficiencies are largely unknown.
   The purpose of this multicenter Study was to evaluate the frequency of muscle CoQ(10) deficiency in a cohort of 76 patients presenting with clinically heterogeneous mitochondrial phenotypes which included myopathy among their clinical features. A reliable diagnostic tool based oil HPLC quantification was employed to measure muscle CoQ(10) levels. A significant proportion of these patients (28 over 76) displayed CoQ(10) deficiency that was clearly secondary in mile patients, who harbored a pathogenic mutation of mitochondrial DNA. This study provides a rationale for future therapeutic trials on the effect of CoQ(10) supplementation in patients with mitochondrial diseases presenting with myopathy among clinical features. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Sacconi, Sabrina] CHU Nice Archet 1, Nice Hosp, UMR 6543, Ctr Reference Malad Neuromusculaires,CNRS,Fac Med, F-06202 Nice 3, France.
   [Trevisson, Eva; Salviati, Leonardo] Univ Padua, Dept Pediat, Genet Unit, I-35100 Padua, Italy.
   [Ayme, Segolene] INSERM SC 11, Paris, France.
   [Rigal, Odile] Hop Robert Debre, Serv Biochim, F-75019 Paris, France.
   [Garcia Redondo, Alberto] Univ Hosp, Ctr Invest, Madrid, Spain.
   [Mancuso, Michelangelo; Siciliano, Gabriele] Dept Neurol, Pisa, Italy.
   [Tonin, Paola] Policlin GB Rossi, Neurol Clin, Verona, Italy.
   [Angelini, Corrado] Univ Padua, Dept Neurosci, Padua, Italy.
   [Aure, Karine; Lombes, Anne] Univ Paris 06, AP HP, GH Pitie Salpetriere, INSERM U 582, F-75013 Paris, France.
C3 CHU Nice; Universite Cote d'Azur; Centre National de la Recherche
   Scientifique (CNRS); University of Padua; Institut National de la Sante
   et de la Recherche Medicale (Inserm); Universite Paris Cite; Assistance
   Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre -
   APHP; University of Verona; Azienda Ospedaliera Universitaria Integrata
   Verona; University of Padua; Sorbonne Universite; Assistance Publique
   Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP;
   Institut National de la Sante et de la Recherche Medicale (Inserm)
RP Sacconi, S (corresponding author), CHU Nice Archet 1, Nice Hosp, UMR 6543, Ctr Reference Malad Neuromusculaires,CNRS,Fac Med, BP 3079, F-06202 Nice 3, France.
EM sacconi@unice.fr
RI Salviati, Leonardo/L-1007-2016; Angelini, Corrado/J-3655-2019;
   GARCÍA-REDONDO, ALBERTO/AAD-9453-2020; Lombes, Anne/G-4684-2014;
   SACCONI, Sabrina/AFT-1096-2022; Tonin, Paola/AAC-5052-2022; Ayme,
   Segolene/ABE-2545-2020; Mancuso, Michelangelo/K-4170-2016; Siciliano,
   Gabriele/K-7259-2016; Trevisson, Eva/K-8462-2016
OI Siciliano, Gabriele/0000-0002-6142-2384; Angelini,
   Corrado/0000-0002-9554-8794; Garcia-Redondo,
   Alberto/0000-0001-7646-386X; SACCONI, Sabrina/0000-0002-0246-1455;
   Trevisson, Eva/0000-0002-5380-6265
FU Telethon [GTB07001D, GGP09207]; Eurobiobank [QLRI-CT-2002-02769]
FX We acknowledge to Telethon Grant No. GTB07001D, and GGP09207 and
   Eurobiobank No. QLRI-CT-2002-02769.
CR Aeby A, 2007, J INHERIT METAB DIS, V30, P827, DOI 10.1007/s10545-007-0612-0
   Benoist JF, 2003, CLIN CHIM ACTA, V329, P147, DOI 10.1016/S0009-8981(02)00423-0
   Boitier E, 1998, J NEUROL SCI, V156, P41, DOI 10.1016/S0022-510X(98)00006-9
   Casarin A, 2008, BIOCHEM BIOPH RES CO, V372, P35, DOI 10.1016/j.bbrc.2008.04.172
   Chinnery P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub2
   CRANE FL, 1993, CLIN INVESTIGATOR, V71, pS55
   Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018
   Fernández-Ayala DJM, 2005, BBA-BIOENERGETICS, V1706, P174, DOI 10.1016/j.bbabio.2004.10.009
   FOLKERS K, 1985, P NATL ACAD SCI USA, V82, P901, DOI 10.1073/pnas.82.3.901
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   Gironi M, 2004, NEUROLOGY, V62, P818, DOI 10.1212/01.WNL.0000113719.67643.B7
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   Lamperti C, 2003, NEUROLOGY, V60, P1206, DOI 10.1212/01.WNL.0000055089.39373.FC
   López LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023
   Miles MV, 2008, MITOCHONDRION, V8, P170, DOI 10.1016/j.mito.2008.01.003
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089
   Montero R, 2005, BIOFACTORS, V25, P109, DOI 10.1002/biof.5520250112
   Montero R, 2008, CLIN BIOCHEM, V41, P697, DOI 10.1016/j.clinbiochem.2008.03.007
   Montero R, 2009, CLIN BIOCHEM, V42, P742, DOI 10.1016/j.clinbiochem.2008.10.027
   Montini G, 2008, NEW ENGL J MED, V358, P2849, DOI 10.1056/NEJMc0800582
   Müller T, 2003, NEUROSCI LETT, V341, P201, DOI 10.1016/S0304-3940(03)00185-X
   Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Quinzii CM, 2007, NEUROCHEM RES, V32, P723, DOI 10.1007/s11064-006-9190-z
   Quinzii CM, 2005, NEUROLOGY, V64, P539, DOI 10.1212/01.WNL.0000150588.75281.58
   Rötig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9
   Salviati L, 2005, NEUROLOGY, V65, P606, DOI 10.1212/01.wnl.0000172859.55579.a7
   Sano Y, 2004, ANN NEUROL, V55, P241, DOI 10.1002/ana.10808
   Sobreira C, 1997, NEUROLOGY, V48, P1238, DOI 10.1212/WNL.48.5.1238
   Van Maldergem L, 2002, ANN NEUROL, V52, P750, DOI 10.1002/ana.10371
NR 32
TC 72
Z9 80
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JAN
PY 2010
VL 20
IS 1
BP 44
EP 48
DI 10.1016/j.nmd.2009.10.014
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 558UG
UT WOS:000274772600006
PM 19945282
DA 2024-11-01
ER

PT J
AU Imai-Okazaki, A
   Yagi, N
   Nitta, KR
   Murayama, K
   Ohtake, A
   Okazaki, Y
AF Imai-Okazaki, Atsuko
   Yagi, Nobuyasu
   Nitta, Kazuhiro R.
   Murayama, Kei
   Ohtake, Akira
   Okazaki, Yasushi
TI Clinical heterogeneity in patients with m.4412G &gt; A MT-TM mutation
   and different heteroplasmy levels
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial disease; Mitochondrial DNA; Mitochondrial respiratory
   chain complex deficiencies; Mitochondrial tRNA; Clinical heterogeneity
AB The identification of the m.4412G > A MT-TM (mt-tRNA(Met)) mutation was first reported in 2019. The affected individual presented with childhood-onset seizures and myopathy and bilateral basal ganglia changes, with heteroplasmy levels in muscle as high as 90%. Here, we describe another adult-onset patient with the same mutation and additional phenotypes, including hearing impairment, cerebellar ataxia, progressive dementia, and myopathy. The 10% heteroplasmy level observed in skin fibroblasts from this patient are lower than those in the previously reported patient. Our report suggests possible clinical heterogeneity in patients with mitochondrial tRNA mutations based on heteroplasmy levels.
C1 [Imai-Okazaki, Atsuko; Nitta, Kazuhiro R.; Okazaki, Yasushi] Juntendo Univ, Grad Sch Med, Intractable Dis Res Ctr, Diagnost & Therapeut Intractable Dis, Tokyo, Japan.
   [Yagi, Nobuyasu] Japanese Red Cross Shizuoka Hosp, Dept Neurol, Shizuoka, Japan.
   [Murayama, Kei] Chiba Childrens Hosp, Dept Metab, Chiba, Japan.
   [Ohtake, Akira] Saitama Med Univ, Dept Pediat & Clin Genom, Saitama, Japan.
   [Ohtake, Akira] Saitama Med Univ Hosp, Ctr Intractable Dis, Saitama, Japan.
   [Okazaki, Yasushi] RIKEN Ctr Integrat Med Sci, Lab Comprehens Genom Anal, Yokohama, Kanagawa, Japan.
C3 Juntendo University; Chiba Children's Hospital; Saitama Medical
   University; Saitama Medical University; RIKEN
RP Okazaki, Y (corresponding author), Juntendo Univ, Intractable Dis Res Ctr, Grad Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.
EM ya-okazaki@juntendo.ac.jp
RI Murayama, Kei/JGM-3674-2023
OI Nitta, Kazuhiro/0000-0003-3151-0962
FU JSPS KAKENHI [JP20K08497, JP18K15863]; MEXT-Supported Program for the
   Private University Research Branding Project; Japan Agency for Medical
   Research and Development, AMED [JP20ek0109468, JP19ek0109273,
   20kk0305015h0001]; Grants-in-Aid for Scientific Research [20K08497]
   Funding Source: KAKEN
FX This work was supported by JSPS KAKENHI Grant Number JP20K08497 and
   JP18K15863; MEXT-Supported Program for the Private University Research
   Branding Project; and the Japan Agency for Medical Research and
   Development, AMED, grant number JP20ek0109468, JP19ek0109273 and
   20kk0305015h0001.
CR GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Lim AZ, 2019, MITOCHONDRION, V47, P18, DOI 10.1016/j.mito.2019.04.007
   Russell OM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20064-2
NR 4
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL
PY 2021
VL 59
BP 214
EP 215
DI 10.1016/j.mito.2021.06.001
EA JUN 2021
PG 2
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA TM4BQ
UT WOS:000675496600009
PM 34089906
DA 2024-11-01
ER

PT J
AU Sarzi, E
   Bourdon, A
   Chrétien, D
   Zarhrate, M
   Corcos, J
   Slama, A
   Cormier-Daire, V
   de Lonlay, P
   Munnich, A
   Rötig, A
AF Sarzi, Emmanuelle
   Bourdon, Alice
   Chretien, Dominique
   Zarhrate, Mohamed
   Corcos, Johanna
   Slama, Abdelhamid
   Cormier-Daire, Valerie
   de Lonlay, Pascale
   Munnich, Arnold
   Rotig, Agnes
TI Mitochondrial DNA depletion is a prevalent cause of multiple respiratory
   chain deficiency in childhood
SO JOURNAL OF PEDIATRICS
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; LEIGH-SYNDROME; MUTATIONS; POLG;
   KINASE; MTDNA; GENE; DELETIONS
AB Objective To determine the actual incidence of mitochondrial DNA (mtDNA) depletion syndrome in multiple respiratory chain deficiency.
   Study design We carried out a real-time polymerase chain reaction quantification of mtDNA in liver or muscle tissue of 100 children with unexplained multiple oxidative phosphorylation enzyme deficiency.
   Results A reduction of mtDNA copy number to < 35% of control values was found in liver and/or muscle in half of the children (50/100). Most of these patients (32/50; 64%) presented with severe neonatal onset liver involvement; 7 (1.4%) had Alpers syndrome, and 11 (22%) exhibited various forms of neurologic involvement. Deoxyguanosine kinase or polymerase gamma (POLG) mutations could be identified in 11 of 32 patients with liver involvement, and POLG imitations were consistently found in all 7 patients with Alpers syndrome. Homozygous thymidine kinase 2 and MPV17 gene mutations were found in 2 patients.
   Conclusions Our findings show that mtDNA depletion is a prevalent cause of multiple respiratory chain deficiency ill infancy.
C1 Hop Necker Enfants Malad, INSERM U781, F-75015 Paris, France.
   Hop Necker Enfants Malad, Genet Unit, F-75015 Paris, France.
   Hop Necker Enfants Malad, Metab Unit, F-75015 Paris, France.
   Hop Bicetre, Biochem Unit, Le Kremlin Bicetre, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Necker-Enfants Malades - APHP; Assistance Publique
   Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire
   Necker-Enfants Malades - APHP; Assistance Publique Hopitaux Paris
   (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants
   Malades - APHP; Universite Paris Saclay; Assistance Publique Hopitaux
   Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Hopital
   Universitaire Bicetre - APHP
RP Rötig, A (corresponding author), Hop Necker Enfants Malad, INSERM U781, 149 Rue Sevres, F-75015 Paris, France.
EM roetig@necker.fr
RI ; ROTIG, AGNES/G-9592-2017; cormier-daire, valerie/H-6520-2017
OI Dominique, Chretien/0000-0002-9954-1549; ROTIG,
   AGNES/0000-0003-0589-0703; cormier-daire, valerie/0000-0002-2839-9856;
   Sarzi, Emmanuelle/0000-0002-7623-6699
CR Absalon MJ, 2001, PEDIATR NEUROL, V24, P60, DOI 10.1016/S0887-8994(00)00226-5
   CormierDaire V, 1997, J PEDIATR-US, V130, P817, DOI 10.1016/S0022-3476(97)80027-3
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filiano JJ, 2002, PEDIATR NEUROL, V26, P239, DOI 10.1016/S0887-8994(01)00377-0
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Labarthe F, 2005, J HEPATOL, V43, P333, DOI 10.1016/j.jhep.2005.03.023
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Petit C, 2003, JAIDS-J ACQ IMM DEF, V33, P461, DOI 10.1097/00126334-200308010-00006
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
NR 23
TC 125
Z9 134
U1 0
U2 7
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-3476
EI 1097-6833
J9 J PEDIATR-US
JI J. Pediatr.
PD MAY
PY 2007
VL 150
IS 5
BP 531
EP 534
DI 10.1016/j.jpeds.2007.01.044
PG 4
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA 164PH
UT WOS:000246245600022
PM 17452231
DA 2024-11-01
ER

PT J
AU Lawless, C
   Greaves, L
   Reeve, AK
   Turnbull, DM
   Vincent, AE
AF Lawless, Conor
   Greaves, Laura
   Reeve, Amy K.
   Turnbull, Doug M.
   Vincent, Amy E.
TI The rise and rise of mitochondrial DNA mutations
SO OPEN BIOLOGY
LA English
DT Review
DE clonal expansion; mtDNA; ageing; disease; mutation; heteroplasmy
ID SUBSTANTIA-NIGRA; SKELETAL-MUSCLE; PARKINSONS-DISEASE; INDIVIDUAL CELLS;
   POINT MUTATIONS; BREAK REPAIR; DELETIONS; MTDNA; MECHANISMS; REPLICATION
AB How mitochondrial DNA mutations clonally expand in an individual cell is a question that has perplexed mitochondrial biologists for decades. A growing body of literature indicates that mitochondrial DNA mutations play a major role in ageing, metabolic diseases, neurodegenerative diseases, neuromuscular disorders and cancers. Importantly, this process of clonal expansion occurs for both inherited and somatic mitochondrial DNA mutations. To complicate matters further there are fundamental differences between mitochondrial DNA point mutations and deletions, and between mitotic and post-mitotic cells, that impact this pathogenic process. These differences, along with the challenges of investigating a longitudinal process occurring over decades in humans, have so far hindered progress towards understanding clonal expansion. Here we summarize our current understanding of the clonal expansion of mitochondrial DNA mutations in different tissues and highlight key unanswered questions. We then discuss the various existing biological models, along with their advantages and disadvantages. Finally, we explore what has been achieved with mathematical modelling so far and suggest future work to advance this important area of research.
C1 [Lawless, Conor; Greaves, Laura; Reeve, Amy K.; Turnbull, Doug M.; Vincent, Amy E.] Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Clin & Translat Res Inst, Newcastle NE2 4HH, England.
C3 Newcastle University - UK
RP Turnbull, DM; Vincent, AE (corresponding author), Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Clin & Translat Res Inst, Newcastle NE2 4HH, England.
EM doug.turnbull@ncl.ac.uk; amy.vincent@ncl.ac.uk
RI Vincent, Amy/J-7284-2019
OI Reeve, Amy/0000-0002-4474-2204; Greaves, Laura/0000-0002-8071-5916;
   Vincent, Amy/0000-0002-0360-6644; Lawless, Conor/0000-0002-4186-8506
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Sir Henry
   Wellcome Fellowship [215888/Z/19/Z]; Senior Parkinson's UK Fellowship
   [F-1401]; Wellcome Trust [215888/Z/19/Z] Funding Source: Wellcome Trust;
   MRC [G0400074, G0502157, G0900652, G1100540] Funding Source: UKRI
FX This work was supported by the Wellcome Centre for Mitochondrial
   Research (203105/Z/16/Z). A.E.V. is in receipt of a Sir Henry Wellcome
   Fellowship (215888/Z/19/Z). A.K.R. is in receipt of a Senior Parkinson's
   UK Fellowship (F-1401).
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Baines HL, 2014, AGING CELL, V13, P201, DOI 10.1111/acel.12199
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bender A, 2008, J NEUROL, V255, P1231, DOI 10.1007/s00415-008-0892-9
   Blackwood JK, 2011, J PATHOL, V225, P181, DOI 10.1002/path.2965
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6
   Boys RJ, 2008, STAT COMPUT, V18, P125, DOI 10.1007/s11222-007-9043-x
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   BROCKINGTON M, 1995, J NEUROL SCI, V131, P78, DOI 10.1016/0022-510X(95)00091-F
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109
   Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01
   Chen C, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104631
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859
   Damas J, 2014, NUCLEIC ACIDS RES, V42, pD1261, DOI 10.1093/nar/gkt982
   Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Dölle C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13548
   Eisner V, 2014, J CELL BIOL, V205, P179, DOI 10.1083/jcb.201312066
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Esser C, 2004, MOL BIOL EVOL, V21, P1643, DOI 10.1093/molbev/msh160
   FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283
   Fellous TG, 2009, STEM CELLS, V27, P1410, DOI 10.1002/stem.67
   Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, pG914, DOI 10.1152/ajpgi.00402.2011
   Frederiksen AL, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039339
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008
   Golightly A, 2011, INTERFACE FOCUS, V1, P807, DOI 10.1098/rsfs.2011.0047
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620
   Greaves LC, 2010, EXP GERONTOL, V45, P573, DOI 10.1016/j.exger.2010.01.013
   Henderson DA, 2009, J AM STAT ASSOC, V104, P76, DOI 10.1198/jasa.2009.0005
   Herbers E, 2019, MITOCHONDRION, V44, P85, DOI 10.1016/j.mito.2018.01.004
   Itoh K, 1997, MOVEMENT DISORD, V12, P9, DOI 10.1002/mds.870120104
   Johnston IG, 2016, AM J HUM GENET, V99, P1150, DOI 10.1016/j.ajhg.2016.09.016
   Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Keeney PM, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-21
   Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0
   Konrad A, 2017, MOL BIOL EVOL, V34, P1319, DOI 10.1093/molbev/msx051
   Kowald A, 2018, GENES-BASEL, V9, DOI 10.3390/genes9030126
   Kowald A, 2014, P NATL ACAD SCI USA, V111, P2972, DOI 10.1073/pnas.1314970111
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Krishnan KJ, 2012, NEUROBIOL AGING, V33, P2210, DOI 10.1016/j.neurobiolaging.2011.08.009
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lakshmanan LN, 2018, AGING CELL, V17, DOI 10.1111/acel.12814
   Lee HF, 2007, EUR J PAEDIATR NEURO, V11, P208, DOI 10.1016/j.ejpn.2006.12.008
   Lehmann D, 2019, NUCLEIC ACIDS RES, V47, P7430, DOI 10.1093/nar/gkz472
   Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Ludwig LS, 2019, CELL, V176, P1325, DOI 10.1016/j.cell.2019.01.022
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035
   McWilliams TG, 2016, J CELL BIOL, V214, P333, DOI 10.1083/jcb.201603039
   Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Mishra P, 2015, CELL METAB, V22, P1033, DOI 10.1016/j.cmet.2015.09.027
   Moad M, 2017, CELL REP, V20, P1609, DOI 10.1016/j.celrep.2017.07.061
   Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417
   Moraes CT, 1999, MOL BIOL CELL, V10, P3345, DOI 10.1091/mbc.10.10.3345
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Nido GS, 2018, NEUROBIOL AGING, V63, P120, DOI 10.1016/j.neurobiolaging.2017.10.024
   Nijtmans LGJ, 2001, J BIOL CHEM, V276, P6755, DOI 10.1074/jbc.M008114200
   Nissanka N, 2019, TRENDS GENET, V35, P235, DOI 10.1016/j.tig.2019.01.001
   Nooteboom M, 2010, AGING CELL, V9, P96, DOI 10.1111/j.1474-9726.2009.00531.x
   Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009
   NOVICK RP, 1976, BACTERIOL REV, V40, P168, DOI 10.1128/MMBR.40.1.168-189.1976
   O'Leary MFN, 2012, AM J PHYSIOL-CELL PH, V303, pC447, DOI 10.1152/ajpcell.00451.2011
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Olsson C, 2001, EUR J HUM GENET, V9, P917, DOI 10.1038/sj.ejhg.5200742
   Persson Ö, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08673-5
   Picard M, 2013, J APPL PHYSIOL, V114, P161, DOI 10.1152/japplphysiol.01096.2012
   Pistilli D, 2003, HUM PATHOL, V34, P1058, DOI 10.1053/S0046-8177(03)00344-7
   Plummer M., 2003, P 3 INT WORKSH DISTR, P1
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088
   Rocha MC, 2018, ANN NEUROL, V83, P115, DOI 10.1002/ana.25127
   Russell OM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20064-2
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Schwartz LM, 2019, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01887
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SOONG NW, 1992, NAT GENET, V2, P318
   Stamp C, 2018, EBIOMEDICINE, V31, P166, DOI 10.1016/j.ebiom.2018.04.017
   Su TH, 2018, GENES-BASEL, V9, DOI 10.3390/genes9040182
   Tadi SK, 2016, MOL BIOL CELL, V27, P223, DOI 10.1091/mbc.E15-05-0260
   Tavare S, 1997, GENETICS, V145, P505
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Verburg J, 2008, J NEUROSCI, V28, P8306, DOI 10.1523/JNEUROSCI.2614-08.2008
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vincent AE, 2018, ANN NEUROL, V84, P289, DOI 10.1002/ana.25288
   WALLACE DC, 1989, TRENDS GENET, V5, P9, DOI 10.1016/0168-9525(89)90005-X
   Wang D, 1998, MUTAT RES-FUND MOL M, V400, P99, DOI 10.1016/S0027-5107(98)00066-9
   Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 108
TC 82
Z9 85
U1 0
U2 14
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
EI 2046-2441
J9 OPEN BIOL
JI Open Biol
PD MAY 20
PY 2020
VL 10
IS 5
AR 200061
DI 10.1098/rsob.200061
PG 12
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA LS6YE
UT WOS:000536526700001
PM 32428418
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Mima, A
   Shiota, F
   Matsubara, T
   Iehara, N
   Akagi, T
   Abe, H
   Nagai, K
   Matsuura, M
   Murakami, T
   Kishi, S
   Araoka, T
   Kishi, F
   Kondo, N
   Shigeta, R
   Yoshikawa, K
   Kita, T
   Doi, T
   Fukatsu, A
AF Mima, Akira
   Shiota, Fumihiko
   Matsubara, Takeshi
   Iehara, Noriyuki
   Akagi, Taro
   Abe, Hideharu
   Nagai, Kojiro
   Matsuura, Motokazu
   Murakami, Taichi
   Kishi, Seiji
   Araoka, Toshikazu
   Kishi, Fumi
   Kondo, Naoki
   Shigeta, Reiko
   Yoshikawa, Kazuhiro
   Kita, Toru
   Doi, Toshio
   Fukatsu, Atsushi
TI An Autopsy Case of Mitochondrial Myopathy, Encephalopathy, Lactic
   Acidosis, and Stroke-Like Episodes (MELAS) with Intestinal Bleeding in
   Chronic Renal Failure
SO RENAL FAILURE
LA English
DT Article
DE MELAS syndrome; end-stage renal disease; gastrointestinal bleeding
ID ENCEPHALOMYOPATHY MELAS; TRNA(LEU(UUR)) GENE; MUTATION
AB A 50-year-old man who underwent hemodialysis (HD) at local outpatient HD center due to end-stage renal disease (ESRD) was transferred to our hospital because of pneumonia. He had severe emaciation and past history of congestive heart failure. Presenting symptoms almost consistently involved difficulty in hearing and recurrent attacks of migraine-like headaches. He was diagnosed with dilated cardiomyopathy, showing diastolic mechanical dyssynchrony by tissue Doppler echocardiography. On the day of death, he had hematemesis and hemorrhagic shock. Autopsy revealed perforation of duodenum, and genetic analysis using mitochondrial DNA from cardiac muscle and iliopsoas muscle revealed a 3243A > G mutation in the mitochondrial tRNA<SULeu(UUR)</SU gene, which is related to mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Multiple organ failure due to the mutation of mitochondrial DNA with gastrointestinal bleeding is not a common.
C1 [Mima, Akira; Abe, Hideharu; Nagai, Kojiro; Matsuura, Motokazu; Murakami, Taichi; Kishi, Seiji; Araoka, Toshikazu; Kishi, Fumi; Kondo, Naoki; Shigeta, Reiko; Yoshikawa, Kazuhiro; Doi, Toshio] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Nephrol, Tokushima 7708503, Japan.
   [Mima, Akira; Shiota, Fumihiko; Matsubara, Takeshi; Iehara, Noriyuki; Fukatsu, Atsushi] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto, Japan.
   [Akagi, Taro] Touseikai Nijo Akagi Clin, Kyoto, Japan.
   [Kita, Toru] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan.
C3 Tokushima University; Kyoto University; Kyoto University
RP Mima, A (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Nephrol, Tokushima 7708503, Japan.
EM akiramima@clin.med.tokushima-u.ac.jp
RI Kondo, Naoki/K-3898-2012; FUKATSU, ATSUSHI/R-7941-2019
FU Grants-in-Aid for Scientific Research [22390169] Funding Source: KAKEN
CR BAN S, 1992, ACTA PATHOL JAPON, V42, P818
   BARAK Y, 1995, ISRAEL J MED SCI, V31, P224
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Kato H, 2006, J NEUROL, V253, P529, DOI 10.1007/s00415-005-0010-1
   Kishnani PS, 1996, EUR J PEDIATR, V155, P898
   MATSUSHITA T, 1993, PEDIATR NEUROL, V9, P391, DOI 10.1016/0887-8994(93)90109-P
   Mochizuki H, 1996, CLIN NEPHROL, V46, P347
   PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915
   RUBANYI GM, 1986, AM J PHYSIOL, V250, pH822, DOI 10.1152/ajpheart.1986.250.5.H822
   SUZUKI S, 1994, DIABETOLOGIA, V37, P818, DOI 10.1007/s001250050183
   Tsujita Y, 2008, INT J CARDIOL, V128, pE43, DOI 10.1016/j.ijcard.2007.05.072
   Yanagihara C, 2001, INTERNAL MED, V40, P662, DOI 10.2169/internalmedicine.40.662
   YONEDA M, 1989, J NEUROL SCI, V92, P143, DOI 10.1016/0022-510X(89)90132-9
NR 14
TC 20
Z9 22
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0886-022X
EI 1525-6049
J9 RENAL FAILURE
JI Ren. Fail.
PY 2011
VL 33
IS 6
BP 622
EP 625
DI 10.3109/0886022X.2011.585730
PG 4
WC Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Urology & Nephrology
GA 776LF
UT WOS:000291535600012
PM 21631236
DA 2024-11-01
ER

PT J
AU Vissing, CR
   Duno, M
   Wibrand, F
   Christensen, M
   Vissing, J
AF Vissing, Christoffer Rasmus
   Duno, Morten
   Wibrand, Flemming
   Christensen, Mette
   Vissing, John
TI Hydroxylated Long-Chain Acylcarnitines are Biomarkers of Mitochondrial
   Myopathy
SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
LA English
DT Article
ID ACID BETA-OXIDATION; SKELETAL-MUSCLE; EXERCISE INTOLERANCE;
   RESPIRATORY-CHAIN; QUANTITATIVE-ANALYSIS; INSULIN-RESISTANCE; MCAD
   DEFICIENCY; BLOOD SPOTS; MUTATION; PLASMA
AB Context: Plasma acylcarnitines are biomarkers of beta-oxidation and are useful in diagnosing several inborn errors of metabolism but have never been investigated systematically in patients with mitochondrial myopathy.
   Objective: We hypothesized that acylcarnitines can also be biomarkers of mitochondrial myopathy and sought to investigate the prevalence and pattern of elevated acylcarnitines.
   Design: This was a prospective cohort study of patients with confirmed mitochondrial myopathy followed at Copenhagen Neuromuscular Center, Rigshospitalet, Copenhagen, Denmark.
   Patients: We included 35 patients (44 +/- 15 years, 15 women) with mitochondrial myopathy caused by single, large-scale deletions of mitochondrial DNA (n = 17), pathogenic variants in mitochondrial transfer RNA (n = 13), or in proteins of the respiratory chain complexes (n = 5).
   Concentrations of 35 acylcarnitines were measured using ultra-HPLC and tandem massspectrometry. Findings were compared with muscle mutation load in all patients and to respiratory chain activity in 26 patients.
   Main Outcome Measures: Prevalence of elevated concentrations of acylcarnitines related to acylcoenzyme A (CoA) dehydrogenases in patients with mitochondrial myopathy and relation to genotypes/phenotypes.
   Results: In total, 27 (77%) patients had elevated concentrations of acylcarnitines related to acyl-CoA dehydrogenases. Elevated concentrations of seven acylcarnitine species were more common in patients compared with a control cohort of >900 individuals, and a specific pattern involving hydroxylated long-chain acylcarnitines occurred in 22 (63%) patients. Severity of derangements was correlated with muscle mutation load and genotypes/phenotypes.
   Conclusion: In conclusion, elevated concentrations of acylcarnitines is common in patients with mitochondrial myopathy and shows a specific pattern affecting hydroxylated long-chain acylcarnitines, which can have implications for future diagnostic workup of patients.
C1 [Vissing, Christoffer Rasmus; Vissing, John] Univ Copenhagen, Rigshosp, Copenhagen Neuromuscular Ctr, Dept Neurol, DK-2100 Copenhagen, Denmark.
   [Duno, Morten; Wibrand, Flemming; Christensen, Mette] Univ Copenhagen, Rigshosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark.
C3 Rigshospitalet; University of Copenhagen; Rigshospitalet; University of
   Copenhagen
RP Vissing, CR (corresponding author), Univ Copenhagen, Copenhagen Neuromuscular Ctr, Dept Neurol, Rigshosp,Sect 3342, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
EM Christoffer.rasmus.vissing@regionh.dk
RI Vissing, Christoffer/AAX-2530-2020; Vissing, John/IUN-4271-2023
OI Vissing, Christoffer/0000-0002-0834-206X; Vissing,
   John/0000-0001-6144-8544
CR Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754
   Aguer C, 2015, FASEB J, V29, P336, DOI 10.1096/fj.14-255901
   Bak AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200817
   Born AP, 2015, EUR J PAEDIATR NEURO, V19, P69, DOI 10.1016/j.ejpn.2014.10.006
   Chace DH, 1997, CLIN CHEM, V43, P2106
   Costa CCG, 1999, PEDIATR RES, V46, P440, DOI 10.1203/00006450-199910000-00013
   DiMauro S, 2007, BIOSCIENCE REP, V27, P5, DOI 10.1007/s10540-007-9032-5
   Eaton S, 1996, BIOCHEM J, V319, P633, DOI 10.1042/bj3190633
   Frye RE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.143
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Indiveri C, 2011, MOL ASPECTS MED, V32, P223, DOI 10.1016/j.mam.2011.10.008
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Jeppesen TD, 2009, ARCH NEUROL-CHICAGO, V66, P365, DOI 10.1001/archneurol.2009.24
   Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013
   KUTTIS J, 1968, ARCH BIOCHEM BIOPHYS, V126, P634, DOI 10.1016/0003-9861(68)90450-5
   Lipina C, 2013, DIABETES, V62, P3426, DOI 10.2337/db13-0264
   LUNDBAEK K, 1948, YALE J BIOL MED, V20, P533
   Makrecka M, 2014, MOL CELL BIOCHEM, V395, P1, DOI 10.1007/s11010-014-2106-3
   Nada MA, 1996, PRENATAL DIAG, V16, P117, DOI 10.1002/(SICI)1097-0223(199602)16:2<117::AID-PD820>3.0.CO;2-Z
   Ostergaard E, 2015, J MED GENET, V52, P203, DOI 10.1136/jmedgenet-2014-102914
   Rafiq J, 2016, JIMD REP, V25, P65, DOI 10.1007/8904_2015_459
   Rebouche CJ, 2004, ANN NY ACAD SCI, V1033, P30, DOI 10.1196/annals.1320.003
   Reuter SE, 2012, CLIN PHARMACOKINET, V51, P553, DOI 10.2165/11633940-000000000-00000
   Rinaldo P, 2008, GENET MED, V10, P151, DOI 10.1097/GIM.0b013e3181614289
   Roos S, 2019, EUR J HUM GENET, V27, P331, DOI 10.1038/s41431-018-0286-0
   Rue N, 2014, J CLIN ENDOCR METAB, V99, P3757, DOI 10.1210/jc.2014-1831
   Schooneman MG, 2014, BBA-MOL CELL BIOL L, V1841, P987, DOI 10.1016/j.bbalip.2014.04.001
   Schooneman MG, 2013, DIABETES, V62, P1, DOI 10.2337/db12-0466
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Sim KG, 2002, METABOLISM, V51, P366, DOI 10.1053/meta.2002.30521
   Soldath P, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1781-0
   Suomalainen A, 2000, MOL BIOTECHNOL, V15, P123, DOI 10.1385/MB:15:2:123
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Tonazzi A, 2015, MINI-REV MED CHEM, V15, P396, DOI 10.2174/138955751505150408142032
   Turpin SM, 2009, J PHYSIOL-LONDON, V587, P1593, DOI 10.1113/jphysiol.2008.166033
   van Eunen K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003186
   Van Hove JLK, 2000, J INHERIT METAB DIS, V23, P571, DOI 10.1023/A:1005673828469
   VANHOVE JLK, 1993, AM J HUM GENET, V52, P958
   Vissing CR, 2013, NEUROLOGY, V80, P1908, DOI 10.1212/WNL.0b013e3182929fb2
   Vissing J, 1998, NEUROLOGY, V50, P1875, DOI 10.1212/WNL.50.6.1875
   Vissing J, 1996, ANN NEUROL, V40, P655, DOI 10.1002/ana.410400416
   WATMOUGH NJ, 1990, J CLIN INVEST, V85, P177, DOI 10.1172/JCI114409
   Wibrand F, 2010, MUSCLE NERVE, V41, P607, DOI 10.1002/mus.21541
   Wilcken B, 2003, NEW ENGL J MED, V348, P2304, DOI 10.1056/NEJMoa025225
NR 44
TC 17
Z9 17
U1 0
U2 8
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0021-972X
EI 1945-7197
J9 J CLIN ENDOCR METAB
JI J. Clin. Endocrinol. Metab.
PD DEC
PY 2019
VL 104
IS 12
BP 5968
EP 5976
DI 10.1210/jc.2019-00721
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA KE0FQ
UT WOS:000508237600032
PM 31294795
OA Bronze
DA 2024-11-01
ER

PT J
AU Naviaux, RK
   Nguyen, KV
AF Naviaux, RK
   Nguyen, KV
TI <i>POLG</i> mutations associated with Alpers' syndrome and mitochondrial
   DNA depletion
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; NEURONAL DEGENERATION;
   POLYMERASE-GAMMA; THYMIDINE KINASE; MTDNA DEPLETION; GENE; DELETIONS;
   DISEASE; DEFICIENCY; CHILDHOOD
AB Alpers' syndrome is a fatal neurogenetic disorder first described more than 70 years ago. It is an autosomal recessive, developmental mitochondrial DNA depletion disorder characterized by deficiency in mitochondrial DNA polymerase gamma (POLG) catalytic activity, refractory seizures, neurodegeneration, and liver disease. In two unrelated pedigrees of Alpers' syndrome, each affected child was found to carry a homozygous mutation in exon 17 of the POLG locus that led to a Glu873Stop mutation just upstream of the polymerase domain of the protein. In addition, each affected child was heterozygous for the G1681A mutation in exon 7 that led to an Ala467Thr substitution in POLG, within the linker region of the protein.
C1 Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92103 USA.
   Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA.
   Univ Calif San Diego, Mitochondrial & Metab Dis Ctr, San Diego, CA 92103 USA.
C3 University of California System; University of California San Diego;
   University of California System; University of California San Diego;
   University of California System; University of California San Diego
RP Naviaux, RK (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, 214 Dickinson St,Bldg CTF,Room C-103, San Diego, CA 92103 USA.
EM naviaux@ucsd.edu
FU NCRR NIH HHS [M01 RR00827] Funding Source: Medline
CR Alam SL, 1999, J MOL BIOL, V288, P837, DOI 10.1006/jmbi.1999.2713
   Alpers BJ, 1931, ARCH NEURO PSYCHIATR, V25, P469, DOI 10.1001/archneurpsyc.1931.02230030027002
   BOHNERT B, 1974, ARCH PSYCHIAT NERVEN, V218, P353, DOI 10.1007/BF00342578
   Burgers PMJ, 2001, J BIOL CHEM, V276, P43487, DOI 10.1074/jbc.R100056200
   Gauthier-Villars M, 2001, NEUROPEDIATRICS, V32, P150, DOI 10.1055/s-2001-16614
   HARDING BN, 1995, J NEUROL NEUROSUR PS, V58, P320, DOI 10.1136/jnnp.58.3.320
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Heath EM, 2001, ARCH PATHOL LAB MED, V125, P127
   HUTTENLOCHER PR, 1976, ARCH NEUROL-CHICAGO, V33, P186, DOI 10.1001/archneur.1976.00500030042009
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4
   Maas S, 2000, BIOESSAYS, V22, P790, DOI 10.1002/1521-1878(200009)22:9<790::AID-BIES4>3.3.CO;2-S
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   MANCUSO M, 2002, J NEUROL SCI, P199
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   NAVIAUX RK, 1998, ATLAS METABOLIC DIS, P314
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Robinson DN, 1997, DEVELOPMENT, V124, P1405
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SANDBANK U, 1972, J NEUROL NEUROSUR PS, V35, P749, DOI 10.1136/jnnp.35.6.749
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   TAANMAN JW, 2000, P 11 EUR BIOEN C EBE
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Van Goethem G, 2002, ACTA NEUROL BELG, V102, P39
NR 29
TC 329
Z9 349
U1 0
U2 20
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0364-5134
J9 ANN NEUROL
JI Ann. Neurol.
PD MAY
PY 2004
VL 55
IS 5
BP 706
EP 712
DI 10.1002/ana.20079
PG 7
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 816NE
UT WOS:000221115800014
PM 15122711
DA 2024-11-01
ER

PT J
AU Pereira, CV
   Peralta, S
   Arguello, T
   Bacman, SR
   Diaz, F
   Moraes, CT
AF Pereira, Claudia, V
   Peralta, Susana
   Arguello, Tania
   Bacman, Sandra R.
   Diaz, Francisca
   Moraes, Carlos T.
TI Myopathy reversion in mice after restauration of mitochondrial complex I
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE adeno-associated virus; complex I; gene therapy; mitochondrial
   myopathies; NDUFS3
ID ADENOASSOCIATED VIRUS; SKELETAL-MUSCLE; MOUSE MODEL; LEIGH-SYNDROME;
   CLINICAL-FEATURES; DNA MUTATIONS; GENE-TRANSFER; DEFICIENCY;
   CARDIOMYOPATHY; EXPRESSION
AB Myopathies are common manifestations of mitochondrial diseases. To investigate whether gene replacement can be used as an effective strategy to treat or cure mitochondrial myopathies, we have generated a complex I conditional knockout mouse model lacking NDUFS3 subunit in skeletal muscle. NDUFS3 protein levels were undetectable in muscle of 15-day-old smKO mice, and myopathy symptoms could be detected by 2 months of age, worsening over time. rAAV9-Ndufs3 delivered systemically into 15- to 18-day-old mice effectively restored NDUFS3 levels in skeletal muscle, precluding the development of the myopathy. To test the ability of rAAV9-mediated gene replacement to revert muscle function after disease onset, we also treated post-symptomatic, 2-month-old mice. The injected mice showed a remarkable improvement of the mitochondrial myopathy and biochemical parameters, which remained for the duration of the study. Our results showed that muscle pathology could be reversed after restoring complex I, which was absent for more than 2 months. These findings have far-reaching implications for the ability of muscle to tolerate a mitochondrial defect and for the treatment of mitochondrial myopathies.
C1 [Pereira, Claudia, V; Peralta, Susana; Arguello, Tania; Bacman, Sandra R.; Diaz, Francisca; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
   [Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA.
C3 University of Miami; University of Miami
RP Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.; Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA.
EM cmoraes@med.miami.edu
RI Moraes, Carlos/AAT-3818-2021
FU National Institutes of Health [R01EY0108041, R01AG036871, R01NS079965,
   R33ES025673]; CHAMP Foundation; Muscular Dystrophy Association
FX We are grateful to Michelle Barragan, Alexis Lopez, Aline Hida, and
   Paula Lima for assistance with mice genotyping and behavior. This work
   was partially supported by the National Institutes of Health grants
   (R01EY0108041, R01AG036871, R01NS079965, R33ES025673), the CHAMP
   Foundation, and the Muscular Dystrophy Association.
CR Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200
   Arii J, 2000, AM J NEURORADIOL, V21, P1502
   Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1
   Bénit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316
   Bénit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225
   Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F
   Chen B, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00265
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Di Meo I, 2017, GENE THER, V24, P661, DOI 10.1038/gt.2017.53
   Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307
   Diaz F., 2009, CURR PROTOC HUM GENE
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Fassone E, 2011, J MED GENET, V48, P691, DOI 10.1136/jmedgenet-2011-100340
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Finsterer J, 2017, AM J MED GENET A, V173, P1450, DOI 10.1002/ajmg.a.38225
   Fisher KJ, 1997, NAT MED, V3, P306, DOI 10.1038/nm0397-306
   Flierl A, 2005, GENE THER, V12, P570, DOI 10.1038/sj.gt.3302443
   Garone C, 2018, BIOCHEM SOC T, V46, P1247, DOI 10.1042/BST20180134
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Guerrero-Castillo S, 2017, CELL METAB, V25, P128, DOI 10.1016/j.cmet.2016.09.002
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Ingraham CA, 2009, MITOCHONDRION, V9, P204, DOI 10.1016/j.mito.2009.02.001
   Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005
   Ke BX, 2012, P NATL ACAD SCI USA, V109, P6165, DOI 10.1073/pnas.1113987109
   Kirches E, 2011, CURR GENOMICS, V12, P44, DOI 10.2174/138920211794520150
   Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004
   LEVAKFRANK S, 1995, J CLIN INVEST, V96, P976, DOI 10.1172/JCI118145
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725
   Lou XT, 2018, J HUM GENET, V63, P1283, DOI 10.1038/s10038-018-0517-9
   Lou XT, 2018, J HUM GENET, V63, P1269, DOI 10.1038/s10038-018-0505-0
   LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465
   Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010
   Peralta S, 2016, HUM MOL GENET, V25, P3178, DOI 10.1093/hmg/ddw167
   Peralta S, 2014, HUM MOL GENET, V23, P1399, DOI 10.1093/hmg/ddt526
   Pruchnic R, 2000, HUM GENE THER, V11, P521, DOI 10.1089/10430340050015716
   Quintana A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042904
   Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rodenburg RJ, 2016, BBA-BIOENERGETICS, V1857, P938, DOI 10.1016/j.bbabio.2016.02.012
   ROWLAND LP, 1991, REV NEUROL-FRANCE, V147, P467
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058
   Suzuki-Hatano S, 2019, HUM GENE THER, V30, P139, DOI 10.1089/hum.2018.020
   Torres-Torronteras J, 2011, GENE THER, V18, P795, DOI 10.1038/gt.2011.24
   Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686
   Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200
   WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U
   Wiedemann N, 2017, ANNU REV BIOCHEM, V86, P685, DOI 10.1146/annurev-biochem-060815-014352
   Wirth C, 2016, BBA-BIOENERGETICS, V1857, P902, DOI 10.1016/j.bbabio.2016.02.013
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
   Xiao XA, 1996, J VIROL, V70, P8098, DOI 10.1128/JVI.70.11.8098-8108.1996
   Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095
NR 59
TC 26
Z9 28
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD FEB 7
PY 2020
VL 12
IS 2
AR e10674
DI 10.15252/emmm.201910674
EA JAN 2020
PG 17
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA KL5VP
UT WOS:000506241800001
PM 31916679
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Papadimas, GK
   Kokkinis, C
   Xirou, S
   Chrysanthou, M
   Kararizou, E
   Papadopoulos, C
AF Papadimas, George K.
   Kokkinis, Charalampos
   Xirou, Sophia
   Chrysanthou, Margarita
   Kararizou, Evangelia
   Papadopoulos, Constantinos
TI Polymyositis with mitochondrial pathology or atypical form of sporadic
   inclusion body myositis: case series and review of the literature
SO RHEUMATOLOGY INTERNATIONAL
LA English
DT Review
DE Polymyositis; Mitochondria; mtDNA; Inclusion body myositis
ID DNA DELETIONS; HYPOTHYROID MYOPATHY; MUSCLE-FIBERS
AB Polymyositis with mitochondrial pathology (PM-Mito) is a rare form of idiopathic inflammatory myopathy with no definite diagnostic criteria and similarities to both PM and sporadic inclusion body myositis (s-IBM). The aim of this study is to address the dilemma of whether PM-Mito is a subtype of inflammatory myopathy or represents a disease falling into the spectrum of s-IBM. Herein, we report four female patients diagnosed with PM-Mito, highlighting their rather atypical clinical and histopathological characteristics that seem to indicate a diagnosis away from s-IBM. Muscle weakness was rather proximal and symmetrical and lacked the selective pattern observed in s-IBM. Patients had large-scale deletions in mtDNA, reflecting the mitochondrial component in the pathology of the disease. Conclusively, our study adds to the limited data in the literature on whether PM-Mito is a distinct form of myositis or represents a prodromal stage of s-IBM. Although the latter seems to be supported by a substantial body of evidence, there are, however, important differences, such as the different patterns of muscle weakness, and the good response to treatment observed in some patients. Larger-scale studies are certainly needed to clarify pathogenesis and clinical characteristics of PM-Mito patients, especially in therapeutic and prognostic terms.
C1 [Papadimas, George K.; Xirou, Sophia; Chrysanthou, Margarita; Kararizou, Evangelia; Papadopoulos, Constantinos] Univ Athens, Eginit Hosp, Sch Med, Dept Neurol 1, 74 Vas Sophias Ave, Athens 11528, Greece.
   [Kokkinis, Charalampos] Univ Athens, St Sofias Childrens Hosp, Sch Med, Dept Med Genet, Athens, Greece.
C3 Athens Medical School; National & Kapodistrian University of Athens;
   Athens Medical School; National & Kapodistrian University of Athens
RP Papadimas, GK (corresponding author), Univ Athens, Eginit Hosp, Sch Med, Dept Neurol 1, 74 Vas Sophias Ave, Athens 11528, Greece.
EM gkpapad@yahoo.gr; haris.kokkinis@gmail.com; sopxir@hotmail.com;
   margarita.chrysanthou@gmail.com; ekarariz@med.uoa.gr;
   constantinospapadopoulos@yahoo.com
OI xirou, sophia/0000-0001-8222-091X
CR Amato Anthony A, 2013, Continuum (Minneap Minn), V19, P1615, DOI 10.1212/01.CON.0000440662.26427.bd
   Blume G, 1997, BRAIN, V120, P39, DOI 10.1093/brain/120.1.39
   Brady S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004552
   Brady S, 2013, J NEUROL NEUROSUR PS, V84, P1240, DOI 10.1136/jnnp-2013-305690
   Chariot P, 1996, ACTA NEUROPATHOL, V91, P530, DOI 10.1007/s004010050462
   Delalande S, 2004, MEDICINE, V83, P280, DOI 10.1097/01.md.0000141099.53742.16
   Fauchais AL, 2010, AUTOIMMUN REV, V9, P595, DOI 10.1016/j.autrev.2010.05.004
   Finsterer J, 1999, HORM RES, V52, P205, DOI 10.1159/000023462
   FLORENCE JM, 1992, PHYS THER, V72, P115, DOI 10.1093/ptj/72.2.115
   Gallay L, 2016, REV NEUROL-FRANCE, V172, P581, DOI 10.1016/j.neurol.2016.07.016
   Greenberg Steven A, 2016, Continuum (Minneap Minn), V22, P1871
   GRIGGS RC, 1995, ANN NEUROL, V38, P705, DOI 10.1002/ana.410380504
   Hiniker A, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-29
   Lamperti C, 2009, Acta Myol, V28, P2
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   Lundberg IE, 2018, NAT REV RHEUMATOL, V14, P269, DOI 10.1038/nrrheum.2018.41
   Mastaglia FL, 2015, J CLIN NEUROSCI, V22, P6, DOI 10.1016/j.jocn.2014.09.012
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Modi G, 2000, J NEUROL SCI, V175, P28, DOI 10.1016/S0022-510X(00)00266-5
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Oh TH, 2007, MAYO CLIN PROC, V82, P441, DOI 10.4065/82.4.441
   Oldfors A, 2006, NEUROLOGY, V66, pS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Rojana-udomsart A, 2011, CLIN NEUROL NEUROSUR, V113, P559, DOI 10.1016/j.clineuro.2011.03.016
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   Siepmann T, 2013, ANN DIAGN PATHOL, V17, P183, DOI 10.1016/j.anndiagpath.2012.10.004
   Simon JP, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00234
   Temiz P, 2009, J NEUROL SCI, V278, P25, DOI 10.1016/j.jns.2008.11.010
   Varadhachary AS, 2010, CURR OPIN RHEUMATOL, V22, P651, DOI 10.1097/BOR.0b013e32833f108a
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
NR 32
TC 9
Z9 11
U1 0
U2 2
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0172-8172
EI 1437-160X
J9 RHEUMATOL INT
JI Rheumatol. Int.
PD AUG
PY 2019
VL 39
IS 8
BP 1459
EP 1466
DI 10.1007/s00296-019-04314-8
PG 8
WC Rheumatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Rheumatology
GA IF6LI
UT WOS:000473191800019
PM 31055642
DA 2024-11-01
ER

PT J
AU Anteneová, N
   Kelifová, S
   Kolárová, H
   Vondrácková, A
   Tóthová, I
   Lisková, P
   Magner, M
   Zámecník, J
   Hansíková, H
   Zeman, J
   Tesarová, M
   Honzík, T
AF Anteneova, Nicole
   Kelifova, Silvie
   Kolarova, Hana
   Vondrackova, Alzbeta
   Tothova, Iveta
   Liskova, Petra
   Magner, Martin
   Zamecnik, Josef
   Hansikova, Hana
   Zeman, Jiri
   Tesarova, Marketa
   Honzik, Tomas
TI The Phenotypic Spectrum of 47 Czech Patients with Single, Large-Scale
   Mitochondrial DNA Deletions
SO BRAIN SCIENCES
LA English
DT Article
DE Kearns-Sayre Syndrome (KSS) Spectrum; Progressive External
   Ophthalmoplegia (PEO); Pearson Syndrome; mtDNA; Single; Large-Scale
   Mitochondrial DNA Deletions (SLSMD)
ID KEARNS-SAYRE-SYNDROME; CEREBRAL FOLATE-DEFICIENCY; CEREBROSPINAL-FLUID;
   PEARSON SYNDROME; OPHTHALMOPLEGIA; MECHANISMS; DISORDERS; ANEMIA; PLUS
AB Background: In this retrospective study, we analysed clinical, biochemical and molecular genetic data of 47 Czech patients with Single, Large-Scale Mitochondrial DNA Deletions (SLSMD). Methods: The diagnosis was based on the long-range PCR (LX-PCR) screening of mtDNA isolated from muscle biopsy in 15 patients, and from the buccal swab, urinary epithelial cells and blood in 32 patients. Results: A total of 57% patients manifested before the age of 16. We did not find any significant difference between paediatric and adult manifestation in either the proportion of patients that would develop extraocular symptoms, or the timespan of its progression. The survival rate in patients with Pearson Syndrome reached 60%. Altogether, five patients manifested with atypical phenotype not fulfilling the latest criteria for SLSMD. No correlation was found between the disease severity and all heteroplasmy levels, lengths of the deletion and respiratory chain activities in muscle. Conclusions: Paediatric manifestation of Progressive External Ophthalmoplegia (PEO) is not associated with a higher risk of multisystemic involvement. Contrary to PEO and Kearns-Sayre Syndrome Spectrum, Pearson Syndrome still contributes to a significant childhood mortality. SLSMD should be considered even in cases with atypical presentation. To successfully identify carriers of SLSMD, a repeated combined analysis of buccal swab and urinary epithelial cells is needed.
C1 [Anteneova, Nicole; Kelifova, Silvie; Kolarova, Hana; Vondrackova, Alzbeta; Tothova, Iveta; Liskova, Petra; Magner, Martin; Hansikova, Hana; Zeman, Jiri; Tesarova, Marketa; Honzik, Tomas] Charles Univ Prague, Fac Med 1, Dept Paediat & Inherited Metab Disorders, Ke Karlovu 2, Prague 12808 2, Czech Republic.
   [Anteneova, Nicole; Kelifova, Silvie; Kolarova, Hana; Vondrackova, Alzbeta; Tothova, Iveta; Liskova, Petra; Magner, Martin; Hansikova, Hana; Zeman, Jiri; Tesarova, Marketa; Honzik, Tomas] Gen Univ Hosp, Ke Karlovu 2, Prague 12808 2, Czech Republic.
   [Liskova, Petra] Charles Univ Prague, Fac Med 1, Dept Ophthalmol, U Nemocnice 2, Prague 12808 2, Czech Republic.
   [Liskova, Petra] Gen Univ Hosp, U Nemocnice 2, Prague 12808 2, Czech Republic.
   [Magner, Martin] Charles Univ Prague, Fac Med 1, Dept Paediat, Videnska 800, Prague 14059 4, Czech Republic.
   [Magner, Martin] Thomayer Hosp, Videnska 800, Prague 14059 4, Czech Republic.
   [Zamecnik, Josef] Charles Univ Prague, Fac Med 2, Dept Pathol & Mol Med, V Uvalu 84, Prague 15006 5, Czech Republic.
   [Zamecnik, Josef] Motol Univ Hosp, V Uvalu 84, Prague 15006 5, Czech Republic.
C3 Charles University Prague; General University Hospital Prague; General
   University Hospital Prague; Charles University Prague; General
   University Hospital Prague; Charles University Prague; Thomayer
   Hospital; Motol University Hospital; Charles University Prague; Motol
   University Hospital
RP Tesarová, M (corresponding author), Charles Univ Prague, Fac Med 1, Dept Paediat & Inherited Metab Disorders, Ke Karlovu 2, Prague 12808 2, Czech Republic.; Tesarová, M (corresponding author), Gen Univ Hosp, Ke Karlovu 2, Prague 12808 2, Czech Republic.
EM nicole.anteneova@vfn.cz; silvie.kelifova@vfn.cz; hana.kolarova@vfn.cz;
   alzbeta.vondrackova@lf1.cuni.cz; iveta.tothova@vfn.cz;
   petra.liskova@lf1.cuni.cz; martin.magner@vfn.cz;
   josef.zamecnik@lfmotol.cuni.cz; hana.hansikova@vfn.cz; jzem@lf1.cuni.cz;
   marketa.tesarova@vfn.cz; tomas.honzik@vfn.cz
RI Vondrackova, Alzbeta/I-9534-2017; Magner, Martin/J-3553-2017; Liskova,
   Petra/C-9680-2011; Hansikova, Hana/E-9350-2017; Tesarova,
   Marketa/I-1531-2016
OI Liskova, Petra/0000-0001-7834-8486; Hansikova, Hana/0000-0002-2734-225X;
   Tesarova, Marketa/0000-0002-5141-2289
FU Ministry of Health of the Czech Republic [AZV 17-30965A, NU20-07-00182,
   RVO VFN 64165]; Charles University [Progress Q26/LF1, UNCE 204064,
   SVV260367]
FX This study was supported by research grants from the Ministry of Health
   of the Czech Republic (AZV 17-30965A, NU20-07-00182, RVO VFN 64165), and
   Charles University (Progress Q26/LF1, UNCE 204064, SVV260367).
   Individual support of Hana Kola.rova was provided by Alzheimer
   Foundation Czech Republic. The funding bodies were not involved in the
   design YYYYof the study, collection, analysis and interpretation of
   data, and in the writing of the manuscript.
CR Akman CI, 2004, J CHILD NEUROL, V19, P258, DOI 10.1177/088307380401900403
   ALLEN RJ, 1983, ANN NEUROL, V13, P679, DOI 10.1002/ana.410130620
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Bosbach S, 2003, BRAIN, V126, P1231, DOI 10.1093/brain/awg101
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Danhelovska T, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-1912-x
   DRACHMAN DA, 1968, ARCH NEUROL-CHICAGO, V18, P654, DOI 10.1001/archneur.1968.00470360076008
   Dvorakova V, 2016, MOL GENET METAB, V118, P288, DOI 10.1016/j.ymgme.2016.06.003
   Farruggia P, 2016, JIMD REP, V26, P37, DOI 10.1007/8904_2015_470
   Garcia-Cazorla A, 2008, NEUROLOGY, V70, P1360, DOI 10.1212/01.wnl.0000309223.98616.e4
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Gustafson MA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221829
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   Lee SJ, 2018, YONSEI MED J, V59, P1190
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Mancuso M., 2019, DIAGNOSIS MANAGEMENT, P141
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Manea EM, 2009, J PEDIAT HEMATOL ONC, V31, P947, DOI 10.1097/MPH.0b013e3181bbc4ef
   Mazurova S, 2020, J DERMATOL, V47, P663, DOI 10.1111/1346-8138.15317
   Ormazabal A, 2006, CLIN CHIM ACTA, V371, P159, DOI 10.1016/j.cca.2006.03.004
   Ruiz EP, 2019, NEUROLOGIA, V34, P618, DOI [10.1016/j.nrl.2017.01.005, 10.1016/j.nrleng.2018.12.005]
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Pineda M, 2006, ANN NEUROL, V59, P394, DOI 10.1002/ana.20746
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Quijada-Fraile P, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0217-2
   Rocha MC, 2018, ANN NEUROL, V83, P115, DOI 10.1002/ana.25127
   ROWLAND LP, 1983, NEUROLOGY, V33, P1179, DOI 10.1212/WNL.33.9.1179
   Sato A, 2007, GENETICS, V177, P2031, DOI 10.1534/genetics.107.081026
   Serrano M, 2010, MITOCHONDRION, V10, P429, DOI 10.1016/j.mito.2010.04.001
   SICILIANO G, 1992, CLIN NEUROL NEUROSUR, V94, P133, DOI 10.1016/0303-8467(92)90070-J
   Tanji K, 2000, J NEUROL SCI, V178, P29, DOI 10.1016/S0022-510X(00)00354-3
   Tesarova M, 2019, PEDIATR BLOOD CANCER, V66, DOI 10.1002/pbc.27591
   Varhaug KN, 2020, ANN CLIN TRANSL NEUR, V7, P1318, DOI 10.1002/acn3.51119
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
NR 36
TC 9
Z9 9
U1 0
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3425
J9 BRAIN SCI
JI Brain Sci.
PD NOV
PY 2020
VL 10
IS 11
AR 766
DI 10.3390/brainsci10110766
PG 13
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA OX4EO
UT WOS:000593520100001
PM 33105723
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Feng, YQ
   Guo, N
   Huang, F
   Li, L
   Yao, XL
   Li, XH
   Zhang, C
   Liang, XL
AF Feng, YQ
   Guo, N
   Huang, F
   Li, L
   Yao, XL
   Li, XH
   Zhang, C
   Liang, XL
TI Clinical, pathological and genetic study of a kindred of mitochondrial
   encephalomyopathy with lactic acidosis and stroke-like episodes
SO CHINESE MEDICAL JOURNAL
LA English
DT Article
DE mitochondrial encephalornyopathy with lactic acidosis; stroke-like
   episodes pathology gene sequencing
ID MUTATION; MELAS; DNA; DIAGNOSIS; MYOPATHY
AB he first description of a syndrome including stroke-like episodes, lactic acidaemia, and ragged red fibres, was reported by Shapira et al in 1975.(1) Pavlakis et al(2) described further cases, introduced the acronym MELAS (mitochondrial encephalomyopathy with lactic acidosis and strokelike episodes), and suggested that this represented a distinct mitochondrial disease phenotype. In 1990, Goto et al(3) identified A3243G mutation in the transfer RNA (tRNA) leucine (UUR) gene in some patients with MELAS. Although this mutation has now been established to be the commonest mtDNA defect it is often misdiagnosed. Here we report a kindred of MELAS including a mother and a son. Clinical, pathological and genetic studies are proceeding.
C1 Sun Yat Sen Univ, Dept Neurol, Affiliated Hosp 1, Guangzhou 510080, Peoples R China.
C3 Sun Yat Sen University
RP Sun Yat Sen Univ, Dept Neurol, Affiliated Hosp 1, Guangzhou 510080, Peoples R China.
EM fyqgz@sina.com
CR GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HAMMANS SR, 1991, LANCET, V337, P1311, DOI 10.1016/0140-6736(91)92981-7
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   SHAPIRA Y, 1975, NEUROLOGY, V25, P614, DOI 10.1212/WNL.25.7.614
   Smith ML, 1997, J CLIN ENDOCR METAB, V82, P2826, DOI 10.1210/jc.82.9.2826
   Song DL, 2001, CHINESE MED J-PEKING, V114, P1273
   Tully LA, 2000, AM J HUM GENET, V67, P432, DOI 10.1086/302996
   Wang ZX, 2002, CHINESE MED J-PEKING, V115, P995
   Wong LJC, 1997, CLIN CHEM, V43, P1241
NR 12
TC 0
Z9 0
U1 0
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0366-6999
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD APR 20
PY 2005
VL 118
IS 8
BP 695
EP 698
PG 4
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 920HH
UT WOS:000228679500014
PM 15899127
DA 2024-11-01
ER

PT J
AU Echaniz-Laguna, A
   Benoilid, A
   Vinzio, S
   Fornecker, LM
   Lannes, B
   Goullé, JP
   Broly, F
   de Camaret, BM
AF Echaniz-Laguna, Andoni
   Benoilid, Aurelien
   Vinzio, Stephane
   Fornecker, Luc-Matthieu
   Lannes, Beatrice
   Goulle, Jean-Pierre
   Broly, Frank
   de Camaret, Benedicte Mousson
TI Mitochondrial myopathy caused by arsenic trioxide therapy
SO BLOOD
LA English
DT Article
ID ACUTE PROMYELOCYTIC LEUKEMIA; MAMMALIAN-CELLS; MUSCLE; RHABDOMYOLYSIS;
   METABOLISM; MECHANISMS; APOPTOSIS; DAMAGE
AB Arsenic trioxide (ATO) has been successfully used as a treatment for acute promyelocytic leukemia (APL) for more than a decade. Here we report a patient with APL who developed a mitochondrial myopathy after treatment with ATO. Three months after ATO therapy withdrawal, the patient was unable to walk without assistance and skeletal muscle studies showed a myopathy with abundant cytoplasmic lipid droplets, decreased activities of the mitochondrial respiratory chain complexes, multiple mitochondrial DNA (mtDNA) deletions, and increased muscle arsenic content. Six months after ATO treatment was interrupted, the patient recovered normal strength, lipid droplets had decreased in size and number, respiratory chain complex activities were partially restored, but multiple mtDNA deletions and increased muscle arsenic content persisted. ATO therapy may provoke a delayed, severe, and partially reversible mitochondrial myopathy, and a long-term careful surveillance for muscle disease should be instituted when ATO is used in patients with APL. (Blood. 2012;119(18):4272-4274)
C1 [Echaniz-Laguna, Andoni; Benoilid, Aurelien] Hop Univ, Dept Neurol, Strasbourg, France.
   [Echaniz-Laguna, Andoni] Univ Strasbourg, INSERM, U692, Strasbourg, France.
   [Vinzio, Stephane] Hop Univ, Serv Med Interne, Strasbourg, France.
   [Fornecker, Luc-Matthieu] Hop Univ, Serv Oncohematol, Strasbourg, France.
   [Lannes, Beatrice] Hop Univ, Dept Pathol, Strasbourg, France.
   [Goulle, Jean-Pierre] Ctr Hosp, Toxicol Lab, Le Havre, France.
   [Broly, Frank] Ctr Hosp Reg & Univ Lille, Ctr Biol & Pathol, F-59037 Lille, France.
   [de Camaret, Benedicte Mousson] Ctr Hosp Univ Lyon, Ctr Biol Est, Serv Malad Hereditaires Metab, Bron, France.
C3 CHU Strasbourg; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Universites de Strasbourg Etablissements Associes;
   Universite de Strasbourg; Universite de Lorraine; CHU Strasbourg; CHU
   Strasbourg; CHU Strasbourg; Universite de Lille; CHU Lille; Universite
   Claude Bernard Lyon 1; CHU Lyon
RP Echaniz-Laguna, A (corresponding author), Hop Hautepierre, Hop Univ Strasbourg, Dept Neurol, 1 Ave Moliere, F-67098 Strasbourg, France.
EM andoni.echaniz-laguna@chru-strasbourg.fr
RI Echaniz-Laguna, Andoni/IUN-5392-2023
CR Argos M, 2010, LANCET, V376, P252, DOI 10.1016/S0140-6736(10)60481-3
   Belzacq AS, 2001, ONCOGENE, V20, P7579, DOI 10.1038/sj.onc.1204953
   Carter DE, 2003, TOXICOL APPL PHARM, V193, P309, DOI 10.1016/j.taap.2003.07.009
   Chen SJ, 2011, BLOOD, V117, P6425, DOI 10.1182/blood-2010-11-283598
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   Das J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012602
   Du L, 2007, FEMS YEAST RES, V7, P860, DOI 10.1111/j.1567-1364.2007.00274.x
   Estey E, 2006, BLOOD, V107, P3469, DOI 10.1182/blood-2005-10-4006
   Fanton L, 1999, HUM EXP TOXICOL, V18, P640, DOI 10.1191/096032799678839509
   FERNANDEZSOLA J, 1991, J TOXICOL-CLIN TOXIC, V29, P131, DOI 10.3109/15563659109038603
   HIGUCHI I, 1989, ACTA NEUROPATHOL, V79, P300, DOI 10.1007/BF00294665
   Klaassen CD, 2008, CASARETT DOULLS TOXI, P936
   Krishnan KJ, 2007, ANN NY ACAD SCI, V1100, P227, DOI 10.1196/annals.1395.024
   Liu SX, 2005, CANCER RES, V65, P3236, DOI 10.1158/0008-5472.CAN-05-0424
   Mathews V, 2006, BLOOD, V107, P2627, DOI 10.1182/blood-2005-08-3532
   MIRANDA N, 1994, LANCET, V344, P1096, DOI 10.1016/S0140-6736(94)91756-6
   Partridge MA, 2007, CANCER RES, V67, P5239, DOI 10.1158/0008-5472.CAN-07-0074
   Santra A, 2007, TOXICOL APPL PHARM, V220, P146, DOI 10.1016/j.taap.2006.12.029
   Sanz MA, 2011, J CLIN ONCOL, V29, P495, DOI 10.1200/JCO.2010.32.1067
   Sanz MA, 2009, BLOOD, V113, P1875, DOI 10.1182/blood-2008-04-150250
   SANZ P, 1989, JAMA-J AM MED ASSOC, V262, P3271, DOI 10.1001/jama.1989.03430230043020
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   Steinmaus C, 2007, J TOXICOL ENV HEAL A, V70, P159, DOI 10.1080/15287390600755240
   Yen YP, 2010, ENVIRON HEALTH PERSP, V118, P949, DOI 10.1289/ehp.0901525
NR 24
TC 15
Z9 18
U1 0
U2 8
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD MAY 3
PY 2012
VL 119
IS 18
BP 4272
EP 4274
DI 10.1182/blood-2011-10-385138
PG 3
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA 959BL
UT WOS:000305284600024
PM 22427206
OA Bronze
DA 2024-11-01
ER

PT J
AU Deschauer, M
   Hudson, G
   Müller, T
   Taylor, RW
   Chinnery, PF
   Zierz, S
AF Deschauer, M
   Hudson, G
   Müller, T
   Taylor, RW
   Chinnery, PF
   Zierz, S
TI A novel <i>ANT1</i> gene mutation with probable germline mosaicism in
   autosomal dominant progressive external ophthalmoplegia
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE mitochondrial disease; multiple mitochondrial DNA deletions; novel
   mutation; ANT1 gene
ID NUCLEOTIDE TRANSLOCATOR-1 GENE; POLG MUTATIONS; MULTIPLE DELETIONS;
   ATAXIC NEUROPATHY; MITOCHONDRIAL-DNA; MTDNA; DISORDER; TWINKLE
AB Only four different mutations in the adenine nucleotide translocator 1(ANT1) gene have been found in families with progressive external ophthalmoplegia (PEO). We report a novel heterozygous C to A transversion at nucleotide 269 in the ANT1 gene in a German family with PEO, predicted to convert a highly conserved alanine at codon 90 to aspartic acid. The mutation was identified in three siblings with PEO, one of them additionally suffered from schizoaffective disorder. Microsatellite analysis showed that the mutation was dominant and inherited from the mother who did not carry the mutation in blood, indicating germ-line mosaicism. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Halle Wittenberg, Klin & Poliklin Neurol, D-06097 Halle Saale, Germany.
   Univ Newcastle Upon Tyne, Mitochondrial Res Grp, Sch Neurol Neurobiol & Psychiat, Sch Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 Martin Luther University Halle Wittenberg; Newcastle University - UK
RP Deschauer, M (corresponding author), Univ Halle Wittenberg, Klin & Poliklin Neurol, Ernst Grube Str 40, D-06097 Halle Saale, Germany.
EM marcus.deschauer@medizin.uni-halle.de
RI Hudson, Gavin/E-7117-2017
OI Hudson, Gavin/0000-0001-7210-2733; Chinnery, Patrick/0000-0002-7065-6617
CR Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
NR 14
TC 53
Z9 68
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD APR
PY 2005
VL 15
IS 4
BP 311
EP 315
DI 10.1016/j.nmd.2004.12.004
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 917UP
UT WOS:000228495000008
PM 15792871
DA 2024-11-01
ER

PT J
AU Uusimaa, J
   Jungbluth, H
   Fratter, C
   Crisponi, G
   Feng, L
   Zeviani, M
   Hughes, I
   Treacy, EP
   Birks, J
   Brown, GK
   Sewry, CA
   McDermott, M
   Muntoni, F
   Poulton, J
AF Uusimaa, J.
   Jungbluth, H.
   Fratter, C.
   Crisponi, G.
   Feng, L.
   Zeviani, M.
   Hughes, I.
   Treacy, E. P.
   Birks, J.
   Brown, G. K.
   Sewry, C. A.
   McDermott, M.
   Muntoni, F.
   Poulton, J.
TI Reversible infantile respiratory chain deficiency is a unique,
   genetically heterogenous mitochondrial disease
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID C-OXIDASE DEFICIENCY; PHENOTYPIC-EXPRESSION; MUTATION; MYOPATHY;
   TRNA(GLU); MTDNA; ENCEPHALOMYOPATHY; INVOLVEMENT; SECONDARY; A3243G
AB Objectives Homoplasmic maternally inherited, m. 14674T>C or m. 14674T>G mt-tRNA(Glu) mutations have recently been identified in reversible infantile cytochrome c oxidase deficiency (or 'benign COX deficiency'). This study sought other genetic defects that may give rise to similar presentations.
   Patients Eight patients from seven families with clinicopathological features of infantile reversible cytochrome c oxidase deficiency were investigated.
   Methods The study reviewed the diagnostic features and performed molecular genetic analyses of mitochondrial DNA and nuclear encoded candidate genes.
   Results Patients presented with subacute onset of profound hypotonia, feeding difficulties and lactic acidosis within the first months of life. Although recovery was remarkable, a mild myopathy persisted into adulthood. Histopathological findings in muscle included increased lipid and/or glycogen content, ragged-red and COX negative fibres. Biochemical studies suggested more generalised abnormalities than pure COX deficiency. Clinical improvement was reflected by normalisation of lactic acidosis and histopathological abnormalities. The m. 14674T>C mt-tRNA(Glu) mutation was identified in four families, but none had the m. 14674T>G mutation. Furthermore, in two families pathogenic mutations were also found in the nuclear TRMU gene which has not previously been associated with this phenotype. In one family, the genetic aetiology still remains unknown.
   Conclusions Benign COX deficiency is better described as 'reversible infantile respiratory chain deficiency'. It is genetically heterogeneous,and patients not carring the m. 14674T>C or T>G mt-tRNA(Glu) mutations may have mutations in the TRMU gene. Diagnosing this disorder at the molecular level is a significant advance for paediatric neurologists and intensive care paediatricians, enabling them to select children with an excellent prognosis for continuing respiratory support from those with severe mitochondrial presentation in infancy.
C1 [Uusimaa, J.; Poulton, J.] John Radcliffe Hosp, Womens Ctr, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.
   [Jungbluth, H.] Kings Coll London, Dept Clin Neurosci, London WC2R 2LS, England.
   [Jungbluth, H.] St Thomas Hosp, Evelina Childrens Hosp, Dept Paediat Neurol, Neuromuscular Serv, London, England.
   [Fratter, C.] Churchill Hosp, Oxford Med Genet Lab, Oxford OX3 7LJ, England.
   [Crisponi, G.] Univ Cagliari, Serv Puericultura, Cagliari, Italy.
   [Feng, L.; Sewry, C. A.; Muntoni, F.] UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, Oxford, England.
   [Zeviani, M.] IRCCS Fdn, C Besta Neurol Inst, Unit Mol Neurogenet, Milan, Italy.
   [Hughes, I.] Manchester Childrens Hosp, Dept Paediat Neurol, Manchester, Lancs, England.
   [Treacy, E. P.] Childrens Univ Hosp, Natl Ctr Inherited Metab Dis, Dublin, Ireland.
   [Birks, J.] Univ Oxford, Ctr Stat Med, Oxford, England.
   [Brown, G. K.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.
   [McDermott, M.] Our Ladys Hosp Sick Children, Dublin, Ireland.
C3 University of Oxford; University of London; King's College London; Guy's
   & St Thomas' NHS Foundation Trust; University of Oxford; University of
   Cagliari; University of London; University College London; Royal
   Manchester Children's Hospital; Childrens University Hospital - Temple
   Street; University of Oxford; University of Oxford; Our Ladys Children
   Hospital Crumlin
RP Poulton, J (corresponding author), John Radcliffe Hosp, Womens Ctr, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.
EM joanna.poulton@obs-gyn.ox.ac.uk
RI Poulton, Joanna/AAB-4828-2021; Zeviani, Massimo/K-2891-2014; Jungbluth,
   Heinz/B-8893-2012
OI Jungbluth, Heinz/0000-0002-7159-3427; Zeviani,
   Massimo/0000-0002-9067-5508; Poulton, Joanna/0000-0002-2460-5587;
   Treacy, Eileen/0000-0002-6226-1615
FU Arvo and Lea Ylppo Foundation; Foundation for Paediatric Research;
   Sigrid Juselius Foundation; MRC; Wellcome Trust; Angus Memorial
   Mitochondrial Fund; MRC [G0601943, G0500695] Funding Source: UKRI
FX We thank the patients and their families for participating, Julie Evans
   and Conrad Smith (Rare Mitochondrial Disorders Service for Adults and
   Children (NCG), Oxford Centre) for DNA analysis, Drs U Kini, H Stewart,
   J Hurst, S Price, D Shears, V Harrison and colleagues for facial
   identification, Stephen Kennedy for support, and Dr Mike Champion,
   Paediatric Metabolic Department at the Evelina Children's Hospital, for
   joint management of patient 5 and discussion of the manuscript. The
   study was supported by grants from the Arvo and Lea Ylppo Foundation
   (JU), Foundation for Paediatric Research (JU), the Sigrid Juselius
   Foundation (JU), the MRC, the Wellcome Trust and the Angus Memorial
   Mitochondrial Fund.
CR Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Bruno C, 2003, J CHILD NEUROL, V18, P300, DOI 10.1177/08830738030180040401
   CORDA S, 2001, PROSPETTIVE PEDIAT, V31, P235
   CormierDaire V, 1996, AM J MED GENET, V66, P457, DOI 10.1002/(SICI)1096-8628(19961230)66:4<457::AID-AJMG15>3.0.CO;2-T
   DIMAURO S, 1983, ANN NEUROL, V14, P226, DOI 10.1002/ana.410140209
   DIMAURO S, 1981, T AM NEUROL ASSOC, V106, P205
   Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   Hargreaves IP, 2007, MITOCHONDRION, V7, P284, DOI 10.1016/j.mito.2007.02.001
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Low E, 2008, PEDIATR NEUROL, V39, P368, DOI 10.1016/j.pediatrneurol.2008.07.023
   Mayr JA, 2006, NEUROMUSCULAR DISORD, V16, P874, DOI 10.1016/j.nmd.2006.08.010
   Meulemans A, 2007, EUR J PAEDIATR NEURO, V11, P17, DOI 10.1016/j.ejpn.2006.10.004
   Mimaki M, 2010, ANN NEUROL, V68, P845, DOI 10.1002/ana.22111
   Nogueira C, 2007, MITOCHONDRION, V7, P396, DOI 10.1016/j.mito.2007.08.002
   NONAKA I, 1988, ACTA NEUROPATHOL, V77, P152
   Pancrudo J, 2007, J CHILD NEUROL, V22, P858, DOI 10.1177/0883073807304199
   Pereira C, 2007, BIOCHEM BIOPH RES CO, V354, P937, DOI 10.1016/j.bbrc.2007.01.068
   PERUCCALOSTANLE.D, 2002, BIOCHIM BIOPHYS ACTA, V588, P210
   Pihlajaniemi TL, 2010, CLEFT PALATE-CRAN J, V47, P234, DOI [10.1597/08-131.1, 10.1597/08-131]
   ROODHOOFT AM, 1986, NEUROPEDIATRICS, V17, P221, DOI 10.1055/s-2008-1052534
   SALO MK, 1992, ARCH DIS CHILD, V67, P1033, DOI 10.1136/adc.67.8.1033
   Sawano T, 1996, BIOCHEM MOL BIOL INT, V38, P693
   Schara U, 2011, J INHERIT METAB DIS, V34, P197, DOI 10.1007/s10545-010-9250-z
   SUZUKI M, 1989, No To Hattatsu, V21, P543
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   TRITSCHLER HJ, 1991, NEUROLOGY, V41, P300, DOI 10.1212/WNL.41.2_Part_1.300
   Tzen CY, 2003, MUSCLE NERVE, V28, P575, DOI 10.1002/mus.10473
   Uusimaa J, 2004, PEDIATRICS, V114, P443, DOI 10.1542/peds.114.2.443
   Vialettes BH, 1997, DIABETES CARE, V20, P1731, DOI 10.2337/diacare.20.11.1731
   Wada H, 1996, BRAIN DEV-JPN, V18, P263, DOI 10.1016/0387-7604(96)00017-4
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
   ZEVIANI M, 1987, NEUROLOGY, V37, P64, DOI 10.1212/WNL.37.1.64
NR 34
TC 49
Z9 51
U1 0
U2 7
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD OCT
PY 2011
VL 48
IS 10
BP 660
EP 668
DI 10.1136/jmg.2011.089995
PG 9
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 822FZ
UT WOS:000295030700003
PM 21931168
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Lin, HP
   Petersen, JD
   Gilsrud, AJ
   Madruga, A
   D'Silva, TM
   Huang, XP
   Shammas, MK
   Randolph, NP
   Johnson, KR
   Li, Y
   Jones, DR
   Pacold, ME
   Narendra, DP
AF Lin, Hsin-Pin
   Petersen, Jennifer D.
   Gilsrud, Alexandra J.
   Madruga, Angelo
   D'Silva, Theresa M.
   Huang, Xiaoping
   Shammas, Mario K.
   Randolph, Nicholas P.
   Johnson, Kory R.
   Li, Yan
   Jones, Drew R.
   Pacold, Michael E.
   Narendra, Derek P.
TI DELE1 maintains muscle proteostasis to promote growth and survival in
   mitochondrial myopathy
SO EMBO JOURNAL
LA English
DT Article; Early Access
DE Mitochondria Unfolded Protein Response (mt-UPR); Mitophagy;
   Mitochondrial Disorders; Mitonuclear Communication; Mitohormesis
ID INTEGRATED STRESS-RESPONSE; PROTEASE; OPA1; INACTIVATION; DEFICIENCY;
   METABOLISM
AB Mitochondrial dysfunction causes devastating disorders, including mitochondrial myopathy, but how muscle senses and adapts to mitochondrial dysfunction is not well understood. Here, we used diverse mouse models of mitochondrial myopathy to show that the signal for mitochondrial dysfunction originates within mitochondria. The mitochondrial proteins OMA1 and DELE1 sensed disruption of the inner mitochondrial membrane and, in response, activated the mitochondrial integrated stress response (mt-ISR) to increase the building blocks for protein synthesis. In the absence of the mt-ISR, protein synthesis in muscle was dysregulated causing protein misfolding, and mice with early-onset mitochondrial myopathy failed to grow and survive. The mt-ISR was similar following disruptions in mtDNA maintenance (Tfam knockout) and mitochondrial protein misfolding (CHCHD10 G58R and S59L knockin) but heterogenous among mitochondria-rich tissues, with broad gene expression changes observed in heart and skeletal muscle and limited changes observed in liver and brown adipose tissue. Taken together, our findings identify that the DELE1 mt-ISR mediates a similar response to diverse forms of mitochondrial stress and is critical for maintaining growth and survival in early-onset mitochondrial myopathy.
   Mitochondrial myopathies caused by diverse mitochondrial stressors, including mitochondrial DNA (mtDNA) depletion or mitochondrial protein misfolding, activate a similar transcriptional response in muscle. This report shows that this transcriptional response is predominately mediated by the DELE1-dependent mitochondrial integrated stress response (mt-ISR) pathway and is critical for maintaining growth and survival in mouse models.DELE1 is responsible for a protective ISR in response diverse mitochondrial stressors, including mtDNA depletion and mitochondrial protein misfolding.The DELE1-dependent mt-ISR is especially critical for growth and survival in the setting of early-onset mitochondrial stress.DELE1 and OMA1 have overlapping but separable protective effects in mitochondrial myopathies.The DELE1 mt-ISR increases the building blocks for cellular protein synthesis but fails to restore OXPHOS or resolve defects in mitochondrial structure.DELE1 is required to maintain folding of newly synthesized proteins in skeletal muscle under stress.
   DELE1, a mitochondrial stress signal, protects striated muscle cells by suppressing the misfolding of newly translated proteins.
C1 [Lin, Hsin-Pin; Petersen, Jennifer D.; Gilsrud, Alexandra J.; Madruga, Angelo; D'Silva, Theresa M.; Huang, Xiaoping; Shammas, Mario K.; Randolph, Nicholas P.; Narendra, Derek P.] NIH, Mitochondrial Biol & Neurodegenerat Unit, Neurogenet Branch, Natl Inst Neurol Disorders & Stroke, Bethesda, MD 20892 USA.
   [Johnson, Kory R.] NIH, Bioinformat Core, Natl Inst Neurol Disorders & Stroke, Bethesda, MD 20892 USA.
   [Li, Yan] NIH, Prote Core Facil, Natl Inst Neurol Disorders & Stroke, Bethesda, MD 20892 USA.
   [Jones, Drew R.] NYU Langone Hlth, Dept Biochem & Mol Pharmacol, New York, NY USA.
   [Pacold, Michael E.] NYU Langone Hlth, Dept Radiat Oncol, New York, NY USA.
   [Pacold, Michael E.] NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Neurological Disorders & Stroke (NINDS); National Institutes of Health
   (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke
   (NINDS); National Institutes of Health (NIH) - USA; NIH National
   Institute of Neurological Disorders & Stroke (NINDS); NYU Langone
   Medical Center; NYU Langone Medical Center; NYU Langone Medical Center
RP Narendra, DP (corresponding author), NIH, Mitochondrial Biol & Neurodegenerat Unit, Neurogenet Branch, Natl Inst Neurol Disorders & Stroke, Bethesda, MD 20892 USA.
EM derek.narendra@nih.gov
FU National Institutes of Health
FX Open access funding provided by the National Institutes of Health.
CR Ahola S, 2022, CELL METAB, V34, P1875, DOI 10.1016/j.cmet.2022.08.017
   Ajroud-Driss S, 2015, NEUROGENETICS, V16, P1, DOI 10.1007/s10048-014-0421-1
   Anderson CJ, 2019, ACTA NEUROPATHOL, V138, P103, DOI 10.1007/s00401-019-01989-y
   Austin S, 2022, EMBO REP, V23, DOI 10.15252/embr.202254978
   Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   Bao XR, 2016, ELIFE, V5, DOI 10.7554/eLife.10575
   Boal RL, 2019, J CLIN ENDOCR METAB, V104, P2057, DOI 10.1210/jc.2018-00957
   Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0
   Conrad R, 2023, CELL SYST, V14, P58, DOI 10.1016/j.cels.2022.12.006
   Das I, 2015, SCIENCE, V348, P239, DOI 10.1126/science.aaa4484
   de Theije CC, 2013, AM J PHYSIOL-LUNG C, V305, pL82, DOI 10.1152/ajplung.00354.2012
   Dogan SA, 2014, CELL METAB, V19, P458, DOI 10.1016/j.cmet.2014.02.004
   Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009
   Ducker GS, 2016, CELL METAB, V23, P1140, DOI 10.1016/j.cmet.2016.04.016
   Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084
   Fessler E, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-29479-y
   Fessler E, 2020, NATURE, V579, P433, DOI 10.1038/s41586-020-2076-4
   Flicker D, 2019, CELL REP, V27, P1364, DOI 10.1016/j.celrep.2019.04.013
   Forsström S, 2019, CELL METAB, V30, P1040, DOI [10.1016/j.cmet.2019.013.019, 10.1016/j.cmet.2019.08.019]
   Franchino CA, 2024, BRAIN, V147, P1043, DOI 10.1093/brain/awad340
   Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478
   Geeraerts SL, 2021, NAT METAB, V3, P131, DOI 10.1038/s42255-020-00329-9
   Genin EC, 2019, ACTA NEUROPATHOL, V138, P123, DOI 10.1007/s00401-019-01988-z
   Gokhin DS, 2008, J EXP BIOL, V211, P837, DOI 10.1242/jeb.014340
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Kalko SG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-91
   Guan BJ, 2017, MOL CELL, V68, P885, DOI 10.1016/j.molcel.2017.11.007
   Guo XY, 2020, NATURE, V579, P427, DOI 10.1038/s41586-020-2078-2
   Guyenet Stephan J, 2010, J Vis Exp, DOI 10.3791/1787
   Hamanaka RB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003638
   Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738
   Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100
   Hathazi D, 2020, EMBO J, V39, DOI 10.15252/embj.2020105364
   He YJ, 2010, J BIOL CHEM, V285, P9516, DOI 10.1074/jbc.M109.092429
   Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083
   HeimanPatterson TD, 1997, MUSCLE NERVE, V20, P1219, DOI 10.1002/(SICI)1097-4598(199710)20:10<1219::AID-MUS2>3.0.CO;2-F
   Huang XP, 2018, HUM MOL GENET, V27, P3881, DOI 10.1093/hmg/ddy270
   Huynh H, 2023, J MOL CELL CARDIOL, V175, P44, DOI 10.1016/j.yjmcc.2022.12.003
   Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184
   Jena J, 2023, ELIFE, V12, DOI 10.7554/eLife.86452
   Kachman M, 2020, BIOINFORMATICS, V36, P1801, DOI 10.1093/bioinformatics/btz798
   Kaspar S, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf0971
   Keller TL, 2012, NAT CHEM BIOL, V8, P311, DOI [10.1038/NCHEMBIO.790, 10.1038/nchembio.790]
   Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008
   Kühl I, 2017, ELIFE, V6, DOI 10.7554/eLife.30952
   Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Levy JL, 2023, AM J PHYSIOL-ENDOC M, V325, pE624, DOI 10.1152/ajpendo.00181.2023
   Li YJ, 2023, RESEARCH-CHINA, V6, DOI 10.34133/research.0175
   Liu YT, 2020, HUM MOL GENET, V29, P1547, DOI 10.1093/hmg/ddaa077
   Luengo A, 2021, MOL CELL, V81, P691, DOI 10.1016/j.molcel.2020.12.012
   Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y
   Mick E, 2020, ELIFE, V9, DOI 10.7554/eLife.49178
   Miller MJ, 2023, GEROSCIENCE, V45, P2525, DOI 10.1007/s11357-023-00772-y
   Murata D, 2020, EMBO J, V39, DOI 10.15252/embj.2020105074
   Nakano H, 2021, CELL TISSUE RES, V385, P239, DOI 10.1007/s00441-021-03450-7
   Nguyen MK, 2022, HUM MOL GENET, V31, P1500, DOI 10.1093/hmg/ddab329
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128
   Ord T, 2023, PLOS GENET, V19, DOI 10.1371/journal.pgen.1011014
   Osto Corey, 2020, Curr Protoc Cell Biol, V89, pe116, DOI 10.1002/cpcb.116
   Overmyer KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117232
   Pachitariu M, 2022, NAT METHODS, V19, P1634, DOI 10.1038/s41592-022-01663-4
   Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195
   Patron M, 2022, EMBO J, V41, DOI 10.15252/embj.2021110476
   Pirinen E, 2020, CELL METAB, V31, P1078, DOI 10.1016/j.cmet.2020.04.008
   Postnikoff SDL, 2017, MICROB CELL, V4, P368, DOI 10.15698/mic2017.11.597
   Quirós PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058
   Quirós PM, 2012, EMBO J, V31, P2117, DOI 10.1038/emboj.2012.70
   Rath S, 2021, NUCLEIC ACIDS RES, V49, pD1541, DOI 10.1093/nar/gkaa1011
   Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369
   Ravi Venkatraman, 2020, Curr Protoc Mol Biol, V133, pe127, DOI 10.1002/cpmb.127
   Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]
   Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]
   Sekine Y, 2023, MOL CELL, V83, P2059, DOI 10.1016/j.molcel.2023.05.031
   Seth PP, 2010, J ORG CHEM, V75, P1569, DOI 10.1021/jo902560f
   Shammas MK, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI157504
   Shi XJ, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-30126-9
   Stein KC, 2022, NATURE, V601, P637, DOI 10.1038/s41586-021-04295-4
   Stein KC, 2019, J BIOL CHEM, V294, P2076, DOI 10.1074/jbc.REV118.002814
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Vincent EE, 2015, MOL CELL, V60, P195, DOI 10.1016/j.molcel.2015.08.013
   Waisman A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91191-6
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang Y, 2021, NATURE, V599, P136, DOI 10.1038/s41586-021-04025-w
   Wek RC, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032870
   Westbrook RL, 2022, CELL REP, V38, DOI 10.1016/j.celrep.2022.110320
   White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21
   Wong YL, 2019, ELIFE, V8, DOI 10.7554/eLife.42940
   Yang J, 2023, NAT STRUCT MOL BIOL, V30, P1295, DOI 10.1038/s41594-023-01061-0
   Zhang L, 2022, LIFE SCI ALLIANCE, V5, DOI 10.26508/lsa.202201478
   Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445
   Zhu ST, 2022, CIRCULATION, V146, P1028, DOI 10.1161/CIRCULATIONAHA.122.059594
NR 95
TC 0
Z9 0
U1 2
U2 2
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD 2024 OCT 8
PY 2024
DI 10.1038/s44318-024-00242-x
EA OCT 2024
PG 38
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA I2D0Q
UT WOS:001328401300001
PM 39379554
DA 2024-11-01
ER

PT J
AU Almalki, A
   Alston, CL
   Parker, A
   Simonic, I
   Mehta, SG
   He, LP
   Reza, M
   Oliveira, JMA
   Lightowlers, RN
   McFarland, R
   Taylor, RW
   Chrzanowska-Lightowlers, ZMA
AF Almalki, Abdulraheem
   Alston, Charlotte L.
   Parker, Alasdair
   Simonic, Ingrid
   Mehta, Sarju G.
   He, Langping
   Reza, Mojgan
   Oliveira, Jorge M. A.
   Lightowlers, Robert N.
   McFarland, Robert
   Taylor, Robert W.
   Chrzanowska-Lightowlers, Zofia M. A.
TI Mutation of the human mitochondrial phenylalanine-tRNA synthetase causes
   infantile-onset epilepsy and cytochrome c oxidase deficiency
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE Mitochondria; Mitochondrial disease; Aminoacyl-tRNA synthetase;
   Aminoacylation; Mitochondrial translation; Protein synthesis
ID DNA MUTATIONS; HUMAN-DISEASE; SIDEROBLASTIC ANEMIA; MISSENSE MUTATIONS;
   PERRAULT SYNDROME; LACTIC-ACIDOSIS; CAUSES MYOPATHY; HEARING-LOSS;
   BRAIN-STEM; LEUKOENCEPHALOPATHY
AB Mitochondrial aminoacyl-tRNA synthetases (aaRSs) are essential enzymes in protein synthesis since they charge tRNAs with their cognate amino acids. Mutations in the genes encoding mitochondrial aaRSs have been associated with a wide spectrum of human mitochondrial diseases. Here we report the identification of pathogenic mutations (a partial genomic deletion and a highly conserved p. Asp325Tyr missense variant) in FARS2, the gene encoding mitochondrial phenylalanyl-tRNA synthetase, in a patient with early-onset epilepsy and isolated complex IV deficiency in muscle. The biochemical defect was expressed in myoblasts but not in fibroblasts and associated with decreased steady state levels of COXI and COXII protein and reduced steady state levels of the mt-tRNAPhe transcript. Functional analysis of the recombinant mutant p.Asp325Tyr FARS2 protein showed an inability to bind ATP and consequently undetectable aminoacylation activity using either bacterial tRNA or human mt-tRNAPhe as substrates. Lentiviral transduction of cells with wildtype FARS2 restored complex IV protein levels, confirming that the pAsp325Tyr mutation is pathogenic, causing respiratory chain deficiency and neurological deficits on account of defective aminoacylation of mt-tRNAPhe. (C) 2013 The Authors. Published by Elsevier B.V. All rights reserved.
C1 [Almalki, Abdulraheem; Alston, Charlotte L.; He, Langping; Oliveira, Jorge M. A.; McFarland, Robert; Taylor, Robert W.; Chrzanowska-Lightowlers, Zofia M. A.] Newcastle Univ, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Parker, Alasdair] Addenbrookes Hosp, Child Dev Ctr, Cambridge, England.
   [Simonic, Ingrid] Cambridge Univ Hosp NHS Fdn Trust, Med Genet Labs, Cambridge, England.
   [Mehta, Sarju G.] Addenbrookes Hosp, Dept Med Genet, Cambridge, England.
   [Reza, Mojgan] Newcastle Univ, Inst Med Genet, Int Ctr Life, Biobank, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
   [Lightowlers, Robert N.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Almalki, Abdulraheem] Taif Univ, Coll Med, At Taif, Saudi Arabia.
   [Oliveira, Jorge M. A.] Univ Porto, Fac Pharm, Dept Drug Sci, REQUIMTE, P-4050313 Oporto, Portugal.
C3 Newcastle University - UK; University of Cambridge; Cambridge University
   Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of
   Cambridge; Cambridge University Hospitals NHS Foundation Trust;
   Addenbrooke's Hospital; University of Cambridge; Newcastle University -
   UK; Newcastle University - UK; Taif University; Universidade do Porto
RP Taylor, RW (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM abdulraheem.almalki@newcastle.ac.uk; charlotte.alston@newcastle.ac.uk;
   alasdair.parker@addenbrookes.nhs.uk; ingrid.simonic@addenbrookes.nhs.uk;
   sarju.mehta@addenbrookes.nhs.uk; langping.he@newcastle.ac.uk;
   mojgan.reza@newcastle.ac.uk; jorgemao@ff.up.pt;
   robert.lightowlers@newcastle.ac.uk; robert.mcfarland@newcastle.ac.uk;
   robert.taylor@newcastle.ac.uk; zofia.chrzanowska-lightowlers@ncl.ac.uk
RI Oliveira, Jorge/D-4787-2013; Almalki, Abdulraheem/KYP-1626-2024; Alston,
   Charlotte/ABG-9602-2020
OI Oliveira, Jorge/0000-0002-6040-5355; McFarland,
   Robert/0000-0002-8833-2688; Alston, Charlotte/0000-0003-2095-5464;
   Chrzanowska-Lightowlers, Zofia/0000-0002-0045-3152
FU Wellcome Trust Strategic Award [096919/Z/11/Z]; Taif University
   sabbatical scholarship; CLA; NIHR CSO Healthcare Science Fellowship; MRC
   [G0800674, MR/K000608/1] Funding Source: UKRI; Wellcome Trust
   [096919/Z/11/Z] Funding Source: Wellcome Trust
FX RNL, RWT and Z1VIACL are supported by a Wellcome Trust Strategic Award
   [096919/Z/11/Z]. M is funded by a Taif University sabbatical scholarship
   and CLA by an NIHR CSO Healthcare Science Fellowship. We thank the
   Biobank of the MRC Centre for Neuromuscular Diseases (a partner of
   EuroBioBank and TREAT-NMD UK), the NHS Specialist Commissioners that
   funds the "Rare Mitochondrial Disorders of Adults and Children"
   Diagnostic Service in Newcastle upon Tyne (http://wvvw.
   newcastle-mitochondria.com/service/clinical/)-and Gavin Falkous for
   excellent technical assistance.
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Bayat V, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001288
   Belostotsky R, 2011, AM J HUM GENET, V88, P193, DOI 10.1016/j.ajhg.2010.12.010
   Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z
   Bozza M, 2013, EUR J PAEDIATR NEURO, V17, P225, DOI 10.1016/j.ejpn.2012.09.008
   Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8
   Descipio C, 2007, AM J MED GENET C, V145C, P377, DOI 10.1002/ajmg.c.30156
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Elo JM, 2012, HUM MOL GENET, V21, P4521, DOI 10.1093/hmg/dds294
   Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Klipcan L, 2008, STRUCTURE, V16, P1095, DOI 10.1016/j.str.2008.03.020
   Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010
   Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86
   Lim SC, 2013, HUM MOL GENET, V22, P4460, DOI 10.1093/hmg/ddt295
   Mathe E, 2006, NUCLEIC ACIDS RES, V34, P1317, DOI 10.1093/nar/gkj518
   Pierce SB, 2013, AM J HUM GENET, V92, P614, DOI 10.1016/j.ajhg.2013.03.007
   Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rötig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010
   Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P3065, DOI 10.1093/nar/gkn147
   Santos-Cortez RLP, 2013, AM J HUM GENET, V93, P132, DOI 10.1016/j.ajhg.2013.05.018
   Sasarman F, 2012, HUM MUTAT, V33, P1201, DOI 10.1002/humu.22098
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Shamseldin HE, 2012, J MED GENET, V49, P234, DOI 10.1136/jmedgenet-2012-100836
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Synofzik M, 2011, J MED GENET, V48, P713, DOI 10.1136/jmg.2011.090282
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Tyreman M, 2009, J MED GENET, V46, P531, DOI 10.1136/jmg.2008.065482
   Yadavalli SS, 2009, FEBS LETT, V583, P3204, DOI 10.1016/j.febslet.2009.09.008
NR 34
TC 56
Z9 63
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 0006-3002
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD JAN
PY 2014
VL 1842
IS 1
BP 56
EP 64
DI 10.1016/j.bbadis.2013.10.008
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA AC4OO
UT WOS:000332500800006
PM 24161539
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Al-Hassnan, ZN
   Al-Dosary, M
   Alfadhel, M
   Faqeih, EA
   Alsagob, M
   Kenana, R
   Almass, R
   Al-Harazi, OS
   Al-Hindi, H
   Malibari, OI
   Almutari, FB
   Tulbah, S
   Alhadeq, F
   Al-Sheddi, T
   Alamro, R
   AlAsmari, A
   Almuntashri, M
   Alshaalan, H
   Al-Mohanna, FA
   Colak, D
   Kaya, N
AF Al-Hassnan, Zuhair N.
   Al-Dosary, Mazhor
   Alfadhel, Majid
   Faqeih, Eissa A.
   Alsagob, Maysoon
   Kenana, Rosan
   Almass, Rawan
   Al-Harazi, Olfat S.
   Al-Hindi, Hindi
   Malibari, Omhani I.
   Almutari, Faten B.
   Tulbah, Sahar
   Alhadeq, Faten
   Al-Sheddi, Tarfa
   Alamro, Rana
   AlAsmari, Ali
   Almuntashri, Makki
   Alshaalan, Hesham
   Al-Mohanna, Futwan A.
   Colak, Dilek
   Kaya, Namik
TI <i>ISCA2</i> mutation causes infantile neurodegenerative mitochondrial
   disorder
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID MULTIPLE RESPIRATORY-CHAIN; IRON-SULFUR CLUSTERS; FRIEDREICHS-ATAXIA;
   PROTEIN MUTATIONS; HUMAN-DISEASE; BIOGENESIS; DEFICIENCY; MATURATION;
   GENE; MYOPATHY
AB Background There are numerous nuclear genes that cause mitochondrial disorders and clinically and genetically heterogeneous disorders whose aetiology often remains unsolved. In this study, we aim to investigate an autosomal recessive syndrome causing leukodystrophy and neuroregression. We studied six patients from five unrelated consanguineous families.
   Methods Patients underwent full neurological, radiological, genetic, metabolic and dysmorphological examinations. Exome sequencing coupled with autozygosity mapping, Sanger sequencing, microsatellite haplotyping, standard and molecular karyotyping and whole mitochondrial DNA sequencing were used to identify the genetic cause of the syndrome. Immunohistochemistry, transmission electron microscopy, confocal microscopy, dipstick assays, quantitative PCR, reverse transcription PCR and quantitative reverse transcription PCR were performed on different tissue samples from the patients.
   Results We identified a homoallelic missense founder mutation in ISCA2 leading to mitochondrial depletion and reduced complex I activity as well as decreased ISCA2, ISCA1 and IBA57 expression in fibroblasts. MRI indicated similar white matter abnormalities in the patients. Histological examination of the skeletal muscle showed mild to moderate variation in myofibre size and the presence of many randomly distributed atrophic fibres.
   Conclusions Our data demonstrate that ISCA2 deficiency leads to a hereditary mitochondrial neurodegenerative white matter disease in infancy.
C1 [Al-Hassnan, Zuhair N.] King Faisal Specialist Hosp & Res Ctr, Dept Med Genet, Riyadh 11211, Saudi Arabia.
   [Al-Hassnan, Zuhair N.; Al-Mohanna, Futwan A.] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia.
   [Al-Dosary, Mazhor; Alsagob, Maysoon; Kenana, Rosan; Almass, Rawan; Almutari, Faten B.; Tulbah, Sahar; Alhadeq, Faten; Al-Sheddi, Tarfa; Alamro, Rana; Kaya, Namik] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.
   [Alfadhel, Majid] King Saud Bin Abdulaziz Univ Hlth Sci, Genet Div, Dept Pediat, King Abdulaziz Med City, Riyadh, Saudi Arabia.
   [Faqeih, Eissa A.; AlAsmari, Ali] King Fahad Med City, Childrens Hosp, Sect Med Genet, Riyadh, Saudi Arabia.
   [Al-Harazi, Olfat S.; Colak, Dilek; Kaya, Namik] King Faisal Specialist Hosp & Res Ctr, Dept Biostat & Sci Comp, Riyadh 11211, Saudi Arabia.
   [Al-Hindi, Hindi] King Faisal Specialist Hosp & Res Ctr, Dept Pathol & Lab Med, Riyadh 11211, Saudi Arabia.
   [Malibari, Omhani I.] Matern & Childrens Hosp, King Abdullah Med City, Dept Pediat, Riyadh, Saudi Arabia.
   [Almuntashri, Makki; Alshaalan, Hesham] King Saud Bin Abdulaziz Univ Hlth Sci, King Abdulaziz Med City, Dept Radiol, Riyadh, Saudi Arabia.
   [Al-Mohanna, Futwan A.] King Faisal Specialist Hosp & Res Ctr, Dept Cell Biol, Riyadh 11211, Saudi Arabia.
C3 King Faisal Specialist Hospital & Research Center; Alfaisal University;
   King Faisal Specialist Hospital & Research Center; King Saud Bin
   Abdulaziz University for Health Sciences; King Fahad Medical City; King
   Faisal Specialist Hospital & Research Center; King Faisal Specialist
   Hospital & Research Center; King Saud Bin Abdulaziz University for
   Health Sciences; King Abdulaziz Medical City - Riyadh; King Faisal
   Specialist Hospital & Research Center
RP Kaya, N (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Neurogenet Unit, MBC 03, Riyadh 11211, Saudi Arabia.
EM nkaya@kfshrc.edu.sa
RI Kaya, Namik/GQA-7857-2022; Colak, Dilek/IQT-4246-2023; Alhindi,
   Hindi/KPY-3428-2024; Alhassnan, Zuhair/LDF-8292-2024
OI Colak, Dilek/0000-0001-6485-8768; Tulbah, Sahar/0000-0002-3031-6669;
   Alsagob, Maysoon/0009-0007-1989-1551; Al-Hindi,
   Hindi/0000-0002-7800-5229; Al-Hassnan, Zuhair/0000-0002-7173-2044
FU King Faisal Specialist Hospital and Research Center's seed grants
   (KFSHRC-RAC) [2120022]; King Abdulaziz Center for Science and
   Technology, Biotech Initiative (KACST) [12-BIO2221-20]
FX This work was supported by King Faisal Specialist Hospital and Research
   Center's seed grants (KFSHRC-RAC# 2120022) and King Abdulaziz Center for
   Science and Technology, Biotech Initiative (KACST# 12-BIO2221-20).
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Alzahrani AS, 2012, CLIN ENDOCRINOL, V76, P540, DOI 10.1111/j.1365-2265.2011.04258.x
   Bolar NA, 2013, HUM MOL GENET, V22, P2590, DOI 10.1093/hmg/ddt107
   Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238
   Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047
   Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659
   Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520
   Cameron JM, 2011, AM J HUM GENET, V89, P486, DOI 10.1016/j.ajhg.2011.08.011
   Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423
   Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423
   Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375
   Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601
   Genin E, 2004, J MED GENET, V41, P445, DOI 10.1136/jmg.2003.017962
   Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918
   Kohler C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-105
   Kollberg G, 2009, BRAIN, V132, P2170, DOI 10.1093/brain/awp152
   Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528
   Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009
   Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301
   Lim SC, 2013, HUM MOL GENET, V22, P4460, DOI 10.1093/hmg/ddt295
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Melin M, 2006, J HUM GENET, V51, P864, DOI 10.1007/s10038-006-0035-z
   Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869
   Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012
   Mondal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057771
   Mühlenhoff U, 2011, J BIOL CHEM, V286, P41205, DOI 10.1074/jbc.M111.296152
   Mühlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446
   Navarro-Sastre A, 2011, AM J HUM GENET, V89, P656, DOI 10.1016/j.ajhg.2011.10.005
   Netz DJA, 2014, TRENDS CELL BIOL, V24, P303, DOI 10.1016/j.tcb.2013.11.005
   Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509
   Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057
   Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407
   Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019
   Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218
   Sheftel A, 2010, TRENDS ENDOCRIN MET, V21, P302, DOI 10.1016/j.tem.2009.12.006
   Sheftel AD, 2012, MOL BIOL CELL, V23, P1157, DOI 10.1091/mbc.E11-09-0772
   Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798
   Ye H, 2010, J CLIN INVEST, V120, P1749, DOI 10.1172/JCI40372
   Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166
NR 39
TC 75
Z9 91
U1 0
U2 18
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD MAR
PY 2015
VL 52
IS 3
BP 186
EP 194
DI 10.1136/jmedgenet-2014-102592
PG 9
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA CB8JD
UT WOS:000349874700006
PM 25539947
DA 2024-11-01
ER

PT J
AU Blakely, EL
   He, L
   Taylor, RW
   Chinnery, PF
   Lightowlers, RN
   Schaefer, AM
   Turnbull, DM
AF Blakely, EL
   He, L
   Taylor, RW
   Chinnery, PF
   Lightowlers, RN
   Schaefer, AM
   Turnbull, DM
TI Mitochondrial DNA deletion in "identical'' twin brothers
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MUTATION; MTDNA; SON
C1 Newcastle Univ, Sch Med, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Newcastle Univ, Sch Med, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM d.m.turnbull@ncl.ac.uk
OI Chinnery, Patrick/0000-0002-7065-6617; Schaefer,
   Andrew/0000-0001-9891-7332
CR Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   BERNES SM, 1993, J PEDIATR-US, V123, P598, DOI 10.1016/S0022-3476(05)80962-X
   CHEN X, 1995, AM J HUM GENET, V57, P239
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   ROWLAND LP, 1988, NEUROLOGY, V38, P1399, DOI 10.1212/WNL.38.9.1399
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Weber K, 1997, AM J HUM GENET, V60, P373
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118
NR 20
TC 48
Z9 52
U1 0
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD FEB 1
PY 2004
VL 41
IS 2
AR e19
DI 10.1136/jmg.2003.011296
PG 4
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 769VE
UT WOS:000188669800017
PM 14757869
OA Bronze, Green Published
DA 2024-11-01
ER

PT J
AU van der Walt, EM
   Smuts, I
   Taylor, RW
   Elson, JL
   Turnbull, DM
   Louw, R
   van der Westhuizen, FH
AF van der Walt, Elizna M.
   Smuts, Izelle
   Taylor, Robert W.
   Elson, Joanna L.
   Turnbull, Douglass M.
   Louw, Roan
   van der Westhuizen, Francois H.
TI Characterization of mtDNA variation in a cohort of South African
   paediatric patients with mitochondrial disease
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE mitochondrial DNA; mitochondrial diseases; paediatrics; Africa;
   high-throughput nucleotide sequencing
ID HEREDITARY OPTIC NEUROPATHY; DNA MUTATIONS; RESPIRATORY-CHAIN;
   COMPLEX-I; DISORDERS; IDENTIFICATION; INCREASE
AB Mitochondrial disease can be attributed to both mitochondrial and nuclear gene mutations. It has a heterogeneous clinical and biochemical profile, which is compounded by the diversity of the genetic background. Disease-based epidemiological information has expanded significantly in recent decades, but little information is known that clarifies the aetiology in African patients. The aim of this study was to investigate mitochondrial DNA variation and pathogenic mutations in the muscle of diagnosed paediatric patients from South Africa. A cohort of 71 South African paediatric patients was included and a high-throughput nucleotide sequencing approach was used to sequence full-length muscle mtDNA. The average coverage of the mtDNA genome was 81 +/- 26 per position. After assigning haplogroups, it was determined that although the nature of non-haplogroup-defining variants was similar in African and non-African haplogroup patients, the number of substitutions were significantly higher in African patients. We describe previously reported disease-associated and novel variants in this cohort. We observed a general lack of commonly reported syndrome-associated mutations, which supports clinical observations and confirms general observations in African patients when using single mutation screening strategies based on (predominantly non-African) mtDNA disease-based information. It is finally concluded that this first extensive report on muscle mtDNA sequences in African paediatric patients highlights the need for a full-length mtDNA sequencing strategy, which applies to all populations where specific mutations is not present. This, in addition to nuclear DNA gene mutation and pathogenicity evaluations, will be required to better unravel the aetiology of these disorders in African patients. European Journal of Human Genetics (2012) 20, 650-656; doi:10.1038/ejhg.2011.262; published online 18 January 2012
C1 [van der Walt, Elizna M.; Louw, Roan; van der Westhuizen, Francois H.] North West Univ, Ctr Human Metabon, ZA-2520 Potchefstroom, South Africa.
   [Smuts, Izelle] Univ Pretoria, Steve Biko Acad Hosp, Dept Paediat & Child Hlth, ZA-0002 Pretoria, South Africa.
   [Taylor, Robert W.; Elson, Joanna L.; Turnbull, Douglass M.; van der Westhuizen, Francois H.] Newcastle Univ, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 North West University - South Africa; University of Pretoria; Newcastle
   University - UK
RP van der Westhuizen, FH (corresponding author), North West Univ, Ctr Human Metabon, Private Bag X6001, ZA-2520 Potchefstroom, South Africa.
EM Francois.vanderWesthuizen@nwu.ac.za
RI Schoeman, Elizna/A-6951-2015; van der Westhuizen, Francois/E-6959-2011
OI Turnbull, Doug/0000-0002-8878-9901; Louw, Roan/0000-0002-6542-8644; van
   der Westhuizen, Francois/0000-0002-7879-1776; Schoeman,
   Elizna/0000-0003-0461-6841; /0000-0002-3551-5624; Smuts,
   Izelle/0000-0002-1091-5912
FU Department of Science and Technology and Medical Research Council of
   South Africa; Wellcome Trust [074454/Z/04/Z]; UK NHS Specialised
   Services 'Rare Mitochondrial Disorders of Adults and Children'
   Diagnostic Service; Newcastle University Research Committee Visiting
   Professorship bursary; MRC [G0800674, MC_G0802536, G0700718] Funding
   Source: UKRI
FX We acknowledge the supporting contribution of the clinical staff of the
   Department of Paediatrics and Child Health, Steve Biko Academic
   Hospital, University of Pretoria, South Africa, as well as Charlotte
   Alston, Emma Watson and John Yarham of the Mitochondrial Research Group,
   Institute for Ageing and Health, Newcastle University. We are grateful
   for the financial support of the Department of Science and Technology
   and Medical Research Council of South Africa. RWT and DMT are funded by
   a Wellcome Trust Programme Grant (074454/Z/04/Z) and the UK NHS
   Specialised Services 'Rare Mitochondrial Disorders of Adults and
   Children' Diagnostic Service (http://www.mitochondrialncg.nhs.uk). FHvdW
   is supported by a Newcastle University Research Committee Visiting
   Professorship bursary.
CR Alston CL, 2010, J NEUROL SCI, V298, P140, DOI 10.1016/j.jns.2010.08.014
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bandelt HJ, 2008, INT J CARDIOL, V126, P439, DOI 10.1016/j.ijcard.2007.02.049
   Bannwarth S, 2008, MITOCHONDRION, V8, P136, DOI 10.1016/j.mito.2007.10.008
   Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447
   Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6
   De Schrijver JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-269
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Gómez-Durán A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Hedges D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008232
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   HOWELL N, 1995, GENETICS, V140, P285
   HOWELL N, 1991, AM J HUM GENET, V48, P935
   Human H, 2010, BIOCHEM BIOPH RES CO, V393, P751, DOI 10.1016/j.bbrc.2010.02.075
   Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873
   JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5
   Joyjinda Y, 2007, THESIS MAHIDOL U MAH
   Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901
   Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014
   MACKEY DA, 1994, EYE, V8, P431, DOI 10.1038/eye.1994.102
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   Pereira L, 2009, AM J HUM GENET, V84, P628, DOI 10.1016/j.ajhg.2009.04.013
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Porcelli AM, 2010, HUM MOL GENET, V19, P1019, DOI 10.1093/hmg/ddp566
   Prasad GN, 2006, INT J CARDIOL, V109, P432, DOI 10.1016/j.ijcard.2005.07.065
   Pye D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl516
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Reinecke F, 2009, BBA-MOL BASIS DIS, V1792, P1113, DOI 10.1016/j.bbadis.2009.04.003
   SHEPHERD D, 1969, BIOCHEM J, V114, P597, DOI 10.1042/bj1140597
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Smuts I, 2010, J INHERIT METAB DIS, V33, pS95, DOI 10.1007/s10545-009-9031-8
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Zaragoza MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012295
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 39
TC 32
Z9 32
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD JUN
PY 2012
VL 20
IS 6
BP 650
EP 656
DI 10.1038/ejhg.2011.262
PG 7
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 944KK
UT WOS:000304200000014
PM 22258525
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Djordjevic, D
   Brady, L
   Bai, R
   Tarnopolsky, MA
AF Djordjevic, Djurdja
   Brady, Lauren
   Bai, Renkui
   Tarnopolsky, Mark A.
TI Two novel mitochondrial tRNA mutations, A7495G (tRNA<SUP>Ser(UCN)</SUP>)
   and C5577T (tRNA<SUP>TrP</SUP>), are associated with seizures and
   cardiac dysfunction
SO MITOCHONDRION
LA English
DT Article
DE Seizures; Cardiomyopathy; tRNA; Mitochondria; De novo; Encephalopathy;
   Metabolic
ID DISEASE; DNA; GENOME
AB We describe here two novel mitochondrial mutations associated with a complex mitochondrial encephalopathy. An A to G transition at position 7495 (MT-TS1 (MT-tRNSer(UCN))) was identified at 83% heteroplasmy in the muscle of a four year old female with ptosis, hypotonia, seizures, and dilated cardiomyopathy (Case 1). A homoplasmic C to T transition at position 5577 (MT-TW (MT-tRNATrp)) was found in a twenty-four year old woman with exercise intolerance, mild muscle weakness, hearing loss, seizures, and cognitive decline (Case 2). The phenotypic information provided here will assist in phenotype-genotype correlations should additional patients be reported in the future. The mutations can be added to the database of mitochondria( DNA variations in conserved regions which result in clinically diverse phenotypes with the shared markers of mitochondrial disease. (C) 2016 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Djordjevic, Djurdja; Brady, Lauren; Tarnopolsky, Mark A.] McMaster Childrens Hosp, Hamilton, ON, Canada.
   [Bai, Renkui] GeneDx, Gaithersburg, MD USA.
C3 McMaster University
RP Tarnopolsky, MA (corresponding author), McMaster Childrens Hosp, Hamilton, ON, Canada.
EM tamopol@mcmaster.ca
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   [Anonymous], 2007, MAMITTRNA COMPILATIO
   [Anonymous], 2016, MITOMAP HUMAN MITOCH
   Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   BROWN MD, 1994, J BIOENERG BIOMEMBR, V26, P273, DOI 10.1007/BF00763099
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   MacNeil LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109189
   Poulton J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001066
   Retterer K., 2015, Genet. Med, P1
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 14
TC 5
Z9 5
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV
PY 2016
VL 31
BP 40
EP 44
DI 10.1016/j.mito.2016.09.002
PG 5
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA EC8ZL
UT WOS:000388431500005
PM 27693765
DA 2024-11-01
ER

PT J
AU Greaves, LC
   Yu-Wai-Man, P
   Blakely, EL
   Krishnan, KJ
   Beadle, NE
   Kerin, J
   Barron, MJ
   Griffiths, PG
   Dickinson, AJ
   Turnbull, DM
   Taylor, RW
AF Greaves, Laura C.
   Yu-Wai-Man, Patrick
   Blakely, Emma L.
   Krishnan, Kim J.
   Beadle, Nina E.
   Kerin, Jamie
   Barron, Martin J.
   Griffiths, Philip G.
   Dickinson, Alison J.
   Turnbull, Douglass M.
   Taylor, Robert W.
TI Mitochondrial DNA Defects and Selective Extraocular Muscle Involvement
   in CPEO
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; CYTOCHROME-C-OXIDASE; HUMAN
   SKELETAL-MUSCLE; REAL-TIME PCR; WILD-TYPE; INDIVIDUAL CELLS; POINT
   MUTATION; NIGRA NEURONS; DELETIONS; DISEASE
AB PURPOSE. Chronic progressive external ophthalmoplegia (CPEO) is a prominent, and often the only, presentation among patients with mitochondrial diseases. The mechanisms underlying the preferential involvement of extraocular muscles (EOMs) in CPEO were explored in a comprehensive histologic and molecular genetic study, to define the extent of mitochondrial dysfunction in EOMs compared with that in skeletal muscle from the same patient.
   METHODS. A well-characterized cohort of 13 CPEO patients harboring a variety of primary and secondary mitochondrial (mt)DNA defects was studied. Mitochondrial enzyme function was determined in EOM and quadriceps muscle sections with cytochrome c oxidase (COX)/succinate dehydrogenase (SDH) histochemistry, and the mutation load in single muscle fibers was quantified by real-time PCR and PCR-RFLP assays.
   RESULTS. CPEO patients with mtDNA deletions had more COX-deficient fibers in EOM (41.6%) than in skeletal muscle (13.7%, P > 0.0001), and single-fiber analysis revealed a lower mutational threshold for COX deficiency in EOM. Patients with mtDNA point mutations had a less severe ocular phenotype, and there was no significant difference in the absolute level of COX deficiency or mutational threshold between these two muscle groups.
   CONCLUSIONS. The more pronounced mitochondrial biochemical defect and lower mutational threshold in EOM compared with skeletal muscle fibers provide an explanation of the selective muscle involvement in CPEO. The data also suggest that tissue-specific mechanisms are involved in the clonal expansion and expression of secondary mtDNA deletions in CPEO patients with nuclear genetic defects. (Invest Ophthalmol Vis Sci. 2010; 51: 3340-3346) DOI:10.1167/iovs.09-4659
C1 [Taylor, Robert W.] Med Sch Newcastle Upon Tyne, Mitochondrial Res Grp, Inst Ageing & Hlth, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Yu-Wai-Man, Patrick; Griffiths, Philip G.; Dickinson, Alison J.] Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK
RP Taylor, RW (corresponding author), Med Sch Newcastle Upon Tyne, Mitochondrial Res Grp, Inst Ageing & Hlth, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.w.taylor@ncl.ac.uk
RI Clugston, Kim/KBA-3107-2024; Barron, Martin/E-9649-2015
OI Turnbull, Doug/0000-0002-8878-9901; Barron, Martin/0000-0002-2047-3513;
   Greaves, Laura/0000-0002-8071-5916
FU Newcastle University Centre; Biotechnology and Biological Sciences
   Research Council (BBSRC); Engineering and Physical Sciences Research
   Council (EPSRC); Economic and Social Research Council (ESRC); MRC
   (Medical Research Council); Wellcome Trust; Newcastle upon Tyne
   Hospitals NHS Trust; U.K. National Commissioning Group; MRC [G0800674,
   G0601943, G0701386] Funding Source: UKRI
FX Supported by the Newcastle University Centre for Brain Ageing and
   Vitality, which is supported by the Biotechnology and Biological
   Sciences Research Council (BBSRC), Engineering and Physical Sciences
   Research Council (EPSRC), Economic and Social Research Council (ESRC),
   and MRC (Medical Research Council) as part of the cross-council Lifelong
   Health and Wellbeing Initiative (LCG); a Wellcome Trust Programme grant,
   and funding from the Newcastle upon Tyne Hospitals NHS Trust (DMT, RWT).
   PYWM is an MRC Research Fellow in neuro-ophthalmology. Diagnostic
   testing was funded by the U.K. National Commissioning Group to provide
   the "Rare Mitochondrial Disorders of Adults and Children" Diagnostic
   Service.
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, EYE, V13, P769, DOI 10.1038/eye.1999.225
   Bau V, 2005, STRABISMUS, V13, P133, DOI 10.1080/09273970500216432
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611
   CARRY MR, 1986, ANAT RECORD, V214, P8, DOI 10.1002/ar.1092140103
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   FUCHS AF, 1983, J NEUROPHYSIOL, V49, P28, DOI 10.1152/jn.1983.49.1.28
   Gage PJ, 2005, INVEST OPHTH VIS SCI, V46, P4200, DOI 10.1167/iovs.05-0691
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Man CYW, 2006, EYE, V20, P564, DOI 10.1038/sj.eye.6701924
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506
   MULLERHOCKER J, 1992, MUTAT RES, V275, P115, DOI 10.1016/0921-8734(92)90016-I
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Porter JD, 1996, NEUROLOGY, V46, P30, DOI 10.1212/WNL.46.1.30
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Richardson C, 2005, EYE, V19, P258, DOI 10.1038/sj.eye.6701488
   ROBINSON DA, 1970, J NEUROPHYSIOL, V33, P393, DOI 10.1152/jn.1970.33.3.393
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Scott AB, 2007, BRIT J OPHTHALMOL, V91, P146, DOI 10.1136/bjo.2006.110619
   Sevel D, 1986, Trans Am Ophthalmol Soc, V84, P488
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   Spencer R F, 1988, Rev Oculomot Res, V2, P33
   Taherian K, 2007, EYE, V21, P639, DOI 10.1038/sj.eye.6702296
   Taylor RW, 1998, BIOCHEM BIOPH RES CO, V243, P47, DOI 10.1006/bbrc.1997.8055
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2002, NEUROMUSCULAR DISORD, V12, P659, DOI 10.1016/S0960-8966(02)00026-3
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   VIVIAN AJ, 1993, EYE, V7, P565, DOI 10.1038/eye.1993.123
   WOOTEN GF, 1972, ARCH NEUROL-CHICAGO, V26, P350, DOI 10.1001/archneur.1972.00490100080008
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
NR 40
TC 43
Z9 45
U1 0
U2 4
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUL
PY 2010
VL 51
IS 7
BP 3340
EP 3346
DI 10.1167/iovs.09-4659
PG 7
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA 614HX
UT WOS:000279047500003
PM 20164463
OA Green Published
DA 2024-11-01
ER

PT J
AU Mahjoub, G
   Habibzadeh, P
   Dastsooz, H
   Mirzaei, M
   Kavosi, A
   Jamali, L
   Javanmardi, H
   Katibeh, P
   Faghihi, MA
   Dastgheib, SA
AF Mahjoub, Ghazale
   Habibzadeh, Parham
   Dastsooz, Hassan
   Mirzaei, Malihe
   Kavosi, Arghavan
   Jamali, Laila
   Javanmardi, Haniyeh
   Katibeh, Pegah
   Faghihi, Mohammad Ali
   Dastgheib, Seyed Alireza
TI Clinical and molecular characterization of three patients with
   Hepatocerebral form of mitochondrial DNA depletion syndrome: a case
   series
SO BMC MEDICAL GENETICS
LA English
DT Article
DE Mitochondrial DNA depletion syndrome; DGUOK; MPV17; Mitochondrial
   disorders
ID DEOXYGUANOSINE KINASE GENE; MUTATIONS; MTDNA; DGUOK; PROTEIN;
   PREDICTION; FEATURES; DISEASES
AB Background: Mitochondrial DNA depletion syndromes (MDS) are clinically and phenotypically heterogeneous disorders resulting from nuclear gene mutations. The affected individuals represent a notable reduction in mitochondrial DNA (mtDNA) content, which leads to malfunction of the components of the respiratory chain. MDS is classified according to the type of affected tissue; the most common type is hepatocerebral form, which is attributed to mutations in nuclear genes such as DGUOK and MPV17. These two genes encode mitochondrial proteins and play major roles in mtDNA synthesis. Case presentation: In this investigation patients in three families affected by hepatocerebral form of MDS who were initially diagnosed with tyrosinemia underwent full clinical evaluation. Furthermore, the causative mutations were identified using next generation sequencing and were subsequently validated using sanger sequencing. The effect of the mutations on the gene expression was also studied using real-time PCR. A pathogenic heterozygous frameshift deletion mutation in DGUOK gene was identified in parents of two affected patients (c.706- 707 + 2 del: p.k236 fs) presenting with jaundice, impaired fetal growth, low-birth weight, and failure to thrive who died at the age of 3 and 6 months in family I. Moreover, a novel splice site mutation in MPV17 gene (c.461 + 1G > C) was identified in a patient with jaundice, muscle weakness, and failure to thrive who died due to hepatic failure at the age of 4 months. A 5-month-old infant presenting with jaundice, dark urine, poor sucking, and feeding problems was also identified to have another novel mutation in MPV17 gene leading to stop gain mutation (c.277C > T: p.(Gln93*)). Conclusions: These patients had overlapping clinical features with tyrosinemia. MDS should be considered a differential diagnosis in patients presenting with signs and symptoms of tyrosinemia.
C1 [Mahjoub, Ghazale; Habibzadeh, Parham; Dastsooz, Hassan; Mirzaei, Malihe; Kavosi, Arghavan; Jamali, Laila; Faghihi, Mohammad Ali] Shiraz Univ Med Sci, Persian BayanGene Res & Training Ctr, Shiraz, Iran.
   [Habibzadeh, Parham; Javanmardi, Haniyeh] Shiraz Univ Med Sci, Student Res Comm, Shiraz, Iran.
   [Dastsooz, Hassan] Univ Turin, IIGM, Turin, Italy.
   [Katibeh, Pegah] Shiraz Univ Med Sci, Dept Pediat, Shiraz, Iran.
   [Faghihi, Mohammad Ali] Univ Miami, Miller Sch Med, Ctr Therapeut Innovat, Dept Psychiat & Behav Sci, Miami, FL 33136 USA.
   [Dastgheib, Seyed Alireza] Shiraz Univ Med Sci, Sch Med, Dept Med Genet, Shiraz, Iran.
C3 Shiraz University of Medical Science; Shiraz University of Medical
   Science; University of Turin; Italian Institute for Genomic Medicine
   (IIGM); Shiraz University of Medical Science; University of Miami;
   Shiraz University of Medical Science
RP Dastgheib, SA (corresponding author), Shiraz Univ Med Sci, Sch Med, Dept Med Genet, Shiraz, Iran.
EM Dastgheib@sums.ac.ir
RI dastgheib, Seyed/C-8613-2019; Faghihi, Mohammad/AAD-7159-2020; Mahjoub,
   Ghazale/AAW-2872-2021; Katibeh, Pegah/V-7821-2018; Habibzadeh,
   Parham/H-1983-2019
OI Dastgheib, Seyed Alireza/0000-0003-4781-301X; Habibzadeh,
   Parham/0000-0002-2086-0425; Dastsooz, Hassan/0000-0002-0679-4425
FU NIMAD research grant [940714]
FX The study was supported by the NIMAD research grant (940714) awarded to
   MAF. The funding body has had no role in the design of the study and
   collection, analysis, interpretation of data and in the writing of the
   manuscript.
CR Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Brahimi N, 2009, MOL GENET METAB, V97, P221, DOI 10.1016/j.ymgme.2009.03.007
   Carreño-Gago L, 2017, BBA-MOL BASIS DIS, V1863, P182, DOI 10.1016/j.bbadis.2016.09.002
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   ENDO F, 1983, PEDIATR RES, V17, P92, DOI 10.1203/00006450-198302000-00002
   Fang WY, 2017, ONCOTARGET, V8, P84309, DOI 10.18632/oncotarget.20905
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Habibzadeh P, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00944
   Johansson K, 2001, NAT STRUCT BIOL, V8, P616, DOI 10.1038/89661
   Johansson M, 1996, GENOMICS, V38, P450, DOI 10.1006/geno.1996.0654
   Kim J, 2016, MOL GENET METAB REP, V8, P74, DOI 10.1016/j.ymgmr.2016.06.006
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Nobre S., 2012, BMJ CASE REP, V2012
   Parini R, 2009, J HEPATOL, V50, P215, DOI 10.1016/j.jhep.2008.08.019
   Rosa ID, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005779
   Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890
   Sezer T, 2015, J CHILD NEUROL, V30, P124, DOI 10.1177/0883073813517000
   Spiegel R, 2016, J MED GENET, V53, P127, DOI 10.1136/jmedgenet-2015-103361
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001
   Strachan T., 2014, Genetics and genomics in medicine, V1st
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tadiboyina VT, 2005, AM J MED GENET A, V135A, P289, DOI 10.1002/ajmg.a.30748
   Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603
   Wang LY, 2003, FEBS LETT, V554, P319, DOI 10.1016/S0014-5793(03)01181-5
   Wang LY, 1996, FEBS LETT, V390, P39, DOI 10.1016/0014-5793(96)00623-0
   Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342
   Zhang CX, 2017, NUCLEIC ACIDS RES, V45, pW291, DOI 10.1093/nar/gkx366
NR 41
TC 9
Z9 12
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2350
J9 BMC MED GENET
JI BMC Med. Genet.
PD OCT 29
PY 2019
VL 20
IS 1
AR 167
DI 10.1186/s12881-019-0893-9
PG 10
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA JZ2HC
UT WOS:000504923600001
PM 31664948
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Sato, K
   Yabe, I
   Yaguchi, H
   Nakano, F
   Kunieda, Y
   Saitoh, S
   Sasaki, H
AF Sato, Kazunori
   Yabe, Ichiro
   Yaguchi, Hiroaki
   Nakano, Fumihito
   Kunieda, Yasuyuki
   Saitoh, Shinji
   Sasaki, Hidenao
TI Genetic analysis of two Japanese families with progressive external
   ophthalmoplegia and parkinsonism
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE Progressive external ophthalmoplegia; DNA polymerase gamma gene;
   Parkinsonism; Mitochondria
ID POLYMERASE-GAMMA MUTATIONS; MITOCHONDRIAL-DNA; POLG1 MUTATIONS; DISEASE;
   REPLICATION; DELETIONS; TWINKLE
AB Mutations in the progressive external ophthalmoplegia 1 (PEO1), adenine nucleotide translocator 1 (ANT1) and DNA polymerase gamma (POLG) genes were reported in patients with progressive external ophthalmoplegia and parkinsonism. However, the genotype-phenotype correlation and pathophysiology of these syndromes are still unknown. In order to define the molecular basis of progressive external ophthalmoplegia and parkinsonism, we screened for mutations in PEO1, ANT1, POLG genes and the whole mitochondrial genome in two families. In results, we identified a compound heterozygous POLG substitutions, c.830A > T (p.H277L) and c.2827C > T (p.R943C) in one of the families. These two mutations in the coding region of POLG alter conserved amino acids in the exonuclease and polymerase domains, respectively, of the POLG protein. Neither of these substitutions was found in the 100 chromosomes of ethnically matched control subjects. In the other family, no mutations were detected in any of the three genes and the whole mitochondrial genome in the blood sample, although mitochondrial DNA deletions were observed in the muscle biopsy sample. Progressive external ophthalmoplegia and parkinsonism are genetically heterogenous disorders, and part of this syndrome may be caused by mutations in other, unknown genes.
C1 [Sato, Kazunori; Yabe, Ichiro; Yaguchi, Hiroaki; Nakano, Fumihito; Sasaki, Hidenao] Hokkaido Univ, Grad Sch Med, Dept Neurol, Kita Ku, Sapporo, Hokkaido 0608638, Japan.
   [Kunieda, Yasuyuki] Wakkanai City Hosp, Dept Internal Med, Wakkanai, Hokkaido, Japan.
   [Saitoh, Shinji] Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido 0608638, Japan.
C3 Hokkaido University; Hokkaido University
RP Yabe, I (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Neurol, Kita Ku, N15W7, Sapporo, Hokkaido 0608638, Japan.
EM yabe@med.hokudai.ac.jp
RI Yabe, Ichiro/AAU-2495-2020; Saitoh, Shinji/AFT-1159-2022
OI Saitoh, Shinji/0000-0001-6911-3351
FU Ministry of Health, Welfare and Labor, Japan; Ministry of Education,
   Science, Sports, and Culture, Japan
FX We thank all patients and control subjects for their active cooperation.
   This work was supported in part by a Grant-in-Aid for the Research
   Committee of CNS Degenerative Diseases of the Research on Measures for
   Intractable Diseases from the Ministry of Health, Welfare and Labor,
   Japan, by a Grant-in-Aid for Scientific Research from the Ministry of
   Education, Science, Sports, and Culture, Japan.
CR Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Errea JM, 1999, MOVEMENT DISORD, V14, P596, DOI 10.1002/1531-8257(199907)14:4<596::AID-MDS1008>3.0.CO;2-U
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Galassi G, 2008, NEUROMUSCULAR DISORD, V18, P465, DOI 10.1016/j.nmd.2008.03.013
   HARADA H, 1983, ARCH NEUROL-CHICAGO, V40, P151, DOI 10.1001/archneur.1983.04050030045008
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Hudson G, 2009, MOVEMENT DISORD, V24, P1092, DOI 10.1002/mds.22310
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Miyako K, 1999, EUR J BIOCHEM, V259, P412, DOI 10.1046/j.1432-1327.1999.00056.x
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   HUMAN DNA POLYM GAMM
NR 27
TC 16
Z9 17
U1 0
U2 1
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
J9 J NEUROL
JI J. Neurol.
PD JUL
PY 2011
VL 258
IS 7
BP 1327
EP 1332
DI 10.1007/s00415-011-5936-x
PG 6
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 789YE
UT WOS:000292554700017
PM 21301859
DA 2024-11-01
ER

PT J
AU Kytövuori, L
   Gardberg, M
   Majamaa, K
   Martikainen, MH
AF Kytovuori, Laura
   Gardberg, Maria
   Majamaa, Kari
   Martikainen, Mika H.
TI The m.7510T&gt;C mutation: Hearing impairment and a complex neurologic
   phenotype
SO BRAIN AND BEHAVIOR
LA English
DT Article
DE hearing impairment; mitochondrial disorder; MT-TS1; neuromuscular
   disorder
ID MITOCHONDRIAL TRNA(SER(UCN)) GENE; RIBOSOMAL-RNA GENE; T7511C MUTATION;
   POINT MUTATION; DNA MUTATIONS; DISEASE; PATIENT; FAMILY; PREVALENCE;
   DISORDERS
AB ObjectivesMutations in mitochondrial DNA cause a variety of clinical phenotypes ranging from a mild hearing impairment (HI) to severe encephalomyopathy. The MT-TS1 gene is a hotspot for mutations causing HI. The m.7510T>C mutation in MT-TS1 has been previously associated with non-syndromic HI in four families from different ethnic backgrounds.
   Materials and MethodsWe describe the clinical, genetic, and histopathological findings in a Finnish family with the heteroplasmic m.7510T>C mutation in mitochondrial DNA.
   ResultsThe family proband presented with a progressive mitochondrial disease phenotype including migraine, epilepsy, mild ataxia, and cognitive impairment in addition to HI. One young adult presented with HI only. Other family members had a mild phenotype comprising ataxia and tremor in addition to HI. Mutation heteroplasmy was 90% in the blood of maternal grandmother and 99% in the muscle and blood of the three other family members. Muscle histology was consistent with mitochondrial myopathy in three family members. The mitochondrial haplogroup of the family was a different branch of the haplogroup H than in the previous reports of this mutation.
   ConclusionOur results suggest that, in addition to sensorineural HI, the m.7510T>C mutation is associated with a spectrum of mitochondrial disease clinical features including migraine, epilepsy, cognitive impairment, ataxia, and tremor, and with evidence of mitochondrial myopathy.
C1 [Kytovuori, Laura; Majamaa, Kari] Univ Oulu, Res Unit Clin Neurosci, Oulu, Finland.
   [Kytovuori, Laura; Majamaa, Kari] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland.
   [Kytovuori, Laura; Majamaa, Kari] Univ Oulu, Oulu, Finland.
   [Kytovuori, Laura; Majamaa, Kari] Oulu Univ Hosp, Dept Neurol, Oulu, Finland.
   [Gardberg, Maria] Univ Turku, Dept Pathol, Turku, Finland.
   [Gardberg, Maria; Martikainen, Mika H.] Turku Univ Hosp, Turku, Finland.
   [Martikainen, Mika H.] Univ Turku, Div Clin Neurosci, Turku, Finland.
C3 University of Oulu; University of Oulu; University of Oulu; University
   of Oulu; University of Turku; University of Turku; University of Turku
RP Martikainen, MH (corresponding author), Turku Univ Hosp, Turku, Finland.; Martikainen, MH (corresponding author), Univ Turku, Div Clin Neurosci, Turku, Finland.
EM mikmar@utu.fi
RI Majamaa, Kari/A-1344-2012; Kytövuori, Laura/AHE-1635-2022
OI Majamaa, Kari/0000-0002-9070-3791; Kytovuori, Laura/0000-0003-2790-5646;
   Martikainen, Mika/0000-0002-7604-8081
FU Stiftelsen Dorothea Olivia, Karl Walter och Jarl Walter Perklens Minne;
   Sigrid Juseliuksen Saatio
FX Stiftelsen Dorothea Olivia, Karl Walter och Jarl Walter Perklens Minne,
   Grant/Award Number: n/a; Sigrid Juseliuksen Saatio, Grant/Award Number:
   n/a
CR Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Bargiela David, 2015, Cerebellum Ataxias, V2, P16, DOI 10.1186/s40673-015-0035-x
   Chapiro E, 2002, EUR J HUM GENET, V10, P851, DOI 10.1038/sj.ejhg.5200894
   delsCastillo F. J., 2002, J MED GENET, V39, pe82
   Dubowitz V., 2006, MUSCLE BIOPSY PRACTI
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hutchin TP, 2000, J MED GENET, V37, P692, DOI 10.1136/jmg.37.9.692
   Jacobs HT, 2005, EUR J HUM GENET, V13, P26, DOI 10.1038/sj.ejhg.5201250
   Jaksch M, 1998, ANN NEUROL, V44, P635, DOI 10.1002/ana.410440409
   Kloss-Brandstätter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382
   Komlósi K, 2013, JIMD REP, V9, P105, DOI 10.1007/8904_2012_187
   Kouzaki H, 2007, J CLIN NEUROSCI, V14, P603, DOI 10.1016/j.jocn.2005.10.012
   Labay V, 2008, CLIN GENET, V73, P50, DOI 10.1111/j.1399-0004.2007.00925.x
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Lehtonen MS, 2000, EUR J HUM GENET, V8, P315, DOI 10.1038/sj.ejhg.5200455
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Martikainen MH, 2016, JAMA NEUROL, V73, P668, DOI 10.1001/jamaneurol.2016.0355
   Martikainen MH, 2013, MITOCHONDRION, V13, P83, DOI 10.1016/j.mito.2013.01.012
   MORGANHUGHES JA, 1995, BBA-MOL BASIS DIS, V1271, P135, DOI 10.1016/0925-4439(95)00020-5
   NAKAMURA M, 1995, BIOCHEM BIOPH RES CO, V214, P86, DOI 10.1006/bbrc.1995.2260
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Raheem O, 2010, ACTA NEUROPATHOL, V119, P495, DOI 10.1007/s00401-010-0643-8
   Santorelli FM, 1999, AM J HUM GENET, V64, P295, DOI 10.1086/302188
   Soares P, 2011, AM J HUM GENET, V88, P239, DOI 10.1016/j.ajhg.2011.01.009
   Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905
   van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921
   Virgilio R, 2009, J NEUROL SCI, V281, P85, DOI 10.1016/j.jns.2009.01.025
   Yamasoba T, 2002, NEUROMUSCULAR DISORD, V12, P506, DOI 10.1016/S0960-8966(01)00329-7
   Yan H, 2006, J BIOL CHEM, V281, P3926, DOI 10.1074/jbc.M509822200
NR 30
TC 4
Z9 4
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 2162-3279
J9 BRAIN BEHAV
JI Brain Behav.
PD DEC
PY 2017
VL 7
IS 12
AR e00859
DI 10.1002/brb3.859
PG 6
WC Behavioral Sciences; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Behavioral Sciences; Neurosciences & Neurology
GA FR1UP
UT WOS:000418853300006
PM 29299381
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Adjadj, E
   Mansouri, K
   Borruat, FX
AF Adjadj, E.
   Mansouri, K.
   Borruat, F. -X.
TI Mitochondrial DNA (mtDNA) A3243G mutation associated with an annular
   perimacular retinal atrophy
SO KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE
LA English
DT Article; Proceedings Paper
CT 100th Annual Congress of the
   Schweizerischen-Ophthalmologischen-Gesellschaft (SOG/SSO)
CY SEP 05-08, 2007
CL Montreux, SWITZERLAND
DE MtDNA; point mutation 3243; macular atrophy
ID PIGMENTARY RETINOPATHY; MELAS; DEAFNESS; INHERITANCE; PREVALENCE;
   DYSTROPHY
AB Background: A point mutation at the locus 3243 of the mitonchondrial DNA (mtDNA) is associated with either the MIDD syndrome (maternally inherited diabetes, deafness), the MELAS syndrome (myopathy, encephalitis, lactic acidosis, stroke) or cardiac, digestive, endocrine or exocrine dysfunctions. We report a peculiar maculopathy in two patients with an mtDNA 3243 mutation. History and Signs: Case 1: A visually asymptomatic 40-year-old woman was examined for screening of diabetic retinopathy. Visual acuity was 10/10 in both eyes. Case 2: A54-year-old woman with deafness and diabetes complained of visual loss. Visual acuity was 6/10 for the right eye and 0.5/10 for the left eye. Both patients exhibited a chorioretinal areolar atrophy. Case 1 was followed over 15 years and exhibited a slow progression of the maculopathy with moderate loss of visual acuity to 6/10 in both eyes, but marked handicap from the annular scotoma. Therapy and Outcome: None. Conclusion: Both patients presented a perimacular annular retinal atrophy. Patients harbouring mtDNA 3243 mutation should be examined for the presence of a maculopathy, even if they are asymptomatic. Conversely, the finding of such a geographic maculopathy should suggest the possibility of a point mutation at the locus 3243 of the mitochondrial DNA, especially in the presences of diabetes mellitus and/or deafness.
C1 [Borruat, F. -X.] Hop Ophtalm Jules Gonin, Unite Neuroophtalmol, CH-1004 Lausanne, Switzerland.
RP Borruat, FX (corresponding author), Hop Ophtalm Jules Gonin, Unite Neuroophtalmol, Ave France 15, CH-1004 Lausanne, Switzerland.
EM francois.borruat@ophtal.vd.ch
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   EGGER J, 1983, NEW ENGL J MED, V309, P142, DOI 10.1056/NEJM198307213090304
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Latkany P, 1999, AM J OPHTHALMOL, V128, P112, DOI 10.1016/S0002-9394(99)00057-4
   Latvala T, 2002, GRAEF ARCH CLIN EXP, V240, P795, DOI 10.1007/s00417-002-0555-y
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Massin P, 1999, OPHTHALMOLOGY, V106, P1821, DOI 10.1016/S0161-6420(99)90356-1
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   SILVESTREAILLAUD P, 1995, DIABETOLOGIA, V38, P1485
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   Sue CM, 1997, NEUROLOGY, V49, P1013, DOI 10.1212/WNL.49.4.1013
   Suzuki S, 1998, DIABETOLOGIA, V41, P584, DOI 10.1007/s001250050950
   Takeshima T, 2005, INTERNAL MED, V44, P276, DOI 10.2169/internalmedicine.44.276
NR 14
TC 8
Z9 10
U1 0
U2 2
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0023-2165
J9 KLIN MONATSBL AUGENH
JI Klinische Monatsblat. Augenheilkunde
PD MAY
PY 2008
VL 225
IS 5
BP 462
EP 464
DI 10.1055/s-2008-1027257
PG 3
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Ophthalmology
GA 306GZ
UT WOS:000256237600037
PM 18454399
DA 2024-11-01
ER

PT J
AU Nasca, A
   Di Meo, I
   Fellig, Y
   Saada, A
   Elpeleg, O
   Ghezzi, D
   Edvardson, S
AF Nasca, Alessia
   Di Meo, Ivano
   Fellig, Yakov
   Saada, Ann
   Elpeleg, Orly
   Ghezzi, Daniele
   Edvardson, Shimon
TI A novel homozygous <i>MSTO1</i> mutation in Ashkenazi Jewish siblings
   with ataxia and myopathy
SO JOURNAL OF HUMAN GENETICS
LA English
DT Article
AB MSTO1 is a cytoplasmic protein that modulates mitochondrial dynamics by promoting mitochondrial fusion. Mutations in the MSTO1 gene are responsible for an extremely rare condition characterized by early-onset myopathy and cerebellar ataxia. We report here two siblings from a large Ashkenazi Jewish family, presenting with a progressive neuromuscular disease characterized by ataxia and myopathy. By whole exome sequencing, we found a novel homozygous missense mutation (c.1403T>A, p.Leu468Gln) in MSTO1. Studies performed on fibroblasts from the index patient demonstrated the pathogenic role of the identified variant; we found that MSTO1 protein level was reduced and that mitochondrial network was fragmented or formed enlarged structures. Moreover, patient's cells showed reduced mitochondrial DNA amount. Our report confirms that MSTO1 mutations are typically recessive, and associated with clinical phenotypes characterized by early-onset muscle impairment and ataxia, often with upper motor neuron signs and varied cognitive impairment.
C1 [Nasca, Alessia; Di Meo, Ivano; Ghezzi, Daniele] Fdn IRCCS Ist Neurol Carlo Besta, Unit Med Genet & Neurogenet, I-20126 Milan, Italy.
   [Fellig, Yakov] Hadassah Hebrew Univ Jerusalem, Dept Pathol, IL-91120 Jerusalem, Israel.
   [Saada, Ann; Elpeleg, Orly] Hadassah Hebrew Univ Jerusalem, Dept Genet, IL-91120 Jerusalem, Israel.
   [Ghezzi, Daniele] Univ Milan, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy.
   [Edvardson, Shimon] Hadassah Hebrew Univ Jerusalem, Pediat Neurol Unit, IL-91240 Jerusalem, Israel.
C3 Fondazione IRCCS Istituto Neurologico Carlo Besta; Hebrew University of
   Jerusalem; Hadassah University Medical Center; Hebrew University of
   Jerusalem; Hadassah University Medical Center; University of Milan;
   Hebrew University of Jerusalem; Hadassah University Medical Center
RP Ghezzi, D (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Unit Med Genet & Neurogenet, I-20126 Milan, Italy.; Ghezzi, D (corresponding author), Univ Milan, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy.; Edvardson, S (corresponding author), Hadassah Hebrew Univ Jerusalem, Pediat Neurol Unit, IL-91240 Jerusalem, Israel.
EM daniele.ghezzi@istituto-besta.it; simon@hadassah.org.il
RI Ghezzi, Daniele/J-7873-2016; Saada, Ann/J-6864-2017; Di Meo,
   Ivano/H-7840-2014; Nasca, Alessia/K-2227-2016
OI Ghezzi, Daniele/0000-0002-6564-3766; Saada, Ann/0000-0003-2951-0656; Di
   Meo, Ivano/0000-0002-4616-5623; Nasca, Alessia/0000-0002-0640-9929
FU Mariani Foundation
FX This project was carried out in the Center for the Study of
   Mitochondrial Pediatric Diseases funded by the Mariani Foundation. DG is
   a member of the European Reference Network for Rare Neuromuscular
   Diseases (ERN EURO-NMD).
CR Ardicli D, 2019, NEUROMUSCULAR DISORD, V29, P448, DOI 10.1016/j.nmd.2019.03.011
   Donkervoort S, 2019, ACTA NEUROPATHOL, V138, P1013, DOI 10.1007/s00401-019-02059-z
   Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266
   Gal A, 2017, EMBO MOL MED, V9, P967, DOI 10.15252/emmm.201607058
   Iwama K, 2018, J HUM GENET, V63, P263, DOI 10.1038/s10038-017-0405-8
   Kimura M, 2007, EXP CELL RES, V313, P1393, DOI 10.1016/j.yexcr.2007.02.004
   Li K, 2020, EUR J MED GENET, V63, DOI 10.1016/j.ejmg.2019.01.013
   Nasca A, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00625
   Nasca A, 2017, HUM MUTAT, V38, P970, DOI 10.1002/humu.23262
   Nasca A, 2016, HUM MUTAT, V37, P898, DOI 10.1002/humu.23033
   Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003
   Schultz-Rogers L, 2019, CSH MOL CASE STUD, V5, DOI 10.1101/mcs.a004309
   Shahrour MA, 2017, CLIN GENET, V91, P690, DOI 10.1111/cge.12855
   Vidoni S, 2013, ANTIOXID REDOX SIGN, V19, P379, DOI 10.1089/ars.2012.4800
NR 14
TC 3
Z9 3
U1 0
U2 9
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1434-5161
EI 1435-232X
J9 J HUM GENET
JI J. Hum. Genet.
PD AUG
PY 2021
VL 66
IS 8
BP 835
EP 840
DI 10.1038/s10038-020-00897-4
EA FEB 2021
PG 6
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA TP7KF
UT WOS:000620106700001
PM 33612823
DA 2024-11-01
ER

PT J
AU Tranah, GJ
   Yaffe, K
   Katzman, SM
   Lam, ET
   Pawlikowska, L
   Kwok, PY
   Schork, NJ
   Manini, TM
   Kritchevsky, S
   Thomas, F
   Newman, AB
   Harris, TB
   Coleman, AL
   Gorin, MB
   Helzner, EP
   Rowbotham, MC
   Browner, WS
   Cummings, SR
AF Tranah, Gregory J.
   Yaffe, Kristine
   Katzman, Shana M.
   Lam, Ernest T.
   Pawlikowska, Ludmila
   Kwok, Pui-Yan
   Schork, Nicholas J.
   Manini, Todd M.
   Kritchevsky, Stephen
   Thomas, Fridtjof
   Newman, Anne B.
   Harris, Tamara B.
   Coleman, Anne L.
   Gorin, Michael B.
   Helzner, Elizabeth P.
   Rowbotham, Michael C.
   Browner, Warren S.
   Cummings, Steven R.
CA Hlth Aging Body Composition
TI Mitochondrial DNA Heteroplasmy Associations With Neurosensory and
   Mobility Function in Elderly Adults
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Mitochondrial DNA; Heteroplasmy; Cognition; Vision; Hearing; Mobility
ID HEREDITARY OPTIC NEUROPATHY; COMPLEX-I DEFICIENCY; SKELETAL-MUSCLE;
   CLONAL EXPANSION; MTDNA MUTATIONS; ND3 GENE; DISEASE; CELLS; SELECTION;
   DYSFUNCTION
AB Background. Mitochondrial DNA ( mtDNA) heteroplasmy is a mixture of normal and mutated mtDNA molecules in a cell. High levels of heteroplasmy at specific mtDNA sites lead to inherited mitochondrial diseases with neurological, sensory, and movement impairments. Here we test the hypothesis that heteroplasmy levels in elderly adults are associated with impaired function resembling mild forms of mitochondrial disease. Methods. We examined platelet mtDNA heteroplasmy at 20 disease-causing sites for associations with neurosensory and mobility function among 137 participants from the community-based Health, Aging, and Body Composition Study. Results. Elevated mtDNA heteroplasmy at four mtDNA sites in complex I and tRNA genes was nominally associated with reduced cognition, vision, hearing, and mobility: m. 10158T> C with Modified Mini-Mental State Examination score ( p =.009); m. 11778G> A with contrast sensitivity ( p =.02); m. 7445A> G with high-frequency hearing ( p =.047); and m. 5703G> A with 400 m walking speed ( p =.007). Conclusions. These results indicate that increased mtDNA heteroplasmy at disease-causing sites is associated with neurosensory and mobility function in older persons. We propose the novel use of mtDNA heteroplasmy as a simple, noninvasive predictor of age-related neurologic, sensory, and movement impairments.
C1 [Tranah, Gregory J.; Rowbotham, Michael C.; Browner, Warren S.; Cummings, Steven R.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA.
   [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.
   [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.
   [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA.
   [Yaffe, Kristine] San Francisco VA Med Ctr, San Francisco, CA USA.
   [Katzman, Shana M.] LA Eye Ctr & Clin, Los Angeles, CA USA.
   [Lam, Ernest T.] BioNano Genom Inc, San Diego, CA USA.
   [Pawlikowska, Ludmila] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA.
   [Pawlikowska, Ludmila; Kwok, Pui-Yan] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.
   [Schork, Nicholas J.] J Craig Venter Inst, San Francisco, CA USA.
   [Schork, Nicholas J.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Manini, Todd M.] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL USA.
   [Kritchevsky, Stephen] Wake Forest Sch Med, Sticht Ctr Aging, Winston Salem, NC USA.
   [Thomas, Fridtjof] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA.
   [Newman, Anne B.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15260 USA.
   [Harris, Tamara B.] NIA, Intramural Res Program, Lab Epidemiol & Populat Sci, Bethesda, MD 20892 USA.
   [Coleman, Anne L.; Gorin, Michael B.] Jules Stein Eye Inst, Los Angeles, CA 90024 USA.
   [Coleman, Anne L.; Gorin, Michael B.] Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA USA.
   [Helzner, Elizabeth P.] Suny Downstate Med Ctr, Dept Epidemiol & Biostat, Brooklyn, NY 11203 USA.
C3 California Pacific Medical Center; California Pacific Medical Center
   Research Institute; University of California System; University of
   California San Francisco; University of California System; University of
   California San Francisco; University of California System; University of
   California San Francisco; US Department of Veterans Affairs; Veterans
   Health Administration (VHA); San Francisco VA Medical Center; University
   of California System; University of California San Francisco; University
   of California System; University of California San Francisco; J. Craig
   Venter Institute; University of California System; University of
   California San Francisco; State University System of Florida; University
   of Florida; Wake Forest University; University of Tennessee System;
   University of Tennessee Health Science Center; Pennsylvania Commonwealth
   System of Higher Education (PCSHE); University of Pittsburgh; University
   of California System; University of California Los Angeles; State
   University of New York (SUNY) System; SUNY Downstate Health Sciences
   University
RP Tranah, GJ (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, Mission Hall Global Hlth & Clin Sci Bldg,550 16th, San Francisco, CA 94143 USA.
EM gtranah@sfcc-cpmc.net
RI Rowbotham, Michael/AAA-3606-2019; , Thomas/AAD-4757-2020; Newman,
   Anne/C-6408-2013; Kwok, Pui-Yan/F-7725-2014
OI Manini, Todd/0000-0002-5970-4462; Purchase-Helzner,
   Elizabeth/0000-0002-7441-0868; Thomas, Fridtjof/0000-0003-1325-4870;
   Schork, Nicholas/0000-0003-0920-5013
FU NIH, National Institute on Aging [N01-AG-6-2101, N01-AG-6-2103,
   N01-AG-6-2106]; National Institutes of Health [R01-AG028050,
   R03-AG032498, R01-NR012459, Z01A6000932, R01-HL121023]; Research and
   Education Leadership Committee of the CPMC Foundation
FX This research was supported in part by the Intramural Research Program
   of the NIH, National Institute on Aging, Contracts N01-AG-6-2101,
   N01-AG-6-2103, and N01-AG-6-2106; National Institutes of Health grants
   R01-AG028050, R03-AG032498, R01-NR012459, Z01A6000932, R01-HL121023, and
   a grant from the Research and Education Leadership Committee of the CPMC
   Foundation.
CR ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   Baracca A, 2005, ARCH NEUROL-CHICAGO, V62, P730, DOI 10.1001/archneur.62.5.730
   Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811
   Catricala S, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-20
   Cesari M, 2012, J GERONTOL A-BIOL, V67, P671, DOI 10.1093/gerona/glr246
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Comte C, 2013, NUCLEIC ACIDS RES, V41, P418, DOI 10.1093/nar/gks965
   Coon KD, 2006, MITOCHONDRION, V6, P194, DOI 10.1016/j.mito.2006.07.002
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   Dai Y, 2014, HUM MOL GENET, V23, P637, DOI 10.1093/hmg/ddt450
   Durham SE, 2006, NEUROMUSCULAR DISORD, V16, P381, DOI 10.1016/j.nmd.2006.03.012
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Figueiredo PA, 2009, J GERONTOL A-BIOL, V64, P21, DOI 10.1093/gerona/gln048
   Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868
   Guy J, 2014, INVEST OPHTH VIS SCI, V55, P841, DOI 10.1167/iovs.13-13365
   Hao HL, 1997, MOL CELL BIOL, V17, P6831, DOI 10.1128/MCB.17.12.6831
   Hao HL, 1999, HUM MOL GENET, V8, P1117, DOI 10.1093/hmg/8.6.1117
   Horan MP, 2012, J GERONTOL A-BIOL, V67, P1022, DOI 10.1093/gerona/glr263
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Khrapko K, 2003, MUTAT RES-FUND MOL M, V522, P13, DOI 10.1016/S0027-5107(02)00306-8
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Lebre AS, 2011, J MED GENET, V48, P16, DOI 10.1136/jmg.2010.079624
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Naviaux RK, 2000, EUR J PEDIATR, V159, pS219, DOI 10.1007/PL00014407
   OZAWA T, 1995, BBA-MOL BASIS DIS, V1271, P177, DOI 10.1016/0925-4439(95)00026-Z
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Qi XP, 2007, ARCH OPHTHALMOL-CHIC, V125, P268, DOI 10.1001/archopht.125.2.268
   Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P3065, DOI 10.1093/nar/gkn147
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Russell O, 2014, EXP CELL RES, V325, P38, DOI 10.1016/j.yexcr.2014.03.012
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   Tranah GJ, 2012, BBA-BIOENERGETICS, V1817, P1691, DOI 10.1016/j.bbabio.2012.05.012
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Tyrrell DJ, 2015, J GERONTOL A-BIOL, V70, P1394, DOI 10.1093/gerona/glu096
   Van Remmen H, 2009, J GERONTOL A-BIOL, V64, P171, DOI 10.1093/gerona/gln058
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002
   Zanna C, 2003, ANN NY ACAD SCI, V1010, P213, DOI 10.1196/annals.1299.037
   Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548
NR 53
TC 21
Z9 22
U1 3
U2 13
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD NOV
PY 2015
VL 70
IS 11
BP 1418
EP 1424
DI 10.1093/gerona/glv097
PG 7
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA CW1QF
UT WOS:000364765700016
PM 26328603
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU de Vries, MC
   Rodenburg, RJ
   Morava, E
   van Kaauwen, EPM
   ter Laak, H
   Mullaart, RA
   Snoeck, IN
   van Hasselt, PM
   Harding, P
   van den Heuvel, LPW
   Smeitink, JAM
AF de Vries, Maaike C.
   Rodenburg, Richard J.
   Morava, Eva
   van Kaauwen, Edwin P. M.
   ter Laak, Henk
   Mullaart, Reinier A.
   Snoeck, Irina N.
   van Hasselt, Peter M.
   Harding, Peter
   van den Heuvel, Lambert P. W.
   Smeitink, Jan A. M.
TI Multiple oxidative phosphorylation deficiencies in severe childhood
   multi-system disorders due to polymerase gamma (<i>POLG1</i>) mutations
SO EUROPEAN JOURNAL OF PEDIATRICS
LA English
DT Article
DE POLG1; combined OXPHOS deficiencies; mitochondrial medicine
ID MITOCHONDRIAL-DNA POLYMERASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   ALPERS-SYNDROME; AUTOSOMAL-DOMINANT; GENE; DEPLETION; DEFECTS; ATAXIA;
   VALPROATE; DELETIONS
AB Failure to thrive, feeding difficulties, variable forms of infantile epilepsy or psychomotor developmental delay and hypotonia were the most frequent clinical disease presentations in eight.children with combined oxidative phosphorylation enzyme complex deficiencies carrying mutations in the polymerase gamma (POLGI) gene. Five out of eight patients developed severe liver dysfunction during the course of the disease. Three of these patients fulfilled the disease criteria for Alpers syndrome. Most children showed deficiencies of respiratory chain enzyme complexes I and III, in combination with complex II, complex IV and/or PDHc in muscle, whereas in fibroblasts normal enzyme activities were measured. All children carried homozygous or compound heterozygous mutations in the POLGI gene, including two novel mutations in association with mtDNA depletion. Conclusion We suggest performing POLGI mutation analysis in children with combined oxidative phosphorylation deficiencies in muscle, even if the clinical picture is not Alpers syndrome.
C1 Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Pediat, NL-6500 HB Nijmegen, Netherlands.
   Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Child Neurol, NL-6500 HB Nijmegen, Netherlands.
   Radboud Univ Nijmegen, Nijmegen Med Ctr, Ctr Mitochondrail Disorders, Dept Pediat,Lab Pediat & Neurol, NL-6500 HB Nijmegen, Netherlands.
   Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Pathol, NL-6500 HB Nijmegen, Netherlands.
   Juliana Childrens Hosp, Dept Neurol, The Hague, Netherlands.
   Acad Med Ctr, Dept Pediat, Utrecht, Netherlands.
   Klinikum Oldenburg, Dept Pediat, Oldenburg, Germany.
C3 Radboud University Nijmegen; Radboud University Nijmegen; Radboud
   University Nijmegen; Radboud University Nijmegen; Klinikum Oldenburg
RP de Vries, MC (corresponding author), Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Pediat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM m.devries@cukz.umcn.nl
RI Morava, E./L-4529-2015; Smeitink, Jan/C-1351-2013; de Vries,
   Maaike/JRH-2447-2023; van den Heuvel, Lambertus/AAM-1772-2021;
   Rodenburg, Richard/N-3579-2014
OI Rodenburg, Richard/0000-0001-5227-3527
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Alpers BJ, 1931, ARCH NEURO PSYCHIATR, V25, P469, DOI 10.1001/archneurpsyc.1931.02230030027002
   CHABROL B, 1994, EUR J PEDIATR, V153, P133, DOI 10.1007/BF01959226
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   GONZALEZ E, 2004, POLG TWINKLE MUTATIO, P59
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   HAAS R, 1981, NEUROLOGY, V31, P1473, DOI 10.1212/WNL.31.11.1473
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Janssen AJM, 2003, ANN CLIN BIOCHEM, V40, P3, DOI 10.1258/000456303321016114
   Lamantea E, 2004, ANN NEUROL, V56, P454, DOI 10.1002/ana.20219
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Smeitink J, 2001, J BIOENERG BIOMEMBR, V33, P259, DOI 10.1023/A:1010743321800
   Taanman JW, 2005, NEUROSCI LETT, V376, P56, DOI 10.1016/j.neulet.2004.11.023
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 32
TC 58
Z9 58
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0340-6199
J9 EUR J PEDIATR
JI Eur. J. Pediatr.
PD MAR
PY 2007
VL 166
IS 3
BP 229
EP 234
DI 10.1007/s00431-006-0234-9
PG 6
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA 142JH
UT WOS:000244645100008
PM 16957900
DA 2024-11-01
ER

PT J
AU Kang, DC
   Hamasaki, N
AF Kang, DC
   Hamasaki, N
TI Alterations of mitochondrial DNA in common diseases and disease states:
   Aging, neurodegeneration, heart failure, diabetes and cancer
SO CURRENT MEDICINAL CHEMISTRY
LA English
DT Review
DE mitochondria; mitochondrial DNA; reactive oxygen species (ROS);
   oxidative stress; aging; DNA damage; DNA repair
ID DEPENDENT LIPID-PEROXIDATION; NADH-UBIQUINONE REDUCTASE;
   1-METHYL-4-PHENYLPYRIDINIUM ION MPP+; MANGANESE SUPEROXIDE-DISMUTASE;
   OXIDATIVE STRESS; FRIEDREICHS-ATAXIA; RESPIRATORY-CHAIN;
   PARKINSONS-DISEASE; ESCHERICHIA-COLI; HUMAN MTDNA
AB It has long been considered that mitochondrial DNA disease is a rare genetic disorder causing neuromyopathy. However, alterations of mitochondrial DNA recently have been recognized to play an important role in the pathogenesis of so-called common diseases such as heart failure, diabetes, and cancer. Although some of these alterations are inherited, more and more attention is being focused on the accumulation of mitochondrial DNA mutations in somatic cells, particularly terminally differentiated cells such as cardiomyocytes and neurons that occurs with age. Mitochondrial DNA is more vulnerable to alteration than nuclear DNA, mainly for two reasons. First, mitochondria are a major source of intracellular reactive oxygen species (ROS). Therefore mitochondrial DNA is under much stronger oxidative stress than is nuclear DNA. Second, mitochondria have a matrix-side negative membrane potential for oxidative phosphorylation. This membrane potential concentrates lipophilic cations inside mitochondria up to similar to1,000-fold. Unfortunately, some therapeutic reagents are lipophilic cations, and such exogenously added chemicals are prone to damage mitochondria. AZT, an anti-HIV drug, causes mitochondrial myopathy as a side effect, which is a typical example of how chemotherapeutics adversely affect metabolism of mitochondrial DNA. In this review, we focus on ROS and chemical damage of mitochondrial DNA in common diseases.
C1 Kyushu Univ, Grad Sch Med Sci, Dept Clin Chem & Lab Med, Higashi Ku, Fukuoka 8128582, Japan.
C3 Kyushu University
RP Kang, DC (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Clin Chem & Lab Med, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.
EM kang@mailserver.med.kyushu-u.ac.jp
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   Bauer MF, 1999, CLIN CHEM LAB MED, V37, P855, DOI 10.1515/CCLM.1999.129
   Beckman K B, 1996, Methods Enzymol, V264, P442, DOI 10.1016/S0076-6879(96)64040-3
   BESTWICK RK, 1982, J BIOL CHEM, V257, P9305
   BESTWICK RK, 1982, J BIOL CHEM, V257, P9300
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a
   CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2
   Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423
   CARLSSON LM, 1995, P NATL ACAD SCI USA, V92, P6264, DOI 10.1073/pnas.92.14.6264
   Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859
   Cossée M, 2000, HUM MOL GENET, V9, P1219, DOI 10.1093/hmg/9.8.1219
   DEGREY A, 1997, BIOESSAYS, V19
   Delatycki MB, 2000, J MED GENET, V37, P1, DOI 10.1136/jmg.37.1.1
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   DOROSHOW JH, 1986, J BIOL CHEM, V261, P3068
   DRIGGERS WJ, 1993, J BIOL CHEM, V268, P22042
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981
   ETO Y, 1992, ARCH BIOCHEM BIOPHYS, V295, P101, DOI 10.1016/0003-9861(92)90493-G
   FELLOUS R, 1988, CANCER RES, V48, P6542
   Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017
   Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5
   Gorogawa S, 2002, DIABETES RES CLIN PR, V57, P1, DOI 10.1016/S0168-8227(02)00005-0
   GRAY MW, 1993, CURR OPIN GENET DEV, V3, P884, DOI 10.1016/0959-437X(93)90009-E
   Gupta S, 2001, LIFE SCI, V69, P2957, DOI 10.1016/S0024-3205(01)01404-7
   Hasegawa E, 1997, ARCH BIOCHEM BIOPHYS, V337, P69, DOI 10.1006/abbi.1996.9726
   HASEGAWA E, 1990, BIOCHEM BIOPH RES CO, V170, P1049, DOI 10.1016/0006-291X(90)90498-C
   HAYAKAWA M, 1992, BIOCHEM BIOPH RES CO, V189, P979, DOI 10.1016/0006-291X(92)92300-M
   Hayakawa T, 1998, J BIOL CHEM, V273, P20300, DOI 10.1074/jbc.273.32.20300
   Hsu TC, 2000, FREE RADICAL BIO MED, V28, P1338, DOI 10.1016/S0891-5849(00)00220-3
   Ide T, 2000, CIRC RES, V86, P152, DOI 10.1161/01.RES.86.2.152
   Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529
   Ide T, 1999, CIRC RES, V85, P357, DOI 10.1161/01.RES.85.4.357
   Ihara Y, 1999, DIABETES, V48, P927, DOI 10.2337/diabetes.48.4.927
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Inoue K, 1997, BIOCHEM BIOPH RES CO, V239, P257, DOI 10.1006/bbrc.1997.7446
   Iwaasa M, 2002, DNA SEQUENCE, V13, P251, DOI 10.1080/1042517021000011654
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821
   Kang D, 1997, ARCH BIOCHEM BIOPHYS, V337, P75, DOI 10.1006/abbi.1996.9727
   Kang D, 2002, CURR GENET, V41, P311, DOI 10.1007/s00294-002-0312-0
   KANG D, 1995, J BIOL CHEM, V270, P14659, DOI 10.1074/jbc.270.24.14659
   Kang D., 1998, MITOCHONDRIAL DNA MU, P1
   KANG DC, 1983, J BIOCHEM, V94, P1301, DOI 10.1093/oxfordjournals.jbchem.a134475
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798
   King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4
   Kinugawa S, 2000, CIRC RES, V87, P392
   LeProust EM, 2000, J MOL BIOL, V302, P1063, DOI 10.1006/jmbi.2000.4073
   LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376
   Lodi R, 2001, ANN NEUROL, V49, P590
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   LOSCHEN G, 1971, FEBS LETT, V18, P261, DOI 10.1016/0014-5793(71)80459-3
   MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0
   Mallat Z, 1998, CIRCULATION, V97, P1536, DOI 10.1161/01.CIR.97.16.1536
   MCMURRAY J, 1993, EUR HEART J, V14, P1493, DOI 10.1093/eurheartj/14.11.1493
   Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846
   Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159
   MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Miquel J, 1998, EXP GERONTOL, V33, P113, DOI 10.1016/S0531-5565(97)00060-0
   MIQUEL J, 1984, EXP GERONTOL, V19, P31, DOI 10.1016/0531-5565(84)90029-9
   Miyako K, 1999, EUR J BIOCHEM, V259, P412, DOI 10.1046/j.1432-1327.1999.00056.x
   Miyako K, 1997, J BIOL CHEM, V272, P9605
   MIZUNO Y, 1987, J NEUROCHEM, V48, P1787, DOI 10.1111/j.1471-4159.1987.tb05737.x
   MO JY, 1992, P NATL ACAD SCI USA, V89, P11021, DOI 10.1073/pnas.89.22.11021
   Modica-Napolitano JS, 2001, ADV DRUG DELIVER REV, V49, P63, DOI 10.1016/S0169-409X(01)00125-9
   MULLERHOCKER J, 1992, BRAIN PATHOL, V2, P149, DOI 10.1111/j.1750-3639.1992.tb00683.x
   Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121
   Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637
   Oda H, 1997, J BIOL CHEM, V272, P17843, DOI 10.1074/jbc.272.28.17843
   Ohtsubo T, 2000, NUCLEIC ACIDS RES, V28, P1355, DOI 10.1093/nar/28.6.1355
   OTABE S, 1994, J CLIN ENDOCR METAB, V79, P768, DOI 10.1210/jc.79.3.768
   Papa S, 1996, BBA-BIOENERGETICS, V1276, P87, DOI 10.1016/0005-2728(96)00077-1
   Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   Przedborski S, 1998, MOVEMENT DISORD, V13, P35
   PRZEDBORSKI S, 1992, J NEUROSCI, V12, P1658
   PZEDOBRSKI S, 1996, P NATL ACAD SCI USA, V93, P4565
   Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010
   RAMSAY RR, 1986, J BIOL CHEM, V261, P7585
   Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43
   Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215
   SAKUMI K, 1993, J BIOL CHEM, V268, P23524
   Schapira AHV, 1999, BBA-BIOENERGETICS, V1410, P159, DOI 10.1016/S0005-2728(98)00164-9
   SCHATZ G, 1995, BBA-MOL BASIS DIS, V1271, P123, DOI 10.1016/0925-4439(95)00018-Y
   SEGALBENDIRDJIAN E, 1988, CANCER RES, V48, P4982
   Sekiguchi M, 1996, GENES CELLS, V1, P139, DOI 10.1046/j.1365-2443.1996.d01-232.x
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Shimura-Miura H, 1999, ANN NEUROL, V46, P920, DOI 10.1002/1531-8249(199912)46:6<920::AID-ANA17>3.0.CO;2-R
   SINGER TP, 1990, FEBS LETT, V274, P1, DOI 10.1016/0014-5793(90)81315-F
   Slupska MM, 1996, J BACTERIOL, V178, P3885, DOI 10.1128/jb.178.13.3885-3892.1996
   Szkudelski T, 2001, PHYSIOL RES, V50, P537
   TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B
   Takamatsu C, 2002, EMBO REP, V3, P451, DOI 10.1093/embo-reports/kvf099
   TAKAYANAGI R, 1980, BIOCHEM J, V192, P853, DOI 10.1042/bj1920853
   TAKESHIGE K, 1979, BIOCHEM J, V180, P129, DOI 10.1042/bj1800129
   TAKESHIGE K, 1980, BIOCHEM J, V192, P861, DOI 10.1042/bj1920861
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tsutsui H, 2001, CIRCULATION, V104, P2883, DOI 10.1161/hc4901.101347
   TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0
   Umeda S, 2000, EUR J BIOCHEM, V267, P200, DOI 10.1046/j.1432-1327.2000.00990.x
   Urata M, 1998, CLIN CHEM, V44, P2088
   vanderKemp PA, 1996, P NATL ACAD SCI USA, V93, P5197, DOI 10.1073/pnas.93.11.5197
   Wilson RB, 1997, NAT GENET, V16, P352, DOI 10.1038/ng0897-352
   Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696
NR 113
TC 104
Z9 122
U1 0
U2 19
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8673
J9 CURR MED CHEM
JI Curr. Med. Chem.
PY 2005
VL 12
IS 4
BP 429
EP 441
DI 10.2174/0929867053363081
PG 13
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology &
   Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA 897IO
UT WOS:000226997500005
PM 15720251
DA 2024-11-01
ER

PT J
AU AlMenabawy, N
   Hassaan, HM
   Ramadan, M
   Meguid, IEA
   El Gindy, HA
   Beetz, C
   Selim, L
AF AlMenabawy, Nihal
   Hassaan, Hebatallah M.
   Ramadan, Manal
   Meguid, Iman Ehsan Abdel
   El Gindy, Hala Ahmed
   Beetz, Christian
   Selim, Laila
TI Clinical and genetic spectrum of mitochondrial DNA depletion syndromes:
   A report of 6 cases with 4 novel variants
SO MITOCHONDRION
LA English
DT Article
ID DEOXYGUANOSINE KINASE GENE; HEPATOCEREBRAL FORM; HOMOZYGOUS MUTATION;
   FBXL4; TK2; NEPHRONOPHTHISIS; ENCEPHALOPATHY; DEFECT
AB Mitochondrial DNA (mtDNA) depletion syndromes (MDS) are a heterogeneous group of rare autosomal recessive genetic disorders characterized by a decrease in the number of mtDNA copies inside the organ involved. There are three distinct forms of MDS including the hepatocerebral, the myopathic and the encephalomyopathic forms. The diversity in the clinical and genetic spectrum of these disorders makes the diagnosis challenging. Here, we describe the clinical phenotype and the genetic spectrum of 6 patients with MDS including 4 novel variants and compare them with previously reported cases.
   Subject and Methods: Six patients from six unrelated families were included in this study. All the patients were subjected to a detailed history, thorough general and neurologic examination, basic laboratory investigations including lactic acid and ammonia, amino acids, acylcarnitine profiles and brain MRI. Whole-exome sequencing was performed for all of them to confirm the suspicion of mitochondrial disorder.
   Results: In our series, four patients presented with the hepatocerebral form of MDS with the major presenting manifestation of progressive liver cell failure with severe hypotonia and global developmental delay. Four variants in the DGUOK gene and the MPV17 have been identified including 2 novel variants. One patient was identified in the myopathic form presenting with myopathy associated with two novel variants in the TK2 gene. One patient was diagnosed with encephalomyopathic form presenting with persistent lactic acidosis and global delay due to a homozygous variant in the FBXL4 gene.
   Conclusion: MDS has a wide spectrum of heterogeneous clinical presentations and about nine different genes involved. Whole exome sequencing (WES) has resulted in faster diagnosis of these challenging cases as the phenotype overlap with many other disorders. This should be considered the first-tier diagnostic test obviating the need for more invasive testing like muscle biopsies.
C1 [AlMenabawy, Nihal; Hassaan, Hebatallah M.; Meguid, Iman Ehsan Abdel; El Gindy, Hala Ahmed; Selim, Laila] Cairo Univ, Children Hosp, Genet Dept, Cairo, Egypt.
   [Ramadan, Manal] Ahmed Maher Teaching Hosp, Pediat Dept, Cairo, Egypt.
   [Beetz, Christian] Centogene, Rostock, Germany.
C3 Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank
   (EKB); General Organization of Teaching Hospitals & Institutes (GOTHI);
   CENTOGENE AG
RP Hassaan, HM (corresponding author), Cairo Univ, Children Hosp, Genet Dept, Cairo, Egypt.
EM Hebahassaan@outlook.com
OI Muhammad, Hebatallah/0009-0004-3300-040X
CR Al-Hussaini A, 2014, J PEDIATR-US, V164, P553, DOI 10.1016/j.jpeds.2013.10.082
   Almannai M., 2017, GENEREVIEWS
   Ballout RA, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00039
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Bellavia S, 2010, NEPHROL DIAL TRANSPL, V25, P4097, DOI 10.1093/ndt/gfq519
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Brahimi N, 2009, MOL GENET METAB, V97, P221, DOI 10.1016/j.ymgme.2009.03.007
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   De Camaret BM, 2007, BIOCHEM J, V402, P377, DOI 10.1042/BJ20060705
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1071-z
   Douglas GV, 2011, J HUM GENET, V56, P834, DOI 10.1038/jhg.2011.112
   El-Hattab AW, 2018, HUM MUTAT, V39, P461, DOI 10.1002/humu.23387
   El-Hattab AW, 2017, HUM MUTAT, V38, P1649, DOI 10.1002/humu.23341
   Fang WY, 2017, ONCOTARGET, V8, P84309, DOI 10.18632/oncotarget.20905
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Jankowska I, 2021, CLIN RES HEPATOL GAS, V45, DOI 10.1016/j.clinre.2020.02.018
   Mahjoub G, 2019, BMC MED GENET, V20, DOI 10.1186/s12881-019-0893-9
   Mancuso M, 2005, ARCH NEUROL-CHICAGO, V62, P745, DOI 10.1001/archneur.62.5.745
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Mazurova S, 2017, CARDIOL YOUNG, V27, P936, DOI 10.1017/S1047951116001876
   Moalem S, 2013, AM J MED GENET A, V161A, P1792, DOI 10.1002/ajmg.a.36036
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Papadimas George K, 2020, Acta Myol, V39, P94, DOI 10.36185/2532-1900-012
   Pyal A, 2017, MITOCHONDRION, V37, P41, DOI 10.1016/j.mito.2017.06.006
   Selim LA, 2017, ADV EXP MED BIOL, V1007, P129, DOI 10.1007/978-3-319-60733-7_8
   Sezer T, 2015, J CHILD NEUROL, V30, P124, DOI 10.1177/0883073813517000
   Smith ED, 2019, GENET MED, V21, P2199, DOI 10.1038/s41436-019-0477-2
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112
   van Rij MC, 2016, CLIN CASE REP, V4, P425, DOI 10.1002/ccr3.511
   Villarroya J, 2009, EXP CELL RES, V315, P1429, DOI 10.1016/j.yexcr.2009.02.018
NR 35
TC 6
Z9 6
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL
PY 2022
VL 65
BP 139
EP 144
DI 10.1016/j.mito.2022.06.004
EA JUN 2022
PG 6
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 4Y8SD
UT WOS:000861791200001
PM 35750291
DA 2024-11-01
ER

PT J
AU Kirches, E
AF Kirches, E.
TI Do mtDNA Mutations Participate in the Pathogenesis of Sporadic
   Parkinson's Disease?
SO CURRENT GENOMICS
LA English
DT Article
ID MITOCHONDRIAL-DNA DELETIONS; SUBSTANTIA-NIGRA NEURONS; COMPLEX-I;
   COENZYME Q(10); RESPIRATORY-CHAIN; OXIDATIVE STRESS; SKELETAL-MUSCLE;
   HYDROGEN-PEROXIDE; SKIN FIBROBLASTS; POINT MUTATIONS
AB The pathogenesis of sporadic Parkinson's disease (PD) remains enigmatic. Mitochondrial complex-I defects are known to occur in the substantia nigra (SN) of PD patients and are also debated in some extracerebral tissues. Early sequencing efforts of the mitochondrial DNA (mtDNA) did not reveal specific mutations, but a long lasting discussion was devoted to the issue of randomly distributed low level point mutations, caused by oxidative stress. However, a potential functional impact remained a matter of speculation, since heteroplasmy (mutational load) at any base position analyzed, remained far below the relevant functional threshold. A clearly age-dependent increase of the 'common mtDNA deletion' had been demonstrated in most brain regions by several authors since 1992. However, heteroplasmy did hardly exceed 1% of total mtDNA. It became necessary to exploit PCR techniques, which were able to detect any deletion in a few micro-dissected dopaminergic neurons of the SN. In 2006, two groups published biochemically relevant loads of somatic mtDNA deletions in these neurons. They seem to accumulate to relevant levels in the SN dopaminergic neurons of aged individuals in general, but faster in those developing PD. It is reasonable to assume that this accumulation causes mitochondrial dysfunction of the SN, although it cannot be taken as a final proof for an early pathogenetic role of this dysfunction. Recent studies demonstrate a distribution of deletion breakpoints, which does not differ between PD, aging and classical mitochondrial disorders, suggesting a common, but yet unknown mechanism.
C1 Otto Von Guericke Univ, Dept Neuropathol, D-39120 Magdeburg, Germany.
C3 Otto von Guericke University
RP Kirches, E (corresponding author), Otto Von Guericke Univ, Dept Neuropathol, Leipziger Str 44, D-39120 Magdeburg, Germany.
EM elmar.kirches@med.ovgu.de
RI Sykora, David/D-2657-2009
OI Sykora, David/0000-0001-8098-3171
CR Abe T, 2003, NEUROSCI LETT, V336, P105, DOI 10.1016/S0304-3940(02)01259-4
   Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x
   ARUOMA OI, 1989, J BIOL CHEM, V264, P20509
   Bandmann O, 1997, J NEUROL, V244, P262, DOI 10.1007/s004150050082
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bender A, 2008, J NEUROL, V255, P1231, DOI 10.1007/s00415-008-0892-9
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   BINDOFF LA, 1989, LANCET, V2, P49, DOI 10.1016/S0140-6736(89)90291-2
   Borland MK, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-21
   Buhmann C, 2004, NEUROBIOL DIS, V15, P160, DOI 10.1016/j.nbd.2003.10.003
   Chinta SJ, 2006, FREE RADICAL BIO MED, V41, P1442, DOI 10.1016/j.freeradbiomed.2006.08.002
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3
   DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x
   Esteves ARF, 2008, MITOCHONDRION, V8, P219, DOI 10.1016/j.mito.2008.03.004
   Floor E, 1998, J NEUROCHEM, V70, P268
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gesi M, 2001, PHARMACOL TOXICOL, V89, P217, DOI 10.1034/j.1600-0773.2001.d01-151.x
   Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985
   Gille G, 2004, ANN NY ACAD SCI, V1018, P533, DOI 10.1196/annals.1296.066
   GRAHAM DG, 1978, MOL PHARMACOL, V14, P633
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   HALLIWELL B, 1992, FREE RADICAL RES COM, V16, P75, DOI 10.3109/10715769209049161
   HASTINGS TG, 1995, J NEUROCHEM, V64, P919
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Hornykiewicz O, 1987, Adv Neurol, V45, P19
   Hsu M, 2005, J NEUROCHEM, V92, P1091, DOI 10.1111/j.1471-4159.2004.02929.x
   Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006
   Kikuchi A, 2002, NEUROBIOL DIS, V9, P244, DOI 10.1006/nbdi.2002.0466
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kuznetsov AV, 1997, BBA-MOL BASIS DIS, V1360, P142, DOI 10.1016/S0925-4439(96)00072-5
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   MADSEN CS, 1993, P NATL ACAD SCI USA, V90, P7671, DOI 10.1073/pnas.90.16.7671
   MAKER HS, 1981, J NEUROCHEM, V36, P589, DOI 10.1111/j.1471-4159.1981.tb01631.x
   MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8
   Müller T, 2003, NEUROSCI LETT, V341, P201, DOI 10.1016/S0304-3940(03)00185-X
   Nakabeppu Y, 2007, J NEUROSCI RES, V85, P919, DOI 10.1002/jnr.21191
   NICKLAS WJ, 1987, LIFE SCI, V40, P721, DOI 10.1016/0024-3205(87)90299-2
   Pallotti F, 1996, AM J HUM GENET, V59, P591
   Panov A, 2005, J BIOL CHEM, V280, P42026, DOI 10.1074/jbc.M508628200
   Parker WD, 2005, BIOCHEM BIOPH RES CO, V326, P667, DOI 10.1016/j.bbrc.2004.11.093
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   Prigione A, 2006, NEUROBIOL DIS, V23, P36, DOI 10.1016/j.nbd.2006.01.013
   Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5
   Przedborski S, 2003, ANN NY ACAD SCI, V991, P189
   Qin ZJ, 2007, J BIOL CHEM, V282, P5862, DOI 10.1074/jbc.M608126200
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Reeve AK, 2009, AGING CELL, V8, P496, DOI 10.1111/j.1474-9726.2009.00492.x
   Richter G, 2002, J NEURAL TRANSM, V109, P721, DOI 10.1007/s007020200060
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Schoeler S, 2007, CLIN NEUROPATHOL, V26, P164
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Selley ML, 1998, FREE RADICAL BIO MED, V25, P169, DOI 10.1016/S0891-5849(98)00021-5
   Shults CW, 2005, BIOFACTORS, V25, P117, DOI 10.1002/biof.5520250113
   Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541
   Shults CW, 1998, NEUROLOGY, V50, P793, DOI 10.1212/WNL.50.3.793
   SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305
   Simon DK, 2000, NEUROLOGY, V54, P703, DOI 10.1212/WNL.54.3.703
   SINGER TP, 1995, BBA-MOL BASIS DIS, V1271, P211, DOI 10.1016/0925-4439(95)00030-8
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B
   Sohmiya M, 2004, J NEUROL SCI, V223, P161, DOI 10.1016/j.jns.2004.05.007
   SOONG NW, 1992, NAT GENET, V2, P318
   Spencer JPE, 1996, CHEM RES TOXICOL, V9, P1152, DOI 10.1021/tx960084i
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Stokes AH, 1999, J NEUROSCI RES, V55, P659, DOI 10.1002/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C
   Storch A, 2007, ARCH NEUROL-CHICAGO, V64, P938, DOI 10.1001/archneur.64.7.nct60005
   Sulzer D, 1999, NEUROTOX RES, V1, P181, DOI 10.1007/BF03033289
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159
   Trimmer PA, 2009, EXP NEUROL, V218, P320, DOI 10.1016/j.expneurol.2009.03.016
   TSE DCS, 1976, J MED CHEM, V19, P37, DOI 10.1021/jm00223a008
   Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x
   Wiedemann FR, 1999, ANN NY ACAD SCI, V893, P426, DOI 10.1111/j.1749-6632.1999.tb07870.x
   Winkler-Stuck K, 2005, J NEURAL TRANSM, V112, P499, DOI 10.1007/s00702-004-0195-y
   Winkler-Stuck K, 2004, J NEUROL SCI, V220, P41, DOI 10.1016/j.jns.2004.02.003
   Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696
   Zhou C, 2008, ANN NY ACAD SCI, V1147, P93, DOI 10.1196/annals.1427.023
NR 82
TC 8
Z9 8
U1 0
U2 3
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2029
J9 CURR GENOMICS
JI Curr. Genomics
PD DEC
PY 2009
VL 10
IS 8
BP 585
EP 593
DI 10.2174/138920209789503879
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 514GD
UT WOS:000271381500007
PM 20514220
OA Green Published, Green Submitted
DA 2024-11-01
ER

PT J
AU Lemoine, S
   Panaye, M
   Rabeyrin, M
   Errazuriz-Cerda, E
   de Camaret, BM
   Petiot, P
   Juillard, L
   Guebre-Egziabher, F
AF Lemoine, Sandrine
   Panaye, Marine
   Rabeyrin, Maud
   Errazuriz-Cerda, Elisabeth
   de Camaret, Benedicte Mousson
   Petiot, Philippe
   Juillard, Laurent
   Guebre-Egziabher, Fitsum
TI Renal Involvement in Neuropathy, Ataxia, Retinitis Pigmentosa (NARP)
   Syndrome: A Case Report
SO AMERICAN JOURNAL OF KIDNEY DISEASES
LA English
DT Article
ID MITOCHONDRIAL DYSFUNCTION; DISEASE; MUTATION; INJURY; GENE
AB We report a case of a patient who had the mitochondrial cytopathy complex of neuropathy, ataxia, and retinitis pigmentosa (NARP) syndrome diagnosed at age 11 years with a biopsy-proven kidney involvement that progressed to end-stage renal disease at age 21 years. Mutations of mitochondrial DNA (mtDNA) are maternally inherited and lead to mitochondrial cytopathies with predominant neurologic manifestations: psychomotor retardation, epilepsy, ataxia, neuropathy, and myopathy. Given the ubiquitous nature of mitochondria, cellular dysfunction can also appear in tissues with high metabolic turnover; thus, there can be cardiac, digestive, ophthalmologic, and kidney complications. Mutations in the MT-ATP6 gene of mtDNA have been shown to cause NARP syndrome without renal involvement. We report a patient who had NARP syndrome diagnosed at age 11 years in whom glomerular proteinuria was present very early after diagnosis. Although neurologic manifestations were stable over time, he developed worsening proteinuria and kidney function. He started dialysis therapy at age 21 years. Kidney biopsy confirmed the mitochondrial cytopathy histologically, with abnormal mitochondria seen on electron microscopy. The MT-ATP6 gene mutation was detected in the kidney biopsy specimen.
C1 [Lemoine, Sandrine; Panaye, Marine; Juillard, Laurent] Hosp Edouard Herriot, Hosp Civils Lyon, Serv Nephrol, Lyon, France.
   [Lemoine, Sandrine; Juillard, Laurent; Guebre-Egziabher, Fitsum] Univ Lyon 1, Univ Lyon, INSERM U1060, CarMeN, Lyon, France.
   [Rabeyrin, Maud] Hosp Civils Lyon, Hop Edouard Herriot, Lab Anat & Cytol Pathol, Lyon, France.
   [Errazuriz-Cerda, Elisabeth] Ctr Imagerie Quantitat Lyon Est, Fac Med Laennec Lyon, Lyon, France.
   [de Camaret, Benedicte Mousson] Hosp Civils Lyon, Ctr Biol & Pathol Est, Serv Maladiea Hereditaires Metab, Lyon, France.
   [Petiot, Philippe] Hop Croix Rousse, Hop Civils Lyon, Ctr Reference Maladies Neuro Musculaires, Explorat Fonctionnelles Neurol, Lyon, France.
   [Guebre-Egziabher, Fitsum] Ctr hosp Univ Grenoble Alpes, Dept Nephrol Dialysis Apheresis Transplantat, Blvd Chantourne, F-38700 La Tronche, France.
C3 bioMerieux; CHU Lyon; Universite Claude Bernard Lyon 1; Institut
   National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; CHU
   Lyon; CHU Lyon; Communaute Universite Grenoble Alpes; Universite
   Grenoble Alpes (UGA); CHU Grenoble Alpes
RP Guebre-Egziabher, F (corresponding author), Ctr hosp Univ Grenoble Alpes, Dept Nephrol Dialysis Apheresis Transplantat, Blvd Chantourne, F-38700 La Tronche, France.
EM fguebreegziabher@chu-grenoble.fr
RI Lemoine, Sandrine/AAL-4365-2021
OI Lab, Carmen/0000-0002-5935-3236; Carmen, Team3/0000-0002-3614-0924
CR Che RC, 2014, AM J PHYSIOL-RENAL, V306, pF367, DOI 10.1152/ajprenal.00571.2013
   DICKMAN KG, 1990, AM J PHYSIOL, V258, pF1608, DOI 10.1152/ajprenal.1990.258.6.F1608
   Emma F, 2016, NAT REV NEPHROL, V12, P267, DOI 10.1038/nrneph.2015.214
   Emma F, 2012, PEDIATR NEPHROL, V27, P539, DOI 10.1007/s00467-011-1926-6
   Gelfand JM, 2011, J NEUROL, V258, P440, DOI 10.1007/s00415-010-5775-1
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x
   Jung J, 2007, NEUROLOGY, V68, P1429, DOI 10.1212/01.wnl.0000264019.53959.10
   Menegon LF, 2004, RENAL FAILURE, V26, P195, DOI 10.1081/JDI-120038522
   Morava E, 2006, AM J MED GENET A, V140A, P863, DOI 10.1002/ajmg.a.31194
   Niaudet P, 2013, NEPHROL THER, V9, P116, DOI 10.1016/j.nephro.2012.10.004
   Parfait B, 1999, EUR J PEDIATR, V158, P55, DOI 10.1007/s004310051009
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
NR 14
TC 15
Z9 16
U1 0
U2 8
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0272-6386
EI 1523-6838
J9 AM J KIDNEY DIS
JI Am. J. Kidney Dis.
PD MAY
PY 2018
VL 71
IS 5
BP 754
EP 757
DI 10.1053/j.ajkd.2017.09.020
PG 4
WC Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Urology & Nephrology
GA GD7EH
UT WOS:000430672400022
PM 29224958
DA 2024-11-01
ER

PT J
AU McHugh, JC
   Lonergan, R
   Howley, R
   O'Rourke, K
   Taylor, RW
   Farrell, M
   Hutchinson, M
   Connolly, S
AF McHugh, John C.
   Lonergan, Roisin
   Howley, Rachel
   O'Rourke, Killian
   Taylor, Robert W.
   Farrell, Michael
   Hutchinson, Michael
   Connolly, Sean
TI SENSORY ATAXIC NEUROPATHY DYSARTHRIA AND OPHTHALMOPARESIS (SANDO) IN A
   SIBLING PAIR WITH A HOMOZYGOUS p.A467T <i>POLG</i> MUTATION
SO MUSCLE & NERVE
LA English
DT Article
DE dysarthria; mitochondrial disease; ophthalmoparesis; polymerase gamma;
   SANDO; sensory ataxic neuropathy
ID MITOCHONDRIAL-DNA DELETIONS; EXTERNAL OPHTHALMOPLEGIA; ANTIBODIES;
   SPECTRUM; DOMINANT; TWINKLE; A467T; ANT1
AB Two siblings who developed fifth-decade-onset, concurrent progressive sensory ataxia, dysarthria, and ophthalmoparesis were found to be homozygous for the p.A467T mutation of the polymerase gamma (POLG) gene. The clinical course in both subjects was progression to severe disability. The enlarging spectrum of sensory ataxic neuropathies associated with mitochondrial DNA (mtDNA) instability and POLG mutations should be recognized and considered in the differential diagnosis of this unusual presentation. Muscle Nerve 41: 265-269, 2010
C1 [McHugh, John C.; Lonergan, Roisin; O'Rourke, Killian; Hutchinson, Michael; Connolly, Sean] St Vincents Univ Hosp, Dept Neurol, Dublin 4, Ireland.
   [McHugh, John C.; Lonergan, Roisin; O'Rourke, Killian; Hutchinson, Michael; Connolly, Sean] St Vincents Univ Hosp, Dept Clin Neurophysiol, Dublin 4, Ireland.
   [Howley, Rachel; Farrell, Michael] Beaumont Hosp, Neuropathol Lab, Dublin 9, Ireland.
   [Taylor, Robert W.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 University College Dublin; Saint Vincent's University Hospital;
   University College Dublin; Saint Vincent's University Hospital;
   Newcastle University - UK
RP McHugh, JC (corresponding author), St Vincents Univ Hosp, Dept Neurol, Dublin 4, Ireland.
EM drjohnmchugh@ireland.com
RI hutchinson, michael/H-3508-2019; Farrell, Michael/A-4769-2012
OI hutchinson, michael/0000-0002-8675-1723
FU Wellcome Trust [074454] Funding Source: Medline
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Camdessanché JP, 2002, BRAIN, V125, P166, DOI 10.1093/brain/awf006
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Isoardo G, 2004, ACTA NEUROL SCAND, V109, P188, DOI 10.1034/j.1600-0404.2003.00203.x
   Kuntzer T, 2004, MUSCLE NERVE, V30, P255, DOI 10.1002/mus.20100
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Notturno F, 2008, MUSCLE NERVE, V37, P265, DOI 10.1002/mus.20875
   SCHAUMBURG H, 1983, NEW ENGL J MED, V309, P445, DOI 10.1056/NEJM198308253090801
   Taylor RW, 2000, METH MOLEC MED, V38, P245, DOI 10.1385/1-59259-070-5:245
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
NR 24
TC 12
Z9 16
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 1097-4598
J9 MUSCLE NERVE
JI Muscle Nerve
PD FEB
PY 2010
VL 41
IS 2
BP 265
EP 269
DI 10.1002/mus.21494
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 550LZ
UT WOS:000274130700019
PM 19813183
DA 2024-11-01
ER

PT J
AU Manzoni, E
   Carli, S
   Gaignard, P
   Schlieben, LD
   Hirano, M
   Ronchi, D
   Gonzales, E
   Shimura, M
   Murayama, K
   Okazaki, Y
   Baric, I
   Ramadza, D
   Karall, D
   Mayr, J
   Martinelli, D
   La Morgia, C
   Primiano, G
   Santer, R
   Servidei, S
   Bris, C
   Cano, A
   Furlan, F
   Gasperini, S
   Laborde, N
   Lamperti, C
   Lenz, D
   Mancuso, M
   Montano, V
   Menni, F
   Musumeci, O
   Nesbitt, V
   Procopio, E
   Rouzier, C
   Staufner, C
   Taanman, JW
   Tal, G
   Ticci, C
   Cordelli, DM
   Carelli, V
   Procaccio, V
   Prokisch, H
   Garone, C
AF Manzoni, Eleonora
   Carli, Sara
   Gaignard, Pauline
   Schlieben, Lea Dewi
   Hirano, Michio
   Ronchi, Dario
   Gonzales, Emmanuel
   Shimura, Masaru
   Murayama, Kei
   Okazaki, Yasushi
   Baric, Ivo
   Ramadza, Danijela Petkovic
   Karall, Daniela
   Mayr, Johannes
   Martinelli, Diego
   La Morgia, Chiara
   Primiano, Guido
   Santer, Rene
   Servidei, Serenella
   Bris, Celine
   Cano, Aline
   Furlan, Francesca
   Gasperini, Serena
   Laborde, Nolwenn
   Lamperti, Costanza
   Lenz, Dominic
   Mancuso, Michelangelo
   Montano, Vincenzo
   Menni, Francesca
   Musumeci, Olimpia
   Nesbitt, Victoria
   Procopio, Elena
   Rouzier, Cecile
   Staufner, Christian
   Taanman, Jan-Willem
   Tal, Galit
   Ticci, Chiara
   Cordelli, Duccio Maria
   Carelli, Valerio
   Procaccio, Vincent
   Prokisch, Holger
   Garone, Caterina
TI Deoxyguanosine kinase deficiency: natural history and liver transplant
   outcome
SO BRAIN COMMUNICATIONS
LA English
DT Article
DE DGUOK; deoxyguanosine kinase; mitochondrial DNA; nucleosides; liver
   transplant
ID MITOCHONDRIAL-DNA DEPLETION; RESPIRATORY-CHAIN; DGUOK MUTATION;
   GENE-MUTATIONS; HEPATOCEREBRAL FORM; UNIPARENTAL DISOMY; MEMBRANE
   PROTEIN; DE-NOVO; FEATURES; MTDNA
AB Autosomal recessive pathogenetic variants in the DGUOK gene cause deficiency of deoxyguanosine kinase activity and mitochondrial deoxynucleotides pool imbalance, consequently, leading to quantitative and/or qualitative impairment of mitochondrial DNA synthesis. Typically, patients present early-onset liver failure with or without neurological involvement and a clinical course rapidly progressing to death. This is an international multicentre study aiming to provide a retrospective natural history of deoxyguanosine kinase deficient patients. A systematic literature review from January 2001 to June 2023 was conducted. Physicians of research centres or clinicians all around the world caring for previously reported patients were contacted to provide followup information or additional clinical, biochemical, histological/histochemical, and molecular genetics data for unreported cases with a confirmed molecular diagnosis of deoxyguanosine kinase deficiency.<br /> A cohort of 202 genetically confirmed patients, 36 unreported, and 166 from a systematic literature review, were analyzed. Patients had a neonatal onset (<= 1 month) in 55.7% of cases, infantile (>1 month and <= 1 year) in 32.3%, pediatric (>1 year and <= 18 years) in 2.5% and adult (>18 years) in 9.5%. Kaplan-Meier analysis showed statistically different survival rates (P < 0.0001) among the four age groups with the highest mortality for neonatal onset. Based on the clinical phenotype, we defined four different clinical subtypes: hepatocerebral (58.8%), isolated hepatopathy (21.9%), hepatomyoencephalopathy (9.6%), and isolated myopathy (9.6%). Muscle involvement was predominant in adult-onset cases whereas liver dysfunction causes morbidity and mortality in early-onset patients with a median survival of less than 1 year. No genotype-phenotype correlation was identified. Liver transplant significantly modified the survival rate in 26 treated patients when compared with untreated. Only six patients had additional mild neurological signs after liver transplant.<br /> In conclusion, deoxyguanosine kinase deficiency is a disease spectrum with a prevalent liver and brain tissue specificity in neonatal and infantile-onset patients and muscle tissue specificity in adult-onset cases. Our study provides clinical, molecular genetics and biochemical data for early diagnosis, clinical trial planning and immediate intervention with liver transplant and/or nucleoside supplementation.
C1 [Manzoni, Eleonora; Carli, Sara; Cordelli, Duccio Maria; Garone, Caterina] Alma Mater Studiorum Univ Bologna, Dept Med & Surg Sci, Via Massarenti 11,Pad 11, I-40138 Bologna, Italy.
   [Carli, Sara; Cordelli, Duccio Maria; Garone, Caterina] IRCCS Ist Sci Neurolog, UO Neuropsichiatria eta Pediat Bologna, I-40124 Bologna, Italy.
   [Gaignard, Pauline] Univ Paris Saclay, Bicetre Hosp, Assistance Publ Hop Paris, Reference Ctr Mitochondrial Dis,Dept Biochem, F-94275 Paris, France.
   [Schlieben, Lea Dewi; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, Sch Med, D-80333 Munich, Germany.
   [Schlieben, Lea Dewi; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Neurogenom, Computat Hlth Ctr, D-80333 Neuherberg, Germany.
   [Hirano, Michio] Columbia Univ, Irving Med Ctr, H Houston Merritt Neuromuscular Res Ctr, Dept Neurol, New York, NY 10033 USA.
   [Ronchi, Dario] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy.
   [Gonzales, Emmanuel] Univ Paris Saclay, Bicetre Hosp, Assistance Publ Hop Paris, Reference Ctr Mitochondrial Dis,Pediat Hepatol & P, F-94270 Paris, France.
   [Shimura, Masaru; Murayama, Kei] Chiba Childrens Hosp, Ctr Med Genet, Dept Metab, Chiba 2600842, Japan.
   [Murayama, Kei; Okazaki, Yasushi] Juntendo Univ, Intractable Dis Res Ctr, Grad Sch Med, Diagnost & Therapeut Intractable Dis, Tokyo 1138421, Japan.
   [Baric, Ivo; Ramadza, Danijela Petkovic] Univ Hosp Ctr Zagreb, Dept Pediat, Zagreb 10000, Croatia.
   [Baric, Ivo; Ramadza, Danijela Petkovic] Univ Zagreb, Sch Med, Zagreb 10000, Croatia.
   [Karall, Daniela] Med Univ Innsbruck, Div Inherited Metab Disorders, Clin Pediat, A-6020 Innsbruck, Austria.
   [Mayr, Johannes] Paracelsus Med Univ PMU, Univ Childrens Hosp, A-5020 Salzburg, Austria.
   [Martinelli, Diego] Bambino Gesu Childrens Hosp IRCCS, Div Metab, I-00165 Rome, Italy.
   [La Morgia, Chiara; Carelli, Valerio] Univ Bologna, Dept Biomed & Neuromotor Sci, I-40123 Bologna, Italy.
   [La Morgia, Chiara; Carelli, Valerio] IRCCS Ist Sci Neurolog Bologna, Programma Neurogenet, I-40124 Bologna, Italy.
   [Primiano, Guido; Servidei, Serenella] Fdn Policlin Univ Agostino Gemelli IRCCS, Dipartimento Neurosci Organi Senso & Torace, Neurol, I-00136 Rome, Italy.
   [Primiano, Guido; Servidei, Serenella] Univ Cattolica Sacro Cuore, Dipartimento Neurosci, I-00168 Rome, Italy.
   [Santer, Rene] Univ Med Ctr Eppendorf, Dept Pediat, D-20246 Hamburg, Germany.
   [Bris, Celine; Procaccio, Vincent] Univ Angers, Angers Hosp, INSERM, CNRS,MITOVASC,SFR ICAT, F-49000 Angers, France.
   [Cano, Aline] CHU Timone Enfants, Ctr reference Malad hereditaires Metab, F-13005 Marseille, France.
   [Furlan, Francesca; Menni, Francesca] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Reg Clin Ctr Expanded Newborn Screening, I-20122 Milan, Italy.
   [Gasperini, Serena] Fdn IRCCS San Gerardo dei Tintori, Dept Pediat, I-20900 Monza, Italy.
   [Laborde, Nolwenn] CHU Toulouse, Hop Enfants, Unite Gastroenterol Hepatol Nutr & Malad Hereditai, F-31300 Toulouse, France.
   [Lamperti, Costanza] Fdn IRCCS Neurol Inst C Besta, Div Med Genet & Neurogenet, I-20133 Milan, Italy.
   [Lenz, Dominic; Staufner, Christian] Univ Hosp Heidelberg, Ctr Paediat & Adolescent Med, Div Neuropaediat & Paediat Metab Med, D-69120 Heidelberg, Germany.
   [Mancuso, Michelangelo; Montano, Vincenzo] Univ Pisa, Neurol Inst, Dept Clin & Expt Med, I-56126 Pisa, Italy.
   [Mancuso, Michelangelo; Montano, Vincenzo] AOUP, I-56126 Pisa, Italy.
   [Musumeci, Olimpia] Univ Messina, Dept Clin & Expt Med, Unit Neurol & Neuromuscular Disorders, I-98125 Messina, Italy.
   [Nesbitt, Victoria] Univ Oxford, Dept Paediat, Med Sci Div, Oxford OX3 9DU, England.
   [Procopio, Elena; Ticci, Chiara] Meyer Childrens Hosp IRCCS, Metab Unit, I-50139 Florence, Italy.
   [Rouzier, Cecile] Univ Cote dAzur, Ctr reference Malad Mitochondriales, Serv Genet Med, CHU Nice,CNRS,INSERM,IRCAN, F-06000 Nice, France.
   [Taanman, Jan-Willem] UCL, UCL Queen Sq Inst Neurol, Dept Clin & Movement Neurosci, London WC1N 3BG, England.
   [Tal, Galit] Ruth Rappaport Childrens Hosp, Metab Clin, Rambam Hlth Care Campus, IL-3109601 Haifa, Israel.
   [Tal, Galit] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, IL-3109601 Haifa, Israel.
C3 University of Bologna; Universite Paris Saclay; Aix-Marseille
   Universite; Assistance Publique-Hopitaux de Marseille; Assistance
   Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP;
   Universite Paris Cite; Hopital Universitaire Saint-Louis - APHP;
   Technical University of Munich; Helmholtz Association; Helmholtz-Center
   Munich - German Research Center for Environmental Health;
   NewYork-Presbyterian Hospital; Columbia University; University of Milan;
   Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre
   - APHP; Aix-Marseille Universite; Assistance Publique-Hopitaux de
   Marseille; Universite Paris Cite; Hopital Universitaire Saint-Louis -
   APHP; Universite Paris Saclay; Chiba Children's Hospital; Juntendo
   University; University of Zagreb; University of Zagreb; Medical
   University of Innsbruck; Paracelsus Private Medical University; IRCCS
   Bambino Gesu; University of Bologna; IRCCS Istituto delle Scienze
   Neurologiche di Bologna (ISNB); Catholic University of the Sacred Heart;
   IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart;
   IRCCS Policlinico Gemelli; University of Hamburg; University Medical
   Center Hamburg-Eppendorf; Institut National de la Sante et de la
   Recherche Medicale (Inserm); Centre National de la Recherche
   Scientifique (CNRS); Universite d'Angers; Centre Hospitalier
   Universitaire d'Angers; Aix-Marseille Universite; Assistance
   Publique-Hopitaux de Marseille; IRCCS Ca Granda Ospedale Maggiore
   Policlinico; Fondazione IRCCS San Gerardo dei Tintori; Universite de
   Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse;
   Ruprecht Karls University Heidelberg; University of Pisa; University of
   Pisa; Azienda Ospedaliero Universitaria Pisana; University of Messina;
   University of Oxford; Centre National de la Recherche Scientifique
   (CNRS); Institut National de la Sante et de la Recherche Medicale
   (Inserm); Universite Cote d'Azur; CHU Nice; University of London;
   University College London; Rambam Health Care Campus; Technion Israel
   Institute of Technology; Rappaport Faculty of Medicine
RP Garone, C (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Med & Surg Sci, Via Massarenti 11,Pad 11, I-40138 Bologna, Italy.
EM caterina.garone@unibo.it
RI Primiano, Guido/AAB-7829-2019; Garone, Caterina/AAB-8659-2019; Cordelli,
   Duccio/Q-4983-2016; carli, Sara/JMQ-7035-2023; Lenz,
   Dominic/GPC-7935-2022; Prokisch, Holger/N-8964-2013; Servidei,
   Serenella/ABC-4262-2021; Rouzier, Cecile/KCY-3619-2024; Ronchi,
   Dario/K-8011-2016; Musumeci, Olimpia/AHE-3041-2022; La Morgia,
   Chiara/H-6765-2012; Montano, Vincenzo/AAB-8681-2022; Taanman,
   Jan-Willem/A-5379-2011
OI Taanman, Jan-Willem/0000-0002-5476-9785; Carli,
   Sara/0000-0001-8130-5364; Murayama, Kei/0000-0002-3923-8636
FU Piano Nazionale di Ripresa e Resilienza [PNRR - M4C2 - 1.4 CN00000041 -
   CUP: J33C22001140001]; European Union
FX MM and VM are grateful to the European Reference Network NMD and RND as
   representatives for the Italian HCP partners. Graphical abstract was
   created by Biorender. This study was funded by the European Union -
   NextGenerationEU, in the framework of the mRNA National Center for Gene
   Therapy and Drugs PNRR - M4C2 - 1.4 CN00000041 - CUP: J33C22001140001.
   The views and opinions expressed are solely those of the authors and do
   not necessarily reflect those of the European Union, nor can the
   European Union be held responsible for them.
CR Al-Hussaini A, 2014, J PEDIATR-US, V164, P553, DOI 10.1016/j.jpeds.2013.10.082
   Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Almannai M, 2022, MOL GENET METAB, V137, P40, DOI 10.1016/j.ymgme.2022.07.003
   Almannai M, 2022, MEMBRANES-BASEL, V12, DOI 10.3390/membranes12060625
   Almannai M, 2018, ESSAYS BIOCHEM, V62, P297, DOI 10.1042/EBC20170101
   AlMenabawy N, 2022, MITOCHONDRION, V65, P139, DOI 10.1016/j.mito.2022.06.004
   Arya VB, 2019, CLIN ENDOCRINOL, V91, P900, DOI 10.1111/cen.14084
   Bliksrud YT, 2005, J MOL MED-JMM, V83, P406, DOI 10.1007/s00109-005-0648-2
   Brahimi N, 2009, MOL GENET METAB, V97, P221, DOI 10.1016/j.ymgme.2009.03.007
   Buchaklian AH, 2012, MOL GENET METAB, V107, P92, DOI 10.1016/j.ymgme.2012.04.019
   Bychkov IO, 2021, MITOCHONDRION, V57, P205, DOI 10.1016/j.mito.2021.01.004
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Cámara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Caporali L, 2018, BRAIN, V141, DOI 10.1093/brain/awx301
   De Camaret BM, 2007, BIOCHEM J, V402, P377, DOI 10.1042/BJ20060705
   De Greef E, 2012, JIMD REP, V4, P5, DOI 10.1007/8904_2011_29
   DiMauro S, 2013, NEUROLOGY, V81, P281, DOI 10.1212/WNL.0b013e31829bfe89
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Dimmock DP, 2008, LIVER TRANSPLANT, V14, P1480, DOI 10.1002/lt.21556
   Dogulu N, 2021, J PEDIATR ENDOCR MET, V34, P1341, DOI 10.1515/jpem-2021-0108
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1071-z
   Douglas GV, 2011, J HUM GENET, V56, P834, DOI 10.1038/jhg.2011.112
   El-Hattab A.W., 1993, GENEREVIEWS
   Eldredge JA, 2024, PEDIATR TRANSPLANT, V28, DOI 10.1111/petr.14625
   Fang WY, 2017, ONCOTARGET, V8, P84309, DOI 10.18632/oncotarget.20905
   Filosto M, 2004, ACTA NEUROPATHOL, V108, P168, DOI 10.1007/s00401-004-0872-9
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Grabhorn E, 2014, LIVER TRANSPLANT, V20, P464, DOI 10.1002/lt.23830
   Hanchard NA, 2011, MOL GENET METAB, V103, P262, DOI 10.1016/j.ymgme.2011.03.006
   Harel T, 2016, AM J HUM GENET, V99, P831, DOI 10.1016/j.ajhg.2016.08.007
   Hassan S, 2020, PEDIATR TRANSPLANT, V24, DOI 10.1111/petr.13714
   Haudry C, 2012, MOL GENET METAB, V107, P700, DOI 10.1016/j.ymgme.2012.10.008
   Jankowska I, 2021, CLIN RES HEPATOL GAS, V45, DOI 10.1016/j.clinre.2020.02.018
   Ji JQ, 2010, MITOCHONDRION, V10, P188, DOI 10.1016/j.mito.2009.11.002
   Kasapkara ÇS, 2013, J PEDIATR GASTR NUTR, V57, pE28, DOI 10.1097/MPG.0b013e31826bd4ed
   Kiliç M, 2011, TURKISH J PEDIATR, V53, P79
   Komal FNU, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000269
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Labarthe F, 2005, J HEPATOL, V43, P333, DOI 10.1016/j.jhep.2005.03.023
   Lam CW, 2019, CLIN CHIM ACTA, V496, P93, DOI 10.1016/j.cca.2019.06.028
   Lee NC, 2009, ARCH DIS CHILD, V94, P55, DOI 10.1136/adc.2008.139584
   Lipinski P, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00414
   Mahjoub G, 2019, BMC MED GENET, V20, DOI 10.1186/s12881-019-0893-9
   Majdalani M, 2023, FRONT GENET, V14, DOI 10.3389/fgene.2023.1215083
   Mancuso M, 2005, ARCH NEUROL-CHICAGO, V62, P745, DOI 10.1001/archneur.62.5.745
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1445, DOI 10.1001/archneur.60.10.1445
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   McKiernan P, 2016, J PEDIATR GASTR NUTR, V63, P592, DOI 10.1097/MPG.0000000000001345
   Montano V, 2019, CASE REP NEUROL MED, V2019, DOI 10.1155/2019/5918632
   Mudd SH, 2012, MOL GENET METAB, V105, P228, DOI 10.1016/j.ymgme.2011.11.006
   Müller-Höcker J, 2002, HUM PATHOL, V33, P247, DOI 10.1053/hupa.2002.31477
   Munro B, 2019, HUM MOL GENET, V28, P796, DOI 10.1093/hmg/ddy389
   Navarro-Sastre A, 2012, MOL GENET METAB, V107, P409, DOI 10.1016/j.ymgme.2012.08.018
   Nobre S., 2012, BMJ Case Rep, V2012
   Pronicka E, 2011, J APPL GENET, V52, P61, DOI 10.1007/s13353-010-0008-y
   Rabinowitz SS, 2004, J PEDIATR GASTR NUTR, V38, P216, DOI 10.1097/00005176-200402000-00022
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Sezer T, 2015, J CHILD NEUROL, V30, P124, DOI 10.1177/0883073813517000
   Shieh JTC, 2009, J PEDIATR GASTR NUTR, V49, P130, DOI 10.1097/MPG.0b013e31819de7a6
   Slama A, 2005, MOL GENET METAB, V86, P462, DOI 10.1016/j.ymgme.2005.09.006
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
   Tadiboyina VT, 2005, AM J MED GENET A, V135A, P289, DOI 10.1002/ajmg.a.30748
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Ünal Ö, 2017, J PEDIATR ENDOCR MET, V30, P697, DOI 10.1515/jpem-2016-0268
   Vilarinho S, 2016, HEPATOLOGY, V63, P1977, DOI 10.1002/hep.28499
   Waich S, 2019, J PEDIATR GASTR NUTR, V68, pE1, DOI 10.1097/MPG.0000000000002149
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
   Xia JK, 2020, PEDIATR NEONATOL, V61, P558, DOI 10.1016/j.pedneo.2020.04.005
   Yamazaki T, 2014, PEDIATR INT, V56, P180, DOI 10.1111/ped.12249
   ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118
NR 76
TC 1
Z9 1
U1 2
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
EI 2632-1297
J9 BRAIN COMMUN
JI Brain Commun.
PD MAY 3
PY 2024
VL 6
IS 3
AR fcae160
DI 10.1093/braincomms/fcae160
EA MAY 2024
PG 14
WC Clinical Neurology; Neurosciences
WE Emerging Sources Citation Index (ESCI)
SC Neurosciences & Neurology
GA QY7F5
UT WOS:001224487900003
PM 38756539
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Bhattacharjee, M
   Venugopal, B
   Wong, KT
   Goto, YI
   Bhattacharjee, MB
AF Bhattacharjee, M.
   Venugopal, B.
   Wong, K. T.
   Goto, Y. -I.
   Bhattacharjee, M. B.
TI Mitochondrial disorder, diabetes mellitus, and findings in three
   muscles, including the heart
SO ULTRASTRUCTURAL PATHOLOGY
LA English
DT Article
DE diabetes mellitus; glycogen; mitochondria; myopathy; opthalmoplegia
ID KEARNS-SAYRE SYNDROME; GENE-EXPRESSION; OPHTHALMOPLEGIA; DYSFUNCTION;
   CARDIOMYOPATHY; ABSENCE; CELLS; BLOCK; MTDNA
AB The authors describe the case of a 50-year-old man with chronic progressive external ophthalmoplegia ( CPEO), diabetes mellitus (DM), and coronary artery disease. The patient had no cardiac conduction abnormalities. During coronary artery bypass surgery, his heart and two skeletal muscles were biopsied. All three muscles showed ragged red fibers. The heart muscle showed significant glycogen accumulation. Analysis of mitochondrial DNA ( mtDNA) showed a 5019-base-pair deletion, with no duplications. There were morphologically abnormal mitochondria in all 3 muscles, with clinically apparent difference in preservation of function. The combination of diabetes mellitus and mtDNA deletion is fortuitous, as they can be causally linked. The cardiac pathology allows speculation about the possible adaptive processes that may occur in the heart in DM. There are few reported cases with CPEO and excess glycogen in the heart. Most show deposition of fat and poorer clinical outcomes as compared to those with glycogen deposition. This observation may lend support to the hypothesis that in the myocardium, adaptive responses are mediated via changes in glucose handling, whereas alterations in fat metabolism likely represent maladaptation.
C1 Natl Heart Inst, Kuala Lumpur, Malaysia.
   Univ Texas, Hlth Sci Ctr Houston, Sch Med, Houston, TX USA.
   Univ Malaya, Dept Pathol, Kuala Lumpur, Malaysia.
   Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, NCNP, Tokyo, Japan.
   Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA.
C3 Institute Jantung Negara; University of Texas System; University of
   Texas Health Science Center Houston; Universiti Malaya; National Center
   for Neurology & Psychiatry - Japan; Baylor College of Medicine
RP Bhattacharjee, M (corresponding author), Univ Texas, Sch Med, Hlth Sci Ctr Houston, Dept Internal Med,Lynda B Johnson Hosp, 4-PO 30 012A-H 5656 Kelly, Houston, TX 77026 USA.
EM Modushudan.Bhattacharjee@uth.tmc.edu
RI Wong, Kum/B-2788-2010
CR BIELAWASKA AE, 1997, AM J PATHOL, V46, P169
   Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329
   CHARLES R, 1981, CIRCULATION, V63, P214, DOI 10.1161/01.CIR.63.1.214
   Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947
   Depre C, 2000, J MOL CELL CARDIOL, V32, P985, DOI 10.1006/jmcc.2000.1139
   DiMauro S, 1998, CURR OPIN CARDIOL, V13, P190
   Enríquez JA, 1999, BIOL CHEM, V380, P737, DOI 10.1515/BC.1999.094
   GALLASTEGUI J, 1987, AM J CARDIOL, V60, P385, DOI 10.1016/0002-9149(87)90255-4
   Hofhaus G, 1999, BIOL CHEM, V380, P871, DOI 10.1515/BC.1999.107
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   JAGER BV, 1960, AM J MED, V29, P888, DOI 10.1016/0002-9343(60)90122-4
   KEARNS THOMAS P., 1965, TRANS AMER OPHTHALMOL SOC, V63, P559
   MCCOMISH M, 1976, BRIT HEART J, V38, P526
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   Ponticos M, 1998, EMBO J, V17, P1688, DOI 10.1093/emboj/17.6.1688
   Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6
   Roduit R, 2000, J BIOL CHEM, V275, P35799, DOI 10.1074/jbc.M006001200
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Wang JM, 2001, P NATL ACAD SCI USA, V98, P4038, DOI 10.1073/pnas.061038798
   Young ME, 2002, CIRCULATION, V105, P1861, DOI 10.1161/01.CIR.0000012467.61045.87
NR 20
TC 7
Z9 7
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0191-3123
J9 ULTRASTRUCT PATHOL
JI Ultrastruct. Pathol.
PD NOV-DEC
PY 2006
VL 30
IS 6
BP 481
EP 487
DI 10.1080/01913120600689624
PG 7
WC Microscopy; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microscopy; Pathology
GA 119BB
UT WOS:000242986100011
PM 17183762
DA 2024-11-01
ER

PT J
AU Bohlega, S
   Van Goethem, G
   Al Semari, A
   Löfgren, A
   Al Hamed, M
   Van Broeckhoven, C
   Kambouris, M
AF Bohlega, S.
   Van Goethem, G.
   Al Semari, A.
   Loefgren, A.
   Al Hamed, M.
   Van Broeckhoven, C.
   Kambouris, M.
TI Novel Twinkle gene mutation in autosomal dominant progressive external
   ophthalmoplegia and multisystem failure
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE mtDNA; PEO; PEO1; Twinkle gene; Mutation; adPEO
ID MITOCHONDRIAL-DNA; DELETIONS; HELICASE
AB A Saudi Arabian family presented with adult onset autosomal dominant progressive external ophthalmoplegia (adPEO) complicated by late onset reversible failure of the CNS, respiratory, hepatic, and endocrine systems. Clinical findings were suggestive of mitochondrial dysfunction and multiple mitochondrial DNA deletions were demonstrated on long range and real time polymerase chain reaction assays but not on Southern blotting. The disorder is caused by a novel heterozygous PEO1 mutation predicting a Leu360Gly substitution in the twinkle protein. The peculiar clinical presentation expands the variable phenotype observed in adPEO and Twinkle gene mutations. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Bohlega, S.] King Faisal Specialist Hosp & Res Ctr, Dept Neurosci, Neurol Sect, Riyadh 11211, Saudi Arabia.
   [Van Goethem, G.] Univ Antwerp Hosp, Dept Neurol, Antwerp, Belgium.
   [Van Goethem, G.; Loefgren, A.; Van Broeckhoven, C.] Inst Born Bunge, Neurogenet Lab, Antwerp, Belgium.
   [Van Goethem, G.; Loefgren, A.; Van Broeckhoven, C.] VIB, Dept Mol Genet, Antwerp, Belgium.
   [Loefgren, A.; Van Broeckhoven, C.] Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium.
   [Al Hamed, M.; Kambouris, M.] King Faisal Specialist Hosp & Res Ctr, Res Ctr, Riyadh 11211, Saudi Arabia.
C3 King Faisal Specialist Hospital & Research Center; University of
   Antwerp; Flanders Institute for Biotechnology (VIB); University of
   Antwerp; King Faisal Specialist Hospital & Research Center
RP Bohlega, S (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Neurosci, Neurol Sect, POB 3354, Riyadh 11211, Saudi Arabia.
EM boholega@kfshrc.edu.sa
RI Al-Hamed, Mohamed/ACE-4638-2022; Van Broeckhoven, Christine/M-7853-2019;
   Van Broeckhoven, Christine/G-8362-2017
OI Al-Hamed, Mohamed/0000-0002-7207-6122; Van Broeckhoven,
   Christine/0000-0003-0183-7665
CR Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Jeppesen TD, 2008, NEUROMUSCULAR DISORD, V18, P306, DOI 10.1016/j.nmd.2007.10.007
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Lewis S, 2002, J NEUROL SCI, V201, P39, DOI 10.1016/S0022-510X(02)00190-9
   Rivera H, 2007, NEUROMUSCULAR DISORD, V17, P677, DOI 10.1016/j.nmd.2007.05.006
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
NR 10
TC 6
Z9 9
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD DEC
PY 2009
VL 19
IS 12
BP 845
EP 848
DI 10.1016/j.nmd.2009.10.002
PG 4
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 534DB
UT WOS:000272874600010
PM 19853444
DA 2024-11-01
ER

PT J
AU Dallabona, C
   Baruffini, E
   Goffrini, P
   Lodi, T
AF Dallabona, Cristina
   Baruffini, Enrico
   Goffrini, Paola
   Lodi, Tiziana
TI Dominance of yeast <i>aac2<SUP>R96H</SUP></i> and
   <i>aac2<SUP>R252G</SUP></i> mutations, equivalent to pathological
   mutations in ant1, is due to gain of function
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Yeast; ANT1; SLC25A4; AAC2; Mitochondrial diseases; Gain of function
ID ADENINE-NUCLEOTIDE TRANSLOCATOR; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   MITOCHONDRIAL ADP/ATP CARRIER; SACCHAROMYCES-CEREVISIAE; GENE MUTATION;
   MYOPATHY; DNA; CARDIOMYOPATHY; DISEASES; FAMILY
AB The mitochondrial ADP/ATP carrier is a nuclear encoded protein, which catalyzes the exchange of ATP generated in mitochondria with ADP produced in the cytosol. In humans, mutations in the major ADP/ATP carrier gene, ANTI, are involved in several degenerative mitochondrial pathologies, leading to instability of mitochondrial DNA. Recessive mutations have been associated with mitochondrial myopathy and cardiomyopathy whereas dominant mutations have been associated with autosomal dominant Progressive External Ophtalmoplegia (adPEO). Recently, two de novo dominant mutations, R8OH and R235G, leading to extremely severe symptoms, have been identified. In order to evaluate if the dominance is due to haploinsufficiency or to a gain of function, the two mutations have been introduced in the equivalent positions of the AAC2 gene, the yeast orthologue of human ANTI, and their dominant effect has been studied in heteroallelic strains, containing both one copy of wild type AAC2 and one copy of mutant aac2 allele. Through phenotypic characterization of these yeast models we showed that the OXPHOS phenotypes in the heteroallelic strains were more affected than in the hemiallelic strain indicating that the dominant trait of the two mutations is due to gain of function. (C) 2017 The Authors. Published by Elsevier Inc.
C1 [Dallabona, Cristina; Baruffini, Enrico; Goffrini, Paola; Lodi, Tiziana] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parco Area Sci 11-A, I-43124 Parma, Italy.
C3 University of Parma
RP Lodi, T (corresponding author), Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parco Area Sci 11-A, I-43124 Parma, Italy.
EM tiziana.lodi@unipr.it
RI Baruffini, Enrico/C-1057-2015; Goffrini, Paola/C-3860-2015
OI Baruffini, Enrico/0000-0002-8280-7849; Goffrini,
   Paola/0000-0002-8650-4765; DALLABONA, Cristina/0000-0003-4397-9143
FU Fondazione Telethon (Italy) [GGP15041]
FX Fondazione Telethon (Italy) (grant GGP15041) supported this work. We
   thank Ileana Ferrero for the critical overview of the paper and
   stimulating discussions. We thank Antonietta Cirasolo (Department of
   Chemistry, Life Sciences and Environmental Sustainability, University of
   Parma, Italy) for the helpful technical assistance.
CR Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023
   Bauer MKA, 1999, J CELL BIOL, V147, P1493, DOI 10.1083/jcb.147.7.1493
   Chen XJ, 2002, HUM MOL GENET, V11, P1835, DOI 10.1093/hmg/11.16.1835
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kawamata H, 2011, HUM MOL GENET, V20, P2964, DOI 10.1093/hmg/ddr200
   Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011
   KOLAROV J, 1990, J BIOL CHEM, V265, P12711
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Körver-Keularts IMLW, 2015, JIMD REP, V22, P39, DOI 10.1007/8904_2015_409
   Kunji ERS, 2016, BBA-MOL CELL RES, V1863, P2379, DOI 10.1016/j.bbamcr.2016.03.015
   Kunji ERS, 2010, BBA-BIOENERGETICS, V1797, P817, DOI 10.1016/j.bbabio.2010.03.023
   LAWSON JE, 1988, J BIOL CHEM, V263, P14812
   Liu YX, 2015, MOL BIOL CELL, V26, P1985, DOI 10.1091/mbc.E15-01-0030
   Lodi T, 2006, BIOCHEM BIOPH RES CO, V341, P810, DOI 10.1016/j.bbrc.2006.01.034
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7
   Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Subrarnaniam V, 2008, BBA-BIOENERGETICS, V1777, P666, DOI 10.1016/j.bbabio.2008.03.015
   THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Wang XW, 2008, HUM MOL GENET, V17, P4036, DOI 10.1093/hmg/ddn306
NR 29
TC 8
Z9 8
U1 0
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD NOV 18
PY 2017
VL 493
IS 2
BP 909
EP 913
DI 10.1016/j.bbrc.2017.09.122
PG 5
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA FK8YI
UT WOS:000413797200006
PM 28947214
DA 2024-11-01
ER

PT J
AU Basu, S
   Xie, X
   Uhler, JP
   Hedberg-Oldfors, C
   Milenkovic, D
   Baris, OR
   Kimoloi, S
   Matic, S
   Stewart, JB
   Larsson, NG
   Wiesner, RJ
   Oldfors, A
   Gustafsson, CM
   Falkenberg, M
   Larsson, E
AF Basu, Swaraj
   Xie, Xie
   Uhler, Jay P.
   Hedberg-Oldfors, Carola
   Milenkovic, Dusanka
   Baris, Olivier R.
   Kimoloi, Sammy
   Matic, Stanka
   Stewart, James B.
   Larsson, Nils-Goran
   Wiesner, Rudolf J.
   Oldfors, Anders
   Gustafsson, Claes M.
   Falkenberg, Maria
   Larsson, Erik
TI Accurate mapping of mitochondrial DNA deletions and duplications using
   deep sequencing
SO PLOS GENETICS
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MTDNA REPLICATION; MUTATIONS;
   GENOME; DEFICIENCY; INCREASE; TWINKLE; DISEASE; HISAT; POLG
AB Deletions and duplications in mitochondrial DNA (mtDNA) cause mitochondrial disease and accumulate in conditions such as cancer and age-related disorders, but validated high-throughput methodology that can readily detect and discriminate between these two types of events is lacking. Here we establish a computational method, MitoSAlt, for accurate identification, quantification and visualization of mtDNA deletions and duplications from genomic sequencing data. Our method was tested on simulated sequencing reads and human patient samples with single deletions and duplications to verify its accuracy. Application to mouse models of mtDNA maintenance disease demonstrated the ability to detect deletions and duplications even at low levels of heteroplasmy.
   Author summary
   Deletions in the mitochondrial genome cause a wide variety of rare disorders, but are also linked to more common conditions such as neurodegeneration, diabetes type 2, and the normal ageing process. There is also a growing awareness that mtDNA duplications, which are also relevant for human disease, may be more common than previously thought. Despite their clinical importance, our current knowledge about the abundance, characteristics and diversity of mtDNA deletions and duplications is fragmented, and based to large extent on a limited view provided by traditional low-throughput analyses. Here, we describe a bioinformatics method, MitoSAlt, that can accurately map and classify mtDNA deletions and duplications using high-throughput sequencing. Application of this methodology to mouse models of mitochondrial deficiencies revealed a large number of duplications, suggesting that these may previously have been underestimated.
C1 [Basu, Swaraj; Xie, Xie; Uhler, Jay P.; Gustafsson, Claes M.; Falkenberg, Maria; Larsson, Erik] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.
   [Hedberg-Oldfors, Carola; Oldfors, Anders] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Lab Med, Gothenburg, Sweden.
   [Milenkovic, Dusanka; Matic, Stanka; Stewart, James B.] Max Planck Inst Biol Ageing, Cologne, Germany.
   [Baris, Olivier R.; Kimoloi, Sammy; Wiesner, Rudolf J.] Univ Cologne, Ctr Physiol & Pathophysiol, Inst Vegetat Physiol, Cologne, Germany.
   [Baris, Olivier R.] Univ Angers, Inst MitoVasc, Equipe MitoLab, INSERM U1083,UMR CNRS 6015,SFRICAT 4208, Angers, France.
   [Stewart, James B.] Newcastle Univ, Biosci Inst, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Larsson, Nils-Goran] Karolinska Inst, Dept Med Biochem & Biophys MBB, Div Mol Metab, Stockholm, Sweden.
   [Wiesner, Rudolf J.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.
C3 University of Gothenburg; University of Gothenburg; Max Planck Society;
   University of Cologne; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Universite d'Angers; Newcastle University - UK;
   Karolinska Institutet; University of Cologne
RP Falkenberg, M; Larsson, E (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.
EM maria.falkenberg@medkem.gu.se; erik.larsson@gu.se
RI Larsson Lekholm, Erik/HDM-8032-2022; Larsson, Nils-Göran/GVS-5578-2022;
   Baris, Olivier/L-3463-2016; Matic, Stanka/LHA-4440-2024; Basu,
   Swaraj/AAN-8338-2020; Stewart, Jim/C-9633-2011
OI Basu, Swaraj/0000-0001-6107-2487; Kimoloi, Sammy/0000-0003-3364-4980;
   Gustafsson, Claes/0000-0003-3531-8468; Falkenberg,
   Maria/0000-0001-8713-173X; Stewart, Jim/0000-0002-2902-4968; Larsson,
   Nils-Goran/0000-0001-5100-996X
FU Swedish Research Council [2018-02439, 2017-01257, 2018-02852]; Swedish
   Cancer Foundation [2019-816, 2017-631, 2018-747]; Knut and Alice
   Wallenberg Foundation [KAW 2017.0080, KAW 2015.0144]; European Research
   Council [683191]; Swedish government; county councils, the ALF agreement
   [ALFGBG-727491, ALFGBG-728151]; Vinnova [2018-02852] Funding Source:
   Vinnova; Swedish Research Council [2018-02439, 2018-02852, 2017-01257]
   Funding Source: Swedish Research Council; European Research Council
   (ERC) [683191] Funding Source: European Research Council (ERC); Formas
   [2018-02852, 2018-02439] Funding Source: Formas
FX The work described here was supported by the Swedish Research Council
   (2018-02439 to M.F., 2017-01257 to C.M.G., and 2018-02852 to E. L.), the
   Swedish Cancer Foundation (2019-816 to M.F., 2017-631 to C.M.G., and
   2018-747 to E.L.), the Knut and Alice Wallenberg Foundation (KAW
   2017.0080 to M.F. and KAW 2015.0144 to E.L.), the European Research
   Council (683191 to M.F.) and grants from the Swedish state under the
   agreement between the Swedish government and the county councils, the
   ALF agreement (ALFGBG-727491 to M.F., and ALFGBG-728151 to C.M.G). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   [Anonymous], 1996, J DONNE J, V15, P95
   [Anonymous], 2019, CIRCULATION, V2019
   Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005
   Bosworth CM, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1821-7
   Calabrese FM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S15
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Durham SE, 2003, BRIT J CANCER, V88, P90, DOI 10.1038/sj.bjc.6600773
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Goudenège D, 2019, GENET MED, V21, P1407, DOI 10.1038/s41436-018-0350-8
   Gourlé H, 2019, BIOINFORMATICS, V35, P521, DOI 10.1093/bioinformatics/bty630
   Hedberg-Oldfors C, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000391
   Hjelm BE, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz164
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HORTON TM, 1995, NEUROLOGY, V45, P1879, DOI 10.1212/WNL.45.10.1879
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110
   Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4
   Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kosugi S, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1720-5
   Macao B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8303
   Matic S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03552-x
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Moraes CT, 2003, J MOL DIAGN, V5, P197, DOI 10.1016/S1525-1578(10)60474-6
   MORAES CT, 1989, BIOCHEM BIOPH RES CO, V160, P765, DOI 10.1016/0006-291X(89)92499-6
   Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336
   Persson Ö, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08673-5
   Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014
   POULTON J, 1989, LANCET, V1, P236
   POULTON J, 1991, CLIN GENET, V39, P33
   POULTON J, 1995, MUSCLE NERVE, pS154
   ROTIG A, 1992, AM J HUM GENET, V50, P364
   SAVRETRAIN I, 1992, HUM MOL GENET, V1, P203, DOI 10.1093/hmg/1.3.203
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Torregrosa-Muñumer R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45244-6
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Uhler JP, 2016, NUCLEIC ACIDS RES, V44, P5861, DOI 10.1093/nar/gkw468
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wendt A, 2000, REV INT STUD, V26, P165, DOI 10.1017/S0260210500001650
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Yuan Y, 2020, NAT GENET, V52, P342, DOI 10.1038/s41588-019-0557-x
   Zambelli F, 2017, EUR J HUM GENET, V25, P1229, DOI 10.1038/ejhg.2017.129
   1992, SPLM SPLA UPDATE, V1, P11
NR 47
TC 40
Z9 42
U1 1
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
J9 PLOS GENET
JI PLoS Genet.
PD DEC
PY 2020
VL 16
IS 12
AR e1009242
DI 10.1371/journal.pgen.1009242
PG 15
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA PG9KP
UT WOS:000600045600004
PM 33315859
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Zapico, SC
   Ubelaker, DH
AF Zapico, Sara C.
   Ubelaker, Douglas H.
TI mtDNA Mutations and Their Role in Aging, Diseases and Forensic Sciences
SO AGING AND DISEASE
LA English
DT Review
DE Mitochondrial DNA (mtDNA); Electron Transport Chain (ETC); Reactive
   Oxygen Species (ROS); Aging; Diseases; Forensic Sciences
ID MITOCHONDRIAL-DNA DELETIONS; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   FAMILIAL ALZHEIMERS-DISEASE; PRECURSOR PROTEIN GENE; RESPIRATORY-CHAIN
   DISEASES; LARGE-SCALE DELETIONS; HUMAN SKELETAL-MUSCLE; OXIDATIVE
   STRESS; POINT MUTATIONS; SUPEROXIDE-DISMUTASE
AB Mitochondria are independent organelles with their own DNA. As a primary function, mitochondria produce the energy for the cell through Oxidative Phosphorylation (OXPHOS) in the Electron Transport Chain (ETC). One of the toxic products of this process is Reactive Oxygen Species (ROS), which can induce oxidative damage in macromolecules like lipids, proteins and DNA. Mitochondrial DNA (mtDNA) is less protected and has fewer reparation mechanisms than nuclear DNA (nDNA), and as such is more exposed to oxidative, mutation-inducing damage. This review analyzes the causes and consequences of mtDNA mutations and their relationship with the aging process. Neurodegenerative diseases, related with the aging, are consequences of mtDNA mutations resulting in a decrease in mitochondrial function. Also described are "mitochondrial diseases", pathologies produced by mtDNA mutations and whose symptoms are related with mitochondrial dysfunction. Finally, mtDNA haplogroups are defined in this review; these groups are important for determination of geographical origin of an individual. Additionally, different haplogroups exhibit variably longevity and risk of certain diseases. mtDNA mutations in aging and haplogroups are of special interest to forensic science research. Therefore this review will help to clarify the key role of mtDNA mutations in these processes and support further research in this area.
C1 [Zapico, Sara C.; Ubelaker, Douglas H.] Natl Museum Nat Hist, Smithsonian Inst, Dept Anthropol, Washington, DC 20560 USA.
C3 Smithsonian Institution; Smithsonian National Museum of Natural History
RP Zapico, SC (corresponding author), Natl Museum Nat Hist, Smithsonian Inst, Dept Anthropol, MRC112, Washington, DC 20560 USA.
EM saiczapico@gmail.com
RI Zapico, Sara/AGE-5028-2022
OI C. Zapico, Sara/0000-0002-3605-5690; Ubelaker,
   Douglas/0000-0001-8027-2919
FU Smithsonian Institution
FX Sara C. Zapico is supported by a Peter Buck Postdoctoral Fellowship from
   the Smithsonian Institution. For editing the manuscript, the authors
   acknowledge Christian Thomas of the Smithsonian Institution.
CR Alexe G, 2007, HUM GENET, V121, P347, DOI 10.1007/s00439-007-0330-6
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458
   Bodyak ND, 2001, HUM MOL GENET, V10, P17, DOI 10.1093/hmg/10.1.17
   Booker LM, 2006, J UROLOGY, V175, P468, DOI 10.1016/S0022-5347(05)00163-1
   Calloway CD, 2000, AM J HUM GENET, V66, P1384, DOI 10.1086/302844
   CAMPION D, 1995, HUM MOL GENET, V4, P2373, DOI 10.1093/hmg/4.12.2373
   Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9
   CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0
   Chen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046473
   Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188
   Coffey G, 1999, NUCLEIC ACIDS RES, V27, P3348, DOI 10.1093/nar/27.16.3348
   Copeland WC, 2002, CANCER INVEST, V20, P557, DOI 10.1081/CNV-120002155
   CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Czarnecka AM, 2011, J AGING RES, V2011, DOI DOI 10.4061/2011/136435
   D'Autréaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256
   Dai DF, 2009, TRENDS CARDIOVAS MED, V19, P213, DOI 10.1016/j.tcm.2009.12.004
   Darvishi K, 2007, CANCER LETT, V249, P249, DOI 10.1016/j.canlet.2006.09.005
   De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532
   de Souza-Pinto NC, 2001, FREE RADICAL BIO MED, V30, P916, DOI 10.1016/S0891-5849(01)00483-X
   Del Bo R, 2003, NEUROBIOL AGING, V24, P829, DOI 10.1016/S0197-4580(02)00233-6
   Del Bo R, 2002, J NEUROL SCI, V202, P85, DOI 10.1016/S0022-510X(02)00247-2
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DRIGGERS WJ, 1993, J BIOL CHEM, V268, P22042
   Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Fogg Vanessa C, 2011, Chin J Cancer, V30, P526, DOI 10.5732/cjc.011.10018
   Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1
   FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525
   Gilkerson RW, 2009, INT J BIOCHEM CELL B, V41, P1899, DOI 10.1016/j.biocel.2009.03.016
   GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Gray MW, 2001, GENOME BIOL, V2
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Gredilla Ricardo, 2010, J Aging Res, V2011, P257093, DOI 10.4061/2011/257093
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   HAMMANS SR, 1991, LANCET, V337, P1311, DOI 10.1016/0140-6736(91)92981-7
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAYAKAWA M, 1991, BIOCHEM BIOPH RES CO, V179, P1023, DOI 10.1016/0006-291X(91)91921-X
   Hebert SL, 2010, MECH AGEING DEV, V131, P451, DOI 10.1016/j.mad.2010.03.007
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1
   Jaarsma D, 2001, ACTA NEUROPATHOL, V102, P293
   Kang DC, 2005, CURR MED CHEM, V12, P429, DOI 10.2174/0929867053363081
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kennedy SR, 2012, MECH AGEING DEV, V133, P118, DOI 10.1016/j.mad.2011.10.009
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024
   Lacan M, 2011, INT J LEGAL MED, V125, P293, DOI 10.1007/s00414-010-0440-x
   Lacan M, 2009, INT J LEGAL MED, V123, P161, DOI 10.1007/s00414-008-0266-y
   Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002
   Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011
   Lee HJ, 2002, J BIOL CHEM, V277, P48976, DOI 10.1074/jbc.M208192200
   LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376
   Malhi RS, 2003, AM J PHYS ANTHROPOL, V120, P108, DOI 10.1002/ajpa.10138
   Mambo E, 2005, ONCOGENE, V24, P4496, DOI 10.1038/sj.onc.1208669
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Mao Chih-Chieh, 2009, Chang Gung Med J, V32, P354
   Martin LJ, 2012, PROG MOL BIOL TRANSL, V107, P355, DOI 10.1016/B978-0-12-385883-2.00005-9
   Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167
   McInerny SC, 2009, MECH AGEING DEV
   Meissner C, 1997, INT J LEGAL MED, V110, P288, DOI 10.1007/s004140050089
   Meissner C, 1999, FORENSIC SCI INT, V105, P115, DOI 10.1016/S0379-0738(99)00126-7
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846
   Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P1419, DOI 10.1093/nar/23.8.1419
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Mielnik-Sikorska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054360
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Mörnstad H, 1999, INT J LEGAL MED, V112, P98, DOI 10.1007/s004140050209
   MUNSCHER C, 1993, FEBS LETT, V317, P27, DOI 10.1016/0014-5793(93)81484-H
   NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Nelson TM, 2007, CROAT MED J, V48, P460
   Niemi AK, 2005, EUR J HUM GENET, V13, P166, DOI 10.1038/sj.ejhg.5201308
   Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Núnez C, 2011, CROAT MED J, V52, P336, DOI 10.3325/cmj.2011.52.336
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   Orth M, 2003, NEUROSCI LETT, V351, P29, DOI 10.1016/S0304-3940(03)00941-8
   Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2
   Papiha SS, 1998, J CLIN PATHOL, V51, P117, DOI 10.1136/jcp.51.2.117
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105
   Quintáns B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005
   Ren WH, 2008, CLIN EXP PHARMACOL P, V35, P1477, DOI 10.1111/j.1440-1681.2008.05028.x
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Ross OA, 2001, EXP GERONTOL, V36, P1161, DOI 10.1016/S0531-5565(01)00094-8
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Schatz G, 1996, J BIOL CHEM, V271, P31763, DOI 10.1074/jbc.271.50.31763
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0
   Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012
   Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277
   SHUSTER RC, 1988, BIOCHEM BIOPH RES CO, V155, P1360, DOI 10.1016/S0006-291X(88)81291-9
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787
   Singh Keshav K., 2009, V471, P291, DOI 10.1007/978-1-59745-416-2_15
   Smeitink J, 1999, AM J HUM GENET, V64, P1505, DOI 10.1086/302432
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Solano A, 2003, ANN NEUROL, V54, P527, DOI 10.1002/ana.10682
   SOONG NW, 1992, NAT GENET, V2, P318
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Sue CM, 2000, BRAIN PATHOL, V10, P442
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Szczesny B, 2003, P NATL ACAD SCI USA, V100, P10670, DOI 10.1073/pnas.1932854100
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Tanaka M, 2004, ANN NY ACAD SCI, V1011, P7, DOI 10.1196/annals.1293.002
   Thèves C, 2006, J FORENSIC SCI, V51, P865, DOI 10.1111/j.1556-4029.2006.00163.x
   Thompson LV, 2006, EXP GERONTOL, V41, P1220, DOI 10.1016/j.exger.2006.10.018
   Thyagarajan B, 1996, J BIOL CHEM, V271, P27536, DOI 10.1074/jbc.271.44.27536
   Tilley L, 1998, J CLIN PATHOL-MOL PA, V51, P293, DOI 10.1136/mp.51.6.293
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Verma Mukesh, 2007, Cancer Res, V67, P437, DOI 10.1158/0008-5472.CAN-06-4119
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   WARBURG O, 1956, SCIENCE, V124, P269
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901
   Whitworth AJ, 2009, J BIOENERG BIOMEMBR, V41, P499, DOI 10.1007/s10863-009-9253-3
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Zapico SC, 2013, AGEING RES REV, V12, P605, DOI 10.1016/j.arr.2013.02.002
   ZEVIANI M, 1990, AM J HUM GENET, V47, P904
   Zhang CF, 1997, BIOCHEM BIOPH RES CO, V230, P630, DOI 10.1006/bbrc.1996.6020
NR 146
TC 47
Z9 65
U1 0
U2 25
PU INT SOC AGING & DISEASE
PI FORT WORTH
PA EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA
SN 2152-5250
J9 AGING DIS
JI Aging Dis.
PD DEC
PY 2013
VL 4
IS 6
BP 364
EP 380
DI 10.14336/AD.2013.0400364
PG 17
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA AI5KB
UT WOS:000336903900006
PM 24307969
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Hedberg-Oldfors, C
   Lindgren, U
   Basu, S
   Visuttijai, K
   Lindberg, C
   Falkenberg, M
   Lekholm, EL
   Oldfors, A
AF Hedberg-Oldfors, Carola
   Lindgren, Ulrika
   Basu, Swaraj
   Visuttijai, Kittichate
   Lindberg, Christopher
   Falkenberg, Maria
   Larsson Lekholm, Erik
   Oldfors, Anders
TI Mitochondrial DNA variants in inclusion body myositis characterized by
   deep sequencing
SO BRAIN PATHOLOGY
LA English
DT Article
DE inclusion body myositis; muscle disease; mitochondrial DNA; mtDNA
   deletions; mtDNA duplications; mtDNA rearrangements; mtDNA point
   mutations
ID REPLICATION MACHINERY; POINT MUTATIONS; MUSCLE; AGE; DELETIONS;
   ABNORMALITIES; INFLAMMATION
AB Muscle pathology in inclusion body myositis (IBM) typically includes inflammatory cell infiltration, muscle fibers with rimmed vacuoles and cytochrome c oxidase (COX)-deficient fibers. Previous studies have revealed clonal expansion of large mitochondrial DNA (mtDNA) deletions in the COX-deficient muscle fibers. Technical limitations have prevented complete investigations of the mtDNA deletions and other mtDNA variants. Detailed characterization by deep sequencing of mtDNA in muscle samples from 21 IBM patients and 10 age-matched controls was performed after whole genome sequencing with a mean depth of mtDNA coverage of 46,000x. Multiple large mtDNA deletions and duplications were identified in all IBM and control muscle samples. In general, the IBM muscles demonstrated a larger number of deletions and duplications with a mean heteroplasmy level of 10% (range 1%-35%) compared to controls (1%, range 0.2%-3%). There was also a small increase in the number of somatic single nucleotide variants in IBM muscle. More than 200 rearrangements were recurrent in at least two or more IBM muscles while 26 were found in both IBM and control muscles. The deletions and duplications, with a high recurrence rate, were mainly observed in three mtDNA regions, m.534-4429, m.6330-13993, and m.8636-16072, where some were flanked by repetitive sequences. The mtDNA copy number in IBM muscle was reduced to 42% of controls. Immunohistochemical and western blot analyses of IBM muscle revealed combined complex I and complex IV deficiency affecting the COX-deficient fibers. In conclusion, deep sequencing and quantitation of mtDNA variants revealed that IBM muscles had markedly increased levels of large deletions and duplications, and there were also indications of increased somatic single nucleotide variants and reduced mtDNA copy numbers compared to age-matched controls. The distribution and type of variants were similar in IBM muscle and controls indicating an accelerated aging process in IBM muscle, possibly associated with chronic inflammation.
C1 [Hedberg-Oldfors, Carola; Lindgren, Ulrika; Visuttijai, Kittichate; Oldfors, Anders] Univ Gothenburg, Dept Lab Med, Gothenburg, Sweden.
   [Lindgren, Ulrika; Lindberg, Christopher] Sahlgrens Univ Hosp, Dept Neurol, Neuromuscular Ctr, Gothenburg, Sweden.
   [Basu, Swaraj; Falkenberg, Maria; Larsson Lekholm, Erik] Univ Gothenburg, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.
C3 University of Gothenburg; Sahlgrenska University Hospital; University of
   Gothenburg
RP Oldfors, A (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Lab Med, Gula Straket 8, S-41345 Gothenburg, Sweden.
EM anders.oldfors@gu.se
RI Lindgren, Ulrika/HJH-0146-2022; Larsson Lekholm, Erik/HDM-8032-2022;
   Basu, Swaraj/AAN-8338-2020; Visuttijai, Kittichate/S-4927-2019
OI Larsson Lekholm, Erik/0000-0003-1400-0119; Oldfors,
   Anders/0000-0003-2523-1414; Falkenberg, Maria/0000-0001-8713-173X; Basu,
   Swaraj/0000-0001-6107-2487; Visuttijai, Kittichate/0000-0002-4800-8533
CR Basu S, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1009242
   Benveniste O, 2011, BRAIN, V134, P3176, DOI 10.1093/brain/awr213
   Blume G, 1997, BRAIN, V120, P39, DOI 10.1093/brain/120.1.39
   Carpenter S., 1975, RECENT ADV MYOLOGY, P374
   Catalán-García M, 2016, CLIN SCI, V130, P1741, DOI 10.1042/CS20160080
   Chung HY, 2019, AGING DIS, V10, P367, DOI 10.14336/AD.2018.0324
   Dahlbom K, 2002, NEUROMUSCULAR DISORD, V12, P853, DOI 10.1016/S0960-8966(02)00098-6
   Dahlbom K, 2019, ACTA NEUROL SCAND, V139, P177, DOI 10.1111/ane.13040
   De Paepe B, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9010015
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   Ding J, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1005306, 10.1371/journal.pgen.1005549]
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Fülöp T, 2019, GERONTOLOGY, V65, P495, DOI 10.1159/000497375
   Greenberg SA, 2019, NAT REV RHEUMATOL, V15, P257, DOI 10.1038/s41584-019-0186-x
   Gupta S, 2018, RHEUM DIS CLIN N AM, V44, P393, DOI 10.1016/j.rdc.2018.03.001
   Hedberg-Oldfors C, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000391
   Herbst A, 2017, J GERONTOL A-BIOL, V72, P1327, DOI 10.1093/gerona/glx058
   Horvath R, 1998, J NEUROPATH EXP NEUR, V57, P396, DOI 10.1097/00005072-199805000-00003
   JOHNSTON W, 1995, ANN NEUROL, V37, P16, DOI 10.1002/ana.410370106
   Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341
   LINDBERG C, 1994, ACTA NEUROL SCAND, V89, P123
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   Maiuri AR, 2018, CANCER METAB, V6, DOI 10.1186/s40170-018-0182-7
   Mastaglia FL, 2015, J CLIN NEUROSCI, V22, P6, DOI 10.1016/j.jocn.2014.09.012
   Molnar M, 1998, ACTA NEUROPATHOL, V96, P41, DOI 10.1007/s004010050858
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Oldfors, 2021, MUSCLE BIOPSY PRACTI
   Oldfors A, 2006, NEUROLOGY, V66, pS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   Persson Ö, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08673-5
   Piber D, 2019, J GERONTOL A-BIOL, V74, P1716, DOI 10.1093/gerona/glz130
   Picca A, 2018, BIOL CHEM, V399, P421, DOI 10.1515/hsz-2017-0331
   Pinti M, 2014, EUR J IMMUNOL, V44, P1552, DOI 10.1002/eji.201343921
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Riuzzi F, 2018, J CACHEXIA SARCOPENI, V9, P1255, DOI 10.1002/jcsm.12363
   Rose MR, 2013, NEUROMUSCULAR DISORD, V23, P1044, DOI 10.1016/j.nmd.2013.08.007
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Tawil R, 2002, CURR OPIN RHEUMATOL, V14, P653, DOI 10.1097/00002281-200211000-00004
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   YUNIS EJ, 1971, LAB INVEST, V25, P240
NR 40
TC 20
Z9 21
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1015-6305
EI 1750-3639
J9 BRAIN PATHOL
JI Brain Pathol.
PD MAY
PY 2021
VL 31
IS 3
AR e12931
DI 10.1111/bpa.12931
PG 12
WC Clinical Neurology; Neurosciences; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pathology
GA SI9AO
UT WOS:000655121800015
PM 33354847
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Plummer, C
   Spring, PJ
   Marotta, R
   Chin, J
   Taylor, G
   Sharpe, D
   Athanasou, NA
   Thyagarajan, D
   Berkovic, SF
AF Plummer, C.
   Spring, P. J.
   Marotta, R.
   Chin, J.
   Taylor, G.
   Sharpe, D.
   Athanasou, N. A.
   Thyagarajan, D.
   Berkovic, S. F.
TI Multiple Symmetrical Lipomatosis - A mitochondrial disorder of brown fat
SO MITOCHONDRION
LA English
DT Article
DE Multiple Symmetrical Lipomatosis; Madelung's Disease; Brown fat;
   Uncoupling protein-1 mRNA; Adipocyte fatty-acid protein-2
ID RED FIBERS MERRF; MADELUNGS-DISEASE; UNCOUPLING PROTEIN; ADIPOSE-TISSUE;
   DNA MUTATIONS; MYOCLONUS EPILEPSY; CEREBELLAR-ATAXIA; A8344G MUTATION;
   MESSENGER-RNA; AP2 PROTEIN
AB Multiple Symmetrical Lipomatosis (MSL) is an unusual disorder characterized by the development of axial lipomas in adulthood. The pathoetiology of lipoma tissue in MSL remains unresolved. Seven patients with MSL were followed for a mean period of 12 years (8-20 years). All patients had cervical lipomas ranging from subtle lesions to disfiguring masses; six patients had peripheral neuropathy and five had proximal myopathy. Myoclonus, cerebellar ataxia and additional lipomas were variably present. All patients showed clinical progression. Muscle histopathology was consistent with mitochondrial disease. Five patients were positive for mtDNA point mutation m.8344A > G, three of whom underwent lipoma resection - all samples were positive for uncoupling protein-1 mRNA (unique to brown fat). Lipoma from one case stained positive for adipocyte fatty-acid protein-2 (unique to brown fat and immature adipocytes). This long-term study hallmarks the phenotypic heterogeneity of MSL's associated clinical features. The clinical, genetic and molecular findings substantiate the hypothesis that lipomas in MSL are due to a mitochondrial disorder of brown fat. (c) 2013 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Plummer, C.; Marotta, R.; Chin, J.] St Vincents Hosp, Ctr Clin Neurosci & Neurol Res, Fitzroy, Vic 3065, Australia.
   [Spring, P. J.; Sharpe, D.] Concord Repatriat Gen Hosp, Dept Neurol, Concord, NSW 2139, Australia.
   [Taylor, G.] Nelson Hosp, Dept Anat Pathol, Nelson 7012, New Zealand.
   [Athanasou, N. A.] Univ Oxford, Dept Musculoskeletal Pathol, Nuffield Dept Orthoped Rheumatol & Musculoskeleta, Oxford OX3 7HE, England.
   [Thyagarajan, D.] Monash Med Ctr, Dept Neurol, Clayton, Vic 3168, Australia.
   [Berkovic, S. F.] Univ Melbourne, Dept Med, Heidelberg, Vic 3084, Australia.
C3 NSW Health; St Vincents Hospital Sydney; St Vincent's Health; St
   Vincent's Hospital Melbourne; Concord Repatriation General Hospital;
   University of Oxford; Monash Health; Monash Medical Centre; Monash
   University; University of Melbourne
RP Plummer, C (corresponding author), St Vincents Hosp, Ctr Clin Neurosci & Neurol Res, Level 5 Daly Wing,35 Victoria Parade, Fitzroy, Vic 3065, Australia.
EM chris.plummer@svhm.org.au
RI Thyagarajan, Dominic/H-6633-2014
OI Berkovic, Samuel/0000-0003-4580-841X; Plummer, Chris/0000-0001-5434-1343
CR Ampollini L, 2011, NEW ENGL J MED, V364, P465, DOI 10.1056/NEJMicm1003531
   Antonická H, 1999, BIOCHEM J, V342, P537, DOI 10.1042/0264-6021:3420537
   Austin SA, 1998, NEUROLOGY, V51, P1447, DOI 10.1212/WNL.51.5.1447
   BANERJEE SP, 1978, NATURE, V276, P407, DOI 10.1038/276407a0
   BENNETT JH, 1995, J CLIN PATHOL, V48, P950, DOI 10.1136/jcp.48.10.950
   BERKOVIC SF, 1991, LANCET, V338, P457, DOI 10.1016/0140-6736(91)91090-H
   BERKOVIC SF, 1991, ANN NEUROL, V29, P566, DOI 10.1002/ana.410290519
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Brodie BC, 1846, Lectures illustrative of various subjects in pathology and surgery. M, P275
   Campos Y, 1996, NEUROLOGY, V47, P1012, DOI 10.1212/WNL.47.4.1012
   Casali C, 1999, NEUROLOGY, V52, P1103, DOI 10.1212/WNL.52.5.1103
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   EKBOM K, 1975, ACTA NEUROL SCAND, V51, P393
   ENZI G, 1984, MEDICINE, V63, P56, DOI 10.1097/00005792-198401000-00004
   Enzi G, 2002, INT J OBESITY, V26, P253, DOI 10.1038/sj.ijo.0801867
   ENZI G, 1985, MEDICINE, V64, P388, DOI 10.1097/00005792-198511000-00003
   Finsterer J, 2005, CLIN NEUROL NEUROSUR, V107, P181, DOI 10.1016/j.clineuro.2004.07.001
   Gabriel YA, 2001, SURGERY, V129, P117, DOI 10.1067/msy.2001.105032
   Gámez J, 1998, NEUROLOGY, V51, P258, DOI 10.1212/WNL.51.1.258
   González-García R, 2004, AESTHET PLAST SURG, V28, P108, DOI 10.1007/s00266-004-3123-5
   HALLER RG, 1984, MED CLIN N AM, V68, P91, DOI 10.1016/S0025-7125(16)31243-3
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   Heckmann JG, 2000, EUR J NEUROL, V7, P243, DOI 10.1046/j.1468-1331.2000.00054.x
   Joyner CJ, 1999, PATHOL RES PRACT, V195, P461, DOI 10.1016/S0344-0338(99)80049-1
   KAZUMI T, 1994, ENDOCR J, V41, P315, DOI 10.1507/endocrj.41.315
   KLOPSTOCK T, 1994, NEUROLOGY, V44, P862, DOI 10.1212/WNL.44.5.862
   Klopstock T, 1997, MOL CELL BIOCHEM, V174, P271, DOI 10.1023/A:1006877012241
   KODISH ME, 1974, METABOLISM, V23, P937, DOI 10.1016/0026-0495(74)90043-2
   Launois P.E., 1898, B SOC M D H P PARIS, V1, P298
   Madelung OW., 1888, Arch Klin Chir, V37, P106
   Manieri M, 2010, NUTR METAB CARDIOVAS, V20, P567, DOI 10.1016/j.numecd.2009.04.020
   Marotta R, 2004, INTERN MED J, V34, P10, DOI 10.1111/j.1444-0903.2004.t01-3-.x
   MATTHEWS PM, 1995, NEUROLOGY, V45, P197, DOI 10.1212/WNL.45.1.197
   Naumann M, 1997, MUSCLE NERVE, V20, P833, DOI 10.1002/(SICI)1097-4598(199707)20:7<833::AID-MUS7>3.0.CO;2-8
   Nechad M., 1986, BROWN ADIPOSE TISSUE, P1
   Nisoli E, 2002, J PATHOL, V198, P378, DOI 10.1002/path.1212
   PUIGSERVER P, 1992, BIOCHEM J, V284, P393, DOI 10.1042/bj2840393
   RICQUIER D, 1991, FASEB J, V5, P2237, DOI 10.1096/fasebj.5.9.1860614
   TRAFF J, 1995, ACTA NEUROL SCAND, V92, P394
   Vilà MR, 2000, BIOCHEM BIOPH RES CO, V278, P800, DOI 10.1006/bbrc.2000.3828
   Yang T T, 2001, Sarcoma, V5, P139, DOI 10.1080/13577140120048593
NR 41
TC 56
Z9 61
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
J9 MITOCHONDRION
JI Mitochondrion
PD JUL
PY 2013
VL 13
IS 4
BP 269
EP 276
DI 10.1016/j.mito.2013.03.003
PG 8
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 162VR
UT WOS:000320294600002
PM 23524250
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Iizuka, T
   Goto, Y
   Miyakawa, S
   Sato, M
   Wang, ZX
   Suzuki, K
   Hamada, J
   Kurata, A
   Sakai, F
AF Iizuka, Takahiro
   Goto, Yu-ichi
   Miyakawa, Saori
   Sato, Mayumi
   Wang, Zhaoxia
   Suzuki, Kosuke
   Hamada, Junichi
   Kurata, Akira
   Sakai, Fumihiko
TI Progressive carotid artery stenosis with a novel tRNA phenylalanine
   mitochondrial DNA mutation
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article; Proceedings Paper
CT 5th International Congress on Vascular Dementia
CY NOV 08-11, 2007
CL Budapest, HUNGARY
DE Carotid stenosis; Brain infarction; Mitochondrial encephalopathy;
   Carotid stenting; Gene mutation
ID STROKE-LIKE EPISODES; LACTIC-ACIDOSIS; MELAS; DISEASE; ENCEPHALOPATHY;
   MECHANISMS; MYOPATHY; PATIENT
AB Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) is a distinct clinical syndrome caused by Mutations in the mitochondrial DNA. The pathogenesis of stroke-like episodes remains unknown but major vessels stenosis is not a cause of stroke-like episodes, We describe a novel heteroplasmic G617A transition in the mitochondrial transfer RNA phenylalanine gene in a patient with encephalomyopathy who presented with recurrent embolic ischemic strokes accompanied by transient occlusion of middle cerebral, anterior cerebral and internal carotid arteries. These ischemic strokes were presumed to be artery-to artery embolisms associated with carotid artery stenosis. Single muscle fiber analysis revealed the pathogenicity of the mutation although its causative role on carotid artery stenosis remains to be elucidated. This case expands phenotypic spectrum of mitochondrial disorders in terms of macroangiopathy, but niacroangiopathy-related ischemic strokes should be distinguished from classic stroke-like episodes of MELAS that are speculated to be microangioapthy-related or non-ischemic neurovascular events. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Iizuka, Takahiro; Miyakawa, Saori; Sato, Mayumi; Suzuki, Kosuke; Hamada, Junichi; Sakai, Fumihiko] Kitasato Univ, Sch Med, Dept Neurol, Kanagawa 2288555, Japan.
   [Kurata, Akira] Kitasato Univ, Sch Med, Dept Neurosurg, Kanagawa 2288555, Japan.
C3 Kitasato University; Kitasato University
RP Iizuka, T (corresponding author), Kitasato Univ, Sch Med, Dept Neurol, 1-15-1 Kitasato, Kanagawa 2288555, Japan.
EM takahiro@med.kitasato-u.ac.jp
OI Iizuka, Takahiro/0000-0002-7234-0720
CR Chinnery PF, 1997, ANN NEUROL, V41, P408, DOI 10.1002/ana.410410319
   Deschauer M, 2006, ARCH NEUROL-CHICAGO, V63, P902, DOI 10.1001/archneur.63.6.902
   DESTEE A, 1989, REV NEUROL, V145, P37
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   ITO J, 1995, J CHILD NEUROL, V10, P337, DOI 10.1177/088307389501000422
   Kleinle S, 1998, BIOCHEM BIOPH RES CO, V247, P112, DOI 10.1006/bbrc.1998.8729
   Komaki H, 2003, MITOCHONDRION, V2, P293, DOI 10.1016/S1567-7249(03)00003-5
   Ling JQ, 2007, P NATL ACAD SCI USA, V104, P15299, DOI 10.1073/pnas.0704441104
   Longo N, 2008, AM J MED GENET A, V146A, P361, DOI 10.1002/ajmg.a.31841
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Martínez-Fernández E, 2001, STROKE, V32, P2507, DOI 10.1161/hs1101.098328
   Moslemi AR, 2004, NEUROMUSCULAR DISORD, V14, P46, DOI 10.1016/S0960-8966(03)00168-8
   Noguchi A, 2005, PEDIATR NEUROL, V33, P70, DOI 10.1016/j.pediatrneurol.2005.01.013
   Tay SHK, 2006, ARCH NEUROL-CHICAGO, V63, P281, DOI 10.1001/archneur.63.2.281
   Tzen CY, 2001, KIDNEY INT, V59, P846, DOI 10.1046/j.1523-1755.2001.00567.x
   VALENTE L, 2008, BIOCH BIOPHYS A 1015
NR 21
TC 28
Z9 29
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD MAR 15
PY 2009
VL 278
IS 1-2
BP 35
EP 40
DI 10.1016/j.jns.2008.11.016
PG 6
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Neurosciences & Neurology
GA 411ZF
UT WOS:000263692300007
PM 19091329
DA 2024-11-01
ER

PT J
AU Berardo, A
   DiMauro, S
   Hirano, M
AF Berardo, Andres
   DiMauro, Salvatore
   Hirano, Michio
TI A Diagnostic Algorithm for Metabolic Myopathies
SO CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
LA English
DT Review
DE Metabolic myopathies; Glycogenosis; Fatty acid; Mitochondrial diseases
ID MITOCHONDRIAL-DNA; COENZYME-Q10 DEFICIENCY; EXERCISE INTOLERANCE; A3243G
   MUTATION; GENE; DISORDERS; DISEASE; FORM; TOLERANCE
AB Metabolic myopathies comprise a clinically and etiologically diverse group of disorders caused by defects in cellular energy metabolism, including the breakdown of carbohydrates and fatty acids to generate adenosine triphosphate, predominantly through mitochondrial oxidative phosphorylation. Accordingly, the three main categories of metabolic myopathies are glycogen storage diseases, fatty acid oxidation defects, and mitochondrial disorders due to respiratory chain impairment. The wide clinical spectrum of metabolic myopathies ranges from severe infantile-onset multisystemic diseases to adult-onset isolated myopathies with exertional cramps. Diagnosing these diverse disorders often is challenging because clinical features such as recurrent myoglobinuria and exercise intolerance are common to all three types of metabolic myopathy. Nevertheless, distinct clinical manifestations are important to recognize as they can guide diagnostic testing and lead to the correct diagnosis. This article briefly reviews general clinical aspects of metabolic myopathies and highlights approaches to diagnosing the relatively more frequent subtypes (Fig. 1).
C1 [Berardo, Andres; DiMauro, Salvatore; Hirano, Michio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA.
C3 Columbia University
RP Hirano, M (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, 630 W 168th St,P&S 4-423, New York, NY 10032 USA.
EM mh29@columbia.edu
FU NICHD NIH HHS [R01 HD057543, R01 HD057543-03] Funding Source: Medline
CR Andreu AL, 1999, ANN NEUROL, V45, P820, DOI 10.1002/1531-8249(199906)45:6<820::AID-ANA22>3.0.CO;2-W
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   [Anonymous], J INHERIT METAB 0707
   Beutler E, 2007, BRIT J HAEMATOL, V136, P3, DOI 10.1111/j.1365-2141.2006.06351.x
   Bortot B, 2009, MITOCHONDRION, V9, P123, DOI 10.1016/j.mito.2009.01.006
   Bruno C, 2008, CURR OPIN NEUROL, V21, P601, DOI 10.1097/WCO.0b013e32830dd5a6
   Curcoy A, 2003, MOL GENET METAB, V78, P247, DOI 10.1016/S1096-7192(03)00024-6
   Darras BT, 2000, PEDIATR NEUROL, V22, P87, DOI 10.1016/S0887-8994(99)00133-2
   Deschauer M, 2005, ARCH NEUROL-CHICAGO, V62, P37, DOI 10.1001/archneur.62.1.37
   DIMAURO S, 1973, SCIENCE, V182, P929, DOI 10.1126/science.182.4115.929
   DiMauro S, 2001, MUSCLE NERVE, V24, P984, DOI 10.1002/mus.1103
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Downham E, 2008, NEUROMUSCULAR DISORD, V18, P310, DOI 10.1016/j.nmd.2008.01.003
   Elston T, 1998, NATURE, V391, P510, DOI 10.1038/35185
   Eymard B, 2001, REV MED INTERNE, V22, p328S
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Haller RG, 2000, ARCH NEUROL-CHICAGO, V57, P923, DOI 10.1001/archneur.57.7.923
   Haller RG, 2004, NEUROLOGY, V62, P82, DOI 10.1212/WNL.62.1.82
   Haller RG, 2002, ARCH NEUROL-CHICAGO, V59, P1395, DOI 10.1001/archneur.59.9.1395
   Hamano Hitoshi, 2003, Rinsho Shinkeigaku, V43, P253
   Hirano M, 2007, NEUROBIOLOGY OF DISEASE, P947, DOI 10.1016/B978-012088592-3/50088-8
   Horvath R, 2006, NEUROLOGY, V66, P253, DOI 10.1212/01.wnl.0000194241.35115.7c
   Klein CJ, 2004, MUSCLE NERVE, V29, P323, DOI 10.1002/mus.10520
   Longo N, 2006, AM J MED GENET C, V142C, P77, DOI 10.1002/ajmg.c.30087
   Marotta R, 2009, J CLIN NEUROSCI, V16, P1223, DOI 10.1016/j.jocn.2008.11.012
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   Melone MAB, 2004, ARCH NEUROL-CHICAGO, V61, P269, DOI 10.1001/archneur.61.2.269
   Noel N, 2006, BRIT J HAEMATOL, V132, P523, DOI 10.1111/j.1365-2141.2005.05882.x
   Noji H, 2001, J BIOL CHEM, V276, P1665, DOI 10.1074/jbc.R000021200
   Orngreen MC, 2008, NEUROLOGY, V70, P1876, DOI 10.1212/01.wnl.0000289190.66955.67
   Orngreen MC, 2005, ANN NEUROL, V57, P60, DOI 10.1002/ana.20320
   Pulkes T, 2005, NEUROLOGY, V64, P1091, DOI 10.1212/01.WNL.0000154471.33156.55
   ROWLAND LP, 1991, REV NEUROL-FRANCE, V147, P467
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Shen JJ, 1996, J CLIN INVEST, V98, P352, DOI 10.1172/JCI118799
   Spiegel R, 2009, NEUROMUSCULAR DISORD, V19, P207, DOI 10.1016/j.nmd.2008.12.004
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Stojkovic T, 2009, NEW ENGL J MED, V361, P425, DOI 10.1056/NEJMc0901158
   Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Tein I, 1999, SEMIN PERINATOL, V23, P125, DOI 10.1016/S0146-0005(99)80046-9
   Toscano A, 2007, Acta Myol, V26, P105
   Tsujino S, 2000, NEUROL CLIN, V18, P125, DOI 10.1016/S0733-8619(05)70181-X
   van Adel Brian A, 2009, J Clin Neuromuscul Dis, V10, P97, DOI 10.1097/CND.0b013e3181903126
   Vissing J, 2005, ARCH NEUROL-CHICAGO, V62, P1440, DOI 10.1001/archneur.62.9.1440
   Vissing J, 2003, NEW ENGL J MED, V349, P2503, DOI 10.1056/NEJMoa031836
   Wiedemann FR, 2008, CLIN NEUROL NEUROSUR, V110, P859, DOI 10.1016/j.clineuro.2008.06.010
   Zeviani M, 1998, NEUROLOGY, V51, P1525, DOI 10.1212/WNL.51.6.1525-a
   Zhu XY, 2009, ACTA BIOCH BIOPH SIN, V41, P179, DOI 10.1093/abbs/gmn021
NR 53
TC 86
Z9 96
U1 0
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1528-4042
EI 1534-6293
J9 CURR NEUROL NEUROSCI
JI Curr. Neurol. Neurosci. Rep.
PD MAR
PY 2010
VL 10
IS 2
BP 118
EP 126
DI 10.1007/s11910-010-0096-4
PG 9
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 571WH
UT WOS:000275786100006
PM 20425236
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Lee, SJ
   Na, JH
   Han, J
   Lee, YM
AF Lee, Sang-Jun
   Na, Ji-Hoon
   Han, Jinu
   Lee, Young-Mock
TI Ophthalmoplegia in Mitochondrial Disease
SO YONSEI MEDICAL JOURNAL
LA English
DT Article
DE Mitochondrial diseases; Kearns-Sayre syndrome; ophthalmoplegia; chronic
   progressive external ophthalmoplegia
ID KEARNS-SAYRE-SYNDROME; PEDIATRIC-PATIENTS; CLINICAL SPECTRUM; DISORDERS;
   CHILDHOOD; CHILDREN; MANIFESTATIONS; ADULTS
AB Purpose: To evaluate the classification, diagnosis, and natural course of ophthalmoplegia associated with mitochondrial disease.
   Materials and Methods: Among 372 patients with mitochondria' disease who visited our hospital between Janu-ary 2006 and January 2016, 21 patients with ophthalmoplegia were retrospectively identified. Inclusion criteria included onset before 20 years of age, pigmentary retinopathy, and cardiac involvement. The 16 patients who were finally included in the study were divided into three groups according to disease type: Kearns-Sayre syndrome (KSS), KSS-like, and chronic progressive external oplithalmoplegia (CPEO).
   Results: The prevalences of clinical findings were as Ibllows: ptosis and retinopathy, both over 80%; myopathy, including extraocular muscles, 75%; lactic acidosis, 71%; and elevated levels of serum creatine kinase, 47%. Half of the patients had normal mag-netic resonance imaging findings. A biochemical enzyme assay revealed mitochondria' respiratory chain complex I defect as the most common (50%). The prevalence of abnormal muscle findings in light or electron microscopic examinations was 50% each, while that of large-scale mitochondria' DNA (mtDNA) deletions in a gene study was 25%. We compared the KSS and KSS-like groups with the CPEO patient group, which showed pigmentary retinopathy (p<0.001), cardiac conduction disease (p=0.013), and large-scale mtDNA deletions (p=0.038). KSS and KSS-like groups also had gastrointestinal tract disorders such as abnormal gastrointestinal motility (p=0.013) unlike the CPEO group.
   Conclusion: Patients with KSS had gastrointestinal symptoms, which may indicate another aspect of systemic involvement. The presence of large-scale mtDNA deletions was an objective diagnostic factor for KSS and a gene study may be helpful for evaluating patients with KSS.
C1 [Lee, Sang-Jun; Na, Ji-Hoon; Lee, Young-Mock] Yonsei Univ, Dept Pediat, Gangnam Severance Hosp, Severance Childrens Hosp,Coll Med, Seoul, South Korea.
   [Han, Jinu] Yonsei Univ, Dept Ophthalmol, Inst Vis Res, Gangnam Severance Hosp,Coll Med, Seoul, South Korea.
   [Lee, Young-Mock] Yonsei Univ, Epilepsy Res Inst, Coll Med, Seoul, South Korea.
C3 Yonsei University; Yonsei University Health System; Yonsei University;
   Yonsei University Health System; Yonsei University; Yonsei University
   Health System
RP Lee, YM (corresponding author), Yonsei Univ, Dept Pediat, Coll Med, 211 Eonju Ro, Seoul 06273, South Korea.
EM ymleemd@yuhs.ac
RI Lee, Jun Young/CAI-2335-2022; Lee, Sang-Jun/A-3892-2015; Han,
   Jinu/AAQ-3059-2021
OI LEE, YOUNG-MOCK/0000-0002-5838-249X; Na, Ji-Hoon/0000-0002-3051-2010;
   Han, Jinu/0000-0002-8607-6625
FU Korea Health Technology R&D Project through the Korea Health Industry
   Development Institute (KHIDI) - Ministry of Health& Welfare, Republic of
   Korea [HI16C0673]
FX This research was supported by a grant from the Korea Health Technology
   R&D Project through the Korea Health Industry Development Institute
   (KHIDI), funded by the Ministry of Health& Welfare, Republic of Korea
   (grant number: HI16C0673).
CR Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Chawla S, 2008, PEDIATR CARDIOL, V29, P659, DOI 10.1007/s00246-007-9040-z
   Choi HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17256-7
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Eom S, 2017, PEDIATR NEUROL, V71, P43, DOI 10.1016/j.pediatrneurol.2017.01.019
   Eom S, 2017, PEDIATR NEUROL, V66, P82, DOI 10.1016/j.pediatrneurol.2016.10.006
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   Finsterer J, 2006, NETH J MED, V64, P61
   García-Cazorla A, 2005, PEDIATRICS, V116, P1170, DOI 10.1542/peds.2004-2407
   Grönlund MA, 2010, BRIT J OPHTHALMOL, V94, P121, DOI 10.1136/bjo.2008.154187
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   Han J, 2015, BRIT J OPHTHALMOL, V99, P528, DOI 10.1136/bjophthalmol-2014-305704
   Heidenreich JO, 2006, AM J ROENTGENOL, V187, P820, DOI 10.2214/AJR.05.0180
   Joyce NC, 2012, PHYS MED REH CLIN N, V23, P609, DOI 10.1016/j.pmr.2012.06.006
   Kisler JE, 2010, DEV MED CHILD NEUROL, V52, P422, DOI 10.1111/j.1469-8749.2009.03605.x
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Mkaouar-Rebai E, 2010, MITOCHONDRION, V10, P449, DOI 10.1016/j.mito.2010.04.003
   Munnich A, 1996, J INHERIT METAB DIS, V19, P521, DOI 10.1007/BF01799112
   Park SB, 2004, YONSEI MED J, V45, P727, DOI 10.3349/ymj.2004.45.4.727
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Sharma A.K., 2016, BMJ CASE REP, V2016
   Skladal D, 2003, CLIN PEDIATR, V42, P703, DOI 10.1177/000992280304200806
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Young TJ, 2005, PACE, V28, P454, DOI 10.1111/j.1540-8159.2005.40049.x
NR 26
TC 13
Z9 14
U1 0
U2 3
PU YONSEI UNIV COLL MEDICINE
PI SEOUL
PA 50-1 YONSEI-RO, SEODAEMUN-GU, SEOUL 120-752, SOUTH KOREA
SN 0513-5796
EI 1976-2437
J9 YONSEI MED J
JI Yonsei Med. J.
PD DEC
PY 2018
VL 59
IS 10
BP 1190
EP 1196
DI 10.3349/ymj.2018.59.10.1190
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA HA6FD
UT WOS:000450374400007
PM 30450853
OA gold, Green Published, Green Submitted
DA 2024-11-01
ER

PT J
AU Vecoli, C
   Borghini, A
   Pulignani, S
   Mercuri, A
   Turchi, S
   Carpeggiani, C
   Picano, E
   Andreassi, MG
AF Vecoli, Cecilia
   Borghini, Andrea
   Pulignani, Silvia
   Mercuri, Antonella
   Turchi, Stefano
   Carpeggiani, Clara
   Picano, Eugenio
   Andreassi, Maria Grazia
TI Prognostic value of mitochondrial DNA<SUP>4977</SUP> deletion and
   mitochondrial DNA copy number in patients with stable coronary artery
   disease
SO ATHEROSCLEROSIS
LA English
DT Article
DE Major adverse cardiac events; mtDNA(4977) common deletion; Mitochondrial
   DNA copy number; Coronary artery disease
ID 4977 BP DELETION; BLOOD-CELLS; DAMAGE; ATHEROSCLEROSIS; ASSOCIATION;
   DYSFUNCTION; MUSCLE; HEART; MUTATIONS; RISK
AB Background and aims: Mitochondrial DNA copy number (mtDNA-CN) depletion has been recently associated with an increased cardiovascular risk. However, the integrity of mtDNA is another key aspect of the energy metabolism and mitochondrial function. We investigated the prognostic role of peripheral blood common mitochondrial deletion (mtDNA(4977)) and mtDNA-CN on long-term major adverse cardiac events (MACEs) and all-cause mortality in a cohort of patients with coronary artery disease (CAD).
   Methods: Within the Italian GENOCOR (Genetic Mapping for Assessment of Cardiovascular Risk) cohort, we studied 515 patients (450 males, 65 +/- 8 years) with known or suspected stable CAD. mtDNA(4977) deletion and mtDNA-CN were assessed in peripheral blood using qRT-PCR.
   Results: During a mean follow-up of 4.5 +/- 1.1 years, 78 (15%) patients had MACEs (15 cardiac deaths, 17 nonfatal myocardial infarction and 46 coronary revascularizations) and 28 patients died for non-cardiac causes. Patients with high levels of mtDNA(4977) deletion (>75th) had increased risk of MACEs (log rank = 7.2, p = 0.007) and all-cause mortality (log rank = 5.7, p = 0.01) compared with patients with low mtDNA(4977) deletion (>75th). Multivariate Cox regression analysis showed that log mtDNA(4977) was a significant predictor of MACEs (HR = 2.17; 95% CI, 1.31-3.59; p = 0.003) and all-cause mortality (HR = 2.03; 95% CI: 1.13-3.65, p = 0.02). Log mtDNA-CN was not significantly associated with MACEs or all-cause mortality. However, patients with high mtDNA(4977) deletion (>75th) and low mtDNA-CN (<25th) had significantly increased risk for MACEs (HR: 3.73; 95% CI: 1.79-7.79; p = 0.0005).
   Conclusions: Mitochondria DNA damage was associated with an increased risk of MACEs and all-cause mortality in patients with stable CAD, confirming the critical role of mitochondrial dysfunction in atherosclerosis. (c) 2018 Elsevier B.V. All rights reserved.
C1 [Vecoli, Cecilia; Borghini, Andrea; Pulignani, Silvia; Mercuri, Antonella; Turchi, Stefano; Carpeggiani, Clara; Picano, Eugenio; Andreassi, Maria Grazia] CNR, Inst Clin Physiol, Via Moruzzi 1, I-56124 Pisa, Italy.
C3 Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica
   (IFC-CNR)
RP Vecoli, C; Andreassi, MG (corresponding author), CNR, Inst Clin Physiol, Via Moruzzi 1, I-56124 Pisa, Italy.
EM vecoli@ifc.cnr.it; andreassi@ifc.cnr.it
RI Picano, Eugenio/JCR-0697-2023; Vecoli, Cecilia/K-8613-2016
OI Andreassi, Maria Grazia/0000-0002-2163-0816; Pulignani,
   Silvia/0000-0003-2097-3160; Borghini, Andrea/0000-0003-1061-8309;
   Vecoli, Cecilia/0000-0002-5921-3604
FU National Research Council (CNR) grant, "Progetto di Interesse Strategico
   Invecchiamento (PNR-CNR Aging Program)"
FX This research was partially funded by National Research Council (CNR)
   grant, "Progetto di Interesse Strategico Invecchiamento (PNR-CNR Aging
   Program)".
CR Andreassi MG, 2003, MUTAT RES-REV MUTAT, V543, P67, DOI 10.1016/S1383-5742(02)00089-3
   Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683
   Ashar FN, 2015, J MOL MED, V93, P177, DOI 10.1007/s00109-014-1233-3
   Ballinger SW, 2002, CIRCULATION, V106, P544, DOI 10.1161/01.CIR.0000023921.93743.89
   Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960
   Bayeva M, 2013, J AM COLL CARDIOL, V61, P599, DOI 10.1016/j.jacc.2012.08.1021
   Baykara O, 2016, CELL MOL BIOL, V62, P109, DOI 10.14715/cmb/2016.62.12.19
   Bogliolo M, 1999, MUTAGENESIS, V14, P77, DOI 10.1093/mutage/14.1.77
   Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003
   Cifkova R, 2003, J Hypertens, V21, P1779
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812
   Dai DF, 2012, CIRC RES, V110, P1109, DOI 10.1161/CIRCRESAHA.111.246140
   Finsterer J, 2014, INT J CARDIOL, V177, P754, DOI 10.1016/j.ijcard.2014.11.014
   Gavin JR, 1999, DIABETES CARE, V22, pS5
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   He YH, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.015
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Huang J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003323
   Knez J, 2016, INT J CARDIOL, V214, P180, DOI 10.1016/j.ijcard.2016.03.090
   Knez J, 2016, AM J EPIDEMIOL, V183, P138, DOI 10.1093/aje/kwv175
   Kuznetsova T, 2017, ADV EXP MED BIOL, V982, P347, DOI 10.1007/978-3-319-55330-6_19
   Lee SR, 2017, FRONT BIOSCI-LANDMRK, V22, P1177, DOI 10.2741/4541
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Mercer JR, 2012, FREE RADICAL BIO MED, V52, P841, DOI 10.1016/j.freeradbiomed.2011.11.026
   Mercer JR, 2010, CIRC RES, V107, P1021, DOI 10.1161/CIRCRESAHA.110.218966
   Sabatino L, 2013, ENVIRON MOL MUTAGEN, V54, P299, DOI 10.1002/em.21783
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Yu EPK, 2017, ARTERIOSCL THROM VAS, V37, P2322, DOI 10.1161/ATVBAHA.117.310042
   Yu EPK, 2016, FREE RADICAL BIO MED, V100, P223, DOI 10.1016/j.freeradbiomed.2016.06.011
   Zhang M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185688
   Zhang YY, 2017, EUR HEART J, V38, P3443, DOI 10.1093/eurheartj/ehx354
NR 37
TC 30
Z9 35
U1 0
U2 10
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2018
VL 276
BP 91
EP 97
DI 10.1016/j.atherosclerosis.2018.07.015
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA GR8UA
UT WOS:000443005800013
PM 30053637
DA 2024-11-01
ER

PT J
AU Kasiviswanathan, R
   Copeland, WC
AF Kasiviswanathan, Rajesh
   Copeland, William C.
TI Biochemical analysis of the G517V <i>POLG</i> variant reveals wild-type
   like activity
SO MITOCHONDRION
LA English
DT Article
DE POLG; DNA polymerase; Mitochondrial disease
ID DNA-POLYMERASE-GAMMA; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; ACCESSORY
   SUBUNIT; DISEASE MUTATIONS; REPLICATION; NEUROPATHY; DEPLETION; DEFECTS
AB The c.1550g --> t mutation in the POW gene causing the G517V substitution has been reported by many groups to be associated with a variety of mitochondrial diseases, including autosomal dominant and recessive forms of ataxia neuropathy, myopathy and microcephaly, progressive external ophthalmoplegia, diabetes, strokes, hypotonia, and epilepsy. However, the variable disease presentation and age of onset raises suspicion of its pathogenicity. Because of the varied reported associated symptoms and request from physicians to address the consequence of this mutation, we have carried out the biochemical analysis of the purified recombinant human DNA polymerase gamma protein harboring the G517V substitution. These analyses revealed that the G517V mutant enzyme retained 80-90% of wild-type DNA polymerase activity, in addition to its functional interaction with the p55 accessory subunit. DNA binding by the mutant was also only slightly lower than the wild-type enzyme. Our data suggest that the G517V mutation by itself in pol gamma most likely does not have a role in mitochondrial disorders. (C) 2011 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Kasiviswanathan, Rajesh; Copeland, William C.] Natl Inst Environm Hlth Sci, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS)
RP Copeland, WC (corresponding author), Natl Inst Environm Hlth Sci, Mol Genet Lab, NIH, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
RI Kasiviswanathan, Rajesh/D-2744-2012; Copeland, William/C-4242-2019
OI Copeland, William/0000-0002-0359-0953
FU NIH, National Institute of Environmental Health Sciences [ES 065078, ES
   065080]
FX We thank Dr. Tammy Collins and Maggie Humble for critically reading this
   manuscript. This research was supported by the Intramural Research
   Program of the NIH, National Institute of Environmental Health Sciences
   (ES 065078 and ES 065080).
CR Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Bolszak M, 2009, EPILEPSY RES, V85, P300, DOI 10.1016/j.eplepsyres.2009.03.004
   Burusnukul P, 2009, J CHILD NEUROL, V24, P482, DOI 10.1177/0883073808324539
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Hopkins SE, 2010, J CHILD NEUROL, V25, P752, DOI 10.1177/0883073809343313
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kasiviswanathan R, 2010, METHODS, V51, P379, DOI 10.1016/j.ymeth.2010.02.015
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Lucas P, 2004, MITOCHONDRION, V4, P13, DOI 10.1016/j.mito.2004.04.001
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Rivera H, 2010, MITOCHONDRION, V10, P362, DOI 10.1016/j.mito.2010.03.003
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Schulte C, 2009, NEUROLOGY, V73, P898, DOI 10.1212/WNL.0b013e3181b78488
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
NR 29
TC 21
Z9 21
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
J9 MITOCHONDRION
JI Mitochondrion
PD NOV
PY 2011
VL 11
IS 6
BP 929
EP 934
DI 10.1016/j.mito.2011.08.003
PG 6
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 846ZI
UT WOS:000296941300014
PM 21856450
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Pinti, MV
   Fink, GK
   Hathaway, QA
   Durr, AJ
   Kunovac, A
   Hollander, JM
AF Pinti, Mark V.
   Fink, Garrett K.
   Hathaway, Quincy A.
   Durr, Andrya J.
   Kunovac, Amina
   Hollander, John M.
TI Mitochondrial dysfunction in type 2 diabetes mellitus: an organ-based
   analysis
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Review
DE diabetes mellitus; mitochondria dysfunction
ID HEPATIC INSULIN-RESISTANCE; NONALCOHOLIC FATTY LIVER; SKELETAL-MUSCLE
   MITOCHONDRIA; ACTIVATED PROTEIN-KINASE; ELECTRON-TRANSPORT CHAIN;
   VISCERAL ADIPOSE-TISSUE; MEMBRANE MAM INTEGRITY; LONG NONCODING RNAS;
   GOTO-KAKIZAKI RATS; BETA-CELL FUNCTION
AB Type 2 diabetes mellitus (T2DM) is a systemic disease characterized by hyperglycemia, hyperlipidemia, and organismic insulin resistance. This pathological shift in both circulating fuel levels and energy substrate utilization by central and peripheral tissues contributes to mitochondrial dysfunction across organ systems. The mitochondrion lies at the intersection of critical cellular pathways such as energy substrate metabolism, reactive oxygen species (ROS) generation, and apoptosis. It is the disequilibrium of these processes in T2DM that results in downstream deficits in vital functions, including hepatocyte metabolism, cardiac output, skeletal muscle contraction, beta-cell insulin production, and neuronal health. Although mitochondria are known to be susceptible to a variety of genetic and environmental insults, the accumulation of mitochondrial DNA (mtDNA) mutations and mtDNA copy number depletion is helping to explain the prevalence of mitochondrial-related diseases such as T2DM. Recent work has uncovered novel mitochondrial biology implicated in disease progressions such as mtDNA heteroplasmy, noncoding RNA (ncRNA), epigenetic modification of the mitochondrial genome, and epitranscriptomic regulation of the mtDNA-encoded mitochondrial transcriptome. The goal of this review is to highlight mitochondrial dysfunction observed throughout major organ systems in the context of T2DM and to present new ideas for future research directions based on novel experimental and technological innovations in mitochondrial biology. Finally, the field of mitochondria-targeted therapeutics is discussed, with an emphasis on novel therapeutic strategies to restore mitochondrial homeostasis in the setting of T2DM.
C1 [Pinti, Mark V.; Fink, Garrett K.; Hathaway, Quincy A.; Durr, Andrya J.; Kunovac, Amina; Hollander, John M.] West Virginia Univ, Sch Med, Div Exercise Physiol, POB 9227 1 Med Ctr Dr, Morgantown, WV 26506 USA.
   [Pinti, Mark V.; Hathaway, Quincy A.; Durr, Andrya J.; Kunovac, Amina; Hollander, John M.] West Virginia Univ, Sch Med, Mitochondria Metab & Bioenerget Working Grp, Morgantown, WV USA.
   [Pinti, Mark V.] West Virginia Univ, Sch Pharm, Morgantown, WV USA.
   [Hathaway, Quincy A.] West Virginia Univ, Sch Med, Toxicol Working Grp, Morgantown, WV USA.
C3 West Virginia University; West Virginia University; West Virginia
   University; West Virginia University
RP Hollander, JM (corresponding author), West Virginia Univ, Sch Med, Div Exercise Physiol, POB 9227 1 Med Ctr Dr, Morgantown, WV 26506 USA.
EM jhollander@hsc.wvu.edu
RI Kunovac, Amina/AAN-6670-2021; Hathaway, Quincy/AAS-8891-2020
OI Kunovac, Amina/0000-0002-5107-3993; Hathaway,
   Quincy/0000-0001-8226-2319; Durr, Andrya/0000-0002-4672-6435
FU Community Foundation for the Ohio Valley Whipkey Trust [R01-HL-128485,
   AHA-17PRE33660333, DGE-1144676]
FX This work was supported by R01-HL-128485 (J. M. Hollander),
   AHA-17PRE33660333 (Q. A. Hathaway), DGE-1144676 (Q. A. Hathaway), and
   the Community Foundation for the Ohio Valley Whipkey Trust.
CR Akude E, 2011, DIABETES, V60, P288, DOI 10.2337/db10-0818
   Anderson EJ, 2011, AM J PHYSIOL-HEART C, V300, pH118, DOI 10.1152/ajpheart.00932.2010
   Anderson EJ, 2009, J AM COLL CARDIOL, V54, P1891, DOI 10.1016/j.jacc.2009.07.031
   Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048
   Andrzejewski S, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-12
   Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9
   Angermueller C, 2016, NAT METHODS, V13, P229, DOI 10.1038/nmeth.3728
   ANTONETTI DA, 1995, J CLIN INVEST, V95, P1383, DOI 10.1172/JCI117790
   Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735
   Asmann YW, 2006, DIABETES, V55, P3309, DOI 10.2337/db05-1230
   Bajpeyi S, 2011, J CLIN ENDOCR METAB, V96, P1160, DOI 10.1210/jc.2010-1621
   Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225
   Balducci S, 2006, J DIABETES COMPLICAT, V20, P216, DOI 10.1016/j.jdiacomp.2005.07.005
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Baseler WA, 2011, AM J PHYSIOL-REG I, V300, pR186, DOI 10.1152/ajpregu.00423.2010
   Beaudoin MS, 2014, J PHYSIOL-LONDON, V592, P2519, DOI 10.1113/jphysiol.2013.270538
   Bianchessi V, 2015, J MOL CELL CARDIOL, V81, P62, DOI 10.1016/j.yjmcc.2015.01.012
   Bloem CJ, 2008, J CLIN ENDOCR METAB, V93, P387, DOI 10.1210/jc.2007-1734
   Bonen A, 2004, FASEB J, V18, P1144, DOI 10.1096/fj.03-1065fje
   Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601
   Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481
   Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3
   Bravard A, 2011, DIABETES, V60, P258, DOI 10.2337/db10-0281
   Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620
   Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052
   Bugger H, 2009, DIABETES, V58, P1986, DOI 10.2337/db09-0259
   Carvalho C, 2015, BBA-MOL BASIS DIS, V1852, P1665, DOI 10.1016/j.bbadis.2015.05.001
   Cassidy S, 2016, DIABETOLOGIA, V59, P56, DOI 10.1007/s00125-015-3741-2
   Chattopadhyay M, 2015, MOL CELL BIOCHEM, V399, P95, DOI 10.1007/s11010-014-2236-7
   Chattopadhyay M, 2011, METABOLISM, V60, P1702, DOI 10.1016/j.metabol.2011.04.015
   Chavin KD, 1999, J BIOL CHEM, V274, P5692, DOI 10.1074/jbc.274.9.5692
   Cheng JT, 2006, DIABETES, V55, P819, DOI 10.2337/diabetes.55.03.06.db05-0934
   Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049
   Cho YE, 2013, AM J PHYSIOL-CELL PH, V305, pC1033, DOI 10.1152/ajpcell.00234.2013
   Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2
   Chowdhury SKR, 2012, BRAIN, V135, P1751, DOI 10.1093/brain/aws097
   Clark MB, 2015, NAT METHODS, V12, P339, DOI [10.1038/NMETH.3321, 10.1038/nmeth.3321]
   Clark SJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03149-4
   Cohen ND, 2008, DIABETES RES CLIN PR, V79, P405, DOI 10.1016/j.diabres.2007.09.020
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Covian R, 2014, BBA-BIOENERGETICS, V1837, P1913, DOI 10.1016/j.bbabio.2014.08.006
   Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4
   Crispim D, 2006, ANN HUM GENET, V70, P488, DOI 10.1111/j.1469-1809.2005.00249.x
   Croston TL, 2014, AM J PHYSIOL-HEART C, V307, pH54, DOI 10.1152/ajpheart.00845.2013
   Dabkowski ER, 2010, AM J PHYSIOL-HEART C, V299, pH529, DOI 10.1152/ajpheart.00267.2010
   Dahlman I, 2006, DIABETES, V55, P1792, DOI 10.2337/db05-1421
   Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732
   de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534
   De Feyter HM, 2008, EUR J ENDOCRINOL, V158, P643, DOI 10.1530/EJE-07-0756
   Dlasková A, 2010, BBA-BIOENERGETICS, V1797, P1327, DOI 10.1016/j.bbabio.2010.02.003
   Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108
   Dzitoyeva S, 2012, NEUROBIOL AGING, V33, P2881, DOI 10.1016/j.neurobiolaging.2012.02.006
   Edwards JL, 2010, DIABETOLOGIA, V53, P160, DOI 10.1007/s00125-009-1553-y
   Escribano-Lopez I, 2016, REDOX BIOL, V10, P200, DOI 10.1016/j.redox.2016.10.017
   Feder J, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-60
   Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008
   Fritz T, 2006, DIABETES-METAB RES, V22, P492, DOI 10.1002/dmrr.656
   Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202
   Gao CL, 2010, MOL CELL ENDOCRINOL, V320, P25, DOI 10.1016/j.mce.2010.01.039
   Ghosh S, 2014, MITOCHONDRION, V18, P58, DOI 10.1016/j.mito.2014.07.007
   Glancy B, 2017, CELL REP, V19, P487, DOI 10.1016/j.celrep.2017.03.063
   Glancy B, 2015, NATURE, V523, P617, DOI 10.1038/nature14614
   Glancy B, 2013, BIOCHEMISTRY-US, V52, P2793, DOI 10.1021/bi3015983
   GORDON ES, 1960, AM J CLIN NUTR, V8, P740, DOI 10.1093/ajcn/8.5.740
   Guo LJ, 2005, MITOCHONDRION, V5, P15, DOI 10.1016/j.mito.2004.09.001
   Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441
   Hey-Mogensen M, 2010, DIABETOLOGIA, V53, P1976, DOI 10.1007/s00125-010-1813-x
   Hinder LM, 2013, J ENDOCRINOL, V216, P1, DOI 10.1530/JOE-12-0356
   Hojlund K, 2003, J BIOL CHEM, V278, P10436, DOI 10.1074/jbc.M212881200
   Holmström MH, 2012, AM J PHYSIOL-ENDOC M, V302, pE731, DOI 10.1152/ajpendo.00159.2011
   Hu YJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0950-z
   Hwang JH, 2007, AM J PHYSIOL-ENDOC M, V293, pE1663, DOI 10.1152/ajpendo.00590.2006
   IDF, 2017, GLOB PICT DIAB FACT, V8th
   Imai Y, 2018, PHARMACOL RES PERSPE, V6, DOI 10.1002/prp2.393
   Jagannathan R, 2015, CIRC-CARDIOVASC GENE, V8, P785, DOI 10.1161/CIRCGENETICS.115.001067
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Kalichman MW, 1998, ACTA NEUROPATHOL, V95, P47, DOI 10.1007/s004010050764
   Kamalden TA, 2017, ANTIOXID REDOX SIGN, V27, P913, DOI 10.1089/ars.2016.6844
   Kanazawa A, 2002, AM J PHYSIOL-ENDOC M, V282, pE778, DOI 10.1152/ajpendo.00255.2001
   KELLEY DE, 1994, J CLIN INVEST, V94, P2349, DOI 10.1172/JCI117600
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Kizhakekuttu TJ, 2012, ARTERIOSCL THROM VAS, V32, P2531, DOI 10.1161/ATVBAHA.112.256024
   Koka S, 2014, AM J PHYSIOL-HEART C, V306, pH1558, DOI 10.1152/ajpheart.00865.2013
   Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004
   Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044
   Koska J, 2008, AM J CLIN NUTR, V87, P295, DOI 10.1093/ajcn/87.2.295
   Kotronen A, 2008, DIABETOLOGIA, V51, P130, DOI 10.1007/s00125-007-0867-x
   Kotronen A, 2008, GASTROENTEROLOGY, V135, P122, DOI 10.1053/j.gastro.2008.03.021
   Krebs M, 2005, DIABETES OBES METAB, V7, P621, DOI 10.1111/j.1463-1326.2004.00439.x
   KROTKIEWSKI M, 1985, DIABETOLOGIA, V28, P881, DOI 10.1007/BF00703130
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Laye MJ, 2009, J PHYSIOL-LONDON, V587, P3729, DOI 10.1113/jphysiol.2009.172601
   LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878
   Li XY, 2017, MOL CELL, V68, P993, DOI 10.1016/j.molcel.2017.10.019
   Liao WQ, 2008, TOHOKU J EXP MED, V215, P377, DOI 10.1620/tjem.215.377
   Lim JH, 2009, CELL SIGNAL, V21, P169, DOI 10.1016/j.cellsig.2008.10.004
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Lindström J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725
   Liou CW, 2007, J CLIN ENDOCR METAB, V92, P235, DOI 10.1210/jc.2006-0653
   Liou CW, 2012, DIABETES, V61, P2642, DOI 10.2337/db11-1369
   Little JP, 2011, J APPL PHYSIOL, V111, P1554, DOI 10.1152/japplphysiol.00921.2011
   Liu BJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23421
   Lokk K, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r54
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   Mariappan N, 2010, CARDIOVASC RES, V85, P473, DOI 10.1093/cvr/cvp305
   Masuoka HC, 2013, ANN NY ACAD SCI, V1281, P106, DOI 10.1111/nyas.12016
   Matilainen O, 2017, TRENDS CELL BIOL, V27, P453, DOI 10.1016/j.tcb.2017.02.004
   Mazumder PK, 2004, DIABETES, V53, P2366, DOI 10.2337/diabetes.53.9.2366
   Meex RCR, 2010, DIABETES, V59, P572, DOI 10.2337/db09-1322
   Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1
   Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285
   Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981
   Mohlke KL, 2005, HUM GENET, V118, P245, DOI 10.1007/s00439-005-0046-4
   Montaigne D, 2014, CIRCULATION, V130, P554, DOI 10.1161/CIRCULATIONAHA.113.008476
   Montgomery MK, 2015, ENDOCR CONNECT, V4, DOI 10.1530/EC-14-0092
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Moreira PI, 2003, DIABETES, V52, P1449, DOI 10.2337/diabetes.52.6.1449
   Moreira PI, 2005, EXP NEUROL, V196, P112, DOI 10.1016/j.expneurol.2005.07.012
   Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371
   Nakamura H, 2014, CIRC-HEART FAIL, V7, P383, DOI 10.1161/HHF.0000000000000001
   Neschen S, 2005, CELL METAB, V2, P55, DOI 10.1016/j.cmet.2005.06.006
   Nieuwoudt S, 2017, AM J PHYSIOL-ENDOC M, V313, pE314, DOI 10.1152/ajpendo.00407.2016
   Nile DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115433
   Nilsson E, 2014, DIABETES, V63, P2962, DOI 10.2337/db13-1459
   Noh JH, 2016, GENE DEV, V30, P1224, DOI 10.1101/gad.276022.115
   Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6
   Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607
   Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868
   Park KS, 2008, DIABETOLOGIA, V51, P602, DOI 10.1007/s00125-008-0933-z
   Patel KD, 2016, BBA-BIOENERGETICS, V1857, P1284, DOI 10.1016/j.bbabio.2016.02.014
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107
   Peila R, 2002, DIABETES, V51, P1256, DOI 10.2337/diabetes.51.4.1256
   Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012
   Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478
   Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603
   Phielix E, 2008, DIABETES, V57, P2943, DOI 10.2337/db08-0391
   Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581
   Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198
   Rackham O, 2011, RNA, V17, P2085, DOI 10.1261/rna.029405.111
   Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108
   Raza H, 2015, CELL PHYSIOL BIOCHEM, V35, P1241, DOI 10.1159/000373947
   Rector RS, 2010, J HEPATOL, V52, P727, DOI 10.1016/j.jhep.2009.11.030
   Rector RS, 2010, AM J PHYSIOL-ENDOC M, V298, pE1179, DOI 10.1152/ajpendo.00703.2009
   Rieusset J, 2016, DIABETOLOGIA, V59, P614, DOI 10.1007/s00125-015-3829-8
   Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8
   Ritov VB, 2010, AM J PHYSIOL-ENDOC M, V298, pE49, DOI 10.1152/ajpendo.00317.2009
   Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533
   Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190
   Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135
   Rovira-Llopis S, 2017, REDOX BIOL, V11, P637, DOI 10.1016/j.redox.2017.01.013
   Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105
   Safra M, 2017, NATURE, V551, P251, DOI 10.1038/nature24456
   Sakai K, 2003, BIOCHEM BIOPH RES CO, V300, P216, DOI 10.1016/S0006-291X(02)02832-2
   Saker PJ, 1997, DIABETIC MED, V14, P42, DOI 10.1002/(SICI)1096-9136(199701)14:1<42::AID-DIA295>3.0.CO;2-T
   Santos MS, 2001, DIABETES-METAB RES, V17, P223, DOI 10.1002/dmrr.200
   Santos RX, 2014, MOL CELL BIOCHEM, V394, P13, DOI 10.1007/s11010-014-2076-5
   Schmid AI, 2011, DIABETES CARE, V34, P448, DOI 10.2337/dc10-1076
   Schrauwen-Hinderling VB, 2007, DIABETOLOGIA, V50, P113, DOI 10.1007/s00125-006-0475-1
   Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506
   Shepherd DL, 2018, J MOL CELL CARDIOL, V119, P104, DOI 10.1016/j.yjmcc.2018.04.016
   Shepherd DL, 2017, J MOL CELL CARDIOL, V110, P15, DOI 10.1016/j.yjmcc.2017.06.012
   Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498
   Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108
   Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642
   Soejima A, 1996, J BIOL CHEM, V271, P26194, DOI 10.1074/jbc.271.42.26194
   Sone H, 2005, DIABETOLOGIA, V48, P58, DOI 10.1007/s00125-004-1605-2
   Sookoian S, 2010, HEPATOLOGY, V52, P1992, DOI 10.1002/hep.23927
   Sorrentino V, 2018, ANNU REV PHARMACOL, V58, P353, DOI 10.1146/annurev-pharmtox-010716-104908
   Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913
   Sun XY, 2016, FEBS LETT, V590, P3510, DOI 10.1002/1873-3468.12440
   Szabo L, 2016, NAT REV GENET, V17, P679, DOI 10.1038/nrg.2016.114
   Szendroedi J, 2009, HEPATOLOGY, V50, P1079, DOI 10.1002/hep.23093
   Tang DL, 2006, DIABETES RES CLIN PR, V73, P77, DOI 10.1016/j.diabres.2005.12.001
   Targher G, 2013, J CLIN ENDOCR METAB, V98, P483, DOI 10.1210/jc.2012-3093
   Tawata M, 1998, DIABETES, V47, P276, DOI 10.2337/diab.47.2.276
   Tawata M, 2000, DIABETES, V49, P1269, DOI 10.2337/diabetes.49.7.1269
   Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20
   Tocchetti CG, 2012, DIABETES, V61, P3094, DOI 10.2337/db12-0072
   Toledo FGS, 2007, DIABETES, V56, P2142, DOI 10.2337/db07-0141
   Tolman KG, 2007, DIABETES CARE, V30, P734, DOI 10.2337/dc06-1539
   Tubbs E, 2018, DIABETES, V67, P636, DOI 10.2337/db17-0316
   Tubbs E, 2014, DIABETES, V63, P3279, DOI 10.2337/db13-1751
   Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596
   van der Wijst MGP, 2015, TRENDS GENET, V31, P353, DOI 10.1016/j.tig.2015.03.009
   van Tienen FHJ, 2012, J CLIN ENDOCR METAB, V97, P3261, DOI 10.1210/jc.2011-3454
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Vial G, 2010, ACTA BIOCHIM POL, V57, P389
   Vianna CR, 2006, CELL METAB, V4, P453, DOI 10.1016/j.cmet.2006.11.003
   Vincent AM, 2010, ACTA NEUROPATHOL, V120, P477, DOI 10.1007/s00401-010-0697-7
   Volkmar M, 2012, EMBO J, V31, P1405, DOI 10.1038/emboj.2011.503
   Wang CH, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0375-3
   Wang D, 2001, EXP CLIN ENDOCR DIAB, V109, P361, DOI 10.1055/s-2001-17407
   Wang QL, 2017, DIABETES, V66, P193, DOI 10.2337/db16-0915
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Ward MS, 2017, SCI REP-UK, V7, DOI [10.1038/s41598-017-10209-0, 10.1038/s41598-017-15589-x]
   Williams M, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00211
   Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047
   Xiao L, 2017, REDOX BIOL, V11, P297, DOI 10.1016/j.redox.2016.12.022
   Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004
   Yang SQ, 2000, ARCH BIOCHEM BIOPHYS, V378, P259, DOI 10.1006/abbi.2000.1829
   Ye G, 2004, DIABETES, V53, P1336, DOI 10.2337/diabetes.53.5.1336
   Ye Z, 2013, DIABETOLOGIA, V56, P1907, DOI 10.1007/s00125-013-2945-6
   Yokota T, 2009, AM J PHYSIOL-HEART C, V297, pH1069, DOI 10.1152/ajpheart.00267.2009
   Yu P, 2004, CHINESE MED J-PEKING, V117, P985
   Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103
   Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104
   Zhong S, 2000, J CLIN PATHOL, V53, P466, DOI 10.1136/jcp.53.6.466
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505
   Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433
   Zoppini G, 2006, NUTR METAB CARDIOVAS, V16, P543, DOI 10.1016/j.numecd.2005.09.004
NR 213
TC 242
Z9 256
U1 2
U2 99
PU AMER PHYSIOLOGICAL SOC
PI Rockville
PA 6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD FEB
PY 2019
VL 316
IS 2
BP E268
EP E285
DI 10.1152/ajpendo.00314.2018
PG 18
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA HK7RQ
UT WOS:000458187400013
PM 30601700
OA Green Published, Bronze
HC Y
HP N
DA 2024-11-01
ER

PT J
AU Turner, CJ
   Granycome, C
   Hurst, R
   Pohler, E
   Juhola, MK
   Juhola, MI
   Jacobs, HT
   Sutherland, L
   Holt, IJ
AF Turner, CJ
   Granycome, C
   Hurst, R
   Pohler, E
   Juhola, MK
   Juhola, MI
   Jacobs, HT
   Sutherland, L
   Holt, IJ
TI Systematic segregation to mutant mitochondrial DNA and accompanying loss
   of mitochondrial DNA in human NT2 teratocarcinoma cybrids
SO GENETICS
LA English
DT Article
ID PROTEIN-SYNTHESIS; MTDNA MUTATION; POINT MUTATION; CELL-LINES;
   EXPRESSION; SELECTION; MYOPATHY; DEFECTS; GENE; ORGANIZATION
AB In this study a well-characterized pathological mutation at nucleotide position 3243 of human mitochondrial DNA was introduced into human rho(0) teratocarcinoma (NT2) cells. In cloned and mixed populations of NT2 cells heteroplasmic for the mutation, mitotic segregation toward increasing levels of mutant mitochondrial DNA always occurred. Rapid segregation was frequently followed by complete loss of mitochondrial DNA. These findings support the idea that pathological mitochondrial DNA mutations are particularly deleterious in specific cell types, which can explain some of the tissue-specific aspects of mitochondrial DNA diseases. Moreover, these findings suggest that mitochondrial DNA depletion may be an important and widespread feature of mitochondrial DNA disease.
C1 MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England.
   Ninewells Med Sch, Dept Mol & Cellular Pathol, Dundee DD1 9SY, Scotland.
   Univ Tampere, Tampere Univ Hosp, FI-33014 Tampere, Finland.
   Univ Tampere, Inst Med Technol, FI-33014 Tampere, Finland.
C3 UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC
   Human Nutrition Research; University of Dundee; Tampere University;
   Tampere University Hospital; Tampere University
RP MRC, Dunn Human Nutr Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.
EM holt@mrc-dunn.cam.ac.uk
RI Jacobs, Howard/G-2434-2011; holt, ian/AFT-2565-2022
OI Jacobs, Howard/0000-0003-1895-6003; holt, ian/0000-0001-5468-0193;
   Hurst, Rachel/0000-0001-8066-324X
FU Medical Research Council [MC_U105663140] Funding Source: Medline;
   Wellcome Trust Funding Source: Medline; MRC [MC_U105663140] Funding
   Source: UKRI
CR Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   BOURGERON T, 1993, J BIOL CHEM, V268, P19369
   Chadalavada Rajendrakumar S. V., 2005, Functional & Integrative Genomics, V5, P59, DOI 10.1007/s10142-005-0132-7
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   CHRISTIANSON TW, 1988, MOL CELL BIOL, V8, P4502, DOI 10.1128/MCB.8.10.4502
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   El Meziane A, 1998, NAT GENET, V18, P350
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HAYASHI J, 1992, J INHERIT METAB DIS, V15, P448
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 1997, HUM MOL GENET, V6, P1251, DOI 10.1093/hmg/6.8.1251
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9
   Jacobs HT, 2000, BIOESSAYS, V22, P564, DOI 10.1002/(SICI)1521-1878(200006)22:6<564::AID-BIES9>3.0.CO;2-4
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Lehtinen SK, 2000, GENETICS, V154, P363
   Loktionov A, 2001, CARCINOGENESIS, V22, P1053, DOI 10.1093/carcin/22.7.1053
   Lynn S, 2003, DIABETOLOGIA, V46, P296, DOI 10.1007/s00125-002-1018-z
   MARIOTTI C, 1994, J CLIN INVEST, V93, P1102, DOI 10.1172/JCI117061
   MATTHEWS PM, 1995, HUM GENET, V96, P261
   POULTON J, 1995, DIABETOLOGIA, V38, P868, DOI 10.1007/s001250050366
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Sambrook J., 1990, MOL CLONING LAB MANU
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SHOUBRIDGE EA, 1995, BIOCHEM BIOPH RES CO, V213, P189, DOI 10.1006/bbrc.1995.2115
   Spelbrink JN, 1997, CURR GENET, V32, P115, DOI 10.1007/s002940050255
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Vergani L, 1999, HUM MOL GENET, V8, P1751, DOI 10.1093/hmg/8.9.1751
   Weber K, 1997, AM J HUM GENET, V60, P373
   Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
   YOUNKIN DP, 1993, P NATL ACAD SCI USA, V90, P2174, DOI 10.1073/pnas.90.6.2174
NR 40
TC 24
Z9 29
U1 0
U2 5
PU GENETICS SOCIETY AMERICA
PI BETHESDA
PA 9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA
SN 0016-6731
EI 1943-2631
J9 GENETICS
JI Genetics
PD AUG
PY 2005
VL 170
IS 4
BP 1879
EP 1885
DI 10.1534/genetics.105.043653
PG 7
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 966PO
UT WOS:000232033300037
PM 15944344
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Steele, H
   Gomez-Duran, A
   Pyle, A
   Hopton, S
   Newman, J
   Stefanetti, RJ
   Charman, SJ
   Parikh, JD
   He, LP
   Viscomi, C
   Jakovljevic, DG
   Hollingsworth, KG
   Robinson, AJ
   Taylor, RW
   Bottolo, L
   Horvath, R
   Chinnery, PF
AF Steele, Hannah
   Gomez-Duran, Aurora
   Pyle, Angela
   Hopton, Sila
   Newman, Jane
   Stefanetti, Renae J.
   Charman, Sarah J.
   Parikh, Jehill D.
   He, Langping
   Viscomi, Carlo
   Jakovljevic, Djordje G.
   Hollingsworth, Kieren G.
   Robinson, Alan J.
   Taylor, Robert W.
   Bottolo, Leonardo
   Horvath, Rita
   Chinnery, Patrick F.
TI Metabolic effects of bezafibrate in mitochondrial disease
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE bezafibrate; metabolomics; mitochondrial disorder; mitochondrial DNA;
   mitochondrial encephalomyopat
ID RESPIRATORY-CHAIN COMPLEX; FALSE DISCOVERY RATE; GLUTAMINE-METABOLISM;
   MOUSE MODEL; MYOPATHY; PROGRESSION; ACTIVATION; DEFICIENCY; EXPRESSION;
   PACKAGE
AB Mitochondrial disorders affect 1/5,000 and have no cure. Inducing mitochondrial biogenesis with bezafibrate improves mitochondrial function in animal models, but there are no comparable human studies. We performed an open-label observational experimental medicine study of six patients with mitochondrial myopathy caused by the m.3243A>G MTTL1 mutation. Our primary aim was to determine the effects of bezafibrate on mitochondrial metabolism, whilst providing preliminary evidence of safety and efficacy using biomarkers. The participants received 600-1,200 mg bezafibrate daily for 12 weeks. There were no clinically significant adverse events, and liver function was not affected. We detected a reduction in the number of complex IV-immunodeficient muscle fibres and improved cardiac function. However, this was accompanied by an increase in serum biomarkers of mitochondrial disease, including fibroblast growth factor 21 (FGF-21), growth and differentiation factor 15 (GDF-15), plus dysregulation of fatty acid and amino acid metabolism. Thus, although potentially beneficial in short term, inducing mitochondrial biogenesis with bezafibrate altered the metabolomic signature of mitochondrial disease, raising concerns about long-term sequelae.
C1 [Steele, Hannah; Pyle, Angela] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England.
   [Gomez-Duran, Aurora; Horvath, Rita; Chinnery, Patrick F.] Univ Cambridge, Dept Clin Neurosci, Cambridge Biomed Campus, Cambridge, England.
   [Gomez-Duran, Aurora; Viscomi, Carlo; Robinson, Alan J.; Chinnery, Patrick F.] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge, England.
   [Pyle, Angela; Hopton, Sila; Newman, Jane; He, Langping; Taylor, Robert W.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Hopton, Sila; He, Langping; Taylor, Robert W.] Newcastle Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Serv Rare Mitochondrial Di, Newcastle Upon Tyne, Tyne & Wear, England.
   [Newman, Jane; Stefanetti, Renae J.; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.
   [Charman, Sarah J.; Parikh, Jehill D.; Jakovljevic, Djordje G.; Hollingsworth, Kieren G.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England.
   [Bottolo, Leonardo] Univ Cambridge, Dept Med Genet, Cambridge, England.
   [Bottolo, Leonardo] Alan Turing Inst, London, England.
   [Bottolo, Leonardo] Univ Cambridge, MRC Biostat Unit, Cambridge, England.
C3 Newcastle University - UK; University of Cambridge; University of
   Cambridge; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS
   Foundation Trust; Newcastle University - UK; Newcastle University - UK;
   University of Cambridge; University of Cambridge; MRC Biostatistics Unit
RP Chinnery, PF (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge Biomed Campus, Cambridge, England.; Chinnery, PF (corresponding author), Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge, England.
EM pfc25@cam.ac.uk
RI Horvath, Rita/AAY-7042-2020; Gomez-Duran, Aurora/ABE-1973-2021; viscomi,
   Carlo/R-1940-2016; Gomez-Duran, Aurora/T-6392-2017
OI Viscomi, Carlo/0000-0001-6050-0566; Stefanetti,
   Renae/0000-0001-6402-6435; Jakovljevic, Professor
   Djordje/0000-0003-2686-6542; Chinnery, Patrick/0000-0002-7065-6617;
   Gomez-Duran, Aurora/0000-0002-5895-6860; Charman,
   Sarah/0000-0002-3029-7672
FU Medical Research Council Mitochondrial Biology Unit [MC_UU_00015/9,
   212219/Z/18/Z]; Evelyn Trust; National Institute for Health Research
   (NIHR) Biomedical Research Centre based at Cambridge University
   Hospitals NHS Foundation Trust; University of Cambridge; Wellcome Centre
   for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council
   (MRC) International Centre for Genomic Medicine in Neuromuscular
   Disease; Mitochondrial Disease Patient Cohort (UK) [G0800674]; Lily
   Foundation; UK National Institute for Health Research Biomedical
   Research Centre in Age and Age-Related Diseases award; MRC/EPSRC
   Molecular Pathology Node; UK NHS Highly Specialised Service for Rare
   Mitochondrial Disorders of Adults and Children; Medical Research Council
   (UK) [MR/N025431/1, 109915/Z/15/Z]; Newton Fund (UK/Turkey)
   [MR/N027302/1]; European Research Council [309548]; Wellcome Trust
   Pathfinder Scheme [201064/Z/16/Z]; Alan Turing Institute under the
   Engineering and Physical Sciences Research Council [EP/N510129/1]; MRC
   [G1100160, G0800674, MC_UU_00015/9, MC_U105674181] Funding Source: UKRI
FX We are grateful to Michael Hanna (UCL Institute of Neurology) and
   Grainne Gorman (Newcastle University) for their role in the trial
   oversight committees, and for the assistance of Andrew Blamire, Alex
   Bright, Jennifer Duff, Gavin Falkous, Lesley Hall, Cecilia
   Jimenez-Moreno, Robert McFarland, Yi Ng, Robert Pitceathly, Alan
   Robinson, Michael Trenell and Patrick Yu-Wai-Man. We would like to
   acknowledge the Wellcome Centre for Mitochondrial Research Patient
   Cohort: A Natural History Study and Patient Registry (Research Ethics
   Committee Reference 13/NE/0326) for facilitating recruitment. PFC is a
   Wellcome Trust Principal Research Fellow (212219/Z/18/Z), and a UK NIHR
   Senior Investigator, who receives support from the Medical Research
   Council Mitochondrial Biology Unit (MC_UU_00015/9), the Evelyn Trust and
   the National Institute for Health Research (NIHR) Biomedical Research
   Centre based at Cambridge University Hospitals NHS Foundation Trust and
   the University of Cambridge. RWT is supported by the Wellcome Centre for
   Mitochondrial Research (203105/Z/16/Z), the Medical Research Council
   (MRC) International Centre for Genomic Medicine in Neuromuscular
   Disease, the Mitochondrial Disease Patient Cohort (UK) (G0800674), the
   Lily Foundation, the UK National Institute for Health Research
   Biomedical Research Centre in Age and Age-Related Diseases award to the
   Newcastle upon Tyne Hospitals NHS Foundation Trust, the MRC/EPSRC
   Molecular Pathology Node and the UK NHS Highly Specialised Service for
   Rare Mitochondrial Disorders of Adults and Children. RH is a Wellcome
   Senior Investigator (109915/Z/15/Z) and supported by the Medical
   Research Council (UK) (MR/N025431/1), the Newton Fund (UK/Turkey,
   MR/N027302/1), the European Research Council (309548) and the Wellcome
   Trust Pathfinder Scheme (201064/Z/16/Z). LB is supported by The Alan
   Turing Institute under the Engineering and Physical Sciences Research
   Council grant EP/N510129/1. The views expressed are those of the
   author(s) and not necessarily those of the NHS, the NIHR or the
   Department of Health.
CR Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Alifano P, 1996, MICROBIOL REV, V60, P44, DOI 10.1128/MMBR.60.1.44-69.1996
   [Anonymous], 1997, PRACTICAL DATA ANAL
   Bénit P, 2017, EBIOMEDICINE, V17, P75, DOI 10.1016/j.ebiom.2017.02.013
   Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bonnefont JP, 2010, CLIN PHARMACOL THER, V88, P101, DOI 10.1038/clpt.2010.55
   Buzkova J, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809091
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Charman SJ, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0428-7
   Chen QY, 2018, CELL METAB, V27, P1007, DOI 10.1016/j.cmet.2018.03.002
   Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310
   Crooks DR, 2014, HUM MOL GENET, V23, P24, DOI 10.1093/hmg/ddt393
   de Laat P, 2016, BBA CLIN, V6, P19, DOI 10.1016/j.bbacli.2016.04.007
   Dillon LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044335
   DUBOIS D, 1989, NUTRITION, V5, P303
   Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97
   Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI 10.1093/nar/gkx1132
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Hayashi G, 2017, HUM MOL GENET, V26, P2864, DOI 10.1093/hmg/ddx167
   Hofer A, 2014, HUM MOL GENET, V23, P2400, DOI 10.1093/hmg/ddt631
   Hollander M, 1973, NONPARAMETRIC STAT M
   Hollingsworth KG, 2012, NEUROMUSCULAR DISORD, V22, P592, DOI 10.1016/j.nmd.2012.03.001
   Hothorn T, 2008, J STAT SOFTW, V28, P1
   Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003
   Jones TW, 2015, BRIT J ANAESTH, V115, P386, DOI 10.1093/bja/aeu560
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Krumsiek J, 2015, METABOLOMICS, V11, P1815, DOI 10.1007/s11306-015-0829-0
   Legault JT, 2015, CELL REP, V13, P981, DOI 10.1016/j.celrep.2015.09.054
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Mao YX, 2004, EMBO J, V23, P2963, DOI 10.1038/sj.emboj.7600327
   Mullen AR, 2014, CELL REP, V7, P1679, DOI 10.1016/j.celrep.2014.04.037
   Nightingale H, 2016, BRAIN, V139, P1633, DOI 10.1093/brain/aww081
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197
   Peralta S, 2016, HUM MOL GENET, V25, P3178, DOI 10.1093/hmg/ddw167
   Pyle A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005040
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rocha MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15037
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Shah JS, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1547-6
   Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982
   Steele HE, 2017, BRAIN, V140, P2530, DOI 10.1093/brain/awx168
   Sullivan LB, 2018, NAT CELL BIOL, V20, P782, DOI 10.1038/s41556-018-0125-0
   Tan HWS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00369-y
   van Hees VT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142533
   van Hees VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061691
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Vo TD, 2007, MOL GENET METAB, V91, P15, DOI 10.1016/j.ymgme.2007.01.012
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
NR 53
TC 47
Z9 47
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD MAR 6
PY 2020
VL 12
IS 3
AR e11589
DI 10.15252/emmm.201911589
EA FEB 2020
PG 12
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA KT8GY
UT WOS:000516812500001
PM 32107855
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Cicero, AFG
   Fogacci, F
   Bove, M
   Borghi, C
AF Cicero, Arrigo F. G.
   Fogacci, Federica
   Bove, Marilisa
   Borghi, Claudio
TI Successful treatment of a patient with mitochondrial myopathy with
   alirocumab
SO JOURNAL OF CLINICAL LIPIDOLOGY
LA English
DT Article
DE Mitochondrial myopathy; Hypercholesterolemia; PCSK9 inhibitor;
   Alirocumab
ID SKELETAL-MUSCLE
AB A 48-year-old man presented to our lipid clinic with statin intolerance and elevated serum creatine kinase levels, being affected by mitochondrial myopathy because of heteroplasmic mitochondrial DNA missense mutation in MTC01 gene (m.7671T>A). He had just been treated with a coronary artery bypass 4 years before because of acute coronary syndrome, and he had consistently high levels of both low-density lipoprotein cholesterol and triglycerides. Dyslipidemia was successfully treated using 75 mg of alirocumab subcutaneously every 2 weeks, 10 mg of ezetimibe daily, 2 g of marine omega-3 fatty acids daily, and 145 mg of micronized fenofibrate every 2 days. Although muscle weakness persisted, myalgia did not reoccur and serum creatine kinase levels remained almost stable over the time. (C) 2020 National Lipid Association. All rights reserved.
C1 [Cicero, Arrigo F. G.; Fogacci, Federica; Bove, Marilisa; Borghi, Claudio] Univ Bologna, Med & Surg Sci Dept, Bologna, Italy.
C3 University of Bologna
RP Cicero, AFG (corresponding author), St Orsola Malpighi Univ Hosp, Med & Surg Sci Dept, Via Albertoni 15, I-40138 Bologna, Italy.
EM arrigo.cicero@unibo.it
RI Fogacci, Federica/R-5931-2016
OI Fogacci, Federica/0000-0001-7853-0042; Cicero, Arrigo Francesco
   Giuseppe/0000-0002-4367-3884
CR DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Hanna MG, 1999, CELL MOL LIFE SCI, V55, P691, DOI 10.1007/s000180050327
   INO H, 1991, LANCET, V337, P234, DOI 10.1016/0140-6736(91)92196-9
   Parker BA, 2012, AM J CARDIOL, V109, P282, DOI [10.1016/j.amjcard.2012.01.369, 10.1016/j.amjcard.2011.08.045]
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Pulkes T, 2005, NEUROMUSCULAR DISORD, V15, P364, DOI 10.1016/j.nmd.2005.01.006
   Quadir A, 2019, NEUROL-GENET, V5, DOI 10.1212/NXG.0000000000000339
   Sirvent P, 2005, BIOCHEM BIOPH RES CO, V338, P1426, DOI 10.1016/j.bbrc.2005.10.108
   Strilchuck L, 2019, EXPERT OPIN DRUG SAF, V18, P611, DOI 10.1080/14740338.2019.1620730
   Thompson PD, 1997, METABOLISM, V46, P1206, DOI 10.1016/S0026-0495(97)90218-3
   Vavlukis Marija, 2018, Drugs Context, V7, P212534, DOI 10.7573/dic.212534
NR 11
TC 2
Z9 2
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1933-2874
EI 1876-4789
J9 J CLIN LIPIDOL
JI J. Clin. Lipidol.
PD SEP-OCT
PY 2020
VL 14
IS 5
BP 646
EP 648
DI 10.1016/j.jacl.2020.07.007
PG 3
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA OJ2UV
UT WOS:000583822800009
PM 32800583
DA 2024-11-01
ER

PT J
AU Suzuki, T
   Nagao, A
   Suzuki, T
AF Suzuki, Tsutomu
   Nagao, Asuteka
   Suzuki, Takeo
TI Human mitochondrial diseases caused by lack of taurine modification in
   mitochondrial tRNAs
SO WILEY INTERDISCIPLINARY REVIEWS-RNA
LA English
DT Review
ID WOBBLE MODIFICATION DEFICIENCY; TRANSFER RNALEU(UUR) GENE; MUTANT
   TRANSFER-RNAS; LACTIC-ACIDOSIS; 1ST POSITION; CODON RECOGNITION; MTDNA
   MUTATION; TRANSCRIPTION TERMINATION; MODIFICATION DEFECT; MYOCLONIC
   EPILEPSY
AB Mitochondrial DNA mutations that cause mitochondrial dysfunction are responsible for a wide spectrum of human diseases, referred to as mitochondrial diseases. Pathogenic point mutations are found frequently in genes encoding mitochondrial (mt) tRNAs, indicating that impaired functioning of mutant mt tRNAs is the primary cause of mitochondrial dysfunction. Our previous studies revealed the absence of posttranscriptional taurine modification at the anticodon wobble uridine in mutant mt tRNAs isolated from cells derived from patients with two major classes of mitochondrial diseases, MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) and MERRF (myoclonus epilepsy associated with ragged red fibers). Defective taurine modification of the mutant mt tRNAs results in a deficiency in protein synthesis as the cognate codons of the mutant mt tRNA cannot be decoded. These findings represent the first evidence of a molecular pathogenesis caused by an RNA modification disorder. (C) 2011 John Wiley & Sons, Ltd. WIREs RNA 2011 2 376-386 DOI: 10.1002/wrna.65
C1 [Suzuki, Tsutomu; Nagao, Asuteka; Suzuki, Takeo] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan.
C3 University of Tokyo
RP Suzuki, T (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan.
EM ts@chembio.t.u-tokyo.ac.jp
RI Suzuki, Tsutomu/J-1776-2015
OI Suzuki, Tsutomu/0000-0002-9731-1731; Nagao, Asuteka/0000-0002-9152-1527
FU Grants-in-Aid for Scientific Research [21115003, 23710265, 23655153]
   Funding Source: KAKEN
CR AGRIS PF, 1973, BIOCHEMISTRY-US, V12, P4331, DOI 10.1021/bi00746a005
   ANDACHI Y, 1987, P NATL ACAD SCI USA, V84, P7398, DOI 10.1073/pnas.84.21.7398
   Ashraf SS, 1999, RNA, V5, P188, DOI 10.1017/S1355838299981529
   BARRELL BG, 1980, P NATL ACAD SCI-BIOL, V77, P3164, DOI 10.1073/pnas.77.6.3164
   BONITZ SG, 1980, P NATL ACAD SCI-BIOL, V77, P3167, DOI 10.1073/pnas.77.6.3167
   Börner GV, 2000, HUM MOL GENET, V9, P467, DOI 10.1093/hmg/9.4.467
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611
   Brulé H, 1998, NUCLEIC ACIDS RES, V26, P537, DOI 10.1093/nar/26.2.537
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Dunbar DR, 1996, HUM MOL GENET, V5, P123, DOI 10.1093/hmg/5.1.123
   El Meziane A, 1998, NAT GENET, V18, P350
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Flierl A, 1997, J BIOL CHEM, V272, P27189, DOI 10.1074/jbc.272.43.27189
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389
   HAYASHI JI, 1993, BIOCHEM BIOPH RES CO, V197, P1049, DOI 10.1006/bbrc.1993.2584
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0
   Hino N, 2004, GENES CELLS, V9, P243, DOI 10.1111/j.1356-9597.2004.00718.x
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   INAGAKI Y, 1995, J MOL BIOL, V251, P486, DOI 10.1006/jmbi.1995.0450
   Janssen GMC, 2007, HUM MOL GENET, V16, P2472, DOI 10.1093/hmg/ddm203
   Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821
   Kirino Y, 2006, HUM MOL GENET, V15, P897, DOI 10.1093/hmg/ddl007
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   KOGA Y, 1988, ANN NEUROL, V24, P749, DOI 10.1002/ana.410240609
   Kogelnik AM, 1996, NUCLEIC ACIDS RES, V24, P177, DOI 10.1093/nar/24.1.177
   Kurata S, 2008, J BIOL CHEM, V283, P18801, DOI 10.1074/jbc.M800233200
   Lehtinen SK, 2000, GENETICS, V154, P363
   Levinger L, 2004, J MOL BIOL, V337, P535, DOI 10.1016/j.jmb.2004.02.008
   Ling JQ, 2007, P NATL ACAD SCI USA, V104, P15299, DOI 10.1073/pnas.0704441104
   LUSTIG F, 1993, P NATL ACAD SCI USA, V90, P3343, DOI 10.1073/pnas.90.8.3343
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MORIYA J, 1994, BIOCHEMISTRY-US, V33, P2234, DOI 10.1021/bi00174a033
   Nagao A, 2009, P NATL ACAD SCI USA, V106, P16209, DOI 10.1073/pnas.0907602106
   Osborne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005636
   Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Sissler M, 2004, RNA, V10, P841, DOI 10.1261/rna.5267604
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656
   Suzuki T, 2005, TOP CURR GENET, V12, P23, DOI 10.1007/b106361
   Suzuki T, 2007, METHOD ENZYMOL, V425, P231, DOI 10.1016/S0076-6879(07)25010-4
   Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Wittenhagen LM, 2002, NAT STRUCT BIOL, V9, P586, DOI 10.1038/nsb820
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   YOKOYAMA S, 1985, P NATL ACAD SCI USA, V82, P4905, DOI 10.1073/pnas.82.15.4905
   YOKOYAMA S, 1979, NUCLEIC ACIDS RES, V6, P2611, DOI 10.1093/nar/6.7.2611
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
NR 64
TC 89
Z9 100
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-7004
EI 1757-7012
J9 WIRES RNA
JI Wiley Interdiscip. Rev.-RNA
PD MAY-JUN
PY 2011
VL 2
IS 3
BP 376
EP 386
DI 10.1002/wrna.65
PG 11
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 913GB
UT WOS:000301863400005
PM 21957023
DA 2024-11-01
ER

PT J
AU Graziewicz, MA
   Longley, MJ
   Bienstock, RJ
   Zeviani, M
   Copeland, WC
AF Graziewicz, MA
   Longley, MJ
   Bienstock, RJ
   Zeviani, M
   Copeland, WC
TI Structure-function defects of human mitochondrial DNA polymerase in
   autosomal dominant progressive external ophthalmoplegia
SO NATURE STRUCTURAL & MOLECULAR BIOLOGY
LA English
DT Article
ID MULTIPLE DELETIONS; ESCHERICHIA-COLI; KLENOW FRAGMENT; GAMMA-A;
   MUTATIONS; ALIGNMENT; BINDING; MTDNA; IDENTIFICATION; REPLICATION
AB Progressive external ophthalmoplegia (PEO) is a mitochondrial disorder associated with mutations in the POLG gene encoding the mitochondrial DNA polymerase (pol gamma). Four autosomal dominant mutations that cause PEO encode the amino acid substitutions G923D, R943H, Y955C and A957S in the polymerase domain of pol gamma. A homology model of the pol gamma catalytic domain in complex with DNA was developed to investigate the effects of these mutations. Two mutations causing the most severe disease phenotype, Y955C and R943H, change residues that directly interact with the incoming dNTP. Polymerase mutants exhibit 0.03 - 30% wild-type polymerase activity and a 2- to 35-fold decrease in nucleotide selectivity in vitro. The reduced selectivity and catalytic efficiency of the autosomal dominant PEO mutants predict in vivo dysfunction, and the extent of biochemical defects correlates with the clinical severity of the disease.
C1 NIEHS, Genet Mol Lab, NIH, Res Triangle Pk, NC 27709 USA.
   NIEHS, Comp Sci Lab, NIH, Res Triangle Pk, NC 27709 USA.
   Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland.
   Natl Neurol Inst Carlo Besta, Unit Mol Neurogenet, I-20126 Milan, Italy.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS); National Institutes of Health
   (NIH) - USA; NIH National Institute of Environmental Health Sciences
   (NIEHS); Polish Academy of Sciences; Institute of Biochemistry &
   Biophysics - Polish Academy of Sciences; Fondazione IRCCS Istituto
   Neurologico Carlo Besta
RP NIEHS, Genet Mol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
RI Zeviani, Massimo/K-2891-2014; Copeland, William/C-4242-2019
OI Copeland, William/0000-0002-0359-0953; Zeviani,
   Massimo/0000-0002-9067-5508; Bienstock, Rachelle/0000-0001-5228-3610
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   ASTATKE M, 1995, J BIOL CHEM, V270, P1945, DOI 10.1074/jbc.270.4.1945
   BIENSTOCK RJ, IN PRESS MITOCHONDRI
   Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329
   BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461
   Doublié S, 1998, NATURE, V391, P251, DOI 10.1038/34593
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489
   ITO J, 1990, NUCLEIC ACIDS RES, V18, P6716, DOI 10.1093/nar/18.22.6716
   ITO J, 1991, NUCLEIC ACIDS RES, V19, P4045, DOI 10.1093/nar/19.15.4045
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0
   POLESKY AH, 1990, J BIOL CHEM, V265, P14579
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 36
TC 108
Z9 123
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1545-9993
EI 1545-9985
J9 NAT STRUCT MOL BIOL
JI Nat. Struct. Mol. Biol.
PD AUG
PY 2004
VL 11
IS 8
BP 770
EP 776
DI 10.1038/nsmb805
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 841LF
UT WOS:000222930600022
PM 15258572
DA 2024-11-01
ER

PT J
AU Orcesi, S
   Gorni, K
   Termine, C
   Uggetti, C
   Veggiotti, P
   Carrara, F
   Zeviani, M
   Berardinelli, A
   Lanzi, G
AF Orcesi, Simona
   Gorni, Ksenija
   Termine, Cristiano
   Uggetti, Carla
   Veggiotti, Pierangelo
   Carrara, Franco
   Zeviani, Massimo
   Berardinelli, Angela
   Lanzi, Giovanni
TI Bilateral putantinal necrosis associated with the mitochondrial DNA
   A8344G myoclonus epilepsy with ragged red fibers (MERRF) mutation: An
   infantile case
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
ID STRIATAL NECROSIS; CLINICAL-FEATURES; METHANOL INTOXICATION; POINT
   MUTATION; DISEASE; GENE; HETEROGENEITY; MTDNA; MR
AB Myoclonus epilepsy with ragged red fibers (MERRF) is one of the major mitochondrial encephalomyopathies. Its main clinical features are myoclonus epilepsy, ataxia, and myopathy with ragged red fibers. Whereas there is a close correlation between MERRF syndrome and the A8344G mutation of mitochondrial DNA, the reverse is not true. In fact, this mutation is also responsible for various other syndromes, such as Leigh syndrome, spinocerebellar degeneration, atypical Charcot-Marie-Tooth disease, and multiple truncal lipomas. We describe a child with the A8344G mutation of mitochondrial DNA and an unusual clinical, neuroradiologic, and biochemical phenotype, characterized by early-onset, nonprogressive cerebellar ataxia, and subclinical myoclonias in association with bilateral putaminal necrosis on magnetic resonance imaging and a reduction in complex V activity. Our case confirms the existence of a relationship between alteration in adenosine triphosphatase activity and basal ganglia involvement. We recommend that the possibility of a mitochondrial pathology should always be taken into consideration in the presence of bilateral symmetric lesions of the basal ganglia, even when the typical clinical picture is lacking.
C1 Univ Pavia, IRCCS, C Mondino Fdn,Reg Referral Ctr Neuromuscular Diso, Dept Child Neurol & Psychiat, I-27100 Pavia, Italy.
   Univ Pavia, IRCCS, C Mondino Fdn, Neuroradiol Unit, I-27100 Pavia, Italy.
   Ist Nazl Neurol Carlo Besta, Pierfranco & Luisa Mariani Ctr Study Childrens Mi, Unit Mol Neurogenet, Milan, Italy.
C3 University of Pavia; IRCCS Fondazione Casimiro Mondino; IRCCS Fondazione
   Casimiro Mondino; University of Pavia; Fondazione IRCCS Istituto
   Neurologico Carlo Besta
RP Orcesi, S (corresponding author), Univ Pavia, IRCCS, C Mondino Fdn,Reg Referral Ctr Neuromuscular Diso, Dept Child Neurol & Psychiat, Via Mondino 23, I-27100 Pavia, Italy.
EM simona.orcesi@mondino.it
RI Berardinelli, angela/AAA-9496-2019; Gorni, Ksenija/HCH-8475-2022;
   Zeviani, Massimo/K-2891-2014; termine, cristiano/AAB-8366-2022; orcesi,
   simona/J-6030-2016
OI termine, cristiano/0000-0003-2325-8293; Uggetti,
   Carla/0000-0002-6717-1280; Zeviani, Massimo/0000-0002-9067-5508; orcesi,
   simona/0000-0001-8947-9342; berardinelli, angela/0000-0002-4645-8055
CR Basel-Vanagaite L, 2004, NEUROLOGY, V62, P87, DOI 10.1212/01.WNL.0000101680.49036.69
   Campos Y, 1997, BIOCHEM BIOPH RES CO, V238, P323, DOI 10.1006/bbrc.1997.7166
   DAVIS PC, 1987, AM J NEURORADIOL, V8, P71
   DEMEIRLEIR L, 1995, PEDIATR NEUROL, V13, P242, DOI 10.1016/0887-8994(95)00184-H
   DiMauro S, 2002, ADV NEUROL, V89, P217
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Howell N, 1996, NEUROLOGY, V46, P219, DOI 10.1212/WNL.46.1.219
   Kawano H, 2000, PEDIATR NEUROL, V22, P222, DOI 10.1016/S0887-8994(99)00123-X
   Krähenbühl S, 2000, LIVER, V20, P346, DOI 10.1034/j.1600-0676.2000.020004346.x
   Martínez-Bermejo A, 2001, REV NEUROLOGIA, V33, P101, DOI 10.33588/rn.3302.2001122
   Nissenkorn A, 2000, J CHILD NEUROL, V15, P44, DOI 10.1177/088307380001500110
   Ragan C.I., 1987, MITOCHONDRIA PRACTIC, P79
   Roberge RJ, 1998, VET HUM TOXICOL, V40, P95
   ROIG M, 1993, PEDIATR NEUROL, V9, P349, DOI 10.1016/0887-8994(93)90103-J
   RUBINSTEIN D, 1995, AM J NEURORADIOL, V16, P1492
   Santorelli FM, 1998, MUSCLE NERVE, V21, P681
   Santorelli FM, 1996, PEDIATR RES, V39, P914, DOI 10.1203/00006450-199605000-00028
   Schon EA, 2001, SEMIN CELL DEV BIOL, V12, P441, DOI 10.1006/scdb.2001.0281
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   Solano A, 2003, ANN NEUROL, V54, P527, DOI 10.1002/ana.10682
   Straussberg R, 2002, NEUROLOGY, V59, P983, DOI 10.1212/WNL.59.7.983
   SWEENEY MG, 1994, J NEUROL SCI, V121, P57, DOI 10.1016/0022-510X(94)90157-0
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   ZEVIANI M, 1991, AM J HUM GENET, V48, P203
NR 24
TC 23
Z9 26
U1 0
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD JAN
PY 2006
VL 21
IS 1
BP 79
EP 82
DI 10.1177/08830738060210010901
PG 4
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 046SP
UT WOS:000237831600017
PM 16551460
DA 2024-11-01
ER

PT J
AU Ueki, I
   Koga, Y
   Povalko, N
   Akita, Y
   Nishioka, J
   Yatsuga, S
   Fukiyama, R
   Matsuishi, T
AF Ueki, I
   Koga, Y
   Povalko, N
   Akita, Y
   Nishioka, J
   Yatsuga, S
   Fukiyama, R
   Matsuishi, T
TI Mitochondrial tRNA gene mutations in patients having mitochondrial
   disease with lactic acidosis
SO MITOCHONDRION
LA English
DT Article
DE mitochondrial tRNA gene; point mutation; lactic acidosis
ID STROKE-LIKE EPISODES; TRNA(LYS) GENE; DNA MUTATIONS; MTDNA MUTATION;
   MYOCLONIC EPILEPSY; A3243G MUTATION; CARDIOMYOPATHY; MYOPATHY; A8296G;
   ENCEPHALOPATHY
AB Lactic acidosis has been associated with a variety of clinical conditions and can be due to mutation in nuclear or mitochondrial genes. We performed mutations screening of all rnitochondrial tRNA genes in 44 patients who referred as hyperlactic acidosis. Patients showed heterogeneous phenotypes including Leigh disease in four, MELAS in six, unclassified rnitochondrial myopathy in 10, cardiomyopathy in five, MERRF in one, pure lactic acidosis in six, and others in 12 including facio-scaplo-femoral muscular dystrophy (FSFD), familial cerebellar ataxia, recurrent Reye syndrome, cerebral palsy with mental retardation. We measured enzymatic activities of pyruvate dehydrogenase complex, and respiratory chain enzymes. All mitochondrial tRNA genes and known mutation of ATPase 6 were studied by single strand conformation polymorphism (SSCP), automated DNA sequence and PCR-RFLP methods. We have found one patient with PDHC deficiency and six patients with Complex I + IV deficiency, though the most of the patients showed subnormal to deficient state of respiratory chain enzyme activities. We have identified one of the nucleotide changes in 29 patients. Single nucleotide changes in rnitochondrial tRNA genes are found in 27 patients and one in ATPase 6 gene in two patients. One of four pathogenic point mutations (A3243G, C3303T, A8348G, and T8993G) was identified in 12 patients who showed the phenotype of Leigh syndrome, MELAS, cardimyopathy and cerebral palsy with epilepsy. Seventeen patients have one of the normal polymorphisms in the mitochondrial tRNA gene reported before. SSCP and PCR-RFLP could detect the heteroplasmic condition when the percentage of mutant up to 5, however, it cannot be observed by direct sequencing method. It is important to screen the mtDNA mutation not only by direct sequence but also by PCR-RFLP and the other sensitive methods to detect the heroplasmy when lactic acidosis has been documented in the patients who are not fulfilled the criteria of mitochondrial disorders. (c) 2005 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 Kurume Univ, Sch Med, Dept Pediat & Child Hlth, Kurume, Fukuoka 8300011, Japan.
   RAMNS, Med Genet Res Ctr, Moscow 115478, Russia.
C3 Kurume University; Research Centre for Medical Genetics
RP Kurume Univ, Sch Med, Dept Pediat & Child Hlth, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.
EM yasukoga@med.kurume-u.ac.jp
OI Koga, Yasutoshi/0000-0002-6664-1295
CR AKITA Y, 1999, HUM MUTAT
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Aral B, 1997, AM J HUM GENET, V61, P1318, DOI 10.1086/301653
   Arenas J, 1999, NEUROLOGY, V52, P377, DOI 10.1212/WNL.52.2.377
   Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   Bornstein B, 2005, BIOCHEM J, V387, P773, DOI 10.1042/BJ20040949
   CHOMYN A, 1994, AM J HUM GENET, V54, P966
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Iwanaga R, 2001, ACTA NEUROPATHOL, V101, P179
   Kameoka K, 1998, BIOCHEM BIOPH RES CO, V245, P523, DOI 10.1006/bbrc.1998.8437
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   KOGA Y, 1988, ACTA NEUROPATHOL, V76, P135, DOI 10.1007/BF00688097
   Koga Y, 2000, ARCH DIS CHILD, V82, P407, DOI 10.1136/adc.82.5.407
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Marotta R, 2004, INTERN MED J, V34, P10, DOI 10.1111/j.1444-0903.2004.t01-3-.x
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   MERANTE F, 1994, AM J HUM GENET, V55, P437
   Naito E, 2002, J NEUROL SCI, V201, P33, DOI 10.1016/S0022-510X(02)00187-9
   Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Pons R, 2004, J PEDIATR-US, V144, P81, DOI 10.1016/j.jpeds.2003.10.023
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   ROBINSON BH, 1987, AM J HUM GENET, V40, P50
   Rozen TD, 2004, HEADACHE, V44, P674, DOI 10.1111/j.1526-4610.2004.04126.x
   Sakuta R, 2002, PEDIATR NEUROL, V27, P397, DOI 10.1016/S0887-8994(02)00456-3
   Sambrook J, 1990, Cold Spring Harbor Laboratories, V186, P182
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   SILVESTRI G, 1994, HUM MUTAT, V3, P37, DOI 10.1002/humu.1380030107
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Sternberg D, 1998, HUM MOL GENET, V7, P33, DOI 10.1093/hmg/7.1.33
   TANIIKE M, 1992, BIOCHEM BIOPH RES CO, V186, P47, DOI 10.1016/S0006-291X(05)80773-9
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Terasaki F, 2001, JPN CIRC J, V65, P691, DOI 10.1253/jcj.65.691
   van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
   YOON KL, 1993, PEDIATR RES, V33, P433, DOI 10.1203/00006450-199305000-00002
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
   Zhang B, 2003, BIOCHEM SOC T, V31, P444, DOI 10.1042/BST0310444
NR 46
TC 21
Z9 26
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD FEB
PY 2006
VL 6
IS 1
BP 29
EP 36
DI 10.1016/j.mito.2005.10.003
PG 8
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 039AY
UT WOS:000237273100002
PM 16337222
DA 2024-11-01
ER

PT J
AU Baranowska, I
   Jäderlund, KH
   Nennesmo, I
   Holmqvist, E
   Heidrich, N
   Larsson, NG
   Andersson, G
   Wagner, EGH
   Hedhammar, Å
   Wibom, R
   Andersson, L
AF Baranowska, Izabella
   Jaderlund, Karin Hultin
   Nennesmo, Inger
   Holmqvist, Erik
   Heidrich, Nadja
   Larsson, Nils-Goran
   Andersson, Goran
   Wagner, E. Gerhart H.
   Hedhammar, Ake
   Wibom, Rolf
   Andersson, Leif
TI Sensory Ataxic Neuropathy in Golden Retriever Dogs Is Caused by a
   Deletion in the Mitochondrial <i>tRNA<SUP>Tyr</SUP></i> Gene
SO PLOS GENETICS
LA English
DT Article
ID RESPIRATORY-CHAIN ENZYMES; SKELETAL-MUSCLE; DNA MUTATIONS;
   LACTIC-ACIDOSIS; HUMAN-DISEASE; MYOPATHY; RNA; DEFICIENCY; MICE
AB Sensory ataxic neuropathy (SAN) is a recently identified neurological disorder in golden retrievers. Pedigree analysis revealed that all affected dogs belong to one maternal lineage, and a statistical analysis showed that the disorder has a mitochondrial origin. A one base pair deletion in the mitochondrial tRNA(Tyr) gene was identified at position 5304 in affected dogs after re-sequencing the complete mitochondrial genome of seven individuals. The deletion was not found among dogs representing 18 different breeds or in six wolves, ruling out this as a common polymorphism. The mutation could be traced back to a common ancestor of all affected dogs that lived in the 1970s. We used a quantitative oligonucleotide ligation assay to establish the degree of heteroplasmy in blood and tissue samples from affected dogs and controls. Affected dogs and their first to fourth degree relatives had 0-11% wild-type (wt) sequence, while more distant relatives ranged between 5% and 60% wt sequence and all unrelated golden retrievers had 100% wt sequence. Northern blot analysis showed that tRNA(Tyr) had a 10-fold lower steady-state level in affected dogs compared with controls. Four out of five affected dogs showed decreases in mitochondrial ATP production rates and respiratory chain enzyme activities together with morphological alterations in muscle tissue, resembling the changes reported in human mitochondrial pathology. Altogether, these results provide conclusive evidence that the deletion in the mitochondrial tRNA(Tyr) gene is the causative mutation for SAN.
C1 [Baranowska, Izabella; Andersson, Goran; Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, S-75007 Uppsala, Sweden.
   [Jaderlund, Karin Hultin; Hedhammar, Ake] Swedish Univ Agr Sci, Dept Clin Sci, S-75007 Uppsala, Sweden.
   [Jaderlund, Karin Hultin] Norwegian Sch Vet Sci, Dept Compan Anim Clin Sci, Oslo, Norway.
   [Nennesmo, Inger; Larsson, Nils-Goran; Wibom, Rolf] Karolinska Inst, Dept Lab Med, Stockholm, Sweden.
   [Holmqvist, Erik; Heidrich, Nadja] Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden.
   [Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.
C3 Swedish University of Agricultural Sciences; Swedish University of
   Agricultural Sciences; Norwegian University of Life Sciences; Karolinska
   Institutet; Uppsala University; Uppsala University
RP Baranowska, I (corresponding author), Swedish Univ Agr Sci, Dept Anim Breeding & Genet, S-75007 Uppsala, Sweden.
EM Leif.Andersson@imbim.uu.se
RI Larsson, Nils-Göran/GVS-5578-2022; Andersson, Goran/AAK-6564-2020;
   Jäderlund, Karin/AAL-8211-2020
OI Larsson, Nils-Goran/0000-0001-5100-996X; Heidrich,
   Nadja/0000-0002-0225-2549; Hedhammar, Ake/0000-0001-7048-3851
FU Swedish Foundation for Strategic Research; Swedish Research Council for
   Environment, Agricultural Sciences, and Spatial Planning, Agria
   Insurance Company, Sweden; Funds of the Karolinska Institutet; Golden
   Retriever Club of Sweden; Swedish Kennel Club
FX This work was supported by grants from the Swedish Foundation for
   Strategic Research, The Swedish Research Council for Environment,
   Agricultural Sciences, and Spatial Planning, Agria Insurance Company,
   Sweden, Funds of the Karolinska Institutet, the Golden Retriever Club of
   Sweden and the Swedish Kennel Club. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript
CR BINDOFF LA, 1991, J NEUROL SCI, V102, P17, DOI 10.1016/0022-510X(91)90088-O
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   BREITSCHWERDT EB, 1992, J AM VET MED ASSOC, V201, P731
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Dufour E, 2008, HUM MOL GENET, V17, P1418, DOI 10.1093/hmg/ddn030
   Graff C, 2002, BEST PRACT RES CL OB, V16, P715, DOI 10.1053/beog.2002.0315
   Greaves LC, 2006, IUBMB LIFE, V58, P143, DOI 10.1080/15216540600686888
   Jäderlund KH, 2007, J VET INTERN MED, V21, P1307, DOI 10.1892/07-005.1
   Li FY, 2006, NEUROBIOL DIS, V21, P35, DOI 10.1016/j.nbd.2005.06.009
   Olby NJ, 1997, J SMALL ANIM PRACT, V38, P213, DOI 10.1111/j.1748-5827.1997.tb03346.x
   Pulkes T, 2000, NEUROLOGY, V55, P1210, DOI 10.1212/WNL.55.8.1210
   Raffelsberger T, 2001, NEUROLOGY, V57, P2298, DOI 10.1212/WNL.57.12.2298
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Sahashi K, 2001, J MED GENET, V38, P703, DOI 10.1136/jmg.38.10.703
   Scaglia F, 2003, AM J MED GENET A, V123A, P172, DOI 10.1002/ajmg.a.20315
   Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Udekwu KI, 2005, GENE DEV, V19, P2355, DOI 10.1101/gad.354405
   Vielhaber S, 2002, J NEUROPATH EXP NEUR, V61, P885, DOI 10.1093/jnen/61.10.885
   VIJAYASARATHY C, 1994, COMP BIOCHEM PHYS A, V109, P887, DOI 10.1016/0300-9629(94)90236-4
   VONDOBELN U, 1993, ACTA PAEDIATR, V82, P1079, DOI 10.1111/j.1651-2227.1993.tb12818.x
   Wakshlag JJ, 2004, AM J VET RES, V65, P480, DOI 10.2460/ajvr.2004.65.480
   Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4
   Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   YUWAIMAN P, 2008, J MED G IN PRES 1117
NR 31
TC 34
Z9 34
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1553-7390
J9 PLOS GENET
JI PLoS Genet.
PD MAY
PY 2009
VL 5
IS 5
AR e1000499
DI 10.1371/journal.pgen.1000499
PG 9
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 459EH
UT WOS:000267083000007
PM 19492087
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU Hoitzing, H
   Gammage, PA
   van Haute, L
   Minczuk, M
   Johnston, IG
   Jones, NS
AF Hoitzing, Hanne
   Gammage, Payam A.
   van Haute, Lindsey
   Minczuk, Michal
   Johnston, Iain G.
   Jones, Nick S.
TI Energetic costs of cellular and therapeutic control of stochastic
   mitochondrial DNA populations
SO PLOS COMPUTATIONAL BIOLOGY
LA English
DT Article
ID OXIDATIVE-PHOSPHORYLATION; DELETION MUTANTS; SKELETAL-MUSCLE; WILD-TYPE;
   SELECTIVE DEGRADATION; RESPIRATORY-CHAIN; CLONAL EXPANSION; COPY NUMBER;
   MTDNA; DYNAMICS
AB The dynamics of the cellular proportion of mutant mtDNA molecules is crucial for mitochondrial diseases. Cellular populations of mitochondria are under homeostatic control, but the details of the control mechanisms involved remain elusive. Here, we use stochastic modelling to derive general results for the impact of cellular control on mtDNA populations, the cost to the cell of different mtDNA states, and the optimisation of therapeutic control of mtDNA populations. This formalism yields a wealth of biological results, including that an increasing mtDNA variance can increase the energetic cost of maintaining a tissue, that intermediate levels of heteroplasmy can be more detrimental than homoplasmy even for a dysfunctional mutant, that heteroplasmy distribution (not mean alone) is crucial for the success of gene therapies, and that long-term rather than short intense gene therapies are more likely to beneficially impact mtDNA populations.
   Author summary Mitochondria, best known for their role in energy production, are crucial to the survival of most of our cells. To respond to energetic demands and mitigate against mutational damage, cells control the mitochondrial populations within them, however the character of these control mechanisms remains open. As experimental elucidation of these mechanisms is challenging, theoretical approaches can help us understand the general principles of cellular control of mitochondria in physiology and disease. We use stochastic modelling to compare control strategies by studying their impact on the dynamics of mitochondrial DNA (mtDNA) populations as well as their energetic burden to the cell. We identify optimal strategies for the cell to control against mtDNA damage and preserve energy production and use this theory to explore the action of recently developed mitochondrial gene therapies, which reduce the fraction of mutant mtDNA molecules inside cells. We show how treatment efficiency might depend on pre-treatment distributions of mutant and wildtype mtDNA molecules: treatments are less effective for tissues consisting of cells with highly varying mutant levels, and long-term, rather than short intense, gene therapies should be favoured.
C1 [Hoitzing, Hanne; Jones, Nick S.] Imperial Coll London, Dept Math, London SW7 2AZ, England.
   [Gammage, Payam A.; van Haute, Lindsey; Minczuk, Michal] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge CB2 0XY, England.
   [Johnston, Iain G.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.
C3 Imperial College London; University of Cambridge; University of
   Birmingham
RP Jones, NS (corresponding author), Imperial Coll London, Dept Math, London SW7 2AZ, England.; Johnston, IG (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.
EM i.johnston.1@bham.ac.uk; nick.jones@imperial.ac.uk
RI Van Haute, Lindsey/GWZ-7600-2022; Johnston, Iain/JDD-2712-2023; Minczuk,
   Michal/G-1638-2014
OI Minczuk, Michal/0000-0001-8242-1420; Johnston, Iain/0000-0001-8559-3519;
   Gammage, Payam A./0000-0003-1968-1726; Jones, Nick/0000-0002-4083-972X
FU Medical Research Council [MC_UU_00015/4] Funding Source: Medline; EPSRC
   [EP/N014529/1] Funding Source: UKRI; MRC [MC_UU_00015/4] Funding Source:
   UKRI
CR Affourtit C, 2008, BIOCHEM J, V409, P199, DOI 10.1042/BJ20070954
   Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200
   ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   ANGULOBROWN F, 1995, NUOVO CIMENTO D, V17, P87, DOI 10.1007/BF02451604
   ATTARDI G, 1995, BBA-MOL BASIS DIS, V1271, P241, DOI 10.1016/0925-4439(95)00034-2
   Bacman SR, 2014, METHOD ENZYMOL, V547, P373, DOI 10.1016/B978-0-12-801415-8.00018-7
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004
   Bibikova M, 2002, GENETICS, V161, P1169
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   BRAND MD, 1993, BIOCHEM J, V291, P739, DOI 10.1042/bj2910739
   Burgstaller JP, 2015, MOL HUM REPROD, V21, P11, DOI 10.1093/molehr/gau090
   Busch KB, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0442
   Capps GJ, 2003, J THEOR BIOL, V221, P565, DOI 10.1006/jtbi.2003.3207
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717
   CIAFALONI E, 1991, NEUROLOGY, V41, P1663, DOI 10.1212/WNL.41.10.1663
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427
   Gammage PA, 2016, NUCLEIC ACIDS RES, V44, P7804, DOI 10.1093/nar/gkw676
   Gammage PA, 2016, METHODS MOL BIOL, V1351, P145, DOI 10.1007/978-1-4939-3040-1_11
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Gitschlag B.L., 2016, BIORXIV
   Grandemange S, 2009, SEMIN CANCER BIOL, V19, P50, DOI 10.1016/j.semcancer.2008.12.001
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934
   Jajoo R, 2016, SCIENCE, V351, P169, DOI 10.1126/science.aaa8714
   Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Johnston IG, 2016, AM J HUM GENET, V99, P1150, DOI 10.1016/j.ajhg.2016.09.016
   Johnston IG, 2015, P ROY SOC A-MATH PHY, V471, DOI 10.1098/rspa.2015.0050
   Johnston IG, 2015, ELIFE, V4, DOI 10.7554/eLife.07464
   Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486
   Kaufmann P, 1996, ANN NEUROL, V40, P172, DOI 10.1002/ana.410400208
   Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156
   KORZENIEWSKI B, 1995, BBA-BIOENERGETICS, V1229, P315, DOI 10.1016/0005-2728(95)00008-7
   Kowald A, 2000, J THEOR BIOL, V202, P145, DOI 10.1006/jtbi.1999.1046
   Kowald A, 2014, PROG MOL BIOL TRANSL, V127, P63, DOI 10.1016/B978-0-12-394625-6.00003-9
   Kowald A, 2014, P NATL ACAD SCI USA, V111, P2972, DOI 10.1073/pnas.1314970111
   Kowald A, 2013, AGING CELL, V12, P728, DOI 10.1111/acel.12098
   Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188
   Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008
   Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009
   Majamaa-Voltti Kirsi, 2002, BMC Cardiovasc Disord, V2, P12
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   Monternier PA, 2014, J EXP BIOL, V217, P2691, DOI 10.1242/jeb.104505
   Moraes C T, 1996, Methods Enzymol, V264, P522, DOI 10.1016/S0076-6879(96)64046-4
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   Morán M, 2012, FREE RADICAL BIO MED, V53, P595, DOI 10.1016/j.freeradbiomed.2012.05.009
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Nicholas A, 2009, EXP NEUROL, V218, P316, DOI 10.1016/j.expneurol.2009.04.029
   NOBES CD, 1990, J BIOL CHEM, V265, P12910
   Otten ABC, 2016, CELL REP, V16, P622, DOI 10.1016/j.celrep.2016.06.023
   Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079
   Pfleger J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.202
   Pittelli M, 2011, MOL PHARMACOL, V80, P1136, DOI 10.1124/mol.111.073916
   Poovathingal SK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000572
   POSAKONY JW, 1977, J CELL BIOL, V74, P468, DOI 10.1083/jcb.74.2.468
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769
   Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Royrvik EC, 2016, MOL HUM REPROD, V22, P809, DOI 10.1093/molehr/gaw062
   Russell O, 2014, EXP CELL RES, V325, P38, DOI 10.1016/j.yexcr.2014.03.012
   Salin K, 2012, J EXP ZOOL PART A, V317A, P283, DOI 10.1002/jez.1722
   Salvatier J, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.55
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   Sriskanthadevan S, 2015, BLOOD, V125, P2120, DOI 10.1182/blood-2014-08-594408
   Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Tang YY, 2000, MOL BIOL CELL, V11, P1471, DOI 10.1091/mbc.11.4.1471
   TOKUNAGA M, 1994, ANN NEUROL, V35, P413, DOI 10.1002/ana.410350407
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556
   Van Laar VS, 2009, EXP NEUROL, V218, P247, DOI 10.1016/j.expneurol.2009.03.019
   VANDIJKEN JP, 1993, ANTON LEEUW INT J G, V63, P343, DOI 10.1007/BF00871229
   Waddell TG, 1999, BIOCHEM EDUC, V27, P12, DOI 10.1016/S0307-4412(98)00266-0
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
   Zhu XW, 2013, J ALZHEIMERS DIS, V33, pS253, DOI 10.3233/JAD-2012-129005
NR 94
TC 17
Z9 17
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-734X
EI 1553-7358
J9 PLOS COMPUT BIOL
JI PLoS Comput. Biol.
PD JUN
PY 2019
VL 15
IS 6
AR e1007023
DI 10.1371/journal.pcbi.1007023
PG 27
WC Biochemical Research Methods; Mathematical & Computational Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Mathematical & Computational Biology
GA IH7RZ
UT WOS:000474703000016
PM 31242175
OA Green Published, Green Accepted, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU Lodi, R
   Rajagopalan, B
   Blamire, AM
   Crilley, JG
   Styles, P
   Chinnery, PF
AF Lodi, R
   Rajagopalan, B
   Blamire, AM
   Crilley, JG
   Styles, P
   Chinnery, PF
TI Abnormal cardiac energetics in patients carrying the A3243G mtDNA
   mutation measured in vivo using phosphorus MR spectroscopy
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article
DE magnetic resonance spectroscopy; metabolism; cardiomyopathy
ID LEFT-VENTRICULAR MASS; STROKE-LIKE EPISODES; MITOCHONDRIAL MYOPATHY;
   LACTIC-ACIDOSIS; MELAS; CARDIOMYOPATHY; EPIDEMIOLOGY; HYPERTROPHY;
   DYSFUNCTION; DEFICIENCY
AB Cardiomyopathy is a frequent cause of morbidity and mortality in patients carrying the A3243G transition in the mitochondrial DNA (mtDNA) tRNALeu(UUR) gene, the most common heteroplasmic single mtDNA defect. We used phosphorus magnetic resonance spectroscopy (P-31-MRS) to look for evidence of an in vivo bioenergetics defect in patients carrying the A3243G mtDNA mutation with and without echocardiographic signs of left ventricle hypertrophy (LVH). Eight patients, three with LVH, carrying the A3243G mtDNA mutation and 10 healthy subjects underwent one-dimensional chemical shift imaging P-31-MRS. In the patients, mean cardiac phosphocreatine to adenosine triphosphate ratio (PCr/ATP) (1.55 +/- 0.58) was significantly reduced compared to the control group (2.34 +/- 0.14; P<0.001). Cardiac PCr/ATP was within the normal range only in one case that showed normal echocardiography. Our results point to a central role of bioenergetics deficit in the development of cardiac hypertrophy in patients with the A3243G mtDNA mutation. Impaired cardiac energy metabolism in patients with normal echocardiography suggests that the enhancement of mitochondrial function may be beneficial not only to patients with cardiac hypertrophy but also to those patients carrying the mutation in the absence of signs of cardiac hypertrophy and/or dysfunction but with cardiac bioenergetics deficit. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Bologna, Policlin S Orsola, Dipartimento Med Clin & Biotechnol Applicata D Ca, I-40138 Bologna, Italy.
   Univ Oxford, Dept Biochem, MRC Biochem & Clin Magnet Resonance Unit, Oxford, England.
   Oxford Radcliffe Hosp, Oxford, England.
   Newcastle Univ, Dept Neurol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di
   Bologna; University of Oxford; University of Oxford; Newcastle
   University - UK
RP Univ Bologna, Policlin S Orsola, Dipartimento Med Clin & Biotechnol Applicata D Ca, Via Massarenti 9, I-40138 Bologna, Italy.
EM raffaele.lodi@unibo.it
RI Blamire, Andrew/AAU-6100-2021; Lodi, Raffaele/K-4984-2016
OI Chinnery, Patrick/0000-0002-7065-6617; Blamire,
   Andrew/0000-0002-8749-1257; Lodi, Raffaele/0000-0003-3878-304X
CR ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   Antozzi C, 1997, CARDIOVASC RES, V35, P184, DOI 10.1016/S0008-6363(97)00141-7
   Barbiroli B, 1999, J CEREBR BLOOD F MET, V19, P528, DOI 10.1097/00004647-199905000-00007
   Blair E, 2001, HUM MOL GENET, V10, P1215, DOI 10.1093/hmg/10.11.1215
   Blamire AM, 1999, MAGN RESON MED, V41, P198, DOI 10.1002/(SICI)1522-2594(199901)41:1<198::AID-MRM28>3.0.CO;2-H
   BOTTOMLEY PA, 1994, MAGNET RESON MED, V32, P137, DOI 10.1002/mrm.1910320120
   Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chinnery PF, 2000, ANN NEUROL, V47, P381, DOI 10.1002/1531-8249(200003)47:3<381::AID-ANA17>3.0.CO;2-2
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Crilley JG, 2000, J AM COLL CARDIOL, V36, P1953, DOI 10.1016/S0735-1097(00)00960-8
   DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z
   Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   Hausse AO, 2002, HEART, V87, P346, DOI 10.1136/heart.87.4.346
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   INGWALL JS, 1985, NEW ENGL J MED, V313, P1050, DOI 10.1056/NEJM198510243131704
   Lerman-Sagie T, 2001, J INHERIT METAB DIS, V24, P28, DOI 10.1023/A:1005642302316
   Lodi R, 1999, P NATL ACAD SCI USA, V96, P11492, DOI 10.1073/pnas.96.20.11492
   Lodi R, 2001, CARDIOVASC RES, V52, P111, DOI 10.1016/S0008-6363(01)00357-1
   Lodi R, 2001, ANN NEUROL, V49, P590
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Majamaa-Voltti Kirsi, 2002, BMC Cardiovasc Disord, V2, P12
   MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873
   RABINOWITZ M, 1974, CIRC RES, V35, P3
   RADDA GK, 1986, SCIENCE, V233, P640, DOI 10.1126/science.3726553
   Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215
   Silvestri G, 1997, MUSCLE NERVE, V20, P221
   Slotboom J, 1998, MAGNET RESON MED, V39, P899, DOI 10.1002/mrm.1910390607
   VEECH RL, 1979, J BIOL CHEM, V254, P6538
   Wikstrand J, 1997, J HYPERTENS, V15, P811, DOI 10.1097/00004872-199715080-00003
NR 34
TC 24
Z9 24
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 1879-2650
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD JUL 9
PY 2004
VL 1657
IS 2-3
BP 146
EP 150
DI 10.1016/j.bbabio.2004.05.003
PG 5
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 838ST
UT WOS:000222734200007
PM 15238271
OA Bronze
DA 2024-11-01
ER

PT J
AU Yang, SL
   Huo, YY
   Wang, HJ
   Ji, JF
   Chen, W
   Huang, YQ
AF Yang, Suliang
   Huo, Yangyang
   Wang, Huanjie
   Ji, Jiefei
   Chen, Wen
   Huang, Yanqun
TI The spatio-temporal features of chicken mitochondrial ND2 gene
   heteroplasmy and the effects of nutrition factors on this gene
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DNA-SEQUENCE VARIATION; MTDNA HETEROPLASMY; ENERGY RESTRICTION;
   ADIPOSE-TISSUE; HEALTH; DYSFUNCTION; EXPRESSION; OMEGA-6; DAMAGE
AB Mitochondrial heterogeneity is the presence of two or more types of mitochondrial (mt)DNA in the same individual/tissue/cell. It is closely related to animal health and disease. ND2 is a protein-coding gene in mtDNA, which participates in mitochondrial respiratory chain and oxidative phosphorylation. In previous studies, we observed that the mt.A5703T and mt.T5727G sites in the ND2 gene were the heteroplasmic variation sites. We used pyrophosphate sequencing technology to examine chicken mt.A5703T and mt.T5727G heteroplasmic sites in the ND2 gene, in different tissues and at different development stages in chickens. We also investigated whether nutritional factors could affect the mt.A5703T and mt.T5727G heteroplasmy. Our results showed that chicken mt.A5703T and mt.T5727G heteroplasmy had clear spatio-temporal specificities, which varied between tissues/development stages. The mtDNA heterogeneity was relatively stable upon nutrition intervention, 30% dietary energy restriction (from 18 to 48 days old) and different types of dietary fats (at 5% concentration, from 1 to 42 days old) did not change the breast muscle heteroplasmy of broilers at the mt.A5703T and mt.T5727G sites. In addition, multiple potential heteroplasmic sites were detected by clone sequencing in the ND2 region, which potentially reflected abundant heteroplasmy in the chicken mitochondrial genome. These results provide an important reference for further research on heteroplasmy in chicken mitochondria.
C1 [Yang, Suliang; Huo, Yangyang; Wang, Huanjie; Ji, Jiefei; Chen, Wen; Huang, Yanqun] Henan Agr Univ, Coll Livestock Husb & Vet Engn, 15 Longzi Lake Univ Campus, Zhengzhou 450046, Peoples R China.
C3 Henan Agricultural University
RP Huang, YQ (corresponding author), Henan Agr Univ, Coll Livestock Husb & Vet Engn, 15 Longzi Lake Univ Campus, Zhengzhou 450046, Peoples R China.
EM hyanqun@aliyun.com
RI Huang, Yanqun/JVD-8692-2023; Wang, Huanjie/AAP-5858-2020
FU National Natural Science Foundation of China [31272434]; National
   infrastructure of domestic animal resource of China
FX The authors are grateful to staff at the College of Livestock Husbandry
   and Veterinary Engineering of the Henan Agricultural University for
   their valuable assistance in sample collecting. This work was supported
   by the National Natural Science Foundation of China (No. 31272434) and
   National infrastructure of domestic animal resource of China.
CR [Anonymous], 1994, NUTRIENT REQUIREMENT
   BAUMER A, 1994, AM J HUM GENET, V54, P618
   Blass JP, 2002, J ALZHEIMERS DIS, V4, P225, DOI 10.3233/JAD-2002-4312
   BROWN JR, 1993, MOL BIOL EVOL, V10, P326
   BROWN JR, 1992, GENETICS, V132, P221
   Duchen MR, 2004, DIABETES, V53, pS96, DOI 10.2337/diabetes.53.2007.S96
   Eckert A, 2003, BIOCHEM PHARMACOL, V66, P1627, DOI 10.1016/S0006-2952(03)00534-3
   Enriquez JA, 2014, MOL SYNDROMOL, V5, P119, DOI 10.1159/000363364
   Ghosh S, 2006, FREE RADICAL BIO MED, V41, P1413, DOI 10.1016/j.freeradbiomed.2006.07.021
   Grazina M, 2006, GENES BRAIN BEHAV, V5, P92, DOI 10.1111/j.1601-183X.2006.00225.x
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Houstek J, 2012, PHYSIOL GENOMICS, V44, P487, DOI 10.1152/physiolgenomics.00156.2011
   Huang YQ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224677
   Hynes GR, 2003, J LIPID RES, V44, P893, DOI 10.1194/jlr.M200318-JLR200
   Lanza IR, 2012, CELL METAB, V16, P777, DOI 10.1016/j.cmet.2012.11.003
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014
   Lu WW, 2016, MITOCHONDRIAL DNA A, V27, P2303, DOI 10.3109/19401736.2014.971022
   Marom S, 2017, SCI REP-UK, V7, DOI 10.1038/srep43449
   MCCLELLAN J, 2012, PLOS ONE, V7, DOI DOI 10.1371/JOURNAL.PONE.00464032012PLOSO...746403B
   McLeod BA, 2010, J HERED, V101, P235, DOI 10.1093/jhered/esp098
   Ministry of Agriculture of the People's Republic of China, 2004, 332004 GB NT MIN AGR
   MITCHELL P, 1967, NATURE, V213, P137, DOI 10.1038/213137a0
   Near TJ, 2003, MOL PHYLOGENET EVOL, V28, P87, DOI 10.1016/S1055-7903(03)00029-0
   Pepe S, 1999, AM J PHYSIOL-HEART C, V276, pH149, DOI 10.1152/ajpheart.1999.276.1.H149
   Pereira SL, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-17
   Rodríguez VM, 2002, BRIT J NUTR, V87, P427, DOI 10.1079/BJN2002570
   Schiff M, 2011, NUTR REV, V69, P65, DOI 10.1111/j.1753-4887.2010.00363.x
   Sealls W, 2008, BBA-MOL CELL BIOL L, V1781, P406, DOI 10.1016/j.bbalip.2008.06.010
   Shao L, 2008, ANN MED, V40, P281, DOI 10.1080/07853890801923753
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   Shi Y, 2018, MITOCHONDRIAL DNA A, V29, P485, DOI 10.1080/24701394.2017.1307976
   Sondheimer N, 2011, HUM MOL GENET, V11, P654, DOI [10.1016/j.mito.2011.03.059, DOI 10.1016/J.MITO.2011.03.059]
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Tranah GJ, 2012, J ALZHEIMERS DIS, V32, P357, DOI 10.3233/JAD-2012-120466
   Ugalde C, 2007, MOL GENET METAB, V90, P10, DOI 10.1016/j.ymgme.2006.08.003
   Vollmer NL, 2011, CURR GENET, V57, P115, DOI 10.1007/s00294-010-0331-1
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wallace DC, 2008, GENETICS, V179, P727, DOI 10.1534/genetics.104.91769
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220
   Wang JW, 2012, POULTRY SCI, V91, P972, DOI 10.3382/ps.2011-01949
   Wiesner RJ, 2006, FREE RADICAL RES, V40, P1284, DOI 10.1080/10715760600913168
   Wilton PR, 2018, GENETICS, V208, P1261, DOI 10.1534/genetics.118.300711
   Wong LJC, 2010, MOL GENET METAB, V100, P111, DOI 10.1016/j.ymgme.2010.02.024
   Yao YG, 2013, MUTAT RES-FUND MOL M, V751, P36, DOI 10.1016/j.mrfmmm.2013.09.001
   Zhang WW, 2016, MITOCHONDRIAL DNA A, V27, P3787, DOI 10.3109/19401736.2015.1079904
NR 46
TC 3
Z9 5
U1 0
U2 7
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 19
PY 2020
VL 10
IS 1
AR 2972
DI 10.1038/s41598-020-59703-y
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA NB2ZC
UT WOS:000560380700001
PM 32075998
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Elson, JL
   Swalwell, H
   Blakely, EL
   McFarland, R
   Taylor, RW
   Turnbull, DM
AF Elson, Joanna L.
   Swalwell, Helen
   Blakely, Emma L.
   McFarland, Robert
   Taylor, Robert W.
   Turnbull, Doug M.
TI Pathogenic Mitochondrial tRNA Mutations - Which Mutations Are Inherited
   and Why?
SO HUMAN MUTATION
LA English
DT Article
DE mitochondrial DNA; tRNA mutation; threshold; inheritance; genetic
   counseling
ID RAGGED-RED FIBERS; POINT MUTATION; DNA MUTATIONS; SPORADIC PATIENT;
   EXERCISE INTOLERANCE; TRNA(LYS) GENE; MYOPATHY; MERRF; MELAS; PREVALENCE
AB Mitochondrial transfer RNA (mt-tRNA) mutations are the commonest mitochondrial (mtDNA) mutations to cause human disease. The majority of mt-tRNA mutations are heteroplasmic and while some exhibit maternal transmission within families, many others are only seen as sporadic mutations. Using the available clinical, biochemical and genetic data from published pathogenic mt-tRNA mutations, we have explored several different factors thought to influence the transmission of mt-tRNA mutations. Our data show that the most important factor in predicting whether a mutation is transmitted to offspring is whether the mt-tRNA mutation is selected against in a rapidly replicating tissue such as blood. This suggests that those mt-tRNA mutations which exert a major phenotype in dividing cells are unlikely to be inherited. This is entirely compatible with recent observations on the mitochondrial genetic bottleneck in early development and has important implications for families with mt-tRNA disease. (C) 2009 Wiley-Liss, Inc.
C1 [Elson, Joanna L.; Swalwell, Helen; Blakely, Emma L.; McFarland, Robert; Taylor, Robert W.; Turnbull, Doug M.] Newcastle Univ, Sch Med, Mitochondrial Res Grp, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Taylor, RW (corresponding author), Newcastle Univ, Sch Med, Mitochondrial Res Grp, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.w.taylor@ncl.ac.uk
OI /0000-0002-3551-5624; McFarland, Robert/0000-0002-8833-2688; Turnbull,
   Doug/0000-0002-8878-9901
FU Research Council UK RCUK; UK National Commissioning Group for Rare
   Mitochondrial Disorders of Children and Adults; Wellcome Trust
   [GR074454]; Medical Research Council [G0800674, G0700718]; BBSRC; EPSRC;
   ESRC; MRC [G0700718, G90/63, G108/539, G0800674] Funding Source: UKRI
FX Contract grant sponsor: Supported by the Wellcome Trust (Grant number
   GR074454), Medical Research Council (Grant number G0800674) and
   Newcastle Centre for Brain Ageing and Vitality supported by BBSRC,
   EPSRC, ESRC and MRC (Grant number G0700718). JLE is supported by a
   Research Council UK RCUK Academic fellowship. Mitochondrial genetic
   diagnostic studies were supported by the UK National Commissioning Group
   for Rare Mitochondrial Disorders of Children and Adults.
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Bataillard M, 2001, NEUROLOGY, V56, P405, DOI 10.1212/WNL.56.3.405
   Bidooki S, 2004, NEUROMUSCULAR DISORD, V14, P417, DOI 10.1016/j.nmd.2004.03.004
   Blakely EL, 2007, J NEUROL, V254, P1283, DOI 10.1007/s00415-006-0490-7
   Blakely EL, 2009, ARCH NEUROL-CHICAGO, V66, P399, DOI 10.1001/archneurol.2008.576
   Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970
   Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Crimi M, 2003, NEUROLOGY, V60, P1200, DOI 10.1212/01.WNL.0000055865.30580.39
   Darin N, 2006, NEUROMUSCULAR DISORD, V16, P504, DOI 10.1016/j.nmd.2006.05.010
   Deschauer M, 2006, ARCH NEUROL-CHICAGO, V63, P902, DOI 10.1001/archneur.63.6.902
   Dey R, 2000, NEUROMUSCULAR DISORD, V10, P488, DOI 10.1016/S0960-8966(00)00125-5
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Houshmand M, 1999, HUM MUTAT, V13, P203, DOI 10.1002/(SICI)1098-1004(1999)13:3<203::AID-HUMU4>3.0.CO;2-3
   ICHIKI T, 1988, ANN NEUROL, V23, P287, DOI 10.1002/ana.410230312
   Jacobs HT, 2003, HUM MOL GENET, V12, pR293, DOI 10.1093/hmg/ddg285
   Karadimas CL, 2002, NEUROMUSCULAR DISORD, V12, P865, DOI 10.1016/S0960-8966(02)00072-X
   Lynn S, 1998, DIABETES, V47, P1800, DOI 10.2337/diabetes.47.11.1800
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Mayr JA, 2006, NEUROMUSCULAR DISORD, V16, P874, DOI 10.1016/j.nmd.2006.08.010
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   McFarland R, 2008, NEUROMUSCULAR DISORD, V18, P63, DOI 10.1016/j.nmd.2007.07.007
   Melone MAB, 2004, ARCH NEUROL-CHICAGO, V61, P269, DOI 10.1001/archneur.61.2.269
   MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   Moslemi AR, 1998, NEUROMUSCULAR DISORD, V8, P345, DOI 10.1016/S0960-8966(98)00029-7
   Moslemi AR, 2004, NEUROMUSCULAR DISORD, V14, P46, DOI 10.1016/S0960-8966(03)00168-8
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Pereira C, 2007, BIOCHEM BIOPH RES CO, V354, P937, DOI 10.1016/j.bbrc.2007.01.068
   Rossmanith W, 2003, ANN NEUROL, V54, P820, DOI 10.1002/ana.10753
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Swalwell H, 2006, NEUROLOGY, V66, P447, DOI 10.1212/01.wnl.0000196490.36349.83
   Swalwell H, 2008, EUR J HUM GENET, V16, P1265, DOI 10.1038/ejhg.2008.65
   Taylor RW, 1998, BIOCHEM BIOPH RES CO, V243, P47, DOI 10.1006/bbrc.1997.8055
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2004, NEUROLOGY, V62, P1420, DOI 10.1212/01.WNL.0000120667.77372.46
   Taylor RW, 2002, NEUROMUSCULAR DISORD, V12, P659, DOI 10.1016/S0960-8966(02)00026-3
   Tiranti V, 1998, ANN NEUROL, V43, P98, DOI 10.1002/ana.410430116
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Weber K, 1997, AM J HUM GENET, V60, P373
NR 51
TC 44
Z9 44
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-7794
EI 1098-1004
J9 HUM MUTAT
JI Hum. Mutat.
PD NOV
PY 2009
VL 30
IS 11
BP E984
EP E992
DI 10.1002/humu.21113
PG 9
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 626QD
UT WOS:000279980700003
PM 19718780
OA gold
DA 2024-11-01
ER

PT J
AU Zhao, MM
   Zuo, C
   Hao, HY
   Xing, X
   Zhao, L
   Li, N
AF Zhao, Mingmin
   Zuo, Chun
   Hao, Hongyu
   Xing, Xing
   Zhao, Lei
   Li, Na
TI A patient with MELAS syndrome combined with autoimmune abnormalities: a
   case report
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE MELAS; mitochondrial encephalomyopathy; autoimmune abnormalities;
   antinuclear antibodies (ANA); antimetabolic glutamate receptor 5
   encephalitis
ID METABOTROPIC GLUTAMATE-RECEPTOR; MITOCHONDRIAL MYOPATHY;
   LACTIC-ACIDOSIS; ENCEPHALOPATHY; EPISODES
AB BackgroundMitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) is a group of maternally inherited disorders caused by mutations or deletions in mitochondrial genes with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes as the main clinical manifestations.Case presentationWe reported a 20-year-old female patient with MELAS syndrome combined with autoimmune abnormalities. She suffered from an intermittent headache in the right temporal region with no obvious cause, and then, after strenuous exercise in dance class, the headache became aggravated, accompanied by unresponsiveness, blurred vision, and diplopia. Her blood lactate levels were elevated, her antinuclear antibodies were positive, and the antimetabolic glutamate receptors 5 in her serum were positive. Brain DWI showed a hypertensive signal in the right temporo-parietal-occipital cortex and subcortical area. Brain MRS showed decreased NAA peak and increased Lac peak. Muscle biopsy showed myogenic damage, and the modified Gomori trichrome (MGT) staining showed ragged red fibers (RRF). A genetic study revealed a mitochondrial DNA A3243G mutation.ConclusionMitochondrial encephalomyopathy is a rare clinical condition; however, the association with autoimmune diseases is not yet clear and still needs further research and analysis.
C1 [Zhao, Mingmin; Zuo, Chun] Hebei North Univ, Grad Sch, Zhangjiakou, Hebei, Peoples R China.
   [Zhao, Mingmin; Zuo, Chun; Hao, Hongyu; Xing, Xing; Zhao, Lei; Li, Na] Hebei Gen Hosp, Neurol Intens Care Unit, Shijiazhuang, Hebei, Peoples R China.
   [Hao, Hongyu; Xing, Xing; Zhao, Lei; Li, Na] Hebei Prov Key Lab Cerebral Networks & Cognit Diso, Shijiazhuang, Hebei, Peoples R China.
C3 Hebei North University
RP Li, N (corresponding author), Hebei Gen Hosp, Neurol Intens Care Unit, Shijiazhuang, Hebei, Peoples R China.; Li, N (corresponding author), Hebei Prov Key Lab Cerebral Networks & Cognit Diso, Shijiazhuang, Hebei, Peoples R China.
EM lihaiying119@sina.com
FU Project of Clinical Medicine Excellent Talents Government-funded Project
   of Hebei Province, China [ZF2023186]; Medical Science Research Project
   of Hebe Province [20230314]
FX This study was supported by the Project of Clinical Medicine Excellent
   Talents Government-funded Project of Hebei Province, China (ZF2023186)
   and the Medical Science Research Project of Hebe Province (Award Number:
   20230314).
CR Chen SX, 2023, BRAIN BEHAV, V13, DOI 10.1002/brb3.3003
   de Laat P, 2013, JIMD REP, V8, P47, DOI 10.1007/8904_2012_159
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Faas MM, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165845
   Finsterer J, 2012, EXPERT OPIN DRUG MET, V8, P71, DOI 10.1517/17425255.2012.644535
   Guevara C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02568
   Hemphill S, 2019, BRIT J ANAESTH, V122, P448, DOI 10.1016/j.bja.2018.12.025
   Hortová-Kohoutková M, 2021, BIOESSAYS, V43, DOI 10.1002/bies.202000067
   Hu CP, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.01000
   Ikawa M, 2020, CURR OPIN CLIN NUTR, V23, P17, DOI 10.1097/MCO.0000000000000610
   Irure-Ventura J, 2022, DIAGNOSTICS, V12, DOI 10.3390/diagnostics12030647
   Lancaster E, 2011, NEUROLOGY, V77, P1698, DOI 10.1212/WNL.0b013e3182364a44
   Makowski L, 2020, IMMUNOL REV, V295, P5, DOI 10.1111/imr.12858
   Marques-Matos C, 2016, JAMA NEUROL, V73, P604, DOI 10.1001/jamaneurol.2015.5061
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Seo KS, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00552
   SHIGEMOTO R, 1993, NEUROSCI LETT, V163, P53, DOI 10.1016/0304-3940(93)90227-C
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   SWEENEY MG, 1993, Q J MED, V86, P709
NR 19
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
J9 FRONT NEUROL
JI Front. Neurol.
PD AUG 24
PY 2023
VL 14
AR 1239664
DI 10.3389/fneur.2023.1239664
PG 8
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA Q8DY5
UT WOS:001059785700001
PM 37693769
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Baslo, SA
   Tekin, B
   Unverengil, GG
   Erdogan, M
   Yusifov, M
   Atakli, D
AF Baslo, Sezin Alpaydin
   Tekin, Betul
   Unverengil, Gokcen Gundogdu
   Erdogan, Mucahid
   Yusifov, Mahir
   Atakli, Dilek
TI Multiple symmetric lipomatosis and MERRF: A case from Turkey
SO NEUROLOGY ASIA
LA English
DT Article
DE lipomatosis; MERRF; mitochondrial disorder; myopathy; MT-TK
ID MITOCHONDRIAL; PREVALENCE; DISORDERS
AB The association of multiple symmetric lipomatosis (MSL) and mitochondrial disorders is not frequent. We report a male patient with multiple lipomas, hearing loss, progressive limb-girdle muscle weakness, neuropathy and myoclonia. Serum creatinine kinase was mildly elevated. Electromyography revealed sensory axonal polyneuropathy and myopathy with sparse denervation. A muscle biopsy showed ragged-red fibers. Next-generation DNA sequencing revealed a heteroplasmic m.8344A>G mutation in the MT-TK gene. To the best of our knowledge, this is the first patient to be reported from Turkey with a diagnosis of MSL and myoclonic epilepsy with ragged red fibers (MERRF).
C1 [Baslo, Sezin Alpaydin; Tekin, Betul; Erdogan, Mucahid; Yusifov, Mahir; Atakli, Dilek] Univ Hlth Sci, Bakirkoy Prof Dr Mazhar Osman Training & Res Hosp, Dept Neurol, Istanbul, Turkiye.
   [Unverengil, Gokcen Gundogdu] Istanbul Univ, Dept Pathol, Istanbul Fac Med, Istanbul, Turkiye.
C3 University of Health Sciences Turkey; Istanbul Bakirkoy Mental Health &
   Neurology Training & Research Hospital; Istanbul University
RP Baslo, SA (corresponding author), Univ Hlth Sci, Bakirkoy Prof Dr Mazhar Osman Training & Res Hosp, Dept Neurol, Istanbul, Turkiye.
EM sznalpaydin@gmail.com
RI alpaydin baslo, sezin/GRR-8860-2022; Erdoğan, Mücahid/LDF-9418-2024
OI Alpaydin Baslo, Sezin/0000-0002-4096-3552; Erdogan,
   Mucahid/0000-0002-4919-602X
CR Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   BERKOVIC SF, 1991, ANN NEUROL, V29, P566, DOI 10.1002/ana.410290519
   Brodie BC, 1846, Lectures illustrative of various subjects in pathology and surgery. M, P275
   Carré F, 2019, EUR ANN OTORHINOLARY, V136, P113, DOI 10.1016/j.anorl.2018.10.015
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chong P Siao Tick, 2003, J Clin Neuromuscul Dis, V5, P1, DOI 10.1097/00131402-200309000-00001
   Enzi G, 2002, INT J OBESITY, V26, P253, DOI 10.1038/sj.ijo.0801867
   Erol I, 2009, NEUROMUSCULAR DISORD, V19, P275, DOI 10.1016/j.nmd.2009.01.012
   Finsterer J, 2018, PEDIATR NEUROL, V80, P8, DOI 10.1016/j.pediatrneurol.2017.12.005
   Klopstock T, 1997, MOL CELL BIOCHEM, V174, P271, DOI 10.1023/A:1006877012241
   Launois P.E., 1898, B SOC M D H P PARIS, V1, P298
   Madelung OW., 1888, Arch Klin Chir, V37, P106
   Mancuso M, 2014, MOVEMENT DISORD, V29, P722, DOI 10.1002/mds.25839
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Musumeci O, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00160
   Muthusamy K, 2021, ANN NEUROL, V89, P623, DOI 10.1002/ana.25992
   Plummer C, 2013, MITOCHONDRION, V13, P269, DOI 10.1016/j.mito.2013.03.003
   Schutte B.C., 1993, GeneReviews()
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
NR 22
TC 0
Z9 0
U1 0
U2 0
PU ASEAN NEUROLOGICAL ASSOC
PI KUALA LUMPUR
PA UNIV MALAYA MEDICAL CENTRE, NEUROLOGY LABORATORY, KUALA LUMPUR, 59100,
   MALAYSIA
SN 1823-6138
J9 NEUROL ASIA
JI Neurol. Asia
PD DEC
PY 2023
VL 28
IS 4
BP 1095
EP 1099
DI 10.54029/2023npx
PG 5
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA IP0Y8
UT WOS:001167427800038
OA Bronze
DA 2024-11-01
ER

PT J
AU Filosto, M
   Mancuso, M
AF Filosto, M.
   Mancuso, M.
TI Mitochondrial diseases: a nosological update
SO ACTA NEUROLOGICA SCANDINAVICA
LA English
DT Review
DE mitochondrial diseases; mtDNA; respiratory chain defects
ID CYTOCHROME-C-OXIDASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   ADENINE-NUCLEOTIDE TRANSLOCATOR; LARGE-SCALE DELETION; COMPLEX-II GENE;
   AUTOSOMAL-DOMINANT; SIDEROBLASTIC ANEMIA; POLG MUTATIONS; DNA DEPLETION;
   PATERNAL INHERITANCE
AB Mitochondrial diseases are disorders caused by impairment of the mitochondrial respiratory chain, characterized by clinical-genetic heterogeneity and frequent multisystemic involvement. It is difficult to establish a precise genotype/phenotype correlation and obtain a definitive nosology. Today's genetic classification distinguishes disorders caused by defects in the mitochondrial genome (sporadic or maternally-inherited) from disorders caused by defects in the nuclear genome (autosomally-inherited). We report an updated classification, briefly review the main clinical syndromes and describe the most recent genetic knowledge.
C1 Univ Hosp Spedali Civili Brescia, Neurol Clin, Sect Neuromuscular Dis & Neuropathies, Brescia, Italy.
   Univ Pisa, Dept Neurosci, Pisa, Italy.
C3 Hospital Spedali Civili Brescia; University of Pisa
RP Filosto, M (corresponding author), Univ Hosp Spedali Civili Brescia, Neurol Clin, Sect Neuromuscular Dis & Neuropathies, Ple Spedali Civili 1, Brescia, Italy.
EM filosto@med.unibs.it
RI Filosto, Massimiliano/S-9446-2019
OI Filosto, Massimiliano/0000-0002-2852-7512
CR Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bénit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225
   Bénit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Birch-Machin MA, 2000, ANN NEUROL, V48, P330, DOI 10.1002/1531-8249(200009)48:3<330::AID-ANA7>3.0.CO;2-A
   Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8
   Bosetti F, 2002, NEUROBIOL AGING, V23, P371, DOI 10.1016/S0197-4580(01)00314-1
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256
   Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257
   Bugiani M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029926
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   DIDONATO S, 2002, MITOCHONDRIAL DISORD, P5
   DiMauro S, 1999, J CHILD NEUROL, V14, pS23, DOI 10.1177/0883073899014001051
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   DiMauro S, 2003, BASIC APPL MYOL, V13, P145
   Dipchand AI, 2001, PEDIATR CARDIOL, V22, P14, DOI 10.1007/s002460010145
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2004, ACTA NEUROPATHOL, V108, P168, DOI 10.1007/s00401-004-0872-9
   Filosto M, 2003, ANN NEUROL, V54, P524, DOI 10.1002/ana.10709
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Gillis L, 2002, PEDIATR CLIN N AM, V49, P203, DOI 10.1016/S0031-3955(03)00115-9
   Gimm O, 2000, CANCER RES, V60, P6822
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003
   Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Koutnikova H, 1997, NAT GENET, V16, P345, DOI 10.1038/ng0897-345
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   Lewis S, 2002, J NEUROL SCI, V201, P39, DOI 10.1016/S0022-510X(02)00190-9
   Limongelli A, 2004, J MED GENET, V41, P342, DOI 10.1136/jmg.2003.016048
   LOEEN J, 1998, AM J HUM GENET, V63, P1598
   LOEEN J, 2001, ANN NEUROL, V49, P195
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Mancuso M, 2004, ACTA NEUROL SCAND, V110, P72, DOI 10.1111/j.1600-0404.2004.00254.x
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1445, DOI 10.1001/archneur.60.10.1445
   Mancuso M, 2003, EXP NEUROL, V182, P421, DOI 10.1016/S0014-4886(03)00092-X
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Mancuso M, 2003, J NEUROL SCI, V209, P61, DOI 10.1016/S0022-510X(02)00462-8
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mancuso M, 2004, NEUROSCI LETT, V371, P158, DOI 10.1016/j.neulet.2004.08.060
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Orth M, 2001, AM J MED GENET, V106, P27, DOI 10.1002/ajmg.1425
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200
   Petruzzella V, 1998, GENOMICS, V54, P494, DOI 10.1006/geno.1998.5580
   Petruzzella V, 2001, HUM MOL GENET, V10, P529, DOI 10.1093/hmg/10.5.529
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   ROTIG A, 1992, AM J HUM GENET, V50, P364
   Rowland LP, 1997, NEUROMUSCULAR DISORD, V7, pS15, DOI 10.1016/S0960-8966(97)00076-X
   Saada A, 2003, BIOCHEM BIOPH RES CO, V310, P963, DOI 10.1016/j.bbrc.2003.09.104
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   SCHON EA, 2001, MITOCHONDRIA PATHOGE, P53
   Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Servidei Serenella, 2003, Neuromuscul Disord, V13, P848
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Simon DK, 2000, NEUROLOGY, V54, P703, DOI 10.1212/WNL.54.3.703
   Simonati A, 2003, J NEUROL, V250, P702, DOI 10.1007/s00415-003-1065-5
   Spagnolo M, 2001, NEUROMUSCULAR DISORD, V11, P481, DOI 10.1016/S0960-8966(01)00195-X
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spencer CT, 2005, PEDIATR CARDIOL, V26, P632, DOI 10.1007/s00246-005-0873-z
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   STRYER L, 1989, BIOCHIMICA, P458
   Taylor RW, 2003, ANN NEUROL, V54, P521, DOI 10.1002/ana.10673
   Triepels RH, 1999, ANN NEUROL, V45, P787, DOI 10.1002/1531-8249(199906)45:6<787::AID-ANA13>3.0.CO;2-6
   Tzen CY, 2001, KIDNEY INT, V59, P846, DOI 10.1046/j.1523-1755.2001.00567.x
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Vu TH, 2002, NEUROL CLIN, V20, P809, DOI 10.1016/S0733-8619(01)00017-2
   Witherell GW, 2001, J MED VIROL, V63, P8, DOI 10.1002/1096-9071(200101)63:1<8::AID-JMV1001>3.0.CO;2-K
   Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469
   Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 117
TC 38
Z9 42
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-6314
EI 1600-0404
J9 ACTA NEUROL SCAND
JI Acta Neurol. Scand.
PD APR
PY 2007
VL 115
IS 4
BP 211
EP 221
DI 10.1111/j.1600-0404.2006.00777.x
PG 11
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 148DN
UT WOS:000245054800001
PM 17376118
OA gold
DA 2024-11-01
ER

PT J
AU Yasukawa, T
   Kirino, Y
   Ishii, N
   Holt, IJ
   Jacobs, HT
   Makifuchi, T
   Fukuhara, N
   Ohta, S
   Suzuki, T
   Watanabe, K
AF Yasukawa, T
   Kirino, Y
   Ishii, N
   Holt, IJ
   Jacobs, HT
   Makifuchi, T
   Fukuhara, N
   Ohta, S
   Suzuki, T
   Watanabe, K
TI Wobble modification deficiency in mutant tRNAs in patients with
   mitochondrial diseases
SO FEBS LETTERS
LA English
DT Article
DE mitochondrial disease; mitochondrial tRNA; patient tissue;
   post-transcriptional modification; taurine
ID TRANSFER RNALEU(UUR) GENE; CELLS LACKING MTDNA; MODIFICATION DEFECT;
   PROTEIN-SYNTHESIS; LACTIC-ACIDOSIS; WILD-TYPE; DNA; MUTATION; MYOPATHY;
   ENCEPHALOPATHY
AB Point mutations in mitochondrial (mt) tRNA genes are associated with a variety of human mitochondrial diseases. We have shown previously that mt tRNA(Leu(UUR)) with a MELAS A3243G mutation and mt tRNA(Lys) with a MERRF A8344G mutation derived from HeLa background cybrid cells are deficient in normal taurine-containing modifications [tau m(5)(s(2))U; 5-taurinomethyl-(2-thio)uridine] at the anticodon wobble position in both cases. The wobble modification deficiency results in defective translation. We report here wobble modification deficiencies of mutant mt tRNAs from cybrid cells with different nuclear backgrounds, as well as from patient tissues. These findings demonstrate the generality of the wobble modification deficiency in mutant tRNAs in MELAS and MERRF. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
C1 Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan.
   Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Bunkyo Ku, Tokyo 1138656, Japan.
   Nippon Med Coll, Grad Sch Med, Dept Biochem & Cell Biol, Inst Dev & Aging Sci, Kanagawa 2118533, Japan.
   MRC Dunn Human Nutr Unit, Cambridge CB2 2XY, England.
   Univ Tampere, Inst Med Technol, FI-33014 Tampere, Finland.
   Univ Tampere, Tampere Univ Hosp, FI-33014 Tampere, Finland.
   Saigata Natl Hosp, Dept Neuropathol, Ohgata Ku, Niigata 9493193, Japan.
   Saigata Natl Hosp, Dept Neurol, Ohgata Ku, Niigata 9493193, Japan.
C3 University of Tokyo; University of Tokyo; Nippon Medical School; UK
   Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC
   Human Nutrition Research; Tampere University; Tampere University;
   Tampere University Hospital
RP Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
EM ts@chembio.t.u-tokyo.ac.jp; kwatanab@jbirc.aist.go.jp
RI Ohta, Shigeo/HKO-9826-2023; Yasukawa, Takehiro/AAP-1335-2020; Jacobs,
   Howard/G-2434-2011; Suzuki, Tsutomu/J-1776-2015; holt, ian/AFT-2565-2022
OI Ohta, Shigeo/0000-0002-2539-470X; Jacobs, Howard/0000-0003-1895-6003;
   Kirino, Yohei/0000-0001-5232-4742; Yasukawa,
   Takehiro/0000-0001-9531-8780; Suzuki, Tsutomu/0000-0002-9731-1731; holt,
   ian/0000-0001-5468-0193
FU Medical Research Council [MC_U105663140] Funding Source: Medline; MRC
   [MC_U105663140] Funding Source: UKRI
CR Bjork G.R., 1995, TRNA, P165
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   DONISKELLER H, 1980, NUCLEIC ACIDS RES, V8, P3133, DOI 10.1093/nar/8.14.3133
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   Dunbar DR, 1996, HUM MOL GENET, V5, P123, DOI 10.1093/hmg/5.1.123
   Flierl A, 1997, J BIOL CHEM, V272, P27189, DOI 10.1074/jbc.272.43.27189
   Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   HAYASHI JI, 1993, BIOCHEM BIOPH RES CO, V197, P1049, DOI 10.1006/bbrc.1993.2584
   Helm M, 1999, NUCLEIC ACIDS RES, V27, P756, DOI 10.1093/nar/27.3.756
   Holt IJ, 1997, HUM MOL GENET, V6, P1251, DOI 10.1093/hmg/6.8.1251
   IGLOI GL, 1988, BIOCHEMISTRY-US, V27, P3842, DOI 10.1021/bi00410a048
   Jacobs HT, 2003, HUM MOL GENET, V12, pR293, DOI 10.1093/hmg/ddg285
   Kaneko T, 2003, EMBO J, V22, P657, DOI 10.1093/emboj/cdg066
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   KIRINO Y, 2005, IN PRESS RNA BIOL, V1
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Nagaike T, 2001, J BIOL CHEM, V276, P40041, DOI 10.1074/jbc.M106202200
   SCHNEIDER A, 1994, NUCLEIC ACIDS RES, V22, P3699, DOI 10.1093/nar/22.18.3699
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Shigi N, 2002, J BIOL CHEM, V277, P39128, DOI 10.1074/jbc.M207323200
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148
   Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656
   Suzuki T, 2005, TOP CURR GENET, V12, P23, DOI 10.1007/b106361
   Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200
   WAKITA K, 1994, NUCLEIC ACIDS RES, V22, P347, DOI 10.1093/nar/22.3.347
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   Yokoyama Shigeyuki, 1995, P207
NR 35
TC 65
Z9 68
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-5793
EI 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD MAY 23
PY 2005
VL 579
IS 13
BP 2948
EP 2952
DI 10.1016/j.febslet.2005.04.038
PG 5
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 931JX
UT WOS:000229482700034
PM 15893315
OA Bronze
DA 2024-11-01
ER

PT J
AU Delgado-Alvarado, M
   de la Riva, P
   Jiménez-Urbieta, H
   Gago, B
   Gabilondo, A
   Bornstein, B
   Rodríguez-Oroz, MC
AF Delgado-Alvarado, Manuel
   de la Riva, Patricia
   Jimenez-Urbieta, Haritz
   Gago, Belen
   Gabilondo, Alazne
   Bornstein, Belen
   Cruz Rodriguez-Oroz, Maria
TI Parkinsonism, cognitive deficit and behavioural disturbance caused by a
   novel mutation in the polymerase gamma gene
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE POLG; Parkinsonism; Progressive external ophthalmoplegia; Ptosis;
   Cognitive impairment; Obsessive disorder
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MITOCHONDRIAL-DNA MUTATIONS; POLG1
   GENE; DISEASE; FAMILY; ASSOCIATION; INHERITANCE; VARIANTS; PATIENT
AB Polymerase gamma (POLG) is the enzyme responsible for the replication and maintenance of mitochondrial DNA (mtDNA). Mutations in the POLG1 gene can lead to mitochondrial dysfunction, producing a wide range of neurological and non-neurological phenotypes. Neurological manifestations include ataxia, muscular weakness, epilepsy, progressive external ophthalmoplegia (PEO), ptosis, neuropathy, psychiatric disorders and, more rarely, parkinsonism. We present the case of an 80-year old female patient with a history of PEO, ptosis, childish behaviour, obsessive disorder, cognitive decline, and parldnsonism. A comprehensive study showed striatal dopamine deficiency on DaT Scan and ragged red fibres as evidenced by Gomori staining in a biopsy of the biceps brachii. Multiple deletions of mtDNA were detected, and sequencing of the POLG1 gene identified a novel substitution, 2834A>T, in exon 18, changing the p.His945Leu amino acid. In silico analysis using PolyPhen-2 (http://genetics.bwh.hardvard.edu/pph2/) predicted that this change is probably damaging, with a score of 1.0 (0-1). (C) 2015 Elsevier B.V. All rights reserved.
C1 [Delgado-Alvarado, Manuel; Jimenez-Urbieta, Haritz; Gago, Belen; Cruz Rodriguez-Oroz, Maria] Biodonostia Res Inst, Neurosci Area, San Sebastian 200014, Spain.
   [de la Riva, Patricia; Gabilondo, Alazne; Cruz Rodriguez-Oroz, Maria] Univ Hosp Donostia, San Sebastian, Spain.
   [Delgado-Alvarado, Manuel; Gago, Belen; Cruz Rodriguez-Oroz, Maria] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.
   [Bornstein, Belen] Hosp Univ Puerta de Hierro, Serv Bioquim, Madrid, Spain.
   [Bornstein, Belen] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain.
   [Cruz Rodriguez-Oroz, Maria] Basque Fdn Sci, Ikerbasque, Bilbao, Spain.
C3 University Hospital Donostia; CIBERNED; Hospital Puerta de
   Hierro-Majadahonda; CIBER - Centro de Investigacion Biomedica en Red;
   CIBERER; Basque Foundation for Science
RP Rodríguez-Oroz, MC (corresponding author), Biodonostia Res Inst, Neurosci Area, Paseo Dr Beguiristain S-N, San Sebastian 200014, Spain.
EM maria.rodriguezoroz@biodonostia.org
RI Gabilondo, Andrea/D-9259-2019; Gago, Belen/K-7234-2017; Jimenez,
   Haritz/E-9624-2018; Rodriguez Oroz, Maria Cruz/D-1490-2018
OI Gago, Belen/0000-0002-7770-9806; Jimenez, Haritz/0000-0003-1418-1634; de
   la Riva, Patricia/0000-0001-6542-868X; Rodriguez Oroz, Maria
   Cruz/0000-0001-5962-772X; GABILONDO, ALAZNE/0000-0001-5006-4481
CR Anvret A, 2010, NEUROSCI LETT, V485, P117, DOI 10.1016/j.neulet.2010.08.082
   Balafkan N, 2012, MITOCHONDRION, V12, P640, DOI 10.1016/j.mito.2012.08.004
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   Brandon BR, 2013, J NEUROL, V260, P1931, DOI 10.1007/s00415-013-6975-2
   Büeler H, 2009, EXP NEUROL, V218, P235, DOI 10.1016/j.expneurol.2009.03.006
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   di Poggio MB, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-105
   Dolhun R, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-92
   Eerola J, 2010, NEUROSCI LETT, V477, P1, DOI 10.1016/j.neulet.2010.04.021
   Famum GA, 2014, BIOCHIM BIOPHYS ACTA, V1837, P1113
   Finsterer J, 2008, J NEUROL SCI, V272, P20, DOI 10.1016/j.jns.2008.05.011
   Gui YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050086
   Gurgel-Giannetti J, 2012, MUSCLE NERVE, V45, P453, DOI 10.1002/mus.22330
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Inczedy-Farkas G, 2014, ARCH CLIN NEUROPSYCH, V29, P315, DOI 10.1093/arclin/acu016
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Milone M, 2011, ARCH NEUROL-CHICAGO, V68, P806, DOI 10.1001/archneurol.2011.124
   Mukai M, 2013, PARKINSONISM RELAT D, V19, P821, DOI 10.1016/j.parkreldis.2013.04.011
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Posada IJ, 2010, MED CLIN-BARCELONA, V135, P452, DOI 10.1016/j.medcli.2010.03.031
   Reeve A, 2013, J NEUROSCI, V33, P10790, DOI 10.1523/JNEUROSCI.3525-12.2013
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Sato K, 2011, J NEUROL, V258, P1327, DOI 10.1007/s00415-011-5936-x
   Synofzik M, 2010, MOVEMENT DISORD, V25, P243, DOI 10.1002/mds.22865
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Ylönen S, 2013, J NEUROL, V260, P3144, DOI 10.1007/s00415-013-7132-7
NR 30
TC 12
Z9 12
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD MAR 15
PY 2015
VL 350
IS 1-2
BP 93
EP 97
DI 10.1016/j.jns.2015.02.011
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA CH0UN
UT WOS:000353738000016
PM 25724872
DA 2024-11-01
ER

PT J
AU Lang-Orsini, M
   Gonzalez-Perez, P
AF Lang-Orsini, Melanie
   Gonzalez-Perez, Paloma
TI Neuropathic Pain as Main Manifestation of <i>POLG</i>-Related Disease: A
   Case Report
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE CPEO; polyneuropathy; neuropathic pain; POLG; mitochondrial disease
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MITOCHONDRIAL; MUTATIONS
AB Mutations in nuclear-encoded genes that are involved in mitochondrial DNA replication and maintenance (e.g., POLG) have been associated with chronic progressive external ophthalmoplegia (CPEO) phenotype. These nuclear genome mutations may lead to multiple mitochondrial DNA deletions or mitochondrial DNA depletion. On the other hand, primary genetic defects of mitochondrial DNA (such as single large-scale deletion or point mutations) have also been associated with the CPEO phenotype. Chronic progressive external ophthalmoplegia (CPEO) may be a manifestation of specific syndromes that, when clinically recognized, prompt clinicians to investigate specific genetic defects. Thus, CPEO, as part of Kearns Sayre syndrome, suggests the presence of a large-scale deletion of mitochondrial DNA. However, in pure CPEO or CPEO plus phenotypes, it is more difficult to know whether causative genetic defects affect the nuclear or mitochondrial DNA. Here, we present a patient with a long-standing history of CPEO plus phenotype, in whom the sequencing of mitochondrial DNA from skeletal muscle was normal, and no other genetic defect was suspected at first. At the time of our evaluation, the presence of polyneuropathy and neuropathic pain prompted us to investigate nuclear genetic defects and, specifically, mutations in the POLG gene. Thus, the sequencing of the POLG gene revealed p.Thr251Ile and p.Pro587Leu mutations in one allele, and p.Ala467Thr mutation in another allele. Although one would expect that mutations in POLG lead to multiple mitochondrial DNA deletions or depletion (loss of copies), the absence of mitochondrial DNA abnormalities in tissue may be explained by heteroplasmy, a lack or no significant involvement of biopsied tissue, or a sampling bias. So, the absence of secondary mitochondrial DNA alterations should not discourage clinicians from further investigating mutations in nuclear-encoded genes. Lastly, mitochondrial point mutations and single mitochondrial DNA deletions very rarely cause CPEO associated with polyneuropathy and neuropathic pain, and POLG-related disease should be considered in this scenario, instead.
C1 [Lang-Orsini, Melanie] Massachusetts Gen Hosp, Harvard Med Sch, Dept Pathol, Boston, MA USA.
   [Gonzalez-Perez, Paloma] Massachusetts Gen Hosp, Harvard Med Sch, Dept Neurol, Boston, MA 02114 USA.
C3 Harvard University; Massachusetts General Hospital; Harvard Medical
   School; Harvard University; Massachusetts General Hospital; Harvard
   Medical School
RP Gonzalez-Perez, P (corresponding author), Massachusetts Gen Hosp, Harvard Med Sch, Dept Neurol, Boston, MA 02114 USA.
EM pgonzalezperez@partners.org
FU Muscle Study Group; American Academy of Neurology; American Brain
   Foundation
FX PG-P is funded by Muscle Study Group in collaboration with American
   Academy of Neurology and American Brain Foundation.
CR Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Finsterer J, 2011, J NEUROL SCI, V304, P9, DOI 10.1016/j.jns.2011.02.012
   Horga A, 2014, BRAIN, V137, P3200, DOI 10.1093/brain/awu279
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   LAFORET P, 1995, NEUROMUSCULAR DISORD, V5, P399, DOI 10.1016/0960-8966(94)00080-S
   Lehmann D, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000113
   Maghbooli M, 2020, NEUROL INDIA, V68, P760, DOI 10.4103/0028-3886.293454
   Mancuso M, 2016, NEUROMUSCULAR DISORD, V26, P272, DOI 10.1016/j.nmd.2016.02.008
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0652-7
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
NR 13
TC 0
Z9 0
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
J9 FRONT NEUROL
JI Front. Neurol.
PD MAR 8
PY 2022
VL 13
AR 846110
DI 10.3389/fneur.2022.846110
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 0F3QW
UT WOS:000777278600001
PM 35350396
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Naïmi, M
   Bannwarth, S
   Procaccio, V
   Pouget, J
   Desnuelle, C
   Pellissier, JF
   Rötig, A
   Munnich, A
   Calvas, P
   Richelme, C
   Jonveaux, P
   Castelnovo, G
   Simon, M
   Clanet, M
   Wallace, D
   Paquis-Flucklinger, V
AF Naimi, Mourad
   Bannwarth, Sylvie
   Procaccio, Vincent
   Pouget, Jean
   Desnuelle, Claude
   Pellissier, Jean-Francois
   Rotig, Agnes
   Munnich, Arnold
   Calvas, Patrick
   Richelme, Christian
   Jonveaux, Philippe
   Castelnovo, Giovanni
   Simon, Melvin
   Clanet, Michel
   Wallace, Douglas
   Paquis-Flucklinger, Veronique
TI Molecular analysis of <i>ANT1</i>, <i>TWINKLE</i> and <i>POLG</i> in
   patients with multiple deletions or depletion of mitochondrial DNA by a
   dHPLC-based assay
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE mtDNA multiple deletions; mtDNA depletion; dHPLC; ANT1; TWINKLE; POLG
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; POLYMERASE-GAMMA MUTATIONS; ATAXIC
   NEUROPATHY; ALPERS-SYNDROME; SPACER-REGION
AB ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), spino-cerebellar ataxia and epilepsy (SCAE) or Alpers syndrome. In this study, we report on the mutational analysis of ANT1, TWINKLE and POLG genes in 15 unrelated patients, using a dHPLC-based protocol. This series of patients illustrates the large array of clinical presentations associated with mtDNA stability defects, ranging from isolated benign PEO to fatal Alpers syndrome. A total of seven different mutations were identified in six of 15 patients (40%). Six different recessive mutations were found in POLG, one in TWINKLE while no mutation was identified in ANT1. Among the POLG mutations, three are novel and include two missense and one frameshift changes. Seventeen neutral changes and polymorphisms were also identified, including four novel neutral polymorphisms. Overall, this study illustrates the variability of phenotypes associated with mtDNA stability defects, increases the mutational spectrum of POLG variants and provides an efficient and reliable detection protocol for ANT1, TWINKLE and POLG mutational screening.
C1 CHU Nice, Dept Med Genet, Archet Hosp 2, F-06202 Nice 3, France.
   INSERM, U145, Sch Med, Nice, France.
   Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA USA.
   CHU Marseille, Timone Hosp, Dept Neurol, Marseille, France.
   Archet Hosp 2, Dept Reeducat, Nice, France.
   CHU Marseille, Timone Hosp, Dept Neuropathol, Marseille, France.
   Hop Necker Enfants Malad, INSERM, U393, Paris, France.
   CHU Toulouse, Purpan Hosp, Dept Genet, Toulouse, France.
   CHU Nice, Dept Pediat, Archet Hosp 2, Nice, France.
   CHU Nancy, Brabois Hosp, Dept Genet, Nancy, France.
   CHU Nimes, Caremeau Hosp, Dept Neurol, Nimes, France.
   CHU Toulouse, Purpan Hosp, Dept Neurol, Toulouse, France.
   CNRS, UMR 6543, Sch Med, F-06034 Nice, France.
C3 CHU Nice; Institut National de la Sante et de la Recherche Medicale
   (Inserm); Universite Cote d'Azur; University of California System;
   University of California Irvine; Aix-Marseille Universite; Assistance
   Publique-Hopitaux de Marseille; CHU Nice; Aix-Marseille Universite;
   Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux
   Paris (APHP); Universite Paris Cite; Hopital Universitaire
   Necker-Enfants Malades - APHP; Institut National de la Sante et de la
   Recherche Medicale (Inserm); CHU de Toulouse; Universite de Toulouse;
   Universite Toulouse III - Paul Sabatier; CHU Nice; CHU de Nancy;
   Universite de Montpellier; CHU de Nimes; CHU de Toulouse; Universite de
   Toulouse; Universite Toulouse III - Paul Sabatier; Universite Cote
   d'Azur; Centre National de la Recherche Scientifique (CNRS)
RP Paquis-Flucklinger, V (corresponding author), CHU Nice, Dept Med Genet, Archet Hosp 2, 151,Route St Antoine Ginestiere,BP 3079, F-06202 Nice 3, France.
EM paquis@hermes.unice.fr
RI Procaccio, Vincent/M-2596-2015; ROTIG, AGNES/G-9592-2017
OI Simon, Mariella/0000-0002-8200-3277; ROTIG, AGNES/0000-0003-0589-0703;
   procaccio, Vincent/0000-0002-1537-4684
CR Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
NR 15
TC 41
Z9 43
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD AUG
PY 2006
VL 14
IS 8
BP 917
EP 922
DI 10.1038/sj.ejhg.5201627
PG 6
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 067TU
UT WOS:000239326300009
PM 16639411
OA Bronze
DA 2024-11-01
ER

PT J
AU Kin, T
   Sugie, K
   Hirano, M
   Goto, Y
   Nishino, I
   Ueno, S
AF Kin, Tesseki
   Sugie, Kazuma
   Hirano, Makito
   Goto, Yu-ichi
   Nishino, Ichizo
   Ueno, Satoshi
TI Humanin expression in skeletal muscles of patients with chronic
   progressive external ophthalmoplegia
SO JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE humanin; chronic progressive external ophthalmoplegia; mitochondrial
   disease; ragged-red fiber; Leigh syndrome
ID MITOCHONDRIAL; MUTATIONS; MELAS
AB We showed that humanin (HN), an endogenous peptide against Alzheimer disease-related insults, was expressed in muscles of patients with chronic progressive external ophthalmoplegia (CPEO), a major mitochondrial disease. Because HN was recently found to block proapoptotic Bax function and exert its versatile cytoprotective effects in association with an increase in ATP levels, HN expression may thus reflect a physiological response against degenerative changes in the muscles of patients with CPEO. We found HN expression in all four patients examined, each of whom had different mitochondrial DNA mutations including two different single DNA deletions, multiple deletions, and no major mutations detected. We also found that HN expression was not linked to focal cytochrome c deficiency, strongly associated with the subtype of CPEO with single deletions. These results suggest that HN expression is more closely related to degenerative changes in all types of CPEO. Notably, HN was also expressed in non-degenerative muscle fibers of patients with CPEO or Leigh syndrome, who had the 8993T > G mutation in the mitochondrial ATPase 6 gene known to be associated with impaired ATP synthesis. Collectively, our findings suggest that HN may be specifically expressed in response to defects in energy production in muscles with mitochondrial abnormalities.
C1 Nara Med Univ, Sch Med, Dept Neurol, Kashihara, Nara 6348522, Japan.
   Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo, Japan.
   Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo, Japan.
C3 Nara Medical University; National Center for Neurology & Psychiatry -
   Japan; National Center for Neurology & Psychiatry - Japan
RP Hirano, M (corresponding author), Nara Med Univ, Sch Med, Dept Neurol, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.
EM hirano_makito@yahoo.co.jp
RI Nishino, Ichizo/G-2676-2010
OI Nishino, Ichizo/0000-0001-9452-112X
CR Akanuma J, 2000, J HUM GENET, V45, P337, DOI 10.1007/s100380070004
   BROWN MD, 1994, J BIOENERG BIOMEMBR, V26, P273, DOI 10.1007/BF00763099
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1995, MUSCLE NERVE       S, V3, P107
   Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627
   Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498
   Kariya S, 2005, ACTA NEUROPATHOL, V109, P367, DOI 10.1007/s00401-004-0965-5
   Kariya S, 2005, NEUROPEPTIDES, V39, P97, DOI 10.1016/j.npep.2004.11.004
   Kariya S, 2003, MOL CELL BIOCHEM, V254, P83, DOI 10.1023/A:1027372519726
   Lee Andrew G, 2002, Curr Neurol Neurosci Rep, V2, P413, DOI 10.1007/s11910-002-0067-5
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   MORGANHUGHES JA, 1994, MYOLOGY BASIC CLIN, V2, P1610
   Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
   Wallace DC, 2000, AM HEART J, V139, pS70, DOI 10.1067/mhj.2000.103934
NR 17
TC 32
Z9 33
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1434-5161
EI 1435-232X
J9 J HUM GENET
JI J. Hum. Genet.
PD JUN
PY 2006
VL 51
IS 6
BP 555
EP 558
DI 10.1007/s10038-006-0397-2
PG 4
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 056NX
UT WOS:000238532300008
PM 16639504
OA Bronze
DA 2024-11-01
ER

PT J
AU Pinto, M
   Moraes, CT
AF Pinto, Milena
   Moraes, Carlos T.
TI Mitochondrial genome changes and neurodegenerative diseases
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Review
DE Mitochondrion; mtDNA; Encephalopathy
ID COMPLEX-I-DEFICIENCY; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; HEREDITARY
   OPTIC NEUROPATHY; MULTIPLE MTDNA DELETIONS; DNA POLYMERASE-GAMMA; MOUSE
   MODEL; ALZHEIMERS-DISEASE; LEIGH-SYNDROME; OXIDATIVE STRESS;
   PEARSON-SYNDROME
AB Mitochondria are essential organelles within the cell where most of the energy production occurs by the oxidative phosphorylation system (OXPHOS). Critical components of the OXPHOS are encoded by the mitochondrial DNA (mtDNA) and therefore, mutations involving this genome can be deleterious to the cell. Post-mitotic tissues, such as muscle and brain, are most sensitive to mtDNA changes, due to their high energy requirements and non-proliferative status. It has been proposed that mtDNA biological features and location make it vulnerable to mutations, which accumulate over time. However, although the role of mtDNA damage has been conclusively connected to neuronal impairment in mitochondrial diseases, its role in age-related neurodegenerative diseases remains speculative. Here we review the pathophysiology of mtDNA mutations leading to neurodegeneration and discuss the insights obtained by studying mouse models of mtDNA dysfunction. This article is part of a Special Issue entitled: Misfolded Proteins, Mitochondrial Dysfunction, and Neurodegenerative Diseases. (C) 2013 Published by Elsevier B.V.
C1 [Pinto, Milena; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
   [Moraes, Carlos T.] Univ Miami, Miller Sch Med, Grad Program Neurosci, Miami, FL 33136 USA.
   [Pinto, Milena; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA.
C3 University of Miami; University of Miami; University of Miami
RP Moraes, CT (corresponding author), Univ Miami, Dept Neurol, 1420 NW 9th Ave, Coconut Grove, FL 33133 USA.
EM cmoraes@med.miami.edu
RI Moraes, Carlos/AAT-3818-2021; pinto, milena/K-6095-2017
OI pinto, milena/0000-0001-9202-1527
FU NEI NIH HHS [R01 EY010804] Funding Source: Medline; NIA NIH HHS [R01
   AG036871] Funding Source: Medline; NINDS NIH HHS [R01 NS079965] Funding
   Source: Medline
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Andalib S, 2013, J NEUROL SCI, V330, P10, DOI 10.1016/j.jns.2013.04.018
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Area-Gomez E, 2012, EMBO J, V31, P4106, DOI 10.1038/emboj.2012.202
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Beretta S, 2004, BRAIN, V127, P2183, DOI 10.1093/brain/awh258
   Borthwick Gillian M, 2006, Ann Neurol, V59, P570, DOI 10.1002/ana.20758
   Bourdon A., NAT GENET, V39
   Braak H., 2002, J NEUROL S3, V249, P1, DOI [10.1007/s00415-002-1301-4, DOI 10.1007/S00415-002-1301-4]
   Brandon BR, 2013, J NEUROL, V260, P1931, DOI 10.1007/s00415-013-6975-2
   Calkins MJ, 2011, HUM MOL GENET, V20, P4515, DOI 10.1093/hmg/ddr381
   Campbell GR, 2013, NEUROPATH APPL NEURO, V39, P377, DOI 10.1111/j.1365-2990.2012.01290.x
   Carelli V, 2004, BBA-BIOENERGETICS, V1658, P172, DOI 10.1016/j.bbabio.2004.05.009
   Chen JX, 2010, J ALZHEIMERS DIS, V20, pS569, DOI 10.3233/JAD-2010-100357
   Chen T, 2011, J HUM GENET, V56, P689, DOI 10.1038/jhg.2011.97
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Dai Y, 2013, MITOCHONDRION, V13, P282, DOI 10.1016/j.mito.2013.03.006
   DeBrosse S, 2012, SEMIN PEDIATR NEUROL, V19, P194, DOI 10.1016/j.spen.2012.09.006
   Dhaliwal GK, 2000, NEUROREPORT, V11, P2507, DOI 10.1097/00001756-200008030-00032
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Donovan LE, 2006, J CLIN ENDOCR METAB, V91, P4737, DOI 10.1210/jc.2006-1498
   Duno M, 2013, GENE, V515, P372, DOI 10.1016/j.gene.2012.12.066
   Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Ekstrand MI, 2009, PARKINSONISM RELAT D, V15, pS185, DOI 10.1016/S1353-8020(09)70811-9
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elson JL, 2006, HUM GENET, V119, P241, DOI 10.1007/s00439-005-0123-8
   Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Fukae J, 2007, MITOCHONDRION, V7, P58, DOI 10.1016/j.mito.2006.12.002
   FUKUHARA N, 1991, REV NEUROL, V147, P476
   Fukui H, 2007, P NATL ACAD SCI USA, V104, P14163, DOI 10.1073/pnas.0705738104
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Ingram CJE, 2012, AMYOTROPH LATERAL SC, V13, P341, DOI 10.3109/17482968.2012.654394
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Jeppesen DK, 2011, PROG NEUROBIOL, V94, P166, DOI 10.1016/j.pneurobio.2011.04.013
   Kasahara A, 2006, HUM MOL GENET, V15, P871, DOI 10.1093/hmg/ddl005
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Keeney PM, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-21
   Kelly RDW, 2012, NUCLEIC ACIDS RES, V40, P10124, DOI 10.1093/nar/gks770
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Kirches E, 1999, PATHOBIOLOGY, V67, P214, DOI 10.1159/000028075
   Koilkonda RD, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/179412
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Krishnan KJ, 2012, NEUROBIOL AGING, V33, P2210, DOI 10.1016/j.neurobiolaging.2011.08.009
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   LARSSON NG, 1995, MUSCLE NERVE, pS102
   Lauritzen KH, 2011, MECH AGEING DEV, V132, P424, DOI 10.1016/j.mad.2011.02.006
   Lee HF, 2007, EUR J PAEDIATR NEURO, V11, P208, DOI 10.1016/j.ejpn.2006.12.008
   Leshinsky-Silver E, 2003, MOL GENET METAB, V79, P288, DOI 10.1016/S1096-7192(03)00097-0
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Long JG, 2012, J ALZHEIMERS DIS, V30, P545, DOI 10.3233/JAD-2012-120283
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Lv H, 2013, CLIN NEUROPATHOL, V32, P16, DOI 10.5414/NP300464
   Mancuso Michelangelo, 2008, Human Genomics, V3, P71
   Manea EM, 2009, J PEDIAT HEMATOL ONC, V31, P947, DOI 10.1097/MPH.0b013e3181bbc4ef
   Marin SE, 2013, GENE, V516, P162, DOI 10.1016/j.gene.2012.12.024
   Martín MA, 2005, ARCH NEUROL-CHICAGO, V62, P659, DOI 10.1001/archneur.62.4.659
   McKenzie M, 2004, P NATL ACAD SCI USA, V101, P1685, DOI 10.1073/pnas.0303184101
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Miller C, 2011, BBA-MOL BASIS DIS, V1812, P625, DOI 10.1016/j.bbadis.2011.01.013
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Nakada K, 2011, EXP ANIM TOKYO, V60, P421
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Olmos PR, 2011, J OTOLARYNGOL-HEAD N, V40, P93, DOI 10.2310/7070.2010.100078
   Palin EJH, 2013, BRAIN, V136, P2379, DOI 10.1093/brain/awt160
   Pandit A, 2009, J NEUROL SCI, V279, P14, DOI 10.1016/j.jns.2009.01.009
   Pickrell AM, 2011, J NEUROSCI, V31, P17649, DOI 10.1523/JNEUROSCI.4871-11.2011
   Pickrell AM, 2011, J NEUROSCI, V31, P9895, DOI 10.1523/JNEUROSCI.6223-10.2011
   Pinkert CA, 2007, METHOD CELL BIOL, V80, P549, DOI 10.1016/S0091-679X(06)80027-0
   Pinto M, 2013, NEUROBIOL AGING, V34, P2399, DOI 10.1016/j.neurobiolaging.2013.04.014
   Pinto M, 2012, BIOL CHEM, V393, P275, DOI 10.1515/hsz-2011-0236
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Reeve A, 2013, J NEUROSCI, V33, P10790, DOI 10.1523/JNEUROSCI.3525-12.2013
   Ro LS, 2003, MUSCLE NERVE, V28, P737, DOI 10.1002/mus.10504
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Santorelli FM, 1997, NEUROLOGY, V49, P270, DOI 10.1212/WNL.49.1.270
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741
   Schon EA, 2013, MOL CELL NEUROSCI, V55, P26, DOI 10.1016/j.mcn.2012.07.011
   Schon EA, 2010, J ALZHEIMERS DIS, V20, pS281, DOI 10.3233/JAD-2010-100495
   Sheng BY, 2012, J NEUROCHEM, V120, P419, DOI 10.1111/j.1471-4159.2011.07581.x
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Song LY, 2012, HUM MOL GENET, V21, P5147, DOI 10.1093/hmg/dds365
   Sorensen L, J NEUROSCI, V21
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   Spector Reynold, 2010, Cerebrospinal Fluid Res, V7, P14, DOI 10.1186/1743-8454-7-14
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A., NAT GENET, V38
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Spruijt L, 2006, AM J OPHTHALMOL, V141, P676, DOI 10.1016/j.ajo.2005.11.007
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011395
   Suh BC, 2013, MOL MED REP, V8, P17, DOI 10.3892/mmr.2013.1479
   Tanaka N, 2010, MITOCHONDRION, V10, P32, DOI 10.1016/j.mito.2009.08.008
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   Thorburn DR, 1993, GENEREVIEWS
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Uusimaa J., 2013, EUR J HUM G IN PRESS
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909
   Weber K, 1997, AM J HUM GENET, V60, P373
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Williams SL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003990
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Witte ME, 2013, ACTA NEUROPATHOL, V125, P231, DOI 10.1007/s00401-012-1052-y
   Xie W., 1802, BIOCH BIOPHYS ACTA
   Yokota M, 2010, FEBS LETT, V584, P3943, DOI 10.1016/j.febslet.2010.07.048
   Zhao DH, 2013, CLIN NEUROL NEUROSUR, V115, P1490, DOI 10.1016/j.clineuro.2012.11.011
   Zhou L, 1997, J NEUROSCI, V17, P7746
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 140
TC 56
Z9 64
U1 1
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD AUG
PY 2014
VL 1842
IS 8
SI SI
BP 1198
EP 1207
DI 10.1016/j.bbadis.2013.11.012
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA AL2TL
UT WOS:000338978200005
PM 24252612
OA Bronze, Green Accepted
DA 2024-11-01
ER

PT J
AU Downham, E
   Winterthun, S
   Nakkestad, HL
   Hirth, A
   Halvorsen, T
   Taylor, RW
   Bindoff, LA
AF Downham, Esther
   Winterthun, Synnove
   Nakkestad, Hanne Linda
   Hirth, Asle
   Halvorsen, Thomas
   Taylor, Robert W.
   Bindoff, Laurence A.
TI A novel mitochondrial ND5 (<i>MTND5</i>) gene mutation giving. isolated
   exercise intolerance
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE miochondrial DNA; exercise intolerance; muscle disease; MTND5
ID RESPIRATORY-CHAIN; DNA; SUBUNIT; DEHYDROGENASE; MYOPATHY; DISEASE
AB We describe a patient with isolated exercise intolerance caused by a new, maternally inherited mutation in mitochondrial DNA. The heteroplasmic T>C transition at position 13271 in MTND5 affects a highly conserved base and segregates with the disease, being present at highest levels in skeletal muscle fibres showing abnormal mitochondrial accumulation. This is the 15th mutation affecting the MTND5 subunit of respiratory chain complex I and confirms this protein as an important site for disease with phenotypes ranging from MELAS and infantile encephalopathies to isolated syndromes affecting a single tissue such as Leber hereditary optic neuropathy and now skeletal muscle. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Downham, Esther; Winterthun, Synnove; Nakkestad, Hanne Linda; Hirth, Asle; Bindoff, Laurence A.] Univ Bergen, Heukeland Univ Hosp, Dept Clin Med, N-5021 Bergen, Norway.
   [Hirth, Asle] Haukeland Hosp, Dept Heart Dis, Bergen, Norway.
   [Halvorsen, Thomas] Haukeland Hosp, Dept Paediat, Bergen, Norway.
   [Taylor, Robert W.] Univ Newcastle, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.
   [Taylor, Robert W.] Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England.
   [Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, Bergen, Norway.
C3 University of Bergen; Haukeland University Hospital; University of
   Bergen; Haukeland University Hospital; University of Bergen; Haukeland
   University Hospital; Newcastle University - UK; Newcastle University -
   UK; University of Bergen; Haukeland University Hospital
RP Bindoff, LA (corresponding author), Univ Bergen, Heukeland Univ Hosp, Dept Clin Med, N-5021 Bergen, Norway.
EM laurence.bindoff@nevro.uib.no
RI Halvorsen, Thomas/P-6741-2015
OI Halvorsen, Thomas/0000-0003-1471-0225; Bindoff,
   Laurence/0000-0003-0988-276X
FU Wellcome Trust Funding Source: Medline; Department of Health Funding
   Source: Medline
CR Andreu AL, 1999, ANN NEUROL, V45, P820, DOI 10.1002/1531-8249(199906)45:6<820::AID-ANA22>3.0.CO;2-W
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Bai YD, 2000, MOL CELL BIOL, V20, P805, DOI 10.1128/MCB.20.3.805-815.2000
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   DiMauro S, 1999, ITAL J NEUROL SCI, V20, P387
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   *MITOMAP, 2007, HUM MIT GEN DAT PROG
   Nakamaru-Ogiso E, 2003, BIOCHEMISTRY-US, V42, P746, DOI 10.1021/bi0269660
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Pulkes T, 2005, NEUROLOGY, V64, P1091, DOI 10.1212/01.WNL.0000154471.33156.55
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Taivassalo T, 2004, BBA-BIOENERGETICS, V1659, P221, DOI 10.1016/j.bbabio.2004.09.007
   Vissing J, 2001, ANN NEUROL, V49, P672, DOI 10.1002/ana.1026
NR 19
TC 18
Z9 21
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD APR
PY 2008
VL 18
IS 4
BP 310
EP 314
DI 10.1016/j.nmd.2008.01.003
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 304PS
UT WOS:000256122000006
PM 18396045
DA 2024-11-01
ER

PT J
AU Sundaram, C
   Meena, AK
   Uppin, MS
   Govindaraj, P
   Vanniarajan, A
   Thangaraj, K
   Kaul, S
   Kekunnaya, R
   Murthy, JMK
AF Sundaram, Challa
   Meena, A. K.
   Uppin, Megha S.
   Govindaraj, P.
   Vanniarajan, A.
   Thangaraj, K.
   Kaul, Subhash
   Kekunnaya, Ramesh
   Murthy, J. M. K.
TI Contribution of muscle biopsy and genetics to the diagnosis of chronic
   progressive external opthalmoplegia of mitochondrial origin
SO JOURNAL OF CLINICAL NEUROSCIENCE
LA English
DT Article
DE Chronic progressive external; opthalmoplegia; Red ragged fiber; COX-SDH
   stain; Genetic study; tRNA
ID KEARNS-SAYRE-SYNDROME; RAGGED-RED FIBERS; PERIPHERAL NEUROPATHY; DNA
   DELETIONS; OPHTHALMOPLEGIA; ENCEPHALOMYOPATHIES; DISEASES; CYTOPATHIES;
   PATHOLOGY
AB Chronic progressive external opthalmoplegia (CPEO) is the most common phenotypic syndrome of the mitochondrial myopathies. Muscle biopsy, which provides important morphological clues for the diagnosis of mitochondrial disorders, is normal in approximately 25% of patients with CPEO, thus necessitating molecular genetic analysis for more accurate diagnosis. We aimed to study the utility of various histochemical stains in the diagnosis of CPEO on muscle biopsy and to correlate these results with genetic studies. Between May 2005 and November 2007 all 45 patients diagnosed with CPEO were included in the study (23 males; mean age at presentation, 35 years). Thirty-nine patients had CPEO only and six had CPEO plus; two had a positive family history but the remaining 39 patients had sporadic CPEO. Muscle biopsy samples were stained with hematoxylin and eosin, modified Gomori's trichrome stain, succinic dehydrogenase (SDH), cytochrome C oxidase (COX) and combined COX-SDH. Ragged red fibers were seen in 27 biopsies; seven showed characteristics of neurogenic atrophy only, and 11 were normal. The abnormal fibers were best identified on COX-SDH stain. A complete mitochondrial genome was amplified in muscle and blood samples of all patients. Mutations were found in transfer RNA, ribosomal RNA, ND, CYTB, COX I, II and III genes. Mitochondrial gene mutations were found in ten of the 11 patients with a normal muscle biopsy. The genetic mutations were classified according to their significance. The observed muscle biopsy findings were correlated with genetic mutations noted. Histological studies should be combined with genetic studies for the definitive diagnosis of CPEO syndrome. (c) 2010 Elsevier Ltd. All rights reserved.
C1 [Sundaram, Challa; Uppin, Megha S.] Nizams Inst Med Sci, Dept Pathol, Hyderabad 500082, Andhra Pradesh, India.
   [Meena, A. K.; Kaul, Subhash] Nizams Inst Med Sci, Dept Neurol, Hyderabad 500082, Andhra Pradesh, India.
   [Govindaraj, P.; Vanniarajan, A.; Thangaraj, K.] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.
   [Kekunnaya, Ramesh] LV Prasad Eye Inst, Jasti V Ramanamma Childrens Eye Care Ctr, Hyderabad, Andhra Pradesh, India.
   [Murthy, J. M. K.] Care Hosp, Inst Neurol Sci, Hyderabad, Andhra Pradesh, India.
C3 Nizam's Institute of Medical Sciences; Nizam's Institute of Medical
   Sciences; Council of Scientific & Industrial Research (CSIR) - India;
   CSIR - Centre for Cellular & Molecular Biology (CCMB); L. V. Prasad Eye
   Institute
RP Sundaram, C (corresponding author), Nizams Inst Med Sci, Dept Pathol, Hyderabad 500082, Andhra Pradesh, India.
EM challa_sundaram@yahoo.com
RI Thangaraj, Kumarasamy/G-5596-2010; Vanniarajan, A./AAB-4896-2022;
   Challa, Sundaram/JZD-6201-2024
CR Biousse V, 2003, CURR OPIN NEUROL, V16, P35, DOI 10.1097/00019052-200302000-00005
   BROCKINGTON M, 1995, J NEUROL SCI, V131, P78, DOI 10.1016/0022-510X(95)00091-F
   Carry M R, 1989, Bull Soc Belge Ophtalmol, V237, P303
   Challa S, 2004, NEUROL INDIA, V52, P512
   Chinnery PF, 1997, NEUROLOGY, V49, P1166, DOI 10.1212/WNL.49.4.1166
   Chu CC, 1997, EUR NEUROL, V37, P110, DOI 10.1159/000117420
   DeCoo IFM, 1997, J NEUROL SCI, V149, P37, DOI 10.1016/S0022-510X(97)05366-5
   DIMAURO S, 1990, NEUROL CLIN, V8, P483, DOI 10.1016/S0733-8619(18)30332-3
   FASSATI A, 1994, J NEUROL SCI, V123, P140, DOI 10.1016/0022-510X(94)90216-X
   Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3
   GEMIGNANI F, 1982, EUR NEUROL, V21, P181, DOI 10.1159/000115478
   GONATAS NK, 1965, EXCERPTA MED INT C S, V100, P606
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010
   Caballero PEJ, 2007, NEUROLOGIST, V13, P33, DOI 10.1097/01.nrl.0000252953.49721.f5
   Johns D R, 1995, Semin Ophthalmol, V10, P295, DOI 10.3109/08820539509063800
   Kawashima S, 1993, Nihon Rinsho, V51, P2391
   Kornblum C, 2004, KLIN MONATSBL AUGENH, V221, P1057, DOI 10.1055/s-2004-813830
   Laforet P, 1997, REV NEUROL, V153, P51
   MANN CYY, 2005, NEUROMUSCULAR DISORD, V15, P17
   Mehndiratta MM, 2002, NEUROL INDIA, V50, P162
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Nardin RA, 2001, MUSCLE NERVE, V24, P170, DOI 10.1002/1097-4598(200102)24:2<170::AID-MUS30>3.0.CO;2-0
   PETERSON PL, 1988, NEUROL CLIN, V6, P529, DOI 10.1016/S0733-8619(18)30859-4
   PEZESHKPOUR G, 1987, J NEUROL SCI, V77, P285, DOI 10.1016/0022-510X(87)90129-8
   RADHAKRISHNAN VV, 1998, J PATHOL MICROBIOL, V41, P5
   Rollins S, 2001, AM J CLIN PATHOL, V116, P326
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Sarnat HB, 2005, CAN J NEUROL SCI, V32, P152, DOI 10.1017/S0317167100003929
   SCHON EA, 1988, ANN NY ACAD SCI, V550, P348, DOI 10.1111/j.1749-6632.1988.tb35349.x
   Schoser BGH, 2006, STRABISMUS, V14, P107, DOI 10.1080/09273970600701218
   Tanji K, 2001, METHOD CELL BIOL, V65, P311, DOI 10.1016/S0091-679X(01)65019-2
   Thangaraj K, 2002, J ANDROL, V23, P815
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   YAMAMOTO M, 1988, ACTA NEUROPATHOL, V76, P558, DOI 10.1007/BF00689593
   YAMAMOTO M, 1991, NEUROLOGY, V41, P1822, DOI 10.1212/WNL.41.11.1822
NR 35
TC 20
Z9 22
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0967-5868
EI 1532-2653
J9 J CLIN NEUROSCI
JI J. Clin. Neurosci.
PD APR
PY 2011
VL 18
IS 4
BP 535
EP 538
DI 10.1016/j.jocn.2010.06.014
PG 4
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 747MY
UT WOS:000289325300019
PM 21277779
DA 2024-11-01
ER

PT J
AU Kelland, E
   Rupar, CA
   Prasad, AN
   Tay, KY
   Downie, A
   Prasad, C
AF Kelland, E.
   Rupar, C. A.
   Prasad, Asuri N.
   Tay, K. Y.
   Downie, A.
   Prasad, C.
TI The expanding phenotype of MELAS caused by the m.3291T&gt;C mutation in
   the <i>MT</i>-<i>TL1</i> gene
SO MOLECULAR GENETICS AND METABOLISM REPORTS
LA English
DT Article
DE MELAS; MELAS 3291T > C; tRNA(leu) ((UUR)) mutation; Phenotypic features;
   Mitochondrial
ID MITOCHONDRIAL MYOPATHY; LACTIC-ACIDOSIS; ENCEPHALOPATHY; EPISODES;
   DISEASE; DNA
AB m.3291T>C mutation in the MT-TL1 gene has been infrequently encountered in association with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS), however remains poorly characterized from a clinical perspective. In the following report we describe in detail the phenotypic features, long term follow up (>7 years) and management in a Caucasian family with MELAS due to the m.3291T>C mutation and review the literature on m.3291T>C mutation. The clinical phenotype in the proposita included overlapping features of MELAS, MERRF (Myoclonic epilepsy and ragged-red fiber syndrome), MNGIE (Mitochondrial neurogastrointestinal encephalopathy), KSS (Kearns-Sayre Syndrome) and CPEO (Chronic progressive external ophthalmoplegia). Crown Copyright (C) 2016 Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
C1 [Kelland, E.; Rupar, C. A.; Prasad, Asuri N.; Prasad, C.] Childrens Hosp London Hlth Sci Ctr, Dept Pediat, London, ON, Canada.
   [Rupar, C. A.] Childrens Hosp London Hlth Sci Ctr, Dept Biochem, London, ON, Canada.
   [Rupar, C. A.] Childrens Hosp London Hlth Sci Ctr, Dept Pathol & Lab Med, London, ON, Canada.
   [Prasad, Asuri N.] Childrens Hosp London Hlth Sci Ctr, Dept Neurol, London, ON, Canada.
   [Rupar, C. A.; Prasad, Asuri N.; Prasad, C.] Childrens Hosp London Hlth Sci Ctr, Childrens Hlth Res Inst, London, ON, Canada.
   [Tay, K. Y.] Childrens Hosp London Hlth Sci Ctr, Med Imaging, London, ON, Canada.
   [Rupar, C. A.; Prasad, Asuri N.; Tay, K. Y.; Downie, A.; Prasad, C.] Western Univ, Childrens Hosp London Hlth Sci Ctr, London, ON, Canada.
   [Downie, A.] Childrens Hosp London Hlth Sci Ctr, Paediat Psychol, London, ON, Canada.
C3 London Health Sciences Centre; London Health Sciences Centre; London
   Health Sciences Centre; London Health Sciences Centre; London Health
   Sciences Centre; London Health Sciences Centre; Western University
   (University of Western Ontario); London Health Sciences Centre; London
   Health Sciences Centre
RP Prasad, C (corresponding author), Childrens Hosp, London Hlth Sci Ctr, 800 Commissioners Rd East, London, ON N6C 2V5, Canada.
EM Chitra.Prasad@lhsc.on.ca
RI Kelland, Erin/HHZ-1599-2022; Prasad, Asuri/I-6068-2019
OI Prasad, Asuri/0000-0002-6057-1038
CR Ding Y, 2012, MITOCHONDR DNA, V23, P323, DOI 10.3109/19401736.2012.674119
   Emmanuele V, 2011, MUSCLE NERVE, V44, P448, DOI 10.1002/mus.22149
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   GOTO YI, 1994, BIOCHEM BIOPH RES CO, V202, P1624, DOI 10.1006/bbrc.1994.2119
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   Koga Y, 2012, BBA-GEN SUBJECTS, V1820, P608, DOI 10.1016/j.bbagen.2011.09.005
   Liu KM, 2014, METAB BRAIN DIS, V29, P139, DOI 10.1007/s11011-013-9464-5
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Salsano E, 2011, J NEUROL SCI, V300, P165, DOI 10.1016/j.jns.2010.09.022
   Sunami Y, 2011, NEUROL SCI, V32, P861, DOI 10.1007/s10072-011-0719-9
   Uziel G, 2000, NEUROMUSCULAR DISORD, V10, P415, DOI 10.1016/S0960-8966(99)00115-7
   Yarham JW, 2013, J NEUROL SCI, V325, P165, DOI 10.1016/j.jns.2012.12.003
NR 12
TC 13
Z9 14
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2214-4269
J9 MOL GENET METAB REP
JI Molec. Genet. Metab. Rep.
PD MAR
PY 2016
VL 6
BP 64
EP 69
DI 10.1016/j.ymgmr.2016.02.003
PG 6
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA DZ7CY
UT WOS:000386022900013
PM 27014580
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Ng, YS
   Lax, NZ
   Blain, AP
   Erskine, D
   Baker, MR
   Polvikoski, T
   Thomas, RH
   Morris, CM
   Lai, M
   Whittaker, RG
   Gebbels, A
   Winder, A
   Hall, J
   Feeney, C
   Farrugia, ME
   Hirst, C
   Roberts, M
   Lawthom, C
   Chrysostomou, A
   Murphy, K
   Baird, T
   Maddison, P
   Duncan, C
   Poulton, J
   Nesbitt, V
   Hanna, MG
   Pitceathly, RDS
   Taylor, RW
   Blakely, EL
   Schaefer, AM
   Turnbull, DM
   McFarland, R
   Gorman, GS
AF Ng, Yi Shiau
   Lax, Nichola Z.
   Blain, Alasdair P.
   Erskine, Daniel
   Baker, Mark R.
   Polvikoski, Tuomo
   Thomas, Rhys H.
   Morris, Christopher M.
   Lai, Ming
   Whittaker, Roger G.
   Gebbels, Alasdair
   Winder, Amy
   Hall, Julie
   Feeney, Catherine
   Farrugia, Maria Elena
   Hirst, Claire
   Roberts, Mark
   Lawthom, Charlotte
   Chrysostomou, Alexia
   Murphy, Kevin
   Baird, Tracey
   Maddison, Paul
   Duncan, Callum
   Poulton, Joanna
   Nesbitt, Victoria
   Hanna, Michael G.
   Pitceathly, Robert D. S.
   Taylor, Robert W.
   Blakely, Emma L.
   Schaefer, Andrew M.
   Turnbull, Doug M.
   McFarland, Robert
   Gorman, Grainne S.
TI Forecasting stroke-like episodes and outcomes in mitochondrial disease
SO BRAIN
LA English
DT Article
DE prognostic modelling; neuropathology; MELAS; mitochondrial DNA (mtDNA);
   seizures
ID MULTIVARIABLE PREDICTION MODEL; CLINICAL-FEATURES; LACTIC-ACIDOSIS; DNA
   MUTATIONS; MELAS; ENCEPHALOPATHY; DIAGNOSIS; EPILEPSY; GENE; MYOPATHY
AB In this retrospective, multicentre, observational cohort study, we sought to determine the clinical, radiological, EEG, genetics and neuropathological characteristics of mitochondrial stroke-like episodes and to identify associated risk predictors. Between January 1998 and June 2018, we identified 111 patients with genetically determined mitochondrial disease who developed stroke-like episodes. Post-mortem cases of mitochondrial disease (n = 26) were identified from Newcastle Brain Tissue Resource. The primary outcome was to interrogate the clinico-radiopathological correlates and prognostic indicators of stroke-like episode in patients with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome (MELAS). The secondary objective was to develop a multivariable prediction model to forecast stroke-like episode risk. The most common genetic cause of stroke-like episodes was the m.3243A>G variant in MT-TL1 (n = 66), followed by recessive pathogenic POLG variants (n = 22), and 11 other rarer pathogenic mitochondrial DNA variants (n = 23). The age of first stroke-like episode was available for 105 patients [mean (SD) age: 31.8 (16.1)]; a total of 35 patients (32%) presented with their first stroke-like episode >= 40 years of age. The median interval (interquartile range) between first and second stroke-like episodes was 1.33 (2.86) years; 43% of patients developed recurrent stroke-like episodes within 12 months. Clinico-radiological, electrophysiological and neuropathological findings of stroke-like episodes were consistent with the hallmarks of medically refractory epilepsy. Patients with POLG-related stroke-like episodes demonstrated more fulminant disease trajectories than cases of m.3243A>G and other mitochondrial DNA pathogenic variants, in terms of the frequency of refractory status epilepticus, rapidity of progression and overall mortality. In multivariate analysis, baseline factors of body mass index, age-adjusted blood m.3243A>G heteroplasmy, sensorineural hearing loss and serum lactate were significantly associated with risk of stroke-like episodes in patients with the m.3243A>G variant. These factors informed the development of a prediction model to assess the risk of developing stroke-like episodes that demonstrated good overall discrimination (area under the curve = 0.87, 95% CI 0.82-0.93; c-statistic = 0.89). Significant radiological and pathological features of neurodegeneration were more evident in patients harbouring pathogenic mtDNA variants compared with POLG: brain atrophy on cranial MRI (90% versus 44%, P < 0.001) and reduced mean brain weight (SD) [1044 g (148) versus 1304 g (142), P = 0.005]. Our findings highlight the often idiosyncratic clinical, radiological and EEG characteristics of mitochondrial stroke-like episodes. Early recognition of seizures and aggressive instigation of treatment may help circumvent or slow neuronal loss and abate increasing disease burden. The risk-prediction model for the m.3243A>G variant can help inform more tailored genetic counselling and prognostication in routine clinical practice.
C1 [Ng, Yi Shiau; Lax, Nichola Z.; Blain, Alasdair P.; Erskine, Daniel; Thomas, Rhys H.; Feeney, Catherine; Chrysostomou, Alexia; Taylor, Robert W.; Blakely, Emma L.; Schaefer, Andrew M.; Turnbull, Doug M.; McFarland, Robert; Gorman, Grainne S.] Newcastle Univ, Translat & Clin Res Inst, Wellcome Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Ng, Yi Shiau; Lax, Nichola Z.; Blain, Alasdair P.; Erskine, Daniel; Thomas, Rhys H.; Feeney, Catherine; Chrysostomou, Alexia; Taylor, Robert W.; Blakely, Emma L.; Schaefer, Andrew M.; Turnbull, Doug M.; McFarland, Robert; Gorman, Grainne S.] Newcastle Univ, NIHR Newcastle Biomed Res Ctr, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Ng, Yi Shiau; Lax, Nichola Z.; Blain, Alasdair P.; Erskine, Daniel; Thomas, Rhys H.; Feeney, Catherine; Chrysostomou, Alexia; Taylor, Robert W.; Blakely, Emma L.; Schaefer, Andrew M.; Turnbull, Doug M.; McFarland, Robert; Gorman, Grainne S.] Newcastle Univ, Campus Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Ng, Yi Shiau; Baker, Mark R.; Thomas, Rhys H.; Lai, Ming; Whittaker, Roger G.; Gebbels, Alasdair; Winder, Amy; Hall, Julie; Feeney, Catherine; Schaefer, Andrew M.; Gorman, Grainne S.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Royal Victoria Infirm, Directorate Neurosci, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Ng, Yi Shiau; Thomas, Rhys H.; Feeney, Catherine; Taylor, Robert W.; Blakely, Emma L.; Schaefer, Andrew M.; Turnbull, Doug M.; McFarland, Robert; Gorman, Grainne S.] NHS Highly Specialised Serv Rare Mitochondrial Di, Dept Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Baker, Mark R.; Polvikoski, Tuomo; Morris, Christopher M.] Newcastle Univ, Newcastle Brain Tissue Resource, Campus Ageing & Vital, Edwardson Bldg, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Whittaker, Roger G.] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Farrugia, Maria Elena; Baird, Tracey] Queen Elizabeth Univ Hosp, Inst Neurol Sci, Glasgow G51 4TF, Lanark, Scotland.
   [Hirst, Claire] Trust Headquarters, One Talbot Gateway,Baglan Energy Pk, Baglan SA12 7BR, Port Talbot, Wales.
   [Roberts, Mark] Salford Royal NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Greater Manchester Neurosci Ctr, Salford M6 8HD, Lancs, England.
   [Lawthom, Charlotte] Aneurin Bevan Univ Hlth Board, Aneurin Bevan Epilepsy Specialist Team, Newport NP20 2UB, Wales.
   [Murphy, Kevin] Sligo Univ Hosp, Dept Neurol, Sligo F91 H684, Ireland.
   [Maddison, Paul] Queens Med Ctr, Dept Neurol, Nottingham NG7 2UH, England.
   [Duncan, Callum] NHS Grampian, Aberdeen Royal Infirm, Dept Neurol, Aberdeen AB25 2ZN, Scotland.
   [Poulton, Joanna] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford OX3 9DU, England.
   [Nesbitt, Victoria] Univ Oxford, Dept Paediat, Med Sci Div, Oxford OX3 9DU, England.
   [Nesbitt, Victoria] Childrens Hosp, Dept Paediat, Oxford OX3 9DU, England.
   [Hanna, Michael G.; Pitceathly, Robert D. S.] UCL, Queen Sq Inst Neurol, Dept Neuromuscular Dis, London WC1N 3BG, England.
   [Hanna, Michael G.; Pitceathly, Robert D. S.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle
   University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust;
   Newcastle University - UK; Newcastle University - UK; Newcastle
   University - UK; University of Glasgow; Queen Elizabeth University
   Hospital (QEUH); Salford Royal NHS Foundation Trust; University of
   Nottingham; University of Aberdeen; University of Oxford; University of
   Oxford; University of Oxford; University of London; University College
   London; University of London; University College London; UCL Medical
   School; University College London Hospitals NHS Foundation Trust
RP Gorman, GS (corresponding author), Newcastle Univ, Translat & Clin Res Inst, Wellcome Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM grainne.gorman@ncl.ac.uk
RI Ng, Yi/AFF-1445-2022; Erskine, Daniel/AAT-6772-2021; Thomas,
   Rhys/I-3840-2019; Morris, Christopher/J-9874-2012; Blain,
   Alasdair/B-9861-2011
OI Thomas, Rhys/0000-0003-2062-8623; Ng, Yi Shiau/0000-0002-7591-2034;
   Erskine, Daniel/0000-0002-1752-5343; Hanna, Michael/0000-0003-0825-4075
FU Wellcome Centre for Mitochondrial Research [203105]; Newcastle
   University Centre for Ageing and Vitality; Biotechnology and Biological
   Sciences Research Council; UK National Institute for Health Research
   (NIHR) Biomedical Research Centre for Ageing and Age-Related Disease
   award; Lily Foundation; UK NHS Specialist Commissioners; UK Medical
   Research Council; Alzheimer's Society; Alzheimer's Research UK;
   Department of Health's National Institute for Health Research Biomedical
   Research Centres funding scheme; NIHR Clinical Lectureship in Neurology
   [CL-2016-01-003]; Medical Research Council Centre of Neuromuscular
   Diseases [MR/K000608/1]; Alzheimer's Research UK Fellowship
   [ARUK-RF2018C-005]; Medical Research Council Clinician Scientist
   Fellowship [MR/S002065/1]; Medical Research Council [MR/S005021/1,
   L016354]; Academy of Finland (AKA) [203105] Funding Source: Academy of
   Finland (AKA)
FX Work in Newcastle is supported by the Wellcome Centre for Mitochondrial
   Research (203105), Newcastle University Centre for Ageing and Vitality
   (supported by the Biotechnology and Biological Sciences Research Council
   and Medical Research Council [L016354]), UK National Institute for
   Health Research (NIHR) Biomedical Research Centre for Ageing and
   Age-Related Disease award to the Newcastle upon Tyne Hospitals National
   Health Service (NHS) Foundation Trust, the Lily Foundation, the UK NHS
   Specialist Commissioners, which funds the Rare Mitochondrial Disorders
   of Adults and Children Diagnostic Service in Newcastle upon Tyne
   (http://www.newcastle-mitochondria.com), London and Oxford. Tissue for
   this study was provided by the Newcastle Brain Tissue Resource, which is
   funded in part by a grant from the UK Medical Research Council and
   Brains for Dementia Research, a joint venture between Alzheimer's
   Society and Alzheimer's Research UK. The University College London
   Hospitals/University College London Queen Square Institute of Neurology
   sequencing facility receives a proportion of funding from the Department
   of Health's National Institute for Health Research Biomedical Research
   Centres funding scheme. Y.S.N. held an NIHR Clinical Lectureship in
   Neurology (CL-2016-01-003) and was funded by the Medical Research
   Council Centre of Neuromuscular Diseases for his PhD study
   (MR/K000608/1). D.E. is funded by an Alzheimer's Research UK Fellowship
   (ARUK-RF2018C-005). R.D.S.P. is supported by a Medical Research Council
   Clinician Scientist Fellowship (MR/S002065/1). R.D.S.P. and M.G.H. are
   funded by a Medical Research Council strategic award to establish an
   International Centre for Genomic Medicine in Neuromuscular Diseases
   (ICGNMD) (MR/S005021/1). The views expressed are those of the author(s)
   and not necessarily those of the NHS, the NIHR, or the Department of
   Health.
CR Adcock JE, 2012, J CLIN NEUROPHYSIOL, V29, P397, DOI 10.1097/WNP.0b013e31826c98fe
   Anagnostou ME, 2016, EPILEPSIA, V57, P1531, DOI 10.1111/epi.13508
   Andersen LW, 2013, MAYO CLIN PROC, V88, P1127, DOI 10.1016/j.mayocp.2013.06.012
   ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976
   Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI [10.1161/CIR.0000000000000659, 10.1161/CIR.0000000000000746]
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bertram EH, 2013, EXP NEUROL, V244, P67, DOI 10.1016/j.expneurol.2012.01.028
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Boal RL, 2019, J CLIN ENDOCR METAB, V104, P2057, DOI 10.1210/jc.2018-00957
   Chan F, 2019, BRAIN, V142, P391, DOI 10.1093/brain/awy320
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chrysostomou A, 2016, NEUROPATH APPL NEURO, V42, P477, DOI 10.1111/nan.12282
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Cianchetti C, 2017, SEIZURE-EUR J EPILEP, V52, P169, DOI 10.1016/j.seizure.2017.10.010
   Cianfoni A, 2013, EUR J RADIOL, V82, P1964, DOI 10.1016/j.ejrad.2013.05.020
   Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.1016/j.eururo.2014.11.025, 10.1038/bjc.2014.639, 10.1136/bmj.g7594, 10.7326/M14-0697, 10.1186/s12916-014-0241-z, 10.1002/bjs.9736, 10.7326/M14-0698]
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Faigle R, 2013, J CLIN NEUROPHYSIOL, V30, P505, DOI 10.1097/WNP.0b013e3182a73db9
   Fernandes Peter M, 2013, Pract Neurol, V13, P21, DOI 10.1136/practneurol-2012-000465
   Foote C, 2017, AM J KIDNEY DIS, V69, P555, DOI 10.1053/j.ajkd.2017.02.005
   Galovic M, 2018, LANCET NEUROL, V17, P143, DOI 10.1016/S1474-4422(17)30404-0
   Gibson LM, 2013, J ROY COLL PHYS EDIN, V43, P114, DOI 10.4997/JRCPE.2013.205
   Giovannini G, 2018, EPILEPSIA, V59, P120, DOI 10.1111/epi.14493
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Grier J, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000230
   Hikmat O, 2020, J INHERIT METAB DIS, V43, P726, DOI 10.1002/jimd.12211
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hocker S, 2016, JAMA NEUROL, V73, P1201, DOI 10.1001/jamaneurol.2016.1572
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kane N, 2017, CLIN NEUROPHYS PRACT, V2, P170, DOI 10.1016/j.cnp.2017.07.002
   Kaplan PW, 2004, J CLIN NEUROPHYSIOL, V21, P307
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kaufmann P, 2009, ARCH NEUROL-CHICAGO, V66, P85, DOI 10.1001/archneurol.2008.526
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Klein P, 2018, EPILEPSIA, V59, P37, DOI 10.1111/epi.13965
   Lax NZ, 2017, NEUROPATH APPL NEURO, V43, P102, DOI 10.1111/nan.12333
   Lax NZ, 2016, NEUROPATH APPL NEURO, V42, P180, DOI 10.1111/nan.12238
   Lax NZ, 2012, BRAIN, V135, P1736, DOI 10.1093/brain/aws110
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Majamaa-Voltti K, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.122648
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mendes A, 2016, SEIZURE-EUR J EPILEP, V38, P63, DOI 10.1016/j.seizure.2016.04.007
   Nakae Y, 2016, J NEUROL, V263, P127, DOI 10.1007/s00415-015-7948-4
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Ng Yi Shiau, 2019, Wellcome Open Res, V4, P201, DOI 10.12688/wellcomeopenres.15599.1
   Ng YS, 2018, EBIOMEDICINE, V30, P86, DOI 10.1016/j.ebiom.2018.02.010
   Ng Yi Shiau, 2018, Epilepsia Open, V3, P103, DOI 10.1002/epi4.12094
   Ng YS, 2016, ANN NEUROL, V80, P686, DOI 10.1002/ana.24736
   Office for National Statistics, 2011 CENS ENGL WAL
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   R Core Team R, A Language and Environment for Statistical Computing
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Samuels MA, 2006, J ROY SOC MED, V99, P219, DOI 10.1258/jrsm.99.5.219-a
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   SHAPIRA Y, 1975, NEUROLOGY, V25, P614, DOI 10.1212/WNL.25.7.614
   Smith SJM, 2005, J NEUROL NEUROSUR PS, V76, P8
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Therneau TM, 2000, STAT BIOL HEALTH, DOI 10.1007/978-1-4757-3294-8_3
   Tzoulis C, 2010, BRAIN, V133, P1428, DOI 10.1093/brain/awq067
   Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318
   Xanthos DN, 2014, NAT REV NEUROSCI, V15, P43, DOI 10.1038/nrn3617
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Zacharia TT, 2019, CLIN ANAT, V32, P1053, DOI 10.1002/ca.23439
   Zerna C, 2018, LANCET, V392, P1247, DOI 10.1016/S0140-6736(18)31874-9
   Zsurka G, 2010, J BIOENERG BIOMEMBR, V42, P443, DOI 10.1007/s10863-010-9314-7
NR 72
TC 30
Z9 31
U1 1
U2 10
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD APR 18
PY 2022
VL 145
IS 2
BP 542
EP 554
DI 10.1093/brain/awab353
EA MAR 2022
PG 13
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 0O1OF
UT WOS:000776236500001
PM 34927673
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Varhaug, KN
   Hikmat, O
   Nakkestad, HL
   Vedeler, CA
   Bindoff, LA
AF Varhaug, Kristin N.
   Hikmat, Omar
   Nakkestad, Hanne Linda
   Vedeler, Christian A.
   Bindoff, Laurence A.
TI Serum biomarkers in primary mitochondrial disorders
SO BRAIN COMMUNICATIONS
LA English
DT Article
DE mitochondrial disease; neurofilaments; FGF-21; GDF-15
AB The aim of this study was to explore the utility of the serum biomarkers neurofilament light chain, fibroblast growth factor 21 and growth and differentiation factor 15 in diagnosing primary mitochondrial disorders. We measured serum neurofilament light chain, fibroblast growth factor 21 and growth and differentiation factor 15 in 26 patients with a genetically proven mitochondrial disease. Fibroblast growth factor 21 and growth and differentiation factor 15 were measured by enzyme-linked immunosorbent assay and neurofilament light chain with the Simoa assay. Neurofilament light chain was highest in patients with multi-systemic involvement that included the central nervous system such as those with the m.3242A>G mutation. Mean neurofilament light chain was also highest in patients with epilepsy versus those without [49.74 pg/ml versus 19.7 pg/ml (P = 0.015)], whereas fibroblast growth factor 21 and growth and differentiation factor 15 levels were highest in patients with prominent myopathy, such as those with single-mitochondrial DNA deletion. Our results suggest that the combination of neurofilament light chain, fibroblast growth factor 21 and growth and differentiation factor 15 is useful in the diagnostic evaluation of mitochondrial disease. Growth and differentiation factor 15 and fibroblast growth factor 21 identify those with muscle involvement, whereas neurofilament light chain is a clear marker for central nervous system involvement independent of underlying mitochondrial pathology. Levels of neurofilament light chain appear to correlate with the degree of ongoing damage suggesting, therefore, that monitoring neurofilament light chain levels may provide prognostic information and a way of monitoring disease activity.
C1 [Varhaug, Kristin N.; Nakkestad, Hanne Linda; Vedeler, Christian A.; Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Varhaug, Kristin N.; Hikmat, Omar; Vedeler, Christian A.; Bindoff, Laurence A.] Univ Bergen, Dept Clin Med, Bergen, Norway.
   [Hikmat, Omar] Haukeland Hosp, Dept Paediat & Adolescents, Bergen, Norway.
   [Nakkestad, Hanne Linda; Vedeler, Christian A.; Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, NeurosysMed, Bergen, Norway.
C3 University of Bergen; Haukeland University Hospital; University of
   Bergen; University of Bergen; Haukeland University Hospital; University
   of Bergen; Haukeland University Hospital
RP Varhaug, KN (corresponding author), Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
EM Kristin.nielsen.varhaug@helse-bergen.no
RI Bindoff, Nathaniel/C-8050-2011
FU Torbjorg Hauge's legacy; Helse Bergen, Stimuleringsmidler [370204];
   Research Council of Norway [288164]
FX The study was supported by the Torbjorg Hauge's legacy. Funding from
   Helse Bergen, Stimuleringsmidler, Project Number 370204. Neuro-SysMed is
   jointly hosted by Haukeland University Hospital and University of
   Bergen, and supported as a Centre for Clinical Treatment Research (FKB)
   by grants from The Research Council of Norway, Project Number 288164.
CR Boenzi S, 2018, ESSAYS BIOCHEM, V62, P443, DOI 10.1042/EBC20170111
   Davis RL, 2016, NEUROLOGY, V86, P2010, DOI 10.1212/WNL.0000000000002705
   Disanto G, 2017, ANN NEUROL, V81, P857, DOI 10.1002/ana.24954
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Kalko SG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-91
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Mancuso M, 2017, NEUROMUSCULAR DISORD, V27, P1126, DOI 10.1016/j.nmd.2017.08.006
   Maresca A, 2020, J MOL MED, V98, P1467, DOI 10.1007/s00109-020-01967-y
   Montero R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148709
   Ng Yi Shiau, 2019, Wellcome Open Res, V4, P201, DOI 10.12688/wellcomeopenres.15599.1
   Sofou K, 2019, MITOCHONDRION, V46, P228, DOI 10.1016/j.mito.2018.07.002
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Turnbull D, 2011, LANCET NEUROL, V10, P777, DOI 10.1016/S1474-4422(11)70172-7
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Varhaug KN, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00338
   Varhaug KN, 2018, NEUROL-NEUROIMMUNOL, V5, DOI 10.1212/NXI.0000000000000422
   Weiss A, 2013, WIRES DEV BIOL, V2, P47, DOI 10.1002/wdev.86
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
NR 18
TC 13
Z9 13
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
EI 2632-1297
J9 BRAIN COMMUN
JI Brain Commun.
PY 2021
VL 3
IS 1
AR fcaa222
DI 10.1093/braincomms/fcaa222
EA JAN 2021
PG 7
WC Clinical Neurology; Neurosciences
WE Emerging Sources Citation Index (ESCI)
SC Neurosciences & Neurology
GA RV0UT
UT WOS:000645553500015
PM 33501425
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Zierz, CM
   Baty, K
   Blakely, EL
   Hopton, S
   Falkous, G
   Schaefer, AM
   Hadjivassiliou, M
   Sarrigiannis, PG
   Ng, YS
   Taylor, RW
AF Zierz, Charlotte M.
   Baty, Karen
   Blakely, Emma L.
   Hopton, Sila
   Falkous, Gavin
   Schaefer, Andrew M.
   Hadjivassiliou, Marios
   Sarrigiannis, Ptolemaios G.
   Ng, Yi Shiau
   Taylor, Robert W.
TI A Novel Pathogenic Variant in MT-CO2 Causes an Isolated Mitochondrial
   Complex IV Deficiency and Late-Onset Cerebellar Ataxia
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE isolated COX deficiency; cerebellar ataxia; mitochondrial DNA; single
   fibre segregation studies; heteroplasmy
ID CYTOCHROME-C-OXIDASE; SUBUNIT-II; CONSENSUS STATEMENT; MUTATION;
   DIAGNOSIS; DISEASE; ALGORITHM; CODON; ASSAY; GENE
AB Both nuclear and mitochondrial DNA defects can cause isolated cytochrome c oxidase (COX; complex IV) deficiency, leading to the development of the mitochondrial disease. We report a 52-year-old female patient who presented with a late-onset, progressive cerebellar ataxia, tremor and axonal neuropathy. No family history of neurological disorder was reported. Although her muscle biopsy demonstrated a significant COX deficiency, there was no clinical and electromyographical evidence of myopathy. Electrophysiological studies identified low frequency sinusoidal postural tremor at 3 Hz, corroborating the clinical finding of cerebellar dysfunction. Complete sequencing of the mitochondrial DNA genome in muscle identified a novel MT-CO2 variant, m.8163A>G predicting p.(Tyr193Cys). We present several lines of evidence, in proving the pathogenicity of this heteroplasmic mitochondrial DNA variant, as the cause of her clinical presentation. Our findings serve as an important reminder that full mitochondrial DNA analysis should be included in the diagnostic pipeline for investigating individuals with spinocerebellar ataxia.
C1 [Zierz, Charlotte M.; Baty, Karen; Blakely, Emma L.; Hopton, Sila; Falkous, Gavin; Schaefer, Andrew M.; Ng, Yi Shiau; Taylor, Robert W.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Baty, Karen; Blakely, Emma L.; Hopton, Sila; Falkous, Gavin; Taylor, Robert W.] Newcastle Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Mitochondrial Diagnost Lab, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Schaefer, Andrew M.; Ng, Yi Shiau] Newcastle Tyne Hosp NHS Fdn Trust, Royal Victoria Infirm, Dept Neurol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Hadjivassiliou, Marios; Sarrigiannis, Ptolemaios G.] Sheffield Teaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Acad Directorate Neurosci, Sheffield S10 2JF, S Yorkshire, England.
   [Sarrigiannis, Ptolemaios G.] Sheffield Teaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Dept Clin Neurophysiol, Sheffield S10 2JF, S Yorkshire, England.
C3 Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation
   Trust; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS
   Foundation Trust; University of Sheffield; University of Sheffield
RP Ng, YS (corresponding author), Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Ng, YS (corresponding author), Newcastle Tyne Hosp NHS Fdn Trust, Royal Victoria Infirm, Dept Neurol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
EM CharlotteZierz@web.de; karen.baty@nuth.nhs.uk; emma.watson@nuth.nhs.uk;
   sila.hopton@ncl.ac.uk; gavin.falkous@nuth.nhs.uk;
   andrew.schaefer@nuth.nhs.uk; m.hadjivassiliou@sheffield.ac.uk;
   p.sarrigiannis@sheffield.ac.uk; yi.ng@ncl.ac.uk; robert.taylor@ncl.ac.uk
RI Ng, Yi/AFF-1445-2022
OI Ng, Yi Shiau/0000-0002-7591-2034; Sarrigiannis, Ptolemaios
   G/0000-0002-8380-8755
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Newcastle
   University Centre for Ageing and Vitality - (Biotechnology and
   Biological Sciences Research Council); Newcastle University Centre for
   Ageing and Vitality - (Medical Research Council) [L016354]; UK NIHR
   Biomedical Research Centre for Ageing and Age-related disease award;
   NIHR Clinical Lectureship in Neurology [CL-2016-01-003]
FX RWT is supported by the Wellcome Centre for Mitochondrial Research
   (203105/Z/16/Z), Newcastle University Centre for Ageing and Vitality
   (supported by the Biotechnology and Biological Sciences Research Council
   and Medical Research Council L016354), UK NIHR Biomedical Research
   Centre for Ageing and Age-related disease award to the Newcastle up on
   Tyne Hospitals NHS Foundation Trust, the Lily Foundation and the UK NHS
   Specialist Commissioners which funds the "Rare Mitochondrial Disorders
   of Adults and Children" Diagnostic Service in Newcastle upon Tyne
   (http://www.newcastle-mitochondria.com/).Y.S.N.holds a NIHR Clinical
   Lectureship in Neurology (CL-2016-01-003). The views expressed are those
   of the authors and not necessarily of the NHS, NIHR, or Department of
   Health.
CR Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Bargiela David, 2015, Cerebellum Ataxias, V2, P16, DOI 10.1186/s40673-015-0035-x
   Bhatia KP, 2018, MOVEMENT DISORD, V33, P75, DOI 10.1002/mds.27121
   Cassim F, 2006, NEUROPHYSIOL CLIN, V36, P281, DOI 10.1016/j.neucli.2006.10.001
   Caviness JN, 2004, LANCET NEUROL, V3, P598, DOI 10.1016/S1474-4422(04)00880-4
   Clark KM, 1999, AM J HUM GENET, V64, P1330, DOI 10.1086/302361
   Cruccu G, 2008, CLIN NEUROPHYSIOL, V119, P1705, DOI 10.1016/j.clinph.2008.03.016
   Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303
   Fogel BL, 2014, JAMA NEUROL, V71, P1237, DOI 10.1001/jamaneurol.2014.1944
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Hadjivassiliou M, 2017, J NEUROL NEUROSUR PS, V88, P301, DOI 10.1136/jnnp-2016-314863
   Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910
   Mallaret M, 2016, J NEUROL, V263, P1314, DOI 10.1007/s00415-016-8112-5
   MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   Oláhová M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Poole OV, 2019, MITOCHONDRION, V47, P294, DOI 10.1016/j.mito.2019.02.004
   Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590
   Rak M, 2016, CLIN SCI, V130, P393, DOI 10.1042/CS20150707
   Renaud M, 2017, ANN NEUROL, V82, P892, DOI 10.1002/ana.25084
   Rocha MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15037
   Rossmanith W, 2008, J MED GENET, V45, P117, DOI 10.1136/jmg.2007.052076
   Shibasaki H, 2005, MUSCLE NERVE, V31, P157, DOI 10.1002/mus.20234
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Tranchant C, 2016, REV NEUROL-FRANCE, V172, P524, DOI 10.1016/j.neurol.2016.07.003
   Uusimaa J, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e262
   Vissing CR, 2013, NEUROLOGY, V80, P1908, DOI 10.1212/WNL.0b013e3182929fb2
   von Kleist-Retzow JC, 1999, BBA-MOL BASIS DIS, V1455, P35, DOI 10.1016/S0925-4439(99)00050-2
   Wong LJC, 2001, AM J MED GENET, V102, P95, DOI 10.1002/1096-8628(20010722)102:1<95::AID-AJMG1412>3.0.CO;2-U
   Zhadanov SI, 2006, J HUM GENET, V51, P161, DOI 10.1007/s10038-005-0340-y
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 34
TC 10
Z9 10
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD JUN
PY 2019
VL 8
IS 6
AR 789
DI 10.3390/jcm8060789
PG 9
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA II7CG
UT WOS:000475349300033
PM 31167410
OA Green Published, Green Accepted, gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Ali, A
   Esmaeil, A
   Behbehani, R
AF Ali, Ali
   Esmaeil, Ali
   Behbehani, Raed
TI Mitochondrial Chronic Progressive External Ophthalmoplegia
SO BRAIN SCIENCES
LA English
DT Review
DE chronic progressive external ophthalmoplegia; CPEO; mitochondrial
   diseases
ID NUCLEOTIDE TRANSLOCATOR 1; ALPHA-LIPOIC ACID; LEIGH-SYNDROME; DNA
   DEPLETION; LIVER-TRANSPLANTATION; DIAGNOSTIC-CRITERIA; MTDNA
   REPLICATION; MELAS SYNDROME; MUTATIONS; DEFICIENCY
AB Background: Chronic progressive external ophthalmoplegia (CPEO) is a rare disorder that can be at the forefront of several mitochondrial diseases. This review overviews mitochondrial CPEO encephalomyopathies to enhance accurate recognition and diagnosis for proper management. Methods: This study is conducted based on publications and guidelines obtained by selective review in PubMed. Randomized, double-blind, placebo-controlled trials, Cochrane reviews, and literature meta-analyses were particularly sought. Discussion: CPEO is a common presentation of mitochondrial encephalomyopathies, which can result from alterations in mitochondrial or nuclear DNA. Genetic sequencing is the gold standard for diagnosing mitochondrial encephalomyopathies, preceded by non-invasive tests such as fibroblast growth factor-21 and growth differentiation factor-15. More invasive options include a muscle biopsy, which can be carried out after uncertain diagnostic testing. No definitive treatment option is available for mitochondrial diseases, and management is mainly focused on lifestyle risk modification and supplementation to reduce mitochondrial load and symptomatic relief, such as ptosis repair in the case of CPEO. Nevertheless, various clinical trials and endeavors are still at large for achieving beneficial therapeutic outcomes for mitochondrial encephalomyopathies. Key Messages: Understanding the varying presentations and genetic aspects of mitochondrial CPEO is crucial for accurate diagnosis and management.
C1 [Ali, Ali; Esmaeil, Ali; Behbehani, Raed] Ibn Sina Hosp, Al Bahar Ophthalmol Ctr, Neuroophthalmol Unit, Kuwait 70035, Kuwait.
RP Behbehani, R (corresponding author), Ibn Sina Hosp, Al Bahar Ophthalmol Ctr, Neuroophthalmol Unit, Kuwait 70035, Kuwait.
EM ali.moh.behbahani@gmail.com; ali.moh.esmaeil@gmail.com;
   rsbehbehani@gmail.com
RI Behbehani, Raed/CAH-5715-2022
OI BEHBEHANI, RAED/0000-0002-6633-3567
CR Ahn J, 2008, BRIT J OPHTHALMOL, V92, P1685, DOI 10.1136/bjo.2008.144816
   Airhart SE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186459
   Al-Enezi M, 2008, MIDDLE EAST AFR J OP, V15, P81, DOI 10.4103/0974-9233.51998
   Alonzo JR, 2018, J BIOL CHEM, V293, P20285, DOI 10.1074/jbc.RA118.004788
   Alves CAPF, 2020, ANN NEUROL, V88, P218, DOI 10.1002/ana.25789
   Ardissone A, 2021, ORPHANET J RARE DIS, V16, DOI 10.1186/s13023-021-02029-3
   Argudo JM, 2022, CUREUS J MED SCIENCE, V14, DOI 10.7759/cureus.32709
   Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426
   Balasubramaniam S., 2020, J. Transl. Genet. Genomics, V4, P285, DOI [10.20517/jtgg.2020.34, DOI 10.20517/JTGG.2020.34]
   Berardo A, 2022, J NEUROMUSCULAR DIS, V9, P225, DOI 10.3233/JND-210786
   Bermejo-Guerrero L, 2022, J CLIN MED, V11, DOI 10.3390/jcm11010022
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Bonora E, 2021, BRAIN, V144, P1451, DOI 10.1093/brain/awab056
   Borsche M, 2024, CEREBELLUM, V23, P479, DOI 10.1007/s12311-023-01557-x
   Brecht M, 2015, JIMD REP, V19, P95, DOI 10.1007/8904_2014_375
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Bugiardini E, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000149
   Caporali L, 2018, BRAIN, V141, DOI 10.1093/brain/awx301
   Cardaioli E, 2010, NEUROL SCI, V31, P491, DOI 10.1007/s10072-010-0225-5
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Cejudo P, 2005, MUSCLE NERVE, V32, P342, DOI 10.1002/mus.20368
   Chang XL, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000018634
   Chatfield KC, 2019, JACC-BASIC TRANSL SC, V4, P147, DOI 10.1016/j.jacbts.2018.12.005
   Chatzistefanou KI, 2019, INT OPHTHALMOL, V39, P213, DOI 10.1007/s10792-017-0781-2
   Cheng WQ, 2022, FRONT NEUROL, V13, DOI 10.3389/fneur.2022.843386
   Ciesielski GL, 2016, METHODS MOL BIOL, V1351, P211, DOI 10.1007/978-1-4939-3040-1_16
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Davis RL, 2016, NEUROLOGY, V86, P2010, DOI 10.1212/WNL.0000000000002705
   de Barcelos IP, 2019, CURR OPIN NEUROL, V32, P715, DOI 10.1097/WCO.0000000000000743
   de Haas R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09417-5
   Parada-Garza JD, 2020, NEUROMUSCULAR DISORD, V30, P590, DOI 10.1016/j.nmd.2020.04.008
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Dimmock DP, 2008, LIVER TRANSPLANT, V14, P1480, DOI 10.1002/lt.21556
   Domínguez-González C, 2022, J NEUROL, V269, P3550, DOI 10.1007/s00415-021-10957-0
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   El-Hattab AW, 2018, HUM MUTAT, V39, P461, DOI 10.1002/humu.23387
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab AW, 2016, MOL GENET METAB, V117, P407, DOI 10.1016/j.ymgme.2016.01.010
   El-Hattab AW, 2012, MOL GENET METAB, V107, P247, DOI 10.1016/j.ymgme.2012.06.018
   El-Hattab AW, 2010, MOL GENET METAB, V99, P300, DOI 10.1016/j.ymgme.2009.10.003
   Erdinc D, 2023, EMBO MOL MED, V15, DOI 10.15252/emmm.202216775
   Esmaeil Ali, 2022, Front Ophthalmol (Lausanne), V2, P1077395, DOI 10.3389/fopht.2022.1077395
   Faraci M, 2007, BONE MARROW TRANSPL, V39, P563, DOI 10.1038/sj.bmt.1705638
   Fava Antonietta, 2013, J Neurodegener Dis, V2013, P454253, DOI 10.1155/2013/454253
   Feichtinger RG, 2017, AM J HUM GENET, V101, P525, DOI 10.1016/j.ajhg.2017.08.015
   Filosto M, 2018, J CLIN MED, V7, DOI 10.3390/jcm7110389
   Finsterer Josef, 2023, J Clin Neuromuscul Dis, V24, P140, DOI 10.1097/CND.0000000000000422
   Finsterer J, 2022, CUREUS J MED SCIENCE, V14, DOI 10.7759/cureus.22716
   Finsterer J, 2018, PEDIATR NEUROL, V80, P8, DOI 10.1016/j.pediatrneurol.2017.12.005
   Finsterer J, 2017, BIOMED REP, V6, P487, DOI 10.3892/br.2017.892
   Gedikbasi A, 2023, FRONT GENET, V14, DOI 10.3389/fgene.2023.1191159
   Gimenes AC, 2015, BRAZ J MED BIOL RES, V48, P354, DOI 10.1590/1414-431X20143467
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Gorman GS, 2015, JAMA NEUROL, V72, P106, DOI 10.1001/jamaneurol.2014.1753
   Grabhorn E, 2014, LIVER TRANSPLANT, V20, P464, DOI 10.1002/lt.23830
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Halter JP, 2015, BRAIN, V138, P2847, DOI 10.1093/brain/awv226
   Han J, 2015, BRIT J OPHTHALMOL, V99, P528, DOI 10.1136/bjophthalmol-2014-305704
   Hanisch F, 2015, J NEUROL NEUROSUR PS, V86, P630, DOI 10.1136/jnnp-2013-306748
   Hikmat O, 2020, J INHERIT METAB DIS, V43, P726, DOI 10.1002/jimd.12211
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Hornby B, 2022, ORPHANET J RARE DIS, V17, DOI 10.1186/s13023-022-02469-5
   Hung KM, 2017, BBA-MOL BASIS DIS, V1863, P406, DOI 10.1016/j.bbadis.2016.11.017
   Jacinto S, 2021, FRONT CELL NEUROSCI, V15, DOI 10.3389/fncel.2021.641264
   Jacoby E, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-113773
   Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje
   Jennifer MS, 2020, ANN NONINVAS ELECTRO, V25, DOI 10.1111/anec.12681
   Jeppesen TD, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00349
   Kang YX, 2017, ANDROLOGIA, V49, DOI 10.1111/and.12711
   Katsanos KH, 2001, DIS ESOPHAGUS, V14, P63, DOI 10.1111/j.1442-2050.2001.00152.x
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kawamata H, 2011, HUM MOL GENET, V20, P2964, DOI 10.1093/hmg/ddr200
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Keshavan N, 2020, GENET MED, V22, P199, DOI 10.1038/s41436-019-0613-z
   Khan NA, 2015, INDIAN J MED RES, V141, P13
   Kistol D, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24021597
   Klumpe I, 2016, J MOL MED, V94, P645, DOI 10.1007/s00109-016-1413-4
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lapatto HAK, 2023, SCI ADV, V9, DOI 10.1126/sciadv.add5163
   Latvala T, 2002, GRAEF ARCH CLIN EXP, V240, P795, DOI 10.1007/s00417-002-0555-y
   Lee H, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7120186
   Lee J, 2009, BBA-BIOENERGETICS, V1787, P364, DOI 10.1016/j.bbabio.2009.01.014
   Lenaers G, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-46
   Li JA, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.675816
   Li YW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174437
   Liu JK, 2008, NEUROCHEM RES, V33, P194, DOI 10.1007/s11064-007-9403-0
   Llauradó A, 2023, CLIN GENET, V103, P492, DOI 10.1111/cge.14287
   Mancuso M, 2005, ARCH NEUROL-CHICAGO, V62, P745, DOI 10.1001/archneur.62.5.745
   Mani S, 2019, J NEUROL SCI, V404, P91, DOI 10.1016/j.jns.2019.07.007
   Manini A, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.906667
   Marcé-Grau A, 2019, J INHERIT METAB DIS, V42, P581, DOI 10.1002/jimd.12125
   Marchet S, 2020, HUM MUTAT, V41, P1745, DOI 10.1002/humu.24081
   Maricich S.M., 2015, Neuromuscular Disorders of Infancy, Childhood, and Adolescence, V2nd ed., P1003
   Martí R, 2004, CLIN CHEM, V50, P120, DOI 10.1373/clinchem.2003.026179
   Misic J, 2022, NUCLEIC ACIDS RES, V50, P8749, DOI 10.1093/nar/gkac661
   Montano V, 2019, CASE REP NEUROL MED, V2019, DOI 10.1155/2019/5918632
   Neergheen Viruna, 2017, J. inborn errors metab. screen., V5, pe160063
   Ng YS, 2021, ENDOCR REV, V43, P583, DOI 10.1210/endrev/bnab036
   Ng Yi Shiau, 2019, Wellcome Open Res, V4, P201, DOI 10.12688/wellcomeopenres.15599.1
   Ogawa E, 2017, J INHERIT METAB DIS, V40, P685, DOI 10.1007/s10545-017-0042-6
   OLSON W, 1972, ARCH NEUROL-CHICAGO, V26, P193, DOI 10.1001/archneur.1972.00490090019001
   Orsucci Daniele, 2019, Drugs Context, V8, P212588, DOI 10.7573/dic.212588
   Ortiz Alvaro, 2017, Int J Retina Vitreous, V3, P24, DOI 10.1186/s40942-017-0077-8
   Pek NMQ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2036-9
   Pérez-Cruz E, 2022, ENDOCRINOL DIAB NUTR, V69, P144, DOI 10.1016/j.endinu.2021.03.004
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pfeffer G, 2011, CAN J NEUROL SCI, V38, P119, DOI 10.1017/S031716710001115X
   Pineda M, 2006, ANN NEUROL, V59, P394, DOI 10.1002/ana.20746
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Quijada-Fraile P, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0217-2
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Rajabi MT, 2014, IRAN J NEUROL, V13, P185
   Ramaekers VT, 2007, NEUROPEDIATRICS, V38, P184, DOI 10.1055/s-2007-991150
   Reddy Jyothi Muni, 2019, Sudan J Paediatr, V19, P161, DOI 10.24911/SJP.106-1534158413
   RESKENIELSEN E, 1976, ACTA OPHTHALMOL, V54, P553
   Richardson C, 2005, EYE, V19, P258, DOI 10.1038/sj.eye.6701488
   Rocha EBD, 2023, NEUROMUSCULAR DISORD, V33, P692, DOI 10.1016/j.nmd.2023.06.004
   Romagnoli M, 2020, ANN CLIN TRANSL NEUR, V7, P590, DOI 10.1002/acn3.51026
   Ronchi D, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00860
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Rusecka J, 2018, J APPL GENET, V59, P43, DOI 10.1007/s13353-017-0424-3
   Sabbah HN, 2022, HEART FAIL REV, V27, P1911, DOI 10.1007/s10741-021-10177-8
   Saini Arushi Gahlot, 2021, Autops Case Rep, V11, pe2021334, DOI 10.4322/acr.2021.334
   Schaefer PM, 2022, MOL METAB, V64, DOI 10.1016/j.molmet.2022.101560
   Seed LM, 2022, MOL GENET GENOM MED, V10, DOI 10.1002/mgg3.1955
   Seitun S, 2016, CASE REP CARDIOL, V2016, DOI 10.1155/2016/1490181
   Seo KS, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00552
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Shemesh A., 2023, StatPearls
   Shintaku J, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI145660
   Shoeleh C, 2023, CUREUS J MED SCIENCE, V15, DOI 10.7759/cureus.33963
   Slone J, 2018, J GENET GENOMICS, V45, P71, DOI 10.1016/j.jgg.2017.11.008
   Sofou K, 2018, J MED GENET, V55, P21, DOI 10.1136/jmedgenet-2017-104891
   Sommerville EW, 2020, CLIN GENET, V97, P276, DOI 10.1111/cge.13652
   Strauss KA, 2013, P NATL ACAD SCI USA, V110, P3453, DOI 10.1073/pnas.1300690110
   Sulaimon LA., 2022, Adv. Redox Res, DOI DOI 10.1016/J.ARRES.2022.100037
   Sun MG, 2019, ORBIT-ABINGDON, V38, P342, DOI 10.1080/01676830.2018.1445760
   Szczesny RJ, 2013, NUCLEIC ACIDS RES, V41, P3144, DOI 10.1093/nar/gkt029
   Takata A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r92
   Tsygankova PG, 2019, J INHERIT METAB DIS, V42, P918, DOI 10.1002/jimd.12142
   Uhler JP, 2016, NUCLEIC ACIDS RES, V44, P5861, DOI 10.1093/nar/gkw468
   Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112
   Vadhul Raghav, 2019, Digit J Ophthalmol, V25, P59, DOI 10.5693/djo.02.2019.09.001
   van Tienen F, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1510-8
   Virmani MA, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23052717
   Watson E., 2020, J. Transl. Genet. Genomics, V4, P188, DOI [DOI 10.20517/JTGG.2020.31, 10.20517/jtgg.2020.31]
   Weiduschat N, 2014, NEUROLOGY, V82, P798, DOI 10.1212/WNL.0000000000000169
   Wong WK, 2022, MOV DISORD CLIN PRAC, V9, pS32, DOI 10.1002/mdc3.13538
   Wu G, 2023, NEUROLOGIST, V28, P190, DOI 10.1097/NRL.0000000000000457
   Yang MG, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.728043
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Ying YQ, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.802402
   Yoshida T, 2013, INTERNAL MED, V52, P1389, DOI 10.2169/internalmedicine.52.0188
   Yu M, 2016, CHINESE MED J-PEKING, V129, P2519, DOI 10.4103/0366-6999.191855
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2014, INVEST OPHTH VIS SCI, V55
   Zaidi AA, 2019, P NATL ACAD SCI USA, V116, P25172, DOI 10.1073/pnas.1906331116
   Zaidman I, 2021, PEDIATR BLOOD CANCER, V68, DOI 10.1002/pbc.28926
   Zelissen R, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24032679
   Zeng T, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-02309-0
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang HX, 2018, ESSAYS BIOCHEM, V62, P225, DOI 10.1042/EBC20170096
   Zhang HL, 2020, ELIFE, V9, DOI 10.7554/eLife.60827
   Zhao H, 2017, INT J BIOCHEM CELL B, V87, P86, DOI 10.1016/j.biocel.2017.04.002
   Zhao LL, 2019, ENZYMES, V45, P311, DOI 10.1016/bs.enz.2019.08.004
   Zhao Y, 2024, MOL GENET GENOM MED, V12, DOI 10.1002/mgg3.2328
   ZINTZ R, 1967, OPHTHALMOLOGICA, V153, P439, DOI 10.1159/000305086
   Zweers H, 2021, ORPHANET J RARE DIS, V16, DOI 10.1186/s13023-021-01927-w
NR 172
TC 0
Z9 0
U1 3
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3425
J9 BRAIN SCI
JI Brain Sci.
PD FEB
PY 2024
VL 14
IS 2
AR 135
DI 10.3390/brainsci14020135
PG 26
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA JI2Y9
UT WOS:001172483500001
PM 38391710
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Chanprasert, S
   Wang, J
   Weng, SW
   Enns, GM
   Boué, DR
   Wong, BL
   Mendell, JR
   Perry, DA
   Sahenk, Z
   Craigen, WJ
   Alcala, FJC
   Pascual, JM
   Melancon, S
   Zhang, VW
   Scaglia, F
   Wong, LJC
AF Chanprasert, Sirisak
   Wang, Jing
   Weng, Shao-Wen
   Enns, Gregory M.
   Boue, Daniel R.
   Wong, Brenda L.
   Mendell, Jerry R.
   Perry, Deborah A.
   Sahenk, Zarife
   Craigen, William J.
   Climent Alcala, Francisco J.
   Pascual, Juan M.
   Melancon, Serge
   Zhang, Victor Wei
   Scaglia, Fernando
   Wong, Lee-Jun C.
TI Molecular and clinical characterization of the myopathic form of
   mitochondrial DNA depletion syndrome caused by mutations in the
   thymidine kinase (<i>TK2</i>) gene
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Thymidine kinase 2 gene; Myopathic mtDNA depletion syndrome
ID MTDNA DEPLETION; TRIPHOSPHATE POOLS; REPLICATION; DEFICIENCY; SPECTRUM;
   DISEASES; DEFECT
AB Mitochondrial DNA (mtDNA) depletion syndromes (MDSs) are a clinically and molecularly heterogeneous group of mitochondrial cytopathies characterized by severe mtDNA copy number reduction in affected tissues. Clinically, MDSs are mainly categorized as myopathic, encephalomyopathic, hepatocerebral, or multi-systemic forms. To date, the myopathic form of MDS is mainly caused by mutations in the TK2 gene, which encodes thymidine kinase 2, the first and rate limiting step enzyme in the phosphorylation of pyrimidine nucleosides. We analyzed 9 unrelated families with 11 affected subjects exhibiting the myopathic form of MDS, by sequencing the TK2 gene. Twelve mutations including 4 novel mutations were detected in 9 families. Skeletal muscle specimens were available from 7 out of 11 subjects. Respiratory chain enzymatic activities in skeletal muscle were measured in 6 subjects, and enzymatic activities were reduced in 3 subjects. Quantitative analysis of mtDNA content in skeletal muscle was performed in 5 subjects, and marked mtDNA content reduction was observed in each. In addition, we outline the molecular and clinical characteristics of this syndrome in a total of 52 patients including those previously reported, and a total of 36 TK2 mutations are summarized. Clinically, hypotonia and proximal muscle weakness are the major phenotypes present in all subjects. In summary, our study expands the molecular and clinical spectrum associated with TK2 deficiency. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Chanprasert, Sirisak; Wang, Jing; Weng, Shao-Wen; Craigen, William J.; Zhang, Victor Wei; Scaglia, Fernando; Wong, Lee-Jun C.] Baylor Coll Med, Houston, TX 77030 USA.
   [Weng, Shao-Wen] Chang Gung Univ, Coll Med, Kaohsiung Med Ctr, Dept Internal Med,Chang Gung Mem Hosp, Kaohsiung, Taiwan.
   [Boue, Daniel R.; Sahenk, Zarife] Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH USA.
   [Boue, Daniel R.; Sahenk, Zarife] Nationwide Childrens Hosp, Clin Neuromuscular Lab, Columbus, OH USA.
   [Wong, Brenda L.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Neurol, Cincinnati, OH 45229 USA.
   [Mendell, Jerry R.] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA.
   [Perry, Deborah A.] Childrens Hosp & Med Ctr, Dept Pathol, Omaha, NE USA.
   [Enns, Gregory M.] Stanford Univ, Sch Med, Dept Pediat, Div Med Genet, Stanford, CA USA.
   [Pascual, Juan M.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA.
   [Climent Alcala, Francisco J.] Hosp La Paz, Madrid, Spain.
   [Melancon, Serge] McGill Univ, Div Med Genet, Montreal, PQ, Canada.
   [Craigen, William J.; Scaglia, Fernando] Texas Childrens Hosp, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Chang Gung Memorial Hospital; Chang Gung
   University; University System of Ohio; Ohio State University; Nationwide
   Childrens Hospital; Research Institute at Nationwide Children's
   Hospital; University System of Ohio; Ohio State University; Nationwide
   Childrens Hospital; Cincinnati Children's Hospital Medical Center;
   University System of Ohio; Ohio State University; Nationwide Childrens
   Hospital; Research Institute at Nationwide Children's Hospital; Stanford
   University; University of Texas System; University of Texas Southwestern
   Medical Center Dallas; Hospital Universitario La Paz; McGill University;
   Baylor College of Medicine
RP Wong, LJC (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,NAB 2015, Houston, TX 77030 USA.
EM ljwong@bcm.edu
RI Chen, Zhenghu/ABB-9207-2021; Weng, Shape wen/GYU-9746-2022
OI Pascual, Juan/0000-0002-0843-8221
CR Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   BESTWICK RK, 1982, J BIOL CHEM, V257, P9300
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Carrozzo R, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9135
   Collins J, 2009, NEUROMUSCULAR DISORD, V19, P784, DOI 10.1016/j.nmd.2009.08.002
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Frangini M, 2009, FEBS J, V276, P1104, DOI 10.1111/j.1742-4658.2008.06853.x
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Leshinsky-Silver E, 2008, EUR J PAEDIATR NEURO, V12, P309, DOI 10.1016/j.ejpn.2007.09.005
   Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Martí R, 2010, PEDIATR RES, V68, P151, DOI 10.1203/00006450-201011001-00294
   Mikkelsen NE, 2003, BIOCHEMISTRY-US, V42, P5706, DOI 10.1021/bi0340043
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Paradas C, 2013, NEUROLOGY, V80, P504, DOI 10.1212/WNL.0b013e31827f0ff7
   Pedersen CB, 2003, J BIOL CHEM, V278, P47449, DOI 10.1074/jbc.M309514200
   Pons R, 1996, PEDIATR NEUROL, V15, P153, DOI 10.1016/0887-8994(96)00118-X
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Tulinius M, 2005, NEUROMUSCULAR DISORD, V15, P412, DOI 10.1016/j.nmd.2005.03.010
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Venegas V., 2011, CURRENT PROTOCOL HUM
   Vu TH, 1998, NEUROLOGY, V50, P1783, DOI 10.1212/WNL.50.6.1783
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
   Zhang SL, 2010, MOL GENET METAB, V99, P53, DOI 10.1016/j.ymgme.2009.09.003
NR 33
TC 31
Z9 40
U1 0
U2 22
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD SEP-OCT
PY 2013
VL 110
IS 1-2
BP 153
EP 161
DI 10.1016/j.ymgme.2013.07.009
PG 9
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 209ZP
UT WOS:000323799400021
PM 23932787
DA 2024-11-01
ER

PT J
AU Celie, BM
   Mariman, A
   Boone, J
   Delesie, L
   Tobback, E
   Seneca, S
   De Paepe, B
   Vogelaers, D
   Van Coster, RN
   Bourgois, JG
AF Celie, Bert M.
   Mariman, An
   Boone, Jan
   Delesie, Liesbeth
   Tobback, Els
   Seneca, Sara
   De Paepe, Boel
   Vogelaers, Dirk
   Van Coster, Rudy N.
   Bourgois, Jan G.
TI Near-Infrared Spectroscopy Screening to Allow Detection of Pathogenic
   Mitochondrial DNA Variants in Individuals with Unexplained Abnormal
   Fatigue: A Preliminary Study
SO APPLIED SPECTROSCOPY
LA English
DT Article
DE Near-infrared spectroscopy; NIR; pathogenic mitochondrial DNA;
   unexplained abnormal fatigue; mitochondrial dysfunction
ID HEREDITARY OPTIC NEUROPATHY; DEAFNESS-ASSOCIATED MUTATIONS;
   1555A-GREATER-THAN-G MUTATION; RIBOSOMAL-RNA; PREVALENCE; NIRS;
   POPULATION
AB Unexplained abnormal fatigue is characterized by chronic fatigue persisting for at least six months and not sufficiently explained by any recognized medical condition. In this pilot study, twelve individuals with abnormal fatigue remaining unexplained after thorough screening were investigated using a near-infrared (NIR) spectroscopy handgrip test. Four of them were found to have an abnormal oxygen extraction pattern similar to participants with documented mitochondrial myopathy. In three of the four individuals, diverse mitochondrial abnormalities were documented by spectrophotometric, immunocytological, fluorescent, and morphological analyses performed in skeletal muscle and in cultured skin fibroblasts. Three of the four participants with decreased muscular oxygen extraction were each shown to harbor a different homoplasmic pathogenic mitochondrial DNA point mutation (m.961T>C, m.1555A>G, m.14484T>C). In the fourth participant, the presence of multiple large mitochondrial DNA deletions was suspected in muscle tissue. In contrast, none of the eight abnormally fatigued participants with normal NIR spectroscopy results harbored either a pathogenic mitochondrial DNA point mutation or large deletions (P<0.001). This pilot study shows that NIR spectroscopy may serve as a noninvasive screening tool to delineate a subgroup (of participants) with mitochondrial dysfunction among the large group of individuals with unexplained abnormal fatigue.
C1 [Celie, Bert M.; Boone, Jan; Bourgois, Jan G.] Univ Ghent, Dept Movement & Sports Sci, Ghent, Belgium.
   [Mariman, An; Delesie, Liesbeth; Tobback, Els; Vogelaers, Dirk] Ghent Univ Hosp, Dept Gen Internal Med, Ghent, Belgium.
   [Mariman, An; Tobback, Els; Vogelaers, Dirk] Ghent Univ Hosp, Ctr Neurophysiol Monitoring, Ghent, Belgium.
   [Boone, Jan; Bourgois, Jan G.] Ghent Univ Hosp, Ctr Sports Med, Ghent, Belgium.
   [Seneca, Sara] VUB, Univ Hosp Brussels, Ctr Med Genet, Reprod Genet & Regenerat Med Res Grp,Neurogenet R, Brussels, Belgium.
   [De Paepe, Boel; Van Coster, Rudy N.] Ghent Univ Hosp, Dept Pediat, Div Pediat Neurol & Metab, Ghent, Belgium.
C3 Ghent University; Ghent University; Ghent University Hospital; Ghent
   University; Ghent University Hospital; Ghent University; Ghent
   University Hospital; University Hospital Brussels; Vrije Universiteit
   Brussel; Ghent University; Ghent University Hospital
RP Bourgois, JG (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Movement & Sport Sci, Watersportlaan 2, B-9000 Ghent, Belgium.
EM jan.bourgois@ugent.be
RI Boone, Jan/AAC-9748-2020; De Paepe, Boel/B-7548-2013
OI Boone, Jan/0000-0002-8485-6169; Seneca, Sara/0000-0002-0853-9890; De
   Paepe, Boel/0000-0001-9403-4401
CR Billing-Ross P, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0771-6
   Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396
   Carruthers BM, 2011, J INTERN MED, V270, P327, DOI 10.1111/j.1365-2796.2011.02428.x
   Celie B, 2012, EUR J APPL PHYSIOL, V112, P2369, DOI 10.1007/s00421-011-2183-x
   Celie BM, 2016, APPL SPECTROSC, V70, P363, DOI 10.1177/0003702815620562
   Celie BM, 2015, APPL SPECTROSC, V69, P342, DOI 10.1366/14-07604
   Chen GM, 2011, INT J PEDIATR OTORHI, V75, P532, DOI 10.1016/j.ijporl.2011.01.013
   De Paepe B, 2012, PEDIATR RES, V72, P232, DOI 10.1038/pr.2012.84
   Gorman GS, 2015, NEUROMUSCULAR DISORD, V25, P563, DOI 10.1016/j.nmd.2015.03.001
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Han B, 2013, INT J PEDIATR OTORHI, V77, P1440, DOI 10.1016/j.ijporl.2013.05.040
   HARDING AE, 1995, AM J HUM GENET, V57, P77
   Leber T., 1871, ARCH OPHTHALMOL-CHIC, V17, P249
   MACKEY D, 1992, AM J HUM GENET, V51, P1218
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Mariman A, 2013, J PSYCHOSOM RES, V75, P491, DOI 10.1016/j.jpsychores.2013.07.010
   Mascialino B, 2012, EUR J OPHTHALMOL, V22, P461, DOI 10.5301/ejo.5000055
   Miller RR, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0527-8
   Gravina LP, 2007, INT J PEDIATR OTORHI, V71, P639, DOI 10.1016/j.ijporl.2006.12.015
   Raducu M, 2012, EUR J HUM GENET, V20, P945, DOI 10.1038/ejhg.2012.40
   Rahman S, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000411
   RIORDANEVA P, 1995, J MED GENET, V32, P81, DOI 10.1136/jmg.32.2.81
   Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378
   Rydzanicz M, 2009, GENET TEST MOL BIOMA, V13, P167, DOI 10.1089/gtmb.2008.0098
   Vancampenhout K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112950
   Vandebona H, 2009, NEW ENGL J MED, V360, P642, DOI 10.1056/NEJMc0806397
   Wang QJ, 2011, INT J PEDIATR OTORHI, V75, P535, DOI 10.1016/j.ijporl.2011.01.016
   Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2
NR 28
TC 1
Z9 1
U1 0
U2 17
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0003-7028
EI 1943-3530
J9 APPL SPECTROSC
JI Appl. Spectrosc.
PD MAY
PY 2018
VL 72
IS 5
BP 715
EP 724
DI 10.1177/0003702818756647
PG 10
WC Instruments & Instrumentation; Spectroscopy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Instruments & Instrumentation; Spectroscopy
GA GF5YS
UT WOS:000432044500004
PM 29336589
DA 2024-11-01
ER

PT J
AU Govers, LP
   Toka, HR
   Hariri, A
   Walsh, SB
   Bockenhauer, D
AF Govers, Larissa P.
   Toka, Hakan R.
   Hariri, Ali
   Walsh, Stephen B.
   Bockenhauer, Detlef
TI Mitochondrial DNA mutations in renal disease: an overview
SO PEDIATRIC NEPHROLOGY
LA English
DT Review
DE Mitochondrial DNA; Renal disease; Renal Fanconi syndrome; Distal
   tubulopathies; Nephrotic syndrome; Tubulointerstitial nephritis
ID KEARNS-SAYRE-SYNDROME; FANCONI-DEBRE SYNDROME; RESPIRATORY-CHAIN;
   COMPLEX-III; LACTIC ACIDEMIA; DELETION; HYPOPARATHYROIDISM;
   TRANSCRIPTION; MYOPATHY; PATIENT
AB Kidneys have a high energy demand to facilitate the reabsorption of the glomerular filtrate. For this reason, renal cells have a high density of mitochondria. Mitochondrial cytopathies can be the result of a mutation in both mitochondrial and nuclear DNA. Mitochondrial dysfunction can lead to a variety of renal manifestations. Examples of tubular manifestations are renal Fanconi Syndrome, which is often found in patients diagnosed with Kearns-Sayre and Pearson's marrow-pancreas syndrome, and distal tubulopathies, which result in electrolyte disturbances such as hypomagnesemia. Nephrotic syndrome can be a glomerular manifestation of mitochondrial dysfunction and is typically associated with focal segmental glomerular sclerosis on histology. Tubulointerstitial nephritis can also be seen in mitochondrial cytopathies and may lead to end-stage renal disease. The underlying mechanisms of these cytopathies remain incompletely understood; therefore, current therapies focus mainly on symptom relief. A better understanding of the molecular disease mechanisms is critical in order to improve treatments.
C1 [Govers, Larissa P.; Walsh, Stephen B.; Bockenhauer, Detlef] UCL, Dept Renal Med, London, England.
   [Toka, Hakan R.] Manatee Kidney Dis Consultants, Bradenton, FL USA.
   [Hariri, Ali] Sanofi Rare Dis, Clin Dev, Boston, MA USA.
   [Bockenhauer, Detlef] Great Ormond St Hosp Children NHS Fdn Trust, Renal Unit, Great Ormond St, London, England.
C3 University of London; University College London; University of London;
   University College London; Great Ormond Street Hospital for Children NHS
   Foundation Trust
RP Bockenhauer, D (corresponding author), UCL, Dept Renal Med, London, England.; Bockenhauer, D (corresponding author), Great Ormond St Hosp Children NHS Fdn Trust, Renal Unit, Great Ormond St, London, England.
EM d.bockenhauer@ucl.ac.uk
RI Toka, Hakan/AAQ-2162-2021; Walsh, Stephen/AAB-9930-2020; Bockenhauer,
   Detlef/AAF-6495-2020; Bockenhauer, Detlef/C-5951-2008
OI Bockenhauer, Detlef/0000-0001-5878-941X; Walsh,
   Stephen/0000-0002-8693-1353
CR ALLEN RJ, 1983, ANN NEUROL, V13, P679, DOI 10.1002/ana.410130620
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ARGOV Z, 1986, ANN NEUROL, V19, P598, DOI 10.1002/ana.410190615
   Astor MC, 2015, ENDOCR CONNECT, V4, P215, DOI 10.1530/EC-15-0066
   Atale A, 2009, EUR J MED GENET, V52, P23, DOI 10.1016/j.ejmg.2008.10.003
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   Au KM, 2007, PEDIATR NEPHROL, V22, P136, DOI 10.1007/s00467-006-0288-y
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Becher MW, 1999, HUM PATHOL, V30, P577, DOI 10.1016/S0046-8177(99)90204-6
   Bénit P, 2009, BBA-MOL CELL RES, V1793, P181, DOI 10.1016/j.bbamcr.2008.06.004
   BERNSEN PLJA, 1993, J NEUROL SCI, V118, P181, DOI 10.1016/0022-510X(93)90108-B
   Bhargava P, 2017, NAT REV NEPHROL, V13, P629, DOI 10.1038/nrneph.2017.107
   Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Burke DG, 2003, INT J SPORT NUTR EXE, V13, P294, DOI 10.1123/ijsnem.13.3.294
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700
   Chevalier RL, 2016, AM J PHYSIOL-RENAL, V311, pF145, DOI 10.1152/ajprenal.00164.2016
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Connor TM, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006620
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   D'Aco KE, 2013, PEDIATR NEPHROL, V28, P515, DOI 10.1007/s00467-012-2354-y
   DAS AM, 1994, EUR J PEDIATR, V153, P267, DOI 10.1007/s004310050134
   DEWHURST AG, 1986, J NEUROL NEUROSUR PS, V49, P1323, DOI 10.1136/jnnp.49.11.1323
   Dinour D, 2004, CLIN NEPHROL, V62, P149
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Emma F, 2006, PEDIATR NEPHROL, V21, P355, DOI 10.1007/s00467-005-2092-5
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   Fazzini F, 2019, KIDNEY INT, V96, P480, DOI 10.1016/j.kint.2019.04.021
   Ganetzky RD, 2018, MOL GENET METAB, V123, P301, DOI 10.1016/j.ymgme.2018.01.010
   Gilbert RD, 1996, ULTRASTRUCT PATHOL, V20, P473, DOI 10.3109/01913129609016351
   GOTO Y, 1990, J PEDIATR-US, V116, P904, DOI 10.1016/S0022-3476(05)80648-1
   Hall AM, 2015, KIDNEY INT, V87, P610, DOI 10.1038/ki.2014.297
   HARVEY JN, 1992, CLIN ENDOCRINOL, V37, P97, DOI 10.1111/j.1365-2265.1992.tb02289.x
   Isotani H, 1996, CLIN ENDOCRINOL, V45, P637, DOI 10.1046/j.1365-2265.1996.00856.x
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   Joyce E, 2017, PEDIATR NEPHROL, V32, P577, DOI 10.1007/s00467-016-3394-5
   Katsanos KH, 2001, AM J NEPHROL, V21, P150, DOI 10.1159/000046239
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Khrapko K, 2008, NAT GENET, V40, P134, DOI 10.1038/ng0208-134
   Kim KM, 2017, BMB REP, V50, P164, DOI 10.5483/BMBRep.2017.50.4.013
   Kleta R, 2018, J AM SOC NEPHROL, V29, P727, DOI 10.1681/ASN.2017060600
   Klootwijk ED, 2015, NEPHROL DIAL TRANSPL, V30, P1456, DOI 10.1093/ndt/gfu377
   Kodner CM, 2003, AM FAM PHYSICIAN, V67, P2527
   Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300
   Kuwertz-Bröking E, 2000, PEDIATR NEPHROL, V14, P495, DOI 10.1007/s004670050802
   Lee JJ, 2012, PEDIATR NEPHROL, V27, P869, DOI 10.1007/s00467-011-2096-2
   Lee YS, 2001, PEDIATR NEPHROL, V16, P710, DOI 10.1007/s004670100637
   Lim Kenneth, 2017, Clin Nephrol Case Stud, V5, P20, DOI 10.5414/CNCS109083
   MAJANDER A, 1991, PEDIATR RES, V30, P327, DOI 10.1203/00006450-199110000-00007
   Marlow FL, 2017, STEM CELL RES, V21, P178, DOI 10.1016/j.scr.2017.03.004
   Meulemans A, 2006, ARCH NEUROL-CHICAGO, V63, P1194, DOI 10.1001/archneur.63.8.1194
   Mihai Cristina Maria, 2009, J Med Case Rep, V3, P101, DOI 10.1186/1752-1947-3-101
   Mima A, 2011, RENAL FAILURE, V33, P622, DOI 10.3109/0886022X.2011.585730
   MORI K, 1991, AM J MED GENET, V38, P583, DOI 10.1002/ajmg.1320380417
   MORRIS AAM, 1995, PEDIATR NEPHROL, V9, P407, DOI 10.1007/BF00866711
   MUNNICH A, 1992, J INHERIT METAB DIS, V15, P448, DOI 10.1007/BF01799603
   NIAUDET P, 1994, PEDIATR NEPHROL, V8, P164, DOI 10.1007/BF00865468
   OGIER H, 1988, J PEDIATR-US, V112, P734, DOI 10.1016/S0022-3476(88)80690-5
   Ormazabal A, 2015, DRUG DISCOV TODAY, V20, P1349, DOI 10.1016/j.drudis.2015.07.002
   Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   PELLOCK JM, 1978, ANN NEUROL, V3, P455, DOI 10.1002/ana.410030519
   Posse V, 2015, NUCLEIC ACIDS RES, V43, P2615, DOI 10.1093/nar/gkv105
   Ramachandran A, 2017, NUCLEIC ACIDS RES, V45, P861, DOI 10.1093/nar/gkw1157
   Reilly RF, 2000, PHYSIOL REV, V80, P277, DOI 10.1152/physrev.2000.80.1.277
   RHEUBAN KS, 1983, CLIN PEDIATR, V22, P822, DOI 10.1177/000992288302201208
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sallevelt SCEH, 2017, J MED GENET, V54, P114, DOI 10.1136/jmedgenet-2016-103876
   SARASTE M, 1983, TRENDS BIOCHEM SCI, V8, P139, DOI 10.1016/0968-0004(83)90239-6
   Sato M, 2012, AUTOPHAGY, V8, P424, DOI 10.4161/auto.19243
   Scaglia F, 2003, AM J MED GENET A, V123A, P172, DOI 10.1002/ajmg.a.20315
   Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578
   SHOFFNER JM, 1995, KIDNEY INT, V47, P1101, DOI 10.1038/ki.1995.157
   SIMOPOULOS AP, 1971, J PEDIATR-US, V79, P633, DOI 10.1016/S0022-3476(71)80312-8
   Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385
   Solano A, 2004, PEDIATR NEPHROL, V19, P790, DOI 10.1007/s00467-004-1473-5
   SPERL W, 1988, EUR J PEDIATR, V147, P418, DOI 10.1007/BF00496424
   Starr MC, 2018, PEDIATR NEPHROL, V33, P1257, DOI 10.1007/s00467-018-3937-z
   SZABOLCS MJ, 1994, KIDNEY INT, V45, P1388, DOI 10.1038/ki.1994.181
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   TANIIKE M, 1992, BIOCHEM BIOPH RES CO, V186, P47, DOI 10.1016/S0006-291X(05)80773-9
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   THORNER P S, 1985, Pediatric Pathology, V4, P25
   TOPPET M, 1977, AM J DIS CHILD, V131, P437, DOI 10.1001/archpedi.1977.02120170063012
   Tzen CY, 2001, KIDNEY INT, V59, P846, DOI 10.1046/j.1523-1755.2001.00567.x
   van den Ouweland JMW, 2000, EUR J HUM GENET, V8, P195, DOI 10.1038/sj.ejhg.5200444
   VANBIERVLIET JPGM, 1977, PEDIATR RES, V11, P1088, DOI 10.1203/00006450-197711100-00005
   Wei YH, 1998, P SOC EXP BIOL MED, V217, P53
   Wilichowski E, 1997, PEDIATR RES, V41, P193, DOI 10.1203/00006450-199702000-00007
   Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521
   Yubero D, 2015, EXPERT REV MOL DIAGN, V15, P1049, DOI 10.1586/14737159.2015.1062727
   Zhang HX, 2018, ESSAYS BIOCHEM, V62, P225, DOI 10.1042/EBC20170096
   Zsurka G, 1997, HUM GENET, V99, P484, DOI 10.1007/s004390050393
NR 95
TC 36
Z9 40
U1 1
U2 6
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0931-041X
EI 1432-198X
J9 PEDIATR NEPHROL
JI Pediatr. Nephrol.
PD JAN
PY 2021
VL 36
IS 1
BP 9
EP 17
DI 10.1007/s00467-019-04404-6
EA JAN 2020
PG 9
WC Pediatrics; Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics; Urology & Nephrology
GA OZ4NF
UT WOS:000574055100001
PM 31925537
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Adhihetty, PJ
   Taivassalo, T
   Haller, RG
   Walkinshaw, DR
   Hood, DA
AF Adhihetty, Peter J.
   Taivassalo, Tanja
   Haller, Ronald G.
   Walkinshaw, Donald R.
   Hood, David A.
TI The effect of training on the expression of mitochondrial biogenesis-
   and apoptosis-related proteins in skeletal muscle of patients with mtDNA
   defects
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
ID TRANSCRIPTION FACTOR-A; RAGGED-RED FIBERS; CONTRACTILE ACTIVITY;
   ANTIOXIDANT ENZYMES; CYTOCHROME-C; OXIDATIVE CAPACITY; COACTIVATOR
   PGC-1; MAMMALIAN-CELLS; THYROID-HORMONE; MUTATION LOAD
AB The effect of training on the expression of mitochondrial biogenesis-and apoptosis-related proteins in skeletal muscle of patients with mtDNA defects. Am J Physiol Endocrinol Metab293: E672-E680, 2007. First published June 5, 2007; doi:10.1152/ajpendo.00043.2007. - Mitochondrial myopathy patients ( MMPs) have impaired oxidative phosphorylation and exercise intolerance. Endurance training of MMPs improves exercise tolerance, but also increases mutational load. To assess the regulation of mitochondrial content in MMPs, we measured proteins involved in 1) biogenesis, 2) oxidative stress, and 3) apoptosis in MMPs and healthy controls (HCs) both before and after endurance training. Before training, MMPs had a greater mitochondrial content, along with a 1.4-fold ( P < 0.05) higher expression of the biogenesis regulator peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC- 1 alpha). The DNA repair enzyme 8-oxoguanine DNA glycolase-1 (OGG-1), the antioxidant manganese superoxide dismutase (MnSOD), and the apoptotic proteins AIF and Bcl-2 were higher in MMPs compared with HCs. Aconitase, an enzyme sensitive to oxidative stress, was 52% lower ( P < 0.05) in MMPs when calculated based on an estimate of mitochondrial volume and oxidative stress-induced protein modifications tended to be higher in MMPs compared with HCs. Endurance training ( ET) induced increases in mitochondrial content in both HC subjects and MMPs, but there was no effect of training on the regulatory proteins Tfam or PGC- 1 alpha. In MMPs, training induced a selective reduction of OGG-1, an increase in MnSOD, and a reduction in aconitase activity. Thus, before training, MMPs exhibited an adaptive response of nuclear proteins indicative of a compensatory increase in mitochondrial content. Following training, several parallel adaptations occurred in MMPs and HCs, which may contribute to previously observed functional improvements of exercise in MMPs. However, our results indicate that muscle from MMPs may be exposed to greater levels of oxidative stress during the course of training. Further investigation is required to evaluate the long-term benefits of endurance training as a therapeutic intervention for mitochondrial myopathy patients.
C1 York Univ, Sch Kinesiol & Hlth Sci, N York, ON M3J 1P3, Canada.
   York Univ, Dept Biol, N York, ON M3J 1P3, Canada.
   Utah Southwestern Med Ctr, Inst Exercise & Environm Med, Dallas, TX USA.
   McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada.
C3 York University - Canada; York University - Canada; McGill University
RP Hood, DA (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, N York, ON M3J 1P3, Canada.
EM dhood@yorku.ca
CR Adhihetty PJ, 2003, EXP PHYSIOL, V88, P99, DOI 10.1113/eph8802505
   Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com
   Bengtsson J, 2001, PFLUG ARCH EUR J PHY, V443, P61, DOI 10.1007/s004240100628
   Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522
   Bohr VA, 2002, GENE, V286, P127, DOI 10.1016/S0378-1119(01)00813-7
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   de Souza-Pinto NC, 2001, CANCER RES, V61, P5378
   Di Giovanni S, 2001, MOL CELL NEUROSCI, V17, P696, DOI 10.1006/mcne.2001.0970
   DiMauro S, 2005, CURR OPIN NEUROL, V18, P538, DOI 10.1097/01.wco.0000179761.63486.1a
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399
   Gordon JW, 2001, J APPL PHYSIOL, V90, P389, DOI 10.1152/jappl.2001.90.1.389
   Grey JY, 2000, AM J PHYSIOL-CELL PH, V279, pC1393, DOI 10.1152/ajpcell.2000.279.5.C1393
   Hamilton KL, 2001, AM J PHYSIOL-HEART C, V281, pH1346, DOI 10.1152/ajpheart.2001.281.3.H1346
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Huang CC, 2002, J BIOMED SCI, V9, P527, DOI 10.1007/BF02254979
   Hudson EK, 1998, FREE RADICAL RES, V29, P573, DOI 10.1080/10715769800300611
   Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Joseph AM, 2004, AM J PHYSIOL-CELL PH, V286, pC867, DOI 10.1152/ajpcell.00191.2003
   Kunishige M, 2003, MUSCLE NERVE, V28, P484, DOI 10.1002/mus.10466
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Ljubicic V, 2004, J APPL PHYSIOL, V97, P976, DOI 10.1152/japplphysiol.00336.2004
   Mirabella M, 2000, BRAIN, V123, P93, DOI 10.1093/brain/123.1.93
   Miranda S, 1999, BIOCHEM BIOPH RES CO, V258, P44, DOI 10.1006/bbrc.1999.0580
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   ORNATSKY OI, 1995, BIOCHEM J, V311, P119, DOI 10.1042/bj3110119
   PFANNER N, 1997, CURR BIOL, V7, P100
   Pilegaard H, 2005, METABOLISM, V54, P1048, DOI 10.1016/j.metabol.2005.03.008
   Rungi AA, 2002, BBA-MOL BASIS DIS, V1586, P146, DOI 10.1016/S0925-4439(01)00072-2
   Rusanen H, 2000, BBA-MOL BASIS DIS, V1500, P10, DOI 10.1016/S0925-4439(99)00081-2
   Schneider JJ, 2000, J ENDOCRINOL, V165, P9, DOI 10.1677/joe.0.1650009
   SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SHOUBRIDGE EA, 1994, J BIOENERG BIOMEMBR, V26, P301, DOI 10.1007/BF00763101
   SHULL S, 1991, J BIOL CHEM, V266, P24398
   Taivassalo T, 1999, MUSCLE NERVE, V22, P1239, DOI 10.1002/(SICI)1097-4598(199909)22:9<1239::AID-MUS11>3.0.CO;2-W
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Takahashi M, 1998, AM J PHYSIOL-CELL PH, V274, pC1380, DOI 10.1152/ajpcell.1998.274.5.C1380
   TERJUNG RL, 1979, BIOCHEM J, V178, P569, DOI 10.1042/bj1780569
   Umaki Y, 2002, ACTA NEUROPATHOL, V103, P163
   van Empel VPM, 2005, CIRC RES, V96, pE92, DOI 10.1161/01.RES.0000172081.30327.28
   Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219
   Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200
   Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333
NR 50
TC 52
Z9 62
U1 0
U2 5
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD SEP
PY 2007
VL 293
IS 3
BP E672
EP E680
DI 10.1152/ajpendo.00043.2007
PG 9
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA 208YJ
UT WOS:000249354800006
PM 17551003
DA 2024-11-01
ER

PT J
AU van der Westhuizen, FH
   Smet, J
   Levanets, O
   Meissner-Roloff, M
   Louw, R
   Van Coster, R
   Smuts, I
AF van der Westhuizen, Francois H.
   Smet, Joel
   Levanets, Oksana
   Meissner-Roloff, Madelein
   Louw, Roan
   Van Coster, Rudy
   Smuts, Izelle
TI Aberrant synthesis of ATP synthase resulting from a novel deletion in
   mitochondrial DNA in an African patient with progressive external
   ophthalmoplegia
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
ID BRAIN MAGNETIC-RESONANCE; SPECTROPHOTOMETRIC ASSAY; DIRECT REPEATS; MR;
   SUBCOMPLEXES; BIOGENESIS; MUTATIONS; DIAGNOSIS; TISSUE; CELLS
AB A young, adult, African male patient presented with progressive proximal muscle weakness, external ophthalmoplegia and ptosis, as well as cardiac conduction abnormalities resembling Kearns-Sayre syndrome (KSS). Magnetic resonance imaging (MRI) of the brain revealed normal basal ganglia but bilateral well-circumscribed lesions in the cerebellar peduncles. Enzyme deficiencies in oxidative phosphorylation (OXPHOS) complexes I, IV and V was measured in muscle tissue. Blue native polyacrylamide gel electrophoresis (BN-PAGE) confirmed decreased protein content and activity of these complexes and revealed the presence of two catalytically active complex V sub-complexes. Upon investigation by molecular genetics, the mitochondrial DNA (mtDNA) copy number was found to be elevated and a novel deletion of 3431 bp was found in 80% of muscle mtDNA between positions 7115 and 10546, flanked by a 5 bp direct repeat sequence. In addition, it could also be concluded that the absence of mtDNA-encoded ATPase6 and ATPase8 genes in this patient clearly resulted in aberrant synthesis of ATP synthase.
C1 [van der Westhuizen, Francois H.; Levanets, Oksana; Meissner-Roloff, Madelein; Louw, Roan] North West Univ, Ctr Human Metabon, Potchefstroom, South Africa.
   [Smet, Joel; Van Coster, Rudy] Ghent Univ Hosp, Dept Paediat, Div Paediat Neurol & Metab, Ghent, Belgium.
   [Smuts, Izelle] Univ Pretoria, Steve Biko Acad Hosp, Dept Paediat, ZA-0002 Pretoria, South Africa.
C3 North West University - South Africa; Ghent University; Ghent University
   Hospital; University of Pretoria
RP Smuts, I (corresponding author), POB 32781, ZA-0134 Totiusdal, South Africa.
EM Izelle.Smuts@up.ac.za
RI van der Westhuizen, Francois/E-6959-2011; Smet, Joel/B-7428-2013
OI van der Westhuizen, Francois/0000-0002-7879-1776; Smuts,
   Izelle/0000-0002-1091-5912; Smet, Joel/0000-0002-9551-6282; Louw,
   Roan/0000-0002-6542-8644
FU Medical Research Council of South Africa
FX The authors would like to thank the Medical Research Council of South
   Africa for financial support.
CR Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Barragán-Campos HM, 2005, ARCH NEUROL-CHICAGO, V62, P737, DOI 10.1001/archneur.62.5.737
   Bianchi MC, 2007, BIOSCIENCE REP, V27, P69, DOI 10.1007/s10540-007-9046-z
   Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729
   CHRETIEN D, 1995, CLIN CHIM ACTA, V240, P129, DOI 10.1016/0009-8981(95)06145-6
   Chu BC, 1999, NEURORADIOLOGY, V41, P759, DOI 10.1007/s002340050838
   De Vriese AS, 2006, CLIN INFECT DIS, V42, P1111, DOI 10.1086/501356
   Devreese B, 2002, ELECTROPHORESIS, V23, P2525, DOI 10.1002/1522-2683(200208)23:15<2525::AID-ELPS2525>3.0.CO;2-I
   Heidenreich JO, 2006, AM J ROENTGENOL, V187, P820, DOI 10.2214/AJR.05.0180
   Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873
   Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010
   Lerman-Sagie T, 2005, MOL GENET METAB, V84, P127, DOI 10.1016/j.ymgme.2004.09.008
   LEUTNER C, 1994, AM J NEURORADIOL, V15, P681
   Mancuso M, 2007, BIOSCIENCE REP, V27, P31, DOI 10.1007/s10540-007-9035-2
   Meulemans A, 2007, ARCH NEUROL-CHICAGO, V64, P1339, DOI 10.1001/archneur.64.9.1339
   Miranda S, 1999, BIOCHEM BIOPH RES CO, V258, P44, DOI 10.1006/bbrc.1999.0580
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Selden RF, 1989, CURRENT PROTOCOLS MO, P291
   SHEPHERD D, 1969, BIOCHEM J, V114, P597, DOI 10.1042/bj1140597
   Smet J., 2005, CELL BIOL LAB HDB, V4, P259
   Smet J, 2009, ELECTROPHORESIS, V30, P3565, DOI 10.1002/elps.200900213
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   WRAY SH, 1995, AM J NEURORADIOL, V16, P1167
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
NR 32
TC 9
Z9 9
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0141-8955
EI 1573-2665
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD DEC
PY 2010
VL 33
SU 3
BP S55
EP S62
DI 10.1007/s10545-009-9020-y
PG 8
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA V33ME
UT WOS:000209022100009
PM 20082143
OA Green Submitted, Green Published
DA 2024-11-01
ER

PT J
AU Kaufmann, P
   Pascual, JM
   Anziska, Y
   Gooch, CL
   Engelstad, K
   Jhung, S
   DiMauro, S
   De Vivo, DC
AF Kaufmann, Petra
   Pascual, Juan M.
   Anziska, Yaacov
   Gooch, Clifton L.
   Engelstad, Kristin
   Jhung, Sarah
   DiMauro, Salvatore
   De Vivo, Darryl C.
TI Nerve conduction abnormalities in patients with MELAS and the A3243G
   mutation
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID PERIPHERAL NEUROPATHY; MITOCHONDRIAL-DNA; LACTIC-ACIDOSIS; MTDNA
   MUTATION; IMPAIRMENT; MYOPATHY; DISEASE
AB Background: Mitochondrial DNA point mutations are especially deleterious to tissues with high energy demand, including the peripheral nervous system. Neuropathy has been associated with several mitochondrial diseases, including MELAS (mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes).
   Objective: To evaluate nerve conduction in a genotypically and phenotypically homogeneous group of patients with MELAS and the A3243G mutation.
   Design: We studied 30 patients with MELAS and the A3243G mutation using neurophysiological techniques, medical history questionnaires, laboratory tests, and a standardized neurological examination.
   Results: Twenty-three subjects (77%) had abnormal nerve conduction measures. Symptoms suggestive of neuropathy were present in only half of the patients, but almost all had decreased reflexes or distal sensory findings on examination. Nerve conduction abnormalities were predominantly axonal and sensory and mainly present in the legs. Patients with nerve conduction abnormalities tended to be older and were more likely male.
   Conclusions: Peripheral nerve impairment is common in those with MELAS and the A3243G mutation, and may be subclinical. Male sex and older age may add to the genetic disposition to develop neuropathy.
C1 Columbia Univ, Dept Neurol, New York, NY 10032 USA.
   Columbia Univ, Dept Pediat, New York, NY 10027 USA.
C3 Columbia University; Columbia University
RP De Vivo, DC (corresponding author), Columbia Univ, Dept Neurol, 710 W 168th St, New York, NY 10032 USA.
EM dcd1@columbia.edu
RI Gooch, Clifton/M-1874-2016
OI Gooch, Clifton/0000-0002-2210-2038; Pascual, Juan/0000-0002-0843-8221
FU NCRR NIH HHS [K12 RR 017648] Funding Source: Medline; NICHD NIH HHS [P01
   HD 32062] Funding Source: Medline
CR Chu CC, 1997, EUR NEUROL, V37, P110, DOI 10.1159/000117420
   Colomer J, 2000, REV NEUROLOGIA, V30, P1117, DOI 10.33588/rn.3012.2000079
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   HARA H, 1994, J NEUROL NEUROSUR PS, V57, P1545, DOI 10.1136/jnnp.57.12.1545-a
   Karnofsky DA, 1949, EVALUATION CHEMOTHER, P196
   Kärppä M, 2003, J NEUROL, V250, P216, DOI 10.1007/s00415-003-0981-8
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   MIZUSAWA H, 1991, REV NEUROL, V147, P501
   Nardin RA, 2001, MUSCLE NERVE, V24, P170, DOI 10.1002/1097-4598(200102)24:2<170::AID-MUS30>3.0.CO;2-0
   Newman NJ, 2004, EYE, V18, P1144, DOI 10.1038/sj.eye.6701591
   PEZESHKPOUR G, 1987, J NEUROL SCI, V77, P285, DOI 10.1016/0022-510X(87)90129-8
   RUSANEN H, 1995, NEUROLOGY, V45, P1188, DOI 10.1212/WNL.45.6.1188
   Takeda K, 1989, Rinsho Shinkeigaku, V29, P643
   Uimonen S, 2001, HUM GENET, V108, P284, DOI 10.1007/s004390100475
   YIANNIKAS C, 1986, ANN NEUROL, V20, P249, DOI 10.1002/ana.410200211
NR 16
TC 42
Z9 47
U1 0
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0003-9942
EI 1538-3687
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD MAY
PY 2006
VL 63
IS 5
BP 746
EP 748
DI 10.1001/archneur.63.5.746
PG 3
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 041XQ
UT WOS:000237490600015
PM 16682545
OA Bronze
DA 2024-11-01
ER

PT J
AU Chaturvedi, S
   Bala, K
   Thakur, R
   Suri, V
AF Chaturvedi, S
   Bala, K
   Thakur, R
   Suri, V
TI Mitochondrial encephalomyopathies: advances in understanding
SO MEDICAL SCIENCE MONITOR
LA English
DT Review
DE encephalomyopathies; mitochondrial disorders
ID RAGGED-RED FIBERS; HEREDITARY OPTIC NEUROPATHY; CYTOCHROME-C-OXIDASE;
   CLINICAL-FEATURES; NECROTIZING ENCEPHALOMYELOPATHY; MYOCLONIC EPILEPSY;
   DNA; DISEASE; MTDNA; MUTATION
AB Mitochondrial encephatomyopathies encompass a group of disorders that have impaired oxidative metabolism in skeletal muscles and central nervous system. As the field of mitochondrial medicine takes shape and physicians in all specialties become increasingly aware of respiratory chain or oxidative phosphorylation (OXPHOS) related disorders, their prevalence remains largely unknown. The unique features of the mitochondrial genome and tire dual control over this important cellular apparatus makes the clinical presentation variable and diagnosis difficult. There is a confounding variation in phenotype and genotype, and the natural history of the disorders in individual patients is not accurately predictable. Only recently have things begun to fall into place and some phenotypes defined. Diagnosis requires a complex battery of clinical studies coupled with diagnostic findings on muscle biopsy (abnormal structure, histochemistry, or enzyme studies) or DNA testing. However, a reasonably confident diagnosis can be made by viewing the clinical presentation in the light of family history and some basic, routinely available laboratory investigations. This review tries to give a brief account of mitochondrial structure, function and genetics, and clinical presentation, evaluation, and treatment in suspected cases of mitochondrial encephalomyopathies.
C1 Inst Human Behav & Allied Sci, Dept Pathol, Delhi, India.
   Inst Human Behav & Allied Sci, Dept Neurol, Delhi, India.
   Inst Human Behav & Allied Sci, Dept Microbiol, Delhi, India.
RP GTB Hosp, D-2, Delhi 110095, India.
EM cysujata@hotmail.com
CR BARDOSI A, 1987, ACTA NEUROPATHOL, V74, P248, DOI 10.1007/BF00688189
   BRESOLIN N, 1985, NEUROLOGY, V35, P802, DOI 10.1212/WNL.35.6.802
   BYRNE E, 1985, J NEUROL SCI, V71, P273, DOI 10.1016/0022-510X(85)90065-6
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   DAVID E, 1998, NEUROPATHOLOGY
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   FUKUHARA N, 1985, ANN NEUROL, V18, P368, DOI 10.1002/ana.410180323
   GEYER CA, 1988, J COMPUT ASSIST TOMO, V12, P40, DOI 10.1097/00004728-198801000-00006
   Ghosh SS, 1996, AM J HUM GENET, V58, P325
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   HALL K, 1978, NEURORADIOLOGY, V16, P48, DOI 10.1007/BF00395200
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P1371
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   JENITH JP, 1996, NAT GENET, V14, P146
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Kimura S, 1997, BRAIN DEV-JPN, V19, P535, DOI 10.1016/S0387-7604(97)00074-0
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KURIYAMA M, 1984, NEUROLOGY, V34, P72, DOI 10.1212/WNL.34.1.72
   Marchington DR, 1998, AM J HUM GENET, V63, P769, DOI 10.1086/302009
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   MUKOYAMA M, 1986, J NEUROL, V233, P228, DOI 10.1007/BF00314025
   MUNNICH A, 1992, J INHERIT METAB DIS, V15, P448, DOI 10.1007/BF01799603
   NASHEF L, 1989, J NEUROL NEUROSUR PS, V52, P1090, DOI 10.1136/jnnp.52.9.1090
   NEVILLE BGR, 1993, BRAINS DIS NERVOUS S, P453
   Newman N.J., 1993, OPHTHALMOL CLIN N AM, V4, P431
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OLSON W, 1972, ARCH NEUROL-CHICAGO, V26, P193, DOI 10.1001/archneur.1972.00490090019001
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   PETERSON PL, 1988, NEUROL CLIN, V6, P529, DOI 10.1016/S0733-8619(18)30859-4
   PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915
   POULTON J, 1995, AM J HUM GENET, V57, P224
   ROBINSON BH, 1989, METABOLIC BASIS INHE, V1, P869
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   ROWLAND LP, 1991, REV NEUROL-FRANCE, V147, P467
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Shoffner JM, 2000, NEUROL CLIN, V18, P105, DOI 10.1016/S0733-8619(05)70180-8
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shoubridge EA, 1998, CURR OPIN NEUROL, V11, P491, DOI 10.1097/00019052-199810000-00012
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace Douglas C., 1993, P63
   ZEMAN J, 1998, MED SCI MONITOR, V4, P436
   Zeviani M, 1997, CURR OPIN NEUROL, V10, P160, DOI 10.1097/00019052-199704000-00015
   Zeviani Massimo, 1993, European Journal of Human Genetics, V1, P80
NR 52
TC 10
Z9 12
U1 0
U2 0
PU INT SCIENTIFIC INFORMATION, INC
PI MELVILLE
PA 150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA
SN 1643-3750
J9 MED SCI MONITOR
JI Med. Sci. Monitor
PD JUL
PY 2005
VL 11
IS 7
BP RA238
EP RA246
PG 9
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 945ZK
UT WOS:000230541300024
PM 15990701
DA 2024-11-01
ER

PT J
AU Mancuso, M
   Ricci, G
   Choub, A
   Filosto, M
   DiMauro, S
   Davidzon, G
   Tessa, A
   Santorelli, FM
   Murri, L
   Siciliano, G
AF Mancuso, Michelangelo
   Ricci, Giulia
   Choub, Anna
   Filosto, Massimiliano
   DiMauro, Salvatore
   Davidzon, Guido
   Tessa, Alessandra
   Santorelli, Filippo M.
   Murri, Luigi
   Siciliano, Gabriele
TI Autosomal dominant psychiatric disorders and mitochondrial DNA multiple
   deletions: Report of a family
SO JOURNAL OF AFFECTIVE DISORDERS
LA English
DT Article
DE mtDNA; mitochondrial disease; psychiatric symptoms; bipolar disorder;
   schizophrenia
ID BIPOLAR AFFECTIVE-DISORDER; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   MUTATION; SCHIZOPHRENIA; SYMPTOMS; DISEASE; MELAS
AB Background: Psychiatric problems, including bipolar affective disorder (BD) and schizophrenia, are common in mitochondrial diseases (MD) and frequently precede the diagnosis of mitochondrial dysfunction. However, they are rarely the only persistent manifestation of a MD and they are usually associated with other neurological or non-neuro logical features.
   Case report: Here, we describe an Italian family with multiple deletions of mtDNA in muscle, in which BD, schizophrenia, and depression recurred over several generations in the absence of other major signs of mitochondrial dysfunction.
   Conclusion: In patients with positive family history of psychiatric problems, the possibility of MD should be kept in mind, even in absence of other canonical features of mitochondrial encephalomyopathies. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Mancuso, Michelangelo; Ricci, Giulia; Choub, Anna; Murri, Luigi; Siciliano, Gabriele] Univ Pisa, Dept Neurosci, Neurol Clin, I-56126 Pisa, Italy.
   [Filosto, Massimiliano] Univ Brescia, Neurol Clin, I-25121 Brescia, Italy.
   [DiMauro, Salvatore; Davidzon, Guido] Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA.
   [Tessa, Alessandra; Santorelli, Filippo M.] Bambino Gesu Pediat Hosp, IRCCS, Rome, Italy.
C3 University of Pisa; University of Brescia; Columbia University; IRCCS
   Bambino Gesu
RP Mancuso, M (corresponding author), Univ Pisa, Dept Neurosci, Neurol Clin, Via Roma 67, I-56126 Pisa, Italy.
EM mmancuso@inwind.it
RI Filosto, Massimiliano/S-9446-2019; Mancuso, Michelangelo/K-4170-2016;
   Santorelli, Filippo M/ABE-5124-2020; Ricci, Giulia/K-6731-2016;
   Siciliano, Gabriele/K-7259-2016; tessa, alessandra/AAA-4442-2021
OI Santorelli, Filippo M/0000-0002-1359-9062; Davidzon,
   Guido/0000-0001-5579-6825; Filosto, Massimiliano/0000-0002-2852-7512;
   Ricci, Giulia/0000-0002-6612-5995; Siciliano,
   Gabriele/0000-0002-6142-2384; tessa, alessandra/0000-0002-1445-6434
CR Ben-Shachar D, 2004, INT REV NEUROBIOL, V59, P273
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Gershon E.S., 1990, Manicdepressive illness, P373
   Inagaki T, 1997, BIOL PSYCHIAT, V42, P1067, DOI 10.1016/S0006-3223(97)00351-X
   Kato T, 1997, BIOL PSYCHIAT, V42, P871, DOI 10.1016/S0006-3223(97)00012-7
   Kato T, 1998, J NEUROPSYCH CLIN N, V10, P133, DOI 10.1176/jnp.10.2.133
   Kato T, 2001, J AFFECT DISORDERS, V62, P151, DOI 10.1016/S0165-0327(99)00173-1
   Kato T, 2000, BIPOLAR DISORD, V2, P180, DOI 10.1034/j.1399-5618.2000.020305.x
   Kirk R, 1999, AM J HUM GENET, V65, P508, DOI 10.1086/302507
   Köller H, 2003, J NEUROL, V250, P1501, DOI 10.1007/s00415-003-0260-8
   Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   MCMAHON FJ, 1995, AM J HUM GENET, V56, P1277
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Thomeer EC, 1998, J NEUROL NEUROSUR PS, V64, P692, DOI 10.1136/jnnp.64.5.692
NR 18
TC 26
Z9 28
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-0327
J9 J AFFECT DISORDERS
JI J. Affect. Disord.
PD FEB
PY 2008
VL 106
IS 1-2
BP 173
EP 177
DI 10.1016/j.jad.2007.05.016
PG 5
WC Clinical Neurology; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Neurosciences & Neurology; Psychiatry
GA 258YC
UT WOS:000252905300018
PM 17588675
DA 2024-11-01
ER

PT J
AU Figuccia, S
   Degiorgi, A
   Berti, CC
   Baruffini, E
   Dallabona, C
   Goffrini, P
AF Figuccia, Sonia
   Degiorgi, Andrea
   Ceccatelli Berti, Camilla
   Baruffini, Enrico
   Dallabona, Cristina
   Goffrini, Paola
TI Mitochondrial Aminoacyl-tRNA Synthetase and Disease: The Yeast
   Contribution for Functional Analysis of Novel Variants
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE mitochondrial aminoacyl-tRNA synthetases; yeast model; novel variants;
   mitochondrial diseases
ID SENSORINEURAL HEARING-LOSS; HOMOZYGOUS YARS2 MUTATION; LACTIC-ACIDOSIS;
   SACCHAROMYCES-CEREVISIAE; COMPOUND HETEROZYGOSITY; PATHOGENIC VARIANTS;
   OVARIAN FAILURE; CAUSES MYOPATHY; GENE ENCODES; LEUKODYSTROPHY
AB In most eukaryotes, mitochondrial protein synthesis is essential for oxidative phosphorylation (OXPHOS) as some subunits of the respiratory chain complexes are encoded by the mitochondrial DNA (mtDNA). Mutations affecting the mitochondrial translation apparatus have been identified as a major cause of mitochondrial diseases. These mutations include either heteroplasmic mtDNA mutations in genes encoding for the mitochondrial rRNA (mtrRNA) and tRNAs (mttRNAs) or mutations in nuclear genes encoding ribosomal proteins, initiation, elongation and termination factors, tRNA-modifying enzymes, and aminoacyl-tRNA synthetases (mtARSs). Aminoacyl-tRNA synthetases (ARSs) catalyze the attachment of specific amino acids to their cognate tRNAs. Differently from most mttRNAs, which are encoded by mitochondrial genome, mtARSs are encoded by nuclear genes and then imported into the mitochondria after translation in the cytosol. Due to the extensive use of next-generation sequencing (NGS), an increasing number of mtARSs variants associated with large clinical heterogeneity have been identified in recent years. Being most of these variants private or sporadic, it is crucial to assess their causative role in the disease by functional analysis in model systems. This review will focus on the contributions of the yeast Saccharomyces cerevisiae in the functional validation of mutations found in mtARSs genes associated with human disorders.
C1 [Figuccia, Sonia; Degiorgi, Andrea; Ceccatelli Berti, Camilla; Baruffini, Enrico; Dallabona, Cristina; Goffrini, Paola] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parco Area Sci 11-A, I-43124 Parma, Italy.
C3 University of Parma
RP Dallabona, C; Goffrini, P (corresponding author), Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parco Area Sci 11-A, I-43124 Parma, Italy.
EM sonia.figuccia@unipr.it; andrea.degiorgi@unipr.it;
   camilla.ceccatelliberti@unipr.it; enrico.baruffini@unipr.it;
   cristina.dallabona@unipr.it; paola.goffrini@unipr.it
RI BERTI, Camilla/IWU-7583-2023; Goffrini, Paola/C-3860-2015; Baruffini,
   Enrico/C-1057-2015
OI Goffrini, Paola/0000-0002-8650-4765; DALLABONA,
   Cristina/0000-0003-4397-9143; Baruffini, Enrico/0000-0002-8280-7849;
   FIGUCCIA, SONIA/0000-0001-9742-6734; CECCATELLI BERTI,
   Camilla/0000-0002-6527-4462; Degiorgi, Andrea/0000-0003-1520-6485
FU Italian Ministry of Health [RF-2016-02361241, GR-2016-02361449];
   COMP-HUB Initiative - 'Departments of Excellence' program of the Italian
   Ministry for Education, University and Research (MIUR, 2018-2022)
FX This study was supported by a grant RF-2016-02361241 from the Italian
   Ministry of Health to P.G. C.C.B. is supported by a fellowship of the
   Italian Ministry of Health GR-2016-02361449 to E.B.; C.D. is supported
   by a fixed-term research assistant contract by the COMP-HUB Initiative,
   funded by the 'Departments of Excellence' program of the Italian
   Ministry for Education, University and Research (MIUR, 2018-2022).
CR Antonellis A, 2006, J NEUROSCI, V26, P10397, DOI 10.1523/JNEUROSCI.1671-06.2006
   Ardissone A, 2015, NEUROLOGY, V84, P2193, DOI 10.1212/WNL.0000000000001613
   Ardissone A, 2015, JIMD REP, V20, P95, DOI 10.1007/8904_2014_397
   Berti CC, 2021, GENES-BASEL, V12, DOI 10.3390/genes12020300
   Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z
   Cappuccio G, 2021, HUM MUTAT, V42, P745, DOI 10.1002/humu.24210
   Cassandrini D, 2013, J INHERIT METAB DIS, V36, P43, DOI 10.1007/s10545-012-9487-9
   Chen SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033363
   Chien CI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094659
   Chihara T, 2007, NAT NEUROSCI, V10, P828, DOI 10.1038/nn1910
   Chin HL, 2019, J MOL MED, V97, P1557, DOI 10.1007/s00109-019-01834-5
   CHIU MI, 1992, GENETICS, V132, P987
   Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819
   Cusack S, 1997, CURR OPIN STRUC BIOL, V7, P881, DOI 10.1016/S0959-440X(97)80161-3
   Dallabona C, 2014, NEUROLOGY, V82, P2063, DOI 10.1212/WNL.0000000000000497
   DELARUE M, 1995, CURR OPIN STRUC BIOL, V5, P48, DOI 10.1016/0959-440X(95)80008-O
   Demain LAM, 2020, J HUM GENET, V65, P305, DOI 10.1038/s10038-019-0706-1
   Di Micco P, 2014, BBA-MOL CELL RES, V1843, P3065, DOI 10.1016/j.bbamcr.2014.09.011
   Dias J, 2012, BIOCHEMISTRY-US, V51, P909, DOI 10.1021/bi201337b
   Diodato Daria, 2014, Int J Cell Biol, V2014, P787956, DOI 10.1155/2014/787956
   Diodato D, 2014, HUM MUTAT, V35, P983, DOI 10.1002/humu.22590
   Dong Q, 2018, J HUM GENET, V63, P841, DOI 10.1038/s10038-018-0446-7
   EDWARDS H, 1987, CELL, V51, P643, DOI 10.1016/0092-8674(87)90133-4
   Euro L, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00021
   Feng L, 2005, J BIOL CHEM, V280, P8150, DOI 10.1074/jbc.M411098200
   Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7
   Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194
   Frechin M, 2009, GENE DEV, V23, P1119, DOI 10.1101/gad.518109
   Freel KC, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov023
   Friederich MW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06250-w
   GATTI DL, 1991, J MOL BIOL, V218, P557, DOI 10.1016/0022-2836(91)90701-7
   González-Serrano LE, 2019, J BIOL CHEM, V294, P5309, DOI 10.1074/jbc.REV118.002953
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Griffin LB, 2014, HUM MUTAT, V35, P1363, DOI 10.1002/humu.22681
   Hamatani M, 2016, J HUM GENET, V61, P899, DOI 10.1038/jhg.2016.64
   Huang HY, 2006, MOL MICROBIOL, V60, P189, DOI 10.1111/j.1365-2958.2006.05083.x
   Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617
   Kamps R, 2018, EUR J HUM GENET, V26, P537, DOI 10.1038/s41431-017-0058-2
   Karstensen HG, 2020, EUR J MED GENET, V63, DOI 10.1016/j.ejmg.2019.103733
   Kim EJ, 2018, NEUROBIOL AGING, V72, DOI 10.1016/j.neurobiolaging.2018.06.031
   Kiraly-Borri C, 2019, CSH MOL CASE STUD, V5, DOI 10.1101/mcs.a003699
   Kohda M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005679
   Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010
   Kuo ME, 2020, CEREBELLUM, V19, P154, DOI 10.1007/s12311-019-01080-y
   LAPOINTE J, 1986, J BACTERIOL, V165, P88, DOI 10.1128/jb.165.1.88-93.1986
   Lee DC, 2019, J PERIPHER NERV SYST, DOI 10.1111/jns.12353
   Ling JQ, 2012, P NATL ACAD SCI USA, V109, P3281, DOI 10.1073/pnas.1200109109
   Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210
   Lynch DS, 2017, BRAIN, V140, P1204, DOI 10.1093/brain/awx045
   Lynch DS, 2016, JAMA NEUROL, V73, P1433, DOI 10.1001/jamaneurol.2016.2229
   Maffezzini C, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.654
   Markovitz R, 2020, AM J MED GENET A, V182, P1167, DOI 10.1002/ajmg.a.61544
   Mazurova S, 2017, CARDIOL YOUNG, V27, P936, DOI 10.1017/S1047951116001876
   McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008
   Merz S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r95
   Morgenstern M, 2017, CELL REP, V19, P2836, DOI 10.1016/j.celrep.2017.06.014
   Motley WW, 2010, TRENDS NEUROSCI, V33, P59, DOI 10.1016/j.tins.2009.11.001
   Moulinier L, 2017, HUM MUTAT, V38, P1316, DOI 10.1002/humu.23277
   MULERO JJ, 1994, CURR GENET, V25, P299, DOI 10.1007/BF00351481
   Nafisinia M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178125
   Nagao A, 2009, P NATL ACAD SCI USA, V106, P16209, DOI 10.1073/pnas.0907602106
   Nakajima J, 2014, J HUM GENET, V59, P229, DOI 10.1038/jhg.2013.143
   Nakamura A, 2006, SCIENCE, V312, P1954, DOI 10.1126/science.1127156
   NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3
   Oprescu SN, 2017, HUM MUTAT, V38, P1412, DOI 10.1002/humu.23287
   Oprescu SN, 2017, METHODS, V113, P139, DOI 10.1016/j.ymeth.2016.11.013
   Peragallo JH, 2018, OPHTHALMIC GENET, V39, P99, DOI 10.1080/13816810.2017.1350723
   Pierce SB, 2013, AM J HUM GENET, V92, P614, DOI 10.1016/j.ajhg.2013.03.007
   Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108
   Qin XJ, 2014, J BIOL CHEM, V289, P20359, DOI 10.1074/jbc.M114.557249
   Riley LG, 2018, HAEMATOLOGICA, V103, P2008, DOI 10.3324/haematol.2017.182659
   Riley LG, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-193
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rinaldi T, 2010, FEMS YEAST RES, V10, P1006, DOI 10.1111/j.1567-1364.2010.00685.x
   Ruan ZR, 2015, J BIOL CHEM, V290, P1664, DOI 10.1074/jbc.M114.599886
   Santos-Cortez RLP, 2013, AM J HUM GENET, V93, P132, DOI 10.1016/j.ajhg.2013.05.018
   Sasarman F, 2012, HUM MUTAT, V33, P1201, DOI 10.1002/humu.22098
   Scheffler IE, 2001, MITOCHONDRION, V1, P3, DOI 10.1016/S1567-7249(00)00002-7
   Scheidecker S, 2019, HUM MUTAT, V40, P1826, DOI 10.1002/humu.23799
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Sekine S, 2001, NAT STRUCT BIOL, V8, P203, DOI 10.1038/84927
   Sepuri NBV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035321
   Shahni R, 2013, AM J MED GENET A, V161, P2334, DOI 10.1002/ajmg.a.36065
   Sissler M, 2017, TRENDS MOL MED, V23, P693, DOI 10.1016/j.molmed.2017.06.002
   Smith F, 2018, HAEMATOLOGICA, V103, pE564, DOI 10.3324/haematol.2018.194464
   Sommerville EW, 2019, HUM MOL GENET, V28, P258, DOI 10.1093/hmg/ddy294
   Sommerville EW, 2017, JAMA NEUROL, V74, P686, DOI 10.1001/jamaneurol.2016.4357
   Srivastava S, 2019, AM J MED GENET A, V179, P1556, DOI 10.1002/ajmg.a.61188
   Stellingwerff MD, 2021, NEUROL-GENET, V7, DOI 10.1212/NXG.0000000000000559
   Su D, 2011, NUCLEIC ACIDS RES, V39, P4866, DOI 10.1093/nar/gkr073
   Sun C, 2019, NEUROL-GENET, V5, DOI 10.1212/NXG.0000000000000316
   Szpisjak L, 2017, J HUM GENET, V62, P329, DOI 10.1038/jhg.2016.126
   Taglia I, 2018, ACTA NEUROL SCAND, V138, P278, DOI 10.1111/ane.12954
   Tang HL, 2004, J BIOL CHEM, V279, P49656, DOI 10.1074/jbc.M408081200
   Tang Y, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.582
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   Tinker RJ, 2021, MOL DIAGN THER, V25, P181, DOI 10.1007/s40291-020-00510-6
   Tolkunova E, 2000, J BIOL CHEM, V275, P35063, DOI 10.1074/jbc.M006265200
   Turner RJ, 2000, J BIOL CHEM, V275, P27681
   Verrigni D, 2017, CLIN GENET, V91, P918, DOI 10.1111/cge.12931
   Wang CC, 2003, BIOCHEMISTRY-US, V42, P1646, DOI 10.1021/bi025964c
   Wang DQ, 2018, J NEUROPATH EXP NEUR, V77, P997, DOI 10.1093/jnen/nly087
   Wang Y, 2020, SCI CHINA LIFE SCI, V63, P1227, DOI 10.1007/s11427-019-1619-x
   Wang Y, 2016, J BIOL CHEM, V291, P6507, DOI 10.1074/jbc.M115.700849
   WILCOX M, 1969, EUR J BIOCHEM, V11, P405, DOI 10.1111/j.1432-1033.1969.tb00788.x
   Yu J, 2020, HEREDITAS, V157, DOI 10.1186/s41065-020-00157-7
NR 106
TC 14
Z9 15
U1 2
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAY
PY 2021
VL 22
IS 9
AR 4524
DI 10.3390/ijms22094524
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA SC0GQ
UT WOS:000650361800001
PM 33926074
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Demarest, ST
   Whitehead, MT
   Turnacioglu, S
   Pearl, PL
   Gropman, AL
AF Demarest, Scott T.
   Whitehead, Matthew T.
   Turnacioglu, Sinan
   Pearl, Phillip L.
   Gropman, Andrea L.
TI Phenotypic Analysis of Epilepsy in the Mitochondrial Encephalomyopathy,
   Lactic Acidosis, and Strokelike Episodes-Associated Mitochondrial DNA
   A3243G Mutation
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE electroencephalogram; Lennox-Gastaut syndrome; mitochondria; seizures
ID PARTIAL STATUS EPILEPTICUS; L-ARGININE; CHAIN DEFECTS; MELAS;
   ENCEPHALOPATHY; MYOPATHY; DISORDERS; CHILDREN; PATIENT
AB The A to G mitochondrial DNA point mutation at position 3243 (A3243G) is the most common cause of mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS), a systemic multiorgan disease. Epilepsy is a common finding but there is wide phenotypic variation that has not been thoroughly explored. We report the epilepsy phenotypes of 7 patients with the A3243G mutation. Most presented with typical MELAS and epilepsy characterized by infrequent prolonged focal seizures, including epilepsia partialis continua, hemiclonic status epilepticus, nonconvulsive status, and occipital status epilepticus. Seizures usually occurred during the acute phase of a strokelike episode. Periodic lateralized epileptiform discharges may be seen electrographically. Some patients with this mutation are completely asymptomatic or have mild symptoms typical for mitochondrial diseases. Slow spike-wave activity consistent with Lennox-Gastaut syndrome and electrographic status epilepticus was seen in 1 patient who responded to ethosuximide.
C1 [Demarest, Scott T.; Whitehead, Matthew T.; Turnacioglu, Sinan; Gropman, Andrea L.] George Washington Univ Sch Med, Childrens Natl Med Ctr, Washington, DC USA.
   [Pearl, Phillip L.] Harvard Univ, Sch Med, Dept Neurol, Boston Childrens Hosp, Boston, MA 02115 USA.
C3 George Washington University; Children's National Health System; Harvard
   University; Boston Children's Hospital; Harvard Medical School
RP Gropman, AL (corresponding author), Childrens Natl Med Ctr, Div Neurogenet & Dev Pediat, 111 Michigan Ave NW, Washington, DC 20010 USA.
EM AGropman@childrensnational.org
OI Pearl, Phillip/0000-0002-6373-1068
CR Anglin RE, 2012, J NEUROPSYCH CLIN N, V24, P394, DOI 10.1176/appi.neuropsych.11110345
   Bolszak M, 2009, EPILEPSY RES, V85, P300, DOI 10.1016/j.eplepsyres.2009.03.004
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Corda D, 2006, EPILEPSY BEHAV, V8, P655, DOI 10.1016/j.yebeh.2005.12.011
   Craig AK, 2012, SEIZURE-EUR J EPILEP, V21, P17, DOI 10.1016/j.seizure.2011.08.010
   Funakawa I, 1997, ELECTROEN CLIN NEURO, V103, P370, DOI 10.1016/S0013-4694(97)00020-9
   Kanaumi T, 2006, PEDIATR NEUROL, V34, P235, DOI 10.1016/j.pediatrneurol.2005.08.024
   Kang HC, 2013, BRAIN DEV-JPN, V35, P757, DOI 10.1016/j.braindev.2013.01.006
   Karkare S, 2009, J CHILD NEUROL, V24, P1564, DOI 10.1177/0883073809334386
   Kaufman KR, 2010, EPILEPSY BEHAV, V18, P494, DOI 10.1016/j.yebeh.2010.05.020
   Kim IO, 1996, AM J ROENTGENOL, V166, P641, DOI 10.2214/ajr.166.3.8623642
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2002, NEUROLOGY, V58, P827, DOI 10.1212/WNL.58.5.827
   Koga Y, 2012, BBA-GEN SUBJECTS, V1820, P608, DOI 10.1016/j.bbagen.2011.09.005
   Lee YM, 2008, EPILEPSIA, V49, P685, DOI 10.1111/j.1528-1167.2007.01522.x
   Leff AP, 1998, EPILEPSIA, V39, P438, DOI 10.1111/j.1528-1157.1998.tb01397.x
   Lin CM, 2007, METAB BRAIN DIS, V22, P105, DOI 10.1007/s11011-006-9039-9
   Oguro H, 2004, INTERNAL MED, V43, P427, DOI 10.2169/internalmedicine.43.427
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Ribacoba R, 2006, NEUROLOGIA, V21, P1
   Toribe Yasuhisa, 2007, No To Hattatsu, V39, P38
   Tzoulis C, 2012, BRAIN, V135, P3627, DOI 10.1093/brain/aws223
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   Yuen AWC, 2011, MED HYPOTHESES, V77, P536, DOI 10.1016/j.mehy.2011.06.025
NR 24
TC 23
Z9 25
U1 0
U2 6
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD SEP
PY 2014
VL 29
IS 9
SI SI
BP 1249
EP 1256
DI 10.1177/0883073814538511
PG 8
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA AP1FK
UT WOS:000341812400018
PM 25038129
DA 2024-11-01
ER

PT J
AU Lopriore, P
   Palermo, G
   Meli, A
   Bellini, G
   Benevento, E
   Montano, V
   Siciliano, G
   Mancuso, M
   Ceravolo, R
AF Lopriore, Piervito
   Palermo, Giovanni
   Meli, Adriana
   Bellini, Gabriele
   Benevento, Elena
   Montano, Vincenzo
   Siciliano, Gabriele
   Mancuso, Michelangelo
   Ceravolo, Roberto
TI Mitochondrial Parkinsonism: A Practical Guide to Genes and Clinical
   Diagnosis
SO MOVEMENT DISORDERS CLINICAL PRACTICE
LA English
DT Review
DE neurogenetics; primary mitochondrial diseases; parkinsonism;
   mitochondrial parkinsonism
ID ONSET SPINOCEREBELLAR ATAXIA; DOMINANT OPTIC ATROPHY; TWNK RARE
   VARIANTS; MOVEMENT-DISORDERS; FAMILIAL PARKINSONISM; SLC25A46 MUTATIONS;
   SPASTIC PARAPLEGIA; DNA DELETIONS; EXTERNAL OPHTHALMOPLEGIA; POLG1
   MUTATIONS
AB BackgroundPrimary mitochondrial diseases (PMDs) are the most common inborn errors of energy metabolism, with a combined prevalence of 1 in 4300. They can result from mutations in either nuclear DNA (nDNA) or mitochondrial DNA (mtDNA). These disorders are multisystemic and mainly affect high energy-demanding tissues, such as muscle and the central nervous system (CNS). Among many clinical features of CNS involvement, parkinsonism is one of the most common movement disorders in PMDs.MethodsThis review provides a pragmatic educational overview of the most recent advances in the field of mitochondrial parkinsonism, from pathophysiology and genetic etiologies to phenotype and diagnosis.ResultsmtDNA maintenance and mitochondrial dynamics alterations represent the principal mechanisms underlying mitochondrial parkinsonism. It can be present in isolation, alongside other movement disorders or, more commonly, as part of a multisystemic phenotype. Mutations in several nuclear-encoded genes (ie, POLG, TWNK, SPG7, and OPA1) and, more rarely, mtDNA mutations, are responsible for mitochondrial parkinsonism. Progressive external opthalmoplegia and optic atrophy may guide genetic etiology identification.ConclusionA comprehensive deep-phenotyping approach is needed to reach a diagnosis of mitochondrial parkinsonism, which lacks distinctive clinical features and exemplifies the intricate genotype-phenotype interplay of PMDs.
C1 [Lopriore, Piervito; Meli, Adriana; Bellini, Gabriele; Benevento, Elena; Montano, Vincenzo; Siciliano, Gabriele; Mancuso, Michelangelo; Ceravolo, Roberto] Univ Pisa, Dept Clin & Expt Med, Unit Neurol, Pisa, Italy.
   [Palermo, Giovanni; Bellini, Gabriele; Benevento, Elena; Ceravolo, Roberto] Univ Pisa, Ctr Neurodegenerat Dis Parkinsons Dis & Movement D, Dept Clin & Expt Med, Unit Neurol, Pisa, Italy.
C3 University of Pisa; University of Pisa
RP Mancuso, M (corresponding author), Univ Pisa, Dept Clin & Expt Med, Unit Neurol, Pisa, Italy.
EM michelangelo.mancuso@unipi.it
RI Siciliano, Gabriele/HTP-1909-2023; Lopriore, Piervito/KZU-8091-2024;
   Montano, Vincenzo/AAB-8681-2022; Palermo, Giovanni/AAL-6147-2020
OI Lopriore, Piervito/0000-0002-9789-3129; Bellini,
   Gabriele/0000-0002-0648-6836; palermo, giovanni/0000-0002-9193-3150
FU Telethon-MITOCON grant [GSP16001]; EJPRD2019 project GENOMIT; Italian
   Ministry of University and Research [2022B9WY4A]
FX This work was partially supported by Telethon-MITOCON grant GSP16001,
   the EJPRD2019 project GENOMIT and Italian Ministry of University and
   Research 2022B9WY4A. The authors declare no conflict of interest
CR Abrams AJ, 2015, NAT GENET, V47, P926, DOI 10.1038/ng.3354
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Aloisio S, 2023, NEUROL SCI, V44, P3379, DOI 10.1007/s10072-023-07044-9
   Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Bellini G, 2021, BMC NEUROL, V21, DOI 10.1186/s12883-021-02345-y
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   Billingsley KJ, 2019, NPJ PARKINSONS DIS, V5, DOI 10.1038/s41531-019-0080-x
   Bitetto G, 2020, PARKINSONISM RELAT D, V74, P1, DOI 10.1016/j.parkreldis.2020.03.018
   Blesa J, 2017, EXP NEUROL, V298, P148, DOI 10.1016/j.expneurol.2017.10.002
   Bloem BR, 2021, LANCET, V397, P2284, DOI 10.1016/S0140-6736(21)00218-X
   Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209
   Bonifati V, 2007, PARKINSONISM RELAT D, V13, pS233, DOI 10.1016/S1353-8020(08)70008-7
   Borsche M, 2021, J PARKINSON DIS, V11, P45, DOI 10.3233/JPD-201981
   Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9
   Breen DP, 2020, NEUROLOGY, V95, P644, DOI 10.1212/WNL.0000000000010674
   Burke EA, 2018, CLIN GENET, V93, P712, DOI 10.1111/cge.13172
   Caporali L, 2020, ANN NEUROL, V88, P18, DOI 10.1002/ana.25723
   Caporali L, 2018, BRAIN, V141, DOI 10.1093/brain/awx301
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Carelli V, 2014, NEURON, V84, P1126, DOI 10.1016/j.neuron.2014.11.022
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   Charif M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00311
   Charlesworth G, 2016, MOVEMENT DISORD, V31, P1249, DOI 10.1002/mds.26716
   Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061
   Chumarina M, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0863-7
   Colavito D, 2017, BIOMED REP, V7, P451, DOI 10.3892/br.2017.987
   D'Sa K, 2023, NAT MACH INTELL, V5, P933, DOI 10.1038/s42256-023-00702-9
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   De la Casa-Fages B, 2019, MOVEMENT DISORD, V34, P1547, DOI 10.1002/mds.27812
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Delgado-Alvarado M, 2015, J NEUROL SCI, V350, P93, DOI 10.1016/j.jns.2015.02.011
   Di Bella D, 2010, NAT GENET, V42, P313, DOI 10.1038/ng.544
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dölle C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13548
   Elkouzi A, 2019, NAT REV NEUROL, V15, P204, DOI 10.1038/s41582-019-0155-7
   Erskine D, 2020, ACTA NEUROPATHOL, V139, P219, DOI 10.1007/s00401-019-02105-w
   Flones IH, 2018, CURR OPIN NEUROL, V31, P472, DOI 10.1097/WCO.0000000000000583
   Gaig C, 2009, MOVEMENT DISORD, V24, pS656, DOI 10.1002/mds.22672
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Gasser T, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001148
   Ghaoui R, 2018, J NEUROL, V265, P1230, DOI 10.1007/s00415-017-8722-6
   Glasgow RIC., 2020, HUMAN MITOCHONDRIAL, P375, DOI [10.1016/B9780128196564.00015-2, DOI 10.1016/B9780128196564.00015-2]
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Haitina T, 2006, GENOMICS, V88, P779, DOI 10.1016/j.ygeno.2006.06.016
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hammer MB, 2017, NEURODEGENER DIS, V17, P208, DOI 10.1159/000464445
   Henrich MT, 2023, MOL NEURODEGENER, V18, DOI 10.1186/s13024-023-00676-7
   Hernandez DG, 2016, J NEUROCHEM, V139, P59, DOI 10.1111/jnc.13593
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Iannielli A, 2018, CELL REP, V22, P2066, DOI 10.1016/j.celrep.2018.01.089
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Janer A, 2016, EMBO MOL MED, V8, P1019, DOI 10.15252/emmm.201506159
   Jellinger KA, 2012, MOVEMENT DISORD, V27, P8, DOI 10.1002/mds.23795
   Johansson M, 1996, P NATL ACAD SCI USA, V93, P7258, DOI 10.1073/pnas.93.14.7258
   Jonikas M, 2018, ANN NEUROL, V83, P915, DOI 10.1002/ana.25221
   Jüllig M, 2000, EUR J BIOCHEM, V267, P5466, DOI 10.1046/j.1432-1327.2000.01607.x
   Kaasinen V, 2017, ANN NEUROL, V82, P873, DOI 10.1002/ana.25103
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Klebe S, 2012, BRAIN, V135, P2980, DOI 10.1093/brain/aws240
   Li CY, 2023, MOVEMENT DISORD, V38, P708, DOI 10.1002/mds.29372
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Lynch DS, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000188
   Magri S, 2018, HUM MUTAT, V39, P2060, DOI 10.1002/humu.23658
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mancuso M, 2008, PARKINSONISM RELAT D, V14, P381, DOI 10.1016/j.parkreldis.2007.10.001
   Mancuso Michelangelo, 2023, Handb Clin Neurol, V194, P117, DOI 10.1016/B978-0-12-821751-1.00003-8
   Mancuso Michelangelo, 2008, Human Genomics, V3, P71
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Manini A, 2022, AGEING RES REV, V76, DOI 10.1016/j.arr.2022.101578
   Maresca A, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11040496
   Martikainen MH, 2016, JAMA NEUROL, V73, P668, DOI 10.1001/jamaneurol.2016.0355
   Martikainen MH, 2013, MITOCHONDRION, V13, P83, DOI 10.1016/j.mito.2013.01.012
   Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806
   Miguel R, 2014, CLIN NEUROL NEUROSUR, V126, P47, DOI 10.1016/j.clineuro.2014.08.020
   Montano V, 2022, J NEUROL, V269, P6555, DOI 10.1007/s00415-022-11324-3
   Montano V, 2022, J NEUROL, V269, P1413, DOI 10.1007/s00415-021-10697-1
   Morino H, 2014, NEUROLOGY, V83, P2054, DOI 10.1212/WNL.0000000000001036
   Müller-Nedebock AC, 2021, MOVEMENT DISORD, V36, P815, DOI 10.1002/mds.28475
   Musumeci O., 2020, J TRANSL GENET GENOM, V4, P221, DOI [10.20517/JTGG.2020.22, DOI 10.20517/JTGG.2020.22]
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Orsucci D, 2011, J MOL NEUROSCI, V44, P17, DOI 10.1007/s12031-010-9488-9
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Palermo G, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222011234
   Palin EJH, 2013, BRAIN, V136, P2379, DOI 10.1093/brain/awt160
   Parra SP, 2021, PARKINSONISM RELAT D, V93, P50, DOI 10.1016/j.parkreldis.2021.10.031
   Pedroso JL, 2018, PARKINSONISM RELAT D, V47, P88, DOI 10.1016/j.parkreldis.2017.12.004
   Percetti M, 2023, MOVEMENT DISORD, V38, P709, DOI 10.1002/mds.29373
   Percetti M, 2022, MOVEMENT DISORD, V37, P1938, DOI 10.1002/mds.29139
   Pierson TM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002325
   Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424
   Prasuhn J, 2021, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.615461
   PRZEDBORSKI S, 1993, ANN NEUROL, V34, P715, DOI 10.1002/ana.410340515
   Qi R, 2023, SCI TRANSL MED, V15, DOI 10.1126/scitranslmed.abo1557
   Remtulla S, 2019, PEDIATR NEUROL, V90, P61, DOI 10.1016/j.pediatrneurol.2018.08.007
   Ronchi D, 2018, BRAIN, V141, DOI 10.1093/brain/awx302
   Sacco T, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-55
   Salgado P, 2019, MOV DISORD CLIN PRAC, V6, P174, DOI 10.1002/mdc3.12711
   Schreglmann SR, 2018, MOVEMENT DISORD, V33, P146, DOI 10.1002/mds.27174
   Senkevich K, 2022, MOVEMENT DISORD, V37, P2318, DOI 10.1002/mds.29216
   Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787
   Song LY, 2012, HUM MOL GENET, V21, P5147, DOI 10.1093/hmg/dds365
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Sulaiman RA, 2017, CLIN GENET, V92, P230, DOI 10.1111/cge.12963
   Synofzik M, 2019, INT REV NEUROBIOL, V149, P277, DOI 10.1016/bs.irn.2019.10.019
   Synofzik M, 2010, MOVEMENT DISORD, V25, P2472, DOI 10.1002/mds.23307
   Thyagarajan D, 2000, ANN NEUROL, V48, P730, DOI 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0
   Titova N, 2017, J NEURAL TRANSM, V124, P907, DOI 10.1007/s00702-016-1667-6
   Tranchant C, 2016, REV NEUROL-FRANCE, V172, P524, DOI 10.1016/j.neurol.2016.07.003
   Trinh J, 2019, MOVEMENT DISORD, V34, P133, DOI 10.1002/mds.27559
   Tzoulis C, 2016, MITOCHONDRION, V28, P33, DOI 10.1016/j.mito.2016.03.003
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   van Gassen KLI, 2012, BRAIN, V135, P2994, DOI 10.1093/brain/aws224
   Vandenberghe W, 2021, NEUROL-GENET, V7, DOI 10.1212/NXG.0000000000000620
   Vital C, 2015, REV NEUROL-FRANCE, V171, P679, DOI 10.1016/j.neurol.2015.03.011
   Wan JJ, 2016, BRAIN, V139, P2877, DOI 10.1093/brain/aww212
   Wilcox RA, 2007, MOVEMENT DISORD, V22, P1020, DOI 10.1002/mds.21416
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Wüllner U, 2023, J NEURAL TRANSM, V130, P827, DOI 10.1007/s00702-023-02635-4
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
NR 130
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2330-1619
J9 MOV DISORD CLIN PRAC
JI MOV. DISORD. CLIN. PRACT.
PD AUG
PY 2024
VL 11
IS 8
BP 948
EP 965
DI 10.1002/mdc3.14148
EA JUN 2024
PG 18
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA D0M9G
UT WOS:001257432100001
PM 38943319
DA 2024-11-01
ER

PT J
AU Jeppesen, TD
   Vissing, J
   González-Alonso, J
AF Jeppesen, Tina D.
   Vissing, John
   Gonzalez-Alonso, Jose
TI Influence of erythrocyte oxygenation and intravascular ATP on resting
   and exercising skeletal muscle blood flow in humans with mitochondrial
   myopathy
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial myopathy; ATP; Erythrocyte signaling
ID FOREARM EXERCISE; RELEASE; CELLS; VASOCONSTRICTION; METABOLISM;
   ACTIVATION; DIAGNOSIS; DELIVERY; MUTATION
AB Oxygen (O-2) extraction is impaired in exercising skeletal muscle of humans with mutations of mitochondria( DNA (mtDNA), but the muscle hemodynamic response to exercise has never been directly investigated. This study sought to examine the extent to which human skeletal muscle perfusion can increase without reductions in blood oxygenation and to determine whether erythrocyte O-2 off-loading and related ATP vascular mechanisms are impaired in humans with mutations of mtDNA. Leg vascular hemodynamic, oxygenation and ATP were investigated in ten patients with mtDNA mutations and ten matched healthy control subjects: 1) at rest during normoxia, hypoxia, hyperoxia and intra-femoral artery ATP infusion, and 2) during passive and dynamic one-legged knee-extensor exercises. At rest, blood flow (LBF), femoral arterial and venous blood oxygenation and plasma ATP were similar in the two groups. During dynamic exercise, LBF and vascular conductance increased 9-10 fold in the patients despite erythrocyte oxygenation and leg O-2 extraction remained unchanged (p<0.01). In the patients, workload-adjusted LBF was 28% to 62% higher during submaximal- and maximal exercises and was associated with augmented plasma ATP. The appropriate hemodynamic adjustments during severe hypoxia and ATP infusion suggest that erythrocyte O-2 off-loading and related ATP vascular mechanisms are intact in patients with mtDNA mutations. Furthermore, greater increase in plasma ATP and LBF at a given metabolic demand in the patients, in concert with unchanged oxyhemoglobin, suggest that erythrocyte O-2 off-loading is not obligatory for the exercise-induced increase in blood flow and intravascular ATP concentration. (C) 2011 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Jeppesen, Tina D.] Univ Copenhagen, Rigshosp, Neuromuscular Res Unit, Sect 3342,Copenhagen Muscle Res Ctr, DK-2100 Copenhagen, Denmark.
   [Gonzalez-Alonso, Jose] Brunel Univ, Ctr Sports Med & Human Performance, London, England.
C3 University of Copenhagen; Rigshospitalet; Brunel University
RP Jeppesen, TD (corresponding author), Univ Copenhagen, Rigshosp, Neuromuscular Res Unit, Sect 3342,Copenhagen Muscle Res Ctr, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
EM tina@dysgaard.dk
RI Jeppesen, Tina/AAV-7195-2020; Vissing, John/IUN-4271-2023
FU Copenhagen Hospital System; Sara and Ludvig Elsa's Foundation; Danish
   Medical Research Council; NOVO Nordic Foundation; University of
   Copenhagen
FX We thank Danuta Olsen for excellent technical help. The study was
   supported by grants from Copenhagen Hospital System, the Sara and Ludvig
   Elsa's Foundation, The Danish Medical Research Council, the NOVO Nordic
   Foundation, and the University of Copenhagen.
CR Abe K, 1997, NEUROLOGY, V49, P837, DOI 10.1212/WNL.49.3.837
   ANDERSEN P, 1985, J PHYSIOL-LONDON, V366, P233, DOI 10.1113/jphysiol.1985.sp015794
   Bank W, 1997, MOL CELL BIOCHEM, V174, P7, DOI 10.1023/A:1006887319200
   BANK W, 1994, ANN NEUROL, V36, P830, DOI 10.1002/ana.410360606
   Beigi R., 1999, AM J PHYSIOL, V276, P267
   BERGFELD GR, 1992, CARDIOVASC RES, V26, P40, DOI 10.1093/cvr/26.1.40
   Burnstock G, 1999, J ANAT, V194, P335, DOI 10.1046/j.1469-7580.1999.19430335.x
   Carroll J, 2006, MOL BIOSYST, V2, P305, DOI 10.1039/b604362n
   Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954
   Despas F, 2009, J HYPERTENS, V27, P1849, DOI 10.1097/HJH.0b013e32832e8d0f
   Di Giovanni S, 2001, MOL CELL NEUROSCI, V17, P696, DOI 10.1006/mcne.2001.0970
   Ellsworth ML, 2009, PHYSIOLOGY, V24, P107, DOI 10.1152/physiol.00038.2008
   Ellsworth ML, 1995, AM J PHYSIOL-HEART C, V269, pH2155, DOI 10.1152/ajpheart.1995.269.6.H2155
   FUJII T, 1995, BRAIN DEV-JPN, V17, P89, DOI 10.1016/0387-7604(94)00115-E
   González-Alonso J, 2006, J PHYSIOL-LONDON, V572, P295, DOI 10.1113/jphysiol.2005.101121
   González-Alonso J, 2002, CIRC RES, V91, P1046, DOI 10.1161/01.RES.0000044939.73286.E2
   González-Alonso J, 2008, J PHYSIOL-LONDON, V586, P4033, DOI 10.1113/jphysiol.2008.160358
   GROPEN TI, 1994, STROKE, V25, P1873, DOI 10.1161/01.STR.25.9.1873
   HALLER RG, 1989, J CLIN INVEST, V84, P155, DOI 10.1172/JCI114135
   Jagger JE, 2001, AM J PHYSIOL-HEART C, V280, pH2833, DOI 10.1152/ajpheart.2001.280.6.H2833
   Jensen TD, 2002, NEUROLOGY, V58, P1533, DOI 10.1212/WNL.58.10.1533
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Kalsi KK, 2010, CIRCULATION, V122
   Kirby BS, 2008, J PHYSIOL-LONDON, V586, P4305, DOI 10.1113/jphysiol.2008.154252
   MATSUKAWA T, 1993, J CLIN INVEST, V92, P25, DOI 10.1172/JCI116558
   Mortensen SP, 2009, AM J PHYSIOL-REG I, V296, pR1140, DOI 10.1152/ajpregu.90822.2008
   Nishioka J, 2008, BRAIN DEV-JPN, V30, P100, DOI 10.1016/j.braindev.2007.06.008
   Notarius CF, 2001, AM J PHYSIOL-HEART C, V280, pH969, DOI 10.1152/ajpheart.2001.280.3.H969
   Olsen DB, 2003, J NEUROL, V250, P1328, DOI 10.1007/s00415-003-0206-1
   OZAWA T, 1995, BIOCHEM BIOPH RES CO, V213, P432, DOI 10.1006/bbrc.1995.2150
   Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560
   Radegran G, 1997, J APPL PHYSIOL, V83, P1383, DOI 10.1152/jappl.1997.83.4.1383
   Rosenmeier JB, 2008, J PHYSIOL-LONDON, V586, P4993, DOI 10.1113/jphysiol.2008.155432
   Rosenmeier JB, 2004, J PHYSIOL-LONDON, V558, P351, DOI 10.1113/jphysiol.2004.063107
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Sprague RS, 1998, AM J PHYSIOL-HEART C, V275, pH1726, DOI 10.1152/ajpheart.1998.275.5.H1726
   Strehler B., 1957, ASSAY ADENOSINE TRIP, P871
   Sumi Y, 2010, AM J PHYSIOL-CELL PH, V299, pC1118, DOI 10.1152/ajpcell.00122.2010
   Taivassalo T, 2002, ANN NEUROL, V51, P38, DOI 10.1002/ana.10027
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Vissing J, 1998, NEUROLOGY, V50, P1875, DOI 10.1212/WNL.50.6.1875
   Vissing J, 1996, ANN NEUROL, V40, P655, DOI 10.1002/ana.410400416
   Zhang ZQ, 2010, NEUROL RES, V32, P403, DOI 10.1179/016164110X12670144526345
NR 44
TC 7
Z9 7
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAY
PY 2012
VL 12
IS 3
BP 414
EP 422
DI 10.1016/j.mito.2011.11.003
PG 9
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 956RA
UT WOS:000305105600007
PM 22155147
DA 2024-11-01
ER

PT J
AU Oliveira, MT
   Pontes, CD
   Ciesielski, GL
AF Oliveira, Marcos T.
   Pontes, Carolina de Bovi
   Ciesielski, Grzegorz L.
TI Roles of the mitochondrial replisome in mitochondrial DNA deletion
   formation
SO GENETICS AND MOLECULAR BIOLOGY
LA English
DT Review
DE Mitochondria; DNA replication; human diseases; Pol gamma; Twinkle
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; LARGE-SCALE DELETIONS; MULTIPLE
   MTDNA DELETIONS; POLYMERASE-GAMMA; HELICASE TWINKLE; SKELETAL-MUSCLE;
   D-LOOP; POINT MUTATIONS; REPLICATIVE DNA; G-QUADRUPLEXES
AB Mitochondrial DNA (mtDNA) deletions are a common cause of human mitochondrial diseases. Mutations in the genes encoding components of the mitochondrial replisome, such as DNA polymerase gamma (Pol gamma) and the mtDNA helicase Twinkle, have been associated with the accumulation of such deletions and the development of pathological conditions in humans. Recently, we demonstrated that changes in the level of wild-type Twinkle promote mtDNA deletions, which implies that not only mutations in, but also dysregulation of the stoichiometry between the replisome components is potentially pathogenic. The mechanism(s) by which alterations to the replisome function generate mtDNA deletions is(are) currently under debate. It is commonly accepted that stalling of the replication fork at sites likely to form secondary structures precedes the deletion formation. The secondary structural elements can be bypassed by the replication-slippage mechanism. Otherwise, stalling of the replication fork can generate single- and double-strand breaks, which can be repaired through recombination leading to the elimination of segments between the recombination sites. Here, we discuss aberrances of the replisome in the context of the two debated outcomes, and suggest new mechanistic explanations based on replication restart and template switching that could account for all the deletion types reported for patients.
C1 [Oliveira, Marcos T.] Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Tecnol, Jaboticabal, SP, Brazil.
   [Pontes, Carolina de Bovi; Ciesielski, Grzegorz L.] Auburn Univ, Dept Chem, Montgomery, AL 36117 USA.
C3 Universidade Estadual Paulista; Auburn University System; Auburn
   University; Auburn University Montgomery
RP Oliveira, MT (corresponding author), Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Tecnol, Jaboticabal, SP, Brazil.; Ciesielski, GL (corresponding author), Auburn Univ, Dept Chem, Montgomery, AL 36117 USA.
EM marcos.t.oliveira@unesp.br; gciesiel@aum.edu
RI Ciesielski, Grzegorz/AAK-2235-2020; Oliveira, Marcos/AAN-2804-2020;
   Oliveira, Marcos Tulio/B-3249-2014
OI Ciesielski, Grzegorz/0000-0001-6528-6781; Oliveira, Marcos
   Tulio/0000-0003-4779-5755
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
   [2014/02253-6, 2017/04372-0, 306974/2017-7]; Swedish Research Council
   [2017-04372] Funding Source: Swedish Research Council
FX GLC and MTO would like to dedicate this article to Dr. Laurie S. Kaguni
   in gratitude for years of mentorship. We also wish to thank Dr. Mike
   Gerards and Ana Paula C. Rodrigues for their critical comments on the
   manuscript, and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) (grant numbers 2014/02253-6, 2017/04372-0 and
   306974/2017-7 to MTO) for financial support.
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Avise JC., 2000, PHYLOGEOGRAPHY HIST, DOI DOI 10.2307/J.CTV1NZFGJ7
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348
   Bannwarth S, 2016, MITOCHONDRION, V30, P126, DOI 10.1016/j.mito.2016.02.005
   Bazzicalupi C, 2013, NUCLEIC ACIDS RES, V41, P632, DOI 10.1093/nar/gks1001
   Bebenek K, 2000, COLD SPRING HARB SYM, V65, P81, DOI 10.1101/sqb.2000.65.81
   Belmonte FR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25186
   Bharti SK, 2014, J BIOL CHEM, V289, P29975, DOI 10.1074/jbc.M114.567073
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   BROWN GG, 1986, J MOL BIOL, V192, P503, DOI 10.1016/0022-2836(86)90272-X
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cannan WJ, 2016, J CELL PHYSIOL, V231, P3, DOI 10.1002/jcp.25048
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Chen T, 2011, J HUM GENET, V56, P689, DOI 10.1038/jhg.2011.97
   Chen XJ, 2013, MICROBIOL MOL BIOL R, V77, P476, DOI 10.1128/MMBR.00007-13
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Cicero AFG, 2016, ADV EXP MED BIOL, V928, P27, DOI 10.1007/978-3-319-41334-1_2
   Ciesielski GL, 2016, ENZYMES, V39, P255, DOI 10.1016/bs.enz.2016.03.006
   Ciesielski GL, 2018, NUCLEIC ACIDS RES, V46, P3034, DOI 10.1093/nar/gky094
   Ciesielski GL, 2015, J BIOL CHEM, V290, P28697, DOI 10.1074/jbc.M115.673707
   Cluett TJ, 2018, NUCLEIC ACIDS RES, V46, P10771, DOI 10.1093/nar/gky852
   Copeland WC, 2014, J CHILD NEUROL, V29, P1216, DOI 10.1177/0883073814537380
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Damas J, 2014, NUCLEIC ACIDS RES, V42, pD1261, DOI 10.1093/nar/gkt982
   Damas J, 2012, NUCLEIC ACIDS RES, V40, P7606, DOI 10.1093/nar/gks500
   de Souza-Pinto NC, 2009, MOL CELL BIOL, V29, P4441, DOI 10.1128/MCB.00265-09
   De S, 2011, NAT STRUCT MOL BIOL, V18, P950, DOI 10.1038/nsmb.2089
   DEGOUL F, 1991, NUCLEIC ACIDS RES, V19, P493, DOI 10.1093/nar/19.3.493
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116
   Dong DW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-677
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Fishel ML, 2007, MUTAT RES-FUND MOL M, V614, P24, DOI 10.1016/j.mrfmmm.2006.06.007
   Montiel-Sosa JF, 2013, MITOCHONDR DNA, V24, P420, DOI 10.3109/19401736.2012.760550
   Fuke S, 2014, ANN CLIN TRANSL NEUR, V1, P909, DOI 10.1002/acn3.133
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   García-Gómez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025
   Giannattasio M, 2014, NAT STRUCT MOL BIOL, V21, P884, DOI 10.1038/nsmb.2888
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Grier J, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000230
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   HARRISON RG, 1989, TRENDS ECOL EVOL, V4, P6, DOI 10.1016/0169-5347(89)90006-2
   Holt IJ, 2014, BIOESSAYS, V36, P1024, DOI 10.1002/bies.201400052
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hou JH, 1996, BIOCHEM J, V318, P1065, DOI 10.1042/bj3181065
   Huang WC, 2015, NUCLEIC ACIDS RES, V43, P10102, DOI 10.1093/nar/gkv1061
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Jemt E, 2015, NUCLEIC ACIDS RES, V43, P9262, DOI 10.1093/nar/gkv804
   Kaguni LS, 2016, CRIT REV BIOCHEM MOL, V51, P53, DOI 10.3109/10409238.2015.1117056
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kalifa L, 2012, GENETICS, V190, P951, DOI 10.1534/genetics.111.138214
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kazak L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062340
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kowald A, 2018, GENES-BASEL, V9, DOI 10.3390/genes9030126
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lee SJ, 2011, CURR OPIN CHEM BIOL, V15, P580, DOI 10.1016/j.cbpa.2011.07.024
   Lehmann D, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000113
   Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316
   Lovett ST, 2017, DNA REPAIR, V56, P118, DOI 10.1016/j.dnarep.2017.06.014
   Macao B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8303
   Matic S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03552-x
   Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y
   McKinney EA, 2013, GENET MOL BIOL, V36, P308, DOI 10.1590/s1415-47572013000300002
   Mendoza O, 2016, NUCLEIC ACIDS RES, V44, P1989, DOI 10.1093/nar/gkw079
   Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   MORAES CT, 1995, MUSCLE NERVE, pS150
   Moretton A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176795
   Naeem MM, 2018, TARGETED REDUCTION P, DOI [10.1101/358101, DOI 10.1101/358101]
   NELSON I, 1989, NUCLEIC ACIDS RES, V17, P8117, DOI 10.1093/nar/17.20.8117
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nissanka N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04895-1
   Nurminen A, 2017, BBA CLIN, V7, P147, DOI 10.1016/j.bbacli.2017.04.001
   Oliveira MT, 2015, GENOME BIOL EVOL, V7, P943, DOI 10.1093/gbe/evv042
   Oliveira MT, 2011, J BIOL CHEM, V286, P40649, DOI 10.1074/jbc.M111.289983
   Oliveira PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059907
   Otten ABC, 2018, HUM REPROD, V33, P1331, DOI 10.1093/humrep/dey114
   Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149
   Pallotti F, 1996, AM J HUM GENET, V59, P591
   Peeva V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04131-w
   Pereira F, 2008, MOL BIOL EVOL, V25, P2759, DOI 10.1093/molbev/msn225
   Pereira GC, 2007, J PHARMACOL EXP THER, V323, P636, DOI 10.1124/jpet.107.128017
   Persson Ö, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08673-5
   Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014
   Picard M, 2016, CELL METAB, V24, P3, DOI 10.1016/j.cmet.2016.06.024
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Pohjoismäki JLO, 2011, MITOCHONDRION, V11, P630, DOI 10.1016/j.mito.2011.04.002
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Qian YF, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00135
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Rajakulendran S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145500
   Rajala N, 2014, NUCLEIC ACIDS RES, V42, P952, DOI 10.1093/nar/gkt988
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Reyes Aurelio, 2007, Methods Mol Biol, V372, P219, DOI 10.1007/978-1-59745-365-3_16
   Reyes A, 2009, METHODS MOL BIOL, V554, P15, DOI 10.1007/978-1-59745-521-3_2
   Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475
   Rocha MC, 2018, ANN NEUROL, V83, P115, DOI 10.1002/ana.25127
   Roos S, 2013, HUM MOL GENET, V22, P2411, DOI 10.1093/hmg/ddt094
   Russell OM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20064-2
   Sage JM, 2010, J BIOL CHEM, V285, P18984, DOI 10.1074/jbc.M109.099846
   Saldaña-Martínez A, 2019, GENE, V688, P171, DOI 10.1016/j.gene.2018.11.085
   Sallevelt SCEH, 2017, J MED GENET, V54, P114, DOI 10.1136/jmedgenet-2016-103876
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Sen D, 2016, NUCLEIC ACIDS RES, V44, P4200, DOI 10.1093/nar/gkw098
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Song Z, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002287
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Stiban J, 2014, J BIOL CHEM, V289, P24032, DOI 10.1074/jbc.M114.587774
   Stojkovic G, 2016, SCI REP-UK, V6, DOI 10.1038/srep28942
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Tadi SK, 2016, MOL BIOL CELL, V27, P223, DOI 10.1091/mbc.E15-05-0260
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Torregrosa-Muñumer R, 2017, P NATL ACAD SCI USA, V114, P11398, DOI 10.1073/pnas.1705367114
   Trifunov S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30143-z
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690
   Viguera E, 2001, EMBO J, V20, P2587, DOI 10.1093/emboj/20.10.2587
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wilson IJ, 2016, HUM MOL GENET, V25, P1031, DOI 10.1093/hmg/ddv626
   Wong LJC, 2007, MITOCHONDRION, V7, P45, DOI 10.1016/j.mito.2006.11.025
   Xu WY, 2019, J MOL BIOL, V431, P673, DOI 10.1016/j.jmb.2019.01.002
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
NR 163
TC 11
Z9 11
U1 0
U2 12
PU SOC BRASIL GENETICA
PI RIBEIRAO PRET
PA RUA CAP ADELMIO NORBET DA SILVA, 736, ALTO DA BOA VISTA, 14025-670
   RIBEIRAO PRET, BRAZIL
SN 1415-4757
EI 1678-4685
J9 GENET MOL BIOL
JI Genet. Mol. Biol.
PY 2020
VL 43
IS 1
SU 1
AR e20190069
DI 10.1590/1678-4685-GMB-2019-0069
PG 16
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA KU4QF
UT WOS:000519693500001
PM 32141473
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Scaglia, F
   Northrop, JL
AF Scaglia, Fernando
   Northrop, Jennifer L.
TI The mitochondrial myopathy encephalopathy, lactic acidosis with
   stroke-like episodes (MELAS) syndrome - A review of treatment options
SO CNS DRUGS
LA English
DT Review
ID MAGNETIC-RESONANCE-SPECTROSCOPY; WOBBLE MODIFICATION DEFICIENCY;
   C-OXIDASE DEFICIENCY; POINT MUTATION; CYTOCHROME-C; L-ARGININE;
   TRNA(LEU(UUR)) GENE; NITRIC-OXIDE; LIPID-PEROXIDATION; CLINICAL-FEATURES
AB Mitochondrial encephalomyopathies are a multisystemic group of disorders that are characterised by a wide range of biochemical and genetic mitochondrial defects and variable modes of inheritance. Among this group of disorders, the mitochondrial myopathy, encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome is one of the most frequently occurring, maternally inherited mitochondrial disorders.
   As the name implies, stroke-like episodes are the defining feature of the MELAS syndrome, often occurring before the age of 15 years. The clinical course of this disorder is highly variable, ranging from asymptomatic, with normal early development, to progressive muscle weakness, lactic acidosis, cognitive dysfunction, seizures, stroke-like episodes, encephalopathy and premature death.
   This syndrome is associated with a number of point mutations in the mitochondrial DNA, with over 80% of the mutations occurring in the dihydrouridine loop of the mitochondrial transfer RNALeu(UUR) [tRNALeu(UUR)] gene. The pathophysiology of the disease is not completely understood; however, several different mechanisms are proposed to contribute to this disease. These include decreased aminoacylation of mitochondrial tRNA, resulting in decreased mitochondrial protein synthesis; changes in calcium homeostasis; and alterations in nitric oxide metabolism.
   Currently, no consensus criteria exist for treating the MELAS syndrome or mitochondrial dysfunction in other diseases. Many of the therapeutic strategies used have been adopted as the result of isolated case reports or limited clinical studies that have included a heterogeneous population of patients with the MELAS syndrome, other defects in oxidative phosphorylation or lactic acidosis due to disorders of pyruvate metabolism. Current approaches to the treatment of the MELAS syndrome are based on the use of antioxidants, respiratory chain substrates and cofactors in the form of vitamins, however, no consistent benefits have been observed with these treatments.
C1 Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   Texas Childrens Hosp, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Baylor College of Medicine
RP Scaglia, F (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Suite 1560,6621 Fannin,Mail Code CC1560, Houston, TX 77030 USA.
EM fscaglia@bcm.tmc.edu
CR ABE K, 1991, ACTA NEUROL SCAND, V83, P356, DOI 10.1111/j.1600-0404.1991.tb03962.x
   ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   Bank William, 1998, Biofactors, V7, P243
   BARAK Y, 1995, ISRAEL J MED SCI, V31, P224
   BARBIROLI B, 1995, J NEUROL, V242, P472, DOI 10.1007/BF00873552
   Barisic N, 2002, NEUROPEDIATRICS, V33, P157, DOI 10.1055/s-2002-33679
   BRESOLIN N, 1990, J NEUROL SCI, V100, P70, DOI 10.1016/0022-510X(90)90015-F
   CAMPOS Y, 1995, PEDIATR NEUROL, V13, P69, DOI 10.1016/0887-8994(95)00082-Q
   CHABROL B, 1994, EUR J PEDIATR, V153, P133, DOI 10.1007/BF01959226
   Chen RS, 1997, EUR NEUROL, V37, P212, DOI 10.1159/000117445
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   CLARK AS, 1987, J CLIN INVEST, V79, P588, DOI 10.1172/JCI112851
   COOPER JM, 1992, BRAIN, V115, P991
   COTARIU D, 1988, CLIN CHEM, V34, P890
   Craigen WJ, 1996, PEDIATR NEUROL, V14, P69, DOI 10.1016/0887-8994(96)00005-7
   Crimi M, 2003, NEUROLOGY, V60, P1857, DOI 10.1212/01.WNL.0000066048.72780.69
   De Vivo D., 1990, Int Pediatr, V5, P134
   DiMauro S, 1996, J INHERIT METAB DIS, V19, P489, DOI 10.1007/BF01799110
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   DOUGHERTY FE, 1994, J PEDIATR-US, V125, P758, DOI 10.1016/S0022-3476(94)70073-7
   ENNS GM, 2000, J PEDIATR, V136, P147
   Fabrizi GM, 1996, J NEUROL NEUROSUR PS, V61, P47, DOI 10.1136/jnnp.61.1.47
   FRACKOWIAK RSJ, 1988, BRAIN, V111, P1009, DOI 10.1093/brain/111.5.1009
   Gold DR, 2001, SEMIN NEUROL, V21, P309, DOI 10.1055/s-2001-17948
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GUBBAY SS, 1989, MED J AUSTRALIA, V151, P100, DOI 10.5694/j.1326-5377.1989.tb101170.x
   Hagen TM, 1999, FASEB J, V13, P411, DOI 10.1096/fasebj.13.2.411
   HAGENFELDT L, 1994, MUSCLE NERVE, V17, P1236
   HARRIS RC, 1992, CLIN SCI, V83, P367, DOI 10.1042/cs0830367
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498
   HeimanPatterson TD, 1997, MUSCLE NERVE, V20, P1219, DOI 10.1002/(SICI)1097-4598(199710)20:10<1219::AID-MUS2>3.0.CO;2-F
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   HSU CC, 1995, ACTA NEUROL SCAND, V92, P252
   ICHIKI T, 1988, ANN NEUROL, V23, P287, DOI 10.1002/ana.410230312
   IHARA Y, 1989, J NEUROL SCI, V90, P263, DOI 10.1016/0022-510X(89)90112-3
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Ikejiri Y, 1996, NEUROLOGY, V47, P583, DOI 10.1212/WNL.47.2.583
   IMADA I, 1989, ARCH GERONTOL GERIAT, V8, P323, DOI 10.1016/0167-4943(89)90014-9
   Jacob S, 1996, EXP CLIN ENDOCR DIAB, V104, P284, DOI 10.1055/s-0029-1211455
   James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Kariya S, 2005, NEUROPEPTIDES, V39, P97, DOI 10.1016/j.npep.2004.11.004
   Kariya S, 2003, MOL CELL BIOCHEM, V254, P83, DOI 10.1023/A:1027372519726
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kaufmann P, 1996, ANN NEUROL, V40, P172, DOI 10.1002/ana.410400208
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   Kishnani PS, 1996, EUR J PEDIATR, V155, P898
   Knip M, 2000, DIABETOLOGIA, V43, P1337, DOI 10.1007/s001250051536
   Koga A, 2003, NEUROMUSCULAR DISORD, V13, P259, DOI 10.1016/S0960-8966(02)00267-5
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2002, NEUROLOGY, V58, P827, DOI 10.1212/WNL.58.5.827
   Koga Y, 2000, ARCH DIS CHILD, V82, P407, DOI 10.1136/adc.82.5.407
   Koge Y, 1998, ANN NEUROL, V43, P835, DOI 10.1002/ana.410430620
   Kubota M, 2004, BRAIN DEV-JPN, V26, P481, DOI 10.1016/j.braindev.2004.01.006
   Kuroda Y, 1997, J PEDIATR-US, V131, P450, DOI 10.1016/S0022-3476(97)80075-3
   Kurogouchi F, 1998, AM J NEPHROL, V18, P551, DOI 10.1159/000013406
   Lam CW, 1997, EUR J PEDIATR, V156, P562, DOI 10.1007/s004310050663
   LANDI L, 1984, BIOCHEM J, V222, P463, DOI 10.1042/bj2220463
   Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Majamaa K, 1997, MOL CELL BIOCHEM, V174, P291, DOI 10.1023/A:1006833200371
   Majamaa K, 1996, LIFE SCI, V58, P691, DOI 10.1016/0024-3205(95)02338-0
   Marriage B, 2003, J AM DIET ASSOC, V103, P1029, DOI 10.1016/S0002-8223(03)00476-0
   MASTAGLIA FL, 1980, AUST NZ J MED, V10, P660, DOI 10.1111/j.1445-5994.1980.tb04250.x
   MATSUURA S, 1981, P NATL ACAD SCI-BIOL, V78, P4368, DOI 10.1073/pnas.78.7.4368
   MATTHEWS PM, 1993, NEUROLOGY, V43, P884, DOI 10.1212/WNL.43.5.884
   MONCADA S, 1993, NEW ENGL J MED, V329, P2002
   MONTAGNA P, 1988, NEUROLOGY, V38, P751, DOI 10.1212/WNL.38.5.751
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   MORGANHUGHES JA, 1995, BBA-MOL BASIS DIS, V1271, P135, DOI 10.1016/0925-4439(95)00020-5
   Mori M, 2004, BRAIN DEV-JPN, V26, P453, DOI 10.1016/j.braindev.2003.12.009
   Morovvati S, 2002, ACTA NEUROL SCAND, V106, P104, DOI 10.1034/j.1600-0404.2002.01172.x
   MOUDY AM, 1995, P NATL ACAD SCI USA, V92, P729, DOI 10.1073/pnas.92.3.729
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   NAKAKI T, 1990, LANCET, V336, P696, DOI 10.1016/0140-6736(90)92196-O
   Napolitano A, 2000, NEUROL SCI, V21, pS981, DOI 10.1007/s100720070015
   Oguro H, 2004, INTERNAL MED, V43, P427, DOI 10.2169/internalmedicine.43.427
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Ohkoshi N, 1998, J MED, V29, P13
   Pavlakis SG, 1998, ARCH NEUROL-CHICAGO, V55, P849, DOI 10.1001/archneur.55.6.849
   PENN AMW, 1992, NEUROLOGY, V42, P2147, DOI 10.1212/WNL.42.11.2147
   Pisano P, 1996, EUR J CLIN PHARMACOL, V51, P167, DOI 10.1007/s002280050179
   PONCHAUT S, 1992, BIOCHEM PHARMACOL, V43, P644, DOI 10.1016/0006-2952(92)90590-F
   RADDA GK, 1995, BBA-MOL BASIS DIS, V1271, P15, DOI 10.1016/0925-4439(95)00004-N
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   RATNIKOVA L A, 1978, Biokhimiya, V43, P1989
   Remes AM, 2002, NEUROLOGY, V59, P1275, DOI 10.1212/WNL.59.8.1275
   Rossi FH, 2002, NEUROLOGIST, V8, P313, DOI 10.1097/00127893-200209000-00004
   RUMBACH L, 1986, MOL PHARMACOL, V30, P270
   Rusanen H, 2000, BBA-MOL BASIS DIS, V1500, P10, DOI 10.1016/S0925-4439(99)00081-2
   Sampson V, 2001, EUR J BIOCHEM, V268, P6534, DOI 10.1046/j.0014-2956.2001.02608.x
   SAUNDERS RD, 1987, J NEUROCHEM, V49, P24, DOI 10.1111/j.1471-4159.1987.tb03388.x
   SCHANNE FAX, 1979, SCIENCE, V206, P700, DOI 10.1126/science.386513
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   SHAPIRA Y, 1975, NEUROLOGY, V25, P614, DOI 10.1212/WNL.25.7.614
   SHIMOMURA T, 1994, LANCET, V344, P625, DOI 10.1016/S0140-6736(94)92015-X
   Shoffner JM, 2001, METABOLIC MOL BASES, P2367
   SHOFFNER JM, 1997, CURRENT THERAPY NEUR, P332
   SKOGLUND RR, 1979, NEUROLOGY, V29, P717, DOI 10.1212/WNL.29.5.717
   Spruijt L, 2001, MUSCLE NERVE, V24, P916, DOI 10.1002/mus.1089.abs
   STACPOOLE PW, 1990, FUND APPL TOXICOL, V14, P327, DOI 10.1016/0272-0590(90)90212-3
   Stacpoole PW, 1998, ENVIRON HEALTH PERSP, V106, P989, DOI 10.1289/ehp.98106s4989
   STANSBIE D, 1976, CLIN SCI MOL MED, V51, P445, DOI 10.1042/cs0510445
   Sue CM, 1998, J NEUROL SCI, V161, P36, DOI 10.1016/S0022-510X(98)00179-8
   Takanashi J, 1997, J NEUROL SCI, V145, P83, DOI 10.1016/S0022-510X(96)00248-1
   TAMOPOLSKY MA, 2001, ANN NEUROL, V49, P561
   Tanaka J, 1997, BRAIN DEV-JPN, V19, P262, DOI 10.1016/S0387-7604(97)00573-1
   Tarnopolsky MA, 1999, MUSCLE NERVE, V22, P1228, DOI 10.1002/(SICI)1097-4598(199909)22:9<1228::AID-MUS9>3.3.CO;2-Y
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   Taylor D E, 1996, New Horiz, V4, P420
   Thambisetty M, 2002, NEUROLOGIST, V8, P302, DOI 10.1097/00127893-200209000-00003
   Toda N, 2003, PHARMACOL REV, V55, P271, DOI 10.1124/pr.55.2.3
   TORII H, 1985, J PHARMACOBIO-DYNAM, V8, P457
   TRITSCHLER HJ, 1993, NEUROLOGY, V43, P280, DOI 10.1212/WNL.43.2.280
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   VOROBJEV IA, 1983, FEBS LETT, V163, P311, DOI 10.1016/0014-5793(83)80842-4
   Vos MH, 2001, BIOCHEMISTRY-US, V40, P7806, DOI 10.1021/bi010060x
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Wallimann T, 1998, BIOFACTORS, V8, P229, DOI 10.1002/biof.5520080310
   Wilichowski E, 1999, NEUROPEDIATRICS, V30, P256, DOI 10.1055/s-2007-973500
   WILLMORE LJ, 1984, J NEUROSURG, V60, P467, DOI 10.3171/jns.1984.60.3.0467
   Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001
   Yoneda M, 1999, NEUROLOGY, V53, P2182, DOI 10.1212/WNL.53.9.2182
   Zeviani Massimo, 1993, European Journal of Human Genetics, V1, P80
NR 132
TC 69
Z9 84
U1 0
U2 12
PU ADIS INT LTD
PI NORTHCOTE
PA 5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND
SN 1172-7047
EI 1179-1934
J9 CNS DRUGS
JI CNS Drugs
PY 2006
VL 20
IS 6
BP 443
EP 464
DI 10.2165/00023210-200620060-00002
PG 22
WC Clinical Neurology; Pharmacology & Pharmacy; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA 063WP
UT WOS:000239050900002
PM 16734497
DA 2024-11-01
ER

PT J
AU Bastian, AE
   Jugulete, G
   Manole, E
   Oprisan, LA
AF Bastian, Alexandra Eugenia
   Jugulete, Gheorghita
   Manole, Emilia
   Oprisan, Luminita Alexandra
TI A rare case of mitochondriopathy with autosomal dominant progressive
   external ophthalmoplegia diagnosed through skeletal muscle biopsy
SO ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY
LA English
DT Article
DE mitochondriopathy; progressive external ophthalmoplegia; nuclear DNA
   mutation; electron microscopy
ID MEMBRANE TOPOLOGY; DNA; MUTATIONS
AB Mitochondriopathies are a heterogeneous group of genetic diseases of all ages, with a very diverse clinical presentation related to genetic heteroplasmy. The clinical symptoms display a large variability and generally, the more severe phenotypes have an early onset, even from the neonatal period, while milder ones are manifested later in the adulthood. Most publications have already demonstrated deletions or point mutations in mitochondrial deoxyribonucleic acid (DNA), but in recent years, the field of investigation has expanded to syndromes caused by mutations in the nuclear DNA (nDNA), with a Mendelian inheritance. We present the case of a male patient with a mitochondriopathy with phenotype of chronic progressive external ophthalmoplegia (PEO), due to an autosomal dominant mutation in nDNA, in the DNA polymerase subunit gamma (POLG) gene, the pathogenic variant c.2864A>G (p.Tyr955Cys), morphologically investigated and diagnosed using a skeletal muscle biopsy. The aim of this presentation is to emphasize the diagnostic value of the muscle biopsy both in cases of clinical suspicion and in more challenging cases of mitochondrial diseases with atypical or unusual features. Although genetic testing may be the initial test of choice in cases with suggestive clinical presentation, muscle biopsy is an alternative diagnostic aid with high value even in our molecular era. We present pathological and ultrastructural data to confirm the diagnosis.
C1 [Bastian, Alexandra Eugenia] Carol Davila Univ Med & Pharm, Fac Dent Med, Dept Pathol, Bucharest, Romania.
   [Bastian, Alexandra Eugenia] Colentina Clin Hosp, Dept Pathol, 19-21 Stefan Cel Mare Highway,Sect 2, Bucharest 020125, Romania.
   [Jugulete, Gheorghita] Carol Davila Univ Med & Pharm, Dept Infect Dis, Bucharest, Romania.
   [Jugulete, Gheorghita] Prof Dr Matei Bais Natl Inst Infect Dis, Clin Sect 9 Pediat, Bucharest, Romania.
   [Manole, Emilia] Colentina Clin Hosp, Colentina Res Ctr, Dept Pathol, Bucharest, Romania.
   [Manole, Emilia] Victor Babes Natl Inst Res & Dev Pathol & Biomed, Dept Mol Biol, 99-101 Independentei Ave,Sect 5, Bucharest 050096, Romania.
   [Oprisan, Luminita Alexandra] Colentina Clin Hosp, Dept Neurol, Bucharest, Romania.
   [Oprisan, Luminita Alexandra] Carol Davila Univ Med & Pharm, Dept Neurol, Bucharest, Romania.
C3 Carol Davila University of Medicine & Pharmacy; National Institute for
   Infectious Diseases "Matei Bals"; Carol Davila University of Medicine &
   Pharmacy; Victor Babes National Institute of Pathology; Carol Davila
   University of Medicine & Pharmacy
RP Manole, E (corresponding author), Colentina Clin Hosp, Dept Pathol, 19-21 Stefan Cel Mare Highway,Sect 2, Bucharest 020125, Romania.; Manole, E (corresponding author), Victor Babes Natl Inst Res & Dev Pathol & Biomed, Dept Mol Biol, 99-101 Independentei Ave,Sect 5, Bucharest 050096, Romania.
EM emilia_manole@yahoo.com
RI Jugulete, Gheorghita/GQA-9118-2022; Jugulete, Gheorghita/U-2768-2017;
   Manole, Emilia/AAF-1147-2021
OI Jugulete, Gheorghita/0000-0002-4193-063X; Manole,
   Emilia/0000-0001-5954-2611
CR Angelini C, 2009, Acta Myol, V28, P16
   [Anonymous], 2000, GENEREVIEWS
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   COLLINS S, 1995, ACTA NEUROL SCAND, V91, P287, DOI 10.1111/j.1600-0404.1995.tb07007.x
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   DiMauro S., 1993, GENEREVIEWS
   Gonzalez-Moron D, 2013, BMJ Case Rep, V2013
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Jackson S, 2015, EUR J NEUROL, V22, P1429, DOI 10.1111/ene.12814
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Mannella CA, 2006, BBA-MOL BASIS DIS, V1762, P140, DOI 10.1016/j.bbadis.2005.07.001
   Mannella CA, 2013, J MOL CELL CARDIOL, V62, P51, DOI 10.1016/j.yjmcc.2013.05.001
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Nascimento A, 2016, SEMIN PEDIATR NEUROL, V23, P290, DOI 10.1016/j.spen.2016.11.004
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011
   Phadke R, 2017, J CLIN MED, V6, DOI 10.3390/jcm6070064
   Sleigh K, 2011, MUSCLE NERVE, V43, P795, DOI 10.1002/mus.21962
   Sommerville Ewen W, 2014, J Neuromuscul Dis, V1, P119
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vincent AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30610
NR 25
TC 2
Z9 2
U1 0
U2 5
PU EDITURA ACAD ROMANE
PI BUCURESTI
PA CALEA 13 SEPTEMBRIE NR 13, SECTOR 5, BUCURESTI 050711, ROMANIA
SN 1220-0522
J9 ROM J MORPHOL EMBRYO
JI Rom. J. Morphol. Embryol.
PY 2019
VL 60
IS 1
BP 273
EP 279
PG 7
WC Developmental Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Developmental Biology
GA IJ1VT
UT WOS:000475687700033
PM 31263856
DA 2024-11-01
ER

PT J
AU Jiang, PP
   Jin, XF
   Peng, YY
   Wang, M
   Liu, H
   Liu, XL
   Zhang, ZJ
   Ji, YC
   Zhang, JJ
   Liang, M
   Zhao, FX
   Sun, YH
   Zhang, ML
   Zhou, XT
   Chen, Y
   Mo, JQ
   Huang, TS
   Qu, J
   Guan, MX
AF Jiang, Pingping
   Jin, Xiaofen
   Peng, Yanyan
   Wang, Meng
   Liu, Hao
   Liu, Xiaoling
   Zhang, Zengjun
   Ji, Yanchun
   Zhang, Juanjuan
   Liang, Min
   Zhao, Fuxin
   Sun, Yan-Hong
   Zhang, Minglian
   Zhou, Xiangtian
   Chen, Ye
   Mo, Jun Qin
   Huang, Taosheng
   Qu, Jia
   Guan, Min-Xin
TI The exome sequencing identified the mutation in YARS2 encoding the
   mitochondrial tyrosyl-tRNA synthetase as a nuclear modifier for the
   phenotypic manifestation of Leber's hereditary optic
   neuropathy-associated mitochondrial DNA mutation
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID ND4 G11778A MUTATION; HAN CHINESE FAMILIES; LACTIC-ACIDOSIS; MTDNA
   MUTATIONS; COMPLEX-I; SIDEROBLASTIC ANEMIA; OXIDATIVE STRESS; CAUSES
   MYOPATHY; HIGH PENETRANCE; CELL-LINES
AB Leber's hereditary optic neuropathy (LHON) is the most common mitochondrial disorder. Nuclear modifier genes are proposed to modify the phenotypic expression of LHON-associated mitochondrial DNA (mtDNA) mutations. By using an exome sequencing approach, we identified a LHON susceptibility allele (c.572G>T, p.191Gly>Val) in YARS2 gene encoding mitochondrial tyrosyl-tRNA synthetase, which interacts with m.11778G>A mutation to cause visual failure. We performed functional assays by using lymphoblastoid cell lines derived from members of Chinese families (asymptomatic individuals carrying m.11778G>A mutation, or both m.11778G>A and heterozygous p.191Gly>Val mutations and symptomatic subjects harboring m.11778G>A and homozygous p.191Gly>Val mutations) and controls lacking these mutations. The 191Gly>Val mutation reduced the YARS2 protein level in the mutant cells. The aminoacylated efficiency and steady-state level of tRNA(Tyr) were markedly decreased in the cell lines derived from patients both carrying homozygous YARS2 p.191Gly>Val and m.11778G>A mutations. The failure in tRNATyr metabolism impaired mitochondrial translation, especially for polypeptides with high content of tyrosine codon such as ND4, ND5, ND6 andCOX2 in cells lines carrying homozygous YARS2 p.191Gly>Val and m.11778G>A mutations. The YARS2 p.191Gly>Val mutation worsened the respiratory phenotypes associated with m.11778G>A mutation, especially reducing activities of complexes I and IV. The respiratory deficiency altered the efficiency of mitochondrial ATP synthesis and increased the production of reactive oxygen species. Thus, mutated YARS2 aggravates mitochondrial dysfunctions associated with the m.11778G>A mutation, exceeding the threshold for the expression of blindness phenotype. Our findings provided new insights into the pathophysiology of LHON that were manifested by interaction between mtDNA mutation and mutated nuclear-modifier YARS2.
C1 [Jiang, Pingping; Jin, Xiaofen; Peng, Yanyan; Wang, Meng; Liu, Hao; Ji, Yanchun; Zhang, Juanjuan; Liang, Min; Chen, Ye; Guan, Min-Xin] Zhejiang Univ, Sch Med, Inst Genet, 866 Yuhangtang Rd, Hangzhou 310003, Zhejiang, Peoples R China.
   [Jiang, Pingping; Chen, Ye; Guan, Min-Xin] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310027, Peoples R China.
   [Peng, Yanyan; Huang, Taosheng] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA.
   [Liu, Xiaoling; Zhang, Zengjun; Zhang, Juanjuan; Zhao, Fuxin; Zhou, Xiangtian; Qu, Jia] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.
   [Liu, Xiaoling; Zhang, Zengjun; Zhang, Juanjuan; Zhao, Fuxin; Zhou, Xiangtian; Qu, Jia] Wenzhou Med Coll, Sch Life Sci, Attardi Inst Mitochondrial Biomed, Wenzhou, Zhejiang, Peoples R China.
   [Sun, Yan-Hong] Beijing Univ Chinese Med & Pharmacol, Dept Ophthalmol, Beijing, Peoples R China.
   [Zhang, Minglian] Hebei Prov Eye Hosp, Dept Ophthalmol, Xingtai, Hebei, Peoples R China.
   [Mo, Jun Qin] Univ Calif San Diego, Sch Med, Rady Childrens Hosp, Dept Pathol, San Diego, CA 92103 USA.
C3 Zhejiang University; Zhejiang University; Collaborative Innovation
   Center for Diagnosis & Treatment of Infectious Diseases; Cincinnati
   Children's Hospital Medical Center; Wenzhou Medical University; Wenzhou
   Medical University; Beijing University of Chinese Medicine; Rady
   Childrens Hospital San Diego; University of California System;
   University of California San Diego
RP Guan, MX (corresponding author), Zhejiang Univ, Sch Med, Inst Genet, 866 Yuhangtang Rd, Hangzhou 310003, Zhejiang, Peoples R China.
EM gminxin88@zju.edu.cn
RI Liu, Xiaoling/HGD-3566-2022; zhou, xt/GWZ-9212-2022; Peng,
   Yanyan/I-1515-2019; Zhang, Juan/GRX-2638-2022; chen, yeye/AAN-2578-2020;
   Chen, Ye/D-1164-2015
OI JIANG, PINGPING/0000-0002-4975-4861; Huang,
   Taosheng/0000-0001-6601-6687; Guan, Min-Xin/0000-0001-5067-6736; Zhao,
   Fuxin/0000-0002-1006-6180; Chen, Ye/0000-0003-3671-2504; peng,
   yanyan/0000-0002-1176-4837
FU National Key Technologies R&D Program from the Ministry of Science and
   Technology of China [2012BAI09B03]; Natural Science Foundation of China
   [31471191, 81200724, 81400434]
FX This work was supported by the National Key Technologies R&D Program
   grant 2012BAI09B03 from the Ministry of Science and Technology of China
   to M.-X.G. and P.J., and grants 31471191, 81200724 and 81400434 from the
   Natural Science Foundation of China to M.-X.G., J.Z. and Y.J.,
   respectively.
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Baracca A, 2005, ARCH NEUROL-CHICAGO, V62, P730, DOI 10.1001/archneur.62.5.730
   Beretta S, 2004, BRAIN, V127, P2183, DOI 10.1093/brain/awh258
   Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4
   Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z
   BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405
   Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200
   BU XD, 1992, GENET EPIDEMIOL, V9, P27, DOI 10.1002/gepi.1370090105
   Carelli V, 2009, BBA-BIOENERGETICS, V1787, P518, DOI 10.1016/j.bbabio.2009.02.024
   Chen C, 2015, PROTEIN CELL, V6, P862, DOI 10.1007/s13238-015-0175-z
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005
   Enriquez J A, 1996, Methods Enzymol, V264, P183, DOI 10.1016/S0076-6879(96)64019-1
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Enriquez JA, 1996, P NATL ACAD SCI USA, V93, P8300, DOI 10.1073/pnas.93.16.8300
   Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200
   Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343
   Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466
   Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389
   Hayashi G, 2015, FREE RADICAL BIO MED, V88, P10, DOI 10.1016/j.freeradbiomed.2015.05.039
   Hofhaus G, 1996, J BIOL CHEM, V271, P13155, DOI 10.1074/jbc.271.22.13155
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Jia XY, 2006, J HUM GENET, V51, P851, DOI 10.1007/s10038-006-0032-2
   Jia ZD, 2013, HUM MOL GENET, V22, P4064, DOI 10.1093/hmg/ddt256
   Jiang PP, 2015, INVEST OPHTH VIS SCI, V56, P4778, DOI 10.1167/iovs.14-16158
   KING MP, 1993, J BIOL CHEM, V268, P10228
   Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013
   Li XM, 2004, NUCLEIC ACIDS RES, V32, P867, DOI 10.1093/nar/gkh226
   Li YF, 2007, J BIOL CHEM, V282, P17557, DOI 10.1074/jbc.M701056200
   Liang M, 2014, INVEST OPHTH VIS SCI, V55, P1321, DOI 10.1167/iovs.13-13011
   Mackey DA, 1996, AM J HUM GENET, V59, P481
   Mahfouz R, 2009, FERTIL STERIL, V92, P819, DOI 10.1016/j.fertnstert.2008.05.087
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Meiklejohn CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003238
   MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190
   Newman N.J., 1993, OPHTHALMOL CLIN N AM, V50, P540
   NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4
   NIKOSKELAINEN EK, 1994, CLIN NEUROSCI, V2, P115
   Paukstelis PJ, 2008, NATURE, V451, P94, DOI 10.1038/nature06413
   Phasukkijwatana N, 2010, HUM GENET, V128, P39, DOI 10.1007/s00439-010-0821-8
   Porcelli AM, 2009, J BIOL CHEM, V284, P2045, DOI 10.1074/jbc.M807321200
   Qian YP, 2011, MITOCHONDRION, V11, P871, DOI 10.1016/j.mito.2011.06.006
   Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665
   Qu J, 2007, MITOCHONDRION, V7, P140, DOI 10.1016/j.mito.2006.11.015
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Riley LG, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-193
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Sasarman F, 2012, HUM MUTAT, V33, P1201, DOI 10.1002/humu.22098
   Scheffler I, 2015, J INHERIT METAB DIS, V38, P405, DOI 10.1007/s10545-014-9768-6
   Shankar SP, 2008, OPHTHALMIC GENET, V29, P17, DOI 10.1080/13816810701867607
   Simon M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005097
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431
   Yen MY, 2006, PROG RETIN EYE RES, V25, P381, DOI 10.1016/j.preteyeres.2006.05.002
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
   Zhang JJ, 2014, MITOCHONDRION, V18, P18, DOI 10.1016/j.mito.2014.08.008
   Zhang JJ, 2013, MITOCHONDRION, V13, P772, DOI 10.1016/j.mito.2013.05.002
   Zhou XT, 2012, INVEST OPHTH VIS SCI, V53, P4586, DOI 10.1167/iovs.11-9109
   Zhou XT, 2010, MOL GENET METAB, V100, P379, DOI 10.1016/j.ymgme.2010.04.013
NR 63
TC 88
Z9 97
U1 1
U2 27
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD FEB 1
PY 2016
VL 25
IS 3
BP 584
EP 596
DI 10.1093/hmg/ddv498
PG 13
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA DG5WH
UT WOS:000372149500014
PM 26647310
OA Bronze
DA 2024-11-01
ER

PT S
AU DiMauro, S
   Mancuso, M
   Naini, A
AF DiMauro, S
   Mancuso, M
   Naini, A
BE Lee, HK
   DiMauro, S
   Tanaka, M
   Wei, YH
TI Mitochondrial encephalomyopathies - Therapeutic approach
SO MITOCHONDRIAL PATHOGENESIS: FROM GENES AND APOPTOSIS TO AGING AND
   DISEASE
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT 1st Scientific Meeting of the
   Asian-Society-for-Mitochondrial-Research-and-Medicine
CY FEB 05-06, 2003
CL Seoul, SOUTH KOREA
SP Asian Soc Mitochondrial Res & Med, Bukwang Pharmaceut, Dalim Pharmaceut, Mitocon Inc
DE encephalomyopathies; mitochondria
ID KEARNS-SAYRE SYNDROME; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; SYSTEMIC
   CARNITINE DEFICIENCY; NADH-QUINONE OXIDOREDUCTASE; COMPLEX-III
   DEFICIENCY; STROKE-LIKE EPISODES; SKELETAL-MUSCLE; COENZYME Q(10);
   LACTIC-ACIDOSIS; IN-VITRO
AB Therapy for mitochondrial diseases is woefully inadequate. However, lack of cure does not equate with lack of treatment. In this review, we consider sequentially several different therapeutic approaches. Palliative therapy is dictated by good medical practice and includes anticonvulsant medication, control of endocrine dysfunction, and surgical procedures. Removal of noxious metabolites is centered on combating lactic acidosis, but it extends to other metabolites, such as thymidine in patients with the mitochondrial neurogastrointestinal encephalomyopathy syndrome. Attempts to bypass blocks in the respiratory chain by administration of artificial electron acceptors have not been successful, but this concept may be amenable to genetic engineering. Administration of metabolites and cofactors is the mainstay of real-life therapy and includes both components of the respiratory chain and other natural compounds. There is increasing interest in the administration of reactive oxygen species scavengers both in primary mitochondrial diseases and in neurodegenerative diseases directly or indirectly related to mitochondrial dysfunction. Aerobic exercise and physical therapy prevent or correct deconditioning and improve exercise tolerance in patients with mitochondrial myopathies due to mtDNA mutations. Gene therapy is a challenge because of polyplasmy and heteroplasmy, but interesting experimental approaches are being pursued and include, for example, decreasing the ratio of mutant to wild-type mitochondrial genomes (gene shifting), converting mutated mtDNA genes into normal nDNA genes (allotropic expression), importing cognate genes from other species, or correcting mtDNA mutations with specific restriction endonucleases. Germline therapy raises ethical problems but is being seriously considered to prevent maternal transmission of mtDNA mutations. Preventive therapy through genetic counseling and prenatal diagnosis is still limited for mtDNA-related disorders but is becoming increasingly important for nDNA-related disorders.
C1 Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.
C3 Columbia University
RP Columbia Univ Coll Phys & Surg, Dept Neurol, 630 W 168th St,4-420, New York, NY 10032 USA.
EM sd12@Columbia.edu
RI Mancuso, Michelangelo/K-4170-2016
OI mancuso, michelangelo/0000-0003-2738-8562
FU NICHD NIH HHS [HD32062] Funding Source: Medline; NINDS NIH HHS [NS11766]
   Funding Source: Medline
CR Abe K, 1999, J NEUROL SCI, V162, P65, DOI 10.1016/S0022-510X(98)00296-2
   ALLEN RJ, 1983, ANN NEUROL, V13, P679, DOI 10.1002/ana.410130620
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Andrews RM, 1999, EYE, V13, P769, DOI 10.1038/eye.1999.225
   ARGOV Z, 1986, ANN NEUROL, V19, P598, DOI 10.1002/ana.410190615
   Bai YD, 2001, J BIOL CHEM, V276, P38808, DOI 10.1074/jbc.M106363200
   Barritt JA, 2001, HUM REPROD, V16, P513, DOI 10.1093/humrep/16.3.513
   Beal M.F., 2002, MITOCHONDRIAL DISORD, P17, DOI [10.1007/978-2-8178-0929-8_3, DOI 10.1007/978-2-8178-0929-8_3]
   BENDAHAN D, 1992, NEUROLOGY, V42, P1203, DOI 10.1212/WNL.42.6.1203
   BERNES SM, 1993, J PEDIATR-US, V123, P598, DOI 10.1016/S0022-3476(05)80962-X
   Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329
   BRESOLIN N, 1988, NEUROLOGY, V38, P892, DOI 10.1212/WNL.38.6.892
   Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396
   Buyse G, 2003, NEUROLOGY, V60, P1679, DOI 10.1212/01.WNL.0000068549.52812.0F
   Chang SC, 1998, INT J ANTIMICROB AG, V10, P245, DOI 10.1016/S0924-8579(98)00040-5
   Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   DESTEFANO N, 1995, NEUROLOGY, V45, P1193, DOI 10.1212/WNL.45.6.1193
   DEVIVO DC, 1990, ANN NEUROL, V28, P437
   DEVIVO DC, 1999, PEDIAT NEUROLOGY PRI, V1, P494
   Di Giovanni S, 2001, NEUROLOGY, V57, P515, DOI 10.1212/WNL.57.3.515
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DIMAURO S, 1976, J NEUROL SCI, V27, P217, DOI 10.1016/0022-510X(76)90063-0
   DIMAURO S, 2002, MITOCHONDRIAL DISORD, P307
   Dubern B, 2001, TRANSPLANTATION, V71, P633, DOI 10.1097/00007890-200103150-00009
   ELEFF S, 1984, P NATL ACAD SCI-BIOL, V81, P3529, DOI 10.1073/pnas.81.11.3529
   Feuermann M, 2003, EMBO REP, V4, P53, DOI 10.1038/sj.embor.embor713
   Filla A, 2003, NEUROLOGY, V60, P1569, DOI 10.1212/01.WNL.0000067492.13062.DC
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354
   HAYDAR NA, 1971, ANN INTERN MED, V74, P548, DOI 10.7326/0003-4819-74-4-548
   HAYES S, 2000, AMYOTROPH LATERAL S3, V3, P119
   IHARA Y, 1989, J NEUROL SCI, V90, P263, DOI 10.1016/0022-510X(89)90112-3
   Ikejiri Y, 1996, NEUROLOGY, V47, P583, DOI 10.1212/WNL.47.2.583
   Jaksch M, 2001, HUM MOL GENET, V10, P3025, DOI 10.1093/hmg/10.26.3025
   Karadimas CL, 2000, NEUROLOGY, V55, P644, DOI 10.1212/WNL.55.5.644
   Keightley JA, 2000, AM J HUM GENET, V67, P1400, DOI 10.1086/316900
   Keightley JA, 1996, NAT GENET, V12, P410, DOI 10.1038/ng0496-410
   KENNAWAY NG, 1984, PEDIATR RES, V18, P991
   Kolesnikova OA, 2000, SCIENCE, V289, P1931, DOI 10.1126/science.289.5486.1931
   Kuroda Y, 1997, J PEDIATR-US, V131, P450, DOI 10.1016/S0022-3476(97)80075-3
   Lamhonwah AM, 1998, BIOCHEM BIOPH RES CO, V252, P396, DOI 10.1006/bbrc.1998.9679
   Lamperti C, 2003, NEUROLOGY, V60, P1206, DOI 10.1212/01.WNL.0000055089.39373.FC
   Lodi R, 2001, ANN NEUROL, V49, P590
   Manfred G, 1999, J BIOL CHEM, V274, P9386, DOI 10.1074/jbc.274.14.9386
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Mariotti C, 2003, NEUROLOGY, V60, P1676, DOI 10.1212/01.WNL.0000055872.50364.FC
   MATSUOKA T, 1992, NEUROMUSCULAR DISORD, V1, P443
   Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849
   Nezu JI, 1999, NAT GENET, V21, P91, DOI 10.1038/5030
   Nishino I, 2000, ANN NEUROL, V47, P792
   OGASAHARA S, 1986, NEUROLOGY, V36, P45, DOI 10.1212/WNL.36.1.45
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   Ojaimi J, 2002, MOL BIOL CELL, V13, P3836, DOI 10.1091/mbc.E02-05-0306
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Puoti G, 2003, J MED GENET, V40, P858, DOI 10.1136/jmg.40.11.858
   Rötig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9
   RUBENSTEIN DS, 1995, CAMB Q HEALTHC ETHIC, V4, P316, DOI 10.1017/S0963180100006071
   Rustin P, 1999, LANCET, V354, P477, DOI 10.1016/S0140-6736(99)01341-0
   Saitoh S, 1998, NEUROLOGY, V50, P531, DOI 10.1212/WNL.50.2.531
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Salviati L, 2002, BIOCHEM J, V363, P321, DOI 10.1042/0264-6021:3630321
   Santorelli FM, 2002, NEUROMUSCULAR DISORD, V12, P56, DOI 10.1016/S0960-8966(01)00248-6
   Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741
   Seo BB, 1998, P NATL ACAD SCI USA, V95, P9167, DOI 10.1073/pnas.95.16.9167
   SERVIDEI S, 2002, MITOCHONDRIAL DISORD, P37
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   SHERWOOD G, 1989, J INHERIT METAB DIS, V12, P393, DOI 10.1007/BF03335432
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541
   Sobreira C, 1997, NEUROLOGY, V48, P1238, DOI 10.1212/WNL.48.5.1238
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   STACPOOLE PW, 1989, METABOLISM, V38, P1124, DOI 10.1016/0026-0495(89)90051-6
   STANLEY CA, 1991, ANN NEUROL, V30, P709, DOI 10.1002/ana.410300512
   Sue CM, 2000, BRAIN PATHOL, V10, P442
   Sue CM, 1998, ANN NEUROL, V43, P350, DOI 10.1002/ana.410430313
   TABRIZI SJ, 2002, MITOCHONDRIAL DISORD, V2, P143
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 1996, NEUROLOGY, V47, P529, DOI 10.1212/WNL.47.2.529
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   TEIN I, 1990, PEDIATR RES, V28, P247, DOI 10.1203/00006450-199009000-00020
   TEIN I, 1993, PEDIATR RES, V34, P281, DOI 10.1203/00006450-199309000-00008
   Thorburn DR, 2001, MITOCHONDRION, V1, P123, DOI 10.1016/S1567-7249(01)00013-7
   TRANCHANT C, 1993, NEUROMUSCULAR DISORD, V3, P561, DOI 10.1016/0960-8966(93)90116-2
   White SL, 1999, PRENATAL DIAG, V19, P1165, DOI 10.1002/(SICI)1097-0223(199912)19:12<1165::AID-PD719>3.3.CO;2-4
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
   YAMAMOTO M, 1987, J NEUROL NEUROSUR PS, V50, P1475, DOI 10.1136/jnnp.50.11.1475
NR 91
TC 44
Z9 50
U1 0
U2 6
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-491-9; 1-57331-490-0
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2004
VL 1011
BP 232
EP 245
DI 10.1196/annals.1293.023
PG 14
WC Biochemistry & Molecular Biology; Multidisciplinary Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Science & Technology - Other Topics
GA BAE70
UT WOS:000221896100023
PM 15126300
DA 2024-11-01
ER

PT J
AU Singh, RK
   Saini, SK
   Prakasam, G
   Kalairasan, P
   Bamezai, RNK
AF Singh, Rajnish Kumar
   Saini, Sunil Kumar
   Prakasam, Gopinath
   Kalairasan, Ponnuusamy
   Bamezai, Rameshwar N. K.
TI Role of ectopically expressed mtDNA encoded cytochrome c oxidase subunit
   I (MT-COI) in tumorigenesis
SO MITOCHONDRION
LA English
DT Article
ID MITOCHONDRIAL-DNA MUTATIONS; LEIGH-SYNDROME; ND5 MUTATION; COMMON-CAUSE;
   COMPLEX-I; CANCER; GENE; BREAST; MYOPATHY; MODEL
AB Somatic mutations within mitochondrial DNA (mtDNA) encoded cytochrome c oxidase subunit I (MT-CO1 or MT-COI) are frequent in various cancer types. In addition, perturbation from orchestrated expression of mitochondrial DNA encoded genes is also associated with complex disorders, including cancer. Since codon bias and the mitochondrial translation system restricts functional characterization of over-expressed wild type or mutant mitochondrial DNA encoded genes, the codon optimization and artificial synthesis of entire MT-CO1 allowed us to over-express the wild type and one of its deleterious mutants into the mitochondria of the transfected cells. Ectopically expressed MT-CO1 was observed to efficiently express and localized to mitochondria but showed high level of aggregation under denaturing condition. Over-expression of wild type or mutant variant of MT-CO1 promoted anchorage dependent and independent proliferation potential in in-vitro experiments and introduced the cancer cell metabolic phenotype of high glucose uptake and lactate release. Reactive oxygen species generated in cells over-expressing MT-CO1 variants acted as key effectors mediating differential expression of apoptosis and DNA damage pathway related genes. High ROS generated also down-regulated the expression of global regulators of gene expression, DNMT3A and DNMT3B. The down-regulated expression of DNMTs co-related with differential methylation of the CpG islands in the promoter region of a select set of studied genes, in a manner to promote pro-cancerous phenotype. Apart from assigning the mechanistic role to the MT-CO1 variants and their perturbed expression in cancer development, the present study provides novel insights into the functional role of somatic mutations within MT-CO1 promoting cancer phenotype.
C1 [Singh, Rajnish Kumar; Saini, Sunil Kumar; Prakasam, Gopinath; Kalairasan, Ponnuusamy; Bamezai, Rameshwar N. K.] Jawaharlal Nehru Univ, Sch Iife Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India.
   [Singh, Rajnish Kumar] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Kalairasan, Ponnuusamy] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi, India.
C3 Jawaharlal Nehru University, New Delhi; University of Pennsylvania;
   Jawaharlal Nehru University, New Delhi
RP Bamezai, RNK (corresponding author), Jawaharlal Nehru Univ, Sch Iife Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India.
EM rajnishsbt2005@gmail.com; bamezai@mail.jnu.ac.in
RI prakasam, Gopinath/S-8438-2017
OI SINGH, RAJNISH/0000-0001-7414-1170; Saini, Sunil/0000-0002-1124-5930;
   prakasam, gopinath/0000-0003-1839-7969
FU Council of Scientific and Industrial Research (CSIR), Govt. of India;
   University grant commission (UGC), Govt. of India
FX RKS acknowledges Council of Scientific and Industrial Research (CSIR),
   Govt. of India, for pre-doctoral fellowship. RNKB acknowledges
   University grant commission (UGC), Govt. of India for the grant to the
   National Centre of Applied Human Genetics.
CR ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   D'Aurelio M, 2006, HUM MOL GENET, V15, P2157, DOI 10.1093/hmg/ddl141
   Darvishi K, 2007, CANCER LETT, V249, P249, DOI 10.1016/j.canlet.2006.09.005
   Das TK, 1998, BIOCHEMISTRY-US, V37, P14471, DOI 10.1021/bi981500w
   Dasgupta S, 2008, CANCER RES, V68, P700, DOI 10.1158/0008-5472.CAN-07-5532
   Dhar SS, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120176
   Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05
   Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P664, DOI 10.1016/j.bbabio.2009.12.013
   Gallardo ME, 2006, HUM MUTAT, V27, P575, DOI 10.1002/humu.20338
   Gao S, 2018, MITOCHONDRION, V38, P41, DOI 10.1016/j.mito.2017.08.002
   Gochhait S, 2008, INT J CANCER, V123, P2580, DOI 10.1002/ijc.23817
   HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010
   Larman TC, 2012, P NATL ACAD SCI USA, V109, P14087, DOI 10.1073/pnas.1211502109
   Leadsham JE, 2013, CELL METAB, V18, P279, DOI 10.1016/j.cmet.2013.07.005
   Lee I, 2012, J PHYSIOL-LONDON, V590, P5231, DOI 10.1113/jphysiol.2012.239707
   Lenaz G, 2009, INT J BIOCHEM CELL B, V41, P1750, DOI 10.1016/j.biocel.2009.04.003
   Liu XL, 2011, OPHTHALMOLOGY, V118, P978, DOI 10.1016/j.ophtha.2010.09.003
   Lloyd RE, 2015, NEURO-ONCOLOGY, V17, P942, DOI 10.1093/neuonc/nov020
   Lloyd RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069003
   LOVE B, 1970, J BIOL CHEM, V245, P6664
   Massie R, 2012, J NEUROL SCI, V319, P158, DOI 10.1016/j.jns.2012.05.003
   Mayorov V, 2005, ANN NEUROL, V58, P807, DOI 10.1002/ana.20669
   Moilanen JS, 2003, MOL BIOL EVOL, V20, P1195, DOI 10.1093/molbev/msg121
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   Nishigaki Y, 2004, HUM MOL GENET, V13, P91, DOI 10.1093/hmg/ddh010
   Pal R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-303
   Parrella P, 2001, CANCER RES, V61, P7623
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Petruzzella V, 2003, NEUROLOGY, V61, P1017, DOI 10.1212/01.WNL.0000080363.10902.E9
   Ramos A, 2011, ELECTROPHORESIS, V32, P782, DOI 10.1002/elps.201000583
   Ray AM, 2009, PROSTATE, V69, P956, DOI 10.1002/pros.20943
   Saini SK, 2018, MITOCHONDRION, V43, P30, DOI 10.1016/j.mito.2018.04.005
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Shen LJ, 2011, J CANCER RES CLIN, V137, P669, DOI 10.1007/s00432-010-0912-x
   Singer VL, 1999, MUTAT RES-GEN TOX EN, V439, P37, DOI 10.1016/S1383-5718(98)00172-7
   Singh RK, 2017, MITOCHONDRION, V35, P35, DOI 10.1016/j.mito.2017.05.001
   Singh RK, 2014, SCI REP-UK, V4, DOI 10.1038/srep06571
   Skonieczna K, 2018, HUM MUTAT, V39, P691, DOI 10.1002/humu.23402
   Sun WY, 2009, CLIN CANCER RES, V15, P476, DOI 10.1158/1078-0432.CCR-08-0930
   Tabebi M, 2015, BIOCHEM BIOPH RES CO, V459, P353, DOI 10.1016/j.bbrc.2015.01.151
   Taylor RW, 2002, EUR J HUM GENET, V10, P141, DOI 10.1038/sj.ejhg.5200773
   Wilkins HM, 2014, REDOX BIOL, V2, P619, DOI 10.1016/j.redox.2014.03.006
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Yin PH, 2010, MITOCHONDRION, V10, P174, DOI 10.1016/j.mito.2009.12.147
   Zambelli F, 2018, STEM CELL REP, V11, P102, DOI 10.1016/j.stemcr.2018.05.007
   Zhao D, 2011, J HUM GENET, V56, P759, DOI 10.1038/jhg.2011.96
   Zhou SY, 2007, P NATL ACAD SCI USA, V104, P7540, DOI 10.1073/pnas.0610818104
NR 48
TC 15
Z9 16
U1 1
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV
PY 2019
VL 49
BP 56
EP 65
DI 10.1016/j.mito.2019.07.002
PG 10
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA JX2AW
UT WOS:000503545000007
PM 31299394
DA 2024-11-01
ER

PT J
AU Mojbafan, M
   Nojehdeh, ST
   Rahiminejad, F
   Nilipour, Y
   Tonekaboni, SH
   Zeinali, S
AF Mojbafan, Marzieh
   Nojehdeh, Somayeh Takrim
   Rahiminejad, Faezeh
   Nilipour, Yalda
   Tonekaboni, Seyed Hasan
   Zeinali, Sirous
TI Reporting a rare form of myopathy, myopathy with extrapyramidal signs,
   in an Iranian family using next generation sequencing: a case report
SO BMC MEDICAL GENETICS
LA English
DT Article
DE Myopathy with extrapyramidal signs; MICU1 gene; Next generation
   sequencing; Autozygosity mapping
ID MITOCHONDRIAL CA2+ UPTAKE; MICU1; GATEKEEPER; BINDING; GENE
AB Background Myopathy with extrapyramidal signs (MPXPS) is an autosomal recessive mitochondrial disorder which is caused by mutation in mitochondrial calcium uptake 1 (MICU1) gene located on chromosome 10q22.1. Next Generation Sequencing (NGS) technology is the most effective method for identification of pathogenic variants with the ability to overcome some limitations which Sanger sequencing may encountered. There are few reports on this rare disease around the world and here in this study we first revealed genetic identification of two affected individuals in an Iranian family with a novel mutation. Case presentation The proband was a 5-year-old girl from consanguenous parents. She was first clinically suspicious of affected with limb-girdle muscular dystrophy (LGMD). Muscle biopsy studies and autozygosity mapping, using four short tandem repeat (STR) markers linked to 6 genes of the most prevalent forms of LGMD, ruled out calpainopathy, dysferlinopathy, and sarcoglycanopathis. DNA sample of the proband was sent for NGS. Whole exome sequencing (WES) revealed a novel mutation c.1295delA in exon 13 of MICU1 gene. This homozygous deletion creates a frameshift and a premature stop codon downstream of canonical EF4 calcium binding motif of MICU1. According to the American College of Medical Genetics and Genomics (ACMG) guidline for sequence interpretation, this variant was a pathogenic one. Sanger sequencing in all family members confirmed the results of the WES. Conclusions This study was the first report of MPXPS in Iranian population which also revealed a novel mutation in the MICU1 gene.
C1 [Mojbafan, Marzieh] Iran Univ Med Sci, Fac Med, Dept Med Genet & Mol Biol, Shahid Hemmat Highway, Tehran, Iran.
   [Mojbafan, Marzieh] Ali Asghar Childrens Hosp, Dept Med Genet, Zafar St,Shahid Modarres Highway, Tehran, Iran.
   [Nojehdeh, Somayeh Takrim; Rahiminejad, Faezeh; Zeinali, Sirous] Kawsar Human Genet Res Ctr, Med Genet Lab, 41 Majlesi St,Valieasr Ave, Tehran, Iran.
   [Nilipour, Yalda] Shahid Beheshti Univ Med Sci, Res Inst Children Hlth, Pediat Pathol Res Ctr, Mofid Hosp,Pathol Dept, Tehran, Iran.
   [Tonekaboni, Seyed Hasan] Shahid Beheshti Med Univ, Dept Pediat Neurol, Pediat Neurol Ctr Excellence, Mofid Children Hosp,Fac Med, Tehran, Iran.
   [Zeinali, Sirous] Pasteur Inst Iran, Dept Mol Med, Biotechnol Res Ctr, 69 Pasteur Ave, Tehran, Iran.
C3 Iran University of Medical Sciences; Shahid Beheshti University Medical
   Sciences; Shahid Beheshti University Medical Sciences; Pasteur Network;
   Pasteur Institute of Iran
RP Zeinali, S (corresponding author), Kawsar Human Genet Res Ctr, Med Genet Lab, 41 Majlesi St,Valieasr Ave, Tehran, Iran.; Zeinali, S (corresponding author), Pasteur Inst Iran, Dept Mol Med, Biotechnol Res Ctr, 69 Pasteur Ave, Tehran, Iran.
EM zeinalipasteur@yahoo.com
RI tonekaboni, seyed/K-1575-2019; Nilipour, Yalda/AAY-2110-2021
OI Tonekaboni, Seyed Hassan/0000-0003-0853-8465
CR Dubowitz V, 1973, HISTOLOGICAL HISTOCH
   Hoffman NE, 2013, CELL REP, V5, P1576, DOI 10.1016/j.celrep.2013.11.026
   Kamer KJ, 2014, EMBO REP, V15, P299, DOI 10.1002/embr.201337946
   Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892
   Lewis-Smith D, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000059
   Liu JC, 2016, CELL REP, V16, P1561, DOI 10.1016/j.celrep.2016.07.011
   Logan CV, 2014, NAT GENET, V46, P188, DOI 10.1038/ng.2851
   M'Angale PG, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16019436
   Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011
   Marchi S, 2014, J PHYSIOL-LONDON, V592, P829, DOI 10.1113/jphysiol.2013.268235
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Mojbafan M, 2018, GENE, V677, P259, DOI 10.1016/j.gene.2018.07.067
   Mojbafan M, 2016, J MOL NEUROSCI, V59, P392, DOI 10.1007/s12031-016-0772-1
   Mojbafan M, 2016, J NEUROGENET, V30, P1, DOI 10.3109/01677063.2016.1141208
   Musa S, 2018, MIDDLE E FOUNDER MUT
   Nigro Vincenzo, 2014, Acta Myol, V33, P1
   Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358
   Petrungaro C, 2015, CELL METAB, V22, P721, DOI 10.1016/j.cmet.2015.08.019
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Safari R, 2016, J INTEGR NEUROSCI, V15, P163, DOI 10.1142/S0219635216500096
   Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890
   Thompson R, 2016, NAT REV NEUROL, V12, P294, DOI 10.1038/nrneurol.2016.35
   Truong AH, 2016, VASCULAR ION CHANNEL
   Wang LL, 2014, EMBO J, V33, P594, DOI 10.1002/embj.201386523
   Woods CG, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016873
NR 25
TC 12
Z9 12
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2350
J9 BMC MED GENET
JI BMC Med. Genet.
PD APR 15
PY 2020
VL 21
IS 1
AR 77
DI 10.1186/s12881-020-01016-y
PG 6
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA LH3ZQ
UT WOS:000528726000003
PM 32293312
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Sarnat, HB
   Marín-García, J
AF Sarnat, HB
   Marín-García, J
TI Pathology of mitochondrial encephalomyopathies
SO CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the Society-for-Pediatric-Pathology
CY MAR   22, 2003
CL WASHINGTON, DC
SP Soc Pediat Pathol
ID KEARNS-SAYRE-SYNDROME; C-OXIDASE DEFICIENCY; HUMAN SKELETAL-MUSCLE;
   SPINAL MUSCULAR-ATROPHY; RAGGED-RED FIBERS; DNA DEPLETION;
   RESPIRATORY-CHAIN; NEUROMUSCULAR DISORDERS; THYMIDINE KINASE; MTDNA
   DELETIONS
AB Muscle biopsy provides the best tissue to confirm a mitochondrial cytopathy. Histochemical features often correlate with specific syndromes and facilitate the selection of biochemical and genetic studies. Ragged-red fibres nearly always indicate a combination defect of respiratory complexes I and IV. Increased punctate lipid within myofibers is a regular feature of Kearns-Sayre and PEO, but not of MELAS and MERRF. Total deficiency of succinate dehydrogenase indicates a severe defect in Complex 11; total absence of cytochrome-c-oxidase activity in all myofibres correlates with a severe deficiency of Complex IV or of coenzyme-Q10. The selective loss of cytochrome-c-oxidase activity in scattered myofibers, particularly if accompanied by strong succinate dehydrogenase staining in these same fibres, is good evidence of mitochondrial cytopathy and often of a significant mtDNA mutation, though not specific for Complex IV disorders. Glycogen may be excessive in ragged-red zones. Ultrastructure provides morphological evidence of mitochondrial cytopathy, in axons and endothelial cells as well as myocytes. Abnormal axonal mitochondria may contribute to neurogenic atrophy of muscle, a secondary chronic feature. Quantitative determinations of respiratory chain enzyme complexes, with citrate synthase as an internal control, confirm the histochemical impressions or may be the only evidence of mitochondrial disease. Biological and technical artifacts may yield falsely low enzymatic activities. Genetic studies screen common point mutations in mtDNA. The brain exhibits characteristic histopathological alterations in mitochondrial diseases. Skin biopsy is useful for mitochondrial ultrastructure in smooth erector pili muscles and axons; skin fibroblasts may be grown in culture. Mitochondrial alterations occur in many nonmitochondrial diseases and also may be induced by drugs and toxins.
C1 Alberta Childrens Prov Gen Hosp, Calgary, AB T2T 5C7, Canada.
   Univ Calgary, Fac Med, Calgary, AB, Canada.
   Mol Cardiol & Neuromuscular Inst, Highland Pk, NJ USA.
C3 Alberta Childrens Hospital; University of Calgary; University of Calgary
RP Sarnat, HB (corresponding author), Alberta Childrens Prov Gen Hosp, 1820 Richmond Rd SW, Calgary, AB T2T 5C7, Canada.
RI Sarnat, Harvey/AAP-6756-2021
CR Arnon S, 2002, PRENATAL DIAG, V22, P34, DOI 10.1002/pd.232
   Berger A, 2003, ACTA NEUROPATHOL, V105, P245, DOI 10.1007/s00401-002-0638-1
   BHAWAT AG, 1971, ARCH PATHOL, V91, P70
   BONILLA E, 1975, J ULTRA MOL STRUCT R, V51, P404, DOI 10.1016/S0022-5320(75)80103-1
   Brierley EJ, 1997, ANN NEUROL, V41, P114, DOI 10.1002/ana.410410120
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   CARPENTER S, 1992, Neurology, V42, P388
   Carpenter S, 2001, PATHOLOGY SKELETAL M, P453
   Castro-Gago M, 2000, REV NEUROLOGIA, V31, P838, DOI 10.33588/rn.3109.2000325
   Chow CK, 2001, BIOL SIGNAL RECEPT, V10, P112
   Darin N, 2003, NEUROPEDIATRICS, V34, P311
   DeCoo IFM, 1997, J NEUROL SCI, V149, P37, DOI 10.1016/S0022-510X(97)05366-5
   DiMauro S, 1999, J CHILD NEUROL, V14, pS23, DOI 10.1177/0883073899014001051
   DIMAURO S, 1983, ANN NEUROL, V14, P226, DOI 10.1002/ana.410140209
   DiMauro S, 2002, ADV NEUROL, V89, P217
   Elpeleg O, 2002, J MOL MED-JMM, V80, P389, DOI 10.1007/s00109-002-0343-5
   Fardeau M, 1981, Acta Neuropathol Suppl, V7, P279
   Fernández R, 1999, NEUROMUSCULAR DISORD, V9, P136, DOI 10.1016/S0960-8966(98)00117-5
   Geromel V, 2002, MOL GENET METAB, V77, P21, DOI 10.1016/S1096-7192(02)00145-2
   GRAU JM, 1995, ANN NEUROL, V38, P273, DOI 10.1002/ana.410380225
   Hargreaves IP, 2002, J INHERIT METAB DIS, V25, P7, DOI 10.1023/A:1015104910239
   Holmuhamedov E, 2003, MITOCHONDRION, V3, P13, DOI 10.1016/S1567-7249(03)00053-9
   Huang CC, 2002, J NEURO-OPHTHALMOL, V22, P66, DOI 10.1097/00041327-200203000-00036
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   JOHNSTON W, 1995, ANN NEUROL, V37, P16, DOI 10.1002/ana.410370106
   JORDAN J, 2003, REV NEUROLOGIA, V37, P1058
   KELLEY RI, 1983, AM J MED GENET, V16, P503, DOI 10.1002/ajmg.1320160409
   Kimata KG, 1998, ARCH NEUROL-CHICAGO, V55, P722, DOI 10.1001/archneur.55.5.722
   Komura K, 2003, PEDIATR NEUROL, V28, P53, DOI 10.1016/S0887-8994(02)00469-1
   Kubota Y, 1999, J AM ACAD DERMATOL, V41, P469, DOI 10.1016/S0190-9622(99)70123-4
   Kyriakides T, 2003, Acta Myol, V22, P48
   LAKE BD, 2002, GREENFIELDS NEUROPAT
   Lamperti C, 2003, NEUROLOGY, V60, P1206, DOI 10.1212/01.WNL.0000055089.39373.FC
   Li X, 2003, MITOCHONDRION, V3, P29, DOI 10.1016/S1567-7249(03)00058-8
   Linnane AW, 2002, FREE RADICAL RES, V36, P445, DOI 10.1080/10715760290021306
   Lorenc A, 2003, MITOCHONDRION, V3, P119, DOI 10.1016/S1567-7249(03)00106-5
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mandel H, 2001, HEPATOLOGY, V34, P776, DOI 10.1053/jhep.2001.27664
   Marin-Garcia J, 2000, J CHILD NEUROL, V15, P555, DOI 10.1177/088307380001500812
   Marin-Garcia J, 2000, PEDIATR NEUROL, V22, P122, DOI 10.1016/S0887-8994(99)00117-4
   Marín-García J, 2003, PEDIATR NEUROL, V29, P26, DOI 10.1016/S0887-8994(03)00013-4
   Marín-García J, 2002, PEDIATR NEUROL, V27, P213, DOI 10.1016/S0887-8994(02)00426-5
   MarinGarcia J, 1997, J INHERIT METAB DIS, V20, P674, DOI 10.1023/A:1005322409330
   MATTHEWS PM, 1993, NEUROLOGY, V43, P884, DOI 10.1212/WNL.43.5.884
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   Melegh B, 1997, NEUROPEDIATRICS, V28, P257, DOI 10.1055/s-2007-973710
   Melone MAB, 2004, ARCH NEUROL-CHICAGO, V61, P269, DOI 10.1001/archneur.61.2.269
   MILES L, 2003, LAB INVEST
   Mitsui T, 2002, ACTA NEUROPATHOL, V104, P260, DOI 10.1007/s00401-002-0553-5
   NAUMANN M, 1995, ACTA NEUROPATHOL, V89, P152
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nikali K, 1997, GENOMICS, V39, P185, DOI 10.1006/geno.1996.4465
   NIKALI K, 2003, EUR J PAEDIATR NEURO, V7, P285
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Oldfors A, 2003, J NEUROPATH EXP NEUR, V62, P217, DOI 10.1093/jnen/62.3.217
   PEYRONNARD JM, 1980, ANN NEUROL, V7, P262, DOI 10.1002/ana.410070310
   Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009
   Pons R, 1996, PEDIATR NEUROL, V15, P153, DOI 10.1016/0887-8994(96)00118-X
   POULTON J, 1991, CLIN GENET, V39, P33
   Ricoy-Campo JR, 2003, REV NEUROLOGIA, V37, P775, DOI 10.33588/rn.3708.2002596
   RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107
   Rollins S, 2001, AM J CLIN PATHOL, V116, P326
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sakuta R, 2002, PEDIATR NEUROL, V27, P397, DOI 10.1016/S0887-8994(02)00456-3
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200
   SARNAT HB, 1983, CAN J NEUROL SCI, V10, P170, DOI 10.1017/S0317167100044863
   Schapira A., 2003, Mitochondrial Function and Dysfunction
   Schapira AHV, 2002, J INHERIT METAB DIS, V25, P207, DOI 10.1023/A:1015629912477
   Schröder R, 2000, J NEUROPATH EXP NEUR, V59, P353, DOI 10.1093/jnen/59.5.353
   Schuelke M, 2002, ANN NEUROL, V51, P388, DOI 10.1002/ana.10151
   Servidei Serenella, 2004, Neuromuscul Disord, V14, P107
   Silver MA, 2003, BIOFACTORS, V18, P125, DOI 10.1002/biof.5520180214
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   Sullivan PG, 2003, ANN NEUROL, V53, P711, DOI 10.1002/ana.10543
   Tanji K, 2003, J NEUROPATH EXP NEUR, V62, P567
   TAYLOR RW, 1993, BIOCHIM BIOPHYS ACTA, V1181, P261, DOI 10.1016/0925-4439(93)90030-5
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   THOMAS L, 1974, LIVES CELL, P72
   Tsao CY, 2000, J CHILD NEUROL, V15, P445, DOI 10.1177/088307380001500704
   Van Maldergem L, 2002, ANN NEUROL, V52, P750, DOI 10.1002/ana.10371
   Vielhaber S, 2002, J NEUROPATH EXP NEUR, V61, P885, DOI 10.1093/jnen/61.10.885
   Vogel H, 2001, J NEUROPATH EXP NEUR, V60, P217, DOI 10.1093/jnen/60.3.217
   Wada H, 1996, BRAIN DEV-JPN, V18, P263, DOI 10.1016/0387-7604(96)00017-4
   Wu SP, 2004, EPILEPSIA, V45, P204, DOI 10.1111/j.0013-9580.2004.29603.x
   Yerroum M, 2000, ACTA NEUROPATHOL, V100, P82, DOI 10.1007/s004010051196
   YIANNIKAS C, 1986, ANN NEUROL, V20, P249, DOI 10.1002/ana.410200211
NR 88
TC 63
Z9 72
U1 0
U2 1
PU CANADIAN J NEUROL SCI INC
PI CALGARY
PA PO BOX 4220, STATION C EDITORIAL & SUBSCRIPTION SERV, CALGARY, AB T2T
   5N1, CANADA
SN 0317-1671
J9 CAN J NEUROL SCI
JI Can. J. Neurol. Sci.
PD MAY
PY 2005
VL 32
IS 2
BP 152
EP 166
DI 10.1017/S0317167100003929
PG 15
WC Clinical Neurology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 930GF
UT WOS:000229403100004
PM 16018150
OA Bronze
DA 2024-11-01
ER

PT J
AU Bayrakci, US
   Baskin, E
   Ozcay, F
   Ozdemir, BH
   Karakayali, H
   Haberal, M
AF Bayrakci, Umut Selda
   Baskin, Esra
   Ozcay, Figen
   Ozdemir, Binnaz Handan
   Karakayali, Hamdi
   Haberal, Mehmet
TI Renal Fanconi syndrome and myopathy after liver transplantation:
   Drug-related mitochondrial cytopathy?
SO PEDIATRIC TRANSPLANTATION
LA English
DT Article
DE renal Fanconi syndrome; mitochondrial cytopathy; liver transplantation;
   tacrolimus; lamivudine; children
ID REVERSE-TRANSCRIPTASE INHIBITORS; TUBULAR-ACIDOSIS SECONDARY;
   WILSONS-DISEASE; DNA; NEPHROTOXICITY; NEPHROPATHY; TACROLIMUS;
   DEPLETION; THERAPY; FAILURE
AB Advances in the field of transplantation provide a better quality of life and allow more favorable conditions for growth and development in children. However, combinations of different therapeutic regimens require consideration of potential adverse reactions. We describe a 15-yr-old girl who had orthotopic liver transplantation because of Wilson's disease. Tacrolimus, MMF, and steroids were given as immunosuppressant. Lamivudine was added because of de nova hepatitis B infection during her follow-up. Three yr after transplantation she developed renal Fanconi syndrome with severe metabolic acidosis, hypophosphatemia, glycosuria, and aminoaciduria. Although tacrolimus was suspected to be the cause of late post-transplant renal acidosis and was replaced by sirolimus, acidosis, and electrolyte imbalance got worse. Proximal muscle weakness has developed during her follow-up. Fanconi syndrome, as well as myopathy, is well recognized in patients with mitochondrial disorders and caused by depletion of mtDNA. We suggest that our patient's tubular dysfunction and myopathy may have resulted from mitochondrial dysfunction which is triggered by tacrolimus and augmented by lamivudine.
C1 [Bayrakci, Umut Selda; Baskin, Esra] Baskent Univ, Tip Fak, Dept Pediat Nephrol, Pediat Nephrol Unitesi 6, TR-06490 Ankara, Turkey.
   [Ozcay, Figen] Baskent Univ, Dept Pediat Gastroenterol, TR-06490 Ankara, Turkey.
   [Ozcay, Figen] Baskent Univ, Dept Pathol, TR-06490 Ankara, Turkey.
   [Karakayali, Hamdi; Haberal, Mehmet] Baskent Univ, Dept Gen Surg, TR-06490 Ankara, Turkey.
C3 Baskent University; Baskent University; Baskent University; Baskent
   University
RP Bayrakci, US (corresponding author), Baskent Univ, Tip Fak, Dept Pediat Nephrol, Pediat Nephrol Unitesi 6, Cad 72-3, TR-06490 Ankara, Turkey.
EM ukavak@yahoo.com
RI Baskin, Esra/B-5785-2018; BAYRAKCI, UMUT SELDA/AFL-2088-2022; Ozcay,
   Figen/ABG-5684-2020; Haberal, Mehmet/AAJ-8097-2021; Ozdemir,
   B.Handan/X-8540-2019
OI BAYRAKCI, UMUT SELDA/0000-0002-5301-2617; Ozcay,
   Figen/0000-0002-5214-516X; Haberal, Mehmet/0000-0002-3462-7632; Ozdemir,
   B.Handan/0000-0002-7528-3557
CR Allen KJ, 2004, J GASTROEN HEPATOL, V19, P1283, DOI 10.1111/j.1440-1746.2004.03451.x
   ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   BELLARY S, 1995, J HEPATOL, V23, P373, DOI 10.1016/0168-8278(95)80194-4
   Bennett WM, 1996, KIDNEY INT, V50, P1089, DOI 10.1038/ki.1996.415
   Bhandari S, 2002, NEPHROL DIAL TRANSPL, V17, P1914, DOI 10.1093/ndt/17.11.1914
   Brinkman K, 1998, AIDS, V12, P1735, DOI 10.1097/00002030-199814000-00004
   Chariot Patrick, 1995, Current Opinion in Rheumatology, V7, P497, DOI 10.1097/00002281-199511000-00006
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   Daugas E, 2005, KIDNEY INT, V67, P393, DOI 10.1111/j.1523-1755.2005.67096.x
   de Mattos AM, 2000, AM J KIDNEY DIS, V35, P333, DOI 10.1016/S0272-6386(00)70348-9
   Haydon GRH, 2003, CURR OPIN INFECT DIS, V16, P473, DOI 10.1097/00001432-200310000-00015
   Johns DR, 1996, NAT MED, V2, P1065, DOI 10.1038/nm1096-1065
   Kitaura K, 1999, JPN J CANCER RES, V90, P385, DOI 10.1111/j.1349-7006.1999.tb00759.x
   Morris AAM, 2001, AIDS, V15, P140, DOI 10.1097/00002030-200101050-00027
   Murphy MD, 2003, CLIN INFECT DIS, V36, P1082, DOI 10.1086/368313
   OGORMAN MA, 1995, CLIN TRANSPLANT, V9, P312
   Oishi M, 2000, TRANSPLANT P, V32, P2225, DOI 10.1016/S0041-1345(00)01645-6
   Olyaei A J, 2001, Curr Opin Crit Care, V7, P384, DOI 10.1097/00075198-200112000-00003
   Rollins S, 2001, AM J CLIN PATHOL, V116, P326
   Schapira AHV, 2002, J INHERIT METAB DIS, V25, P207, DOI 10.1023/A:1015629912477
   Schwarz C, 2006, NEPHROL DIAL TRANSPL, V21, P2615, DOI 10.1093/ndt/gfl211
   Simon N, 2003, BRIT J PHARMACOL, V138, P369, DOI 10.1038/sj.bjp.0705038
   Tanji N, 2001, HUM PATHOL, V32, P734, DOI 10.1053/hupa.2001.25586
   UZMANN LL, 1948, AM J MED SCI, V260, P381
   WOLFF SM, 1964, LANCET, V1, P843
NR 25
TC 15
Z9 20
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1397-3142
EI 1399-3046
J9 PEDIATR TRANSPLANT
JI Pediatr. Transplant.
PD FEB
PY 2008
VL 12
IS 1
BP 109
EP 112
DI 10.1111/j.1399-3046.2007.00839.x
PG 4
WC Pediatrics; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics; Transplantation
GA 247ZX
UT WOS:000252122200020
PM 18186898
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Mishra, A
   Wakil, S
   Pennuto, M
   Soraru, G
AF Finsterer, Josef
   Mishra, Anushree
   Wakil, Salma
   Pennuto, Maria
   Soraru, Gianni
TI Mitochondrial implications in bulbospinal muscular atrophy (Kennedy
   disease)
SO AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION
LA English
DT Review
DE Mitochondrial disorder; mitochondrial DNA; X-linked spinal muscular
   atrophy; bulbospinal neuronopathy; spinobulbar muscular atrophy; motor
   neuron disease
ID HUMAN ANDROGEN RECEPTOR; OXIDATIVE STRESS; SKELETAL-MUSCLE;
   POLYGLUTAMINE TRACT; DYSFUNCTION; BIOGENESIS; DEFICIENCY; MUTATIONS;
   PATHOLOGY; BRAIN
AB There is increasing evidence that mitochondrial functions are secondarily disturbed in bulbospinal muscular atrophy (BSMA). This review focuses on the relation between BSMA and the effect of the expanded polyglutamine (poly-Q) androgen receptor (AR) on mitochondrial functions. Mitochondrial functions in bulbospinal muscular atrophy (SBMA) are affected on the molecular, clinical, and therapeutic level. On the molecular level there is down-regulation of various nuclear-DNA-encoded mitochondrial proteins by mutant androgen receptor (mAR), colocalization of the mAR with various mitochondrial proteins, association of mAR aggregates with mitochondria resulting in abnormal distribution of mitochondria, mtDNA depletion or multiple mtDNA deletions, mitochondrial membrane depolarization, increase in reactive oxidative species, and activation of the mitochondrial caspase pathway. On the clinical level various mitochondrial disorders mimic SBMA, and on the therapeutic level pioglitazone expresses PPAR-, cyclosporine-A restores mitochondrial membrane potentials, coenzyme-Q and idebenone reduce oxidative stress, and geldanamycin up-regulates protective mitochondrial heat shock proteins. In conclusion, in BSMA mitochondrial dysfunction results from various interactions of elongated poly-Q AR with mitochondria, mitochondrial proteins, nuclear or mitochondrial DNA, causing oxidative stress, decreased mitochondrial membrane potential, or activation of the mitochondrial caspase pathway. Additionally, mitochondrial disease may mimic BSMA and therapeutic approaches may depend on modifications of mitochondrial pathways.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Vienna, Austria.
   [Mishra, Anushree] All India Inst Med Sci, Delhi, India.
   [Wakil, Salma] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.
   [Pennuto, Maria] Univ Trento, Dulbecco Telethon Inst Lab Neurodegenerat Dis, Ctr Integrat Biol CIBIO, Trento, Italy.
   [Soraru, Gianni] Univ Padua, Dept Neurosci, I-35100 Padua, Italy.
C3 Rudolfstiftung Hospital; All India Institute of Medical Sciences (AIIMS)
   New Delhi; King Faisal Specialist Hospital & Research Center; University
   of Trento; University of Padua
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
RI Sorarù, Gianni/AAB-8891-2019; Majid, Salma/AAT-2616-2020; Pennuto,
   Maria.Pennuto/E-3270-2019
OI Soraru, Gianni/0000-0001-9691-6328; Pennuto, Maria/0000-0001-8634-0767;
   WAKIL, SALMA/0000-0002-7883-2515
CR Beauchemin AMJ, 2001, BRAIN RES BULL, V56, P285, DOI 10.1016/S0361-9230(01)00583-4
   Beitel LK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00053
   Bellafante E, 2014, P NATL ACAD SCI USA, V111, pE4523, DOI 10.1073/pnas.1415279111
   Brum M, 2014, CASE REP NEUROL MED, V2014, DOI 10.1155/2014/701761
   Chanprasert S., 2012, GENEREVIEWS
   Di Filippo M, 2010, J ALZHEIMERS DIS, V20, pS369, DOI 10.3233/JAD-2010-100543
   Ehinger JK, 2015, J NEUROL, V262, P1493, DOI 10.1007/s00415-015-7737-0
   Eschbach J, 2013, NEUROBIOL DIS, V58, P220, DOI 10.1016/j.nbd.2013.05.015
   Fischbeck KH, 2012, PROG NEUROBIOL, V99, P257, DOI 10.1016/j.pneurobio.2012.05.012
   Fukunaga K, 2015, J PHARMACOL SCI, V127, P36, DOI 10.1016/j.jphs.2014.12.012
   GANIE SA, 2015, REJUVENATIO IN PRESS
   Gavrilova-Jordan LP, 2007, SEMIN REPROD MED, V25, P154, DOI 10.1055/s-2007-973428
   Hayashi M, 2012, ADV EXP MED BIOL, V724, P278, DOI 10.1007/978-1-4614-0653-2_21
   Iida M, 2015, HUM MOL GENET, V24, P314, DOI 10.1093/hmg/ddu445
   Jordan CL, 2008, CURR OPIN PHARMACOL, V8, P752, DOI 10.1016/j.coph.2008.08.006
   Katsetos CD, 2013, SEMIN PEDIATR NEUROL, V20, P202, DOI 10.1016/j.spen.2013.10.010
   Katsuno M, 2012, PROG NEUROBIOL, V99, P246, DOI 10.1016/j.pneurobio.2012.05.007
   Katsuno M, 2012, ARCH NEUROL-CHICAGO, V69, P436, DOI 10.1001/archneurol.2011.2308
   KAZEMIESFARJANI P, 1995, HUM MOL GENET, V4, P523, DOI 10.1093/hmg/4.4.523
   Lee JS, 2007, PEDIATR NEUROL, V36, P45, DOI 10.1016/j.pediatrneurol.2006.07.007
   Liu CS, 2008, J NEUROL SCI, V264, P18, DOI 10.1016/j.jns.2007.07.016
   Mano T, 2012, MUSCLE NERVE, V46, P692, DOI 10.1002/mus.23413
   McMillan HJ, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-36
   MHATRE AN, 1993, NAT GENET, V5, P184, DOI 10.1038/ng1093-184
   Monks DA, 2007, P NATL ACAD SCI USA, V104, P18259, DOI 10.1073/pnas.0705501104
   Orsucci D, 2014, CURR MOL MED, V14, P598, DOI 10.2174/1566524014666140603100131
   Piccioni F, 2002, FASEB J, V16, P1418, DOI 10.1096/fj.01-1035fje
   Preisler N, 2009, NEUROLOGY, V72, P317, DOI 10.1212/01.wnl.0000341274.61236.02
   Pronicka E, 2013, MITOCHONDRION, V13, P810, DOI 10.1016/j.mito.2013.05.007
   Ranganathan S, 2010, TRENDS PHARMACOL SCI, V31, P523, DOI 10.1016/j.tips.2010.08.005
   Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310
   Ripolone M, 2015, JAMA NEUROL, V72, P666, DOI 10.1001/jamaneurol.2015.0178
   Sirianni AC, 2015, J NEUROCHEM, V134, P956, DOI 10.1111/jnc.13190
   Solakidi S, 2005, HUM REPROD, V20, P3481, DOI 10.1093/humrep/dei267
   Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0
   Sorarù G, 2008, J NEUROL SCI, V264, P100, DOI 10.1016/j.jns.2007.08.012
   Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731
   Su SL, 2010, CLIN CHIM ACTA, V411, P626, DOI 10.1016/j.cca.2009.12.007
   Tanaka F, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/369284
   Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056
   Usui T, 2014, FEBS LETT, V588, P1935, DOI 10.1016/j.febslet.2014.03.051
   Wang RS, 2015, INT J MOL SCI, V16, P9831, DOI 10.3390/ijms16059831
   Weber JJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/701758
   Yonutas HM, 2015, J BIOENERG BIOMEMBR, V47, P149, DOI 10.1007/s10863-014-9593-5
   Young JE, 2009, J NEUROSCI, V29, P1987, DOI 10.1523/JNEUROSCI.4072-08.2009
   Zoccolella S, 2012, EUR J NEUROL, V19, pe63, DOI 10.1111/j.1468-1331.2012.03720.x
NR 46
TC 8
Z9 9
U1 0
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2167-8421
EI 2167-9223
J9 AMYOTROPH LAT SCL FR
JI Amyotroph. Lateral Scher. Frontotemp. Degenerat.
PD FEB 17
PY 2016
VL 17
IS 1-2
BP 112
EP 118
DI 10.3109/21678421.2015.1089910
PG 7
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA DB8BZ
UT WOS:000368742700014
PM 26428534
DA 2024-11-01
ER

PT J
AU Hudson, G
   Deschauer, M
   Taylor, RW
   Hanna, MG
   Fialho, D
   Schaefer, AM
   He, LP
   Blakely, E
   Turnbull, DM
   Chinnery, PF
AF Hudson, G
   Deschauer, M
   Taylor, RW
   Hanna, MG
   Fialho, D
   Schaefer, AM
   He, LP
   Blakely, E
   Turnbull, DM
   Chinnery, PF
TI <i>POLG1</i>, <i>C10ORF2</i>, and <i>ANT1</i> mutations are uncommon in
   sporadic progressive external ophthalmoplegia with multiple
   mitochondrial DNA deletions
SO NEUROLOGY
LA English
DT Article
ID DISORDERS
AB The authors sequenced POLG1, C10ORF2, and ANT1 in 38 sporadic progressive external ophthalmoplegia patients with multiple mitochondrial DNA (mtDNA) deletions. Causative mutations were identified in approximately 10% of cases, with two unrelated individuals harboring a novel premature stop codon mutation (1356T > G). None had a mutation in C10ORF2 or ANT1. In the majority of patients, the primary nuclear genetic defect is likely to affect other unknown genes important for mtDNA maintenance.
C1 Newcastle Univ, Sch Med, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   Univ Halle Wittenberg, Dept Neurol, Halle, Saale, Germany.
   UCL, Inst Neurol, Dept Mol Neurosci, London, England.
C3 Newcastle University - UK; Newcastle University - UK; Martin Luther
   University Halle Wittenberg; University of London; University College
   London
RP Newcastle Univ, Sch Med, Mitochondrial Res Grp, Neurol M4104,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM p.f.chinnery@ncl.ac.uk
RI Hanna, Michael/B-1995-2009; Hudson, Gavin/E-7117-2017
OI Hudson, Gavin/0000-0001-7210-2733; Chinnery,
   Patrick/0000-0002-7065-6617; Fialho, Doreen/0000-0001-7161-6185; Hanna,
   Michael/0000-0003-0825-4075; Schaefer, Andrew/0000-0001-9891-7332
FU Wellcome Trust [074454] Funding Source: Medline
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Hisama FM, 2005, AM J MED GENET A, V135A, P217, DOI 10.1002/ajmg.a.30672
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
NR 10
TC 20
Z9 20
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD MAY 9
PY 2006
VL 66
IS 9
BP 1439
EP 1441
DI 10.1212/01.wnl.0000210486.32196.24
PG 3
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 040FS
UT WOS:000237365000030
PM 16682683
DA 2024-11-01
ER

PT J
AU Sacher, M
   Fatterpekar, GM
   Edelstein, S
   Sansaricq, C
   Naidich, TP
AF Sacher, M
   Fatterpekar, GM
   Edelstein, S
   Sansaricq, C
   Naidich, TP
TI MRI findings in an atypical case of Kearns-Sayre syndrome: a case report
SO NEURORADIOLOGY
LA English
DT Article
DE mitochondrial deletion; diffusion; status spongiosus
ID STROKE-LIKE EPISODES; MITOCHONDRIAL ENCEPHALOMYOPATHIES; EXTERNAL
   OPHTHALMOPLEGIA; LACTIC-ACIDOSIS; MUTATION; ENCEPHALOPATHY; MYOPATHY;
   MELAS
AB MR imaging features of mitochondrial encephalomyopathies, lactic acidosis, and stroke-like episodes, Kearns-Sayre/Pearson syndrome have been described in the literature. We describe extensive white matter changes with abnormal signal intensity lesions involving the deep gray nuclei and myelinated white matter tracts in an 18-year-old female with a large-scale 7.4 kb mitochondrial DNA deletion and a atypical presentation of Kearns-Sayre syndrome. Restricted diffusion due to status spongiosus at the involved sites is also discussed.
C1 Mt Sinai Med Ctr, Dept Radiol, New York, NY 10029 USA.
   Mt Sinai Med Ctr, Dept Med Genet, New York, NY 10029 USA.
C3 Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at
   Mount Sinai
RP Sacher, M (corresponding author), Mt Sinai Med Ctr, Dept Radiol, 1 Gustave L Levy Pl, New York, NY 10029 USA.
EM Michael.Sacher@mssm.edu
CR CASTILLO M, 1995, AM J NEURORADIOL, V16, P2333
   DIMAURO S, 1990, NEUROL CLIN, V8, P483, DOI 10.1016/S0733-8619(18)30332-3
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Mittal S, 2002, ARCH NEUROL-CHICAGO, V59, P128, DOI 10.1001/archneur.59.1.128
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Valanne L, 1998, AM J NEURORADIOL, V19, P369
   Yonemura K, 2001, AM J NEURORADIOL, V22, P269
NR 10
TC 19
Z9 20
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0028-3940
J9 NEURORADIOLOGY
JI Neuroradiology
PD APR
PY 2005
VL 47
IS 4
BP 241
EP 244
DI 10.1007/s00234-004-1314-z
PG 4
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA 922QJ
UT WOS:000228852600001
PM 15789203
DA 2024-11-01
ER

PT J
AU Suomalainen, A
   Isohanni, P
AF Suomalainen, Anu
   Isohanni, Pirjo
TI Mitochondrial DNA depletion syndromes - Many genes, common mechanisms
SO NEUROMUSCULAR DISORDERS
LA English
DT Review
DE Mitochondrial DNA; Mitochondrial DNA depletion syndrome; Encephalopathy;
   Hepatoencephalopathy; Leigh syndrome; Alpers syndrome
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; ONSET SPINOCEREBELLAR ATAXIA;
   NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY MNGIE; RECESSIVE TWINKLE
   MUTATIONS; POLYMERASE-GAMMA MUTATIONS; SUCCINYL-COA SYNTHETASES; MTDNA
   DEPLETION; THYMIDINE KINASE; DEOXYGUANOSINE KINASE; POLG1 MUTATIONS
AB Mitochondrial DNA depletion syndrome has become an important cause of inherited metabolic disorders, especially in children, but also in adults. The manifestations vary from tissue-specific mtDNA depletion to wide-spread multisystemic disorders. Nine genes are known to underlie this group of disorders, and many disease genes are still unidentified. However, the disease mechanisms seem to be intimately associated with mtDNA replication and nucleotide pool regulation. We review here the current knowledge on the clinical and molecular genetic features of mitochondrial DNA depletion syndrome. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Suomalainen, Anu; Isohanni, Pirjo] Univ Helsinki, Res Program Mol Neurol, Biomedicum Helsinki, FIN-00290 Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, FIN-00290 Helsinki, Finland.
   [Isohanni, Pirjo] Univ Helsinki, Cent Hosp, Hosp Children & Adolescents, Div Child Neurol, FIN-00290 Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; Helsinki University
   Central Hospital; University of Helsinki; Helsinki University Central
   Hospital
RP Suomalainen, A (corresponding author), Univ Helsinki, Res Program Mol Neurol, Biomedicum Helsinki, R C523B,POB 63, FIN-00290 Helsinki, Finland.
EM anu.wartiovaara@helsinki.fi
OI Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195
FU Juselius Foundation; Aatos and Jane Erkko Foundation; Academy of
   Finland; Helsinki University; Helsinki University Central Hospital
FX The authors wish to thank the grant support from the Juselius
   Foundation, Aatos and Jane Erkko Foundation, Academy of Finland,
   Helsinki University and EVO-funds of the Helsinki University Central
   Hospital.
CR Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Blondon H, 2005, GASTROEN CLIN BIOL, V29, P773, DOI 10.1016/S0399-8320(05)86346-8
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bulst S, 2009, HUM MOL GENET, V18, P1590, DOI 10.1093/hmg/ddp074
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   CHINNERY PF, 2007, NEUROMUSCULAR DISORD, V18, P259
   Dallabona C, 2010, HUM MOL GENET, V19, P1098, DOI 10.1093/hmg/ddp581
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Delarue A, 2000, Pediatr Transplant, V4, P67, DOI 10.1034/j.1399-3046.2000.00090.x
   DEVRIES MC, 2008, J INHERIT METAB DIS
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Dimmock DP, 2008, LIVER TRANSPLANT, V14, P1480, DOI 10.1002/lt.21556
   ELHATTAB AW, 2009, MOL GENET METAB
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Eriksson S, 2008, NUCLEOS NUCLEOT NUCL, V27, P800, DOI 10.1080/15257770802146197
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Giordano C, 2008, AM J PATHOL, V173, P1120, DOI 10.2353/ajpath.2008.080252
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Holve S, 1999, J PEDIATR-US, V135, P482, DOI 10.1016/S0022-3476(99)70172-1
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Johnson JD, 1998, J BIOL CHEM, V273, P27580, DOI 10.1074/jbc.273.42.27580
   Kaji S, 2009, MOL GENET METAB, V97, P292, DOI 10.1016/j.ymgme.2009.04.014
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kayihan N, 2000, Pediatr Transplant, V4, P211, DOI 10.1034/j.1399-3046.2000.00115.x
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   KOSKINEN T, 1994, J NEUROL SCI, V121, P50, DOI 10.1016/0022-510X(94)90156-2
   Lambeth DO, 2004, J BIOL CHEM, V279, P36621, DOI 10.1074/jbc.M406884200
   Lara MC, 2007, BIOSCIENCE REP, V27, P151, DOI 10.1007/s10540-007-9043-2
   Lara MC, 2006, NEUROLOGY, V67, P1461, DOI 10.1212/01.wnl.0000239824.95411.52
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   MANDERBACKA K, 2001, SCANDINAVIAN J P S55, V29, P41
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Morava E, 2009, MITOCHONDRION, V9, P438, DOI 10.1016/j.mito.2009.08.003
   Morten KJ, 2007, MITOCHONDRION, V7, P386, DOI 10.1016/j.mito.2007.09.001
   Navarro-Sastre A, 2008, MOL GENET METAB, V94, P234, DOI 10.1016/j.ymgme.2008.01.012
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Ostergaard E., 2008, J INHERIT METAB DIS
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Ostergaard E, 2010, EUR J PEDIATR, V169, P201, DOI 10.1007/s00431-009-1007-z
   Papadimitriou A, 1998, NEUROLOGY, V51, P1086, DOI 10.1212/WNL.51.4.1086
   Parini R, 2009, J HEPATOL, V50, P215, DOI 10.1016/j.jhep.2008.08.019
   Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105
   Poulton J, 2009, BBA-MOL BASIS DIS, V1792, P1109, DOI 10.1016/j.bbadis.2009.08.016
   Poulton Joanna, 2009, Neuromuscul Disord, V19, P439, DOI 10.1016/j.nmd.2009.04.009
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Vilà MR, 2003, NEUROLOGY, V60, P1203, DOI 10.1212/01.WNL.0000055928.58122.47
   Vu TH, 2001, HEPATOLOGY, V34, P116, DOI 10.1053/jhep.2001.25921
   Walker UA, 2004, HEPATOLOGY, V39, P311, DOI 10.1002/hep.20074
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Yavuz H, 2007, ARCH NEUROL-CHICAGO, V64, P435, DOI 10.1001/archneur.64.3.435
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 88
TC 152
Z9 175
U1 3
U2 40
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JUL
PY 2010
VL 20
IS 7
BP 429
EP 437
DI 10.1016/j.nmd.2010.03.017
PG 9
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 630PH
UT WOS:000280285000001
PM 20444604
DA 2024-11-01
ER

PT J
AU Lombès, A
   Auré, K
   Bellanné-Chantelot, C
   Gilleron, M
   Jardel, C
AF Lombes, Anne
   Aure, Karine
   Bellanne-Chantelot, Christine
   Gilleron, Mylene
   Jardel, Claude
TI Unsolved issues related to human mitochondrial diseases
SO BIOCHIMIE
LA English
DT Review
DE Mitochondrial DNA; Heteroplasmy; Oxidative phosphorylation; Human
   diseases; Tissue specificity
ID HEREDITARY OPTIC NEUROPATHY; HUMAN SKELETAL-MUSCLE; KEARNS-SAYRE
   SYNDROME; TISSUE-SPECIFICITY; RAPID SEGREGATION; MTDNA MUTATION; MELAS
   SYNDROME; DNA DELETIONS; MOUSE MODEL; PHENOTYPE
AB Human mitochondrial diseases, defined as the diseases due to a mitochondrial oxidative phosphorylation defect, represent a large group of very diverse diseases with respect to phenotype and genetic causes. They present with many unsolved issues, the comprehensive analysis of which is beyond the scope of this review. We here essentially focus on the mechanisms underlying the diversity of targeted tissues, which is an important component of the large panel of these diseases phenotypic expression. The reproducibility of genotype/phenotype expression, the presence of modifying factors, and the potential causes for the restricted pattern of tissular expression are reviewed.
   Special emphasis is made on heteroplasmy, a specific feature of mitochondrial diseases, defined as the coexistence within the cell of mutant and wild type mitochondrial DNA molecules. Its existence permits unequal segregation during mitoses of the mitochondrial DNA populations and consequently heterogeneous tissue distribution of the mutation load. The observed tissue distributions of recurrent human mitochondrial DNA deleterious mutations are diverse but reproducible for a given mutation demonstrating that the segregation is not a random process. Its extent and mechanisms remain essentially unknown despite recent advances obtained in animal models. (C) 2013 Elsevier Masson SAS. All rights reserved.
C1 [Lombes, Anne; Aure, Karine; Gilleron, Mylene; Jardel, Claude] INSERM, U1016, Inst Cochin, UMR 8104,CNRS, F-75014 Paris, France.
   [Lombes, Anne] Univ Paris 05, F-75014 Paris, France.
   [Lombes, Anne; Bellanne-Chantelot, Christine; Gilleron, Mylene; Jardel, Claude] GHU Pitie Salpetriere, AP HP, Serv Biochim Metab, F-75651 Paris, France.
   [Lombes, Anne; Bellanne-Chantelot, Christine; Gilleron, Mylene; Jardel, Claude] GHU Pitie Salpetriere, Ctr Genet Mol & Chromosom, F-75651 Paris, France.
   [Aure, Karine] Hop Ambroise Pare, AP HP, Serv Explorat Fonct, F-92100 Boulogne, France.
   [Aure, Karine] Univ Versailles St Quentin Yvelines, Fac Med, F-78180 Versailles, France.
C3 Universite Paris Cite; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS);
   CNRS - National Institute for Biology (INSB); Universite Paris Cite;
   Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Assistance
   Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere
   - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Ambroise-Pare - APHP; Universite Paris Saclay
RP Lombès, A (corresponding author), INSERM, U1016, Inst Cochin, Fac Med, 24 Rue Fb St Jacques, F-75014 Paris, France.
EM anne.lombes@inserm.fr; karine.aure@apr.aphp.fr;
   Christine.bellanne-chantelot@psl.aphp.fr; mylene.gilleron@psl.aphp.fr;
   claude.jardel@psl.aphp.fr
RI Lombes, Anne/G-4684-2014
FU Association Francaise contre les Myopathies (AFM); Association contre
   les Maladies Mitochondriales (AMMO); Fondation pour la Recherche
   Medicale (FRM)
FX This work was supported by grants from the Association Francaise contre
   les Myopathies (AFM), from the Association contre les Maladies
   Mitochondriales (AMMi), and from the Fondation pour la Recherche
   Medicale (FRM) to AL.
CR Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Battersby BJ, 2007, NAT GENET, V39, P571, DOI 10.1038/ng0507-571
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chinnery PF, 2002, TRENDS GENET, V18, P173, DOI 10.1016/S0168-9525(01)02636-1
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Hudson G, 2010, MOL VIS, V16, P2760
   Hudson G, 2009, MOL VIS, V15, P870
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Jokinen R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001161
   Karicheva OZ, 2011, NUCLEIC ACIDS RES, V39, P8173, DOI 10.1093/nar/gkr546
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   Manfred G, 1999, J BIOL CHEM, V274, P9386, DOI 10.1074/jbc.274.14.9386
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Neeve VCM, 2012, BRAIN, V135, P3614, DOI 10.1093/brain/aws298
   Noe N, 2013, MITOCHONDRION, V13, P417, DOI 10.1016/j.mito.2012.12.003
   OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stewart JB, 2008, NAT REV GENET, V9, P657, DOI 10.1038/nrg2396
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Weber K, 1997, AM J HUM GENET, V60, P373
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
NR 45
TC 17
Z9 19
U1 0
U2 16
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0300-9084
EI 1638-6183
J9 BIOCHIMIE
JI Biochimie
PD MAY
PY 2014
VL 100
BP 171
EP 176
DI 10.1016/j.biochi.2013.08.012
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA AG0JI
UT WOS:000335101400019
PM 23973280
OA Green Submitted
DA 2024-11-01
ER

PT J
AU Lehnhardt, FG
   Horvath, R
   Ullrich, R
   Kracht, L
   Sobesky, J
   Möller-Hartmann, W
   Jacobs, AH
   Haupt, WF
AF Lehnhardt, Fritz-Georg
   Horvath, Rita
   Ullrich, Roland
   Kracht, Lutz
   Sobesky, Jan
   Moeller-Hartmann, Walter
   Jacobs, Andreas H.
   Haupt, Walter F.
TI Altered cerebral glucose metabolism in a family with clinical features
   resembling mitochondrial neurogastrointestinal encephalomyopathy
   syndrome in association with multiple mitochondrial DNA deletions
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; PARALYTIC ILEUS; PROTON MRS;
   MNGIE; MELAS; TOMOGRAPHY; MUTATIONS; CHILDREN
AB Objective: To determine the involvement of cerebral metabolism in 2 siblings with mitochondrial neurogastrointestinal encephalomyopathy syndrome (MNGIE)-like disease with multiple mitochondrial DNA(mtDNA) deletions.
   Design: Case report.
   Setting: Department of Neurology at a university medical center.
   Patients: Two siblings with MNGIE-like disease with multiple mtDNA deletions.
   Main Outcome Measures: Clinical, biochemical, genetic, and imaging findings, including cerebral magnetic resonance imaging, proton magnetic resonance spectroscopy, and positron emission tomography with fluorine 18-labeled deoxyglucose (FDG-PET).
   Results: Genetic analysis of muscle DNA revealed multiple mtDNA deletions, while no mutations were detected in ECGF1, POLG1, ANT1, or Twinkle. Cerebral magnetic resonance imaging and proton magnetic resonance spectroscopy findings were unremarkable. Reduced regional glucose metabolism was found in a patchy and asymmetrical pattern predominantly in the frontotemporal region in both siblings by means of FDG-PET.
   Conclusions: The discrepancy between absence of clinical signs of cerebral involvement and the substantial impairment of glucose metabolism reflects a chronic subclinical encephalopathy. To our knowledge, the predominantly frontotemporal distribution has not been described previously in mitochondrial disorders.
C1 [Lehnhardt, Fritz-Georg; Sobesky, Jan; Jacobs, Andreas H.; Haupt, Walter F.] Univ Cologne, Dept Neurol, D-50931 Cologne, Germany.
   [Moeller-Hartmann, Walter] Univ Cologne, Dept Radiol, D-50931 Cologne, Germany.
   [Ullrich, Roland; Kracht, Lutz] Max Planck Inst Neurol Res, Cologne, Germany.
   [Horvath, Rita] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-8000 Munich, Germany.
   [Horvath, Rita] Med Genet Ctr Munich, Munich, Germany.
C3 University of Cologne; University of Cologne; Max Planck Society;
   University of Munich
RP Haupt, WF (corresponding author), Univ Cologne, Dept Neurol, Joseph Stelzmann Str 9, D-50931 Cologne, Germany.
EM walter.haupt@uk-koeln.de
RI Jacobs, Andreas/AAA-6794-2020; Horvath, Rita/AAY-7042-2020
OI Sobesky, Jan/0000-0001-5459-3655; Horvath, Rita/0000-0002-9841-170X
CR BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231
   Chang TM, 2004, PEDIATR NEUROL, V31, P374, DOI 10.1016/j.pediatrneurol.2004.05.009
   Damian MS, 1998, EUR NEUROL, V39, P9, DOI 10.1159/000007892
   Dinopoulos A, 2005, NEUROPEDIATRICS, V36, P290, DOI 10.1055/s-2005-872807
   DUNCAN DB, 1995, ANN NEUROL, V37, P351, DOI 10.1002/ana.410370311
   FISCHER JC, 1986, EUR J PEDIATR, V144, P441, DOI 10.1007/BF00441735
   FRACKOWIAK RSJ, 1988, BRAIN, V111, P1009, DOI 10.1093/brain/111.5.1009
   Gamez J, 2005, PEDIATR NEUROL, V33, P151, DOI 10.1016/j.pediatrneurol.2005.05.023
   Herholz K, 2002, NEUROIMAGE, V17, P302, DOI 10.1006/nimg.2002.1208
   MATTHEWS PM, 1993, NEUROLOGY, V43, P2484, DOI 10.1212/WNL.43.12.2484
   Molnár MJ, 2000, NEUROLOGY, V55, P544, DOI 10.1212/WNL.55.4.544
   Nishino I, 2000, ANN NEUROL, V47, P792
   Salvan AM, 1998, EUR NEUROL, V40, P46, DOI 10.1159/000007955
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Vissing J, 2002, NEUROLOGY, V59, P926, DOI 10.1212/WNL.59.6.926
NR 15
TC 13
Z9 13
U1 0
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0003-9942
EI 1538-3687
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD MAR
PY 2008
VL 65
IS 3
BP 407
EP 411
DI 10.1001/archneur.65.3.407
PG 5
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 272TD
UT WOS:000253881900018
PM 18332256
DA 2024-11-01
ER

PT J
AU Ylikallio, E
   Tyynismaa, H
   Tsutsui, H
   Ide, T
   Suomalainen, A
AF Ylikallio, Emil
   Tyynismaa, Henna
   Tsutsui, Hiroyuki
   Ide, Tomomi
   Suomalainen, Anu
TI High mitochondrial DNA copy number has detrimental effects in mice
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID TRANSCRIPTION FACTOR-A; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   SUBSTANTIA-NIGRA NEURONS; MULTIPLE MTDNA DELETIONS; DOUBLE-STRAND
   BREAKS; HELICASE TWINKLE; REPLICATION; MUTATIONS; POLYMERASE; NUCLEOIDS
AB Mitochondrial DNA (mtDNA) is an essential multicopy genome, compacted into protein-DNA clusters called nucleoids. Maintaining an adequate mtDNA copy number is crucial for cellular viability. Loss of mtDNA results in severe human syndromes, whereas increased mtDNA copy number has been suggested to improve survival from myocardial infarction in mice and to be a promising therapeutic strategy for mitochondrial disease. The mechanisms that regulate mtDNA amount and organization are, however, not fully understood. Of the proteins required for mtDNA existence, only the mitochondrial helicase Twinkle and mitochondrial transcription factor A (TFAM) have been shown to increase mtDNA copy number in vivo, when expressed in physiological levels. Here we studied how Twinkle and TFAM affect mtDNA synthesis and nucleoid structure in mice. Using in vivo BrdU labeling, we show that Twinkle specifically regulates de novo mtDNA synthesis. Remarkably, high mtDNA copy number in mice is accompanied by nucleoid enlargement, which in turn correlates with defective transcription, age-related accumulation of mtDNA deletions and respiratory chain (RC) deficiency. Simultaneous overexpression of Twinkle and TFAM in bitransgenic mice has an additive effect on mtDNA copy number, increasing it up to 6-fold in skeletal muscle. Bitransgenic mice also exhibit further enlargement of nucleoids and aggravation of the RC defect. In conclusion, we show that Twinkle acts as a regulator of mtDNA replication initiation, and provide evidence that high mtDNA copy number and alteration of nucleoid architecture may be detrimental to mitochondrial function.
C1 [Ylikallio, Emil; Tyynismaa, Henna; Suomalainen, Anu] Univ Helsinki, Res Program Mol Neurol, Biomedicum Helsinki, FIN-00290 Helsinki, Finland.
   [Tsutsui, Hiroyuki] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan.
   [Ide, Tomomi] Kyushu Univ, Dept Cardiovasc Med, Higashi Ku, Fukuoka 8128582, Japan.
   [Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki 00014, Finland.
C3 University of Helsinki; Hokkaido University; Kyushu University;
   University of Helsinki; Helsinki University Central Hospital
RP Suomalainen, A (corresponding author), Univ Helsinki, Res Program Mol Neurol, Biomedicum Helsinki, Room c523B,Haartmaninkatu 8, FIN-00290 Helsinki, Finland.
EM anu.wartiovaara@helsinki.fi
RI Tyynismaa, Henna/F-1428-2011; Ylikallio, Emil/S-9434-2019; Tsutsui,
   Hiroyuki/A-4070-2012
OI Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195; Ylikallio,
   Emil/0000-0001-5178-0703; Tyynismaa, Henna/0000-0002-2493-2422
FU Academy of Finland; University of Helsinki; Sigrid Juselius Foundation;
   Jane and Aatos Erkko Foundation; Helsinki Biomedical Graduate School
FX This work was supported by Academy of Finland [to H. T. and A. S.];
   University of Helsinki [to A. S.]; Sigrid Juselius Foundation [to A.
   S.]; Jane and Aatos Erkko Foundation [to A. S.]; Helsinki Biomedical
   Graduate School [to E.Y.].
CR Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106
   Ashley N, 2009, ONCOGENE, V28, P3880, DOI 10.1038/onc.2009.242
   Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348
   Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Di Re M, 2009, NUCLEIC ACIDS RES, V37, P5701, DOI 10.1093/nar/gkp614
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Hayashi Y, 2008, J NEUROSCI, V28, P8624, DOI 10.1523/JNEUROSCI.1957-08.2008
   He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158
   Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   LARSSON NG, 1994, BIOCHEM BIOPH RES CO, V200, P1374, DOI 10.1006/bbrc.1994.1603
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Liu BY, 2009, MOL CELL, V35, P490, DOI 10.1016/j.molcel.2009.07.004
   Lyly A, 2008, HUM MOL GENET, V17, P1406, DOI 10.1093/hmg/ddn028
   Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027
   Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046
   Pohjoismäki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
NR 40
TC 104
Z9 112
U1 4
U2 19
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JUL 1
PY 2010
VL 19
IS 13
BP 2695
EP 2705
DI 10.1093/hmg/ddq163
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 622OX
UT WOS:000279674200014
PM 20413656
DA 2024-11-01
ER

PT J
AU Heidenreich, JO
   Klopstock, T
   Schirmer, T
   Saemann, P
   Mueller-Felber, W
   Auer, DP
AF Heidenreich, Jens O.
   Klopstock, Thomas
   Schirmer, Timo
   Saemann, Philipp
   Mueller-Felber, Wolfgang
   Auer, Dorothee P.
TI Chronic progressive external ophthalmoplegia: MR spectroscopy and MR
   diffusion studies in the brain
SO AMERICAN JOURNAL OF ROENTGENOLOGY
LA English
DT Article
DE brain; CNS; diffusion-weighted MRI; MRI; ophthalmoplegia
ID KEARNS-SAYRE SYNDROME; MAGNETIC-RESONANCE-SPECTROSCOPY; MITOCHONDRIAL
   ENCEPHALOMYOPATHY; PHOTIC-STIMULATION; MELAS; METABOLISM; MYOPATHY;
   ENCEPHALOPATHY; DISORDERS; DISEASES
AB OBJECTIVE. The purpose of our study was to show how, despite pathognomonic signs of cerebral involvement in chronic progressive external ophthalmoplegia (CPEO), mitochondrial respiratory chain insufficiency is associated with increased lactate and reduced N-acetylaspartate. CPEO and mitochondrial myopathy are caused by mitochondrial DNA mutations leading to impaired oxidative phosphorylation. Cortical and subcortical metabolites, cerebral diffusivity, and structural MRI were assessed to characterize possible subclinical cerebral pathology in CPEO.
   SUBJECTS AND METHODS. Ten patients with CPEO (n = 8), mitochondrial myopathy (n = 1), and Kearns-Sayre syndrome (n = 1) and 13 control group volunteers were studied by MRI, both long TE (144) proton MR spectroscopic imaging (H-1 MRSI), and diffusion-weighted imaging. Relative concentrations of N-acetylaspartate, choline, creatine, and lactate were estimated by Linear Combination of Model Spectra (LCModel) in healthy-appearing white matter, gray matter, and white matter hyperintensities.
   RESULTS. Of five patients with cortical atrophy, it was moderate in three and severe in two. One patient had severe and four had moderate cerebellar atrophy. Six of 10 patients showed unspecific white matter lesions, whereas the remainder had hyperintensities in the pyramidal tract (n = 2) and middle cerebellar peduncle (n = 1) despite clinical signs. No basal ganglia lesions were found. Physiologic metabolite ratios were normal and lactate was absent in supratentorial healthy-appearing cortex and subcortical white matter. Global diffusion histogram metrics revealed no abnormalities.
   CONCLUSION. Normal spectroscopic imaging in radiologic unaffected brain and healthy global brain parenchymal diffusion findings do not support the hypothesis of a generalized cerebral energy loss in CPEO. Bilateral structural alteration of central motor pathways in two patients without clinical pyramidal signs may, however, reflect subclinical axonal injury in predilection sites in some patients.
C1 Dept Radiol & Nucl Med, D-12200 Berlin, Germany.
   AG NMR, Max Planck Inst Psychiat, Dept Radiol, Munich, Germany.
   Univ Munich, Klinikum Grosshadern, Dept Neurol, Munich, Germany.
   Friedrich Baur Inst, Munich, Germany.
C3 Max Planck Society; University of Munich; University of Munich
RP Heidenreich, JO (corresponding author), Dept Radiol & Nucl Med, Charite Campus Benjamin Franklin,Hindenburgdamm 3, D-12200 Berlin, Germany.
OI Auer, Dorothee P./0000-0002-4745-3635
CR Auer DP, 2001, NEUROLOGY, V56, P635, DOI 10.1212/WNL.56.5.635
   BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
   BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231
   Carlow TJ, 1998, AM J NEURORADIOL, V19, P95
   CASTILLO M, 1995, AM J NEURORADIOL, V16, P233
   Clark JM, 1996, NEUROLOGY, V46, P223, DOI 10.1212/WNL.46.1.223
   Conturo TE, 1996, MAGNET RESON MED, V35, P399, DOI 10.1002/mrm.1910350319
   DAROFF RB, 1966, NEUROLOGY, V16, P161, DOI 10.1212/WNL.16.2_Part_1.161
   DESTEFANO N, 1995, NEUROLOGY, V45, P1193, DOI 10.1212/WNL.45.6.1193
   Dichgans M, 2003, AM J NEURORADIOL, V24, P1083
   Engelbrecht V, 2002, RADIOLOGY, V222, P410, DOI 10.1148/radiol.2222010492
   Fadic R, 1996, SEMIN NEUROL, V16, P11, DOI 10.1055/s-2008-1040954
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Kapeller P, 1996, J NEUROL SCI, V135, P126, DOI 10.1016/0022-510X(95)00290-I
   Kato T, 1998, J NEUROL SCI, V155, P182, DOI 10.1016/S0022-510X(97)00308-0
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   KUWABARA T, 1994, NEUROLOGY, V44, P557, DOI 10.1212/WNL.44.3_Part_1.557
   LEUTNER C, 1994, AM J NEURORADIOL, V15, P681
   MATTHEWS PM, 1991, ANN NEUROL, V29, P435, DOI 10.1002/ana.410290416
   OLDORFS A, 1990, ACTA NEUROPATHOL BER, V80, P541
   Pavlakis SG, 1998, ARCH NEUROL-CHICAGO, V55, P849, DOI 10.1001/archneur.55.6.849
   PELLOCK JM, 1978, ANN NEUROL, V3, P455, DOI 10.1002/ana.410030519
   PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604
   Provenzale JM, 1996, NEUROLOGY, V46, P826, DOI 10.1212/WNL.46.3.826
   Purucker M, 1996, J EPILEPSY, V9, P79, DOI 10.1016/0896-6974(95)00072-0
   Salvan AM, 1998, EUR NEUROL, V40, P46, DOI 10.1159/000007955
   WRAY SH, 1995, AM J NEURORADIOL, V16, P1167
NR 27
TC 16
Z9 16
U1 0
U2 4
PU AMER ROENTGEN RAY SOC
PI RESTON
PA 1891 PRESTON WHITE DR, SUBSCRIPTION FULFILLMENT, RESTON, VA 22091 USA
SN 0361-803X
J9 AM J ROENTGENOL
JI Am. J. Roentgenol.
PD SEP
PY 2006
VL 187
IS 3
BP 820
EP 824
DI 10.2214/AJR.05.0180
PG 5
WC Radiology, Nuclear Medicine & Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Radiology, Nuclear Medicine & Medical Imaging
GA 080PF
UT WOS:000240259300038
PM 16928952
DA 2024-11-01
ER

PT J
AU Wortmann, SB
   Rodenburg, RJT
   Jonckheere, A
   de Vries, MC
   Huizing, M
   Heldt, K
   van den Heuvel, LP
   Wendel, U
   Kluijtmans, LA
   Engelke, UF
   Wevers, RA
   Smeitink, JAM
   Morava, E
AF Wortmann, Saskia B.
   Rodenburg, Richard J. T.
   Jonckheere, An
   de Vries, Maaike C.
   Huizing, Marjan
   Heldt, Katrin
   van den Heuvel, Lambert P.
   Wendel, Udo
   Kluijtmans, Leo A.
   Engelke, Udo F.
   Wevers, Ron A.
   Smeitink, Jan A. M.
   Morava, Eva
TI Biochemical and genetic analysis of 3-methylglutaconic aciduria type IV:
   a diagnostic strategy
SO BRAIN
LA English
DT Article
ID MITOCHONDRIAL-DNA DEPLETION; HYPERTROPHIC CARDIOMYOPATHY;
   BARTH-SYNDROME; OXIDATIVE-PHOSPHORYLATION; CONGENITAL CATARACT;
   LACTIC-ACIDOSIS; MYOPATHY; DEFICIENCIES; MUTATIONS; DISORDER
AB The heterogeneous group of 3-methylglutaconic aciduria type IV consists of patients with various organ involvement and mostly progressive neurological impairment in combination with 3-methylglutaconic aciduria and biochemical features of dysfunctional oxidative phosphorylation. Here we describe the clinical and biochemical phenotype in 18 children and define 4 clinical subgroups (encephalomyopathic, hepatocerebral, cardiomyopathic, myopathic). In the encephalomyopathic group with neurodegenerative symptoms and respiratory chain complex I deficiency, two of the children, presenting with mild Methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness, harboured SUCLA2 mutations. In children with a hepatocerebral phenotype most patients presented with complex I deficiency and mtDNA-depletion, three of which carried POLG1-mutations. In the cardiomyopathic subgroup most patients had complex V deficiency and an overlapping phenotype with that previously described in isolated complex V deficiency, in three patients a TMEM70 mutation was confirmed. In one male with a pure myopathic form and severe combined respiratory chain disorder, based on the pathogenomic histology of central core disease, RYR1 mutations were detected. In our patient group the presence of the biochemical marker 3-methylglutaconic acid was indicative for nuclear coded respiratory chain disorders. By delineating patient-groups we elucidated the genetic defect in 10 out of 18 children. Depending on the clinical and biochemical phenotype we suggest POLG1, SUCLA2, TMEM70 and RYR1 sequence analysis and mtDNA-depletion studies in children with 3-methylglutaconic aciduria type IV.
C1 [Wortmann, Saskia B.; Rodenburg, Richard J. T.; de Vries, Maaike C.; Smeitink, Jan A. M.; Morava, Eva] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Dept Paediat, NL-6500 HB Nijmegen, Netherlands.
   [Jonckheere, An; van den Heuvel, Lambert P.; Kluijtmans, Leo A.; Engelke, Udo F.; Wevers, Ron A.] Radboud Univ Nijmegen, Med Ctr, Lab Paediat & Neurol, NL-6500 HB Nijmegen, Netherlands.
   [Huizing, Marjan] NHGRI, NIH, Bethesda, MD 20892 USA.
   [Heldt, Katrin; Wendel, Udo] Univ Childrens Hosp, Dept Gen Paediat, Dusseldorf, Germany.
C3 Radboud University Nijmegen; Radboud University Nijmegen; National
   Institutes of Health (NIH) - USA; NIH National Human Genome Research
   Institute (NHGRI)
RP Morava, E (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Dept Paediat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM e.morava@cukz.umcn.nl
RI Smeitink, Jan/C-1351-2013; Wevers, Ron/H-8116-2014; Wortmann,
   Saskia/E-6125-2010; Kluijtmans, Leo/L-4437-2015; Engelke,
   U.F.H./L-4293-2015; Huizing, Marjan/AAR-8860-2020; de Vries,
   Maaike/JRH-2447-2023; Morava, E./L-4529-2015; van den Heuvel,
   Lambertus/AAM-1772-2021; Rodenburg, Richard/N-3579-2014
OI Rodenburg, Richard/0000-0001-5227-3527
CR Anikster Y, 2001, AM J HUM GENET, V69, P1218, DOI 10.1086/324651
   Bene J, 2003, EUR J HUM GENET, V11, P375, DOI 10.1038/sj.ejhg.5200975
   BESLEY GTN, 1995, J INHERIT METAB DIS, V18, P221, DOI 10.1007/BF00711772
   Cantlay AM, 1999, J PEDIATR-US, V135, P311, DOI 10.1016/S0022-3476(99)70126-5
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   CHRISTODOULOU J, 1994, AM J MED GENET, V50, P255, DOI 10.1002/ajmg.1320500309
   CIZKOVA A, 2008, ABSTRACTBOOK EUROM A, V7, P137
   Davey KM, 2006, J MED GENET, V43, P385, DOI 10.1136/jmg.2005.036657
   De Kremer RD, 2001, AM J MED GENET, V99, P83, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1136>3.0.CO;2-X
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Di Rosa G, 2006, J INHERIT METAB DIS, V29, P546, DOI 10.1007/s10545-006-0279-y
   ELPELEG ON, 1994, DEV MED CHILD NEUROL, V36, P167
   Engelke UFH, 2006, NMR BIOMED, V19, P271, DOI 10.1002/nbm.1018
   Engelke UFH, 2004, CLIN CHEM, V50, P58, DOI 10.1373/clinchem.2003.020214
   FIGARELLABRANGER D, 1992, J NEUROL SCI, V108, P105, DOI 10.1016/0022-510X(92)90195-Q
   GIBSON KM, 1991, J PEDIATR-US, V118, P885, DOI 10.1016/S0022-3476(05)82199-7
   GIBSON KM, 1992, J PEDIATR-US, V121, P940, DOI 10.1016/S0022-3476(05)80348-8
   Gunay-Aygun M, 2005, MOL GENET METAB, V84, P1, DOI 10.1016/j.ymgme.2004.12.003
   IBEL H, 1993, EUR J PEDIATR, V152, P665, DOI 10.1007/BF01955244
   JAKOBS C, 1991, EUR J PEDIATR, V150, P684, DOI 10.1007/BF02072635
   Janssen AJM, 2006, CLIN CHEM, V52, P860, DOI 10.1373/clinchem.2005.062414
   KELLEY RI, 1995, PEDIATR RES, V37, P671, DOI 10.1203/00006450-199505000-00020
   Law LK, 2003, J INHERIT METAB DIS, V26, P705, DOI 10.1023/B:BOLI.0000005603.04633.21
   LICHTERKONECKI U, 1993, EUR J PEDIATR, V152, P378, DOI 10.1007/BF01956761
   McFarland R, 2008, ARCH DIS CHILD, V93, P151, DOI 10.1136/adc.2007.122911
   Monnier N, 2008, HUM MUTAT, V29, P670, DOI 10.1002/humu.20696
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Morava E, 2004, EUR J PEDIATR, V163, P467, DOI 10.1007/s00431-004-1465-2
   MULLERHOCKER J, 1991, VIRCHOWS ARCH A, V419, P355, DOI 10.1007/BF01606527
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   Ruesch S, 1996, ENZYME PROTEIN, V49, P321, DOI 10.1159/000468642
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Scaglia F, 2001, J CHILD NEUROL, V16, P136, DOI 10.1177/088307380101600214
   SENGERS RCA, 1975, J PEDIATR-US, V86, P873, DOI 10.1016/S0022-3476(75)80217-4
   Sperl W, 2006, NEUROMUSCULAR DISORD, V16, P821, DOI 10.1016/j.nmd.2006.08.008
   Valianpour F, 2002, J PEDIATR-US, V141, P729, DOI 10.1067/mpd.2002.129174
   Woods CG, 2006, AM J HUM GENET, V78, P889, DOI 10.1086/503875
   Wortmann S, 2006, MOL GENET METAB, V88, P47, DOI 10.1016/j.ymgme.2006.01.013
NR 38
TC 65
Z9 69
U1 1
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD JAN
PY 2009
VL 132
BP 136
EP 146
DI 10.1093/brain/awn296
PN 1
PG 11
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 398FN
UT WOS:000262718100015
PM 19015156
OA Bronze
DA 2024-11-01
ER

PT S
AU Sasarman, F
   Shoubridge, EA
AF Sasarman, Florin
   Shoubridge, Eric A.
BE Wong, LJC
TI Radioactive Labeling of Mitochondrial Translation Products in Cultured
   Cells
SO MITOCHONDRIAL DISORDERS: BIOCHEMICAL AND MOLECULAR ANALYSIS
SE Methods in Molecular Biology
LA English
DT Article; Book Chapter
DE Mitochondria; Oxidative Phosphorylation (OXPHOS); Mitochondrial DNA
   (mtDNA); Pulse-chase labeling; Mitochondrial translation
ID PROTEIN-SYNTHESIS; LACTIC-ACIDOSIS; MELAS MUTATION; HELA-CELLS;
   MYOPATHY; DEFECTS; ENCEPHALOPATHY; RESPIRATION; TERMINATION; DEFICIENCY
AB The mammalian mitochondrial genome contains 37 genes, 13 of which encode polypeptide subunits in the enzyme complexes of the oxidative phosphorylation system. The other genes encode the rRNAs and tRNAs necessary for their translation. The mitochondrial translation machinery is located in the mitochondrial matrix, and is exclusively dedicated to the synthesis of these 13 enzyme subunits. Mitochondrial disease in humans is often associated with defects in mitochondria! translation. This can manifest as a global decrease in the rate of mitochondrial protein synthesis, a decrease in the synthesis of specific polypeptides, the synthesis of abnormal polypeptides, or in altered stability of specific translation products. All of these changes in the normal pattern of mitochondrial translation can be assessed by a straightforward technique that takes advantage of he insensitivity of the mitochondrial translation machinery to antibiotics that completely inhibit cytoplasmic translation. Thus, specific radioactive labeling of the mitochondrial translation products can be achieved in cultured cells, and the results can be visualized on gradient gels. The analysis of mitochondrial translation in cells cultured from patient biopsies is useful in the study of disease-causing mutations in both the mitochondrial and the nuclear genomes.
C1 [Sasarman, Florin; Shoubridge, Eric A.] McGill Univ, Montreal Neurol Inst, Dept Human Genet, Montreal, PQ, Canada.
C3 McGill University
RP Sasarman, F (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Human Genet, Montreal, PQ, Canada.
CR Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106
   Antonicka H, 2010, AM J HUM GENET, V87, P115, DOI 10.1016/j.ajhg.2010.06.004
   Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878
   COSTANTINO P, 1977, J BIOL CHEM, V252, P1702
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Fernández-Silva P, 2007, METHOD CELL BIOL, V80, P571, DOI 10.1016/S0091-679X(06)80028-2
   Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Kemp JP, 2011, BRAIN, V134, P183, DOI 10.1093/brain/awq320
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   MARIOTTINI P, 1986, J BIOL CHEM, V261, P3355
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
NR 20
TC 47
Z9 50
U1 0
U2 2
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1064-3745
BN 978-1-61779-503-9
J9 METHODS MOL BIOL
JI Methods Mol. Biol.
PY 2012
VL 837
BP 207
EP 217
DI 10.1007/978-1-61779-504-6_14
D2 10.1007/978-1-61779-504-6
PG 11
WC Biochemical Research Methods; Biochemistry & Molecular Biology
WE Book Citation Index – Science (BKCI-S)
SC Biochemistry & Molecular Biology
GA BAG90
UT WOS:000304125100014
PM 22215550
DA 2024-11-01
ER

PT J
AU Kim, J
   Medsinge, A
   Chauhan, B
   Wiest, C
   Scanga, H
   Monaghan, R
   Moore, WH
   Nischal, KK
AF Kim, Jocelyn
   Medsinge, Anagha
   Chauhan, Bharesh
   Wiest, Cara
   Scanga, Hannah
   Monaghan, Rachael
   Moore, William H.
   Nischal, Ken K.
TI Coenzyme Q10 in the Treatment of Corneal Edema in Kearns-Sayre: Is There
   an Application in Fuchs Endothelial Corneal Dystrophy?
SO CORNEA
LA English
DT Article
DE Fuchs endothelial corneal dystrophy; mitochondrial disease; 4977 bp;
   CoQ10
ID MITOCHONDRIAL-DNA DELETION; OPHTHALMOPLEGIA-PLUS; DISEASE; DISORDER;
   MUSCLE; MUTATIONS; APOPTOSIS; MEMBRANE; MYOPATHY; Q(10)
AB Purpose: Corneal involvement in mitochondrial disease is seldom described. Kearns-Sayre syndrome (KSS) is a mitochondrial disorder characterized by retinitis pigmentosa, external ophthalmoplegia, and heart block. We report 2 patients with KSS with corneal lesions involving the endothelium, which improved with Coenzyme Q10 (CoQ10). Based on recent research regarding the role of dysfunctional oxidative metabolism in Fuchs Endothelial Corneal Dystrophy (FECD), we propose that mitochondrial diseases and FECD share a final pathway.
   Methods: A chart review was performed and a review of the literature was completed with a PubMed search using the terms "Kearns-Sayre Syndrome", "mitochondria", "endothelium", "Fuchs endothelial corneal dystrophy", and "cornea".
   Results: There are 19 reports of corneal involvement in clinical phenotypes of mitochondrial disease. Nine of these 19 cases had findings consistent with KSS. Our patients with KSS had microcystic changes throughout the cornea and excrescences on the endothelial surface seen with ultrasound biomicroscopy, similar to the clinical findings in FECD. CoQ10 improved corneal disease in both children. CoQ10 deficiency has been reported in a variety of mitochondrial diseases, and efficacy of supplementation has been demonstrated. It may be beneficial in these patients because of its antioxidant properties and role in oxidative phosphorylation.
   Conclusions: The common deletion found in patients with KSS has recently been implicated in FECD, which has recently been shown to be a disease related to dysfunctional oxidative metabolism. Future research should explore the use of antioxidants, such as CoQ10 in patients with FECD.
C1 [Kim, Jocelyn; Nischal, Ken K.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA.
   [Medsinge, Anagha; Chauhan, Bharesh; Scanga, Hannah; Monaghan, Rachael; Nischal, Ken K.] Childrens Hosp Pittsburgh, UPMC Eye Ctr, Pediat Ophthalmol Strabismus & Adult Motil, Pittsburgh, PA 15213 USA.
   [Wiest, Cara] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA.
   [Moore, William H.] Great Ormond St Hosp Sick Children, Clin & Acad Dept Ophthalmol, London, England.
   [Nischal, Ken K.] UPMC Eye Ctr, Pittsburgh, PA USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh; Drexel University; University of
   London; University College London; Great Ormond Street Hospital for
   Children NHS Foundation Trust
RP Nischal, KK (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat Ophthalmol, 4401 Penn Ave,FP 5105, Pittsburgh, PA 15224 USA.
EM nischalkk@upmc.edu
OI Chauhan, Bharesh/0000-0002-6429-9190
CR BACHYNSKI BN, 1986, OPHTHALMOLOGY, V93, P391
   BERENBERG RA, 1977, ANN NEUROL, V1, P37, DOI 10.1002/ana.410010104
   Bergmanson JPG, 1999, OPHTHAL PHYSL OPT, V19, P210, DOI 10.1046/j.1475-1313.1999.00408.x
   Bourne WM, 2003, EYE, V17, P912, DOI 10.1038/sj.eye.6700559
   BOURNE WM, 1982, ARCH OPHTHALMOL-CHIC, V100, P1952, DOI 10.1001/archopht.1982.01030040932013
   BROCKINGTON M, 1995, J NEUROL SCI, V131, P78, DOI 10.1016/0022-510X(95)00091-F
   CHANG TS, 1994, CORNEA, V13, P269, DOI 10.1097/00003226-199405000-00014
   Chen CC, 2013, J BIOL CHEM, V288, P11689, DOI 10.1074/jbc.M112.401844
   Colyer MH, 2007, BRIT J OPHTHALMOL, V91, P696, DOI 10.1136/bjo.2006.101055
   Czarny P, 2014, MUTAT RES-FUND MOL M, V760, P42, DOI 10.1016/j.mrfmmm.2013.12.001
   Elhalis H, 2010, OCUL SURF, V8, P173, DOI 10.1016/S1542-0124(12)70232-X
   Haas RH, 2007, MITOCHONDRION, V7, pS136, DOI 10.1016/j.mito.2007.03.008
   HOWELL N, 1994, AM J HUM GENET, V55, P219
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Jurkunas UV, 2010, AM J PATHOL, V177, P2278, DOI 10.2353/ajpath.2010.100279
   Kanpolat A, 2003, CORNEA, V22, P726, DOI 10.1097/00003226-200311000-00004
   Kasbekar SA, 2013, OPHTHALMIC GENET, V34, P55, DOI 10.3109/13816810.2011.610862
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   KOSMORSKY GS, 1989, NEURO-OPHTHALMOLOGY, V9, P271, DOI 10.3109/01658108908997367
   Lee HF, 2006, PEDIATR NEUROL, V34, P464, DOI 10.1016/j.pediatrneurol.2005.12.002
   Lee JJ, 2012, PEDIATR NEPHROL, V27, P869, DOI 10.1007/s00467-011-2096-2
   Malbran E S, 1966, Int Ophthalmol Clin, V6, P711, DOI 10.1097/00004397-196600630-00020
   Miles MV, 2008, MITOCHONDRION, V8, P170, DOI 10.1016/j.mito.2008.01.003
   Mkaouar-Rebai E, 2010, MITOCHONDRION, V10, P449, DOI 10.1016/j.mito.2010.04.003
   OHKOSHI K, 1989, CORNEA, V8, P210
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Sacconi S, 2010, NEUROMUSCULAR DISORD, V20, P44, DOI 10.1016/j.nmd.2009.10.014
   Seneca S, 2001, ARCH NEUROL-CHICAGO, V58, P1113, DOI 10.1001/archneur.58.7.1113
   SHY GM, 1967, AM J MED, V42, P163, DOI 10.1016/0002-9343(67)90015-0
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012
   Zarnowski T, 2003, ACTA OPHTHALMOL SCAN, V81, P543, DOI 10.1034/j.1600-0420.2003.00120.x
   Zhang J, 2015, EXP EYE RES, V130, P97, DOI 10.1016/j.exer.2014.10.023
   Ziaei A, 2013, INVEST OPHTH VIS SCI, V54, P6724, DOI 10.1167/iovs.13-12699
NR 34
TC 11
Z9 11
U1 1
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0277-3740
EI 1536-4798
J9 CORNEA
JI Cornea
PD SEP
PY 2016
VL 35
IS 9
BP 1250
EP 1254
PG 5
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA DT4GA
UT WOS:000381437000026
PM 27442316
DA 2024-11-01
ER

PT J
AU Yis, U
   Ezgü, FS
   Karakaya, P
   Polat, I
   Arslan, N
   Çankaya, T
   Bozkaya, ÖG
   Kurul, SH
AF Yis, Uluc
   Ezgu, Fatih Suheyl
   Karakaya, Pakize
   Polat, Ipek
   Arslan, Nur
   Cankaya, Tufan
   Bozkaya, Ozlem Giray
   Kurul, Semra Hiz
TI A Novel Mutation in the Mitochondrial DNA Cytochrome b Gene
   (<i>MTCYB</i>) in a Patient with Prader Willi Syndrome
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE Prader-Willi syndrome; mitochondria disease; mitochondrial cytochrome b
   gene
ID SUDDEN-DEATH; DYSFUNCTION; DUPLICATION; DELETION
AB In recent years, it has been suggested that defects in energy metabolism may accompany Prader Willi syndrome. Mutations in the mitochondrial cytochrome b gene have been commonly associated isolated mitochondrial myopathy and exercise intolerance, rarely with multisystem disorders. The authors describe a novel mutation (mt. 15209T>C) in mitochondrial cytochrome b gene in a 2-year-old girl with Prader-Willi syndrome with a clinical history of lactic acidosis attacks, renal sodium loss, hepatopathy, progressive cerebral atrophy, and sudden death. The authors suggest that atypical clinical findings in patients with Prader-Willi syndrome should direct the physician to search for a mitochondrial disease.
C1 [Yis, Uluc; Karakaya, Pakize; Polat, Ipek; Kurul, Semra Hiz] Dokuz Eylul Univ, Sch Med, Dept Pediat, Div Child Neurol, Izmir, Turkey.
   [Ezgu, Fatih Suheyl] Gazi Univ, Sch Med, Div Pediat Metab & Nutr, Dept Pediat, Ankara, Turkey.
   [Arslan, Nur] Dokuz Eylul Univ, Dept Pediat, Div Pediat Metab & Nutr, Sch Med, Ankara, Turkey.
   [Cankaya, Tufan; Bozkaya, Ozlem Giray] Dokuz Eylul Univ, Sch Med, Div Genet, Dept Pediat, Ankara, Turkey.
C3 Dokuz Eylul University; Gazi University; Dokuz Eylul University; Dokuz
   Eylul University
RP Yis, U (corresponding author), Dokuz Eylul Univ, Sch Med, Dept Pediat, Div Child Neurol, Izmir, Turkey.
EM ulyis@yahoo.com
RI Cavalleri, Gianpiero/A-6632-2010; Karaoğlu, Pakize/ADK-2689-2022; Hiz,
   Semra/O-4943-2018; KALAFATCILAR POLAT, Ayşe İpek/A-9714-2016
OI Cankaya, Tufan/0000-0002-5189-6420
CR Cassidy SB, 2012, GENET MED, V14, P10, DOI 10.1038/gim.0b013e31822bead0
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   Emmanuele V, 2013, J CHILD NEUROL, V28, P236, DOI 10.1177/0883073812445787
   Filipek PA, 2003, ANN NEUROL, V53, P801, DOI 10.1002/ana.10596
   Fragaki K, 2009, MITOCHONDRION, V9, P346, DOI 10.1016/j.mito.2009.06.002
   Frye RE, 2009, J CHILD NEUROL, V24, P1316, DOI 10.1177/0883073809333531
   Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005
   Legros F, 2001, EUR J HUM GENET, V9, P510, DOI 10.1038/sj.ejhg.5200678
   Nagai T, 2005, AM J MED GENET A, V136A, P45, DOI 10.1002/ajmg.a.30777
   Rodriguez-Jato S, 2005, NUCLEIC ACIDS RES, V33, P4740, DOI 10.1093/nar/gki786
   Sacco M, 2005, HORM RES, V63, P29, DOI 10.1159/000082525
   Schuelke M, 2002, ANN NEUROL, V51, P388, DOI 10.1002/ana.10151
   Valnot I, 1999, HUM GENET, V104, P460, DOI 10.1007/s004390050988
   Van Vliet G, 2004, J PEDIATR-US, V144, P129, DOI 10.1016/j.jpeds.2003.09.049
   Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224
   Yazdi PG, 2013, CTS-CLIN TRANSL SCI, V6, P347, DOI 10.1111/cts.12083
NR 16
TC 2
Z9 2
U1 1
U2 10
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD MAR
PY 2015
VL 30
IS 3
BP 378
EP 381
DI 10.1177/0883073814530499
PG 4
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA CB9VY
UT WOS:000349982900017
PM 24771578
DA 2024-11-01
ER

PT J
AU DiFrancesco, JC
   Cooper, JM
   Lam, A
   Hart, PE
   Tremolizzo, L
   Ferrarese, C
   Schapira, AH
AF DiFrancesco, Jacopo C.
   Cooper, J. Mark
   Lam, Amanda
   Hart, Paul E.
   Tremolizzo, Lucio
   Ferrarese, Carlo
   Schapira, Antony H.
TI MELAS mitochondrial DNA mutation A3243G reduces glutamate transport in
   cybrids cell lines
SO EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE MELAS; A3243G; excitotoxicity; glutamate; mitochondria; cybrid
ID STROKE-LIKE EPISODES; LHON/MELAS OVERLAP SYNDROME; OXIDATIVE DAMAGE;
   LACTIC-ACIDOSIS; COMPLEX-I; ENCEPHALOMYOPATHY; DEFECTS; DISEASE;
   ENCEPHALOPATHY; PATHOGENESIS
AB MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes) is commonly associated with the A3243G mitochondrial DNA (mtDNA) mutation encoding the transfer RNA of leucine (UUR) (tRNA (Le(UUR))). The pathogenetic mechanisms of this mutation are not completely understood. Neuronal functions are particularly vulnerable to alterations in oxidative phosphorylation, which may affect the function of the neurotransmitter glutamate, leading to excitotoxicity. In order to investigate the possible effects of A3243G upon glutamate homeostasis, we assessed glutamate uptake in osteosarcoma-derived cytoplasmic hybrids (cybrids) expressing high levels of this mutation. High-affinity Na+-dependent glutamate uptake was assessed as radioactive [H-3]-glutamate influx mediated by specific excitatory amino acid transporters (EAATs). The maximal rate (V-max) of Na+-dependent glutamate uptake was significantly reduced in all the mutant clones. Although the defect did not relate to either the mutant load or magnitude of oxidative phosphorylation defect, we found an inverse relationship between A3243G mutation load and mitochondrial ATP synthesis, without any evidence of increased cellular or mitochondrial free radical production in these A3243G clones. These data suggest that a defect of glutamate transport in MELAS neurons may be due to decreased energy production and might be involved in mediating the pathogenic effects of the A3243G mtDNA mutation. (C) 2008 Elsevier Inc. All rights reserved.
C1 [DiFrancesco, Jacopo C.; Tremolizzo, Lucio; Ferrarese, Carlo] Univ Milano Bicocca, Dept Neurosci & Biomed Technol, I-20052 Monza, MI, Italy.
   [Tremolizzo, Lucio; Ferrarese, Carlo] San Gerardo Hosp, Dept Neurol, Monza, Italy.
   [DiFrancesco, Jacopo C.; Ferrarese, Carlo] Inst Sci E Medea, Bosisio Parini, IC, Italy.
   [DiFrancesco, Jacopo C.; Cooper, J. Mark; Lam, Amanda; Hart, Paul E.; Schapira, Antony H.] Royal Free & Univ Coll Med Sch, Univ Dept Clin Neurosci, London WC1E 6BT, England.
   [Schapira, Antony H.] UCL, Inst Neurol, London, England.
C3 University of Milano-Bicocca; San Gerardo Hospital; IRCCS Eugenio Medea;
   University of London; University College London; University of London;
   University College London
RP DiFrancesco, JC (corresponding author), Univ Milano Bicocca, Dept Neurosci, Neurol Sect, Via Cadore 48, I-20052 Monza, MI, Italy.
EM jacopo.difrancesco@unimib.it
RI Ferrarese, Carlo/AAC-4903-2022; Cooper, J/D-5826-2013; DiFrancesco,
   Jacopo C./J-8785-2018; Schapira, Anthony/A-1245-2010; Cooper,
   Jonathan/E-9000-2010
OI DiFrancesco, Jacopo C./0000-0002-4102-1188; Schapira,
   Anthony/0000-0002-3018-3966; Ferrarese, Carlo/0000-0002-7499-6600;
   Cooper, Jonathan/0000-0002-2358-1050
FU Medical Research Council [G0601943] Funding Source: Medline; MRC
   [G0601943] Funding Source: UKRI
CR ALBIN RL, 1992, NEUROLOGY, V42, P733, DOI 10.1212/WNL.42.4.733
   Beretta S, 2004, BRAIN, V127, P2183, DOI 10.1093/brain/awh258
   Beretta S, 2006, NEUROBIOL DIS, V24, P308, DOI 10.1016/j.nbd.2006.07.016
   Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   El Meziane A, 1998, NAT GENET, V18, P350
   Ferrarese C., 2004, EXCITOTOXICITY NEURO
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   Helm M, 1999, NUCLEIC ACIDS RES, V27, P756, DOI 10.1093/nar/27.3.756
   Hirata K, 2008, BRAIN DEV-JPN, V30, P238, DOI 10.1016/j.braindev.2007.08.007
   ICHIKI T, 1988, ANN NEUROL, V23, P287, DOI 10.1002/ana.410230312
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x
   Kariya S, 2005, NEUROPEPTIDES, V39, P97, DOI 10.1016/j.npep.2004.11.004
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Korlipara LVP, 2004, NEUROPHARMACOLOGY, V46, P562, DOI 10.1016/j.neuropharm.2003.10.015
   Liu CY, 2004, ANN NY ACAD SCI, V1011, P133, DOI 10.1196/annals.1293.014
   MOUDY AM, 1995, P NATL ACAD SCI USA, V92, P729, DOI 10.1073/pnas.92.3.729
   ONEILL CM, 1994, J NEUROCHEM, V63, P603
   Pang CY, 2001, DIABETES RES CLIN PR, V54, pS45, DOI 10.1016/S0168-8227(01)00335-7
   Pulkes T, 1999, ANN NEUROL, V46, P916, DOI 10.1002/1531-8249(199912)46:6<916::AID-ANA16>3.0.CO;2-R
   Rusanen H, 2000, BBA-MOL BASIS DIS, V1500, P10, DOI 10.1016/S0925-4439(99)00081-2
   Sandhu JK, 2005, BIOCHEM J, V391, P191, DOI 10.1042/BJ20050272
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Shepherd RK, 2006, J INHERIT METAB DIS, V29, P86, DOI 10.1007/s10545-006-0148-8
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   Turner LF, 1998, EUR HEART J, V19, P1725, DOI 10.1053/euhj.1998.1125
   Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431
   Wong A, 1997, BIOCHEM BIOPH RES CO, V239, P139, DOI 10.1006/bbrc.1997.7443
   YONEDA M, 1989, J NEUROL SCI, V92, P143, DOI 10.1016/0022-510X(89)90132-9
NR 33
TC 12
Z9 16
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4886
J9 EXP NEUROL
JI Exp. Neurol.
PD JUL
PY 2008
VL 212
IS 1
BP 152
EP 156
DI 10.1016/j.expneurol.2008.03.015
PG 5
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 316NU
UT WOS:000256957700016
PM 18455161
DA 2024-11-01
ER

PT J
AU Smith, PM
   Ross, GF
   Taylor, RW
   Turnbull, DA
   Lightowlers, RN
AF Smith, PM
   Ross, GF
   Taylor, RW
   Turnbull, DA
   Lightowlers, RN
TI Strategies for treating disorders of the mitochondrial genome
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article; Proceedings Paper
CT 6th European Meeting on Mitochondrial Pathology (Euromit 6)
CY JUN 30-JUL 04, 2004
CL Nijmegen, NETHERLANDS
DE antigenomic hypothesis; mtDNA disease; treatment of mtDNA disease;
   alloptic expression; mithocondrial tRNA import
ID PEPTIDE NUCLEIC-ACIDS; MISMATCH REPAIR ACTIVITY; TRANSFER-RNA IMPORT;
   HUMAN-CELLS; SACCHAROMYCES-CEREVISIAE; MAMMALIAN MITOCHONDRIA; DNA
   HETEROPLASMY; SKELETAL-MUSCLE; GENE-THERAPY; RESTRICTION-ENDONUCLEASE
AB Defects of the mitochondrial genome are a significant cause of disease. Patients suffer from a wide variety of clinical presentations, ranging from fatal infantile disease to mild muscle weakness. Most disorders, however, are characterized by inexorable progression: As mutations often cause defects in several components of the complexes that couple oxidative phosphorylation, this terminal state of oxidative metabolism cannot be readily bypassed by dietary means, leading to the search for novel therapies. In this article, we present the theory behind several concepts and report progress. We also discuss some of the recent difficulties encountered in the progress towards an antigenome approach to treating mtDNA disorders. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Newcastle Upon Tyne, Sch Med, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Univ Newcastle Upon Tyne, Sch Med, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.n.lightowlers@nct.ac.uk
CR [Anonymous], A Human Mitochondrial Genome Database
   Bai YD, 2004, ANN NY ACAD SCI, V1011, P272, DOI 10.1196/annals.1293.026
   Bai YD, 2001, J BIOL CHEM, V276, P38808, DOI 10.1074/jbc.M106363200
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Bayona M, 2004, BBA-BIOENERGETICS, V1657, P89
   Bidooki SK, 1997, AM J HUM GENET, V60, P1430, DOI 10.1086/515460
   BOUGERON T, 1993, J BIOL CHEM, V268, P19369
   Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061
   CHRZANOWSKALIGHTOWLERS ZMA, 1995, GENE THER, V2, P311
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   CLAROS MG, 1995, EUR J BIOCHEM, V228, P762, DOI 10.1111/j.1432-1033.1995.0762m.x
   Coulter CV, 2000, FREE RADICAL BIO MED, V28, P1547, DOI 10.1016/S0891-5849(00)00255-0
   D'Souza GGM, 2003, J CONTROL RELEASE, V92, P189, DOI 10.1016/S0168-3659(03)00297-9
   Demidov VV, 2002, P NATL ACAD SCI USA, V99, P5953, DOI 10.1073/pnas.092127999
   DEVRIES S, 1988, EUR J BIOCHEM, V176, P377
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Glover KE, 2001, J BIOL CHEM, V276, P639, DOI 10.1074/jbc.M007708200
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kolesnikova OA, 2000, SCIENCE, V289, P1931, DOI 10.1126/science.289.5486.1931
   Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267
   Koulintchenko M, 2003, EMBO J, V22, P1245, DOI 10.1093/emboj/cdg128
   Kuhn H, 1999, J MOL BIOL, V286, P1337, DOI 10.1006/jmbi.1998.2578
   Kumar R, 1996, MOL GEN GENET, V252, P404, DOI 10.1007/BF02173005
   LI K, 1994, J CELL BIOL, V124, P871, DOI 10.1083/jcb.124.6.871
   Liebling MR, 2003, MOL BIOTECHNOL, V25, P229, DOI 10.1385/MB:25:3:229
   Magalhaes PJ, 1998, MOL BIOL CELL, V9, P2375, DOI 10.1091/mbc.9.9.2375
   Mahoney DJ, 2002, CURR OPIN CLIN NUTR, V5, P619, DOI 10.1097/00075197-200211000-00004
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Marriage B, 2003, J AM DIET ASSOC, V103, P1029, DOI 10.1016/S0002-8223(03)00476-0
   Mason PA, 2003, FEBS LETT, V554, P6, DOI 10.1016/S0014-5793(03)01169-4
   Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167
   Muratovska A, 2001, NUCLEIC ACIDS RES, V29, P1852, DOI 10.1093/nar/29.9.1852
   NAGLEY P, 1988, P NATL ACAD SCI USA, V85, P2091, DOI 10.1073/pnas.85.7.2091
   Oca-Cossio J, 2003, GENETICS, V165, P707
   Ojaimi J, 2002, MOL BIOL CELL, V13, P3836, DOI 10.1091/mbc.E02-05-0306
   ONO A, 1994, BIOCHEMISTRY-US, V33, P4312, DOI 10.1021/bi00180a027
   Puranam RS, 2001, MOL CELL BIOL, V21, P548, DOI 10.1128/MCB.21.2.548-561.2001
   Ross GF, 2003, BIOCONJUGATE CHEM, V14, P962, DOI 10.1021/bc034050f
   ROSS MF, 2004, IN PRESS BIOCH J
   Schneider A, 2000, TRENDS CELL BIOL, V10, P509, DOI 10.1016/S0962-8924(00)01854-7
   Seo BB, 2000, J BIOL CHEM, V275, P37774, DOI 10.1074/jbc.M007033200
   Seo BB, 2002, MOL THER, V6, P336, DOI 10.1006/mthe.2002.0674
   SMITH PM, 2003, THESIS NEWCASTLE UPO
   Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   Turnbull DM, 2002, NAT GENET, V30, P345, DOI 10.1038/ng0402-345
   VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0
   Weber K, 1997, AM J HUM GENET, V60, P373
   Weissig V, 1998, PHARMACEUT RES, V15, P334, DOI 10.1023/A:1011991307631
   Weissig V, 2001, ADV DRUG DELIVER REV, V49, P127, DOI 10.1016/S0169-409X(01)00131-4
NR 56
TC 22
Z9 29
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 0006-3002
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD DEC 6
PY 2004
VL 1659
IS 2-3
SI SI
BP 232
EP 239
DI 10.1016/j.bbabio.2004.09.003
PG 8
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology; Biophysics
GA 882KT
UT WOS:000225938500017
PM 15576056
DA 2024-11-01
ER

PT J
AU Herbst, A
   Aiken, JM
   Kim, C
   Gushue, D
   McKenzie, D
   Moore, TM
   Zhou, J
   Hoang, AN
   Choi, S
   Wanagat, J
AF Herbst, Allen
   Aiken, Judd M.
   Kim, Chiye
   Gushue, Danielle
   McKenzie, Debbie
   Moore, Timothy M.
   Zhou, Jin
   Hoang, Austin N.
   Choi, Solbie
   Wanagat, Jonathan
TI Age- and time-dependent mitochondrial genotoxic and myopathic effects of
   beta-guanidinopropionic acid, a creatine analog, on rodent skeletal
   muscles
SO GEROSCIENCE
LA English
DT Article
DE Guanidinopropionic acid; Aging; Skeletal muscle; Mitochondria; Genetics;
   Creatine
ID ABNORMALITIES; DISABILITY; MUTATIONS; DEPLETION; ENTRY
AB Beta-guanidinopropionic acid (GPA) is a creatine analog suggested as a treatment for hypertension, diabetes, and obesity, which manifest primarily in older adults. A notable side effect of GPA is the induction of mitochondrial DNA deletion mutations. We hypothesized that mtDNA deletions contribute to muscle aging and used the mutation promoting effect of GPA to examine the impact of mtDNA deletions on muscles with differential vulnerability to aging. Rats were treated with GPA for up to 4 months starting at 14 or 30 months of age. We examined quadriceps and adductor longus muscles as the quadriceps exhibits profound age-induced deterioration, while adductor longus is maintained. GPA decreased body and muscle mass and mtDNA copy number while increasing mtDNA deletion frequency. The interactions between age and GPA treatment observed in the quadriceps were not observed in the adductor longus. GPA had negative mitochondrial effects in as little as 4 weeks. GPA treatment exacerbated mtDNA deletions and muscle aging phenotypes in the quadriceps, an age-sensitive muscle, while the adductor longus was spared. GPA has been proposed for use in age-associated diseases, yet the pharmacodynamics of GPA differ with age and include the detrimental induction of mtDNA deletions, a mitochondrial genotoxic stress that is pronounced in muscles that are most vulnerable to aging. Further research is needed to determine if the proposed benefits of GPA on hypertension, diabetes, and obesity outweigh the detrimental mitochondrial and myopathic side effects.
C1 [Herbst, Allen; Aiken, Judd M.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.
   [Herbst, Allen] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA.
   [Kim, Chiye; Gushue, Danielle; McKenzie, Debbie] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.
   [Moore, Timothy M.] UCLA, Dept Med, Div Cardiol, Los Angeles, CA 90024 USA.
   [Zhou, Jin] UCLA, Dept Med, Stat Core, Los Angeles, CA 90024 USA.
   [Zhou, Jin] UCLA, Dept Biostat, Los Angeles, CA USA.
   [Hoang, Austin N.; Choi, Solbie; Wanagat, Jonathan] UCLA, Dept Med, Div Geriatr, 10945 Le Conte Ave,Suite 2339, Los Angeles, CA 90095 USA.
   [Wanagat, Jonathan] Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA.
C3 University of Alberta; United States Department of the Interior; United
   States Geological Survey; University of Alberta; University of
   California System; University of California Los Angeles; University of
   California System; University of California Los Angeles; University of
   California System; University of California Los Angeles; University of
   California System; University of California Los Angeles; US Department
   of Veterans Affairs; Veterans Health Administration (VHA); VA Greater
   Los Angeles Healthcare System
RP Wanagat, J (corresponding author), UCLA, Dept Med, Div Geriatr, 10945 Le Conte Ave,Suite 2339, Los Angeles, CA 90095 USA.; Wanagat, J (corresponding author), Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA.
EM jwanagat@mednet.ucla.edu
RI Wanagat, Jonathan/B-2856-2009
OI Wanagat, Jonathan/0000-0002-8460-8616; Aiken, Judd/0000-0001-6119-4521;
   Herbst, Allen/0000-0001-6601-1245
FU National Institutes of Health [R56AG060880, R01AG055518, K02AG059847,
   R21AR072950]; UCLA CFAR [P30AI028697]
FX This work is supported by the National Institutes of Health grant
   numbers R56AG060880, R01AG055518, K02AG059847, R21AR072950, and UCLA
   CFAR grant number P30AI028697.
CR Acin-Perez R, 2020, EMBO J, V39, DOI 10.15252/embj.2019104073
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Cesari M, 2009, J AM GERIATR SOC, V57, P251, DOI 10.1111/j.1532-5415.2008.02126.x
   Cheema N, 2015, AGING CELL, V14, P1085, DOI 10.1111/acel.12399
   DALY MM, 1980, ARCH BIOCHEM BIOPHYS, V203, P317, DOI 10.1016/0003-9861(80)90182-4
   den Ouden MEM, 2013, MATURITAS, V74, P89, DOI 10.1016/j.maturitas.2012.10.011
   den Ouden MEM, 2011, MATURITAS, V69, P208, DOI 10.1016/j.maturitas.2011.04.008
   DETATA V, 1993, INT J EXP PATHOL, V74, P501
   Dorigatti JD, 2021, GEROSCIENCE, V43, P1497, DOI 10.1007/s11357-021-00372-8
   FITCH CD, 1968, J BIOL CHEM, V243, P2024
   FITCH CD, 1974, J BIOL CHEM, V249, P1060
   GORI Z, 1988, BRIT J EXP PATHOL, V69, P639
   Herbst A, 2021, GEROSCIENCE, V43, P1253, DOI 10.1007/s11357-021-00351-z
   Herbst A, 2021, AGING CLIN EXP RES, V33, P1811, DOI 10.1007/s40520-020-01698-7
   Herbst A, 2017, J GERONTOL A-BIOL, V72, P1327, DOI 10.1093/gerona/glx058
   Herbst A, 2016, AGING CELL, V15, P1132, DOI 10.1111/acel.12520
   Herbst A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1884-7
   Herbst A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059006
   Karamat FA, 2017, BRIT J CLIN PHARMACO, V83, P2626, DOI 10.1111/bcp.13390
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248
   Lushaj EB, 2008, J GERONTOL A-BIOL, V63, P921, DOI 10.1093/gerona/63.9.921
   Mayhew AJ, 2020, J GERONTOL A-BIOL, V75, P147, DOI 10.1093/gerona/glz122
   MEGLASSON MD, 1993, J PHARMACOL EXP THER, V266, P1454
   Oudman I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052879
   Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008
   Ross TT, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13192
   Shea CA, 2018, AM J PHYS MED REHAB, V97, P426, DOI 10.1097/PHM.0000000000000889
   SHIELDS RP, 1973, CAN J BIOCHEM CELL B, V51, P1046, DOI 10.1139/o73-136
   Strong R, 2020, AGING CELL, V19, DOI 10.1111/acel.13269
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492
   Virani SS, 2021, CIRCULATION, V143, pe254, DOI 10.1161/CIR.0000000000000950
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
NR 34
TC 3
Z9 3
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD FEB
PY 2023
VL 45
IS 1
SI SI
BP 555
EP 567
DI 10.1007/s11357-022-00667-4
EA SEP 2022
PG 13
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 8R9OV
UT WOS:000862216000001
PM 36178599
OA Green Published
DA 2024-11-01
ER

PT J
AU Pohjoismäki, JLO
   Goffart, S
   Taylor, RW
   Turnbull, DM
   Suomalainen, A
   Jacobs, HT
   Karhunen, PJ
AF Pohjoismaki, Jaakko L. O.
   Goffart, Steffi
   Taylor, Robert W.
   Turnbull, Douglas M.
   Suomalainen, Anu
   Jacobs, Howard T.
   Karhunen, Pekka J.
TI Developmental and Pathological Changes in the Human Cardiac Muscle
   Mitochondrial DNA Organization, Replication and Copy Number
SO PLOS ONE
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MULTIPLE MTDNA DELETIONS;
   TRANSCRIPTION FACTOR-A; AUTOSOMAL-DOMINANT; HELICASE TWINKLE; MUTATIONS;
   HEART; EXPRESSION; SKELETAL; FAILURE
AB Adult human heart mitochondrial DNA (mtDNA) has recently been shown to have a complex organization with abundant dimeric molecules, branched structures and four-way junctions. In order to understand the physiological significance of the heart-specific mtDNA maintenance mode and to find conditions that modify human heart mtDNA structure and replication, we analyzed healthy human heart of various ages as well as several different heart diseases, including ischemic heart disease, dilated as well as hypertrophic cardiomyopathies, and several mitochondrial disorders. By using one-and two-dimensional agarose gel electrophoresis, various enzymatic treatments and quantitative PCR we found that in human newborns heart mtDNA has a simple organization, lacking junctional forms and dimers. The adult-type branched forms are acquired in the early childhood, correlating with an increase in mtDNA copy number. Mitochondrial disorders involving either mutations in the mtDNA polymerase gamma (PolG alpha) or mtDNA helicase Twinkle, while having no obvious cardiac manifestation, show distinct mtDNA maintenance phenotypes, which are not seen in various types of diseased heart or in mitochondrial disorders caused by point mutations or large-scale deletions of mtDNA. The findings suggest a link between cardiac muscle development, mtDNA copy number, replication mode and topological organization. Additionally, we show that Twinkle might have a direct role in the maintenance of four-way junctions in human heart mtDNA.
C1 [Pohjoismaki, Jaakko L. O.; Karhunen, Pekka J.] Univ Tampere, Sch Med, Dept Forens Med, FIN-33101 Tampere, Finland.
   [Goffart, Steffi; Jacobs, Howard T.] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland.
   [Taylor, Robert W.; Turnbull, Douglas M.] Univ Newcastle, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.
   [Suomalainen, Anu] Univ Helsinki, Res Program Mol Neurol, Helsinki, Finland.
C3 Tampere University; Tampere University; Newcastle University - UK;
   University of Helsinki
RP Pohjoismäki, JLO (corresponding author), Univ Tampere, Sch Med, Dept Forens Med, FIN-33101 Tampere, Finland.
EM Jaakko.Pohjoismaki@uta.fi
RI Pohjoismaeki, Jaakko/AAC-7995-2019; Jacobs, Howard/G-2434-2011; Goffart,
   Steffi/N-3597-2015
OI Jacobs, Howard/0000-0003-1895-6003; Pohjoismaki,
   Jaakko/0000-0002-1185-3610; Turnbull, Doug/0000-0002-8878-9901;
   Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195
FU EU; Wellcome Trust; Newcastle upon Tyne Hospitals NHS Trust; UK National
   Comissioning Group
FX JLP was funded by the EU's 7th Framework Program Collaborative Project,
   AtheroRemo. RWT and DMT acknowledge the continuing financial support of
   a Wellcome Trust Programme Grant and the Newcastle upon Tyne Hospitals
   NHS Trust. Mitochondrial diagnostic testing in Newcastle is funded by
   the UK National Comissioning Group to provide the "Rare Mitochondrial
   Disorders of Adults and Children'' Diagnostics Service. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Backert S, 2000, CURR GENET, V37, P304, DOI 10.1007/s002940050532
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   BOGENHAGEN D, 1981, J MOL BIOL, V148, P77, DOI 10.1016/0022-2836(81)90236-9
   Brunetti-Pierri N, 2008, NEUROPEDIATRICS, V39, P179, DOI 10.1055/s-0028-1093334
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Goffart S, 2004, CARDIOVASC RES, V64, P198, DOI 10.1016/j.cardiores.2004.06.030
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942
   Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710
   Hyvärinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676
   Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Kreuzer KN, 2000, TRENDS BIOCHEM SCI, V25, P165, DOI 10.1016/S0968-0004(00)01559-0
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Leipe DD, 2000, GENOME RES, V10, P5
   Ling F, 2007, MOL CELL BIOL, V27, P1133, DOI 10.1128/MCB.00770-06
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   Pohjoismäki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703
   Pohjoismäki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Preiser PR, 1996, EMBO J, V15, P684, DOI 10.1002/j.1460-2075.1996.tb00401.x
   Russell LK, 2005, J MOL CELL CARDIOL, V38, P81, DOI 10.1016/j.yjmcc.2004.10.010
   Singh DK, 2009, BIOGERONTOLOGY, V10, P235, DOI 10.1007/s10522-008-9205-z
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SWALWELL H, 2008, EUR J HUM GENET, V18, P63
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
NR 36
TC 41
Z9 43
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 3
PY 2010
VL 5
IS 5
AR e10426
DI 10.1371/journal.pone.0010426
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 590PW
UT WOS:000277240300006
PM 20454654
OA Green Submitted, Green Published, gold
DA 2024-11-01
ER

PT J
AU Saxena, R
   de Bakker, PIW
   Singer, K
   Mootha, V
   Burtt, N
   Hirschhorn, JN
   Gaudet, D
   Isomaa, B
   Daly, MJ
   Groop, L
   Ardlie, KG
   Altshuler, D
AF Saxena, Richa
   de Bakker, Paul I. W.
   Singer, Karyn
   Mootha, Vamsi
   Burtt, Noel
   Hirschhorn, Joel N.
   Gaudet, Daniel
   Isomaa, Bo
   Daly, Mark J.
   Groop, Leif
   Ardlie, Kristin G.
   Altshuler, David
TI Comprehensive association testing of common mitochondrial DNA variation
   in metabolic disease
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID INSULIN-RESISTANCE; PARKINSONS-DISEASE; FRIEDREICHS-ATAXIA;
   SKELETAL-MUSCLE; POLYMORPHISMS; LONGEVITY; POPULATION; VARIANT; HUMANS;
   RISK
AB Many lines of evidence implicate mitochondria in phenotypic variation: ( a) rare mutations in mitochondrial proteins cause metabolic, neurological, and muscular disorders; ( b) alterations in oxidative phosphorylation are characteristic of type 2 diabetes, Parkinson disease, Huntington disease, and other diseases; and ( c) common missense variants in the mitochondrial genome ( mtDNA) have been implicated as having been subject to natural selection for adaptation to cold climates and contributing to "energy deficiency" diseases today. To test the hypothesis that common mtDNA variation influences human physiology and disease, we identified all 144 variants with frequency > 1% in Europeans from > 900 publicly available European mtDNA sequences and selected 64 tagging single-nucleotide polymorphisms that efficiently capture all common variation ( except the hypervariable D-loop). Next, we evaluated the complete set of common mtDNA variants for association with type 2 diabetes in a sample of 3,304 diabetics and 3,304 matched nondiabetic individuals. Association of mtDNA variants with other metabolic traits ( body mass index, measures of insulin secretion and action, blood pressure, and cholesterol) was also tested in subsets of this sample. We did not find a significant association of common mtDNA variants with these metabolic phenotypes. Moreover, we failed to identify any physiological effect of alleles that were previously proposed to have been adaptive for energy metabolism in human evolution. More generally, this comprehensive association-testing framework can readily be applied to other diseases for which mitochondrial dysfunction has been implicated.
C1 Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.
   Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.
   Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA.
   Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA.
   Childrens Hosp, Div Genet, Boston, MA 02115 USA.
   Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA.
   Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA USA.
   MIT, Cambridge, MA USA.
   Univ Montreal, Chicoutimi Hosp, Community Genom Ctr, Montreal, PQ, Canada.
   Folkhalsan Res Ctr, Folkhalsan Genet Inst, Helsinki, Finland.
   Malmska Municipal Hlth Ctr & Hosp, Pietarsaari, Finland.
   Lund Univ, Malmo Univ Hosp, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden.
C3 Harvard University; Massachusetts General Hospital; Harvard University;
   Massachusetts General Hospital; Harvard University; Harvard Medical
   School; Harvard University; Harvard Medical School; Harvard University;
   Boston Children's Hospital; Harvard University; Boston Children's
   Hospital; Harvard University; Massachusetts Institute of Technology
   (MIT); Broad Institute; Massachusetts Institute of Technology (MIT);
   Universite de Montreal; Folkhalsan Research Center; Lund University;
   Skane University Hospital
RP Altshuler, D (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Sinches Res Bldg,175 Cambridge St,CPZN-6818, Boston, MA 02114 USA.
EM altshuler@molbio.mgh.harvard.edu
RI Saxena, Richa/AAG-7279-2020; Daly, Mark/B-2453-2017; Altshuler,
   David/A-4476-2009; de Bakker, Paul/B-8730-2009
OI Altshuler, David/0000-0002-7250-4107; Saxena, Richa/0000-0003-2233-1065
CR Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226
   Autere J, 2004, HUM GENET, V115, P29, DOI 10.1007/s00439-004-1123-9
   Barrett TG, 2001, BEST PRACT RES CL EN, V15, P325, DOI 10.1053/beem.2001.0149
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   Carrieri G, 2001, HUM GENET, V108, P194, DOI 10.1007/s004390100463
   Chinnery PF, 2005, LANCET, V366, P1650, DOI 10.1016/S0140-6736(05)67492-2
   Dato S, 2004, EUR J HUM GENET, V12, P1080, DOI 10.1038/sj.ejhg.5201278
   de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669
   De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532
   De Benedictis G, 2000, ANN NY ACAD SCI, V908, P208
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Florez JC, 2004, DIABETES, V53, P3313, DOI 10.2337/diabetes.53.12.3313
   Giacchetti M, 2004, J MED GENET, V41, P293, DOI 10.1136/jmg.2003.015289
   Herrnstadt C, 2004, MITOCHONDRION, V4, P791, DOI 10.1016/j.mito.2004.07.041
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016
   Jazin EE, 1996, P NATL ACAD SCI USA, V93, P12382, DOI 10.1073/pnas.93.22.12382
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Khogali SS, 2001, LANCET, V357, P1265, DOI 10.1016/S0140-6736(00)04422-6
   Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901
   Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504
   Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537
   Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100
   Mohlke KL, 2005, HUM GENET, V118, P245, DOI 10.1007/s00439-005-0046-4
   Momiyama Y, 2003, BIOCHEM BIOPH RES CO, V312, P858, DOI 10.1016/j.bbrc.2003.10.195
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7
   Niemi AK, 2005, EUR J HUM GENET, V13, P166, DOI 10.1038/sj.ejhg.5201308
   Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Petersen KF, 2005, PLOS MED, V2, P879, DOI 10.1371/journal.pmed.0020233
   Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Poulton J, 1998, DIABETOLOGIA, V41, P54, DOI 10.1007/s001250050866
   Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581
   Poulton J, 2002, DIABETIC MED, V19, P969, DOI 10.1046/j.0742-3071.2002.00836.x
   Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149
   Reich DE, 2003, NAT GENET, V33, P457, DOI 10.1038/ng1133
   Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8
   Ross OA, 2001, EXP GERONTOL, V36, P1161, DOI 10.1016/S0531-5565(01)00094-8
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Savage DB, 2005, HYPERTENSION, V45, P828, DOI 10.1161/01.HYP.0000163475.04421.e4
   Schapira AHV, 1999, BBA-BIOENERGETICS, V1410, P159, DOI 10.1016/S0005-2728(98)00164-9
   Simoneau JA, 1997, J APPL PHYSIOL, V83, P166, DOI 10.1152/jappl.1997.83.1.166
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8
   Tanaka Masashi, 2002, Journal of Neurology, V249, P11
   Tang K, 2004, J PROTEOME RES, V3, P218, DOI 10.1021/pr034080s
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Torroni A, 1996, GENETICS, V144, P1835
   van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521
   Winckler W, 2005, DIABETES, V54, P886, DOI 10.2337/diabetes.54.3.886
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 59
TC 153
Z9 166
U1 0
U2 6
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 1427 E 60TH ST, CHICAGO, IL 60637-2954 USA
SN 0002-9297
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD JUL
PY 2006
VL 79
IS 1
BP 54
EP 61
DI 10.1086/504926
PG 8
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 053YD
UT WOS:000238341200006
PM 16773565
OA Bronze, Green Published
DA 2024-11-01
ER

PT J
AU Zanolini, A
   Potic, A
   Carrara, F
   Lamantea, E
   Diodato, D
   Blasevich, F
   Marchet, S
   Marina, M
   Pallotti, F
   Morandi, L
   Zeviani, M
   Lamperti, C
AF Zanolini, Alice
   Potic, Ana
   Carrara, Franco
   Lamantea, Eleonora
   Diodato, Daria
   Blasevich, Flavia
   Marchet, Silvia
   Marina, Mora
   Pallotti, Francesco
   Morandi, Lucia
   Zeviani, Massimo
   Lamperti, Costanza
TI Pure myopathy with enlarged mitochondria associated to a new mutation in
   <i>MTND2</i> gene
SO MOLECULAR GENETICS AND METABOLISM REPORTS
LA English
DT Article
DE ND2; Exercise intolerance; Complex I deficiency
ID CYTOCHROME-B GENE; EXERCISE INTOLERANCE; COMPLEX-I; NONSENSE MUTATION;
   DNA; DEFICIENCY
AB To date, only few mutations in the mitochondrial DNA (mtDNA)-encoded ND2 subunit of Complex I have been reported, usually presenting a severe phenotype characterized by early onset encephalomyopathy and early death. In this report, we describe a new mutation in the MTND2 gene in a 21-year-old man with a mild myopathic phenotype characterized by exercise intolerance and increased plasma lactate at rest. Electromyography and brain NMR were normal, and no cardiac involvement was present. Muscle biopsy showed a massive presence of ragged red - COX-positive fibres, with enlarged mitochondria containing osmiophilic inclusions. Biochemical assays revealed a severe isolated complex I deficiency. We identified a novel, heteroplasmic mutation m.4831G>A in the MTND2 gene, causing the p.Gly121Asp substitution in the ND2 protein. The mutation was present in the 95% of mitochondrial genomes from patient's muscle tissue, at a lower level in cells from the urinary tract and at a lowest level in lymphocytes from patient's blood; the base substitution was absent in fibroblasts and in the tissues from proband's healthy mother and brother. The specific skeletal muscle tissue involvement can explain the childhood-onset and the relatively benign, exclusively myopathic course of the disease. (C) 2017 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Zanolini, Alice; Carrara, Franco; Lamantea, Eleonora; Diodato, Daria; Marchet, Silvia; Zeviani, Massimo; Lamperti, Costanza] Fdn IRCCS Ist Neurol Carlo Besta, Unit Mol Neurogenet, I-20126 Milan, Italy.
   [Potic, Ana] Univ Belgrade, Fac Med, Dept Neurol, Clin Child Neurol & Psychiat, Belgrade 11000, Serbia.
   [Blasevich, Flavia; Marina, Mora; Morandi, Lucia] Fdn IRCCS Ist Neurol Carlo Besta, Div Neurol 4, I-20126 Milan, Italy.
   [Diodato, Daria] Osped Pediat Bambin Gesu, Div Neuromuscular & Neurodegenerat Disorders, Rome, Italy.
   [Zeviani, Massimo] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England.
   [Pallotti, Francesco] Univ Insubria, Dept Surg & Morphol Sci, Varese, Italy.
C3 Fondazione IRCCS Istituto Neurologico Carlo Besta; University of
   Belgrade; Fondazione IRCCS Istituto Neurologico Carlo Besta; IRCCS
   Bambino Gesu; University of Insubria
RP Lamperti, C (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Unit Mol Neurogenet, I-20126 Milan, Italy.
EM costanza.lamperti@istituto-besta.it
RI lamperti, costanza/J-8801-2016; Zeviani, Massimo/AAU-2632-2021; MARCHET,
   SILVIA/AAF-5898-2021; Mora, Marina/J-2883-2018; Lamantea,
   Eleonora/J-8339-2016; Blasevich, Flavia/AAM-5171-2021; Diodato,
   Daria/K-2639-2016
OI MARCHET, SILVIA/0000-0002-7858-3256; Mora, Marina/0000-0002-5765-2320;
   Lamantea, Eleonora/0000-0001-5090-6028; Zeviani,
   Massimo/0000-0002-9067-5508; Blasevich, Flavia/0000-0001-6974-1729;
   Pallotti, Francesco/0000-0001-9946-8516; Diodato,
   Daria/0000-0003-3607-8523
FU Fondazione Pierfranco e Luisa Mariani [CM23]; Italian Association of
   Mitochondrial Disease Patients and Families (Mitocon ONLUS); Cell line
   and DNA Bank of Genetic Movement Disorders and Mitochondrial Diseases of
   Telethon Network of Genetics Biobanks [GTB12001J]; MRC [MC_UP_1002/1]
   Funding Source: UKRI
FX This work was supported by Fondazione Pierfranco e Luisa Mariani (CM23),
   the Italian Association of Mitochondrial Disease Patients and Families
   (Mitocon ONLUS), and Cell line and DNA Bank of Genetic Movement
   Disorders and Mitochondrial Diseases of Telethon Network of Genetics
   Biobanks (grant GTB12001J).
CR Andreu AL, 1999, ANN NEUROL, V45, P820, DOI 10.1002/1531-8249(199906)45:6<820::AID-ANA22>3.0.CO;2-W
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   BROWN MD, 1992, GENETICS, V130, P163
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Debray FG, 2008, CURR OPIN PEDIATR, V20, P471, DOI 10.1097/MOP.0b013e328306ebb6
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Downham E, 2008, NEUROMUSCULAR DISORD, V18, P310, DOI 10.1016/j.nmd.2008.01.003
   Lamantea E, 2002, NEUROMUSCULAR DISORD, V12, P49, DOI 10.1016/S0960-8966(01)00244-9
   Massie R, 2010, MUSCLE NERVE, V42, P136, DOI 10.1002/mus.21649
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Ugalde C, 2007, MOL GENET METAB, V90, P10, DOI 10.1016/j.ymgme.2006.08.003
   Zeviani M, 2006, SCI MED, V10, P154
NR 13
TC 8
Z9 8
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2214-4269
J9 MOL GENET METAB REP
JI Molec. Genet. Metab. Rep.
PD MAR
PY 2017
VL 10
BP 24
EP 27
DI 10.1016/j.ymgmr.2016.11.009
PG 4
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA FC4ZB
UT WOS:000406849200008
PM 28070494
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Wedding, IM
   Koht, J
   Tran, GT
   Misceo, D
   Selmer, KK
   Holmgren, A
   Frengen, E
   Bindoff, L
   Tallaksen, CME
   Tzoulis, C
AF Wedding, Iselin Marie
   Koht, Jeanette
   Gia Tuong Tran
   Misceo, Doriana
   Selmer, Kaja Kristine
   Holmgren, Asbjorn
   Frengen, Eirik
   Bindoff, Laurence
   Tallaksen, Chantal M. E.
   Tzoulis, Charalampos
TI Spastic Paraplegia Type 7 Is Associated with Multiple Mitochondrial DNA
   Deletions
SO PLOS ONE
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; M-AAA PROTEASE; REAL-TIME PCR;
   OPTIC ATROPHY; SPINOCEREBELLAR ATAXIA; SPG7 MUTATIONS; GENE;
   INSTABILITY; DISEASE
AB Spastic paraplegia 7 is an autosomal recessive disorder caused by mutations in the gene encoding paraplegin, a protein located at the inner mitochondrial membrane and involved in the processing of other mitochondrial proteins. The mechanism whereby paraplegin mutations cause disease is unknown. We studied two female and two male adult patients from two Norwegian families with a combination of progressive external ophthalmoplegia and spastic paraplegia. Sequencing of SPG7 revealed a novel missense mutation, c.2102A>C, p. H 701P, which was homozygous in one family and compound heterozygous in trans with a known pathogenic mutation c.1454_1462del in the other. Muscle was examined from an additional, unrelated adult female patient with a similar phenotype caused by a homozygous c.1047insC mutation in SPG7. Immunohistochemical studies in skeletal muscle showed mosaic deficiency predominantly affecting respiratory complex I, but also complexes III and IV. Molecular studies in single, microdissected fibres showed multiple mitochondrial DNA deletions segregating at high levels (38-97%) in respiratory deficient fibres. Our findings demonstrate for the first time that paraplegin mutations cause accumulation of mitochondrial DNA damage and multiple respiratory chain deficiencies. While paraplegin is not known to be directly associated with the mitochondrial nucleoid, it is known to process other mitochondrial proteins and it is possible therefore that paraplegin mutations lead to mitochondrial DNA deletions by impairing proteins involved in the homeostasis of the mitochondrial genome. These studies increase our understanding of the molecular pathogenesis of SPG7 mutations and suggest that SPG7 testing should be included in the diagnostic workup of autosomal recessive, progressive external ophthalmoplegia, especially if spasticity is present.
C1 [Wedding, Iselin Marie; Tallaksen, Chantal M. E.] Oslo Univ Hosp, Dept Neurol, Oslo, Norway.
   [Wedding, Iselin Marie; Koht, Jeanette; Misceo, Doriana; Selmer, Kaja Kristine; Holmgren, Asbjorn; Frengen, Eirik; Tallaksen, Chantal M. E.] Univ Oslo, Fac Med, Oslo, Norway.
   [Misceo, Doriana; Selmer, Kaja Kristine; Holmgren, Asbjorn; Frengen, Eirik] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway.
   [Gia Tuong Tran; Bindoff, Laurence; Tzoulis, Charalampos] Univ Bergen, Dept Clin Med, Bergen, Norway.
   [Gia Tuong Tran; Bindoff, Laurence; Tzoulis, Charalampos] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Koht, Jeanette] Vestre Viken Hlth Trust, Drammen Hosp, Dept Neurol, Al, Norway.
C3 University of Oslo; University of Oslo; University of Oslo; University
   of Bergen; University of Bergen; Haukeland University Hospital
RP Tzoulis, C (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.
EM charalampos.tzoulis@helse-bergen.no
RI Selmer, Kaja/AAM-7284-2021; Bindoff, Nathaniel/C-8050-2011; Misceo,
   Doriana/AAR-9085-2020; Frengen, Eirik/AGK-2453-2022; Tzoulis,
   Charalampos/AGD-5114-2022
OI Holmgren, Asbjorn/0000-0003-1434-0957; Bindoff,
   Laurence/0000-0003-0988-276X; Koht, Jeanette/0000-0002-5499-0818;
   Frengen, Eirik/0000-0002-8387-2247; Selmer, Kaja
   Kristine/0000-0003-4871-112X; Tzoulis, Charalampos/0000-0003-0341-5191
FU South-Eastern Norway Regional Health Authority; Western Norway Health
   Trust; University of Oslo; University of Bergen
FX This work was supported by grants from the South-Eastern Norway Regional
   Health Authority, Western Norway Health Trust, University of Oslo and
   University of Bergen. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Arnoldi A, 2008, HUM MUTAT, V29, P522, DOI 10.1002/humu.20682
   Atorino L, 2003, J CELL BIOL, V163, P777, DOI 10.1083/jcb.200304112
   Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946
   Brugman F, 2008, NEUROLOGY, V71, P1500, DOI 10.1212/01.wnl.0000319700.11606.21
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   Casari G, 1993, SPASTIC PARAPLEGIA
   Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405
   De Michele G, 1998, AM J HUM GENET, V63, P135, DOI 10.1086/301930
   Dürr A, 2008, NEUROLOGY, V71, P236, DOI 10.1212/01.wnl.0000320131.36091.a5
   Elleuch N, 2006, NEUROLOGY, V66, P654, DOI 10.1212/01.wnl.0000201185.91110.15
   Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9
   Fink JK, 2002, ANN NEUROL, V51, P669, DOI 10.1002/ana.10258
   Fink JK, 2008, NEUROLOGY, V71, P1468, DOI 10.1212/01.wnl.0000334294.99658.2d
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   HARDING AE, 1983, LANCET, V1, P1151
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Karlberg T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006975
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KENWRICK S, 1986, HUM GENET, V73, P264, DOI 10.1007/BF00401241
   Klebe S, 2012, BRAIN, V135, P2980, DOI 10.1093/brain/aws240
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Lee V, 2002, BRIT J OPHTHALMOL, V86, P1282, DOI 10.1136/bjo.86.11.1282
   McDermott CJ, 2001, NEUROLOGY, V56, P467, DOI 10.1212/WNL.56.4.467
   Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509
   Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Pierson TM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002325
   Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8
   Schlipf NA, 2011, CLIN GENET, V80, P148, DOI 10.1111/j.1399-0004.2011.01715.x
   Schmitz-Hübsch T, 2006, MOVEMENT DISORD, V21, P699, DOI 10.1002/mds.20781
   Schüle R, 2006, NEUROLOGY, V67, P430, DOI 10.1212/01.wnl.0000228242.53336.90
   Schüle R, 2011, SEMIN NEUROL, V31, P484, DOI 10.1055/s-0031-1299787
   Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Tzoulis C, 2008, J NEUROL, V255, P1142, DOI 10.1007/s00415-008-0858-y
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Tzoulis C, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-55
   van Gassen KLI, 2012, BRAIN, V135, P2994, DOI 10.1093/brain/aws224
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Warnecke T, 2007, NEUROLOGY, V69, P368, DOI 10.1212/01.wnl.0000266667.91074.fe
   Wechsler D., 1997, Wechsler Adult Intelligence Scale - Fourth Edition (WAIS-IV)
   Wilkinson PA, 2004, BRAIN, V127, P973, DOI 10.1093/brain/awh125
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
NR 53
TC 40
Z9 44
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 22
PY 2014
VL 9
IS 1
AR e86340
DI 10.1371/journal.pone.0086340
PG 8
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 297VL
UT WOS:000330283100142
PM 24466038
OA Green Published, gold, Green Submitted
DA 2024-11-01
ER

PT B
AU Tonska, K
AF Tonska, Katarzyna
BE Ahmad, SI
TI Instability of Human Mitochondrial DNA, Nuclear Genes and Diseases
SO HANDBOOK OF MITOCHONDRIAL DYSFUNCTION
LA English
DT Article; Book Chapter
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; IMPAIR MTDNA REPLICATION;
   THYMIDINE KINASE; MPV17 ENCODES; OPTIC ATROPHY; MUTATIONS; DELETIONS;
   TWINKLE; ACCUMULATION; POLYMERASE
C1 [Tonska, Katarzyna] Univ Warsaw, Fac Biol, Inst Genet & Biotechnol, Warsaw, Poland.
C3 University of Warsaw
RP Tonska, K (corresponding author), Univ Warsaw, Fac Biol, Inst Genet & Biotechnol, Warsaw, Poland.
FU Polish National Science Center [2014/15/B/NZ5/00434]
FX I thank Prof. Ewa Bartnik for the correction of the manuscript and all
   the helpful comments. This work was supported by Polish National Science
   Center grant 2014/15/B/NZ5/00434.
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Antonenkov VD, 2015, J BIOL CHEM, V290, P13840, DOI 10.1074/jbc.M114.608083
   Barshad G, 2018, TRENDS GENET, V34, P682, DOI 10.1016/j.tig.2018.05.009
   Bartsakoulia M, 2018, HUM MOL GENET, V27, P1186, DOI 10.1093/hmg/ddy033
   Benbrik E, 1997, J NEUROL SCI, V149, P19, DOI 10.1016/S0022-510X(97)05376-8
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   Blakely EL, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011296
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bradshaw E, 2012, FEBS LETT, V586, P1245, DOI 10.1016/j.febslet.2012.03.046
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   El-Hattab AW, 2017, HUM MUTAT, V38, P1649, DOI 10.1002/humu.23341
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Elson JL, 2010, GENET MED, V12, P313, DOI 10.1097/GIM.0b013e3181da76e3
   Farr CL, 2004, J BIOL CHEM, V279, P17047, DOI 10.1074/jbc.M400283200
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   García-Gómez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025
   García-Sobrino T, 2017, NEUROMUSCULAR DISORD, V27, P667, DOI 10.1016/j.nmd.2017.01.008
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   Hillen HS, 2017, CELL, V171, P1082, DOI 10.1016/j.cell.2017.09.035
   Holt IJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012971
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Hoyle JC, 2015, APPL CLIN GENET, V8, P235, DOI 10.2147/TACG.S69969
   Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506
   Hyvärinen AK, 2011, MOL BIOL REP, V38, P1321, DOI 10.1007/s11033-010-0233-9
   Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907
   Kanfer G, 2016, BIOCHEM SOC T, V44, P510, DOI 10.1042/BST20150274
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Keen BA, 2014, NUCLEIC ACIDS RES, V42, P12102, DOI 10.1093/nar/gku879
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Krasich R, 2017, FRONT BIOSCI-LANDMRK, V22, P692, DOI 10.2741/4510
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Krishnan KJ, 2012, NEUROBIOL AGING, V33, P2210, DOI 10.1016/j.neurobiolaging.2011.08.009
   Kühl I, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600963
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Li JL, 2015, INVEST OPHTH VIS SCI, V56, P1181, DOI 10.1167/iovs.14-16072
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Maier D, 2001, MOL BIOL CELL, V12, P821, DOI 10.1091/mbc.12.4.821
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Melov S, 1999, NEUROBIOL AGING, V20, P565, DOI 10.1016/S0197-4580(99)00092-5
   Namba K, 2016, OTOL NEUROTOL, V37, P394, DOI 10.1097/MAO.0000000000000978
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Phillips NR, 2014, ALZHEIMERS DEMENT, V10, P393, DOI 10.1016/j.jalz.2013.04.508
   Piekutowska-Abramczuk D, 2019, MITOCHONDRION, V47, P179, DOI 10.1016/j.mito.2018.11.004
   Pohjoismäki JLO, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201800102
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   ROBBERSO.DL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Rosa ID, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005779
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Ryu SW, 2010, CELL MOL LIFE SCI, V67, P2839, DOI 10.1007/s00018-010-0365-z
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Sasaki T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10843-8
   Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spiegel R, 2016, J MED GENET, V53, P127, DOI 10.1136/jmedgenet-2015-103361
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Stewart JD, 2008, NEUROLOGY, V71, P1829, DOI 10.1212/01.wnl.0000335931.54095.0a
   Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Vielhaber S, 2013, ACTA NEUROPATHOL, V125, P245, DOI 10.1007/s00401-012-1036-y
   WALLACE DC, 1989, TRENDS GENET, V5, P9, DOI 10.1016/0168-9525(89)90005-X
   Wang LY, 2016, NUCLEOS NUCLEOT NUCL, V35, P578, DOI 10.1080/15257770.2015.1125001
   Wei W, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-016-0404-6
   Wiesner RJ, 2006, FREE RADICAL RES, V40, P1284, DOI 10.1080/10715760600913168
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Young MJ, 2015, HUM MOL GENET, V24, P5184, DOI 10.1093/hmg/ddv240
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
   Zhang LL, 2017, ADV EXP MED BIOL, V1038, P85, DOI 10.1007/978-981-10-6674-0_7
   Zhao FX, 2013, HUM GENET, V132, P913, DOI 10.1007/s00439-013-1303-6
NR 88
TC 0
Z9 0
U1 0
U2 0
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-1-138-33608-7
PY 2019
BP 39
EP 54
PG 16
WC Cell Biology; Genetics & Heredity; Pathology
WE Book Citation Index – Science (BKCI-S)
SC Cell Biology; Genetics & Heredity; Pathology
GA BQ1CL
UT WOS:000575159400005
DA 2024-11-01
ER

PT J
AU Giannoccaro, MP
   La Morgia, C
   Rizzo, G
   Carelli, V
AF Giannoccaro, Maria Pia
   La Morgia, Chiara
   Rizzo, Giovanni
   Carelli, Valerio
TI Mitochondrial DNA and Primary Mitochondrial Dysfunction in Parkinson's
   Disease
SO MOVEMENT DISORDERS
LA English
DT Review
DE Parkinson disease; parkinsonism; mitochondrial DNA; mtDNA; quality
   control; mitophagy
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; HEREDITARY OPTIC NEUROPATHY;
   RESPIRATORY-CHAIN ACTIVITY; MULTIPLE MTDNA DELETIONS; COMPLEX I
   DEFICIENCY; LOSS-OF-FUNCTION; ALPHA-SYNUCLEIN; POLYMERASE-GAMMA;
   SUBSTANTIA-NIGRA; SKELETAL-MUSCLE
AB In 1979, it was observed that parkinsonism could be induced by a toxin inhibiting mitochondrial respiratory complex I. This initiated the long- standing hypothesis that mitochondrial dysfunction may play a key role in the pathogenesis of Parkinson's disease (PD). This hypothesis evolved, with accumulating evidence pointing to complex I dysfunction, which could be caused by environmental or genetic factors. Attention was focused on the mitochondrial DNA, considering the occurrence of mutations, polymorphic haplogroupspecific variants, and defective mitochondrial DNA maintenance with the accumulation of multiple deletions and a reduction of copy number. Genetically determined diseases of mitochondrial DNA maintenance frequently manifest with parkinsonism, but the age-related accumulation of somatic mitochondrial DNA errors also represents a major driving mechanism for PD. Recently, the discovery of the genetic cause of rare inherited forms of PD highlighted an extremely complex homeostatic control over mitochondria, involving their dynamic fission/fusion cycle, the balancing of mitobiogenesis and mitophagy, and consequently the quality control surveillance that corrects faulty mitochondrial DNA maintenance. Many genes came into play, including the PINK1/parkin axis, but also OPA1, as pieces of the same puzzle, together with mitochondrial DNA damage, complex I deficiency and increased oxidative stress. The search for answers will drive future research to reach the understanding necessary to provide therapeutic options directed not only at limiting the clinical evolution of symptoms but also finally addressing the pathogenic mechanisms of neurodegeneration in PD. (C) 2017 International Parkinson and Movement Disorder Society
C1 [Giannoccaro, Maria Pia; La Morgia, Chiara; Rizzo, Giovanni; Carelli, Valerio] Bellaria Hosp, IRCCS Inst Neurol Sci Bologna, Bologna, Italy.
   [Giannoccaro, Maria Pia; La Morgia, Chiara; Rizzo, Giovanni; Carelli, Valerio] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy.
   [Giannoccaro, Maria Pia] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England.
C3 IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); AUSL di
   Bologna; University of Bologna; University of Oxford
RP Carelli, V (corresponding author), Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Osped Bellaria, Via Altura 3, I-40139 Bologna, Italy.
EM valerio.carelli@unibo.it
RI Rizzo, Giovanni/AAB-9888-2020; La Morgia, Chiara/H-6765-2012;
   Giannoccaro, Maria Pia/I-9073-2018
OI Giannoccaro, Maria Pia/0000-0003-2208-376X; Rizzo,
   Giovanni/0000-0002-9718-2044
FU Italian Ministry of Health; Italian Ministries of Health and of
   Research; Emilia Romagna Region; Telethon-Italy; e-RARE
FX C.L.M. receives financial support from the Italian Ministry of Health.
   V.C. is funded by the Italian Ministries of Health and of Research, the
   Emilia Romagna Region, Telethon-Italy, and e-RARE.
CR Ahlskog JE, 2009, PARKINSONISM RELAT D, V15, P721, DOI 10.1016/j.parkreldis.2009.09.010
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Amboni M, 2009, MOVEMENT DISORD, V24, P303, DOI 10.1002/mds.22342
   Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104
   [Anonymous], 2012, ANN SAUDI MED
   Enríquez JA, 2016, ANNU REV PHYSIOL, V78, P533, DOI 10.1146/annurev-physiol-021115-105031
   Anvret A, 2010, NEUROSCI LETT, V485, P117, DOI 10.1016/j.neulet.2010.08.082
   Balafkan N, 2012, MITOCHONDRION, V12, P640, DOI 10.1016/j.mito.2012.08.004
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7
   Belenguer P, 2013, BBA-MOL CELL RES, V1833, P176, DOI 10.1016/j.bbamcr.2012.08.004
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bentley SR, 2014, MITOCHONDRION, V15, P65, DOI 10.1016/j.mito.2014.01.004
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   BINDOFF LA, 1989, LANCET, V2, P49, DOI 10.1016/S0140-6736(89)90291-2
   Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019
   Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209
   Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P
   BURKHARDT C, 1993, ANN NEUROL, V33, P512, DOI 10.1002/ana.410330516
   BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546
   Burté F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228
   BUTTERFIELD PG, 1993, NEUROLOGY, V43, P1150, DOI 10.1212/WNL.43.6.1150
   CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258
   Carelli V, 2002, BBA-MOL BASIS DIS, V1588, P7, DOI 10.1016/S0925-4439(02)00097-2
   Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Casali C, 2001, NEUROLOGY, V56, P802, DOI 10.1212/WNL.56.6.802
   Chalmers RM, 1996, J NEUROL SCI, V143, P41, DOI 10.1016/S0022-510X(96)00032-9
   CHECCARELLI N, 1994, J NEUROL SCI, V123, P74, DOI 10.1016/0022-510X(94)90206-2
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061
   Choi WS, 2008, P NATL ACAD SCI USA, V105, P15136, DOI 10.1073/pnas.0807581105
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Coxhead J, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.036
   Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662
   Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200
   Dato S, 2004, EUR J HUM GENET, V12, P1080, DOI 10.1038/sj.ejhg.5201278
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   DAVIS GC, 1979, PSYCHIAT RES, V1, P249, DOI 10.1016/0165-1781(79)90006-4
   De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532
   de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9
   De Rosa P, 2015, CLIN CHIM ACTA, V449, P68, DOI 10.1016/j.cca.2015.04.042
   Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105
   Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200
   Devine MJ, 2011, MOVEMENT DISORD, V26, P2160, DOI 10.1002/mds.23948
   Di Maio R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf3634
   DIDONATO S, 1993, NEUROLOGY, V43, P2262, DOI 10.1212/WNL.43.11.2262
   DiMauro S, 2000, BRAIN PATHOL, V10, P431
   DIMAURO S, 1993, NEUROLOGY, V43, P2170, DOI 10.1212/WNL.43.11.2170
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Dölle C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13548
   Eerola J, 2010, NEUROSCI LETT, V477, P1, DOI 10.1016/j.neulet.2010.04.021
   Erro R, 2015, MOVEMENT DISORD, V30, P780, DOI 10.1002/mds.26209
   Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2
   Esteves AR, 2009, ANTIOXID REDOX SIGN, V11, P439, DOI [10.1089/ars.2008.2247, 10.1089/ARS.2008.2247]
   Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007
   Fato R, 2008, NEUROCHEM RES, V33, P2487, DOI 10.1007/s11064-008-9747-0
   Firestone JA, 2005, ARCH NEUROL-CHICAGO, V62, P91, DOI 10.1001/archneur.62.1.91
   Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108
   Galassi G, 2008, NEUROMUSCULAR DISORD, V18, P465, DOI 10.1016/j.nmd.2008.03.013
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   Gómez-Durán A, 2012, BBA-MOL BASIS DIS, V1822, P1216, DOI 10.1016/j.bbadis.2012.04.014
   Gómez-Durán A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246
   Goo HG, 2013, BBA-MOL CELL RES, V1833, P1866, DOI 10.1016/j.bbamcr.2013.03.016
   Gorell JM, 1998, NEUROLOGY, V50, P1346, DOI 10.1212/WNL.50.5.1346
   Gorman GS, 2015, JAMA NEUROL, V72, P106, DOI 10.1001/jamaneurol.2014.1753
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Grenier K, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00100
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Grünewald A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012962
   Gu GY, 2002, J NEUROPATH EXP NEUR, V61, P634, DOI 10.1093/jnen/61.7.634
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   Guarás A, 2016, CELL REP, V15, P197, DOI 10.1016/j.celrep.2016.03.009
   Guardia-Laguarta C, 2014, J NEUROSCI, V34, P249, DOI 10.1523/JNEUROSCI.2507-13.2014
   Gui YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050086
   Gulsuner HU, 2014, P NATL ACAD SCI USA, V111, P18285, DOI 10.1073/pnas.1419581111
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110
   Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022
   HATTORI N, 1991, ANN NEUROL, V30, P563, DOI 10.1002/ana.410300409
   Heeman B, 2011, J CELL SCI, V124, P1115, DOI 10.1242/jcs.078303
   HEIKKILA RE, 1984, SCIENCE, V224, P1451, DOI 10.1126/science.6610213
   Heo JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032629
   HERTZMAN C, 1990, AM J IND MED, V17, P349, DOI 10.1002/ajim.4700170307
   Höglinger GU, 2003, J NEUROCHEM, V84, P491, DOI 10.1046/j.1471-4159.2003.01533.x
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Houlden H, 2012, ACTA NEUROPATHOL, V124, P325, DOI 10.1007/s00401-012-1013-5
   Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Hudson G, 2009, MOVEMENT DISORD, V24, P1092, DOI 10.1002/mds.22310
   HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892
   Iaccarino C, 2007, HUM MOL GENET, V16, P1319, DOI 10.1093/hmg/ddm080
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   IKEBE S, 1995, MOL BRAIN RES, V28, P281, DOI 10.1016/0169-328X(94)00209-W
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173
   Jenner P, 2001, TRENDS NEUROSCI, V24, P245, DOI 10.1016/S0166-2236(00)01789-6
   Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223
   Kapsa RMI, 1996, J NEUROL SCI, V144, P204, DOI 10.1016/S0022-510X(96)00247-X
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Khusnutdinova E, 2008, ANN NY ACAD SCI, V1147, P1, DOI 10.1196/annals.1427.001
   Kieper N, 2010, EXP CELL RES, V316, P1213, DOI 10.1016/j.yexcr.2010.01.005
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   KOLATA G, 1983, SCIENCE, V220, P705, DOI 10.1126/science.6403987
   Kosel S, 1998, NEUROGENETICS, V1, P197, DOI 10.1007/s100480050029
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krüger R, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2009.11.021
   Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   LESTIENNE P, 1990, J NEUROCHEM, V55, P1810, DOI 10.1111/j.1471-4159.1990.tb04973.x
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774
   Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333
   Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006
   Martin MA, 1996, NEUROLOGY, V46, P1343, DOI 10.1212/WNL.46.5.1343
   Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004
   Mehta SH, 2016, PARKINSONISM RELAT D, V30, P83, DOI 10.1016/j.parkreldis.2016.06.013
   Melberg A, 2005, ACTA NEUROPATHOL, V110, P315, DOI 10.1007/s00401-005-1047-z
   Melov S, 1999, NEUROBIOL AGING, V20, P565, DOI 10.1016/S0197-4580(99)00092-5
   MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161
   Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492
   Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506
   Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79
   Müller-Rischart AK, 2013, MOL CELL, V49, P908, DOI 10.1016/j.molcel.2013.01.036
   Müftüoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695
   Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538
   Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Nguyen TN, 2016, TRENDS CELL BIOL, V26, P733, DOI 10.1016/j.tcb.2016.05.008
   NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8
   Niu JW, 2012, J NEUROCHEM, V122, P650, DOI 10.1111/j.1471-4159.2012.07809.x
   OZAWA T, 1991, BIOCHEM BIOPH RES CO, V177, P518, DOI 10.1016/0006-291X(91)92014-B
   OZAWA T, 1991, BIOCHEM BIOPH RES CO, V176, P938, DOI 10.1016/S0006-291X(05)80276-1
   OZAWA T, 1990, BIOCHEM BIOPH RES CO, V172, P483, DOI 10.1016/0006-291X(90)90698-M
   Paisán-Ruíz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023
   Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   Perier C, 2013, BRAIN, V136, P2369, DOI 10.1093/brain/awt196
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007
   Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644
   Pogson JH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004815
   Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045
   Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105
   Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424
   Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5
   Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417
   Pyle A, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.033
   Ramonet D, 2013, CELL DEATH DIFFER, V20, P77, DOI 10.1038/cdd.2012.95
   RAMSAY RR, 1986, J BIOL CHEM, V261, P7585
   Rana M, 2000, ANN NEUROL, V48, P774, DOI 10.1002/1531-8249(200011)48:5<774::AID-ANA11>3.3.CO;2-9
   Raule N, 2014, AGING CELL, V13, P401, DOI 10.1111/acel.12186
   Reeve A, 2013, J NEUROSCI, V33, P10790, DOI 10.1523/JNEUROSCI.3525-12.2013
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Richardson JR, 2009, ARCH NEUROL-CHICAGO, V66, P870, DOI 10.1001/archneurol.2009.89
   Rizzo G, 2016, NEUROLOGY, V86, P566, DOI 10.1212/WNL.0000000000002350
   Rodriguez M, 2015, AGING CELL, V14, P293, DOI 10.1111/acel.12312
   Rose G, 2001, EUR J HUM GENET, V9, P701, DOI 10.1038/sj.ejhg.5200703
   Rostovtseva TK, 2015, J BIOL CHEM, V290, P18467, DOI 10.1074/jbc.M115.641746
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Sanders LH, 2014, NEUROBIOL DIS, V62, P381, DOI 10.1016/j.nbd.2013.10.013
   Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043
   SCHAPIRA AHV, 1993, ADV NEUROL, V60, P288
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   SCHAPIRA AHV, 1994, MOVEMENT DISORD, V9, P125, DOI 10.1002/mds.870090202
   SCHAPIRA AHV, 1990, MOVEMENT DISORD, V5, P294, DOI 10.1002/mds.870050406
   Schlossmacher MG, 2002, AM J PATHOL, V160, P1655, DOI 10.1016/S0002-9440(10)61113-3
   Schon EA, 1998, NEUROLOGY, V51, P326, DOI 10.1212/WNL.51.1.326
   Sherer TB, 2002, J NEUROSCI, V22, P7006
   Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060
   Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627
   Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z
   Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010
   SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Siciliano G, 2001, J NEUROL NEUROSUR PS, V71, P685, DOI 10.1136/jnnp.71.5.685
   Siddiqui A, 2012, FREE RADICAL BIO MED, V53, P993, DOI 10.1016/j.freeradbiomed.2012.05.024
   Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787
   Simon DK, 2000, NEUROLOGY, V54, P703, DOI 10.1212/WNL.54.3.703
   Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278
   Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102
   SOONG NW, 1992, NAT GENET, V2, P318
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108
   Stevens DA, 2015, P NATL ACAD SCI USA, V112, P11696, DOI 10.1073/pnas.1500624112
   Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215
   Subramaniam S.R., 2013, MITOCHONDRIAL DYSFUN, V107, P17, DOI DOI 10.1016/J.PNEUR0BI0.2013.04.004
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Swerdlow RH, 1998, ANN NEUROL, V44, P873, DOI 10.1002/ana.410440605
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Swerdlow RH, 2012, ANTIOXID REDOX SIGN, V16, P950, DOI 10.1089/ars.2011.3948
   Taanman JW, 2005, NEUROSCI LETT, V376, P56, DOI 10.1016/j.neulet.2004.11.023
   Thyagarajan D, 2000, ANN NEUROL, V48, P730, DOI 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Trimmer PA, 2004, J NEUROCHEM, V88, P800, DOI 10.1046/j.1471-4159.2003.02168.x
   Trimmer PA, 2009, EXP NEUROL, V218, P320, DOI 10.1016/j.expneurol.2009.03.016
   Tufi R, 2014, NAT CELL BIOL, V16, P157, DOI 10.1038/ncb2901
   Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Tzoulis C, 2016, MITOCHONDRION, V28, P33, DOI 10.1016/j.mito.2016.03.003
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   UHL GR, 1985, LANCET, V1, P956
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vande Walle L, 2008, CELL DEATH DIFFER, V15, P453, DOI 10.1038/sj.cdd.4402291
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   VERGANI L, 1995, BIOCHEM BIOPH RES CO, V210, P880, DOI 10.1006/bbrc.1995.1740
   Vilain S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002456
   Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110
   Vives-Bauza C, 2002, BIOCHEM BIOPH RES CO, V290, P1593, DOI 10.1006/bbrc.2002.6388
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   Voigt A, 2016, J NEUROCHEM, V139, P232, DOI 10.1111/jnc.13655
   Wakabayashi K, 2013, MOL NEUROBIOL, V47, P495, DOI 10.1007/s12035-012-8280-y
   WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X
   Wallace DC, 2003, COLD SPRING HARB SYM, V68, P479
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang XL, 2012, J NEUROCHEM, V121, P830, DOI 10.1111/j.1471-4159.2012.07734.x
   Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436
   Winkler-Stuck K, 2005, J NEURAL TRANSM, V112, P499, DOI 10.1007/s00702-004-0195-y
   Winklhofer KF, 2014, TRENDS CELL BIOL, V24, P332, DOI 10.1016/j.tcb.2014.01.001
   Wirth C, 2016, BBA-BIOENERGETICS, V1857, P902, DOI 10.1016/j.bbabio.2016.02.013
   Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105
   Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103
   Ylönen S, 2013, J NEUROL, V260, P3144, DOI 10.1007/s00415-013-7132-7
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   ZEVIANI M, 1992, J INHERIT METAB DIS, V15, P456, DOI 10.1007/BF01799604
   Zeviani M, 2008, BRAIN, V131, P314, DOI 10.1093/brain/awm339
   Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211
   Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059
   Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095
   Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005
NR 263
TC 105
Z9 115
U1 1
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-3185
EI 1531-8257
J9 MOVEMENT DISORD
JI Mov. Disord.
PD MAR
PY 2017
VL 32
IS 3
SI SI
BP 346
EP 363
DI 10.1002/mds.26966
PG 18
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA EQ4QS
UT WOS:000398063600006
PM 28251677
DA 2024-11-01
ER

PT J
AU Taivassalo, T
   Ayyad, K
   Haller, RG
AF Taivassalo, Tanja
   Ayyad, Karen
   Haller, Ronald G.
TI Increased capillaries in mitochondrial myopathy: implications for the
   regulation of oxygen delivery
SO BRAIN
LA English
DT Article
DE mitochondrial DNA defects; skeletal muscle; angiogenesis; regulation of
   oxygen delivery; oxidative metabolism
ID QUADRICEPS FEMORIS MUSCLE; HUMAN SKELETAL-MUSCLE; EXERCISE INTOLERANCE;
   METABOLIC MYOPATHIES; OXIDATIVE DEFECT; ANGIOGENESIS; MUTATIONS;
   CAPACITY; SYSTEM; TRANSCRIPTION
AB Human skeletal muscle respiratory chain defects restrict the ability of working muscle to extract oxygen from blood, and result in a hyperkinetic circulation during exercise in which oxygen delivery is excessive relative to oxygen uptake and oxygen levels within contracting muscle are abnormally high. To investigate the role of the muscle microcirculation in this anomalous circulatory response and possible implications for the regulation of muscle angiogenesis, we assessed muscle oxidative capacity during cycle exercise and determined capillary levels and distribution and vascular endothelial growth factor expression in quadriceps muscle biopsies in patients with mitochondrial myopathy attributable to heteroplasmic mitochondrial DNA mutations. We found that in patients with mitochondrial myopathy, muscle capillary levels were twice that of sedentary healthy subjects (3.0 +/- 0.9% compared with 1.4 +/- 0.3%, P < 0.001) despite the fact that oxygen utilization during peak cycle exercise was half that of control subjects (11.1 +/- 4.0 ml/kg/min compared with 20.7 +/- 7.9 ml/kg/min, P < 0.01); that capillary area was greatest in patients with the most severe muscle oxidative defects and was more than two times higher around muscle fibre segments with defective (i.e. cytochrome oxidase negative/succinic dehydrogenase-positive or 'ragged-red' fibres) compared with more preserved respiratory chain function; and that vascular endothelial growth factor expression paralleled capillary distribution. The increased muscle capillary levels in patients correlated directly (r(2) = 0.68, P < 0.05) with the severity of the mismatch between systemic oxygen delivery (cardiac output) and oxygen utilization during cycle exercise. Our results suggest that capillary growth is increased as a result of impaired muscle oxidative phosphorylation in mitochondrial myopathy, thus promoting increased blood flow to respiration-incompetent muscle fibres and a mismatch between oxygen delivery and utilization during exercise. Furthermore, the finding of high capillary levels despite elevated tissue oxygen levels during exercise in respiration-deficient muscle fibres implies that mitochondrial metabolism activates angiogenesis in skeletal muscle by a mechanism that is independent of hypoxia.
C1 [Taivassalo, Tanja; Ayyad, Karen; Haller, Ronald G.] Texas Hlth Presbyterian Hosp, Inst Exercise & Environm Med, Neuromuscular Ctr, Dallas, TX 75231 USA.
   [Taivassalo, Tanja] McGill Univ, Dept Kinesiol, Montreal, PQ H2W 1S4, Canada.
   [Haller, Ronald G.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA.
   [Ayyad, Karen; Haller, Ronald G.] N Texas VA Med Ctr, Div Neurol, Dallas, TX 75216 USA.
C3 McGill University; University of Texas System; University of Texas
   Southwestern Medical Center Dallas; US Department of Veterans Affairs;
   Veterans Health Administration (VHA); VA North Texas Health Care System
RP Haller, RG (corresponding author), Texas Hlth Presbyterian Hosp, Inst Exercise & Environm Med, Neuromuscular Ctr, 7232 Greenville Ave, Dallas, TX 75231 USA.
EM Ronald.Haller@UTSouthwestern.edu
FU National Institutes of Health [National Institute of Arthritis,
   Musculoskeletal and Skin Diseases (NIAMS)] [RO1-AR050597]; Muscular
   Dystrophy Association USA; Natural Sciences and Engineering Council of
   Canada (NSERC); Canadian Institutes of Health Research
FX The National Institutes of Health [National Institute of Arthritis,
   Musculoskeletal and Skin Diseases (NIAMS); RO1-AR050597 to R.G.H.]; the
   Muscular Dystrophy Association USA (to R.G.H. and T.T.); the Natural
   Sciences and Engineering Council of Canada (NSERC; to T.T.); the
   Canadian Institutes of Health Research (to T.T.).
CR ADAIR TH, 1990, AM J PHYSIOL, V259, pR393, DOI 10.1152/ajpregu.1990.259.3.R393
   Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE672, DOI 10.1152/ajpendo.00043.2007
   ANDERSEN P, 1977, J PHYSIOL-LONDON, V270, P677, DOI 10.1113/jphysiol.1977.sp011975
   Andreu AL, 1999, ANN NEUROL, V45, P820, DOI 10.1002/1531-8249(199906)45:6<820::AID-ANA22>3.0.CO;2-W
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613
   BANK W, 1994, ANN NEUROL, V36, P830, DOI 10.1002/ana.410360606
   Breen EC, 1996, J APPL PHYSIOL, V81, P355, DOI 10.1152/jappl.1996.81.1.355
   Brown GK, 1996, J INHERIT METAB DIS, V19, P553, DOI 10.1007/BF01799116
   CARPENTER S, 1978, NEUROLOGY, V28, P8, DOI 10.1212/WNL.28.1.8
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Grassi B, 2007, MUSCLE NERVE, V35, P510, DOI 10.1002/mus.20708
   GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x
   Gustafsson T, 1999, AM J PHYSIOL-HEART C, V276, pH679, DOI 10.1152/ajpheart.1999.276.2.H679
   HALLER RG, 1989, J CLIN INVEST, V84, P155, DOI 10.1172/JCI114135
   HALLER RG, 1991, J CLIN INVEST, V88, P1197, DOI 10.1172/JCI115422
   Hedges LV, 1985, PROCEDURE IDENTIFY O
   Hepple RT, 2000, MED SCI SPORT EXER, V32, P117
   Hepple RT, 1997, J APPL PHYSIOL, V82, P1305, DOI 10.1152/jappl.1997.82.4.1305
   INGJER F, 1978, ACTA PHYSIOL SCAND, V104, P238, DOI 10.1111/j.1748-1716.1978.tb06273.x
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   KLAUSEN K, 1981, ACTA PHYSIOL SCAND, V113, P9, DOI 10.1111/j.1748-1716.1981.tb06854.x
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Mathieu-Costello O, 2002, EXERC SPORT SCI REV, V30, P80, DOI 10.1097/00003677-200204000-00007
   Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677
   Richardson RS, 2006, J PHYSIOL-LONDON, V571, P415, DOI 10.1113/jphysiol.2005.102327
   Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6
   STADHOUDERS AM, 1987, J INHERIT METAB DIS, V10, P62, DOI 10.1007/BF01812848
   Swalwell H, 2008, EUR J HUM GENET, V16, P1265, DOI 10.1038/ejhg.2008.65
   Taivassalo T, 2002, ANN NEUROL, V51, P38, DOI 10.1002/ana.10027
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Tang K, 2004, PHYSIOL GENOMICS, V18, P63, DOI 10.1152/physiolgenomics.00023.2004
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
NR 34
TC 25
Z9 26
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
J9 BRAIN
JI Brain
PD JAN
PY 2012
VL 135
BP 53
EP 61
DI 10.1093/brain/awr293
PN 1
PG 9
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 888ZX
UT WOS:000300044400014
PM 22232594
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Bayona-Bafaluy, MP
   Blits, B
   Battersby, BJ
   Shoubridge, EA
   Moraes, CT
AF Bayona-Bafaluy, MP
   Blits, B
   Battersby, BJ
   Shoubridge, EA
   Moraes, CT
TI Rapid directional shift of mitochondrial DNA heteroplasmy in animal
   tissues by a mitochondrially targeted restriction endonuclease
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE gene therapy; mitochondria
ID CENTRAL-NERVOUS-SYSTEM; MTDNA; VECTORS; TRANSDUCTION; EXPRESSION;
   THERAPY; DISEASE; MUSCLE; MICE; REPLICATION
AB Frequently, mtDNA with pathogenic mutations coexist with wildtype genomes (mtDNA heteroplasmy). Mitochondrial dysfunction and disease ensue only when the proportion of mutated mtDNAs is high, thus a reduction in this proportion should provide an effective therapy for these disorders. We developed a system to decrease specific mtDNA haplotypes by expressing a mitochondrially targeted restriction endonuclease, ApaLI, in cells of heteroplasmic mice. These mice have two mtDNA haplotypes, of which only one contains an ApaLI site. After transfection of cultured hepatocytes with mitochondrially targeted ApaLI, we found a rapid, directional, and complete shift in mtDNA heteroplasmy (2-6 h). We tested the efficacy of this approach in vivo, by using recombinant viral vectors expressing the mitochondrially targeted ApaLI. We observed a significant shift in mtDNA heteroplasmy in muscle and brain transduced with recombinant viruses. This strategy could prevent disease onset or reverse clinical symptoms in patients harboring certain heteroplasmic pathogenic mutations in mtDNA.
C1 Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
   Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA.
   Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA.
   McGill Univ, Montreal Neurol Inst, Dept Human Genet, Montreal, PQ H3A B34, Canada.
C3 University of Miami; University of Miami; University of Miami; McGill
   University
RP Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
EM cmoraes@med.miami.edu
RI Moraes, Carlos/AAT-3818-2021
FU NEI NIH HHS [P30 EY014801, R01 EY010804, EY014801, R01 EY010804-08,
   EY10804, R01 EY010804-07] Funding Source: Medline; NINDS NIH HHS
   [NS41777, R56 NS041777, R01 NS041777] Funding Source: Medline
CR Amalfitano A, 2004, METHODS, V33, P173, DOI 10.1016/j.ymeth.2003.11.006
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Battersby BJ, 2001, HUM MOL GENET, V10, P2469, DOI 10.1093/hmg/10.22.2469
   Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200
   Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024
   Cao HB, 2004, VIRAL IMMUNOL, V17, P327, DOI 10.1089/vim.2004.17.327
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   Davidson BL, 2000, P NATL ACAD SCI USA, V97, P3428, DOI 10.1073/pnas.050581197
   De Giorgi F, 1999, METHOD CELL BIOL, V58, P75
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Jazayeri M, 2003, J BIOL CHEM, V278, P9823, DOI 10.1074/jbc.M211730200
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Monahan PE, 2000, MOL MED TODAY, V6, P433, DOI 10.1016/S1357-4310(00)01810-4
   Muratovska A, 2001, NUCLEIC ACIDS RES, V29, P1852, DOI 10.1093/nar/29.9.1852
   Passini MA, 2003, J VIROL, V77, P7034, DOI 10.1128/JVI.77.12.7034-7040.2003
   Rabinowitz JE, 2002, J VIROL, V76, P791, DOI 10.1128/JVI.76.2.791-801.2002
   Santos MAS, 2004, TRENDS GENET, V20, P95, DOI 10.1016/j.tig.2003.12.009
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 2004, BBA-BIOENERGETICS, V1659, P221, DOI 10.1016/j.bbabio.2004.09.007
   Taylor RW, 2000, NEUROL SCI, V21, pS909, DOI 10.1007/s100720070002
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380
   Wang YL, 2000, ADV PHARMACOL, V47, P343
NR 32
TC 127
Z9 152
U1 0
U2 12
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD OCT 4
PY 2005
VL 102
IS 40
BP 14392
EP 14397
DI 10.1073/pnas.0502896102
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 971OD
UT WOS:000232392900049
PM 16179392
OA Green Published
DA 2024-11-01
ER

PT J
AU Montiel-Sosa, JF
   Herrero, MD
   Munoz, MD
   Aguirre-Campa, LE
   Pérez-Ramírez, G
   García-Ramírez, R
   Ruiz-Pesini, E
   Montoya, J
AF Francisco Montiel-Sosa, Jose
   Dolores Herrero, Maria
   de Lourdes Munoz, Maria
   Enrique Aguirre-Campa, Luis
   Perez-Ramirez, Gerardo
   Garcia-Ramirez, Ruben
   Ruiz-Pesini, Eduardo
   Montoya, Julio
TI Phylogenetic analysis of mitochondrial DNA in a patient with
   Kearns-Sayre syndrome containing a novel 7629-bp deletion
SO MITOCHONDRIAL DNA
LA English
DT Article
DE Disease; native American; haplogroup
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; LARGE-SCALE DELETIONS; DIRECT
   REPEATS; RESPIRATORY-CHAIN; COMMON DELETION; MTDNA; SEQUENCES; CELLS;
   GENERATION; INTEGRITY
AB Mitochondrial DNA mutations have been associated with different illnesses in humans, such as Kearns-Sayre syndrome (KSS), which is related to deletions of different sizes and positions among patients. Here, we report a Mexican patient with typical features of KSS containing a novel deletion of 7629 bp in size with 85% heteroplasmy, which has not been previously reported. Sequence analysis revealed 3-bp perfect short direct repeats flanking the deletion region, in addition to 7-bp imperfect direct repeats within 9-10 bp. Furthermore, sequencing, alignment and phylogenetic analysis of the hypervariable region revealed that the patient may belong to a founder Native American haplogroup C4c.
C1 [Francisco Montiel-Sosa, Jose; Dolores Herrero, Maria; Ruiz-Pesini, Eduardo; Montoya, Julio] Univ Zaragoza, CIBER Enfermedades Raras CIBERER, Dept Biochem & Mol & Cellular Biol, Zaragoza, Spain.
   [Francisco Montiel-Sosa, Jose] UNAM, Fac Estudios Super Cuautitlan, Dept Biol Sci, Cuautitlan 54740, Mexico.
   [de Lourdes Munoz, Maria; Perez-Ramirez, Gerardo] Ctr Invest & Estudios Avanzados IPN, San Pedro Zacatenco 07360, Gustavo A Mader, Mexico.
   [Enrique Aguirre-Campa, Luis; Garcia-Ramirez, Ruben] IMSS, Ctr Med Nacl Siglo XXI, Dept Neurol & Paediat, Mexico City, DF, Mexico.
C3 University of Zaragoza; CIBER - Centro de Investigacion Biomedica en
   Red; CIBERER; Universidad Nacional Autonoma de Mexico; CINVESTAV -
   Centro de Investigacion y de Estudios Avanzados del Instituto
   Politecnico Nacional; Instituto Mexicano del Seguro Social
RP Munoz, MD (corresponding author), Ctr Invest & Estudios Avanzados IPN, Av Inst Politecn Nacl 2508, San Pedro Zacatenco 07360, Gustavo A Mader, Mexico.
EM lmunoz@cinvestav.mx
RI MuNoz, Maria/KFB-3378-2024
OI Munoz, Maria de Lourdes/0000-0002-4185-2205
FU Direccion General de Asuntos del Personal Academico from UNAM; Instituto
   de Ciencia y Tecnologia del Distrito Federal [PICSA10-189]
FX Part of this research was performed during a sabbatical year of Dr
   Montiel-Sosa at the Department of Biochemistry and Molecular and
   Cellular Biology at the Universidad de Zaragoza Espana through a
   scholarship from the Direccion General de Asuntos del Personal Academico
   from UNAM. This work was also supported by grant PICSA10-189 (Instituto
   de Ciencia y Tecnologia del Distrito Federal, 01/11/2010-2011). The
   authors report no conflicts of interest. The authors alone are
   responsible for the content and writing of the paper.
CR ALBERTINI AM, 1982, CELL, V29, P319, DOI 10.1016/0092-8674(82)90148-9
   Ascaso FJ, 2010, CLIN EXP OPHTHALMOL, V38, P812, DOI 10.1111/j.1442-9071.2010.02335.x
   Ashizawa T, 2001, ARCH NEUROL-CHICAGO, V58, P1053, DOI 10.1001/archneur.58.7.1053
   BARRIENTOS A, 1995, MED CLIN-BARCELONA, V105, P180
   BERENBAUM F, 1990, NEUROLOGY, V40, P193, DOI 10.1212/WNL.40.1.193
   BLOK RB, 1995, HUM GENET, V95, P75
   Bosbach S, 2003, BRAIN, V126, P1231, DOI 10.1093/brain/awg101
   Carling PJ, 2011, MITOCHONDRION, V11, P686, DOI 10.1016/j.mito.2011.05.004
   Carod-Artal FJ, 2006, NEUROLOGIA, V21, P357
   Carod-Artal FJ, 2006, MED CLIN-BARCELONA, V126, P457, DOI 10.1016/S0025-7753(06)71972-8
   Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729
   Chabrol B, 1997, NEUROLOGY, V49, P308, DOI 10.1212/WNL.49.1.308-b
   Chen T, 2011, J HUM GENET, V56, P689, DOI 10.1038/jhg.2011.97
   Chiaratti MR, 2011, MITOCHONDRION, V11, P820, DOI 10.1016/j.mito.2010.11.004
   Chu BC, 1999, NEURORADIOLOGY, V41, P759, DOI 10.1007/s002340050838
   Coulter-Mackie MB, 1998, CLIN BIOCHEM, V31, P627, DOI 10.1016/S0009-9120(98)00074-5
   Cwerman-Thibault H, 2011, J INHERIT METAB DIS, V34, P327, DOI 10.1007/s10545-010-9131-5
   De Paepe B, 2009, J CLIN PATHOL, V62, P172, DOI 10.1136/jcp.2008.061267
   DeCoo IFM, 1997, J NEUROL SCI, V149, P37, DOI 10.1016/S0022-510X(97)05366-5
   DEGOUL F, 1991, NUCLEIC ACIDS RES, V19, P493, DOI 10.1093/nar/19.3.493
   Delgado-Sánchez R, 2007, REV NEUROLOGIA, V44, P18, DOI 10.33588/rn.4401.2006032
   Derenko M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032179
   Derenko M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015214
   DiMauro S, 2003, MITOCHONDRIAL DNA DE
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773
   Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569
   Gómez-Durán A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246
   Gutiérrez A, 2009, REV NEUROLOGIA, V49, P248, DOI 10.33588/rn.4905.2009282
   Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9
   HARDING AE, 1992, J INHERIT METAB DIS, V15, P480, DOI 10.1007/BF01799606
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   JOHNS DR, 1989, P NATL ACAD SCI USA, V86, P8059, DOI 10.1073/pnas.86.20.8059
   Jonckheere AI, 2011, MITOCHONDRION, V11, P954, DOI 10.1016/j.mito.2011.08.012
   Kasiviswanathan R, 2011, J BIOL CHEM, V286, P31490, DOI 10.1074/jbc.M111.252460
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   KOSINSKI C, 1995, STROKE, V26, P1950, DOI 10.1161/01.STR.26.10.1950
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   Longo N, 2003, NEUROL CLIN, V21, P817, DOI 10.1016/S0733-8619(03)00015-X
   Malhi RS, 2010, AM J PHYS ANTHROPOL, V141, P494, DOI 10.1002/ajpa.21238
   Manfredi G, 1997, ANN NEUROL, V42, P180, DOI 10.1002/ana.410420208
   Marin-Garcia J, 2000, J CHILD NEUROL, V15, P555, DOI 10.1177/088307380001500812
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   Mkaouar-Rebai E, 2010, MITOCHONDRION, V10, P449, DOI 10.1016/j.mito.2010.04.003
   Mohri I, 1998, J NEUROL SCI, V158, P106, DOI 10.1016/S0022-510X(98)00082-3
   Montiel-Sosa F, 2006, GENE, V368, P21, DOI 10.1016/j.gene.2005.09.015
   NARANJO IC, 1988, STROKE, V19, P533, DOI 10.1161/01.STR.19.4.533
   Provenzale JM, 1996, NEUROLOGY, V46, P826, DOI 10.1212/WNL.46.3.826
   Puoti G, 2003, J MED GENET, V40, P858, DOI 10.1136/jmg.40.11.858
   REMES AM, 1993, GENOMICS, V16, P256, DOI 10.1006/geno.1993.1170
   Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000
   Roels F, 2009, BMC CLIN PATHOL, V9, DOI 10.1186/1472-6890-9-4
   Sadikovic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015687
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Santos Janine H, 2002, Methods Mol Biol, V197, P159, DOI 10.1385/1-59259-284-8:159
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Solano A, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.7.e86
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tanji K, 1999, ANN NEUROL, V45, P377, DOI 10.1002/1531-8249(199903)45:3<377::AID-ANA14>3.0.CO;2-M
   Tanji K, 1999, J NEUROL SCI, V166, P64, DOI 10.1016/S0022-510X(99)00114-8
   Tengan CH, 1996, BIOCHEM MOL MED, V58, P130, DOI 10.1006/bmme.1996.0040
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   van der Westhuizen FH, 2010, J INHERIT METAB DIS, V33, pS55, DOI 10.1007/s10545-009-9020-y
   Vázquez-Acevedo M, 2002, NEUROL SCI, V23, P247, DOI 10.1007/s100720200050
   Wilichowski E, 1997, PEDIATR RES, V41, P193, DOI 10.1203/00006450-199702000-00007
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 72
TC 6
Z9 7
U1 0
U2 15
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1940-1736
EI 1940-1744
J9 MITOCHONDR DNA
JI Mitochondrial DNA
PD AUG
PY 2013
VL 24
IS 4
BP 420
EP 431
DI 10.3109/19401736.2012.760550
PG 12
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 181UT
UT WOS:000321695300036
PM 23391298
DA 2024-11-01
ER

PT J
AU Roefs, AM
   Waters, PJ
   Moore, GRW
   Dolman, PJ
AF Roefs, Anne M.
   Waters, Paula J.
   Moore, G. R. Wayne
   Dolman, Peter J.
TI Orbicularis oculi muscle biopsies for mitochondrial DNA analysis in
   suspected mitochondrial myopathy
SO BRITISH JOURNAL OF OPHTHALMOLOGY
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA
AB Aims We wished to demonstrate the feasibility of performing diagnostic mitochondrial DNA (mtDNA) analysis on biopsies of the orbicularis oculi muscle in patients with a chronic progressive external ophthalmoplegia (CPEO) phenotype and suspicion of an underlying mitochondrial disorder.
   Method Case series of three patients who underwent ptosis surgery and had simultaneous biopsy of the orbicularis oculi muscle because of a suspicion of a mitochondrial disorder. Orbicularis muscle samples were divided into two pieces at the time of biopsy. The first was snap-frozen in liquid nitrogen, DNA was extracted and mtDNA deletion analysis was performed by two complementary methods (long PCR and Southern blot analysis). The second piece of muscle was assessed using routine histopathology, electron microscopy and immuno-histochemical analysis.
   Results Three patients with clinical features of CPEO, without any positive family history, underwent orbicularis muscle biopsies at time of eyelid ptosis surgery. All biopsies were adequate to conduct histopathological and immuno-histochemical analysis, which showed evidence of abnormal muscle structure and function. mtDNA was successfully extracted from all biopsies, and long PCR and Southern blot analysis confirmed diagnostic large single mtDNA deletions in all three cases.
   Conclusions Orbicularis oculi muscle biopsies are useful in patients with CPEO to perform mtDNA analysis, thus avoiding a separate biopsy of skeletal muscle elsewhere.
C1 [Roefs, Anne M.; Dolman, Peter J.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 3N9, Canada.
   [Roefs, Anne M.] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands.
   [Waters, Paula J.; Moore, G. R. Wayne] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 3N9, Canada.
   [Waters, Paula J.] Univ Sherbrooke, Gen Med Serv, Quebec City, PQ, Canada.
   [Moore, G. R. Wayne] Vancouver Gen Hosp, Dept Pathol & Lab Med, Vancouver, BC, Canada.
C3 University of British Columbia; Erasmus University Rotterdam; Erasmus
   MC; University of British Columbia; University of Sherbrooke; University
   of British Columbia
RP Dolman, PJ (corresponding author), Univ British Columbia, Dept Ophthalmol, Eye Care Ctr, 2550 Willow St, Vancouver, BC V5Z 3N9, Canada.
EM peterdolman@hotmail.com
OI Waters, Paula/0000-0003-4898-1859
CR Almousa R, 2009, OPHTHAL PLAST RECONS, V25, P366, DOI 10.1097/IOP.0b013e3181b2fd06
   Di Mauro S, 1993, GENE REV
   ESHAGHIAN J, 1980, ARCH OPHTHALMOL-CHIC, V98, P1070
   FASSATI A, 1994, J NEUROL SCI, V123, P140, DOI 10.1016/0022-510X(94)90216-X
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Schoser BGH, 2006, STRABISMUS, V14, P107, DOI 10.1080/09273970600701218
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
NR 8
TC 6
Z9 7
U1 0
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0007-1161
J9 BRIT J OPHTHALMOL
JI Br. J. Ophthalmol.
PD OCT
PY 2012
VL 96
IS 10
BP 1296
EP 1299
DI 10.1136/bjophthalmol-2012-301853
PG 4
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA 012DK
UT WOS:000309215500005
PM 22893396
DA 2024-11-01
ER

PT J
AU Lu, JL
   Dai, YC
   Ji, KQ
   Peng, GX
   Li, H
   Yan, CZ
   Shen, B
   Zhou, XL
AF Lu, Jia-Li
   Dai, Yichen
   Ji, Kunqian
   Peng, Gui-Xin
   Li, Hong
   Yan, Chuanzhu
   Shen, Bin
   Zhou, Xiao-Long
TI Taurine hypomodification underlies mitochondrial
   tRNA<SUP>Trp</SUP>-related genetic diseases
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article; Early Access
ID TRANSFER-RNA MODIFICATION; WOBBLE MODIFICATION DEFICIENCY; GTP-BINDING
   PROTEIN; HYPERTROPHIC CARDIOMYOPATHY; MODIFICATION DEFECT;
   LACTIC-ACIDOSIS; 1ST POSITION; MUTATION; MNME; MYOPATHY
AB Escherichia coli MnmE and MnmG form a complex (EcMnmEG), generating transfer RNA (tRNA) 5-carboxymethylaminomethyluridine (cmnm(5)U) modification. Both cmnm(5)U and equivalent 5-taurinomethyluridine (tau m(5)U, catalyzed by homologous GTPBP3 and MTO1) are found at U34 in several human mitochondrial tRNAs (hmtRNAs). Certain mitochondrial DNA (mtDNA) mutations, including m.3243A > G in tRNA(Leu)(UUR) and m.8344A > G in tRNA(Lys), cause genetic diseases, partially due to tau m(5)U hypomodification. However, whether other mtDNA variants in different tRNAs cause a defect in tau m(5)U biogenesis remains unknown. Here, we purified naturally assembled EcMnmEG from E. coli. Notably, EcMnmEG was able to incorporate both cmnm(5)U and tau m(5)U into hmtRNA(Trp) (encoded by MT-TW), providing a valuable basis for directly monitoring the effects of mtDNA mutations on U34 modification. In vitro, several clinical hmtRNA(Trp) pathogenic mutations caused U34 hypomodification. A patient harboring an m.5541C > T mutation exhibited hmtRNA(Trp) tau m(5)U hypomodification. Moreover, using mtDNA base editing, we constructed two cell lines carrying m.5532G > A or m.5545C > T mutations, both of which exhibited hmtRNA(Trp) tau m(5)U hypomodification. Taurine supplementation improved mitochondrial translation in patient cells. Our findings describe the third hmtRNA species with mutation-related tau m(5)U-hypomodification and provide new insights into the pathogenesis and intervention strategy for hmtRNA(Trp)-related genetic diseases.
C1 [Lu, Jia-Li; Peng, Gui-Xin; Zhou, Xiao-Long] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci,Key Lab RNA Innova, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.
   [Dai, Yichen; Shen, Bin] Nanjing Med Univ, Womens Hosp, Nanjing Women & Childrens Healthcare Hosp, Ctr Global Hlth,Gusu Sch,State Key Lab Reprod Med, 101 Long Mian Ave, Nanjing 211166, Peoples R China.
   [Ji, Kunqian; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Res Inst Neuromuscular & Neurodegenerat Dis, 107 West Wenhua Rd, Jinan 250012, Peoples R China.
   [Ji, Kunqian; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Peoples R China.
   [Li, Hong] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, Core Facil Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Qilu Hosp Qingdao, Mitochondrial Med Lab, 758 Hefei Rd, Qingdao 266035, Peoples R China.
   [Zhou, Xiao-Long] Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Sch Life Sci, Key Lab Syst Hlth Sci Zhejiang Prov, 1 Xiangshan Sub-Lane, Hangzhou 310024, Peoples R China.
C3 Chinese Academy of Sciences; University of Chinese Academy of Sciences,
   CAS; Center for Excellence in Molecular Cell Science, CAS; Nanjing
   Medical University; Shandong University; Shandong University; Chinese
   Academy of Sciences; Center for Excellence in Molecular Cell Science,
   CAS; Shandong University; Chinese Academy of Sciences; University of
   Chinese Academy of Sciences, CAS
RP Zhou, XL (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci,Key Lab RNA Innova, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.; Shen, B (corresponding author), Nanjing Med Univ, Womens Hosp, Nanjing Women & Childrens Healthcare Hosp, Ctr Global Hlth,Gusu Sch,State Key Lab Reprod Med, 101 Long Mian Ave, Nanjing 211166, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Res Inst Neuromuscular & Neurodegenerat Dis, 107 West Wenhua Rd, Jinan 250012, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp Qingdao, Mitochondrial Med Lab, 758 Hefei Rd, Qingdao 266035, Peoples R China.; Zhou, XL (corresponding author), Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Sch Life Sci, Key Lab Syst Hlth Sci Zhejiang Prov, 1 Xiangshan Sub-Lane, Hangzhou 310024, Peoples R China.
EM czyan@sdu.edu.cn; binshen@njmu.edu.cn; xlzhou@sibcb.ac.cn
OI Ji, Kunqian/0000-0001-9330-0405; zhou, xiao long/0000-0002-3701-5965
FU National Key Research and Development Program of China [2021YFA1300800];
   Strategic Priority Research Program of the Chinese Academy of Sciences
   [XDB0570000]; Natural Science Foundation of China [32271300, 32371546];
   Committee of Science and Technology in Shanghai [22ZR1481300,
   22JC1400503]; CAS Project for Young Scientists in Basic Research
   [YSBR-075]
FX National Key Research and Development Program of China (2021YFA1300800);
   Strategic Priority Research Program of the Chinese Academy of Sciences
   (XDB0570000); Natural Science Foundation of China (32271300 and
   32371546); Committee of Science and Technology in Shanghai (22ZR1481300
   and 22JC1400503); CAS Project for Young Scientists in Basic Research
   (YSBR-075). Funding for open access charge: Research grant.
CR Agris PF, 2008, EMBO REP, V9, P629, DOI 10.1038/embor.2008.104
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Asano K, 2018, NUCLEIC ACIDS RES, V46, P1565, DOI 10.1093/nar/gky068
   Baric I, 2013, EUR J HUM GENET, V21, P871, DOI 10.1038/ejhg.2012.272
   BASAVAPPA R, 1991, EMBO J, V10, P3105, DOI 10.1002/j.1460-2075.1991.tb07864.x
   Becker L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114918
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Bommisetti P, 2023, J AM CHEM SOC, V145, P26947, DOI 10.1021/jacs.3c10182
   Bommisetti P, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2022.102548
   Cappannini A, 2023, NUCLEIC ACIDS RES, DOI 10.1093/nar/gkad1083
   Chen DN, 2019, NUCLEIC ACIDS RES, V47, P5341, DOI 10.1093/nar/gkz218
   de Crécy-Lagard V, 2021, TRENDS MICROBIOL, V29, P41, DOI 10.1016/j.tim.2020.06.010
   Dey R, 2000, NEUROMUSCULAR DISORD, V10, P488, DOI 10.1016/S0960-8966(00)00125-5
   Herrero-Martín MD, 2010, J NEUROL NEUROSUR PS, V81, P471, DOI 10.1136/jnnp.2009.173831
   Duan HC, 2024, NAT COMMUN, V15, DOI 10.1038/s41467-024-45166-6
   Fakruddin M, 2018, CELL REP, V22, P482, DOI 10.1016/j.celrep.2017.12.051
   Fislage M, 2014, NUCLEIC ACIDS RES, V42, P5978, DOI 10.1093/nar/gku213
   Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011
   Giegé R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017
   Giege R, 2023, NUCLEIC ACIDS RES, V51, P1528, DOI 10.1093/nar/gkad007
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guo JY, 2021, CELL DISCOV, V7, DOI 10.1038/s41421-021-00307-9
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   Hatakeyama H, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0227-x
   Huang MH, 2023, SCI BULL, V68, P2094, DOI 10.1016/j.scib.2023.08.002
   Ji KQ, 2022, J MED GENET, V59, P79, DOI 10.1136/jmedgenet-2020-107323
   Kazuhito T, 2020, J BIOCHEM, V168, P435, DOI 10.1093/jb/mvaa098
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   Kopajtich R, 2014, AM J HUM GENET, V95, P708, DOI 10.1016/j.ajhg.2014.10.017
   Kurata S, 2008, J BIOL CHEM, V283, P18801, DOI 10.1074/jbc.M800233200
   Lambert IH, 2015, ACTA PHYSIOL, V213, P191, DOI 10.1111/apha.12365
   Li XM, 2002, MOL CELL BIOL, V22, P7701, DOI 10.1128/MCB.22.21.7701-7711.2002
   Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   Meyer S, 2008, J MOL BIOL, V380, P532, DOI 10.1016/j.jmb.2008.04.072
   Meyer S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000212
   Meyer S, 2009, J MOL BIOL, V392, P910, DOI 10.1016/j.jmb.2009.07.004
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Moukadiri I, 2009, NUCLEIC ACIDS RES, V37, P7177, DOI 10.1093/nar/gkp762
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   Ohsawa Y, 2019, J NEUROL NEUROSUR PS, V90, P529, DOI 10.1136/jnnp-2018-317964
   Osawa T, 2009, STRUCTURE, V17, P713, DOI 10.1016/j.str.2009.03.013
   Peng GX, 2021, NUCLEIC ACIDS RES, V49, P2816, DOI 10.1093/nar/gkab104
   Pütz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407
   Richter U, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06471-z
   Rikimaru M, 2012, INTERNAL MED, V51, P3351, DOI 10.2169/internalmedicine.51.7529
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Scrima A, 2005, EMBO J, V24, P23, DOI 10.1038/sj.emboj.7600507
   Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171
   Shi R, 2009, J BACTERIOL, V191, P7614, DOI 10.1128/JB.00650-09
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Silvestri G, 2000, NEUROLOGY, V54, P1693, DOI 10.1212/WNL.54.8.1693
   Singh P, 2023, SCIENCE, V380, DOI 10.1126/science.abn9257
   Sissler M, 2004, RNA, V10, P841, DOI 10.1261/rna.5267604
   Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656
   Suzuki T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18068-6
   Suzuki T, 2021, NAT REV MOL CELL BIO, V22, P375, DOI 10.1038/s41580-021-00342-0
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Suzuki T, 2011, WIRES RNA, V2, P376, DOI 10.1002/wrna.65
   Tulinius M, 2003, NEUROPEDIATRICS, V34, P87
   Wang M, 2013, BIOCHEM J, V453, P455, DOI 10.1042/BJ20130294
   Wang Y, 2020, SCI CHINA LIFE SCI, V63, P1227, DOI 10.1007/s11427-019-1619-x
   Wang Y, 2018, NUCLEIC ACIDS RES, V46, P4662, DOI 10.1093/nar/gky243
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
   Wolff P, 2020, RNA, V26, P1957, DOI 10.1261/rna.077537.120
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   Yim L, 2006, NUCLEIC ACIDS RES, V34, P5892, DOI 10.1093/nar/gkl752
   YOKOYAMA S, 1985, P NATL ACAD SCI USA, V82, P4905, DOI 10.1073/pnas.82.15.4905
   Zhang QH, 2021, NUCLEIC ACIDS RES, V49, P4689, DOI 10.1093/nar/gkab228
   Zheng WQ, 2023, P NATL ACAD SCI USA, V120, DOI 10.1073/pnas.2309714120
NR 75
TC 0
Z9 0
U1 3
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD 2024 OCT 9
PY 2024
DI 10.1093/nar/gkae854
EA OCT 2024
PG 17
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA I6N4W
UT WOS:001331406100001
PM 39380483
OA gold
DA 2024-11-01
ER

PT J
AU Grady, JP
   Pickett, SJ
   Ng, YS
   Alston, CL
   Blakely, EL
   Hardy, SA
   Feeney, CL
   Bright, AA
   Schaefer, AM
   Gorman, GS
   McNally, RJQ
   Taylor, RW
   Turnbull, DM
   McFarland, R
AF Grady, John P.
   Pickett, Sarah J.
   Ng, Yi Shiau
   Alston, Charlotte L.
   Blakely, Emma L.
   Hardy, Steven A.
   Feeney, Catherine L.
   Bright, Alexandra A.
   Schaefer, Andrew M.
   Gorman, Grainne S.
   McNally, Richard J. Q.
   Taylor, Robert W.
   Turnbull, Doug M.
   McFarland, Robert
TI mtDNA heteroplasmy level and copy number indicate disease burden in
   m.3243A&gt;G mitochondrial disease
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE m.3243A > G; MELAS; mitochondrial disease; mtDNA copy number; mtDNA
   heteroplasmy
ID 3243A-GREATER-THAN-G MUTATION; DNA MUTATIONS; MELAS; PHENOTYPE; URINE;
   BLOOD; ENCEPHALOMYOPATHY; PROGRESSION; LEUKOCYTES; FAMILIES
AB Mitochondrial disease associated with the pathogenic m.3243A>G variant is a common, clinically heterogeneous, neurogenetic disorder. Using multiple linear regression and linear mixed modelling, we evaluated which commonly assayed tissue (blood N=231, urine N=235, skeletal muscle N=77) represents the m.3243A>G mutation load and mitochondrial DNA (mtDNA) copy number most strongly associated with disease burden and progression. m.3243A>G levels are correlated in blood, muscle and urine (R-2=0.61-0.73). Blood heteroplasmy declines by similar to 2.3%/year; we have extended previously published methodology to adjust for age. In urine, males have higher mtDNA copy number and similar to 20% higher m.3243A>G mutation load; we present formulas to adjust for this. Blood is the most highly correlated mutation measure for disease burden and progression in m.3243A>G-harbouring individuals; increasing age and heteroplasmy contribute (R-2=0.27, P<0.001). In muscle, heteroplasmy, age and mtDNA copy number explain a higher proportion of variability in disease burden (R-2=0.40, P<0.001), although activity level and disease severity are likely to affect copy number. Whilst our data indicate that age-corrected blood m.3243A>G heteroplasmy is the most convenient and reliable measure for routine clinical assessment, additional factors such as mtDNA copy number may also influence disease severity.
C1 [Grady, John P.; Pickett, Sarah J.; Ng, Yi Shiau; Alston, Charlotte L.; Blakely, Emma L.; Hardy, Steven A.; Feeney, Catherine L.; Bright, Alexandra A.; Schaefer, Andrew M.; Gorman, Grainne S.; Taylor, Robert W.; Turnbull, Doug M.; McFarland, Robert] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.
   [Alston, Charlotte L.; Blakely, Emma L.; Hardy, Steven A.; Taylor, Robert W.] Newcastle Upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Mitochondrial Diagnost Lab, Newcastle Upon Tyne, Tyne & Wear, England.
   [McNally, Richard J. Q.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England.
   [Grady, John P.] Garvan Inst, Kinghorn Ctr Clin Genom, Sydney, NSW, Australia.
C3 Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation
   Trust; Newcastle University - UK; Garvan Institute of Medical Research
RP Pickett, SJ; McFarland, R (corresponding author), Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.
EM sarah.pickett@ncl.ac.uk; robert.mcfarland@ncl.ac.uk
RI Alston, Charlotte/ABG-9602-2020; Ng, Yi/AFF-1445-2022
OI Alston, Charlotte/0000-0003-2095-5464; Pickett,
   Sarah/0000-0002-1242-2927; Turnbull, Doug/0000-0002-8878-9901; Ng, Yi
   Shiau/0000-0002-7591-2034; Gorman, Grainne/0000-0002-7585-3409;
   McFarland, Robert/0000-0002-8833-2688; Grady, John/0000-0001-9667-3872;
   McNally, Richard/0000-0001-6685-6467; Schaefer,
   Andrew/0000-0001-9891-7332; Feeney, Catherine/0000-0003-3189-3991
FU Wellcome Trust Fellowship [204709/Z/16/Z]; Wellcome Centre for
   Mitochondrial Research [203105/Z/16/Z]; Medical Research Council (MRC)
   Centre for Translational Research in Neuromuscular Disease;
   Mitochondrial Disease Patient Cohort (UK) [G0800674]; Lily Foundation;
   UK NIHR Biomedical Research Centre for Ageing and Age-related Disease
   Award; UK NHS Highly Specialised Service for Rare Mitochondrial
   Disorders of Adults and Children; National Institute for Health Research
   (NIHR) doctoral fellowship [NIHR-HCS-D12-03-04]; MRC [G0800674] Funding
   Source: UKRI; Wellcome Trust [204709/Z/16/Z] Funding Source: Wellcome
   Trust
FX We thank the patients who participated in this study and the
   Mitochondrial Disease Patient Cohort administrative team. We are
   grateful to Dr. Mark Roberts (Salford Royal NHS Foundation Trust), Dr.
   Maria E. Farrugia and Dr. Richard K Petty (Queen Elizabeth University
   Hospital, Glasgow), Dr. David Dick, (Norfolk and Norwich University
   Hospital), Dr. Mellisa Maguire (The Leeds Teaching Hospitals NHS Trust),
   Dr. Colin Mumford (Western General Hospital, Edinburgh) and Dr. Cheryl
   Longman (NHS Greater Glasgow and Clyde) for patient referral. We would
   also like to thank the anonymous reviewers whose insightful comments
   have improved the manuscript, to Dr. Helen A. Tuppen for technical
   assistance with the mtDNA copy number assay and to Mr. Doug Jerry for
   cohort data entry. Ethical approval was granted by the Newcastle and
   North Tyneside Research Ethics Committee (13/NE/0326). This work was
   supported by a Wellcome Trust Fellowship (204709/Z/16/Z) to SJP, the
   Wellcome Centre for Mitochondrial Research (203105/Z/16/Z), the Medical
   Research Council (MRC) Centre for Translational Research in
   Neuromuscular Disease, the Mitochondrial Disease Patient Cohort (UK)
   (G0800674), the Lily Foundation, the UK NIHR Biomedical Research Centre
   for Ageing and Age-related Disease Award to the Newcastle upon Tyne
   Foundation Hospitals NHS Trust and the UK NHS Highly Specialised Service
   for Rare Mitochondrial Disorders of Adults and Children. CLA was
   supported by a National Institute for Health Research (NIHR) doctoral
   fellowship (NIHR-HCS-D12-03-04). YSN holds an NIHR clinical lectureship.
   The views expressed in the submitted article are the authors' own and
   not an official position of the institution or funder.
CR [Anonymous], 2016, COMPUTER SOFTWARE
   Apabhai S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022294
   Benda C, 2013, ADV BIOCHEM ENG BIOT, V129, P19, DOI 10.1007/10_2012_157
   Bentlage HACM, 1996, HUM MOL GENET, V5, P197, DOI 10.1093/hmg/5.2.197
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Brown C.E., 1998, Applied multivariate statistics in geohydrology and related sciences, DOI [10.1007/978-3-642-80328-413, DOI 10.1007/978-3-642-80328-413]
   Cao X, 2012, MOL MED REP, V6, P426, DOI 10.3892/mmr.2012.913
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   de Laat P, 2016, BBA CLIN, V6, P19, DOI 10.1016/j.bbacli.2016.04.007
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fayssoil A, 2017, EUR J NEUROL, V24, P255, DOI 10.1111/ene.13176
   Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114462
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110
   HOLTZMAN WH, 1950, AM J PSYCHOL, V63, P615, DOI 10.2307/1418879
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kodaira M, 2015, FEBS OPEN BIO, V5, P219, DOI 10.1016/j.fob.2015.03.008
   Liu CS, 2006, ACTA NEUROL SCAND, V113, P334, DOI 10.1111/j.1600-0404.2006.00586.x
   Liu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067146
   Maeda K, 2016, JAMA NEUROL, V73, P990, DOI 10.1001/jamaneurol.2016.0886
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236
   Picard M, 2016, JAMA NEUROL, V73, P923, DOI 10.1001/jamaneurol.2016.1676
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   R Development Core Team, 2016, R: A language and environment for statistical computing
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Sue CM, 1998, J NEUROL SCI, V161, P36, DOI 10.1016/S0022-510X(98)00179-8
   Weiduschat N, 2014, NEUROLOGY, V82, P798, DOI 10.1212/WNL.0000000000000169
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
NR 39
TC 176
Z9 186
U1 3
U2 12
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD JUN
PY 2018
VL 10
IS 6
AR e8262
DI 10.15252/emmm.201708262
PG 13
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA GI5LW
UT WOS:000434413000001
PM 29735722
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Takeda, Y
   Suzuki, H
   Hosono, K
   Hikoya, A
   Komori, M
   Inagaki, R
   Haseoka, T
   Arai, S
   Takagi, Y
   Hotta, Y
   Sato, M
AF Takeda, Yu
   Suzuki, Hiroko
   Hosono, Katsuhiro
   Hikoya, Akiko
   Komori, Miwa
   Inagaki, Risako
   Haseoka, Takashi
   Arai, Shinji
   Takagi, Yuri
   Hotta, Yoshihiro
   Sato, Miho
TI Exophthalmos associated with chronic progressive external
   ophthalmoplegia
SO JAPANESE JOURNAL OF OPHTHALMOLOGY
LA English
DT Article
DE Exophthalmos; Chronic progressive external ophthalmoplegia; Strabismus;
   Ptosis
ID EXTRAOCULAR-MUSCLES; VALUES
AB Purpose Chronic progressive external ophthalmoplegia (CPEO) is a mitochondrial disease characterized by slowly progressive ptosis and limitations in ocular motility. Although exophthalmos is not considered to be a common feature of CPEO, this study focused on the incidence of exophthalmos in patients with CPEO. Study design Retrospective observational case series Methods We reviewed the clinical charts of patients who received a diagnosis of CPEO sometime during the period between January 2010 and December 2018. CPEO was diagnosed on the basis of detection of a deletion of mitochondrial DNA (mtDNA) from saliva, buccal mucosa, or extraocular muscle specimens obtained during strabismus surgery. Horizontal MRI/CT images or Hertel ophthalmometry was used in determining exophthalmos. Results Seven patients (4 males) were identified. The mean age at diagnosis was 32.6 years (range 13-53 years). mtDNA deletion mutations were detected in the buccal mucous membrane DNA in 5 patients and in the saliva and extraocular muscle DNA in 2 patients. MRI/CT was recorded in 6 patients, four of whom showed exophthalmos (cases 1-4), and case 5 was determined as exophthalmos on the basis of a Hertel ophthalmometer reading. Exophthalmos was bilateral in 4 of the patients (cases 1, 2, 4, and 5) and unilateral in 1 patient (case 3). Exophthalmos was the chief concern of 2 of the patients; however, it was not clinically significant in the other patients. Conclusions Although exophthalmos may not be recognized by either the patient or the clinician, it may be one of the common features of CPEO. A large multiethnic study should be performed.
C1 [Takeda, Yu; Suzuki, Hiroko; Hosono, Katsuhiro; Hikoya, Akiko; Komori, Miwa; Inagaki, Risako; Haseoka, Takashi; Arai, Shinji; Takagi, Yuri; Hotta, Yoshihiro; Sato, Miho] Hamamatsu Univ, Dept Ophthalmol, Sch Med, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.
C3 Hamamatsu University School of Medicine
RP Sato, M (corresponding author), Hamamatsu Univ, Dept Ophthalmol, Sch Med, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.
EM mihosato@hama-med.ac.jp
FU Japan Society for the Promotion of Science [JP17K11479, JP16K11284,
   JP20K09825]
FX This work was supported by Japan Society for the Promotion of Science
   Grants-in-Aid for Scientific Research (grant numbers JP17K11479 to A.H.,
   JP16K11284 to K.H., and JP20K09825 to Y.H.). We would like to thank
   Editage for English editing and proofreading.
CR Brodsky M.C., 2016, PEDIAT NEUROOPHTHALM
   Carlow TJ, 1998, AM J NEURORADIOL, V19, P95
   Chehade LK, 2017, CLIN EXP OPHTHALMOL, V45, P929, DOI 10.1111/ceo.12987
   Cohen J M, 1997, J Am Optom Assoc, V68, P663
   Daut PM, 2000, AM J OPHTHALMOL, V130, P519, DOI 10.1016/S0002-9394(00)00558-4
   GROVE AS, 1975, NEW ENGL J MED, V292, P1005, DOI 10.1056/NEJM197505082921905
   Hwang JM, 2009, OPHTHALMOLOGY, V116, P813, DOI 10.1016/j.ophtha.2008.12.006
   Japan Thyroid Association the Japan Endocrine Society, 2020, TREATM GUID THYR ASS
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Kashkouli MB, 2008, OPTOMETRY VISION SCI, V85, P1012, DOI 10.1097/OPX.0b013e3181890dc7
   Kim IT, 2001, OPHTHALMOLOGICA, V215, P156, DOI 10.1159/000050850
   Lambert S LJ., 2017, Taylor Hoyt's Pediatric Ophthalmology and Strabismus, V5th editio
   Lee Andrew G, 2002, Curr Neurol Neurosci Rep, V2, P413, DOI 10.1007/s11910-002-0067-5
   Maeda K, 2012, INTERNAL MED, V51, P989, DOI 10.2169/internalmedicine.51.7119
   Miller N., 2004, Walsh and Hoyt's clinical neuro-ophthalmology
   Nakayama T., 1992, JPN J CLIN OPHTHAL, V46, P1031
   Ortube MC, 2006, J AAPOS, V10, P414, DOI 10.1016/j.jaapos.2006.04.012
   Pitceathly RDS, 2016, EUR RADIOL, V26, P130, DOI 10.1007/s00330-015-3801-5
   Schmidt P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211817
   Schoser BGH, 2006, STRABISMUS, V14, P107, DOI 10.1080/09273970600701218
   Tauber J, 2019, J AAPOS, V23, P295, DOI 10.1016/j.jaapos.2019.05.005
   Torii K., 2012, JPN J CLIN OPHTHAL, V66, P1497
   Yu-Wai-Man C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075048
NR 23
TC 0
Z9 0
U1 1
U2 2
PU SPRINGER JAPAN KK
PI TOKYO
PA SHIROYAMA TRUST TOWER 5F, 4-3-1 TORANOMON, MINATO-KU, TOKYO, 105-6005,
   JAPAN
SN 0021-5155
EI 1613-2246
J9 JPN J OPHTHALMOL
JI Jpn. J. Ophthalmol.
PD MAY
PY 2022
VL 66
IS 3
BP 314
EP 319
DI 10.1007/s10384-022-00920-5
EA APR 2022
PG 6
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA 0V8UO
UT WOS:000784822200003
PM 35438395
DA 2024-11-01
ER

PT J
AU Cameron, JM
   Levandovskiy, V
   MacKay, N
   Ackerley, C
   Chitayat, D
   Raiman, J
   Halliday, WH
   Schulze, A
   Robinson, BH
AF Cameron, Jessie M.
   Levandovskiy, Valeriy
   MacKay, Nevena
   Ackerley, Cameron
   Chitayat, David
   Raiman, Julian
   Halliday, W. H.
   Schulze, Andreas
   Robinson, Brian H.
TI Complex V TMEM70 deficiency results in mitochondrial nucleoid
   disorganization
SO MITOCHONDRION
LA English
DT Article
DE ATP synthase; Mitochondria; TMEM70; Nucleoids
ID SKIN FIBROBLAST-CULTURES; ATP-SYNTHASE DEFICIENCY; INNER MEMBRANE;
   SACCHAROMYCES-CEREVISIAE; DNA NUCLEOIDS; MUTATION; GENE; SUBUNIT-6;
   MORPHOLOGY; CRISTAE
AB Mutations in the TMEM70 gene are responsible for a familial form of complex V deficiency presenting with 3-methylglutaconic aciduria, lactic acidosis, cardiomyopathy and mitochondria! myopathy. Here we present a case of TMEM70 deficiency due to compound heterozygous mutations, who displayed abnormal mitochondria with whorled cristae in muscle. Immunogold electron microscopy and tomography shows for the first time that nucleoid clusters of mtDNA are disrupted in the abnormal mitochondria, with both nucleoids and mitochondrial respiratory chain complexes confined to the outer rings of the whorls. This could explain the differential effects on the expression and assembly of complex V in different tissues. (C) 2010 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Cameron, Jessie M.; Levandovskiy, Valeriy; MacKay, Nevena; Robinson, Brian H.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada.
   [Ackerley, Cameron; Halliday, W. H.] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON M5G 1X8, Canada.
   [Chitayat, David; Raiman, Julian; Schulze, Andreas] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada.
   [Robinson, Brian H.] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A8, Canada.
   [Robinson, Brian H.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada.
C3 University of Toronto; Hospital for Sick Children (SickKids); University
   of Toronto; Hospital for Sick Children (SickKids); University of
   Toronto; Hospital for Sick Children (SickKids); University of Toronto;
   University of Toronto
RP Robinson, BH (corresponding author), Hosp Sick Children, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
EM bhr@sickkids.ca
RI Robinson, B/LBH-2242-2024; Schulze, Andreas/I-5706-2019
FU MitoMarch for Kirkland
FX We thank "MitoMarch for Kirkland" for funding.
CR Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   BREEN GAM, 1986, J BIOL CHEM, V261, P1680
   Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   García JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075
   Gilkerson RW, 2003, FEBS LETT, V546, P355, DOI 10.1016/S0014-5793(03)00633-1
   HOLME E, 1992, PEDIATR RES, V32, P731, DOI 10.1203/00006450-199212000-00022
   Houstek J, 1999, HUM MOL GENET, V8, P1967
   HOUSTEK J, 1995, BBA-MOL BASIS DIS, V1271, P349, DOI 10.1016/0925-4439(95)00063-A
   John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.E04-08-0697
   JOHN UP, 1986, FEBS LETT, V207, P79, DOI 10.1016/0014-5793(86)80016-3
   Lefebvre-Legendre L, 2005, J BIOL CHEM, V280, P18386, DOI 10.1074/jbc.M410789200
   Manfred G, 1999, J BIOL CHEM, V274, P9386, DOI 10.1074/jbc.274.14.9386
   Margineantu DH, 2002, MITOCHONDRION, V1, P327, DOI 10.1016/S1567-7249(01)00033-2
   Mayr JA, 2004, PEDIATR RES, V55, P988, DOI 10.1203/01.pdr.0000127016.67809.6b
   Mun JY, 2010, J CELL PHYSIOL, V224, P748, DOI 10.1002/jcp.22177
   Nijtmans LGJ, 2001, J BIOL CHEM, V276, P6755, DOI 10.1074/jbc.M008114200
   OZAWA T, 1973, J BIOENERG, V4, P507, DOI 10.1007/BF01515942
   Pitkanen S, 1996, BIOCHEM MOL MED, V59, P134, DOI 10.1006/bmme.1996.0078
   Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200
   Robinson B H, 1996, Methods Enzymol, V264, P454, DOI 10.1016/S0076-6879(96)64041-5
   ROBINSON BH, 1990, PEDIATR RES, V28, P549, DOI 10.1203/00006450-199011000-00027
   ROBINSON BH, 1983, EUR J PEDIATR, V140, P98, DOI 10.1007/BF00441651
   Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282
   Sperl W, 2006, NEUROMUSCULAR DISORD, V16, P821, DOI 10.1016/j.nmd.2006.08.008
   Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tatuch Yuriy, 1994, European Journal of Human Genetics, V2, P35
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200
   Xu F, 2008, BIOCHEM J, V416, P15, DOI 10.1042/BJ20080847
   YOTSUYANAGI Y, 1962, J ULTRA MOL STRUCT R, V7, P141, DOI 10.1016/S0022-5320(62)80032-X
   YOTSUYANAGI Y, 1988, J ULTRA MOL STRUCT R, V98, P254, DOI 10.1016/S0889-1605(88)80918-2
   Zeng XM, 2007, MOL BIOL CELL, V18, P617, DOI 10.1091/mbc.E06-09-0801
NR 36
TC 37
Z9 38
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JAN
PY 2011
VL 11
IS 1
BP 191
EP 199
DI 10.1016/j.mito.2010.09.008
PG 9
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 709OP
UT WOS:000286450300026
PM 20920610
DA 2024-11-01
ER

PT S
AU Wu, SL
   Longley, MJ
   Lujan, SA
   Kunkel, TA
   Copeland, WC
AF Wu, Shilan
   Longley, Matthew J.
   Lujan, Scott A.
   Kunkel, Thomas A.
   Copeland, William C.
BE Nicholls, TJ
   Uhler, JP
   Falkenberg, M
TI Mitochondrial DNA Enrichment for Sensitive Next-Generation Sequencing
SO MITOCHONDRIAL DNA: Methods and Protocols
SE Methods in Molecular Biology
LA English
DT Article; Book Chapter
DE Mitochondrial DNA; DNA deletions; Next-Generation Sequencing;
   Mitochondrial disease; POLG; Mitochondrial DNA Replication
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; DELETIONS; MUTATIONS
AB Mitochondrial DNA (mtDNA) encodes components essential for cellular respiration. Low levels of point mutations and deletions accumulate in mtDNA during normal aging. However, improper maintenance of mtDNA results in mitochondrial diseases, stemming from progressive loss of mitochondrial function through the accelerated formation of deletions and mutations in mtDNA. To better understand the molecular mechanisms underlying the creation and propagation of mtDNA deletions, we developed the LostArc next-generation DNA sequencing pipeline to detect and quantify rare mtDNA species in small tissue samples. LostArc procedures are designed to minimize PCR amplification of mtDNA and instead achieve enrichment of mtDNA by selective destruction of nuclear DNA. This approach leads to cost-effective, high-depth sequencing of mtDNA with a sensitivity sufficient to identify one mtDNA deletion per million mtDNA circles. Here, we describe detailed protocols for isolation of genomic DNA from mouse tissues, enrichment of mtDNA through enzymatic destruction of linear nuclear DNA, and preparation of libraries for unbiased next-generation sequencing of mtDNA.
C1 [Wu, Shilan; Longley, Matthew J.; Copeland, William C.] NIEHS, Genome Integr & Struct Biol Lab, Mitochondrial DNA Replicat Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.
   [Lujan, Scott A.; Kunkel, Thomas A.] NIEHS, Genome Integr & Struct Biol Lab, DNA Replicat Fidel Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS); National Institutes of Health
   (NIH) - USA; NIH National Institute of Environmental Health Sciences
   (NIEHS)
RP Wu, SL (corresponding author), NIEHS, Genome Integr & Struct Biol Lab, Mitochondrial DNA Replicat Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.
RI Kunkel, Thomas/D-5088-2019; Copeland, William/C-4242-2019
OI Copeland, William/0000-0002-0359-0953
FU Division of Intramural Research of the NIH, NIEHS [Z01 ES065078, Z01
   ES065080, Z01 ES065070]
FX We acknowledge the Epigenomics and DNA Sequencing Core Laboratory at the
   National Institute of Environmental Health Sciences (NIEHS) for
   sequencing. This work was supported by Projects Z01 ES065078 and Z01
   ES065080 to W.C.C. and Z01 ES065070 to T.A.K. from the Division of
   Intramural Research of the NIH, NIEHS.
CR Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Lujan SA, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02138-5
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   NaviauxRK NguyenKV, 2004, AnnNeurol55
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146
   Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
NR 23
TC 0
Z9 0
U1 3
U2 9
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1064-3745
EI 1940-6029
BN 978-1-0716-2924-6; 978-1-0716-2922-2; 978-1-0716-2921-5
J9 METHODS MOL BIOL
JI Methods Mol. Biol.
PY 2023
VL 2615
BP 427
EP 441
DI 10.1007/978-1-0716-2922-2_28
D2 10.1007/978-1-0716-2922-2
PG 15
WC Biochemical Research Methods; Biochemistry & Molecular Biology; Genetics
   & Heredity
WE Book Citation Index – Science (BKCI-S)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA BW2FG
UT WOS:001116120000029
PM 36807807
DA 2024-11-01
ER

PT J
AU Cardaioli, E
   Da Pozzo, P
   Malfatti, E
   Battisti, C
   Gallus, GN
   Gaudiano, C
   Macucci, M
   Malandrini, A
   Margollicci, M
   Rubegni, A
   Dotti, MT
   Federico, A
AF Cardaioli, Elena
   Da Pozzo, Paola
   Malfatti, Edoardo
   Battisti, Carla
   Gallus, Gian Nicola
   Gaudiano, Carmen
   Macucci, Marco
   Malandrini, Alessandro
   Margollicci, Maria
   Rubegni, Anna
   Dotti, Maria Teresa
   Federico, Antonio
TI A second MNGIE patient without typical mitochondrial skeletal muscle
   involvement
SO NEUROLOGICAL SCIENCES
LA English
DT Article
DE Thymidine phosphorylase gene; MNGIE syndrome; mtDNA; Muscle biopsy
ID NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY MNGIE; THYMIDINE PHOSPHORYLASE;
   MUTATIONS; SIBLINGS; DISORDER
AB Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive disease caused by mutations in the gene encoding thymidine phosphorylase (TYMP). Clinically, MNGIE is characterized by gastrointestinal dysmotility, cachexia, ptosis, ophthalmoparesis, peripheral neuropathy and leukoencephalopathy. Most MNGIE patients have signs of mitochondrial dysfunction in skeletal muscle at morphological and enzyme level, as well as mitochondrial DNA depletion, multiple deletions and point mutations. A case without mitochondrial skeletal muscle involvement and with a TYMP splice-acceptor site mutation (c. 215-1 G > C) has been reported. Here, we describe an Italian patient with the same mutation and without mitochondrial skeletal muscle involvement, suggesting a possible genotype-phenotype correlation.
C1 [Cardaioli, Elena; Da Pozzo, Paola; Malfatti, Edoardo; Battisti, Carla; Gallus, Gian Nicola; Gaudiano, Carmen; Malandrini, Alessandro; Rubegni, Anna; Dotti, Maria Teresa; Federico, Antonio] Univ Siena, Dept Neurol Neurosurg & Behav Sci, I-53100 Siena, Italy.
   [Macucci, Marco] S Giuseppe Hosp, Neurol Unit, Florence, Italy.
   [Margollicci, Maria] Univ Siena, Paediat Sect, Dept Paediat Obstet & Reprod Med, I-53100 Siena, Italy.
C3 University of Siena; University of Siena
RP Federico, A (corresponding author), Univ Siena, Dept Neurol Neurosurg & Behav Sci, Viale Bracci 2, I-53100 Siena, Italy.
EM federico@unisi.it
RI Macucci, Marco/KQU-2846-2024; Federico, Antonio/H-8871-2017; Malfatti,
   Edoardo/KEI-9379-2024; GALLUS, GIAN NICOLA/Q-3489-2016; Rubegni,
   Anna/I-3221-2018
OI federico, antonio/0000-0002-5246-1621; GALLUS, GIAN
   NICOLA/0000-0001-5801-223X; Macucci, Marco/0000-0001-5138-6888; Rubegni,
   Anna/0000-0002-0484-3799; Cardaioli, Elena/0000-0003-2850-6698
FU University of Siena
FX The study was partially supported by a grant from the University of
   Siena to AF ( PAR 2007).
CR Blondon H, 2005, GASTROEN CLIN BIOL, V29, P773, DOI 10.1016/S0399-8320(05)86346-8
   Debouverie M, 1997, REV NEUROL, V153, P547
   Hamano H, 1997, Rinsho Shinkeigaku, V37, P917
   Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Nishino I, 2000, ANN NEUROL, V47, P792
   Schuepbach WMM, 2007, J NEUROL, V254, P146, DOI 10.1007/s00415-006-0255-3
   Slama A, 2005, MOL GENET METAB, V84, P326, DOI 10.1016/j.ymgme.2004.12.004
   Szigeti K, 2004, J MED GENET, V41, P125, DOI 10.1136/jmg.2003.013789
   Valentino ML, 2007, FEBS LETT, V581, P3410, DOI 10.1016/j.febslet.2007.06.042
   van Adel Brian A, 2009, J Clin Neuromuscul Dis, V10, P97, DOI 10.1097/CND.0b013e3181903126
   YOSHIMURA A, 1990, BIOCHIM BIOPHYS ACTA, V1034, P107, DOI 10.1016/0304-4165(90)90160-X
NR 12
TC 15
Z9 16
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1590-1874
J9 NEUROL SCI
JI Neurol. Sci.
PD AUG
PY 2010
VL 31
IS 4
BP 491
EP 494
DI 10.1007/s10072-010-0225-5
PG 4
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 624RK
UT WOS:000279837500012
PM 20232099
DA 2024-11-01
ER

PT J
AU Rygiel, KA
   Grady, JP
   Taylor, RW
   Tuppen, HAL
   Turnbull, DM
AF Rygiel, Karolina A.
   Grady, John P.
   Taylor, Robert W.
   Tuppen, Helen A. L.
   Turnbull, Doug M.
TI Triplex real-time PCR-an improved method to detect a wide spectrum of
   mitochondrial DNA deletions in single cells
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MTDNA; MUTATIONS; QUANTIFICATION; REPLICATION; REVEALS; ORIGIN
AB Mitochondrial DNA (mtDNA) mutations are commonly found in the skeletal muscle of patients with mitochondrial disease, inflammatory myopathies and sarcopenia. The majority of these mutations are mtDNA deletions, which accumulate to high levels in individual muscle fibres causing a respiratory defect. Most mtDNA deletions are major arc deletions with breakpoints located between the origin of light strand (OL) and heavy strand (OH) replication within the major arc. However, under certain disease conditions, rarer, minor arc deletions are detected. Currently, there are few techniques which would allow the detection and quantification of both types of mtDNA deletions in single muscle fibres. We have designed a novel triplex real-time PCR assay which simultaneously amplifies the MT-ND4 gene in the major arc, the MT-ND1 gene in the minor arc, and the non-coding D-Loop region. We demonstrate that this assay is a highly sensitive and reliable tool for the detection and quantification of a broad range of major and minor arc mtDNA deletions with the potential to investigate the molecular pathogenesis in both research and diagnostic settings.
C1 [Rygiel, Karolina A.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   Newcastle Univ, Ctr Ageing & Vital, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK
RP Rygiel, KA (corresponding author), Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM karolina.rygiel@ncl.ac.uk
OI Tuppen, Helen/0000-0001-8762-0824; Grady, John/0000-0001-9667-3872;
   Turnbull, Doug/0000-0002-8878-9901
FU Wellcome Trust Centre for Mitochondrial Research [G906919]; Newcastle
   University Centre for Ageing and Vitality; MRC Centre for Neuromuscular
   Disease [G000608-1]; MRC Centre for Translational Research in
   Neuromuscular Disease Mitochondrial Disease Patient Cohort (UK)
   [G0800674]; Lily Foundation; Medical Research Council [M501700];
   Biotechnology and Biological Sciences Research Council; UK NIHR
   Biomedical Research Centre; UK NHS Specialist Commissioners "Rare
   Mitochondrial Disorders of Adults and Children" Service; Wellcome Trust
   [090194/Z/09/Z]; MRC [G0700718, MR/L016451/1, MR/K000608/1, G0900652,
   G0800674, G0502157, G0400074, MR/K006312/1, G1100540] Funding Source:
   UKRI; Wellcome Trust [090194/Z/09/Z] Funding Source: Wellcome Trust
FX This work was funded by The Wellcome Trust Centre for Mitochondrial
   Research [G906919], Newcastle University Centre for Ageing and Vitality
   (supported by the Biotechnology and Biological Sciences Research Council
   and Medical Research Council [M501700]), MRC Centre for Neuromuscular
   Disease [G000608-1], The MRC Centre for Translational Research in
   Neuromuscular Disease Mitochondrial Disease Patient Cohort (UK)
   [G0800674], Lily Foundation, the UK NIHR Biomedical Research Centre in
   Age and Age Related Diseases award to the Newcastle upon Tyne Hospitals
   NHS Foundation Trust and UK NHS Specialist Commissioners "Rare
   Mitochondrial Disorders of Adults and Children" Service. JPG was funded
   by a Wellcome Trust Studentship [090194/Z/09/Z].
CR Bank C, 2000, BIOCHEM BIOPH RES CO, V279, P595, DOI 10.1006/bbrc.2000.3951
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bodyak ND, 2001, HUM MOL GENET, V10, P17, DOI 10.1093/hmg/10.1.17
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Budowle B, 2002, INT J LEGAL MED, V116, P212, DOI 10.1007/s00414-001-0283-6
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   Grady J. P., 2014, PLOS ONE IN PRESS
   Greaves LC, 2006, IUBMB LIFE, V58, P143, DOI 10.1080/15216540600686888
   Greaves LC, 2009, BBA-GEN SUBJECTS, V1790, P1015, DOI 10.1016/j.bbagen.2009.04.018
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P244, DOI 10.1016/0006-291X(91)90512-6
   KASAMATSU H, 1971, P NATL ACAD SCI USA, V68, P2252, DOI 10.1073/pnas.68.9.2252
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Moraes CT, 2003, J MOL DIAGN, V5, P197, DOI 10.1016/S1525-1578(10)60474-6
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Phillips NR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03887
   Poe BG, 2007, ANAL BIOCHEM, V362, P193, DOI 10.1016/j.ab.2006.12.035
   Razali N.M., 2011, Math, V2, P21
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Wanrooij S, 2012, EMBO REP, V13, P1130, DOI 10.1038/embor.2012.161
   WEI YH, 1992, MUTAT RES, V275, P145, DOI 10.1016/0921-8734(92)90019-L
NR 27
TC 28
Z9 29
U1 0
U2 12
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 19
PY 2015
VL 5
AR 09906
DI 10.1038/srep09906
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CJ2DE
UT WOS:000355293600001
PM 25989140
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Uusimaa, J
   Hinttala, R
   Rantala, H
   Päivärinta, M
   Herva, R
   Röyttä, M
   Soini, H
   Moilanen, JS
   Remes, AM
   Hassinen, IE
   Majamaa, K
AF Uusimaa, Johanna
   Hinttala, Reetta
   Rantala, Heikki
   Paivarinta, Markku
   Herva, Riitta
   Roytta, Matias
   Soini, Heidi
   Moilanen, Jukka S.
   Remes, Anne M.
   Hassinen, Ilmo E.
   Majamaa, Kari
TI Homozygous W748S mutation in the <i>POLG1</i> gene in patients with
   juvenile-onset Alpers syndrome and status epilepticus
SO EPILEPSIA
LA English
DT Article
DE status epilepticus; metabolic diseases; mitochondrial diseases; genetic
   diseases
ID DNA-POLYMERASE-GAMMA; PROGRESSIVE NEURONAL DEGENERATION; AUTOSOMAL
   RECESSIVE ATAXIA; LIVER-DISEASE; EXTERNAL OPHTHALMOPLEGIA;
   HUTTENLOCHER-SYNDROME; CHILDHOOD; DEPLETION; DELETIONS; PARKINSONISM
AB Purpose: Polymerase gamma (POLG) is the sole enzyme in the replication of mitochondrial DNA (mtDNA). Numerous mutations in the POLG1 gene have been detected recently in patients with various phenotypes including a classic infantile-onset Alpers-Huttenlocher syndrome (AHS). Here we studied the molecular etiology of juvenile-onset AHS manifesting with status epilepticus and liver disease in three teenagers.
   Patients and Methods: We examined 14- and 17-year-old female siblings (patients 1 and 2) and an unrelated 15-year-old girl (patient 3) with juvenile-onset AHS, sequenced POLG1, and the entire mtDNA, examined mtDNA deletions by amplification of the full-length mtDNA with the long PCR method and used real-time PCR to quantify mtDNA in the tissue samples.
   Results: The initial manifestations were migraine-like headache and epilepsy, and the terminal manifestations status epilepticus and hepatic failure. A homozygous W748S mutation in POLG1 was detected in the three patients. No deletions or pathogenic point mutations were found in mtDNA, but all three patients had mtDNA depletion.
   Conclusions: POLG mutations should be considered in cases of teenagers and young adults with a sudden onset of intractable seizures or status epilepticus, and acute liver failure. The W748S POLG1 mutation seems to lead to tissue-specific, partial mtDNA depletion in patients with juvenile-onset Alpers syndrome. Valproic acid should be avoided in the treatment of epileptic seizures in these patients.
C1 [Paivarinta, Markku; Majamaa, Kari] Univ Turku, Dept Neurol, FIN-20014 Turku, Finland.
   [Uusimaa, Johanna; Rantala, Heikki] Univ Oulu, Dept Pediat, SF-90100 Oulu, Finland.
   [Uusimaa, Johanna; Hinttala, Reetta; Soini, Heidi; Moilanen, Jukka S.; Remes, Anne M.; Majamaa, Kari] Oulu Univ Hosp, Clin Res Ctr, Oulu, Finland.
   [Hinttala, Reetta; Soini, Heidi; Remes, Anne M.; Majamaa, Kari] Univ Oulu, Dept Neurol, Oulu, Finland.
   [Herva, Riitta] Univ Oulu, Dept Pathol, Oulu, Finland.
   [Roytta, Matias] Univ Turku, Dept Pathol, FIN-20014 Turku, Finland.
   [Moilanen, Jukka S.] Univ Oulu, Dept Clin Genet, Oulu, Finland.
   [Hassinen, Ilmo E.] Univ Oulu, Dept Med Biochem & Mol Biol, Oulu, Finland.
C3 University of Turku; University of Oulu; University of Oulu; University
   of Oulu; University of Oulu; University of Turku; University of Oulu;
   University of Oulu
RP Majamaa, K (corresponding author), Univ Turku, Dept Neurol, FIN-20014 Turku, Finland.
EM kari.majamaa@utu.fi
RI Majamaa, Kari/A-1344-2012; Moilanen, Jukka/G-2604-2012
OI Majamaa, Kari/0000-0002-9070-3791; Moilanen, Jukka/0000-0002-8041-3205;
   Hinttala, Reetta/0000-0002-7642-4008
CR Alpers BJ, 1931, ARCH NEURO PSYCHIATR, V25, P469, DOI 10.1001/archneurpsyc.1931.02230030027002
   BOHNERT B, 1974, ARCH PSYCHIAT NERVEN, V218, P353, DOI 10.1007/BF00342578
   Braasch DA, 2001, CHEM BIOL, V8, P1, DOI 10.1016/S1074-5521(00)00058-2
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Gordon N, 2006, DEV MED CHILD NEUROL, V48, P1001, DOI 10.1017/S0012162206002209
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   HARDING BN, 1995, J NEUROL NEUROSUR PS, V58, P320, DOI 10.1136/jnnp.58.3.320
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Hinttala R, 2005, J MOL MED, V83, P786, DOI 10.1007/s00109-005-0712-y
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   KLEIN H, 1969, Archiv fuer Psychiatrie und Nervenkrankheiten, V212, P400, DOI 10.1007/BF00341587
   Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   MONTINE TJ, 1995, CLIN NEUROPATHOL, V14, P322
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Rantamäki M, 2001, NEUROLOGY, V57, P1043, DOI 10.1212/WNL.57.6.1043
   Remes AM, 2005, NEUROLOGY, V64, P976, DOI 10.1212/01.WNL.0000154518.31302.ED
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Schwabe MJ, 1997, PEDIATR NEUROL, V16, P337, DOI 10.1016/S0887-8994(97)00030-1
   Simonati A, 2003, J NEUROL, V250, P702, DOI 10.1007/s00415-003-1065-5
   Tesarova M, 2004, NEUROPEDIATRICS, V35, P217, DOI 10.1055/s-2004-821081
   Ulmer S, 2002, J COMPUT ASSIST TOMO, V26, P641, DOI 10.1097/00004728-200207000-00030
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Worle H, 1998, CLIN NEUROPATHOL, V17, P63
NR 39
TC 58
Z9 62
U1 0
U2 7
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0013-9580
J9 EPILEPSIA
JI Epilepsia
PD JUN
PY 2008
VL 49
IS 6
BP 1038
EP 1045
DI 10.1111/j.1528-1167.2008.01544.x
PG 8
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 309XE
UT WOS:000256492700012
PM 18294203
OA Bronze
DA 2024-11-01
ER

PT J
AU Peralta, S
   Goffart, S
   Williams, SL
   Diaz, F
   Garcia, S
   Nissanka, N
   Area-Gomez, E
   Pohjoismäki, J
   Moraes, CT
AF Peralta, Susana
   Goffart, Steffi
   Williams, Sion L.
   Diaz, Francisca
   Garcia, Sofia
   Nissanka, Nadee
   Area-Gomez, Estela
   Pohjoismaki, Jaakko
   Moraes, Carlos T.
TI ATAD3 controls mitochondrial cristae structure in mouse muscle,
   influencing mtDNA replication and cholesterol levels
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE ATAD3; Mitochondria; Cristae; MICOS complex; Muscle; Cholesterol
ID DOMAIN-CONTAINING 3A; MEMBRANE-PROTEIN; SKELETAL-MUSCLE; ATP SYNTHASE;
   MOLECULAR CHARACTERIZATION; HELICASE TWINKLE; CONTROL REGION; CONTACT
   SITE; CELL-LINES; DNA
AB Mutations in the mitochondrial inner membrane ATPase ATAD3A result in neurological syndromes in humans. In mice, the ubiquitous disruption of Atad3 (also known as Atad3a) was embryonic lethal, but a skeletal muscle-specific conditional knockout (KO) was viable. At birth, ATAD3 muscle KO mice had normal weight, but from 2 months onwards they showed progressive motor-impaired coordination and weakness. Loss of ATAD3 caused early and severe mitochondrial structural abnormalities, mitochondrial proliferation and muscle atrophy. There was dramatic reduction in mitochondrial cristae junctions and overall cristae morphology. The lack of mitochondrial cristae was accompanied by a reduction in high molecular weight mitochondrial contact site and cristae organizing system (MICOS) complexes, and to a lesser extent in OPA1. Moreover, muscles lacking ATAD3 showed altered cholesterol metabolism, accumulation of mitochondrial DNA (mtDNA) replication intermediates, progressive mtDNA depletion and deletions. Unexpectedly, decreases in the levels of some OXPHOS components occurred after cristae destabilization, indicating that ATAD3 is not crucial for mitochondrial translation, as previously suggested. Our results show a critical early role of ATAD3 in regulating mitochondrial inner membrane structure, leading to secondary defects in mtDNA replication and complex V and cholesterol levels in postmitotic tissue.
   This article has an associated First Person interview with the first author of the paper.
C1 [Peralta, Susana; Williams, Sion L.; Diaz, Francisca; Garcia, Sofia; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
   [Goffart, Steffi; Pohjoismaki, Jaakko] Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu 80101, Finland.
   [Nissanka, Nadee; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Neurosci Grad Program, Miami, FL 33136 USA.
   [Area-Gomez, Estela] Columbia Univ, Dept Neurol, Res ARTICLE ATAD3 controls mitochondrial cristae, New York, NY 10032 USA.
   [Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA.
C3 University of Miami; University of Eastern Finland; University of Miami;
   Columbia University; University of Miami
RP Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.; Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Neurosci Grad Program, Miami, FL 33136 USA.; Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA.
EM cmoraes@med.miami.edu
RI Pohjoismaeki, Jaakko/AAC-7995-2019; Moraes, Carlos/AAT-3818-2021
OI Area Gomez, Estela/0000-0002-0962-1570; Pohjoismaki,
   Jaakko/0000-0002-1185-3610; Nissanka, Nadee/0000-0002-4639-7192
FU National Institute of Neurological Disorders and Stroke [1R01NS079965];
   National Institute on Aging [1R01AG036871]; National Eye Institute
   [5R01EY010804]; National Institutes of Health [P30-EY014801]; American
   Heart Association [16PRE30480009]; American Heart Association (AHA)
   [16PRE30480009] Funding Source: American Heart Association (AHA)
FX This work was supported by the National Institute of Neurological
   Disorders and Stroke [1R01NS079965], National Institute on Aging
   [1R01AG036871], National Eye Institute [5R01EY010804 to C.T.M.],
   National Institutes of Health [P30-EY014801] and American Heart
   Association [16PRE30480009 to N.N.]. Deposited in PMC for release after
   12 months.
CR [Anonymous], 2009, CURRENT PROTOCOLS HU, DOI DOI 10.1002/0471142905.HG1904S63
   Barrientos Antoni, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1903s63
   Baudier J, 2018, BIOL REV, V93, P827, DOI 10.1111/brv.12373
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F
   BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8
   Cámara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002
   Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729
   Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005
   Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Civiletto G, 2015, CELL METAB, V21, P845, DOI 10.1016/j.cmet.2015.04.016
   Cogliati S, 2016, TRENDS BIOCHEM SCI, V41, P261, DOI 10.1016/j.tibs.2016.01.001
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Cooper HM, 2017, HUM MOL GENET, V26, P1432, DOI 10.1093/hmg/ddx042
   Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109
   Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108
   Desai R, 2017, BRAIN, V140, P1595, DOI 10.1093/brain/awx094
   Dogan SA, 2014, CELL METAB, V19, P458, DOI 10.1016/j.cmet.2014.02.004
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Fang HY, 2010, J CELL SCI, V123, P1171, DOI 10.1242/jcs.062034
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Frickey T, 2004, J STRUCT BIOL, V146, P2, DOI 10.1016/j.jsb.2003.11.020
   Friedman KL, 1995, METHOD ENZYMOL, V262, P613
   Gerhold JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15292
   Gilkerson RW, 2003, FEBS LETT, V546, P355, DOI 10.1016/S0014-5793(03)00633-1
   Gilquin B, 2010, MOL CELL BIOL, V30, P1984, DOI 10.1128/MCB.00007-10
   Glytsou C, 2016, CELL REP, V17, P3024, DOI 10.1016/j.celrep.2016.11.049
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Goller T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054799
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Harel T, 2016, AM J HUM GENET, V99, P831, DOI 10.1016/j.ajhg.2016.08.007
   HARMALA AS, 1994, BBA-LIPID LIPID MET, V1211, P317, DOI 10.1016/0005-2760(94)90156-2
   Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379
   He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266
   He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158
   Hoffmann M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007644
   Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004
   Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053
   Hubstenberger A, 2008, EXP CELL RES, V314, P2870, DOI 10.1016/j.yexcr.2008.06.017
   Hubstenberger A, 2010, J BIOENERG BIOMEMBR, V42, P143, DOI 10.1007/s10863-010-9269-8
   Iaea DB, 2015, ESSAYS BIOCHEM, V57, P43, DOI [10.1042/bse0570043, 10.1042/BSE0570043]
   Iommarini L, 2015, MITOCHONDRION, V22, P96, DOI 10.1016/j.mito.2015.01.008
   Issop L, 2015, ENDOCRINOLOGY, V156, P334, DOI 10.1210/en.2014-1503
   John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.E04-08-0697
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Lewis SC, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5549
   Li H, 2016, CELL DEATH DIFFER, V23, P380, DOI 10.1038/cdd.2015.102
   Li SJ, 2014, GENE, V535, P60, DOI 10.1016/j.gene.2013.10.062
   Li SJ, 2012, J BIOENERG BIOMEMBR, V44, P189, DOI 10.1007/s10863-012-9424-5
   LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465
   Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Mourier A, 2014, HUM MOL GENET, V23, P2580, DOI 10.1093/hmg/ddt652
   Neuhaus JFG, 2014, BRAIN, V137, P354, DOI 10.1093/brain/awt291
   Odgren PR, 1996, J CELL SCI, V109, P2253
   Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046
   Peralta S, 2016, HUM MOL GENET, V25, P3178, DOI 10.1093/hmg/ddw167
   Pfanner N, 2014, J CELL BIOL, V204, P1083, DOI 10.1083/jcb.201401006
   Pohjoismäki JLO, 2011, MITOCHONDRION, V11, P630, DOI 10.1016/j.mito.2011.04.002
   Rebelo AP, 2009, NUCLEIC ACIDS RES, V37, P6701, DOI 10.1093/nar/gkp727
   ROWLAND LP, 1991, REV NEUROL-FRANCE, V147, P467
   Schaffrik M, 2006, CELL MOL LIFE SCI, V63, P2162, DOI 10.1007/s00018-006-6200-x
   SCHMALBRUCH H, 1977, ANAT RECORD, V189, P169, DOI 10.1002/ar.1091890204
   SLOTTE JP, 1990, BIOCHIM BIOPHYS ACTA, V1030, P251, DOI 10.1016/0005-2736(90)90301-4
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Szczepanowska K, 2016, EMBO J, V35, P2566, DOI 10.15252/embj.201694253
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138
   von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wiedemann N, 2017, ANNU REV BIOCHEM, V86, P685, DOI 10.1146/annurev-biochem-060815-014352
   Williams SL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003990
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
   You WC, 2013, NEURO-ONCOLOGY, V15, P1342, DOI 10.1093/neuonc/not077
NR 83
TC 65
Z9 71
U1 1
U2 18
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD JUL
PY 2018
VL 131
IS 13
AR jcs217075
DI 10.1242/jcs.217075
PG 15
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA GS2WE
UT WOS:000443422700013
PM 29898916
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Zifa, E
   Theotokis, P
   Kaminari, A
   Maridaki, H
   Leze, H
   Petsiava, E
   Mamuris, Z
   Stathopoulos, C
AF Zifa, Emily
   Theotokis, Paschalis
   Kaminari, Archontia
   Maridaki, Helen
   Leze, Helen
   Petsiava, Efrosini
   Mamuris, Zissis
   Stathopoulos, Constantinos
TI A novel G3337A mitochondrial ND1 mutation related to cardiomyopathy
   co-segregates with tRNA<SUP>Leu(CUN)</SUP> A12308G and
   tRNA<SUP>Thr</SUP> C15946T mutations
SO MITOCHONDRION
LA English
DT Article
DE tRNA; NADH dehydrogenase 1; mitochondrial DNA; cardiomyopathies
ID RIBOSOMAL-RNA C1494T; COMPLEX-I ACTIVITY; HEARING-LOSS; PHENOTYPIC
   MANIFESTATION; HYPERTROPHIC CARDIOMYOPATHY; CHINESE FAMILY; DNA
   MUTATIONS; GENE; MYOPATHY; DEAFNESS
AB We describe a novel Mutation in human mitochondrial NADH dehydrogenase 1 gene (ND1), a G to A transition at nucleotide position 3337,which is co-segregated with two known mutations in tRNA(Leu(CUN)) A12308G and tRNA(Thr) C15946T. These mutations were detected in two unrelated patients with different clinical phenotypes, exhibiting cardiomyopathy as the common symptom. The ND1 G3337A mutation that was detected was found almost homoplasmic in the two patients and it was absent in 150 individuals that were tested as control group. Mitochondrial respiratory chain complex I activity of the patients platelets was also tested and found decreased compared to those of controls. We suggest that the co-existence of mutations in tRNA and ND1 genes may act synergistically affecting the clinical phenotype. Our study highlights the enormous phenotypic diversity that exists among pathogenic mtDNA mutations and re-emphasizes the need for a more careful clinical approach. (c) 2008 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Zifa, Emily; Theotokis, Paschalis; Kaminari, Archontia; Mamuris, Zissis; Stathopoulos, Constantinos] Univ Thessaly, Dept Biochem & Biotechnol, Larisa 41221, Greece.
   [Maridaki, Helen; Leze, Helen; Petsiava, Efrosini] Achillopoule Reg Gen Hosp Volos, Paediat Clin, Volos 38222, Greece.
   [Mamuris, Zissis; Stathopoulos, Constantinos] Inst Biomed Res & Technol BIOMED, Larisa 41221, Greece.
C3 University of Thessaly
RP Mamuris, Z (corresponding author), Univ Thessaly, Dept Biochem & Biotechnol, 26 Ploutonos St, Larisa 41221, Greece.
EM zmamur@uth.gr; cstath@bio.uth.gr
RI Kaminari, Archontia/AAY-1546-2021; Mamuris, Zissis/AAN-2576-2021;
   Theotokis, Paschalis/AAU-8003-2021
OI Kaminari, Archontia/0000-0003-4271-4450; Theotokis,
   Paschalis/0000-0001-8607-6695; Stathopoulos,
   Constantinos/0000-0002-5699-4118
CR Akita Y, 2000, HUM MUTAT, V15, P382, DOI 10.1002/(SICI)1098-1004(200004)15:4<382::AID-HUMU15>3.0.CO;2-B
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Ballana E, 2008, HUM MUTAT, V29, P248, DOI 10.1002/humu.20639
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Chen J, 2006, DIABETES RES CLIN PR, V74, P148, DOI 10.1016/j.diabres.2006.03.024
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   DIMAURO S, 1989, CURR OPIN CARDIOL, V13, P90
   Dror N, 2002, MOL PSYCHIATR, V7, P995, DOI 10.1038/sj.mp.4001116
   Feigenbaum A, 2006, AM J MED GENET A, V140A, P2216, DOI 10.1002/ajmg.a.31436
   Grasso M, 2001, EUR J HUM GENET, V9, P311, DOI 10.1038/sj.ejhg.5200622
   Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389
   Han DY, 2007, BIOCHEM BIOPH RES CO, V357, P554, DOI 10.1016/j.bbrc.2007.03.199
   Hattori Y, 2005, EXP CLIN ENDOCR DIAB, V113, P318, DOI 10.1055/s-2005-865646
   Higashikata T, 2001, INTERNAL MED, V40, P405, DOI 10.2169/internalmedicine.40.405
   Hudson G, 2007, MOL VIS, V13, P2339
   Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873
   LAUBER J, 1991, NUCLEIC ACIDS RES, V19, P1393, DOI 10.1093/nar/19.7.1393
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   LEWIN HA, 1992, BIOTECHNIQUES, V13, P522
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   Mancuso M, 2007, BIOSCIENCE REP, V27, P31, DOI 10.1007/s10540-007-9035-2
   ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766
   Pulkes T, 2000, LANCET, V356, P2068, DOI 10.1016/S0140-6736(00)03408-5
   Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665
   Ronghua L, 2006, GENE, V376, P79, DOI 10.1016/j.gene.2006.02.014
   Santorelli FM, 2001, AM HEART J, V141, P1
   Shin WS, 2000, AM J HUM GENET, V67, P1617, DOI 10.1086/316896
   SILVESTRI G, 1994, HUM MUTAT, V3, P37, DOI 10.1002/humu.1380030107
   SWEENEY MG, 1993, Q J MED, V86, P435
   TANIIKE M, 1992, BIOCHEM BIOPH RES CO, V186, P47, DOI 10.1016/S0006-291X(05)80773-9
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Tong Y, 2007, BIOCHEM BIOPH RES CO, V357, P524, DOI 10.1016/j.bbrc.2007.03.189
   TSUJITA Y, INT J CARDI IN PRESS
   VANHOVE JL, EUR J PEDIA IN PRESS
   Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807
   Wu CC, 2007, EAR HEARING, V28, P332, DOI 10.1097/AUD.0b013e318047941e
   Young WY, 2006, AM J MED GENET A, V140A, P2188, DOI 10.1002/ajmg.a.31434
   Yuan H, 2007, BIOCHEM BIOPH RES CO, V362, P94, DOI 10.1016/j.bbrc.2007.07.161
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548
NR 41
TC 22
Z9 25
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUN
PY 2008
VL 8
IS 3
BP 229
EP 236
DI 10.1016/j.mito.2008.04.001
PG 8
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 329UG
UT WOS:000257895500004
PM 18502698
DA 2024-11-01
ER

PT J
AU Caballero, PEJ
   Candela, MS
   Alvarez, CIC
   Tejerina, AA
AF Jimenez Caballero, Pedro Enrique
   Servia Candela, Monica
   Cabeza Alvarez, Clara Isabel
   Alvarez Tejerina, Araceli
TI Chronic progressive external ophthalmoplegia - A report of 6 cases and a
   review of the literature
SO NEUROLOGIST
LA English
DT Article
DE chronic progressive external ophthalmoplegia; mitochondrial disease;
   ragged-red fibers; jitter
ID MITOCHONDRIAL-DNA; A3243G MUTATION; DELETIONS; ENCEPHALOMYOPATHIES;
   MYOPATHIES; FEATURES; DISEASE
AB Introduction: Chronic progressive external ophthalmoplegia is a common mitochondrial disease that shares clinical, enzymatic, and genetic features with other mitochondrial disorders. Effective treatment does not exist, and corrective surgery of the ptosis as a palliative measure is a treatment option.
   Patients and Methods: This was a retrospective study of 10 years' duration gathering patients with the diagnosis. Information related to clinical features, ancillary tests, and genetic data was obtained from our patients.
   Results: Six patients were identified with this disease, 5 of them women, aged 44 to 72 years. All patients presented with ptosis, and in 50% of the patients it was asymmetric. Half of the patients noted mild dysphagia for liquids. The CPK and acetylcholine receptor antibody levels were normal. Jitter was increased in half of the patients and ragged-red fibers were present in 5 of them. The most common enzyme alteration was the combined deficit of complexes I and IV. Familial forms were not found among our patients. The most common genetic anomaly was a single deletion in the mitochondrial DNA.
   Conclusion: Knowledge of this disorder enables us to avoid the use of drugs with significant side effects in cases of ptosis and ophthalmoplegia that do not respond to anticholinesterases.
C1 Hosp Virgen Salud, Dept Neurol, Toledo, Spain.
   Hosp Virgen Salud, Dept Clin Biochem, Toledo, Spain.
C3 Complejo Hospitalario de Toledo; Complejo Hospitalario de Toledo
RP Caballero, PEJ (corresponding author), Calle Murillo 14, Bargas, Toledo, Spain.
EM pjimenez1010j@yahoo.es
CR Arpa-Gutiérrez FJ, 2005, REV NEUROLOGIA, V41, P449, DOI 10.33588/rn.4108.2005206
   Becker R, 2002, METABOLISM, V51, P796, DOI 10.1053/meta.2002.32625
   BERENBERG RA, 1977, ANN NEUROL, V1, P37, DOI 10.1002/ana.410010104
   CESEN W, 1972, ARCH NEUROL-CHICAGO, V26, P193
   COHEN JM, 1997, J AM OPTOM ASSOC, V155, P57
   Daut PM, 2000, AM J OPHTHALMOL, V130, P519, DOI 10.1016/S0002-9394(00)00558-4
   Deschauer M, 2001, NERVENARZT, V72, P122, DOI 10.1007/s001150050724
   Drouet A, 1996, REV MED INTERNE, V17, P200, DOI 10.1016/0248-8663(96)81246-X
   HAMMANS SR, 1991, LANCET, V337, P1311, DOI 10.1016/0140-6736(91)92981-7
   Hansrote S, 2002, J NEUROL SCI, V197, P63, DOI 10.1016/S0022-510X(02)00048-5
   Hart P.E., 2002, Mitochondrial Disorders in Neurology, V2, P35
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   Koga Y, 2000, ACTA NEUROPATHOL, V99, P186, DOI 10.1007/PL00007423
   Kornblum C, 2004, KLIN MONATSBL AUGENH, V221, P1057, DOI 10.1055/s-2004-813830
   MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873
   MITSIKOSTAS D, 1995, FUNCT NEUROL, V10, P209
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Okulla T, 2005, GRAEF ARCH CLIN EXP, V243, P380, DOI 10.1007/s00417-004-1000-1
   PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915
   Pineda M, 2004, REV NEUROLOGIA, V38, P1023, DOI 10.33588/rn.3811.2004019
   Richardson C, 2005, EYE, V19, P258, DOI 10.1038/sj.eye.6701488
   ROBERTS NK, 1979, AM J CARDIOL, V44, P1396, DOI 10.1016/0002-9149(79)90459-4
   Rossier J, 1996, KLIN MONATSBL AUGENH, V208, P366, DOI 10.1055/s-2008-1035241
   ROWLAND LP, 1991, REV NEUROL-FRANCE, V147, P467
   Schaefer AM, 2005, MUSCLE NERVE, V32, P104, DOI 10.1002/mus.20319
   TRUONG DD, 1990, MOVEMENT DISORD, V5, P109, DOI 10.1002/mds.870050204
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Wong VA, 2002, OPHTHALMOLOGY, V109, P1023, DOI 10.1016/S0161-6420(02)01009-6
NR 29
TC 26
Z9 27
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1074-7931
EI 2331-2637
J9 NEUROLOGIST
JI Neurologist
PD JAN
PY 2007
VL 13
IS 1
BP 33
EP 36
DI 10.1097/01.nrl.0000252953.49721.f5
PG 4
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 123ML
UT WOS:000243299900005
PM 17215725
DA 2024-11-01
ER

PT J
AU Orsucci, D
   Rocchi, A
   Ienco, EC
   Alì, G
   LoGerfo, A
   Petrozzi, L
   Scarpelli, M
   Filosto, M
   Carlesi, C
   Siciliano, G
   Bonuccelli, U
   Mancuso, M
AF Orsucci, D.
   Rocchi, A.
   Ienco, E. Caldarazzo
   Ali, G.
   LoGerfo, A.
   Petrozzi, L.
   Scarpelli, M.
   Filosto, M.
   Carlesi, C.
   Siciliano, G.
   Bonuccelli, U.
   Mancuso, M.
TI Myopathic Involvement and Mitochondrial Pathology in Kennedy Disease and
   in Other Motor Neuron Diseases
SO CURRENT MOLECULAR MEDICINE
LA English
DT Article
DE ALS; AR; Kennedy's disease; motoneuron disease; multiple deletions;
   mtDNA; SMA; SBMA
ID BULBAR MUSCULAR-ATROPHY; AMYOTROPHIC-LATERAL-SCLEROSIS; SKELETAL-MUSCLE;
   ANDROGEN RECEPTOR; DNA DEPLETION; MUTATION; DYSFUNCTION; PHENOTYPE;
   PATIENT; MODEL
AB Kennedy disease (spinal and bulbar muscular atrophy, or SBMA) is a motor neuron disease caused by a CAG expansion in the androgen-receptor (AR) gene. Increasing evidence shows that SBMA may have a primary myopathic component and that mitochondrial dysfunction may have some role in the pathogenesis of this disease. In this article, we review the role of mitochondrial dysfunction and of the mitochondrial genome (mtDNA) in SBMA, and we present the illustrative case of a patient who presented with increased CK levels and exercise intolerance. Molecular analysis led to definitive diagnosis of SBMA, whereas muscle biopsy showed a mixed myopathic and neurogenic process with "mitochondrial features" and multiple mtDNA deletions, supporting some role of mitochondria in the pathogenesis of the myopathic component of Kennedy disease. Furthermore, we briefly review the role of mitochondrial dysfunction in two other motor neuron diseases (namely spinal muscular atrophy and amyotrophic lateral sclerosis). Most likely, in most cases mtDNA does not play a primary role and it is involved subsequently. MtDNA deletions may contribute to the neurodegenerative process, but the exact mechanisms are still unclear. It will be important to develop a better understanding of the role of mitochondrial dysfunction in motoneuron diseases, since it may lead to the development of more effective strategies for the treatment of this devastating disorder.
C1 [Orsucci, D.; Rocchi, A.; Ienco, E. Caldarazzo; LoGerfo, A.; Petrozzi, L.; Carlesi, C.; Siciliano, G.; Bonuccelli, U.; Mancuso, M.] Univ Pisa, Dept Expt & Clin Med, Pisa, Italy.
   [Ali, G.] Univ Pisa, Div Anat Patol, I-56100 Pisa, Italy.
   [Scarpelli, M.] Univ Verona, Div Clin Neurol, I-37100 Verona, Italy.
   [Filosto, M.] Univ Brescia, Neurol Clin, I-25121 Brescia, Italy.
C3 University of Pisa; University of Pisa; University of Verona; University
   of Brescia
RP Mancuso, M (corresponding author), Univ Pisa, Dept Expt & Clin Med, Pisa, Italy.
EM mancusomichelangelo@gmail.com
RI Filosto, Massimiliano/S-9446-2019; Mancuso, Michelangelo/K-4170-2016;
   Orsucci, Daniele/AAA-7576-2019; Ienco, Elena/K-9142-2016; Siciliano,
   Gabriele/K-7259-2016; LoGerfo, Annalisa/K-6491-2016; Bonuccelli,
   Ubaldo/K-8681-2016; Ali, Greta/J-9642-2016
OI Orsucci, Daniele/0000-0003-4847-7812; Siciliano,
   Gabriele/0000-0002-6142-2384; LoGerfo, Annalisa/0000-0001-7825-0649;
   mancuso, michelangelo/0000-0003-2738-8562; Caldarazzo Ienco,
   Elena/0000-0003-0134-5062; Bonuccelli, Ubaldo/0000-0001-6218-6312;
   Filosto, Massimiliano/0000-0002-2852-7512; Ali,
   Greta/0000-0001-9258-3466
CR Acsadi G, 2009, J NEUROSCI RES, V87, P2748, DOI 10.1002/jnr.22106
   Ansved T, 1998, NEUROLOGY, V51, P1442, DOI 10.1212/WNL.51.5.1442
   Artuso L, 2013, AMYOTROPH LAT SCL FR, V14, P261, DOI 10.3109/21678421.2012.735239
   Beitel LK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00053
   Berger A, 2003, ACTA NEUROPATHOL, V105, P245, DOI 10.1007/s00401-002-0638-1
   Borthwick Gillian M, 2006, Ann Neurol, V59, P570, DOI 10.1002/ana.20758
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Crugnola V, 2010, ARCH NEUROL-CHICAGO, V67, P849, DOI 10.1001/archneurol.2010.128
   Dhaliwal GK, 2000, NEUROREPORT, V11, P2507, DOI 10.1097/00001756-200008030-00032
   Fernández-Rhodes LE, 2011, LANCET NEUROL, V10, P140, DOI 10.1016/S1474-4422(10)70321-5
   Finsterer J, 2010, J NEUROL SCI, V298, P1, DOI 10.1016/j.jns.2010.08.025
   Gajewski CD, 2003, EXP NEUROL, V179, P229, DOI 10.1016/S0014-4886(02)00022-5
   Hamano T, 2004, J NEUROL SCI, V222, P93, DOI 10.1016/j.jns.2004.04.028
   Hashizume A, 2012, BRAIN, V135, P2838, DOI 10.1093/brain/aws170
   Jochum T, 2012, BBA-MOL BASIS DIS, V1822, P1070, DOI 10.1016/j.bbadis.2012.02.006
   Jordan CL, 2008, CURR OPIN PHARMACOL, V8, P752, DOI 10.1016/j.coph.2008.08.006
   Katsuno M, 2012, ARCH NEUROL-CHICAGO, V69, P436, DOI 10.1001/archneurol.2011.2308
   Kirches E, 1999, PATHOBIOLOGY, V67, P214, DOI 10.1159/000028075
   Liu CS, 2008, J NEUROL SCI, V264, P18, DOI 10.1016/j.jns.2007.07.016
   Malik B, 2011, HUM MOL GENET, V20, P1776, DOI 10.1093/hmg/ddr061
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mancuso M, 2010, J NEUROL, V257, P774, DOI 10.1007/s00415-009-5409-7
   Mancuso Michelangelo, 2008, Human Genomics, V3, P71
   Mano T, 2012, MUSCLE NERVE, V46, P692, DOI 10.1002/mus.23413
   Meriggioli MN, 2003, MUSCLE NERVE, V27, P249, DOI 10.1002/mus.10295
   Mo KG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012922
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Pons R, 1996, PEDIATR NEUROL, V15, P153, DOI 10.1016/0887-8994(96)00118-X
   Preisler N, 2009, NEUROLOGY, V72, P317, DOI 10.1212/01.wnl.0000341274.61236.02
   Pronicki M, 2010, EUR J PAEDIATR NEURO, V14, P253, DOI 10.1016/j.ejpn.2009.09.008
   Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310
   Rhodes LE, 2009, BRAIN, V132, P3242, DOI 10.1093/brain/awp258
   Ro LS, 2003, MUSCLE NERVE, V28, P737, DOI 10.1002/mus.10504
   Russell AP, 2013, NEUROBIOL DIS, V49, P107, DOI 10.1016/j.nbd.2012.08.015
   Sorarù G, 2008, J NEUROL SCI, V264, P100, DOI 10.1016/j.jns.2007.08.012
   Su SL, 2010, CLIN CHIM ACTA, V411, P626, DOI 10.1016/j.cca.2009.12.007
   Swerdlow RH, 1998, EXP NEUROL, V153, P135, DOI 10.1006/exnr.1998.6866
   Tarnopolsky MA, 2004, AM J MED GENET A, V125A, P310, DOI 10.1002/ajmg.a.20466
   Vucic S, 2011, MUSCLE NERVE, V44, P197, DOI 10.1002/mus.22017
   Yu Z, 2006, J CLIN INVEST, V116, P2663, DOI 10.1172/JCI28773
NR 40
TC 10
Z9 11
U1 0
U2 5
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1566-5240
EI 1875-5666
J9 CURR MOL MED
JI Curr. Mol. Med.
PY 2014
VL 14
IS 5
BP 598
EP 602
DI 10.2174/1566524014666140603100131
PG 5
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA AK6HG
UT WOS:000338528100003
PM 24894177
DA 2024-11-01
ER

PT J
AU Finsterer, J
AF Finsterer, Josef
TI Pharmacotherapeutic management of epilepsy in MERRF syndrome
SO EXPERT OPINION ON PHARMACOTHERAPY
LA English
DT Review
DE MERRF syndrome; m; 8344A>G; seizures; antiepileptic drugs; gene;
   mitochondrial disorder; epilepsy
ID RAGGED-RED FIBERS; MERRF/MELAS OVERLAP SYNDROME; STROKE-LIKE EPISODES;
   MYOCLONIC-ASTATIC EPILEPSY; TRANSFER-RNA LYS; MITOCHONDRIAL-DNA; A8344G
   MUTATION; G8363A MUTATION; PATIENT; PHENOTYPE
AB Introduction: Epilepsy is a prominent feature of myoclonic epilepsy with ragged-red fibers (MERRF)-syndrome. The most frequent seizure type is myoclonic seizures, of which the treatment is challenging and empiric. Areas covered: Herein, the author summarises and discusses previous and recent findings of antiepileptic drug (AED) treatment in MERRF-syndrome. Expert opinion: MERRF-syndrome is a predominantly maternally inherited, multisystem mitochondrial disorder caused by pathogenic variants predominantly of the mitochondrial DNA (mtDNA). Canonical clinical features of MERRF include myoclonus, epilepsy, ataxia, and myopathy. Additionally, other manifestations in the CNS, peripheral nerves, eyes, ears, heart, gastrointestinal tract, and endocrine organs may occur (MERRF-plus). Today, MERRF is considered rather as myoclonic ataxia than as myoclonic epilepsy. Genotypically, MERRF is due to mutations in 13 mtDNA-located genes and 1 nDNA-located gene. According to the modified Smith-score, the strongest gene-disease relationship exists for MT-TK, MT-TL1, and POLG1. Epilepsy is the second most frequent phenotypic feature of MERRF. Seizure-types associated with MERRF include focal myoclonic, focal clonic, and focal atonic seizures, generalized myoclonic, tonic-clonic, atonic, and myoclonic-atonic seizures, or typical absences. Treatment of myoclonic epilepsy relies on expert judgments recommending levetiracetam, together with clonazepam, or topiramate, zonisamide, or piracetam in monotherapy as the first line AEDs.
C1 [Finsterer, Josef] Messerli Inst, Krankenanstalt Rudolfstiftung, Postfach 20, A-1180 Vienna, Austria.
C3 Rudolfstiftung Hospital
RP Finsterer, J (corresponding author), Messerli Inst, Krankenanstalt Rudolfstiftung, Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Abou-Khalil Bassel, 2008, Neuropsychiatr Dis Treat, V4, P507
   Afra P, 2012, SEIZURE-EUR J EPILEP, V21, P202, DOI 10.1016/j.seizure.2011.12.010
   Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   Arenas J, 1999, NEUROLOGY, V52, P377, DOI 10.1212/WNL.52.2.377
   Austin SA, 1998, NEUROLOGY, V51, P1447, DOI 10.1212/WNL.51.5.1447
   Ban R, 2018, CHINESE MED J-PEKING, V131, P1569, DOI 10.4103/0366-6999.235120
   BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231
   Biancheri R, 2010, AJNR Am J Neuroradiol, V31, pE78, DOI 10.3174/ajnr.A2182
   Bindoff LA, 2012, EPILEPSIA, V53, P92, DOI 10.1111/j.1528-1167.2012.03618.x
   Bindu PS, 2018, CLIN NEUROL NEUROSUR, V164, P182, DOI 10.1016/j.clineuro.2017.12.010
   Blakely EL, 2014, NEUROMUSCULAR DISORD, V24, P533, DOI 10.1016/j.nmd.2014.03.011
   CALABRESI PA, 1994, MUSCLE NERVE, V17, P943, DOI 10.1002/mus.880170815
   Campos Y, 1996, MUSCLE NERVE, V19, P187, DOI 10.1002/(SICI)1097-4598(199602)19:2<187::AID-MUS10>3.0.CO;2-S
   Carré F, 2019, EUR ANN OTORHINOLARY, V136, P113, DOI 10.1016/j.anorl.2018.10.015
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Caviness JN, 2014, NEUROTHERAPEUTICS, V11, P188, DOI 10.1007/s13311-013-0216-3
   Chandra SR, 2015, J POSTGRAD MED, V61, P200, DOI 10.4103/0022-3859.150905
   CHEN RS, 1993, ACTA NEUROL SCAND, V87, P494
   Chen ST, 2008, J CHILD NEUROL, V23, P1447, DOI 10.1177/0883073808318541
   Choi BO, 2010, EXP MOL MED, V42, P446, DOI 10.3858/emm.2010.42.6.046
   COQUET M, 1993, NEUROMUSCULAR DISORD, V3, P593, DOI 10.1016/0960-8966(93)90122-Z
   Crest C, 2004, NEUROLOGY, V62, P640, DOI 10.1212/01.WNL.0000110193.78872.DD
   De la Mata M, 2012, NEUROTHERAPEUTICS, V9, P446, DOI 10.1007/s13311-012-0103-3
   O'Callaghan MD, 2012, NEUROGENETICS, V13, P245, DOI 10.1007/s10048-012-0322-0
   Delgado-Escueta AV, 2001, AM J MED GENET, V106, P129, DOI 10.1002/ajmg.1575
   DiMauro S, 2002, ADV NEUROL, V89, P217
   DiMauro S., 2003, GeneReviews
   Herrero-Martín MD, 2010, J NEUROL NEUROSUR PS, V81, P471, DOI 10.1136/jnnp.2009.173831
   Emmanuele V, 2011, MUSCLE NERVE, V44, P448, DOI 10.1002/mus.22149
   Erdocia-Goñi A, 2018, REV NEUROLOGIA, V66, P268, DOI 10.33588/rn.6608.2017503
   Erol I, 2009, NEUROMUSCULAR DISORD, V19, P275, DOI 10.1016/j.nmd.2009.01.012
   Fan PC, 2014, J FORMOS MED ASSOC, V113, P258, DOI 10.1016/j.jfma.2013.02.008
   FANG W, 1994, MUSCLE NERVE, V17, P52, DOI 10.1002/mus.880170107
   Fedi M, 2001, ARCH NEUROL-CHICAGO, V58, P781, DOI 10.1001/archneur.58.5.781
   Finsterer J, 2013, ACTA NEUROL SCAND, V128, P141, DOI 10.1111/ane.12122
   Finsterer J, 2018, PEDIATR NEUROL, V80, P8, DOI 10.1016/j.pediatrneurol.2017.12.005
   Finsterer J, 2017, IRAN J NEUROL, V16, P45
   Finsterer J, 2017, SEIZURE-EUR J EPILEP, V50, P166, DOI 10.1016/j.seizure.2017.06.010
   Finsterer J, 2016, EUR J PAEDIATR NEURO, V20, P824, DOI 10.1016/j.ejpn.2016.08.002
   Finsterer J, 2016, J NEUROL, V263, P586, DOI 10.1007/s00415-016-8028-0
   Finsterer J, 2012, SEIZURE-EUR J EPILEP, V21, P316, DOI 10.1016/j.seizure.2012.03.003
   Finsterer J, 2012, EXPERT OPIN DRUG MET, V8, P71, DOI 10.1517/17425255.2012.644535
   Florian A, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0145-x
   Frye RE, 2015, EPILEPSY BEHAV, V47, P147, DOI 10.1016/j.yebeh.2014.08.134
   Fukuhara Nobuyoshi, 2008, Brain and Nerve (Tokyo), V60, P53
   Gilson Robert Christopher, 2018, JAAD Case Rep, V4, P822, DOI 10.1016/j.jdcr.2018.05.004
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Howell N, 1996, NEUROLOGY, V46, P219, DOI 10.1212/WNL.46.1.219
   Ito S, 2008, AM J NEURORADIOL, V29, P392, DOI 10.3174/ajnr.A0865
   Iwanga K, 1992, Rinsho Shinkeigaku, V32, P870
   Kilaru S, 2007, EPILEPSIA, V48, P1703, DOI 10.1111/j.1528-1167.2007.01186.x
   Kobayashi J, 2010, INTERNAL MED, V49, P479, DOI 10.2169/internalmedicine.49.2996
   Koubeissi MZ, 2009, NEUROLOGY, V72, P858, DOI 10.1212/01.wnl.0000343959.15205.52
   Lamperti C, 2016, EPILEPTIC DISORD, V18, pS94
   Levy A, 2016, CURR TREAT OPTION NE, V18, DOI 10.1007/s11940-016-0404-7
   Liu KM, 2014, METAB BRAIN DIS, V29, P139, DOI 10.1007/s11011-013-9464-5
   Lorenzoni PJ, 2014, ARQ NEURO-PSIQUIAT, V72, P803, DOI 10.1590/0004-282X20140124
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Mancuso M, 2006, J NEUROL SCI, V243, P97, DOI 10.1016/j.jns.2005.11.021
   Mancuso M, 2014, MOVEMENT DISORD, V29, P722, DOI 10.1002/mds.25839
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Mantoan L, 2011, CURR TREAT OPTION NE, V13, P355, DOI 10.1007/s11940-011-0131-z
   Martín-Jiménez R, 2012, MITOCHONDRION, V12, P288, DOI 10.1016/j.mito.2011.10.004
   Michelucci R, 2016, EPILEPTIC DISORD, V18, pS145, DOI 10.1684/epd.2016.0861
   Miyaue N, 2018, INTERNAL MED, V57, P3439, DOI 10.2169/internalmedicine.1210-18
   Molnar MJ, 2009, J NEUROL, V256, P264, DOI 10.1007/s00415-009-0841-2
   Monden Y, 2013, BRAIN DEV-JPN, V35, P582, DOI 10.1016/j.braindev.2012.08.006
   Mongini T, 2002, CLIN NEUROPATHOL, V21, P72
   Morales-López RA, 2019, UROL CASE REP, V22, P21, DOI 10.1016/j.eucr.2018.10.006
   Najjar RP, 2019, J NEURO-OPHTHALMOL, V39, P18, DOI 10.1097/WNO.0000000000000690
   Nakamura M, 2010, J MED GENET, V47, P659, DOI 10.1136/jmg.2009.072058
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Nomura T, 1993, Rinsho Shinkeigaku, V33, P1198
   Orcesi S, 2006, J CHILD NEUROL, V21, P79, DOI 10.1177/08830738060210010901
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Park SY, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00520
   Peng Y, 2003, MOVEMENT DISORD, V18, P716, DOI 10.1002/mds.10428
   PRANZATELLI MR, 1995, EPILEPSIA, V36, P783, DOI 10.1111/j.1528-1157.1995.tb01615.x
   Santamarina E, 2015, EPILEPSY BEHAV CASE, V4, P56, DOI 10.1016/j.ebcr.2015.06.007
   Scalais E, 2013, EUR J PAEDIATR NEURO, V17, P625, DOI 10.1016/j.ejpn.2013.05.013
   Shen CZ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00724
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shtilbans A, 2000, J CHILD NEUROL, V15, P759, DOI 10.1177/088307380001501109
   SILVA MTG, 1987, NEUROPEDIATRICS, V18, P200, DOI 10.1055/s-2008-1052480
   Sinha S, 2007, EPILEPSY RES, V74, P55, DOI 10.1016/j.eplepsyres.2006.12.003
   Sitburana Oraporn, 2001, Journal of the Medical Association of Thailand, V84, P1051
   Sort R, 2013, EUR J PAEDIATR NEURO, V17, P531, DOI 10.1016/j.ejpn.2013.05.001
   Steele HE, 2015, SEMIN NEUROL, V35, P300, DOI 10.1055/s-0035-1552624
   Su LJ, 2018, CHINESE MED J-PEKING, V131, P2433, DOI 10.4103/0366-6999.243568
   Suzuki Y, 1997, DIABETES CARE, V20, P1138, DOI 10.2337/diacare.20.7.1138
   Tanji K, 2003, ACTA NEUROPATHOL, V105, P69, DOI 10.1007/s00401-002-0604-y
   Taylor D, 2013, CASE REP NEUROL MED, V2013, DOI 10.1155/2013/125672
   Toyono M, 2001, NEUROMUSCULAR DISORD, V11, P300, DOI 10.1016/S0960-8966(00)00176-0
   TSAIRIS P, 1973, NEUROLOGY, V23, P408
   Vallance HD, 2004, PEDIATR CARDIOL, V25, P538, DOI 10.1007/s00246-003-0446-y
   van de Glind G, 2007, EUR J PAEDIATR NEURO, V11, P243, DOI 10.1016/j.ejpn.2007.01.004
   Vastagh I, 2011, IDEGGYOGY SZEMLE, V64, P399
   Verma A, 1996, NEUROLOGY, V46, P1334, DOI 10.1212/WNL.46.5.1334
   Vilela H, 2005, PEDIATR ANESTH, V15, P77, DOI 10.1111/j.1460-9592.2005.01384.x
   Virgilio R, 2009, J NEUROL SCI, V281, P85, DOI 10.1016/j.jns.2009.01.025
   von Stülpnagel C, 2012, EUR J PAEDIATR NEURO, V16, P459, DOI 10.1016/j.ejpn.2011.12.012
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   Wang YL, 1999, AM J HEMATOL, V60, P83, DOI 10.1002/(SICI)1096-8652(199901)60:1<83::AID-AJH19>3.0.CO;2-N
   Whittaker RG, 2015, ANN NEUROL, V78, P949, DOI 10.1002/ana.24525
   Wiedemann FR, 2008, CLIN NEUROL NEUROSUR, V110, P859, DOI 10.1016/j.clineuro.2008.06.010
   Yang Hecheng, 2014, Pediatr Neurol, V51, pe19, DOI 10.1016/j.pediatrneurol.2014.08.020
   Zaganas I, 2009, J NEUROL, V256, P271, DOI 10.1007/s00415-009-0921-3
   Zhao Juan, 2012, Zhonghua Yi Xue Za Zhi, V92, P2835
   Zhao Man-man, 2015, Beijing Da Xue Xue Bao Yi Xue Ban, V47, P1034
   Zsurka G, 2013, SEIZURE-EUR J EPILEP, V22, P483, DOI 10.1016/j.seizure.2013.03.003
   Zupanc ML, 2010, PEDIATR NEUROL, V42, P396, DOI 10.1016/j.pediatrneurol.2010.02.013
NR 113
TC 6
Z9 8
U1 0
U2 8
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1465-6566
EI 1744-7666
J9 EXPERT OPIN PHARMACO
JI Expert Opin. Pharmacother.
PD JUL 3
PY 2019
VL 20
IS 10
BP 1289
EP 1297
DI 10.1080/14656566.2019.1609941
EA APR 2019
PG 9
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA IG0ZA
UT WOS:000470379300001
PM 31063406
DA 2024-11-01
ER

PT J
AU Yazdani, M
AF Yazdani, Mazyar
TI Cellular and Molecular Responses to Mitochondrial DNA Deletions in
   Kearns-Sayre Syndrome: Some Underlying Mechanisms
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE Reactive Oxygen Species (ROS); Myelin Vacuolation; Autophagy; Apoptosis;
   Oligodendrocyte; Lipid raft
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MYELIN-ASSOCIATED GLYCOPROTEIN;
   REACTIVE OXYGEN; NEURODEGENERATIVE DISEASES; TISSUE DISTRIBUTION; ENERGY
   DEMAND; MTDNA; NEUROPATHOLOGY; MUTATIONS; APOPTOSIS
AB Kearns-Sayre syndrome (KSS) is a rare multisystem mitochondrial disorder. It is caused by mitochondrial DNA (mtDNA) rearrangements, mostly large-scale deletions of 1.1-10 kb. These deletions primarily affect energy supply through impaired oxidative phosphorylation and reduced ATP production. This impairment gives rise to dysfunction of several tissues, in particular those with high energy demand like brain and muscles. Over the past decades, changes in respiratory chain complexes and energy metabolism have been emphasized, whereas little attention has been paid to other reports on ROS overproduction, protein synthesis inhibition, myelin vacuolation, demyelination, autophagy, apoptosis, and involvement of lipid raft and oligodendrocytes in KSS. Therefore, this paper draws attention towards these relatively underemphasized findings that might further clarify the pathologic cascades following deletions in the mtDNA.
C1 [Yazdani, Mazyar] Oslo Univ Hosp, Dept Med Biochem, Rikshosp, N-0027 Oslo, Norway.
C3 University of Oslo; National Hospital Norway
RP Yazdani, M (corresponding author), Oslo Univ Hosp, Dept Med Biochem, Rikshosp, N-0027 Oslo, Norway.
EM mazyar.yazdani.edu@gmail.com
RI Yazdani, Mazyar/GRJ-3086-2022
OI Yazdani, Mazyar/0000-0002-9187-3231
CR Ajoolabady A, 2021, CLIN EXP PHARMACOL P, V48, P943, DOI 10.1111/1440-1681.13500
   Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014
   ALLEN RJ, 1983, ANN NEUROL, V13, P679, DOI 10.1002/ana.410130620
   Amador MD, 2018, J INHERIT METAB DIS, V41, P447, DOI 10.1007/s10545-017-0134-3
   ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Atkinson JB, 2009, MODERN SURG PATHOLOG, P2069
   BALL EH, 1982, P NATL ACAD SCI-BIOL, V79, P123, DOI 10.1073/pnas.79.1.123
   Barkovich AJ, 2000, AM J NEURORADIOL, V21, P1099
   Barrera-Ramirez CF, REV ESP CARDIOL
   Berardo A, 2010, CURR NEUROL NEUROSCI, V10, P118, DOI 10.1007/s11910-010-0096-4
   BERENBAUM F, 1990, NEUROLOGY, V40, P193, DOI 10.1212/WNL.40.1.193
   Berio A, 2017, PEDIAT MED CHIR, V39
   Betts J, 2004, NEUROCHEM RES, V29, P505, DOI 10.1023/B:NERE.0000014821.07269.8d
   BRESOLIN N, 1987, ANN NEUROL, V21, P564, DOI 10.1002/ana.410210607
   Brown GK, 2005, J INHERIT METAB DIS, V28, P393, DOI 10.1007/s10545-005-7051-6
   Brown GK, 1996, J INHERIT METAB DIS, V19, P553, DOI 10.1007/BF01799116
   CHEN X, 1995, AM J HUM GENET, V57, P239
   Chertkof J, 2020, OPHTHALMIC GENET, V41, P497, DOI 10.1080/13816810.2020.1799416
   Cisneros A, 2021, J STUD RES, V10
   CLARKE A, 1990, J MED GENET, V27, P451, DOI 10.1136/jmg.27.7.451
   Collins BE, 1997, J BIOL CHEM, V272, P1248, DOI 10.1074/jbc.272.2.1248
   CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Dailah HG, 2022, MOLECULES, V27, DOI 10.3390/molecules27217207
   Deigner HP, 2000, EXPERT OPIN INV DRUG, V9, P747, DOI 10.1517/13543784.9.4.747
   Delcarlo M, 2006, AM J PHYSIOL-CELL PH, V290, pC802, DOI 10.1152/ajpcell.00214.2005
   Duncan ID, 2016, EXP NEUROL, V283, P452, DOI 10.1016/j.expneurol.2016.04.002
   Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3
   Finsterer J, 2020, CASE REP NEUROL MED, V2020, DOI 10.1155/2020/7368527
   George KS, 2012, TOXICOL APPL PHARM, V259, P311, DOI 10.1016/j.taap.2012.01.007
   Gibson BW, 2005, INT J BIOCHEM CELL B, V37, P927, DOI 10.1016/j.biocel.2004.11.013
   Giussani P, 2021, J NEUROCHEM, V156, P403, DOI 10.1111/jnc.15133
   Goldstein A., 1993, GeneReviews((R))
   Goldstein A, 2019, MITOCHONDRIAL DNA DE
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Grigalioniene K, 2023, MOL GENET GENOM MED, V11, DOI 10.1002/mgg3.2059
   GUENTHARD J, 1995, ARCH DIS CHILD, V72, P223, DOI 10.1136/adc.72.3.223
   Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007
   Guo WT, 2020, SEMIN CELL DEV BIOL, V99, P133, DOI 10.1016/j.semcdb.2019.07.010
   Gustafson MA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221829
   Hamano T, 2012, NEUROBIOL AGING, V33, P2306, DOI 10.1016/j.neurobiolaging.2011.10.020
   Hardwick JP, 2014, GCT, V1
   HARVEY JN, 1992, CLIN ENDOCRINOL, V37, P97, DOI 10.1111/j.1365-2265.1992.tb02289.x
   Hastings N, 2022, CELL TRANSPLANT, V31, DOI 10.1177/09636897221105499
   Heiman P, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-07076-9
   Holloman CM, 2013, Case Rep, V2013
   HYLAND K, 1988, NEUROLOGY, V38, P459, DOI 10.1212/WNL.38.3.459
   Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026
   Inoue K, 1999, ANN NEUROL, V46, P313, DOI 10.1002/1531-8249(199909)46:3<313::AID-ANA6>3.0.CO;2-7
   Jacoby E, 2021, NPJ REGEN MED, V6, DOI 10.1038/s41536-021-00167-7
   James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x
   Jou MJ, 2005, ANN NY ACAD SCI, V1042, P221, DOI 10.1196/annals.1338.024
   Kandel J, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0071
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1
   Kennedy PGE, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23147584
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282
   Kleinle S, 1997, HUM GENET, V100, P643, DOI 10.1007/s004390050567
   Komen JC, 2014, BRIT J PHARMACOL, V171, P1818, DOI 10.1111/bph.12413
   Kontou M, 2009, BIOL CHEM, V390, P575, DOI 10.1515/BC.2009.058
   Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911
   Lackner LL, 2013, CURR OPIN CELL BIOL, V25, P471, DOI 10.1016/j.ceb.2013.02.011
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   Lax NZ, 2012, ARCH NEUROL-CHICAGO, V69, P490, DOI 10.1001/archneurol.2011.2167
   Lee CM, 1999, ONCOGENE, V18, P2997, DOI 10.1038/sj.onc.1202786
   Lee HG, 2022, NAT REV DRUG DISCOV, V21, P339, DOI 10.1038/s41573-022-00390-x
   Li WL, 2021, AGING DIS, V12, P2096, DOI 10.14336/AD.2021.0416
   Lightowlers RN, 2020, EMBO REP, V21, DOI 10.15252/embr.202050964
   Liu F, 2002, FEBS LETT, V512, P101, DOI 10.1016/S0014-5793(02)02228-7
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Maceluch Jaros Aw, 2006, Pediatr Endocrinol Rev, V4, P117
   Madan S, 2022, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.781933
   Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247
   MARTENS ME, 1988, ANN NEUROL, V24, P630, DOI 10.1002/ana.410240507
   Mayorga L, 2016, MITOCHONDRIAL DNA A, V27, P2864, DOI 10.3109/19401736.2015.1053132
   Meske V, 2003, EUR J NEUROSCI, V17, P93, DOI 10.1046/j.1460-9568.2003.02433.x
   Mokranjac D, 2009, BBA-MOL CELL RES, V1793, P33, DOI 10.1016/j.bbamcr.2008.06.021
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1995, MUSCLE NERVE, pS150
   Moroni I, 2002, NEUROPEDIATRICS, V33, P79, DOI 10.1055/s-2002-32372
   MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315
   Nadeem Arsalan, 2023, eNeurologicalSci, V30, P100448, DOI 10.1016/j.ensci.2023.100448
   Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409
   NIH, 2020, FACT SHEET HLTH PROF
   Nissanka N, 2018, FEBS LETT, V592, P728, DOI 10.1002/1873-3468.12956
   Obeid R, 2006, FEBS LETT, V580, P2994, DOI 10.1016/j.febslet.2006.04.088
   Obeid R, 2007, CLIN CHEM, V53, P1129, DOI 10.1373/clinchem.2006.085241
   OBERMAIERKUSSER B, 1990, BIOCHEM BIOPH RES CO, V169, P1007, DOI 10.1016/0006-291X(90)91994-4
   OLDFORS A, 1990, ACTA NEUROPATHOL, V80, P541, DOI 10.1007/BF00294616
   Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003
   Park H, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093369
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Pitceathly RDS, 2011, J MED GENET, V48, P610, DOI 10.1136/jmg.2010.088328
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Porteous WK, 1998, EUR J BIOCHEM, V257, P192, DOI 10.1046/j.1432-1327.1998.2570192.x
   POULTON J, 1994, HUM MOL GENET, V3, P947, DOI 10.1093/hmg/3.6.947
   POULTON J, 1993, HUM MOL GENET, V2, P23, DOI 10.1093/hmg/2.1.23
   POULTON J, 1995, MUSCLE NERVE, pS154
   Prigione A, 2007, AGING CELL, V6, P619, DOI 10.1111/j.1474-9726.2007.00323.x
   Prolo LM, 2009, J NEUROSCI, V29, P15355, DOI 10.1523/JNEUROSCI.3005-09.2009
   Quntanilla RA, 2020, CURR NEUROPHARMACOL, V18, P1076, DOI 10.2174/1570159X18666200525020259
   Raine CS, 1999, ANN NEUROL, V46, P144, DOI 10.1002/1531-8249(199908)46:2<144::AID-ANA3>3.0.CO;2-K
   Redza-Dutordoir M, 2021, BBA-MOL CELL RES, V1868, DOI 10.1016/j.bbamcr.2021.119041
   Redza-Dutordoir M, 2016, BBA-MOL CELL RES, V1863, P2977, DOI 10.1016/j.bbamcr.2016.09.012
   REICHMANN H, 1993, ACTA NEUROPATHOL, V85, P679, DOI 10.1007/BF00334681
   Rius R, 2019, GENET MED, V21, P2823, DOI 10.1038/s41436-019-0568-0
   Rose MR, 1998, ARCH NEUROL-CHICAGO, V55, P17, DOI 10.1001/archneur.55.1.17
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   ROTIG A, 1991, GENOMICS, V10, P502, DOI 10.1016/0888-7543(91)90342-C
   Ruiz-Pesini E, 2010, MITOMAP HUMAN MITOCH
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   Ryzhkova AI, 2018, THER CLIN RISK MANAG, V14, P1933, DOI 10.2147/TCRM.S154863
   Sabella-Jiménez V, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1509
   Saldaña-Martínez A, 2019, GENE, V688, P171, DOI 10.1016/j.gene.2018.11.085
   Salvador CL, 2023, PEDIATR NEUROL
   Sarnat HB, 2005, CAN J NEUROL SCI, V32, P152, DOI 10.1017/S0317167100003929
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Scrivo A, 2018, LANCET NEUROL, V17, P802, DOI 10.1016/S1474-4422(18)30238-2
   Sequiera GL, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10030568
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   Shemesh A., 2022, MARGOLIN KEARNS SAYR
   Simoes-Costa M, 2013, GENOME RES, V23, P1069, DOI 10.1101/gr.157586.113
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408
   Smith KJ, 1999, BRAIN PATHOL, V9, P69
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Srivastava A, 2021, STEM CELL RES, V53, DOI 10.1016/j.scr.2021.102283
   Stankiewicz TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00314
   Stefano GB, 2022, CELL MOL NEUROBIOL, V42, P99, DOI 10.1007/s10571-021-01117-z
   Stefano GB, 2016, BIOMED REP, V4, P259, DOI 10.3892/br.2016.590
   Steinfeld R, 2009, AM J HUM GENET, V85, P354, DOI 10.1016/j.ajhg.2009.08.005
   Szalardy L, 2016, FOLIA NEUROPATHOL, V54, P9, DOI 10.5114/fn.2016.58911
   Szalardy L, 2013, NEURODEGENER DIS, V12, P177, DOI 10.1159/000346267
   Tang YY, 2000, MOL BIOL CELL, V11, P1471, DOI 10.1091/mbc.11.4.1471
   Tanji K, 1999, J NEUROL SCI, V166, P64, DOI 10.1016/S0022-510X(99)00114-8
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   Tatton WG, 1999, BBA-BIOENERGETICS, V1410, P195, DOI 10.1016/S0005-2728(98)00167-4
   Tonska K, 2012, GENE, V506, P161, DOI 10.1016/j.gene.2012.06.081
   Valiente-Pallejà A, 2022, EBIOMEDICINE, V76, DOI 10.1016/j.ebiom.2022.103815
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vidal RL, 2014, TRENDS PHARMACOL SCI, V35, P39, DOI 10.1016/j.tips.2014.09.002
   Vielhaber S, 2000, MUSCLE FIBRES APPL S
   Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100
   Vogel H, 2001, J NEUROPATH EXP NEUR, V60, P217, DOI 10.1093/jnen/60.3.217
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wang XH, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.749244
   Yazdani M, 2015, TOXICOL IN VITRO, V30, P578, DOI 10.1016/j.tiv.2015.08.010
   YORIFUJI S, 1985, J NEUROL SCI, V71, P65, DOI 10.1016/0022-510X(85)90037-1
   Yoshimi A, 2022, ORPHANET J RARE DIS, V17, DOI 10.1186/s13023-022-02538-9
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118
   Zhang L, 2018, CIRCULATION, V137, P1374, DOI 10.1161/CIRCULATIONAHA.117.031139
   Zhu Q, 2022, BMC OPHTHALMOL, V22, DOI 10.1186/s12886-021-02224-7
NR 160
TC 1
Z9 1
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD AUG
PY 2024
VL 61
IS 8
BP 5665
EP 5679
DI 10.1007/s12035-024-03938-7
EA JAN 2024
PG 15
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA YV3A9
UT WOS:001142024400001
PM 38224444
DA 2024-11-01
ER

PT J
AU Plutino, M
   Chaussenot, A
   Rouzier, C
   Ait-El-Mkadem, S
   Fragaki, K
   Paquis-Flucklinger, V
   Bannwarth, S
AF Plutino, Morgane
   Chaussenot, Annabelle
   Rouzier, Cecile
   Ait-El-Mkadem, Samira
   Fragaki, Konstantina
   Paquis-Flucklinger, Veronique
   Bannwarth, Sylvie
TI Targeted next generation sequencing with an extended gene panel does not
   impact variant detection in mitochondrial diseases
SO BMC MEDICAL GENETICS
LA English
DT Article
DE Mitochondrial disorders; Next generation sequencing; Targeted panel;
   Exome
ID MUTATIONS; NEUROPATHY; PHENOTYPE; MYOPATHY; SPECTRUM; COHORT; ATAXIA;
   COMMON
AB Background: Since the advent of next generation sequencing (NGS), several studies have tried to evaluate the relevance of targeted gene panel sequencing and whole exome sequencing for molecular diagnosis of mitochondrial diseases. The comparison between these different strategies is extremely difficult. A recent study analysed a cohort of patients affected by a mitochondrial disease using a NGS approach based on a targeted gene panel including 132 genes. This strategy led to identify the causative mutations in 15.2% of cases. The number of novel genes responsible for respiratory chain deficiency increases very rapidly.
   Methods: In order to determine the impact of larger panels used as a first screening strategy on molecular diagnosis success, we analysed a cohort of 80 patients affected by a mitochondrial disease with a first mitochondrial DNA (mtDNA) NGS screening and secondarily a targeted mitochondrial panel of 281 nuclear genes.
   Results: Pathogenic mtDNA abnormalities were identified in 4.1% (1/24) of children and 25% (14/56) of adult patients. The remaining 65 patients were analysed with our targeted mitochondrial panel and this approach enabled us to achieve an identification rate of 21.7% (5/23) in children versus 7.1% (3/42) in adults.
   Conclusions: Our results confirm that larger gene panels do not improve diagnostic yield of mitochondrial diseases due to (i) their very high genetic heterogeneity, (ii) the ongoing discovery of novel genes and (iii) mutations in genes apparently not related to mitochondrial function that lead to secondary respiratory chain deficiency.
C1 [Plutino, Morgane; Chaussenot, Annabelle; Rouzier, Cecile; Ait-El-Mkadem, Samira; Fragaki, Konstantina; Paquis-Flucklinger, Veronique; Bannwarth, Sylvie] Univ Cote Azur, CHU Nice, INSERM, CNRS,IRCAN, Nice, France.
   [Bannwarth, Sylvie] INSERM U1081, IRCAN, UMR CNRS 7284, Sch Med, 28 Valombrose, F-06107 Nice 2, France.
C3 CHU Nice; Centre National de la Recherche Scientifique (CNRS);
   Universite Cote d'Azur; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Institut National de la Sante et de la Recherche
   Medicale (Inserm); Universite Cote d'Azur
RP Paquis-Flucklinger, V; Bannwarth, S (corresponding author), Univ Cote Azur, CHU Nice, INSERM, CNRS,IRCAN, Nice, France.; Bannwarth, S (corresponding author), INSERM U1081, IRCAN, UMR CNRS 7284, Sch Med, 28 Valombrose, F-06107 Nice 2, France.
EM paquis@unice.fr; bannwarth@unice.fr
RI Rouzier, Cecile/KCY-3619-2024; Plutino, Morgane/JGD-4310-2023
FU French ministry health
FX This work was made possible by grant to VP-F from the French ministry
   health.
CR Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200
   Ardissone A, 2015, NEUROLOGY, V84, P2193, DOI 10.1212/WNL.0000000000001613
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Chung KW, 2006, BRAIN, V129, P2103, DOI 10.1093/brain/awl174
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   DaRe JT, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-118
   Di Meglio C, 2016, BRAIN DEV-JPN, V38, P498, DOI 10.1016/j.braindev.2015.11.006
   Duis J, 2016, ANN NEUROL, V80, P633, DOI 10.1002/ana.24744
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Ferré M, 2009, HUM MUTAT, V30, pE692, DOI 10.1002/humu.21025
   Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378
   Gros-Louis F, 2007, NAT GENET, V39, P80, DOI 10.1038/ng1927
   Kocaefe YÇ, 2003, EUR J HUM GENET, V11, P102, DOI 10.1038/sj.ejhg.5200908
   Legati A, 2016, BBA-BIOENERGETICS, V1857, P1326, DOI 10.1016/j.bbabio.2016.02.022
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40
   Liu YT, 2014, NEUROLOGY, V83, P612, DOI 10.1212/WNL.0000000000000691
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   Monnot S, 2009, HUM MUTAT, V30, P734, DOI 10.1002/humu.20908
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Morel G, 2016, NEUROMUSCULAR DISORD, V26, P885, DOI 10.1016/j.nmd.2016.09.012
   Neubauer J, 2017, EUR J HUM GENET, V25, P404, DOI 10.1038/ejhg.2016.199
   Ohtake A, 2014, BBA-GEN SUBJECTS, V1840, P1355, DOI 10.1016/j.bbagen.2014.01.025
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Saneto RP, 2017, ADV GENET, V98, P63, DOI 10.1016/bs.adgen.2017.06.002
   Sergouniotis PI, 2015, NEUROGENETICS, V16, P69, DOI 10.1007/s10048-014-0416-y
   Synofzik M, 2016, BRAIN, V139, P1378, DOI 10.1093/brain/aww079
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Tiranti V, 2006, J MED GENET, V43, P340, DOI 10.1136/jmg.2005.036210
   Van Maldergem L, 2017, ANN CLIN TRANSL NEUR, V4, P4, DOI 10.1002/acn3.361
   Vasta V, 2012, PEDIATR INT, V54, P585, DOI 10.1111/j.1442-200X.2012.03644.x
   Vasta V, 2009, GENOME MED, V1, DOI 10.1186/gm100
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Wightman PJ, 2003, HUM MUTAT, V22, P288, DOI 10.1002/humu.10264
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 42
TC 16
Z9 17
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2350
J9 BMC MED GENET
JI BMC Med. Genet.
PD APR 7
PY 2018
VL 19
AR 57
DI 10.1186/s12881-018-0568-y
PG 13
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA GC1UR
UT WOS:000429568400001
PM 29625556
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Gwaltney, C
   Stokes, J
   Aiudi, A
   Mazar, I
   Ollis, S
   Love, E
   Karaa, A
   Houts, CR
   Wirth, RJ
   Shields, AL
AF Gwaltney, Chad
   Stokes, Jonathan
   Aiudi, Anthony
   Mazar, Iyar
   Ollis, Sarah
   Love, Emily
   Karaa, Amel
   Houts, Carrie R.
   Wirth, R. J.
   Shields, Alan L.
TI Psychometric performance of the Primary Mitochondrial Myopathy Symptom
   Assessment (PMMSA) in a randomized, double-blind, placebo-controlled
   crossover study in subjects with mitochondrial disease
SO JOURNAL OF PATIENT-REPORTED OUTCOMES
LA English
DT Article
DE Psychometric evaluation; Patient-reported outcomes; Mitochondrial
   disease; Primary Mitochondrial Myopathy; Primary Mitochondrial Myopathy
   Symptom Assessment
ID PATIENT-REPORTED OUTCOMES; QUALITY-OF-LIFE; TASK-FORCE; PRO INSTRUMENTS;
   DNA MUTATIONS; PREVALENCE; SCALE; TIME
AB Background: The Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) is a 10-item patient-reported outcome (PRO) measure designed to assess the severity of mitochondrial disease symptoms. Analyses of data from a clinical trial with PMM patients were conducted to evaluate the psychometric properties of the PMMSA and to provide score interpretation guidelines for the measure.Methods: The PMMSA was completed as a daily diary for approximately 14 weeks by individuals in a Phase 2 randomized, placebo-controlled crossover trial evaluating the safety, tolerability, and efficacy of subcutaneous injections of elamipretide in patents with mitochondrial disease. In addition to the PMMSA, performance-based assessments, clinician ratings, and other PRO measures were also completed. Descriptive statistics, psychometric analyses, and score interpretation guidelines were evaluated for the PMMSA.Results: Participants (N = 30) had a mean age of 45.3 years, with the majority of the sample being female (n = 25, 83.3%) and non-Hispanic white (n = 29, 96.6%). The 10 PMMSA items assessing a diverse symptomology were not found to form a single underlying construct. However, four items assessing tiredness and muscle weakness were grouped into a "general fatigue " domain score. The PMMSA Fatigue 4 summary score (4FS) demonstrated stable test-retest scores, internal consistency, correlations with the scores produced by reference measures, and the ability to differentiate between different global health levels. Changes on the PMMSA 4FS were also related to change scores produced by the reference measures. PMMSA severity scores were higher for the symptom rated as "most bothersome " by each subject relative to the remaining nine PMMSA items (most bothersome symptom mean = 2.88 vs. 2.18 for other items). Distribution- and anchor-based evaluations suggested that reduction in weekly scores between 0.79 and 2.14 (scale range: 4-16) may represent a meaningful change on the PMMSA 4FS and reduction in weekly scores between 0.03 and 0.61 may represent a responder for each of the remaining six non-fatigue items, scored independently.Conclusions: Upon evaluation of its psychometric properties, the PMMSA, specifically the 4FS domain, demonstrated strong reliability and construct-related validity. The PMMSA can be used to evaluate treatment benefit in clinical trials with individuals with PMM.
C1 [Gwaltney, Chad] Gwaltney Consulting Grp, 1 Bucks Trail, Westerly, RI 02891 USA.
   [Stokes, Jonathan; Mazar, Iyar; Ollis, Sarah; Love, Emily; Shields, Alan L.] Adelphi Values, Boston, MA USA.
   [Aiudi, Anthony] Stealth BioTherapeut Inc, Newton, MA USA.
   [Karaa, Amel] Massachusetts Gen Hosp, Boston, MA USA.
   [Houts, Carrie R.; Wirth, R. J.] Vector Psychometr Grp LLC, Chapel Hill, NC USA.
C3 Harvard University; Massachusetts General Hospital
RP Gwaltney, C (corresponding author), Gwaltney Consulting Grp, 1 Bucks Trail, Westerly, RI 02891 USA.
EM cgwaltney@gwaltneyconsulting.com
RI Karaa, Amel/HNJ-5504-2023
FU Stealth Bio Therapeutics Inc.
FX Design, study conduct, and financial support for the study were provided
   by Stealth Bio Therapeutics Inc.
CR Béhin A, 2015, REV NEUROL-FRANCE, V171, P715, DOI 10.1016/j.neurol.2015.06.002
   Benjamin K, 2017, VALUE HEALTH, V20, P838, DOI 10.1016/j.jval.2017.05.015
   Brown TA., 2006, CONFIRMATORY FACTOR
   Cappelleri JC, 2014, CH CRC BIOSTAT SER, P1
   Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744
   Chinnery P.F., 1993, MITOCHONDRIAL DISORD
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155
   Cohen J., 1988, Statistical power analysis for the behavioral sciences, V2nd ed
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2006, CURR OPIN RHEUMATOL, V18, P636, DOI 10.1097/01.bor.0000245729.17759.f2
   DiMauro S, 2013, NEUROLOGY, V81, P281, DOI 10.1212/WNL.0b013e31829bfe89
   Elson JL, 2013, NEUROMUSCULAR DISORD, V23, P324, DOI 10.1016/j.nmd.2012.12.012
   Enright Paul L, 2003, Respir Care, V48, P783
   Goldstein A, 2021, J INHERIT METAB DIS, V44, P343, DOI 10.1002/jimd.12320
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Gwaltney Chad, 2020, J Clin Neuromuscul Dis, V22, P65, DOI 10.1097/CND.0000000000000303
   Husted JA, 2001, ARTHRIT RHEUM-ARTHR, V45, P151
   Karaa A, 2020, J CACHEXIA SARCOPENI, V11, P909, DOI 10.1002/jcsm.12559
   Karaa A, 2018, NEUROLOGY, V90, pE1212, DOI 10.1212/WNL.0000000000005255
   Mancuso M, 2017, NEUROMUSCULAR DISORD, V27, P1126, DOI 10.1016/j.nmd.2017.08.006
   National Institutes of Health, 2017, US
   Orsucci D, 2012, NEUROEPIDEMIOLOGY, V38, P195, DOI 10.1159/000337161
   Parikh S, 2019, J MED GENET, V56, P123, DOI 10.1136/jmedgenet-2018-105800
   Patrick DL, 2011, VALUE HEALTH, V14, P978, DOI 10.1016/j.jval.2011.06.013
   Patrick DL, 2011, VALUE HEALTH, V14, P967, DOI 10.1016/j.jval.2011.06.014
   Peipert JD, 2023, QUAL LIFE RES, V32, P1341, DOI 10.1007/s11136-022-03200-4
   Pfeffer G, 2013, NAT REV NEUROL, V9, P474, DOI 10.1038/nrneurol.2013.129
   PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x
   Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schmitz-Hübsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92
   Shields A, 2015, EXPERT REV PHARM OUT, V15, P951, DOI 10.1586/14737167.2015.1115348
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   U.S. Department of Health and Human Services Food and Drug Administration, 2009, GUID IND PAT REP OUT
   United Mitochondrial Disease Foundation, 2018, VOIC PAT REP MIT DIS, P1
   Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x
   Wirth RJ, 2007, PSYCHOL METHODS, V12, P58, DOI 10.1037/1082-989X.12.1.58
   Wyrwich KW, 2013, QUAL LIFE RES, V22, P475, DOI 10.1007/s11136-012-0175-x
   Zolkipli-Cunningham Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197513
NR 41
TC 2
Z9 2
U1 0
U2 0
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2509-8020
J9 J PATIENT-REP OUTCOM
JI J. Patient-Rep. Outcomes
PD DEC 23
PY 2022
VL 6
IS 1
AR 129
DI 10.1186/s41687-022-00534-y
PG 17
WC Health Care Sciences & Services; Health Policy & Services
WE Emerging Sources Citation Index (ESCI)
SC Health Care Sciences & Services
GA 7H9FU
UT WOS:000903502500001
PM 36562873
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Stumpf, JD
   Copeland, WC
AF Stumpf, Jeffrey D.
   Copeland, William C.
TI MMS Exposure Promotes Increased MtDNA Mutagenesis in the Presence of
   Replication-Defective Disease-Associated DNA Polymerase γ Variants
SO PLOS GENETICS
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MITOCHONDRIAL-DNA;
   SACCHAROMYCES-CEREVISIAE; EXONUCLEASE ACTIVITY; CATALYTIC SUBUNIT;
   OXIDATIVE STRESS; MISMATCH REPAIR; MUTATIONS; YEAST; GENE
AB Mitochondrial DNA (mtDNA) encodes proteins essential for ATP production. Mutant variants of the mtDNA polymerase cause mutagenesis that contributes to aging, genetic diseases, and sensitivity to environmental agents. We interrogated mtDNA replication in Saccharomyces cerevisiae strains with disease-associated mutations affecting conserved regions of the mtDNA polymerase, Mip1, in the presence of the wild type Mip1. Mutant frequency arising from mtDNA base substitutions that confer erythromycin resistance and deletions between 21-nucleotide direct repeats was determined. Previously, increased mutagenesis was observed in strains encoding mutant variants that were insufficient to maintain mtDNA and that were not expected to reduce polymerase fidelity or exonuclease proofreading. Increased mutagenesis could be explained by mutant variants stalling the replication fork, thereby predisposing the template DNA to irreparable damage that is bypassed with poor fidelity. This hypothesis suggests that the exogenous base-alkylating agent, methyl methanesulfonate (MMS), would further increase mtDNA mutagenesis. Mitochondrial mutagenesis associated with MMS exposure was increased up to 30-fold in mip1 mutants containing disease-associated alterations that affect polymerase activity. Disrupting exonuclease activity of mutant variants was not associated with increased spontaneous mutagenesis compared with exonuclease-proficient alleles, suggesting that most or all of the mtDNA was replicated by wild type Mip1. A novel subset of C to G transversions was responsible for about half of the mutants arising after MMS exposure implicating error-prone bypass of methylated cytosines as the predominant mutational mechanism. Exposure to MMS does not disrupt exonuclease activity that suppresses deletions between 21-nucleotide direct repeats, suggesting the MMS-induce mutagenesis is not explained by inactivated exonuclease activity. Further, trace amounts of CdCl2 inhibit mtDNA replication but suppresses MMS-induced mutagenesis. These results suggest a novel mechanism wherein mutations that lead to hypermutation by DNA base-damaging agents and associate with mitochondrial disease may contribute to previously unexplained phenomena, such as the wide variation of age of disease onset and acquired mitochondrial toxicities.
C1 [Stumpf, Jeffrey D.; Copeland, William C.] NIEHS, Mitochondrial DNA Replicat Grp, Mol Genet Lab, NIH,DHHS, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS)
RP Stumpf, JD (corresponding author), NIEHS, Mitochondrial DNA Replicat Grp, Mol Genet Lab, NIH,DHHS, POB 12233, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
RI Copeland, William/C-4242-2019
OI Copeland, William/0000-0002-0359-0953
FU National Institute of Environmental Health Sciences, National Institute
   of Health [ES-065078]
FX This work was supported by intramural funds from the National Institute
   of Environmental Health Sciences, National Institute of Health
   (ES-065078). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Acevedo-Torres K, 2009, ENVIRON MOL MUTAGEN, V50, P317, DOI 10.1002/em.20462
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023
   BLACKWOOD W, 1963, ARCH DIS CHILD, V38, P193, DOI 10.1136/adc.38.199.193
   Bogenhagen DF, 2001, PROG NUCLEIC ACID RE, V68, P257
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2009, MITOCHONDRION, V9, P340, DOI 10.1016/j.mito.2009.05.002
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   COPELAND WC, 1993, J BIOL CHEM, V268, P11028
   Doudican NA, 2005, MOL CELL BIOL, V25, P5196, DOI 10.1128/MCB.25.12.5196-5204.2005
   FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x
   FOURY F, 1989, J BIOL CHEM, V264, P20552
   Furda AM, 2012, DNA REPAIR, V11, P684, DOI 10.1016/j.dnarep.2012.06.002
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Jin YH, 2003, NAT GENET, V34, P326, DOI 10.1038/ng1172
   Johnson AA, 2001, J BIOL CHEM, V276, P38097
   Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3
   Kalifa L, 2007, DNA REPAIR, V6, P1732, DOI 10.1016/j.dnarep.2007.06.005
   Kalifa L, 2009, DNA REPAIR, V8, P1242, DOI 10.1016/j.dnarep.2009.07.008
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   Phadnis N, 2006, DNA REPAIR, V5, P829, DOI 10.1016/j.dnarep.2006.04.002
   PIRSEL M, 1993, CARCINOGENESIS, V14, P2105, DOI 10.1093/carcin/14.10.2105
   Pogorzala L, 2009, GENETICS, V182, P699, DOI 10.1534/genetics.109.103796
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   SOR F, 1984, NUCLEIC ACIDS RES, V12, P8313, DOI 10.1093/nar/12.22.8313
   Strand MK, 2003, EUKARYOT CELL, V2, P809, DOI 10.1128/EC.2.4.809-820.2003
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Stumpf JD, 2013, GENETICS, V194, P519, DOI 10.1534/genetics.113.150920
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011395
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Yang Y, 2010, DNA REPAIR, V9, P914, DOI 10.1016/j.dnarep.2010.06.005
   Yang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000264
   You HJ, 1999, BIOCHEMISTRY-US, V38, P11298, DOI 10.1021/bi991121i
NR 55
TC 18
Z9 21
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
J9 PLOS GENET
JI PLoS Genet.
PD OCT
PY 2014
VL 10
IS 10
AR e1004748
DI 10.1371/journal.pgen.1004748
PG 13
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA AT0UR
UT WOS:000344650700100
PM 25340760
OA gold, Green Published, Green Submitted
DA 2024-11-01
ER

PT J
AU Houshmand, M
   Panahi, MSS
   Hosseini, BN
   Dorraj, G
   Tabassi, AR
AF Houshmand, M.
   Panahi, M. Shafa Shariat
   Hosseini, B. N.
   Dorraj, Gh.
   Tabassi, A. R.
TI Investigation on mtDNA deletions and twinkle gene mutation (G1423C) in
   Iranian patients with chronic progressive external opthalmoplagia
SO NEUROLOGY INDIA
LA English
DT Article
DE CPEO; mitochondria; mtDNA deletion; twinkle gene
ID MITOCHONDRIAL-DNA DELETIONS; MULTIPLE DELETIONS; OPHTHALMOPLEGIA;
   GENOME; KINASE; POLG; ANT1
AB Background: Chronic progressive external ophthalmoplagia (CPEO) is a phenotypic mitochondrial disorder that affects external ocular and skeletal muscles and is associated with a single or multiple mitochondrial DNA (mtDNA) deletions and also nuclear gene mutations. There are also some reports about the relationship between CPEO and the nuclear Twinkle gene which encodes a kind of mitochondrial protein called Twinkle. Aims: To study the mtDNA deletions and Twinkle gene G1423C point mutation in Iranian patients with CPEO. Materials and Methods: We collected 23 muscle samples from patients with CPEO, 9 women (mean age 34.3 years) and 14 men (36.7 years). Multiplex polymerase chain reaction (PCR) method was used to find the presence of single or multiple deletions in mtDNA. Single stranded conformational polymorphism (SSCP) and restriction fragment length polymorphism (PCR-RFLP) methods were carried out to investigate point mutation (G1423C) in the Twinkle gene in all DNA samples. Results: Different sizes of mtDNA deletions were detected in 16 patients (69.6%). Each of the 5.5, 7, 7.5 and 9 kb deletions existed only in 1 patient. Common deletion (4977bp) and 8 kb deletion were detected in 5 and 3 patients respectively. Multiple deletions were also present in 4 patients. Out of 23 patients included in our study, two cases (8.7%) had Twinkle gene mutation (G1423C) and 5 patients (21.7%) did not show any deletions in mtDNA or the Twinkle gene mutation. Conclusion: Our study provides evidence that the investigation of mtDNA and Twinkle gene mutations in CPEO may help with early diagnosis and prevention of the disease. Patients who did not show deletions in the mtDNA or G1423C mutation in the Twinkle gene may have other mtDNA, Twinkle or nuclear gene mutations.
C1 Farabi Eyes Hosp, NIGEB, Dept Med Genet, Tehran, Iran.
C3 Tehran University of Medical Sciences
RP Houshmand, M (corresponding author), Farabi Eyes Hosp, NIGEB, Dept Med Genet, 17th Km Tehran Karaj Highway,Pajoohesh Blvd,POB 1, Tehran, Iran.
EM massoudh@nrcgeb.ac.ir
RI Houshmand, Massoud/AEG-9909-2022
OI , Masoud/0000-0001-7687-7464
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Arenas J, 2003, ANN NEUROL, V53, P278, DOI 10.1002/ana.10430
   Chaturvedi S, 2005, MED SCI MONITOR, V11, pRA238
   CORMIER V, 1991, AM J HUM GENET, V48, P643
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E
   Grossman LI, 1996, BIOESSAYS, V18, P983, DOI 10.1002/bies.950181208
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kiechl S, 2004, J NEUROL NEUROSUR PS, V75, P1125, DOI 10.1136/jnnp.2003.025890
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   OGASAHARA S, 1986, NEUROLOGY, V36, P45, DOI 10.1212/WNL.36.1.45
   Quigley A, 2001, J Clin Neuromuscul Dis, V3, P77, DOI 10.1097/00131402-200112000-00006
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   Shimko JW., 2005, American Orthoptic Journal, V55, P13, DOI [10.3368/aoj.55.1.13, DOI 10.3368/AOJ.55.1.13]
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2002, ACTA NEUROL BELG, V102, P39
   ZEVIANI M, 1990, AM J HUM GENET, V47, P904
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 25
TC 11
Z9 14
U1 0
U2 4
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0028-3886
EI 1998-4022
J9 NEUROL INDIA
JI Neurol. India
PD JUN
PY 2006
VL 54
IS 2
BP 182
EP 185
PG 4
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 066EG
UT WOS:000239211900015
PM 16804265
DA 2024-11-01
ER

PT J
AU Scholle, LM
   Zierz, S
   Mawrin, C
   Wickenhauser, C
   Urban, DL
AF Motlagh Scholle, Leila
   Zierz, Stephan
   Mawrin, Christian
   Wickenhauser, Claudia
   Lehmann Urban, Diana
TI Heteroplasmy and Copy Number in the Common m.3243A&gt;G Mutation-A
   Post-Mortem Genotype-Phenotype Analysis
SO GENES
LA English
DT Article
DE MELAS-syndrome; genotype-phenotype correlation; mtDNA heteroplasmy; m;
   3243A > G
ID STROKE-LIKE EPISODES; MUTANT MITOCHONDRIAL-DNA; POINT MUTATION;
   LACTIC-ACIDOSIS; TISSUE DISTRIBUTION; MELAS SUBGROUP; MTDNA MUTATION;
   A3243G; GENE; ENCEPHALOPATHY
AB Different mitochondrial DNA (mtDNA) mutations have been identified to cause mitochondrial encephalopathy, lactate acidosis and stroke-like episodes (MELAS). The underlying genetic cause leading to an enormous clinical heterogeneity associated with m.3243A>G-related mitochondrial diseases is still poorly understood. Genotype-phenotype correlation (heteroplasmy levels and clinical symptoms) was analysed in 16 patients (15 literature cases and one unreported case) harbouring the m.3243A>G mutation. mtDNA copy numbers were correlated to heteroplasmy levels in 30 different post-mortem tissue samples, including 14 brain samples of a 46-year-old female. In the central nervous system, higher levels of heteroplasmy correlated significantly with lower mtDNA copy numbers. Skeletal muscle levels of heteroplasmy correlated significantly with kidney and liver. There was no significant difference of heteroplasmy levels between clinically affected and unaffected patients. In the patient presented, we found >75% heteroplasmy levels in all central nervous system samples, without harbouring a MELAS phenotype. This underlines previous suggestions, that really high levels in tissues do not automatically lead to a specific phenotype. Missing significant differences of heteroplasmy levels between clinically affected and unaffected patients underline recent suggestions that there are additional factors such as mtDNA copy number and nuclear factors that may also influence disease severity.
C1 [Motlagh Scholle, Leila; Zierz, Stephan] Martin Luther Univ Halle Wittenberg, Dept Neurol, D-06120 Halle, Saale, Germany.
   [Mawrin, Christian] Otto von Guericke Univ, Inst Neuropathol, D-39120 Magdeburg, Germany.
   [Wickenhauser, Claudia] Martin Luther Univ Halle Wittenberg, Inst Pathol, D-06108 Halle, Saale, Germany.
   [Lehmann Urban, Diana] Univ Ulm, Dept Neurol, D-89081 Ulm, Germany.
C3 Martin Luther University Halle Wittenberg; Otto von Guericke University;
   Martin Luther University Halle Wittenberg; Ulm University
RP Scholle, LM (corresponding author), Martin Luther Univ Halle Wittenberg, Dept Neurol, D-06120 Halle, Saale, Germany.
EM Leila.scholle@medizin.uni-halle.de; stephan.zierz@medizin.uni-halle.de;
   christian.mawrin@med.ovgu.de; claudia.wickenhauser@uk-halle.de;
   diana.lehmann@rku.de
OI Motlagh Scholle, Leila/0000-0003-1363-4726
FU German Ministry of Education and Research - Hertha-Nathor ff-Programm
   (HNP) of the Ulm Medical University, Germany
FX L.M.S., S.Z. and D.L.U. are members of the German mitoNET funded by the
   German Ministry of Education and Research. D.L.U. is funded by the
   Hertha-Nathor ff-Programm (HNP) of the Ulm Medical University, Germany.
CR Cardaioli E, 1999, J SUBMICR CYTOL PATH, V31, P301
   CIAFALONI E, 1991, NEUROLOGY, V41, P1663, DOI 10.1212/WNL.41.10.1663
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   ENTER C, 1991, HUM GENET, V88, P233
   Filograna R, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav9824
   Fornuskova D, 2008, BBA-MOL BASIS DIS, V1782, P317, DOI 10.1016/j.bbadis.2008.02.001
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Grady JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114462
   HAMAZAKI S, 1993, ACTA PATHOL JAPON, V43, P187
   KOBAYASHI Y, 1992, J INHERIT METAB DIS, V15, P803, DOI 10.1007/BF01800025
   Koga Y, 2000, ARCH DIS CHILD, V82, P407, DOI 10.1136/adc.82.5.407
   Lehmann D, 2015, NEUROMUSCULAR DISORD, V25, P81, DOI 10.1016/j.nmd.2014.09.008
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   MATTHEWS PM, 1994, J MED GENET, V31, P41, DOI 10.1136/jmg.31.1.41
   O'Hara R, 2019, GENOME RES, V29, P1878, DOI 10.1101/gr.250480.119
   OBERMAIERKUSSER B, 1991, FEBS LETT, V286, P67, DOI 10.1016/0014-5793(91)80942-V
   Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Prasad M, 2014, CAN J NEUROL SCI, V41, P210, DOI 10.1017/S0317167100016607
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   SHIRAIWA N, 1993, J NEUROL SCI, V120, P174, DOI 10.1016/0022-510X(93)90270-9
   SHOJI Y, 1993, J INHERIT METAB DIS, V16, P27, DOI 10.1007/BF00711311
   Sue CM, 1998, J NEUROL SCI, V161, P36, DOI 10.1016/S0022-510X(98)00179-8
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006
NR 30
TC 26
Z9 26
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD FEB
PY 2020
VL 11
IS 2
AR 212
DI 10.3390/genes11020212
PG 11
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA KT8OP
UT WOS:000519271500056
PM 32085658
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Maeda, K
   Kawai, H
   Sanada, M
   Terashima, T
   Ogawa, N
   Idehara, R
   Makiishi, T
   Yasuda, H
   Sato, S
   Hoshi, K
   Yahikozawa, H
   Nishi, K
   Itoh, Y
   Ogasawara, K
   Tomita, K
   Indo, HP
   Majima, HJ
AF Maeda, Kengo
   Kawai, Hiromichi
   Sanada, Mitsuru
   Terashima, Tomoya
   Ogawa, Nobuhiro
   Idehara, Ryo
   Makiishi, Tetsuya
   Yasuda, Hitoshi
   Sato, Shun-ichi
   Hoshi, Ken-ichi
   Yahikozawa, Hiroyuki
   Nishi, Katsuji
   Itoh, Yasushi
   Ogasawara, Kazumasa
   Tomita, Kazuo
   Indo, Hiroko P.
   Majima, Hideyuki J.
TI Clinical Phenotype and Segregation of Mitochondrial 3243A&gt;G Mutation
   in 2 Pairs of Monozygotic Twins
SO JAMA NEUROLOGY
LA English
DT Article
ID TISSUE DISTRIBUTION; DNA DELETIONS; DISEASE; MTDNA; TRANSMISSION;
   MYOPATHIES
AB IMPORTANCE The regulatory factors explaining the wide spectrum of clinical phenotypes for mitochondrial 3243A>G mutation are not known. Crosstalk between nuclear genes and mitochondrial DNA might be one factor.
   OBSERVATIONS In this case series, we compared 2 pairs of male twins with the mitochondrial 3243 A>G mutation and mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome with a female control patient. One pair of monozygotic twins presented with diabetes and deafness in their 30s, stroke-like episodes in their 40s, and cardiac events and death in their 50s. Another pair of twins presented with deafness and stroke-like episodes in their 20s. The degree of heteroplasmy of 3243A>G mutation in the various tissues and organs was similar in the first pair of twins compared with the control patient.
   CONCLUSIONS AND RELEVANCE The clinical phenotype and segregation of mitochondrial 3243A>G mutation was similar in monozygotic twins. The onset age and distribution of the symptoms might be regulated by nuclear genes. Our findings might help to predict the clinical course of the surviving twins and afford an opportunity for therapy before the onset of mitochondrial disease, especially for monozygotic twins caused by nuclear transfer with a small amount of nuclear-donor mitochondrial DNA.
C1 [Maeda, Kengo; Ogawa, Nobuhiro; Idehara, Ryo] Natl Hosp Org Higashi Ohmi Gen Med Ctr, Dept Neurol, 255 Gochi, Higashi Ohmi, Shiga 5278505, Japan.
   [Maeda, Kengo; Kawai, Hiromichi; Sanada, Mitsuru; Terashima, Tomoya; Ogawa, Nobuhiro; Yasuda, Hitoshi] Shiga Univ Med Sci, Dept Internal Med, Div Neurol, Otsu, Shiga, Japan.
   [Makiishi, Tetsuya] Yabase Chuo Hosp, Dept Internal Med, Kusatsu, Shiga, Japan.
   [Sato, Shun-ichi; Hoshi, Ken-ichi; Yahikozawa, Hiroyuki] Nagano Red Cross Hosp, Dept Neurol, Nagano, Japan.
   [Nishi, Katsuji] Shiga Univ Med Sci, Dept Legal Med, Otsu, Shiga, Japan.
   [Itoh, Yasushi; Ogasawara, Kazumasa] Shiga Univ Med Sci, Div Pathol & Dis Regulat, Dept Pathol, Otsu, Shiga, Japan.
   [Tomita, Kazuo; Indo, Hiroko P.; Majima, Hideyuki J.] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oncol, Kagoshima, Kagoshima, Japan.
   [Tomita, Kazuo; Indo, Hiroko P.; Majima, Hideyuki J.] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Space Environm Med, Kagoshima, Kagoshima, Japan.
C3 Shiga University of Medical Science; Nagano Red Cross Hospital; Shiga
   University of Medical Science; Shiga University of Medical Science;
   Kagoshima University; Kagoshima University
RP Maeda, K (corresponding author), Natl Hosp Org Higashi Ohmi Gen Med Ctr, Dept Neurol, 255 Gochi, Higashi Ohmi, Shiga 5278505, Japan.
EM maeda-kengo@shiga-hosp.jp
RI Terashima, Tomoya/KLE-1906-2024; Majima, Hideyuki/K-3778-2019
OI Tomita, Kazuo/0000-0003-1266-7948; Itoh, Yasushi/0000-0001-7462-2193;
   Terashima, Tomoya/0000-0001-9050-7101
FU Grants-in-Aid for Scientific Research [16K11513, 26460876] Funding
   Source: KAKEN
CR Blakely EL, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011296
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   DEGOUL F, 1994, ANN NEUROL, V35, P365, DOI 10.1002/ana.410350321
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   Feigenbaum A, 1996, AM J MED GENET, V62, P404, DOI 10.1002/(SICI)1096-8628(19960424)62:4<404::AID-AJMG14>3.0.CO;2-S
   Hankins GVD, 2005, PAEDIATR PERINAT EP, V19, P8, DOI 10.1111/j.1365-3016.2005.00609.x
   Hao HL, 1999, HUM MOL GENET, V8, P1117, DOI 10.1093/hmg/8.6.1117
   HARDING AE, 1992, AM J HUM GENET, V50, P629
   MATTHEWS PM, 1994, J MED GENET, V31, P41, DOI 10.1136/jmg.31.1.41
   MATTHEWS PM, 1995, HUM GENET, V96, P261
   MORGANHUGHES JA, 1995, BBA-MOL BASIS DIS, V1271, P135, DOI 10.1016/0925-4439(95)00020-5
   Nakashima-Kamimura N, 2005, J CELL SCI, V118, P5357, DOI 10.1242/jcs.02645
   Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800
   Rose MR, 1998, ARCH NEUROL-CHICAGO, V55, P17, DOI 10.1001/archneur.55.1.17
   Scott Lynette, 2002, Reprod Biomed Online, V5, P276
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   Spyropoulos A, 2013, JAMA NEUROL, V70, P1552, DOI 10.1001/jamaneurol.2013.4111
   ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118
NR 18
TC 28
Z9 29
U1 1
U2 5
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD AUG
PY 2016
VL 73
IS 8
BP 990
EP 993
DI 10.1001/jamaneurol.2016.0886
PG 4
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA DX2MS
UT WOS:000384204900021
PM 27323007
OA Bronze
DA 2024-11-01
ER

PT J
AU Borgione, E
   Lo Giudice, M
   Santa Paola, S
   Giuliano, M
   Di Blasi, FD
   Di Stefano, V
   Lupica, A
   Brighina, F
   Pettinato, R
   Romano, C
   Scuderi, C
AF Borgione, Eugenia
   Lo Giudice, Mariangela
   Santa Paola, Sandro
   Giuliano, Marika
   Di Blasi, Francesco Domenico
   Di Stefano, Vincenzo
   Lupica, Antonino
   Brighina, Filippo
   Pettinato, Rosa
   Romano, Corrado
   Scuderi, Carmela
TI The Mitochondrial tRNA<SUP>Ser(UCN)</SUP> Gene: A Novel m.7484A&gt;G
   Mutation Associated with Mitochondrial Encephalomyopathy and Literature
   Review
SO LIFE-BASEL
LA English
DT Review
DE mitochondrial DNA; tRNA(Ser(UCN)); homoplasmic mutation;
   encephalomyopathy
ID INHERITED HEARING-LOSS; POINT MUTATION; PALMOPLANTAR KERATODERMA;
   COI/TRNA(SER(UCN)) GENES; 7472INSC MUTATION; CHINESE PEDIGREES; G7444A
   MUTATION; LACTIC-ACIDOSIS; A1555G MUTATION; ANTICODON SWAP
AB Mitochondrial tRNA(Ser(UCN)) is considered a hot-spot for non-syndromic and aminoglycoside-induced hearing loss. However, many patients have been described with more extensive neurological diseases, mainly including epilepsy, myoclonus, ataxia, and myopathy. We describe a novel homoplasmic m.7484A>G mutation in the tRNA(Ser(UCN)) gene affecting the third base of the anticodon triplet in a girl with profound intellectual disability, spastic tetraplegia, sensorineural hearing loss, a clinical history of epilepsia partialis continua and vomiting, typical of MELAS syndrome, leading to a myoclonic epilepticus status, and myopathy with severe COX deficiency at muscle biopsy. The mutation was also found in the homoplasmic condition in the mother who presented with mild cognitive deficit, cerebellar ataxia, myoclonic epilepsy, sensorineural hearing loss and myopathy with COX deficient ragged-red fibers consistent with MERRF syndrome. This is the first anticodon mutation in the tRNA(Ser(UCN)) and the second homoplasmic mutation in the anticodon triplet reported to date.
C1 [Borgione, Eugenia; Lo Giudice, Mariangela; Santa Paola, Sandro; Giuliano, Marika; Scuderi, Carmela] Oasi Res Inst IRCCS, Unit Neuromuscular Dis, Via Conte Ruggero 73, I-94018 Troina, Italy.
   [Di Blasi, Francesco Domenico] Oasi Res Inst IRCCS, Unit Psychol, Via Conte Ruggero 73, I-94018 Troina, Italy.
   [Di Stefano, Vincenzo; Lupica, Antonino; Brighina, Filippo] Univ Palermo, Dept Biomed Neurosci & Adv Diagnost BiND, Unit Neurophysiopathol, I-90129 Palermo, Italy.
   [Pettinato, Rosa] Oasi Res Inst IRCCS, Unit Pediat & Med Genet, Via Conte Ruggero 73, I-94018 Troina, Italy.
   [Romano, Corrado] Oasi Res Inst IRCCS, Res Unit Rare Dis & Neurodev Disorders, Via Conte Ruggero 73, I-94018 Troina, Italy.
   [Romano, Corrado] Univ Catania, Dept Biomed & Biotechnol Sci, Sect Med Biochem, Med Genet, I-95123 Catania, Italy.
C3 University of Palermo; University of Catania
RP Di Stefano, V (corresponding author), Univ Palermo, Dept Biomed Neurosci & Adv Diagnost BiND, Unit Neurophysiopathol, I-90129 Palermo, Italy.
EM vincenzo19689@gmail.com
RI Lupica, Antonino/IAQ-7593-2023; Brighina, Filippo/K-9864-2016; Di
   Stefano, Vincenzo/AAT-1689-2020; Giudice, Mariangela/D-4261-2017; Di
   Blasi, Francesco Domenico/D-8146-2017; Santa Paola, Sandro/D-4174-2017;
   Romano, Corrado/B-9695-2008; Borgione, Eugenia/D-9168-2017; Marika,
   Giuliano/JVZ-6377-2024; BRIGHINA, Filippo/K-9873-2016
OI Di Blasi, Francesco Domenico/0000-0002-2958-2927; Santa Paola,
   Sandro/0000-0002-3310-782X; Romano, Corrado/0000-0003-1049-0683;
   Borgione, Eugenia/0000-0001-5458-7415; Marika,
   Giuliano/0000-0002-5083-1174; BRIGHINA, Filippo/0000-0001-5875-3126
FU Italian Ministry of Health [RC2022]
FX This research received no external funding.
CR Abu-Amero EK, 2006, J CHILD NEUROL, V21, P971, DOI 10.2310/7010.2006.00208
   Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Bacalhau M, 2018, NEUROMUSCULAR DISORD, V28, P350, DOI 10.1016/j.nmd.2017.11.006
   Bidooki S, 2004, NEUROMUSCULAR DISORD, V14, P417, DOI 10.1016/j.nmd.2004.03.004
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405
   Cardaioli E, 2006, NEUROMUSCULAR DISORD, V16, P26, DOI 10.1016/j.nmd.2005.11.001
   Cardaioli E, 2007, NEUROMUSCULAR DISORD, V17, P681, DOI 10.1016/j.nmd.2007.05.001
   Chen J, 2008, MITOCHONDRION, V8, P285, DOI 10.1016/j.mito.2008.05.002
   Chen Z, 2019, J GENET GENOMICS, V46, P201, DOI 10.1016/j.jgg.2019.03.009
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   Ding Y, 2017, AM J TRANSL RES, V9, P2984
   Fetoni V, 2004, NEUROMUSCULAR DISORD, V14, P723, DOI 10.1016/j.nmd.2004.07.002
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Götz A, 2012, PEDIATR RES, V72, P90, DOI 10.1038/pr.2012.43
   Grafakou O, 2003, J INHERIT METAB DIS, V26, P593, DOI 10.1023/A:1025960300710
   Hutchin TP, 2001, J MED GENET, V38, P229, DOI 10.1136/jmg.38.4.229
   Hutchin TP, 2000, J MED GENET, V37, P692, DOI 10.1136/jmg.37.9.692
   Imasawa T, 2014, RENAL FAILURE, V36, P1461, DOI 10.3109/0886022X.2014.945181
   Jacobs HT, 2005, EUR J HUM GENET, V13, P26, DOI 10.1038/sj.ejhg.5201250
   Jaksch M, 1998, ANN NEUROL, V44, P635, DOI 10.1002/ana.410440409
   Jaksch M, 1998, J MED GENET, V35, P895, DOI 10.1136/jmg.35.11.895
   Jiang PF, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20201856
   Lindberg C, 2008, ACTA NEUROL SCAND, V117, P128, DOI 10.1111/j.1600-0404.2007.00913.x
   Liu YQ, 2014, BMC MED GENOMICS, V7, DOI 10.1186/s12920-014-0073-x
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Martin L, 2000, BRIT J DERMATOL, V143, P876, DOI 10.1046/j.1365-2133.2000.03797.x
   McCann BJ, 2015, NEUROMUSCULAR DISORD, V25, P262, DOI 10.1016/j.nmd.2014.11.002
   Mkaouar-Rebai E, 2013, BIOCHEM BIOPH RES CO, V430, P585, DOI 10.1016/j.bbrc.2012.11.109
   MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284
   Müller T, 2005, ACTA NEUROPATHOL, V110, P426, DOI 10.1007/s00401-005-1063-z
   NAKAMURA M, 1995, BIOCHEM BIOPH RES CO, V214, P86, DOI 10.1006/bbrc.1995.2260
   NORMANLY J, 1989, ANNU REV BIOCHEM, V58, P1029, DOI 10.1146/annurev.bi.58.070189.005121
   Pandya A, 1999, AM J HUM GENET, V65, P1803, DOI 10.1086/302658
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Peng W, 2020, MOL MED REP, V22, P77, DOI 10.3892/mmr.2020.11100
   Pulkes T, 2005, NEUROMUSCULAR DISORD, V15, P364, DOI 10.1016/j.nmd.2005.01.006
   Ramelli GP, 2006, J CHILD NEUROL, V21, P253, DOI 10.2310/7010.2006.00047
   REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Riley LG, 2020, GENET MED, V22, P1254, DOI 10.1038/s41436-020-0793-6
   Roos S, 2013, EUR J HUM GENET, V21, P571, DOI 10.1038/ejhg.2012.153
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125
   Schuelke M, 1998, ANN NEUROL, V44, P700, DOI 10.1002/ana.410440420
   SCHULMAN LH, 1991, PROG NUCLEIC ACID RE, V41, P23
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Scuderi C, 2007, NEUROMUSCULAR DISORD, V17, P258, DOI 10.1016/j.nmd.2006.11.006
   Sevior KB, 1998, AM J MED GENET, V75, P179, DOI 10.1002/(SICI)1096-8628(19980113)75:2<179::AID-AJMG11>3.0.CO;2-M
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Souilem S, 2010, DIAGN MOL PATHOL, V19, P28, DOI 10.1097/PDM.0b013e3181b00f02
   Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905
   Tang XW, 2015, MITOCHONDRION, V23, P17, DOI 10.1016/j.mito.2015.05.001
   Tang XW, 2010, MOL GENET METAB, V100, P57, DOI 10.1016/j.ymgme.2010.01.008
   TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421
   Toompuu M, 2002, J BIOL CHEM, V277, P22240, DOI 10.1074/jbc.M200338200
   Uehara DT, 2010, GENET TEST MOL BIOMA, V14, P611, DOI 10.1089/gtmb.2010.0011
   Wong LJC, 2020, GENET MED, DOI 10.1038/s41436-019-0746-0
   Wong LJC, 2002, CLIN CHEM, V48, P1901
   Yan CJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040379
   Yang P, 2020, IRISH J MED SCI, V189, P489, DOI 10.1007/s11845-019-02143-z
   Yuan HJ, 2005, AM J MED GENET A, V138A, P133, DOI 10.1002/ajmg.a.30952
   Yuan H, 2007, BIOCHEM BIOPH RES CO, V362, P94, DOI 10.1016/j.bbrc.2007.07.161
   Zanssen S, 1997, MOL CELL BIOCHEM, V174, P231, DOI 10.1023/A:1006864709515
   Zaragoza MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012295
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
   Zhao Han-Yue, 2008, Yichuan, V30, P1557, DOI 10.3724/SP.J.1005.2008.01557
   Zheng J, 2020, MITOCHONDRION, V52, P163, DOI 10.1016/j.mito.2020.03.005
   Zhu Y, 2006, BIOCHEM BIOPH RES CO, V342, P843, DOI 10.1016/j.bbrc.2006.02.027
NR 69
TC 3
Z9 3
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-1729
J9 LIFE-BASEL
JI Life-Basel
PD FEB
PY 2023
VL 13
IS 2
AR 554
DI 10.3390/life13020554
PG 16
WC Biology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Microbiology
GA 9J3OQ
UT WOS:000940100900001
PM 36836911
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Möllers, M
   Maniura-Weber, K
   Kiseljakovic, E
   Bust, M
   Hayrapetyan, A
   Jaksch, M
   Helm, M
   Wiesner, RJ
   von Kleist-Retzow, JC
AF Möllers, M
   Maniura-Weber, K
   Kiseljakovic, E
   Bust, M
   Hayrapetyan, A
   Jaksch, M
   Helm, M
   Wiesner, RJ
   von Kleist-Retzow, JC
TI A new mechanism for mtDNA pathogenesis:: impairment of
   post-transcriptional maturation leads to severe depletion of
   mitochondrial tRNA<SUP>Ser(UCN)</SUP> caused by T7512C and G7497A point
   mutations
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID ANTICODON WOBBLE NUCLEOTIDE; HIGHER-ORDER STRUCTURE; TRANSFER-RNA;
   CLOVERLEAF STRUCTURE; MODIFICATION DEFECT; LACTIC-ACIDOSIS; DNA;
   AMINOACYLATION; RECOGNITION; MYOPATHY
AB We have studied the consequences of two homoplasmic, pathogenic point mutations (T7512C and G7497A) in the tRNA(Ser(UCN)) gene of mitochondrial (mt) DNA using osteosarcoma cybrids. We identified a severe reduction of tRNA(Ser(UCN)) to levels below 10% of controls for both mutations, resulting in a 40% reduction in mitochondrial protein synthesis rate and in a respiratory chain deficiency resembling that in the patients muscle. Aminoacylation was apparently unaffected. On non-denaturating northern blots we detected an altered electrophoretic mobility for G7497A containing tRNA molecules suggesting a structural impact of this mutation, which was confirmed by structural probing. By comparing in vitro transcribed molecules with native RNA in such gels, we also identified tRNA(Ser(UCN)) being present in two isoforms in vivo, probably corresponding to the nascent, unmodified transcripts co-migrating with the in vitro transcripts and a second, faster moving isoform corresponding to the mature tRNA. In cybrids containing either mutations the unmodified isoforms were severely reduced. We hypothesize that both mutations lead to an impairment of post-transcriptional modification processes, ultimately leading to a preponderance of degradation by nucleases over maturation by modifying enzymes, resulting in severely reduced tRNA(Ser(UCN)) steady state levels. We infer that an increased degradation rate, caused by disturbance of tRNA maturation and, in the case of the G7497A mutant, alteration of tRNA structure, is a new pathogenic mechanism of mt tRNA point mutations.
C1 Univ Cologne, Inst Vegetat Physiol, D-50931 Cologne, Germany.
   Fac Med, Dept Biochem, Sarajevo, Bosnia & Herceg.
   Heidelberg Univ, Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany.
   Inst Clin Chem & Mitochondrial Genet, D-80804 Munich, Germany.
   Univ Cologne, CMMC, D-50931 Cologne, Germany.
   Univ Cologne, Dept Pediat, D-50924 Cologne, Germany.
C3 University of Cologne; Ruprecht Karls University Heidelberg; University
   of Cologne; University of Cologne
RP Univ Cologne, Inst Vegetat Physiol, Robert Koch Str 39, D-50931 Cologne, Germany.
EM rudolf.wiesner@uni-koeln.de
RI Kiseljaković, Emina/HJI-9324-2023; Helm, Mark/AAD-5433-2022; Maniura,
   Katharina/N-2955-2016
OI Maniura, Katharina/0000-0001-7895-3563; Helm, Mark/0000-0002-0154-0928
CR Bacman SR, 2003, BIOCHEM J, V374, P131, DOI 10.1042/BJ20030222
   BINDOFF LA, 1993, J BIOL CHEM, V268, P19559
   Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   Christian EL, 2002, METHODS, V28, P307, DOI 10.1016/S1046-2023(02)00238-4
   Dunbar DR, 1996, HUM MOL GENET, V5, P123, DOI 10.1093/hmg/5.1.123
   El Meziane A, 1998, NAT GENET, V18, P350
   El Meziane A, 1998, HUM MOL GENET, V7, P2141, DOI 10.1093/hmg/7.13.2141
   EUBANKS JH, 1991, GENOMICS, V11, P720, DOI 10.1016/0888-7543(91)90080-X
   Fechter P, 1998, FEBS LETT, V436, P99, DOI 10.1016/S0014-5793(98)01096-5
   Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1
   Florentz C, 2001, EMBO REP, V2, P481, DOI 10.1093/embo-reports/kve111
   Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153
   FRIEDERICH MW, 1995, P NATL ACAD SCI USA, V92, P4803, DOI 10.1073/pnas.92.11.4803
   Grafakou O, 2003, J INHERIT METAB DIS, V26, P593, DOI 10.1023/A:1025960300710
   Hao R, 2005, NUCLEIC ACIDS RES, V33, P3606, DOI 10.1093/nar/gki677
   Hayashi I, 1998, J MOL BIOL, V284, P57, DOI 10.1006/jmbi.1998.2151
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   Helm M, 2004, J MOL BIOL, V337, P545, DOI 10.1016/j.jmb.2004.01.036
   Helm M, 1998, NUCLEIC ACIDS RES, V26, P1636, DOI 10.1093/nar/26.7.1636
   Hofhaus G, 1996, Methods Enzymol, V264, P476, DOI 10.1016/S0076-6879(96)64043-9
   Huang Z, 1996, NUCLEIC ACIDS RES, V24, P4360, DOI 10.1093/nar/24.21.4360
   Jaksch M, 1998, ANN NEUROL, V44, P635, DOI 10.1002/ana.410440409
   Kaufmann P, 1996, ANN NEUROL, V40, P172, DOI 10.1002/ana.410400208
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Koga A, 2003, NEUROMUSCULAR DISORD, V13, P259, DOI 10.1016/S0960-8966(02)00267-5
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Levinger L, 2004, NUCLEIC ACIDS RES, V32, P5430, DOI 10.1093/nar/gkh884
   Levinger L, 2004, J MOL BIOL, V337, P535, DOI 10.1016/j.jmb.2004.02.008
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   Rossmanith W, 1998, FEBS LETT, V433, P269, DOI 10.1016/S0014-5793(98)00928-4
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Sambrook J., 1989, Molecular cloning: a laboratory manual
   Schneider A, 1996, NUCLEIC ACIDS RES, V24, P1225, DOI 10.1093/nar/24.7.1225
   Shimada N, 2001, J BIOL CHEM, V276, P46770, DOI 10.1074/jbc.M105150200
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Toompuu M, 1999, HUM MOL GENET, V8, P2275, DOI 10.1093/hmg/8.12.2275
   Toompuu M, 2004, BIOCHEM BIOPH RES CO, V322, P803, DOI 10.1016/j.bbrc.2004.07.181
   Toompuu M, 2002, J BIOL CHEM, V277, P22240, DOI 10.1074/jbc.M200338200
   UEDA T, 1992, NUCLEIC ACIDS RES, V20, P2217, DOI 10.1093/nar/20.9.2217
   Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200
   WATANABE Y, 1994, NUCLEIC ACIDS RES, V22, P5378, DOI 10.1093/nar/22.24.5378
   WILSON GN, 1978, P NATL ACAD SCI USA, V75, P5367, DOI 10.1073/pnas.75.11.5367
   Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006
   Wittenhagen LM, 2003, NUCLEIC ACIDS RES, V31, P596, DOI 10.1093/nar/gkg131
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   Yokogawa T, 1991, NUCLEIC ACIDS RES, V19, P6101, DOI 10.1093/nar/19.22.6101
NR 49
TC 27
Z9 32
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PY 2005
VL 33
IS 17
BP 5647
EP 5658
DI 10.1093/nar/gki876
PG 12
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 974LS
UT WOS:000232593700037
PM 16199753
OA Green Submitted, Green Published, gold
DA 2024-11-01
ER

PT J
AU Mancuso, M
   Conforti, FL
   Rocchi, A
   Tessitore, A
   Muglia, M
   Tedeschi, G
   Panza, D
   Monsurrò, M
   Sola, P
   Mandrioli, J
   Choub, A
   DelCorona, A
   Manca, ML
   Mazzei, R
   Sprovieri, T
   Filosto, M
   Salviati, A
   Valentino, P
   Bono, F
   Caracciolo, M
   Simone, IL
   La Bella, V
   Majorana, G
   Siciliano, G
   Murri, L
   Quattrone, A
AF Mancuso, M
   Conforti, FL
   Rocchi, A
   Tessitore, A
   Muglia, M
   Tedeschi, G
   Panza, D
   Monsurrò, M
   Sola, P
   Mandrioli, J
   Choub, A
   DelCorona, A
   Manca, ML
   Mazzei, R
   Sprovieri, T
   Filosto, M
   Salviati, A
   Valentino, P
   Bono, F
   Caracciolo, M
   Simone, IL
   La Bella, V
   Majorana, G
   Siciliano, G
   Murri, L
   Quattrone, A
TI Could mitochondrial haplogroups play a role in sporadic amyotrophic
   lateral sclerosis?
SO NEUROSCIENCE LETTERS
LA English
DT Article
DE ALS; mtDNA; haplogroups
ID DNA HAPLOGROUPS; SKELETAL-MUSCLE; NEURON DISEASE; GENE-MUTATIONS; ALS
   PATIENTS; LOCUS; IMPAIRMENT; TRANSPORT; RISK; FORM
AB Mitochondrial impairment has been implicated in the pathogenesis of the amyotrophic lateral sclerosis (ALS). Furthermore, mitochondrial-specific polymorphisms were previously related to other neurodegenerative diseases, such as Parkinson, Friedreich and Alzheimer disease. To investigate if specific genetic polymorphisms within the mitochondrial genome (mtDNA) could act as susceptibility factors and contribute to the clinical expression of sporadic ALS (sALS), we have genotyped predefined European mtDNA haplogroups in 222 Italian patients with sALS and 151 matched controls. Individuals classified as haplogroup I demonstrated a significant decrease in risk of ALS versus individuals carrying the most common haplogroup, H (odds ratio 0.08, 95% confidence interval 0.04-0.4, p < 0.01). Further stratification of the dataset by sex, age and site of onset of disease and survival failed to reach significance for association.
   Our study provides evidence of the contribution of mitochondrial variation to the risk of ALS development in Caucasians. Further it may help elucidate the mechanism of the mitochondrial dysfunction detectable in ALS, and may be of relevance in development of strategies for the treatment of this disease. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Pisa, Neurol Clin, Dept Neurosci, I-56126 Pisa, Italy.
   CNR, Inst Neurol Sci, Cosenza, Italy.
   Univ Naples 2, Div Neurol 2, Naples, Italy.
   Univ Modena, Dept Neurosci, I-41100 Modena, Italy.
   Univ Verona, Dept Neurol Sci & Vis, Sect Clin Neurol, I-37100 Verona, Italy.
   Univ Magna Graecia, Neurol Inst, Catanzaro, Italy.
   Univ Bari, Dept Neurol & Psychiat Sci, Bari, Italy.
   Univ Palermo, Dept Neurol & Psychiat, Palermo, Italy.
   Univ Messina, Dept Neurosci Psychiat & Anaesthesiol Sci, Messina, Italy.
C3 University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto
   di Scienze Neurologiche (ISN-CNR); Universita della Campania Vanvitelli;
   Universita di Modena e Reggio Emilia; University of Verona; Magna
   Graecia University of Catanzaro; Universita degli Studi di Bari Aldo
   Moro; University of Palermo; University of Messina
RP Mancuso, M (corresponding author), Univ Pisa, Neurol Clin, Dept Neurosci, Via Roma 67, I-56126 Pisa, Italy.
EM mmancuso@inwind.it
RI Mancuso, Michelangelo/K-4170-2016; Simone, sabella/K-9755-2018;
   Conforti, Francesca Luisa/AAT-2428-2020; Filosto,
   Massimiliano/S-9446-2019; Tessitore, Alessandro/K-3124-2018; La Bella,
   Vincenzo/H-4532-2012; Grandis, Marina/J-3627-2014; Sprovieri,
   Teresa/ITV-1657-2023; QUATTRONE, Aldo/A-6734-2016; Mazzei,
   Rosalucia/G-3874-2014; MANDRIOLI, JESSICA/K-7235-2016; Conforti,
   Francesca Luisa/K-8877-2016; Manca, Maria Laura/AAK-5995-2020;
   Siciliano, Gabriele/K-7259-2016
OI SALVIATI, Alessandro/0000-0002-7269-9063; Sprovieri,
   Teresa/0000-0002-1544-569X; QUATTRONE, Aldo/0000-0003-2001-957X; Mazzei,
   Rosalucia/0000-0001-6619-6075; MANDRIOLI, JESSICA/0000-0002-9244-9782;
   La Bella, Vincenzo/0000-0003-2045-1864; Conforti, Francesca
   Luisa/0000-0001-8364-1783; Manca, Maria Laura/0000-0002-9274-2313;
   Siciliano, Gabriele/0000-0002-6142-2384; Bono,
   Francesco/0000-0002-4650-6635; MUGLIA, MARIA/0000-0001-6413-3935;
   Tessitore, Alessandro/0000-0003-1740-8566; Filosto,
   Massimiliano/0000-0002-2852-7512; Simone, Isabella
   Laura/0000-0002-7429-3091
CR Abalkhail H, 2003, AM J HUM GENET, V73, P383, DOI 10.1086/377156
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304
   Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8
   BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0
   Carrieri G, 2001, HUM GENET, V108, P194, DOI 10.1007/s004390100463
   Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054
   Chinnery PF, 2000, NEUROLOGY, V55, P302, DOI 10.1212/WNL.55.2.302
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   deBelleroche J, 1996, J NEUROPATH EXP NEUR, V55, P747
   Dhaliwal GK, 2000, NEUROREPORT, V11, P2507, DOI 10.1097/00001756-200008030-00032
   Echaniz-Laguna A, 2002, ANN NEUROL, V52, P623, DOI 10.1002/ana.10357
   Gajewski CD, 2003, EXP NEUROL, V179, P229, DOI 10.1016/S0014-4886(02)00022-5
   Giacchetti M, 2004, J MED GENET, V41, P293, DOI 10.1136/jmg.2003.015289
   Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166
   Hand CK, 2002, AM J HUM GENET, V70, P251, DOI 10.1086/337945
   Hentati A, 1998, NEUROGENETICS, V2, P55, DOI 10.1007/s100480050052
   Mancuso M, 2002, AMYOTROPH LATERAL SC, V3, P215, DOI 10.1080/146608202760839007
   Menzies FM, 2002, NEUROCHEM INT, V40, P543, DOI 10.1016/S0197-0186(01)00125-5
   Nishimura AL, 2004, J MED GENET, V41, P315, DOI 10.1136/jmg.2003.013029
   Orrell RW, 2000, NEUROMUSCULAR DISORD, V10, P63, DOI 10.1016/S0960-8966(99)00071-1
   Ro LS, 2003, MUSCLE NERVE, V28, P737, DOI 10.1002/mus.10504
   ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204
   Sambrook J., 2001, Molecular cloning: A laboratory manual, V3rd, P6
   Sapp PC, 2003, AM J HUM GENET, V73, P397, DOI 10.1086/377158
   Sasaki S, 1996, NEUROLOGY, V47, P535, DOI 10.1212/WNL.47.2.535
   Swerdlow RH, 1998, EXP NEUROL, V153, P135, DOI 10.1006/exnr.1998.6866
   Torroni A, 1996, GENETICS, V144, P1835
   van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Vielhaber S, 2000, BRAIN, V123, P1339, DOI 10.1093/brain/123.7.1339
   Wiedemann FR, 1998, J NEUROL SCI, V156, P65, DOI 10.1016/S0022-510X(98)00008-2
NR 32
TC 59
Z9 65
U1 0
U2 13
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0304-3940
J9 NEUROSCI LETT
JI Neurosci. Lett.
PD NOV 23
PY 2004
VL 371
IS 2-3
BP 158
EP 162
DI 10.1016/j.neulet.2004.08.060
PG 5
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 872JP
UT WOS:000225203800015
PM 15519748
DA 2024-11-01
ER

PT J
AU Chen, L
   Zhou, MN
   Li, H
   Liu, DL
   Liao, P
   Zong, Y
   Zhang, CQ
   Zou, WG
   Gao, JJ
AF Chen, Long
   Zhou, Mengnan
   Li, Hao
   Liu, Delin
   Liao, Peng
   Zong, Yao
   Zhang, Changqing
   Zou, Weiguo
   Gao, Junjie
TI Mitochondrial heterogeneity in diseases
SO SIGNAL TRANSDUCTION AND TARGETED THERAPY
LA English
DT Review
ID NONALCOHOLIC FATTY LIVER; KETOGLUTARATE DEHYDROGENASE COMPLEX;
   SUPEROXIDE-DISMUTASE 2; HUMAN SKELETAL-MUSCLE; ONE-CARBON METABOLISM;
   OVARIAN-CANCER CELLS; DIET-INDUCED OBESITY; OXYGEN SPECIES ROS;
   OXIDATIVE STRESS; ADIPOSE-TISSUE
AB As key organelles involved in cellular metabolism, mitochondria frequently undergo adaptive changes in morphology, components and functions in response to various environmental stresses and cellular demands. Previous studies of mitochondria research have gradually evolved, from focusing on morphological change analysis to systematic multiomics, thereby revealing the mitochondrial variation between cells or within the mitochondrial population within a single cell. The phenomenon of mitochondrial variation features is defined as mitochondrial heterogeneity. Moreover, mitochondrial heterogeneity has been reported to influence a variety of physiological processes, including tissue homeostasis, tissue repair, immunoregulation, and tumor progression. Here, we comprehensively review the mitochondrial heterogeneity in different tissues under pathological states, involving variant features of mitochondrial DNA, RNA, protein and lipid components. Then, the mechanisms that contribute to mitochondrial heterogeneity are also summarized, such as the mutation of the mitochondrial genome and the import of mitochondrial proteins that result in the heterogeneity of mitochondrial DNA and protein components. Additionally, multiple perspectives are investigated to better comprehend the mysteries of mitochondrial heterogeneity between cells. Finally, we summarize the prospective mitochondrial heterogeneity-targeting therapies in terms of alleviating mitochondrial oxidative damage, reducing mitochondrial carbon stress and enhancing mitochondrial biogenesis to relieve various pathological conditions. The possibility of recent technological advances in targeted mitochondrial gene editing is also discussed.
C1 [Chen, Long; Zou, Weiguo] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, Univ Chinese Acad Sci,State Key Lab Cell Biol, Shanghai 200031, Peoples R China.
   [Zhou, Mengnan] China Med Univ, Sch Basic Med Sci, Dept Pathogen Biol, Shenyang 110001, Peoples R China.
   [Li, Hao; Liu, Delin; Liao, Peng; Zhang, Changqing; Gao, Junjie] Shanghai Peoples Hosp Shanghai Jiao Tong Univ 6, Dept Orthopaed, Sch Med, Shanghai 200233, Peoples R China.
   [Zong, Yao] Univ Western Australia, Ctr Orthopaed Res, Med Sch, Nedlands, WA 6009, Australia.
   [Zou, Weiguo; Gao, Junjie] Shanghai Peoples Hosp Shanghai Jiao Tong Univ 6, Inst Microsurg Extrem, Sch Med, Shanghai 200233, Peoples R China.
   [Zou, Weiguo; Gao, Junjie] Shanghai Peoples Hosp Shanghai Jiao Tong Univ 6, Sch Med, Dept Orthoped Surg, Shanghai 200233, Peoples R China.
   [Gao, Junjie] Shanghai Sixth Peoples Hosp Fujian, 16 Luoshan Sect,Jinguang Rd,Luoshan St, Quanzhou, Fujian, Peoples R China.
C3 Chinese Academy of Sciences; University of Chinese Academy of Sciences,
   CAS; Center for Excellence in Molecular Cell Science, CAS; China Medical
   University; University of Western Australia
RP Zou, WG (corresponding author), Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, Univ Chinese Acad Sci,State Key Lab Cell Biol, Shanghai 200031, Peoples R China.; Zhang, CQ; Gao, JJ (corresponding author), Shanghai Peoples Hosp Shanghai Jiao Tong Univ 6, Dept Orthopaed, Sch Med, Shanghai 200233, Peoples R China.; Zou, WG; Gao, JJ (corresponding author), Shanghai Peoples Hosp Shanghai Jiao Tong Univ 6, Inst Microsurg Extrem, Sch Med, Shanghai 200233, Peoples R China.; Zou, WG; Gao, JJ (corresponding author), Shanghai Peoples Hosp Shanghai Jiao Tong Univ 6, Sch Med, Dept Orthoped Surg, Shanghai 200233, Peoples R China.; Gao, JJ (corresponding author), Shanghai Sixth Peoples Hosp Fujian, 16 Luoshan Sect,Jinguang Rd,Luoshan St, Quanzhou, Fujian, Peoples R China.
EM zhangcq@sjtu.edu.cn; zouwg94@sibcb.ac.cn; colingjj@163.com
RI zhang, chao/IXD-9965-2023; Gao, jie/JXW-9886-2024
OI Gao, Junjie/0000-0003-4820-8524; Liao, Peng/0000-0002-4583-5285
FU National Natural Science Foundation of China [82002339, 81820108020];
   Shanghai Frontiers Science Center of Degeneration and Regeneration in
   Skeletal System [BJ1-9000-22-4002]; Shanghai Municipal Hospital
   Orthopedic Specialist Alliance; Shanghai Municipal Health Commission key
   priority discipline project; Shanghai Spinal Disease and Trauma
   Orthopedics Research Center
FX This study was performed with the support of the National Natural
   Science Foundation of China (82002339, 81820108020), Shanghai Frontiers
   Science Center of Degeneration and Regeneration in Skeletal System
   (BJ1-9000-22-4002), Shanghai Municipal Hospital Orthopedic Specialist
   Alliance, and Shanghai Municipal Health Commission key priority
   discipline project; Shanghai Spinal Disease and Trauma Orthopedics
   Research Center.
CR Abdelmegeed MA, 2017, SCI REP-UK, V7, DOI 10.1038/srep39764
   Abdullahi A, 2017, ENDOCR REV, V38, P538, DOI 10.1210/er.2017-00163
   Abuaita BH, 2018, CELL HOST MICROBE, V24, P625, DOI 10.1016/j.chom.2018.10.005
   Ahmad T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.213
   Ahn CS, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0128-2
   Al-Serri A, 2012, J HEPATOL, V56, P448, DOI 10.1016/j.jhep.2011.05.029
   Albert CJ, 2007, FRONT BIOSCI, V12, P2750, DOI 10.2741/2269
   Aldiss P, 2018, METABOLISM, V81, P63, DOI 10.1016/j.metabol.2017.11.009
   Allio R, 2017, MOL BIOL EVOL, V34, P2762, DOI 10.1093/molbev/msx197
   Area-Gomez E, 2019, J CLIN INVEST, V129, P34, DOI 10.1172/JCI120848
   Arguello T, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.110139
   Asif S, 2022, MOL METAB, V61, DOI 10.1016/j.molmet.2022.101494
   Aung LHH, 2021, MOL THER-NUCL ACIDS, V25, P416, DOI 10.1016/j.omtn.2021.06.006
   Baeza J, 2016, TRENDS BIOCHEM SCI, V41, P231, DOI 10.1016/j.tibs.2015.12.006
   Bak S, 2013, J PROTEOME RES, V12, P4327, DOI 10.1021/pr400281r
   Ban T, 2017, NAT CELL BIOL, V19, P856, DOI 10.1038/ncb3560
   Bao FX, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abk2376
   Barbosa PO, 2021, BIOMED PHARMACOTHER, V139, DOI 10.1016/j.biopha.2021.111627
   Barcena B, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10101535
   BARTH E, 1992, J MOL CELL CARDIOL, V24, P669, DOI 10.1016/0022-2828(92)93381-S
   Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848
   Beck SJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11483
   Begum HM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47593-8
   Benador IY, 2018, CELL METAB, V27, P869, DOI 10.1016/j.cmet.2018.03.003
   Berenguer-Escuder C, 2020, HUM MOL GENET, V29, P1353, DOI 10.1093/hmg/ddaa066
   Bhatia D, 2022, KIDNEY INT, V101, P963, DOI 10.1016/j.kint.2022.01.030
   BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7
   Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013
   Blokhuis AM, 2016, ACTA NEUROPATHOL, V132, P175, DOI 10.1007/s00401-016-1575-8
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   Bond ST, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00543
   Bonora M, 2019, NAT REV CARDIOL, V16, P33, DOI 10.1038/s41569-018-0074-0
   Bosch A, 2019, METHODS MOL BIOL, V2040, P99, DOI 10.1007/978-1-4939-9686-5_6
   Boufroura FZ, 2018, HUM MOL GENET, V27, P3417, DOI 10.1093/hmg/ddy254
   Boutant M, 2017, EMBO J, V36, P1543, DOI 10.15252/embj.201694914
   Bozi LHM, 2020, MOL ASPECTS MED, V71, DOI 10.1016/j.mam.2019.100836
   BRANDT JT, 1974, BIOCHEM BIOPH RES CO, V59, P1097, DOI 10.1016/S0006-291X(74)80091-4
   Brautbar A, 2008, MOL GENET METAB, V94, P485, DOI 10.1016/j.ymgme.2008.04.004
   Brea-Calvo G, 2015, AM J HUM GENET, V96, P309, DOI 10.1016/j.ajhg.2014.12.023
   Brown AD, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.727585
   Brown DA, 2017, NAT REV CARDIOL, V14, P238, DOI 10.1038/nrcardio.2016.203
   Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200
   Bruton JD, 2008, J PHYSIOL-LONDON, V586, P175, DOI 10.1113/jphysiol.2007.147470
   Bryleva EY, 2010, P NATL ACAD SCI USA, V107, P3081, DOI 10.1073/pnas.0913828107
   Buchner DA, 2011, OBESITY, V19, P917, DOI 10.1038/oby.2010.214
   Bulthuis EP, 2019, ANTIOXID REDOX SIGN, V30, P2066, DOI 10.1089/ars.2018.7534
   Burke PJ, 2017, TRENDS CANCER, V3, P857, DOI 10.1016/j.trecan.2017.10.006
   Burté F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228
   Butterick TA, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0555-4
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Cao W, 2017, BIOMED PHARMACOTHER, V85, P611, DOI 10.1016/j.biopha.2016.11.071
   Carley AN, 2021, CIRCULATION, V143, P1797, DOI 10.1161/CIRCULATIONAHA.120.052671
   Carrasco P, 2012, J BIOL CHEM, V287, P21224, DOI 10.1074/jbc.M111.337493
   Carruthers NJ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-96995-0
   Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019
   Cervantes-Silva MP, 2021, EMBO REP, V22, DOI 10.15252/embr.202153086
   Chae S, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0154-6
   Chandhok G, 2018, BIOL REV, V93, P933, DOI 10.1111/brv.12378
   Chen FQ, 2022, OXID MED CELL LONGEV, V2022, DOI 10.1155/2022/9565545
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chen M, 2015, CANCER SCI, V106, P1075, DOI 10.1111/cas.12710
   Chen XL, 2014, THERANOSTICS, V4, P1164, DOI 10.7150/thno.8502
   Chen X, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2018.101068
   Chen Y, 2013, FOOD CHEM TOXICOL, V60, P38, DOI 10.1016/j.fct.2013.07.008
   Chen Y, 2007, HEPATOLOGY, V45, P1118, DOI 10.1002/hep.21635
   Cho SI, 2022, CELL, V185, P1764, DOI 10.1016/j.cell.2022.03.039
   Choi J, 2020, REDOX BIOL, V30, DOI 10.1016/j.redox.2020.101437
   Choi KM, 2022, ENDOCRINOLOGY, V163, DOI 10.1210/endocr/bqac018
   Chouchani ET, 2016, NATURE, V532, P112, DOI 10.1038/nature17399
   Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909
   Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212
   CHRISTIANSEN EG, 1949, NATURE, V163, P361, DOI 10.1038/163361a0
   Chung SJ, 2017, NEUROBIOL AGING, V49, DOI 10.1016/j.neurobiolaging.2016.09.017
   Cluntun AA, 2021, CELL METAB, V3, P629, DOI 10.1016/j.cmet.2020.12.003
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616
   Cotter DG, 2014, J CLIN INVEST, V124, P5175, DOI 10.1172/JCI76388
   Couto N, 2016, FREE RADICAL BIO MED, V95, P27, DOI 10.1016/j.freeradbiomed.2016.02.028
   Cribbs JT, 2009, METHOD ENZYMOL, V457, P231, DOI 10.1016/S0076-6879(09)05013-7
   Crimi M, 2008, INT J NANOMED, V3, P51
   d'Avignon DA, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99762
   D'Souza AR, 2018, ESSAYS BIOCHEM, V62, P309, DOI 10.1042/EBC20170102
   Dabravolski SA, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23020952
   Dabravolski SA, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094459
   Dahl ES, 2019, MOL CANCER RES, V17, P1710, DOI 10.1158/1541-7786.MCR-18-1233
   Dai ZQ, 2010, PROTEOMICS, V10, P3789, DOI 10.1002/pmic.200900685
   Das S, 2012, PFLUG ARCH EUR J PHY, V464, P101, DOI 10.1007/s00424-012-1100-4
   Rodrigues PMD, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-94474-0
   De Blasio MJ, 2015, FREE RADICAL BIO MED, V87, P137, DOI 10.1016/j.freeradbiomed.2015.04.028
   De Souza AI, 2010, J MOL CELL CARDIOL, V49, P851, DOI 10.1016/j.yjmcc.2010.07.008
   De Vos KJ, 2005, CURR BIOL, V15, P678, DOI 10.1016/j.cub.2005.02.064
   Delaunay S, 2022, NATURE, V607, P593, DOI 10.1038/s41586-022-04898-5
   Demarest TG, 2020, ACTA NEUROPATHOL, V140, P25, DOI 10.1007/s00401-020-02152-8
   Deng LD, 2022, STEM CELL RES THER, V13, DOI 10.1186/s13287-022-02836-w
   Deng WJ, 2010, MOL CELL PROTEOMICS, V9, P100, DOI 10.1074/mcp.M900020-MCP200
   Deng Y, 2021, BIOMED PHARMACOTHER, V140, DOI 10.1016/j.biopha.2021.111689
   Deshmukh AS, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20556-8
   Dhir A, 2018, NATURE, V560, P238, DOI 10.1038/s41586-018-0363-0
   Di Francesco A, 2020, NPJ AGING MECH DIS, V6, DOI 10.1038/s41514-020-00051-6
   Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230
   Ding F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059825
   Ding MG, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12491
   Ding YY, 2021, BIOENGINEERED, V12, P5440, DOI 10.1080/21655979.2021.1967032
   Dittenhafer-Reed KE, 2015, CELL METAB, V21, P637, DOI 10.1016/j.cmet.2015.03.007
   Doll S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01747-2
   Donega V, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0736-0
   Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI [10.1172/JCI200523621, 10.1172/JCI23621]
   E QK, 2013, ACTA BIOCH BIOPH SIN, V45, P129, DOI 10.1093/abbs/gms098
   Eccleston HB, 2011, ANTIOXID REDOX SIGN, V15, P447, DOI 10.1089/ars.2010.3395
   del Dedo JE, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202010016
   Faas MM, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165845
   Fais M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22147630
   Faitg J, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109509
   Fatehi F, 2020, EUR J NEUROL, V27, P2257, DOI 10.1111/ene.14402
   Favaro G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10226-9
   Fecher C, 2019, NAT NEUROSCI, V22, P1731, DOI 10.1038/s41593-019-0479-z
   Feichtinger RG, 2017, AM J HUM GENET, V101, P525, DOI 10.1016/j.ajhg.2017.08.015
   Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748
   Ferreira R, 2010, PROTEOMICS, V10, P3142, DOI 10.1002/pmic.201000173
   Field CS, 2020, CELL METAB, V31, P422, DOI 10.1016/j.cmet.2019.11.021
   Filali-Mouncef Y, 2022, AUTOPHAGY, V18, P50, DOI 10.1080/15548627.2021.1895658
   Fischer CA, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101601
   Fogarty MJ, 2020, J APPL PHYSIOL, V128, P70, DOI 10.1152/japplphysiol.00644.2019
   Fontana GA, 2020, NUCLEIC ACIDS RES, V48, P11244, DOI 10.1093/nar/gkaa804
   Forner F, 2009, CELL METAB, V10, P324, DOI 10.1016/j.cmet.2009.08.014
   Francis BM, 2014, J ALZHEIMERS DIS, V39, P347, DOI 10.3233/JAD-131499
   Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385
   Fritsch M, 2015, AM J CLIN NUTR, V102, P1051, DOI 10.3945/ajcn.115.107599
   Fu QH, 2020, J PROTEOMICS, V223, DOI 10.1016/j.jprot.2020.103821
   Fu R, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3527809
   Galera-Monge T, 2019, J CELL PHYSIOL, V234, P19511, DOI 10.1002/jcp.28549
   Galloway CA, 2013, ANTIOXID REDOX SIGN, V19, P415, DOI 10.1089/ars.2012.4779
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gao S, 2018, MITOCHONDRION, V38, P41, DOI 10.1016/j.mito.2017.08.002
   Gao ZJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01919-0
   Gariani K, 2016, HEPATOLOGY, V63, P1190, DOI 10.1002/hep.28245
   Gauba E, 2021, NEUROBIOL AGING, V98, P63, DOI 10.1016/j.neurobiolaging.2020.09.018
   Gauba E, 2019, NEUROBIOL DIS, V121, P138, DOI 10.1016/j.nbd.2018.09.020
   Geltink RIK, 2020, NAT METAB, V2, P703, DOI 10.1038/s42255-020-0256-z
   Genin EC, 2016, EMBO MOL MED, V8, P58, DOI 10.15252/emmm.201505496
   Giacomello M, 2016, CELL DEATH DIFFER, V23, P1417, DOI 10.1038/cdd.2016.52
   Giebelstein J, 2012, DIABETOLOGIA, V55, P1114, DOI 10.1007/s00125-012-2456-x
   Giedt RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32985
   Gimenez-Roqueplo AP, 2001, AM J HUM GENET, V69, P1186, DOI 10.1086/324413
   Giovannoni MP, 2003, MINI-REV MED CHEM, V3, P576, DOI 10.2174/1389557033487890
   Goh KY, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2019.101100
   Goldsmith J, 2022, AUTOPHAGY, V18, P2003, DOI 10.1080/15548627.2022.2056865
   Gómez-Serrano M, 2017, REDOX BIOL, V11, P415, DOI 10.1016/j.redox.2016.12.013
   Gómez-Serrano M, 2016, SCI REP-UK, V6, DOI 10.1038/srep25756
   Gómez-Valadés AG, 2021, CELL METAB, V33, P1820, DOI 10.1016/j.cmet.2021.07.008
   Gonzalez-Rodríguez P, 2021, NATURE, V599, P650, DOI 10.1038/s41586-021-04059-0
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Grabowski P, 2019, MOL CELL PROTEOMICS, V18, P760, DOI 10.1074/mcp.RA118.001141
   Graham LC, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0221-9
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Grimsrud PA, 2012, CELL METAB, V16, P672, DOI 10.1016/j.cmet.2012.10.004
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   Gumucio JP, 2019, FASEB J, V33, P7863, DOI 10.1096/fj.201802457RR
   Hahn A, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8090392
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110
   Han YH, 2016, DIABETES, V65, P2639, DOI 10.2337/db16-0283
   Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928
   He L, 2012, CIRCULATION, V126, P1705, DOI 10.1161/CIRCULATIONAHA.111.075978
   He QF, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100960
   Heerdt BG, 2005, CANCER RES, V65, P9861, DOI 10.1158/0008-5472.CAN-05-2444
   Heerdt BG, 1998, CANCER RES, V58, P2869
   Heine KB, 2020, BIOL REV, V95, P730, DOI 10.1111/brv.12584
   Hesse R, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0847-7
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Hojlund K, 2003, J BIOL CHEM, V278, P10436, DOI 10.1074/jbc.M212881200
   Hojlund K, 2010, DIABETOLOGIA, V53, P541, DOI 10.1007/s00125-009-1624-0
   Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI [10.1242/jcs.02745, 10.1242/jcs.053850]
   Holmquist L, 2007, PHARMACOL THERAPEUT, V113, P154, DOI 10.1016/j.pharmthera.2006.07.001
   Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070
   Hood DA, 2019, ANNU REV PHYSIOL, V81, P19, DOI 10.1146/annurev-physiol-020518-114310
   Horton JL, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.84897
   Hou TT, 2019, CELL RES, V29, P754, DOI 10.1038/s41422-019-0208-x
   Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188
   Hsieh CH, 2019, CELL METAB, V30, P1131, DOI 10.1016/j.cmet.2019.08.023
   Hu C, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03152-y
   Hu FF, 2020, EUR J PHARMACOL, V883, DOI 10.1016/j.ejphar.2020.173286
   Huang J, 2021, CELL DEATH DIFFER, V28, P1174, DOI 10.1038/s41418-020-00641-7
   Huang YS, 2014, LIVER INT, V34, P931, DOI 10.1111/liv.12533
   Huang ZL, 2019, TOXICOLOGY, V428, DOI 10.1016/j.tox.2019.152307
   Huttunen HJ, 2007, FEBS LETT, V581, P1688, DOI 10.1016/j.febslet.2007.03.056
   Hwang H, 2010, DIABETES, V59, P33, DOI 10.2337/db09-0214
   Iannetti EF, 2016, NAT PROTOC, V11, P1693, DOI 10.1038/nprot.2016.094
   Ikeda K, 2017, NAT MED, V23, P1454, DOI 10.1038/nm.4429
   Iozzo P, 2010, GASTROENTEROLOGY, V139, P846, DOI 10.1053/j.gastro.2010.05.039
   Itsumi M, 2015, CELL DEATH DIFFER, V22, P1837, DOI 10.1038/cdd.2015.38
   Jaberi E, 2020, EBIOMEDICINE, V57, DOI 10.1016/j.ebiom.2020.102868
   Jacob KJ, 2021, FRONT NUTR, V7, DOI 10.3389/fnut.2020.619216
   Jiao HF, 2021, CELL, V184, P2896, DOI 10.1016/j.cell.2021.04.027
   Ju YS, 2014, ELIFE, V3, DOI 10.7554/eLife.02935
   Jusic A, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-0783-5
   Kalyanaraman B, 2018, REDOX BIOL, V14, P316, DOI 10.1016/j.redox.2017.09.020
   Kanno T, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.109921
   Kaurov I, 2018, CURR BIOL, V28, P3393, DOI 10.1016/j.cub.2018.09.008
   Kawamata H, 2017, J CELL BIOL, V216, P3917, DOI 10.1083/jcb.201709172
   Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035
   Kiebish MA, 2008, J NEUROCHEM, V106, P299, DOI 10.1111/j.1471-4159.2008.05383.x
   Kim HE, 2016, CELL, V166, P1539, DOI 10.1016/j.cell.2016.08.027
   Kim SJ, 2014, MOL CELL PROTEOMICS, V13, P811, DOI 10.1074/mcp.M113.035501
   Kleele T, 2021, NATURE, V593, P435, DOI 10.1038/s41586-021-03510-6
   Ko LW, 2001, J MOL NEUROSCI, V17, P361, DOI 10.1385/JMN:17:3:361
   Koenen M, 2021, CIRC RES, V128, P951, DOI 10.1161/CIRCRESAHA.121.318093
   Kojima R, 2019, CELL REP, V26, P518, DOI 10.1016/j.celrep.2018.12.070
   Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004
   Kolwicz SC, 2013, CIRC RES, V113, P603, DOI 10.1161/CIRCRESAHA.113.302095
   Komakula SSB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33151-1
   Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300
   Koopman WJH, 2006, CYTOM PART A, V69A, P1, DOI 10.1002/cyto.a.20198
   Kopecky J, 2001, BIOCHEM SOC T, V29, P791, DOI 10.1042/bst0290791
   Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360
   Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012
   Koves TR, 2005, AM J PHYSIOL-CELL PH, V288, pC1074, DOI 10.1152/ajpcell.00391.2004
   Kras KA, 2018, METABOLISM, V89, P18, DOI 10.1016/j.metabol.2018.09.006
   Kraus F, 2021, NATURE, V590, P57, DOI 10.1038/s41586-021-03214-x
   Krishnan KC, 2021, NAT METAB, V3, P1552, DOI 10.1038/s42255-021-00481-w
   Kristián T, 2002, J NEUROCHEM, V83, P1297, DOI 10.1046/j.1471-4159.2002.01238.x
   Kruse R, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155374
   Ku HJ, 2015, FREE RADICAL BIO MED, V80, P84, DOI 10.1016/j.freeradbiomed.2014.12.018
   Kukreja L, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-16
   Kummer E, 2021, NAT REV MOL CELL BIO, V22, P307, DOI 10.1038/s41580-021-00332-2
   Kuwahara Y, 2016, INT J RADIAT ONCOL, V96, P556, DOI 10.1016/j.ijrobp.2016.07.002
   Kuznetsov AV, 2004, MOL CELL BIOCHEM, V256, P359, DOI 10.1023/B:MCBI.0000009881.01943.68
   Kuznetsov AV, 1998, J CELL BIOL, V140, P1091, DOI 10.1083/jcb.140.5.1091
   Lahiri V, 2017, AUTOPHAGY, V13, P1259, DOI 10.1080/15548627.2017.1327512
   LAI JCK, 1977, J NEUROCHEM, V28, P625, DOI 10.1111/j.1471-4159.1977.tb10434.x
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Latorre-Muro P, 2021, CELL METAB, V3, P598, DOI 10.1016/j.cmet.2021.01.013
   LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039
   Leduc-Gaudet JP, 2015, ONCOTARGET, V6, P17923, DOI 10.18632/oncotarget.4235
   Lee JE, 2016, NATURE, V540, P139, DOI 10.1038/nature20555
   Lefebvre AEYT, 2021, NAT METHODS, V18, P1091, DOI 10.1038/s41592-021-01234-z
   Lei ZX, 2022, NATURE, V606, P804, DOI 10.1038/s41586-022-04836-5
   Li CF, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.698679
   Li L, 2021, NAT METAB, V3, P1242, DOI 10.1038/s42255-021-00443-2
   Li M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010121
   Li N, 2020, MASS SPECTROM REV, V39, P471, DOI 10.1002/mas.21618
   Li N, 2019, AGING-US, V11, P6449, DOI 10.18632/aging.102199
   Li N, 2018, GYNECOL ONCOL, V150, P343, DOI 10.1016/j.ygyno.2018.06.013
   Li WM, 2012, J CELL MOL MED, V16, P59, DOI 10.1111/j.1582-4934.2011.01336.x
   Li X, 2018, INT J CANCER, V143, P1143, DOI 10.1002/ijc.31395
   Li Y, 2020, THERANOSTICS, V10, P2897, DOI 10.7150/thno.40495
   Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003
   Lihavainen E, 2012, BIOINFORMATICS, V28, P1050, DOI 10.1093/bioinformatics/bts073
   Lim D, 2021, CELL CALCIUM, V98, DOI 10.1016/j.ceca.2021.102453
   Lindinger PW, 2015, J PROTEOMICS, V124, P79, DOI 10.1016/j.jprot.2015.03.037
   Linscheid N, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001144
   Liu JP, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-62
   Liu W, 2020, CELL DEATH DIFFER, V27, P2014, DOI 10.1038/s41418-019-0482-7
   Liu X, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.713729
   Liu X, 2020, SCI CHINA LIFE SCI, V63, P1429, DOI 10.1007/s11427-020-1631-9
   Liu YY, 2019, ACTA PHARM SIN B, V9, P745, DOI 10.1016/j.apsb.2019.02.006
   Longo M, 2021, METABOLISM, V117, DOI 10.1016/j.metabol.2021.154708
   Lorenz C, 2017, CELL STEM CELL, V20, P659, DOI 10.1016/j.stem.2016.12.013
   Lung B, 2006, NUCLEIC ACIDS RES, V34, P3842, DOI 10.1093/nar/gkl448
   Luo J, 2019, TRENDS BIOCHEM SCI, V44, P273, DOI 10.1016/j.tibs.2018.10.001
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Maeda R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67686-z
   Malpartida AB, 2021, TRENDS BIOCHEM SCI, V46, P329, DOI 10.1016/j.tibs.2020.11.007
   Mardinoglu A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4083
   Neila PM, 2016, NEUROINFORMATICS, V14, P235, DOI 10.1007/s12021-015-9288-z
   Mårtensson CU, 2017, TRENDS CELL BIOL, V27, P700, DOI 10.1016/j.tcb.2017.08.006
   Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094
   Martínez-Reyes I, 2014, CANCER DISCOV, V4, P1371, DOI 10.1158/2159-8290.CD-14-1228
   Matsushima S, 2006, CIRCULATION, V113, P1779, DOI 10.1161/CIRCULATIONAHA.105.582239
   McCommis KS, 2015, CELL METAB, V22, P682, DOI 10.1016/j.cmet.2015.07.028
   McWilliams TG, 2019, NATURE, V565, P296, DOI 10.1038/d41586-019-00093-1
   Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949
   Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051
   Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001
   Merkley ED, 2014, MASS SPECTROM REV, V33, P98, DOI 10.1002/mas.21382
   Merry TL, 2016, DIABETOLOGIA, V59, P2632, DOI 10.1007/s00125-016-4084-3
   Mewton N, 2010, J AM COLL CARDIOL, V55, P1200, DOI 10.1016/j.jacc.2009.10.052
   Michurina SS, 2021, MITOCHONDRION, V59, P157, DOI 10.1016/j.mito.2021.05.001
   Miele L, 2003, AM J GASTROENTEROL, V98, P2335, DOI 10.1111/j.1572-0241.2003.07725.x
   Migliavacca E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13694-1
   Miliara X, 2015, EMBO REP, V16, P824, DOI 10.15252/embr.201540229
   Miller KE, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00435
   Mills EL, 2022, CELL METAB, V34, P140, DOI 10.1016/j.cmet.2021.11.003
   Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064
   Mitchell TW, 2007, EXP GERONTOL, V42, P1053, DOI 10.1016/j.exger.2007.09.004
   Miyata M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061898
   MIZUNO Y, 1994, ANN NEUROL, V35, P204, DOI 10.1002/ana.410350212
   Modi S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12382-4
   Mohamed BA, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0898-5
   Mohs A, 2021, J HEPATOL, V74, P638, DOI 10.1016/j.jhep.2020.09.037
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Molnar M, 1996, ACTA NEUROPATHOL, V91, P654, DOI 10.1007/s004010050480
   Moore AS, 2021, NATURE, V591, P659, DOI 10.1038/s41586-021-03309-5
   Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7
   Morgenstern M, 2021, CELL METAB, V33, P2464, DOI 10.1016/j.cmet.2021.11.001
   Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034
   Murgia M, 2017, CELL REP, V19, P2396, DOI 10.1016/j.celrep.2017.05.054
   Murgia M, 2015, EMBO REP, V16, P387, DOI 10.15252/embr.201439757
   Murphy E, 2016, CIRC RES, V118, P1960, DOI 10.1161/RES.0000000000000104
   Murphy MP, 2018, NAT REV DRUG DISCOV, V17, P865, DOI 10.1038/nrd.2018.174
   Murphy SR, 2013, MOL THER, V21, P1497, DOI 10.1038/mt.2013.118
   Nahon P, 2009, HEPATOLOGY, V50, P1484, DOI 10.1002/hep.23187
   Nakamura T, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-35
   Nasrallah CM, 2014, NAT REV ENDOCRINOL, V10, P650, DOI 10.1038/nrendo.2014.160
   Nastasi C, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80933-7
   Neupert W, 2015, J MOL BIOL, V427, P1135, DOI 10.1016/j.jmb.2015.02.001
   Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038
   Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006
   Nickel AG, 2015, CELL METAB, V22, P472, DOI 10.1016/j.cmet.2015.07.008
   Nie Y, 2022, ACTA NEUROPATHOL, V143, P687, DOI 10.1007/s00401-022-02423-6
   Niemann J, 2017, FREE RADICAL BIO MED, V102, P174, DOI 10.1016/j.freeradbiomed.2016.11.035
   Nikolaisen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101365
   Nissanka N, 2018, FEBS LETT, V592, P728, DOI 10.1002/1873-3468.12956
   Ogando J, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0628-7
   Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237
   Otsuka H, 2020, J INHERIT METAB DIS, V43, P960, DOI 10.1002/jimd.12243
   Ouellet M, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005612
   Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607
   Parakh S, 2021, SEMIN CELL DEV BIOL, V112, P105, DOI 10.1016/j.semcdb.2021.02.002
   Park H, 2019, J CLIN INVEST, V129, P694, DOI 10.1172/JCI120606
   Park MK, 2001, EMBO J, V20, P1863, DOI 10.1093/emboj/20.8.1863
   Park SJ, 2014, J BIOL CHEM, V289, P2195, DOI 10.1074/jbc.M113.492587
   Pataky MW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12682-z
   Patterson RE, 2016, AM J PHYSIOL-ENDOC M, V310, pE484, DOI 10.1152/ajpendo.00492.2015
   Pekkurnaz G, 2022, NAT METAB, V4, P802, DOI 10.1038/s42255-022-00594-w
   Peng JY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002212
   Peng W, 2020, P NATL ACAD SCI USA, V117, P19266, DOI 10.1073/pnas.2003236117
   Peng YH, 2022, FREE RADICAL BIO MED, V179, P11, DOI 10.1016/j.freeradbiomed.2021.12.264
   Peralta S, 2018, J CELL SCI, V131, DOI 10.1242/jcs.217075
   Pérez-Pérez R, 2012, J PROTEOMICS, V75, P783, DOI 10.1016/j.jprot.2011.09.016
   Pérez-Treviño P, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165761
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Pfanner N, 2019, NAT REV MOL CELL BIO, V20, P267, DOI 10.1038/s41580-018-0092-0
   Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004
   Plubell DL, 2017, MOL CELL PROTEOMICS, V16, P873, DOI 10.1074/mcp.M116.065524
   POLLISTER ARTHUR W., 1941, PHYSIOL ZOOL, V14, P268
   Porporato PE, 2018, CELL RES, V28, P265, DOI 10.1038/cr.2017.155
   Pound KM, 2009, CIRC RES, V104, P805, DOI 10.1161/CIRCRESAHA.108.189951
   Prasetyanti PR, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0600-4
   Qian XL, 2021, AGING-US, V13, P8960, DOI 10.18632/aging.202717
   Rackham O, 2022, NAT REV GENET, V23, P606, DOI 10.1038/s41576-022-00480-x
   Rafelski SM, 2012, SCIENCE, V338, P822, DOI 10.1126/science.1225720
   Rangel-Azevedo C, 2022, J NUTR BIOCHEM, V105, DOI 10.1016/j.jnutbio.2022.109002
   Rath S, 2021, NUCLEIC ACIDS RES, V49, pD1541, DOI 10.1093/nar/gkaa1011
   Reamy AA, 2011, J NEUROCHEM, V118, P388, DOI 10.1111/j.1471-4159.2011.07312.x
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   Reeve A, 2013, J NEUROSCI, V33, P10790, DOI 10.1523/JNEUROSCI.3525-12.2013
   Renkema GH, 2015, EUR J HUM GENET, V23, P202, DOI 10.1038/ejhg.2014.80
   Rensvold JW, 2022, NATURE, V606, P382, DOI 10.1038/s41586-022-04765-3
   Ribeiro RF, 2018, FREE RADICAL BIO MED, V117, P18, DOI 10.1016/j.freeradbiomed.2018.01.012
   Rieusset J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0416-1
   Robinson MM, 2017, CELL METAB, V25, P581, DOI 10.1016/j.cmet.2017.02.009
   Rohani A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75899-5
   Ron-Harel N, 2018, P NATL ACAD SCI USA, V115, P13347, DOI 10.1073/pnas.1804149115
   Ron-Harel N, 2016, CELL METAB, V24, P104, DOI 10.1016/j.cmet.2016.06.007
   Rossi M, 2022, NATURE, V605, P747, DOI 10.1038/s41586-022-04758-2
   Rubio-Gozalbo M. E., 2004, Molecular Aspects of Medicine, V25, P521, DOI 10.1016/j.mam.2004.06.007
   Ruepp SU, 2002, TOXICOL SCI, V65, P135, DOI 10.1093/toxsci/65.1.135
   Ruiz A, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00003
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132
   Safiulina D, 2019, EMBO J, V38, DOI 10.15252/embj.201899384
   Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382
   SCHAPER J, 1985, CIRC RES, V56, P377, DOI 10.1161/01.RES.56.3.377
   Scharwey M, 2013, J CELL SCI, V126, P5317, DOI 10.1242/jcs.134130
   Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010
   Schilf P, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031006
   Schmid AI, 2011, DIABETES CARE, V34, P448, DOI 10.2337/dc10-1076
   Schmidt NM, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22967-7
   Schmidt O, 2011, CELL, V144, P227, DOI 10.1016/j.cell.2010.12.015
   Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959
   Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025
   Shah SI, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223014
   Shaltouki A, 2018, ACTA NEUROPATHOL, V136, P607, DOI 10.1007/s00401-018-1873-4
   Shami GJ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82884-z
   Shamseldin HE, 2016, HUM GENET, V135, P21, DOI 10.1007/s00439-015-1608-8
   Shao D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05362-7
   Sharma S, 2020, REDOX BIOL, V37, DOI 10.1016/j.redox.2020.101740
   SHEU KFR, 1994, ANN NEUROL, V35, P312, DOI 10.1002/ana.410350311
   Shi JR, 2015, LIFE SCI, V141, P170, DOI 10.1016/j.lfs.2015.09.022
   Shi QL, 2011, J BIOL CHEM, V286, P17640, DOI 10.1074/jbc.M110.203018
   Shi XJ, 2020, J CELL MOL MED, V24, P13151, DOI 10.1111/jcmm.15921
   Shin CS, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20597-z
   Shirakabe A, 2016, CIRCULATION, V133, P1249, DOI 10.1161/CIRCULATIONAHA.115.020502
   Siebers EM, 2018, J NEUROPATH EXP NEUR, V77, P665, DOI 10.1093/jnen/nly042
   SIERRA MF, 1973, P NATL ACAD SCI USA, V70, P3155, DOI 10.1073/pnas.70.11.3155
   Sim WC, 2020, METABOLISM, V102, DOI 10.1016/j.metabol.2019.154000
   Simoes ICM, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22136848
   Simpson DSA, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9080743
   Sinha D, 2014, MOL CELL BIOL, V34, P1757, DOI 10.1128/MCB.01527-13
   Smith ALM, 2020, NAT CANCER, V1, P976, DOI 10.1038/s43018-020-00112-5
   Song MS, 2017, CELL METAB, V26, P872, DOI 10.1016/j.cmet.2017.09.023
   Sonn SK, 2022, REDOX BIOL, V51, DOI 10.1016/j.redox.2022.102275
   Sorrentino V, 2017, NATURE, V552, P187, DOI 10.1038/nature25143
   Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057
   Stauch KL, 2014, J PROTEOME RES, V13, P2620, DOI 10.1021/pr500295n
   Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x
   Sun WQ, 2016, TOXICOL SCI, V151, P193, DOI 10.1093/toxsci/kfw035
   Sunny NE, 2017, TRENDS ENDOCRIN MET, V28, P250, DOI 10.1016/j.tem.2016.11.006
   Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004
   Szeto HH, 2016, KIDNEY INT, V90, P997, DOI 10.1016/j.kint.2016.06.013
   Tan HY, 2017, IMMUNITY, V46, P488, DOI 10.1016/j.immuni.2017.02.010
   Tan MJ, 2020, CELL DEATH DIFFER, V27, P2143, DOI 10.1038/s41418-020-0491-6
   Tan YQ, 2021, BBA-REV CANCER, V1876, DOI 10.1016/j.bbcan.2021.188534
   Tang ZJ, 2022, MOL BIOL EVOL, V39, DOI 10.1093/molbev/msac090
   Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793
   Tews D, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101286
   Thelen MP, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-01101-6
   Towers CG, 2021, DEV CELL, V56, P2029, DOI 10.1016/j.devcel.2021.06.003
   Tracy TE, 2022, CELL, V185, P712, DOI 10.1016/j.cell.2021.12.041
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Ubaida-Mohien C, 2019, ELIFE, V8, DOI 10.7554/eLife.49874
   Ubaida-Mohien C, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00312
   Uchihashi M, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.117.004417
   Unni S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47018-6
   Dietz JV, 2021, REDOX BIOL, V46, DOI 10.1016/j.redox.2021.102125
   Vaillant-Beuchot L, 2021, ACTA NEUROPATHOL, V141, P39, DOI 10.1007/s00401-020-02234-7
   Vairetti M, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10030364
   Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001
   van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007
   VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122
   Villarroya J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029691
   Virmani A, 2015, MOL NEUROBIOL, V52, P826, DOI 10.1007/s12035-015-9238-7
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Völgyi K, 2015, J PROTEOMICS, V120, P142, DOI 10.1016/j.jprot.2015.03.005
   von Montfort C, 2012, J HEPATOL, V57, P852, DOI 10.1016/j.jhep.2012.05.024
   Walker JM, 2022, ACTA NEUROPATHOL COM, V10, DOI 10.1186/s40478-022-01324-9
   Wang G, 2016, J AGR FOOD CHEM, V64, P1610, DOI 10.1021/acs.jafc.5b05897
   Wang GX, 2019, MOL CELL, V74, P844, DOI 10.1016/j.molcel.2019.03.021
   Wang PW, 2014, ANTIOXID REDOX SIGN, V20, P2572, DOI 10.1089/ars.2013.5334
   Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324
   Wang X, 2022, NATURE AGING, V2, P155, DOI 10.1038/s43587-021-00164-x
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Wang Y, 2020, J CARD FAIL, V26, P243, DOI 10.1016/j.cardfail.2019.09.003
   Wang YH, 2020, CANCERS, V12, DOI 10.3390/cancers12071797
   Wang ZC, 2020, MOL THER-NUCL ACIDS, V21, P751, DOI 10.1016/j.omtn.2020.07.013
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   Weber M, 2020, FASEB J, V34, P11816, DOI 10.1096/fj.202000678R
   Weiduschat N, 2014, NEUROLOGY, V82, P798, DOI 10.1212/WNL.0000000000000169
   Weinheimer EM, 2007, AM J PHYSIOL-REG I, V292, pR2241, DOI 10.1152/ajpregu.00718.2006
   Wenes M, 2022, CELL METAB, V34, P731, DOI 10.1016/j.cmet.2022.03.013
   Whitaker RM, 2016, ANNU REV PHARMACOL, V56, P229, DOI 10.1146/annurev-pharmtox-010715-103155
   Wiedemann N, 2017, ANNU REV BIOCHEM, V86, P685, DOI 10.1146/annurev-biochem-060815-014352
   Willcox JAL, 2022, AM J HUM GENET, V109, P961, DOI 10.1016/j.ajhg.2022.03.011
   Wong CO, 2017, CELL HOST MICROBE, V21, P719, DOI 10.1016/j.chom.2017.05.002
   Wong YC, 2018, NATURE, V554, P382, DOI 10.1038/nature25486
   Wu NN, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9825061
   Wu ZJ, 2020, MOL THER-NUCL ACIDS, V20, P801, DOI 10.1016/j.omtn.2020.04.017
   Xian HX, 2021, IMMUNITY, V54, P1463, DOI 10.1016/j.immuni.2021.05.004
   Xu L, 2022, ACTA PHARMACOL SIN, V43, P316, DOI 10.1038/s41401-021-00658-9
   Xu ZS, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28557-5
   Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009
   Yang KC, 2014, CIRCULATION, V129, P1009, DOI 10.1161/CIRCULATIONAHA.113.003863
   Yang LC, 2009, NEUROBIOL DIS, V36, P320, DOI 10.1016/j.nbd.2009.07.023
   Ye J, 2017, P NATL ACAD SCI USA, V114, P292, DOI 10.1073/pnas.1618605114
   Yin C, 2019, ANN ONCOL, V30, P953, DOI 10.1093/annonc/mdz105
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Yu XH, 2009, HUM MOL GENET, V18, P4689, DOI 10.1093/hmg/ddp432
   Yuan Y, 2020, NAT GENET, V52, P342, DOI 10.1038/s41588-019-0557-x
   Zahedi A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34455-y
   Zekonyte U, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23561-7
   Zhang S, 2021, PROG NEUROBIOL, V204, DOI 10.1016/j.pneurobio.2021.102089
   Zhang X, 2020, ARCH TOXICOL, V94, P2691, DOI 10.1007/s00204-020-02785-4
   Zhanghao K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19747-0
   Zhao QY, 2022, DIABETES, V71, P233, DOI 10.2337/db21-0173
   Zhao QY, 2020, CELL, V183, P76, DOI 10.1016/j.cell.2020.08.009
   Zhao W, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.713819
   Zhao Y, 2019, THERANOSTICS, V9, P1510, DOI 10.7150/thno.29620
   Zheng YX, 2018, CELL, V175, P1546, DOI 10.1016/j.cell.2018.09.041
   Zhou B, 2018, J CLIN INVEST, V128, P3716, DOI 10.1172/JCI120849
   Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001
   Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013
   Zou Y, 2017, BIOMED PHARMACOTHER, V94, P140, DOI 10.1016/j.biopha.2017.07.074
   Zuliani I, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073746
NR 476
TC 10
Z9 10
U1 13
U2 39
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2095-9907
EI 2059-3635
J9 SIGNAL TRANSDUCT TAR
JI Signal Transduct. Target. Ther.
PD AUG 23
PY 2023
VL 8
IS 1
AR 311
DI 10.1038/s41392-023-01546-w
PG 27
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA P8BF3
UT WOS:001052862100003
PM 37607925
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Omidsalar, AA
   Mccullough, CG
   Xu, LL
   Boedijono, S
   Gerke, D
   Webb, MG
   Manojlovic, Z
   Sequeira, A
   Lew, MF
   Santorelli, M
   Serrano, GE
   Beach, TG
   Limon, A
   Vawter, MP
   Hjelm, BE
AF Omidsalar, Audrey A.
   Mccullough, Carmel G.
   Xu, Lili
   Boedijono, Stanley
   Gerke, Daniel
   Webb, Michelle G.
   Manojlovic, Zarko
   Sequeira, Adolfo
   Lew, Mark F.
   Santorelli, Marco
   Serrano, Geidy E.
   Beach, Thomas G.
   Limon, Agenor
   Vawter, Marquis P.
   Hjelm, Brooke E.
TI Common mitochondrial deletions in RNA-Seq: evaluation of bulk,
   single-cell, and spatial transcriptomic datasets
SO COMMUNICATIONS BIOLOGY
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; DNA DELETIONS; MAMMALIAN
   MITOCHONDRIA; DEGENERATIVE DISEASES; HUMAN BRAIN; SEQUENCE; MUTATION;
   GENOME; POLYADENYLATION; RECOMBINATION
AB Common mitochondrial DNA (mtDNA) deletions are large structural variants in the mitochondrial genome that accumulate in metabolically active tissues with age and have been investigated in various diseases. We applied the Splice-Break2 pipeline (designed for high-throughput quantification of mtDNA deletions) to human RNA-Seq datasets and describe the methodological considerations for evaluating common deletions in bulk, single-cell, and spatial transcriptomics datasets. A robust evaluation of 1570 samples from 14 RNA-Seq studies showed: (i) the abundance of some common deletions detected in PCR-amplified mtDNA correlates with levels observed in RNA-Seq data; (ii) RNA-Seq library preparation method has a strong effect on deletion detection; (iii) deletions had a significant, positive correlation with age in brain and muscle; (iv) deletions were enriched in cortical grey matter, specifically in layers 3 and 5; and (v) brain regions with dopaminergic neurons (i.e., substantia nigra, ventral tegmental area, and caudate nucleus) had remarkable enrichment of common mtDNA deletions.
   A methods application study demonstrates that the Splice-Break2 pipeline can detect large mitochondrial DNA deletions in RNA-Seq data. Analyses includes GTEx and GEO datasets and demonstrate differences across tissues, brain regions, and age.
C1 [Omidsalar, Audrey A.; Mccullough, Carmel G.; Xu, Lili; Boedijono, Stanley; Gerke, Daniel; Webb, Michelle G.; Manojlovic, Zarko; Hjelm, Brooke E.] Keck Sch Med USC, Dept Translat Genom, Los Angeles, CA 90033 USA.
   [Sequeira, Adolfo; Vawter, Marquis P.] Univ Calif Irvine UCI, Sch Med, Dept Psychiat & Human Behav, Irvine, CA USA.
   [Lew, Mark F.] Keck Sch Med USC, Dept Neurol, Los Angeles, CA USA.
   [Santorelli, Marco] Keck Sch Med USC, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA USA.
   [Serrano, Geidy E.; Beach, Thomas G.] Banner Sun Hlth Res Inst BSHRI, Sun City, AZ USA.
   [Limon, Agenor] Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Sch Med, Dept Neurol, Galveston, TX USA.
C3 University of California System; University of California Irvine;
   University of Texas System; University of Texas Medical Branch Galveston
RP Hjelm, BE (corresponding author), Keck Sch Med USC, Dept Translat Genom, Los Angeles, CA 90033 USA.
EM bhjelm@usc.edu
RI Limon, Agenor/AAQ-7961-2021; Sequeira, Adolfo/K-7278-2015
OI McCullough, Carmel/0000-0003-2092-7180; Omidsalar,
   Audrey/0000-0002-5070-1417; Sequeira, Adolfo/0000-0003-3040-1190
FU USC Department of Translational Genomics; NINDS; NIMH; USC Department of
   Translational Genomics - William Lyon Penzner Foundation; Della Martin
   Foundation; Pritzker Neuropsychiatric Disorders Research Consortium; NIA
   [P30 AG19610, P30AG072980]; Arizona Department of Health Services
   [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901,
   1001]; Michael J. Fox Foundation for Parkinson's Research; Common Fund
   of the Office of the Director of the National Institutes of Health; NCI;
   NHGRI; NHLBI; NIDA
FX Funding support for A.A.O. was provided by the USC Department of
   Translational Genomics, the Anenberg Center for Parkinson's Disease and
   Other Neurodegenerative Disorders (USC), and NINDS U01 NS120260. B.E.H.
   was supported by the USC Department of Translational Genomics. Funding
   for paired RNA and DNA samples was provided by NIMH R21 MH113177 and
   NIMH R01 MH085801, respectively. Funding for spatial transcriptomics
   experiments was provided by the USC Department of Translational Genomics
   and 10x Genomics. Brain tissue used for paired RNA and DNA analyses was
   collected at the University of California Irvine Brain Bank and funded
   by philanthropic gifts from the William Lyon Penzner Foundation, the
   Della Martin Foundation, and the Pritzker Neuropsychiatric Disorders
   Research Consortium. Brain tissue used for spatial transcriptomics and
   bulk RNA-Seq was collected through the BSHRI Brain and Body Donation
   Program, which has been supported by NINDS (U24 NS072026 National Brain
   and Tissue Resource for Parkinson's Disease and Related Disorders), NIA
   (P30 AG19610 and P30AG072980, Arizona Alzheimer's Disease Center), the
   Arizona Department of Health Services (contract 211002, Arizona
   Alzheimer's Research Center), the Arizona Biomedical Research Commission
   (contracts 4001, 0011, 05-901 and 1001 to the Arizona Parkinson's
   Disease Consortium) and the Michael J. Fox Foundation for Parkinson's
   Research. The Genotype-Tissue Expression (GTEx) Project was supported by
   the Common Fund of the Office of the Director of the National Institutes
   of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS.
   Mitochondrial DNA data used for this analysis are available in: dbGaP
   accession number phs002395.v1.p1. The GTEx data used for the analyses
   described in this manuscript were obtained from: dbGaP accession number
   phs000424.vN.pN on 07/17/2023. We would like to thank the laboratory of
   Leonardo Morsut (USC) for the use of their microscope. We would also
   like to thank the authors of the various human RNA-Seq studies analyzed
   here for making their data publicly available to the research community.
   In addition, we are always greatly appreciative to all the patients and
   tissue donors, as well as their families, without whom this work would
   not be possible.
CR Aguila J, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.699562
   Alvarez M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67513-5
   Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Basu S, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1009242
   Belmonte FR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25186
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bosworth CM, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1821-7
   Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109
   Cline SD, 2012, BBA-GENE REGUL MECH, V1819, P979, DOI 10.1016/j.bbagrm.2012.06.002
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Damas J, 2014, NUCLEIC ACIDS RES, V42, pD1261, DOI 10.1093/nar/gkt982
   Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112
   Dölle C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13548
   Enge M, 2017, CELL, V171, P321, DOI 10.1016/j.cell.2017.09.004
   Goudenège D, 2019, GENET MED, V21, P1407, DOI 10.1038/s41436-018-0350-8
   Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313
   Harris JJ, 2012, J NEUROSCI, V32, P356, DOI 10.1523/JNEUROSCI.3430-11.2012
   Harris KD, 2015, NAT NEUROSCI, V18, P170, DOI 10.1038/nn.3917
   Hjelm B. E., Zenodo, DOI [10.5281/zenodo.10499097, DOI 10.5281/ZENODO.10499097]
   Hjelm BE, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz164
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Hwang Y, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.94
   JOHNS DR, 1993, AM J OPHTHALMOL, V115, P108, DOI 10.1016/S0002-9394(14)73533-0
   Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4
   Kim HR, 2015, ANN LAB MED, V35, P1, DOI 10.3343/alm.2015.35.1.1
   Kim S, 2010, NEUROPSYCHOPHARMACOL, V35, P473, DOI 10.1038/npp.2009.151
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024
   Lakshmipathy U, 1999, NUCLEIC ACIDS RES, V27, P1198, DOI 10.1093/nar/27.4.1198
   Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662
   Lavin KM, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00653
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Li X, 2015, METHODS MOL BIOL, V1269, P137, DOI 10.1007/978-1-4939-2291-8_8
   Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653
   Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44
   Lujan SA, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02138-5
   Ma S, 2020, CELL, V183, P1103, DOI 10.1016/j.cell.2020.09.056
   Mamdani F, 2014, SCHIZOPHR RES, V159, P370, DOI 10.1016/j.schres.2014.08.026
   Martin FJ, 2023, NUCLEIC ACIDS RES, V51, pD933, DOI 10.1093/nar/gkac958
   Maynard KR, 2021, NAT NEUROSCI, V24, P425, DOI 10.1038/s41593-020-00787-0
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   Monzón-Sandoval J, 2020, ANN NEUROL, V87, P853, DOI 10.1002/ana.25719
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Moraes CT, 2003, J MOL DIAGN, V5, P197, DOI 10.1016/S1525-1578(10)60474-6
   MORAES CT, 1989, BIOCHEM BIOPH RES CO, V160, P765, DOI 10.1016/0006-291X(89)92499-6
   Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506
   Nagaike T, 2008, BBA-GENE REGUL MECH, V1779, P266, DOI 10.1016/j.bbagrm.2008.02.001
   NAKAI A, 1994, LANCET, V343, P1397, DOI 10.1016/S0140-6736(94)92527-5
   Nativio R, 2020, NAT GENET, V52, P1024, DOI 10.1038/s41588-020-0696-0
   Nissanka N, 2019, TRENDS GENET, V35, P235, DOI 10.1016/j.tig.2019.01.001
   Omidsalar A. A., Zenodo, DOI [10.5281/zenodo.10499375, DOI 10.5281/ZENODO.10499375]
   OZAWA T, 1990, BIOCHEM BIOPH RES CO, V172, P483, DOI 10.1016/0006-291X(90)90698-M
   Paramasivam A, 2016, MITOCHONDRION, V26, P81, DOI 10.1016/j.mito.2015.12.006
   Phillips NR, 2014, ALZHEIMERS DEMENT, V10, P393, DOI 10.1016/j.jalz.2013.04.508
   Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758
   Prakrithi P, 2023, BRIEF BIOINFORM, V24, DOI 10.1093/bib/bbad031
   Preissl S, 2018, NAT NEUROSCI, V21, P1015, DOI 10.1038/s41593-018-0114-4
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Rickner HD, 2019, JOVE-J VIS EXP, DOI 10.3791/59120
   Rollins Brandi L, 2018, Mol Neuropsychiatry, V3, P157, DOI 10.1159/000484348
   Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Simchovitz A, 2020, AGING CELL, V19, DOI 10.1111/acel.13115
   Slomovic S, 2005, MOL CELL BIOL, V25, P6427, DOI 10.1128/MCB.25.15.6427-6435.2005
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Thompson LV, 2006, EXP GERONTOL, V41, P1220, DOI 10.1016/j.exger.2006.10.018
   Thyagarajan B, 1996, J BIOL CHEM, V271, P27536, DOI 10.1074/jbc.271.44.27536
   Tumasian RA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22168-2
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 1997, SCI AM, V277, P40, DOI 10.1038/scientificamerican0897-40
   WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   WEI YH, 1992, MUTAT RES, V275, P145, DOI 10.1016/0921-8734(92)90019-L
   Wickham H., 2016, ggplot2: Elegant Graphics for Data Analysis, DOI 10.1007/978-3-319-24277-4
   Yan F, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-1929-3
   Yu YG, 2018, J CEREBR BLOOD F MET, V38, P1339, DOI 10.1177/0271678X17708691
   Zeppillo T, 2022, SCHIZOPHR RES, V249, P25, DOI 10.1016/j.schres.2020.03.037
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
   Zhou L, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbac222
NR 89
TC 0
Z9 0
U1 5
U2 10
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2399-3642
J9 COMMUN BIOL
JI Commun. Biol.
PD FEB 17
PY 2024
VL 7
IS 1
AR 200
DI 10.1038/s42003-024-05877-4
PG 20
WC Biology; Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Science & Technology - Other
   Topics
GA IB1Q5
UT WOS:001163774500004
PM 38368460
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Mancuso, M
   Filosto, M
   Bellan, M
   Liguori, R
   Montagna, P
   Baruzzi, A
   DiMauro, S
   Carelli, V
AF Mancuso, M
   Filosto, M
   Bellan, M
   Liguori, R
   Montagna, P
   Baruzzi, A
   DiMauro, S
   Carelli, V
TI <i>POLG</i> mutations causing ophthalmoplegia, sensorimotor
   polyneuropathy, ataxia, and deafness
SO NEUROLOGY
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; NUCLEOTIDE TRANSLOCATOR-1 GENE;
   AUTOSOMAL-DOMINANT; MITOCHONDRIAL-DNA; MULTIPLE DELETIONS;
   POLYMERASE-GAMMA; TWINKLE; ADPEO; ANT1
AB The authors identified two novel heterozygous missense transitions in the gene for the mitochondrial polymerase gammaA subunit (POLG) in a family with an autosomal recessive syndrome comprising progressive external ophthalmoplegia (PEO), polyneuropathy, ataxia, sensorineural hearing loss, and affective disorders. These mutations were not detected in 120 healthy control subjects.
C1 Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.
   Univ Bologna, Dept Neurol Sci, I-40126 Bologna, Italy.
C3 Columbia University; University of Bologna
RP Columbia Univ Coll Phys & Surg, Dept Neurol, 4-420,630 W 168th St, New York, NY 10032 USA.
EM sd12@columbia.edu
RI Mancuso, Michelangelo/K-4170-2016; Liguori, Rocco/AAB-7860-2020;
   Filosto, Massimiliano/S-9446-2019
OI Liguori, Rocco/0000-0002-1815-1013; CARELLI,
   VALERIO/0000-0003-4923-6404; Filosto, Massimiliano/0000-0002-2852-7512
FU NICHD NIH HHS [P01HD 32062] Funding Source: Medline; NINDS NIH HHS
   [NS11766] Funding Source: Medline
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lewis S, 2002, J NEUROL SCI, V201, P39, DOI 10.1016/S0022-510X(02)00190-9
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
NR 9
TC 66
Z9 72
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD JAN 27
PY 2004
VL 62
IS 2
BP 316
EP 318
DI 10.1212/WNL.62.2.316
PG 3
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 767KT
UT WOS:000188439300036
PM 14745080
DA 2024-11-01
ER

PT J
AU Ashley, N
   Adams, S
   Slama, A
   Zeviani, M
   Suomalainen, A
   Andreu, AL
   Naviaux, RK
   Poulton, J
AF Ashley, Neil
   Adams, Susan
   Slama, Abdelhamid
   Zeviani, Massimo
   Suomalainen, Anu
   Andreu, Antonio L.
   Naviaux, Robert K.
   Poulton, Joanna
TI Defects in maintenance of mitochondrial DNA are associated with
   intramitochondrial nucleotide imbalances
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; THYMIDINE
   PHOSPHORYLASE-DEFICIENCY; MTDNA DEPLETION; NEUROGASTROINTESTINAL
   ENCEPHALOMYOPATHY; POLYMERASE-GAMMA; ALPERS-SYNDROME; HELICASE ACTIVITY;
   TK2 DEFICIENCY; GENE-MUTATIONS; HUMAN-CELLS
AB Defects in mtDNA maintenance range from fatal multisystem childhood diseases, such as Alpers syndrome, to milder diseases in adults, including mtDNA depletion syndromes (MDS) and familial progressive external ophthalmoplegia (AdPEO). Most are associated with defects in genes involved in mitochondrial deoxynucleotide metabolism or utilization, such as mutations in thymidine kinase 2 (TK2) as well as the mtDNA replicative helicase, Twinkle and gamma polymerase (POLG). We have developed an in vitro system to measure incorporation of radiolabelled dNTPs into mitochondria of saponin permeabilized cells. We used this to compare the rates of mtDNA synthesis in cells from 12 patients with diseases of mtDNA maintenance. We observed reduced incorporation of exogenous alpha P-32-dTTP in fibroblasts from a patient with Alpers syndrome associated with the A467T substitution in POLG, a patient with dGK mutations, and a patient with mtDNA depletion of unknown origin compared to controls. However, incorporation of alpha P-32-dTTP relative to either cell doubling time or alpha P-32-dCTP incorporation was increased in patients with thymidine kinase deficiency or PEO as the result of TWINKLE mutations compared with controls. The specific activity of newly synthesized mtDNA depends on the size of the endogenous pool diluting the exogenous labelled nucleotide. Our result is consistent with a deficiency in the intramitochondrial pool of dTTP relative to dCTP in cells from patients with TK2 deficiency and TWINKLE mutations. Such DNA precursor asymmetry could cause pausing of the replication complex and hence exacerbate the propensity for age-related mtDNA mutations. Because deviations from the normal concentrations of dNTPs are known to be mutagenic, we suggest that intramitochondrial nucleoticle imbalance could underlie the multiple mtDNA mutations observed in these patients.
C1 Hop Bicetre, Lab Biochim 1, APHP, Le Kremlin Bicetre, France.
   Natl Neurol Inst C Besta, Div Mol Neurogenet, I-20126 Milan, Italy.
   Biomedicum, Programme Neurosci, Helsinki, Finland.
   Univ Calif San Diego, Mitochondrial & Metab Dis Ctr, San Diego, CA 92103 USA.
C3 Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Ambroise-Pare - APHP; Universite Paris Saclay; Hopital Universitaire
   Bicetre - APHP; Hopital Universitaire Antoine-Beclere - APHP; Fondazione
   IRCCS Istituto Neurologico Carlo Besta; University of Helsinki;
   University of California System; University of California San Diego
RP Poulton, J (corresponding author), John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Mitochondrial Genet Grp, Level 3,Womens Ctr, Oxford OX3 9DU, England.
EM joanna.poulton@obs-gyn.ox.ac.uk
RI Poulton, Joanna/AAB-4828-2021; Zeviani, Massimo/K-2891-2014; adams,
   susan/I-7423-2016
OI Zeviani, Massimo/0000-0002-9067-5508; Suomalainen-Wartiovaara,
   Anu/0000-0003-4833-5195; Ashley, Neil/0000-0002-1655-5137; ANDREU,
   antonio luis/0000-0002-3936-3234; Poulton, Joanna/0000-0002-2460-5587
FU MRC [G0500695] Funding Source: UKRI; Medical Research Council [G0500695]
   Funding Source: Medline
CR Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bradshaw PC, 2005, AM J PHYSIOL-CELL PH, V288, pC989, DOI 10.1152/ajpcell.00530.2004
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   CHENG S, 1994, NAT GENET, V7, P350, DOI 10.1038/ng0794-350
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Emmerson CF, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.2.e1
   Fairbanks LD, 2002, J INHERIT METAB DIS, V25, P603, DOI 10.1023/A:1022007827133
   Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200
   GRAHAM J, 1997, SUBCELLULAR FRACTION, P135
   Iida R, 2006, BIOCHEM BIOPH RES CO, V344, P948, DOI 10.1016/j.bbrc.2006.04.008
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   KUNKEL TA, 1988, BIOCHIM BIOPHYS ACTA, V951, P1, DOI 10.1016/0167-4781(88)90020-6
   KUNZ BA, 1991, ANNU REV GENET, V25, P339, DOI 10.1146/annurev.ge.25.120191.002011
   Lindhurst MJ, 2006, P NATL ACAD SCI USA, V103, P15927, DOI 10.1073/pnas.0607661103
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Martí R, 2003, BIOCHEM BIOPH RES CO, V303, P14, DOI 10.1016/S0006-291X(03)00294-8
   MATSON SW, 1983, J BIOL CHEM, V258, P4017
   Minamikawa T, 1999, J CELL SCI, V112, P2419
   Morten KJ, 1996, J INHERIT METAB DIS, V19, P123, DOI 10.1007/BF01799409
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5
   Pombo A, 1999, EMBO J, V18, P2241, DOI 10.1093/emboj/18.8.2241
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200
   Rampazzo C, 2004, J BIOL CHEM, V279, P17019, DOI 10.1074/jbc.M313957200
   Saada A, 2003, BIOCHEM BIOPH RES CO, V310, P963, DOI 10.1016/j.bbrc.2003.09.104
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Saks VA, 1998, MOL CELL BIOCHEM, V184, P1, DOI 10.1023/A:1006894531396
   Slama A, 2005, MOL GENET METAB, V84, P326, DOI 10.1016/j.ymgme.2004.12.004
   Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102
   Song SW, 2003, J BIOL CHEM, V278, P43893, DOI 10.1074/jbc.C300401200
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Taanman JW, 1997, HUM MOL GENET, V6, P935, DOI 10.1093/hmg/6.6.935
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Viguera E, 2001, EMBO J, V20, P2587, DOI 10.1093/emboj/20.10.2587
   Vilà MR, 2003, NEUROLOGY, V60, P1203, DOI 10.1212/01.WNL.0000055928.58122.47
   Wang LY, 2000, BIOCHEM J, V351, P469, DOI 10.1042/0264-6021:3510469
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825
   WERNETTE CM, 1988, BIOCHEMISTRY-US, V27, P6046, DOI 10.1021/bi00416a033
NR 53
TC 40
Z9 43
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JUN 15
PY 2007
VL 16
IS 12
BP 1400
EP 1411
DI 10.1093/hmg/ddm090
PG 12
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 190UA
UT WOS:000248084900002
PM 17483096
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Werner, KGE
   Morel, CF
   Kirton, A
   Benseler, SM
   Shoffner, JM
   Addis, JBL
   Robinson, BH
   Burrowes, DM
   Blaser, SI
   Epstein, LG
   Feigenbaum, ASJ
AF Werner, Klaus G. E.
   Morel, Chantal F.
   Kirton, Adam
   Benseler, Susanne M.
   Shoffner, John M.
   Addis, Jane B. L.
   Robinson, Brian H.
   Burrowes, Delilah M.
   Blaser, Susan I.
   Epstein, Leon G.
   Feigenbaum, Annette S. J.
TI Rolandic Mitochondrial Encephalomyelopathy and <i>MT</i>-<i>ND3</i>
   Mutations
SO PEDIATRIC NEUROLOGY
LA English
DT Article
ID COMPLEX-I DEFICIENCY; ND3 GENE; LEIGH-SYNDROME; DNA MUTATION; MISSENSE
   MUTATION; LACTIC-ACIDOSIS; ENCEPHALOPATHY; CHILDREN; MYOPATHY; FEATURES
AB Mitochondrial encephalopathies may be caused by mutations in the respiratory chain complex I subunit genes. Described here are the cases of two pediatric patients who presented with MELAS-like calcarine lesions in addition to novel, bilateral rolandic lesions and epilepsia partialis continua, secondary to MT-ND3 mutations. Data were collected included neurologic symptoms, serial brain imaging, metabolic evaluations, skeletal muscle biopsies, mitochondrial biochemical and molecular testing. Permission for publication was given by the families. Muscle histology revealed nonspecific changes, with no ragged red or blue or COX-negative fibers. Sequencing of the mitochondrial DNA indicated patient 2 to be homoplasmic in muscle for the mt.10158T>C mutation in the ND3 subunit and Patient 1 to be 75% heteroplasmic for the mt.10191T>C mutation, also in ND3. Bilateral rolandic lesions and epilepsia partialis continua accompanied by suspicion of mitochondrial disease are indications to search for an underlying mutation in the MT-ND3 gene. (C) 2009 by Elsevier Inc. All rights reserved.
C1 [Morel, Chantal F.; Feigenbaum, Annette S. J.] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada.
   [Werner, Klaus G. E.] Hosp Sick Children, Div Neurol & Pediat Emergency Med, Toronto, ON M5G 1X8, Canada.
   [Benseler, Susanne M.] Hosp Sick Children, Div Rheumatol & Pediat Emergency Med, Inst Res, Toronto, ON M5G 1X8, Canada.
   [Blaser, Susan I.] Hosp Sick Children, Dept Diagnost Imaging, Div Neuroradiol, Toronto, ON M5G 1X8, Canada.
   [Addis, Jane B. L.; Robinson, Brian H.] Hosp Sick Children, Metab Res Program, Res Inst, Dept Biochem, Toronto, ON M5G 1X8, Canada.
   [Kirton, Adam] Alberta Childrens Prov Gen Hosp, Div Neurol, Calgary, AB T2T 5C7, Canada.
   [Shoffner, John M.] Med Neurogenet, Atlanta, GA USA.
   [Burrowes, Delilah M.] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA.
   [Epstein, Leon G.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA.
   [Epstein, Leon G.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA.
C3 University of Toronto; Hospital for Sick Children (SickKids); University
   of Toronto; Hospital for Sick Children (SickKids); University of
   Toronto; Hospital for Sick Children (SickKids); University of Toronto;
   Hospital for Sick Children (SickKids); University of Toronto; Hospital
   for Sick Children (SickKids); University of Calgary; Alberta Childrens
   Hospital; Northwestern University; Feinberg School of Medicine;
   Northwestern University; Feinberg School of Medicine; Northwestern
   University; Feinberg School of Medicine
RP Feigenbaum, ASJ (corresponding author), Hosp Sick Children, Div Clin & Metab Genet, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
EM Annette.feigenbaum@sickkids.ca
RI Kirton, Adam/L-8875-2016; Robinson, B/LBH-2242-2024
OI Benseler, Susanne Maria/0000-0001-5756-3638; Epstein,
   Leon/0000-0003-4264-3867
CR Bénit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603
   Chae JH, 2007, PEDIATR RES, V61, P622, DOI 10.1203/pdr.0b013e3180459f2d
   Cockerell OC, 1996, BRAIN, V119, P393, DOI 10.1093/brain/119.2.393
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   Galkin A, 2008, J BIOL CHEM, V283, P20907, DOI 10.1074/jbc.M803190200
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Leshinsky-Silver E, 2005, BIOCHEM BIOPH RES CO, V334, P582, DOI 10.1016/j.bbrc.2005.06.134
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   MORTEN KJ, 1993, HUM MOL GENET, V2, P2081, DOI 10.1093/hmg/2.12.2081
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pitkanen S, 1996, J INHERIT METAB DIS, V19, P675, DOI 10.1007/BF01799845
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   ROBINSON BH, 1990, PEDIATR RES, V28, P549, DOI 10.1203/00006450-199011000-00027
   Robinson BH, 1998, BBA-BIOENERGETICS, V1364, P271, DOI 10.1016/S0005-2728(98)00033-4
   ROBINSON DS, 1993, CLIN EXP ALLERGY, V23, P1, DOI 10.1111/j.1365-2222.1993.tb02475.x
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
NR 24
TC 27
Z9 29
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD JUL
PY 2009
VL 41
IS 1
BP 27
EP 33
DI 10.1016/j.pediatrneurol.2009.02.010
PG 7
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 460OF
UT WOS:000267196300005
PM 19520270
DA 2024-11-01
ER

PT J
AU Nalbandian, A
   Donkervoort, S
   Dec, E
   Badadani, M
   Katheria, V
   Rana, P
   Nguyen, C
   Mukherjee, J
   Caiozzo, V
   Martin, B
   Watts, GD
   Vesa, J
   Smith, C
   Kimonis, VE
AF Nalbandian, Angele
   Donkervoort, Sandra
   Dec, Eric
   Badadani, Mallikarjun
   Katheria, Veeral
   Rana, Prachi
   Christopher Nguyen
   Mukherjee, Jogeshwar
   Caiozzo, Vincent
   Martin, Barbara
   Watts, Giles D.
   Vesa, Jouni
   Smith, Charles
   Kimonis, Virginia E.
TI The Multiple Faces of Valosin-Containing Protein-Associated Diseases:
   Inclusion Body Myopathy with Paget's Disease of Bone, Frontotemporal
   Dementia, and Amyotrophic Lateral Sclerosis
SO JOURNAL OF MOLECULAR NEUROSCIENCE
LA English
DT Article
DE Valosin containing protein; Amyotrophic lateral sclerosis; Inclusion
   body myopathy; Paget's disease of bone; Frontotemporal dementia;
   Autophagy; NFKB; Ubiquitin; TAR DNA Binding Protein-43; Endoplasmic
   reticulum associated degradation
ID MOTOR-NEURON DISEASE; KAPPA-B; ENDOPLASMIC-RETICULUM; VCP MUTATIONS;
   AAA-ATPASE; LOBAR DEGENERATION; AUTOPHAGIC REMOVAL; UBIQUITIN; TDP-43;
   FAMILY
AB Inclusion body myopathy associated with Paget's disease of bone and frontotemporal dementia (IBMPFD) is a progressive, fatal genetic disorder with variable penetrance, predominantly affecting three main tissue types: muscle (IBM), bone (PDB), and brain (FTD). IBMPFD is caused by mutations in the ubiquitously expressed valosin-containing protein (VCP) gene, a member of the AAA-ATPase superfamily. The majority of individuals who develop IBM have progressive proximal muscle weakness. Muscle biopsies reveal rimmed vacuoles and inclusions that are ubiquitin- and TAR DNA binding protein-43 (TDP-43)-positive using immunohistochemistry. PDB, seen in half the individuals, is caused by overactive osteoclasts and is associated clinically with pain, elevated serum alkaline phosphatase, and X-ray findings of coarse trabeculation and sclerotic lesions. FTD diagnosed at a mean age of 55 years in a third of individuals is characterized clinically by comprehension deficits, dysnomia, dyscalculia, and social unawareness. Ubiquitin- and TDP-43-positive neuronal inclusions are also found in the brain. Genotype-phenotype correlations are difficult with marked intra-familial and inter-familial variations being seen. Varied phenotypes within families include frontotemporal dementia, amyotrophic lateral sclerosis, Parkinsonism, myotonia, cataracts, and anal incompetence, among others. Cellular and animal models indicate pathogenetic disturbances in IBMPFD tissues including altered protein degradation, autophagy pathway alterations, apoptosis, and mitochondrial dysfunction. Currently, mouse and drosophila models carrying VCP mutations provide insights into the human IBMPFD pathology and are useful as tools for preclinical studies and testing of therapeutic strategies. In this review, we will explore the pathogenesis and clinical phenotype of IBMPFD caused by VCP mutations.
C1 [Nalbandian, Angele; Donkervoort, Sandra; Dec, Eric; Badadani, Mallikarjun; Katheria, Veeral; Rana, Prachi; Christopher Nguyen; Vesa, Jouni; Kimonis, Virginia E.] Univ Calif Irvine, Dept Pediat, Div Genet & Metab, Irvine, CA 92696 USA.
   [Mukherjee, Jogeshwar] Univ Calif Irvine, Dept Psychiat & Human Behav, Preclin Imaging Ctr, Irvine, CA 92697 USA.
   [Caiozzo, Vincent] Univ Calif Irvine, Coll Hlth Sci, Dept Physiol & Biophys, Irvine, CA 92697 USA.
   [Caiozzo, Vincent] Univ Calif Irvine, Coll Hlth Sci, Dept Orthoped, Irvine, CA 92697 USA.
   [Martin, Barbara; Smith, Charles] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.
   [Watts, Giles D.] Univ E Anglia, Sch Med Hlth Policy & Practice, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England.
C3 University of California System; University of California Irvine;
   University of California System; University of California Irvine;
   University of California System; University of California Irvine;
   University of California System; University of California Irvine;
   University of Kentucky; University of East Anglia
RP Kimonis, VE (corresponding author), Univ Calif Irvine, Dept Pediat, Div Genet & Metab, 2501 Hewitt Hall, Irvine, CA 92696 USA.
EM vkimonis@uci.edu
RI /O-1320-2013
OI /0000-0003-1009-877X
FU NIH [AR050236, AG025159]; Muscular Dystrophy Association; UC Irvine
   Institute of Translational Science (ICTS)
FX We would like to thank the families, providers, and our numerous
   collaborators for their contribution to this manuscript. We acknowledge
   funding by the NIH for grants AR050236 and AG025159, the Muscular
   Dystrophy Association, and UC Irvine Institute of Translational Science
   (ICTS). We thank Mehrdad Zoleikhaeian and Mariella Simon for their
   critical reading of the manuscript.
CR Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556
   Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003
   Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048
   Alonso A, 2009, EUR J NEUROL, V16, P745, DOI 10.1111/j.1468-1331.2009.02586.x
   Arnold SE, 2000, NEUROBIOL AGING, V21, P913, DOI 10.1016/S0197-4580(00)00173-1
   Badadani M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013183
   Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448
   Bersano A, 2009, NEUROBIOL AGING, V30, P752, DOI 10.1016/j.neurobiolaging.2007.08.009
   Bhatnagar S, 2010, J MOL MED, V88, P155, DOI 10.1007/s00109-009-0550-4
   Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182
   Chang YC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001288
   CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710
   Crippa V, 2010, AUTOPHAGY, V6, P958, DOI 10.4161/auto.6.7.13042
   Crippa V, 2010, HUM MOL GENET, V19, P3440, DOI 10.1093/hmg/ddq257
   Custer SK, 2010, HUM MOL GENET, V19, P1741, DOI 10.1093/hmg/ddq050
   Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056
   Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562
   DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036
   Djamshidian A, 2009, MUSCLE NERVE, V39, P389, DOI 10.1002/mus.21225
   Fanganiello RD, 2011, BRAZ J MED BIOL RES, V44, P374, DOI 10.1590/S0100-879X2011007500028
   Farpour F, 2011, RADIOLOGICAL FEATURE
   Fernández-Sáiz V, 2010, EMBO REP, V11, P479, DOI 10.1038/embor.2010.49
   Gidaro T, 2008, MUSCLE NERVE, V37, P111, DOI 10.1002/mus.20890
   Graham KM, 2010, J NEUROL SCI, V294, P43, DOI 10.1016/j.jns.2010.04.007
   Guyant-Maréchal L, 2006, NEUROLOGY, V67, P644, DOI 10.1212/01.wnl.0000225184.14578.d3
   Haslbeck KM, 2005, ACTA NEUROPATHOL, V110, P247, DOI 10.1007/s00401-005-1043-3
   Haubenberger D, 2005, NEUROLOGY, V65, P1304, DOI 10.1212/01.wnl.0000180407.15369.92
   Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704
   Hübbers CU, 2007, BRAIN, V130, P381, DOI 10.1093/brain/awl238
   Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554
   Jarosch E, 2002, TRAFFIC, V3, P530, DOI 10.1034/j.1600-0854.2002.30803.x
   Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036
   Ju JS, 2010, HUM MOL GENET, V19, pR38, DOI 10.1093/hmg/ddq157
   Kakizuka A, 2008, BIOCHEM SOC T, V36, P105, DOI 10.1042/BST0360105
   Kaleem M, 2007, NEURODEGENER DIS, V4, P376, DOI 10.1159/000105158
   Kim EJ, 2011, ARCH NEUROL-CHICAGO, V68, P787, DOI 10.1001/archneurol.2010.376
   Kimonis VE, 2000, GENET MED, V2, P232, DOI 10.1097/00125817-200007000-00006
   Kimonis VE, 2008, AM J MED GENET A, V146A, P745, DOI 10.1002/ajmg.a.31862
   Kimonis VE, 2008, BBA-MOL BASIS DIS, V1782, P744, DOI 10.1016/j.bbadis.2008.09.003
   Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411
   Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021
   Kovach MJ, 2001, MOL GENET METAB, V74, P458, DOI 10.1006/mgme.2001.3256
   Krause S, 2007, CLIN NEUROPATHOL, V26, P232
   Kumar KR, 2010, NEUROMUSCULAR DISORD, V20, P330, DOI 10.1016/j.nmd.2010.03.002
   Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066
   Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137
   Leigh PN, 2010, NAT REV NEUROL, V6, P191, DOI 10.1038/nrneurol.2010.33
   Leyton CE, 2010, ANN INDIAN ACAD NEUR, V13, P74, DOI 10.4103/0972-2327.74249
   Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107
   Logroscino G, 2008, J NEUROL NEUROSUR PS, V79, P6, DOI 10.1136/jnnp.2006.104828
   Lomen-Hoerth C, 2003, NEUROLOGY, V60, P1094, DOI 10.1212/01.WNL.0000055861.95202.8D
   McGuire V, 1996, NEUROLOGY, V47, P571, DOI 10.1212/WNL.47.2.571
   Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181
   Miller TD, 2009, J NEUROL NEUROSUR PS, V80, P583, DOI 10.1136/jnnp.2008.148676
   Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704
   Müller JMM, 2007, BIOCHEM BIOPH RES CO, V354, P459, DOI 10.1016/j.bbrc.2006.12.206
   Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546
   Pasquali L, 2010, CNS NEUROL DISORD-DR, V9, P268, DOI 10.2174/187152710791292594
   Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002
   Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9
   Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5
   Reid IR, 2005, NEW ENGL J MED, V353, P898, DOI 10.1056/NEJMoa044241
   Roberson ED, 2011, METHODS MOL BIOL, V670, P1, DOI 10.1007/978-1-60761-744-0_1
   Rohrer JD, 2011, J NEUROL, V258, P1494, DOI 10.1007/s00415-011-5966-4
   Rusten TE, 2008, AUTOPHAGY, V4, P233, DOI 10.4161/auto.5396
   Schröder R, 2005, ANN NEUROL, V57, P457, DOI 10.1002/ana.20407
   Shaw CE, 2010, NEURON, V68, P812, DOI 10.1016/j.neuron.2010.11.040
   Siciliano G, 2010, CNS NEUROL DISORD-DR, V9, P305, DOI 10.2174/187152710791292648
   Siris E, 1996, J CLIN ENDOCR METAB, V81, P961, DOI 10.1210/jc.81.3.961
   Spina, 2008, FASEB J, V22, P584
   Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584
   Stojkovic T, 2009, NEUROMUSCULAR DISORD, V19, P316, DOI 10.1016/j.nmd.2009.02.012
   Strong MJ, 2003, ANN NEUROL, V54, pS20, DOI 10.1002/ana.10574
   Traynor BJ, 1999, NEUROLOGY, V52, P504, DOI 10.1212/WNL.52.3.504
   Turner RS, 1996, ANN NEUROL, V39, P166, DOI 10.1002/ana.410390205
   van der Zee J, 2009, NEUROLOGY, V73, P626, DOI 10.1212/WNL.0b013e3181b389d9
   Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942
   Vesa J, 2009, NEUROMUSCULAR DISORD, V19, P766, DOI 10.1016/j.nmd.2009.08.003
   Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014
   Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x
   Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332
   Watts GDJ, 2003, NEUROMUSCULAR DISORD, V13, P559, DOI 10.1016/S0960-8966(03)00070-1
   Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426
   Weihl CC, 2007, HUM MOL GENET, V16, P919, DOI 10.1093/hmg/ddm037
   Weihl CC, 2009, NEUROMUSCULAR DISORD, V19, P308, DOI 10.1016/j.nmd.2009.01.009
   Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575
   Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a
   Zhukareva V, 2001, ANN NEUROL, V49, P165, DOI 10.1002/1531-8249(20010201)49:2<165::AID-ANA36>3.0.CO;2-3
NR 88
TC 103
Z9 115
U1 0
U2 16
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0895-8696
EI 1559-1166
J9 J MOL NEUROSCI
JI J. Mol. Neurosci.
PD NOV
PY 2011
VL 45
IS 3
SI SI
BP 522
EP 531
DI 10.1007/s12031-011-9627-y
PG 10
WC Biochemistry & Molecular Biology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 841NL
UT WOS:000296518900029
PM 21892620
DA 2024-11-01
ER

PT J
AU Kim, MJ
   Lee, W
   Park, EJ
   Park, SY
AF Kim, Mi-Jin
   Lee, Wan
   Park, Eun-Ju
   Park, Seung-Yoon
TI Depletion of Mitochondrial DNA Stabilizes C1qTNF-Related Protein 6 mRNA
   in Muscle Cells
SO JOURNAL OF KOREAN MEDICAL SCIENCE
LA English
DT Article
DE DNA, Mitochondrial; CTRP6; C1qTNF-6; mRNA Stability; C2C12 Cells
ID L6 GLUT4MYC MYOCYTES; FATTY-ACID OXIDATION; INSULIN-RESISTANCE; ETHIDIUM
   BROMIDE; GLUCOSE-UTILIZATION; STRESS; KINASE; INHIBITION; ACTIVATION;
   EXPRESSION
AB Mutation and reduction of mitochondrial DNA (mtDNA) have been suggested as factors in the pathogenesis of several metabolic diseases. Recently, we demonstrated that C1qTNF-related protein-6 (CTRP6) is involved in fatty acid metabolism in muscle cells. In this study, we showed that expression of CTRP6 was up-regulated in mtDNA-depleted C2C12 cells, which displayed a marked decrease in cellular mtDNA and ATP content. Replacement of mtDNA normalized the expression level of CTRP6 similar to that in normal C2C12 cells, indicating that CTRP6 expression was up-regulated by mtDNA depletion. However, CTRP6 promoter activity remained unchanged in mtDNA-depleted cells. We also found that mtDNA depletion inhibited decay of CTRP6 mRNA. Taken together, mtDNA depletion induces an increase in CTRP6 expression by increasing mRNA stability.
C1 [Kim, Mi-Jin; Lee, Wan; Park, Eun-Ju; Park, Seung-Yoon] Dongguk Univ, Sch Med, Dept Biochem, Gyeongju 780714, South Korea.
C3 Dongguk University
RP Park, SY (corresponding author), Dongguk Univ, Sch Med, Dept Biochem, 87 Dongdae Ro, Gyeongju 780714, South Korea.
EM psyoon@dongguk.ac.kr
RI Lee, Wan/B-6252-2013; lee, jungmin/IXW-6580-2023
OI Lee, Wan/0000-0002-5181-2135
FU National Research Foundation of Korea (NRF); Ministry of Education,
   Science and Technology [2011-0016102, M108KM010008-08K1301-00810]
FX This study was supported by the Basic Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Education, Science and Technology (2011-0016102) and by a grant from
   21C Frontier Functional Proteomics Project from Ministry of Education,
   Science and Technology (M108KM010008-08K1301-00810).
CR Amuthan G, 2001, EMBO J, V20, P1910, DOI 10.1093/emboj/20.8.1910
   Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983
   Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522
   Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104
   Biswas G, 2005, GENE, V354, P132, DOI 10.1016/j.gene.2005.03.028
   Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005
   Choi HS, 2007, J BIOL CHEM, V282, P31217, DOI 10.1074/jbc.M705098200
   DESJARDINS P, 1985, MOL CELL BIOL, V5, P1163, DOI 10.1128/MCB.5.5.1163
   Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297
   García-Ruiz I, 2006, HEPATOLOGY, V44, P581, DOI 10.1002/hep.21313
   Hayakawa T, 1998, J BIOL CHEM, V273, P20300, DOI 10.1074/jbc.273.32.20300
   Kim MJ, 2010, MOL CELLS, V30, P59, DOI 10.1007/s10059-010-0088-x
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Koh EH, 2007, DIABETES, V56, P2973, DOI 10.2337/db07-0510
   Lee W, 2008, EXP MOL MED, V40, P109, DOI 10.3858/emm.2008.40.1.109
   Lee W, 2010, FEBS LETT, V584, P968, DOI 10.1016/j.febslet.2010.01.040
   Park SY, 2009, J BIOL CHEM, V284, P27780, DOI 10.1074/jbc.M109.005611
   Park SY, 2005, J BIOL CHEM, V280, P9855, DOI 10.1074/jbc.M409399200
   Park SY, 2006, PROTEOMICS, V6, P1210, DOI 10.1002/pmic.200500284
   Park SY, 2005, EXP MOL MED, V37, P220, DOI 10.1038/emm.2005.30
   Prigione A, 2007, AGING CELL, V6, P619, DOI 10.1111/j.1474-9726.2007.00323.x
   Ryu HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017343
   Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583
   Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240
   Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788
   ZYLBER E, 1969, J MOL BIOL, V44, P195, DOI 10.1016/0022-2836(69)90414-8
NR 28
TC 7
Z9 9
U1 0
U2 5
PU KOREAN ACAD MEDICAL SCIENCES
PI SEOUL
PA 302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA
SN 1011-8934
EI 1598-6357
J9 J KOREAN MED SCI
JI J. Korean Med. Sci.
PD MAY
PY 2012
VL 27
IS 5
BP 465
EP 470
DI 10.3346/jkms.2012.27.5.465
PG 6
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 938TJ
UT WOS:000303755600002
PM 22563208
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU Zhou, XS
   Johansson, M
   Solaroli, N
   Rozell, B
   Grandien, A
   Karlsson, A
AF Zhou, Xiaoshan
   Johansson, Magnus
   Solaroli, Nicola
   Rozell, Bjorn
   Grandien, Alf
   Karlsson, Anna
TI Hematopoiesis in the thymidine kinase 2 deficient mouse model of
   mitochondrial DNA depletion syndrome
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
ID MTDNA; TRIPHOSPHATE; SPECIFICITY; ASSOCIATION; MYOPATHY; GENE; MICE
AB Mitochondria are important for normal blood-cell development, and several diseases linked to mitochondrial DNA (mtDNA) show hematological manifestations. We recently generated a mouse strain deficient in expression of the mitochondrial pyrimidine nucleoside kinase thymidine kinase 2 (Tk2), showing that these mice exhibit progressive mtDNA depletion in multiple organs. We used this mouse strain as a model for mtDNA depletion syndromes to investigate the effects of mtDNA depletion on hematopoiesis. MtDNA levels in spleen from the Tk2-deficient mice were decreased 50%, but in contrast to all other investigated organs, both thymus and peripheral blood leukocytes showed normal mtDNA levels. Analysis of peripheral blood and cell populations in spleen, thymus, and bone marrow showed normal findings in the Tk2-deficient mice. The total rates of thymidine phosphorylation-which also include phosphorylation catalyzed by cytosolic Tk 1-in both spleen and thymus from wild-type mice were > 50-fold higher than in liver, brain, and muscle. In summary, our data show that blood cells are less dependent on mitochondrial Tk2 compared with several other tissues and that these cells can synthesize deoxyribonucleotides required for mtDNA replication by alternative pathways such as phosphorylation of thymidine by cytosolic Tk1.
C1 [Zhou, Xiaoshan; Johansson, Magnus; Solaroli, Nicola; Karlsson, Anna] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Lab Med, SE-14186 Stockholm, Sweden.
   [Rozell, Bjorn] Karolinska Univ Hosp Huddinge, Dept Lab Med, Clin Res Ctr, SE-14186 Stockholm, Sweden.
   [Grandien, Alf] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Med, Ctr Infect Med, SE-14186 Stockholm, Sweden.
   [Grandien, Alf] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Med, Ctr Expt Hematol, SE-14186 Stockholm, Sweden.
C3 Karolinska Institutet; Karolinska University Hospital; Karolinska
   Institutet; Karolinska University Hospital; Karolinska Institutet;
   Karolinska University Hospital; Karolinska Institutet; Karolinska
   University Hospital
RP Karlsson, A (corresponding author), Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Lab Med, SE-14186 Stockholm, Sweden.
EM anna.karlsson@ki.se
RI Karlsson, Anna/E-7945-2018
OI Karlsson, Anna/0000-0001-6843-6685
FU Swedish Cancer Society
FX This work was supported by grants from the Swedish Cancer Society.
CR Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   ARNER ESJ, 1992, BIOCHEM BIOPH RES CO, V188, P712, DOI 10.1016/0006-291X(92)91114-6
   Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660
   ERIKSSON S, 1991, ADV EXP MED BIOL, V309, P239
   Finsterer J, 2007, ACTA HAEMATOL-BASEL, V118, P88, DOI 10.1159/000105676
   FISCHELGHODSIAN N, 1992, PEDIATR RES, V31, P557, DOI 10.1203/00006450-199206000-00004
   Goel HC, 2007, MOL CELL BIOCHEM, V295, P93, DOI 10.1007/s11010-006-9277-5
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454
   Leung TF, 1999, J INHERIT METAB DIS, V22, P86, DOI 10.1023/A:1005415802893
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Muraki K, 1997, J INHERIT METAB DIS, V20, P697, DOI 10.1023/A:1005378527077
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046
   Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100
   Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200
   Rampazzo C, 2007, J BIOL CHEM, V282, P34758, DOI 10.1074/jbc.M705923200
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Rylova SN, 2007, BIOCHEM PHARMACOL, V74, P169, DOI 10.1016/j.bcp.2007.03.029
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261
   TOY G, 2010, P NATL ACAD SCI US
   Van Rompay AR, 2003, PHARMACOL THERAPEUT, V100, P119, DOI 10.1016/j.pharmthera.2003.07.001
   Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 26
TC 4
Z9 6
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0141-8955
EI 1573-2665
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD JUN
PY 2010
VL 33
IS 3
BP 231
EP 236
DI 10.1007/s10545-010-9102-x
PG 6
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 602DV
UT WOS:000278119600004
PM 20440651
DA 2024-11-01
ER

PT J
AU Saini, SK
   McDermott, MM
   Picca, A
   Li, LY
   Wohlgemuth, SE
   Kosmac, K
   Peterson, CA
   Tian, L
   Ferrucci, L
   Guralnik, JM
   Sufit, RL
   Leeuwenburgh, C
AF Saini, Sunil K.
   McDermott, Mary M.
   Picca, Anna
   Li, Lingyu
   Wohlgemuth, Stephanie E.
   Kosmac, Kate
   Peterson, Charlotte A.
   Tian, Lu
   Ferrucci, Luigi
   Guralnik, Jack M.
   Sufit, Robert L.
   Leeuwenburgh, Christiaan
TI Mitochondrial DNA damage in calf skeletal muscle and walking performance
   in people with peripheral artery disease
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Ischemia-reperfusion; mtDNA copy number; mtDNA deletion; mtDNA
   mutations; mtDNA heteroplasmy; Oxidative stress; Peripheral artery
   disease (PAD)
ID ANKLE BRACHIAL INDEX; CALORIE RESTRICTION; REPERFUSION INJURY;
   PHYSICAL-ACTIVITY; OXIDATIVE DAMAGE; OLDER-PEOPLE; COPY NUMBER;
   ASSOCIATION; DELETION; BRAIN
AB Background: Peripheral artery disease (PAD) is associated with mitochondrial dysfunction in calf skeletal muscle and a greater abundance of mitochondrial DNA (mtDNA) heteroplasmy. However, it is unknown whether calf skeletal muscle mtDNA of PAD participants harbors a greater abundance of mitochondrial DNA 4977-bp common deletion (mtDNA4977), strand breaks and oxidative damage (i.e., oxidized purines) compared to non PAD participants and whether these mtDNA abnormalities are associated with poor walking performance in participants with PAD.
   Methods: Calf muscle biopsies were obtained from 50 PAD participants (ankle-brachial index (ABI) < 0.95) and 25 non-PAD participants (ABI = 0.99-1.40) matched by age, sex, and race. The abundance of mtDNA copy number, mtDNA4977 deletion, strand breaks, and oxidized purines in selected mtDNA regions coding for electron transport chain (ETC) constituents and the non-coding D-Loop region was determined in calf muscle. All participants completed measurement of 6-min walk and usual and fast-paced 4-m walking velocity test.
   Results: Participants with PAD (mean age = 65.4 years, SD = 6.9; 14 (28%) women, 38 (76%) black) and without PAD (mean age = 65.2 years, SD = 6.7; 7 (28%) women, 16 (64%) black) did not differ in the abundance of calf muscle mtDNA4977 deletion, mtDNA strand breaks, and oxidized purines. Though, a greater abundance of mtDNA strand breaks within ND4/5 genes was significantly associated with poorer 6-min walk distance, lower usual-paced 4-m walking velocity, and lower fast-paced 4-m walking velocity in non-PAD participants. Significant associations were also found in the density of strand break damage (i.e., damage per mtDNA copy) within ND1/2, ND4/5 and COII/ATPase 6/8 region with 6-min walk distance, usual-paced 4-m walking velocity and fast-paced 4-m walking velocity in non-PAD participants. Significant interactions were found between PAD presence vs. absence and density of strand break damage within ND1/2, ND4/5, COII/ ATPase 6/8 regions for the associations with 6-min walk distance, usual-paced 4-m walking velocity, fast-paced 4-m walking velocity. Conversely, of the three walking performance measures only the usual-paced 4-m walking velocity showed a significant, although modest, negative association with the abundance of oxidized purines in the D-Loop (P = 0.031) and ND4/5 (P = 0.033) regions in the calf skeletal muscle of people with PAD.
   Conclusion: Overall, these data suggest that the abundance of calf muscle mtDNA strand breaks and mtDNA4977 common deletion are not associated with walking performance in people with PAD and may not be directly involved in the pathophysiology of PAD. Conversely, strand breaks in specific mtDNA regions may contribute to poor walking performance in people without PAD. Further study is needed to confirm whether usual-paced 4-m walking velocity is associated significantly with a greater abundance of oxidized purines in the D-loop, a "mutational hotspot" for oxidative damage, and why this association may differ from the association with 6-min walk distance and fast-paced 4-m walking velocity.
C1 [Saini, Sunil K.; Wohlgemuth, Stephanie E.; Leeuwenburgh, Christiaan] Univ Florida, Dept Aging & Geriatr Res, Inst Aging, Gainesville, FL USA.
   [Saini, Sunil K.; McDermott, Mary M.] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA.
   [McDermott, Mary M.; Li, Lingyu; Sufit, Robert L.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA.
   [Picca, Anna] Fdn Policlin Univ Agostino Gemelli IRCCS, Rome, Italy.
   [Kosmac, Kate; Peterson, Charlotte A.] Univ Kentucky, Coll Hlth Sci, Dept Epidemiol, Lexington, KY USA.
   [Tian, Lu] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA.
   [Ferrucci, Luigi] NIA, Div Intramural Res, Baltimore, MD 21224 USA.
   [Guralnik, Jack M.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA.
C3 State University System of Florida; University of Florida; Northwestern
   University; Feinberg School of Medicine; Northwestern University;
   Feinberg School of Medicine; Catholic University of the Sacred Heart;
   IRCCS Policlinico Gemelli; University of Kentucky; Stanford University;
   National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA); University System of Maryland; University of Maryland
   Baltimore
RP Leeuwenburgh, C (corresponding author), Off CTRB 3125,2004 Mowry Rd,POB 100107, Gainesville, FL 32611 USA.
EM cleeuwen@ufl.edu
RI Kosmac, Kate/JOK-2532-2023; Ferrucci, Luigi/AED-9724-2022; Picca,
   Anna/K-2305-2018
OI Leeuwenburgh, Christiaan/0000-0003-0826-4257; tian,
   lu/0000-0002-5893-0169; Saini, Sunil/0000-0002-1124-5930; Ferrucci,
   Luigi/0000-0002-6273-1613
FU AHA SFRN [18SFRN33900136]; American Heart Association (AHA)
   [18SFRN33900136] Funding Source: American Heart Association (AHA)
FX AHA SFRN 18SFRN33900136.
CR Andrienko TN, 2017, J MOL CELL CARDIOL, V110, P1, DOI 10.1016/j.yjmcc.2017.06.016
   Bhat HK, 1999, CIRCULATION, V99, P807, DOI 10.1161/01.CIR.99.6.807
   Brass EP, 2000, VASC MED, V5, P225, DOI 10.1177/1358836X0000500405
   Butler TJ, 2020, HUM MOL GENET, V29, P1292, DOI 10.1093/hmg/ddaa043
   Chimienti G, 2018, FREE RADICAL BIO MED, V124, P447, DOI 10.1016/j.freeradbiomed.2018.06.041
   Criqui MH, 2015, CIRC RES, V116, P1509, DOI 10.1161/CIRCRESAHA.116.303849
   Fetterman JL, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0372-y
   Gonzalez-Freire M, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.015197
   Granger DN, 2015, REDOX BIOL, V6, P524, DOI 10.1016/j.redox.2015.08.020
   Groennebaek T, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030570
   Hernansanz-Agustin P., 2020, NATURE, P1
   Kang D, 2003, CLIN CHEM LAB MED, V41, P1281, DOI 10.1515/CCLM.2003.195
   Koutakis P, 2014, REDOX BIOL, V2, P921, DOI 10.1016/j.redox.2014.07.002
   Lindegard Pedersen B, 2017, INT ANGIOL, V36, P482, DOI 10.23736/S0392-9590.17.03824-X
   Liu J, 2015, CLIN LAB, V61, P661, DOI 10.7754/Clin.Lab.2014.141132
   McDermott MM, 2008, J VASC SURG, V48, P1231, DOI 10.1016/j.jvs.2008.06.050
   McDermott MM, 2020, CIRC RES, V126, P589, DOI 10.1161/CIRCRESAHA.119.315600
   McDermott MM, 2018, VASC MED, V23, P340, DOI 10.1177/1358863X18765667
   McDermott MM, 2017, JAMA CARDIOL, V2, P902, DOI 10.1001/jamacardio.2017.0538
   McDermott MM, 2014, CIRCULATION, V130, P61, DOI 10.1161/CIRCULATIONAHA.114.007002
   McDermott MM, 2015, CIRC RES, V116, P1540, DOI 10.1161/CIRCRESAHA.114.303517
   McDermott M, 2017, JAMA-J AM MED ASSOC, V318, P2089, DOI 10.1001/jama.2017.17437
   McDermott MM, 2000, J VASC SURG, V32, P1164, DOI 10.1067/mva.2000.108640
   McDermott MM, 2002, ANN INTERN MED, V136, P873, DOI 10.7326/0003-4819-136-12-200206180-00008
   McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Pastukh VM, 2016, FREE RADICAL BIO MED, V96, P78, DOI 10.1016/j.freeradbiomed.2016.04.011
   Pérez-Treviño P, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165761
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Picca A, 2018, REJUV RES, V21, P350, DOI 10.1089/rej.2017.1989
   Picca A, 2014, BBA-GEN SUBJECTS, V1840, P2184, DOI 10.1016/j.bbagen.2014.03.004
   Picca A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074644
   Picca A, 2013, AGE, V35, P1607, DOI 10.1007/s11357-012-9465-z
   Pipinos II, 2006, FREE RADICAL BIO MED, V41, P262, DOI 10.1016/j.freeradbiomed.2006.04.003
   Rothfuss O, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1082
   Ryan TE, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.123235
   Shadman R, 2004, J AM COLL CARDIOL, V44, P618, DOI 10.1016/j.jacc.2004.04.044
   Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104
   Umbria M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59631-x
   Vecoli C, 2018, ATHEROSCLEROSIS, V276, P91, DOI 10.1016/j.atherosclerosis.2018.07.015
   White SH, 2016, J TRANSL MED, V14, DOI [10.1186/s12967-016-1030-6, 10.1186/s12967-017-1127-6]
   Wiersma M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051159
   Yu EPK, 2016, FREE RADICAL BIO MED, V100, P223, DOI 10.1016/j.freeradbiomed.2016.06.011
   Zhang RY, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4287-0
NR 44
TC 4
Z9 4
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD NOV 20
PY 2020
VL 160
BP 680
EP 689
DI 10.1016/j.freeradbiomed.2020.09.004
PG 10
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA OY7PN
UT WOS:000594435300005
PM 32911084
DA 2024-11-01
ER

PT J
AU Billing-Ross, P
   Germain, A
   Ye, KX
   Keinan, A
   Gu, ZL
   Hanson, MR
AF Billing-Ross, Paul
   Germain, Arnaud
   Ye, Kaixiong
   Keinan, Alon
   Gu, Zhenglong
   Hanson, Maureen R.
TI Mitochondrial DNA variants correlate with symptoms in myalgic
   encephalomyelitis/chronic fatigue syndrome
SO JOURNAL OF TRANSLATIONAL MEDICINE
LA English
DT Article
DE Myalgic encephalomyelitis (ME); Chronic fatigue syndrome (CFS);
   Next-generation sequencing; Mitochondrial DNA; mtDNA; Heteroplasmy;
   Association; SNPs; Haplogroup; Variants
ID MAGNETIC-RESONANCE-SPECTROSCOPY; MUSCLE METABOLISM; SYNDROME ME/CFS;
   BLOOD-FLOW; GENOME; HETEROPLASMY; PATHOGENICITY; FIBROMYALGIA;
   DYSFUNCTION; MUTATIONS
AB Background: Mitochondrial dysfunction has been hypothesized to occur in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a disease characterized by fatigue, cognitive difficulties, pain, malaise, and exercise intolerance. We investigated whether haplogroup, single nucleotide polymorphisms (SNPs), or heteroplasmy of mitochondrial DNA (mtDNA) were associated with health status and/or symptoms.
   Methods: Illumina sequencing of PCR-amplified mtDNA was performed to analyze sequence and extent of heteroplasmy of mtDNAs of 193 cases and 196 age-and gender-matched controls from DNA samples collected by the Chronic Fatigue Initiative. Association testing was carried out to examine possible correlations of mitochondrial sequences with case/control status and symptom constellation and severity as reported by subjects on Short Form-36 and DePaul Symptom Questionnaires.
   Results: No ME/CFS subject exhibited known disease-causing mtDNA mutations. Extent of heteroplasmy was low in all subjects. Although no association between mtDNA SNPs and ME/CFS vs. healthy status was observed, haplogroups J, U and H as well as eight SNPs in ME/CFS cases were significantly associated with individual symptoms, symptom clusters, or symptom severity.
   Conclusions: Analysis of mitochondrial genomes in ME/CFS cases indicates that individuals of a certain haplogroup or carrying specific SNPs are more likely to exhibit certain neurological, inflammatory, and/or gastrointestinal symptoms. No increase in susceptibility to ME/CFS of individuals carrying particular mitochondrial genomes or SNPs was observed.
C1 [Billing-Ross, Paul; Gu, Zhenglong] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.
   [Germain, Arnaud; Hanson, Maureen R.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.
   [Ye, Kaixiong; Keinan, Alon] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA.
C3 Cornell University; Cornell University; Cornell University
RP Hanson, MR (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.
EM mrh5@cornell.edu
RI Ye, Kaixiong/C-2297-2017; Hanson, Maureen/D-3879-2009
OI Ye, Kaixiong/0000-0003-4658-7292; Hanson, Maureen/0000-0001-8141-3058;
   Keinan, Alon/0000-0002-9760-1122
FU National Science Foundation predoctoral fellowship; NIH [R01 HG006849]
FX We thank the CFI physicians for selecting subjects, obtaining blood
   samples, and administering survey forms as part of the CFI study, and
   the subjects for their participation. We thank the Chronic Fatigue
   Initiative and the Hutchins Family Foundation for funding for this
   project, and Yiqin Wang for verification of some of the computational
   analysis. P. B-R was also supported by a National Science Foundation
   predoctoral fellowship. KY was also supported by NIH grant R01 HG006849
   to AK.
CR Aaron LA, 2000, ARCH INTERN MED, V160, P221, DOI 10.1001/archinte.160.2.221
   [Anonymous], J GENET GENOME RES
   Bandelt HJ, 2014, J HUM GENET, V59, P66, DOI 10.1038/jhg.2013.120
   Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Boles RG, 2015, MITOCHONDRION, V23, P1, DOI 10.1016/j.mito.2015.04.005
   Boles RG, 2015, MITOCHONDRION, V23, P64, DOI 10.1016/j.mito.2015.05.002
   Brown AA, 2014, FATIGUE, V2, DOI 10.1080/21641846.2014.928014
   Carruthers BM, 2011, J INTERN MED, V270, P327, DOI 10.1111/j.1365-2796.2011.02428.x
   Carruthers B. M., 2003, J. Chronic Fatigue Syndr, V11, P7, DOI DOI 10.1300/J092V11N0102
   Castro-Marrero J, 2013, ANTIOXID REDOX SIGN, V19, P1855, DOI 10.1089/ars.2013.5346
   Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209
   Dayama G, 2014, NUCLEIC ACIDS RES, V42, P12640, DOI 10.1093/nar/gku1038
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202
   FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009
   Goto H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r59
   Hart AB, 2013, AIDS REV, V15, P213
   Hollingsworth KG, 2010, EUR J CLIN INVEST, V40, P608, DOI 10.1111/j.1365-2362.2010.02310.x
   Hornig M, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400121
   Hutchinson CV, 2014, BRIT J OPHTHALMOL, V98, P144, DOI 10.1136/bjophthalmol-2013-304439
   Jason L.A., 2010, Am. J. Biochem. Biotechnol, V6, P120, DOI DOI 10.3844/AJBBSP.2010.120.135
   Jason LA, 2015, FATIGUE, V3, P16, DOI 10.1080/21641846.2014.978110
   Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892
   Klimas NG, 2015, FATIGUE, V3, P75, DOI 10.1080/21641846.2015.1023652
   Kloss-Brandstätter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382
   KOMAROFF AL, 1991, REV INFECT DIS, V13, pS8
   Lane RJM, 1998, NEUROMUSCULAR DISORD, V8, P204, DOI 10.1016/S0960-8966(98)00021-2
   Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Lyons EA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-881
   Maes M, 2009, NEUROENDOCRINOL LETT, V30, P470
   McCully KK, 2004, J APPL PHYSIOL, V96, P871, DOI 10.1152/japplphysiol.00141.2003
   McCully KK, 2003, CLIN SCI, V104, P641, DOI 10.1042/CS20020279
   Mueller EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052367
   Myhill S, 2013, INT J CLIN EXP MED, V6, P1
   PLIOPLYS AV, 1995, NEUROPSYCHOBIOLOGY, V32, P175, DOI 10.1159/000119233
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Smits B, 2011, MITOCHONDRION, V11, P735, DOI 10.1016/j.mito.2011.05.005
   van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921
   Vermeulen RCW, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-93
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   WARE JE, 1995, MED CARE, V33, pAS264, DOI 10.1097/00005650-199501001-00005
   WONG R, 1992, CHEST, V102, P1716, DOI 10.1378/chest.102.6.1716
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
NR 45
TC 41
Z9 45
U1 0
U2 23
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1479-5876
J9 J TRANSL MED
JI J. Transl. Med.
PD JAN 20
PY 2016
VL 14
AR 19
DI 10.1186/s12967-016-0771-6
PG 12
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA DB3FC
UT WOS:000368394500002
PM 26791940
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Kang, EJ
   Wang, XJ
   Tippner-Hedges, R
   Ma, H
   Folmes, CDL
   Gutierrez, NM
   Lee, YM
   Van Dyken, C
   Ahmed, R
   Li, Y
   Koski, A
   Hayama, T
   Luo, SY
   Harding, CO
   Amato, P
   Jensen, J
   Battaglia, D
   Lee, D
   Wu, D
   Terzic, A
   Wolf, DP
   Huang, TS
   Mitalipov, S
AF Kang, Eunju
   Wang, Xinjian
   Tippner-Hedges, Rebecca
   Ma, Hong
   Folmes, Clifford D. L.
   Gutierrez, Nuria Marti
   Lee, Yeonmi
   Van Dyken, Crystal
   Ahmed, Riffat
   Li, Ying
   Koski, Amy
   Hayama, Tomonari
   Luo, Shiyu
   Harding, Cary O.
   Amato, Paula
   Jensen, Jeffrey
   Battaglia, David
   Lee, David
   Wu, Diana
   Terzic, Andre
   Wolf, Don P.
   Huang, Taosheng
   Mitalipov, Shoukhrat
TI Age-Related Accumulation of Somatic Mitochondrial DNA Mutations in
   Adult-Derived Human iPSCs
SO CELL STEM CELL
LA English
DT Article
ID PLURIPOTENT STEM-CELLS; HUMAN SKELETAL-MUSCLE; RESPIRATORY-CHAIN;
   NUCLEAR TRANSFER; COPY NUMBER; DISEASE; DELETIONS; HETEROPLASMY; GENOME;
   CANCER
AB The genetic integrity of iPSCs is an important consideration for therapeutic application. In this study, we examine the accumulation of somatic mitochondrial genome (mtDNA) mutations in skin fibroblasts, blood, and iPSCs derived from young and elderly subjects (24-72 years). We found that pooled skin and blood mtDNA contained low heteroplasmic point mutations, but a panel of ten individual iPSC lines from each tissue or clonally expanded fibroblasts carried an elevated load of heteroplasmic or homoplasmic mutations, suggesting that somatic mutations randomly arise within individual cells but are not detectable in whole tissues. The frequency of mtDNA defects in iPSCs increased with age, and many mutations were non-synonymous or resided in RNA coding genes and thus can lead to respiratory defects. Our results highlight a need to monitor mtDNA mutations in iPSCs, especially those generated from older patients, and to examine the metabolic status of iPSCs destined for clinical applications.
C1 [Kang, Eunju; Tippner-Hedges, Rebecca; Ma, Hong; Gutierrez, Nuria Marti; Lee, Yeonmi; Van Dyken, Crystal; Ahmed, Riffat; Li, Ying; Koski, Amy; Hayama, Tomonari; Wolf, Don P.; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, 3303 SW Bond Ave, Portland, OR 97239 USA.
   [Kang, Eunju; Tippner-Hedges, Rebecca; Ma, Hong; Gutierrez, Nuria Marti; Lee, Yeonmi; Van Dyken, Crystal; Ahmed, Riffat; Li, Ying; Koski, Amy; Hayama, Tomonari; Wolf, Don P.; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, 505 NW 185th Ave, Beaverton, OR 97006 USA.
   [Wang, Xinjian; Luo, Shiyu; Huang, Taosheng] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, 3333 Burnet Ave, Cincinnati, OH 45229 USA.
   [Folmes, Clifford D. L.; Terzic, Andre] Mayo Clin, Div Cardiovasc Dis, Dept Med, Rochester, MN 55905 USA.
   [Harding, Cary O.; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.
   [Amato, Paula; Jensen, Jeffrey; Battaglia, David; Lee, David; Wu, Diana; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Div Reprod Endocrinol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.
   [Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.
   [Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Dept Biomed Engn, 3303 SW Bond Ave, Portland, OR 97239 USA.
C3 Oregon Health & Science University; Oregon Health & Science University;
   Oregon National Primate Research Center; Cincinnati Children's Hospital
   Medical Center; Mayo Clinic; Oregon Health & Science University; Oregon
   Health & Science University; Oregon Health & Science University; Oregon
   Health & Science University
RP Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, 3303 SW Bond Ave, Portland, OR 97239 USA.; Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, 505 NW 185th Ave, Beaverton, OR 97006 USA.; Huang, TS (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Human Genet, 3333 Burnet Ave, Cincinnati, OH 45229 USA.; Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.; Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Div Reprod Endocrinol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.; Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.; Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Dept Biomed Engn, 3303 SW Bond Ave, Portland, OR 97239 USA.
EM taosheng.huang@cchmc.org; mitalipo@ohsu.edu
RI Luo, Shiyu/AAD-7020-2020; Jensen, Jeffrey/C-7421-2014
OI Folmes, Clifford/0000-0002-3683-9970; Jensen,
   Jeffrey/0000-0002-4733-1224; Luo, Shiyu/0000-0002-6965-8674; Huang,
   Taosheng/0000-0001-6601-6687
FU Leducq Foundation; OHSU; Mayo Clinic Center for Regenerative Medicine;
   Collins Medical Trust
FX The authors acknowledge the OHSU Embryonic Stem Cell Research Oversight
   Committee and the Institutional Review Board for oversight and guidance.
   We thank all study participants for tissue donations and the Women's
   Health Research Unit staff, University Fertility Consultants and the
   Reproductive Endocrinology and Infertility Division in the Department of
   Obstetrics and Gynecology, Oregon Health & Science University for
   support and procurement of human gametes. We are indebted to Dr.
   Masahito Tachibana, Michelle Sparman, and Ammar Husami for technical
   support. Studies were supported by the Leducq Foundation, OHSU
   institutional funds, and the Mayo Clinic Center for Regenerative
   Medicine. E.K. was partially funded by a fellowship from the Collins
   Medical Trust.
CR Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604
   Chinnery PF, 2000, MOL MED TODAY, V6, P425, DOI 10.1016/S1357-4310(00)01805-0
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088
   Fauser S, 2002, BIOCHEM BIOPH RES CO, V295, P342, DOI 10.1016/S0006-291X(02)00672-1
   Folmes CDL, 2013, STEM CELLS, V31, P1298, DOI 10.1002/stem.1389
   Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241
   Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620
   Greaves LC, 2010, EXP GERONTOL, V45, P573, DOI 10.1016/j.exger.2010.01.013
   Hashizume O, 2015, SCI REP-UK, V5, DOI 10.1038/srep10434
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Horvath R, 2009, J NEUROL, V256, P810, DOI 10.1007/s00415-009-5023-8
   Johannesson B, 2014, CELL STEM CELL, V15, P634, DOI 10.1016/j.stem.2014.10.002
   Ju YS, 2014, ELIFE, V3, DOI 10.7554/eLife.02935
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003
   Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028
   Ma H, 2015, NATURE, V524, P234, DOI 10.1038/nature14546
   Ma H, 2014, NATURE, V511, P177, DOI 10.1038/nature13551
   Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Mohamed SA, 2006, EXP GERONTOL, V41, P508, DOI 10.1016/j.exger.2006.03.014
   Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Prasad GN, 2006, INT J CARDIOL, V109, P432, DOI 10.1016/j.ijcard.2005.07.065
   Prigione A, 2011, STEM CELLS, V29, P1338, DOI 10.1002/stem.683
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058
   Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006
   Tang S, 2010, BIOTECHNIQUES, V48, P287, DOI 10.2144/000113389
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   WALLACE DC, 1986, SOMAT CELL MOLEC GEN, V12, P41, DOI 10.1007/BF01560726
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739
   Yan XK, 2011, J MED GENET, V48, P682, DOI 10.1136/jmedgenet-2011-100219
   Yao YG, 2015, MUTAT RES-FUND MOL M, V779, P68, DOI 10.1016/j.mrfmmm.2015.06.009
   Yu EPK, 2014, TRENDS ENDOCRIN MET, V25, P481, DOI 10.1016/j.tem.2014.06.008
NR 47
TC 168
Z9 181
U1 1
U2 37
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD MAY 5
PY 2016
VL 18
IS 5
BP 625
EP 636
DI 10.1016/j.stem.2016.02.005
PG 12
WC Cell & Tissue Engineering; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA DL4HE
UT WOS:000375594200013
PM 27151456
OA Bronze
DA 2024-11-01
ER

PT S
AU Szczepanowska, K
   Trifunovic, A
AF Szczepanowska, Karolina
   Trifunovic, Aleksandra
BE Kirkwood, TBL
   Korolchuk, VI
TI Origins of mtDNA mutations in ageing
SO BIOLOGICAL MECHANISMS OF AGEING
SE Essays in Biochemistry
LA English
DT Review; Book Chapter
ID DNA-POLYMERASE-GAMMA; BASE EXCISION-REPAIR; MITOCHONDRIAL DELETION
   MUTANTS; ENDOGENOUS OXIDATIVE DAMAGE; ANTIRETROVIRAL THERAPY; CLONAL
   EXPANSION; SKELETAL-MUSCLE; LIFE-SPAN; IN-VIVO; ACCUMULATION
AB MtDNA mutations are one of the hallmarks of ageing and age-related diseases. It is well established that somatic point mutations accumulate in mtDNA of multiple organs and tissues with increasing age and heteroplasmy is universal in mammals. However, the origin of these mutations remains controversial. The long-lasting hypothesis stating that mtDNA mutations emanate from oxidative damage via a self-perpetuating mechanism has been extensively challenged in recent years. Contrary to this initial ascertainment, mtDNA appears to be well protected from action of reactive oxygen species (ROS) through robust protein coating and endomitochondrial microcompartmentalization. Extensive development of scrupulous high-throughput DNA sequencing methods suggests that an imperfect replication process, rather than oxidative lesions are the main sources of mtDNA point mutations, indicating that mtDNA polymerase. (POLG) might be responsible for the majority of mtDNA mutagenic events. Here, we summarize the recent knowledge in prevention and defence of mtDNA oxidative lesions and discuss the plausible mechanisms of mtDNA point mutation generation and fixation.
C1 [Szczepanowska, Karolina; Trifunovic, Aleksandra] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany.
   [Szczepanowska, Karolina; Trifunovic, Aleksandra] Univ Cologne, Inst Mitochondrial Dis & Aging, Fac Med, D-50931 Cologne, Germany.
   [Trifunovic, Aleksandra] Ctr Mol Med Cologne CMMC, D-50931 Cologne, Germany.
C3 University of Cologne; University of Cologne; University of Cologne
RP Trifunovic, A (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany.; Trifunovic, A (corresponding author), Univ Cologne, Inst Mitochondrial Dis & Aging, Fac Med, D-50931 Cologne, Germany.; Trifunovic, A (corresponding author), Ctr Mol Med Cologne CMMC, D-50931 Cologne, Germany.
EM aleksandra.trifunovic@uk-koeln.de
RI Trifunovic, Aleksandra/HHZ-1296-2022; Szczepanowska,
   Karolina/ABC-1404-2020
OI Szczepanowska, Karolina/0000-0003-4689-2350; Trifunovic,
   Aleksandra/0000-0002-5472-3517
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Alexeyev M., 2013, Cold Spring Harb Perspect Biol, V5, DOI DOI 10.1101/CSHPERSPECT.A012641
   Alexeyev MF, 2009, FEBS J, V276, P5768, DOI 10.1111/j.1742-4658.2009.07269.x
   Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028
   Anson RM, 2000, FASEB J, V14, P355, DOI 10.1096/fasebj.14.2.355
   Appelhans T, 2012, NANO LETT, V12, P610, DOI 10.1021/nl203343a
   Baines HL, 2014, AGING CELL, V13, P201, DOI 10.1111/acel.12199
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   Beckman KB, 1999, MUTAT RES-FUND MOL M, V424, P51, DOI 10.1016/S0027-5107(99)00007-X
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bjelland S, 2003, MUTAT RES-FUND MOL M, V531, P37, DOI 10.1016/j.mrfmmm.2003.07.002
   Bokov A, 2004, MECH AGEING DEV, V125, P811, DOI 10.1016/j.mad.2004.07.009
   Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Burgstaller JP, 2014, CELL REP, V7, P2031, DOI 10.1016/j.celrep.2014.05.020
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chatterjee A, 2001, NUCLEIC ACIDS RES, V29, P4935, DOI 10.1093/nar/29.24.4935
   Chiappini F, 2009, CURR HIV RES, V7, P244, DOI 10.2174/157016209787581409
   Collins Y, 2012, J CELL SCI, V125, P801, DOI 10.1242/jcs.098475
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Coxhead J, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.036
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   de Souza-Pinto NC, 2009, DNA REPAIR, V8, P704, DOI 10.1016/j.dnarep.2009.01.021
   Dizdaroglu M, 2012, CANCER LETT, V327, P26, DOI 10.1016/j.canlet.2012.01.016
   Dong DW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-677
   Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200
   Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X
   Durham SE, 2006, NEUROMUSCULAR DISORD, V16, P381, DOI 10.1016/j.nmd.2006.03.012
   ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.bi.60.070191.002401
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001
   Foury F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027847
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Garcia-Diaz M, 2007, CRIT REV PLANT SCI, V26, P105, DOI 10.1080/07352680701252817
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620
   Greaves LC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003082
   Guo WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070718
   Halliwell B, 2007, BIOCHEM SOC T, V35, P1147, DOI 10.1042/BST0351147
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hashiguchi K, 2004, NUCLEIC ACIDS RES, V32, P5596, DOI 10.1093/nar/gkh863
   Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Itsara LS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003974
   Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907
   Johnson AA, 2001, J BIOL CHEM, V276, P38090
   JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345
   Kachhap S, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-32
   KATAYAMA M, 1991, BIOCHEM INT, V25, P47
   Kauppila JHK, 2015, BBA-BIOENERGETICS, V1847, P1354, DOI 10.1016/j.bbabio.2015.06.001
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794
   Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798
   Kowald A, 2014, P NATL ACAD SCI USA, V111, P2972, DOI 10.1073/pnas.1314970111
   Kowald A, 2013, AGING CELL, V12, P728, DOI 10.1111/acel.12098
   Kreutzer DA, 1998, P NATL ACAD SCI USA, V95, P3578, DOI 10.1073/pnas.95.7.3578
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   KUNKEL TA, 1988, BIOCHIM BIOPHYS ACTA, V951, P1, DOI 10.1016/0167-4781(88)90020-6
   Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497
   KUNKEL TA, 1988, J BIOL CHEM, V263, P4450
   Lapointe J, 2010, CELL MOL LIFE SCI, V67, P1, DOI 10.1007/s00018-009-0138-8
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Lim KS, 2005, ANN NY ACAD SCI, V1042, P210, DOI 10.1196/annals.1338.023
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mandal SM, 2012, J BIOL CHEM, V287, P2819, DOI 10.1074/jbc.M111.272179
   Miquel J, 1998, EXP GERONTOL, V33, P113, DOI 10.1016/S0531-5565(97)00060-0
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nachman MW, 2000, GENETICS, V156, P297
   Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3
   Ocampo MTA, 2002, MOL CELL BIOL, V22, P6111, DOI 10.1128/MCB.22.17.6111-6121.2002
   Orogo AM, 2015, J BIOL CHEM, V290, P22061, DOI 10.1074/jbc.M115.649657
   Osterod M, 2001, CARCINOGENESIS, V22, P1459, DOI 10.1093/carcin/22.9.1459
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Pérez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   Pinto M, 2015, FREE RADICAL BIO MED, V85, P250, DOI 10.1016/j.freeradbiomed.2015.05.005
   PINZ KG, 1995, J BIOL CHEM, V270, P9202, DOI 10.1074/jbc.270.16.9202
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Popanda O, 2013, INT J CANCER, V132, P55, DOI 10.1002/ijc.27665
   Prakash A, 2015, J CELL BIOCHEM, V116, P1490, DOI 10.1002/jcb.25103
   Prithivirajsingh S, 2004, FEBS LETT, V571, P227, DOI 10.1016/j.febslet.2004.06.078
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014
   Sakamoto K, 2007, CANCER RES, V67, P6599, DOI 10.1158/0008-5472.CAN-06-4802
   Samuels DC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003929
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Scheibye-Knudsen M, 2015, TRENDS CELL BIOL, V25, P158, DOI 10.1016/j.tcb.2014.11.002
   Schneider S, 1999, GENETICS, V152, P1079
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Sheng ZJ, 2012, J CLIN INVEST, V122, P4344, DOI 10.1172/JCI65053
   SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Sies H, 2015, REDOX BIOL, V4, P180, DOI 10.1016/j.redox.2015.01.002
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stewart JB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004670
   Stojkovic G, 2016, SCI REP-UK, V6, DOI 10.1038/srep28942
   Stuart JA, 2005, FREE RADICAL BIO MED, V38, P737, DOI 10.1016/j.freeradbiomed.2004.12.003
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011395
   Szczepanowska K, 2015, BBA-BIOENERGETICS, V1847, P1362, DOI 10.1016/j.bbabio.2015.05.016
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103
   Wang GJ, 1997, BIOCHEM PHARMACOL, V54, P181, DOI 10.1016/S0006-2952(97)00158-5
   Wiederholt CJ, 2002, BIOCHEMISTRY-US, V41, P15838, DOI 10.1021/bi025903e
   Williams SL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003990
   Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x
   Yasui M, 2014, DNA REPAIR, V15, P11, DOI 10.1016/j.dnarep.2014.01.003
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
   Zharkov DO, 2010, MUTAT RES-FUND MOL M, V685, P11, DOI 10.1016/j.mrfmmm.2009.10.017
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 120
TC 45
Z9 51
U1 0
U2 13
PU PORTLAND PRESS LTD
PI LONDON
PA 5TH FL, 90 HIGH HOLBORN, LONDON, WC1V 6LJ, ENGLAND
SN 0071-1365
EI 1744-1358
J9 ESSAYS BIOCHEM
JI Essays Biochem.
PY 2017
VL 61
IS 3
BP 325
EP 337
DI 10.1042/EBC20160090
PG 13
WC Biochemistry & Molecular Biology
WE Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA BL4SO
UT WOS:000450752900003
PM 28698307
DA 2024-11-01
ER

PT J
AU Rocha, MC
   Rosa, HS
   Grady, JP
   Blakely, EL
   He, LP
   Romain, N
   Haller, RG
   Newman, J
   McFarland, R
   Ng, YS
   Gorman, GS
   Schaefer, AM
   Tuppen, HA
   Taylor, RW
   Turnbull, DM
AF Rocha, Mariana C.
   Rosa, Hannah S.
   Grady, John P.
   Blakely, Emma L.
   He, Langping
   Romain, Nadine
   Haller, Ronald G.
   Newman, Jane
   McFarland, Robert
   Ng, Yi Shiau
   Gorman, Grainne S.
   Schaefer, Andrew M.
   Tuppen, Helen A.
   Taylor, Robert W.
   Turnbull, Doug M.
TI Pathological Mechanisms Underlying Single Large-Scale Mitochondrial DNA
   Deletions
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; REAL-TIME PCR; DEFICIENT
   MUSCLE-FIBERS; RAGGED-RED FIBERS; WILD-TYPE; PROTEIN-SYNTHESIS;
   LACTIC-ACIDOSIS; EPISODES MELAS; DISEASE; MTDNA
AB Objective: Single, large-scale deletions in mitochondrial DNA (mtDNA) are a common cause of mitochondrial disease. This study aimed to investigate the relationship between the genetic defect and molecular phenotype to improve understanding of pathogenic mechanisms associated with single, large-scale mtDNA deletions in skeletal muscle.
   Methods: We investigated 23 muscle biopsies taken from adult patients (6 males/17 females with a mean age of 43 years) with characterized single, large-scale mtDNA deletions. Mitochondrial respiratory chain deficiency in skeletal muscle biopsies was quantified by immunoreactivity levels for complex I and complex IV proteins. Single muscle fibers with varying degrees of deficiency were selected from 6 patient biopsies for determination of mtDNA deletion level and copy number by quantitative polymerase chain reaction.
   Results: We have defined 3 "classes" of single, large-scale deletion with distinct patterns of mitochondrial deficiency, determined by the size and location of the deletion. Single fiber analyses showed that fibers with greater respiratory chain deficiency harbored higher levels of mtDNA deletion with an increase in total mtDNA copy number. For the first time, we have demonstrated that threshold levels for complex I and complex IV deficiency differ based on deletion class.
   Interpretation: Combining genetic and immunofluorescent assays, we conclude that thresholds for complex I and complex IV deficiency are modulated by the deletion of complex-specific protein-encoding genes. Furthermore, removal of mt-tRNA genes impacts specific complexes only at high deletion levels, when complex-specific protein-encoding genes remain. These novel findings provide valuable insight into the pathogenic mechanisms associated with these mutations.
C1 [Rocha, Mariana C.] Kings Coll London, Cardiovasc Div, British Heart Fdn, Ctr Excellence, London, England.
   [Grady, John P.] Garvan Inst, Sydney, NSW, Australia.
   [Rocha, Mariana C.; Rosa, Hannah S.; Grady, John P.; Blakely, Emma L.; He, Langping; Newman, Jane; McFarland, Robert; Ng, Yi Shiau; Gorman, Grainne S.; Schaefer, Andrew M.; Tuppen, Helen A.; Taylor, Robert W.; Turnbull, Doug M.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Blakely, Emma L.; He, Langping; Taylor, Robert W.] Natl Hlth Serv Fdn Trust, Newcastle Upon Tyne Hosp, Natl Hlth Serv, Highly Specialised Mitochondrial Diagnost Lab, Newcastle Upon Tyne, Tyne & Wear, England.
   [Romain, Nadine; Haller, Ronald G.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA.
   [Romain, Nadine; Haller, Ronald G.] Texas Hlth Presbyterian Hosp, Inst Exercise & Environm Med, Dallas, TX USA.
C3 University of London; University College London; King's College London;
   Garvan Institute of Medical Research; Newcastle University - UK; NHS
   Blood & Transplant (NHSBT); Newcastle Upon Tyne Hospitals NHS Foundation
   Trust; Newcastle University - UK; University of Texas System; University
   of Texas Southwestern Medical Center Dallas
RP Turnbull, DM (corresponding author), Newcastle Univ, Med Sch, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM doug.turnbull@ncl.ac.uk
RI Ng, Yi/AFF-1445-2022; Rocha, Mariana/O-4313-2017
OI Rocha, Mariana/0000-0002-0056-9315; Grady, John/0000-0001-9667-3872;
   McFarland, Robert/0000-0002-8833-2688; Gorman,
   Grainne/0000-0002-7585-3409; Rosa, Hannah/0000-0003-4624-752X; Ng, Yi
   Shiau/0000-0002-7591-2034; Turnbull, Doug/0000-0002-8878-9901; Tuppen,
   Helen/0000-0001-8762-0824; Schaefer, Andrew/0000-0001-9891-7332; Romain,
   Nadine/0000-0003-2492-549X
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical
   Research Council (MRC) Centre for Translational Research in
   Neuromuscular Disease; Newcastle University Centre for Ageing and
   Vitality (Biotechnology and Biological Sciences Research Council);
   Newcastle University Centre for Ageing and Vitality (MRC); Mitochondrial
   Disease Patient Cohort (U.K.) [G0800674]; Lily Foundation; U.K. National
   Institute for Health Research Biomedical Research Centre for Ageing and
   Age-Related Disease award; MRC/Engineering and Physical Sciences
   Research Council Molecular Pathology Node; U.K. NHS Highly Specialised
   Service for Rare Mitochondrial Disorders of Adults and Children; NIH
   National Institute of Arthritis and Musculoskeletal and Skin Diseases
   [R01 AR050597]; MRC [MR/L016354/1, MR/K000608/1] Funding Source: UKRI
FX This work was supported by the Wellcome Centre for Mitochondrial
   Research (203105/Z/16/Z), the Medical Research Council (MRC) Centre for
   Translational Research in Neuromuscular Disease, Newcastle University
   Centre for Ageing and Vitality (supported by the Biotechnology and
   Biological Sciences Research Council and MRC), Mitochondrial Disease
   Patient Cohort (U.K.; G0800674), the Lily Foundation, the U.K. National
   Institute for Health Research Biomedical Research Centre for Ageing and
   Age-Related Disease award to the Newcastle upon Tyne Foundation
   Hospitals NHS Trust, the MRC/Engineering and Physical Sciences Research
   Council Molecular Pathology Node, the U.K. NHS Highly Specialised
   Service for Rare Mitochondrial Disorders of Adults and Children, and NIH
   National Institute of Arthritis and Musculoskeletal and Skin Diseases
   grant R01 AR050597.
CR ARPE J, 1994, ACTA NEUROL SCAND, V90, P281
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   COLLINS S, 1991, BIOCHIM BIOPHYS ACTA, V1097, P309, DOI 10.1016/0925-4439(91)90086-O
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Enns GM, 2005, CLIN GENET, V68, P337, DOI 10.1111/j.1399-0004.2005.00499.x
   FASSATI A, 1994, J NEUROL SCI, V123, P140, DOI 10.1016/0022-510X(94)90216-X
   Gehrig SM, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0488-x
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   GERBITZ KD, 1990, J NEUROL, V237, P5, DOI 10.1007/BF00319660
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   HAMMANS SR, 1992, J NEUROL SCI, V107, P87, DOI 10.1016/0022-510X(92)90213-5
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kiyomoto BH, 1997, J NEUROL SCI, V152, P160, DOI 10.1016/S0022-510X(97)00158-5
   KOO B, 1993, ANN NEUROL, V34, P25, DOI 10.1002/ana.410340107
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   LAFORET P, 1995, NEUROMUSCULAR DISORD, V5, P399, DOI 10.1016/0960-8966(94)00080-S
   LERTRIT P, 1992, AM J HUM GENET, V51, P457
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   MARIOTTI C, 1994, J CLIN INVEST, V93, P1102, DOI 10.1172/JCI117061
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   NAKASE H, 1990, AM J HUM GENET, V46, P418
   OLDFORS A, 1992, J NEUROL SCI, V110, P169, DOI 10.1016/0022-510X(92)90025-G
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Porteous WK, 1998, EUR J BIOCHEM, V257, P192, DOI 10.1046/j.1432-1327.1998.2570192.x
   R Development Core Team, 2016, R: A language and environment for statistical computing
   Rocha MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15037
   Rowan SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029082
   Rygiel KA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09906
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schröder R, 2000, J NEUROPATH EXP NEUR, V59, P353, DOI 10.1093/jnen/59.5.353
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   YAMAMOTO M, 1991, NEUROLOGY, V41, P1822, DOI 10.1212/WNL.41.11.1822
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
NR 47
TC 32
Z9 32
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD JAN
PY 2018
VL 83
IS 1
BP 115
EP 130
DI 10.1002/ana.25127
PG 16
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA FT5FE
UT WOS:000423178600012
PM 29283441
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Rötig, A
AF Roetig, Agnes
TI Genetic bases of mitochondrial respiratory chain disorders
SO DIABETES & METABOLISM
LA English
DT Review
DE Genetics; Mitochondria; Respiratory chain; Review
ID CYTOCHROME-C-OXIDASE; COMPLEX-III DEFICIENCY; PROGRESSIVE EXTERNAL
   OPHTHALMOPLEGIA; DNA DEPLETION; LEIGH-SYNDROME; DIABETES-MELLITUS;
   OXIDATIVE-PHOSPHORYLATION; SUCCINATE-DEHYDROGENASE; THYMIDINE KINASE;
   LACTIC-ACIDOSIS
AB Oxidative phosphorylation ATP synthesis by the oxygen-consuming respiratory chain (RC) supplies most organs and tissues with a readily usable energy source, and is already fully functioning at birth. This means that, in theory. RC deficiency can give rise to any symptom in any organ or tissue at any age and with any mode of inheritance, due to the two-fold genetic origin of RC components (nuclear DNA and mitochondrial DNA). It has long been erroneously believed that RC disorders originate from mutations of mtDNA as, for some time, only mutations or deletions of mtDNA could be identified. However, the number of disease-causing mutations in nuclear genes is now steadily growing. These genes not only encode the various subunits of each complex, but also the ancillary proteins involved in the different stages of holoenzyme biogenesis, including transcription, translation, chaperoning, addition of prosthetic groups and assembly of proteins, as well as the various enzymes involved in mtDNA metabolism. (c) 2010 Elsevier Masson SAS. All rights reserved.
C1 Univ Paris 05, Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France.
C3 Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Necker-Enfants Malades - APHP; Institut National
   de la Sante et de la Recherche Medicale (Inserm)
RP Rötig, A (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, INSERM, U781, 149 Rue Sevres, F-75015 Paris, France.
EM agnes.Rotig@inserm.fr
RI ROTIG, AGNES/G-9592-2017
OI ROTIG, AGNES/0000-0003-0589-0703
CR Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Barel O, 2008, AM J HUM GENET, V82, P1211, DOI 10.1016/j.ajhg.2008.03.020
   Baysal BE, 2008, J MED GENET, V45, P689, DOI 10.1136/jmg.2008.058560
   Bénit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Bogenhagen DF, 1999, AM J HUM GENET, V64, P1276, DOI 10.1086/302392
   BOUCHET C, 2006, J MED GENET
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   Bugiani M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029926
   BUNDSCHUH FA, 2009, J BIOL CHEM
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Clayton DA, 2003, IUBMB LIFE, V55, P213, DOI 10.1080/1521654031000134824
   Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878
   Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000
   CORMIER V, 1991, J PEDIATR-US, V119, P951, DOI 10.1016/S0022-3476(05)83054-9
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   DiMauro S, 2006, CURR OPIN RHEUMATOL, V18, P636, DOI 10.1097/01.bor.0000245729.17759.f2
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972
   Ghezzi D., 2009, Nat Genet
   Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Grivell LA, 1999, FEBS LETT, V452, P57, DOI 10.1016/S0014-5793(99)00532-3
   Guéry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689
   HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015
   Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0
   Hinson JT, 2007, NEW ENGL J MED, V356, P809, DOI 10.1056/NEJMoa055262
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horváth R, 2006, J NEUROL NEUROSUR PS, V77, P74, DOI 10.1136/jnnp.2005.067041
   Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680
   Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   MANDERBACKA K, 2001, SCANDINAVIAN J P S55, V29, P41
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nicolino M, 1997, J CLIN ENDOCR METAB, V82, P3063, DOI 10.1210/jc.82.9.3063
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057
   Oquendo CE, 2004, J MED GENET, V41, P540, DOI 10.1136/jmg.2003.017426
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Paquis-Flucklinger V, 1998, DIABETOLOGIA, V41, P740, DOI 10.1007/s001250050978
   Parfait B, 2000, HUM GENET, V106, P236, DOI 10.1007/s004390051033
   Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rötig A, 2009, BBA-MOL BASIS DIS, V1792, P1103, DOI 10.1016/j.bbadis.2009.06.009
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215
   ROTIG A, 1992, AM J HUM GENET, V50, P364
   Rötig A, 2007, MITOCHONDRION, V7, pS112, DOI 10.1016/j.mito.2007.02.008
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SARZI E, 1931, J PEDIAT, V150
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shteyer E, 2009, AM J HUM GENET, V84, P412, DOI 10.1016/j.ajhg.2009.02.006
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   Souied EH, 1998, AM J OPHTHALMOL, V125, P100, DOI 10.1016/S0002-9394(99)80243-8
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Sue CM, 2000, ANN NEUROL, V47, P589, DOI 10.1002/1531-8249(200005)47:5<589::AID-ANA6>3.3.CO;2-4
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   Valnot I, 1999, HUM GENET, V104, P460, DOI 10.1007/s004390050988
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Visapää I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773
   von Kleist-Retzow JC, 1998, AM J HUM GENET, V63, P428, DOI 10.1086/301957
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
NR 103
TC 29
Z9 32
U1 0
U2 9
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 1262-3636
J9 DIABETES METAB
JI Diabetes Metab.
PD APR
PY 2010
VL 36
IS 2
BP 97
EP 107
DI 10.1016/j.diabet.2009.11.002
PG 11
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 598KN
UT WOS:000277835800002
PM 20093061
DA 2024-11-01
ER

PT J
AU Rötig, A
AF Roetig, A.
TI Genetics of mitochondrial respiratory chain deficiencies
SO REVUE NEUROLOGIQUE
LA English
DT Article
DE Genetic diseases; Mitochondria; Respiratory chain
ID CYTOCHROME-C-OXIDASE; TRANSFER-RNA-SYNTHETASE; COMPLEX-III DEFICIENCY;
   PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; SIDEROBLASTIC ANEMIA-MLASA; ATP
   SYNTHASE DEFICIENCY; DNA DEPLETION; LACTIC-ACIDOSIS; LEIGH-SYNDROME;
   OXIDATIVE-PHOSPHORYLATION
AB Oxidative phosphorylation, i.e. ATP synthesis by the oxygen-consuming respiratory chain (RC), supplies most organs and tissues with a readily usable energy source, and is already fully functioning before birth. This means that, in theory, RC deficiency can give rise to any symptom in any organ or tissue at any age and with any mode of inheritance, due to the twofold genetic origin of RC components (nuclear DNA and mitochondrial DNA). It has long been erroneously believed that RC disorders originate from mutations of mtDNA as, for some time, only mutations or deletions of mtDNA could be identified. However, the number of disease-causing mutations in nuclear genes is now steadily growing. These genes not only encode the various subunits of each complex, but also the ancillary proteins involved in the different stages of holoenzyme biogenesis, including transcription, translation, chaperoning, addition of prosthetic groups and assembly of proteins, as well as the various enzymes involved in mtDNA metabolism. (C) 2014 Elsevier Masson SAS. All rights reserved.
C1 Univ Paris 05, Sorbonne Paris Cite, Hop Necker Enfants Malad, Inserm U1163, F-75015 Paris, France.
C3 Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Necker-Enfants Malades - APHP; Institut National
   de la Sante et de la Recherche Medicale (Inserm)
RP Rötig, A (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Hop Necker Enfants Malad, Inserm U1163, 149 Rue Sevres, F-75015 Paris, France.
EM agnes.rotig@inserm.fr
RI ROTIG, AGNES/G-9592-2017
OI ROTIG, AGNES/0000-0003-0589-0703
CR Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Antonicka H, 2010, AM J HUM GENET, V87, P115, DOI 10.1016/j.ajhg.2010.06.004
   Barel O, 2008, AM J HUM GENET, V82, P1211, DOI 10.1016/j.ajhg.2008.03.020
   Bayat V, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001288
   Baysal BE, 2008, J MED GENET, V45, P689, DOI 10.1136/jmg.2008.058560
   Belostotsky R, 2011, AM J HUM GENET, V88, P193, DOI 10.1016/j.ajhg.2010.12.010
   Bénit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Bogenhagen DF, 1999, AM J HUM GENET, V64, P1276, DOI 10.1086/302392
   Bouchet C, 2006, J MED GENET, V43, P788, DOI 10.1136/jmg.2005.034140
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   Bugiani M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029926
   Bundschuh FA, 2009, J BIOL CHEM, V284, P25735, DOI 10.1074/jbc.M109.040295
   Cameron JM, 2011, AM J HUM GENET, V89, P486, DOI 10.1016/j.ajhg.2011.08.011
   Carroll CJ, 2013, J MED GENET, V50, P151, DOI 10.1136/jmedgenet-2012-101375
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Clayton DA, 2003, IUBMB LIFE, V55, P213, DOI 10.1080/1521654031000134824
   Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878
   Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000
   CORMIER V, 1991, J PEDIATR-US, V119, P951, DOI 10.1016/S0022-3476(05)83054-9
   Crosby AH, 2010, AM J HUM GENET, V87, P655, DOI 10.1016/j.ajhg.2010.09.013
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   DiMauro S, 2006, CURR OPIN RHEUMATOL, V18, P636, DOI 10.1097/01.bor.0000245729.17759.f2
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Elo J.M., 2012, HUM MOL GENET
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Galmiche L, 2011, HUM MUTAT, V32, P1225, DOI 10.1002/humu.21562
   Garcia-Diaz B, 2012, AM J HUM GENET, V91, P729, DOI 10.1016/j.ajhg.2012.08.019
   Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972
   Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009
   Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011
   Ghezzi D, 2011, NAT GENET, V43, P259, DOI 10.1038/ng.761
   Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Grivell LA, 1999, FEBS LETT, V452, P57, DOI 10.1016/S0014-5793(99)00532-3
   Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689
   HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015
   Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0
   Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693
   Hinson JT, 2007, NEW ENGL J MED, V356, P809, DOI 10.1056/NEJMoa055262
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horváth R, 2006, J NEUROL NEUROSUR PS, V77, P74, DOI 10.1136/jnnp.2005.067041
   Indrieri A, 2012, AM J HUM GENET, V91, P942, DOI 10.1016/j.ajhg.2012.09.016
   Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003
   Janer A, 2012, AM J HUM GENET, V91, P737, DOI 10.1016/j.ajhg.2012.08.020
   Jonckheere AI, 2013, BRAIN, V136, P1544, DOI 10.1093/brain/awt086
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kevelam SH, 2013, NEUROLOGY, V80, P1577, DOI 10.1212/WNL.0b013e31828f1914
   Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158
   Lebre AS, 2011, J MED GENET, V48, P16, DOI 10.1136/jmg.2010.079624
   Lim SC, 2013, HUM MOL GENET, V22, P4460, DOI 10.1093/hmg/ddt295
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391
   Navarro-Sastre A, 2011, AM J HUM GENET, V89, P656, DOI 10.1016/j.ajhg.2011.10.005
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nicolino M, 1997, J CLIN ENDOCR METAB, V82, P3063, DOI 10.1210/jc.82.9.3063
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057
   Oquendo CE, 2004, J MED GENET, V41, P540, DOI 10.1136/jmg.2003.017426
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Paquis-Flucklinger V, 1998, DIABETOLOGIA, V41, P740, DOI 10.1007/s001250050978
   Parfait B, 2000, HUM GENET, V106, P236, DOI 10.1007/s004390051033
   Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200
   Pierce SB, 2013, AM J HUM GENET, V92, P614, DOI 10.1016/j.ajhg.2013.03.007
   Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215
   ROTIG A, 1992, AM J HUM GENET, V50, P364
   Rotig A, 2009, BIOCH BIOPHYS ACTA
   Rötig A, 2007, MITOCHONDRION, V7, pS112, DOI 10.1016/j.mito.2007.02.008
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salviati L, 2012, J MED GENET, V49, P187, DOI 10.1136/jmedgenet-2011-100394
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Serre V, 2013, BBA-MOL BASIS DIS, V1832, P1304, DOI 10.1016/j.bbadis.2013.04.014
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shteyer E, 2009, AM J HUM GENET, V84, P412, DOI 10.1016/j.ajhg.2009.02.006
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   Souied EH, 1998, AM J OPHTHALMOL, V125, P100, DOI 10.1016/S0002-9394(99)80243-8
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Sue CM, 2000, ANN NEUROL, V47, P589, DOI 10.1002/1531-8249(200005)47:5<589::AID-ANA6>3.3.CO;2-4
   Szklarczyk R, 2013, HUM MOL GENET, V22, P656, DOI 10.1093/hmg/dds473
   Tenisch EV, 2012, NEUROLOGY, V79, P391, DOI 10.1212/WNL.0b013e3182611232
   Tucker EJ, 2011, CELL METAB, V14, P428, DOI 10.1016/j.cmet.2011.07.010
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   Valnot I, 1999, HUM GENET, V104, P460, DOI 10.1007/s004390050988
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vedrenne V, 2012, AM J HUM GENET, V91, P912, DOI 10.1016/j.ajhg.2012.09.001
   Visapää I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773
   von Ameln S, 2012, AM J HUM GENET, V91, P919, DOI 10.1016/j.ajhg.2012.09.002
   von Kleist-Retzow JC, 1998, AM J HUM GENET, V63, P428, DOI 10.1086/301957
   Weraarpachai W, 2012, AM J HUM GENET, V90, P142, DOI 10.1016/j.ajhg.2011.11.027
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Ye H, 2010, J CLIN INVEST, V120, P1749, DOI 10.1172/JCI40372
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
NR 132
TC 7
Z9 12
U1 0
U2 15
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0035-3787
EI 2213-0004
J9 REV NEUROL-FRANCE
JI Rev. Neurol.
PD MAY
PY 2014
VL 170
IS 5
BP 309
EP 322
DI 10.1016/j.neurol.2013.11.006
PG 14
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA AH4JK
UT WOS:000336093000002
PM 24798924
DA 2024-11-01
ER

PT J
AU Curbo, S
   Lagier-Tourenne, C
   Carrozzo, R
   Palenzuela, L
   Lucioli, S
   Hirano, M
   Santorelli, F
   Arenas, J
   Karlsson, A
   Johansson, M
AF Curbo, S
   Lagier-Tourenne, C
   Carrozzo, R
   Palenzuela, L
   Lucioli, S
   Hirano, M
   Santorelli, F
   Arenas, J
   Karlsson, A
   Johansson, M
TI Human mitochondrial pyrophosphatase: cDNA cloning and analysis of the
   gene in patients with mtDNA depletion syndromes
SO GENOMICS
LA English
DT Article
DE human pyrophosphatase; inorganic pyrophosphate; mitochondrial DNA;
   mitochondrial depletion syndrome; mitochondrial localization;
   mitochondrial enzyme
ID RAT-LIVER MITOCHONDRIA; INORGANIC PYROPHOSPHATASE; ESCHERICHIA-COLI;
   EXPRESSION; LOCALIZATION; DNA; CEREVISIAE; DELETIONS; KINASE; ASSAY
AB Pyrophosphatases (PPases) catalyze the hydrolysis of inorganic pyrophosphate generated in several cellular enzymatic reactions. A novel human pyrophosphatase cDNA encoding a 334-amino-acid protein approximate to 60% identical to the previously identified human cytosolic PPase was cloned and characterized. The novel enzyme, named PPase-2, was enzymatically active and catalyzed hydrolysis of pyrophosphate at a rate similar to that of the previously identified PPase-1. A functional mitochondrial import signal sequence was identified in the N-terminus of PPase-2, which targeted the enzyme to the mitochondrial matrix. The human pyrophosphatase 2 gene (PPase-2) was mapped to chromosome 4q25 and the 1.4-kb mRNA was ubiquitously expressed in human tissues, with highest levels in muscle, liver, and kidney. The yeast homologue of the mitochondrial PPase-2 is required for mitochondrial DNA maintenance and yeast cells lacking the enzyme exhibit mitochondrial DNA depletion. We sequenced the PPA2 gene in 13 patients with mitochondrial DNA depletion syndromes (MDS) of unknown cause to determine if mutations in the PPA2 gene of these patients were associated with this disease. No pathogenic mutations were identified in the PPA2 gene of these patients and we found no evidence that PPA2 gene mutations are a common cause of MDS in humans. (c) 2005 Elsevier Inc. All rights reserved.
C1 Karolinska Inst, Div Metab Disorders, Stockholm, Sweden.
   Columbia Univ Coll Phys & Surg, New York, NY 10027 USA.
   Childrens Hosp Bambino Gesu, Unit Mol Med, Rome, Italy.
   Hosp 12 Octubre, Ctr Invest, E-28041 Madrid, Spain.
C3 Karolinska Institutet; Columbia University; IRCCS Bambino Gesu; Hospital
   Universitario 12 de Octubre
RP Karolinska Inst, Novum, Dept Lab Med, Div Metab Disorders, S-14157 Huddinge, Sweden.
EM magnus.johansson@mbb.ki.se
RI Lucioli, Simona/AAW-5596-2021; Karlsson, Anna/E-7945-2018; curbo,
   sophie/AAA-8614-2020; Carrozzo, Rosalba/A-2808-2014; Santorelli, Filippo
   M/ABE-5124-2020
OI Karlsson, Anna/0000-0001-6843-6685; Lucioli, Simona/0000-0002-7267-937X;
   Carrozzo, Rosalba/0000-0002-3327-4054; Curbo,
   Sophie/0000-0002-0964-0712; Santorelli, Filippo M/0000-0002-1359-9062;
   Arenas, Joaquin/0000-0002-2877-5049
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8
   Carrozzo R, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9135
   CHEN J, 1990, J BACTERIOL, V172, P5686, DOI 10.1128/jb.172.10.5686-5689.1990
   COOPERMAN BS, 1992, TRENDS BIOCHEM SCI, V17, P262, DOI 10.1016/0968-0004(92)90406-Y
   DUBNOVA EB, 1992, ARCH BIOCHEM BIOPHYS, V292, P16, DOI 10.1016/0003-9861(92)90044-W
   Fairchild TA, 1999, BBA-GENE STRUCT EXPR, V1447, P133, DOI 10.1016/S0167-4781(99)00175-X
   GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X
   Heikinheimo P, 1996, STRUCTURE, V4, P1491, DOI 10.1016/S0969-2126(96)00155-4
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KOLAKOWSKI LF, 1988, NUCLEIC ACIDS RES, V16, P10441, DOI 10.1093/nar/16.22.10441
   LAHTI R, 1988, J BACTERIOL, V170, P5901, DOI 10.1128/jb.170.12.5901-5907.1988
   Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177
   LUNDIN M, 1991, J BIOL CHEM, V266, P12168
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MANSUROVA SE, 1989, BIOCHIM BIOPHYS ACTA, V977, P237, DOI 10.1016/S0005-2728(89)80078-7
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X
   Rumsfeld J, 2000, PROTEIN EXPRES PURIF, V18, P303, DOI 10.1006/prep.1999.1189
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SHATTON JB, 1983, CANCER RES, V43, P3742
   Sivula T, 1999, FEBS LETT, V454, P75, DOI 10.1016/S0014-5793(99)00779-6
   VOLK SE, 1984, BIOCHIM BIOPHYS ACTA, V791, P198, DOI 10.1016/0167-4838(84)90009-8
   VOLK SE, 1983, BIOCHIM BIOPHYS ACTA, V744, P127, DOI 10.1016/0167-4838(83)90081-X
   YANG ZH, 1992, J BIOL CHEM, V267, P24634
   YANG ZH, 1992, J BIOL CHEM, V267, P24641
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 28
TC 24
Z9 26
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0888-7543
EI 1089-8646
J9 GENOMICS
JI Genomics
PD MAR
PY 2006
VL 87
IS 3
BP 410
EP 416
DI 10.1016/j.ygeno.2005.09.017
PG 7
WC Biotechnology & Applied Microbiology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 017VD
UT WOS:000235720500010
PM 16300924
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Forsström, S
   Jackson, CB
   Carroll, CJ
   Kuronen, M
   Pirinen, E
   Pradhan, S
   Marmyleva, A
   Auranen, M
   Kleine, IM
   Khan, NA
   Roivainen, A
   Marjamäki, P
   Liljenbäck, H
   Wang, LY
   Battersby, BJ
   Richter, U
   Velagapudi, V
   Nikkanen, J
   Euro, L
   Suomalainen, A
AF Forsstrom, Saara
   Jackson, Christopher B.
   Carroll, Christopher J.
   Kuronen, Mervi
   Pirinen, Eija
   Pradhan, Swagat
   Marmyleva, Anastasiia
   Auranen, Mari
   Kleine, Iida-Marja
   Khan, Nahid A.
   Roivainen, Anne
   Marjamaki, Paivi
   Liljenback, Heidi
   Wang, Liya
   Battersby, Brendan J.
   Richter, Uwe
   Velagapudi, Vidya
   Nikkanen, Joni
   Euro, Liliya
   Suomalainen, Anu
TI Fibroblast Growth Factor 21 Drives Dynamics of Local and Systemic Stress
   Responses in Mitochondrial Myopathy with mtDNA Deletions
SO CELL METABOLISM
LA English
DT Article
ID MULTIPLE DELETIONS; METABOLIC-ACTIVITY; DNA DELETIONS; BETA-KLOTHO;
   PPAR-ALPHA; MUSCLE; FGF21; OPA1; ACTIVATION; DEFICIENCIES
AB Mitochondrial dysfunction elicits stress responses that safeguard cellular homeostasis against metabolic insults. Mitochondrial integrated stress response (ISRmt) is a major response to mitochondrial (mt)DNA expression stress (mtDNA maintenance, translation defects), but the knowledge of dynamics or interdependence of components is lacking. We report that in mitochondrial myopathy, ISRmt progresses in temporal stages and development from early to chronic and is regulated by autocrine and endocrine effects of FGF21, a metabolic hormone with pleiotropic effects. Initial disease signs induce transcriptional ISRmt (ATF5, mitochondria) one-carbon cycle, FGF21, and GDF15). The local progression to 2nd metabolic ISRmt stage (ATF3, ATF4, glucose uptake, serine biosynthesis, and transsulfuration) is FGF21 dependent. Mitochondria! unfolded protein response marks the 3rd ISRmt stage of failing tissue. Systemically, FGF21 drives weight loss and glucose preference, and modifies metabolism and respiratory chain deficiency in a specific hippocampal brain region. Our evidence indicates that FGF21 is a local and systemic messenger of mtDNA stress in mice and humans with mitochondrial disease.
C1 [Forsstrom, Saara; Jackson, Christopher B.; Carroll, Christopher J.; Kuronen, Mervi; Pradhan, Swagat; Marmyleva, Anastasiia; Kleine, Iida-Marja; Khan, Nahid A.; Nikkanen, Joni; Euro, Liliya; Suomalainen, Anu] Univ Helsinki, Fac Med, Stem Cells & Metab Res Program, FIN-00290 Helsinki, Finland.
   [Carroll, Christopher J.] St Georges Univ London, Mol & Clin Sci Res Inst, London SW17 0RE, England.
   [Pirinen, Eija] Univ Helsinki, Fac Med, Clin & Mol Metab Res Program, FIN-00290 Helsinki, Finland.
   [Auranen, Mari; Suomalainen, Anu] Helsinki Univ Cent Hosp, Dept Neurosci, Helsinki 00290, Finland.
   [Roivainen, Anne; Marjamaki, Paivi; Liljenback, Heidi] Univ Turku, Turku PET Ctr, FIN-20520 Turku, Finland.
   [Roivainen, Anne; Liljenback, Heidi] Univ Turku, Inst Biomed, Turku Ctr Dis Modeling, FIN-20520 Turku, Finland.
   [Wang, Liya] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, S-75007 Uppsala, Sweden.
   [Battersby, Brendan J.; Richter, Uwe] Univ Helsinki, Inst Biotechnol, Helsinki 00790, Finland.
   [Velagapudi, Vidya] Univ Helsinki, HiLIFE, Inst Mol Med Finland FIMM, Metabol Unit, FIN-00290 Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Neurosci Ctr, FIN-00290 Helsinki, Finland.
C3 University of Helsinki; City St Georges, University of London;
   University of Helsinki; University of Helsinki; Helsinki University
   Central Hospital; University of Turku; University of Turku; Swedish
   University of Agricultural Sciences; University of Helsinki; University
   of Helsinki; University of Helsinki
RP Suomalainen, A (corresponding author), Univ Helsinki, Fac Med, Stem Cells & Metab Res Program, FIN-00290 Helsinki, Finland.; Suomalainen, A (corresponding author), Helsinki Univ Cent Hosp, Dept Neurosci, Helsinki 00290, Finland.; Suomalainen, A (corresponding author), Univ Helsinki, Neurosci Ctr, FIN-00290 Helsinki, Finland.
EM anu.wartiovaara@helsinki.fi
RI Richter, Uwe/Y-3643-2019; Carroll, Christopher/AAV-8023-2021;
   Velagapudi, Vidya/L-7278-2015; Pradhan, Swagat/ABC-1053-2021; Liliya,
   Euro/F-3808-2015; Pirinen, Eija/H-9153-2015; Jackson, Christopher
   B./M-3222-2013
OI Liliya, Euro/0000-0001-9705-3886; Nikkanen, Joni/0000-0001-7099-4061;
   Liljenback, Heidi/0000-0001-9372-1584; Suomalainen-Wartiovaara,
   Anu/0000-0003-4833-5195; Roivainen, Anne/0000-0002-4006-7977; Carroll,
   Christopher/0000-0002-2814-6955; Richter, Uwe/0000-0002-0724-6957;
   Pradhan, Swagat/0000-0002-3173-6542; Pirinen, Eija/0000-0003-1495-3972;
   Forsstrom, Saara/0000-0003-1610-6793; Jackson, Christopher
   B./0000-0003-1035-6417; Marmyleva, Anastasiia/0000-0003-0671-105X; Khan,
   Nahid/0000-0002-2835-3655
FU Academy of Finland; European Research Council; Sigrid Juselius
   Foundation; Swiss National Science Foundation; Novartis Foundation for
   Medical-Biological Research; Helsinki Biomedical Graduate Program; Maud
   Kuistila Memorial Foundation; Oskar Oflund Foundation; Waldemar von
   Frenkell's Foundation; Biomedicum Helsinki Foundation
FX The authors wish to thank A. Harju, M. Innila, T. Manninen, B. Hollmann,
   and A. Honkaniemi for technical contributions and expertise; the
   Functional Genomics Unit for virus production; the University of
   Helsinki Electron Microscopy Core Facility for their expertise in
   ultrastructural experiments; and the University of Helsinki Laboratory
   Animal Center. J. Palmio is thanked for patient recruitment. We wish to
   acknowledge funding support from the Academy of Finland (A.S. and
   B.J.B.), European Research Council, and Sigrid Juselius Foundation
   (A.S.); Swiss National Science Foundation and Novartis Foundation for
   Medical-Biological Research (C.J.); and Helsinki Biomedical Graduate
   Program, Maud Kuistila Memorial Foundation, Oskar Oflund Foundation,
   Waldemar von Frenkell's Foundation, and Biomedicum Helsinki Foundation
   (S.F.).
CR Agnew T, 2018, CELL REP, V25, P3315, DOI 10.1016/j.celrep.2018.11.080
   Ahola S, 2016, EMBO MOL MED, V8, P1234, DOI 10.15252/emmm.201606592
   Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
   Bao XR, 2016, ELIFE, V5, DOI 10.7554/eLife.10575
   Dogan SA, 2014, CELL METAB, V19, P458, DOI 10.1016/j.cmet.2014.02.004
   Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016
   Fiorese CJ, 2016, CURR BIOL, V26, P2037, DOI 10.1016/j.cub.2016.06.002
   French JB, 2016, SCIENCE, V351, P733, DOI 10.1126/science.aac6054
   Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016
   Haynes CM, 2013, TRENDS CELL BIOL, V23, P311, DOI 10.1016/j.tcb.2013.02.002
   Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003
   Keipert S, 2014, AM J PHYSIOL-ENDOC M, V306, pE469, DOI 10.1152/ajpendo.00330.2013
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606
   Kharitonenkov A, 2009, CURR OPIN INVEST DR, V10, P359
   Kühl I, 2017, ELIFE, V6, DOI 10.7554/eLife.30952
   Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200
   Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   MacVicar T, 2016, J CELL SCI, V129, P2297, DOI 10.1242/jcs.159186
   Martí R, 2012, METHODS MOL BIOL, V837, P135, DOI 10.1007/978-1-61779-504-6_9
   Merkwirth C, 2016, CELL, V165, P1209, DOI 10.1016/j.cell.2016.04.012
   Nandania J, 2018, METABOLITES, V8, DOI 10.3390/metabo8030044
   Nandania J, 2018, J CHROMATOGR B, V1092, P168, DOI 10.1016/j.jchromb.2018.06.008
   Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Ost M, 2016, MOL METAB, V5, P79, DOI 10.1016/j.molmet.2015.11.002
   Ost M, 2015, FASEB J, V29, P1314, DOI 10.1096/fj.14-261503
   Pereira RO, 2017, EMBO J, V36, P2126, DOI 10.15252/embj.201696179
   Potthoff MJ, 2017, NAT REV ENDOCRINOL, V13, P74, DOI 10.1038/nrendo.2016.206
   Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106
   Pulliam DA, 2014, BIOCHEM J, V462, P359, DOI 10.1042/BJ20140291
   Quirós PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058
   Richter U, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800219
   Richter U, 2015, J CELL BIOL, V211, P373, DOI 10.1083/jcb.201504062
   Richter U, 2013, CURR BIOL, V23, P535, DOI 10.1016/j.cub.2013.02.019
   Rygiel KA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09906
   Seiferling D, 2016, EMBO REP, V17, P953, DOI 10.15252/embr.201642077
   Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Taylor RC, 2013, CELL, V153, P1435, DOI 10.1016/j.cell.2013.05.042
   Tezze C, 2017, CELL METAB, V25, P1374, DOI 10.1016/j.cmet.2017.04.021
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392
   Zhang J, 2014, MOL CELL, V56, P205, DOI 10.1016/j.molcel.2014.08.018
   Zhang Q, 2018, CELL, V174, P870, DOI 10.1016/j.cell.2018.06.029
   Zhang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069282
   Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445
NR 59
TC 152
Z9 158
U1 1
U2 23
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD DEC 3
PY 2019
VL 30
IS 6
BP 1040
EP +
DI 10.1016/j.cmet.2019.013.019
PG 22
WC Cell Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Endocrinology & Metabolism
GA JT2BD
UT WOS:000500800300007
PM 31523008
DA 2024-11-01
ER

PT S
AU Venegas, V
   Halberg, MC
AF Venegas, Victor
   Halberg, Michelle C.
BE Wong, LJC
TI Measurement of Mitochondrial DNA Copy Number
SO MITOCHONDRIAL DISORDERS: BIOCHEMICAL AND MOLECULAR ANALYSIS
SE Methods in Molecular Biology
LA English
DT Article; Book Chapter
DE mtDNA copy number; mtDNA content; mtDNA qPCR; Quantification of mtDNA
   content; mtDNA depletion
ID COMPARATIVE GENOMIC HYBRIDIZATION; SUCLA2 MUTATIONS; DEPLETION; GENE;
   ENCEPHALOMYOPATHY; DISORDERS; ENCEPHALOPATHY; DEFICIENCY; RRM2B
AB Mitochondrial disorders are complex and heterogeneous diseases that may be caused by molecular defects in either the nuclear or Mitochondrial genome. The biosynthesis and maintenance of the integrity of the mitochondrial genome is solely dependent on a number of nuclear proteins. Defects in these nuclear genes can lead to mitochondria! DNA (mrDNA) depletion (Spinazzola et al. Biosci Rep 27:39-51, 2007). The mitochondria! DNA (mtDNA) depletion syndromes (MDDSs) arc autosomal recessive disorders characterized by a significant reduction in mtDNA content. These genes include POLG, DGUOK, TK2, MPV17, SUCLA2, SUCLG1, RRM2B, and C10orf2, all nine genes have mutations reported to cause various forms of MDDSs. In this chapter, we outline the real-time quantitative polymerase chain reaction (qPCR) analysis of mtDNA content in muscle or liver tissues.
C1 [Venegas, Victor; Halberg, Michelle C.] Baylor Coll Med, Dept Mol & Human Genet, Med Genet Labs, Houston, TX 77030 USA.
C3 Baylor College of Medicine
RP Venegas, V (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Med Genet Labs, Houston, TX 77030 USA.
CR [Anonymous], CURR PROTOC HUM GENE
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Lee NC, 2009, ARCH DIS CHILD, V94, P55, DOI 10.1136/adc.2008.139584
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Shanske S, 2004, MITOCHONDRION, V4, P403, DOI 10.1016/j.mito.2004.07.026
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Tay SKH, 2004, ARCH NEUROL-CHICAGO, V61, P950, DOI 10.1001/archneur.61.6.950
   Wong LJC, 2008, CLIN CHEM, V54, P1141, DOI 10.1373/clinchem.2008.103721
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
NR 22
TC 120
Z9 134
U1 0
U2 9
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1064-3745
BN 978-1-61779-503-9
J9 METHODS MOL BIOL
JI Methods Mol. Biol.
PY 2012
VL 837
BP 327
EP 335
DI 10.1007/978-1-61779-504-6_22
D2 10.1007/978-1-61779-504-6
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology
WE Book Citation Index – Science (BKCI-S)
SC Biochemistry & Molecular Biology
GA BAG90
UT WOS:000304125100022
PM 22215558
DA 2024-11-01
ER

PT J
AU Zeviani, M
   Carelli, V
AF Zeviani, Massimo
   Carelli, Valerio
TI Mitochondrial Retinopathies
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE retina; mitochondrial disorders; mitochondrial DNA; retinitis
   pigmentosa; optic atrophy; mtDNA heteroplasmic deletions; Kearns-Sayre
   syndrome; neurogenic muscle weakness; ataxia and retinitis pigmentosa
   (NARP); Leber's hereditary optic neuropathy (LHON); autosomal dominant
   optic atrophy (ADOA)
ID HEREDITARY-OPTIC-NEUROPATHY; RETINAL-PIGMENT EPITHELIUM; SCLEROSIS-LIKE
   DISORDER; EXTERNAL OPHTHALMOPLEGIA; DNA DELETIONS; OPHTHALMOSCOPIC
   FINDINGS; INCOMPLETE PENETRANCE; ALLOTOPIC EXPRESSION; BIALLELIC
   VARIANTS; GLUCOSE-METABOLISM
AB The retina is an exquisite target for defects of oxidative phosphorylation (OXPHOS) associated with mitochondrial impairment. Retinal involvement occurs in two ways, retinal dystrophy (retinitis pigmentosa) and subacute or chronic optic atrophy, which are the most common clinical entities. Both can present as isolated or virtually exclusive conditions, or as part of more complex, frequently multisystem syndromes. In most cases, mutations of mtDNA have been found in association with mitochondrial retinopathy. The main genetic abnormalities of mtDNA include mutations associated with neurogenic muscle weakness, ataxia and retinitis pigmentosa (NARP) sometimes with earlier onset and increased severity (maternally inherited Leigh syndrome, MILS), single large-scale deletions determining Kearns-Sayre syndrome (KSS, of which retinal dystrophy is a cardinal symptom), and mutations, particularly in mtDNA-encoded ND genes, associated with Leber hereditary optic neuropathy (LHON). However, mutations in nuclear genes can also cause mitochondrial retinopathy, including autosomal recessive phenocopies of LHON, and slowly progressive optic atrophy caused by dominant or, more rarely, recessive, mutations in the fusion/mitochondrial shaping protein OPA1, encoded by a nuclear gene on chromosome 3q29.
C1 [Zeviani, Massimo] Univ Padua, Dept Neurosci, Sch Clin, I-35128 Padua, Italy.
   [Zeviani, Massimo] Veneto Inst Mol Med, Via Orus 2, I-35128 Padua, Italy.
   [Carelli, Valerio] Univ Bologna, Dept Biomed & Neuromotor Sci, I-40139 Bologna, Italy.
   [Carelli, Valerio] IRCCS Ist Sci Neurol Bologna, Programma Neurogenet, Via Altura 6, I-40139 Bologna, Italy.
C3 University of Padua; Veneto Institute Molecular Medicine; University of
   Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB)
RP Zeviani, M (corresponding author), Univ Padua, Dept Neurosci, Sch Clin, I-35128 Padua, Italy.; Zeviani, M (corresponding author), Veneto Inst Mol Med, Via Orus 2, I-35128 Padua, Italy.; Carelli, V (corresponding author), Univ Bologna, Dept Biomed & Neuromotor Sci, I-40139 Bologna, Italy.; Carelli, V (corresponding author), IRCCS Ist Sci Neurol Bologna, Programma Neurogenet, Via Altura 6, I-40139 Bologna, Italy.
EM massimo.zeviani@unipd.it; valerio.carelli@unibo.it
RI Zeviani, Massimo/AAU-2632-2021
OI CARELLI, VALERIO/0000-0003-4923-6404; Zeviani,
   Massimo/0000-0002-9067-5508
FU Telethon-Italy [GP19007]; Associazione Renato Comini ONLUS; Italian
   Ministry of Health; Italian Ministry of Research and University,
   Telethon-Italy; EU Horizon 2020 program; MITOCON; IFOND
FX This research was supported by Telethon-Italy, Associazione Renato
   Comini ONLUS, Italian Ministry of Health, Italian Ministry of Research
   and University, Telethon-Italy, EU Horizon 2020 program, MITOCON, IFOND.
CR Abrams AJ, 2018, HUM MUTAT, V39, P1995, DOI 10.1002/humu.23639
   Achilli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042242
   Aït-Ali N, 2015, CELL, V161, P817, DOI 10.1016/j.cell.2015.03.023
   Aleo SJ, 2020, HUM MOL GENET, V29, P3631, DOI 10.1093/hmg/ddaa244
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   AMES A, 1992, J NEUROSCI, V12, P840, DOI 10.1523/jneurosci.12-03-00840.1992
   ANDERSON B, 1964, ARCH OPHTHALMOL-CHIC, V72, P792
   Angebault C, 2015, AM J HUM GENET, V97, P754, DOI 10.1016/j.ajhg.2015.09.012
   [Anonymous], 1909, KLIN MON AUGENHEILKD
   Bacman SR, 2020, METHOD CELL BIOL, V155, P441, DOI 10.1016/bs.mcb.2019.12.004
   Balducci N, 2018, CLIN EXP OPHTHALMOL, V46, P1055, DOI 10.1111/ceo.13326
   Baracca A, 2005, ARCH NEUROL-CHICAGO, V62, P730, DOI 10.1001/archneur.62.5.730
   Barboni P, 2006, INVEST OPHTH VIS SCI, V47, P5303, DOI 10.1167/iovs.06-0520
   Barboni P, 2010, OPHTHALMOLOGY, V117, P623, DOI 10.1016/j.ophtha.2009.07.026
   Bargiela D, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2017.06.051
   BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
   Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560
   Berardo A, 2020, J NEUROL, V267, P823, DOI 10.1007/s00415-019-09619-z
   Birtel J, 2022, OPHTHALMOL RETINA, V6, P65, DOI 10.1016/j.oret.2021.02.017
   Blasiak J, 2015, BIORESEARCH OPEN ACC, V4, P334, DOI 10.1089/biores.2015.0022
   Bonora E, 2021, BRAIN, V144, P1451, DOI 10.1093/brain/awab056
   Brown EE, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101201
   Bursle C, 2018, JIMD Rep, V42, P53, DOI 10.1007/8904_2017_79
   Burté F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228
   Calkins DJ, 2021, MOL THER-METH CLIN D, V23, P307, DOI 10.1016/j.omtm.2021.09.013
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Caporali L, 2020, ANN NEUROL, V88, P18, DOI 10.1002/ana.25723
   Caporali L, 2017, MITOCHONDRION, V36, P130, DOI 10.1016/j.mito.2017.07.004
   Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carelli V., 2006, Mitochondrial Medicine, DOI DOI 10.1201/B14623-7
   Carelli V, 2008, NEUROLOGY, V70, P1075, DOI 10.1212/01.wnl.0000307668.75233.35
   Carelli V, 2017, J NEURO-OPHTHALMOL, V37, P371, DOI 10.1097/WNO.0000000000000570
   Carelli V, 2017, HUM MOL GENET, V26, pR139, DOI 10.1093/hmg/ddx273
   Carelli V, 2016, BRAIN, V139, DOI 10.1093/brain/awv339
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Carelli V, 2015, BRAIN, V138, DOI 10.1093/brain/awu234
   Carelli V, 2011, BRAIN, V134, DOI 10.1093/brain/awr180
   Casson RJ, 2014, OPHTHALMOLOGY, V121, P1203, DOI 10.1016/j.ophtha.2013.12.011
   Catarino CB, 2020, J NEURO-OPHTHALMOL, V40, P558, DOI 10.1097/WNO.0000000000001023
   Charif M, 2021, BRAIN COMMUN, V3, DOI 10.1093/braincomms/fcab063
   Charif M, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000428
   Charif M, 2018, JAMA NEUROL, V75, P105, DOI 10.1001/jamaneurol.2017.2065
   Charlesworth G, 2016, MOVEMENT DISORD, V31, P1249, DOI 10.1002/mds.26716
   Chinchore Y, 2017, ELIFE, V6, DOI 10.7554/eLife.25946
   Chinnery PF, 2000, MOL MED TODAY, V6, P425, DOI 10.1016/S1357-4310(00)01805-0
   Cretin E, 2021, EMBO MOL MED, V13, DOI 10.15252/emmm.202013579
   Cringle SJ, 2002, INVEST OPHTH VIS SCI, V43, P1922
   D'Angelo L, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109002
   Danielson SR, 2002, J BIOL CHEM, V277, P5810, DOI 10.1074/jbc.M110119200
   de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534
   Del Dotto V, 2020, J CLIN INVEST, V130, P108, DOI 10.1172/JCI128514
   Del Dotto V, 2018, PHARMACOL RES, V131, P199, DOI 10.1016/j.phrs.2018.02.018
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Dimitriadis K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0158-9
   Dzbek J, 2008, J BIOL CHEM, V283, P33232, DOI 10.1074/jbc.M802404200
   Eiberg H, 2006, J MED GENET, V43, P435, DOI 10.1136/jmg.2005.034892
   ERICKSON RP, 1972, AM J HUM GENET, V24, P348
   Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012
   Fisher CR, 2018, INVEST OPHTH VIS SCI, V59, pAMD41, DOI 10.1167/iovs.18-24289
   Floreani M, 2005, FEBS J, V272, P1124, DOI 10.1111/j.1742-4658.2004.04542.x
   Formosa LE, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2019665118
   Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001
   Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724
   Gerber S, 2017, BRAIN, V140, P2586, DOI 10.1093/brain/awx219
   Gerber S, 2017, J MED GENET, V54, P346, DOI 10.1136/jmedgenet-2016-104212
   Giacomello M, 2020, NAT REV MOL CELL BIO, V21, P204, DOI 10.1038/s41580-020-0210-7
   Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Giordano L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.364
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, JAMA NEUROL, V72, P106, DOI 10.1001/jamaneurol.2014.1753
   Gueven N, 2021, REDOX BIOL, V38, DOI 10.1016/j.redox.2020.101812
   Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354
   Guy J, 2017, OPHTHALMOLOGY, V124, P1621, DOI 10.1016/j.ophtha.2017.05.016
   Hanein S, 2009, AM J HUM GENET, V84, P493, DOI 10.1016/j.ajhg.2009.03.003
   HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Hwang TJ, 2017, OPHTHALMOLOGY, V124, P843, DOI 10.1016/j.ophtha.2017.01.002
   Invernizzi F, 2021, BRAIN, V144, DOI 10.1093/brain/awab238
   Janer A, 2016, EMBO MOL MED, V8, P1019, DOI 10.15252/emmm.201506159
   Jezek P, 2018, ANTIOXID REDOX SIGN, V29, P667, DOI 10.1089/ars.2017.7225
   Jiang PP, 2016, HUM MOL GENET, V25, P584, DOI 10.1093/hmg/ddv498
   Jurkute N, 2021, INVEST OPHTH VIS SCI, V62, DOI 10.1167/iovs.62.15.12
   Jurkute N, 2019, ANN NEUROL, V86, P368, DOI 10.1002/ana.25550
   Kaarniranta K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102374
   Kanow MA, 2017, ELIFE, V6, DOI 10.7554/eLife.28899
   Karunadharma PP, 2010, INVEST OPHTH VIS SCI, V51, P5470, DOI 10.1167/iovs.10-5429
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   KJER P, 1959, Acta Ophthalmol Suppl, V164, P1
   Kleffner I, 2015, J NEUROL SCI, V357, P115, DOI 10.1016/j.jns.2015.07.009
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   La Morgia C, 2008, NEUROLOGY, V70, P762, DOI 10.1212/01.wnl.0000295505.74234.d0
   La Morgia Chiara, 2021, Handb Clin Neurol, V179, P315, DOI 10.1016/B978-0-12-819975-6.00020-0
   La Morgia C, 2019, NEUROL-GENET, V5, DOI 10.1212/NXG.0000000000000329
   Leber T., 1871, ARCH OPHTHALMOL-CHIC, V17, P249
   Lee J, 2016, MOL MED REP, V14, P33, DOI 10.3892/mmr.2016.5209
   Lenaers G, 2021, PROG RETIN EYE RES, V83, DOI 10.1016/j.preteyeres.2020.100935
   Liang FQ, 2003, EXP EYE RES, V76, P397, DOI 10.1016/S0014-4835(03)00023-X
   Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P3521, DOI 10.1167/iovs.10-6163
   Majander A, 2017, BRIT J OPHTHALMOL, V101, P1505, DOI 10.1136/bjophthalmol-2016-310072
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Maresca A, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11040496
   MARIOTTI C, 1994, J CLIN INVEST, V93, P1102, DOI 10.1172/JCI117061
   Mascialino B, 2012, EUR J OPHTHALMOL, V22, P461, DOI 10.5301/ejo.5000055
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198
   Meunier I, 2021, RETINA-J RET VIT DIS, V41, P1771, DOI 10.1097/IAE.0000000000003054
   Miller NR., 2005, WALSH HOYTS CLIN NEU, V6th
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   Mitchell P, 2011, BBA-BIOENERGETICS, V1807, P1507, DOI 10.1016/j.bbabio.2011.09.018
   Mnatsakanyan L, 2011, J NEURO-OPHTHALMOL, V31, P6, DOI 10.1097/WNO.0b013e3181fab1b4
   Montava-Garriga L, 2020, J MOL BIOL, V432, P206, DOI 10.1016/j.jmb.2019.06.032
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Mori M, 2014, JIMD REP, V17, P47, DOI 10.1007/8904_2014_332
   Murakami T, 1996, J NEUROL SCI, V142, P111, DOI 10.1016/0022-510X(96)00165-7
   Narayan DS, 2017, CLIN EXP OPHTHALMOL, V45, P730, DOI 10.1111/ceo.12952
   Narayan DS, 2016, ACTA OPHTHALMOL, V94, P748, DOI 10.1111/aos.13141
   Newman NJ, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.662838
   Newman NJ, 2021, OPHTHALMOLOGY, V128, P649, DOI 10.1016/j.ophtha.2020.12.012
   Newman NJ, 2020, J NEURO-OPHTHALMOL, V40, P547, DOI 10.1097/WNO.0000000000001045
   Nicholson GA, 2008, NEUROLOGY, V70, P1678, DOI 10.1212/01.wnl.0000311275.89032.22
   NIKOSKELAINEN E, 1982, ARCH OPHTHALMOL-CHIC, V100, P1597, DOI 10.1001/archopht.1982.01030040575003
   NIKOSKELAINEN E, 1983, ARCH OPHTHALMOL-CHIC, V101, P1059, DOI 10.1001/archopht.1983.01040020061011
   NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160
   Nissanka N, 2018, FEBS LETT, V592, P728, DOI 10.1002/1873-3468.12956
   Niven JE, 2007, PLOS BIOL, V5, P828, DOI 10.1371/journal.pbio.0050116
   Oca-Cossio J, 2003, GENETICS, V165, P707
   Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029
   Pan BX, 2012, INVEST OPHTH VIS SCI, V53, P7608, DOI 10.1167/iovs.12-10452
   Pareyson D, 2015, NEUROSCI LETT, V596, P66, DOI 10.1016/j.neulet.2015.04.001
   Perales-Clemente E, 2011, NUCLEIC ACIDS RES, V39, P225, DOI 10.1093/nar/gkq769
   Petit L, 2018, CELL REP, V23, P2629, DOI 10.1016/j.celrep.2018.04.111
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pfeffer G, 2013, NEUROLOGY, V81, P2073, DOI 10.1212/01.wnl.0000437308.22603.43
   Piro-Mégy C, 2020, J CLIN INVEST, V130, P143, DOI 10.1172/JCI128513
   POULTON J, 1989, LANCET, V1, P236
   Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234
   Rajabian F, 2021, J NEURO-OPHTHALMOL, V41, pE290, DOI 10.1097/WNO.0000000000001124
   Reynier P, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016576
   Romagnoli M, 2020, ANN CLIN TRANSL NEUR, V7, P590, DOI 10.1002/acn3.51026
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Sadun F, 2004, AM J OPHTHALMOL, V137, P271, DOI 10.1016/j.ajo.2003.08.010
   Savini G, 2005, OPHTHALMOLOGY, V112, P127, DOI 10.1016/j.ophtha.2004.09.033
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schon Eric A, 2007, Novartis Found Symp, V287, P214
   Shankar SP, 2008, OPHTHALMIC GENET, V29, P17, DOI 10.1080/13816810701867607
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   Shibeeb O, 2016, CLIN EXP OPHTHALMOL, V44, P24, DOI 10.1111/ceo.12581
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Spikes TE, 2020, P NATL ACAD SCI USA, V117, P23519, DOI 10.1073/pnas.2013998117
   Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093
   STEINBERG RH, 1983, VISION RES, V23, P1315, DOI 10.1016/0042-6989(83)90107-4
   Stenton SL, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI138267
   Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004
   Terluk MR, 2015, J NEUROSCI, V35, P7304, DOI 10.1523/JNEUROSCI.0190-15.2015
   Thorburn D.R., 1993, GENEREVIEWS
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
   Verny C, 2008, NEUROLOGY, V70, P1152, DOI 10.1212/01.wnl.0000289194.89359.a1
   Viscomi C, 2020, J INTERN MED, V287, P665, DOI 10.1111/joim.13046
   Wallace DC, 2009, COLD SH Q B, V74, P383, DOI 10.1101/sqb.2009.74.031
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955
   Wan JJ, 2016, BRAIN, V139, P2877, DOI 10.1093/brain/aww212
   Wan X, 2016, SCI REP-UK, V6, DOI 10.1038/srep21587
   Wang L, 1997, INVEST OPHTH VIS SCI, V38, P48
   Wang W, 2016, CELL REP, V15, P372, DOI 10.1016/j.celrep.2016.03.022
   WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667
   Yu JL, 2020, J CLIN INVEST, V130, P4935, DOI 10.1172/JCI134965
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2008, J NEURO-OPHTHALMOL, V28, P155, DOI 10.1097/WNO.0b013e3181772db4
   Yu-Wai-Man P, 2022, EYE, V36, P818, DOI 10.1038/s41433-021-01535-9
   Yu-Wai-Man P, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz7423
   Yu-Wai-Man P, 2016, ANN CLIN TRANSL NEUR, V3, P723, DOI 10.1002/acn3.323
   Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002
   Zaninello M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17821-1
   Zanna C, 2005, APOPTOSIS, V10, P997, DOI 10.1007/s10495-005-0742-5
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   Zekonyte U, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23561-7
   Zeviani M, 1998, NEUROLOGY, V51, P1525, DOI 10.1212/WNL.51.6.1525-a
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 195
TC 33
Z9 34
U1 0
U2 19
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JAN
PY 2022
VL 23
IS 1
AR 210
DI 10.3390/ijms23010210
PG 33
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA YF3UT
UT WOS:000741736600001
PM 35008635
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Mathews, CK
   Song, SW
AF Mathews, Christopher K.
   Song, Shiwei
TI Maintaining precursor pools for mitochondrial DNA replication
SO FASEB JOURNAL
LA English
DT Review
DE mitochondria; DNA precursors; deoxyribonucleotides; nucleotide pools
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MOUSE L-CELLS; DEOXYNUCLEOTIDE
   CARRIER; THYMIDINE PHOSPHORYLASE; NUCLEOSIDE ANALOGS; POLYMERASE-GAMMA;
   NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY; 3'-AZIDO-3'-DEOXYTHYMIDINE AZT;
   RIBONUCLEOTIDE REDUCTASE; COMPUTATIONAL MODEL
AB Among the human diseases that result from abnormalities in mitochondrial genome stability or maintenance are several that result from mutations affecting enzymes of deoxyribonucleoside triphosphate ( dNTP) metabolism. In addition, it is evident that the toxicity of antiviral nucleoside analogs is determined in part by the extent to which their intracellular conversion to dNTP analogs occurs within the mitochondrion. Finally, recent work from this laboratory has shown considerable variation among different mammalian tissues with respect to mitochondrial dNTP pool sizes and has suggested that natural asymmetries in mitochondrial dNTP concentrations may contribute to the high rates at which the mitochondrial genome undergoes mutation. These factors suggest that much more information is needed about maintenance and regulation of dNTP pools within mammalian mitochondria. This review summarizes our current understanding and suggests directions for future research.
C1 Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.
C3 Oregon State University
RP Mathews, CK (corresponding author), Oregon State Univ, Dept Biochem & Biophys, 2011 Agr & Life Sci Bldg, Corvallis, OR 97331 USA.
EM mathewsc@onid.orst.edu
CR ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   BESTWICK RK, 1982, J BIOL CHEM, V257, P9305
   BESTWICK RK, 1982, J BIOL CHEM, V257, P9300
   BOGENHAGEN D, 1976, J BIOL CHEM, V251, P2938
   Bradshaw PC, 2005, BIOCHEM J, V392, P363, DOI 10.1042/BJ20050749
   Bradshaw PC, 2005, AM J PHYSIOL-CELL PH, V288, pC989, DOI 10.1152/ajpcell.00530.2004
   Bridges EG, 1999, J BIOL CHEM, V274, P4620, DOI 10.1074/jbc.274.8.4620
   Desler C, 2006, NUCLEOS NUCLEOT NUCL, V25, P1171, DOI 10.1080/15257770600894501
   Dolce V, 2001, P NATL ACAD SCI USA, V98, P2284, DOI 10.1073/pnas.031430998
   ENRIQUEZ JA, 1994, NUCLEIC ACIDS RES, V22, P1861, DOI 10.1093/nar/22.10.1861
   Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200
   Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200
   KANG D, 1995, J BIOL CHEM, V270, P14659, DOI 10.1074/jbc.270.24.14659
   KAROL MH, 1968, SCIENCE, V162, P470, DOI 10.1126/science.162.3852.470
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kumagai Y, 2006, INTERNAL MED, V45, P443, DOI 10.2169/internalmedicine.45.1371
   Lacombe ML, 2000, J BIOENERG BIOMEMBR, V32, P247, DOI 10.1023/A:1005584929050
   Ladner RD, 1997, J BIOL CHEM, V272, P19072, DOI 10.1074/jbc.272.30.19072
   Lam W, 2005, MOL PHARMACOL, V67, P408, DOI 10.1124/mol.104.007120
   Lara MC, 2006, NEUROLOGY, V67, P1461, DOI 10.1212/01.wnl.0000239824.95411.52
   Lee H, 2003, BIOCHEMISTRY-US, V42, P14711, DOI 10.1021/bi035596s
   LEEDS JM, 1987, MOL CELL BIOL, V7, P532, DOI 10.1128/MCB.7.1.532
   Lewis W, 2005, LAB INVEST, V85, P972, DOI 10.1038/labinvest.3700301
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Lindhurst MJ, 2006, P NATL ACAD SCI USA, V103, P15927, DOI 10.1073/pnas.0607661103
   Lynx MD, 2006, BIOCHEM PHARMACOL, V72, P239, DOI 10.1016/j.bcp.2006.04.004
   Lynx MD, 2006, BIOCHEM PHARMACOL, V71, P1342, DOI 10.1016/j.bcp.2006.01.003
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Marcelino LA, 1999, MUTAT RES-DNA REPAIR, V434, P177, DOI 10.1016/S0921-8777(99)00028-2
   Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev
   MATHEWS CK, 1986, EXP CELL RES, V162, P285, DOI 10.1016/0014-4827(86)90335-6
   McKee Edward E, 2004, Cardiovasc Toxicol, V4, P155, DOI 10.1385/CT:4:2:155
   Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Parker W.B., 1994, J. Natl. Inst. Health Res, V6, P57
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100
   Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200
   Rampazzo C, 2004, J BIOL CHEM, V279, P17019, DOI 10.1074/jbc.M313957200
   Rampazzo C, 2000, P NATL ACAD SCI USA, V97, P8239, DOI 10.1073/pnas.97.15.8239
   Rosenberg MJ, 2002, NAT GENET, V32, P175, DOI 10.1038/ng948
   Saada A, 2003, BIOCHEM BIOPH RES CO, V310, P963, DOI 10.1016/j.bbrc.2003.09.104
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102
   Song SW, 2003, J BIOL CHEM, V278, P43893, DOI 10.1074/jbc.C300401200
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Suh JH, 2003, FREE RADICAL BIO MED, V35, P1064, DOI 10.1016/S0891-5849(03)00468-4
   Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wang LY, 2003, FEBS LETT, V554, P319, DOI 10.1016/S0014-5793(03)01181-5
   Wang LY, 2003, J BIOL CHEM, V278, P6963, DOI 10.1074/jbc.M206143200
   YOUNG P, 1994, BIOCHEM BIOPH RES CO, V203, P46, DOI 10.1006/bbrc.1994.2146
NR 62
TC 33
Z9 40
U1 0
U2 6
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD AUG
PY 2007
VL 21
IS 10
BP 2294
EP 2303
DI 10.1096/fj.06-7977rev
PG 10
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 196AS
UT WOS:000248454400004
PM 17403938
DA 2024-11-01
ER

PT J
AU Mullin, NK
   Voigt, AP
   Flamme-Wiese, MJ
   Liu, XY
   Riker, MJ
   Varzavand, K
   Stone, EM
   Tucker, BA
   Mullins, RF
AF Mullin, Nathaniel K.
   Voigt, Andrew P.
   Flamme-Wiese, Miles J.
   Liu, Xiuying
   Riker, Megan J.
   Varzavand, Katayoun
   Stone, Edwin M.
   Tucker, Budd A.
   Mullins, Robert F.
TI Multimodal single-cell analysis of nonrandom heteroplasmy distribution
   in human retinal mitochondrial disease
SO JCI INSIGHT
LA English
DT Article
ID CLINICAL-FEATURES; LACTIC-ACIDOSIS; MELAS; MUTATION; DEAFNESS;
   ENCEPHALOPATHY; DEFICIENCY; TUBULATION; MYOPATHY; FAMILIES
AB Variants within the high copy number mitochondrial genome (mtDNA) can disrupt organelle function and lead to severe multisystem disease. The wide range of manifestations observed in patients with mitochondrial disease results from varying fractions of abnormal mtDNA molecules in different cells and tissues, a phenomenon termed heteroplasmy. However, the landscape of heteroplasmy across cell types within tissues and its influence on phenotype expression in affected patients remains largely unexplored. Here, we identify nonrandom distribution of a pathogenic mtDNA variant across a complex tissue using single-cell RNA-Seq, mitochondrial single-cell ATAC sequencing, and multimodal single-cell sequencing. We profiled the transcriptome, chromatin accessibility state, and heteroplasmy in cells from the eyes of a patient with mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) and from healthy control donors. Utilizing the retina as a model for complex multilineage tissues, we found that the proportion of the pathogenic m.3243A>G allele was neither evenly nor randomly distributed across diverse cell types. All neuroectoderm-derived neural cells exhibited a high percentage of the mutant variant. However, a subset of mesoderm-derived lineage, namely the vasculature of the choroid, was near homoplasmic for the WT allele. Gene expression and chromatin accessibility profiles of cell types with high and low proportions of m.3243A>G implicate mTOR signaling in the cellular response to heteroplasmy. We further found by multimodal single-cell sequencing of retinal pigment epithelial cells that a high proportion of the pathogenic mtDNA variant was associated with transcriptionally and morphologically abnormal cells. Together, these findings show the nonrandom nature of mitochondrial variant partitioning in human mitochondrial disease and underscore its implications for mitochondrial disease pathogenesis and treatment.
C1 [Mullin, Nathaniel K.; Voigt, Andrew P.; Flamme-Wiese, Miles J.; Liu, Xiuying; Riker, Megan J.; Varzavand, Katayoun; Stone, Edwin M.; Tucker, Budd A.; Mullins, Robert F.] Univ Iowa, Inst Vis Res, Iowa City, IA USA.
   [Mullin, Nathaniel K.; Voigt, Andrew P.; Flamme-Wiese, Miles J.; Liu, Xiuying; Riker, Megan J.; Varzavand, Katayoun; Stone, Edwin M.; Tucker, Budd A.; Mullins, Robert F.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA.
   [Mullin, Nathaniel K.; Voigt, Andrew P.] Univ Iowa, Med Scientist Training Program, Iowa City, IA USA.
   [Mullins, Robert F.] 4130 MERF,375 Newton Rd, Iowa City, IA 52242 USA.
C3 University of Iowa; University of Iowa; University of Iowa
RP Mullins, RF (corresponding author), 4130 MERF,375 Newton Rd, Iowa City, IA 52242 USA.
EM robert-mullins@uiowa.edu
RI Mullins, Robert/I-6717-2013; Mullin, Nathaniel/AAY-6875-2020; Liu,
   Xiuying/AAT-8022-2021
OI Tucker, Budd/0000-0003-2178-1742; Mullin, Nathaniel/0000-0003-4320-2852;
   Voigt, Andrew/0000-0001-8107-8317
FU NIH [T32GM008629, T32GM139776, F30EY034009, P30EY025580, F30EY031923,
   R01EY033308]; Research to Prevent Blindness; Elmer and Sylvia Sramek
   Charitable Trust; Edward N. amp; Della L. Thome Memorial Foundation;
   University of Iowa Carver College of Medicine; NIH SIG [1 S10
   RR018998-01]
FX This work was supported by the NIH (T32GM008629, T32GM139776,
   F30EY034009, P30EY025580, F30EY031923, R01EY033308) , Research to
   Prevent Blindness, the Elmer and Sylvia Sramek Charitable Trust, and The
   Edward N. & Della L. Thome Memorial Foundation. The authors would like
   to acknowledge the extraordinary generosity of the tissue donors and
   their families. We would also like to thank E. Burnight, L. Lozano, K.
   Mulfaul, and the other members of the Tucker and Mullins laboratories
   for their helpful conversation and advice. Data presented herein were
   obtained at the Genomics Division of the Iowa Institute of Human
   Genetics, which is supported, in part, by the University of Iowa Carver
   College of Medicine. We would like to acknowledge specifically the
   advice and support of M. Boes, G. Hauser, K. Knudt- son, A. Sheehan, and
   E. Snir. This work utilized the Hitachi HT7800 transmission electron
   microscope in the University of Iowa Central Microscopy Research
   Facilities that was purchased with funding from the NIH SIG grant 1 S10
   RR018998-01. Colors used in plots were based on www.colorbrewer2.org by
   Cynthia A. Brewer, Department of Geography, Pennsylvania State
   University, Centre County, Pennsylvania, USA.
CR Adijanto J, 2014, J BIOL CHEM, V289, P20570, DOI 10.1074/jbc.M114.565457
   Aryaman J, 2019, FRONT GENET, V9, DOI 10.3389/fgene.2018.00718
   Barrett A, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0175
   Boggan RM, 2019, MOL GENET METAB, V128, P19, DOI 10.1016/j.ymgme.2019.09.003
   Cao DF, 2021, INVEST OPHTH VIS SCI, V62, DOI 10.1167/iovs.62.10.34
   Castro-Mondragon JA, 2022, NUCLEIC ACIDS RES, V50, pD165, DOI 10.1093/nar/gkab1113
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   Chung CY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26746-2
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Coussa RG, 2021, SURV OPHTHALMOL, V66, P838, DOI 10.1016/j.survophthal.2021.02.008
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   DOLLERY CT, 1969, INVEST OPHTH VISUAL, V8, P588
   Dolz-Marco R, 2017, OPHTHALMOLOGY, V124, P1353, DOI 10.1016/j.ophtha.2017.03.043
   Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021
   Finsterer J, 2020, AM J CASE REP, V21, DOI 10.12659/AJCR.927938
   Flierl A, 1997, J BIOL CHEM, V272, P27189, DOI 10.1074/jbc.272.43.27189
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Hahn A, 2019, TRENDS CELL BIOL, V29, P227, DOI 10.1016/j.tcb.2018.11.004
   Han Ian C, 2020, Ophthalmol Retina, V4, P1102, DOI 10.1016/j.oret.2020.04.027
   Hao YH, 2021, CELL, V184, P3573, DOI 10.1016/j.cell.2021.04.048
   Hasegawa T, 2007, DEV DYNAM, V236, P2089, DOI 10.1002/dvdy.21231
   Homma K, 2021, REDOX BIOL, V41, DOI 10.1016/j.redox.2021.101921
   Hübner A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47570-1
   Iwanicka-Pronicka K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044054
   Janssen GMC, 2007, HUM MOL GENET, V16, P2472, DOI 10.1093/hmg/ddm203
   Kanow MA, 2017, ELIFE, V6, DOI 10.7554/eLife.28899
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   Kopinski PK, 2019, P NATL ACAD SCI USA, V116, P16028, DOI 10.1073/pnas.1906896116
   Lareau CA, 2021, NAT BIOTECHNOL, V39, P451, DOI 10.1038/s41587-020-0645-6
   Latkany P, 1999, AM J OPHTHALMOL, V128, P112, DOI 10.1016/S0002-9394(99)00057-4
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44
   Lutty GA, 2010, EYE, V24, P408, DOI 10.1038/eye.2009.318
   Lutty GA, 2018, PROG RETIN EYE RES, V62, P58, DOI 10.1016/j.preteyeres.2017.10.001
   Mimitou EP, 2021, NAT BIOTECHNOL, V39, P1246, DOI 10.1038/s41587-021-00927-2
   Moggio Maurizio, 2014, Acta Myol, V33, P86
   Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417
   Scholle LM, 2020, GENES-BASEL, V11, DOI 10.3390/genes11020212
   Müller PL, 2020, AM J OPHTHALMOL, V213, P134, DOI 10.1016/j.ajo.2020.01.013
   Mullin NK, 2022, HUM MOL GENET, V31, P775, DOI 10.1093/hmg/ddab289
   Oh JK, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.12.12
   Ortolan D, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2117553119
   Pan WW, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01765-3
   Parakatselaki ME, 2021, LIFE-BASEL, V11, DOI 10.3390/life11070633
   Pek NMQ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2036-9
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Raja MS, 2013, GRAEF ARCH CLIN EXP, V251, P2265, DOI 10.1007/s00417-012-2217-z
   Rao SR, 2021, J LIPID RES, V62, DOI 10.1194/jlr.TR120000979
   Richter U, 2021, FEBS LETT, V595, P1003, DOI 10.1002/1873-3468.14049
   SAKUTA R, 1993, J NEUROL SCI, V115, P158, DOI 10.1016/0022-510X(93)90219-O
   Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   Sreekumar PG, 2016, INVEST OPHTH VIS SCI, V57, P1238, DOI 10.1167/iovs.15-17053
   Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stone EM, 2017, OPHTHALMOLOGY, V124, P1314, DOI 10.1016/j.ophtha.2017.04.008
   Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031
   Tripathy K, 2020, INDIAN J OPHTHALMOL, V68, P250, DOI 10.4103/ijo.IJO_577_19
   Viegas FO, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.656000
   Voigt AP, 2019, EXP EYE RES, V184, P234, DOI 10.1016/j.exer.2019.05.001
   Voigt AP, 2021, HUM MOL GENET, V30, P1543, DOI 10.1093/hmg/ddab140
   Voigt AP, 2019, P NATL ACAD SCI USA, V116, P24100, DOI 10.1073/pnas.1914143116
   Walker MA, 2020, NEW ENGL J MED, V383, P1556, DOI 10.1056/NEJMoa2001265
   Xue YL, 2021, ELIFE, V10, DOI 10.7554/eLife.66240
   Yang SH, 2016, CANCER RES, V76, P3838, DOI 10.1158/0008-5472.CAN-15-2841
   Zhou M, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00501
NR 72
TC 8
Z9 8
U1 0
U2 7
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
EI 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD JUL 24
PY 2023
VL 8
IS 14
AR e165937
DI 10.1172/jci.insight.165937
PG 21
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA N9VT0
UT WOS:001040409700001
PM 37289546
OA gold
DA 2024-11-01
ER

PT J
AU Polisecki, EY
   Schreier, LE
   Ravioli, J
   Corach, D
AF Polisecki, EY
   Schreier, LE
   Ravioli, J
   Corach, D
TI Common mitochondrial DNA deletion associated with sudden natural death
   in adults
SO JOURNAL OF FORENSIC SCIENCES
LA English
DT Article
DE forensic science; sudden natural death; mitochondrial DNA; 4977 bp
   mitochondrial DNA deletion; aging
ID OXIDATIVE STRESS; CARDIAC DEATH; TISSUES; DISEASE; AUTOPSY; DAMAGE;
   CARDIOMYOPATHIES; POPULATION; MUTATIONS; INCREASE
AB One of the most frequent causes of death in developed countries is sudden natural death (SND), which is the most common indication for medico-legal autopsies. Cardiac diseases are frequently detected among SND. Mitochondrial DNA (mtDNA) is easily damaged by reactive oxygen species, and it may cause dysfunction in tissues, leading to early events in cardiovascular disease. A specific mtDNA deletion of 4977 bp is associated to aging, myocardial dysfunction, and bioenergetic deficit. The potential link between mtDNA damage and SND has not been investigated before. Our aim was to evaluate the accumulation of the common mtDNA4977-deletion in cardiac muscle samples from autopsies of SND in adults (n = 14) in comparison to control samples from unnatural deaths (n = 12). Serial dilution-polymerase chain reaction method was performed to estimate the proportion of the total mtDNA harboring the mtDNA4977-deletion. Coefficient variation intra-assay was 8%, and inter-assay was 12%. MtDNA4977-deletion percentage was higher in samples obtained from victims of SND than in those from subjects who died of unnatural causes (p < 0.05). No differences in mtDNA4977-deletion were found between SND victims 39-51 years old, and no correlation was found between these samples and age, r = 0.30, p = 0.29 while it was significant among control samples, r = 0.68, p < 0.05. The association between mtDNA4977 deletion with SND victims might offer a tool to provide additional information to clarify complex SND investigations.
C1 Univ Buenos Aires, Serv Huellas Digitales Genet, Fac Farm & Bioquim, Catedra Genet & Biol Mol, Buenos Aires, DF, Argentina.
   Univ Buenos Aires, Dept Bioquim Clin, Fac Farm & Bioquim, Buenos Aires, DF, Argentina.
   Univ Buenos Aires, Fac Med, Catedra Med Legal, Buenos Aires, DF, Argentina.
C3 University of Buenos Aires; University of Buenos Aires; University of
   Buenos Aires
RP Corach, D (corresponding author), Univ Buenos Aires, Serv Huellas Digitales Genet, Fac Farm & Bioquim, Catedra Genet & Biol Mol, Junin 956,C113AAD, Buenos Aires, DF, Argentina.
OI Corach, Daniel/0000-0002-0662-7424
CR Aizaki T, 1997, JPN CIRC J, V61, P1004, DOI 10.1253/jcj.61.1004
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Antozzi C, 1997, CARDIOVASC RES, V35, P184, DOI 10.1016/S0008-6363(97)00141-7
   Ballinger SW, 2002, CIRCULATION, V106, P544, DOI 10.1161/01.CIR.0000023921.93743.89
   Berdanier CD, 2001, MUTAT RES-FUND MOL M, V475, P169, DOI 10.1016/S0027-5107(01)00068-9
   Bogliolo M, 1999, MUTAGENESIS, V14, P77, DOI 10.1093/mutage/14.1.77
   CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   DIMAIO VJM, 1991, J FORENSIC SCI, V36, P17
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Doolan A, 2004, MED J AUSTRALIA, V180, P110, DOI 10.5694/j.1326-5377.2004.tb05830.x
   Escoffery CT, 2002, FORENSIC SCI INT, V129, P116, DOI 10.1016/S0379-0738(02)00268-2
   HIRSCH CS, 1984, ARCH PATHOL LAB MED, V108, P484
   KANNEL WB, 1990, CAN J CARDIOL, V6, P439
   Knight-Lozano CA, 2002, CIRCULATION, V105, P849, DOI 10.1161/hc0702.103977
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   Levitsky S, 2003, EUR J CARDIO-THORAC, V24, P777, DOI 10.1016/S1010-7940(03)00501-3
   Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268
   Porteous WK, 1998, EUR J BIOCHEM, V257, P192, DOI 10.1046/j.1432-1327.1998.2570192.x
   Ruppert V, 2000, HERZ, V25, P161, DOI 10.1007/s000590050002
   SHEN WK, 1995, AM J CARDIOL, V76, P148, DOI 10.1016/S0002-9149(99)80047-2
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Tang YY, 2000, MOL BIOL CELL, V11, P1471, DOI 10.1091/mbc.11.4.1471
   Wei YH, 1998, P SOC EXP BIOL MED, V217, P53
   World Health Organization, 1992, MAN INT STAT CLASS D, V1
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
NR 27
TC 7
Z9 8
U1 0
U2 0
PU AMER SOC TESTING MATERIALS
PI W CONSHOHOCKEN
PA 100 BARR HARBOR DR, W CONSHOHOCKEN, PA 19428-2959 USA
SN 0022-1198
J9 J FORENSIC SCI
JI J. Forensic Sci.
PD NOV
PY 2004
VL 49
IS 6
BP 1335
EP 1338
PG 4
WC Medicine, Legal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Legal Medicine
GA 868IY
UT WOS:000224908500026
PM 15568709
DA 2024-11-01
ER

PT J
AU Jackson, CB
   Neuwirth, C
   Hahn, D
   Nuoffer, JM
   Frank, S
   Gallati, S
   Schaller, A
AF Jackson, Christopher B.
   Neuwirth, Christoph
   Hahn, Dagmar
   Nuoffer, J-M
   Frank, Stephan
   Gallati, Sabina
   Schaller, Andre
TI Novel mitochondrial tRNA<SUP>Ile</SUP> m. 4282A&gt;G gene mutation leads
   to chronic progressive external ophthalmoplegia plus phenotype
SO BRITISH JOURNAL OF OPHTHALMOLOGY
LA English
DT Article
ID TRANSFER-RNA ISOLEUCINE; DNA POINT MUTATION; MTDNA MUTATION; DISEASE;
   DATABASE; PATIENT
AB Background/aim To investigate the underlying pathomechanism in a 33-year-old female Caucasian patient presenting with chronic progressive external ophthalmoplegia (CPEO) plus symptoms.
   Methods Histochemical anaylsis of skeletal muscle and biochemical measurements of individual oxidative phosphorylation (OXPHOS) complexes. Genetic analysis of mitochondrial DNA in various tissues with subsequent investigation of single muscle fibres for correlation of mutational load.
   Results The patient's skeletal muscle showed 20% of cytochrome c oxidase-negative fibres and 8% ragged-red fibres. Genetic analysis of the mitochondrial DNA revealed a novel point mutation in the mitochondrial tRNA(Ile) (MTTI) gene at position m. 4282G> A. The heteroplasmy was determined in blood, buccal cells and muscle by restriction fragment length polymorphism (RFLP) combined with a last fluorescent cycle. The total mutational load was 38% in skeletal muscle, but was not detectable in blood or buccal cells of the patient. The phenotype segregated with the mutational load as determined by analysis of single cytochrome c oxidasenegative/ positive fibres by laser capture microdissection and subsequent LFC-RFLP.
   Conclusions We describe a novel MTTI transition mutation at nucleotide position m. 4282G> A associated with a CPEO plus phenotype. The novel variant at position m. 4282G> A disrupts the middle bond of the D-stem of the tRNA(Ile) and is highly conserved. The conservation and phenotype-genotype segregation strongly suggest pathogenicity and is in good agreement with the MTTI gene being frequently associated with CPEO. This novel variant broadens the spectrum of MTTI mutations causing CPEO.
C1 [Jackson, Christopher B.; Gallati, Sabina; Schaller, Andre] Univ Bern, Inselspital, Div Human Genet, Dept Pediat, CH-3010 Bern, Switzerland.
   [Jackson, Christopher B.; Gallati, Sabina; Schaller, Andre] Univ Bern, Inselspital, Div Human Genet, Dept Clin Res, CH-3010 Bern, Switzerland.
   [Jackson, Christopher B.; Hahn, Dagmar; Nuoffer, J-M] Univ Bern, Inselspital, Inst Clin Chem, CH-3010 Bern, Switzerland.
   [Jackson, Christopher B.] Univ Bern, Grad Sch Cellular & Biomed Sci, CH-3010 Bern, Switzerland.
   [Neuwirth, Christoph] Cantonal Hosp St Gallen, Neuromuscular Dis Ctr, St Gallen, Switzerland.
   [Frank, Stephan] Basle Univ Hosp, Inst Pathol, Div Neuropathol, Basel, Switzerland.
C3 University of Bern; University Hospital of Bern; University of Bern;
   University Hospital of Bern; University of Bern; University Hospital of
   Bern; University of Bern; Kantonsspital St. Gallen
RP Schaller, A (corresponding author), Univ Bern, Inselspital, Div Human Genet, Dept Pediat, Freiburgstr, CH-3010 Bern, Switzerland.
EM andre.schaller@insel.ch
RI Neuwirth, Christoph/AAE-2211-2020; Schaller, Andre/L-4174-2018; Nuoffer,
   Jean-Marc/C-8936-2009; Jackson, Christopher B./M-3222-2013
OI Schaller, Andre/0000-0001-5174-5764; Nuoffer,
   Jean-Marc/0000-0003-3650-6153; Jackson, Christopher
   B./0000-0003-1035-6417
FU Novartis Foundation for medical biological research; Vinetum Foundation;
   Gottfried and Julia Bangerter Foundation
FX This work was supported by grants of the Novartis Foundation for medical
   biological research (to AS), the Vinetum Foundation (to AS) and the
   Gottfried and Julia Bangerter Foundation (to SG).
CR Al-Dosary M, 2009, NEUROMUSCULAR DISORD, V19, P841, DOI 10.1016/j.nmd.2009.10.001
   Berardo A, 2010, NEUROMUSCULAR DISORD, V20, P204, DOI 10.1016/j.nmd.2010.01.006
   Borthwick Gillian M, 2006, Ann Neurol, V59, P570, DOI 10.1002/ana.20758
   Campos Y, 2002, MUSCLE NERVE, V25, P185, DOI 10.1002/mus.10012.abs
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chinnery PF, 1997, NEUROLOGY, V49, P1166, DOI 10.1212/WNL.49.4.1166
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   Cox R, 2012, MITOCHONDRION, V12, P258, DOI 10.1016/j.mito.2011.09.006
   Elson JL, 2009, HUM MUTAT, V30, pE984, DOI 10.1002/humu.21113
   Emmanuele V, 2011, J NEUROL SCI, V303, P39, DOI 10.1016/j.jns.2011.01.018
   Kleinle S, 1997, HUM GENET, V100, P643, DOI 10.1007/s004390050567
   Kleinle S, 1998, BIOCHEM BIOPH RES CO, V247, P112, DOI 10.1006/bbrc.1998.8729
   Kogelnik AM, 1996, NUCLEIC ACIDS RES, V24, P177, DOI 10.1093/nar/24.1.177
   Liechti-Gallati S, 1999, EUR J HUM GENET, V7, P590, DOI 10.1038/sj.ejhg.5200338
   Pütz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Schaller A, 2011, MITOCHONDRION, V11, P488, DOI 10.1016/j.mito.2011.01.005
   Schaller A, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-4
   SHEPHERD D, 1969, BIOCHEM J, V114, P597, DOI 10.1042/bj1140597
   Silvestri G, 1996, BIOCHEM BIOPH RES CO, V220, P623, DOI 10.1006/bbrc.1996.0453
   Sissler M, 2008, METHODS, V44, P176, DOI 10.1016/j.ymeth.2007.11.002
   Taylor RW, 1998, BIOCHEM BIOPH RES CO, V243, P47, DOI 10.1006/bbrc.1997.8055
   Valentino ML, 2002, ANN NEUROL, V51, P774, DOI 10.1002/ana.10193
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
NR 25
TC 7
Z9 8
U1 0
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0007-1161
EI 1468-2079
J9 BRIT J OPHTHALMOL
JI Br. J. Ophthalmol.
PD OCT
PY 2014
VL 98
IS 10
BP 1453
EP 1459
DI 10.1136/bjophthalmol-2014-305300
PG 7
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA AQ3HF
UT WOS:000342681400031
PM 25034047
DA 2024-11-01
ER

PT J
AU Copeland, WC
AF Copeland, William C.
TI Defects of Mitochondrial DNA Replication
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE Alpers syndrome; ataxia-neuropathy; DNA polymerase; mitochondrial DNA
   depletion syndrome; mitochondrial DNA replication; POLG; progressive
   external ophthalmoplegia
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; RECESSIVE TWINKLE MUTATIONS;
   POLYMERASE-GAMMA; MULTIPLE DELETIONS; ACCESSORY SUBUNIT; DISEASE
   MUTATIONS; POLG MUTATIONS; SACCHAROMYCES-CEREVISIAE; EXONUCLEASE
   ACTIVITY; PHENOTYPIC SPECTRUM
AB Mitochondrial DNA is replicated by DNA polymerase in concert with accessory proteins such as the mitochondrial DNA helicase, single-stranded DNA binding protein, topoisomerase, and initiating factors. Defects in mitochondrial DNA replication or nucleotide metabolism can cause mitochondrial genetic diseases due to mitochondrial DNA deletions, point mutations, or depletion, which ultimately cause loss of oxidative phosphorylation. These genetic diseases include mitochondrial DNA depletion syndromes such as Alpers or early infantile hepatocerebral syndromes, and mitochondrial DNA deletion disorders, such as progressive external ophthalmoplegia, ataxia-neuropathy, or mitochondrial neurogastrointestinal encephalomyopathy. This review focuses on our current knowledge of genetic defects of mitochondrial DNA replication (POLG, POLG2, C10orf2, and MGME1) that cause instability of mitochondrial DNA and mitochondrial disease.
C1 NIEHS, Mol Genet Lab, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS)
RP Copeland, WC (corresponding author), NIEHS, Mol Genet Lab, POB 12233, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
RI Copeland, William/C-4242-2019
OI Copeland, William/0000-0002-0359-0953
FU National Institute of Environmental Health Sciences, National Institutes
   of Health [ES 065078, ES 065080]; National Institute of Neurological
   Disorders and Stroke [R13NS04925]
FX The author disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: This work was
   supported by intramural funds from the National Institute of
   Environmental Health Sciences, National Institutes of Health (ES 065078
   and ES 065080), and the National Institute of Neurological Disorders and
   Stroke (R13NS04925).
CR Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Cohen BH, 1997, POLG RELATED DISORDE
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Craig K, 2012, MITOCHONDRION, V12, P313, DOI 10.1016/j.mito.2011.11.006
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fan L, 1999, P NATL ACAD SCI USA, V96, P9527, DOI 10.1073/pnas.96.17.9527
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Stumpf JD, 2013, GENETICS, V194, P519, DOI 10.1534/genetics.113.150920
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 78
TC 37
Z9 43
U1 2
U2 53
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD SEP
PY 2014
VL 29
IS 9
SI SI
BP 1216
EP 1224
DI 10.1177/0883073814537380
PG 9
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA AP1FK
UT WOS:000341812400014
PM 24985751
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Ghirigato, E
   Terenzi, F
   Baglivo, M
   Zanetti, N
   Baldo, F
   Murru, FM
   Bobbo, M
   Barbi, E
   Zeviani, M
   Bruno, I
   Lamantea, E
AF Ghirigato, Elena
   Terenzi, Francesca
   Baglivo, Mirko
   Zanetti, Nadia
   Baldo, Francesco
   Murru, Flora Maria
   Bobbo, Marco
   Barbi, Egidio
   Zeviani, Massimo
   Bruno, Irene
   Lamantea, Eleonora
TI A new family with a case of severe early-onset muscle fatigue and a
   peculiar maternally inherited painful swelling in chewing muscles
   associated with homoplasmic m.15992A &gt; T mutation in mitochondrial
   tRNA<SUP>Pro</SUP>
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondrial tRNA; Masseter muscle swelling; Mitochondrial myopathy;
   MT-TP
ID POINT MUTATIONS; GENE; MYOPATHY; PATIENT
AB A 16-year-old boy was evaluated for a history of exercise-induced fatigability associated with nausea even after minimal effort, lower limbs muscle hypotrophy, and swelling of the masseter muscles after chewing. Laboratory tests were remarkable for hyperlactatemia and metabolic acidosis after short physical activity. The muscle biopsy showed non-specific mitochondrial alterations and an increase in intrafibral lipids. Biochemical analysis showed reduced activity of the respiratory chain complexes. Mitochondrial DNA sequencing revealed the presence of a homoplasmic variant m.15992A > T in the MT-TP gene, coding for the mt-tRNA(Pro) in the patient, in his mother and in his brother. Pathogenic or likely pathogenic variants in MT-TP gene are rare. They are responsible for different clinical presentation, almost ever involving the muscle tissue. We report the first family with exercise-induced muscle weakness and swelling of the chewing muscles due to m.15992A > T variant in absence of J1c10 haplogroup, confirming its pathogenicity.(c) 2023 Elsevier B.V. All rights reserved.
C1 [Ghirigato, Elena; Terenzi, Francesca; Barbi, Egidio] Univ Trieste, Trieste, Italy.
   [Baglivo, Mirko; Zanetti, Nadia; Lamantea, Eleonora] Fdn IRCCS Ist Neurol Carlo Besta, Unit Med Genet & Neurogenet, Milan, Italy.
   [Baldo, Francesco; Murru, Flora Maria; Bobbo, Marco; Barbi, Egidio; Zeviani, Massimo; Bruno, Irene] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
   [Baldo, Francesco] Via Istria 65-1, I-34137 Trieste, Italy.
C3 University of Trieste; Fondazione IRCCS Istituto Neurologico Carlo
   Besta; IRCCS Burlo Garofolo
RP Baldo, F (corresponding author), Via Istria 65-1, I-34137 Trieste, Italy.
EM francesco.baldo@burlo.trieste.it
RI Zeviani, Massimo/AAU-2632-2021; Lamantea, Eleonora/J-8339-2016; Barbi,
   Egidio/K-4016-2018; Zanetti, Nadia/AAK-4682-2021
OI Baldo, Francesco/0000-0002-7523-3154
FU Mariani Foundation; ERA PerMed project PerMiM (Italian Ministry of
   Health) [ERP-2019-23671048]; Ministry of Health , Rome - Italy;
   Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste -
   Italy
FX The biochemical and molecular studies were carried out at the Center for
   the Study of Mitochondrial Pediatric Diseases funded by the Mariani
   Foundation. M.B. is supported by ERA PerMed project PerMiM (Italian
   Ministry of Health ERP-2019-23671048).This work was supported by the
   Ministry of Health , Rome - Italy, in collaboration with the Institute
   for Maternal and Child Health IRCCS Burlo Garofolo, Trieste - Italy.
CR Auré K, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000480
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Blakely EL, 2009, ARCH NEUROL-CHICAGO, V66, P399, DOI 10.1001/archneurol.2008.576
   Da Pozzo P, 2009, EUR J HUM GENET, V17, P1092, DOI 10.1038/ejhg.2009.12
   de Barcelos IP, 2019, CURR OPIN NEUROL, V32, P715, DOI 10.1097/WCO.0000000000000743
   Grasbon-Frodl EM, 1999, NEUROGENETICS, V2, P121, DOI 10.1007/s100480050063
   Guo H, 2022, AM J HYPERTENS, V35, P96, DOI 10.1093/ajh/hpab123
   Gyimesi G, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10121611
   Hardy SA, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000082
   Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001
   IONASESCU VV, 1994, NEUROLOGY, V44, P975, DOI 10.1212/WNL.44.5.975
   Joshi PR, 2020, NEUROMUSCULAR DISORD, V30, P346, DOI 10.1016/j.nmd.2020.02.020
   Legati A, 2021, J MOL DIAGN, V23, P732, DOI 10.1016/j.jmoldx.2021.03.002
   Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44
   Mayr JA, 2011, NEUROMUSCULAR DISORD, V21, P803, DOI 10.1016/j.nmd.2011.06.005
   McCann C, 2022, FRONT MOL BIOSCI, V9, DOI 10.3389/fmolb.2022.1037941
   MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284
   Morel G, 2016, NEUROMUSCULAR DISORD, V26, P885, DOI 10.1016/j.nmd.2016.09.012
   Rusu MC, 2019, ANN ANAT, V224, P117, DOI 10.1016/j.aanat.2019.05.006
   Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917
   Seneca S, 2000, J INHERIT METAB DIS, V23, P853, DOI 10.1023/A:1026729223050
   Simon MT, 2017, MITOCHONDRION, V34, P84, DOI 10.1016/j.mito.2017.02.004
   Cardena MMSG, 2013, MITOCHONDR DNA, V24, P46, DOI 10.3109/19401736.2012.717933
   Sonney S, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005867
   Wong LJC, 2020, GENET MED, DOI 10.1038/s41436-019-0746-0
   Wong LJC, 2002, AM J MED GENET, V113, P59, DOI 10.1002/ajmg.10767
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
NR 28
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD DEC
PY 2023
VL 33
IS 12
BP 972
EP 977
DI 10.1016/j.nmd.2023.11.001
EA DEC 2023
PG 6
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA EC9D3
UT WOS:001136824200001
PM 38030461
DA 2024-11-01
ER

PT J
AU Fan, WW
   Waymire, KG
   Narula, N
   Li, P
   Rocher, C
   Coskun, PE
   Vannan, MA
   Narula, J
   MacGregor, GR
   Wallace, DC
AF Fan, Weiwei
   Waymire, Katrina G.
   Narula, Navneet
   Li, Peng
   Rocher, Christophe
   Coskun, Pinar E.
   Vannan, Mani A.
   Narula, Jagat
   MacGregor, Grant R.
   Wallace, Douglas C.
TI A mouse model of mitochondrial disease reveals germline selection
   against severe mtDNA mutations
SO SCIENCE
LA English
DT Article
ID FOLLICLE-STIMULATING-HORMONE; ADAPTIVE SELECTION; APOPTOSIS; GENE; DNA
AB The majority of mitochondrial DNA ( mtDNA) mutations that cause human disease are mild to moderately deleterious, yet many random mtDNA mutations would be expected to be severe. To determine the fate of the more severe mtDNA mutations, we introduced mtDNAs containing two mutations that affect oxidative phosphorylation into the female mouse germ line. The severe ND6 mutation was selectively eliminated during oogenesis within four generations, whereas the milder COI mutation was retained throughout multiple generations even though the offspring consistently developed mitochondrial myopathy and cardiomyopathy. Thus, severe mtDNA mutations appear to be selectively eliminated from the female germ line, thereby minimizing their impact on population fitness.
C1 [Fan, Weiwei; Waymire, Katrina G.; Rocher, Christophe; Coskun, Pinar E.; MacGregor, Grant R.; Wallace, Douglas C.] Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA.
   [Fan, Weiwei; Waymire, Katrina G.; Rocher, Christophe; Coskun, Pinar E.; Wallace, Douglas C.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA.
   [Narula, Navneet] Univ Calif Irvine, Dept Pathol, Irvine, CA 92697 USA.
   [Li, Peng; Vannan, Mani A.; Narula, Jagat] Univ Calif Irvine, Div Cardiol, Dept Med, Irvine, CA 92697 USA.
   [MacGregor, Grant R.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA.
   [MacGregor, Grant R.] Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92697 USA.
   [Wallace, Douglas C.] Univ Calif Irvine, Dept Ecol & Evolut Biol, Irvine, CA 92697 USA.
   [Wallace, Douglas C.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA.
C3 University of California System; University of California Irvine;
   University of California System; University of California Irvine;
   University of California System; University of California Irvine;
   University of California System; University of California Irvine;
   University of California System; University of California Irvine;
   University of California System; University of California Irvine;
   University of California System; University of California Irvine;
   University of California System; University of California Irvine
RP Wallace, DC (corresponding author), Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA.
EM dwallace@uci.edu
RI Rocher, Christophe/JYP-4475-2024; Vannan, Mani/AAQ-5992-2020; Fan,
   Weiwei/B-3782-2010; peng, li/AAJ-5708-2021
OI Rocher, Christophe/0000-0003-1859-9704; li, peng/0000-0003-2030-1807
FU NIA NIH HHS [AG24373, AG13154, AG16573] Funding Source: Medline; NICHD
   NIH HHS [U01 HD045913-03, U01 HD045913-02, HD45913, U01 HD045913-01, U01
   HD045913-04] Funding Source: Medline; NIDDK NIH HHS [DK73691] Funding
   Source: Medline; NINDS NIH HHS [NS21328] Funding Source: Medline
CR Acín-Pérez R, 2003, HUM MOL GENET, V12, P329, DOI 10.1093/hmg/ddg021
   Bai YD, 1998, EMBO J, V17, P4848, DOI 10.1093/emboj/17.16.4848
   Hussein MR, 2005, HUM REPROD UPDATE, V11, P162, DOI 10.1093/humupd/dmi001
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Kasahara A, 2006, HUM MOL GENET, V15, P871, DOI 10.1093/hmg/ddl005
   Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229
   Levy SE, 1999, TRANSGENIC RES, V8, P137, DOI 10.1023/A:1008967412955
   MacGregor GR., 2006, EMBRYONIC STEM CELLS, P72
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597
   TILLY JL, 1995, ENDOCRINOLOGY, V136, P242, DOI 10.1210/en.136.1.242
   Trounce I, 1996, SOMAT CELL MOLEC GEN, V22, P81, DOI 10.1007/BF02374379
   Tsai-Turton M, 2006, ENDOCRINOLOGY, V147, P1224, DOI 10.1210/en.2005-1281
   Wallace D.C., 2007, Emery and Rimoin's Principles and Practice of Medical Genetics, V5th, P194
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955
NR 19
TC 343
Z9 389
U1 1
U2 24
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD FEB 15
PY 2008
VL 319
IS 5865
BP 958
EP 962
DI 10.1126/science.1147786
PG 5
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 262RM
UT WOS:000253165700048
PM 18276892
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Steriade, C
   Andrade, DM
   Faghfoury, H
   Tarnopolsky, MA
   Tai, P
AF Steriade, Claude
   Andrade, Danielle M.
   Faghfoury, Hanna
   Tarnopolsky, Mark A.
   Tai, Peter
TI Mitochondrial Encephalopathy With Lactic Acidosis and Stroke-like
   Episodes (MELAS) May Respond to Adjunctive Ketogenic Diet
SO PEDIATRIC NEUROLOGY
LA English
DT Article
DE MELAS; status epilepticus; ketogenic diet; magnesium; refractory
   seizures; respiratory chain complexes
ID COMPLEX-I DEFICIENCY; MUTATION; EPILEPSY; MYOPATHY; DNA
AB BACKGROUND: Mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) syndrome can present management challenges. Refractory seizures and stroke-like episodes leading to disability are common.
   PATIENT: We analyzed the clinical, electrophysiologic, and radiologic data of a 22-year-old woman with multiple episodes of generalized and focal status epilepticus and migratory cortical stroke-like lesions who underwent muscle biopsy for mitochondrial genome sequencing.
   RESULTS: Although initial mitochondrial genetic testing was negative, muscle biopsy demonstrated a mitochondrial DNA disease-causing mutation (m.3260A > G). New antiepileptic medications were added with each episode of focal status epilepticus with only temporary improvement, until a modified ketogenic diet and magnesium were introduced, leading to seizure freedom despite development of a new stroke-like lesion, and subsequent decrease in frequency of stroke-like episodes. We propose a metabolic model in which the ketogenic diet may lead to improvement of the function of respiratory chain complexes.
   CONCLUSIONS: The ketogenic diet may lead to improvement of mitochondrial dysfunction in MELAS, which in turn may promote better seizure control and less frequent stroke-like episodes.
C1 [Steriade, Claude; Andrade, Danielle M.; Tai, Peter] Univ Toronto, Toronto Western Hosp, Dept Med, Div Neurol, Toronto, ON M5T 2S8, Canada.
   [Faghfoury, Hanna] Univ Toronto, Univ Hlth Network, Dept Med, Div Clin & Metab Genet, Toronto, ON, Canada.
   [Tarnopolsky, Mark A.] McMaster Univ, Med Ctr, Dept Neuromuscular & Neurometab Dis, Hamilton, ON, Canada.
C3 University of Toronto; University Health Network Toronto; University of
   Toronto; University Health Network Toronto; McMaster University
RP Steriade, C (corresponding author), Toronto Western Hosp, Dept Med, Div Neurol, 399 Bathurst St,5th Floor,West Wing,Room 446, Toronto, ON M5T 2S8, Canada.
EM claude.steriade@mail.mcgill.ca
OI Andrade, Danielle/0000-0003-0953-2698; Steriade,
   Claude/0000-0001-6799-9005
CR Connolly BS, 2010, BIOCHEM BIOPH RES CO, V402, P443, DOI 10.1016/j.bbrc.2010.10.060
   Fornuskova D, 2008, BBA-MOL BASIS DIS, V1782, P317, DOI 10.1016/j.bbadis.2008.02.001
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hirano M, 1997, EPILEPSY COMPREHENSI
   Kang HC, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2006.00906.x
   Kossoff EH, 2008, EPILEPSIA, V49, P316, DOI 10.1111/j.1528-1167.2007.01256.x
   Levy RG, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001903.pub2, 10.1002/14651858.CD001903.pub3]
   Majamaa K, 1997, MOL CELL BIOCHEM, V174, P291, DOI 10.1023/A:1006833200371
   Martikainen MH, 2012, EPILEPTIC DISORD, V14, P438, DOI 10.1684/epd.2012.0543
   Nishino I, 1996, MUSCLE NERVE, V19, P1603, DOI 10.1002/(SICI)1097-4598(199612)19:12<1603::AID-MUS10>3.0.CO;2-S
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Roef MJ, 2002, AM J CLIN NUTR, V75, P228, DOI 10.1093/ajcn/75.2.228
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945
   ZEVIANI M, 1995, MUSCLE NERVE, pS170
NR 16
TC 59
Z9 64
U1 0
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD MAY
PY 2014
VL 50
IS 5
BP 498
EP 502
DI 10.1016/j.pediatrneurol.2014.01.009
PG 5
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA AG9CZ
UT WOS:000335717600012
PM 24656211
DA 2024-11-01
ER

PT J
AU Wang, S
   Song, T
   Wang, SP
AF Wang, Shuai
   Song, Tao
   Wang, Suping
TI Mitochondrial DNA 10158T&gt;C mutation in a patient with mitochondrial
   encephalomyopathy with lactic acidosis, and stroke-like episodes
   syndrome A case-report and literature review (CARE-complaint)
SO MEDICINE
LA English
DT Review
DE M.10158T > C mutation; mitochondrial encephalomyopathy with lactic
   acidosis; and stroke-like episodes; mitochondrial disorder
ID MELAS; ENCEPHALOPATHY; MYOPATHY; GENE; MANIFESTATIONS; DISEASE
AB Rationale: Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) syndrome is caused by mitochondrial respiratory chain dysfunction and oxidative phosphorylation disorder. It is a rare clinical metabolic disease involved with multiple systems.
   Patient concerns: A 22-year-old patient presented with limb convulsion accompanied by loss of consciousness, headache, partial blindness, blurred vision, and so on.
   Diagnoses: Brain magnetic resonance imaging showed a high-intensity area in bilateral occipital cortex, left parietal lobe and cerebellum on diffusion-weighted imaging. These focus did not distribute as vascular territory. The pathological examination of skeletal muscle revealed several succinate dehydrogenase reactive vessels with overreaction and increased content of lipid droplets in some muscle fibers. Genetic testing showed that the patient carried m.10158T>C mutation.
   Interventions: She was provided with traditional arginine hydrochloride therapy and orally medication of coenzyme Q (10 mg).
   Outcomes: Mitochondrial DNA of blood and hair follicle of patient carried m.10158T>C mutation
   Lessons: For the suspected patients of MELAS syndrome, if the hot-spot mutation test is negative, more detection sites should be selected.
C1 [Wang, Shuai; Song, Tao; Wang, Suping] Third Peoples Hosp Qingdao, Dept Neurol Rehabil, 29 Yongping Rd, Qingdao 266041, Peoples R China.
RP Wang, SP (corresponding author), Third Peoples Hosp Qingdao, Dept Neurol Rehabil, 29 Yongping Rd, Qingdao 266041, Peoples R China.
EM supingwangqd@sina.com
RI Wang, Anxin/AAD-4073-2021
CR El-Hattab AW, 2017, J NUTR, V147, P1251, DOI 10.3945/jn.117.248435
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   El-Hattab AW, 2014, MITOCHONDRION, V18, P63, DOI 10.1016/j.mito.2014.07.008
   Finsterer J, 2015, J CHILD NEUROL, V30, P1553, DOI 10.1177/0883073814567539
   Goodfellow JA, 2012, POSTGRAD MED J, V88, P326, DOI 10.1136/postgradmedj-2011-130326
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grosso S, 2017, BRAIN DEV-JPN, V39, P261, DOI 10.1016/j.braindev.2016.09.013
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Kondo H, 2018, PEDIATR INT, V60, P300, DOI 10.1111/ped.13472
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Mukai M, 2015, NEUROL CLIN NEUROSCI, V3, P153, DOI 10.1111/ncn3.173
   Mukai M, 2017, INTERNAL MED, V56, P95, DOI 10.2169/internalmedicine.56.7301
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Tarnopolsky MA, 2008, ADV DRUG DELIVER REV, V60, P1561, DOI 10.1016/j.addr.2008.05.001
   Tzoulis C, 2009, STROKE, V40, pE15, DOI 10.1161/STROKEAHA.108.523118
   Vandana VP, 2016, CLIN NEUROL NEUROSUR, V148, P17, DOI 10.1016/j.clineuro.2016.04.024
   Vodopivec I, 2016, NEUROLOGIST, V21, P61, DOI 10.1097/NRL.0000000000000084
NR 19
TC 4
Z9 5
U1 1
U2 10
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD JUN
PY 2020
VL 99
IS 24
AR e20310
DI 10.1097/MD.0000000000020310
PG 6
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA MM0WU
UT WOS:000549881200009
PM 32541454
OA Green Published, gold
DA 2024-11-01
ER

PT S
AU Deschauer, M
   Zierz, S
AF Deschauer, Marcus
   Zierz, Stephan
BE Lorenz, B
   Borruat, FX
TI Chronic Progressive External Ophthalmoplegia - A Common Ocular
   Manifestation of Mitochondrial Disorders
SO PEDIATRIC OPHTHALMOLOGY, NEURO-OPHTHALMOLOGY, GENETICS
SE Essentials in Ophthalmology
LA English
DT Article; Book Chapter
ID PROBABLE GERMLINE MOSAICISM; KEARNS-SAYRE-SYNDROME; DNA DELETIONS; GENE
   MUTATION; RETINAL MANIFESTATIONS; MUSCULAR-DYSTROPHY; MYASTHENIA-GRAVIS;
   A3243G MUTATION; MTDNA DELETIONS; HEARING-LOSS
C1 [Deschauer, Marcus] Univ Halle Wittenberg, Neurol Klin, D-06097 Halle, Germany.
   [Zierz, Stephan] Neurol Univ Klin, D-06120 Halle, Saale, Germany.
C3 Martin Luther University Halle Wittenberg; Martin Luther University
   Halle Wittenberg
RP Deschauer, M (corresponding author), Univ Halle Wittenberg, Neurol Klin, Ernst Grube Str 40, D-06097 Halle, Germany.
CR Andrews RM, 1999, EYE, V13, P769, DOI 10.1038/eye.1999.225
   Baker SK, 2003, EXPERT OPIN INV DRUG, V12, P1655, DOI 10.1517/eoid.12.10.1655.21840
   Bau V, 2005, STRABISMUS, V13, P133, DOI 10.1080/09273970500216432
   BEYENBURG S, 1993, ACTA NEUROL SCAND, V87, P397
   Brown DT, 2006, LANCET, V368, P87, DOI 10.1016/S0140-6736(06)68972-1
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Deschauer M, 2004, GENET TEST, V8, P395, DOI 10.1089/gte.2004.8.395
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Deschauer M, 2001, ARCH NEUROL-CHICAGO, V58, P1885, DOI 10.1001/archneur.58.11.1885
   Deschauer M, 2000, MOL GENET METAB, V70, P235, DOI 10.1006/mgme.2000.3002
   DiMauro S, 2007, J CLIN INVEST, V117, P587, DOI 10.1172/JCI31423
   Gamez J, 2002, NEUROLOGY, V59, P455, DOI 10.1212/WNL.59.3.455
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   GOETHEM GV, 2001, NAT GENET, V28, P211
   Hanisch E, 2005, EUR J MED RES, V10, P366
   Hanisch F, 2006, J NEUROL, V253, P417, DOI 10.1007/s00415-006-0987-0
   Hanisch F, 2006, J NEUROL, V253, P659, DOI 10.1007/s00415-005-0032-8
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, NEUROLOGY, V66, P1439, DOI 10.1212/01.wnl.0000210486.32196.24
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Isashiki Y, 1998, ACTA OPHTHALMOL SCAN, V76, P6, DOI 10.1034/j.1600-0420.1998.760103.x
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Jones KJ, 1997, NEUROMUSCULAR DISORD, V7, P143, DOI 10.1016/S0960-8966(97)00447-1
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KAWAI H, 1995, MUSCLE NERVEL, V8, P753
   Kornblum C, 2001, NEUROLOGY, V56, P1409, DOI 10.1212/WNL.56.10.1409
   Krasnianski M, 2004, NEUROMUSCULAR DISORD, V14, P438, DOI 10.1016/j.nmd.2004.03.007
   Krasnianski M, 2003, ARCH NEUROL-CHICAGO, V60, P1421, DOI 10.1001/archneur.60.10.1421
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Müller JS, 2007, BRAIN, V130, P1497, DOI 10.1093/brain/awm068
   Müller T, 2006, J NEUROL, V253, P892, DOI 10.1007/s00415-006-0126-y
   Müller T, 2005, ACTA NEUROPATHOL, V110, P426, DOI 10.1007/s00401-005-1063-z
   MULLIE MA, 1985, ARCH OPHTHALMOL-CHIC, V103, P1825, DOI 10.1001/archopht.1985.01050120059020
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   NITSCH J, 1990, Z KARDIOL, V79, P60
   Pineda M, 2006, ANN NEUROL, V59, P394, DOI 10.1002/ana.20746
   Remes AM, 2005, NEUROLOGY, V64, P976, DOI 10.1212/01.WNL.0000154518.31302.ED
   Richardson C, 2005, EYE, V19, P258, DOI 10.1038/sj.eye.6701488
   Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102
   SATOYOSHI E, 1977, ARCH NEUROL-CHICAGO, V34, P89, DOI 10.1001/archneur.1977.00500140043007
   Shipton EA, 2004, EUR J ANAESTH, V21, P173, DOI 10.1017/S0265021504003023
   Sinnathuray AR, 2003, OTOL NEUROTOL, V24, P418, DOI 10.1097/00129492-200305000-00012
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Swalwell H, 2006, NEUROLOGY, V66, P447, DOI 10.1212/01.wnl.0000196490.36349.83
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Walker M, 2005, DIABETIC MED, V22, P18, DOI 10.1111/j.1464-5491.2005.1761f.x
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DK, 1997, OPHTHALMOLOGY, V104, P695, DOI 10.1016/S0161-6420(97)30250-4
   Wong VA, 2002, OPHTHALMOLOGY, V109, P1023, DOI 10.1016/S0161-6420(02)01009-6
   Yamashita T, 2004, NEUROLOGY, V63, P759, DOI 10.1212/01.WNL.0000134678.45047.F4
   YU WMC, 2005, NEUROMUSCULAR DISORD, V15, P17
   YU WMC, 2005, EYE, V20, P564
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   ZEVIANI M, 1989, J NEUROL, V236, P97
   ZIERZ S, 1990, NERVENARZT, V61, P322
NR 63
TC 4
Z9 4
U1 0
U2 0
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 1612-3212
BN 978-3-540-33679-2
J9 ESSENT OPHTHALMOL
PY 2008
BP 267
EP 282
DI 10.1007/978-3-540-33679-2_15
D2 10.1007/978-3-540-33679-2
PG 16
WC Neurosciences; Ophthalmology; Pediatrics
WE Book Citation Index – Science (BKCI-S)
SC Neurosciences & Neurology; Ophthalmology; Pediatrics
GA BMM20
UT WOS:000272789100015
DA 2024-11-01
ER

PT J
AU Schaller, A
   Hahn, D
   Jackson, CB
   Kern, I
   Chardot, C
   Belli, DC
   Gallati, S
   Nuoffer, JM
AF Schaller, Andre
   Hahn, Dagmar
   Jackson, Christopher B.
   Kern, Ilse
   Chardot, Christophe
   Belli, Dominique C.
   Gallati, Sabina
   Nuoffer, Jean-Marc
TI Molecular and biochemical characterisation of a novel mutation in
   <i>POLG</i> associated with Alpers syndrome
SO BMC NEUROLOGY
LA English
DT Article
ID MITOCHONDRIAL-DNA POLYMERASE; ATAXIC NEUROPATHY; QUANTIFICATION;
   HEPATOTOXICITY; PHENOTYPES; DEPLETION; SPECTRUM
AB Background: DNA polymerase g (POLG) is the only known mitochondrial DNA (mtDNA) polymerase. It mediates mtDNA replication and base excision repair. Mutations in the POLG gene lead to reduction of functional mtDNA (mtDNA depletion and/or deletions) and are therefore predicted to result in defective oxidative phosphorylation (OXPHOS). Many mutations map to the polymerase and exonuclease domains of the enzyme and produce a broad clinical spectrum. The most frequent mutation p.A467T is localised in the linker region between these domains. In compound heterozygote patients the p.A467T mutation has been described to be associated amongst others with fatal childhood encephalopathy. These patients have a poorer survival rate compared to homozygotes.
   Methods: mtDNA content in various tissues (fibroblasts, muscle and liver) was quantified using quantitative PCR (qPCR). OXPHOS activities in the same tissues were assessed using spectrophotometric methods and catalytic stain of BN-PAGE.
   Results: We characterise a novel splice site mutation in POLG found in trans with the p.A467T mutation in a 3.5 years old boy with valproic acid induced acute liver failure (Alpers-Huttenlocher syndrome). These mutations result in a tissue specific depletion of the mtDNA which correlates with the OXPHOS-activities.
   Conclusions: mtDNA depletion can be expressed in a high tissue-specific manner and confirms the need to analyse primary tissue. Furthermore, POLG analysis optimises clinical management in the early stages of disease and reinforces the need for its evaluation before starting valproic acid treatment.
C1 [Schaller, Andre; Jackson, Christopher B.; Gallati, Sabina] Univ Hosp Bern, Div Human Genet, CH-3010 Bern, Switzerland.
   [Hahn, Dagmar; Nuoffer, Jean-Marc] Univ Hosp Bern, Inst Clin Chem, CH-3010 Bern, Switzerland.
   [Kern, Ilse; Belli, Dominique C.] Univ Geneva, Childrens Hosp, Dept Paediat, Geneva, Switzerland.
   [Chardot, Christophe] Univ Geneva, Childrens Hosp, Paediat Surg Unit, Geneva, Switzerland.
   [Chardot, Christophe] Hop Necker Enfants Malad, Paediat Surg Unit, Paris, France.
C3 University of Bern; University Hospital of Bern; University of Bern;
   University Hospital of Bern; University of Geneva; University of Geneva;
   Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Necker-Enfants Malades - APHP
RP Schaller, A (corresponding author), Univ Hosp Bern, Div Human Genet, CH-3010 Bern, Switzerland.
EM andre.schaller@insel.ch
RI Jackson, Christopher B./M-3222-2013; Schaller, Andre/L-4174-2018;
   Nuoffer, Jean-Marc/C-8936-2009
OI Jackson, Christopher B./0000-0003-1035-6417; Schaller,
   Andre/0000-0001-5174-5764; Nuoffer, Jean-Marc/0000-0003-3650-6153
FU Novartis Research Foundation; Novartis
FX We are indebted to the family participating in this study. We thank A.
   Haberli for excellent technical assistance. This work was supported by a
   grant of the Novartis Research Foundation to AS. This study has been
   funded by an unrestricted grant from Novartis. The authors have no
   conflict of interest with the source of funding of the study.
CR Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137
   Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Delarue A, 2000, Pediatr Transplant, V4, P67, DOI 10.1034/j.1399-3046.2000.00090.x
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   HUTTENLOCHER PR, 1976, ARCH NEUROL-CHICAGO, V33, P186, DOI 10.1001/archneur.1976.00500030042009
   KONIG SA, 1994, EPILEPSIA, V35, P1005
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Liechti-Gallati S, 1999, EUR J HUM GENET, V7, P590, DOI 10.1038/sj.ejhg.5200338
   McFarland R, 2008, ARCH DIS CHILD, V93, P151, DOI 10.1136/adc.2007.122911
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Schägger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3
   SHEPHERD D, 1969, BIOCHEM J, V114, P597, DOI 10.1042/bj1140597
   Silva MFB, 2008, J INHERIT METAB DIS, V31, P205, DOI 10.1007/s10545-008-0841-x
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   Sweasy JB, 2006, RADIAT RES, V166, P693, DOI 10.1667/RR0706.1
   Thomson M, 1998, J PEDIATR GASTR NUTR, V26, P478, DOI 10.1097/00005176-199804000-00024
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131
NR 33
TC 30
Z9 34
U1 0
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2377
J9 BMC NEUROL
JI BMC Neurol.
PD JAN 14
PY 2011
VL 11
AR 4
DI 10.1186/1471-2377-11-4
PG 7
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 714LQ
UT WOS:000286811500001
PM 21235791
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Lv, ZY
   Xu, XM
   Cao, XF
   Wang, Q
   Sun, DF
   Tian, WJ
   Yang, Y
   Wang, YZ
   Hao, YL
AF Lv, Zhan-Yun
   Xu, Xue-Mei
   Cao, Xiao-Fu
   Wang, Qian
   Sun, Da-Fang
   Tian, Wen-Jing
   Yang, Yan
   Wang, Yu-Zhong
   Hao, Yan-Lei
TI Mitochondrial mutations in 12S rRNA and 16S rRNA presenting as chronic
   progressive external ophthalmoplegia (CPEO) plus A case report
SO MEDICINE
LA English
DT Article
DE 12S rRNA; 16S rRNA; C2835T; C960del; chronic progressive external
   ophthalmoplegia plus; mitochondrial; MRI
ID DIAGNOSIS; DNA; DISEASE
AB Rationale: Chronic progressive external ophthalmoplegia (CPEO) is a classical mitochondrial ocular disorder characterized by bilateral progressive ptosis and ophthalmoplegia. Kearns-Sayre syndrome (KSS) is a multisystem disorder with PEO, cardiac conduction block, and pigmentary retinopathy. A few individuals with CPEO have other manifestations of KSS, but do not meet all the clinical diagnosis criteria, and this is called "CPEO plus."
   Patient concerns: We report a 48-year-old woman exhibiting limb weakness, ptosis, ophthalmoparesis, and cerebellar dysfunctions.
   Diagnoses: The patient was diagnosed as exhibiting CPEO plus syndrome.
   Interventions: The patient underwent clinical, genetic, histological, and histochemical analysis. She was treated orally with CoQ10, vitamin Bs, L-carnitine, and vitamin E.
   Outcomes: The patient's serum creatine kinase levels, electrocardiography, and nerve conduction study results were normal; an electromyogram revealed myopathic findings. Magnetic resonance imaging showed global brain atrophy, particularly in the brainstem and cerebellum areas. A muscle biopsy showed the presence of abundant ragged red fibers. Sequencing of the mitochondrial DNA from the skeletal muscle biopsy revealed C960del mutation in 12S rRNA and homozygous mutation C2835T in 16S rRNA. She took medicines on schedule, the clinical features were similar as 2 years ago.
   Lessons: This is the first report of 2 rRNA mutations in a patient with MRI findings showing global brain atrophy, particularly in brainstem and cerebellum areas. Early recognition and appropriate treatment is crucial. This case highlights the cerebellar ataxia can occur in CPEO plus.
C1 [Lv, Zhan-Yun; Xu, Xue-Mei; Cao, Xiao-Fu; Wang, Qian; Sun, Da-Fang; Tian, Wen-Jing; Yang, Yan; Wang, Yu-Zhong; Hao, Yan-Lei] Jining Med Coll, Affiliated Hosp, Dept Neurol, 89 Guhuai Rd, Jining 272000, Shandong, Peoples R China.
C3 Jining Medical University
RP Hao, YL (corresponding author), Jining Med Coll, Affiliated Hosp, Dept Neurol, 89 Guhuai Rd, Jining 272000, Shandong, Peoples R China.
EM yhao@mail.jnmc.edu.cn
RI XU, XUEMEI/KLZ-1684-2024; hao, yan/HGB-0465-2022; lu, yuan/JZD-0832-2024
FU National Natural Science Foundation of China [81401064, 81271398];
   Affiliated Hospital of Jining Medical College [2013-ZD-003]
FX This work was supported by grant 81401064 from the National Natural
   Science Foundation of China (to Dr Zhanyun Lv), grant 81271398 from the
   National Natural Science Foundation of China (to Dr Yanlei Hao), and
   2013-ZD-003 from the MiaoPu project of the Affiliated Hospital of Jining
   Medical College (to Dr Zhanyun Lv, 2013).
CR Bindu PS, 2015, MITOCHONDRION, V25, P6, DOI 10.1016/j.mito.2015.08.002
   Cianfaglione R, 2015, J NEURODEV DISORD, V7, DOI 10.1186/s11689-015-9104-y
   Davis RL, 2011, SEMIN NEUROL, V31, P519, DOI 10.1055/s-0031-1299790
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Elstner M, 2008, BIOCHEM BIOPH RES CO, V377, P379, DOI 10.1016/j.bbrc.2008.09.134
   Filosto M, 2007, ACTA NEUROL SCAND, V115, P211, DOI 10.1111/j.1600-0404.2006.00777.x
   Finsterer J, 2009, EUR J NEUROL, V16, P1255, DOI 10.1111/j.1468-1331.2009.02811.x
   Finsterer J, 2009, CAN J NEUROL SCI, V36, P543, DOI 10.1017/S0317167100008027
   Heidenreich JO, 2006, AM J ROENTGENOL, V187, P820, DOI 10.2214/AJR.05.0180
   Horga A, 2014, BRAIN, V137, P3200, DOI 10.1093/brain/awu279
   KAWAI H, 1995, MUSCLE NERVE, V18, P753, DOI 10.1002/mus.880180712
   Lyst MJ, 2015, NAT REV GENET, V16, P261, DOI 10.1038/nrg3897
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Meyers DE, 2013, TEX HEART I J, V40, P385
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Mount RH, 2002, J CHILD PSYCHOL PSYC, V43, P1099, DOI 10.1111/1469-7610.00236
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3
   Pitceathly RDS, 2016, EUR RADIOL, V26, P130, DOI 10.1007/s00330-015-3801-5
   Qu J, 2009, OPHTHALMOLOGY, V116, P558, DOI 10.1016/j.ophtha.2008.10.022
   Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378
   Salvatore D, 1993, MITOCHONDRIAL DNA DE
   Tang J, 1997, PEDIATR NEUROL, V17, P327, DOI 10.1016/S0887-8994(97)00151-3
   Yu-Wai-Man C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075048
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zeviani Massimo, 2012, Handb Clin Neurol, V103, P359, DOI 10.1016/B978-0-444-51892-7.00022-X
NR 28
TC 9
Z9 10
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD DEC
PY 2017
VL 96
IS 48
AR e8869
DI 10.1097/MD.0000000000008869
PG 5
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA FS2VD
UT WOS:000419636400049
PM 29310369
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Pitceathly, RDS
   Morrow, JM
   Sinclair, CDJ
   Woodward, C
   Sweeney, MG
   Rahman, S
   Plant, GT
   Ali, N
   Bremner, F
   Davagnanam, I
   Yousry, TA
   Hanna, MG
   Thornton, JS
AF Pitceathly, Robert D. S.
   Morrow, Jasper M.
   Sinclair, Christopher D. J.
   Woodward, Cathy
   Sweeney, Mary G.
   Rahman, Shamima
   Plant, Gordon T.
   Ali, Nadeem
   Bremner, Fion
   Davagnanam, Indran
   Yousry, Tarek A.
   Hanna, Michael G.
   Thornton, John S.
TI Extra-ocular muscle MRI in genetically-defined mitochondrial disease
SO EUROPEAN RADIOLOGY
LA English
DT Article
DE Magnetic resonance imaging; Mitochondrial diseases; Mitochondrial DNA;
   Chronic progressive external ophthalmoplegia; Kearns-Sayre syndrome
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; EXTRAOCULAR-MUSCLES; CONGENITAL
   FIBROSIS; RELAXATION-TIME; MUTATIONS; FEATURES
AB Conventional and quantitative MRI was performed in patients with chronic progressive external ophthalmoplegia (CPEO), a common manifestation of mitochondrial disease, to characterise MRI findings in the extra-ocular muscles (EOMs) and investigate whether quantitative MRI provides clinically relevant measures of disease.
   Patients with CPEO due to single mitochondrial DNA deletions were compared with controls. Range of eye movement (ROEM) measurements, peri-orbital 3 T MRI T1-weighted (T1w) and short-tau-inversion-recovery (STIR) images, and T2 relaxation time maps were obtained. Blinded observers graded muscle atrophy and T1w/STIR hyperintensity. Cross-sectional areas and EOM mean T2s were recorded and correlated with clinical parameters.
   Nine patients and nine healthy controls were examined. Patients had reduced ROEM (patients 13.3A degrees, controls 49.3A degrees, p < 0.001), greater mean atrophy score and increased T1w hyperintensities. EOM mean cross-sectional area was 43 % of controls and mean T2s were prolonged (patients 75.6 A +/- 7.0 ms, controls 55.2 A +/- 4.1 ms, p < 0.001). ROEM correlated negatively with EOM T2 (rho = -0.89, p < 0.01), whilst cross-sectional area failed to correlate with any clinical measures.
   MRI demonstrates EOM atrophy, characteristic signal changes and prolonged T2 in CPEO. Correlation between elevated EOM T2 and ROEM impairment represents a potential measure of disease severity that warrants further evaluation.
   aEuro cent Chronic progressive external ophthalmoplegia is a common clinical manifestation of mitochondrial disease.
   aEuro cent Existing extra-ocular muscle MRI data in CPEO reports variable radiological findings.
   aEuro cent MRI confirmed EOM atrophy and characteristic signal changes in CPEO.
   aEuro cent EOM T2 was significantly elevated in CPEO and correlated negatively with ocular movements.
   aEuro cent EOM T2 represents a potential quantitative measure of disease severity in CPEO.
C1 [Pitceathly, Robert D. S.; Morrow, Jasper M.; Sinclair, Christopher D. J.; Rahman, Shamima; Yousry, Tarek A.; Hanna, Michael G.; Thornton, John S.] UCL, MRC Ctr Neuromuscular Dis, Inst Neurol, London WC1N 3BG, England.
   [Pitceathly, Robert D. S.; Morrow, Jasper M.; Sinclair, Christopher D. J.; Rahman, Shamima; Yousry, Tarek A.; Hanna, Michael G.; Thornton, John S.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
   [Sinclair, Christopher D. J.; Yousry, Tarek A.; Thornton, John S.] UCL, Inst Neurol, Dept Brain Repair & Rehabil, Neuroradiol Acad Unit, London WC1N 3BG, England.
   [Woodward, Cathy; Sweeney, Mary G.] Natl Hosp Neurol & Neurosurg, Neurogenet Unit, London WC1N 3BG, England.
   [Rahman, Shamima] UCL, Inst Child Hlth, Clin & Mol Genet Unit, Mitochondrial Res Grp, London WC1N 1EH, England.
   [Plant, Gordon T.; Ali, Nadeem; Bremner, Fion] Natl Hosp Neurol & Neurosurg, Dept Neuroophthalmol, London WC1N 3BG, England.
   [Plant, Gordon T.; Ali, Nadeem] Moorfields Eye Hosp, Dept Neuroophthalmol, London EC1V 2PD, England.
   [Davagnanam, Indran] Natl Hosp Neurol & Neurosurg, Lysholm Dept Neuroradiol, London WC1N 3BG, England.
C3 University of London; University College London; University of London;
   University College London; UCL Medical School; University College London
   Hospitals NHS Foundation Trust; University of London; University College
   London; University of London; University College London; UCL Medical
   School; University College London Hospitals NHS Foundation Trust;
   University of London; University College London; University of London;
   University College London; UCL Medical School; University College London
   Hospitals NHS Foundation Trust; University of London; University College
   London; Moorfields Eye Hospital NHS Foundation Trust; University of
   London; University College London; UCL Medical School; University
   College London Hospitals NHS Foundation Trust
RP Pitceathly, RDS (corresponding author), UCL, MRC Ctr Neuromuscular Dis, Inst Neurol, Queen Sq, London WC1N 3BG, England.
EM r.pitceathly@ucl.ac.uk
RI Thornton, John/C-1934-2008; Sinclair, Chris/D-8078-2011; Rahman,
   Shamima/C-5232-2008; Morrow, Jasper/E-2496-2013; Bremner,
   Fion/AAQ-8923-2020
OI Hanna, Michael/0000-0003-0825-4075; Thornton, John/0000-0003-3248-8437;
   Morrow, Jasper M/0000-0001-6879-8539; Pitceathly,
   Robert/0000-0002-6123-4551
FU MRC [G0800674]; MRC Centre [G0601943]; Great Ormond Street Hospital
   Children's Charity; NIHR UCLH/UCL Comprehensive Biomedical Research
   Centre; Department of Health's National Institute for Health Research
   Biomedical Research Centres funding scheme; MRC [G0700718, MR/L016354/1,
   G0601943, MR/K000608/1, MC_G0802536, G0800674] Funding Source: UKRI
FX R.D.S.P. is funded by MRC grant number G0800674. M.G.H., J.M.M. and
   C.D.J.S. are supported by an MRC Centre grant G0601943. S.R. is
   supported by Great Ormond Street Hospital Children's Charity. This study
   was supported by the NIHR UCLH/UCL Comprehensive Biomedical Research
   Centre and undertaken at University College London Hospitals/University
   College London, which received a proportion of funding from the
   Department of Health's National Institute for Health Research Biomedical
   Research Centres funding scheme. Methodology: prospective,
   observational, performed at one institution.
CR Bosley TM, 2006, BRAIN, V129, P2363, DOI 10.1093/brain/awl161
   Carlow TJ, 1998, AM J NEURORADIOL, V19, P95
   Demer JL, 2005, INVEST OPHTH VIS SCI, V46, P530, DOI 10.1167/iovs.04-1125
   Haggerty H, 2005, ARCH OPHTHALMOL-CHIC, V123, P356, DOI 10.1001/archopht.123.3.356
   Nagy EV, 2000, EUR J ENDOCRINOL, V142, P591, DOI 10.1530/eje.0.1420591
   Okamoto K, 1996, J NEURO-OPHTHALMOL, V16, P286
   Ortube MC, 2006, J AAPOS, V10, P414, DOI 10.1016/j.jaapos.2006.04.012
   Pauleit D, 1997, ROFO-FORTSCHR RONTG, V167, P557, DOI 10.1055/s-2007-1015583
   Peters S, 2006, ROFO-FORTSCHR RONTG, V178, P1030, DOI 10.1055/s-2006-926685
   Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3
   Pitceathly RDS, 2014, CURR OPIN NEUROL, V27, P576, DOI 10.1097/WCO.0000000000000126
   Politi LS, 2014, EUR RADIOL, V24, P1118, DOI 10.1007/s00330-014-3103-3
   Richardson C, 2005, EYE, V19, P258, DOI 10.1038/sj.eye.6701488
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Ulmer JL, 1998, AM J NEURORADIOL, V19, P943
   UTECH CI, 1995, THYROID, V5, P185, DOI 10.1089/thy.1995.5.185
   Wattjes MP, 2010, EUR RADIOL, V20, P2447, DOI 10.1007/s00330-010-1799-2
   Yu-Wai-Man C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075048
   Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015
NR 19
TC 16
Z9 16
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0938-7994
EI 1432-1084
J9 EUR RADIOL
JI Eur. Radiol.
PD JAN
PY 2016
VL 26
IS 1
BP 130
EP 137
DI 10.1007/s00330-015-3801-5
PG 8
WC Radiology, Nuclear Medicine & Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Radiology, Nuclear Medicine & Medical Imaging
GA CX5EP
UT WOS:000365725200016
PM 25994195
OA Green Published, hybrid, Green Submitted
DA 2024-11-01
ER

PT J
AU Cardaioli, E
   Malfatti, E
   Battisti, C
   Da Pozzo, P
   Rubegni, A
   Gallus, GN
   Malandrini, A
   Federico, A
AF Cardaioli, Elena
   Malfatti, Edoardo
   Battisti, Carla
   Da Pozzo, Paola
   Rubegni, Anna
   Gallus, Gian Nicola
   Malandrini, Alessandro
   Federico, Antonio
TI Sporadic myopathy, myoclonus, leukoencephalopathy, neurosensory
   deafness, hypertrophic cardiomyopathy and insulin resistance associated
   with the mitochondrial 8306 T&gt;C <i>MTTK</i> mutation
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Encephalomyopathies; Mitochondrial DNA; MTTK; Heteroplasmy; Single fibre
   studies; Pathogenicity; Muscle biochemical analysis
ID TRANSFER-RNA MUTATIONS; DISEASES; GENES
AB We report a new T8306C transition in the D-stem of the MTTK gene of a 67-year-old man who manifested severe adult onset myopathy, myoclonus, leukoencephalopathy, neurosensory hypoacusis, hypertrophic cardiomyopathy and insulin resistance. No other family member was affected, suggesting that our patient was a sporadic case. The T8306C mutation was heteroplasmic in several tissues of the proband, while it was absent from his asymptomatic siblings. Single fibre analysis confirmed the segregation of higher mutational load in cytochrome c oxidase-deficient fibres. The mutation T8306C is predicted to disrupt a highly conserved base pair and was not found in more than 120 controls. This finding broadens the phenotypic and molecular spectrum of mitochondrial tRNA(Lys) associated disorders. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Cardaioli, Elena; Malfatti, Edoardo; Battisti, Carla; Da Pozzo, Paola; Rubegni, Anna; Gallus, Gian Nicola; Malandrini, Alessandro; Federico, Antonio] Univ Siena, Dept Neurol Neurosurg & Behav Sci, I-53100 Siena, Italy.
   [Malfatti, Edoardo] GH Pitie Salpetriere, Inst Myol, Unite Morphol Neuromusculaire, Paris, France.
C3 University of Siena; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite
RP Federico, A (corresponding author), Univ Siena, Dept Neurol Neurosurg & Behav Sci, Viale Bracci 2, I-53100 Siena, Italy.
EM federico@unisi.it
RI Federico, Antonio/H-8871-2017; Malfatti, Edoardo/KEI-9379-2024; gallus,
   gian/Q-3489-2016; Rubegni, Anna/I-3221-2018
OI Cardaioli, Elena/0000-0003-2850-6698; Rubegni, Anna/0000-0002-0484-3799;
   Malandrini, Alessandro/0000-0003-1034-0845; federico,
   antonio/0000-0002-5246-1621
FU University of Siena
FX This research is partially financed by a grant from the University of
   Siena to AF.
CR Di Mauro S, 2008, MOL GENETIC BASIS NE, P169
   HOLME E, 1995, BBA-MOL BASIS DIS, V1271, P249, DOI 10.1016/0925-4439(95)00035-3
   Houshmand M, 1999, HUM MUTAT, V13, P203, DOI 10.1002/(SICI)1098-1004(1999)13:3<203::AID-HUMU4>3.0.CO;2-3
   LAUBER J, 1991, NUCLEIC ACIDS RES, V19, P1393, DOI 10.1093/nar/19.7.1393
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Zeviani M, 1996, J INHERIT METAB DIS, V19, P504, DOI 10.1007/BF01799111
   Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548
NR 10
TC 5
Z9 5
U1 0
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD OCT 15
PY 2012
VL 321
IS 1-2
BP 92
EP 95
DI 10.1016/j.jns.2012.07.027
PG 4
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 017DJ
UT WOS:000309570000017
PM 22925535
DA 2024-11-01
ER

PT J
AU Rajasimha, HK
   Chinnery, PF
   Samuels, DC
AF Rajasimha, Harsha Karur
   Chinnery, Patrick F.
   Samuels, David C.
TI Selection against pathogenic mtDNA mutations in a stem cell population
   leads to the loss of the 3243A→G mutation in blood
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID MITOCHONDRIAL-DNA MUTATIONS; RAGGED-RED FIBERS; STROKE-LIKE EPISODES;
   RANDOM GENETIC DRIFT; DIABETES-MELLITUS; A3243G MUTATION; TISSUE
   DISTRIBUTION; MYOCLONUS EPILEPSY; LACTIC-ACIDOSIS; POINT MUTATION
AB The mutation 3243A -> G is the most common heteroplasmic pathogenic mitochondrial DNA (mtDNA) mutation in humans, but it is not understood why the proportion of this mution decreases in blood during life. Changing levels of mtDNA heteroplasmy are fundamentally related to the pathophysiology of the mitochondrial disease and correlate with clinical progression. To understand this process, we simulated the segregation of mtDNA in hematopoietic stem cells and leukocyte precursors. Our observations show that the percentage of mutant mtDNA in blood decreases exponentially over time. This is consistent with the existence of a selective process acting at the stem cell level and explains why the level of mutant mtDNA in blood is almost invariably lower than in nondividing (postmitotic) tissues such as skeletal muscle. By using this approach, we derived a formula from human data to correct for the change in heteroplasmy over time. A comparison of age-corrected blood heteroplasmy levels with skeletal muscle, an embryologically distinct postmitotic tissue, provides independent confirmation of the model. These findings indicate that selection against pathogenic mtDNA mutations occurs in a stem cell population.
C1 [Rajasimha, Harsha Karur; Samuels, David C.] Virginia Polytech Inst & State Univ, Virgina Bioinformat Inst, Blacksburg, VA 24061 USA.
   [Chinnery, Patrick F.] Univ Newcastle, Sch Med, Mitochondria Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Chinnery, Patrick F.] Univ Newcastle, Sch Med, Inst Human Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Virginia Polytechnic Institute & State University; Newcastle University
   - UK; Newcastle University - UK
RP Samuels, DC (corresponding author), Virginia Polytech Inst & State Univ, Virgina Bioinformat Inst, Blacksburg, VA 24061 USA.
EM dsamuels@vbi.vt.edu
RI ; Samuels, David/A-5393-2008
OI RAJASIMHA, HARSHA/0000-0002-2703-9939; Samuels,
   David/0000-0003-3529-7791; Chinnery, Patrick/0000-0002-7065-6617
FU Wellcome Trust Funding Source: Medline
CR Akala OO, 2006, CURR OPIN GENET DEV, V16, P496, DOI 10.1016/j.gde.2006.08.011
   AVISE JC, 1984, J MOL EVOL, V20, P99, DOI 10.1007/BF02257369
   Barron MJ, 2005, NEUROMUSCULAR DISORD, V15, P768, DOI 10.1016/j.nmd.2005.06.018
   Battersby BJ, 2005, HUM MOL GENET, V14, P2587, DOI 10.1093/hmg/ddi293
   Bidooki SK, 1997, AM J HUM GENET, V60, P1430, DOI 10.1086/515460
   Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231
   Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190
   Canter JA, 2005, FREE RADICAL BIO MED, V38, P678, DOI 10.1016/j.freeradbiomed.2004.11.031
   Capps GJ, 2003, J THEOR BIOL, V221, P565, DOI 10.1006/jtbi.2003.3207
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 1997, LANCET, V350, P1402, DOI 10.1016/S0140-6736(05)65183-5
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 1999, AM J MED GENET, V85, P498
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   Colijn C, 2005, J THEOR BIOL, V237, P117, DOI 10.1016/j.jtbi.2005.03.033
   Deschauer M, 1999, NEUROMUSCULAR DISORD, V9, P305, DOI 10.1016/S0960-8966(99)00019-X
   DEVRIES D, 1994, J NEUROL SCI, V124, P77, DOI 10.1016/0022-510X(94)90014-0
   Durham SE, 2006, NEUROMUSCULAR DISORD, V16, P381, DOI 10.1016/j.nmd.2006.03.012
   El Meziane A, 1998, NAT GENET, V18, P350
   Elson JL, 2002, NEUROMUSCULAR DISORD, V12, P858, DOI 10.1016/S0960-8966(02)00047-0
   Frederiksen AL, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039339
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   Ho AD, 2005, EXP HEMATOL, V33, P1, DOI 10.1016/j.exphem.2004.09.004
   Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x
   Howell N, 2000, J NEUROL SCI, V172, P1, DOI 10.1016/S0022-510X(99)00207-5
   HUANG CC, 1994, J NEUROL NEUROSUR PS, V57, P586, DOI 10.1136/jnnp.57.5.586
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Jacobi FK, 2001, INVEST OPHTH VIS SCI, V42, P1208
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Kato Y, 2002, DIABETIC MED, V19, P784, DOI 10.1046/j.1464-5491.2002.00777.x
   Kerrison JB, 2000, AM J OPHTHALMOL, V130, P803, DOI 10.1016/S0002-9394(00)00603-6
   Kirches E, 2001, J MED GENET, V38, P312, DOI 10.1136/jmg.38.5.312
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   Lien LM, 2001, ACTA NEUROL SCAND, V103, P159, DOI 10.1034/j.1600-0404.2001.103003159.x
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Lu JX, 2006, BIOCHEM BIOPH RES CO, V348, P115, DOI 10.1016/j.bbrc.2006.07.010
   Mackey MC, 2001, CELL PROLIFERAT, V34, P71, DOI 10.1046/j.1365-2184.2001.00195.x
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Majamaa-Voltti Kirsi, 2002, BMC Cardiovasc Disord, V2, P12
   MARTINUZZI A, 1992, J NEUROL SCI, V113, P222, DOI 10.1016/0022-510X(92)90250-O
   MATTHEWS PM, 1995, HUM GENET, V96, P261
   McDonald SAC, 2006, CELL CYCLE, V5, P808, DOI 10.4161/cc.5.8.2641
   MOSEWICH RK, 1993, ARCH NEUROL-CHICAGO, V50, P275, DOI 10.1001/archneur.1993.00540030041012
   Ng MCY, 2000, CLIN ENDOCRINOL, V52, P557, DOI 10.1046/j.1365-2265.2000.00989.x
   OBERMAIERKUSSER B, 1991, FEBS LETT, V286, P67, DOI 10.1016/0014-5793(91)80942-V
   OGAWA M, 1993, BLOOD, V81, P2844
   Olsson C, 2001, EUR J HUM GENET, V9, P917, DOI 10.1038/sj.ejhg.5200742
   Olsson C, 1998, HUM MUTAT, V12, P52, DOI 10.1002/(SICI)1098-1004(1998)12:1<52::AID-HUMU8>3.0.CO;2-K
   PICCOLO G, 1993, ACTA NEUROL SCAND, V88, P406, DOI 10.1111/j.1600-0404.1993.tb05368.x
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Rossignol R, 2000, BIOCHEM J, V347, P45, DOI 10.1042/0264-6021:3470045
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Sadun F, 2004, AM J OPHTHALMOL, V137, P271, DOI 10.1016/j.ajo.2003.08.010
   Saitoh S, 1999, J INHERIT METAB DIS, V22, P608, DOI 10.1023/A:1005569711521
   Sciacco M, 2001, NEUROLOGY, V56, P1070, DOI 10.1212/WNL.56.8.1070
   Shepherd BE, 2004, EXP HEMATOL, V32, P1040, DOI 10.1016/j.exphem.2004.07.023
   SHOUBRIDGE EA, 1994, J BIOENERG BIOMEMBR, V26, P301, DOI 10.1007/BF00763101
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   tHart LM, 1996, HUM MUTAT, V7, P193
   TRAFF J, 1995, ACTA NEUROL SCAND, V92, P394
   van Essen EHR, 2000, DIABETIC MED, V17, P841, DOI 10.1046/j.1464-5491.2000.00379.x
   Vilarinho L, 1997, J MED GENET, V34, P607, DOI 10.1136/jmg.34.7.607
   Wilichowski E, 1998, J NEUROL SCI, V157, P206, DOI 10.1016/S0022-510X(98)00068-9
   Zhong S, 2000, J CLIN PATHOL, V53, P466, DOI 10.1136/jcp.53.6.466
NR 73
TC 84
Z9 91
U1 2
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD FEB
PY 2008
VL 82
IS 2
BP 333
EP 343
DI 10.1016/j.ajhg.2007.10.007
PG 11
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 263NN
UT WOS:000253223900006
PM 18252214
OA Bronze, Green Accepted, Green Published
DA 2024-11-01
ER

PT J
AU Lin, Y
   Du, JX
   Wang, W
   Ren, H
   Zhao, DD
   Liu, FC
   Lin, PF
   Ji, KQ
   Zhao, YY
   Yan, CZ
AF Lin, Yan
   Du, Jixiang
   Wang, Wei
   Ren, Hong
   Zhao, Dandan
   Liu, Fuchen
   Lin, Pengfei
   Ji, Kunqian
   Zhao, Yuying
   Yan, Chuanzhu
TI Novel biallelic mutations in <i>POLG</i> gene: large deletion and
   missense variant associated with PEO
SO NEUROLOGICAL SCIENCES
LA English
DT Article
DE Mitochondrial disease; POLG; Large deletion; Missense variant; PEO
ID PHENOTYPIC SPECTRUM; DISEASE MUTATIONS; MITOCHONDRIAL; DEFECTS;
   REPLICATION; FRAGMENTS; NUCLEAR; ATAXIA
AB Background Mitochondrial disorders are clinically heterogeneous diseases associated with impaired oxidative phosphorylation (OXPHOS) activity. POLG, which encodes the DNA polymerase-gamma (Pol gamma) catalytic subunit, is the most commonly mutated nuclear gene associated with mitochondrial disorders. Methods We carried out whole-exome sequencing (WES) to identify the gene associated with progressive external ophthalmoplegia (PEO). We then performed histopathological analyses, assessed mitochondrial biology, and executed functional studies to evaluate the potential pathogenicity of the identified genetic mutations. Results Novel biallelic POLG mutations, including a large deletion mutation (exons 7-21) and a missense variant c.1796C>T (p.Thr599Ile) were detected in the proband. Histopathological analysis of a biopsied muscle sample from this patient revealed the presence of approximately 20% COX-negative fibers. Bioinformatics analyses confirmed that the detected mutations were pathogenic. Furthermore, levels of mitochondrial complex I, II, and IV subunit protein expressions were found to be decreased in the proband, and marked impairment of mitochondrial respiration was evident in cells harboring these mutations. Conclusion This study expands the spectrum of known POLG variants associated with PEO and advances current understanding regarding the structural and functional impacts of these mutations.
C1 [Lin, Yan; Du, Jixiang; Wang, Wei; Ren, Hong; Zhao, Dandan; Liu, Fuchen; Lin, Pengfei; Ji, Kunqian; Zhao, Yuying; Yan, Chuanzhu] Shandong Univ, Res Inst Neuromuscular & Neurodegenerat Dis, Qilu Hosp, Cheeloo Coll Med, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
   [Lin, Yan; Du, Jixiang; Wang, Wei; Ren, Hong; Zhao, Dandan; Liu, Fuchen; Lin, Pengfei; Ji, Kunqian; Zhao, Yuying; Yan, Chuanzhu] Shandong Univ, Dept Neurol, Qilu Hosp, Cheeloo Coll Med, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Mitochondrial Med Lab, Qilu Hosp Qingdao, Qingdao 266035, Shandong, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Brain Sci Res Inst, Jinan 250012, Shandong, Peoples R China.
C3 Shandong University; Shandong University; Shandong University; Shandong
   University
RP Ji, KQ; Yan, CZ (corresponding author), Shandong Univ, Res Inst Neuromuscular & Neurodegenerat Dis, Qilu Hosp, Cheeloo Coll Med, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.; Ji, KQ; Yan, CZ (corresponding author), Shandong Univ, Dept Neurol, Qilu Hosp, Cheeloo Coll Med, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Mitochondrial Med Lab, Qilu Hosp Qingdao, Qingdao 266035, Shandong, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Brain Sci Res Inst, Jinan 250012, Shandong, Peoples R China.
EM jikunqian@qq.com; czyan@sdu.edu.cn
RI zhao, dandan/AAP-3407-2021; Wang, Yuanzhuo/A-9114-2012
OI Du, Jixiang/0000-0002-5365-0336; Lin, Yan/0000-0003-0282-6749
FU National Natural Science Foundation of China [81701237, 81671235];
   People's Benefit Project of Science and Technology in Qingdao
   [16-6-2-1-nsh]; Collaborative Innovation and Achievement Transformation
   in Universities and Research Institutes of Jinan [2019GXRC050]; Qingdao
   Key Health Discipline Development Fund; Taishan Scholars Program of
   Shandong Province
FX This study was supported by the National Natural Science Foundation of
   China (No. 81701237 and 81671235), People's Benefit Project of Science
   and Technology in Qingdao (16-6-2-1-nsh), Collaborative Innovation and
   Achievement Transformation in Universities and Research Institutes of
   Jinan (2019GXRC050), Qingdao Key Health Discipline Development Fund, and
   the Taishan Scholars Program of Shandong Province.
CR Anderson AP, 2020, NUCLEIC ACIDS RES, V48, P817, DOI 10.1093/nar/gkz1018
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   Craig K, 2007, BRAIN, V130, DOI 10.1093/brain/awm009
   Da Pozzo P, 2017, NEUROL SCI, V38, P563, DOI 10.1007/s10072-016-2734-3
   Da Pozzo P, 2015, NEUROL SCI, V36, P1713, DOI 10.1007/s10072-015-2247-5
   Dubowitz V., 2013, MUSCLE BIOPSY PRACTI, V4th, P1, DOI DOI 10.1177/000271623618500112
   Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618
   Finsterer J, 2018, NEUROL SCI, V39, P571, DOI 10.1007/s10072-017-3116-1
   Fuke S, 2014, ANN CLIN TRANSL NEUR, V1, P909, DOI 10.1002/acn3.133
   Gaudó P, 2020, NEUROGENETICS, V21, P19, DOI 10.1007/s10048-019-00593-2
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hedberg-Oldfors C, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000391
   Heighton JN, 2019, MITOCHONDRION, V49, P227, DOI 10.1016/j.mito.2019.09.002
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Ji KQ, 2014, NEUROL SCI, V35, P443, DOI 10.1007/s10072-013-1557-8
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Krasich R, 2017, FRONT BIOSCI-LANDMRK, V22, P692, DOI 10.2741/4510
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Milone M, 2011, NEUROLOGY, V77, P1847, DOI 10.1212/WNL.0b013e318238863a
   Neeve VCM, 2012, BRAIN, V135, P3614, DOI 10.1093/brain/aws298
   Nissanka N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04895-1
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae
   Rodríguez-López C, 2020, J MED GENET, V57, P643, DOI 10.1136/jmedgenet-2019-106649
   Roos S, 2013, HUM MOL GENET, V22, P2411, DOI 10.1093/hmg/ddt094
   Rouzier C, 2014, EUR J HUM GENET, V22, P542, DOI 10.1038/ejhg.2013.171
   Sommerville Ewen W, 2014, J Neuromuscul Dis, V1, P119
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   van der Windt Gerritje J W, 2016, Curr Protoc Immunol, V113, DOI 10.1002/0471142735.im0316bs113
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003
   Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213
NR 40
TC 3
Z9 4
U1 0
U2 8
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1590-1874
EI 1590-3478
J9 NEUROL SCI
JI Neurol. Sci.
PD OCT
PY 2021
VL 42
IS 10
BP 4271
EP 4280
DI 10.1007/s10072-021-05380-2
EA JUN 2021
PG 10
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA UQ8HB
UT WOS:000668063500006
PM 34189666
DA 2024-11-01
ER

PT J
AU Yu-Wai-Man, P
   Sitarz, KS
   Samuels, DC
   Griffiths, PG
   Reeve, AK
   Bindoff, LA
   Horvath, R
   Chinnery, PF
AF Yu-Wai-Man, Patrick
   Sitarz, Kamil S.
   Samuels, David C.
   Griffiths, Philip G.
   Reeve, Amy K.
   Bindoff, Laurence A.
   Horvath, Rita
   Chinnery, Patrick F.
TI <i>OPA1</i> mutations cause cytochrome <i>c</i> oxidase deficiency due
   to loss of wild-type mtDNA molecules
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID MITOCHONDRIAL TRANSCRIPTION FACTOR; DOMINANT OPTIC ATROPHY;
   SKELETAL-MUSCLE; FACTOR-A; EXTERNAL OPHTHALMOPLEGIA; DNA MUTATIONS;
   APOPTOSIS; EXPRESSION; DELETIONS; EXERCISE
AB Pathogenic OPA1 mutations cause autosomal dominant optic atrophy (DOA),a condition characterized by the preferential loss of retinal ganglion cells and progressive optic nerve degeneration. Approximately 20% of affected patients will also develop more severe neuromuscular complications, an important disease subgroup known as DOA(+). Cytochrome c oxidase (COX)-negative fibres and multiple mitochondrial DNA (mtDNA) deletions have been identified in skeletal muscle biopsies from patients manifesting both the pure and syndromal variants, raising the possibility that the accumulation of somatic mtDNA defects contribute to the disease process. In this study, we investigated the mtDNA changes induced by OPA1 mutations in skeletal muscle biopsies from 15 patients with both pure DOA and DOA(+) phenotypes. We observed a 2-to 4-fold increase in mtDNA copy number at the single-fibre level, and patients with DOA(+) features had significantly greater mtDNA proliferation in their COX-negative skeletal muscle fibres compared with patients with isolated optic neuropathy. Low levels of wild-type mtDNA molecules were present in COX-deficient muscle fibres from both pure DOA and DOA(+) patients, implicating haplo-insufficiency as the mechanism responsible for the biochemical defect. Our findings are consistent with the 'maintenance of wild-type' hypothesis, the secondary mtDNA deletions induced by OPA1 mutations triggering a compensatory mitochondrial proliferative response in order to maintain an optimal level of wild-type mtDNA genomes. However, when deletion levels reach a critical level, further mitochondrial proliferation leads to replication of the mutant species at the expense of wild-type mtDNA, resulting in the loss of respiratory chain COX activity.
C1 [Yu-Wai-Man, Patrick; Sitarz, Kamil S.; Griffiths, Philip G.; Reeve, Amy K.; Horvath, Rita; Chinnery, Patrick F.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.
   [Yu-Wai-Man, Patrick; Griffiths, Philip G.] Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Samuels, David C.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN USA.
   [Bindoff, Laurence A.] Univ Bergen, Dept Clin Med, Bergen, Norway.
   [Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Chinnery, Patrick F.] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Vanderbilt
   University; University of Bergen; University of Bergen; Haukeland
   University Hospital; Newcastle University - UK
RP Chinnery, PF (corresponding author), Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.
EM P.F.Chinnery@ncl.ac.uk
RI Horvath, Rita/AAY-7042-2020; Samuels, David/A-5393-2008
OI Chinnery, Patrick/0000-0002-7065-6617; Bindoff,
   Laurence/0000-0003-0988-276X; Reeve, Amy/0000-0002-4474-2204; Samuels,
   David/0000-0003-3529-7791; Horvath, Rita/0000-0002-9841-170X
FU Clinical Research Fellowship [G0701386]; Parkinson's Disease Society
   (UK); Medical Research Council Translational Muscle Centre; UK NIHR
   Biomedical Research Centre in Ageing and Age related disease; NIH/NIGMS
   [R01GM073744]; Helse Vest (RHF); Norwegian Research Council; Academy of
   Medical Sciences; Deutsche Forschungsgemeinschaft [HO 2505/2-1];
   Wellcome Trust; MRC [G0700718, G0701386] Funding Source: UKRI
FX This work was supported by a Medical Research Council (MRC, UK) Clinical
   Research Fellowship to P.Y.W.M. (G0701386). P.F.C. is a Wellcome Trust
   Senior Fellow in Clinical Science, and also receives funding from the
   Parkinson's Disease Society (UK), the Medical Research Council
   Translational Muscle Centre and the UK NIHR Biomedical Research Centre
   in Ageing and Age related disease. D.C.S. is supported by an NIH/NIGMS
   grant R01GM073744. L.A.B. receives funding from Helse Vest (RHF) and the
   Norwegian Research Council. R.H. is supported by the Academy of Medical
   Sciences and the Deutsche Forschungsgemeinschaft (HO 2505/2-1). Funding
   to pay the Open Access Charge was provided by the Wellcome Trust.
CR Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE672, DOI 10.1152/ajpendo.00043.2007
   Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Amati-Bonneau P, 2009, INT J BIOCHEM CELL B, V41, P1855, DOI 10.1016/j.biocel.2009.04.012
   Auré K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061
   Bengtsson J, 2001, PFLUG ARCH EUR J PHY, V443, P61, DOI 10.1007/s004240100628
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Capps GJ, 2003, J THEOR BIOL, V221, P565, DOI 10.1006/jtbi.2003.3207
   Chevrollier A, 2008, ANN NEUROL, V63, P794, DOI 10.1002/ana.21385
   Chinnery Patrick F, 2008, Neuromuscul Disord, V18, P259, DOI 10.1016/j.nmd.2007.11.005
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Davies V, 2006, EXP EYE RES, V83, P1003, DOI 10.1016/j.exer.2005.11.021
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Gordon JW, 2001, J APPL PHYSIOL, V90, P389, DOI 10.1152/jappl.2001.90.1.389
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   JOHNSON MA, 1996, HDB MUSCLE DIS, P61
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lenaers G, 2009, INT J BIOCHEM CELL B, V41, P1866, DOI 10.1016/j.biocel.2009.04.013
   LJUBICIC V, 2009, BIOCHIM BIOPHYS ACTA, V1800, P223, DOI DOI 10.1111/J.1474-9726.2009.00483.X
   Martinelli P, 2010, BBA-BIOENERGETICS, V1797, P1, DOI 10.1016/j.bbabio.2009.07.013
   Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534
   Mirabella M, 2000, BRAIN, V123, P93, DOI 10.1093/brain/123.1.93
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Newman NJ, 2004, EYE, V18, P1144, DOI 10.1038/sj.eye.6701591
   Norrbom J, 2010, ACTA PHYSIOL, V198, P71, DOI 10.1111/j.1748-1716.2009.02030.x
   Olichow A, 2007, J CELL PHYSIOL, V211, P423, DOI 10.1002/jcp.20950
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Reeve AK, 2009, AGING CELL, V8, P496, DOI 10.1111/j.1474-9726.2009.00492.x
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   Spinazzi M, 2008, HUM MOL GENET, V17, P3291, DOI 10.1093/hmg/ddn225
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
   YUWAIMAN P, 2010, OPHTHALMOLOGY   0422
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   Zeviani M, 2008, BRAIN, V131, P314, DOI 10.1093/brain/awm339
NR 46
TC 81
Z9 85
U1 0
U2 9
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD AUG 1
PY 2010
VL 19
IS 15
BP 3043
EP 3052
DI 10.1093/hmg/ddq209
PG 10
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 633HA
UT WOS:000280491200011
PM 20484224
OA Green Published, hybrid, Green Submitted
DA 2024-11-01
ER

PT J
AU Elpeleg, O
   Miller, C
   Hershkovitz, E
   Bitner-Glindzicz, M
   Bondi-Rubenstein, G
   Rahman, S
   Pagnamenta, A
   Eshhar, S
   Saada, A
AF Elpeleg, O
   Miller, C
   Hershkovitz, E
   Bitner-Glindzicz, M
   Bondi-Rubenstein, G
   Rahman, S
   Pagnamenta, A
   Eshhar, S
   Saada, A
TI Deficiency of the ADP-forming succinyl-CoA synthase activity is
   associated with encephalomyopathy and mitochondrial DNA depletion
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID NUCLEOSIDE-DIPHOSPHATE KINASE; THYMIDINE KINASE; MUTATIONS; GENE;
   SYNTHETASES; THIOKINASE; EXPRESSION; EUKARYOTES; PROTEINS; DISEASES
AB The mitochondrial DNA (mtDNA) depletion syndrome is a quantitative defect of mtDNA resulting from dysfunction of one of several nuclear-encoded factors responsible for maintenance of mitochondrial deoxyribonucleoside triphosphate (dNTP) pools or replication of mtDNA. Markedly decreased succinyl-CoA synthetase activity due to a deleterious mutation in SUCLA2, the gene encoding the beta subunit of the ADP-forming succinyl-CoA synthetase ligase, was found in muscle mitochondria of patients with encephalomyopathy and mtDNA depletion. Succinyl-CoA synthetase is invariably in a complex with mitochondrial nucleotide diphosphate kinase; hence, we propose that a defect in the last step of mitochondrial dNTP salvage is a novel cause of the mtDNA depletion syndrome.
C1 Shaare Zedek Med Ctr, Metab Dis Unit, IL-91031 Jerusalem, Israel.
   Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel.
   Ben Gurion Univ Negev, Fac Med, Soroka Med Ctr, Dept Pediat, IL-84105 Beer Sheva, Israel.
   UCL, Inst Child Hlth, Clin & Mol Genet Unit, London, England.
   UCL, Inst Child Hlth, Biochem Endocrinol & Metab Unit, London, England.
C3 Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew
   University of Jerusalem; Ben Gurion University; Soroka Medical Center;
   University of London; University College London; University of London;
   University College London
RP Elpeleg, O (corresponding author), Shaare Zedek Med Ctr, Metab Dis Unit, IL-91031 Jerusalem, Israel.
EM Elpeleg@cc.huji.ac.il
RI Bitner-Glindzicz, Maria/A-4231-2009; Rahman, Shamima/C-5232-2008;
   Hershkovitz, Eli/F-1922-2012; Saada, Ann/J-6864-2017
OI Hershkovitz, Eli/0000-0003-1624-1960; Saada, Ann/0000-0003-2951-0656
CR ALLEN DA, 1986, FEBS LETT, V194, P171, DOI 10.1016/0014-5793(86)80071-0
   Andreoli C, 2004, NUCLEIC ACIDS RES, V32, pD459, DOI 10.1093/nar/gkh137
   Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848
   BOGENHAGEN D, 1976, J BIOL CHEM, V251, P2938
   Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200
   BRADSHAW PC, 2005, AM J PHYSL CELL PHYS
   CHA S, 1964, J BIOL CHEM, V239, P1961
   Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391
   DOOIJEWAARD G, 1976, BIOCHIM BIOPHYS ACTA, V440, P1, DOI 10.1016/0005-2728(76)90109-2
   Ducluzeau PH, 1999, J HEPATOL, V30, P149, DOI 10.1016/S0168-8278(99)80019-1
   Elpeleg O, 2003, PEDIATR RES, V54, P153, DOI 10.1203/01.PDR.0000072796.25097.A5
   Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8
   Johnson JD, 1998, J BIOL CHEM, V273, P27580, DOI 10.1074/jbc.273.42.27580
   Johnson JD, 1998, J BIOL CHEM, V273, P27573, DOI 10.1074/jbc.273.42.27573
   KADRMAS EF, 1991, BIOCHIM BIOPHYS ACTA, V1074, P339, DOI 10.1016/0304-4165(91)90083-S
   KAVANAUGHBLACK A, 1994, P NATL ACAD SCI USA, V91, P5883, DOI 10.1073/pnas.91.13.5883
   Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710
   Lambeth DO, 2004, J BIOL CHEM, V279, P36621, DOI 10.1074/jbc.M406884200
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Milon L, 2000, J BIOL CHEM, V275, P14264, DOI 10.1074/jbc.275.19.14264
   Milon L, 1997, HUM GENET, V99, P550, DOI 10.1007/s004390050405
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Parks RE., 1973, ENZYMES, VVIII, P307
   Rustin P, 1997, BBA-MOL BASIS DIS, V1361, P185, DOI 10.1016/S0925-4439(97)00035-5
   Saada A, 2004, DNA CELL BIOL, V23, P797
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SANADI DR, 1954, BIOCHIM BIOPHYS ACTA, V14, P434, DOI 10.1016/0006-3002(54)90205-X
   Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849
   TRITSCHLER HJ, 1992, NEUROLOGY, V42, P209, DOI 10.1212/WNL.42.1.209
   Vu TH, 1998, NEUROLOGY, V50, P1783, DOI 10.1212/WNL.50.6.1783
   WEITZMAN PDJ, 1986, FEBS LETT, V199, P57, DOI 10.1016/0014-5793(86)81223-6
NR 33
TC 240
Z9 259
U1 0
U2 17
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0002-9297
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD JUN
PY 2005
VL 76
IS 6
BP 1081
EP 1086
DI 10.1086/430843
PG 6
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 925IX
UT WOS:000229047900014
PM 15877282
OA Green Accepted, Bronze, Green Published
DA 2024-11-01
ER

PT J
AU Andalib, S
   Vafaee, MS
   Gjedde, A
AF Andalib, Sasan
   Vafaee, Manouchehr Seyedi
   Gjedde, Albert
TI Parkinson's disease and mitochondrial gene variations: A review
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Review
DE Parkinson's disease; Mitochondrial DNA variations; Mitochondrial
   dysfunction; Mitochondrial DNA nucleotide position; Genetic
   susceptibility; Central nervous system
ID HEREDITARY OPTIC NEUROPATHY; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   TRANSFER-RNA GENES; DNA MUTATIONS; OXIDATIVE DAMAGE; SEQUENCE-ANALYSIS;
   LACTIC-ACIDOSIS; ALPHA-SYNUCLEIN; COMPLEX I; PHYLOGENETIC ANALYSIS
AB Parkinson's disease (PD) is a common disorder of the central nervous system in the elderly. The pathogenesis of PD is a complex process, with genetics as an important contributing factor. This factor may stem from mitochondrial gene variations and mutations as well as from nuclear gene variations and mutations. More recently, a particular role of mitochondrial dysfunction has been suggested, arising from mitochondrial DNA variations or acquired mutations in PD pathogenesis. The present review summarizes and weighs the evidence in support of mitochondrial DNA (mtDNA) variations as important contributors to the development and course of PD. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Andalib, Sasan] Tabriz Univ Med Sci, Imam Reza Hosp, Neurosci Res Ctr, Tabriz, Iran.
   [Vafaee, Manouchehr Seyedi; Gjedde, Albert] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Copenhagen, Denmark.
C3 Tabriz University of Medical Science; University of Copenhagen
RP Andalib, S (corresponding author), Tabriz Univ Med Sci, Imam Reza Hosp, Neurosci Res Ctr, Tabriz, Iran.
EM andalibsa@tbzmed.ac.ir
RI Gjedde, Albert/I-2452-2019; Andalib, Sasan/H-9062-2017
OI Gjedde, Albert/0000-0002-3756-7401; Andalib, Sasan/0000-0003-0904-0925
CR Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868
   Andalib S, 2013, J NEUROL SCI, V330, P10, DOI 10.1016/j.jns.2013.04.018
   [Anonymous], 2002, Mov Disord, V17 Suppl 4, pS38
   [Anonymous], J CHIN CLIN MED
   [Anonymous], FRONT NEUROENERG
   [Anonymous], C R ACAD SCI 3
   [Anonymous], BIOMED RES INT
   [Anonymous], J ANAL RES CLIN MED
   [Anonymous], ADV CELL AGING GERON
   Autere J, 2004, HUM GENET, V115, P29, DOI 10.1007/s00439-004-1123-9
   Awadalla P, 1999, SCIENCE, V286, P2524, DOI 10.1126/science.286.5449.2524
   Bandmann O, 1997, J NEUROL, V244, P262, DOI 10.1007/s004150050082
   BEAL MF, 1993, TRENDS NEUROSCI, V16, P125, DOI 10.1016/0166-2236(93)90117-5
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Berardelli A, 2001, BRAIN, V124, P2131, DOI 10.1093/brain/124.11.2131
   Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0
   Borghammer P, 2008, ACTA NEUROL SCAND, V117, P317, DOI 10.1111/j.1600-0404.2007.00943.x
   Borghammer P, 2012, J NEUROL SCI, V313, P123, DOI 10.1016/j.jns.2011.09.010
   Bronte-Stewart HM, 2002, BRAIN, V125, P2100, DOI 10.1093/brain/awf207
   Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P
   Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8
   Brown MD, 1997, AM J HUM GENET, V60, P381
   Brown MD, 2001, HUM GENET, V109, P33, DOI 10.1007/s004390100538
   BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405
   Caballol N, 2007, MOVEMENT DISORD, V22, pS358, DOI 10.1002/mds.21677
   Carod-Artal FJ, 2006, NEUROLOGIA, V21, P357
   Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8
   Chen CM, 2007, J NEURAL TRANSM, V114, P1017, DOI 10.1007/s00702-007-0658-z
   Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188
   Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209
   CHUI HC, 1985, NEUROLOGY, V35, P1544, DOI 10.1212/WNL.35.11.1544
   Clark J, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-69
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008
   CURTIS L, 1984, LANCET, V2, P211
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Davie CA, 2008, BRIT MED BULL, V86, P109, DOI 10.1093/bmb/ldn013
   de la Monte SM, 2000, LAB INVEST, V80, P1323, DOI 10.1038/labinvest.3780140
   de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9
   DITTER SM, 1987, NEUROLOGY, V37, P754, DOI 10.1212/WNL.37.5.754
   Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x
   Eerola J, 2010, NEUROSCI LETT, V477, P1, DOI 10.1016/j.neulet.2010.04.021
   Egensperger R, 1997, NEUROPATH APPL NEURO, V23, P315, DOI 10.1046/j.1365-2990.1997.4098040.x
   Floor E, 1998, J NEUROCHEM, V70, P268
   García-Lozano JR, 2002, EUR NEUROL, V48, P34, DOI 10.1159/000064955
   Gaweda-Walerych K, 2010, NEUROSCI LETT, V469, P24, DOI 10.1016/j.neulet.2009.11.037
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   Giladi N, 2000, PARKINSONISM RELAT D, V6, P165, DOI 10.1016/S1353-8020(99)00062-0
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198
   Golbe LI, 1996, ANN NEUROL, V40, P767, DOI 10.1002/ana.410400513
   GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   Grasbon-Frodl EM, 1999, NEUROGENETICS, V2, P121, DOI 10.1007/s100480050063
   Grazina M, 2006, GENES BRAIN BEHAV, V5, P92, DOI 10.1111/j.1601-183X.2006.00225.x
   Gu GY, 2002, J NEUROPATH EXP NEUR, V61, P634, DOI 10.1093/jnen/61.7.634
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924
   Hoehn MM, 2001, NEUROLOGY, V57, pS11
   HOWELL N, 1995, GENETICS, V140, P285
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016
   IKEBE S, 1995, MOL BRAIN RES, V28, P281, DOI 10.1016/0169-328X(94)00209-W
   Inoue M, 2003, CURR MED CHEM, V10, P2495, DOI 10.2174/0929867033456477
   Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045
   Jenner P, 1995, Neurology, V45, pS6
   Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483
   Jenner P, 1998, ANN NEUROL, V44, pS72, DOI 10.1002/ana.410440712
   Jenner P, 1998, MOVEMENT DISORD, V13, P24
   JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5
   Jun AS, 1996, MOL CELL BIOL, V16, P771
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017
   Kirchner SC, 2000, NEUROTOXICOLOGY, V21, P441
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Klein C, 2006, NAT CLIN PRACT NEURO, V2, P136, DOI 10.1038/ncpneuro0126
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Kosel S, 1998, NEUROGENETICS, V1, P197, DOI 10.1007/s100480050029
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540
   Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012
   Lin CH, 2008, NEUROLOGY, V71, P1727, DOI 10.1212/01.wnl.0000335167.72412.68
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Lodi R, 2000, BRAIN, V123, P1896, DOI 10.1093/brain/123.9.1896
   Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102
   Lücking CB, 2000, CELL MOL LIFE SCI, V57, P1894, DOI 10.1007/PL00000671
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Marder K, 1996, NEUROLOGY, V47, P155, DOI 10.1212/WNL.47.1.155
   Matsumine H, 1997, AM J HUM GENET, V60, P588
   MAYEUX R, 1985, NEUROLOGY, V35, P453, DOI 10.1212/WNL.35.4.453
   Mellick GD, 2009, PARKINSONISM RELAT D, V15, P105, DOI 10.1016/j.parkreldis.2007.11.016
   Mihailova SM, 2007, EUR J NEUROL, V14, P44, DOI 10.1111/j.1468-1331.2006.01541.x
   Mizuno Y, 1998, ANN NEUROL, V44, pS99, DOI 10.1002/ana.410440715
   Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165
   Otaegui D, 2004, NEUROSCI LETT, V370, P171, DOI 10.1016/j.neulet.2004.08.012
   Paisán-Ruíz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023
   Parker WD, 2005, BIOCHEM BIOPH RES CO, V326, P667, DOI 10.1016/j.bbrc.2004.11.093
   PAYAMI H, 1994, ANN NEUROL, V36, P659, DOI 10.1002/ana.410360417
   Perry G, 2002, FREE RADICAL BIO MED, V33, P1475, DOI 10.1016/S0891-5849(02)01113-9
   Petrozzi L, 2007, BIOSCIENCE REP, V27, P87, DOI 10.1007/s10540-007-9038-z
   Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045
   Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884
   Richard Irene H, 2004, Cogn Behav Neurol, V17, P201
   RICHTER C, 1995, INT J BIOCHEM CELL B, V27, P647, DOI 10.1016/1357-2725(95)00025-K
   Richter G, 2002, J NEURAL TRANSM, V109, P721, DOI 10.1007/s007020200060
   RINNE UK, 1972, Z NEUROL, V202, P1, DOI 10.1007/BF00316422
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8
   Rozen TD, 2004, HEADACHE, V44, P674, DOI 10.1111/j.1526-4610.2004.04126.x
   Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8
   Sapir S, 2008, CURR OPIN OTOLARYNGO, V16, P205, DOI 10.1097/MOO.0b013e3282febd3a
   Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7
   Schapira AHV, 2006, NEUROLOGY, V66, pS10, DOI 10.1212/WNL.66.10_suppl_4.S10
   Schulz-Schaeffer WJ, 2010, ACTA NEUROPATHOL, V120, P131, DOI 10.1007/s00401-010-0711-0
   SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Simon DK, 2000, NEUROLOGY, V54, P703, DOI 10.1212/WNL.54.3.703
   SPEHLMANN R, 1976, LANCET, V1, P724
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Takasaki S, 2008, COMPUT BIOL CHEM, V32, P332, DOI 10.1016/j.compbiolchem.2008.03.014
   TANAKA M, 1991, BIOCHEM BIOPH RES CO, V174, P861, DOI 10.1016/0006-291X(91)91497-Z
   Thomas B, 2010, MOVEMENT DISORD, V25, pS155, DOI 10.1002/mds.22781
   Torroni A, 1997, AM J HUM GENET, V60, P1107
   Tsunemi T, 2012, PROG NEUROBIOL, V97, P142, DOI 10.1016/j.pneurobio.2011.10.004
   Vafaee MS, 2004, NEUROIMAGE, V22, P966, DOI 10.1016/j.neuroimage.2004.02.019
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Vila M, 2008, J NEUROCHEM, V107, P317, DOI 10.1111/j.1471-4159.2008.05604.x
   Vives-Bauza C, 2002, BIOCHEM BIOPH RES CO, V290, P1593, DOI 10.1006/bbrc.2002.6388
   Wallace D.C., 2001, The Metabolic and Molecular Basis of Inherited Disease, P2425
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901
   Wei YH, 1998, ANN NY ACAD SCI, V854, P155, DOI 10.1111/j.1749-6632.1998.tb09899.x
   Yen MY, 2002, JPN J OPHTHALMOL, V46, P45, DOI 10.1016/S0021-5155(01)00460-9
   Zhang J, 1999, AM J PATHOL, V154, P1423, DOI 10.1016/S0002-9440(10)65396-5
NR 140
TC 23
Z9 28
U1 0
U2 29
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD NOV 15
PY 2014
VL 346
IS 1-2
BP 11
EP 19
DI 10.1016/j.jns.2014.07.067
PG 9
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA AU9YH
UT WOS:000345947400004
PM 25151610
DA 2024-11-01
ER

PT J
AU Finsterer, J
AF Finsterer, Josef
TI Atheromatosis of the Scalp: A Novel Feature of Chronic Progressive
   External Ophthalmoplegia Plus Due to a Single Mitochondrial DNA Deletion
SO CUREUS JOURNAL OF MEDICAL SCIENCE
LA English
DT Article
DE phenotypic heterogeneity; phenotype; psoriasis; respiratory chain;
   atheroma; mitochondrial; multisystem; ophthalmoplegia; deletion; mtdna
ID RETINAL DEGENERATION; MUTATION
AB Chronic progressive external ophthalmoplegia (CPEO) manifests phenotypically as ptosis with ophthalmoplegia or CPEO-plus, with the affection of muscles or organs other than the extra-ocular eye muscles. Herein, a case of CPEO-plus caused by a single mitochondrial DNA (mtDNA) deletion is represented, along with several previously unreported phenotypic features. The patient is a 76-year-old Caucasian female who had experienced slowly progressive bilateral ptosis since the age of 15, followed by gradual ophthalmoparesis without double vision. Since the age of 56, she had developed mild quadriparesis, depression, easy fatigability, hypersomnia, a facial tic, optic atrophy, cataract, glaucoma, hepatomegaly, hepatic steatosis, cholecystolithiasis, diverticulosis, hyperhidrosis, mild hyper-creatine-kinase-emia, hyperlipidemia, and hyperuricemia. Moreover, she had faced previously unreported manifestations of mitochondrial disorders, psoriasis, and multiple scalp atheromas. The phenotype and a single 5kb mtDNA deletion were employed to diagnose CPEO-plus. This case demonstrates that the phenotypic spectrum of CPEO-plus is broader than expected, that psoriasis and scalp atheromas are unique features of a mitochondrial disorder, and that CPEO progresses to CPEO-plus during the years.
C1 [Finsterer, Josef] Neurol Neurol & Neurophysiol Ctr, Vienna, Austria.
RP Finsterer, J (corresponding author), Neurol Neurol & Neurophysiol Ctr, Vienna, Austria.
EM fipaps@yahoo.de
RI Finsterer, J/AAE-5733-2020
CR BEC P, 1974, ARCH OPHTALMOL-PARIS, V34, P879
   Berardo A, 2010, NEUROMUSCULAR DISORD, V20, P204, DOI 10.1016/j.nmd.2010.01.006
   BROCKINGTON M, 1993, NAT GENET, V4, P67, DOI 10.1038/ng0593-67
   Filosto M, 2016, MOL GENET METAB REP, V6, P70, DOI 10.1016/j.ymgmr.2016.02.001
   Finsterer J, 2013, CAN J NEUROL SCI, V40, P635, DOI 10.1017/S0317167100014852
   Finsterer J, 2013, NEUROL INT, V5, P28, DOI 10.4081/ni.2013.e9
   Guo L, 2021, NEUROMUSCULAR DISORD, V31, P859, DOI 10.1016/j.nmd.2021.06.014
   Hansrote S, 2002, J NEUROL SCI, V197, P63, DOI 10.1016/S0022-510X(02)00048-5
   Jiang PF, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20201856
   Lv ZY, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008869
   Ma L, 2020, INT J NEUROSCI, V130, P319, DOI 10.1080/00207454.2019.1681422
   Maghbooli M, 2020, NEUROL INDIA, V68, P760, DOI 10.4103/0028-3886.293454
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0652-7
   Orimo S, 1992, Rinsho Shinkeigaku, V32, P37
   Pfeffer G, 2011, CAN J NEUROL SCI, V38, P119, DOI 10.1017/S031716710001115X
   Rodríguez-López C, 2020, J MED GENET, V57, P643, DOI 10.1136/jmedgenet-2019-106649
   Santoro L, 2006, J NEUROL, V253, P869, DOI 10.1007/s00415-006-0082-6
   Tafakhori A, 2016, ARCH IRAN MED, V19, P87, DOI 0161902/AIM.004
   TROBE JD, 1977, AM J OPHTHALMOL, V83, P372, DOI 10.1016/0002-9394(77)90736-X
   Wong LJC, 2003, J MED GENET, V40
   Yasui M, 1993, No To Shinkei, V45, P741
NR 21
TC 0
Z9 0
U1 0
U2 0
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2168-8184
J9 CUREUS J MED SCIENCE
JI Cureus J Med Sci
PD DEC 23
PY 2021
VL 13
IS 12
AR e20641
DI 10.7759/cureus.20641
PG 6
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA XX2FX
UT WOS:000736119600005
PM 35103203
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Lin, TK
   Chen, SD
   Chuang, YC
   Lan, MY
   Chuang, JH
   Wang, PW
   Hsu, TY
   Wang, FS
   Tsai, MH
   Huang, ST
   Wang, XW
   Tsai, PC
   Lin, HY
   Liou, CW
AF Lin, Tsu-Kung
   Chen, Shang-Der
   Chuang, Yao-Chung
   Lan, Min-Yu
   Chuang, Jiin-Haur
   Wang, Pei-Wen
   Hsu, Te-Yao
   Wang, Feng-Sheng
   Tsai, Meng-Han
   Huang, Sheng-Teng
   Wang, Xiao-Wen
   Tsai, Po-Chin
   Lin, Hung-Yu
   Liou, Chia-Wei
TI Mitochondrial Transfer of Wharton's Jelly Mesenchymal Stem Cells
   Eliminates Mutation Burden and Rescues Mitochondrial Bioenergetics in
   Rotenone-Stressed MELAS Fibroblasts
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
AB Wharton's jelly mesenchymal stem cells (WJMSCs) transfer healthy mitochondria to cells harboring a mitochondrial DNA (mtDNA) defect. Mitochondrial myopathy, encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) is one of the major subgroups of mitochondrial diseases, caused by the mt.3243A>G point mutation in the mitochondrial tRNALeu((UUR)) gene. The specific aim of the study is to investigate whether WJMSCs exert therapeutic effect for mitochondrial dysfunction in cells of MELAS patient through donating healthy mitochondria. We herein demonstrate that WJMSCs transfer healthy mitochondria into rotenone-stressed fibroblasts of a MELAS patient, thereby eliminating mutation burden and rescuing mitochondria! functions. In the coculture system in vitro study, WJMSCs transferred healthy mitochondria to rotenone-stressed MELAS fibroblasts. By inhibiting actin polymerization to block tunneling nanotubes (TNTs), the WJMSC-conducted mitochondria! transfer was abrogated. After mitochondrial transfer, the mt.3243A>G mutation burden of MELAS fibroblasts was reduced to an undetectable level, with long-term retention. Sequencing results confirmed that the transferred mitochondria were donated from WJMSCs. Furthermore, mitochondrial transfer of WJMSCs to MELAS fibroblasts improves mitochondria! functions and cellular performance, including protein translation of respiratory complexes, ROS overexpression, mitochondrial membrane potential, mitochondrial morphology and bioenergetics, cell proliferation, mitochondrion-dependent viability, and apoptotic resistance. This study demonstrates that WJMSCs exert bioenergetic therapeutic effects through mitochondrial transfer. This finding paves the way for the development of innovative treatments for MELAS and other mitochondrial diseases.
C1 [Lin, Tsu-Kung; Chen, Shang-Der; Chuang, Yao-Chung; Lan, Min-Yu; Tsai, Meng-Han; Wang, Xiao-Wen; Tsai, Po-Chin; Liou, Chia-Wei] Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung 833, Taiwan.
   [Lin, Tsu-Kung; Chen, Shang-Der; Chuang, Yao-Chung; Lan, Min-Yu; Chuang, Jiin-Haur; Wang, Pei-Wen; Hsu, Te-Yao; Wang, Feng-Sheng; Tsai, Meng-Han; Wang, Xiao-Wen; Tsai, Po-Chin; Lin, Hung-Yu; Liou, Chia-Wei] Chang Gung Univ, Coll Med, Kaohsiung 833, Taiwan.
   [Lin, Tsu-Kung; Chuang, Jiin-Haur; Wang, Pei-Wen; Wang, Feng-Sheng; Wang, Xiao-Wen; Tsai, Po-Chin; Lin, Hung-Yu] Kaohsiung Chang Gung Mem Hosp, Mitochondrial Res Unit, Kaohsiung 833, Taiwan.
   [Lin, Tsu-Kung] Kaohsiung Chang Gung Mem Hosp, Ctr Parkinsons Dis, Kaohsiung 833, Taiwan.
   [Chuang, Jiin-Haur; Lin, Hung-Yu] Kaohsiung Chang Gung Mem Hosp, Dept Pediat Surg, Kaohsiung 833, Taiwan.
   [Wang, Pei-Wen] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Kaohsiung 833, Taiwan.
   [Hsu, Te-Yao; Liou, Chia-Wei] Kaohsiung Chang Gung Mem Hosp, Dept Obstet & Gynecol, Kaohsiung 833, Taiwan.
   [Wang, Feng-Sheng; Liou, Chia-Wei] Chang Gung Univ, Core Lab Phen & Diagnost, Coll Med, Kaohsiung, Taiwan.
   [Wang, Feng-Sheng] Chang Gung Univ, Dept Med Res, Coll Med, Kaohsiung, Taiwan.
   [Huang, Sheng-Teng] China Med Univ Hosp, Dept Chinese Med, Taichung, Taiwan.
C3 Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial
   Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital;
   Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung
   University; Chang Gung University; China Medical University Taiwan;
   China Medical University Hospital - Taiwan
RP Liou, CW (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung 833, Taiwan.; Lin, HY; Liou, CW (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung 833, Taiwan.; Lin, HY (corresponding author), Kaohsiung Chang Gung Mem Hosp, Mitochondrial Res Unit, Kaohsiung 833, Taiwan.; Lin, HY (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Pediat Surg, Kaohsiung 833, Taiwan.; Liou, CW (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Obstet & Gynecol, Kaohsiung 833, Taiwan.; Liou, CW (corresponding author), Chang Gung Univ, Core Lab Phen & Diagnost, Coll Med, Kaohsiung, Taiwan.
EM linhungyu700218@gmail.com; cwliou@ms22.hinet.net
RI Tsai, Meng-Han/ABE-7540-2021; Wu, mingyang/ABA-7526-2021
OI Wang, Pei-Wen/0000-0002-6369-8712; Tsai, Meng-Han/0000-0002-4570-5712;
   Lin, Tsu-Kung/0000-0001-6656-1319; Lan, Min-Yu/0000-0001-7361-8475; Lin,
   Hung-Yu/0000-0002-9035-5408
FU Chang Gung Memorial Hospital [CORPG8F1021-2, CMRPG8E0291-3, CMRPG8H0191,
   CMRPG8I0231]; Ministry of Science and Technology, Taiwan
   [105-2314-B-182A-010, 106-2314-B-182A-057-MY3]
FX This work was supported by grants from the Chang Gung Memorial Hospital
   (CORPG8F1021-2, CMRPG8E0291-3, CMRPG8H0191, and CMRPG8I0231) and the
   Ministry of Science and Technology, Taiwan (105-2314-B-182A-010 and
   106-2314-B-182A-057-MY3). The authors acknowledge the kind gifts,
   Cox4-DsRedand Su9-EGFP plasmids, from Dr. David Chan (California
   Institute of Technology, Pasadena, CA 91125, USA). The authors thank the
   Stem Cell Research Core Laboratory Facilities at Kaohsiung Chang Gung
   Memorial Hospital for technical support. The authors would like to thank
   Drs. Kuang-Tzu Huang and Li-Wen Hsu for their assistance in operating
   the ImageXpress Micro High-Content Imaging ? System, located in the
   Institute of Translational Research in Biomedicine, Kaohsiung Chang Gung
   Memorial Hospital. The authors would like to thank James Waddell for his
   assistance in the proofreading and editing of this manuscript.
CR Ahmad T, 2014, EMBO J, V33, P994, DOI 10.1002/embj.201386030
   Arutyunyan I, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/6901286
   Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019
   Chen MY, 2009, EXP HEMATOL, V37, P629, DOI 10.1016/j.exphem.2009.02.003
   Chuang YC, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5691215
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje
   de Andrade PBM, 2006, DIABETOLOGIA, V49, P1816, DOI 10.1007/s00125-006-0301-9
   Dimmeler S, 2008, CIRC RES, V102, P1319, DOI 10.1161/CIRCRESAHA.108.175943
   Fong CY, 2011, STEM CELL REV REP, V7, P1, DOI 10.1007/s12015-010-9166-x
   Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946
   Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606
   Gropman AL, 2001, PEDIATR NEUROL, V1, P185, DOI DOI 10.1007/S11910-001-0015-9
   HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0
   Hsu YC, 2016, SEMIN CELL DEV BIOL, V52, P119, DOI 10.1016/j.semcdb.2016.02.011
   ICHIKI T, 1988, ANN NEUROL, V23, P287, DOI 10.1002/ana.410230312
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736
   Jezek P, 2009, INT J BIOCHEM CELL B, V41, P1790, DOI 10.1016/j.biocel.2009.02.014
   KOBAYASHI M, 1987, J PEDIATR-US, V110, P223, DOI 10.1016/S0022-3476(87)80158-0
   Li XY, 2014, INT J MOL MED, V34, P695, DOI 10.3892/ijmm.2014.1821
   Lin HY, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7514383
   Lin HY, 2015, MITOCHONDRION, V22, P31, DOI 10.1016/j.mito.2015.02.006
   LIOU C, 2002, ACTA NEUROL SCAND, V90, P354
   Otera H, 2012, INT J CELL BIOL, V2012, P821676, DOI 10.1155/2012/821676
   Peng JY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002212
   Rusanen H, 2000, BBA-MOL BASIS DIS, V1500, P10, DOI 10.1016/S0925-4439(99)00081-2
   Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133
   Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Szczepanowska J, 2012, BBA-BIOENERGETICS, V1817, P1740, DOI 10.1016/j.bbabio.2012.02.028
   Tafrechi RSJ, 2005, MUTAT RES-FUND MOL M, V578, P43, DOI 10.1016/j.mrfmmm.2005.02.002
   Tang BL, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5010001
   Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312
   Torralba D, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00107
   Wang X, 2015, CELL DEATH DIFFER, V22, P1181, DOI 10.1038/cdd.2014.211
   Wittenhagen LM, 2002, NAT STRUCT BIOL, V9, P586, DOI 10.1038/nsb820
   Wolf DP, 2015, TRENDS MOL MED, V21, P68, DOI 10.1016/j.molmed.2014.12.001
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
NR 39
TC 27
Z9 28
U1 0
U2 5
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PY 2019
VL 2019
AR 9537504
DI 10.1155/2019/9537504
PG 17
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA IB3RZ
UT WOS:000470186000001
PM 31249652
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU Karkos, PD
   Waldron, M
   Johnson, IJ
AF Karkos, PD
   Waldron, M
   Johnson, IJ
TI The MELAS syndrome. Review of the literature: the role of the otologist
SO CLINICAL OTOLARYNGOLOGY
LA English
DT Review
DE MELAS syndrome; sensorineural hearing loss; mitochondrial cytopathy
ID SENSORINEURAL HEARING-LOSS; STROKE-LIKE EPISODES; MITOCHONDRIAL
   MYOPATHY; LACTIC-ACIDOSIS; COCHLEAR IMPLANTATION; MUTATION;
   ENCEPHALOPATHY; DISEASE; DNA; ENCEPHALOMYOPATHY
AB The mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome is a rare congenital disorder of mitochondrial DNA (mt-DNA). Patients with this syndrome may present to the otolaryngologist with sensorineural hearing loss (SNHL), which is genetic in origin. A high index of suspicion is required because this hearing loss is part of a syndrome for which early diagnosis and intervention is required.
C1 Freeman Rd Hosp, Dept Otolaryngol, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle Freeman Hospital
RP Freeman Rd Hosp, Dept Otolaryngol, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.
EM pkarkos@aol.com
CR BINDOFF LA, 1994, DIS VOLUNTARY MUSCLE, P717
   CARROLL JE, 1976, NEUROLOGY, V26, P140, DOI 10.1212/WNL.26.2.140
   Cerri C, 1983, MITOCHONDRIAL PATHOL, P141
   Chinnery PF, 1997, J NEUROL NEUROSUR PS, V63, P559, DOI 10.1136/jnnp.63.5.559
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chinnery PF, 2000, BRAIN, V123, P82, DOI 10.1093/brain/123.1.82
   CHINNERY PF, 1999, LANCET S1, V354, P1721
   DALLOS P, 1995, SCIENCE, V267, P2006, DOI 10.1126/science.7701325
   Deschauer M, 2001, ARCH NEUROL-CHICAGO, V58, P1885, DOI 10.1001/archneur.58.11.1885
   DONOVAN TJ, 1995, ANN OTO RHINOL LARYN, V104, P786, DOI 10.1177/000348949510401007
   Edmonds JL, 2002, ARCH OTOLARYNGOL, V128, P355, DOI 10.1001/archotol.128.4.355
   FERNANDEZ C, 1974, ACTA OTO-LARYNGOL, V78, P173, DOI 10.3109/00016487409126343
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hill D, 2001, J NEUROL NEUROSUR PS, V71, P281, DOI 10.1136/jnnp.71.2.281
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Keats BJB, 2002, J COMMUN DISORD, V35, P355, DOI 10.1016/S0021-9924(02)00090-4
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Nadol JB, 2001, INT J PEDIATR OTORHI, V61, P1, DOI 10.1016/S0165-5876(01)00546-8
   Nance W E, 1980, Birth Defects Orig Artic Ser, V16, P263
   NAVIAUX RK, 1999, ATLAS METABOLIC DIS, P314
   OSHIMA T, 1999, ASS RES OTOLARYNGOLO, P11
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385
   Rosenthal EL, 1999, AM J OTOL, V20, P187
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   SHAPIRA Y, 1975, NEUROLOGY, V25, P614, DOI 10.1212/WNL.25.7.614
   SKOGLUND RR, 1979, NEUROLOGY, V29, P717, DOI 10.1212/WNL.29.5.717
   Sue CM, 1998, ANN NEUROL, V43, P350, DOI 10.1002/ana.410430313
   SWIFT AC, 1988, J LARYNGOL OTOL, V102, P626, DOI 10.1017/S0022215100105912
   Thompson VA, 1997, ANESTH ANALG, V85, P1404, DOI 10.1097/00000539-199712000-00041
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   VERNHAM GA, 1994, CLIN OTOLARYNGOL, V19, P314, DOI 10.1111/j.1365-2273.1994.tb01238.x
   Warrick PD, 1997, J LARYNGOL OTOL, V111, P279, DOI 10.1017/S0022215100137089
NR 35
TC 9
Z9 13
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1749-4478
EI 1749-4486
J9 CLIN OTOLARYNGOL
JI Clin. Otolaryngol.
PD FEB
PY 2004
VL 29
IS 1
BP 1
EP 4
DI 10.1111/j.1365-2273.2004.00769.x
PG 4
WC Otorhinolaryngology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Otorhinolaryngology
GA 760TB
UT WOS:000187849600001
PM 14961844
DA 2024-11-01
ER

PT J
AU Daher, R
   Mansouri, A
   Martelli, A
   Bayart, S
   Manceau, H
   Callebaut, I
   Moulouel, B
   Gouya, L
   Puy, H
   Kannengiesser, C
   Karim, Z
AF Daher, Raed
   Mansouri, Abdellah
   Martelli, Alain
   Bayart, Sophie
   Manceau, Hana
   Callebaut, Isabelle
   Moulouel, Boualem
   Gouya, Laurent
   Puy, Herve
   Kannengiesser, Caroline
   Karim, Zoubida
TI <i>GLRX5</i> mutations impair heme biosynthetic enzymes ALA synthase 2
   and ferrochelatase in Human congenital sideroblastic anemia
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE GLRX5; Sideroblastic anemia; Porphyrins; Mitochondria; Heme; Iron
ID HEPATIC MITOCHONDRIAL-DNA; MONOTHIOL GLUTAREDOXINS; GENE; DEGRADATION;
   DEFICIENCY; DELETIONS; CLUSTERS; MYOPATHY; COMPLEX
AB Non-syndromic microcytic congenital sideroblastic anemia (cSA) is predominantly caused by defective genes encoding for either ALAS2, the first enzyme of heme biosynthesis pathway or SLC25A38, the mitochondrial importer of glycine, an ALAS2 substrate. Herein we explored a new case of cSA with two mutations in GLRX5, a gene for which only two patients have been reported so far. The patient was a young female with biallelic compound heterozygous mutations in GLRX5 (p.Cys67Tyr and p.Met128Lys). Three-D structure analysis confirmed the involvement of Cys67 in the coordination of the [2Fe-2S] cluster and suggested a potential role of Met128 in partner interactions. The protein-level of ferrochelatase, the terminal-enzyme of heme process, was increased both in patient-derived lymphoblastoid and CD34 + cells, however, its activity was drastically decreased. The activity of ALAS2 was found altered and possibly related to a defect in the biogenesis of its cosubstrate, the succinyl-CoA. Thus, the patient exhibits both a very low ferrochelatase activity without any accumulation of porphyrins precursors in contrast to what is reported in erythropoietic protoporphyria with solely impaired ferrochelatase activity. A significant oxidative stress was evidenced by decreased reduced glutathione and aconitase activity, and increased MnSOD protein expression. This oxidative stress depleted and damaged mtDNA, decreased complex I and IV activities and depleted ATP content. Collectively, our study demonstrates the key role of GLRX5 in modulating ALAS2 and ferrochelatase activities and in maintaining mitochondrial function.
C1 [Daher, Raed; Mansouri, Abdellah; Manceau, Hana; Gouya, Laurent; Puy, Herve; Kannengiesser, Caroline; Karim, Zoubida] INSERM, U1149, CRI, Paris, France.
   [Daher, Raed; Mansouri, Abdellah; Manceau, Hana; Gouya, Laurent; Puy, Herve; Kannengiesser, Caroline; Karim, Zoubida] Univ Paris Diderot, Sorbonne Paris Cite, DHU UNITY, Site Bichat, Paris, France.
   [Daher, Raed; Manceau, Hana; Gouya, Laurent; Puy, Herve; Kannengiesser, Caroline; Karim, Zoubida] Lab Excellence GR Ex, Paris, France.
   [Martelli, Alain] Dept Translat Med & Neurogenet, Illkirch Graffenstaden, France.
   [Bayart, Sophie] CHU Rennes, Hop Sud, Dept Pediat Hematol, Rennes, France.
   [Callebaut, Isabelle] Univ Pierre & Marie Curie Paris6, Sorbonne Univ, CNRS, UMR7590,MNHN,IRD,IUC, Paris, France.
   [Daher, Raed; Moulouel, Boualem; Gouya, Laurent; Puy, Herve] Hop Louis Mourier, AP HP, CFP, Colombes, France.
   [Daher, Raed; Kannengiesser, Caroline] Hop Bichat Claude Bernard, AP HP, Dept Genet, Paris, France.
   [Martelli, Alain] Pfizer Inc, Rare Dis Res Unit, Cambridge, MA USA.
C3 Universite Paris Cite; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Universite Paris Cite; Universite de Rennes; CHU
   Rennes; Universite Paris Cite; Centre National de la Recherche
   Scientifique (CNRS); CNRS - Institute of Physics (INP); Museum National
   d'Histoire Naturelle (MNHN); Institut de Recherche pour le Developpement
   (IRD); Sorbonne Universite; Universite Paris Cite; Assistance Publique
   Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP;
   Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Bichat-Claude Bernard - APHP; Pfizer
RP Puy, H; Karim, Z (corresponding author), INSERM, U1149, CRI, Paris, France.
EM herve.puy@aphp.fr; Zoubida.karim@inserm.fr
RI PUY, HERVE/O-1785-2017; Manceau, Hana/P-2970-2017; Mansouri,
   Abdellah/B-3002-2017
OI Callebaut, Isabelle/0000-0003-3124-887X; Manceau,
   Hana/0000-0003-4158-0964; Mansouri, Abdellah/0000-0003-3856-5771; KARIM,
   Zoubida/0000-0002-3724-5592
FU INSEAM; Paris Diderot University, France; Laboratory of excellence
   GR-Ex, Paris, France [ANR-11-LABX-0051]; program "Investissements
   d'avenir " of the French National Research Agency [ANR-11-IDEX-0005-02]
FX INSEAM and Paris Diderot University, France supported this work. Raed
   Daher was supported by the Laboratory of excellence GR-Ex, Paris,
   France, reference ANR-11-LABX-0051, which is funded by the program
   "Investissements d'avenir " of the French National Research Agency,
   reference ANR-11-IDEX-0005-02. We are very grateful to "Association
   LEYLA" for supporting Raed Daher's congress participation.
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Baker PR, 2014, BRAIN, V137, P366, DOI 10.1093/brain/awt328
   Bandyopadhyay S, 2008, EMBO J, V27, P1122, DOI 10.1038/emboj.2008.50
   Bekri S, 2000, BLOOD, V96, P3256
   Bergmann AK, 2010, PEDIATR BLOOD CANCER, V54, P273, DOI 10.1002/pbc.22244
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Camaschella C, 2008, BRIT J HAEMATOL, V143, P27, DOI 10.1111/j.1365-2141.2008.07290.x
   Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520
   Cazzola M, 2003, BLOOD, V101, P1996, DOI 10.1182/blood-2002-07-2006
   Cazzola M, 2015, HEMATOL-AM SOC HEMAT, P19, DOI 10.1182/asheducation-2015.1.19
   Chakraborty PK, 2014, BLOOD, V124, P2867, DOI 10.1182/blood-2014-08-591370
   Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954
   Furuyama K, 2007, TOHOKU J EXP MED, V213, P1, DOI 10.1620/tjem.213.1
   Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359
   HOLMGREN A, 1989, J BIOL CHEM, V264, P13963
   Johansson C, 2011, BIOCHEM J, V433, P303, DOI 10.1042/BJ20101286
   Kannengiesser C, 2011, HAEMATOL-HEMATOL J, V96, P808, DOI 10.3324/haematol.2010.039164
   Karim Z, 2015, CLIN RES HEPATOL GAS, V39, P412, DOI 10.1016/j.clinre.2015.05.009
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   Lichtenstein DA, 2016, BLOOD, V128, P1913, DOI 10.1182/blood-2016-05-719062
   Liu G, 2016, J CELL BIOCHEM, V117, P207, DOI 10.1002/jcb.25267
   Liu G, 2014, BLOOD, V124, P2750, DOI 10.1182/blood-2014-08-598508
   Mansouri A, 1999, GASTROENTEROLOGY, V117, P181, DOI 10.1016/S0016-5085(99)70566-4
   Mansouri A, 1997, J HEPATOL, V27, P96, DOI 10.1016/S0168-8278(97)80286-3
   Marquet A, 2001, VITAM HORM, V61, P51
   Matthes T, 2006, EUR J HAEMATOL, V77, P169, DOI 10.1111/j.1600-0609.2006.00674.x
   Miller JR, 2000, BIOCHEMISTRY-US, V39, P15166, DOI 10.1021/bi002060n
   Mühlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446
   Puy H, 2010, LANCET, V375, P924, DOI 10.1016/S0140-6736(09)61925-5
   Ricketts CJ, 2006, ACTA PAEDIATR, V95, P99, DOI 10.1080/08035250500323715
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Robin MA, 2005, HEPATOLOGY, V42, P1280, DOI 10.1002/hep.20949
   Rodríguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517
   Schmitz-Abe K, 2015, BLOOD, V126, P2734, DOI 10.1182/blood-2015-09-659854
   Vilella F, 2004, COMP FUNCT GENOM, V5, P328, DOI 10.1002/cfg.406
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Walter PB, 2002, P NATL ACAD SCI USA, V99, P2264, DOI 10.1073/pnas.261708798
   Whatley SD, 2008, AM J HUM GENET, V83, P408, DOI 10.1016/j.ajhg.2008.08.003
   Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887
   Ye H, 2010, J CLIN INVEST, V120, P1749, DOI 10.1172/JCI40372
NR 40
TC 22
Z9 22
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD NOV
PY 2019
VL 128
IS 3
BP 342
EP 351
DI 10.1016/j.ymgme.2018.12.012
PG 10
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA JY4EK
UT WOS:000504369700022
PM 30660387
OA Bronze, Green Published
DA 2024-11-01
ER

PT J
AU Phadke, R
AF Phadke, Rahul
TI Myopathology of Adult and Paediatric Mitochondrial Diseases
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Review
DE mitochondrial; muscle biopsy; ragged red; COX-negative; subsarcolemmal;
   immunohistochemistry
ID CYTOCHROME-C-OXIDASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; RAGGED-RED
   FIBERS; OF-FUNCTION MUTATIONS; SKELETAL-MUSCLE; COMPLEX-II; DNA
   DELETIONS; SUCCINATE-DEHYDROGENASE; RECURRENT MYOGLOBINURIA;
   DIAGNOSTIC-CRITERIA
AB Mitochondria are dynamic organelles ubiquitously present in nucleated eukaryotic cells, subserving multiple metabolic functions, including cellular ATP generation by oxidative phosphorylation (OXPHOS). The OXPHOS machinery comprises five transmembrane respiratory chain enzyme complexes (RC). Defective OXPHOS gives rise to mitochondrial diseases (mtD). The incredible phenotypic and genetic diversity of mtD can be attributed at least in part to the RC dual genetic control (nuclear DNA (nDNA) and mitochondrial DNA (mtDNA)) and the complex interaction between the two genomes. Despite the increasing use of next-generation-sequencing (NGS) and various omics platforms in unravelling novel mtD genes and pathomechanisms, current clinical practice for investigating mtD essentially involves a multipronged approach including clinical assessment, metabolic screening, imaging, pathological, biochemical and functional testing to guide molecular genetic analysis. This review addresses the broad muscle pathology landscape including genotype-phenotype correlations in adult and paediatric mtD, the role of immunodiagnostics in understanding some of the pathomechanisms underpinning the canonical features of mtD, and recent diagnostic advances in the field.
C1 [Phadke, Rahul] UCLH NHS Fdn Trust, Div Neuropathol, UCL Inst Neurol, Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
   [Phadke, Rahul] Great Ormond St Hosp Children NHS Fdn Trust, Dubowitz Neuromuscular Ctr, London WC1N 3JH, England.
C3 University of London; University College London; UCL Medical School;
   University College London Hospitals NHS Foundation Trust; University of
   London; University College London; Great Ormond Street Hospital for
   Children NHS Foundation Trust
RP Phadke, R (corresponding author), UCLH NHS Fdn Trust, Div Neuropathol, UCL Inst Neurol, Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.; Phadke, R (corresponding author), Great Ormond St Hosp Children NHS Fdn Trust, Dubowitz Neuromuscular Ctr, London WC1N 3JH, England.
EM r.phadke@ucl.ac.uk
RI Phadke, Rahul/U-6960-2019
CR Alfadhel M, 2011, AM J MED GENET A, V155A, P840, DOI 10.1002/ajmg.a.33881
   Alhatou MI, 2004, J MOL HISTOL, V35, P615
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Alston CL, 2012, J MED GENET, V49, P569, DOI 10.1136/jmedgenet-2012-101146
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Birch-Machin MA, 2000, ANN NEUROL, V48, P330, DOI 10.1002/1531-8249(200009)48:3<330::AID-ANA7>3.0.CO;2-A
   BLANCO CE, 1988, HISTOCHEM J, V20, P230, DOI 10.1007/BF01747468
   Blum S, 2011, INTERN MED J, V41, P200, DOI 10.1111/j.1445-5994.2010.02379.x
   Boczonadi V, 2015, J INHERIT METAB DIS, V38, P427, DOI 10.1007/s10545-014-9784-6
   Boczonadi V, 2015, INT J BIOCHEM CELL B, V63, P32, DOI 10.1016/j.biocel.2015.01.025
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   BOURGERON T, 1993, J BIOL CHEM, V268, P19369
   BRESOLIN N, 1985, NEUROLOGY, V35, P802, DOI 10.1212/WNL.35.6.802
   Brockmann K, 2002, ANN NEUROL, V52, P38, DOI 10.1002/ana.10232
   BYRNE E, 1992, MUTAT RES, V275, P125, DOI 10.1016/0921-8734(92)90017-J
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Carry M R, 1989, Bull Soc Belge Ophtalmol, V237, P303
   Chaturvedi S, 2005, MED SCI MONITOR, V11, pRA238
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 2003, J NEUROL SCI, V211, P63, DOI 10.1016/S0022-510X(03)00039-X
   Choi BO, 2010, EXP MOL MED, V42, P446, DOI 10.3858/emm.2010.42.6.046
   COQUET M, 1990, ANN PATHOL, V10, P181
   Cotta A, 2014, ARQ NEURO-PSIQUIAT, V72, P721, DOI 10.1590/0004-282X20140110
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   De Meirleir L, 2003, AM J MED GENET A, V121A, P126, DOI 10.1002/ajmg.a.20171
   De Paepe B, 2006, PEDIATR RES, V59, P2, DOI 10.1203/01.pdr.0000191294.34122.ab
   Debray FG, 2007, CLIN CHEM, V53, P916, DOI 10.1373/clinchem.2006.081166
   Delonlay P, 2013, HAND CLINIC, V113, P1651, DOI 10.1016/B978-0-444-59565-2.00033-2
   DEVIVO DC, 1993, BRAIN DEV-JPN, V15, P1, DOI 10.1016/0387-7604(93)90002-P
   Di Giovanni S, 2001, NEUROLOGY, V57, P515, DOI 10.1212/WNL.57.3.515
   DIMAURO S, 1983, ANN NEUROL, V14, P226, DOI 10.1002/ana.410140209
   DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   DIMAURO S, 1990, PEDIATR RES, V28, P536, DOI 10.1203/00006450-199011000-00025
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Dinopoulos A, 2005, NEUROPEDIATRICS, V36, P290, DOI 10.1055/s-2005-872807
   Dubowitz V., 2013, MUSCLE BIOPSY PRACTI, V4th, P1, DOI DOI 10.1177/000271623618500112
   Durham SE, 2005, NEUROLOGY, V65, P453, DOI 10.1212/01.wnl.0000171861.30277.88
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Elson JL, 2002, NEUROMUSCULAR DISORD, V12, P858, DOI 10.1016/S0960-8966(02)00047-0
   Emmanuele V, 2011, J NEUROL SCI, V303, P39, DOI 10.1016/j.jns.2011.01.018
   ENGEL WK, 1963, NEUROLOGY, V13, P919, DOI 10.1212/WNL.13.11.919
   Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3
   Finsterer J, 2001, ACTA MED AUST, V28, P152, DOI 10.1046/j.1563-2571.2001.01036.x
   Finsterer J, 2016, WORLD J CARDIOL, V8, P333, DOI 10.4330/wjc.v8.i5.333
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Gal A., 2017, EMBO MOL MED
   Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378
   Ghosh A, 2014, HUM MOL GENET, V23, P3596, DOI 10.1093/hmg/ddu069
   Gilkerson RW, 2000, FEBS LETT, V474, P1, DOI 10.1016/S0014-5793(00)01527-1
   Gire C, 2002, CHILD NERV SYST, V18, P621, DOI 10.1007/s00381-002-0621-0
   Goldstein AC, 2013, NEUROTHERAPEUTICS, V10, P212, DOI 10.1007/s13311-013-0185-6
   Gonzalez-Lima F., 1998, Cytochrome Oxidase in Neuronal Metabolism and Alzheimer's Disease
   GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E
   Kalko SG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-91
   Gropman AL, 2013, NEUROTHERAPEUTICS, V10, P273, DOI 10.1007/s13311-012-0161-6
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   HALLER RG, 1991, J CLIN INVEST, V88, P1197, DOI 10.1172/JCI115422
   Hanson BJ, 2002, J HISTOCHEM CYTOCHEM, V50, P1281, DOI 10.1177/002215540205001001
   HASEGAWA H, 1993, ACTA NEUROPATHOL, V85, P280
   Hoekstra AS, 2013, BBA-BIOENERGETICS, V1827, P543, DOI 10.1016/j.bbabio.2012.11.005
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Huigsloot M, 2011, AM J HUM GENET, V88, P488, DOI 10.1016/j.ajhg.2011.03.002
   Jackson CB, 2014, J MED GENET, V51, P170, DOI 10.1136/jmedgenet-2013-101932
   Ji KQ, 2015, FREE RADICAL BIO MED, V84, P161, DOI 10.1016/j.freeradbiomed.2015.03.020
   JOHNSON MA, 1993, ANN NEUROL, V33, P28, DOI 10.1002/ana.410330106
   JOHNSTON W, 1995, ANN NEUROL, V37, P16, DOI 10.1002/ana.410370106
   Kalra A. A., 2012, ARCH NEUROL-CHICAGO, V69, P657, DOI DOI 10.1001/archneurol.2011.2333
   Karadimas CL, 2000, NEUROLOGY, V55, P644, DOI 10.1212/WNL.55.5.644
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Keightley JA, 1996, NAT GENET, V12, P410, DOI 10.1038/ng0496-410
   Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Köller H, 1998, J NEUROL NEUROSUR PS, V64, P407, DOI 10.1136/jnnp.64.3.407
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Laforêt P, 2010, NEUROMUSCULAR DISORD, V20, P693, DOI 10.1016/j.nmd.2010.06.018
   Lamont PJ, 1998, ARCH DIS CHILD, V79, P22, DOI 10.1136/adc.79.1.22
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Larsson NG, 2001, ACTA PHYSIOL SCAND, V171, P385, DOI 10.1046/j.1365-201x.2001.00842.x
   Lax NZ, 2012, BRAIN, V135, P1736, DOI 10.1093/brain/aws110
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Logan CV, 2014, NAT GENET, V46, P188, DOI 10.1038/ng.2851
   Machado PM, 2014, CURR OPIN NEUROL, V27, P591, DOI 10.1097/WCO.0000000000000129
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Marín-García J, 2003, PEDIATR NEUROL, V29, P26, DOI 10.1016/S0887-8994(03)00013-4
   Marotta R, 2011, J CLIN NEUROSCI, V18, P290, DOI 10.1016/j.jocn.2010.06.001
   Mastaglia FL, 2012, CURR NEUROL NEUROSCI, V12, P54, DOI 10.1007/s11910-011-0232-9
   MATSUOKA T, 1991, J NEUROL SCI, V106, P193, DOI 10.1016/0022-510X(91)90257-8
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   McFarland R, 2009, J INTERN MED, V265, P210, DOI 10.1111/j.1365-2796.2008.02066.x
   Miles L, 2006, HUM PATHOL, V37, P173, DOI 10.1016/j.humpath.2005.10.008
   Miles L, 2012, HUM PATHOL, V43, P1249, DOI 10.1016/j.humpath.2011.09.016
   Milone M, 2013, MOL GENET METAB, V110, P35, DOI 10.1016/j.ymgme.2013.07.007
   Mitsuhashi S, 2013, CURR OPIN NEUROL, V26, P536, DOI 10.1097/WCO.0b013e328364c82d
   Montero R., 2016, PLOS ONE, V11
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Morava E, 2009, MITOCHONDRION, V9, P438, DOI 10.1016/j.mito.2009.08.003
   Moslemi AR, 2000, CARDIOLOGY, V94, P68, DOI 10.1159/000007049
   MULLERHOCKER J, 1992, MUTAT RES, V275, P115, DOI 10.1016/0921-8734(92)90016-I
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   MULLERHOCKER J, 1986, VIRCHOWS ARCH B, V52, P353, DOI 10.1007/BF02889977
   MUNSCHER C, 1993, FEBS LETT, V317, P27, DOI 10.1016/0014-5793(93)81484-H
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   Nance JR, 2015, MUSCLE NERVE, V51, P793, DOI 10.1002/mus.24606
   Nasca A., 2017, HUM MUTAT
   Nascimento A, 2016, SEMIN PEDIATR NEUROL, V23, P290, DOI 10.1016/j.spen.2016.11.004
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Paradas C, 2013, NEUROLOGY, V80, P504, DOI 10.1212/WNL.0b013e31827f0ff7
   Patterson K, 2004, PEDIATR DEVEL PATHOL, V7, P629, DOI 10.1007/s10024-004-5051-4
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Quinzii CM, 2007, NEUROCHEM RES, V32, P723, DOI 10.1007/s11064-006-9190-z
   Rahman S, 2000, BRAIN, V123, P591, DOI 10.1093/brain/123.3.591
   RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107
   Rocha MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15037
   Rötig A, 2010, DIABETES METAB, V36, P97, DOI 10.1016/j.diabet.2009.11.002
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Ross JM, 2011, JOVE-J VIS EXP, DOI 10.3791/3266
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Sacconi S, 2006, NEUROLOGY, V67, P1464, DOI 10.1212/01.wnl.0000240071.62540.6f
   Sanaker PS, 2010, BBA-MOL BASIS DIS, V1802, P539, DOI 10.1016/j.bbadis.2010.02.010
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Sarnat HB, 2012, NEUROPATHOLOGY, V32, P617, DOI 10.1111/j.1440-1789.2012.01308.x
   Sarnat HB, 2005, CAN J NEUROL SCI, V32, P152, DOI 10.1017/S0317167100003929
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Schon EA, 2013, MOL CELL NEUROSCI, V55, P26, DOI 10.1016/j.mcn.2012.07.011
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1
   Shiva S, 2001, P NATL ACAD SCI USA, V98, P7212, DOI 10.1073/pnas.131128898
   SHY GM, 1966, BRAIN, V89, P133, DOI 10.1093/brain/89.1.133
   SHY GM, 1964, SCIENCE, V145, P493, DOI 10.1126/science.145.3631.493
   Siciliano G, 2007, BIOSCIENCE REP, V27, P53, DOI 10.1007/s10540-007-9037-0
   Simon NG, 2016, J CLIN NEUROSCI, V33, P1, DOI 10.1016/j.jocn.2016.01.041
   Sleigh K, 2011, MUSCLE NERVE, V43, P795, DOI 10.1002/mus.21962
   SMEITINK J.A. M., 2004, MED INTELL UNIT
   Sobreira C, 1997, NEUROLOGY, V48, P1238, DOI 10.1212/WNL.48.5.1238
   SPARACO M, 1995, BRAIN PATHOL, V5, P125, DOI 10.1111/j.1750-3639.1995.tb00586.x
   Sue CM, 2000, ANN NEUROL, V47, P589, DOI 10.1002/1531-8249(200005)47:5<589::AID-ANA6>3.3.CO;2-4
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Taivassalo T, 2012, BRAIN, V135, P53, DOI 10.1093/brain/awr293
   Tanji K, 2008, METHODS, V46, P274, DOI 10.1016/j.ymeth.2008.09.027
   Tarnopolsky MA, 2004, AM J MED GENET A, V124A, P372, DOI 10.1002/ajmg.a.20449
   Tay SHK, 2006, ARCH NEUROL-CHICAGO, V63, P281, DOI 10.1001/archneur.63.2.281
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Teraoka M, 1999, HUM GENET, V105, P560, DOI 10.1007/s004390051145
   Thorburn DR, 2001, J INHERIT METAB DIS, V24, P312, DOI 10.1023/A:1010347808082
   Tiranti V, 1999, HUM MOL GENET, V8, P2533, DOI 10.1093/hmg/8.13.2533
   TORRES J, 1995, BIOCHEM J, V312, P169, DOI 10.1042/bj3120169
   Triepels RH, 1999, ANN NEUROL, V45, P787, DOI 10.1002/1531-8249(199906)45:6<787::AID-ANA13>3.0.CO;2-6
   Tulinius M, 2011, SEMIN FETAL NEONAT M, V16, P229, DOI 10.1016/j.siny.2011.04.001
   TULINIUS MH, 1995, EUR J PEDIATR, V154, P35, DOI 10.1007/BF01972970
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Van Coster R, 2003, AM J MED GENET A, V120A, P13, DOI 10.1002/ajmg.a.10202
   van den Heuvel LP, 2004, MITOCHONDRION, V4, P395, DOI 10.1016/j.mito.2004.07.005
   Vincent AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30610
   Vissing CR, 2013, NEUROLOGY, V80, P1908, DOI 10.1212/WNL.0b013e3182929fb2
   Vladutiu GD, 2000, ARCH PATHOL LAB MED, V124, P1755
   Vogel H, 2001, J NEUROPATH EXP NEUR, V60, P217, DOI 10.1093/jnen/60.3.217
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Weber K, 1997, AM J HUM GENET, V60, P373
   Willis JH, 2009, BBA-BIOENERGETICS, V1787, P533, DOI 10.1016/j.bbabio.2008.10.009
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Wong L.-J.C, 2013, BIOCH MOL METHODS ST, P27
   Wong LJC, 2010, MOL GENET METAB, V100, P111, DOI 10.1016/j.ymgme.2010.02.024
   YAMAMOTO M, 1989, J NEUROL SCI, V91, P207, DOI 10.1016/0022-510X(89)90088-9
   YAMAMOTO M, 1988, ACTA NEUROPATHOL, V76, P558, DOI 10.1007/BF00689593
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   YONEDA M, 1995, MUSCLE NERVE, pS95
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
   ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
   Zierz CM, 2015, NEUROPATHOLOGY, V35, P130, DOI 10.1111/neup.12173
NR 192
TC 28
Z9 28
U1 0
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD JUL
PY 2017
VL 6
IS 7
AR 64
DI 10.3390/jcm6070064
PG 24
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA FD2AH
UT WOS:000407337300002
PM 28677615
OA gold, Green Published, Green Submitted
DA 2024-11-01
ER

PT J
AU White, HE
   Durston, VJ
   Seller, A
   Fratter, C
   Harvey, JF
   Cross, NCP
AF White, HE
   Durston, VJ
   Seller, A
   Fratter, C
   Harvey, JF
   Cross, NCP
TI Accurate detection and quantitation of heteroplasmic mitochondrial point
   mutations by pyrosequencing
SO GENETIC TESTING
LA English
DT Article
ID HEREDITARY OPTIC NEUROPATHY; GRADIENT-GEL-ELECTROPHORESIS;
   FALSE-POSITIVE DIAGNOSIS; PEPTIDE NUCLEIC-ACID; MTDNA CONTROL REGION;
   CLINICAL-FEATURES; PRENATAL-DIAGNOSIS; DNA HETEROPLASMY; A3243G
   MUTATION; QUANTIFICATION
AB Disease-causing mutations in mitochondrial DNA (mtDNA) are typically heteroplasmic and therefore interpretation of genetic tests for mitochondrial disorders can be problematic. Detection of low level heteroplasmy is technically demanding and it is often difficult to discriminate between the absence of a mutation or the failure of a technique to detect the mutation in a particular tissue. The reliable measurement of heteroplasmy in different tissues may help identify individuals who are at risk of developing specific complications and allow improved prognostic advice for patients and family members. We have evaluated Pyrosequencing technology for the detection and estimation of heteroplasmy for six mitochondrial point mutations associated with the following diseases: Leber's hereditary optical neuropathy (LHON), G3460A, G11778A, and T14484C; mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS), A3243G; myoclonus epilepsy with ragged red fibers (MERRF), A8344G, and neurogenic muscle weakness, ataxia, and retinitis pigmentosa (NARP)/Leighs: T8993G/C. Results obtained from the Pyrosequencing assays for 50 patients with presumptive mitochondrial disease were compared to those obtained using the commonly used diagnostic technique of polymerase chain reaction (PCR) and restriction enzyme digestion. The Pyrosequencing assays provided accurate genotyping and quantitative determination of mutational load with a sensitivity and specificity of 100%. The MELAS A3243G mutation was detected reliably at a level of 1% heteroplasmy. We conclude that Pyrosequencing is a rapid and robust method for detecting heteroplasmic mitochondrial point mutations.
C1 Salisbury Dist Hosp, Natl Genet Reference Lab Wessex, Salisbury SP2 8BJ, Wilts, England.
   Churchill Hosp, Oxford Med Genet Lab, Oxford OX3 7LJ, England.
C3 Salisbury District Hospital; University of Oxford
RP White, HE (corresponding author), Salisbury Dist Hosp, Natl Genet Reference Lab Wessex, Salisbury SP2 8BJ, Wilts, England.
EM H.E.White@soton.ac.uk
RI Cross, Nicholas/B-4817-2009
OI Cross, Nicholas/0000-0001-5481-2555
CR Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   Boles RG, 2003, CLIN CHEM, V49, P198, DOI 10.1373/49.1.198
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Conley YP, 2003, BRAIN RES PROTOC, V12, P99, DOI 10.1016/j.brainresprot.2003.08.005
   DiMauro S, 1998, NAT GENET, V19, P214, DOI 10.1038/883
   Hancock DK, 2002, CLIN CHEM, V48, P2155
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   HUOPONEN K, 1991, AM J HUM GENET, V48, P1147
   JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5
   JUVONEN V, 1994, HUM GENET, V93, P16
   Kirby DM, 1998, MOL DIAGN, V3, P211, DOI 10.1016/S1084-8592(98)80042-8
   Lagerström-Fermér M, 2001, AM J HUM GENET, V68, P1299, DOI 10.1086/320115
   Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   MASHIMA Y, 1995, INVEST OPHTH VIS SCI, V36, P1714
   Mashima Y, 2004, CLIN BIOCHEM, V37, P268, DOI 10.1016/j.clinbiochem.2003.11.011
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363
   Santorelli FM, 1997, NEUROLOGY, V49, P270, DOI 10.1212/WNL.49.1.270
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   Suomalainen A, 2000, MOL BIOTECHNOL, V15, P123, DOI 10.1385/MB:15:2:123
   Szuhai K, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e13
   TANNO Y, 1995, MUSCLE NERVE, V18, P1390, DOI 10.1002/mus.880181208
   Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380
   Tully LA, 2000, AM J HUM GENET, V67, P432, DOI 10.1086/302996
   Urata M, 2004, CLIN CHEM, V50, P2045, DOI 10.1373/clinchem.2004.033761
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   White SL, 1998, MOL DIAGN, V3, P113, DOI 10.1016/S1084-8592(98)80059-3
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Wong LJC, 1997, CLIN CHEM, V43, P1857
NR 33
TC 88
Z9 95
U1 0
U2 9
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1090-6576
J9 GENET TEST
JI Genet. Test.
PD FAL
PY 2005
VL 9
IS 3
BP 190
EP 199
DI 10.1089/gte.2005.9.190
PG 10
WC Genetics & Heredity; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Research & Experimental Medicine
GA 977EG
UT WOS:000232784600003
PM 16225398
OA Green Submitted
DA 2024-11-01
ER

PT J
AU DiMauro, S
   Hirano, M
   Schon, EA
AF DiMauro, Salvatore
   Hirano, Michio
   Schon, Eric A.
TI Approaches to the treatment of Mitochondrial Diseases - Invited review
SO MUSCLE & NERVE
LA English
DT Review
DE exercise; gene shifting; genetic counseling; ooplasmic transfer; oxygen
   radical scavenging; palliative therapy; preimplantation diagnosis;
   supplementation; therapy
ID COENZYME Q(10) DEFICIENCY; KEARNS-SAYRE-SYNDROME; PROGRESSIVE EXTERNAL
   OPHTHALMOPLEGIA; COPPER-BINDING PROTEIN; COMPLEX-III DEFICIENCY; HUMAN
   SKELETAL-MUSCLE; PEPTIDE NUCLEIC-ACID; STROKE-LIKE EPISODES; CULTURED
   HUMAN-CELLS; CYTOCHROME-B GENE
AB Therapy for mitochondrial diseases is woefully inadequate. However, lack of a cure does not equate with lack of treatment. Palliative therapy is dictated by good medical practice and includes anticonvulsant medication, control of endocrine dysfunction, and surgical procedures. Removal of noxious metabolites is centered on combating lactic acidosis, but extends to other metabolites. Attempts to bypass blocks in the respiratory chain by administration of electron acceptors have not been successful, but this may be amenable to genetic engineering. Administration of metabolites and cofactors is the mainstay of real-life therapy and is especially important in disorders due to primary deficiencies of specific compounds, such as carnitine or coenzyme Q10 (CoQ10). There is increasing interest in the administration of reactive oxygen radicals (ROS) scavengers, both in primary mitochondrial diseases and in neurodegenerative diseases. Gene therapy is a challenge because of polyplasmy and heteroplasmy, but novel experimental approaches are being pursued. One important strategy is to decrease the ratio of mutant to wild-type mitochondrial genomes ("gene shifting") by different means: (1) converting mutated mitochondrial DNA (mtDNA) genes into normal nuclear DNA genes ("allotopic expression"); (2) importing cognate genes from other species ("xenotopic expression"); (3) correcting mtDNA mutations by importing specific restriction endonucleases; (4) selecting for respiratory function; and (5) inducing muscle regeneration. Germline therapy raises ethical problems but is being considered for prevention of maternal transmission of mtDNA mutations. Preventive therapy through genetic counseling and prenatal diagnosis is becoming increasingly important for nuclear DNA-related disorders.
C1 Columbia Univ, Coll Phys & Surg, Med Ctr, Dept Neurol, New York, NY 10032 USA.
   Columbia Univ, Coll Phys & Surg, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA.
C3 Columbia University; Columbia University
RP DiMauro, S (corresponding author), Columbia Univ, Coll Phys & Surg, Med Ctr, Dept Neurol, 630 W 168th St, New York, NY 10032 USA.
EM sdl2@columbia.edu
FU NICHD NIH HHS [HD32062] Funding Source: Medline; NINDS NIH HHS [NS1176]
   Funding Source: Medline
CR ALLEN RJ, 1983, ANN NEUROL, V13, P679, DOI 10.1002/ana.410130620
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Andrews RM, 1999, EYE, V13, P769, DOI 10.1038/eye.1999.225
   ARGOV Z, 1986, ANN NEUROL, V19, P598, DOI 10.1002/ana.410190615
   Auré K, 2004, NEUROLOGY, V63, P727, DOI 10.1212/01.WNL.0000134607.76780.B2
   Bai YD, 2001, J BIOL CHEM, V276, P38808, DOI 10.1074/jbc.M106363200
   BAKER SK, 2003, EXPERT OPIN INV DRUG, V12, P1
   Barritt JA, 2001, HUM REPROD, V16, P513, DOI 10.1093/humrep/16.3.513
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   BICKNESE AR, 1992, ANN NEUROL, V32, P767, DOI 10.1002/ana.410320610
   Bindoff L., 2006, Mitochondrial Medicine, P143
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329
   Boitier E, 1998, J NEUROL SCI, V156, P41, DOI 10.1016/S0022-510X(98)00006-9
   Bonnet D, 2001, HEART, V86, P570, DOI 10.1136/heart.86.5.570
   Brenner CA, 2000, FERTIL STERIL, V74, P573, DOI 10.1016/S0015-0282(00)00681-6
   Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396
   Carelli V., 2006, Mitochondrial Medicine, P105
   Carroll PV, 1997, CLIN ENDOCRINOL, V47, P113, DOI 10.1046/j.1365-2265.1997.2241031.x
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061
   Chinnery PF, 2006, MITOCHONDRIAL MED, P161
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   Crameri RM, 2004, J PHYSIOL-LONDON, V558, P333, DOI 10.1113/jphysiol.2004.061846
   DEVIVO DC, 1999, PEDIAT NEUROLOGY PRI, V1, P494
   Di Giovanni S, 2001, NEUROLOGY, V57, P515, DOI 10.1212/WNL.57.3.515
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S., 2006, Mitochondrial Medicine, P261
   DOUGADOS M, 1983, ANN NEUROL, V13, P687, DOI 10.1002/ana.410130624
   Edmonds JL, 2004, MITOCHONDRION, V4, P543, DOI 10.1016/j.mito.2004.07.012
   Eells JT, 2003, P NATL ACAD SCI USA, V100, P3439, DOI 10.1073/pnas.0534746100
   ELEFF S, 1984, P NATL ACAD SCI-BIOL, V81, P3529, DOI 10.1073/pnas.81.11.3529
   Flierl A, 2005, GENE THER, V12, P570, DOI 10.1038/sj.gt.3302443
   Flierl A, 2003, MOL THER, V7, P550, DOI 10.1016/S1525-0016(03)00037-6
   Freisinger P, 2004, J INHERIT METAB DIS, V27, P67, DOI 10.1023/B:BOLI.0000016614.47380.2f
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   GATTERMANN N, 2006, MITOCHONDRIAL MED, P209
   Gironi M, 2004, NEUROLOGY, V62, P818, DOI 10.1212/01.WNL.0000113719.67643.B7
   Grad LI, 2005, P NATL ACAD SCI USA, V102, P18367, DOI 10.1073/pnas.0506939102
   Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354
   Hakkaart GAJ, 2006, EMBO REP, V7, P341, DOI 10.1038/sj.embor.7400601
   Hargreaves IP, 2005, J INHERIT METAB DIS, V28, P81, DOI 10.1007/s10545-005-4160-1
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   Hassanein T, 2004, MITOCHONDRION, V4, P609, DOI 10.1016/j.mito.2004.07.015
   HAYDAR NA, 1971, ANN INTERN MED, V74, P548, DOI 10.7326/0003-4819-74-4-548
   Hays AP., 2006, Mitochondrial Medicine, P45
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   Hirano M., 2006, Mitochondrial Medicine, P27
   Horvath R, 2006, NEUROLOGY, V66, P253, DOI 10.1212/01.wnl.0000194241.35115.7c
   Iuso A, 2006, J BIOL CHEM, V281, P10374, DOI 10.1074/jbc.M513387200
   Jaksch M, 2001, HUM MOL GENET, V10, P3025, DOI 10.1093/hmg/10.26.3025
   James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200
   Karadimas CL, 2000, NEUROLOGY, V55, P644, DOI 10.1212/WNL.55.5.644
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Keightley JA, 2000, AM J HUM GENET, V67, P1400, DOI 10.1086/316900
   KENNAWAY NG, 1984, PEDIATR RES, V18, P991
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Klopstock T, 1999, NEUROLOGY, V52, pA543
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Kolesnikova OA, 2000, SCIENCE, V289, P1931, DOI 10.1126/science.289.5486.1931
   Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267
   Kornblum C, 2001, NEUROLOGY, V56, P1409, DOI 10.1212/WNL.56.10.1409
   Lalani SR, 2005, ARCH NEUROL-CHICAGO, V62, P317, DOI 10.1001/archneur.62.2.317
   Lamperti C, 2003, NEUROLOGY, V60, P1206, DOI 10.1212/01.WNL.0000055089.39373.FC
   Manfred G, 1999, J BIOL CHEM, V274, P9386, DOI 10.1074/jbc.274.14.9386
   Manfredi G, 2004, ANN NEUROL, V56, P171, DOI 10.1002/ana.20243
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Marriage BJ, 2004, MOL GENET METAB, V81, P263, DOI 10.1016/j.ymgme.2003.12.008
   McGregor A, 2003, BBA-GENE STRUCT EXPR, V1629, P73, DOI 10.1016/j.bbaexp.2003.08.005
   Melacini P, 2001, TRANSPLANT P, V33, P1596, DOI 10.1016/S0041-1345(00)02607-5
   Millhouse-Flourie TJ, 2004, MITOCHONDRION, V4, P549, DOI 10.1016/j.mito.2004.07.013
   Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849
   NAGLEY P, 1988, P NATL ACAD SCI USA, V85, P2091, DOI 10.1073/pnas.85.7.2091
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   Oguro H, 2004, INTERNAL MED, V43, P427, DOI 10.2169/internalmedicine.43.427
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Ojaimi J, 2002, MOL BIOL CELL, V13, P3836, DOI 10.1091/mbc.E02-05-0306
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   Pineda M, 2006, ANN NEUROL, V59, P394, DOI 10.1002/ana.20746
   Qi XP, 2004, ANN NEUROL, V56, P182, DOI 10.1002/ana.20175
   Qi XP, 2003, INVEST OPHTH VIS SCI, V44, P1088, DOI 10.1167/iovs.02-0864
   Qi XP, 2003, ANN NEUROL, V53, P198, DOI 10.1002/ana.10426
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Quinzii CM, 2005, NEUROLOGY, V64, P539, DOI 10.1212/01.WNL.0000150588.75281.58
   Rahman S, 2001, J PEDIATR-US, V139, P456, DOI 10.1067/mpd.2001.117575
   Rake JP, 2000, EUR J PEDIATR, V159, P523, DOI 10.1007/s004310051324
   Rötig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9
   Rotig A., 2006, Mitochondrial Medicine, P197
   SAKUTA R, 1989, ANN NEUROL, V25, P594, DOI 10.1002/ana.410250611
   Salviati L, 2005, NEUROLOGY, V65, P606, DOI 10.1212/01.wnl.0000172859.55579.a7
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Salviati L, 2002, BIOCHEM J, V363, P321, DOI 10.1042/0264-6021:3630321
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102
   SCHON EA, 2006, MITOCHONDRIAL MED, P329
   Seo BB, 2004, HUM GENE THER, V15, P887, DOI 10.1089/1043034041839217
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   Shults CW, 2001, NEUROLOGY, V57, P375, DOI 10.1212/WNL.57.3.375
   Sinnathuray AR, 2003, OTOL NEUROTOL, V24, P418, DOI 10.1097/00129492-200305000-00012
   Sobreira C, 1997, NEUROLOGY, V48, P1238, DOI 10.1212/WNL.48.5.1238
   Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   STACPOOLE PW, 1989, METABOLISM, V38, P1124, DOI 10.1016/0026-0495(89)90051-6
   Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 2005, MED SCI SPORT EXER, V37, P2094, DOI 10.1249/01.mss.0000177446.97671.2a
   Taivassalo T, 2004, BBA-BIOENERGETICS, V1659, P221, DOI 10.1016/j.bbabio.2004.09.007
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Tarnopolsky MA, 1999, MUSCLE NERVE, V22, P1228, DOI 10.1002/(SICI)1097-4598(199909)22:9<1228::AID-MUS9>3.3.CO;2-Y
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   Tein I, 2003, J INHERIT METAB DIS, V26, P147, DOI 10.1023/A:1024481016187
   TEIN I, 1990, PEDIATR RES, V28, P247, DOI 10.1203/00006450-199009000-00020
   Templeton A, 2002, NEW ENGL J MED, V346, P773, DOI 10.1056/NEJM200203073461013
   THORBURN DR, 2006, MITOCHONDRIAL MED, P241
   Tieu K., 2006, Mitochondrial Medicine, P279
   Towbin JA., 2006, Mitochondrial Medicine, P75
   TRANCHANT C, 1993, NEUROMUSCULAR DISORD, V3, P561, DOI 10.1016/0960-8966(93)90116-2
   Visch HJ, 2004, J BIOL CHEM, V279, P40328, DOI 10.1074/jbc.M408068200
   Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
   Wong VA, 2002, OPHTHALMOLOGY, V109, P1023, DOI 10.1016/S0161-6420(02)01009-6
   YIALAMAS MA, 2006, MITOCHONDRIAL MED, P179
NR 128
TC 99
Z9 109
U1 0
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 1097-4598
J9 MUSCLE NERVE
JI Muscle Nerve
PD SEP
PY 2006
VL 34
IS 3
BP 265
EP 283
DI 10.1002/mus.20598
PG 19
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 074XX
UT WOS:000239846800002
PM 16810684
DA 2024-11-01
ER

PT J
AU Pitceathly, RDS
   Tomlinson, SE
   Hargreaves, I
   Bhardwaj, N
   Holton, JL
   Morrow, JM
   Evans, J
   Smith, C
   Fratter, C
   Woodward, CE
   Sweeney, MG
   Rahman, S
   Hanna, MG
AF Pitceathly, Robert D. S.
   Tomlinson, Susan E.
   Hargreaves, Iain
   Bhardwaj, Nisha
   Holton, Janice L.
   Morrow, Jasper M.
   Evans, Julie
   Smith, Conrad
   Fratter, Carl
   Woodward, Cathy E.
   Sweeney, Mary G.
   Rahman, Shamima
   Hanna, Michael G.
TI Distal myopathy with cachexia: an unrecognised phenotype caused by
   dominantly-inherited mitochondrial polymerase γ mutations
SO JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
LA English
DT Article
ID DNA-POLYMERASE; ACCESSORY SUBUNIT; POLG; DISORDERS; DEPLETION; BINDING
AB Background The myopathy associated with mutations in the nuclear-encoded mitochondrial DNA maintenance gene POLG, coding for the catalytic subunit of DNA polymerase, is typically proximal with early ophthalmoplegia.
   Results We report two unrelated patients in whom a distal, mainly upper limb, myopathy was the predominant and early clinical feature. One patient also suffered with marked cachexia. DNA genomic sequence analysis identified novel dominant heterozygous missense POLG mutations (Leu896Arg and Tyr951His) located within the conserved catalytic polymerase domain of the protein in both cases.
   Conclusions Distal upper limb myopathy/cachexia is not previously described with dominant POLG mutations and our observations further highlight the diverse clinical spectrum of POLG-related mitochondrial disorders. These data indicate that dominant POLG mutations should be considered in the differential diagnosis of distal upper limb predominant myopathy.
C1 [Rahman, Shamima] Natl Hosp Neurol & Neurosurg, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England.
   [Pitceathly, Robert D. S.; Tomlinson, Susan E.; Holton, Janice L.; Morrow, Jasper M.; Rahman, Shamima; Hanna, Michael G.] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London, England.
   [Tomlinson, Susan E.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.
   [Hargreaves, Iain] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London WC1N 3BG, England.
   [Bhardwaj, Nisha] UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England.
   [Holton, Janice L.; Hanna, Michael G.] UCL Inst Neurol, Dept Mol Neurosci, London, England.
   [Evans, Julie; Smith, Conrad; Fratter, Carl] Oxford Univ Hosp NHS Trust, Oxford Med Genet Labs, Oxford, England.
   [Woodward, Cathy E.; Sweeney, Mary G.] Natl Hosp Neurol & Neurosurg, Neurogenet Unit, London WC1N 3BG, England.
   [Rahman, Shamima] UCL Inst Child Hlth, Mitochondrial Res Grp, London, England.
C3 University of London; University College London; UCL Medical School;
   University College London Hospitals NHS Foundation Trust; University of
   London; University College London; University of Sydney; University of
   London; University College London; UCL Medical School; University
   College London Hospitals NHS Foundation Trust; University of London;
   University College London; University of London; University College
   London; Oxford University Hospitals NHS Foundation Trust; University of
   London; University College London; UCL Medical School; University
   College London Hospitals NHS Foundation Trust; University of London;
   University College London
RP Rahman, S (corresponding author), Natl Hosp Neurol & Neurosurg, MRC Ctr Neuromuscular Dis, 8-11 Queen Sq, London WC1N 3BG, England.
EM shamima.rahman@ucl.ac.uk
RI Rahman, Shamima/C-5232-2008; Hargreaves, Iain/AAJ-6757-2020; Hanna,
   Michael/B-1995-2009; Morrow, Jasper/E-2496-2013; Holton,
   Janice/F-6831-2011
OI Morrow, Jasper M/0000-0001-6879-8539; Hanna,
   Michael/0000-0003-0825-4075; Pitceathly, Robert/0000-0002-6123-4551
FU MRC [G0800674, G0601943]; Great Ormond Street Hospital Children's
   Charity; Myositis Support Group; UK NHS Specialised Service for Rare
   Mitochondrial Diseases of Adults and Children; NIHR UCLH/UCL
   Comprehensive Biomedical Research Centre; Department of Health's
   National Institute for Health Research Biomedical Research Centres; MRC
   [G0200335, MR/K000608/1, G0800674, G0601943] Funding Source: UKRI
FX RDSP is funded by MRC grant number G0800674. SR is supported by Great
   Ormond Street Hospital Children's Charity. MGH and JMM receive funding
   from an MRC Centre grant (G0601943). JH and MGH are supported by The
   Myositis Support Group. This study was supported by the UK NHS
   Specialised Service for Rare Mitochondrial Diseases of Adults and
   Children and the NIHR UCLH/UCL Comprehensive Biomedical Research Centre
   and undertaken at the University College London Hospitals/University
   College London, which received a proportion of funding from the
   Department of Health's National Institute for Health Research Biomedical
   Research Centres funding scheme.
CR Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Chinnery PF, 2010, BRAIN, V133, P1865, DOI 10.1093/brain/awq161
   Cohen BH, 2010, POLG RELATED DISORDE
   ERNSTER L, 1959, NATURE, V184, P1851, DOI 10.1038/1841851a0
   Giordano C, 2010, ARCH NEUROL-CHICAGO, V67, P1144, DOI 10.1001/archneurol.2010.200
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200
   Rahman S, 2009, J NEUROL NEUROSUR PS, V80, P943, DOI 10.1136/jnnp.2008.158279
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
NR 16
TC 15
Z9 15
U1 0
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-3050
J9 J NEUROL NEUROSUR PS
JI J. Neurol. Neurosurg. Psychiatry
PD JAN
PY 2013
VL 84
IS 1
BP 107
EP 110
DI 10.1136/jnnp-2012-303232
PG 4
WC Clinical Neurology; Psychiatry; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Psychiatry; Surgery
GA 055WD
UT WOS:000312447600021
PM 22933815
DA 2024-11-01
ER

PT J
AU Blok, MJ
   van den Bosch, BJ
   Jongen, E
   Hendrickx, A
   de Die-Smulders, CE
   Hoogendijk, JE
   Brusse, E
   de Visser, M
   Poll-The, BT
   Bierau, J
   de Coo, IF
   Smeets, HJ
AF Blok, M. J.
   van den Bosch, B. J.
   Jongen, E.
   Hendrickx, A.
   de Die-Smulders, C. E.
   Hoogendijk, J. E.
   Brusse, E.
   de Visser, M.
   Poll-The, B. T.
   Bierau, J.
   de Coo, I. F.
   Smeets, H. J.
TI The unfolding clinical spectrum of <i>POLG</i> mutations
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID MITOCHONDRIAL-DNA POLYMERASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   ALPERS-SYNDROME; GAMMA-A; SPACER-REGION; DELETIONS; DISEASE; DISORDERS;
   DEPLETION; GENE
AB Background: Mutations in the DNA polymerase-gamma (POLG) gene are a major cause of clinically heterogeneous mitochondrial diseases, associated with mtDNA depletion and multiple deletions.
   Objective: To determine the spectrum of POLG mutations in our Dutch patient cohort, to evaluate the pathogenicity of novel mutations, and to establish genotype-phenotype correlations.
   Results: The authors identified 64 predominantly recessive mutations in 37 patients from a total of 232 patients, consisting of 23 different mutations. The substitution p.A467T was most frequently observed (n=23), but was as frequent in childhood cases as in adult cases. Five new pathogenic recessive mutations, p.Lys925ArgfsX42, p.R275X, p.G426S, p.A804T and p.R869Q were identified. The known dominant chronic progressive external ophthalmoplegia (CPEO) mutation p.R943H was for the first time associated with premature ovarian failure as well. In 19 patients the authors identified only a single recessive mutation, or a sequence variant with unclear clinical significance. The data substantiate earlier observations that in POLG patients a fatal status epilepticus and liver failure can be triggered by sodium valproate. It is therefore important to exclude POLG mutations before administering this treatment.
   Conclusion: The clinical features of the patient are the most important features to select putative POLG mutation carriers and not the presence of mtDNA deletions or OXPHOS (oxidative phosphorylation) activity. The authors conclude that POLG mutations are an important cause of heterogeneous mitochondrial pathology and that more accurate genotype-phenotype correlations allow a more rapid genetic diagnosis and improved prognosis for mutation carriers.
C1 [Blok, M. J.; van den Bosch, B. J.; Jongen, E.; Hendrickx, A.; de Die-Smulders, C. E.; Bierau, J.; Smeets, H. J.] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6202 AZ Maastricht, Netherlands.
   [van den Bosch, B. J.; Smeets, H. J.] Maastricht Univ, Med Ctr, Dept Genet & Cell Biol, NL-6202 AZ Maastricht, Netherlands.
   [Hoogendijk, J. E.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands.
   [Brusse, E.] Erasmus MC Univ Med Ctr, Dept Neurol, Rotterdam, Netherlands.
   [de Visser, M.] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1012 WX Amsterdam, Netherlands.
   [Poll-The, B. T.] Univ Amsterdam, Emmas Children Hosp, Dept Pediat, Amsterdam, Netherlands.
   [de Coo, I. F.] Erasmus MC Univ Med Ctr, Dept Neurol, Rotterdam, Netherlands.
C3 Maastricht University; Maastricht University; Utrecht University;
   Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus
   MC; University of Amsterdam; Academic Medical Center Amsterdam;
   University of Amsterdam; Emma Children's Hospital; Erasmus University
   Rotterdam; Erasmus MC
RP van den Bosch, BJ (corresponding author), Maastricht Univ, Med Ctr, Dept Clin Genet, POB 5800, NL-6202 AZ Maastricht, Netherlands.
EM bianca.vandenbosch@gen.unimaas.nl
OI Brusse, Esther/0000-0002-1452-2219; de Coo,
   Irenaeus/0000-0003-0533-7422; Poll-The, Bwee Tien/0000-0002-8118-5419
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   CHINNERY PF, 2007, NEUROMUSCULAR DISORD, V18, P259
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Eyer F, 2005, J CLIN PSYCHOPHARM, V25, P376, DOI 10.1097/01.jcp.0000168485.76397.5c
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Lamantea E, 2004, ANN NEUROL, V56, P454, DOI 10.1002/ana.20219
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Naviaux RK, 2005, ANN NEUROL, V58, P491, DOI 10.1002/ana.20544
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Rovio AT, 2004, MAMM GENOME, V15, P492, DOI 10.1007/s00335-004-3049-x
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
NR 40
TC 65
Z9 71
U1 0
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD NOV
PY 2009
VL 46
IS 11
BP 776
EP 785
DI 10.1136/jmg.2009.067686
PG 10
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 514EE
UT WOS:000271376300009
PM 19578034
OA Green Submitted, Green Published
DA 2024-11-01
ER

PT J
AU Gang, Q
   Bettencourt, C
   Machado, P
   Hanna, MG
   Houlden, H
AF Gang, Qiang
   Bettencourt, Conceicao
   Machado, Pedro
   Hanna, Michael G.
   Houlden, Henry
TI Sporadic inclusion body myositis: the genetic contributions to the
   pathogenesis
SO ORPHANET JOURNAL OF RARE DISEASES
LA English
DT Review
DE Inclusion body myositis; Inclusion body myopathy; IBM; Genes; Genetics;
   Exome sequencing
ID AMYLOID PRECURSOR PROTEIN; MITOCHONDRIAL-DNA DELETIONS; IDIOPATHIC
   INFLAMMATORY MYOPATHIES; CYTOSOLIC 5'-NUCLEOTIDASE 1A;
   ENDOPLASMIC-RETICULUM STRESS; HLA CLASS-I; APOLIPOPROTEIN-E;
   MUSCLE-FIBERS; MESSENGER-RNA; HEXANUCLEOTIDE REPEAT
AB Sporadic inclusion body myositis (sIBM) is the commonest idiopathic inflammatory muscle disease in people over 50 years old. It is characterized by slowly progressive muscle weakness and atrophy, with typical pathological changes of inflammation, degeneration and mitochondrial abnormality in affected muscle fibres. The cause(s) of sIBM are still unknown, but are considered complex, with the contribution of multiple factors such as environmental triggers, ageing and genetic susceptibility. This review summarizes the current understanding of the genetic contributions to sIBM and provides some insights for future research in this mysterious disease with the advantage of the rapid development of advanced genetic technology. An international sIBM genetic study is ongoing and whole-exome sequencing will be applied in a large cohort of sIBM patients with the aim of unravelling important genetic risk factors for sIBM.
C1 [Gang, Qiang; Bettencourt, Conceicao; Hanna, Michael G.; Houlden, Henry] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England.
   [Gang, Qiang; Machado, Pedro; Hanna, Michael G.; Houlden, Henry] UCL, Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England.
C3 University of London; University College London; University of London;
   University College London
RP Gang, Q (corresponding author), UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England.
EM q.gang@ucl.ac.uk
RI Houlden, Henry/C-1532-2008; Bettencourt, Conceição/A-8791-2008; Machado,
   Pedro/C-8621-2013
OI Hanna, Michael/0000-0003-0825-4075; Bettencourt,
   Conceicao/0000-0001-9090-7690; Machado, Pedro/0000-0002-8411-7972;
   Houlden, Henry/0000-0002-2866-7777
FU UCL Impact Studentship; Chinese Scholarship Council; MRC Centre
   [MR/K000608/01]; MRC [MR/J004758/1]; MRC [G0802760, MR/J004758/1,
   G108/638, G1001253] Funding Source: UKRI
FX Q.G. is supported by a UCL Impact Studentship and the Chinese
   Scholarship Council. M.G.H. is supported by an MRC Centre grant
   2013-2018 (MR/K000608/01). C.B. is also supported by the MRC. The
   International IBM Consortium Genetic Study (IIBMCGS) is also supported
   by an MRC grant (MR/J004758/1). We thank all the study collaborators
   from UK, USA, and Europe, and especially thank all the patients and
   their families for participating in our study.
CR Abdo WF, 2009, ACTA NEUROPATHOL, V118, P429, DOI 10.1007/s00401-009-0554-8
   Amato AA, 1998, NEUROLOGY, V51, P598, DOI 10.1212/WNL.51.2.598
   ASKANAS V, 1994, LANCET, V343, P364, DOI 10.1016/S0140-6736(94)91208-4
   Askanas V, 2005, MICROSC RES TECHNIQ, V67, P114, DOI 10.1002/jemt.20186
   ASKANAS V, 1993, NEUROREPORT, V5, P25, DOI 10.1097/00001756-199310000-00006
   ASKANAS V, 1992, LANCET, V339, P560, DOI 10.1016/0140-6736(92)90388-J
   Askanas V, 2002, CURR OPIN NEUROL, V15, P525, DOI 10.1097/00019052-200210000-00002
   Askanas V, 2001, J NEUROPATH EXP NEUR, V60, P1
   Askanas V, 1998, AM J PATHOL, V152, P889
   ASKANAS V, 1993, ANN NEUROL, V34, P551, DOI 10.1002/ana.410340408
   Askanas V, 1996, ANN NEUROL, V40, P264, DOI 10.1002/ana.410400223
   Askanas V, 2009, BRAIN PATHOL, V19, P493, DOI 10.1111/j.1750-3639.2009.00290.x
   Badrising UA, 2000, NEUROLOGY, V55, P1385, DOI 10.1212/WNL.55.9.1385
   Badrising UA, 2004, NEUROLOGY, V63, P2396, DOI 10.1212/01.WNL.0000148588.15052.4C
   Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711
   Barthélémy F, 2011, MOL MED, V17, P875, DOI 10.2119/molmed.2011.00084
   Benveniste Olivier, 2010, Neuromuscul Disord, V20, P414, DOI 10.1016/j.nmd.2010.03.014
   Bieniek KF, 2013, ACTA NEUROPATHOL, V125, P289, DOI 10.1007/s00401-012-1048-7
   BILAK M, 1993, ACTA NEUROPATHOL, V85, P378, DOI 10.1007/BF00334447
   Cacciottolo M, 2013, ACTA NEUROPATHOL, V126, P781, DOI 10.1007/s00401-013-1186-6
   Cai HY, 2012, J NEUROL, V259, P1913, DOI 10.1007/s00415-012-6439-0
   Cortese A, 2013, NEUROMUSCULAR DISORD, V23, P404, DOI 10.1016/j.nmd.2013.02.010
   Cox FM, 2011, BRAIN, V134, P3167, DOI 10.1093/brain/awr217
   Dalakas MC, 2008, ANN NEUROL, V64, P1, DOI 10.1002/ana.21452
   Dalakas MC, 2006, NEUROLOGY, V66, pS33, DOI 10.1212/01.wnl.0000192129.65677.87
   DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011
   Di Blasi C, 2000, ANN NEUROL, V47, P811, DOI 10.1002/1531-8249(200006)47:6<811::AID-ANA16>3.3.CO;2-0
   Felice KJ, 2001, MEDICINE, V80, P320, DOI 10.1097/00005792-200109000-00006
   Ferrer I, 2004, J NEUROPATH EXP NEUR, V63, P484, DOI 10.1093/jnen/63.5.484
   Fratta P, 2004, NEUROLOGY, V63, P1114, DOI 10.1212/01.WNL.0000138574.56908.5D
   GARLEPP MJ, 1994, CLIN EXP IMMUNOL, V98, P40
   Garlepp MJ, 1995, ANN NEUROL, V38, P957, DOI 10.1002/ana.410380619
   Gossrau G, 2004, EUR NEUROL, V51, P215, DOI 10.1159/000078488
   Greenberg SA, 2012, CURR OPIN NEUROL, V25, P630, DOI 10.1097/WCO.0b013e328357f211
   GRIGGS RC, 1995, ANN NEUROL, V38, P705, DOI 10.1002/ana.410380504
   Guerreiro R, 2014, HUM MOL GENET, V23, pR47, DOI 10.1093/hmg/ddu203
   Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851
   Guerreiro RJ, 2012, ARCH NEUROL-CHICAGO, V69, P1243, DOI 10.1001/archneurol.2012.1935
   HARRINGTON CR, 1995, NEUROSCI LETT, V183, P35, DOI 10.1016/0304-3940(94)11108-U
   Lain AH, 2011, J NEUROL NEUROSUR PS, V82, P1414, DOI 10.1136/jnnp.2010.208868
   Hilton-Jones D, 2010, NEUROMUSCULAR DISORD, V20, P622, DOI [10.1016/j.nmd.2010.07.087, 10.1016/j.nmd.2009.11.003]
   Ipata PL, 2013, CURR MED CHEM, V20, P4205
   Jaworska-Wilczynska M, 2002, NEUROLOGY, V58, P438, DOI 10.1212/WNL.58.3.438
   Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132
   KaipiainenSeppanen O, 1996, J INTERN MED, V240, P81, DOI 10.1046/j.1365-2796.1996.14843000.x
   KAMBOH MI, 1995, NAT GENET, V10, P486, DOI 10.1038/ng0895-486
   Karpati G, 2009, ANN NEUROL, V65, P7, DOI 10.1002/ana.21622
   Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922
   Koffman BM, 1998, J NEUROIMMUNOL, V84, P139, DOI 10.1016/S0165-5728(97)00245-2
   Kok CC, 1999, IMMUNOGENETICS, V49, P508, DOI 10.1007/s002510050528
   Kok CC, 2000, NEUROMUSCULAR DISORD, V10, P604, DOI 10.1016/S0960-8966(00)00144-9
   Lampe J, 2001, NEUROLOGY, V57, P368
   Lampe J, 1999, LANCET, V353, P465, DOI 10.1016/S0140-6736(98)05208-8
   Lampe JB, 2003, J NEUROL, V250, P1313, DOI 10.1007/s00415-003-0204-3
   Larman HB, 2013, ANN NEUROL, V73, P408, DOI 10.1002/ana.23840
   LINDBERG C, 1994, ACTA NEUROL SCAND, V89, P123
   Love S, 1996, MUSCLE NERVE, V19, P1605, DOI 10.1002/(SICI)1097-4598(199612)19:12<1605::AID-MUS11>3.0.CO;2-Q
   Machado P, 2013, CURR OPIN RHEUMATOL, V25, P763, DOI 10.1097/01.bor.0000434671.77891.9a
   Mastaglia FL, 2013, NEUROMUSCULAR DISORD, V23, P969, DOI 10.1016/j.nmd.2013.09.008
   Mastaglia FL, 2009, NEUROMUSCULAR DISORD, V19, P763, DOI 10.1016/j.nmd.2009.07.015
   Masuda Y, 2009, CHEMBIOCHEM, V10, P287, DOI 10.1002/cbic.200800411
   Maurage CA, 2004, NEUROPATH APPL NEURO, V30, P624, DOI 10.1111/j.1365-2990.2004.00577.x
   Mirabella M, 1996, ANN NEUROL, V40, P864, DOI 10.1002/ana.410400608
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Müntzing K, 2003, SCAND J IMMUNOL, V58, P195, DOI 10.1046/j.1365-3083.2003.01251.x
   Needham M, 2008, J NEUROL NEUROSUR PS, V79, P1056, DOI 10.1136/jnnp.2007.138891
   Needham M, 2007, MUSCLE NERVE, V35, P549, DOI 10.1002/mus.20766
   Needham M, 2008, NEUROMUSCULAR DISORD, V18, P150, DOI 10.1016/j.nmd.2007.09.005
   Needham M, 2008, J CLIN NEUROSCI, V15, P1350, DOI 10.1016/j.jocn.2008.01.011
   Nogalska A, 2010, ACTA NEUROPATHOL, V120, P661, DOI 10.1007/s00401-010-0737-3
   Nogalska A, 2010, AM J PATHOL, V177, P1377, DOI 10.2353/ajpath.2010.100050
   O'Hanlon TP, 2005, MEDICINE, V84, P338, DOI 10.1097/01.md.0000189818.63141.8c
   Oflazer P Serdaroglu, 2011, Acta Myol, V30, P34
   Oldfors A, 2006, NEUROLOGY, V66, pS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   Olivé M, 2009, J NEUROPATH EXP NEUR, V68, P262, DOI 10.1097/NEN.0b013e3181996d8f
   Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105
   Phillips BA, 2000, MUSCLE NERVE, V23, P970, DOI 10.1002/(SICI)1097-4598(200006)23:6<970::AID-MUS20>3.0.CO;2-I
   Pinkus JL, 2014, NEUROMUSCULAR DISORD, V24, P611, DOI 10.1016/j.nmd.2014.04.012
   Pluk H, 2013, ANN NEUROL, V73, P397, DOI 10.1002/ana.23822
   Price P, 2004, TISSUE ANTIGENS, V64, P575, DOI 10.1111/j.1399-0039.2004.00310.x
   Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038
   Ranque-Francois B, 2005, ANN RHEUM DIS, V64, P634, DOI 10.1136/ard.2004.025494
   RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107
   Rojana-udomsart A, 2013, J NEUROIMMUNOL, V254, P174, DOI 10.1016/j.jneuroim.2012.09.003
   Rojana-Udomsart A, 2012, J NEUROIMMUNOL, V250, P77, DOI 10.1016/j.jneuroim.2012.05.003
   Rose MR, 2013, NEUROMUSCULAR DISORD, V23, P1044, DOI 10.1016/j.nmd.2013.08.007
   Roses AD, 2013, ALZHEIMERS DEMENT, V9, P132, DOI 10.1016/j.jalz.2012.10.009
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Salajegheh M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020266
   Salajegheh M, 2009, MUSCLE NERVE, V40, P19, DOI 10.1002/mus.21386
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   SARKOZI E, 1994, AM J PATHOL, V145, P1280
   SARKOZI E, 1993, NEUROREPORT, V4, P815, DOI 10.1097/00001756-199306000-00055
   Scott AP, 2012, J NEUROIMMUNOL, V250, P66, DOI 10.1016/j.jneuroim.2012.04.021
   Scott AP, 2011, J NEUROIMMUNOL, V235, P77, DOI 10.1016/j.jneuroim.2011.02.011
   Scott AP, 2006, NEUROMUSCULAR DISORD, V16, P311, DOI 10.1016/j.nmd.2006.02.002
   Sivakumar K, 1997, BRAIN, V120, P653, DOI 10.1093/brain/120.4.653
   SIVAKUMAR K, 1995, ANN NEUROL, V38, P267, DOI 10.1002/ana.410380222
   Suzuki N, 2012, J NEUROL, V259, P554, DOI 10.1007/s00415-011-6185-8
   Tan JA, 2013, INT J RHEUM DIS, V16, P331, DOI 10.1111/j.1756-185X.2011.01669.x
   Tateyama M, 2003, INTERNAL MED, V42, P1035, DOI 10.2169/internalmedicine.42.1035
   Tawil R, 2002, CURR OPIN RHEUMATOL, V14, P653, DOI 10.1097/00002281-200211000-00004
   van Slegtenhorst M, 2000, EXP GERONTOL, V35, P461, DOI 10.1016/S0531-5565(00)00114-5
   Verschuuren JJ., 1997, DIAGNOSTIC CRITERIA, P81
   Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39
   Weggen S, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt107
   Weihl CC, 2008, J NEUROL NEUROSUR PS, V79, P1186, DOI 10.1136/jnnp.2007.131334
   Wilson FC, 2008, J RHEUMATOL, V35, P445
   Yang CC, 1996, NEUROREPORT, V8, P153, DOI 10.1097/00001756-199612200-00031
NR 110
TC 25
Z9 26
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1750-1172
J9 ORPHANET J RARE DIS
JI Orphanet J. Rare Dis.
PD JUN 19
PY 2014
VL 9
AR 88
DI 10.1186/1750-1172-9-88
PG 11
WC Genetics & Heredity; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Research & Experimental Medicine
GA AK3DS
UT WOS:000338303800002
PM 24948216
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Bourgeois, JM
   Tarnopolsky, MA
AF Bourgeois, JM
   Tarnopolsky, MA
TI Pathology of skeletal muscle in mitochondrial disorders
SO MITOCHONDRION
LA English
DT Article; Proceedings Paper
CT 1st Mitochondrial Standards Workshop
CY 2002
CL Dallas, TX
SP United Mitochondrial Dis Fdn, Mitochondrial Res Soc, Natl Inst Stand & Technol
DE electron microscopy; light microscopy; ragged red fibers; COX negative
   fibers; histology; ultrastructure; paracrystalline inclusion;
   mitochondria
ID OCULOPHARYNGEAL MUSCULAR-DYSTROPHY; CYTOCHROME-B GENE; RAGGED-RED
   FIBERS; DNA DEPLETION; CREATINE-KINASE; NEEDLE-BIOPSY; ENZYME
   HISTOCHEMISTRY; EXERCISE INTOLERANCE; MUTATION; MYOPATHY
AB Muscle histology is an essential component of the diagnostic work-up for mitochondrial cytopathies and is very important in both ruling in disease as well as ruling out the disease (i.e., alternate diagnoses). A muscle biopsy method must provide tissue for histology, electron microscopy, enzymes and DNA and this can be obtained with a suction-modified 5mm needle. Proper embedding and processing is important for optimal diagnostic yield. The essential stains for mitochondrial histology remain the modified Gomori trichrome, cytochrome oxidase, succinate dehydrogenase, and NADH. Electron microscopy can be helpful in selected cases, however, the decision to perform this on all samples remains a contentious issue. Some cases of mitochondrial cytopathy may show no abnormalities on histology or electron microscopy (i.e., LHON), whereas, other conditions can mimic mitochondrial disease through secondary mitochondrial changes (i.e., inclusion body myositis). Athletes show evidence of increased mitochondrial numbers but do not normally develop ragged red fibers or paracrystalline inclusions. Aging is associated with an accumulation of mitochondrial abnormalities and is an important factor to consider in the interpretation of the sample. For example, biopsies in young children with mitochondrial disease may be normal at the histological level and otherwise healthy older adults can show mitochondrial changes such as ragged red and COX-negative fibers. (C) 2004 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 McMaster Univ, Med Ctr, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada.
   McMaster Univ, Dept Pediat & Med, Hamilton, ON L8N 3Z5, Canada.
C3 McMaster University; McMaster University
RP McMaster Univ, Med Ctr, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada.
CR Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   BERGSTROM J, 1969, ACTA MED SCAND, V186, P177
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bruno C, 2003, MUSCLE NERVE, V28, P508, DOI 10.1002/mus.10429
   Calore E. E., 1994, Pathologica (Genoa), V86, P649
   Campos Y, 2001, NEUROMUSCULAR DISORD, V11, P477, DOI 10.1016/S0960-8966(00)00223-6
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Carnpos Y, 2003, NEUROMUSCULAR DISORD, V13, P416, DOI 10.1016/S0960-8966(03)00039-7
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   DEVIVO DC, 1993, BRAIN DEV-JPN, V15, P1, DOI 10.1016/0387-7604(93)90002-P
   DUBOWITZ V, 1965, J NEUROL NEUROSUR PS, V28, P516, DOI 10.1136/jnnp.28.6.516
   DUBOWITZ V, 1966, J NEUROL NEUROSUR PS, V29, P23, DOI 10.1136/jnnp.29.1.23
   EDWARDS R, 1980, NEW ENGL J MED, V302, P261, DOI 10.1056/NEJM198001313020504
   ENGEL WK, 1963, NEUROLOGY, V13, P919, DOI 10.1212/WNL.13.11.919
   EPPENBERGEREBERHARDT M, 1991, J CELL BIOL, V113, P289, DOI 10.1083/jcb.113.2.289
   EVANS WJ, 1982, MED SCI SPORT EXER, V14, P101
   Gambelli S, 2004, EUR NEUROL, V51, P144, DOI 10.1159/000077070
   Gilkerson RW, 2000, FEBS LETT, V474, P1, DOI 10.1016/S0014-5793(00)01527-1
   GREIG PD, 1985, SURG GYNECOL OBSTET, V160, P466
   Horvath R, 1998, J NEUROPATH EXP NEUR, V57, P396, DOI 10.1097/00005072-199805000-00003
   HULTMAN E, 1967, ACTA MED SCAND, V182, P109
   Jacobs HT, 2003, AGING CELL, V2, P11, DOI 10.1046/j.1474-9728.2003.00032.x
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Lacomis D, 2000, Curr Rheumatol Rep, V2, P225, DOI 10.1007/s11926-000-0083-x
   LINDAL S, 1992, ULTRASTRUCT PATHOL, V16, P263, DOI 10.3109/01913129209061355
   Lindner A, 1997, MOL CELL BIOCHEM, V174, P297, DOI 10.1023/A:1006823818118
   LYNCH GS, 1993, ACTA PHYSIOL SCAND, V148, P27, DOI 10.1111/j.1748-1716.1993.tb09528.x
   Magistris MR, 1998, MUSCLE NERVE, V21, P194, DOI 10.1002/(SICI)1097-4598(199802)21:2<194::AID-MUS6>3.0.CO;2-6
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   MANZ HJ, 1980, VIRCHOWS ARCH A, V386, P1, DOI 10.1007/BF00432641
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   Nevo Y, 2002, J CHILD NEUROL, V17, P499, DOI 10.1177/088307380201700705
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   OROURKE KS, 1994, J RHEUMATOL, V21, P413
   Ozawa M, 1998, J NEUROL SCI, V159, P170, DOI 10.1016/S0022-510X(98)00152-X
   PAMPHLETT R, 1985, AUST NZ J MED, V15, P199, DOI 10.1111/j.1445-5994.1985.tb04005.x
   PAUZNER R, 1991, MUSCLE NERVE, V14, P947, DOI 10.1002/mus.880141004
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009
   RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107
   Silvestri G, 2000, AM J MED GENET, V94, P201, DOI 10.1002/1096-8628(20000918)94:3<201::AID-AJMG5>3.0.CO;2-2
   Stachowiak O, 1998, J BIOL CHEM, V273, P16694, DOI 10.1074/jbc.273.27.16694
   Tarnopolsky M, 2003, MUSCLE NERVE, V27, P359, DOI 10.1002/mus.10330
   Tarnopolsky MA, 2004, AM J MED GENET A, V125A, P310, DOI 10.1002/ajmg.a.20466
   Tarnopolsky MA, 2004, AM J MED GENET A, V124A, P372, DOI 10.1002/ajmg.a.20449
   Tein I, 2002, J CHILD NEUROL, V17, pS57
   Vogel H, 2001, J NEUROPATH EXP NEUR, V60, P217, DOI 10.1093/jnen/60.3.217
NR 48
TC 70
Z9 78
U1 1
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD SEP
PY 2004
VL 4
IS 5-6
BP 441
EP 452
DI 10.1016/j.mito.2004.07.036
PG 12
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Cell Biology; Genetics & Heredity
GA 885QS
UT WOS:000226172600010
PM 16120405
DA 2024-11-01
ER

PT J
AU Khan, IA
   Shaik, NA
   Pasupuleti, N
   Chava, S
   Jahan, P
   Hasan, Q
   Rao, P
AF Khan, Imran Ali
   Shaik, Noor Ahmad
   Pasupuleti, Nagarjuna
   Chava, Srinivas
   Jahan, Parveen
   Hasan, Qurratulain
   Rao, Pragna
TI Screening of mitochondrial mutations and insertion-deletion polymorphism
   in gestational diabetes mellitus in the Asian Indian population
SO SAUDI JOURNAL OF BIOLOGICAL SCIENCES
LA English
DT Article
DE GDM; MELAS; A3243G; MERRF; A8344G; Mitochondria
ID GENE-MUTATIONS; PREVALENCE; RNA; DNA; ASSOCIATION; VARIANTS; WOMEN
AB In this study we scrutinized the association between the A8344G/A3243G mutations and a 9-bp deletion polymorphism with gestational diabetes mellitus (GDM) in an Asian Indian population. The A3243G mutation in the mitochondrial tRNA(Leu(UUR)) causes mitochondrial encephalopathy myopathy, lactic acidosis, and stroke-like episodes (MELAS), while the A8344G mutation in tRNA(Lys) causes myoclonus epilepsy with ragged red fibers (MERRF). We screened 140 pregnant women diagnosed with GDM and 140 non-GDM participants for these mutations by PCR-RFLP analysis. Both A3243G and A8344G were associated with GDM (A3243: OR-3.667, 95% CI = 1.001-13.43, p = 0.03; A8344G: OR-11.00, 95% CI = 0.6026-200.8, p = 0.04). Mitochondrial DNA mutations contribute to the development of GDM. Our results conclude that mitochondrial mutations are associated with the GDM women in our population. Thus it is important to screen other mitochondrial mutations in the GDM women. (C) 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.
C1 [Khan, Imran Ali; Pasupuleti, Nagarjuna; Hasan, Qurratulain] Kamineni Hosp, Dept Genet & Mol Med, Hyderabad 500068, Andhra Pradesh, India.
   [Khan, Imran Ali; Chava, Srinivas; Hasan, Qurratulain] Vasavi Med & Res Ctr, Dept Genet, Hyderabad 500004, Andhra Pradesh, India.
   [Khan, Imran Ali; Jahan, Parveen] Osmania Univ, Dept Genet & Biotechnol, Hyderabad 500007, Andhra Pradesh, India.
   [Shaik, Noor Ahmad] King Abdulaziz Univ, Fac Med, Dept Med Genet, Jeddah 21413, Saudi Arabia.
   [Rao, Pragna] Manipal Univ, Kasturba Med Coll, Dept Biochem, Manipal 576104, Karnataka, India.
C3 Osmania University; King Abdulaziz University; Manipal Academy of Higher
   Education (MAHE); Kasturba Medical College, Manipal
RP Rao, P (corresponding author), Manipal Univ, Kasturba Med Coll, Dept Biochem, Manipal 576104, Karnataka, India.
EM drpragnarao@gmail.com
RI Rao, Pragna/H-4636-2019; jahan, parveen/AAW-8428-2021; shaik,
   noor/ABE-4084-2020; Ali Khan, Imran/GRE-9605-2022
OI shaik, noor/0000-0002-7133-656X; Ali Khan, Imran/0000-0002-9746-5300;
   Parveen Jahan, DR/0000-0003-3203-1816; Rao, Pragna/0000-0002-1200-889X
FU Indian Council for Medical Research [5-3-8-39-2007]
FX We are thankful to all the volunteers who have participated in this
   study. We are thankful to the Department of gynecology and obstetrics,
   Kamineni hospitals and Muslim maternity hospitals for helping with the
   samples. We are thankful to the Indian Council for Medical Research for
   the funding of this research (Sanction no. 5-3-8-39-2007; RHN).
CR Allan CJ, 1997, DIABETES RES CLIN PR, V36, P135, DOI 10.1016/S0168-8227(97)00042-9
   Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS62, DOI [10.2337/dc09-S062, 10.2337/dc10-s062]
   [Anonymous], 2015, J REPROD HLTH MED
   Bao XY, 2012, MOL BIOL REP, V39, P2447, DOI 10.1007/s11033-011-0995-8
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611
   Chae JH, 2004, BRAIN DEV-JPN, V26, P459, DOI 10.1016/j.braindev.2004.01.002
   Chen Y, 2000, DIABETES RES CLIN PR, V48, P29, DOI 10.1016/S0168-8227(99)00138-2
   Chou YJ, 2004, PRENATAL DIAG, V24, P367, DOI 10.1002/pd.876
   Crispim D, 2008, ARQ BRAS ENDOCRINOL, V52, P1228, DOI 10.1590/S0004-27302008000800005
   Duraisamy P, 2010, GENET TEST MOL BIOMA, V14, P49, DOI 10.1089/gtmb.2009.0024
   Hirano Michio, 2010, Curr Neurol Neurosci Rep, V10, P71
   Jacobs HT, 2003, AGING CELL, V2, P11, DOI 10.1046/j.1474-9728.2003.00032.x
   Khan IA, 2014, J RENIN-ANGIO-ALDO S, V15, P566, DOI 10.1177/1470320313502106
   Komandur S, 2011, GENET TEST MOL BIOMA, V15, P361, DOI 10.1089/gtmb.2010.0205
   Larsson NG, 2002, ANN NEUROL, V52, P529, DOI 10.1002/ana.10387
   Lee HC, 1997, J FORMOS MED ASSOC, V96, P770
   Lee H, 2008, DIABETES RES CLIN PR, V81, P124, DOI 10.1016/j.diabres.2008.02.017
   Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Malecki M T, 2001, Pol Arch Med Wewn, V105 Suppl, P357
   Matharoo K, 2013, GENE, V527, P228, DOI 10.1016/j.gene.2013.05.075
   Mathews CE, 1998, P SOC EXP BIOL MED, V219, P97
   Mkaouar-Rebai E, 2007, BIOCHEM BIOPH RES CO, V355, P1031, DOI 10.1016/j.bbrc.2007.02.083
   OTABE S, 1994, J CLIN ENDOCR METAB, V79, P768, DOI 10.1210/jc.79.3.768
   Padma VV, 2010, MOL CELL BIOCHEM, V345, P223, DOI 10.1007/s11010-010-0576-5
   Padma VV, 2010, BIOL TRACE ELEM RES, V137, P344, DOI 10.1007/s12011-009-8590-8
   Petry CJ, 2011, DIABETES, V60, P3090, DOI 10.2337/db11-0689
   Shen LJ, 2011, J CANCER RES CLIN, V137, P669, DOI 10.1007/s00432-010-0912-x
   Thangaraj K, 2005, HUM GENET, V116, P507, DOI 10.1007/s00439-005-1271-6
   Viola G, 2008, BIOCHEM PHARMACOL, V75, P810, DOI 10.1016/j.bcp.2007.10.007
   Wallace DC, 2005, COLD SH Q B, V70, P363, DOI 10.1101/sqb.2005.70.035
   Wang CY, 2013, MOL BIOL REP, V40, P811, DOI 10.1007/s11033-012-2119-5
   WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529
NR 33
TC 15
Z9 18
U1 0
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1319-562X
EI 2213-7106
J9 SAUDI J BIOL SCI
JI Saudi J. Biol. Sci.
PD MAY
PY 2015
VL 22
IS 3
BP 243
EP 248
DI 10.1016/j.sjbs.2014.11.001
PG 6
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA CH4TR
UT WOS:000354026300001
PM 25972744
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Alston, CL
   Morak, M
   Reid, C
   Hargreaves, IP
   Pope, SAS
   Land, JM
   Heales, SJ
   Horvath, R
   Mundy, H
   Taylor, RW
AF Alston, Charlotte L.
   Morak, Monika
   Reid, Christopher
   Hargreaves, Iain P.
   Pope, Simon A. S.
   Land, John M.
   Heales, Simon J.
   Horvath, Rita
   Mundy, Helen
   Taylor, Robert W.
TI A novel mitochondrial <i>MTND5</i> frameshift mutation causing isolated
   complex I deficiency, renal failure and myopathy
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondrial DNA; Complex I; Frameshift mutation; Myopathy;
   Heteroplasmy
ID LEIGH-SYNDROME; G13513A MUTATION; DNA MUTATIONS; ND3 GENE; DISEASE;
   MELAS; ENCEPHALOPATHY; SEQUENCE
AB Isolated complex I deficiency is the most commonly reported enzyme defect in paediatric mitochondrial disorders, and may arise due to mutations in nuclear-encoded structural or assembly genes, or the mitochondrial genome. We present the clinical, biochemical and molecular genetic data in a young girl whose clinical picture is dominated by chronic renal failure, myopathy and persistent lactic acidosis. An isolated complex I deficiency in muscle was identified due to a novel mutation (m.12425delA) in the MTND5 gene. This single nucleotide deletion is heteroplasmic and detectable in several tissues from the proband but not her mother, suggesting a de novo Mutation event. The description of the first frameshift mutation in a mitochondrial complex I gene affirms mitochondrial DNA mutations as an important cause of isolated complex I deficiency in children and the importance of whole mitochondrial genome sequencing in the diagnostic work-up to elucidate the underlying molecular genetic abnormality and provide important genetic advice. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Taylor, Robert W.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Alston, Charlotte L.; Horvath, Rita; Taylor, Robert W.] Newcastle Univ, NCG Rare Mitochondrial Disorders Adults, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Alston, Charlotte L.; Horvath, Rita; Taylor, Robert W.] Newcastle Univ, Childrens Serv, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Morak, Monika] Univ Munich, Univ Hosp, Munich, Germany.
   [Morak, Monika] Ctr Med Genet, MGZ, Munich, Germany.
   [Reid, Christopher] Evelina Childrens Hosp, Dept Paediat Nephrol, Guys & St Thomas NHS Fdn Trust, London, England.
   [Hargreaves, Iain P.; Pope, Simon A. S.; Land, John M.; Heales, Simon J.] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London WC1N 3BG, England.
   [Heales, Simon J.] Great Ormond St Hosp Sick Children, London, England.
   [Mundy, Helen] Guys St Thomas NHS Fdn Trust, Ctr Inherited Metab Dis, London, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle
   University - UK; University of Munich; Guy's & St Thomas' NHS Foundation
   Trust; University of London; University College London; UCL Medical
   School; University College London Hospitals NHS Foundation Trust;
   University of London; University College London; Great Ormond Street
   Hospital for Children NHS Foundation Trust; Guy's & St Thomas' NHS
   Foundation Trust
RP Taylor, RW (corresponding author), Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.w.taylor@ncl.ac.uk
RI Alston, Charlotte/ABG-9602-2020; Reid, Christopher/F-4387-2014; Horvath,
   Rita/AAY-7042-2020; Hargreaves, Iain/AAJ-6757-2020
OI Pope, Simon Alexander Samuel/0000-0002-2991-3722; Horvath,
   Rita/0000-0002-9841-170X; Alston, Charlotte/0000-0003-2095-5464
FU Deutsche Forschungsgemeinschaft [HO2505/2-1]; Academy of Medical
   Sciences [BH090164]; RVI/NGH; Newcastle upon Tyne Hospitals NHS Charity
   [RES0211/7262]; Wellcome Trust; UK National Commissioning Group
FX R.H. is supported by the Deutsche Forschungsgemeinschaft HO2505/2-1, the
   Academy of Medical Sciences (BH090164) and the RVI/NGH and Newcastle
   upon Tyne Hospitals NHS Charity (RES0211/7262). R.W.T. acknowledges the
   continuing financial support of the Wellcome Trust. The mitochondrial
   diagnostic services in Newcastle upon Tyne and at the Neurometabolic
   Unit at the National Hospital for Neurology and Neurosurgery are funded
   by the UK National Commissioning Group (Rare Mitochondrial Disorders of
   Adults and Children Service).
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Downham E, 2008, NEUROMUSCULAR DISORD, V18, P310, DOI 10.1016/j.nmd.2008.01.003
   Hall AM, 2008, QJM-INT J MED, V101, P755, DOI 10.1093/qjmed/hcn060
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010
   Kirby DM, 2000, ANN NEUROL, V48, P102, DOI 10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.3.CO;2-D
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Martín-Hernández E, 2005, PEDIATR NEPHROL, V20, P1299, DOI 10.1007/s00467-005-1948-z
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   Moslemi AR, 2008, NEUROPEDIATRICS, V39, P24, DOI 10.1055/s-2008-1076739
   Oppenheim MLS, 2009, J INHERIT METAB DIS, V32, P269, DOI 10.1007/s10545-009-1061-8
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Ugalde C, 2003, ANN NEUROL, V54, P665, DOI 10.1002/ana.10734
   Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001
   Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200
NR 23
TC 28
Z9 33
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD FEB
PY 2010
VL 20
IS 2
BP 131
EP 135
DI 10.1016/j.nmd.2009.10.010
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 563RP
UT WOS:000275151400009
PM 20018511
DA 2024-11-01
ER

PT J
AU Chin, HL
   San Lai, P
   Tay, SKH
AF Chin, Hui -Lin
   San Lai, Poh
   Tay, Stacey Kiat Hong
TI A clinical approach to diagnosis and management of mitochondrial
   myopathies
SO NEUROTHERAPEUTICS
LA English
DT Review
DE Mitochondrial myopathy; Mitochondrial disease; Genetic sequencing;
   Diagnostic approach; Mitochondrial disease treatment
ID REPLACEMENT THERAPY; LACTIC-ACIDOSIS; MOUSE MODEL; MUTATION; DISEASES;
   GENE; DEFICIENCY; EXERCISE; METABOLISM; DISORDERS
AB This paper provides an overview of the different types of mitochondrial myopathies (MM), associated phenotypes, genotypes as well as a practical clinical approach towards disease diagnosis, surveillance, and management. nDNA-related MM are more common in pediatric-onset disease whilst mtDNA-related MMs are more frequent in adults. Genotype-phenotype correlation in MM is challenging due to clinical and genetic heterogeneity. The multisystemic nature of many MMs adds to the diagnostic challenge. Diagnostic approaches utilizing genetic sequencing with next generation sequencing approaches such as gene panel, exome and genome sequencing are available. This aids molecular diagnosis, heteroplasmy detection in MM patients and furthers knowledge of known mitochondrial genes. Precise disease diagnosis can end the diagnostic odyssey for patients, avoid unnecessary testing, provide prognosis, facilitate anticipatory management, and enable access to available therapies or clinical trials. Adjunctive tests such as functional and exercise testing could aid surveillance of MM patients. Management requires a multi-disciplinary approach, systemic screening for comorbidities, cofactor supplementation, avoidance of substances that inhibit the respiratory chain and exercise training. This update of the current understanding on MMs provides practical perspectives on current diagnostic and management approaches for this complex group of disorders.
C1 [Chin, Hui -Lin; Tay, Stacey Kiat Hong] Khoo Teck Puat Natl Univ, Childrens Med Inst, Natl Univ Hosp, Dept Paediat,Div Genet & Metab, Singapore, Singapore.
   [Chin, Hui -Lin; San Lai, Poh; Tay, Stacey Kiat Hong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore, Singapore.
   [Tay, Stacey Kiat Hong] Khoo Teck Puat Natl Univ, Natl Univ Hosp, Dept Paediat, Div Neurol,Childrens Med Inst, Singapore, Singapore.
C3 National University of Singapore; National University of Singapore;
   National University of Singapore
RP Tay, SKH (corresponding author), Khoo Teck Puat Natl Univ, Childrens Med Inst, Natl Univ Hosp, Dept Paediat,Div Genet & Metab, Singapore, Singapore.; Tay, SKH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore, Singapore.; Tay, SKH (corresponding author), Khoo Teck Puat Natl Univ, Natl Univ Hosp, Dept Paediat, Div Neurol,Childrens Med Inst, Singapore, Singapore.
EM paetaykh@nus.edu.sg
RI Chin, Hui-Lin/GYJ-0119-2022
CR Abouhajar A, 2022, TRIALS, V23, DOI 10.1186/s13063-022-06544-x
   Arena IG, 2022, J CLIN MED, V11, DOI 10.3390/jcm11030632
   Ashworth BE, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0259-6
   Barcelos I, 2020, CURR OPIN PEDIATR, V32, P707, DOI 10.1097/MOP.0000000000000954
   Bartsakoulia M, 2018, HUM MOL GENET, V27, P1186, DOI 10.1093/hmg/ddy033
   Basu S, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1009242
   Bax BE, 2019, J CLIN MED, V8, DOI 10.3390/jcm8081096
   Bi R, 2022, INNOVATION-AMSTERDAM, V3, DOI 10.1016/j.xinn.2022.100329
   Bian WP, 2019, ACS SYNTH BIOL, V8, P621, DOI 10.1021/acssynbio.8b00411
   Bottoni P, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24010124
   Chini EN, 2020, CELL METAB, V31, P1041, DOI 10.1016/j.cmet.2020.05.013
   Cicero AFG, 2020, J CLIN LIPIDOL, V14, P646, DOI 10.1016/j.jacl.2020.07.007
   Comte C, 2013, NUCLEIC ACIDS RES, V41, P418, DOI 10.1093/nar/gks965
   D'Annibale OM, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11172635
   de Barcelos IP, 2019, CURR OPIN NEUROL, V32, P715, DOI 10.1097/WCO.0000000000000743
   de la Barca JMC, 2016, BRAIN, V139, P2864, DOI 10.1093/brain/aww222
   de Laat P, 2021, J MED GENET, V58, P48, DOI 10.1136/jmedgenet-2019-106800
   De Vries MC, 2020, J INHERIT METAB DIS, V43, P800, DOI 10.1002/jimd.12196
   Desbats MA, 2015, J INHERIT METAB DIS, V38, P145, DOI 10.1007/s10545-014-9749-9
   Di Meo I, 2017, GENE THER, V24, P661, DOI 10.1038/gt.2017.53
   Diebold I, 2019, MOL CELL PROBE, V44, P14, DOI 10.1016/j.mcp.2019.01.003
   Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Elstner M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222011080
   Eshaghi M, 2021, EUR J OPHTHALMOL, V31, P2064, DOI 10.1177/1120672120952344
   Fan SP, 2021, eNeurologicalSci, V24
   Fan XY, 2022, NAT BIOMED ENG, V6, P339, DOI 10.1038/s41551-022-00881-7
   Fayssoil A, 2017, EUR J NEUROL, V24, P255, DOI 10.1111/ene.13176
   Finsterer J, 2018, J CLIN MED, V7, DOI 10.3390/jcm7020016
   FRACKOWIAK RSJ, 1988, BRAIN, V111, P1009, DOI 10.1093/brain/111.5.1009
   Frascarelli C, 2023, FRONT GENET, V14, DOI 10.3389/fgene.2023.1089956
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   Gervasoni J, 2020, GENES-BASEL, V11, DOI 10.3390/genes11121522
   Giacci MK, 2015, JOVE-J VIS EXP, DOI 10.3791/52221
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Grazina MM, 2012, METHODS MOL BIOL, V837, P73, DOI 10.1007/978-1-61779-504-6_6
   Gwaltney C, 2022, J PATIENT-REP OUTCOM, V6, DOI 10.1186/s41687-022-00534-y
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hathazi D, 2020, EMBO J, V39, DOI 10.15252/embj.2020105364
   Hebbar M, 2017, EUR J MED GENET, V60, P533, DOI 10.1016/j.ejmg.2017.07.010
   Hemphill S, 2019, BRIT J ANAESTH, V122, P448, DOI 10.1016/j.bja.2018.12.025
   Hernandez-Voth A, 2020, BMJ OPEN RESPIR RES, V7, DOI 10.1136/bmjresp-2020-000774
   Hinojosa JC, 2023, Muscles, V2, P75
   Hoppe K, 2017, ANASTH INTENSIVMED, V58, pS125, DOI 10.19224/ai2017.S125
   Hornby B, 2022, ORPHANET J RARE DIS, V17, DOI 10.1186/s13023-022-02469-5
   Hsieh Vincent C., 2017, J. inborn errors metab. screen., V5, pe160057
   Ip EKK, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.692257
   Jeppesen TD, 2021, J CLIN MED, V10, DOI 10.3390/jcm10081796
   Karaa A, 2023, NEUROLOGY, V101, pE238, DOI 10.1212/WNL.0000000000207402
   Karaa A, 2020, J CACHEXIA SARCOPENI, V11, P909, DOI 10.1002/jcsm.12559
   Karaa A, 2018, NEUROLOGY, V90, pE1212, DOI 10.1212/WNL.0000000000005255
   Kipper K, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030788
   Koene S, 2016, J INHERIT METAB DIS, V39, P705, DOI 10.1007/s10545-016-9948-7
   Koenig Mary Kay, 2023, JIMD Rep, V64, P65, DOI 10.1002/jmd2.12335
   Koga Y, 2018, J NEUROL, V265, P2861, DOI 10.1007/s00415-018-9057-7
   Kyriakides T, 2010, EUR J NEUROL, V17, P767, DOI 10.1111/j.1468-1331.2010.03012.x
   Lee SB, 2019, NEUROCHEM INT, V129, DOI 10.1016/j.neuint.2019.104491
   Legati A, 2017, J MED GENET, V54, P815, DOI 10.1136/jmedgenet-2017-104822
   Leslie N.D., 1993, GeneReviews()
   Levene M, 2019, J CLIN MED, V8, DOI 10.3390/jcm8040457
   Lim AZ., 1993, GENEREVIEWS
   Lokken N, 2021, J INHERIT METAB DIS, V44, P1186, DOI 10.1002/jimd.12393
   Longo N, 2006, AM J MED GENET C, V142C, P77, DOI 10.1002/ajmg.c.30087
   Lopez-Gomez C, 2021, ANN NEUROL, V90, P640, DOI 10.1002/ana.26185
   Macken WL, 2021, NAT REV NEUROL, V17, P215, DOI 10.1038/s41582-021-00455-2
   Madsen KL, 2020, NEUROLOGY, V94, pE687, DOI 10.1212/WNL.0000000000008861
   Mancuso M, 2019, Diagnosis and Management of Mitochondrial Disorders, DOI DOI 10.1016/j.braindev.2012.08.006
   Mancuso M, 2017, NEUROMUSCULAR DISORD, V27, P1126, DOI 10.1016/j.nmd.2017.08.006
   Mancuso M, 2012, EXPERT OPIN PHARMACO, V13, P527, DOI 10.1517/14656566.2012.657177
   McCormick EM, 2020, HUM MUTAT, V41, P2028, DOI 10.1002/humu.24107
   Mok BY, 2022, NAT BIOTECHNOL, V40, P1378, DOI 10.1038/s41587-022-01256-8
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Montano V, 2021, ARCH BIOCHEM BIOPHYS, V697, DOI 10.1016/j.abb.2020.108689
   Montano V, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000519
   Morovat A, 2017, J CLIN MED, V6, DOI 10.3390/jcm6080080
   Scholle LM, 2020, GENES-BASEL, V11, DOI 10.3390/genes11020212
   Munnich A, 1996, J INHERIT METAB DIS, V19, P521, DOI 10.1007/BF01799112
   Murray AJ, 2016, J PHYSIOL-LONDON, V594, P1137, DOI 10.1113/JP270079
   Nesbitt V, 2014, EUR J HUM GENET, V22, P1255, DOI 10.1038/ejhg.2014.35
   Noohi F, 2022, J LAW MED ETHICS, V50, P597, DOI 10.1017/jme.2022.98
   Ohsawa Y, 2019, J NEUROL NEUROSUR PS, V90, P529, DOI 10.1136/jnnp-2018-317964
   Okhuijsen-Kroes EJ, 2001, NEUROPEDIATRICS, V32, P183, DOI 10.1055/s-2001-17372
   Olimpio C, 2021, NEUROMUSCULAR DISORD, V31, P978, DOI 10.1016/j.nmd.2021.08.005
   Oncul U, 2021, J PEDIAT HEMATOL ONC, V43, pE592, DOI 10.1097/MPH.0000000000001806
   Parikh S, 2017, GENET MED, V19, DOI 10.1038/gim.2017.107
   Guerrero-Molina MP, 2023, EUR J NEUROL, V30, P538, DOI 10.1111/ene.15626
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Pirinen E, 2020, CELL METAB, V31, P1078, DOI 10.1016/j.cmet.2020.04.008
   Porcelli S, 2016, J APPL PHYSIOL, V121, P699, DOI 10.1152/japplphysiol.00885.2015
   Protti A, 2010, CRIT CARE, V14, DOI 10.1186/cc8885
   Qu CB, 2021, INT J BIOCHEM CELL B, V138, DOI 10.1016/j.biocel.2021.106050
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   Raymond FL, 2018, NAT REV GENET, V19, P399, DOI 10.1038/s41576-018-0022-1
   Reynaud-Dulaurier R, 2020, BRAIN, V143, P1686, DOI 10.1093/brain/awaa105
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rocha MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15037
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   Salehinejad MA, 2022, BRAIN BEHAV, V12, DOI 10.1002/brb3.2724
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Schirris TJJ, 2015, CELL METAB, V22, P399, DOI 10.1016/j.cmet.2015.08.002
   Schoenmann N, 2023, BBA-MOL BASIS DIS, V1869, DOI 10.1016/j.bbadis.2023.166769
   Schon KR, 2020, TRENDS GENET, V36, P702, DOI 10.1016/j.tig.2020.06.009
   Schrank B, 2017, NEUROMUSCULAR DISORD, V27, P473, DOI 10.1016/j.nmd.2017.02.005
   Seo KS, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00552
   Silva-Pinheiro P, 2020, MOL THER-METH CLIN D, V17, P1071, DOI 10.1016/j.omtm.2020.04.026
   Spiegel R, 2014, EUR J HUM GENET, V22, P902, DOI 10.1038/ejhg.2013.269
   Steele H, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911589
   Stefanetti RJ, 2022, NEUROLOGY, V98, pE2318, DOI 10.1212/WNL.0000000000200299
   Storgaard JH, 2022, J INHERIT METAB DIS, V45, P517, DOI 10.1002/jimd.12479
   Tachibana M, 2018, REPROD MED BIOL, V17, P421, DOI 10.1002/rmb2.12230
   Tarnopolsky MA, 2014, J CHILD NEUROL, V29, P1225, DOI 10.1177/0883073814538512
   Tinker RJ, 2021, MOL DIAGN THER, V25, P181, DOI 10.1007/s40291-020-00510-6
   Tolle I, 2023, EMBO REP, V24, DOI 10.15252/embr.202255678
   Tomoda E, 2023, NUCLEIC ACIDS RES, V51, P7563, DOI 10.1093/nar/gkad139
   Tonin Y, 2014, J BIOL CHEM, V289, P13323, DOI 10.1074/jbc.M113.528968
   van de Weijer T, 2015, DIABETES, V64, P1193, DOI 10.2337/db14-0667
   van den Bersselaar LR, 2022, EUR J NEUROL, V29, P3486, DOI 10.1111/ene.15526
   Vandiver AR, 2022, MITOCHONDRION, V65, P176, DOI 10.1016/j.mito.2022.06.003
   Voet NBM, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003907.pub5
   Wang J., 1993, GeneReviews
   Wang W, 2023, ANN CLIN TRANSL NEUR, V10, P1035, DOI 10.1002/acn3.51787
   Zuccarini Nichole Suzzanne, 2016, J Clin Med Res, V8, P753, DOI 10.14740/jocmr2687w
NR 124
TC 2
Z9 2
U1 12
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1933-7213
EI 1878-7479
J9 NEUROTHERAPEUTICS
JI Neurotherapeutics
PD JAN
PY 2024
VL 21
IS 1
AR e00304
DI 10.1016/j.neurot.2023.11.001
EA JAN 2024
PG 11
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA RC2N9
UT WOS:001225408900001
PM 38241155
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Brady, L
   Sadikovic, B
   Rupar, CA
   Tarnopolsky, MA
AF Brady, Lauren
   Sadikovic, Bekim
   Rupar, C. Anthony
   Tarnopolsky, Mark A.
TI Complete elimination of a pathogenic homoplasmic mtDNA mutation in one
   generation
SO MITOCHONDRION
LA English
DT Article
ID HEREDITARY OPTIC NEUROPATHY; MITOCHONDRIAL-DNA MUTATIONS;
   LEIGH-SYNDROME; OOGENESIS; DISEASE; PATIENT; MUSCLE
AB Mitochondrial DNA (mtDNA) mutations have been implicated in a wide variety of neurological conditions and are maternally inherited through a complex process which is not fully understood. Genetic counselling for mitochondrial conditions secondary to a mtDNA mutation can be challenging as it is not currently possible to accurately predict the mutational load/heteroplasmy of the mutation which could be passed to the offspring. In general, one expects that the higher the level of heteroplasmy the more likely that the same mtDNA mutation will be seen in the offspring. We report here a family which places a caveat on genetic counselling for mtDNA disorders. The proband is a 63 year old woman with m.14459G > A associated dystonia/spasticity/ataxia. The m.14459G > A mutation was detected at homoplasmic/near homoplasmic levels in her muscle tissue and fibroblasts, but did not appear to have been passed on to any of her offspring. To our knowledge, this is the first report of complete selection against a homoplasmic variant within maternally transmitted mtDNA. It is not clear if this novel phenomenon occurred by random chance or by another method of mitochondrial selection.
C1 [Brady, Lauren; Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada.
   [Sadikovic, Bekim; Rupar, C. Anthony] Childrens Hlth Res Inst, London Hlth Sci Ctr, Mol Diagnost Div, Mol Genet Lab, London, ON, Canada.
   [Sadikovic, Bekim; Rupar, C. Anthony] Western Univ, Dept Pathol & Lab Med, London, ON, Canada.
   [Sadikovic, Bekim; Rupar, C. Anthony] Western Univ, Dept Pediat, London, ON, Canada.
   [Sadikovic, Bekim; Rupar, C. Anthony] Western Univ, Dept Biochem, London, ON, Canada.
   [Sadikovic, Bekim; Rupar, C. Anthony] Western Univ, Childrens Hlth Res Inst, London, ON, Canada.
C3 McMaster University; London Health Sciences Centre; Western University
   (University of Western Ontario); Western University (University of
   Western Ontario); Western University (University of Western Ontario);
   Western University (University of Western Ontario)
RP Tarnopolsky, MA (corresponding author), McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada.
EM tarnopol@mcmaster.ca
CR Blakely EL, 2006, PEDIATR RES, V59, P440, DOI 10.1203/01.pdr.0000198771.78290.c4
   Degoul F, 1997, J INHERIT METAB DIS, V20, P49, DOI 10.1023/A:1005357506614
   DeVries DD, 1996, AM J HUM GENET, V58, P703
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Götz A, 2012, PEDIATR RES, V72, P90, DOI 10.1038/pr.2012.43
   Gropman A, 2004, AM J MED GENET A, V124A, P377, DOI 10.1002/ajmg.a.20456
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Kerkhof J, 2017, J MOL GENET
   Kirby DM, 2000, ANN NEUROL, V48, P102, DOI 10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.3.CO;2-D
   Marlow FL, 2017, STEM CELL RES, V21, P178, DOI 10.1016/j.scr.2017.03.004
   Nesbitt V, 2014, EUR J HUM GENET, V22, P1255, DOI 10.1038/ejhg.2014.35
   Ronchi D, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-85
   Schenkel LC, 2016, J MOL DIAGN, V18, P657, DOI 10.1016/j.jmoldx.2016.04.002
   SHOFFNER JM, 1995, ANN NEUROL, V38, P163, DOI 10.1002/ana.410380207
   St John JC, 2004, GENETICS, V167, P897, DOI 10.1534/genetics.103.025049
   Tarnopoisky M, 2013, AM J MED GENET A, V161, P2020, DOI 10.1002/ajmg.a.36000
   Tarnopolsky MA, 2004, AM J MED GENET A, V124A, P372, DOI 10.1002/ajmg.a.20449
   Taylor RW, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.7.e85
   Taylor RW, 2002, NEUROMUSCULAR DISORD, V12, P659, DOI 10.1016/S0960-8966(02)00026-3
   Tworzydlo W, 2016, CELL TISSUE RES, V366, P191, DOI 10.1007/s00441-016-2414-x
   Wallace D, 2007, EMERY RIMOINS PRINCI
   Weber K, 1997, AM J HUM GENET, V60, P373
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Wilding M, 2001, ZYGOTE, V9, P347, DOI 10.1017/S096719940100140X
   Wilson IJ, 2016, HUM MOL GENET, V25, P1031, DOI 10.1093/hmg/ddv626
   Wray CD, 2013, MITOCHONDRION, V13, P656, DOI 10.1016/j.mito.2013.09.004
   Zhang YZ, 2008, DEV GROWTH DIFFER, V50, P189, DOI [10.1111/j.1440-169X.2008.00988.x, 10.1111/j.1440-169x.2008.00988.x]
NR 29
TC 1
Z9 1
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAR
PY 2019
VL 45
BP 18
EP 21
DI 10.1016/j.mito.2018.01.010
PG 4
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA HO3WI
UT WOS:000460853300003
PM 29408632
DA 2024-11-01
ER

PT J
AU Zhang, RY
   Wang, YQ
   Ye, KX
   Picard, M
   Gu, ZL
AF Zhang, Ruoyu
   Wang, Yiqin
   Ye, Kaixiong
   Picard, Martin
   Gu, Zhenglong
TI Independent impacts of aging on mitochondrial DNA quantity and quality
   in humans
SO BMC GENOMICS
LA English
DT Article
DE Aging; Heteroplasmy; mtDNA copy number; Whole genome sequencing
ID COPY NUMBER; MTDNA HETEROPLASMY; APOLIPOPROTEIN-B; SKELETAL-MUSCLE;
   MUTATIONS; ASSOCIATION; DISEASE; HEALTH; RISK; CONTAMINATION
AB Background: The accumulation of mitochondrial DNA (mtDNA) mutations, and the reduction of mtDNA copy number, both disrupt mitochondrial energetics, and may contribute to aging and age-associated phenotypes. However, there are few genetic and epidemiological studies on the spectra of blood mtDNA heteroplasmies, and the distribution of mtDNA copy numbers in different age groups and their impact on age-related phenotypes. In this work, we used whole-genome sequencing data of isolated peripheral blood mononuclear cells (PBMCs) from the UK10K project to investigate in parallel mtDNA heteroplasmy and copy number in 1511 women, between 17 and 85 years old, recruited in the TwinsUK cohorts.
   Results: We report a high prevalence of pathogenic mtDNA heteroplasmies in this population. We also find an increase in mtDNA heteroplasmies with age (beta = 0.011, P = 5.77e-6), and showed that, on average, individuals aged 70-years or older had 58.5% more mtDNA heteroplasmies than those under 40-years old. Conversely, mtDNA copy number decreased by an average of 0.4 copies per year (beta = -0.395, P = 0.0097). Multiple regression analyses also showed that age had independent effects on mtDNA copy number decrease and heteroplasmy accumulation. Finally, mtDNA copy number was positively associated with serum bicarbonate level (P = 4.46e-5), and inversely correlated with white blood cell count (P = 0.0006). Moreover, the aggregated heteroplasmy load was associated with blood apolipoprotein B level (P = 1.33e-5), linking the accumulation of mtDNA mutations to age-related physiological markers.
   Conclusions: Our population-based study indicates that both mtDNA quality and quantity are influenced by age. An open question for the future is whether interventions that would contribute to maintain optimal mtDNA copy number and prevent the expansion of heteroplasmy could promote healthy aging.
C1 [Zhang, Ruoyu; Wang, Yiqin; Gu, Zhenglong] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.
   [Ye, Kaixiong] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA.
   [Picard, Martin] Columbia Univ, Div Behav Med, Dept Psychiat, Med Ctr,Columbia Aging Ctr,Dept Neurol, New York, NY 10032 USA.
   [Picard, Martin] Columbia Univ, Columbia Translat Neurosci Initiat, Columbia Aging Ctr, Med Ctr, New York, NY 10032 USA.
C3 Cornell University; Cornell University; Columbia University; Columbia
   University
RP Gu, ZL (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.
EM zg27@cornell.edu
RI Ye, Kaixiong/C-2297-2017; chen, shuo/KHV-7129-2024; Zhang,
   Ruoyu/AAB-6508-2019
OI Wang, Yiqin/0000-0003-4714-774X; Zhang, Ruoyu/0000-0001-5672-5527;
   Picard, Martin/0000-0003-2835-0478
FU Cornell University; National Science Foundation [MCB-1243588]; National
   Institute of Health [1R01AI085286]; ENN Science and Technology
   Development
FX This work was supported by various funds from Cornell University,
   National Science Foundation [MCB-1243588], and National Institute of
   Health [1R01AI085286], a research grant from ENN Science and Technology
   Development to Z. G.
CR Andrikoula M, 2008, DIABETES OBES METAB, V10, P271, DOI 10.1111/j.1463-1326.2007.00714.x
   [Anonymous], 2007, ORIGINS GENOME ARCHI
   Arnedo J, 2015, AM J PSYCHIAT, V172, P139, DOI 10.1176/appi.ajp.2014.14040435
   Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x
   Barati M, 2008, BURNS, V34, P770, DOI 10.1016/j.burns.2008.01.014
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Benn M, 2009, ATHEROSCLEROSIS, V206, P17, DOI 10.1016/j.atherosclerosis.2009.01.004
   Bishop DJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE225, DOI 10.1152/ajpendo.00738.2009
   Boekholdt SM, 2012, JAMA-J AM MED ASSOC, V307, P1302, DOI 10.1001/jama.2012.366
   Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   Carré JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC
   Choi SH, 2011, TRENDS ENDOCRIN MET, V22, P353, DOI 10.1016/j.tem.2011.04.007
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Ding J, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1005306, 10.1371/journal.pgen.1005549]
   Durand T, 1999, CRYOBIOLOGY, V38, P68, DOI 10.1006/cryo.1999.2152
   Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343
   Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620
   Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940
   Hurtado-Roca Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163770
   Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015
   Itsara LS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003974
   Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004
   Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892
   Knez J, 2016, AM J EPIDEMIOL, V183, P138, DOI 10.1093/aje/kwv175
   Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006
   Kwak SH, 2010, J DIABETES INVEST, V1, P161, DOI 10.1111/j.2040-1124.2010.00047.x
   Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lee JW, 2010, CLIN CHIM ACTA, V411, P592, DOI 10.1016/j.cca.2010.01.024
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li MK, 2016, GENOME RES, V26, P417, DOI 10.1101/gr.203216.115
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Liu SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138716
   Lohmueller KE, 2013, AM J HUM GENET, V93, P1072, DOI 10.1016/j.ajhg.2013.11.005
   López-Armada MJ, 2013, MITOCHONDRION, V13, P106, DOI 10.1016/j.mito.2013.01.003
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   MAHLEY RW, 1984, J LIPID RES, V25, P1277
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Moskalev AA, 2013, AGEING RES REV, V12, P661, DOI 10.1016/j.arr.2012.02.001
   Niccoli T, 2012, CURR BIOL, V22, pR741, DOI 10.1016/j.cub.2012.07.024
   Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45
   Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003
   Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111
   Raffaello A, 2011, BBA-MOL CELL RES, V1813, P260, DOI 10.1016/j.bbamcr.2010.10.007
   Reiling E, 2010, J CLIN ENDOCR METAB, V95, P1909, DOI 10.1210/jc.2009-1775
   Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769
   Ridge PG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S7-S6
   Ross JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06569
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Russell O, 2014, EXP CELL RES, V325, P38, DOI 10.1016/j.yexcr.2014.03.012
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   SIMPSON DP, 1984, AM J PHYSIOL, V247, pF440, DOI 10.1152/ajprenal.1984.247.3.F440
   Sondheimer N, 2011, HUM MOL GENET, V20, P1653, DOI 10.1093/hmg/ddr043
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092
   Su QZ, 2014, AM J PHYSIOL-ENDOC M, V306, pE1264, DOI 10.1152/ajpendo.00438.2013
   Suissa S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000474
   Urata M, 2008, ANN CLIN BIOCHEM, V45, P513, DOI 10.1258/acb.2008.008008
   Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]
   Wachsmuth M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005939
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962
   Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, pW58, DOI 10.1093/nar/gkw233
   Williams SL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003990
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Yoon CY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002717
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
NR 83
TC 113
Z9 124
U1 7
U2 25
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD NOV 21
PY 2017
VL 18
AR 890
DI 10.1186/s12864-017-4287-0
PG 14
WC Biotechnology & Applied Microbiology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA FN5NA
UT WOS:000416053400004
PM 29157198
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Hance, N
   Ekstrand, MI
   Trifunovic, A
AF Hance, N
   Ekstrand, MI
   Trifunovic, A
TI Mitochondrial DNA polymerase gamma is essential for mammalian
   embryogenesis
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; TRANSCRIPTION FACTOR;
   XENOPUS-LAEVIS; ACCESSORY SUBUNIT; GENE-EXPRESSION; POLG MUTATIONS;
   MICE; BIOGENESIS; NUCLEAR; BINDING
AB Mitochondrial DNA (mtDNA) polymerase gamma (Polg) is a heterodimeric enzyme containing a Poll I-like catalytic core (PolgA) and an accessory subunit. Mutations in POLGA, affecting the stability of mtDNA, have been identified in several human pathologies such as progressive external ophthalmoplegia and Alpers' syndrome. Extensive literature shows mitochondrial toxicity effects nucleoside analogue reverse transcriptase inhibitors used in the treatment of HIV and chronic hepatitis B as a consequence of an inhibitory effect on Polg. We have previously shown that mice with an error-prone version of PolgA accumulate higher levels of somatic mtDNA mutations resulting in a premature aging phenotype. In the present paper, we demonstrate PolgA deficiency in mouse embryos causes an early developmental arrest between embryonic days 7.5 and 8.5 associated with severe mtDNA depletion. Heterozygous knockout mice have half the wild-type levels of PolgA transcripts and a slight reduction in mtDNA levels but develop normally. Surprisingly, amounts of PoIgA transcripts in heterozygous knockout mice are increased in response to artificially elevated mtDNA copy number, revealing a possible regulatory link between mtDNA maintenance and PoIgA expression. Our results show that Polg indeed is the only DNA polymerase capable of maintaining mtDNA in mammalian mitochondria. In addition, presence of Polg is absolutely essential for the organogenesis during mammalian embryonic development.
C1 Karolinska Inst, Novum, Dept Med Nutr, Stockholm, Sweden.
   Karolinska Inst, Novum, Dept Biosci, Stockholm, Sweden.
C3 Karolinska Institutet; Karolinska Institutet
RP Karolinska Inst, Novum, Dept Med Nutr, Stockholm, Sweden.
EM aleksandra.trifunovic@mednut.ki.se
RI Trifunovic, Aleksandra/HHZ-1296-2022
OI Trifunovic, Aleksandra/0000-0002-5472-3517; Ekstrand,
   Mats/0000-0003-0019-9462
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   ANNEX BH, 1990, MOL CELL BIOL, V10, P5671, DOI 10.1128/MCB.10.11.5671
   Burgers PMJ, 2001, J BIOL CHEM, V276, P43487, DOI 10.1074/jbc.R100056200
   Carrodeguas JA, 2002, J BIOL CHEM, V277, P50008, DOI 10.1074/jbc.M207030200
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   CHASE JW, 1972, DEV BIOL, V27, P504, DOI 10.1016/0012-1606(72)90189-3
   Davis AF, 1996, NUCLEIC ACIDS RES, V24, P2753, DOI 10.1093/nar/24.14.2753
   DAWID IB, 1972, J MOL BIOL, V63, P217, DOI 10.1016/0022-2836(72)90371-3
   EBERT KM, 1988, J REPROD FERTIL, V82, P145, DOI 10.1530/jrf.0.0820145
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Fan L, 2001, BIOCHEMISTRY-US, V40, P4780, DOI 10.1021/bi010102h
   Farr CL, 1999, J BIOL CHEM, V274, P14779, DOI 10.1074/jbc.274.21.14779
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   HARDT N, 1980, EXP CELL RES, V127, P269, DOI 10.1016/0014-4827(80)90432-2
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4
   Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201
   LEWIS W, 1994, CIRC RES, V74, P344, DOI 10.1161/01.RES.74.2.344
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   PIKO L, 1976, DEV BIOL, V49, P1, DOI 10.1016/0012-1606(76)90253-0
   PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Scarpulla RC, 1997, J BIOENERG BIOMEMBR, V29, P109, DOI 10.1023/A:1022681828846
   Schultz RA, 1998, J BIOL CHEM, V273, P3447, DOI 10.1074/jbc.273.6.3447
   Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690
   VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Ye F, 1996, NUCLEIC ACIDS RES, V24, P1481, DOI 10.1093/nar/24.8.1481
NR 38
TC 192
Z9 232
U1 0
U2 11
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JUL 1
PY 2005
VL 14
IS 13
BP 1775
EP 1783
DI 10.1093/hmg/ddi184
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 950XJ
UT WOS:000230891700006
PM 15888483
OA Bronze, Green Submitted
DA 2024-11-01
ER

PT J
AU Van Hove, JLK
   Saenz, MS
   Thomas, JA
   Gallagher, RC
   Lovell, MA
   Fenton, LZ
   Shanske, S
   Myers, SM
   Wanders, RJA
   Ruiter, J
   Turkenburg, M
   Waterham, HR
AF Van Hove, Johan L. K.
   Saenz, Margarita S.
   Thomas, Janet A.
   Gallagher, Renata C.
   Lovell, Mark A.
   Fenton, Laura Z.
   Shanske, Sarah
   Myers, Sommer M.
   Wanders, Ronald J. A.
   Ruiter, Jos
   Turkenburg, Marjolein
   Waterham, Hans R.
TI Succinyl-CoA Ligase Deficiency: A Mitochondrial Hepatoencephalomyopathy
SO PEDIATRIC RESEARCH
LA English
DT Article
ID ENCEPHALOMYOPATHY; SYNTHETASES; NONSENSE; EXPRESSION; MUTATIONS; DECAY
AB This patient presented on the first day of life with pronounced lactic acidosis with an elevated lactate/pyruvate ratio. Urine organic acids showed Krebs cycle metabolites and mildly elevated methylmalonate and methylcitrate. The acylcarnitine profile showed elevated propionylcarnitine and succinylcarnitine. Amino acids showed elevated glutamic acid, glutamine, proline, and alanine. From the age 2 of mo on, she had elevated transaminases and intermittent episodes of liver failure. Liver biopsy showed steatosis and a decrease of mitochondrial DNA to 50% of control. She had bilateral sensorineural hearing loss. Over the course of the first 2 y of life, she developed a progressively severe myopathy with pronounced muscle weakness eventually leading to respiratory failure, Leigh disease, and recurrent hepatic failure. The hepatic symptoms and the metabolic parameters temporarily improved on treatment with aspartate, but neither muscle symptoms nor brain lesions improved. Laboratory testing revealed a deficiency of succinyl-CoA ligase enzyme activity and protein in fibroblasts because of a novel homozygous mutation in the SUCLG1 gene: c.40A>T (p.M14L). Functional analysis suggests that this methionine is more likely to function as the translation initiator methionine, explaining the pathogenic nature of the mutation. Succinyl-CoA ligase deficiency due to an SUCLG1 mutation is a new cause for mitochondrial hepatoencephalomyopathy. (Pediatr Res 68: 159-164, 2010)
C1 [Van Hove, Johan L. K.] Univ Colorado Denver, Dept Pediat, Sect Clin Genet & Metab, Aurora, CO 80045 USA.
   [Lovell, Mark A.] Univ Colorado Denver, Dept Pathol, Aurora, CO 80045 USA.
   [Fenton, Laura Z.] Childrens Hosp, Dept Radiol, Aurora, CO 80045 USA.
   [Shanske, Sarah] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.
   [Wanders, Ronald J. A.; Ruiter, Jos; Turkenburg, Marjolein; Waterham, Hans R.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metabol Dis, NL-1100 DD Amsterdam, Netherlands.
C3 Children's Hospital Colorado; University of Colorado System; University
   of Colorado Anschutz Medical Campus; Children's Hospital Colorado;
   University of Colorado System; University of Colorado Anschutz Medical
   Campus; Children's Hospital Colorado; Columbia University; University of
   Amsterdam; Academic Medical Center Amsterdam
RP Van Hove, JLK (corresponding author), Univ Colorado Denver, Dept Pediat, Sect Clin Genet & Metab, Educ 2 S,L28-4122,13121 E 17th Ave, Aurora, CO 80045 USA.
EM Vanhove.Johan@tchden.org
RI Saenz, Margarita/JZT-9029-2024
FU National Institutes of Health (Cholestatic Liver Disease Consortium)
   [U54 DK078377]; National Institutes of Health (Cholestatic Liver Disease
   Research and Education Network) [U01 DK062453]
FX Supported by a grant from the National Institutes of Health U54 DK078377
   (Cholestatic Liver Disease Consortium) and U01 DK062453 (Cholestatic
   Liver Disease Research and Education Network).
CR Ahmad A, 1999, AM J MED GENET, V87, P331, DOI 10.1002/(SICI)1096-8628(19991203)87:4<331::AID-AJMG10>3.0.CO;2-K
   Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Amrani N, 2006, BIOCHEM SOC T, V34, P39, DOI 10.1042/BST0340039
   Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Johnson JD, 1998, J BIOL CHEM, V273, P27580, DOI 10.1074/jbc.273.42.27580
   Johnson JD, 1998, J BIOL CHEM, V273, P27573, DOI 10.1074/jbc.273.42.27573
   Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710
   Lambeth DO, 2004, J BIOL CHEM, V279, P36621, DOI 10.1074/jbc.M406884200
   Morava E, 2009, MITOCHONDRION, V9, P438, DOI 10.1016/j.mito.2009.08.003
   Naini A, 2007, METHOD CELL BIOL, V80, P437, DOI 10.1016/S0091-679X(06)80022-1
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Ostergaard E, 2010, EUR J PEDIATR, V169, P201, DOI 10.1007/s00431-009-1007-z
   Phillips D, 2009, BIOCHEMISTRY-US, V48, P7140, DOI 10.1021/bi900725c
   Saada A, 2004, DNA CELL BIOL, V23, P797
   Welch EM, 1999, EMBO J, V18, P6134, DOI 10.1093/emboj/18.21.6134
NR 19
TC 58
Z9 59
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0031-3998
EI 1530-0447
J9 PEDIATR RES
JI Pediatr. Res.
PD AUG
PY 2010
VL 68
IS 2
BP 159
EP 164
DI 10.1203/PDR.0b013e3181e5c3a4
PG 6
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA 629PJ
UT WOS:000280211900014
PM 20453710
OA Green Accepted, Bronze
DA 2024-11-01
ER

PT J
AU García, E
   Macarrón, JL
   de la Maza, L
   Jiménez, S
   Cabello, A
   Martín, MA
   Ruíz, E
AF Garcia, Elena
   Macarron, Jesus Luis
   de la Maza, Laura
   Jimenez, Sara
   Cabello, Ana
   Martin, Miguel Angel
   Ruiz, Enrique
TI Diabetes and Mitochondrial Encephalomyopathy
SO ENDOCRINOLOGIST
LA English
DT Article
DE mitochondrial diabetes; sensorineural deafness; epilepsy; MELAS syndrome
ID STROKE-LIKE EPISODES; 3243A-GREATER-THAN-G MUTATION; OXIDATIVE STRESS;
   LACTIC-ACIDOSIS; DNA MUTATION; MELLITUS; DEAFNESS; A3243G; DAMAGE; CELLS
AB The identification of patients with monogenic forms of diabetes is challenging. Nonetheless, the importance of identifying such individuals has been underscored by the different therapeutic and prognostic implications. The mutation m3243 A>G in the mitochondrial DNA tRNA(Leu)(UUR) gene has been found to be associated with the syndrome of maternally inherited diabetes and deafness. In the presence of higher levels of mutant mitochondrial DNA, the phenotypic presentation consists of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes syndrome and epilepsy. We report a family with mitochondrial diabetes and the mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes syndrome.
C1 [Garcia, Elena; de la Maza, Laura; Ruiz, Enrique] Dept Endocrinol, Burgos, Spain.
   [Macarron, Jesus Luis] Dept Neurol, Burgos, Spain.
   [Jimenez, Sara; Martin, Miguel Angel] CIBERER, U723, Madrid, Spain.
C3 CIBER - Centro de Investigacion Biomedica en Red; CIBERER
RP García, E (corresponding author), Complejo Hosp Burgos, Secc Endocrinol, Paseo Comendadores S-N, Burgos 09001, Spain.
EM elenagarciafer@hotmail.com
RI Jimenez, Sara/HMW-1788-2023; Martin, Miguel/S-2758-2018; Martin, Miguel
   Angel/B-6261-2017
OI Martin, Miguel Angel/0000-0003-4741-772X
FU ISCIII (Ministry of Health) [PI060547, PI0690088]
FX Supported in part by ISCIII (Ministry of Health) (grant PI060547 and
   PI0690088) and by ISCIII "Programa de intensificacion de la actividad
   investigadora" (to M.A.M).
CR Aggarwal P, 2000, HUM HERED, V51, P114
   ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bonakdar RA, 2005, AM FAM PHYSICIAN, V72, P1065
   Dandona P, 1996, LANCET, V347, P444, DOI 10.1016/S0140-6736(96)90013-6
   Donovan LE, 2006, J CLIN ENDOCR METAB, V91, P4737, DOI 10.1210/jc.2006-1498
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   HAMAZAKI S, 1993, ACTA PATHOL JAPON, V43, P187
   Hosono T, 2001, J Matern Fetal Med, V10, P355, DOI 10.1080/714052760
   Jansen JJ, 1997, J AM SOC NEPHROL, V8, P1118
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Kärppä M, 2005, BRAIN, V128, P1861, DOI 10.1093/brain/awh515
   Kobayashi T, 1997, DIABETES, V46, P1567, DOI 10.2337/diabetes.46.10.1567
   LORENZI M, 1986, J CLIN INVEST, V77, P322, DOI 10.1172/JCI112295
   Lynn S, 2003, DIABETOLOGIA, V46, P296, DOI 10.1007/s00125-002-1018-z
   Maassen JA, 2006, ENDOCRIN METAB CLIN, V35, P385, DOI 10.1016/j.ecl.2006.02.014
   Maassen JA, 2005, ANN MED, V37, P213, DOI 10.1080/07853890510007188
   Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   MAJAMAAVOLTTI L, 2002, BMC CARDIOVASC DISOR, V2, P12
   Marriage BJ, 2004, MOL GENET METAB, V81, P263, DOI 10.1016/j.ymgme.2003.12.008
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   Pang CY, 2001, DIABETES RES CLIN PR, V54, pS45, DOI 10.1016/S0168-8227(01)00335-7
   Salles JE, 2007, PANCREAS, V34, P133, DOI 10.1097/01.mpa.0000246659.38375.4d
   SILVESTREAILLAUD P, 1995, DIABETOLOGIA, V38, P1485
   Suzuki S, 2004, ANN NY ACAD SCI, V1011, P185, DOI 10.1196/annals.1293.019
   Suzuki S, 1998, DIABETOLOGIA, V41, P584, DOI 10.1007/s001250050950
   Todd JA, 2001, IMMUNITY, V15, P387, DOI 10.1016/S1074-7613(01)00202-3
   Uimonen S, 2001, HUM GENET, V108, P284, DOI 10.1007/s004390100475
   VANDAM PS, 1995, DIABETES METAB REV, V11, P181, DOI 10.1002/dmr.5610110303
   Whittaker RG, 2007, DIABETES CARE, V30, P2238, DOI 10.2337/dc07-0466
NR 31
TC 0
Z9 0
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1051-2144
EI 1539-9192
J9 ENDOCRINOLOGIST
JI Endocrinologist
PD MAY-JUN
PY 2010
VL 20
IS 3
BP 105
EP 108
DI 10.1097/TEN.0b013e3181dfdb01
PG 4
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 597QL
UT WOS:000277773900006
DA 2024-11-01
ER

PT J
AU Chen, C
   Vincent, AE
   Blain, AP
   Smith, AL
   Turnbull, DM
   Reeve, AK
AF Chen, Chun
   Vincent, Amy E.
   Blain, Alasdair P.
   Smith, Anna L.
   Turnbull, Doug M.
   Reeve, Amy K.
TI Investigation of mitochondrial biogenesis defects in single substantia
   nigra neurons using post-mortem human tissues
SO NEUROBIOLOGY OF DISEASE
LA English
DT Article
DE PD; mtDNA; Mitochondrial disease; POLG mutation; Neurodegeneration;
   Dopaminergic neuron
ID COMPLEX I DEFICIENCY; DNA DELETIONS; PARKINSONISM; MUTATIONS;
   PHOSPHORYLATION; MECHANISMS; DEPLETION; MUSCLE; TFAM
AB Mitochondrial respiratory chain deficiency and mitochondria] DNA deletions are reported in substantia nigra neurons from healthy aged and Parkinson's disease cases, with extensive neuronal loss only seen in the latter. This study aimed to understand the pathological relevance of mitochondrial defects for neuronal survival. Using post-mortem human midbrain, substantia nigra neurons exposed to different types of mitochondrial defects (including mitochondrial DNA point mutations, single and multiple deletions) were compared to neurons from healthy aged and Parkinson's disease cases (either sex) at a single neuronal level. We identified mitochondrial deficiencies in all cases, though these deficiencies were more severe in the mitochondrial disease patients with multiple deletions. A significant reduction in TFAM expression was detected in Parkinson's disease compared to cases with other mitochondria] defects. Higher mitochondrial DNA copy number was detected in healthy aged neurons, despite a deletion level equivalent to Parkinson's disease. Our data support that in individuals with pathogenic mitochondrial defects, neurons respond to mitochondrial defect to survive and such an adaptation may involve TFAM.
C1 [Chen, Chun; Vincent, Amy E.; Blain, Alasdair P.; Smith, Anna L.; Turnbull, Doug M.; Reeve, Amy K.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Chen, Chun; Vincent, Amy E.; Blain, Alasdair P.; Smith, Anna L.; Turnbull, Doug M.; Reeve, Amy K.] Newcastle Univ, Inst Ageing, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Chen, Chun; Vincent, Amy E.; Smith, Anna L.; Turnbull, Doug M.; Reeve, Amy K.] Newcastle Univ, LLHW Ctr Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle
   University - UK
RP Reeve, AK (corresponding author), Newcastle Univ, Med Sch, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM chun.chen@ncl.ac.uk; amy.vincent@ncl.ac.uk; alasdair.blain@ncl.ac.uk;
   anna.smith@ncl.ac.uk; doug.turnbull@ncl.ac.uk; amy.reeve@ncl.ac.uk
RI Vincent, Amy/J-7284-2019; chen, chun/AFI-5126-2022; Blain,
   Alasdair/B-9861-2011
OI Reeve, Amy/0000-0002-4474-2204; Vincent, Amy/0000-0002-0360-6644; chen,
   chun/0000-0002-6162-0284
FU Wellcome Centre for Mitochondrial Research [203105/Z16/Z]; MRC as part
   of the Newcastle Centre for Ageing and Vitality [MR/L016354/1]; senior
   Parkinson's UK fellowship [F-1401]; MRC [MR/L016354/1, MR/K000608/1,
   G0800674, G1100540] Funding Source: UKRI
FX This work was supported by the Wellcome Centre for Mitochondrial
   Research (203105/Z16/Z) and MRC as part of the Newcastle Centre for
   Ageing and Vitality (MR/L016354/1). A.K.R. is also supported by a senior
   Parkinson's UK fellowship (F-1401). No authors have received any funding
   from any institution, including personal relationships, interests,
   grants, employment, affiliations, patents, inventions, honoraria,
   consultancies, royalties, stock options/ownership, or expert testimony.
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024
   di Poggio MB, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-105
   Dölle C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13548
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Flones IH, 2018, ACTA NEUROPATHOL, V135, P409, DOI 10.1007/s00401-017-1794-7
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Grünewald A, 2014, J NEUROSCI METH, V232, P143, DOI 10.1016/j.jneumeth.2014.05.026
   Islam H, 2018, METABOLISM, V79, P42, DOI 10.1016/j.metabol.2017.11.001
   Jiang M, 2017, CELL METAB, V26, P429, DOI 10.1016/j.cmet.2017.07.003
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Lu B, 2013, MOL CELL, V49, P121, DOI 10.1016/j.molcel.2012.10.023
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Miguel R, 2014, CLIN NEUROL NEUROSUR, V126, P47, DOI 10.1016/j.clineuro.2014.08.020
   Moslemi AR, 1998, NEUROMUSCULAR DISORD, V8, P345, DOI 10.1016/S0960-8966(98)00029-7
   Nicholls TJ, 2018, MOL CELL, V69, P9, DOI 10.1016/j.molcel.2017.11.033
   Nido GS, 2018, NEUROBIOL AGING, V63, P120, DOI 10.1016/j.neurobiolaging.2017.10.024
   Perier C, 2013, BRAIN, V136, P2369, DOI 10.1093/brain/awt196
   Picca A, 2015, MITOCHONDRION, V25, P67, DOI 10.1016/j.mito.2015.10.001
   Pyle A, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.033
   Reeve A, 2013, J NEUROSCI, V33, P10790, DOI 10.1523/JNEUROSCI.3525-12.2013
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Rempe T, 2016, PARKINSONISM RELAT D, V29, P135, DOI 10.1016/j.parkreldis.2016.04.020
   Rocha MC, 2018, ANN NEUROL, V83, P115, DOI 10.1002/ana.25127
   Rocha MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15037
   Rygiel KA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09906
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stewart JD, 2011, BBA-MOL BASIS DIS, V1812, P321, DOI 10.1016/j.bbadis.2010.11.012
   Team, 2018, R C R LANG ENV STAT
   Tzoulis C, 2014, ANN NEUROL, V76, P66, DOI 10.1002/ana.24185
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059
NR 33
TC 29
Z9 29
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0969-9961
EI 1095-953X
J9 NEUROBIOL DIS
JI Neurobiol. Dis.
PD FEB
PY 2020
VL 134
AR 104631
DI 10.1016/j.nbd.2019.104631
PG 10
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA KG3BV
UT WOS:000509818400023
PM 31689514
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Legati, A
   Reyes, A
   Berti, CC
   Stehling, O
   Marchet, S
   Lamperti, C
   Ferrari, A
   Robinson, AJ
   Mühlenhoff, U
   Lill, R
   Zeviani, M
   Goffrini, P
   Ghezzi, D
AF Legati, Andrea
   Reyes, Aurelio
   Berti, Camilla Ceccatelli
   Stehling, Oliver
   Marchet, Silvia
   Lamperti, Costanza
   Ferrari, Alberto
   Robinson, Alan J.
   Muhlenhoff, Ulrich
   Lill, Roland
   Zeviani, Massimo
   Goffrini, Paola
   Ghezzi, Daniele
TI A novel de novo dominant mutation in <i>ISCU</i> associated with
   mitochondrial myopathy
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID IRON-SULFUR CLUSTERS; PROTEIN BIOGENESIS; METABOLISM; RECONSTITUTION;
   ARCHITECTURE; FERREDOXINS; INVOLVEMENT; REVEALS; FAMILY; LEADS
AB Background Hereditary myopathy with lactic acidosis and myopathy with deficiency of succinate dehydrogenase and aconitase are variants of a recessive disorder characterised by childhood-onset early fatigue, dyspnoea and palpitations on trivial exercise. The disease is non-progressive, but life-threatening episodes of widespread weakness, metabolic acidosis and rhabdomyolysis may occur. So far, this disease has been molecularly defined only in Swedish patients, all homozygous for a deep intronic splicing affecting mutation in ISCU encoding a scaffold protein for the assembly of iron-sulfur (Fe-S) clusters. A single Scandinavian family was identified with a different mutation, a missense change in compound heterozygosity with the common intronic mutation. The aim of the study was to identify the genetic defect in our proband.
   Methods A next-generation sequencing (NGS) approach was carried out on an Italian male who presented in childhood with ptosis, severe muscle weakness and exercise intolerance. His disease was slowly progressive, with partial recovery between episodes. Patient's specimens and yeast models were investigated.
   Results Histochemical and biochemical analyses on muscle biopsy showed multiple defects affecting mitochondrial respiratory chain complexes. We identified a single heterozygous mutation p. Gly96Val in ISCU, which was absent in DNA from his parents indicating a possible de novo dominant effect in the patient. Patient fibroblasts showed normal levels of ISCU protein and a few variably affected Fe-S cluster-dependent enzymes. Yeast studies confirmed both pathogenicity and dominance of the identified missense mutation.
   Conclusion We describe the first heterozygous dominant mutation in ISCU which results in a phenotype reminiscent of the recessive disease previously reported.
C1 [Legati, Andrea; Marchet, Silvia; Lamperti, Costanza; Ghezzi, Daniele] Fdn IRCCS Neurol Inst Besta, Mol Neurogenet Unit, Milan, Italy.
   [Reyes, Aurelio; Robinson, Alan J.; Zeviani, Massimo] Univ Cambridge, Med Res Council, Mitochondrial Biol Unit, Cambridge, England.
   [Berti, Camilla Ceccatelli; Ferrari, Alberto; Goffrini, Paola] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parma, Italy.
   [Stehling, Oliver; Muhlenhoff, Ulrich; Lill, Roland] Philipps Univ, Inst Zytobiol & Zytopathol, Dept Med, Marburg, Germany.
   [Lill, Roland] LOEWE Zentrum Synthet Mikrobiol SynMikro, Unit Metab, Marburg, Germany.
C3 UK Research & Innovation (UKRI); Medical Research Council UK (MRC);
   University of Cambridge; University of Parma; Philipps University
   Marburg
RP Goffrini, P (corresponding author), Univ Parma, Dept Chem, Life Sci & Environm Sustainabil, Viale Sci 11-A, I-43124 Parma, Italy.; Ghezzi, D (corresponding author), Ist Nazl Neurol Carlo Besta, Mol Neurogenet, I-20126 Milan, Italy.
EM paola.goffrini@unipr.it; daniele.ghezzi@istituto-besta.it
RI BERTI, Camilla/IWU-7583-2023; Zeviani, Massimo/AAU-2632-2021; lamperti,
   costanza/J-8801-2016; Legati, Andrea/K-2181-2016; MARCHET,
   SILVIA/AAF-5898-2021; Ghezzi, Daniele/J-7873-2016
OI CECCATELLI BERTI, Camilla/0000-0002-6527-4462; Lill,
   Roland/0000-0002-8345-6518; Legati, Andrea/0000-0002-8178-6126; MARCHET,
   SILVIA/0000-0002-7858-3256; Zeviani, Massimo/0000-0002-9067-5508;
   Ghezzi, Daniele/0000-0002-6564-3766
FU TelethonItaly [GGP15041]; Pierfranco and Luisa Mariani Foundation;
   MRC7QQR [201572020]; ERC advanced grant [FP77322424]; NRJ
   Foundation7Institut de France; E7Rare project GENOMIT; Deutsche
   Forschungsgemeinschaft [SFB 987, SPP 1927]; LOEWE program of state
   Hessen; MRC [MC_U105674181, MC_UP_1002/1, MC_UU_00015/5] Funding Source:
   UKRI
FX This work was supported by the TelethonItaly [GrantGGP15041]; the
   Pierfranco and Luisa Mariani Foundation; the MRC7QQR [201572020] grant;
   the ERC advanced grant [FP77322424]; the NRJ Foundation7Institut de
   France; the E7Rare project GENOMIT. RL acknowledges generous financial
   support from Deutsche Forschungsgemeinschaft [SFB 987 and SPP 1927] and
   the LOEWE program of state Hessen.
CR Almeida T, 2008, MOL BIOL CELL, V19, P865, DOI 10.1091/mbc.E07-06-0604
   Barrientos Antoni, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1903s63
   Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06
   BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609
   Brachmann CB, 1998, YEAST, V14, P115
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Cory SA, 2017, P NATL ACAD SCI USA, V114, pE5325, DOI 10.1073/pnas.1702849114
   Crooks DR, 2012, J BIOL CHEM, V287, P40119, DOI 10.1074/jbc.M112.418889
   DAILEY HA, 1994, BIOCHEMISTRY-US, V33, P403, DOI 10.1021/bi00168a003
   Freibert SA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13932
   Gakh O, 2016, J BIOL CHEM, V291, P21296, DOI 10.1074/jbc.M116.738542
   Garland SA, 1999, J MOL BIOL, V294, P897, DOI 10.1006/jmbi.1999.3294
   Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07
   Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004
   Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2
   Holmes-Hampton GP, 2016, HUM MOL GENET, V25, P5178, DOI 10.1093/hmg/ddw338
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Kollberg G, 2009, BRAIN, V132, P2170, DOI 10.1093/brain/awp152
   Legati A, 2016, BBA-BIOENERGETICS, V1857, P1326, DOI 10.1016/j.bbabio.2016.02.022
   Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009
   Maio N, 2017, CELL METAB, V25, P945, DOI 10.1016/j.cmet.2017.03.010
   Maio N, 2016, CELL METAB, V23, P292, DOI 10.1016/j.cmet.2015.12.005
   Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012
   Molik S, 2007, METHOD CELL BIOL, V80, P261, DOI 10.1016/S0091-679X(06)80013-0
   Mühlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446
   Nachbauer W, 2012, J NEUROPATH EXP NEUR, V71, P708, DOI 10.1097/NEN.0b013e31825fed76
   Nordin A, 2011, HUM GENET, V129, P371, DOI 10.1007/s00439-010-0931-3
   Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057
   Patil VA, 2013, J BIOL CHEM, V288, P1696, DOI 10.1074/jbc.M112.428938
   Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007
   Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019
   Saha PP, 2014, J BIOL CHEM, V289, P10359, DOI 10.1074/jbc.M113.526665
   Sambrook J, 1990, Cold Spring Harbor Laboratories, V186, P182
   Sanaker PS, 2010, BBA-MOL BASIS DIS, V1802, P539, DOI 10.1016/j.bbadis.2010.02.010
   Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206
   Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Sheftel AD, 2012, MOL BIOL CELL, V23, P1157, DOI 10.1091/mbc.E11-09-0772
   Sheftel AD, 2010, P NATL ACAD SCI USA, V107, P11775, DOI 10.1073/pnas.1004250107
   Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354
   Shi YB, 2012, BBA-MOL CELL RES, V1823, P484, DOI 10.1016/j.bbamcr.2011.11.002
   Soto IC, 2009, BBA-MOL CELL RES, V1793, P1776, DOI 10.1016/j.bbamcr.2009.09.002
   Stehling O, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011312
   Stevens A, 1990, THEORY PRACTICE HIST, P245
   Stiban J, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1066, DOI 10.1134/S0006297916100059
   Tamarit J, 2006, ANAL BIOCHEM, V351, P149, DOI 10.1016/j.ab.2005.12.001
   UZIEL G, 1988, MUSCLE NERVE, V11, P720, DOI 10.1002/mus.880110708
   Webert H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6013
   Ye H, 2010, J CLIN INVEST, V120, P1749, DOI 10.1172/JCI40372
NR 51
TC 25
Z9 28
U1 0
U2 3
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD DEC
PY 2017
VL 54
IS 12
BP 815
EP 824
DI 10.1136/jmedgenet-2017-104822
PG 10
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA FN6SU
UT WOS:000416147100005
PM 29079705
OA hybrid, Green Published, Green Submitted
DA 2024-11-01
ER

PT J
AU Guitart, T
   Picchioni, D
   Pineyro, D
   de Pouplana, LR
AF Guitart, Tanit
   Picchioni, Daria
   Pineyro, David
   Ribas de Pouplana, Lluis
TI Human mitochondrial disease-like symptoms caused by a reduced tRNA
   aminoacylation activity in flies
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID TRANSFER RNALEU(UUR) GENE; DNA MUTATION; SYNTHETASE MUTATIONS;
   LACTIC-ACIDOSIS; TRANSMITOCHONDRIAL MICE; POINT MUTATION; BRAIN-STEM;
   DROSOPHILA; MYOPATHY; MTDNA
AB The translation of genes encoded in the mitochondrial genome requires specific machinery that functions in the organelle. Among the many mutations linked to human disease that affect mitochondrial translation, several are localized to nuclear genes coding for mitochondrial aminoacyl-transfer RNA synthetases. The molecular significance of these mutations is poorly understood, but it is expected to be similar to that of the mutations affecting mitochondrial transfer RNAs. To better understand the molecular features of diseases caused by these mutations, and to improve their diagnosis and therapeutics, we have constructed a Drosophila melanogaster model disrupting the mitochondrial seryl-tRNA synthetase by RNA interference. At the molecular level, the knockdown generates a reduction in transfer RNA serylation, which correlates with the severity of the phenotype observed. The silencing compromises viability, longevity, motility and tissue development. At the cellular level, the knockdown alters mitochondrial morphology, biogenesis and function, and induces lactic acidosis and reactive oxygen species accumulation. We report that administration of antioxidant compounds has a palliative effect of some of these phenotypes. In conclusion, the fly model generated in this work reproduces typical characteristics of pathologies caused by mutations in the mitochondrial aminoacylation system, and can be useful to assess therapeutic approaches.
C1 [Guitart, Tanit; Picchioni, Daria; Pineyro, David; Ribas de Pouplana, Lluis] Inst Res Biomed IRB Barcelona, Gene Translat Lab, Barcelona 08028, Catalonia, Spain.
   [Ribas de Pouplana, Lluis] Catalan Inst Res & Adv Studies ICREA, Barcelona 08010, Catalonia, Spain.
C3 Barcelona Institute of Science & Technology; Institute for Research in
   Biomedicine - IRB Barcelona; ICREA
RP de Pouplana, LR (corresponding author), Inst Res Biomed IRB Barcelona, Gene Translat Lab, C Baldiri Reixac 10, Barcelona 08028, Catalonia, Spain.
EM lluis.ribas@irbbarcelona.org
RI de Pouplana, Lluis/AAA-4738-2019; Guitart Rodes, Tanit/G-9772-2015
OI Guitart Rodes, Tanit/0000-0003-2992-9895; Pineyro,
   David/0000-0001-5633-3339
FU Spanish Ministry of Economy and Innovation [BIO2012-32200,
   BIO2013-09776]; Government of Catalonia [FI-DGR 2011]; ICREA Funding
   Source: Custom
FX Spanish Ministry of Economy and Innovation [BIO2012-32200]; PhD
   fellowship from the Government of Catalonia [FI-DGR 2011 to D. P.].
   Funding for open access charge: Spanish Ministry of Economy and
   Innovation [BIO2013-09776].
CR Abramoff M.D., 2004, Biophotonics Int, V11, P36
   Achilli F, 2009, DIS MODEL MECH, V2, P359, DOI 10.1242/dmm.002527
   Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039
   Bayat V, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001288
   Belostotsky R, 2011, AM J HUM GENET, V88, P193, DOI 10.1016/j.ajhg.2010.12.010
   Bonnefoy N, 2001, METHOD CELL BIOL, V65, P381, DOI 10.1016/S0091-679X(01)65022-2
   Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Butow R A, 1996, Methods Enzymol, V264, P265, DOI 10.1016/S0076-6879(96)64026-9
   Cardaioli E, 2006, NEUROMUSCULAR DISORD, V16, P26, DOI 10.1016/j.nmd.2005.11.001
   Chihara T, 2007, NAT NEUROSCI, V10, P828, DOI 10.1038/nn1910
   Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954
   Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Elo JM, 2012, HUM MOL GENET, V21, P4521, DOI 10.1093/hmg/dds294
   Feuermann M, 2003, EMBO REP, V4, P53, DOI 10.1038/sj.embor.embor713
   Froelich CA, 2011, BIOCHEMISTRY-US, V50, P7132, DOI 10.1021/bi200989h
   Gnaiger E., 2011, MITOPATHWAYS RESP ST
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Guitart T, 2010, J BIOL CHEM, V285, P38157, DOI 10.1074/jbc.M110.167486
   Gutmann I., 1974, Methods of enzymatic analysis. L-
   He WW, 2011, P NATL ACAD SCI USA, V108, P12307, DOI 10.1073/pnas.1104293108
   Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727
   Karicheva OZ, 2011, NUCLEIC ACIDS RES, V39, P8173, DOI 10.1093/nar/gkr546
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267
   Latour P, 2010, AM J HUM GENET, V86, P77, DOI 10.1016/j.ajhg.2009.12.005
   Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010
   Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3
   Li J, 2008, GENET MOL RES, V7, P1054, DOI 10.4238/vol7-4gmr480
   Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09
   Mahata B, 2006, SCIENCE, V314, P471, DOI 10.1126/science.1129754
   Marchington DR, 1999, NAT MED, V5, P957, DOI 10.1038/11403
   McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008
   Melone MAB, 2004, ARCH NEUROL-CHICAGO, V61, P269, DOI 10.1001/archneur.61.2.269
   MITA S, 1995, MUSCLE NERVE, pS113
   Motley WW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002399
   Ogasawara E, 2010, HUM MOL GENET, V19, P3179, DOI 10.1093/hmg/ddq228
   OLDFORS A, 1995, ACTA NEUROPATHOL, V90, P328
   Owusu-Ansah E., 2008, NAT PROTOC, DOI [10.1038/nprot.2008.23, DOI 10.1038/NPR0T.2008.23;EPUB]
   Park H, 2008, RNA, V14, P2407, DOI 10.1261/rna.1208808
   PHILLIPS RG, 1990, DEVELOPMENT, V110, P105
   Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108
   REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Saini N, 2011, MOL CELL BIOL, V31, P2151, DOI 10.1128/MCB.05207-11
   Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Schrier SA, 2012, DISCOV MED, V13, P143
   Seburn KL, 2006, NEURON, V51, P715, DOI 10.1016/j.neuron.2006.08.027
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Storkebaum E, 2009, P NATL ACAD SCI USA, V106, P11782, DOI 10.1073/pnas.0905339106
   Swerdlow RH, 2007, J NEUROSCI RES, V85, P3416, DOI 10.1002/jnr.21167
   Toivonen JM, 2001, GENETICS, V159, P241
   Toompuu M, 2002, J BIOL CHEM, V277, P22240, DOI 10.1074/jbc.M200338200
   Tuppen HAL, 2012, EUR J HUM GENET, V20, P897, DOI 10.1038/ejhg.2012.44
   Walker SE, 2008, METHODS, V44, P81, DOI 10.1016/j.ymeth.2007.09.003
   Wang G, 2012, P NATL ACAD SCI USA, V109, P4840, DOI 10.1073/pnas.1116792109
   WILHELM ML, 1992, NUCLEIC ACIDS RES, V20, P4106, DOI 10.1093/nar/20.15.4106
   Wong LJC, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.040626
   Zhu AP, 2009, ANAL BIOCHEM, V388, P97, DOI 10.1016/j.ab.2009.02.009
NR 69
TC 10
Z9 11
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JUL
PY 2013
VL 41
IS 13
BP 6595
EP 6608
DI 10.1093/nar/gkt402
PG 14
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 192BK
UT WOS:000322458800027
PM 23677612
OA Green Published, Green Submitted
DA 2024-11-01
ER

PT J
AU Dimmick, J
AF Dimmick, J
TI Conjugated hyperbilirubinemia in infancy (mitochondrial DNA depletion
   syndrome, liver)
SO PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
LA English
DT Article
ID MTDNA DEPLETION; MYOPATHY; DISEASES; KINASE; GENE
C1 Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada.
   British Columbia Childrens & Womens Hosp, Vancouver, BC V6T 2B5, Canada.
C3 University of British Columbia; University of British Columbia
RP Dimmick, J (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, 2211 Wesbrook Mall,UBC, Vancouver, BC V6T 2B5, Canada.
EM jdimmick@pathology.ubc.ca
CR Blake JC, 1999, AM J PATHOL, V155, P67, DOI 10.1016/S0002-9440(10)65100-0
   Coté HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035
   Ducluzeau PH, 1999, J HEPATOL, V30, P149, DOI 10.1016/S0168-8278(99)80019-1
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MAZZIOTTA MRM, 1992, J PEDIATR-US, V121, P896, DOI 10.1016/S0022-3476(05)80335-X
   MIERAU GW, 2004, IN PRESS PEDIAT DEV, V7
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Müller-Höcker J, 2002, HUM PATHOL, V33, P247, DOI 10.1053/hupa.2002.31477
   POULTON J, 1994, HUM MOL GENET, V3, P1763, DOI 10.1093/hmg/3.10.1763
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379
   Taanman JW, 1997, HUM MOL GENET, V6, P935, DOI 10.1093/hmg/6.6.935
   TRITSCHLER HJ, 1992, NEUROLOGY, V42, P209, DOI 10.1212/WNL.42.1.209
   Vu TH, 2001, HEPATOLOGY, V34, P116, DOI 10.1053/jhep.2001.25921
NR 15
TC 1
Z9 1
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 1093-5266
J9 PEDIATR DEVEL PATHOL
JI Pediatr. Dev. Pathol.
PD NOV-DEC
PY 2004
VL 7
IS 6
BP 625
EP 628
DI 10.1007/s10024-004-5052-3
PG 4
WC Pathology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology; Pediatrics
GA 883QU
UT WOS:000226031600010
PM 15630532
DA 2024-11-01
ER

PT J
AU Chiaratti, MR
   Chinnery, PF
AF Chiaratti, Marcos R.
   Chinnery, Patrick F.
TI Modulating mitochondrial DNA mutations: factors shaping heteroplasmy in
   the germ line and somatic cells
SO PHARMACOLOGICAL RESEARCH
LA English
DT Article
DE Mitochondria; MtDNA; Mutant; Selection; Mitophagy; Selfish
ID COPY NUMBER; MTDNA HETEROPLASMY; QUALITY-CONTROL; SEQUENCE
   HETEROGENEITY; GENETIC BOTTLENECK; RAPID SEGREGATION; OXIDATIVE STRESS;
   HELICASE TWINKLE; SKELETAL-MUSCLE; IN-VIVO
AB Until recently it was thought that most humans only harbor one type of mitochondrial DNA (mtDNA), however, deep sequencing and single-cell analysis has shown the converse - that mixed populations of mtDNA (heteroplasmy) are the norm. This is important because heteroplasmy levels can change dramatically during transmission in the female germ line, leading to high levels causing severe mitochondrial diseases. There is also emerging evidence that low level mtDNA mutations contribute to common late onset diseases such as neurodegenerative disorders and cardiometabolic diseases because the inherited mutation levels can change within developing organs and non-dividing cells over time. Initial predictions suggested that the segregation of mtDNA heteroplasmy was largely stochastic, with an equal tendency for levels to increase or decrease. However, transgenic animal work and single-cell analysis have shown this not to be the case during germ-line transmission and in somatic tissues during life. Mutation levels in specific mtDNA regions can increase or decrease in different contexts and the underlying molecular mechanisms are starting to be unraveled. In this review we provide a synthesis of recent literature on the mechanisms of selection for and against mtDNA variants. We identify the most pertinent gaps in our understanding and suggest ways these could be addressed using state of the art techniques.
C1 [Chiaratti, Marcos R.] Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Genet & Evolucao, Sao Carlos, Brazil.
   [Chinnery, Patrick F.] Univ Cambridge, Cambridge Biomed Campus, Sch Clin Med, Dept Clin Neurosci, Cambridge, England.
   [Chinnery, Patrick F.] Univ Cambridge, Cambridge Biomed Campus, Med Res Council, Mitochondrial Biol Unit, Cambridge, England.
C3 Universidade Federal de Sao Carlos; University of Cambridge; UK Research
   & Innovation (UKRI); Medical Research Council UK (MRC); University of
   Cambridge
RP Chiaratti, MR (corresponding author), Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Genet & Evolucao, Sao Carlos, Brazil.; Chinnery, PF (corresponding author), Univ Cambridge, Cambridge Biomed Campus, Sch Clin Med, Dept Clin Neurosci, Cambridge, England.
EM marcos.chiaratti@ufscar.br; pfc25@cam.ac.uk
RI ; Chiaratti, Marcos/C-2727-2012
OI Chinnery, Patrick/0000-0002-7065-6617; Chiaratti,
   Marcos/0000-0001-8805-9469
FU Sao Paulo Research Foundation (FAPESP/Brazil) [2017/04372-0,
   2020/15412-6]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq/Brazil); Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES/Brazil) [001]; Academy of Medical Sciences-Newton
   Advanced Fellowship; Wellcome Trust [212219/Z/18/Z]; Medical Research
   Council Mitochondrial Biology Unit [MC_UU_00028/7]; Medical Research
   Council (MRC) International Center for Genomic Medicine in Neuromuscular
   Disease [MR/S005021/1]; Leverhulme Trust [RPG2018-408]; MRC
   [MR/S035699/1]; Alzheimer's Society [AS-PG-18b-022]; NIHR Cambridge
   Biomedical Research Center [BRC-1215-20014]; EPSRC [EP/N01426X/1]
   Funding Source: UKRI; MRC [MR/M008886/1, MC_PC_13047, MR/S035699/1,
   MR/S005021/1, MC_UU_00028/7] Funding Source: UKRI; Wellcome Trust
   [212219/Z/18/Z] Funding Source: Wellcome Trust
FX M.R.C. is funded by the Sao Paulo Research Foundation (FAPESP/Brazil
   -grants #2017/04372-0 and 2020/15412-6), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil), the Coordenacao
   de Aperfeicoamento de Pessoal de N i vel Superior (CAPES/Brazil -finance
   code 001), and the Academy of Medical Sciences-Newton Advanced
   Fellowship. P.F.C. is a Wellcome Trust Principal Research Fellow
   (212219/Z/18/Z), and a UK NIHR Senior Investigator, who receives support
   from the Medical Research Council Mitochondrial Biology Unit
   (MC_UU_00028/7), the Medical Research Council (MRC) International Center
   for Genomic Medicine in Neuromuscular Disease (MR/S005021/1), the
   Leverhulme Trust (RPG2018-408), an MRC research grant (MR/S035699/1), an
   Alzheimer's Society Project Grant (AS-PG-18b-022). This research was
   supported by the NIHR Cambridge Biomedical Research Center
   (BRC-1215-20014). The views expressed are those of the author(s) and not
   necessarily those of the NIHR or the Department of Health and Social
   Care. Figures were created with BioRender.com.
CR Acton BM, 2007, BIOL REPROD, V77, P569, DOI 10.1095/biolreprod.107.060806
   Agaronyan K, 2015, SCIENCE, V347, P548, DOI 10.1126/science.aaa0986
   Ahier A, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109203
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Aiken CEM, 2008, REPROD BIOMED ONLINE, V17, P806, DOI 10.1016/S1472-6483(10)60409-9
   Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028
   Anderson NS, 2020, TRENDS CELL BIOL, V30, P428, DOI 10.1016/j.tcb.2020.03.001
   Arbeithuber B, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2118740119
   Arbeithuber B, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000745
   Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005
   Barriocanal-Casado E, 2019, EBIOMEDICINE, V42, P511, DOI 10.1016/j.ebiom.2019.03.025
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Blackwood JK, 2011, J PATHOL, V225, P181, DOI 10.1002/path.2965
   Boucret L, 2017, HUM REPROD, V32, P2101, DOI 10.1093/humrep/dex268
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Brüser C, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.110000
   Bruni F, 2017, FEBS J, V284, P1767, DOI 10.1111/febs.13981
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Burgstaller JP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04797-2
   Burgstaller JP, 2014, CELL REP, V7, P2031, DOI 10.1016/j.celrep.2014.05.020
   Burman JL, 2017, J CELL BIOL, V216, P3231, DOI 10.1083/jcb.201612106
   Cai N, 2021, NAT MED, V27, P1564, DOI 10.1038/s41591-021-01441-3
   Calabrese C, 2022, PLOS GENET, V18, DOI 10.1371/journal.pgen.1010068
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970
   Carvalho KF, 2020, FASEB J, V34, P7644, DOI 10.1096/fj.201901761R
   Chan DC, 2020, ANNU REV PATHOL-MECH, V15, P235, DOI 10.1146/annurev-pathmechdis-012419-032711
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Chen Z, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201905160
   Cherezov V., 2013, SCIENCE, V342, P1524, DOI [10.1126/ science.1244360, DOI 10.1126/SCIENCE.1244360]
   Chiang ACY, 2019, CURR BIOL, V29, P4330, DOI 10.1016/j.cub.2019.10.060
   Chiaratti MR, 2021, BIOPHYS REV-GER, V13, P967, DOI 10.1007/s12551-021-00891-w
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Cho SI, 2022, CELL, V185, P1764, DOI 10.1016/j.cell.2022.03.039
   Chung CY, 2022, TRENDS CELL BIOL, V32, P391, DOI 10.1016/j.tcb.2021.10.005
   Chung CY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26746-2
   Collins ML, 2003, J APPL PHYSIOL, V94, P2203, DOI 10.1152/japplphysiol.00691.2002
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Dai Y, 2014, HUM MOL GENET, V23, P637, DOI 10.1093/hmg/ddt450
   Davis RE, 1997, P NATL ACAD SCI USA, V94, P4526, DOI 10.1073/pnas.94.9.4526
   Dayama G, 2014, NUCLEIC ACIDS RES, V42, P12640, DOI 10.1093/nar/gku1038
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Diez-Juan A, 2015, FERTIL STERIL, V104, P534, DOI 10.1016/j.fertnstert.2015.05.022
   DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116
   Dölle C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13548
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Durham SE, 2006, NEUROLOGY, V67, P502, DOI 10.1212/01.wnl.0000227961.55640.2f
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fan XY, 2022, NAT BIOMED ENG, V6, P339, DOI 10.1038/s41551-022-00881-7
   Fellous TG, 2009, STEM CELLS, V27, P1410, DOI 10.1002/stem.67
   Filograna R, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav9824
   Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021
   Floros VI, 2018, NAT CELL BIOL, V20, P144, DOI 10.1038/s41556-017-0017-8
   Fonseca MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106654
   Forsström S, 2019, CELL METAB, V30, P1040, DOI [10.1016/j.cmet.2019.013.019, 10.1016/j.cmet.2019.08.019]
   Fragouli E, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005241
   Frederiksen AL, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039339
   Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427
   Garrido-Maraver J, 2015, BBA-MOL BASIS DIS, V1852, P2535, DOI 10.1016/j.bbadis.2015.08.027
   Gates KS, 2009, CHEM RES TOXICOL, V22, P1747, DOI 10.1021/tx900242k
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Granatiero V, 2016, CELL DEATH DIFFER, V23, P231, DOI 10.1038/cdd.2015.84
   Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686
   Herbers E, 2019, MITOCHONDRION, V44, P85, DOI 10.1016/j.mito.2018.01.004
   Hill JH, 2014, NAT GENET, V46, P389, DOI 10.1038/ng.2920
   Hirano M, 1997, P NATL ACAD SCI USA, V94, P14894, DOI 10.1073/pnas.94.26.14894
   Holt AG, 2021, ACTA BIOTHEOR, V69, P671, DOI 10.1007/s10441-021-09417-z
   Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264
   Hyslop LA, 2016, NATURE, V534, P383, DOI [10.1038/nature183030, 10.1038/nature18303]
   Jemt E, 2015, NUCLEIC ACIDS RES, V43, P9262, DOI 10.1093/nar/gkv804
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Ji FY, 2012, P NATL ACAD SCI USA, V109, P7391, DOI 10.1073/pnas.1202484109
   Jiang M, 2017, CELL METAB, V26, P429, DOI 10.1016/j.cmet.2017.07.003
   Jin SM, 2013, AUTOPHAGY, V9, P1750, DOI 10.4161/auto.26122
   Johnson MT, 2007, BIOL REPROD, V77, P2, DOI 10.1095/biolreprod.106.059899
   Jokinen R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001161
   Ju YS, 2014, ELIFE, V3, DOI 10.7554/eLife.02935
   Kandul NP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13100
   Kang EJ, 2016, NATURE, V540, P270, DOI 10.1038/nature20592
   Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Kleele T, 2021, NATURE, V593, P435, DOI 10.1038/s41586-021-03510-6
   Kowald A, 2018, GENES-BASEL, V9, DOI 10.3390/genes9030126
   Kraja AT, 2019, AM J HUM GENET, V104, P112, DOI 10.1016/j.ajhg.2018.12.001
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Latorre-Pellicer A, 2019, CELL METAB, V30, P1120, DOI 10.1016/j.cmet.2019.09.007
   Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011
   Li J, 2020, BIOCHEM BIOPH RES CO, V521, P1024, DOI 10.1016/j.bbrc.2019.10.112
   Li MK, 2016, GENOME RES, V26, P417, DOI 10.1101/gr.203216.115
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Lieber T, 2019, NATURE, V570, P380, DOI 10.1038/s41586-019-1213-4
   Lima A, 2021, NAT METAB, V3, P1091, DOI 10.1038/s42255-021-00422-7
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Lorente L, 2016, J CRIT CARE, V33, P95, DOI 10.1016/j.jcrc.2016.02.003
   Lorente L, 2012, CRIT CARE, V16, DOI 10.1186/cc11150
   Ma HS, 2016, NAT GENET, V48, P798, DOI 10.1038/ng.3587
   Ma HS, 2014, NAT GENET, V46, P393, DOI 10.1038/ng.2919
   Ma H, 2020, BIOL REPROD, V102, P607, DOI 10.1093/biolre/ioz202
   Ma H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201304
   Ma H, 2016, CELL METAB, V24, P283, DOI 10.1016/j.cmet.2016.06.012
   Machado TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133650
   Malena A, 2016, AUTOPHAGY, V12, P2098, DOI 10.1080/15548627.2016.1226734
   Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281
   Martinus RD, 1996, EUR J BIOCHEM, V240, P98, DOI 10.1111/j.1432-1033.1996.0098h.x
   Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035
   McLelland GL, 2016, J CELL BIOL, V214, P275, DOI 10.1083/jcb.201603105
   Meshnik L, 2022, BMC BIOL, V20, DOI 10.1186/s12915-022-01241-2
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Mick E, 2020, ELIFE, V9, DOI 10.7554/eLife.49178
   Miller B, 2020, EXP CELL RES, V393, DOI 10.1016/j.yexcr.2020.112056
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Mueller EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016455
   Murakoshi Y, 2013, J ASSIST REPROD GEN, V30, P1367, DOI 10.1007/s10815-013-0062-6
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008
   Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038
   Ng MYW, 2021, DEV CELL, V56, P881, DOI 10.1016/j.devcel.2021.02.009
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Nido GS, 2018, NEUROBIOL AGING, V63, P120, DOI 10.1016/j.neurobiolaging.2017.10.024
   Nie Y, 2022, ACTA NEUROPATHOL, V143, P687, DOI 10.1007/s00401-022-02423-6
   Okamoto K, 1998, J CELL BIOL, V142, P613, DOI 10.1083/jcb.142.3.613
   OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0
   Otten ABC, 2018, HUM REPROD, V33, P1331, DOI 10.1093/humrep/dey114
   Palombo F, 2021, STEM CELL REP, V16, P1953, DOI 10.1016/j.stemcr.2021.06.016
   Papa L, 2014, MOL CELL BIOL, V34, P699, DOI 10.1128/MCB.01337-13
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Pezet MG, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02069-2
   Phillips WS, 2015, GENOME BIOL EVOL, V7, P2023, DOI 10.1093/gbe/evv116
   Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2
   Pla-Martin D, 2021, bioRxiv, DOI [10.1101/2021.08.06.455397, DOI 10.1101/2021.08.06.455397, 10.1101/2021.08.06.455397]
   Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581
   Pozzi A, 2019, GENOME BIOL EVOL, V11, P1883, DOI 10.1093/gbe/evz132
   Rainbolt TK, 2013, CELL METAB, V18, P908, DOI 10.1016/j.cmet.2013.11.006
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Ramírez S, 2017, CELL METAB, V25, P1390, DOI 10.1016/j.cmet.2017.05.010
   Rand DM, 2008, PLOS BIOL, V6, P229, DOI 10.1371/journal.pbio.0060035
   Rath S, 2021, NUCLEIC ACIDS RES, V49, pD1541, DOI 10.1093/nar/gkaa1011
   Rebolledo-Jaramillo B, 2014, P NATL ACAD SCI USA, V111, P15474, DOI 10.1073/pnas.1409328111
   Rius-Pérez S, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/1452696
   Rodríguez-Nuevo A, 2022, NATURE, V607, P756, DOI 10.1038/s41586-022-04979-5
   Rojansky R, 2016, ELIFE, V5, DOI 10.7554/eLife.17896
   Samstag CL, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007805
   Samuels DC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003929
   Sanchez-Contreras M, 2021, NUCLEIC ACIDS RES, V49, P11103, DOI 10.1093/nar/gkab901
   Sato A, 2007, GENETICS, V177, P2031, DOI 10.1534/genetics.107.081026
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   Shibata T, 2007, MITOCHONDRION, V7, P17, DOI 10.1016/j.mito.2006.11.024
   Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010
   Shin MG, 2004, BLOOD, V103, P4466, DOI 10.1182/blood-2003-11-3949
   Shin MG, 2004, BLOOD, V103, P553, DOI 10.1182/blood-2003-05-1724
   Silva-Pinheiro P, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28358-w
   Song LY, 2017, NEUROBIOL DIS, V100, P30, DOI 10.1016/j.nbd.2016.12.024
   Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057
   Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1
   Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x
   Stewart JB, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005333
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162
   Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466
   Szczepanowska K, 2021, BBA-BIOENERGETICS, V1862, DOI 10.1016/j.bbabio.2020.148365
   Tan JX, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202002179
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Tostes K, 2022, AUTOPHAGY, V18, P2397, DOI 10.1080/15548627.2022.2038501
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trinh J, 2022, medRxiv, DOI [10.1101/2022.05.17.22275087, 10.1101/2022.05.17.22275087, DOI 10.1101/2022.05.17.22275087]
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Udagawa O, 2014, CURR BIOL, V24, P2451, DOI 10.1016/j.cub.2014.08.060
   Uhler JP, 2015, DNA REPAIR, V34, P28, DOI 10.1016/j.dnarep.2015.07.003
   Umbria M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59631-x
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   Valenci I, 2015, MITOCHONDRION, V20, P64, DOI 10.1016/j.mito.2014.11.001
   Lechuga-Vieco AV, 2022, CIRCULATION, V145, P1084, DOI 10.1161/CIRCULATIONAHA.121.056286
   Lechuga-Vieco AV, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba5345
   Wachsmuth M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005939
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Wallace DC, 2015, CELL, V163, P33, DOI 10.1016/j.cell.2015.08.067
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Wang YQ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014610118
   Wei W, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25482-x
   Wei W, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15336-3
   Wei W, 2019, SCIENCE, V364, P749, DOI 10.1126/science.aau6520
   Wei W, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007126
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Williams SL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003990
   Wojewoda M, 2011, INT J BIOCHEM CELL B, V43, P1178, DOI 10.1016/j.biocel.2011.04.011
   Wolf DP, 2017, EMBO J, V36, P2177, DOI 10.15252/embj.201797606
   Wu SB, 2012, BBA-MOL BASIS DIS, V1822, P233, DOI 10.1016/j.bbadis.2011.09.014
   Yamada M, 2016, CELL STEM CELL, V18, P749, DOI 10.1016/j.stem.2016.04.001
   Yamamoto K, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0812-9
   Yang QY, 2022, NAT CELL BIOL, V24, P181, DOI 10.1038/s41556-021-00840-5
   Yang Y, 2008, GENET MED, V10, P187, DOI 10.1097/GIM.0b013e318163c343
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Yonova-Doing E, 2021, NAT GENET, V53, P982, DOI 10.1038/s41588-021-00868-1
   Yuan Y, 2020, NAT GENET, V52, P342, DOI 10.1038/s41588-019-0557-x
   Zaidi AA, 2019, P NATL ACAD SCI USA, V116, P25172, DOI 10.1073/pnas.1906331116
   Zhang HX, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abi5657
   Zhang Y, 2019, MOL CELL, V73, P1127, DOI 10.1016/j.molcel.2019.01.013
   Zhang Y, 2016, EMBO J, V35, P1045, DOI 10.15252/embj.201592994
   Zheng XD, 2016, ELIFE, V5, DOI 10.7554/eLife.13378
   Zhou QH, 2016, SCIENCE, V353, P394, DOI 10.1126/science.aaf4777
   Zinovkina LA, 2018, BIOCHEMISTRY-MOSCOW+, V83, P233, DOI 10.1134/S0006297918030045
NR 220
TC 11
Z9 14
U1 0
U2 21
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-6618
EI 1096-1186
J9 PHARMACOL RES
JI Pharmacol. Res.
PD NOV
PY 2022
VL 185
AR 106466
DI 10.1016/j.phrs.2022.106466
PG 17
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 5N9QI
UT WOS:000872120100002
PM 36174964
OA hybrid
DA 2024-11-01
ER

PT J
AU Ishiyama, A
   Komaki, H
   Saito, T
   Saito, Y
   Nakagawa, E
   Sugai, K
   Itagaki, Y
   Matsuzaki, K
   Nakura, M
   Nishino, I
   Goto, Y
   Sasaki, M
AF Ishiyama, Akihiko
   Komaki, Hirofumi
   Saito, Takashi
   Saito, Yoshiaki
   Nakagawa, Eiji
   Sugai, Kenji
   Itagaki, Yusuke
   Matsuzaki, Koji
   Nakura, Michiaki
   Nishino, Ichizo
   Goto, Yu-ichi
   Sasaki, Masayuki
TI Unusual exocrine complication of pancreatitis in mitochondrial disease
SO BRAIN & DEVELOPMENT
LA English
DT Article
DE Mitochondrial disease; Pancreatitis; CPEO; MELAS
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; RAGGED-RED FIBERS;
   LACTIC-ACIDOSIS; RECURRENT PANCREATITIS; TRNA(LEU(UUR)) GENE; TISSUE
   DISTRIBUTION; DIABETES-MELLITUS; A3243G MUTATION; EPISODES MELAS; DNA
AB No association between mitochondrial disease and pancreatitis has yet been established, although diabetes mellitus and diseases caused by exocrine insufficiency, such as Pearson syndrome, are the commonest pancreatic complications of mitochondrial diseases. Here, we report 2 cases of mitochondrial disease complicated by pancreatitis as an unusual pancreatic exocrine manifestation. One patient was a 10-year-old girl with mild retardation of psychomotor development who had experienced recurrent pancreatitis since the age of 4 years. Chronic progressive external ophthalmoplegia (CPEO) due to m.8344A>G mutation was diagnosed when the patient was 10 years old. The other patient was a 28-year-old woman who was diagnosed with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) due to m.3243A>G mutation at 10 years of age. She had experienced regular recurrent vomiting since the age of 16 and suffered an episode of critical pancreatitis at 23 years. In both cases, no possible etiological, morphological, or genetic factors for pancreatitis were identified, including anomalous pancreaticobiliary duct. A combination therapy of the standard treatment for chronic pancreatitis and supportive therapy for mitochondrial energy production may be beneficial to prevent the recurrence of acute pancreatitis complicating mitochondrial diseases. The pathophysiological mechanism of pancreatitis in mitochondrial disease has not been adequately established; however, our observations suggest that pancreatitis should be included in the list of pancreatic complications of mitochondrial disease. (C) 2012 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
C1 [Ishiyama, Akihiko; Komaki, Hirofumi; Saito, Takashi; Saito, Yoshiaki; Nakagawa, Eiji; Sugai, Kenji; Sasaki, Masayuki] Natl Ctr Neurol & Psychiat, Natl Ctr Hosp, Dept Child Neurol, Kodaira, Tokyo 1878551, Japan.
   [Itagaki, Yusuke; Matsuzaki, Koji] Suita Municipal Hosp, Dept Pediat, Osaka, Japan.
   [Nakura, Michiaki] Japanese Red Cross Mito Hosp, Dept Pediat, Ibaraki, Japan.
   [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo 1878551, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Kodaira, Tokyo 1878551, Japan.
C3 National Center for Neurology & Psychiatry - Japan; National Center for
   Neurology & Psychiatry - Japan; National Center for Neurology &
   Psychiatry - Japan
RP Komaki, H (corresponding author), Natl Ctr Neurol & Psychiat, Natl Ctr Hosp, Dept Child Neurol, 4-1-1 Ogawahigashi Cho, Kodaira, Tokyo 1878551, Japan.
EM komakih@ncnp.go.jp
RI ; Nishino, Ichizo/G-2676-2010
OI Saito, Yoshiaki/0000-0001-5893-3565; Nishino, Ichizo/0000-0001-9452-112X
FU Ministry of Health, Labour and Welfare of Japan [24-Y7, 23-6]
FX This work was partly supported by Intramural Research Grant (24-Y7) for
   Neurological and Psychiatric Disorders of NCNP (AI), Research Grant
   (23-6) for Nervous and Mental Disorders (HK) and Grants-in-Aid for
   Research on Intractable Diseases (Mitochondrial Disease) (YG and HK)
   from the Ministry of Health, Labour and Welfare of Japan.
CR Abe K, 1999, J NEUROL SCI, V162, P65, DOI 10.1016/S0022-510X(98)00296-2
   Braganza JM, 2011, LANCET, V377, P1184, DOI 10.1016/S0140-6736(10)61852-1
   Chang YJ, 2011, ACTA PAEDIATR, V100, P740, DOI 10.1111/j.1651-2227.2011.02158.x
   Chen RS, 1997, EUR NEUROL, V37, P212, DOI 10.1159/000117445
   CHINNERY PF, 1999, LANCET S1, V354, P17
   Debray FG, 2006, AM J MED GENET A, V140A, P2330, DOI 10.1002/ajmg.a.31457
   DOUGHERTY FE, 1994, J PEDIATR-US, V125, P758, DOI 10.1016/S0022-3476(94)70073-7
   GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E
   Hom XB, 2004, MITOCHONDRION, V4, P601
   KAHLER SG, 1994, J PEDIATR-US, V124, P239, DOI 10.1016/S0022-3476(94)70311-6
   KATO S, 1990, J PEDIATR GASTR NUTR, V11, P549, DOI 10.1097/00005176-199011000-00018
   Kishnani PS, 1996, EUR J PEDIATR, V155, P898
   LAFORET P, 1995, NEUROMUSCULAR DISORD, V5, P399, DOI 10.1016/0960-8966(94)00080-S
   Lal A, 2010, PEDIATR SURG INT, V26, P1193, DOI 10.1007/s00383-010-2684-4
   Maassen JA, 2002, AM J MED GENET, V115, P66, DOI 10.1002/ajmg.10346
   MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873
   Mukheriee R, 2008, CELL CALCIUM, V44, P14, DOI 10.1016/j.ceca.2007.11.013
   Oexle K, 1996, EXP CLIN ENDOCR DIAB, V104, P212, DOI 10.1055/s-0029-1211445
   OLDFORS A, 1995, ACTA NEUROPATHOL, V90, P328
   Remes AM, 2002, NEUROLOGY, V59, P1275, DOI 10.1212/WNL.59.8.1275
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   TANNO Y, 1993, NEUROLOGY, V43, P1198, DOI 10.1212/WNL.43.6.1198
   Toyono M, 2001, NEUROMUSCULAR DISORD, V11, P300, DOI 10.1016/S0960-8966(00)00176-0
   Tsai K, 1998, GUT, V42, P850, DOI 10.1136/gut.42.6.850
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Verny C, 2008, DIABETES METAB, V34, P620, DOI 10.1016/j.diabet.2008.06.001
NR 27
TC 5
Z9 6
U1 0
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0387-7604
J9 BRAIN DEV-JPN
JI Brain Dev.
PD AUG
PY 2013
VL 35
IS 7
BP 654
EP 659
DI 10.1016/j.braindev.2012.10.015
PG 6
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 184IG
UT WOS:000321882700008
PM 23182449
DA 2024-11-01
ER

PT J
AU Bakhoum, MF
   Wu, WP
   White, EC
   Sengillo, JD
   Sanfilippo, C
   Morcos, MM
   Freund, KB
   Perry, HD
   Sarraf, D
   Tsang, SH
AF Bakhoum, Mathieu F.
   Wu, Wei-Pu
   White, Eugenia C.
   Sengillo, Jesse D.
   Sanfilippo, Christian
   Morcos, Marcelle M.
   Freund, K. Bailey
   Perry, Henry D.
   Sarraf, David
   Tsang, Stephen H.
TI Mitochondrial A3243G mutation results in corneal endothelial
   polymegathism
SO GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
LA English
DT Article
DE Mitochondrial diseases; Endothelial corneal dystrophy; Retinal
   dystrophy; Specular microscopy; Genetics
ID KEARNS-SAYRE-SYNDROME; II DIABETES-MELLITUS; SPECULAR MICROSCOPY;
   POPULATION; DYSTROPHY; GENE; MORPHOLOGY; MYOPATHY; DEAFNESS
AB The mitochondrial DNA point mutation A3243G leads to a spectrum of syndromes ranging from MIDD to MELAS. Ocular manifestations include pattern macular dystrophy and concentric perifoveal atrophy. Given the high metabolic demand of corneal endothelial cells, we performed specular biomicroscopy analysis in patients harboring the mitochondrial DNA point mutation A3243G to assess for the associated presence of corneal endothelial abnormalities.
   We present a case series with participants from two institutions. Patients diagnosed with macular dystrophy associated with MIDD or MELAS, and the mitochondrial DNA point mutation A3243G were recruited. Exclusion criteria included a prior diagnosis, or a positive family history, of endothelial corneal dystrophy. Slit-lamp corneal examination and specular biomicroscopy were performed. Corneal endothelial cell count, cell size and polymegathism, and central corneal thickness were assessed. Patients diagnosed with MIDD or MELAS based on clinical history and examination were genetically tested for the mitochondrial DNA point mutation A3243G using pyrosequencing.
   Five patients (two male and three female participants) from five different families, and with different ethnic backgrounds, met the inclusion criteria. Their ages ranged from 41 to 60 years. Corneal endothelial changes observed using slit-lamp examination were primarily mild to rare guttata. Specular biomicroscopy displayed mainly polymegathism associated with guttata. The average endothelial cell count was 2358 +/- 456 cells per mm(2), the average endothelial cell size was 442 +/- 103 mu m(2) and the average central corneal thickness (CCT) was 551 +/- 33 mu m. These values were similar to that of the average population. The average coefficient of variation (COV), an index of heterogeneity in cell size, was 42.0 +/- 4.1%. When compared to the average population, the average COV was significantly higher than predicted for the patients' age. None of the patients had signs of corneal edema. One patient had a pre-Descemet's opacity.
   In patients with the mitochondrial DNA point mutation A3243G, corneal endothelial polymegathism is present. This is mainly associated with mild guttata. The findings of corneal endothelial cell polymegathism may be a biomarker of mitochondrial disease, specifically in patients with the mitochondrial DNA A3243G mutation.
C1 [Bakhoum, Mathieu F.; Wu, Wei-Pu; White, Eugenia C.; Sengillo, Jesse D.; Tsang, Stephen H.] Columbia Univ, Jonas Childrens Vis Care, New York, NY 10027 USA.
   [Bakhoum, Mathieu F.; Wu, Wei-Pu; White, Eugenia C.; Sengillo, Jesse D.; Tsang, Stephen H.] Columbia Univ, Bernard & Shirlee Brown Glaucoma Lab, New York, NY 10027 USA.
   [Bakhoum, Mathieu F.; Wu, Wei-Pu; Sengillo, Jesse D.; Freund, K. Bailey; Tsang, Stephen H.] Columbia Univ, Dept Ophthalmol, Coll Phys & Surg, New York, NY 10027 USA.
   [Bakhoum, Mathieu F.; Morcos, Marcelle M.; Perry, Henry D.] Nassau Univ, Dept Ophthalmol, Med Ctr, E Meadow, NY USA.
   [Sanfilippo, Christian; Sarraf, David] Univ Calif Los Angeles, David Geffen Sch Med, Stein Eye Inst, Dept Ophthalmol, Los Angeles, CA 90095 USA.
   [Freund, K. Bailey] Vitreous Retina Macula Consultants New York, New York, NY USA.
   [Perry, Henry D.] Ophthalm Consultants Long Isl, Long Isl City, NY USA.
   [Sarraf, David] Greater Los Angeles Vet Affairs Healthcare Syst, Los Angeles, CA USA.
   [Tsang, Stephen H.] Columbia Univ, Dept Pathol, Inst Human Nutr, Coll Phys & Surg, New York, NY 10027 USA.
   [Tsang, Stephen H.] Columbia Univ, Dept Cell Biol, Inst Human Nutr, Coll Phys & Surg, New York, NY 10027 USA.
C3 Columbia University; Columbia University; Columbia University;
   University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; Vitreous Retina Macula Consultants of New York; US
   Department of Veterans Affairs; Veterans Health Administration (VHA); VA
   Greater Los Angeles Healthcare System; Columbia University; Columbia
   University
RP Tsang, SH (corresponding author), Columbia Univ, Jonas Childrens Vis Care, New York, NY 10027 USA.; Tsang, SH (corresponding author), Columbia Univ, Bernard & Shirlee Brown Glaucoma Lab, New York, NY 10027 USA.; Tsang, SH (corresponding author), Columbia Univ, Dept Ophthalmol, Coll Phys & Surg, New York, NY 10027 USA.; Tsang, SH (corresponding author), Columbia Univ, Dept Pathol, Inst Human Nutr, Coll Phys & Surg, New York, NY 10027 USA.; Tsang, SH (corresponding author), Columbia Univ, Dept Cell Biol, Inst Human Nutr, Coll Phys & Surg, New York, NY 10027 USA.
EM sht2@cumc.columbia.edu
RI ; Freund, K. Bailey/V-7488-2018
OI Bakhoum, Mathieu/0000-0001-8989-8205; Freund, K.
   Bailey/0000-0002-7888-9773
FU National Institute of Health [5P30EY019007, R01EY018213, R01EY024698,
   R01EY026682, R21AG050437]; National Cancer Institute Core
   [5P30CA013696]; Research to Prevent Blindness (RPB) Physician-Scientist
   Award; RPB, New York, NY, USA; RPB medical student fellowship; Tistou
   and Charlotte Kerstan Foundation; Schneeweiss Stem Cell Fund, New York
   State [C029572]; Foundation Fighting Blindness New York Regional
   Research Center Grant [C-NY05-0705-0312]; Gebroe Family Foundation
FX Jonas Children's Vision Care, and Bernard & Shirlee Brown Glaucoma
   Laboratory are supported by the National Institute of Health
   [5P30EY019007, R01EY018213, R01EY024698, R01EY026682, R21AG050437],
   National Cancer Institute Core [5P30CA013696], the Research to Prevent
   Blindness (RPB) Physician-Scientist Award, unrestricted funds from RPB,
   New York, NY, USA. J.D.S is supported by the RPB medical student
   fellowship. S.H.T. is a member of the RD-CURE Consortium and is
   supported by the Tistou and Charlotte Kerstan Foundation, the
   Schneeweiss Stem Cell Fund, New York State [C029572], the Foundation
   Fighting Blindness New York Regional Research Center Grant
   [C-NY05-0705-0312], and the Gebroe Family Foundation.
CR Albin RL, 1998, J MED GENET, V35, P258, DOI 10.1136/jmg.35.3.258
   Alfawaz AM, 2016, OPHTHALMOLOGY, V123, P1637, DOI 10.1016/j.ophtha.2016.04.036
   BACHYNSKI BN, 1986, OPHTHALMOLOGY, V93, P391
   CARLSON KH, 1988, EXP EYE RES, V47, P27, DOI 10.1016/0014-4835(88)90021-8
   CHANG TS, 1993, ARCH OPHTHALMOL-CHIC, V111, P1254, DOI 10.1001/archopht.1993.01090090106028
   CHANG TS, 1994, CORNEA, V13, P269, DOI 10.1097/00003226-199405000-00014
   Colyer MH, 2007, BRIT J OPHTHALMOL, V91, P696, DOI 10.1136/bjo.2006.101055
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Gottsch JD, 2003, INVEST OPHTH VIS SCI, V44, P594, DOI 10.1167/iovs.02-0300
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Maassen JA, 1996, DIABETOLOGIA, V39, P375
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   MATSUDA M, 1985, ARCH OPHTHALMOL-CHIC, V103, P68
   McCarey BE, 2008, CORNEA, V27, P1, DOI 10.1097/ICO.0b013e31815892da
   Michaelides M, 2008, ARCH OPHTHALMOL-CHIC, V126, P320, DOI 10.1001/archopht.126.3.320
   OHKOSHI K, 1989, CORNEA, V8, P210
   RUMMELT V, 1993, OPHTHALMOLOGY, V100, P1757
   SCHULTZ RO, 1984, AM J OPHTHALMOL, V98, P401, DOI 10.1016/0002-9394(84)90120-X
   STEFANSSON A, 1982, GRAEF ARCH CLIN EXP, V218, P200, DOI 10.1007/BF02150095
   Sudhir RR, 2012, CORNEA, V31, P1119, DOI 10.1097/ICO.0b013e31823f8e00
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Yan JB, 2014, J MOL DIAGN, V16, P431, DOI 10.1016/j.jmoldx.2014.03.005
   Zarnowski T, 2003, ACTA OPHTHALMOL SCAN, V81, P543, DOI 10.1034/j.1600-0420.2003.00120.x
NR 23
TC 8
Z9 8
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0721-832X
EI 1435-702X
J9 GRAEF ARCH CLIN EXP
JI Graefes Arch. Clin. Exp. Ophthalmol.
PD MAR
PY 2018
VL 256
IS 3
BP 583
EP 588
DI 10.1007/s00417-018-3914-z
PG 6
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA FX4QC
UT WOS:000426062100018
PM 29376197
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Saneto, RP
   Singh, KK
AF Saneto, Russell P.
   Singh, Keshav K.
TI Illness-induced exacerbation of Leigh syndrome in a patient with the
   <i>MTATP6</i> mutation, m. 9185 T&gt;C
SO MITOCHONDRION
LA English
DT Article
DE Leigh syndrome; Brainstem; Magnetic resonance imaging; Complex V
ID MITOCHONDRIAL-DNA; DISEASE; CHILDREN; CARDIOMYOPATHY; HETEROPLASMY;
   DEFICIENCY; MTDNA; ACID
AB The most common mitochondrial DNA (mtDNA) mutations giving rise to Leigh syndrome reside in the MTATP6 gene. We report a rare mutation, m. 9185 T>C that gives rise to a progressive, but episodic pattern of neurological impairment with partial recovery. Disease progression corresponded to febrile viral illness and nuclear magnetic resonance imaging (MRI) changes. The patient displayed nearly 100% homoplasmy, while his asymptomatic mother was 30%. Phenotypically, exacerbations of muscle weakness with endurance intolerance, dysarthric speech, ataxia, and eyelid ptosis accompanied febrile viral illness. This case demonstrates an episodic pattern of febrile illness-induced disease exacerbation with corresponding MRI changes. (C) 2010 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Saneto, Russell P.] Seattle Childrens Hosp, Div Pediat Neurol, Seattle, WA 98105 USA.
   [Saneto, Russell P.] Univ Washington, Seattle, WA 98105 USA.
   [Singh, Keshav K.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14623 USA.
C3 Seattle Children's Hospital; University of Washington; University of
   Washington Seattle; Roswell Park Comprehensive Cancer Center
RP Saneto, RP (corresponding author), Seattle Childrens Hosp, Div Pediat Neurol, 4800 Sand Point Way NE, Seattle, WA 98105 USA.
EM russ.saneto@seattlechildrens.org
FU Mitochondrial Disease Research Guild at Seattle Children's Hospital; NIH
   [R01 CA121904]
FX RPS is supported in part by the Mitochondrial Disease Research Guild at
   Seattle Children's Hospital. This study was also supported by a Grant
   from NIH (R01 CA121904) to KKS.
CR Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   Castagna AE, 2007, AM J MED GENET A, V143A, P808, DOI 10.1002/ajmg.a.31637
   Chapiro E, 2002, EUR J HUM GENET, V10, P851, DOI 10.1038/sj.ejhg.5200894
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M
   Marin-Garcia J, 1999, PEDIATRICS, V103, P456, DOI 10.1542/peds.103.2.456
   McFarland R, 2007, NEUROLOGY, V69, P911, DOI 10.1212/01.wnl.0000267843.10977.4a
   Moslemi AR, 2005, NEUROPEDIATRICS, V36, P314, DOI 10.1055/s-2005-872845
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rossi A, 2003, AM J NEURORADIOL, V24, P1188
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
NR 20
TC 13
Z9 18
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
J9 MITOCHONDRION
JI Mitochondrion
PD AUG
PY 2010
VL 10
IS 5
BP 567
EP 572
DI 10.1016/j.mito.2010.05.006
PG 6
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 640LA
UT WOS:000281051500021
PM 20546952
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Zhao, DH
   Wang, ZX
   Hong, DJ
   Zhang, W
   Yuan, Y
AF Zhao, Danhua
   Wang, Zhaoxia
   Hong, Daojun
   Zhang, Wei
   Yuan, Yun
TI Chronic progressive external ophthalmoplegia coexistent with motor
   neuron disease in a patient with a novel large-scale mitochondrial DNA
   deletion
SO CLINICAL NEUROLOGY AND NEUROSURGERY
LA English
DT Article
DE Chronic progressive external; ophthalmoplegia; Motor neuron disease;
   Mitochondrial DNA; Large-scale deletion
ID MUTATION; POINT; GENE
C1 [Zhao, Danhua; Wang, Zhaoxia; Hong, Daojun; Zhang, Wei; Yuan, Yun] Peking Univ, Hosp 1, Dept Neurol, Beijing 100034, Peoples R China.
C3 Peking University
RP Wang, ZX (corresponding author), Peking Univ, Hosp 1, Dept Neurol, 8 Xishiku St, Beijing 100034, Peoples R China.
EM drwangzx@yahoo.com.cn
RI Zhao, Wensi/JDW-1266-2023
CR Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Borthwick Gillian M, 2006, Ann Neurol, V59, P570, DOI 10.1002/ana.20758
   Chinnery PF, 1997, NEUROLOGY, V49, P1166, DOI 10.1212/WNL.49.4.1166
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Cozzolino M, 2012, MOL CELLULAR NEUROSC
   Hanna MG, 1997, J NEUROL NEUROSUR PS, V62, P544, DOI 10.1136/jnnp.62.5.544
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Salviati L, 2002, ARCH NEUROL-CHICAGO, V59, P862, DOI 10.1001/archneur.59.5.862
   Shi P, 2010, J ALZHEIMERS DIS, V20, pS311, DOI 10.3233/JAD-2010-100366
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
NR 10
TC 7
Z9 8
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0303-8467
J9 CLIN NEUROL NEUROSUR
JI Clin. Neurol. Neurosurg.
PD AUG
PY 2013
VL 115
IS 8
BP 1490
EP 1492
DI 10.1016/j.clineuro.2012.11.011
PG 3
WC Clinical Neurology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Surgery
GA 198NJ
UT WOS:000322929300056
PM 23266267
DA 2024-11-01
ER

PT J
AU Wagner, M
   Berutti, R
   Lorenz-Depiereux, B
   Graf, E
   Eckstein, G
   Mayr, JA
   Meitinger, T
   Ahting, U
   Prokisch, H
   Strom, TM
   Wortmann, SB
AF Wagner, Matias
   Berutti, Riccardo
   Lorenz-Depiereux, Bettina
   Graf, Elisabeth
   Eckstein, Gertrud
   Mayr, Johannes A.
   Meitinger, Thomas
   Ahting, Uwe
   Prokisch, Holger
   Strom, Tim M.
   Wortmann, Saskia B.
TI Mitochondrial DNA mutation analysis from exome sequencing-A more
   holistic approach in diagnostics of suspected mitochondrial disease
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
DE bioinformatics; diagnostics; mitochondrial disorders; muscle biopsy;
   nuclear DNA
ID GENOME; IDENTIFY
AB Diagnostics for suspected mitochondrial disease (MD) can be challenging and necessitate invasive procedures like muscle biopsy. This is due to the extremely broad genetic and phenotypic spectrum, disease genes on both nuclear and mitochondrial DNA (mtDNA), and the tissue specificity of mtDNA variants. Exome sequencing (ES) has revolutionized the diagnostics for MD. However, the nuclear and mtDNA are investigated with separate tests, increasing costs and duration of diagnostics. The full potential of ES is often not exploited as the additional analysis of "off-target reads" deriving from the mtDNA can be used to analyze both genomes. We performed mtDNA analysis by ES of 2111 cases in a clinical setting. We further assessed the recall rate and precision as well as the estimation of heteroplasmy by ES data by comparison with targeted mtDNA next generation sequencing in 49 cases. ES identified known pathogenic mtDNA point mutations in 38 individuals, increasing the diagnostic yield by nearly 2%. Analysis of mtDNA variants by ES had a high recall rate (96.2 +/- 5.6%) and an excellent precision (99.5 +/- 2.2%) when compared to the gold standard of targeted mtDNA next generation sequencing. ES estimated heteroplasmy levels with an average difference of 6.6 +/- 3.8%, sufficient for clinical decision making. Taken together, the mtDNA analysis from ES is of sufficient quality for clinical diagnostics. We therefore propose ES, investigating both nuclear and mtDNA, as first line test in individuals with suspected MD. One should be aware, that a negative result does not exclude MD and necessitates further test (in additional tissues).
C1 [Wagner, Matias; Berutti, Riccardo; Meitinger, Thomas; Ahting, Uwe; Prokisch, Holger; Strom, Tim M.; Wortmann, Saskia B.] Tech Univ Munich, Inst Human Genet, Munich, Germany.
   [Wagner, Matias; Berutti, Riccardo; Lorenz-Depiereux, Bettina; Graf, Elisabeth; Eckstein, Gertrud; Meitinger, Thomas; Prokisch, Holger; Strom, Tim M.; Wortmann, Saskia B.] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany.
   [Wagner, Matias] Helmholtz Zentrum Munchen, Inst Neurogen, Neuherberg, Germany.
   [Mayr, Johannes A.; Wortmann, Saskia B.] PMU, Univ Childrens Hosp, Salzburg, Austria.
C3 Technical University of Munich; Helmholtz Association; Helmholtz-Center
   Munich - German Research Center for Environmental Health; Helmholtz
   Association; Helmholtz-Center Munich - German Research Center for
   Environmental Health; Paracelsus Private Medical University
RP Wortmann, SB (corresponding author), Tech Univ Munich, Inst Human Genet, Munich, Germany.
EM wortmann-hagemann@helmholtz-muenchen.de
RI Prokisch, Holger/N-8964-2013; Wortmann, Saskia/E-6125-2010; Wagner,
   Matias/AEB-0432-2022
OI Graf, Elisabeth/0000-0002-1119-2285; Wagner, Matias/0000-0002-4454-8823
CR Bergant G, 2018, GENET MED, V20, P303, DOI 10.1038/gim.2017.142
   Chinnery PF, 1993, GENEREVIEWS R
   Griffin HR, 2014, GENET MED, V16, P962, DOI 10.1038/gim.2014.66
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   King JL, 2014, FORENSIC SCI INT-GEN, V12, P128, DOI 10.1016/j.fsigen.2014.06.001
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Pfundt R, 2017, GENET MED, V19, P667, DOI 10.1038/gim.2016.163
   Picardi E, 2012, NAT METHODS, V9, P523, DOI 10.1038/nmeth.2029
   Samuels DC, 2013, TRENDS GENET, V29, P593, DOI 10.1016/j.tig.2013.07.006
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Theunissen TEJ, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00400
   Witters P, 2018, GENET MED, V20, P444, DOI 10.1038/gim.2017.125
   Wortmann SB, 2017, NEUROPEDIATRICS, V48, P309, DOI 10.1055/s-0037-1603776
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 16
TC 52
Z9 52
U1 1
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0141-8955
EI 1573-2665
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD SEP
PY 2019
VL 42
IS 5
BP 909
EP 917
DI 10.1002/jimd.12109
PG 9
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA IX9US
UT WOS:000486036500018
PM 31059585
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Lodi, T
   Dallabona, C
   Nolli, C
   Goffrini, P
   Donnini, C
   Baruffini, E
AF Lodi, Tiziana
   Dallabona, Cristina
   Nolli, Cecilia
   Goffrini, Paola
   Donnini, Claudia
   Baruffini, Enrico
TI DNA polymerase γ and disease: what we have learned from yeast
SO FRONTIERS IN GENETICS
LA English
DT Review
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; IN-VITRO SUPPLEMENTATION; P55
   ACCESSORY SUBUNIT; ENCODING MIP1 GENE; MITOCHONDRIAL-DNA;
   SACCHAROMYCES-CEREVISIAE; RIBONUCLEOTIDE REDUCTASE; NUCLEOSIDE ANALOGS;
   PATHOGENIC MUTATIONS; DEPLETION SYNDROMES
AB Mip1 is the Saccharomyces cerevisiae DNA polymerase gamma (Pol gamma), which is responsible for the replication of mitochondrial DNA (mtDNA). It belongs to the family A of the DNA polymerases and it is orthologs to human POLGA. In humans, mutations in POLG(1) cause many mitochondria' pathologies, such as progressive external ophthalmoplegia (PEO), Alpers' syndrome, and ataxia-neuropathy syndrome, all of which present instability of mtDNA, which results in impaired mitochondria' function in several tissues with variable degrees of severity. In this review, we summarize the genetic and biochemical knowledge published on yeast mitochondria' DNA polymerase from 1989, when the MIP1 gene was first cloned, up until now. The role of yeast is particularly emphasized in (i) validating the pathological mutations found in human POLO and modeled in MIP1, (ii) determining the molecular defects caused by these mutations and (iii) finding the correlation between mutations/polymorphisms in POLGA and mtDNA toxicity induced by specific drugs. We also describe recent findings regarding the discovery of molecules able to rescue the phenotypic defects caused by pathological mutations in Mip1, and the construction of a model system in which the human Pol gamma holoenzyme is expressed in yeast and complements the loss of Mip1.
C1 [Lodi, Tiziana; Dallabona, Cristina; Nolli, Cecilia; Goffrini, Paola; Donnini, Claudia; Baruffini, Enrico] Univ Parma, Dept Life Sci, I-43124 Parma, Italy.
C3 University of Parma
RP Baruffini, E (corresponding author), Univ Parma, Dept Life Sci, Parco Area Sci 11-A, I-43124 Parma, Italy.
EM enrico.baruffini@unipr.it
RI Donnini, Claudia/B-5548-2015; Goffrini, Paola/C-3860-2015; Baruffini,
   Enrico/C-1057-2015; Lodi, Tiziana/A-5993-2012
OI Donnini, Claudia/0000-0002-4901-2358; Goffrini,
   Paola/0000-0002-8650-4765; DALLABONA, Cristina/0000-0003-4397-9143;
   Baruffini, Enrico/0000-0002-8280-7849; Lodi, Tiziana/0000-0002-7294-8971
CR Aiyar RS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6585
   Atanassova N, 2011, HUM MOL GENET, V20, P1212, DOI 10.1093/hmg/ddq565
   Bailey CM, 2009, ANTIMICROB AGENTS CH, V53, P2610, DOI 10.1128/AAC.01659-08
   BALDACCI G, 1984, EMBO J, V3, P2115, DOI 10.1002/j.1460-2075.1984.tb02099.x
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2007, GENETICS, V177, P1227, DOI 10.1534/genetics.107.079293
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Baruffini E, 2015, MITOCHONDRION, V20, P52, DOI 10.1016/j.mito.2014.11.003
   Baruffini E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034322
   Baruffini E, 2011, MITOCHONDRION, V11, P182, DOI 10.1016/j.mito.2010.09.007
   Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023
   Baruffini E, 2010, MITOCHONDRION, V10, P183, DOI 10.1016/j.mito.2009.10.002
   BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0
   Bulst S, 2012, MOL GENET METAB, V107, P95, DOI 10.1016/j.ymgme.2012.04.022
   Bulst S, 2009, HUM MOL GENET, V18, P1590, DOI 10.1093/hmg/ddp074
   Chabes A, 1999, J BIOL CHEM, V274, P36679, DOI 10.1074/jbc.274.51.36679
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Chatterjee N, 2013, BIOCHEM BIOPH RES CO, V431, P270, DOI 10.1016/j.bbrc.2012.12.119
   Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391
   Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708
   Cheng X, 2010, EUR J CELL BIOL, V89, P742, DOI 10.1016/j.ejcb.2010.06.008
   CHI NW, 1994, J BIOL CHEM, V269, P29984
   Chiappini F, 2009, CURR HIV RES, V7, P244, DOI 10.2174/157016209787581409
   Copeland WC, 2008, MOL CELL, V32, P457, DOI 10.1016/j.molcel.2008.11.007
   Couplan E, 2011, P NATL ACAD SCI USA, V108, P11989, DOI 10.1073/pnas.1101478108
   Dimitrov LN, 2009, GENETICS, V183, P365, DOI 10.1534/genetics.109.104497
   Duchniewicz M, 1999, MOL CELL BIOL, V19, P8201
   DUJON B, 1974, GENETICS, V78, P415
   Dujon B., 1981, MOL BIOL YEAST SACCH, P505
   Dzierzbicki P, 2004, DNA REPAIR, V3, P403, DOI 10.1016/j.dnarep.2003.12.005
   ELLEDGE SJ, 1990, GENE DEV, V4, P740, DOI 10.1101/gad.4.5.740
   EPHRUSSI B, 1955, NATURE, V176, P1207, DOI 10.1038/1761207b0
   ERIKSSON S, 1995, J BIOL CHEM, V270, P18929, DOI 10.1074/jbc.270.32.18929
   Estep PA, 2011, BIOCHEMISTRY-US, V50, P6376, DOI 10.1021/bi200280r
   Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618
   Farnum GA, 2014, BBA-BIOENERGETICS, V1837, P1113, DOI 10.1016/j.bbabio.2014.01.021
   Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7
   FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x
   FOURY F, 1989, J BIOL CHEM, V264, P20552
   Foury F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027847
   GAILLARD C, 1980, NATURE, V283, P218, DOI 10.1038/283218a0
   GENGA A, 1986, J BIOL CHEM, V261, P9328
   Gerhold JM, 2010, MOL CELL, V39, P851, DOI 10.1016/j.molcel.2010.09.002
   Germaniuk A, 2002, J BIOL CHEM, V277, P27801, DOI 10.1074/jbc.M201756200
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Hanes JW, 2007, NUCLEIC ACIDS RES, V35, P6973, DOI 10.1093/nar/gkm695
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   HU JP, 1995, GENE, V160, P105, DOI 10.1016/0378-1119(95)00215-R
   Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200
   Kalifa L, 2007, DNA REPAIR, V6, P1732, DOI 10.1016/j.dnarep.2007.06.005
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Koczor CA, 2010, EXPERT OPIN DRUG MET, V6, P1493, DOI 10.1517/17425255.2010.526602
   Koprowski P, 2002, MOL GENET GENOMICS, V266, P988, DOI 10.1007/s00438-001-0621-x
   Kucej M, 2008, J CELL SCI, V121, P1861, DOI 10.1242/jcs.028605
   Lasserre JP, 2013, BIOCHIMIE, V95, P759, DOI 10.1016/j.biochi.2012.11.003
   Lecrenier N, 2000, GENE, V246, P37, DOI 10.1016/S0378-1119(00)00107-4
   LECRENIER N, 1995, MOL GEN GENET, V249, P1, DOI 10.1007/BF00290229
   Lee H, 2003, BIOCHEMISTRY-US, V42, P14711, DOI 10.1021/bi035596s
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewandowska A, 2006, BBA-MOL CELL RES, V1763, P141, DOI 10.1016/j.bbamcr.2006.01.007
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Ling F, 2002, EMBO J, V21, P4730, DOI 10.1093/emboj/cdf466
   Ling F, 2007, MOL CELL BIOL, V27, P1133, DOI 10.1128/MCB.00770-06
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Lucas P, 2004, MITOCHONDRION, V4, P13, DOI 10.1016/j.mito.2004.04.001
   MALESZKA R, 1991, EMBO J, V10, P3923, DOI 10.1002/j.1460-2075.1991.tb04962.x
   McKinney EA, 2013, GENET MOL BIOL, V36, P308, DOI 10.1590/s1415-47572013000300002
   Meeusen S, 2003, J CELL BIOL, V163, P503, DOI 10.1083/jcb.200304040
   Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443
   Phadnis N, 2005, GENETICS, V171, P1549, DOI 10.1534/genetics.105.047092
   Phadnis N, 2004, J MOL BIOL, V342, P1115, DOI 10.1016/j.jmb.2004.07.096
   PUTRAMENT A, 1975, J GEN MICROBIOL, V90, P265, DOI 10.1099/00221287-90-2-265
   Qian YF, 2014, J BIOL CHEM, V289, P5970, DOI 10.1074/jbc.M113.526418
   REENAN RAG, 1992, GENETICS, V132, P975
   RICHARDS.JP, 1973, J MOL BIOL, V78, P715, DOI 10.1016/0022-2836(73)90291-X
   Roos S, 2013, HUM MOL GENET, V22, P2411, DOI 10.1093/hmg/ddt094
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   ROPP PA, 1995, GENE, V165, P103, DOI 10.1016/0378-1119(95)00412-Y
   Schacherer J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000322
   Sen Sribir, 1994, Acta Biochimica Polonica, V41, P79
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   SHERMAN F, 1963, GENETICS, V48, P375
   SLONIMSKI PP, 1968, BIOCHEM BIOPH RES CO, V30, P232, DOI 10.1016/0006-291X(68)90440-3
   Slonimski PP, 1977, Mitochondria 1977: Genetics and Biogenesis of Mitochondria, P39
   SOR F, 1984, NUCLEIC ACIDS RES, V12, P8313, DOI 10.1093/nar/12.22.8313
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   Stricker S, 2009, J NEUROL NEUROSUR PS, V80, P1181, DOI 10.1136/jnnp.2008.166066
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Stumpf JD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004748
   Stumpf JD, 2013, GENETICS, V194, P519, DOI 10.1534/genetics.113.150920
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690
   Viikov K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033482
   Viikov K, 2011, MITOCHONDRION, V11, P119, DOI 10.1016/j.mito.2010.08.007
   WINTERSBERGER U, 1976, EUR J BIOCHEM, V68, P199, DOI 10.1111/j.1432-1033.1976.tb10779.x
   WINTERSBERGER U, 1970, EUR J BIOCHEM, V13, P20, DOI 10.1111/j.1432-1033.1970.tb00894.x
   Xu X, 2008, CANCER RES, V68, P2652, DOI 10.1158/0008-5472.CAN-07-5873
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872
   Young MJ, 2008, YEAST, V25, P903, DOI 10.1002/yea.1644
   Young MJ, 2006, YEAST, V23, P101, DOI 10.1002/yea.1344
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang HS, 2006, GENETICS, V172, P2683, DOI 10.1534/genetics.105.051029
   Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4
   Zhao XL, 2000, MOL CELL BIOL, V20, P9076, DOI 10.1128/MCB.20.23.9076-9083.2000
NR 117
TC 21
Z9 26
U1 1
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD MAR 17
PY 2015
VL 6
AR 106
DI 10.3389/fgene.2015.00106
PG 16
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA CF7XA
UT WOS:000352768500001
PM 25852747
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Donti, TR
   Stromberger, C
   Ge, M
   Eldin, KW
   Craigen, WJ
   Graham, BH
AF Donti, Taraka R.
   Stromberger, Carmen
   Ge, Ming
   Eldin, Karen W.
   Craigen, William J.
   Graham, Brett H.
TI Screen for abnormal mitochondrial phenotypes in mouse embryonic stem
   cells identifies a model for succinyl-CoA ligase deficiency and mtDNA
   depletion
SO DISEASE MODELS & MECHANISMS
LA English
DT Article
DE TCA cycle; Mitochondrial DNA depletion; Gene trap; Mitochondria
ID NUCLEOSIDE-DIPHOSPHATE KINASE; TANDEM MASS-SPECTROMETRY; METHYLMALONIC
   ACID; PLACENTAL CALCIFICATION; THYMIDINE PHOSPHORYLASE; DEOXYNUCLEOTIDE
   POOLS; SUCLA2 MUTATIONS; DNA MAINTENANCE; MICE; DISEASE
AB Mutations in subunits of succinyl-CoA synthetase/ligase (SCS), a component of the citric acid cycle, are associated with mitochondrial encephalomyopathy, elevation of methylmalonic acid (MMA), and mitochondrial DNA (mtDNA) depletion. A FACS-based retroviral-mediated gene trap mutagenesis screen in mouse embryonic stem (ES) cells for abnormal mitochondrial phenotypes identified a gene trap allele of Sucla2 (Sucla2(SA beta geo)), which was used to generate transgenic mice. Sucla2 encodes the ADP-specific beta-subunit isoform of SCS. Sucla2(SA beta geo) homozygotes exhibited recessive lethality, with most mutants dying late in gestation (e18.5). Mutant placenta and embryonic (e17.5) brain, heart and muscle showed varying degrees of mtDNA depletion (20-60%). However, there was no mtDNA depletion in mutant liver, where the gene is not normally expressed. Elevated levels of MMA were observed in embryonic brain. SCS-deficient mouse embryonic fibroblasts (MEFs) demonstrated a 50% reduction in mtDNA content compared with wild-type MEFs. The mtDNA depletion resulted in reduced steady state levels of mtDNA encoded proteins and multiple respiratory chain deficiencies. mtDNA content could be restored by reintroduction of Sucla2. This mouse model of SCS deficiency and mtDNA depletion promises to provide insights into the pathogenesis of mitochondrial diseases with mtDNA depletion and into the biology of mtDNA maintenance. In addition, this report demonstrates the power of a genetic screen that combines gene trap mutagenesis and FACS analysis in mouse ES cells to identify mitochondrial phenotypes and to develop animal models of mitochondrial dysfunction.
C1 [Donti, Taraka R.; Stromberger, Carmen; Ge, Ming; Craigen, William J.; Graham, Brett H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Eldin, Karen W.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.
   [Craigen, William J.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College
   of Medicine
RP Graham, BH (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza, Houston, TX 77030 USA.
EM bgraham@bcm.edu
RI Graham, Brett/R-8685-2018; Donti, Taraka/K-5648-2013
OI Graham, Brett/0000-0001-8451-8154; Donti, Taraka/0000-0002-3830-155X;
   Stromberger, Carmen/0000-0001-6165-1729
FU National Institutes of Health [R03 AR052112, R21 HL084239, R01
   GM098387]; March of Dimes [5-FY05-96, 1-FY07-507]; Eunice Kennedy
   Shriver National Institute of Child Health & Human Development
   [P30HD024064]; Cytometry and Cell Sorting Core at Baylor College of
   Medicine; National Institute of Health [AI036211, CA125123, RR024574]
FX This work was supported in part by the National Institutes of Health
   [grant numbers R03 AR052112 to B.H.G., R21 HL084239 to W.J.C. and R01
   GM098387 to B.H.G.]. This work was also supported in part by March of
   Dimes [grant numbers 5-FY05-96 to B.H.G. and 1-FY07-507 to B.H.G.]. The
   project described was also supported by the Eunice Kennedy Shriver
   National Institute of Child Health & Human Development [award number
   P30HD024064]. This project was also supported by the Cytometry and Cell
   Sorting Core at Baylor College of Medicine with funding from the
   National Institute of Health [grant numbers AI036211, CA125123 and
   RR024574].
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Chen KH, 2012, ULTRASOUND MED BIOL, V38, P1011, DOI 10.1016/j.ultrasmedbio.2012.02.004
   Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391
   Conner D. A., 2001, CURR PROTOC MOL BIOL, V51
   De Paepe B, 2009, J CLIN PATHOL, V62, P172, DOI 10.1136/jcp.2008.061267
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513
   González-Vioque E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002035
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Graham BH, 2012, METHODS MOL BIOL, V837, P35, DOI 10.1007/978-1-61779-504-6_3
   Graham BH, 2010, J BIOL CHEM, V285, P11143, DOI 10.1074/jbc.M109.080317
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Haraguchi M, 2002, MOL CELL BIOL, V22, P5212, DOI 10.1128/MCB.22.14.5212-5221.2002
   KAVANAUGHBLACK A, 1994, P NATL ACAD SCI USA, V91, P5883, DOI 10.1073/pnas.91.13.5883
   Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008
   Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212
   Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710
   Kushnir MM, 2001, CLIN CHEM, V47, P1993
   Lambeth DO, 2004, J BIOL CHEM, V279, P36621, DOI 10.1074/jbc.M406884200
   LEISER R, 1994, EXP CLIN ENDOCRINOL, V102, P122, DOI 10.1055/s-0029-1211275
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Malassiné A, 2003, HUM REPROD UPDATE, V9, P531, DOI 10.1093/humupd/dmg043
   Martínez-Azorín F, 2008, J NEUROCHEM, V105, P165, DOI 10.1111/j.1471-4159.2007.05122.x
   Mattiasson G, 2004, CYTOM PART A, V60A, P145, DOI 10.1002/cyto.a.20024
   Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108
   Miller C, 2011, BBA-MOL BASIS DIS, V1812, P625, DOI 10.1016/j.bbadis.2011.01.013
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Peters H, 2003, J BIOL CHEM, V278, P52909, DOI 10.1074/jbc.M310533200
   Poggi SH, 2001, PLACENTA, V22, P591, DOI 10.1053/plac.2001.0688
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schmedes A, 2006, CLIN CHEM, V52, P754, DOI 10.1373/clinchem.2005.058586
   Soares MJ, 1996, PLACENTA, V17, P277, DOI 10.1016/S0143-4004(96)90051-X
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309
   Voss AK, 1998, DEV DYNAM, V212, P258
   Yang H, 2013, MOL CELL ENDOCRINOL, V367, P21, DOI 10.1016/j.mce.2012.12.012
   Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910
NR 46
TC 23
Z9 25
U1 0
U2 5
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 1754-8403
EI 1754-8411
J9 DIS MODEL MECH
JI Dis. Model. Mech.
PD FEB
PY 2014
VL 7
IS 2
BP 271
EP 280
DI 10.1242/dmm.013466
PG 10
WC Cell Biology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Pathology
GA AJ4CY
UT WOS:000337619300014
PM 24271779
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Falk, MJ
   Sondheimer, N
AF Falk, Marni J.
   Sondheimer, Neal
TI Mitochondrial genetic diseases
SO CURRENT OPINION IN PEDIATRICS
LA English
DT Review
DE diagnosis; mtDNA; nDNA; respiratory chain; therapy
ID C-OXIDASE DEFICIENCY; LEIGH-SYNDROME; DISORDERS; DNA; MYOPATHY;
   MUTATIONS; DIAGNOSIS; DEFECTS; PATIENT; MUSCLE
AB Purpose of review
   Mitochondrial diseases are individually uncommon, but collectively pose a significant burden on human health. Primary mitochondrial disease is caused by defects in the mitochondrial DNA-encoded genes or in nuclear genes whose products are imported into the mitochondrion. Great strides have been made in determining the cause of mitochondrial disorders, but the clinical ability to diagnose these conditions lags behind because of phenotypic overlap between distinct genetic entities and the complexity and invasiveness of standard diagnostic testing. In this review, we evaluate new findings in mitochondrial genetics, recent developments in mitochondrial disease diagnostic testing, and emerging ideas for mitochondrial disease therapies.
   Recent findings
   Clinical cohort studies have revealed important themes in patient care relative to manifestations of mitochondrial disease. Significant strides have also been made toward creating embryos free from the risk of maternally inherited mitochondrial DNA-based disease. Several new genetic causes of both nuclear and mitochondrial DNA-based diseases have been identified in the past year. In addition, novel insights have emerged from basic studies of mitochondrial biology that hold promise for the development of targeted mitochondrial disease therapies.
   Summary
   Research on mitochondrial biology and disease continues to improve the clinical capacity to diagnose the heterogeneous group of mitochondrial diseases that afflict the pediatric population. This research also provides a framework for future approaches to devise effective mitochondrial disease therapies.
C1 [Falk, Marni J.] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Philadelphia, PA 19104 USA.
   [Sondheimer, Neal] Childrens Hosp Philadelphia, Dept Pediat, Div Metab Dis, Philadelphia, PA 19104 USA.
   Univ Penn, Philadelphia, PA 19104 USA.
C3 University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of
   Philadelphia; University of Pennsylvania; Pennsylvania Medicine;
   Childrens Hospital of Philadelphia; University of Pennsylvania
RP Falk, MJ (corresponding author), ARC 1002C,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.
EM falkm@email.chop.edu
RI Falk, Marni/K-1997-2014; Sondheimer, Neal/X-7846-2019
OI Sondheimer, Neal/0000-0001-9982-5712; Falk, Marni/0000-0002-1723-6728
FU National Institutes of Health [K08-DK073545-05, K08-HD058022]
FX The authors are supported in part by the National Institutes of Health
   (K08-DK073545-05 to M.J.F. and K08-HD058022 to N.S.). The authors have
   no conflicts of interest to disclose.
CR Acin-Perez R, 2009, EMBO MOL MED, V1, P392, DOI 10.1002/emmm.200900046
   Almousa R, 2009, OPHTHAL PLAST RECONS, V25, P366, DOI 10.1097/IOP.0b013e3181b2fd06
   Amiot A, 2009, GASTROENTEROLOGY, V137, P101, DOI 10.1053/j.gastro.2009.03.054
   Atkuri KR, 2009, P NATL ACAD SCI USA, V106, P3941, DOI 10.1073/pnas.0813409106
   Blackwood JK, 2010, BIOCHEM BIOPH RES CO, V393, P740, DOI 10.1016/j.bbrc.2010.02.072
   Bredenoord AL, 2010, CLIN GENET, V77, P10, DOI 10.1111/j.1399-0004.2009.01312.x
   Bredenoord A, 2009, EUR J HUM GENET, V17, P1550, DOI 10.1038/ejhg.2009.88
   Coppola G, 2009, HUM MOL GENET, V18, P2452, DOI 10.1093/hmg/ddp183
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Cree LM, 2009, BBA-MOL BASIS DIS, V1792, P1097, DOI 10.1016/j.bbadis.2009.03.002
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Diogo L, 2010, PEDIATR NEUROL, V42, P196, DOI 10.1016/j.pediatrneurol.2009.09.010
   Distelmaier F, 2009, J MOL MED, V87, P515, DOI 10.1007/s00109-009-0452-5
   Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018
   Grönlund MA, 2010, BRIT J OPHTHALMOL, V94, P121, DOI 10.1136/bjo.2008.154187
   Haginoya K, 2009, J NEUROL SCI, V278, P112, DOI 10.1016/j.jns.2008.11.008
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Janssen RJRJ, 2009, HUM MOL GENET, V18, P3365, DOI 10.1093/hmg/ddp276
   Jonckheere AI, 2010, CLIN CHEM, V56, P424, DOI 10.1373/clinchem.2009.131441
   Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254
   Parini R, 2009, J HEPATOL, V50, P215, DOI 10.1016/j.jhep.2008.08.019
   Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020
   Sacconi S, 2010, NEUROMUSCULAR DISORD, V20, P44, DOI 10.1016/j.nmd.2009.10.014
   Smet J, 2009, ELECTROPHORESIS, V30, P3565, DOI 10.1002/elps.200900213
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Vasta V, 2009, GENOME MED, V1, DOI 10.1186/gm100
   Vercauteren K, 2009, J BIOL CHEM, V284, P2307, DOI 10.1074/jbc.M806434200
   Wenz T, 2009, IUBMB LIFE, V61, P1051, DOI 10.1002/iub.261
   Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Wibrand F, 2010, MUSCLE NERVE, V41, P607, DOI 10.1002/mus.21541
   Zhang R, 2010, FOOD CHEM TOXICOL, V48, P922, DOI 10.1016/j.fct.2010.01.001
NR 32
TC 31
Z9 36
U1 0
U2 22
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1040-8703
J9 CURR OPIN PEDIATR
JI CURR. OPIN. PEDIATR.
PD DEC
PY 2010
VL 22
IS 6
BP 711
EP 716
DI 10.1097/MOP.0b013e3283402e21
PG 6
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA 679EL
UT WOS:000284143600005
PM 21045694
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Santacatterina, F
   Torresano, L
   Núñez-Salgado, A
   Esparza-Molto, PB
   Olive, M
   Gallardo, E
   García-Arumi, E
   Blazquez, A
   González-Quintana, A
   Martín, MA
   Cuezva, JM
AF Santacatterina, Fulvio
   Torresano, Laura
   Nunez-Salgado, Alfonso
   Esparza-Molto, Pau B.
   Olive, Montse
   Gallardo, Eduard
   Garcia-Arumi, Elena
   Blazquez, Alberto
   Gonzalez-Quintana, Adrian
   Martin, Miguel A.
   Cuezva, Jose M.
TI Different mitochondrial genetic defects exhibit the same protein
   signature of metabolism in skeletal muscle of PEO and MELAS patients: A
   role for oxidative stress
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Oxidative stress; Mitochondrial diseases; Metabolic enzymes; Protein
   arrays; Mn-superoxide dismutase; Catalase
ID STROKE-LIKE EPISODES; DNA MUTATIONS; SUPEROXIDE-DISMUTASE; BIOMARKER
   DISCOVERY; LACTIC-ACIDOSIS; DOWN-REGULATION; MICROARRAYS; DELETIONS;
   ARRAY; PHOSPHORYLATION
AB A major challenge in mitochondrial diseases (MDs) is the identification of biomarkers that could inform of the mechanisms involved in the phenotypic expression of genetic defects. Herein, we have investigated the protein signature of metabolism and of the antioxidant response in muscle biopsies of clinically and genetically diagnosed patients with Progressive External Ophthalmoplegia due to single large-scale (PEO-sD) or multiple (PEO-mD) deletions of mtDNA and Mitochondrial Encephalopathy Lactic Acidosis and Stroke-like episode (MELAS) syndrome, and healthy donors. A high-throughput immunoassay technique that quantitates the expression of relevant proteins of glycolysis, glycogenolysis, pentose phosphate pathway, oxidative phosphorylation, pyruvate and fatty acid oxidation, tricarboxylic acid cycle and the antioxidant response in two large independent and retrospectively collected cohorts of PEO-sD, PEO-mD and MELAS patients revealed that despite the heterogeneity of the genetic alterations, the three MDs showed the same metabolic signatures in both cohorts of patients, which were highly divergent from those of healthy individuals. Linear Discriminant Analysis and Support Vector Machine classifier provided a minimum of four biomarkers to discriminate healthy from pathological samples. Regardless of the induction of a large number of enzymes involved in ameliorating oxidative stress, the down-regulation of mitochondrial superoxide dismutase (SOD2) and catalase expression favored the accumulation of oxidative damage in patients' proteins. Down-regulation of SOD2 and catalase expression in MD patients is not due to relevant changes in the availability of their mRNAs, suggesting that oxidative stress regulates the expression of the two enzymes post-transcriptionally. We suggest that SOD2 and catalase could provide specific targets to improve the detoxification of reactive oxygen species that affects muscle proteins in these patients.
C1 [Santacatterina, Fulvio; Torresano, Laura; Nunez-Salgado, Alfonso; Esparza-Molto, Pau B.; Cuezva, Jose M.] CSIC UAM, Ctr Biol Mol Severo Ochoa, Dept Biol Mol, Madrid, Spain.
   [Santacatterina, Fulvio; Torresano, Laura; Esparza-Molto, Pau B.; Gallardo, Eduard; Garcia-Arumi, Elena; Blazquez, Alberto; Gonzalez-Quintana, Adrian; Martin, Miguel A.; Cuezva, Jose M.] ISCIII, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Bizkaia, Spain.
   [Santacatterina, Fulvio; Torresano, Laura; Esparza-Molto, Pau B.; Blazquez, Alberto; Gonzalez-Quintana, Adrian; Martin, Miguel A.; Cuezva, Jose M.] Inst Invest Hosp, 12 Octubre I 12, Madrid, Spain.
   [Olive, Montse] IDIBELL Hosp Univ Bellvitge, Serv Anat Patol, Unidad Patol Neuromuscular, Barcelona, Spain.
   [Gallardo, Eduard] Hosp Santa Creu & Sant Pau, Inst Recerca, Barcelona, Spain.
   [Garcia-Arumi, Elena] Univ Autonoma Barcelona, Hosp Univ Vali dHebron Inst Recerca VHIR, Area Genet Clin & Mol, Lab Patol Mitocondrial & Neuromuscular, Barcelona, Spain.
   [Blazquez, Alberto; Gonzalez-Quintana, Adrian; Martin, Miguel A.] Hosp Univ, Lab Enfermedades Mitocondriales & Neuromusculares, Octubre 12, Madrid, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de
   Biologia Molecular Severo Ochoa (CBM); Instituto de Salud Carlos III;
   CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Institut
   d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University
   Hospital; CIBERNED; University of Barcelona; Autonomous University of
   Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut
   de Recerca (VHIR); Hospital of Santa Creu i Sant Pau; Autonomous
   University of Barcelona; University of Sevilla
RP Cuezva, JM (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.
EM jmcuezva@cbm.csic.es
RI Garcia-Arumi, Elena/ABH-4229-2020; González-Quintana,
   Adrián/S-3724-2018; Esparza-Moltó, Pau/S-5584-2018; Cuezva,
   Jose/AAR-5392-2020; Martin, Miguel/S-2758-2018; Olivé,
   Montse/AAI-6150-2021; Martin, Miguel Angel/B-6261-2017; Blazquez
   Encinar, Alberto/S-4425-2018; Santacatterina, Fulvio/F-5722-2016
OI Gonzalez-Quintana, Adrian/0000-0002-4011-362X; Martin, Miguel
   Angel/0000-0003-4741-772X; Esparza-Molto, Pau B./0000-0001-9034-1121;
   Garcia-Arumi, Elena/0000-0003-0096-3336; Blazquez Encinar,
   Alberto/0000-0002-6479-3615; Santacatterina, Fulvio/0000-0002-4831-5402;
   Olive, Montse/0000-0001-5727-0165
FU Fundacion La Caixa (Obra Social La Caixa); ACCI-CIBERER-2015; MINECO
   [SAF2016-75916-R]; CIBERER-ISCIII; Fundacion Ramon Areces; ISCIII-FIS,
   Spain [PI15-0435, PI15/01428, PMP15-00025]
FX PBEM was supported by a predoctoral fellowship from Fundacion La Caixa
   (Obra Social La Caixa). The work was supported by grants from
   ACCI-CIBERER-2015, MINECO (SAF2016-75916-R), CIBERER-ISCIII, Fundacion
   Ramon Areces, ISCIII-FIS PI15-0435, PI15/01428 and PMP15-00025, Spain.
CR Aitken RJ, 2012, J BIOL CHEM, V287, P33048, DOI 10.1074/jbc.M112.366690
   Aldea M, 2011, CANCER LETT, V311, P210, DOI 10.1016/j.canlet.2011.07.022
   Baldelli E, 2017, METHODS MOL BIOL, V1606, P149, DOI 10.1007/978-1-4939-6990-6_11
   Berardo A, 2010, NEUROMUSCULAR DISORD, V20, P204, DOI 10.1016/j.nmd.2010.01.006
   Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637
   Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Campos Y, 1996, NEUROLOGY, V47, P1012, DOI 10.1212/WNL.47.4.1012
   Chandel NS, 2015, CELL METAB, V22, P204, DOI 10.1016/j.cmet.2015.05.013
   Choksi KB, 2008, FREE RADICAL BIO MED, V45, P826, DOI 10.1016/j.freeradbiomed.2008.06.006
   Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje
   Da Pozzo P, 2015, NEUROL SCI, V36, P1713, DOI 10.1007/s10072-015-2247-5
   DiMauro S., 1993, GENEREVIEWS
   El-Hattab AW, 2016, MOL GENET METAB, V117, P407, DOI 10.1016/j.ymgme.2016.01.010
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Enns GM, 2017, J CLIN MED, V6, DOI 10.3390/jcm6050050
   Fryer RH, 2016, PEDIATR NEUROL, V56, P59, DOI 10.1016/j.pediatrneurol.2015.12.010
   Gallego-Villar L, 2016, FREE RADICAL BIO MED, V96, P1, DOI 10.1016/j.freeradbiomed.2016.04.007
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Guo J, 2011, J PROTEOMICS, V74, P2370, DOI 10.1016/j.jprot.2011.07.009
   Hayashi G, 2015, FREE RADICAL BIO MED, V88, P10, DOI 10.1016/j.freeradbiomed.2015.05.039
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Huang Y, 2017, GENOM PROTEOM BIOINF, V15, P73, DOI 10.1016/j.gpb.2017.03.001
   Jones E., 2001, SciPy: Open Source Scientific Tools for Python [Online; accessed 2016-11-29] see p. 50
   Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282
   Klotz LO, 2015, REDOX BIOL, V6, P51, DOI 10.1016/j.redox.2015.06.019
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   LARSSON NG, 1994, BIOCHEM BIOPH RES CO, V200, P1374, DOI 10.1006/bbrc.1994.1603
   Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013
   Li MY, 2006, J BIOL CHEM, V281, P40429, DOI 10.1074/jbc.M606596200
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Lu CY, 2002, CLIN CHIM ACTA, V318, P97, DOI 10.1016/S0009-8981(01)00809-9
   Luo XP, 1997, J CLIN INVEST, V99, P2877, DOI 10.1172/JCI119481
   Mancuso M, 2009, CURR MOL MED, V9, P1095, DOI 10.2174/156652409789839099
   May C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089596
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0652-7
   Mesegueri S, 2015, HUM MOL GENET, V24, P167, DOI 10.1093/hmg/ddu427
   Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Mrácek T, 2013, BBA-BIOENERGETICS, V1827, P401, DOI 10.1016/j.bbabio.2012.11.014
   Mueller C, 2010, MOL ONCOL, V4, P461, DOI 10.1016/j.molonc.2010.09.003
   Nenoi M, 2001, CANCER RES, V61, P5885
   Nishigaki Y, 2004, HUM MOL GENET, V13, P91, DOI 10.1093/hmg/ddh010
   Owusu-Ansah E, 2013, CELL, V155, P699, DOI 10.1016/j.cell.2013.09.021
   Pagano G, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/541230
   Papa S, 1996, BBA-BIOENERGETICS, V1276, P87, DOI 10.1016/0005-2728(96)00077-1
   Pedregosa F, 2011, J MACH LEARN RES, V12, P2825
   PICCOLO G, 1991, J NEUROL SCI, V105, P57, DOI 10.1016/0022-510X(91)90118-Q
   Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798
   Qin HL, 2011, DIABETES, V60, P857, DOI 10.2337/db09-1706
   Ramachandran P, 2011, COMPUT SCI ENG, V13, P40, DOI 10.1109/MCSE.2011.35
   Reinecke F, 2009, BBA-MOL BASIS DIS, V1792, P1113, DOI 10.1016/j.bbadis.2009.04.003
   Rikimaru M, 2012, INTERNAL MED, V51, P3351, DOI 10.2169/internalmedicine.51.7529
   Santacatterina F, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1136-5
   Santacatterina F, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0424-1
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Shadel GS, 2015, CELL, V163, P560, DOI 10.1016/j.cell.2015.10.001
   Sheehan KM, 2005, MOL CELL PROTEOMICS, V4, P346, DOI 10.1074/mcp.T500003-MCP200
   Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037
   Soldevilla B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178376
   Sommerville Ewen W, 2014, J Neuromuscul Dis, V1, P119
   Sundaram C, 2011, J CLIN NEUROSCI, V18, P535, DOI 10.1016/j.jocn.2010.06.014
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tessa A, 2000, FUNCT NEUROL, V15, P211
   Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Ummanni R, 2014, BBA-PROTEINS PROTEOM, V1844, P950, DOI 10.1016/j.bbapap.2013.11.017
   Vamecq J, 2012, CURR DRUG METAB, V13, P1388, DOI 10.2174/138920012803762792
   VanMeter A, 2007, EXPERT REV MOL DIAGN, V7, P625, DOI 10.1586/14737159.7.5.625
   Venkatesan B, 2007, J CELL PHYSIOL, V211, P457, DOI 10.1002/jcp.20953
   Villarroya J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029691
   Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603
   Wei YH, 1998, P SOC EXP BIOL MED, V217, P53
   Witten IH, 2011, MOR KAUF D, P1
   YEN TC, 1994, FREE RADICAL BIO MED, V16, P207, DOI 10.1016/0891-5849(94)90145-7
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zhao Y, 2014, FREE RADICAL BIO MED, V72, P55, DOI 10.1016/j.freeradbiomed.2014.03.001
NR 80
TC 10
Z9 10
U1 0
U2 20
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD OCT
PY 2018
VL 126
BP 235
EP 248
DI 10.1016/j.freeradbiomed.2018.08.020
PG 14
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA GV0NQ
UT WOS:000445759000022
PM 30138712
DA 2024-11-01
ER

PT J
AU Paramasiyam, A
   Venkatapathi, C
   Sandeep, G
   Meena, AK
   Uppin, MS
   Mohapatra, S
   Pitceathly, RDS
   Thangaraj, K
AF Paramasiyam, Arumugam
   Venkatapathi, Challa
   Sandeep, Gampa
   Meena, Angamuthu K.
   Uppin, Megha S.
   Mohapatra, Swati
   Pitceathly, Robert D. S.
   Thangaraj, Kumarasamy
TI Homozygous R627W mutations in <i>POLG</i> cause mitochondrial DNA
   depletion leading to encephalopathy, seizures and stroke-like episodes
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial disease; POLG; Encephalopathy; Seizures; Status
   epilepticus; Stroke-like episode; mtDNA
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; POLYMERASE GAMMA; READ ALIGNMENT;
   CONSEQUENCE; PHENOTYPE; SPECTRUM
AB Mutations in the mitochondrial DNA maintenance gene POLG (DNA Polymerase Gamma, Catalytic Subunit), encoding mitochondrial DNA polymerase gamma (pol gamma), are associated with an extremely broad phenotypic spectrum. We identified homozygous POLG c.1879C > T; p.R627W mutations in two siblings from a consanguineous South Asian family following targeted resequencing of 75 nuclear-encoded mitochondrial genes. Both patients presented with encephalopathy, seizures and stroke-like episodes, and mitochondrial DNA depletion was confirmed in the proband's muscle tissue. Subsequent Sanger sequencing of POLG in a further 275 unrelated probands with genetically unconfirmed mitochondrial disease revealed a third unrelated proband with a similar phenotype harboring homozygous c.1879C > T; p.R627W mutations and a fourth patient, with a milder clinical disorder, harboring compound heterozygous POLG c.1879C > T; p.R627W and c.2341G > A; p.A781T mutations. Given endogamous practices in the Indian subcontinent, homozygous POLG c.1879C > T; p.R627W mutations should be excluded in South Asian patients presenting with encephalopathy, seizures and stroke-like episodes.
C1 [Paramasiyam, Arumugam; Venkatapathi, Challa; Mohapatra, Swati; Thangaraj, Kumarasamy] Ctr Cellular & Mol Biol, CSIR, Hyderabad 500007, India.
   [Paramasiyam, Arumugam] Saveetha Univ, Saveetha Inst Med & Tech Sci SIMMS, Saveetha Dent Coll & Hosp, BRULAC DRC, Chennai, Tamil Nadu, India.
   [Sandeep, Gampa] Bhimavaram Hosp, Dept Neurol, Bhimavaram, India.
   [Meena, Angamuthu K.] Nizams Inst Med Sci, Dept Neurol, Hyderabad, India.
   [Uppin, Megha S.] Nizams Inst Med Sci, Dept Pathol, Hyderabad, India.
   [Pitceathly, Robert D. S.] Inst Neurol, MRC Ctr Neuromuscular Dis, UCL Queen Sq, London, England.
   [Pitceathly, Robert D. S.] Natl Hosp Neurol & Neurosurg, London, England.
   [Pitceathly, Robert D. S.] UCL, Dept Neuromuscular Dis, Inst Neurol, Queen Sq, London, England.
C3 Council of Scientific & Industrial Research (CSIR) - India; CSIR -
   Centre for Cellular & Molecular Biology (CCMB); Saveetha Institute of
   Medical & Technical Science; Saveetha Dental College & Hospital; Nizam's
   Institute of Medical Sciences; Nizam's Institute of Medical Sciences;
   University of London; University College London; University of London;
   University College London; UCL Medical School; University College London
   Hospitals NHS Foundation Trust; University of London; University College
   London
RP Thangaraj, K (corresponding author), Ctr Cellular & Mol Biol, CSIR, Hyderabad 500007, India.
EM thangs@ccmb.res.in
RI Thangaraj, Kumarasamy/G-5596-2010; Arumugam, Paramasivam/JAC-6846-2023;
   Jayaseelan, Dr. Vijayashree Priyadharsini/AAD-4261-2019
OI Challa, Venkatapathi/0000-0001-9022-8946; Arumugam,
   Paramasivam/0000-0001-6117-1178; Jayaseelan, Dr. Vijayashree
   Priyadharsini/0000-0001-7884-5466; Pitceathly,
   Robert/0000-0002-6123-4551; Mohapatra, Swati/0000-0002-6681-1637
FU NCP project from the Council of Scientific and Industrial Research
   (CSIR), Government of India [MLP0117, GAP0517]; Science and Engineering
   Research Board (SERB), Government of India [GAP0517, PDF/2016/000881];
   Medical Research Council Clinician Scientist Fellowship [MR/S002065/1];
   MRC [MR/S002065/1] Funding Source: UKRI
FX Authors would like to thank the patients, their families and other
   participants for their contribution to this research. This work was
   supported by the NCP project (MLP0117) from the Council of Scientific
   and Industrial Research (CSIR), Government of India (GAP0517) and
   Science and Engineering Research Board (SERB), Government of India
   (GAP0517) to KT; the Science and Engineering Research Board (SERB)
   (reference no.PDF/2016/000881), Government of India to AP. RDSP is
   supported by a Medical Research Council Clinician Scientist Fellowship
   (MR/S002065/1).
CR Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Boengler K, 2011, BBA-MOL CELL RES, V1813, P1286, DOI 10.1016/j.bbamcr.2011.01.009
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chinnery P.F., 1993, SOURCE GENEREVIEWS
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048
   Nakatsuka N, 2017, NAT GENET, V49, P1403, DOI 10.1038/ng.3917
   Nolte KW, 2013, NEUROPATHOLOGY, V33, P59, DOI 10.1111/j.1440-1789.2012.01317.x
   Paramasivam A, 2016, MITOCHONDRION, V26, P81, DOI 10.1016/j.mito.2015.12.006
   Pitceathly RDS, 2013, J NEUROL NEUROSUR PS, V84, P107, DOI 10.1136/jnnp-2012-303232
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Strauss KA, 2015, AM J HUM GENET, V96, P121, DOI 10.1016/j.ajhg.2014.12.003
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011395
   Tang S, 2012, J NEUROL, V259, P862, DOI 10.1007/s00415-011-6268-6
   Thangaraj K, 2002, J ANDROL, V23, P815
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
NR 21
TC 8
Z9 8
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD SEP
PY 2019
VL 48
SI SI
BP 78
EP 83
DI 10.1016/j.mito.2019.08.003
PG 6
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA JA3YX
UT WOS:000487766600009
PM 31425757
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Tarnopolsky, MA
AF Tarnopolsky, M. A.
TI Mitochondrial DNA shifting in older adults following resistance exercise
   training
SO APPLIED PHYSIOLOGY NUTRITION AND METABOLISM-PHYSIOLOGIE APPLIQUEE
   NUTRITION ET METABOLISME
LA English
DT Article
CT 14th International Biochemistry of Exercise Conference
CY JUN 01-04, 2009
CL Guelph, CANADA
SP Univ Guelph, Brock Univ, McMaster Univ, Univ Waterloo, York Univ
DE mitochondrial disease; resistance exercise; satellite cells; gene
   shifting
ID HUMAN SKELETAL-MUSCLE; FREE-RADICAL THEORY; ELDERLY-MEN;
   PROTEIN-SYNTHESIS; OXIDATIVE DAMAGE; CREATINE SUPPLEMENTATION; DELETION
   MUTATIONS; BODY-COMPOSITION; LIFE-SPAN; YOUNG MEN
AB Aging is associated with a reduction in muscle mass and strength, which compromises functional independence. Skeletal muscle also shows an increase in mitochondrial dysfunction and oxidative stress in older adults. Resistance-exercise training is an important countermeasure for aging-associated muscle weakness. It has been shown that resistance-exercise training increases muscle strength and function in older adults, in association with a reduction in markers of oxidative stress and an improvement in mitochondrial function. Patients with sporadic mitochondrial cytopathies show an accumulation of mitochondrial DNA mutations and deletions in mature muscle, but not in satellite cells. Such patients have shown an activation of the satellite cells following myotoxic trauma and resistance, likely due to a fusion of the relatively quiescent satellite cells with mature muscle, which dilutes the mutational burden, a process called mitochondrial DNA shifting. Preliminary data strongly suggest that mitochondrial DNA shifting occurs in skeletal muscle from older adults following resistance-exercise training.
C1 McMaster Univ, Dept Pediat & Med, Hamilton, ON L8N 3Z5, Canada.
C3 McMaster University
RP Tarnopolsky, MA (corresponding author), McMaster Univ, Dept Pediat & Med, Hamilton, ON L8N 3Z5, Canada.
EM tarnopol@mcmaster.ca
CR Ades PA, 1996, ANN INTERN MED, V124, P568, DOI 10.7326/0003-4819-124-6-199603150-00005
   Aiken J, 2002, ANN NY ACAD SCI, V959, P412, DOI 10.1111/j.1749-6632.2002.tb02111.x
   ALWAY SE, 1988, J APPL PHYSIOL, V64, P1114, DOI 10.1152/jappl.1988.64.3.1114
   Ashok BT, 1999, EXP GERONTOL, V34, P293, DOI 10.1016/S0531-5565(99)00005-4
   Baker DJ, 2006, EXP GERONTOL, V41, P1149, DOI 10.1016/j.exger.2006.08.007
   Balagopal P, 1997, AM J PHYSIOL-ENDOC M, V273, pE790, DOI 10.1152/ajpendo.1997.273.4.E790
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Brose A, 2003, J GERONTOL A-BIOL, V58, P11
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Candow DG, 2007, J NUTR HEALTH AGING, V11, P185
   Castillo EM, 2003, AM J PREV MED, V25, P226, DOI 10.1016/S0749-3797(03)00197-1
   Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   COGGAN AR, 1992, J GERONTOL, V47, pB71, DOI 10.1093/geronj/47.3.B71
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Dirks A, 2002, AM J PHYSIOL-REG I, V282, pR519, DOI 10.1152/ajpregu.00458.2001
   Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002
   Esmarck B, 2001, J PHYSIOL-LONDON, V535, P301, DOI 10.1111/j.1469-7793.2001.00301.x
   FIATARONE MA, 1990, JAMA-J AM MED ASSOC, V263, P3029, DOI 10.1001/jama.263.22.3029
   FRONTERA WR, 1988, J APPL PHYSIOL, V64, P1038, DOI 10.1152/jappl.1988.64.3.1038
   Gianni P, 2004, EXP GERONTOL, V39, P1391, DOI 10.1016/j.exger.2004.06.002
   Gillette-Goyonnet S, 2003, MECH AGEING DEV, V124, P311, DOI 10.1016/S0047-6374(02)00198-7
   Giresi PG, 2005, PHYSIOL GENOMICS, V21, P253, DOI 10.1152/physiolgenomics.00249.2004
   Greenlund LJS, 2003, MECH AGEING DEV, V124, P287, DOI 10.1016/S0047-6374(02)00196-3
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x
   KLITGAARD H, 1990, ACTA PHYSIOL SCAND, V140, P41, DOI 10.1111/j.1748-1716.1990.tb08974.x
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lau EMC, 2005, J GERONTOL A-BIOL, V60, P213, DOI 10.1093/gerona/60.2.213
   Leeuwenburgh C, 2003, J GERONTOL A-BIOL, V58, P999
   LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11
   LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3
   Mecocci P, 1999, FREE RADICAL BIO MED, V26, P303, DOI 10.1016/S0891-5849(98)00208-1
   Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567
   Melov S, 2002, ANN NY ACAD SCI, V959, P330, DOI 10.1111/j.1749-6632.2002.tb02104.x
   Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000465
   Melton LJ, 2000, J AM GERIATR SOC, V48, P625
   Moore DR, 2005, AM J PHYSIOL-ENDOC M, V288, pE1153, DOI 10.1152/ajpendo.00387.2004
   Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   NICHOLS JF, 1993, J AM GERIATR SOC, V41, P205, DOI 10.1111/j.1532-5415.1993.tb06692.x
   Olsen S, 2006, J PHYSIOL-LONDON, V573, P525, DOI 10.1113/jphysiol.2006.107359
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   Parise G, 2005, FREE RADICAL BIO MED, V39, P289, DOI 10.1016/j.freeradbiomed.2005.03.024
   Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002
   ROGERS MA, 1990, J APPL PHYSIOL, V68, P2195, DOI 10.1152/jappl.1990.68.5.2195
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   SKELTON DA, 1995, J AM GERIATR SOC, V43, P1081, DOI 10.1111/j.1532-5415.1995.tb07004.x
   SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Tamilselvan J, 2007, FREE RADICAL BIO MED, V43, P1656, DOI 10.1016/j.freeradbiomed.2007.08.028
   Tang JE, 2006, APPL PHYSIOL NUTR ME, V31, P495, DOI 10.1139/H06-026
   Tarnopolsky M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000991
   Tarnopolsky MA, 2008, APPL PHYSIOL NUTR ME, V33, P213, DOI 10.1139/H07-142
   TESCH PA, 1988, MED SCI SPORT EXER, V20, pS132, DOI 10.1249/00005768-198810001-00008
   TOMONAGA M, 1977, J AM GERIATR SOC, V25, P125, DOI 10.1111/j.1532-5415.1977.tb00274.x
   Tracy BL, 1999, J APPL PHYSIOL, V86, P195, DOI 10.1152/jappl.1999.86.1.195
   Trappe S, 2000, J APPL PHYSIOL, V89, P143, DOI 10.1152/jappl.2000.89.1.143
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vincent KR, 2002, ARCH INTERN MED, V162, P673, DOI 10.1001/archinte.162.6.673
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011
   Welle S, 2000, J APPL PHYSIOL, V89, P297, DOI 10.1152/jappl.2000.89.1.297
   Wilkinson SB, 2008, J PHYSIOL-LONDON, V586, P3701, DOI 10.1113/jphysiol.2008.153916
   YARASHESKI KE, 1993, AM J PHYSIOL, V265, pE210, DOI 10.1152/ajpendo.1993.265.2.E210
   Yasuda N, 2005, J APPL PHYSIOL, V99, P1085, DOI 10.1152/japplphysiol.00247.2005
   Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115
NR 71
TC 48
Z9 54
U1 2
U2 3
PU NATL RESEARCH COUNCIL CANADA-N R C RESEARCH PRESS
PI OTTAWA
PA BUILDING M 55, OTTAWA, ON K1A 0R6, CANADA
SN 1715-5312
J9 APPL PHYSIOL NUTR ME
JI Appl. Physiol. Nutr. Metab.
PD JUN
PY 2009
VL 34
IS 3
BP 348
EP 354
DI 10.1139/H09-022
PG 7
WC Nutrition & Dietetics; Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics; Physiology; Sport Sciences
GA 450ZV
UT WOS:000266441400007
PM 19448697
DA 2024-11-01
ER

PT J
AU Hedberg-Oldfors, C
   Lindgren, U
   Visuttijai, K
   Lööf, D
   Roos, S
   Thomsen, C
   Oldfors, A
AF Hedberg-Oldfors, Carola
   Lindgren, Ulrika
   Visuttijai, Kittichate
   Loof, Daniel
   Roos, Sara
   Thomsen, Christer
   Oldfors, Anders
TI Respiratory chain dysfunction in perifascicular muscle fibres in
   patients with dermatomyositis is associated with mitochondrial DNA
   depletion
SO NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
LA English
DT Article
DE dermatomyositis; inflammatory myopathy; mitochondria; mitochondrial DNA;
   oxidative phosphorylation; respiratory chain
ID MAINTENANCE; CLASSIFICATION; ABNORMALITIES; PATHOLOGY; DELETIONS
AB Aims Patients with dermatomyositis (DM) suffer from reduced aerobic metabolism contributing to impaired muscle function, which has been linked to cytochrome c oxidase (COX) deficiency in muscle tissue. This mitochondrial respiratory chain dysfunction is typically seen in perifascicular regions, which also show the most intense inflammatory reaction along with capillary loss and muscle fibre atrophy. The objective of this study was to investigate the pathobiology of the oxidative phosphorylation deficiency in DM. Methods Muscle biopsy specimens with perifascicular COX deficiency from five juveniles and seven adults with DM were investigated. We combined immunohistochemical analyses of subunits in the respiratory chain including complex I (subunit NDUFB8), complex II (succinate dehydrogenase, subunit SDHB) and complex IV (COX, subunit MTCO1) with in situ hybridisation, next generation deep sequencing and quantitative polymerase chain reaction (PCR). Results There was a profound deficiency of complexes I and IV in the perifascicular regions with enzyme histochemical COX deficiency, whereas succinate dehydrogenase activity and complex II were preserved. In situ hybridisation of mitochondrial RNA showed depletion of mitochondrial DNA (mtDNA) transcripts in the perifascicular regions. Analysis of mtDNA by next generation deep sequencing and quantitative PCR in affected muscle regions showed an overall reduction of mtDNA copy number particularly in the perifascicular regions. Conclusion The respiratory chain dysfunction in DM muscle is associated with mtDNA depletion causing deficiency of complexes I and IV, which are partially encoded by mtDNA, whereas complex II, which is entirely encoded by nuclear DNA, is preserved. The depletion of mtDNA indicates a perturbed replication of mtDNA explaining the muscle pathology and the disturbed aerobic metabolism.
C1 [Hedberg-Oldfors, Carola; Lindgren, Ulrika; Visuttijai, Kittichate; Loof, Daniel; Roos, Sara; Thomsen, Christer; Oldfors, Anders] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Lab Med, Gothenburg, Sweden.
   [Lindgren, Ulrika] Sahlgrens Univ Hosp, Neuromuscular Ctr, Dept Neurol, Gothenburg, Sweden.
C3 University of Gothenburg; Sahlgrenska University Hospital
RP Oldfors, A (corresponding author), Sahlgrens Univ Hosp, Dept Pathol, S-41345 Gothenburg, Sweden.
EM anders.oldfors@gu.se
RI Visuttijai, Kittichate/S-4927-2019; Lindgren, Ulrika/HJH-0146-2022
OI Visuttijai, Kittichate/0000-0002-4800-8533
FU Vetenskapsradet
FX Vetenskapsradet
CR Alhatou MI, 2004, J MOL HISTOL, V35, P615
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Basu S, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1009242
   Cea G, 2002, BRAIN, V125, P1635, DOI 10.1093/brain/awf163
   Dalakas MC, 2015, NEW ENGL J MED, V372, P1734, DOI 10.1056/NEJMra1402225
   De Paepe B, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2016.12.68
   Ding J, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1005306, 10.1371/journal.pgen.1005549]
   Dubowitz V., 2007, Muscle Biopsy: A Practical Approach
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Hedberg-Oldfors C, 2021, BRAIN PATHOL, V31, DOI 10.1111/bpa.12931
   Lahoria R, 2016, BRAIN, V139, P1891, DOI 10.1093/brain/aww122
   Larsson NG, 2001, ACTA PHYSIOL SCAND, V171, P385, DOI 10.1046/j.1365-201x.2001.00842.x
   Lundberg IE, 2018, NAT REV RHEUMATOL, V14, P269, DOI 10.1038/nrrheum.2018.41
   Maiuri AR, 2018, CANCER METAB, V6, DOI 10.1186/s40170-018-0182-7
   Mammen AL, 2020, NEUROMUSCULAR DISORD, V30, P70, DOI 10.1016/j.nmd.2019.10.005
   Mariampillai K, 2018, JAMA NEUROL, V75, P1528, DOI 10.1001/jamaneurol.2018.2598
   Meyer A, 2017, ACTA NEUROPATHOL, V134, P655, DOI 10.1007/s00401-017-1731-9
   Oldfors A, 2006, NEUROLOGY, V66, pS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Rocha MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15037
   Roos S, 2014, NEUROMUSCULAR DISORD, V24, P713, DOI 10.1016/j.nmd.2014.05.009
   Roos S, 2022, BRAIN PATHOL, V32, DOI 10.1111/bpa.13038
   Roos S, 2013, HUM MOL GENET, V22, P2411, DOI 10.1093/hmg/ddt094
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Varadhachary AS, 2010, CURR OPIN RHEUMATOL, V22, P651, DOI 10.1097/BOR.0b013e32833f108a
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wiesinger GF, 2000, ARCH PHYS MED REHAB, V81, P1, DOI 10.1016/S0003-9993(00)90212-0
   WOO M, 1988, J NEUROL SCI, V88, P133, DOI 10.1016/0022-510X(88)90211-0
   Zhong DL, 2020, PEERJ, V8, DOI 10.7717/peerj.8611
NR 31
TC 9
Z9 9
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0305-1846
EI 1365-2990
J9 NEUROPATH APPL NEURO
JI Neuropathol. Appl. Neurobiol.
PD DEC
PY 2022
VL 48
IS 7
AR e12841
DI 10.1111/nan.12841
EA AUG 2022
PG 10
WC Clinical Neurology; Neurosciences; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pathology
GA 5W2ED
UT WOS:000836877300001
PM 35894812
OA Green Published
DA 2024-11-01
ER

PT J
AU Ferraris, S
   Clark, S
   Garelli, E
   Davidzon, G
   Moore, SA
   Kardon, RH
   Bienstock, RJ
   Longley, MJ
   Mancuso, M
   Ríos, PG
   Hirano, M
   Copeland, WC
   DiMauro, S
AF Ferraris, Silvio
   Clark, Susanna
   Garelli, Emanuela
   Davidzon, Guido
   Moore, Steven A.
   Kardon, Randy H.
   Bienstock, Rachelle J.
   Longley, Matthew J.
   Mancuso, Michelangelo
   Rios, Purificacion Gutierrez
   Hirano, Michio
   Copeland, William C.
   DiMauro, Salvatore
TI Progressive external ophthalmoplegia and vision and hearing loss in a
   patient with mutations in <i>POLG2</i> and <i>OPA1</i>
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID ACCESSORY SUBUNIT; AUTOSOMAL-DOMINANT; DNA-SYNTHESIS; POLYMERASE;
   DELETIONS; BINDING
AB objective: To describe the clinical features, muscle pathological characteristics, and molecular studies of a patient with a mutation in the gene encoding the accessory subunit (p55) of polymerase gamma (POLG2) and a mutation in the OPAL gene.
   Design: Clinical examination and morphological., biochemical, and molecular analyses.
   Setting: Tertiary care university hospitals and molecular genetics and scientific computing laboratory.
   Patient: A 42-year-old man experienced hearing loss, progressive external ophthalmoplegia (PEO), loss of central vision, macrocytic anemia, and hypogonadism. His family history was negative for neurological disease, and his serum lactate level was normal.
   Results: A muscle biopsy specimen showed scattered intensely succinate dehydrogenase-positive and cytochrome-c oxidase-negative fibers. Southern blot of muscle mitochondrial DNA showed multiple deletions. The results of screening for mutations in the nuclear genes associated with PEO and multiple mitochondrial DNA deletions, including those in POLG (polymerase gamma gene), ANTI (gene. encoding adenine nucleotide translocator 1), and PEO1, were negative, but sequencing of POLG2 revealed a G1247C mutation in exon 7, resulting in the substitution of a highly conserved glycine with an alanine at codon 416 (G416A). Because biochemical analysis of the mutant protein showed no alteration in chromatographic properties and normal ability to protect the catalytic subunit from N-ethylmaleimide, we also sequenced the OPAL gene and identified a novel heterozygous mutation (Y582C).
   Conclusion: Although we initially focused on the mutation in POLG2, the mutation in OPAL is more likely to explain the late-onset PEO and multisystem disorder in this patient.
C1 [Davidzon, Guido; Rios, Purificacion Gutierrez; Hirano, Michio; DiMauro, Salvatore] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA.
   [Ferraris, Silvio; Garelli, Emanuela] Univ Turin, Dept Pediat, I-10124 Turin, Italy.
   [Clark, Susanna; Bienstock, Rachelle J.; Longley, Matthew J.; Copeland, William C.] Natl Inst Environm Hlth Sci, Lab Mol Genet & Sci Comp Lab, NIH, Res Triangle Pk, NC USA.
   [Moore, Steven A.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA.
   [Kardon, Randy H.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA.
   [Mancuso, Michelangelo] Univ Pisa, Dept Neurosci, Neurol Inst, Pisa, Italy.
C3 Columbia University; University of Turin; National Institutes of Health
   (NIH) - USA; NIH National Institute of Environmental Health Sciences
   (NIEHS); University of Iowa; University of Iowa; University of Pisa
RP DiMauro, S (corresponding author), Columbia Univ, Dept Neurol, Med Ctr, 1150 St Nicholas Ave,Room 313, New York, NY 10032 USA.
EM sd12@columbia.edu
RI Ríos, Purificación/I-4234-2015; Mancuso, Michelangelo/K-4170-2016;
   Copeland, William/C-4242-2019
OI Copeland, William/0000-0002-0359-0953; Kardon,
   Randy/0000-0002-3173-7123; Bienstock, Rachelle/0000-0001-5228-3610;
   Moore, Steven/0000-0002-6353-7900
FU Intramural NIH HHS [Z01 ES065078-14] Funding Source: Medline; NICHD NIH
   HHS [HD32062, P01 HD032062] Funding Source: Medline; NINDS NIH HHS
   [NS11766, P01 NS011766] Funding Source: Medline
CR AMATIBONNEAU P, IN PRESS BRAIN
   Carr M J, 2001, Curr Opin Pulm Med, V7, P1, DOI 10.1097/00063198-200101000-00001
   Carrodeguas JA, 2002, J BIOL CHEM, V277, P50008, DOI 10.1074/jbc.M207030200
   Di Mauro S., 2004, MYOLOGY PHILADELPHIA, P1623
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Hudson G, 2006, NEUROLOGY, V66, P1439, DOI 10.1212/01.wnl.0000210486.32196.24
   HUDSON G, IN PRESS BRAIN
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley Matthew J, 2002, Methods Mol Biol, V197, P245, DOI 10.1385/1-59259-284-8:245
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   Pinz KG, 2006, DNA REPAIR, V5, P121, DOI 10.1016/j.dnarep.2005.08.014
   Rowland LP., 1994, Mitochondrial Disorders in Neurology, P116
   Sambrook J, 1990, Cold Spring Harbor Laboratories, V186, P182
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 23
TC 40
Z9 45
U1 0
U2 3
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0003-9942
EI 1538-3687
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD JAN
PY 2008
VL 65
IS 1
BP 125
EP 131
DI 10.1001/archneurol.2007.9
PG 7
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 250PR
UT WOS:000252313000017
PM 18195150
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Longley, MJ
   Humble, MM
   Sharief, FS
   Copeland, WC
AF Longley, Matthew J.
   Humble, Margaret M.
   Sharief, Farida S.
   Copeland, William C.
TI Disease Variants of the Human Mitochondrial DNA Helicase Encoded by
   <i>C10orf2</i> Differentially Alter Protein Stability, Nucleotide
   Hydrolysis, and Helicase Activity
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; SINGLE-STRANDED-DNA; ONSET
   SPINOCEREBELLAR ATAXIA; RECESSIVE TWINKLE MUTATIONS; STRUCTURE-FUNCTION
   DEFECTS; PRIMASE-HELICASE; GENE MUTATION; MTDNA MAINTENANCE;
   BACTERIOPHAGE T7; LINKER REGION
AB Missense mutations in the human C10orf2 gene, encoding the mitochondrial DNA (mtDNA) helicase, co-segregate with mitochondrial diseases such as adult-onset progressive external ophthalmoplegia, hepatocerebral syndrome with mtDNA depletion syndrome, and infantile-onset spinocerebellar ataxia. To understand the biochemical consequences of C10orf2 mutations, we overproduced wild type and 20 mutant forms of human mtDNA helicase in Escherichia coli and developed novel schemes to purify the recombinant enzymes to near homogeneity. A combination of molecular crowding, non-ionic detergents, Mg2+ ions, and elevated ionic strength was required to combat insolubility and intrinsic instability of certain mutant variants. Asystematic biochemical assessment of the enzymes included analysis of DNA binding affinity, DNA helicase activity, the kinetics of nucleotide hydrolysis, and estimates of thermal stability. In contrast to other studies, we found that all 20 mutant variants retain helicase function under optimized in vitro conditions despite partial reductions in DNA binding affinity, nucleotide hydrolysis, or thermal stability for some mutants. Such partial defects are consistent with the delayed presentation of mitochondrial diseases associated with mutation of C10orf2.
C1 [Longley, Matthew J.; Humble, Margaret M.; Sharief, Farida S.; Copeland, William C.] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS)
RP Copeland, WC (corresponding author), NIEHS, Mol Genet Lab, NIH, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
RI Copeland, William/C-4242-2019
OI Copeland, William/0000-0002-0359-0953
FU National Institutes of Health through the NIEHS [ES 065078]
FX This work was supported, in whole or in part, by the Intramural Research
   Program of the National Institutes of Health through the NIEHS (Grant ES
   065078) (to W.C.C.).
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31350
   Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037
   DEBYSER Z, 1994, CELL, V77, P157, DOI 10.1016/0092-8674(94)90243-7
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Gajewski CD, 2003, MOL BIOL CELL, V14, P3628, DOI 10.1091/mbc.E02-12-0796
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744
   Heyduk T, 1996, METHOD ENZYMOL, V274, P492
   HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   Houshmand M, 2006, NEUROL INDIA, V54, P182
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   ILYINA TV, 1992, J MOL EVOL, V34, P351, DOI 10.1007/BF00160243
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281
   Kiechl S, 2004, J NEUROL NEUROSUR PS, V75, P1125, DOI 10.1136/jnnp.2003.025890
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Lee SJ, 2008, P NATL ACAD SCI USA, V105, P8908, DOI 10.1073/pnas.0802732105
   Leipe DD, 2000, GENOME RES, V10, P5
   Lewis S, 2002, J NEUROL SCI, V201, P39, DOI 10.1016/S0022-510X(02)00190-9
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   MATSON SW, 1985, J BIOL CHEM, V260, P2281
   MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445
   Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   NOTARNICOLA SM, 1995, J BIOL CHEM, V270, P20215, DOI 10.1074/jbc.270.34.20215
   Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651
   Rivera H, 2007, NEUROMUSCULAR DISORD, V17, P677, DOI 10.1016/j.nmd.2007.05.006
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Satapathy AK, 2010, P NATL ACAD SCI USA, V107, P6782, DOI 10.1073/pnas.1002734107
   Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146
   Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   VAN GOETHEM G, 2003, HUM MUTAT, V22, P175
   VAN HOVE JLK, 2009, AM J MED GENET A A, V149, P861
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079
   Ziebarth TD, 2010, J BIOL CHEM, V285, P14639, DOI 10.1074/jbc.M109.099663
NR 62
TC 41
Z9 49
U1 1
U2 6
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 24
PY 2010
VL 285
IS 39
BP 29690
EP 29702
DI 10.1074/jbc.M110.151795
PG 13
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 652EK
UT WOS:000281984300004
PM 20659899
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Davidzon, G
   Greene, P
   Mancuso, M
   Klos, KJ
   Ahlskog, JE
   Hirano, M
   DiMauro, S
AF Davidzon, G
   Greene, P
   Mancuso, M
   Klos, KJ
   Ahlskog, JE
   Hirano, M
   DiMauro, S
TI Early-onset familial Parkinsonism due to <i>POLG</i> mutations
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID MITOCHONDRIAL-DNA POLYMERASE; DISEASE; GAMMA; OPHTHALMOPLEGIA;
   NEUROPATHY; DISORDERS; GENE
AB Objective: To define the Molecular etiology of early-onset parkinsonism and peripheral neuropathy.
   Methods: Two sisters had early-onset parkinsonism (dystonic toe curling, action tremor, masked face, bradykinesia, stooped posture, and rigidity), together with clinical and electrophysiological signs of sensorimotor axonal peripheral neuropathy.
   Results: No mutations were found in the genes for Parkin or PINK1. Muscle biopsies showed ragged-red and cytochrome c oxidase-negative Fibers, and biochemistry showed decreased activities of respiratory chain complexes containing mitochondrial DNA-encoded subunits. Multiple mitochondrial DNA deletions were seen by long polymerase chain reaction, and sequencing of the POLG gene showed that the patients were compound heterozygous for two patogenic mutations.
   Interpretation: POLG mutations can cause early-onset parkinsonism in the absence of progressive external ophthalmoplegia.
C1 Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA.
   Univ Pisa, Dept Neurol, Inst Neurol, Pisa, Italy.
   Mayo Clin, Dept Neurol, Rochester, MN USA.
C3 Columbia University; University of Pisa; Mayo Clinic
RP 4-420 Coll Phys & Surg,630 W 168th St, New York, NY 10032 USA.
EM sd12@columbia.edu
RI Mancuso, Michelangelo/K-4170-2016
OI Davidzon, Guido/0000-0001-5579-6825
FU NICHD NIH HHS [HD32062] Funding Source: Medline; NINDS NIH HHS [NS11766]
   Funding Source: Medline
CR Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   DIMAURO S, 1993, NEUROLOGY, V43, P2170, DOI 10.1212/WNL.43.11.2170
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mizuno Y, 1998, ANN NEUROL, V44, pS99, DOI 10.1002/ana.410440715
   Nishigaki Y, 2004, HUM MOL GENET, V13, P91, DOI 10.1093/hmg/ddh010
   Sambrook J., 2001, MOL CLONING LAB MANU, P69
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Shiba M, 2000, MOVEMENT DISORD, V15, P669, DOI 10.1002/1531-8257(200007)15:4<669::AID-MDS1011>3.0.CO;2-5
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Tay SKH, 2004, NEUROMUSCULAR DISORD, V14, P253, DOI 10.1016/j.nmd.2003.12.006
   Thyagarajan D, 2000, ANN NEUROL, V48, P730, DOI 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   VYAS I, 1986, J NEUROCHEM, V46, P1501, DOI 10.1111/j.1471-4159.1986.tb01768.x
NR 20
TC 188
Z9 201
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD MAY
PY 2006
VL 59
IS 5
BP 859
EP 862
DI 10.1002/ana.20831
PG 4
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 037RM
UT WOS:000237164600020
PM 16634032
DA 2024-11-01
ER

PT J
AU Stiles, AR
   Simon, MT
   Stover, A
   Eftekharian, S
   Khanlou, N
   Wang, HLL
   Magaki, S
   Lee, H
   Partynski, K
   Dorrani, N
   Chang, R
   Martinez-Agosto, JA
   Abdenur, JE
AF Stiles, Ashlee R.
   Simon, Mariella T.
   Stover, Alexander
   Eftekharian, Shaya
   Khanlou, Negar
   Wang, Hanlin L.
   Magaki, Shino
   Lee, Hane
   Partynski, Kate
   Dorrani, Nagmeh
   Chang, Richard
   Martinez-Agosto, Julian A.
   Abdenur, Jose E.
TI Mutations in TFAM, encoding mitochondrial transcription factor A, cause
   neonatal liver failure associated with mtDNA depletion
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE TFAM mutation; mtDNA depletion syndrome; Liver failure; Newborn
   screening; Mitochondrial disease
ID DNA DEPLETION; DISORDERS; MAINTENANCE; BINDING; GENE; PROTEIN
AB In humans, mitochondrial DNA (mtDNA) depletion syndromes are a group of genetically and clinically heterogeneous autosomal recessive disorders that arise as a consequence of defects in mtDNA replication or nucleotide synthesis. Clinical manifestations are variable and include myopathic, encephalomyopathic, neurogastrointestinal or hepatocerebral phenotypes. Through clinical exome sequencing, we identified a homozygous missense variant (c.533C>T; p.Pro178Leu) in mitochondrial transcription factor A (TFAM) segregating in a consanguineous kindred of Colombian Basque descent in which two siblings presented with IUGR, elevated transaminases, conjugated hyperbilirubinemia and hypoglycemia with progression to liver failure and death in early infancy. Results of the liver biopsy in the proband revealed cirrhosis, micro-and macrovesicular steatosis, cholestasis and mitochondrial pleomorphism. Electron microscopy of muscle revealed abnormal mitochondrial morphology and distribution while enzyme histochemistry was underwhelming. Electron transport chain testing in muscle showed increased citrate synthase activity suggesting mitochondrial proliferation, while respiratory chain activities were at the lower end of normal. mtDNA content was reduced in liver and muscle (11% and 21% of normal controls respectively). While Tfam mRNA expression was upregulated in primary fibroblasts, Tfam protein level was significantly reduced. Furthermore, functional investigations of the mitochondria revealed reduced basal respiration and spare respiratory capacity, decreased mtDNA copy number and markedly reduced nucleoids.
   TFAM is essential for transcription, replication and packaging of mtDNA into nucleoids. Tfam knockout mice display embryonic lethality secondary to severe mtDNA depletion. In this report, for the first time, we associate a homozygous variant in TFAM with a novel mtDNA depletion syndrome. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Stiles, Ashlee R.; Khanlou, Negar; Wang, Hanlin L.; Magaki, Shino; Lee, Hane] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.
   [Stiles, Ashlee R.; Lee, Hane; Martinez-Agosto, Julian A.] Univ Calif Los Angeles, Clin Genom Ctr, Los Angeles, CA 90095 USA.
   [Simon, Mariella T.; Stover, Alexander; Eftekharian, Shaya; Partynski, Kate; Chang, Richard; Abdenur, Jose E.] CHOC Childrens, Div Metab Disorders, Orange, CA 92868 USA.
   [Simon, Mariella T.] Univ Calif Irvine, Sch Biol Sci, Dept Dev & Cellular Biol, Irvine, CA 92697 USA.
   [Dorrani, Nagmeh; Martinez-Agosto, Julian A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA.
   [Martinez-Agosto, Julian A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.
   [Abdenur, Jose E.] Univ Calif Irvine, Dept Pediat, Orange, CA 92868 USA.
C3 University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; University of California System; University of
   California Los Angeles; University of California System; University of
   California Irvine; University of California System; University of
   California Los Angeles; University of California Los Angeles Medical
   Center; David Geffen School of Medicine at UCLA; University of
   California System; University of California Los Angeles; University of
   California Los Angeles Medical Center; David Geffen School of Medicine
   at UCLA; University of California System; University of California
   Irvine
RP Abdenur, JE (corresponding author), Div Metab Disorders, 1201 W La Veta Ave, Orange, CA 92868 USA.
EM jabdenur@choc.org
RI Martinez-Agosto, Julian/I-9435-2019
OI Chang, Richard/0000-0002-6920-8059; Simon, Mariella/0000-0002-8200-3277
FU Fry Family Foundation [40031028]; Energy Laboratory
FX We thank the family for their steadfast commitment to participation in
   this study and the generous support of the Fry Family Foundation
   (40031028) to the CHOC Children's Metabolic Program and the Energy
   Laboratory.
CR [Anonymous], 2013, MUSCLE BIOPSY PRACTI
   BENNETT RL, 1995, AM J HUM GENET, V56, P745, DOI 10.1007/BF01408073
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Debray FG, 2008, CURR OPIN PEDIATR, V20, P471, DOI 10.1097/MOP.0b013e328306ebb6
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   El-Hattab A.W., 2016, Cell Calcium
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   El-Hattab AW, 2010, MOL GENET METAB, V99, P300, DOI 10.1016/j.ymgme.2009.10.003
   Fellman V, 2011, SEMIN FETAL NEONAT M, V16, P222, DOI 10.1016/j.siny.2011.05.002
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Gangelhoff TA, 2009, NUCLEIC ACIDS RES, V37, P3153, DOI 10.1093/nar/gkp157
   Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017
   Kasashima K., 2015, GENES CELLS
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604
   Lu B, 2013, MOL CELL, V49, P121, DOI 10.1016/j.molcel.2012.10.023
   Müller-Höcker J, 2011, J CELL MOL MED, V15, P445, DOI 10.1111/j.1582-4934.2009.00819.x
   Ngo HB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4077
   Nobre S., 2012, BMJ CASE REP, V2012, P1
   Nogueira C, 2014, ITAL J PEDIATR, V40, DOI 10.1186/1824-7288-40-34
   PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027
   Picca A, 2015, MITOCHONDRION, V25, P67, DOI 10.1016/j.mito.2015.10.001
   Prasad C, 2013, MOL GENET METAB, V108, P190, DOI 10.1016/j.ymgme.2012.12.007
   Pronicka E, 2011, J APPL GENET, V52, P61, DOI 10.1007/s13353-010-0008-y
   Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92
   RH H., 2008, MOL GENET METAB, V94, P16
   Rötig A, 2009, BBA-MOL BASIS DIS, V1792, P1103, DOI 10.1016/j.bbadis.2009.06.009
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sezer T, 2015, J CHILD NEUROL, V30, P124, DOI 10.1177/0883073813517000
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Tiranti V. ER, 1994, GENOMICS, V25, P6
   Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807
   Wong LJC, 2007, MITOCHONDRION, V7, P45, DOI 10.1016/j.mito.2006.11.025
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
NR 43
TC 85
Z9 93
U1 2
U2 20
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD SEP-OCT
PY 2016
VL 119
IS 1-2
SI SI
BP 91
EP 99
DI 10.1016/j.ymgme.2016.07.001
PG 9
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA DX8IJ
UT WOS:000384631000013
PM 27448789
DA 2024-11-01
ER

PT J
AU Kytovuori, L
   Junttila, J
   Huikuri, H
   Keinanen-Kiukaanniemi, S
   Majamaa, K
   Martikainen, MH
AF Kytovuori, Laura
   Junttila, Juhani
   Huikuri, Heikki
   Keinanen-Kiukaanniemi, Sirkka
   Majamaa, Kari
   Martikainen, Mika H.
TI Mitochondrial DNA variation in sudden cardiac death: a population-based
   study
SO INTERNATIONAL JOURNAL OF LEGAL MEDICINE
LA English
DT Article
DE Mitochondrial disease; Mitochondrial DNA; Mitochondrial haplogroups;
   Non-ischaemic; Sudden cardiac death
ID INFANTILE CARDIOMYOPATHY; ATPASE 6; MUTATION; ASSOCIATION; PREVALENCE;
   DISEASE; LONGEVITY; DIAGNOSIS; GENETICS; NUCLEAR
AB Cardiomyopathy and cardiac conduction defects are common manifestations of mitochondrial disease. Previous studies suggest that clinically asymptomatic individuals harbouring pathogenic mitochondrial DNA (mtDNA) mutations in the cardiac muscle may have sudden cardiac death (SCD) as the first manifestation of mitochondrial disease. We investigated the contribution of pathogenic mtDNA point mutations and mtDNA haplogroups in cardiac muscle in a cohort of 280 Finnish subjects that had died from non-ischaemic SCD with the median age of death at 59 years and in 537 population controls. We did not find any common or novel pathogenic mutations, but the frequency of haplogroup H1 was higher in the SCD subjects than that in 537 population controls (odds ratio: 1.76, confidence interval 95%: 1.02-3.04). We conclude that, at the population level, pathogenic point mutations in mtDNA do not contribute to non-ischaemic SCD, but natural variation may modify the risk.
C1 [Kytovuori, Laura; Majamaa, Kari] Univ Oulu, Res Unit Clin Neurosci, POB 5000, Oulu 90014, Finland.
   [Kytovuori, Laura; Junttila, Juhani; Huikuri, Heikki; Keinanen-Kiukaanniemi, Sirkka; Majamaa, Kari] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland.
   [Kytovuori, Laura; Junttila, Juhani; Huikuri, Heikki; Keinanen-Kiukaanniemi, Sirkka; Majamaa, Kari] Univ Oulu, Oulu, Finland.
   [Kytovuori, Laura; Majamaa, Kari] Oulu Univ Hosp, Dept Neurol, POB 20, Oulu 90029, Finland.
   [Junttila, Juhani; Huikuri, Heikki] Univ Oulu, Res Unit Internal Med, POB 5000, Oulu 90014, Finland.
   [Keinanen-Kiukaanniemi, Sirkka] Univ Oulu, Ctr Life Course Hlth Res, POB 5000, Oulu 90014, Finland.
   [Keinanen-Kiukaanniemi, Sirkka] Healthcare & Social Serv Selanne, Pyhajarvi, Finland.
   [Martikainen, Mika H.] Univ Turku, Div Clin Neurosci, Kiinamyllynkatu 4-8, FIN-20520 Turku, Finland.
   [Martikainen, Mika H.] Turku Univ Hosp, Kiinamyllynkatu 4-8, FIN-20520 Turku, Finland.
C3 University of Oulu; University of Oulu; University of Oulu; University
   of Oulu; University of Oulu; University of Oulu; University of Turku;
   University of Turku
RP Kytovuori, L (corresponding author), Univ Oulu, Res Unit Clin Neurosci, POB 5000, Oulu 90014, Finland.; Kytovuori, L (corresponding author), Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland.; Kytovuori, L (corresponding author), Univ Oulu, Oulu, Finland.; Kytovuori, L (corresponding author), Oulu Univ Hosp, Dept Neurol, POB 20, Oulu 90029, Finland.
EM laura.kytovuori@oulu.fi; juhani.junttila@oulu.fi;
   heikki.huikuri@oulu.fi; sirkka.keinanen-kiukaanniemi@oulu.fi;
   kari.majamaa@oulu.fi; mikmar@utu.fi
RI Kytövuori, Laura/AHE-1635-2022
OI Kytovuori, Laura/0000-0003-2790-5646; Majamaa, Kari/0000-0002-9070-3791
FU University of Oulu; Oulu University Hospital; Sigrid Juselius
   Foundation; Finnish Foundation for Cardiovascular Research
FX Open access funding provided by University of Oulu including Oulu
   University Hospital. This work was supported by The Sigrid Juselius
   Foundation, Finnish Foundation for Cardiovascular Research and by State
   Research Funding from Oulu University Hospital.
CR Anderson JH, 2016, CIRC-CARDIOVASC GENE, V9, P259, DOI 10.1161/CIRCGENETICS.115.001370
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Bendl J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003440
   Bray AW, 2017, CURR OPIN CARDIOL, V32, P267, DOI 10.1097/HCO.0000000000000383
   Deo R, 2012, CIRCULATION, V125, P620, DOI 10.1161/CIRCULATIONAHA.111.023838
   Ebner S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135622
   Fernández-Caggiano M, 2013, MITOCHONDRION, V13, P263, DOI 10.1016/j.mito.2013.03.005
   Finnilä S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591
   Gallardo ME, 2012, EUR HEART J, V33, P346, DOI 10.1093/eurheartj/ehr280
   Gómez-Durán A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Hookana E, 2011, HEART RHYTHM, V8, P1570, DOI 10.1016/j.hrthm.2011.06.031
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Imai A, 2016, INT J CARDIOL, V207, P203, DOI 10.1016/j.ijcard.2016.01.026
   Junttila MJ, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.115.003723
   Kenney MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054339
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   Majamaa-Voltti K, 2004, ANN MED, V36, P225, DOI 10.1080/07853890410028456
   Majamaa-Voltti K, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.122648
   Martikainen MH, 2013, ACTA DIABETOL, V50, P737, DOI 10.1007/s00592-012-0393-2
   Mimaki M, 2003, J HUM GENET, V48, P47, DOI 10.1007/s100380300005
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Ng YS, 2016, EUR HEART J, V37, P2552, DOI 10.1093/eurheartj/ehv306
   Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y
   RAJALA U, 1995, SCAND J PRIM HEALTH, V13, P222, DOI 10.3109/02813439508996765
   Raule N, 2014, AGING CELL, V13, P401, DOI 10.1111/acel.12186
   Santorelli FM, 1999, AM J HUM GENET, V64, P295, DOI 10.1086/302188
   Sheskin DJ, 2000, Handbook of parametric and nonparametric statistical procedures
   Sonney S, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005867
   Stallmeyer B, 2015, EUR HEART J, V36, P1643, DOI 10.1093/eurheartj/ehv173
   Szumilas M, 2010, J CAN ACAD CHILD ADO, V19, P227
   Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203
   van Oven M, 2015, FORENS SCI INT-GEN S, V5, pE392, DOI 10.1016/j.fsigss.2015.09.155
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
   Ware SM, 2009, J MED GENET, V46, P308, DOI 10.1136/jmg.2008.063149
   Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, pW58, DOI 10.1093/nar/gkw233
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
   Zhang YY, 2017, EUR HEART J, V38, P3443, DOI 10.1093/eurheartj/ehx354
NR 39
TC 2
Z9 4
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0937-9827
EI 1437-1596
J9 INT J LEGAL MED
JI Int. J. Legal Med.
PD JAN
PY 2020
VL 134
IS 1
BP 39
EP 44
DI 10.1007/s00414-019-02091-4
PG 6
WC Medicine, Legal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Legal Medicine
GA KG5BM
UT WOS:000509962400004
PM 31152278
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Facchinello, N
   Laquatra, C
   Locatello, L
   Beffagna, G
   Casas, RB
   Fornetto, C
   Dinarello, A
   Martorano, L
   Vettori, A
   Risato, G
   Celeghin, R
   Meneghetti, G
   Santoro, MM
   Delahodde, A
   Vanzi, F
   Rasola, A
   Dalla Valle, L
   Rasotto, MB
   Lodi, T
   Baruffini, E
   Argenton, F
   Tiso, N
AF Facchinello, Nicola
   Laquatra, Claudio
   Locatello, Lisa
   Beffagna, Giorgia
   Branas Casas, Raquel
   Fornetto, Chiara
   Dinarello, Alberto
   Martorano, Laura
   Vettori, Andrea
   Risato, Giovanni
   Celeghin, Rudy
   Meneghetti, Giacomo
   Santoro, Massimo Mattia
   Delahodde, Agnes
   Vanzi, Francesco
   Rasola, Andrea
   Dalla Valle, Luisa
   Rasotto, Maria Berica
   Lodi, Tiziana
   Baruffini, Enrico
   Argenton, Francesco
   Tiso, Natascia
TI Efficient clofilium tosylate-mediated rescue of POLG-related disease
   phenotypes in zebrafish
SO CELL DEATH & DISEASE
LA English
DT Article
ID MITOCHONDRIAL-DNA DEPLETION; POLYMERASE GAMMA; CAENORHABDITIS-ELEGANS;
   GENE
AB The DNA polymerase gamma (Polg) is a nuclear-encoded enzyme involved in DNA replication in animal mitochondria. In humans, mutations in the POLG gene underlie a set of mitochondrial diseases characterized by mitochondrial DNA (mtDNA) depletion or deletion and multiorgan defects, named POLG disorders, for which an effective therapy is still needed. By applying antisense strategies, ENU- and CRISPR/Cas9-based mutagenesis, we have generated embryonic, larval-lethal and adult-viable zebrafish Polg models. Morphological and functional characterizations detected a set of phenotypes remarkably associated to POLG disorders, including cardiac, skeletal muscle, hepatic and gonadal defects, as well as mitochondrial dysfunctions and, notably, a perturbed mitochondria-to-nucleus retrograde signaling (CREB and Hypoxia pathways). Next, taking advantage of preliminary evidence on the candidate molecule Clofilium tosylate (CLO), we tested CLO toxicity and then its efficacy in our zebrafish lines. Interestingly, at well tolerated doses, the CLO drug could successfully rescue mtDNA and Complex I respiratory activity to normal levels, even in mutant phenotypes worsened by treatment with Ethidium Bromide. In addition, the CLO drug could efficiently restore cardio-skeletal parameters and mitochondrial mass back to normal values. Altogether, these evidences point to zebrafish as a valuable vertebrate organism to faithfully phenocopy multiple defects detected in POLG patients. Moreover, this model represents an excellent platform to screen, at the whole-animal level, candidate molecules with therapeutic effects in POLG disorders.
C1 [Facchinello, Nicola; Locatello, Lisa; Beffagna, Giorgia; Dinarello, Alberto; Martorano, Laura; Risato, Giovanni; Celeghin, Rudy; Meneghetti, Giacomo; Santoro, Massimo Mattia; Dalla Valle, Luisa; Rasotto, Maria Berica; Argenton, Francesco; Tiso, Natascia] Univ Padua, Dept Biol, I-35131 Padua, Italy.
   [Laquatra, Claudio; Rasola, Andrea] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy.
   [Beffagna, Giorgia; Risato, Giovanni] Univ Padua, Dept Cardiothoraco Vasc Sci & Publ Hlth, I-35128 Padua, Italy.
   [Branas Casas, Raquel] Univ Barcelona, Fac Biol, Barcelona 08028, Spain.
   [Fornetto, Chiara; Vanzi, Francesco] Univ Florence, Dept Biol, I-50019 Sesto Fiorentino, FI, Italy.
   [Fornetto, Chiara; Vanzi, Francesco] Univ Florence, LENS, I-50019 Sesto Fiorentino, FI, Italy.
   [Vettori, Andrea] Univ Verona, Dept Biotechnol, I-37134 Verona, Italy.
   [Delahodde, Agnes] Inst Biol Integrat Cellule I2BC, F-91190 Gif Sur Yvette, France.
   [Lodi, Tiziana; Baruffini, Enrico] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, I-43124 Parma, Italy.
C3 University of Padua; University of Padua; University of Padua;
   University of Barcelona; University of Florence; University of Florence;
   University of Verona; Universite Paris Saclay; University of Parma
RP Argenton, F (corresponding author), Univ Padua, Dept Biol, I-35131 Padua, Italy.; Lodi, T; Baruffini, E (corresponding author), Univ Parma, Dept Chem Life Sci & Environm Sustainabil, I-43124 Parma, Italy.
EM tiziana.lodi@unipr.it; enrico.baruffini@unipr.it;
   francesco.argenton@unipd.it
RI LOCATELLO, LISA/AAC-5612-2020; Argenton, Francesco/AAS-8494-2021;
   Celeghin, Rudy/HKO-1478-2023; Dalla Valle, Luisa/G-6721-2011; Rasotto,
   Maria/A-8724-2012; Facchinello, Nicola/P-5255-2019; Vettori,
   Andrea/J-3951-2014; Tiso, Natascia/E-2182-2011; Baruffini,
   Enrico/C-1057-2015
OI Vettori, Andrea/0000-0003-4958-0619; Tiso, Natascia/0000-0002-5444-9853;
   Fornetto, Chiara/0000-0002-7951-1350; Facchinello,
   Nicola/0000-0003-4898-4064; Celeghin, Rudy/0000-0001-9047-9032;
   LOCATELLO, LISA/0000-0002-3530-2565; Branas Casas,
   Raquel/0000-0002-0908-4330; RASOTTO, MARIA BERICA/0000-0001-5711-2810;
   Dalla Valle, Luisa/0000-0001-8097-6369; Baruffini,
   Enrico/0000-0002-8280-7849; Dinarello, Alberto/0000-0003-3124-7236;
   Laquatra, Claudio/0000-0001-9663-7054; Risato,
   Giovanni/0000-0003-0651-7409; SANTORO, Massimo
   Mattia/0000-0003-4605-5085
FU Department of Biology, University of Padova [BIRD192500]; French
   Muscular Dystrophy Association (AFM-Telethon) [POLYGON 18572]; Italian
   Association for Cancer Research (AIRC) [IG-2017-19928]; Italian Telethon
   Foundation [GGP15041, GGP19287]; CARIPARO grant SHoCD; Italian Ministry
   University Research (MIUR) [PRIN 20173ZWACS]; AIRC [IG-2017/20749];
   European Research Council (ERC) Consolidator Grant-Rendox [ERC-CoG
   647057]
FX We are thankful to the personnel at the Zebrafish Centre of the
   University of Padova (Dr Martina Milanetto, Dr Luigi Pivotti and Mrs.
   Shkendy Iljazi). N.F. is an Umberto Veronesi Foundation fellow. R.C. is
   a post-doc fellow of the Department of Biology, University of Padova
   (grant BIRD192500). This paper is dedicated to the memory of one of our
   co-authors, Prof. Agnes Delahodde, outstanding researcher and
   exceptional human being, who suddenly and unexpectedly passed away
   during the revision of this work. This work was supported by the French
   Muscular Dystrophy Association (AFM-Telethon) [POLYGON 18572 to N.T.];
   the Italian Association for Cancer Research (AIRC) [IG-2017-19928 to
   F.A.]; and the Italian Telethon Foundation [GGP15041 and GGP19287 to
   F.A., E.B., T.L. and N.T.]. G.B. was supported by the CARIPARO grant
   SHoCD and the Italian Ministry University Research (MIUR) grant PRIN
   20173ZWACS. A.R. was supported by the AIRC grant IG-2017/20749. M.M.S.
   was supported by the European Research Council (ERC) Consolidator
   Grant-Rendox (ERC-CoG 647057). Funding for open access charge: Italian
   Telethon Foundation.
CR Aleström P, 2020, LAB ANIM-UK, V54, P213, DOI 10.1177/0023677219869037
   Alway SE, 2017, EXERC SPORT SCI REV, V45, P58, DOI 10.1249/JES.0000000000000101
   Artuso L, 2012, BBA-BIOENERGETICS, V1817, P1002, DOI 10.1016/j.bbabio.2012.03.019
   Becker W. A., 1984, Manual of quantitative genetics.
   Bratic I, 2009, NUCLEIC ACIDS RES, V37, P1817, DOI 10.1093/nar/gkp018
   Cannino G, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00333
   da Cunha FM, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/482582
   Facchinello N, 2016, METHODS MOL BIOL, V1481, P81, DOI 10.1007/978-1-4939-6393-5_9
   Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186
   Giannelli F, 2001, AM J HUM GENET, V68, P1535, DOI 10.1086/320613
   Giuliodori A, 2018, CARDIOVASC RES, V114, P1082, DOI 10.1093/cvr/cvy057
   Guha M, 2013, MITOCHONDRION, V13, P577, DOI 10.1016/j.mito.2013.08.007
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Korzh S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-84
   Kumar H, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/584758
   Kuo CW, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061220
   Lodi T, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00106
   MacPhail RC, 2009, NEUROTOXICOLOGY, V30, P52, DOI 10.1016/j.neuro.2008.09.011
   Martorano L, 2019, DIS MODEL MECH, V12, DOI 10.1242/dmm.037226
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Müller-Höcker J, 2011, J CELL MOL MED, V15, P445, DOI 10.1111/j.1582-4934.2009.00819.x
   Mugoni V, 2014, JOVE-J VIS EXP, DOI 10.3791/51328
   PARIKH VS, 1987, SCIENCE, V235, P576, DOI 10.1126/science.3027892
   Pauls S, 2007, DEV BIOL, V304, P875, DOI 10.1016/j.ydbio.2007.01.024
   Pitayu L, 2016, HUM MOL GENET, V25, P715, DOI 10.1093/hmg/ddv509
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Rahn JJ, 2015, NUCLEIC ACIDS RES, V43, P10338, DOI 10.1093/nar/gkv1139
   Schönenberger MJ, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00042
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514
   Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596
   Vankoningsloo S, 2006, J CELL SCI, V119, P1266, DOI 10.1242/jcs.02848
   Verhoeven WMA, 2011, NEUROPSYCH DIS TREAT, V7, P293, DOI 10.2147/NDT.S20153
   Vettori A, 2017, P NATL ACAD SCI USA, V114, P9948, DOI 10.1073/pnas.1705338114
   Wilson-Leedy JG, 2007, THERIOGENOLOGY, V67, P661, DOI 10.1016/j.theriogenology.2006.10.003
   Zhou WQ, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.033027
NR 36
TC 15
Z9 15
U1 1
U2 10
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD JAN 19
PY 2021
VL 12
IS 1
AR 100
DI 10.1038/s41419-020-03359-z
PG 18
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA PY4VZ
UT WOS:000612045000003
PM 33469036
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Garrido-Maraver, J
   Cordero, MD
   Moñino, ID
   Pereira-Arenas, S
   Lechuga-Vieco, AV
   Cotán, D
   De la Mata, M
   Oropesa-Avila, M
   De Miguel, M
   Lorite, JB
   Infante, ER
   Alvarez-Dolado, M
   Navas, P
   Jackson, S
   Francisci, S
   Sánchez-Alcázar, JA
AF Garrido-Maraver, Juan
   Cordero, Mario D.
   Dominguez Monino, Irene
   Pereira-Arenas, Sheila
   Lechuga-Vieco, Ana V.
   Cotan, David
   De la Mata, Mario
   Oropesa-Avila, Manuel
   De Miguel, Manuel
   Bautista Lorite, Juan
   Rivas Infante, Eloy
   Alvarez-Dolado, Manuel
   Navas, Placido
   Jackson, Sandra
   Francisci, Silvia
   Sanchez-Alcazar, Jose A.
TI Screening of effective pharmacological treatments for MELAS syndrome
   using yeasts, fibroblasts and cybrid models of the disease
SO BRITISH JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE coenzyme Q10; riboflavin; mitochondrial disease; MELAS; mitophagy
ID TRANSFER RNALEU(UUR) GENE; MITOCHONDRIAL-DNA; LACTIC-ACIDOSIS;
   TRANSFER-RNA; COENZYME Q(10); PROTEIN-SYNTHESIS; MUTATION;
   ENCEPHALOPATHY; MYOPATHY; RIBOFLAVIN
AB BACKGROUND AND PURPOSE MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes) is a mitochondrial disease most usually caused by point mutations in tRNA genes encoded by mitochondrial DNA (mtDNA). Approximately 80% of cases of MELAS syndrome are associated with a m.3243A > G mutation in the MT-TL1 gene, which encodes the mitochondrial tRNALeu (UUR). Currently, no effective treatments are available for this chronic progressive disorder. Treatment strategies in MELAS and other mitochondrial diseases consist of several drugs that diminish the deleterious effects of the abnormal respiratory chain function, reduce the presence of toxic agents or correct deficiencies in essential cofactors. EXPERIMENTAL APPROACH We evaluated the effectiveness of some common pharmacological agents that have been utilized in the treatment of MELAS, in yeast, fibroblast and cybrid models of the disease. The yeast model harbouring the A14G mutation in the mitochondrial tRNALeu(UUR) gene, which is equivalent to the A3243G mutation in humans, was used in the initial screening. Next, the most effective drugs that were able to rescue the respiratory deficiency in MELAS yeast mutants were tested in fibroblasts and cybrid models of MELAS disease. KEY RESULTS According to our results, supplementation with riboflavin or coenzyme Q10 effectively reversed the respiratory defect in MELAS yeast and improved the pathologic alterations in MELAS fibroblast and cybrid cell models. CONCLUSIONS AND IMPLICATIONS Our results indicate that cell models have great potential for screening and validating the effects of novel drug candidates for MELAS treatment and presumably also for other diseases with mitochondrial impairment.
C1 [Garrido-Maraver, Juan; Cordero, Mario D.; Dominguez Monino, Irene; Pereira-Arenas, Sheila; Lechuga-Vieco, Ana V.; Cotan, David; De la Mata, Mario; Oropesa-Avila, Manuel; Navas, Placido; Sanchez-Alcazar, Jose A.] Univ Pablo Olavide, Consejo Super Invest Cient Junta de Andalucia, Inst Salud Carlos III, CABD, Seville 41013, Spain.
   [Garrido-Maraver, Juan; Cordero, Mario D.; Dominguez Monino, Irene; Pereira-Arenas, Sheila; Lechuga-Vieco, Ana V.; Cotan, David; De la Mata, Mario; Oropesa-Avila, Manuel; Navas, Placido; Sanchez-Alcazar, Jose A.] Univ Pablo Olavide, Consejo Super Invest Cient Junta de Andalucia, Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Seville 41013, Spain.
   [Rivas Infante, Eloy] Hosp Virgen del Rocio, Dept Anat Patol, Seville, Spain.
   [De Miguel, Manuel] Univ Seville, Fac Med, Dept Citol & Histol Normal & Patol, Seville, Spain.
   [Bautista Lorite, Juan] Hosp Sagrado Corazon, Seville, Spain.
   [Alvarez-Dolado, Manuel] Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville, Spain.
   [Jackson, Sandra] Uniklinikum CG Carus, Dresden, Germany.
   [Francisci, Silvia] Univ Roma La Sapienza, Dept Biol & Biotechnol, Rome, Italy.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); Universidad
   Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology
   (CABD); Instituto de Salud Carlos III; Universidad Pablo de Olavide;
   Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica
   en Red; CIBERER; Virgen del Rocio University Hospital; University of
   Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC);
   Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro
   Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER);
   Technische Universitat Dresden; Sapienza University Rome
RP Sánchez-Alcázar, JA (corresponding author), Univ Pablo Olavide, Consejo Super Invest Cient Junta de Andalucia, Inst Salud Carlos III, CABD, Carretera Utrera Km 1, Seville 41013, Spain.
EM jasanalc@upo.es
RI NAVAS, PLACIDO/R-5943-2019; De-Miguel, Manuel/B-3713-2017;
   GARRIDO-MARAVER, JUAN/S-3846-2016; Alvarez-Dolado, Manuel/C-2706-2017;
   Sanchez-Alcazar, Jose A./L-4925-2014; Cordero, Mario D./L-8006-2014; DE
   LA MATA, MARIO/O-8844-2015
OI De-Miguel, Manuel/0000-0002-6751-1695; Lechuga-Vieco, Ana
   Victoria/0000-0001-5546-9752; Dominguez Monino,
   Irene/0000-0001-6991-7931; GARRIDO-MARAVER, JUAN/0000-0003-4534-4109;
   Alvarez-Dolado, Manuel/0000-0002-0655-8289; Sanchez-Alcazar, Jose
   A./0000-0001-9705-1469; Cordero, Mario D./0000-0003-0151-3644;
   Francisci, silvia/0000-0002-6756-9491; DE LA MATA,
   MARIO/0000-0003-1640-7887; Rivas Infante, Eloy/0000-0001-6014-8048
FU Ministerio de Sanidad, Spain [FIS PI10/00543, FIS EC08/00076]; Fondo
   Europeo de Desarrollo Regional (FEDER-Union Europea) [SAS 111242];
   Servicio Andaluz de Salud-Junta de Andalucia, Proyecto de Investigacion
   de Excelencia de la Junta de Andalucia [CTS-5725]; AEPMI (Asociacion de
   Enfermos de Patologia Mitocondrial); FEEL (Fundacion Espanola de
   Enfermedades Lisosomales); Federacion Andaluza de Fibromialgia y Fatiga
   Cronica (ALBA Andalucia); Colegio Oficial de Farmaceuticos de Sevilla
FX This work was supported by FIS PI10/00543 grant, FIS EC08/00076 grant,
   Ministerio de Sanidad, Spain and Fondo Europeo de Desarrollo Regional
   (FEDER-Union Europea), SAS 111242 grant, Servicio Andaluz de Salud-Junta
   de Andalucia, Proyecto de Investigacion de Excelencia de la Junta de
   Andalucia CTS-5725, and by AEPMI (Asociacion de Enfermos de Patologia
   Mitocondrial), FEEL (Fundacion Espanola de Enfermedades Lisosomales) and
   Federacion Andaluza de Fibromialgia y Fatiga Cronica (ALBA Andalucia).
   MM received a fellowship from Colegio Oficial de Farmaceuticos de
   Sevilla. We thank to Dr Santos-Ocana for his help with the yeast
   cultures. This group was founded by the Centro de Investigacion
   Biomedica en Red de Enfermedades Raras (CIBERER), ISCIII.
CR ADDISON R, 1978, BIOCHEM BIOPH RES CO, V81, P133, DOI 10.1016/0006-291X(78)91640-6
   Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   Barrientos A, 2003, IUBMB LIFE, V55, P83, DOI 10.1080/1521654031000098122
   BODNAR AG, 1995, BIOCHEM J, V305, P817, DOI 10.1042/bj3050817
   Chinnery P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub2
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Cotán D, 2011, FASEB J, V25, P2669, DOI 10.1096/fj.10-165340
   Crestanello JA, 2002, J SURG RES, V102, P221, DOI 10.1006/jsre.2001.6324
   Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje
   de Andrade PBM, 2006, DIABETOLOGIA, V49, P1816, DOI 10.1007/s00125-006-0301-9
   Depeint F, 2006, CHEM-BIOL INTERACT, V163, P94, DOI 10.1016/j.cbi.2006.04.014
   DiMauro S, 2006, MUSCLE NERVE, V34, P265, DOI 10.1002/mus.20598
   ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3
   FATO R, 1984, FEBS LETT, V172, P6, DOI 10.1016/0014-5793(84)80861-3
   Feuermann M, 2003, EMBO REP, V4, P53, DOI 10.1038/sj.embor.embor713
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   FOX TD, 1991, METHOD ENZYMOL, V194, P149
   Gajewski CD, 2003, MOL BIOL CELL, V14, P3628, DOI 10.1091/mbc.E02-12-0796
   Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546
   Gold DR, 2001, SEMIN NEUROL, V21, P309, DOI 10.1055/s-2001-17948
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341
   Herbert V, 1996, J NUTR, V126, pS1197, DOI 10.1093/jn/126.suppl_4.1197S
   Higashi-Okai Kiyoka, 2006, Journal of UOEH, V28, P359
   Hilton G, 1995, J Neurosci Nurs, V27, P278
   Hudson JR, 1997, GENOME RES, V7, P1169, DOI 10.1101/gr.7.12.1169
   Jacobson J, 2002, J NEUROCHEM, V82, P224, DOI 10.1046/j.1471-4159.2002.00945.x
   James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Kerr DS, 2010, MOL GENET METAB, V99, P246, DOI 10.1016/j.ymgme.2009.11.005
   Khan SM, 2007, AM J PHYSIOL-CELL PH, V292, pC658, DOI 10.1152/ajpcell.00224.2006
   Kim G, 2002, MUTAGENESIS, V17, P375, DOI 10.1093/mutage/17.5.375
   Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Koga Y, 2010, ANN NY ACAD SCI, V1201, P104, DOI 10.1111/j.1749-6632.2010.05624.x
   Levinger L, 2004, NUCLEIC ACIDS RES, V32, P5430, DOI 10.1093/nar/gkh884
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Ma D, 2001, Prog Drug Res, V57, P117
   Marriage B, 2003, J AM DIET ASSOC, V103, P1029, DOI 10.1016/S0002-8223(03)00476-0
   MATTHEWS PM, 1993, NEUROLOGY, V43, P884, DOI 10.1212/WNL.43.5.884
   Montanari A, 2008, RNA, V14, P275, DOI 10.1261/rna.740108
   Montini G, 2008, NEW ENGL J MED, V358, P2849, DOI 10.1056/NEJMc0800582
   Powers HJ, 1999, P NUTR SOC, V58, P435, DOI 10.1017/S0029665199000579
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Quinzii CM, 2007, NEUROCHEM RES, V32, P723, DOI 10.1007/s11064-006-9190-z
   Quinzii CM, 2010, DEV DISABIL RES REV, V16, P183, DOI 10.1002/ddrr.108
   Rinaldi T, 2010, FEMS YEAST RES, V10, P1006, DOI 10.1111/j.1567-1364.2010.00685.x
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Saada A, 2011, MOL GENET METAB, V104, P39, DOI 10.1016/j.ymgme.2011.07.016
   Sacconi S, 2010, NEUROMUSCULAR DISORD, V20, P44, DOI 10.1016/j.nmd.2009.10.014
   Santa KM, 2010, PHARMACOTHERAPY, V30, P1179, DOI 10.1592/phco.30.11.1179
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
   Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009
   Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007
   SCHON EA, 1992, BIOCHIM BIOPHYS ACTA, V1101, P206, DOI 10.1016/0005-2728(92)90226-R
   Smith M.G., 2006, Current protocols in human genetics
   Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Tafrechi RSJ, 2005, MUTAT RES-FUND MOL M, V578, P43, DOI 10.1016/j.mrfmmm.2005.02.002
   Thambisetty M, 2002, NEUROLOGIST, V8, P302, DOI 10.1097/00127893-200209000-00003
   Vergani L, 1999, BRAIN, V122, P2401, DOI 10.1093/brain/122.12.2401
   Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd
NR 65
TC 32
Z9 35
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0007-1188
EI 1476-5381
J9 BRIT J PHARMACOL
JI Br. J. Pharmacol.
PD NOV
PY 2012
VL 167
IS 6
BP 1311
EP 1328
DI 10.1111/j.1476-5381.2012.02086.x
PG 18
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 024AR
UT WOS:000310080300012
PM 22747838
OA Green Published
DA 2024-11-01
ER

PT J
AU Pitceathly, RDS
   McFarland, R
AF Pitceathly, Robert D. S.
   McFarland, Robert
TI Mitochondrial myopathies in adults and children: management and therapy
   development
SO CURRENT OPINION IN NEUROLOGY
LA English
DT Review
DE biomarkers; genotype or phenotype; mitochondrial disease;
   neurodegeneration; treatment
ID GROWTH-FACTOR 21; POINT MUTATIONS; MERRF MUTATION; DNA DELETIONS;
   DISEASE; PREVALENCE; POPULATION; A3243G; EPIDEMIOLOGY; DYSFUNCTION
AB Purpose of review
   The clinical and genetic heterogeneity of mitochondrial myopathies presents considerable diagnostic challenges. In addition, mitochondrial dysfunction seems to contribute to the development and progression of many age-related neurodegenerative diseases. This review presents recently published data concerning prevalence, phenotype, gene discovery, disease mechanisms, diagnostic tools and treatment strategies for mitochondrial diseases, and summarizes current understanding concerning the role mitochondria play in the pathogenesis of other common neurological disorders.
   Recent findings
   Heteroplasmic levels of pathogenic mitochondrial DNA mutations are common amongst the general population, although there is considerable geographic variation. Mitochondrial abnormalities also occur in common neurodegenerative disorders, implying a mechanistic link between mitochondrial dysfunction and development or progression of disease. The phenotypic spectrum associated with well recognized pathogenic variants continues to expand, whereas next-generation sequencing is identifying new disease-causing nuclear genetic mutations. Biomarkers and imaging modalities for diagnosis and disease monitoring are now in place and novel treatment strategies are emerging. Alas, no clinical trial data for treatment in mitochondrial disease have been published in the last 12 months.
   Summary
   Despite rapid advances in gene discovery, details concerning the altered protein products and cellular pathways that result in mitochondrial disease remain elusive. Understanding the consequences of deleterious mutations and the cellular adaptive response is imperative so that therapeutic targets can be identified.
C1 [Pitceathly, Robert D. S.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Basic & Clin Neurosci, London WC2R 2LS, England.
   [McFarland, Robert] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [McFarland, Robert] NUTH NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England.
C3 University of London; King's College London; Newcastle University - UK;
   Newcastle Upon Tyne Hospitals NHS Foundation Trust
RP Pitceathly, RDS (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Basic & Clin Neurosci, London WC2R 2LS, England.
EM robert.pitceathly@kcl.ac.uk
OI Pitceathly, Robert/0000-0002-6123-4551; McFarland,
   Robert/0000-0002-8833-2688
FU NHS England Rare Mitochondrial Disease Service for Adults and Children;
   Medical Research Council UK; Wellcome Trust; MRC [G0800674] Funding
   Source: UKRI
FX This work was supported by NHS England Rare Mitochondrial Disease
   Service for Adults and Children; the Medical Research Council UK; and
   the Wellcome Trust.
CR Abdulhag UN, 2014, EUR J HUM GENET EJHG
   Auré K, 2013, NEUROLOGY, V81, P1810, DOI 10.1212/01.wnl.0000436067.43384.0b
   Bates MGD, 2013, INT J CARDIOL, V168, P3599, DOI 10.1016/j.ijcard.2013.05.062
   Bax BE, 2013, NEUROLOGY, V81, P1269, DOI 10.1212/WNL.0b013e3182a6cb4b
   Bender A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062277
   Blakely EL, 2014, NEUROMUSCULAR DISORD, V24, P533, DOI 10.1016/j.nmd.2014.03.011
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Brady S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004552
   Bricout M, 2014, J MED GENET, V51, P429, DOI 10.1136/jmedgenet-2013-102256
   Campbell G, 2014, HUM MOL GENET
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Davis RL, 2013, NEUROLOGY, V81, P1819, DOI 10.1212/01.wnl.0000436068.43384.ef
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Garone C, 2014, EMBO MOL MED
   Gavrilova R, 2013, NEUROLOGY, V81, P1808, DOI 10.1212/01.wnl.0000436076.06159.2c
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Hue THD, 2014, EMBO MOL MED, V6, P183, DOI 10.1002/emmm.201303202
   Johri A, 2013, FREE RADICAL BIO MED, V62, P37, DOI 10.1016/j.freeradbiomed.2013.04.016
   Kevelam SH, 2013, BRAIN, V136, P1534, DOI 10.1093/brain/awt054
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Korkiamäki P, 2013, ACTA OPHTHALMOL, V91, P630, DOI 10.1111/j.1755-3768.2012.02506.x
   Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Nesbitt V, 2014, EUR J HUM GENET
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Perli E, 2014, EMBO MOL MED, V6, P169, DOI 10.1002/emmm.201303198
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pfeffer G, 2013, NEUROLOGY, V81, P2073, DOI 10.1212/01.wnl.0000437308.22603.43
   Pitceathly RDS, 2013, JAMA NEUROL, V70, P1556, DOI 10.1001/jamaneurol.2013.3242
   Pitceathly RDS, 2013, CELL REP, V3, P1795, DOI 10.1016/j.celrep.2013.05.005
   Rygiel K. A., 2014, NEUROPATHOL APPL NEU
   Scarpelli M, 2013, NEURORADIOL J, V26, P520, DOI 10.1177/197140091302600505
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Spendiff S, 2013, HUM MOL GENET, V22, P4739, DOI 10.1093/hmg/ddt327
   Suomalainen Anu, 2013, Expert Opin Med Diagn, V7, P313, DOI 10.1517/17530059.2013.812070
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Wedding IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086340
   Weiduschat N, 2014, NEUROLOGY, V82, P798, DOI 10.1212/WNL.0000000000000169
NR 43
TC 27
Z9 29
U1 0
U2 16
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1350-7540
EI 1473-6551
J9 CURR OPIN NEUROL
JI Curr. Opin. Neurol.
PD OCT
PY 2014
VL 27
IS 5
BP 576
EP 582
DI 10.1097/WCO.0000000000000126
PG 7
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA AP1UD
UT WOS:000341856200010
PM 25188013
DA 2024-11-01
ER

PT J
AU Kasahara, T
   Kubota, M
   Miyauchi, T
   Noda, Y
   Mouri, A
   Nabeshima, T
   Kato, T
AF Kasahara, T.
   Kubota, M.
   Miyauchi, T.
   Noda, Y.
   Mouri, A.
   Nabeshima, T.
   Kato, T.
TI Mice with neuron-specific accumulation of mitochondrial DNA mutations
   show mood disorder-like phenotypes
SO MOLECULAR PSYCHIATRY
LA English
DT Article
DE bipolar disorder; chronic progressive external ophthalmoplegia;
   mitochondria; POLG; lithium; wheel-running activity; circadian rhythm
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MAGNETIC-RESONANCE-SPECTROSCOPY;
   BIPOLAR AFFECTIVE-DISORDER; BRAIN ENERGY-METABOLISM; PREPULSE
   INHIBITION; POLG MUTATIONS; INVIVO P-31; ANT1 GENE; DYSFUNCTION;
   POLYMERASE
AB There is no established genetic model of bipolar disorder or major depression, which hampers research of these mood disorders. Although mood disorders are multifactorial diseases, they are sometimes manifested by one of pleiotropic effects of a single major gene defect. We focused on chronic progressive external ophthalmoplegia (CPEO), patients with which sometimes have comorbid mood disorders. Chronic progressive external ophthalmoplegia is a mitochondrial disease, which is accompanied by accumulation of mitochondrial DNA (mtDNA) deletions caused by mutations in nuclear-encoded genes such as POLG (mtDNA polymerase). We generated transgenic mice, in which mutant POLG was expressed in a neuron-specific manner. The mice showed forebrain-specific defects of mtDNA and had altered monoaminergic functions in the brain. The mutant mice exhibited characteristic behavioral phenotypes, a distorted day-night rhythm and a robust periodic activity pattern associated with estrous cycle. These abnormal behaviors resembling mood disorder were worsened by tricyclic antidepressant treatment and improved by lithium, a mood stabilizer. We also observed antidepressant-induced mania-like behavior and long-lasting irregularity of activity in some mutant animals. Our data suggest that accumulation of mtDNA defects in brain caused mood disorder-like mental symptoms with similar treatment responses to bipolar disorder. These findings are compatible with mitochondrial dysfunction hypothesis of bipolar disorder.
C1 RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama 3510198, Japan.
   Nagoya Univ, Grad Sch Med, Dept Neuropsychopharmacol, Nagoya, Aichi, Japan.
   Nagoya Univ, Grad Sch Med, Hosp Pharm, Nagoya, Aichi, Japan.
C3 RIKEN; Nagoya University; Nagoya University
RP Kato, T (corresponding author), RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
EM kato@brain.riken.jp
RI Kato, Tadafumi/J-3583-2014
OI Kato, Tadafumi/0000-0001-7856-3952
CR [Anonymous], 2000, DIAGN STAT MAN MENT, DOI [DOI 10.1176/APPI.BOOKS.9780890425787, 10.1176/appi.books.9780890425787]
   BARBIROLI B, 1993, J CEREBR BLOOD F MET, V13, P469, DOI 10.1038/jcbfm.1993.61
   Barrett SL, 2005, PSYCHOL MED, V35, P1737, DOI 10.1017/S0033291705005702
   Belke TW, 1997, J EXP ANAL BEHAV, V67, P337, DOI 10.1901/jeab.1997.67-337
   Blehar MC, 1998, PSYCHOPHARMACOL BULL, V34, P239
   Bschor T, 2003, PHARMACOPSYCHIATRY, V36, pS230
   Carney SM, 2005, ACTA PSYCHIAT SCAND, V111, P7, DOI 10.1111/j.1600-0447.2005.00521.x
   Charney DS, 1998, J CLIN PSYCHIAT, V59, P11
   Dager SR, 2004, ARCH GEN PSYCHIAT, V61, P450, DOI 10.1001/archpsyc.61.5.450
   DAIMON K, 1992, J AFFECT DISORDERS, V26, P191, DOI 10.1016/0165-0327(92)90015-X
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Einat Haim, 2003, Psychopharmacol Bull, V37, P47
   Goldberg JF, 2003, BIPOLAR DISORD, V5, P407, DOI 10.1046/j.1399-5618.2003.00067.x
   Goodwin F.K., 2007, MANIC DEPRESSIVE ILL
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Hahn CG, 2005, AM J PSYCHIAT, V162, P616, DOI 10.1176/appi.ajp.162.3.616
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hirschfeld RMA, 2000, J CLIN PSYCHIAT, V61, P4
   Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022
   Karadag F, 2004, BIPOLAR DISORD, V6, P253, DOI 10.1111/j.1399-5618.2004.00112.x
   KASAMATSU H, 1971, P NATL ACAD SCI USA, V68, P2252, DOI 10.1073/pnas.68.9.2252
   Kato T, 1997, BIOL PSYCHIAT, V42, P871, DOI 10.1016/S0006-3223(97)00012-7
   Kato T, 2001, J AFFECT DISORDERS, V62, P151, DOI 10.1016/S0165-0327(99)00173-1
   KATO T, 1994, J AFFECT DISORDERS, V31, P125, DOI 10.1016/0165-0327(94)90116-3
   KATO T, 1993, J AFFECT DISORDERS, V27, P53, DOI 10.1016/0165-0327(93)90097-4
   Kato T, 2000, BIPOLAR DISORD, V2, P180, DOI 10.1034/j.1399-5618.2000.020305.x
   Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300
   Krishnan KRR, 2005, PSYCHOSOM MED, V67, P1, DOI 10.1097/01.psy.0000151489.36347.18
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Ludewig S, 2005, J PSYCHIATR NEUROSCI, V30, P37
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Machado-Vieira R, 2004, PROG NEURO-PSYCHOPH, V28, P209, DOI 10.1016/j.pnpbp.2003.10.015
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250
   Merikangas Kathleen Ries, 2004, Curr Psychiatry Rep, V6, P411, DOI 10.1007/s11920-004-0004-1
   Miyamoto Y, 2002, J NEUROSCI, V22, P2335, DOI 10.1523/JNEUROSCI.22-06-02335.2002
   Munakata K, 2005, BIOL PSYCHIAT, V57, P525, DOI 10.1016/j.biopsych.2004.11.041
   Munakata K, 2004, GENOMICS, V84, P1041, DOI 10.1016/j.ygeno.2004.08.015
   Murashita J, 2000, PSYCHOL MED, V30, P107, DOI 10.1017/S0033291799001439
   NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327
   Perry W, 2001, BIOL PSYCHIAT, V50, P418, DOI 10.1016/S0006-3223(01)01184-2
   Pozzan T, 2000, CELL CALCIUM, V28, P279, DOI 10.1054/ceca.2000.0166
   Rango M, 2001, J CEREBR BLOOD F MET, V21, P85, DOI 10.1097/00004647-200101000-00011
   Rasgon N, 2005, J PSYCHIAT RES, V39, P77, DOI 10.1016/j.jpsychires.2004.05.006
   Rich BA, 2005, BIPOLAR DISORD, V7, P198, DOI 10.1111/j.1399-5618.2005.00183.x
   Ruf T, 1999, BIOL RHYTHM RES, V30, P178, DOI 10.1076/brhm.30.2.178.1422
   Sherwin CM, 1998, ANIM BEHAV, V56, P11, DOI 10.1006/anbe.1998.0836
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Simon NM, 2004, AM J PSYCHIAT, V161, P2222, DOI 10.1176/appi.ajp.161.12.2222
   Soares JC, 1997, PSYCHOPHARMACOL BULL, V33, P685
   Sobczak S, 2002, BIPOLAR DISORD, V4, P347, DOI 10.1034/j.1399-5618.2002.01217.x
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   STEINER M, 1980, ACTA PSYCHIAT SCAND, V61, P96, DOI 10.1111/j.1600-0447.1980.tb00569.x
   Stork C, 2005, MOL PSYCHIATR, V10, P900, DOI 10.1038/sj.mp.4001711
   STORLIEN LH, 1985, PHARMACOL BIOCHEM BE, V22, P119, DOI 10.1016/0091-3057(85)90494-0
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Washizuka S, 2004, BIOL PSYCHIAT, V56, P483, DOI 10.1016/j.biopsych.2004.07.004
   World Health Organization, 1992, ICD 10 INT STAT CLAS
   Yamawaki S, 1996, J PSYCHIATR NEUROSCI, V21, P321
   YOUNG LT, 1994, BIOL PSYCHIAT, V35, P121, DOI 10.1016/0006-3223(94)91201-7
   Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333
NR 67
TC 127
Z9 148
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1359-4184
EI 1476-5578
J9 MOL PSYCHIATR
JI Mol. Psychiatr.
PD JUN
PY 2006
VL 11
IS 6
BP 577
EP 593
DI 10.1038/sj.mp.4001824
PG 17
WC Biochemistry & Molecular Biology; Neurosciences; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry
GA 047RB
UT WOS:000237895300008
PM 16619054
DA 2024-11-01
ER

PT J
AU Peter, B
   Falkenberg, M
AF Peter, Bradley
   Falkenberg, Maria
TI TWINKLE and Other Human Mitochondrial DNA Helicases: Structure, Function
   and Disease
SO GENES
LA English
DT Review
DE mitochondria; mtDNA; replication; PEO; TWINKLE
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; HUMAN PIF1 HELICASE; N-TERMINAL
   DOMAIN; ONSET SPINOCEREBELLAR ATAXIA; STRUCTURE-FUNCTION DEFECTS;
   G-QUADRUPLEX DNA; BINDING-PROTEIN; CRYSTAL-STRUCTURE; LINKER REGION;
   MULTIPLE DELETIONS
AB Mammalian mitochondria contain a circular genome (mtDNA) which encodes subunits of the oxidative phosphorylation machinery. The replication and maintenance of mtDNA is carried out by a set of nuclear-encoded factors-of which, helicases form an important group. The TWINKLE helicase is the main helicase in mitochondria and is the only helicase required for mtDNA replication. Mutations in TWINKLE cause a number of human disorders associated with mitochondrial dysfunction, neurodegeneration and premature ageing. In addition, a number of other helicases with a putative role in mitochondria have been identified. In this review, we discuss our current knowledge of TWINKLE structure and function and its role in diseases of mtDNA maintenance. We also briefly discuss other potential mitochondrial helicases and postulate on their role(s) in mitochondria.
C1 [Peter, Bradley; Falkenberg, Maria] Univ Gothenburg, Dept Med Biochem & Cell Biol, POB 440, SE-40530 Gothenburg, Sweden.
C3 University of Gothenburg
RP Peter, B; Falkenberg, M (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, POB 440, SE-40530 Gothenburg, Sweden.
EM peter.bradley@gu.se; maria.falkenberg@medkem.gu.se
OI Falkenberg, Maria/0000-0001-8713-173X
FU Swedish Research Council [2018-02439]; Swedish Cancer Foundation
   [2019-816]; Knut and AliceWallenberg Foundation [KAW2017.0080]; European
   Research Council [683191]; Swedish government [ALFGBG-727491]; county
   councils, the ALF agreement [ALFGBG-727491]; European Research Council
   (ERC) [683191] Funding Source: European Research Council (ERC); Formas
   [2018-02439] Funding Source: Formas; Swedish Research Council
   [2018-02439] Funding Source: Swedish Research Council
FX The work described here was supported by the Swedish Research Council
   (2018-02439 to M.F), the Swedish Cancer Foundation (2019-816 to M.F.),
   the Knut and AliceWallenberg Foundation (KAW2017.0080 to M.F.) the
   European Research Council (683191 to M.F.) and grants from the Swedish
   state under the agreement between the Swedish government and the county
   councils, the ALF agreement (ALFGBG-727491 to M.F.).
CR Ahnert P, 1997, J BIOL CHEM, V272, P32267, DOI 10.1074/jbc.272.51.32267
   ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348
   Antonicka H, 2015, CELL REP, V10, P920, DOI 10.1016/j.celrep.2015.01.030
   Ariza A, 2005, NUCLEIC ACIDS RES, V33, P1465, DOI 10.1093/nar/gki288
   Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200
   Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353
   Bannwarth S, 2016, MITOCHONDRION, V30, P126, DOI 10.1016/j.mito.2016.02.005
   Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008
   BOGENHAGEN D, 1978, J MOL BIOL, V119, P69, DOI 10.1016/0022-2836(78)90270-X
   Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003
   Borowski LS, 2013, NUCLEIC ACIDS RES, V41, P1223, DOI 10.1093/nar/gks1130
   Boulé JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199
   BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766
   Butler TJ, 2020, HUM MOL GENET, V29, P1292, DOI 10.1093/hmg/ddaa043
   Byrd AK, 2017, BIOCHEM SOC T, V45, P1159, DOI 10.1042/BST20170096
   Chen H, 2010, ANN NY ACAD SCI, V1201, P21, DOI 10.1111/j.1749-6632.2010.05615.x
   Chen PL, 2013, ONCOGENE, V32, P1193, DOI 10.1038/onc.2012.120
   Chen XJ, 2013, MICROBIOL MOL BIOL R, V77, P476, DOI 10.1128/MMBR.00007-13
   Chi ZF, 2012, INT J BIOCHEM CELL B, V44, P1942, DOI 10.1016/j.biocel.2012.07.016
   Corn JE, 2008, NAT STRUCT MOL BIOL, V15, P163, DOI 10.1038/nsmb.1373
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101
   Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037
   Croteau DL, 2012, AGING CELL, V11, P456, DOI 10.1111/j.1474-9726.2012.00803.x
   De S, 2012, J CELL SCI, V125, P2509, DOI 10.1242/jcs.101501
   de Souza-Pinto NC, 2010, MECH AGEING DEV, V131, P503, DOI 10.1016/j.mad.2010.04.009
   Del Dotto V, 2020, J CLIN INVEST, V130, P108, DOI 10.1172/JCI128514
   Delagoutte E, 2001, BIOCHEMISTRY-US, V40, P4459, DOI 10.1021/bi001306l
   Dmochowska A, 1999, ACTA BIOCHIM POL, V46, P155, DOI 10.18388/abp.1999_4193
   DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116
   Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508
   Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08
   Echaniz-Laguna A, 2010, NEUROGENETICS, V11, P21, DOI 10.1007/s10048-009-0202-4
   Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011
   Falkenberg M, 1997, J BIOL CHEM, V272, P22766, DOI 10.1074/jbc.272.36.22766
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Farr CL, 1999, J BIOL CHEM, V274, P14779, DOI 10.1074/jbc.274.21.14779
   Fekete B, 2019, BMC MED GENET, V20, DOI 10.1186/s12881-019-0934-4
   Fernández-Millán P, 2015, NUCLEIC ACIDS RES, V43, P4284, DOI 10.1093/nar/gkv189
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39
   Fusté JM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004832
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Futami K, 2007, BIOL PHARM BULL, V30, P1685, DOI 10.1248/bpb.30.1685
   Gao Y, 2019, SCIENCE, V363, P835, DOI 10.1126/science.aav7003
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   George T, 2009, NUCLEIC ACIDS RES, V37, P6491, DOI 10.1093/nar/gkp671
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Gottschalk ME, 1996, AM J MED GENET, V65, P274, DOI 10.1002/(SICI)1096-8628(19961111)65:4<274::AID-AJMG5>3.0.CO;2-P
   GRAY H, 1992, J BIOL CHEM, V267, P5835
   Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303
   Hagström E, 2014, NUCLEIC ACIDS RES, V42, P1111, DOI 10.1093/nar/gkt969
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   Howell N, 1996, AM J HUM GENET, V59, P749
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Imamura O, 2003, P NATL ACAD SCI USA, V100, P8193, DOI 10.1073/pnas.1431624100
   Jemt E, 2011, NUCLEIC ACIDS RES, V39, P9238, DOI 10.1093/nar/gkr653
   Jia PP, 2017, DNA REPAIR, V59, P9, DOI 10.1016/j.dnarep.2017.09.001
   Kaur P, 2020, J BIOL CHEM, V295, P5564, DOI 10.1074/jbc.RA120.012795
   Kazak L, 2013, NUCLEIC ACIDS RES, V41, P2354, DOI 10.1093/nar/gks1347
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Keller H, 2014, NUCLEIC ACIDS RES, V42, P12614, DOI 10.1093/nar/gku993
   Khan I, 2016, J BIOL CHEM, V291, P14324, DOI 10.1074/jbc.M115.712026
   Khidr L, 2008, J BIOL CHEM, V283, P27064, DOI 10.1074/jbc.M802991200
   Kitao S, 1998, GENOMICS, V54, P443, DOI 10.1006/geno.1998.5595
   Kong DC, 1996, EMBO J, V15, P2010, DOI 10.1002/j.1460-2075.1996.tb00552.x
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kulczyk AW, 2017, P NATL ACAD SCI USA, V114, pE1848, DOI 10.1073/pnas.1701252114
   Kusakabe T, 1996, J BIOL CHEM, V271, P19563, DOI 10.1074/jbc.271.32.19563
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873
   Lee SJ, 2006, J BIOL CHEM, V281, P25841, DOI 10.1074/jbc.M604602200
   Lee SJ, 2012, J BIOL CHEM, V287, P39030, DOI 10.1074/jbc.M112.414151
   Lee SJ, 2004, J BIOL CHEM, V279, P23384, DOI 10.1074/jbc.M400857200
   Lee SR, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8060949
   LeGac NT, 1996, J BIOL CHEM, V271, P21645
   Lin WQ, 2013, EMBO J, V32, P1425, DOI 10.1038/emboj.2013.88
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Loparo JJ, 2011, P NATL ACAD SCI USA, V108, P3584, DOI 10.1073/pnas.1018824108
   Marino F, 2016, SCI REP-UK, V6, DOI 10.1038/srep21501
   Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   Matsushima Y, 2009, BBA-BIOENERGETICS, V1787, P290, DOI 10.1016/j.bbabio.2008.11.005
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0652-7
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Minczuk M, 2002, YEAST, V19, P1285, DOI 10.1002/yea.906
   Morino H, 2014, NEUROLOGY, V83, P2054, DOI 10.1212/WNL.0000000000001036
   Muftuoglu M, 2014, MITOCHONDRION, V17, P164, DOI 10.1016/j.mito.2014.03.007
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811
   Notarnicola SM, 1997, J BIOL CHEM, V272, P18425, DOI 10.1074/jbc.272.29.18425
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   O'Shea VL, 2014, CURR OPIN STRUC BIOL, V25, P16, DOI 10.1016/j.sbi.2013.11.006
   Oliveira MT, 2011, J BIOL CHEM, V286, P40649, DOI 10.1074/jbc.M111.289983
   Patel SS, 2011, CURR OPIN CHEM BIOL, V15, P595, DOI 10.1016/j.cbpa.2011.08.003
   Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651
   PERRAULT M, 1951, Bull Mem Soc Med Hop Paris, V67, P79
   Peter B, 2019, HUM MOL GENET, V28, P1090, DOI 10.1093/hmg/ddy415
   Picha KM, 2000, BIOCHEMISTRY-US, V39, P6401, DOI 10.1021/bi992857i
   Pierce SB, 2016, CSH MOL CASE STUD, V2, DOI 10.1101/mcs.a001107
   Piro-Mégy C, 2020, J CLIN INVEST, V130, P143, DOI 10.1172/JCI128513
   Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908
   Rajala N, 2014, NUCLEIC ACIDS RES, V42, P952, DOI 10.1093/nar/gkt988
   Ramanagoudr-Bhojappa R, 2013, NUCLEIC ACIDS RES, V41, P1029, DOI 10.1093/nar/gks1088
   Ramos ES, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008085
   Remtulla S, 2019, PEDIATR NEUROL, V90, P61, DOI 10.1016/j.pediatrneurol.2018.08.007
   ROBBERSO.DL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Sanders CM, 2010, BIOCHEM J, V430, P119, DOI 10.1042/BJ20100612
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7
   Sedlackova H, 2015, DNA REPAIR, V30, P80, DOI 10.1016/j.dnarep.2015.02.020
   Sen D, 2016, NUCLEIC ACIDS RES, V44, P4200, DOI 10.1093/nar/gkw098
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007
   Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300
   Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5
   Snow BE, 2007, MOL CELL BIOL, V27, P1017, DOI 10.1128/MCB.01866-06
   Sparks MA, 2019, NUCLEIC ACIDS RES, V47, P8595, DOI 10.1093/nar/gkz608
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282
   Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Suzuki T, 2009, J BIOCHEM, V146, P327, DOI 10.1093/jb/mvp074
   Szczesny RJ, 2007, BIOL CELL, V99, P323, DOI 10.1042/BC20060108
   Szczesny RJ, 2013, BBA-GENE REGUL MECH, V1829, P842, DOI 10.1016/j.bbagrm.2013.02.009
   Szczesny RJ, 2010, NUCLEIC ACIDS RES, V38, P279, DOI 10.1093/nar/gkp903
   TAPPER DP, 1981, J BIOL CHEM, V256, P5109
   Taylor RW, 2007, CELL, V130, P211, DOI 10.1016/j.cell.2007.07.002
   Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TSURUMI C, 1990, BIOCHEM BIOPH RES CO, V169, P136, DOI 10.1016/0006-291X(90)91444-W
   Tu YT, 2015, CELL REP, V10, P854, DOI 10.1016/j.celrep.2015.01.033
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Valgardsdottir R, 2001, J BIOL CHEM, V276, P32056, DOI 10.1074/jbc.M011629200
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Wallen JR, 2017, STRUCTURE, V25, P157, DOI 10.1016/j.str.2016.11.019
   Wang JT, 2014, CELL REP, V7, P848, DOI 10.1016/j.celrep.2014.03.037
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825
   Weissman L, 2007, NEUROSCIENCE, V145, P1318, DOI 10.1016/j.neuroscience.2006.08.061
   Wu JH, 2008, DEV BIOL, V323, P130, DOI 10.1016/j.ydbio.2008.08.006
   Xu XH, 2009, EMBO J, V28, P568, DOI 10.1038/emboj.2009.13
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang DH, 2006, NUCLEIC ACIDS RES, V34, P1393, DOI 10.1093/nar/gkl029
   Zhang Y, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/37/374101
   Zheng HJ, 2015, STEM CELLS DEV, V24, P372, DOI 10.1089/scd.2014.0077
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
   Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079
   Ziebarth TD, 2010, J BIOL CHEM, V285, P14639, DOI 10.1074/jbc.M109.099663
NR 168
TC 35
Z9 37
U1 1
U2 17
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD APR
PY 2020
VL 11
IS 4
AR 408
DI 10.3390/genes11040408
PG 21
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA LT7CM
UT WOS:000537224600102
PM 32283748
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Laloi-Michelin, M
   Virally, M
   Jardell, C
   Meas, T
   Ingster-Moati, I
   Lombès, A
   Massin, P
   Chabriat, H
   Tielmans, A
   Mikol, J
   Guillausseau, PJ
AF Laloi-Michelin, M
   Virally, M
   Jardell, C
   Meas, T
   Ingster-Moati, I
   Lombès, A
   Massin, P
   Chabriat, H
   Tielmans, A
   Mikol, J
   Guillausseau, PJ
TI Kearns Sayre syndrome:: an unusual form of mitochondrial diabetes
SO DIABETES & METABOLISM
LA English
DT Article
DE Kearns Sayre syndrome; mitochondrial DNA; mitochondrial diabetes;
   monogenic diabetes
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; DNA DELETIONS; MUTATION;
   PATHOLOGY; MELLITUS; GENE
AB Kearns Sayre syndrome (KSS) is a mitochondrial disorder characterized by the emergence before age 20 of progressive external ophthalmoplegia, pigmentary retinopathy, together with other heterogeneous clinical manifestations, including cardiac conduction defects, muscle abnormalities and endocrinopathies. KSS is associated with large heteroplasmic deletions in mitochondrial DNA. We report the case of a 43-year-old woman, with diabetes mellitus as a first manifestation at age 19. Later, she exhibited bilateral ptosis and external ophthalmoplegia with progressive worsening. DNA analysis identified a large mitochondrial DNA ((mt)DNA) deletion, which confirmed the diagnosis of KSS. By reporting this case with diabetes mellitus as first manifestation,we aim at emphasizing problems of diagnosis in these subtypes of mitochondrial diabetes.
C1 Hop Lariboisiere, Dept Internal Med Diabet & Metab Dis, AP HP, F-75010 Paris, France.
   Grp Hosp Pitie Salpetriere, INSERM, U582, F-75013 Paris, France.
   Hop Lariboisiere, Dept Biophys, F-75010 Paris, France.
   Hop Lariboisiere, Dept Ophthalmol, F-75010 Paris, France.
   Hop Lariboisiere, Dept Neurol, F-75010 Paris, France.
   Hop Lariboisiere, Dept Pathol, F-75010 Paris, France.
C3 Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Sorbonne
   Universite; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et
   de la Recherche Medicale (Inserm); Universite Paris Cite; Assistance
   Publique Hopitaux Paris (APHP); Hopital Universitaire
   Lariboisiere-Fernand-Widal - APHP; Assistance Publique Hopitaux Paris
   (APHP); Universite Paris Cite; Hopital Universitaire
   Lariboisiere-Fernand-Widal - APHP; Universite Paris Cite; Assistance
   Publique Hopitaux Paris (APHP); Hopital Universitaire
   Lariboisiere-Fernand-Widal - APHP; Assistance Publique Hopitaux Paris
   (APHP); Universite Paris Cite; Hopital Universitaire
   Lariboisiere-Fernand-Widal - APHP
RP Hop Lariboisiere, Dept Internal Med Diabet & Metab Dis, AP HP, 2,Rue Ambroise Pare, F-75010 Paris, France.
EM marie.laloi-michelin@lrb.ap-hop-paris.fr
RI Lombes, Anne/G-4684-2014; Chabriat, Hugues/G-5699-2010
OI Chabriat, Hugues/0000-0001-8436-6074
CR ASHCROFT E, 1992, INSULIN MOL BIOL PAT, P97
   Barragán-Campos HM, 2005, ARCH NEUROL-CHICAGO, V62, P737, DOI 10.1001/archneur.62.5.737
   Boles RG, 1998, EUR J PEDIATR, V157, P643, DOI 10.1007/s004310050902
   Choi C, 2000, YONSEI MED J, V41, P676, DOI 10.3349/ymj.2000.41.5.676
   De Block CEM, 2004, EXP CLIN ENDOCR DIAB, V112, P80, DOI 10.1055/s-2004-815754
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   HARVEY JN, 1992, CLIN ENDOCRINOL, V37, P97, DOI 10.1111/j.1365-2265.1992.tb02289.x
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   KISHIMOTO M, 1995, DIABETOLOGIA, V38, P193, DOI 10.1007/s001250050270
   Marín-García J, 2002, PEDIATR NEUROL, V27, P213, DOI 10.1016/S0887-8994(02)00426-5
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   OKA Y, 1993, LANCET, V342, P527, DOI 10.1016/0140-6736(93)91649-7
   POULTON J, 1995, DIABETOLOGIA, V38, P868, DOI 10.1007/s001250050366
   REICHMANN H, 1991, EUR NEUROL, V31, P108, DOI 10.1159/000116656
   ROBERTSON WC, 1979, ARCH NEUROL-CHICAGO, V36, P711, DOI 10.1001/archneur.1979.00500470081017
   Rubi-Palomares I, 2002, An Esp Pediatr, V56, P180
   SCHNITZLER ER, 1979, NEUROLOGY, V29, P1172, DOI 10.1212/WNL.29.8.1172
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
NR 19
TC 20
Z9 22
U1 0
U2 2
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 1262-3636
EI 1878-1780
J9 DIABETES METAB
JI Diabetes Metab.
PD APR
PY 2006
VL 32
IS 2
BP 182
EP 186
DI 10.1016/S1262-3636(07)70267-7
PG 5
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 039OR
UT WOS:000237316600012
PM 16735969
DA 2024-11-01
ER

PT J
AU Scarcella, S
   Dell'Arti, L
   Gagliardi, D
   Magri, F
   Govoni, A
   Velardo, D
   Mainetti, C
   Minorini, V
   Ronchi, D
   Piga, D
   Comi, GP
   Corti, S
   Meneri, M
AF Scarcella, Simone
   Dell'Arti, Laura
   Gagliardi, Delia
   Magri, Francesca
   Govoni, Alessandra
   Velardo, Daniele
   Mainetti, Claudia
   Minorini, Valeria
   Ronchi, Dario
   Piga, Daniela
   Comi, Giacomo Pietro
   Corti, Stefania
   Meneri, Megi
TI Ischemic optic neuropathy as first presentation in patient with m.3243 A
   &gt; G MELAS classic mutation
SO BMC NEUROLOGY
LA English
DT Article
DE Optic neuropathy; Mitochondrial disease; MELAS; Stroke-like episodes;
   NAION
ID LACTIC-ACIDOSIS; MITOCHONDRIAL
AB BackgroundMitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is a systemic disorder in which multi-organ dysfunction may occur from mitochondrial metabolism failure. Maternally inherited mutations in the MT-TL1 gene are the most frequent causes for this disorder. Clinical manifestations may include stroke-like episodes, epilepsy, dementia, headache and myopathy. Among these, acute visual failure, usually in association with cortical blindness, can occur because of stroke-like episodes affecting the occipital cortex or the visual pathways. Vision loss due to optic neuropathy is otherwise considered a typical manifestation of other mitochondrial diseases such as Leber hereditary optic neuropathy (LHON).Case presentationHere we describe a 55-year-old woman, sister of a previously described patient with MELAS harbouring the m.3243A > G (p.0, MT-TL1) mutation, with otherwise unremarkable medical history, that presented with subacute, painful visual impairment of one eye, accompanied by proximal muscular pain and headache. Over the next weeks, she developed severe and progressive vision loss limited to one eye. Ocular examination confirmed unilateral swelling of the optic nerve head; fluorescein angiography showed segmental perfusion delay in the optic disc and papillary leakage. Neuroimaging, blood and CSF examination and temporal artery biopsy ruled out neuroinflammatory disorders and giant cell arteritis (GCA). Mitochondrial sequencing analysis confirmed the m.3243A > G transition, and excluded the three most common LHON mutations, as well as the m.3376G > A LHON/MELAS overlap syndrome mutation. Based on the constellation of clinical symptoms and signs presented in our patient, including the muscular involvement, and the results of the investigations, the diagnosis of optic neuropathy as a stroke-like event affecting the optic disc was performed. L-arginine and ubidecarenone therapies were started with the aim to improve stroke-like episode symptoms and prevention. The visual defect remained stable with no further progression or outbreak of new symptoms.ConclusionsAtypical clinical presentations must be always considered in mitochondrial disorders, even in well-described phenotypes and when mutational load in peripheral tissue is low. Mitotic segregation of mitochondrial DNA (mtDNA) does not allow to know the exact degree of heteroplasmy existent within different tissue, such as retina and optic nerve. Important therapeutic implications arise from a correct diagnosis of atypical presentation of mitochondrial disorders.
C1 [Scarcella, Simone; Gagliardi, Delia; Govoni, Alessandra; Velardo, Daniele; Ronchi, Dario; Comi, Giacomo Pietro; Corti, Stefania; Meneri, Megi] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat DEPT, Neurosci Sect, Via Francesco Sforza 35, I-20122 Milan, Italy.
   [Scarcella, Simone; Gagliardi, Delia; Piga, Daniela; Corti, Stefania; Meneri, Megi] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurol Unit, Milan, Italy.
   [Dell'Arti, Laura; Minorini, Valeria] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Ophthalmol Unit, Milan, Italy.
   [Magri, Francesca; Mainetti, Claudia; Ronchi, Dario; Comi, Giacomo Pietro] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Neurosci, Neuromuscular & Rare Dis Unit, I-20122 Milan, Italy.
C3 University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico;
   IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale
   Maggiore Policlinico
RP Meneri, M (corresponding author), Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat DEPT, Neurosci Sect, Via Francesco Sforza 35, I-20122 Milan, Italy.; Meneri, M (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurol Unit, Milan, Italy.
EM megi.meneri@unimi.it
RI Dell'Arti, Laura/AAB-9520-2019; Scarcella, Simone/AAK-2580-2021; Corti,
   Stefania/K-6034-2016; Govoni, Alessandra/K-7944-2016; Magri,
   Francesca/K-5739-2016; Gagliardi, Delia/AAD-6240-2021; Ronchi,
   Dario/K-8011-2016
OI MENERI, MEGI/0000-0002-3429-1809
FU Universita degli Studi di Milano within the CRUI-CARE Agreement; Italian
   Ministry of Health (Ministero della Salute); Foundation IRCCS Ca' Granda
   Ospedale Maggiore Policlinico Grant Ricerca Corrente 2022
FX Open access funding provided by Universita degli Studi di Milano within
   the CRUI-CARE Agreement. This work was partially supported by Italian
   Ministry of Health (Ministero della Salute), Foundation IRCCS Ca' Granda
   Ospedale Maggiore Policlinico Grant Ricerca Corrente 2022 to GPC.
CR Biousse V, 2015, NEW ENGL J MED, V372, P2428, DOI 10.1056/NEJMra1413352
   Birtel J, 2022, OPHTHALMOL RETINA, V6, P65, DOI 10.1016/j.oret.2021.02.017
   Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363
   Cho KJ, 2015, CAN J OPHTHALMOL, V50, pE85, DOI 10.1016/j.jcjo.2015.05.019
   de Laat P, 2013, OPHTHALMOLOGY, V120, P2684, DOI 10.1016/j.ophtha.2013.05.013
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Finsterer J, 2019, J NEUROL SCI, V400, P135, DOI 10.1016/j.jns.2019.03.021
   Gagliardi D, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00038
   Kisilevsley E, 2020, SURV OPHTHALMOL, V65, P294, DOI 10.1016/j.survophthal.2019.11.001
   Koenig MK, 2016, JAMA NEUROL, V73, P591, DOI 10.1001/jamaneurol.2015.5072
   Mack HG, 2018, CAN J OPHTHALMOL, V53, pE208, DOI 10.1016/j.jcjo.2017.11.010
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Shinkai A, 2021, MITOCHONDRION, V56, P47, DOI 10.1016/j.mito.2020.11.003
   Tetsuka S, 2021, METAB BRAIN DIS, V36, P2181, DOI 10.1007/s11011-021-00772-x
   Tournaire-Marques E, 2020, J FR OPHTALMOL, V43, P552, DOI 10.1016/j.jfo.2019.10.020
NR 15
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2377
J9 BMC NEUROL
JI BMC Neurol.
PD APR 24
PY 2023
VL 23
IS 1
AR 165
DI 10.1186/s12883-023-03198-3
PG 7
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA E9QE1
UT WOS:000978792900001
PM 37095452
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Zoccolella, S
   Torraco, A
   Amati, A
   Lamberti, P
   Serlenga, L
   Papa, S
   Petruzzella, V
AF Zoccolella, Stefano
   Torraco, Alessandra
   Amati, Angela
   Lamberti, Paolo
   Serlenga, Luigi
   Papa, Sergio
   Petruzzella, Vittoria
TI Unusual clinical presentation of a patient carrying a novel single 1.8
   kb deletion of mitochondrial DNA
SO FUNCTIONAL NEUROLOGY
LA English
DT Article
DE cerebellar ataxia; Kearns-Sayre syndrome; mitochondrial DNA deletion
ID KEARNS-SAYRE-SYNDROME; MUTATION
AB Kearns-Sayre syndrome (KSS) is a mitochondrial encephalomyopathy characterized by progressive external ophthalmoplegia (PEO), pigmentary retinopathy and onset before the age of 20 years. Cerebellar ataxia, as well as short stature and increased protein content in the cerebrospinal fluid, are frequent additional symptoms. A single large mitochondrial (mt) DNA deletion of 4,977 bp is the most common molecular defect in KSS. Recently, different mutations have also been associated with incomplete, KSS-like phenotypes.
   We describe the unusual clinical presentation of a patient carrying a novel 1,814-bp deletion of mtDNA. In contrast with typical KSS, the clinical picture of this patient did not include either palpebral ptosis or IPEO and was dominated by an ataxic syndrome.
C1 Univ Bari, Dept Med Biochem Med Biol & Med Phys, I-70124 Bari, Italy.
   Univ Bari, Dept Neurol Sci, I-70124 Bari, Italy.
   L Bonomo Hosp, Dept Neurol, Bari, Italy.
   Italian Res Council, Inst Biomembranes & Bioenerget, Bari, Italy.
C3 Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari
   Aldo Moro
RP Petruzzella, V (corresponding author), Univ Bari, Dept Med Biochem Med Biol & Med Phys, Piazza Giulio Cesare 11, I-70124 Bari, Italy.
EM v.petruzzella@biochem.uniba.it
RI d’Amati, Antonio/AAT-7253-2021; Torraco, Alessandra/AAA-6212-2020;
   zoccolella, stefano/AAA-2515-2020; Petruzzella, Vittoria/K-8863-2016
OI Torraco, Alessandra/0000-0002-8148-9295; Papa,
   Sergio/0000-0002-4417-1763; Petruzzella, Vittoria/0000-0001-8771-6033
CR Becher MW, 1999, HUM PATHOL, V30, P577, DOI 10.1016/S0046-8177(99)90204-6
   *EM U CTR MOL MED, 2002, MIT HUM MIT GEN DAT
   Marin-Garcia J, 2000, J CHILD NEUROL, V15, P555, DOI 10.1177/088307380001500812
   Petruzzella V, 2004, CLIN GENET, V65, P64, DOI 10.1111/j..2004.00185.x
   Pistilli D, 2003, HUM PATHOL, V34, P1058, DOI 10.1053/S0046-8177(03)00344-7
   Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741
   SCIACCO M, 1994, HUM MOL GENET, V3, P687
   Seneca S, 2001, ARCH NEUROL-CHICAGO, V58, P1113, DOI 10.1001/archneur.58.7.1113
   Tanji K, 1999, ANN NEUROL, V45, P377, DOI 10.1002/1531-8249(199903)45:3<377::AID-ANA14>3.0.CO;2-M
   Vázquez-Acevedo M, 2002, NEUROL SCI, V23, P247, DOI 10.1007/s100720200050
NR 10
TC 5
Z9 6
U1 0
U2 5
PU C I C-EDIZIONI INTERNAZIONALI SRL
PI ROME
PA CORSO TRIESTE, 42, 00198 ROME, ITALY
SN 0393-5264
J9 FUNCT NEUROL
JI Funct. Neurol.
PD JAN-MAR
PY 2006
VL 21
IS 1
BP 39
EP 41
PG 3
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 062AG
UT WOS:000238916000005
PM 16735000
DA 2024-11-01
ER

EF